<SEC-DOCUMENT>0001558370-24-003164.txt : 20240314
<SEC-HEADER>0001558370-24-003164.hdr.sgml : 20240314
<ACCEPTANCE-DATETIME>20240314073034
ACCESSION NUMBER:		0001558370-24-003164
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		161
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240314
DATE AS OF CHANGE:		20240314

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AC Immune SA
		CENTRAL INDEX KEY:			0001651625
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37891
		FILM NUMBER:		24747925

	BUSINESS ADDRESS:	
		STREET 1:		EPFL INNOVATION PARK, BUILDING B
		CITY:			1015 LAUSANNE
		STATE:			V8
		ZIP:			00000
		BUSINESS PHONE:		41 21 345 91 21

	MAIL ADDRESS:	
		STREET 1:		EPFL INNOVATION PARK, BUILDING B
		CITY:			1015 LAUSANNE
		STATE:			V8
		ZIP:			00000
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>aciu-20231231x20f.htm
<DESCRIPTION>20-F
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:aciu="http://acimume.com/20231231" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrldi="http://xbrl.org/2006/xbrldi"><head><meta content="text/html" http-equiv="content-type"/><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:EntityCentralIndexKey" id="Tc_n4TQPYT_8Ee7ClZEsTMCUw_2_1">0001651625</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:CurrentFiscalYearEndDate" id="Tc_uWL2PN3j40GgM7eE_kR8ug_3_1">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:DocumentFiscalYearFocus" id="Tc_EbslL9GZ8U-1R_6l8nGqdg_4_1">2023</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:DocumentFiscalPeriodFocus" id="Tc_LmjSJ9a_8Uq2f8CS3rIv6w_5_1">FY</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:AmendmentFlag" id="Tc_8EyFCVY0PkGv17vQ_ETVdw_6_1">false</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_N4NtcRpK7UmEpR8gT_3kcQ" name="aciu:MaturityPeriodOtherCurrentReceivables" id="Hidden_JBrWQoLofk6Gyr7gN4-sJQ">P3M</ix:nonNumeric><ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_CounterpartiesAxis_aciu_FirstCapitalPartnerGmbHMember_ysIhGOhpH0C61mPSZDx7HA" decimals="0" name="aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" id="Hidden_RHGPfxiSZ0Wm65Cc6mThNQ">1513317</ix:nonFraction><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_ShYkYUEckEG0-k_MozRQGg" name="aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod" id="Hidden_9VUHy5QxNUOhdyJftjpzFw">P3M</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_uOvzhs9BoEiLV6rS9IZVFg" name="aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod" id="Hidden_0OEUZRutDEesJMh1BBGUqQ">P90D</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_ByH_9hbrL0KcrDFzfvtYQg" name="aciu:CollaborativeAgreementJointResearchCollaborationPeriod" id="Hidden_fQR8tACVGEO4UDivdKvMdQ">P2Y</ix:nonNumeric><ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-5" name="ifrs-full:DeferredTaxLiabilities" id="Hidden_HV19mOg_skeZVhyj5rvzCA">0</ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="aciu-20231231.xsd"/></ix:references><ix:resources><xbrli:context id="Duration_1_1_2020_To_12_31_2020_ohLEZMTSR0Cbq8KqJ4eLSg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_srt_CurrencyAxis_currency_USD_6KDez0fNPESv6PiMVQDs7w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_srt_CurrencyAxis_currency_CHF_EovKNEREAkumK2wjyAvm6g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_srt_CurrencyAxis_currency_USD_fZkHo-Mvv0iaC9kcViPDDQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_srt_CurrencyAxis_currency_CHF_8K3Jpoq190ueOAUG42rgKg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LeaseholdImprovementsAndFixturesAndFittingsMember_5r6Agu4tSEaOWsUui3fyog"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LeaseholdImprovementsAndFixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_a18c9vqNJ0Gpex9n_raHoQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312030Member_O4olP_9OfE6MhoH0EV3nbQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312029Member_RxSJlFvxd0uLTKolUL3zSQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312028Member_r0Sy7JDN_k2I6y5Q8lYXcQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312027Member_1R5SXknjqkWUWP0mLRRZ_A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312026Member_iGQ4s9Lt50alrF3FP1KcQA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312025Member_1bi1vT0nc0u2Xh-S7Lt9PQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312024Member_9PsLbtvfWkWuSDEFjmSZYA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312030Member_UxPXRokBZESrDLq3Evh4eQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312029Member_AnOPccdCO0yOmasUrlkU1A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312028Member_PSDaq1Iknkqy7hP1uOdwxw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312027Member_4_H5GnUE2EO-6fMiAfFadQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312026Member_AZE5FSsJIkCOiIDjG4AMqg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312025Member_GGbghK-VE0StWeUg1GPupQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312024Member_ODQ0kdFPZUG27qH4k1wNgA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312030Member_5kb1PG5AuUO0S-gCtjrH-Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312029Member_3dOqpfnfckCEIMcHBimfcQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312028Member__3-rt4ONB0WjYegP6jLv5A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312027Member_focY9wr8pUGC-t4W6eLn8w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312026Member_R-5b-bEhfk2AijECdFfhAg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312025Member_qeqHInhEQkOUN0SZFu9S6g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312024Member_aAlt2XZpC0uOboJTpNYv4g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_R3OS4EvnIk6VR8SwYkbQTw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_RegulatoryAndSalesBasedMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_dbU2qmyhJ0Wd2ybcWsnSQQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:RegulatoryAndSalesBasedMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_MilestonePaymentsCommercialMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_I-ylj3lgB0ySClC4h_2t1A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:MilestonePaymentsCommercialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_KLZBu4QGhUm541e0XMZ9xA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:MilestonePaymentsClinicalAndRegulatoryMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_ClinicalMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_URY6Jrdr0k-HLTt2WogjzA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:ClinicalMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_w6UU7BFQQ02Es-wkhoNeRA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_MFct5TYRLEOKaNzhRr9ydA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_eiJAYeQIpEq75LD86tbZwQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aciu:AssetAcquisitionsAxis">aciu:ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:IprDIntangibleAssetAssociatedWithAci7104.056Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_axPzzAyDNE2qnFNbJxmuAw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_3hsE5ajj2EqsW8OwqIjDRQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_zn6P6shP0UCItAsEakOVgw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_FgXJNffw_kyxmi2k_Q8KhQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_-Hj-hSllxE-LEUa_Gmj16A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_ezBq1LNFIUGJdNTu7a4HwQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_Y2dI5zRkP0aEdOSvnjsAaA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_Ecik1PzbbE2L7iBY1hl-Tg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_w5Il_SwGi0K8Y_peNUATtA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_mEjjRoDiAEuxYNk_x45n1g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_kiGHGOXq1EeHpusggsUgOg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_MOvL_KRv-0GMjYdNMWJfSw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_12_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_bZFp8RtyQk6ZpSOXniefvg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfContractsAxis_aciu_OtherAgreementMember_V2ITfmJTz0yHhlWkR5uY7A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:OtherAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_BnlIEVOTy0C3K8dqAK4rRg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_FFPrWYguC0WQvj3Hxaw5Vg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2022_To_9_30_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_hMfnkYwHjk67Rec2qW4oRA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_oPmjvi14mk-DBu82Bl8nzQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_l0LL76dIKke62bpBgsqmmQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_lCg_5YHbNEWrV3IHIK-hlw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_OtherAgreementMember_jXhHVI8hAkaS4H4FPEcpag"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:OtherAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_-kkhAXq1C0GMDfXoDk10TQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_RcIGZbdaj0SjODk2XEasNg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_8EC0rLfa2kiP5VlheRCDlg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_VGUKHPz2X0mctIHDOt8IbQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_WpYdq5tOqkCYnWaYgg7hoQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_OtherAgreementMember_kOOLpfgr3EGhGolAWb9Uwg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:OtherAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_VvfAYTJbdkC0T1wF_MSJTg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_jafX0AFm5kKHcXl4f6GawA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_RightOfUseLicenseMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_oqIIqklRBUe5UQlvHuNHMA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:RightOfUseLicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_l5M7oS6RAUSbE60FpTK73g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_23_2019_To_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_ResearchAndDevelopmentMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_N22GJ9LsrUiWJLyFN-RIXQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:ResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-23</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_23_2019_To_1_23_2019_ifrs-full_PerformanceObligationsAxis_aciu_RightOfUseLicenseMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_bs5y_HFUuE2bgfNkGXeFQQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:RightOfUseLicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-23</xbrli:startDate><xbrli:endDate>2019-01-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_12_31_2015_To_12_31_2015_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_7HL2iR7LZEGx9pYpDWzsWg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-12-31</xbrli:startDate><xbrli:endDate>2015-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_12_1_2014_To_12_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_zDLbltOLTEaxOQqGKQjBBw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-12-01</xbrli:startDate><xbrli:endDate>2014-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_31_2020_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_gl9YWNvWuka0-golVkbkyA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aciu:SkaneUniversityHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AlphaSynucleinPetImagingDiagnosticAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_31_2020_ifrs-full_CounterpartiesAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_QTd8z-CMpECa_iMHqUPauA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">aciu:SkaneUniversityHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_vQvK76RUJ0KnStBAGwXxYA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillySecondAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_0EMLps-d40CSIT6HT2so_w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:March312020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillySecondAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_76PTD23ZjE2mpl9bl8usJw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:March312020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyFirstAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_ifrs-full_MaturityAxis_aciu_Quarter32019Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_G-GdzKub6UqJhnJZLbz4Xw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:Quarter32019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyFirstAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_nsmmt4NryUSnwKwUgB5e9A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:March312020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyFirstAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_pNs8WMywAEOk7jBfV42CCg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_iv5cJCl-0E6vtlPSj3s5AQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_Y_Ay0M36UkuaBV4tSfcAjg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_jydRYd9OWEWk671dwbd0rw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember__IeyEFArwEeikIeuLj91BA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_DuVSPEFd10mbFQqwmoueOg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_jTG84pzUu0O1uFc9oRxVZg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_OAXVMW-Syk2ZrIbWtW1baA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_SHu6D0sv4U-6qvxwsj--IA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_ym4hANZchU2ZB9m4tnIJFw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_W50NBzU5qEa09mv6NhCP5A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_Ahyp8QOgJU6aUxLJFusyPw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_6VOKv2eGyUeHs3MGzC7vIw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_Cj6a41-HWECUkiVv0bW4qQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_g2VJr2LWH0mkATiItb2LEg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_yA_PZPRqLUu_kKp2zZYt1A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_CCFaY6n0-UeoiGMVZgAhJA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_HJ03XueB8EKX-2gIlzBjqw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_d7-guilVV0mvoM9Oa34iJg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_fJB_6ZN-dU6RdeM0v4FQzA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_Qn1sc58q206NmPfW1osPPQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_oO6Nlwpj2ECOa1vYcsigFA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_4w7KMGsDgUqUG5MpjLDW-g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_MUVGPZ2Zo0C3Z2S_N5wdKA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_0r2ljY84p02g_MFTZyXL2A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_Su1JgXKRt0O2ssj-e_25TQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_nzoCPNgdt0WOxkRNR6rgNg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_6lS4zjbF4Eac-GIZUgE2jw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_058A2xbE90SyAgqdMWXaeQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_mfV4owp-bEem-93-p6NYFQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_NZr3F8nBAUuCT_VetHuh3A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_oYg1VVE1MUmNWowfojvvlw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_unPNYQAq0U61GM9DA5BHWQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_F9b8H9FLJ02EvHvZhkDIBA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_obdYBDyo_E-bUxAogvIKSw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_Bj1308vFcUO5rHCNyanwEg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_15_CvNFzPUOQfoII6rlmNA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_IfzHfIthHkO6dbcYO8zgwg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_9RCvElW3fUCypuHlovaGjA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_eU6vEoc2fEeUkwgp4Q4hyA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_n8Zissrm5UiC3zmhjJsmyw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_xOhhxIMNr063CjxwJupX8w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Bpznvb8IJkGFAZJKePilRQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_qq5UY0wRK0iOGrB4wG2l3A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_AlsPMZbssk6ZJn1U2wtykg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_k-R7euyY30qLrbKzofgXgw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember_IjKN6eosDESMY_UjEdsFrQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConditionalShareCapitalForFinancingAndOtherPurposesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_Ob3729tHb0aScFgPO3DcVw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConditionalShareCapitalForEmployeeBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_JlWBK3HwBk-ZtFV9txVOUw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:AtTheMarketEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_bRpB8WDxq0WCH-NheX05aQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:AtTheMarketEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfContractsAxis_aciu_GrantRevenueMember_Kn--ZLK--EWCGZTxnKU9YQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_GrantRevenueMember_7FTossETZUGpmYwf0I08Iw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_GrantRevenueMember__Ki26gI4UUqU71aLzAD8KQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_FsucBjEq20ymDerczI9DZw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_11_1_2016_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_bPPz5P3NMUuhICp34QnZTQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-11-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_1_2016_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_5cV-aWe_h0Wf6H9bD9joXg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:EmployeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-11-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_1_2016_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_StockOptionPlanC1Member_FrVjSQB1UkeUeoCfQYkO8Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:StockOptionPlanC1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-11-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Usd5.04ToUsd12.30Member_aFkOCQ_l5E2NLCrRmzt_fg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aciu:Usd5.04ToUsd12.30Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Usd2.76ToUsd4.57Member_ei0vM12DHU2YvZXAIwnk_A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aciu:Usd2.76ToUsd4.57Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Usd2.03ToUsd2.32Member_JcYFgrKmAkGmDL6Nc1PZGw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aciu:Usd2.03ToUsd2.32Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Chf9.53Member_QyUb_OU0dUmrWfmJfQRjJA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aciu:Chf9.53Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Chf0.15Member_bCuGS8xth02AS1EG44_CZw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aciu:Chf0.15Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_ShareOptionsMember_JiVYK5fqYUO7VCxTOIhfZA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_RestrictedShareUnitsMember_1v9vOL78NEaUqskdXpyvxQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_ShareOptionsMember_xjjfByq3kEexxYKCccxAuA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_RestrictedShareUnitsMember_7RuOmuGIaUSc_wFc7wHO3A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_ShareOptionsMember_hb7EZRsk9k2Xc_o9Y1Cx3w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_RestrictedShareUnitsMember_xIISRYveiEabLLH78AYB7w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_ConvertibleInstrumentsMember_fIduMxC3S0aqyPa52saM_A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ConvertibleInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_16_2016_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_9q9dI6YGDkGRYsQk62I2nA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:ExecutiveManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-11-16</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_16_2016_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_la6xlFr4Qk-ItVH571xacw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:EmployeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-11-16</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_16_2016_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_BoardOfDirectorsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_Mg69nDEnSECdfeZEURGoNw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:BoardOfDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-11-16</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_JjEtusAETU-e1_9QP3d1Ig"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_1XJ24mu0_k2BAymKVrDuJA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_VqvB-19b-ky0XrrBCaxruQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_WNkxs9Sy4kSxSAoCQwsxGw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_8zOs7UR4806DfHazcSGULA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_lp_ntzhbq0OJga_mHVbrOw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_ncAHP2PXEEG29m0kCbCu1w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_v1U_eyxTiEaM8eTayPpQkw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_Aj1yGEPLv0OsHOLlVg5leg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_HTCG4hUqoUOTQ98ao4z1DA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_bOl8wEKNyEqYyzQR0ioW-w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_ml_R3Ylar0-YvNfrWq7Svg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_41heKF3EykimTDNXOnweeg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_s9rQXTEfUUmFpg2sTDXMlQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_MVjsqGrUmkGNOKc737qEYQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_CaCTeKx2c0qPmNfApsv9IQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_xfEun2NfTUKZr40nuUKpOA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_GjTctvZEfEW6pg7_LZJEHA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember__d04PmuBgEKP0NcNI_xEpg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_aGfEhz_sAkK6Z9G5vRsASQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_E9kBrJ2W50Sic6i55dJjIg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_LiquidityRiskMember_I2s7qAhdwEmG_1icOvNOVw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:TradeAndOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_LiquidityRiskMember_7cEHP4wXJk6XdglcX0L3aA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:AccruedExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_oD9AY5W7QE2lsvFz7v9VSA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:TradeAndOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_ShortTermLeaseLiabilitiesMember_9v_cqh_W1kSGuzLlAQyFFQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:ShortTermLeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_LongTermLeaseLiabilitiesMember_hTP2bhts4kGVi8zQZgg2Lw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:LongTermLeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_V5SiFGlhwU2nqSRCE0iIlg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:AccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_hN_4u153REGiz2cDaHHvaQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:TradeAndOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_ShortTermLeaseLiabilitiesMember_7EJHTDPGpE2MU58MnWl9gw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:ShortTermLeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_LongTermLeaseLiabilitiesMember_iE9c6Qe9dkmCxyhOVMjHlQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:LongTermLeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_SxsHygJzykiKANoKiEryBA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:AccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_ifrs-full_TradeReceivablesMember_LwJz8BFRY0mDYAyF8DxskQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_ShortTermFinancialAssetsMember_GQvxTZCyeUSHnqXgqhDQ9g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:ShortTermFinancialAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_RightOfUseFinancialAssetsMember_8nM6TuHsfUWJ_Eb5DPpcMw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:RightOfUseFinancialAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_OtherCurrentReceivablesMember_uVd4y6WmRkq8Gnp7VhbSAg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:OtherCurrentReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_LongTermFinancialAssetsMember_2GPCrMxC3kuP50IVhioaJQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:LongTermFinancialAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_CashOnHandAndCashEquivalentsMember_Tt_fmEFayUCvEgmVza7MFQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:CashOnHandAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_ShortTermFinancialAssetsMember_7XpjIGDTfUu8O9YtHM9T2Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:ShortTermFinancialAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_RightOfUseFinancialAssetsMember_tR8m7PTQZE-3qL6hTCbwPg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:RightOfUseFinancialAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_OtherCurrentReceivablesMember_sZ3Yzb3XREu_tDsA08-5Sw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:OtherCurrentReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_LongTermFinancialAssetsMember_Sp4G8pRwNkqsYvkUz4YI2g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:LongTermFinancialAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_CashOnHandAndCashEquivalentsMember_W820bIc2s0iHiLwstBYlKg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:CashOnHandAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_nZ4TKeIWaU2aelb5_LYCwg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_uUyHwiQf7UuXXrnxpFOqyA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_LnJjfw_Os02BiS6mZGfzUQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_VgBLVB9e1Uq5yTwvVD7SXQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_BScHwbOd1k6qH5tEPUdwhw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_gyBgxwFR8kautCu5uepUmg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EBAKwd98FkqCN-vAl_B6vg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_xRUXLA2a4UCunihbdGlUlg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_VRz4mc9TT0moisjLJVOICA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_BQ7VKwgtOkWlTCNJHXciww"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_YIPudTTsa0KFHmU0vwZo5w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_qGLJKw1KlEeLkJJRaoX5Rw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_3boVlL-e1EKk5lMRqO3nuA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_M0EemXYDV0aBwNXVy2D5wA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_N2SF2wL5eUe8CGabD_HwrA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_x2Rf-qjjC0q1OoOX5aYBuw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_4Nainf_0SEuwFd4uqOjiSQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_XpmQIKbzzk-A4QLCviO8sw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_XAtED10_YUaz8Tcq-re46w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_NtOri1sWtESc64I6yGlDKA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_pYUVZEM920exX1Cwj8qiVg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_5xasXe81HU2amQaNWKJlDA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_wEOJWOe0kkyVwPPcjL51Bg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_kZxWf5plpkyqcnxdVx9WnA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_CvwXkZmKrE2y_nrcwbCWUQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_FT-o_AOWWUmsEyj11IwpRQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_aTa03kZvVk2UVSOXZ_yZVQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_dAA0zRsjHUGlsbYsE9T1jQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_hzU9_UsRaUqQjrz3YAAlrQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_Ch-n85pVKk-WOgs80YsR9A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Wgnl3QSM2k-AdkHzUwxq5w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_8n56hl5TbUu6RGNb82sfRQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_L9p_QHOSw06twWSsiEgdWA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_pm-qrsouoE6flbV62qtS-Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_pTeQuKx_DkypZ9jWGI7C8A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_5DSHt4xHMUioT5NnjVwFog"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_iSoz2SOpp0qMTfUmXq481w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">aciu:ActuarialAssumptionOfInterestRateOnSavingsCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_SYvFKt1x10y-adlxxUg4jg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">aciu:ActuarialAssumptionOfInterestRateOnSavingsCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_982Pjk152UCG0tmlUgcu9w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_1VZZ1KUX8k2zfVZBeU_XRA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Z7UvVqXOEUmoT9JRq5CiYA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_Vku2j2aw2USeLFl-mDb8ow"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_9z7dk_eBH0qm1qbNW_X2xQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_UfDNPUrGmUWnzu7Kv8E6RQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_fdq-KvKHrE64gHajV_F_bQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">aciu:ActuarialAssumptionOfInterestRateOnSavingsCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_FSXKfZmS80elUOwthR4Uxw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">aciu:ActuarialAssumptionOfInterestRateOnSavingsCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_2nj8zIQ95U6QDxkvALWpOw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_7dWOVnOSFUq1x4XujqX_oA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RightOfUseAssetsAndLeaseLiabilitiesNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_sNU1oHf-Q0i6Of2JKbOZPA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RetirementBenefitPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_vDSFPVowe067uhYZQdHFgQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_RA7Xt4V3fUCJ2nNa8SxwcA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RightOfUseAssetsAndLeaseLiabilitiesNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_TabmlKnxSE2DHBh6lcLTdA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RetirementBenefitPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_DnkavB3_kUKnU6RtWKx2Ow"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_ikz_e9A97Ea1rUgxFPK-vg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RightOfUseAssetsAndLeaseLiabilitiesNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_vxoJ2RbCcEe-EQHCnzF_IQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RetirementBenefitPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_BxvFqCM4M0ufUbFvjtlCMQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_CounterpartiesAxis_aciu_JJInnovativeMedicineMember_vsI7p2vgBE6RmjAsmPNw1A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">aciu:JJInnovativeMedicineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_NUhuhpmnrEShL-ErqVzeXQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_CD3sQ6Iqhk-fx5WexG8VXQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_UEQ5-Qdp-ECfZVHJXapb-w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_VKrtDLypPEOuxz3CjSgM6A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_ZpFwqYls3EejWQUqS6jVtA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_vnWZvKBRW0CV9s94BbcDrg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_O05oIcvQHECcE7b4dXGvbQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_aAOfPJhSHU-AqBUvHn8pLQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_1_23_2019_ifrs-full_PerformanceObligationsAxis_aciu_ResearchAndDevelopmentMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_blE7iuHcaUG9QmZUisEt3A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:ResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_yMfhf5U-BEOkEesawNwGtw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_O8tZdJpRvEaGkATdj9JKqA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_srt_CurrencyAxis_currency_USD_hCYaW1c4MEeE5iAbGkvRtw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_srt_CurrencyAxis_currency_EUR_CKOjyw5J1Um-SGovJ4ejYw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_srt_CurrencyAxis_currency_CHF_JfNLzHvH80WbSrRE58qKYg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_srt_CurrencyAxis_currency_USD_vlpq5OPW5UKEsC2zk4jyEg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_srt_CurrencyAxis_currency_EUR_gXKgjdqF5ECk_GGPperSYA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_srt_CurrencyAxis_currency_CHF_9dJzU0_HhECZUKUigq7XAg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_kISrj4aRVketNj-9seXAtQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_WeightedAverageMember_4FG0vtdOM0qVouBNBJxDYA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_A0fLCvnZXkWCpt0V9v-hlQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_GeographicalAreasAxis_country_CH_hI8bZ3TK70-bfSp_6iHWkw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_WeightedAverageMember_X-fZxVt670yVn-ag8aFnSg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_mTTN5Hw7J0uG4plqeYxbIg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_kJ9M4JxOBEuo1siTgMfdYQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_WeightedAverageMember_ZWzC0poj30O0x-cniAS5CA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_kF_Z_GmDe0uYNVNKIyLhww"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ZaXds3ifpU6wdPGK9Rol-A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_oH_yOQmg0kGMBs0pfoK_pQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_0Jtnd8m_I0enHD9zlLU-pg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_dz45p3-Mt0Kum8kISicdTg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_JX8Xpx6XvkGjBXaj4z4PEA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_SK2Ewb7ptEmzydRvB1J-Mw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_Gl68ge7NsE6HRhfhKLgLLg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_hLWNWYEvyU-dudu8IMjYcQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_LgaMFEMN_kKAtkztR9a8KA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_jU5Jt8mUF0iciQdpO6t7sA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_SGqTYRos7Eu0uaWKvQowsQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_kkPxG2DcNk29JpuIBItYrw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember__F425--_EEOXAYSsaoxgOA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_W-r0ii74bU-k1a5qR2sk3Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_yNTxg0S0g0mhMxkN6R3p8g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_FrBVzS7Gp0e3Hgpbb7-EyQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_KQhq8CmXDUufwm79fj3u-A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_JgXeFoa0LUuPeRfQafgJng"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_46FANMS68kquMVeskjfbwA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_Ks574WurXUmKeYPNctUQnw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_u5V2Ukxsi0ip1fGh-0PIFw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_5pdQTfFdGEKkjeGhrAzNRw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_pY3XYcoQoUeP48UTVCm8pg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_E1XpL1U-zkqFSbWZ-KwCTA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_eitFANd6O0-px2XAzxnmbA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_uW0txdsBO0WLBMLzEw4mWQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_RaV3Vku3aUu2A_2JfVmVng"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember_vo7YKlf8sk2Zu9M-P0T-9A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember_nRoCAsTLTkuEeahglu5EzQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember_li18Qm89cUyqRwPnUzHoyQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanVestingTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsSecondVestingConditionsMember_E41WId3rVUaJryS3yoer-A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:ExecutiveManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsSecondVestingConditionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsFirstVestingConditionsMember_b85Kv7MimEGfeEIsinaPEA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:ExecutiveManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsFirstVestingConditionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_rCWc9moZ-UuoKzp2P9kXqQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aciu:AssetAcquisitionsAxis">aciu:ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_Xg5G0gTL6EuVoA1i-tphyA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_tP2T60QRpUq6QbSwDp-rdw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_VpbnclTokEKa1COLbTmtgQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_srt_StatementScenarioAxis_aciu_IfNotesAreConvertedMember_mHIt3iiUYEiJe-LbY2MlYg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConvertibleNoteAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">aciu:IfNotesAreConvertedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_W22DIGpxCU2PCY_voUKfnA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConditionalShareCapitalForFinancingAndOtherPurposesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_bdFBuO5wp0WWfm-NR5fv1A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConditionalShareCapitalForEmployeeBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_pAWtnvgYa0iVnloXstoYVQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConditionalShareCapitalForFinancingAndOtherPurposesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfRisksAxis_ifrs-full_InterestRateRiskMember_RtyTGF5IIEeDAR3KKFiYmQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_ItAndLaboratoryEquipmentMember_KRQK-6opkEi3py3xSmjCrA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:ItAndLaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_0CVyLgPoV0-0eUUJiC7Vxg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_QwGnbZHs2kOQD9MkvKz_JQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_12_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_AdvanceSmallMoleculePdProgramsMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember__xRQy4sDnU2wuTVhB0eVUA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AdvanceSmallMoleculePdProgramsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_wNVuSSWxUEaFOSDEm36rwg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_12_19_2023_To_12_19_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_FollowOnOfferingMember_TqOyBPKfi0OoLSsHlenN0Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:FollowOnOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-19</xbrli:startDate><xbrli:endDate>2023-12-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_T_CAdfRv-0yh8ZcvUy-2eA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:ExecutiveManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_XCIxfyCaLUqoZoXevZDdCg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:EmployeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_BoardOfDirectorsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_oEAbzyJtoEmkfKv74BICBg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:BoardOfDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_wf3hN50uXkG2UnV3ktGKUw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_L33vJ60m_km7tdKwdLwwQQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:EmployeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_StockOptionPlanC1Member_-sFGqj5mB02y1Y2vj-EJCg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:StockOptionPlanC1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_N4NtcRpK7UmEpR8gT_3kcQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_-N7k4qC--ki40tn2usH_qQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_vS7Y6wSi3Um8_4n891ZL5w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_JT6GJaAKkE28v8kpSUYthw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_BBkqnTW0KUyG6jmwGuQriQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aciu:AssetAcquisitionsAxis">aciu:ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:IprDIntangibleAssetAssociatedWithAci7104.056Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EY1gzyuyDkGmaP05xj1GQw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_orlAcRiayEeFUpKo8cWUgA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_SWcjwMgDv0e8bZSucJUMHQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_I-ActLB-JUyJBWOVjhi2gA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_6KGZQVq8r0a0vl5N0ZyV-g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_FjH3oKJjQkm4GluJmDL1ig"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_CounterpartiesAxis_aciu_FirstCapitalPartnerGmbHMember_ysIhGOhpH0C61mPSZDx7HA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConvertibleNoteAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">aciu:FirstCapitalPartnerGmbHMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_CounterpartiesAxis_aciu_AthosServiceGmbHMember_G1spMOk49EyTvfHJIEKQUA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConvertibleNoteAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">aciu:AthosServiceGmbHMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_B7geHyH670-gkbX2o14NvA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConvertibleNoteAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2021_To_9_30_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_I1T_yUrSRkSlCVKjmbusrw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:AtTheMarketEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_0AVWXMYRNE20fsfI1erXKg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_qxkJG_5AGkCst7uW2JVkmg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_BX74hOhBS0CUAeUr_BZQyA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_7S9fMiZwfUK5NJDPYOhCdA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfRisksAxis_ifrs-full_InterestRateRiskMember__VIlp5fvWECjGqiYiWCbsA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_vEGhjd8tq0OSqur2Fe4jnA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_u2Lf31padU-hQMejGWu9Jg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_-rFc59jcN0aZx3IBH9mm7A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_JOULfIYynEyk9vA-N_O54Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_BeNb7Z3yiUS-lTANhWp0_g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_NAuDi-J-j0OrVs4jx0zGUw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_8_1_2022_To_8_31_2022_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_i3ZUuVbirEiuOT-5rYcByg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aciu:SkaneUniversityHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AlphaSynucleinPetImagingDiagnosticAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_8_1_2022_To_8_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_zfR7x4gHWUCfKEves1438g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AlphaSynucleinPetImagingDiagnosticAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OfficeEquipmentMember_FZ2FsUgsLUK0QPYMKCCp5g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_5KJXBEAcDUOmq3jDvWNEeA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_aaNuoy-t_Eiw3M3BbRrSzA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6gI4nc20YE2v2UMn230IjA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_mVdbPS_pZEOvR8-xErVVJg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">aciu:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_018DD5MHx0yR9siTflNYPw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_i4oh9OLRKk237CD7aWKajQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">aciu:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_bid3n8U3yUu4WF-DywHH4Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_elQwz5L0xki93eiu__qmNA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">aciu:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_QSzyXEXHe06wEWxr_MXXgQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_IkPNS4jBTECfjFa4xwgBQQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_PEDQ9Y0GpEGR7Fz3aVtJ5Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2020_To_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_-1G5nnVneEOy-bPbsmwMqw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:AtTheMarketEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_vK1WQ4fPI0adSnT7gMpfmg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:SecondOpenMarketSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2014_To_12_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_ai62qsBmbECbBpWbHN1gqg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-01-01</xbrli:startDate><xbrli:endDate>2014-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_AdvanceSmallMoleculePdProgramsMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_BWrRdrxLXEiE2A8T_eUqAA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AdvanceSmallMoleculePdProgramsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_yFg7_K4Sj06ntHrtmFJMMw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AlphaSynucleinPetImagingDiagnosticAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_vLBVN6gNy0CM2OL-a8F6nw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyFirstAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember__-SkUIIH_UKKHcFlP4uAVA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_lWKxGd9870-RZpUwXYweFQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_uOvzhs9BoEiLV6rS9IZVFg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_wERnesaBIkyF2ZYGAWOS5g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_ShYkYUEckEG0-k_MozRQGg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_3_31_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_BPMBGqeh1UCBtCXz0LDlDg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2017_To_3_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_ufWSkNfIkECZWt_mcMr6vA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_5_1_2016_To_5_31_2016_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_z6odcKKiUk6PMIxagqtGiA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-05-01</xbrli:startDate><xbrli:endDate>2016-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_3_31_2020_To_3_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_ClmKil5lr0WdBtvIaUaFEA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillySecondAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-31</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_DUqbXvvbHUeikVmBLUHq3A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyFirstAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_ByH_9hbrL0KcrDFzfvtYQg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AlphaSynucleinPetImagingDiagnosticAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_2_1_2024_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_aciu_ReceiptOfMilestonePaymentsMember_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_zyTb0RhISEWfD4ePpEx1Hg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">aciu:ReceiptOfMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_8aUhNs9mtU-Truhn6_ij4A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aciu:AssetAcquisitionsAxis">aciu:ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_4_28_2021_To_4_28_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_wJ7EdKp2Ok2kaiso3_KHVw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-28</xbrli:startDate><xbrli:endDate>2021-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_gz-ausjwKkGgVkKLeTU3Ng"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConvertibleNoteAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_1_2023_To_2_28_2023_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_uKAhF0e3t0OofFPtWQBOnw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AlphaSynucleinPetImagingDiagnosticAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001651625</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="Unit_Standard_Institution_2XG7OWvIxkqRwCgZCSpPJw"><xbrli:measure>aciu:Institution</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg"><xbrli:measure>aciu:EquityInstruments</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_person_7ny7-oR7aEaZQqs0BxZVCQ"><xbrli:measure>aciu:person</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_segment_uSnHfk8yHkqj2bvGJo9Fng"><xbrli:measure>aciu:segment</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Divide_CHF_USD_FPtD7vL32kaT4HamUiI0aw"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Unit_Standard_employee_Y_HtOjq0F0i_9evdy7ujWw"><xbrli:measure>aciu:employee</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Unit_Divide_CHF_EUR_tPOVrZBRTEKkYMGLwOeV4w"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Unit_Standard_Y_vGNa0xS6h0m8DtazE3ChHg"><xbrli:measure>aciu:Y</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ"><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw"><xbrli:measure>aciu:Options</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_installment_NWKLjjbZOEujM9f04o9HSA"><xbrli:measure>aciu:installment</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_EUR_QpqDW6JdmEqpVHDpBHxA4g"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_agreement_5eg0SdvY8kqQI3hiVdpf-Q"><xbrli:measure>aciu:agreement</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_item_lel3bReemU2v4xdKyUvjzA"><xbrli:measure>aciu:item</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_plan_aEIYineoxU60B5qoFDN6Ig"><xbrli:measure>aciu:plan</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><div style="max-width:100%;padding-left:4.47%;padding-right:4.47%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:1pt;line-height:1.19;padding-bottom:1pt;padding-top:1pt;text-align:center;text-indent:0pt;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;">,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_cd705ee3_9683_46ee_aaf0_816037309abd"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">UNITED STATES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">SECURITIES AND EXCHANGE COMMISSION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">Washington, D.C. 20549</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">FORM&#160;</b><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:DocumentType" id="Narr_KrL4TbkElEOsGK_jxrlGwQ"><b style="font-weight:bold;">20-F</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 5pt 0pt;">(Mark One)</p><a id="_88e1fb7c_77b4_4da7_86d2_2b9c3dc3756a"></a><a id="Tc_8oB4d_FMfk2BW6vk7NpRKw_1_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:0.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:3.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:96.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:0.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:DocumentRegistrationStatement" id="Tc_Kf9RNUIisEOWhW-6G4X8Wg_1_1"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:96.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">REGISTRATION STATEMENT PURSUANT TO SECTION&#160;12(b)&#160;OR (g)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-size:5pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">OR</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_3d47ba62_f733_427f_a99d_2b7eabf70caf"></a><a id="Tc_2jXq0fxVI0eL9tUh6YeONg_1_1"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:2.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:2.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:DocumentAnnualReport" id="Tc_wVP8GHkAB0OmRXzxzC0t7g_1_0"><span style="font-family:'Segoe UI Symbol';">&#9746;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">ANNUAL REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">For the fiscal&#160;year ended </b><ix:nonNumeric format="ixt:datemonthdayyearen" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:DocumentPeriodEndDate" id="Narr_pwQRRJoKGEOoESecuGUMlA"><b style="font-weight:bold;">December&#160;31, 2023</b></ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">OR</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_4f604c73_3a6d_40ed_ad19_932c8e6eadf2"></a><a id="Tc_VR0johHZ70y6Ow3HBg-mow_1_1"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:3.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:96.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:3.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:DocumentTransitionReport" id="Tc_CRluZi6GwEWkIQDklB7HQw_1_0"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:96.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-size:5pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">OR</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_d713b36b_4603_48dd_8609_7a8c5b0e95d6"></a><a id="Tc_quFL_Y8hNEqHIVT0kiGE5g_1_1"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:3.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:96.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:3.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:DocumentShellCompanyReport" id="Tc_6pt20wBe_U6fFiD_nw9rLQ_1_0"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:96.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">SHELL COMPANY REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934 </b>Date of event requiring this shell company report</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-size:7pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">For the transition period from ____________ to ____________</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-size:7pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">Commission file number: <ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:EntityFileNumber" id="Narr_MeT-KeyF9kqCk_FVxGUXYA">001-37891</ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:EntityRegistrantName" id="Narr_6LyBJpP1gUas4DLZQRtNyA"><b style="font-weight:bold;">AC IMMUNE SA</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><i style="font-style:italic;">(Exact name of Registrant as specified in its charter)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;font-style:italic;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">N/A</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><i style="font-style:italic;">(Translation of Registrant&#8217;s name into English)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:edgarprovcountryen" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:EntityIncorporationStateCountryCode" id="Narr_pJlmJoJL00WrAAhisZiWEw"><b style="font-weight:bold;">Switzerland</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><i style="font-style:italic;">(Jurisdiction of incorporation)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:EntityAddressAddressLine1" id="Narr_NpPIpukbM0S-si9-IM4hSA"><b style="font-weight:bold;">EPFL INNOVATION PARK</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:EntityAddressAddressLine2" id="Narr_0RpKE8t44USNZZlVYiLepg"><b style="font-weight:bold;">Building B</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:EntityAddressPostalZipCode" id="Narr_jy3mLcueCUyG5A6PfJisTg"><b style="font-weight:bold;">1015</b></ix:nonNumeric><b style="font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:EntityAddressCityOrTown" id="Narr_K9B5T70GWkCMy-SwyOJqMw"><b style="font-weight:bold;">Lausanne</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:countrynameen" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:EntityAddressCountry" id="Narr_bqV2V5XGbkCVefME4e2rvg"><b style="font-weight:bold;">Switzerland</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><i style="font-style:italic;">(Address of principal executive offices)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_46FANMS68kquMVeskjfbwA" name="dei:ContactPersonnelName" id="Narr_0tV4_Y1SBU6HHNQtn-ceOQ"><b style="font-weight:bold;">Andrea Pfeifer</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Tel: +</b><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_46FANMS68kquMVeskjfbwA" name="dei:CityAreaCode" id="Narr_OauvTsufIkO52YTBIyf9nA"><b style="font-weight:bold;">41</b></ix:nonNumeric><b style="font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_46FANMS68kquMVeskjfbwA" name="dei:LocalPhoneNumber" id="Narr_8KGYefYkA0a8KoLs6RM6Og"><b style="font-weight:bold;">21 345 91 21</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_46FANMS68kquMVeskjfbwA" name="dei:EntityAddressAddressLine1" id="Narr_ywBzYpeKlkiXOnGxlQDM4w"><b style="font-weight:bold;">EPFL INNOVATION PARK</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_46FANMS68kquMVeskjfbwA" name="dei:EntityAddressAddressLine2" id="Narr_sOtY_vExNkiJzgFH_-RBVQ"><b style="font-weight:bold;">Building B</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_46FANMS68kquMVeskjfbwA" name="dei:EntityAddressPostalZipCode" id="Narr_BISRy9IK6kuzXbExCrynPw"><b style="font-weight:bold;">1015</b></ix:nonNumeric><b style="font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_46FANMS68kquMVeskjfbwA" name="dei:EntityAddressCityOrTown" id="Narr_GTW1iCwCyUS0jrYqFk6GEA"><b style="font-weight:bold;">Lausanne</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:countrynameen" contextRef="Duration_1_1_2023_To_12_31_2023_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_46FANMS68kquMVeskjfbwA" name="dei:EntityAddressCountry" id="Narr_RI9qToB6AEe-0xTBDNTEUg"><b style="font-weight:bold;">Switzerland</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><i style="font-style:italic;">(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><i style="font-style:italic;">Copies to:</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:middle;width:100%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:middle;width:100%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Derek J. Dostal</b><br/><b style="font-weight:bold;">Davis Polk&#160;&amp; Wardwell LLP</b><br/><b style="font-weight:bold;">450 Lexington Avenue</b><br/><b style="font-weight:bold;">New York, NY 10017</b><br/><b style="font-weight:bold;">(212) 450-4000</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Securities registered or to be registered pursuant to Section&#160;12(b)&#160;of the Act:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_bac46a70_3741_4d17_acf3_1bf29b7370b0"></a><a id="Tc_51tW2_mYiU2l3y3_gsO_pA_1_0"></a><a id="Tc_NygxZdZEdESGtWBImI11nA_1_2"></a><a id="Tc_w1ck3SWlrUOj8QGreyjXZw_1_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:31.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:31.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">Title of each class</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:top;width:32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">Trading Symbol</p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:top;width:32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">Name of each exchange on which registered</p></td></tr><tr><td style="vertical-align:top;width:31.99%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:Security12bTitle" id="Tc_zntIGR7qakKnwVhbt_UCaw_2_0">Common Shares, nominal value CHF 0.02 per share</ix:nonNumeric></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:TradingSymbol" id="Tc_Rzx3U_pRGkWjj0dyurHHcg_2_2">ACIU</ix:nonNumeric></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:exchnameen" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:SecurityExchangeName" id="Tc_7MPHqy97dEGU5B6cvwuscA_2_4">The Nasdaq Stock Market LLC</ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-size:5pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:91.06%;border:0;margin:30pt 4.47% 30pt 4.47%;"></div><div style="max-width:100%;padding-left:4.47%;padding-right:4.47%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Securities registered or to be registered pursuant to Section&#160;12(g)&#160;of the Act:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">None</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Securities for which there is a reporting obligation pursuant to Section&#160;15(d)&#160;of the Act:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">None</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Indicate the number of outstanding shares of each of the issuer&#8217;s classes of capital stock or common stock as of the close of the period covered by the annual report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">Common shares: <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="Narr_1Bkof3hECkm0lbvXx0O66A">99,197,829</ix:nonFraction></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span> Yes <span style="font-family:'Segoe UI Symbol';">&#9746;</span> <ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:EntityWellKnownSeasonedIssuer" id="Narr_Y75PeUWdjE6_tEW09MaiMw">No</ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or 15(d)&#160;of the Securities Exchange Act&#160;of&#160;1934.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span> Yes <span style="font-family:'Segoe UI Symbol';">&#9746;</span> <ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:EntityVoluntaryFilers" id="Narr_oVisrm9tMUyqs5DjXjH3Qw">No</ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Note&#160;&#8211; Checking the box above will not relieve any registrant required to file reports pursuant to Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 from their obligations under those Sections.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9746;</span> <ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:EntityCurrentReportingStatus" id="Narr_clS8XpqEoUOX8a-Xd1O3ig">Yes</ix:nonNumeric> <span style="font-family:'Segoe UI Symbol';">&#9744;</span> No</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9746;</span> <ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:EntityInteractiveDataCurrent" id="Narr_o52whONl4EegXDzUIcBsBg">Yes</ix:nonNumeric> <span style="font-family:'Segoe UI Symbol';">&#9744;</span> No</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:32.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:32.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">Large accelerated filer <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td><td style="vertical-align:top;width:32.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="Narr_TIGO7rBbrkGbgBimUw-cxA">Accelerated filer</ix:nonNumeric> <span style="font-family:'Segoe UI Symbol';">&#9746;</span></p></td><td style="vertical-align:top;width:32.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">Non-accelerated filer <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td></tr><tr><td style="vertical-align:top;width:34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">Emerging growth company <ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_9moG08PV50Sz2BjAqnwMoA"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section&#160;404(b)&#160;of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="Narr_huYeCZVgGUOpFuOe-yp5Pw"><span style="font-family:'Segoe UI Symbol';">&#9746;</span></ix:nonNumeric> Yes <span style="font-family:'Segoe UI Symbol';">&#9744;</span> No</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" format="ixt-sec:boolballotbox" name="dei:DocumentFinStmtErrorCorrectionFlag" id="Narr_W6n3E7CP-kGnI7h1Ahr6Ew"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167; 240.10D-1(b).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:91.06%;border:0;margin:30pt 4.47% 30pt 4.47%;"></div><div style="max-width:100%;padding-left:4.47%;padding-right:4.47%;position:relative;"><div style="margin-top:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">U.S. GAAP <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td><td style="vertical-align:top;width:33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:DocumentAccountingStandard" id="Narr_tSufsKnzZUaJ64o1YvPe3w">International Financial Reporting Standards</ix:nonNumeric> as issued by the International Accounting Standards Board <span style="font-family:'Segoe UI Symbol';">&#9746;</span></p></td><td style="vertical-align:top;width:33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;">Other <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">If &#8220;Other&#8221; has been checked in response to the previous question indicate by check mark which financial statement item the registrant has elected to follow.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span> Item&#160;17 <span style="font-family:'Segoe UI Symbol';">&#9744;</span> Item&#160;18</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:18pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="Narr_05GB2CKUoUWXsWogtEvgzQ"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric> Yes <span style="font-family:'Segoe UI Symbol';">&#9746;</span> No</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:1pt;padding-top:1pt;text-align:center;text-indent:0pt;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><p style="display:none;line-height:0pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:0pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:91.06%;border:0;margin:30pt 4.47% 30pt 4.47%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_4596ee5f_1f8f_4479_a96f_0d5a6d6eb867"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;text-align:center;margin:0pt;">AC IMMUNE SA</p><a id="TOC"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;">TABLE OF CONTENTS</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#FORWARDLOOKINGSTATEMENTS_785824"><span style="font-style:normal;font-weight:normal;">FORWARD-LOOKING STATEMENTS</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">1</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#PARTI_417258"><span style="font-style:normal;font-weight:normal;">PART I</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM1IDENTITYOFDIRECTORSSENIORMANAGEMENT"><span style="font-style:normal;font-weight:normal;">ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#ADirectorsandseniormanagement_945095"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ADirectorsandseniormanagement_945095"><span style="font-style:normal;font-weight:normal;">Directors and senior management</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BAdvisers_224952"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BAdvisers_224952"><span style="font-style:normal;font-weight:normal;">Advisers</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#CAuditors_712026"><span style="font-style:normal;font-weight:normal;">C.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#CAuditors_712026"><span style="font-style:normal;font-weight:normal;">Auditors</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM2OFFERSTATISTICSANDEXPECTEDTIMETABLE"><span style="font-style:normal;font-weight:normal;">ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#AOfferstatistics_380962"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#AOfferstatistics_380962"><span style="font-style:normal;font-weight:normal;">Offer statistics</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BMethodandexpectedtimetable_121512"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BMethodandexpectedtimetable_121512"><span style="font-style:normal;font-weight:normal;">Method and expected timetable</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM3KEYINFORMATION_215446"><span style="font-style:normal;font-weight:normal;">ITEM 3. KEY INFORMATION</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#AReserved_203174"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#AReserved_203174"><span style="font-style:normal;font-weight:normal;">[Reserved]</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BCapitalizationandindebtedness_75989"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BCapitalizationandindebtedness_75989"><span style="font-style:normal;font-weight:normal;">Capitalization and indebtedness</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#CReasonsfortheofferanduseofproceeds_6854"><span style="font-style:normal;font-weight:normal;">C.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#CReasonsfortheofferanduseofproceeds_6854"><span style="font-style:normal;font-weight:normal;">Reasons for the offer and use of proceeds</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#DRiskfactors_669294"><span style="font-style:normal;font-weight:normal;">D.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#DRiskfactors_669294"><span style="font-style:normal;font-weight:normal;">Risk factors</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">3</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM4INFORMATIONONTHECOMPANY_87372"><span style="font-style:normal;font-weight:normal;">ITEM 4. INFORMATION ON THE COMPANY</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">54</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#AHistoryanddevelopmentofthecompany_39409"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#AHistoryanddevelopmentofthecompany_39409"><span style="font-style:normal;font-weight:normal;">History and development of the company</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">54</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BBusinessoverview_517701"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BBusinessoverview_517701"><span style="font-style:normal;font-weight:normal;">Business overview</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">54</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#COrganizationalstructure_904091"><span style="font-style:normal;font-weight:normal;">C.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#COrganizationalstructure_904091"><span style="font-style:normal;font-weight:normal;">Organizational structure</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">119</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#DPropertyplantandequipment_864198"><span style="font-style:normal;font-weight:normal;">D.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#DPropertyplantandequipment_864198"><span style="font-style:normal;font-weight:normal;">Property, plant and equipment</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">119</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM4AUNRESOLVEDSTAFFCOMMENTS_558751"><span style="font-style:normal;font-weight:normal;">ITEM 4A. UNRESOLVED STAFF COMMENTS</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">120</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM5OPERATINGANDFINANCIALREVIEWANDPROSP"><span style="font-style:normal;font-weight:normal;">ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">120</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#AOperatingresults_466589"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#AOperatingresults_466589"><span style="font-style:normal;font-weight:normal;">Operating results</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">120</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BLiquidityandcapitalresources_635978"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BLiquidityandcapitalresources_635978"><span style="font-style:normal;font-weight:normal;">Liquidity and capital resources</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">135</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#CResearchanddevelopmentpatentsandlicense"><span style="font-style:normal;font-weight:normal;">C.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#CResearchanddevelopmentpatentsandlicense"><span style="font-style:normal;font-weight:normal;">Research and development, patents and licenses, etc.</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">137</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#DTrendinformation_775981"><span style="font-style:normal;font-weight:normal;">D.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#DTrendinformation_775981"><span style="font-style:normal;font-weight:normal;">Trend information</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">137</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#ECriticalAccountingEstimates_860985"><span style="font-style:normal;font-weight:normal;">E.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ECriticalAccountingEstimates_860985"><span style="font-style:normal;font-weight:normal;">Critical Accounting Estimates</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">137</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM6DIRECTORSSENIORMANAGEMENTANDEMPLOYE"><span style="font-style:normal;font-weight:normal;">ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">137</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#ADirectorsandseniormanagement_124887"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ADirectorsandseniormanagement_124887"><span style="font-style:normal;font-weight:normal;">Directors and senior management</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">137</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BCompensation_249678"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BCompensation_249678"><span style="font-style:normal;font-weight:normal;">Compensation</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">142</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#CBoardpractices_883818"><span style="font-style:normal;font-weight:normal;">C.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#CBoardpractices_883818"><span style="font-style:normal;font-weight:normal;">Board practices</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">144</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#DEmployees_312467"><span style="font-style:normal;font-weight:normal;">D.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#DEmployees_312467"><span style="font-style:normal;font-weight:normal;">Employees</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">147</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#EShareownership_36027"><span style="font-style:normal;font-weight:normal;">E.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#EShareownership_36027"><span style="font-style:normal;font-weight:normal;">Share ownership</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">147</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a href="#Item6F"><span style="font-style:normal;font-weight:normal;">F.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#Item6F"><span style="font-style:normal;font-weight:normal;">Disclosure of a registrant&#8217;s action to recover erroneously awarded compensation</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">147</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM7MAJORSHAREHOLDERSANDRELATEDPARTYTRA"><span style="font-style:normal;font-weight:normal;">ITEM 7. MAJOR SHAREHOLDERS AND RELATED-PARTY TRANSACTIONS</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">147</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#AMajorshareholders_980950"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#AMajorshareholders_980950"><span style="font-style:normal;font-weight:normal;">Major shareholders</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">147</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BRelatedpartytransactions_285369"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BRelatedpartytransactions_285369"><span style="font-style:normal;font-weight:normal;">Related-party transactions</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">150</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#CInterestsofexpertsandcounsel_884840"><span style="font-style:normal;font-weight:normal;">C.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#CInterestsofexpertsandcounsel_884840"><span style="font-style:normal;font-weight:normal;">Interests of experts and counsel</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">150</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM8FINANCIALINFORMATION_353349"><span style="font-style:normal;font-weight:normal;">ITEM 8. FINANCIAL INFORMATION</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">150</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#AConsolidatedstatementsandotherfinancial"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#AConsolidatedstatementsandotherfinancial"><span style="font-style:normal;font-weight:normal;">Consolidated statements and other financial information</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">150</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BSignificantchanges_559132"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BSignificantchanges_559132"><span style="font-style:normal;font-weight:normal;">Significant changes</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">151</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM9THEOFFERANDLISTING_667173"><span style="font-style:normal;font-weight:normal;">ITEM 9. THE OFFER AND LISTING</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">151</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#AOfferingandlistingdetails_815430"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#AOfferingandlistingdetails_815430"><span style="font-style:normal;font-weight:normal;">Offering and listing details</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">151</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BPlanofdistribution_857538"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BPlanofdistribution_857538"><span style="font-style:normal;font-weight:normal;">Plan of distribution</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">151</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#CMarkets_858091"><span style="font-style:normal;font-weight:normal;">C.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#CMarkets_858091"><span style="font-style:normal;font-weight:normal;">Markets</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">151</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#DSellingshareholders_381670"><span style="font-style:normal;font-weight:normal;">D.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#DSellingshareholders_381670"><span style="font-style:normal;font-weight:normal;">Selling shareholders</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">151</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#EDilution_693805"><span style="font-style:normal;font-weight:normal;">E.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#EDilution_693805"><span style="font-style:normal;font-weight:normal;">Dilution</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">151</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#FExpensesoftheissue_68420"><span style="font-style:normal;font-weight:normal;">F.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#FExpensesoftheissue_68420"><span style="font-style:normal;font-weight:normal;">Expenses of the issue</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">151</span></p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">i</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM10ADDITIONALINFORMATION_834727"><span style="font-style:normal;font-weight:normal;">ITEM 10. ADDITIONAL INFORMATION</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">151</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#ASharecapital_904810"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ASharecapital_904810"><span style="font-style:normal;font-weight:normal;">Share capital</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">151</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BMemorandumandarticlesofassociation_4543"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BMemorandumandarticlesofassociation_4543"><span style="font-style:normal;font-weight:normal;">Memorandum and articles of association</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">152</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#CMaterialcontracts_220743"><span style="font-style:normal;font-weight:normal;">C.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#CMaterialcontracts_220743"><span style="font-style:normal;font-weight:normal;">Material contracts</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">152</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#DExchangecontrols_45681"><span style="font-style:normal;font-weight:normal;">D.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#DExchangecontrols_45681"><span style="font-style:normal;font-weight:normal;">Exchange controls</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">152</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#ETaxation_74576"><span style="font-style:normal;font-weight:normal;">E.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ETaxation_74576"><span style="font-style:normal;font-weight:normal;">Taxation</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">152</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#FDividendsandpayingagents_343344"><span style="font-style:normal;font-weight:normal;">F.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#FDividendsandpayingagents_343344"><span style="font-style:normal;font-weight:normal;">Dividends and paying agents</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">160</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#GStatementbyexperts_563927"><span style="font-style:normal;font-weight:normal;">G.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#GStatementbyexperts_563927"><span style="font-style:normal;font-weight:normal;">Statement by experts</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">160</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#HDocumentsondisplay_893312"><span style="font-style:normal;font-weight:normal;">H.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#HDocumentsondisplay_893312"><span style="font-style:normal;font-weight:normal;">Documents on display</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">160</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#ISubsidiaryinformation_453406"><span style="font-style:normal;font-weight:normal;">I.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ISubsidiaryinformation_453406"><span style="font-style:normal;font-weight:normal;">Subsidiary information</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">160</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#JAnnualReportToSecurityHolders"><span style="font-style:normal;font-weight:normal;">J.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#JAnnualReportToSecurityHolders"><span style="font-style:normal;font-weight:normal;">Annual report to security holders</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">160</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM11QUANTITATIVEANDQUALITATIVEDISCLOSU"><span style="font-style:normal;font-weight:normal;">ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">160</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM12DESCRIPTIONOFSECURITIESOTHERTHANEQ"><span style="font-style:normal;font-weight:normal;">ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">162</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#ADebtsecurities_509592"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ADebtsecurities_509592"><span style="font-style:normal;font-weight:normal;">Debt securities</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">162</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BWarrantsandrights_307246"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BWarrantsandrights_307246"><span style="font-style:normal;font-weight:normal;">Warrants and rights</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">162</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#COthersecurities_247673"><span style="font-style:normal;font-weight:normal;">C.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#COthersecurities_247673"><span style="font-style:normal;font-weight:normal;">Other securities</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">162</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#DAmericandepositaryshares_477448"><span style="font-style:normal;font-weight:normal;">D.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#DAmericandepositaryshares_477448"><span style="font-style:normal;font-weight:normal;">American depositary shares</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">162</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#PARTII_983451"><span style="font-style:normal;font-weight:normal;">PART II</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">163</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM13DEFAULTSDIVIDENDARREARAGESANDDELIN"><span style="font-style:normal;font-weight:normal;">ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">163</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#ADefaults_798645"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ADefaults_798645"><span style="font-style:normal;font-weight:normal;">Defaults</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">163</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BArrearsanddelinquencies_675487"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BArrearsanddelinquencies_675487"><span style="font-style:normal;font-weight:normal;">Arrears and delinquencies</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">163</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM14MATERIALMODIFICATIONSTOTHERIGHTSOF"><span style="font-style:normal;font-weight:normal;">ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">163</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM15CONTROLSANDPROCEDURES_751037"><span style="font-style:normal;font-weight:normal;">ITEM 15. CONTROLS AND PROCEDURES</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">163</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#ADisclosurecontrolsandprocedures_342570"><span style="font-style:normal;font-weight:normal;">A.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ADisclosurecontrolsandprocedures_342570"><span style="font-style:normal;font-weight:normal;">Disclosure controls and procedures</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">163</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#BManagementsAnnualReportoninternalcontro"><span style="font-style:normal;font-weight:normal;">B.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#BManagementsAnnualReportoninternalcontro"><span style="font-style:normal;font-weight:normal;">Management&#8217;s Annual Report on internal control over financial reporting</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">163</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#CAttestationreportoftheregisteredpublica"><span style="font-style:normal;font-weight:normal;">C.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#CAttestationreportoftheregisteredpublica"><span style="font-style:normal;font-weight:normal;">Attestation report of the registered public accounting firm</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">164</span></p></td></tr><tr><td style="vertical-align:bottom;width:9.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt;"><a style="font-size:10pt;" href="#DChangesininternalcontroloverfinancialre"><span style="font-style:normal;font-weight:normal;">D.</span></a></p></td><td style="vertical-align:bottom;width:84.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#DChangesininternalcontroloverfinancialre"><span style="font-style:normal;font-weight:normal;">Changes in internal control over financial reporting</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">164</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM16RESERVED_843348"><span style="font-style:normal;font-weight:normal;">ITEM 16. [RESERVED]</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">164</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM16AAuditcommitteefinancialexperts_94"><span style="font-style:normal;font-weight:normal;">ITEM 16A. Audit committee financial expert</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">164</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM16BCodeofEthics_857383"><span style="font-style:normal;font-weight:normal;">ITEM 16B. Code of Ethics</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">164</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM16CPrincipalaccountantfeesandservice"><span style="font-style:normal;font-weight:normal;">ITEM 16C. Principal accountant fees and services</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">164</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM16DExemptionsfromthelistingstandards"><span style="font-style:normal;font-weight:normal;">ITEM 16D. Exemptions from the listing standards for audit committees</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">165</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM16EPurchasesofequitysecuritiesbythei"><span style="font-style:normal;font-weight:normal;">ITEM 16E. Purchases of equity securities by the issuer and affiliated purchasers</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">165</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM16FChangeinregistrantscertifyingacco"><span style="font-style:normal;font-weight:normal;">ITEM 16F. Change in registrant&#8217;s certifying accountant</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">165</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM16GCorporategovernance_299481"><span style="font-style:normal;font-weight:normal;">ITEM 16G. Corporate governance</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">165</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM16HMinesafetydisclosure_873677"><span style="font-style:normal;font-weight:normal;">ITEM 16H. Mine safety disclosure</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">166</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM16IDisclosureregardingforeignjurisdi"><span style="font-style:normal;font-weight:normal;">ITEM 16I. Disclosure regarding foreign jurisdictions that prevent inspections</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">166</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM16JInsiderTradingPolicies"><span style="font-style:normal;font-weight:normal;">ITEM 16J. Insider trading policies</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">166</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM16KCybersecurity"><span style="font-style:normal;font-weight:normal;">ITEM 16K. Cybersecurity</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">166</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#PARTIII_805425"><span style="font-style:normal;font-weight:normal;">PART III</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">168</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM17Financialstatements_563714"><span style="font-style:normal;font-weight:normal;">ITEM 17. Financial statements</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">168</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM18Financialstatements_869202"><span style="font-style:normal;font-weight:normal;">ITEM 18. Financial statements</span></a></p></td><td style="vertical-align:bottom;width:6.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">168</span></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:93.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="font-size:10pt;" href="#ITEM19Exhibits_807810"><span style="font-style:normal;font-weight:normal;">ITEM 19. Exhibits</span></a></p></td><td style="vertical-align:bottom;width:6.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt;"><span style="font-size:10pt;">168</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="display:none;line-height:0pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:0pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">ii</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_a7054548_6f82_43e5_9619_45231836f0d0"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;">PRESENTATION OF FINANCIAL AND OTHER INFORMATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Unless otherwise indicated or the context otherwise requires, all references in this annual report on Form&#160;20-F (the &#8220;Annual Report&#8221;) to &#8220;AC Immune,&#8221; &#8220;ACIU,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;ours,&#8221; &#8220;us&#8221; or similar terms refer to AC Immune SA together with its subsidiary. The Company owns various registered and unregistered trademarks, for some of which protection has been obtained or is being sought, including Morphomer&#8482;, SupraAntigen<sup style="color:#222222;font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">&#174;</sup> and its corporate name, logo and Nasdaq Global Market symbol. All other trademarks, trade names and service marks of other companies appearing in this Annual Report are the property of their respective owners. Solely for convenience, the trademarks and trade names in this Annual Report may be referred to without the respective <sup style="color:#222222;font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">&#174;</sup> and &#8482; symbols, but such references should not be construed as any indicator that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. The Company does not intend to use or display other companies&#8217; trademarks and/or trade names to imply a relationship with, or endorsement or sponsorship of the Company by, any other companies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Financial statements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our consolidated financial statements are presented in Swiss Francs and in accordance with International Financial Reporting Standards (IFRS) Accounting Standards, as issued by the International Accounting Standards Board (IASB). None of the consolidated financial statements was prepared in accordance with generally accepted accounting principles in the United States (U.S.). The terms &#8220;dollar&#8221; and &#8220;USD&#8221; refer to U.S. dollars, and the terms &#8220;Swiss Franc&#8221; and &#8220;CHF&#8221; refer to the legal currency of Switzerland, unless otherwise indicated. We have made rounding adjustments to some of the figures included in this Annual Report. Accordingly, any numerical discrepancies in any table between totals and sums of the amounts listed are due to rounding.</p><a id="_ec387ed8_38d5_4d3e_a0fa_2a4ca7c7a3dc"></a><a id="FORWARDLOOKINGSTATEMENTS_785824"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;">FORWARD-LOOKING STATEMENTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This Annual Report contains statements that constitute forward-looking statements. All statements other than statements of historical facts contained in this Annual Report, including statements regarding our future results of operations and financial position, business strategy, product candidates, product pipeline, ongoing and planned clinical studies, including those of our collaboration partners, regulatory approvals, research and development (R&amp;D) costs, timing and likelihood of success, as well as plans and objectives of management for future operations, are forward-looking statements. Many of the forward-looking statements contained in this Annual Report can be identified by the use of forward-looking words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;expect,&#8221; &#8220;should,&#8221; &#8220;plan,&#8221; &#8220;intend,&#8221; &#8220;estimate,&#8221; &#8220;will&#8221; and &#8220;potential,&#8221; among others.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Forward-looking statements appear in a number of places in this Annual Report and include, but are not limited to, statements regarding our intent, belief or current expectations. Forward-looking statements are based on our management&#8217;s beliefs and assumptions, and on information currently available to our management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to, those identified under &#8220;Item&#160;3. Key information&#8212;D. Risk factors&#8221; in this Annual Report. These risks and uncertainties include multiple factors:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin-bottom:8pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the success of our and our collaboration partners&#8217; clinical studies, and our and their ability to obtain and maintain regulatory approval and to commercialize our active immunotherapies (ACI-35.030, ACI-24.060 and ACI-7104.056), monoclonal antibodies (semorinemab and crenezumab) and diagnostics (Tau-PET tracer PI-2620 and a-syn-PET tracer ACI-12589) and to a lesser extent our preclinical candidates;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the preclinical and clinical safety, efficacy and utility of our product candidates;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the ability of our competitors to discover, develop or commercialize competing products before or more successfully than we do;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our plans to research, develop and commercialize our product candidates;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the identification of serious adverse, undesirable or unacceptable side effects related to our product candidates;</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">1</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our ability to maintain our current strategic relationships with our collaboration partners;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our ability to protect and maintain our, and not infringe on third parties&#8217;, intellectual property rights throughout the world;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our ability to raise capital when needed in order to continue our product development programs or commercialization efforts;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our ability to attract and retain qualified employees and key personnel;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the acceptance by the Food and Drug Administration (FDA) and applicable foreign regulatory authorities of data from studies that we and our collaboration partners conduct within and outside the U.S. now and in the future;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our foreign private issuer (FPI) status, the loss of which would require us to comply with the Exchange Act&#8217;s domestic reporting regime, and cause us to incur significant legal, accounting and other expenses;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our incorporation in Switzerland, the laws of which govern our corporate affairs and may differ from those applicable to companies incorporated in the U.S.; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the other risk factors discussed under &#8220;Item&#160;3. Key information&#8212;D. Risk factors.&#8221;</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">These forward-looking statements are applicable only as of the date of this Annual Report, and are subject to a number of risks, uncertainties and assumptions described under the sections in this Annual Report entitled &#8220;Item&#160;3. Key information&#8212;D. Risk factors&#8221; and &#8220;Item&#160;5. Operating and financial review and prospects,&#8221; and elsewhere in this Annual Report. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond our control, you should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">2</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_9d869979_acb7_43fd_ae83_05434c133636"></a><a id="PARTI_417258"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;">PART&#160;I</p><a id="ITEM1IDENTITYOFDIRECTORSSENIORMANAGEMENT"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</p><a id="ADirectorsandseniormanagement_945095"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Directors and senior management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="BAdvisers_224952"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Advisers</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="CAuditors_712026"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Auditors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="_b018fa35_e7a9_460f_967e_ba49c623b3c5"></a><a id="ITEM2OFFERSTATISTICSANDEXPECTEDTIMETABLE"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;2. OFFER STATISTICS AND EXPECTED TIMETABLE</p><a id="AOfferstatistics_380962"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Offer statistics</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="BMethodandexpectedtimetable_121512"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Method and expected timetable</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="_724c27fa_47b3_4a2b_a81b_e68dccac5d40"></a><a id="ITEM3KEYINFORMATION_215446"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;3. KEY INFORMATION</p><a id="AReserved_203174"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>[Reserved]</p><a id="BCapitalizationandindebtedness_75989"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Capitalization and indebtedness</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="CReasonsfortheofferanduseofproceeds_6854"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Reasons for the offer and use of proceeds</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="DRiskfactors_669294"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Risk factors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">You should carefully consider the risks and uncertainties described below and the other information in this Annual Report before making an investment in our common shares. Our business, financial condition or results of operations could be materially and adversely affected if any of these risks occurs, and as a result, the market price of our common shares could decline and you could lose all or part of your investment. This Annual Report also contains forward-looking statements that involve risks and uncertainties. See &#8220;Forward-Looking Statements.&#8221; Our actual results could differ materially and adversely from those anticipated in these forward-looking statements as a result of certain factors.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">The below provides a summary of our principal risk factors:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to our business:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We depend heavily on the success of our clinical and, to a lesser extent, preclinical products:</span></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">3</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a.</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our ability to generate product revenues, which we do not expect to occur for several&#160;years, will depend on clinical and regulatory success which have low probabilities of success in the central nervous system (CNS) space in which we operate.</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Results of early preclinical and clinical studies may not be predictive of future results:</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Products that show positive or timely preclinical or early clinical results may not show sufficient safety or efficacy in later-stage clinical studies and therefore may fail to obtain regulatory approvals.</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our products may not gain market acceptance or may be preempted by competitors:</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Even if our products obtain regulatory approval, they may not be accepted by healthcare providers, patients or the medical community.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b.</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our success is dependent on the ability to discover, develop and obtain marketing approval for our products. We face and will continue to face intense competition from a variety of businesses, including large fully integrated biopharmaceutical and pharmaceutical companies and others that may have greater financial, technical and human resources.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">c.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">A competitor may enter with a generic of an approved innovator product.</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may not be successful in using and expanding our Morphomer and SupraAntigen proprietary technology platforms.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We operate in highly competitive and rapidly changing industries, which may result in others discovering, developing or commercializing competing products before or more successfully than we do.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our future growth and ability to compete depends on retaining our key personnel and recruiting additional qualified personnel including members of our Executive Committee.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">A breakdown or breach of our information technology systems and cybersecurity efforts, or those of our key business partners, contract research organizations (CROs) or service providers, could subject us to liability or reputational damage or interrupt the operation of our business.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to our relationships with third parties:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If we fail to maintain, or realize the benefits from, our current strategic relationships with our current and potential future license and collaboration partners our financial condition may be materially adversely affected.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may seek to form additional strategic alliances in the future with respect to our product candidates, and if we do not realize the benefits of such alliances, our business, financial condition, commercialization prospects and results of operations may be materially adversely affected.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our collaboration agreements may make us an attractive acquisition target under certain circumstances.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to intellectual property:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We or our licensing or collaboration partners may not have sufficient patent terms to protect our products and business effectively, which may adversely affect our product sales and technology development.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If we fail to comply with the obligations to obtain and maintain patent protection such as compliance with intellectual property agreements, including those under which we license intellectual property and other rights to or from third parties, or otherwise experience disruptions to our business relationships with our licensees, our </span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">4</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"/><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">licensors and collaboration partners, we could lose intellectual property rights that are important to our business.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We may be subject to claims challenging the inventorship of our patents and other intellectual property.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to our financial condition and capital requirements:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We are a clinical stage biopharmaceutical company with a history of losses. We anticipate incurring losses for the foreseeable future. As such, if we fail to obtain additional funding via product revenues, license and collaboration agreements, equity offerings or other forms of financing, we may need to delay, reduce or eliminate certain of our product development programs.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If we fail to obtain additional funding, we may delay, reduce or eliminate our product development programs or commercialization efforts.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to the regulatory environment:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We cannot give any assurance that any of our product candidates will receive regulatory approval, which is necessary before they can be commercialized.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Even if we obtain regulatory approvals in one jurisdiction, we may not be able to obtain approval in other jurisdictions. Additionally, we will be subject to ongoing obligations and review which may result in significant additional expenses.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We have conducted and may in the future conduct clinical studies for our product candidates outside the U.S., and the FDA and applicable foreign regulatory authorities may not accept data from such studies.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Enacted and future legislation may increase the difficulty and cost for us to obtain marketing approval of and commercialize our product candidates and may affect the prices we may set.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to our common shares:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We have limited free float in our common shares which may have a negative impact on the liquidity and market price of our common shares.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Certain of our existing shareholders exercise significant control over us, and your or other shareholders&#8217; interests may conflict with the interests of such shareholders.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We are a Swiss corporation. The rights of our shareholders may be different from the rights of shareholders in companies governed by the laws of U.S. jurisdictions.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We are an FPI and, as a result, we are not subject to U.S. proxy rules&#160;and are subject to Exchange Act reporting obligations that, to some extent, are more lenient and less frequent than those of a U.S. domestic public company.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">As an FPI, and as permitted by the listing requirements of Nasdaq, we rely on certain home country governance practices rather than the corporate governance requirements of Nasdaq. Should we lose our FPI status, we would be required to comply with the Exchange Act&#8217;s domestic reporting regime, which would cause us to incur significant legal, accounting and other expenses.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We were likely a passive foreign investment company (a &#8220;PFIC&#8221;) for our 2019, 2020, and 2022 taxable years. Although we believe we were likely not a PFIC for 2023, there can be no assurance that the Internal Revenue Service will agree. We cannot express any expectation regarding our PFIC status for 2024 or future taxable </span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">5</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"/><td style="padding:0pt;"><span style="color:#222222;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">years. If we are a PFIC for any taxable year during which a U.S. investor owns our common shares, the investor generally will be subject to adverse U.S. federal income tax consequences.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to our business</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 9.35pt;"><span style="font-style:italic;font-weight:bold;">We depend heavily on the success of our clinical and, to a lesser extent, preclinical products. Our clinical product candidates include our active immunotherapies (ACI-35.030, ACI-24.060 and ACI-7104.056), monoclonal antibodies (semorinemab and crenezumab) and diagnostics (Tau-PET tracer PI-2620 and a-syn-PET tracer ACI-12589). If our clinical studies are unsuccessful, if we or our collaboration partners do not obtain regulatory approval or if we or our collaboration partners are unable to commercialize our active immunotherapies (ACI-35.030, ACI-24.060 and ACI-7104.056), monoclonal antibodies (semorinemab and crenezumab) and diagnostics (Tau-PET tracer PI-2620 and a-syn-PET tracer ACI-12589), or if we experience significant delays in doing so, our business, financial condition and results of operations will be materially adversely affected.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We currently have no products approved for sale and have invested a significant portion of our efforts and financial resources in the development of our active immunotherapies (ACI-35.030, ACI-24.060 and ACI-7104.056), monoclonal antibodies (semorinemab and crenezumab) and diagnostics (Tau-PET tracer PI-2620 and a-syn-PET tracer ACI-12589), all of which are in clinical development as well as other preclinical candidates such as our small molecule programs including therapeutics (Morphomer Tau), our TDP-43 antibody, Morphomer a-syn and inflammasome therapeutics (NLRP3 small molecule and ASC antibody). Our ability to generate product revenues, which we do not expect will occur for at least the next several years, if ever, will depend heavily on successful clinical development, obtaining regulatory approval and eventual commercialization of these product candidates. In this regard, we rely heavily on our collaboration partners for clinical development of certain of our product candidates, and they may choose to discontinue the clinical development process in certain cases. In addition, we currently generate no revenues from sales of any drugs or diagnostics, and we may never be able to develop or commercialize a marketable drug or diagnostic. The success of our current and future product candidates will depend on several factors, including, but not limited to, the following:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">completing preclinical and clinical studies that demonstrate the efficacy, safety and clinical utility of our preclinical and clinical product candidates;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">receiving marketing approvals from applicable regulatory authorities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">establishing commercial manufacturing capabilities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">launching commercial sales, marketing and distribution operations;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">acceptance of our product candidates by patients, the medical community and third-party payors;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a continued acceptable safety profile following approval;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">competing effectively with other therapies or diagnostic approaches; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">obtaining, maintaining, enforcing and defending our intellectual property rights and claims and not infringing on third parties&#8217; intellectual property rights.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If we or our collaboration partners do not achieve one or more of these factors in a timely manner or at all, we could experience significant delays or an inability to successfully commercialize our current or future product candidates, which would materially adversely affect our business, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 9.35pt;">Results of early clinical studies may not be predictive of future study results.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Positive or timely results from preclinical or early-stage clinical studies do not ensure positive or timely results in mid-to late-stage clinical studies or product approval by the U.S. FDA, the European Medicines Agency (EMA), or </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">6</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">comparable foreign regulatory authorities. Products that show positive preclinical or early clinical results may not show sufficient safety or efficacy in later-stage clinical studies and therefore may fail to obtain regulatory approvals. In addition, preclinical and clinical data are often susceptible to varying interpretations and analyses. Many companies that believed their product candidates performed satisfactorily in preclinical and clinical studies have nonetheless failed to obtain marketing approval for the product candidates. The FDA, the EMA and comparable foreign regulatory authorities have substantial discretion in the approval process and in determining when or whether regulatory approval will be obtained for any of our product candidates. Even if we believe that the data collected from clinical studies of our product candidates are promising, such data may not be sufficient to support approval by the FDA, the EMA or any other regulatory authority.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In some instances, there can be significant variability in safety and/or efficacy results between different studies of the same product candidate due to numerous factors, including changes in study procedures set forth in protocols, differences in the size and type of the patient populations, adherence to the dosing regimen and other study protocols, and the rate of dropout among clinical study participants. In the case of our later-stage clinical product candidates, results may differ in general on the basis of the larger number of clinical study sites and the additional countries and languages involved in these clinical studies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Clinical studies may include subject-reported outcomes, some of which may be captured with electronic diaries. We have no assurance and cannot rely on past experience that the high frequency of questioning is not influencing the measured outcome. In addition, low compliance with daily reporting requirements may impact the studies&#8217; validity or statistical power. We cannot assure you that any Phase 2, Phase 3 or other clinical studies that either we or our collaboration partners are conducting and may conduct will demonstrate consistent or adequate efficacy and safety to obtain regulatory approval to market our product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If we or our collaboration partners are required to conduct additional clinical studies or other testing of any of our current or future product candidates that we or our collaboration partners develop, beyond the studies and testing that we or our collaboration partners contemplate, if we or our collaboration partners are unable to successfully complete clinical studies of our product candidates or other testing, if the results of these studies or tests are unfavorable or are only modestly favorable, or if there are safety concerns associated with our current or future product candidates, we may:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">be delayed in obtaining marketing approval for our product candidates;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">not obtain marketing approval;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">obtain approval for indications or patient populations that are not as broad as intended or desired;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">obtain approval with labeling that includes significant use or distribution restrictions or significant safety warnings, including boxed warnings;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">be subject to conditional approval or otherwise to additional post-marketing studies or other requirements; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">remove the product from the market after obtaining marketing approval.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our product development costs will also increase if we experience delays in testing or receiving marketing approvals and we may be required to obtain additional funds to complete clinical studies. We cannot assure you that our clinical studies will begin as planned or be completed on schedule, if at all, or that we will not need to amend our studies after they have begun. Significant clinical study delays could also shorten any periods during which we or our collaboration partners may have the exclusive right to commercialize our product candidates, or allow our competitors to bring products to market before we do, which may harm our business and results of operations. In addition, some of the factors that cause, or lead to, clinical study delays may ultimately lead to the denial of regulatory approval of our product candidates.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">7</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We may undertake one or more significant corporate transactions that may not achieve their intended results, may adversely affect our financial condition and our results of operations or result in unforeseeable risks to our business.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We continuously evaluate the acquisition or disposition of operating businesses and assets and may in the future undertake one or more significant transactions, such as our purchase in 2021 of Affiris AG&#8217;s (Affiris) program portfolio of therapeutics targeting a-syn, notably our ACI-7104.056, a clinically-validated active immunotherapy candidate for the treatment of Parkinson&#8217;s disease (PD). Any such transaction could be material to our business and could take any number of forms, including mergers, joint ventures and the purchase of equity interests, amongst others. The consideration for such&#160;acquisitive&#160;transactions may include, among other things, cash, common shares or equity interests in us or our subsidiary, or a contribution of equipment to obtain equity interests, and in conjunction with a transaction we might incur additional indebtedness. We also routinely evaluate the benefits of disposing of certain of our assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">These transactions may present significant risks such as insufficient revenue to offset liabilities assumed, potential loss of significant revenue and income streams, increased or unexpected expenses, inadequate return of capital, regulatory or compliance issues, the triggering of certain covenants in our debt agreements (including accelerated repayment) and unidentified issues not discovered in due diligence. In addition, such transactions could distract management from current operations. As a result of the risks inherent in such transactions, we cannot guarantee that any such transaction will ultimately result in the realization of its anticipated benefits or that it will not have a material adverse effect on our business, financial condition and results of operations. If we were to complete such an acquisition, disposition, investment or other strategic transaction, we may require additional debt or equity financing that could result in a significant increase in our amount of debt and our debt service obligations or the number of outstanding common shares, thereby diluting holders of our common shares outstanding prior to such acquisition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Additional competitors could enter the market with generic versions of our products, which may result in a material decline in sales of affected products.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under the Drug Price Competition and Patent Term Restoration Act of 1984, or the Hatch-Waxman Act, a pharmaceutical manufacturer may file an abbreviated new drug application (ANDA), seeking approval of a generic copy of an approved innovator product. Under the Hatch-Waxman Act, a manufacturer may also submit a new drug application (NDA) under Section&#160;505(b)(2)&#160;that references the FDA&#8217;s prior approval of the innovator product. A 505(b)(2)&#160;NDA product may be submitted for a new or improved version of the original innovator product. Hatch-Waxman also provides for certain periods of regulatory exclusivity, which preclude FDA approval (or in some circumstances, FDA filing and reviewing) of an ANDA or 505(b)(2)&#160;NDA. These include, subject to certain exceptions, the period during which an FDA-approved drug is subject to orphan-drug exclusivity. In addition to the benefits of regulatory exclusivity, an innovator NDA holder may have patents claiming the active ingredient, product formulation or an approved use of the drug, which would be listed with the product in the FDA publication, &#8220;Approved Drug Products with Therapeutic Equivalence Evaluations,&#8221; known as the &#8220;Orange Book.&#8221; If there are patents listed in the Orange Book, a generic or 505(b)(2)&#160;applicant that seeks to market its product before expiration of the patents must include in the ANDA what is known as a &#8220;Paragraph IV certification,&#8221; challenging the validity or enforceability of, or claiming non-infringement of, the listed patent or patents. Notice of the certification must also be given to the innovator, and if within 45&#160;days of receiving notice the innovator, in order to protect its patents, sues the company that manufactures the generic, approval of the ANDA is stayed for 30&#160;months, or as lengthened or shortened by the court.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Accordingly, if our active immunotherapies (ACI-35.030, ACI-24.060 and ACI-7104.056), monoclonal antibodies (semorinemab and crenezumab) and diagnostics (Tau-PET tracer PI-2620 and a-syn-PET tracer ACI-12589) are approved, competitors could file ANDAs for generic versions of our active immunotherapies (ACI-35.030, ACI-24.060 and ACI-7104.056), monoclonal antibodies (semorinemab and crenezumab) and diagnostics (Tau-PET tracer PI-2620 and a-syn-PET tracer ACI-12589) or 505(b)(2) NDAs that reference our active immunotherapies (ACI-35.030, ACI-24.060 and ACI-7104.056), monoclonal antibodies (semorinemab and crenezumab) and diagnostics (Tau-PET tracer PI-2620 and a-syn-PET tracer ACI-12589), respectively. If there are patents listed in the Orange Book for our active immunotherapies (ACI-35.030, ACI-24.060 and ACI-7104.056), monoclonal antibodies (semorinemab and crenezumab) and diagnostics (Tau-PET tracer PI-2620 and a-syn-PET tracer ACI-12589), respectively, those ANDAs and 505(b)(2) NDAs would be required to include a certification for each listed patent, indicating whether the ANDA applicant does or </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">8</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">does not intend to challenge the patent. We cannot predict whether any patents issuing from our pending patent applications will be eligible for listing in the Orange Book, how any generic competitor would address such patents, whether we would sue on any such patents or the outcome of any such suit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We may not be successful in securing or maintaining patent protection for products and technologies we develop or license. Moreover, if any patents that are granted and listed in the Orange Book are successfully challenged by way of a Paragraph IV certification and subsequent litigation, the affected product could immediately face generic competition and its sales would likely decline rapidly and materially. Should sales decline, we may have to write off a portion or all of the intangible assets associated with the affected product, and our results of operations and cash flows could be materially and adversely affected.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">The successful commercialization of our product candidates will depend in part on the extent to which governmental authorities and health insurers establish adequate coverage and reimbursement levels and pricing policies.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The successful commercialization of our product candidates will depend, in part, on the extent to which coverage and reimbursement for our products will be available from government and health administration authorities, private health insurers and other third-party payors. To manage healthcare costs, many governments and third-party payors increasingly scrutinize the pricing of new technologies and require greater levels of evidence of favorable clinical outcomes and cost-effectiveness before extending coverage. For example, the Inflation Reduction Act (IRA) of 2022, among other things, incentivizes the renegotiation with the U.S. government of the prices of certain pharmaceutical drugs and imposes penalties for Medicare drugs that increase in price faster than the rate of inflation. See &#8220;&#8212;Enacted and future legislation may increase the difficulty and cost for us to obtain marketing approval of and commercialize our product candidates and may affect the prices we may set&#8221; below. In light of such challenges to prices and the requirement for increasing levels of evidence of the benefits and clinical outcomes of new technologies, we cannot be sure that coverage will be available for any of our current or future product candidates that we or our collaboration partners will commercialize or, if available, that the reimbursement rates will be adequate in each respective region. If we are unable to obtain adequate levels of coverage and reimbursement for our product candidates, their marketability will be negatively and materially impacted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Third-party payors may deny coverage and reimbursement status altogether for a given drug product, or may cover the product but also establish prices at levels that are too low to enable us to realize an appropriate return on our investment in product development. Because the rules&#160;and regulations regarding coverage and reimbursement change frequently, in some cases at short notice, even when there is favorable coverage and reimbursement, future changes may occur that adversely impact the favorable status. Further, the net reimbursement for drug products may be subject to additional reductions in the future depending on policy changes enacted by the U.S. Congress.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The unavailability or inadequacy and variability of third-party coverage and reimbursement could have a material adverse effect on the market acceptance of our product candidates and the future revenues we may expect to receive from those products. In addition, we are unable to predict what additional legislation or regulation relating to the healthcare industry or third-party coverage and reimbursement may be enacted in the future, or what effect such legislation or regulation would have on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Our products may not gain market acceptance, in which case we or our collaboration partners may not be able to generate product revenues, which will materially adversely affect our business, financial condition and results of operations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Even if the FDA, the EMA or any other regulatory authority approves the marketing of any product candidates that we develop, physicians, healthcare providers, patients or the medical community may not accept or use them. Efforts to educate the medical community and third-party payors on the benefits of our product candidates may require significant resources and may not be successful. If any of our current or future product candidates does not achieve an adequate level of acceptance, we or our collaboration partners may not generate significant product or royalty revenues or any </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">9</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">profits from operations. The degree of market acceptance of our product candidates that are approved for commercial sale will depend on a variety of factors, including:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">how clinicians and potential patients perceive our novel products;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the timing of market introduction;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the number and clinical profile of competing products;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our ability to provide acceptable evidence of safety and efficacy or clinical utility;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the prevalence and severity of any side effects;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">relative convenience and ease of administration;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">cost-effectiveness;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">patient diagnostics and screening infrastructure in each market;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">marketing and distribution support;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">availability of coverage, reimbursement and adequate payment from health maintenance organizations and other third-party payors, both public and private; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">other potential advantages over alternative treatment methods.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If our product candidates fail to gain market acceptance, this will have a material adverse impact on our ability to generate revenues to provide a satisfactory, or any, return on our investments. Even if some products achieve market acceptance, the market may prove to not be large enough to allow us to generate significant revenues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, the potential market opportunity of our product candidates is difficult to estimate precisely. Our estimates of the potential market opportunity are predicated on several key assumptions such as industry knowledge and publications, third-party research reports and other surveys. These assumptions involve the exercise of significant judgment on the part of our management and are inherently uncertain, and the reasonableness of these assumptions could not have been assessed by an independent source in every detail. If any of the assumptions proves to be inaccurate, then the actual market for our product candidates could be smaller than our estimates of the potential market opportunity. If the actual market for our product candidates is smaller than we expect, or if any approved products fail to achieve an adequate level of acceptance by physicians, healthcare payors and patients, our product or royalty revenue may be limited and it may be more difficult for us to achieve or maintain profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We depend on enrollment of patients in our clinical studies for our product candidates. If we are unable to enroll patients in our clinical studies, our research and development efforts could be materially adversely affected.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Successful and timely completion of clinical studies will require that we enroll a sufficient number of patient candidates. Studies may be subject to delays as a result of patient enrollment taking longer than anticipated or by patient withdrawal. Patient enrollment depends on many factors, including the size and nature of the patient population, the eligibility criteria for the study, the proximity of patients to clinical sites, the design of the clinical protocol, the existence of competing clinical studies, the availability of new drugs approved for the indication the clinical study is investigating, and clinicians&#8217; and patients&#8217; perceptions as to the potential advantages of the drug being studied in relation to other available therapies. In addition, with the passage of the Food and Drug Omnibus Reform Act of 2022 (FDORA), Congress required sponsors to develop and submit a diversity action plan for each Phase 3 clinical trial or any other pivotal study of a new drug. These plans are meant to encourage the enrollment of more diverse patient populations in late-stage clinical trials of FDA-regulated products. Specifically, action plans must include the sponsor&#8217;s goals for </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">10</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">enrollment, the underlying rationale for those goals, and an explanation of how the sponsor intends to meet them. In addition to these requirements, the legislation directs the FDA to issue new guidance on diversity action plans.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Generally, the specific target population of patients and therapeutic time windows may make it difficult for us to enroll enough patients to complete clinical studies for our product candidates in a timely and cost-effective manner. Delays in the completion of any clinical study of our product candidates will increase our costs, slow down our product candidate development and approval process, and delay or potentially jeopardize our or our collaboration partners&#8217; ability to commence product sales and generate revenue. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical studies may also ultimately lead to the denial of regulatory approval of our product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">If serious adverse, undesirable or unacceptable side effects are identified during the development of our product candidates or following approval, if any, we may need to abandon our development of such product candidates, the commercial profile of any approved label may be limited, or we may be subject to other significant negative consequences following marketing approval, if any.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If our product candidates are associated with serious adverse, undesirable or unacceptable side effects, we may need to abandon their development or limit development to certain uses or subpopulations in which such side effects are less prevalent, less severe or more acceptable from a risk&#8211;benefit perspective. Many compounds that initially showed promise in preclinical or early-stage testing were later found to cause side effects that restricted their use and prevented further development of the compound for larger indications.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Occurrence of serious procedure- or treatment-related side effects could impede clinical study enrollment and receipt of marketing approval from the FDA, the EMA and comparable foreign regulatory authorities. Adverse events (AEs) could also adversely affect physician or patient acceptance of our product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, if one or more of our product candidates receives marketing approval, and we or others later identify undesirable side effects caused by such products, a number of potentially significant negative consequences could result, including the following:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">regulatory authorities may withdraw approvals of such product and require us or our collaboration partners to take any approved products off the market;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">regulatory authorities may require the addition of labeling statements, specific warnings, a contraindication or field alerts to physicians and pharmacies;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we may be required to create a medication guide outlining the risks of such side effects for distribution to patients;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we may be required to change the way the product is administered, to conduct additional studies or to change the labeling of the product;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we or our collaboration partners may be subject to limitations in how we promote the product;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">sales of the product may decrease significantly;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we could be sued and held liable for harm caused to patients; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our reputation and physician or patient acceptance of our products may suffer.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any of these events could prevent us from achieving or maintaining market acceptance of the particular product candidate, if approved, and could significantly harm our business, results of operations and prospects.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">11</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We operate in highly competitive and rapidly changing industries, which may result in others discovering, developing or commercializing competing products before or more successfully than we do.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The biopharmaceutical and pharmaceutical industries are highly competitive and subject to significant and rapid technological change. Our success is highly dependent on our ability to discover, develop and obtain marketing approval for new and innovative products on a cost-effective basis and to market them successfully. In doing so, we face and will continue to face intense competition from a variety of businesses, including large, fully integrated pharmaceutical companies, specialty pharmaceutical companies and biopharmaceutical companies, academic institutions, government agencies and other private and public research institutions in Europe, the U.S. and other jurisdictions. Many of our potential competitors, alone or with their strategic partners, have substantially greater financial, technical and human resources than we do and significantly greater experience in the discovery and development of product candidates, obtaining FDA and other regulatory approvals of treatments, and the commercialization of those treatments. Mergers and acquisitions in the pharmaceutical and biopharmaceutical industries may result in even more resources being concentrated among a smaller number of our competitors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The highly competitive nature of and rapid technological changes in the pharmaceutical and biopharmaceutical industries could render our product candidates or our technology obsolete or noncompetitive. The commercial opportunity for our products could be reduced or eliminated if our competitors:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">develop and commercialize products that are safer, more effective, less expensive, or more convenient or easier to administer;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">obtain quicker FDA or other regulatory approval for their products;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">establish superior intellectual property and proprietary positions;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">have access to more manufacturing capacity;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">implement more effective approaches to sales, marketing and distribution; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">form more advantageous strategic alliances.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Should any of these occur, our business, financial condition and results of operations could be materially adversely affected.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We believe that our key competitor product candidates are (i)&#160;AADvac1 (Axon Neuroscience) for ACI-35.030; (ii)&#160;UB-311 (Vaxxinity) and ABvac-40 (Araclon Biotech) for ACI-24.060; (iii)&#160;UB-312 (Vaxxinity) for ACI-7104.056; (iv)&#160;bepranemab (UCB/Roche), E-2814 (Eisai) and JNJ63733657 (Janssen) for semorinemab; (v)&#160;Leqembi (BioArctic/Eisai), donanemab (Eli Lilly and Company) and their subcutaneous formulations, trontinemab (Roche) and ACU193 (Acumen Pharmaceuticals) for crenezumab; (vi)&#160;HMTM (TauRx Pharmaceuticals) for Morphomer Tau; (vii)&#160;Tauvid (Eli Lilly and Company), florzolotau (Aprinoia Therapeutics), MK-6240 (Cerveau/Merck) and GTP1 (Genentech) for PI-2620; and (viii) UCB-2897 (UCB) for ACI-12589, as described under &#8220;Item&#160;4. Information on the Company&#8212;B. Business overview&#8212;Competition.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We may not be successful in our efforts to use and expand our Morphomer and SupraAntigen proprietary technology platforms to build additional product candidates for our pipeline.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">A key element of our strategy is to use and expand our Morphomer and SupraAntigen proprietary technology platforms to create unique therapies and diagnostics misfolded proteins in diseases, such as AD, PD and others (including NeuroOrphan diseases e.g. ALS and PSP), and progress these product candidates through clinical development. Although our research and development efforts to date have resulted in a pipeline of product candidates, we may not be able in the future to develop product candidates that are safe and effective. Even if we are successful in continuing to build our pipelines, the potential product candidates that we identify may not be suitable for clinical </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">12</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">development, potentially as a result of having harmful side effects or other characteristics indicating they may be unlikely to receive marketing approval and achieve market acceptance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Our business is subject to economic, political, regulatory and other risks associated with international operations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our business is subject to risks associated with conducting business internationally. We and a number of our suppliers and collaborative and clinical study relationships are located outside the U.S. Accordingly, our future results could be harmed by a variety of factors, including:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">economic weakness, including inflation, or political instability in particular non-U.S. economies and markets;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">differing regulatory requirements for drug approvals in non-U.S. countries;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">potentially reduced protection for intellectual property rights;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">difficulties in compliance with non-U.S. laws and regulations;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changes in non-U.S. regulations and customs, tariffs and trade barriers;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changes in non-U.S. currency exchange rates and currency controls;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changes in a specific country&#8217;s or region&#8217;s political or economic environment;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">trade protection measures, import or export licensing requirements or other restrictive actions such as sanctions by U.S. or non-U.S. governments;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">negative consequences from changes in tax laws;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">compliance with tax, employment, immigration and labor laws for employees living or traveling abroad;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">workforce uncertainty in countries where labor unrest is more common than in the U.S.;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">difficulties associated with staffing and managing international operations, including differing labor relations;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">business interruptions resulting from geopolitical actions, including war and terrorism, or natural disasters including earthquakes, typhoons, floods and fires.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, Hamas&#8217; attacks against Israelis in Gaza and Israel&#8217;s military responses have spawned or may spawn regional military confrontations between Israel and neighboring Arab countries and their respective allies around the world that may cause political and economic disruptions. Moreover, since the end of 2021, tensions between the United States and Russia escalated when Russia amassed large numbers of military ground forces and support personnel on the Ukraine-Russia border and, in February&#160;2022, Russia invaded Ukraine. In response, NATO has deployed additional military forces to Eastern Europe, including to Lithuania, and the Biden administration announced certain sanctions against Russia. The invasion of Ukraine and the retaliatory measures that have been taken, or could be taken in the future, by the United States, NATO, and other countries have created global security concerns that could result in a regional conflict and otherwise have a lasting impact on regional and global economies, any or all of which could disrupt our supply chain, adversely affect our ability to conduct ongoing and future clinical trials of our product candidates, and adversely affect our ability to commercialize our products (subject to regulatory approval) in this region. Currently, none of our clinical development or business activities are conducted directly or otherwise in Russia or Ukraine.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">13</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Unfavorable global economic conditions could adversely affect our business, financial condition or results of </span><span style="font-style:italic;font-weight:bold;">operations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our results of operations could be adversely affected by general conditions in the global economy and in the global financial markets. For example, rising interest rates and high inflation may cause our cost of doing business to materially increase and may adversely impact our ability to operate or may adversely impact other parties upon whom we rely for research and development capabilities to operate. The most recent global financial crisis caused extreme volatility and disruptions in the capital and credit markets. A severe or prolonged economic downturn, such as the most recent global financial crisis, could result in a variety of risks to our business, including our ability to raise additional capital when needed on acceptable terms, if at all. A weak or declining economy could strain our suppliers, possibly resulting in supply disruption, or cause delays in payments for our services by third-party payors or our collaborators. Any of the foregoing could harm our business and we cannot anticipate all of the ways in which the current economic climate and financial market conditions could adversely impact our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">A public health crisis, such as the Covid-19 pandemic may impact our business, including preclinical and clinical trials and regulatory approvals.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In response to a public health crisis, governments, public institutions, and other organizations in countries and localities may take certain preventative or protective measures to combat the transmission of the virus, including the implementation of travel restrictions or bans, closures of non-essential businesses, limitations of public gatherings, other social distancing and shelter-in-place measures, and delays or cancellations of elective surgeries. A public health crisis could pose the risk that the Company, our employees, contractors, suppliers, and other partners may be prevented from conducting business activities for an indefinite period of time due to shutdowns that may be requested or mandated by state and federal governmental authorities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our business and planned clinical trials could be materially impacted by disruptions such as:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">delays or difficulties in conducting preclinical research and clinical trials;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">interruption in global manufacturing and shipping that may affect the manufacturing and/or transport of clinical trial materials and other materials, including testing equipment and personal protective equipment, used at our or our CROs&#8217; and contract manufacturing organizations&#8217; (CMOs&#8217;) facilities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changes in local regulations as part of a response to the public health crisis which may require us to change the way in which clinical trials are conducted and may result in unexpected costs; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">impact our ability to secure additional financing.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, a public health crisis could disrupt our operations due to absenteeism by infected or ill members of Executive Management or other employees, or absenteeism by members of Executive Management and other employees who elect not to come to work due to the illness affecting others in our office or laboratory facilities, or due to quarantines. Such a public health crisis could also impact members of our Board and its ability to hold meetings. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Our ability to effectively monitor and respond to the rapid and ongoing developments and expectations relating to environmental, social and governance (ESG) matters, including related social expectations and concerns, may impose unexpected costs on us or result in reputational or other harm to us that could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If we are not able to adequately recognize and respond to the rapid and ongoing developments and governmental and social expectations relating to ESG matters such as climate change and access to health care and affordable drugs, this failure could result in missed corporate opportunities, additional regulatory, social or other scrutiny of us and our business, the imposition of unexpected costs or in damage to our reputation or our various relationships with governments, customers, employees, third parties and the communities in which we operate, in each case that could have a material adverse effect on our business, financial condition and results of operations.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">14</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Climate change, and laws, regulations and policies regarding climate change, could also pose additional legal or regulatory requirements related to greenhouse gas emissions reporting, carbon pricing, and mandatory reduction targets.  These more stringent requirements could increase our costs of sourcing, production, and transportation, as well as have negative reputational impacts if we fail to meet such requirements.  Failure to respond to risks regarding climate change may have a material adverse effect on our business, financial condition, results of operations and reputation.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We have no history of commercializing biologics or pharmaceutical products, which may make it difficult to evaluate the prospects for our future viability.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We began our operations in 2003. Our operations to date have been limited to financing and staffing our company, developing our technology and developing our product candidates as well as clinical trials. We have not yet demonstrated an ability to successfully complete a large-scale, pivotal clinical study, obtain marketing approval, manufacture a commercial-scale product, or conduct sales and marketing activities necessary for successful product commercialization. Consequently, predictions about our future success or viability may not be as accurate as they could be if we had a history of successfully developing and commercializing biologics or pharmaceutical products.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Our future growth and ability to compete depends on retaining our key personnel and recruiting additional qualified personnel.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our success depends upon the continued contributions of our key management, scientific and technical personnel, many of whom have substantial experience with or been instrumental for us and our projects. Members of our key management include Dr.&#160;Andrea Pfeifer, our Chief Executive Officer; Dr.&#160;Madiha Derouazi, our Chief Scientific Officer; Dr.&#160;Nuno Mendon&#231;a, our Chief Medical Officer; Piergiorgio Donati, our Chief Technical Operations Officer; Christopher Roberts, our Chief Financial Officer; Howard Donovan, our Chief Human Resources Officer; Jean-Fabien Monin, our Chief Administrative Officer; Dr.&#160;Julien Rong&#232;re, our Senior Vice President (SVP) for Regulatory Affairs and Quality Assurance; Dr.&#160;Olivier Sol, our Vice President (VP) Head of Clinical Development; Dr.&#160;Bojana Portmann, our VP for Intellectual Property and Business Development (VP IP and BD); Alexandre Caratsch, our General Counsel; and Mark Danton, our SVP Information Systems and Artificial Intelligence.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The loss of our key managers and senior scientists could delay our research and development activities. Laws and regulations on executive compensation, including legislation in our home country, Switzerland, may restrict our ability to attract, motivate and retain the required level of qualified personnel. In Switzerland, legislation affecting public companies is in force that, among other things, imposes an annual binding shareholders&#8217; &#8220;say on pay&#8221; vote with respect to the total compensation of executive management, including executive officers and the board of directors, and prohibits severance or similar payment, bonuses for company purchases and sales, and additional contracts as consultants to or employees of other companies in the group. In addition, the competition for qualified personnel in the pharmaceutical and biopharmaceutical field is intense, and our future success depends upon our ability to attract, retain and motivate highly skilled scientific, technical and managerial employees. We face competition for personnel from other companies, universities, public and private research institutions and other organizations. If our recruitment and retention efforts are unsuccessful in the future, it may be difficult for us to implement our business strategy, which could have a material adverse effect on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We may become exposed to costly and damaging liability claims, either when testing our product candidates in the clinic or at the commercial stage or as a result of claims against our directors and officers; and our liability insurance may not cover all damages from such claims.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are exposed to potential clinical trial liability and professional indemnity risks that are inherent in the research, development, manufacturing, marketing and use of pharmaceutical or biopharmaceutical products. Currently we have no products that have been approved for commercial sale, however, our current and future use of product candidates in clinical studies, and the sale of any approved products in the future, may expose us to liability claims. These claims might be made by patients that use the product, by healthcare providers, or by pharmaceutical or biopharmaceutical companies or others selling such products. Any claims against us, regardless of their merit, could be difficult and costly to defend and could materially adversely affect the market for our product candidates or any prospects for commercialization of our product candidates.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">15</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Although the clinical study process is designed to identify and assess potential side effects, it is always possible that a drug, even after regulatory approval, may exhibit unforeseen side effects. If any of our product candidates were to cause adverse side effects during clinical studies or after approval of the product candidate, we may be exposed to substantial liabilities. Physicians and patients may not comply with any warnings that identify known potential adverse effects and patients who should not use our product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We purchase liability insurance in connection with the clinical studies that we undertake and for the purpose of indemnifying our directors and officers for claims against them in amounts that we consider to be consistent with industry norms. It is possible that our liabilities could exceed our insurance coverage. For example, if we obtain marketing approval for any of our product candidates, we will intend to expand our insurance coverage to include the sale of commercial products. However, we may not be able to maintain insurance coverage at a reasonable cost or obtain insurance coverage that will be adequate to satisfy any liability that may arise. If a successful liability claim or series of claims is brought against us for uninsured liabilities or in excess of insured liabilities, our assets may not be sufficient to cover such claims and our business operations could be impaired.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Should any of the events described above occur, this could have a material adverse effect on our business, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We may seek to obtain orphan-drug designation for certain of our product candidates. Orphan-drug designation may not ensure that we will enjoy market exclusivity in a particular market, and if we fail to obtain or maintain orphan-drug exclusivity for such product candidates, we may be subject to earlier competition and our potential revenue will be reduced.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under the Orphan Drug Act, the FDA may designate a product as an orphan drug if it is intended to treat a rare disease or condition, defined as a patient population of fewer than 200,000 in the U.S., or a patient population greater than 200,000 in the U.S. where there is no reasonable expectation that the cost of developing the drug will be recovered from sales in the U.S. In the European Union (EU), the EMA&#8217;s Committee for Orphan Medicinal Products grants orphan-drug designation to promote the development of products that meet the following criteria: a) they are intended for the diagnosis, prevention, or treatment of a life-threatening or chronically debilitating condition affecting not more than 5 in 10,000 persons in the EU or for products that are intended for the diagnosis, prevention or treatment of a life-threatening, seriously debilitating or serious and chronic condition when, without incentives, it is unlikely that sales of the drug in the EU would be sufficient to justify the necessary investment in developing the drug or biological product; and b) there is no satisfactory method of diagnosis, prevention, or treatment, or, if such a method exists, the medicine must be of significant benefit to those affected by the condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the U.S., orphan-drug designation entitles a party to financial incentives such as opportunities for grant funding toward clinical study costs, tax advantages and user-fee waivers. In addition, if a product receives the first FDA approval for the indication for which it has orphan designation, the product is entitled to orphan-drug exclusivity, which means that the FDA cannot approve any other application to market the same drug for the same indication for a period of 7&#160;years, except in limited circumstances, such as a showing of clinical superiority over the product with orphan exclusivity or if the manufacturer is unable to assure sufficient product quantity. In the EU, orphan-drug designation entitles a party to financial incentives such as reduction of fees or fee waivers and 10&#160;years of market exclusivity for the orphan indication following drug or biological product approval, provided that the criteria for orphan designation are still applicable at the time of the granting of the marketing authorization. This period may be reduced to 6&#160;years if at the end of the fifth&#160;year, the orphan-drug designation criteria are no longer met, including where it is shown that the product is sufficiently profitable not to justify maintenance of market exclusivity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We may not be able to obtain orphan-drug designation for any of our product candidates, and even if we do, we may not be the first to obtain marketing approval for any particular orphan indication due to the uncertainties associated with developing pharmaceutical or biopharmaceutical products. Further, even if we obtain orphan-drug designation for a product, that exclusivity may not effectively protect the product from competition because different drugs with different active moieties can be approved for the same condition. Orphan-drug designation neither shortens the development time or regulatory review time of a drug nor gives the drug any advantage in the regulatory review or approval process.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">16</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Due to our limited resources and access to capital, we must prioritize development of certain product candidates.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Because we have limited resources and access to capital to fund our operations, we must decide which product candidates to pursue and the amount of resources to allocate to each. Our decisions concerning the allocation of research, collaboration, management and financial resources toward particular compounds, product candidates or therapeutic areas may not lead to the development of viable commercial products and may divert resources away from better opportunities. Similarly, our potential decisions to delay, terminate or collaborate with third parties in respect of certain product development programs may also prove not to be optimal and could cause us to miss valuable opportunities. If we make incorrect determinations regarding the market potential of our product candidates or misread trends in the pharmaceutical or biopharmaceutical industry, in particular for neurological disorders, our business, financial condition and results of operations could be materially adversely affected.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Our research and development activities could be affected or delayed as a result of possible restrictions on animal testing.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Certain laws and regulations require us to test our product candidates on animals before initiating clinical studies in humans. Animal testing activities have been the subject of controversy and adverse publicity. Animal rights groups and other organizations and individuals have attempted to stop animal testing activities by pressing for legislation and regulation in these areas and by disrupting these activities through protests and other means. To the extent that the activities of these groups are successful, our research and development activities may be interrupted, delayed or become more expensive.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">A breakdown or breach of our information technology systems and cybersecurity efforts, or those of our key business partners, CROs or service providers, could subject us to liability or reputational damage or interrupt the operation of our business.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are increasingly dependent upon technology systems and data. Our computer systems continue to increase in multitude and complexity due to the growth in our business, making them potentially vulnerable to breakdown, malicious intrusion and random attack.&#160;Despite the implementation of security measures, our internal computer systems and those of our key business partners, CROs and service providers may be vulnerable to damage from computer viruses, unauthorized access or other similar cyber-attacks or incidents. Events such as these have significantly increased in recent years, in part because of the proliferation of new technologies (including artificial intelligence), and if such an event were to occur and cause interruptions in our operations, it could result in a material disruption of our development programs and our business operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Data privacy or security breaches, cyber-attacks and other cybersecurity incidents, including those by individuals authorized to access our technology systems or others, may pose a risk that sensitive data, including intellectual property, trade secrets or personal information belonging to us, our patients, study subjects or other business partners, may be exposed to unauthorized persons or to the public. Cyber-attacks are increasing in their frequency, sophistication and intensity, and are becoming increasingly difficult to detect. They are often carried out by motivated, well-resourced, skilled and persistent actors, including nation states, state-sponsored actors, organized crime groups, &#8220;hacktivists&#8221;, employees or contractors acting with malicious intent and other external actors, and such actors may see their effectiveness enhanced by the use of artificial intelligence. Cyber-attacks could include the deployment of harmful malware and key loggers, ransomware, a denial-of-service attack, a malicious website, phishing attacks, computer viruses, social engineering and other means to affect the confidentiality, integrity and availability of our technology systems and data. Our systems and networks are also vulnerable to damage or interruption from, among other things, software bugs, server malfunctions, software or hardware failure, telecommunications failures, insider theft, fire, terrorist attacks, natural disasters, power loss, war, misuse, mistake, fraud, misconduct or other events that may harm our systems and networks. Our key business partners, CROs and service providers face similar risks, and any security breach or other failure of their systems could adversely affect our security posture. For example, the loss of clinical trial data from completed, ongoing or future clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. Likewise, we rely on our third-party research institution collaborators for research and development of our product candidates and on other third parties for the manufacture of our product candidates and to conduct clinical trials, and similar events relating to their computer systems could also have a material </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">17</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">adverse effect on our business. Our ability to evaluate and monitor our CROs&#8217;, contractors&#8217; and consultants&#8217; data security practices are limited, and due to applicable laws and regulations or contractual obligations, we may be held responsible for any security breaches or cybersecurity attack attributed to them as they relate to the information we share with them. To the extent that any disruption or security breach were to result in a loss of, or damage to, our data or systems, or inappropriate disclosure of confidential or proprietary information or personal data of our employees, partners or study subjects, we could incur liability including notification obligations (including to the impacted individuals and applicable regulators or supervisory authorities), and the further development and commercialization of our product candidates could be delayed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Although we continue to build and improve our systems and infrastructure, and to implement technical, organizational and legal security measures, and believe we have taken appropriate security measures to reduce these risks to our data and information technology systems, there can be no assurance that our efforts will prevent, detect or appropriately respond to breakdowns or breaches in our systems that could adversely affect our business and operations and/or result in the loss of critical or sensitive information, including personal information, which could result in financial, legal, business or reputational harm to us. We continue to invest in industry standard IS/IT solutions and managed services that often include the relevant, layered protection and monitoring practices surrounding our data and IT systems and related infrastructure. These investments reduce further these risks in that they enable organizations such as ours to leverage the resources necessary to monitor IT systems and infrastructure for any current or potential threats. We also regularly perform risk and impact assessments, the results of which generally lead to the implementation of certain measures designed to increase our level of data protection. These investments are costly, and as cyber threats continue to evolve, we may be required to expend significant, additional resources to continue to modify and/or enhance our protective, detective and responsive measures required to remediate any identified information security vulnerabilities. In addition, our liability insurance may not be sufficient in type or amount to cover us against claims related to security breaches, cyber-attacks and other related breaches, and we cannot be sure that our existing coverage will continue to be available on acceptable terms or at all, or that our insurers will not deny coverage as to any future claim. We may be required to expend significant capital and other resources to protect against and respond to any attempted or existing cybersecurity incidents. In addition, our remediation efforts may not be successful.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, certain global geo-political events can increase our cybersecurity risk. For example, due to the recent Russia-Ukraine conflict, there have been publicized threats to increase cyber-attack activity against the critical infrastructure of any nation or organization that retaliates against Russia for its invasion of Ukraine. There may also be increased risks of cyber-attacks as a result of the unfolding events in Israel and the Gaza Strip. Any such increase in such attacks on us or our key business partners, CROs or service providers could adversely affect our systems or other operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Changes in laws, rules&#160;or regulations relating to data privacy and security, or any actual or perceived failure by us to comply with such laws, rules, regulations and standards, or contractual or other obligations relating to data privacy and security, could result in claims, changes to our business practices, penalties, increased cost of operations and could have a material adverse effect on our reputation, results of operations, financial condition and cash flows.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are, and may increasingly become, subject to various laws, rules, regulations, treaties, decisions and standards, as well as contractual obligations, relating to data privacy and security in the jurisdictions in which we operate. The regulatory environment related to data privacy and security is increasingly rigorous, with new and constantly changing requirements applicable to our business, and enforcement practices are likely to remain uncertain for the foreseeable future. These laws, rules, regulations, treaties, decisions and standards may be interpreted and applied differently over time and from jurisdiction to jurisdiction and in a manner that is inconsistent with our data practices and that could have a material adverse effect on our results of operations, financial condition and cash flows. New laws, amendments to or reinterpretations of existing laws, rules, regulations, treaties, decisions, standards and other obligations may require us to incur additional costs and restrict our business operations, and may require us to change how we use, collect, store, transfer or otherwise process certain types of personal information and to implement new processes to comply with those laws.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">18</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the U.S., there are numerous federal and state laws and regulations related to the privacy and security of personal information. Regulations promulgated pursuant to the U.S. Health Insurance Portability and Accountability Act of 1996 (HIPAA) establish privacy and security standards that limit the use and disclosure of protected health information, and require the implementation of administrative, physical and technological safeguards to protect the privacy of protected health information and to ensure the confidentiality, integrity and availability of electronic protected health information. Determining whether protected health information has been handled in compliance with applicable privacy standards and our contractual obligations can be complex and may be subject to changing interpretation. Numerous states have enacted or are in the process of enacting state level data privacy laws and regulations governing the collection, use, and other processing of state residents&#8217; personal information, such as the California Consumer Privacy Act (CCPA) as amended by the California Privacy Rights Act of 2020 (CPRA), which provides new and enhanced data privacy rights to California residents, such as affording California residents the right to access and delete their information and to opt out of certain sharing and sales of personal information. In addition, laws in all 50 states require businesses to provide notice to individuals whose personal information has been disclosed as a result of a data breach.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Internationally, laws, regulations and standards in many jurisdictions apply broadly to the collection, use, retention, security, disclosure, transfer and other processing of personal information. For example, the EU General Data Protection Regulation (GDPR), which became effective in May&#160;2018, greatly increased the European Commission&#8217;s jurisdictional reach of its laws and adds a broad array of requirements for handling personal data. EU Member States are tasked under the GDPR to enact, and to have enacted, certain implementing legislation that adds to and/or further interprets the GDPR requirements and potentially extends our obligations and potential liability for failing to meet such obligations. The GDPR, together with national legislation, regulations and guidelines of the EU Member States and Switzerland (via its Federal Data Protection Act) governing the processing of personal data, impose strict obligations and restrictions on the ability to collect, use, retain, protect, disclose, transfer and otherwise process personal data. In particular, the GDPR includes obligations and restrictions concerning the consent and rights of individuals to whom the personal data relates (and the obligations of sponsors of clinical trials acting as data controllers), the transfer of personal data out of the European Economic Area (EEA), the notification of security breaches and the security and confidentiality of personal data. The GDPR authorizes fines for certain violations of up to 4% of global annual revenue or EUR 20 million, whichever is greater. The GDPR also applies to our key business partners, CROs and service providers, whether or not they are located in Europe, with which we share personal data subject to the GDPR. Additionally, following Brexit, we also are subject to the UK General Data Protection Regulation (UK GDPR) (i.e. a version of the GDPR as implemented into UK law), exposing us to two parallel regimes with potentially divergent interpretations and enforcement actions for certain violations. While the European Commission issued an adequacy decision intended to remain in effect until June 2025 in respect of the UK&#8217;s data protection framework, enabling data transfers from EU Member States to the UK to continue without requiring organizations to put in place contractual or other measures in order to lawfully transfer personal data between the territories, the relationship between the UK and the EU in relation to certain aspects of data privacy and security law remains unclear. For example, such decision may be revoked in the future by the European Commission if the UK data protection regime is reformed in ways that deviate substantially from the GDPR. Although we do not have material operations in the UK, we cannot rule&#160;out potential disruptions in relation to the clinical regulatory framework applicable to our clinical studies in the UK, and to data privacy and security rules&#160;with respect to personal data sharing with vendors and clinical investigators in the UK, and we cannot predict future implications. Similarly, while on July 10, 2023 the European Commission adopted an adequacy decision concluding that the U.S. ensures an adequate level of protection for personal data transferred from the EEA to the U.S. under the EU-U.S. Data Privacy Framework (followed on October 12, 2023 with the adoption of an adequacy decision in the UK for the UK-U.S. Data Bridge), such decision does not foreclose, and is likely to face, future legal challenges and ongoing legal uncertainty. In addition, additional costs may need to be incurred in order to implement necessary safeguards to comply with the GDPR and the UK GDPR and potential new rules and restrictions on the flow of data across borders could increase the cost and complexity of conducting business in some markets. If our policies and practices or those of our key business partners, CROs or service providers are, or are perceived to be, insufficient, or if our users have concerns regarding our transfers of data, we could be subject to enforcement actions or investigations by individual EU or UK data protection authorities or lawsuits by private parties. While we have taken steps to mitigate the impact of such complexities and uncertainties on us by implementing supplementary measures in accordance with the applicable regulations, the efficacy and longevity of these mechanisms remains uncertain due to the fast-moving regulatory environment.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">19</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">All of these evolving compliance and operational requirements impose significant costs, which are likely to increase over time. In addition, such requirements may require us to modify our data processing practices and policies, distract management or divert resources from other initiatives and projects. If we are unable to properly protect the privacy and security of personal information, including protected health information, we could be found to have breached our contracts. In addition, any failure or perceived failure by us to comply with any applicable federal, state or similar foreign laws and regulations relating to data privacy and security could result in damage to our reputation and our relationship with our customers, as well as proceedings or litigation by governmental agencies, customers, partners, collaborators and/or study subjects, including class action privacy litigation in certain jurisdictions, which would subject us to significant fines, sanctions, awards, penalties or judgments, all of which could have a material adverse effect on our business, results of operations, financial condition and prospects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Business disruptions could seriously harm our future revenue and financial condition and increase our costs and expenses.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our operations, and those of our third-party research institution collaborators, CROs, CMOs, suppliers, and other contractors and consultants, could be subject to earthquakes, power shortages, telecommunications failures, water shortages, floods, hurricanes, typhoons, fires, extreme weather conditions, medical epidemics, and other natural or man-made disasters or business interruptions, for which we are partly uninsured. In addition, we rely on our third-party research institution collaborators for conducting research and development of our product candidates, and they may be affected by government shutdowns or withdrawn funding. In addition, Hamas&#8217; attacks against Israelis in Gaza and Israel&#8217;s military responses have spawned or may spawn regional military confrontations between Israel and neighboring Arab countries and their respective allies around the world that may cause political and economic disruptions. Moreover, since the end of 2021, tensions between the United States and Russia escalated when Russia amassed large numbers of military ground forces and support personnel on the Ukraine-Russia border and, in February&#160;2022, Russia invaded Ukraine. In response, North Atlantic Treaty Organization, or NATO has deployed additional military forces to Eastern Europe, including to Lithuania, and the Biden administration announced certain sanctions against Russia. The invasion of Ukraine and the retaliatory measures that have been taken, or could be taken in the future, by the United States, NATO, and other countries have created global security concerns that could result in a regional conflict and otherwise have a lasting impact on regional and global economies, any or all of which could disrupt our supply chain, adversely affect our ability to conduct ongoing and future clinical trials of our product candidates, and adversely affect our ability to commercialize our products (subject to regulatory approval) in this region. Currently, none of our clinical development or business activities are conducted directly or otherwise in Russia or Ukraine. The occurrence of any of these business disruptions could seriously harm our operations and financial condition and increase our costs and expenses. We rely on third-party manufacturers to produce and process our product candidates. Our ability to obtain clinical supplies of our product candidates could be disrupted if the operations of these suppliers are affected by a man-made or natural disaster or by other business interruption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The vast majority of our operations including our corporate headquarters are located in Ecublens, near Lausanne, Canton of Vaud, Switzerland. Damage or extended periods of interruption to our corporate, development or research facilities due to fire, natural disaster, power loss, communications failure, unauthorized entry or other events could cause us to cease or delay development of some or all of our product candidates. Although we maintain property damage and business interruption insurance coverage on these facilities, our insurance might not cover all losses under such circumstances and our business may be seriously harmed by such delays and interruption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We have never commercialized a product candidate before and may lack the necessary expertise, personnel and resources to successfully commercialize our products on our own or together with suitable partners.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have never commercialized a product candidate, and we currently have no sales force, marketing or distribution capabilities. To achieve commercial success for our product candidates, we will have to develop our own sales, marketing and supply organization or outsource these activities to third parties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Factors that may affect our ability to commercialize our product candidates on our own include recruiting and retaining adequate numbers of effective sales and marketing personnel, obtaining access to or persuading adequate numbers of physicians to prescribe our product candidates, and other unforeseen costs associated with creating an </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">20</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">independent sales and marketing organization. Developing a sales and marketing organization requires significant investment, is time-consuming and could delay the launch of our product candidates. We may not be able to build an effective sales and marketing organization. In addition, successful commercialization also requires an enhanced regulatory organization which we currently do not have. If we are unable to build our own distribution and marketing capabilities, are unable to find suitable partners for the commercialization of our product candidates or do not successfully obtain the necessary regulatory capabilities, we may not generate revenues from them or be able to reach or sustain profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Inadequate funding for the FDA, the SEC, and other government agencies, including from government shutdowns, or other disruptions to these agencies' operations, could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal business functions on which the operation of our business may rely, which could negatively impact our business.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels, the ability to hire and retain key personnel and the acceptance of user fees payments, and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in recent years as a result. If a prolonged government shutdown occurs, if the FDA is required to furlough review staff or necessary employees, or if the agency operations are otherwise impacted, it could significantly affect the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business. Further, future government shutdowns could impact our ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to our relationships with third parties</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">If we fail to maintain our current strategic relationships with Eli Lilly and Company (Lilly), Janssen Pharmaceuticals Inc. (Janssen) part of the Janssen Pharmaceutical Companies of Johnson &amp; Johnson, Life Molecular Imaging SA (LMI) and other of our current or future strategic partners, our business, commercialization prospects and financial condition may be materially adversely affected.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In December&#160;2018, we signed a license agreement with Lilly to research and develop Morphomer Tau small molecules for the treatment of AD and other neurodegenerative diseases (NDD). This collaboration commenced in Q1 2019. We are in a partnership with Janssen to develop and commercialize therapeutic anti-Tau active immunotherapies for the treatment of AD and potentially other Tauopathies. We also have a diagnostic partnership with LMI for compounds, which bind pathological Tau for use as a PET tracer. Our collaboration partners each have the right to terminate their agreements with us for any reason upon providing us with a certain notice period. If Lilly, Janssen, LMI or other of our current or future strategic partners terminates its agreement with us at any time, it could delay or prevent development of our product candidates and materially harm our business, financial condition, commercialization prospects and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Good relationships with Lilly, Janssen, LMI and other of our current or future strategic partners are important for our business prospects. If our relationships with Lilly, Janssen, LMI or other of our current or future strategic partners were to deteriorate substantially or if Lilly, Janssen, LMI or other of our current or future strategic partners were to challenge our use of their intellectual property or our calculations of the payments we are owed under our agreements, our business, financial condition, commercialization prospects and results of operations could be materially adversely affected.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Lastly, our collaboration agreements with Lilly, Janssen and LMI provide each partner with control over, and responsibility for, the clinical development process, including obtaining regulatory and marketing approvals, manufacturing costs and sales and marketing costs. Future collaboration agreements may also relinquish development control to our partners. Our current or future collaboration partners may and do separately pursue competing products, therapeutic approaches or technologies to develop treatments for the diseases targeted by us or our collaborative efforts. Even if our partners continue their contributions to the collaborative agreements to which we are a party, they may nevertheless determine not to actively pursue the development or commercialization of any resulting products. Our </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">21</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">partners may also fail to fulfill their obligations under the collaboration agreements or may be slow in performing their obligations. Any of these circumstances could result in a material adverse impact on our business, financial condition, commercialization prospects or results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We may seek to form additional strategic alliances in the future with respect to our product candidates, and if we do not realize the benefits of such alliances, our business, financial condition, commercialization prospects and results of operations may be materially adversely affected.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our product development programs and the potential commercialization of our product candidates will require substantial additional liquidity to fund expenses and may require expertise, such as sales and marketing expertise, which we do not currently possess. Therefore, in addition to our relationships with Lilly, Janssen and LMI, we may decide to enter into strategic alliances or to create joint ventures or collaborations with pharmaceutical or biopharmaceutical companies for the further development and potential commercialization of those and other of our product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We face significant competition in seeking appropriate collaborators. Collaborations are complex and time-consuming to negotiate, document and manage. Any delays in entering into new strategic partnership agreements related to our product candidates could delay the development and commercialization of our product candidates and reduce their competitiveness even if they reach the market. We may also be restricted under existing and future collaboration agreements from entering into strategic partnerships or collaboration agreements on certain terms with other potential collaborators. We may not be able to negotiate collaborations on acceptable terms, or at all, for any of our existing or future product candidates and programs because the potential partner may consider that our research and development pipeline is insufficiently developed to justify a collaborative effort, or that our product candidates and programs do not have the requisite potential to demonstrate safety and efficacy in the target population. If we are unsuccessful in establishing and maintaining a collaboration with respect to a particular product candidate, we may have to curtail the development of that product candidate, reduce the scope of or delay its development program or one or more of our other development programs, delay its potential commercialization or reduce the scope of our sales or marketing activities, or increase our expenditures and undertake development or commercialization activities at our own expense, for which we have not budgeted. If we elect to increase our expenditures to fund development or commercialization activities on our own, we may need to obtain additional capital, which may not be available to us on acceptable terms or at all. If we do not have sufficient funds, we will not be able to bring our product candidates to market and generate product revenue. Even if we are successful in establishing a new strategic partnership or entering into a collaboration agreement, we cannot be certain that, following such a strategic transaction or license, we will be able to progress the development and commercialization of the applicable product candidates as envisaged, or that we will achieve the revenues that would justify such transaction, and we could be subject to the following risks, each of which may materially harm our business, commercialization prospects and financial condition:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we may not be able to control the amount and timing of resources that the collaboration partner devotes to the product development program;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the collaboration partner may experience financial difficulties;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we may be required to grant or otherwise relinquish important rights such as marketing, distribution and intellectual property rights;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a collaboration partner could move forward with a competing product developed either independently or in collaboration with third parties, including our competitors; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">business combinations or significant changes in a collaboration partner&#8217;s business strategy may adversely affect our willingness to continue any arrangement.</span></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">22</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We rely on third parties to conduct our nonclinical and clinical studies and perform other tasks for us. If these third parties do not successfully carry out their contractual duties, meet expected deadlines or comply with regulatory requirements, we may not be able to obtain regulatory approval for or commercialize our product candidates, and our business could be substantially harmed.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have relied upon and plan to continue to rely upon third-party clinical CROs, to monitor and manage data for our ongoing preclinical and clinical programs, including the clinical studies of our product candidates. We rely on these parties for execution of our nonclinical and clinical studies and control only certain aspects of their activities. Nevertheless, we are responsible for ensuring that each of our studies is conducted in accordance with the applicable protocol, legal, regulatory and scientific standards and our reliance on the clinical CROs does not relieve us of our regulatory responsibilities. We and our clinical CROs and other vendors are required to comply with current Good Manufacturing Practice (cGMP), current Good Clinical Practice (cGCP), and current Good Laboratory Practice (cGLP), which are regulations and guidelines enforced by the FDA, the Competent Authorities of the Member States of the EU and comparable foreign regulatory authorities for our product candidates in nonclinical and clinical development (where applicable). Regulatory authorities enforce these regulations through periodic inspections of study sponsors, principal investigators, study sites and other contractors. If we or any of our clinical CROs or vendors fail to comply with applicable regulations, the data generated in our nonclinical and clinical studies may be deemed unreliable and the EMA, FDA, other regulatory authorities may require us to perform additional nonclinical and clinical studies before approving our marketing applications. We cannot assure you that upon inspection by a given regulatory authority, such regulatory authority will determine that all of our clinical studies comply with cGCP regulations. In addition, our clinical studies must be conducted with products produced under cGMP regulations. Our failure to comply with these regulations may require us to repeat clinical studies, which would delay the regulatory approval process.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If any of our relationships with these third-party clinical CROs terminates, we may not be able to enter into arrangements with alternative clinical CROs or do so on commercially reasonable terms. In addition, our clinical CROs are not our employees, and except for remedies available to us under our agreements with such clinical CROs, we cannot control whether or not they devote sufficient time and resources to our ongoing nonclinical and clinical programs. If clinical CROs do not successfully carry out their contractual duties or obligations or meet expected deadlines, if they need to be replaced or if the quality or accuracy of the data they obtain is compromised due to their failure to adhere to our protocols, regulatory requirements, or for other reasons, our clinical studies may be extended, delayed, or terminated and we may not be able to obtain regulatory approval for or successfully commercialize our product candidates. Clinical CROs may also generate higher costs than anticipated. As a result, our results of operations and the commercial prospects for our product candidates would be harmed, our costs could increase, and our ability to generate revenue could be delayed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Switching or adding additional clinical CROs involves additional cost and requires management time and focus. In addition, there is a natural transition period when a new clinical CRO commences work. As a result, delays occur, which could materially impact our ability to meet our desired clinical development timelines. Though we carefully manage our relationships with our clinical CROs, there can be no assurance that we will not encounter similar challenges or delays in the future or that these delays or challenges will not have a material adverse impact on our business, financial condition and prospects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We currently rely on third-party suppliers and other third parties for production of our product candidates and our dependence on these third parties may impair the advancement of our research and development programs and the development of our product candidates.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We currently rely on, and expect to continue to rely on, third parties for the manufacturing and supply of chemical and biological compounds and formulations for the clinical studies of our current and future product candidates. For the foreseeable future, we expect to continue to rely on such third parties for the manufacture of any of our product candidates on a clinical or commercial scale, if any of our product candidates receives regulatory approval. Reliance on third-party providers may expose us to different risks than if we were to manufacture product candidates ourselves. The facilities used by our contract manufacturers to manufacture our product candidates must be approved by the FDA or other regulatory authorities, pursuant to inspections that will be conducted after we submit our NDA or comparable marketing application to the FDA or other regulatory authority. We do not have control over a supplier&#8217;s or </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">23</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">manufacturer&#8217;s compliance with these laws, regulations and applicable cGMP standards and other laws and regulations, such as those related to environmental health and safety matters. If our contract manufacturers cannot successfully manufacture material that conforms to our specifications and the strict regulatory requirements of the FDA or others, they will not be able to secure and/or maintain regulatory approval for their manufacturing facilities. In addition, we have no control over the ability of our contract manufacturers to maintain adequate quality control (QC), quality assurance (QA) and qualified personnel. If we are compelled or we wish to find alternative manufacturing facilities, this could significantly impact our ability to develop, obtain regulatory approval for or market our product candidates. Any failure to achieve and maintain compliance with these laws, regulations and standards could subject us to the risk that we may have to suspend the manufacturing of our product candidates or that obtained approvals could be revoked, which would adversely affect our business and reputation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Third-party providers may breach agreements they have with us because of factors beyond our control. Contract manufacturers often encounter difficulties involving production yields, QC and QA, as well as shortages of qualified personnel. They may also terminate or refuse to renew their agreements because of their own financial difficulties or business priorities, potentially at a time that is costly or otherwise inconvenient for us. If we are unable to find adequate replacement or another acceptable solution in time, our clinical studies could be delayed or our commercial activities could be harmed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, the fact that we are dependent on our suppliers and other third parties for the manufacture, storage and distribution of our product candidates means that we are subject to the risk that our product candidates and, if approved, commercial products may have manufacturing defects that we have limited ability to prevent or control. The sale of products containing such defects could result in recalls or regulatory enforcement action that could adversely affect our business, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Growth in the costs and expenses of components or raw materials, in particular as a result of rising inflation, may also adversely influence our business, financial condition and results of operations. Supply sources could be interrupted from time to time and, if interrupted, we cannot be certain that supplies could be resumed (whether in part or in whole) within a reasonable timeframe and at an acceptable cost or at all. Our current and anticipated future dependence upon others for the manufacturing of our current and future product candidates may adversely affect our future profit margins and our, or our collaboration partners&#8217;, ability to commercialize any products that receive marketing approval on a timely and competitive basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Our collaboration arrangements with our strategic partners may make us an attractive target for potential acquisition under certain circumstances.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under certain circumstances, due to the structure of our collaboration arrangements with our strategic partners, our strategic partners may prefer to acquire us rather than pay the milestone payments or royalties under the collaboration arrangements, which may bring additional uncertainties to our business development and prospects. For example, under our collaboration arrangements with Lilly and Janssen, we may become entitled to substantial milestone payments and royalties. As a result, rather than paying the milestone payments or royalties, Lilly or Johnson &amp; Johnson, or one of their affiliates may choose to acquire us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to intellectual property</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">We may not have sufficient patent terms to protect our products and business effectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Patents have a limited lifespan. In the U.S., the natural expiration of a patent is generally 20&#160;years after it is filed. Although various extensions or adjustments may be available, such as adjustments based on certain delays caused by the U.S. Patent and Trademark Office (USPTO) the life of a patent, and the protection it affords, is limited. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, our owned, co-owned and licensed patent portfolios may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours or otherwise provide us with a competitive advantage. Even if </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">24</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">patents covering our product candidates are obtained and unchallenged, once the patent life has expired for a product, we may be open to competition from generic medications.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Although patent term extensions under the Hatch-Waxman Act, in the U.S. and under supplementary protection certificates (SPCs) in Europe may be available to extend the patent exclusivity term for our products, we cannot provide any assurances that any such patent term extension will be obtained and, if so, for how long. The Hatch-Waxman Act permits a patent extension term of up to 5&#160;years as compensation for patent term lost during the FDA regulatory review process. A patent term extension cannot extend the remaining term of a patent beyond a total of 14&#160;years from the date of product approval, only one patent may be extended, and only those claims covering the approved drug, a method for using it or a method for manufacturing it may be extended. However, we may not be granted any extension because of, for example, failing to exercise due diligence during the testing phase or regulatory review process, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant patents or otherwise failing to satisfy applicable requirements. It is not possible to base an SPC in Europe on a patent in a European Member State if that patent expires before the Market Authorization (MA) of the clinical product, protected by the patent, is obtained. As the &#8220;product&#8221; (active ingredient(s)) must be &#8220;protected by a basic patent in force,&#8221; only a granted patent that is in force, and remains in force until it reaches the end of its full term, can serve as a &#8220;basic patent&#8221; upon which an SPC can be based. Therefore, expired patents and pending patent applications cannot serve as the basis for an SPC. Given the relatively long clinical development timelines of biologicals and new chemical entities for therapeutic purposes, we may not be granted any patent extensions as we might fail to apply for the extensions prior to expiration of relevant patents. Moreover, the applicable time period or the scope of patent protection afforded could be less than we request. If we are unable to obtain patent term extension or if the term of any such extension is less than we request, such result could have a material adverse effect on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We or our licensing or collaboration partners may become subject to intellectual property-related litigation or other proceedings to protect or enforce our patents or the patents of our licensors or licensees and collaborators, any of which could be expensive, time-consuming, and unsuccessful, and may ultimately result in our loss of ownership of intellectual property.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Competitors may infringe our patents or the patents of our licensors or collaborators. To counter such infringement, we may be required to file infringement claims against those competitors, which can be expensive and time-consuming. If we or one of our licensing or collaboration partners were to initiate legal proceedings against a third party to enforce a patent covering one of our product candidates, the defendant could counterclaim that the patent covering our product candidate is invalid or unenforceable or that the defendant&#8217;s products do not infringe our or our licensing collaborators&#8217; patents or that we or our licensing collaborators infringe the defendant&#8217;s patents. In patent litigation in the U.S., defendant counterclaims alleging invalidity, unenforceability and non-infringement are commonplace. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness, obviousness-type double patenting, lack of written description, or non-enablement. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the USPTO, or made a misleading statement, during prosecution. In addition, third parties may raise similar claims before administrative bodies in the U.S. or abroad, even outside the context of litigation. Such mechanisms include re-examination, post-grant review<i style="font-style:italic;">, inter partes</i> review, interference and derivation proceedings as well as equivalent proceedings in foreign jurisdictions, such as opposition proceedings in Europe. The outcome following legal assertions of invalidity and unenforceability is unpredictable. Such proceedings or patent litigations could result in the revocation or cancellation of or amendment to our patents in such a way that they no longer cover our product candidates or otherwise provide any competitive advantage. With respect to the validity question, for example, we cannot be certain that there is no invalidating prior art, of which the patent examiner and we or our licensing or collaboration partners were unaware during prosecution. A court may also refuse to stop a third party from using the technology in question on the grounds that our patents do not cover that technology. An adverse result in any proceeding could put one or more of our patents at risk of being invalidated or interpreted narrowly, which could have a material adverse effect on our business and financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Interference, derivation or other proceedings provoked by third parties, brought by us or declared by the USPTO may be necessary to determine the priority of inventions with respect to our patents or patent applications or those of our licensors, licensees or collaborators. An unfavorable outcome could require us or our licensing or collaboration partners </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">25</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">to cease using the related technology or to attempt to license rights to it from the prevailing party. Our business could be materially harmed if the prevailing party does not offer us or our licensing or collaboration partners a license on commercially reasonable terms or at all. If we or our licensing or collaboration partners are unsuccessful in any interference, derivation or other proceedings, we may lose our ownership of intellectual property or our patents may be narrowed or invalidated. There can be no assurance as to the outcome of the interference, derivation or other proceedings, and any of the foregoing could result in a material adverse effect on our business, financial condition, results of operations or prospects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our defense of litigation, interference, derivation or other proceedings or other intellectual property-related proceedings may fail and, even if successful, may result in substantial costs and distract our management and other employees from their normal responsibilities. Such litigation or proceedings could substantially increase our operating losses and could substantially reduce the funds necessary to continue our clinical studies and research programs or force us to license necessary technology from third parties, or enter into development partnerships that would help us bring our product candidates to market. We may not be able to prevent, alone or with our licensing or collaboration partners, misappropriation of our intellectual property rights, particularly in countries where the laws may not protect those rights as fully as in the U.S.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. There could also be public announcements of the results of hearings, motions, decisions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of our common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">If we or our licensing or collaboration partners are unable to obtain and maintain effective patent rights for our technologies, product candidates or any future product candidates, or if the scope of the patent rights obtained is not sufficiently broad, our competitors could develop and commercialize products and technology similar or identical to ours, and our, or our collaboration partners&#8217; ability to successfully commercialize our products and technology may be adversely affected.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We rely upon a combination of patents, trade secret protection and confidentiality agreements to protect the intellectual property related to our technologies and product candidates. Our success depends in large part on our and our licensing or collaboration partners&#8217; ability to obtain and maintain patent and other intellectual property protection in the U.S., the EU and other countries with respect to our proprietary technologies and product candidates. In particular, Lilly, Janssen or our other licensing or collaboration partners may be dependent on a license with a third party for the development and future commercialization of our product candidates. If such license is not granted or is terminated, Lilly, Janssen or other licensing or collaboration partners may be required to cease development and commercialization of our product candidates, any of which could have a material adverse effect on our business, financial condition, results of operations or prospects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have sought to protect our proprietary position by filing patent applications in the U.S. and abroad related to any of our novel technologies and products that are important to our business. This process is expensive, time-consuming, and complex, and we may not be able to file and prosecute all necessary or desirable patent applications at a reasonable cost, in a timely manner or in all jurisdictions. It is also possible that we will fail to identify patentable aspects of our or our licensing or collaboration partners&#8217; research and development output before it is too late to obtain patent protection. Moreover, in some circumstances, we do not have the right to control the preparation, filing and prosecution of patent applications, or to maintain the patents, covering technology that we license to or from third parties. Therefore, these patents and applications may not be prosecuted and enforced in a manner consistent with the best interests of our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The patent position of pharmaceutical and biopharmaceutical companies generally is highly uncertain and involves complex legal and factual questions for which legal principles remain unsolved. As a result, the inventorship, issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain. The pending or future patent applications that we own, co-own or in-license may fail to issue, fail to result in issued patents with claims that cover our product candidates in the U.S. or in other foreign countries, or fail to effectively prevent others from </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">26</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">commercializing competitive technologies and product candidates. Changes in either the patent laws or interpretation of the patent laws in the U.S. and other countries may diminish the value of our patents or narrow the scope of our patent protection.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We may not be aware of all third-party intellectual property rights potentially relating to our technologies or product candidates. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the U.S. and other jurisdictions remain confidential for a period of time after filing, and some remain so until issued. Therefore, we cannot be certain that we were the first to file any patent application related to our product candidates or technologies, or whether we were the first to make the inventions claimed in our owned or co-owned patents or pending patent applications, nor can we know whether those from whom we license patents were the first to make the inventions claimed or were the first to file.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">There is no assurance that all potentially relevant prior art relating to our patents and patent applications has been found, which can invalidate a patent or prevent a patent from issuing from a pending patent application. Even if patents do successfully issue, and even if such patents cover our product candidates, third parties may challenge their validity, enforceability, or scope, which may result in such patents being narrowed, found unenforceable or invalidated, which could allow third parties to commercialize our technology or products and compete directly with us, without payment to us, or result in our or our collaboration partners&#8217; inability to manufacture or commercialize products without infringing third-party patent rights. Furthermore, even if they are unchallenged, our patents and patent applications may not adequately protect our intellectual property, provide exclusivity for our product candidates, prevent others from designing around our claims or provide us with a competitive advantage. Any of these outcomes could impair our ability to prevent competition from third parties, which may have a material adverse effect on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We may be subject to claims challenging the inventorship of our patents and other intellectual property.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We may be subject to claims that former employees, collaborators or other third parties have an interest or title in our patents or other intellectual property as an inventor or co-inventor. For example, we may have inventorship disputes arise from conflicting obligations of consultants, CROs, CMOs, academic institutions or others who are involved in developing our product candidates. Litigation may be necessary to defend against these and other claims challenging inventorship or our ownership of our patents or other intellectual property. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or the right to use, valuable intellectual property. Such an outcome could have a material adverse effect on our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Patent policy and rule&#160;changes could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, thereby impairing our ability to protect our technologies and products.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Changes in either the patent laws or interpretation of the patent laws in the U.S., EU or elsewhere could increase the uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents. Assuming the other requirements for patentability are met, in the U.S. prior to March&#160;15, 2013, the first to make the claimed invention is entitled to the patent, whereas outside the U.S., the first to file a patent application was entitled to the patent. After March&#160;15, 2013, under the Leahy-Smith America Invents Act (the Leahy-Smith Act), enacted on September&#160;16, 2011, the U.S. has moved to a first-to-file system. Under a first-to-file system, assuming the other requirements for patentability are met, the first inventor to file a patent application generally will be entitled to the patent on an invention regardless of whether a third party was the first to invent the invention. The Leahy-Smith Act also includes a number of significant changes that affect the way patent applications are prosecuted and may also affect patent litigation. These include allowing third-party submission of prior art to the USPTO during patent prosecution and additional procedures to attack the validity of a patent by the USPTO administered during post grant proceedings, including re-examination proceedings, <i style="font-style:italic;">inter partes </i>review, post-grant review and derivation proceedings. Therefore, the Leahy-Smith Act and its implementation increases the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business, financial condition, results of operations and prospects. In addition, future actions by the U.S. Congress, </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">27</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">the federal courts and the USPTO could cause the laws and regulations governing patents to change in unpredictable ways. Any of the foregoing could harm our business, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">In Europe, the Unified Patent Court (UPC) entered into force in June 2023. The UPC provides a new centralized forum for pan-European litigation in contracting EU Member States (17 out of 27 EU Member States). Litigation of European patents in European Patent Convention countries outside of the EU (e.g. Switzerland, UK, Turkey) and in non-contracting EU countries (e.g. Spain, Poland) continues to be on a country-by-country basis in front of national courts. During a transition period (initially seven-years), patent owners can elect to keep their European patents outside of the jurisdiction of the UPC (&#8220;opt-out&#8221;). Whilst European patents may be opted-out of the UPC during such transition period, after expiry of such transition period EU legislation provides that the UPC jurisdiction will apply, in respect of the UPC contracting states for all European patents. Accordingly, the emergence of the UPC and its implementation increase the uncertainties surrounding the enforcement or defense of issued patents and related costs, which could have a material adverse effect on our business, financial condition, results of operations and prospects.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, the patent positions of companies in the development and commercialization of biologics and pharmaceuticals are particularly uncertain. U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. This combination of events has created uncertainty with respect to the validity and enforceability of patents, once obtained. Depending on future actions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that could have a material adverse effect on our existing patent portfolio and our ability to protect and enforce our intellectual property in the future in the U.S.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">If we are unable to maintain effective proprietary rights for our technologies, product candidates or any future product candidates, we may not be able to compete effectively in our markets.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition to the protection afforded by patents, we rely on trade secret protection and confidentiality agreements to protect proprietary know-how that is not patentable or that we elect not to patent, processes for which patents are difficult to enforce, and any other elements of our product candidate discovery and development processes that involve proprietary know-how, information or technology that is not covered by patents. However, trade secrets can be difficult to protect and some courts inside and outside the U.S. are less willing or unwilling to protect trade secrets. The EU has introduced a Directive on trade secrets increasing the standards for protection. Because we rely on our advisors, employees and third-party contractors and consultants to research and develop and to manufacture our product candidates, we must, at times, share our intellectual property with them. We seek to protect our intellectual property and other proprietary technology in part by entering into confidentiality agreements and master service agreements, if applicable, material transfer agreements, consulting agreements or other similar agreements with our advisors, employees, contractors, consultants, licensing and collaboration partners, and other third parties with confidentiality provisions. These agreements typically limit the rights of these third parties to use or disclose our confidential information, including our intellectual property and trade secrets. These agreements also typically restrict the ability of third parties to publish data potentially relating to our intellectual property, although our agreements may contain certain limited publication rights. For example, any academic institution that we may collaborate with in the future may expect to be granted rights to publish data arising out of such collaboration, provided that we may have the right to be notified in advance and given the opportunity to delay publication for a limited time period in order for us to secure patent protection of intellectual property rights arising from the collaboration, in addition to the opportunity to remove confidential or trade secret information from any such publication. We also conduct joint research and development programs that may require us to share intellectual property under the terms of our research and development or similar agreements. However, we cannot guarantee that we have entered into such agreements with each party that may have or have had access to our trade secrets or other confidential information or proprietary technology and processes, or that such agreements will not be breached or that our trade secrets or other confidential information will not otherwise be disclosed. Despite the contractual provisions employed when working with these advisors, employees and third-party contractors and consultants, the need to share intellectual property and other confidential information increases the risk that such confidential information becomes known by our competitors, is inadvertently incorporated into the product development of others or is disclosed or used in violation of these agreements. Additionally, our grant agreements typically provide for dissemination of results to academic institutions and to the general public. As a result, our information may be disseminated with the loss of protection status.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">28</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We also seek to preserve the integrity and confidentiality of our data and trade secrets by maintaining the physical security of our premises and the physical and electronic security of our information technology systems. Despite our efforts to protect our intellectual property, our competitors may discover our trade secrets through breach of our agreements by third parties, for which we may not have adequate remedies for any breach, or publication of information by any of our CROs, academic partners, funding organizations or our licensing or collaboration partners. Additionally, if the steps we take or that we impose on our CROs to maintain our trade secrets are deemed inadequate by law, we may have insufficient recourse against third parties for misappropriating such trade secrets. Misappropriation or unauthorized disclosure of our trade secrets could impair our competitive position and may have a material adverse effect on our business. Moreover, if any of our trade secrets were to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to prevent such competitor or other third party from using that technology or information to compete with us. A competitor&#8217;s or other third party&#8217;s discovery of our intellectual property would impair our competitive position and have a material adverse effect on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Further, the laws of some foreign countries do not protect proprietary rights to the same extent or in the same manner as the laws of the U.S. As a result, we may encounter significant problems in protecting and defending our intellectual property both in the U.S. and abroad. If we are unable to prevent material disclosure of the intellectual property related to our technologies to third parties, we will not be able to establish or maintain a competitive advantage in our market, which could materially adversely affect our business, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Despite confidentiality clauses within our employment and other agreements with employees, we cannot ensure that departing employees will not breach any post-termination commitments in such agreements by allowing others to access our trade secrets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Obtaining and maintaining our patent protection depends on compliance with various procedural, document-submission, fee-payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for noncompliance with these requirements.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Periodic maintenance fees, renewal fees, annuity fees and various other government fees on a patent and patent application are due to be paid to the USPTO and foreign patent agencies in several stages over the lifetime of the patent and patent application. The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee-payment and other similar provisions during the patent application process. We employ reputable law firms and other professionals to help us comply with these requirements and we are also dependent on our licensors or collaboration partners to take the necessary action to comply with these requirements with respect to certain of our intellectual property. Although an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Noncompliance events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to official actions within prescribed time limits, nonpayment of fees and failure to properly legalize and submit formal documents. In such an event, our competitors might be able to enter the market, which would have a material adverse effect on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">The patent protection and patent prosecution for some of our product candidates is dependent on third parties.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Although we normally seek to obtain the right to control prosecution, maintenance and enforcement of the patents relating to our product candidates, there may be times when the filing and prosecution activities for patents relating to our product candidates are controlled by our licensors or collaboration partners. If any of our current or future licensing or collaboration partners fail to prosecute, maintain and enforce such patents and patent applications in a manner consistent with the best interests of our business, including by payment of all applicable fees for patents covering our product candidates, we could lose our rights to the intellectual property or our exclusivity with respect to those rights, our or our collaboration partners&#8217; ability to develop and commercialize those product candidates may be adversely affected and we may not be able to prevent competitors from making, using, and selling competing products. In addition, even where we have the right to control patent prosecution of patents and patent applications we have licensed to and from third parties, we may still be adversely affected or prejudiced by actions or inactions of our licensees, our licensors and their counsel that took place prior to the date upon which we assumed control over patent prosecution.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">29</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, we may be adversely affected or prejudiced by actions or inactions of our external and internal patent counsels working solely on our projects or our joint patent counsels representing us and our collaboration partners.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">If we fail to comply with the obligations in our intellectual property agreements, including those under which we license intellectual property and other rights to or from third parties, or otherwise experience disruptions to our business relationships with our licensees, our licensors and collaboration partners, we could lose intellectual property rights that are important to our business.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are a party to a number of intellectual property license and co-ownership agreements and research and development collaborations that are important to our business and expect to enter into additional such agreements in the future. Under certain circumstances, the royalties payable to us under these agreements are subject to certain reductions, which may have a materially adverse effect on our business, financial condition, results of operations and prospects. In addition, our existing agreements impose, and we expect that future agreements will impose, various diligence, commercialization, milestone payment, royalty and other obligations on us. If we fail to comply with our obligations under these agreements, we may be required to make certain payments to the licensor, we may lose the exclusivity of our license or the licensor may have the right to terminate the license, in which event we would not be able to develop or market products covered by the license.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Licensing of intellectual property is of critical importance to our business and involves complex legal, business and scientific issues. Disputes may arise regarding intellectual property subject to a licensing or co-ownership agreement, including:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the scope of rights granted under the agreement, any restrictions in licensed fields and other interpretation-related issues;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the extent to which our technology and processes infringe or otherwise violate the intellectual property of any third parties;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the sublicensing of patents and other intellectual property rights;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the diligence, development and commercialization obligations under the agreement and what activities satisfy those obligations;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the ownership of inventions and know-how resulting from the joint or mutual creation or use of intellectual property by our licensors or collaboration partners and us;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">non-compete commitments; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">consequences for changes in control.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If disputes over intellectual property and other rights that we own, have licensed or co-own prevent or impair our ability to maintain our current licensing or exclusivity arrangements on acceptable terms, we or our collaboration partners may be unable to successfully develop and commercialize the affected product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, certain provisions in the agreements under which we currently license intellectual property or technology to and from third parties may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, increase what we believe to be our financial or other obligations under the relevant agreement, or decrease the third party&#8217;s financial or other obligations under the relevant agreement, any of which could have a material adverse effect on our business, financial condition, results of operations and prospects.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">30</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We or our licensors or licensees and collaborators may not be successful in obtaining or maintaining the necessary rights to our product candidates from third parties through acquisitions and in-licenses.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We or our licensors or licensees and collaborators may require the use of proprietary rights held by third parties in the future, and the growth of our business will likely depend in part on our ability to acquire, in-license, maintain or use these proprietary rights. In addition, our product candidates may require specific processes and/or formulations to work effectively and efficiently and the rights to these processes and/or formulations may be held by others. We or our licensors or licensees may be unable to acquire or in-license from third parties any compositions, methods of use, processes, or other third-party intellectual property rights that we identify as necessary for our product candidates. The licensing and acquisition of third-party intellectual property rights is a competitive area, and a number of more established companies may pursue strategies to license or acquire third-party intellectual property rights that we may consider attractive or necessary. These established companies may have a competitive advantage over us due to their size, cash resources, and greater clinical development and commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. We or our licensors or licensees also may be unable to license or acquire third-party intellectual property rights on terms that would allow us to make an appropriate return on our investment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For example, we sometimes collaborate with U.S. and foreign academic institutions to accelerate our preclinical research or development under written agreements with these institutions. Typically, these institutions provide us with an option to negotiate a license to any of the institution&#8217;s rights in technology resulting from the collaboration. Regardless of such option, we may be unable to negotiate a license within the specified timeframe or under terms that are acceptable to us. If we are unable to do so, the institution may offer the intellectual property rights to other parties, potentially blocking our ability to pursue our applicable product candidate or program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If we are unable to successfully obtain a license to third-party intellectual property rights necessary for the development of a product candidate or program, we may have to abandon development of that product candidate or program and our business and financial condition could suffer.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Third-party claims of intellectual property infringement may expose us to substantial liability or may prevent or delay our or our collaboration partners&#8217; development and commercialization efforts.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Numerous U.S.- and foreign-issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are developing product candidates. For example, we are aware of third-party patents or patent applications that may be construed to cover one or more of our product candidates. If these patents are asserted against us or our licensing or collaboration partners and either we or our licensing or collaboration partners are found to infringe any of these patents, and are unsuccessful in demonstrating that such patents are invalid or unenforceable, then we and our licensing or collaboration partners could be required to pay substantial monetary damages or cease further development or commercialization of one or more of our product candidates or be compelled to enter into onerous licenses with such third parties. There may also be other third-party patents or patent applications with claims to materials, formulations, methods of manufacture or methods of treatment related to the use or manufacture of our product candidates and technology. Although we generally conduct a freedom-to-operate search and review with respect to our product candidates, we cannot guarantee that our search and review is complete and thorough, nor can we be sure that we have identified each and every patent and pending application in the U.S. and abroad that is relevant or necessary to the manufacturing or commercialization of our product candidates or use of our technology. Because patent applications can take many&#160;years to issue, there may be currently pending patent applications that may later result in issued patents that our product candidates may infringe. In addition, third parties may file and obtain additional patents in the future and claim that use of our technologies infringes upon these patents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Third parties may assert infringement claims against us based on existing patents or on patents that may be granted in the future, regardless of merit. Even if we believe such claims are without merit, a court of competent jurisdiction could hold that these third-party patents are valid, enforceable and infringed, which could materially and adversely affect our or our collaboration partners&#8217; ability to commercialize our product candidates or technologies covered by the asserted third-party patents.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">31</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Parties making claims against us may also obtain injunctive or other equitable relief, which could effectively block our or our collaboration partners&#8217; ability to further develop and commercialize one or more of our product candidates. Defense of these claims, regardless of their merit, would involve substantial litigation expense and would be a substantial diversion of management and employee resources from our business. In the event of a successful claim of infringement against us, we may have to pay substantial damages, including treble damages and attorneys&#8217; fees for willful infringement, pay royalties, redesign our infringing products or obtain one or more licenses from third parties, which may be impossible or require substantial time and monetary expenditure. Any of the foregoing could have a material and adverse effect on our business, financial conditions, results of operations and prospects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar negative impact on our business, financial condition, results of operations and prospects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">There could also be public announcements of the results of hearings, motions, decisions, or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of our common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Some of our competitors may have substantially greater resources and more mature and developed intellectual property portfolios than we do, and may be able to sustain the costs of complex intellectual property litigation to a greater degree and for longer periods of time than we could. In addition, patent-holding companies that focus solely on extracting royalties and settlements by enforcing patent rights may target us. As the pharmaceutical and biopharmaceutical industries expand and more patents are issued, the risk increases that our product candidates may be subject to claims of infringement of the patent rights of third parties. The uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have a material adverse effect on our ability to compete in the marketplace.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We may be subject to claims that our employees, consultants, or independent contractors have wrongfully used or disclosed confidential information of third parties or that our employees have wrongfully used or disclosed alleged trade secrets of their former employers.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We employ and utilize the services of individuals who were previously employed or provided services to universities or other pharmaceutical or biopharmaceutical companies, including our competitors or potential competitors. Although we try to ensure that our employees, consultants, and independent contractors do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other proprietary information, of any of our employees&#8217;, consultants&#8217; or independent contractors&#8217; former employers or of other third parties. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel, which could have a material adverse effect on our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, although it is our policy to require our employees, consultants and independent contractors who may be involved in the conception or development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who, in fact, conceives or develops intellectual property that we regard as our own. The assignment of intellectual property rights may not be self-executing or the assignment agreements may be breached, and we may be forced to bring claims against third parties, or defend claims that they may bring against us, to determine the ownership of what we regard as our intellectual property.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">We may not be able to protect our intellectual property rights throughout the world.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Filing, prosecuting and defending patents on product candidates in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the U.S. may be less extensive than those in the U.S. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as the laws in the U.S. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the U.S., or from selling or importing products made using our inventions in and into </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">32</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">the U.S. or other jurisdictions. In the ordinary course of prosecution and maintenance activities, we determine whether to seek patent protection outside the U.S. and in which countries. This also applies to patents we have acquired or in-licensed from third parties. In some cases, we, or our predecessors in interest or licensors of patents within our portfolio, have sought patent protection in a limited number of countries for patents covering our product candidates. Competitors may use our technologies and products in jurisdictions where we have not obtained or are unable to adequately enforce patent protection to develop their own products and further, may export otherwise infringing products to territories where we have patent protection but enforcement is not as strong as that in the U.S. These products may compete with our products and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing, which would have a material adverse effect on our business and financial positions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets, and other intellectual property protection, particularly those relating to biotechnology products, which could make it difficult for us to stop the infringement, misappropriation or other violations of our intellectual property and proprietary rights. Proceedings to enforce our patent rights in foreign jurisdictions, whether or not successful, could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing, and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest, our names and brands may be misappropriated by third parties, and our business may be adversely affected.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have filed trademark applications seeking protection for our corporate name, logo, Nasdaq Global Market symbol and selected names of our technology platforms in selected geographies. While we have been granted registrations in certain geographies for certain trademarks, there is no guarantee that our trademark applications will be approved by the respective authorities at all or that we will not be required to narrow the scope of protection in certain or all geographies. Our applications have in the past faced and may in the future face opposition from third parties, potentially resulting in the lack of protection or narrower protection. Our trademarks or trade names may be challenged, infringed, circumvented, declared generic or determined to be infringing on other marks. We may not be able to protect our rights to these trademarks and trade names, which we need to build name recognition among potential partners or customers in our markets of interest. At times, competitors or other third parties may adopt trade names, domain names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate variations of our trademarks or trade names. Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively and our business may be adversely affected. Our efforts to enforce or protect our proprietary rights related to trademarks and domain names may be ineffective and could result in substantial costs and diversion of resources, and could adversely affect our business, financial condition, results of operations and growth prospects.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to our financial condition and capital requirements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">We are a clinical-stage company and have a history of operating losses. We anticipate that we will continue to incur losses for the foreseeable future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are a clinical-stage biopharmaceutical company. Since 2003, although we have received upfront and milestone payments from our collaboration partners and certain other contract revenue, we have also incurred significant operating losses. We incurred net losses (defined as net loss attributable to owners of the Company) of CHF 54.2 million for the&#160;year ended December&#160;31, 2023. In addition, we had accumulated losses of CHF 316.2 million as of December&#160;31, 2023.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">33</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our losses have resulted principally from research and development expenses and from general business and administrative expenses. We expect to continue to incur significant operating losses in the future as we continue our research and development efforts for our current and future product candidates and seek to obtain regulatory approval and commercialization of such product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To date, the Company has financed its liquidity requirements primarily from its public offerings, share issuances, contract revenues from license and collaboration agreements and grants. We have no products approved for commercialization and have never generated any revenues from product sales. Biopharmaceutical and pharmaceutical product development is a highly speculative undertaking and involves a substantial degree of risk. It may be several&#160;years, if ever, before we or our collaboration partners complete pivotal clinical studies and have a product candidate approved for commercialization and we begin to generate revenue or royalties from product sales.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Although we have generated revenues from upfront and milestone payments related to our license and collaboration agreements, we have never generated any revenue from product sales and may never be profitable.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Although we have generated contract revenue from upfront and milestone payments related to our license and collaboration agreements, we have no products approved for commercialization and have never generated any revenue from product sales. Our ability to generate revenue and achieve profitability depends on our and our licensors&#8217; and collaboration partners&#8217; ability to successfully complete the development of, and obtain the marketing approvals necessary, to commercialize one or more of our product candidates. We do not anticipate generating revenue from product sales unless and until we or our collaboration partners obtain regulatory approval for, and commercialize, our product candidates. Our ability to generate future revenue from product sales depends heavily on our and our collaboration partners&#8217; success in many areas, including but not limited to:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">successfully completing research and clinical development of our product candidates, by us or our collaboration partners, as the case may be;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">obtaining marketing approvals for our clinical product candidates, including our active immunotherapies (ACI-35.030, ACI-24.060 and ACI-7104.056), monoclonal antibodies (semorinemab and crenezumab) and diagnostics (Tau-PET tracer PI-2620 and a-syn-PET tracer ACI-12589), for which we or our collaboration partners complete clinical studies;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">developing a sustainable and scalable manufacturing process for any approved product candidates, and maintaining supply and manufacturing relationships with third parties that can conduct the process and provide adequate (in amount, quality and time) products to support clinical development and the market demand for our product candidates, if approved;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">launching and commercializing product candidates for which we obtain marketing approval, either directly or with a collaborator or distributor;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">obtaining market acceptance of our product candidates as viable treatment or diagnostic options;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">addressing any competing technological and market developments;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">identifying, assessing, acquiring and/or developing new product candidates;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">negotiating favorable terms in any collaboration, licensing, or other similar arrangements into which we may enter;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">maintaining, protecting, acquiring and expanding our portfolio of intellectual property rights, including patents, trade secrets and know-how; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">attracting, hiring and retaining qualified personnel.</span></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">34</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Because of the numerous risks and uncertainties with biopharmaceutical and pharmaceutical product development, we are unable to accurately predict the timing or amount of increased expenses and when, or if, we will be able to achieve profitability. Our expenses could increase beyond expectations if we are required by the FDA, the EMA or other regulatory agencies, domestic or foreign, to change our manufacturing processes, or to perform clinical, nonclinical or other types of studies in addition to those that we currently anticipate. In cases where we are successful in obtaining regulatory approvals to market one or more of our product candidates, our revenue will be dependent, in part, upon the size of the markets in the territories for which we gain regulatory approval, the accepted price for the product, the ability to obtain coverage and reimbursement at any price, and whether we own the commercial rights for that territory. If the number of our addressable patients is not as significant as we estimate, the indication approved by regulatory authorities is narrower than we expect, the treatment population is narrowed by competition, physician choice or treatment guidelines or other commercial related factors we may not generate significant revenue from sales of such products, even if approved. Accordingly, we may not be profitable in the future from the sale of any approved products.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We or our collaboration partners may be unable to develop and commercialize any of our current or future product candidates and, even if we do, may not achieve profitability in the future. Even if we do achieve profitability in the future, we may not be able to sustain or increase profitability on a quarterly or annual basis. Our failure to be profitable in the future would decrease the value of our company and could impair our ability to raise capital, expand our business or continue our operations. A decline in the value of our company could cause you to lose all or part of your investment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">If we fail to obtain additional funding, we may delay, reduce or eliminate our product development programs or commercialization efforts.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are currently advancing our clinical product candidates through clinical development, either together with a collaboration partner (ACI-35.030 and PI-2620) or independently (ACI-24.060, ACI-7104.056, ACI-12589 semorinemab and crenezumab). We expect our research and development expenses to continue to increase in connection with our ongoing activities, particularly as we and/or our collaboration partners continue our ongoing studies and initiate new studies of ACI-35.030, ACI-24.060, ACI-7104.056, Morphomer Tau, PI-2620 and ACI-12589 and initiate preclinical and clinical development of our other product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2023, we had cash and cash equivalents of CHF 78.5&#160;million and short-term financial assets of CHF 24.6 million resulting in a total liquidity position of CHF 103.1 million. On February 1, 2024, the Company received the milestone payment of CHF 14.8 million due from Janssen for the commencement of first Phase 2b clinical study. We currently believe that our existing capital resources, assuming potential milestone payment of CHF 24.6 million related to achieving a non-disclosed enrollment target for our ACI-35.030 and no other milestones, will be sufficient to meet our projected operating requirements into Q1 2026. We have based this estimate on assumptions that may prove to be wrong, and we could exhaust our capital resources sooner than we currently expect. In addition, changing circumstances, including inflation, may cause us to adjust our projected spending to amounts more than currently expected. We may also need to raise additional funds sooner than we anticipate due to various factors such as the scope and rate of progress of our development activities, regulatory approval outcomes and emergence of competing technologies, among others.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We expect that we will require additional capital to develop and commercialize certain of our product candidates. If we receive regulatory approval for our current and future product candidates, and if we have not already licensed such product candidate to a collaboration partner and choose to commercialize such product candidate independently, we expect to incur significant commercialization expenses related to product manufacturing, sales, marketing, distribution and establishing a regulatory structure, depending on where we choose to commercialize. Additional funds may not be available on a timely basis, on favorable terms, or at all, and such funds, if raised, may not be sufficient to enable us to continue to implement our long-term business strategy, in particular as a result of inflation. Additionally, we may be dependent on the status of the capital markets at the time such capital is sought. In addition, our ability to raise sufficient capital under our &#8220;at the market&#8221; program may be diminished depending on the market price of our shares. If we are not able to raise capital when needed, we could be forced to delay, reduce or eliminate our product development programs or commercialization efforts.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">35</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Raising additional capital may cause dilution to our shareholders, restrict our operations or require us to relinquish rights to our intellectual property or future revenue streams.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Until such time, if ever, as we can generate substantial product royalty revenue, we expect to finance our liquidity needs through a combination of equity offerings, debt financings, grants, and license and development agreements in connection with collaborations. In September&#160;2020, the Company established an &#8220;at the market offering&#8221; (ATM) for the sale of up to USD 80.0 (CHF 68.1) million worth of our common shares from time to time by entering into an Open Market Sale Agreement (Sales Agreement) with Jefferies LLC (Jefferies). In Q2 2021, we filed a new registration statement on Form&#160;F-3 and entered into a new Sales Agreement to replace and extend the ATM program. We do not have any material committed external source of funds. In the event we need to seek additional funds, we may raise additional capital through the sale of equity, convertible debt or other securities. In such an event, your ownership interest will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect your rights as a holder of our common shares. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or proposing dividends to our shareholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If we raise additional funds through collaborations, strategic alliances, or marketing, distribution or licensing arrangements with third parties, we may have to grant or otherwise relinquish valuable rights to our intellectual property or future revenue streams.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Our ability to use tax loss carry-forwards in Switzerland may be limited.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2023, we reported tax loss carry-forwards from financial&#160;years 2017 until 2023 for purposes of Swiss corporate income tax in the aggregate amount of CHF 313.0 million, which could be available to offset future taxable income. If not used, these tax losses will expire 7&#160;years after the&#160;year in which they were incurred. Due to our limited income, there is a high risk that the tax loss carry-forwards will expire partly or entirely and we will not be able to use them to offset future taxable income thereafter for Swiss corporate income tax purposes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Exchange rate fluctuations may materially affect our results of operations and financial condition.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under our existing agreements, we receive and make a significant amount of payments in Swiss Franc, USD and EUR. As a result, changes and fluctuations in currency exchange rates between the Swiss Franc and other currencies, especially the USD and EUR, could have a materially adverse effect on our operating results. As our reporting currency is the Swiss Franc, financial line items are converted into Swiss Francs at the applicable exchange rates. We also expect that in the future, a significant portion of our revenues and expenses will be denominated in Swiss Franc, USD and EUR. Therefore, unfavorable developments in the value of the Swiss Franc as compared to the USD and EUR or any other currency could have a material adverse effect on our business, financial condition and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Our significant in-process research and development (IPR&amp;D) asset may become impaired.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our consolidated balance sheet contains a material IPR&amp;D asset. For an IPR&amp;D asset, the risk of failure is significant, and there can be no certainty that the asset will become a successful candidate. Our ability to realize value on this significant investment is often contingent upon, among other things, regulatory approvals and market acceptance. As such, this IPR&amp;D may become impaired and/or be written off at some time in the future if the associated R&amp;D effort is abandoned or is curtailed. For a complete discussion of our IPR&amp;D asset, see &#8220;Note 7. Intangible assets&#8221;.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to the regulatory environment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We cannot give any assurance that any of our product candidates will receive regulatory approval, which is necessary before they can be commercialized.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Our future success is dependent on our and our collaboration partners&#8217; ability to successfully develop, obtain regulatory approval for, and then successfully commercialize one or more product candidates. We currently have five product candidates that are in a Phase 2 clinical study and one in a Phase 3 clinical study. We are not permitted to market </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">36</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">or promote any of our product candidates before we receive regulatory approval from the FDA, EMA or comparable foreign regulatory authorities, and we may never receive such regulatory approval for any of our product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We cannot be certain that any of our product candidates will be successful in clinical studies or receive regulatory approval. Applications for our product candidates could fail to receive regulatory approval for many reasons, including but not limited to the following:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the FDA, EMA or comparable foreign regulatory authorities may disagree with the design or implementation of our clinical studies;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the population studied in the clinical program may not be sufficiently broad or representative to assure safety in the full population for which we seek approval;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the FDA, EMA or comparable foreign regulatory authorities may disagree with our interpretation of data from nonclinical or clinical studies;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the data collected from clinical studies of our product candidates may not be sufficient to support the submission of an NDA or other submission or to obtain regulatory approval in the U.S. or elsewhere;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we may be unable to demonstrate to the FDA, EMA or comparable foreign regulatory authorities that a product candidate&#8217;s benefit-risk ratio for its proposed indication is acceptable;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the FDA, EMA or other regulatory authorities may fail to approve the manufacturing processes, test procedures and specifications, or facilities of third-party manufacturers with which we contract for clinical and commercial supplies; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the approval policies or regulations of the FDA, EMA or comparable foreign regulatory authorities may change significantly in a manner rendering our clinical data insufficient for approval.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In response to scrutiny of the accelerated approval pathway, Section 3210 of the FDORA (incorporated in the 2023 Appropriations Act) revised this pathway to, among other things: require the FDA to specify the conditions for required post&#8208;marketing trials; permit the FDA to require such trials to be underway prior to approval, or within a specific period after approval; require sponsors to provide reports on postmarketing trial progress no later than 180 days after approval and every 180 days thereafter until such trials are completed; make the failure to conduct required post&#8208;marketing trials with due diligence and the failure to submit the required reports prohibited acts; and detail procedures the FDA must follow to withdraw an accelerated approval on an expedited basis. This legislation did not, however, change the standard for accelerated approval. Even prior to this legislation, the FDA had held Oncologic Drugs Advisory Committee meetings to discuss accelerated approvals for which confirmatory trials have not verified clinical benefit, resulting in voluntary withdrawals of certain products and indications approved on an accelerated basis. While it is not clear at this time how these legislative and regulatory initiatives will affect our ability to pursue accelerated approval for any of our product candidates, these developments may have a material adverse impact on our business, financial condition, and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We generally plan to seek regulatory approval to commercialize our product candidates in the U.S., the EU and in additional foreign countries where we have commercial and typically intellectual property rights. To obtain regulatory approval in other countries, we must comply with numerous and varying regulatory requirements of such other countries regarding safety, efficacy, chemistry, manufacturing and controls, clinical studies, commercial sales, pricing, marketing and distribution of our product candidates. Even if we are successful in obtaining approval in one jurisdiction, we cannot ensure that we will obtain approval in any other jurisdictions. Failure to obtain marketing authorization for our product candidates will result in our being unable to market and sell such products, which would materially adversely affect our business, financial condition and results of operations. If we fail to obtain approval in any jurisdiction, the geographic market for our product candidates could be limited. Similarly, regulatory agencies may not approve the labeling claims that are necessary or desirable for the successful commercialization of our product candidates.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">37</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Clinical drug development involves a lengthy and expensive process with uncertain timelines and uncertain outcomes. If clinical studies of our product candidates are prolonged or delayed, we may be unable to obtain required regulatory approvals, and therefore be unable to commercialize our product candidates on a timely basis or at all.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To obtain the necessary regulatory approvals to market and sell any of our product candidates, we must demonstrate through extensive preclinical and clinical studies that our products are safe and effective in humans. Clinical testing is expensive and can take many&#160;years to complete, and its outcome is inherently uncertain. Failure can occur at any time during the clinical study process. The results of preclinical and early clinical studies of our product candidates may not be predictive of the results of later-stage clinical studies. For example, the positive results generated to date in clinical studies for our product candidates do not ensure that later clinical studies will demonstrate similar results. Product candidates in later stages of clinical studies may fail to show the desired safety and efficacy traits despite having progressed through preclinical studies and initial clinical studies. A number of companies in the pharmaceutical or biopharmaceutical industry, including us, have suffered significant setbacks in advanced clinical studies due to lack of efficacy or adverse safety profiles, notwithstanding promising results in earlier studies. Our future clinical study results may not be successful.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Clinical studies must be conducted in accordance with the legal requirements, regulations and guidelines of the FDA, EMA and comparable foreign regulatory authorities, and are subject to oversight by these governmental agencies and Institutional Review Boards (IRBs) at the medical institutions where the clinical studies are conducted. In addition, clinical studies must be conducted with supplies of our product candidates produced under cGMP and other requirements. We depend on medical institutions and CROs to conduct our clinical studies in compliance with cGCP standards. To the extent the CROs fail to enroll participants for our clinical studies, fail to conduct the study to cGCP standards or are delayed for a significant time in the execution of studies, including achieving full enrollment, we may be affected by increased costs, program delays or both, which may harm our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To date, neither we nor our collaboration partners have completed all clinical studies required for the approval of any of our product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The completion of clinical studies for our product candidates may be delayed, suspended or terminated as a result of many factors, including but not limited to:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the delay or refusal of regulators or IRBs to authorize us to commence or amend a clinical study at a prospective study site or changes in regulatory requirements, policies and guidelines;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">delays or failure to reach agreement on acceptable terms with prospective CROs and clinical study sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and study sites;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">delays in patient enrollment and variability in the number and types of patients available for clinical studies;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the inability to enroll a sufficient number of patients in studies to ensure adequate statistical power to detect statistically significant treatment effects;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">negative or inconclusive results, which may require us to conduct additional preclinical or clinical studies or to abandon projects that we expected to be promising;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">safety or tolerability concerns, which could cause us to suspend or terminate a study if we find that the participants are being exposed to unacceptable health risks;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">regulators or IRBs requiring that we or our investigators suspend or terminate clinical research for various reasons, including noncompliance with regulatory requirements or safety concerns, among others;</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">38</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">lower than anticipated retention rates of patients and volunteers in clinical studies;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our CROs or clinical study sites failing to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all, deviating from the protocol or dropping out of a study;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">delays relating to adding new clinical study sites;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">difficulty in maintaining contact with patients after treatment, resulting in incomplete data;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">delays in establishing the appropriate dosage levels;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the quality or stability of the product candidate falling below acceptable standards;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the inability to produce or obtain sufficient quantities of the product candidate to complete clinical studies; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">exceeding budgeted costs due to difficulty in accurately predicting costs associated with clinical studies.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Further, with the passage of FDORA, Congress clarified the FDA&#8217;s authority to conduct inspections by expressly permitting inspection of facilities involved in the preparation, conduct or analysis of clinical and nonclinical studies submitted to FDA, as well as of other persons holding study records or otherwise involved in the study process, which could delay or add complexity to our clinical trials.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any delays in completing our clinical studies will increase our costs, slow our product candidate development and approval process, and jeopardize our ability to commence product sales and generate sales revenues. Any of these occurrences may significantly harm our business, financial condition and prospects. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical studies may also ultimately lead to the denial of regulatory approval of our product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Even if we obtain and maintain approval for our product candidates from one jurisdiction, we may never obtain approval for our product candidates in other jurisdictions, which would limit our market opportunities and adversely affect our business.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Sales by us of our approved drugs will be subject to U.S. and non-U.S. regulatory requirements governing clinical studies and regulatory approval, and we plan to seek regulatory approval to commercialize our product candidates in the U.S., the European Economic Area (EEA), and other countries. Clinical studies conducted in one country may not be accepted by regulatory authorities in other countries, and regulatory approval in one country does not ensure approval in any other country, while a failure or delay in obtaining regulatory approval in one country may have a negative effect on the regulatory approval process in others. For example, approval in the U.S. by the FDA does not ensure approval by the regulatory authorities in other countries or jurisdictions, and similarly, approval by a non-U.S. regulatory authority, such as the EMA, does not ensure approval by regulatory authorities in other countries, including by the FDA. Approval processes and regulatory requirements vary among countries and can involve additional drug testing and validation and additional administrative review periods. Even if a drug is approved, the FDA or EMA, as the case may be, may limit the indications for which the drug may be marketed, require extensive warnings on the drug labeling, or require expensive and time-consuming clinical studies or reporting as conditions of approval. In many countries outside the U.S., a product candidate must be approved for reimbursement before it can be approved for sale in that country. In some cases, the price that would be charged for a drug is also subject to approval. Regulatory authorities in other countries also have their own requirements for approval of product candidates with which we must comply prior to marketing in those countries. Obtaining non-U.S. regulatory approvals and compliance with such non-U.S. regulatory requirements could result in significant delays, difficulties and costs for us and could delay or prevent the introduction of our current and any future drugs, in certain countries. If we fail to comply with regulatory requirements in international markets or to obtain and maintain required approvals, or if regulatory approvals in international markets are delayed, our target market will be reduced and our ability to realize the full market potential of our product candidates will be unrealized.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">39</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Even if our product candidates obtain regulatory approval, we will be subject to ongoing obligations and continued regulatory review, which may result in significant additional expense. Additionally, our product candidates, if approved, could be subject to labeling and other restrictions and market withdrawal and we may be subject to penalties if we fail to comply with regulatory requirements or experience unanticipated problems with our products.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If a marketing authorization is obtained for any of our product candidates, the product will remain subject to continual regulatory review and therefore authorization could be subsequently withdrawn or restricted. Any regulatory approvals that we receive for our product candidates may also be subject to limitations on the approved indicated uses for which the product may be marketed or to the conditions of approval, or contain requirements for potentially costly post-marketing testing, including Phase 4 clinical studies and surveillance to monitor the safety and efficacy of the product candidate. In addition, if the FDA or a comparable foreign regulatory authority approves any of our product candidates, we will be subject to ongoing regulatory obligations and oversight by regulatory authorities, including with respect to the manufacturing processes, labeling, packing, distribution, adverse event reporting, storage, advertising and marketing restrictions, and record-keeping and, potentially, other post-marketing obligations, all of which may result in significant expense and limit our or our collaboration partners&#8217; ability to commercialize such products. These requirements include submissions of safety and other post-marketing information and reports, registration, as well as continued compliance with cGMP and cGCP requirements for any clinical studies that we conduct post-approval. Later discovery of previously unknown problems with a product, including AEs of unanticipated severity or frequency, or with our third-party manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may result in, among other things:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">restrictions on the marketing or manufacturing of the product, withdrawal of the product from the market, or voluntary or mandatory product recalls;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fines, warning letters or holds on clinical studies;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">refusal by the FDA or an applicable foreign regulatory authority to approve pending applications or supplements to approved applications filed by us or our collaborations partners, or suspension or revocation of product license approvals;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">regulatory constraints in promotion and distribution of drug products in various markets;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">product seizure or detention, or refusal to permit the import or export of products; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">injunctions or the imposition of civil or criminal penalties.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If any of these events occurs, our ability to sell such product may be impaired, and we may incur substantial additional expense to comply with regulatory requirements, which could materially adversely affect our business, financial condition and results of operations. The FDA&#8217;s or those of an applicable foreign regulatory authority&#8217;s policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product candidates. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained, which would adversely affect our business, prospects and ability to achieve or sustain profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We have conducted and may in the future conduct clinical studies for our product candidates outside the U.S., and the FDA and applicable foreign regulatory authorities may not accept data from such studies.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We have conducted and may in the future choose to conduct one or more of our clinical studies outside the U.S., including in Germany, Austria, Denmark, Sweden, Finland, the UK, Poland, Spain and the Netherlands. The acceptance of study data from clinical studies conducted outside the U.S. or another jurisdiction by the FDA or applicable foreign regulatory authority may be subject to certain conditions. In cases where data from foreign clinical studies are intended </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">40</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">to serve as the basis for marketing approval in the U.S., the FDA will not approve the application on the basis of foreign data alone unless the following are true: the data are applicable to the U.S. population and U.S. medical practice; the studies were performed by clinical investigators of recognized competence; and the data are considered valid without the need for an on-site inspection by the FDA or, if the FDA considers such an inspection to be necessary, the FDA is able to validate the data through an on-site inspection or other appropriate means. Additionally, the FDA&#8217;s clinical study requirements, including sufficient size of patient populations and statistical powering, must be met. Many foreign regulatory bodies have similar requirements. In addition, such foreign studies would be subject to the applicable local laws of the foreign jurisdictions in which the studies are conducted. There can be no assurance that the FDA or any applicable foreign regulatory authority will accept data from studies conducted outside of the U.S. or the applicable jurisdiction. If the FDA or any applicable foreign regulatory authority does not accept such data, it would result in the need for additional studies, which would be costly and time-consuming and delay aspects of our business plan, and which may result in our drugs or product candidates not receiving approval or clearance for commercialization in the applicable jurisdiction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Enacted and future legislation may increase the difficulty and cost for us to obtain marketing approval of and commercialize our product candidates and may affect the prices we may set.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the U.S., the EU and some foreign jurisdictions, there have been a number of adopted and proposed legislative and regulatory changes regarding the healthcare system that could prevent or delay regulatory approval of our product candidates, restrict or regulate post-approval activities and affect our ability to profitably sell any of our product candidates for which we obtain regulatory approval.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the U.S., the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (&#8220;MMA&#8221;) changed the way Medicare covers and pays for pharmaceutical products. Cost reduction initiatives and other provisions of this legislation could limit the coverage and reimbursement rate that we receive for any of our approved product candidates. While the MMA only applies to drug benefits for Medicare beneficiaries, private payors often follow Medicare coverage policy and payment limitations in setting their own reimbursement rates. Therefore, any reduction in reimbursement that results from the MMA may result in a similar reduction in payments from private payors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In March 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (collectively, the Health Care Reform Law), was enacted. The Health Care Reform Law was intended to broaden access to health insurance, reduce or constrain the growth of healthcare spending, enhance remedies against healthcare fraud and abuse, add new transparency requirements for healthcare and health insurance industries, impose new taxes and fees on the health industry and impose additional health policy reforms. The Health Care Reform Law increased manufacturers&#8217; rebate liability under the Medicaid Drug Rebate Program by increasing the minimum rebate amount for both branded and generic drugs and revised the definition of &#8220;average manufacturer price&#8221; (&#8220;AMP&#8221;), which may also increase the amount of Medicaid drug rebates manufacturers are required to pay to states. The legislation also expanded Medicaid drug rebates and created an alternative rebate formula for certain new formulations of certain existing products that is intended to increase the rebates due on those drugs. The Centers for Medicare &amp; Medicaid Services, which administers the Medicaid Drug Rebate Program, also has proposed to expand Medicaid rebates to the utilization that occurs in the territories of the U.S., such as Puerto Rico and the Virgin Islands. Further, beginning in 2011, the Health Care Reform Law imposed a significant annual fee on companies that manufacture or import branded prescription drug products. Legislative and regulatory proposals have been introduced at both the state and federal level to expand post-approval requirements and restrict sales and promotional activities for pharmaceutical products.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are not sure whether additional legislative changes will be enacted, or whether the FDA regulations, guidance or interpretations will be changed, or what the impact of such changes on the marketing approvals of our product candidates, if any, may be. In addition, increased scrutiny by the U.S. Congress of the FDA&#8217;s approval process may significantly delay or prevent marketing approval, as well as subject us to more stringent product labeling and post-marketing approval testing and other requirements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In addition, there has been heightened governmental scrutiny in the U.S. of pharmaceutical pricing practices in light of the rising cost of prescription drugs and biologics. Such scrutiny has resulted in several recent congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">41</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for products. At both the federal and state level, legislatures are increasingly passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. One significant example of recent legislative action is the Inflation Reduction Act of 2022 (the &#8220;IRA&#8221;), which has been considered a scaled-back version of the Build Back Better Act. The IRA was signed into law on August 16, 2022. While the IRA is still subject to rulemaking (with more information to come via guidance documents from the responsible federal agencies), the IRA, as written, will, among other changes, give HHS the ability and authority to directly negotiate with manufacturers the price that Medicare will pay for certain high-priced drugs. The IRA will also require manufacturers of certain Part B and Part D drugs to issue to HHS rebates based on certain calculations and triggers (i.e. when drug prices increase and outpace the rate of inflation). On March 15, 2023 and June 30, 2023, HHS issued guidance regarding implementation of the Medicare drug price negotiation program in initial price applicability year 2026. HHS stated it would provide additional information in the future related to implementation for initial price applicability years 2027 and beyond. Several manufacturers and industry groups have challenged the drug price negotiation program for Medicare Parts B and D in federal court. These lawsuits are ongoing, and additional lawsuits may be filed in the future related to provisions of the IRA. It is unknown whether such litigation or other litigation, if brought, will be successful. For these and other reasons, we cannot predict the implications the IRA provisions will have on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, in the EU, the new clinical trial regulation came into force on January&#160;31, 2022. This new legislation enforces the centralization of clinical trial applications (CTAs) and approvals, which eliminates redundancy, but in some cases, this may extend timelines for clinical study approvals, due to potentially longer wait times. Austerity measures in certain European nations may also affect the prices we are able to seek if our products are approved. Both in the U.S. and in the EU, legislative and regulatory proposals have been made to expand post-approval requirements and restrict sales and promotional activities for pharmaceutical and biopharmaceutical products. We do not know whether additional legislative changes will be enacted, whether the regulations, guidance or interpretations will be changed, or what the impact of such changes on the marketing approvals of our product candidates, if any, may be.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We could be subject to liabilities under environmental, health and safety laws or regulations, or fines, penalties or other sanctions, if we fail to comply with such laws or regulations or otherwise incur costs that could have a material adverse effect on the success of our business.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are subject to numerous environmental, health and safety laws, regulations, and permitting requirements, including those governing laboratory procedures, decontamination activities, and the handling, transportation, use, remediation, storage, treatment and disposal of hazardous materials, human substances and wastes. Our operations involve the use of hazardous and flammable materials, including chemicals and biological materials that produce hazardous waste products. We generally contract with third parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials or wastes either at our sites or at third-party disposal sites. In the event of such contamination or injury, we could be held liable for any resulting damages, and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines and penalties. Although we maintain workers&#8217; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous materials, human substances or other work-related injuries, this insurance may not provide adequate coverage against potential liabilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws, regulations or permitting requirements. Such laws, regulations and requirements are becoming increasingly more stringent and may impair our research, development or production efforts. Failure to comply with these laws, regulations and permitting requirements also may result in substantial fines, penalties or other sanctions.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">42</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Our relationships with clinical centers are, and potentials customers and payors will be, subject to applicable anti-kickback, fraud and abuse and other healthcare laws and regulations, which, if violated, could expose us to criminal sanctions, civil penalties, exclusion from government healthcare programs, contractual damages, reputational harm and diminished profits and future earnings.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Healthcare providers, physicians and others play a primary role in the recommendation and prescription of any products for which we obtain marketing approval. Our future arrangements with third-party payors and customers may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations, which constrain the business or financial arrangements and relationships through which we market, sell and distribute our products for which we obtain marketing approval. Restrictions under applicable healthcare laws and regulations include the following:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the U.S. healthcare Anti-Kickback Statute prohibits, among other things, persons from knowingly and willfully soliciting, offering, receiving or providing remuneration, directly or indirectly, in cash or in kind, to induce or reward either the referral of an individual for, or the purchase, order or recommendation of, any good or service, for which payment may be made under U.S. government healthcare programs such as Medicare and Medicaid;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the U.S. False Claims Act imposes criminal and civil penalties, including civil whistleblower or </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">qui tam</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> actions, against individuals or entities for knowingly presenting, or causing to be presented, to the U.S. government, claims for payment that are false or fraudulent or making a false statement to avoid, decrease or conceal an obligation to pay money to the federal government;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the U.S. HIPAA imposes criminal and civil liability for executing a scheme to defraud any healthcare benefit program or making false statements relating to healthcare matters;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, imposes obligations, including mandatory contractual terms, with respect to safeguarding the privacy, security and transmission of individually identifiable health information;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the transparency requirements under the Health Care Reform Law require manufacturers of drugs, devices, biologics and medical supplies to report to the U.S. Department of Health and Human Services information related to payments and other transfers of value made by such manufacturers to physicians and teaching hospitals, and ownership and investment interests held by physicians or their immediate family members; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">analogous laws and regulations, such as state anti-kickback and false claims laws, will apply to sales or marketing arrangements, consultancy and service agreements, and claims involving healthcare items or services reimbursed by nongovernmental third-party payors, including private insurers, and some state laws require pharmaceutical and biopharmaceutical companies to comply with the pharmaceutical and biopharmaceutical industries&#8217; voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government, in addition to requiring manufacturers to report information related to payments to physicians and other healthcare providers or marketing expenditures.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Because of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available under the U.S. federal Anti-Kickback Statute, it is possible that some of our future business activities could be subject to challenge under one or more of such laws. In addition, recent healthcare-reform legislation has strengthened these laws. For example, the Health Care Reform Law, among other things, amends the intent requirement of the federal anti-kickback and criminal healthcare fraud statutes. A person or entity no longer needs to have actual knowledge of this statute or specific intent to violate it. Moreover, the Health Care Reform Law provides that the government may assert that a claim including items or services resulting from a violation of the federal anti-kickback statute constitutes a false or fraudulent claim for purposes of the False Claims Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Jurisdictions outside of the U.S. have enacted laws and regulations defining the framework of business practices of pharmaceutical organizations in their interactions with government offices, medical institutions and healthcare professionals (HCP) in order to safeguard the independence of medical judgement and of prescription and purchasing decisions. These regulations typically prohibit illegitimate payments and other transfers of values to institutional players </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">43</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">and HCPs and regulate the bases for their remuneration, such as for consultancy and other service arrangements, as well as the reimbursement of costs; in certain jurisdictions, regulations prescribe the disclosure of the existing relationships and/or the remunerations paid. In addition to government regulations, pharmaceutical industry associations, such as the European Federation of Pharmaceutical Industries and Associations (EFPIA), of which we have been a member since 2021, have enacted industry codes of conduct providing their own rules&#160;of compliance for their members&#8217; interactions with government offices, medical institutions and HCPs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Efforts to ensure that our business arrangements with third parties will comply with applicable healthcare laws and regulations will involve substantial costs. It is possible that governmental authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant civil, criminal and administrative penalties, damages, fines, exclusion from U.S. government-funded healthcare programs, such as Medicare and Medicaid, other foreign healthcare reimbursement and procurement programs, and the curtailment or restructuring of our operations. If any of the physicians or other providers or entities with whom we expect to do business with is found to be not in compliance with applicable laws, they may be subject to criminal, civil or administrative sanctions, including exclusions from government-funded healthcare programs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Risks from the improper conduct of employees, agents, contractors, or collaborators could adversely affect our reputation and our business, prospects, operating results, and financial condition.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We cannot ensure that our compliance controls, policies, and procedures will in every instance protect us from acts committed by our employees, agents, contractors, collaborators, or other parties, which would violate the laws or regulations of the jurisdictions in which we operate, including, without limitation, healthcare, employment, foreign corrupt practices, environmental, competition, and patient privacy and other privacy laws and regulations. Such improper actions could subject us to civil or criminal investigations, and monetary and injunctive penalties, and could adversely impact our operating results, our ability to conduct business and our reputation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are exposed to the risk of employee fraud or other misconduct. Misconduct by employees could include intentional failures to comply with FDA or EMA regulations, to provide accurate information to the FDA or the EMA, or intentional failures to report financial information or data accurately or to disclose unauthorized activities to us. Employee misconduct could also involve the improper use of information obtained in the course of clinical studies, which could result in regulatory sanctions and serious harm to our reputation. In June 2023, we amended our code of conduct, but it is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant fines or other sanctions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Our business activities may be subject to the Foreign Corrupt Practices Act (FCPA), and similar anti-bribery and anti-corruption laws.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Our business activities may be subject to the FCPA and similar anti-bribery or anti-corruption laws, regulations or rules&#160;of other countries in which we operate, including the UK Bribery Act. The FCPA generally prohibits offering, promising, giving or authorizing others to give anything of value, either directly or indirectly, to a non-U.S. government official in order to influence official action, or otherwise obtain or retain business. The FCPA also requires public companies to make and keep books and records that accurately and fairly reflect the transactions of the corporation, and to devise and maintain an adequate system of internal accounting controls. Our business is heavily regulated and therefore involves significant interaction with public officials, including officials of non-U.S. governments. Additionally, in many other countries, the healthcare providers who prescribe pharmaceuticals or biopharmaceuticals and the investigators who perform our studies are employed by their government, and the purchasers of pharmaceuticals are government entities; therefore, our dealings with these decision makers are subject to regulation under the FCPA. The SEC and the Department of Justice have increased their FCPA enforcement activities with respect to pharmaceutical </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">44</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">companies. There is no certainty that all of our employees, agents, contractors, collaborators, or other parties or those of our affiliates, will comply with all applicable laws and regulations, particularly given the high level of complexity of these laws. Violations of these laws and regulations could result in fines, criminal sanctions against us, our officers or our employees, the closing down of our facilities, requirements to obtain export licenses, cessation of business activities in sanctioned countries, implementation of compliance programs, and prohibitions on the conduct of our business. Any such violations could include prohibitions on our ability to offer our products in one or more countries and could materially damage our reputation, our brand, our international expansion efforts, our ability to attract and retain employees, and our business, prospects, operating results and financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Risks related to our common shares</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">The price of our common shares is volatile and may fluctuate due to factors beyond our control.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The share prices of publicly traded pharmaceutical, biopharmaceutical and drug discovery and development companies have been highly volatile and are likely to remain highly volatile in the future. The market price of our common shares may fluctuate significantly due to a variety of factors, including:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">positive or negative results of testing and clinical studies by us, strategic partners, or competitors;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">delays in entering into strategic relationships with respect to development and/or commercialization of our product candidates or entry into strategic relationships on terms that are not deemed to be favorable to us;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the sentiment of retail investors, including the perception of our clinical trial results by such retail investors, which investors may be subject to the influence of information provided by social media, third party investor websites and independent authors distributing information on the internet;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">technological innovations or commercial product introductions by us or our collaboration partners or competitors;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changes in government regulations;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">developments concerning proprietary rights, including patents and litigation matters;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">public concern relating to the commercial value or safety of any of our product candidates;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">financing or other corporate transactions;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">publication of research reports or comments by securities or industry analysts or key opinion leaders;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">general market conditions in the pharmaceutical or biopharmaceutical industry or in the economy as a whole; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">other events and factors beyond our control.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Broad market and industry factors may materially affect the market price of companies&#8217; stock, including ours, regardless of actual operating performance. Furthermore, issuers such as ourselves, whose securities have historically had limited trading volumes and/or have been susceptible to relatively high volatility levels, can be particularly vulnerable to short-seller attacks and trading in our common shares by non-fundamental investors such as hedge funds and others who may enter and exit positions in our common shares frequently and suddenly, causing increased volatility of our share price. Short selling is the practice of selling securities that the seller does not own but rather has borrowed or intends to borrow from a third party with the intention of buying identical securities at a later date to return to the lender, and profit from a decline in the value of the securities in the process. The publication of any commentary by short sellers with the intent of creating negative market momentum may bring about a temporary, or possibly long-term, decline in the market price of our common shares.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">45</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">There is only a limited free float of our common shares; this may have a negative impact on the liquidity of and the market price for our common shares.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of the date hereof, certain principal shareholders controlling 5% or more of our common shares as well as our executive officers and directors together beneficially own approximately 54.7% of our common shares. The limited free float may have a negative impact on the liquidity of our common shares and result in a low trading volume of our common shares, which could adversely affect the price of our common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Certain of our existing shareholders exercise significant control over us, and your interests may conflict with the interests of such shareholders.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Certain principal shareholders as well as our executive officers and directors together beneficially own approximately 54.7% of our common shares. Depending on the level of attendance at our general meetings of shareholders, these shareholders may be in a position to determine the outcome of decisions taken at any such general meeting. To the extent that the interests of these shareholders may differ from the interests of the Company&#8217;s other shareholders, the latter may be disadvantaged by any action that these shareholders may seek to pursue. Among other consequences, this concentration of ownership may have the effect of delaying or preventing a change in control and might therefore negatively affect the market price of our common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Future sales, or the possibility of future sales, of a substantial number of our common shares could adversely affect the price of our common shares.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Future sales of a substantial number of our common shares, or the perception that such sales will occur, could cause a decline in the market price of our common shares. If certain of our shareholders sell substantial amounts of common shares in the public market, or the market perceives that such sales may occur, the market price of our common shares and our ability to raise capital through an issue of equity securities in the future could be adversely affected. In 2019, we adopted a new omnibus equity incentive plan under which we have the discretion to grant a broad range of equity-based awards to eligible participants. These shares were registered pursuant to the registration statement on Form&#160;S-8 that we filed with the SEC and, therefore, can be freely sold in the public market upon issuance, subject to volume limitations applicable to affiliates. If a large number of our common shares are sold in the public market after they become eligible for sale, the sales could reduce the trading price of our common shares and impede our ability to raise future capital.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We have broad discretion in the use of our cash and cash equivalents and short-term financial assets (liquidity) and may not use them effectively.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our management has broad discretion in the application of our cash and cash equivalents and short-term financial assets. Our or our collaboration partners&#8217; decisions concerning the allocation of research, development, collaboration, management and financial resources toward particular product candidates or therapeutic areas may not lead to the development of any viable commercial product and may divert resources away from better opportunities. If we make incorrect determinations regarding the viability or market potential of any of our programs or product candidates or misread trends in the pharmaceutical or biopharmaceutical industry, in particular for neurodegenerative diseases, our business, financial condition and results of operations could be materially adversely affected. As a result, we may fail to capitalize on viable commercial products or profitable market opportunities, be required to forego or delay pursuit of opportunities with other product candidates or other diseases and disease pathways that may later prove to have greater commercial potential than those we choose to pursue, or relinquish valuable rights to such product candidates through collaboration, licensing or other royalty arrangements in cases in which it would have been advantageous for us to invest additional resources to retain sole development and commercialization rights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">We do not expect to pay dividends in the foreseeable future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We have not paid any dividends since our incorporation. Even if future operations lead to significant levels of distributable profits, we currently intend that any earnings will be reinvested in our business and that dividends will not be paid until we have an established revenue stream to support continuing dividends. Based on Swiss law and our articles of association, the declaration of dividends requires a resolution passed by a simple majority of the votes cast at a </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">46</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 10pt 0pt;">shareholders&#8217; meeting regardless of abstentions and empty or invalid votes. The proposal to pay future dividends to shareholders will in addition effectively be at the discretion of our board of directors after considering various factors including our business prospects, liquidity requirements, financial performance and new product development. In addition, payment of future dividends is subject to certain limitations pursuant to Swiss law or by our articles of association compliance with which must be confirmed by our auditors. Accordingly, investors cannot rely on dividend income from our common shares and any returns on an investment in our common shares will likely depend entirely upon any future appreciation in the price of our common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:2pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We are a Swiss corporation. The rights of our shareholders may be different from the rights of shareholders in companies governed by the laws of U.S. jurisdictions.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">We are a Swiss corporation. Our corporate affairs are governed by our articles of association and by the laws governing companies, including listed companies, incorporated in Switzerland. The rights of our shareholders and the responsibilities of members of our board of directors may be different from the rights and obligations of shareholders and directors of companies governed by the laws of U.S. jurisdictions. In the performance of its duties, our board of directors is required by Swiss law to consider the interests of our Company first, then of our shareholders, our employees and other stakeholders, in all cases, with due observation of their fiduciary duties of care and loyalty. It is possible that some of these parties will have interests that are different from, or in addition to, your interests as a shareholder. Swiss corporate law limits the ability of our shareholders to challenge resolutions made or other actions taken by our board of directors in court. Our shareholders generally are not permitted to file a suit to reverse a decision or an action taken by our board of directors but are instead only permitted to seek damages for breaches of their fiduciary duties by the directors. As a matter of Swiss law, shareholder claims against a member of our board of directors for breach of fiduciary duty would have to be brought in Lausanne, Switzerland, or the country in which the relevant member of our board of directors is domiciled. In addition, under Swiss law, any claims by our shareholders against us must be in principle brought exclusively in Lausanne, Switzerland (except for certain U.S. securities and other claims that may be brought in U.S. federal court).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:2pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Our common shares are issued under the laws of Switzerland, which may not protect investors in a similar fashion afforded by incorporation in a U.S. state.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are organized under the laws of Switzerland. There can be no assurance that Swiss law will not change in the future in a way detrimental to shareholders or that it will serve to protect investors in a similar fashion afforded under corporate law principles in the U.S., which could adversely affect the rights of investors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:2pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Our status as a Swiss corporation may limit our flexibility with respect to certain aspects of capital management and may cause us to be unable to make distributions without subjecting our shareholders to Swiss withholding tax.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The Swiss law effective at the time according to which our current Articles were established allowed our shareholders to authorize share capital that can be issued by the board of directors without additional shareholder approval. This authorization is limited to 50% of the existing registered share capital and may be renewed by the shareholders once expired. As of January 1, 2023, the new Swiss corporate law introducing the capital band mechanism has come into force. It will no longer be possible to renew the Company's current Authorized Share Capital beyond June 24, 2024. Instead, the Company can only introduce the capital band pursuant to Article 653s et seq. of the revised Swiss Code of Obligations which requires an amendment of the Articles of Association by way of a resolution of a duly convened general meeting of shareholders of the Company. Under the capital band mechanism, the general meeting of shareholders can authorize the board of directors at any time within a maximum term of five years to increase or decrease the share capital by a maximum amount of 50% of the current share capital. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Additionally, as a principle, Swiss law grants pre-emptive subscription rights to existing shareholders to subscribe to any new issuance of shares. Any common share capital increase resolution preserving pre-emptive subscription rights expires after 3 months and requires a simple majority of the votes cast at the shareholder&#8217;s meeting regardless of abstentions and empty or invalid votes. Swiss law also does not provide as much flexibility in the various terms that can attach to different classes of shares as do the laws of some other jurisdictions. Swiss law also reserves for approval by </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">47</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 10pt 0pt;">shareholders certain corporate actions over which a board of directors would have authority in some other jurisdictions. For example, dividends must be approved by shareholders. These Swiss law requirements relating to our capital management may limit our flexibility, and situations may arise in which greater flexibility would have provided substantial benefits to our shareholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under Swiss law, a Swiss corporation may pay dividends only if the corporation has sufficient distributable profits from previous fiscal years, or if the corporation has distributable reserves, each as evidenced by its audited statutory balance sheet. Freely distributable reserves are generally booked either as &#8220;free reserves&#8221; or as &#8220;capital contributions&#8221; (<i style="font-style:italic;">apports de capital</i>, contributions received from shareholders) in the &#8220;reserve from capital contributions.&#8221; Distributions may be made out of issued share capital&#8212;the aggregate nominal value of a company&#8217;s issued shares&#8212;only by way of a capital reduction. To the extent the Company introduces the capital band in 2024, only net proceeds from capital increase using the capital band (less certain expenses and net of repayments from the Company) will be recognized as reserves from capital contributions at the end of validity period of the respective capital band). As of December&#160;31, 2023, the Company has CHF 432.5 million of reserves from capital contributions confirmed by the Swiss Federal Tax Administration and CHF 2,082,858 of issued share capital (consisting of 104,142,905 common shares each with a nominal value of CHF 0.02 and no preferred shares) on its audited statutory balance sheet. Of the total issued shares and issued share capital, the Company holds 5,243,958 fully paid-in treasury shares representing CHF 104,879 of issued share capital.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Generally, Swiss withholding tax of 35% is due on dividends and similar distributions to our shareholders, regardless of the place of residency of the shareholder, unless the distribution is made to shareholders out of (i) a reduction of nominal value or (ii) assuming certain conditions are met, reserves from capital contributions accumulated on or after January 1, 1997. We expect the aggregate of the reserves from capital contributions confirmed by the Swiss Federal Tax Administration and share capital, less the total losses brought forward (to the extent set off against reserves from capital contributions or share capital), less the treasury shares (to the extent booked against reserves from capital contributions), less the lowest legally possible issued share capital and legal reserve to represent the maximum amount potentially available for future dividends or capital reductions on a Swiss withholding tax-free basis. We would also be able to pay dividends out of distributable profits or freely distributable reserves but such dividends would be subject to Swiss withholding taxes. There can be no assurance that we will have sufficient distributable profits, free reserves, reserves from capital contributions or registered share capital to pay a dividend or effect a capital reduction, that our shareholders will approve dividends or capital reductions proposed by us, or that we will be able to meet the other legal requirements for dividend payments or distributions as a result of capital reductions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">A U.S. investor who qualifies for benefits under the Convention Between the United States of America and the Swiss Confederation for the Avoidance of Double Taxation with Respect to Taxes on Income, which we refer to as the &#8220;U.S.-Swiss Treaty,&#8221; may apply for a refund of the tax withheld in excess of the 15% treaty rate (or in excess of the 5% reduced treaty rate for qualifying corporate shareholders with at least 10% participation in our voting stock, or for a full refund in the case of qualified pension funds). There can be no assurance that we will have sufficient reserves from capital contributions to pay dividends free from Swiss withholding tax, or that Swiss withholding tax rules will not be changed in the future. In addition, we cannot provide assurance that the current Swiss law with respect to distributions out of reserves from capital contributions will not be changed or that a change in Swiss law will not adversely affect us or our shareholders, in particular as a result of distributions out of reserves from capital contributions becoming subject to additional corporate law or other restrictions. If we are unable to make a distribution through a reduction in nominal value or out of confirmed reserves from capital contributions, we will not be able to make distributions without subjecting our shareholders to Swiss withholding taxes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:2pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">U.S. shareholders may not be able to obtain judgments or enforce civil liabilities against us or our executive officers or members of our board of directors.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We are organized under the laws of Switzerland and our registered office and domicile is located in Ecublens, near Lausanne, Canton of Vaud, Switzerland. Moreover, a number of our directors and executive officers are not residents of the U.S., and all or a substantial portion of the assets of such persons are located outside the U.S. As a result, it may not be possible for investors to effect service of process within the U.S. upon us or upon such persons or to enforce against them judgments obtained in U.S. courts, including judgments in actions predicated upon the civil liability provisions of the federal securities laws of the U.S. We have been advised by our Swiss counsel that there is doubt as to the </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">48</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 10pt 0pt;">enforceability in Switzerland of original actions, or of actions for enforcement of judgments of U.S. courts, for civil liabilities to the extent solely predicated upon the federal and state securities laws of the U.S. Original actions against persons in Switzerland based solely upon the U.S. federal or state securities laws are governed, among other things, by the principles set forth in the Swiss Federal Act on Private International Law. This statute provides that the application of provisions of non-Swiss law by the courts in Switzerland shall be precluded if the result is incompatible with Swiss public policy. Additionally, certain mandatory provisions of Swiss law may be applicable regardless of any other law that would otherwise apply.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Switzerland and the U.S. do not have a treaty providing for reciprocal recognition and enforcement of judgments in civil and commercial matters. The recognition and enforcement of a judgment of the courts of the U.S. in Switzerland is governed by the principles set forth in the Swiss Federal Act on Private International Law. This statute provides in principle that a judgment rendered by a non-Swiss court may be enforced in Switzerland only if:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the non-Swiss court had jurisdiction pursuant to the Swiss Federal Act on Private International Law;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the judgment of such non-Swiss court has become final and non-appealable;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the judgment does not contravene Swiss public policy;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the court procedures and the service of documents leading to the judgment were in accordance with the due process of law; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">no proceeding involving the same parties and the same subject matter was first brought in Switzerland, or adjudicated in Switzerland, or was earlier adjudicated in a third state for which the decision is recognizable in Switzerland.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:2pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Our status as a Swiss corporation means that our shareholders enjoy certain rights that may limit our flexibility to raise capital, issue dividends and otherwise manage ongoing capital needs.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Swiss law reserves for approval by shareholders certain corporate actions over which a board of directors would have authority in some other jurisdictions. For example, the payment of dividends and cancellation of treasury shares must be approved by shareholders. Swiss law also requires that our shareholders themselves resolve, or authorize our board of directors, to increase our share capital. Although under the current Swiss law our shareholders may resolve a capital band which authorizes the board of directors to increase or decrease the share capital without additional shareholder approval, Swiss law limits this authorization to 50% of the issued share capital at the time of the authorization. The authorization, furthermore, has a limited duration of up to five years and must be renewed by the shareholders from time to time thereafter. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Since January 1, 2023, the new Swiss corporate law introducing the capital band mechanism has come into force. It will no longer be possible to renew the Company's current Authorized Share Capital beyond June 24, 2024. Instead, the Company can only introduce the capital band pursuant to Article 653s et seq. of the revised Swiss Code of Obligations which requires an amendment of the Articles of Association by way of a resolution of a duly convened general meeting of shareholders of the Company. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Additionally, subject to specified exceptions, including exceptions explicitly described in our articles of association, Swiss law grants pre-emptive subscription rights to existing shareholders to subscribe for new issuances of shares. Swiss law also does not provide as much flexibility in the various rights and regulations that can attach to different categories of shares as do the laws of some other jurisdictions. These Swiss law requirements relating to our capital management may limit our flexibility, and situations may arise where greater flexibility would have provided benefits to our shareholders.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">49</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Swiss law restricts our ability to pay dividends.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">See &#8220;Item&#160;10. Additional information&#8212;E. Taxation&#8212;Swiss tax considerations&#8221; for a summary of certain Swiss tax consequences regarding dividends distributed to holders of our common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">Shareholders in countries with a currency other than the Swiss Franc face additional investment risks from currency exchange rate fluctuations in connection with their holding of our common shares.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any future payments of dividends, if any, will likely be denominated in Swiss Francs. The foreign currency equivalent of any dividend, if any, paid on our common shares or received in connection with any sale of our common shares could be adversely affected by the depreciation of the Swiss Franc against such other currency.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We are a foreign private issuer and, as a result, we are not subject to U.S. proxy rules&#160;and are subject to Exchange Act reporting obligations that, to some extent, are more lenient and less frequent than those of a U.S. domestic public company.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are reporting under the Exchange Act as a non-U.S. company with foreign private issuer status. Because we qualify as a foreign private issuer under the Exchange Act and although we are subject to Swiss laws and regulations with regard to such matters and intend to furnish quarterly financial information to the SEC, we are exempt from certain provisions of the Exchange Act that are applicable to U.S. domestic public companies, including (i)&#160;the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act; (ii)&#160;the sections of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and their liability for insiders who profit from trades made in a short period of time; and (iii)&#160;the rules&#160;under the Exchange Act requiring the filing with the SEC of quarterly reports on Form&#160;10-Q containing unaudited financial and other specified information, or of current reports on Form&#160;8-K, upon the occurrence of specified significant events. In addition, foreign private issuers are not required to file their annual report on Form&#160;20-F until 4&#160;months after the end of each financial&#160;year, whereas U.S. domestic issuers that are accelerated filers are required to file their annual report on Form&#160;10-K within 75&#160;days after the end of each fiscal&#160;year. Foreign private issuers are also exempt from the Regulation Fair Disclosure, aimed at preventing issuers from making selective disclosures of material information. As a result of the above, you may not have the same protections afforded to shareholders of companies that are not foreign private issuers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">As a foreign private issuer and as permitted by the listing requirements of Nasdaq, we rely on certain home country governance practices rather than the corporate governance requirements of Nasdaq.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">We are a foreign private issuer. As a result, in accordance with Nasdaq Listing Rule 5615(a)(3), we comply with home country (in this case, Swiss) governance requirements and certain exemptions thereunder rather than complying with certain of the corporate governance requirements of Nasdaq. Swiss law does not require that a majority of our board of directors consist of independent directors. Our board of directors therefore may include fewer independent directors than would be required if we were subject to Nasdaq Listing Rule 5605(b)(1). In addition, we are not subject to Nasdaq Listing Rule 5605(b)(2), which requires that independent directors regularly have scheduled meetings at which only independent directors are present.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">While Swiss law also requires that our board of directors elects an audit and finance committee from among its members, as a foreign private issuer, the independence of the members of such committee is determined by home country regulations and the conditions of Section 10B of the Securities Exchange Act, excluding any Nasdaq Listing Rules. Section 10B of the Securities Exchange Act also prescribes qualification requirements for the audit and finance committee. Swiss law also requires that we elect a compensation committee, we follow home country requirements with respect to such committee and our compensation, nomination and corporate governance committee is tasked with certain director nomination and governance responsibilities. As a result, our practice varies from the requirements of Nasdaq Listing Rule 5605(d), which sets forth certain requirements as to the responsibilities, composition and independence of compensation committees, and from the independent director oversight of director nominations requirements of Nasdaq Listing Rule 5605(e).</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">50</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Furthermore, in accordance with Swiss law and generally accepted business practices, our articles of association do not provide quorum requirements generally applicable to general meetings of shareholders. Our practice thus varies from the requirement of Nasdaq Listing Rule 5620(c), which requires an issuer to provide in its bylaws for a generally applicable quorum, and that such quorum may not be less than one-third of the outstanding voting stock. Our articles of association provide for an independent proxy holder elected by our shareholders, who may represent our shareholders at a general meeting of shareholders, and we must provide shareholders with an agenda and other relevant documents for the general meeting of shareholders. Our practice varies from the requirement of Nasdaq Listing Rule 5620(b), which sets forth certain requirements regarding the solicitation of proxies. In addition, we have opted out of shareholder approval requirements for the issuance of securities in connection with certain events such as the acquisition of stock or assets of another company, the establishment of or amendments to equity-based compensation plans for employees, a change of control of us, and certain private placements. To this extent, our practice varies from the requirements of Nasdaq Listing Rule 5635, which generally requires an issuer to obtain shareholder approval for the issuance of securities in connection with such events.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For an overview of our corporate governance principles, see &#8220;Item&#160;16G. Corporate governance.&#8221; As a result of the above, you may not have the same protections afforded to shareholders of companies that are not foreign private issuers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">We may lose our foreign private issuer status, which would then require us to comply with the Exchange Act&#8217;s domestic reporting regime and cause us to incur significant legal, accounting and other expenses.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">We are a foreign private issuer and therefore we are not required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act applicable to U.S. domestic issuers. We may no longer be a foreign private issuer as of June 30, 2024 (or the end of our second fiscal quarter in any subsequent fiscal year), which would require us to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act applicable to U.S. domestic issuers as of January 1, 2025 (or the first day of the fiscal year immediately succeeding the end of such second quarter). In order to maintain our current status as a foreign private issuer, either (a) a majority of our common shares must be either directly or indirectly owned of record by non-residents of the U.S. or (b) (i) a majority of our executive officers or directors may not be U.S. citizens or residents, (ii) more than 50 percent of our assets cannot be located in the U.S. and (iii) our business must be administered principally outside the U.S. If we lost this status, we would be required to comply with the Exchange Act reporting and other requirements applicable to U.S. domestic issuers, which are more detailed and extensive than the requirements for foreign private issuers. We may also be required to make changes in our corporate governance practices in accordance with various SEC and stock exchange rules. The regulatory and compliance costs to us under U.S. securities laws if we are required to comply with the reporting requirements applicable to a U.S. domestic issuer may be significantly higher than the cost we would incur as a foreign private issuer. As a result, we expect that a loss of foreign private issuer status would increase our legal and financial compliance costs and would make some activities highly time-consuming and costly. We also expect that if we were required to comply with the rules and regulations applicable to U.S. domestic issuers, it would make it more difficult and expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. These rules and regulations could also make it more difficult for us to attract and retain qualified members of our board of directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">If we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results or prevent fraud. As a result, shareholders could lose confidence in our financial and other public reporting, which would harm our business and the trading price of our common shares.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Our management is responsible for establishing and maintaining adequate internal controls over financial reporting. Effective internal controls over financial reporting are necessary for us to provide reliable financial reports and, together with adequate disclosure controls and procedures, are designed to prevent fraud, among other objectives. Any failure to implement any required new or improved controls, or difficulties encountered in their implementation could cause us to fail to meet our reporting obligations. In addition, any testing by us conducted in connection with Section 404 of the Sarbanes-Oxley Act of 2002, or any testing by our independent registered public accounting firm, may reveal deficiencies in our internal controls over financial reporting, which are deemed to be material weaknesses or that may </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">51</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 10pt 0pt;">require prospective or retroactive changes to our consolidated financial statements or identify other areas for further attention or improvement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Moreover, if we are not able to comply with the requirements of Section 404 applicable to us in a timely manner, or if we or our independent registered public accounting firm identifies deficiencies in our internal control over financial reporting that are deemed to be material weaknesses, the market price of our common shares could decline, and we could be subject to sanctions or investigations by the SEC or other regulatory authorities, which would require additional financial and management resources. Furthermore, investor perceptions of our company may suffer if deficiencies are found, and this could cause a decline in the market price of our common shares. Irrespective of compliance with Section 404, any failure of our internal control over financial reporting could have a material adverse effect on our stated operating results and harm our reputation. If we are unable to implement these requirements effectively or efficiently, it could harm our operations, financial reporting, or financial results and could result in an adverse opinion on our internal control over financial reporting from our independent registered public accounting firm.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;font-weight:bold;">If securities or industry analysts do not publish research, or publish inaccurate or unfavorable research, about our business, the price of our common shares and our trading volume could decline.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The trading market for our common shares will depend in part on the research and reports that securities or industry analysts publish about us or our business. If no or too few securities or industry analysts cover our company, the trading price for our common shares would likely be negatively affected. In addition, if one or more of the analysts who cover us downgrade our common shares or publish inaccurate or unfavorable research about our business, the price of our common shares would likely decline. If one or more of these analysts cease coverage of our company or fail to publish reports on us regularly, demand for our common shares could decrease, which might cause the price of our common shares and trading volume to decline.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 10pt 9.35pt;">We were likely a passive foreign investment company (a &#8220;PFIC&#8221;) for our 2019, 2020 and 2022 taxable years. Although we believe we were likely not a PFIC for 2023, there can be no assurance that the Internal Revenue Service will agree. We cannot express any expectation regarding our PFIC status for 2024 or future taxable years. If we are a PFIC for any taxable year during which a U.S. investor owns our common shares, the investor generally will be subject to adverse U.S. federal income tax consequences.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Under the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), we will be a PFIC for any taxable year in which, after the application of certain look-through rules with respect to subsidiaries, either (i) 75% or more of our gross income consists of passive income (the &#8220;income test&#8221;) or (ii) 50% or more of the average value of our assets (generally determined on a quarterly basis) consists of assets that produce, or are held for the production of, passive income (the &#8220;asset test&#8221;). Passive income generally includes dividends, interest, certain non-active rents and royalties, and gains from financial investments. Cash is generally a passive asset. Goodwill and other intangible assets (the value of which may be determined by reference to the excess of the sum of a corporation&#8217;s market capitalization and liabilities over the value of its assets) are generally active assets to the extent attributable to business activities that produce active income. For purposes of the above calculations, we will be treated as if we hold our proportionate share of the assets of, and directly receive our proportionate share of the income of, any other corporation in which we directly or indirectly own at least 25% of the shares of such corporation by value. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Although, the application of the income test to a company like us (whose overall losses from research and development activities significantly exceed its gross income) is not entirely clear, we will be a PFIC for any taxable year under the income test if 75% or more of our gross income (as determined for U.S. federal income tax purposes) for such year consists of interest and other passive income. Prior to the commercialization and sales of any of our product candidates, our gross income may consist primarily of upfront or milestone payments and grants (which we believe are likely to be treated as active income) and interest (which is passive income). The receipt of upfront payments is non-recurring in nature, and the receipt of grants or milestone payments is subject to various conditions. Therefore, there can be no assurance as to the amount of grants, milestone payments or upfront payments (if any) that we will receive for any taxable year. Moreover, we may earn income from sublicensing, which may be passive unless certain conditions are satisfied. There is no assurance that the Internal Revenue Service (&#8220;IRS&#8221;) will not challenge the classification of any of our income items for PFIC purposes for any taxable year. Accordingly, there is no assurance that we will not be a PFIC for any taxable year under the income test.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">52</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">In addition, we currently hold, and expect to continue to hold, a substantial amount of passive assets, including cash. The average value of our assets (including goodwill and other intangible assets) for purposes of determining our PFIC status for any taxable year may be determined, in large part, by reference to our market capitalization, which has fluctuated substantially over time and may continue to be volatile. Due to the volatility of our market capitalization, we may be a PFIC under the asset test for any taxable year if our cash and other passive assets constitute 50% or more of the value of our total assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">As discussed in our Annual Reports on Form 20-F for 2019, 2020, and 2022, we were likely a PFIC for these years. If we were a PFIC for 2019, 2020 or 2022, or any other taxable year, we generally will continue to be treated as a PFIC with respect to a U.S. investor who owned our common shares during any portion of such years, even if we are not a PFIC for 2023 or any subsequent taxable year, unless the U.S. investor makes a &#8220;deemed sale&#8221; election with respect to our common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Although we have not obtained valuations of our assets (including goodwill or going concern value) for 2023 and thus are not in a position to make a definitive determination regarding whether we were a PFIC for 2023, based on the composition of our income and assets during 2023 and the estimated value of our assets (which is based on our average market capitalization during 2023), we believe that we were likely not a PFIC for 2023. However, for the reasons described above there can be no assurance that the IRS will agree. Because our PFIC status is a factual annual determination that can be determined only after the end of the relevant taxable year, we cannot express a view regarding our PFIC status for 2024 or any future taxable year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">U.S. investors that own our common shares during any taxable year in which we are (or were) a PFIC generally will be subject to adverse U.S. federal income tax consequences, including (i) the treatment of all or a portion of any gain on disposition of our common shares as ordinary income, (ii) the application of a deferred interest charge on such gain and the receipt of certain dividends and (iii) the requirement to file certain reports to the IRS. We do not intend to provide the information that would enable investors to make a &#8220;qualified electing fund&#8221; election which, if available, could materially affect the U.S. federal income tax consequences to investors if we are a PFIC for any taxable year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For further discussion, see &#8220;Item&#160;10. Additional information&#8212;Section&#160;E. Taxation.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 8pt 0pt;"><span style="font-size:10pt;line-height:1.28;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">53</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_b3863825_f06c_4461_853a_1737685883a7"></a><a id="ITEM4INFORMATIONONTHECOMPANY_87372"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;4. INFORMATION ON THE COMPANY</p><a id="AHistoryanddevelopmentofthecompany_39409"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>History and development of the company</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are a Swiss stock corporation (<i style="font-style:italic;">soci&#233;t&#233; anonyme</i>) organized under the laws of Switzerland. We were formed as a Swiss limited liability company (<i style="font-style:italic;">soci&#233;t&#233; &#224; responsabilit&#233; limit&#233;e</i>) on February&#160;13, 2003 with our registered office and domicile in Basel, Switzerland. We converted to a Swiss stock corporation (<i style="font-style:italic;">soci&#233;t&#233; anonyme</i>) under the laws of Switzerland on August&#160;25, 2003. Our Swiss enterprise identification number is CHE-109.878.825. Our domicile and registered office is in Ecublens, at the &#201;cole Polytechnique F&#233;d&#233;rale Lausanne (EPFL) Innovation Park Building B, 1015 Lausanne, Vaud, Switzerland. Our common shares were admitted to trading on Nasdaq Global Market on September&#160;23, 2016, and trade under the symbol ACIU.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our general telephone number is (41) 21 345 91 21 and our internet address is www.acimmune.com. <span style="background:#ffffff;">References to our website address do not constitute incorporation by reference of the information contained on the website, and the information contained on the website is not part of this document or any other document that we file with or furnish to the SEC. </span>The SEC maintains an internet site that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC, which can be found at http://www.sec.gov. Our agent for service of process in the United States is Cogency Global&#160;Inc. located at 122 East 42nd Street, 18th Floor, New York, New York 10168. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our principal expenditures since January&#160;1, 2021 have been our research and development expenses, as more fully described elsewhere in this Annual Report.</p><a id="BBusinessoverview_517701"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Business overview</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune is a leading, clinical stage biopharmaceutical company advancing one of the broadest portfolios focused on pioneering Precision Medicine for neurodegenerative diseases. Our highly differentiated approach integrates novel therapeutics and diagnostics to overcome the fundamental challenge in this therapeutic area&#160;&#8211; the high number of co-pathologies driving disease development and progression and the urgent need for more tailored therapeutic regimens.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Leveraging our dual proprietary technology platforms, SupraAntigen and Morphomer, we have built a comprehensive pipeline of first-in-class or best-in-class candidates spanning multiple treatment modalities and targeting both established and emerging neurodegenerative pathologies. We are currently advancing 16 therapeutic and diagnostic programs, with one in a Phase 3 and five in Phase 2 clinical trials, targeting five different types of misfolded pathological proteins related to Alzheimer&#8217;s disease (AD), Parkinson&#8217;s disease (PD) and other neurodegenerative disorders. Our pipeline assets are further validated by the multiple partnerships we have established with leading global pharmaceutical companies. We believe our clinically validated technology platforms and multi-target, multimodal approach position AC Immune to revolutionize the treatment paradigm for neurodegenerative disease by shifting it towards Precision Medicine and disease prevention.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">54</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:249.03pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 1: AC Immune investment highlights</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;"><img src="aciu-20231231x20f001.jpg" alt="Graphic" style="display:inline-block;height:248.48pt;left:0%;padding-bottom:0.55pt;position:relative;top:0pt;width:474.57pt;"/></b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">(1) As of December 31, 2023; excluding treasury shares; (2) Including CHF 14.8 million milestone from Janssen, which was received on February 1, 2024; (3) Assumes second ACI-35-related milestone payment of CHF 24.6 million to be received in 2025 and no other milestones </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Our Team</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have assembled an outstanding management team with relevant scientific, clinical and regulatory expertise. Our scientific founders, Jean-Marie Lehn, Claude Nicolau, and Fred van Leuven, are regarded as pioneers in their respective scientific domains, including in the study of AD. Our co-founder and Chief Executive Officer, Andrea Pfeifer, a Pharmacologist with a Ph.D. in cancer research and a former National Institute of Health researcher, has a 30-year track record in product innovation and implementation, and was formerly Head of Nestl&#233; Global Research and the co-founder of Nestl&#233; Venture Fund. Madiha Derouazi, our Chief Scientific Officer, has an international track record as immunologist, entrepreneur and active immunotherapy developer. Nuno Mendon&#231;a, our Chief Medical Officer, is a certified Neurologist with international industry experience in the clinical development of investigational therapeutics for neurodegenerative diseases, including in senior roles at leading global pharmaceutical companies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Unmet need in neurodegenerative diseases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Neurodegenerative diseases, including dementias and motor disorders associated with protein misfolding, are prevalent, but there is currently an absence of reliable, early-stage diagnosis and disease-modifying treatments for these diseases. The growth in the number of people with neurodegenerative diseases has been significant, as evidenced by the prevalence of people affected by AD and PD, two of the most common neurodegenerative diseases.</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The World Health Organization recognizes dementia as a global public health priority</span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">. </b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Worldwide, there is a new case of dementia every 3 seconds, with an estimated global patient population of greater than 50&#160;million in 2020. This is predicted to increase to 139&#160;million by 2050 (Alzheimer&#8217;s Disease International).</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The estimated total healthcare costs for the treatment of Alzheimer&#8217;s disease in the United States in 2022 is USD 321 billion per the Alzheimer&#8217;s Association. The worldwide cost for dementia is expected to increase to approximately USD 2.8 trillion annually by 2030 as the population ages (Alzheimer&#8217;s Disease International). If the estimated global costs of dementia were a country, it would be the 14</span><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;line-height:100%;top:0pt;vertical-align:top;">th</sup><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> largest economy in the world.</span></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">55</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:193.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 2: Neurodegenerative diseases represent a large and growing market</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20231231x20f002.jpg" alt="Graphic" style="display:inline-block;height:193pt;left:0%;padding-bottom:0.5pt;position:relative;top:0pt;width:462.5pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">(1) Alzheimer&#8217;s Disease International 2019; (2) Gustavsson <i style="font-style:italic;">et al.</i>, 2023 (3) Alzheimer&#8217;s disease; (4) Monoclonal antibody</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Diagnosis typically takes the form of observation of cognitive, functional and behavioral impairment and other symptoms of the diseases, which are generally only apparent after irreversible neuronal damage has already occurred. In the United States, through Q1 2024, there were only two approved disease-modifying therapies for AD. These provided incomplete clinical efficacy, presented non-negligible safety risks or failed to halt disease progression. A subcutaneously administered formulation of one of the approved products resulted in a higher rate of ARIA-E (amyloid related imaging abnormalities &#8211; edema related) and still required frequent dosing making it unsuitable for prevention. Despite these shortcomings, marketed therapies, such as Eisai and Pfizer&#8217;s Aricept which only address symptoms, have achieved peak annual global sales of approximately USD 2.4&#160;billion prior to loss of exclusivity. Similarly, in the treatment of PD, the current standard of care is intended only to alleviate clinical symptoms.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In July 2022, the FDA accepted Eisai Co., Ltd.&#8217;s Biologics License Application (BLA) for lecanemab, an investigational anti-Abeta (amyloid beta) protofibril antibody for early AD that is partnered with Biogen Inc. In September 2022, Eisai and Biogen announced that lecanemab&#8217;s confirmatory Phase 3 AD study met its primary endpoint. As a result, lecanemab was granted accelerated approval as a treatment for AD in the U.S. by the U.S. FDA on January 6, 2023. On July 6, 2023, FDA converted lecanemab&#8217;s accelerated approval to a traditional approval for the treatment of Alzheimer&#8217;s disease. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In Europe, Eisai submitted marketing authorization application to the EMA on January 9, 2023. In China, Eisai initiated submission of data for BLA to the National Medical Products Administration (NMPA) on December 23, 2022 and was approved for the treatment of AD on January 9, 2024. On September 25, 2023, lecanemab was approved in Japan as a treatment for slowing progression of mild cognitive impairment (MCI) and mild dementia due to Alzheimer&#8217;s disease (AD). The administration by intravenous infusion every 2 weeks remains a significant inconvenience for vulnerable patients and their care givers as well as a further burden on healthcare infrastructure.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Neurodegenerative disease overview</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Folding and unfolding of proteins are important ways of regulating the biological activity and cellular location of those proteins. Misfolding of proteins occurs due to a breakdown of cellular quality control systems and is a common feature of many neurodegenerative diseases. Misfolded proteins are unable to carry out their normal functions and aggregate to form insoluble deposits in the brain, which eventually lead to neuronal damage and cell death. The progression of neurodegenerative diseases, such as AD and PD, is linked to the spread of misfolded, pathological protein </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">56</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:184.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">aggregates throughout the brain. Figure 3 shows how misfolded proteins play a key role in the pathology of neurodegenerative diseases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;text-align:center;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Figure 3: Misfolded proteins key impact on the pathology of neurodegenerative diseases</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 8pt 0pt;"><img src="aciu-20231231x20f003.jpg" alt="Graphic" style="display:inline-block;height:184pt;left:0%;padding-bottom:0.5pt;position:relative;top:0pt;width:468.62pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Typically, protein misfolding occurs in response to cellular stress, which can be triggered by many different, largely unknown, causes. A cascade of molecular events begins with the misfolding of single proteins within a cell, which then aggregate and ultimately form larger aggregates including plaques and tangles. These misfolded proteins are then exported or shed from dying neurons where they can spread to healthy cells nearby. Once inside, misfolded proteins can interact with normal proteins and cause them to misfold in a process known as &#8220;seeding,&#8221; leading to spreading of the disease pathology throughout the brain, increased neuronal death and a progressive decline in cognitive function.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Figure above also shows how our therapies are designed to intervene and prevent key pathological steps in the progression of neurodegenerative diseases. They are designed to (i)&#160;prevent initial misfolding; (ii)&#160;promote disaggregation of misfolded proteins; (iii)&#160;inhibit spreading of pathological protein to healthy cells; (iv)&#160;prevent seeding of new misfolded protein aggregates inside healthy cells; and (v)&#160;inhibit downstream neurodegeneration. This robust approach to targeting neurodegenerative diseases is enabled by our two validated technology platforms, SupraAntigen and Morphomer, which generate highly specific biologics and small molecule inhibitors that can distinguish normal from misfolded proteins and inhibit key disease pathways both inside and outside of cells.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Our strategic vision</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our goal is to continue leveraging our proprietary discovery platforms, SupraAntigen and Morphomer, to shift the treatment paradigm for neurodegenerative disease towards Precision Medicine and disease prevention. We are executing a clear business strategy built on three pillars: (i)&#160;accelerate development of novel therapeutics in AD with our partners; (ii)&#160;expand our strategic focus in Parkinson&#8217; disease (PD) and non-AD neurodegenerative diseases, including NeuroOrphan indications and limbic-predominant age-related TDP-43 encephalopathy (LATE); and (iii)&#160;a continued focus on diagnostics enabling Precision Medicine to be an ultimate differentiator for the Company.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">57</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:196.52pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 4: AC Immune&#8217;s three-pillar strategy</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;"><img src="aciu-20231231x20f004.jpg" alt="Graphic" style="display:inline-block;height:196.52pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:475.2pt;"/></b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">(1) Alzheimer&#8217;s disease; (2) Down syndrome; (3) alpha-synuclein; (4) TAR DNA-binding protein 43</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our three-pillar execution strategy reflects our unique Precision Medicine approach, which ultimately creates differentiation due to our ability to address the high levels of co-pathologies present in AD and other neurodegenerative diseases. Much like cancer, neurodegenerative diseases are heterogeneous and may require multiple therapeutic interventions tailored to patients&#8217; specific disease drivers, to be used in combination in order to slow or stop the disease course. Ultimately, it is our belief that Precision Medicine will increase the chance of treatment success by enabling clinical trial participants to be better defined by their various proteinopathies, allowing for treatment with the right therapies at the right time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune has established itself as a leader in developing Precision Medicines for neurodegenerative diseases by utilizing our diagnostic capabilities to enable improved diagnosis of co-pathologies, patient selection and assessment of clinical trial outcomes. Our dual technology platforms allow for a multi-modal approach encompassing a portfolio of active immunotherapies, antibodies and small molecules tailored to the underlying pathology driving patients&#8217; disease. In addition to generating targeted monotherapies, this approach creates the potential for combination regimens, which may treat a broader spectrum of disease and offer greater efficacy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Precision Medicine for neurodegenerative diseases</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The development of therapeutics for neurodegenerative diseases is moving towards treating early-stage disease to delay or prevent progression by preserving neurological function before it is irretrievably lost. Therefore, early detection of neurodegenerative diseases will be critical to enhancing the effectiveness of both symptomatic and disease-modifying therapies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">This begins with a real challenge. The commonly used approach of taking a biopsy of the affected tissue to detect the corresponding pathology is not possible with diseases of the brain. Given these complexities, it becomes more important that we develop improved methods to fully characterize the underlying pathologies in different patients to ultimately provide better opportunities for therapeutic intervention at all stages of disease. Samples of blood or cerebrospinal fluid can be used to monitor biomarker levels indirectly but neither of these fluids provide exact anatomical information on where protein misfolding and aggregation occur. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">At AC Immune, we have a strong track record in discovering highly sensitive and specific imaging agents to detect and quantify pathological proteins and their aggregated forms directly in patients&#8217; brains using PET scans. These agents </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">58</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:210pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">can provide critical information to confirm or exclude certain diagnoses and thus to determine which might be the most appropriate therapeutic strategy for a patient. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We are developing an integrated diagnostic and therapeutic strategy to deliver Precision Medicine for patients with neurodegenerative conditions. This will lead to a combination therapy approach to treat each patient's unique disease by addressing the right proteinopathy, in the right patient, at the right time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Active immunotherapies for Alzheimer&#8217;s and Parkinson&#8217;s disease</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Consistent with this approach, we are progressing our active immunotherapies targeting the hallmark proteins driving neurodegenerative diseases such as Abeta, Tau, and alpha-synuclein (a-syn). Our clinical stage active immunotherapy programs, ACI-24.060 (anti-Abeta active immunotherapy), ACI-35.030 (anti-pTau active immunotherapy), and ACI-7104.056 (anti-a-syn active immunotherapy) have been shown to stimulate a patient&#8217;s own immune system to produce antibodies directed specifically against the pathological species of these target proteins. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt;">We believe that these antibodies will modify the course of disease by supporting clearance of toxic protein aggregates (as recent clinical data from certain monoclonal antibodies have shown), or by preventing their spreading and accumulation, thereby preserving neuronal health and function. Importantly, the use of active immunotherapies over the longer-term and in people identified as &#8220;at risk&#8221; before symptomatic disease development will provide the rational, targeted approach consistent with our Precision Medicine strategy. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-indent:17.85pt;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Key elements of our approach include:</p><div style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-left:18pt;margin-top:0pt;text-indent:0pt;"><span style="display:inline-block;font-size:10pt;font-style:italic;font-weight:bold;min-width:18pt;white-space:nowrap;">1.</span><span style="font-size:10pt;font-style:italic;font-weight:bold;">Execution on advancing our product candidates, in partnership or alone, from clinical development to regulatory approval and potential commercialization</span></div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 5: Our broad and robust clinical stage pipeline</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;"><img src="aciu-20231231x20f005.jpg" alt="Graphic" style="display:inline-block;height:209.9pt;left:0%;padding-bottom:0.1pt;position:relative;top:0pt;width:485.3pt;"/></b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt;">(1) Alzheimer&#8217;s disease; (2) Down syndrome-related Alzheimer&#8217;s disease; (3) Refers to expected readouts from the ABATE Phase 1b/2 trial of ACI-24.060 in patients with AD; (4) alpha-synuclein; (5) Parkinson&#8217;s disease; (6) Positron emission tomography; (7) Progressive supranuclear palsy; (8) Multiple system atrophy; * licensed to Genentech (a member of the Roche Group) until April 19, 2024</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.28;margin:0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.28;margin:0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">59</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our clinical stage product candidates include:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.27;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">ACI-24.060 for </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">AD and for AD in DS</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">.&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Based on safety, tolerability, immunogenicity, and pharmacodynamics results</span><span style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">with an earlier version of ACI-24, an enhanced formulation, ACI-24.060, which incorporates Abeta unrelated T-helper cell epitopes to increase the magnitude and the boostability of the antibody response, is currently being tested at 3 different incremental doses in the ABATE Phase 1b/2 trial (NCT05462106) and Abeta plaque reduction is being assessed using Abeta-PET imaging.</span></td></tr></table><div style="margin-top:8pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 8pt 36pt;">ABATE is a multicenter, adaptive, double-blind, randomized, placebo-controlled study designed to assess the safety, tolerability, immunogenicity, and pharmacodynamic effects of ACl-24.060 in subjects with prodromal AD and in adults with DS. The CTA has been approved by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) and Spanish Agency for Medicines and Health Products (AEMPS) with the first AD patient dosed in June 2022. In June 2023, AC Immune received Fast Track designation from the FDA for ACI-24.060, for the treatment of AD. This followed FDA clearance of the Investigational New Drug (IND) application in May 2023 enabling the initiation of the ABATE study to include clinical trial sites to enroll participants with DS in the U.S.<span style="background:#ffffff;"> Based on the safety profiling and induction of an antibody response post dosing of ACI-24.060 in patients with AD, dosing of the first individual with DS occurred in June 2023</span>.</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin-bottom:8pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">ACI-7104.056.</span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"> </b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ACI-7104.056, </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">the optimized formulation of the clinically-validated PD active immunotherapy PD01A, </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">is currently being tested in a placebo-controlled, double-blind,</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> adaptive, biomarker-based Phase 2 study (VacSYn; </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">NCT06015841) in the EU and in the UK</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">.</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> This trial is evaluating </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">safety and immunogenicity</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of ACI-7104.056</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> against a-syn and pathological a-syn species</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> in early PD</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">. Additionally, disease-specific </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">imaging and fluid </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">biomarkers and progression of motor and non-motor symptoms of PD will be monitored. The </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">VacSYn </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">trial </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">commenced in July 2023 with the dosing of the first patient, and enrollment of co</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">hort 1 has been completed in December 2023, with 16 patients randomized. No safety concerns have been reported to date.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">ACI-35.030.</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;AC Immune and Janssen Pharmaceuticals, Inc. (Janssen), part of the Janssen Pharmaceutical Companies of Johnson &amp; Johnson, have evaluated the anti-phosphorylated-Tau (anti-pTau) active immunotherapy ACI-35.030 in a Phase 1b/2a study in subjects with early AD (NCT04445831). Results showed that ACI-35.030 immunization generated a rapid antibody response (anti-pTau, anti-ePHF and anti-Tau IgG) after the first injection (at week 2) at the 3 tested doses. An apparent dose-effect was observed between low and mid doses but not between the mid and high doses. A boosting effect was observed after each injection especially against pathological Tau species (pTau and ePHF). The antibody response was strongly directed against pathological Tau species but not against non-phosphorylated Tau. Long-term maintenance of the anti-ePHF IgG titers against endogenous pathological Tau was observed at the mid- and high-dose. </span></td></tr></table><div style="margin-top:8pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 8pt 36pt;">In addition to ACI-35.030, an exploratory alternative pTau active immunotherapy candidate, JACI-35.054, was also evaluated in the Phase 1b/2a trial. It generated a more varied antibody response (anti-pTau, anti-ePHF and anti-Tau IgG) after the second injection (at week 10) at the 2 tested doses. While there was no apparent dose-effect between the 2 tested doses, a higher variability of titers was observed at the low dose. A boosting effect was seen against pathological Tau and non-phosphorylated Tau species from the 2nd injection. For JACI-35.054, there was a lower extent of specific antibody response against pathological Tau species compared to non-phosphorylated Tau as observed with ACI-35.030. Both ACI-35.030 and JACI-35.054 showed good safety and tolerability profiles. The majority of adverse events (AEs) were of mild intensity. No death was reported. No AE led to study discontinuation or to study treatment discontinuation. The injection site reactions were one of the most frequently reported AEs in actively treated subjects. Serious adverse events (SAEs) mainly observed in subjects treated with ACI-35.030, did not appear to have any particular relationship to the dose.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0pt 36pt;">Consequently, ACI-35.030 (JNJ-64042056) that is selective for pathological phosphorylated Tau (pTau) is being advanced and will be assessed in subjects with preclinical (ie., pre-symptomatic) AD in a Phase 2b study in which the first patient will be dosed in H1 2024. The trial will randomize approximately 500 participants </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">60</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 8pt 36pt;">with confirmed early-stage Tau pathology, who will be treated over a four-year period. The trial will include interim analyses potentially allowing for acceleration towards a regulatory filing<span style="background:#ffffff;">.</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin-bottom:8pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">PI-2620</span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">.</b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">PI</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">-</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">2620 is the Tau-PET imaging agent discovered during the collaboration of AC Immune and LMI. We are working with our partner, LMI, to advance PI</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">-</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">2620 as a highly differentiated, best-in-class Tau diagnostic for AD as well as non-AD Tauopathies such as progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). Results have demonstrated PI</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">-</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">2620&#8217;s differentiated characteristics as a diagnostic tool for studying Tau-related diseases. Results on the use of PI-2620 in AD patients from an investigator sponsored Phase 2 trial at the Asan Medical Center (NCT03903211) were presented at the 2022 AAIC. Following these results, LMI moved PI-2620 into late-stage clinical development in AD and made a miles</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">tone payment. The first Alzheimer&#8217;s patient in ADvance, the pivotal Phase 3 histopathology study in AD (NCT05641688), was imaged in January 2023. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin-bottom:8pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">ACI-12589.</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;Our Morphomer platform has delivered the first clinically validated a-syn-PET tracer which now can support the d</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ifferential diagnosis of multiple system atrophy (MSA) from other neurodegenerative disease and allow precision medicine approaches and biomarker-based clinical development in this indication. ACI-12589 preclinical and clinical data have been published in October 2023 in </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Nature Communications</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. In addition, medicinal chemistry optimization strategies have allowed the identification of our next-generation clinical candidate, ACI-15916. Compared to ACI-12589, ACI-15916 shows significantly higher target occupancy in brain slices from idiopathic forms of Parkinson&#8217;s disease (PD) and has therefore the potential to enable imaging of a-syn pathology in patients with PD. IND/CTA-enabling studies for ACI-15196 will be initiated in Q1 2024 with the regulatory submission planned in Q4 2024</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin-bottom:8pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Morphomer Tau aggregation inhibitors.</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;background:#ffffff;">&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">In collaboration with our partner, Lilly, we are researching and developing small molecule Tau aggregation inhibitors with plans to evaluate candidates in AD and NeuroOrphan Tauopathies. Continued candidate characterization across the research program has also identified new and highly differentiated candidates with excellent cerebrospinal fluid exposure and selectivity for </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">pathological</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;"> aggregated Tau.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin-bottom:8pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Semorinemab</span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">.</b><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">&#160;</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">Semorinemab is an investigational monoclonal anti-Tau antibody that targets the N-terminal portion of the Tau protein and is designed to bind to Tau and slow its spread between neurons for the treatment of AD. As announced on January 22, 2024, AC Immune will regain the global rights to semorinemab following termination of the collaboration agreement with Genentech, a member of the Roche Group, which termination will be effective in April 2024. Semorinemab has been studied in two Phase 2 studies: Tauriel in early (prodromal-to-mild) AD, where the primary efficacy endpoint was not met; and Lauriet in mild-to-moderate AD. In Lauriet, a strongly positive and highly statistically significant effect was seen on ADAS-Cog11 (one of two co-primary endpoints) plus statistically significant effects on several key biomarkers, including total Tau and pTau217 in CSF and plasma. The second co-primary endpoint, ADCS-ADL and the secondary efficacy endpoints did not reach significance. Final open label extension results from the Lauriet trial will be reviewed when they become available and are received in full by AC Immune. The Company will then carefully review and evaluate available data sets, before decisions are made on potential further development and other opportunities.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;background:#ffffff;">Crenezumab.</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">&#160;Crenezumab is a humanized monoclonal antibody, an investigational treatment designed to slow AD progression by neutralizing neurotoxic Abeta oligomers. It was designed by AC Immune to be a conformation-specific monoclonal antibody targeting multiple forms of misfolded Abeta. As announced on January 22, 2024, AC Immune will regain the global rights to crenezumab following termination of the collaboration agreement with Genentech, a member of the Roche Group, which termination will be effective in April 2024. Crenezumab has an antibody backbone (IgG4) designed to minimize the inflammatory response in the brain, which may result in a lower incidence of side effects known as ARIA (Amyloid-Related Imaging Abnormalities). The investigational medicine has demonstrated excellent safety (e.g. less than 1% of ARIA-E cases in the Phase 3 studies; Ostrowitzki et al., JAMA Neurology, 2022) and encouraging efficacy signals while </span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">61</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:160.5pt;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"/><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">undergoing extensive Phase 2 clinical testing. While the Colombian autosomal-dominant AD prevention trial was not sufficiently powered to show significant cognitive benefits, crenezumab was proven to be safe with numeric trends on the primary and vast majority of secondary and exploratory endpoints in its favor. The lessons from this study provided useful insights regarding the desired anti-amyloid immunotherapy profile and designs for prevention trials. AC Immune will carefully review and evaluate available data sets, before decisions are made on potential further development and other opportunities.</span></td></tr></table><div style="margin-top:8pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">2.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Expand product development into NeuroOrphan and additional neurodegenerative diseases</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Beyond AD, we are pursuing additional neurodegenerative diseases such as Parkinson&#8217;s disease (PD) and NeuroOrphan indications, specifically Tau-, a-syn- and TDP-43-driven diseases, such as FTLD-Tau (e.g. PSP, CBD, FTLD-MAPT), MSA, and ALS and FTLD-TDP, respectively. As part of this strategic move, AC Immune acquired certain a-syn assets from Affiris in 2021, gaining an advanced, clinical stage and validated a-syn active immunotherapy candidate for development against PD in the process.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuing NeuroOrphan indications may enable us to obtain a streamlined regulatory approval pathway and favorable reimbursement for any approved products. In addition, we are accelerating our novel therapeutic and diagnostic candidates targeting a-syn as a primary pathology in Parkinson&#8217;s disease and other a-synucleinopathies. See Figure 6 for a summary of our early-stage diversified novel targets pipeline including non-AD neurodegenerative diseases, with an in-house focus on NeuroOrphan indications.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 6: Robust novel targets pipeline: diversification into non-AD</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">1</sup><b style="font-weight:bold;"> and non-CNS</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">2</sup><b style="font-weight:bold;"> diseases</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><img src="aciu-20231231x20f006.jpg" alt="Graphic" style="display:inline-block;height:160pt;left:0%;padding-bottom:0.5pt;position:relative;top:0pt;width:485.3pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">(1) Alzheimer&#8217;s disease; (2) Central nervous system; (3) TAR DNA-binding protein 43; (4) Limbic-predominant age-related TDP-43 encephalopathy; (5) alpha-synuclein; (6) Parkinson&#8217;s disease; (7) (NOD)-like receptor protein 3; (8) Apoptosis-associated speck-like protein containing a CARD, also PYCARD; (9) Positron emission tomography </p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">3.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Accelerating the advancement of our diagnostic portfolio</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Early detection of neurodegenerative diseases may be critical to enhancing the effectiveness of both symptomatic and disease-modifying therapies. As a result, therapeutic development for AD increasingly focuses on treating early-stage disease to delay or prevent progression and to preserve the maximum amount of cognitive function before it is irreversibly lost. Most clinical studies now target mild or even preclinical stages of the disease increasing the need for accurate diagnosis that is independent of potentially subjective cognitive metrics. At least one study estimates that as many as one third of patients in previous AD studies did not in fact have AD. Accurate and early diagnosis of AD is thus a substantial unmet market need, and diagnostic products will have a key role in generating a new treatment paradigm, including by selecting more uniform and stage-specific clinical study subjects, tracking patient progress and results, </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">62</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:202.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">managing patients who are receiving treatment, and ultimately diagnosing disease at its earliest stage for immediate treatment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 7: The need for Precision Medicine in AD: improved clinical trials, diagnosis and treatment of neurodegenerative diseases</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20231231x20f007.jpg" alt="Graphic" style="display:inline-block;height:202.05pt;left:0%;padding-bottom:0.45pt;position:relative;top:0pt;width:476pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">(1) alpha-synuclein; (2) TAR DNA-binding protein 43; (3)&#160;Amyotrophic lateral sclerosis; (4)&#160;Limbic-predominant age-related TDP-43 encephalopathy</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 3pt 0pt;">Refs: Attems <i style="font-style:italic;">et al.</i>, Newcastle University, AAIC 2017; Nelson <i style="font-style:italic;">et al.</i>, Brain, 2019</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.28;margin:0pt 0pt 3pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are developing a suite of diagnostics designed to be first-in-class or best-in-class, which will enable improved diagnosis of pathologies, patient selection and assessment of clinical trial outcomes. We currently have four diagnostic programs in our pipeline, developed using our proprietary technology platforms and targeting: Tau, a-syn and TDP-43.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Leveraging our Morphomer platform, we are developing proprietary PET imaging diagnostics for diseases resulting from the misfolding of a-syn and TDP-43 proteins. No such diagnostics are currently available for these important pathologies and AC Immune has identified promising compounds with high affinity and target specificity, as well as favorable central nervous system (CNS) pharmacokinetic properties. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our various PET Tracers, including for a-syn and TDP-43, have been validated through prestigious and competitive grants from the MJFF, EU Joint Programme &#8211; Neurodegenerative Disease Research&#8217; (JPND) amongst and Target ALS Foundation. If validated clinically, our tracers could become the first in the world to effectively diagnose these respective proteinopathies, which are highly relevant for multiple neurodegenerative diseases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">4.</span></span><span style="font-style:italic;">Continuing to optimize our long-term growth by selectively partnering product candidates for global development and commercialization</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We have a strong track record of establishing value-driving collaboration agreements with leading pharmaceutical companies, such as Janssen, Lilly and LMI. This strategy allows us to leverage our partners&#8217; scientific, development, manufacturing and commercialization expertise and other resources while partially monetizing our investments, de-risking and accelerating the development of our product candidates. This strategy also enables us to use non-dilutive </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">63</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:169.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">partnership revenue to bolster our investment into our early-stage proprietary programs and fuel our continued growth. Our collaboration agreements are summarized in the table below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 8: External validation and cash generation through external collaborations</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">1</sup></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20231231x20f008.jpg" alt="Graphic" style="display:inline-block;height:169.35pt;left:0%;padding-bottom:0.15pt;position:relative;top:0pt;width:480.95pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">(1) Disclosure limited due to confidentiality agreements with collaboration partners; (2) In millions; (3) Total payments received from partner until termination of agreement; (4) Positron emission tomography; (5) In Alzheimer&#8217;s disease; (6) Phase 1 completed; (7) Equity investment; (8) Converted to CHF on date of receipt;  (9) Excludes convertible note agreement of USD 50 million ; * licensed to Genentech (a member of the Roche Group) until April 19, 2024</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For any additional product candidates targeting large markets, we may, if appropriate, selectively partner with leading companies that we believe can contribute development, manufacturing and marketing expertise, geographic reach and/or other resources that can enhance the value of our wholly-owned products. We will continue to seek to retain certain indications (e.g. NeuroOrphan) and/or geographies, such that we could begin to grow our own marketing capabilities and develop AC Immune into a fully integrated pharmaceutical company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">The benefits of our clinically-validated, proprietary technology platforms</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The engines that drive our growth are our two unique proprietary and versatile technology platforms: our SupraAntigen platform, which is our biological and immunological platform, and our Morphomer platform, which is our chemical platform. These platforms generate biologics (active immunotherapies and antibodies) and small molecules, respectively, which are designed to selectively interact with the misfolded proteins that are common in a broad range of neurodegenerative diseases. These clinically-validated platforms form the basis of our ongoing pipeline development and the value-driving strategic partnerships we have established to date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The key aspect of both our SupraAntigen and Morphomer technology platforms is conformational specificity, which we believe is central to the development of effective and safe therapeutics for neurodegenerative diseases. Our SupraAntigen platform targets misfolded proteins through antigens displayed on the surface of liposomes, which mimic the targeted pathological form of the protein. In a complementary approach, our Morphomer platform uses small molecular weight compounds to target the aggregation and seeding process, which prevents the misfolded proteins from aggregating inside the cell and prevents the formation of new misfolded proteins in healthy neighboring cells through a seeding mechanism. Small molecules derived from our Morphomer platform, which we refer to as Morphomers, not only inhibit aggregation of pathological proteins, but also promote disaggregation of already formed aggregates, thereby potentially enhancing their therapeutic potential even in established disease states.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">64</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:185.19pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 9: SupraAntigen and Morphomer platforms: an integrated approach to CNS-specific therapies</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;"><img src="aciu-20231231x20f009.jpg" alt="Graphic" style="display:inline-block;height:185.19pt;width:474.78pt;"/></b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">(1) Nanomolar; (2) Picomolar; (3) Central nervous system; (4)&#160;Blood-brain barrier; (5)&#160;alpha-synuclein; (6) TAR DNA-binding protein 43</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The SupraAntigen platform was first developed by AC Immune&#8217;s scientific co-founders to overcome a challenge common to neurodegenerative diseases: the lack of immunogenicity of disease-causing self-proteins. The SupraAntigen platform uses liposomes (small spherical vesicles formed by a lipid bilayer) to present specific antigens designed to evoke an immune response. SupraAntigen is used to generate conformation-specific antibodies for immunotherapy in neurodegenerative diseases. The overarching idea behind the platform is that antibodies, which are large in size, are well-suited to target extracellular proteins, interrupt spreading of pathological proteins, and break up and clear aggregates of misfolded proteins through phagocytosis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune has acquired advanced mastery of the design and manipulation of liposomes to develop either passive or active immunization techniques to generate antibodies targeting neurodegenerative diseases. When pursuing active immunization approaches, we use liposomes carrying a specific antigen as an active immunotherapy. After treatment with an active immunotherapy, antibodies that specifically target the pathological forms of the target proteins are produced naturally by the host with very high affinity without further optimization. This immune response can be long-lasting and may be ideal to prevent the onset of a disease, as the immune system is now primed to rapidly identify disease-causing misfolded proteins.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Product candidates generated utilizing the SupraAntigen platform include active immunotherapies (i) ACI-35.030, which has now been advanced into a large Phase 2b clinical trial in preclinical in early AD, and (ii) ACI-24.060 in the ABATE Phase 1b/2 study in subjects with prodromal AD and in adults with DS. Antibodies include: the preclinical candidates targeting a-syn, TDP-43 and ASC (apoptosis-associated speck-like protein containing a C-terminal caspase recruitment domain) for PD and NeuroOrphan indications.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Morphomer platform is designed to enable the development of small molecules (Morphomers) able to bind/interact with beta-sheets containing fibrillary aggregates from candidate selection through preclinical proof-of-concept. Morphomers can target pathological protein aggregates in any brain compartment and are equally well suited for therapeutic and diagnostic applications.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The first key component of the Morphomer platform is its library of rationally designed, CNS-optimized non-dye compounds. AC Immune&#8217;s extensive know-how has enabled the identification of CNS compounds that penetrate the brain and demonstrate high selectivity for the target. This knowledge has been used to focus the Morphomer library to approximately 16,000 compounds that display these favorable characteristics, making this library an ideal starting point when developing molecules to target human proteinopathies of the CNS. Thus, rather than using the non-directed trial and error strategy of the typical drug development process, the Morphomer platform utilizes its bias for successful CNS </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">65</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:210pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">candidates to improve efficiency and accelerate the early stages of the drug development process. Extensive expertise in medicinal chemistry and a suite of proprietary assays developed to screen and validate candidate compounds enables AC Immune to rapidly optimize multiple, highly diversified lead compounds for further preclinical and clinical development.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Therapeutic product candidates generated by the Morphomer platform include our Morphomer Tau candidates. We also have Morphomer a-syn candidates and the diagnostic programs PI-2620 in Phase 3, respectively, and ACI-12589 in a Phase 1 clinical trial in PD, MSA and other synucleinopathies. Finally, we also have- TDP-43-PET imaging agents and Morphomer a-syn candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Shifting the current treatment paradigm for neurodegenerative diseases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Modifying the progression of the disease requires targeting the specific underlying biological processes that drive disease progression. Unfortunately, these processes evolve over the course of many&#160;years prior to manifestation of symptoms and a high&#160;percentage of neurons may be lost prior to clinical manifestation. Earlier intervention or prevention of the disease could have a major impact, but it requires accurate disease detection prior to developing symptoms. Due to recent advancement in biomarker research, people at risk of developing AD can be diagnosed 10-20&#160;years before symptoms occur. This is opening a completely new market segment for the prevention of NDD in which active immunization will play a key role. This early, and potentially preventative, Precision Medicine approach may ultimately lead to better disease management for patients with neurodegenerative diseases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 10: Active immunotherapies as a new class of treatment for neurodegenerative diseases</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20231231x20f010.jpg" alt="Graphic" style="display:inline-block;height:209.65pt;left:0%;padding-bottom:0.35pt;position:relative;top:0pt;width:482.3pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Given the inherent advantages of active immunotherapies compared to monoclonal antibodies, we believe that our programs could have a profound global social and economic impact as a new class of therapy for neurogenerative diseases in various settings. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">With regard to treatment, active immunotherapies have potentially improved safety and efficacy profiles. By stimulating the patient&#8217;s own immune system to produce antibodies, we believe safety and tolerability would be enhanced by avoiding the need to introduce repeated large doses of externally manufactured antibodies. Additionally, due to their ability to target multiple epitopes with a long-lasting and consistent immune response, the polyclonal antibody response generated by an active immunotherapy could potentially address multiple pathological species of the targeted protein.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">66</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:164.2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Active immunotherapies are also much simpler to administer. They are amenable to convenient annual or biannual dosing whereas monoclonal antibodies require frequent intravenous infusions (up to twice per month). These dosing regimens position active immunotherapies as an obvious solution for a maintenance therapy for patients who have previously achieved plaque clearance with antibodies. This approach will reduce the burden for infusion centers and enhance access to a broader patient population.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition to these advantages, active immunotherapies allow for more simplified distribution logistics and cost-effectiveness. These factors are crucial to enable their global application as preventative therapies. Given the irreversible nature of neuronal damage, earlier intervention, even before symptoms become visible, promises to be the best strategy to preserve patient function and quality of life.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 11: Market opportunities targeting key primary and co-pathologies</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20231231x20f011.jpg" alt="Graphic" style="display:inline-block;height:164.2pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:485.3pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">(1) Alzheimer&#8217;s Association; (2)&#160;(NOD)-like receptor protein; (3)&#160;Apoptosis-associated speck-like protein containing a CARD, also PYCARD; (4)&#160;GBD 2016 Parkinson&#8217;s Disease Collaborators <i style="font-style:italic;">Lancet Neurology</i> 2018; (5) Limbic-predominant age-related TDP-43 encephalopathy; (6)&#160;Nelson et. al. <i style="font-style:italic;">Brain</i> 2019; (7)&#160;TAR DNA-binding protein 43; (8)&#160;National Institute of Neurological Disorders and Stroke (NINDS) Progressive Supranuclear Palsy Fact Sheet; (9)&#160;NINDS Multiple System Atrophy Fact Sheer; (10)&#160;ALS Association <i style="font-style:italic;">Rare Disease </i>2013; (199) NINDS Amyotrophic Lateral Sclerosis Fact Sheer; (12) Knopman and Roberts <i style="font-style:italic;">J. Mol. Neurosci. </i>2011</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Due to the high level of co-pathologies involved in neurodegenerative diseases, future treatment paradigms may involve different combinations of disease modifiers at various stages of a disease. Therefore, combination therapies may include combinations of immunotherapies or combinations of small and large molecules targeting proteinopathies and neuroinflammation. Our therapeutic product candidates seek to modify the course of AD by intervening at an earlier stage of the disease progression, prior to irreversible neuronal damage. Beyond AD, we believe that we can leverage our proprietary platforms to generate and employ molecules that address the pathologies of other neurodegenerative diseases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In support of shifting the current treatment paradigm from treatment to prevention, we are the leader in discovering new PET imaging agents to improve the timing and accuracy of diagnoses in neurodegenerative diseases. In our pipeline, we have three families of diagnostic candidates that were developed through our Morphomer platform, which target Tau, a-syn and TDP-43. We believe our Tau-PET imaging program has received external validation through our partnership with LMI, a leader in imaging agents, as well as from several investigator-sponsored trials. We are also developing a-syn and TDP-43 PET imaging agents for PD and other neurodegenerative diseases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">With our unique integrated approach focused on Precision Medicine, we believe that our diagnostic product candidate pipeline will complement our disease-modifying treatment product candidate pipeline and potentially reshape the clinical course and treatment of neurodegenerative diseases.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">67</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:207pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20231231x20f012.jpg" alt="Graphic" style="display:inline-block;height:206.8pt;left:0%;padding-bottom:0.2pt;position:relative;top:0pt;width:485.25pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Our clinical programs </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ACI-24.060</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-24.060 derives from AC Immune&#8217;s anti-Abeta active immunotherapy, ACI-24, that was assessed in patients with AD and in subjects with DS. As ACI-24 was shown to be safe and well tolerated with preliminary evidence of immunogenicity and pharmacodynamic effects in these two study populations, the enhanced version ACI-24.060 was created. ACI-24.060 contains additional Abeta unrelated T-helper cell epitopes and has demonstrated similar safety and tolerability in NHPs with superior immunogenicity in mouse and NHP studies as compared to the original ACI-24.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The aim of the active immunotherapy is to stimulate the patient&#8217;s immune system to produce and maintain antibodies that bind and remove pathological Abeta with the goal to prevent plaque accumulation and enhance clearance of toxic Abeta species. The Company is pursuing clinical development of ACI-24.060 in early AD as well as in people living with DS exhibiting the presence of brain amyloid pathology.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-24.060 is proprietarily owned.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Mechanism of Action</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ACI-24.060 consists of an immunogenic peptide (Pal1-15) containing the amino acid sequence 1-15 of the human Abeta1-42 protein, an antigenic peptide with Abeta unrelated T-helper cell epitopes and an adjuvant, formulated together as a liposomal suspension. In this formulation, the immunogenic peptide, Pal1-15, is presented to B cells of the immune cells on the surface of the liposomes in a conformational format mimicking the pathological form of the protein. This presentation optimally drives antigen-specific antibody responses that bind to the pathological forms of Abeta, i.e. oligomeric and pyroglutamate (pyroGlu) Abeta. The incorporation of the Abeta-unrelated T-helper cell epitopes aims to prime, boost and maintain a strong anti-Abeta IgG response while preserving the safety profile observed with the original formulation of ACI-24;</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">In preclinical proof-of-concept studies in models of Abeta pathology, treatment with the immunogen, Pal1-15 in the original ACI-24 formulation demonstrated anti-Abeta IgG titers with concomitant plaque reduction and restoration of memory; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">In preclinical safety studies, </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">treatment of NHPs with ACI-24.060 led to the anticipated enhanced anti-Abeta IgG&#160;titers (as compared to ACI-24) while maintaining with boosting effect the</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> favorable safety profile, confirming the suitability to add the Abeta-unrelated T-helper cell epitopes to the active immunotherapy;</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">68</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:194.15pt;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Furthermore, assessment of the kinetics and binding profile of the antibodies elicited by immunization of NHPs with ACI-24.060 demonstrated enhanced antigen-specific antibody titers with immunization as well as target binding to Abeta oligomers and pyroGlu Abeta, in quantities similar to pK profiles achieved with clinically validated lecanemab and donanemab </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(antibody titers against Abeta1-42 and pyroGlu Abeta shown in the Figure 12). Of note, antibodies raised in NHPs have &gt;1000-fold preference for oligomers over monomers, similar to lecanemab (antibody titers against oligomeric Abeta shown in the Figure 13);</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Target engagement was confirmed </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">in situ,</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> using sections from AD patients in which sera from the NHPs immunized with ACI-24.060 bound to the Abeta plaques while showing no reactivity to other tissues.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 12: Abeta1-42 and pyroGlu Abeta IgG titers in NHP immunized with ACI-24.060</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20231231x20f013.jpg" alt="Graphic" style="display:inline-block;height:194.15pt;width:402.9pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref : Fiorini <i style="font-style:italic;">et al.</i>, CTAD 2023</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">69</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:185.45pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 13: Oligomeric Abeta IgG titers in NHP immunized with ACI-24.060 and preferential binding over Abeta monomers</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20231231x20f014.jpg" alt="Graphic" style="display:inline-block;height:185.45pt;width:444.1pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20231231x20f015.jpg" alt="Graphic" style="display:inline-block;height:183.15pt;width:425.1pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref : Fiorini <i style="font-style:italic;">et al.</i>, CTAD 2023</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Clinical development</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ABATE Phase 1b/2</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">ABATE Phase 1b/2 study design</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The ABATE clinical study (NCT05462106) is a multicenter, adaptive, placebo-controlled, dose-escalation, double-blind, randomized study containing two parts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-indent:17.85pt;margin:0pt 14.45pt 12pt 0pt;"><i style="font-style:italic;">Study part 1:</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Study part 1 is currently conducted in subjects with prodromal AD to assess the effect of study treatment (ACI-24.060 at three different incremental doses or placebo) administered over 48 weeks. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The study drug is being administered via intramuscular injections.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">70</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Randomized AD subjects receive five study drug injections (ACI-24.060 or placebo) at weeks 0, 4, 12, 24, and 48. For each study subject, the treatment period is followed by a 26-week follow-up period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Up to four cohorts may be included in study part 1. Each cohort may differ from the others in terms of the dose per injection and/or the administration regimen with the possibility to expand any cohort at any time point to better understand antibody response and/or safety and tolerability. The initiation of randomization in the subsequent cohort(s) is based on interim safety and tolerability data review from the previous cohort(s) and Data and Safety Monitoring Board (DSMB) approval. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Interim analyses on safety/tolerability and immunogenicity are being conducted in each cohort at different predefined study time points.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">No clinically relevant safety concerns related to study drug have been observed to date in prodromal AD subjects as per the periodic review by the DSMB, especially no case of ARIA-E (Amyloid-Related Imaging Abnormalities- vasogenic edema) has been reported to date at brain MRI. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The data from the initial blinded interim analyses on immunogenicity of ACI-24.060 have shown clear evidence of anti-Abeta antibody responses against toxic Abeta species.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Abeta positron emission tomography (PET) imaging interim results from the expanded second dose-level cohort in subjects with prodromal AD after 6-months of treatment are expected in H1 2024, and Abeta-PET interim data after 12-months of treatment are expected in H2 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">The Company&#8217;s CTA received approval from the UK MHRA in Q2 2022 and from the AEMPS in Q3 2022 to initiate development of the enhanced formulation of ACI-24 in patients with prodromal AD and in adult subjects with DS with presence of brain amyloid pathology.   </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Study part 1 is being conducted in several centers located in the UK and Spain. Dosing in prodromal AD subjects was initiated in June 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-indent:17.85pt;margin:0pt 14.45pt 12pt 0pt;"><i style="font-style:italic;">Study part 2:</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Study part 2 is planned to be conducted in up to 88 non-demented adults living with DS and with confirmed presence of amyloid pathology by PET scan. The goal is to assess the effect of study treatment (ACI-24.060 or placebo) administered over 74 weeks. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Randomized subjects with DS receive their first five injections (ACI-24.060 or placebo) according to the same schedule administered in study part 1, at weeks 0, 4, 12, 24, 48, plus an additional injection at week 74 in order to boost/maintain the response. For each study subject, the treatment period is followed by a 26-week follow-up period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Dosing in DS subject in study part 2 has been initiated in June 2023 with the first dose-level of ACI-24.060 in prodromal AD subjects that was previously shown to be immunogenic, safe and well tolerated. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The dose level of ACI-24.060 may need to be adjusted in the DS study population based on immunogenicity and safety/tolerability data. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Interim analyses may be conducted at different predefined study time points, during the treatment period and during the follow-up period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In June 2023, AC Immune also received Fast Track designation from the FDA for ACI-24.060, for the treatment of AD. This followed FDA clearance of the Investigational New Drug (IND) application enabling expansion of the ABATE study to include clinical trial sites and participants in the USA.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">71</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Dosing of DS subjects from study part 2 has been initiated in Spain and in the UK. Study part 2 is now being actively expanded in the USA where the IND approval has been granted in May 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ACI-24 development in AD in DS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The AD pathology that commonly develops in people with DS bears remarkable similarities to familial and sporadic forms of AD, and is characterized by a progressive accumulation in the brain of Abeta into amyloid plaques leading to the appearance of AD-related cognitive decline and a modification of other relevant biomarkers. The Company is pioneering the development of its anti-Abeta active immunotherapy in AD patients and subjects with DS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Individuals with DS have an extra copy of chromosome 21, which is where the gene for amyloid precursor protein (APP) resides. These individuals develop AD at a rate that is three to five times that of the general population and develop the disease at a much younger age. At autopsy, AD pathology has been reported in 80% of people with DS over the age of 40 and 100% over the age of 60 years. The prevalence of AD in people with DS is more than 50% over the age of 50 and 75&#8211;100% over the age of 60 years (Strydom, 2018). It is estimated that there are six million people with DS worldwide, with 250,000 in the U.S. Preclinical results published by AC Immune in collaboration with Dr. Mobley of the University of California, San Diego in March 2016, showed, in a DS mouse model (Ts65Dn), a significant 20% memory improvement and a 27% reduction of Abeta in the brain following immunization with ACI-DS-01, the mouse equivalent of ACI-24.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ACI-7104.056&#160;&#8211; anti-a-syn active immunotherapy</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-7104.056 is an optimized peptide-conjugate active immunotherapy formulation designed to induce a-syn-specific antibodies recognizing aggregated a-syn species that have been demonstrated to be toxic to neurons. In contrast, ACI-7104.056-induced antibodies do not bind to the monomeric, physiological form of a-syn and do not cross-react with other members of the synuclein family such as beta- and gamma-synuclein.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A substantial package of preclinical and clinical data has been generated with PD01 (predecessor of ACI-7104.056). This candidate was tested in two different transgenic mouse models of PD and Dementia with Lewy bodies (DLB), the mThy1- and the PDGF-human a-syn transgenic mice. Active immunization with PD01 resulted in decreased a-syn pathology in brain areas most affected by transgene overexpression, including the substantia nigra and the striatum. This decrease was accompanied by a reduced neurodegeneration in both <i style="font-style:italic;">in vivo</i> models and by improvements in motor and memory deficits in the mThy1 and the PDGF-human a-syn transgenic mice, respectively. Furthermore, ACI-7104.056 has been shown to be highly immunogenic in non-human primates, with induced antibodies binding selectively to pathological forms of a-syn.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">PD01 was the first active immunotherapy candidate against pathological a-syn to be tested in a clinical study involving patients with early PD. A series of Phase 1 studies were completed in June&#160;2018. The first dosing in the Phase 2 VacSYn trial in early PD patients to evaluate ACI-7104.056 was performed in July 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Mechanism of action</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ACI-7104.056 comprises a short engineered antigenic a-syn peptide. This peptide coupled to a carrier protein facilitates the induction of an a-syn-specific antibody response that binds to toxic aggregated a-syn species with high selectivity (</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Mandler M </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">et al</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">., Acta Neuropathol, 2014</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">).</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Immunization of wild-type and transgenic mice, </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">resulted in high antibody titres in plasma, which crossed into the cerebrospinal fluid (CSF) and recognized </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a-syn</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> aggregates. Immunization resulted in a decreased aggregation and accumulation of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a-syn</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> oligomers in brains of transgenic animals (Mandler M </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">et al</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">., Acta Neuropathol, 2014).</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Clearance of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a-syn</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> was accompanied by reduced neurodegeneration in both </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">in vivo</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> models and by improvements in motor and memory deficits</span><span style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the mThy1 and the PDGF-human a-syn transgenic mice, respectively (Mandler M </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">et al</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">., Acta Neuropathol, 2014).</span><span style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;"> </span></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">72</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Clinical development</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Phase 1 study design</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The safety, tolerability and immunogenicity of the ACI-7104.056 anti-a-syn active immunotherapy predecessor were studied over a three-and-a-half-year period in 24 early PD subjects and have been previously published (Volc<i style="font-style:italic;"> et al</i>., The Lancet Neurology, 2020). There were four consecutive studies in this group of patients, with patients randomized to receive a lower or higher dose of the alpha synuclein active immunotherapy. After four priming doses, subjects were re-randomized to receive a booster injection at one of the two doses, followed by a second booster injection at the high dose.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Safety</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This Phase 1 study series demonstrated a favorable long-term safety profile for PD01.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Antibody response</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">PD01 induced a long lasting and boostable antibody response (Figure 14, left). Such induced antibodies have been shown to bind preferentially the aggregated species of a-syn. The induced antibodies were also demonstrated to bind to a-syn aggregates in human PD and DLB brain tissue.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Pharmacological and clinical effect</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Evidence for <i style="font-style:italic;">in vivo </i>target engagement and signals for clinical efficacy have been observed in these Phase 1 studies in PD, as immunization was associated with a decrease in oligomeric a-syn in CSF of treated patients and with a stabilization of clinical scores as shown by the MDS-UPDRS Part III scores (Volc <i style="font-style:italic;">et al</i>., The Lancet Neurology, 2020). Post hoc analyses of this study series delivered highly encouraging data with respect to target engagement and identification of a potential biomarker for PD, including:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">I</i><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">n vivo </i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">target engagement of induced antibodies was demonstrated by lowering of oligomeric a-syn in CSF of immunized subjects (Figure 14, middle).</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">A highly significant correlation between oligomeric a-syn concentration in CSF and MDS-UPDRS III score (motor-symptoms) in PD patients at baseline was shown for the first time.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The reduction of oligomeric a-syn in CSF correlated significantly with clinical improvement, the changes in MDS-UPDRS III score over time (Figure 14, right)</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">73</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:185.06pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 14: Pharmacokinetic and pharmacodynamic effect of PD01 immunization in early PD patients</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20231231x20f016.jpg" alt="Graphic" style="display:inline-block;height:185.06pt;width:475.69pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">(1) Data from 75 ug dose group; (4) Cerebrospinal fluid; (5) Change in oligomeric a-syn calculated at week 26, change in UPDRS III calculated at week 100; (6) Unified Parkinson&#8217;s Disease Rating Scale</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref: Volc <i style="font-style:italic;">et al</i>., Lancet Neurology, 2020</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">These combined data provide a validation of the role of a-syn in disease progression and demonstrate that a-syn directed immunization has the potential to positively impact clinical outcome. The optimized formulation, ACI-7104.056, is now being tested in early PD subjects in EU and in the UK in a Phase 2, multicenter, placebo-controlled, double-blind, randomized study (VacSYn study; NCT06015841). The study profile includes a screening period of up to 8 weeks, a 74-week double-blind treatment period, and a 26-week post-treatment follow-up period. The first dosing was performed in July 2023 and enrollment of cohort 1 was completed by the end of 2023. Following the DSMB review, no safety concerns have been raised to date, consistent with previous results, triggering the initial expansion of cohort 1 up to 32 subjects. Updates on safety and immunogenicity interim analyses from the trial will be reported in H2 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">ACI-35.030 &#8211; anti-pTau </b><b style="font-weight:bold;">active immunotherapy</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-35.030, AC Immune&#8217;s active immunotherapy developed in collaboration with Janssen, is selective for pathological phosphorylated Tau (pTau) and is being advanced into a Phase 2b study that is planned to be initiated in H1 2024. ACI-35.030 (JNJ-64042056) will be assessed in subjects with preclinical (ie., pre-symptomatic) AD. The trial will randomize approximately 500 participants with confirmed early-stage Tau pathology who will be treated over a four-year period. The trial will include analysis of Tau PET as a potential surrogate biomarker, which might be used for an accelerated regulatory filing. Developed using our SupraAntigen technology, ACI-35.030 (JNJ-64042056) is designed to stimulate a patient&#8217;s immune system to produce antibodies against pathological phosphorylated Tau, which aggregates to create the neurofibrillary tangles that characterize AD.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Potential advantages of anti-pTau active immunotherapy over other therapeutic approaches</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-35.030 induces a specific, early, long-lasting and boostable polyclonal antibody response against pathological Tau species. Compared to anti-tau monoclonal antibodies, which typically show much shorter half-lives <i style="font-style:italic;">in vivo</i> and require more frequent administration of higher drug volumes (delivered iv or sc), ACI-35.030 may thus offer a more cost effective and less burdensome approach for the treatment of Tau pathology. This may be particularly relevant for addressing chronic neurodegenerative Tauopathies such as AD.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">74</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:166.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">ACI-35.030</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-35.030 is an optimized liposomal anti-pTau active immunotherapy formulation designed to elicit antibodies against extracellular pTau protein in order to prevent and reduce the spread and development of Tau pathology within the brain. In non-clinical studies, ACI-35.030 demonstrated an excellent non-clinical safety profile and highly specific antibody response against pTau that was improved compared to the initial formulation, ACI-35. ACI-35.030 (JNJ-64042056) is now entering a Phase 2b clinical study with potential pathways for acceleration with Janssen, in accordance with our collaboration agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Mechanism of action</b></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ACI-35.030 comprises a pTau peptide and a T-cell epitope capable of binding to human leukocyte antigen-major histocompatibility complex, class II (HLA-DR) molecules.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">In rhesus monkeys, ACI-35.030 induced IgG antibodies with a strong specificity towards the pTau peptide, with very low binding to the non-pTau peptide (Figure 15). This is meaningful as Tau hyper-phosphorylation is considered an early event in the development of Tau pathology, occurring even several decades before the onset of Tau deposits.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt 0pt 8pt 36pt;"><b style="font-weight:bold;">Figure 15: pTau-specific IgG titers in Non-Human Primate (NHP) induced by ACI-35.030 and JACI-35.054</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20231231x20f017.jpg" alt="Graphic" style="display:inline-block;height:166.5pt;width:320pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Ref: Kosco-Vilbois<i style="font-style:italic;">,</i> CTAD 2022</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Sera from rhesus monkeys immunized with ACI-35.030 binds specifically to pathological Tau in brain sections with AD as compared to healthy human brain tissue (Kosco-Vilbois, KOL event &#8216;Untangling&#8217; Tau Pathology to Treat Alzheimer&#8217;s and Neurodegenerative Diseases NYC, Nov 2019).</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Epitope mapping analyses revealed that immunization of NHPs with ACI-35.030 induces a wide range of antibodies covering the pTau antigenic sequence (Kosco-Vilbois, CTAD 2022).</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">JACI-35.054</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">JACI-35.054 is an alternative pTau active immunotherapy, which was developed with Janssen in accordance with our collaboration agreement. In non-clinical studies, JACI-35.054 showed good safety and induced a strong antibody response against pTau. </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">75</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Mechanism of action</b></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">JACI-35.054 is an alternative anti-pTau active immunotherapy comprising a pTau peptide antigen conjugated to an immunogenic carrier protein CRM197, combined with adjuvants.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">CRM197 is a well-defined recombinant protein that is a commercially available version of a non-toxic mutant of diphtheria toxin-A (DTA) chain and has been shown to be a safe carrier protein in commercial prophylactic active immunotherapies and clinical trials for a plethora of different active immunotherapy candidates.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Immunization of rhesus monkeys with JACI-35.054 induced antibodies that bind to pathological Tau structures in human AD brain, although they bind similarly to pTau and non-pTau peptides (Figure 15).</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Following a head-to-head comparison between ACI-35.030 and JACI-35.054 described below, ACI-35.030 was selected over JACI-35.054 to progress into the next clinical phase based on an earlier trigger of the antibody response (shortly after the first immunization) and a more specific antibody response profile against pathological Tau species (notably against the endogenous ePHF).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Clinical development</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 18pt;"><i style="font-style:italic;">Phase 1b/2a study</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Phase 1b/2a study (NCT04445831) was a randomized, multicenter, double-blind, placebo-controlled clinical study with a primary objective to assess the safety, tolerability and immunogenicity of different dosages of ACI-35.030 and JACI-35.054 in participants with early AD. Secondary objectives assessed additional immunogenicity parameters, while exploratory endpoints included notable biomarkers of progression of AD as well as clinical assessments. This Phase 1b/2a study conducted in Europe aimed at evaluating ACI-35.030 and JACI-35.054. The clinical trial was completed in September 2023. The clinical study report will be finalized in H1 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 18pt;"><i style="font-style:italic;">Safety (data will be consolidated</i><i style="font-style:italic;"> in the </i><i style="font-style:italic;">final clinical</i><i style="font-style:italic;"> study </i><i style="font-style:italic;">report)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A total of 57 subjects were randomized, of which 41 subjects were randomized into the Cohort 1 (low-, mid-, or high- dose levels of ACI-35.030 or placebo), and 16 subjects were randomized into the Cohort 2 (low- or mid-dose levels of JACI-35.054 or placebo). The active/placebo ratio was 3:1 in each Cohort.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-35.030 and JACI-35.054 showed a good safety and tolerability profile. The majority of adverse events (AEs) were of mild intensity. No death was reported. No AE led to study discontinuation or to study treatment discontinuation. Injection site reactions were one of the most frequently reported AEs in actively treated subjects. The serious adverse events (SAEs) were mainly observed in subjects treated with ACI-35.030 with no relationship to dose. They were considered unlikely to be related to the study drug (except one episode of injection site reaction and dizziness in one subject in whom hospitalization occurred, as a precaution, since the subject was anxious to return home alone). No clinically relevant findings were reported at MRI. There was no difference in the incidence of cardiovascular disorders between the active and placebo arms. One case of sinus node dysfunction was observed in one subject treated with the low dose of ACI-35.030. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 18pt;"><i style="font-style:italic;">Antibody response (data will be consolidated in the final clinical study report)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-35.030 (liposomal formulation) generated a rapid antibody response (anti-pTau, anti-ePHF and anti-Tau IgG) after the first injection (at week 2) at all three tested doses. A dose-effect was observed between low and mid doses but not between the mid and high doses. A boosting effect was observed after each injection especially against pathological Tau species (pTau and ePHF). The antibody response was strongly directed against pathological Tau species but not against non-phosphorylated Tau. A long-lasting response, observed in the anti-ePHF IgG titers against endogenous pathological Tau, was observed at the mid- and high-dose.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">76</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:205.8pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A more varied antibody response (anti-pTau, anti-ePHF and anti-Tau IgG) was elicited after the second injection of JACI-35.054 (carrier-protein formulation) at week 10 at the two tested doses. While there was no apparent dose-effect between the two tested doses, a higher variability of titers was observed at the low dose. A boosting effect was seen against pathological Tau and non-phosphorylated Tau species from the<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;"> </sup>second injection. The specificity of the antibody response against pathological Tau species compared to non-phosphorylated Tau was of a lesser extent than observed with ACI-35.030.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Figure 16: </b><b style="font-weight:bold;">ACI-</b><b style="font-weight:bold;">35.030</b><b style="font-weight:bold;"> generates</b><b style="font-weight:bold;"> antibody response with preference for pathological Tau</b><b style="font-weight:bold;"> (ePHF) and phosphorylated Tau (pTau), over non-phosphorylated Tau (Tau)</b> </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"> <span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><img src="aciu-20231231x20f018.jpg" alt="Graphic" style="display:inline-block;height:205.8pt;width:466.55pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">(1) ACI-35.030 original sub-cohort 1.2 data; (2) Enriched paired helical filaments; (3) Phosphorylated Tau; (4) Alzheimer&#8217;s disease; (5) Antibody</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Ref: Streffer, <i style="font-style:italic;">et al.</i>, 2022 CTAD</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">High responder rates were observed for ACI-35.030 after the first and all following immunizations, across all dose levels. At all time points measured, a 100% response rate for pTau was observed at the mid-dose (i.e. higher than a pretreatment value multiplied by a threshold factor of greater than 2x). A higher responder rate on ePHF was observed for the mid-dose compared to the high dose at all time points measured. JACI 35.054 generates a potent antibody response without preference for pathological Tau (ePHF) or phosphorylated Tau (pTau), over non-phosphorylated Tau (Tau).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The polyclonal sera at week 26 from 7/8 subjects immunized with either ACI-35.030 or placebo, and from 8/8 subjects immunized with JACI-35.054 or placebo, were analyzed for their binding profiles to the pTau or Tau peptide, either without or including 1 additional amino acid (1aa) onto the C-terminal end of the peptide.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Binding analyses show that the polyclonal antibodies induced by ACI-35.030 bind preferentially to pTau peptide without binding to the truncated C-terminal end of the peptide (Streffer <i style="font-style:italic;">et al.,</i> CTAD 2022). In contrast, JACI-35.054 induces antibodies mostly binding to the C-terminus of the peptide in a non-phospho specific manner. Together, these data indicate that the presentation of the B-cell peptide upon the surface of the liposomes in ACI-35.030 drives the antibody response towards pathological Tau species.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On December 15, 2023, the Company announced that its collaborator has programmed the launch of Phase 2b clinical study to evaluate ACI-35.030 (JNJ-64042056) in patients with preclinical AD, i.e. individuals not yet showing symptoms.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">77</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Tau diagnostics</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The severity of cognitive impairment in patients with AD is correlated with the presence of Tau protein tangles, leading us to believe that an imaging agent for Tau is equally, if not more important than Abeta-PET to assess spreading of pathology in the brain. In May&#160;2020, Eli Lilly received FDA approval for the first Tau-PET tracer TAUVID (flortaucipir F18 injection). However, TAUVID received approval only for a pathology indication (i.e. correlation with histopathology findings in Braak 5 and 6 patients), but has not received a prognostic label (i.e. prediction of cognitive deterioration based on a positive Tau-PET scan.)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our Tau-PET tracers are designed to bind specifically to the pathological forms of human Tau in AD and other Tauopathies. They have demonstrated an excellent PET tracer profile with their ability to cross the blood brain barrier and a high selectivity to pathological Tau even in the early-stage disease.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In May 2014, we established a license and collaboration agreement for our Tau-PET imaging program with LMI. The Phase 1 clinical study of our clinical candidate PI-2620 in AD was completed in Q1 2018. The Phase 2 longitudinal study in AD in South Korea (Asan Medical Center, NCT03903211) was completed in Q4 2021 and results presented at AAIC 2022. The study showed that Tau accumulation measured by <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">18</sup>F-PI-2620 in early onset subjects (&lt;65 years with positive Abeta-PET) showed rapid accumulation in Braak III-V areas and correlated with deterioration of the visuospatial function and verbal memory, suggesting that <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">18</sup>F-PI-2620 PET is a potential biomarker for therapeutic target selection and for monitoring treatment effect of Tau-targeting therapeutics (Oh M <i style="font-style:italic;">et al.</i>, Alzheimer&#8217;s Dement, 2023 (Suppl. 3)). The pivotal ADvance Phase 3 histopathology study in AD (NCT05641688) was initiated in December 2022 and the first Alzheimer&#8217;s patient imaged with PI-2620 in January 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The ADvance study will be performed exclusively in the US and will enroll approximately 200 end-of-life subjects. The primary objective is to determine the sensitivity and specificity of the visual assessment of <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">18</sup>F-PI-2620 PET imaging compared to postmortem histopathological verification of tau neurofibrillary pathology associated with AD as the standard of truth. <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">18</sup>F-PI-2620 is a potentially best-in-class Tau-PET tracer with high binding affinity and selectivity for aggregated Tau.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">PI-2620 is selective for Tau over Abeta and other &#8220;off-target&#8221; binding compared with current published Tau-PET agents in development, as no binding to Abeta <i style="font-style:italic;">in vivo </i>and no &#8220;off-target&#8221; retention in basal ganglia or choroid plexus was observed. In addition, PI-2620 was shown to be suitable for measuring longitudinal Tau accumulation. A major differentiator for PI-2620 is its ability to bind 4-repeat (4R) Tau isoforms, which are present in varying amounts in different neurodegenerative diseases. Most Tau-PET tracers in development are not able to bind 4R Tau and are of limited use for certain diseases driven by these Tau species.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Tau PET tracer <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">18</sup>F-PI-2620 was included into a sub-study of the MissionAD trial of elenbecestat to evaluate Tau deposition in Abeta positive subjects with a diagnosis of mild cognitive impairment (MCI) due to AD or mild AD dementia (Bullich S <i style="font-style:italic;">et al.,</i> Alzheimers Res Ther., 2022). The findings support the hypothesis that <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">18</sup>F-PI-2620 PET imaging of neuropathologic Tau deposits may reflect underlying neurodegeneration in AD. Significant correlations were observed with hippocampal volume and CSF biomarkers, and an association between Tau and Abeta load. Quantifiable increases in <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">18</sup>F-PI-2620 PET SUVR over 1 year were observed in regions with early Tau deposition and the results are consistent with the hypothesis that cortical Tau is associated with cognitive impairment. This study supports the utility of <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">18</sup>F-PI-2620 PET to assess Tau load in an early AD population. Quantifiable Tau load and its corresponding increase in early AD could be a relevant target engagement marker of anti-Tau but also anti-amyloid clinical trials.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">78</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:246pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 17: PI-2620 &#8211; Ability to detect Tau deposits in an early AD population</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20231231x20f019.jpg" alt="Graphic" style="display:inline-block;height:245.35pt;left:0%;padding-bottom:0.65pt;position:relative;top:0pt;width:393.15pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Ref: Bullich <i style="font-style:italic;">et al.</i>, Alzheimer's Research &amp; Therapy, 2022</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Figure 17 shows <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">18</sup>F-PI-2620 SUVR PET images (scalp stripped) registered to the T1-weighted MRI illustrating the tracer distribution in a Tau negative subject (upper row), a Tau-positive subject with uptake in the mesial temporal cortex (center row), and a Tau-positive subject with extensive neocortical uptake (bottom row).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Malarte <i style="font-style:italic;">et al.</i>, Mol. Psychiatry, 2022 showed that <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">3</sup>H-PI-2620 has comparable binding affinity in AD, CBD and PSP brain tissue, although the binding site density can vary between these pathologies in the order: AD &gt; CBD &gt; PSP. Competitive binding studies indicate that PI-2620 can detect multiple binding sites in AD, CBD and PSP brain tissue. Importantly, in CBD and PSP brains, PI-2620 displayed high specificity which was not observed with other tracers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Franzmeier <i style="font-style:italic;">et al.</i>, Nat. Communications, 2022 compared <i style="font-style:italic;">in vivo </i>Tau-PET analyses to independent post-mortem samples thereby providing further evidence that PI-2620 binds to 4R Tau. This study demonstrated a close link between 4R Tau deposition patterns and connectivity supporting the concept of trans-neuronal Tau spreading in 4R Tauopathies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">PSP and CBD are atypical parkinsonisms (APs) that are classified as tauopathies. Patients with these APs may present with similar early clinical manifestations to PD, but they prove unresponsive to anti-parkinsonian medications. Mena <i style="font-style:italic;">et al.</i>, Mov Disord Clin Pract., 2023 found that the second-generation tracer <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">18</sup>F-PI-2620 was the most optimal of those included in this study for imaging Tau in PSP and CBD.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Tau diagnostics are a major market opportunity that will be driven by the growth in the aging population and the testing and availability of disease-modifying drugs. We believe a best-in-class Tau tracer has the potential to achieve a substantial global market share in this large and growing market, which includes AD as well as other important Tauopathies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">A-syn diagnostics</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We are also developing PET imaging agents to detect a-syn aggregates, which progressively accumulate in the brains of PD patients and are believed to be central to the neurodegenerative process of PD, as well as several other disorders, including Lewy body dementia and MSA, making it a priority target for development of therapeutics and </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">79</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:180.7pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">diagnostics. We have identified molecules leveraging our Morphomer technology that selectively bind to a-syn pathological structures from human PD brain with high affinity and selectivity versus common co-pathologies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are advancing clinical development of ACI-12589, the first molecule capable to detect pathological a-syn in the brain of patients with MSA and to differentiate them from controls, other synucleinopathies and more generally other neurodegenerative diseases (Figure 18). The preclinical and clinical data were published in October 2023 in Nature Communications. Currently, ACI-12589 has completed the biodistribution study in healthy volunteers and all the manufacturing activities required to advance into later stage of clinical development, including PET studies to monitor the longitudinal progression of the a-syn pathology in MSA.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 18: ACI-12589 PET signal in patients with MSA compared to controls</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><img src="aciu-20231231x20f020.jpg" alt="Graphic" style="display:inline-block;height:180.7pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:208.3pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref: Smith <i style="font-style:italic;">et al.</i>, Nature Communications, 2023</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Moreover, in 2023 we have identified our next-generation clinical candidate, ACI-15916. ACI-15916 shows significantly higher binding and target occupancy in human brain tissues from cases with different synucleinopathies, including idiopathic PD, which is the most common form. ACI-15916 also retains the excellent selectivity and pharmacokinetic profile of ACI-12589 and has no major off-target binding. This compound will advance into IND/CTA-enabling studies in Q1 2024 with an anticipated initiation of the FiH in Q1 2025.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Currently there are no commercialized imaging products that target a-syn. This provides us with the opportunity to become the market leader in a-syn-PET imaging. We believe the ability to image a-syn deposits in the brain will enable a fundamental change in the approach toward diagnosing and treating a-syn-associated diseases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Morphomer Tau</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Approximately 2,550 compounds have been screened thus far for the Morphomer Tau program. This has allowed for the identification of several chemical series of orally bioavailable small molecules with suitable CNS properties. The lead compounds displayed selectivity for binding to pathological Tau aggregates in preference to other protein aggregates. In addition, the lead compounds were able to prevent Tau aggregation and promote its disaggregation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ACI-3024</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-3024 is a potent Tau aggregation inhibitor active against the 3R and 4R human Tau isoforms as well as the mutant forms associated with human Tauopathies, such as FTLD-Tau (e.g. PSP, Pick&#8217;s disease, corticobasal degeneration). ACI-3024 selectively binds to aggregated Tau and does not bind to the monomeric forms of Tau. Moreover, the binding to Tau aggregates is selective, with no cross-reactivity to aggregates of Abeta and a-syn.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">80</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">In vitro</i> ACI-3024 showed a potent and dose-dependent reduction in spontaneous intracellular Tau aggregation and misfolding, and promoted <i style="font-style:italic;">ex vivo</i> disaggregation of Tau neurofibrillary tangles on human AD brain sections. In <i style="font-style:italic;">in vivo</i> preclinical studies (Ramsden <i style="font-style:italic;">et al.</i>, 2005) ACI-3024 reduced aggregated and insoluble hyper-phosphorylated Tau and reduced misfolded Tau with effects proportional to its plasma concentration.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Total Tau concentration in cerebrospinal fluid (CSF) was inversely correlated with ACI-3024 exposure in plasma, suggesting the possibility of exploring CSF Tau concentrations as a biomarker of target engagement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Preclinical safety assessments demonstrated that ACI-3024 has a good <i style="font-style:italic;">in vitro</i> and <i style="font-style:italic;">in vivo</i> ADME profile, including low clearance, long half-life and good CNS disposition as assessed by brain and CSF concentrations. ACI-3024 was negative in <i style="font-style:italic;">in vitro</i> and <i style="font-style:italic;">in vivo</i> genotoxicity assays and cleared extensive toxicology and safety pharmacology assessments. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-3024 was also shown to potently reduce pathological Tau-induced neuroinflammation in both <i style="font-style:italic;">in vitro</i> and <i style="font-style:italic;">in vivo</i> models.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Clinical development</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 36pt;">Phase 1 study</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This Phase 1 study was a first-in-human (FiH), randomized, placebo-controlled, double-blind, sequential single and multiple ascending dose study. The study assessed the safety, tolerability, pharmacokinetics, and pharmacodynamics of ACI-3024. Part&#160;I included five single ascending doses in healthy volunteers, with a food effect assessment in the fourth dose cohort. In Part&#160;II, three escalating multiple dose regimens were evaluated; regimen two was assessed in different populations of healthy volunteers. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-3024 will not be further developed under the collaboration and the Companies have decided to pursue other promising Tau Morphomer candidates from AC Immune&#8217;s research platform for potential clinical development in AD.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To this end, the Company has successfully identified several additional chemical series of potent small molecule Tau aggregation inhibitors. Biological activity for these compounds is assessed using multiple <i style="font-style:italic;">in vitro</i> and <i style="font-style:italic;">ex-vivo</i> assays and using <i style="font-style:italic;">in vivo</i> mouse models. Potent reduction of intracellular misfolded Tau was observed <i style="font-style:italic;">in vitro</i> with a cellular assay. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Semorinemab</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Semorinemab is a humanized high-affinity IgG4 isotype antibody candidate that binds all forms of Tau. Semorinemab is designed to intercept extracellular Tau, stopping or slowing cell-to-cell spread and propagation of pathological Tau in the brain. Semorinemab completed two Phase 2 clinical trials in AD. As announced on January 22<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">nd</sup>, 2024, AC Immune will regain the global rights to semorinemab following termination of the collaboration agreement with Genentech, a member of the Roche Group, which termination will be effective in April 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Clinical development</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Following on from successful Phase 1 clinical testing, a Phase 2 clinical trial (Tauriel) commenced in Q4 2017 with the dosing of the first patient. This multicenter trial, which enrolled 457 participants, assessed the safety, tolerability and efficacy of semorinemab in people with prodromal-to-mild AD. Participants received one of three active doses or a placebo for 72 weeks, followed by a 96-week optional open-label extension (OLE). Primary endpoints included safety assessment and the composite functional and cognitive endpoint CDR-SB score.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In September 2020, the Company reported that Genentech informed us of top line results which showed that semorinemab did not meet its primary efficacy endpoint of reducing decline on CDR-SB compared to placebo. Two secondary endpoints, Alzheimer&#8217;s Disease Assessment Scale-Cognitive Subscale 13 (ADAS-Cog13) and Alzheimer&#8217;s </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">81</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Disease Cooperative Study Group&#160;&#8211; Activities of Daily Living Inventory (ADCS-ADL), were also not met. The primary safety endpoint was however met.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Further analyses revealed a dose-dependent increase in serum pharmacokinetics and evidence of target engagement, measured by an increase in plasma Tau levels, which is consistent with previous Phase 1 study results.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A second Phase 2 trial (Lauriet) was initiated in Q1 2019. This was a multicenter study enrolling 272 participants, and was designed to evaluate the clinical efficacy, safety, pharmacokinetics and pharmacodynamics of semorinemab in patients with moderate AD.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In August 2021 the Company reported that the Lauriet study had met one of its co-primary endpoints, ADAS-Cog 11. The second co-primary endpoint, ADCS-ADL, was not met. Safety data showed that semorinemab was well tolerated with an acceptable safety profile and no unanticipated safety signals. In November 2021, the Company reported that Genentech had presented the full top-line data from the Lauriet study during a late-breaking session at the 14<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> Clinical Trials on Alzheimer&#8217;s Disease conference.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In Lauriet, 272 subjects were randomized into the study and 267 dosed. 49 study centers participated in the U.S., France, Spain and Poland. In a modified intent to treat (mITT) population of all trial participants who had received at least one dose of study drug and had at least one post-baseline ADAS-Cog 11 assessment, there was a 42.2% slowing of cognitive decline compared to placebo, the result being highly statistically significant (p=0.0008).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">There was no apparent effect on global or regional brain Tau load assessed by GTP-1 PET. However, CSF biomarker data were presented by Genentech at CTAD 2022 and showed statistically significant reduction in pTau181, pTau217 and total Tau, but not N-terminal Tau. These results were similar to those observed in the Tauriel study.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At the Keystone Conference in 2023, Schauer et al. presented additional biomarker data indicating trends towards effects on biomarkers of glial and synaptic function in subjects under treatment wih semornemab in the Lauriet study. In terms of glial function CSF YKL-40 increased significantly after treatment with semorinemab, but no changes were observed in plasma YKL-40. CSF GFAP increased non-significantly over the study period in both arms. Plasma GFAP increased over the study in the placebo group but was stable in the treatment group. Together, these results suggest that semorinemab may moderate reactive astrogliosis. In terms of changes in synaptic biomarkers CSF Ng and SNAP-25 were stable for 49 and 61 weeks in the placebo group but trended towards a decrease in the treatment group. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Safety data indicated that semorinemab was well tolerated, with no difference in the frequency of serious or non-serious adverse events or discontinuations due to adverse events. Infusion related reactions were more common in the semorinemab group compared to placebo (10.4% vs 3.8%, respectively). None were Grade 3 or higher (i.e. severe) in intensity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Semorinemab&#8217;s results provided the first positive cognitive results for an anti-Tau mAb therapy in AD.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">82</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:207pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 19: Positive effect of semorinemab on cognition assessed by ADAS-Cog11</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-align:left;width:18pt;"></span><img src="aciu-20231231x20f021.jpg" alt="Graphic" style="display:inline-block;height:206.45pt;left:0%;padding-bottom:0.55pt;position:relative;top:0pt;width:206.85pt;"/><span style="display:inline-block;width:9pt;"></span><img src="aciu-20231231x20f022.jpg" alt="Graphic" style="display:inline-block;height:204.75pt;width:192.7pt;"/><span style="display:inline-block;width:5.3pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref&#160;: Monteiro <i style="font-style:italic;">et al.</i>, CTAD 2021<span style="display:inline-block;width:7.5pt;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Crenezumab</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Crenezumab is a humanized, conformation-specific monoclonal antibody that targets misfolded Abeta and has a broad binding profile, with high affinity binding to oligomeric Abeta. Its IgG4 backbone reduces microglial activation compared to IgG1 based antibodies, which together with its specificity for oligomeric Abeta leads to an excellent safety profile with ARIA-E comparable to placebo in clinical studies (Cummings et al. 2014:2018; Ostrowitzki et al., JAMA Neurology, 2022). Crenezumab was developed using our proprietary SupraAntigen platform. In 2006, crenezumab was licensed to Genentech. <span style="background:#ffffff;">As announced on January 22</span><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;background:#ffffff;">nd</sup><span style="background:#ffffff;">, 2024, AC Immune will regain the global rights to crenezumab following termination of the collaboration agreement with Genentech, a member of the Roche Group, which termination will be effective in April 2024</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Summary of activity in Phase 2 and 3 clinical trials</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">Phase 2 studies (ABBY and BLAZE)</b></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">In the proof-of-concept Phase 2 studies of crenezumab, a positive trend in cognition was observed, with a greater effect on cognition in patients with a milder stage of AD (MMSE 22&#8211;26).</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">In the Phase 2 ABBY cognition study, there was a statistically significant 35% reduction in the rate of cognitive decline in the non-pre-specified milder AD patient population (MMSE 22&#8211;26) for the high-dose arm.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">In the Phase 2 BLAZE biomarker study, the high-dose arm showed a consistent trend of reduced Abeta accumulation in the brain over time, as shown in two independent exploratory analyses of florbetapir-PET data. In addition, results have shown that crenezumab has the ability to enhance the removal of these proteins from the brain as evidenced by a significant increase in CSF Abeta, confirming target engagement by crenezumab.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 18pt;"><b style="font-weight:bold;">Phase 3 studies (CREAD and CREAD 2)</b></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The randomized, double-blind, placebo-controlled, parallel-group Phase 3 CREAD study enrolled about 750 participants with prodromal or mild AD at the age of 50&#8722;85&#160;years. A high dose of crenezumab (60 mg/kg) was </span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">83</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"/><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">administered intravenously once every 4 weeks for 100 weeks. The primary outcome measure was the change from baseline to week 105 in CDR-SB score.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">In January 2019, Roche, the parent company of our collaboration partner, announced the discontinuation of the CREAD and CREAD 2 (BN29552 and BN29553) Phase 3 studies of crenezumab in people with prodromal-to-mild sporadic AD. The decision came after an interim analysis of the first CREAD study conducted by the IDMC, which indicated that crenezumab was unlikely to meet its primary endpoint of change from baseline in CDR-SB score.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Favorable safety profile</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Phase 2 data from ABBY and BLAZE studies suggested that there were no imbalances in overall rate of AEs.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">No patients in the studies experienced SAEs that were believed related to the administration of crenezumab.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The good safety profile and lack of induction of ARIA-E was confirmed in the Phase 3 CREAD and CREAD 2 studies, as well as the API prevention study in which there was no increase in incidence of SAEs compared with placebo.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Latest clinical trial, Phase 2 AD prevention study (API-ADAD) completed</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">There is increasing understanding from studies in patients at risk of AD due to genetic mutations that the accumulation of Abeta in the brain is a very early event in the condition, starting approximately 25&#160;years before symptoms develop (McDade <i style="font-style:italic;">et al.</i> 2018). To treat the underlying amyloid pathology effectively it may therefore be necessary to use anti-amyloid therapies in a preventive mode, starting in patients in whom symptoms have not yet emerged.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In 2012, crenezumab was independently selected from among 25 product candidates for use in the first-ever AD prevention study of its kind. The study, a collaboration worth USD 100 million between the NIH, Banner Alzheimer&#8217;s Institute and Genentech, was the cornerstone of the global Alzheimer&#8217;s Prevention Initiative (API). Family members usually develop symptoms before the 45&#160;years of age. 252 subjects were enrolled.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">169 carriers of the PSEN1 E280A mutation, who did not have mild cognitive impairment or dementia, were randomized to receive crenezumab (85 subjects) or placebo (84 subjects). A separate group of non-carriers (83 subjects) received a placebo. The mean age of the mutation carriers was 37 years old. This was approximately seven years before the median age for development of mild cognitive impairment. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Subjects were followed under treatment for 5-8 years, with the double-blind treatment continuing until the last subject received treatment for 5 years. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Primary endpoints were the annualized rate of change in the API autosomal dominant AD (ADAD) composite score and the Free and Cued Selective Reminding Test Cueing Index (FCRST). The latter scale was promoted to a coprimary endpoint after a blinded interim analysis had indicated less decline than expected on the composite endpoint. Consequently, in the final assessment the study was  not adequately powered for statistical significance.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">As reported by Tariot et al. at AAIC 2022, numerical differences favoring crenezumab were observed consistently across a wide range of clinical and biomarker endpoints. Plasma Abeta40 and Abeta42 rose throughout the study indicating peripheral target engagement. A small difference favoring crenezumab was observed in amyloid PET scan measures of fibrillary amyloid. Numerical differences favoring crenezumab compared to placebo were seen for clinical scales including both the two primary endpoints (i.e. API ADAD composite score, FCRST). Results did not reach statistical significance.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">84</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Numerical changes favoring crenezumab were also seen for the secondary endpoints including time to MCI/dementia due to AD, CDR-SB, time to non-zero score on CDR Global Score and RBANS total score. Similarly, numerical differences favoring crenezumab were seen across all reported biomarkers. Only plasma GFAP reached statistical significance (p=0.04, not corrected for multiplicity). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">The dose of crenezumab was raised seven-fold during the study in response to emerging data from Phase 2 that higher doses may be more effective. Thus, subjects were exposed to intravenous dosing for less than half of the treatment period. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Tolerability was good, with low rates of ARIA, no instances of ARIA-E and no macrohemorrhages.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Our preclinical programs</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Using our SupraAntigen and Morphomer platforms, we have generated additional discovery and preclinical stage molecules targeting key pathologies that drive a range of neurodegenerative diseases, including TDP-43, a-syn, and NLRP3-ASC. We are accelerating the development of several therapeutic product candidates currently in preclinical development, including several programs focused on indications outside of AD as a critical part of our expansion strategy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Based on the data to date, our technology platforms can be applied to misfolded proteins across a broad range of indications. See our novel targets pipeline above at Figure 6.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:20%;margin:0pt;padding:1.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:19.99%;margin:0pt;padding:1.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:19.99%;margin:0pt;padding:1.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:19.99%;margin:0pt;padding:1.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:19.99%;margin:0pt;padding:1.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">A-syn antibody</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The a-syn antibodies generated using our SupraAntigen platform have unique binding properties allowing them to bind preferentially to the pathological forms of a-syn. Leveraging the wide collection of anti-a-syn antibodies generated with diverse binding epitopes and sub-nM binding affinities to aggregated a-syn, new immunoassays are being developed for the detection of pathological a-syn in biofluids. A-syn aggregation and spreading are established targets for PD, MSA and other synucleinopathies. Antibodies that interfere with the aggregation and spreading mechanisms of a-syn provide a therapeutic option for the treatment of PD. The a-syn antibodies were able to significantly delay the seeded aggregation of pathological a-syn in an <i style="font-style:italic;">in vitro</i> aggregation assay, and were able to significantly decrease pathological a-syn spreading in an <i style="font-style:italic;">in vivo</i> animal model of PD. Characterization using multiple orthogonal <i style="font-style:italic;">in vitro</i> and <i style="font-style:italic;">in vivo</i> tests addressing binding, specificity, functionality and pharmacological properties has led to the identification of the lead candidate ACI-5755.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Lead characterization</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-5755 selectively binds to pathological forms of a-syn with low-nanomolar affinity and shows a significant preference over monomeric a-syn. Additionally, ACI-5755 shows strong recognition for pathological a-syn in patient-derived tissues in both PD and MSA. ACI-5755 showed a potent and dose-dependent reduction in the seeding capacity of pathological a-syn in a proprietary <i style="font-style:italic;">in vitro</i> aggregation assay. Moreover, ACI-5755 substantially reduced the propagation of a-syn aggregates in a cell-based model. The <i style="font-style:italic;">in vivo</i> efficacy of ACI-5755 was evaluated in the M83 propagation mouse model (Luk <i style="font-style:italic;">et al</i>., 2012). Treatment of mice with ACI-5755 significantly decreased pathological a-syn spreading <i style="font-style:italic;">in vivo</i>. Furthermore, a significant reduction in the rate of body weight loss compared with the vehicle-treated control group was observed for mice treated with ACI-5755.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Morphomer a-syn</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Leveraging our Morphomer platform, we discovered and characterized the first biologically active small molecule inhibitors targeting intracellular a-syn aggregates. Identified compounds, from several distinct chemical series, which significantly decrease a-syn aggregate accumulation in neurons by interfering with the seeding and fibrillation processes. Iterative medicinal chemistry optimization led to the identification of orally available compounds with favorable CNS-penetrant pharmacokinetic properties, which progressed into <i style="font-style:italic;">in vivo</i> proof-of-concept study in an animal model of alpha-synucleinopathies. Treatment with hit compound resulted in significant, dose-dependent decrease of pathological a-syn </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">85</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">aggregates <i style="font-style:italic;">in vivo</i>. Successful medicinal chemistry optimization yielded a new candidate with improved potency <i style="font-style:italic;">in vitro</i> and affinity for pathologic a-syn than earlier compounds as well as an <i style="font-style:italic;">in vitro</i> safety and pharmacokinetic profiles. This compound progressed into <i style="font-style:italic;">in vivo</i> efficacy evaluation in an animal model of Parkinson&#8217;s disease. Medicinal chemistry efforts will continue improving properties of lead chemical series, in parallel to identifying structurally diverse compounds fulfilling the target product profile.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">TDP-43 antibody</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">TDP-43 is a recently identified target of growing interest for NeuroOrphan indications such as frontotemporal dementia (FTD) and ALS. Interestingly, TDP-43 also plays an important role in other significant neurodegenerative indications such as AD or LATE.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Anti-TDP-43 antibodies binding to various regions of TDP-43 were generated by our SupraAntigen platform. A subset displayed conformational selectivity to misfolded TDP-43, while others recognized all TDP-43 isoforms (Figure 20A). Multiple antibodies were generated and characterized <i style="font-style:italic;">in vitro</i>, from which two pan-TDP-43 antibodies (ACI-5891 and ACI-5886) were selected for the evaluation of their efficacy in mitigating TDP-43 aggregation <i style="font-style:italic;">in vitro</i> and <i style="font-style:italic;">in vivo </i>(Figure 20B-C). ACI-5891 showed a high binding affinity for TDP-43 and ability to reduce TDP-43 aggregation <i style="font-style:italic;">in vitro and in vivo</i>. ACI-5891 was successfully humanized and clinical lead selected (ACI-5891.9). The lead molecule shows excellent pharmacokinetics in non-human primates and good developability profile.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Lead characterization</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To evaluate the functional efficacy of TDP-43 antibodies <i style="font-style:italic;">in vitro</i>, the ability of ACI-5891 to inhibit TDP-43 aggregation was tested. In an <i style="font-style:italic;">in vitro</i> assay with recombinant TDP-43, ACI-5891 significantly inhibited TDP-43 aggregation compared with the isotype control and significantly promoted their phagocytosis by mouse primary and ALS patient-derived microglia. Using FTLD-TDP patient-derived brain extracts to induce templated TDP-43 aggregation <i style="font-style:italic;">in vitro</i>, ACI-5891, which binds to the C-terminal domain of TDP-43, was able to substantially interfere with this process of seeding (Figure 20B). Moreover, ACI-5891 demonstrated functional efficacy <i style="font-style:italic;">in vivo</i> by reducing pathological TDP-43 in two different mouse models of ALS and FTD (Figure 20C). Importantly, these beneficial effects are achieved while preserving physiological TDP-43 activity. Our findings demonstrate, for the first time, that a monoclonal antibody targeting the C-terminal region of TDP-43 limits pathology and neurotoxicity by enabling clearance of misfolded TDP-43 through microglia engagement and support the clinical strategy to target TDP-43 by passive immunotherapy (Afroz <i style="font-style:italic;">et al.</i>, 2023).</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">86</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:249pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 20: Key results for TDP-43 antibodies program</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20231231x20f023.jpg" alt="Graphic" style="display:inline-block;height:248.95pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:274.45pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref: Afroz, AD/PD 2022</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Clinical lead declaration and initiation of IND-enabling studies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">ACI-5891 was successfully humanized on a human antibody framework. Several variants had a similar binding capacity for TDP-43 while retaining the potency for inhibition of TDP-43 aggregation as compared to the chimeric monoclonal antibody. The target values were achieved for the lead candidates in terms of target affinity, functional efficacy, and&#160;percentage humanness. These variants were then evaluated for pharmacokinetics in non-human primates. The selected clinical lead (ACI-5891.9) shows excellent pharmacokinetics in non-human primates. Developability of clinical lead candidates was further confirmed in manufacturability assessment studies (Ollier <i style="font-style:italic;">et al., </i>2023). Dose-range finding study to evaluate safety of clinical lead in non-human primates demonstrated dose proportional increase in mAb exposure in serum, no immunogenicity and no adverse effects on all parameters evaluated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">TDP-43 antibody-based biofluid assay</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Since the levels of TDP-43 are low in biofluids, a real-time quaking-induced conversion (RT-QuIC) assay was developed for the detection of pathological TDP-43 seeds. Using this assay, the presence of seeding-competent TDP-43 species was confirmed in CSF of sporadic ALS donors compared to healthy controls (Figure 21A-C). The ability to neutralize seeding-competent species was demonstrated for ACI-5891.9 using this assay Figure 21D-E). In addition, to evaluate target engagement of the clinical lead in vivo, novel assays to measure free TDP-43 in biofluids were established using SIMOA technology. The assay allows the measurement of free TDP-43 in serum and CSF from animals dosed with the clinical lead (Figure 21F).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">87</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:245.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 21: Biomarker assays to assess the presence of seeding-competent TDP-43 in CSF</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20231231x20f024.jpg" alt="Graphic" style="display:inline-block;height:245.5pt;width:485.3pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref: Audrain <i style="font-style:italic;">et al.</i>, Brain Communications, 2023</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Neuroinflammation and the NLRP3-ASC inflammasome pathway</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Microglial cells are the main resident immune cells in the brain, which maintain a healthy environment by removing damaged cells and misfolded protein aggregates. When overstimulated, microglia can drive neuroinflammation, leading to increased neuronal death and disease progression. A key molecular pathway that is activated by misfolded proteins related to neurodegenerative and other diseases, is the NLRP3 inflammasome, a multi-protein complex that forms within microglia leading to production of pro-inflammatory factors that exacerbate neuronal atrophy. A critical component of the NLRP3 pathway is ASC (apoptosis-associated speck-like protein containing a C-terminal caspase recruitment domain), which is formed and released by activated microglia. Intracellularly, ASC specks participate in the production of pro-inflammatory cytokines, whereas extracellular ASC specks cause acute inflammatory reactions. ASC specks have been identified in microglia within the CNS of patients with NDD (Venegas <i style="font-style:italic;">et al.</i>, Nature 2017) as well as patients&#8217; body fluids.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As illustrated in Figure 22, pathological species of Abeta, Tau, a-syn and TDP-43 induce NLRP3 inflammasome activation and ASC speck formation. AC Immune is developing multiple small molecule and antibody-based candidates with the potential to inhibit the NLRP3 pathway. Recent <i style="font-style:italic;">in vitro</i> studies and <i style="font-style:italic;">in vivo</i> experiments in animal models of AD, PD and ALS have validated this approach.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">88</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:251.21pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 22: </b><b style="font-weight:bold;">Proteinopathies exacerbate NLRP3-driven neuronal damage and promote further neurodegeneration</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20231231x20f025.jpg" alt="Graphic" style="display:inline-block;height:251.21pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:449.94pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">(1) Amyotrophic lateral sclerosis; (2)&#160;Frontotemporal lobar dementia; (3)&#160;TAR DNA-binding protein 43; (4)&#160;NOD-like receptor protein 3; (5)&#160;Apoptosis-associated speck-like protein containing a CARD, also PYCARD; (6)&#160;Neurofibrillary tangle</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Targeting NLRP3-ASC in neurodegenerative diseases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In AD, Abeta peptides, which accumulate to form the characteristic plaques in AD activate the NLRP3 inflammasome (Halle<i style="font-style:italic;"> et al.</i>, Nature Immunology, 2008). The downstream pro-inflammatory factors, IL-1b and IL-18, are increased in cells isolated in these patients (Saresella<i style="font-style:italic;"> et al.</i>, Molecular Neurodegeneration, 2016). Further validation of these targets in AD involve crossing NLRP3 or ASC knockout mice to models of Abeta-driven pathology. In these models, neuroinflammation decreased and neuronal and memory function improved (Heneka<i style="font-style:italic;"> et al.</i>, Nature, 2013; Dempsey<i style="font-style:italic;"> et al.</i>, Brain Behavior and Immunity, 2017; Venegas <i style="font-style:italic;">et al.</i>, Nature, 2017). Recently, ASC speck and IL-18 levels were shown to be higher in human Mild Cognitive Impairment (MCI) and AD brain samples indicating that ASC is a promising biomarker of MCI and AD (Scott <i style="font-style:italic;">et al.</i>, International Journal of Molecular Science, 2020).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In Parkinson&#8217;s disease, NLRP3 is activated and ASC formation is upregulated (Gordon<i style="font-style:italic;"> et al.</i>, Science Translational Medicine, 2018; Anderson<i style="font-style:italic;"> et al.</i>, NPJ Parkinson&#8217;s Disease, 2021). Exome sequencing analysis identified multiple single-nucleotide polymorphisms of NLRP3 including rs7525979, which was associated with a significantly reduced risk of developing PD (von Herrmann<i style="font-style:italic;"> et al.</i>, NPJ Parkinson&#8217;s Disease, 2018). In vitro, NLRP3 inhibition decreases a-syn-mediated inflammasome activation in mouse microglial cells and extracellular ASC release. In multiple PD animal models, targeting NLRP3 effectively mitigates motor deficits, nigrostriatal dopaminergic degeneration and accumulation of a-syn aggregates (Gordon<i style="font-style:italic;"> et al.,</i> Science Translational Medicine, 2018). Taken together, NLRP3 is responsible for driving neuroinflammation that results in progressive dopaminergic neuropathology, highlighting NLRP3 as a potential target for PD disease-modifying treatments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">As illustrated in Figure 22, extracellular Tau activates NLRP3 and ASC formation in microglia. In patients with frontotemporal dementia, elevated cleavage of caspase-1, increased ASC levels and mature IL-1b are observed (Ising <i style="font-style:italic;">et al.</i>, Nature, 2019). Furthermore, in preclinical models, injection of fibrillar Abeta induces Tau pathology in an NLRP3-dependent manner (Ising<i style="font-style:italic;"> et al.</i>, Nature, 2019) and the absence of ASC or inhibition of NLRP3 decreases seeding by Tau <i style="font-style:italic;">in vivo</i> and <i style="font-style:italic;">in vitro</i> (Stancu<i style="font-style:italic;"> et al.</i>, Acta Neuropathologica, 2019). Finally, NLRP3 inhibition ameliorates </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">89</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:214.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">inflammation and ER stress signaling in a model of Tau-driven pathology, as well as partially normalizes phospho-Tau levels (Hull<i style="font-style:italic;"> et al.</i>, Neuropharmacology, 2020).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Concerning ALS, TDP-43-mediated activation of microglia causes motor neuron cell death <i style="font-style:italic;">in vitro</i> (Zhao<i style="font-style:italic;"> et al.</i>, Experimental Neurology, 2015) with downstream activation of NF-kB and NLRP3 (Clarke<i style="font-style:italic;"> et al.</i>, Brain, 2020) and involves CD14. This finding is clinically relevant as increased CD14 expression by microglia is observed in postmortem spinal cord tissue from patients with ALS, a TDP-43-driven disease (Clarke<i style="font-style:italic;"> et al.</i>, Brain, 2020). Furthermore, wildtype and mutant forms of TDP-43 activate microglia to generate IL-1b, which is abolished by NLRP3 inhibition (Deora<i style="font-style:italic;"> et al.</i>, Glia, 2020).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Microglia isolated from the ALS mouse model, SOD1G93A, express elevated levels of NLRP3 (Deora, 2019). When microglia are incubated with soluble or aggregated SOD1G93A, NLRP3 is activated, ASC specks are formed and IL 1b is secreted which is prevented by treatment with an NLRP3 inhibitor (Deora<i style="font-style:italic;"> et al.</i>, Glia, 2020).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Our strategy for targeting the NLRP3-ASC inflammasome</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune is exploring this key pathway in order to reduce the unwanted progression of inflammation in diseases and syndromes caused by the hyper-activation of the NLRP3 inflammasome. Our aim is to develop therapeutics that decrease production of pro-inflammatory factors yet maintain normal phagocytosis of debris and misfolded proteins as well as allow the function of other pathogen-sensing pathways. Currently, AC Immune is targeting the NLRP3-ASC pathway using two complementary approaches, derived from our two technology platforms (Figure 23):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 23: Strategy to use our dual proprietary technology platforms to target NLRP3-ASC</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><img src="aciu-20231231x20f026.jpg" alt="Graphic" style="display:inline-block;height:214.35pt;left:0%;padding-bottom:0.15pt;position:relative;top:0pt;width:457.85pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">(1) (NOD)-like receptor protein 3; (2) Neurodegenerative disease; (3) Central nervous system; (4) Nanomolar; (5) Parkinson&#8217;s Disease; (6) picomolar affinity to human and mouse ASC; (7) Apoptosis-associated speck-like protein containing a CARD, also PYCARD; (8) Alzheimer&#8217;s Disease; (9) Down syndrome; (10) Multiple sclerosis; (11) Cryopyrin-associated periodic syndrome; (12) Hidradenitis suppurativa</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref: Adapted from Ransohoff, Nature, 2017</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Small molecule inhibitors of NLRP3</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Leveraging our proprietary Morphomer platform, several chemical series have been identified that provide compounds that are very potent NLRP3 inhibitors. Numerous compounds, including ACI-19764 (Figure 24A), demonstrate a low nM IC50 when tested <i style="font-style:italic;">in vitro</i> using a standard IL-1b induction assay, and is at least a log more </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">90</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:184.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">efficacious than the reference standard compound, MCC950. Furthermore, when tested <i style="font-style:italic;">in vivo</i> using an LPS-ATP-mediated model of systemic inflammation, ACI-19764 inhibited production of IL-1b in a dose dependent matter with 100% inhibition at the low dose of 2 mg/kg.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 24: </b><b style="font-weight:bold;">Highly potent inhibition of IL-1&#946; production by ACI-19764 in activated human whole blood and </b><span style="font-style:italic;font-weight:bold;">in vivo</span><b style="font-weight:bold;"> in a mouse model of peripheral inflammation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;"><img src="aciu-20231231x20f027.jpg" alt="Graphic" style="display:inline-block;height:184.4pt;left:0%;padding-bottom:0.1pt;position:relative;top:0pt;width:485.3pt;"/></b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">(1) LPS: Lipopolysaccaride; (2) ATP: Adenosine triphosphate</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Ref: Basco, 5th Inflammasome Therapeutics Summit, 2023</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">These exceptional inhibitory properties of ACI-19764 led us to evaluate the pharmacokinetics properties in a 10 day study in mice. For this, the compound was formulated in food pellets to deliver orally a consistent exposure, confirmed by the daily unbound concentration of ACI-19764 in the plasma of the mice (Figure 25). At the termination of the study, the unbound concentration in the cerebral spinal fluid (CSF) and brain was obtained. The data demonstrated a highly impressive brain to plasma ratio of 0.7. Plotting on the same graph (dotted line) the nM concentration of the 80% level of NLRP3 inhibition using mouse microglia, the results demonstrate that the compound has good brain penetration and can reach relevant levels to potently inhibit NLRP3 in the brain. ACI-19764 and other compounds are now being evaluated in mouse models of neurodegenerative disease and with <i style="font-style:italic;">ex vivo</i> biopsies obtained from patients with Hidradenitis suppurativa, a painful, long-term skin condition that causes skin abscesses and scarring on the skin.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">91</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:237.03pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 25: </b><b style="font-weight:bold;">Evaluation of the level of brain to plasma concentration of ACI-19764 in a 10 day pharmacokinetic study in mice fed with compound formulated in food pellets</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;"><img src="aciu-20231231x20f028.jpg" alt="Graphic" style="display:inline-block;height:236.28pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:342.04pt;"/></b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">(1)  Cerebrospinal fluid; (2)&#160; NOD-like receptor protein 3; (3) in mouse microglia.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.7pt;margin:0pt 0pt 12pt 0pt;">Ref: Basco, 5th Inflammasome Therapeutics Summit, 2023</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 18pt;"><i style="font-style:italic;">Therapeutic monoclonal antibodies for neuroinflammation (mAb-ASC)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.7pt;margin:0pt 0pt 12pt 0pt;">Apoptosis associated speck like protein containing CARD (ASC) is widely researched and recognized as an adaptor protein participating in inflammasome assembly and pyroptosis. It contains a bipartite structure comprising of a pyrin (PYD) and a caspase recruitment domain (CARD) domain. These two domains help ASC function as an adaptor molecule. ASC plays pivotal role in various inflammatory diseases in the CNS as well as peripherally. Thus, the use of antibodies against ASC is an attractive therapeutic approach. It has been shown in the APP/PS1 mouse model of AD, intracellular and extracellular ASC specks are present. Treatment using an anti-ASC antibody, which targets extracellular ASC specks, decreases the Abeta load in these mice (Figure 26).</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">92</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:171.03pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 26: ASC</b><sup style="font-size:7.5pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">1</sup><b style="font-weight:bold;"> specks in AD patients and mouse model of AD</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><img src="aciu-20231231x20f029.jpg" alt="Graphic" style="display:inline-block;height:170.68pt;left:0%;padding-bottom:0.35pt;position:relative;top:0pt;width:305.5pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">(1) Apoptosis-associated speck-like protein containing a CARD; (2)&#160;Amyloid precursor protein/presenilin 1</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref: Venegas&#160;<i style="font-style:italic;">et al.</i>, Nature, 2017</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Using our proprietary SupraAntigen platform, numerous monoclonal antibodies (mAbs) were generated that bind to different regions of ASC with picomolar affinities including the CARD and PYD domains. Importantly, binding was confirmed to native ASC or aggregates, called ASC specks, obtain from activated human and mouse macrophages. Using an in house developed assay for ASC polymerization, selected mAbs were also potently able to inhibit aggregation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">With these favorable characteristics of our novel, first in class mAbs, we set up an assay to evaluate the ability to mediate uptake and removal of these pathological ASC polymers by human phagocytic cells. In the absence of the selected anti-ASC mAb, ACI-6635, little uptake is observed over 24 hours by the differentiated macrophages. However, a strong, significant uptake measured by the phagocytosis index was observed within hours. This internalization was mediated by having a full effector function of the antibody as uptake was delayed and reduced when testing a variant of ACI-6635 with reduced effector function (ACI-6635-ER). Thus, the therapeutic candidate is envisioned to retain this feature.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 27: </b><b style="font-weight:bold;">ACI-6635 induces the phagocytosis of pathological aggregated species of ASC</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><img src="aciu-20231231x20f030.jpg" alt="Graphic" style="display:inline-block;height:160.25pt;left:0%;padding-bottom:0.25pt;position:relative;top:0pt;width:451.3pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">(1) Effector-reduced</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">93</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:138.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref: Basco, 5th Inflammasome Therapeutics Summit, 2023</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">With these data of potent inhibition capacity in various <i style="font-style:italic;">in vitro</i> assays, the efficacy of ACI-6635 was evaluated <i style="font-style:italic;">in vivo</i> using a mouse model of neuroinflammation and demyelination. Post induction of myelin oligodendrocyte glycoprotein (MOG)-induced inflammation, ACI-6635 significantly delayed the onset of paralysis as well as progression of disease (Figure 28A). At the level of the spinal cord, mAb treatment resulted in decreased demyelination (black arrows, Figure 28B) and significantly limited proinflammatory T-cell infiltration (black arrows, Figure 28C). This proprietary, disease-modifying mAb is now being tested in other models of human neurodegeneration as well as peripheral inflammation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Figure 28: </b><b style="font-weight:bold;">ACI-6635 significantly delays disease onset and protects from severe disease in a model of demyelination driven by neuroinflammation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="aciu-20231231x20f031.jpg" alt="Graphic" style="display:inline-block;height:138.5pt;width:477.15pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">(1) Myelin basic protein; (2)&#160;Immunohistochemistry</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref: Seredenina, 4th Inflammasome Therapeutics Summit, 2022</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">TDP-43 imaging diagnostics</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To complement our pipeline of PET imaging tracers, we also selected TDP-43 as a third target (after Tau and a-syn). Using proprietary assays, a set of small molecular weight compounds from seven chemically distinct series were identified using our Morphomer platform. These bind to patient-derived pathological TDP-43. Several of these compounds demonstrated favorable pharmacokinetic profiles in rodents suggesting suitable properties for further development as PET ligands. Medicinal chemistry optimization led to the identification of two first-in-class TDP-43 ligands, ACI-19278 and ACI-19626, that show: 1) Low nM affinity (Kd) on FTLD-TDP brain tissue, 2) Potential to detect TDP-43 pathology in various indications, including FTLD-TDP, ALS, AD and LATE, 3) Selectivity over common co-pathologies including Abeta, Tau and a-syn, 4) Clean off-target profile, including MAO-A, MAO-B, and 5) Rapid brain uptake and fast washout in non-human primates. ACI-19626 was selected as the clinical candidate for the FiH study that is expected to start in H2 2024. The preclinical, FiH-enabling activities around ACI-19626 have been initiated.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">94</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:375pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Figure 29: ACI-19278 and ACI-19626, potential first-in-class TDP-43 PET tracers, identified using the Morphomer platform</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><img src="aciu-20231231x20f032.jpg" alt="Graphic" style="display:inline-block;height:374.45pt;left:0%;padding-bottom:0.55pt;position:relative;top:0pt;width:456.8pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt 0pt 12pt 0pt;">Ref: Vokali <i style="font-style:italic;">et al., </i>ALS/MND international conference, 2023</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">There are currently no imaging products targeting TDP-43 in the market. We believe the ability to image TDP-43 deposits in the brain will enable fundamental change in the approach toward treating primary and secondary TDP-43 proteinopathies including improved design for AD clinical trials to provide better outcomes for patients.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">License agreements and collaborations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our SupraAntigen and Morphomer platforms have generated large numbers of clinical assets that address multiple diseases related to protein misfolding. Selected key assets in the product pipeline have been licensed for upfront payments, milestones and royalties to help offset the cost of our research and internal product development. We have signed a number of licensing agreements with leading pharmaceutical companies to assist and accelerate the development of our product pipeline, including:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a worldwide licensing agreement with Genentech signed in November&#160;2006 (and amended in March&#160;2009, January&#160;2013, May&#160;2014 and May&#160;2015) for anti-Abeta antibodies for AD. As announced on January 22, 2024, this agreement is being terminated;</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">95</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a worldwide licensing agreement with Genentech signed in June&#160;2012 (and amended in December&#160;2015) for anti-Tau antibodies to treat AD. As announced on January 22, 2024, this agreement is being terminated;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a worldwide licensing agreement with Janssen signed in December&#160;2014 (and amended in April&#160;2016, July&#160;2017, January&#160;2019, November&#160;2019, December 2022 and November 2023) for therapeutic anti-Tau active immunotherapies for AD, and potentially other Tauopathies, under which we may become eligible to receive payments totaling up to CHF 500&#160;million, excluding royalties;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a worldwide licensing and collaboration agreement (LCA) with LMI (formerly Piramal Imaging SA) signed in May&#160;2014 (and amended in June 2022) for small-molecule Tau ligands for use as PET tracers under which we may become eligible to receive payments totaling up to EUR 160 (CHF 151)&#160;million, excluding royalties; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a worldwide license agreement with Lilly to research and develop Morphomer Tau small molecules for the treatment of AD and other neurodegenerative diseases, which was entered into in December&#160;2018 (and amended in September&#160;2019 and March&#160;2020). The agreement was deemed effective on January&#160;23, 2019. Under this agreement, we may become eligible to receive payments up to approximately CHF 1.9 billion, excluding royalties.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Further information concerning details of our agreements and collaborations can be found under &#8220;Item&#160;5: Operating and financial review and prospects.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Competition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The pharmaceutical and biopharmaceutical industries are highly competitive across all therapeutic fields. In the field of neurodegenerative diseases, there are many public and private companies or institutions that are actively engaged in the discovery and development of therapeutic and diagnostic products. Some of these products may have a similar target to our product candidates or address similar markets. The industry is still in its infancy in terms of defining the pathology of neurodegenerative diseases. As disease understanding progresses, the number of novel product candidates may well increase and broaden the therapeutic and diagnostic options in our product markets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Currently, there are two approved disease-modifying products for AD. Most currently approved therapies seek to treat the symptoms of AD, but do not slow or stop the progression of the disease. In addition, commonly, there is off-label prescription of antidepressant and antipsychotic agents for more patients with advanced AD who may have agitation, aggressive behaviors, psychosis and depression.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Several new classes of disease-modifying agents could enter the AD market. Beyond monoclonal antibodies, our pipeline includes active immunotherapies: ACI-35.030 (targeting aggregated, phosphorylated Tau) and ACI-24.060 (targeting oligomeric and pyroGlu Abeta), and our small molecule Morphomer Tau program (inhibiting Tau aggregation).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The availability of novel diagnostic agents to visualize the disease development in patients with AD is critical for successful clinical development and commercialization of disease-modifying products in AD. At the forefront of this new diagnostic effort are PET agents for imaging of disease pathology, and in particular, Tau-targeting PET agents, which we believe will allow precise assessment of disease in patients with AD. A similar situation is developing in other NDDs, such as PD, where PET imaging is becoming available.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">ACI-35.030.</span> ACI-35.030, if approved, would potentially compete with other Tau-targeting active immunotherapies currently being developed. This could include, for example, the AADvac1 active immunotherapy being developed by Axon Neuroscience, which completed a Phase 2 study in 2019 and AV-1980R (Nuravax) which is expected to enter Phase 1 clinical development in the near future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">ACI-24.060 for AD. </span>ACI-24.060, if approved, would potentially compete with other anti-Abeta-targeting active immunotherapies currently being developed. This includes the ABvac 40 (Araclon Biotech),which has completed a </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">96</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Phase 2 study and UB-311(Vaxxinity), which has completed a Phase 2a study. In addition, Alzinova has completed a Phase 1b evaluation of ALZ-101 (Alzinova) and AV-1959D (Nuravax) is being evaluated in Phase 1 study.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">ACI-24.060 for DS.</span> ACI-24.060 is the first disease-modifying active immunotherapy candidate addressing DS-related AD, with a potential preventive and therapeutic application. Although there are symptomatic treatments of DS in clinical development, to our knowledge there are currently no other disease-modifying treatments in clinical development for AD in DS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">ACI-7104.056. </span>ACI-7104.056, if approved, would potentially compete with other a-syn-targeting active immunotherapies. This includes the UB-312 active immunotherapy developed by Vaxxinity, for which a Phase 1b study was completed in June 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Tau-PET tracer.</span> Tauvid (previously known as Flortaucipir) was developed by Eli Lilly and approved by FDA in May&#160;2020. However, should the Company&#8217;s PI-2620 be approved, it would also compete with (i)&#160;18F-florzolotau (previously known as APN-1607), a product candidate in a Phase 3 study and being advanced by Aprinoia; (ii)&#160;18F-MK-6240, which is being evaluated by Cerveau/Merck in a Phase 2 clinical trial in patients with ADAD; (iii)&#160;18F-GTP1, which is being developed by Genentech and has completed a Phase 2 study in subjects at risk of developing ADAD, (iv)&#160;18F-RO6958948, for which Roche has completed a Phase 1 study in patients with AD and (v) 18F-JNJ-067, for which Janssen has completed a Phase 1 study in patients with AD.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">ACI-12589.</span> ACI-12589, if approved, would potentially compete with other a-syn-targeting PET tracers. This includes the 18F-UCB-2897 tracer developed by UCB, which is being evaluated in a Phase 1 study. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Morphomer Tau. </span>In collaboration with Lilly, we are researching and developing small molecule Tau aggregation inhibitors with plans to evaluate candidates in AD and NeuroOrphan tauopathies. Continued candidate characterization across the research program also identified new and highly differentiated candidates with excellent cerebrospinal fluid exposure and selectivity for pathological aggregated Tau. There are only a few small molecule inhibitors of Tau aggregation in clinical development. TauRx has completed several Phase 3 trials of HMTM (TRx0037) for patients with AD or FTD. OLX07010 (Oligomerix) is undergoing a Phase 1 study.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Semorinemab. </span>Semorinemab if further developed, would potentially compete with other Tau-targeting monoclonal antibodies in development. Bepranemab (UCB/Roche) and JNJ-63733657 (Janssen) are being evaluated in Phase 2 studies. E-2814 (Eisai) is being evaluated in a Phase 2/3 prevention study. A Phase 2 study of BMS-986446 (BMS/Prothena) is expected to start in H1 2024. Lu AF87908 (Lundbeck), APNmAb005 (Aprinoia Therapeutics), and MK-2214 (Merck/Teijin Pharma) are being evaluated in Phase 1 studies.<span style="font-style:italic;font-weight:bold;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Crenezumab.</span><i style="font-style:italic;"> </i>Crenezumab, if further developed, would potentially compete with other monoclonal antibodies targeting Abeta. Eli Lilly is evaluating donanemab in studies of presymptomatic AD and has completed a Phase 3 study of donanemab for early symptomatic AD. Other Phase 3 studies of donanemab and remternetug (Eli Lilly) are ongoing. Aduhelm (Biogen) and Leqembi (BioArctic/Eisai/Biogen) have been approved by FDA under the accelerated (Aduhelm) and traditional (Leqembi) pathways for the treatment of patients with mild cognitive impairment and mild dementia. Eisai/Biogen are currently also developing a subcutaneous formulation of Leqembi. Roche is conducting a Phase 1/2 study of RO7126209 (trontinemab) in patients with mild to moderate AD. Acumen Pharmaceuticals completed a Phase 1 trial evaluating ACU193 in June 2023. Prothena&#8217;s Phase 1 trial assessing PRX012 is ongoing and an update is expected in 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">TDP-43 antibodies. </span>To our knowledge, there are no TDP-43 antibodies in the clinic.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Many of our competitors have significantly greater financial, technical and human resources than we have. Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. Our commercial opportunities and our success will be based in part on our ability to identify, develop and manage a portfolio of product candidates that are safer and more effective than competing products. However, this opportunity could be eroded or even eliminated if our competitors develop </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">97</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">and/or market products that are novel and have superior safety and efficacy profiles, that may be brought to the market more rapidly due to greater available resources, or that are less costly than our current or future product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Commercialization strategy</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our strategy to date has been to focus on identifying partnerships for our early-stage product candidates as both a way to secure non-dilutive capital to fund our other research and development programs and also as a way to accelerate the development of these partnered products by leveraging our partners&#8217; extensive knowledge in clinical studies, drug development, manufacturing and commercialization.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">With greater financial resources at our disposal and the significant knowledge acquired by our scientists and scientific leadership, we intend to retain selected promising product candidates in-house for a longer period of time and fund their development from our own resources. This will allow us to generate greater value from these product candidates, allowing us to demand more significant terms from a prospective partner. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have commenced a Phase 1b/2 study for AD in advance of potentially partnering this program. In the field of diagnostics, the parallel development of therapeutic compounds and companion diagnostics is of growing importance to the pharmaceutical and biopharmaceutical industries. The development timeframe of a PET diagnostic agent is significantly shorter than for a therapeutic product, providing the prospect for potential diagnostic product revenues to be realized quicker than potential therapeutic product revenues. Our Morphomer platform is particularly well suited to generate molecules for use in the development of diagnostics for NDDs which provides additional partnering opportunities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Given our current stage of product development, we currently do not have a commercialization infrastructure. If any of our product candidates is granted marketing approval, we intend to focus our initial commercial efforts in the U.S. and select European markets, which we believe represent the largest market opportunities for us. In those markets, we expect our commercial operations to potentially include our own specialty sales force that will target Neurologists and Gerontologists, both in hospitals and in private practice. In other markets, we expect to seek partnerships that would maximize our products&#8217; commercial potential.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Intellectual property</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We strive to protect the proprietary technology that we believe is important to our business, including seeking and maintaining U.S. and foreign patents intended to cover our products and compositions, their methods of use and processes for their manufacture, and our proprietary technology platforms, diagnostic candidates and any other inventions that are commercially important to the development of our business. We also rely on trade secrets and know-how to protect aspects of our business that are not amenable to, or that we do not consider appropriate for, patent protection.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our success will significantly depend on our and our collaboration and licensing partners&#8217; ability to obtain and maintain patent and other proprietary protection for commercially important technology, inventions and know-how related to our business, to defend and enforce patents, to preserve the confidentiality of our trade secrets and to operate our business without infringing any patents and other intellectual property or proprietary rights of third parties. See the section titled &#8220;Risk factors&#8212; Risks related to intellectual property&#8221; for additional information.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2023, we owned or co-owned with our collaboration and licensing partners, approximately 53 issued U.S. patents and 421 issued patents in other jurisdictions, as well as 37 pending U.S. patent applications and 515 pending foreign patent applications. As of December&#160;31, 2023, we licensed approximately 34 issued U.S. patents and 312 issued patents in other jurisdictions, as well as 10 pending U.S. patent applications and 213 pending foreign patent applications.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">98</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The patent portfolios for our most advanced product candidates as of December&#160;31, 2023 are summarized below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Anti-Tau active immunotherapies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio for anti-Tau active immunotherapies includes a patent family with composition-of-matter claims (including claims directed to the ACI-35 antigenic peptide and a pharmaceutical composition comprising such an antigenic peptide), claims directed to treating certain indications using ACI-35 including AD, and claims directed to using ACI-35 to induce an immune response. This patent family currently contains approximately 29 issued patents and two pending patent applications in 27 countries. The issued patents in this patent family, if the appropriate maintenance, renewal, annuity or other governmental fees are paid, are expected to expire in 2030, excluding any additional term for patent term adjustments or patent term extensions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio for anti-Tau active immunotherapies also includes a patent family relating to therapeutic Tau active immunotherapies, including claims directed to a pharmaceutical composition comprising an antigenic Tau peptide, claims directed to using such active immunotherapies to induce an immune response in a subject, and claims directed to methods for preventing or treating a neurodegenerative disease or disorder, including AD, among others. This patent family currently contains 4 issued patents and approximately 51 pending patent applications in 41 countries. The issued patents and any patents issuing in this patent family, if the appropriate maintenance, renewal, annuity or other governmental fees are paid, are expected to expire in 2038, excluding any additional term for patent term adjustments or patent term extensions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;">ACI-24</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio for ACI-24 includes a patent family with composition-of-matter claims (including claims directed to the ACI-24 antigenic construct), claims directed to treating certain indications using ACI-24 including AD, and claims directed to using ACI-24 to induce an immune response. As of December 31, 2023, in this patent family, we owned approximately 29 issued patents and 4 pending patent applications in 30 countries. With respect to the U.S., we owned two issued U.S. patents. The issued patents in this patent family, if the appropriate maintenance, renewal, annuity or other governmental fees are paid, are expected to expire in 2026, excluding any additional term for patent term adjustments or patent term extensions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio for ACI-24 also includes a patent family directed to the use of the ACI-24 active immunotherapy in the treatment and/or prevention of memory and/or cognitive impairments or abnormalities in the DS population, among others. As of December&#160;31, 2023, in this patent family, we owned approximately 14 issued patents and 5 pending patent applications in 18 countries. Issued patents in this patent family, if the appropriate maintenance, renewal, annuity or other governmental fees are paid, are expected to expire in 2032, excluding any additional term for patent term adjustments or patent term extensions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio for ACI-24 also includes a patent family relating to therapeutic anti-Abeta treatment claims (including claims directed to a pharmaceutical composition comprising an antigenic peptide), and claims directed to using such active immunotherapies in treating, preventing, inducing a protective immune response against or alleviating the symptoms associated with an Abeta-associated disease in a subject, among others. As of December 31, 2023, in this patent family, we owned one issued U.S. patent and approximately 34 pending patent applications in 32 countries. Any issued patents in this patent family, if the appropriate maintenance, renewal, annuity or other governmental fees are paid, are expected to expire in 2039, excluding any additional term for patent term adjustments or patent term extensions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;">ACI-7104</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio relating to ACI-7104 includes patents and patent applications with composition-of-matter claims (including claims directed to the peptide, as well as pharmaceutical formulations comprising the peptide), and claims directed to the use of compounds comprising the peptide in treating or preventing synucleinopathies including PD and MSA.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">99</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio relating to ACI-7104 includes patents and patent applications that we own in two different patent families. As of December&#160;31, 2023, in these patent families, we owned approximately 16 issued patents and 16 pending patent applications, in 11 countries. With respect to the U.S., we owned three issued U.S. patents. Issued patents in the basic patent family, if the appropriate maintenance, renewal, annuity or other governmental fees are paid, are expected to expire in 2029, excluding any additional term for patent term adjustments or patent term extensions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;">PI-2620</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio relating to PI-2620 includes patent applications with claims directed to composition of matter (including claims directed to the molecule, its precursor and a diagnostic composition comprising such molecule), claims directed to diagnosis of certain indications using PI-2620 including AD and PSP, and claims directed to a method of manufacturing PI-2620, among others.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio relating to PI-2620 includes patent applications that we own or co-own in three different patent families. As of December&#160;31, 2023, we owned or co-owned 12 patents and approximately 6 patent applications in 16 countries in our main patent family directed to the PI-2620 molecule, its precursor and methods of using the PI-2620 to diagnose certain indications, including AD and PSP. This main patent family includes one issued U.S. patent. If the appropriate maintenance, renewal, annuity, or other governmental fees are paid, national-stage applications claiming priority from this PCT patent application, if issued, are expected to expire in 2037, excluding any additional term for patent term adjustments or patent term extensions, as applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">ACI-12589</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio relating to a-syn diagnostics includes composition of matter claims (including claims directed to the ACI-12589 molecule, its precursor, and diagnostic compositions comprising the molecule), and claims directed to use of the molecule in imaging and in diagnostics of a-synucleinopathies including PD and MSA.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio relating to a-syn diagnostics includes patents and patent applications that we own in ten different patent families. As of December 31, 2023, we owned or co-owned approximately 17 patent applications in 17 countries in our main patent family directed to the ACI-12589 molecule, its precursor, diagnostic compositions, and methods of using ACI-12589 for imaging and diagnostics of a-synucleinopathies including PD and MSA. If the appropriate maintenance, renewal, annuity or other governmental fees are paid, any issued patents are expected to provide protection up to 2041, excluding any additional term for patent term adjustments or patent term extensions, as applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Morphomer Tau</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio relating to Morphomer Tau therapeutics includes patent applications with claims directed to composition of matter (including claims directed to the molecule, a pharmaceutical composition comprising such molecule and a mixture comprising such molecule), and claims directed to prevention and treatment of certain indications using such molecules including AD and PSP, among others.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio relating to the Morphomer Tau therapeutic program includes patent applications that we own or co-own in four different patent families. As of December&#160;31, 2023, we owned approximately 10 pending patent applications and 6 issued patents, including one U.S. issued patent in our main patent family directed to the ACI-3024 small molecule Tau aggregation inhibitor. If the appropriate maintenance, renewal, annuity, or other governmental fees are paid, national-stage applications claiming priority from this PCT patent application, if issued, are expected to expire in 2039, excluding any additional term for patent term adjustments or patent term extensions, as applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Semorinemab</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our global patent portfolio relating to semorinemab includes patents and patent applications with claims directed to compositions of matter, methods of treatment for certain indications including AD, and methods of use, among others.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">100</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Crenezumab</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio relating to crenezumab includes patents and patent applications with claims directed to composition of matter (including claims directed to the crenezumab antibody or a fragment thereof, a polynucleotide encoding the crenezumab antibody or a fragment thereof, a cell line used to produce the crenezumab antibody as well as pharmaceutical compositions comprising the crenezumab antibody), claims directed to treating certain indications using the crenezumab antibody including AD, claims directed to a method of manufacturing the crenezumab antibody and claims directed to diagnostic and prognostic uses of the crenezumab antibody.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our patent portfolio relating to crenezumab includes patents and patent applications that we own or co-own in four different patent families. As of December&#160;31, 2023, we owned or co-owned approximately 51 patents (not including the patents in the individual countries where the issued European patent was validated) and 13 patent applications in 34 countries in our main patent family directed to the crenezumab antibody and methods of using the crenezumab antibody to treat certain indications, including AD. This patent portfolio includes three issued U.S. patents and one pending U.S. patent applications, which, if the appropriate maintenance or other governmental fees are paid, are expected to expire in 2027, excluding any additional term for patent term adjustments or patent term extensions. This patent portfolio also includes a PCT patent application that was filed on July&#160;13, 2007. If the appropriate maintenance, renewal, annuity, or other governmental fees are paid, national-stage applications claiming priority from this PCT patent application, if issued, are expected to expire in 2027, excluding any additional term for patent term adjustments or patent term extensions, as applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Manufacturing and supply</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We do not own or operate facilities for the manufacture, testing, packaging, labeling, storage or distribution of preclinical or clinical supplies of any of our product candidates. We instead contract with and rely on third-party CMOs to manufacture, package, label, store, test and distribute all preclinical and clinical supplies of our product candidates, and we plan to continue to do so for the foreseeable future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Compliance with governing rules&#160;and quality requirements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The facilities used by our collaboration partners and CMOs to manufacture our product candidates are systematically audited by local authorities and occasionally inspected by competent authorities where the clinical studies are ongoing. The facilities where the commercial productions are performed will have to be approved by the FDA or other relevant regulatory authorities, pursuant to inspections that are conducted after we submit our NDA or comparable marketing applications. We perform periodic quality audits of the manufacturing facilities and CMOs to monitor their compliance with the regional laws, regulations and applicable cGMP standards and other laws and regulations, such as those related to environmental health and safety matters. The scope of our audits also involves monitoring the ability of our providers to maintain adequate QCs and QA systems including personnel qualification.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">After manufacturing, our products are submitted to extensive characterization and QC testing plans performed by using either generic or properly developed analytical methods that are qualified or validated; this ensures the accuracy of the results generated and provides evidence of the quality of our products. In addition, our products are submitted to periodic, standardized and controlled stability programs aimed at demonstrating product stability during the storage period and thus assign an expiry date after which the products cannot longer be used; this, in addition to guaranteeing the safety of the products, supports the definition of a suitable supply chain that may encompass the distribution of the products in different continents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Contractual framework</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We have established, with CMOs supplying and testing active pharmaceutical ingredients, drug substances or drug products under cGMP, quality agreements and master service agreements. Quality agreements define the quality standards required to develop, produce and supply the product, and also define the responsibilities related to the collaboration with regards to the quality related aspects. Manufacturing service agreements define the commercial and financial framework under which product manufacturing and testing under cGMP is performed. Any failure to achieve </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">101</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">and maintain compliance with the laws, regulations and standards, suspension of the manufacturing of our product candidates or withdrawals of cGMP permissions, which would adversely affect our business and reputation, are defined in the master service agreements and quality agreements. The risk that any third-party providers may breach the agreements they have with us because of factors beyond our control and the possibility that they may also terminate or refuse to renew their agreements because of their own financial difficulties or business priorities, potentially at a time that is costly or otherwise inconvenient for us, is managed by us with constant investments toward maintaining reserve stocks and in-depth process know-how. The latter is supported by continuous in-house process development and production activities of small-scale/research grade materials, which may offer the chance to rapidly identify alternative contract manufacturers to whom the manufacturing process could be transferred providing continuity for the clinical study. Finally, our contracts may also offer us limited remedies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Interaction with CMOs</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Finally, our partnerships with CMOs are managed through an efficient project management platform in which teams are formed with the representatives of each key function from both parties. Meetings occur either through virtual on-line conferences aimed at updating short-term actions or face-to-face conferences when mid- to long-term development plans are discussed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Government regulation and our regulatory department</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our regulatory department has a strong culture of regulatory compliance, operating under three guiding principles, to:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">provide constructive regulatory input for development products;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ensure smooth regulatory approvals by anticipating hurdles; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">build confidence with regulators by continuous communication.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The QA group is included within the regulatory department with the mission to:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">create and maintain a corporate quality management system; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ensure cGCP, cGMP, cGLP and current Good Distribution Practice (cGDP) compliance.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A science-driven approach is the cornerstone of our interactions and this has helped us to build and maintain a high level of trust with regulators. Besides informal conversations with the authorities, our regulatory department has conducted several pre-Investigational New Drug (pre-IND), Type B and Type C meetings with the FDA (ACI-24.060 for AD and DS, ACI-7104.056 and PI-2620) and Scientific Advice meetings, which are the European equivalent of pre-IND meetings (with the German Paul-Ehrlich-Institut, Swedish Medical Products Agency; UK Medicine&#160;&amp; Healthcare Products Regulatory Agency, Finnish Medicines Agency, the Spanish Agency of Medicines and Medical Devices and the EMA). Since 2008, our regulatory department has filed a total of 24 clinical trial applications in the EU (one each in Austria, Denmark, the Netherlands and Poland, two in Spain, three in Germany, three in Sweden, four in Finland and eight in the UK) and 5 INDs in the U.S. Furthermore, our regulatory department successfully applied for and obtained FDA Fast Track designation for ACI-24.060 in AD. Given the seriousness of AD and public pressure for new therapeutics, we consider regulatory agencies to be important stakeholders in our product development strategies. We are committed to working closely with global regulatory authorities to adhere to and achieve the highest levels of safety and quality of our product candidates in the most timely and efficient manner. The transparency we have achieved and our goal of a close working relationship with the regulatory agencies, in particular the FDA and the EMA, are intended to facilitate expeditious execution through the regulatory approval process.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Our regulatory department contains a QA group. As every quality issue ultimately requires regulatory involvement and input, this approach is intended to lead to rapid resolution of issues and ensure full compliance to satisfy both the </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">102</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">reviewers and the inspectors at the government health authorities. Our regulatory department is charged with keeping our entire organization, directly or indirectly involved in the clinical study application process, in a state of &#8220;inspection readiness.&#8221; To that end, we ensure that the Trial Master Files are complete and regularly updated. Our QA group is also tasked with generating our annual quality plan. The personnel tasked with QA have issued a set of approximately 136 standard operating procedures and working instructions and continuously train the relevant staff. Our QA personnel conduct regular audits, including in-person audits of the contract manufacturers, contract research organizations and laboratories conducting primary endpoint analysis. In addition, we have a full-time QA documentation assistant to ensure good documentation practice and archiving.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Product approval process</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The clinical studies, manufacturing, labeling, storage, distribution, record-keeping, advertising, promotion, import, export and marketing, among other things, of our product candidates are subject to extensive regulation by governmental authorities in the U.S. and other countries. The U.S. FDA, under the Federal Food, Drug, and Cosmetic Act (FDCA), regulates pharmaceutical products in the U.S. The steps required before a drug may be approved for marketing in the U.S. generally include:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the completion of preclinical laboratory tests and animal tests conducted under cGLP regulations;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the submission to the FDA of an IND application for human clinical testing, which must become effective before human clinical studies commence;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">obtaining a positive opinion from the ethics committee (Europe)/institutional review board (U.S.) to commence study on human subjects;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the performance of adequate and well-controlled human clinical studies to establish the safety and efficacy of the product candidate for each proposed indication and conducted in accordance with cGCP requirements;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">pre-NDA submission meeting with FDA (highly recommended);</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the submission to the FDA of an NDA;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the FDA&#8217;s acceptance of the NDA;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">satisfactory completion of an FDA Pre-Approval Inspection (PAI) of the manufacturing facilities at which the product is made to assess compliance with cGMP requirements;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the FDA&#8217;s review and approval of an NDA prior to any commercial marketing or sale of the drug in the U.S.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">In the EU, a similar process exists as in the US, with the additional involvement of payors early on in the development process. Notably, the possibility of having parallel scientific advice from the EMA or Health Technology Assessment body whereby the payors are involved at the outset (Phase 2), which is intended to facilitate the design of clinical studies to target primarily populations with a high chance of obtaining reimbursement and accelerate the process of time to reimbursement.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The FDA has various programs, including Fast Track, Priority review, Accelerated Approval and Breakthrough Therapy designation, which are intended to increase agency interactions, expedite or facilitate the process for reviewing product candidates, and/or provide for initial approval based on surrogate endpoints. We believe that one or more of our product candidates may qualify for some of these expedited development and review programs, as exemplified by the Fast Track designation granted for ACI-24.060. However, even if a product candidate qualifies for one or more of these programs, the FDA may later decide that the product candidate no longer meets the conditions for qualification.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">103</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Fast Track program is intended to expedite or facilitate the process for reviewing new drugs that meet certain criteria. Specifically, new drugs are eligible for Fast Track designation if they are designed to treat a serious or life-threatening condition and demonstrate the potential to address unmet medical needs for the condition. Fast Track designation applies to the combination of the product and the specific indication for which it is being studied. The sponsor of a new drug may request the FDA to designate the drug as a Fast Track product at any time during the clinical development of the product. AD, for example, meets both pre-requisites&#8212;it is life-threatening and constitutes an unmet medical need. Unique to a Fast Track product, the FDA may consider for review sections of the marketing application on a rolling basis before the complete application is submitted if the sponsor provides a schedule for the submission of the sections of the application, the FDA agrees to accept sections of the application and determines that the schedule is acceptable, and the sponsor pays any required user fees upon submission of the first section of the application.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any product submitted to the FDA for marketing, including under a Fast Track program may be eligible for other types of FDA programs intended to expedite development and review, such as Priority Review and Accelerated Approval. Any product is eligible for priority review if it has the potential to provide safe and effective therapy where no satisfactory alternative therapy exists or it provides a significant improvement in the treatment, diagnosis or prevention of a disease compared with marketed products. The FDA will attempt to direct additional resources to the evaluation of an application for a new drug designated for Priority Review to facilitate the review. Additionally, a product may be eligible for the Accelerated Approval program. Product candidates that are studied for their safety and effectiveness in treating serious or life-threatening illnesses and that provide meaningful therapeutic benefit over existing treatments may receive Accelerated Approval, which means that they may be approved on the basis of adequate and well-controlled clinical studies establishing that the product has an effect on a surrogate endpoint that is reasonably likely to predict a clinical benefit, or on the basis of an effect on a clinical endpoint other than survival or irreversible morbidity. As a condition of approval, the FDA may require that a sponsor of a drug receiving Accelerated Approval perform adequate and well-controlled post-marketing clinical studies. Failure to conduct required post-approval trials, or the inability to confirm a clinical benefit during post-marketing trials, may allow the FDA to withdraw the drug from the market on an expedited basis. In addition, as a condition for Accelerated Approval the FDA currently requires pre-approval of promotional materials, which could adversely impact the timing of the commercial launch of the product. The Fast Track, Priority Review and Accelerated Approval programs do not change the standards for approval but may expedite the development or approval process.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Food and Drug Administration Safety and Innovation Act of 2012 also amended the FDCA to require the FDA to expedite the development and review of a breakthrough therapy. A drug can be designated as a breakthrough therapy if it is intended to treat a serious or life-threatening disease or condition and preliminary clinical evidence indicates that it may demonstrate substantial improvement over existing therapies in one or more clinically significant endpoints. A sponsor may request that a drug be designated as a breakthrough therapy at any time during the clinical development of the product. If so designated, the FDA shall act to expedite the development and review of the product&#8217;s marketing application, including by meeting with the sponsor throughout the product&#8217;s development, providing timely advice to the sponsor to ensure that the development program to gather nonclinical and clinical data is as efficient as practicable, involving senior managers and experienced review staff in a cross-disciplinary review, assigning a cross-disciplinary project lead for the FDA review team to facilitate an efficient review of the development program and to serve as a scientific liaison between the review team and the sponsor, and taking steps to ensure that the design of the clinical trials is as efficient as practicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The testing and approval process requires substantial time, effort and financial resources, and the receipt and timing of any approval is uncertain. Given this paradigm, AD has been given Life-Threatening Disease status by the FDA and therefore AD therapies are eligible for the expanded access program for investigational drugs and other pathways such as Breakthrough Therapy, Accelerated Approval and Priority Review. Additionally, a single well-designed, well-conducted, pivotal clinical study could be sufficient to trigger market approval pending a successful PAI.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Preclinical studies include laboratory evaluations of the product candidate, as well as animal studies to assess the potential safety and efficacy of the product candidate. The results of the preclinical studies, together with manufacturing information and analytical data, are submitted to the FDA as part of the IND, which must become effective before clinical studies may be commenced. The IND will automatically become effective 30&#160;days after receipt by the FDA, </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">104</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">unless the FDA raises concerns or questions about the conduct of the studies as outlined in the IND prior to that time. In this case, the IND sponsor and the FDA must resolve any outstanding concerns before clinical studies can proceed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Clinical studies involve the administration of the product candidates to healthy volunteers or patients with the disease to be treated under the supervision of a qualified principal investigator. Clinical studies are conducted under protocols detailing, among other things, the objectives of the study, the parameters to be used in monitoring safety and the efficacy criteria to be evaluated. A protocol for each clinical study and any subsequent protocol amendments must be submitted to the FDA as part of the IND. Further, each clinical study must be reviewed and approved by an independent IRB, either centrally or individually at each institution at which the clinical study will be conducted. The IRB will consider, among other things, ethical factors, the safety of human subjects and the possible liability of the institution. There are also requirements governing the reporting of ongoing clinical studies and clinical study results to public registries. The FDA, the IRB or the clinical study sponsor may suspend or terminate clinical studies at any time on various grounds, including a finding that the subjects or patients are being exposed to an unacceptable health risk. Additionally, some clinical studies are overseen by an independent group of qualified experts organized by the clinical study sponsor, known as a Data Safety Monitoring Board/Committee. This group provides authorization for whether or not a study may move forward at designated checkpoints based on access to certain data from the study. We may also suspend or terminate a clinical study based on evolving business objectives and/or competitive climate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Clinical studies are typically conducted in three sequential phases prior to approval, but the phases may overlap. These phases generally include the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Phase 1. Phase 1 clinical studies represent the initial introduction of a product candidate into human subjects, frequently healthy volunteers. In Phase 1, the product candidate is usually tested for safety, including adverse effects, dosage tolerance, absorption, distribution, metabolism, excretion and pharmacodynamics.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Phase&#160;2. Phase 2 clinical studies usually involve studies in a limited patient population to (i)&#160;evaluate the efficacy of the product candidate for specific indications, (ii)&#160;determine dosage tolerance and optimal dosage, and (iii)&#160;identify possible adverse effects and safety risks.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Phase&#160;3. If a product candidate is found to be potentially effective and to have an acceptable safety profile in Phase 2 studies, the clinical study program will be expanded to Phase 3 clinical studies to further demonstrate clinical efficacy, optimal dosage and safety within an expanded patient population at geographically dispersed clinical study sites.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Phase 4. Phase 4 clinical studies are conducted after approval to gain additional experience from the treatment of patients in the intended therapeutic indication and to document a clinical benefit in the case of drugs approved under Accelerated Approval regulations, or when otherwise requested by the FDA in the form of post-marketing requirements or commitments. Failure to conduct any required Phase 4 clinical studies promptly could result in withdrawal of approval.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The results of preclinical studies and clinical studies, including negative or ambiguous results as well as positive findings, together with detailed information on the manufacture, composition and quality of the product, are submitted to the FDA in the form of an NDA requesting approval to market the product. The NDA must be accompanied by a significant user-fee payment. The FDA has substantial discretion in the approval process and may refuse to accept any application or decide that the data is insufficient for approval and require additional preclinical, clinical or other studies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We estimate that it generally takes 10 to 15&#160;years, or possibly longer, to discover, develop and bring to market a new pharmaceutical or biopharmaceutical product in the U.S. Several&#160;years may be needed to complete each phase, including discovery, preclinical, Phase 1, 2 or 3, or marketing authorization.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In addition, under the Pediatric Research Equity Act, an NDA or supplement to an NDA must contain data to assess the safety and effectiveness of the drug for the claimed indications in all relevant pediatric subpopulations and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective. Recently, the Food and Drug Administration Safety and Innovation Act (FDASIA), which was signed into law on July&#160;9, 2012, amended the FDCA. The FDASIA requires that a sponsor who is planning to submit a marketing application for a drug </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">105</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">or biological product that includes a new active ingredient, new indication, new dosage form, new dosing regimen or new route of administration submit an initial Pediatric Study Plan within 60&#160;days of an end-of-Phase-2 meeting or as may be agreed between the sponsor and the FDA. The initial Pediatric Study Plan must include an outline of the pediatric study or studies that the sponsor plans to conduct, including study objectives and design, age groups, relevant endpoints and statistical approach, or a justification for not including such detailed information, and any request for a deferral of pediatric assessments or a full or partial waiver of the requirement to provide data from pediatric studies along with supporting information. The FDA and the sponsor must reach agreement on the Pediatric Study Plan. A sponsor can submit amendments to an agreed-upon initial Pediatric Study Plan at any time if changes to the pediatric plan need to be considered based on data collected from nonclinical studies, early-phase clinical trials, and/or other clinical development programs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The cost of preparing and submitting an NDA is substantial. Under federal law, NDAs are subject to substantial application user fees and the sponsor of an approved NDA is also subject to annual product and establishment user fees. Under the Prescription Drug User Fee Act (PDUFA), as amended, each NDA must be accompanied by a user fee. The FDA adjusts the PDUFA user fees on an annual basis. PDUFA VI eliminates fees for supplements as well as for establishments, although applicants will be assessed for annual prescription drug program fees for prescription drug products, rather than the prescription drug product fee assessed under the previous iteration of PDUFA. According to the FDA&#8217;s fee schedule for the 2024 FY, the user fee for each NDA application requiring clinical data is USD 4,048,695 and the annual program fee is USD 416,734. Fee waivers or reductions are available in certain circumstances, including a waiver of the application fee for the first application filed by a small business. Additionally, no user fees are assessed on NDAs for products designated as orphan drugs, unless the product also includes a non-orphan indication.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Once the NDA submission has been submitted, the FDA has 60&#160;days after submission of the NDA to conduct an initial review to determine whether it is sufficient to accept for filing. Under the PDUFA, the FDA sets a goal date by which it plans to complete its review. This is typically 12&#160;months from the date of submission of the NDA application. The review process is often extended by FDA requests for additional information or clarification. Before approving an NDA, the FDA will inspect the facilities at which the product is manufactured and will not approve the product unless the manufacturing facility complies with cGMP regulations and may also inspect clinical study sites for integrity of the data supporting safety and efficacy. The FDA may also convene an advisory committee of external experts to provide input on certain review issues relating to risk, benefit and interpretation of clinical study data. The FDA is not bound by the recommendations of an advisory committee, but generally follows such recommendations in making its decisions. The FDA may delay approval of an NDA if applicable regulatory criteria are not satisfied and/or the FDA requires additional testing or information. The FDA may require post-marketing testing and surveillance to monitor safety or efficacy of a product.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">After the FDA evaluates the NDA and conducts inspections of the manufacturing facilities where the drug product and/or its API will be produced, it may issue an Approval Letter or a Complete Response Letter. An Approval Letter authorizes commercial marketing of the drug with specific prescribing information for specific indications. A Complete Response Letter indicates that the review cycle of the application is complete and the application is not ready for approval. A Complete Response Letter may require additional clinical data and/or an additional pivotal Phase 3 clinical study or studies, and/or other significant, expensive and time-consuming requirements related to clinical studies, preclinical studies or manufacturing. Even if such additional information is submitted, the FDA may ultimately decide that the NDA does not satisfy the criteria for approval. The FDA could also approve the NDA with a Risk Evaluation and Mitigation Strategy (REMS), plan to mitigate risks, which could include medication guides, physician communication plans, or elements to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. The FDA also may condition approval on, among other things, changes to proposed labeling, development of adequate controls and specifications, or a commitment to conduct one or more post-marketing studies or clinical studies. Such post-marketing testing may include Phase 4 clinical studies and surveillance to further assess and monitor the product&#8217;s safety and effectiveness after commercialization.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Special protocol assessment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The FDA and an IND sponsor may agree in writing on the design and size of clinical studies intended to form the primary basis of a claim of effectiveness in an NDA. This process is known as a special protocol assessment (SPA). </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">106</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Upon a specific request for a SPA by an IND sponsor, the FDA will evaluate the protocol. If an SPA agreement is reached, however, it is not a guarantee of product approval by the FDA or approval of any permissible claims about the product. The FDA retains significant latitude and discretion in interpreting the terms of the SPA agreement and the data and results from any study that is the subject of the SPA agreement. In particular, the SPA agreement is not binding on the FDA if previously unrecognized public health concerns later come to light, other new scientific concerns regarding product safety or efficacy arise, the IND sponsor fails to comply with the agreed-upon protocol, or the relevant data, assumptions, or information provided by the IND sponsor when requesting a SPA agreement change, are found to be false statements or misstatements, or are found to omit relevant facts. An SPA agreement may not be changed by the sponsor or the FDA after the study begins except with the written agreement of the sponsor and the FDA, or if the FDA determines that a substantial scientific issue essential to determining the safety or effectiveness of the drug was identified after the testing began.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Orphan-drug designation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under the Orphan Drug Act, the FDA may grant orphan designation to a drug or biological product intended to treat a rare disease or condition, which is a disease or condition that either affects fewer than 200,000 individuals in the U.S., or affects more than 200,000 individuals in the U.S. but there is no reasonable expectation that the cost of developing and making a drug product available in the U.S. for this type of disease or condition will be recovered from sales of the product in the U.S. Orphan-product designation must be requested before submitting an NDA. After the FDA grants orphan-product designation, the identity of the therapeutic agent and its potential orphan use are disclosed publicly by the FDA. Orphan-product designation does not convey any advantage in or shorten the duration of the regulatory review and approval process.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If a product that has orphan designation subsequently receives the first FDA approval for the disease or condition for which it has such designation, the product is entitled to orphan-product exclusivity, which means that the FDA cannot approve any other applications to market the same drug or biological product for the same indication for 7&#160;years, except in limited circumstances, such as a showing of clinical superiority to the product with orphan exclusivity. The designation of such drug also entitles a party to financial incentives such as opportunities for grant funding toward clinical study costs, tax advantages and user-fee waivers. Competitors, however, may receive approval of different products for the indication for which the orphan product has exclusivity or obtain approval for the same product but for a different indication for which the orphan product has exclusivity. Orphan-product exclusivity also could block the approval of one of our products for 7&#160;years if a competitor obtains approval of the same drug or biological product as defined by the FDA or if our product candidate is determined to be contained within the competitor&#8217;s product for the same indication or disease. If a drug product designated as an orphan product receives marketing approval for an indication broader than what is designated, it may not be entitled to orphan-product exclusivity. Orphan-drug status in the EU has similar but not identical benefits in that jurisdiction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Disclosure of clinical trial information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Sponsors of clinical trials (other than Phase 1 trials) of FDA-regulated products, including drugs, are required to register and disclose certain clinical trial information. Information related to the product, comparator, patient population, phase of investigation, trial sites and investigators and other aspects of the clinical trial is made public as part of the registration. Sponsors are also obligated to disclose the results of their clinical trials after completion. Disclosure of the results of certain trials may be delayed until the new product or new indication being studied has been approved. However, there are evolving rules&#160;and increasing requirements for publication of trial-related information, and it is possible that data and other information from trials involving drugs that never garner approval could be required to be disclosed in the future. In addition, publication policies of major medical journals mandate certain registration and disclosures as a pre-condition for potential publication, even when this is not presently mandated as a matter of law. Competitors may use this publicly available information to gain knowledge regarding the progress of development programs.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">107</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Post-approval requirements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Drugs manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to record-keeping, periodic reporting, product distribution, advertising and promotion and reporting of adverse experiences with the product. After approval, most changes to the approved product, such as adding new indications or other labeling claims, are subject to prior FDA review and approval. There also are continuing, annual user-fee requirements for any marketed products and the establishments at which such products are manufactured, as well as new application fees for supplemental applications with clinical data.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, drug manufacturers and other entities involved in the manufacture and distribution of approved drugs are required to register their establishments with the FDA and state agencies, and are subject to periodic unannounced inspections by the FDA and these state agencies for compliance with cGMP requirements. Changes to the manufacturing process are strictly regulated and often require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMP and impose reporting and documentation requirements upon the sponsor and any third-party manufacturers that the sponsor may decide to use. Accordingly, manufacturers must continue to expend time, money, and effort in the areas of production and QC to maintain cGMP compliance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Once an approval is granted, the FDA may withdraw the approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including AEs of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information, imposition of post-marketing studies or clinical studies to assess new safety risks, or imposition of distribution or other restrictions under a REMS program. Other potential consequences include, among other things:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market or product recalls;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fines, warning letters or holds on post-approval clinical studies;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">refusal of the FDA to approve pending NDAs or supplements to approved NDAs, or suspension or revocation of product license approvals;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">product seizure or detention, or refusal to permit the import or export of products; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">injunctions or the imposition of civil or criminal penalties.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The FDA strictly regulates marketing, labeling, advertising and promotion of products that are placed on the market. Drugs may be promoted only for the approved indications and in accordance with the provisions of the approved label. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant liability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Patent term restoration and marketing exclusivity</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Depending upon the timing, duration, and specifics of FDA approval of the use of our product candidates, some of our U.S. patents may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Act of 1984, referred to as the Hatch-Waxman Act. The Hatch-Waxman Act permits a patent term to be extended up to 5&#160;years as compensation for patent term effectively lost due to the FDA&#8217;s pre-market approval requirements. However, patent term restoration cannot extend the remaining term of a patent beyond a total of 14&#160;years from the product&#8217;s approval date. The patent term restoration period is generally one-half of the time between the effective date of an IND and the submission date of an NDA, plus the time between the submission date of an NDA and the approval of that application, except that the review period is reduced by any time during which the applicant failed to </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">108</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">exercise due diligence. Only one patent applicable to an approved drug is eligible for the extension. Extensions are not granted as a matter of right and the extension must be applied for prior to expiration of the patent and within a 60-day period from the date the product is first approved for commercial marketing. The USPTO, in consultation with the FDA, reviews and approves the application for any patent term extension or restoration. Where a product contains multiple active ingredients, if any one active ingredient has not been previously approved, it can form the basis of an extension of patent term provided the patent claims that ingredient or the combination containing it.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the future, we may apply for patent term restoration for some of our presently owned patents to add patent life beyond their current expiration date, depending on the expected length of clinical studies and other factors involved in the submission of the relevant NDA; however, there can be no assurance that any such extension will be granted to us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Biologics Price Competition and Innovation Act of 2009 provides up to 12&#160;years of non-patent data exclusivity within the U.S. to the first applicant to gain approval of a Biologics License Application for a new biologic product that has not previously been approved by the FDA, which we refer to as a reference product. This 12-year data exclusivity does prohibit the FDA from approving a biosimilar or interchangeable product of such reference product until 12&#160;years after the licensure of such reference product. In addition, the FDA will not accept a biosimilar or interchangeable product application for review until 4&#160;years after the date of first licensure of such reference product. Under 21CFR314.108, 5&#160;years&#8217; exclusivity is also granted to new chemical entities that contain no active moiety that has been approved by the FDA under section 505(b). This market exclusivity bars the FDA from accepting for review any ANDA or 505(b)(2)&#160;application for a drug containing the same active moiety for (i)&#160;5&#160;years if an ANDA or 505(b)(2)&#160;application does not contain a paragraph IV certification to a listed patent, or (ii)&#160;4&#160;years if an ANDA or 505(b)(2)&#160;is submitted containing a paragraph IV certification to a listed patent. Moreover, pediatric exclusivity, if granted, may add 6&#160;months of exclusivity if the reference product has been studied with respect to a pediatric indication in accordance with certain regulatory requirements. A reference product may also be granted 7&#160;years of orphan-drug exclusivity for the treatment of a rare disease or condition under section 527(a)&#160;of FDCA, which would run in parallel with the 12&#160;years of data exclusivity of the reference product, if applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Non-U.S. regulation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In order to market any product outside of the U.S., we would need to comply with numerous and varying regulatory requirements of other countries and jurisdictions regarding quality, safety and efficacy, and governing, among other things, clinical studies, marketing authorization, commercial sales and distribution of our products. Whether or not we obtain FDA approval for a product, we would need to obtain the necessary approvals by the comparable foreign regulatory authorities before we can commence clinical studies or marketing of the product in foreign countries and jurisdictions. Although many of the issues discussed above with respect to the U.S. apply similarly in the context of the EU, the approval process varies between countries and jurisdictions and can involve additional product testing and additional administrative review periods, as described in greater detail below. The time required to obtain approval in other countries and jurisdictions might differ from and be longer than that required to obtain FDA approval. Regulatory approval in one country or jurisdiction does not ensure regulatory approval in another, but a failure or delay in obtaining regulatory approval in one country or jurisdiction may negatively impact the regulatory process in others.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">EU drug review approval</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the EEA, which is comprised of the 27 Member States of the EU plus Norway, Iceland and Liechtenstein medicinal products can only be commercialized after obtaining a marketing authorization. There are two types of marketing authorization: the Community Marketing Authorization, which is issued by the EC through the Centralized Procedure based on the opinion of the Committee for Medicinal Products for Human Use (CHMP), a body of the EMA, and which is valid throughout the entire territory of the EEA; and the National Marketing Authorization, which is issued by the competent authorities of the Member States of the EEA and authorizes marketing only in that Member State&#8217;s national territory and not the EEA as a whole.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The Centralized Procedure is compulsory for human medicines for the treatment of human immunodeficiency virus or acquired immune deficiency syndrome (AIDS), cancer, diabetes, neurodegenerative diseases, autoimmune and other immune dysfunctions, and viral diseases; for veterinary medicines for use as growth or yield enhancers; for medicines </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">109</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">derived from biotechnology processes, such as genetic engineering; for advanced-therapy medicines, such as gene-therapy, somatic cell-therapy or tissue-engineered medicines; and for officially designated &#8216;orphan medicines&#8217; (medicines used for rare human diseases). The Centralized Procedure is optional for products containing a new active substance not yet authorized in the EEA, or for products that constitute a significant therapeutic, scientific or technical innovation, or for products that are in the interest of public health in the EU. The National Marketing Authorization is for products not falling within the mandatory scope of the Centralized Procedure. Where a product has already been authorized for marketing in a Member State of the EEA, this National Marketing Authorization can be recognized in another Member State through the Mutual Recognition Procedure. If the product has not received a National Marketing Authorization in any Member State at the time of application, it can be approved simultaneously in various Member States through the Decentralized Procedure. Under the Decentralized Procedure, an identical dossier is submitted to the competent authorities of each of the Member States in which the marketing authorization is sought, one of which is selected by the applicant as the Reference Member State (RMS). If the RMS proposes to authorize the product, and the other Member States do not raise objections, the product is granted a National Marketing Authorization in all the Member States in which the authorization was sought. Before granting the marketing authorization, the EMA or the competent authorities of the Member States of the EEA assesses the risk&#8211;benefit balance of the product on the basis of scientific criteria concerning its quality, safety and efficacy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Regulation in the EU</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Product development, the regulatory approval process, and safety monitoring of medicinal products and their manufacturers in the EU proceed in much the same manner as they do in the U.S. Therefore, many of the issues discussed above apply similarly in the context of the EU. In addition, drugs are subject to the extensive price and reimbursement regulations of the various EU Member States.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Clinical studies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As is the case in the U.S., the various phases of preclinical and clinical research in the EU are subject to significant regulatory controls. The new Clinical Trials Regulation (Regulation (EU) No 536/2014) came into force on 31 January 2022. The new Regulation repealed the Clinical Trials Directive (EC) No. 2001/20/EC and national implementing legislation in the EU Member States, which regulated clinical trials in the EU until the Regulation's entry into application. A transition period applies to new clinical trial submissions under the Regulation. New clinical trial applications could be submitted under the Clinical Trials Directive until 30 January 2023, after which all new clinical trial applications were required to be submitted under the Regulation. Ongoing clinical trials under the Clinical Trials Directive have until 30 January 2025 to transition to the Regulation. The Regulation, provides a system for the approval of clinical studies in the European Union via a single online platform known as the Clinical Trials Information System (CTIS) for approval to run a clinical trial in several European countries, making it more efficient to carry out such multinational trials. Under this system, a single application dossier is submitted through CTIS to all Concerned Member States (CMS) where it is intended to conduct the trial. Using a harmonized format, the dossier consists of two parts, Part I contains the more scientific documents, whereas Part II contains the national documents. The review and evaluation is coordinated by one of the Member States, referred to as the Reference Member State (RMS). The Reference Member State is responsible for the evaluation of Part I whereas Part II assessment will be conducted separately by each individual CMS for its own country, including the review by the Ethics Committee. A clinical trial may only be started after the positive assessment by the RMS, and the approval by each CMS. A clinical trial may only be undertaken if provision has been made for insurance or indemnity to cover the liability of the investigator or sponsor. In certain countries, the sponsor of a clinical trial has a strict (faultless) liability for any (direct or indirect) damage suffered by trial subjects. The sponsor of a clinical trial, or its legal representative, must be based in the EEA. European regulators and ethics committees also require the submission of AE reports during a study and a copy of the final study report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Marketing approval</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Marketing approvals under the EU regulatory system may be obtained through a centralized or decentralized procedure. The centralized procedure results in the grant of a single marketing authorization, which is valid for all (currently 27) EU Member States and the three European Free Trade Association (EFTA) members (Norway, Iceland and Liechtenstein).</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">110</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to Regulation (EC) No.&#160;726/2004, as amended, the centralized procedure is mandatory for drugs developed by means of specified biotechnological processes, advanced-therapy medicinal products, drugs for human use containing a new active substance for which the therapeutic indication is the treatment of specified diseases, including but not limited to AIDS, neurodegenerative disorders, auto-immune diseases and other immune dysfunctions, as well as drugs designated as orphan drugs. The CHMP also has the discretion to permit other products to use the centralized procedure if it considers them sufficiently innovative or they contain a new active substance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the marketing authorization application, the applicant must properly and sufficiently demonstrate the quality, safety and efficacy of the drug. Under the centralized approval procedure, the CHMP, possibly in conjunction with other committees, is responsible for drawing up the opinion of the EMA on any matter concerning the admissibility of the files submitted in accordance with the centralized procedure, such as an opinion on the granting, variation, suspension or revocation of a marketing authorization, and pharmacovigilance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The CHMP and other committees are also responsible for providing guidelines and have published numerous guidelines that may apply to our product candidates. These guidelines provide additional guidance on the factors that the EMA will consider in relation to the development and evaluation of drug products and may include, among other things, the preclinical studies required in specific cases, the manufacturing and control information that should be submitted in a marketing authorization application, and the post-approval measures required to monitor patients and evaluate the long-term efficacy and potential adverse reactions. Although these guidelines are not legally binding, we believe that our compliance with them is likely to be necessary to gain approval for any of our product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The maximum timeframe for the evaluation of a marketing authorization application by the CHMP under the centralized procedure is 210&#160;days after receipt of a valid application. This period will be suspended until such time as the supplementary information requested by the CHMP has been provided by the applicant. Likewise, this time limit will be suspended for the time allowed for the applicant to prepare oral or written explanations. When an application is submitted for a marketing authorization in respect of a drug that is of major interest from the viewpoint of public health and in particular therapeutic innovation, the applicant may request an accelerated assessment procedure. If the CHMP accepts such a request, the time limit of 210&#160;days will be reduced to 150&#160;days, but it is possible that the CHMP can revert to the standard time limit for the centralized procedure if it considers that it is no longer appropriate to conduct an accelerated assessment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the CHMP concludes that the quality, safety and efficacy of the product are sufficiently proven, it adopts a positive opinion. This is sent to the EC, which drafts a decision within approximately 67&#160;days following the CHMP opinion. After consulting with the Member States, the EC adopts a decision and grants a marketing authorization, which is valid for the whole of the EEA. The marketing authorization may be subject to certain conditions, which may include, without limitation, the performance of post-authorization safety and/or efficacy studies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The EMA has various programs, including accelerated assessment, conditional approval and PRIority MEdicines (PRIME), which are intended to increase agency interactions, expedite or facilitate the process for reviewing product candidates, and/or provide for initial approval on the basis of surrogate endpoints. One or more of our product candidates may qualify for some of these expedited development and review programs. However, even if a product candidate qualifies for one or more of these programs, the EMA may later decide that the product candidate no longer meets the conditions for qualification. Eligibility to the PRIME scheme is limited to products considered to offer a major therapeutic advantage in populations with high unmet need. PRIME is a voluntary scheme aimed at enhancing interaction and early dialogue with developers of promising medicines through achieving the early appointment of the Rapporteur for the product, optimizing development plans and speeding up evaluation so these medicines can reach patients earlier. Products benefiting from PRIME can expect to be eligible for accelerated assessment at the time of application for a marketing authorization application.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">EU legislation also provides for a system of regulatory data and market exclusivity. According to Article&#160;14(11) of Regulation (EC) No.&#160;726/2004, as amended, and Article&#160;10(1)&#160;of Directive 2001/83/EC, as amended, upon receiving marketing authorization, new chemical entities approved on the basis of a complete independent data package benefit from 8&#160;years of data exclusivity and an additional 2&#160;years of market exclusivity. Data exclusivity prevents regulatory authorities in the EU from referencing the innovator&#8217;s data to assess a generic (abbreviated) application. During the </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">111</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">additional 2-year period of market exclusivity, a generic marketing authorization can be submitted, and the innovator&#8217;s data may be referenced, but no generic medicinal product can be marketed until the expiration of the market exclusivity. The overall 10-year period will be extended to a maximum of 11&#160;years if, during the first 8&#160;years of those 10&#160;years, the marketing authorization holder (MAH) obtains an authorization for one or more new therapeutic indications that, during the scientific evaluation prior to their authorization, are held to bring a significant clinical benefit in comparison with existing therapies. Even if a compound is considered to be a new chemical entity and the innovator can gain the period of data exclusivity, another company nevertheless could also market another version of the drug if such company obtained marketing authorization based on a marketing authorization application with a completely independent data package of pharmaceutical test, preclinical tests and clinical studies. However, products designated as orphan medicinal products enjoy, upon receiving marketing authorization, a period of 10&#160;years of orphan market exclusivity. See also &#8220;&#8212;Orphan drug regulation&#8221; below. Depending upon the timing and duration of the EU marketing authorization process, products may be eligible for an SPC of up to 5&#160;years&#8217;, pursuant to Regulation (EC) No.&#160;469/2009. Such SPCs extend the rights under the basic patent for the drug.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the EU, the pediatric regulation [Regulation (EC) No 1901/2006 as amended] requires sponsors to submit a pediatric investigation plan at the end of Phase 1. This plan will provide the details of the quality, non-clinical and clinical studies required to support the authorization of a pediatric indication. Additional rules&#160;apply to medicinal products for pediatric use under Regulation (EC) No.&#160;1901/2006. Potential incentives include a six-month extension of any supplementary protection certificate granted pursuant to Regulation (EC) No.&#160;469/2009, but not in cases in which the relevant product is designated as an orphan medicinal product pursuant to Regulation (EC) No.&#160;141/2000, as amended. Instead, a medicinal product designated as an orphan medicinal product may enjoy an extension of the 10-year market exclusivity period granted under Regulation (EC) No.&#160;141/2000 to 12&#160;years subject to the conditions applicable to orphan drugs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Orphan drug regulation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the EU, Regulation (EC) No.&#160;141/2000, as amended, states that a drug will be designated as an orphan drug if its sponsor can establish:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">that it is intended for the diagnosis, prevention or treatment of a life-threatening or chronically debilitating condition affecting not more than 5 in 10,000 persons in the EU when the application is made, or that it is intended for the diagnosis, prevention or treatment of a life-threatening, seriously debilitating or serious and chronic condition in the EU and that without incentives it is unlikely that the marketing of the drug in the EU would generate sufficient return to justify the necessary investment; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">that there exists no satisfactory method of diagnosis, prevention or treatment of the condition in question that has been authorized in the EU or, if such method exists, that the drug will be of significant benefit to those affected by that condition.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Regulation (EC) No.&#160;847/2000 sets out further provisions for implementation of the criteria for designation of a drug as an orphan drug. An application for the designation of a drug as an orphan drug must be submitted at any stage of development of the drug before filing of a marketing authorization application.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">If an EU-wide community marketing authorization in respect of an orphan drug is granted or if all the EU Member States have granted marketing authorizations in accordance with the procedures for mutual recognition, the EU and the Member States will not, for a period of 10&#160;years, accept another application for a marketing authorization, or grant a marketing authorization or accept an application to extend an existing marketing authorization, for the same therapeutic indication, in respect of a similar drug. This period may, however, be reduced to 6&#160;years if, at the end of the fifth&#160;year, it is established, with respect to the drug concerned, that the criteria for orphan-drug designation are no longer met; in other words, when it is shown on the basis of available evidence that the product is sufficiently profitable not to justify </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">112</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">maintenance of market exclusivity. Notwithstanding the foregoing, a marketing authorization may be granted, for the same therapeutic indication, to a similar drug if:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the holder of the marketing authorization for the original orphan drug has given its consent to the second applicant;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the holder of the marketing authorization for the original orphan drug is unable to supply sufficient quantities of the drug; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the second applicant can establish in the application that the second drug, although similar to the orphan drug already authorized, is safer, more effective or otherwise clinically superior.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Other incentives available to orphan drugs in the EU include financial incentives such as a reduction of fees or fee waivers and protocol assistance. Orphan-drug designation does not shorten the duration of the regulatory review and approval process.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Manufacturing and manufacturers&#8217; license</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to Directive 2003/94/EC, as transposed into the national laws of the Member States, the manufacturing of investigational medicinal products and approved drugs is subject to a separate manufacturer&#8217;s license and must be conducted in strict compliance with cGMP requirements, which mandate the methods, facilities and controls used in manufacturing, processing and packing of drugs to assure their safety and identity. Manufacturers must have at least one qualified person permanently and continuously at their disposal. The qualified person is ultimately responsible for certifying that each batch of finished product released onto the market has been manufactured in accordance with cGMP and the specifications set out in the marketing authorization or investigational medicinal product dossier. cGMP requirements are enforced through mandatory registration of facilities and inspections of those facilities. Failure to comply with these requirements could interrupt supply and result in delays, unanticipated costs and lost revenues, and subject the applicant to potential legal or regulatory action, including but not limited to warning letters, suspension of manufacturing, seizure of product, injunctive action, or possible civil and criminal penalties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Wholesale distribution and license</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Pursuant to Directive 2001/83/EC, the wholesale distribution of medicinal products is subject to the possession of an authorization to engage in activity as a wholesaler in medicinal products. Possession of a manufacturing authorization includes authorization to distribute by wholesale the medicinal products covered by that authorization. The distribution of medicinal products must comply with the principles and guidelines of cGDP.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Advertising</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the EU, the promotion of prescription medicines is subject to intense regulation and control, including EU and national legislation as well as self-regulatory codes (industry codes). Advertising legislation <i style="font-style:italic;">inter alia</i> includes a prohibition on direct-to-consumer advertising. All advertising of prescription medicines must be consistent with the product&#8217;s approved Summary of Product Characteristics, and must be factual, accurate, balanced and not misleading. Advertising of prescription medicines pre-approval or off-label is not allowed. Some jurisdictions require that all promotional materials for prescription medicines be subjected to prior review and approval, either internal or regulatory.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Other regulatory requirements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">An MAH for a medicinal product is legally obliged to fulfill a number of obligations by virtue of its status as an MAH. The MAH can delegate the performance of related tasks to third parties, such as distributors or marketing partners, provided that this delegation is appropriately documented and the MAH maintains legal responsibility and liability.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">113</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 36pt;">The obligations of an MAH include the following:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Manufacturing and batch release</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8212;MAHs should guarantee that all manufacturing operations comply with relevant laws and regulations, applicable GMPs, and the product specifications and manufacturing conditions set out in the marketing authorization, and that each batch of product is subject to appropriate release formalities.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Availability and continuous supply</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8212;Pursuant to Directive 2001/83/EC, as transposed into the national laws of the Member States, the MAH for a medicinal product and the distributors of the said medicinal product actually placed on the market in a Member State shall, within the limits of their responsibilities, ensure appropriate and continued supplies of that medical product to pharmacies and persons authorized to supply medicinal products so that the needs of patients in the Member State in question are covered.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Pharmacovigilance</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8212;MAHs are obliged to establish and maintain a pharmacovigilance system, including a qualified person responsible for oversight, to submit safety reports to the regulators and to comply with the good pharmacovigilance practice guidelines adopted by the EMA.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Advertising and promotion</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8212;MAHs remain responsible for all advertising and promotion of their products, including promotional activities by other companies or individuals on their behalf, and in some cases must conduct internal or regulatory pre-approval of promotional materials. Regulation in this area also covers interactions with healthcare practitioners and/or patient groups, and in some jurisdictions legal or self-regulatory obligations to disclose such interactions exist.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Medical affairs/scientific service</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8212;MAHs are required to disseminate scientific and medical information on their medicinal products to healthcare professionals, regulators and patients.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Legal representation and distributor issues</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8212;MAHs are responsible for regulatory actions or inactions of their distributors and agents.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Preparation, filing and maintenance of the application and subsequent marketing authorization</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8212; MAHs must maintain appropriate records, comply with the marketing authorization&#8217;s terms and conditions, fulfill reporting obligations to regulators, submit renewal applications and pay all appropriate fees to the authorities. We may hold any future marketing authorizations granted for our product candidates in our own name, or appoint an affiliate or a collaboration partner to hold marketing authorizations on our behalf. Any failure by an MAH to comply with these obligations may result in regulatory action against an MAH and ultimately threaten our ability to commercialize our products.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Pricing and reimbursement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the EU, the pricing and reimbursement mechanisms by private and public health insurers vary largely by country and even within countries. The public systems reimbursement for standard drugs is determined by guidelines established by the legislator or responsible national authority. The approach taken varies by Member State. Some jurisdictions operate positive and negative list systems under which products may only be marketed once a reimbursement price has been agreed. Other Member States allow companies to fix their own prices for medicines, but monitor and control company profits and may limit or restrict reimbursement. The downward pressure on healthcare costs in general, particularly prescription drugs, has become very intense. As a result, increasingly high barriers to the entry of new products are being erected and some EU countries require the completion of studies that compare the cost-effectiveness of a particular product candidate with that of currently available therapies in order to obtain reimbursement or pricing approval. Special pricing and reimbursement rules&#160;may apply to orphan drugs. Inclusion of orphan drugs in reimbursement systems tend to focus on the medical usefulness, need, quality and economic benefits to patients and the healthcare system as for any drug. Acceptance of any medicinal product for reimbursement may come with cost, use and often volume restrictions, which again can vary by country. In addition, results based rules&#160;of reimbursement may apply.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">114</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Other U.S. healthcare laws</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition to FDA restrictions on marketing of pharmaceutical or biopharmaceutical products, federal and state healthcare laws restrict certain business practices in the pharmaceutical and biopharmaceutical industries. These laws include, but are not limited to, anti-kickback, false claims, data privacy and security, and transparency statutes and regulations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The U.S. federal Anti-Kickback Statute prohibits, among other things, knowingly and willfully offering, paying, soliciting or receiving remuneration, directly or indirectly, to induce, or in return for, purchasing, leasing, ordering or arranging for the purchase, lease or order of any good, facility, item or service reimbursable under Medicare, Medicaid or other federal healthcare programs. The term &#8220;remuneration&#8221; has been broadly interpreted to include anything of value, including for example, gifts, discounts, the furnishing of supplies or equipment, credit arrangements, payments of cash, waivers of payment, ownership interests and providing anything at less than its fair market value. The Anti-Kickback Statute has been interpreted to apply to arrangements between pharmaceutical and biopharmaceutical manufacturers on the one hand and prescribers, purchasers and formulary managers on the other. Although there are a number of statutory exceptions and regulatory safe harbors protecting certain common activities from prosecution, the exceptions and safe harbors are drawn narrowly, and our practices may not in all cases meet all the criteria for a statutory exception or safe harbor protection. Practices involving remuneration that may be alleged to be intended to induce prescribing, purchases or recommendations may be subject to scrutiny if they do not qualify for an exception or safe harbor. Failure to meet all the requirements of a particular applicable statutory exception or regulatory safe harbor does not make the conduct <i style="font-style:italic;">per se</i> illegal under the Anti-Kickback Statute. Instead, the legality of the arrangement will be evaluated on a case-by-case basis based on a cumulative review of all its facts and circumstances. Several courts have interpreted the statute&#8217;s intent requirement to mean that if any one purpose of an arrangement involving remuneration is to induce referrals of federal healthcare-covered business, the statute has been violated. The Patient Protection and Affordable Care Act as amended by the Health Care and Education Reconciliation Act (collectively, the Health Care Reform Law), amended the intent requirement under the Anti-Kickback Statute and criminal healthcare fraud statutes (discussed below) such that a person or entity no longer needs to have actual knowledge of the statute or the specific intent to violate it in order to have committed a violation. In addition, the Health Care Reform Law provides that the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the civil False Claims Act (discussed below). Further, the Civil Monetary Penalties Law imposes penalties against any person or entity that, among other things, is determined to have presented or caused to be presented a claim to a federal health program that the person knows or should know is for an item or service that was not provided as claimed or is false or fraudulent.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The federal false claims laws prohibit, among other things, any person or entity from knowingly presenting, or causing to be presented, a false or fraudulent claim for payment or approval to the federal government or knowingly making, using or causing to be made or used a false record or statement material to a false or fraudulent claim to the federal government. As a result of a modification made by the Fraud Enforcement and Recovery Act of 2009, a claim includes &#8220;any request or demand&#8221; for money or property presented to the U.S. government. Recently, several pharmaceutical and other healthcare companies have been prosecuted under these laws for, among other things, allegedly providing free product to customers with the expectation that the customers would bill federal programs for the product. Other companies have been prosecuted for causing false claims to be submitted because of the companies&#8217; marketing of the product for unapproved, and thus non-covered, uses. The federal HIPAA created new federal criminal statutes that prohibit knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, including private third-party payors, and knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of, or payment for, healthcare benefits, items or services.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, the Health Care Reform Law also included the federal Physician Payments Sunshine Act, which requires that certain manufacturers of drugs, devices, biologicals and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program (with certain exceptions) to report information related to certain payments or other transfers of value made or distributed to physicians and teaching hospitals, or to entities or individuals at the request of, or designated on behalf of, the physicians and teaching hospitals and to report annually certain ownership and investment interests held by physicians and their immediate family members.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">115</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, many states have similar healthcare statutes or regulations that apply to items and services reimbursed under Medicaid and other state programs, or, in several states, apply regardless of the payor. Certain states require the posting of information relating to clinical studies, and require pharmaceutical companies to implement a comprehensive compliance program that includes a limit on expenditures for, or payments to, individual medical or health professionals and to track and report gifts and other payments made to physicians and other healthcare providers. If our operations are found to be in violation of any of the health regulatory laws described above or any other laws that apply to us, we may be subject to penalties, including potentially significant criminal, civil and/or administrative penalties, damages, fines, disgorgement, individual imprisonment, exclusion of products from reimbursement under government programs, contractual damages, reputational harm, administrative burdens, diminished profits and future earnings, and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations. To the extent that any of our products will be sold in a foreign country, we may be subject to similar foreign laws and regulations, which may include, for instance, applicable post-marketing requirements, including safety surveillance, anti-fraud and abuse laws, implementation of corporate compliance programs and reporting of payments or transfers of value to healthcare professionals.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Data privacy and security laws</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, we may be subject to international, federal and state data privacy and security laws, regulations, rules&#160;and standards. Internationally, laws, regulations and standards in many jurisdictions, such as the GDPR, the Swiss Federal Data Protection Act and the UK GDPR, apply broadly to the collection, use, retention, security, disclosure, transfer and other processing of personal information. At the federal level, HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act (HITECH), and its implementing regulations, imposes certain requirements relating to the privacy, security and transmission of individually identifiable health information. Among other things, HITECH makes HIPAA&#8217;s privacy and security standards directly applicable to business associates&#8212;independent contractors or agents of covered entities that receive or obtain protected health information in connection with providing a service on behalf of a covered entity. HITECH also created four new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and to seek attorneys&#8217; fees and costs associated with pursuing federal civil actions. In addition, state laws, (such as the CCPA and the CPRA,) govern the privacy and security of health and other personal information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts. Non-compliance with these laws, regulations, rules&#160;and standards could result in significant penalties or legal liability. Although we take steps to comply with applicable laws, rules&#160;and regulations, we cannot ensure that we will not be subject to regulatory or private actions, investigations, disputes and litigation, which may include substantial fines or other legal liability for noncompliance of data privacy and security laws, rules&#160;and regulations, including in the event of a cybersecurity breach or other security incident. We could be adversely affected if legislation or regulations are expanded to require changes in our or our third-party service providers&#8217; business practices or if governing jurisdictions interpret or implement their legislation or regulations in ways that negatively affect our business, results of operations or financial condition. See &#8220;Risk Factors&#8212; <i style="font-style:italic;">Changes in laws, rules&#160;or regulations relating to data privacy and security, or any actual or perceived failure by us to comply with such laws, rules, regulations and standards, or contractual or other obligations relating to data privacy and security, could have a material adverse effect on our reputation, results of operations, financial condition and cash flows.</i>&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Pharmaceutical coverage, pricing and reimbursement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In both domestic and foreign markets, our or our collaboration partners&#8217; sales of any approved products will depend in part on the availability of coverage and adequate reimbursement from third-party payors. Third-party payors include government authorities, managed care providers, private health insurers and other organizations. Patients who are prescribed treatments for their conditions and providers performing the prescribed services generally rely on third-party payors to reimburse all or part of the associated healthcare costs. Patients are unlikely to use our products, if approved, unless coverage is provided and reimbursement is adequate to cover a significant portion of the cost of our products. Sales of our products will therefore depend substantially, both domestically and abroad, on the extent to which the costs of our products will be paid by third-party payors. These third-party payors are increasingly focused on containing healthcare costs by challenging the price and examining the cost-effectiveness of medical products and services.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">116</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, significant uncertainty exists as to the coverage and reimbursement status of newly approved healthcare product candidates. The market for our product candidates for which we may receive regulatory approval will depend significantly on access to third-party payors&#8217; drug formularies, or lists of medications for which third-party payors provide coverage and reimbursement. The industry competition to be included in such formularies often leads to downward pricing pressures on pharmaceutical or biopharmaceutical companies. Additionally, third-party payors may refuse to include a particular branded drug in their formularies or otherwise restrict patient access to a branded drug when a less costly generic equivalent or another alternative is available. Because each third-party payor individually approves coverage and reimbursement levels, obtaining coverage and adequate reimbursement is a time-consuming, costly and sometimes unpredictable process. We may be required to provide scientific and clinical support for the use of any product to each third-party payor separately with no assurance that approval would be obtained, and we may need to conduct expensive pharmacoeconomic studies in order to demonstrate the cost-effectiveness of our products. This process could delay the market acceptance of any product and could have a negative effect on our future revenues and operating results. We cannot be certain that our product candidates will be considered cost-effective. Because coverage and reimbursement determinations are made on a payor-by-payor basis, obtaining acceptable coverage and reimbursement from one payor does not guarantee we will obtain similar acceptable coverage or reimbursement from another payor. If we are unable to obtain coverage of, and adequate reimbursement and payment levels for, our product candidates from third-party payors, physicians may limit how much or under what circumstances they will prescribe or administer them and patients may decline to purchase them. This in turn could affect our ability to successfully commercialize our products and impact our profitability, results of operations, financial condition and future success.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Furthermore, in many foreign countries, particularly the countries of the EU, the pricing of prescription drugs is subject to government control. In some non-U.S. jurisdictions, the proposed pricing for a drug must be approved before it may be lawfully marketed. The requirements governing drug pricing vary widely from country to country. For example, the EU provides options for its Member States to restrict the range of medicinal products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. A Member State may approve a specific price for the medicinal product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the medicinal product on the market. We may face competition for our product candidates from lower-priced products in foreign countries that have placed price controls on pharmaceutical or biopharmaceutical products. In addition, there may be importation of foreign products that compete with our own products, which could negatively impact our profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Healthcare reform</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the U.S., EU and other jurisdictions, there have been, and we expect there will continue to be, a number of legislative and regulatory changes to the healthcare system that could affect our future results of operations as we begin to commercialize our products directly.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In particular, there have been and continue to be a number of initiatives at the U.S. federal and state level that seek to reduce healthcare costs. Initiatives to reduce the federal deficit and to reform healthcare delivery are increasing cost-containment efforts. We anticipate that Congress, state legislatures and the private sector will continue to review and assess alternative benefits, controls on healthcare spending through limitations on the growth of private health insurance premiums and Medicare and Medicaid spending, the creation of large insurance purchasing groups, price controls on pharmaceuticals and other fundamental changes to the healthcare delivery system. Any proposed or actual changes could limit or eliminate our spending on development projects and affect our ultimate profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are not sure whether additional legislative changes will be enacted, or whether the FDA regulations, guidance or interpretations will be changed, or what the impact of such changes on the marketing approvals of our product candidates, if any, may be. In addition, increased scrutiny by the U.S. Congress of the FDA&#8217;s approval process may significantly delay or prevent marketing approval, as well as subject us to more stringent product labeling and post-marketing approval testing and other requirements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In addition, there has been heightened governmental scrutiny in the U.S. of pharmaceutical pricing practices in light of the rising cost of prescription drugs and biologics. Such scrutiny has resulted in several recent congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">117</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for products. At both the federal and state level, legislatures are increasingly passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. One significant example of recent legislative action is the IRA, which has been considered a scaled-back version of the Build Back Better Act. The IRA was signed into law on August 16, 2022. While the IRA is still subject to rulemaking (with more information to come via guidance documents from the responsible federal agencies), the IRA, as written, will, among other changes, give HHS the ability and authority to directly negotiate with manufacturers the price that Medicare will pay for certain high-priced drugs. The IRA will also require manufacturers of certain Part B and Part D drugs to issue to HHS rebates based on certain calculations and triggers (i.e. when drug prices increase and outpace the rate of inflation). At this time, we cannot predict the implications the IRA provisions will have on our business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the future, there may continue to be additional proposals relating to the reform of the U.S. healthcare system, some of which could further limit the prices we are able to charge for our products candidates, or the amounts of reimbursement available for our product candidates. If future legislation were to impose direct governmental price controls and access restrictions, it could have a significant adverse impact on our business. Managed care organizations, as well as Medicaid and other government agencies, continue to seek price discounts. Some states have implemented, and other states are considering, price controls or patient access constraints under the Medicaid program, and some states are considering price-control regimes that would apply to broader segments of their populations that are not Medicaid-eligible. Due to the volatility in the current economic and market dynamics, we are unable to predict the impact of any unforeseen or unknown legislative, regulatory, payor or policy actions, which may include cost-containment and healthcare-reform measures. Such policy actions could have a material adverse impact on our profitability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Moreover, the federal Drug Supply Chain Security Act imposes new obligations on manufacturers of pharmaceutical or biopharmaceutical products, among others, related to product tracking and tracing. Among the requirements of this new federal legislation, manufacturers will be required to provide certain information regarding the drug product to individuals and entities to which product ownership is transferred, label drug product with a product identifier, and keep certain records regarding the drug product. Further, under this new legislation, manufacturers will have drug product investigation, quarantine, disposition and notification responsibilities related to counterfeit, diverted, stolen and intentionally adulterated products, as well as products that are the subject of fraudulent transactions or that are otherwise unfit for distribution such that they would be reasonably likely to result in serious health consequences or death.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Physician Payment Sunshine Act and transparency</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Physician Payment Sunshine Act requires most pharmaceutical and biopharmaceutical manufacturers to report annually to the Secretary of Health and Human Services any and all financial arrangements, payments, or other transfers of value made by that entity to physicians and teaching hospitals. The payment information is made publicly available in a searchable format on a content management system website. Once we have an approved product, we will need to dedicate significant resources to establish and maintain systems and processes in order to comply with these regulations. Failure to comply with the reporting requirements can result in significant civil monetary penalties. Similar laws have been enacted or are under consideration in foreign jurisdictions, including France, which has adopted the Loi Bertrand, or French Sunshine Act, which became effective in 2013. In addition, the Code of Ethics from the EFPIA requires certain disclosures of interactions with institutions and healthcare professionals, depending on the jurisdictions in which we operate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Environmental, health and safety laws and regulations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We are subject to numerous environmental, health and safety laws and regulations and permitting requirements, including those governing laboratory procedures, decontamination activities, and the handling, transportation, use, remediation, storage, treatment, and disposal of hazardous materials and wastes. Our operations involve the use of hazardous and flammable materials, and the risk of injury, contamination or noncompliance with environmental, health </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">118</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">and safety requirements cannot be eliminated. Although compliance with such laws and regulations and permitting requirements has not had a material effect on our capital expenditures, earnings or competitive position, environmental, health and safety laws, and regulations and permitting requirements have tended to become increasingly stringent and, to the extent that legal or regulatory changes may occur in the future, they could result in, among other things, increased costs to us or the impairment of our research, development or production efforts.</p><a id="COrganizationalstructure_904091"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Organizational structure</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are a Swiss stock corporation (<i style="font-style:italic;">soci&#233;t&#233; anonyme</i>) organized under the laws of Switzerland. We were formed as a Swiss limited liability company (<i style="font-style:italic;">soci&#233;t&#233; &#224; responsabilit&#233; limit&#233;e</i>) on February&#160;13, 2003 with our registered office and domicile in Basel, Switzerland. We converted to a Swiss stock corporation (<i style="font-style:italic;">soci&#233;t&#233; anonyme</i>) under the laws of Switzerland on August&#160;25, 2003. Our Swiss enterprise identification number is CHE-109.878.825. Our domicile and registered office is in Ecublens, at the &#201;cole Polytechnique F&#233;d&#233;rale Lausanne (EPFL) Innovation Park Building B, 1015 Lausanne, Vaud, Switzerland. Our common shares were admitted to trading on Nasdaq Global Market on September&#160;23, 2016, and trade under the symbol ACIU.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our general telephone number is (41) 21 345 91 21 and our internet address is www.acimmune.com. <span style="background:#ffffff;">References to our website address do not constitute incorporation by reference of the information contained on the website, and the information contained on the website is not part of this document or any other document that we file with or furnish to the SEC. </span>The SEC maintains an internet site that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC, which can be found at http://www.sec.gov. Our agent for service of process in the United States is Cogency Global&#160;Inc. located at 122 East 42nd Street, 18th Floor, New York, New York 10168. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company controls a fully-owned subsidiary, AC Immune USA,&#160;Inc. (&#8220;AC Immune USA&#8221; or &#8220;Subsidiary&#8221;), which was registered and organized under the laws of Delaware, USA in Q2 2021. The Company and its Subsidiary form the Group.</p><a id="DPropertyplantandequipment_864198"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Property, plant and equipment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s capital expenditures were CHF 0.8 million in 2023 with CHF 0.5 million for laboratory equipment and leasehold improvements. These investments were made to enhance our research facilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Facilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We do not own any real property. The table below details the sizes and uses of our leased facilities as of December&#160;31, 2023:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0.5pt;padding-right:0.5pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.56%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:3.35%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:31.15%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:3.35%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:28.55%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr style="height:12.25pt;"><td style="vertical-align:top;width:33.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Location</b></p></td><td style="vertical-align:top;width:3.35%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:31.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Primary Function</b></p></td><td style="vertical-align:top;width:3.35%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:28.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Approximate Size </b></p></td></tr><tr style="height:12.8pt;"><td style="vertical-align:top;width:33.56%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">&#201;cole Polytechnique F&#233;d&#233;rale Lausanne (EPFL) </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Innovation Park Building B,</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">1015 Lausanne, Vaud, Switzerland</p></td><td style="vertical-align:top;width:3.35%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:31.15%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Headquarters</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Research, discovery, preclinical and clinical development</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Chemistry manufacturing and control</p></td><td style="vertical-align:top;width:3.35%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:28.55%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">29,000 square feet</p></td></tr><tr style="height:3.5pt;"><td style="vertical-align:top;width:33.56%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">1230 Avenue of the Americas</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Suite&#160;1634</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">New York, New York 10020</p></td><td style="vertical-align:top;width:3.35%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:31.15%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">U.S. operations</p></td><td style="vertical-align:top;width:3.35%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:28.55%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">1,600 square feet</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The Innovation Park of the EPFL serves as our corporate headquarters, our research facility and laboratories. We believe that using the EPFL facilities instead of building our own infrastructure helps us to maximize the value of our </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">119</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_Hlk114777300"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">research and development capital and make efficient use of our funds as we continue to build and develop our pipeline. We believe that the space of our existing facilities is sufficient to meet our current needs.</p><a id="_50050d8b_936a_4089_9a9b_b7a0e2362c6f"></a><a id="ITEM4AUNRESOLVEDSTAFFCOMMENTS_558751"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;4A. UNRESOLVED STAFF COMMENTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">None.</p><a id="_631fca85_86bd_45ce_ac8a_1dec19397412"></a><a id="ITEM5OPERATINGANDFINANCIALREVIEWANDPROSP"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">You should read the following discussion and analysis of our financial condition and results of operations together with our audited consolidated financial statements, including the notes thereto, included in this Annual Report. The following discussion is based on our financial information prepared in accordance with IFRS as issued by the IASB, which might differ in material respects from generally accepted accounting principles in other jurisdictions. The following discussion includes forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including but not limited to those described under &#8220;Item&#160;3. Key information&#8212;D. Risk factors&#8221; and elsewhere in this Annual Report.</p><a id="AOperatingresults_466589"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Operating results</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Overview</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To date, we have primarily financed our operations through the proceeds from our public offerings, share issuances, contract revenues from license and collaboration agreements and grants. We have no products approved for commercialization and have never generated any revenues from product sales. Pharmaceutical and biopharmaceutical product development is a highly speculative undertaking and involves a substantial degree of risk. It may be several&#160;years, if ever, before we or our collaboration partners complete pivotal clinical studies and have a product candidate approved for commercialization, and we begin to generate revenue and royalties from product sales. Since our inception, we have received upfront and milestone payments from our collaboration partners and certain other revenue. However, we have also incurred significant operating losses. We incurred net losses of CHF 54.2&#160;million for the fiscal&#160;year ended December&#160;31, 2023 and have an accumulated losses balance of CHF&#160;316.2 million as of December&#160;31, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Strategic collaborations and licensing agreements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Since our inception, we have entered into strategic collaboration agreements with a range of partners covering a number of our product candidates. We entered into a strategic collaboration with Genentech in November&#160;2006 (as amended in March&#160;2009, January&#160;2013, May&#160;2014 and May&#160;2015) regarding the development, manufacture and commercialization of anti-Abeta antibodies including crenezumab, and we refer to this agreement as the 2006 Agreement. As announced on January 22, 2024, AC Immune will regain the global rights to crenezumab following termination of the collaboration agreement with Genentech, which termination will be effective in April 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In June&#160;2012, we entered into an additional strategic collaboration agreement with Genentech regarding the development, manufacture and commercialization of anti-Tau antibodies, which covers semorinemab, and we refer to this agreement as the 2012 Agreement. As announced on January 22, 2024, AC Immune will regain the global rights to semorinemab following termination of the collaboration agreement with Genentech, which termination will be effective in April 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In May&#160;2014 (as amended in June 2022), we entered into a license and collaboration agreement with LMI (formerly Piramal Imaging SA) covering our Tau-PET Imaging tracers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In December&#160;2014 (as amended in April&#160;2016, July&#160;2017, January&#160;2019, November&#160;2019, December 2022 and November 2023), we entered into a strategic collaboration agreement with Janssen regarding the development, manufacture and commercialization of anti-Tau active immunotherapies, which covers ACI-35.030. We expect to </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">120</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">capitalize on Johnson&#160;&amp; Johnson&#8217;s extensive regulatory expertise and experience in developing, manufacturing and, if approved, commercializing active immunotherapies to bring ACI-35.030 to market.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We entered into a license agreement with Lilly in December&#160;2018 (as amended in September&#160;2019 and March&#160;2020) to research and develop Morphomer Tau small molecules for the treatment of AD and other neurodegenerative diseases. Under the terms of this agreement, we have completed a Phase 1 clinical study with ACI-3024. Lilly is responsible for leading and funding further clinical development for small molecule Tau aggregation inhibitors with plans to evaluate candidates in AD and NeuroOrphan tauopathies. Lilly will also retain global commercialization rights for all indications.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Genentech, a member of the Roche Group</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As mentioned above, the Company announced on January 22, 2024 that it will regain the global rights to crenezumab and semorinemab following termination of the collaboration agreements with Genentech, which will be effective in April 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Anti-Abeta antibody in AD&#160;&#8211; 2006 agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In November&#160;2006, we signed an exclusive, worldwide licensing agreement for crenezumab, our humanized monoclonal therapeutic antibody targeting misfolded Abeta. The agreement was amended March&#160;2009, January&#160;2013, May&#160;2014 and May&#160;2015. The collaboration agreement will be terminated effective April 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have received total milestone payments of USD 65 (CHF 70.1) million comprised of an upfront payment of USD 25 (CHF 31.6) million and of USD 40 (CHF 38.2) million for clinical development milestones achieved, all prior to January&#160;1, 2017.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Anti-Tau antibody in AD&#160;&#8211; 2012 agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In June&#160;2012, we entered into a second agreement with Genentech to research, develop and commercialize our anti-Tau antibodies for use as immunotherapeutics and diagnostics. The agreement was amended in December&#160;2015. This collaboration agreement will be terminated effective April 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have received payments totaling CHF 59 million, including a milestone payment of CHF 14 million received and recognized in Q4 2017 associated with the first patient dosing in a Phase 2 clinical trial for AD with an anti-Tau monoclonal body known as semorinemab, a milestone payment of CHF 14 million recognized in Q2 2016 and received in July&#160;2016, associated with the announcement of the commencement of the Phase 1 clinical study of semorinemab, and a milestone payment of CHF 14 million received in 2015 in connection with the ED-GO decision.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Janssen Pharmaceuticals,&#160;Inc.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Tau Active Immunotherapy in AD&#160;&#8211; 2014 agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In December&#160;2014, we entered into an agreement with Janssen Pharmaceuticals, Inc. (Janssen), part of the Janssen Pharmaceutical Companies of Johnson &amp; Johnson, to develop and commercialize therapeutic anti-Tau active immunotherapies for the treatment of AD and potentially other Tauopathies. The value of this collaboration is potentially up to CHF 500 million and includes upfront and clinical, regulatory and commercial milestones. In addition to milestones, we will be eligible to receive royalties on sales at a&#160;percentage rate ranging from the low-double digits to the mid-teens for the ACI-35.030 active immunotherapy program. In April&#160;2016, July&#160;2017, January&#160;2019, November&#160;2019, December 2022 and November 2023, the companies entered into the first, second, third, fourth, fifth and sixth amendments, respectively. These amendments allow for the alignment of certain payment and activity provisions with the Development Plan and Research Plan activities. We and Janssen have completed the co-development of the second-generation lead active immunotherapies, ACI-35.030 and JACI-35.054, through Phase 1b/2a. In November 2022, it was announced that ACI-35.030 was selected to advance into further development based on interim data from the ongoing Phase 1b/2a trial. In December 2023, it was announced that Janssen has programmed the launch of the Phase 2b clinical study to evaluate ACI-35.030 (JNJ-64042056) in patients with preclinical AD, those individuals not yet showing </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">121</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">symptoms.AC Immune and Janssen will jointly share research and development costs until the completion of the first Phase 2b (AC Immune&#8217;s contribution to the first Phase 2b trial is capped). From Phase 2b and onwards, Janssen will assume responsibility for the clinical development, manufacturing and commercialization of ACI-35.030. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company received an upfront, non-refundable license fee of CHF 25.9 million, which we recognized as revenue in 2014. In May&#160;2016, we received a payment of CHF 4.9 million for reaching a clinical milestone in the Phase 1b study. In December 2023, we were entitled to receive a milestone payment of CHF 14.8 million for the commencement of the first Phase 2b clinical study. The Company recognized this income as revenue because we deemed it highly probable that this milestone would be obtained and would not be subject to reversal in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The structure of the collaboration agreement is as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">A right-of-use license.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Clinical milestone payments</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable upon reaching certain milestones in the Phase 1b study, commencement of the first Phase 2b development, upon reaching enrollment thresholds in the first Phase 2b, commencement of the first Phase 3 trial or regulatory filing of a product for AD indication based on Phase 2b data without a Phase 3 trial. In addition, for a second indication, clinical milestone payments would be payable upon commencement of a Phase 3 clinical study, which would be payable concurrently with the first regulatory milestone, if Janssen were to file for regulatory approval based on Phase 2 clinical data.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Regulatory milestone payments</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable upon making regulatory filings in the U.S., Europe, and Japan, respectively. In addition, for a second indication, similar regulatory milestones would be payable. For a second indication, additional regulatory milestone payments are payable by Janssen to us upon receipt of each of the regulatory approvals in the U.S., Europe and Japan.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Commercialization milestones</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable upon making a first commercial sale in each of the U.S., Europe and Japan, and upon achieving certain commercial milestones.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Royalties</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable on sales, with royalty rates differing based on the level of annual sales. We may receive royalties on sales at a&#160;percentage rate ranging from the low-double digits to the mid-teens for the ACI-35.030 active immunotherapy program.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under the terms of the agreement, Janssen may terminate the agreement at any time after completion of the first Phase 1b clinical study in 2016 by providing 90&#160;days&#8217; notice to us. If not otherwise terminated, the agreement shall continue until the expiration of all royalty obligations as outlined in the contract.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">LMI (formerly Piramal Imaging SA)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Tau-PET imaging agent&#160;&#8211; 2014 agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In May&#160;2014 (as amended in June 2022), we entered into an agreement, our first diagnostic partnership, with LMI, the former Piramal Imaging SA. The partnership with LMI is an exclusive, worldwide licensing agreement for the research, development and commercialization of the Company&#8217;s Tau protein PET tracers supporting the early diagnosis and clinical management of AD and other Tau-related disorders and includes upfront and sales milestone payments totaling up to EUR 160 (CHF 151) million, plus royalties on sales at a&#160;percentage rate ranging from mid-single digits to low-teens. LMI may terminate the LCA at any time by providing 3&#160;months&#8217; notice to us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The structure of the collaboration agreement is as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">A right-of-use license.</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">122</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Clinical milestone payments</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable upon the commencement of the Phase 1, 2 and 3 studies for generation of data intended to support a regulatory submission in the U.S. or the EU. We would be entitled to further clinical milestone payments for the commencement of a Phase 2 and 3 study for a second indication.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Regulatory milestone payments</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable upon acceptance of Regulatory filing (NDA) and Regulatory approval for Commercialization in the U.S. or the EU.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Commercialization milestones</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: tied to specific annual net sales amounts.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Royalties: </i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">payable on sales, with royalty rates differing based on the level of annual sales. We may receive royalties on sales at a&#160;percentage rate ranging from the mid-single digits to the low-teens.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Eli Lilly and Company</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Morphomer Tau small molecule&#160;&#8211; 2018 license agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In December&#160;2018, we entered into an exclusive, worldwide licensing agreement with Eli Lilly and Company (Lilly) to research and develop Morphomer Tau small molecules for the treatment of AD and other neurodegenerative diseases. Per the terms of the agreement, the Company received an initial upfront payment of CHF 80 million in Q1 2019 for the rights granted by the Company to Lilly. To date, the Company has completed a Phase 1 clinical study with ACI-3024. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, the Company and Lilly have continued candidate characterization across the research program, identifying new and highly differentiated candidates with desired cerebrospinal fluid exposure and selectivity for pathological aggregated Tau. These will be broadly developed in Tau-dependent neurodegenerative diseases by Lilly. Lilly is responsible for leading and funding further clinical development and will retain global commercialization rights for all indications.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Per the terms of the agreement, the Company may become eligible to receive additional milestone payments totaling up to approximately CHF 1.9 billion.&#160;In addition to milestones, we will be eligible to receive royalties on sales at a&#160;percentage rate ranging from the low double-digits to the mid-teens. The agreement became effective in January 2019 when the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, expired. In Q3 2019, the Company and Lilly entered into the first amendment to divide the first discretionary milestone payment under the agreement of CHF 60 million into two installments with the first CHF 30 million paid in Q3 2019 and the second CHF 30 million to be paid on or before March&#160;31, 2020 unless Lilly terminated the agreement earlier. In Q1 2020, the Company and Lilly entered into a second amendment to replace the second CHF 30 million to be paid on or before March&#160;31, 2020 with two milestone payments, one of CHF 10 million to be paid on or before March&#160;31, 2020 and the other of CHF 60 million following the first patient dosed in a Phase 2 clinical study of a licensed product in the U.S. or the EU.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company received an initial upfront payment of CHF 80 million in February&#160;2019. We used the residual approach to estimate the selling price for the right-of-use license and an expected cost plus margin approach for estimating the research and development activities. The right-of-use license was delivered on the effective date. The research and development activities were delivered over time as the services were performed. For these services, revenue was recognized over time using the input method, based on costs incurred to perform the services, as the level of costs incurred over time is thought to best reflect the transfer of services to Lilly.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The structure of the collaboration agreement is as follows.</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">A</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">n </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">exclusive license: </i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">granted by us to Lilly under certain of our intellectual property to develop, manufacture and commercialize products containing Morphomer Tau small molecules for the treatment of AD and other neurodegenerative diseases throughout the world in any indication.</span></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">123</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Clinical milestone payment</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">s: payable upon completion of the Lilly preclinical activities period and following the first patient dosed in a Phase 2 and Phase 3 clinical study of a licensed product in the U.S. or the EU.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Regulatory milestone payments</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable within 60&#160;days after obtaining regulatory approval for any licensed product in the first indication and any licensed product in certain additional indications in the U.S., Europe and Japan, respectively.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Commercialization milestones</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable upon achieving certain commercial sales milestones.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Royalties</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">: payable on sales with royalty rates differing based on the level of annual sales of licensed products. We may receive royalties on sales at a&#160;percentage rate ranging from the low double-digits to the mid-teens.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The agreement will terminate by the date of expiration of the last royalty term for the last licensed product. However, under the terms of the agreement, Lilly may terminate the agreement at any time after March&#160;31, 2020 by providing 3&#160;months&#8217; notice to us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We and Lilly also entered into a convertible note agreement that became effective in January 2019 for USD 50 (CHF 50.3) million from Lilly. In Q2 2019, the Convertible Note&#160;Agreement with Lilly automatically converted in line with the terms of the agreement. As a result of this conversion, 3,615,328 of our common shares were issued to Lilly. This note is now fully settled and there is no further equity or cash consideration due to Lilly thereunder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Grants</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Michael J. Fox Foundation for Parkinson&#8217;s Research</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In May&#160;2020, the Company, as part of a joint arrangement with Sk&#229;ne University Hospital (Sk&#229;ne) in Sweden, was awarded a USD 3.2 (CHF 3.0) million grant from the MJFF&#8217;s Ken Griffin Alpha-synuclein Imaging Competition. As part of this grant, AC Immune was eligible to receive USD 2.5 (CHF 2.3) million directly from the MJFF. Sk&#229;ne was to receive USD 0.7 (CHF 0.7) million of the total grant directly from the MJFF over two&#160;years to conduct and support the clinical arm of the project. <span style="background:#ffffff;">In August 2022, the Company received follow-on grant funding as part of its joint arrangement with Sk&#229;ne totaling USD&#160;0.5&#160;(CHF&#160;0.5) million for the continued development of its alpha-synuclein PET imaging diagnostic agent. As part of this grant, the Company received USD&#160;0.4&#160;(CHF&#160;0.4) million directly from the MJFF. Sk&#229;ne received USD&#160;0.1&#160;(CHF&#160;0.1) million of the total grant directly from the MJFF over the duration of the grant period.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In December&#160;2021, the Company announced that it had been awarded two grants totaling USD 1.5 (CHF 1.4) million to advance small molecule PD programs. One award supported an existing early-stage program to develop small molecules that can prevent intracellular aggregation and spreading of a-syn. The other award funded research on the therapeutic potential of chemically and mechanistically novel, brain penetrant small molecule inhibitors of NLRP3 inflammasome activation for the treatment of PD.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In February 2023, the Company announced that it had been awarded a new grant totaling USD 0.5 (CHF 0.4) million from the MJFF to support the development of its TDP-43 PET tracer program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Grant from the Target ALS Foundation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In Q1 2021, AC Immune was awarded a USD 0.3 (CHF 0.2) million grant from Target ALS. This grant funded a collaboration between the Company and the Investigators at the Healey Center for ALS at Massachusetts General Hospital (MGH) to accelerate the development of the Company&#8217;s proprietary immunoassays to detect disease-associated forms of TDP-43 in CSF and blood samples. The Company was awarded an additional one-year grant in December 2022 for USD 0.1 (CHF 0.1) million to continue the project, which was completed in 2023. Subsequently, in December 2023, AC Immune was awarded another one-year grant for the same amount, USD 0.1 (CHF 0.1) million, to continue its work.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">124</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Critical accounting policies and significant judgments and estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Revenue recognition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In May&#160;2014, the IASB issued IFRS 15 <i style="font-style:italic;">Revenue from Contracts with Customers, </i>which amends the guidance for accounting for revenues from contracts with customers. This IFRS replaces all current revenue standards in IFRS including IAS 11 <i style="font-style:italic;">Construction Contracts</i>, IAS 18 <i style="font-style:italic;">Revenue </i>and various interpretations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. Under IFRS 15, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of IFRS 15, the entity performs the following five steps: (i)&#160;identify the contract(s)&#160;with a customer; (ii)&#160;identify the performance obligations in the contract; (iii)&#160;determine the transaction price; (iv)&#160;allocate the transaction price to the performance obligations in the contract; and (v)&#160;recognize revenue when (or as) the entity satisfies a performance obligation. The Company applies the five-step model to contracts only when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of IFRS 15, the Company assesses the goods or services promised within each contract, and determines those that are performance obligations, and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Contract revenue</i>. The Company enters into LCAs, which are within the scope of IFRS 15, under which it licenses certain proprietary rights to its product candidates and intellectual property to third parties. The terms of these arrangements typically include payment to the Company of one or more of the following: non-refundable, upfront license fees, development, regulatory and/or commercial milestone payments,&#160;payments for research and clinical services the Company provides through either its full-time employees or third-party vendors, and royalties on net sales of licensed commercialized products depending on the Company&#8217;s intellectual property. Each of these payments results in license, collaboration and other revenues, which are classified as contract revenue on the consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Licenses of intellectual property</i>.&#160;If the license to the Company&#8217;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, upfront fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are sold in conjunction with a related service, the Company uses judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time. If the performance obligation is settled over time, the Company determines the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, upfront fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Milestone payments</i>.&#160;At the inception of each arrangement that includes development, regulatory and/or commercial milestone payments, the Company evaluates whether the milestones are considered highly probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is highly probable that a significant cumulative revenue reversal would not occur in future periods, the associated milestone value is included in the transaction price. These amounts for the performance obligations under the contract are recognized as they are satisfied. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of such milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments recorded would affect contract revenues and earnings in the period of adjustment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><i style="font-style:italic;">Research and development services</i>.&#160;The Company has certain arrangements with our collaboration partners that include contracting our employees for research and development programs. The Company assesses if these services are </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">125</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">considered distinct in the context of each contract and, if so, they are accounted for as separate performance obligations. These revenues are recorded in contract revenue as the services are performed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Sublicense revenues</i>.&#160;The Company has certain arrangements with our collaboration partners that include provisions for sublicensing. The Company recognizes any sublicense revenues at the point in time it is highly probable to obtain and not subject to reversal in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Contract balances:</i>&#160;The Company receives payments and determines credit terms from its customers for its various performance obligations based on billing schedules established in each contract. The timing of revenue recognition, billings and cash collections results in billed other current receivables, accrued income (contract assets), and deferred income (contract liabilities) on the consolidated balance sheets. Amounts are recorded as other current receivables when the Company&#8217;s right to consideration is unconditional. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be 1&#160;year or less.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Accrued research and development costs</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We record accrued expenses for estimated costs of our research and development activities conducted by third-party service providers, which include among others the conduct of preclinical studies and clinical studies and contract manufacturing activities. We record accrued expenses for estimated costs of our research and development activities based upon the estimated amount of services provided but not yet invoiced, and we include these costs in accrued expenses on the consolidated balance sheets and within research and development expenses in the consolidated statements of income/(loss). These costs are a significant component of our research and development expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We record accrued expenses for these costs based on the estimated amount of work completed in accordance with agreements established with these third parties, which involves the following process:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">communicating with our applicable personnel to identify services that have been performed on our behalf and estimating the level of service performed and the associated cost incurred for the service when we have not yet been invoiced or otherwise notified of actual costs;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">estimating and accruing expenses in our consolidated financial statements as of each balance sheet date based on facts and circumstances known to us at the time; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">periodically confirming the accuracy of our estimates with selected providers and adjusting, if necessary.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Examples of estimated research and development expenses that we accrue include:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fees paid to CROs in connection with preclinical and toxicology studies and clinical studies;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fees paid to investigative sites in connection with clinical studies;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fees paid to CMOs in connection with the production of our product candidates prior to qualifying for capitalization as inventory; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">professional service fees for consulting and related services.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We base our expense accruals related to clinical studies on our estimates of the services received and efforts expended pursuant to contracts with multiple research institutions and clinical CROs that conduct and manage clinical studies on our behalf. The financial terms of these agreements vary from contract to contract and may result in uneven payment flows. Payments under some of these contracts depend on factors such as the successful enrollment of patients and the completion of clinical study milestones. Our service providers predominantly invoice us&#160;monthly in arrears for services performed. In accruing service fees, we estimate the time period over which the services will be performed and </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">126</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">the level of effort to be expended in each period. If we do not identify costs that we have begun to incur or if we underestimate or overestimate the level of services performed or the costs of these services, our actual expenses could differ from our estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To date, we have not experienced significant changes in our estimates of accrued research and development expenses after a reporting period. However, due to the nature of estimates, we may be required to make changes to our estimates in the future as we become aware of additional information about the status or conduct of our clinical studies and other research activities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Share-based compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Options</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company operates an equity-settled, share-based compensation plan. The fair value of the employee services received in exchange for the grant of equity-based awards is recognized as an expense. The total amount to be expensed over the vesting period is determined by reference to the fair value of the instruments granted, excluding the impact of any non-market vesting conditions. Non-market vesting conditions are included in assumptions about the number of instruments that are expected to become exercisable. At each balance sheet date, the Company revises its estimates of the number of instruments that are expected to become exercisable. It recognizes the impact of the revision of original estimates, if any, prospectively in the consolidated statements of income/(loss), and a corresponding adjustment to equity over the remaining vesting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We estimate the fair value of all time-vested options as of the date of grant using the Black-Scholes option-pricing model. Key assumptions in determining the fair value of share options granted utilizing the Black-Scholes valuation method include the following:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:2.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:51.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:43.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:51.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Assumption</b></p></td><td style="vertical-align:bottom;width:2.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:43.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Method of estimation</b></p></td></tr><tr><td style="vertical-align:bottom;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:51.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:43.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;">&#9679;</p></td><td style="vertical-align:bottom;width:51.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Estimated expected term of options</p></td><td style="vertical-align:bottom;width:2.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;">&#9679;</p></td><td style="vertical-align:bottom;width:43.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Simplified method</p></td></tr><tr><td style="vertical-align:bottom;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;">&#9679;</p></td><td style="vertical-align:bottom;width:51.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Expected volatility</p></td><td style="vertical-align:top;width:2.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;">&#9679;</p></td><td style="vertical-align:bottom;width:43.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">The Company&#8217;s actual volatility for the period congruent with the expected term of the underlying option</p></td></tr><tr><td style="vertical-align:bottom;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;">&#9679;</p></td><td style="vertical-align:bottom;width:51.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Risk-free interest rate</p></td><td style="vertical-align:top;width:2.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;">&#9679;</p></td><td style="vertical-align:bottom;width:43.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Yields of long-dated U.S. Treasury notes</p></td></tr><tr><td style="vertical-align:bottom;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;">&#9679;</p></td><td style="vertical-align:bottom;width:51.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Expected dividends</p></td><td style="vertical-align:top;width:2.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;">&#9679;</p></td><td style="vertical-align:bottom;width:43.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Zero percent as dividends have not been paid</p></td></tr><tr><td style="vertical-align:bottom;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;">&#9679;</p></td><td style="vertical-align:bottom;width:51.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Forfeiture rates</p></td><td style="vertical-align:top;width:2.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;">&#9679;</p></td><td style="vertical-align:bottom;width:43.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Historical and expected forfeiture data</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Restricted share units</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We estimate the fair value of restricted share units using a reasonable estimate of market value of the common shares on the date of the award. We classify our share-based payments as equity-classified awards as they are settled in our common shares. We measure equity-classified awards at their grant date fair value and do not subsequently re-measure them. Compensation costs related to equity-classified awards are equal to the fair value of the award at grant date amortized over the vesting period of the award using the graded method. We reclassify that portion of vested awards to share premium as the awards vested.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Right-of-use assets and lease liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company applies IFRS 16 <i style="font-style:italic;">Leases</i>, which provides the model for lessee accounting in which all leases, other than short-term and low-value leases, are accounted for by the recognition on the consolidated balance sheet of a right-of-use asset and a lease liability, and the subsequent amortization of the right-of-use asset over the earlier of the end of the useful life or the lease term. In accordance with IFRS 16, the Company (i)&#160;does not recognize right-of-use assets and lease liabilities for leases of low value (i.e. approximate fair value of USD 5,000). For a complete discussion of accounting, see &#8220;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities.&#8221;</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">127</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">In-process research and development (IPR&amp;D) asset</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s acquired IPR&amp;D asset is stated at cost less any impairments. Our IPR&amp;D asset is subject to impairment testing at least annually or when there are indications that the carrying value may not be recoverable until the completion of the development process. At that point, the capitalized amounts are amortized over their estimated useful life. The determination of the recoverable amounts include key estimates which are highly sensitive to, and depend upon, key assumptions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company will not capitalize future development costs in respect to this IPR&amp;D asset until they meet the criteria for capitalization of research and development costs in accordance with IAS 38 <i style="font-style:italic;">Intangible Assets</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Net employee defined benefit liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company operates the mandatory pension schemes for its employees in Switzerland. The schemes are generally funded through payments to insurance companies. The Company has a pension plan designed to pay pensions based on accumulated contributions on individual savings accounts. However, this plan is classified as a defined benefit plan under IAS 19.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The net defined benefit liability is the present value of the defined benefit obligation at the balance sheet date minus the fair value of plan assets. Significant estimates are used in determining the assumptions incorporated in the calculation of the pension obligations, which is supported by input from independent actuaries. The defined benefit obligation is calculated annually with the assistance of an independent actuary using the projected unit credit method, which reflects services rendered by employees to the date of valuation, incorporates assumptions concerning employees&#8217; projected salaries and pension increases as well as discount rates of highly liquid corporate bonds that have terms to maturity approximating the terms of the related liability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To the extent that the fair value of the plan assets is greater than the present value of the defined benefit obligation as calculated by our independent actuary, the Company accounts for the effect of the asset ceiling test under IAS 19.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Re-measurements of the net defined benefit liability, which comprise actuarial gains and losses and the return on plan assets (excluding interest) are recognized immediately in the consolidated statements of other comprehensive income/(loss). Past service costs, including curtailment gains or losses, are recognized immediately as a split in research and development and general and administrative expenses within the operating results. Settlement gains or losses are recognized in either research and development and/or general and administrative expenses within the operating results. The Company determines the net interest expense/(income) on the net defined benefit liability for the period by applying the discount rate used to measure the defined benefit obligation at the beginning of the annual period or in case of any significant events between measurement dates to the then-net defined benefit liability, considering any changes in the net defined benefit liability during the period as a result of contributions and benefit payments. Net interest expense/(income) and other expenses related to defined benefit plans are recognized in the consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Financial operations overview</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Contract revenues</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Given our stage of development, we have not generated any revenue from product sales. Our contract revenues to date have been derived primarily from separate license and collaboration agreements on some of our product candidates in various stages of preclinical and clinical development.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our contract revenues have experienced fluctuations over the past three&#160;years as a result of the timing of milestone achievement and the size of each milestone payment. We expect that any revenue we generate from our collaboration agreements with each of Lilly, Janssen and LMI and/or from any other current or future collaboration partners will fluctuate from&#160;year to&#160;year as a result of the timing and amount of milestones and other payments.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">128</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Research and development expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Research and development costs are expensed as incurred, and consist of salaries and benefits, laboratory supplies, materials, intellectual property, facility and information technology (IT) costs, as well as fees paid to other non-employees and entities that conduct certain research and development activities on our behalf and all other allocated expenses. Amounts incurred in connection with license and collaboration agreements are also included in research and development expense. Payments made prior to the receipt of goods or services to be used in research and development are capitalized until those goods or services are received.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Clinical trial costs are a component of research and development expenses. We accrue and expense clinical trial activities performed by third parties based upon actual work completed in accordance with agreements established with clinical CROs and clinical sites. We determine the actual costs through monitoring patient enrollment and discussions with internal personnel and external service providers as to the progress or stage of completion of trials or services and the agreed-upon fee to be paid for such services.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Manufacturing start-up costs are a component of research and development expenses. Additionally, manufacturing costs incurred after regulatory approval but in connection with significant changes and/or enhancements to the approved manufacturing process are recorded as research and development expenses. We accrue and expense the manufacturing activities performed by third parties based upon actual work completed in accordance with agreements established with contract manufacturers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our investment in research and development activities, including the clinical development of our product candidates has historically been, and is projected to be, more than 75% of our total annual operating costs. Research and development expenses represent costs incurred to conduct research, such as the discovery and development of our product candidates, as well as development of new product candidates from our SupraAntigen and Morphomer platforms and the development of product candidates pursuant to our collaboration agreements with Lilly, Janssen and LMI. We recognize all research and development costs as they are incurred. Clinical study costs, contract manufacturing and other development costs incurred by third parties are expensed as the contracted work is performed. At present, most of our research activities comprise three major areas:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">AD;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">focused non-AD NDD including Parkinson&#8217;s disease, ALS and NeuroOrphan indications; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">diagnostics.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We expect our research and development expenses to continue to increase in the future and expect to fund a broader number of projects, which will impact our research strategy in four key ways:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(i)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we expect to undertake later-stage research and development for certain of our product candidates and, if approved, to take some of those product candidates into commercialization;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(ii)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we will allocate more funding to existing programs to advance the development of these programs;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(iii)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we will increase our research and development efforts on non-AD indications including NeuroOrphans and diagnostics; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(iv)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we will initiate a number of new research initiatives that are complementary to our existing and planned research initiatives.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We expect that our total future research and development costs will increase over current levels in line with our three-pillar strategy that focuses on (i)&#160;AD, (ii)&#160;focused non-AD NDD including PD, ALS and NeuroOrphan indications and (iii)&#160;diagnostics.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">129</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">General and administrative expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">General and administrative expenses include personnel costs, expenses for outside professional services and all other allocated expenses. Personnel costs consist of salaries, cash bonuses, benefits and share-based compensation. Outside professional services consist of legal, accounting and audit services, IT and other consulting fees. Allocated expenses consist of certain IT, facilities and depreciation expenses. We continue to incur additional expenses as a result of operating as a public company, including expenses related to compliance with the rules&#160;and regulations of the SEC, and those of any national securities exchange on which our securities are traded (Nasdaq), additional insurance expenses, investor relations activities and other administrative and professional services.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Other operating income/(expense), net</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Other operating income/(expense) consists primarily of income associated with foundation grants such as those from the MJFF or Target ALS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Finance result, net</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Financial income and expenses include bank fees associated with charges levied by banks on foreign payments, interest income and expense associated with our cash balances and interest expense associated with lease liabilities. For the&#160;year ended December&#160;31, 2021, we recognized a gain on the change in fair value of derivative financial assets associated with two convertible notes sold to certain Affiris affiliated entities that did not occur in the current or comparable prior period. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Exchange differences consist of foreign exchange transactions and re-measurement gains and losses that arise from our cash being held in currency other than Swiss Francs, certain collaboration agreements such as the collaboration agreements with LMI being denominated in currencies other than Swiss Francs, and selected purchases, which we effect in foreign currencies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Taxation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune is subject to corporate Swiss federal, cantonal and communal taxation, respectively, in Switzerland, Canton of Vaud, Commune of Ecublens, near Lausanne. We are also subject to taxation in other jurisdictions in which we operate, in particular, the United States where our wholly-owned subsidiary is incorporated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are entitled under Swiss laws to carry forward any losses incurred for a period of 7&#160;years and can offset our losses carried forward against future taxes. As of December&#160;31, 2023, we had tax loss carry-forwards totaling CHF 313.0 million (provisional amount; tax loss is definitively recognized by Swiss tax authorities once set-off against taxable income). There is no certainty that we will make sufficient profits to be able to utilize these tax loss carry-forwards in full.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The effective corporate income tax rate (federal, cantonal and communal) where we are domiciled is currently 13.6%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of January&#160;1, 2020, the Company may request for 2020 and future tax&#160;years a tax relief of 60%, which would be applied to income from patents and similar rights at the communal and cantonal levels. This relief would first require the reintegration of all expensed and deducted research and development costs related to the concerned patents and similar rights for consideration in our taxable results from the prior ten&#160;years. The Company has not currently made any decision to enter this patent box system. Additionally, a &#8220;super-deduction&#8221; may be granted for payroll and other expenses of research and development of Swiss origins.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">However, the aforementioned tax relief based on the patent box and deductions for research and development may not exceed 50% of the overall taxable profit before these tax relief and deductions.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">130</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Notwithstanding the corporate income tax, the corporate capital is taxed at a rate of 0.1305% (cantonal and communal tax only, as there is no federal tax on capital).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Value added tax (VAT) is charged on all qualifying goods and services supplied by VAT-registered businesses. Rates vary based on category, but the Company applies a standard rate of 8.1% since January 1, 2024 on the value of the goods or services to all sales invoices, which is payable to the Swiss tax authorities. Similarly, VAT paid on purchase invoices is reclaimable from the Swiss tax authorities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Results of operations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The numbers below have been derived from our audited consolidated financial statements included elsewhere in this Annual Report. The discussion below should be read along with these consolidated financial statements and it is qualified in its entirety by reference to them.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Comparison of the&#160;years ended December&#160;31, 2023 and 2022</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Contract revenue</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">For the&#160;year ended December&#160;31, 2023, AC Immune generated CHF 14.8 million in contract revenues compared with CHF 3.9 million for the comparable period in 2022. This represents an increase of CHF 10.9 million. The following table summarizes our contract revenues during the&#160;years ended December&#160;31, 2023 and 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:20.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:20.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Change</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Contract revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 14,801</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,935</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 10,866</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total revenue</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 14,801</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,935</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 10,866</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our contract revenues experience fluctuations as a result of securing new collaboration agreements, the timing of milestone achievements and the size of each milestone payment. For the&#160;year ended December&#160;31, 2023, our contract revenues of CHF 14.8 million were related to the commencement of the first Phase 2b clinical study of ACI-35.056 per our agreement with Janssen. For the year ended December 31, 2022 our contract revenues of CHF 3.9 million were wholly related to the progression of the Tau-PET Tracer PI-2620 into late-stage development in AD per our agreement with LMI.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Research and development expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Research and development activities are essential to our business and represent the majority of our costs incurred. Costs for certain development activities, such as clinical trials, are recognized based on an evaluation of the progress to completion of specific tasks using information from the clinical sites and our vendors. Our collaboration agreements have different agreements to share costs for the development of our product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have completed our co-development costs with Janssen for the Phase 1b/2a studies for our active immunotherapy, ACI-35.030 and JACI-35.054. AC Immune and Janssen will jointly share research and development costs for the first Phase 2b (however, AC Immune&#8217;s contribution to the first Phase 2b trial is capped (and remaining costs for AC Immune are non-material). From Phase 2b and onwards, Janssen will assume responsibility for the clinical development, manufacturing and commercialization. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We intend to increase our R&amp;D costs associated with the advancement of our active immunotherapies, ACI-24.060 targeting Abeta in AD and AD in DS and ACI-7104.056 targeting a-syn in PD, through mid- and late-stage clinical development, as well as through investments in our diagnostic programs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Finally, we intend to further advance the characterization of our other clinical and preclinical candidates, such as our Morphomer Tau program. In addition to the collaborative arrangements and proprietarily held assets, we expect that our </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">131</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">total future R&amp;D costs will increase over current levels, in line with our three-pillar strategy that focuses on (i)&#160;AD, (ii)&#160;expand in PD and non-AD neurodegenerative diseases, including NeuroOrphan indications and LATE and (iii)&#160;diagnostics.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The table below provides a breakdown of our research and development costs, including direct research and development costs, manufacturing costs related to research and development and other research and development costs not allocated directly to programs for the periods covered by this Annual Report. The research and development costs not allocated to specific programs include employment costs, regulatory, QA and intellectual property costs. We do not assign our internal costs, such as salary and benefits, share-based compensation expenses, laboratory supplies, and other direct expenses and infrastructure costs to individual R&amp;D projects, because the employees within our R&amp;D groups are typically deployed across multiple research and development programs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;year ended December&#160;31, 2023, research and development expenses totaled CHF 54.6 million compared with CHF 60.3 million for the comparable period in 2022. This represents a decrease of CHF 5.7 million. The following table presents the research and development expenses during the&#160;years ended December&#160;31, 2023 and 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Detailed research and development expenditures by major development category</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Change</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Discovery and preclinical expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 11,117</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 16,889</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (5,772)</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Clinical expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 11,095</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 13,089</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1,994)</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Group function expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,363</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,574</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (211)</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total direct R&amp;D expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 23,575</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 31,552</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (7,977)</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Payroll expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 19,499</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 17,548</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,951</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,909</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,622</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 287</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other non-allocated</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 9,623</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 9,614</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 9</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total R&amp;D expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 54,606</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 60,336</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (5,730)</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Change</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Operating expenses<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">1</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 33,198</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 41,166</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (7,968)</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Salaries and related costs<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">2</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 21,408</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 19,170</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,238</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total R&amp;D expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 54,606</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 60,336</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (5,730)</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">1</sup>Includes depreciation expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">2</sup>Includes share-based compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">For the&#160;year ended December&#160;31, 2023:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Discovery and preclinical expenses decreased by CHF 5.8 million, primarily due to:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a decrease of CHF 1.8 million due to the completion of preclinical studies for our Morphomer Tau program, CHF 1.0 million in ACI-24.060 due to the program advancing into the Phase 1b/2 ABATE study, CHF 0.9 million for our anti-TDP-43 antibody due to the completion of certain manufacturing activities in the prior period, CHF 0.8 million in ACI-7104.056 due to toxicology studies and validation activities conducted in the prior period and CHF 1.3 million in other discovery and preclinical programs.</span></td></tr></table><div style="margin-top:8pt;"></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">132</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:12.65pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Clinical expenses decreased by CHF 2.0 million, primarily due to:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a decrease of CHF 3.4 million for the clinical development of ACI-35.030 driven by the completion of the Phase 1b/2a and the advancement into Phase 2b, where the costs are assumed by Janssen and CHF 0.1 million in other clinical programs. </span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">partially offset by:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">an increase of CHF 1.5 million for the continued clinical development of our Phase 1b/2 ABATE study for our ACI-24.060.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The variances in Group function expenses relate to regulatory and quality assurance, intellectual property and other non-allocated costs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Total salaries and related costs increased by CHF 2.2 million, primarily due to the annualization of 2022 hires, which resulted in an increase in salary- and benefit-related costs of CHF 1.9 million, as well as an incremental CHF 0.3 million in share-based compensation expense.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The increase in other non-allocated expenses, which is immaterial, relates to certain non-allocated functional expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">General and administrative expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">General and administrative expenses consist primarily of salaries and related costs, including share-based compensation, professional fees such as legal and accounting related services, infrastructure expenses, and other operating expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">For the&#160;year ended December&#160;31, 2023, general and administrative expenses totaled CHF 15.3 million compared with CHF 15.8 million for the comparable period in 2022. This represents a decrease of CHF 0.5 million. The following table presents the general and administrative expenses during the&#160;years ended December&#160;31, 2023 and 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Change</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Operating expenses<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">1</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4,729</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 6,207</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1,478)</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Salaries and related costs<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">2</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 10,576</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 9,582</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 994</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total general and administrative expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 15,305</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 15,789</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (484)</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:11.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">1</sup>Includes depreciation expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">2</sup>Includes share-based compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;year ended December&#160;31, 2023, this decrease is primarily due to:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:17.85pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:17.85pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a decrease of CHF 1.5 million in operating expenses related to a reduction of CHF 0.5 million in our directors&#8217; and officers&#8217; insurance for the period and a reduction across various cost centers,</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">partially offset by:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a CHF 1.0 million increase in salaries and related costs, mostly related to an increase in share-based compensation expense, resulting from the equity awards granted in 2023 to the members of management and employees.</span></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">133</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Other operating income/(expense), net</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">For the&#160;year ended December&#160;31, 2023, other operating income/(expense), net totaled CHF 1.5 million in income compared with CHF 1.3 million in income for the comparable period in 2022. This represents an increase of CHF 0.2 million, which is immaterial. The following table presents the other operating income/(expense) during the&#160;years ended December&#160;31, 2023 and 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:16.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:16.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Change</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other operating income/(expense), net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,486</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,343</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 143</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total other operating income/(expense), net</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,486</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,343</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 143</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Finance result, net</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">For the&#160;year ended December&#160;31, 2023, finance result was a CHF 0.6 million loss compared with a CHF 0.1 million gain for the comparable period in 2022. This represents a decrease of CHF 0.7 million. The following table presents the finance result during the&#160;years ended December&#160;31, 2023 and 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Change</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Financial income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,044</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 69</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 975</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Financial expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (176)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (355)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 179</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exchange differences</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1,467)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 393</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1,860)</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Finance result, net</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (599)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.54%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 107</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (706)</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The change in net finance result of CHF 0.7 million primarily related to:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:17.85pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:17.85pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a CHF 1.9 million decrease explained by unfavorable foreign currency exchange differences related to movement in the CHF versus foreign currencies, predominantly the US Dollar,</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 35.7pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;">partially offset by:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a CHF 1.0 million increase in financial income, combined with a decrease of CHF 0.2 million in financial expense, due to the transition from negative to positive interest rates for our interest-bearing deposit accounts.</span></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">134</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="BLiquidityandcapitalresources_635978"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Liquidity and capital resources</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Cash flows</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Comparison of the&#160;years ended December&#160;31, 2023 and 2022</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table summarizes our cash flows for the periods indicated:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:70.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:17.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Change</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Net cash provided by/ (used in):</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:70.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Operating activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (60,408)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (73,568)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 13,160</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Investing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 65,645</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 23,763</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 41,882</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Financing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 43,250</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1,346)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 44,596</span></p></td></tr><tr><td style="vertical-align:bottom;width:70.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net increase/(decrease) in cash and cash equivalents</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 48,487</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (51,151)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 99,638</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Operating activities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Net cash used in operating activities was CHF 60.4 million for the&#160;year ended December&#160;31, 2023 compared with net cash used in operating activities of CHF 73.6 million for the&#160;year ended December&#160;31, 2022. The change in cash used in operating activities for the&#160;year ended December&#160;31, 2023 was due to (i) the Company&#8217;s reporting a net loss of CHF 54.2 million for the&#160;year ended December&#160;31, 2023 compared with net loss of CHF 70.8 million for the same period in 2022, (ii) an increase of CHF 2.5 million in non-cash adjustments, predominantly driven by an increase of CHF 1.5 million in finance (income)/expense, net, (iii) an increase of CHF 14.8 million in account receivable for the period, which relates to the milestone recognized from Janssen and (iv) an increase of CHF 1.1 million and CHF 0.8 million in accrued expenses and trade and other payables for the period, respectively, compared with a decrease of CHF 6.1 million and CHF 1.1 million in the prior period, respectively, representing cash outflows associated with the timing of certain payments during the period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Investing activities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Net cash provided by investing activities was CHF 65.6 million for the&#160;year ended December&#160;31, 2023 compared with net cash provided by investing activities of CHF 23.8 million for the&#160;year ended December&#160;31, 2022. A net amount of CHF 66.4 million of short-term financial assets matured for the&#160;year ended December&#160;31, 2023, compared to a net maturation of CHF 25.0 million of short-term financial assets in the prior period. Additionally, the Company spent CHF 0.8 million on property, plant and equipment, predominantly to enhance its laboratory and IT equipment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Financing activities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Net cash provided by financing activities was CHF 43.3 million for the&#160;year ended December&#160;31, 2023, compared with net cash used in financing activities of CHF 1.3 million for the&#160;year ended December&#160;31, 2022. The increase of CHF 44.6 million is predominantly related to (i) CHF 41.1 million in net proceeds raised from follow-on offering in 2023 compared to no such activity in 2022 and (ii) CHF 2.7 million received from proceeds from the sale of treasury shares in public offerings, net of underwriting fees and transaction costs compared to a limited activity in 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Operating capital requirements and plan of operations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We do not expect to generate revenues from royalties based on product sales unless and until our collaboration partners or we obtain regulatory approval of, and successfully commercialize, our current or any future product candidates. As of December&#160;31, 2023, we had cash and cash equivalents of CHF 78.5 million and short-term financial assets of CHF 24.6 million, resulting in CHF 103.1 million of liquidity. The decrease of CHF 19.5 million relative to December&#160;31, 2022 was predominantly related to R&amp;D spending on our major discovery and R&amp;D programs, the </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">135</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">strengthening of the Company&#8217;s infrastructure, systems and organization and other operating expenditures. This was partially offset by net proceeds received from the follow-on offering and the sale of treasury shares in 2023. On February 1, 2024, the Company received the milestone payment of CHF 14.8 million due from Janssen for the commencement of first Phase 2b clinical study. We believe that our existing capital resources will be sufficient to meet our projected operating requirements into Q1 2026, assuming potential milestone payment of CHF 24.6 million related to achieving a non-disclosed enrollment target for our ACI-35.030 and no other milestones. There can be no certainty as to the exact timing of future milestone payments, or in fact, whether any of these will ever be made, given that they are contingent on clear milestones being reached.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We expect to generate losses for the foreseeable future, and these losses could increase as we continue product development until we successfully achieve regulatory approvals for our product candidates and begin to commercialize any approved products. We are subject to all the risks pertinent to the development of new products, and we may encounter unforeseen expenses, difficulties, complications, delays and other unknown factors that may harm our business. We anticipate that we will need substantial additional funding in connection with our continuing operations. If we need to raise additional capital to fund our operations and complete our ongoing and planned clinical studies, funding may not be available to us on acceptable terms, or at all.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our future funding requirements will depend on many factors, including but not limited to the following:</p><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';font-size:10pt;">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-size:10pt;">The scope, rate of progress, results and cost of our preclinical and clinical studies and other related activities, according to our long-term strategic plan;</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';font-size:10pt;">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-size:10pt;">The cost of manufacturing clinical supplies and establishing commercial supplies of our product candidates and any other products we may develop;</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';font-size:10pt;">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-size:10pt;">The cost, timing and outcomes of regulatory approvals;</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';font-size:10pt;">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-size:10pt;">The costs and timing of establishing sales, marketing and distribution capabilities;</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';font-size:10pt;">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-size:10pt;">The terms and timing of any collaborative, licensing and other arrangements that we may establish, including any required milestone and royalty payments thereunder;</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';font-size:10pt;">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-size:10pt;">The emergence of competing technologies or other adverse market developments; and</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"/><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-family:'Symbol';font-size:10pt;">&#183;</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><span style="font-size:10pt;">The potential cost and timing of managing, protecting, defending and enforcing our portfolio of intellectual property.</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Contractual obligations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, the Company has been a tenant at our current location in the EPFL Innovation Park since shortly after our inception in 2003. We have entered into long-term rental lease agreements with respect to these facilities. However, our lease agreements are structured such that we can exit these lease agreements without penalty provided we give the owner of our premises sufficient notice. We have capitalized a portion of our lease liabilities in accordance with IFRS 16. See &#8220;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company currently projects CHF 1.1 million in undiscounted short-term lease obligations and CHF 3.0 million in undiscounted long-term lease obligations. Additionally, the Company projects CHF 21.4 million in short-term purchase commitments and CHF 25.8 million in long-term purchase commitments predominantly driven by R&amp;D activities.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">136</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">ATM program</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Commencing in September&#160;2020, the Company established an &#8220;at the market offering&#8221; (ATM) for the sale of up to USD 80.0 (CHF 68.1) million worth of our common shares from time to time by entering into an Open Market Sale Agreement (Sales Agreement) with Jefferies LLC (Jefferies). In Q2 2021, we filed a new registration statement on Form&#160;F-3 and entered into a new Sales Agreement in Q2 2021 to replace and extend the ATM program. To date, the Company has sold 2,149,202 common shares previously held as treasury shares pursuant to the new Sales Agreement, raising USD 16.3 (CHF 14.8) million, net of underwriting fees and transaction costs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Comparison of the&#160;years ended December&#160;31, 2022 and 2021</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For a discussion of the financial results and condition for the fiscal&#160;year ended December&#160;31, 2021, please refer to &#8220;Item&#160;5. Operating and financial review and prospects&#8212;A. Operating results&#8212;Comparison of the&#160;years ended December&#160;31, 2022 and 2021&#8221; of our Annual Report on Form&#160;20-F for the&#160;year ended December&#160;31, 2022 filed on March&#160;16, 2023.</p><a id="CResearchanddevelopmentpatentsandlicense"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Research and development, patents and licenses, etc.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">See &#8220;Item&#160;4. Information on the Company&#8212;B. Business overview&#8221; and &#8220;Item&#160;5. Operating and financial review and prospects&#8212;A. Operating results&#8212;results of operations.&#8221;</p><a id="DTrendinformation_775981"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Trend information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">See &#8220;Item&#160;5. Operating and financial review and prospects.&#8221;</p><a id="ECriticalAccountingEstimates_860985"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">E.</b></span>Critical Accounting Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We prepare our consolidated financial statements in accordance with IFRS as issued by the IASB. See &#8220;Note&#160;3. Summary of material accounting policies&#8221; to our consolidated financial statements for a description of the most significant accounting policies applied in the preparation of our consolidated financial statements.</p><a id="_c4b1dfb9_232e_4405_96ae_9a6777514e14"></a><a id="ITEM6DIRECTORSSENIORMANAGEMENTANDEMPLOYE"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</p><a id="ADirectorsandseniormanagement_124887"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Directors and senior management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Executive Officers, other key employees and board of directors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following table presents information about our executive officers, other key employees, and directors and director nominees, including their ages, as of March&#160;1, 2024. The term of each of our directors is 1&#160;year and, accordingly, will expire at our 2024 annual shareholder meeting to be held in June&#160;2024.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:31.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:46.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th></tr><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:31.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:46.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Initial&#160;year&#160;of&#160;</b></p></th></tr><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:31.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Name</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:46.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Position</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:3.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Age</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">appointment</b></p></th></tr><tr><td style="vertical-align:bottom;width:31.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Executive Officers</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Andrea Pfeifer, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Chief Executive Officer and Director</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">66</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2003</p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Madiha Derouazi, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Chief Scientific Officer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">51</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2024</p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Nuno Mendon&#231;a, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Chief Medical Officer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">42</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2023</p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Piergiorgio Donati</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Chief Technical Operations Officer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">53</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2019</p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Christopher Roberts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Chief Financial Officer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">35</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022</p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Howard Donovan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Chief Human Resources Officer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">49</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2022</p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Jean-Fabien Monin</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Chief Administrative Officer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">53</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2009</p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Other Key Employees</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">137</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:31.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:46.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></th></tr><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:31.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:46.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Initial&#160;year&#160;of&#160;</b></p></th></tr><tr><th style="font-weight:normal;text-align:left;vertical-align:bottom;width:31.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Name</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:46.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Position</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:3.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Age</b></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></th><th style="font-weight:normal;text-align:left;vertical-align:bottom;white-space:nowrap;width:12.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">appointment</b></p></th></tr><tr><td style="vertical-align:bottom;width:31.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Marie Kosco-Vilbois, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Scientific Advisor</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">66</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2024</p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Julien Rong&#232;re, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">SVP Regulatory Affairs and Quality Assurance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">46</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2017</p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Gary Waanders, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">SVP Investor Relations and Corporate Communications</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">60</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2021</p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Olivier Sol, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">VP Head of Clinical Development</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">57</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2016</p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Alexandre Caratsch</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">General Counsel</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">58</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2018</p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Bojana Portmann, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">VP IP and Business Development</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">44</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2011</p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Julian Gray, M.D., Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Clinical Advisor</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">66</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2007</p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Mark Danton</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">SVP Information Systems and Artificial Intelligence</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">60</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2019</p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-Executive Directors</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Douglas Williams, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Chair and Director</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">65</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2018</p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Monika B&#252;tler, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Vice Chair and Director</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">62</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2021</p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Werner Lanthaler, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Director</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">55</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2018</p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Roy Twyman, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Director</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">67</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2019</p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Carl June, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Director</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">70</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2020</p></td></tr><tr><td style="vertical-align:bottom;width:31.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Monica Shaw, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:46.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Director</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:3.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">45</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:12.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">2021</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The current business addresses for our executive officers, other key employees, directors and director nominee is AC Immune SA, EPFL Innovation Park, Building B, 1015 Lausanne, Switzerland.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Executive Officers</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Andrea Pfeifer, Ph.D., Co-Founder, Chief Executive Officer and Director: </b>Andrea Pfeifer co-founded AC Immune SA in 2003, successfully leading it to an IPO in 2016, since when she has served as a Director on the Board. Under her leadership, multiple transformative partnerships have been established with leading pharmaceutical companies, yielding a potential value of up to CHF 3.3 billion plus additional royalties. Before founding the Company, she was the Head of Nestl&#233; Research Centre in Lausanne, Switzerland where she played a major role in connecting science and business. Whilst at Nestl&#233; she led the scientific development of a number of highly innovative, critically acclaimed products from laboratory to market, established the microbiome as a major cross-category product development platform and co-founded the Life Science focused Nestl&#233; Venture Capital Fund. Prior to this she was a Visiting Fellow at the Human Carcinogenesis Branch of The National Institute of Health, Bethesda, USA. She currently serves as the Chair of Investment Fund BioMedInvest, Basel and AB2 Bio SA, Lausanne. Prof. Pfeifer is a Non-Executive Member of the Board of Directors of E.M.S. Electro Medical Systems SA, Nyon, and is a member of the Supervisory Board of Symrise AG, Holzminden, Germany. She is also a key member of the CEOi initiative on Alzheimer&#8217;s Disease and the Davos Alzheimer&#8217;s Collaborative (DAC).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Prof. Pfeifer holds a Ph.D. in Toxicology (Cancer Research) from the University of W&#252;rzburg, Germany and is a registered Toxicologist and Pharmacist. She received her Habilitation from the University of Lausanne, Switzerland and is an Honorary Professor at the Ecole Polytechnique F&#233;d&#233;rale de Lausanne (EPFL).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Madiha Derouazi, Ph.D., Chief Scientific Officer</b>: Dr. Derouazi joined AC Immune SA in January 2024 as Chief Scientific Officer from Speransa Therapeutics where she had been CEO since inception in 2021, leading development of a novel platform of prophylactic vaccines. Previously, she founded AMAL Therapeutics in 2012, an immuno-oncology company developing a new generation of therapeutic cancer vaccines, and served as CEO and CSO of the company until 2022. Dr. Derouazi led AMAL&#8217;s acquisition by Boehringer Ingelheim for EUR 425 million in 2019. She holds a PhD in Cellular Biotechnology from the Swiss Federal Institute of Technology (EPFL) in Lausanne which was followed by postdoctoral work concentrating on tumor immunology and vaccine development.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">Nuno Mendon&#231;a, M.D., Chief Medical Officer: </b>Dr. Nuno Mendon&#231;a joined AC Immune in October 2023 as Chief Medical Officer from Bial where he was SVP, Chief Medical Officer and where he led early and late-stage development </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">138</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">programs across neuroscience and Orphan diseases. He has further managed medical affairs and clinical operations in North America and Europe including increasingly senior roles in Neuroscience with AbbVie in Germany and then in the USA where he was responsible for overall Tau antibody development in Alzheimer&#8217;s and Progressive Supranuclear Palsy followed by leading the late-stage clinical development of Zolgensma for spinal muscular atrophy in the EMEA with Novartis Gene Therapies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A certified Neurologist, he obtained his MD from the University of Coimbra in Portugal and was subsequently appointed as Neurology Consultant at the Centro Hospitalar de Lisboa Central in Lisbon (Portugal). He also completed a Clinical Scholars Research Training program at Harvard Medical School (USA).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Piergiorgio Donati, Chief Technical Operations Officer: </b>Piergiorgio&#160;Donati joined AC Immune in June&#160;2018 as Director, Global Program Management, having previously worked for AC Immune from 2011 to 2015 as Head of Manufacturing and Project Management. Between 2015 and 2018, Mr.&#160;Donati was Head of CMC program development at Glenmark Pharmaceuticals and Biotech CMC Lead at Merck KGaA. Prior to 2011, he held R&amp;D positions at Abiogen, Merck Group and Serono. Mr.&#160;Donati holds a degree in Analytical Chemistry from the Technical Institute G.L. Bernini.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Christopher Roberts, Chief Financial Officer: </b>Christopher Roberts joined AC Immune in 2019 serving in various roles within the Company&#8217;s finance leadership team prior to his promotion in 2022. Previously, Mr. Roberts worked as a Senior Manager for Ernst &amp; Young for more than 10 years and supported the AC Immune IPO. During that time, he served high-growth life science companies in Switzerland, the San Francisco Bay Area, and the UK, focusing on initial and follow-on offerings, SEC reporting, and SOX 404 implementation projects. Mr. Roberts is a Trustee and Treasurer of Msizi Africa, a charity dedicated to sustainably improving the lives of children in Lesotho.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Mr. Roberts is a Chartered Accountant with the Institute of Chartered Accountants in Scotland (ICAS) and holds a Bachelor of Science in Accounting, Auditing and Finance with first class honours from Lancaster University.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Howard Donovan, Chief Human Resources Officer: </b>Howard Donovan joined AC Immune in 2022 and is an internationally experienced, commercially focused leader who has competencies in all aspects of employee services, well-being, benefit design, international mobility, talent management, operations and HR business partnering. He has been at the World Economic Forum since 2015, where he led People Services and was responsible for global reward, employee experience, people insights, strategic sourcing, new office launches, and business partnering with the Board of Directors across its locations in Switzerland, United States, China, Japan and India. Howard previously worked as the inhouse Global Head of Reward for Puma Energy and prior to that he held senior HR leadership roles with a strong reward focus with multinational companies, including SGS Group and Xerox Corporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Jean-Fabien Monin, Chief Administrative Officer:</b> Jean-Fabien&#160;Monin was nominated Chief Administrative Officer in July&#160;2015 following his role as our Chief Financial Officer from March&#160;2009 to July&#160;2015. Prior to AC Immune, he held several positions during his tenure of 14&#160;years at bioM&#233;rieux, a leading international <i style="font-style:italic;">in vitro</i> diagnostics group, culminating in his nomination as Chief Financial Officer. His last position was CFO of bioM&#233;rieux Central Europe based in Vienna, Austria from December&#160;2006 to March&#160;2009. Mr.&#160;Monin holds a Masters in Finance and International Business from the University of Paris-Dauphine, France.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Other key employees</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Marie Kosco-Vilbois, Ph.D., Scientific Advisor</b>: A U.S. citizen, Marie Kosco-Vilbois has extensive experience in the biopharmaceutical industry and served as Chief Scientific Officer of Novimmune since 2005. Prior to joining Novimmune in 2002, Dr. Kosco-Vilbois was Head of Immunology and Preclinical Pharmacology at the Serono Pharmaceutical Research Institute, a Senior Scientist and then Head of Immunology at the Glaxo Wellcome Research Institute in Geneva, and a Scientific Member of the Basel Institute for Immunology. During her career, she has taken numerous biologicals from discovery into preclinical studies and clinical development, most notably filing market applications of a biological for an orphan indication. Dr. Kosco-Vilbois gained her Bachelor&#8217;s Degree in Biology from Rutgers University, New Jersey, U.S., and a PhD in Anatomy and Immunology from the Medical College of Virginia/Virginia Commonwealth University School of Medicine, U.S.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">139</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Julien Rong&#232;re, Ph.D., SVP Regulatory Affairs and Quality Assurance</b>: Julien&#160;Rong&#232;re joined AC Immune in July&#160;2017 as Head of European Regulatory Affairs and Quality Assurance. Prior to joining AC Immune, Dr.&#160;Rong&#232;re held positions of increasing responsibility at Celgene in Switzerland. Most recently, he served as Director, Regulatory Affairs, leading the development of regulatory strategies for small molecules and CAR-T cell therapies and contributed to the development and approval of Revlimid in multiple myeloma and mantle cell lymphoma. Prior to Celgene, Dr.&#160;Rong&#232;re served as a Regulatory Expert at Apoxis, SA in Switzerland. During his career, Dr.&#160;Rong&#232;re gained specific expertise in the development of regulatory strategies for taking products from Phase 1 through to commercialization in the field of hematology/oncology and immunology/inflammation, including fast-to-market approaches, orphan drugs and pediatric development. Dr.&#160;Rong&#232;re gained his Master&#8217;s Degree in Medical Genetics from the University of Aberdeen, UK, and holds a Ph.D. in Molecular Biology from the University of Lausanne, Switzerland.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Gary Waanders, Ph.D., SVP Investor Relations and Corporate Communications</b>: Dr. Gary Waanders joined AC Immune in November 2021 as the Head of Investor Relations and Corporate Communications. Prior to AC Immune he was Head of Investor Relations at Medigene (Munich, Germany) from mid-2019. Before these roles, he worked from 2001 until 2019 as a Life Sciences Equity analyst for several Investment Banks based in London, UK, including Nomura Code Securities, KBC Peel Hunt, and Bryan, Garnier &amp; Co. He obtained a Ph.D. in Immunology from Monash University in Melbourne, Australia, and worked as a postdoctoral fellow at the Ludwig Institute for Cancer Research in Lausanne, Switzerland. He gained an MBA with distinction from the University of Durham Business School in the UK.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Oliver Sol, M.D., VP Head of Clinical Development</b>: Prior to joining AC Immune,&#160;Olivier Sol was Clinical Director of Exonhit (Paris) and thereafter Medical&#160;&amp; Regulatory Affairs Director for Diaxonhit, where he was responsible for the development and medical validation of <i style="font-style:italic;">in vitro</i> diagnostic products in cancer, infectious diseases and Alzheimer&#8217;s disease. Dr.&#160;Sol spent his over 20-year career as a Medical Expert in several therapeutic areas with a strong focus on central nervous system diseases, within pharmaceutical companies as Janssen, UCB-Pharma, GlaxoSmithKline and Sanofi. He contributed to the clinical development of currently marketed drugs in epilepsy (topiramate and levetiracetam) and galantamine in Alzheimer&#8217;s disease. He has also gained significant experience in the field of biological biomarkers. Dr.&#160;Sol holds an M.D. from the Paris-Sud University (Paris-Saclay) with a specialization in Medical Biology.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Alexandre Caratsch, General Counsel</b>:<b style="font-weight:bold;"> </b>Alexandre Caratsch is a Swiss-qualified attorney with 30&#160;years&#8217; experience in private practice, multinational companies and in ventures. He initially worked as an in-house lawyer for E&amp;Y and the SGS Group before specializing in healthcare, holding senior legal positions at Novartis and Medtronic. Before joining AC Immune, he led the Corporate Legal Affairs and Intellectual Property group for Medtronic&#8217;s Europe, Middle East and Africa (EMEA) region. Mr.&#160;Caratsch has also co-founded two start-up companies in the field of information technology and medical technology, respectively, and has supported other start-up companies with strategic, transactional and general counsel. Mr.&#160;Caratsch holds a Master&#8217;s degree in Law from the University of Neuch&#226;tel, Switzerland and is admitted to the Bar of Geneva, Switzerland.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Bojana Portmann, Ph.D., VP IP and Business Development</b>: Bojana&#160;Portmann joined AC Immune in 2011 as Intellectual Property Manager and has held multiple roles within the IP department with increasing responsibility over the past&#160;years, during which her work was mainly focused on creating and strengthening patent portfolios for biologicals, small molecules and liposomal technology. Dr.&#160;Portmann holds a Ph.D. degree from the EPFL University in Switzerland, and a LL.M. degree, Master of Intellectual Property Law and Management (MIPLM), from the CEIPI in France. She also received a M.Sc. (Dipl. Ing.) degree in Polymer and Chemical Engineering from the University of Belgrade in Serbia.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">Julian Gray, M.D., Ph.D., Clinical Advisor</b>: Julian&#160;Gray has served as Clinical Advisor to our programs in neurodegenerative diseases since January&#160;2007 and works in this function exclusively for AC Immune. He has previously held the position of Head of CNS Therapeutics at Eisai Ltd in London leading the global development of early and late-stage CNS projects in Alzheimer&#8217;s disease, Parkinson&#8217;s disease and other CNS areas. Prior to this he served as Head of Alzheimer Clinical Research at Hoffmann-La Roche in Basel where he conducted large-scale clinical trials in the U.S. and Europe. After his studies he was Medical Expert at Sandoz Pharmaceuticals in Basel undertaking clinical studies of different compounds in dementia and Parkinson&#8217;s disease. Dr.&#160;Gray holds the title of a Specialist in </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">140</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Pharmaceutical Medicine (Switzerland). He received his medical degree (MBBS) from the University of London, a B.A. and Ph.D. from the University of Oxford and an MBA from Oxford Brookes University.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Mark Danton, SVP Information Systems and Artificial Intelligence</b>:&#160;Mark Danton is a globally recognized and experienced executive in Information Systems/Information Technology (IS/IT) with extensive experience in developing, launching and managing business-relevant IS, cybersecurity and digital technology solutions and services.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Prior to joining AC Immune, Mr.&#160;Danton served as IS/IT Global Manager at Nestl&#233; and held a number of global roles at BT Global Services and in Dimension Data&#160;PLC. Mr.&#160;Danton holds an Executive MBA from the Business School Lausanne, graduating&#160;cum laude&#160;and as the Executive MBA Student of the&#160;Year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Non-Executive Directors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Douglas Williams, Ph.D., Chair and Director: </b>Douglas E. Williams is currently the President of Research and Development at Sana Biotechnology. He was previously CEO of Codiak BioSciences, prior to which he was Biogen&#8217;s Executive Vice President, Research and Development, serving in this role from January 2011 to July 2015. He joined Biogen from ZymoGenetics, where he was most recently CEO and member of the Board of Directors. ZymoGenetics was purchased for $985 million by Bristol Myers Squibb during Dr. Williams&#8217; tenure. Previously, he held leadership positions within the biotechnology industry, including Chief Scientific Officer and Executive Vice President of Research and Development at Seattle Genetics, and Senior Vice President and Washington Site Leader at Amgen. Dr. Williams served in a series of scientific and senior leadership positions over a decade at Immunex, including Executive Vice President and Chief Technology Officer and a member of the Board of Directors. During his 30+ year career in the biotechnology industry he has played a role in the development of several novel drugs including Enbrel, Tecfidera, and Spinraza. He has served on the board of numerous biotechnology companies and is currently Chair of the Board of AC Immune.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Monika B&#252;tler, Ph.D., Vice Chair and Director: </b><span style="white-space:pre-wrap;">Monika B&#252;tler is a leading Swiss economist and former Vice President of the independent Swiss Covid-19 Science Taskforce. She is a member of the Board of Directors and of the audit committees of both Schindler Holding AG and Swiss Life Holding AG.  Prof. B&#252;tler is also a member of the Board of Directors of Huber+Suhner Ltd, where she chairs the nomination and remuneration committee. Her international economic expertise is in public policy and managerial economics, including an advisory role to the World Bank and visiting appointments in the U.S., Australia and Europe. Prof. B&#252;tler is a Vice President of the Foundation Board of the Gebert R&#252;f Foundation, a science and innovation foundation that supports entrepreneurial projects which are committed to achieving an impact.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Prof. B&#252;tler holds a Doctorate in Economics from the University of St. Gallen, a Doctorate Honoris Causa from the University of Lucerne, and a Diploma in Mathematics/Physics from the University of Zurich.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Werner Lanthaler, Ph.D., Director:</b>&#160;Werner Lanthaler is the managing director of W.Lan Holding GmbH, an advisory and investment firm. Up to January 2024, he was the CEO of Evotec AG, a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. Dr. Lanthaler focused the company on collaborating with biotech and pharma companies and academia, supporting biotech innovation. He previously served as Chief Financial Officer at Intercell AG where he played a key role in many of that company&#8217;s major milestones. During his tenure, Intercell undertook an IPO and developed from a venture-backed biotechnology company into a global vaccine player. Dr. Lanthaler has also served as Director of the Federation of Austrian Industry, and from 1995 to 1998 was a Senior Management Consultant at McKinsey &amp; Company. Dr. Lanthaler is a Non-Executive Member of the Board of Directors of arGEN-X and is a member of the Supervisory Board of Topas Therapeutics GmbH. He holds a Doctorate in Economics from Vienna University, a Master&#8217;s degree in Business Administration from Harvard University, and a degree in Psychology.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">Roy Twyman, M.D., Director</b>: Roy&#160;Twyman is a Neurologist and is founder and current CEO of Amron Neuroscience, LLC, a private consulting company focused on neuroscience drug development. Prior to this, Dr.&#160;Twyman spent almost 20&#160;years at Janssen Research&#160;&amp; Development, LLC (a Johnson&#160;&amp; Johnson company) and was </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">141</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">a member of the Neuroscience Therapeutic Area Leadership team responsible for clinical R&amp;D and strategic planning of CNS neurology and psychiatry pipeline products. From 2012 to March&#160;2018, Dr.&#160;Twyman was a Senior Vice President in the Neuroscience Therapeutic Area overseeing the Alzheimer&#8217;s Disease Area. He currently participates as an independent Board Member or as a Scientific Advisory Board Member for a number of small biotech or pharmaceutical companies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Carl June, M.D., Director: </b>Carl June&#160;is Richard W. Vague Professor in Immunotherapy, Director of the Center for Cellular Immunotherapies and Director of the Parker Institute for Cancer Immunotherapy at the Perelman School of Medicine at the University of Pennsylvania. Due to his lifelong work on lymphocyte activation, Prof. June&#160;is considered a world authority on mechanisms related to immune tolerance and adoptive immunotherapy in the fields of chronic inflammation and cancer. He and his team pioneered the groundbreaking work in immunotherapy in which patients with refractory and relapsed chronic lymphocytic leukemia are treated with genetically engineered versions of their own T cells. This CAR-T therapy approach, which trains the immune system to attack and destroy cancer cells, has opened a new era of innovative treatments and personalized medicine for cancer patients.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Prof. June&#160;is a graduate of the Naval Academy in Annapolis, USA, and Baylor College of Medicine in Houston, USA, where he received his medical degree. Prof. June&#160;also completed graduate training in immunology and malaria with Dr.&#160;Paul-Henri Lambert at the World Health Organization, Geneva, Switzerland, and post-doctoral training in transplantation biology with E. Donnell Thomas and John Hansen at the Fred Hutchinson Cancer Research Center in Seattle, USA. He has published more than 500 manuscripts and is the recipient of numerous honors and prizes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Monica Shaw, M.D., Director: </b>Monica Shaw is a pharmaceutical industry expert who has held senior leadership positions and was involved in advancing more than 15 therapeutic products from first-in-human studies through regulatory approvals and commercialization across multiple geographies. She also played key business development roles in company acquisition and integration and co-development partnerships. Through her work, Dr. Shaw gained extensive specialty experience in the fields of dermatology, immuno-inflammation, HIV, neurology, and oncology.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Currently, Dr. Shaw is Senior Vice President, Head of Major Markets at Bristol Myers Squibb. Prior to this she was CEO for Oncopeptides a Swedish listed biotech company and before that, Executive Vice President Head Region Europe, Canada, Australia, for Leo Pharma. In addition, she has previously held broad leadership roles at other leading pharmaceutical companies, including as Vice President Commercial Head Asia Pacific region at GSK/ViiV Healthcare, and Medical Director and Chief Scientific Officer UK for Novartis, in addition to previous leadership positions at Norgine, Shire and Merck KGaA.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Monica Shaw holds an M.D. from the University of Oxford Medical School and is a Member of the Royal College of Physicians.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Family Relationships</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">None of our directors or executive officers has a family relationship as defined in Item&#160;401 of Regulation S-K.</p><a id="BCompensation_249678"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Compensation of directors and executive officers</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;year ended December&#160;31, 2023, the aggregate compensation accrued or paid to the members of our board of directors and our executive officers for services in all capacities was CHF 8.6 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">During the&#160;year ended December&#160;31, 2023, the total fair value of equity awards granted to directors and executive officers was CHF 3.5 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The amount set aside or accrued by us to provide pension, retirement or similar benefits to members of our board of directors and executive officers amounted to a total of CHF 0.4 million in the&#160;year ended December&#160;31, 2023.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">142</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We incorporate by reference into this Annual Report the information contained in the section &#8220;Directors and Executive Management Compensation Report&#8221; under &#8220;Item&#160;2. C&#8212;2023 and 2022 Board Compensation&#8221; and &#8220;Item&#160;3. C&#8212;2023 and 2022 Executive Compensation&#8221; of Exhibit&#160;99.2 to our report on Form&#160;6-K filed with the SEC on March 14, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Equity incentive plans</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In 2016, we ceased issuing new grants under our prior equity incentive plans, which we refer to as the Prior Plans, and adopted a new omnibus equity incentive plan under which we have the discretion to grant a broad range of equity-based awards to eligible participants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Prior plan: C1</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Since our inception in 2003, we have had four separate Prior Plans under which stock options were granted (Prior Plans A, B and C2 have terminated): Options granted under Plan C1 from 2013 through the adoption of the current 2016 Stock Option and Incentive Plan (SOIP) were taxed upon exercise instead of at grant due to a change in taxation rules.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Plan administration</i>. Under Plan C1, an option, which can only be granted with the approval of our board of directors, is evidenced by an option agreement signed by the participant to indicate his or her acceptance of the option and is subject to the terms and conditions of the applicable Prior Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Eligibility</i>. Under Plan C1, options were granted to our directors, employees, advisors and agents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Options exercise price</i>. The exercise price of all options issued under the Prior Plan is CHF 0.15.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0.15pt;margin:0pt 0pt 12pt 17.85pt;"><i style="font-style:italic;">Vesting period</i>. Under Plan C1, the options vesting period was 4&#160;years with 25% of the options vesting each&#160;year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Expiration period. </i>The expiry dates for each plan are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Plan C1: 10&#160;years</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Amendment</i>. Our board of directors has the authority to amend each of the Prior Plans.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">2016 SOIP</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At the November&#160;15, 2016 AGM of the Company, our board of directors approved the 2016 SOIP (as amended and restated the &#8220;2016 SOIP&#8221;). In June 2019, the Board authorized, and the shareholders approved, an amendment and restatement of the 2016 SOIP to increase the maximum number of shares reserved for issuance under the 2016 SOIP. In October 2019, the Board authorized a second amendment and restatement of the 2016 SOIP (which did not require shareholder approval). As of December 31, 2023, the maximum number of shares available for issuance under the 2016 SOIP is 4,689,750 common shares.&#160;The shares available for issuance under the 2016 SOIP were initially registered with the SEC on a Form&#160;S-8 on March&#160;8, 2017, and additional shares were registered on a Form&#160;S-8 on August&#160;5, 2019. As of December&#160;31, 2023, there were a total of 3,022,345 shares underlying options that were exercisable and 4,949,177 shares underlying outstanding options and 1,003,743 shares underlying outstanding restricted share units issued from both our Prior Plans and the 2016 SOIP.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Plan Administration</i>. The 2016 SOIP is administered by either our board of directors or the compensation committee, or a similar committee performing the functions of the compensation committee. Approval of the plan administrator is required for all grants of awards under the 2016 SOIP, but the administrator may delegate to our CEO the authority to grant awards, subject to certain limitations set forth on the plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Awards. </i>Awards may be granted in the form of incentive stock options, non-qualified stock options, stock appreciation rights, restricted share units, restricted share awards, unrestricted share awards, performance share awards and dividend equivalent rights.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">143</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Eligibility. </i>Under the 2016 SOIP, full or part-time officers and other employees, non-employee directors and consultants of the Company and its subsidiaries who are selected by the administrator are eligible to participate in the plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Options exercise price. </i>Under the 2016 SOIP, the option exercise price is determined by the plan administrator at the time of grant, but will not be less than fair market value (as defined in the 2016 SOIP) on the grant date, and for incentive stock options granted to any employee who is a 10&#160;percent owner in the Company, will not be less than 110&#160;percent of the fair market value on the grant date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Vesting period. </i>Vesting conditions are determined by the administrator at the time of grant and are specified in the applicable award certificate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Accelerated vesting. </i>The administrator may accelerate the exercisability or vesting of all or any portion of any award in circumstances involving the grantee&#8217;s death, disability, retirement or termination of employment, or a change in control.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Amendment</i>. Our board of directors has the authority to amend the 2016 SOIP.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Equity compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the fiscal&#160;year ended December&#160;31, 2023, the Company has granted our directors and executive officers, in the aggregate, options for the right to acquire 1,554,281 shares at an exercise price ranging from USD 2.03 to USD 3.11 per share, which vest either over a 1&#160;year or 3&#160;year period with vesting to occur quarterly or annually depending on the nature of the award. The expiration date for these options granted in 2023 is 2033. The Company also granted to our directors and executive officers a total of 736,435 restricted share units in 2023. Restricted share units granted to directors vest over a 1&#160;year period with vesting to occur annually. Restricted share units granted to executive officers vest over a 3 year period with vesting to occur quarterly or semi-annually. Please see &#8220;Note&#160;19. Share-based compensation&#8221; for further detail.</p><a id="CBoardpractices_883818"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Board practices</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Composition of board of directors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our board of directors is composed of seven directors. Each director is elected for a 1-year renewable term, no later than the next Annual General Meeting (AGM). The current members of our board of directors were appointed at shareholders&#8217; meetings held on June&#160;23, 2023 to serve until the 2024 AGM to be held in June&#160;2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are a foreign private issuer. As a result, in accordance with the Nasdaq stock exchange listing requirements, we rely on home country governance requirements and certain exemptions thereunder rather than relying on the stock exchange corporate governance requirements. For an overview of our corporate governance principles, see &#8220;Item&#160;16G. Corporate governance.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Board meetings</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our Board of Directors met in accordance with their respective mandate both physically, by video-conference and telephonically throughout 2023. The Board members analyzed the scientific, business, financial, organizational and legal risks of the Company based on the external factors and internal changes that could potentially impact the risks for the Company in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Director independence</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">As a foreign private issuer, under the listing requirements and rules&#160;of Nasdaq, we are not required to have independent directors on our board of directors, except to the extent that our audit and finance committee is required to comply with independence requirements, subject to certain phase-in schedules. However, our board of directors has </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">144</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">determined that, under current listing requirements and rules&#160;of Nasdaq (which we are not subject to) and considering any applicable committee independence standards, Douglas Williams, Werner Lanthaler, Roy Twyman, Carl June, Monika B&#252;tler and Monica Shaw are &#8220;independent directors.&#8221; In making such determination, our board of directors considered the relationships that each non-employee director has with us and all other facts and circumstances our board of directors deemed relevant in determining the director&#8217;s independence, including the number of common shares beneficially owned by the director and his or her affiliated entities, if any.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Committees of the board of directors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our board of directors established two separate permanent committees: an audit and finance committee and a compensation, nomination and corporate governance committee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Audit and finance committee</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The audit and finance committee, which consists of Monika B&#252;tler (Chair), Monica Shaw (Member), and Douglas Williams (Member), assists our board of directors in overseeing our accounting and financial reporting processes and the audits of our consolidated financial statements. In addition, the audit and finance committee is directly responsible for the appointment, compensation, retention and oversight of the work of our independent registered public accounting firm. The audit and finance committee consists exclusively of members of our board who are financially literate, and Monika B&#252;tler is considered to be &#8220;audit committee financial expert&#8221; as defined by the SEC. Our board of directors has determined that Monika B&#252;tler, Monica Shaw and Douglas Williams satisfy the &#8220;independence&#8221; requirements set forth in Rule&#160;10A-3 under the Exchange Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The audit and finance committee is governed by a charter that complies with Nasdaq rules. The audit and finance committee has the responsibility to, among other things:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">review and assess the qualifications, independence, performance and effectiveness of the independent auditor;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">review the scope of the prospective audit by the independent auditor, the estimated fees, and any other matters pertaining to the audit;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">approve any audit and non-audit services proposed to be provided by the independent auditor to ensure independent auditor independence;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">review and assess the independent auditor&#8217;s report and management letters and take notice of all comments of the independent auditor on accounting procedures and systems of control, and review the independent auditor&#8217;s reports with management;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">be responsible for the resolution of disagreements between the management and the independent auditor;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">review and evaluate the lead audit partner of the independent audit team and confirm and evaluate their rotation;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">review and discuss all (i)&#160;consolidated financial statements, (ii)&#160;reports intended for publication and (iii)&#160;any other financial statements intended for publication to consider significant financial reporting issues and judgments made in connection with the preparation of our consolidated financial statements, including any significant changes in our selection or application of accounting principles;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">approve the quarterly condensed consolidated financial statements;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">review with the management, personnel responsible for the design and implementation of the internal audit function, and the independent auditor in separate meetings any analysis or other written communication prepared by the management and/or the independent auditor setting forth significant financial reporting issues </span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">145</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"/><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">and judgments made in connection with the preparation of the consolidated financial statements, including critical accounting policies, the effect of regulatory and accounting initiatives, and off-balance sheet transactions and structures on our consolidated financial statements;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">review in cooperation with the independent auditor and the management whether the accounting principles applied are appropriate in view of our size and complexity;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">periodically review our policies and procedures for risk management and assess the effectiveness thereof, including discussing with management our major financial risk exposures and the steps that have been taken to monitor and control such exposure;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">discuss with management and external advisors any legal matters that may have a material impact on our consolidated financial statements and any material reports or inquiries from regulatory or governmental agencies that could materially impact our contingent liabilities and risks;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">review our disclosure controls and procedures and internal control over financial reporting, including significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">establish procedures for the receipt, retention and treatment of complaints received regarding accounting, internal accounting controls or auditing matters, and the confidential, anonymous submission by employees of concerns regarding questionable accounting or auditing matters; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">review and approve or ratify any related-person transaction in accordance with our related-person transaction policy.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The audit and finance committee will meet as often as it determines is appropriate to carry out its responsibilities, but in any event will meet at least four times per&#160;year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Compensation, nomination and corporate governance committee</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The compensation, nomination and corporate governance committee, consists of Monika B&#252;tler (Chair), Douglas Williams (Member) and Roy Twyman (Member).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The compensation, nomination and corporate governance committee is governed by a charter that complies with SEC and home country governance rules. The compensation, nomination and corporate governance committee has the responsibility to, among other things:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">recommend to the board the guidelines for the overall compensation and equity awards for the board of directors and executive officers along with the rationale for such recommendations;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">recommend to the board the compensation of executive officers;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">propose the maximum total compensation of the board of directors and executive officers for approval at the Annual General Meeting;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">periodically review policies and principles for the Company&#8217;s corporate governance;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">establish the process for assessment of the performance of members of the board, its committees and individual members;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">prepare and review the Company&#8217;s succession plan for members of the board and the executive committee;</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">146</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">periodically review the Company&#8217;s code of conduct and recommends changes as needed;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">recommend for presentation to our shareholders the compensation report for shareholder vote; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">define guidelines for the selection of candidates for election or re-election as members of the board and our executive officers.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">administer the Compensation Recoupment Policy.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Swiss law requires that we adopt a compensation committee, so in accordance with Nasdaq Listing Rule&#160;5615(a)(3), we will follow home country requirements with respect to the compensation, nomination and corporate governance committee. As a result, our practice will vary from the requirements of Nasdaq Listing Rule&#160;5605(d), which sets forth certain requirements as to the responsibilities, composition and independence of compensation committees, and from the independent director oversight of director nomination requirements of Nasdaq Listing Rule&#160;5605(e). We are subject to the Swiss Executive Compensation (Say on Pay) Rule as enforced in the Code of Obligations. In addition, this committee will also be responsible for director and board committee nominations as well as reviewing and amending, if required, our corporate governance framework and guidelines.</p><a id="DEmployees_312467"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Employees</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2023, we employed 161 employees, 28 of whom were part-time employees. 75 of our employees hold Ph.D. degrees and 59 hold M.Sc. degrees. Our 161 employees are from 28 countries. The average number of employees (calculated on full-time equivalents) in 2023 was 144. As of December&#160;31, 2022 and 2021 we had 156 and 143 employees, respectively. We have never had a work stoppage, and none of our employees is represented by a labor organization or under any collective-bargaining arrangements. We consider our employee relations to be good.</p><a id="EShareownership_36027"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">E.</b></span>Share ownership</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">See &#8220;Item&#160;7. Major shareholders and related-party transactions&#8212;A. Major shareholders.&#8221;</p><a id="Item6F"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">F.</b></span>Disclosure of a Registrant&#8217;s Action to Recover Erroneously Awarded Compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"></span><span style="font-size:10pt;">Not applicable.</span></p><a id="_72b2c0be_a987_4981_8956_98cd4ef69095"></a><a id="ITEM7MAJORSHAREHOLDERSANDRELATEDPARTYTRA"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 10pt 0pt;">ITEM&#160;7. MAJOR SHAREHOLDERS AND RELATED-PARTY TRANSACTIONS</p><a id="AMajorshareholders_980950"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 10pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Major shareholders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">The following table presents information relating to the beneficial ownership of our common shares as of the date of this Annual Report by:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">each person, or group of affiliated persons, known by us to own beneficially 5% or more of our outstanding common shares;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">each of our executive officers and directors; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">all executive officers and directors as a group.</span></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The number of common shares beneficially owned by each entity, person, executive officer or director is determined in accordance with the rules&#160;of the SEC, and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any common shares over which the individual has sole or shared voting power or investment power as well as any common shares that the individual has the right to acquire within 60&#160;days of March&#160;1, 2024 through the exercise of any option, warrant or other right. Except as otherwise </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">147</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 10pt 0pt;">indicated, and subject to applicable community property laws, the persons named in the table have sole voting and investment power with respect to all common shares held by that person.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The&#160;percentage of outstanding common shares is computed on the basis of 99,197,829 common shares outstanding as of March&#160;1, 2024. Common shares that a person has the right to acquire within 60&#160;days of March&#160;1, 2024 are deemed outstanding for purposes of computing the&#160;percentage ownership of the person holding such rights, but are not deemed outstanding for purposes of computing the&#160;percentage ownership of any other person, except with respect to the&#160;percentage ownership of all executive officers and directors as a group. Unless otherwise indicated below, the address for each beneficial owner is AC Immune, EPFL Innovation Park, Building B, 1015 Lausanne, Switzerland.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares&#160;beneficially</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shareholder</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">owned&#160;(%)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:69.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">5% Shareholders</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">dievini Hopp BioTech holding GmbH &amp; Co KG<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">1</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 16,316,742</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 16.4</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Biotechnology Value Fund (BVF) Inc.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">2</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 14,571,236</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 14.7</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Varuma AG<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">3</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 11,999,999</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 12.1</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Affiris AG<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">4</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 6,578,100</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 6.6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Executive Officers and Directors</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Andrea Pfeifer<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">5</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,466,526</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3.5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Madiha Derouazi<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">6</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Nuno Mendon&#231;a<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">7</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Piergiorgio Donati<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">8</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Christopher Roberts<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">9</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Howard Donovan<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">10</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Jean-Fabien Monin<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">11</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Douglas Williams<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">12</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Monika B&#252;tler<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">13</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Werner Lanthaler<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">14</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Roy Twyman<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">15</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Carl June<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">16</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Monica Shaw<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">17</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">All executive officers and directors as a group (13 persons)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4,850,665</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4.9</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;">*</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;">Indicates beneficial ownership of less than 1% of the total issued and outstanding common shares.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">1</sup><span style="white-space:pre-wrap;">Based on information set form in a Schedule 13G/A filed with the SEC by dievini Hopp BioTech holding GmbH &amp; Co KG (&#8220;dievini&#8221;) on February 10, 2023. These shares consist of 16,316,742 shares held by dievini.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;">DH-Capital GmbH &amp; Co. KG (&#8220;DH-Capital&#8221;) and OH Beteiligungen GmbH &amp; Co. KG (&#8220;OH Beteiligungen&#8221;) are collectively the holders of 100% of the limited partner interest in dievini and therefore, control the voting and dispositive decisions of dievini together and may be deemed to beneficially own the shares held by dievini. Dietmar Hopp, Oliver Hopp and Daniel Hopp are the ultimate controlling persons of dievini, DH-Capital and OH Beteiligungen, and control the voting and investment decisions of the ultimate parent company of dievini and therefore, may be deemed to beneficially own the shares held by dievini by virtue of their status as controlling persons of dievini.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;">The address of the principal business office of dievini and Dietmar Hopp is c/o dievini Hopp BioTech holding GmbH &amp; Co. KG, Johann-Jakob-Astor Stra&#223;e 57, 69190 Walldorf, Germany. The address of the principal business office of DH-Capital GmbH &amp; Co. KG and OH Beteiligungen GmbH &amp; Co. KG is Opelstra&#223;e 28, 68789 St. Leon-Rot, Germany. The address of the principal business office of Oliver Hopp is Johann-Jakob-Astor-Stra&#223;e 59, 69190 Walldorf, Germany. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">2</sup>Based on information set forth in a Schedule 13G/A filed with the SEC by BVF on December&#160;19, 2023, these shares consist of 14,571,236 shares held of record by BVF&#160;Inc. The address of BVF&#160;Inc. is 44 Montgomery St., 40<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> Floor, San Francisco, California 94104.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">148</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">3</sup>Represents 11,999,999 shares held by Varuma AG set forth in a Schedule 13G/A filed with the SEC on February&#160;12, 2019. The address for Varuma AG is Aeschenvorstadt 55, CH-4051 Basel, Switzerland. Rudolf Maag controls the voting and investment decisions of Varuma AG.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">4</sup>Based on information set forth in a Schedule 13G/A filed with the SEC by Affiris AG on February 19, 2024, these shares consist of 6,578,100 shares held of record by Affiris AG. The address of Affiris AG is Karl-Farkas-Gasse 22, 1030 Vienna, Austria.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">5</sup>Consists of 2,421,226 of our common shares and options to purchase 1,045,300 of our common shares exercisable within 60 days of March 1, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">6</sup>Consists of 3,175 of our common shares and no options to purchase our common shares exercisable within 60 days of March 1, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">7</sup>Consists of 8,225 of our common shares and options to purchase 8,286 of our common shares exercisable within 60 days of March 1, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">8</sup>Consists of 24,521 of our common shares and options to purchase 141,131 of our common shares exercisable within 60 days of March 1, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">9</sup>Consists of 12,601 of our common shares and options to purchase 26,737 of our common shares exercisable within 60 days of March 1, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">10</sup>Consists of 20,136 of our common shares and options to purchase 40,902 of our common shares exercisable within 60 days of March 1, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">11</sup>Consists of 311,950 of our common shares and options to purchase 129,986 of our common shares exercisable within 60 days of March 1, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">12</sup>Consists of 38,929 of our common shares and options to purchase 86,980 of our common shares exercisable within 60 days of March 1, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">13</sup>Consists of 9,150 of our common shares and options to purchase 59,514 of our common shares exercisable within 60 days of March 1, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">14</sup>Consists of 123,184 of our common shares and options to purchase 70,533 of our common shares exercisable within 60 days of March 1, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">15</sup>Consists of 34,150 of our common shares and options to purchase 88,715 of our common shares exercisable within 60 days of March 1, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">16</sup>Consists of 9,150 of our common shares and options to purchase 67,520 of our common shares exercisable within 60 days of March 1, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">17</sup>Consists of 9,150 of our common shares and options to purchase 59,514 of our common shares exercisable within 60 days of March 1, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Holders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of March&#160;1, 2024, we had approximately 250 shareholders of record of our common shares. The actual number of stockholders is greater than this number of record holders and includes stockholders who are beneficial owners but whose shares are held in street name by brokers and other nominees. This number of holders of record also does not include stockholders whose shares may be held in trust or by other entities.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">149</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Significant changes in ownership by major shareholders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have experienced significant changes in the&#160;percentage ownership held by major shareholders as a result of our IPO. Prior to our IPO in September&#160;2016, our principal shareholders were dievini Hopp BioTech holding GmbH&#160;&amp; Co KG and Varuma AG, which held shares representing 36.5% and 23.1%, respectively. As of March&#160;1, 2024, dievini Hopp BioTech holding GmbH &amp; Co KG and Varuma AG held 16.4% and 12.1% of our outstanding common shares, respectively. BVF&#160;Inc. increased its holdings from 8.5% to 14.7% of our outstanding common shares as part of the follow-on offering. Affiris became major shareholder in 2021 and owns 6.6% of our outstanding common shares as of March 1, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In September&#160;2016, we completed our IPO and listed our common shares on the Nasdaq Global Market. In the IPO, we issued and sold 6,900,000 common shares, including 900,000 common shares sold to the underwriters pursuant to the underwriters&#8217; over-allotment option. While none of our existing shareholders sold common shares in the IPO, the&#160;percentage ownership held by certain shareholders decreased as a result of the issuance of the common shares sold by us in the IPO.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In July&#160;2018, we completed three offerings of our common shares. In these offerings, we issued and sold 10,000,000 common shares, including 1,108,695 sold to the underwriters pursuant to the underwriters&#8217; over-allotment option. The&#160;percentage ownership held by certain shareholders decreased as a result of the issuance of the common shares sold by us in these offerings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In December 2023, we completed an offering of our common shares. In this offering, we issued and sold 14,300,000 common shares to the underwriters pursuant to the underwriters&#8217; agreement. The&#160;percentage ownership held by certain shareholders decreased as a result of the issuance of the common shares sold by us in this offering.</p><a id="BRelatedpartytransactions_285369"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Related-party transactions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">None.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Indemnification of directors and executive management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our Articles of Association require us to indemnify our executive officers and directors to the fullest extent permitted by law. We entered into indemnification agreements with our executive officers and directors.</p><a id="CInterestsofexpertsandcounsel_884840"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Interests of experts and counsel</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="_83e4b1fc_1af7_45ef_b4b4_dc325113f66e"></a><a id="ITEM8FINANCIALINFORMATION_353349"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;8. FINANCIAL INFORMATION</p><a id="AConsolidatedstatementsandotherfinancial"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Consolidated statements and other financial information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Financial statements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">See &#8220;Item&#160;18. Financial statements,&#8221; which contains our consolidated financial statements prepared in accordance with IFRS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Legal proceedings</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">From time to time we may become involved in legal proceedings that arise in the ordinary course of business. As of the date of this Annual Report, we have not been a party to or paid any damages in connection with litigation that has had a material adverse effect on our financial position. No assurance can be given that future litigation will not have a material adverse effect on our financial position. When appropriate in the executive management&#8217;s estimation, we may record reserves in our consolidated financial statements for pending litigation and other claims.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">150</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Dividends and dividend policy</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have never declared or distributed dividends on our capital stock. We intend to retain all available funds and any future earnings, if any, to fund the development and expansion of our business and we do not anticipate distributing any dividends in the foreseeable future. Any future determination related to dividend policy will be made at the discretion of our board of directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under Swiss law, any dividend must be approved by our shareholders. In addition, our auditors must confirm that the dividend proposal of our board of directors conforms to Swiss statutory law and our articles of incorporation. A Swiss corporation may pay dividends only if it has sufficient distributable profits brought forward from the previous business years (<i style="font-style:italic;">report des b&#233;n&#233;fices</i>) or if it has distributable reserves (<i style="font-style:italic;">r&#233;serves &#224; libre disposition</i>), each as evidenced by its audited standalone statutory balance sheet prepared pursuant to Swiss law and after allocations to reserves required by Swiss law and its articles of association have been deducted. Distributable reserves are generally booked either as &#8220;free reserves&#8221; (<i style="font-style:italic;">r&#233;serves libres</i>) or as &#8220;reserve from capital contributions&#8221; (<i style="font-style:italic;">apports de capital</i>). Distributions out of nominal share capital, which is the aggregate nominal value of a corporation&#8217;s issued shares, may be made only by way of a share capital reduction.</p><a id="BSignificantchanges_559132"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Significant changes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A discussion of the significant changes in our business can be found under &#8220;Item&#160;4. Information on the Company&#8212;A. History and development of the Company&#8221; and &#8220;Item&#160;4. Information on the Company&#8212;B. Business overview.&#8221;</p><a id="_5794f9d3_5148_4346_85b2_6af129302314"></a><a id="ITEM9THEOFFERANDLISTING_667173"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;9. THE OFFER AND LISTING</p><a id="AOfferingandlistingdetails_815430"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Offering and listing details</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">See &#8220;Item&#160;9&#8211;C. Markets&#8221; below.</p><a id="BPlanofdistribution_857538"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Plan of distribution</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="CMarkets_858091"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Markets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our common shares trade on the Nasdaq Global Market under the symbol &#8220;ACIU.&#8221;</p><a id="DSellingshareholders_381670"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Selling shareholders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="EDilution_693805"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">E.</b></span>Dilution</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="FExpensesoftheissue_68420"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">F.</b></span>Expenses of the issue</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="_d9e864d2_7c53_4bfd_a932_3ef83773bc08"></a><a id="ITEM10ADDITIONALINFORMATION_834727"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;10. ADDITIONAL INFORMATION</p><a id="ASharecapital_904810"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Share capital</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">151</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="BMemorandumandarticlesofassociation_4543"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Memorandum and articles of association</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Please see the Articles of Association of AC Immune SA (Exhibit 3.1 to this Form 20-F).</p><a id="CMaterialcontracts_220743"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Material contracts</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Except as otherwise disclosed in this Annual Report on Form&#160;20-F (including the Exhibits), we are not currently, and have not been in the past 2&#160;years, party to any material contract, other than contracts entered into in the ordinary course of business.</p><a id="DExchangecontrols_45681"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Exchange controls</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">There are no Swiss governmental laws, decrees or regulations that restrict, in a manner material to us, the export or import of capital, including any foreign exchange controls, or that generally affect the remittance of dividends or other payments to non-residents or non-citizens of Switzerland who hold our common shares.</p><a id="ETaxation_74576"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">E.</b></span>Taxation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following summary contains a description of the material Swiss and U.S. federal income tax consequences of the acquisition, ownership and disposition of common shares, but it does not purport to be a comprehensive description of all the tax considerations that may be relevant to a decision to purchase common shares. The summary is based upon the tax laws of Switzerland and regulations thereunder and on the tax laws of the United States and regulations thereunder as of the date hereof, which are subject to change.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Swiss tax considerations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This summary of material Swiss tax consequences is based on Swiss law and regulations and the practice of the Swiss tax administration as in effect on the date hereof, all of which are subject to change (or subject to changes in interpretation), possibly with retroactive effect. The summary does not purport to consider the specific circumstances of any particular shareholder or potential investor and does not relate to persons in the business of buying and selling common shares or other securities. The summary is not intended to be, and should not be interpreted as, legal or tax advice to any particular potential shareholder, and no representation with respect to the tax consequences to any particular shareholder is made.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Current and prospective shareholders are advised to consult their own tax advisors in light of their particular circumstances as to the Swiss tax laws, regulations and regulatory practices that could be relevant to them in connection with the acquiring, owning and selling or otherwise disposing of common shares and receiving dividends and similar cash or in-kind distributions on common shares (including dividends on liquidation proceeds and stock dividends) or distributions on common shares based upon a capital reduction (<i style="font-style:italic;">remboursements de la valeur nominale</i>) or reserves paid out of capital contributions (<i style="font-style:italic;">r&#233;serves sur les apports en capital</i>) and the consequences thereof under the tax laws, regulations and regulatory practices of Switzerland.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Taxation of AC Immune</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune is subject to corporate Swiss federal, cantonal and communal taxation in Switzerland, Canton of Vaud, Commune of Ecublens, near Lausanne, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are entitled under Swiss laws to carry forward any losses incurred for a period of 7&#160;years and can offset our losses carried forward against future taxes. As of December&#160;31, 2023, we had tax loss carry-forwards totaling CHF 313.0 million (provisional amount; tax loss is definitively recognized by Swiss tax authorities once set-off against taxable income). There is no certainty that we will make sufficient profits to be able to utilize these tax loss carry-forwards in full.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">152</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The effective corporate income tax rate (federal, cantonal and communal) where we are domiciled is currently 13.6%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of January&#160;1, 2020, the Company may request a tax relief of 60%, which would be applied to income from patents and similar rights at communal and cantonal levels. Additionally, a so-called &#8220;super-deduction&#8221; may be granted for payroll and other expenses of research and development of Swiss origins.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">However, the aforementioned tax relief based on the patent box and deductions for research and development may not exceed 50% of the overall taxable profit before these tax relief and deductions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Notwithstanding the corporate income tax, the corporate capital is taxed at a rate of 0.1305% (cantonal and communal tax only, as there is no federal tax on capital). As of January&#160;1, 2020 the capital attributable to patents and similar rights is considered with 50% relief in the capital tax calculation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Federal, cantonal and communal individual income tax and corporate income tax</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Non-resident shareholders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Except as described in &#8220;&#8212;<i style="font-style:italic;">Swiss federal withholding tax&#8221;</i> below, shareholders who are not resident in Switzerland for tax purposes, and who, during the relevant taxation&#160;year, have not engaged in a trade or business carried on through a permanent establishment or fixed place of business situated in Switzerland for tax purposes (all such shareholders for purposes of this section termed, &#8220;Non-resident shareholders&#8221;), will not be subject to any Swiss federal, cantonal and communal income tax on dividends and similar cash or in-kind distributions on Shares (including liquidation proceeds and stock dividends) (for the purposes of this section, &#8220;dividends&#8221;), distributions based upon a capital reduction (<i style="font-style:italic;">remboursements li&#233;s &#224; la r&#233;duction de la valeur nominale des actions</i>) and distributions paid out of reserves from capital contributions (<i style="font-style:italic;">apports de capital</i>) on shares, or capital gains realized on the sale or other disposition of shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Resident private shareholders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Swiss-resident individuals who hold their shares as private assets are required to include dividends, but not distributions based upon a capital reduction (<i style="font-style:italic;">remboursements li&#233;s &#224; la r&#233;duction de la valeur nominale des actions</i>) and distributions paid out of reserves from capital contributions confirmed by the Swiss Federal Tax Administration (<i style="font-style:italic;">apports de capital</i>), in their personal income tax return and are subject to Swiss federal, cantonal and communal income tax on any net taxable income for the relevant taxation period, including the dividends, but not the distributions based upon a capital reduction (<i style="font-style:italic;">remboursements li&#233;s &#224; la r&#233;duction de la valeur nominale des actions</i>) and distributions paid out of reserves from capital contributions confirmed by the Swiss Federal Tax Administration (<i style="font-style:italic;">apports de capital)</i>. Shareholders holding shares representing at least 10% of the nominal share capital of the Company may be able to decrease the taxable dividend basis by 30% (70% taxable) at the federal level and up to 50% at the cantonal level, depending on their respective cantonal rates, as partial relief from economic double taxation. Capital gains resulting from the sale or other disposition of shares are, subject to a few exceptions such as in case of Taxable Repurchases as described in &#8220;&#8212;<i style="font-style:italic;">Swiss federal withholding tax&#8221;</i> below, not subject to Swiss federal, cantonal and communal income tax, and conversely, capital losses are not tax-deductible for resident private shareholders (the shareholders referred to in this paragraph for the purposes of this section, &#8220;Resident private shareholders&#8221;). See &#8220;<i style="font-style:italic;">Domestic commercial shareholders</i>&#8221; below for a summary of the taxation treatment applicable to Swiss-resident individuals, who, for income tax purposes, are classified as &#8220;professional securities dealers&#8221; or are otherwise deemed to hold Company shares in their commercial wealth.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Domestic commercial shareholders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Corporate and individual shareholders who hold their shares as part of a trade or business carried on in Switzerland, in the case of corporate and individual shareholders not resident in Switzerland, through a permanent establishment or fixed place of business situated, for tax purposes, in Switzerland, are required to recognize dividends, distributions based upon a capital reduction (<i style="font-style:italic;">remboursements li&#233;s &#224; la r&#233;duction de la valeur nominale des actions</i>) and distributions paid out of reserves from capital contributions (<i style="font-style:italic;">apports de capital</i>) received on shares and capital gains or losses realized on </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">153</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">the sale or other disposition of shares in their income statement for the relevant taxation period and are subject to Swiss federal, cantonal and communal individual or corporate income tax, as the case may be, on any net taxable earnings for such taxation period. The same taxation treatment also applies to Swiss-resident private individuals who, for income tax purposes, are classified as &#8220;professional securities dealers&#8221; for reasons of, <i style="font-style:italic;">inter alia</i>, frequent dealing, or leveraged investments, in shares and other securities (the shareholders referred to in this paragraph for purposes of this section, &#8220;Domestic commercial shareholders&#8221;). Domestic commercial shareholders who are natural persons holding shares representing at least 10% of the nominal share capital of the Company may be able to decrease the taxable basis by 30% (70% taxable) at the federal level and up to 50% at the cantonal level, depending on their respective cantonal rates, as partial relief from economic double taxation (in the case of capital gains provide the shares have been held for at least one year). Domestic commercial shareholders who are corporate taxpayers may be eligible for tax relief (<i style="font-style:italic;">r&#233;duction pour participations</i>) in respect of dividends and distributions based upon a capital reduction (<i style="font-style:italic;">remboursements li&#233;s &#224; la r&#233;duction de la valeur nominale des actions</i>) and distributions paid out of reserves from capital contributions (<i style="font-style:italic;">apports de capital</i>) if the shares held by them as part of a Swiss business have an aggregate market value of at least CHF&#160;1 million or represent 10% or more of the outstanding share capital or the dividend rights, of the Company. Capital gains relief is generally available only if the sold shares represent 10% or more of the outstanding share capital or the dividend rights, of the Company and provided that the shares have been held for at least one&#160;year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Swiss cantonal and communal private wealth tax and capital tax</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Non-resident shareholders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Non-resident shareholders are not subject to Swiss cantonal and communal private wealth tax or capital tax.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Resident private shareholders and domestic commercial shareholders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Resident private shareholders and Domestic commercial shareholders who are individuals are required to report their shares as part of their private wealth or their Swiss business assets, as the case may be, and will be subject to Swiss cantonal and communal private wealth tax on any net taxable wealth (including shares), in the case of Domestic commercial shareholders to the extent the aggregate taxable wealth is allocable to Switzerland. Domestic commercial shareholders who are corporate taxpayers are subject to Swiss cantonal and communal capital tax on taxable capital to the extent the aggregate taxable capital is allocable to Switzerland.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Swiss federal withholding tax</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Dividends (including scrip or stock dividends) that the Company pays on the shares are subject to Swiss Federal withholding tax <i style="font-style:italic;">(imp&#244;t anticip&#233;)</i> imposed on the gross amount of the taxable distribution at the then prevailing rate (currently, at a rate of 35% of the gross amount of the taxable distribution). The Company is required to withhold the Swiss federal withholding tax from the dividend and remit it to the Swiss Federal Tax Administration. Distributions based upon a capital reduction (<i style="font-style:italic;">remboursements li&#233;s &#224; la r&#233;duction de la valeur nominale des actions</i>) and distributions paid out of reserves from contributions confirmed by the Swiss Federal Tax Administration (<i style="font-style:italic;">apports de capital</i>) are not subject to Swiss federal withholding tax. Capital gains realized on the sale of the shares are not subject to the Swiss federal withholding tax (other than in case of a sale to the Company (i) for cancellation, (ii) if the total of repurchased shares exceeds 10% of the Company's share capital or (iii) if the repurchased shares are not resold within the applicable time period after the repurchase, if and to the extent the redemption price less the nominal value of the redeemed shares is not booked against reserves from capital contributions confirmed by the Swiss Federal Tax Administration ("Taxable Repurchases")).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Swiss federal withholding tax on a dividend will be refundable in full to a resident private shareholder and to a Domestic commercial shareholder, who, in each case, <i style="font-style:italic;">inter alia,</i> as a condition to a refund, is the beneficial owner of the shares and the dividends or the distributions made or paid on the share and duly reports the dividend in his individual income tax return as income or recognizes the dividend in his income statement as earnings, as applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">A Non-resident shareholder may be entitled to a partial or full refund, as the case may be, of the Swiss federal withholding tax on a dividend if the country of his or her residence for tax purposes has entered into a bilateral treaty for </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">154</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">the avoidance of double taxation with Switzerland and the conditions of such treaty are met. Such shareholders should be aware that the procedures for claiming treaty benefits (and the time required for obtaining a refund) might differ from country to country. A holder of the shares who is a resident of the U.S. for purposes of the Convention between the United States of America and the Swiss Confederation for the Avoidance of Double Taxation with Respect to Taxes on Income (Treaty), without taxable presence in Switzerland to which the shares are attributable or who is a qualified U.S. pension fund and who, in each case, is the beneficial owner of the shares and the dividend or distribution and who meets the other conditions of the Treaty may (i) in the case of qualified U.S. pension funds, apply for a full refund of the Swiss federal withholding tax, (ii) if the holder is a corporation owning at least 10% of the voting rights of the Company, apply for a refund of the Swiss federal withholding tax withheld in excess of the 5% reduced treaty rate, or (iii) apply for a refund of the Swiss federal withholding tax withheld in excess of the 15% treaty rate in all other cases. The applicable refund request form may be filed with the Swiss Federal Tax Administration following receipt of the dividend and the relevant deduction certificate, however no later than 31&#160;December&#160;of the third&#160;year following the calendar&#160;year in which the dividend was payable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Swiss federal stamp taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company will be subject to and pay to the Swiss Federal Tax Administration a 1% Swiss federal issuance stamp duty (droit de timbre <i style="font-style:italic;">d&#8217;&#233;missions</i>) on the consideration received for the issuance of the shares less certain costs incurred in connection with the issuance (in case of the implementation of the capital band, the issuance stamp duty is payable based on the net-principle at the end of the period of the validity of the capital band). The issuance and delivery of the shares to the initial shareholders at the settlement date is not subject to Swiss federal securities transfer stamp duty (<i style="font-style:italic;">droit de timbre de n&#233;gociation</i>).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any subsequent dealings in the shares, for which a bank or another securities dealer in Switzerland or Liechtenstein, as defined in the Swiss Federal Stamp Tax Act, acts as an intermediary, or is a party, to the transaction, are, subject to certain exemptions provided for in the Swiss Federal Stamp Tax Act, subject to Swiss securities transfer stamp duty tax at an aggregate tax rate of up to 0.15% of the consideration paid for such shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Additional tax considerations associated with our ATM program</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2023, the Company held in total 5,243,958 fully paid-in treasury shares as part of its ATM offerings. These shares were established via two tranches (one in September&#160;2020 and one in September&#160;2021, respectively). Under present Swiss tax laws, repurchases of shares for the purposes of cancellation are treated as a partial liquidation and are subject to 35% Swiss withholding tax on the difference between the repurchase price and the nominal value of the shares except, since January&#160;1, 2011, to the extent these are booked against the reserves from capital contributions confirmed by the Swiss Federal Tax Administration (<i style="font-style:italic;">apports de capital</i>) if any. No partial liquidation treatment applies and no withholding tax is triggered if the shares are not repurchased for cancellation but held by the Company as treasury shares, provided the limitations imposed by corporate law are respected (the nominal value of such shares does not exceed 10% of the outstanding share capital and the purchase price is covered by freely disposable equity). However, regarding the above-mentioned 5,243,958 treasury shares and given the specificities of the ATM offering, the Company sought and obtained a tax ruling from the Swiss Federal Tax Administration confirming that their acquisition by the Company did not constitute a direct partial liquidation and therefore does not trigger withholding tax. Further, the Company has obtained a tax ruling from the concerned Cantonal Tax Authority at its place of incorporation, to obtain confirmation that the placement of these treasury shares for a subscription price superior to their nominal value will not trigger any corporate income tax for the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">As of December 31, 2023, 250,798 shares from the first tranche have not been sold and are still recorded as treasury shares. In addition, 2,393,160 fully paid in treasury shares issued as part of second tranche for the ATM for future subscription (or, possibly, as part of a future share-dividend program, should the Company become profitable and have enough earnings carried forward to cover such distribution) have not been sold and are still recorded as treasury shares as of December&#160;31, 2023. In October 2023, the board of directors approved to reverse the earmarking of 2,600,000 treasury shares decided in 2021 and to de-purpose these treasury shares such that they are freely useable within the scope authorized by Swiss law, the articles of association and any potential applicable Board resolution. All these shares are </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">155</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">covered by the same above-mentioned tax rulings (i.e. their acquisition does not trigger any withholding tax and their placement will not trigger any corporate income tax).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Material U.S. federal income tax considerations for U.S. Holders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following is a description of material U.S. federal income tax consequences to the U.S. Holders described below of owning and disposing of our common shares. It does not describe all tax considerations that may be relevant to a particular person&#8217;s decision to own common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This discussion applies only to a U.S. Holder that holds common shares as capital assets for U.S. federal income tax purposes. In addition, it does not describe all of the U.S. federal income tax consequences that may be relevant in light of a U.S. Holder&#8217;s particular circumstances, including alternative minimum tax consequences, the potential application of the provisions of the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) known as the Medicare contribution tax and tax consequences applicable to U.S. Holders subject to special rules, such as:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">certain financial institutions;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">dealers or electing traders in securities that use a mark-to-market method of tax accounting;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">persons holding our common shares as part of a straddle, integrated transaction or similar transaction;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">U.S. Holders whose functional currency for U.S. federal income tax purposes is not the U.S. dollar;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">entities classified as partnerships for U.S. federal income tax purposes;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">tax-exempt entities, &#8220;individual retirement accounts&#8221; or &#8220;Roth IRAs;&#8221;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">persons that received their common shares as compensation;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">persons that own or are deemed to own 10% or more of our shares, by vote or value; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">persons holding our common shares in connection with a trade or business conducted outside of the United States.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If an entity that is classified as a partnership for U.S. federal income tax purposes holds common shares, the U.S. federal income tax treatment of a partner will generally depend on the status of the partner and the activities of the partnership. Partnerships and their partners should consult their tax advisers as to the particular U.S. federal income tax consequences of owning and disposing of the common shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This discussion is based on the Code, administrative pronouncements, judicial decisions, final, temporary and proposed Treasury regulations, and the income tax treaty between Switzerland and the United States ( the &#8220;Treaty&#8221;), all as of the date hereof, any of which is subject to change or differing interpretations, possibly with retroactive effect.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A &#8220;U.S. Holder&#8221; is a person that, for U.S. federal income tax purposes, is a beneficial owner of common shares and is any of the following:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a citizen or individual resident of the United States;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a corporation, or other entity taxable as a corporation, created or organized in or under the laws of the United States, any state therein or the District of Columbia; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">an estate or trust the income of which is subject to U.S. federal income taxation regardless of its source.</span></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">156</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">U.S. Holders should consult their tax advisers concerning the U.S. federal, state, local and non-U.S. tax consequences of owning and disposing of common shares in their particular circumstances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Passive foreign investment company rules </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We will be a passive foreign investment company (a &#8220;PFIC&#8221;) under the Code for any taxable year in which, after the application of certain look-through rules with respect to subsidiaries, either (i) 75% or more of our gross income consists of passive income (the &#8220;income test&#8221;) or (ii) 50% or more of the average value of our assets (generally determined on a quarterly basis) consists of assets that produce, or are held for the production of, passive income (the &#8220;asset test&#8221;). Passive income generally includes dividends, interest, certain non-active rents and royalties, and gains from financial investments. Cash is generally a passive asset. Goodwill and other intangible assets (the value of which may be determined by reference to the excess of the sum of a corporation&#8217;s market capitalization and liabilities over the value of its assets) are generally active assets to the extent attributable to business activities that produce active income. For purposes of the above calculations, we will be treated as if we hold our proportionate share of the assets of, and directly receive our proportionate share of the income of, any other corporation in which we directly or indirectly own at least 25% of the shares of such corporation by value. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Although, the application of the income test to a company like us (whose overall losses from research and development activities significantly exceed its gross income) is not entirely clear, we will be a PFIC for any taxable year under the income test if 75% or more of our gross income (as determined for U.S. federal income tax purposes) for such year consists of interest and other passive income. Prior to the commercialization and sales of any of our product candidates, our gross income may consist primarily of upfront or milestone payments and grants (which we believe are likely to be treated as active income) and interest (which is passive income). The receipt of upfront payments is non-recurring in nature, and the receipt of grants or milestone payments is subject to various conditions. Therefore, there can be no assurance as to the amount of grants, milestone payments or upfront payments (if any) that we will receive for any taxable year. Moreover, we may earn income from sublicensing, which may be passive unless certain conditions are satisfied. There is no assurance that the Internal Revenue Service (&#8220;IRS&#8221;) will not challenge the classification of any of our income items for PFIC purposes for any taxable year. Accordingly, there is no assurance that we will not be a PFIC for any taxable year under the income test.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, we currently hold, and expect to continue to hold, a substantial amount of passive assets, including cash. The average value of our assets (including goodwill and other intangible assets) for purposes of determining our PFIC status for any taxable year may be determined, in large part, by reference to our market capitalization, which has fluctuated substantially over time and may continue to be volatile. Due to the volatility of our market capitalization, we may be a PFIC under the asset test for any taxable year if our cash and other passive assets constitute 50% or more of the value of our total assets (including goodwill and other intangibles).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As discussed in our Annual Reports on Form 20-F for 2019, 2020 and 2022, we were likely a PFIC for these years. If we were a PFIC for 2019, 2020 or 2022, or any other taxable year, under a rule commonly referred to as the &#8220;once a PFIC always a PFIC&#8221; rule, we generally will continue to be treated as a PFIC with respect to a U.S. Holder who owned our common shares during any portion of such years, even if we are not a PFIC for 2023 or any subsequent taxable year, unless the U.S. Holder makes a &#8220;deemed sale&#8221; election with respect to our common shares. As a result of this election, the U.S. Holder (i) may recognize gain subject to the PFIC anti-deferral rules described below, (ii) will have additional tax basis in the common shares to the extent of any gain recognized in the deemed sale, and (iii) solely for purposes of the PFIC rules, will have a new holding period for the common shares. U.S. Holders are urged to consult their tax advisers regarding the potential application of the deemed sale election rules to their particular circumstances and the advisability of making a deemed sale election in light of the uncertainty regarding our PFIC status for the current or future taxable years, as described below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Although we have not obtained valuations of our assets (including goodwill and other intangibles) for 2023 and thus are not in a position to make a definitive determination regarding whether we were a PFIC for 2023, based on the composition of our income and assets during 2023 and the estimated value of our assets (which is based on our average market capitalization during 2023), we believe that we were likely not a PFIC for 2023. However, for the reasons described above there can be no assurance that the IRS will agree. Because our PFIC status is a factual annual </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">157</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">determination that can be determined only after the end of the relevant taxable year, we cannot express a view regarding our PFIC status for 2024 or any future taxable year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If a U.S. Holder owns our common shares in any&#160;year in which we are a PFIC, subject to the discussion above regarding the deemed sale election and the discussion below regarding the mark-to-market election, any gain recognized by the U.S. Holder on a sale or other disposition (including certain pledges) of the common shares will be allocated ratably over the U.S. Holder&#8217;s holding period for the common shares. The amounts allocated to the taxable&#160;year of the sale or other disposition and to any&#160;year before we became a PFIC will be taxed as ordinary income. The amount allocated to any other taxable&#160;year will be subject to tax at the highest rate in effect for individuals or corporations, as appropriate, for that taxable&#160;year, and an interest charge will be imposed on the amount of tax allocated to that taxable&#160;year. Further, to the extent that distributions received by a U.S. Holder on its common shares during a taxable&#160;year exceed 125% of the average of the annual distributions on the common shares received during the preceding three taxable years or the U.S. Holder&#8217;s holding period, whichever is shorter, the excess distribution will be subject to taxation in the same manner.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">A U.S. Holder may be able to avoid the rules&#160;described above by making a mark-to-market election with respect to the common shares, provided that the common shares are regularly traded on Nasdaq or any other qualified exchange. If a U.S. Holder makes the mark-to-market election, it generally will recognize as ordinary income any excess of the fair market value of the common shares at the end of each taxable&#160;year in which we are a PFIC over their adjusted tax basis, and will recognize an ordinary loss in respect of any excess of the adjusted tax basis of the common shares over their fair market value at the end of the taxable&#160;year (but only to the extent of the net amount of income previously included as a result of the mark-to-market election). If a U.S. Holder makes this election, the U.S. Holder&#8217;s tax basis in the common shares will be adjusted to reflect the income or loss amounts recognized. Any gain recognized on the sale or other disposition of common shares in a&#160;year in which we are a PFIC will be treated as ordinary income and any loss will be treated as an ordinary loss (but only to the extent of the net amount of income previously included as a result of the mark-to-market election, with any excess loss treated as a capital loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We do not intend to provide the information necessary for U.S. Holders to make a &#8220;qualified electing fund&#8221; election, which if available could materially affect the tax consequences to U.S. Holders of the ownership and disposition of our common shares if we are or were a PFIC for any taxable&#160;year. Therefore, U.S. Holders will not be able to make such elections.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In addition, if we are a PFIC (or are treated as a PFIC with respect to a particular U.S. Holder under the &#8220;once a PFIC always a PFIC&#8221; rule) for the taxable&#160;year in which we pay a dividend or for the prior taxable&#160;year, the preferential tax rate discussed below with respect to &#8220;qualified dividend income&#8221; received by certain non-corporate U.S. Holders will not be available.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If a U.S. Holder owns common shares during any&#160;taxable year in which we are a PFIC, the U.S. Holder generally must file annual reports on IRS Form&#160;8621 with respect to us with the U.S. Holder&#8217;s federal income tax return.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">U.S. Holders should consult their tax advisers concerning our PFIC status for any taxable year and the consequences thereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Taxation of distributions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following is subject to the discussion under &#8220;&#8212;<i style="font-style:italic;">Passive foreign investment company rules</i>&#8221; above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">As discussed under &#8220;Item 8. Financial Information&#8212;Section A. Consolidated statements and other financial information&#8212;Dividends and dividend policy,&#8221; we do not currently expect to make distributions on our common shares. In the event that we do make distributions of cash or other property on our common shares, other than certain <i style="font-style:italic;">pro rata</i> distributions of our common shares, they will generally be treated as dividends to the extent paid out of our current or accumulated earnings and profits (as determined under U.S. federal income tax principles). Because we do not maintain calculations of our earnings and profits under U.S. federal income tax principles, we expect that distributions generally will be reported to U.S. Holders as dividends. Dividends paid to certain non-corporate U.S. Holders may be eligible for </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">158</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">taxation as &#8220;qualified dividend income&#8221; and therefore, subject to applicable limitations, may be taxable at rates applicable to long-term capital gains, provided that we are not a PFIC (and are not treated as a PFIC with respect to a particular U.S. Holder under the &#8220;once a PFIC always a PFIC&#8221; rule) for our taxable year in which the dividend is paid or the preceding taxable year. Non-corporate U.S. Holders should consult their tax advisers regarding the availability of the reduced tax rate on dividends, if any, in their particular circumstances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Dividends will not be eligible for the dividends-received deduction generally available to U.S. corporations under the Code. Dividends will be included in a U.S. Holder&#8217;s income on the date of receipt. The amount of any dividend income paid in Swiss Francs will be the U.S. dollar amount calculated by reference to the exchange rate in effect on the date of actual or constructive receipt, regardless of whether the payment is in fact converted into U.S. dollars at that time. If the dividend is converted into U.S. dollars on the date of receipt, a U.S. Holder should not be required to recognize foreign currency gain or loss in respect of the dividend income. A U.S. Holder may have foreign currency gain or loss if the dividend is converted into U.S. dollars after the date of receipt.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Dividends will be foreign-source income. The amount of dividend income will include any amounts withheld by us in respect of Swiss income taxes. Subject to applicable limitations, some of which vary depending upon the U.S. Holder&#8217;s particular circumstances, Swiss income taxes withheld from dividends on our common shares (at a rate not exceeding the applicable Treaty rate in the case of U.S. Holders eligible for Treaty benefits) may be creditable against the U.S. Holder&#8217;s U.S. federal income tax liability. The rules governing foreign tax credits are complex. For example, Treasury regulations provide that, in the absence of an election to apply the benefits of an applicable income tax treaty, in order for foreign income taxes to be creditable the relevant foreign income tax rules must be consistent with certain U.S. federal income tax principles, and we have not determined whether the Swiss income tax system meets this requirement. The IRS released notices which provide relief from certain of the Treasury regulations&#8217; requirements for taxable years ending before the date that a notice or other guidance withdrawing or modifying the temporary relief is issued (or any later date specified in such notice or other guidance). U.S. Holders should consult their tax advisers regarding the creditability of any Swiss taxes in their particular circumstances (including the U.S. Holder&#8217;s eligibility for Treaty benefits). In lieu of claiming a credit, U.S. Holders may be able to elect to deduct any Swiss income taxes in computing their taxable income, subject to generally applicable limitations under U.S. law. An election to deduct non-U.S. taxes instead of claiming foreign tax credits applies to all otherwise creditable non-U.S. taxes paid or accrued in the taxable year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Sale or other disposition of common shares</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The following is subject to the discussion under &#8220;&#8212;<i style="font-style:italic;">Passive foreign investment company rules</i>&#8221; above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Gain or loss realized on the sale or other disposition of common shares will be capital gain or loss, and will be long-term capital gain or loss if the U.S. Holder owned the common shares for more than one&#160;year, or short-term capital gain or loss otherwise. The amount of the gain or loss will equal the difference between the U.S. Holder&#8217;s tax basis in the common shares disposed of and the amount realized on the disposition, in each case as determined in U.S. dollars. This gain or loss will generally be U.S.-source gain or loss for foreign tax credit purposes. The deductibility of capital losses is subject to various limitations. Any Swiss securities transfer stamp duty tax on the sale will not be creditable, but may reduce the amount realized on any gain.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Information reporting and backup withholding</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Payments of dividends and sales proceeds that are made within the United States or through certain U.S.-related financial intermediaries generally are subject to information reporting, and may be subject to backup withholding, unless (i)&#160;the U.S. Holder is a corporation or other exempt recipient (and establishes that status if required to do so) or (ii)&#160;in the case of backup withholding, the U.S. Holder provides a correct taxpayer identification number and certifies that it is not subject to backup withholding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The amount of any backup withholding from a payment to a U.S. Holder will be allowed as a credit against the U.S. Holder&#8217;s U.S. federal income tax liability and may entitle the U.S. Holder to a refund, provided that the required information is furnished in a timely manner to the IRS. </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">159</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Certain U.S. Holders who are individuals (or certain specified entities) may be required to report information relating to our common shares or non-U.S. accounts through which the common shares may be held. U.S. Holders should consult their tax advisers regarding their reporting obligations with respect to the ownership and disposition of our common shares.</p><a id="FDividendsandpayingagents_343344"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">F.</b></span>Dividends and paying agents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="GStatementbyexperts_563927"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">G.</b></span>Statement by experts</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="HDocumentsondisplay_893312"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">H.</b></span>Documents on display</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are subject to the informational requirements of the Exchange Act. Accordingly, we are required to file reports and other information with the SEC, including Annual Reports on Form&#160;20-F and reports on Form&#160;6-K. In addition, the SEC maintains an Internet website that contains reports and other information about issuers, such as us, that file electronically with the SEC. The address of that website is www.sec.gov.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, pursuant to Swiss law, any shareholder of record has the right to receive a free copy of this Annual Report and to inspect this Annual Report at any time at our registered office in Ecublens, near Lausanne, Canton of Vaud, Switzerland.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As a foreign private issuer, we are exempt under the Exchange Act from, among other things, the rules&#160;prescribing the furnishing and content of proxy statements, and our executive officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section&#160;16 of the Exchange Act. In addition, we will not be required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act.</p><a id="ISubsidiaryinformation_453406"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">I.</b></span>Subsidiary information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="JAnnualReportToSecurityHolders"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">J.</b></span>Annual report to security holders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="_fb1794cf_cbff_4a55_9dc2_163b480193f1"></a><a id="ITEM11QUANTITATIVEANDQUALITATIVEDISCLOSU"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s activities expose it to the following financial risks: market risk (currency and interest rate risk), credit risk and liquidity risk. The Company&#8217;s overall risk management program focuses on the unpredictability of financial markets and seeks to minimize potential adverse effects on the Company&#8217;s financial performance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Market risk arises from our exposure to fluctuation in currency exchange rates. We are exposed to market risks in the ordinary course of our business, which are principally limited to foreign currency exchange rate fluctuations and to a lesser degree, interest rate fluctuations.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">160</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Market risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Foreign exchange risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is exposed to foreign exchange risk arising from currency exposures, primarily with respect to the EUR, USD and to a lesser extent to GBP, DKK and SEK. The currency exposure is not hedged. However, the Company has the policy of matching its cash holdings to the currency structure of its expenses. As of December&#160;31, 2023, the Company holds approximately 67% of its overall cash and cash equivalents balance in CHF with the remainder predominantly in USD and EUR (see &#8220;Note&#160;8. Cash and cash equivalents and short-term financial assets&#8221; of the consolidated financial statements). The Company holds almost 72% of its liquidity (cash and cash equivalents plus short-term financial assets) in CHF.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have a number of collaboration agreements for which the upfront payments, milestone payments and future royalty payments are not denominated in Swiss Francs, our reporting currency. Furthermore, many of our research and development activities are subcontracted to parties outside of Switzerland and we purchase materials from suppliers outside of Switzerland. As a result, we are exposed to foreign exchange risk. Approximately 40% of our total costs are incurred in currencies other than the Swiss Franc. Due to the size of some of the income received from collaboration agreements and also the high&#160;percentage of our costs indirectly being in foreign currencies, a hypothetical 10% change in exchange rates relative to the Swiss Franc could have a material impact on our consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Interest rate risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We maintain financial instruments in accordance with our treasury management policy. The primary objectives of our policy are to preserve principal, maintain proper liquidity and meet operating needs. Our financial assets are subject to interest rate risk and will decrease in value if market interest rates increase. Due to our policy to maintain the majority of our cash and cash equivalents in our functional currency and to the conservative nature of our investments and relatively short duration, interest rate risk is mitigated. We do not own derivative financial instruments. Accordingly, we do not believe that there is any material market risk exposure with respect to derivative or other financial instruments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Credit risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company maintains a formal treasury risk and investment management policy to limit counterparty credit risk. As of December&#160;31, 2023, the Company&#8217;s cash and cash equivalents and short-term financial assets are held with five financial institutions, each with a high credit rating assigned by international credit-rating agencies. The maximum amount of credit risk is the carrying amount of the financial assets. Receivables are fully performing, not past due and not impaired (see &#8220;Note&#160;8. Cash and cash equivalents and short-term financial assets&#8221;, &#8220;Note 10. Accounts receivable&#8221; and &#8220;Note&#160;11. Other current receivables&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Liquidity risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Inherent in the Company&#8217;s business are various risks and uncertainties, including the high uncertainty that new therapeutic and diagnostic concepts will succeed. AC Immune&#8217;s success may depend in part upon its ability to (i)&#160;establish and maintain a strong patent position and protection, (ii)&#160;enter into collaborations with partners in the pharmaceutical and biopharmaceutical industries, (iii)&#160;acquire and keep key personnel employed, and (iv)&#160;acquire additional capital to support its operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s approach of managing liquidity is to ensure sufficient cash to meet its liabilities when due. Therefore, management closely monitors the cash position on rolling forecasts based on expected cash flow to enable the Company to finance its operations for at least 12&#160;months.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Based on the Company&#8217;s current liquidity position, comprised of cash and cash equivalents, short-term financial assets, and the milestone payment of CHF 14.8 million received from Janssen on February 1, 2024, the Company is financed into Q1 2026, assuming potential milestone payment of CHF 24.6 million related to achieving a non-disclosed enrollment target for our ACI-35.030 and no other milestones.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">161</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Safe Harbor</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">See &#8220;Forward-looking Statements.&#8221;</p><a id="_325e1ca8_972f_417c_b86c_3baf8f6722aa"></a><a id="ITEM12DESCRIPTIONOFSECURITIESOTHERTHANEQ"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</p><a id="ADebtsecurities_509592"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Debt securities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="BWarrantsandrights_307246"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Warrants and rights</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="COthersecurities_247673"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Other securities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="DAmericandepositaryshares_477448"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>American depositary shares</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">162</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_ef98bac6_77b7_44bf_93f5_0574eb04fe4b"></a><a id="PARTII_983451"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;">PART&#160;II</p><a id="ITEM13DEFAULTSDIVIDENDARREARAGESANDDELIN"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</p><a id="ADefaults_798645"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Defaults</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">No matters to report.</p><a id="BArrearsanddelinquencies_675487"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Arrears and delinquencies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">No matters to report.</p><a id="_769cc3d9_057f_4168_a492_2a2d44cf6378"></a><a id="ITEM14MATERIALMODIFICATIONSTOTHERIGHTSOF"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="_36788ca3_fa0c_4c6f_b290_2a342a3342eb"></a><a id="ITEM15CONTROLSANDPROCEDURES_751037"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;15. CONTROLS AND PROCEDURES</p><a id="ADisclosurecontrolsandprocedures_342570"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">A.</b></span>Disclosure controls and procedures</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2023, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we performed an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule&#160;13a-15(e)&#160;under the Exchange Act). There are inherent limitations to the effectiveness of any disclosure controls and procedures system, including the possibility of human error and circumventing or overriding them. Even if effective, disclosure controls and procedures can provide only reasonable assurance of achieving their control objectives.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective in recording, processing, summarizing and reporting on a timely basis the information required to be included in periodic filings under the Exchange Act and that such information is accumulated and communicated to management, including our Chief Executive and Chief Financial Officers, as appropriate to allow timely decisions regarding required disclosure.</p><a id="BManagementsAnnualReportoninternalcontro"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Management&#8217;s Annual Report on internal control over financial reporting</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule&#160;13a-15(f)&#160;of the Exchange Act. Our internal control over financial reporting is supported by written policies and procedures. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, management conducted an evaluation of the effectiveness of our internal control over financial reporting based upon criteria established in&#160;<i style="font-style:italic;">Internal Control&#160;&#8211; Integrated Framework&#160;</i>(2013) by the Committee of Sponsoring Organizations of the Treadway Commission. Based on that evaluation, our management, including our Chief Executive Officer and Chief Financial Officer concluded that our internal control over financial reporting was effective as of December&#160;31, 2023.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">163</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="CAttestationreportoftheregisteredpublica"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Attestation report of the registered public accounting firm</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The effectiveness of our internal control over financial reporting as of December&#160;31, 2023 has been audited by PricewaterhouseCoopers SA, an independent registered public accounting firm. Their report is included on page&#160;F-2. PricewaterhouseCoopers SA is a member of the Chamber of Public Accountants, Lausanne, Switzerland.</p><a id="DChangesininternalcontroloverfinancialre"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Changes in internal control over financial reporting</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">There have been no changes in the Company&#8217;s internal control over financial reporting during the&#160;year ended December&#160;31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</p><a id="_604e2f2f_8721_4c48_a23f_4b1cbc6d4305"></a><a id="ITEM16RESERVED_843348"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">ITEM&#160;16. [RESERVED]</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><a id="_e7e8cb69_9f42_4fd0_bb0b_ea9d4a0e2663"></a><a id="ITEM16AAuditcommitteefinancialexperts_94"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;16A. Audit committee financial expert</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our board of directors has determined that Monika B&#252;tler is an audit committee financial expert, as that term is defined by the SEC, and is independent for the purposes of SEC rules.</p><a id="_ae324d90_1b4b_4290_a29d_935ef609e678"></a><a id="ITEM16BCodeofEthics_857383"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;16B. Code of Ethics</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Code of Business Conduct and Ethics</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have adopted a Code of Business Conduct and Ethics, which covers a broad range of matters including the handling of conflicts of interest, compliance issues and other corporate policies such as insider trading and equal opportunity and non-discrimination standards. Our Code of Business Conduct and Ethics applies to all of our directors, executive officers and employees. We have published our Code of Business Conduct and Ethics on our website, <i style="font-style:italic;">www.acimmune.com</i>. The information contained on our website is not a part of this Annual Report.</p><a id="_83a66582_ae01_47b1_a722_8892f09629e4"></a><a id="ITEM16CPrincipalaccountantfeesandservice"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">ITEM&#160;16C. Principal accountant fees and services</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:12pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Audit fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 763</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 725</span></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Audit-related fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 20</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5</span></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total fees</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 783</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 730</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:12pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;year ended December&#160;31, 2023, PwC was the Company&#8217;s auditor for the IFRS and statutory accounts. At the ordinary Annual General Meeting on June&#160;23, 2023, the shareholders appointed PwC as the Company&#8217;s auditor for a term of office of 1&#160;year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="color:#0d0e00;">Audit fees i</span>nclude fees for audit services primarily related to the audit of the statutory financial statements and to the integrated audit of (i)&#160;our annual consolidated financial statements and our internal control over financial reporting as required by Section&#160;404(b)&#160;of the Sarbanes-Oxley Act of 2002, (ii)&#160;the review of our quarterly condensed consolidated financial statements, (iii)&#160;comfort letters, consents and assistance with and review of documents relating to our securities offerings and (iv)&#160;other accounting and financial reporting consultation billed as audit fees or necessary to comply with the standards of the Public Company Accounting Oversight Board (United States).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Audit-related fees consisted of fees billed for assurance and related services that were reasonably related to the performance of the audit or review of our financial statements or for services that were traditionally performed by the external auditor.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">164</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Pre-approval policies and procedures</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In accordance with the requirements of the U.S. Sarbanes-Oxley Act of 2002 and rules&#160;issued by the SEC, we review and pre-approve any services performed by PwC. The procedure requires that all proposed future engagements of PwC for audit and permitted non-audit services are submitted to the Audit and Finance Committee for approval prior to the beginning of any such services. In accordance with this policy, all services performed by and fees paid to PwC in this Item&#160;16C, were approved by the Audit and Finance Committee.</p><a id="_09a7198d_9702_4456_8c86_4dcc96e15db2"></a><a id="ITEM16DExemptionsfromthelistingstandards"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;16D. Exemptions from the listing standards for audit committees</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="_2dee28f0_3508_4fc8_b2a9_f71ca019774b"></a><a id="ITEM16EPurchasesofequitysecuritiesbythei"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;16E. Purchases of equity securities by the issuer and affiliated purchasers</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In 2023, no purchases of our equity securities were made by or on behalf of AC Immune SA or any affiliated purchaser.</p><a id="_8aebfc39_3c4b_4a5b_873a_0904a6042e0b"></a><a id="ITEM16FChangeinregistrantscertifyingacco"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;16F. Change in registrant&#8217;s certifying accountant</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="_15e3047d_0fc9_4a01_b56b_c1d29a79ea40"></a><a id="ITEM16GCorporategovernance_299481"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;16G. Corporate governance</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Summary of Significant Corporate Governance Differences from Nasdaq Listing Standards</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our common shares are listed on the Nasdaq Global Market. We are therefore required to comply with certain of the Nasdaq&#8217;s corporate governance listing standards (Nasdaq Standards). As a foreign private issuer, we may follow our home country&#8217;s corporate governance practices in lieu of certain of the Nasdaq Standards. Our corporate governance practices differ in certain respects from those that U.S. companies must adopt in order to maintain a Nasdaq listing. A brief, general summary of those differences is provided as follows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Independent directors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Swiss law does not require that a majority of our board of directors consist of independent directors. Our board of directors therefore may include fewer independent directors than would be required if we were subject to Nasdaq Listing Rule&#160;5605(b)(1). In addition, we are not subject to Nasdaq Listing Rule&#160;5605(b)(2), which requires that independent directors must regularly have scheduled meetings at which only independent directors are present.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Compensation, nomination and corporate governance committee</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As Swiss law requires that we have a compensation, nomination and corporate governance committee, we will follow home country requirements with respect to such committee. As a result, our practice will vary from the requirements of Nasdaq Listing Rule&#160;5605(d), which sets forth certain requirements as to the responsibilities, composition and independence of compensation, nomination and corporate governance committees.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Quorum requirements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In accordance with Swiss law and generally accepted business practices, our articles of association do not provide quorum requirements generally applicable to general meetings of shareholders. Our practice thus varies from the requirement of Nasdaq Listing Rule&#160;5620(c), which requires an issuer to provide in its bylaws for a generally applicable quorum, and that such quorum may not be less than one-third of the outstanding voting stock.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">165</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Solicitation of proxies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our articles of association provide for an independent proxy holder elected by our shareholders, who may represent our shareholders at a general meeting of shareholders, and we must provide shareholders with an agenda and other relevant documents for the general meeting of shareholders. However, Swiss law does not have a regulatory regime for the solicitation of proxies, and company solicitation of proxies is prohibited for public companies in Switzerland. Thus, our practice will vary from the requirement of Nasdaq Listing Rule&#160;5620(b), which sets forth certain requirements regarding the solicitation of proxies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Shareholder approval</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have opted out of shareholder approval requirements for the issuance of securities in connection with certain events such as the acquisition of stock or assets of another company, the establishment of or amendments to equity-based compensation plans for employees, a change of control of us and certain private placements. To this extent, our practice varies from the requirements of Nasdaq Listing Rule&#160;5635, which generally requires an issuer to obtain shareholder approval for the issuance of securities in connection with such events.</p><a id="_703bb621_0346_4e48_beda_b9f3347d79d1"></a><a id="ITEM16HMinesafetydisclosure_873677"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;16H. Mine safety disclosure</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Not applicable.</p><a id="_ba296130_fd65_4594_88fa_391e88826e33"></a><a id="ITEM16IDisclosureregardingforeignjurisdi"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;16I. Disclosure regarding foreign jurisdictions that prevent inspections</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_1bc4899c_502b_4348_9ba4_eed5559e8acb"></a><a id="ITEM16JInsiderTradingPolicies"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;16J. Insider trading policies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 8pt 0pt;">Not applicable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_c839b7b6_3806_4866_a505_7eb29315f0c8"></a><a id="ITEM16KCybersecurity"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;16K. Cybersecurity</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 8pt 0pt;">To more effectively protect against, detect and respond to cybersecurity threats, the Company maintains a cybersecurity risk management program, which is supervised by our SVP Information Systems and Artificial Intelligence, whose team is responsible for leading enterprise-wide cybersecurity strategy, policy, standards, architecture and processes. The Company&#8217;s SVP Information Systems and Artificial Intelligence and his team possess expertise with cybersecurity, as demonstrated by prior work experience. The Company has designed its cybersecurity program based on the COBIT 2019 framework (and other certain industry standards) with the aim of protecting our networks, applications and systems and the confidentiality of sensitive information maintained as part of our business operations as well as securing our resources against cybersecurity threats. A breach, compromise or other security incident involving such information and resources could have a material impact on the Company&#8217;s operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 8pt 0pt;">The goal of our cybersecurity program is to design, implement and maintain effective operational risk techniques and strategies, protect intellectual property and other proprietary and sensitive information, including personal information, minimize operational and fraud losses, and enhance our overall performance. As part of our cybersecurity program, we utilize security monitoring capabilities that alert us of suspicious activity, supported by an incident response program that is designed to support our ability to restore critical business operations in a controlled and step-wise manner. The Company also has procedures for evaluating the privacy, data protection and information security practices of our third-party service providers that provide us with IT services or that otherwise have access to our systems or our confidential or sensitive data. Additionally, we continually evaluate our internal systems, processes and controls to identify potential vulnerabilities and mitigate potential loss from cyber-attacks.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">166</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 8pt 0pt;">Furthermore, our cybersecurity program is focused on companywide awareness geared toward enabling our employees and other key personnel to effectively handle the ever-increasing threat vectors such as phishing and other sophisticated social engineering attacks. Our management takes the position that cybersecurity is owned companywide as a collective team, not just by the SVP Information Systems and Artificial Intelligence. Our security awareness program focuses on improving awareness through training, including realistic phishing simulation campaigns. Our key areas of focus in 2024 and beyond will include requiring further training for employees that fail simulated phishing campaigns and encouraging our employees to report any suspicious activity they encounter.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 8pt 0pt;">Our Board of Directors has overall oversight responsibility for our overall enterprise risk management, including cybersecurity risks and threats, and the SVP Information Systems and Artificial Intelligence reports to the Board of Directors at least annually on such cybersecurity risks or threats as well as current trends and developments within the cybersecurity landscape.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 8pt 0pt;">Finally, the SVP Information Systems and Artificial Intelligence is also a member of the Company&#8217;s SOX Committee, which drives awareness, ownership and alignment across broad governance and risk stakeholder groups for effective cybersecurity risk management and reporting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 8pt 0pt;">Despite our efforts, we cannot eliminate all risks from cybersecurity threats, or provide assurances that we have not experienced an undetected cybersecurity incident. For more information about these risks, please see &#8220;Risk factors&#8212;A breakdown or breach of our information technology systems and cybersecurity efforts, or those of our key business partners, CROs or service providers, could subject us to liability or reputational damage or interrupt the operation of our business&#8221; in this annual report on Form 20-F.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">167</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;visibility:hidden;">&#8203;</span></p><a id="_e0b9eea3_2e7f_4570_8630_e96bf98a36eb"></a><a id="PARTIII_805425"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;">PART&#160;III</p><a id="ITEM17Financialstatements_563714"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;17. Financial statements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We have responded to Item&#160;18 in lieu of this item.</p><a id="_1eecf650_d89e_4894_8df6_7214581bc6ab"></a><a id="ITEM18Financialstatements_869202"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;18. Financial statements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Financial Statements are filed as part of this Annual Report, see page&#160;F-1.</p><a id="_a4a7f476_d760_413e_8344_d791f7dc3df5"></a><a id="ITEM19Exhibits_807810"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">ITEM&#160;19. Exhibits</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 36pt;">(a) The following documents are filed as part of Annual Report on Form&#160;20-F:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">3.1*</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="aciu-20231231xex3d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Articles of Association of AC Immune SA</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.1</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000119312516607922/d16439dex101.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Research Collaboration and License Agreement between AC Immune SA Corporation and Genentech,&#160;Inc. dated November&#160;6, 2006 (incorporated herein by reference to Exhibit&#160;10.1 to the Company&#8217;s Registration Statement on Form&#160;F-1 (File No.&#160;333-211714) filed with the SEC on May&#160;31, 2016)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.2</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000119312516607922/d16439dex102.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Amendment to the Research Collaboration and License Agreement between AC Immune SA Corporation and Genentech,&#160;Inc. dated May&#160;7, 2015 (incorporated herein by reference to Exhibit&#160;10.2 to the Company&#8217;s Registration Statement on Form&#160;F-1 (File No.&#160;333-211714) filed with the SEC on May&#160;31, 2016)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.3</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000119312516607922/d16439dex103.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Research Collaboration and License Agreement between AC Immune SA Corporation and Genentech,&#160;Inc. dated June&#160;15, 2012 (incorporated herein by reference to Exhibit&#160;10.3 to the Company&#8217;s Registration Statement on Form&#160;F-1 (File No.&#160;333-211714) filed with the SEC on May&#160;31, 2016)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.4</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000119312516607922/d16439dex104.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">License and Collaboration Agreement between Piramal Imaging&#160;Ltd., Piramal Imaging SA and AC Immune SA, dated May&#160;9, 2014 (incorporated herein by reference to Exhibit&#160;10.4 to the Company&#8217;s Registration Statement on Form&#160;F-1 (File No.&#160;333-211714) filed with the SEC on May&#160;31, 2016)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.5</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000119312516607922/d16439dex105.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">License, Development and Commercialization Agreement between Janssen Pharmaceuticals,&#160;Inc. and AC Immune SA, dated December&#160;24, 2014 (incorporated herein by reference to Exhibit&#160;10.5 to the Company&#8217;s Registration Statement on Form&#160;F-1 (File No.&#160;333-211714) filed with the SEC on May&#160;31, 2016)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.6</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000155837023003963/aciu-20221231xex4d6.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form&#160;of Indemnity Agreement (incorporated herein by reference to Exhibit 4.6 to the Company&#8217;s Annual Report on Form 20-F (File No. 001-37891) filed with the SEC on March 16, 2023)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.7</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000119312516607922/d16439dex107.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">AC Immune SA 2013 Equity Incentive Plan (incorporated herein by reference to Exhibit&#160;10.7 to the Company&#8217;s Registration Statement on Form&#160;F-1 (File No.&#160;333-211714) filed with the SEC on May&#160;31, 2016)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.8</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000095010316017052/dp69421_ex9908.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">AC Immune SA 2016 Stock Option and Incentive Plan,</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;"> As Amended and Restated as of June 28, 2019</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;"> (incorporated herein by reference to Exhibit&#160;99 to the Company&#8217;s R</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">egistration Statement </span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">on Form&#160;S</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">-8</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">, filed with the SEC on </span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">August 5, 2019</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.9</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000095010319004949/dp105140_ex0414.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">License Agreement between AC Immune SA and Eli Lilly and Company, dated December&#160;11, 2018 (incorporated herein by reference to Exhibit&#160;4.14 to the Amendment No.&#160;1 to the Company&#8217;s Annual Report on Form&#160;20-F/A, filed with the SEC on April&#160;19, 2019)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.10</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000095010319003578/dp103711_ex0415.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Convertible Note&#160;Agreement between AC Immune SA and Eli Lilly and Company, dated December&#160;11, 2018 (incorporated herein by reference to Exhibit&#160;4.15 to the Company&#8217;s Annual Report on Form&#160;20-F, filed with the SEC on March&#160;21, 2019)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.11</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000095010319012523/dp112992_ex1001.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">First Amendment to License Agreement between AC Immune SA and Eli Lilly and Company, dated September&#160;19, 2019 (incorporated herein by reference to Exhibit&#160;10.1 to the Company&#8217;s Report on Form&#160;6-K, filed with the SEC on September&#160;20, 2019)</span></a></p></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">168</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.12</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000095010320005734/dp124366_ex1001.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Second Amendment to License Agreement between AC Immune SA and Eli Lilly and Company, dated March&#160;20, 2020 (incorporated herein by reference to Exhibit&#160;10.1 to the Company&#8217;s Current Report on Form&#160;6-K (File No.&#160;001-37891) filed with the SEC on March&#160;23, 2020)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.13</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000095010321006778/dp1150581_ex0101.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Open Market Sale Agreement, dated as of May&#160;5, 2021, between AC Immune SA and Jefferies LLC (incorporated herein by reference to Exhibit&#160;1.1 to the Company&#8217;s Current Report on Form&#160;6-K (File No.&#160;001-37891) filed with the SEC on May&#160;5, 2021)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.14</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000095010321011884/dp155670_ex1001.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Asset Purchase and Contribution in Kind Agreement, dated as of July&#160;26, 2021, between AC Immune SA and Affiris AG (incorporated herein by reference to Exhibit&#160;10.1 to the Company&#8217;s Current Report on Form&#160;6-K (File No.&#160;001-37891) filed with the SEC on August&#160;4, 2021)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.15</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000095010321011884/dp155670_ex1002.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Convertible Note&#160;Agreement, dated as of July&#160;26, 2021, between AC Immune SA and Santo Venture GmbH (incorporated herein by reference to Exhibit&#160;10.2 to the Company&#8217;s Current Report on Form&#160;6-K (File No.&#160;001-37891) filed with the SEC on August&#160;4, 2021)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.16</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1651625/000095010321011884/dp155670_ex1003.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Convertible Note&#160;Agreement, dated as of July&#160;26, 2021, between AC Immune SA and FCPB Affi GmbH (incorporated herein by reference to Exhibit&#160;10.3 to the Company&#8217;s Current Report on Form&#160;6-K (File No.&#160;001-37891) filed with the SEC on August&#160;4, 2021)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">4.17*</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="aciu-20231231xex4d17.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Description of Securities</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">8.1*</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="aciu-20231231xex8d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">List of subsidiaries</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">12.1*</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="aciu-20231231xex12d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Certification of Andrea Pfeifer pursuant to 17 CFR 240.13a-14(a)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">12.2*</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="aciu-20231231xex12d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Certification of Christopher Roberts pursuant to 17 CFR 240.13a-14(a)</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">13.1*</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="aciu-20231231xex13d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Certification of Andrea Pfeifer pursuant to 17 CFR 240.13a-14(b)&#160;and 18 U.S.C.1350</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">13.2*</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="aciu-20231231xex13d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Certification of Christopher Roberts pursuant to 17 CFR 240.13a-14(b)&#160;and 18 U.S.C.1350</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">15.1*</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">97.1*</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="aciu-20231231xex15d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Consent of PricewaterhouseCoopers SA</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="aciu-20231231xex97d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Compensation Recoupment Policy</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">101.INS</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">XBRL Instance Document</p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">101.SCH</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">XBRL Taxonomy Extension Schema Document</p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">101.CAL</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">XBRL Taxonomy Extension Calculation Linkbase Document</p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">101.DEF</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">XBRL Taxonomy Extension Definition Linkbase Document</p></td></tr><tr><td style="vertical-align:top;width:12.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">101.LAB</p></td><td style="vertical-align:top;width:87.56%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">XBRL Taxonomy Extension Label Linkbase Document</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;">*</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;">Filed herewith</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 36pt;">(b) Financial Statement Schedules</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">None.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">169</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_bc80b803_fde7_4fb7_a5d4_fdf9d299f388"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Signatures</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The registrant hereby certifies that it meets all of the requirements for filing on Form&#160;20-F and that it has duly caused and authorized the undersigned to sign this Annual Report on its behalf.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:99.89%;"><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">AC IMMUNE SA</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Date: March&#160;14, 2024</p></td><td colspan="3" style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">By:</p></td><td colspan="2" style="vertical-align:top;width:46.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">/s/ Andrea Pfeifer</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.56%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:40.59%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Andrea Pfeifer</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:40.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Chief Executive Officer</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">By:</p></td><td colspan="2" style="vertical-align:top;width:46.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">/s/ Christopher Roberts</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.56%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:40.59%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Christopher Roberts</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:40.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">Chief Financial Officer</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 8pt 0pt;"><span style="font-size:10pt;line-height:1.28;visibility:hidden;">&#8203;</span></p><p style="display:none;line-height:0pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:0pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="font-size:10pt;">170</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_9ff0dcc9_ae84_4269_b3be_abb13c338593"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Audited consolidated financial statements&#160;&#8212; AC IMMUNE SA</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:95%;margin:0pt;padding:0pt 5pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:4.99%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:95%;background:#cceeff;margin:0pt;padding:0pt 5pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="font-size:10pt;" href="#ReportofIndependentRegusteredPublicAccou"><span style="font-style:normal;font-weight:normal;">Report of independent registered public accounting firm</span></a><span style="font-size:10pt;"> </span><b style="font-size:10pt;font-weight:bold;">(PCAOB ID </b><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:AuditorFirmId" id="Narr_K5A5tZ4pG0u00cAANpf3LA"><b style="font-size:10pt;font-weight:bold;">1358</b></ix:nonNumeric><b style="font-size:10pt;font-weight:bold;">)</b></p></td><td style="vertical-align:bottom;width:4.99%;background:#cceeff;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;">F-2</p></td></tr><tr><td style="vertical-align:top;width:95%;margin:0pt;padding:0pt 5pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="font-size:10pt;" href="#ConsolidatedBalanceSheets_928033"><span style="font-style:normal;font-weight:normal;">Consolidated Balance Sheets as of December&#160;31, 2023 and 2022</span></a></p></td><td style="vertical-align:bottom;width:4.99%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;">F-5</p></td></tr><tr style="height:23pt;"><td style="vertical-align:top;width:95%;background:#cceeff;margin:0pt;padding:0pt 5pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="font-size:10pt;" href="#ConsolidatedStatementsofIncomeLoss_50901"><span style="font-style:normal;font-weight:normal;">Consolidated Statements of Income/(Loss) and Consolidated Statements of Comprehensive Income/(Loss) for the fiscal&#160;years ended December&#160;31, 2023, 2022 and 2021</span></a></p></td><td style="vertical-align:bottom;width:4.99%;background:#cceeff;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;">F-6</p></td></tr><tr><td style="vertical-align:top;width:95%;margin:0pt;padding:0pt 5pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="font-size:10pt;" href="#ConsolidatedStatementsofChangesinEquity_"><span style="font-style:normal;font-weight:normal;">Consolidated Statements of Changes in Equity for the fiscal&#160;years ended December&#160;31, 2023, 2022 and 2021</span></a></p></td><td style="vertical-align:bottom;width:4.99%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;">F-7</p></td></tr><tr><td style="vertical-align:top;width:95%;background:#cceeff;margin:0pt;padding:0pt 5pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="font-size:10pt;" href="#ConsolidatedStatementsofCashFlows_14317"><span style="font-style:normal;font-weight:normal;">Consolidated Statements of Cash Flows for the fiscal&#160;years ended December&#160;31, 2023, 2022 and 2021</span></a></p></td><td style="vertical-align:bottom;width:4.99%;background:#cceeff;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;">F-8</p></td></tr><tr><td style="vertical-align:top;width:95%;margin:0pt;padding:0pt 5pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="font-size:10pt;" href="#NotestotheConsolidatedFinancialStatement"><span style="font-style:normal;font-weight:normal;">Notes&#160;to the Consolidated Financial Statements</span></a></p></td><td style="vertical-align:bottom;width:4.99%;margin:0pt;padding:0pt 2pt 0pt 2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;">F-9</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 8pt 0pt;"><span style="font-size:10pt;line-height:1.28;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-1</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="ReportofIndependentRegusteredPublicAccou"></a><a id="_f159532c_9d17_47aa_a115_3851114c0558"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-style:normal;font-weight:bold;">Report of Independent Registered Public Accounting Firm</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">To the Board of Directors and Shareholders of AC Immune SA</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Opinions on the Financial Statements and Internal Control over Financial Reporting</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;">We have audited the accompanying consolidated balance sheets of AC Immune SA and its subsidiary (the &#8220;Company&#8221;) as of<span style="color:#ff0000;"> </span>December 31, 2023 and December 31, 2022,<b style="color:#ff0000;font-weight:bold;"> </b>and the related consolidated statements of income/(loss), comprehensive income/(loss), changes in equity and cash flows for each of the three years in the period ended December 31, 2023, including the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). We also have audited the Company&#8217;s internal control over financial reporting as of December 31, 2023, based on criteria established in<b style="color:#ff0000;font-weight:bold;"> </b><i style="font-style:italic;">Internal Control - Integrated Framework</i><span style="color:#ff0000;"> </span>(2013)<span style="color:#ff0000;"> </span>issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and December 31, 2022, and the results of its operations and its cash flows for each of the three years in the period ended<span style="color:#ff0000;"> </span>December 31, 2023<b style="color:#ff0000;font-weight:bold;"> </b>in conformity with IFRS Accounting Standards as issued by the International Accounting Standards Board. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2023, based on criteria established in <i style="font-style:italic;">Internal Control - Integrated Framework</i> (2013)<span style="color:#ff0000;"> </span>issued by the COSO.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="color:#ff0000;font-size:10pt;font-style:italic;font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Basis for Opinions</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;">The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management&#8217;s Annual Report on Internal Control over Financial Reporting appearing under Item 15B. Our responsibility is to express opinions on the Company&#8217;s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="white-space:pre-wrap;">Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks.  Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Definition and Limitations of Internal Control over Financial Reporting</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (i)&#160;pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii)&#160;provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii)&#160;provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="white-space:pre-wrap;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Critical Audit Matters</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated<b style="color:#ff0000;font-weight:bold;"> </b>financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;font-style:italic;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><i style="font-style:italic;">Intangible asset &#8211; valuation</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;font-style:italic;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">As described in Notes 6 and 7 to the consolidated financial statements, the Company has CHF 50,416 thousand of an in-process research and development (IPR&amp;D) intangible asset as of December 31, 2023. The asset is defined as an intangible asset not yet ready for use. Therefore, in accordance with IAS 36 &#8216;Impairment of asset&#8217;, the IPR&amp;D asset is reviewed at least annually for impairment by assessing the fair value less costs to sell (recoverable amount) and comparing this to the carrying value of the asset. To determine the recoverable amount, management estimated the fair value less costs to sell of the intangible asset, using a risk-adjusted discounted cash flow method. The significant assumptions used in the model include anticipated research and development costs, anticipated costs of goods and sales and marketing expenditures, probability of achieving clinical and regulatory development milestones in accordance with certain industry benchmarks, target indication prevalence and incidence rates, anticipated market share, general commercialization expectations such as anticipated pricing and uptake, expected patent life and market exclusivity periods, and the discount rate used to discount future cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">The principal considerations for our determination that performing procedures relating to the intangible asset &#8211; valuation is a critical audit matter are the significant judgment by management when determining the value of the intangible asset. This in turn led to a high degree of auditor judgment, subjectivity and effort in performing procedures and evaluating the audit evidence obtained related to the valuation of the intangible asset and management&#8217;s assumptions related to anticipated research and development costs, anticipated costs of goods and sales and marketing expenditures, probability of achieving clinical and regulatory development milestones in accordance with certain industry benchmarks, target indication prevalence and incidence rates, anticipated market share, general commercialization expectations such as anticipated pricing and uptake, expected patent life and market exclusivity periods, and the discount rate used to discount future cash flows. In addition, the audit effort involved the use of professionals with specialized skill and knowledge.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management&#8217;s valuation of the intangible asset. These procedures also included, among others, (i) testing management&#8217;s process for developing the fair value estimate; (ii) evaluating the appropriateness of the discounted cash flow model; (iii) testing the completeness and accuracy of underlying data used in the model; and (iv) evaluating the reasonableness of the significant assumptions used by management related to anticipated research and development costs, anticipated costs of goods and sales and marketing expenditures, probability of achieving clinical and regulatory development milestones in accordance with certain industry benchmarks, target indication prevalence and incidence rates, anticipated market share, general commercialization expectations such as anticipated pricing and uptake, expected patent life and market exclusivity periods, and the discount rate. Evaluating management&#8217;s assumptions related to anticipated research and development costs, anticipated costs of goods and sales and marketing expenditures, probability of achieving clinical and regulatory development milestones in accordance with certain industry benchmarks, target indication prevalence and incidence rates, anticipated market share, general commercialization expectations such as anticipated pricing and uptake, expected patent life and market exclusivity periods, involved evaluating whether the assumptions used by management were reasonable considering (i) the consistency with market and industry data; and (ii) whether these assumptions were consistent with evidence obtained in other areas of the audit. Professionals with specialized skill and knowledge were used to assist in the evaluation of the Company&#8217;s discounted cash flow model and the discount rate assumption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;">/s/ </span><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:AuditorName" id="Narr_fvjOURydu0SVrb1aRuRZWw"><span style="font-size:10pt;">PricewaterhouseCoopers SA</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="dei:AuditorLocation" id="Narr_tNZtCQVjC0ekM4RB5IA9UA"><span style="font-size:10pt;">Lausanne, Switzerland</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">March 14, 2024</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">We have served as the Company&#8217;s auditor since 2018.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 8pt 0pt;"><span style="font-size:10pt;line-height:1.28;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_751eaeaa_3e8a_46a4_aafc_11be847c128d"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">Consolidated Financial Statements (IFRS)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">AC Immune SA</p><a id="ConsolidatedBalanceSheets_928033"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">Consolidated Balance Sheets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">(In CHF thousands)</p><a id="_e666ccfc_fc4d_4f50_a6e5_3c96fab0f902"></a><a id="Tc_i0hB6DPKVkaChZEZRokWqA_1_4"></a><a id="Tc_Sviv6Q1e-kKLE6PxNRiQfA_2_4"></a><a id="Tc_L9Gts98NYUCswmINrxQWmA_3_2"></a><a id="Tc_d_NdumV5vUu_Ef5GIdc2-A_3_4"></a><a id="Tc_k5nt73Jx50KUMrfu99ReIA_3_6"></a><a id="Tc_zrb4bDGRRkupGDgrooQBxA_4_0"></a><a id="Tc_QE7mYlC310KtwdESmE3XYA_5_0"></a><a id="Tc_Hms-SaNBGU2aImpqO-cDtw_6_0"></a><a id="Tc_jmb9s0m_pUWOOc4yZs57PQ_6_2"></a><a id="Tc_xMP2-QTgEk60XtxGe1ciiQ_7_0"></a><a id="Tc_yeMMR7i-RkOjFEWz_5dkKA_7_2"></a><a id="Tc_PLwIX4th-UiLhGO9Ul1iCA_8_0"></a><a id="Tc_4VdcBEMFNU6a0BG_T4_ZYQ_8_2"></a><a id="Tc_Mevfo1oxX0qoflVVRm8adg_9_0"></a><a id="Tc_n-MMhuwwTUK1WQo-bvbw9A_9_2"></a><a id="Tc_TrKNvfHI1E2CJq1BGqXybQ_10_0"></a><a id="Tc_lStxnpeR20uytfJ1pC03KA_12_0"></a><a id="Tc_Av5LfsucH0adzkWwdD9huA_13_0"></a><a id="Tc_fC-vne9Sv0iGXfoqfqM4NQ_13_2"></a><a id="Tc_CNnmVbDjPkudCFDDrk2GRQ_14_0"></a><a id="Tc_JcjXByYgE0SGrhfx8GkcCQ_14_2"></a><a id="Tc_5vM5GsjtekOfpC0SmAxGrg_15_0"></a><a id="Tc_tEHLm2Li10OubzJPnKLicQ_15_2"></a><a id="Tc_fq9hQsYE8kankrp_5P2zpg_16_0"></a><a id="Tc_Lq1vKxn3-kyWcuIjk6mBDQ_16_2"></a><a id="Tc_ikxKpQJUu0CocZRSUo2yog_16_6"></a><a id="Tc_aoiznmTiHUGsOD6AmYFunw_17_0"></a><a id="Tc_1i-QZJnIg06pfzBXfDMSjA_17_2"></a><a id="Tc_3Jr2Olpa8kW14Y_xsYGL0g_18_0"></a><a id="Tc_HFlJW6R6ME6l1va1ZWrnaQ_18_2"></a><a id="Tc_bs3urb-Vv0ul51gWo-Tfcg_19_0"></a><a id="Tc_L4U7LXXQPUa8KSBMQzgFwg_20_0"></a><a id="Tc_R5Cr_alUGE-dx6cJiIcdOw_22_0"></a><a id="Tc_9YtGHcHHqkeIhkmjB4BWdA_24_0"></a><a id="Tc_zgwo2O-71UOucziBkXuZog_25_0"></a><a id="Tc_b7YPFxd2TkuCsUaumzpk7w_25_2"></a><a id="Tc_4ezwDrSX5E6poONhIh0UIA_26_0"></a><a id="Tc_vI3cb__Ihka7tk52p4TXlw_26_2"></a><a id="Tc_8tAZ-vuJaEe8r5l7wnoN6g_27_0"></a><a id="Tc_ut7Z3sPElEOJiUOfGsd9KQ_27_2"></a><a id="Tc_8mDhhDSzPU2_WnZkQWV8JA_28_0"></a><a id="Tc_Cu7rJsWeHE-BoeZhLboxMQ_29_0"></a><a id="Tc_zXxzV8F2jkGQGg5IjegLJQ_30_0"></a><a id="Tc_Scna9YcI-0mmUsTfZH9MJA_32_0"></a><a id="Tc_4EX_K-dQkEGTvPoIiWzD4A_33_0"></a><a id="Tc_6iD0hk2sjEm7AAM3TDzYoQ_33_2"></a><a id="Tc_4J6K5GjlDkiMOmDEkCjsuQ_34_0"></a><a id="Tc_Cy5S2f-FG0OWM4C0cWQGLw_34_2"></a><a id="Tc_4weRSKgAyUi0jtkOBZvOjg_35_0"></a><a id="Tc_TOejlnafyk-FEZIdtpsOwQ_37_0"></a><a id="Tc_lIWtceBOw0qntSX5imfLQA_38_0"></a><a id="Tc_X_bdmcdRRU69tyJrtMZ5_A_38_2"></a><a id="Tc_KsbcNDOC1ka7aDpNiF97oQ_39_0"></a><a id="Tc_QFuSC1bynUKVgw1soef0BQ_39_2"></a><a id="Tc_dOf5j80470qTZEUgqI9Ixw_40_0"></a><a id="Tc_E92bS5uERUePns_f45k5gw_40_2"></a><a id="Tc_U5aaIVxUxUCCPSwGbFx6Kw_41_0"></a><a id="Tc_hDuJbOVOwU6vQkuQBGFmcw_41_2"></a><a id="Tc_5vgiZzAiPEa-nw-yTr3ohg_42_0"></a><a id="Tc_tnsOKxSnEkqsEJ2x6dhPsg_43_0"></a><a id="Tc_q4PLhEmHd0KUZslOQ6O0VA_44_0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-current assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Property, plant and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_KqTx97iDtEepw0dieCNGiw_6_4">3,376</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_r9d1JRzby0m19cKpEkQNdA_6_6">4,259</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_JfMvRZAciUCELlAsDbyh9A_7_4">3,508</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_Rz1pwDDghUCMbA3YPyWw9A_7_6">2,808</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Intangible asset</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">6/7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_aZIMjUgMXkeAqlmwMwgUvw_8_4">50,416</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_FpWBThdx80yHOrr1PFeBcg_8_6">50,416</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Long-term financial assets </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentRestrictedCashAndCashEquivalents" scale="3" id="Tc_WqLWRqtE5U6awMgu2ZEVMw_9_4">361</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentRestrictedCashAndCashEquivalents" scale="3" id="Tc_dRwRWPq4lEGqKGyePLvlCg_9_6">361</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total non-current assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentAssets" scale="3" id="Tc_H_TX4-RBgEusUcjZsVg5kQ_10_4">57,661</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentAssets" scale="3" id="Tc_iSS5gdub0UWxIygGJxLUKw_10_6">57,844</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Prepaid expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentPrepaidExpenses" scale="3" id="Tc_jss4oqSGk0K6yQhI7j0EPg_13_4">6,437</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentPrepaidExpenses" scale="3" id="Tc_STuYkcoPnkau9h43f1I6nw_13_6">4,708</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">9/14</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets" scale="3" id="Tc_1lt4CLRnJ0yYCNF5hCdyVg_14_4">246</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets" scale="3" id="Tc_gex5Nc9NdkK-OYR031GS2Q_14_6">408</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other current receivables </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherCurrentReceivables" scale="3" id="Tc_74uceI5_C0WMpjxARFGFUA_15_4">622</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherCurrentReceivables" scale="3" id="Tc_FcTrdD39QkK8F1TGa16Whg_15_6">392</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accounts receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentTradeReceivables" scale="3" id="Tc_gONCKNjjmUK3uvEpK0tixA_16_4">14,800</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term financial assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" scale="3" id="Tc_KFkfxVbp7EqiNJxj7Q8XUA_17_4">24,554</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" scale="3" id="Tc_pdpOQbzuU0efFmGP-leiTg_17_6">91,000</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Cash and cash equivalents </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_qFf6rwHw60SNgxsS-M1CKg_18_4">78,494</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_eVyQQb8h50mKuj2JxKysqg_18_6">31,586</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total current assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentAssets" scale="3" id="Tc_YxwJQa-4FUyobQoYMdHSPg_19_4">125,153</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentAssets" scale="3" id="Tc_Mn7zIig9W0amVaeiH_6tlA_19_6">128,094</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total assets </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Assets" scale="3" id="Tc_tXWyMYc9Q0St-PdzerykGw_20_4">182,814</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Assets" scale="3" id="Tc_z-czZT9HFECpGCbrk9yGWQ_20_6">185,938</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shareholders' equity and liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shareholders&#8217; equity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share capital </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IssuedCapital" scale="3" id="Tc_R8MkcRHD1EKSxbfW0E2paw_25_4">2,089</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IssuedCapital" scale="3" id="Tc_SIX1gXlHUUeB0yiOHFsbuQ_25_6">1,797</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share premium </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:SharePremium" scale="3" id="Tc_gM3NKdHh6EKIlByASVEx7w_26_4">474,907</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:SharePremium" scale="3" id="Tc_s_ef3GDCF0ec68B86LIqAA_26_6">431,323</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Treasury shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TreasuryShares" scale="3" id="Tc_isN3V_GfVUWNehOy7DfU7Q_27_4">105</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TreasuryShares" scale="3" id="Tc_lgT5gsKzZUqFsy3l1e11jg_27_6">124</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Currency translation differences</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" sign="-" scale="3" id="Tc_hv5MfWAWd0Wkp-6bdXr_tw_28_4">51</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="3" id="Tc_WlvyqTB1EEuutO9K_e6aRA_28_6">10</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accumulated losses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RetainedEarnings" sign="-" scale="3" id="Tc_LMH-0FuLCkSRRgKNycVyrQ_29_4">316,197</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RetainedEarnings" sign="-" scale="3" id="Tc_8vHCXkhYpUi9LeD-wGlqfg_29_6">264,015</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total shareholders&#8217; equity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_DMVbkRupgkmWqEFv3_D4xw_30_4">160,643</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_menIu7meSU6u6AayG1cIng_30_6">168,991</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Long-term lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentLeaseLiabilities" scale="3" id="Tc_OhjKNiliAU6aQpfL2BNwZg_33_4">2,825</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentLeaseLiabilities" scale="3" id="Tc_y_k-rlykR0eHSBSWDye-zQ_33_6">2,253</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Net employee defined benefit liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentProvisionsForEmployeeBenefits" scale="3" id="Tc_2MgioHri00O2DCFyZ6-DwA_34_4">5,770</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentProvisionsForEmployeeBenefits" scale="3" id="Tc_Pa-eKAgp502QpQiNEgEbYA_34_6">3,213</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total non-current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentLiabilities" scale="3" id="Tc_zbYFpENmJUuHGd6IycCzNw_35_4">8,595</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:NoncurrentLiabilities" scale="3" id="Tc_yWDf7CD0RUaARAYwKftcUw_35_6">5,466</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Trade and other payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" id="Tc_LJsxB-SuEEK1fODKiSHKJA_38_4">1,679</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" id="Tc_82xj4tPbhkyaoCkvSkQyIg_38_6">929</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities" scale="3" id="Tc_gFOYNiIvhUeOqPXs2PL-2A_39_4">11,087</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities" scale="3" id="Tc_NbXA44Q2zkawN0gX0_hCKg_39_6">9,417</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Deferred income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">14</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities" scale="3" id="Tc_0AfHkTfQ-Uu2APdKCvjMEQ_40_4">138</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities" scale="3" id="Tc_gm5cBTqAJUu2i74YYWCseQ_40_6">587</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentLeaseLiabilities" scale="3" id="Tc_UXq4o_SIJES51qs3bAIeAg_41_4">672</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentLeaseLiabilities" scale="3" id="Tc_gQmVLL5pB024ah3_8ZWbYA_41_6">548</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentLiabilities" scale="3" id="Tc_mk90Bo1yH0a16v3mqtBRlw_42_4">13,576</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentLiabilities" scale="3" id="Tc_r9p7iPcfSU-NVOG1NxWQOQ_42_6">11,481</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Liabilities" scale="3" id="Tc_L1YiS6twXkeQosa2UYitcw_43_4">22,171</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Liabilities" scale="3" id="Tc_9EDizDlzm02A-mU6R547BQ_43_6">16,947</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total shareholders&#8217; equity and liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:EquityAndLiabilities" scale="3" id="Tc_J0108HVN60WgtM3K-xGZqg_44_4">182,814</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:EquityAndLiabilities" scale="3" id="Tc_jxnC5gL4H02PCPWy_GqENA_44_6">185,938</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying notes are an integral part of these consolidated financial statements.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-5</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_e7163ab9_14ce_4bd1_afc3_1c73aa99b0f5"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">AC Immune SA</p><a id="ConsolidatedStatementsofIncomeLoss_50901"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">Consolidated Statements of Income/(Loss)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;">(<b style="font-weight:bold;">In CHF thousands, except for per-share data)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><a id="_bae1927b_7f33_4114_94c7_8a46f44d8e05"></a><a id="_1344c316_02ba_4627_9fab_c2a0473bce7b"></a><a id="Tc_lCsbFaTzd0yumx-Rpaqxow_1_2"></a><a id="Tc__x3KHfa51kKV3gcEACGsqg_2_2"></a><a id="Tc_5jdw6npawE6UxNO_vDP-4g_3_2"></a><a id="Tc_PnRPiUaRk0KQah1xALh7kg_3_4"></a><a id="Tc_h4smNEc7mkiUE3EfcNuudQ_3_6"></a><a id="Tc_JQCNby9JMUeMxjNFvZhKmA_3_8"></a><a id="Tc_SNh6KIdi7kSDs_uCK3nD8g_4_0"></a><a id="Tc_XyDYIxA_pkGT_Fjqgt7Ydg_5_0"></a><a id="Tc_nwux57In7E-hnP9FCSFJoA_5_2"></a><a id="Tc_OcDcsKJOQUWwt_Duv_XTeg_6_0"></a><a id="Tc_qTB5bYo-d0O5yIA9ETDk3w_8_0"></a><a id="Tc_AL5hdilxckWVY5fewp7UaQ_9_0"></a><a id="Tc_SxF-gGUcP0GfW3gKgDF0DA_9_2"></a><a id="Tc_9Mg4Eh_jiESwevy2C-ifTw_10_0"></a><a id="Tc_HYC-Xq-stk277zNnb6OziA_10_2"></a><a id="Tc_wXdz2se4QUWh9qt6jrHvow_11_0"></a><a id="Tc_ivlTKA7nMkylPYKHkmj7RQ_11_2"></a><a id="Tc_3AT2P6476USitb3jI2wY2Q_12_0"></a><a id="Tc_VfMaXjFyWE6UbKualbLv9Q_13_0"></a><a id="Tc_MURwcwVT3kenO2gyQ-pAGA_15_0"></a><a id="Tc_gvWbHfDyZ0GRWlVZdiecgw_15_2"></a><a id="Tc_XKTdTkYHTEucbLK1LOobJg_16_0"></a><a id="Tc_H9KCQ84-YECvbCY1Q2wQIA_16_2"></a><a id="Tc_b0_bF0VhDkqg1bZ-vfI9cg_17_0"></a><a id="Tc_Bqf0s32400WmyrA83J8NjA_17_2"></a><a id="Tc_u1rirt_fSEW-xg3QyMwG8g_18_0"></a><a id="Tc_oCq6JpwN_0WG7fXf9ZRZhg_20_0"></a><a id="Tc_tsG8wlu9VE6zROZ4vJ0ZRw_21_0"></a><a id="Tc_l9vxURLQ-ki6M0EkZRl3Og_21_2"></a><a id="Tc_NouRjBR7gEOsuf6D5sVkrA_22_0"></a><a id="Tc_lfD7oUtUCkSClJZJSwoprQ_24_0"></a><a id="Tc_PFk70kVADkaPxNSZcm_-bA_25_0"></a><a id="Tc_VhHR0OxbTE2hkOlc4rmpCw_25_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:38.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:38.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Revenue</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Contract revenue </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">14</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_3zdeJSxeL0qpsd6zTHIr5A_5_4">14,801</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_wahkRDWxOEuCC26KOt1dGg_5_6">3,935</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_Hm2fTpBJ2kuzLieBc3_w3Q_5_8">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total revenue</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Revenue" scale="3" id="Tc_2-aVimowUEu7bRMi5kEIIw_6_4">14,801</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Revenue" scale="3" id="Tc__W_xLPcJoU-3dqmJ8DgXFQ_6_6">3,935</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:Revenue" scale="3" id="Tc_wbpuKNVFX06pRyebAKMuoA_6_8">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Operating expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Research &amp; development expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" id="Tc_HXu7guXQLEWyZ_MkOxj-VA_9_4">54,606</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" id="Tc_oF7kDP__iEOisR4Fc7h4JQ_9_6">60,336</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="3" id="Tc_LFObzgdiP0SUW4hpGGOfnw_9_8">62,282</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">General &amp; administrative expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GeneralAndAdministrativeExpense" scale="3" id="Tc_KvVy_L_q9UGNDtECOlfjZg_10_4">15,305</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GeneralAndAdministrativeExpense" scale="3" id="Tc_vD0wpJKlBkWVIPH_eRljlA_10_6">15,789</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GeneralAndAdministrativeExpense" scale="3" id="Tc_PIK56W-UYk-RO3FPolWlbw_10_8">17,910</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other operating income/(expense), net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">14.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="3" id="Tc_X1bcJOIm9km9Vb2l6AHOow_11_4">1,486</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="3" id="Tc_4B9ZfnlsdkeHuNvjJHis2w_11_6">1,343</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="3" id="Tc_MRZuWtya8EWdAXaRUAc0GA_11_8">1,182</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total operating expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OperatingExpense" scale="3" id="Tc_3HzZFduTx0u_Dn8muaqdGg_12_4">68,425</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OperatingExpense" scale="3" id="Tc_M2qWhv0aBkiNzeKY6uJ0NQ_12_6">74,782</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OperatingExpense" scale="3" id="Tc_q6Kjk9Tl10-c12pwPpMLdw_12_8">79,010</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Operating loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossFromOperatingActivities" sign="-" scale="3" id="Tc_0pz8TFTYNUWti-UAe5vlUA_13_4">53,624</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossFromOperatingActivities" sign="-" scale="3" id="Tc_2Zswfw5FX061opAAcaFEkQ_13_6">70,847</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossFromOperatingActivities" sign="-" scale="3" id="Tc_LhFVOnLUEkWH-JUz2rs6jA_13_8">79,010</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Financial income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncome" scale="3" id="Tc_32hddMMjwUuDGMmYetqn1g_15_4">1,044</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncome" scale="3" id="Tc_y84j-vyrJkmMXoSVYghXbw_15_6">69</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncome" scale="3" id="Tc_wbHpj6jEAUqZSgu-jww7xA_15_8">6,485</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Financial expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceCosts" scale="3" id="Tc_2CSNeL-id0SMYwMeg78iJA_16_4">176</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceCosts" scale="3" id="Tc_kdpYILw4ZkK1vb6MmEqPjg_16_6">355</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceCosts" scale="3" id="Tc_XuxqCtZe50K7GWyrBw8kzw_16_8">581</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exchange differences</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" sign="-" scale="3" id="Tc_n0RL7pEXeEG4zd1eXItzPQ_17_4">1,467</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="3" id="Tc_nmnhTj2zHE-R4Uwqxpxkpw_17_6">393</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="3" id="Tc_bs6ryLm_DEWtxgPvwnrskg_17_8">113</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Finance result, net</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncomeCost" sign="-" scale="3" id="Tc_9w2gA47-IE-BG08hbeXwAA_18_4">599</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncomeCost" scale="3" id="Tc_Js8dnHqXu0i4iiQ9NGl1kw_18_6">107</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncomeCost" scale="3" id="Tc_u1WEqhzmA0CkEhlHbmYBuQ_18_8">6,017</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Loss before tax</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossBeforeTax" sign="-" scale="3" id="Tc_3Z6wVYfcMUWLwN5S9AfGlg_20_4">54,223</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossBeforeTax" sign="-" scale="3" id="Tc_ti3315O680mQ-fvIq2X-Rw_20_6">70,740</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossBeforeTax" sign="-" scale="3" id="Tc_olehwZ_PQUqyJTzzrlnr4g_20_8">72,993</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Income tax expense </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">17</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" id="Tc_XvxTf42A_0KoVHjHCTUWGA_21_4">10</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" id="Tc_EjH3t1e7GkuT9NEutOMyxQ_21_6">13</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" id="Tc_qXkZnRudG0e5oW0HTfPLiw_21_8">3</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Loss for the period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_sMaaySHJZ02YSYcPJrCndw_22_4">54,233</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_yVIdrTAg1Eq-7PhtfXxdOQ_22_6">70,753</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_u1pRzKfLq0u9S_iANJK6hQ_22_8">72,996</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Loss per share:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted loss for the period attributable to equity holders</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">21</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:BasicEarningsLossPerShare" sign="-" scale="0" id="Tc_Nv-5J-YKrEKRVYEGaBG31g_25_4"><ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:DilutedEarningsLossPerShare" sign="-" scale="0" id="Tc_Nv-5J-YKrEKRVYEGaBG31g_25_4_2">0.64</ix:nonFraction></ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:BasicEarningsLossPerShare" sign="-" scale="0" id="Tc_HVarc84yLku9Lsla63hEwA_25_6"><ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:DilutedEarningsLossPerShare" sign="-" scale="0" id="Tc_HVarc84yLku9Lsla63hEwA_25_6_2">0.85</ix:nonFraction></ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:BasicEarningsLossPerShare" sign="-" scale="0" id="Tc_dWDUubRAIkGrsqOrNWOz7w_25_8"><ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:DilutedEarningsLossPerShare" sign="-" scale="0" id="Tc_dWDUubRAIkGrsqOrNWOz7w_25_8_2">0.97</ix:nonFraction></ix:nonFraction>)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><a id="_abadd73f_a03b_4411_8683_bfc6a0388284"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">Consolidated Statements of Comprehensive Income/(Loss)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">(In CHF thousands)</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><a id="_f4767c4d_8acc_4c14_9f5a_2abf981cc067"></a><a id="Tc_OLLi59i6PUS4VDs2cJbFww_1_2"></a><a id="Tc_CaIw-PT7eU6MQqWT3Xr6EA_2_2"></a><a id="Tc_5XhTthIR3ka2KQ-FgRV1iw_3_2"></a><a id="Tc_eQ_EdoD8c0ufwQUBEbXeMQ_3_4"></a><a id="Tc_TYoU1LGqc0qWNS44K7LE2g_3_6"></a><a id="Tc_Gzem-e7oREKCFbc4W_O3Sg_3_8"></a><a id="Tc_fQwhhCRmh0Wh5ssT-QL3ow_4_0"></a><a id="Tc_7UHUMnfvR0ie46795jMTQw_5_0"></a><a id="Tc_tfx2NtZm30azbH9BHD81_w_6_0"></a><a id="Tc_t4PILATG7UadOLcccJNeww_7_0"></a><a id="Tc_f8uJpZnzrU6CKQoqNR1Yag_8_0"></a><a id="Tc__nGbx3OyG02v1VNzecWdjQ_8_2"></a><a id="Tc_e2Qf2P-KqkSkCuMZgllXLw_9_0"></a><a id="Tc_HtvQjEYPy06fopZMC36Wyg_10_0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:38.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:38.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Loss for the period </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_7OyHC7KvQUWkIiWjRtRqdg_4_4">54,233</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_F4ihZhMEZ0S-xEc9EeG1gw_4_6">70,753</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_YATofSVHw0W47HOBCwpukg_4_8">72,996</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Items that may be reclassified to income or loss in subsequent periods (net of tax):</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Currency translation differences</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" sign="-" scale="3" id="Tc_NcT3t1hYc0656hEqKnwaSA_6_4">61</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" id="Tc_6kFOQHU2S0a3GSEzrIY0dg_6_6">10</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="3" id="Tc_9HT8HTmCakKvTbpIVM2_ag_6_8">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Items that will not to be reclassified to income or loss in subsequent periods (net of tax):</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Remeasurement gains/(losses) on defined-benefit plans (net of tax)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"> 18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" sign="-" scale="3" id="Tc_Kj-AryQPbk2I3HgntYWSWw_8_4">1,669</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="Tc_dfmIeKpezkWH8A-AjxSoKQ_8_6">4,426</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="Tc_jwjadhRwF0-LNdrPOUPgmA_8_8">956</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other comprehensive income/(loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" sign="-" scale="3" id="Tc_au1svJ5K80qZmPRfZlWDsw_9_4">1,730</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_PySK_L3N5Eqa0yMr-OCNzg_9_6">4,436</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_xw5TyRE_5kWU0Akh8z2Aew_9_8">956</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:59.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total comprehensive loss, net of tax </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc__ne9MlVkPEWK_Jcyds1Y1g_10_4">55,963</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_5rmCwe5hokeyLmkUJEM4BA_10_6">66,317</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_APVn7niRzkayFrWQFQwzog_10_8">72,040</ix:nonFraction>)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying notes are an integral part of these consolidated financial statements.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-6</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_06efddb8_86bb_49ef_bd84_a5e26becd10c"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">AC Immune SA</p><a id="ConsolidatedStatementsofChangesinEquity_"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">Consolidated Statements of Changes in Equity</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">(In CHF thousands)</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><a id="_7d1b9b74_d44d_4518_b6c7_3ffaded049fc"></a><a id="Tc_9A4pu8X9gUeU9vETtohIzg_1_12"></a><a id="Tc_9r6XL7bj0EOMEm0HbetIcQ_2_4"></a><a id="Tc_WzgwFWROzECKC917FmmQ2A_2_6"></a><a id="Tc_2b45OZVaN0y0RyzsPWTPBw_2_8"></a><a id="Tc_wppDl_ybxU6UVipgijBkJw_2_10"></a><a id="Tc_jYuUPfnrfUy2qmxnb34ghw_2_12"></a><a id="Tc_A8fnZN0ObEOVFl5ylucg-g_3_2"></a><a id="Tc_tpU0j14vW0ejWvKHYbDwnA_3_4"></a><a id="Tc_AjQvlgskT0i3a1ajerDbXA_3_6"></a><a id="Tc_AIX80NjuQU-luHJEkkhAMg_3_8"></a><a id="Tc_EbwQOhj39EqBrAqQnMr2ug_3_10"></a><a id="Tc_cDg7ccM8b0aOaFeyQ0jW6A_3_12"></a><a id="Tc_RTvhiLrz00SZlF4LyFzqNw_3_14"></a><a id="Tc_mpYKU_lKrUml7CQ62mLYDw_4_0"></a><a id="Tc_gidRTvrX-U2Dxnfg59ldMg_4_12"></a><a id="Tc_IuvAYgJ9MU2kcb5fF1UF2w_5_0"></a><a id="Tc_eP5FOHRrHEiaw2zCRocnqQ_5_4"></a><a id="Tc_uT-Vl2dbmEq9M-_ZC26iRw_5_6"></a><a id="Tc_tiHopZTmO06dz93cJuGxFA_5_8"></a><a id="Tc_mqxyfhxMdUaGntwHGWX5fw_5_12"></a><a id="Tc_xCYC-XJ1yU2OINBkwVEPeQ_6_0"></a><a id="Tc_zGdXI_XJf0i64I_Tg8vOhw_6_2"></a><a id="Tc_i_3cDb4qrkiB_QPKJyOyxQ_6_4"></a><a id="Tc_kioAXV6uGEqA6xKvU5LnFw_6_6"></a><a id="Tc_Svx-u3tp8EqoetK02v_n4w_6_8"></a><a id="Tc_LQbGfG4R8UKnSAhIWWPCQQ_6_12"></a><a id="Tc_JU26sZMOmkmBAtg8p7SDtQ_7_0"></a><a id="Tc_zNVegwsjzUejhWWggMVMIA_7_4"></a><a id="Tc_za3gxv-xY0mXBXt0XkWTOw_7_6"></a><a id="Tc_GQ0c91KJQkmzFybQW4Pjhg_7_8"></a><a id="Tc_zauApKHngUKUBl5jP_Niew_7_12"></a><a id="Tc_cwtP_M3ZE0CsVxGR4d7PDw_9_0"></a><a id="Tc_HPiLQ4dDLECiS922L8g5ag_9_2"></a><a id="Tc_ta38ak5A_Eerrh8pb_R4qg_9_4"></a><a id="Tc_37z6iYCpUE-74oezIPUgtA_9_6"></a><a id="Tc_WXl5NxUXiUCgKKQwsf3rJg_9_8"></a><a id="Tc_QkDQV4yqXk-uWPGSNxhoHQ_9_12"></a><a id="Tc_kKU90A8fSkKFLoSksToL7A_10_0"></a><a id="Tc_Gw24QS1NbU2sb1owLkw7Fw_10_4"></a><a id="Tc_jx3X9lB9qUGE8LlFnXnzLw_10_10"></a><a id="Tc_fqAcbCttbUGNMxouRBkW2g_10_12"></a><a id="Tc_nQg3NlaOg0OhTeGU_eyBfA_11_0"></a><a id="Tc_yA_YOSbA9kCn0vi63__LmQ_12_0"></a><a id="Tc_vsRQ8eUew0K99AMvfX-1Vg_12_2"></a><a id="Tc_5fKSNI_w202WPXFKKRvzSg_12_8"></a><a id="Tc_FOn3O3kJdEC5H4xI8AkI-w_12_10"></a><a id="Tc_bFEqvKJWnE-O5JEgyC3Iig_12_12"></a><a id="Tc_d37ey2JIfkuSG9Gh_-GlwA_13_0"></a><a id="Tc_waSCPJr7bU2eVGi_bhtYIg_13_2"></a><a id="Tc_VlFNzOC0W0CJHnHdJbrEWA_13_8"></a><a id="Tc_DPcJrCiNV0GHN-r80tgglA_13_10"></a><a id="Tc_XKKi97aug0GWYhRgSyFKvQ_13_12"></a><a id="Tc_XXkSC86ENESvOBbf8yfBbw_14_0"></a><a id="Tc_IR5QsWKSdUqzn9ofXeuWtg_14_2"></a><a id="Tc_L1Y4XmDDYkKQwYv3yK6rGw_14_8"></a><a id="Tc_mD86AkWX7EGL8es4sI2smw_14_10"></a><a id="Tc_VrHmymHc-UCdYK9dV1K8Pg_14_12"></a><a id="Tc_qGHYfLZ9U0Kirx8H-uy8rg_15_0"></a><a id="Tc_gOTvYw3-ekKxQvAQn_EDLw_15_2"></a><a id="Tc_SUrfpvCBpE666TT8Fs2_4Q_15_6"></a><a id="Tc_5jQpmhPpSker3YqnMfb1Zg_15_10"></a><a id="Tc_23e77cdLwkyN7x5PzBqwNw_15_12"></a><a id="Tc_VrBGkInMe06fTfBUgoRw4Q_15_14"></a><a id="Tc_m068FjscGESJPDFEjKPQGQ_16_0"></a><a id="Tc_AL5B-4P1f0-mjbakQ3Aa3g_16_2"></a><a id="Tc_UmQCF_FKi06tto-x4ZoiqQ_16_8"></a><a id="Tc_h24fJgU6eU6EgaE-I8Nt3A_16_12"></a><a id="Tc_FesjAxoWGkW0VRJyA9IOpw_17_0"></a><a id="Tc_RmGFqPe3aUSCH3iOwQoI5g_17_2"></a><a id="Tc_JrqL-41ghkqpScj496hF8w_17_8"></a><a id="Tc_wwYgYPG2a0SGTqGMo_JG5w_17_10"></a><a id="Tc_pWIlpq4nFEGXIkAzK6Kvqw_17_12"></a><a id="Tc_LlZwilQC10WB1rwF0iK3OA_18_0"></a><a id="Tc_RymPL-r5VEGVB5fYhvoIsA_18_12"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:35.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:35.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Currency </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Treasury</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">translation </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">premium</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">losses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">differences</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of January 1, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_XpmQIKbzzk-A4QLCviO8sw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_Wid9JSUllUaqPebUi1enVw_4_4">1,538</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_x2Rf-qjjC0q1OoOX5aYBuw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_N8Ravae_okqABtt0d-iQXQ_4_6">346,890</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_N2SF2wL5eUe8CGabD_HwrA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_79nF2h-ty02JzgfJNUszSw_4_8">100</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_4Nainf_0SEuwFd4uqOjiSQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_CFX0Pf2dPkaRaVisaP1z-w_4_10">132,850</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2020_kISrj4aRVketNj-9seXAtQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_PeAoRhZCKkaLbGcVbTIuWw_4_14">215,478</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Net loss for the period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_JT6GJaAKkE28v8kpSUYthw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_PtdbD5u7KEK0fD282FxcFA_5_10">72,996</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_b3jY_NfPn0KdFd0W1KjYjw_5_14">72,996</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other comprehensive income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_JT6GJaAKkE28v8kpSUYthw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_ZsJ6A9YNQUm0dvvnTUHxCQ_6_10">956</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_7Lea8Q86f0y_dBiiooh2dw_6_14">956</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total comprehensive loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_JT6GJaAKkE28v8kpSUYthw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_jUlMSsP5jE2YGo_rGMkgSw_7_10">72,040</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_aPHuBmRojEWdBOAjR-utjw_7_14">72,040</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_JT6GJaAKkE28v8kpSUYthw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_FN-zQ1xVZU2GP8n4u2fbYw_9_10">4,126</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_1qz6hah4NEKPlcBOnYz0SA_9_14">4,126</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_0AVWXMYRNE20fsfI1erXKg" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" scale="3" id="Tc_fptv6iWu9Eqn6hnbR8aydA_10_6">12,097</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_VpbnclTokEKa1COLbTmtgQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" scale="3" id="Tc__KqnZVXfREO_gxI2Mpalhg_10_8">24</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" scale="3" id="Tc_hK7_PYUv9E-SNkYQ3O4XTw_10_14">12,121</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Issuance of shares, net of transaction costs:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">IPR&amp;D asset purchase</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_qxkJG_5AGkCst7uW2JVkmg" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" scale="3" id="Tc_bz9KBFaP30CIMcpMv1oeFg_12_4">130</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_0AVWXMYRNE20fsfI1erXKg" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" scale="3" id="Tc_gtuUl1RCzkaJIrqJySs1Rw_12_6">49,741</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" scale="3" id="Tc_7vyaXyrfWUy7rqubq23mww_12_14">49,871</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Asset acquisition - common shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_qxkJG_5AGkCst7uW2JVkmg" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseThroughAcquisitionOfAssetsEquity" scale="3" id="Tc_DlzAd9b2pEC_PTeAioI1YQ_13_4">12</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_0AVWXMYRNE20fsfI1erXKg" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseThroughAcquisitionOfAssetsEquity" scale="3" id="Tc_vbZnZBOMl0W7pP4AvNYx3A_13_6">4,587</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseThroughAcquisitionOfAssetsEquity" scale="3" id="Tc_jnBixp-3y0W_VyNYQaNCww_13_14">4,599</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Conversion note agreements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_qxkJG_5AGkCst7uW2JVkmg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments" scale="3" id="Tc_c_1YCjI-ZUmG6W_iLTAMLg_14_4">61</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_0AVWXMYRNE20fsfI1erXKg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments" scale="3" id="Tc_9224pxVsi0KVuJkAzTnFiw_14_6">16,683</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments" scale="3" id="Tc_3t1tUG9TNE2YxvR-8a69sg_14_14">16,744</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Held as treasury shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_qxkJG_5AGkCst7uW2JVkmg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" scale="3" id="Tc_hSEj08DS5kyv02pt17-KMA_15_4">48</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_VpbnclTokEKa1COLbTmtgQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions" sign="-" scale="3" id="Tc_aO31JmUwt0CBTw_AiMCbKQ_15_8">48</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Restricted share awards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_qxkJG_5AGkCst7uW2JVkmg" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssueOfEquityRestrictedShareAwards" scale="3" id="Tc_ymS9drJQQU2w-k7aoRyFNA_16_4">1</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_0AVWXMYRNE20fsfI1erXKg" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssueOfEquityRestrictedShareAwards" scale="3" id="Tc_z7GvliuWaEmL9xvI9wBF0Q_16_6">171</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_JT6GJaAKkE28v8kpSUYthw" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssueOfEquityRestrictedShareAwards" sign="-" scale="3" id="Tc__yvQ2y7IaEC3WTWNaYFr7Q_16_10">178</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssueOfEquityRestrictedShareAwards" sign="-" scale="3" id="Tc_gZdDalFZBU-38AL53SN0kw_16_14">6</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Exercise of options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_qxkJG_5AGkCst7uW2JVkmg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_Irgq7QhifkmeBnpsxhzmcg_17_4">4</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_0AVWXMYRNE20fsfI1erXKg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_0jXnp6q21kWOnuY0utxcaQ_17_6">1,082</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_Rv3zTKW1YkerFaae916eLA_17_14">1,086</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_M0EemXYDV0aBwNXVy2D5wA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_KZ-z9t-gFU-fx1LY0K0BJg_18_4">1,794</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_qGLJKw1KlEeLkJJRaoX5Rw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_GrjnK2VfK0iSwY_909yxlQ_18_6">431,251</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_YIPudTTsa0KFHmU0vwZo5w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_LFyVktCBfkieIWD30lVBvQ_18_8">124</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_3boVlL-e1EKk5lMRqO3nuA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_5kaBTl74PE272Qb8izK8uQ_18_10">200,942</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_ILI9LGejcUCCqEQ2fdDAkQ_18_14">231,979</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><a id="_d1b12acc_d421_4da4_94a1_f149e4304d10"></a><a id="Tc_bxImhoc5aEaxgiN8a5sYog_1_12"></a><a id="Tc_CnZsnKyN3kiy6ooGNI7oSQ_2_4"></a><a id="Tc_6U_m2lrqw0On9DUIwqjlyg_2_6"></a><a id="Tc_mqL7dj3ELEadb0URWCYOyw_2_8"></a><a id="Tc_96hcDnKvaUugkfghW_ddQw_2_10"></a><a id="Tc_uHa-QF8rukqp0_x2me2pVg_2_12"></a><a id="Tc_7warXs7uGEqbuUUs9EWVqw_3_2"></a><a id="Tc_0fxeIjhP20qFW4mXEtpU7g_3_4"></a><a id="Tc_uctN6hujuEmSE3M3uUQkqg_3_6"></a><a id="Tc_UIKqULEwX0K8As_EcEd80w_3_8"></a><a id="Tc_6va9wPbpYEiumXXiJKKr2g_3_10"></a><a id="Tc_rwM0XRXOSUGTlQJY_YIRSA_3_12"></a><a id="Tc_UUeDkveMf06qVbaeYiQN_A_3_14"></a><a id="Tc_drYmP48np0WQHpfLbYukqg_4_0"></a><a id="Tc_-Jk_jFmTNU-dAHjYwpQiVA_4_12"></a><a id="Tc_DSlA8gZT5UOaTKiD9WY89Q_5_0"></a><a id="Tc_Iw5OgYpET06tEayBg-a-KQ_5_4"></a><a id="Tc_y0TCjeWgcUaWZlXpEhR_sQ_5_6"></a><a id="Tc_EbV1YSyHYkuwcujuLjRCdg_5_8"></a><a id="Tc_74Kq486FeEeSnJHO4n8IIg_5_12"></a><a id="Tc__ytrv2d_pkeD11IAFdtRTA_6_0"></a><a id="Tc_7NgJV0bLCEGm6wiWuP89tA_6_2"></a><a id="Tc_ABXebjwXvEejFvvbFaS4PA_6_4"></a><a id="Tc_q7moobLi4E2iPe2D5sp26w_6_6"></a><a id="Tc_RpDEPdgPQ0u-iQaKrfSbUw_6_8"></a><a id="Tc_nfxLBpJtDka1ThJlRi0MOw_7_0"></a><a id="Tc_L5JhuKP5J0StSFwWPhe-7A_7_4"></a><a id="Tc_oa5pyvplSkOZ958tDIQN8g_7_6"></a><a id="Tc_U5fOxKRTnEmCDZ6vZZRLMA_7_8"></a><a id="Tc_z_tcDW3Lv0ih0J3ats_euw_9_0"></a><a id="Tc_mURIsDgNh0OSZBctHzsA5Q_9_2"></a><a id="Tc_foTt5Kp6i0Key9F7_SmoHA_9_4"></a><a id="Tc_hJkLD32S2kGkKEt3yQoupA_9_6"></a><a id="Tc_og1xzNNBuE-Yb0gTaM-Xlg_9_8"></a><a id="Tc_80G6_6Z7i0KVggjYGESGkQ_9_12"></a><a id="Tc_S4gQLQjvCEex-ianuS-29Q_10_0"></a><a id="Tc_8AK5Fa2QtkGm2YSy27LTvQ_10_2"></a><a id="Tc_EE8WLY3ZpUuVXK4TWIGCFg_10_4"></a><a id="Tc_yzn7neZQtE6f8vgqIYtpcA_10_10"></a><a id="Tc_CY-6fmFBdEKrUEXkl5Acyw_10_12"></a><a id="Tc_84wQFFJ5pEqUKfzpgkGULA_11_0"></a><a id="Tc_tDIwYeDuok65ge5gUsfbmw_11_14"></a><a id="Tc_2Wn-6MEXbE6T4XZljSPLaw_12_0"></a><a id="Tc_X1tDD-pJaE63vlxo8NdkSA_12_2"></a><a id="Tc_EFzq5BAehUusKb2WTh-BtA_12_8"></a><a id="Tc_PDgBWEl1f0WHfhkb9Fvu7A_12_12"></a><a id="Tc_8sfjf45ytkKkbJ6BhO8oTA_13_0"></a><a id="Tc_5T0qYXWp1UeFsqw5K9e8LQ_13_2"></a><a id="Tc_1g4_0bUPMUixL-7WgQd2ww_13_8"></a><a id="Tc_XDW0XTIZk0WvaaLtGNfFQg_13_10"></a><a id="Tc_ojXzsU0epEy7Ub4oC603-A_13_12"></a><a id="Tc_1vSBzoTmXkmTu5zwCP8geQ_14_0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:35.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:35.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Currency </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:35.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Treasury</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">translation </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:35.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">premium</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">losses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">differences</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:35.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of January 1, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_M0EemXYDV0aBwNXVy2D5wA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_-G5IxysNIEGuMtDNn69t_A_4_4">1,794</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_qGLJKw1KlEeLkJJRaoX5Rw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_0pAuzO5e4UmKvjMuDWJ0dg_4_6">431,251</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_YIPudTTsa0KFHmU0vwZo5w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_upu9XhA14k2_BiTWAr0cGw_4_8">124</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_3boVlL-e1EKk5lMRqO3nuA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_DD06s3mJ4ECpTr7z8Ec1yw_4_10">200,942</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_pBWQSsq_GkSiS-tI0pE07g_4_14">231,979</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Net loss for the period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_vS7Y6wSi3Um8_4n891ZL5w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_02pU0KLjnkCNmqxn-1z5Iw_5_10">70,753</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_Mie1xR7-rUqr_BdUAHNCsg_5_14">70,753</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other comprehensive income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_vS7Y6wSi3Um8_4n891ZL5w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_2yow6WcHTE6SVv68Je4RmQ_6_10">4,426</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_O8tZdJpRvEaGkATdj9JKqA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_v5_Cyvz40k2Otx9Mpgb8WQ_6_12">10</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" scale="3" id="Tc_LEWvJezpOEOgB3Hglc3kBQ_6_14">4,436</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total comprehensive loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_vS7Y6wSi3Um8_4n891ZL5w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_9xL38Y93OUOyUE-MOGZYGg_7_10">66,327</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_O8tZdJpRvEaGkATdj9JKqA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" scale="3" id="Tc_tn1GazP9H0S9grVqSDAaRg_7_12">10</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_OlekY10TSE-pUX35PqzkpA_7_14">66,317</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:35.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_vS7Y6wSi3Um8_4n891ZL5w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_xF-OIN1d_06uJ0hclcV5_g_9_10">3,330</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_Y_KYZf8vt0-Vp0t3odjgWA_9_14">3,330</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_SWcjwMgDv0e8bZSucJUMHQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" sign="-" scale="3" id="Tc_eojbgN3k7kOs4yzcrZdlsw_10_6">8</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_tP2T60QRpUq6QbSwDp-rdw" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" scale="3" id="Tc_WxjQe5apVUS4S2OgxaczcQ_10_8">0</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" sign="-" scale="3" id="Tc_GPe9EIpDaUG_QrLrnpELnw_10_14">8</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Issuance of shares, net of transaction costs:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:35.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Restricted share awards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_I-ActLB-JUyJBWOVjhi2gA" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssueOfEquityRestrictedShareAwards" scale="3" id="Tc_MSmczdU0XEiiO_Mv5_EBwg_12_4">0</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_SWcjwMgDv0e8bZSucJUMHQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssueOfEquityRestrictedShareAwards" scale="3" id="Tc_zsRhUBZHrUKBEJ66LM8Iag_12_6">76</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_vS7Y6wSi3Um8_4n891ZL5w" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssueOfEquityRestrictedShareAwards" sign="-" scale="3" id="Tc_zpcZO-Im2EuYrFYSnlleGQ_12_10">76</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssueOfEquityRestrictedShareAwards" scale="3" id="Tc_9iUksCYFsEyUfNLzz7U27g_12_14">0</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Exercise of options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_I-ActLB-JUyJBWOVjhi2gA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_sLyw2qaa2Ea70sqV255izA_13_4">3</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_SWcjwMgDv0e8bZSucJUMHQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_gkeemmdUT0CIb1F_NUaEFQ_13_6">4</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_mxoe8g0VKkGc3b8XJud0RA_13_14">7</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_BQ7VKwgtOkWlTCNJHXciww" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_DjyqYgd8VU6oHl3RcPYH2A_14_4">1,797</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EBAKwd98FkqCN-vAl_B6vg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_icQ_D4CV70C0RdsCazlibg_14_6">431,323</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_gyBgxwFR8kautCu5uepUmg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_vgGmmQFTrEa3y2dcJrxGgg_14_8">124</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_xRUXLA2a4UCunihbdGlUlg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_yqP7szhkzEyCsjEMpVnQKw_14_10">264,015</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_VRz4mc9TT0moisjLJVOICA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_XkgPrsYZw0CtPXKv6DCSOQ_14_12">10</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_B134O9-KXUS7hfchpQAr6g_14_14">168,991</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><a id="_c5200fb1_5ba2_4295_a170_9632b5f92be2"></a><a id="Tc_ZjndETYpMUK8V_BOx5Lmhg_1_12"></a><a id="Tc_eOSTedARSk-iCzV3corfyQ_2_4"></a><a id="Tc_GsgbWJ_4REu38EF8LXIYGA_2_6"></a><a id="Tc_rQeh9rJYZ0u9OFLMIy2hbg_2_8"></a><a id="Tc_cOAVQFd7FEaqyzrTMynVyg_2_10"></a><a id="Tc_0AEyXCUBVUCfgSTDAlfr4w_2_12"></a><a id="Tc_44MhszMZxkGjWkGAEVVjLw_3_2"></a><a id="Tc_pPgPFM81hkeazna-1KBr2w_3_4"></a><a id="Tc_CH6BbjnzAkGu1nKGhJVx0Q_3_6"></a><a id="Tc_H4KBLSW1BEuKIjGd0Ke8Sg_3_8"></a><a id="Tc_XRLsEYj2T0KjtM1kyNMOfw_3_10"></a><a id="Tc_Ze327WqPlEO0zF2OLyI4DA_3_12"></a><a id="Tc_RH1BPpOYZE-ddkxtvc6v-Q_3_14"></a><a id="Tc_w01IwLCnNE6uQQFYvoFDZw_4_0"></a><a id="Tc_jZTPvNEiLU2AoWhH29_1ig_5_0"></a><a id="Tc_LF2WPd4ioUqc9P9mXyV7RA_5_4"></a><a id="Tc_YWv0nQ4iE0uSNSuyraGOVQ_5_6"></a><a id="Tc_MPIW_b9gnkuzZ4VxfGzVmg_5_8"></a><a id="Tc_jo4Nfk2cO0CaLYSUr5_jjQ_5_12"></a><a id="Tc_0WseQKIYKkOZl7RJo6P-4A_6_0"></a><a id="Tc_TRtZl7vtOkGXtZ2Vr5uC4Q_6_2"></a><a id="Tc_UsdLqkxWPU29YBCHaDmMzw_6_4"></a><a id="Tc_7EssgbloVU-DfvqV9OnlRw_6_6"></a><a id="Tc_ZhOgr5pu8kqRluriKhzSXw_6_8"></a><a id="Tc_CU0IzvR35UGRkGQziUvb1w_7_0"></a><a id="Tc_E97gcwH0pE26YS3O90dbDQ_7_4"></a><a id="Tc_n3isSKeUfEKkqF5D8DhJXg_7_6"></a><a id="Tc_8PHLzA5LxkGAkXzLaCWKzQ_7_8"></a><a id="Tc_LaD6i9nVFUG_lNXHXbPTNA_9_0"></a><a id="Tc_ueiNAuYdiEau1ztpNNejRA_9_2"></a><a id="Tc_gip44PrvPUOejjzW5sTWeA_9_4"></a><a id="Tc_b-Q6CjJmxE69SMh051ucww_9_6"></a><a id="Tc_Zym-enzi7EyELNPl3hlSKQ_9_8"></a><a id="Tc_2HVDCFMeQ0WfurtPR23KvA_9_12"></a><a id="Tc_t93D_RMdKkKdMNxRZk9alg_10_0"></a><a id="Tc_EJy2WR-GakKL7NR8d1SIwA_10_2"></a><a id="Tc_E2MnoYy-jE-ZPLXhyuQtyQ_10_8"></a><a id="Tc_z0vwCe_KlEicWDRc_I6ZkQ_10_10"></a><a id="Tc_1xM4SGv64ESasH5XKmlsRA_10_12"></a><a id="Tc_LZA6b9somUW_O0T3Jy3nbA_11_0"></a><a id="Tc_iAXVCW3BiUGWlXWgyMr_mw_11_2"></a><a id="Tc_yu16UkjtYEeESnG6LfMSwg_11_4"></a><a id="Tc_7VG2NNJnb02GZJWN4dUa4w_11_10"></a><a id="Tc_JTdjt0EosUKkWiBpI2hwzg_11_12"></a><a id="Tc_5Vn2VJs-TkGbSSWBZqaqPQ_12_0"></a><a id="Tc_7nMxkZFz8EKKZB_D0YrJsQ_13_0"></a><a id="Tc_ACMCepx1CEigrNe2oszHxw_13_2"></a><a id="Tc_dnhMKDezb0aHT-a7YfvV6g_13_8"></a><a id="Tc_0MuqM4wSQU-C5TpoO-R0sA_13_12"></a><a id="Tc_oLElrPILy06WKJWxPwRCpQ_14_0"></a><a id="Tc_DCTG8RqgGEyjcpazSf2XxA_14_2"></a><a id="Tc_8ECnxJytB0mb1tZfrUvArQ_14_8"></a><a id="Tc_GKNEl3J5i0y5DohXcebZSQ_14_10"></a><a id="Tc_y55enL1IwEuh1A607YXyCQ_14_12"></a><a id="Tc_lfXpg4lt4ky9QMtQbyH_ag_15_0"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:35.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:35.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Currency</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:35.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Treasury</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">translation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:35.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">premium</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">losses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">differences</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:35.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of January 1, 2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_BQ7VKwgtOkWlTCNJHXciww" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_6kHp3aSiH0WP1JzcQ3Hxxw_4_4">1,797</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EBAKwd98FkqCN-vAl_B6vg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_aiK3E6AB5UWEdd7J-Ysivg_4_6">431,323</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_gyBgxwFR8kautCu5uepUmg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_4uy2QUsMukmfeUJQpRLHTA_4_8">124</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_xRUXLA2a4UCunihbdGlUlg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_cOwYI0qY-UCUuuEsp8h9dw_4_10">264,015</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_VRz4mc9TT0moisjLJVOICA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_n_3z3-0Dhky4EGRY6WAQAw_4_12">10</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_pq3Vqm2vx0ONWY0eyCzdWA_4_14">168,991</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Net loss for the period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_-N7k4qC--ki40tn2usH_qQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_7PgWBmIIykSgOkU0QnAEIQ_5_10">54,233</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_orEyWOfHxU2Y5lkdFzZRdQ_5_14">54,233</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other comprehensive loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_-N7k4qC--ki40tn2usH_qQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" sign="-" scale="3" id="Tc_FeyFfFVQ6EaWTv4LunEzyg_6_10">1,669</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_yMfhf5U-BEOkEesawNwGtw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" sign="-" scale="3" id="Tc_sQFz6DUa1EWE7XMFyaTRcg_6_12">61</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncome" sign="-" scale="3" id="Tc_0GAojcIQbESwYmEkILcEGQ_6_14">1,730</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total comprehensive loss</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_-N7k4qC--ki40tn2usH_qQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_NtimvQKrGEC0mGl0KKBXvw_7_10">55,902</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_yMfhf5U-BEOkEesawNwGtw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc_wvfI_hbgR0mN45Y3MxPNsw_7_12">61</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ComprehensiveIncome" sign="-" scale="3" id="Tc__oN3dam3VESqo7ShbXgydA_7_14">55,963</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:35.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_-N7k4qC--ki40tn2usH_qQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_xncdO_Dp30SZPC5hmCMmag_9_10">4,365</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="3" id="Tc_xLVtE-zsOEShumktib2apQ_9_14">4,365</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Proceeds from public offerings, net of underwriting fees, transaction costs and stamp duty</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_orlAcRiayEeFUpKo8cWUgA" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost" scale="3" id="Tc_1tm6Xp2X9k6nBJFc02yPJw_10_4">286</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EY1gzyuyDkGmaP05xj1GQw" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost" scale="3" id="Tc_LNmdsqins0u35RLvqF67oQ_10_6">40,249</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost" scale="3" id="Tc_oOQ7E_ljc02ITh_DRFMdRw_10_14">40,535</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EY1gzyuyDkGmaP05xj1GQw" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" scale="3" id="Tc_DTfRViSLIUmK6P3rodcguA_11_6">2,631</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_Xg5G0gTL6EuVoA1i-tphyA" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" scale="3" id="Tc_P8VtG8iL_kqhyAY6tUG5AA_11_8">19</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" scale="3" id="Tc_xYkMD1UkPUGo3O0kton5Sg_11_14">2,650</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Issuance of shares, net of transaction costs:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:35.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Restricted share awards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_orlAcRiayEeFUpKo8cWUgA" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssueOfEquityRestrictedShareAwards" scale="3" id="Tc_bX99uWU-e0-n_4tX0kX93w_13_4">5</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EY1gzyuyDkGmaP05xj1GQw" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssueOfEquityRestrictedShareAwards" scale="3" id="Tc_Oh6GR0jnHEyZkDjo27xk6A_13_6">645</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_-N7k4qC--ki40tn2usH_qQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssueOfEquityRestrictedShareAwards" sign="-" scale="3" id="Tc_kGcQEwU03USKzP3VfOPphw_13_10">645</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssueOfEquityRestrictedShareAwards" scale="3" id="Tc_pgQvKEVOfkS_E8wVeCAmnw_13_14">5</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Exercise of options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_orlAcRiayEeFUpKo8cWUgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_vn5NnDbMRUuqW0VYZSmdsw_14_4">1</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EY1gzyuyDkGmaP05xj1GQw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_2ME7JT9Z_kiav0C77pjJvQ_14_6">59</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" scale="3" id="Tc_AX7WWrnIUk2p6mm3SdY9SA_14_14">60</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_BScHwbOd1k6qH5tEPUdwhw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_Ch6HN_P2kUGLX05X3w3hRQ_15_4">2,089</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_uUyHwiQf7UuXXrnxpFOqyA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_lMTRnhZAokW82Gs6f7LC5Q_15_6">474,907</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_nZ4TKeIWaU2aelb5_LYCwg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_jkkBLgme6k6l-NHbpkT20g_15_8">105</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_LnJjfw_Os02BiS6mZGfzUQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_86hXcGCdz0em9GWoEI0tRQ_15_10">316,197</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_VgBLVB9e1Uq5yTwvVD7SXQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_DQtzEDc1Q0GEzUITeOIW3Q_15_12">51</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_ALIxMup3k0CqpQ3DDZnGCg_15_14">160,643</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The accompanying notes are an integral part of these consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="font-size:5pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-7</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_e17921f8_7293_4d2b_8e1a_99803f42190e"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">AC Immune SA</p><a id="ConsolidatedStatementsofCashFlows_14317"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">Consolidated Statements of Cash Flows</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">(In CHF thousands)</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><a id="_b809213e_e5a9_4e6b_8cb0_ab394d9550d1"></a><a id="Tc_3FnI7P0qDk2nCigwbqUJow_1_2"></a><a id="Tc_QeOH7T5qAkWtF_mlg4Opuw_2_2"></a><a id="Tc_5DUzSwB5BUKNhponwC5baQ_3_2"></a><a id="Tc_UEOHGxhDLkOjOwFT1kGEDA_3_4"></a><a id="Tc_9pyB_X0oW06fCPPHMXlNaw_3_6"></a><a id="Tc_TtjiqcBMTUSZ1tWeOe6KJg_3_8"></a><a id="Tc_NKdGeoJOTEyT5GiQakwQCg_4_0"></a><a id="Tc_wXa87xf0D0ONRkK-jke9Fg_5_0"></a><a id="Tc_KWErKGrik0ujFSPxmumtNg_6_0"></a><a id="Tc_DMef6Gi5RUy3XbRTnkjlHw_7_0"></a><a id="Tc_QD3FodOgVUS-OClz5BM8UA_7_2"></a><a id="Tc_gOFtVqjGkUqOMfhL8ojYtw_8_0"></a><a id="Tc_i_RN9AdpA0K1zbiJYEi4Cg_8_2"></a><a id="Tc_zc5-XP87V0GwercOqtiXbw_9_0"></a><a id="Tc_e_1QiGdqxEmVjL04Fylmgg_9_2"></a><a id="Tc_YiHxtDZjmEKMN4PSv-zLOA_10_0"></a><a id="Tc_IcIvbQj4VUyPbW-PnccRdQ_10_2"></a><a id="Tc_OeVdArhfLEC-aJDLONMLHA_11_0"></a><a id="Tc_v32dgpljq0uXmbZ8se4rNA_11_2"></a><a id="Tc_F9xJSFFejUCawHnSqE3qxw_12_0"></a><a id="Tc_B6EDrFELAE-IjUQLJRNG5A_12_2"></a><a id="Tc_HPRpi3_nT0OZVqOFs8VtoA_13_0"></a><a id="Tc_N0yWvN_IuEeJJp_lUNYBbA_14_0"></a><a id="Tc_Ld53k9TuMk283MwzxVD5QQ_15_0"></a><a id="Tc_fMToVSgkN02O8C35JYRV1Q_15_2"></a><a id="Tc_p5Nje9ADGkagTyvNcdxZQQ_16_0"></a><a id="Tc_NZyrsOWXck6RQ_SjBeRhJg_16_2"></a><a id="Tc_kPXideRyf0y81zLJqaCvlA_17_0"></a><a id="Tc_0s0whIHMxUuwBiK3ASSbmQ_17_2"></a><a id="Tc_26O7RSzvAECz1CKc877A2A_17_6"></a><a id="Tc_P-SnAKWb6UGBYFFkV25htg_17_8"></a><a id="Tc_vhWx_4h6AUmU--zSxdwsgw_18_0"></a><a id="Tc_b4zvHwlqYkmS0g4nB6Evkg_18_2"></a><a id="Tc_KlqLssrsakWB2n4wOS_L8A_19_0"></a><a id="Tc_RBMuk3PFREyqEHG-tS1EWQ_19_2"></a><a id="Tc_3syzU_e6-U2WjQh1qEkinA_20_0"></a><a id="Tc_Or1oyW-lKkSBN1G4ViHUww_20_2"></a><a id="Tc_k415XOnE-E6yKjDLw5iYuA_21_0"></a><a id="Tc_UT9vTNetKEWAQA3HiXIdiw_21_2"></a><a id="Tc_UMjXhGgN6k-puRl16A3brQ_22_0"></a><a id="Tc_JRjaPLsAvEGwHAqKpzr1dA_23_0"></a><a id="Tc_3v-QokF6ZEqDp0HW1y9bWA_23_2"></a><a id="Tc_vCAvxnd-o0ur8-uqyoEDkA_24_0"></a><a id="Tc_tOUIRhC7z0i2gxZi9gq3MA_24_2"></a><a id="Tc_6qCOwrC3UkKA0EcYj_iYNg_25_0"></a><a id="Tc_ubdEUez-FECVd7x5pYiDig_25_2"></a><a id="Tc_0PqIt7-6VECj5K5_pDa6-A_26_0"></a><a id="Tc_hWktNroIGUqg5ZPSy8tyYw_28_0"></a><a id="Tc_lErURveiuES0qwOO08Qs3A_29_0"></a><a id="Tc_No63xfR-OEOct_25tJ_O_g_29_2"></a><a id="Tc_eVzY5YGlZ0yTaSvWu3TNBQ_30_0"></a><a id="Tc_JJzVLgjUn0-cF-jBRsbiOA_30_2"></a><a id="Tc_6sP45n9eME-eI-Jzoj_saw_31_0"></a><a id="Tc_rBbMsFtQBkqQ4XhRzdiN_A_31_2"></a><a id="Tc_l3OWA4f3bUu_UK3k_uD2Ww_32_0"></a><a id="Tc_NMOi2hfdqUGkVTX74kNZvA_34_0"></a><a id="Tc_j1fTFFPBcUG7xDQ_FgnpGQ_35_0"></a><a id="Tc_5KBdhu7_sUWky7B7VYE4hA_35_2"></a><a id="Tc_1vjtjNb-BEmqss9Wu6QgVg_36_0"></a><a id="Tc_ZvOGeQZldEmZDMZvjvjGCw_36_2"></a><a id="Tc_7a5Bk3lGHE6FBMCpW_GqLQ_37_0"></a><a id="Tc_S9xoLPi0JkuaLtFl83HdVQ_37_2"></a><a id="Tc_ZfpjZd72w0mqq_LlUOMpQQ_37_6"></a><a id="Tc_4ue3pNOOlEi7jQm_J3HGwA_37_8"></a><a id="Tc_j8fgd1cIGE-Ii-hCMpg_QQ_38_0"></a><a id="Tc_otLcxaQkzEWsKcZc9yhFrg_38_2"></a><a id="Tc_H8Rz5eZimEG_p0QDw9Mlhw_39_0"></a><a id="Tc_WPzczBDTmEmpNzmGGvfqlw_39_2"></a><a id="Tc_D-RU7pjzdUiA4QTCmppT2Q_40_0"></a><a id="Tc_Vx46lCIq0k-55Wfr5UOE-A_40_2"></a><a id="Tc_zIko8OloGkWC9lEi2O-3mw_41_0"></a><a id="Tc_yMy3FcIaCkycNlF5p5t5fQ_41_2"></a><a id="Tc_Uvw8nqM8TUycQCHGQpnMfA_42_0"></a><a id="Tc_VK1BoNdA2Uq8LLP6VDNFJQ_43_0"></a><a id="Tc_PWUTl3kpiUyXiXTt4AIR5Q_45_0"></a><a id="Tc_uv1VDriJ7UuSpuzxaX862w_47_0"></a><a id="Tc_Oqe66y16Hkyj27j1In89kg_48_0"></a><a id="Tc_BCgZkMh0sECopjrEroDqPw_49_0"></a><a id="Tc_SHKm-v2uRUaP1lHnoEvKbQ_51_0"></a><a id="Tc_Rbp7cE-PokiNIHqa8Ai6uQ_53_0"></a><a id="Tc_Md2sPkgUuUaIDdT5f_RgYw_54_0"></a><a id="Tc_uMatgcPuFUGK_qWtgzgGfg_54_2"></a><a id="Tc_w6v2Ff3rSkiiGAioT5qJtA_55_0"></a><a id="Tc_P5yzlXHP5E6Cf9ClA1bNnw_55_2"></a><a id="Tc_Er3hCCFzdUGUQ7_2cReAGA_56_0"></a><a id="Tc_RRNMQtLif064mwqEMo9aZQ_56_2"></a><a id="Tc_8tKiYAc6tU6v6rCWDFOzbQ_57_0"></a><a id="Tc_LUWW7_WYtUSYrwZiFLIpsg_57_2"></a><a id="Tc_Uxtj29X1PUyq5TrayuDXyw_58_0"></a><a id="Tc_xUzCIfAJ40WCCP4qudK98g_58_2"></a><a id="Tc_ovHd5Ll_ZUimEEfSXvNmbg_58_6"></a><a id="Tc_A45jFqJGfEaP6rw9M3ycng_58_8"></a><a id="Tc_2GxyfICwAUiKdnShvhUVpA_59_0"></a><a id="Tc_8mf6h58Gv0qrtk2Z1E3lTg_59_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:25.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:25.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Operating activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Loss for the period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_kv77R65N80OB3qoOilzkpg_5_4">54,233</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_dGCot9bTWEWNvO87iv4sFA_5_6">70,753</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLoss" sign="-" scale="3" id="Tc_CCTYAayMe0eOjcvSD-5PJA_5_8">72,996</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Adjustments to reconcile net loss for the period to net cash flows:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Depreciation of property, plant and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDepreciationExpense" scale="3" id="Tc_rLJKcBwRFU2ZKCc8xxYTqg_7_4">1,672</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDepreciationExpense" scale="3" id="Tc_Fn3gclFlKka9y6Vq4AOk2g_7_6">1,793</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDepreciationExpense" scale="3" id="Tc_Ac51hWn5kEyvGMtiU83cdQ_7_8">1,897</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Depreciation of right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="aciu:AdjustmentsForDepreciationExpenseRightOfUseAssets" scale="3" id="Tc_cfOPlutlpkS48GuiELhX2w_8_4">543</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="aciu:AdjustmentsForDepreciationExpenseRightOfUseAssets" scale="3" id="Tc_s-1Y-KgB002XfHZQTY7qvw_8_6">566</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:AdjustmentsForDepreciationExpenseRightOfUseAssets" scale="3" id="Tc_pkW2ebuVOkmUpTKVBMBYmw_8_8">509</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Finance (income)/expense, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForFinanceIncomeCost" sign="-" scale="3" id="Tc_Pm2KmD4KukWf4M81LWZBhg_9_4">922</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForFinanceIncomeCost" scale="3" id="Tc_uJnVAroxAEm7LwkwlrYeBg_9_6">559</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForFinanceIncomeCost" scale="3" id="Tc_FxXY5pUlKUKawJucyeGfqg_9_8">6,769</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Share-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="3" id="Tc_5xYtcCgX60--g_62eVXn8Q_10_4">4,365</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="3" id="Tc_Y6wSI7N5j0G6BS6jgDzu-w_10_6">3,330</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="3" id="Tc_XZcHLCgzqESK_kvzmCVwEQ_10_8">4,126</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Change in net employee defined benefit liability</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" scale="3" id="Tc_COZNW8ocBkOMSfp9SX7wFg_11_4">888</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" scale="3" id="Tc_S17aOkgSRECMX5qkuzNFEw_11_6">541</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" scale="3" id="Tc_x7dc2Q_RWU2Y6TBTyZ3p-w_11_8">590</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Interest expense </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5/15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForInterestExpense" scale="3" id="Tc_MrkxeZbLK0OmVbgJmr8_Xw_12_4">176</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForInterestExpense" scale="3" id="Tc_qlezLuFG7ka5L9KF5PXzAQ_12_6">355</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForInterestExpense" scale="3" id="Tc_WBB4lRgJ1UGTjjt9Y4ondg_12_8">573</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">(Gain)/loss on sale of fixed assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:zerodash" name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" scale="3" id="Tc_8wzoMGTt7UOGvAqK0IOeDg_13_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:zerodash" name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" scale="3" id="Tc_8_2Wbi1yJUq00iz26z69Ag_13_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" sign="-" scale="3" id="Tc_1BBlb9stV02gIxy0jFGAsw_13_8">13</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Changes in working capital:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">(Increase)/decrease in prepaid expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses" sign="-" scale="3" id="Tc_-oyPhVlTl0CksHSXHgEruw_15_4">1,748</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses" sign="-" scale="3" id="Tc_s4jjnMLi-E-enZtq465jlg_15_6">1,718</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses" scale="3" id="Tc_IV3Ip0X0sUKhDU1NdYRYHA_15_8">791</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">(Increase)/decrease in accrued income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets" scale="3" id="Tc_R5EDizm16kS5WCccYn86CA_16_4">162</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets" scale="3" id="Tc_Yvp72E-F6U6cp0aOvCB7Dg_16_6">567</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets" scale="3" id="Tc_WgUmmxud30u8MrmO4OytZQ_16_8">594</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">(Increase)/decrease in accounts receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" sign="-" scale="3" id="Tc_5rjqox6OWE6BropSoHGPFg_17_4">14,800</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">(Increase)/decrease in other current receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" sign="-" scale="3" id="Tc_OUpFKinshEeVBhIGm9uVgA_18_4">232</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" scale="3" id="Tc_CN9DgTUqVUelj0oWY61vuw_18_6">36</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" sign="-" scale="3" id="Tc_dJWDVa7Za0aJLXG-R7vzeg_18_8">99</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">(Decrease)/increase in accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="aciu:AdjustmentsForIncreaseDecreaseInAccruedExpenses" sign="-" scale="3" id="Tc_fLSXybMOJ06XomHbthP_0w_19_4">1,137</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="aciu:AdjustmentsForIncreaseDecreaseInAccruedExpenses" scale="3" id="Tc_u2MExGnvSUSpVAyi3lCygg_19_6">6,114</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:AdjustmentsForIncreaseDecreaseInAccruedExpenses" sign="-" scale="3" id="Tc_3SYrpY--IEytYq93j_edoQ_19_8">5,214</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">(Decrease)/increase in deferred income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">14</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" sign="-" scale="3" id="Tc_ygDSA_yEw02g69FXS4dpHA_20_4">449</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" sign="-" scale="3" id="Tc_gnGhhgIzUkWdGB-ftL7e5A_20_6">130</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" scale="3" id="Tc_pOOZVstyUE-bG-lo8BQMUw_20_8">425</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">(Decrease)/increase in trade and other payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" scale="3" id="Tc_YIBmC7UJukGEFUQLwcVHEg_21_4">770</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" sign="-" scale="3" id="Tc_KJcSKn3T5EqJnTDfw4a_Ew_21_6">1,073</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" sign="-" scale="3" id="Tc_aRf7CLt9EU-tpOgyGe8U1A_21_8">84</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cash used in operating activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInOperations" sign="-" scale="3" id="Tc_sGVIo89W00axl1cO7viczQ_22_4">60,827</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInOperations" sign="-" scale="3" id="Tc_ftMciTjs3U2yIh12iTpQCQ_22_6">73,159</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInOperations" sign="-" scale="3" id="Tc_udfdZIWHsEaUIsYXkOGQZg_22_8">65,216</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Interest received</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" scale="3" id="Tc_b5eOJibDWkaGS_b0iVS7_Q_23_4">595</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" scale="3" id="Tc_EmdHDZT4XUe9snx61i17jg_23_6">69</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" scale="3" id="Tc_Z1_kmFfbnUSYe3ihLDQ3bA_23_8">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Interest paid</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5/15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" scale="3" id="Tc_zGE4LOSrt0qyfadAHQruNw_24_4">163</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" scale="3" id="Tc_FRkkN4Ujuk6QlVStSRsKSg_24_6">470</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" scale="3" id="Tc_0w5gSP6wj0CfGOzUKIXanA_24_8">465</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Finance expenses paid</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities" scale="3" id="Tc_-ww_pMLEa0WFwcAOh34oXw_25_4">13</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities" scale="3" id="Tc_6gqTj-Z3pUW7R9-056iPiQ_25_6">8</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities" scale="3" id="Tc_SrET3LVfwU2Au9Ey8sei3w_25_8">8</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net cash flows used in operating activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" sign="-" scale="3" id="Tc_ZKT-xfcMxkydxHBOnj9A_A_26_4">60,408</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" sign="-" scale="3" id="Tc_DaAbyJ9uhkSyoHqbR7FrkQ_26_6">73,568</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" sign="-" scale="3" id="Tc_lOqWa_idp02gXW77_RMnOQ_26_8">65,689</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Investing activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Short-term financial assets, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="aciu:PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities" sign="-" scale="3" id="Tc_wgPTdhrUxkeFd-jH1MW13Q_29_4">66,446</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="aciu:PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities" sign="-" scale="3" id="Tc_4nCzRUBH0UGqAGPCJiaZDA_29_6">25,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities" scale="3" id="Tc_z-A1_mvoCkK2Gg1VYD0RbA_29_8">51,000</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Purchases of property, plant and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="Tc_ojYK8kVbOEOnf9-67UfZdw_30_4">801</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="Tc_emarYhn71ESdJwiEPltxLg_30_6">1,239</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="Tc_SGspuO4JDkaOd12MJq0Krg_30_8">2,635</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Rental deposits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:zerodash" name="aciu:CashAdvancesForRentDeposit" scale="3" id="Tc_ni2WiWO5xEOkfXycoH5pzw_31_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="aciu:CashAdvancesForRentDeposit" sign="-" scale="3" id="Tc_DiYImNB5SEybksQRKPOqfA_31_6">2</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:CashAdvancesForRentDeposit" scale="3" id="Tc_VXZ6kO9sgkOF8IKKm42CSQ_31_8">29</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net cash flows provided by/(used in) investing activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="3" id="Tc_nGS9aw625UGCgm0IRJTZKg_32_4">65,645</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="3" id="Tc_F-QrekcNXk2mtx3RkSyM_g_32_6">23,763</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" sign="-" scale="3" id="Tc_Jok31FD_tUOYXOSHlhZQAQ_32_8">53,664</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Financing activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Proceeds from issuance of convertible loan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:zerodash" name="aciu:ProceedsFromIssueOfConvertibleDebt" scale="3" id="Tc_iK0v0pgWj0Kih0kqnN0_7g_35_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:zerodash" name="aciu:ProceedsFromIssueOfConvertibleDebt" scale="3" id="Tc_UDSo-ve5SEiVNnwDcET2xQ_35_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:ProceedsFromIssueOfConvertibleDebt" scale="3" id="Tc_-R-s5ATtCE-eUnvdAjaT0A_35_8">23,463</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Transaction costs on issuance of shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:zerodash" name="ifrs-full:PaymentsForShareIssueCosts" scale="3" id="Tc_jDGB5Ugwi0ipXvXHDuANIg_36_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:zerodash" name="ifrs-full:PaymentsForShareIssueCosts" scale="3" id="Tc_aDvrxqXnNUmDp9OwFFxAQA_36_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PaymentsForShareIssueCosts" scale="3" id="Tc_QtiG1U2lREGSxg5opC08FA_36_8">6</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Proceeds from public offerings of common shares, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="aciu:ProceedsFromIssuanceOfPublicOfferingsOfCommonSharesNetOfUnderwritingFeesAndTransactionCosts" scale="3" id="Tc_ocXxnuWw2k24co-UlH4Mog_37_4">41,056</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="aciu:ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts" scale="3" id="Tc_Ju9nTkl67kWs9JPbtyNiSg_38_4">2,677</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="aciu:ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts" sign="-" scale="3" id="Tc_Z9T348MtH0Ww_3xHNFIHwg_38_6">8</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts" scale="3" id="Tc_9EhT5rmsOE6JmkliFyEFaw_38_8">12,121</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Proceeds from issuance of common shares &#8211; asset acquisition, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:zerodash" name="aciu:ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions" scale="3" id="Tc_F49IcXt2qUaN1p1yen_TdQ_39_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:zerodash" name="aciu:ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions" scale="3" id="Tc_NKPxT_0HskSPI5s8e7scCw_39_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions" scale="3" id="Tc__NTLZ1djHkqqwYOMF1dnjg_39_8">4,599</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Proceeds from issuance of common shares &#8211; equity plan, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromExerciseOfOptions" scale="3" id="Tc_lmfmcSXpekyEc_-Eykadkg_40_4">65</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromExerciseOfOptions" scale="3" id="Tc_CZgVTYLzOkOzl4-JOI6scA_40_6">7</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromExerciseOfOptions" scale="3" id="Tc_jyCzQHu47kaxRphirF5Ftw_40_8">1,082</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Principal payments of lease obligations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="3" id="Tc_lGkijVhPc0K4zMiZw3qC8w_41_4">548</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="3" id="Tc_5iJIChGurkiK4_6JG4s6BQ_41_6">569</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="3" id="Tc_SJnbR5ICBEOttwWTJ91YdA_41_8">513</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Transaction costs associated with issuance of shares in relation to asset acquisition previously recorded in Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:zerodash" name="aciu:PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions" scale="3" id="Tc_nS87Vm4IzkyFNKntCUT5qA_42_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="aciu:PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions" scale="3" id="Tc_90SyVeuSoUG_UsH-QE_YAw_42_6">776</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:zerodash" name="aciu:PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions" scale="3" id="Tc_YkyvAF2ON0K8o-OXVySDmQ_42_8">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net cash flows (used in)/provided by financing activities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="3" id="Tc_DPjsh0iZw0eHf1QDU3Rgiw_43_4">43,250</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" sign="-" scale="3" id="Tc_5o_6h5ZFN0yuco1Qgq2Tww_43_6">1,346</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="3" id="Tc_LpPDkeipI0S9EiAdyb7PhA_43_8">40,746</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net increase/(decrease) in cash and cash equivalents</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" scale="3" id="Tc_b_oOi2KDFk6fzgTzaiB1eA_45_4">48,487</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" sign="-" scale="3" id="Tc_-TFbz6P4oE64IRyMfwmjcA_45_6">51,151</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" sign="-" scale="3" id="Tc_W1myTgom0kOnet95Gxm7KQ_45_8">78,607</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Cash and cash equivalents at January 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_ypCqup6GikmMjSkcqJiu5g_47_4">31,586</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_0L6699zwxUmSVpNJnzup4w_47_6">82,216</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2020_kISrj4aRVketNj-9seXAtQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_fALkBBaTKEiVha2Zr5Bk2g_47_8">160,893</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Exchange gain/(loss) on cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" sign="-" scale="3" id="Tc_Xsh5xVnlckia2OAX-qring_48_4">1,579</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="3" id="Tc_FSN7LtIe0kuOCQkb7oyQ4A_48_6">521</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" sign="-" scale="3" id="Tc_cLF6WMXzQkekSplC7DnrTQ_48_8">70</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Cash and cash equivalents at December 31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_gMuTmOs4bEKvT59lGfROug_49_4">78,494</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_Z-18I-Rzx06msoCpbNUSbQ_49_6">31,586</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_sU5P5qrrmky1L5gPdMjiGQ_49_8">82,216</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net increase/(decrease) in cash and cash equivalents</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" scale="3" id="Tc_elGzBL4JP0a6f4MBoGQtXg_51_4">48,487</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" sign="-" scale="3" id="Tc_bxHEIlJA306VQo9-gtQ5nQ_51_6">51,151</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" sign="-" scale="3" id="Tc_4fh3reOVU0yvoSFrjNwSVw_51_8">78,607</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Supplemental non-cash activity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Capital expenditures in Trade and other payables or Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:zerodash" name="aciu:PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities" scale="3" id="Tc_LfaMLkn-AkmZYqZXUHJrIQ_54_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:zerodash" name="aciu:PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities" scale="3" id="Tc_x2XCQlDtf0eHiWwTr8wcmQ_54_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities" scale="3" id="Tc_SzN-BHWf2UKHMonpNNZ4zg_54_8">303</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Issuance of shares for purchase of IPR&amp;D asset in asset acquisition</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">6/7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:zerodash" name="aciu:IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition" scale="3" id="Tc_gSWQWPwC-kWsKsXj-O7N6Q_55_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:zerodash" name="aciu:IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition" scale="3" id="Tc_KyMS9U4OdEWE7lVRb4yzeA_55_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition" scale="3" id="Tc_Z4eXT1OOC0anANii23C7lw_55_8">50,416</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Transaction costs associated with issuance of shares in relation to the asset acquisition recorded in Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:zerodash" name="ifrs-full:ShareIssueRelatedCost" scale="3" id="Tc_Lc-6GCfJkkybhYy41g8BVw_56_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:zerodash" name="ifrs-full:ShareIssueRelatedCost" scale="3" id="Tc_sNdTEfOQSUaWdYJkpe6Ahw_56_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShareIssueRelatedCost" scale="3" id="Tc_ReReOyl2-kmEhG54I0OCmQ_56_8">776</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Settlement of convertible notes recorded within Shareholders&#8217; equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:zerodash" name="aciu:RepaymentOfConvertibleDebtEquitySettlementAmount" scale="3" id="Tc_raJtKKjMJU2f3xLGs2GT_Q_57_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:zerodash" name="aciu:RepaymentOfConvertibleDebtEquitySettlementAmount" scale="3" id="Tc_NlAN4l6-UUGfg3jZPdO7uA_57_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:RepaymentOfConvertibleDebtEquitySettlementAmount" scale="3" id="Tc_zY7A-jrM7kiMjmZMXgS2gg_57_8">16,920</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Transaction costs and stamp duty associated with the public offerings of common shares recorded in Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="aciu:TransactionCostAndStampDutyAssociatedWithPublicOfferingsOfCommonSharesRecordedInAccruedExpenses" scale="3" id="Tc_TVXwKUQVLUK6yB_Fa_Rv8g_58_4">521</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:73.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Transaction costs associated with the sale of treasury shares in public offering recorded in Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="aciu:TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses" scale="3" id="Tc_FzuWPfRlgEiL2wOXyCqPcA_59_4">27</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:zerodash" name="aciu:TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses" scale="3" id="Tc_AlNXvsR5n0iE9s301dFN9A_59_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;line-height:1.28;text-align:right;margin:0pt 2.25pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:zerodash" name="aciu:TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses" scale="3" id="Tc_63E6DL3Xs0KOdhj_7AwXaQ_59_8">&#8212;</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The accompanying notes are an integral part of these consolidated financial statements.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-8</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_b4e4f10a_f080_4609_ae97_27e2927a2207"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">AC Immune SA</p><a id="NotestotheConsolidatedFinancialStatement"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">Notes&#160;to the Consolidated Financial Statements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">(In CHF thousands except for share and per share data)</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock" id="Tb_eZhSdobZh0u4STdIQZoiww" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">1.</b></span>General information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune SA was founded in 2003. The Company controls a fully-owned subsidiary, AC Immune USA,&#160;Inc. (&#8220;AC Immune USA&#8221; or &#8220;Subsidiary&#8221; and, together with AC Immune SA, &#8220;AC Immune,&#8221; &#8220;ACIU,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;ours,&#8221; &#8220;us&#8221;), which was registered and organized under the laws of Delaware, USA in June&#160;2021. The Company and its Subsidiary form the Group.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune SA is a clinical-stage biopharmaceutical company leveraging our <ix:nonFraction unitRef="Unit_Standard_item_lel3bReemU2v4xdKyUvjzA" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfTechnologyPlatforms" scale="0" id="Narr_D028PsB190CDna1AwSdfLQ">two</ix:nonFraction> proprietary technology platforms to discover, design and develop novel proprietary medicines and diagnostics for prevention and treatment of neurodegenerative diseases (NDD) associated with protein misfolding. Misfolded proteins are generally recognized as the leading cause of NDD, such as Alzheimer&#8217;s disease (AD) and Parkinson&#8217;s disease (PD), with common mechanisms and drug targets, such as amyloid beta (Abeta), Tau, alpha-synuclein (a-syn) and TDP-43. Our corporate strategy is founded upon a three-pillar approach that targets (i)&#160;AD, (ii)&#160;focused non-AD NDD including Parkinson&#8217;s disease, ALS and NeuroOrphan indications and (iii)&#160;diagnostics. We use our <ix:nonFraction unitRef="Unit_Standard_item_lel3bReemU2v4xdKyUvjzA" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfTechnologyPlatforms" scale="0" id="Narr__y25ibHWgUmTr6nvvUL9_A">two</ix:nonFraction> unique proprietary platform technologies, SupraAntigen (conformation-specific biologics) and Morphomer (conformation-specific small molecules), to discover, design and develop novel medicines and diagnostics to target misfolded proteins.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company was initially incorporated as a limited liability company on February&#160;13, 2003 in Basel, and effective August&#160;25, 2003 was transformed into a stock company. The Company&#8217;s corporate headquarters are located at EPFL Innovation Park Building B, 1015 Lausanne, Switzerland.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" id="Tb_wD3l96j440-xO4h7Q7ut2A" continuedAt="Tb_wD3l96j440-xO4h7Q7ut2A_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">2.</b></span>Basis of preparation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Going concern</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company believes that it will be able to meet all of its obligations as they fall due for at least 12&#160;months from the filing date of this Form 20-F, after considering the Company&#8217;s cash position of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="6" id="Narr_3O1B-mnWJ0Gk_gvJNE6eXA">78.5</ix:nonFraction> million and short-term financial assets of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" scale="6" id="Narr_8afOsZH4XEaFGLtfKf48cQ">24.6</ix:nonFraction> million as of December&#160;31, 2023. Hence, these consolidated financial statements have been prepared on a going-concern basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To date, the Company has financed its cash requirements primarily from its public offerings, share issuances, contract revenues from license and collaboration agreements (LCAs) and grants. The Company is a clinical stage company and is exposed to all the risks inherent to establishing a business. Inherent to the Company&#8217;s business are various risks and uncertainties, including the substantial uncertainty as to whether current projects will succeed and our ability to raise additional capital as needed. These risks may require us to take certain measures such as delaying, reducing or eliminating certain programs. The Company&#8217;s success may depend in part upon its ability to (i)&#160;establish and maintain a strong patent position and protection, (ii)&#160;enter into collaborations with partners in the pharmaceutical and biopharmaceutical industries, (iii)&#160;successfully move its product candidates through clinical development, (iv)&#160;attract and retain key personnel and (v)&#160;acquire capital to support its operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Statement of compliance</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) Accounting Standards as issued by the International Accounting Standards Board (IASB). These consolidated financial statements were approved for issue by the Board of Directors on March&#160;13, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Basis of measurement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The consolidated financial statements have been prepared under the historical cost convention except for items that are required to be accounted for at fair value.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-9</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_wD3l96j440-xO4h7Q7ut2A_cont1"></ix:continuation><a id="_9fba7a65_626e_4bd1_b41b_53b1dec3c591"></a><a id="Tc___xY7U0uu0qSc6Fe5FjwYA_1_2"></a><a id="Tc_ivj6YeD3MEGdEmKI95ml0Q_2_2"></a><a id="Tc_Pg4ZnAMRoUmVxLlmMcD9PA_3_2"></a><a id="Tc_D6tc-0EqhEyEoom38Bar3Q_3_4"></a><a id="Tc_GOyhJso7_UeGPLUmXbvWVg_3_6"></a><a id="Tc_EnZ6tFYfMUWepmhb8bQy-w_4_0"></a><a id="Tc_LSvf6UOiYEiXDpBifc49MQ_5_0"></a><a id="Tc_d93SrXhti0GO3OqI_qme-g_6_0"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory" id="Tb_hP8KXO1zrky32kAxTn0NcA" continuedAt="Tb_hP8KXO1zrky32kAxTn0NcA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">3.</b></span>Summary of material accounting policies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The principal accounting policies adopted in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all the&#160;years presented, unless otherwise stated.</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory" id="Tb_QGlLdlajHkmkOXiy700puA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Functional and reporting currency</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">These consolidated financial statements and accompanying notes are presented in Swiss Francs (CHF), which is AC Immune SA&#8217;s functional currency and the Group&#8217;s reporting currency. The Company&#8217;s subsidiary has a functional currency of the U.S. Dollar (USD). The respective functional currency represents the primary economic environment in which the entities operate.</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory" id="Tb_kw4Ckp6KpEeaDBPpRn0Dtw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following exchange rates have been used for the translation of the financial statements of AC Immune USA:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">CHF/USD</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Closing rate, USD 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_USD_FPtD7vL32kaT4HamUiI0aw" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Tc_psyornBPzkuGThOjaSjNFQ_5_2">0.851</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_USD_FPtD7vL32kaT4HamUiI0aw" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Tc_MvMdThf6zUuYQxTKen3Ksw_5_4">0.933</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_USD_FPtD7vL32kaT4HamUiI0aw" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Tc_qv5oVkiZlEmMzUXiLKZj8w_5_6">0.923</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Weighted average exchange rate, USD 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_USD_FPtD7vL32kaT4HamUiI0aw" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="Tc_qEVRPgf4_kueCaXhZYa4Cw_6_2">0.908</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_USD_FPtD7vL32kaT4HamUiI0aw" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="Tc_cnrFZl3FnUCSq5kiNyKNsA_6_4">0.965</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_USD_FPtD7vL32kaT4HamUiI0aw" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:AverageForeignExchangeRate" scale="0" id="Tc_qayPoGxYBUaUzqtoRqYOGA_6_6">0.929</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The results and financial position of AC Immune USA are translated into the presentation currency as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">i.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">assets and liabilities for each balance sheet presented are translated at the closing rate at the date of that balance sheet;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">ii.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">income and expenses for each statement of income/(loss) are translated at average exchange rates; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">iii.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">all resulting exchange differences are recognized in other comprehensive income/(loss), within cumulative translation differences.</span></td></tr></table><div style="margin-top:12pt;"></div></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfBasisOfConsolidationExplanatory" id="Tb_cSvTbwWtzkWjcfWjBm9hIw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Basis of consolidation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The annual closing date of the individual financial statements is December&#160;31. The Company fully-owns its Subsidiary and fully consolidates its financial statements into these consolidated financial statements. All intercompany transactions have been eliminated.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" id="Tb_-525khLp0UeS4_m1Jjifug" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Foreign currency transactions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Foreign currency transactions are translated into the respective functional currency using prevailing exchange rates at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at&#160;year-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognized in the consolidated statements of income/(loss). Any gains or losses from these translations are included in the consolidated statements of income/(loss) in the period in which they arise.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock" id="Tb_qQ_MbnTRVUW1MDIHqUMCFA" continuedAt="Tb_qQ_MbnTRVUW1MDIHqUMCFA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Current vs. non-current classification</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company presents assets and liabilities in the consolidated balance sheets based on current/non-current classification. The Company classifies all amounts to be realized or settled within 12&#160;months after the reporting period to be current and all other amounts to be non-current.</p></ix:nonNumeric></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-10</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_hP8KXO1zrky32kAxTn0NcA_cont1" continuedAt="Tb_hP8KXO1zrky32kAxTn0NcA_cont2"><ix:continuation id="Tb_qQ_MbnTRVUW1MDIHqUMCFA_cont1"></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue" id="Tb_H7d-2ctrWUCx_bjOvcY_dg" continuedAt="Tb_H7d-2ctrWUCx_bjOvcY_dg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Revenue recognition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company applies IFRS 15&#160;<i style="font-style:italic;">Revenue from Contracts with Customers</i>. This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. Under IFRS 15, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of IFRS 15, the entity performs the following five steps: (i)&#160;identify the contract(s)&#160;with a customer; (ii)&#160;identify the performance obligations in the contract; (iii)&#160;determine the transaction price; (iv)&#160;allocate the transaction price to the performance obligations in the contract; and (v)&#160;recognize revenue when (or as) the entity satisfies a performance obligation. The Company applies the five-step model to contracts only when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of IFRS 15, the Company assesses the goods or services promised within each contract, and determines those that are performance obligations, and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company enters into LCAs which are within the scope of IFRS 15, under which it licenses certain rights to its product candidates and intellectual property to third parties. The terms of these arrangements typically include payment to the Company of one or more of the following: non-refundable, upfront license fees, development, regulatory and/or commercial milestone payments;&#160;payments for research and clinical services the Company provides through either its full-time employees or third-party vendors, and royalties on net sales of licensed products commercialized from the Company&#8217;s intellectual property. Each of these payments results in license, collaboration and other revenues, which are classified as contract revenue on the consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Licenses of intellectual property</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the license to the Company&#8217;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, upfront fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are sold in conjunction with a related service, the Company uses judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time. If the performance obligation is settled over time, the Company determines the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, upfront fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Milestone payments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At the inception of each arrangement that includes development, regulatory and/or commercial milestone payments, the Company evaluates whether the milestones are considered highly probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is highly probable that a significant cumulative revenue reversal would not occur in future periods, the associated milestone value is included in the transaction price. These amounts for the performance obligations under the contract are recognized as they are satisfied. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of such milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments recorded would affect contract revenues and earnings in the period of adjustment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Research and development services</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has certain arrangements with our collaboration partners that include contracting our employees for research and development programs. The Company assesses if these services are considered distinct in the context of each contract and, if so, they are accounted for as separate performance obligations. These revenues are recorded in contract revenue as the services are performed.</p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-11</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_hP8KXO1zrky32kAxTn0NcA_cont2" continuedAt="Tb_hP8KXO1zrky32kAxTn0NcA_cont3"><ix:continuation id="Tb_H7d-2ctrWUCx_bjOvcY_dg_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Sublicense revenues</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has certain arrangements with our collaboration partners that include provisions for sublicensing. The Company recognizes any sublicense revenues at the point in time it is highly probable to obtain and not subject to reversal in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Contract balances</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company receives payments and determines credit terms from its customers for its various performance obligations based on billing schedules established in each contract. The timing of revenue recognition, billings and cash collections results in billed other current receivables, accrued income (contract assets), and deferred income (contract liabilities) on the consolidated balance sheets. Amounts are recorded as other current receivables when the Company&#8217;s right to consideration is unconditional. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be 1&#160;year or less.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For a complete discussion of accounting for contract revenue, see &#8220;Note&#160;14. Contract revenues.&#8221;</p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" id="Tb_uLFvyx7k50-_OuQOsQc9oQ" continuedAt="Tb_uLFvyx7k50-_OuQOsQc9oQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Research and development expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Given the stage of development of the Company&#8217;s products, all research and development expenditure is expensed as incurred as it does not meet the capitalization criteria outlined in IAS 38 <i style="font-style:italic;">Intangible Assets</i>. The Company has not capitalized any R&amp;D expenses to date. Research and development expenditures include:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the cost of acquiring, developing and manufacturing active pharmaceutical ingredients for product candidates that have not received regulatory approval, clinical trial materials and other research and development materials;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fees and expenses incurred under agreements with contract research organizations, investigative sites and other entities in connection with the conduct of clinical trials and preclinical studies and related services, such as administrative, data-management and laboratory services;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fees and costs related to regulatory filings and activities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">costs associated with preclinical and clinical activities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">employee-related expenses, including salaries and bonuses, benefits, travel and share-based compensation expenses; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">all other allocated expenses such as facilities and information technology (IT) costs.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For external research contracts, expenses include those associated with contract research organizations, or CROs, or contract manufacturing organizations, or CMOs. The invoicing from CROs or CMOs for services rendered do not always align with work performed. We accrue the cost of services rendered in connection with CRO or CMO activities based on our estimate of the &#8220;stage of completion&#8221; for such contracted services. We maintain regular communication with our CRO or CMO vendors to gauge the reasonableness of our estimates and accrued expenses as of the balance sheet date in the consolidated financial statements based on facts and circumstances known at the time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Registration costs for patents are part of the expenditure for research and development projects. Therefore, registration costs for patents are expensed when incurred as long as the research and development project concerned does not meet the criteria for capitalization.</p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-12</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_hP8KXO1zrky32kAxTn0NcA_cont3" continuedAt="Tb_hP8KXO1zrky32kAxTn0NcA_cont4"><ix:continuation id="Tb_uLFvyx7k50-_OuQOsQc9oQ_cont1"></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DescriptionOfAccountingPolicyForExpensesExplanatory" id="Tb_htPhSDWiXkW6gfTN1DyKbg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">General and administrative expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">General and administrative expenses are expensed as incurred and include personnel costs, expenses for outside professional services and all other allocated expenses. Personnel costs consist of salaries, cash bonuses, benefits and share-based compensation. Outside professional services consist of legal, accounting and audit services, IT and other consulting fees. Allocated expenses consist of certain IT, facilities and depreciation expenses.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:GrantIncomePolicyTextBlock" id="Tb_GWbCfHpgLkCeCkXTxJXwug" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Grant income</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has received grants, from time to time, from the Michael J. Fox Foundation (MJFF), the Target ALS Foundation (Target ALS) and other institutions to support certain research projects. Grants are recorded at their fair value in the consolidated statements of income/(loss) within other operating income/(expenses), net when there is reasonable assurance that the Company will satisfy the underlying grant conditions and the grants will be received. In certain circumstances, grant income may be recognized before formal grantor acknowledgement of milestone achievements. To the extent required, grant income is deferred and recognized on a systematic basis over the periods in which the Company expects to recognize the related expenses for which the grants are intended to compensate.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory" id="Tb_Fg7ygjJGyEef-Hvl7eMqgQ" continuedAt="Tb_Fg7ygjJGyEef-Hvl7eMqgQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Leases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company applies IFRS 16 <i style="font-style:italic;">Leases</i>, which provides the model for lessee accounting in which all leases, other than short-term and low-value leases, are accounted for by the recognition on the consolidated balance sheet of a right-of-use asset and a lease liability, and the subsequent amortization of the right-of-use asset over the earlier of the end of the useful life or the lease term. In accordance with IFRS 16, the Company (i)&#160;does not recognize right-of-use assets and lease liabilities for leases of low value (i.e. approximate fair value of USD 5,000). For a complete discussion of accounting, see &#8220;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Right-of-use assets and lease liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At inception of a leasing contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company recognizes a right-of-use asset and a lease liability at the lease commencement date. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company&#8217;s incremental borrowing rate. The lease liabilities are classified as current or non-current based on the due dates of the underlying principal payments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Lease payments generally are fixed for the contract term. The lease liability is measured at amortized cost using the effective interest method. The lease liability is re-measured if there is a change in the estimated lease term, a change in future lease payments arising from a change in an index or rate, a change in the Company&#8217;s estimate of the amount expected to be payable under a residual value guarantee or a change in assessment of whether it will exercise a purchase, extension or termination option.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At inception, the right-of-use asset comprises the initial lease liability and any initial direct costs. The right-of-use asset is depreciated over the shorter of the lease term or the useful life of the underlying asset. The right-of-use asset is periodically reduced by impairment losses, if any, and adjusted for certain re-measurements of the lease liability performed on as certain potential triggering events may arise (e.g. lease modifications). When the lease liability is re-measured, a corresponding adjustment is made to the carrying amount of the right-of-use asset or is recorded in profit or loss if the carrying amount of the right-of-use asset has been reduced to zero.</p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-13</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_-5IWMH8dUEW369NOZbBT-A_1_0"></a><a id="Tc_1vLReJ_eskekaE526-oucw_1_3"></a><a id="Tc_qTPRZyKjXUiYPYIm9u6cFw_2_0"></a><a id="Tc_hSc8_Kv5g0GS49fKGrL0Kw_2_3"></a><a id="Tc_cIpC4NvshkWi_q3Ldd3p6Q_3_0"></a><a id="Tc_fJGs3h-VUk25Db0ISBvS6w_3_3"></a><a id="_c2a33482_52c5_4d96_8967_1333ff745b3e"></a><a id="Tc_5i0rnNLUN0yIxL7AlbHqXg_1_0"></a><a id="Tc_DI8eYbn36U26_qiERhf14w_1_3"></a><a id="Tc_a_-pw6DlH0C5Wppsruz6IQ_2_0"></a><a id="Tc_VftW5IQv90qOeBT5XulaAA_2_3"></a><a id="Tc_ebpSKFjG1UeGm442KkvKnA_3_0"></a><a id="Tc_tN4avjznEkWGA0U5BScKhw_3_3"></a><ix:continuation id="Tb_hP8KXO1zrky32kAxTn0NcA_cont4" continuedAt="Tb_hP8KXO1zrky32kAxTn0NcA_cont5"><ix:continuation id="Tb_Fg7ygjJGyEef-Hvl7eMqgQ_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The estimated lease term by right-of-use asset categories are as follows:</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock" id="Tb_FaS6AuAT8U2A7PY-PWkIcg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Buildings</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_aaNuoy-t_Eiw3M3BbRrSzA" format="ixt-sec:duryear" name="aciu:EstimatedLeaseTerm" id="Tc_0OUXngmBP06oDgMbzRpMmA_1_2"><span style="font-size:10pt;">5</span></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Office equipment</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OfficeEquipmentMember_FZ2FsUgsLUK0QPYMKCCp5g" format="ixt-sec:duryear" name="aciu:EstimatedLeaseTerm" id="Tc_Ha9M2ZRCSkuc2jb8JiQtuw_2_2"><span style="font-size:10pt;">5</span></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">IT equipment</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_5KJXBEAcDUOmq3jDvWNEeA" format="ixt-sec:duryear" name="aciu:EstimatedLeaseTerm" id="Tc_xD1M8OQ6u0yF3vjByKHbIA_3_2"><span style="font-size:10pt;">5</span></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">years</p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Both the right-of-use-assets and lease liabilities are recognized in the consolidated balance sheets.</p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" id="Tb_eOCVcC21kUmdoYRQ8FQoNA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Property, plant and equipment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Equipment is shown at historical acquisition cost, less accumulated depreciation and any accumulated impairment losses. Historical costs include expenditures that are directly attributable to the acquisition of the property, plant and equipment. Depreciation is calculated using a straight-line method to write off the cost of each asset to its residual value over its estimated useful life as follows:</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock" id="Tb_Ji8XAmsHMkOofzyufE_cTw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">IT equipment</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_5KJXBEAcDUOmq3jDvWNEeA" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" id="Tc_-TPVh-eTsEmfw6v2yZ4WqA_1_2"><span style="font-size:10pt;">3</span></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Laboratory equipment</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_a18c9vqNJ0Gpex9n_raHoQ" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" id="Tc_jzHrVXV1okiEnl6hTAfw3w_2_2"><span style="font-size:10pt;">5</span></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Leasehold improvements/furniture</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LeaseholdImprovementsAndFixturesAndFittingsMember_5r6Agu4tSEaOWsUui3fyog" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" id="Tc_pfh1Fv5TxkS-FCvHGeMLsw_3_2"><span style="font-size:10pt;">5</span></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The assets&#8217; residual values and useful lives are reviewed, and adjusted if appropriate, at each balance sheet date. Where an asset&#8217;s carrying amount is greater than its estimated recoverable amount, it is written down to its recoverable amount.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Gains and losses on disposals are determined by comparing the disposal proceeds with the carrying amount and are included in the consolidated statements of income/(loss).</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" id="Tb_3tvKS8EDEUSNR25vtQDFrQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Intangible assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune&#8217;s acquired in process research and development (IPR&amp;D) asset is stated at cost less any impairments. The Company does not deem this asset ready for use until the asset obtains market approval. Therefore, during the development period after the date of acquisition until market approval, the IPR&amp;D asset is not amortized. Upon market approval, the Company will determine the useful life of the asset, reclassify it from IPR&amp;D and commence amortization. If the associated R&amp;D effort is abandoned, the related IPR&amp;D will likely be written off and we will record the relevant impairment charge. Finally, the Company will not capitalize future development costs in respect to this IPR&amp;D asset until they meet the criteria for capitalization of research and development costs in accordance with IAS 38 <i style="font-style:italic;">Intangible Assets</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our IPR&amp;D asset is subject to impairment testing at least annually or when there are indications that the carrying value may not be recoverable until the completion of the development process. The determination of the recoverable amounts include key estimates which are highly sensitive to, and dependent upon, key assumptions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company uses a discounted cash flow method to determine the fair value less costs to sell (recoverable amount) of our IPR&amp;D intangible asset. The Company starts with a forecast of all the expected net cash flows, which incorporates the consideration of a terminal value and then the Company applies a discount rate to arrive at a risk-adjusted net present value amount.</p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any impairment losses are recognized immediately in the consolidated statements of income/(loss).</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" id="Tb_I1GB47gkgE2TVGqs1TzqdQ" continuedAt="Tb_I1GB47gkgE2TVGqs1TzqdQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Fair value of financial assets&#160;and liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The Company&#8217;s financial assets and liabilities are composed of receivables, short-term financial assets, cash and cash equivalents, trade payables and lease liabilities. The fair value of these financial instruments approximates their </p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-14</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_hP8KXO1zrky32kAxTn0NcA_cont5" continuedAt="Tb_hP8KXO1zrky32kAxTn0NcA_cont6"><ix:continuation id="Tb_I1GB47gkgE2TVGqs1TzqdQ_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">respective carrying values due to the short-term maturity of these instruments, and are held at their amortized cost in accordance with IFRS 9, unless otherwise explicitly noted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Receivables</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Receivables are recognized at their billing value. An allowance for doubtful accounts is recorded for potential estimated losses when there is evidence of the debtor&#8217;s inability to make required payments and the Company assesses on a forward-looking basis the expected credit losses associated with these receivables held at amortized cost.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Short-term financial assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Short-term financial assets are held with external financial institutions and comprise fixed-term deposits with maturities ranging from more than 3 through 12&#160;months in duration.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company assesses whether there is objective evidence that financial assets are impaired annually or whenever potential impairment triggers may occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Cash and cash equivalents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Cash and cash equivalents include deposits held with external financial institutions and cash on hand. All cash and cash equivalents are either in cash or in deposits with original duration of less than 3&#160;months.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Trade payables</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Trade payables are amounts due to third parties in the ordinary course of business.</p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" id="Tb_-0YXPc5AcUC2zJjaAKPX9Q" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Share capital and public offerings</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Common shares are classified as equity. Share issuance costs are capitalized as incurred and will be shown in equity as a deduction, net of tax, from the proceeds received from existing or future offerings. Should a planned equity offering not be assessed as probable, the issuance costs would be expensed immediately in the consolidated statements of income/(loss). See &#8220;Note&#160;12. Share capital.&#8221;</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory" id="Tb_v48LLGy4BEeSTUoJA4bLDQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Treasury shares</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Treasury shares are recognized at acquisition cost and deducted from shareholders&#8217; equity at the time of acquisition, until they are subsequently resold, distributed or cancelled. Where such shares are subsequently sold, any consideration received is included in shareholders&#8217; equity. See &#8220;Note&#160;12. Share capital.&#8221;</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" id="Tb_abIdVLvMIkqMUVyNHmD53g" continuedAt="Tb_abIdVLvMIkqMUVyNHmD53g_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Employee benefits</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Post-employment benefits</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company operates the mandatory pension schemes for its employees in Switzerland. The schemes are generally funded through payments to insurance companies. The Company has a pension plan designed to pay pensions based on accumulated contributions on individual savings accounts. However, this plan is classified as a defined benefit plan under IAS 19.</p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-15</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_hP8KXO1zrky32kAxTn0NcA_cont6" continuedAt="Tb_hP8KXO1zrky32kAxTn0NcA_cont7"><ix:continuation id="Tb_abIdVLvMIkqMUVyNHmD53g_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The net defined benefit liability is the present value of the defined benefit obligation at the balance sheet date minus the fair value of plan assets. Significant estimates are used in determining the assumptions incorporated in the calculation of the pension obligations, which is supported by input from independent actuaries. The defined benefit obligation is calculated annually with the assistance of an independent actuary using the projected unit credit method, which reflects services rendered by employees to the date of valuation, incorporates assumptions concerning employees&#8217; projected salaries and pension increases as well as discount rates of highly liquid corporate bonds that have terms to maturity approximating the terms of the related liability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To the extent that the fair value of the plan assets is greater than the present value of the defined benefit obligation as calculated by our independent actuary, the Company accounts for the effect of the asset ceiling test under IAS 19.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Re-measurements of the net defined benefit liability, which comprise actuarial gains and losses and the return on plan assets (excluding interest) are recognized immediately in the consolidated statements of other comprehensive income/(loss). Past service costs, including curtailment gains or losses, are recognized immediately as a split in research and development and general and administrative expenses within the operating results. Settlement gains or losses are recognized in either research and development and/or general and administrative expenses within the operating results. The Company determines the net interest expense/(income) on the net defined benefit liability for the period by applying the discount rate used to measure the defined benefit obligation at the beginning of the annual period or in case of any significant events between measurement dates to the then-net defined benefit liability, considering any changes in the net defined benefit liability during the period as a result of contributions and benefit payments. Net interest expense/(income) and other expenses related to defined benefit plans are recognized in the consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Share-based compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company operates an equity-settled, share-based compensation plan. The fair value of the employee services received in exchange for the grant of equity-based awards is recognized as an expense. The total amount to be expensed over the vesting period is determined by reference to the fair value of the instruments granted, excluding the impact of any non-market vesting conditions. Non-market vesting conditions are included in assumptions about the number of instruments that are expected to become exercisable. At each balance sheet date, the Company revises its estimates of the number of instruments that are expected to become exercisable. It recognizes the impact of the revision of original estimates, if any, prospectively in the consolidated statements of income/(loss), and a corresponding adjustment to equity over the remaining vesting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Stock options granted under the Company&#8217;s stock option plans C1 and the 2016 Stock Option and Incentive Plan are valued using the Black-Scholes option-pricing model (see &#8220;Note&#160;19. Share-based compensation&#8221;). This valuation model as well as parameters used such as expected volatility and expected term of the stock options are partially based on management&#8217;s estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and share premium when the options are exercised.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We estimate the fair value of restricted share units using a reasonable estimate of market value of the common shares on the date of the award. We classify our share-based payments as equity-classified awards as they are settled in common shares. We measure equity-classified awards at their grant date fair value and do not subsequently re-measure them. Compensation costs related to equity-classified awards are equal to the fair value of the award at grant date amortized over the vesting period of the award using the graded method. We reclassify that portion of vested awards to share capital and share premium as the awards vest.</p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory" id="Tb_MgO8KxcyakuPTD-xYugIpA" continuedAt="Tb_MgO8KxcyakuPTD-xYugIpA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Provisions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Provisions are recognized when the Company has a present legal or constructive obligation as a result of past events where it is more likely than not that an outflow of resources will be required to settle the obligation, and a reliable estimate of the amount can be made.</p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-16</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_hP8KXO1zrky32kAxTn0NcA_cont7" continuedAt="Tb_hP8KXO1zrky32kAxTn0NcA_cont8"><ix:continuation id="Tb_MgO8KxcyakuPTD-xYugIpA_cont1"></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory" id="Tb_t9GvV07STUuusEulYQTk4A" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Taxation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Current income tax assets and liabilities for the period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the tax amounts are those that are enacted or substantively enacted, at the reporting date in accordance with the fiscal regulations of the respective country where the Company operates and generates taxable income. Deferred tax is provided using the liability method on temporary differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes at the reporting date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the&#160;year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted at the reporting date. If required, deferred taxation is provided in full using the liability method, on all temporary differences at the reporting dates. It is calculated at the tax rates that are expected to apply to the period when it is anticipated the liabilities will be settled, and it is based on tax rates (and laws) that have been enacted or substantively enacted at the reporting date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Deferred income tax assets are recognized to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilized. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized. Although the Company has substantial tax loss carry-forwards, historically, due to the fact that the Company had limited certainty on the achievement of key milestones, it has not recognized any deferred tax assets as the probability for use is low.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As disclosed in &#8220;Note&#160;17. Income taxes,&#8221; the Company has tax losses that can generally be carried forward for a period of <ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" format="ixt-sec:duryear" name="aciu:IncomeTaxLossCarryforwardPeriod" id="Narr_EfFfb5yYRUq-2gTudoN3Uw">7</ix:nonNumeric>&#160;years from the period the loss was incurred. These tax losses represent potential value to the Company to the extent that the Company is able to create taxable profits before the expiry period of these tax losses. The Company has <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt-sec:numwordsen" name="ifrs-full:DeferredTaxAssets" scale="3" id="Narr_Ml41wDGVGESUVf_5Yf1uWg">no</ix:nonFraction>t recorded any deferred tax assets in relation to these tax losses.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" id="Tb_XSzMrATwu0e1s6Qc0pGSdA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Earnings per share</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company presents basic earnings per share for each period in the consolidated financial statements. The earnings per share are calculated by dividing the earnings of the period by the weighted-average number of shares outstanding during the period. Diluted earnings per share reflect the potential dilution that could occur if dilutive securities such as share options or non-vested restricted share units were vested or exercised into common shares or resulted in the issuance of common shares that would participate in net income. Anti-dilutive shares are excluded from the dilutive earnings per share calculation.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock" id="Tb_rlK88uqpD0eA8IIdZPlxmg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Critical judgments and accounting estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The areas where AC Immune has had to make judgments, estimates and assumptions relate to (i)&#160;revenue recognition on LCAs, (ii)&#160;clinical development accruals, (iii)&#160;net employee defined benefit liability, (iv)&#160;share-based compensation, (v)&#160;right-of-use assets and lease liabilities and (vi)&#160;our IPR&amp;D asset. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory" id="Tb_NtrYGYm2ik-ZK71dmTDNkQ" continuedAt="Tb_NtrYGYm2ik-ZK71dmTDNkQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Segment reporting</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has <ix:nonFraction unitRef="Unit_Standard_segment_uSnHfk8yHkqj2bvGJo9Fng" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="INF" format="ixt-sec:numwordsen" name="aciu:OperatingSegmentsNumber" scale="0" id="Narr_XydYXzDx_kCml49Sa2tQ9g">one</ix:nonFraction> segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins.</p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-17</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_hP8KXO1zrky32kAxTn0NcA_cont8"><ix:continuation id="Tb_NtrYGYm2ik-ZK71dmTDNkQ_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is managed and operated as <ix:nonFraction unitRef="Unit_Standard_segment_uSnHfk8yHkqj2bvGJo9Fng" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="INF" format="ixt-sec:numwordsen" name="aciu:ReportableSegmentsNumber" scale="0" id="Narr_0lPMr2XxNEO3xWM-cvUWyQ">one</ix:nonFraction> business. A single management team that reports to the chief operating decision maker comprehensively manages the entire business. Accordingly, the Company views its business and manages its operations as <ix:nonFraction unitRef="Unit_Standard_segment_uSnHfk8yHkqj2bvGJo9Fng" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="INF" format="ixt-sec:numwordsen" name="aciu:OperatingSegmentsNumber" scale="0" id="Narr_WnqN8JJ9GUSbtOmkgQv_Dg">one</ix:nonFraction> operating segment. Non-current assets are located in, and revenue is allocated and recorded within, the Company&#8217;s country of domicile, Switzerland.</p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock" id="Tb_4laWSXrKH0KDxu3IzmLZiw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Accounting policies, new standards, interpretations and amendments adopted by the Company</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">There are no new IFRS standards, amendments or interpretations that are mandatory as of January 1, 2023 that are relevant to the Company. Additionally, the Company has not adopted any standard, interpretation or amendment that has been issued but is not yet effective. Such standards are not currently expected to have a material impact on the entity in the current or future reporting periods and on foreseeable future transactions.</p></ix:nonNumeric></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-18</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_1c5b8bed_6a4b_4a40_8977_7137d5f14906"></a><a id="Tc_MmYgDW1zwk6R9DkLGkgbbg_1_2"></a><a id="Tc_NhKinSedJk-2leThPBuEbA_2_4"></a><a id="Tc_zZis2NnHIkW4UI5klKGGew_2_6"></a><a id="Tc_fvmnnC3jYUWfd0fbQhL1zw_2_8"></a><a id="Tc_JIXyeIUA-EaaHEBAA_wGZA_2_10"></a><a id="Tc_elnAOYJ1aUy1RXtYeusdGw_3_0"></a><a id="Tc_QnZDIrSxQ0W32mJWpBuEQQ_3_2"></a><a id="Tc_x9O_6FZ8-0mqxRGubiLhUA_3_4"></a><a id="Tc_6NTW4Z31RkaA76YZzpAr0g_3_6"></a><a id="Tc_jAhxad51HUKAUdzauLpUvQ_3_8"></a><a id="Tc_Eh40AQdEg0GdBlo3fUkBpA_3_10"></a><a id="Tc_jn9yFAznx0emQSeowTh3VQ_3_12"></a><a id="Tc_iiSlEGdTvE29MGL0v5pftQ_4_0"></a><a id="Tc_z3f78g_YQkmFnburtW_F1A_5_0"></a><a id="Tc_Purpvi1Nm0uIcrwqUTanAA_6_0"></a><a id="Tc_JRQ6wMpHvkCL3QRRKn3zxA_6_10"></a><a id="Tc_BqONd9WpTUuKYn3pjXuxrw_7_0"></a><a id="Tc_h-qS5i-WWESaYcdw6fKG4A_8_0"></a><a id="Tc_kxoD2a48Fk6CyfcOv5G0-w_8_2"></a><a id="Tc_ortXQudNU0WQmgbBMa5ewQ_8_4"></a><a id="Tc_wvO9sb9bok65PNWk9OPMKw_8_6"></a><a id="Tc_7JaKehxMlkyLmDqtkgP6gg_8_12"></a><a id="Tc_ZHBd7pap-USsDumC1HWZJw_9_0"></a><a id="Tc_TuoLUqe1LUuuyDqLi0496g_9_10"></a><a id="Tc_8tXATMPyZ0-X4geAd0Tzjw_11_0"></a><a id="Tc_CvlHAt95Q0qF2QMrmpTHGg_12_0"></a><a id="Tc_hk2m8tyFNkiNhXRqL1RJIg_12_10"></a><a id="Tc_H8hlIpx9F0SAveJ6omfg4g_13_0"></a><a id="Tc_YY6NReJggESuicz8yKPzbw_13_10"></a><a id="Tc_vvHOf2vcOEyhQVj14dY2NA_14_0"></a><a id="Tc_F3A6XHqKs0qUB6DIrWFL-w_14_2"></a><a id="Tc_lDkpkjYMKEynKWMqpX04xg_14_6"></a><a id="Tc_iF9cAK7XZUaOOOdtX8Dqlw_14_8"></a><a id="Tc_1d9DrqCSp0-cFIHW2sQZzg_14_10"></a><a id="Tc_8BSnqYvtcEWnNGuCgjmTiQ_15_0"></a><a id="Tc_4-mGPtfnF0ewCy0dBLBVJg_15_10"></a><a id="Tc_1h53jJaGqka3yLJLFOIl0Q_17_0"></a><a id="Tc_qnec_MTc70mEjbxmrdBStA_18_0"></a><a id="Tc_s23axTwsmE6Xa0H4pGWAnQ_19_0"></a><a id="Tc_qw0miSTvY0yclR9GQnf0ow_19_10"></a><a id="_f3fa9b62_869d_4eeb_a89e_7f2e72c7e950"></a><a id="Tc_qAQf4PmBtEmCcl_NW0DgPg_1_2"></a><a id="Tc_Xqpi7J5o6UascZKuj4DVbQ_2_4"></a><a id="Tc_eEFAF1ya60ma2HUkBD1tBQ_2_6"></a><a id="Tc_jSLV54-GJECct8BzcBJ7vg_2_8"></a><a id="Tc_QhV62adH30i090EeATSb1A_2_10"></a><a id="Tc_mRNcdWe2gkSnx73X7EN-uw_3_0"></a><a id="Tc_COxfw1Hom0uAjOMkXmujaA_3_2"></a><a id="Tc_LdZhscBYZ0CcpY3hC2IMQg_3_4"></a><a id="Tc_pKH8cJMWDUm3Gt5KNGDK1Q_3_6"></a><a id="Tc_OcI5bWZz3kOb9UQIOpqZnw_3_8"></a><a id="Tc_q93vxITySE2J27e0PXrSgg_3_10"></a><a id="Tc_HiSJ2JGcIkK1oD4kSvgdaQ_3_12"></a><a id="Tc_LlrStCHo0UueCtDH568hJA_4_0"></a><a id="Tc_TzLVHN3A4U6dwW-VF4IiVQ_5_0"></a><a id="Tc_INxrZVMCu0-VXqFnc6Y_9A_6_0"></a><a id="Tc_8HLeBjR6nkmBWTdC6NoDsQ_7_0"></a><a id="Tc_ZYAcRqXG-029y5LpYIyHNQ_7_2"></a><a id="Tc_6q4gufmG5kyP5LXn2alsRw_7_12"></a><a id="Tc_Tu3CK0K-QE2YX22IM5CF3w_8_0"></a><a id="Tc_tE3yhoBpgkm3JIl8RWWdig_10_0"></a><a id="Tc_iON1ppHi70qKmM4LsdCGuQ_11_0"></a><a id="Tc_wNMMwo5w6EamlaOZq9R74A_11_10"></a><a id="Tc_7zN1bm0jiE6LG9iUDKgWVw_12_0"></a><a id="Tc_qFjenlCcCUyEVh49rrAnag_12_10"></a><a id="Tc_uRxMcD_-x0ygU_gtF1KrCQ_13_0"></a><a id="Tc_OANgq54LCE2ESfZttwmPIw_13_10"></a><a id="Tc_oq1LFuuLfUWu1VjAqDHP6A_15_0"></a><a id="Tc_3VZksYP74EmLVW1xxT3bPw_16_0"></a><a id="Tc_DcVWj-InFk6vic3ud7de8A_17_0"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory" id="Tb_bQnBrxZKMkO64fLIQYQqpA" continuedAt="Tb_bQnBrxZKMkO64fLIQYQqpA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">4.</b></span>Property, plant and equipment</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" id="Tb__6mBxQb5o0eC65pToWMKeA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following tables show the movements in the net book values of property, plant and equipment for the&#160;years ended December&#160;31, 2023 and 2022, respectively:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:40.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:57.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2023</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Laboratory</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Leasehold</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assets under</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Furniture</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">improvements</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">construction</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquisition cost:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_Cj6a41-HWECUkiVv0bW4qQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_9rsEK4YsGUufP8wK1FDyeg_5_2">285</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_yA_PZPRqLUu_kKp2zZYt1A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc__EOTeSpPbESfRLzh9E8yfg_5_4">1,909</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_CCFaY6n0-UeoiGMVZgAhJA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_AgCPy7GH4ki3yJ8XaHyMog_5_6">9,765</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_6VOKv2eGyUeHs3MGzC7vIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_3GxqC52Q2EaEZXCCrUMsCA_5_8">1,640</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_g2VJr2LWH0mkATiItb2LEg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_sWCMEE2hg0mT5UHO7U5Juw_5_10">3</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_GjTctvZEfEW6pg7_LZJEHA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_cu0FUEcuYkKSIY4SozabNg_5_12">13,602</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_LgaMFEMN_kKAtkztR9a8KA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_I9u5r6yY0Ui6tRGmu2VKwQ_6_2">24</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_jU5Jt8mUF0iciQdpO6t7sA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_MF5fYoNS8ESSkUr2jsHY5A_6_4">278</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_SGqTYRos7Eu0uaWKvQowsQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_34LhJy-5JECteJlgmOMTBg_6_6">468</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_hLWNWYEvyU-dudu8IMjYcQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_bdENm1h6i0OZ3KXmFGDKgA_6_8">31</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_kkPxG2DcNk29JpuIBItYrw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_zKOgntQhyUmqdONwW9vyQQ_6_12">801</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Disposals</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_LgaMFEMN_kKAtkztR9a8KA" decimals="-3" format="ixt:zerodash" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="Tc_72Mg_WI2YU-dPekd6TxgLg_7_2">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_jU5Jt8mUF0iciQdpO6t7sA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="Tc_M6hLUdC5x0K6d3gQWOlJSA_7_4">19</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_SGqTYRos7Eu0uaWKvQowsQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="Tc_BVFD0xJyQ0WUhjpoBvbLKQ_7_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_hLWNWYEvyU-dudu8IMjYcQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="Tc_iWJ4i4l3HUWMyAU6chNBrg_7_8">12</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_XAtED10_YUaz8Tcq-re46w" decimals="-3" format="ixt:zerodash" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="Tc_ZSae2vCjfkCEw_Kj00xszA_7_10">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_kkPxG2DcNk29JpuIBItYrw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="Tc_R6CJ_b1ME0KkpukeyUk0Rg_7_12">31</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Transfers</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_hLWNWYEvyU-dudu8IMjYcQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="3" id="Tc_cp51sQCzm0qpx-N9gpFLmQ_8_8">3</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_XAtED10_YUaz8Tcq-re46w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" sign="-" scale="3" id="Tc_Tn-hYA4jx0-QbLDi9dCsnw_8_10">3</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_iv5cJCl-0E6vtlPSj3s5AQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_DcjqZlKg3EC0rAFj3lemCw_9_2">309</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_Y_Ay0M36UkuaBV4tSfcAjg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_vipdgPtK_kq6pCl-sqLGaA_9_4">2,168</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_jydRYd9OWEWk671dwbd0rw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_2FFHeHeHzU6EM23PL--BHw_9_6">10,233</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_pNs8WMywAEOk7jBfV42CCg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_jM1KzrQNRkaF7jj0NvCdpQ_9_8">1,662</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_41heKF3EykimTDNXOnweeg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_rk1Klssn502RVFm0iMPQMw_9_12">14,372</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated depreciation:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_d7-guilVV0mvoM9Oa34iJg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_OMrCL_jJ6UKRmRlso9E7FA_12_2">159</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_fJB_6ZN-dU6RdeM0v4FQzA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_97DKDxrKLkWxk2jafPYNOQ_12_4">1,599</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_Qn1sc58q206NmPfW1osPPQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_xLGPjnJJKkqMsXC6TXwCNw_12_6">7,017</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_HJ03XueB8EKX-2gIlzBjqw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_zwHdzSMYlUGcml4DQJeE-Q_12_8">568</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember__d04PmuBgEKP0NcNI_xEpg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_fKk57GqzYkuZu5wVL9j4YQ_12_12">9,343</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_pYUVZEM920exX1Cwj8qiVg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_J3PYtxCMgESYkRmofyvJ1Q_13_2">53</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_5xasXe81HU2amQaNWKJlDA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_tcGjMe9f9k-xq4FvALqYiA_13_4">271</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_wEOJWOe0kkyVwPPcjL51Bg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_9JhWjMOXdESsDVJbvoj7Zw_13_6">1,084</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_NtOri1sWtESc64I6yGlDKA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_j5DShYMwzUqL_p-8MHiCEw_13_8">264</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_kZxWf5plpkyqcnxdVx9WnA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_tGZmoRaaMkaSWvHdcTTT2A_13_12">1,672</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Disposals</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_5xasXe81HU2amQaNWKJlDA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DisposalsPropertyPlantAndEquipment" sign="-" scale="3" id="Tc_SlKEqCaDMk6R6wwxR573Kg_14_4">19</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_kZxWf5plpkyqcnxdVx9WnA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DisposalsPropertyPlantAndEquipment" sign="-" scale="3" id="Tc_Brn_02bpBE6xOdTA2NxEQg_14_12">19</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_DuVSPEFd10mbFQqwmoueOg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_Z1NBW-z3tU28oXV-m6C_fQ_15_2">212</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_jTG84pzUu0O1uFc9oRxVZg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_sq5ssPAg60OdzhkJyDP52g_15_4">1,851</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_OAXVMW-Syk2ZrIbWtW1baA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_9izPDsIeYE6omTPY6VsR5g_15_6">8,101</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember__IeyEFArwEeikIeuLj91BA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_hhUaVLgADUSKjLCvKlZCdw_15_8">832</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_s9rQXTEfUUmFpg2sTDXMlQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_AaBetvPK_EmvxW4B3WnI6w_15_12">10,996</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying amount:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_4w7KMGsDgUqUG5MpjLDW-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_tLkpumbnGEqLtxxHwciqvg_18_2">126</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_0r2ljY84p02g_MFTZyXL2A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_6TrZL8EmoEqvKlsNUnGR2Q_18_4">310</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_Su1JgXKRt0O2ssj-e_25TQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_Nwl1MIgqQ0OuozkyWJdi-w_18_6">2,748</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_oO6Nlwpj2ECOa1vYcsigFA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_poUFvmLZDUO2qeDfNDyi2Q_18_8">1,072</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_MUVGPZ2Zo0C3Z2S_N5wdKA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_VaHGEGVC_E6JphIf9lRXmw_18_10">3</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_xU5GyUcvgkiPWTq9YrfnaQ_18_12">4,259</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_ym4hANZchU2ZB9m4tnIJFw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_918cnvN-mk2ClNJoqJpsPA_19_2">97</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_W50NBzU5qEa09mv6NhCP5A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_oEzrf6bQCUeOGSvo7QgNMg_19_4">317</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_Ahyp8QOgJU6aUxLJFusyPw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_z0eHmQmkJ0u1TGbJiMgqQw_19_6">2,132</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_SHu6D0sv4U-6qvxwsj--IA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_r30_uXLED0aTaqsGTsi6yA_19_8">830</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_RSgXYisKw0ieDH_MtkA0ag_19_12">3,376</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:42.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:56.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2022</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Laboratory</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Leasehold</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assets under</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Furniture</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">improvements</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">construction</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquisition cost:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_6lS4zjbF4Eac-GIZUgE2jw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_dMatj5rEd06xUr93SjJtZg_5_2">265</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_mfV4owp-bEem-93-p6NYFQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_V_SJrX-AxkCCN8_wt1SetQ_5_4">1,754</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_NZr3F8nBAUuCT_VetHuh3A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_pcS5JQbQ6U-wyOBAG11W_w_5_6">9,142</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_nzoCPNgdt0WOxkRNR6rgNg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_0ls3c9vLQEqAwgEXXmeDbA_5_8">810</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_058A2xbE90SyAgqdMWXaeQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_yhJIUz4oTUuU6U1CFo-ZoA_5_10">695</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_15_CvNFzPUOQfoII6rlmNA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_GDFhOmWbgUq91mj-S1VVPg_5_12">12,666</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_W-r0ii74bU-k1a5qR2sk3Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_wP7BsDuJRU-I-qMI_lr2zA_6_2">20</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_FrBVzS7Gp0e3Hgpbb7-EyQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_scAfyIg4LUGKbQ5OTaHIPw_6_4">151</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_KQhq8CmXDUufwm79fj3u-A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_8hab46Zjc0SB1W0vdeSzUQ_6_6">576</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember__F425--_EEOXAYSsaoxgOA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_SyzL_LRKhk6ff_Vnhff6gg_6_8">184</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_yNTxg0S0g0mhMxkN6R3p8g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_HgTHB0cAAkSzFQRT1HSWiQ_6_10">5</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_JgXeFoa0LUuPeRfQafgJng" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="Tc_LPPo-0vVPkamtIGHpP2AlA_6_12">936</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Transfers</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_FrBVzS7Gp0e3Hgpbb7-EyQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="3" id="Tc_Oz75KeVVPEqb41Z_6n_vTg_7_4">4</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_KQhq8CmXDUufwm79fj3u-A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="3" id="Tc_qA0I5D9m-EGKTw2wZ-p62Q_7_6">47</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember__F425--_EEOXAYSsaoxgOA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" scale="3" id="Tc_IS1VTE6tAU--t2Y2mcObZw_7_8">646</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_yNTxg0S0g0mhMxkN6R3p8g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" sign="-" scale="3" id="Tc_3Texu1uE8EKOfYazTQRszw_7_10">697</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_Cj6a41-HWECUkiVv0bW4qQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_cPu9SmKn7k-XoYRHEuSU4w_8_2">285</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_yA_PZPRqLUu_kKp2zZYt1A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_XycCC4MfjE2DBwygptGR_w_8_4">1,909</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_CCFaY6n0-UeoiGMVZgAhJA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_cC8ws9zpI0uE4Vu6wVn_tQ_8_6">9,765</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_6VOKv2eGyUeHs3MGzC7vIw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_KTA21gYtcUaVMjMxnVtipw_8_8">1,640</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_g2VJr2LWH0mkATiItb2LEg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_ro4SYCyrgE2CtLwPnWEgZw_8_10">3</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_GjTctvZEfEW6pg7_LZJEHA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_4M26Pb_iEUayHxTwOylhPQ_8_12">13,602</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated depreciation:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_unPNYQAq0U61GM9DA5BHWQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_yS9tOkM5ZkuWj5ML_24e1g_11_2">106</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_F9b8H9FLJ02EvHvZhkDIBA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_KDY-Gnzv-k6uG5b0FD-JXA_11_4">1,316</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_obdYBDyo_E-bUxAogvIKSw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_it1FhZkEH0mTInW0MiidBw_11_6">5,739</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_oYg1VVE1MUmNWowfojvvlw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_9TYvJBhFykSL4HS6uzG1cw_11_8">389</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_n8Zissrm5UiC3zmhjJsmyw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_Ruh-eqdHP0eF-7OozPkytQ_11_12">7,550</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_FT-o_AOWWUmsEyj11IwpRQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_YhIRkKsrREapxpjqPopV7g_12_2">53</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_aTa03kZvVk2UVSOXZ_yZVQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_cVA185WQzkyw3hqBAyh4FA_12_4">283</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_dAA0zRsjHUGlsbYsE9T1jQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_TO4MveAm7kGqjxPKUf8JQw_12_6">1,278</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_CvwXkZmKrE2y_nrcwbCWUQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_LJGXO0YVi0-9sLE2tgPD7Q_12_8">179</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_hzU9_UsRaUqQjrz3YAAlrQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="3" id="Tc_5clT40VxyEmsltSmenrRTw_12_12">1,793</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_d7-guilVV0mvoM9Oa34iJg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_qyaeX5gpXEGUxRQS5m-tLg_13_2">159</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_fJB_6ZN-dU6RdeM0v4FQzA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_c5TPSbW-kECiSW80VCsJ0A_13_4">1,599</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_Qn1sc58q206NmPfW1osPPQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_T8asuq0KCEGDcF_FV1Cs8Q_13_6">7,017</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_HJ03XueB8EKX-2gIlzBjqw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_xEljYLQ4CUaCjJ-9L4cXFA_13_8">568</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember__d04PmuBgEKP0NcNI_xEpg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" sign="-" scale="3" id="Tc_sDT-WBibGEqx6Oh3eQT4_A_13_12">9,343</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying amount:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_IfzHfIthHkO6dbcYO8zgwg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_GZ91__63BkyIV2FkPiQLrg_16_2">159</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_eU6vEoc2fEeUkwgp4Q4hyA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_VDrFiwqAJU2n3-nz3Zt9PQ_16_4">438</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_xOhhxIMNr063CjxwJupX8w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_lzT7p3peiEOFQvdWSA-2iw_16_6">3,403</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_Bj1308vFcUO5rHCNyanwEg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_mZNQ91uzj0O8j6gPM9fYeQ_16_8">421</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_9RCvElW3fUCypuHlovaGjA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_CLIJ3e1JV0yIrzbD-O1UVg_16_10">695</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_oyGyaoUit0ya8jUc61B3lQ_16_12">5,116</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_4w7KMGsDgUqUG5MpjLDW-g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_QplKknaJrEGGKvpyJj0Kmg_17_2">126</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_0r2ljY84p02g_MFTZyXL2A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_aBIU8XnrwEuhB0MKGlPfkQ_17_4">310</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_Su1JgXKRt0O2ssj-e_25TQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_m3e4xLpw50a7BPKTWJdu4A_17_6">2,748</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_oO6Nlwpj2ECOa1vYcsigFA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_cNmc9NkHb0SXulZF9W5MwQ_17_8">1,072</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_MUVGPZ2Zo0C3Z2S_N5wdKA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_mj0aAvZtD0Of0jvH4nlnvg_17_10">3</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="Tc_aSe2B9MldkuwnQTbYr9INg_17_12">4,259</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune continues to enhance its laboratory equipment to support its R&amp;D functions. This effort has continued for the&#160;year ended December&#160;31, 2023, with CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_ItAndLaboratoryEquipmentMember_KRQK-6opkEi3py3xSmjCrA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="6" id="Narr_4zYjbTtwEkaZQPWBGzsMhw">0.7</ix:nonFraction> million invested in lab equipment and IT equipment, representing an increase of <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_ItAndLaboratoryEquipmentMember_KRQK-6opkEi3py3xSmjCrA" decimals="INF" format="ixt:numdotdecimal" name="aciu:PercentageIncreaseInPropertyPlantAndEquipment" scale="-2" id="Narr_M2FKgFFKSE-WSEtMdZpQpA">6</ix:nonFraction>%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2023, 2022 and 2021, the Company incurred CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_kZxWf5plpkyqcnxdVx9WnA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="6" id="Narr_lO6CAheeLU6XII2UWqZvRw">1.7</ix:nonFraction> million, CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_hzU9_UsRaUqQjrz3YAAlrQ" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="6" id="Narr_AWMU47-c50KwEDv83F1mig">1.8</ix:nonFraction> million and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_Ch-n85pVKk-WOgs80YsR9A" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="6" id="Narr_b4jRXiZy-kityiqYVJnxEg">1.9</ix:nonFraction> million in depreciation expenses, respectively.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-19</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_bQnBrxZKMkO64fLIQYQqpA_cont1"></ix:continuation><a id="_fee1e3ce_8645_4a9a_ab6d_58b848b7d83f"></a><a id="Tc_dPTHqbd7iECKshTr0JCkvg_1_4"></a><a id="Tc_jLXemFeivEyH_hiQI81JRQ_1_6"></a><a id="Tc_j1eSpLgVjUSC2uh268UcSg_2_0"></a><a id="Tc_3hN4VH9YTUeIYuHiYm3FFQ_2_2"></a><a id="Tc_EeHWgoDowk2uBp-UD6rfBw_2_4"></a><a id="Tc_Erez8PdWCkyKHyQuTxERUQ_2_6"></a><a id="Tc_WREgck2wbEOAZwNot5g1ag_2_8"></a><a id="Tc_qXrscLxirkOV8kXq4m-J8g_3_0"></a><a id="Tc_-S_e_cMVzkCb91i49rb5iQ_4_0"></a><a id="Tc_n4fHCwuankupN5SRfwBi8A_5_0"></a><a id="Tc_hkFIgzYCEkC6VOUS2eOOVw_6_0"></a><a id="_34e1da34_00dc_41b9_8d2f_461e287b5847"></a><a id="Tc_aUfgvG7BEESvMj1Q3J7Jgg_1_4"></a><a id="Tc_69T_Gg-yjEK-iw2fi7E0CA_1_6"></a><a id="Tc_KmxSJ8B4z0CZ45yPhxZW2A_2_0"></a><a id="Tc_DEc--0ZE9ECVXqWlUU-XZg_2_2"></a><a id="Tc_ERsidzSd9UGcm9Vi4NvgcQ_2_4"></a><a id="Tc_0xy0sUce8km49g5zwxFq-w_2_6"></a><a id="Tc_YokW310lbkiZEOXU3n26Tw_2_8"></a><a id="Tc_INnF1GWtoki2drXoa71oMg_3_0"></a><a id="Tc_PZegYLh4Sk-fGfSrvBZf4w_4_0"></a><a id="Tc_tlbd2p3Pw0-riHTmDy04_A_5_0"></a><a id="Tc_f4e-I-VIR0SDaD_oZhCAFQ_6_0"></a><a id="_a3a6db8e_cb85_4941_b7bb_7fd329480864"></a><a id="Tc_eHAEHIA1rUOOUh7qbDbryw_1_2"></a><a id="Tc_cuA33ZDFGE6ZtRGRWfbF8A_2_2"></a><a id="Tc_kwnurHBOvE6N_TMQAO7IpQ_3_0"></a><a id="Tc_bi5ILlK5-k28KbZGrB2p0g_3_2"></a><a id="Tc_c3dSCvESjUWVohFjrGwgxQ_3_4"></a><a id="Tc__6vAzlbO_UmCckXH_4hwxg_4_0"></a><a id="Tc_5wc3UiAjFkCTI9D7aEHFPg_5_0"></a><a id="Tc__TzgNkUT6kWbUkStqcN2FQ_6_0"></a><a id="Tc_CDwlbCkfwk291-bKNWDX4A_7_0"></a><a id="Tc_g2zV6a0MO06tCrRdPTBNVA_8_0"></a><a id="Tc_Bpq0YnET9UiJH1t7JjCUOA_10_0"></a><a id="Tc_ThettJe1Hk21lq5YBrgTAA_11_0"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfLeasesExplanatory" id="Tb_vJl5h82DvE2y5uC_1rl0HQ" continuedAt="Tb_vJl5h82DvE2y5uC_1rl0HQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">5.</b></span>Right-of-use assets, long-term financial assets and lease liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company recognized additions and reassessment of right-of-use of leased assets for buildings or for office equipment totaling CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="6" id="Narr_02r8X2psfkKrwFcB74LBmQ">1.2</ix:nonFraction> million and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="6" id="Narr_0ki5qAgWjkumBGBOXWZufg">0.5</ix:nonFraction> million for the&#160;years ended December&#160;31, 2023 and 2022, respectively. In 2023, these increases are predominantly associated with a new lease and the reassessment of our existing leased office space.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Regarding lease liabilities, the amortization depends on the rate implicit in the contract or the incremental borrowing rate for the respective lease component. The weighted averages of the incremental borrowing rates as of December&#160;31, 2023 are <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_ezBq1LNFIUGJdNTu7a4HwQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" scale="-2" id="Narr_ZSEqbmzwRUO7fcJ36_1P2g">3.5</ix:nonFraction>% (<ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_w5Il_SwGi0K8Y_peNUATtA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" scale="-2" id="Narr_9j7yZlyUakWhtKYm8he5Qg">3.5</ix:nonFraction>% for 2022) for buildings, <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_FgXJNffw_kyxmi2k_Q8KhQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" scale="-2" id="Narr_hubZjBQdfkuK9veYnZu0Jw">5.3</ix:nonFraction>% (<ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_Y2dI5zRkP0aEdOSvnjsAaA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" scale="-2" id="Narr_mMPXPzSRZk2doaPebZbb0Q">5.3</ix:nonFraction>% for 2022) for office equipment and <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_-Hj-hSllxE-LEUa_Gmj16A" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" scale="-2" id="Narr_JYbuHaFT6k6L5qkDhyX6WA">2.6</ix:nonFraction>% (<ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_Ecik1PzbbE2L7iBY1hl-Tg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" scale="-2" id="Narr_9SlsvUB8rk-1IPc0EtRW3g">2.6</ix:nonFraction>% for 2022) for IT equipment.</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" id="Tb_dKCp2YYv8UauQcouYRLD2A" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following tables show the movements in the net book values of right-of-use of leased assets for the&#160;years ended December&#160;31, 2023 and 2022, respectively:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:61.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:61.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Office</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:61.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Buildings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_w5Il_SwGi0K8Y_peNUATtA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_xbTp1kVWIEeA35XhhQ2j2Q_3_2">2,708</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_Y2dI5zRkP0aEdOSvnjsAaA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_r5AqGrtMg0m2J88RLPuUGw_3_4">74</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_Ecik1PzbbE2L7iBY1hl-Tg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_RAqSVBO0zUKaTjSnE9_5og_3_6">26</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_CZXkbSX0EECnlErDSucEPA_3_8">2,808</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:61.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions and reassessment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_dz45p3-Mt0Kum8kISicdTg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_HF2W65zGWUKEuwMJAWjF3A_4_2">1,243</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_oH_yOQmg0kGMBs0pfoK_pQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_SRjiPAWJDkahkJepOYjNSg_4_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_0Jtnd8m_I0enHD9zlLU-pg" decimals="-3" format="ixt:zerodash" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_Dl3E0NGBa0uAzLL0SPPYBQ_4_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_mhNR4Sn_40--rPrm8iOeqA_4_8">1,243</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:61.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_dz45p3-Mt0Kum8kISicdTg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_7MBz8olxD0WtW9230pKhnQ_5_2">505</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_oH_yOQmg0kGMBs0pfoK_pQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_WuPYrLUPAUGuhWYVGd1XfA_5_4">24</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_0Jtnd8m_I0enHD9zlLU-pg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_6Ts5xsO-9k6OJrOcX_4Ryg_5_6">14</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_yoy4-QkyY0CUdcIbDxG_ng_5_8">543</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:61.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_ezBq1LNFIUGJdNTu7a4HwQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_PNSzYQmXiEO4Phm06u5cKw_6_2">3,446</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_FgXJNffw_kyxmi2k_Q8KhQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_M61zHs3NH0S1A8FnaZYoTw_6_4">50</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_-Hj-hSllxE-LEUa_Gmj16A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_Si3Aayo7QUGQwKD9VCb9SA_6_6">12</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_kIElU8O4RUWNvtWbSwx61Q_6_8">3,508</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:61.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:61.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Office</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:61.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Buildings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_MOvL_KRv-0GMjYdNMWJfSw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_flCpEXYITUOq_O_DYEAH3g_3_2">2,776</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_mEjjRoDiAEuxYNk_x45n1g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_j1Z3_INPGkybD3cy9kROeA_3_4">98</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_kiGHGOXq1EeHpusggsUgOg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_Rw-_RUN2tUSPMtjzeMAMqg_3_6">40</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_YBl5IvFQUES5CUTqDJ9_PA_3_8">2,914</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:61.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions and reassessment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_Gl68ge7NsE6HRhfhKLgLLg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_nAibFLYHi0-w0ApeYrwMNw_4_2">460</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_JX8Xpx6XvkGjBXaj4z4PEA" decimals="-3" format="ixt:zerodash" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_xdzywVddUUymt5b5qgPPGA_4_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_SK2Ewb7ptEmzydRvB1J-Mw" decimals="-3" format="ixt:zerodash" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_XhuAmijBikyeZgZCoAZaAA_4_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="3" id="Tc_qKCnqKeFuES_p3wmtm_KwA_4_8">460</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:61.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_Gl68ge7NsE6HRhfhKLgLLg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_qu9tJBG0o02O_hJJrv78Qg_5_2">528</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_JX8Xpx6XvkGjBXaj4z4PEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_sOx-XVJTsEmVq5OQvzi6mw_5_4">24</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_SK2Ewb7ptEmzydRvB1J-Mw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_UOfEg8DXeEetLNf0nBSzmA_5_6">14</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_oqiSuj48mEqwD3UJVyGP8w_5_8">566</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:61.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_w5Il_SwGi0K8Y_peNUATtA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_O9X7X2mHKUSKcOJSwZ7PFw_6_2">2,708</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_Y2dI5zRkP0aEdOSvnjsAaA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_8EyGMBpFwkukyNGRoWJIDw_6_4">74</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_Ecik1PzbbE2L7iBY1hl-Tg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc__DADJaQegEmJ69oXWAT5sw_6_6">26</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RightofuseAssets" scale="3" id="Tc_lAsUo90n6kic_XT7SYnfUQ_6_8">2,808</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock" id="Tb_Jqz_vma7dEuU51_fxjdHMA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">For the&#160;years ended December&#160;31, 2023, and 2022, the impact on the Company&#8217;s consolidated statements of income/(loss) and consolidated statements of cash flows is detailed in the table below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Statements of income/(loss)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation of right-of-use assets </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_npuE-0zSdk-n-AKkd1fpdw_5_2">543</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DepreciationRightofuseAssets" scale="3" id="Tc_SVP6yrzAnEiPr33KG6vnoQ_5_4">566</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest expense on lease liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" id="Tc_qkDqMJaWKk-cyrGi5YXb6w_6_2">90</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" id="Tc_9XpugJSQE0SBWtI0Xytlxg_6_4">68</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expense for short-term leases and leases of low value </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" scale="3" id="Tc_OH3iIcqUaUG4kYmdQYvuHQ_7_2">793</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" scale="3" id="Tc_3SvOfAc_70C2uP7ysSYIxw_7_4">750</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="aciu:ExpenseRelatingToLeases" scale="3" id="Tc_EhPOipuYRkGBt85RIAG52g_8_2">1,426</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="aciu:ExpenseRelatingToLeases" scale="3" id="Tc_ehJ6IDlU5kCjhIKfPffpVA_8_4">1,384</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Statements of cash flows</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total cash outflow for leases</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashOutflowForLeases" scale="3" id="Tc_Y7PudUmjk0mv6lUh1QwjIw_11_2">1,431</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashOutflowForLeases" scale="3" id="Tc_7Z-lAibSikCsKlAhowT1iw_11_4">1,388</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-20</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_168ad3cd_f1de_4d3d_a673_6462d565b868"></a><a id="Tc_E6z-iN40wUekbqK88OPOqg_1_2"></a><a id="Tc_kqYaUQPjQ0qasCr0Dfy21g_2_2"></a><a id="Tc_0SNjtfbuxkGmfkkV38SbQQ_3_0"></a><a id="Tc_3cTLjNN-zkytYQO2ilj3tQ_3_2"></a><a id="Tc_ScvVvwn_1kul7ut-yLXTpA_3_4"></a><a id="Tc_yKvQ2vCbnUGBsc2swloW-A_4_0"></a><a id="Tc_vVcIbQkaFkOCidW-3vNATg_5_0"></a><a id="Tc_NGHcOeyV3kOiyN_kFW0kUw_6_0"></a><a id="Tc_shR_Hpw5e0Gl2aebfUiqgQ_7_0"></a><ix:continuation id="Tb_vJl5h82DvE2y5uC_1rl0HQ_cont1"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:ScheduleOfContractualUndiscountedCashFlowsTableTextBlock" id="Tb_Tmh-_GLafEujibvI1WlAAQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table presents the contractual undiscounted cash flows for lease liabilities as of December&#160;31, 2023 and 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Less than one year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_PEDQ9Y0GpEGR7Fz3aVtJ5Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="Tc_Z5FQ9Lwigk6-rU8aag8_ag_4_2">784</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_ZpFwqYls3EejWQUqS6jVtA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="Tc_NpS1e5XDrk2YqCOtHJ3qGg_4_4">638</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">1-3 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_UEQ5-Qdp-ECfZVHJXapb-w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="Tc_Wig30PxVh0W5u5T14HDXNA_5_2">1,526</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_O05oIcvQHECcE7b4dXGvbQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="Tc_hbTQhha2-kmAw2n96Yy63g_5_4">1,230</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">3-5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_CD3sQ6Iqhk-fx5WexG8VXQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="Tc_XXgH2RQM7kqeGNayqIX3FA_6_2">1,505</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_vnWZvKBRW0CV9s94BbcDrg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="Tc_GkhRoM3jN0u3IjjXrbl4FQ_6_4">1,187</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="Tc_jqUGM-Fd00ili1vuY9Nw2A_7_2">3,815</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GrossLeaseLiabilities" scale="3" id="Tc_H0OJptAxL0CDQDWiEaWO0w_7_4">3,055</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company also has <ix:nonFraction unitRef="Unit_Standard_item_lel3bReemU2v4xdKyUvjzA" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfDepositsInEscrowAccounts" scale="0" id="Narr_Co8nfHuAWk-cJWQmYYm3fA">two</ix:nonFraction> deposits in escrow accounts totaling CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-5" format="ixt:numdotdecimal" name="aciu:EscrowDepositAmount" scale="6" id="Narr_W09uRrR1b0-LtWnJs9983g"><ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-5" format="ixt:numdotdecimal" name="aciu:EscrowDepositAmount" scale="6" id="Narr_fr9TeBepkE6XAcXFO5H7gQ">0.4</ix:nonFraction></ix:nonFraction> million for the lease of the Company&#8217;s premises as of December&#160;31, 2023 and 2022, respectively.</p></ix:continuation><a id="_f79381b7_d143_4c58_b45d_26a5c5b56a0c"></a><a id="Tc_njohiZPPuUG5mskEcgueoA_1_0"></a><a id="Tc_pYGvzV8dIUikpggi3zvMmA_2_0"></a><a id="Tc_rd2xLCHx_ESuzk2lf3DS2A_3_0"></a><a id="Tc_MqMKqR_0jkOgfr9PHsZE_A_4_0"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:DisclosureOfAssetAcquisitionsTextBlock" id="Tb_NCtBl8yOAECrTI90zQV4Cg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">6.</b></span>Asset acquisition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In 2021, the Company closed its acquisition with Affiris AG (Affiris) for the program portfolio of therapeutics targeting a-syn, notably ACI-7104.056 (previously PD01), a clinically-validated active immunotherapy candidate for the treatment of Parkinson&#8217;s disease (the Transferred Assets). The Company acquired the Transferred Assets and USD <ix:nonFraction unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ" contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_8aUhNs9mtU-Truhn6_ij4A" decimals="-5" format="ixt:numdotdecimal" name="aciu:CashAcquiredAsPartOfAssetAcquisition" scale="6" id="Narr_ceOMX5YHAkezvploOUPl2A">5.0</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_8aUhNs9mtU-Truhn6_ij4A" decimals="-5" format="ixt:numdotdecimal" name="aciu:CashAcquiredAsPartOfAssetAcquisition" scale="6" id="Narr_W9UC67--80GVO2ldBgf7oA">4.6</ix:nonFraction>) million in cash in exchange for <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2021_To_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_rCWc9moZ-UuoKzp2P9kXqQ" decimals="INF" format="ixt:numdotdecimal" name="aciu:SharesTransferredAsConsiderationInAssetAcquisition" scale="0" id="Narr_NLydTM62p0effhfvOgJ0sA">7,106,840</ix:nonFraction> shares of the Company at closing, for a total value of USD <ix:nonFraction unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ" contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_8aUhNs9mtU-Truhn6_ij4A" decimals="-5" format="ixt:numdotdecimal" name="aciu:TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition" scale="6" id="Narr_-5XRXXXlTE2r1vxuGVWKlA">58.7</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_8aUhNs9mtU-Truhn6_ij4A" decimals="-5" format="ixt:numdotdecimal" name="aciu:TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition" scale="6" id="Narr_uOP9esEKUkGozHoRjoY-qA">55.1</ix:nonFraction>) million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">With the closing of this transaction, the Company recorded an IPR&amp;D intangible asset associated with ACI-7104.056 for USD <ix:nonFraction unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ" contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_BBkqnTW0KUyG6jmwGuQriQ" decimals="-5" format="ixt:numdotdecimal" name="aciu:IntangibleAssetsAcquiredAsPartOfAssetAcquisition" scale="6" id="Narr_xLMxddKNzEWEQMlp7iKtlQ">53.7</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_BBkqnTW0KUyG6jmwGuQriQ" decimals="-5" format="ixt:numdotdecimal" name="aciu:IntangibleAssetsAcquiredAsPartOfAssetAcquisition" scale="6" id="Narr_Wb_lm3hLdku3w1rX9T5LyQ">50.4</ix:nonFraction>) million. The Company used a risk-adjusted discounted cash flow method to determine the fair value of the intangible asset using a discount rate of <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_eiJAYeQIpEq75LD86tbZwQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:SignificantUnobservableInputAssets" scale="-2" id="Narr_clw7c-RaLkCSiODPKwWwlw">15</ix:nonFraction>%. See &#8220;Note&#160;7. Intangible assets&#8221; for further details on assumptions used.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As the Company transferred its own equity instruments in consideration for the asset transferred, the acquisition was assessed in accordance with IFRS 2 <i style="font-style:italic;">Share-based Payment</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company determined that the acquisition of the Transferred Assets did not qualify as a business combination in accordance with IFRS 3 <i style="font-style:italic;">Business Combinations</i> and therefore was accounted for as an asset acquisition. Most of the fair value of the Transferred Assets is attributable to a single identifiable asset which is the in-process research and development asset. The purchase consideration for the Transferred Assets was allocated based on their relative fair values.</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:DisclosureOfAssetAcquisitionsTableTextBlock" id="Tb_GlUEowlfo02ceOtRgufO3A" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table summarizes the amounts of the Transferred Assets acquired:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:86.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:86.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:86.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Cash</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_8aUhNs9mtU-Truhn6_ij4A" decimals="-3" format="ixt:numdotdecimal" name="aciu:CashAcquiredAsPartOfAssetAcquisition" scale="3" id="Tc_6CDS4v4mhk6qoMHSEcRpwg_2_2">4,634</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:86.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">IPR&amp;D asset</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_8aUhNs9mtU-Truhn6_ij4A" decimals="-3" format="ixt:numdotdecimal" name="aciu:IntangibleAssetsAcquiredAsPartOfAssetAcquisition" scale="3" id="Tc_Iw1d00C4wUyZC_Q5-QZHlg_3_2">50,416</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:86.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_8aUhNs9mtU-Truhn6_ij4A" decimals="-3" format="ixt:numdotdecimal" name="aciu:TotalAssetsAcquiredInAssetAcquisition" scale="3" id="Tc_lgY4Cw4se0aP6FAzWolnpw_4_2">55,050</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-21</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_ad65134c_019e_44cb_a963_9abc52c1f73c"></a><a id="Tc_rauOc7WxT0yeL50D3Z5Sgg_1_2"></a><a id="Tc_KCWWV6SVoU-K4hvOB-gQIw_1_8"></a><a id="Tc_G2401iRjw06PMvoXyt6_ng_2_2"></a><a id="Tc_CDcPscnp90OPSixVpM0XFw_2_8"></a><a id="Tc_ReCDKiAjak6kBVO6u5cVdg_3_2"></a><a id="Tc_UvUnkHPAkUqKd-SPD_1A6Q_3_4"></a><a id="Tc_iedWuEKuDkykRHPQmYsnDA_3_6"></a><a id="Tc_hWxSznzip06oyXnhr4D1zw_3_8"></a><a id="Tc_-Hg_6O32Lk2s-_qht2XbuA_3_10"></a><a id="Tc_rg-wi8gSwkqvOi9EUAlNcQ_3_12"></a><a id="Tc_UYlel0XvY0a9V048BpqbZA_4_0"></a><a id="Tc_f3USbM1MiUSoDiS39NtmIQ_4_2"></a><a id="Tc_Wo8Txo9oG0SB9g3YEz7qtQ_4_4"></a><a id="Tc_NtTCJKcyVUixPpbOkL3r7Q_4_6"></a><a id="Tc_Pubo-jwRwkyq0p6eJCFdcg_4_8"></a><a id="Tc_Pw9TE6M1SEeRnafapdZjVA_4_10"></a><a id="Tc_xysdWSUks0ewpfX00gU0Eg_4_12"></a><a id="Tc_kcNXqDO76k2rL1palWK3wA_5_0"></a><a id="Tc_kNIzzpXDB0yaeGD4zs2ExQ_6_0"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfIntangibleAssetsExplanatory" id="Tb_d6Y_P7x7XEWoDMroFdlnXQ" continuedAt="Tb_d6Y_P7x7XEWoDMroFdlnXQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">7.</b></span>Intangible assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">AC Immune&#8217;s acquired IPR&amp;D asset is a clinically-validated active immunotherapy candidate for the treatment of Parkinson&#8217;s disease. The asset is not yet ready for use until the asset obtains market approval. The carrying amount and net book value are detailed below:</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" id="Tb_AhQ3VXKaPUaLGiN8Efp3Ng" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net book</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net book</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> value</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Acquired IPR&amp;D asset</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_bOl8wEKNyEqYyzQR0ioW-w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_ONITgH43RkSDOIchAa5NcQ_5_2">50,416</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_ml_R3Ylar0-YvNfrWq7Svg" decimals="-3" format="ixt:zerodash" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_YpxC39MRNESEYUxKZ7oEKw_5_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_MVjsqGrUmkGNOKc737qEYQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_T0e61wsLNk-tFxzs_0jkjw_5_6">50,416</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_CaCTeKx2c0qPmNfApsv9IQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_-ZNWJtD8X0Kv6XZ7dSp1AQ_5_8">50,416</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_xfEun2NfTUKZr40nuUKpOA" decimals="-3" format="ixt:zerodash" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_67poRgpHOUiRE_ebq7p-jw_5_10">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_aGfEhz_sAkK6Z9G5vRsASQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_UEs_N49HgUiFYs9zFjKhlw_5_12">50,416</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total intangible assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_41heKF3EykimTDNXOnweeg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_1Z_E6I9d1kKzs9QM-ioLTQ_6_2">50,416</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_s9rQXTEfUUmFpg2sTDXMlQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_T3lXkhOIMUy3upmAsvHDxA_6_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_JATE2Nxegku2uYzlRfZAtw_6_6">50,416</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_GjTctvZEfEW6pg7_LZJEHA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_EbK7kfNWOkmidHntrCMKcw_6_8">50,416</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember__d04PmuBgEKP0NcNI_xEpg" decimals="-3" format="ixt:zerodash" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_96poi-gzU0arOVHILWS0iw_6_10">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="3" id="Tc_iFqJvbNiHUyCP5_y19cPKg_6_12">50,416</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In accordance with IAS 36 <i style="font-style:italic;">Impairment of Assets</i>, the IPR&amp;D asset is reviewed at least annually for impairment by assessing the fair value less costs to sell (recoverable amount) and comparing this to the carrying value of the asset. The valuation is considered to be Level&#160;3 in the fair value hierarchy in accordance with IFRS 13 <i style="font-style:italic;">Fair Value Measurement</i> due to unobservable inputs used in the valuation. The Company has determined the IPR&amp;D asset was not impaired as of December&#160;31, 2023 and 2022, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The key assumptions used in the valuation model in accordance with an income approach to determine the recoverable amount include observable and unobservable key inputs as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Anticipated research and development costs;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Anticipated costs of goods and sales and marketing expenditures;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Probability of achieving clinical and regulatory development milestones in accordance with certain industry benchmarks;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Target indication prevalence and incidence rates;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Anticipated market share;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">General commercialization expectations such as anticipated pricing and uptake;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Expected patent life and market exclusivity periods; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Other metrics such as the tax rate.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s valuation model calculates the risk-adjusted, net cash flows through the projected period of market exclusivity across target sales regions. The Company uses a discount rate of <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_w6UU7BFQQ02Es-wkhoNeRA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:SignificantUnobservableInputAssets" scale="-2" id="Narr_BnYa6hIAZ0-fMSCDo7_9Og">17</ix:nonFraction>% (<ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_MFct5TYRLEOKaNzhRr9ydA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:SignificantUnobservableInputAssets" scale="-2" id="Narr_GTCldp2Qf0SZKoJ8L94tAQ">17</ix:nonFraction>% for 2022), based on the assumed cost of capital for the Company over the forecast period.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-22</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_d6Y_P7x7XEWoDMroFdlnXQ_cont1"></ix:continuation><a id="_aea4a2d5_f835_473e_9dc3_ddd661d6622b"></a><a id="Tc_PiIuiW3sGEST4zfvmWeZWA_1_2"></a><a id="Tc_IplZiDUZrkKeHrWwZTPo-Q_2_2"></a><a id="Tc_nnEP1CrvfU6OlS67_Qy3mw_3_0"></a><a id="Tc_092-DjTLkEaBrAkiyC_jNQ_3_2"></a><a id="Tc_Lf3FHtWc6UKWlQWAKHIMAw_3_4"></a><a id="Tc_Sh7UM5oY_k-MnZimgLasvQ_4_0"></a><a id="Tc_f-y1QI-AyUKxj42UYkkqFQ_5_0"></a><a id="Tc_KuKyqYe9r0C3cxb_numDig_6_0"></a><a id="Tc_ujH4c0G1NUqfvRzU_KbkyQ_7_0"></a><a id="Tc_IxRVdIQhtUS2is76rBv2Hw_8_0"></a><a id="Tc_f_aXWEOv1kOrgy5iIyhKNw_9_0"></a><a id="Tc_EJIuRWVavkuEXv855yHmww_10_0"></a><a id="_180b70ac_a2d6_4f2e_b332_87d0d531c92e"></a><a id="Tc_YUV_2wqEIEqN9leMKRzG-A_1_2"></a><a id="Tc_EazB1zP9iUO6DVBSBnAwEA_2_2"></a><a id="Tc_ivNx52Q9N0ui5F2YJVRRcQ_3_0"></a><a id="Tc_14JgZbAxuU-L72wIJAlFWQ_3_2"></a><a id="Tc_5lp6tBA81kCAxQLoyssPqA_3_4"></a><a id="Tc_FQ7vnPV2XUyAfTvD6JFy4A_4_0"></a><a id="Tc_7vZXQ18ezEm7ULpfKN1m4Q_5_0"></a><a id="Tc_oUCoAKi64UGvqTKcJDVrQA_6_0"></a><a id="Tc_wOifHIY0hE2FnNUq1NKs_Q_7_0"></a><a id="Tc_kZz4haJQQEumylSUa2VGyQ_8_0"></a><a id="Tc_ZAPoiJJzxEqfL_9ykAIx1w_8_4"></a><a id="Tc_KZu1jRERdUGh44uBFslqAg_9_0"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock" id="Tb_x0HiLTXBVU674WMU_DqKpQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">8.</b></span>Cash and cash equivalents and short-term financial assets</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock" id="Tb_FzM6DkslPkGG4TUMWdzLmg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The Company&#8217;s cash and cash equivalents are maintained in the following respective currencies as of December&#160;31, 2023 and 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_GX3Q2SMazE-Y7a86rGaluQ_4_2">78,494</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_hJtiq80T_kecwA6aZW_bJQ_4_4">31,586</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_BJOd-y2_zUKXx0cgJNKHNQ_5_2">78,494</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_MDhtftzU9U28OpDWdWbyLw_5_4">31,586</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">By currency</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">CHF</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_srt_CurrencyAxis_currency_CHF_JfNLzHvH80WbSrRE58qKYg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_wt_bU7MI2kqkDablQXIvCA_7_2">52,437</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_srt_CurrencyAxis_currency_CHF_9dJzU0_HhECZUKUigq7XAg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_ADn8PbzPXEiCPJvM2dSa4Q_7_4">24,418</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">EUR</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_srt_CurrencyAxis_currency_EUR_CKOjyw5J1Um-SGovJ4ejYw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_KNngDcWbHEe6GqZDZzZT_Q_8_2">8,155</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_srt_CurrencyAxis_currency_EUR_gXKgjdqF5ECk_GGPperSYA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_9zrGAzVZlUWZo6bV-5xjqg_8_4">1,313</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_srt_CurrencyAxis_currency_USD_hCYaW1c4MEeE5iAbGkvRtw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_n1RhQ-QIxkqd4Xf-p4hHsg_9_2">17,902</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_srt_CurrencyAxis_currency_USD_vlpq5OPW5UKEsC2zk4jyEg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_xhYuA7LhR0e5zFcF0B0puA_9_4">5,855</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total cash and cash equivalents</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_2k6yN90e_kiBS0kjubVT4A_10_2">78,494</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CashAndCashEquivalents" scale="3" id="Tc_SwviPZNoh0CcQqLDPu2C2g_10_4">31,586</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2023 and 2022, the Company&#8217;s funds were held in CHF, EUR and USD currencies. Funds held in EUR and USD were translated into CHF at a rate of <ix:nonFraction unitRef="Unit_Divide_CHF_EUR_tPOVrZBRTEKkYMGLwOeV4w" contextRef="As_Of_12_31_2023_srt_CurrencyAxis_currency_EUR_CKOjyw5J1Um-SGovJ4ejYw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Narr_aKyQ2oz1S0qeWGGw42fF4Q">0.942</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Divide_CHF_USD_FPtD7vL32kaT4HamUiI0aw" contextRef="As_Of_12_31_2023_srt_CurrencyAxis_currency_USD_hCYaW1c4MEeE5iAbGkvRtw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Narr_uDitPxHAvUuVqALyrCkgYQ">0.851</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Divide_CHF_EUR_tPOVrZBRTEKkYMGLwOeV4w" contextRef="As_Of_12_31_2022_srt_CurrencyAxis_currency_EUR_gXKgjdqF5ECk_GGPperSYA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Narr_ZGQUaDYEeU2NiYEg4X9aSA">0.994</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Divide_CHF_USD_FPtD7vL32kaT4HamUiI0aw" contextRef="As_Of_12_31_2022_srt_CurrencyAxis_currency_USD_vlpq5OPW5UKEsC2zk4jyEg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ClosingForeignExchangeRate" scale="0" id="Narr_s5pIKgIQBEqBeiutuZiBFA">0.933</ix:nonFraction>, respectively, for each currency and&#160;year.</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock" id="Group_7ht7pSyCckO_8Ube1bufyQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table summarizes the Company&#8217;s short-term financial assets as of December&#160;31, 2023 and 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term financial assets due in one year or less</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" scale="3" id="Tc_Z7xbCWn9-UeyY-EmZwX3eA_4_2">24,554</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" scale="3" id="Tc_2zoWvsTHUUqZ31m5VRZq4Q_4_4">91,000</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" scale="3" id="Tc_ibdftW7QrEe0Q5GtKkHDHw_5_2">24,554</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" scale="3" id="Tc_sEdhYQQOSkmi-92DXTgIvA_5_4">91,000</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">By currency</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">CHF</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_srt_CurrencyAxis_currency_CHF_JfNLzHvH80WbSrRE58qKYg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" scale="3" id="Tc_vg_aLtSa1E6vclvWtWq2Xw_7_2">22,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_srt_CurrencyAxis_currency_CHF_9dJzU0_HhECZUKUigq7XAg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" scale="3" id="Tc_D86FTiuBnEOlT3Hxp_CVkQ_7_4">91,000</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_srt_CurrencyAxis_currency_USD_hCYaW1c4MEeE5iAbGkvRtw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" scale="3" id="Tc_goIZrcy37U2_GSKuE_ZRzA_8_2">2,554</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total short-term financial assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" scale="3" id="Tc_nIhK7SK5NUWRUz7rivgZuQ_9_2">24,554</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents" scale="3" id="Tc_7L6tI5tL7U6u2JcwTawNhw_9_4">91,000</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="Tc_umEy6fxPGkShlDnb-eF1GQ_1_2"></a><a id="Tc_PLm0QRmyNE-HgjDYb8VGFw_2_2"></a><a id="Tc_sdcDux648kiNewyVVNRU9A_3_0"></a><a id="Tc_Sg5m06k_1UCrmwOU17oh6Q_3_2"></a><a id="Tc_CC2mqSlT_0uVniPN7xAH2Q_3_4"></a><a id="Tc__JkdIGWLGkKvZ1VtGh-m1g_4_0"></a><a id="Tc_8jfxCBYwGUGUQRcZbejTmw_5_0"></a><a id="Tc_mHAy8T_M-k20joe4MRtHgQ_6_0"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock" id="Tb_JLtq8eYb1kWUlelVrHMf6A" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">9.</b></span>Prepaid expenses and accrued income</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock" id="Tb_IWK5voygSkCflC9Fu0JQkw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Prepaid expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentPrepaidExpenses" scale="3" id="Tc_zbE4VpAJvky2EJ8xP5KQLA_4_2">6,437</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentPrepaidExpenses" scale="3" id="Tc_v8cJDdciBE6Di4Sio46_FA_4_4">4,708</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets" scale="3" id="Tc_eini_tiK2UqJC8pzYBV88w_5_2">246</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets" scale="3" id="Tc_zS7qFosjwEKqVG7sB8rI3g_5_4">408</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total prepaid expenses and accrued income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets" scale="3" id="Tc_e1UK3gKAG0SPrDEmpabzig_6_2">6,683</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets" scale="3" id="Tc_HmZrsNqZMkma5xwmKShluQ_6_4">5,116</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s prepaid expenses relate mainly to research contracts with down-payments at contract signature with the related activities to start or continue into 2024, prepaid expenses recorded as part of our cost sharing arrangement with Janssen, as well as prepaid payroll-related expenses. </p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:DisclosureOfAccountsReceivableTableTextBlock" id="Tb_wQfOFgZOhkmEdx7YVU1geQ" continuedAt="Tb_wQfOFgZOhkmEdx7YVU1geQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">10.</b></span>Accounts receivable</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 8pt 0pt;">As of December 31, 2023, accounts receivable includes the CHF <ix:nonFraction unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ" contextRef="As_Of_12_31_2023_ifrs-full_CounterpartiesAxis_aciu_JJInnovativeMedicineMember_vsI7p2vgBE6RmjAsmPNw1A" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:CurrentTradeReceivables" scale="6" id="Narr_IiNH4H_cUkygS-XxdcP3GQ">14.8</ix:nonFraction> million milestone payment due from Janssen as part of our collaboration and license agreement for reaching the programmed launch of the Phase 2b clinical study. This balance was not overdue as of December 31, 2023.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-23</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_wQfOFgZOhkmEdx7YVU1geQ_cont1"></ix:continuation><a id="Tc_uDCd55Z_iEONB_0U76MN2w_1_2"></a><a id="Tc_fW9rU0ZbS06sXIrBL0c8SA_2_2"></a><a id="Tc_dzgecCu6hUKuwjy-gVa3IQ_3_0"></a><a id="Tc_MNSnpWbaYk-35LQa9_a3tw_3_2"></a><a id="Tc_bjbHlz3adkqhBc2d32uMlQ_3_4"></a><a id="Tc_xAvd1v6Uqk2TI3DImqmiog_4_0"></a><a id="Tc_BNTGJtVlgke7BXAveWZB6w_5_0"></a><a id="Tc_vVjNKzT0ZkiiFJn8sVNuFQ_6_0"></a><a id="Tc_qirr08ZRPEOhoCk_2SQBRg_7_0"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:DisclosureOfOtherCurrentReceivablesTextBlock" id="Tb_8Phb2F1joUuZ7ZzfNb2uFQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">11.</b></span>Other current receivables</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock" id="Tb_fM63yE5MA0CSXjJUMX8t-w" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other current receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="aciu:MiscellaneousOtherCurrentReceivables" scale="3" id="Tc_fi_YXGYPfEyNfyJv4bEBiw_4_2">45</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="aciu:MiscellaneousOtherCurrentReceivables" scale="3" id="Tc_QkIAPoUoWEq67WX8cRvr3g_4_4">124</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Swiss VAT</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentValueAddedTaxReceivables" scale="3" id="Tc_fE8D_hhUsUm-flkWI3ZebQ_5_2">259</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentValueAddedTaxReceivables" scale="3" id="Tc_cYcf4IqtFEGHnz91V010tA_5_4">249</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Withholding tax</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="aciu:WithholdingTaxReceivables" scale="3" id="Tc_53C8M05gyEydswc6GiNhXg_6_2">318</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="aciu:WithholdingTaxReceivables" scale="3" id="Tc_a7Vj-1RnAE6lotbNrCP26Q_6_4">19</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total other current receivables</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherCurrentReceivables" scale="3" id="Tc_mLxYPU71XUuWnf2G4dsOlw_7_2">622</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherCurrentReceivables" scale="3" id="Tc_y6yagdnpYkGx8ome41rUCQ_7_4">392</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The maturity of these assets is less than <span style="-sec-ix-hidden:Hidden_JBrWQoLofk6Gyr7gN4-sJQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3&#160;months</span></span>. The Company considers the counterparty risk as low and the carrying amount of these receivables is considered to approximate their fair value.</p></ix:nonNumeric><a id="_2bd71fac_36b1_4741_85c6_4646dacd3dfc"></a><a id="Tc_HFvwQ__-D0moTPOcTlL0Qg_1_6"></a><a id="Tc_zPwgeSmDoEmLMlsPort2tg_2_2"></a><a id="Tc_9tYv14ey_UK-yCDCVSZw1g_2_4"></a><a id="Tc_xuBQI1T-rUyN5WjZKE6LAg_2_6"></a><a id="Tc_CAhkIBXUnkyR6EUZ9Q5DDg_2_8"></a><a id="Tc_a64a5AZJVE2NPEn9Gt4T7Q_2_10"></a><a id="Tc_lRHnbDdDDUOm9l8mPnT4wQ_3_2"></a><a id="Tc_UHO5JBe-dUybpA42aqishg_3_4"></a><a id="Tc_NmHAVDGuIUG98INgYliaVQ_3_6"></a><a id="Tc_Rt9SDLRTBEO1cEKjC3OsXw_3_8"></a><a id="Tc_mJRz5IzFc0GTyjQiEjIgEQ_3_10"></a><a id="Tc_ANAe_xS2BUuunBJyfaNQ7A_4_0"></a><a id="Tc_28q1nYto0kmHygrHSIYAfQ_5_0"></a><a id="Tc_8DTmK7x-oECpFyplKwcEOw_5_2"></a><a id="Tc_UBjVf79l3EyB1YD513JSJA_5_6"></a><a id="Tc_E7d3gNqGuU68HFlqgAwvGQ_6_0"></a><a id="Tc_RMagljmIe0mzO_euKWlK5Q_6_4"></a><a id="Tc_A1kZHOQHskOMh8sVeAFk8Q_6_10"></a><a id="Tc_w_OmuOe_rUSg3pxSEVoQdg_7_0"></a><a id="Tc_DYB4X8Xxm0CDRsyHrVZSHQ_8_0"></a><a id="Tc_JoKgxpC_4ky06n2vHf5b_g_8_4"></a><a id="Tc_1yJDNs6v_UWr-WeaeUEk1A_8_10"></a><a id="Tc_5eKUEDs0BUSe6se17Ngltg_9_0"></a><a id="Tc_MjwrwkJF_0icK9OA4dT34A_9_2"></a><a id="Tc_6g18FzzQqUaM7pduxfPNuQ_9_6"></a><a id="Tc_P10LHzsLD0yNNHEBugT1hQ_10_0"></a><a id="Tc_czhYjSruTkORwMSBhdaqYA_10_4"></a><a id="Tc_4DI9jJbRBkqzg9_go70aEw_10_10"></a><a id="Tc_s-HzCUGKtEetIdphjaDZ2w_11_0"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" id="Tb_YpJUwUvNgEC5XDVvEN2A9A" continuedAt="Tb_YpJUwUvNgEC5XDVvEN2A9A_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">12.</b></span>Share capital</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2023 and 2022, the issued share capital amounted to CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_Aj1yGEPLv0OsHOLlVg5leg" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:IssuedCapital" scale="0" id="Narr_STbaD7VQKUugRw_3tQVd9g">2,088,823</ix:nonFraction> and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_HTCG4hUqoUOTQ98ao4z1DA" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:IssuedCapital" scale="0" id="Narr_J2KSbMlLN0W4qkIPxhaUBg">1,796,675</ix:nonFraction>, respectively, and is composed of outstanding common shares of <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_Aj1yGEPLv0OsHOLlVg5leg" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:NumberOfSharesIssued" scale="0" id="Narr__z0C5kpebEmBI3MIjlsTlA">99,197,829</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_HTCG4hUqoUOTQ98ao4z1DA" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:NumberOfSharesIssued" scale="0" id="Narr_Y7tJv8UXjkeog59p-gzXyw">83,620,364</ix:nonFraction>, respectively, and treasury shares of <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" scale="0" id="Narr_mSx61I_wek2LPQDQu2bZhw">5,243,958</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" scale="0" id="Narr_Mm6twDKQk0GRa8bDtVNpDQ">6,214,021</ix:nonFraction>, respectively.</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory" id="Tb_Xpo18v2ltU--zqnsgdB-dQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The table below summarizes the Company&#8217;s capital structure:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Common</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Treasury</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Treasury</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">premium</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_FsucBjEq20ymDerczI9DZw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfSharesOutstanding" scale="0" id="Tc_lG6GGGL9YkSwb3aW5FpMYg_4_2">89,700,630</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_zn6P6shP0UCItAsEakOVgw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" scale="0" id="Tc_OStCuordckW1qoQMTF4dXQ_4_4">6,221,617</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_M0EemXYDV0aBwNXVy2D5wA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_VBkRrMeUrEuL81THNQAlTQ_4_6">1,794</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_qGLJKw1KlEeLkJJRaoX5Rw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_9G5TIaSMSk-BgblFSgtpLQ_4_8">431,251</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_YIPudTTsa0KFHmU0vwZo5w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_1ZcrJSlMAUGDzr92ktHf0Q_4_10">124</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_IkPNS4jBTECfjFa4xwgBQQ" decimals="INF" format="ixt:numdotdecimal" name="aciu:DecreaseInNumberOfTreasurySharesFromSalesOrIssuance" scale="0" id="Tc_4_6AcQDJGE2K6glR_A9AUw_5_4">7,596</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_SWcjwMgDv0e8bZSucJUMHQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" sign="-" scale="3" id="Tc_AYmmKBvwfkC6PlNn-xLOfw_5_8">8</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_tP2T60QRpUq6QbSwDp-rdw" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" scale="3" id="Tc_SGKP2aP-s0KFGh0sEP0tow_5_10">0</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Issuance of shares &#8211; incentive plans, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_FjH3oKJjQkm4GluJmDL1ig" decimals="INF" format="ixt:numdotdecimal" name="aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans" scale="0" id="Tc_JidavHhESkCF_c4r1_eeVg_6_2">133,755</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_I-ActLB-JUyJBWOVjhi2gA" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseThroughSharesIssuedUnderIncentivePlans" scale="3" id="Tc_cXH8r-uMRk-kQZvwio8fsw_6_6">3</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_SWcjwMgDv0e8bZSucJUMHQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseThroughSharesIssuedUnderIncentivePlans" scale="3" id="Tc_jU-ENS2md0SMErZ1t2p0pQ_6_8">80</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_HTCG4hUqoUOTQ98ao4z1DA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfSharesOutstanding" scale="0" id="Tc_BiF68naQhkGn4TtCd4E0NQ_7_2">89,834,385</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_3hsE5ajj2EqsW8OwqIjDRQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" scale="0" id="Tc_o06qHYjvGEKZoZpA3Li7GA_7_4">6,214,021</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_BQ7VKwgtOkWlTCNJHXciww" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_09KKVf89OUun3Pddomp1PQ_7_6">1,797</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EBAKwd98FkqCN-vAl_B6vg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_i997QNej20qnTo-dgkuO2Q_7_8">431,323</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_gyBgxwFR8kautCu5uepUmg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_TtZXKsQ6j0GF2mt5luMbNA_7_10">124</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Proceeds from public offerings, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_6KGZQVq8r0a0vl5N0ZyV-g" decimals="INF" format="ixt:numdotdecimal" name="aciu:ProceedsFromPublicOfferingsNetOfUnderwritingFeesAndTransactionEquityShares" scale="0" id="Tc_oOc03tsWRECXuOLXPJ8fLQ_8_2">14,300,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_orlAcRiayEeFUpKo8cWUgA" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost" scale="3" id="Tc_bTYq85LjLkyOT-kgPWinrA_8_6">286</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EY1gzyuyDkGmaP05xj1GQw" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost" scale="3" id="Tc_Mx4MQVbbaECNdFCi14y9hA_8_8">40,249</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_QSzyXEXHe06wEWxr_MXXgQ" decimals="INF" format="ixt:numdotdecimal" name="aciu:DecreaseInNumberOfTreasurySharesFromSalesOrIssuance" scale="0" id="Tc_nqepc8mXRUq-u6mz3xdAxg_9_4">970,063</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EY1gzyuyDkGmaP05xj1GQw" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" scale="3" id="Tc_3LTtxFu6RUm5eJ4_OBD99w_9_8">2,631</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_Xg5G0gTL6EuVoA1i-tphyA" decimals="-3" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" scale="3" id="Tc_0GZMPMiXrEyGhiA_Z9E9mA_9_10">19</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Issuance of shares &#8211; incentive plans, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_6KGZQVq8r0a0vl5N0ZyV-g" decimals="INF" format="ixt:numdotdecimal" name="aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans" scale="0" id="Tc_8qdWcER1n0SLXtQwVJYy8w_10_2">307,402</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_orlAcRiayEeFUpKo8cWUgA" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseThroughSharesIssuedUnderIncentivePlans" scale="3" id="Tc_E4xO20ss2ESUfUVpNU0B5w_10_6">6</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EY1gzyuyDkGmaP05xj1GQw" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseThroughSharesIssuedUnderIncentivePlans" scale="3" id="Tc_EhbkYwKNtUSBYGcSCAwxjw_10_8">704</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_Aj1yGEPLv0OsHOLlVg5leg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfSharesOutstanding" scale="0" id="Tc_vM6qOLJYzk69O4eHT6Rk6A_11_2">104,441,787</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_axPzzAyDNE2qnFNbJxmuAw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" scale="0" id="Tc_xDHxB4GBDU-gckvYpI9KCw_11_4">5,243,958</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_BScHwbOd1k6qH5tEPUdwhw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_on3mY5z3SE6lBinb53dhPw_11_6">2,089</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_uUyHwiQf7UuXXrnxpFOqyA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" scale="3" id="Tc_oC0zXpVYKE2CYIZ8_hwIZg_11_8">474,907</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_nZ4TKeIWaU2aelb5_LYCwg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:Equity" sign="-" scale="3" id="Tc_Tobs506p0EqYcvrvICPWgw_11_10">105</ix:nonFraction>)</p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The common shares and treasury shares have nominal values of CHF <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ParValuePerShare" scale="0" id="Narr_B6srjBBOrEu8XG-B9-PFoQ">0.02</ix:nonFraction> per share. All shares have been fully paid. These treasury shares held by the Company are not considered outstanding shares as of December&#160;31, 2023 or 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Authorized capital</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s Board of Directors is authorized to increase the share capital, in one or several steps, until June 24, 2024, by a maximum amount of CHF&#160;<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="0" format="ixt:numdotdecimal" name="aciu:AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue" scale="0" id="Narr_F7Wqkm3yRUeb4_YZrzcjJw">114,000</ix:nonFraction> by issuing a maximum of <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="INF" format="ixt:numdotdecimal" name="aciu:NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue" scale="0" id="Narr_BUI74o7gOkm-bAMGyt9SfQ">5,700,000</ix:nonFraction> registered shares with a par value of CHF&#160;<ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ParValuePerShare" scale="0" id="Narr_fYktXDhnMESLnIOKMe9wvQ">0.02</ix:nonFraction> each, to be fully paid up. An increase of the share capital (i) by means of an offering underwritten by a financial institution, a syndicate or another third party or third parties, followed by an offer to the then-existing shareholders of the Company and (ii) in partial amounts, shall also be permissible.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Conditional share capital for financing and other purposes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The Company&#8217;s share capital may be increased by a maximum aggregate amount of CHF&#160;<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_pAWtnvgYa0iVnloXstoYVQ" decimals="0" format="ixt:numdotdecimal" name="aciu:PotentialIncreaseIsEquityThroughConversionOfDebtInstruments" scale="0" id="Narr_xloIudEz6UeC_qMcIwWECw">100,000</ix:nonFraction>&#160;through the issuance of a maximum of <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_W22DIGpxCU2PCY_voUKfnA" decimals="INF" format="ixt:numdotdecimal" name="aciu:PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments" scale="0" id="Narr_ZHIHBbVFeU6i6J7pfrYXMw">5,000,000</ix:nonFraction> registered shares, payable in full, each with a nominal value of CHF&#160;<ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember_IjKN6eosDESMY_UjEdsFrQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ParValuePerShare" scale="0" id="Narr_s94sn1RFKkSQeXE_Qm_OLw">0.02</ix:nonFraction>&#160;per share, through the exercise of conversion and/or option or warrant rights granted in connection with bonds or similar </p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-24</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_YpJUwUvNgEC5XDVvEN2A9A_cont1" continuedAt="Tb_YpJUwUvNgEC5XDVvEN2A9A_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">instruments, issued or to be issued by the Company or by subsidiaries of the Company, including convertible debt instruments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Conditional share capital for employee benefit plans</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s share capital may be increased by a maximum aggregate amount of CHF&#160;<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_bdFBuO5wp0WWfm-NR5fv1A" decimals="0" format="ixt:numdotdecimal" name="aciu:PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions" scale="0" id="Narr_vLKMylyDk0yhEZOBnm5AjA">93,795</ix:nonFraction>&#160;through the issuance of not more than&#160;<ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_bdFBuO5wp0WWfm-NR5fv1A" decimals="INF" format="ixt:numdotdecimal" name="aciu:PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions" scale="0" id="Narr_9RJ9bA3qx0yIEpApz8S6BQ">4,689,750</ix:nonFraction>&#160;common shares, payable in full, each with a nominal value of CHF&#160;<ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_Ob3729tHb0aScFgPO3DcVw" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ParValuePerShare" scale="0" id="Narr_q6DHoWZI-E2UXBWlCAiqCQ">0.02</ix:nonFraction>&#160;per share, by the exercise of options rights that have been granted to employees, consultants, members of the board of directors, or other person providing services to the Company or a subsidiary. As of December 31, 2023, <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="INF" format="ixt:numdotdecimal" name="aciu:NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits" scale="0" id="Narr_LbdmOuxgvUeZQCueOQHKmg">97,540</ix:nonFraction> of our common shares, which were issued upon the exercise of options and restricted share units, have not yet been registered with the commercial register of the Canton of Vaud.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Follow-On Offering</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On December 19, 2023, the Company announced that it had closed an underwritten offering of <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_12_19_2023_To_12_19_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_FollowOnOfferingMember_TqOyBPKfi0OoLSsHlenN0Q" decimals="INF" format="ixt:numdotdecimal" name="aciu:NumberOfSharesIssuedDuringPeriod" scale="0" id="Narr_9ElKGIce7UC1L7bRtH5DvA">14,300,000</ix:nonFraction> common shares, resulting in gross proceeds of approximately USD <ix:nonFraction unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ" contextRef="Duration_12_19_2023_To_12_19_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_FollowOnOfferingMember_TqOyBPKfi0OoLSsHlenN0Q" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" scale="6" id="Narr_MsdDTMlp9UCFe2NWXO3faA">50.1</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_12_19_2023_To_12_19_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_FollowOnOfferingMember_TqOyBPKfi0OoLSsHlenN0Q" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" scale="6" id="Narr_t_k4MiE2m0GRQQkOewERwA">43.8</ix:nonFraction>) million. Net underwriting fees and transaction costs totaled CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_12_19_2023_To_12_19_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_FollowOnOfferingMember_TqOyBPKfi0OoLSsHlenN0Q" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ShareIssueRelatedCost" scale="6" id="Narr_m72hZuComUOD3GM2spEESw">3.3</ix:nonFraction> million for net proceeds of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_12_19_2023_To_12_19_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_FollowOnOfferingMember_TqOyBPKfi0OoLSsHlenN0Q" decimals="-5" format="ixt:numdotdecimal" name="aciu:NetProceedsFromIssuanceOfShares" scale="6" id="Narr_nyFQYXQKZUmHjAaRPhkIcQ">40.5</ix:nonFraction> million. Transaction costs associated with these offerings and related to the issuance of new shares were charged directly against the share premium account thereby reducing the total equity reported.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Shelf registration statement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On April&#160;28, 2021, the Company filed a Shelf Registration Statement on Form&#160;F-3 (Reg. No.&#160;333-255576) (the &#8220;Shelf Registration Statement&#8221;) with the SEC. The Shelf Registration Statement was declared effective by the SEC on May&#160;5, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Shelf Registration Statement allows the Company to offer and sell, from time to time, up to USD <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_4_28_2021_To_4_28_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_wJ7EdKp2Ok2kaiso3_KHVw" decimals="0" format="ixt:numdotdecimal" name="aciu:CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement" scale="0" id="Narr_D82fCjRXbUSL9AFQL3lAYw">350,000,000</ix:nonFraction> of common shares, debt securities, warrants, purchase contracts, units, subscription rights or any combination of the foregoing in one or more future public offerings. The terms of any future offering would be determined at the time of the offering and would be subject to market conditions and approval by the Company&#8217;s Board of Directors. Any offering of securities covered by the Shelf Registration Statement will be made only by means of a written prospectus and prospectus supplement authorized and filed by the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">At the market equity offering</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In Q3 2020, AC Immune issued <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_7_1_2020_To_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_-1G5nnVneEOy-bPbsmwMqw" decimals="INF" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" scale="0" id="Narr_Tjh5_JhTH0aGkkttmIAhKg">5,000,000</ix:nonFraction> common shares with a nominal value of CHF <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="As_Of_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_bRpB8WDxq0WCH-NheX05aQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ParValuePerShare" scale="0" id="Narr_qCOw2oDt1UmbZaBVVW_Njw">0.02</ix:nonFraction>, which became treasury shares. The Company also established an &#8220;at the market offering program&#8221; (&#8220;ATM&#8221;) for the sale of up to USD <ix:nonFraction unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ" contextRef="Duration_7_1_2020_To_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_-1G5nnVneEOy-bPbsmwMqw" decimals="-5" format="ixt:numdotdecimal" name="aciu:CommonSharesAuthorizedForIssuanceSalesInInOpenMarket" scale="6" id="Narr_fcCNFvfXwkWSK3pMdRdzmg">80.0</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_7_1_2020_To_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_-1G5nnVneEOy-bPbsmwMqw" decimals="-5" format="ixt:numdotdecimal" name="aciu:CommonSharesAuthorizedForIssuanceSalesInInOpenMarket" scale="6" id="Narr_ZBIbEB8jYEemvEHu98VwtQ">68.1</ix:nonFraction>) million worth of our common shares issued from time to time by entering into an Open Market Sale Agreement (&#8220;Sales Agreement&#8221;) with Jefferies LLC (&#8220;Jefferies&#8221;) as the sales agent under a prior registration statement on Form&#160;F-3 which expired in Q2 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In Q2 2021, the Company filed a new registration statement on Form&#160;F-3 and an accompanying prospectus supplement in order to renew its ATM program. The Company also entered into a second Open Market Sale Agreement (the &#8220;new Sales Agreement&#8221;) with Jefferies to continue the ATM program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In Q3, 2021, the Company issued <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_7_1_2021_To_9_30_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_I1T_yUrSRkSlCVKjmbusrw" decimals="0" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" scale="0" id="Narr_ybIU4FXHE0ax7jRnk2UnlA">2,393,160</ix:nonFraction> common shares with a nominal value of CHF <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="As_Of_9_30_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_JlWBK3HwBk-ZtFV9txVOUw" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ParValuePerShare" scale="0" id="Narr_iLY_ehUhVUSFW_KBM5DuBQ">0.02</ix:nonFraction> to be held as treasury shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Through December 31, 2023, the Company has sold <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_vK1WQ4fPI0adSnT7gMpfmg" decimals="INF" format="ixt:numdotdecimal" name="aciu:SaleOrIssueOfTreasurySharesShares" scale="0" id="Narr_WAdunjWc7kK75cbiwN00kQ">2,149,202</ix:nonFraction> common shares previously held as treasury shares pursuant to the new Sales Agreement, raising USD <ix:nonFraction unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_vK1WQ4fPI0adSnT7gMpfmg" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares" scale="6" id="Narr_j7PVfVtNJkqgweqj4SWvIw">16.3</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_vK1WQ4fPI0adSnT7gMpfmg" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares" scale="6" id="Narr_7QP9wns8oUKk7UHq8t7Xhw">14.8</ix:nonFraction>) million, net of underwriting fees and transaction costs. We have paid commissions to Jefferies totaling USD <ix:nonFraction unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_vK1WQ4fPI0adSnT7gMpfmg" decimals="-5" format="ixt:numdotdecimal" name="aciu:CommissionsPaidForIssuanceOrdinaryShares" scale="6" id="Narr_7_Qkg9hnd0SjnmJ8Q2RwiQ">0.5</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_vK1WQ4fPI0adSnT7gMpfmg" decimals="-5" format="ixt:numdotdecimal" name="aciu:CommissionsPaidForIssuanceOrdinaryShares" scale="6" id="Narr_Wv1DuUFj-E6hco84L-8GgQ">0.5</ix:nonFraction>) million through December 31, 2023, for share issuances in accordance with our ATM programs.</p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-25</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_YpJUwUvNgEC5XDVvEN2A9A_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Convertible note agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Concurrently with the Asset Purchase Agreement, the Company entered into <ix:nonFraction unitRef="Unit_Standard_agreement_5eg0SdvY8kqQI3hiVdpf-Q" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_gz-ausjwKkGgVkKLeTU3Ng" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfConvertibleNoteAgreements" scale="0" id="Narr_KQRSohtmeUKdU_teA9szUQ">two</ix:nonFraction> separate Convertible Note&#160;Agreements with entities affiliated with each of Athos Service GmbH and First Capital Partner GmbH, both of which entities are shareholders of Affiris.&#160;Each Convertible Note&#160;Agreement provided for the sale of an unsecured subordinated Convertible Note&#160;of the Company with an aggregate principal amount of USD <ix:nonFraction unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_gz-ausjwKkGgVkKLeTU3Ng" decimals="-5" format="ixt:numdotdecimal" name="aciu:AggregatePrincipalAmountOfEachConvertibleNote" scale="6" id="Narr_IsEYgb56vkChzBHVZWaswQ">12.5</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_gz-ausjwKkGgVkKLeTU3Ng" decimals="-5" format="ixt:numdotdecimal" name="aciu:AggregatePrincipalAmountOfEachConvertibleNote" scale="6" id="Narr_0TAbFIkSx0m1u4LHXWFhyw">11.7</ix:nonFraction>) million for total net proceeds of USD <ix:nonFraction unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_srt_StatementScenarioAxis_aciu_IfNotesAreConvertedMember_mHIt3iiUYEiJe-LbY2MlYg" decimals="-6" format="ixt:numdotdecimal" name="aciu:ProceedsFromIssueOfConvertibleDebt" scale="6" id="Narr_QMJK3gKgoU2KaGFMCPpu5A">25</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_srt_StatementScenarioAxis_aciu_IfNotesAreConvertedMember_mHIt3iiUYEiJe-LbY2MlYg" decimals="-5" format="ixt:numdotdecimal" name="aciu:ProceedsFromIssueOfConvertibleDebt" scale="6" id="Narr_tbFs0HFi-EGrLxdBLPs5kg">23.5</ix:nonFraction>) million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In 2021, the affiliated entities exercised their options to convert their respective USD <ix:nonFraction unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_B7geHyH670-gkbX2o14NvA" decimals="-5" format="ixt:numdotdecimal" name="aciu:ProceedsFromConversionOfConvertibleDebtPerIndividualNote" scale="6" id="Narr_F-hwV43XS0Oo_ieXGx0sdA">12.5</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_B7geHyH670-gkbX2o14NvA" decimals="-5" format="ixt:numdotdecimal" name="aciu:ProceedsFromConversionOfConvertibleDebtPerIndividualNote" scale="6" id="Narr_NjADuL9GGkmV9bRqAMPQUg">11.7</ix:nonFraction>) million notes. As a result of these conversions, <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_CounterpartiesAxis_aciu_AthosServiceGmbHMember_G1spMOk49EyTvfHJIEKQUA" decimals="0" format="ixt:numdotdecimal" name="aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" scale="0" id="Narr_pqdKGp9rgkiACO0QZtcjMw">1,513,317</ix:nonFraction> <span style="-sec-ix-hidden:Hidden_RHGPfxiSZ0Wm65Cc6mThNQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">common</span></span> shares were issued to each Investor, totaling <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_B7geHyH670-gkbX2o14NvA" decimals="0" format="ixt:numdotdecimal" name="aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" scale="0" id="Narr_XGjQPdOia0mN2YKW0DdYMw">3,026,634</ix:nonFraction> common shares. The Company recorded an increase to its share capital for the nominal value of its shares and share premium for the difference associated with settlement of this liability. The Company also settled its derivative financial assets, which were embedded conversion features associated with the convertible debt, via an offset to its share premium. These convertible notes and derivative financial assets were fully settled in 2021 and there is <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_gz-ausjwKkGgVkKLeTU3Ng" decimals="0" format="ixt-sec:numwordsen" name="aciu:OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements" scale="0" id="Narr_onR2pP-cj0yk1Wjd23oAHw">no</ix:nonFraction> further equity or cash consideration due to the affiliated entities thereunder.</p></ix:continuation><a id="Tc_Haj1uapCM0KPv7DGXqqK8Q_1_2"></a><a id="Tc_cQxr1jrRJEqeTQ2Z8ax8XA_2_2"></a><a id="Tc_r7L24rON_U-iLi3jKr1zwQ_3_0"></a><a id="Tc_Q_EOW-FtBU-mDd1e0n8Quw_3_2"></a><a id="Tc_lSqL1iBdJUqSnub2GcXDuw_3_4"></a><a id="Tc_xDlqmwJ1AESXFVjK_WmHLQ_4_0"></a><a id="Tc_XzDj8efrJU-d1MOPPYdf7w_5_0"></a><a id="Tc_N_GZxJz8BkWXdaJBZlOOow_7_0"></a><a id="Tc_2ImxojdrQk-aXaLty3Io0Q_8_0"></a><a id="Tc_6o3VGm8F-06CUMx5sWoUKQ_9_0"></a><a id="Tc_1VE5P0GzdkyptgSJfzcU-A_10_0"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock" id="Tb_yeUKHJkr9Uii5KugOlTqFw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">13.</b></span>Trade and other payables and accrued expenses</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock" id="Tb_17cZcm5zdESdvVSOECQbvQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Trade and other payables </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" id="Tc_1Oqsd_UiVE-XQQzk7z7VFg_4_2">1,679</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" id="Tc_Ospn8-d4wka4CY_I12gWuA_4_4">929</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total trade and other payables</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" id="Tc_WvqaNK_Y6U2EgXyNnFJxJg_5_2">1,679</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="3" id="Tc_ODP_FxouN0CDdPX-nc3oWA_5_4">929</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued research and development costs </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="aciu:CurrentAccruedResearchAndDevelopmentCosts" scale="3" id="Tc_krIFUMy2I0WxB_GgS6oDsA_7_2">4,722</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="aciu:CurrentAccruedResearchAndDevelopmentCosts" scale="3" id="Tc_iOhvRoV4vEyFX6GMeNnNUQ_7_4">5,360</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued payroll expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShorttermEmployeeBenefitsAccruals" scale="3" id="Tc_3AXSCrU_BE-gaQ5-ahp_zw_8_2">4,649</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ShorttermEmployeeBenefitsAccruals" scale="3" id="Tc_RxMrQQKbpk6EoGW4d6ILwA_8_4">2,898</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other accrued expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="aciu:OtherAccruedExpenses" scale="3" id="Tc_94-pK_yhIkaqp3d7EXzv9A_9_2">1,716</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="aciu:OtherAccruedExpenses" scale="3" id="Tc_hA-T-aJvO0abZ9C4mBCyQA_9_4">1,159</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total accrued expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities" scale="3" id="Tc_YhRzrGe8LEKy0UppUT_XDA_10_2">11,087</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities" scale="3" id="Tc_bO2vEWfUVEeBG61ghMUBUQ_10_4">9,417</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The increase in accrued payroll expenses is mostly due to the timing of certain payroll-related payments and an increase in performance-related remuneration. Additionally, CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-5" format="ixt:numdotdecimal" name="aciu:AccruedStampDuty" scale="6" id="Narr_A6o0aml6C0CymsGQFe_vXA">0.4</ix:nonFraction> million was recognized as accrued stamp duty within other accrued expenses for the issuance of shares as part of the Company&#8217;s follow-on offering as of December 31, 2023.</p></ix:nonNumeric><a id="Tc_RH_xSyhsZkKz1LRMtAKFLw_1_2"></a><a id="Tc_QPJtAhWDJUKcyP8HclA7LA_2_2"></a><a id="Tc_ifq1kohqUk-lGF51yThaeg_3_0"></a><a id="Tc_Kc75CoVpXkaHuItaglyrfQ_3_2"></a><a id="Tc_xGMW9aRbe0W38o0XV3L2EQ_3_4"></a><a id="Tc_ZOboabqBzEa3_OAIHkB33Q_3_6"></a><a id="Tc_phWpJ98kTUWpe4Z6eMwu3A_4_0"></a><a id="Tc_5crdo30ZoUeOxDPHU3fR7Q_5_0"></a><a id="Tc_lmxnqOIGCUetdjWShQyIog_6_0"></a><a id="Tc_TuydNE-gz0auoicW-3V9bw_7_0"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfRevenueExplanatory" id="Tb_LC1JdTUSnkCBH58-47IFcA" continuedAt="Tb_LC1JdTUSnkCBH58-47IFcA_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">14.</b></span>Contract revenues</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2023, 2022 and 2021, AC Immune generated contract revenues of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_R0iZSFkPYESsBHe9xC24cg">14.8</ix:nonFraction> million, CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_VuE5f0hUv0a2m8CZVXhDcw">3.9</ix:nonFraction> million and <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-5" format="ixt-sec:numwordsen" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" id="Narr_hnOOG7susEO9dyQrfj_qoA">nil</ix:nonFraction>, respectively. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following tables provide contract revenue amounts from its LCAs for the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively.</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory" id="Tb_njXc_y6DRE2hyNg_BratYw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Janssen</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_FFPrWYguC0WQvj3Hxaw5Vg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_3gd1WB89JUqq7eQx5uSFmg_4_2">14,800</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_RcIGZbdaj0SjODk2XEasNg" decimals="-3" format="ixt:zerodash" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_QZ-nzgJvfEKMWlQrBSeA3Q_4_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_jafX0AFm5kKHcXl4f6GawA" decimals="-3" format="ixt:zerodash" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_Wg7UXeR5W0KKiTkZv4R_ag_4_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Life Molecular Imaging</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_BnlIEVOTy0C3K8dqAK4rRg" decimals="-3" format="ixt:zerodash" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_p2jWL8OIhUWebUM324ebTA_5_2">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_-kkhAXq1C0GMDfXoDk10TQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_opta8W-wBkGLPNJ9lDwjOw_5_4">3,935</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_VvfAYTJbdkC0T1wF_MSJTg" decimals="-3" format="ixt:zerodash" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_k-m5JU7B9EK2M4RS0mqEuA_5_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfContractsAxis_aciu_OtherAgreementMember_V2ITfmJTz0yHhlWkR5uY7A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_Sez3LvO4l06Qv6YgZO2JNw_6_2">1</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_OtherAgreementMember_jXhHVI8hAkaS4H4FPEcpag" decimals="-3" format="ixt:zerodash" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_8xADK_Pvr0OFW2wQFJ2H4A_6_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_OtherAgreementMember_kOOLpfgr3EGhGolAWb9Uwg" decimals="-3" format="ixt:zerodash" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_hTeNpX-stUad1E808zi2gQ_6_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total contract revenues</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_Zw6JOypVx0qigQl9TCwMvg_7_2">14,801</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_vHteYg2neUOkLgwRnnnCmw_7_4">3,935</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Tc_6GGFKcDZu0eN9iqurwrrRg_7_6">&#8212;</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-26</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_U1vuyRWJsUWIuceAd6snEA_1_2"></a><a id="Tc_Rg3xPXLQsE6C8cbZyCkhwg_2_2"></a><a id="Tc_ILxPGvS-sEi2VvCgz-4jgQ_3_0"></a><a id="Tc_RK7KgY4JZUKrBkL6bd3W8g_3_2"></a><a id="Tc_BlIR3W80_EmBh4w19hpHYQ_3_4"></a><a id="Tc_lXZGQag7a0yORaBNf6hnlw_3_6"></a><a id="Tc_SNrT8vbAC0KDZaQa2kFw8g_4_0"></a><a id="Tc_00TPeXukvkWKljrxWCGGGw_5_0"></a><a id="Tc_nyX50xSy2ECFowkzSurTbQ_5_4"></a><a id="Tc_yayM_Z7sBkid3BbMfwo2_A_5_6"></a><a id="Tc_JZSHjxq0I0e-LBU6Fd6sww_6_0"></a><a id="Tc_x5l-oiawYUymsylYMWh6Rw_6_6"></a><ix:continuation id="Tb_LC1JdTUSnkCBH58-47IFcA_cont1" continuedAt="Tb_LC1JdTUSnkCBH58-47IFcA_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">During the&#160;years ended December&#160;31, 2023, 2022 and 2021, the Company recognized the following contract revenues as a result of changes in the contract asset and the contract liability balances in the respective periods:</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory" id="Tb_3k2CwMgUZUyBcw9GChwpHA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Revenues recognized in the period from:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Amounts included in the contract liability at the beginning of the period </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:zerodash" name="ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" scale="3" id="Tc__bkPOPkwAEGHK1puYjNK4g_5_2">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Performance obligations satisfied in previous periods</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" scale="3" id="Tc_2k_pEs7BoUCgDuOnOOzhOQ_6_2">14,801</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" scale="3" id="Tc_99Vb8uICEUGtaoYR_w4SDw_6_4">3,935</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">14.1</b></span> Licensing and collaboration agreements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Morphomer Tau small molecule&#160;&#8211; 2018 license agreement with Eli Lilly and Company</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In December&#160;2018, we entered into an exclusive, worldwide licensing agreement with Eli Lilly and Company (Lilly) to research and develop Morphomer Tau small molecules for the treatment of AD and other neurodegenerative diseases. More specifically, this is an exclusive license with the right to Lilly to grant sublicenses under the ACIU Patents, the ACIU know-how, and ACIU&#8217;s interests in the Joint Patents and the joint know-how to Exploit the Licensed Compounds and Licensed Products. The agreement became effective on January&#160;23, 2019 (the &#8220;effective date&#8221;) when the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, expired. In Q3 2019, the Company and Lilly entered into the first amendment to divide the first discretionary milestone payment under the agreement of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_vLBVN6gNy0CM2OL-a8F6nw" decimals="-6" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementPotentialValue" scale="6" id="Narr_aHZAjp0FSkan1rGzifHYAA">60</ix:nonFraction> million into <ix:nonFraction unitRef="Unit_Standard_installment_NWKLjjbZOEujM9f04o9HSA" contextRef="Duration_7_1_2019_To_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_DUqbXvvbHUeikVmBLUHq3A" decimals="INF" format="ixt-sec:numwordsen" name="aciu:CollaborativeAgreementMilestonePaymentNumberOfInstallments" scale="0" id="Narr_2yKF5NCpakGA0Z5QTWIphw">two</ix:nonFraction> installments, with the first CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_9_30_2019_ifrs-full_MaturityAxis_aciu_Quarter32019Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_G-GdzKub6UqJhnJZLbz4Xw" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:ReceivablesFromContractsWithCustomers" scale="6" id="Narr_hXPoGkECv0mldtn6pAHRXQ">30</ix:nonFraction> million paid in Q3 2019 and the second CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_9_30_2019_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_nsmmt4NryUSnwKwUgB5e9A" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:ReceivablesFromContractsWithCustomers" scale="6" id="Narr_4EGsVI61fUm23rQPGC4X6w">30</ix:nonFraction> million to be paid on or before March&#160;31, 2020 unless Lilly terminated the agreement earlier. In Q1 2020, the Company and Lilly entered into a second amendment to replace the second CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_76PTD23ZjE2mpl9bl8usJw" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:ReceivablesFromContractsWithCustomers" scale="6" id="Narr_LXsgoTOIgkCCx16yhC5sVg">30</ix:nonFraction> million to be paid on or before March&#160;31, 2020 with <ix:nonFraction unitRef="Unit_Standard_installment_NWKLjjbZOEujM9f04o9HSA" contextRef="Duration_3_31_2020_To_3_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_ClmKil5lr0WdBtvIaUaFEA" decimals="INF" format="ixt-sec:numwordsen" name="aciu:CollaborativeAgreementMilestonePaymentNumberOfInstallments" scale="0" id="Narr_qellxOwBUUa48exIpsjB_w">two</ix:nonFraction> milestone payments, one of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_0EMLps-d40CSIT6HT2so_w" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:ReceivablesFromContractsWithCustomers" scale="6" id="Narr_6R0z_b8QPEWah8vnmFQF_A">10</ix:nonFraction> million to be paid on or before March&#160;31, 2020 and the other of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_vQvK76RUJ0KnStBAGwXxYA" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:ReceivablesFromContractsWithCustomers" scale="6" id="Narr_sDlqOhrA90-vhMAmkqOadg">60</ix:nonFraction> million following the first patient dosed in a Phase 2 clinical study of a licensed product in the U.S. or EU.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Per the terms of the agreement, the Company received an initial upfront payment of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2019_To_3_31_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_BPMBGqeh1UCBtCXz0LDlDg" decimals="-6" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementMilestonePaymentReceived" scale="6" id="Narr_U76A5hF5U0iRpRYlMNJKUQ">80</ix:nonFraction> million in Q1 2019 for the rights granted by the Company to Lilly. To date, the Company has completed a Phase 1 clinical study with ACI-3024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, the Company and Lilly have continued candidate characterization across the research program, identifying new and highly differentiated candidates with desired cerebrospinal fluid exposure and selectivity for pathological aggregated Tau. These will be broadly developed in Tau-dependent neurodegenerative diseases by Lilly. Lilly is responsible for leading and funding further clinical development and will retain global commercialization rights for all indications.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Per the terms of the agreement, the Company may become eligible to receive additional milestone payments totaling up to approximately CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_KLZBu4QGhUm541e0XMZ9xA" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="6" id="Narr_1DmfhXT0RkKXiBc5N60aXA">880</ix:nonFraction> million for clinical and regulatory milestones and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_MilestonePaymentsCommercialMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_I-ylj3lgB0ySClC4h_2t1A" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="6" id="Narr_AKjSRENpWkCbI1zaKp_J8Q">900</ix:nonFraction> million upon achievement of certain commercial milestones. In addition to milestones, we will be eligible to receive royalties on sales at a&#160;percentage rate ranging from the low double-digits to the mid-teens. The agreement will terminate by the date of expiration of the last royalty term for the last licensed product. However, under the terms of the agreement, Lilly may terminate the agreement at any time by providing <span style="-sec-ix-hidden:Hidden_9VUHy5QxNUOhdyJftjpzFw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3&#160;months</span></span>&#8217; prior notice to us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that Lilly is a customer. The Company identified the following significant performance obligations under the contract: (i)&#160;a right-of-use license and (ii)&#160;research and development activities outlined in the development plan. Per the agreement, the Company was responsible for the preclinical and Phase 1 activities for the first clinical candidate, ACI-3024, which the Company determined was distinct and capable of being completed by Lilly or a third party. Preclinical activities for which AC Immune was responsible prior to their completion in Q2 2019 included final manufacturing of materials for use in the regulatory submission of the protocol and in the Phase 1 study. For the completed Phase 1, AC Immune was responsible for leading the study design, obtaining relevant regulatory agency approvals, arranging necessary third-party contracts, completing patient selection, ensuring patient treatment, following up with patients, drafting the clinical study report </p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-27</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_LC1JdTUSnkCBH58-47IFcA_cont2" continuedAt="Tb_LC1JdTUSnkCBH58-47IFcA_cont3"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">development and other relevant clinical activities to ensure that the primary objective of the study was completed. The Company used CMOs for certain of its preclinical activities and CROs to complete certain Phase 1 activities and to issue the final clinical study report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Finally, per the agreement, each party has <ix:nonFraction unitRef="Unit_Standard_item_lel3bReemU2v4xdKyUvjzA" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_ShYkYUEckEG0-k_MozRQGg" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfRepresentativesInJointSteeringCommitteeByEachParty" scale="0" id="Narr_LoJloJQtnkG0mXpVeat0Hw">three</ix:nonFraction> representatives on a joint steering committee (JSC). Depending upon the agenda, additional field experts can attend the JSC to provide the technical and scientific contribution required. The JSC meets on a regular basis depending on agreements between the representatives. The JSC is responsible for serving as the forum to (i)&#160;discuss, review and approve certain activities by reviewing and discussing the development progress with updates on back-up candidates, (ii)&#160;discuss, review and approve all amendments to the global development plan, (iii)&#160;periodically discuss and review commercialization of licensed products and (iv)&#160;review and approve reports related to development costs among other activities. The JSC is intended to ensure that communication between the parties remains consistent and that the development plan is progressing as intended.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The valuation of each performance obligation involves estimates and assumptions with revenue recognition timing to be determined by either delivery or the provision of services.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company used the residual approach to estimate the selling price for the right-of-use license and an expected cost plus margin approach for estimating the research and development activities. The right-of-use license was delivered on the effective date. The research and development activities were delivered over time as the services were performed. For these services, revenue was recognized over time using the input method, based on costs incurred to perform the services, as the level of costs incurred over time is thought to best reflect the transfer of services to Lilly. The Company determined the value of the research and development activities to be CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_1_23_2019_ifrs-full_PerformanceObligationsAxis_aciu_ResearchAndDevelopmentMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_blE7iuHcaUG9QmZUisEt3A" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ContractAssets" scale="6" id="Narr_XrrHPattIk-Q9HkL2bxv0Q">6.9</ix:nonFraction> million and deferred this balance from the effective date. To date, the Company has cumulatively recognized CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_23_2019_To_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_ResearchAndDevelopmentMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_N22GJ9LsrUiWJLyFN-RIXQ" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_a9mbykm2fkayYyO5OS5-xA">6.9</ix:nonFraction> million in contract revenue, resulting in <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_NUhuhpmnrEShL-ErqVzeXQ" decimals="-6" format="ixt-sec:numwordsen" name="ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities" scale="6" id="Narr_bCro6UTdnkuv1dEWBoXQnQ">no</ix:nonFraction> deferred income (contract liability) on the consolidated balance sheets. The remaining CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_23_2019_To_1_23_2019_ifrs-full_PerformanceObligationsAxis_aciu_RightOfUseLicenseMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_bs5y_HFUuE2bgfNkGXeFQQ" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_Aw33KmuPk0ytGMkjRy6nzA">73.1</ix:nonFraction> million from the upfront payment was allocated to the right-of-use license and recognized on the effective date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At inception of the agreement, none of the clinical, regulatory or commercial milestones had been included in the transaction price, as all milestone amounts were fully constrained. To date, the Company has recognized CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_7_1_2019_To_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_RightOfUseLicenseMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_oqIIqklRBUe5UQlvHuNHMA" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_J5FUV60RVUeicJI0ShKBew">40</ix:nonFraction> million from milestone payments triggered in Q3 2019 and Q1 2020 related to the right-of-use license for intellectual property as there were no further constraints related to these milestones. In assessing that future clinical, regulatory or commercial milestones are fully constrained, the Company considered numerous factors to determine that these milestones are not highly probable to obtain, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials and the licensee&#8217;s efforts. Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as they were determined to relate predominantly to the license granted to Lilly and therefore have also been excluded from the transaction price. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2023, 2022 and 2021, we have recognized <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_WpYdq5tOqkCYnWaYgg7hoQ" decimals="-5" format="ixt-sec:numwordsen" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_uyehSOTB1Uu23h3Rkqnr6w"><ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_lCg_5YHbNEWrV3IHIK-hlw" decimals="-5" format="ixt-sec:numwordsen" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_xgnh_2EZlk6kDWdwQkLecA"><ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_ShYkYUEckEG0-k_MozRQGg" decimals="-5" format="ixt-sec:numwordsen" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_e9qHvHrkLkmRI1JQY-pO5Q">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> revenues from this arrangement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Tau active immunotherapy in AD&#160;&#8211; 2014 agreement with Janssen Pharmaceuticals,&#160;Inc.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In December&#160;2014, we entered into an agreement with Janssen Pharmaceuticals, Inc. (Janssen), part of the Janssen Pharmaceutical Companies of Johnson &amp; Johnson, to develop and commercialize therapeutic anti-Tau active immunotherapies for the treatment of AD and potentially other Tauopathies. The value of this collaboration is potentially up to CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember__-SkUIIH_UKKHcFlP4uAVA" decimals="-6" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementPotentialValue" scale="6" id="Narr_nUo5nANFREuSP9EXbyeQeA">500</ix:nonFraction> million and includes upfront and clinical, regulatory and commercial milestones. In addition to milestones, we will be eligible to receive royalties on sales at a&#160;percentage rate ranging from the low-double digits to the mid-teens for the ACI-35.030 active immunotherapy program. In April&#160;2016, July&#160;2017, January&#160;2019, November&#160;2019, December 2022, and November 2023, the companies entered into the first, second, third, fourth, fifth and sixth amendments, respectively. These amendments allow for the alignment of certain payment and activity provisions with the Development Plan and Research Plan activities. We and Janssen have completed the co-development of the second-generation lead active immunotherapies, ACI-35.030 and JACI-35.054, through Phase 1b/2a. In November 2022, it was announced that ACI-35.030 was selected to advance into further development based on interim data from the ongoing Phase 1b/2a trial. In December 2023, it was announced that Janssen has programmed the launch of Phase 2b clinical </p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-28</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_LC1JdTUSnkCBH58-47IFcA_cont3" continuedAt="Tb_LC1JdTUSnkCBH58-47IFcA_cont4"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">study to evaluate ACI-35.030 (JNJ-64042056) in patients with preclinical AD, those individuals not yet showing symptoms. AC Immune and Janssen will jointly share research and development costs until the completion of the first Phase 2b (AC Immune&#8217;s contribution to the first Phase 2b trial is capped). From Phase 2b and onwards, Janssen will assume responsibility for the clinical development, manufacturing and commercialization of ACI-35.030.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under the terms of the agreement, Janssen may terminate the agreement at any time after completion of the first Phase 1b clinical study in 2016 by providing <span style="-sec-ix-hidden:Hidden_0OEUZRutDEesJMh1BBGUqQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">90&#160;days</span></span>&#8217; notice to us. If not otherwise terminated, the agreement shall continue until the expiration of all royalty obligations as outlined in the contract.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The agreement also allows for the expansion to a second indication based on the same anti-Tau active immunotherapy program and based on intellectual property related to this program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company received an upfront, non-refundable license fee of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_12_1_2014_To_12_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_zDLbltOLTEaxOQqGKQjBBw" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_AV3npfzTMkmnwIAVkDsgDQ">25.9</ix:nonFraction> million, which we recognized as revenue in 2014. In May&#160;2016, we received a payment of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_5_1_2016_To_5_31_2016_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_z6odcKKiUk6PMIxagqtGiA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_7bwae9Tzqk6nx2MPOnqUSw">4.9</ix:nonFraction> million for reaching a clinical milestone in the first Phase 1b study. In December 2023, we were entitled to receive a milestone payment of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_12_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_bZFp8RtyQk6ZpSOXniefvg" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_gce5T_dfQ0KoNazn-JRwrQ">14.8</ix:nonFraction> million for the commencement of the first Phase 2b clinical study. The Company recognized this income as revenue because we deemed it highly probable that this milestone would be obtained and would not be subject to reversal in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that Janssen is a customer. The Company identified the following performance obligations under the contract: (i)&#160;a right-of-use license and (ii)&#160;research and development services including a development and chemistry, manufacturing and controls work plan. The Company considered the research and development capabilities of Janssen, Janssen&#8217;s right to sublicense, and the fact that the research and development services are not proprietary and can be provided by other vendors, to conclude that the license has stand-alone functionality and is distinct. The Company&#8217;s obligation to perform research and development services does not significantly impact or modify the licenses&#8217; granted functionality. Based on these assessments, the Company identified the license and the research and development services as the performance obligations at the inception of the arrangement, which were deemed to be distinct in the context of the contract.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At execution of the agreement, the transaction price included only the upfront consideration received of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2014_To_12_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_ai62qsBmbECbBpWbHN1gqg" decimals="-5" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementUpfrontPaymentsReceived" scale="6" id="Narr_Wy8F9T4nPUqJ1oMRz6ujXg">25.9</ix:nonFraction> million. At inception, none of the clinical, regulatory or commercial milestones has been included in the transaction price, as all milestone amounts were fully constrained. The Company did receive a payment of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_5_1_2016_To_5_31_2016_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_z6odcKKiUk6PMIxagqtGiA" decimals="-5" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementMilestonePaymentReceived" scale="6" id="Narr_dw254aWnNE2Imab8umM_Fw">4.9</ix:nonFraction> million for reaching a clinical milestone in the first Phase 1b study in May&#160;2016 and was entitled, in December 2023, to receive a milestone payment of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_BxvFqCM4M0ufUbFvjtlCMQ" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:CurrentTradeReceivables" scale="6" id="Narr_Htp1ddP6uEWlC_ksBQ1N2w">14.8</ix:nonFraction> million for the commencement of the Phase above. The Company could also receive up to more than CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_R3OS4EvnIk6VR8SwYkbQTw" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="6" id="Narr_0kVoJ_17GU2R5PH9PzrXBg">443</ix:nonFraction> million in clinical, regulatory and commercial milestones as well as tiered, low-double digits to mid-teen royalties on aggregate net sales for the ACI-35.030 active immunotherapy program. In assessing that future clinical, regulatory or commercial milestones are fully constrained, the Company considered numerous factors to determine that these milestones are not highly probable to obtain, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials and the licensee&#8217;s efforts. Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as they were determined to relate predominantly to the license granted to Janssen and therefore have also been excluded from the transaction price. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2023, 2022 and 2021, we have recognized CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_uOvzhs9BoEiLV6rS9IZVFg" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_LBG2A6L2g0GTeuzB_dBxxw">14.8</ix:nonFraction> million, <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_oPmjvi14mk-DBu82Bl8nzQ" decimals="-5" format="ixt-sec:numwordsen" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_GMpcCthoy0GvGE5e9pQGcw">nil</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_8EC0rLfa2kiP5VlheRCDlg" decimals="-5" format="ixt-sec:numwordsen" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_JxZ_D7J5UUWeFDd8H8ap_g">nil</ix:nonFraction>, respectively, from this arrangement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><i style="font-style:italic;">Tau-PET imaging agent&#160;&#8211;2014 agreement with Life Molecular Imaging (LMI)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In May&#160;2014 (as amended in June 2022), we entered into an agreement, our first diagnostic partnership, with LMI, the former Piramal Imaging SA. The partnership with LMI is an exclusive, worldwide licensing agreement for the research, development and commercialization of the Company&#8217;s Tau protein PET tracers supporting the early diagnosis and clinical management of AD and other Tau-related disorders and includes upfront and sales milestone payments totaling up to EUR <ix:nonFraction unitRef="Unit_Standard_EUR_QpqDW6JdmEqpVHDpBHxA4g" contextRef="As_Of_5_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_lWKxGd9870-RZpUwXYweFQ" decimals="-6" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementPotentialValue" scale="6" id="Narr_ZJo-tLT7gEqfG4HqqjFDFQ">160</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_5_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_lWKxGd9870-RZpUwXYweFQ" decimals="-6" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementPotentialValue" scale="6" id="Narr_7WSUyz5saUO9lncSOASifw">151</ix:nonFraction>) million, plus royalties on sales at a&#160;percentage rate ranging from mid-single digits to low-teens. LMI may terminate the LCA at any time by providing <ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_wERnesaBIkyF2ZYGAWOS5g" format="ixt-sec:durmonth" name="aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod" id="Narr__bd7i7UZPUWNRXOw9blOGA">3</ix:nonNumeric>&#160;months&#8217; notice to us.</p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-29</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_LC1JdTUSnkCBH58-47IFcA_cont4" continuedAt="Tb_LC1JdTUSnkCBH58-47IFcA_cont5"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In connection with this agreement, AC Immune received a payment of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_QpqDW6JdmEqpVHDpBHxA4g" contextRef="Duration_12_31_2015_To_12_31_2015_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_7HL2iR7LZEGx9pYpDWzsWg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Narr_RbaM3-n-nE2bO3YLNUOM1w">500</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_12_31_2015_To_12_31_2015_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_7HL2iR7LZEGx9pYpDWzsWg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="3" id="Narr_WruP7rDrPUG_jtgDBeHHbA">664</ix:nonFraction>) thousand, which was fully recognized in 2015. In Q1 2017, we recorded a milestone payment of EUR <ix:nonFraction unitRef="Unit_Standard_EUR_QpqDW6JdmEqpVHDpBHxA4g" contextRef="Duration_1_1_2017_To_3_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_ufWSkNfIkECZWt_mcMr6vA" decimals="-6" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementMilestonePaymentReceived" scale="6" id="Narr_obaGZIaZDUCgZqH7pzgpaA">1</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2017_To_3_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_ufWSkNfIkECZWt_mcMr6vA" decimals="-5" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementMilestonePaymentReceived" scale="6" id="Narr_X3Ss2l1fH0mqKXkZ4-S_TQ">1.1</ix:nonFraction>) million related to the initiation of &#8220;Part&#160;B&#8221; of the first-in-man Phase 1 study. In Q3 2019, the Company recognized EUR <ix:nonFraction unitRef="Unit_Standard_EUR_QpqDW6JdmEqpVHDpBHxA4g" contextRef="Duration_7_1_2019_To_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_l5M7oS6RAUSbE60FpTK73g" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_3LYJkmzwbE-7KYVJVSkH_Q">2</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_7_1_2019_To_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_l5M7oS6RAUSbE60FpTK73g" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_-ZGLDMmLpUqdxNPj4JdYWQ">2.2</ix:nonFraction>) million in connection with the initiation of a Phase 2 trial of Tau-PET tracer in patients with mild cognitive impairment and mild&#8211;to-moderate AD in comparison with non-demented control participants. In Q3 2022, the Company recognized EUR <ix:nonFraction unitRef="Unit_Standard_EUR_QpqDW6JdmEqpVHDpBHxA4g" contextRef="Duration_7_1_2022_To_9_30_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_hMfnkYwHjk67Rec2qW4oRA" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_0SWgXJtiyEOgsJXUzMRjrA">4</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_7_1_2022_To_9_30_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_hMfnkYwHjk67Rec2qW4oRA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_-XhsMpqq2UOftYcjfLto1g">3.9</ix:nonFraction>) million linked to the progression of the Tau-PET tracer into late-stage development in AD. The Company is eligible to receive additional variable consideration related to the achievement of certain clinical milestones totaling EUR <ix:nonFraction unitRef="Unit_Standard_EUR_QpqDW6JdmEqpVHDpBHxA4g" contextRef="As_Of_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_ClinicalMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_URY6Jrdr0k-HLTt2WogjzA" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="6" id="Narr_hOyK-qhRVkWlv8wMzTESSA">4</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_ClinicalMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_URY6Jrdr0k-HLTt2WogjzA" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="6" id="Narr_w8ge9es1jEK3VNHYeqpOEg">4</ix:nonFraction>) million should the compound make it through Phase 3 clinical studies. We are also eligible to receive potential regulatory and sales-based milestones totaling EUR <ix:nonFraction unitRef="Unit_Standard_EUR_QpqDW6JdmEqpVHDpBHxA4g" contextRef="As_Of_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_RegulatoryAndSalesBasedMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_dbU2qmyhJ0Wd2ybcWsnSQQ" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="6" id="Narr_OGw7ibnU4kGY9FsY2dSHfw">148</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_RegulatoryAndSalesBasedMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_dbU2qmyhJ0Wd2ybcWsnSQQ" decimals="-6" format="ixt:numdotdecimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="6" id="Narr_aYK-oxrdKU27_Wlx_DIoGA">139</ix:nonFraction>) million. Finally, the Company is eligible for royalties from the mid-single digits to low-teens.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that LMI is a customer. The Company has identified that the right-of-use license as the only performance obligation. The Company determined that transaction price based on the defined terms allocated to each performance obligation specified in the contract.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The upfront payment constitutes the amount of consideration to be included in the transaction price and has been allocated to the license. None of the clinical, regulatory or commercial milestones has been included in the transaction price as these variable consideration elements are considered fully constrained. As part of its evaluation of the constraint, the Company considered numerous factors, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials and the licensee&#8217;s efforts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as these amounts have been determined to relate predominantly to the license granted to LMI and therefore are recognized at the later of when the performance obligation is satisfied or the related sales occur. The Company considered LMI&#8217;s right to sublicense and develop the Tau protein PET tracers, and the fact that LMI could perform the research and development work themselves within the license term without AC Immune, to conclude that the license has stand-alone functionality and is distinct. The Company believes that the contracted amount represents the fair value. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2023, 2022 and 2021, the Company has recognized <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_wERnesaBIkyF2ZYGAWOS5g" decimals="-5" format="ixt-sec:numwordsen" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_5-alL4wC4E-g_clZdYuzDQ"><ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_wERnesaBIkyF2ZYGAWOS5g" decimals="-5" format="ixt-sec:numwordsen" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_Dl-fv0szP0GyPAmW8Q84pA">nil</ix:nonFraction></ix:nonFraction>, CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_l0LL76dIKke62bpBgsqmmQ" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_MwmcXN1YekqWMriP8cJwFA">3.9</ix:nonFraction> million and <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_VGUKHPz2X0mctIHDOt8IbQ" decimals="-5" format="ixt-sec:numwordsen" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="Narr_9H8A9SNWM0quS7Ko7LdbHw">nil</ix:nonFraction>, respectively, from this arrangement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">14.2</b></span> Grant income</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Grants from the Michael J. Fox Foundation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In May&#160;2020, the Company, as part of a joint arrangement with Sk&#229;ne University Hospital (Sk&#229;ne) in Sweden, was awarded a USD <ix:nonFraction unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ" contextRef="As_Of_5_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_yFg7_K4Sj06ntHrtmFJMMw" decimals="-5" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementPotentialValue" scale="6" id="Narr_7QQZKZ9eZEy1Zw-cyaznIQ">3.2</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_5_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_yFg7_K4Sj06ntHrtmFJMMw" decimals="-5" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementPotentialValue" scale="6" id="Narr_X2oNVw8VAEiFz7pbzvkyCg">3.0</ix:nonFraction>) million grant from the MJFF&#8217;s Ken Griffin Alpha-synuclein Imaging Competition. As part of this grant, AC Immune was eligible to receive USD <ix:nonFraction unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ" contextRef="As_Of_5_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_yFg7_K4Sj06ntHrtmFJMMw" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ReceivablesFromContractsWithCustomers" scale="6" id="Narr_4x5jeO2LgEeltnCWYXZ_0A">2.5</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_5_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_yFg7_K4Sj06ntHrtmFJMMw" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ReceivablesFromContractsWithCustomers" scale="6" id="Narr_RBvt41vCDE-CflZYW7Kdjw">2.3</ix:nonFraction>) million directly from the MJFF. Sk&#229;ne was to receive USD <ix:nonFraction unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ" contextRef="As_Of_5_31_2020_ifrs-full_CounterpartiesAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_QTd8z-CMpECa_iMHqUPauA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ReceivablesFromContractsWithCustomers" scale="6" id="Narr_19dfnu0I2UyTOPbtm7j9qA"><ix:nonFraction unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ" contextRef="As_Of_5_31_2020_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_gl9YWNvWuka0-golVkbkyA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ReceivablesFromContractsWithCustomers" scale="6" id="Narr_tbAFhlzO7EmiqvVxhDnkEQ">0.7</ix:nonFraction></ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_5_31_2020_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_gl9YWNvWuka0-golVkbkyA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ReceivablesFromContractsWithCustomers" scale="6" id="Narr_LvKVo_yhJEm0bbvqiHpi1A">0.7</ix:nonFraction>) million of the total grant directly from the MJFF over <span style="-sec-ix-hidden:Hidden_fQR8tACVGEO4UDivdKvMdQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">two</span></span>&#160;years to conduct and support the clinical arm of the project. In August 2022, the Company received follow-on grant funding as part of its joint arrangement with Sk&#229;ne in Sweden totaling USD&#160;<ix:nonFraction unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ" contextRef="Duration_8_1_2022_To_8_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_zfR7x4gHWUCfKEves1438g" decimals="-5" format="ixt:numdotdecimal" name="aciu:FollowOnGrantFundingReceivedTotalForJointArrangement" scale="6" id="Narr_9xleVYKGJ0ikMxPKAoDG8A">0.5</ix:nonFraction>&#160;(CHF&#160;<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_8_1_2022_To_8_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_zfR7x4gHWUCfKEves1438g" decimals="-5" format="ixt:numdotdecimal" name="aciu:FollowOnGrantFundingReceivedTotalForJointArrangement" scale="6" id="Narr_IM6rlZcML06TWRA37iHurw">0.5</ix:nonFraction>) million for the continued development of its alpha-synuclein PET imaging diagnostic agent. As part of this grant, AC Immune received USD&#160;<ix:nonFraction unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ" contextRef="Duration_8_1_2022_To_8_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_zfR7x4gHWUCfKEves1438g" decimals="-5" format="ixt:numdotdecimal" name="aciu:FollowOnGrantFundingReceived" scale="6" id="Narr_Jy1oROOeZkS85CGlnOmkwQ">0.4</ix:nonFraction>&#160;(CHF&#160;<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_8_1_2022_To_8_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_zfR7x4gHWUCfKEves1438g" decimals="-5" format="ixt:numdotdecimal" name="aciu:FollowOnGrantFundingReceived" scale="6" id="Narr_1UmkOxX7yUWB_BOu8evzTg">0.4</ix:nonFraction>) million directly from the MJFF. Sk&#229;ne received USD&#160;<ix:nonFraction unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ" contextRef="Duration_8_1_2022_To_8_31_2022_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_i3ZUuVbirEiuOT-5rYcByg" decimals="-5" format="ixt:numdotdecimal" name="aciu:FollowOnGrantFundingReceived" scale="6" id="Narr_zuW6YOKs3EmoPjTfDQrl4A">0.1</ix:nonFraction>&#160;(CHF&#160;<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_8_1_2022_To_8_31_2022_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_i3ZUuVbirEiuOT-5rYcByg" decimals="-5" format="ixt:numdotdecimal" name="aciu:FollowOnGrantFundingReceived" scale="6" id="Narr_U2-85bXnzUuilKcT9_pd5A">0.1</ix:nonFraction>) million of the total grant directly from the MJFF over the duration of the grant period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In December&#160;2021, the Company announced that it had been awarded <ix:nonFraction unitRef="Unit_Standard_item_lel3bReemU2v4xdKyUvjzA" contextRef="Duration_12_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_AdvanceSmallMoleculePdProgramsMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember__xRQy4sDnU2wuTVhB0eVUA" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfGrants" scale="0" id="Narr_N70Su9tUYUeaF4Kp1Jx1Hg">two</ix:nonFraction> grants totaling USD <ix:nonFraction unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ" contextRef="As_Of_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_AdvanceSmallMoleculePdProgramsMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_BWrRdrxLXEiE2A8T_eUqAA" decimals="-5" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementPotentialValue" scale="6" id="Narr_yIqo8-pnf0CG_zgKixjZNA">1.5</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_AdvanceSmallMoleculePdProgramsMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_BWrRdrxLXEiE2A8T_eUqAA" decimals="-5" format="ixt:numdotdecimal" name="aciu:CollaborativeAgreementPotentialValue" scale="6" id="Narr_Uuo9rXdeoUCgtLkEWbrSoQ">1.4</ix:nonFraction>) million to advance small molecule PD programs. One award supported an existing early-stage program to develop small molecules that can prevent intracellular aggregation and spreading of a-syn. The other award funded research on the therapeutic potential of chemically and mechanistically novel, brain penetrant small molecule inhibitors of NLRP3 inflammasome activation for the treatment of PD.</p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-30</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_LC1JdTUSnkCBH58-47IFcA_cont5"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In February 2023, the Company announced that it had been awarded a new grant totaling USD <ix:nonFraction unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ" contextRef="Duration_2_1_2023_To_2_28_2023_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_uKAhF0e3t0OofFPtWQBOnw" decimals="-5" format="ixt:numdotdecimal" name="aciu:AdditionalGrantAwarded" scale="6" id="Narr_jVatzcX_UkmycmGd8SnBRw">0.5</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_2_1_2023_To_2_28_2023_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_uKAhF0e3t0OofFPtWQBOnw" decimals="-5" format="ixt:numdotdecimal" name="aciu:AdditionalGrantAwarded" scale="6" id="Narr_b1ueMrf56Umk2TGOVjbBcA">0.4</ix:nonFraction>) million from the MJFF to support the development of its TDP-43 PET tracer program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2023, 2022 and 2021, the Company has recognized CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfContractsAxis_aciu_GrantRevenueMember_Kn--ZLK--EWCGZTxnKU9YQ" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="6" id="Narr_0RNT7YHvEUGg2CoQcLRvfQ">1.2</ix:nonFraction> million, CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_GrantRevenueMember_7FTossETZUGpmYwf0I08Iw" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="6" id="Narr_Da9Mi3mJyUmOyTnXAP2FOg">1.2</ix:nonFraction> million and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_GrantRevenueMember__Ki26gI4UUqU71aLzAD8KQ" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="6" id="Narr_3-iU9zxoFkmp1UIpey1n-w">1.1</ix:nonFraction> million, respectively, from its MJFF grants, under &#8220;Other operating income/(expense), net&#8221;. </p></ix:continuation><a id="_312f105c_3db6_4036_b359_e34751e1a777"></a><a id="Tc_y3JGfEh2lUK1hDIy-z55fQ_1_2"></a><a id="Tc_qJJAH7rmi0eK2uKT90sAgQ_2_2"></a><a id="Tc_IQh7GaZL30WJO1EJ7Vu3rg_3_0"></a><a id="Tc_3GwWEMnorEOsbcq8Cm1yrQ_3_2"></a><a id="Tc_E609n4D8w0KtdX0nI92WZA_3_4"></a><a id="Tc_tqO7oBjQGEGFyLQabeLKCA_3_6"></a><a id="Tc_PQiHs2pTXEueb-frvrqNvg_4_0"></a><a id="Tc_n-SMiM1-TEKr3q5Mzx13kw_5_0"></a><a id="Tc_gCTT1FobV0eu_qXpqQZflg_6_0"></a><a id="Tc_Pe_YWiI2W0uscRA6BuGlQw_7_0"></a><a id="_5fe3fca3_65d6_41c5_95b4_f7ed198f2e4c"></a><a id="Tc_r0o7s9nykEW2zhM0TH8mag_1_2"></a><a id="Tc_StXIzCrGAEeipJGyaWCxKA_2_2"></a><a id="Tc_AoOrGL-sIUGIeA3SbdxF1Q_3_0"></a><a id="Tc_iAmMoEe6HU6o4KQQoPMaLw_3_2"></a><a id="Tc_wnfbfW5nUkG0xpOkvUf4lQ_3_4"></a><a id="Tc_CunVRccAskm6vaWytuFnBw_3_6"></a><a id="Tc_S9xWZnAp5UKzJ3BXpb3CmA_4_0"></a><a id="Tc_yyR7NcgpWk6mIfeOWPv9mQ_5_0"></a><a id="Tc_EaRwr4gZukGNhndtmmEBOA_6_0"></a><a id="Tc_bepelAfXC0y1HPkPiZvEow_7_0"></a><a id="_ce958e8c_1680_4386_816d_ee5d747e635d"></a><a id="Tc_kgWLuTtceUaVAOujAkZ-hw_1_2"></a><a id="Tc_VwnDD2OqR0ax-imDc-yV2A_2_2"></a><a id="Tc_RISGzXfT_UCd9FDGZiiROQ_3_0"></a><a id="Tc_K2yxjxqPgEet7eqombQfZA_3_2"></a><a id="Tc_6_8vbiJnP0ip6_ZIFkLkIA_3_4"></a><a id="Tc_e9QqMb6FaU-MRCZbqNeCaw_3_6"></a><a id="Tc_AT1kTVRSH0evZvhXPN47zQ_4_0"></a><a id="Tc_LngtqnYf1EyqUyxjJcwFoA_5_0"></a><a id="Tc_gacf3IsXUk2C-y_nYQ8rhw_6_0"></a><a id="Tc_t6yIwhFe0E-SO3_wppzJ2w_7_0"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfExpensesExplanatory" id="Tb_aeuiJiVHy0qxi4GZ1ZEA-w" continuedAt="Tb_aeuiJiVHy0qxi4GZ1ZEA-w_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">15.</b></span>Expenses by category</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory" id="Tb_6PnoAc9w5EG8MGLI3_pCJQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;">Research and development</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Operating expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_mVdbPS_pZEOvR8-xErVVJg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OperatingExpense" scale="3" id="Tc_KQ0AnDfqKE-pvpM8tA86Iw_4_2">33,198</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_i4oh9OLRKk237CD7aWKajQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OperatingExpense" scale="3" id="Tc_ktHPAhFJlEehwJCuKes5bw_4_4">41,166</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_elQwz5L0xki93eiu__qmNA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OperatingExpense" scale="3" id="Tc_hfKsJH-fkky2VRz9iqZ2Rg_4_6">44,289</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Payroll expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_mVdbPS_pZEOvR8-xErVVJg" decimals="-3" format="ixt:numdotdecimal" name="aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation" scale="3" id="Tc_U1kVVHjOEk-Y-fqk3n94iA_5_2">19,499</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_i4oh9OLRKk237CD7aWKajQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation" scale="3" id="Tc_Z7e8WBdarUyFU7B5blTmMQ_5_4">17,548</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_elQwz5L0xki93eiu__qmNA" decimals="-3" format="ixt:numdotdecimal" name="aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation" scale="3" id="Tc_GEg9tYbQKEe14t3fywTBRw_5_6">16,465</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based compensation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_mVdbPS_pZEOvR8-xErVVJg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_9dVgZ6SRqEmsBBvySVnnJA_6_2">1,909</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_i4oh9OLRKk237CD7aWKajQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_C9J7V71PM0KM_HQAZ0ovoQ_6_4">1,622</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_elQwz5L0xki93eiu__qmNA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_Z6k5FiBNkE2cFZLZAko9zw_6_6">1,528</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total research and development expenses </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_mVdbPS_pZEOvR8-xErVVJg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseByNature" scale="3" id="Tc_Lpz4_pfLZ0mDBh5b2pi2XA_7_2">54,606</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_i4oh9OLRKk237CD7aWKajQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseByNature" scale="3" id="Tc_GTYqfXzYoU-2VaXv0tt8PQ_7_4">60,336</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_elQwz5L0xki93eiu__qmNA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseByNature" scale="3" id="Tc_QQdqoi16uUqTKcFg2_CngQ_7_6">62,282</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The decrease in 2023 is mainly driven by a decrease of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-5" format="ixt:numdotdecimal" name="aciu:DecreaseInResearchAndDevelopmentExpenseThroughReductionsInVariousCostCenters" scale="6" id="Narr_Ka3cBouJyEiAifRN-0PIyQ">5.8</ix:nonFraction> million in direct R&amp;D expenditures across various programs. This is partially offset by an increase of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-5" format="ixt:numdotdecimal" name="aciu:IncreaseInResearchAndDevelopmentExpenseThroughIncreaseInSalariesAndRelatedCosts" scale="6" id="Narr_UmKUiskZCU6dzdoutQGYWw">2.2</ix:nonFraction> million in salaries and related costs, including share-based compensation expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2023, 2022 and 2021, the Company had <ix:nonFraction unitRef="Unit_Standard_employee_Y_HtOjq0F0i_9evdy7ujWw" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_mVdbPS_pZEOvR8-xErVVJg" decimals="1" format="ixt:numdotdecimal" name="ifrs-full:AverageNumberOfEmployees" scale="0" id="Narr_VlgyVwY710OrAdl7Gh5aLA">115.4</ix:nonFraction>, <ix:nonFraction unitRef="Unit_Standard_employee_Y_HtOjq0F0i_9evdy7ujWw" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_i4oh9OLRKk237CD7aWKajQ" decimals="1" format="ixt:numdotdecimal" name="ifrs-full:AverageNumberOfEmployees" scale="0" id="Narr_BSsGmXy8HUKcfaiWL-8oKg">122.4</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_employee_Y_HtOjq0F0i_9evdy7ujWw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_elQwz5L0xki93eiu__qmNA" decimals="1" format="ixt:numdotdecimal" name="ifrs-full:AverageNumberOfEmployees" scale="0" id="Narr_jGOJGs34ikSO4RII-FiAKQ">108.6</ix:nonFraction> FTEs in our research and development functions.</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory" id="Tb_qFu7P49dCUyWcunI7lXoQA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;">General and administrative</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Operating expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6gI4nc20YE2v2UMn230IjA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OperatingExpense" scale="3" id="Tc_fNcGyOaPp0qiJ42-ervJYw_4_2">4,729</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_018DD5MHx0yR9siTflNYPw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OperatingExpense" scale="3" id="Tc_BmzltLtNDUuhYQ05Z_DHiQ_4_4">6,207</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_bid3n8U3yUu4WF-DywHH4Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OperatingExpense" scale="3" id="Tc_LYY1R8b-NUWy0qf7PrxTpA_4_6">7,031</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Payroll expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6gI4nc20YE2v2UMn230IjA" decimals="-3" format="ixt:numdotdecimal" name="aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation" scale="3" id="Tc_yuPFIZ8M4kyC86c-0apqjw_5_2">7,755</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_018DD5MHx0yR9siTflNYPw" decimals="-3" format="ixt:numdotdecimal" name="aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation" scale="3" id="Tc_Ey_NUFZ1KUaRdji8pY-2PQ_5_4">7,874</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_bid3n8U3yUu4WF-DywHH4Q" decimals="-3" format="ixt:numdotdecimal" name="aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation" scale="3" id="Tc_EraAxZ3gyUyUdrerVYs66w_5_6">8,281</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based compensation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6gI4nc20YE2v2UMn230IjA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_F8DTJkwyA0mfGIIkTkbDag_6_2">2,821</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_018DD5MHx0yR9siTflNYPw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_JDAcba11r02XIwYkLkrgVQ_6_4">1,708</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_bid3n8U3yUu4WF-DywHH4Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="3" id="Tc_UiwaVXyDmke8pviO-UExFQ_6_6">2,598</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total general and administrative expenses </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6gI4nc20YE2v2UMn230IjA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseByNature" scale="3" id="Tc_LywFyL7lWE2EbaBii5cP_g_7_2">15,305</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_018DD5MHx0yR9siTflNYPw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseByNature" scale="3" id="Tc_fBiOnw_sykaAVPc2yd6nBw_7_4">15,789</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_bid3n8U3yUu4WF-DywHH4Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ExpenseByNature" scale="3" id="Tc_6ksbtp7RDkSR5DOSNyZBmQ_7_6">17,910</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The decrease in 2023 compared with the prior&#160;year predominantly relates to a reduction of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-5" format="ixt:numdotdecimal" name="aciu:DecreaseInGeneralAndAdministrativeExpenseThroughReductionsInVariousCostCenters" scale="6" id="Narr_AlIqWdjEGU-D94QfkPWfoQ">1.5</ix:nonFraction> million across various cost centers. This is partially offset by an increase of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-5" format="ixt:numdotdecimal" name="aciu:IncreaseInGeneralAndAdministrativeExpenseThroughIncreaseInShareBasedCompensationExpense" scale="6" id="Narr_1BTVxK-yyUaodi8_aBlKQg">1.1</ix:nonFraction> million in share-based compensation expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2023, 2022 and 2021, the Company had <ix:nonFraction unitRef="Unit_Standard_employee_Y_HtOjq0F0i_9evdy7ujWw" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6gI4nc20YE2v2UMn230IjA" decimals="1" format="ixt:numdotdecimal" name="ifrs-full:AverageNumberOfEmployees" scale="0" id="Narr_9otZ-3mt_UCM0hFHDLXGHg">26.2</ix:nonFraction>, <ix:nonFraction unitRef="Unit_Standard_employee_Y_HtOjq0F0i_9evdy7ujWw" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_018DD5MHx0yR9siTflNYPw" decimals="1" format="ixt:numdotdecimal" name="ifrs-full:AverageNumberOfEmployees" scale="0" id="Narr_AUMkb3hVFUqK7AmPeYwGuw">22.5</ix:nonFraction> and <ix:nonFraction unitRef="Unit_Standard_employee_Y_HtOjq0F0i_9evdy7ujWw" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_bid3n8U3yUu4WF-DywHH4Q" decimals="1" format="ixt:numdotdecimal" name="ifrs-full:AverageNumberOfEmployees" scale="0" id="Narr_Zb-YH9jhLk-0uUTH-Zy0LA">27.3</ix:nonFraction> FTEs in our general and administrative functions.</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory" id="Tb_4edXN6rzvUCziMKTS4DH9g" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;">Financial result, net</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Financial income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncome" scale="3" id="Tc_lhOQWvERg0WNEtmBAfZEag_4_2">1,044</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncome" scale="3" id="Tc_HxsN1Qm7p02YGvRWkQI5Yw_4_4">69</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncome" scale="3" id="Tc_GCZBM79IHESid7-9YDbiFg_4_6">6,485</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Financial expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceCosts" scale="3" id="Tc_HBAwpQZ9okCuhpl-s0izJw_5_2">176</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceCosts" scale="3" id="Tc_eEXqXUk-VEWf8Fy-YYibVQ_5_4">355</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceCosts" scale="3" id="Tc_dt0tZUf64k-pW_rU_KZMXg_5_6">581</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exchange differences</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" sign="-" scale="3" id="Tc_HvyGv22v8Eq9sRyoPKP6UQ_6_2">1,467</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="3" id="Tc_OeHF-Yu7qU2P_i11NVsX5Q_6_4">393</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="3" id="Tc_IRXwsJy9XEmE2DrHoWPUmQ_6_6">113</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Finance result, net </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncomeCost" sign="-" scale="3" id="Tc_owWox-sRt0yXSJ9FKkLPpw_7_2">599</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncomeCost" scale="3" id="Tc_UHZHg03sskaa33eIfnFZNQ_7_4">107</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinanceIncomeCost" scale="3" id="Tc_nPKjmdH63UKn92rZZKty9Q_7_6">6,017</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our finance result primarily consists of interest expense associated with our short-term financial assets and lease liabilities as well as foreign currency exchange differences.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-31</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_aeuiJiVHy0qxi4GZ1ZEA-w_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;year ended December&#160;31, 2023, the decrease in financial result, net relates primarily to unfavorable foreign currency exchange differences related to movement in the CHF versus foreign currencies, predominantly the US Dollar. This is partially offset by an increase in financial income, combined with a decrease in financial expense, due to the transition from negative to positive interest rates for our interest-bearing deposit accounts.</p></ix:continuation><a id="_167a5eea_21f7_498e_9f36_5aa9e3b59c22"></a><a id="Tc_dKjb0598pUikfKIIcEYUyQ_1_2"></a><a id="Tc_XIWeKlqVwk6dNVs7G3hlVw_2_2"></a><a id="Tc_Ci62tVLPSEmPPfQFzqBiXA_3_0"></a><a id="Tc_gYGa7NujQ0edkBOUXyrevA_3_2"></a><a id="Tc_hM9QdKWz7UG4240VUZRTzA_3_4"></a><a id="Tc_r3ictDl6H0ydOMGuhKqwfQ_3_6"></a><a id="Tc_ZWfCjEOvWkOMn-vHY4TK5g_4_0"></a><a id="Tc_OPl6E8JT60-sHqfOCco2lA_5_0"></a><a id="Tc_HwEB4pHLE0GqT-RtOXTuHg_6_0"></a><a id="Tc_oBqsRQJN6kOd-OwJ6kaf0w_7_0"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfRelatedPartyExplanatory" id="Tb_gXvK2VwpgEeZg5i4d35m-Q" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">16.</b></span>Related-party transactions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Board of directors and executive management compensation</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" id="Tb_tjqr7RpvT0eyEkt3F2C--g" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Key management includes the board of directors and executive management. For 2023, there were <ix:nonFraction unitRef="Unit_Standard_person_7ny7-oR7aEaZQqs0BxZVCQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfPersonsKeyManagementBoardOfDirectors" scale="0" id="Narr_ZG7saATdTkGPsZzWGrnNdA">eight</ix:nonFraction> members (2022 and 2021: <ix:nonFraction unitRef="Unit_Standard_person_7ny7-oR7aEaZQqs0BxZVCQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfPersonsKeyManagementBoardOfDirectors" scale="0" id="Narr_4aGtjUNbREixjzQFzIzKig"><ix:nonFraction unitRef="Unit_Standard_person_7ny7-oR7aEaZQqs0BxZVCQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfPersonsKeyManagementBoardOfDirectors" scale="0" id="Narr_LDGY3UAbxEyKgUL3wuWkqA">eight</ix:nonFraction></ix:nonFraction>) of the Board (excluding the CEO) and <ix:nonFraction unitRef="Unit_Standard_person_7ny7-oR7aEaZQqs0BxZVCQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfPersonsKeyManagementExecutiveManagement" scale="0" id="Narr_bNxyvN6lUE-AFJG7HxFBfw">seven</ix:nonFraction> members (2022: <ix:nonFraction unitRef="Unit_Standard_person_7ny7-oR7aEaZQqs0BxZVCQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfPersonsKeyManagementExecutiveManagement" scale="0" id="Narr_MS8TQPHqo0qYEvvWSU5_AQ">seven</ix:nonFraction> and 2021: <ix:nonFraction unitRef="Unit_Standard_person_7ny7-oR7aEaZQqs0BxZVCQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfPersonsKeyManagementExecutiveManagement" scale="0" id="Narr_gZ6-ySvz70iH2HPjgV89Pw">six</ix:nonFraction>) of executive management (including the CEO). Compensation was as follows:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term employee benefits </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" scale="3" id="Tc_ZySttk5Z6E6gyUrRX64sLA_4_2">4,661</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" scale="3" id="Tc_jaQu8FyyQkuEXTALx7kJtg_4_4">4,187</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" scale="3" id="Tc_dT1ZS9L9i0mmM71sfn203A_4_6">4,403</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Post-employment benefits </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" scale="3" id="Tc_xoZqyT9XFUabkaeK0fV_JQ_5_2">446</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" scale="3" id="Tc_AIEUEVFL2U2bn1ajtAUkBQ_5_4">295</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" scale="3" id="Tc_hgMYBRxtjEakXpPFT5hhNA_5_6">266</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based compensation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" scale="3" id="Tc_yDzXxkwHEkm11q8rI0M6oQ_6_2">3,251</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" scale="3" id="Tc_8bgXmc2pQEqFslMMed-JvQ_6_4">2,503</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" scale="3" id="Tc_kft0ewVzeUW9GVy0ASdyvg_6_6">2,997</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total compensation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensation" scale="3" id="Tc_Wz9mhmQ090uM0MFZZ3Mdpw_7_2">8,358</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensation" scale="3" id="Tc_-jxCr7Z4ukGOzv48EGNvxQ_7_4">6,985</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:KeyManagementPersonnelCompensation" scale="3" id="Tc_6yPGJKfWWUaftiLuInqDag_7_6">7,666</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_64a97536_e11a_4ae3_9dd4_8ca9e5c17dc3"></a><a id="Tc_SWwFHt7eTE6RfCHxOIOJLw_1_2"></a><a id="Tc_wxk_gAi6WUOEdjWVzS7vrA_2_2"></a><a id="Tc_2DMNmqjtdUWDHTr9y0sFug_3_0"></a><a id="Tc_JSDIPl2EUESdy8h7WNM9vw_3_2"></a><a id="Tc_XD9KDJgZvka4tQEsVo49gw_3_4"></a><a id="Tc_nNX07z1S9kaeL7tasVt2ig_3_6"></a><a id="Tc_LYCQR4xq2E266ektr0FmvA_4_0"></a><a id="Tc_bXldm4q5KEqsj2CW0tDilg_5_0"></a><a id="Tc_GhlFqTsdNU-u6w2b8mxcAw_6_0"></a><a id="Tc_8sIvKYmO70Gx9-SMcQENGA_7_0"></a><a id="Tc_rN8r2EDlKkqlDKywcUGOiw_8_0"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfIncomeTaxExplanatory" id="Tb_-aIyargqz0St4vG3XzZZ3Q" continuedAt="Tb_-aIyargqz0St4vG3XzZZ3Q_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">17.</b></span>Income taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Group recognized less than CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_N4NtcRpK7UmEpR8gT_3kcQ" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="6" id="Narr_2CMe3YXz7U2GpnPsBJIzBg">0.1</ix:nonFraction> million in income taxes and <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-5" format="ixt-sec:numwordsen" name="ifrs-full:DeferredTaxAssets" scale="6" id="Narr_3YHlZ05ycEKdUjgdgW3gBg">no</ix:nonFraction> deferred tax asset or <span style="-sec-ix-hidden:Hidden_HV19mOg_skeZVhyj5rvzCA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">liability</span></span> positions for the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively. The Group&#8217;s expected tax expense for each&#160;year is based on the applicable tax rates in each jurisdiction. In 2023, these rates ranged from <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_A0fLCvnZXkWCpt0V9v-hlQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_OQjYdgkSV0GgDylZfGtciA">13.6</ix:nonFraction>% to <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_N4NtcRpK7UmEpR8gT_3kcQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_4U5uZjl4A02C592TbClP4g">33.8</ix:nonFraction>% (<ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_kJ9M4JxOBEuo1siTgMfdYQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_sMkYxWUxMUarBplfgdTQuQ">13.6</ix:nonFraction>% - <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_mTTN5Hw7J0uG4plqeYxbIg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_CIrRc5esm0ykb06utdeehQ">33.8</ix:nonFraction>% for 2022 and <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_8Bc9-4UKrUm1j0Wj8jL6XQ"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ZaXds3ifpU6wdPGK9Rol-A" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_2Lg1vApRH0KSeUDArhrdhQ">13.6</ix:nonFraction></ix:nonFraction>% - <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_kF_Z_GmDe0uYNVNKIyLhww" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_rOYlNkellkSOvVXedhBCNw">32.9</ix:nonFraction>% for 2021) in the Group&#8217;s respective tax jurisdictions. The weighted average tax rate applicable to the Group was <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_WeightedAverageMember_4FG0vtdOM0qVouBNBJxDYA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_cENN7tG1S0CQHU6IS0P0Ig">13.6</ix:nonFraction>% (<ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_WeightedAverageMember_ZWzC0poj30O0x-cniAS5CA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_Dofu4HogWkqBaqeTnrFq8g"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_WeightedAverageMember_X-fZxVt670yVn-ag8aFnSg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_JHArfPSexEekE9mbhOF2rA">13.6</ix:nonFraction></ix:nonFraction>% for 2022 and 2021, respectively). </p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock" id="Tb_SmIZ2Gkb7EO3eoVpnQkBrw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The Group&#8217;s income tax expense for each&#160;year can be reconciled to loss before tax as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Loss before income tax </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AccountingProfit" sign="-" scale="3" id="Tc_fTgydbH3skCU6XGYT3cz7g_4_2">54,223</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AccountingProfit" sign="-" scale="3" id="Tc_leYI750fNUKCsyHDrdjeXw_4_4">70,740</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:AccountingProfit" sign="-" scale="3" id="Tc_MUc1SBSZ4UmXg-LA5ms11w_4_6">72,993</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Tax benefit calculated at the domestic rates applicable in the respective countries </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" sign="-" scale="3" id="Tc_joKZbwVVO0y54OiPix0Zrg_5_2">7,371</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" sign="-" scale="3" id="Tc_w6Fmw0PiC0GOOjEIFM7s5A_5_4">9,616</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" sign="-" scale="3" id="Tc_PqfJPmwvaEu5dVmMz4ds6Q_5_6">9,930</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">(Income not subject to tax)/expenses not deductible for tax purposes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="aciu:TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" scale="3" id="Tc_6oARy5De1kGs7FIazhmpnQ_6_2">611</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="aciu:TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" scale="3" id="Tc_pgC66Skk-0atw9TM0TyxXw_6_4">455</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="aciu:TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" sign="-" scale="3" id="Tc_CADJYtv3B0GneaX_Ri_Evw_6_6">375</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of unused tax losses and tax offsets not recognized as deferred tax assets </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="3" id="Tc_V649yho-w06R37RZuvrVmQ_7_2">6,770</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="3" id="Tc_TwKDOoXl2EOQsXsXHnuRHg_7_4">9,174</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:TaxEffectOfTaxLosses" scale="3" id="Tc_u0H48-MUTkiKDst1HzHlKA_7_6">10,308</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Effective income tax rate expense </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" id="Tc_psBcifw2z0qJaNQYMNevdQ_8_2">10</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" id="Tc_qECH2RrxRECCFaMFqtyT_g_8_4">13</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" id="Tc_7XNBo_22IUOOtJoTcrVtbQ_8_6">3</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Swiss tax rate used for the 2023 reconciliations is the corporate tax rate of <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_GeographicalAreasAxis_country_CH_hI8bZ3TK70-bfSp_6iHWkw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_zeLnkTCQq0aYPq9HCrEU4w">13.6</ix:nonFraction>% (<ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_8c82EEneiU6KZyv_9C-IyQ"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:ApplicableTaxRate" scale="-2" id="Narr_HU9I7mRaVUuGK2XzV8tAtA">13.6</ix:nonFraction></ix:nonFraction>% in 2022 and 2021, respectively) payable by corporate entities in the Canton of Vaud, Switzerland on taxable profits under tax law in that jurisdiction.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-32</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_a28ac5f1_0518_4782_aa93_f98ab4483e02"></a><a id="Tc_0Z-fwJbXS0m2SG6c1MJbjA_1_2"></a><a id="Tc_h34bWOLoh0eulOiHTbdh6w_2_2"></a><a id="Tc_cZLeDZKOYUua38GMNVVniQ_3_0"></a><a id="Tc_WWIic2KbaE-DipLWN1SUzQ_3_2"></a><a id="Tc_xGoN6ZK3oUGQscMI-7NlCw_3_4"></a><a id="Tc_okuUzDdySkWtbfsHHYHvkw_3_6"></a><a id="Tc_33UBMfzKvkKMsYpakuTZIg_4_0"></a><a id="Tc_ES_MS83JU0uF18mE1GB7Fw_5_0"></a><a id="Tc_hA1cTo101UK3WJ3kSDRT4w_6_0"></a><a id="Tc_SGOg7pkzrE-FiEoIWUmmVg_7_0"></a><a id="Tc_PxnCep8jwEqi4hAl_PKIcQ_8_0"></a><a id="Tc_qIDQcJMo8E6ARntWDvhHvA_9_0"></a><a id="Tc_K5bz6RRi5US_ykpjdYQDRQ_10_0"></a><a id="_6a658abf_3768_4301_b6d9_87cba248c55a"></a><a id="Tc_pPsxk_5TpUCD1amfVHd_5A_1_2"></a><a id="Tc_hCI1GBJPAk2C0iQ05Iaucw_2_2"></a><a id="Tc_VMyo0Y01O0K-lgqx8DOnJg_3_0"></a><a id="Tc_Vg0Pji3-rEu8s86-hXe7aw_3_2"></a><a id="Tc_dduwn6cSw0qrZTXEPcFRgQ_3_4"></a><a id="Tc_pPRHtRQHLEa4WUqumI3dIA_3_6"></a><a id="Tc_CYeH49IDP0ORNLl6Xs7sLw_4_0"></a><a id="Tc_EPBRS5kSmEi393ASjEGM0w_5_0"></a><a id="Tc_7GkE7ii2LE-bJnCnZipIgQ_6_0"></a><a id="Tc_dzphpStd1UmmiUo8aWbQTg_7_0"></a><a id="Tc_95W9FrbwxUaN89Xr6_gFXA_8_0"></a><a id="Tc_jOPRVjilKE6aLxnbSlJMRA_9_0"></a><a id="Tc_vuTQvM7uh0eugloQquBL3g_10_0"></a><a id="Tc_POFUwZ-8rU23hWLexdIOrw_11_0"></a><a id="Tc_pIfd5OU47keEaY6wjPLVzw_12_0"></a><ix:continuation id="Tb_-aIyargqz0St4vG3XzZZ3Q_cont1"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" id="Tb_SxvluN1mO0O-n_X6IdtTSg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The below table details the total unrecognized deductible temporary differences, unused tax losses and unused tax credits:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unrecognized deductible temporary differences, unused tax losses and unused tax credits</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Deductible temporary differences, unused tax losses and unused tax credits for which no deferred tax assets have been recognized are attributable to the following:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Tax losses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_2nj8zIQ95U6QDxkvALWpOw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc_JYB5rmGR90a_Km2cNA8sMw_6_2">312,972</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_vDSFPVowe067uhYZQdHFgQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc_GEwQ3vCWMkyHp_unhI7yoA_6_4">264,089</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_DnkavB3_kUKnU6RtWKx2Ow" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc_MxvoyS-pqk2uVSlg0Lda8Q_6_6">197,152</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Deductible temporary differences related to:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 18pt;">Right-of-use assets and lease liabilities, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_7dWOVnOSFUq1x4XujqX_oA" decimals="-3" format="ixt:zerodash" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc_VkzG74TYEkO_xjPsPbchiw_8_2">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_RA7Xt4V3fUCJ2nNa8SxwcA" decimals="-3" format="ixt:zerodash" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc_bEMA6Ea09UmwdVAnXWuUuA_8_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_ikz_e9A97Ea1rUgxFPK-vg" decimals="-3" format="ixt:zerodash" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc_imLWY1IwREiVDWmbXDp2gA_8_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 18pt;">Retirement benefit plan </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_sNU1oHf-Q0i6Of2JKbOZPA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc_kR0o2GecOUuLNf0FY3wMzw_9_2">5,770</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_TabmlKnxSE2DHBh6lcLTdA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc_h7voRhWAUEyMNKbiuPg-Dw_9_4">3,213</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_vxoJ2RbCcEe-EQHCnzF_IQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc_qsP82sffiESwn6mII0v89Q_9_6">7,098</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc_dZ5oJ1E38UOuDCmRo9g2Jg_10_2">318,742</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc_0upwON2YtkqfioClev5GCQ_10_4">267,302</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" scale="3" id="Tc_-57LrJb7mUmM7wh_C2U3fg_10_6">204,250</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock" id="Tb_ofEh2lE5q0av3g1DE2pc4Q" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table details the tax losses carry forwards of the Company and their respective expiry dates:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Tax losses split by expiry date:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312024Member_9PsLbtvfWkWuSDEFjmSZYA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_XqkW7jR8yUqZu_F-KdiEFQ_5_2">15,231</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312024Member_ODQ0kdFPZUG27qH4k1wNgA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_PxhaZ9zI-0CMiY1px5UNhg_5_4">15,231</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312024Member_aAlt2XZpC0uOboJTpNYv4g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_GarT8MRyFUWNNH7ScdADqA_5_6">15,231</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312025Member_1bi1vT0nc0u2Xh-S7Lt9PQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_vcKgsQDT0kytNGrOMpJzAQ_6_2">48,894</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312025Member_GGbghK-VE0StWeUg1GPupQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_ihGbNHjdl0m2DxKEnWWXJw_6_4">48,894</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312025Member_qeqHInhEQkOUN0SZFu9S6g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_MfbkenJuk0WoKu2LhroyWQ_6_6">48,894</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312026Member_iGQ4s9Lt50alrF3FP1KcQA" decimals="-3" format="ixt:zerodash" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_V8yxxJYUPUyQmPLrO6VsTQ_7_2">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312026Member_AZE5FSsJIkCOiIDjG4AMqg" decimals="-3" format="ixt:zerodash" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_DrcdnUSB-0m9BzZVUulObQ_7_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312026Member_R-5b-bEhfk2AijECdFfhAg" decimals="-3" format="ixt:zerodash" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_dpiv_sev206OEo8FBZptYw_7_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312027Member_1R5SXknjqkWUWP0mLRRZ_A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_xTv-TYNhaEuA_Y7Ofl93_w_8_2">57,824</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312027Member_4_H5GnUE2EO-6fMiAfFadQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_S_XZf97TbUqnZAnPX76BRg_8_4">57,824</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312027Member_focY9wr8pUGC-t4W6eLn8w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_IDGAlCw9YEyVOtbAnUyuNw_8_6">57,824</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312028Member_r0Sy7JDN_k2I6y5Q8lYXcQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_Czt-neBkHUen8qDML3msbg_9_2">75,204</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312028Member_PSDaq1Iknkqy7hP1uOdwxw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_d_ev2AwZs0a-Pay9dSMRWw_9_4">75,204</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312028Member__3-rt4ONB0WjYegP6jLv5A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_u4hL3D2MTkyj__O6Fmm3gg_9_6">75,204</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2029</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312029Member_RxSJlFvxd0uLTKolUL3zSQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_P5jyEO4J9k-Q-t_ijF_syQ_10_2">66,936</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312029Member_AnOPccdCO0yOmasUrlkU1A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_m1Mw3kHjCUuh0jHLXXEE0w_10_4">66,936</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312029Member_3dOqpfnfckCEIMcHBimfcQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_92jBAtRoWE2O3-EAy-WG2Q_10_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2030</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312030Member_O4olP_9OfE6MhoH0EV3nbQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_JYNRAgg5J0e5V0J8vFKCqw_11_2">48,883</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312030Member_UxPXRokBZESrDLq3Evh4eQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_kGeAZcYo-E6gokKxIqA_2g_11_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312030Member_5kb1PG5AuUO0S-gCtjrH-Q" decimals="-3" format="ixt:zerodash" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_AuZX9y-RV02T5HH_A5Zepg_11_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total unrecorded tax loss carryforwards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_6_m7YMFHEke8YbwXqqacWw_12_2">312,972</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_dv12CS6VrUedA1akDA5ixQ_12_4">264,089</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="3" id="Tc_nqfoSiAZ3UGwZvWUYgVOCw_12_6">197,153</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The tax losses available for future offset against taxable profits have increased by CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-5" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits" scale="6" id="Narr_kb9txZolNEO_W2yyKAEEIA">48.9</ix:nonFraction>&#160;million from 2022, representing the amount of tax losses that are additionally available as an offset, subject to expiration as disclosed in the table above, against future taxable income.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Consistent with prior&#160;years, the Company has not recorded any deferred tax assets in relation to the past tax losses available for offset against future profits as the recognition criteria were not met at the balance sheet date.</p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory" id="Tb_SD-XVkt9XUG0GQTxUaHzNg" continuedAt="Tb_SD-XVkt9XUG0GQTxUaHzNg_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">18.</b></span>Retirement benefit plan</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company participates in a collective foundation covering all of its employees including its executive officers. In addition to retirement benefits, the plan provides death or long-term disability benefits.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Contributions paid to the plan are computed as a&#160;percentage of salary, adjusted for the age of the employee and shared approximately <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="2" format="ixt:numdotdecimal" name="aciu:DefinedBenefitPlansPercentageOfContributionsByEmployees" scale="-2" id="Narr_IdL_34__w0aqSNpr9qDciA">47</ix:nonFraction>% and <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="2" format="ixt:numdotdecimal" name="aciu:DefinedBenefitPlansPercentageOfContributionsByEmployer" scale="-2" id="Narr_5M9YoSYkhUO1X9iuMKd9xg">53</ix:nonFraction>% by employee and employer, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This plan is governed by the Swiss Law on Occupational Retirement, Survivors and Disability Pension Plans (BVG), which requires contributions to be made to a separately administered fund. The fund has the legal form of a foundation and it is governed by a board of trustees, which consists of an equal number of employer and employee representatives of its members. The board of trustees is responsible for the administration of the plan assets and for the definition of the investment strategy. The Company has no direct influence on the investment strategy of the foundation board.</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-33</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_751b3081_98bc_4025_a362_ba56cd939f83"></a><a id="Tc_JArAQ_BWiECrPQ_rV8MN4w_1_2"></a><a id="Tc_7mhppR4yv0KTUXUmMVvV-Q_2_2"></a><a id="Tc_t8-W1TCz1k-4Jv235gimMw_3_0"></a><a id="Tc_P6maygxda0KAm31zrtmqtQ_3_2"></a><a id="Tc_8A9fGfkt5Ey0QHbhB8e8uw_3_4"></a><a id="Tc_lIWLkPvgBEi7g1FlvTfPMg_3_6"></a><a id="Tc_SxncXDj_8UGFdGysf9mnNQ_4_0"></a><a id="Tc_T1xtFabxj0qjpDCkZjGccA_5_0"></a><a id="Tc_3d6mpkyenUGanIisW1OsHw_6_0"></a><a id="_7874535a_4702_4728_a83b_95a5a6503f44"></a><a id="Tc_icUGA9QvOUyoT1k9rWWGfg_1_2"></a><a id="Tc_rcnaPUpRHkm-oQ7_CPyu3A_2_2"></a><a id="Tc_6qbZW1h1EkaKlPxmOpPbmQ_3_0"></a><a id="Tc__URqHVB9wkaBe3Y5KRRVEA_3_2"></a><a id="Tc_74xgDIKIs0qVXzUFidUpgw_3_4"></a><a id="Tc_fyAJtjm_906omf81ofh2sw_3_6"></a><a id="Tc_j1UU-_FH-UGmm__vV3bFSw_4_0"></a><a id="Tc_wNCaZ1TLA0-SAbe5ajwMJg_5_0"></a><a id="Tc_NZNCredMBEGWJTRLggkrrA_5_4"></a><a id="Tc_87gR5awp20yIjAXeP9QSyw_5_6"></a><a id="Tc_qyQn6lTli0-1KHK0ypRV5Q_6_0"></a><a id="Tc_x1ZExp2Xs0CCpewlf_MNsg_7_0"></a><a id="Tc_4PJKuU8UZ0eiJJgMr1o6zQ_8_0"></a><ix:continuation id="Tb_SD-XVkt9XUG0GQTxUaHzNg_cont1" continuedAt="Tb_SD-XVkt9XUG0GQTxUaHzNg_cont2"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The assets are invested by the pension plan, to which many companies contribute, in a diversified portfolio that respects the requirements of the Swiss BVG. Therefore, disaggregation of the pension assets and presentation of plan assets in classes that distinguish the nature and risks of those assets is not possible. Under the plan, both the Company and the employee share the costs. The structure of the plan and the legal provisions of the BVG mean that the employer is exposed to actuarial risks. The main risks are investment risk, interest risk, disability risk and the life expectancy of pensioners. Through our affiliation with the pension plan, the Company has minimized these risks, as they are shared between a much greater number of participants. On leaving the Company, a departing employee&#8217;s retirement savings are transferred to the pension institution of the new employer or to a vested benefits institution. This transfer mechanism may result in pension payments varying considerably from&#160;year to&#160;year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The pension plan is exposed to Swiss inflation, interest rate risks and changes in the life expectancy for pensioners. For accounting purposes under IFRS, the plan is treated as a defined benefit plan in accordance with IAS 19.</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock" id="Tb_owVyOu-Yekio5kOdPUfTtw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table sets forth the status of the defined benefit pension plan and the amount that is recognized in the consolidated balance sheets:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Defined benefit obligation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_T4RUiYena0iebgdROd5Ygw_4_2">41,060</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_YUiWoM7oXU6hiZ2-b-ktHQ_4_4">32,410</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_zDFBZPyQAEO-ClVPRmCL2g_4_6">33,889</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Fair value of plan assets </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PlanAssetsAtFairValue" scale="3" id="Tc_nHzHsleX7UGh8_1ru_1qjg_5_2">35,290</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PlanAssetsAtFairValue" scale="3" id="Tc_g9DtPbS4RkyFILqt-3ZT1Q_5_4">29,197</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PlanAssetsAtFairValue" scale="3" id="Tc_A7cDxQvgmUGP1BRj7MXctA_5_6">26,791</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total liability </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:SurplusDeficitInPlan" sign="-" scale="3" id="Tc_ipHmqd1egEWqT5_dhX_Uog_6_2">5,770</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:SurplusDeficitInPlan" sign="-" scale="3" id="Tc_gvk5732V20y35pInX-vmUg_6_4">3,213</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:SurplusDeficitInPlan" sign="-" scale="3" id="Tc_LO6xDPqpMEyinIg8XoLgRw_6_6">7,098</ix:nonFraction>)</p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock" id="Tb_-hm33go8q0OJ1kJwYaSOaw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following amounts have been recorded as net pension cost in the consolidated statements of income/(loss):</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Current service cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentServiceCostDefinedBenefitPlans" scale="3" id="Tc_HmYCdzxnCU6mNJHtvsqw7w_4_2">1,453</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentServiceCostDefinedBenefitPlans" scale="3" id="Tc_wqoUBtacvEy8YXdOS8VKmA_4_4">1,712</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentServiceCostDefinedBenefitPlans" scale="3" id="Tc_SfvaBjqzLESr0OsxRCWd6g_4_6">1,648</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Past service cost</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PastServiceCostDefinedBenefitPlans" scale="3" id="Tc_O133A6iQEEmgc0GNcacoSg_5_2">903</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseDefinedBenefitPlans" scale="3" id="Tc_S6Yruhx2lEOyIJ9xHOSDaA_6_2">804</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseDefinedBenefitPlans" scale="3" id="Tc_oUaYgZAyHkuPVC7cOFgJPA_6_4">126</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseDefinedBenefitPlans" scale="3" id="Tc_bIsD4c2YrEK9CqdF647TMQ_6_6">79</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestIncomeDefinedBenefitPlans" scale="3" id="Tc_wIyJx2d3XEu0pA_8NTrtwg_7_2">705</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestIncomeDefinedBenefitPlans" scale="3" id="Tc_UAO879tVPU2PzrBsoEuEGQ_7_4">87</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestIncomeDefinedBenefitPlans" scale="3" id="Tc_mllZAQyCLEOHyYV6yEUeQw_7_6">48</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net pension cost </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="3" id="Tc_EXZ6gN6O7EyrGZlGzA0e7A_8_2">2,455</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="3" id="Tc_3uED-SSSKEu_BoHyUI_ytg_8_4">1,751</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="3" id="Tc_6vly2y0g906G0o1JYzQ-iQ_8_6">1,679</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" id="Tb_cSy3P_Sd10ix4CiX8hG_WQ" continuedAt="Tb_cSy3P_Sd10ix4CiX8hG_WQ_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The changes in defined benefit obligation, fair value of plan assets and unrecognized gains/(losses) are as follows.</p></ix:nonNumeric></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-34</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_b1bcb0a5_511f_4a8f_bc5d_8cd9bb0f6c7a"></a><a id="Tc_OJXE754VYUO6aK9msuM6RA_1_2"></a><a id="Tc_AH9_iA30MEGkqwOa-QA6Bw_2_2"></a><a id="Tc_IyqTQsw1Akq2moJgsjNIAw_3_0"></a><a id="Tc_qYpdu89OH0WBLSCRFwiMvg_3_2"></a><a id="Tc_d6AicvWP4USjYOmKp68XBQ_3_4"></a><a id="Tc_ZWDCxQKd-EGlX3GhuU6x4w_3_6"></a><a id="Tc_qyKqfqxAXUCyaOrTLQ_JKQ_4_0"></a><a id="Tc_o2_D-dNzsUu2T8Ly9T6Fwg_5_0"></a><a id="Tc_TebFt2OHRkao3L4Ybxgngw_6_0"></a><a id="Tc_ZNjS2WExskCUOK5kX_5m6A_6_4"></a><a id="Tc_2tzvjiU8HEWykRrLq7iXeg_6_6"></a><a id="Tc_oy4UF6TMakiAdGepE8AQjg_7_0"></a><a id="Tc_Kzq4DZl0Y0KyRObK1H4c1g_8_0"></a><a id="Tc_VgLTE4QrtUiinFVXogRASA_9_0"></a><a id="Tc_xPytKAfcXEi3O9-QbYWrlg_10_0"></a><a id="Tc__iQfk-a7uEOEpJsPuvPYGA_11_0"></a><a id="Tc_w7tfFejjnkif0VN59EWMCQ_12_0"></a><a id="Tc_CBmYWECWPka3sFbZcIex5A_13_0"></a><a id="_ee253468_ce52_486d_9dd4_15eb0c0ba0ff"></a><a id="Tc_ZR5t0ZgLPUGJA24adt9P_w_1_2"></a><a id="Tc_v96eUtAnnU2t5OoTfjLoaQ_2_2"></a><a id="Tc_941G1Sb2GUCMJ7gN9AcJZA_3_0"></a><a id="Tc_WUr0s4l2q0qdI-GDIpbyIA_3_2"></a><a id="Tc_AEgTPnZQYUabRT1bTr3fjA_3_4"></a><a id="Tc_lu3tc1SeqUmelciXhgdEAg_3_6"></a><a id="Tc_sNkAdYHYbEOSrB02pYRJbA_4_0"></a><a id="Tc_b9yv43tcoUqiHDy__9anLw_5_0"></a><a id="Tc_oIwOhRxLkkOnr8X37UCEtA_6_0"></a><a id="Tc_6oecSpjfJ0eN52cXYJKgLA_7_0"></a><a id="Tc_EOH9Wok9qEWuI9hBmxGABQ_8_0"></a><a id="Tc_FLQLiwND9kO4XDe30tSW8g_9_0"></a><a id="Tc_qyLmOn9r_keumEv8J50pgw_10_0"></a><a id="_6c905d6c_849d_4dc5_8f3e_f6308d71dfa0"></a><a id="Tc_CPHC_QOVn0u6Fid3dzGa1A_1_2"></a><a id="Tc_yg6wbqjUbUKXdKHYeGy9VA_2_2"></a><a id="Tc_11i0ZGo6k0699sIz82b9Xw_3_0"></a><a id="Tc_7M0QayDXVUm5QfxW9tzEnA_3_2"></a><a id="Tc_8R5wlicE6kOFz_8tQ1sCLA_3_4"></a><a id="Tc_z4NlziDZYkO7xu3RY5yZhA_3_6"></a><a id="Tc_Uy0D8j9V4UuOD-_rS48pqw_4_0"></a><a id="Tc_yov0lKlmPUSHavJpUuj7NQ_5_0"></a><a id="Tc_weN6MmaVV0a-vGPUCl72xw_6_0"></a><a id="Tc_If6Emk67zEKlmd2zyNlSSg_7_0"></a><a id="Tc_eszUIHsdtk6xZko6WmIfXA_8_0"></a><ix:continuation id="Tb_SD-XVkt9XUG0GQTxUaHzNg_cont2" continuedAt="Tb_SD-XVkt9XUG0GQTxUaHzNg_cont3"><ix:continuation id="Tb_cSy3P_Sd10ix4CiX8hG_WQ_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">A. Change in defined benefit obligation</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Defined benefit obligation as of January 1 </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_VqvB-19b-ky0XrrBCaxruQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc_9UJCcD_dUUuF-3C5-MWqOw_4_2">32,410</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_8zOs7UR4806DfHazcSGULA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc_pMx4je6pFk6QZ2R1YFc73Q_4_4">33,889</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_ncAHP2PXEEG29m0kCbCu1w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc_kFTkscGb2ESuWwWn0NXncg_4_6">30,213</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Current service cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_vEGhjd8tq0OSqur2Fe4jnA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_jc7BVsBi5UW4JPjVVehwWA_5_2">1,453</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_-rFc59jcN0aZx3IBH9mm7A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_ZEMqdEO6xEag21yshqEy8w_5_4">1,712</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_BeNb7Z3yiUS-lTANhWp0_g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_9FRLhbqj7EmboUZaRjPjMA_5_6">1,648</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Past service cost</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_vEGhjd8tq0OSqur2Fe4jnA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_uXcMORbExEilJbWDTnWNNQ_6_2">903</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_vEGhjd8tq0OSqur2Fe4jnA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_e6R8C6GWX0mdOrZYjaEHdg_7_2">804</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_-rFc59jcN0aZx3IBH9mm7A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_W2EckpyZw029Gr0tUSwU8Q_7_4">126</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_BeNb7Z3yiUS-lTANhWp0_g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_Ttp96B6cpEmpqZxgOgX3mw_7_6">79</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Change in demographic assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_vEGhjd8tq0OSqur2Fe4jnA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_nWatZh-ZIkqjWdmvPa0NoA_8_2">136</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_-rFc59jcN0aZx3IBH9mm7A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_l8TtXdqwOUKvIfy8AT_v1g_8_4">29</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_BeNb7Z3yiUS-lTANhWp0_g" decimals="-3" format="ixt:zerodash" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_PZFIe_VVAUKvCBStV3yTLQ_8_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Change in financial assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_vEGhjd8tq0OSqur2Fe4jnA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" sign="-" scale="3" id="Tc_8o8cEY-K_0KHoN2dg57ojA_9_2">2,908</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_-rFc59jcN0aZx3IBH9mm7A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_FULMdSe_D0-7PWQEDGwaJg_9_4">8,397</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_BeNb7Z3yiUS-lTANhWp0_g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_s9XVZIsNSkmyRjujCcDapg_9_6">156</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Change in experience assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_vEGhjd8tq0OSqur2Fe4jnA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" sign="-" scale="3" id="Tc_sekSSrqREEmOdc9NvhbprA_10_2">57</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_-rFc59jcN0aZx3IBH9mm7A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" sign="-" scale="3" id="Tc_dhE9AAjaHEGeRPgm7Irm-g_10_4">1,726</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_BeNb7Z3yiUS-lTANhWp0_g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" sign="-" scale="3" id="Tc_99QS5eW5QkOQYFP-j35BMw_10_6">252</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Benefits deposited </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_vEGhjd8tq0OSqur2Fe4jnA" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" scale="3" id="Tc_PJ-55GRShUW1I9YdOK1fxw_11_2">1,265</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_-rFc59jcN0aZx3IBH9mm7A" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" scale="3" id="Tc_kLH2z7xbBkmcK86Mu9E5aw_11_4">2,327</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_BeNb7Z3yiUS-lTANhWp0_g" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" scale="3" id="Tc_l2gNph9Epkq7qUz0I_i9YA_11_6">894</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employees&#8217; contributions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_vEGhjd8tq0OSqur2Fe4jnA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" sign="-" scale="3" id="Tc_FohUsvyCJUKaYqtVun5Qbg_12_2">1,396</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_-rFc59jcN0aZx3IBH9mm7A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" sign="-" scale="3" id="Tc_WJQls0gEzEuTYY4xDE_ehg_12_4">1,056</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_BeNb7Z3yiUS-lTANhWp0_g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" sign="-" scale="3" id="Tc_AS7Q3jWE30WxT1szgorxzg_12_6">959</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Defined benefit obligation as of December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_JjEtusAETU-e1_9QP3d1Ig" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc_W-PhQDkWwkmuOXDepwkC-w_13_2">41,060</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_VqvB-19b-ky0XrrBCaxruQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc_GU0TmoQn_0uS7m2orWlYDA_13_4">32,410</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_8zOs7UR4806DfHazcSGULA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc_1gOmK67jl0-CUXHH_JBbqg_13_6">33,889</ix:nonFraction>)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Change in fair value of plan assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair value of plan assets as of January 1 </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_WNkxs9Sy4kSxSAoCQwsxGw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" sign="-" scale="3" id="Tc__i75Ex4m6ECl4f87C6izYQ_4_2">29,197</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_lp_ntzhbq0OJga_mHVbrOw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" sign="-" scale="3" id="Tc__IWKEbJhTEyRHA56muWFXA_4_4">26,791</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_v1U_eyxTiEaM8eTayPpQkw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" sign="-" scale="3" id="Tc_2zKFxumbHkuYWmNkmZsFVQ_4_6">22,749</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_u2Lf31padU-hQMejGWu9Jg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" sign="-" scale="3" id="Tc_6_bbnPwdakiKQI31MkL7ZQ_5_2">705</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_JOULfIYynEyk9vA-N_O54Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" sign="-" scale="3" id="Tc_QzXrjmaUHE6l1AIFV0CRcA_5_4">87</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_NAuDi-J-j0OrVs4jx0zGUw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" sign="-" scale="3" id="Tc_X5YQt6I9LUmQJ8HcY3KcRQ_5_6">48</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employees&#8217; contributions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_u2Lf31padU-hQMejGWu9Jg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_4H_y4S6ycUeqj8a79Fjmfw_6_2">1,396</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_JOULfIYynEyk9vA-N_O54Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_agZTyb_yiEmQoq7naLyaKg_6_4">1,056</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_NAuDi-J-j0OrVs4jx0zGUw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_dJ7RT2HDQUerjIgrz1F5yw_6_6">959</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employer&#8217;s contributions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_u2Lf31padU-hQMejGWu9Jg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_Al_DxBS7nEKi-IEo9BZb8g_7_2">1,567</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_JOULfIYynEyk9vA-N_O54Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_xz4L-7LvUES0SCOeoidQ_A_7_4">1,210</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_NAuDi-J-j0OrVs4jx0zGUw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_xM5uB4WftUytB27ALI3UUA_7_6">1,089</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Benefits deposited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_u2Lf31padU-hQMejGWu9Jg" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" sign="-" scale="3" id="Tc_U87JFrORYUyab8toGOR4oA_8_2">1,265</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_JOULfIYynEyk9vA-N_O54Q" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" sign="-" scale="3" id="Tc_TvnVvpeP1kC3Z8c_Fp6SVg_8_4">2,327</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_NAuDi-J-j0OrVs4jx0zGUw" decimals="-3" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" sign="-" scale="3" id="Tc_s9VL3fm35U-9gSK65TafZA_8_6">894</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Return on plan assets excluding interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_u2Lf31padU-hQMejGWu9Jg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_n-5W5HQ_mUSGgx_fNY7LLw_9_2">1,160</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_JOULfIYynEyk9vA-N_O54Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" sign="-" scale="3" id="Tc_1bhwM6sZ4kacPVdqCCOerw_9_4">2,274</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_NAuDi-J-j0OrVs4jx0zGUw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_SErQXpAg8EaJLlgQkljF6w_9_6">1,052</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair value of plan assets as of December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_1XJ24mu0_k2BAymKVrDuJA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" sign="-" scale="3" id="Tc_JUupohq6jkGtvkuovIyhow_10_2">35,290</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_WNkxs9Sy4kSxSAoCQwsxGw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" sign="-" scale="3" id="Tc_M0f6Da7BjkqoHm2Cltj_Yg_10_4">29,197</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_lp_ntzhbq0OJga_mHVbrOw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" sign="-" scale="3" id="Tc_T4QqQHIdJkKgev53XmNkVQ_10_6">26,791</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Expected contributions by the employer to be paid to the post-employment benefit plans during the annual period beginning after the end of the reporting period amount to approximately CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan" scale="6" id="Narr_Kvbs9-NcDkeYmIR9mjpKPA">1.6</ix:nonFraction> million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Change in net defined benefit liability</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net defined benefit liabilities as of January 1 </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc_VZUvtm0scEiDHAjPTYdSSw_4_2">3,213</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc_iUnfAljRlkKEXuN_d7ymWQ_4_4">7,098</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2020_kISrj4aRVketNj-9seXAtQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc_8tEobPIq2U6ObErzhOK6tw_4_6">7,464</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Net pension cost through statement of income/(loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" scale="3" id="Tc_LREuZrdsuUevji7H26RJ2w_5_2">2,455</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" scale="3" id="Tc_FZNKzdJc-ESEMGKhD66J4w_5_4">1,751</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" scale="3" id="Tc_t14Z84JwtkyE2VqT81lTKw_5_6">1,679</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Remeasurement through other comprehensive income/(loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" sign="-" scale="3" id="Tc_OhnUeuyoXEGLt8wB_vTqlQ_6_2">1,669</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_9Ow-l3KqAUK5aUTnXoCg1A_6_4">4,426</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_JYgVW6kfSk2z4-ilDmd5fQ_6_6">956</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employer&#8217;s contribution </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_aqEB8ZTeiE-YGnx-pq0m4Q_7_2">1,567</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_GLMP_6AAwUOVo-Wo47sNig_7_4">1,210</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" scale="3" id="Tc_lTysNqnt8EOxrd6PqWkWeg_7_6">1,089</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net defined benefit liabilities as of December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc_aJzGcAh3-U-towRfGolrZA_8_2">5,770</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc_5Pv_CO2P10mropOooQmprQ_8_4">3,213</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" scale="3" id="Tc_D8Yg46OL40SuFwjWVVFc0w_8_6">7,098</ix:nonFraction></p></td></tr></table></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-35</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_d5b41c1a_39d1_4f8a_8171_7ebd0c352df4"></a><a id="Tc_vwnDTT801E-RdifjfJHgrw_1_2"></a><a id="Tc_G5LGARY0RUSenoBOL4iJOQ_2_2"></a><a id="Tc_F2IvkeUxw0miFb-IVWBGFA_3_0"></a><a id="Tc_pgu25yNNCU6ByFtoebop5g_3_2"></a><a id="Tc_4fPtlbTFEkGtVKHxBiSgiQ_3_4"></a><a id="Tc_lRqZjrVWskGjNOo00-f4ug_3_6"></a><a id="Tc_dK6r_MhMA0GR1sOi9GnoHQ_4_0"></a><a id="Tc_1BZf1B7wMUayUrxHMC1AKA_5_0"></a><a id="Tc_YOF7MqQN80-NztfCTXIlww_6_0"></a><a id="Tc_kqv_n_O400q3Kock0xVBIQ_7_0"></a><a id="Tc_C39pOYyUF0O1Xai7xO__-Q_8_0"></a><a id="_85f9a9cd_729c_4d85_a434_4c913cdcd59f"></a><a id="Tc_W-70sb2NoUiTfEPhHPJBNA_1_2"></a><a id="Tc_xkyVzKp0vkKXPFSnf1_JaA_2_2"></a><a id="Tc_c394xlFRGEqOF-i7SEvWAA_3_2"></a><a id="Tc_GMJ1VETYnUOjC-PaMIxUcw_3_4"></a><a id="Tc_x5VkEW5GeUqpIUxT250HPA_3_6"></a><a id="Tc_dFR9fGFhFEm45RF5a9zeNw_4_0"></a><a id="Tc_5SuB6Uvs7kyVO7KPfsJeqA_4_3"></a><a id="Tc_gsfDS1kwlkeDiSxOsALyKQ_4_5"></a><a id="Tc_X7h1OjGQikOiNQuoFrXzMg_4_7"></a><a id="Tc_2dTUGSzgxkaDyyU6pHV1gw_5_0"></a><a id="Tc_lFFl1XqM20a48041gXvAtg_5_3"></a><a id="Tc_v6sCNtZJAkKG2yb25zLQ0w_5_5"></a><a id="Tc_-f4nHVAPsEqCt2ZU7VDTYg_5_7"></a><a id="Tc_R4GcKCVk7kGmfdMzapS58Q_6_0"></a><a id="Tc_N2qp8Uy_kUq_6UPECoBCiQ_6_3"></a><a id="Tc_O9mYK-zTDU2exlRcpY7RTw_6_5"></a><a id="Tc_Wgi5l0EFhkCToqHVP9rSXw_6_7"></a><a id="Tc_ZuoeEUmLj0amyeA_H9iYdA_7_0"></a><a id="Tc_Sb5XHrQC7UWYP3KY-s7zeA_7_3"></a><a id="Tc_N03NMPhh6EyiqzbEywmvYA_7_5"></a><a id="Tc_WAcWTH7BikSs6KjVGnrF4Q_7_7"></a><a id="Tc_DGNolbImfUikrxRv-1xBrw_8_0"></a><a id="Tc_bbX3FjvLQ0iDlbBAs73MPg_8_2"></a><a id="Tc_YUjaKsrqwUG2fYmFbdVGSQ_8_4"></a><a id="Tc_TQH2d3DR306DczWQQm6vOg_8_6"></a><a id="_bbb3d597_2f4d_4d60_a549_3c701b818360"></a><a id="Tc_y_4D83ZNq02HJw-OVWvlng_1_14"></a><a id="Tc_GbLiSFUwbkqbNDxbkosWOQ_2_2"></a><a id="Tc_1_aJyoUOj06e2wslacSd0g_2_6"></a><a id="Tc_CxwO73M130irI5nJDjliKw_2_10"></a><a id="Tc_LVw6DZ9EHEyInbxAWnhy3g_2_14"></a><a id="Tc_eXa-l6Kzw0iXTeNakyDk8Q_4_0"></a><a id="Tc_t8qSP37UhUeZh-Bdze5tSQ_4_2"></a><a id="Tc_N7fyEBxbW0CQC9vGmEZStw_4_4"></a><a id="Tc_dECdoMuh4UCVsjEBL5uCJA_4_6"></a><a id="Tc_E3gZQq7rJkC_fl3yF5346A_4_8"></a><a id="Tc_XwVRQxE4hUq7T3K131ZOig_4_10"></a><a id="Tc_ziCG9q8hOUm7ilxjtF6OoQ_4_12"></a><a id="Tc_fccDOqluDEGdAIBCnTNCKg_4_14"></a><a id="Tc_MF6M3NJfUEan-EV5Z2FXIg_4_16"></a><a id="Tc_jmvdOcg0oE-87ZJhaVD5fQ_5_2"></a><a id="Tc_lgAzXxH-okizDKzREfY7hQ_6_0"></a><a id="Tc_DjDiKs9goUOiq1uo_5kNJA_7_0"></a><ix:continuation id="Tb_SD-XVkt9XUG0GQTxUaHzNg_cont3" continuedAt="Tb_SD-XVkt9XUG0GQTxUaHzNg_cont4"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock" id="Tb_Tl1BgA-X9UKGibLxf2wWuw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Other comprehensive gains/(losses)</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of changes in demographic assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" scale="3" id="Tc_r3xAFZOL-0SGbmldxK5s7w_4_2">136</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" scale="3" id="Tc_RpYe4Cd130mlyT5eHWnU_Q_4_4">29</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:zerodash" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" scale="3" id="Tc_fxeNG6Qk5USkkeOfmO2UtQ_4_6">&#8212;</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of changes in financial assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" sign="-" scale="3" id="Tc_qY9sRc2dLk2a5x1Toy-IBw_5_2">2,908</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" scale="3" id="Tc_cVueCX75_kGyaanDPw9W4Q_5_4">8,397</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" scale="3" id="Tc__FH8C1ZLR0-xPx_2kLEyQA_5_6">156</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of changes in experience assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" sign="-" scale="3" id="Tc_bQCM2Ew7skKo672UXl8VsA_6_2">57</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" sign="-" scale="3" id="Tc_yOzY8SDnOUiwZ5-G21NPsg_6_4">1,726</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" sign="-" scale="3" id="Tc_UiGmBBP_K0mv73HuztFcEg_6_6">252</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Return on plan assets excluding interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans" scale="3" id="Tc_Bc3zMn905kagoXDsBzLZIQ_7_2">1,160</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans" sign="-" scale="3" id="Tc_nhpz3opD-0-PwM7-PtaRkA_7_4">2,274</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans" scale="3" id="Tc_jQv04Mounk-tEUR9U4I4Aw_7_6">1,052</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total other comprehensive gain/(loss)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" sign="-" scale="3" id="Tc_sYXwWTfj6kSOTLGbmcdpMg_8_2">1,669</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="Tc_MGKtTf5smEiaRYoz1as_hQ_8_4">4,426</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="Tc_LEoEhReE5kOjcMuzNRworQ_8_6">956</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In 2022, the change in experience assumptions results from an increased sum of insured salaries.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The fair value of the plan assets is the cash surrender value of the insurance with the insurance company (AXA). The investment strategy defined by the board of trustees follows a conservative profile.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The plan assets are primarily held within instruments with quoted market prices in an active market, with the exception of real estate and mortgages.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The weighted-average duration of the defined benefit obligation is <ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" id="Narr_ZFX2pWnfG0CrA4dTsRVLfA">15.5</ix:nonNumeric>&#160;years and <ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" id="Narr_nmUOCaBH8kC13SKg3fan-g">14.9</ix:nonNumeric>&#160;years as of December&#160;31, 2023 and 2022, respectively.</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" id="Group_PCsCG1bA0EGglTrD9KqjyA" continuedAt="Group_PCsCG1bA0EGglTrD9KqjyA_2" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The actuarial assumptions used for the calculation of the pension cost and the defined benefit obligation of the defined benefit pension plan for the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively, are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:52.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:52.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:44.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Discount rate </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="Tc_JmKKEFSuhUWCGq1anXQOzg_4_2">1.50</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="Tc_O2_tlSwMEkSDk2geWaaDOQ_4_4">2.25</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="Tc_NCN6i1LFGkiPWbD7zX5otQ_4_6">0.30</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Rate of future increase in compensations </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" scale="-2" id="Tc_QGUz2df4UUWkcL8Y6X9ahg_5_2">1.75</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" scale="-2" id="Tc_R0dzhcFPC0KX3L1rc8w02Q_5_4">1.75</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" scale="-2" id="Tc_cJxzbVdtrEONTDy0Os7nVQ_5_6">1.75</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:44.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Rate of future increase in current pensions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" scale="-2" id="Tc_t2Z9Ae0XQEKAqh3CvqU70A_6_2">0.00</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" scale="-2" id="Tc_nAg__9-8DUSlsO7hYBC6vw_6_4">0.00</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="4" format="ixt:numdotdecimal" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases" scale="-2" id="Tc_bxdqE-csfU22gnW50KYJIw_6_6">0.00</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest rate on retirement savings capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="4" format="ixt:numdotdecimal" name="aciu:ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" scale="-2" id="Tc_ksaaVO26wEeiuaW05D6pOA_7_2">1.50</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="4" format="ixt:numdotdecimal" name="aciu:ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" scale="-2" id="Tc_qdaUrBSIVkehjRZmkbMSHA_7_4">2.25</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="4" format="ixt:numdotdecimal" name="aciu:ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" scale="-2" id="Tc_SViwxF5BzEuLa5g-IdmaNg_7_6">0.75</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:44.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Mortality and disability rates </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">BVG 2020 GT (CMI)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">BVG 2020-CMI</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">BVG 2020-CMI</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In defining the benefits, the minimum requirements of the Swiss BVG and its implementing provisions must be observed. The BVG defines the minimum pensionable salary and the minimum retirement credits.</p><ix:continuation id="Group_PCsCG1bA0EGglTrD9KqjyA_2" continuedAt="Group_PCsCG1bA0EGglTrD9KqjyA_3"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">A quantitative sensitivity analysis for significant assumptions as of December&#160;31, 2023 is shown below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Interest&#160;rate&#160;on</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Discount&#160;rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;salary&#160;increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;pension&#160;cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">savings&#160;capital</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_pTeQuKx_DkypZ9jWGI7C8A" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Tc_dyepyaCC-EqDGldJohFVsw_3_2">0.5</ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2023_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_AlsPMZbssk6ZJn1U2wtykg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Narr_GHGEibaYJ0WG0y0H4HRwFA"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_5DSHt4xHMUioT5NnjVwFog" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Tc_sMK5e37SdEmS5DQbJ7XqHA_3_4">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2023_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Bpznvb8IJkGFAZJKePilRQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Narr_AIoaz07IDk-hnSPRIt0ByA"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Wgnl3QSM2k-AdkHzUwxq5w" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Tc_pQyIBujgSk2RHQW3UO6VYA_3_6">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2023_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_AlsPMZbssk6ZJn1U2wtykg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Narr_sp9Np68QDE274ELdTho4vg"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_8n56hl5TbUu6RGNb82sfRQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Tc_ay8IH11A00mDvzHu3AKBQg_3_8">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2023_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Bpznvb8IJkGFAZJKePilRQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Narr_IQQ8W79My0Gz2eRU54g3CA"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_L9p_QHOSw06twWSsiEgdWA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Tc_o9P4mT4EFkKKmf1brLyEsQ_3_10">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2023_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_AlsPMZbssk6ZJn1U2wtykg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Narr_mt550t3fZ0SRO53UptnwLA"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_pm-qrsouoE6flbV62qtS-Q" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Tc_T5yXCqVXPk2nQkgOozz5sA_3_12">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2023_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Bpznvb8IJkGFAZJKePilRQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Narr_j2GWIzGNOkGf1Qbf3O6qKg"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_iSoz2SOpp0qMTfUmXq481w" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Tc_XOwt0yw2uE2TnzB3hF_INw_3_14">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2023_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_AlsPMZbssk6ZJn1U2wtykg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Narr_iExxwUkKGkSr-R6mHXnVXg"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_SYvFKt1x10y-adlxxUg4jg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Tc_OCj5nEgQKEahqT6GnZdh8g_3_16">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assumptions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="17" style="padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:68.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In&#160;CHF&#160;thousands</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Potential defined benefit obligation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_pTeQuKx_DkypZ9jWGI7C8A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_LOk5mYAALESooAIuPNcryQ_6_2">38,132</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_5DSHt4xHMUioT5NnjVwFog" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_M6RQXvrd9kqoK7uQ7Kiwnw_6_4">44,390</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Wgnl3QSM2k-AdkHzUwxq5w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_sdbJPboknEiH6d45zddbDQ_6_6">41,997</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_8n56hl5TbUu6RGNb82sfRQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_XKcX7sq9fEuIkPNUsWDCdg_6_8">40,205</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_L9p_QHOSw06twWSsiEgdWA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_SI3luqPB_Ua5AUTgTMuEow_6_10">42,681</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_pm-qrsouoE6flbV62qtS-Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_V-M7BQHG_UuAiiTSyLpkOg_6_12">39,578</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_iSoz2SOpp0qMTfUmXq481w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_ACDAjXaVgkqdSZLF8Rxy4Q_6_14">42,158</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_SYvFKt1x10y-adlxxUg4jg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_N23A6WYloUWdKNMT4UyyoA_6_16">40,030</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Decrease/(increase) from actual defined benefit obligation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_pTeQuKx_DkypZ9jWGI7C8A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" sign="-" scale="3" id="Tc_qtbY4R1SnEeRUdaoFdFNZQ_7_2">2,928</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_5DSHt4xHMUioT5NnjVwFog" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="3" id="Tc_j6aue2hbJ0y2T11pkZV-cQ_7_4">3,330</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Wgnl3QSM2k-AdkHzUwxq5w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="Tc_wZ3Q1i5NpUuYrJEInwpZTw_7_6">937</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_8n56hl5TbUu6RGNb82sfRQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" sign="-" scale="3" id="Tc_aM3Pe3pisk6gD5_HKqMREQ_7_8">855</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_L9p_QHOSw06twWSsiEgdWA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="Tc_wEsMkwYrBkS8Wtv_0vApiw_7_10">1,621</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_pm-qrsouoE6flbV62qtS-Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" sign="-" scale="3" id="Tc_QD9rQi5G4kqjod3p4tU8yA_7_12">1,482</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_iSoz2SOpp0qMTfUmXq481w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="Tc_x0tWYBCBfEu9M6mLN3bM7Q_7_14">1,098</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_SYvFKt1x10y-adlxxUg4jg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" sign="-" scale="3" id="Tc_rHP_y08qN0yM9SMg6jlBbA_7_16">1,030</ix:nonFraction></p></td></tr></table></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-36</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_028c189a_2265_4330_b4dd_7ed064599e91"></a><a id="Tc_1tl3SO3y2ky-l6U7wCQ53w_1_14"></a><a id="Tc_AbJXxyT8_EWKWlg4qeEX9g_2_2"></a><a id="Tc_IVO3mgXXRk6WaOBWLE_cUg_2_6"></a><a id="Tc_EfC6NI-Qt02V_bbqgb4CCg_2_10"></a><a id="Tc_m3ARmtZ8AEu4VrZPvDBGnA_2_14"></a><a id="Tc_-Cd22wpuu02hsNiUeU9JDA_4_0"></a><a id="Tc_7eRykKGbTUOWXsdYd3ITPA_4_2"></a><a id="Tc_16oNh0mBj0SpIy38L38Ffg_4_4"></a><a id="Tc_XVxQBZ2ZgEu5n9LvpUJGzQ_4_6"></a><a id="Tc_puIHbxFlk0u4HzVFY8qudA_4_8"></a><a id="Tc_FdSGpqH7BEeXUA9ui1Itcw_4_10"></a><a id="Tc_5i3nzsXHM0CzxcE9fXNW5w_4_12"></a><a id="Tc_rvMe_ZHItUSiUJpJ5C3uNg_4_14"></a><a id="Tc_ErsKWHDukUa_eDW5frjKGQ_4_16"></a><a id="Tc_YnBxEZGaeEWSOZqJ5v4Fpw_5_2"></a><a id="Tc_T7Xs-l6_60WFBHbhuyQQWg_6_0"></a><a id="Tc_P4DGP6EA9Uu5LYxNArm-Xg_7_0"></a><ix:continuation id="Tb_SD-XVkt9XUG0GQTxUaHzNg_cont4"><ix:continuation id="Group_PCsCG1bA0EGglTrD9KqjyA_3"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">A quantitative sensitivity analysis for significant assumptions as of December&#160;31, 2022 is shown below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Interest&#160;rate&#160;on</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Discount&#160;rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;salary&#160;increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;pension&#160;cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">savings&#160;capital</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_qq5UY0wRK0iOGrB4wG2l3A" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Narr_Fhg4f3REG0CQVyb5Ln-mUQ"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_9z7dk_eBH0qm1qbNW_X2xQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Tc_iT5oKHOd9USm7oBWkeCjjA_3_2">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_k-R7euyY30qLrbKzofgXgw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Narr_IoMufbagt0Oi0jKqp1L0MA"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_UfDNPUrGmUWnzu7Kv8E6RQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Tc_e7dk8l3gtEioXeTfihnY_Q_3_4">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_qq5UY0wRK0iOGrB4wG2l3A" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Narr_PUpUoUGYKEaj2--YWdEiyg"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_982Pjk152UCG0tmlUgcu9w" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Tc_PhuMQ8_XgkiF2RendVnQBQ_3_6">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_k-R7euyY30qLrbKzofgXgw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Narr_EKWstZUQh0OqqCLO3JTszA"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_1VZZ1KUX8k2zfVZBeU_XRA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Tc_nw4yA4J_QUuvmsdeVdCm2A_3_8">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_qq5UY0wRK0iOGrB4wG2l3A" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Narr_P4hfwMptjUCiBElRYxqRsw"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Z7UvVqXOEUmoT9JRq5CiYA" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Tc_H3EeKtvu1k2ANHTL4WrQKQ_3_10">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_k-R7euyY30qLrbKzofgXgw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Narr_uzV7byXth0CGNWtiHqrPMA"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_Vku2j2aw2USeLFl-mDb8ow" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Tc_x260BT4y6Ue0zYXCr6rR-A_3_12">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_qq5UY0wRK0iOGrB4wG2l3A" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Narr_Mtk7dHVQtUKP79D1aini_g"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_fdq-KvKHrE64gHajV_F_bQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-2" id="Tc_Uy0VXNSczES8Y5Ie31Tdnw_3_14">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_k-R7euyY30qLrbKzofgXgw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Narr_C45W52SIJUCJmVr7YuwCoQ"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_FSXKfZmS80elUOwthR4Uxw" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-2" id="Tc_lMHUkuQjvU-mCCs3vjP7sg_3_16">0.5</ix:nonFraction></ix:nonFraction>%</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assumptions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="17" style="padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:68.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in&#160;CHF&#160;thousands</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Potential defined benefit obligation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_9z7dk_eBH0qm1qbNW_X2xQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_ZXb067J8f0SsOxfH5og52Q_6_2">30,201</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_UfDNPUrGmUWnzu7Kv8E6RQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_axYPdwuZNU2SBGanowkx6g_6_4">34,916</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_982Pjk152UCG0tmlUgcu9w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_RprlaC-iT0yEYyGwIbaqjg_6_6">32,940</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_1VZZ1KUX8k2zfVZBeU_XRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_uuevBtmJCUmDaBZDMv0P7Q_6_8">31,841</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Z7UvVqXOEUmoT9JRq5CiYA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_WIC45Ot-IEKZTsoDsSrUDg_6_10">33,601</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_Vku2j2aw2USeLFl-mDb8ow" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_6AuwZ6lLv0ij_mBRofwg0w_6_12">31,322</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_fdq-KvKHrE64gHajV_F_bQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_xkEm29NN7Eil6sYa_foYRg_6_14">33,322</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_FSXKfZmS80elUOwthR4Uxw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="Tc_i59kPyKrOUOCk0VXOZaJRw_6_16">31,545</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Decrease/(increase) from actual defined benefit obligation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_9z7dk_eBH0qm1qbNW_X2xQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" sign="-" scale="3" id="Tc_zxBYLn71R0O96I13xdxgUg_7_2">2,209</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_UfDNPUrGmUWnzu7Kv8E6RQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="3" id="Tc_FDK3v7b5DkGrMqckpGB3wA_7_4">2,506</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_982Pjk152UCG0tmlUgcu9w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="Tc_X-8r1Pk7aECpmuCH1A0Rqg_7_6">530</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_1VZZ1KUX8k2zfVZBeU_XRA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" sign="-" scale="3" id="Tc_iVlDB3KGwkiikAK-5Qk-GA_7_8">569</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Z7UvVqXOEUmoT9JRq5CiYA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="Tc_QO6QPKjX10q-ktmwJ8tEzQ_7_10">1,191</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_Vku2j2aw2USeLFl-mDb8ow" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" sign="-" scale="3" id="Tc_6vHF45ey3E6atB2uZSdMEw_7_12">1,088</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_fdq-KvKHrE64gHajV_F_bQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="Tc_t7aMSadb0UeayODWaB8A2g_7_14">912</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_FSXKfZmS80elUOwthR4Uxw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" sign="-" scale="3" id="Tc_fKbfM5pVFUyhEgK6JyDDnA_7_16">865</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The sensitivity analyses above are subject to limitations and have been determined based on a method that extrapolates the impact on net defined benefit obligation as a result of reasonable changes in key assumptions occurring at the end of the reporting period.</p></ix:continuation><a id="_03b26153_e976_46ab_88dd_4af9b936df64"></a><a id="Tc_AAIzGmrKz0y8PAvbKBSXDQ_1_2"></a><a id="Tc_7YS8V2UiR0-mKk_Q2k-ybw_2_2"></a><a id="Tc_DWNj7ooP3E2UxNeUOeyQNA_2_6"></a><a id="Tc_awdfdeI9aES2BHkTMut5zw_3_0"></a><a id="Tc_wpugjLzYAkm1EhcIpadT1g_3_2"></a><a id="Tc_Fmd6I2xIikuf-a8LfCLJig_3_4"></a><a id="Tc_SSWCEyM6XUiUSSxyQIxMyQ_3_6"></a><a id="Tc_9z9i-HHgI0GX5-b02iutZQ_4_0"></a><a id="Tc_xmMGlns9a06FGSuKzEFIZw_4_4"></a><a id="Tc_kl2QpfVECU6PnBQYbYDLtg_5_0"></a><a id="Tc_8DmU2v2aBE6rJsOZefrTeg_6_0"></a><a id="Tc_FAAcT_XouEWho71kHCpNqg_6_4"></a><a id="Tc__xDJR1vG9kaQAAwFWZVjQA_7_0"></a><a id="Tc_Oyotntil60Wd7K6wuixTyg_7_4"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory" id="Tb_cQZp6FwNWUmVOzNSgPLPrw" continuedAt="Tb_cQZp6FwNWUmVOzNSgPLPrw_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">19.</b></span>Share-based compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Share-based option awards</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2023, there are equity-based instruments outstanding that the Company has granted under <ix:nonFraction unitRef="Unit_Standard_plan_aEIYineoxU60B5qoFDN6Ig" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfEquityBasedInstrumentPlans" scale="0" id="Narr_e_XjTef-WEamUrGWH9PQQg">two</ix:nonFraction> different plans.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s 2016 Share Option and Incentive Plan (SOIP) was approved by the shareholders at the ordinary shareholders&#8217; meeting in November&#160;2016. The 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights. The Company only grants equity-based instruments from the SOIP as of December&#160;31, 2023.</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" id="Tb_0TKmS9FokUGK-fOSdyEPEw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table summarizes equity-settled share option grants for plans that existed during the period:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">options&#160;awarded</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractual</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Plan</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(since&#160;inception)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vesting&#160;conditions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">life&#160;of&#160;options</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share option plan C1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="Duration_11_1_2016_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_StockOptionPlanC1Member_FrVjSQB1UkeUeoCfQYkO8Q" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Tc_w5K4j8Rq8kCK-UB3CAt-cw_4_2">6,775,250</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_StockOptionPlanC1Member_-sFGqj5mB02y1Y2vj-EJCg" format="ixt-sec:durwordsen" name="aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" id="Narr_6iH0tvgzHESRNukH1GR2Cg"><span style="font-size:10pt;">4 years</span></ix:nonNumeric><span style="font-size:10pt;">&#8217; service from grant date</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_StockOptionPlanC1Member_-sFGqj5mB02y1Y2vj-EJCg" format="ixt-sec:durwordsen" name="aciu:MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" id="Tc_l6a7jFdepUKGVYuiKrsKrQ_4_6"><span style="font-size:10pt;">10 years</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">2016 SOIP:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:top;width:39.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Executives and directors</p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="Duration_11_1_2016_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_bPPz5P3NMUuhICp34QnZTQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Tc_QvirM0rt8kWBvzbz-j4K5g_6_2">4,831,325</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;width:26.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember_li18Qm89cUyqRwPnUzHoyQ" format="ixt-sec:durwordsen" name="aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" id="Narr_1xC6dHLvh0a6rdxPbUeTWA"><span style="font-size:10pt;">1 year</span></ix:nonNumeric><span style="font-size:10pt;">, </span><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember_vo7YKlf8sk2Zu9M-P0T-9A" format="ixt-sec:durwordsen" name="aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" id="Narr_OIHyyWkcPkOKZW7NxM42Sg"><span style="font-size:10pt;">3 year</span></ix:nonNumeric><span style="font-size:10pt;"> and </span><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember_nRoCAsTLTkuEeahglu5EzQ" format="ixt-sec:durwordsen" name="aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" id="Narr_2KrXz4iIXkKIgvvxzDg9DQ"><span style="font-size:10pt;">4 years</span></ix:nonNumeric><span style="font-size:10pt;">&#8217; service from the date of grant, quarterly and annually</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:16.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_wf3hN50uXkG2UnV3ktGKUw" format="ixt-sec:durwordsen" name="aciu:MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" id="Tc_QhJBRUA8fECe79eJcYXumg_6_6"><span style="font-size:10pt;">10 years</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:39.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employees</p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="Duration_11_1_2016_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_5cV-aWe_h0Wf6H9bD9joXg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Tc_VE7w7AIYDEyFA8KefpWh9w_7_2">1,811,687</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_L33vJ60m_km7tdKwdLwwQQ" format="ixt-sec:durwordsen" name="aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" id="Narr_r7TgKxSp10KtQO-chi2xtg"><span style="font-size:10pt;">4 years</span></ix:nonNumeric><span style="font-size:10pt;">&#8217; service from the date of grant, annually</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_L33vJ60m_km7tdKwdLwwQQ" format="ixt-sec:durwordsen" name="aciu:MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" id="Tc_EA6lQL6w2kKqbOd52IzOaw_7_6"><span style="font-size:10pt;">10 years</span></ix:nonNumeric></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-37</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_45d65cc2_ddc0_4902_bad6_0b2690679c76"></a><a id="Tc_RW2-_whHx0i1McYuj4Y36Q_1_4"></a><a id="Tc_JVzobK7jd0iBMg3e_FqMdg_1_6"></a><a id="Tc_vJwe4A4A2EGtGKUe6Xo6tA_2_4"></a><a id="Tc_o3-EmnMU5E-4Y_pwvwkQmw_2_6"></a><a id="Tc_lkJDKIAOiEejjImPYSRbOA_3_2"></a><a id="Tc_3f-p2y2qBkGVcIJjkCa3jw_3_4"></a><a id="Tc_5jF_JGP9nEKp-XYjvJlicQ_3_6"></a><a id="Tc__6rr_NN5Q0ixUulp5Jb97w_4_2"></a><a id="Tc_Y32mxRJz90C6JbitCTTjlg_4_4"></a><a id="Tc_BbaX-0VbOEi6jzcZSvGGDQ_4_6"></a><a id="Tc_W4eZTVN_8kurV7MbDbx04w_5_0"></a><a id="Tc_o-V5RwdWVEu4p3sNinsALA_6_0"></a><a id="Tc_GooO_lraAECm6FYw4BLnJg_6_6"></a><a id="Tc_DxoEHA4enUiuQ5UogpLYcw_7_0"></a><a id="Tc_f8AbPmD27ESlSLmmvs4CKQ_7_6"></a><a id="Tc_NPYcmbOjxEeIcEcbjbowxw_8_0"></a><a id="Tc_lvPTA7pWAkW_paH0MbP2gw_8_6"></a><a id="Tc_rG0pg3PwzUqLFDuvPqpf6A_9_0"></a><a id="Tc_uQlZXnepWEiQBCHdCr9ITg_10_0"></a><a id="Tc_lfd_hd3o0UKzfZ5EYPM4wg_11_0"></a><a id="Tc_9xSBkfJ3v0Oe8aQVfUv90w_12_0"></a><a id="Tc_rF8ZII7icECsFo3YpEyX3g_12_6"></a><a id="Tc_QMpwwmqg20CN_Fr1DyGNiA_13_0"></a><a id="Tc_gO4NHVz8gEmiDml7zPLGSA_13_6"></a><a id="Tc_uqEZo7y2FkijNnmZCmO2Yw_14_0"></a><a id="Tc_VIsY_5TqzkeCMw9mGh7AqQ_14_6"></a><a id="Tc_xsTghqc66E2SJ-RVmnRo7Q_15_0"></a><a id="Tc_Kif3q3qAIk2c1WOdnIdiZQ_16_0"></a><a id="Tc_rj5BHaBmm0ehili2xEnMPw_17_0"></a><a id="Tc_T2z2ttoxwkSML6GYBSzotQ_18_0"></a><a id="Tc_8cIgwIAoi0OH1MMURVWn2A_18_6"></a><a id="Tc_t50bSr92k0uynrakoHBRow_19_0"></a><a id="Tc_p3qFVHcylE-BH7jH-A3JCA_19_6"></a><a id="Tc_vjqthwlsNU-g6cFXSeaeYw_20_0"></a><a id="Tc_7y8mby-xyUiaD2HjKBCLNw_20_6"></a><a id="Tc_TT_JwoX960yvsJVdbfimBg_21_0"></a><a id="Tc__tMOqco3LUSwgGHWnZIsrA_22_0"></a><a id="_666dc2df_ae13_453f_a9e2_11a39bae7c80"></a><a id="Tc_XWvMBLFpEkSBHvR9WiVFNg_1_4"></a><a id="Tc_PEVvzJo_jEeulh65tYzL6g_2_4"></a><a id="Tc_9ePeTatOvE6x68JDg7Yw2A_3_2"></a><a id="Tc_MkgUvzMc-EC4yShru-ldeg_3_4"></a><a id="Tc_IFms8iKR2keLgx26-PBLBA_4_0"></a><a id="Tc_utFC8Z4M5kiqiqPx39QNig_5_0"></a><a id="Tc_C19YHLhMT0GsOE-9-ehnuw_5_4"></a><a id="Tc_Wb8iiYfLU0aIYHbTJyviWw_6_0"></a><a id="Tc_kUw8EsVx8UWBp3uKGvBKiQ_6_4"></a><a id="Tc_pixmIi6sUEC3SonzxgSW7g_7_0"></a><a id="Tc_vNAGOwr8YEmOghSx1h7plg_7_4"></a><a id="Tc_Bxg-wTQQI0GFeKV6TeHtOg_8_0"></a><a id="Tc_SRayUulpkUajujMInaaRYQ_8_4"></a><a id="Tc_xI4b6Yr8jkulEeiuqZb03A_9_0"></a><a id="Tc_CVEe1GjrYkCH2m14i3rmNQ_9_4"></a><a id="Tc_xCv3upyqAk-zd38IP2d0Nw_10_0"></a><ix:continuation id="Tb_cQZp6FwNWUmVOzNSgPLPrw_cont1" continuedAt="Tb_cQZp6FwNWUmVOzNSgPLPrw_cont2"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" id="Tb_waslBDuVcUutIdeUy1QcVA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The number and weighted-average exercise prices (in CHF) of options under the share option programs for Plans C1 and the 2016 SOIP are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted-</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted-</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">average</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">exercise&#160;price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">remaining</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(CHF)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">term&#160;(years)</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="As_Of_12_31_2020_kISrj4aRVketNj-9seXAtQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_JPn6s21L0Uu_vUtnWDAPGQ_5_2">2,900,667</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="As_Of_12_31_2020_kISrj4aRVketNj-9seXAtQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="Tc_d6AtGJ9icEerceQL5vLX3A_5_4">5.90</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2020_To_12_31_2020_ohLEZMTSR0Cbq8KqJ4eLSg" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" id="Tc_x1JGN1O-3EqdnDumMfP-zA_5_6"><span style="font-size:10pt;"> 8.2</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" scale="0" id="Tc_43e5ePvxuE-FdXRXKs9ygg_6_2">207,331</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" scale="0" id="Tc_AK1rBd5Ga02aTlhdutAAAw_6_4">6.13</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" scale="0" id="Tc_CTKBvQb530GLrWKiPOcpSg_7_2">218,561</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" id="Tc_ZrYLokthBkeRbrw2kYonSQ_7_4">4.97</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Tc_r1F166wwMk2GVliZbT-ZKw_8_2">1,110,914</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Tc_QrUBnndGC02p1M9fIp7ELw_8_4">6.34</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December&#160;31,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_CKZJoiky802tc0clEczeDQ_9_2">3,585,689</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="Tc_owiA4_lHoU6dgG9ujr_sGw_9_4">6.21</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" id="Tc_My1_pRW5_0iSpQIjmQ3hiQ_9_6"><span style="font-size:10pt;"> 7.8</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" scale="0" id="Tc_e0hmxa2A70OglhtudGBUQQ_10_2">1,613,242</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="Tc_HlXnZv74EEKfVa1v6EjthQ_10_4">6.13</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" format="ixt-sec:duryear" name="aciu:WeightedAverageRemainingContractualLifeOfShareOptionsExercisable" id="Tc_o9zGcj3jE0GBQRSDtz0ffw_10_6"><span style="font-size:10pt;"> 6.8</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_qDuTq4d0FUetnq9Lt1IP6A_11_2">3,585,689</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="Tc_6uqyycddvU2GLcVrKom2PA_11_4">6.21</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" id="Tc_-R4F-RT8jEOW_q6aOIeDeQ_11_6"><span style="font-size:10pt;"> 7.8</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" scale="0" id="Tc_az5C9scxdkaYS6yTNPh5vA_12_2">304,738</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" scale="0" id="Tc_5bM4tHuDz0atePQnAEbm-Q_12_4">6.32</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" scale="0" id="Tc_IIP89khAP0yqnNWeA3HCqg_13_2">110,250</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" id="Tc_U96gnPce4EaZmJCjYXDiAQ_13_4">0.15</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Tc_hs4OUG1r2Ummeh07VXk9BQ_14_2">1,090,316</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Tc_V5PNraCBKUmDJkBIp7vX_A_14_4">3.18</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December&#160;31,&#160;2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_J78dNXyCqE-ZMtxLJuUnAQ_15_2">4,261,017</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="Tc_uN-JxyUdyUqgkdTKzYvB1Q_15_4">5.65</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" id="Tc_OzMKbsMGG0StBMJclhGxEQ_15_6"><span style="font-size:10pt;"> 7.6</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" scale="0" id="Tc_1xooaeWFeUi1whF_KLrLeg_16_2">2,345,648</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#ff0000;font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="Tc_kfpQIUcMiUOGWeB59fsKfw_16_4">6.41</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" format="ixt-sec:duryear" name="aciu:WeightedAverageRemainingContractualLifeOfShareOptionsExercisable" id="Tc_uxye7Kz8UEKOk8Lt9f0vhw_16_6"><span style="font-size:10pt;"> 6.6</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_Ae_zvdAPVkSPZ2OuGmb-wQ_17_2">4,261,017</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="Tc_HshaC8NCZU2gAUl63O-RXg_17_4">5.65</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" id="Tc_XET25zq6OkSNh4242OhVVw_17_6"><span style="font-size:10pt;"> 7.6</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" scale="0" id="Tc_I7NT1O8I3EigGuEoxmEtkw_18_2">824,084</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" scale="0" id="Tc_wIcOrwOc0EG48WwxzY2ytw_18_4">5.34</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" scale="0" id="Tc_dNQmUqWPdkyGQgSnsPfedQ_19_2">42,037</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" id="Tc_nrVMH3s-CUWAEVBIcPd3oQ_19_4">1.52</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" id="Tc_wWvi4pZxgUOLL2RHpIpXTw_20_2">1,554,281</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Tc_gyH20Eoe10OJdSOXeCIKiw_20_4">1.75</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December&#160;31,&#160;2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_xKWfjaottEGvs48K_SxGXg_21_2">4,949,177</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="Tc_icdsfYuMLEuOtjjkCRIY2g_21_4">4.11</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" format="ixt-sec:duryear" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" id="Tc_WcptmSj8Yk2TIUYymJcm_w_21_6"><span style="font-size:10pt;"> 7.2</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable at December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" scale="0" id="Tc_2CCLcA7f9UC3LZjXLSxtPQ_22_2">3,022,345</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="Tc_JYw1yzwbeEGS7hkhClBWCg_22_4">4.88</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" format="ixt-sec:duryear" name="aciu:WeightedAverageRemainingContractualLifeOfShareOptionsExercisable" id="Tc_UvY__VhGZE6GnMrToKs8Jw_22_6"><span style="font-size:10pt;"> 6.4</span></ix:nonNumeric></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" id="Tb_mDGDuhKCJU6qdL-PEPOCdw" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The outstanding stock options as of December&#160;31, 2023 have the following range of exercise prices:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Range&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">expiration</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total&#160;options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">dates</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Range of exercise prices</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">CHF 0.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="As_Of_12_31_2023_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Chf0.15Member_bCuGS8xth02AS1EG44_CZw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_XlS6OyLb60-s8GT7CuC9fw_5_2">92,875</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2024&#8211;2026</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">CHF 9.53</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="As_Of_12_31_2023_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Chf9.53Member_QyUb_OU0dUmrWfmJfQRjJA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_RZ1dWW0SVUuUj8BHojp8qA_6_2">109,665</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2027</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD 5.04 to USD 12.30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="As_Of_12_31_2023_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Usd5.04ToUsd12.30Member_aFkOCQ_l5E2NLCrRmzt_fg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_7IaOWn56aEqdxDKTAYvrrA_7_2">2,417,545</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2027&#8211;2031</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD 2.76 to USD 4.57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="As_Of_12_31_2023_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Usd2.76ToUsd4.57Member_ei0vM12DHU2YvZXAIwnk_A" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_KkdCfOHfmUCSXvn73Q3FwQ_8_2">1,034,326</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2032&#8211;2033</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD 2.03 to USD 2.32</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="As_Of_12_31_2023_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Usd2.03ToUsd2.32Member_JcYFgrKmAkGmDL6Nc1PZGw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_2pgX-WIiKUiZXa8Bt4qPwA_9_2">1,294,766</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2032&#8211;2033</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total outstanding options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" id="Tc_Gud-cZ4MGU63Ht_-wumHGA_10_2">4,949,177</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The weighted-average exercise price for options granted in 2023, 2022 and 2021 is USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Narr_prDCgOu2jkqYryD4Xy7uMQ">2.08</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Narr_z3v2TxtJCkuMbPEpIe_IQw">1.75</ix:nonFraction>), USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Narr_7WeACYPXHk2cqUwd4Yhlkw">3.44</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Narr_dmF2uu-4O0mDsiVLIDfBCw">3.18</ix:nonFraction>) and USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Narr_g---t9HJkkO_Kxd9dmAbXg">6.95</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="Narr_8pYPBthfj02Dwhly9S4Vgg">6.34</ix:nonFraction>), respectively. The range of exercise prices for outstanding options was CHF <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="As_Of_12_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_srt_CurrencyAxis_currency_CHF_8K3Jpoq190ueOAUG42rgKg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="Narr_qPBHxNxwyUqrEG7OUpM7vQ">0.15</ix:nonFraction> to CHF <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="As_Of_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_srt_CurrencyAxis_currency_CHF_EovKNEREAkumK2wjyAvm6g" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="Narr_ft7YkUEr_UO4GtpvN5hksg">9.53</ix:nonFraction> for awards previously granted in CHF (prior to 2018) and USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA" contextRef="As_Of_12_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_srt_CurrencyAxis_currency_USD_fZkHo-Mvv0iaC9kcViPDDQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="Narr_wF3K1Vxmp0i8g600OyePHw">2.03</ix:nonFraction> to USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA" contextRef="As_Of_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_srt_CurrencyAxis_currency_USD_6KDez0fNPESv6PiMVQDs7w" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="Narr_RKIrCV5H_Ue3Uof2QzCZZw">12.30</ix:nonFraction> for awards granted in USD as of December&#160;31, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For awards issued in 2023, the volatility is based on the Company&#8217;s actual volatility for the period congruent with the expected term of the underlying option. The risk-free interest rate is based on yields of long-dated U.S. Treasury notes that align with the expected term of the award. The weighted-average share price of common share options exercised in 2023 is USD <ix:nonFraction unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageSharePrice2019" scale="0" id="Narr_-H1zQ-am7EWuZ2bGvXJdQA">3.18</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageSharePrice2019" scale="0" id="Narr_pDMOBLQr5EKRr9RO6MRNWg">2.68</ix:nonFraction>).</p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-38</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_6e10bf45_c3d2_4642_83b4_086ee10baee5"></a><a id="Tc_Ds5PMES9MU2BIx8EW1U5wQ_1_2"></a><a id="Tc_uw8n8L2RjUeLtx5mbXvh1g_2_2"></a><a id="Tc_jlaXHsSsEke1VliWSsaMJw_3_2"></a><a id="Tc_-dlPnQtRUkW-pVLz8TFhvA_3_4"></a><a id="Tc_nk7L1UmLikmUViUugWRjzQ_3_6"></a><a id="Tc_2PGcDFrch0KUTpfn1yhfiw_4_0"></a><a id="Tc_e0EkSvoGtUGUuHFVKzU8GQ_4_2"></a><a id="Tc_MQ7h_t3myU-HTD-KdpZKYA_4_4"></a><a id="Tc_uFJcCPQ1rU2X36eEGFmzLA_4_6"></a><a id="Tc_5taoccfGv0yZpl66u6jYSw_5_0"></a><a id="Tc_eMN39RSu00WWObef9KimxA_6_0"></a><a id="Tc_wf_Upgx3ZEGm4-YLrKcpYw_6_2"></a><a id="Tc_uGVidPUjhkiC8hDMF1r7gA_6_3"></a><a id="Tc_3oMIrginAE6BxO_KnSTIjg_6_4"></a><a id="Tc_QpLA05AkR0-dUB78sIzt9A_6_5"></a><a id="Tc_Di2Fajq_c0G3GgT3PKavcQ_6_7"></a><a id="Tc_8rAXF9t4yUSMk5h9kF-G4w_7_0"></a><a id="Tc_y4T9tpA6-0S_hrObjw1eFw_7_2"></a><a id="Tc_1e8E_Tm5b0CeWQjDHcuLRA_7_3"></a><a id="Tc_orUEaIVhI0OoClT5E-H2qw_7_4"></a><a id="Tc_AwO9twRMaEabGwD0VWiplA_7_5"></a><a id="Tc_VNUjEKmUIk2hz0psJ0ipxw_7_7"></a><a id="Tc_tzygUrN4QUKEQbQSZtKIew_8_0"></a><a id="Tc_KesHgj1o20OevfFkjb-DfA_8_2"></a><a id="Tc__6OBAMQb3EyLlLcxVvpJyg_8_4"></a><a id="Tc_cdbRxMDJeE6UE_py8BTckA_8_6"></a><a id="Tc_uokR0JLNEEKWNpgzoxFTbw_9_0"></a><a id="_ea8de387_1a07_45da_a8c8_268e18d01d72"></a><a id="Tc_lxqavaKZeE67Dw8mIZGaOw_1_6"></a><a id="Tc_PBx5Bh5hM0-j40nnajjpSQ_2_2"></a><a id="Tc_TLQoJkDOMkanp6xk9dwsfg_2_6"></a><a id="Tc_b_O6ujkbnkmIKEbermAznw_3_2"></a><a id="Tc_qvjthPaXkkqqdTNA3RU61A_3_6"></a><a id="Tc_6k6VBY3JY02S0WmRaOJ23w_4_0"></a><a id="Tc_EiEWlc3auUe_6-LFoibmxg_4_2"></a><a id="Tc_dlt0gZeZCkSQeFH5Iyj5Cw_4_4"></a><a id="Tc_Cm15xuAyr0qGFv7_8ioEKA_4_6"></a><a id="Tc_FTVtngpT7keNdb4Bc1wK_A_5_0"></a><a id="Tc_QT5nbGrDcEyHlSWeou1zVA_6_0"></a><a id="Tc_czMEI42PIEy4BipWYrIawA_6_4"></a><a id="Tc_o0rARiDdfUmeLNYjBZ9PNg_7_0"></a><a id="Tc_Z_EHZxHqFkuI-roUHTFPBQ_7_4"></a><a id="Tc_J2g4Hl3ta06RicY9Q2oEzw_8_0"></a><a id="Tc_sr7tNfGp6kGYxmEU4f3MFw_8_4"></a><a id="_1eb82027_bc96_4755_a4c0_b7a0ba6da7e4"></a><a id="Tc_lmcN-vALTEOZlLlVMSlKAw_1_4"></a><a id="Tc_BqWivb_zokmuVDm1CYk7Lw_2_4"></a><a id="Tc_JtPVCZ2hg0mKonkslpAYbw_3_2"></a><a id="Tc_xekyOBfqgUCJ-o3RXw3qmw_3_4"></a><a id="Tc_5BHLpRF9s064Vs-da_Oc6A_4_2"></a><a id="Tc_bk2H6YA360CiyTwQYbicWA_4_4"></a><a id="Tc_698A53nnlUuv4AXbfjhr_g_5_0"></a><a id="Tc_3HeYOytnAUmTrxSDe6G-ww_6_0"></a><a id="Tc_xmsBstq5akWYIRkwi8vOuw_7_0"></a><a id="Tc_BhRJWDl-MUia3x-xtIPqNg_8_0"></a><a id="Tc_66LGyjY3j0C_nxZc4rbwSQ_9_0"></a><a id="Tc_-eutKnRYZke-KxFiijkX4A_10_0"></a><a id="Tc_tXVkQifiqESfZdOqIv3Vvw_11_0"></a><a id="Tc_IrV2rD2gAk-9G-SzRYdtVA_12_0"></a><a id="Tc_cFde5KWhfEe-7-jEG5CnCg_13_0"></a><a id="Tc_EYCweRbCjUiWD1I8YKk-tg_14_0"></a><a id="Tc_Xwgonmb2tEuJ20uGhsdpaA_15_0"></a><a id="Tc_ptS5e4Nr7UasG_dLqVAiig_16_0"></a><a id="Tc_xKWf4Xp8BE64si6HMfA5eg_17_0"></a><a id="Tc_sNa0SpXCJEKZ1Xf_ls1xDw_18_0"></a><a id="Tc_aBslOv9ITkOx1RDCfv07PQ_19_0"></a><a id="Tc_LbiYiFwVDkC0zFIcr3pp5A_20_0"></a><a id="Tc_P-6O7hlBEEaUPfy3t1j55Q_21_0"></a><ix:continuation id="Tb_cQZp6FwNWUmVOzNSgPLPrw_cont2" continuedAt="Tb_cQZp6FwNWUmVOzNSgPLPrw_cont3"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The weighted-average grant date fair values of the options granted in 2023, 2022 and 2021 are USD <ix:nonFraction unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" scale="0" id="Narr_QYlv3Q4ZqE23ZmGZlzKvWg">1.57</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" scale="0" id="Narr_q964l5HwVESddeMLeyx-Aw">1.33</ix:nonFraction>), USD <ix:nonFraction unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" scale="0" id="Narr_M6RJ9QWk20WqOc5StPws3w">2.38</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" scale="0" id="Narr_Q52JaPxGmkuMfhiFQS9tJA">2.20</ix:nonFraction>) and USD <ix:nonFraction unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" scale="0" id="Narr_2t6bIMF3RE-6tbTh4dHWGg">5.23</ix:nonFraction> (CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" scale="0" id="Narr_xCBXn5a-nkmIoIxYVWTAmg">4.78</ix:nonFraction>), respectively. The following table illustrates the weighted-average assumptions for the Black-Scholes option-pricing model used in determining the fair value of these awards:</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" id="Tb_LK-MJEXiaU-QcQsjG51QoQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:31.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:31.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercise price (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_A0fLCvnZXkWCpt0V9v-hlQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" id="Narr_lIutJRcYs0KCC6quPX9b7Q">2.03</ix:nonFraction>-<ix:nonFraction unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_N4NtcRpK7UmEpR8gT_3kcQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" id="Narr_CvBBRCEjl0mI5eXaxiF5Ow">3.11</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_kJ9M4JxOBEuo1siTgMfdYQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" id="Narr_AFE9IKqLsUWYaQGLQ7ewnw">2.76</ix:nonFraction>-<ix:nonFraction unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_mTTN5Hw7J0uG4plqeYxbIg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" id="Narr_LMJ0J1nE4USa5WVsrujG1g">4.57</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ZaXds3ifpU6wdPGK9Rol-A" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" id="Narr_Gi4XCARGmkuEkMGyDOftAA">5.31</ix:nonFraction>-<ix:nonFraction unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_kF_Z_GmDe0uYNVNKIyLhww" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" id="Narr_zoUwZWQUcEazoIpaBi-n2Q">7.72</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share price (USD and weighted average)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" scale="0" id="Tc_1KrEwp4SI02OFVMB8TpDuQ_5_2">2.08</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" scale="0" id="Tc_L9KiXwnu30Sp5uf-JEgp9A_5_4">3.44</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" scale="0" id="Tc_wg3LSuEPdUKWlSIEVER1Nw_5_6">6.95</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_A0fLCvnZXkWCpt0V9v-hlQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" id="Narr_URucbdZIBEaQhMj7TyoiOw">4.0</ix:nonFraction>-<ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_N4NtcRpK7UmEpR8gT_3kcQ" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" id="Narr_ARM_bMKdnk-v8uW731I1KA">4.6</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_kJ9M4JxOBEuo1siTgMfdYQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" id="Narr_jxkicBiKuE6f-LUiCsU3tg">0</ix:nonFraction>-<ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_mTTN5Hw7J0uG4plqeYxbIg" decimals="3" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" id="Narr_9L7lQFpR8kGjknCzWNKoaQ">2.4</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" id="Tc_s8opL-gDYkWgl15zHwP__Q_6_6">0</ix:nonFraction> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_A0fLCvnZXkWCpt0V9v-hlQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" id="Narr_MtXF_x0stU2vpQDi-2JN_w">72</ix:nonFraction>-<ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_N4NtcRpK7UmEpR8gT_3kcQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" id="Narr_j_o_9V4rnki-eoxxEN9VKA">86</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_kJ9M4JxOBEuo1siTgMfdYQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" id="Narr_-CSmKkN0G0OFlHsO3N43oQ">67</ix:nonFraction>-<ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_mTTN5Hw7J0uG4plqeYxbIg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" id="Narr_-WtBX9IQHkG-PBnImpEKTw">80</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" id="Tc_FNQcACSWbE699F0UCf4NwA_7_6">80</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expected term (in years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_Y_vGNa0xS6h0m8DtazE3ChHg" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_A0fLCvnZXkWCpt0V9v-hlQ" decimals="1" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" id="Narr_jza-bmF5eku_kDXxryimtw">5.5</ix:nonFraction>-<ix:nonFraction unitRef="Unit_Standard_Y_vGNa0xS6h0m8DtazE3ChHg" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_N4NtcRpK7UmEpR8gT_3kcQ" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" id="Narr_Nn7qd23Q_kq59zMBVIRUGg">6</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_Y_vGNa0xS6h0m8DtazE3ChHg" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_kJ9M4JxOBEuo1siTgMfdYQ" decimals="1" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" id="Narr_3pcKeN90fEC73IXOLXu5xQ">5.5</ix:nonFraction> - <ix:nonFraction unitRef="Unit_Standard_Y_vGNa0xS6h0m8DtazE3ChHg" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_mTTN5Hw7J0uG4plqeYxbIg" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" id="Narr_-tZbPvOXM0GPdls_r7g6DQ">6.25</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><ix:nonFraction unitRef="Unit_Standard_Y_vGNa0xS6h0m8DtazE3ChHg" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ZaXds3ifpU6wdPGK9Rol-A" decimals="1" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" id="Narr_lRxf2qdxJU687S7-kcYLMA">5.1</ix:nonFraction> - <ix:nonFraction unitRef="Unit_Standard_Y_vGNa0xS6h0m8DtazE3ChHg" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_kF_Z_GmDe0uYNVNKIyLhww" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" id="Narr_xxiST3yBBkmVdxv-Gae2XQ">6</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Dividend yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="2" format="ixt:zerodash" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" scale="-2" id="Tc_I0xs7Nqa4UecYlLodE_vMw_9_2">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="2" format="ixt:zerodash" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" scale="-2" id="Tc_9K2K4KQfkUOB3Nt8Vnbl6A_9_4">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="2" format="ixt:zerodash" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" scale="-2" id="Tc_r6FbWM6Nb0e6xiphmMDkiw_9_6">&#8212;</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Restricted share awards</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" id="Tb_C2dXit67fkyqTFLknRvDMQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">A summary of share awards (restricted share and restricted share units) activity as of&#160;December&#160;31, 2023&#160;and changes during the&#160;year then ended is presented below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractual</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">life&#160;of&#160;non-</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">share&#160;awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">vested&#160;share</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grantee type</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">granted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vesting&#160;conditions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">awards</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Restricted share units</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:top;width:38.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Directors</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg" contextRef="Duration_11_16_2016_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_BoardOfDirectorsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_Mg69nDEnSECdfeZEURGoNw" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Tc_MbswrOiREE6yoYh40kTocA_6_2">257,329</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_BoardOfDirectorsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_oEAbzyJtoEmkfKv74BICBg" format="ixt-sec:durwordsen" name="aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" id="Narr_mEhlpT30ZE68pmBtRlcoiA"><span style="font-size:10pt;">1 year</span></ix:nonNumeric><span style="font-size:10pt;"> service from date of grant, annually</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_BoardOfDirectorsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_oEAbzyJtoEmkfKv74BICBg" format="ixt-sec:durwordsen" name="aciu:MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement" id="Tc_cHtRArW4JEC1kD3of6KIpg_6_6"><span style="font-size:10pt;">10 years</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Executives</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg" contextRef="Duration_11_16_2016_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_9q9dI6YGDkGRYsQk62I2nA" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Tc_siQTG5uy7Ue4vlOg_JZmEA_7_2">905,803</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsFirstVestingConditionsMember_b85Kv7MimEGfeEIsinaPEA" format="ixt-sec:durwordsen" name="aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" id="Narr_wx844IXaSk-Tmd0NI7nGKA"><span style="font-size:10pt;">3 year</span></ix:nonNumeric><span style="font-size:10pt;"> and </span><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsSecondVestingConditionsMember_E41WId3rVUaJryS3yoer-A" format="ixt-sec:durwordsen" name="aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" id="Narr_6Of0UB_GjUWrkEh3UEA1YA"><span style="font-size:10pt;">4 years</span></ix:nonNumeric><span style="font-size:10pt;">&#8217; service from the date of grant, quarterly and semi-annually</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_T_CAdfRv-0yh8ZcvUy-2eA" format="ixt-sec:durwordsen" name="aciu:MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement" id="Tc_9jiPbQ_QlkyiL7oAyhSVDw_7_6"><span style="font-size:10pt;">10 years</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:38.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employees</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg" contextRef="Duration_11_16_2016_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_la6xlFr4Qk-ItVH571xacw" decimals="0" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Tc_YEF9OQijZk24mq8rgm6K0g_8_2">458,335</ix:nonFraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;width:35.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_XCIxfyCaLUqoZoXevZDdCg" format="ixt-sec:durwordsen" name="aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" id="Narr_TSePuOSUBkmOyiydetuKRQ"><span style="font-size:10pt;">3 years</span></ix:nonNumeric><span style="font-size:10pt;">&#8217; service from the date of grant, annually</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:11.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_XCIxfyCaLUqoZoXevZDdCg" format="ixt-sec:durwordsen" name="aciu:MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement" id="Tc_wjniJmyWzUmwCvet7n5cdQ_8_6"><span style="font-size:10pt;">10 years</span></ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted-</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">average</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">grant</b>&#160;<b style="font-weight:bold;">date&#160;fair</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">value&#160;(CHF)</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at January 1, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_uW0txdsBO0WLBMLzEw4mWQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" scale="0" id="Tc_q2V6wD0d_EynPkHR19lSFw_5_2">19,494</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_uW0txdsBO0WLBMLzEw4mWQ" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" scale="0" id="Tc_D8pHWvqof06Y2FGQ__SziA_5_4">9.51</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_QwGnbZHs2kOQD9MkvKz_JQ" decimals="INF" format="ixt:numdotdecimal" name="aciu:NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement" scale="0" id="Tc_B3xThjRSfEiitlNiEjzEBA_6_2">2,471</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_QwGnbZHs2kOQD9MkvKz_JQ" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised" scale="0" id="Tc_KooqsU3PqUyea1gpzL7ygw_6_4">9.46</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Vested during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_QwGnbZHs2kOQD9MkvKz_JQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" scale="0" id="Tc_Ev15Bm79S0aWRt9OXbCzWg_7_2">18,697</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_QwGnbZHs2kOQD9MkvKz_JQ" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" scale="0" id="Tc_cfzHcNP-a0SVsjXYCBRtBw_7_4">9.52</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_eitFANd6O0-px2XAzxnmbA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" scale="0" id="Tc_DRvutG3z6Um5989lYHTWvw_8_2">797</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_eitFANd6O0-px2XAzxnmbA" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" scale="0" id="Tc_pWnyxc7txEO0mE3mAmlw8Q_8_4">9.41</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vested and exercisable at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_eitFANd6O0-px2XAzxnmbA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" scale="0" id="Tc_8FKnhAXWSUqWVGZbWN3DTQ_9_2">65,515</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_eitFANd6O0-px2XAzxnmbA" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" scale="0" id="Tc_IeH_qgTiX0qLqCeuf1zpoQ_9_4">9.48</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_eitFANd6O0-px2XAzxnmbA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" scale="0" id="Tc__3ki0TTs8kOr8uWZJYGY3Q_10_2">797</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_eitFANd6O0-px2XAzxnmbA" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" scale="0" id="Tc_VIYpX5sGYUWFHVUei0WhDQ_10_4">9.41</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_RaV3Vku3aUu2A_2JfVmVng" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Tc_7RKOfkABSUe8kAhbz6S7SA_11_2">239,194</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_RaV3Vku3aUu2A_2JfVmVng" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised" scale="0" id="Tc_Pk2gfe2GiUWv73wji1KaSA_11_4">3.06</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Vested during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_RaV3Vku3aUu2A_2JfVmVng" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" scale="0" id="Tc_fe8YgQ2dJ0OBYQqcc2K8FQ_12_2">23,505</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_RaV3Vku3aUu2A_2JfVmVng" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" scale="0" id="Tc_XGy87PWo6UOdMr0GUAAfBw_12_4">3.28</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_pY3XYcoQoUeP48UTVCm8pg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" scale="0" id="Tc_AwRa_92W5USu0f6uzOB0Aw_13_2">216,486</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_pY3XYcoQoUeP48UTVCm8pg" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" scale="0" id="Tc_F8s3oqBZYUKLxZ7BWemB3Q_13_4">3.06</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vested and exercisable at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_pY3XYcoQoUeP48UTVCm8pg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" scale="0" id="Tc_Ahfqie8egEamVoyFmn7M5A_14_2">89,020</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_pY3XYcoQoUeP48UTVCm8pg" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" scale="0" id="Tc_fAgwG8IJDUSofGeEHB688w_14_4">7.84</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_pY3XYcoQoUeP48UTVCm8pg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" scale="0" id="Tc_FsmboiSrpkiVio3IozYw7A_15_2">216,486</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_pY3XYcoQoUeP48UTVCm8pg" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" scale="0" id="Tc_5X3GibOd8U6j3JFV-bTFiA_15_4">3.06</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_0CVyLgPoV0-0eUUJiC7Vxg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" scale="0" id="Tc_DiITQcFwSkG1QQQWnTAtNA_16_2">134,947</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_0CVyLgPoV0-0eUUJiC7Vxg" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited" scale="0" id="Tc_Q4U6GWxF6kuqI-yx4v_n4Q_16_4">2.05</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_0CVyLgPoV0-0eUUJiC7Vxg" decimals="INF" format="ixt:numdotdecimal" name="aciu:NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement" scale="0" id="Tc_l6yCy8XBH0Cw8FwpBhOeLg_17_2">55,503</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_0CVyLgPoV0-0eUUJiC7Vxg" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised" scale="0" id="Tc_7FV13IK0g0OUdm2hn5BFIg_17_4">2.37</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_0CVyLgPoV0-0eUUJiC7Vxg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" scale="0" id="Tc_ccvdcp3l2UGA58co_bn3zw_18_2">1,187,570</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_0CVyLgPoV0-0eUUJiC7Vxg" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted" scale="0" id="Tc_iVwVNtuMxk6GXPaqCkYZ8A_18_4">1.89</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Vested during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_0CVyLgPoV0-0eUUJiC7Vxg" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" scale="0" id="Tc_V5-EDetBO0y9R0dmzpOV1w_19_2">265,366</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_0CVyLgPoV0-0eUUJiC7Vxg" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" scale="0" id="Tc_r90jOzoUqEmLN-TtHqFhcw_19_4">2.46</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg" contextRef="As_Of_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_u5V2Ukxsi0ip1fGh-0PIFw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" scale="0" id="Tc_BmJOCbjrcEyp7Kr1lrOBew_20_2">1,003,743</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_u5V2Ukxsi0ip1fGh-0PIFw" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" scale="0" id="Tc_AhW3YisJhkKnW-OWavN0NA_20_4">1.97</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vested and exercisable at December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg" contextRef="As_Of_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_u5V2Ukxsi0ip1fGh-0PIFw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" scale="0" id="Tc_9nXYfSwCUE6EbjZILvBCHg_21_2">298,883</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_u5V2Ukxsi0ip1fGh-0PIFw" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" scale="0" id="Tc_LBjoPTsdYku88f46j5ypaQ_21_4">4.08</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-39</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_cQZp6FwNWUmVOzNSgPLPrw_cont3"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The weighted-average grant date fair values of the remaining non-vested share awards as of the respective&#160;year end for the restricted share units were CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_Ks574WurXUmKeYPNctUQnw" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" scale="0" id="Narr_ufVWB6rTj0i3NUYbMGhgSw">1.97</ix:nonFraction>, CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_5pdQTfFdGEKkjeGhrAzNRw" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" scale="0" id="Narr_Pq2Dq59JPUidiQzNh9rB3A">3.06</ix:nonFraction> and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_E1XpL1U-zkqFSbWZ-KwCTA" decimals="2" format="ixt:numdotdecimal" name="aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" scale="0" id="Narr_-7fYoq3N602_ENogxMtaYA">9.41</ix:nonFraction> for the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively. The fair values of these non-vested share awards granted were determined using a reasonable estimate of market value of the common shares on the date of the award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The expense charged against the income statement was CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="Narr_RQw91cahZEOlLdwLlZF8SQ">4.4</ix:nonFraction> million, CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="Narr_eE3Pd10KR06_NQa9uq4Vmg">3.3</ix:nonFraction> million and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="Narr_cwql16Z-L0y9vOdzxsSLWA">4.1</ix:nonFraction> million for the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively. The expense is revised by the Company based on the number of instruments that are expected to become exercisable.</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:11pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="Tc_vhgzaYN3iU2QLFDazSQlVQ_1_2"></a><a id="Tc_yZeOvsSPf06jB2cAXXhZUg_2_2"></a><a id="Tc_osnCiFl8YEG0yfRa_O_t3Q_3_0"></a><a id="Tc_vsAWMjpCC06WLdcCXMauzA_3_2"></a><a id="Tc_RwZf24zq_E-IcIxlCqcRtg_3_4"></a><a id="Tc_zFcjdjUY3UeTQK9jm4song_4_0"></a><a id="Tc_Kfywh4dgEESkxp6xyEqBAQ_5_0"></a><a id="Tc_iEctsuGoHEqh3uRqjnQtGw_6_0"></a><a id="Tc_dCBRWVtfz0OMexg4ztUhoA_7_0"></a><a id="Tc_nu8fH6V3NEuqRVDftgbBYQ_8_0"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" id="Tb_w4BbEcCVUkmNc7Su6S_G3A" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">20.</b></span>Commitments and contingencies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s commitments and contingencies relate to its ongoing operating activities, mainly research and development programs, as well as its leased corporate space.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the normal course of business,&#160;we conduct product research and development programs through collaborative programs that include, among others, arrangements with universities, contract research organizations and clinical research sites. We have contractual arrangements with these organizations. As of December&#160;31, 2023, we have contractual obligations, other than for leases (see below), totaling CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_PEDQ9Y0GpEGR7Fz3aVtJ5Q" decimals="-5" format="ixt:numdotdecimal" name="aciu:ContractualCapitalCommitmentsOtherThanForLeases" scale="6" id="Narr_BywtZGRBwk-S68B_7tiS2w">21.4</ix:nonFraction>&#160;million for 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We lease our corporate, laboratory and other facilities under multiple leases at the EPFL Innovation Park in Ecublens, near Lausanne, Canton of Vaud, Switzerland. Our lease agreements have no termination clauses longer than a <ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" format="ixt-sec:durmonth" name="aciu:RentalContractPeriodForNoticeOfCancellation" id="Narr_h0EeSk41AkGStE-iGiaipQ">12</ix:nonNumeric>-month contractual notice period. The Company recognizes a right-of-use asset for its leases, except for short-term and low-value leases as indicated in Note&#160;3<i style="font-style:italic;">.</i> See &#8220;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities&#8221; for the contractual undiscounted cash flows for lease obligations.</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfCommitmentsExplanatory" id="Tb_f1aaoIWIFkiLaNEbC7r-nQ" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Within 1 year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_PEDQ9Y0GpEGR7Fz3aVtJ5Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractualCapitalCommitments" scale="3" id="Tc_Lh6MrYZe0kGt8B1QiVnLVg_4_2">21,746</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_ZpFwqYls3EejWQUqS6jVtA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractualCapitalCommitments" scale="3" id="Tc_RwwSFEsydUa63Jn82XsVyw_4_4">23,336</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Between 1 and 3 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_UEQ5-Qdp-ECfZVHJXapb-w" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractualCapitalCommitments" scale="3" id="Tc_B6xUTdHlHUCnnDP4q05pLg_5_2">16,920</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_O05oIcvQHECcE7b4dXGvbQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractualCapitalCommitments" scale="3" id="Tc_7hD8R7x4IUKaNnxT1lQeKQ_5_4">18,516</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Between 3 and 5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_CD3sQ6Iqhk-fx5WexG8VXQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractualCapitalCommitments" scale="3" id="Tc_J7UXiOVi1Uq3Ln0uDoRcxQ_6_2">7,632</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_vnWZvKBRW0CV9s94BbcDrg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractualCapitalCommitments" scale="3" id="Tc_Tsp0VWt1d0Om5_0zxCOPjw_6_4">9,229</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">More than 5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_VKrtDLypPEOuxz3CjSgM6A" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractualCapitalCommitments" scale="3" id="Tc_ZcZ10evDOUuXwj91MYvVXg_7_2">1,270</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_aAOfPJhSHU-AqBUvHn8pLQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractualCapitalCommitments" scale="3" id="Tc_babIs3ge5UWInmqc3IAnHA_7_4">1,407</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractualCapitalCommitments" scale="3" id="Tc_B96DbKCv-E2jNHydkpAWGg_8_2">47,568</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ContractualCapitalCommitments" scale="3" id="Tc_alvp02huL0aLObPmd5A0EA_8_4">52,488</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="font-weight:normal;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_45a165fb_ce86_4170_85a5_2866b12b45fc"></a><a id="Tc_266ggzBRjEiCVlgL3i3ifQ_1_2"></a><a id="Tc_bjfwGBoODkuu3ASR7MDMng_2_2"></a><a id="Tc_zpSreM50K0aPDfmGOMG9WA_3_0"></a><a id="Tc_3JWYThtXZEqh3FJ0Ijkkcw_3_2"></a><a id="Tc_Rj5ju7YhXEargRjLfyF39A_3_4"></a><a id="Tc_wwFcj9XhN0iU4p7FNODe_Q_3_6"></a><a id="Tc_nCwiVyhJzEqIRN2UcHlgow_4_0"></a><a id="Tc__WjwC-61QUu1lCMUzGLvlA_5_0"></a><a id="Tc__HXDITCAaEKghPs5-sE3Jg_6_0"></a><a id="Tc_8VjPOSSf_0yovMr0AyP42Q_7_0"></a><a id="Tc_e8GVOjmG4E66-k9SC0wwpg_8_0"></a><a id="Tc_HUAFBZAK9kiVQWrBxGQjEw_9_0"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfEarningsPerShareExplanatory" id="Tb_Q60D0j_aPEy_FCP9VU0ZGw" continuedAt="Tb_Q60D0j_aPEy_FCP9VU0ZGw_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">21.</b></span>Earnings per share</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:EarningsPerShareExplanatory" id="Tb_xBQ6yfs7v0q2BCw9XMNNxg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.07212067%;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands except for share and per share data</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Loss per share (EPS)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Numerator</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Net loss attributable to equity holders of the Company</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" sign="-" scale="3" id="Tc_zwlWPtCIvk-n0t8SdWcZwg_6_2">54,233</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" sign="-" scale="3" id="Tc_0fvZ2srAA02Fd0mGKRgyBg_6_4">70,753</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" sign="-" scale="3" id="Tc_g212Lja00E6-EaFz_jud_w_6_6">72,996</ix:nonFraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Denominator</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Weighted-average number of shares outstanding used to compute EPS basic and diluted attributable to equity holders</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageShares" scale="0" id="Tc_TrN7mibnnkuLmaLkTJ5n4A_8_2">84,694,616</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageShares" scale="0" id="Tc_iucRZ0gtHE-vTdsWm78CaQ_8_4">83,554,412</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:WeightedAverageShares" scale="0" id="Tc_iRaYx19QUEe01ndxKuPUoA_8_6">74,951,833</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted loss per share for the period attributable to equity holders</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:BasicEarningsLossPerShare" sign="-" scale="0" id="Tc_qa26pu8t_0KFxgJEuHePCQ_9_2">0.64</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:BasicEarningsLossPerShare" sign="-" scale="0" id="Tc_LKQ87iRHq0m62shoORRehA_9_4">0.85</ix:nonFraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (<ix:nonFraction unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="2" format="ixt:numdotdecimal" name="ifrs-full:BasicEarningsLossPerShare" sign="-" scale="0" id="Tc_19XQ4G39rkugvYop-oxL1w_9_6">0.97</ix:nonFraction>)</p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-40</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_bkEjOktgSE62jcgE_QxSBw_1_3"></a><a id="Tc_3NeY71SvCkavtjpfMZUVEA_2_3"></a><a id="Tc_1HcD_3U570asynQBFxYKHQ_3_3"></a><a id="Tc_S5H_WElOLkmenGBzsKNCdg_3_5"></a><a id="Tc_jsuoxw09QEC8fr-Z8EXpHw_3_7"></a><a id="Tc_mUK1k5Re5k6x8ZlRBz3a-Q_4_0"></a><a id="Tc_QBuG25Hf8UqPWZ3SEt33Ug_5_0"></a><a id="Tc_wy9W_nYrAEGTNjQlSIdnfg_6_0"></a><a id="Tc_WRDGRMvFxEGUfuwwgt-Atw_6_3"></a><a id="Tc_3DlBXP3AP0Ks8OTO6p7SKA_6_5"></a><a id="Tc_R_pA6tlleECnW6sJjfVt-w_7_0"></a><ix:continuation id="Tb_Q60D0j_aPEy_FCP9VU0ZGw_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In periods for which we have a loss, basic net loss per share is the same as diluted net loss per share. We have excluded from our calculation of diluted loss per share all potentially dilutive in-the-money (i)&#160;share options, (ii)&#160;non-vested restricted share awards and (iii)&#160;shares that were issued upon conversion of two different convertible notes as their inclusion would have been anti-dilutive. The weighted-average number of potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows:</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023" id="Tb_OcyMrFfyJk2RLMS3RDGnow" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:30.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:30.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share options issued and outstanding (in-the-money)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_ShareOptionsMember_JiVYK5fqYUO7VCxTOIhfZA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" scale="0" id="Tc_Jv12yoWMAkm9jC3EStKURg_4_3">97,683</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_ShareOptionsMember_xjjfByq3kEexxYKCccxAuA" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" scale="0" id="Tc_RdjLkVIDBEWxRJqGLQKTCQ_4_5">135,827</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_ShareOptionsMember_hb7EZRsk9k2Xc_o9Y1Cx3w" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" scale="0" id="Tc_8JbpVYnMRkKKMWckMvUQ7Q_4_7">1,140,388</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Restricted share awards subject to future vesting</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_RestrictedShareUnitsMember_1v9vOL78NEaUqskdXpyvxQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" scale="0" id="Tc_oaV3Zn4-_k60aXzoCKCzXg_5_3">1,160,240</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_RestrictedShareUnitsMember_7RuOmuGIaUSc_wFc7wHO3A" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" scale="0" id="Tc_N83UfwyYSE-yqDh_Q_i_HQ_5_5">117,292</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_RestrictedShareUnitsMember_xIISRYveiEabLLH78AYB7w" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" scale="0" id="Tc_GXdExj0_JUCEDKiP1H50JA_5_7">6,264</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Convertible shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_ConvertibleInstrumentsMember_fIduMxC3S0aqyPa52saM_A" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" scale="0" id="Tc_n15aeKnUU0iciX8Hl-8WTA_6_7">41,461</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total potentially dilutive securities </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" scale="0" id="Tc_pwUJCCW1rEWxHyd2k3npAw_7_3">1,257,923</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" scale="0" id="Tc_8bl64QbKHkyunvauNPRQsA_7_5">253,119</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g" contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ" decimals="INF" format="ixt:numdotdecimal" name="ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" scale="0" id="Tc_jidLC_2WxEONtOTVqm8EHw_7_7">1,188,113</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></ix:nonNumeric></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_27fb36d1_0b1b_45d3_b4c5_bdfdbbe3534d"></a><a id="Tc_goHVjeW5I0qeoyBstC6MEw_1_2"></a><a id="Tc_fzIIPwGiRkitoKXL4a0uhA_2_2"></a><a id="Tc_QeDJmUTDn0-t6P1ZqA63SQ_3_0"></a><a id="Tc_Drl0gjGTv06KF-DnPme9VQ_3_2"></a><a id="Tc_6BtMEOvsKU-UbNpSI3O2Kw_3_4"></a><a id="Tc_Ws6VAkICRUakNeUePwZevA_4_0"></a><a id="Tc_9iXW5YkCSE285cxcNozc0Q_5_0"></a><a id="Tc_nv3yfJzLnESIG-IO_StNVQ_6_0"></a><a id="Tc_iEW0j49890mKWDZGO8HURg_7_0"></a><a id="Tc_9faU8Bz1cU69L1pOrHQvEw_8_0"></a><a id="Tc__6d23n8Q50C2pXefdsW1pw_8_4"></a><a id="Tc_XRLCb89_AE2lhU5kucuQ-w_9_0"></a><a id="Tc_GjN95M6qQECmkRovZO1c-Q_10_0"></a><a id="Tc_tjWlI4Gkh0e9xo4KgNnJiQ_11_0"></a><a id="_09240381_049c_4c2a_9328_abe9e5830cd9"></a><a id="Tc_zsxkDNzWkUOjoT8MJ7saKA_1_2"></a><a id="Tc_16o9POw8wU-tVBNy07DEGg_2_2"></a><a id="Tc_OE0FL15-_kCNHnF_D_AKew_3_0"></a><a id="Tc_I9uLAcuJoESurog6U50_rw_3_2"></a><a id="Tc_a033B5M2w0eVdsdQ_0ld8g_3_4"></a><a id="Tc_LfsBvW99DE6TLAEo_78hwg_4_0"></a><a id="Tc_ddNcMlTt-EmSw3ukrxuggw_5_0"></a><a id="Tc_Cev3-mkDUkucwijOpVl7hg_6_0"></a><a id="Tc_vGeTpeWVzk2bObJtWnr-nw_7_0"></a><a id="Tc_DD43O-_BRk6VMU9qqZG8CA_8_0"></a><a id="Tc_v4jwejlYm0a1eLMKLOaMAg_9_0"></a><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfFinancialRiskManagementExplanatory" id="Tb_8Zzq9ZycO0K-wygzKEqkFw" continuedAt="Tb_8Zzq9ZycO0K-wygzKEqkFw_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">22.</b></span>Financial instruments and risk management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s activities expose it to the following financial risks: market risk (foreign exchange and interest rate risk), credit risk and liquidity risk. The Company&#8217;s overall risk management program focuses on the unpredictability of financial markets and seeks to minimize potential adverse effects on the Company&#8217;s financial performance.</p><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="aciu:DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock" id="Tb_lS_cHlXb0UmGrYgsq7nvhA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table shows the carrying amounts of financial assets and financial liabilities:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Financial assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_RightOfUseFinancialAssetsMember_8nM6TuHsfUWJ_Eb5DPpcMw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_NjtWXXqOr0udsqRz1Bfbhg_5_2">3,508</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_RightOfUseFinancialAssetsMember_tR8m7PTQZE-3qL6hTCbwPg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_pFDZvDiNokGOwysEWZw_3w_5_4">2,808</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Long-term financial assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_LongTermFinancialAssetsMember_2GPCrMxC3kuP50IVhioaJQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_9Vd99Y9SDUicg2UTHdmYUw_6_2">361</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_LongTermFinancialAssetsMember_Sp4G8pRwNkqsYvkUz4YI2g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_8l_AR_j82EiMBXtsbqZsHA_6_4">361</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other current receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_OtherCurrentReceivablesMember_uVd4y6WmRkq8Gnp7VhbSAg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_8fNDgRaJVEqcnsxU5sDQxQ_7_2">622</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_OtherCurrentReceivablesMember_sZ3Yzb3XREu_tDsA08-5Sw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_mCpLPbYq90C93d8rbnOlSw_7_4">392</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accounts receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_ifrs-full_TradeReceivablesMember_LwJz8BFRY0mDYAyF8DxskQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_sH9TP-ORlk2Ulg7Dd4tJ2w_8_2">14,800</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term financial assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_ShortTermFinancialAssetsMember_GQvxTZCyeUSHnqXgqhDQ9g" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_j5yUda6yYEylZEtaOmvMlw_9_2">24,554</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_ShortTermFinancialAssetsMember_7XpjIGDTfUu8O9YtHM9T2Q" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_j2wL7eYZgE6-G2eoQazY3w_9_4">91,000</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_CashOnHandAndCashEquivalentsMember_Tt_fmEFayUCvEgmVza7MFQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_IpV4lXf7EEOkNv4dGtLoIg_10_2">78,494</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_CashOnHandAndCashEquivalentsMember_W820bIc2s0iHiLwstBYlKg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_pB-XS0lHxk-R__4xxSXxog_10_4">31,586</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total financial assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_7YZ6FiyQuESSw3LJivPHfA_11_2">122,339</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialAssets" scale="3" id="Tc_WeWcnqXRrUKkTyL10YIl-Q_11_4">126,147</ix:nonFraction></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Long-term lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_LongTermLeaseLiabilitiesMember_hTP2bhts4kGVi8zQZgg2Lw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_Y6DI8pt-nEu-7lcCWhGktg_5_2">2,825</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_LongTermLeaseLiabilitiesMember_iE9c6Qe9dkmCxyhOVMjHlQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_CPvkZh4rbUGoy2JluLtAPw_5_4">2,253</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Trade and other payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_oD9AY5W7QE2lsvFz7v9VSA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_zDyfbORZ5Eq3tTkvrzVkQg_6_2">1,679</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_hN_4u153REGiz2cDaHHvaQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_w8ClRdCG1kGdYCD1LnpXdw_6_4">929</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_V5SiFGlhwU2nqSRCE0iIlg" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_szjUuoWpskiSohQVkySK8Q_7_2">11,087</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_SxsHygJzykiKANoKiEryBA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_lSSltJ1gIkWVw9Pig54V3g_7_4">9,417</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_ShortTermLeaseLiabilitiesMember_9v_cqh_W1kSGuzLlAQyFFQ" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_R-v_ZAfmKE2fk_Ij_9peSg_8_2">672</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_ShortTermLeaseLiabilitiesMember_7EJHTDPGpE2MU58MnWl9gw" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_GnswF16UJU6U78RZu0smEg_8_4">548</ix:nonFraction></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_9_0ng22kckmv2FQcJmxwwA_9_2">16,263</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA" decimals="-3" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="3" id="Tc_RLkqNRPDtEeHSW6UkFEYjA_9_4">13,147</ix:nonFraction></p></td></tr></table></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Foreign exchange risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is exposed to foreign exchange risk arising from currency exposures, primarily with respect to the EUR, USD and to a lesser extent to GBP, DKK and SEK. The currency exposure is not hedged. However, the Company has a policy of matching its cash holdings to the currency structure of its expenses, which means that the Company holds predominately CHF, with lesser balances of EUR and USD (see &#8220;Note&#160;8. Cash and cash equivalents and short-term financial assets&#8221;). The Company recognized a loss of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_BX74hOhBS0CUAeUr_BZQyA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" sign="-" scale="6" id="Narr_ce5h2QT9EUyWNtBAhMcL8g">1.5</ix:nonFraction> million, a gain of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_7S9fMiZwfUK5NJDPYOhCdA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="6" id="Narr_QI1Ep-w9Tk-YVK56NqDCGw">0.5</ix:nonFraction> million and a loss of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_E9kBrJ2W50Sic6i55dJjIg" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" sign="-" scale="6" id="Narr_jeY4TlBSs0uyHsQKzE3YQQ">0.1</ix:nonFraction> million for the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively, within &#8220;Finance result, net.&#8221;</p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-41</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_8Zzq9ZycO0K-wygzKEqkFw_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2023, if the CHF had strengthened/weakened by <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_BX74hOhBS0CUAeUr_BZQyA" decimals="2" format="ixt:numdotdecimal" name="aciu:PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" scale="-2" id="Narr_5J4KlzbGo0eOurvsKjNHiQ">10</ix:nonFraction>% against the EUR and the USD with all other variables held constant, the net loss for the period would have been lower/higher by CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_BX74hOhBS0CUAeUr_BZQyA" decimals="-5" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" scale="6" id="Narr_irBURrn7002vwEUv9ys2vQ">2.6</ix:nonFraction> million (2022: CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_7S9fMiZwfUK5NJDPYOhCdA" decimals="-5" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" scale="6" id="Narr_oxaiuFlomkuLIv9TgG8Kgg">0.7</ix:nonFraction> million), mainly as a result of foreign exchange gains/losses on predominantly EUR/USD denominated cash and cash equivalents and short-term financial assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Interest rates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s CHF cash holdings (inclusive of those held in short-term financial assets) were subject to positive interest rates at certain counterparty thresholds through 2023. As of December&#160;31, 2023 if the interest rates granted by the counterparties had increased/decreased by <ix:nonFraction unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfRisksAxis_ifrs-full_InterestRateRiskMember_RtyTGF5IIEeDAR3KKFiYmQ" decimals="2" format="ixt:numdotdecimal" name="aciu:PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates" scale="-2" id="Narr__k4eACEjlEKHWI97mPLA0w">10</ix:nonFraction>%, the net income for the period would have been higher/lower by CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfRisksAxis_ifrs-full_InterestRateRiskMember__VIlp5fvWECjGqiYiWCbsA" decimals="-5" format="ixt:numdotdecimal" name="aciu:IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates" scale="6" id="Narr_AYIEpD2t_0WWImUlK-6RnA">0.1</ix:nonFraction> million. Interest income and interest expense are recorded within finance results, net in our consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Credit risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company maintains a formal treasury risk and investment management policy to limit counterparty credit risk. As of December&#160;31, 2023, the Company&#8217;s cash and cash equivalents and short-term financial assets are held with <ix:nonFraction unitRef="Unit_Standard_Institution_2XG7OWvIxkqRwCgZCSpPJw" contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_wNVuSSWxUEaFOSDEm36rwg" decimals="INF" format="ixt-sec:numwordsen" name="aciu:NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets" scale="0" id="Narr_Hnhg8MTyJUaludl_4g8lBA">five</ix:nonFraction> financial institutions, each with a high credit rating ranging from A+ to AA- assigned by international credit-rating agencies. The maximum amount of credit risk is the carrying amount of the financial assets. Accounts receivable and other receivables are fully performing, not past due and not impaired (see &#8220;Note&#160;8. Cash and cash equivalents and short-term financial assets&#8221;, &#8220;Note 10. Accounts receivable&#8221; and &#8220;Note&#160;11. Other current receivables&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Liquidity risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Inherent in the Company&#8217;s business are various risks and uncertainties, including the high uncertainty that new therapeutic concepts will succeed. AC Immune&#8217;s success may depend in part upon its ability to (i)&#160;establish and maintain a strong patent position and protection, (ii)&#160;enter into collaborations with partners in the pharmaceutical and biopharmaceutical industries, (iii)&#160;acquire and keep key personnel employed and (iv)&#160;acquire additional capital to support its operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s approach of managing liquidity is to ensure sufficient cash to meet its liabilities when due. Therefore, management closely monitors the cash position on rolling forecasts based on expected cash flow to enable the Company to finance its operations for at least 12&#160;months. The Company has CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_LiquidityRiskMember_I2s7qAhdwEmG_1icOvNOVw" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="6" id="Narr_qfrKStnuzUS8iFveucQZSQ">1.7</ix:nonFraction> million in trade and other payables, and CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_LiquidityRiskMember_7cEHP4wXJk6XdglcX0L3aA" decimals="-5" format="ixt:numdotdecimal" name="ifrs-full:FinancialLiabilities" scale="6" id="Narr_IyF_mxyj1kuTqoys17ykZw">11.1</ix:nonFraction> million in accrued expenses which are due within 12&#160;months from the reporting date. Finally, as it relates to the Company&#8217;s lease liabilities please see &#8220;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities&#8221; for detail of when corresponding lease liabilities are due.</p></ix:continuation><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory" id="Tb_3l_mKRf0-061RsiFzzmfpA" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">23.</b></span>Capital risk management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s objectives when managing capital are to safeguard the Company&#8217;s ability to continue as a going concern and to preserve the capital on the required statutory level in order to succeed in developing a cure against (i)&#160;AD, (ii)&#160;focused non-Alzheimer&#8217;s neurodegenerative diseases including NeuroOrphan indications and (iii)&#160;diagnostics.</p></ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew" name="ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory" id="Tb_ZX48rcfG2E67hhpHkOKe8w" continuedAt="Tb_ZX48rcfG2E67hhpHkOKe8w_cont1" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">24.</b></span>Subsequent events</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Management has evaluated subsequent events after the balance sheet date, through the issuance of these consolidated financial statements, for appropriate accounting and disclosures. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">On January 22, 2024, the Company announced that it will regain all global rights to the anti-amyloid beta antibody crenezumab and the anti-Tau antibody semorinemab following termination of the collaboration agreements with Genentech, a member of the Roche Group, and Roche, which termination will be effective in April 2024. Both antibodies have been evaluated in clinical studies for AD. AC Immune will also regain rights to existing GMP drug-product for clinical testing as well as associated data generated under each of the agreements. AC Immune will carefully </p></ix:nonNumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-42</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 30pt 0pt;"><a style="font-size:10pt;" href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_ZX48rcfG2E67hhpHkOKe8w_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">review and evaluate available data sets, including the final open label extension results from the Lauriet trial when they become available and are received in full by AC Immune, before decisions are made on potential further development and other opportunities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On February 1, 2024, the Company received the milestone payment of CHF <ix:nonFraction unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ" contextRef="As_Of_2_1_2024_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_aciu_ReceiptOfMilestonePaymentsMember_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_zyTb0RhISEWfD4ePpEx1Hg" decimals="-5" format="ixt:numdotdecimal" name="aciu:CollaborationAgreementMileStonePaymentReceived" scale="6" id="Narr_G2Ai2OwgHU2fgjyXJD9Ssw">14.8</ix:nonFraction> million due from Janssen for the commencement of first Phase 2b clinical study.</p></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:24pt 0pt 0pt 0pt;">F-43</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>aciu-20231231xex3d1.htm
<DESCRIPTION>EX-3.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.5.122.0--><!--Created on: 3/13/2024 05:01:47 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;min-height:36.85pt;width:100%;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:center;margin:0pt;"><font style="font-family:'Garamond';font-size:13pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:right;margin:6pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Exhibit 3.1</b></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr style="height:1pt;"><td style="vertical-align:top;width:47.9%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;min-height:14.5pt;text-align:center;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"><font style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</font><br></b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(AC Immune AG)</b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"><br></b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(AC Immune Ltd)</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'CG Omega';font-size:12pt;letter-spacing:0.2pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;letter-spacing:0pt;line-height:16pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:4.24%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:47.84%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"><font style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</font><br></b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(AC Immune AG)</b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"><br></b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(AC Immune Ltd)</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;min-height:14.5pt;text-align:center;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Articles of Association</b></p><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;min-height:14.5pt;text-align:center;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;text-transform:none;">of</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">AC Immune SA</b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"><br></b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(AC Immune AG)</b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"><br></b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(AC Immune Ltd)</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">with registered office in </b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Ecublens (VD)</b></p><p style="font-family:'CG Omega';font-size:10pt;letter-spacing:0.2pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';letter-spacing:0pt;">The French version of these articles of association shall prevail.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;min-height:14.5pt;text-align:center;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">STATUTS</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">de</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">AC Immune SA</b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"><br></b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(AC Immune AG)</b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"><br></b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(AC Immune Ltd)</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">avec si&#232;ge &#224;</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Ecublens (VD)</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">La version fran&#231;aise de ces statuts fait foi.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:49.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">I.</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Corporate Name, Principal Office, Duration and Purpose of the Company</b></p></div></div></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:46.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">I.</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">rAISON socialE, Si&#232;ge,</b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"><br></b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">dur&#233;e et BUT de la soci&#233;t&#233;</b></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:67.85pt;text-indent:-67.85pt;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 1</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Corporate Name and Duration </b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Under the name</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">AC Immune SA</font><font style="font-family:'Times New Roman','Times','serif';"><br></font><font style="font-family:'Times New Roman','Times','serif';">(AC Immune AG)</font><font style="font-family:'Times New Roman','Times','serif';"><br></font><font style="font-family:'Times New Roman','Times','serif';">(AC Immune Ltd)</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">there exists a Company pursuant to the provisions of </font><font style="font-family:'Times New Roman','Times','serif';">Articles</font><font style="font-family:'Times New Roman','Times','serif';"> 620 </font><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">et seq.</i><font style="font-family:'Times New Roman','Times','serif';"> of the Swiss Code of Obligations (CO) with registered office in Ecublens (VD). The duration of the Company is unlimited.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:67.85pt;text-indent:-67.85pt;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 1</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Raison sociale et dur&#233;e</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Sous la raison sociale</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">AC Immune SA</font><font style="font-family:'Times New Roman','Times','serif';"><br></font><font style="font-family:'Times New Roman','Times','serif';">(AC Immune AG)</font><font style="font-family:'Times New Roman','Times','serif';"><br></font><font style="font-family:'Times New Roman','Times','serif';">(AC Immune Ltd)</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">il existe une soci&#233;t&#233; conform&#233;ment aux articles 620 ss. du Code des Obligations suisse (CO) ayant son si&#232;ge &#224; Ecublens (VD). La dur&#233;e de la soci&#233;t&#233; est illimit&#233;e.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:67.85pt;text-indent:-67.85pt;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 2</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Purpose</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The purpose of the Company is the research, study, development, manufacture, promotion, sale and marketing of products and substances within the pharmaceutical and nutrition industry as well as the purchase, sale and exploitation of patents and licenses in this field.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:67.85pt;text-indent:-67.85pt;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 2</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">But</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le but de la soci&#233;t&#233; est la recherche, les &#233;tudes, le d&#233;veloppement, la fabrication, la promotion, la vente et le marketing des produits et des substances au sein de l&#39;industrie pharmaceutique et de la nutrition ainsi que l&#39;achat, la vente et l&#39;exploitation de brevets et de licences dans ce domaine.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Company may engage in any activities which are apt to favor the purpose of the Company directly or indirectly. The Company may also acquire and sell real estate.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">La soci&#233;t&#233; peut se livrer &#224; des activit&#233;s qui sont de nature &#224; favoriser directement ou indirectement le but de la soci&#233;t&#233;. La soci&#233;t&#233; peut &#233;galement acqu&#233;rir et vendre des biens immobiliers.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Company may open branch offices in Switzerland and abroad and may also acquire participations in other companies.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">La soci&#233;t&#233; peut ouvrir des succursales en Suisse et &#224; l&#39;&#233;tranger et peut &#233;galement acqu&#233;rir des participations dans d&#39;autres soci&#233;t&#233;s.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Company may provide securities to its subsidiaries </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">La soci&#233;t&#233; peut fournir des titres &#224; ses filiales et des </font></p></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">and supply guarantees.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">garanties d&#39;approvisionnement.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:49.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">II.</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Share Capital and Shares </b></p></div></div></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;padding-left:39.5pt;text-indent:-39.5pt;text-transform:uppercase;margin:6pt 0pt 6pt -39.5pt;"><font style="font-family:'Times New Roman','Times','serif';margin-left:0pt;margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:46.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">II.</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Capital-actions et actions </b></p></div></div></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:42.55pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 3</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Share Capital and Shares</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Share Capital of the Company is CHF&#160;</font><font style="font-family:'Times New Roman','Times','serif';">2&#39;082&#39;858.10</font><font style="font-family:'Times New Roman','Times','serif';">. It is divided into </font><font style="font-family:'Times New Roman','Times','serif';">104&#39;142&#39;905</font><i style="font-family:'Times New Roman','Times','serif';font-size:13pt;font-style:italic;"> </i><font style="font-family:'Times New Roman','Times','serif';">registered shares with a nominal value of CHF 0.02 each, fully paid-in.</font><font style="font-family:'Times New Roman','Times','serif';"><br></font><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">According to the contribution in kind agreement dated October 12th, 2021, the Company acquires from Affiris AG (FN 240538), a company incorporated under Austrian law with its registered office in Vienna (Austria), the rights related to patents, patent applications, trademarks and know-how. This contribution is made and accepted for the price of USD 53,702,500.--, and paid by the delivery to the contributor of a total of 6,501,513 fully paid up registered shares of the Company with a nominal value of CHF 0.02 each.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:67.85pt;text-indent:-67.85pt;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 3</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Capital-actions et actions</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le capital-actions de la soci&#233;t&#233; se monte &#224; CHF&#160;2&#39;082&#39;858.10. Il est divis&#233; en 104&#39;142&#39;905 actions nominatives d&#39;une valeur nominale de CHF 0.02 chacune, enti&#232;rement lib&#233;r&#233;es.</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Selon contrat d&#8217;apport du 12 octobre 2021, la Soci&#233;t&#233; acquiert de Affiris AG (FN 240538), soci&#233;t&#233; de droit autrichien ayant son si&#232;ge &#224; Vienne (Autriche) les droits li&#233;s &#224; des brevets, d&#233;p&#244;ts de brevets, marques et savoir-faire. Cet apport est fait et accept&#233; pour le prix de USD 53&#39;702&#39;500.--, et pay&#233; par la remise &#224; l&#39;apporteur d&#8217;un total de 6&#39;501&#39;513 actions nominatives de la Soci&#233;t&#233; d&#39;une valeur nominale de CHF 0.02 chacune, enti&#232;rement lib&#233;r&#233;es.</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:49.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 3a</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Authorized Capital Increase of Share Capital</b></p></div></div></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:46.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 3a</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Augmentation autoris&#233;e du</b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"><br></b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">capital-actions</b></p></div></div></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Board of Directors is authorized to increase the share capital, in one or several steps, until 24&#160;June&#160;2024, by a maximum amount of CHF&#160;114&#8217;000 by issuing a maximum of 5&#39;700&#39;000 registered shares with a par value of CHF&#160;0.02 each, to be fully paid up. An increase of the share capital (i) by means of an offering underwritten by a financial institution, a syndicate or another third party or third parties, followed by an offer to the then-existing shareholders of the Company and (ii) in partial amounts, shall also be permissible.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:normal;margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le conseil d&#39;administration est autoris&#233; &#224; augmenter le capital-actions, en une ou plusieurs &#233;tapes jusqu&#39;au 24&#160;juin 2024, d&#39;un montant maximum de CHF&#160;114&#39;000 par l&#39;&#233;mission d&#39;un nombre maximum de 5&#39;700&#39;000 actions nominatives d&#39;une valeur nominale de CHF&#160;0.02 chacune, &#224; lib&#233;rer enti&#232;rement. Une augmentation de capital (i)&#160;par souscription d&#39;actions par une institution financi&#232;re, un syndicat ou un tiers ou des tiers, suivie par une souscription d&#39;actions par les actionnaires de la soci&#233;t&#233; alors existants et (ii) par montants partiels, est &#233;galement autoris&#233;e.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:9pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;">The Board of Directors shall determine the time of the issuance, the issue price, the manner in which the new</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;">registered shares have to be paid up, the date from which the registered shares carry the right to dividends, the conditions for the exercise of the preemptive rights and the allotment of preemptive rights that have not been exercised. The Board of Directors may allow the preemptive rights that have not been exercised to expire, or it may place with third parties such rights or registered shares, the preemptive rights of which have not been exercised, at market conditions or use them otherwise in the interest of the Company.</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:normal;margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le conseil d&#39;administration fixe la date d&#39;&#233;mission, le prix d&#39;&#233;mission, la mani&#232;re de lib&#233;rer les nouvelles actions nominatives, la date &#224; partir de laquelle les actions nominatives donnent droit &#224; un dividende, les conditions pour l&#39;exercice des droits de souscription pr&#233;f&#233;rentiels et l&#39;attribution des droits de souscription pr&#233;f&#233;rentiels qui n&#39;ont pas &#233;t&#233; exerc&#233;s. Le conseil d&#39;administration peut autoriser que des droits de souscription pr&#233;f&#233;rentiels qui n&#39;ont pas &#233;t&#233; exerc&#233;s expirent ou attribuer &#224; des tiers ces droits ou actions nominatives, dont les droits de souscription pr&#233;f&#233;rentiels n&#39;ont pas &#233;t&#233; exerc&#233;s, aux conditions du march&#233; ou les utiliser autrement dans l&#39;int&#233;r&#234;t de la soci&#233;t&#233;.</font></p></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Board of Directors is authorized to withdraw or limit the preemptive rights of the shareholders and to allot them to third parties:</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">a) if the issue price of the new registered shares is determined by reference to the market price (with a customary discount); or</font><font style="font-family:'Times New Roman','Times','serif';"><br></font><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">b) for the acquisition of an enterprise, part of an enterprise or participations, or for the financing or refinancing of any of such acquisition, or in the event of share placement for the financing or refinancing of such placement; or</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">c) for raising of capital (including private placements) in a fast and flexible manner which probably could not be reached without the exclusion of the statutory pre-emptive right of the existing shareholders.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:normal;margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le conseil d&#39;administration est autoris&#233; &#224; retirer ou &#224; limiter les droits pr&#233;f&#233;rentiels de souscription des actionnaires et &#224; les attribuer &#224; des tiers:</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">a) si le prix d&#39;&#233;mission des nouvelles actions nominatives est d&#233;termin&#233; avec une r&#233;f&#233;rence au prix de march&#233; (avec un rabais usuel); ou </font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">b) pour l&#39;acquisition d&#39;une entreprise, part d&#39;entreprise ou participation, ou pour le financement ou le refinancement de ladite acquisition, ou en cas de placement d&#39;actions pour le financement ou le refinancement dudit placement; ou</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">c) pour lever des capitaux (y compris des placements priv&#233;s) dans un d&#233;lai rapide et flexible, ce qui ne pourrait probablement pas &#234;tre r&#233;alis&#233; sans l&#39;exclusion du droit pr&#233;f&#233;rentiel de souscription statuaire des actionnaires existants.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The acquisition of registered shares out of authorized capital increase of share capital for general purposes and any transfers of registered shares shall be subject to the restrictions specified in Article 4 of the Articles of Association.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:normal;margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">L&#39;acquisition d&#39;actions nominatives dans le cadre d&#39;une augmentation autoris&#233;e du capital-actions &#224; des fins g&#233;n&#233;rales et les transferts d&#39;actions nominatives sont soumis aux restrictions pr&#233;vues &#224; l&#39;article 4 des statuts.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:49.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 3b </b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Conditional capital for financing and other purposes</b></p></div></div></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:46.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 3b </b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Capital conditionnel pour des financements et autres objets</b></p></div></div></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The share capital of the Company shall be increased by a maximum amount of CHF 100,000 through the issue of a maximum of 5,000,000 registered shares, payable in full, each with a nominal value of CHF 0.02 through the optional or mandatory exercise of conversion, exchange, option, warrant or similar rights or obligations for the subscription of shares granted to shareholders or third parties on a standalone basis or in connection with bonds, notes, options, warrants or other securities or contractual obligations of the Company or any subsidiaries of the Company, including convertible debt instruments, as may be amended or novated from time to time.</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le capital-actions de la soci&#233;t&#233; peut &#234;tre augment&#233; d&#39;un montant maximum de CHF 100&#8217;000 par l&#39;&#233;mission d&#39;un maximum de 5&#8217;000&#8217;000 d&#8217;actions nominatives, d&#39;une valeur nominale de CHF 0.02 chacune, &#224; lib&#233;rer enti&#232;rement, suite &#224; l&#39;exercice optionnel ou obligatoire de droits de conversion, d&#8217;&#233;change, d&#39;option, d&#8217;acquisition (&#171; warrants &#187;) ou de droits ou obligations similaires portant sur la souscription d&#8217;actions, accord&#233;s aux actionnaires ou &#224; des tiers sur une base individuelle ou en relation avec des obligations, reconnaissances de dette (&#171; notes &#187;), options, droits d&#8217;acquisition (&#171; warrants &#187;) ou autres titres ou obligations contractuelles de la soci&#233;t&#233; ou de filiales de la soci&#233;t&#233;, y compris les instruments d&#39;emprunt convertible, tels que modifi&#233;s ou nov&#233;s ult&#233;rieurement.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Shareholders&#39; subscription rights are excluded. Shareholders&#39; advance subscription rights with regard to the new bonds, warrants or similar instruments may be restricted or excluded by decision of the Board of Directors in order to finance or re-finance the acquisition of companies, parts of companies or holdings, or new investments planned by the Company, or in order to </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le droit de souscription pr&#233;f&#233;rentiel des actionnaires est exclu. Les droits de souscription pr&#233;f&#233;rentiels pr&#233;alables des actionnaires &#224; l&#39;&#233;gard des nouvelles obligations, nouveaux droits d&#8217;acquisition (&#171; warrants &#187;) ou instruments similaires peuvent &#234;tre limit&#233;s ou exclus par d&#233;cision du conseil d&#39;administration afin de financer ou de refinancer l&#39;acquisition d&#39;entreprises, parts </font></p></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">issue </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">convertible bonds and warrants on the international capital markets or through private placement. If advance subscription rights are excluded, then (1) the instruments are to be placed at market conditions, (2) the exercise period is not to exceed ten years from the date of issue for warrants and twenty years for conversion rights and (3) the conversion or exercise price for the new shares is to be set at least in line with the market conditions prevailing at the date on which the instruments are issued. The respective holders of conversion and/or option or warrant rights are entitled to subscribe the new shares.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">d&#39;entreprises ou de holdings, ou de nouveaux investissements pr&#233;vus par la soci&#233;t&#233;, ou en vue d&#39;&#233;mettre des obligations convertibles et des droits d&#8217;acquisition (&#171; warrants &#187;) sur les march&#233;s internationaux de capitaux ou par placement priv&#233;. Si les droits de souscription pr&#233;f&#233;rentiels pr&#233;alables sont exclus, (1) les instruments doivent &#234;tre attribu&#233;s aux conditions du march&#233;, (2) la p&#233;riode d&#39;exercice ne doit pas d&#233;passer dix ans &#224; partir de la date d&#39;&#233;mission des droits d&#8217;acquisitions (&#171; warrants &#187;) et vingt ans pour les droits de conversion et (3) le prix de conversion ou d&#39;exercice des actions nouvelles doit &#234;tre fix&#233; au moins aux conditions du march&#233; pr&#233;valant &#224; la date &#224; laquelle les instruments sont &#233;mis. Les d&#233;tenteurs respectifs de droits de conversion et/ou option ou de droits d&#8217;acquisition (&#171; warrants &#187;) ont le droit de souscrire les nouvelles actions.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The exercise of conversion or option rights, as well as the waiver of such rights, may be exercised by written declaration or by electronic means.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">L&#8217;exercice des droits de conversion ou d&#8217;options, de m&#234;me que la renonciation &#224; ces droits, s&#8217;exercent par d&#233;claration &#233;crite ou par voie &#233;lectronique.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The acquisition of registered shares through the exercise of conversion rights or warrants and any transfers of registered shares shall be subject to the restrictions specified in Article 4 of the Articles of Association.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">L&#39;acquisition d&#39;actions nominatives par l&#39;exercice de droits ou de bons de conversion et les transferts d&#39;actions nominatives sont assujetties aux restrictions pr&#233;vues par l&#39;article 4 des statuts.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:67.85pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 3c</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Conditional Share Capital Increase for Employee Benefit Plans</b></p></div></div></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:67.85pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 3c</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Augmentation conditionnelle du capital-actions pour les plans d&#39;avantages sociaux </b></p></div></div></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">The share capital of the Company shall be increased by an amount not exceeding CHF&#160;</font><font style="font-family:'Times New Roman','Times','serif';">91&#39;844.20</font><i style="font-family:'Times New Roman','Times','serif';font-size:13pt;font-style:italic;"> </i><font style="font-family:'Times New Roman','Times','serif';">through the issue of a maximum of </font><font style="font-family:'Times New Roman','Times','serif';">4&#39;592&#39;210</font><font style="font-family:'Times New Roman','Times','serif';"> registered shares, payable in full, each with a nominal value of CHF 0.02, in connection with the exercise of option rights granted to any employee of the Company or a subsidiary, and any consultant, members of the Board of Directors, or other person providing services to the Company or a subsidiary.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:normal;margin-bottom:6pt;margin-top:18pt;text-transform:none;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le capital social de la soci&#233;t&#233; sera augment&#233; d&#39;un montant ne d&#233;passant pas </font><font style="font-family:'Times New Roman','Times','serif';"><br></font><font style="font-family:'Times New Roman','Times','serif';">CHF&#160;91&#39;844.20 par l&#39;&#233;mission d&#39;un maximum de 4&#39;592&#39;210 actions nominatives, enti&#232;rement lib&#233;r&#233;es, chacune avec une valeur nominale de CHF 0.02, dans le cadre de l&#39;exercice de droits d&#39;option accord&#233;s &#224; tout employ&#233; de la Soci&#233;t&#233; ou d&#39;une succursale, et &#224; tout consultant, aux membres du conseil d&#39;administration, ou &#224; d&#39;autres personnes fournissant des services en faveur de la Soci&#233;t&#233; ou d&#39;une filiale.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Shareholders&#39; subscription rights shall be excluded with regard to these shares. These new registered shares may be issued at a price below the current market price. The Board of Directors shall specify the precise conditions of issue including the issue price of the shares.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-bottom:6pt;margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le droit de souscription pr&#233;f&#233;rentiel des actionnaires est exclu &#224; l&#39;&#233;gard de ces actions. Ces nouvelles actions nominatives peuvent &#234;tre &#233;mises &#224; un prix inf&#233;rieur au prix du march&#233; actuel. Le conseil d&#39;administration doit pr&#233;ciser les conditions pr&#233;cises d&#39;&#233;mission, y compris le prix d&#39;&#233;mission des actions.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">The acquisition of registered shares in connection with employee participation and any further transfers of registered shares shall be subject to the restrictions </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-bottom:6pt;margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">L&#39;acquisition d&#39;actions nominatives dans le cadre de la participation des employ&#233;s et d&#39;autres transferts d&#39;actions </font></p></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">specified </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">in Article 4 of the Articles of Association.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">nominatives sont soumis aux restrictions pr&#233;vues &#224; l&#39;article 4 des statuts.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:49.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 4</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Share Register</b></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Company shall maintain a share register in which it shall register the name, first name and place of residence (in case of legal persons the place of incorporation) of the owners and usufructuaries of its registered shares. Natural and legal persons as well as legal representatives of minors etc. entitled by law to the voting rights of a share which they do not own will be noted in the share register upon request.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:67.85pt;text-indent:-67.85pt;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:42.55pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 4</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Registre des actions</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">La soci&#233;t&#233; tient un registre des actions nominatives, dans lequel sont inscrits le nom, le pr&#233;nom et l&#39;adresse (dans le cas d&#39;une personne morale, le si&#232;ge) des propri&#233;taires et des usufruitiers des actions. Les personnes physiques et morales ainsi que les repr&#233;sentants l&#233;gaux des mineurs etc. autoris&#233;s par la loi &#224; voter alors qu&#39;ils ne sont pas propri&#233;taires des actions seront, sur demande, inscrits dans le registre des actions.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Upon request, acquirers of shares will be registered in the share register without limitation as shareholders if they expressly certify that they acquired the shares in their own name and for their own account.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Sur demande, les acqu&#233;reurs d&#39;actions seront inscrits dans le registre des actions sans limitation comme actionnaires s&#39;ils attestent express&#233;ment qu&#39;ils ont acquis les actions en leur propre nom et pour leur propre compte.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Persons who do not expressly declare in the registration application that they are holding the shares on their own account (thereafter: nominees) shall forthwith be entered on the share register as shareholders with voting rights up to a maximum of 3 percent of the share capital. Beyond that limit, registered shares of nominees shall only be entered as voting if the nominees in question confirm in writing that they are willing to disclose the names, addresses and shareholdings of the persons on whose account they hold 0.5 percent or more of the share capital. The Board of Directors concludes agreements with nominees that among other things govern the representation of shareholders and the voting rights.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Les personnes qui ne d&#233;clarent pas express&#233;ment dans la demande d&#39;inscription qu&#39;ils d&#233;tiennent les actions pour leur propre compte (par la suite: les candidats) doivent imm&#233;diatement &#234;tre inscrits dans le registre des actions comme actionnaires avec droit de vote pour un maximum de 3 pour cent du capital-actions. Au-del&#224; de cette limite, les actions nominatives des candidats ne sont inscrites avec droit de vote que si les candidats en question confirment par &#233;crit qu&#39;ils sont pr&#234;ts &#224; divulguer les noms, adresses et participations des personnes pour le compte desquelles ils d&#233;tiennent 0,5 pour cent ou plus du capital-actions. Le conseil d&#39;administration conclut des accords avec les candidats qui, entre autres choses, r&#233;gissent la repr&#233;sentation des actionnaires et des droits de vote.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">After hearing the registered shareholder or nominee, the Board of Directors may remove entries in the share register with retroactive effect as per the date of entry, if such entry was based on false information. The party affected must be informed of such removal immediately.</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-bottom:6pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-bottom:6pt;margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Apr&#232;s avoir entendu l&#39;actionnaire enregistr&#233; ou le candidat, le conseil d&#39;administration peut supprimer des inscriptions dans le registre des actions avec effet r&#233;troactif &#224; la date d&#39;inscription, si cette inscription &#233;tait bas&#233;e sur de fausses informations. La partie touch&#233;e doit &#234;tre imm&#233;diatement inform&#233;e de cette suppression. </font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">No individual or legal entity may, directly or indirectly, formally, constructively or beneficially own (as defined in the next paragraph below) or otherwise control voting rights (&quot;Controlled Shares&quot;) with respect to 33 </font><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;">1</sup><font style="font-family:'Times New Roman','Times','serif';">/</font><sub style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:sub;">3</sub><font style="font-family:'Times New Roman','Times','serif';"> % or more of the registered share capital recorded in the Commercial Register except if such individual or legal entity has submitted prior to the acquisition of such </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-bottom:6pt;margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Aucune personne physique ou morale ne peut, directement ou indirectement, formellement ou implicitement d&#233;tenir &#224; son profit (comme d&#233;fini dans le paragraphe ci-dessous) ou, d&#39;une autre mani&#232;re, contr&#244;ler le droit de vote (les &quot;Actions Contr&#244;l&#233;es&quot;) de 33 </font><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;">1</sup><font style="font-family:'Times New Roman','Times','serif';">/</font><sub style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:sub;">3</sub><font style="font-family:'Times New Roman','Times','serif';"> % ou plus du capital-actions nominatif tel qu&#39;inscrit au registre du commerce sauf si cette personne </font></p></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Controlled Shares an orderly tender offer to all shareholders with a minimum price of the higher of (i) the volume weighted average price of the last 60 trading days </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">physique ou morale a pr&#233;sent&#233; avant l&#39;acquisition de ces Actions Contr&#244;l&#233;e une offre publique d&#39;achat en bonne et due forme &#224; tous les actionnaires &#224; un prix minimum &#233;quivalent au montant le </font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">prior to the publication of the tender offer or (ii) the highest price paid by such individual or legal entity in the 12 months preceding to the publication of the tender offer. Those associated through capital, voting power, joint management or in any other way, or joining for the acquisition of shares, shall be regarded as one person. The registered shares exceeding the limit of 33 </font><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;">1</sup><font style="font-family:'Times New Roman','Times','serif';">/</font><sub style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:sub;">3</sub><font style="font-family:'Times New Roman','Times','serif';"> % and not benefiting from the exemption regarding a tender offer shall be entered in the share register as shares without voting rights.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">plus &#233;lev&#233; entre (i) le cours moyen pond&#233;r&#233; en fonction du volume des 60 derniers jours de bourse pr&#233;c&#233;dant la publication de l&#39;offre publique d&#39;achat et (ii) le plus haut prix pay&#233; par cette personne physique ou morale dans les 12 mois pr&#233;c&#233;dant la publication de l&#39;offre publique d&#39;achat. Les personnes associ&#233;es par le capital, les droits de vote, une gestion commune ou de toute autre mani&#232;re, ou qui se joignent pour une acquisition d&#39;actions, sont consid&#233;r&#233;es comme une personne. Les actions nominatives d&#233;passant la limite de 33 </font><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;">1</sup><font style="font-family:'Times New Roman','Times','serif';">/</font><sub style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:sub;">3</sub><font style="font-family:'Times New Roman','Times','serif';"> % et ne b&#233;n&#233;ficiant pas de l&#39;exemption relative &#224; une offre publique d&#39;achat sont inscrites dans le registre des actions comme des actions sans droit de vote.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">For the purposes of this Article 4, &quot;Controlled Shares&quot; in reference to any individual or entity means:</font></p><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><font style="font-family:'Times New Roman','Times','serif';">(a)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><font style="font-family:'Times New Roman','Times','serif';">all shares of the Company directly, indirectly or constructively owned by such individual or entity; provided that</font></p></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:21.25pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(i) </font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">shares owned, directly or indirectly, by or for a partnership, or trust or estate will be considered as being owned proportionately by its partners, or beneficiaries; and</font><font style="display:inline-block;width:3.97pt;"></font><font style="font-family:'Times New Roman','Times','serif';"><br></font><font style="font-family:'Times New Roman','Times','serif';margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:21.25pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(ii)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">shares owned, directly or indirectly, by or for a corporation will be considered as being owned proportionately by any shareholder owning 50% or more of the outstanding voting shares of such corporation; and</font></p></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:21.25pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(iii)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">shares subject to options, warrants or other similar rights shall be deemed to be owned; and</font><font style="font-family:'Times New Roman','Times','serif';"><br></font><font style="font-family:'Times New Roman','Times','serif';margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(b)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">all shares of the Company directly, indirectly beneficially owned by such individual or entity; provided that</font><font style="font-family:'Times New Roman','Times','serif';"><br></font><font style="font-family:'Times New Roman','Times','serif';margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:21.25pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(i)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">a beneficial owner of a security includes any person who, directly or indirectly, through any contract, arrangement, understanding, relationship, or otherwise alone or together with other such persons has or shares:</font></p></div></div></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Aux fins du pr&#233;sent article 4, Actions Contr&#244;l&#233;es signifie en r&#233;f&#233;rence &#224; toute personne physique ou morale:</font></p><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(a)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">toutes actions directement, indirectement ou implicitement d&#233;tenues par cette personne physique ou morale, &#224; condition que</font></p></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:21.25pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(i) </font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">les actions d&#233;tenues, directement ou indirectement, par ou pour un partenariat, une fiducie ou une communaut&#233; d&#39;h&#233;ritiers sont consid&#233;r&#233;es comme &#233;tant d&#233;tenues proportionnellement par leurs partenaires ou b&#233;n&#233;ficiaires; et </font></p></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:21.25pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(ii)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">les </font><font style="font-family:'Times New Roman','Times','serif';">actions d&#233;tenues, directement ou indirectement, par ou pour une soci&#233;t&#233; seront consid&#233;r&#233;es comme &#233;tant d&#233;tenues proportionnellement par tout actionnaire d&#233;tenant 50% ou plus des actions avec droit de vote en circulation de cette soci&#233;t&#233;; et </font></p></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:21.25pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(iii)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">les </font><font style="font-family:'Times New Roman','Times','serif';">actions sujettes &#224; des options, des bons de souscription ou autres droits semblables sont r&#233;put&#233;es &#234;tre d&#233;tenues; et</font><font style="display:inline-block;width:12.67pt;"></font><font style="font-family:'Times New Roman','Times','serif';"><br></font><font style="font-family:'Times New Roman','Times','serif';margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(b)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">toutes actions de la soci&#233;t&#233; d&#233;tenues directement, indirectement ou &#224; son profit par cette </font><font style="font-family:'Times New Roman','Times','serif';">personne physique ou morale</font><font style="font-family:'Times New Roman','Times','serif';">, &#224; condition que</font></p></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:21.25pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(i)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">un b&#233;n&#233;ficiaire effectif d&#39;un titre comprend toute personne qui, directement ou indirectement, par le biais d&#39;un contrat, d&#39;un accord, d&#39;une entente, d&#39;une relation, ou </font></p></div></div></div></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:42.55pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(1)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">voting power which includes the power to vote, or to direct the voting of, such security; and/or</font></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 42.5pt;"><font style="font-family:'Times New Roman','Times','serif';">autrement, seul ou avec d&#39;autres personnes a ou partage:</font><font style="display:inline-block;width:12.05pt;"></font></p><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:42.55pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(1)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">le </font><font style="font-family:'Times New Roman','Times','serif';">pouvoir de voter, y compris le pouvoir de voter ou de diriger le vote d&#39;un tel titre; et/ou</font></p></div></div></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:42.55pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(2)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">investment power which includes the power to dispose, or to direct the disposition of, such security.</font></p></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:21.25pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(ii)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">Any person who, directly or indirectly, creates or uses a trust, proxy, power of attorney, pooling arrangement or any other contract, arrangement, or device with the purpose or effect of divesting such person of beneficial ownership of shares of the Company or preventing the vesting of such beneficial ownership as part of a plan or scheme to evade the provisions of these articles of association shall be deemed to be the beneficial owner of such shares.</font></p></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:21.25pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(iii)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">A person shall be deemed to be the beneficial owner of shares if that person has the right to acquire beneficial ownership of such shares within 60 days, including but not limited to any right acquired: (A) through the exercise of any option, warrant or right; (B) through the conversion of a security; (C) pursuant to the power to revoke a trust, discretionary account, or similar arrangement; or (D) pursuant to the automatic termination of a trust, discretionary account or similar arrangement.</font></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The limit of 33 </font><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;">1</sup><font style="font-family:'Times New Roman','Times','serif';">/</font><sub style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:sub;">3</sub><font style="font-family:'Times New Roman','Times','serif';"> % of the registered share capital also applies to the subscription for, or acquisition of, registered shares by exercising option or convertible rights arising from registered or bearer securities or any other securities issued by the Company or third parties, as well as by means of exercising purchased preemptive rights arising from either registered or bearer shares. The registered shares exceeding the limit of 33 </font><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;">1</sup><font style="font-family:'Times New Roman','Times','serif';">/</font><sub style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:sub;">3</sub><font style="font-family:'Times New Roman','Times','serif';"> % shall be entered in the share register as shares without voting rights.</font><font style="display:inline-block;width:17.27pt;"></font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Board of Directors may in special cases approve exceptions to the above regulations. The Board of Directors is in addition authorized, after due consultation with the person concerned, to delete with retroactive effect entries in the share register which were effected </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:42.55pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(2)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">le </font><font style="font-family:'Times New Roman','Times','serif';">pouvoir d&#39;investir, y compris le pouvoir de disposer ou de diriger la disposition d&#39;un tel titre.</font></p></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:21.25pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(ii)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">Toute personne qui, directement ou indirectement, cr&#233;e ou utilise une fiducie, une procuration, un pooling ou tout autre contrat, accord, ou un dispositif ayant pour objet ou pour effet de priver cette personne de la propri&#233;t&#233; effective des actions de la soci&#233;t&#233; ou d&#39;en emp&#234;cher l&#39;acquisition </font><font style="font-family:'Times New Roman','Times','serif';">effective </font><font style="font-family:'Times New Roman','Times','serif';">au moyen d&#39;un plan ou programme visant &#224; se soustraire aux dispositions de ces statuts est r&#233;put&#233;e &#234;tre le propri&#233;taire effectif de ces actions.</font><font style="display:inline-block;width:25.92pt;"></font></p></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:21.25pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(iii)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">Une personne est r&#233;put&#233;e &#234;tre propri&#233;taire effective d&#39;actions si cette personne a le droit d&#39;acqu&#233;rir la propri&#233;t&#233; effective de ces actions dans les 60 jours, y compris, mais pas limit&#233; &#224; un droit acquis: (A) au moyen de l&#39;exercice d&#39;une option, d&#39;un bon ou d&#39;un droit de souscription; (B) par la conversion d&#39;un titre; (C) en vertu du pouvoir de r&#233;voquer une fiducie, compte discr&#233;tionnaire ou accord semblable; ou (D) conform&#233;ment &#224; la r&#233;siliation automatique d&#39;une fiducie, compte discr&#233;tionnaire ou accord semblable. </font></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">La limite de 33 </font><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;">1</sup><font style="font-family:'Times New Roman','Times','serif';">/</font><sub style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:sub;">3</sub><font style="font-family:'Times New Roman','Times','serif';"> % du capital-actions nominatif s&#39;applique &#233;galement &#224; la souscription ou l&#39;acquisition d&#39;actions nominatives par l&#39;exercice d&#39;options ou de droits convertibles d&#233;coulant de titres nominatifs ou au porteur ou d&#39;autres titres &#233;mis par la soci&#233;t&#233; ou par des tiers, ainsi que par le biais de l&#39;exercice de droits de souscription pr&#233;f&#233;rentiels achet&#233;s d&#233;coulant d&#39;actions nominatives ou au porteur. Les actions nominatives d&#233;passant la limite de 33 </font><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;">1</sup><font style="font-family:'Times New Roman','Times','serif';">/</font><sub style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:sub;">3</sub><font style="font-family:'Times New Roman','Times','serif';"> % sont inscrites dans le registre des actions comme des actions sans droit de vote.</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le conseil d&#39;administration peut dans des cas particuliers approuver des exceptions aux r&#232;gles pr&#233;cit&#233;es. Il est en outre autoris&#233;, apr&#232;s consultation avec la personne concern&#233;e, de supprimer avec effet r&#233;troactif des inscriptions du registre des actions qui ont &#233;t&#233; effectu&#233;es </font></p></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">on the basis of false information.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">sur la base de fausses informations.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:49.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 5</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Share Certificates and Intermediated Securities</b></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Company may issue registered shares in the form of single certificates, global certificates and uncertificated securities. Under the conditions set forth by statutory law, the Company may convert its registered shares from one form into another form at any time and without the approval of the shareholders.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:46.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 5</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Certificats d&#39;actions et titres</b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"><br></b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">interm&#233;di&#233;s</b></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">La soci&#233;t&#233; peut &#233;mettre des actions nominatives sous forme de certificats individuels, de certificats globaux et de titres d&#233;mat&#233;rialis&#233;s. Dans les conditions pr&#233;vues par la loi, la soci&#233;t&#233; peut convertir ses actions nominatives d&#39;une forme en une autre forme, &#224; tout moment et sans l&#39;approbation des actionnaires.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The shareholder has no right to demand a conversion of the registered shares. Each shareholder may, however, at any time request a written confirmation from the Company of the registered shares held by such shareholder, as reflected in the share register.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">L&#39;actionnaire n&#39;a pas le droit d&#39;exiger une conversion d&#39;actions nominatives. Chaque actionnaire peut toutefois, &#224; tout moment, demander une confirmation &#233;crite de la soci&#233;t&#233; du nombres d&#39;actions nominatives d&#233;tenues par cet actionnaire telles qu&#39;inscrites au registre du commerce.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The transfer of intermediated securities and the pledging of these intermediated securities shall be based on the provisions of the Swiss Federal Intermediated Securities Act. Transfer of propriety as collateral by means of written assignment are not permitted.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le transfert des titres interm&#233;di&#233;s et la mise en gage de ces titres interm&#233;di&#233;s suivent les dispositions de la Loi f&#233;d&#233;rale sur les titres interm&#233;di&#233;s. Le transfert de propri&#233;t&#233; &#224; titre de s&#251;ret&#233; par cession &#233;crite n&#39;est pas autoris&#233;.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:49.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 6</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Exercise of Shareholders Rights</b></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The shares are indivisible and the Company recognizes only one single representative per share.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:46.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 6</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Exercice des droits des actionnaires</b></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Les actions sont indivisibles et la soci&#233;t&#233; ne reconna&#238;t qu&#39;un seul repr&#233;sentant par action.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The right to vote and the other rights pertaining to a registered share may only be exercised by a shareholder, a usufructuary or a nominee who is registered with the right to vote in the share register and by persons who are entitled by law to the voting rights of a share.</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le droit de vote et les autres droits relatifs &#224; une action nominative ne peut &#234;tre exerc&#233; que par un actionnaire, un usufruitier ou un candidat qui est inscrit avec le droit de vote dans le registre des actions et par des personnes autoris&#233;es par la loi &#224; exercer les droits de vote d&#39;une action.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:49.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">III.</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Corporate structure</b></p></div></div></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;padding-left:39.5pt;text-indent:-39.5pt;text-transform:uppercase;margin:6pt 0pt 6pt -39.5pt;"><font style="font-family:'Times New Roman','Times','serif';margin-left:0pt;margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;min-height:14.5pt;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;text-transform:uppercase;">III.</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">sTRUCTURE DE LA SOCI&#201;T&#201;</b></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:49.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 7</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Organization</b></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The corporate bodies are:</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:20pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">A.</font></font><font style="font-family:'Times New Roman','Times','serif';">the General Meeting;</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:20pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">B.</font></font><font style="font-family:'Times New Roman','Times','serif';">the Board of Directors;</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:20pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">C.</font></font><font style="font-family:'Times New Roman','Times','serif';">the Auditors.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:67.85pt;text-indent:-67.85pt;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 7</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Organisation</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Les organes de la soci&#233;t&#233; sont:</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:20pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">A.</font></font><font style="font-family:'Times New Roman','Times','serif';">L&#39;assembl&#233; g&#233;n&#233;rale;</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:20pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">B.</font></font><font style="font-family:'Times New Roman','Times','serif';">Le conseil d&#39;administration;</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:18.25pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">C.</font></font><font style="font-family:'Times New Roman','Times','serif';">l&#39;organe de r&#233;vision.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:49.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">IV.</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">THe General Meeting</b></p></div></div></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;padding-left:39.5pt;text-indent:-39.5pt;text-transform:uppercase;margin:6pt 0pt 6pt -39.5pt;"><font style="font-family:'Times New Roman','Times','serif';margin-left:0pt;margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;min-height:14.5pt;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;text-transform:uppercase;">IV.</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">L&#39;assembl&#233;e G&#233;n&#233;rale</b></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:67.85pt;text-indent:-67.85pt;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 8</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Powers</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The General Meeting is the supreme body of the </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:67.85pt;text-align:justify;text-indent:-67.85pt;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 8</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Pouvoirs</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">L&#39;assembl&#233;e g&#233;n&#233;rale des actionnaires est le pouvoir supr&#234;me de la soci&#233;t&#233;. Elle a les droits intransmissibles </font></p></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Company. It has the following non delegable powers:</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">suivants:</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to adopt and amend the Articles of Association (Articles 651a, 652g, 653g und 653i CO remain reserved);</font></div></div></div><div style="margin-top:6pt;"></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">adapter et modifier les statuts (articles 651a, 652g, 653g et 653i CO </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">sont r&#233;serv&#233;s</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">); </font></div></div></div><div style="margin-top:6pt;"></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to elect and remove the members of the Board of Directors, the Chairman of the Board of Directors, the members of the Compensation Committee, the Auditors and the Independent Proxy;</font></div></div></div><div style="margin-top:6pt;"></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">nommer et r&#233;voquer les membres du conseil d&#39;administration, le pr&#233;sident du conseil d&#39;administration, les membres du </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">comit&#233; de r&#233;mun&#233;ration</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">, </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">l&#39;organe de r&#233;vision</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> et le mandataire ind&#233;pendant</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">;</font></div></div></div><div style="margin-top:6pt;"></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">c)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to approve the management report and the annual accounts and to determine the allocation of profits, in particular with regard to dividends and bonus payments;</font></div></div></div><div style="margin-top:6pt;"></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">c)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">approuver le rapport de gestion et les comptes annuels et d&#233;terminer la r&#233;partition des b&#233;n&#233;fices, en particulier en ce qui concerne les dividendes et les bonus;</font></div></div></div><div style="margin-top:6pt;"></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">d)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to discharge the members of the Board of Directors and of the Executive Committee;</font></div></div></div><div style="margin-top:6pt;"></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">d)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">donner d&#233;charge aux membres du conseil d&#39;administration et au comit&#233; ex&#233;cutif;</font></div></div></div><div style="margin-top:6pt;"></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">e)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to approve the aggregate amounts of &#160;compensation of the Board of Directors and the Executive Committee in accordance with Article 18 of the Articles of Association;</font></div></div></div><div style="margin-top:6pt;"></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">e)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">approuver les montants globaux des r&#233;mun&#233;rations du conseil d&#39;administration et du comit&#233; ex&#233;cutif conform&#233;ment &#224; l&#39;article 18 </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">des statuts</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">;</font></div></div></div><div style="margin-top:6pt;"></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;">f)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to pass resolutions concerning all matters which are reserved to the authority of the General Meeting by law or by the Articles of Association.</font></div></div></div><div style="margin-top:6pt;"></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">f)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">prendre les d&#233;cisions sur toutes les affaires qui sont attribu&#233;es &#224; </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">l&#39;assembl&#233;e g&#233;n&#233;rale</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> par la loi ou les statuts.</font></div></div></div><div style="margin-top:6pt;"></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:67.75pt;text-indent:-67.75pt;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 9</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Ordinary General Meeting</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Ordinary General Meeting shall be held annually within six months after the close of the business year at such time and at such location, which may be within or outside Switzerland, as determined by the Board of Directors.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:67.75pt;text-indent:-67.75pt;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 9</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Assembl&#233;e g&#233;n&#233;rale ordinaire</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-indent:-0.2pt;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">L&#39;assembl&#233;e g&#233;n&#233;rale ordinaire aura lieu chaque ann&#233;e dans les six mois qui suivent la cl&#244;ture de l&#39;exercice &#224; la date et &#224; l&#39;endroit, qui peut &#234;tre en ou hors de la Suisse, tel que d&#233;termin&#233; par le conseil d&#39;administration.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:67.85pt;text-indent:-67.85pt;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 10</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Extraordinary General Meeting</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Extraordinary General Meetings may be called by resolution of the General Meeting, the Auditors or the Board of Directors, or by shareholders with voting powers, provided they represent at least 10% of the share capital and who submit (a)(1) a request signed by such shareholder(s) that specifies the item(s) to be included on the agenda, (2) the respective proposals of the shareholders and (3) evidence of the required shareholdings recorded in the share register and (b) such other information as would be required to be included in a proxy statement pursuant to the rules of the country where the Company&#39;s shares are primarily listed.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:46.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 10</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Assembl&#233;e g&#233;n&#233;rale extraordinaire</b></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Les assembl&#233;es g&#233;n&#233;rales extraordinaires peuvent &#234;tre convoqu&#233;es par d&#233;cision de l&#39;assembl&#233;e g&#233;n&#233;rale, l&#39;organe de r&#233;vision</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">ou le conseil d&#39;administration, ou par des actionnaires avec droit de vote, &#224; condition qu&#39;ils repr&#233;sentent au moins 10% du capital-actions et qu&#39;ils soumettent (a) (1) une demande sign&#233;e par le(s)dit(s) actionnaire(s) qui sp&#233;cifie les objets &#224; faire figurer sur l&#39;ordre du jour, (2) les propositions respectives de ces actionnaires et (3) la preuve des participations requises inscrites dans le registre des actions et (b) les autres informations qui doivent &#234;tre mentionn&#233;es dans une d&#233;claration (proxy statement) conform&#233;ment aux r&#232;gles du pays o&#249; les actions de la soci&#233;t&#233; sont principalement </font></p></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">cot&#233;es.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:49.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 11</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Notice and Agenda of Shareholders&#39; Meetings</b></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Notice of a General Meeting of Shareholders shall be given by the Board of Directors or, if necessary, by the Auditor, not later than twenty calendar days prior to the date of the General Meeting of Shareholders. Notice of the General Meeting of Shareholders shall be given by way of a one-time announcement in the official means of publication of the Company pursuant to Article 46 of these Articles of Association. The notice period shall be deemed to have been observed if notice of the General Meeting of Shareholders is published in such official means of publication, it being understood that the date of publication shall not be computed in the notice period. Shareholders of record may in addition be informed of the General Meeting of Shareholders by ordinary mail or e-mail.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:46.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 11</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-align:justify;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Convocations et ordres du jour des assembl&#233;es g&#233;n&#233;rales</b></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-indent:-0.2pt;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">L&#39;assembl&#233;e g&#233;n&#233;rale est convoqu&#233;e par le conseil d&#39;administration ou, si n&#233;cessaire, par l&#39;organe de r&#233;vision, au moins 20 jours avant la tenue de l&#39;assembl&#233;e g&#233;n&#233;rale des actionnaires. La convocation &#224; l&#39;assembl&#233;e g&#233;n&#233;rale des actionnaires doit &#234;tre faite au moyen d&#39;une seule publication conform&#233;ment &#224; l&#39;article 46 de ces statuts. La p&#233;riode de pr&#233;avis sera r&#233;put&#233;e avoir &#233;t&#233; respect&#233;e si la convocation &#224; l&#39;assembl&#233;e g&#233;n&#233;rale des actionnaires est publi&#233;e conform&#233;ment &#224; l&#39;article 46 de ces statuts, &#233;tant entendu que la date de publication ne doit pas &#234;tre calcul&#233;e dans la p&#233;riode de pr&#233;avis. Les actionnaires inscrits peuvent en outre &#234;tre inform&#233;s de l&#39;assembl&#233;e g&#233;n&#233;rale des actionnaires par courrier ordinaire ou par e-mail.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The notice of a General Meeting of Shareholders shall specify the items on the agenda and the proposals of the Board of Directors and the shareholder(s) who requested that a General Meeting of Shareholders be held or an item be included on the agenda, and, in the event of elections, the name(s) of the candidate(s) that has or have been put on the ballot for election.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-indent:-0.2pt;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">La convocation &#224; l&#39;assembl&#233;e g&#233;n&#233;rale des actionnaires doit pr&#233;ciser les objets de l&#39;ordre du jour et les propositions du conseil d&#39;administration et l&#39;/les actionnaire(s) qui a/ont demand&#233; que l&#39;assembl&#233;e g&#233;n&#233;rale des actionnaires ait lieu ou qu&#39;un objet soit inscrit &#224; l&#39;ordre du jour, et, dans le cas d&#39;&#233;lections, le/les nom(s) du/des candidat(s) qui a ou ont &#233;t&#233; mis sur le bulletin de vote pour l&#39;&#233;lection.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Board of Directors shall state the matters on the agenda.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-indent:-0.2pt;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le conseil d&#39;administration doit indiquer les objets de l&#39;ordre du jour.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Shareholders who represent an aggregate of at least 10 percent of the share capital or together representing shares with a nominal value of 1 million Swiss francs may demand that an item be placed on the agenda of a General Meeting of Shareholders. A request for inclusion of an item on the agenda must be requested in writing delivered to or mailed and received at the registered office of the Company at least 120 calendar days before the first anniversary of the date that the Company&#39;s proxy statement was released to shareholders in connection with the previous year&#39;s ordinary General Meeting of Shareholders. However, if no ordinary General Meeting of Shareholders was held in the previous year or if the date of the ordinary General Meeting of Shareholders has been changed by more than 30 calendar days from the date contemplated at the time of the previous year&#39;s proxy statement, request for inclusion of an item on the agenda must be requested not </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;text-indent:-0.3pt;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Les actionnaires qui repr&#233;sentent un total d&#39;au moins 10 pour cent du capital-actions ou qui repr&#233;sentent ensemble une valeur nominale de CHF 1 million d&#39;actions peuvent exiger qu&#39;un objet soit inscrit &#224; l&#39;ordre du jour d&#39;une assembl&#233;e g&#233;n&#233;rale des actionnaires. Une demande d&#39;inscription d&#39;un objet &#224; l&#39;ordre du jour doit &#234;tre faite par &#233;crit et remise ou envoy&#233;e et re&#231;ue au si&#232;ge de la soci&#233;t&#233; au moins 120 jours avant le premier anniversaire de la date &#224; laquelle la d&#233;claration (proxy statement) de la Soci&#233;t&#233; a &#233;t&#233; communiqu&#233;e aux actionnaires lors de l&#39;assembl&#233;e g&#233;n&#233;rale ordinaire des actionnaires de l&#39;ann&#233;e pr&#233;c&#233;dente. Toutefois, si aucune assembl&#233;e g&#233;n&#233;rale ordinaire des actionnaires n&#39;a eu lieu l&#39;ann&#233;e pr&#233;c&#233;dente ou si la date de l&#39;assembl&#233;e g&#233;n&#233;rale ordinaire des actionnaires a &#233;t&#233; modifi&#233;e de plus de 30 jours calendaires &#224; compter de la date pr&#233;vue au moment de la d&#233;claration (proxy statement) de l&#39;ann&#233;e pr&#233;c&#233;dente, une demande d&#39;inscription d&#39;un objet &#224; </font></p></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">fewer than the later of (i) 150 calendar days prior to the date of the contemplated annual </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">l&#39;ordre du jour doit &#234;tre demand&#233;e au moins &#224; la date la plus tardive entre (i) 150 </font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">General Meeting or (ii) the date which is ten calendar days after the date of the first public announcement or other notification to the shareholders of the date of the contemplated annual General Meeting. To be timely for an extraordinary General Meeting, a shareholder&#39;s notice to the Secretary must be delivered to or mailed and received at the registered office of the Company not fewer than the later of (i) 120 calendar days before the date of the extraordinary General Meeting of Shareholders or (ii) the date which is ten calendar days after the date of the first public announcement or other notification to the shareholders of the date of the contemplated extraordinary General Meeting of Shareholders.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;text-indent:-0.2pt;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">jours calendaires avant la date de l&#39;assembl&#233;e g&#233;n&#233;rale ordinaire envisag&#233;e ou (ii) la date qui est dix jours calendaires plus tard que la date de la premi&#232;re annonce publique ou autre notification aux actionnaires de la date envisag&#233;e de l&#39;assembl&#233;e g&#233;n&#233;rale ordinaire. Pour &#234;tre dans les d&#233;lais pour une assembl&#233;e g&#233;n&#233;rale extraordinaire, l&#39;avis d&#39;un actionnaire au secr&#233;taire doit &#234;tre livr&#233; ou envoy&#233; et re&#231;u au si&#232;ge de la soci&#233;t&#233; au moins &#224; la date la plus tardive entre (i) 120 jours calendaires avant la date de l&#39;assembl&#233;e g&#233;n&#233;rale extraordinaire des actionnaires ou (ii) la date qui est dix jours calendaires plus tard que la date de la premi&#232;re annonce publique ou autre notification aux actionnaires de la date envisag&#233;e de l&#39;assembl&#233;e g&#233;n&#233;rale extraordinaire des actionnaires.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Each request for inclusion of an item on the agenda must include (i) a brief description of the business desired to be brought before the meeting and the reasons for conducting such business at the meeting; (ii) the name and address, as they appear on the Company&#39;s register of shareholders, of the shareholder proposing such business; (iii) the number of shares of the Company which are beneficially owned by such shareholder; (iv) the dates upon which the shareholder acquired such shares; (v) documentary support for any claim of beneficial ownership; (vi) any material interest of such shareholder in such business; and (vii) a statement in support of the matter and, for proposals sought to be included in the Company&#39;s proxy statement, any other information required by Securities and Exchange Commission Rule &quot;14a-8&quot;.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;text-indent:-0.2pt;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Chaque</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">demande d&#39;inscription</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">d&#39;un objet &#224;</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">l&#39;ordre du jour</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">doit inclure</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">(</font><font style="font-family:'Times New Roman','Times','serif';">i) une br&#232;ve </font><font style="font-family:'Times New Roman','Times','serif';">description de l&#39;affaire</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">qui sera</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">soumise &#224; l&#39;assembl&#233;e</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">et les raisons</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">pour lesquelles cette affaire est soumise</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">&#224; l&#39;assembl&#233;e</font><font style="font-family:'Times New Roman','Times','serif';">; </font><font style="font-family:'Times New Roman','Times','serif';">(</font><font style="font-family:'Times New Roman','Times','serif';">ii) </font><font style="font-family:'Times New Roman','Times','serif';">le nom</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">et l&#39;adresse</font><font style="font-family:'Times New Roman','Times','serif';">, </font><font style="font-family:'Times New Roman','Times','serif';">tels qu&#39;ils apparaissent dans</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">le registre des</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">actionnaires de la soci&#233;t&#233;</font><font style="font-family:'Times New Roman','Times','serif';">, </font><font style="font-family:'Times New Roman','Times','serif';">de l&#39;/des actionnaire(s)</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">proposant</font><font style="font-family:'Times New Roman','Times','serif';"> un tel objet</font><font style="font-family:'Times New Roman','Times','serif';">;</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">(</font><font style="font-family:'Times New Roman','Times','serif';">iii) </font><font style="font-family:'Times New Roman','Times','serif';">le nombre d&#39;actions</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">de la soci&#233;t&#233;</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">effectivement d&#233;tenues</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">par (un) tel(s) actionnaire(s)</font><font style="font-family:'Times New Roman','Times','serif';">; </font><font style="font-family:'Times New Roman','Times','serif';">(</font><font style="font-family:'Times New Roman','Times','serif';">iv) </font><font style="font-family:'Times New Roman','Times','serif';">les dates auxquelles</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">l&#39;/les actionnaire(s)</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">a/ont acquis</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">ces actions</font><font style="font-family:'Times New Roman','Times','serif';">; </font><font style="font-family:'Times New Roman','Times','serif';">(</font><font style="font-family:'Times New Roman','Times','serif';">v) l&#39;appui </font><font style="font-family:'Times New Roman','Times','serif';">documentaire pour</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">toute revendication de</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">propri&#233;t&#233; effective;</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">(</font><font style="font-family:'Times New Roman','Times','serif';">vi) </font><font style="font-family:'Times New Roman','Times','serif';">un int&#233;r&#234;t important</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">de cet/ces actionnaire(s)</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">par rapport &#224; cet objet</font><font style="font-family:'Times New Roman','Times','serif';">; </font><font style="font-family:'Times New Roman','Times','serif';">et (vii</font><font style="font-family:'Times New Roman','Times','serif';">) </font><font style="font-family:'Times New Roman','Times','serif';">une d&#233;claration &#224; l&#39;appui de cet objet et</font><font style="font-family:'Times New Roman','Times','serif';">, </font><font style="font-family:'Times New Roman','Times','serif';">pour les</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">propositions</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">devant</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">&#234;tre incluses dans</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">la d&#233;claration (proxy statement)</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">de la soci&#233;t&#233;</font><font style="font-family:'Times New Roman','Times','serif';">, </font><font style="font-family:'Times New Roman','Times','serif';">toute autre information</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">requise par</font><font style="font-family:'Times New Roman','Times','serif';"> la </font><font style="font-family:'Times New Roman','Times','serif';">Securities and Exchange Commission</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">r&#232;gle</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">&quot;</font><font style="font-family:'Times New Roman','Times','serif';">14a</font><font style="font-family:'Times New Roman','Times','serif';">-</font><font style="font-family:'Times New Roman','Times','serif';">8&quot;.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">In addition, if the shareholder intends to solicit proxies from the shareholders of the Company, such shareholder shall notify the Company of this intent in accordance with Securities and Exchange Commission Rule &quot;14a-4&quot; and/or Rule &quot;14a-8&quot;.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;text-indent:-0.3pt;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">En outre</font><font style="font-family:'Times New Roman','Times','serif';">, </font><font style="font-family:'Times New Roman','Times','serif';">si un actionnaire</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">a l&#39;intention de</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">solliciter des procurations</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">des</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">actionnaires de la soci&#233;t&#233;</font><font style="font-family:'Times New Roman','Times','serif';">, </font><font style="font-family:'Times New Roman','Times','serif';">cet actionnaire</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">doit en</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">informer la soci&#233;t&#233;</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">conform&#233;ment aux dispositions de la </font><font style="font-family:'Times New Roman','Times','serif';">Securities and Exchange Commission </font><font style="font-family:'Times New Roman','Times','serif';">r&#232;gle</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">&quot;</font><font style="font-family:'Times New Roman','Times','serif';">14a</font><font style="font-family:'Times New Roman','Times','serif';">-</font><font style="font-family:'Times New Roman','Times','serif';">4&quot; </font><font style="font-family:'Times New Roman','Times','serif';">et &quot;</font><font style="font-family:'Times New Roman','Times','serif';">14a</font><font style="font-family:'Times New Roman','Times','serif';">-</font><font style="font-family:'Times New Roman','Times','serif';">8&quot;.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">No resolution may be passed at a General Meeting of Shareholders concerning an item in relation to which due notice was not given. Proposals made during a General Meeting of Shareholders to (i) convene a extraordinary General Meeting or (ii) initiate a special investigation in accordance with article 697a of the Swiss Code of </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;text-indent:-0.2pt;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Aucune d&#233;cision ne peut &#234;tre adopt&#233;e lors d&#39;une assembl&#233;e g&#233;n&#233;rale des actionnaires si un objet n&#39;a pas &#233;t&#233; inscrit &#224; l&#39;ordre du jour dans le d&#233;lai de pr&#233;avis. Les propositions faites au cours d&#39;une assembl&#233;e g&#233;n&#233;rale des actionnaires pour (i) convoquer une assembl&#233;e g&#233;n&#233;rale extraordinaire ou (ii) instituer un contr&#244;le </font></p></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Obligations are not subject to the due notice requirement set forth herein.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">sp&#233;cial au sens de l&#39;article 697a CO ne sont pas soumises &#224; l&#39;obligation d&#39;inscription pr&#233;vue dans ces statuts.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">No advance notice is required to propose motions on duly notified agenda items and to debate items without passing resolutions.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-indent:-0.2pt;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Aucun pr&#233;avis n&#39;est n&#233;cessaire pour proposer des motions sur les objets inscrits &#224; l&#39;ordre du jour ou d&#233;battre desdits objets sans prendre de d&#233;cisions.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 12</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Documentation</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The annual business report, the compensation report and the Auditor&#39;s report must be submitted for examination by the shareholders at the registered office of the Company at least 20 days prior to the date of the Ordinary General Meeting. Each shareholder may request that a copy of this documentation be sent to him promptly by e-mail. Such right shall be included in the invitation to the General Meeting.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 12</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Documents</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le rapport de gestion annuel, le rapport de r&#233;mun&#233;ration et le rapport du r&#233;viseur doivent &#234;tre pr&#233;sent&#233;s aux actionnaires pour examen au si&#232;ge de la soci&#233;t&#233; au moins 20 jours avant la date de l&#39;assembl&#233;e g&#233;n&#233;rale ordinaire. Chaque actionnaire peut demander une copie de ces documents qui doivent lui &#234;tre envoy&#233;s promptement par e-mail. Ce droit doit &#234;tre mentionn&#233; dans l&#39;invitation &#224; l&#39;assembl&#233;e g&#233;n&#233;rale.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:67.85pt;text-indent:-67.85pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 13</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Meeting of All Shareholders</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Shareholders or their proxies representing all shares issued may hold a General Meeting without observing the formalities required for calling a meeting, unless objection is raised. At such a meeting, discussions may be held and resolutions passed on all matters within the scope of the powers of a General Meeting for so long as the shareholders or proxies representing all shares issued are present.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:67.85pt;text-indent:-67.85pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 13</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Assembl&#233;e universelle</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Les propri&#233;taires ou les repr&#233;sentants de la totalit&#233; des actions peuvent, s&#39;il n&#39;y a pas d&#39;opposition, tenir une assembl&#233;e g&#233;n&#233;rale sans observer les formes pr&#233;vues pour sa convocation. Aussi longtemps que les propri&#233;taires ou les repr&#233;sentants de la totalit&#233; des actions sont pr&#233;sents, cette assembl&#233;e a le droit de d&#233;lib&#233;rer et de statuer valablement sur tous les objets qui sont du ressort de l&#39;assembl&#233;e g&#233;n&#233;rale.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:67.85pt;text-indent:-67.85pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 14</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Chairman and Scrutineers</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Chairman of the Board of Directors shall preside over the General Meeting. In his absence, a member of the Board of Directors or another Chairman of the Meeting designated by the General Meeting shall preside.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:67.85pt;text-indent:-67.85pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 14</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Pr&#233;sident et scrutateurs</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">L&#39;assembl&#233;e g&#233;n&#233;rale est pr&#233;sid&#233;e par le pr&#233;sident du conseil d&#39;administration. En cas d&#39;emp&#234;chement, un autre membre du conseil d&#39;administration ou un pr&#233;sident ad hoc nomm&#233; par l&#39;assembl&#233;e g&#233;n&#233;rale pr&#233;side celle-ci.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Chairman of the Meeting shall designate a Secretary and the scrutineers who need not be shareholders.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:6pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le pr&#233;sident de l&#39;assembl&#233;e g&#233;n&#233;rale d&#233;signe un secr&#233;taire et les scrutateurs qui ne doivent pas n&#233;cessairement &#234;tre actionnaires.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 15</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Minutes</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Board of Directors is responsible for the keeping of the minutes of the Meeting, which shall state the number, kind, nominal value of shares represented by the shareholders, by the corporate bodies and by the independent proxy and gives information on resolutions passed, elections, requests for information and information as well as declarations given by the shareholders. The minutes shall be signed by the Chairman and the Secretary.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 15</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Proc&#232;s-verbal</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le conseil d&#39;administration est responsable de la tenue du proc&#232;s-verbal de l&#39;assembl&#233;e, qui doit indiquer le nombre, le type, la valeur nominale des actions repr&#233;sent&#233;es par les actionnaires, par les organes sociaux et par le repr&#233;sentant ind&#233;pendant et donne des informations sur les d&#233;cisions adopt&#233;es, les &#233;lections, les demandes de renseignements et les informations ainsi que les d&#233;clarations faites par les actionnaires. Le proc&#232;s-verbal est sign&#233; par le pr&#233;sident et le secr&#233;taire.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The shareholders are entitled to inspect the minutes.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:6pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Les actionnaires ont le droit d&#39;examiner le proc&#232;s-verbal.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 16</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Right to Vote</b></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 16</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Droit de vote</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Chaque action donne droit &#224; une voix.</font></p></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Each share entitles to one vote.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Each shareholder may be represented at a General Meeting by any person who is so authorized by a written </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Chaque actionnaire peut se faire repr&#233;senter &#224; l&#39;assembl&#233;e g&#233;n&#233;rale par toute personne qui est autoris&#233;e par une </font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">proxy. </font><font style="font-family:'Times New Roman','Times','serif';">A proxy need not be a shareholder.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">procuration &#233;crite. Le repr&#233;sentant ne doit pas n&#233;cessairement &#234;tre un actionnaire.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Each shareholder may be represented by the Independent Proxy. The requirements regarding proxies an</font><font style="font-family:'Times New Roman','Times','serif';">d instructions are determined by the Board of Directors. </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Chaque actionnaire peut se faire repr&#233;senter par le repr&#233;sentant ind&#233;pendant. Les exigences en mati&#232;re de procurations et les instructions sont d&#233;termin&#233;es par le conseil d&#39;administration.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 17</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Resolutions and Elections</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">All voting and elections are held openly or electronically. A written voting or election shall be held if instructed so by the Chairman or if decided by the General Meeting.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 17</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">D&#233;cisions and &#233;lections</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Tous votes et &#233;lections sont tenus ouvertement ou par voie &#233;lectronique. Sur instruction du pr&#233;sident ou de l&#39;assembl&#233;e g&#233;n&#233;rale, un vote ou une &#233;lection doit &#234;tre tenu par &#233;crit.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The General Meeting shall pass its resolutions and carry out its elections with the simple majority of the votes cast regardless of abstentions and empty or invalid votes, unless statutory law or articles of association state otherwise. In the event of tie votes, the request shall be refused. </font><font style="font-family:'Times New Roman','Times','serif';">The Chairman shall not have a casting vote.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Sous r&#233;serve des dispositions imp&#233;ratives de la loi ou des statuts, </font><font style="font-family:'Times New Roman','Times','serif';">l&#39;assembl&#233;e g&#233;n&#233;rale</font><font style="font-family:'Times New Roman','Times','serif';"> prend ses d&#233;cisions et proc&#232;de aux &#233;lections &#224; la majorit&#233; simple des voix &#233;mises. En cas de partage &#233;gal des voix, la requ&#234;te sera refus&#233;e. Le pr&#233;sident n&#39;a pas voix pr&#233;pond&#233;rante.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">A resolution of the General Meeting passed by at least two thirds of the represented share votes and the absolute majority of the represented shares par value is required for:</font></p><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The cases listed in art. 704 para. 1 CO, i.e.:</font></div></div></div><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:21.25pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(i)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">the change of the company purpose;</font></p></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:21.25pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(ii)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">the creation of shares with privileged voting rights;</font></p></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:21.25pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(iii)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">the restriction of the transferability of registered shares;</font></p></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:21.25pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(iv)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">an increase of capital, authorized or subject to a condition;</font><font style="display:inline-block;width:9.26pt;"></font></p></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:21.25pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(v)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">an increase of capital out of equity, against contribution in kind, or for the purpose of acquisition of assets and the granting of special benefits;</font></p></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:21.25pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(vi)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">the limitation or withdrawal of subscription rights;</font></p></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:21.25pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(vii)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">the change of the domicile of the Company; and</font></p></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:21.25pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(viii)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">the liquidation of the Company;</font></p></div></div></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Une d&#233;cision de l&#39;assembl&#233;e g&#233;n&#233;rale recueillant au moins les deux tiers des voix attribu&#233;es aux actions repr&#233;sent&#233;es et la majorit&#233; absolue des valeurs nominales repr&#233;sent&#233;es est n&#233;cessaire pour:</font></p><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">les cas &#233;num&#233;r&#233;s dans l&#39;art. 704 al. 1 CO, i.e.:</font></div></div></div><div style="margin-top:6pt;"></div><div style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-left:25.35pt;margin-top:0pt;min-height:14.5pt;padding-left:36pt;text-align:justify;text-indent:-36pt;"><font style="display:inline-block;font-family:'Times New Roman','Times','serif';min-width:17.2pt;text-indent:0pt;white-space:nowrap;">(i)</font><font style="font-family:'Times New Roman','Times','serif';">la modification du but social;</font></div><div style="font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-left:25.35pt;margin-top:0pt;min-height:14.5pt;padding-left:36pt;text-align:justify;text-indent:-36pt;"><font style="display:inline-block;font-family:'Times New Roman','Times','serif';min-width:17.2pt;text-indent:0pt;white-space:nowrap;">(ii)</font><font style="font-family:'Times New Roman','Times','serif';">l&#39;introduction d&#39;actions &#224; droit de vote privil&#233;gi&#233;;</font></div><div style="margin-top:6pt;"></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:21.25pt;text-align:justify;text-indent:-21.25pt;margin:0pt 0pt 6pt 25.34pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:17.2pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iii)</font></font><font style="font-family:'Times New Roman','Times','serif';">la restriction de la transmissibilit&#233; des actions nominatives;</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:21.25pt;text-align:justify;text-indent:-21.25pt;margin:0pt 0pt 6pt 25.34pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:17.2pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(iv)</font></font><font style="font-family:'Times New Roman','Times','serif';">l&#39;augmentation autoris&#233;e ou conditionnelle du capital-actions;</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:21.25pt;text-align:justify;text-indent:-21.25pt;margin:0pt 0pt 6pt 25.34pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:17.2pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(v)</font></font><font style="font-family:'Times New Roman','Times','serif';">l&#39;augmentation du capital-actions au moyen des fonds propres, contre apport en nature ou en vue d&#39;une reprise de biens et l&#39;octroi d&#39;avantages particuliers;</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:21.25pt;text-align:justify;text-indent:-21.25pt;margin:0pt 0pt 6pt 25.34pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:17.2pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(vi)</font></font><font style="font-family:'Times New Roman','Times','serif';">la limitation ou la suppression du droit de souscription pr&#233;f&#233;rentiel;</font></p><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:25.35pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">(vii)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;text-align:justify;"><font style="font-family:'Times New Roman','Times','serif';">le transfert du si&#232;ge de la soci&#233;t&#233;; et</font></p></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;width:25.35pt;padding:0pt;"></div><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:21.25pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;"><font style="font-family:'Times New Roman','Times','serif';">(viii)</font></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;"><font style="font-family:'Times New Roman','Times','serif';">la dissolution de la soci&#233;t&#233;;</font><font style="font-family:'Times New Roman','Times','serif';"><br></font><font style="font-family:'Times New Roman','Times','serif';margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">la fusion, la scission ou la conversion de la soci&#233;t&#233; (sous r&#233;serve des dispositions imp&#233;ratives);</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">c)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">l&#39;att&#233;nuation ou la suppression des restrictions sur </font></div></div></div></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the merger, de-merger or conversion of the Company (subject to mandatory law);</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">c)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the alleviating or withdrawal of restrictions upon the </font></div></div></div><div style="margin-top:6pt;"></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 18pt;"><font style="font-family:'Times New Roman','Times','serif';">transfer of registered shares;</font><font style="display:inline-block;width:10.24pt;"></font></p><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">d)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the conversion of registered shares into bearer shares and vice versa; and</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">e)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the amendment or elimination of the provisions of Article 4 and 29 of the Articles of Association as well as those contained in this Article 17.</font></div></div></div><div style="margin-top:6pt;"></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 18pt;"><font style="font-family:'Times New Roman','Times','serif';">le transfert des actions nominatives;</font></p><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">d)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">la conversion d&#39;actions nominatives en actions au porteur et vice versa; et</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">e)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">la modification ou la suppression des dispositions des articles 4 et 29 des statuts ainsi que ceux contenues dans le pr&#233;sent article 17.</font></div></div></div><div style="margin-top:6pt;"></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 18</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Votes on Compensation</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The General Meeting shall approve annually and separately the proposals of the Board of Directors in relation to the maximum aggregate amount of:</font></p><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">compensation of the Board of Directors for the period until the next Ordinary General Meeting;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">compensation of the Executive Committee for the following financial year.</font></div></div></div><div style="margin-top:6pt;"></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 18</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Votes sur la r&#233;mun&#233;ration</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">L&#39;assembl&#233;e g&#233;n&#233;rale approuve annuellement et s&#233;par&#233;&#173;ment les propositions du conseil d&#8217;administration relatives au montant global maximal de:</font></p><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">la r&#233;mun&#233;ration du conseil d&#39;administration pour la p&#233;riode allant jusqu&#39;&#224; l&#39;assembl&#233;e g&#233;n&#233;rale ordinaire suivante;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">la r&#233;mun&#233;ration du comit&#233; ex&#233;cutif pour l&#8217;exercice annuel suivant.</font></div></div></div><div style="margin-top:6pt;"></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The respective total compensation amounts include social security and occupational pension contributions for the benefit of the members of the Board of Directors, the Executive Committee and the Company.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Les montants totaux de r&#233;mun&#233;ration respectifs comprennent la s&#233;curit&#233; sociale et les cotisations de retraite professionnelle au profit des membres du conseil d&#39;administration, du </font><font style="font-family:'Times New Roman','Times','serif';">comit&#233; ex&#233;cutif</font><font style="font-family:'Times New Roman','Times','serif';"> et de la soci&#233;t&#233;.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">If the General Meeting refuses to approve a respective motion by the Board of Directors, the Board of Directors may either submit a new motion at the same meeting or determine a maximum total remuneration or several maximum partial remunerations, subject to the relevant principles of the compensation, or submit a new motion to the next General Meeting for approval. The Company may pay remunerations within the framework of the maximum total or partial remuneration and subject to the approval by the General Meeting.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Si l&#39;assembl&#233;e g&#233;n&#233;rale refuse d&#39;approuver une motion soumise par le conseil d&#39;administration, le conseil d&#39;administration peut, soit pr&#233;senter une nouvelle motion &#224; la m&#234;me s&#233;ance ou d&#233;terminer une r&#233;mun&#233;ration maximale totale ou plusieurs r&#233;mun&#233;rations maximales partielles, sous r&#233;serve des principes concernant la r&#233;mun&#233;ration, soit soumettre une nouvelle motion &#224; la prochaine assembl&#233;e g&#233;n&#233;rale pour approbation. La soci&#233;t&#233; peut verser des r&#233;mun&#233;rations dans le cadre de la r&#233;mun&#233;ration maximale totale ou partielle et sous r&#233;serve de l&#39;approbation par l&#39;assembl&#233;e g&#233;n&#233;rale.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Board of Directors shall submit the compensation report to an advisory vote of the General Meeting.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le conseil d&#39;administration soumet le rapport de r&#233;mun&#233;ra&#173;tion &#224; un vote consultatif de l&#39;assembl&#233;e g&#233;n&#233;rale.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 19</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Independent Proxy</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Independent Proxy shall be elected by the Ordinary General Meeting for a term of one year until the end of the next Ordinary General Meeting. Re-election is permitted. The Independent Proxy informs the Company about number, type, par value and category of the </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 19</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Repr&#233;sentant ind&#233;pendant</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le repr&#233;sentant ind&#233;pendant est &#233;lu par l&#39;assembl&#233;e g&#233;n&#233;rale ordinaire pour une dur&#233;e d&#39;un an jusqu&#39;&#224; la fin de la prochaine assembl&#233;e g&#233;n&#233;rale ordinaire. Une r&#233;&#233;lection est possible. Le repr&#233;sentant ind&#233;pendant informe la soci&#233;t&#233; sur le nombre, le type, la valeur </font></p></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">represented shares. The Chairman of the Board discloses the information to the General Meeting. The other duties of the Independent Proxy are determined by the </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">nominale et la cat&#233;gorie des actions repr&#233;sent&#233;es. Le pr&#233;sident du conseil d&#39;administration communique ces informations &#224; l&#39;assembl&#233;e g&#233;n&#233;rale. Les autres fonctions du repr&#233;sentant ind&#233;pendant sont d&#233;termin&#233;es par les dispositions </font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">applicable statutory provisions.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">statutaires applicables.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:39.4pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">V.</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Board of directors</b></p></div></div></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;padding-left:39.5pt;text-indent:-39.5pt;text-transform:uppercase;margin:6pt 0pt 6pt -39.5pt;"><font style="font-family:'Times New Roman','Times','serif';margin-left:0pt;margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:46.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">V.</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Conseil d&#39;administration</b></p></div></div></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:49.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 20</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Number of Members, Term of Office</b></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Board of Directors shall consist of at least 3 and not more than 9 members. This maximum number may be exceeded if it is necessary to satisfy nationality, residency and/or gender requirements under Swiss or foreign laws. The chairman and the members of the Board of Directors are individually elected by the General Meeting for a term of one year until the end of the next Ordinary General Meeting, provided that he/she does not resign or is not replaced during his/her term. </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:46.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 20</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Nombre de membres, dur&#233;e de la fonction</b></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le conseil d&#39;administration se compose d&#39;au minimum 3 et au maximum 9 membres. Ce nombre maximum pourra &#234;tre d&#233;pass&#233; s&#8217;il est n&#233;cessaire de satisfaire &#224; des conditions de nationalit&#233;s, de r&#233;sidences ou de genres selon le droit suisse ou &#233;tranger. Le pr&#233;sident et les membres du conseil d&#39;administration sont &#233;lus individuellement par l&#39;assembl&#233;e g&#233;n&#233;rale pour un mandat d&#39;un an jusqu&#39;&#224; la fin de la prochaine assembl&#233;e g&#233;n&#233;rale ordinaire, &#224; condition qu&#39;il/elle ne d&#233;missionne pas ou ne soit pas remplac&#233;(e) durant son mandat.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The members of the Board of Directors may be re-elected without limitation. The maximum age limit of members of the Board shall be 75 years. When a member of the Board of Directors reaches this age limit during his term of office, such term shall automatically extend to the next ordinary shareholders&#39; meeting. The shareholders&#39; meeting may resolve to grant an exception to the age limit.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Les membres du conseil d&#39;administration peuvent &#234;tre r&#233;&#233;lus sans limitation. La limite d&#8217;&#226;ge des membres du conseil d&#39;administration est fix&#233;e &#224; 75 ans. Lorsqu&#39;un membre du conseil d&#39;administration atteint cette limite d&#39;&#226;ge durant son mandat, ledit mandat sera automatiquement prolong&#233; jusqu&#39;&#224; la prochaine assembl&#233;e g&#233;n&#233;rale ordinaire. L&#39;assembl&#233;e g&#233;n&#233;rale des actionnaires peut d&#233;cider d&#39;accorder une d&#233;rogation &#224; la limite d&#39;&#226;ge.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 21</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Constitution</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Subject to the powers of the General Meeting, the Board of Directors determines its own organization. It appoints a Secretary who needs not be a member of the Board of Directors.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 21</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Constitution</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Sous r&#233;serve des pouvoirs de l&#39;assembl&#233;e g&#233;n&#233;rale, le conseil d&#39;administration d&#233;termine sa propre organisation. Il nomme un secr&#233;taire qui ne doit pas n&#233;cessairement &#234;tre un membre du conseil d&#39;administration.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 22</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Function, Organization</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">It is the Board of Director&#39;s duty to lead the Company and to supervise the management. The Board of Director represents the Company and may take decisions on all affairs which are not assigned to any other body of the Company by law, the Articles of Association or the organizational regulations.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 22</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Fonction, organisation</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le conseil d&#39;administration exerce la direction de la soci&#233;t&#233; et en supervise la gestion. Le conseil d&#39;administration repr&#233;sente la soci&#233;t&#233; et peut prendre les d&#233;cisions sur toutes les affaires qui ne sont pas attribu&#233;es &#224; un autre organe de la soci&#233;t&#233; par la loi, les statuts ou le r&#232;glement d&#39;organisation.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Board of Directors shall enact the organizational regulations and arrange for the appropriate contractual </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le conseil d&#39;administration &#233;dicte le r&#232;glement d&#39;organisation et s&#39;occupe des relations contractuelles </font></p></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">relationships.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">appropri&#233;es.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 23</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Powers</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Board of Directors has the following non-delegable and inalienable duties:</font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the overall management of the company and the </font></div></div></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 23</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Pouvoirs</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le conseil d&#39;administration a les attributions intransmissibles et inali&#233;nables suivantes:</font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18.25pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">exercer la haute direction de la soci&#233;t&#233; et &#233;tablir les </font></div></div></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 18pt;"><font style="font-family:'Times New Roman','Times','serif';">issuing of all necessary directives;</font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">determination of the company&#39;s organisation;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">c)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the organisation of the accounting, financial control and financial planning systems as required for management of the company;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">d)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the appointment and dismissal of persons entrusted with managing and representing the company;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">e)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">overall supervision of the persons entrusted with managing the company, in particular with regard to compliance with the law, articles of association, operational regulations and directives;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">f)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">compilation of the annual report, preparation for the general meeting and implementation of its resolutions;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">g)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the preparation of the compensation report and to request approval by the General Meeting regarding compensation of the Board of Directors and the Executive Committee; and</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">h)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">notification of the court in the event that the company is overindebted.</font></div></div></div><div style="margin-top:6pt;"></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:normal;margin-top:18pt;text-transform:none;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 0pt 18pt;"><font style="font-family:'Times New Roman','Times','serif';">instructions n&#233;cessaires;</font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fixer l&#39;organisation;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18.25pt;padding:0pt;">c)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fixer les principes de la comptabilit&#233; et du contr&#244;le financier ainsi que le plan financier pour autant que celui-ci soit n&#233;cessaire &#224; la gestion de la soci&#233;t&#233;;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18.25pt;padding:0pt;">d)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">nommer et r&#233;voquer les personnes charg&#233;es de la gestion et de la repr&#233;sentation;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18.25pt;padding:0pt;">e)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">exercer la haute surveillance sur les personnes charg&#233;es de la gestion pour s&#39;assurer notamment qu&#39;elles observent la loi, les statuts, les r&#232;glements et les instructions donn&#233;es;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18.25pt;padding:0pt;">f)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#233;tablir le rapport de gestion, pr&#233;parer l&#39;assembl&#233;e g&#233;n&#233;rale et ex&#233;cuter ses d&#233;cisions;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18.25pt;padding:0pt;">g)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">la pr&#233;paration du rapport de r&#233;mun&#233;ration et de demander l&#39;approbation par l&#39;assembl&#233;e g&#233;n&#233;rale en ce qui concerne la r&#233;mun&#233;ration du conseil d&#39;administration et du </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">comit&#233; ex&#233;cutif</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">; et</font></div></div></div><div style="margin-top:6pt;"></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">informer le juge en cas de surendettement.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The board of directors may assign responsibility for preparing and implementing its resolutions or monitoring transactions to committees or individual members. </font><font style="font-family:'Times New Roman','Times','serif';">It </font><font style="font-family:'Times New Roman','Times','serif';">must ensure appropriate reporting to its members.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:normal;margin-top:18pt;text-transform:none;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le conseil d&#39;administration peut d&#233;l&#233;guer &#224; un ou plusieurs membres, regroup&#233;s en comit&#233;s, la charge de pr&#233;parer et d&#39;ex&#233;cuter ses d&#233;cisions ou de surveiller certaines affaires. Il veille &#224; ce que ses membres soient convenablement inform&#233;s.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:67.85pt;text-indent:-67.85pt;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 24</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Representation of the Company</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Board of Directors shall assign the persons with signatory power for the company and the kind of signatory power.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:67.85pt;text-indent:-67.85pt;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 24</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Repr&#233;sentation de la soci&#233;t&#233;</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le conseil d&#39;administration nomme les personnes pouvant repr&#233;senter la soci&#233;t&#233; ainsi que le mode de signature.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:67.85pt;text-indent:-67.85pt;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 25</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Delegation</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Moreover, the Board of Directors is authorized to delegate, in part or entirely, the management and the representation of the Company, within the limits of the law, to one or more individual directors (Delegates) or to third parties pursuant to organizational regulations.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 25</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">D&#233;l&#233;gation</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">En outre, le conseil d&#39;administration peut, dans les limites de la loi, d&#233;l&#233;guer, en partie ou enti&#232;rement, la gestion et la repr&#233;sentation de la soci&#233;t&#233; &#224; un ou plusieurs administrateurs (d&#233;l&#233;gu&#233;s) ou &#224; des tiers conform&#233;ment au r&#232;glement d&#39;organisation.</font></p></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:49.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 26</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Meetings, Resolutions and Minutes</b></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The organization of the meetings, the presence quorum and the passing of resolutions of the Board of Directors is determined by the organizational regulations. No presence quorum is required for the approval of the capital increase.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:46.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 26</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">R&#233;unions, d&#233;cisions et proc&#232;s-verbal</b></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:0.3pt;text-align:justify;text-indent:-0.3pt;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">L&#39;organisation des r&#233;unions, le quorum de pr&#233;sence et l&#39;adoption de d&#233;cisions du conseil d&#39;administration sont pr&#233;vus dans le r&#232;glement d&#39;organisation. Aucun quorum de pr&#233;sence n&#39;est n&#233;cessaire pour l&#39;approbation d&#39;un rapport d&#39;augmentation de capital.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Resolutions may be passed via telephone or videoconference. Resolutions may also be passed by way of circulation, provided that no member requests oral deliberation.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-indent:-0.2pt;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Les d&#233;cisions peuvent &#234;tre</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">prises</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">par t&#233;l&#233;phone ou par</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">vid&#233;oconf&#233;rence</font><font style="font-family:'Times New Roman','Times','serif';">. </font><font style="font-family:'Times New Roman','Times','serif';">Les d&#233;cisions peuvent &#233;galement</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">&#234;tre prises par voie</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">de</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">circulation</font><font style="font-family:'Times New Roman','Times','serif';">, &#224; condition qu&#39;</font><font style="font-family:'Times New Roman','Times','serif';">aucun membre ne demande</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">une d&#233;lib&#233;ration</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">orale</font><font style="font-family:'Times New Roman','Times','serif';">.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Minutes are kept of the board&#39;s discussions and resolutions and signed by the chairman and the minute-taker.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-indent:-0.2pt;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Les d&#233;lib&#233;rations et les d&#233;cisions du conseil d&#39;administration sont consign&#233;es dans un proc&#232;s-verbal sign&#233; par le pr&#233;sident et le r&#233;dacteur du proc&#232;s-verbal.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:49.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 27</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Right to information and inspection</b></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Any member of the board of directors may request information on any company business.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:46.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 27</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Droit aux renseignements et &#224; la consultation</b></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-indent:-0.2pt;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Chaque membre du conseil d&#39;administration a le droit d&#39;obtenir des renseignements sur toutes les affaires de la soci&#233;t&#233;.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Outside meetings, any member may request information from the persons entrusted with managing the company&#39;s business concerning the company&#39;s business performance and, with the chairman&#39;s authorisation, specific transactions.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-indent:-0.2pt;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">En dehors des s&#233;ances, chaque membre du conseil d&#39;administration peut exiger des personnes charg&#233;es de la gestion des renseignements sur la marche de l&#39;entreprise et, avec l&#39;autorisation du pr&#233;sident, sur des affaires d&#233;termin&#233;es.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Where required for the performance of his duties, any member may request the chairman to have books of account and documents made available to him for inspection.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-indent:-0.2pt;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Dans la mesure o&#249; cela est n&#233;cessaire &#224; l&#39;accomplissement de ses t&#226;ches, chaque membre du conseil d&#39;administration peut demander au pr&#233;sident la production des livres ou des dossiers.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">If the chairman refuses a request for information, a request to be heard or an application to inspect documents, the board of directors rules on the matter.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Si le pr&#233;sident rejette une demande de renseignement, d&#39;audition ou de consultation, le conseil d&#39;administration tranche.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 28</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Compensation Committee</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Compensation Committee shall comprise at least 2 members. The members of the Compensation Committee shall be individually elected by the Ordinary General Meeting from among the members of the Board of Directors for a term of one year until the next Ordinary General Meeting. Re-election is permitted. The Compensation Committee has the following duties:</font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to draw up principles for compensation of members of the Board of Directors and the Executive Committee and to submit them to the Board of </font></div></div></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 28</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Comit&#233; de r&#233;mun&#233;ration</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le comit&#233; de r&#233;mun&#233;ration se compose d&#39;au moins 2 membres. Les membres du comit&#233; de r&#233;mun&#233;ration sont &#233;lus par l&#39;assembl&#233;e g&#233;n&#233;rale ordinaire parmi les membres du conseil d&#39;administration pour un mandat d&#39;un an jusqu&#39;&#224; la prochaine assembl&#233;e g&#233;n&#233;rale ordinaire. Une r&#233;&#233;lection est possible. Le comit&#233; de r&#233;mun&#233;ration a les fonctions suivantes:</font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Times New Roman','Times','serif';font-size:12pt;letter-spacing:0.3pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;letter-spacing:0pt;">&#233;laborer des principes de r&#233;mun&#233;ration des membres du conseil d&#39;administration et du </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">comit&#233; ex&#233;cutif</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;letter-spacing:0pt;"> et de les soumettre au conseil </font></div></div></div></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;"></div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Directors for approval;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to propose to the Board of Directors the resolution to be submitted to the Ordinary General Meeting for the maximum total compensation of the Board of Directors and Executive Committee;</font><font style="display:inline-block;width:34.23pt;"></font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">c)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">subject to and within the bounds of the maximum compensation approved by the Ordinary General </font></div></div></div><div style="margin-top:6pt;"></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Times New Roman','Times','serif';font-size:12pt;letter-spacing:0.3pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;"></div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;letter-spacing:0pt;">d&#39;administration pour approbation;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Times New Roman','Times','serif';font-size:12pt;letter-spacing:0.3pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;letter-spacing:0pt;">proposer au conseil d&#39;administration la d&#233;cision sera soumise &#224; l&#39;assembl&#233;e g&#233;n&#233;rale ordinaire pour la r&#233;mun&#233;ration totale maximale du conseil d&#39;administration et du </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">comit&#233; ex&#233;cutif</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;letter-spacing:0pt;">;</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;letter-spacing:0pt;"><br></font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;letter-spacing:0pt;margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Times New Roman','Times','serif';font-size:12pt;letter-spacing:0.3pt;margin-bottom:0pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:12pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">c)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;letter-spacing:0pt;">sous r&#233;serve et dans les limites de la r&#233;mun&#233;ration </font></div></div></div><div style="margin-top:6pt;"></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 18pt;"><font style="font-family:'Times New Roman','Times','serif';">Meeting, to request approval by the Board of Directors of the individual remuneration packages to be paid to members of the Board of Directors and members of the Executive Committee;</font><font style="display:inline-block;width:4.85pt;"></font><font style="font-family:'Times New Roman','Times','serif';"><br></font><font style="font-family:'Times New Roman','Times','serif';margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">d)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to request approval by the Board of Directors regarding the determination of the compensation-related targets for the Executive Committee;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">e)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to request approval by the Board of Directors regarding the adjustments to the Articles of Association relating to remuneration; and</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">f)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to prepare the Compensation Report and submit it to the Board of Directors.</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><br></font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></div></div></div><div style="margin-top:6pt;"></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Board of Directors shall set out any further duties and responsibilities vested on the Compensation Committee in the Company&#39;s Organizational Rules.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 18pt;"><font style="font-family:'Times New Roman','Times','serif';">maximale approuv&#233;e par l&#39;assembl&#233;e g&#233;n&#233;rale ordinaire, demander l&#39;approbation du conseil d&#39;administration quant aux paquets de r&#233;mun&#233;ration individuels devant &#234;tre vers&#233;s aux membres du conseil d&#39;administration et aux membres du </font><font style="font-family:'Times New Roman','Times','serif';">comit&#233; ex&#233;cutif</font><font style="font-family:'Times New Roman','Times','serif';">;</font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Times New Roman','Times','serif';font-size:12pt;letter-spacing:0.3pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">d)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;letter-spacing:0pt;">requ&#233;rir l&#39;approbation du conseil d&#39;administration sur la fixation d&#39;objectifs li&#233;s &#224; la r&#233;mun&#233;ration pour le </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">comit&#233; ex&#233;cutif</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;letter-spacing:0pt;">;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Times New Roman','Times','serif';font-size:12pt;letter-spacing:0.3pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">e)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;letter-spacing:0pt;">requ&#233;rir l&#39;approbation du conseil d&#39;administration sur les adaptations des statuts relatives &#224; la r&#233;mun&#233;ration; et</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Times New Roman','Times','serif';font-size:12pt;letter-spacing:0.3pt;margin-bottom:0pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">f)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;letter-spacing:0pt;">pr&#233;parer le rapport de r&#233;mun&#233;ration et de le soumettre au conseil d&#39;administration.</font></div></div></div><div style="margin-top:6pt;"></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le conseil d&#39;administration fixe toutes les autres fonctions et responsabilit&#233;s d&#233;volues au comit&#233; de r&#233;mun&#233;ration dans le r&#232;glement d&#39;organisation de la soci&#233;t&#233;.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">If there are vacancies on the Compensation Committee, the Board of Directors may appoint substitutes from amongst its members for the remaining term of office.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">S&#39;il y a des postes vacants au sein du comit&#233; de r&#233;mun&#233;ra&#173;tion, le conseil d&#39;administration peut d&#233;signer des substituts parmi ses membres pour la dur&#233;e restante du terme de fonction.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Board of Directors shall elect a chairman of the Compensation Committee. </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le conseil d&#39;administration &#233;lit un pr&#233;sident du comit&#233; de r&#233;mun&#233;ration. </font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 29</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Indemnification</b></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 29</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Indemnisation</b></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">As far as is permissible under applicable law, the Company shall indemnify any current or former member of the Board of Directors, former members of the Executive Committee, or any person who is serving or has served at the request of the Company as a member of the Board of Directors or member of the Executive Committee (each individually, a &quot;Covered Person&quot;), against any expenses, including attorneys&#39; fees, judgments, fines, and amounts paid in settlement actually and reasonably incurred by him or her in connection with any threatened, pending, or completed </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Dans la mesure permise par la loi applicable, la soci&#233;t&#233; indemnisera tout membre actuel ou ancien du conseil d&#39;administration, les anciens membres du </font><font style="font-family:'Times New Roman','Times','serif';">comit&#233; ex&#233;cutif</font><font style="font-family:'Times New Roman','Times','serif';">, ou toute personne qui sert ou a servi &#224; la demande de la soci&#233;t&#233; en tant que membre du conseil d&#39;administration ou membre du </font><font style="font-family:'Times New Roman','Times','serif';">comit&#233; ex&#233;cutif</font><font style="font-family:'Times New Roman','Times','serif';"> (chacun individuellement, une &quot;Personne Couverte&quot;), pour toutes les d&#233;penses, y compris les honoraires d&#39;avocat, jugements, amendes, et montants vers&#233;s effectivement et raisonnablement &#224; titre de r&#232;glement dans le cadre de toute action, poursuite ou proc&#233;dure imminente, </font></p></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">action, suit or proceeding, whether civil, criminal or administrative, to which he or she was, is, or is threatened to be made a party, or is otherwise involved (a &quot;Proceeding&quot;). This provision shall not indemnify any Covered Person against any liability arising out of (a) any fraud or dishonesty in the performance of such Covered Person&#39;s duty to the Company, or (b) such Covered Party&#39;s conscious, intentional or willful or grossly negligent breach of the obligation to act honestly and in good faith with a view to the best interests of the Company. Notwithstanding the </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">pendante ou termin&#233;e, qu&#39;elle soit civile, p&#233;nale ou administrative, &#224; laquelle il ou elle a &#233;t&#233;, est, ou est menac&#233; d&#39;&#234;tre partie, ou est impliqu&#233; de toute autre mani&#232;re (une &quot;Proc&#233;dure&quot;). Cette disposition ne doit pas indemniser une Personne Couverte contre une responsabilit&#233; d&#233;coulant de (a) une fraude ou une malhonn&#234;tet&#233; de cette Personne Couverte dans l&#39;exercice de ses fonctions vis-&#224;-vis de la soci&#233;t&#233;, ou (b) une violation consciente, intentionnelle ou volontaire ou gravement n&#233;gligente de l&#39;obligation de cette Personne Couverte d&#39;agir avec honn&#234;tet&#233; en tenant compte du </font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">preceding sentence, this section shall not extend to any person holding the office of auditor or special auditor of the Company.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">meilleur int&#233;r&#234;t de la soci&#233;t&#233;. Nonobstant ce qui pr&#233;c&#232;de, cette disposition ne s&#39;&#233;tend pas aux personnes qui occupent le poste de r&#233;viseur ou de r&#233;viseur sp&#233;cial de la soci&#233;t&#233;.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">In the case of any Proceeding by or in the name of the Company, the Company shall indemnify each Covered Person against expenses, including attorneys&#39; fees, actually and reasonably incurred in connection with the defense or settlement thereof, except no indemnification shall be made in respect of any claim, issue or matter as to which a Covered Person shall have been adjudged to be liable for fraud or dishonesty in the performance of his or her duty to the Company, or for conscious, intentional or willful or grossly negligent breach of his or her obligation to act honestly and in good faith with a view to the best interests of the Company, unless and only to the extent that a court in which such action or suit was brought shall determine upon application that despite the adjudication of liability, but in view of all the circumstances of the case, such Covered Person is fairly and reasonably entitled to indemnity for such expenses as the court shall deem proper. Notwithstanding the preceding sentence, this section shall not extend to any person holding the office of auditor or special auditor of the Company. </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Dans le cas de toute Proc&#233;dure intent&#233;e par ou au nom de la soci&#233;t&#233;, la soci&#233;t&#233; doit indemniser chaque Personne Couverte pour les d&#233;penses, y compris les honoraires d&#39;avocat, effectivement et raisonnablement encourus dans le cadre de la d&#233;fense ou du r&#232;glement dans le cadre de la Proc&#233;dure. Aucune indemnisation ne sera octroy&#233;e pour une r&#233;clamation, probl&#232;me ou affaire pour laquelle une Personne Couverte est tenue responsable &#224; la suite de fraude ou de malhonn&#234;tet&#233; dans l&#39;exercice de ses fonctions vis-&#224;-vis de la soci&#233;t&#233;, ou &#224; cause d&#39;une violation consciente, intentionnelle ou volontaire ou gravement n&#233;gligente de l&#39;obligation de la Personne Couverte d&#39;agir avec honn&#234;tet&#233; en tenant compte du meilleur int&#233;r&#234;t de la soci&#233;t&#233;, sauf et uniquement si un tribunal auquel une telle action ou poursuite a &#233;t&#233; port&#233; d&#233;termine que, malgr&#233; la reconnaissance de la responsabilit&#233;, mais compte tenu de toutes les circonstances du cas d&#39;esp&#232;ce, cette Personne Couverte a &#233;quitablement et raisonnablement droit &#224; une indemnisation de ces d&#233;penses, mais uniquement &#224; hauteur du montant que le tribunal jugera convenable. Nonobstant la phrase pr&#233;c&#233;dente, cette disposition ne s&#39;&#233;tend pas aux personnes qui occupent le poste de r&#233;viseur ou de r&#233;viseur sp&#233;cial de la soci&#233;t&#233;.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Any indemnification under this Article 29 (unless ordered by a court) shall be made by the Company only as authorized in the specific case upon a determination that indemnification of the Covered Person is proper in the circumstances because such person has met the applicable Standard of conduct set forth in this Article 29. Such determination shall be made, with respect to a Covered Person (a) by a majority vote of the members of the Board of Directors who are not parties to such </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Toute indemnisation en vertu du pr&#233;sent article 29 (sauf si ordonn&#233;e par un tribunal) doit &#234;tre octroy&#233;e par la soci&#233;t&#233; dans chaque cas dans les limites de l&#39;autorisation sur la base d&#39;une d&#233;termination que l&#39;indemnisation de la Personne Couverte est appropri&#233;e dans les circonstances parce que cette personne a satisfait au standard de conduite applicable &#233;nonc&#233; dans le pr&#233;sent article 29. Une telle d&#233;cision concernant une Personne Couverte doit &#234;tre prise (a) par la majorit&#233; des votes des membres </font></p></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">proceeding, even though less than a quorum; (b) by a committee of such members of the Board of Directors designated by a majority vote of such the Board of Directors, even though less than a quorum; (c) if there are no such member of the Board of Directors, or if such member of the Board of Directors so direct, by independent legal counsel in a written opinion; or (d) by the General Meeting of Shareholders. Such determination shall be made, with respect to any other Covered Person, by any person or persons having the authority to act on the matter on behalf of the Company. To the extent, however, that any </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">du conseil d&#39;administration qui ne sont pas parties &#224; cette proc&#233;dure, m&#234;me si le quorum requis n&#39;est pas r&#233;uni; (b) par un comit&#233; de membres du conseil d&#39;administration d&#233;sign&#233;s par une majorit&#233; des votes du conseil d&#39;administration, m&#234;me si le quorum requis n&#39;est pas r&#233;uni; (c) s&#39;il n&#39;y a pas de tel membre du conseil d&#39;administration, ou si ce membre du conseil d&#39;administration l&#39;ordonne, par un conseiller juridique ind&#233;pendant dans un avis &#233;crit; ou (d) par l&#39;assembl&#233;e g&#233;n&#233;rale des actionnaires. Une telle d&#233;cision concernant une Personne Couverte doit &#234;tre prise par une personne ou des personnes ayant le pouvoir d&#39;agir </font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Covered Person has been successful on the merits or otherwise in defense of any proceeding, or in defense of any claim, issue or matter therein, such Covered Person shall be indemnified against expenses (including attorneys&#39; fees) actually and reasonably incurred by such person in connection therewith, without the necessity of authorization in the specific case.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">dans cet affaire au nom de la soci&#233;t&#233;. Dans la mesure, cependant, o&#249; une Personne Couverte a gagn&#233; sur le fond ou autrement dans la d&#233;fense d&#39;une proc&#233;dure, ou dans la d&#233;fense de toute r&#233;clamation, probl&#232;me ou affaire dans cette proc&#233;dure, cette Personne Couverte doit &#234;tre indemnis&#233;e pour les d&#233;penses (y compris les honoraires d&#39;avocat) effectivement et raisonnablement encourus dans le cadre de l&#39;affaire en question sans qu&#39;il soit n&#233;cessaire d&#39;avoir une autorisation dans le cas sp&#233;cifique.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">As far as is permissible under applicable law, expenses, including attorneys&#39; fees, incurred in defending any proceeding for which indemnification is permitted pursuant to this Article 29 shall be paid by the Company in advance of the final disposition of such proceeding upon receipt by the Board of Directors of an undertaking by or on behalf of the Covered Person to repay such amount if it shall ultimately be determined that he or she is not entitled to be indemnified by the Company under these Articles of Association.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Dans la mesure permise par la loi applicable, les d&#233;penses, y compris les honoraires d&#39;avocats, encourus dans la d&#233;fense de toute proc&#233;dure pour laquelle l&#39;indemnisation est permise en vertu du pr&#233;sent article 29, doivent &#234;tre pay&#233;es par la soci&#233;t&#233; avant la d&#233;cision finale dans cette proc&#233;dure &#224; r&#233;ception par le conseil d&#39;administration d&#39;une promesse faite par ou au nom de la Personne Couverte de rembourser ce montant s&#39;il s&#39;av&#232;re finalement que cette Personne Couverte n&#39;a pas droit &#224; l&#39;indemnisation par la soci&#233;t&#233; en vertu de ces statuts.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">It being the policy of the Company that indemnification of the persons specified in this Article 29 shall be made to the fullest extent permitted by law and the indemnification provided by this Article 29 shall not be deemed exclusive (a) of any other rights to which those seeking indemnification or advancement of expenses may be entitled under these Articles of Association, any agreement, any insurance purchased by the Company, vote of shareholders or disinterested members of the Board of Directors, or pursuant to the decision of any court of competent jurisdiction, or otherwise, both as to action in his or her official capacity and as to action in another capacity while holding such office, or (b) of the power of the Company to indemnify any person who is or was an employee or agent of the Company or of </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">La politique de la soci&#233;t&#233; pr&#233;voit que l&#39;indemnisation des personnes vis&#233;es au pr&#233;sent article 29 doit &#234;tre pay&#233;e dans toute la mesure autoris&#233;e par la loi et l&#39;indemnisation pr&#233;vue par cet article 29 ne sera pas consid&#233;r&#233;e comme exclusive (a) d&#39;autres droits auxquels les personnes demandant une indemnisation ou une avance des d&#233;penses ont droit en vertu de ces statuts, d&#39;un accord, d&#39;une assurance souscrite par la soci&#233;t&#233;, d&#39;un vote d&#39;actionnaires ou de membres du conseil d&#39;administration n&#39;ayant pas d&#39;int&#233;r&#234;t direct, ou en vertu d&#39;une d&#233;cision d&#39;un tribunal comp&#233;tent, ou autrement, soit &#224; l&#39;&#233;gard d&#39;actions faites en sa capacit&#233; officielle, soit &#224; l&#39;&#233;gard d&#39;actions faites &#224; un autre titre tout en ayant une telle fonction, ou (b) du pouvoir de la soci&#233;t&#233; d&#39;indemniser toute personne qui est ou &#233;tait un employ&#233; </font></p></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">another corporation, joint venture, trust or other enterprise which he or she is serving or has served at the request of the Company, to the same extent and in the same situations and subject to the same determinations as are hereinabove set forth with respect to a Covered Person.</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';"><font style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</font><br><font style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</font><br></font><font style="font-family:'Times New Roman','Times','serif';">As used in this Article 29, references to the &quot;Company&quot; include all constituent corporations in a consolidation or merger in which the Company or a predecessor to the Company by consolidation or merger was involved. </font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The indemnification provided by this Article 29 shall continue as to a person who has ceased to be a member of </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">ou un mandataire de la soci&#233;t&#233; ou d&#39;une autre soci&#233;t&#233;, d&#39;une joint venture, d&#39;une fiducie ou d&#39;une autre entreprise pour laquelle il ou elle travaille ou a travaill&#233; &#224; la demande de la soci&#233;t&#233;, dans la m&#234;me mesure et dans les m&#234;mes situations et sous r&#233;serve des m&#234;mes principes concernant une Personne Couverte &#233;voqu&#233;es ci-dessus. </font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Tel qu&#39;utilis&#233; dans le pr&#233;sent article 29, les r&#233;f&#233;rences &#224; la &quot;soci&#233;t&#233;&quot; comprennent toutes les soci&#233;t&#233;s ayant fait l&#39;objet d&#39;un regroupement ou d&#39;une fusion dans laquelle la soci&#233;t&#233; ou un pr&#233;d&#233;cesseur &#224; la soci&#233;t&#233; a &#233;t&#233; impliqu&#233;. &#160;</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">L&#39;indemnisation pr&#233;vue par cet article 29 est maintenue &#224; l&#39;&#233;gard d&#39;une personne qui a cess&#233; d&#39;&#234;tre un membre du conseil d&#39;administration ou le comit&#233; ex&#233;cutif et sera en </font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">the Board of Directors or the Executive Committee and shall inure to the benefit of their heirs, executors, and administrators.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">vigueur au b&#233;n&#233;fice de ses h&#233;ritiers, ex&#233;cuteurs et administrateurs.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:42.55pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">VI.</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Auditors</b></p></div></div></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;padding-left:39.5pt;text-indent:-39.5pt;text-transform:uppercase;margin:6pt 0pt 6pt -39.5pt;"><font style="font-family:'Times New Roman','Times','serif';margin-left:0pt;margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:46.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">VI.</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">organe de r&#233;vision</b></p></div></div></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 30</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Election, Term</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The General Meeting shall elect one or more accountants as its Auditors in terms of Articles 727 </font><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">et seq.</i><font style="font-family:'Times New Roman','Times','serif';"> CO every year with the rights and duties determined by law. </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 30</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">&#201;lection, dur&#233;e</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">L&#39;assembl&#233;e g&#233;n&#233;rale nomme chaque ann&#233;e un ou plusieurs r&#233;viseurs comme organe de r&#233;vision selon les articles 727 ss. CO avec les droits et les devoirs d&#233;termin&#233;s par la loi.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The General Meeting may appoint Special Auditors for a term of up to three years who provide the attestations required for capital increases.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">L&#39;assembl&#233;e g&#233;n&#233;rale peut nommer des r&#233;viseurs sp&#233;ciaux pour une dur&#233;e de trois ans au maximum qui fournissent les attestations requises pour les augmentations de capital.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 31</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Duties</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Auditors shall perform their duties to audit and report whether the accounting, the annual accounts and the proposal regarding allocation of profits are in accordance with law and the Articles of Association.</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 31</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Fonctions</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">L&#39;organe de r&#233;vision v&#233;rifie et rapporte si la comptabilit&#233;, les comptes annuels et la proposition relative &#224; la r&#233;partition des b&#233;n&#233;fices sont en conformit&#233; avec la loi et les statuts.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:49.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">VII.</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">compensation and related provisions </b></p></div></div></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;padding-left:39.5pt;text-indent:-39.5pt;text-transform:uppercase;margin:6pt 0pt 6pt -39.5pt;"><font style="font-family:'Times New Roman','Times','serif';margin-left:0pt;margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:46.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">VII.</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">R&#233;mun&#233;ration et dispositions analogues </b></p></div></div></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:49.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 32</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Principles of the Compensation of the Board of Directors</b></p></div></div></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:46.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 32</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Principes de r&#233;mun&#233;ration du conseil d&#39;administration</b></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">La r&#233;mun&#233;ration des membres du conseil d&#39;administration comprend, sous r&#233;serve et dans les limites de l&#39;approbation de la r&#233;mun&#233;ration totale par l&#39;assembl&#233;e g&#233;n&#233;rale, les &#233;l&#233;ments suivants:</font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">une r&#233;mun&#233;ration fixe de base;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">des frais de commission fixes pour le travail dans un comit&#233; du conseil d&#39;administration;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">c)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">une compensation forfaitaire pour les d&#233;penses;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">d)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">un nombre d&#39;actions ou d&#39;options dans la soci&#233;t&#233;, comme d&#233;taill&#233;e &#224; l&#39;art. 41.</font></div></div></div><div style="margin-top:6pt;"></div></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The compensation payable to the members of the Board of Directors comprises, subject to and within the bounds of the approval by the General Meeting of the total compensation, the following elements:</font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a fixed basic </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">remuneration</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a fixed committee fee for work in a committee of the Board of Directors;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">c)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a lump sum compensation for expenses;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">d)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a number of options or shares in the Company, as further outlined in Art. 41.</font></div></div></div><div style="margin-top:6pt;"></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The compensation is paid in cash and in form of options or shares in the Company. The board of directors or, to the extent delegated to it, the compensation committee shall determine grant, exercise and forfeiture conditions. In particular, they may provide for continuation, acceleration or removal of vesting, exercise and forfeiture conditions, for payment or grant of compensation based </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">La r&#233;mun&#233;ration est vers&#233;e en esp&#232;ces et sous forme d&#39;options ou d&#39;actions de la soci&#233;t&#233;. Le conseil d&#39;administration ou, en cas de d&#233;l&#233;gation des fonctions, le comit&#233; de r&#233;mun&#233;ration doit fixer les conditions de l&#39;octroi, de l&#39;exercice et de la p&#233;remption. En particulier, il peut pr&#233;voir la poursuite, l&#39;acc&#233;l&#233;ration ou la suppression des conditions d&#39;acquisition, d&#39;exercice et de </font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">upon assumed target achievement, or for forfeiture, in each case in the event of pre-determined events such as a change-of-control or termination of an employment or mandate agreement. The Company may procure the required shares through purchases in the market, from treasury shares or by using contingent or authorized share capital.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">p&#233;remption, pour le paiement ou l&#39;octroi d&#39;une r&#233;mun&#233;ration bas&#233;e sur la r&#233;alisation des objectifs suppos&#233;s, ou pour la p&#233;remption, dans chaque cas, dans le cas d&#39;&#233;v&#233;nements pr&#233;d&#233;termin&#233;s tels qu&#39;un changement de contr&#244;le ou la r&#233;siliation d&#39;un contrat de travail ou d&#39;un mandat. La soci&#233;t&#233; peut fournir les actions n&#233;cessaires par des achats sur le march&#233;, par ses actions propres ou en utilisant du capital conditionnel ou autoris&#233;.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Subject to the approval by the General Meeting, the members of the Board of Directors may receive remuneration in cash at customary conditions for advisory services rendered outside their capacity as Board member for the benefit of the Company or companies under its control. The General Meeting may approve an additional bonus for the members of the Board of Directors in exceptional cases.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Sous r&#233;serve de l&#39;approbation par l&#39;assembl&#233;e g&#233;n&#233;rale, les membres du conseil d&#39;administration peuvent recevoir une r&#233;mun&#233;ration en esp&#232;ces dans les conditions habituelles pour des services consultatifs rendus en-dehors de leur qualit&#233; de membre du conseil pour le b&#233;n&#233;fice de la soci&#233;t&#233; ou des soci&#233;t&#233;s sous son contr&#244;le. L&#39;assembl&#233;e g&#233;n&#233;rale peut approuver un bonus suppl&#233;mentaire pour les membres du conseil d&#39;administration dans des cas exceptionnels.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The compensation may also be paid for activities in companies that are directly or indirectly controlled by the Company and may be paid by the Company or by a company controlled by it.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">La r&#233;mun&#233;ration peut &#233;galement &#234;tre accord&#233;e pour des activit&#233;s dans des entreprises qui sont contr&#244;l&#233;es directement ou indirectement par la soci&#233;t&#233; et peuvent &#234;tre vers&#233;es par la soci&#233;t&#233; ou par une soci&#233;t&#233; contr&#244;l&#233;e par elle.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:49.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 33</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Principles of the Compensation of the Executive Committee</b></p></div></div></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:46.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 33</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Principe de r&#233;mun&#233;ration du comit&#233; ex&#233;cutif</b></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">La r&#233;mun&#233;ration des membres du </font><font style="font-family:'Times New Roman','Times','serif';">comit&#233; ex&#233;cutif</font><font style="font-family:'Times New Roman','Times','serif';"> est soumis &#224; l&#39;approbation l&#39;assembl&#233;e g&#233;n&#233;rale et comprend les &#233;l&#233;ments suivants </font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">une r&#233;mun&#233;ration fixe payable en esp&#232;ces;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">une r&#233;mun&#233;ration li&#233;e &#224; la performance payable en esp&#232;ces (variable);</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">c)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">un nombre d&#39;actions ou d&#39;options dans la soci&#233;t&#233;, comme d&#233;taill&#233;e &#224; l&#39;art. 41.</font></div></div></div><div style="margin-top:6pt;"></div></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The compensation payable to the members of the Executive Committee is subject to the approval by the General Meeting and comprises the following elements: </font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a fixed remuneration payable in cash;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a performance-related remuneration payable in cash (variable);</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">c)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a number of options or shares in the Company, as further outlined in Art. 41.</font></div></div></div><div style="margin-top:6pt;"></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The performance-related remuneration depends on the Company&#39;s business success and the individual performance of the member of the Executive Committee based on the achievement of pre-determined targets during a business year. The Board of Directors determines annually at the beginning of each relevant business year the decisive targets and their weighting upon proposal by the Compensation Committee. The amount of the performance-related remuneration for each member of the Executive Committee is determined by the Board of Directors and may not exceed 100 percent of the respective individual fixed remuneration for the same </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">La r&#233;mun&#233;ration li&#233;e &#224; la performance d&#233;pend de la r&#233;ussite &#233;conomique de la soci&#233;t&#233; et de la performance individuelle du membre du </font><font style="font-family:'Times New Roman','Times','serif';">comit&#233; ex&#233;cutif</font><font style="font-family:'Times New Roman','Times','serif';"> sur la base de la r&#233;alisation des objectifs pr&#233;d&#233;termin&#233;s au cours d&#39;une ann&#233;e d&#39;activit&#233;. Le conseil d&#39;administration d&#233;termine au d&#233;but de chaque exercice les objectifs d&#233;cisifs et leur pond&#233;ration sur proposition du comit&#233; de r&#233;mun&#233;ration. Le montant de la r&#233;mun&#233;ration li&#233;e &#224; la performance pour chaque membre du comit&#233; ex&#233;cutif est d&#233;termin&#233; par le conseil d&#39;administration et ne peut d&#233;passer 100 pour cent de la r&#233;mun&#233;ration fixe individuelle respective pour la m&#234;me ann&#233;e.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">year.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The compensation may also be paid for activities in companies that are directly or indirectly controlled by the Company and may be paid by the Company or by a company controlled by it.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">La r&#233;mun&#233;ration peut &#233;galement &#234;tre vers&#233;e pour activit&#233;s dans des entreprises qui sont contr&#244;l&#233;es directement ou indirectement par la soci&#233;t&#233; et peut &#234;tre vers&#233;e par la soci&#233;t&#233; ou par une soci&#233;t&#233; contr&#244;l&#233;e par elle.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:49.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 34</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Compensation for new Members of the Executive Committee</b></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">If new members of the Executive Committee are appointed and take up their position in the Company after the General Meeting has approved the maximum total compensation for members of the Executive Committee for the year in question, the new members may be paid an additional amount for the period until the next Ordinary Meeting of Shareholder. The additional amount payable to all new members of the Executive Committee may not exceed 50 percent of the respective total compensation already approved by the General Meeting. The additional compensation may only be paid if the total compensation amount that has been approved by the General Meeting for the compensation of the members of the Executive Committee is insufficient to compensate the newly appointed members. The General </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:46.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 34</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">R&#233;mun&#233;ration pour les nouveaux membres du comit&#233; ex&#233;cutif</b></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Si de nouveaux membres du </font><font style="font-family:'Times New Roman','Times','serif';">comit&#233; ex&#233;cutif</font><font style="font-family:'Times New Roman','Times','serif';"> sont nomm&#233;s et prennent leur position dans la soci&#233;t&#233; apr&#232;s que l&#39;assembl&#233;e g&#233;n&#233;rale a approuv&#233; la r&#233;mun&#233;ration totale maximale pour les membres du </font><font style="font-family:'Times New Roman','Times','serif';">comit&#233; ex&#233;cutif</font><font style="font-family:'Times New Roman','Times','serif';"> pour l&#39;ann&#233;e en question, les nouveaux membres peuvent &#234;tre pay&#233;s au moyen d&#39;un montant additionnel pour la p&#233;riode allant jusqu&#39;&#224; la prochaine assembl&#233;e ordinaire des actionnaires. Le montant additionnel payable &#224; tous les nouveaux membres du </font><font style="font-family:'Times New Roman','Times','serif';">comit&#233; ex&#233;cutif</font><font style="font-family:'Times New Roman','Times','serif';"> ne peut pas d&#233;passer 50 pour cent de la r&#233;mun&#233;ration totale respective d&#233;j&#224; approuv&#233; par l&#39;assembl&#233;e g&#233;n&#233;rale. La r&#233;mun&#233;ration additionnelle ne peut &#234;tre vers&#233;e que si le montant total de la r&#233;mun&#233;ration qui a &#233;t&#233; approuv&#233; par l&#39;assembl&#233;e g&#233;n&#233;rale pour la r&#233;mun&#233;ration des membres du </font><font style="font-family:'Times New Roman','Times','serif';">comit&#233; ex&#233;cutif</font><font style="font-family:'Times New Roman','Times','serif';"> est insuffisant pour r&#233;mun&#233;rer les </font></p></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Meeting is not required to vote on this additional amount.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">membres nouvellement nomm&#233;s. L&#39;assembl&#233;e g&#233;n&#233;rale n&#39;a pas &#224; se prononcer sur ce montant suppl&#233;mentaire.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">This additional overall compensation is understood to include any settlements for any disadvantage suffered as a result of the change of job.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Cette r&#233;mun&#233;ration additionnelle globale est sens&#233;e comprendre tous les r&#232;glements pour tout inconv&#233;nient subi &#224; la suite du changement de travail.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 35</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Expenses</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Expenses which are not covered by the lump sum compensation pursuant to the Company&#39;s expense regulations shall be reimbursed following presentation of the supporting receipts. This additional remuneration is not subject to a separate vote by the General Meeting.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 35</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">D&#233;penses</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Les d&#233;penses qui ne sont pas couvertes par l&#39;indemnit&#233; forfaitaire conform&#233;ment aux r&#232;glements de frais de la soci&#233;t&#233; sont rembours&#233;es &#224; la suite de la pr&#233;sentation des re&#231;us correspondants. Cette r&#233;mun&#233;ration additionnelle n&#39;est pas soumise &#224; un vote s&#233;par&#233; par l&#39;assembl&#233;e g&#233;n&#233;rale.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:67.75pt;text-indent:-67.75pt;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 36</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Compensation Agreements</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Agreements on compensation with members of the Board of Directors may not exceed the term of maximal one year.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:67.75pt;text-indent:-67.75pt;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 36</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Accords sur la r&#233;mun&#233;ration</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Les accords sur la r&#233;mun&#233;ration des membres du conseil d&#39;administration ne peuvent pas exc&#233;der la dur&#233;e maximale d&#39;une ann&#233;e.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Employment agreements of the members of the Executive Committee are principally concluded for an indefinite period of time whereas a notice period may not exceed 12 months. If an employment agreement is concluded for a fixed term such term may not exceed one year.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Les contrats de travail des membres du comit&#233; ex&#233;cutif sont principalement conclus pour une dur&#233;e ind&#233;termin&#233;e. Un d&#233;lai de pr&#233;avis ne peut pas exc&#233;der 12 mois. Si un accord de travail est conclu pour une dur&#233;e d&#233;termin&#233;e, telle dur&#233;e ne peut pas exc&#233;der un an.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:51.1pt;text-align:justify;text-indent:-51.1pt;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 37 </b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Mandates of a Member of the Board of Directors outside the Company</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">A member of the Board of Directors may cumulatively assume not more than the following number of mandates in the board of directors, the superior management or an administrative body of a legal entity which is obliged to be registered in the Swiss commercial register or an equivalent foreign register:</font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">7 mandates for publicly traded companies pursuant to art. 727 para. 1 number 1 CO; and</font><font style="display:inline-block;width:8.76pt;"></font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">8 mandates for companies pursuant to art. 727 para. 1 number 2 CO; and</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">c)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">5 mandates for companies which do not fulfil the criteria under a) and b) above.</font></div></div></div><div style="margin-top:6pt;"></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:46.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 37</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Mandats d&#39;un membre du conseil d&#39;administration de la soci&#233;t&#233;</b></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Un membre du conseil d&#39;administration ne peut pas cumuler plus que le nombre suivant de mandats dans un conseil d&#39;administration, une direction sup&#233;rieure ou un organisme administratif d&#39;une personne morale qui est oblig&#233;e d&#39;&#234;tre inscrite au registre du commerce suisse ou un registre &#233;tranger &#233;quivalent:</font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">7 mandats pour les entreprises cot&#233;es en bourse selon l&#39;art. 727 al. 1 chiffre 1 CO; et</font><font style="display:inline-block;width:7.92pt;"></font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">8 mandats pour des entreprises selon l&#39;art. 727 al. 1 chiffre 2 CO; et</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">c)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">5 mandats pour les entreprises qui ne remplissent pas les crit&#232;res sous a) et b) ci-dessus.</font></div></div></div><div style="margin-top:6pt;"></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Mandates held in several legal entities each operating under the same management or same beneficial owner (group) are deemed to be a single mandate.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Les mandats exerc&#233;s dans plusieurs entit&#233;s juridiques op&#233;rant chacune sous la m&#234;me direction ou le m&#234;me </font><font style="font-family:'Times New Roman','Times','serif';">b&#233;n&#233;ficiaire effectif </font><font style="font-family:'Times New Roman','Times','serif';">(groupe) sont r&#233;put&#233;s &#234;tre un seul mandat.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">If a legal entity fulfills several of the above mentioned criteria, it can be freely counted towards any category. </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Si une entit&#233; juridique remplit plusieurs des crit&#232;res mentionn&#233;s ci-dessus, elle peut &#234;tre librement plac&#233;e </font></p></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The following mandates are excepted from these restrictions:</font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">mandates in legal entities which are controlled by the Company or which control the Company;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">honorary mandates in charitable legal entities.</font></div></div></div><div style="margin-top:6pt;"></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">dans une cat&#233;gorie. Les mandats suivants sont except&#233;s de ces restrictions:</font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">les mandats dans des entit&#233;s juridiques qui sont contr&#244;l&#233;es par la soci&#233;t&#233; ou qui contr&#244;lent la soci&#233;t&#233;;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">des mandats d&#39;honneur &#224; des personnes morales de bienfaisance. </font></div></div></div><div style="margin-top:6pt;"></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:49.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 38</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Mandates of a Member of the Executive Committee outside the Company</b></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Each member of the Executive Committee may, with approval of the Board of Directors, cumulatively assume not more than the following number of mandates in the board of directors, the superior management or an administrative body of a legal entity which is obliged to be registered in the Swiss commercial register or an equivalent foreign register:</font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2 mandates for publicly traded companies pursuant to Art. 727 para. 1 number 1 CO; and</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3 mandates for companies pursuant to Art.&#160;727 para. 1 number 2 CO; and</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">c)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">5 mandates for companies which do not fulfil the criteria under litera a) and b) above.</font></div></div></div><div style="margin-top:6pt;"></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:46.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Art. 38</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Mandats d&#39;un membre du comit&#233; ex&#233;cutif en-dehors de la soci&#233;t&#233;</b></p></div></div></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Chaque membre du comit&#233; ex&#233;cutif peut, avec l&#39;approbation du conseil d&#39;administration, cumuler pas plus que le nombre suivant de mandats dans un conseil d&#39;administration, une direction sup&#233;rieure ou un organisme administratif d&#39;une personne morale qui est oblig&#233;e d&#39;&#234;tre inscrite dans le registre du commerce suisse ou un registre &#233;tranger &#233;quivalent:</font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2 mandats pour les entreprises cot&#233;es en bourse selon l&#39;art. 727 al. 1 chiffre 1 CO; et</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3 mandats pour des entreprises selon l&#39;art. 727 al. 1 chiffre 2 CO; et</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">c)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">5 mandats pour les entreprises qui ne remplissent pas les crit&#232;res sous a) et b) ci-dessus.</font></div></div></div><div style="margin-top:6pt;"></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Mandates held in several legal entities each operating under the same management or same beneficial owner (group) are deemed to be a single mandate.</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">If a legal entity fulfills several of the above mentioned criteria, it can be freely counted towards any category. The following mandates are excepted from this restrictions:</font><font style="display:inline-block;width:23.69pt;"></font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">mandates in legal entities which are controlled by the Company or which control the Company;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">honorary mandates in charitable legal entities.</font></div></div></div><div style="margin-top:6pt;"></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Les mandats exerc&#233;s dans plusieurs entit&#233;s juridiques op&#233;rant chacun sous la m&#234;me direction ou m&#234;me </font><font style="font-family:'Times New Roman','Times','serif';">b&#233;n&#233;ficiaire effectif </font><font style="font-family:'Times New Roman','Times','serif';">(groupe) sont r&#233;put&#233;s &#234;tre un seul mandat.</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Si une entit&#233; juridique remplit plusieurs des crit&#232;res mentionn&#233;s ci-dessus, elle peut &#234;tre librement plac&#233;e dans une cat&#233;gorie. Les mandats suivants sont except&#233;s de ces restrictions:</font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">les mandats dans des entit&#233;s juridiques qui sont contr&#244;l&#233;es par la soci&#233;t&#233; ou qui contr&#244;lent la soci&#233;t&#233;;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">mandats d&#39;honneur dans des entit&#233;s juridiques de bienfaisance.</font></div></div></div><div style="margin-top:6pt;"></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 39</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Loans and Credits </b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The members of the Board of Directors and the Executive Committee may not be granted any loans, credits or securities. Excepted from the above are advances in the maximum amount of CHF 500&#39;000 per person for attorneys&#39; fees, court and other similar costs required for the defence of third-party liability claims permitted by Article 29.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 39</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Pr&#234;ts et cr&#233;dits </b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Les membres du conseil d&#39;administration et du comit&#233; ex&#233;cutif ne peuvent pas souscrire des pr&#234;ts, des cr&#233;dits ou des titres. Sont except&#233;es les avances d&#39;un montant maximum de CHF 500&#39;000 par personne pour les frais d&#39;avocat, des co&#251;ts de tribunaux et d&#39;autres co&#251;ts similaires n&#233;cessaires &#224; la d&#233;fense contre des actions en responsabilit&#233; civile autoris&#233;s par l&#39;article 29.</font></p></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 40</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Pension Funds</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Company shall remunerate members of the Board of Directors only in respect of the employer&#39;s mandatory contributions to social insurance. Above and beyond this, the Company shall not make any contributions to pension funds or other such pension plans. In exceptional cases, contributions such as these may be made subject to a request by the Compensation Committee and the approval of the General Meeting.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 40</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Fonds de pension</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">La soci&#233;t&#233; ne doit r&#233;mun&#233;rer les membres du conseil d&#39;administration que du montant d&#251; au titre de contributions obligatoire de l&#39;employeur &#224; l&#39;assurance sociale. Au-del&#224; de ce montant, la soci&#233;t&#233; ne doit pas verser de cotisations &#224; des institutions de pr&#233;voyance &#160;ou &#224; d&#39;autres r&#233;gimes de retraite. Dans des cas exceptionnels, des contributions comme celles-ci peuvent &#234;tre faites sur demande au comit&#233; de r&#233;mun&#233;ration et sous r&#233;serve de l&#39;approbation de l&#39;assembl&#233;e g&#233;n&#233;rale.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Members of the Executive Committee participate in the Company&#39;s pension plans (the Company&#39;s pension fund and the management pension plan). The pension plans conform to the legal requirements. For members of the Executive Committee, the insured income is defined as the fixed remuneration plus 50 percent of the target performance-related remuneration, up to the legal maximum. Equity-linked income components are not included.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Les membres du comit&#233; ex&#233;cutif participent aux r&#233;gimes de retraite de la soci&#233;t&#233; (le fond de pension de la soci&#233;t&#233; et le r&#233;gime de retraite du management). Les r&#233;gimes de retraite sont conformes aux exigences l&#233;gales (LPP). Pour les membres du comit&#233; ex&#233;cutif, le revenu assur&#233; est d&#233;fini comme la r&#233;mun&#233;ration fixe plus les 50 pour cent de la r&#233;mun&#233;ration li&#233;e &#224; la performance, jusqu&#39;au maximum l&#233;gal. Les composantes du revenu li&#233;es au capital propre ne sont pas inclus.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Within the overall compensation approved by the General Meeting, the Company may make additional payments into the Company&#39;s pension funds for the benefit of members of the Executive Committee in order to cover </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Dans la r&#233;mun&#233;ration globale approuv&#233;e par l&#39;assembl&#233;e g&#233;n&#233;rale, la soci&#233;t&#233; pourra effectuer des paiements suppl&#233;mentaires dans les caisses de retraite de la soci&#233;t&#233; pour le b&#233;n&#233;fice des membres du comit&#233; ex&#233;cutif afin de </font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">any disadvantage suffered as a result of the change of jobs or to purchase additional pension entitlements. In this context</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">the Company may conclude life insurance policies on behalf of members of the Executive Committee and pay the insurance premiums either fully or in part.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">couvrir tout d&#233;savantage subi par suite de la modification de l&#39;emploi ou pour acheter des droits de pension suppl&#233;mentaires. Dans ce contexte, la soci&#233;t&#233; peut conclure des contrats d&#39;assurance-vie au nom des membres du comit&#233; ex&#233;cutif et payer en totalit&#233; ou en partie les primes d&#39;assurance.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Upon retirement, the Company may also grant members of the Executive Committee a bridging pension to cover the period between early retirement at 62 and the ordinary age of retirement, if such bridging pension does not exceed 100 percent of the total annual compensation of the respective member last paid.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#192; la retraite, la soci&#233;t&#233; peut &#233;galement accorder aux membres du comit&#233; ex&#233;cutif, une pension de transition pour couvrir la p&#233;riode entre la retraite anticip&#233;e &#224; 62 ans et l&#39;&#226;ge ordinaire de la retraite, si cette rente transitoire ne d&#233;passe pas 100 pour cent du dernier montant de la r&#233;mun&#233;ration annuelle totale pay&#233;e au membre respectif.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 41</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Option and Share Plans</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Under the Company&#39;s Long Term Incentive Plan, the Board of Directors, upon proposal of the Compensation Committee, allocates the participating members of the Executive Committee and the Board of Directors a fixed number of options or shares with a vesting or a blocking period (the vesting period). At the end of the vesting period, participants in the Long Term Incentive </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 41</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Options et plan d&#39;actions</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">En vertu du plan d&#8217;int&#233;ressement &#224; long terme de la soci&#233;t&#233;, le conseil d&#39;administration, sur proposition du comit&#233; de r&#233;mun&#233;ration, attribue aux membres participants du comit&#233; ex&#233;cutif et du conseil d&#39;administration un nombre fixe d&#39;options ou d&#39;actions avec une p&#233;riode de vesting ou de blocage (la &quot;P&#233;riode de Vesting &quot;). &#192; la fin de la P&#233;riode de Vesting, les </font></p></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Plan are entitled to exercise the options granted against payment of the strike price. These options to acquire shares in the Company or allocated shares are subject to the basic principles set out in the following:</font><font style="font-family:'Times New Roman','Times','serif';"><br></font><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">it is the sole discretion of the Board of Directors to decide whether to allocate options or shares and to whom and to determine the valuation of each compensation element on the basis of the principles that apply to the establishment of the compensation report;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">each year, the Board of Directors, upon proposal of the Compensation Committee, stipulates the number of options and shares to be allocated, the date of allocation and the strike price;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">c)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">each option incorporates a non-transferable, pre-emptive, and contingent right to acquire a certain number of Company&#39;s shares;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:21.3pt;padding:0pt;">d)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">in the case of a change of control (as defined in the Long Term Incentive Plan) or delisting of the Company&#39;s shares, the vesting period shall end (accelerated vesting) and the participant shall be entitled to exercise the options on a pro rata basis on the day the transaction that led to the change of control or delisting was executed. It is at the sole discretion of the Board of Directors to decide upon </font></div></div></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">participants au plan d&#8217;int&#233;ressement &#224; long terme sont habilit&#233;s &#224; exercer les options attribu&#233;es contre paiement du prix d&#39;exercice. Ces options d&#39;achat d&#39;actions de la soci&#233;t&#233; ou d&#39;actions attribu&#233;es sont soumises aux principes de base suivants:</font></p><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">il rel&#232;ve de la libre appr&#233;ciation du conseil d&#39;administration de d&#233;cider si des options ou actions sont attribu&#233;es et &#224; qui et de d&#233;terminer l&#39;&#233;valuation de chaque &#233;l&#233;ment de r&#233;mun&#233;ration sur la base des principes qui s&#39;appliquent &#224; l&#39;&#233;tablissement du rapport de r&#233;mun&#233;ration;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">chaque ann&#233;e, le conseil d&#39;administration, sur proposition du comit&#233; de r&#233;mun&#233;ration, fixe le nombre d&#39;options et d&#39;actions &#224; attribuer, la date d&#39;attribution et le prix d&#39;exercice;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">c)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">chaque option comporte un droit non transf&#233;rable, de souscription pr&#233;f&#233;rentielle et optionnel d&#39;acqu&#233;rir un certain nombre d&#39;actions de la soci&#233;t&#233;;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:25.35pt;padding:0pt;">d)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">dans le cas d&#39;un changement de contr&#244;le (tel que d&#233;fini dans le plan d&#8217;int&#233;ressement &#224; long terme) ou la radiation des actions de la soci&#233;t&#233;, la P&#233;riode de Vesting prend fin (vesting acc&#233;l&#233;r&#233;) et le participant est en droit d&#39;exercer les options sur une base pro rata, le jour de la transaction qui a conduit &#224; un changement de contr&#244;le ou le jour o&#249; la radiation a &#233;t&#233; ex&#233;cut&#233;e. Il rel&#232;ve de la libre</font></div></div></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 18pt;"><font style="font-family:'Times New Roman','Times','serif';">proposal of the Compensation Committee whether the financial objectives have been met;</font><font style="display:inline-block;width:3.48pt;"></font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">e)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the individual members of the Executive Committee or the Board of Directors participating in the Long Term Incentive Plan are responsible for paying any taxes or social security contributions and for declaring income correctly to the authorities;</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><br></font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">f)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">it is at the sole discretion of the Board of Directors to decide whether to supplement the Long Term Incentive Plan within the bounds of the principles set out above or to discontinue it.</font></div></div></div><div style="margin-top:6pt;"></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 0pt 18pt;"><font style="font-family:'Times New Roman','Times','serif';">appr&#233;ciation du conseil d&#39;administration de d&#233;cider, sur proposition du comit&#233; de r&#233;mun&#233;ration, si les objectifs financiers ont &#233;t&#233; atteints;</font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">e)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">les membres individuels du comit&#233; ex&#233;cutif ou du conseil d&#39;administration qui participent au plan d&#8217;int&#233;ressement &#224; long terme sont responsables du paiement de tous les imp&#244;ts ou cotisations de s&#233;curit&#233; sociale et de d&#233;clarer correctement le revenu aux autorit&#233;s;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">f)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">il rel&#232;ve de la libre appr&#233;ciation du conseil d&#39;administration de compl&#233;ter le plan d&#8217;int&#233;ressement &#224; long terme dans les limites des principes &#233;nonc&#233;s ci-dessus ou de l&#39;interrompre.</font></div></div></div><div style="margin-top:6pt;"></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Company may periodically offer shares in the Company to important and long-term employees for a price being at maximum ten percent below the average volume-weighted price of the last 30 trading days at the stock exchange. Members of the Board of Directors and the Executive Committee may be included in this </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">La soci&#233;t&#233; peut p&#233;riodiquement offrir des actions de la soci&#233;t&#233; aux salari&#233;s importants et &#224; long terme pour un prix &#233;tant au maximum dix pour cent au-dessous du prix moyen pond&#233;r&#233; par les volumes des 30 derniers jours &#224; la bourse. Les membres du conseil d&#39;administration et du comit&#233; ex&#233;cutif peuvent &#234;tre inclus dans ce programme. </font></p></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">program. The shares acquired thereby shall be blocked for a period of at least 3 years. </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Les actions ainsi acquises seront bloqu&#233;es pour une p&#233;riode d&#39;au moins 3 ans. </font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:49.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">VIII.</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Business Year, Accounting, Allocation of Profits</b></p></div></div></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;padding-left:39.5pt;text-indent:-39.5pt;text-transform:uppercase;margin:6pt 0pt 6pt -39.5pt;"><font style="font-family:'Times New Roman','Times','serif';margin-left:0pt;margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:46.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">VIII.</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Exercice, comptabilit&#233;, R&#233;partition des b&#233;n&#233;fices</b></p></div></div></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 42</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Business Year</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Board of Directors shall determine the start and the end of the Company&#39;s business year. </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 42</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Exercice</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Le conseil d&#39;administration d&#233;termine le d&#233;but et la fin de l&#39;exercice de la soci&#233;t&#233;.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 43</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Accounting</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The annual accounts consist of the profit and loss statement, the balance sheet, the cash flow statement, the annex and the management report, and shall be drawn up pursuant to the provisions of the CO, particularly of Articles 958 </font><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">et seq.</i><font style="font-family:'Times New Roman','Times','serif';"> CO, and the generally accepted commercial principles and customary rules in that business area.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 43</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Comptabilit&#233;</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Les comptes annuels se composent du compte de profits et pertes, du bilan, du tableau des flux de tr&#233;sorerie, de l&#39;annexe et du rapport de gestion, et sont &#233;tablis conform&#233;ment aux dispositions du CO, en particulier des articles 958 ss. CO, et aux principes commerciaux g&#233;n&#233;ralement reconnus et aux r&#232;gles coutumi&#232;res dans ce secteur d&#39;activit&#233;.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">If required by law, the consolidated financial statements shall be drawn in accordance with the provisions of Article 962 CO.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Si requis par la loi, les &#233;tats financiers consolid&#233;s sont &#233;tablis en conformit&#233; avec les dispositions de l&#39;article 962 CO.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 44</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Allocation of Profits</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Subject to the legal provisions regarding distribution of profits, the profit as shown on the balance sheet shall be allocated by the General Meeting at its discretion after receipt of the proposals of the Board of Directors and the </font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 44</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">R&#233;partition des b&#233;n&#233;fices</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Sous r&#233;serve des dispositions l&#233;gales en mati&#232;re de r&#233;partition des b&#233;n&#233;fices, le b&#233;n&#233;fice comme indiqu&#233; sur le bilan doit &#234;tre allou&#233; &#224; la libre appr&#233;ciation de l&#39;assembl&#233;e g&#233;n&#233;rale apr&#232;s r&#233;ception des propositions du </font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Auditors.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">conseil d&#39;administration et de l&#39;organe de r&#233;vision.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">In addition to the legal reserves, the General Meeting may create supplemental reserves.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">En plus des r&#233;serves l&#233;gales, l&#39;assembl&#233;e g&#233;n&#233;rale peut cr&#233;er des r&#233;serves suppl&#233;mentaires.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Dividends not claimed within five years after the due date shall remain with the Company and be allocated to the general reserves.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Les dividendes non r&#233;clam&#233;s dans les cinq ans apr&#232;s la date d&#39;&#233;ch&#233;ance restent avec la soci&#233;t&#233; et sont attribu&#233;s aux r&#233;serves g&#233;n&#233;rales.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:49.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Ix.</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Dissolution and Liquidation</b></p></div></div></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;padding-left:39.5pt;text-indent:-39.5pt;text-transform:uppercase;margin:6pt 0pt 6pt -39.5pt;"><font style="font-family:'Times New Roman','Times','serif';margin-left:0pt;margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:46.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Ix.</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Dissolution et Liquidation</b></p></div></div></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:67.85pt;text-indent:-67.85pt;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 45</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Dissolution and Liquidation</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The dissolution and liquidation of the Company shall take place in accordance with the provisions of the CO.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;padding-left:67.85pt;text-indent:-67.85pt;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 45</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Dissolution et Liquidation</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">La dissolution et la liquidation de la soci&#233;t&#233; ont lieu en conformit&#233; avec les dispositions du CO.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:49.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">X.</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Notices and Publications</b></p></div></div></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;padding-left:39.5pt;text-indent:-39.5pt;text-transform:uppercase;margin:6pt 0pt 6pt -39.5pt;"><font style="font-family:'Times New Roman','Times','serif';margin-left:0pt;margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><div border="0" cellpadding="0" cellspacing="0" style="display:table;"><div style="display:table-row;"><div style="display:table-cell;vertical-align:text-top;white-space:nowrap;width:46.65pt;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">X.</b></p></div><div style="display:table-cell;padding:0pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;margin-bottom:6pt;margin-top:6pt;min-height:14.5pt;text-transform:uppercase;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">avis et Publications</b></p></div></div></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 46</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Notices and Publications</b><font style="display:inline-block;width:1.29pt;"></font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The Swiss Official Gazette of Commerce is the official publication medium.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;font-weight:bold;line-height:1.19;text-indent:0pt;text-transform:uppercase;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-top:18pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:46.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 46</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Avis et Publications</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">L&#39;organe de publication l&#233;gal est la Feuille officielle suisse du commerce.</font></p></td></tr></table></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:always;width:79.76%;border-width:0;"><div style="max-width:100%;padding-left:11.91%;padding-right:8.33%;position:relative;"><div style="margin-top:19.85pt;width:100%;"><p style="font-family:'Verdana';font-size:10pt;min-height:10.0pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:103.26%;"><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Shareholder communications and notices to the shareholders shall be made by publication in the Swiss Official Gazette of Commerce or sent by mail or e-mail to the addresses registered in the share register.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Les communications et avis aux actionnaires sont effectu&#233;s par publication dans la Feuille officielle suisse du commerce ou envoy&#233;s par courrier ou e-mail aux adresses enregistr&#233;es dans le registre des actions.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Unless the law provides otherwise, notices shall be given to creditors by publication in the Swiss Official Gazette of Commerce. The Board of Directors may assign further means of communication.</font></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Sauf si la loi en dispose autrement, les avis seront envoy&#233;s aux cr&#233;anciers par publication dans la Feuille officielle suisse du commerce. Le conseil d&#39;administration peut pr&#233;voir d&#39;autres moyens de communication.</font></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:42.55pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">XI.</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">TRANSITIONAL PROVISIONS</b></p></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:42.55pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">XI.</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">DISPOSITIONS TRANSITOIRES</b></p></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 47</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Transitional Provisions concerning the Compensation of the Executive Committee</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">In the event that no vote was taken prior to the Ordinary General Meeting 2022 with respect to i) and ii) below, the shareholders shall vote, at the Ordinary General Meeting 2022, among other things, separately on the approval of the proposals of the Board of Directors in relation to (i) the maximum aggregate amount of compensation of the Executive Committee for the following financial year 2023 in accordance with the amended Articles 8 para. 1 lit. e) and 18 of the Articles of Association approved by the Ordinary General Meeting held on 25 June 2021 and the Articles 33 and 35 of the Articles of Association, and (ii) the total maximum amount of compensation of the Executive Committee for </font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the non-performance-related compensation of the </font></div></div></div><div style="margin-top:6pt;"></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;margin:6pt 0pt 6pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:49.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Art. 47</b></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Dispositions transitoires concernant la r&#233;mun&#233;ration du comit&#233; ex&#233;cutif</b></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Dans l&#8217;hypoth&#232;se o&#249; aucun vote n&#8217;a eu lieu avant l&#39;assembl&#233;e g&#233;n&#233;rale ordinaire 2022 sur les objets (i) et (ii) ci-dessous, les actionnaires voteront lors de l&#39;assembl&#233;e g&#233;n&#233;rale ordinaire 2022, entre autres, s&#233;par&#233;ment sur l&#39;approbation des propositions du conseil d&#39;administration concernant (i) le montant global maximum de la r&#233;mun&#233;ration du comit&#233; ex&#233;cutif pour l&#39;exercice suivant 2023 conform&#233;ment aux articles 8, al. 1 let. e) et 18 des statuts approuv&#233;s par l&#39;assembl&#233;e g&#233;n&#233;rale ordinaire du 25 juin 2021 et les articles 33 et 35 des statuts, et (ii) le montant total maximum de la r&#233;mun&#233;ration du comit&#233; ex&#233;cutif pour</font><font style="font-family:'Times New Roman','Times','serif';"><br></font><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">la r&#233;mun&#233;ration non li&#233;e &#224; la performance du comit&#233; </font></div></div></div><div style="margin-top:6pt;"></div></td></tr><tr><td style="vertical-align:top;width:47.9%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Executive Committee for the 6-month period starting on 1 July 2022 to 31 December 2022; </font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the variable compensation for the Executive Committee for the 12-month period starting on 1 January 2022 to 31 December 2022; and</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">c)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the grant of Equity in the Company to the Executive Committee for the 6-month period starting on 1 July 2022 to 31 December 2022, in accordance with Articles 18 para. 2 and 3, 33 as well as 35 of the Articles of Association.</font></div></div></div><div style="margin-top:6pt;"></div></td><td style="vertical-align:top;width:4.24%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:47.84%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">ex&#233;cutif pour la p&#233;riode de 6 mois du 1er juillet 2022 au 31 d&#233;cembre 2022;</font></p><div style="margin-top:6pt;"></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:6pt;margin-top:0pt;min-height:14.5pt;table-layout:fixed;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">la r&#233;mun&#233;ration variable pour le </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">comit&#233; ex&#233;cutif</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> pour la p&#233;riode de 12 mois du 1er janvier 2022 au 31 d&#233;cembre 2022;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Verdana';font-size:10pt;margin-bottom:0pt;margin-top:6pt;min-height:14.5pt;table-layout:fixed;width:100%;border:0pt;"><div style="display:table-row;"><div style="display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">c)</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">l&#39;octroi de participations dans la soci&#233;t&#233; au </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">comit&#233; ex&#233;cutif </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">pour la p&#233;riode de 6 mois du 1er juillet 2022 au 31 d&#233;cembre 2022</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">, </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">conform&#233;ment &#224; l&#39;article 18 al. 2 et 3, ainsi que 33 et 35 des statuts.</font></div></div></div><div style="margin-top:6pt;"></div></td></tr></table></div><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Verdana';font-size:10pt;min-height:14.5pt;text-align:justify;margin:6pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Statuts modifi&#233;s lors de la s&#233;ance du conseil d&#8217;administration du 26 f&#233;vrier 2024.</font></p><p style="font-family:'Verdana';font-size:10pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">L&#8217;atteste&#160;: </font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.91%;margin-right:8.33%;margin-top:30pt;page-break-after:avoid;width:79.76%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.17
<SEQUENCE>3
<FILENAME>aciu-20231231xex4d17.htm
<DESCRIPTION>EX-4.17
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.5.122.0--><!--Created on: 3/13/2024 05:01:46 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Exhibit 4.17</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">DESCRIPTION OF THE REGISTRANT&#8217;S SECURITIES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">EXCHANGE ACT OF 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><i style="font-style:italic;">The following is a summary of the material terms of our securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), as of March 14, 2024. The following description of the terms of our common shares is not meant to be complete and is qualified by reference to our articles of association (&#8220;articles of association&#8221;), which is incorporated by reference as an exhibit to our Annual Report on Form 20-F, of which this exhibit is a part. We encourage you to read our articles of association and the applicable provisions of Swiss law for additional information.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">The Company</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">We are a Swiss stock corporation (<i style="font-style:italic;">soci&#233;t&#233; anonyme</i>) organized under the laws of Switzerland. We were formed as a Swiss limited liability company (<i style="font-style:italic;">soci&#233;t&#233; &#224; responsabilit&#233; limit&#233;e</i>) on February&#160;13, 2003 with our registered office and domicile in Basel, Switzerland. We converted to a Swiss stock corporation (<i style="font-style:italic;">soci&#233;t&#233; anonyme</i>) under the laws of Switzerland on August 25, 2003. Our Swiss enterprise identification number is CHE-109.878.825. Our domicile and registered office is in Ecublens, at the &#201;cole Polytechnique F&#233;d&#233;rale Lausanne (EPFL) Innovation Park Building B, 1015 Lausanne, Vaud, Switzerland.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Share Capital</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">As of March 14, 2024, our issued share capital is CHF 2,082,858.10, consisting of 104,142,905 common shares of which 5,243,958 are held as treasury shares, leaving 98,898,947 common shares outstanding with a nominal value of CHF 0.02 each. We have no dividend rights certificates (<i style="font-style:italic;">bons de jouissance</i>).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Articles of Association</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">On February 26, 2024, we adopted amended articles of association and when we refer to our articles of association, we refer to the articles of association as filed as Exhibit 3.1 to our Annual Report on Form 20-F for the fiscal year ended December 31, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Purpose</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Under our articles of association, our purpose is the research, study, development, manufacture, promotion, sale and marketing of products and substances within the pharmaceutical and nutrition industry as well as the purchase, sale and exploitation of patents and licenses in this field. We may engage in any activities which are apt to favor our purpose directly or indirectly. We may also acquire and sell real estate. We may open branch offices in Switzerland and abroad and may also acquire participations in other companies. We may provide securities to our subsidiaries and supply guarantees.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Ordinary Capital Increase, Authorized and Conditional Share Capital</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Under Swiss law, we may increase our share capital (<i style="font-style:italic;">capital-actions</i>) with a resolution of the general meeting of shareholders (ordinary capital increase) that must be carried out by the board of directors within three months of the general meeting of shareholders in order to become effective. Under our articles of association, in the case of an increase of capital against payment of contributions in cash, a resolution passed by a simple majority of the votes cast at the general meeting of shareholders regardless of abstentions and empty or invalid votes is required. In the case of the limitation or withdrawal of subscription rights or in the case of an increase of capital out of equity, against contribution in kind, or for the purpose of acquisition of assets and the granting of special benefits, a resolution passed by at least two-thirds of the shares represented at a general meeting of shareholders and the absolute majority of the nominal amount of the shares represented is required.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Furthermore, under the Swiss Code of Obligations, the CO, as effective at the time when our current conditional capitals and authorized share capital were voted by the general meeting, our shareholders, by a resolution passed by at least two-thirds of the shares represented at a general meeting of shareholders and the absolute majority of the nominal amount of the shares represented, may empower our board of directors to issue shares of a specific aggregate nominal amount up to a maximum of 50% of the share capital in the form of:</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">conditional capital (</font><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">capital conditionnel</i><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">) for the purpose of issuing shares in connection with, among other things, (i) the exercise of conversion and/or option or warrant rights granted on a standalone basis or in connection with bonds or similar instruments, issued or to be issued by the Company or by one of our subsidiaries or (ii) the exercise of option rights granted to employees of the Company or a subsidiary, members of our board of directors or any consultant of the Company, or other persons providing services to the Company or a subsidiary; or</font></td></tr></table></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">authorized capital (</font><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">capital-actions autoris&#233;</i><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">) to be utilized by the board of directors within a period determined by the shareholders but not exceeding two years from the date of the shareholder approval</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.</font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Pre-Emptive Rights</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Pursuant to the CO, shareholders have in principle pre-emptive subscription rights (<i style="font-style:italic;">droit pr&#233;f&#233;rentiel de souscription</i>). With respect to conditional capital in connection with the issuance of conversion rights, convertible bonds or similar debt instruments, shareholders have in principle advance subscription rights (<i style="font-style:italic;">droit de souscrire pr&#233;alablement</i>).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">A resolution passed at a general meeting of shareholders by at least two-thirds of the shares represented and the absolute majority of the nominal value of the shares represented may authorize our board of directors to withdraw or limit pre-emptive subscription rights or advance subscription rights in certain circumstances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">If pre-emptive subscription rights are granted, but not exercised, the board of directors may allocate the non-exercised pre-emptive subscription rights as it elects but has to follow the principle of equal treatment of the shareholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Our Authorized Share Capital</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Under Article 3a of our articles of association, the board of directors is authorized to increase the share capital, in one or several steps until 24 June 2024, by a maximum amount of CHF 114,000 by issuing a maximum of 5,700,000 registered shares with a par value of CHF 0.02 each, to be fully paid up. An increase of the share capital (i) by means of an offering underwritten by a financial institution, a syndicate or another third party or third parties, followed by an offer to the then-existing shareholders of the Company and (ii) in partial amounts shall also be permissible.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">For the currently effective Authorized Share Capital, the board of directors is authorized to determine the time of the issuance, the issue price, the manner in which the new registered shares have to be paid up, the date from which the registered shares carry the right to dividends, the conditions for the exercise of the preemptive rights and the allotment of preemptive rights that have not been exercised. The board of directors may allow the pre-emptive rights that have not been exercised to expire, or it may place with third parties such rights or registered shares, the pre-emptive rights of which have not been exercised, at market conditions or use them otherwise in the interest of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The board of directors is authorized to withdraw or limit the pre-emptive rights of the shareholders and to allot them to third parties:</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if the issue price of the new registered shares is determined by reference to the market price (with a customary discount); or </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">for the acquisition of an enterprise, part of an enterprise or participations, or for the financing or refinancing of any of such acquisition, or in the event of share placement for the financing or refinancing of such placement; or </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">for raising of capital (including private placements) in a fast and flexible manner which probably could not be reached without the exclusion of the statutory pre-emptive right of the existing shareholders. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">As of January 1, 2023, the new Swiss corporate law introducing the capital band mechanism has come into force. It will no longer be possible to renew the Company&#39;s current Authorized Share Capital beyond June 24, 2024. Instead, the Company can only introduce the capital band pursuant to Article 653s et seq. of the revised Swiss Code of Obligations which requires an amendment of the Articles by way of a resolution of a duly convened general meeting of shareholders of the Company. Under the capital band mechanism, the general meeting of shareholders can authorize the board of directors at any time within a maximum of five years to increase or decrease the share capital by a maximum amount of 50% of the current share capital.</font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Our Conditional Share Capital</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 18pt;"><i style="font-style:italic;">Conditional Share Capital for Financing and Other Purposes</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Under Article 3b of our articles of association, our share capital may be increased by a maximum aggregate amount of CHF 100,000 through the issue of a maximum of 5,000,000 common shares, payable in full, each with a nominal value of CHF 0.02, through the optional or mandatory exercise of conversion, exchange, option, warrant or similar rights or obligations for the subscription of shares granted to shareholders or third parties on a standalone basis or in connection with bonds, notes, options, warrants or other securities or contractual obligations of the Company or any subsidiaries of the Company, including convertible debt instruments. Shareholders do not have pre-emptive subscription rights in such circumstances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Shareholders&#8217; subscription rights are excluded. Shareholders&#8217; advance subscription rights with regard to the new bonds, warrants or similar instruments may be restricted or excluded by decision of the board of directors in order to finance or re-finance the acquisition of companies, parts of companies or holdings, or new investments planned by the Company, or in order to issue </p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;">convertible bonds and warrants on the international capital markets or through private placement. If advance subscription rights are excluded, then (i) the instruments are to be placed at market conditions&#894; (ii) the exercise period is not to exceed ten years from the date of issue for warrants and twenty years for conversion rights&#894; and (iii) the conversion or exercise price for the new shares is to be set at least in line with the market conditions prevailing at the date on which the instruments are issued. The respective holders of conversion and/or option or warrant rights are entitled to subscribe the new shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 18pt;"><i style="font-style:italic;">Conditional Share Capital for Employee Benefit Plans</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Under Article 3c of our articles of association, our share capital may, to the exclusion of the pre-emptive subscription rights of shareholders, be increased by a maximum aggregate amount of CHF 91,844.20 through the issue of a maximum of 4,592,210 registered shares, payable in full, each with a nominal value of CHF 0.02, in connection with the exercise of option rights granted to employee of the Company or a subsidiary, members of the board of directors or any consultant, or other persons providing services to the Company or a subsidiary. The board of directors specifies the precise conditions of issue including the issue price of the shares. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Uncertificated Securities</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Our shares are uncertificated securities (<i style="font-style:italic;">droits-valeurs</i>, within the meaning of Article 973c of the CO) and, when administered by a financial intermediary (<i style="font-style:italic;">d&#233;positaire</i>, within the meaning of the Federal Act on Intermediated Securities, &#8220;FISA&#8221;), qualify as intermediated securities (<i style="font-style:italic;">titres interm&#233;di&#233;s</i>, within the meaning of the FISA). In accordance with Article 973c of the CO, we maintain a non-public register of uncertificated securities (<i style="font-style:italic;">registre des droits-valeurs</i>). We may at any time convert uncertificated securities into share certificates (including global certificates), one kind of certificate into another, or share certificates (including global certificates) into uncertificated securities. Following entry in our share register, a shareholder may at any time request from us a written confirmation in respect of the shares held by such shareholder, as reflected in the share register.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">General Meeting of Shareholders</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 18pt;"><i style="font-style:italic;">Ordinary/Extraordinary Meetings, Powers</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The general meeting of shareholders is our supreme corporate body. Under Swiss law, ordinary and extraordinary general meetings of shareholders may be held. Under Swiss law, an ordinary general meeting of shareholders must be held annually within six months after the end of a Company&#8217;s financial year. In our case, this generally means on or before June 30.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The following powers are vested exclusively in the general meeting of shareholders:</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">adopting and amending the articles of association, including change of a company&#8217;s purpose or domicile&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">electing and removal of the members of the board of directors, the chairman of the board of directors, the members of the compensation committee, the auditors and the independent proxy&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">approving the management report and the consolidated accounts&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">approving the annual accounts and resolutions on the allocation of the disposable profits, and in particular setting the dividend and the shares of profit to board members&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">approving the total compensation paid to members of the board of directors and executive management&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">resolving the interim dividend and approve the interim account required therefor;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">resolving on repaying the statutory capital reserve;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">discharging the members of the board of directors and executive management from liability with respect to their tenure in the previous financial year&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">dissolving a company with or without liquidation&#894; </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">resolving to delist the equity securities of the company; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">passing resolutions concerning all matters which are reserved to the authority of the general meeting of shareholders by law or by the articles of association.&#160;</font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">An extraordinary general meeting of shareholders may be called by a resolution of the general meeting, the board of directors or, under certain circumstances, by a company&#8217;s auditor, liquidator or the representatives of convertible bond holders, if any. In addition, our articles of association require the board of directors to convene an extraordinary general meeting of shareholders if shareholders representing at least 10% of the share capital request such general meeting of shareholders in writing. The amended Swiss corporation </p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;">law requires the board of directors of a listed company to convene an extraordinary general meeting of shareholders if shareholders representing at least 5% of the share capital or of the voting rights so request in writing. Our current articles of association do not yet reflect this amendment in law. Such request to convene an extraordinary general meeting must set forth the items to be discussed and the proposals to be acted upon. The board of directors must convene an extraordinary general meeting of shareholders and propose financial restructuring measures if, based on a company&#8217;s stand-alone annual statutory balance sheet, half of the share capital and reserves are not covered by its assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Voting and Quorum Requirements</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Shareholder resolutions and elections (including elections of members of the board of directors) require the affirmative vote of the simple majority of the votes cast at the general meeting of shareholders regardless of abstentions or empty or invalid votes, unless statutory law or the articles of association state otherwise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">A resolution of the general meeting of the shareholders passed by at least two-thirds of the shares represented at the meeting, and the absolute majority of the nominal value of the shares represented is required for:</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">amending a company&#8217;s corporate purpose&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the consolidation of shares, unless the consent of all the shareholders concerned is required;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">creating shares with privileged voting rights&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">restricting the transferability of common shares&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">creating conditional share capital or a capital band&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">increasing the share capital out of equity, against contributions in-kind or for the purpose of acquiring assets and granting of special benefits&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">limiting or withdrawing shareholder&#8217;s pre-emptive subscription rights&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">changing a company&#8217;s domicile&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">introducing a casting vote for the person chairing the general meeting;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">introducing a provision on holding the general meeting abroad;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">resolving the delisting of the equity securities of the company;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">introducing an arbitration clause in the articles of association;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">alleviating or withdrawing of restrictions upon the transfer of common shares and the removal of the voting cap of 33 1&#8725;3% as contained in article 4 of the articles of association&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">removing the indemnification provision for the board of directors and executive management as contained in article 29 of the articles of association&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">converting common shares into bearer shares and vice versa&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">dissolving or liquidating a company; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">amending or eliminating article 17 (</font><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">resolutions and elections</i><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">) of the articles of association.&#160;</font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The same voting requirements apply, subject to mandatory law, to resolutions regarding transactions among corporations (including a merger, demerger or conversion of a corporation) based on Switzerland&#8217;s Federal Act on Mergers, Demergers, Transformations and Transfer of Assets, or the Merger Act, see &#8220;&#8212;Compulsory Acquisitions&#894; Appraisal Rights.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">In accordance with Swiss law and generally accepted business practices, our articles of association do not provide quorum requirements generally applicable to general meetings of shareholders. To this extent, our practice varies from the requirement of NASDAQ Listing Rule 5620(c), which requires an issuer to provide in its bylaws for a generally applicable quorum, and that such quorum may not be less than one-third of the outstanding voting stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Notice</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">General meetings of shareholders must be convened by the board of directors or, if necessary, by the auditors at least 20 days before the date of the meeting. The general meeting of shareholders is convened by way of a notice appearing in our official publication medium, currently the Swiss Official Gazette of Commerce. Registered shareholders may also be informed by ordinary mail or e-mail. The notice of a general meeting of shareholders must state the items on the agenda, the proposals to be acted upon and, in case of elections, the names of the nominated candidates. Except in the limited circumstances listed below, a resolution may not be passed at a general meeting without proper notice. This limitation does not apply to proposals to convene an extraordinary general meeting of shareholders or to initiate a special investigation. No previous notification is required for proposals concerning items included in the agenda or for debates that do not result in a vote.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">All of the owners or representatives of our shares may, if no objection is raised, hold a general meeting of shareholders without complying with the formal requirements for convening general meetings of shareholders (a universal meeting). This universal meeting of shareholders may discuss and pass binding resolutions on all matters within the purview of the ordinary general meeting of shareholders, provided that the owners or representatives of all the shares are present at the meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Agenda Requests</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Pursuant to our current articles of association, one or more shareholders, whose combined shareholdings represent the lower of (i) at least one tenth of the share capital or (ii) an aggregate nominal value of at least CHF 1,000,000, may request that an item be included in the agenda for an ordinary general meeting of shareholders. A request for inclusion of an item on the agenda must in principle be requested in writing delivered to or mailed and received at the registered office of the Company at least 120 calendar days before the first anniversary of the date that the Company&#8217;s proxy statement was released to shareholders in connection with the previous year&#8217;s ordinary general meeting of shareholders. The request must contain, for each of the agenda items, the following information:</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a brief description of the business desired to be brought before the ordinary general meeting of shareholders and the reasons for conducting such business at the ordinary general meeting of shareholders&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the name and address, as they appear in our share register, of the shareholder proposing such business&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the number of shares of the Company which are beneficially owned by such shareholder; </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the dates upon which the shareholder acquired such shares;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">documentary support for any claim of beneficial ownership;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any material interest of such shareholder in such business; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a statement in support of the matter and, for proposals sought to be included in the Company&#8217;s proxy statement, any other information required by Securities and Exchange Commission Rule 14a-8.</font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">In addition, if the shareholder intends to solicit proxies from the shareholders of the Company, such shareholder shall notify the Company of this intent in accordance with Securities and Exchange Commission Rule 14a-4 and/or Rule 14a-8.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Our annual business report, the compensation report and the auditor&#8217;s report must be made available for inspection by the shareholders at our registered office no later than 20 days prior to the general meeting of shareholders. Shareholders of record may be notified of this in writing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Voting Rights</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Each of our shares entitles its holder to one vote, regardless of its nominal value. The shares are not divisible. The right to vote and the other rights of share ownership may only be exercised by shareholders (including any nominees) or usufructuaries who are entered in our share register at cut-off date determined by the board of directors. Those entitled to vote in the general meeting of shareholders may be represented by the independent proxy holder (annually elected by the general meeting of shareholders), another registered shareholder or third person with written authorization to act as proxy or the shareholder&#8217;s legal representative. The chairman has the power to decide whether to recognize a power of attorney.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Our articles of association state that no individual or legal entity may, directly or indirectly, formally, constructively or beneficially own or otherwise control voting rights (&#8220;Controlled Shares&#8221;) with respect to 33 1&#8725;3% or more of the registered share capital recorded in the Commercial Register except if such individual or legal entity submits prior to the acquisition of such Controlled Shares an orderly tender offer to all shareholders with a minimum price of the higher of (i) the volume weighted average price of the </p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;">last 60 trading days prior to the publication of the tender offer or (ii) the highest price paid by such individual or legal entity in the 12 months preceding to the publication of the tender offer. Those associated through capital, voting power, joint management or in any other way, or joining for the acquisition of shares, will be regarded as one person. The common shares exceeding the limit of 33 1/3% and not benefitting from the exemption regarding a tender offer will be entered in our share registered as shares without voting rights. The board of directors may in special cases approve exceptions to the above regulations. Additional voting caps apply to shareholders acquiring shares for other persons (nominees).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Dividends and Other Distributions</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Our board of directors may propose to shareholders that a dividend or other distribution be paid but cannot itself authorize the distribution. Dividend payments require a resolution passed by a simple majority of the votes cast at a general meeting of shareholders regardless of abstentions or empty or invalid votes. In addition, our auditors must confirm that the dividend proposal of our board of directors conforms to Swiss statutory law and our articles of association.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Under Swiss law, we may pay dividends only from the disposable profit and from reserves formed for this purpose, each as evidenced by our audited stand-alone statutory balance sheet prepared pursuant to Swiss law, and after allocations to reserves required by Swiss law and the articles of association have been deducted. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Distributable reserves are generally booked either as &#8220;free reserves&#8221; (<i style="font-style:italic;">r&#233;serves libres</i>) or as &#8220;reserve from capital contributions&#8221; (<i style="font-style:italic;">apports de capital</i>). Under the CO, if our general reserves (<i style="font-style:italic;">r&#233;serve g&#233;n&#233;rale</i>) amount to less than 20% of our share capital recorded in the Commercial Register (i.e., 20% of the aggregate nominal value of our issued capital), then at least 5% of our annual profit must be retained as general reserves. The CO permits us to accrue additional general reserves. Further, a purchase of our own shares (whether by us or a subsidiary) reduces the distributable reserves in an amount corresponding to the purchase price of such own shares. Finally, the CO under certain circumstances requires the creation of revaluation reserves which are not distributable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Distributions out of issued share capital (i.e. the aggregate nominal value of our issued shares) are not allowed and may be made only by way of a share capital reduction. Such a capital reduction requires a resolution passed by a simple majority of the votes cast at a general meeting of shareholders regardless of abstentions or empty or invalid votes. The resolution of the shareholders must be recorded in a public deed and a special audit report must confirm that claims of our creditors remain fully covered despite the reduction in the share capital recorded in the Commercial Register. The share capital may be reduced below CHF 100,000 only if and to the extent that at the same time the statutory minimum share capital of CHF 100,000 is reestablished by sufficient new fully paid-up capital An ordinary capital reduction must be completed within six months after the resolution of shareholders, otherwise such resolution becomes invalid.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Our board of directors determines the date on which the dividend entitlement starts. Dividends are usually due and payable shortly after the shareholders have passed the resolution approving the payment, but shareholders may also resolve at the ordinary general meeting of shareholders to pay dividends in quarterly or other installments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Transfer of Shares</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Shares in uncertificated form (<i style="font-style:italic;">droits-valeurs</i>) may only be transferred by way of assignment. Shares that constitute intermediated securities (<i style="font-style:italic;">titres interm&#233;di&#233;s</i>) may only be transferred when a credit of the relevant intermediated securities to the acquirer&#8217;s securities account is made in accordance with the relevant provisions of the FISA. Article 5 of our articles of association provides that the transfer of intermediated securities and the pledging of these intermediated securities are based on the provisions of the FISA and that transfer of propriety as collateral by means of written assignment are not permitted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Voting rights may be exercised only after a shareholder (or usufructuaries) has been entered in our share register (<i style="font-style:italic;">registre des actions</i>) with his or her name, first name and address (in the case of legal entities, the registered office) as a shareholder with voting rights. Our articles of association state that no individual or legal entity may, directly or indirectly, formally, constructively or beneficially own or otherwise control voting rights (&#8220;Controlled Shares&#8221;) with respect to 33 1&#8725;3% or more of the registered share capital recorded in the Commercial Register except if such individual or legal entity submits prior to the acquisition of such Controlled Shares an orderly tender offer to all shareholders with a minimum price of the higher of (i) the volume weighted average price of the last 60 trading days prior to the publication of the tender offer or (ii) the highest price paid by such individual or legal entity in the 12 months preceding to the publication of the tender offer. Those associated through capital, voting power, joint management or in any other way, or joining for the acquisition of shares, will be regarded as one person. The common shares exceeding the limit of 33 1/3% and not benefitting from the exemption regarding a tender offer will be entered in our share registered as shares without voting rights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Additional voting caps apply to shareholders acquiring shares for other persons (nominees).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Inspection of Books and Records</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Under the CO, a shareholder has a right to inspect our share register with respect to his own shares and otherwise to the extent necessary to exercise his shareholder rights. No other person has a right to inspect our share register. Our books and correspondence </p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;">may be inspected with the express authorization of the general meeting of shareholders or by resolution of the board of directors and subject to the safeguarding of our business secrets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 18pt;"><i style="font-style:italic;">Special Investigation</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">If the shareholders&#8217; inspection rights as outlined above prove to be insufficient in the judgment of the shareholder, any shareholder may propose to the general meeting of shareholders that specific facts be examined by a special commissioner in a special investigation. If the general meeting of shareholders approves the proposal, we or any shareholder may, within 30 calendar days after the general meeting of shareholders, request the competent court sitting in Lausanne, Switzerland, our registered office, to appoint a special commissioner. If the general meeting of shareholders rejects the request, one or more shareholders representing at least 5 percent of the share capital may request that the court appoint a special commissioner. The court will issue such an order if the petitioners can demonstrate that the board of directors, any member of the board of directors or our executive management infringed the law or our articles of association and thereby caused damages to the Company or the shareholders. The costs of the investigation would generally be allocated to us and only in exceptional cases to the petitioners.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Compulsory Acquisitions&#894; Appraisal Rights</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Business combinations and other similar transactions (i.e. mergers, demergers, transformations and certain asset transfers) that are governed by the Swiss Merger Act are, if approved in accordance with the applicable provisions of the Swiss Merger Act, binding on all shareholders of the involved companies. A statutory merger or demerger requires approval by at least two-thirds of the shares represented at a general meeting of shareholders and the absolute majority of the nominal value of the shares represented. If the merger agreement provides, however, only for a compensation payment, or in the event of an asymmetrical demerger, at least 90 percent of all shareholders of the transferring company who are entitled to vote must approve the merger agreement and the asymmetrical demerger, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Swiss corporations may be acquired by an acquirer through the direct acquisition of shares of the Swiss corporation. The Swiss Merger Act provides for the possibility of a so-called &#8220;cash-out&#8221; or &#8220;squeeze-out&#8221; merger if the acquirer controls 90% of the outstanding shares. If such a squeeze-out merger under the Swiss Merger Act occurs, a minority shareholder subject to the squeeze-out merger could seek to claim, within two months of the publication of the squeeze-out merger, that the consideration offered is &#8220;inadequate&#8221; and petition a Swiss competent court to determine what &#8220;adequate&#8221; consideration is.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">In addition, under Swiss law, the sale of &#8220;all or substantially all of our assets&#8221; by us may require the approval of at least two-thirds of the number of shares represented at a general meeting shareholders and the absolute majority of the nominal value of the shares represented. Whether a shareholder resolution is required depends on the particular transaction, including whether the following test is satisfied:</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a core part of our business is sold without which it is economically impracticable or unreasonable to continue to operate the remaining business&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our assets, after the divestment, are not invested in accordance with our statutory business purpose&#894; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the proceeds of the divestment are not earmarked for reinvestment in accordance with our business purpose but, instead, are intended for distribution to our shareholders or for financial investments unrelated to our business.</font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">If in a merger, demerger or transformation, equity or shareholder rights are not adequately preserved or the compensation paid is unreasonable, within two months after the publication of the merger, demerger or transformation resolution, each shareholder may demand that the competent court determines what is a reasonable amount of compensation. The decision of the court is legally binding on all shareholders of the company involved, provided that they are in the same legal position as the plaintiff. The costs of proceedings shall be borne by the acquiring company. If the particular circumstances justify it, the court may decide that the plaintiff shall bear all or part of the cost. An action to obtain a review of the protection of equity or shareholder rights does not affect the legal validity of the merger, demerger or transformation resolution.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Board of Directors</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Our articles of association provide that the board of directors shall consist of at least three and not more than nine members.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The members of the board of directors and the chairman are elected annually by the general meeting of shareholders for a period until the completion of the subsequent ordinary general meeting of shareholders and are eligible for re-election. Each member of the board of directors must be elected individually.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 18pt;"><i style="font-style:italic;">Powers</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The board of directors has the following non-delegable and inalienable powers and duties:</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the overall management of the Company and the issuing of all necessary directives&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the determination of the Company&#8217;s organization&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the organization of the accounting, financial control and financial planning systems as required for management of the Company&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the appointment and dismissal of persons entrusted with managing and representing the Company&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the overall supervision of the persons entrusted with managing the Company, in particular with regard to compliance with the law, articles of association, operational regulations and directives&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the compilation of the annual report, and the preparation for the general meeting of shareholders and implementing its resolutions&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the preparation of the compensation report and to request approval by the general meeting of shareholders regarding the compensation of the board of directors and the executive committee; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the notification of the court in the event that the Company is over-indebted.</font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The board of directors may assign responsibility for preparing and implementing its resolutions or monitoring transactions to committees or individual members. It must ensure appropriate reporting to its members. Furthermore, the board of directors may, while retaining such non-delegable and inalienable powers and duties, delegate, in part or entirely, the management and the representation of the Company, within the limits of the law, to a one or more individual directors (Delegates) or to third parties pursuant to the organizational regulations issued by the board of directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Pursuant to Swiss law and Article 25 of our articles of association, details of the delegation and other procedural rules such as quorum requirements must be set in the organizational rules issued by the board of directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The board of directors assigns the persons with signatory power for the Company and the kind of signatory power.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 18pt;"><i style="font-style:italic;">Indemnification of Executive Management and Directors</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Subject to Swiss law, Article 29 of our articles of association provides for indemnification of the current and former members of the board of directors, executive management and their heirs, executors and administrators, against liabilities arising in connection with the performance of their duties in such capacity, and permits us to advance the expenses of defending any act, suit or proceeding to our directors and members of the executive management.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">In addition, under general principles of Swiss employment law, an employer may be required to indemnify an employee against losses and expenses incurred by such employee in the proper execution of their duties under the employment agreement with the employer.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Conflict of Interest, Management Transactions</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Swiss law does not have a general provision regarding conflicts of interest. However, the CO contains a provision that requires our directors and the members of the executive management to safeguard the Company&#8217;s interests and imposes a duty of loyalty and duty of care on our directors and the members of the executive management. This rule is generally understood to disqualify directors and members of the executive management from participating in decisions that directly affect them. Our directors and executive officers are personally liable to us for any breach of these provisions. In addition, Swiss law contains provisions under which directors and all persons engaged in the Company&#8217;s management are liable to the Company, each shareholder and the Company&#8217;s creditors for damages caused by an intentional or negligent violation of their duties. Furthermore, Swiss law contains a provision under which payments made to any of the Company&#8217;s shareholders or directors or any person associated with any such shareholder or director, other than payments made at arm&#8217;s length, must be repaid to the Company if such shareholder or director acted in bad faith.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Our board of directors has adopted a Code of Business Conduct and Ethics that covers a broad range of matters, including the handling of conflicts of interest.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Principles of the Compensation of the Board of Directors and the Executive Management</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Pursuant to Swiss law, our shareholders must annually approve the compensation of the board of directors and the persons whom the board of directors has, fully or partially, entrusted with the management of the Company. The board of directors must issue, on an annual basis, a written compensation report that must be reviewed together with a report on our business by our auditor. The compensation report must disclose all compensation (as defined in section 14 of the Swiss Ordinance against Excessive Compensation in Listed Companies) granted by the Company, directly or indirectly, to current members of the board of directors and executive </p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;">management as well as to former members of the board of directors and executive management but in the latter case only to the extent if such compensation is related to their former role within the Company or if such compensation is not on customary market terms.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The disclosure concerning compensation must in particular include the aggregate amount for the board of directors and the aggregate amount for the executive management, as well as the particular amount of compensation for each member of the board of directors and the highest paid member of the executive management, specifying the name and function of each person.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Certain forms of compensation are prohibited for members of our board of directors and executive management, such as:</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">severance payments provided for either contractually or in the articles of association (compensation due until the termination of a contractual relationship does not qualify as severance payment)&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">advance compensation&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">incentive fees for the acquisition or transfer of corporations, or parts thereof, by the Company or by companies being, directly or indirectly, controlled by the us&#894;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">loans, other forms of indebtedness, pension benefits not based on occupational pension schemes and performance-based compensation not provided for in the articles of association&#894; and </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">equity securities and conversion and option rights awards not provided for in the articles of association.&#160;</font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Compensation to members of the board of directors and executive management for activities in entities that are, directly or indirectly, controlled by the Company is prohibited if the compensation (i) would have been prohibited if it was paid directly by the Company, (ii) is not provided for in the articles of association or (iii) has not been approved by the general meeting of shareholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The general meeting of shareholders annually votes on the proposals of the board of directors with respect to:</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the maximum aggregate amount of compensation of the board of directors for the period until the next Ordinary General Meeting&#894; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the maximum aggregate amount of compensation of the executive committee for the following financial year.</font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The respective total compensation amounts include social security and occupational pension contributions for the benefit of the members of the board of directors, the executive management and the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">If the general meeting of shareholders refuses to approve a respective motion by the board of directors, the board of directors may either submit a new motion at the same meeting or determine a maximum total remuneration or several maximum partial remunerations, subject to the relevant principles of the compensation, or submit a new motion to the next general meeting of shareholders for approval.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">In addition to fixed compensation, members of the executive management may be paid in cash a variable compensation, depending on the achievement of certain performance criteria. The performance criteria may include individual targets, targets of the Company or parts thereof and targets in relation to the market, other companies or comparable benchmarks, taking into account the position and level of responsibility of the recipient of the variable compensation. The board of directors or, where delegated to it, the compensation committee determines the relative weight of the performance criteria and the respective target values.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Compensation may be paid in cash or granted in form of options or shares in the Company. The board of directors or, to the extent delegated to it, the compensation committee determines grant, vesting, exercise and forfeiture conditions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Borrowing Powers</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Neither Swiss law nor our articles of association restrict in any way our power to borrow and raise funds. The decision to borrow funds is made by or under the direction of our board of directors, and no approval by the shareholders is required in relation to any such borrowing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Repurchases of Shares and Purchases of Own Shares</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The CO limits our right to purchase and hold our own shares. We and our subsidiaries may purchase shares only if and to the extent that (i) we have freely distributable reserves in the amount of the purchase price&#894; and (ii) the aggregate nominal value of all shares held by us does not exceed 10 percent of our share capital. Pursuant to Swiss law, where shares are acquired in connection with a transfer restriction set out in the articles of association, the foregoing upper limit is 20 percent. If we own shares that exceed the threshold of 10 percent of our share capital, the excess must be sold or cancelled by means of a capital reduction within two years.</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">We currently hold 5,243,958 fully paid up common shares of par value CHF 0.02 each, as treasury shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Shares of the Company held by us or our subsidiaries are not entitled to vote at the general meeting of shareholders but are entitled to the economic benefits applicable to the shares generally, including dividends and pre-emptive subscription rights in the case of share capital increases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">In addition, selective share repurchases are only permitted under certain circumstances. Within these limitations, as is customary for Swiss corporations, we may purchase and sell our own shares from time to time in order to meet imbalances of supply and demand, to provide liquidity and to even out variances in the market price of shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 9.35pt;"><font style="font-style:italic;font-weight:bold;">Notification and Disclosure of Substantial Share Interests</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The disclosure obligations generally applicable to shareholders of Swiss corporations under the Swiss Financial Market Infrastructure Act, FinMIA, do not apply to us since our shares are not listed on a Swiss stock exchange.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Stock Exchange Listing</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Our common shares are listed on the NASDAQ Global Market under the symbol &#8220;ACIU.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Transfer Agent and Registrar of Shares</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Computershare Trust Company, N.A. acts as transfer agent and registrar for our common shares. The share register reflects only record owners of our shares. Swiss law does not recognize fractional share interests.</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.1
<SEQUENCE>4
<FILENAME>aciu-20231231xex8d1.htm
<DESCRIPTION>EX-8.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.5.122.0--><!--Created on: 3/13/2024 05:01:46 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Exhibit 8.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Subsidiaries of AC Immune SA</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Name of Subsidiary</b></p></td><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Jurisdiction of Organization</b></p></td></tr><tr><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">AC Immune USA, Inc.</p></td><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;United States</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>5
<FILENAME>aciu-20231231xex12d1.htm
<DESCRIPTION>EX-12.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.5.122.0--><!--Created on: 3/13/2024 05:01:46 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 12.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CERTIFICATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">I, Andrea Pfeifer, certify that:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1. I have reviewed this annual report on Form 20-F of AC Immune SA;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4. The company&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(c) Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(d) Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5. The company&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the audit committee of the company&#8217;s board of directors (or persons performing the equivalent functions):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s ability to record, process, summarize and report financial information; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: March 14, 2024</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Andrea Pfeifer</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Andrea Pfeifer</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>6
<FILENAME>aciu-20231231xex12d2.htm
<DESCRIPTION>EX-12.2
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.5.122.0--><!--Created on: 3/13/2024 05:02:07 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 12.2</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CERTIFICATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">I, Christopher Roberts, certify that:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1. I have reviewed this annual report on Form 20-F of AC Immune SA;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4. The company&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(c) Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(d) Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5. The company&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the audit committee of the company&#8217;s board of directors (or persons performing the equivalent functions):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s ability to record, process, summarize and report financial information; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: March 14, 2024</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Christopher Roberts</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Christopher Roberts</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>7
<FILENAME>aciu-20231231xex13d1.htm
<DESCRIPTION>EX-13.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.5.122.0--><!--Created on: 3/13/2024 05:02:07 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 13.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CERTIFICATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The certification set forth below is being submitted in connection with AC Immune SA&#8217;s annual report on Form 20-F for the year ended December 31, 2023 (the &#8220;Report&#8221;) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Andrea Pfeifer, the Chief Executive Officer of AC Immune SA, certifies that, to the best of her knowledge:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of AC Immune SA.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: March 14, 2024</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Andrea Pfeifer</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name: Andrea Pfeifer</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>8
<FILENAME>aciu-20231231xex13d2.htm
<DESCRIPTION>EX-13.2
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.5.122.0--><!--Created on: 3/13/2024 05:02:08 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 13.2</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CERTIFICATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The certification set forth below is being submitted in connection with AC Immune SA&#8217;s annual report on Form 20-F for the year ended December 31, 2023 (the &#8220;Report&#8221;) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Christopher Roberts, the Chief Financial Officer of AC Immune SA, certifies that, to the best of his knowledge:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of AC Immune SA.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: March 14, 2024</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Christopher Roberts</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name: Christopher Roberts</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.1
<SEQUENCE>9
<FILENAME>aciu-20231231xex15d1.htm
<DESCRIPTION>EX-15.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.5.122.0--><!--Created on: 3/13/2024 05:02:15 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">EXHIBIT 15.1</b></p><p style="border-top-style:none;font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="border-top-style:none;font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:center;margin:0pt;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</p><p style="border-top-style:none;font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;margin:0pt;">We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-249655 and No. 333-255576) and on Form S-8 (No 333-216539, No 333-213865 and No. 333-233019) of AC Immune SA of our report dated March 14, 2024 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F.</p><p style="border-top-style:none;font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;margin:0pt;">/s/ PricewaterhouseCoopers SA </p><p style="border-top-style:none;font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;">Lausanne, Switzerland<br>March 14, 2024</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>10
<FILENAME>aciu-20231231xex97d1.htm
<DESCRIPTION>EX-97.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.5.122.0--><!--Created on: 3/13/2024 05:02:27 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:right;background:#ffffff;margin:9pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Exhibit 97.1</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;padding-top:9pt;text-align:center;background:#ffffff;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">AC Immune SA</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;padding-top:9pt;text-align:center;background:#ffffff;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.37;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:center;background:#ffffff;margin:0pt;"><font style="font-size:11pt;"><a name="_Hlk144902706"></a></font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">COMPENSATION RECOUPMENT POLICY</b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"><br></b><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><a name="_DV_M2"></a><font style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:18pt;"></font><font style="display:inline-block;width:18pt;"></font><font style="font-size:10pt;">This Compensation Recoupment Policy (the &#8220;</font><b style="font-size:10pt;font-weight:bold;">Policy</b><font style="font-size:10pt;">&#8221;) has been adopted by the Board of Directors (the &#8220;</font><b style="font-size:10pt;font-weight:bold;">Board</b><font style="font-size:10pt;">&#8221;) of AC Immune (the &#8220;</font><b style="font-size:10pt;font-weight:bold;">Company</b><font style="font-size:10pt;">&#8221;) on </font><a name="_cp_change_25"></a><font style="font-size:10pt;">October 6, 2023.</font><a name="_cp_change_26"></a><u style="border-bottom-style:solid;border-bottom-width:0.5pt;font-size:10pt;text-decoration-line:underline;text-decoration-style:double;"> </u></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:18pt;"></font><font style="font-size:10pt;">This Policy provides for the recoupment of certain executive compensation in the event of an accounting restatement resulting from material noncompliance with financial reporting requirements under U.S. federal securities laws in accordance with the terms and conditions set forth herein. This Policy is intended to comply with the requirements of Section 10D of the Exchange Act (as defined below) and Section 5608 of the Nasdaq Listing Rules (the &#8220;</font><b style="font-size:10pt;font-weight:bold;">Listing Rule</b><font style="font-size:10pt;">&#8221;).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:18pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">1.</font><u style="font-size:10pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Definitions</u><font style="font-size:10pt;">. For the purposes of this Policy, the following terms shall have the meanings set forth below. </font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 18pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:36pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(a)</font><font style="font-size:10pt;">&#8220;</font><b style="font-size:10pt;font-weight:bold;">Committee</b><font style="font-size:10pt;text-decoration-color:#ff0000;">&#8221; </font><font style="font-size:10pt;"> means the Compensation Nomination and Corporate Governance Committee of the Board.</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:36pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(b)</font><font style="font-size:10pt;">&#8220;</font><b style="font-size:10pt;font-weight:bold;">Covered Compensation</b><font style="font-size:10pt;">&#8221; means any Incentive-based Compensation &#8220;received&#8221; by a Covered Executive during the applicable Recoupment Period; </font><i style="font-size:10pt;font-style:italic;">provided</i><font style="font-size:10pt;"> that:</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(i)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">such Incentive-based Compensation was received by such Covered Executive (A) on or after the Effective Date, (B) after he or she commenced service as an Executive Officer and (C) while the Company had a class of securities publicly listed on a United States national securities exchange; and </font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(ii)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">such Covered Executive served as an Executive Officer at any time during the performance period applicable to such Incentive-based Compensation. </font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">For purposes of this Policy, Incentive-based Compensation is &#8220;<b style="font-weight:bold;">received</b>&#8221; by a Covered Executive during the fiscal period in which the Financial Reporting Measure applicable to such Incentive-based Compensation (or portion thereof) is attained, even if the payment or grant of such Incentive-based Compensation is made thereafter.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:36pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(c)</font><font style="font-size:10pt;">&#8220;</font><b style="font-size:10pt;font-weight:bold;">Covered Executive</b><font style="font-size:10pt;">&#8221; means any (i) current or former Executive Officer and (ii)</font><font style="font-size:10pt;"> </font><font style="font-size:10pt;">any other employee of the Company and its subsidiaries designated by the Committee as subject to this Policy from time to time, including any member of the Company&#8217;s Executive Management team who is not an Executive Officer.</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:36pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(d)</font><font style="font-size:10pt;">&#8220;</font><b style="font-size:10pt;font-weight:bold;">Effective Date</b><font style="font-size:10pt;">&#8221; means the date on which the Listing Rule becomes effective.</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"> <font style="margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:36pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(e)</font><font style="font-size:10pt;">&#8220;</font><b style="font-size:10pt;font-weight:bold;">Exchange Act</b><font style="font-size:10pt;">&#8221; means the U.S. Securities Exchange Act of 1934, as amended. </font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:36pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(f)</font><font style="font-size:10pt;">&#8220;</font><b style="font-size:10pt;font-weight:bold;">Executive Officer</b><font style="font-size:10pt;">&#8221; means, with respect to the Company, (i) its </font><a name="_cp_change_37"></a><font style="font-size:10pt;text-decoration-color:#ff0000;">chief executive officer, (ii) </font><a name="_cp_change_38"></a><font style="font-size:10pt;">its principal financial officer</font><font style="font-size:10pt;">, (iii) its principal accounting officer (or if there is no such accounting officer, its controller), (iv) any vice-president in charge of a principal business unit, division or function (such as sales, administration or finance), (v) any other officer who performs a policy-making function for the Company (including any officer of the Company</font><font style="font-size:10pt;">&#8217;</font><font style="font-size:10pt;">s subsidiaries if they perform policy-making functions for the Company) and (vi) any other person who performs similar policy-making functions for the Company. Policy-making function is not intended to include policy-making functions that are not significant. The determination as to an individual</font><font style="font-size:10pt;">&#8217;</font><font style="font-size:10pt;">s status as an Executive Officer shall be made by the Committee and such determination shall be final, conclusive and binding on such individual and all other interested persons.</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:36pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(g)</font><font style="font-size:10pt;">&#8220;</font><b style="font-size:10pt;font-weight:bold;">Financial Reporting Measure</b><font style="font-size:10pt;white-space:pre-wrap;">&#8221; means any (i) measure that is determined and presented in accordance with the accounting principles used in preparing the Company&#8217;s financial statements, (ii) stock price measure or (iii) total shareholder return measure (and any measures that are derived wholly or in part from any measure referenced in clause (i), (ii) or (iii) above).  For the avoidance of doubt, any such measure does not need to be presented within the Company&#8217;s financial statements or included in a filing with the U.S. Securities and Exchange Commission</font><font style="color:#0000ff;font-size:10pt;"> </font><font style="font-size:10pt;">to constitute a Financial Reporting Measure. </font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:36pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(h)</font><font style="font-size:10pt;">&#8220;</font><b style="font-size:10pt;font-weight:bold;">Financial Restatement</b><font style="font-size:10pt;">&#8221; means a restatement of the Company&#8217;s financial statements due to the Company&#8217;s material noncompliance with any financial reporting requirement under U.S. federal securities laws that is required in order to correct:</font><font style="font-size:10pt;"><br></font><font style="font-size:10pt;margin-right:0pt;visibility:hidden;">&#8203;</font></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(i)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">an error in previously issued financial statements that is material to the previously issued financial statements; or </font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(ii)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">an error that would result in a material misstatement if the error were (A) corrected in the current period or (B) left uncorrected in the current period. </font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">For purposes of this Policy, a Financial Restatement shall not be deemed to occur in the event of a revision of the Company&#8217;s financial statements due to an out-of-period adjustment (i.e., when the error is immaterial to the previously issued financial statements and the correction of the error is also immaterial to the current period) or a retrospective (1) application of a change in accounting principles; (2) revision to reportable segment information due to a change in the structure of the Company&#8217;s internal organization; (3) reclassification due to a discontinued operation; (4) application of a change in reporting entity, such as from a reorganization of entities under common control; (5) revision for stock splits, reverse stock splits, stock dividends<font style="text-decoration-color:#ff0000;">, </font>or other changes in capital structure; or (6) adjustment to provisional amounts in connection with a prior business combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:36pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(i)</font><font style="font-size:10pt;">&#8220;</font><b style="font-size:10pt;font-weight:bold;">Incentive-based Compensation</b><font style="font-size:10pt;">&#8221; means any compensation (including, for the avoidance of doubt, any cash or equity or equity-based compensation, whether deferred or current) that is granted, earned and/or vested based wholly or in part upon the achievement of a Financial Reporting Measure. For purposes of this Policy, </font><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;">Incentive-based Compensation</font><font style="font-size:10pt;">&#8221;</font><font style="font-size:10pt;"> shall also be deemed to include any amounts which were determined based on (or were otherwise calculated by reference to) Incentive-based Compensation (including, without limitation, any amounts under any long-term disability, life insurance or supplemental retirement or severance plan or agreement or any notional account that is based on Incentive-based Compensation, as well as any earnings accrued thereon).</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:36pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(j)</font><font style="font-size:10pt;">&#8220;</font><b style="font-size:10pt;font-weight:bold;">Nasdaq</b><font style="font-size:10pt;">&#8221; means the NASDAQ Global Select Market, or any successor thereof.</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:36pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(k)</font><font style="font-size:10pt;">&#8220;</font><b style="font-size:10pt;font-weight:bold;">Recoupment Period</b><font style="font-size:10pt;">&#8221; means the three fiscal years completed immediately preceding the date of any applicable Recoupment Trigger Date. Notwithstanding the foregoing, the Recoupment Period additionally includes any transition period (that results from a change in the Company&#8217;s fiscal year) within or immediately following those three completed fiscal years, provided that a transition period between the last day of the Company&#8217;s previous fiscal year end and the first day of its new fiscal year that comprises a period of nine (9) to twelve (12) months would be deemed a completed fiscal year.</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:36pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(l)</font><font style="font-size:10pt;">&#8220;</font><b style="font-size:10pt;font-weight:bold;">Recoupment Trigger Date</b><font style="font-size:10pt;">&#8221; means the earlier of (i) the date that the Board (or a committee thereof or the officer(s) of the Company authorized to take such action if Board action is not required) concludes, or reasonably should have concluded, that the Company is required to prepare a Financial Restatement, and (ii) the date on which a court, regulator or other legally authorized body directs the Company to prepare a Financial Restatement.</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">2.</td><td style="padding:0pt;"><u style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Recoupment of Erroneously Awarded Compensation</u><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. </font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:36pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(a)</font><a name="_Ref462245452"></a><font style="font-size:10pt;">In the event of a Financial Restatement, if the amount of any Covered Compensation received by a Covered Executive (the &#8220;</font><b style="font-size:10pt;font-weight:bold;">Awarded Compensation</b><font style="font-size:10pt;">&#8221;) exceeds the amount of such Covered Compensation that would have otherwise been received by such Covered Executive if calculated based on the Financial Restatement (the &#8220;</font><b style="font-size:10pt;font-weight:bold;">Adjusted Compensation</b><font style="font-size:10pt;">&#8221;), the Company shall reasonably promptly recover from such Covered Executive an amount equal to the excess of the Awarded Compensation over the Adjusted Compensation, each calculated on a </font></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="font-size:10pt;">pre-tax basis (such excess amount, the &#8220;</font><b style="font-size:10pt;font-weight:bold;">Erroneously Awarded Compensation</b><font style="font-size:10pt;">&#8221;). </font><font style="font-size:10pt;"><br></font><font style="font-size:10pt;margin-right:0pt;visibility:hidden;">&#8203;</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:36pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(b)</font><a name="_Ref120538755"></a><font style="font-size:10pt;">If (i) the Financial Reporting Measure applicable to the relevant Covered Compensation is stock price or total shareholder return (or any measure derived wholly or in part from either of such measures) and (ii) the amount of Erroneously Awarded Compensation is not subject to mathematical recalculation directly from the information in the Financial Restatement, then the amount of Erroneously Awarded Compensation shall be determined (on a pre-tax basis) based on the Company&#8217;s reasonable estimate of the effect of the Financial Restatement on the Company&#8217;s stock price or total shareholder return (or the derivative measure thereof) upon which such Covered Compensation was received.</font><font style="font-size:10pt;"> </font><font style="font-size:10pt;"><br></font><font style="font-size:10pt;margin-right:0pt;visibility:hidden;">&#8203;</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:36pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(c)</font><a name="_Ref120542150"></a><font style="font-size:10pt;">For the avoidance of doubt, the Company&#8217;s obligation to recover Erroneously Awarded Compensation is not dependent on (i) if restated financial statements are filed or when the Financial Restatements are filed</font><font style="font-size:10pt;"> or</font><i style="font-size:10pt;font-style:italic;"> </i><font style="font-size:10pt;">(ii) any fault of any Covered Executive for the accounting errors or other actions leading to a Financial Restatement.</font><font style="font-size:10pt;"> </font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:36pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(d)</font><a name="_Ref120538922"></a><font style="font-size:10pt;">Notwithstanding anything to the contrary in Sections 2</font><u style="border-bottom-style:solid;border-bottom-width:0.5pt;color:#0000ff;font-size:10pt;text-decoration-line:underline;text-decoration-style:double;">&#8206;</u><font style="font-size:10pt;">(a) through &#8206;(c) hereof, the Company shall not be required to recover any Erroneously Awarded Compensation if both (x) the conditions set forth in either of the following clauses (i), (ii) or (iii) are satisfied and (y) the </font><font style="font-size:10pt;text-decoration-color:#ff0000;">Committee </font><font style="font-size:10pt;">has determined that recovery of the Erroneously Awarded Compensation would be impracticable:</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-indent:54pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(i)</font><font style="font-size:10pt;">the direct expense paid to a third party to assist in enforcing the recovery of the Erroneously Awarded Compensation under this Policy would exceed the amount of such Erroneously Awarded Compensation to be recovered; </font><i style="font-size:10pt;font-style:italic;">provided</i><font style="font-size:10pt;"> that, before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation pursuant to this Section 2&#8206;(d), the Company shall have first made a reasonable attempt to recover such Erroneously Awarded Compensation, document such reasonable attempt(s) to make such recovery and provide that documentation to the Nasdaq;</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 90pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-indent:54pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(ii)</font><font style="font-size:10pt;">recovery of the Erroneously Awarded Compensation would violate </font><a name="_cp_change_55"></a><font style="font-size:10pt;text-decoration-color:#ff0000;">(i) </font><font style="font-size:10pt;">Swiss law to the extent such law was adopted prior to November 28, 2022 </font><a name="_cp_change_56"></a><font style="font-size:10pt;text-decoration-color:#ff0000;">or (ii) statutory </font><a name="_cp_change_57"></a><font style="font-size:10pt;text-decoration-color:#008000;">Swiss law adopted after November 28, 2022</font><font style="color:#008000;font-size:10pt;text-decoration-color:#008000;"> </font><font style="font-size:10pt;">(</font><i style="font-size:10pt;font-style:italic;">provided that</i><font style="font-size:10pt;">, before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation pursuant to this Section 2</font><u style="border-bottom-style:solid;border-bottom-width:0.5pt;color:#0000ff;font-size:10pt;text-decoration-line:underline;text-decoration-style:double;">&#8206;</u><font style="font-size:10pt;">(d)), the Company shall have first obtained a legal opinion of a Swiss-qualified attorney, that is acceptable to the Nasdaq, that recovery would result in such a violation, and the Company must provide such opinion to the Nasdaq, or </font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 90pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-indent:54pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(iii)</font><font style="font-size:10pt;">recovery of the Erroneously Awarded Compensation would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of Sections 401(a)(13) or 411(a) of the U.S. Internal Revenue Code of 1986, as amended (the &#8220;</font><b style="font-size:10pt;font-weight:bold;">Code</b><font style="font-size:10pt;">&#8221;).</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 90pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:36pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(e)</font><font style="font-size:10pt;">The Company shall not indemnify any Covered Executive, directly or indirectly, for any losses that such Covered Executive may incur in connection with the recovery of Erroneously Awarded Compensation pursuant to this Policy, including through the payment of insurance premiums or gross-up payments.</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:36pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(f)</font><font style="font-size:10pt;">The Committee shall determine, in its sole discretion, the manner and timing in which any Erroneously Awarded Compensation shall be recovered from a Covered Executive in accordance with applicable law, including, without limitation, by (i) requiring reimbursement of Covered Compensation previously paid in cash; (ii) seeking recovery of any gain realized on the vesting, exercise, settlement, sale, transfer</font><a name="_cp_change_71"></a><font style="color:#ff0000;font-size:10pt;text-decoration-color:#ff0000;text-decoration-line:line-through;text-decoration-style:solid;">, </font><font style="font-size:10pt;"> or other disposition of any equity or equity-based awards; (iii) offsetting the Erroneously Awarded Compensation amount from any compensation otherwise owed by the Company or any of its affiliates to the Covered Executive; (iv) cancelling outstanding vested or unvested equity or equity-based awards; and/or (v) taking any other remedial and recovery action permitted by applicable law. For the avoidance of doubt, except as set forth in Section 2&#8206;(d), in no event may the Company accept an amount that is less than the amount of Erroneously Awarded Compensation; </font><i style="font-size:10pt;font-style:italic;">provided</i><font style="font-size:10pt;"> that, to the extent necessary to avoid any adverse tax consequences to the Covered Executive, including, to the extent applicable, pursuant to Section 409A of the Code, any offsets against amounts under any nonqualified deferred compensation plans (as defined under Section 409A of the Code) shall be made in compliance with Section 409A of the Code or such other applicable law.</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 27pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:22.5pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">3.</font><u style="font-size:10pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Administration</u><font style="font-size:10pt;white-space:pre-wrap;">. This Policy shall be administered by the Committee.  All decisions of the Committee shall be final, conclusive and binding upon the Company and the Covered Executives. The Committee shall have full power and authority to (i) administer and interpret this Policy; (ii) correct any defect, supply any omission and reconcile any inconsistency in this Policy; and (iii) make any other determination and take any other action that the Committee deems necessary or desirable for the administration of this Policy and to comply with applicable law (including, if applicable, Article 64 and 678 of the Swiss Code of Obligations and Section 10D of the Exchange Act) and applicable stock market or exchange rules and regulations.</font> <font style="font-size:10pt;">Notwithstanding anything to the contrary contained herein, to the extent permitted by Section 10D of the Exchange Act and the Listing Rule, the Board may, in its sole discretion, at any time and from time to time, administer this Policy in the same manner as the Committee.</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-indent:22.5pt;margin:0pt 0pt 0pt -4.5pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:22.5pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">4.</font><u style="font-size:10pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Amendment/Termination</u><font style="font-size:10pt;">. Subject to the Articles of Associations and the Organizational Rules of the Company and Section 10D of the Exchange Act and the Listing Rule, this Policy may be amended or terminated by the Board at any time. To the extent that any applicable law, or stock market or exchange rules or regulations require recovery of Erroneously Awarded Compensation in circumstances in addition to those specified herein, nothing in this Policy shall be deemed to limit or restrict the right or obligation of the Company to recover Erroneously Awarded Compensation to the fullest extent required by such applicable law, stock market or exchange rules and regulations. Unless otherwise required by applicable law, this Policy shall no longer be effective from and after the date that the Company no longer has a class of securities publicly listed on a United States national securities exchange.</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-indent:22.5pt;margin:0pt 0pt 0pt -4.5pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:22.5pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">5.</font><u style="font-size:10pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Other Compensation Clawback/Recoupment Rights</u><font style="font-size:10pt;">. Any right of recoupment under this Policy is in addition to, and not in lieu of, any other remedies, rights, or requirements with respect to the clawback or recoupment of any compensation that may be available to the Company pursuant to the terms of any other recoupment or clawback policy of the Company (or any of its affiliates) that may be in effect from time to time, any provisions in any employment agreement, offer letter, equity plan, equity award agreement or similar plan or agreement, and any other legal remedies available to the Company, as well as applicable law, stock market or exchange rules, listing standards or regulations; </font><i style="font-size:10pt;font-style:italic;">provided</i><font style="font-size:10pt;">, </font><i style="font-size:10pt;font-style:italic;">however</i><font style="font-size:10pt;">, that any amounts recouped or clawed back under any other policy that would be recoupable under this Policy shall count toward any required clawback or recoupment under this Policy and vice versa.</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 18pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:22.5pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">6.</font><u style="font-size:10pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exempt Compensation</u><font style="font-size:10pt;">. Notwithstanding anything to the contrary herein, the Company has no obligation under this Policy to seek recoupment of amounts paid to a Covered Executive which are granted, vested or earned based solely upon the occurrence or non-occurrence of nonfinancial events. Such exempt compensation includes, without limitation, base salary, time-vesting awards, compensation awarded on the basis of the achievement of metrics that are not Financial Reporting Measures or compensation awarded solely at the discretion of the Committee or the Board, </font><i style="font-size:10pt;font-style:italic;">provided</i><font style="font-size:10pt;text-decoration-color:#ff0000;"> t</font><font style="font-size:10pt;">hat</font><i style="font-size:10pt;font-style:italic;"> </i><font style="font-size:10pt;">such amounts are in no way contingent on, and were not in any way granted on the basis of, the achievement of any Financial Reporting Measure performance goal.</font><font style="font-size:10pt;"><br></font><font style="font-size:10pt;margin-right:0pt;visibility:hidden;">&#8203;</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:22.5pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">7.</font><u style="font-size:10pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Miscellaneous</u><font style="font-size:10pt;">.</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:40.5pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(a)</font><font style="font-size:10pt;">Any applicable award agreement or other document setting forth the terms and conditions of any compensation covered by this Policy shall be deemed to include the restrictions imposed herein and incorporate this Policy by reference and, in the event of any inconsistency, the terms of this Policy will govern. </font><a name="_Hlk121150545"></a><font style="font-size:10pt;">For the avoidance of doubt, this Policy applies to all compensation that is received on or after the Effective Date, regardless of the date on which the award agreement or other document setting forth the terms and conditions of the Covered Executive&#8217;s compensation became effective.</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:40.5pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(b)</font><font style="font-size:10pt;">Notwithstanding anything to the contrary herein, this Policy is intended to comply with the requirements of Article 64 and 678 of the Swiss Code of Obligations, as applicable, and of Section 10D of the Exchange Act and the Listing Rule (and any applicable regulations, administrative interpretations or stock market or exchange rules and regulations adopted in connection therewith). The provisions of this Policy shall be interpreted in a manner that satisfies such requirements and this Policy shall be operated accordingly. If any provision of this Policy would otherwise frustrate or conflict with this intent, the provision shall be interpreted and deemed amended so as to avoid such conflict.</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:40.5pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(c)</font><a name="_Ref120703520"></a><font style="font-size:10pt;">This Policy shall be binding and enforceable against all Covered Executives.</font><font style="font-size:10pt;"><br></font><font style="font-size:10pt;margin-right:0pt;visibility:hidden;">&#8203;</font></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:40.5pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(d)</font><font style="font-size:10pt;">All issues concerning the construction, validity, enforcement and interpretation of this Policy and all related documents, including, without limitation, any employment agreement, offer letter, equity award agreement or similar agreement, shall be governed by, and construed in accordance with, the laws of Switzerland, without giving effect to any choice of law or conflict of law rules or provisions that would cause the application of the laws of any other jurisdiction.</font><font style="color:#c0504d;font-size:10pt;"><br></font><font style="font-size:10pt;margin-right:0pt;visibility:hidden;">&#8203;</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:40.5pt;"><font style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(e)</font><font style="font-size:10pt;">If any provision of this Policy is determined to be unenforceable or invalid under any applicable law, such provision will be applied to the maximum extent permitted by applicable law, and</font> <font style="font-size:10pt;">shall automatically be deemed amended in a manner consistent with its objectives to the extent necessary to conform to any limitations required under applicable law.</font><font style="color:#c0504d;font-size:10pt;"> </font></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>aciu-20231231x20f001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 'R [<# 2(  A$! Q$!_\0
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M0X;S*IC*&$JTG!U963>WG]RU:W/HZBO-?@%\1K?XB^ ;*6#2=7THV$,-J_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >+_
M +77C]_ /P2U=K9V&I:L5TNT5,[F>4'=C'^P'KPWP1X\\0^%/@?'\/)?@9XQ
MNX)+&2WNKD6L@$TD@)=\&(]SP/0"O9OB]\'/$7Q2^-'@749VM%\$^'V-U+$T
MQ\V6?.<[,8Q\J#KZ^M>Z5Y<J-2M6E._*EHM%JNNY^@T<TP65Y7A\-[-5IRE[
M67O27+)>[!>ZUJE=Z[7/EK]A+QK>7?@?6O 6KI<66K>&[ET6VNE*3112,3M9
M3R"K[QSTR!VJO^P\PT76/BGX<NR4U2UUHRO')PS*2RY_,?J*[2]^"_B/0OVH
M;;XA^&S9KH6I6HMM<MI9BCN=NW>JA<$_+&W7JI]:/BE^S_KD_P 01\0OAKKL
M7AKQ7)&(KZ"XCWVU^HP,N,'!P #Q_"#P>3C"G5IJ#M=TVUZKNCU<5CLNQE7%
M0C45..,A"=]U"K%W<963:3=];=4^Y[O)(L,;.[!$4%F9C@ #J37&?"OXN:!\
M8]%N]5\.M<O9VURUH[W,/EY=0"=O)##!'(]:\?\ %7@S]H'XI:2WAW6M2\*^
M%='N1Y=Y=Z+YSSS1G[R_,3@$=@1UZXKVOX8_#C2?A1X+T[PUHR,+2T3F63[\
MSGEG;W)KOA4J5*FD;17?=OR/C<5@<%@L&^>LJE>35E!WC&*O=R=K-O2R6V[[
M&MXH_P"19U?_ *\YO_0#7S1^QG_R:_XF_P"OS4?_ $2E?3VMVDFH:-?VL6/-
MGMY(DW' R5(&?SKQK]GCX-^(/AA\%=9\*ZR;0ZI=W%W+&;:4O'B2-57+$#N#
MGBHJPDZ\9):6?Z'7E^*HT\HQ%&<TI2J4FEU:7/=_*Z,/]@K1K*S^ %K=Q6Z+
M<WU[<O<2;1NDVOL )] JCCZ^M8/[$V@6%OXE^+&H1VT:W2ZXUJCA>4C!=MH]
M 2?T%>K?LQ_#36/A)\(M.\-ZZ;<ZC!//(_V60NF'D+#!('8^E9W[.?PEUWX6
MW?CN36C:E=:UAKZU^S2E_P!V<_>R!@\].:YJ5&26'O'X4[^6A[>8YG1JRSEP
MJI^UG'EU^)*I?3NDOP.&^%<26O[;OQ/BA4112:1'*R+P&;=!R??D_G2?L2:+
M9)-\4-6$"'4)/$UQ:F<J-PC7Y@H/4#+L?R]*[CP9\)-=T']I?QEX[N3:_P!A
MZMIJ6MN$E)FW@Q$[EQP/D;OZ5/\ LW_"K6_A78^,HM;-J7U;7I]2M_LTI<>4
MX4#=D#!X/%%*E)5(MK9S_'8O,<RP\\#7ITZJ<I4L-'?=Q7O+Y=3SWX2>'-.;
M]M;XM7GV.'SK.UMF@.P?NVECA:1E]&)!YZ_,?4U<\71);?MV^!9(E$;W&A7(
MF91@R 1S8SZXP/RKM_ 7PJUOPW^T)\1/&=V;;^Q]>@M8[01R$RYCC16W+CCE
M3W--\1_"C6]4_::\)^/(3:_V%IFFSVDX:4B;>Z2 ;5QR,N.]"I25-+E^W?Y<
MV_W$SS*A/&3FZJ<?JO)O]KV*7+Z\W3N>>? @8_;"^-'_ %SC_P#0DK3_ &C)
MD;]HSX!Q!U,BWUZS)GD B#!Q[X/Y&K?C3X+^//"_QHU#XC?#2]TF6?5X$AU+
M2=:WK"Y557<&7G^%3U&#GJ#BL63X!?$OQ+\8/!'Q \4ZSIE[>:?=L;K3[,M'
M;V5L!\BP@@EV+,Y))].3VS<:D:;H\COS7OTMS7/0A7P-7&0S-XF"C[#DY;OF
MY_8N'*U;379[/2VK(-=TBSU?]OK21>6Z7"V^A>?&L@R X5\-CU&:N?MM6T2R
M?"R\5%6[C\3P1I,!AU5L$@'T)5?RKM;CX2:[+^U-;?$$&U_L"/2#9,#*?.\S
M!'W<8QSUS3_VD?A-KGQ5@\%)HAM0=(UR'4+G[3*4_=*#G;@')]JN=*;HU4HZ
MN5_R./#YEAXYGEM255<E.BHR=]$[3NG]ZN>,_'*^\0WO[9'AZ'2/#$7BZZTK
M1Q=66DW5W'!&S'S-TH+L%RO!P><KGM5CX[V_QD^+_@.71=2^$EEI+I-%/;:D
M=?LRULZN.1F4?>&5Z]Z]9^.OP*U7QSXBT+QIX.UE- \:Z)E8)YEW13QG/R/^
M9'0@AB*XSQ;\)/C)\<TT[1/'FH^'?#_A>"=)[N/0/->6[*G(SO)Q[<X!YYP*
MQJ4:EZD;2?,^EK._=M.UO^&/3P.:X-PP.(C*C%T(I2<_:<\7%MWC&,XJ2E>Z
MLM6VI:'OOP_34X_ ^@IK*A=52RA6Z =7_>! &^920>>X)%>8?M0>*?!OAG3_
M  PWB3PW+XOUN2_W:%I$+N&DN%VY8@'! )08(.=P&.37LVFZ=;Z1I]M8VL8B
MMK:)88D'\*J, ?D*\>_:,^"FM?$NY\*^(?"FHV^F^*?#5R\]HUVN8I0Q0E6X
M/0H.W<^M>E7C-4&H*[T\SX/)JN&EFT*N*GR0;D[IN-KIV5U=QBW9.VJ39YA\
M:/%?QD\6?"/Q)_:_@'1/"_AS["SW#W]^L\X0?W$0G:_3&<8JIXW=G_X)R6A9
MBQ_L^P&2>PO8@*ZKQU\,/C=\:O"UYHGBG5O#GAO3C$6-IH*RLU[*!E%D>0G:
MF[&0/UK=?X%:]KO[)D?PSU"6TL]=2T2$2Q2&2'='.)4.[ ."%4'CC)KS72J3
ME-I-W@UK;?Y'WD,?@<+1P<93I1<,3"<HTW)I16[;DVV]-;-I:=3U[X?_ /(B
M>'/^P=;_ /HM:YKX_:SX1T+X5:S<^.+5M0\/ ();*-F5[A]P,<:[2#DL!WQQ
MD\"G?!6T\=Z9X533O'5MH\%S8I%;VCZ1(["6)4"[GW=&X[<5'\?OA*/C5\-+
M_P -K>"PNFD2XMKAEW*LJ'(W#T()'XYKTY.4J#Y5K;9GP%&-"AG$%B*MJ:FF
MYP>RO>Z:[=UJO4\L\(^/OBWK_A;3[;P5\)],\.^'/)6.REUO4 %$./E)C!WD
M8QR1S[TG[ H=?A9XA20Q[DU^X7$/^K'R1YV_[.>E6M/\(?M!ZGX9M_">H:QX
M8T33DA6TDUW3UE>^:$#;\JDA0Q'&0!^%=/\ LN_![6O@EX:\0Z!JCV]Q:R:K
M)=6-S#*6>2$JJ@R# VM\@)QGK7#2C4=:$FI62>]E]R1]?F6(P<,KQ="$J2E*
M<&E!RDVDWK*4F[O79:[MI'5?'[4[K1O@IXUO;)VCNH=+G,;)U!VD<?G7-?LD
M^'-,T7]GWPG]BAC)OK4W5U( "9978EMQ[X^[]%Q7I?C(:4?">L#7.-&-K(+P
ME2V(MIW' !/3/05\R?"/PU\4?"/A1K/X6^)O"_BSP#=22OIM_JHE$UF"QW *
M,<ALY5N_89Q735?)B(SM?1K3=:]CP\O@L7DM7"JHJ;52,KRNHR]UKEYK6YEN
MD]U>VQ:_9_T*P\-_M%_&_3],B2"RC\MDBC&%0N-[*!V +$8[5B?LL:CX=TK]
MF?XEW7BU3)X;37KW[=&"P,D9@MAL&T@Y8D* ".34O[(.B7UG\6_B]'=:J-?N
M$=(+C55&$GG+,7(]MV[\!75?#3]F+5K/X!>./ 'B:YMK:YUS59[ZWN+-S*L0
M*0>6QR!SNB.1Z=^:\^C&<E&<(_S^FKT1]GFF(PM"M7P^*K[_ %2\E=2:C'WI
M+K=+7NC/^'7Q(^(>J^#[.U^&'PAM-'\)!<6-QK&HJBE"3\VTG>V>N>?J:I_L
MB)?P7?QO@U,6B7\>K.+F/3\BV6;$V_RP>=N1Q[ 5M^$O!/[0?AOPE:>#(-3\
M)VFF6L7V6'7@LKWD<70$)PFX#H2.P^M:W[/'P%\0?!R?X@V-_>0ZI8ZQ(DME
MJ#2DSRMM<.95QP27!ZGO6E.%1U*;:>E[W226G1(X\=B<#3P6.ITYTDYN+CRR
MG*4DJB;<I2;UMK;1[MK0P_\ @G_H]G;?![4-1C@1;VZU:=)9L#<RH$VC/H,F
MH?AY$FA_MA?&B*P06T/]F6MQY4?"F1K>)RV/4LS'\37H?[+7PKUOX/?#*30=
M?-L;YM0GN1]DD,B;'"XY('/!IGA'X3ZUHW[27CWQQ=?93H6MV5K;VRK(3+NC
MAB1MRXP!E&[GM6L*4E2H*VJ>OEHSSL9F6'J9EFU7VJ<:D&HZZ2_>4VDN^B=O
M)'$_L(:9:3_#G7_$4B+-K>I:Y<_:[E^9,*$PA/7'S%L?[5=)\5_A_H7@*R^)
M/Q"T&6:T\6W>@SI+##<!8P!'CS?+&/F&W=GU!-8-C\%OB5\%_%FNWGPNOM$U
M#P[K-P;N31=>\Q5MY3U*,AS[?3 (X!K<^%OP%UI?%OB+QI\2M0M-;\0:W:&P
M:QLE9;2VMB,-&N>3E>/89Y).:5.$U3C0<-5UZ+?5%XW$X9X^OF\,6O9SY6H*
M[E)7B_9RCI9*VK;MHK7N>1?LR^(?BCX3^$NEIX4^%%EK>FW1DG.JG6;:&2Z8
ML02ZLX8$8Q@^E=A\"?"OQ T_]HKQ/XEUSPC;>$M(UO3_ /2K*VU.VG47"LA6
M39'(6R1OYVX^8^M6?"OPD^,?P,%[HO@#4] \0>$Y)6EM+;Q#YBRV>XY(!3&?
M?G!ZX&379_ KX):SX)\1>(/&?C/5XM;\9ZYA)I;=2L-M$"#Y:#CCA>W10/7.
M=&C.].,E+W?2R]--;_\ #G?FN9X1QQV(I2HM5TTN7VCJ2YI)^\G/EBXVNVU:
MZM%.Y[11117N'Y"%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZXP/Q%>,^,=3M)_&W@B6'QS?^-Y(]7B:XE 46=N3P-NP! S<X [*: .W\/\
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MF#+,1$<@HF<@\_WA67X8U*T?]H3P^UIXCU'QFAT^[C^VWF/*>3RV;RXC@+C
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_9L_UGQ,_P"Q+OO_ $=;UM_MR?\ )?\ 4/\ KQMO_0*Q/V;/]9\3/^Q+OO\
MT=;U\9/_ 'J7JS^G,/\ \DW1_P $/S1WGC_PSX$^+DV@:W+XXO=&FBT6SLY+
M3_A&KZXVM''@G>J;3R>V1QP37+?\*(\ _P#13;W_ ,)'4/\ XFM[X_?%3QGX
M*\0^&]-\/^(-0TK3QX<T^06]I(53<8N3@?05YC_PT#\3O^AQUG_O\:JI.DIM
M2C=_/_Y(QP&&S*>&A+#UG&#6BYHZ+_P2_P V;W[0,,7B+Q%X>B\-1ZCK6GZ5
MH=MIK7ITV> 221M(20CJ& PPKR__ (136_\ H#ZA_P" K_X5V7_#0/Q._P"A
MQUG_ +_&C_AH'XG?]#CK/_?XUS3E3G)R;?W?\$]W"TL?A*,:,8P:75R=_G:"
M7X'&'PIK8'_('O\ _P !7_PK,92C%6!5@<$$<@U[K\(?C?\ $/6?BAX7L;_Q
M5JMU97&H0QS0RRDHZEAD$>E>6?$H!?B+XJ   &JW0 '_ %V:HE"*CS19UX?$
MXB6(EAZ\8IJ*E=-OJUU2.<HHHK$]8_6?P-_R3[PC_P!@:S_]%+6S6-X&_P"2
M?>$?^P-9_P#HI:V:^ZA\*/XXQ7\>IZO\S\RO$EOX"O/C5\5_^$TT3QOK-PFO
MW(M&\+*C1QKO;(DW,,'.,8[5ZC\'OCEK?PC_ &4M2\2PSIXD-KK_ -CL],U&
MY9Y[.W=@!'*1RK<$A>G/X#T=OV;_ (J>'/'7C/6_!7Q.L?#EGXDU*74);5]'
MCN6&YB5!:0-R <<8J%OV,[Y_A)KWAN;Q6EYXBU[6HM:U#5IK8B-W1BQ"H#QG
M).?4]*LYCH?$?Q\\;^#=!T"'5?"VDW'B[Q5?QVNA:98WKF+RV16+W$C*-I4M
M@A>.#SBKGAC]H37;;Q/XM\(>,?#EE9^+=#TTZK!'IM^OV2^AVYPLLVWRSG'+
MX Y].>@^+?P1E^(FG>%;G3=8.B>)_#%Q'=:=J/E"6,.H *NA^\IP.*XZ3]EF
M_P#%LGC?5_&GB>/4O$_B33!I27.G6GD6]E",$!$+$G)49R>F?6@# ^''[7VK
M^)?BAX;\+:MIN@2PZZ) DNA7LMPUFZ@G9*[((W/_ %S9A[UB?%WXY>+/B=\+
MOBQ)X>\.Z>_@C2?M&DRZA+>.EY*R_*TT:!=NP=<$@X/'.0.F\)?LK^*]'\7?
M#S6=4\6Z9>P^#E-M;V=KII@5X"N"2VXDR'C)/'RCCK3];_96\3PZ3XZ\->&/
M&-EI/A#Q3<2WDEE<:>99[>1SEHTD#@>6>AR"<#@CK0!Z[\!6+? SX=$DDGPY
MIQ)/?_18ZR/V@?C1)\&O#>ES6.EC6=<UB_CTW3[-Y/+C:5SU=O0<=/45EZ!X
M;\<^"_%7PI\,Z;JC3>$=&T'['KRK8H(9WBM_*B=96!96,@4[%;. 2>.NS\>O
M@P/C+X;TZWM]3.C:UI-]'J.G7_E^8L<R'(W+W!X_(4 >"Z-J_B:X_:]UAO&&
ME65EJ4'@R026VGW3RVLZ#<P96(5@#DJ<C(*GVK5^"OQS;PWX+^$J6GAC3]#\
M(>)[VZTZ3R;B>4V5R)#Y8#2,Q(D.>I/(/;%=IX>_9\\6?\+:U#QWXF\66&JW
MM[H;Z0T%I8M D1((!4;C\HZ\G.2?:J]K^RO.G[-=K\-)=<B_M:RG^UV>L10L
MHAF$QD5PN<C&2.#0!'=?M8-IO@OXC>,+C2(9?#^A:J-(T=X9"'U"4':[,3P%
MW$8([ U1^''[7$_B7Q+J?AW58?#USJ2Z/-JUE<^'=1:[MF,:%V@D) *N #G'
M'!P>AKIG_9=TVX_9QMOA=+?F.2)$F.IQ1\FZ#[_-VD]-W&,]*?X0^!GBBVU+
M6-3\4^+8-3NKC27TJTM-,M#:6<6Y=IG>(-AI#Z].3@#C !Q?A/\ :G\<:I\$
M=3^*6H^#],'A^UMW6&WL[J0W,]P+E80VTJ0L0#$DY)_=MQC%=9\%OCWXA^(-
MU--JMCX<N="6Q-Z=5\.ZL)A;$#)BFADVRAL \A2OO6Q\._@KK7P^_9\L/A]8
M>)TL]8LTG$>L0V4<J9>XDFP890RE</M.>>I&*YCP'^S#J&E_$N'Q?XAU+0_-
MAL9;$VGAO21I\=WYBE6>X 8[VP3[=.F* .)T?]N];W4]+U"YL]!C\,:CJ7V!
M;6'4BVKV\9;:MQ+!C:$/7 .<?AGZ(^,_CNY^&/PN\1^*;2VBO+G2[8SI!,2$
M<[@,$CGO7D'@[]E7Q!X4?1]#3QI&O@C2M1-]%:VEF8+^9-Q86\MPK?-'DG/&
M3Z],=W^U;!)<_L[>.XH8WEE;3R%1%)8G>O0"@#@_#G[3/C&TUOX<_P#"9^$M
M.TK0O'$2"PN;&\>6:&0HK#S4(P V]2 "2 W)R"*YA?C=%\-K'X_>)=#\)V,.
MIZ#KL,,I:YG<7[R72Q&1PS$(<.3A !GM6O\ "?X"^)/&6D?!_7_%OB>*^T+P
MYI=K?:;I,=CY,Z2/!&0LTF?FV851P.%YY)-<_P#M _!/4/ /P8^.VL"]75&\
M5:I::A#;6T+!X1]NB.T\G<<'J/2@#T7PY^T#XLT_XB^%?#WCOPSIVBVGBJSD
MNM-N-/O&G>)DCWF.8%1AL?W<C)')YQYZ_P"WND5ZVK/8:&/"BZE]A-H-2)UG
MR@V#<^1C;L[XSG\.:] \$? CQ%K7B[P;XL\:^)[?6[;P_IIBTJRM['[.X:6+
M:SS-N.Y@#VP,@' K(T+]DS7?#[)H-EXU6T\#KJIU+R+2T,.I%2VYK?[2K#]V
M3UXS_*@#C/&&K06/[2_QON[BV35;&'P&LS6<DKI',NVW.TLA! ([@@\UK>&/
MV@]:\/:%\'/#7@[P?I>/%.G2R0V<][,L=H5=@!YC%F*CDDG<?2N^\5?LWWOB
M'XD?$3Q-'K5O!#XI\-_V%%;&!BUNVV,>83G!'[OH/6L_PU^R[?Z#KGPDOWUZ
MVF7P19S6LR+ P-T78D%>?EQGOF@"+1?VK+O3/ WQ+U/QAH,%CK'@>[%G<VNF
MSF2&X=W"1[&89 +$#)'0Y]JC^#?[5T_COXCZ;X0UF+P^]SJ]F]W93^'-2-VL
M3(I=H)\@;7"ACQD<=ZT;O]E=-;B^+MKJNL*]EXZNH[F(01$/:-&V]"<G#88*
M>W2M?X7_  4\4>&?%UEKGBCQ;#JJZ;8?8;.PTJU-G _&#-.@8AY-N1G&.> *
M /0O&7Q,\*?#PVO_  DWB'3M"^U;O(^WW"Q>9MQNVYZXR/SK-\-_'#X?^,-7
MATK1/&.C:KJ4V?+M;2[1Y'P,G !]*Z^[TVTU#;]JM8;G;]WSHP^/ID5';Z+I
MUI*)8+"VAE'1XX55A^(% 'EW[2_@_P 4^,_ US:Z)XC7P]HT5G=S:OY<9:XN
M46/<D49_A!(8,<C@CK7S9!XFOO"W_!.&VFT^X>UFNIS9O-&2&6-[HA\8]5R/
MQK[>\3Z0VO\ AK5M+200O>VDULLC#(4NA7)'MFO(/#W[,MO#^S8?A1KFI+>(
MR/\ Z?;1E-K^;YJ,%)/W6Q]<4 >;_ MO!WAKXR>&;";P!J7PW\07NB%=*9KR
M)H=7@";F:=(^DV!N^<DY7DY SZ9^U?\ %SQ'\'O!>BZEX92TDO[W58K(I>1E
MU96#<#D8.0.:K^"_V??$*?$CP[XP\=>*;;Q'=^&K%[+2H[2R\@?,I0RRDL=S
M[2>F!GGM7,_M\:7<ZQ\./"]M:I,9'\06X+P(69 0PW<>F: -S0?BOX[\(_'C
M2/ /CB31]2@U_3GO;&[TJ%X3!(N[=$P9CNQM/S=^#QR!ROP;^/7Q"\1_"*^^
M*?BFYT<>&].ANB^F6=DR7%TT8PK"0N0H+_+C!X&<]J] \+? O7W^+5IX[\:^
M)[?7[W2K%M/TN"SLS;I&ASF23YCN<Y.>W/; %3_"C]GJ'P5\ YOAGKM\FKV]
MPES'/<VZ&+*RLS#:"3@KD?B* /,S^T#\3/"?@;PE\2_$R:#<>$=>O(89=(LX
M9$NK.&;=Y<@E+$/PN2,#J.O..DNOB_\ $#QU\3O'6D>"'T;3]&\'1*)WU2W>
M5[Z<H6**58; ,$9P>@XYXK6/[*_B6]T3PUX/\1^-H-4\ ^'[Q+NWL(=/\JZN
M/+)\N.67<05&X\ ?G@8X#XH:M!\+/C=X\?2=:U;PHGB&R3[='<^'I;R&\D\L
M -9RQ,<.=Q!+@*#NSVH >?VK_B%+\#_!OB>"+2GU_6/$DFD2Q-;GRC&&PH W
M9!]Z]2^(/C?Q[\.M'T>WUSQ[X(T>[N)96GU&[M)S(Z<;$@M%)+D<Y;>.V!7F
M7PD_9JU_QA^SY\/;._N#X?N].\02:\8+^!C*\7F':K+D;68 -SV(KV3XM? W
M6O&'Q/\ #OCOPWKMCI>KZ59R6)@U2Q^U0-&Q8[@H8$,-QYSV% 'C7_#87BR7
M]G;Q)XNABTZ37M#\0II)N%MG6"ZA.#O$;'<A()X/3CWKH[KXN?&*Q^-NF_#>
M6Y\,F_UK31J$5T+.4)I_#,ZD;\RD!&';.0>*@E_8NUJ7X4>,O!TOBVTN)]>U
MN+61J#V;*58?ZP,@;')P1C '->JZM\$;K4?VD-$^)JZI"EII^F/8-IYB)D<L
ML@W!LX ^?ICM0!Y19?M2^-(/@5XM\076EV5[XD\/ZZ=%GGM87-N%#8:<Q@EL
M#TSW%=]^S]\5=;^(NJW;2^,_"7C#1/LXD1]*AFLK^"7(^5[9P?DZ_-N!SCBF
M^#/V?_$W@7PKXRL-&\8Q:;JFN:[+J\-XFGQSHB.23#)'*&# YY(P>.#4?PX_
M9QU'0?BW'\0?$.IZ.^IP6;VD5IX=TS[#!)N!#22C<Q=L$^W3T% 'O5%%% !1
M110 4444 %%%% !1110 4444 %%%% !4MI_Q\Q?[PJ*I;3_CYB_WA0!O4444
M %%%% !1110!\N?MZQS-X-\,O$BNB7LAD)."!Y?6OAU/M6F7Y82Q6Q&&E92'
MSC/'&17WO^VGX;U#Q%X7\/"R@EGA@N9WN%A(W;3$0.,C(]A7QAIWA3_7W"BW
MF@:-]L;NRM@9R-HPYQC!/3I73":C$YYPYG<P)=234()ELXD<2./.$4*J'8>H
M ZY]:A;1]0N)(X?W4$0(,C21DG;QR=N?\:ZG1?#&I1&.VT<O C'[9(L:3()<
M$#)*]AZ?2JOB"V\5?VD\ZFZ5S\I,<TA4'N/F.?QJDU?0GV?<=J/A[2=,L_M'
M_"3VD]Y#M:.WAM9Q([<8"ED S]:HSZ]KVG6EJ;NQLE68LL=S*H\U#D@Y)Y4\
M'MSGBJLFM>))8X'GM9]1MXI3_P ?,9=2P^\N0,]3R,U<C\:ZA:0M:W&CQ67F
M,DI@CLP?-!)(R74G'0#!P0/7)I)A;>PNCZ\UM>@37%AET5F>8-*L9.<C@8S[
MC/\ .JQ@NIYEN8K^TFP)$4O+)"K/QU.P G'('N.E=;X%USPM=0-IVMZ->S:N
M]P!')E4@$9SC<RXVXXZ]37<6/B'3KV"-K;PTFN:<@\V:*)0?*P6"B0X7;D*.
M>>OM7/4J3B[PC<NG35MSQ>77_$UPT,Y>"0#]VI4Q.0P/(/3_  JGJ7B/4-52
MW%T2)(S@J(P&8XZ'&<C@''3VKU'QOK7@6]T.[F3P?#IUZ\:R>=;7DA$>3R"F
M1@]NE>=:=I>F/>QZAJ-G>^1=?,L]LWRA !_ JG'4>GZUO"IW1,HR.=L-3N-0
M4VT,EW+NDWX#X Z[OZ_E70VGVJ>WD$D4[VC<$2@2<KD@ $9Z@UT%K/H>F:#J
M TMGFBES')"9"LC/NP'5=O+#CIQUS65_8$EMIPM1%+8,LOGMJ%PJ2B*!\#E5
M!8G*L<CID\ 53G<E4K;LY^ZL;4M<M-$D'FCR\>6K%& S\H'0GCD52TFW33O-
M,L<YE"CR"O'\0YSW&,UW7A>S\/2_NK[4YWO7+$"&,(YV)S_%G: "2<=L9K/>
MU\//(Y_M6:&XGBVI8 $@1@9):0D 9(XZC-"GT8>R2U.:U7R]3M6EG>X%RD2I
M">.2&&0<+V&?7I3$\.M?Y6#4SYA0'RW#?-E@,*<9/'/3M6JVBK=M<)*;RWCM
MNL-TV"&)! P3DL0#G%:I\/:EX=T^VO+1MMM=1Y0O$))(MY.Q8SSM.<Y&,T^>
MP>SN</>V[Z;;Y")*[_,)"<-LSCD'E3P3],50;[1#;R&2.64L/DD8 AFSWP>!
MBO4;+PQ;ZUK5G;ZA?QO!.JM<R-$8\%UZ\@=.,@<?>]#77WOP_P#A[9W%U''J
ML3Q(%"C][)O?)&U5!& ,9[=0>E/VZB5[!R=D['A.G7.J7T2Z;;VK2,&,VQ",
MDXQ]1]*V4\'>,;X)/'X:U&YMF3DP19R<8QGN,5U_B?PEX:M;I[F/5].2UCB1
MD2T664R?Q9)4<'L>?453\-7T6DO;P6WBO5+3325W6B))$PR>3P#G !-9SJ3:
MO3M\R?9)/5W,>Q@BM[E=-@22"XED*RH!M,9&0>,G! ZG/:M5[&ZOY[L/K4DK
MK&555+;9&4#:KL2% ]\GZ5T5[X8\-ZA>20V.LW^JW(OUB\]K9(87B\MB[>8>
M-Q*_Q']:Z"Y^"]G%IUB^FW$:6YC$EY-J'FHRS8Y"-MV[/NXYYSZ4G)6UW*46
MSR<KK#*L%Y>+(81OCM?.\P')QM4KD$]^35&]U2\>(M%!+;O&V"%1CGGWKO/$
MGPYU#PSJ:W%M&]_8,C(MPH5FC+KT**0S;6((POMS6J/AM/>6\=S_ &7?2VDC
M(JRI'(JLRA29 ""<GH<#(Z#/-5S(S]E<\T6SU.ZGBAM[::>60;C L3[S[XQW
MK3TRTE^QQW3VUU#;,3'OBF((/<8'3IWXKT8^&];BNW\J+47?S607<T<I60!3
MMVD)D@9([$$GMT9-$RZ?+;WNK31&U;RE5[8J[G!P3QR"..Q/IWHYQ^R7<S_#
M&C6XE$%S=OY\K"8?:;AGDCA(*DQX[Y.<>H&>E;B_!F/6-(BO+6^U*[N+AV$
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M,9&2<#CIZYHKBF[R;-TN56/C7]N3_DO^H?\ 7C;?^@5B?LV?ZSXF?]B7??\
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M*?$5=8;0WMEN;:\\(V-L")F95PVQL_<;M7DO_"H_!O\ T5K0?_ *Z_\ B*Z
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MKX:EFAYMKFX:.7( .4<J"#G!''TS5/6O@I+:#[?J&NI8VLMTT:7UQ=R1+<$
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MQ*^(5EJ=M=)&VGI;YNTGB*R300G:<.6&&ZXP!T/&<5WGACX@Z%\9=?U+1YM
M-]J/DI>M>+L&X(%!B(1 2?0\<D9Z4^9L-.IS/B7X9:/>75TVG6-RQ:5@B!T6
M=,*28RV"B@L3@@*"/4FN:\1Z4U[J%D@T^""S8'[3$MRK2K"NP&)FW$KRA^4X
M/S]P.._2[^%VCS/-J6M7FF3#;YE@S[PK#)R2H/W3ZGJ.,5EZ=\:_AYHMW;O*
MS.L,)7[7 @!D+  Y;()(!ZGU-2ZEE=@HINR,^XU9]3UZ"YEN+:^NK.SBM;B
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MP79@VRQQ\?*.V<9YJY5(W]TS2?VCI]!TOPTMU:7Y@N0LA87=N92L; @;_*
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M@\#FNHHHJSF.;^'?@2R^&WA.V\/Z?//<VL$UQ.LER5+DS3R3,#M & TA XZ
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M(((&P3WY=J*:V*0?&7]D#2?C)XXG\2WGB&]TZ>6&.$P00HR@(, Y)SS7#_\
M#NWP_P#]#?J?_@-'_C7US17)+"4)MRE'5GU%#B;-\-2C1HUVHQ5DK1T2^1\C
M?\.[?#__ $-^I_\ @-'_ (T?\.[?#_\ T-^I_P#@-'_C7US14_4L/_+^9O\
MZVYW_P!!#^Z/^1\C?\.[?#__ $-^I_\ @-'_ (T?\.[?#_\ T-^I_P#@-'_C
M7US11]2P_P#+^8?ZVYW_ -!#^Z/^1\C?\.[?#_\ T-^I_P#@-'_C1_P[M\/_
M /0WZG_X#1_XU]<T4?4L/_+^8?ZVYW_T$/[H_P"1\C?\.[?#_P#T-^I_^ T?
M^-'_  [M\/\ _0WZG_X#1_XU]<T4?4L/_+^8?ZVYW_T$/[H_Y&)HWAB+1M"T
MK3$G>1+"TBM%D8 %PBA03[G%6_[(3_GHWY5H45VI65D?)RDYR<I;LSSI"_\
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M_P#Q-'_"1^)O^@FW_?B+_P")KK_^$;']V@^&P?X30!R \1>)3_S%&_[\1?\
MQ-._X2+Q+_T$V_[\1_\ Q-=;_P (V!_!1_PC@_NT <C_ ,)%XE_Z";?]^(__
M (FE'B'Q)_T$V'_;"/\ ^)KKAX;']VE'AL9^[0!R8\0>)/\ H)M_WXC_ /B:
M<-?\1_\ 03;_ +\1_P#Q-=8/#@_NTX>'!_=H Y,:]XB_Z";?]^(__B:>NN>(
M3UU-O^_$?_Q-=8/#H_NT]?#RC^&@#E%UK7SUU)O^_$?_ ,34BZMKQ_YB3?\
M?B/_ .)KJAX? _AJ5=!4?PT <JNIZ[WU!C_VQC_^)J5-1UL];]O^_*?_ !-=
M2NAJ/X:E71E'\- ',)>ZP1S?-_WY3_"K"7.K'K>M_P!^D_PKHUT@?W:E72E'
M\- '/))J9ZWC?]^E_P *G0Z@>MVQ_P"V:_X5OKIH]*F6P4=J ,)([T];IO\
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MELVL5L.?0[FP/T/2M;4O%.D:1(J?:I)RV.(E!!]1UJ"V\=:"Z7$E_HHOHHV
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M/^>B?]]"LZB@#1\J#_GHG_?0H\J#_GHG_?0K.HH T?+@_P">D?\ WU2[(/\
MGI'_ -]"LVB@#2V0?\]$_P"^A3ML'_/1/^^A6710!J 0_P#/1/\ OH4N(/\
MGHG_ 'T*RJ* -?\ <?\ /2/_ +Z% ,(_Y:1_]]"LBB@#8WP?\]$_[Z%+YD/_
M #TC_P"^A6-10!M>;!_ST3_OH4OFP_\ /1/^^A6)10!N>;#_ ,]8_P#OH4>=
M#_SUC_[Z%8=% &[Y\/\ SU3_ +Z%'GP_\]4_[Z%85% &]]HA_P">J?\ ?0H^
MT0_\]8_^^A6#10!O?:8?^>J?]]"C[3#_ ,]4_P"^A6#10!O?:8?^>J?]]"C[
M3#_SU3_OH5@T4 ;WVF'_ )ZI_P!]"C[3#_SU3_OH5@T4 ;WVF'_GJG_?0I1<
M1,0!(A)[!A6!4MI_Q\Q?[PH WJ*** "BBB@ HHHH ^2O^"ATEJG@[P@+EXU+
M:A*J++$7#'R^G0X_K7S!X)G\[PP;.UG2YO[0&3#Q;8\MD[=IZJ3D?0U]7?M\
M>$+_ ,7^#_"T.GPI++#?R.=[ 8'E^]?)?A#P?XC\*ZXEWJ:#[)(AAE<S*Q .
M,'&>F<9]J\:I54,59HJ,)WYDM#A--TF_T;QOJ=_X7OD@BU"T\N>T>V((4X9A
ME>!M89S[5WWPY@CGTK5K3Q;JER\$X$"?V=<LJRPL,E7*J#VXP>A-87CJQM=!
MU,H&DM%N0RY!.UN,L">Q/)Z5;L-8T+5].^RZE96\]Y<MN:\@N&M6. ?OE6.<
MC'5#R:[*52,*OOM:&4UHXIZG8G1_AGX:TY+>">QLH(5^2/4I7./Q8Y/X]*PY
M?BM\/M(B=%U[3]N-K1Z9!YI('0?+NKCM:^&/@B5);DZS>:%,O*B]5+J%R#U$
MD>#@^ZBO,[SX%^%]2N2Z^++JZN"YD*:/HTDKNN>OSE!^->S'$4NR.=TIVW/6
MI?BEX(\;I?Q:1=/<36T>[$EJP8Y./E'WB?85S6D0ZI<WUS<MHNHW;SW.5F>U
M8G;P,!G (P!TR:PM$^"'A#17%['IGC;4948'S9+FWT]5Z=EWL/S[5Z_I'B?Q
M-#%%8V>FV5M%%A+:76M5N-0E5>F"H"'IV!J:E>+^$J$&MS1L/#UM?SR0Z7/I
MVM>2V9+995:5".N5!##!_P!FM#7+?6M)U1K:_P!)N=&NI0 #/;=4[@,P ;=^
ME>NVGP=TC7=&TO68I?[,\03:?$\EY:+L02/&"QP?G"D]BW3BNRT_Q7XWTFSA
MLM4TG3_$FGJ@B#P3[6V_WGBF# GZ./PK&]]4;;:'QGXL\,:1>6]ZMYX?GANF
M1VC+VY57;&0<$9Z_W<5S'@[X.V'C8R36##1]0L;=+J5;IMUJJ\;?E?G<6SD$
MXK[OA_X0_7KA]/U/PQ/H]Q(_EJMM&]ND@]<#=&<^YK&U#]G_ ,.R7%U+X<U>
MWT^^:'RI4U"T"NJ]0OF1X &<<%32?+RM.)/*VT[GQ_J7[/\ =ZWJQFO-9\EI
ML,HAVA7/0E3GD' [=ZGUCX$7"+<F#7H1<%EWK=D+Y(..AP.N.X->U>/?V9O%
M\.CW,VE0VTJ,"[7,!%QA0,Y1U*%!CU5J\#7X>>-_#&IE]1TR6\A:1)),1EY'
MC'.1O4'&._ZUR.%)/6-RW=Z%:7X,O!:?\2[Q#8ZKJ3R+LL(1N8]V<D$\#Z#K
MUK \1_"#6-"6"XU7R(UFB+(J2!FSNR3M7G&T-SZFNOU'Q'IN@>($GN-,U-7@
M=5GLHK7:J@C.PDJ1C!]>];7B#QIH$'V+68/#6K7ES*#!#_:DZB!8EZH '+#'
M08(^E:2PL&_=)35CQ33O",_B&6WTG3'_ +0FN5>X6*,[0$52Q89(/"@TJ^#]
M>\&QP8L[NZE1V!D\HL50G&#CK_\ 7KT:UUF&S\0C4-$\"-H=^L+@7-G-]L4Q
MR*0Q.\@ $$_PYP:UM>72)=&L;F[N;[199&59H[9A DN#R^UDVDX+#Y23Q7.L
M-?23-^1]6>7R?"G7M0L9M:CMI+BVM55I&A.4C#9Y( /ITK=L?A*=0M(UL]=T
M:=[A5F-JUUM=%&>60@8QZGIS75Z3X8T<65T]_KFO&W0A[:&W!9#SQNVD+Z9X
MQ54^";1K621$O+K4B,A;LQ;%!Z;@4W8_&MU24=&-TVUS19SE[\([O1?,N-14
MQVUN)!(]NHD";>I/((4CD'%=7\-?%O@7P_H<<-Q833WJ;FDN9+<I')EB48[C
MA/E91SZ9JM8:=J&D136=Q8R3:=(R)+!;2D&502>CDJ<<^@Z=:OMJ>IZ09DTF
MXUW1M/NU_<VSP1E0H[N4SDXZ#BG"G%.X2E%046M>YTDGC;1]5D4Z?IVE%Y&V
M3"81R1JF22S%2Q).01QZ^U>;>)+6&.2>2_O=*MWG)C1;.Y,1;TVJ-W/8<"K-
M]X?C\4E$GU"2\EBC=O*<Q6C!,9&W;'E2>N23U[=:@TV:UT768=*-N8HUB&V\
MOG;=)_>0LW7\SUI5'""M*-_R+A>HGKIYD/A'PM-?>($065]-.J%Q:W(6(;2/
MO%B0V.0<@5V%CX4GN'N%M+Z"*Y@(,EM/?%L$CN#N/ZUG:;\8X;?1KW68+:UC
M>SN#$J,8SN.>P4*<>V:GTSX\G1[2WNM6T6UG$TS6S7"PYA4%#MVX8_,H(R,<
MFHIUH0B^5)?(PG!1:NS7;PMKHEB-A=:==.B#"Q6<D;*>N-V[)/X58^('[/A\
M1"ZB_P"$AOA-IZJ;@M;F9 64.0 IW<;NX%5(?BG?^*+"X2S\4:>T"2NWE*?L
MLN<#Y5)&< 8XSR,CO46K_$2\NO*EEU);9R=EW.[B8G(V$' W8P?6M'-3UD*R
MZ'I7@;3+7X??!3QG:P22WL%WHD-Q:R3IM<QJ#OW]0,Y.#M^M4_V>?$^CV_B#
M5FU6[LH(3I,K0I/.-AF)&WJ>#CZ?2N!7XI6.@^%/$WAQ[V*]^VVT=I:7$2E1
M)&."&!/]T=>_H*\MT*R@GN'NGC348I4R8+N?R2F<\EA@8)QUKDJUW%VAJB]=
M#VY?'&IV;PQW6LR74:H5@>1Q<VY! W[&.Y3V!PU=Y\'["V\9W&OZIY5D7TRQ
M^TQ7%G"(R^=V05'!4@'M^-?.6A^)-4TK3M;@TVS>6S#QQS0%S<*K8;;@C& .
M>N<\5FRZSK.B7]C#/=K;_;D,5O'ISLH"*!\K#'3&/UI2K7C?ENP2/J[1/B_'
MJ<$K#2TT);$QO=3Z>WF-+N8*24*E@5&3QCIBLGQS\6_AM=V&MV;WFH>)+<P^
M88);22%I6&"J[N-OS=3VKQ7POJOB'5KF/P[;%9;>X58I9Y4S(KKE@< C 'K^
M)KUWX.C1/"=_JRZMJUP;W4+<1+]ICW0YWY 10I/09SD?I51JRK/EBM.MR7&2
M9QIU:+Q5H^FZEI-]-I5[=2QFQL3.)X89(0-Y (+E2<#@GOP*7P\E]J9T6/6K
MN*Y\13RS()()%382QRV2/NJ.,8/)KT3XE:1#HLVG:HLT,MA*IDC\F1U25B<?
M=^[_  MDX[5P/A+Q>GA^QM)OM$6LZFRL\FV(M)9C<,1%N1M8<_@>>*F>$IPD
MG3BK]RZ<KNTWH=!\5[X^'M.LO!]A*R")4-RZ81W!^9F]F(YQ7DGBWX66O@R\
MTS6/#=Y?:_'*ZS71^S&-H9#T&YA@CYU)([K75/XFM]:\:RZG=>+SX?U'R)3]
MOFM'G$KMQY8C' !48SVQ5[QGX9ATKQG:6&EW>G>*[1M/AD=+6!1/%$T:N_DQ
MJQ F&3R?3D5I%67NZFD[2>IR/B7P])96UO<Z:UQJ<MZ8HK[4I(0EK$2X!7>#
M@Y8<MQ_.L>Z^&&I7ECKFI0VFDV>JV6]IV>\ $H'5H S?.#D $ Y)Q3=?\20:
MY;+H]G,-)TJX:.V$Q"1M"OF<M*54%\#KQD8]A5RX\+W7VQ=-\0ZK+J%C HMM
M.U**YW!N@\Q%;JO&0/K^#25^9:&7+S.UCF[#4&T+1HY9TW75X@7R@Q4HWOM;
MKR.".]1-H4E[;PS:M?R6=JC%I8)5.['LW0'D^O6K&JZKJWA7Q'!H>MZ=$Y5?
M,22X<P-<1 G!4D?+D*><'ZU0_P"$SCU/Q?+<7=A<1:?Y8CBBCE\W$N.'+-P<
ML23TX^E+EDM4S.2OI<LW5UJ4.KVT"7BS:5!&%@4R!G"*."5/U^E=3#-?16L:
MPSPW,ER1+'!&=N[=D=,#OZ5!K,7A6'7[2[N-.OKFWBBC@GEB=',) RQ!7Y2,
MC )SWXK+\%7VD>+?%,"R7<>EVD#_ +LR#A509 ^\ ,A3^)K&5.4[:Z ER[L_
M1;_@GJ]\_P &]>_M" VUP/$4X\HG.%^S6V.]%:G[#/BC3?%GPNU^[TJV2WM8
M]>D@WQH469A:VI,FTD[<Y QD\@T5WP5HI(K<Y7]H_P#Y*?=?]>T/_H->7UZA
M^T?_ ,E/NO\ KVA_]!KR^OSC'?[U4]6?T#E'_(OH?X5^0O6O0?#WPOAATR+6
MO%NHC0=)?F*(KFYN!_L)V'N?RI/A=X>L%@U+Q5K<8ETG2%#) QP+B<_<3WY_
MIVKE_%GBN_\ &.LSZCJ$S22.?DCS\L2]E4=@*4(0I052HKM[+]7^@5*E7$U9
M4*$N51^*76_9=+VU;Z>NWHWACQ=X'L/%FC6FD>%GEW7L*+J6I7)$B$R ;]@X
M&.O6KOQ$\6^#O^$\UBRUGPI]H*3;9-1LKHK,W YVGY2?Q%>* X-!8L2222>Y
MK3Z[/V?)RK>^RM]UOQW,?[(I>V5;GEM;XI7O=.][_AL>CZI\,;#7=.FU7P3J
M1U>WB7?-ILR[;N$?[O\ $![?K7G#*48JP((."#VJ]H6NWOAO5+?4=/G:WNH&
MW*ZGKZ@^H/<5W?Q(T^S\3Z#9>.-*MEMA=R&#4[:/I#<_WOHW7\?4U$HPKP<X
M*TENNENZ_5&T)U<)5C1K2YH2T4GNGV?>_1_)GFM%%%<)ZY]LZ)_R+6@_]@Z#
M_P! %6JJZ)_R+6@_]@Z#_P! %6J_5*?P1]#^;J_\6?J_S.-T?XO^%-<E\5I;
M:H%'A>=[;5GGB>)+=USN^9@ P&#R,BG_  U^*_AWXMZ3-JGAFXN+W3HI#%]I
MEM)84=AUV%U&['J,U\%>)_A_X\^(?BKX]P>'KI$\-Z9KT^H7]@&(?4I4D8K!
M\O. @9N>,@=3C'M?Q%_: %G^R)X?U_X:QIHS7=U;:+)!:A4?33M82HN>$;*!
M0Q[.&ZD5H8'US17Q?\/(/B=K/B#QCX$NM6US1K>\T W5JVH>+;?4=2LKP$&*
M5)(9/-6-SCC&,9&>:L?#7XO>(?C9XI^$WA2#5M3LKW0X)=0\6-;W+Q-*\#F%
M(9BI!8,R$LIR"'&: /LBN5UKXG^'?#WCG1/"%]>O%KVLQO+96XA=A(J@EB7
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MT% %?XL?'GP7\$O[*_X2_4Y-._M/S?LOEVLLV_R]F_[BG&/,3KZU#\+?VAO
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M!M/&&L^*=/AMI;9] U :?-)*1ME;8K[EQV^8#FNBN;Z&UM)[AG!CA1G?:0<
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M&<[/+W;.O?;GWJMJOQ*T[2O&=SX:>*62_M]%DUMF7 3RED\O:#G[Q.?P%7?
M'C2U^('@W1?$-K$]K#JEJEW';S,#(BL,@''>@#G8?V??A_!X0UGPNOAV-M"U
M>Z-[>VDES,_F3D@[PS.60Y4?=(Q4VD_ OP/HFHZ'?VFB;;O1+.6PL));N>7R
MH)"Q="'<A\EVY?)YZUW;2HK!2ZACT!/-#2HAPSJI]"<4 >26O[)GPHL;F*XM
M_"4<$\-TEY \=]<J8)5;<ICQ+^[&[!VK@' R.*Z#4_@5X&U?QC=^*KG0@VO7
M<#6UQ=QW4\?FHR%"&17"D[21G&?>NZ,J!]A=0W]W/-#2HAPSJI]S0!P#? #X
M?R> K/P9)X;AE\.6;F6VM))I6:%R22R2E_,4Y)Y#9YJ;0_@7X%\->$=8\,Z;
MH$5MH^L1/#J$0GE:2Y5E*L'F+F0\$C.[([5W;.J+N9@J^I-)YB;0VY=IZ'/!
MH XJ\^"W@W4+#P?97&C>9;>$989]%3[5,/LCQ;?+.0^7QL7A]V<<YK0T'X:>
M&_#/BW7/$VFZ;]FUS6]O]H77GR/YVW[ORLQ5<?[(%=#=W<=E;S32, L2&1AG
MG &:YCPOX_'C'2_#.J:9I=S+I>M6YN3<M)&OV5=H90ZELDMG'R@XQS0!:\1?
M#OP]XK\2^'=?U73_ +5J_A]Y9-,N/.D3[.T@4.=JL%;(1?O XQQBMG5=,MM:
MTR\T^]C\ZSNX7MYH]Q7>C*589!!&03R#FK E0OM#J6_NYYH\U-^S>N[^[GF@
M#EM&^%GA70?A^G@BTT:'_A%5B>$:;.[SH4=R[ F0LQRS$\GCMT%4/A]\#O _
MPLN;NY\,:#'IUS=((I9WGEGD*#H@:5V*K_LC ]J[KI34E23.UU;'7!S0!YMI
MO[-WPUTCQ8OB6T\*6T6K).;E'\V5H4E/_+182YC5N^0H.>:OW'P*\"7E[XHN
M[GP]#=3>)PG]K>?++(MSLSM.UF(0C)P4"FNY$T;-M#J6ZX!YK(\9>*+?P9X3
MUO7;A&GBTNQGOW@C8!Y%BC9RJY[D+B@#F/ ?P!\ _#36&U7P]X?2SU)HS"+N
M>YFN9$0]51I78H/9<4:=\ /A_I7@&7P5!X;@;PQ),UR;">:68"4XRX=W+J>.
M"&&.U=9X3\01>+?"VC:Y!$\$.IV4-ZD4A!9%D0.%..X#8K(^(OQ$L_ASHUKJ
M%U;R7BSW]M8"*!E#*TT@0,<]@3DT 4/"/P-\#^!-+U33]$T&.S@U2,Q7KM/+
M+-.A!&UI7=GQ@G W<=J@N?@#X"N_!.B>$9=!W^'M%N!=6%G]LN!Y,@9F#;Q)
MO;EV.&)'-=?I>JW-]=ZG%<Z;+816D_E0SRR(RW*[0?,4*25&21AL'BM%)$D&
M496'^R<T 9GBKPMI?C;P[J&A:U:_;=*OXC#<V_F-'YB'J-RD,/P(KF;7X&>!
M[+6O#.K0Z$JZCX;M?L>E3FYF)MX>?EP7P_WCRX)Y/-=P)HR<!U)SC -'G1[@
MN]<GH,T <%;? /P#:^$=2\+KX<ADT+4;IKVYM)II90T[')D#,Y93GIM(QVQ5
MWP3\'/!OP[TG4--T#0H+2TU#_C\65WN'N!C&'>5F9A@D8)P*[%Y$CQO=5SZG
M%#2(B[F8*/4G% 'DME^R;\*-.OK*\MO"217%E=K>VSB^N?W,JMN!4>;@*#SL
M^[[5U>G_  ?\'Z9J7BB_AT2)KCQ.<ZOY\DDR7?!&"CL5 Y/"@5<\:>/=/\$#
M0OMJR2G6-4@TFW\K'$DN[#-D_= 4YK0TC5[K4+O58KG3)M.BM+CRH9Y98V6Z
M3:#YBA22HR2,-@\=,8H Y/P'\ / 'PSUB35?#GAV*PU!T,0N'GFG:-#U6/S'
M;8/9<5%9_L\?#ZP\*Z+X;@\/^7HNC:FNL6-K]MN#Y-VI8B3<9-S?>;Y6)7GI
M7HBRHZEE=64=P>*$D2091@P_V3F@#F3\,O#)\<7OB]M+5_$-YI_]E7%T\LC+
M):[E;RS&6V8RJ\[<\=:PO!W[//P[\ >(SKV@^&+>PU0;_+F\V618=WWO*1W*
MQYY^X!P2.]>BT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !4MI_P ?
M,7^\*BJ6T_X^8O\ >% &]1110 4444 %%%% 'SM^V5IVO:EH'AB+0(;::Z:\
ME5UN;I+<;#'@X9V K\M/&GB*34/%FGIJFF07&I6\\ME]DOX,P!B^&1GX 4GO
MR#GBOT=_X*)W'D>"?"1\T19U&3K"),CR^G/2OAK0M4M8?$=M)/<)/!YJ$(;"
M/Y3GKG/K7B8FO"%;D;[&WMGR*GT.N\<:[8:/\5+'58Y(HUW_ &.[LX<DQ1JJ
MH6/;!RV .1L]Q57XO>&Y&>*_:-#+$YA<HP(8@_*V[L& _45QOQ,A,?C+6YBN
MV);MU^]G')X]^]>C:$Q\9?#^S,K8!C-C([<D2Q@>6?Q7:?PK%_O95*?S1C%W
M;BQW[+WQ0BT#XC68UNRD-G;'SC=Q."B.%94SD\MMD9<#LV3TXD\::[8V/B75
M?L%C"\SW&\S26YE^1@K,=N'Y ?IP<C.<5X=H^/"OB^]N+UX5@D)C\F=I L)Y
M^<X."01@ Y'/2OI[X&Z3X,\12>(;KQ6;.6Y6SMI&OA*ZC;D1D @_+D&/T/(K
MU,'42IJ[!KFT/.]1\374T<)L5%M 04C=UWDGCJ"<KW)&,8(K+E.NZA?L;2WN
M;P;P@CMXBP55).>./FR <GL>:^I=<^"6DZ+K5NVF7MN-/NI!) MG9+))C825
M9B26Z=<@U6AM[?3M#>PN?"-YJ<<D?D^;JTD:N6SDDB,,PQQ@X[UZ7M+K0APM
MN8^K_!CX<):Z<;57U)-1N8XO(NYF%S <JO()R5^;G(S[UGVGP]EM?M;Z/IEA
M86D%R]N;JTTU"59?667<1T'/'6K%EX#M-/N'OM+\/Z/H1#&19")+V5.<\-))
MM&/]WM6KX.\97W@N*\L+RVN[G3[Z23SVU.ZB"?."&;Y%.![$CM4M26P[Q>YR
M5T=9T&2*YO[MK+YR(UO+^1WDQW6&!3Q[]/>@ZQK&L:3I]A)<7EW'9APMW%I\
M=N[[B227F)/KT3M4/B'XA^&[?P[H.G6OB6U+P2WL;&T<':#<N4SE<A=I&#D<
M5R[^.I+V[DAL]+O;XPNT'VMX]T!Z_/G/S+SU!YYYI\UE=H=K['JFD:/;WV@7
MP34KR"[TZ W;QNT<H>+< 0Y"8!R2?NDXZ5XEXS\4Z1?>*K]X9#;FV> +M5F\
MV0KR$P,G[IQA!U/(P:ZS2_B7JWA[Q#):30:'=V%]8I%-&;HH\L;2<[4&6'*E
M<YYYYKB->\87>B>+;J\TU+34K#3Q(DMC#;[VW-\G!8_-L!(4 <<DDU@KU-C2
M_(<Y=^*==\+Z[?S:?<;+S4&B$,-W X5+8(VY6#KAB3@Y(KJ=1UKPZMW!+;:1
M&UW<6T+S+!;-*1(4!=E7E<%LD<#@BJGAK6;?3=%:QU^\CUU7VW0OKM(E^QK&
M'+J<>HV\!CR*9<?$'0H+.)X;SSK>3[HLHB[Q'KE@H/';G@9').*QJ2Y/=46:
M12>K9Z%HFCZQK]EY.D)90D198W<ZVIA &-Y!QW[>_2GV?A$V"?9?$'C'36:-
M 671HFFE? QCYAZ#UY.>*Y*ZTO4K*[!FNK54>W#)<*SL6BE52I(*CG.PX/'&
M,4NB: -.O9+R;4KJ_E=07=]JQ.,<9 'W>Q(.1^-<<G%)MM?F=%FWHBU>^#TU
MK4+VWL=5OI[<V<L\<5T1;"14*[V##A=N]<@XZ]Z] \*?$ZU\+:':6^I0VES>
M6L0B62%GDF.W@?,HR<;CT&.>M>/MXPTS0O%!NUU6ZU>6UDDM[C3+=(U6/D>9
M$\A^9=VT=NF.35F\O/$/CRYNI-+T6XT70KU5B01<VFW/ +2X4'/4J5YK/VT4
MN62_ P<TGH?1^G^/[^ZL")O"NDSV-_(&1)Y(HWG?&XC'.YS@$9]*QG^.W@=]
M9N=!\1:)>:3>%DMY5MY4N88RW &5.4//.!\OMBO&_$7P9^*?A^WTR%!,8K&[
M6[MSYJ[8)QD _,0N,$YP2.>:H2> ]*U:YGN==UF]E\0RS^?=1:;%F(2'[WSA
M,*,]P3QWK>E2]JFJD+H'6:MR.S/IGQS\*O"6K>'Y)_(N904CBC&F7A+I\X4!
M%9L '=AB.@R37F]OX"L]/;4KVUL=,TJ*U5XK<W%DA4N.-[[LJ1QN V@G)ZG%
M=C:^(6TSP'86P+Z-9RI&@U,P+/&W8@2(<!C@_>Y^M;4\5I=_V;;Z1;100JWF
M2:A))YTD9 X95X)8^M=<<(HQM%V\NB$\2V_>7D<3:_#;X?\ CLVVHZE;&^E/
MRM/97S^5(1UX&-H.#P!Q@UMWOP_L]+CC3P@=,T:T<%!#:*RSS/C/SW ;S#P#
M\H*U-XL\7:/ITJ:?+:PZTUN6<33Q^4Z.1@E=FT@_E7**UB=&E6>:_P!$>=_-
MM;N.,S\#&'95^5<\C)Y(QWK@KT)89<[C>_8UI>RK.T=&>>:QX2UWPWXC.K:C
M92:I)&S!+2UE^1@01SR[XY[GFLD?&J;5XKK2?$)GCL+:0/'''<DSV[1'S(8O
MGPW#9!!/1OH*]Q\#>-UNI/[-B\6Z/J"(1&EM<QFWO(6)QCYVW9)S@8STK@]=
M^!<NBM?W7C+7=(G6\O);J*[EF\O+$Y0/G:6;D@]B !64)IZPG8RG1E%71S?Q
M!^-EG\2XM.^UW/\ PCHM]_GC1H]OVG=MQOVDD8P>GJ:RXOBYH>EF)DTV3Q&U
MO;_9[==68O&B@?+@?+@9Y/&3W-4--^'6EB/3]+O5CU+5Y[F6!)-&N!+)(HV>
M6S(N=K'Y_E([5B^(/A_#HUIIK1W=PE_=1LTNEW$&^>!QC"$IPQYY. !CFIG]
M9J? [G*U*/0AU3XF:[K48CN+Z.*'H+6VB6&(?\ 0!2?<C-5K:\OY(B#<RPNQ
M_P!7%B,%?]K:!W]:UK'X=7\%HUY<+':Q(ID:24X<J.NT=\9'W<_45U?@;X0Z
M[X\TV74O#\$36:2&(7MX<!F&,A$&3D9'7UHIX6S_ 'KN^P6=KLX2#3(4:/\
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M,<!U'*Y]>U<_+"%FU8YH>TY[-'Z+?LD:?#IW@3Q D;)ODUR666-&SY;-;VY
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MDAXV.>4(.-O0 "OK+4_"VBZU>VUYJ.D6%_>6H(@N+JV222$'KL9@2N?:G?\
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MJ_YT 9%2VG_'S%_O"M+^RH?5_P Z='IT4;JP+9!R,F@"U1110 4444 %%%%
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MXES:/O2!M@66)QF.56.<JP/KP01VKI_A]\0)/%>HSP7]F$O+8M&8WM_+\Y%
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M =^I]J]E\/:_\.K[PQ::%-I]QH5W;V\=NTUDQ@CN57@E_*XYQD\<_C7G6H?
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MU%_:<'JWY4G]IP?[7Y4 2&+--, --_M*#_:_*C^TH/5ORH 0VXIC6H(Z4_\
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M!7^[4BZ(O]VMS[9![_E1]LM_?\J ,==&4?PU(-(4?PXK5^VP>I_*C[;;^_\
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M17L4X\D5$P>Y2^.__)0KC_KA%_Z#7GM>A?'?_DH5Q_UPB_\ 0:\]K^*.*/\
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M)PJ@DG Z 9- %BBLKPMXFL?&&AVVK:=]H^QW )C^U6TEO)P<<I( PZ=Q6K0
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MTC!AT>WD>-8S*N"P;[V1R<+CVKQ;6_&ETWAE_#VKWJS6LK+%Y-N"L7W@RD#
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M@P?T.1D$U>T^0:9I;Q-\J *H4>IY8_7"J*Y&V\/7=[XBEB@NY[:YO8WE5S(
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MLUNN -JM$RG;@#C.* /B7Q!XS\2^)_V0OB+8>)M5FUBXT7Q/'8PW%S<FYD5
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M\7>'IG\17J:=!J%PL>D)Y&\Q;3@X P0G(7/XUYU>:,VEZ]+IE],MN89C#+,
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M!K ^,WQIM/AJMAI%F;6Y\5ZN&6PMKRX6"",#[TTTC$!8U_-CP.M0_"&R\-^
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MZB;S397DC)!@SQ&0$^9!TR#WH ]THHHH **** "BBB@ HHHH **** "BBB@
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M,(-)G+!@H)).TG)/]:[<+1E&7++6[&M4<AX%TF">]O)67-II@A7:.F%W.?\
MT'-;^@Q,+$:A-DI;B2YE('\6WC\<M7H_@;X"^*=!^&OB>>]\*:W<7U_)'%#%
M_9<_F#D[F"[=WW<C\:U/$?PS\5V?PL33[#P3KGVFXF!:.+2)RP V@EAMS_"W
MYU[%1.*E+^M!*VAXJU]I\UY'IYOHK9IU+>?+E5+$9P2!QWY]J^I?!?Q<\ Z%
M\+FT;4O"4&L7VF:5-'#J$4,4Z7#ACY:H5!8'YA@MC[O6OFR3X.?$ .Q'@3Q-
MM8XVG1[G/Z1X_E6_X4^ ?Q"UC5[/3#X4U^R@O7$,LEQILT<<:GJS%D  '6OG
MJ%><*JY86N"ET/-K2WM+G3$N)M-GMHA$9)6ESO<KPW3!&2,@X]JZ37OA+K\'
M@*S\66FEW']B2Q"4_:89 DRL, ;SP>I[^E?07B/]C;Q9X.T=-;LMFM/8JES#
M:064PE==R#RMG<D-T_V3TZBE?^(OB1#\.];\/77@/Q7<()6M;?2O[+NIK-XM
M^4D4[#M*XSCU'!YXZYX.,9.<V;)P5^IYI\&O@;XO\>V'VW0?#OGZ=&7C,WFA
M8P=N2@WMDL01],U/XB\%6?AQXXO$DNK:3J6YH)8([HHR@D@)(F1QQWXY'K7U
M_P#L^:]<_"7X8:=INN^$O$L$TMW+<JMIH\TQ"N 1N"+E3_O"OGCX^_#/4?B3
M\3]8\7P>$?$QA2\$P']B76Z[B5 J)LV]0<G/\A75.BY4TT]37VTG#D:T1XUK
M>MV?B?Q%::-KEQ<7D%E<J;6&8MNC@"!0/]H84=^PYKB=;^&VC^([Z[O+'Q!+
M"A+*L$T>Y$3DXSDGKBO8[3X5>/;2_L;^+P)XGN+0HK&*6QG5L\Y#ILZ=/>NX
MT[]E_7M6M[N_CT:]LGU 9-M+H\J^4>NT@@$@&O+FJM"TK78HWJ+E/A"W1H+G
MR@A0HVS;@J>#Z5]1?LRZ%!I[ZU=2R&2]GB2(?NMH6/.XD'OU4=OQJW\0_P!E
M/Q+X7-E?1^"=2UNYE<QM+8:9.<<8RZ*#V[UZ7\%?ASXLTO0]2!\)^(+*(7$)
M2*YTV=&X'S;0R\@<>U=5"JYU$N5F/+R2LR?XD_ /3/C!JUMJ%AK*+-I]DL3(
M5W0R19<J0Z$,/XNA[>]9WAW]A7QW:>5J?A_7['26:!MDIN9)'N$=5^7./E!Q
MW!KN=;^#_BG5[WQ_J5IH>JVYFT$V5K%]GEC)<HQ4JH3#-G(^4Y'<<BOI'X/S
MZQ<?"WPK)J6G7UC>"PB6:WN+21)4=5P0RD9!X[UZ<:4)3<F@>EFMSP"/]E[X
M>>&M!MH-?\1W6DZY:CSYH;NYC2&Z)89V[@N0>!E6SZ\U\X:A86-OK=ZT]FE]
M#:WCQ12% Y4;BJ]>H Q_.OO[XQ?#2V\=KI"W^E7-X@D>-76W9S%N&XL1CI\N
M.1SD=*^?O$'P"^S^);R*R\':\T]G*8P+*-Q;S QQG<I=2K#YFYW#!&WG&:X<
M7A:E;X.AWX7$.E5A)NZZH^*_BS_:%SK?VV:R^QZ4X58KB&%1 2 <$L.,G\",
M&NU^&_P67QYX#7Q;?6VG31Z==K%&&O LT<JD .T0(W1DGN#TXXKV7Q9^S;XM
MT7Q'/I_A_0-8U30KU9!>0M:R+&L^P! "W!!+9+<C@\TVP_9\UCX>^$Y%N?!>
MKZA<+,S6T=KICR7*$)E1O0'Y,DCG.#D\U:HMR7M%TZ$5G"I4]K![[KL>3>(O
M$FC>+;B)(7MI[.&=[6_VQ'R1(N Y49P5P1TZD&N=\5^!?#?A:QU:]TLO)&(9
M88BAP"AR X1NF:^N_P!ESX0:?HUAXC3Q5\/;^'[>83;6U_I<S[,"8L02@"_>
MC7 (^[G-<E^T?^S7JE]=SW'A7PO>1Z-O6"UCLK"=I$<*-SE,$["<\DX]*QQ&
M'C"ES4KW.2;N]5J>!?!C0-,T^'2[#Q/I,ESID<2P)Y$FV2,<@,<<DCCVZY%?
M4?C[]F;PY\,M.T[Q%H/B"\F@EC6^2SN5P60]"LB@ ,"1@<?7BOGZP^%_Q3TE
MD=_ FOR21')>'39B,#)!4;,]@,>]>IZIJ'QIUC1]/M-6T#7M8LG5((K.719T
M:#)XRP3@#U/;K7)A,95<W"O'?8(R:M9GU3^PQXQ'C?X1:I?![XF+7)[<QZ@7
M,L16& E?GYQSGJ1SUHJC^P)IFMZ1\*/$MMK^AZGH-^OB:Y/D:G T32H8+<B1
M-P!9/X0V.J,.U%?3T_A5S&;O)V$^._\ R4*X_P"N$7_H->>UZ9\<-,O+KQ]<
M20VD\T9@B&Z.-F'W?4"N _L/4?\ H'W7_?EO\*_B[B>A5EG>,:@[>TET?<_?
MLGJ067T$Y+X5^12KJ-+\?7D-A)IVJ*^M:6ZJHM9YF&S:<@JW:L3^P]1_Z!]U
M_P!^6_PH_L/4?^@?=?\ ?EO\*\7#3QN#DYT%)7T>ETUV::LUY--'H5HX>NN6
MI9_/5>CW7R/4(S8:SJ,GB'39X[XZ;9(UCH:(Q>%Q@<C'*JQ+<9S5^-I+K3M+
MD\5-IUS<NTCWQOBB30VS %5 X;=D9&.G3O7D]G8ZUIUPEQ:6]_;3I]V6%'1A
M]".:9/I>K74S2S6E[-*QRSR1.S$^Y(K[.GQ!4A%R>&?-+625^1NZ?,TT^RCR
M[*-^6U]/ EE<)-)559;/[25FK)Z=[WW;WO8T]>\7B\L8=,TJWDTK2HBY\A9V
M<REB,ESQGH..U<W5W^P]1_Z!]U_WY;_"C^P]1_Z!]U_WY;_"OB\3+&8RI[2M
M%M[;622T2222279(^@HJA0CR4VOON_FWJRE15W^P]1_Z!]U_WY;_  H_L/4?
M^@?=?]^6_P *Y/J];^1_<S?VM/\ F7WGU)IG_(!T;_KQA_\ 0!4]1:<C1Z'H
MZL"K+8P@@C!!VBI:_O#!Z8:G_A7Y'\VU_P"+/U?YA535='L-=L9++4[*VU&S
MEX>WNXEEC?ZJP(-6Z*ZS RM \)Z'X5LWM-$T;3]'M7.7@L+5($8^I5  :MZ7
MI5EHEC%9:=9V]A9Q#$=O:Q+'&@SGA5  JUFC(H R;?PCH5G;Z;;P:+IT$&F,
M7L8H[6-5M&(()B &$."?NXZFM:DW#U%&X>H_.@# \1?#SPKXON8[G7O#.CZW
M<1KL274;"*X=%SG +J2![4RS^&WA'3M+ETRT\+:+:Z;-*L\EG#I\*0O(I!5R
M@7!8$ @D9&!71;U_O#\Z3S%_O#\Z ,C7?!?A[Q3/;S:UH6F:O-;',$E_9QSM
M$>ORE@=OX5L*H10J@*H& !T%)YJ?WU_.D\^/_GHOYB@#"A^'GA6VU*#48O#.
MCQ:A S-#=I81"6,L2S%7"Y!)))P>235R]\*Z+J1O#=Z/871O?+^U>=:H_G[#
MF/?D?-M(R,YQVK0^T1#_ ):)_P!]"C[3#_SU3_OH4 9MUX2T*]-\;C1=/N#?
M^7]K,MK&WVCR\>7YF1\^W QG.,#'2F:WX+\/>)KJVN=8T+3-5N;;F":^LXYG
MBYS\I8$K^%:GVJ'_ )[1_P#?0H^UP#_EM'_WV* (7TFQDU&'4&LK=K^&-H8K
MHQ*98T8@LJMC(!P,@<<"EL=+LM,-P;.T@M#<2F>8P1*GFR'J[8'+' Y//%2?
M;+?_ )[Q_P#?8H^VV_\ S\1?]]B@"E<^%]&O/MOVC2+&?[:R/=>9;(WV@IC8
M9,CYBN!C.<8&*L2:38RZA!?O9V[WT"-%#=-$IEC1L;E5L9 .!D#K@5)]OMO^
M?B+_ +[%']H6O_/S#_W\% '*^-?AM:>.?$OA?4K]X)K/1GNFET^YMA-'=K-
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M^>2_]\TG_",)_P \E_[YKU8Z O\ =I/[ 3^Z* /*QX7C'_+%?^^:=_PC*?\
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MO"9XK?$*@MND=47J1QEAGVK6KY?U!]&U+PS'J&KZK(OC=O$<4<UJ]XXD!%V
M(O(W8V! "#M[ YKZ@H **** "BBB@ HHHH **** "BBB@ HHHH **** /._&
MOQJTOP1KLFEW5C=SS(BN7AV[<,,]R*PO^&F-"_Z!>H_^0_\ XJO._P!H'_DI
M%S_U[Q?^@UYM0!]&_P##3&A?] O4?_(?_P 51_PTQH7_ $"]1_\ (?\ \57S
ME10!]&_\-,:%_P! O4?_ "'_ /%4?\-,:%_T"]1_\A__ !5?/-E8W&I74=M:
MPO<7$AVI'&N6)^E/U+2[S1KM[6^MI;6X7K'*I4T ?0?_  TQH7_0+U'_ ,A_
M_%4?\-,:%_T"]1_\A_\ Q5?.5% 'T;_PTQH7_0+U'_R'_P#%4?\ #3&A?] O
M4?\ R'_\57SE10!]N6VN175C:72QN$N84G4'&0&&0#[U)_:T?]Q_TK"TC_D7
MM$_Z\(/_ $ 58H U?[6C_N/^E']K1_W'_2LJB@#5_M:/^X_Z4?VM'_<?]*RJ
M* -7^UH_[C_I1_:T?]Q_TK*HH U?[6B_N-^E)_:T7]QOTK+HH U/[5B_N-^E
M']JQ?W'K+HH U/[5B_N/^E)_:D7]Q_TK,HH T_[4B_N-^E)_:<7]QJS:* -+
M^TXO[C4?VG%_<:LVB@#1_M*+^XWZ4?VC%_<;]*SJ* -'^T8O[C4G]H1?W&_2
ML^B@#0_M"+^XWZ4?VA%_<;]*SZ* +_V^+^XU'V^+^XWZ50HH O\ VZ+^XWZ4
M?;HO[C?I5"B@"_\ ;XO^>;?I1]OB_N-^E4** +_V^+_GFWZ4?;XO[C50HH O
M_;XO[C?I2_VA%_SS:L^B@#0_M"+^XWZ4O]HQ?W&K.HH T?[1B_N-^E']HQ?W
M&_2LZB@#2_M*+^XWZ4?VG%_<:LVB@#2_M.+^XU+_ &I%_<;]*S** -/^U(O[
MC?I2_P!J1?W'_2LNB@#4_M6+^X]']JQ?W'K+HH U/[6B_N-^E+_:T?\ <;]*
MRJ* -7^UH_[C_I1_:T?]Q_TK*HH U?[6C_N/^E']K1_W'_2LJB@#5_M:/^X_
MZ4?VM'_<?]*RJ* -7^UH_P"X_P"E']K1_P!Q_P!*RJ* -7^UH_[C_I4MM?)<
MN556! SS6+5W2?\ CY;_ '#_ #% &M1110 4444 %%%% %74M*LM9M'M-0LX
M+ZU<@M!<Q+(C8.1E6!%4=)\':!H-R;C3-$TW3K@KM,MI:1Q.1Z94 XK8HI<J
M;O8U56I&+@I-)]+Z!67>^%M%U.Y:XO-(L+NX;&99[9'<XZ<D9K4HIF11NM"T
MV]M(K6XTZTN+6+_5PRP*R)]%(P*:?#VE-;RVYTRS,$I!DB-NFU\# R,8.!Q6
MA10!271-.33S8+86JV)ZVPA41G_@.,4MOH]A:636<%C;0V;9W6\<2K&<]<J!
MBKE% %+3]$T[2238V%K9DKM)MX5CR,YQP.F2:?/I5E=-,TUG!,9@JR&2)6WA
M3E0V1R >1GI5JB@"$6=N+D7(@C%P$\L3;!OVYSMSUQ[55U+P]I6LR))J&F6=
M\Z#:K7,"2%1Z D'%:%% &4?"NBM:1VIT>P-M&Q=(3:IL5CU(7& ?>I7\/Z7)
M:/:OIMF]L[;WA:!"C-ZE<8)X'-:%% %#^P=,^R26O]G6GV:0@O#Y"[&P,#*X
MP< #\J0^'=*.GBP.F69L0=PMC;IY6?7;C&:T** ,Y?#FDI&472[)4.W*BW3!
MVG*\8['IZ5-=:38WK2M<6=O.TL8AD,L2L70'(4Y'(R2<=.:MT4 0?8;;[1'/
M]GB\^)#''+L&Y%/50>H''2H++0M-TVXDGM-/M+6>3[\L$"HS?4@9-7J* ,SP
MYX?MO"^D1:=:%V@C:1PTF-Q9W9V/  ^\QX  I]WX>TJ_NUNKK3+.YNEQB:6W
M1G&.GS$9K0HH AELK>>>&:2"*2: DQ2,@+1DC!VGMD<<5"='L&MI[8V-L;>X
M8O-"8EV2,<9+#&">!R?2KE% &;?^&M(U2=IKW2K*[F90IDGMT=B!T&2.E%CX
M:T?3#*;/2K&T,J[)#!;HF]?0X'(]JTJ* ,^V\/:596\\%OIEG!!.,2Q16Z*L
M@_V@!@_C5EK"V>6*5K>)I8E*1N4&Y%/! /8&IZ* ,VU\-:/8R+);:58V\BMO
M#16Z*0V",Y ZX)Y]ZG72+%((H%LK=887\R.,1+M1LYW 8X.>XJW10!GS>']+
MN+PW<NFV<MT<9G>!"YQT^8C/85H444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% 'RU^T#_R4BY_Z]XO_0:\VKTG]H'_ )*1<_\ 7O%_Z#7*^#_!>H>-
M;^2WL0B1PKYD\\K82)/4]S]!0!@@$D #)/85V&C_  \D^R+J/B&[70-*(RK3
M#,TWM''U/U/%73KOA_P)(R:%;KK>JIP=3O8_W4;=_+C/I_>-<=JVLWVNWKW>
MH74MW</U>5L_@/0>PH ZJZ^($&B02V7A*S.DPL-CW\F&NYA[M_ /9:CL/B*]
MY9Q:=XFM1KVGIQ')(<7, _V).OIP>.*XRB@#MM2^'T>HVS:CX5O/[9LL;GM2
M-MW;^S)_%CU7/]:XMT:-V1U*LIP5(P0:FL=0N=,NH[FTN)+:XC.5EB8JP/U%
M=H?%^C^--D7BFT^S7^-HUFP0*Q]#+&.&^HYH X.BNE\8^!;WP>]O)+)%=Z?=
MC?;7D#?+*OT/(/UKFJ /L/2/^1>T3_KP@_\ 0!5BJ^D?\B]HG_7A!_Z *L4
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M "BBB@ HHHH **** "KND_\ 'RW^X?YBJ57=)_X^6_W#_,4 :U%%% !1110
M4444 8/C?QSHOPY\.W&N^(+P6&EP,JR3E&?:68*O"@GJ1VKE_A]^T+X!^*6M
M/I/AG71J5^D1F,0MY8\(,9.64#N*K_M'_#/5?B[\)M4\,:--:6^H74D+I)>N
MR1 )(K')56/0>E>+_LK_ +)WC#X)?$2?7M>OM&N;.2R>W"6$\KR;B01PT2C'
M'K7GU*N(CB(PA&\'NS[7 9?DU;)J^*Q6(<<3%OEA=6>BMI9O5WZK8^MJY34/
MBKX.TKQ ^AWOB73+35TQOLY[E4=<C(R">."*ZNL35_!'AWQ!'+'JF@:7J4<K
M^9(MW9QRAVP!N(93DX &?:NV7-;W3Y.A[#F?MT[>5OU_X'J>=_&CQQXIM_!P
MU?P1-IW]BK#]HN-::42, ) OEPI@AB?[QX SWJ'XJ?$6;3/%7A_PXNNW6@17
M-C)?W%SIUD;J[EVE56.--C\$EF)VGA>V<UVOQ \$G7_AOJ7AK1(K2P\Z!8;>
M+;Y4$8#*<84' P.PK+\6^"=<7Q=HGBKPX-.GU6RLI-.GMM2D>..6)RK95T5B
M&#+_ '>037-.,[NS[?\ !L>[A*V$Y::G%*SJ6VN[I<O,VFM[I:678XS3_&_B
M'Q%I?@O0K3Q1!)=:Q=W:RZ[80CS3;0 D QR( DQRJL"N 0<5VOPH\1:G>7OB
MOP]K%ZVIWV@:@+=;UT5'GA>-9(RP4 ;AE@<#L*Y>Q^#?B'0K;3-:L+K3)O%D
M&K7>JW$,I=+.3[2NV2%6"EE4 )@[>2N<<UVOPS\':AX;&O:EK;VLFN:W?&\N
M19LS0Q*$5(XU+ $A0O4@9+'VI4U4YES7_P"!;_,TQL\&Z,U2<7VLE?FYV[[)
M\O)IT7DB#6?C#I6CZC?P'3M5O+/3I!%?:G:VZO;6K<$AV+!C@$9VJ<5%KGQI
MTG0]0U2V_LO5[]-+6.2\NK.!'AAC= XD+%QE<'L">#Q7%^(_@%>7NLZ[+;6V
MG7]OJER]R)[W4KV!H=^-RF&)@CC.<<@\\UT5Q\*=073?'=E:RVB1:S8PVEB&
M=_D\N#R_GR"0,CL6.*[3Y4U[/XPZ9<F^\W2]7L1;Z>^J1F[MU3[5;KC+1_/[
MCAMIY%&A_%W3O$-W:6J:;JVFG4(7EL+F_ME2*Z"KN.PAB<@<X8#('%9WQ"\+
M7<=A?ZL7A^S6GAB\L74,=YD8*P(&,8PA[^G%4O!OAWQ-XHM_!NI:RVF06.EV
MAFM_LCNTL[R0&,%P5 0!6)P">: )O"?Q:\GPCX8CO+74_$7B*_T\7DL&FP(\
MFS<5\QLLBJ"1@<\D<"NCT;XIZ/KE_HMK;QW:_P!K1SM!++&$5)(2!)"^6RL@
MSTQC@\URGAWX;^*?!1T*_P!*DTJ\O[?1DTF\MKN61(B$D>171U0GJY!!7TK(
M\<^&KOPG\.;&V.IVX\:2:J]_8F#Y=]S+(0ZQ@\E0)<9^A- ':3?&?1_W,=EI
M^J:K=SW,\%O:6,*/).L+;9)ERX7R\\!B1GTJ1_C'HG]B6=]#;ZA=75W=/91:
M3#;YO#.G^LC*$@ J 226QCOTKE?$GP&#P^&#I:6]Z-'T\Z<]K=WEQ:+*I(8R
MB2$[@VX$D'(.[V%9\_[/ER^@Z64AT]=1M+^>\DLDO;Q8)5E4(5,^\R[@%4[A
M@'&"* .TF^->B6^EFXDLM32_%Z-/;1V@47BSE=P4J7VX*\@[L8[UT_A7Q/%X
MKT^6Y2QOM->&9K>6VU&'RI4=0"> 2",$<@D5Y?9?!C4K+P[J5L-)\/3R7]Y'
M--87=Q=W$;1HA5?W\A9U<$\,JC XKL/A-X(U/P/I>HV^H72-%<7/G6UC%<27
M$5G'M V+))\Q!()YX';O0!W5%%% !1110 4444 %%%% !1110 4444 %%%%
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MHK[._P"%>^%_^A=TK_P#C_PH_P"%>^%_^A=TK_P#C_PH ^,:*^SO^%>^%_\
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M'!BXB7"* /<DG).>O2O1* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK45D_P!K3?W4_(_XT?VM-_=3\C_C0!JXS1MK*_M:;^ZGY'_&C^UIO[J?D?\
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MV(K \%_"7PC\/+NXNM T6&QNYT$<ER9'EE*#HF]V8A1_=!Q75&1A_P L9?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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<@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>aciu-20231231x20f002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &" YT# 2(  A$! Q$!_\0
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MT =!YJ?WU_.CS4_OK^=<_P#G^='Y_G0!T'FI_?7\Z/-3^^OYUS_Y_G1^?YT
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MV-N<$<9SS0!NT4?B/SJGIVKVFK&Z^R3"7[+.UM-\I&R1?O+R.WKTH N4444
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MG7FL73OA_<6/CCP'I^)KBQ\+:7*[7YA,<<TK@1*HZC.-S$ G''K0!ZU1110
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M1FC;^5)F@M6QYHZBBB@ IH7!S3J* "BBB@ HHHH *;MYS3J* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ IIIU-- 'Q_P#'[_DJFK_2'_T4M>=UZ)\?
MO^2J:O\ 2'_T4M>=U^:8W_>:GJ?T!D__ "+Z/^%!7W=>?\>MG_N?T%?"-?=U
MY_QZV?\ N?T%>]D7_+SY?J?%\:?\N/\ M[_VTJ4445]:?F84444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M *^/_L:T?^$6']V@^%Q_=H SQ\1)C_S"3_X$?_84?\+#E[Z5C_MX_P#L:O\
M_"*C^[2CPN/[M &?_P +$E_Z!?\ Y,?_ &- ^(<I_P"87_Y,?_8UHCPP/[M
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M4 :O]K1_W'_2C^UH_P"X_P"E95% &K_:T>/N-^E7JYP_=-='0 4444 %%%%
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MQ]G'=GZGP/D:QE=X^NO<A\/G+_@?F5J***^;/WT**** "BBB@ HHHH ****
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MYQBE3PW>>()4F\12(\ ^9-)MF)MU/K(Q ,I'H0%_V20#73I$L:A44*HX 48
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M\37.I>'89;7PFNGQVB2R3NXU*<-G[0JDG("\>:>9-W<*"?3J "BBB@ HHHH
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MAIJ7Q!^(WBCQ->ZQXA\*B&1=(TX:>4@::VCPS.?-B8E6D)((P"!GG->U4?\
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MSH/B"RU_RO"7ACQ5X/\ %)U#?*EM<"7P]*IE!DE9G^7#)D[4"MGC!/%?4%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA[QI)V?1R]?+R^\Y7XC_ !+L/ .FY?;<:E*/W%H&Y/\ M-Z+_.OE;Q!X@O\
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M_P#VN_\ SS7\Z/[6?_GFOYU0HH O?VJW_/-?SI?[6?\ YYK^=4** +_]K/\
M\\UI/[5?^XM4:* +W]JO_P \UI/[4;_GFOYU2HH N_VFW_/-?SH_M-O^>:_G
M5*B@"Y_:3?\ /-?SI?[3;_GFM4J* +G]HM_SS6C^T6_YYK5.B@"W_:!_YYK1
M_:!_YYK52B@"W_:!_P">:T?;S_SS7\ZJ44 6_MY_YYK^='V\_P#/-?SJI10!
M<_M _P#/)?SI/[0/_/-:J44 7/[1/_/-:/[1;_GFM4Z* +G]I-_SS6C^TF_N
M+5.B@"Y_:3?W%_.E&IL/^6:U2HH N_VFW_/-?SH_M-O^>:_G5*B@"]_:K_W%
MH&JN/^6:U1HH O\ ]K/_ ,\UI/[5;_GFOYU1HH O_P!K./\ EFOYT?VN_P#S
MS7\ZH44 7_[7?_GFOYT?VN__ #S7\ZH44 7_ .UW_P">:_G1_:[_ //-?SJA
M10!?_M=_^>:_G1_:[_\ /-?SJA10!?\ [7?_ )YK^=']KO\ \\U_.J%% %_^
MUW_YYK^=']KO_P \U_.J%% %_P#M=_\ GFOYT?VN_P#SS7\ZH44 7_[7?_GF
MOYT?VN__ #S7\ZH44 7_ .UGQ_JU_.M2N</W371T %%%% !1110 4444 (>E
M?+G[?GA%M8^&6EZ[$N9=(O0'/I%*-I_\>6/]:^HS7$?&GP8WC_X7>(]!C :X
MN[1Q!GIY@&Y/_'@*PKP]I2E$]C)\7]1S"CB+Z1DK^CT?X'Y*44Z6-X97CD4I
M(C%65A@@CJ*;7Q-K:'];IIJZ"BBB@84444 %%%% !1110 4444 %%%% 'IGP
M,^.VM_!+Q$+JR9[O2;@@7NFL^$E']Y?[KCL?P-?I=\/OB%HOQ,\,VVN:%=I=
M6DPP1G#Q/W1U_A8>GXU^0M>B?!3XV:Y\%?$T>H:=(9].E8"]TYF^2X7^C#LW
M],UZF$QCH/DGK'\C\[XHX6AFT7B<,K5E]TO)^?G]Y^GOC'P98>--*:TO5VN.
M8IE^_&WJ/\*^8/%OA&_\':L]E?)QR8I5^[(OJ/\ "OI+X:?$S1/BIX7MM;T.
MY$L$HQ)"Q'F0/W1QV(K2\6>$[#Q?I,EE?1Y!YCE7[T9]0:^>XLX2H<0T?K%"
MT:Z6CZ2\G^CZ'Y%E.;U\EK/#XA/DO9I[Q?=?UJ?(<<CQ.'C9D8="IP:ZG0OB
MCXET !8-3DGB'_+*Y_>#]>1^!JEXR\&W_@K56M+U=T;<PW"CY9%]1[^U8-?S
M![;,<DQ$J49RI5(Z-7:/UWV>$S*BIN*G%[=3VG1/VBF#*FJ:7E>\MHW3_@)_
MQKT'1OBQX8UK CU..W<_\L[G]V<_CQ^M?*AS1]#BON\O\1LXPEHUVJJ\U9_>
MCYO%<*8&OK3O!^6J_$^R+_2=,UZWQ=VEM?1,./-C5P1[9K@M=_9]\,ZH6>S$
M^ER'G$+[DS_NMG]"*\)TCQ/JV@$'3[^>U YVHYV_ETKN]!^/^N:?M34+>#4H
MQU8CRY/S''Z5^EY?XFY9B+1Q<)4W_P"!+[UK^!\CBN$<92NZ$E-?<_QT_$K>
M(/V=->T\E]-N;?5(NRD^5)^1X_6O/M6\'ZUH,JQZAIES:%FVJTD9VDGH-W2O
MHG1?CUX=U)E2\\_39#QF5=R9^J_X5W>GZUIVM0[K2\M[M&'_ "RD#9%?I.!S
MK+LQ5\+7C+T>OW;GR>(P.*PCM7IN/RT^_8;X9TP:+X>TRP48%M;1Q?B% -:9
MH%!Z5[1PF;XCOFTO0=1O5&YK:VDF /<JI/\ 2JW@NP6Q\):/"&+$6D1=SU=B
MH+,?<DDGW-'CC_D3-=_Z\)__ $6U6O#7_(N:5_UZQ?\ H J%\1T6_<7\_P!#
M0VTNVEHJSG$Q1M!ZTM% "#BD*Y.<TZB@!NP&@(!CVIU% "8I-HYIU% #=GO1
ML]S3J* "BBB@ IO:G4WM0!^97[9G_)Q'B7_<MO\ TGCKQ.O;/VS/^3B/$O\
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M0NH]?E?2^KLM['M%%>'>(OVGH]'\2>)-#L?!VL:W>Z)+MF-B Z>6!EI&./E
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M_:P>S)>6XF.KCTO^'-^6IZ;17F7A3XU/XIU;3@GA35;7P]JDC1Z=K<A1HYR
M2"T8.^-6"G#,!GCUJMXC^.5YHDFJ7EOX)UB_\.:5*T5YJX>*(#:<.T<3L'D4
M9^\!@\^E/VL+7N2LNQ+G[/EU]5Z=][]-SU;%';)XQU]J\TL_$]U?_'>&Q@O9
M)-%F\,1WR6^X^67:X8"3'J5P/IBL_P".NN>(KF72/"G@^\>QU^^6:^:XB(W1
M0PID#GIOD,:<^II.JE%R[%0R^<JT*+:7,KW[+S/6Z.E>+?$+XAWFO_L[P^)=
M(O+C2KV]%FK36S;)(':>..50>Q'S+3?%G@_Q#\+/#=YXKTCQQX@UN33(_M=Q
MIVN313P7,"\R(,1J5;&2&SP1[TG571>9I'+F[1G-1DY.*3[KS7J>U;AG&1GZ
MTM>1^.ETG6M+_P"$FTK[--?PO975S.TC-=P191T2$$XC9U)&!@-N.0<UZQ/<
M);6TL\F5CC0NQQD@ 9/'7MTK2,N9V.*M0]C",N]]/2W^9)1UKR>#XZW4-_H\
MFJ^"=7T?0-8NDM++5KB6%BSOG9YD(;?&#@_>%'PP\:^)O$'Q)\=:=JNCW%MI
MME=(D$LEW"Z6_P"[7"!5.3O!\S/.,X/-6<AZQ17"_$/XH-X&UK0](MM#NM=U
M361,+2VM9$0L\84E27P ,,3DD !3[5RH^,=OX9E\77^J66L"\MI=.M_[(EN8
MI52XG3Y88B,*O)^8EB#C(/:@#V2BO)]:^)>KZCX#\;K=:#J/A#7M,TJ2ZC$L
MT<RL"C['CFC)4D%>1U''K6I\/OB+_P )!'H.D6T4NK72:7!<:MJ(?]W:R-$I
M5&)^](Q).T<@<G' (!Z)17.>//&]KX"T+^T;FWN+Z669+6ULK--TUS.YPD:#
MU/)Y[ URMC\7-3NHM:T^\\(7VC>*+.Q:_MM*N;F%UNXAQN296*<-@$$C&1ZT
M >FT5Y!^S-=^(=<\#MKOB*YU:>ZU-EFC.HW<,T17GYH$C ,2G."K\_*.@J;Q
M'\;+I3XA71/"FK:OI&D&2WO=;MGB2.&55^;RT9@\NPD9*CC!Z@4 >M8Q[?6D
MKP[P'\1O(TKP'=ZUJ.IRS3>%)M4NI?.4P2",(7>1-I9GY^4@CJ>#FNG\&?&&
M[\3ZII<%]X0U/1;#5XVETW49)8;B*90N[#^6S&(E>@;OQUH ]*HKRN]^.K6[
MW>HP^$]4O/!UG<-;W'B.&2(QKM;:\BPEO,:-3U<#& 3SBM7Q1\3=2T[5WT_P
M[X/U+Q6\-NES<3VTT5O#&KC*A6E(\QB!G:N<<4 =_17ETOQVMK[0O#-WH.@W
MNM:EX@65K73#+%;NHBXEWO(P4%3QC/-:"_&&WC\%OK5UH.JVFHK>?V:-$>-3
M<R76[ C0YVL#U#@XP">U 'H-%<3X-^(UUK^N7&AZYX<O/"VM1P?:H[:ZFBG2
M>'=M+))&Q!() (ZC(KMJ "BBB@ HHHH #]TUT=<X?NFNCH **** "BBB@ HH
MHH 0]*:PS3J0K[XH$?F'^UI\.I/A[\9-6V1>7IVK$ZA:L!\IWGYQ^#[OS'K7
MC5?I+^V1\)F^(OPPEO["'S=9T0F[A"CYI(L?O4'_  $;A[J!WK\VJ^1QM'V-
M5VV9_3O">:K,\M@I/WX>Z_EL_FOU"BBBN ^T"BBB@ HHHH **** "BBB@ HH
MHH **** .[^#WQBUWX->)TU72)/,@?"75E(?W=PGH?0CG!ZC\<5^F/PJ^*^A
M?%SPQ#K.B7 92 L]L^!+;R8R4<?UZ'J*_).NT^$_Q8USX0>*8-8T:<[<A;FT
M=B(KF/NK#^1Z@_E7I83&2H/EE\)\!Q-PO3SB#KT%RUE]TO)_HS]5?%'ABP\6
MZ5)8W\7F1L/E<?>C;LRGL:^8/''@>^\#ZH;>Z&^V<DP7 &%D7_'U%>]_"'XP
M:'\8O"\.K:1,%F "W5D[#S;:3^ZP_D>A%=1XA\.6/BG2Y;"_B$D+CJ/O(>Q!
M[&O&XIX4PW$=#VU*T:R6DN_D_P"M#\;RO-,3D6(="O%\M_>CV\UY_F?'5%=/
MX\\!7O@;4C%,#+9R']S<@<./0^A'I7,5_)N,P5?+Z\L-B8\LX[IG[1A\12Q5
M-5:,KQ8444^"&2YFCAB0R2R,%5%Y))X %<BBY.R-VU%78P_3-/M[F:TD$D,S
MPN#D,C%2/Q%;,_@C6[:^M;22Q;[1<[A$J2(P;;][Y@2!COD\50U?0[W0IUAO
MK<PNR!U^97#*>X*D@_@:]&>#QF%3J3IRCRO5V:LSBCB<-7:A&:E=7MH[HZG1
M/C#XFT5%7[=]MC' 2[7S#_WUU_6O>_AUXGN_%_AN/4KRU2T=V*JL;$AP/XN>
MG.?RKY4L+.;4;R&UA7S)II%CC4=R3@5]@^&]'CT#0K+3XN5MXE3..I Y/XFO
MW3PWQ>9XZM5=>M*5&"M9ZZO;?71'YSQ90P>&A!4J:523OIII_P .5_''_(EZ
M[_UX3_\ HMJM>&O^1<TK_KUB_P#0!53QP?\ BC->_P"O"?\ ]%M5OPS_ ,BY
MI7_7I%_Z *_>%\1^??\ +A>OZ&E1116ASA1110 4444 %%%% !1110 4444
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M_2(C*K!A\V!P#U(^E=%/\/O$+?$SX0ZF--<V.B:9)!?S"1,6\A@*@$9R>>.
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M"S(3\LB^JG^>1VKFJ^/E%Q;B]T?U#1K4\13C5I.\7JF%%%%(V"BBB@ HHHH
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MKJ/BM[NXGC62TCW06['#R,>-X'<+WQW(Z=_HP<9KE]+^'^EV/ANST>2W$D<
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M\$_ZME'W@>./85^L7A"^U/5/#6G76LV"Z7JLL*O<V:RB40N1RNX=:\5_9O\
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MA0!G/:9[5"]AGM6L9H#_ ,M4_P"^A2>;!_SU3_OH4 8;Z;FJ[Z3[5T9> _\
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M*B^U0_\ /:/_ +Z%'VJ'_GM'_P!]"@"6BHOM4/\ SVC_ .^A1]JA_P">T?\
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M%2I24D^SN%%%%2;!1110 44'CKQ]:U/#_A76O%EY]ET72;W5KGO%90-*1[G
MX_&FDWLC.=2%*/--I+ST,N@ L0 "2>@%?1_P\_89\<^*I8IM>DM_"]@W+>=^
M^N#](U./S8?0U]7?"K]E'P+\+7CNX[$:UJZC_C_U%1(4/JB?=3Z@9]Z]"C@*
MM75JR/A\SXRRS )QIR]I/M';[]ONN?&WP7_9'\6_%4Q7U]$_AW021_I=W'B6
M4=_+C."?]XX'IFOO+X6_!CPQ\(-)^Q>'[$12N!Y]Y,=T\Y'=V^O88 ["NZ5
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MY_1_\&?\$][_ .'B>D_]";>_^!B?_$T?\/$])_Z$V]_\#$_^)KP3_ACKXO\
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M0V\_\#$_^)J];_M_:7<8_P"*1O%S_P!/B?\ Q-?.R?L>?%X,,^#V'_<1M/\
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MP&C8]%'>N>_X8I\#_P#05\0?^!$'_P 9H ^*:_3^]_X]K/\ W/Z"O%?^&*?
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M  L*Z/\ S#4_[^G_  H [>BN*'Q NO\ H')_W]/^%+_PGUU_T#E_[^'_  H
M[2BN-'CNZ/\ S#T_[^'_  IX\<7)_P"7!/\ OX?\* .OHKDU\:7!_P"7%/\
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M ->C^QQ_SU/Y?_7H S:*TO[''_/4_E_]>C^QQ_SU/Y?_ %Z ,T_=-='6=_9
M'_+4G_@-: Z4 +1110 5%<SI:V\DTK!(XU+LQZ #DFI:XOXNQZI=> ]0T_1K
M>:?4=1VV49B0L(A(P5Y&QT55W'/TH T?!?CG2/B#HYU/1IGGM!(8B9(S&P8
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M1_PD6BC_ )BMC_X$)_C1[6G_ #(.279E1-' _AJ9=+ /2IAXCT4?\Q:Q_P#
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M[D%WW-;[/%_SS7\J/L\7_/-?RJG/X@TRUM)[J;4+6&V@<QRS23*J1N.JLQ.
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M!KU_P9KUQKFE^9<Q%)(SL\S'RO[C^M?I?#V=O'+ZIB=9I;]UY^?YGR6:9?\
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MIM(B^[KG8,Y]ZTE0*,   < 4M '@NW0;'Q;JUEKN@7NH>,)]=^TV,\%L_F-
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M^1YRH$BN2"/F/8^]7-<NQI7AE5O-'M;BUD\4:B[7NIV$U[!9_.^US#'RQ;)
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M>*R=2TJQM_!_@2^O[B33;R#23"G]HZ$VI6$F9,E&559HI./O8!Q7U-Q1@>E
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M+T_2K!+RRTB."]M_&\<4$\</SQ6_VH#8AQE8]K-P.,$U]#8'I1@#M0!\[1^
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M_D>*45[7_P ,U-_T,*_^ 7_VRC_AFIO^AA7_ , O_ME'^H/$/_0/_P"31_\
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MU^F95E-+*J-H*\WN^_EZ'R.,QL\;4O+2/1=BAJ.H[<Q1'GNPK(Y]*U3H'/\
MK_\ QS_Z]']@G_GN/^^/_KT5J.)K2O*(4ZE*FK)F6JLY"@9)["MS3[ 6RAWY
MD/Z5G2:+JL-QOLM0LXDQTGLVD;/U$J_RIWV'Q)_T%M-_\%LG_P ?IX>C*D^:
M=-M_+_,BK44U:,M/G_D;M%87V'Q)_P!!?3?_  6R?_'Z/L7B3_H+Z;_X+9/_
M (_7I^WG_P ^G^'^9R<B_F7X_P"1N4;1Z5A_8O$G_07TW_P6R?\ Q^C[%XD_
MZ"^F_P#@MD_^/T>WG_SZ?X?YAR+^9?C_ )&YCVHQ[5A_8O$G_07TW_P6R?\
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M/;S_ .?;_#_,.1?S+\?\C<Q1BL/[%XD_Z"^F_P#@MD_^/T?8O$G_ $%]-_\
M!;)_\?H]O/\ Y]O\/\PY%_,OQ_R-S%&!Z5A_8O$G_07TW_P6R?\ Q^C[%XD_
MZ"^F_P#@MD_^/T>WG_SZ?X?YAR+^9?C_ )&Y@>E,FB66-HV!VL"#@D<&L;[%
MXD_Z"^F_^"V3_P"/T?8O$G_07TW_ ,%LG_Q^CV\_^?;_  _S#D7\R_'_ "'^
M&O"6E^$;22VTJV-M%+(99"\KRO(YQ\S.Y+,> .3TK9Q6']B\2?\ 07TW_P %
MLG_Q^C[%XD_Z"^F_^"V3_P"/T>WG_P ^G^'^8<B_F7X_Y&YBC'M6']B\2?\
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M:WSJ<5NUHD^]N(F8,5VYV]0#G&:T]H]*P_L7B3_H+Z;_ ."V3_X_1]B\2?\
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M !^C[%XD_P"@OIO_ (+9/_C]'MY_\^W^'^8<B_F7X_Y&[16%]B\2?]!?3?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
B*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>aciu-20231231x20f003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %Q ZL# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5?-4=PHHHK0R"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>[_JQRUZD96IT_AC^/=_,****Z#E"BBB@ HHHH **** "BBB@ HHHH ****
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M^82IROADI+;16?XF=XI\5:MX%\10Q1VD44D<>]4NX]^&)/S @\_6H?\ A?\
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M !1_=L/^_!_^*K)D^&YMQ=23ZS:16T$4,OG>7(0XDSL"@#.?\:GNOA'JENL
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M77/!QMH_M-@TCB+YO(+G>H]8W^\#[9Q4>F7MUX/U-=,OI3-I\G^HF/\  /\
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M/K5M?B-K"W@N1]G\T7)NN8>-Y39TSTQVKWC_ (4GX/\ ^@6W_@1)_P#%4?\
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MDD #V13WK"K[[5-?/T.S#+V495WTV]1J?#FSD0"YEP0<_P"API;G\'4&0?\
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M_@<?\P_LG'_\^)?^ O\ R._HK@/^%Y>$?^?^;_P&D_PH_P"%Y>$?^?\ F_\
M :3_  H_U@RC_H+I_P#@<?\ ,/[)Q_\ SXE_X"_\COZ*X#_A>7A'_G_F_P#
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MAE>V2&?3M&;RIKL#G_2Y5X<^N,D^M?3>A:MH5G':Z-IDB1);H((;=%8!548
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MCC![]/:NE5,DB_X;?_@6U_\ %O;?I?;0PY,R?VDON[>FU]NMM]2>T\ SW5O
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M'->A_K9E+_Y>/_P&7^1S_P!DXM?9_%?YGIMGK6I:<H6VU"=$' 1R)%'X-FM
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MLXK*TTK=KI+[D>_T8 .<<U\N7?Q;UF^NTN)]LDBL& $C*!@]  <"NE'[1NK
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MZ1-(A_?O^[A'JYX'Y=?PKSV*,0QHB\A0!GUKR,=.[4%ZGO9=3M&51]=/\_T
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MP0?W*=#[FO6X0:_MS#>K_P#26<.?_P#(LK>B_-'OE%%%?U<?A@4444 %%%%
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M\/5I47SRNWVTM;L4=,\:Z7J"A9+F.UG_ (HI7'Z-T(J#7]8T*^M3;SSK=O\
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MH^VQKRO03*/X3[^AK@PPD4,,^F",$>H/O7L=<1XS\-F%I-3M$RIYN8E'7_;
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MFL Q^TK&)2N.-N<=:MTDT]BG%QW04444R0HHHH **** "BBB@ HHHH ****
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MO/5**R=/\4Z7J<JQ07:&9ND;@HQ^@(&:UJ]B,XS5XNYX$X3INTU9^844459
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MC"-?F2"%8K73XA#$B !0[?,Q^N-M=#UK"?[7HFI7<T=E)?6ETPD/V<KYD;
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M4 %%%% &+XM;&E;?[TBC]:R)6BM/#,:+DSW;9('5N?Y5L^*86ETIF49\M@Y
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M/P K5CB2% D:*B#@*HP!^%/HJU&,=D92J3G\3N%%%%49A1110 4444 %%%%
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MMNLWQ(H;0-0!&1Y#_P JVJ+W6<M%_O%Y_J<?\0O@OHGQ#D^VN[V&I%0/M=N
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MNF:WHWBCP9/=,$MY?$9N[:&0GH/,\T@9]\"O<%^%/AEU#+;7+*1D$:E<X/\
MY$I1G&?PLSH8FCB4W1DG;?R.PS1FN0_X5/X:_P"?6Z_\&-S_ /'*/^%4>&O^
M?6Z_\&-S_P#'*LZ3K\T9KD/^%3^&O^?6Z_\ !C<__'*/^%3^&O\ GUNO_!C<
M_P#QR@#K\T9KD/\ A4_AK_GUNO\ P8W/_P <H_X5/X:_Y];K_P &-S_\<H Z
M_-&:Y#_A4_AK_GUNO_!C<_\ QRC_ (5/X:_Y];K_ ,&-S_\ '* .OS1FN0_X
M5/X:_P"?6Z_\&-S_ /'*/^%3^&O^?6Z_\&-S_P#'* .OS1FN0_X5/X:_Y];K
M_P &-S_\<H_X5/X:_P"?6Z_\&-S_ /'* .OS1FN0_P"%3^&O^?6Z_P#!C<__
M !RC_A4_AK_GUNO_  8W/_QR@#KZ6O.[SPCIOA7Q;X4ETQ;FW>>\EBE#7L\B
MNGV:5L%7<@\@'IVKT2@ HHHH **** "BBB@ HHHH **** "BBB@"AK&C0:S;
M>5+E64Y21?O*?45S%SX)O8LF&XAN!Z.#&?ZBNVHKGJ8>G5=Y+4ZZ6*JT5RQ>
MAYI=:1?V>3-9S*H_B0;U_-:JQ_O7"1@RR$X"*,L3]*]5I-H!S@9]:XW@5?21
MW+,G;WHZ^IYM?:9=Z7M^UQ[5(R)5Y3Z9[&JHEC_YZ*3['->ID C!&135A1/N
MHJ_04/ J_NRT".8Z>]'7U/,5D0GAL_@:EAB>X<)#&\KG@!5/^17I> *6FL%W
ME^ /,>T/Q_X!PL_AO4K8@>2+@$?>A8<>Q!-/B\-:E( 3#'%G_GI)S^@-=O16
MOU2G?=F'U^K:UD<BGA&]/WIK=/IN;_"M72?#BZ=<>?),9I0,+A=JKZULT5M'
M#TX.Z1A/%59KE;T"BBBN@Y KDO$DHM]722-=DB*K;@,[CGBNMK(UK29;R6WN
M+8A;B-ARQXQFN>O%RA[IUX:<85+RV+6F:I#JD >-AO ^9,\J:S]9T1WE%Y9?
M)<J=Q4<;CZCW_G4ESX8MYY?.C=[68\DPG S].U6-/TAK&9I&O+BX)&,2OD5+
MC*:Y9KYE*4*;YZ<ODU^ :/K":G%M;]W<IQ)&>"#ZUHUAZ_I9XOK4;+F/EBO5
MA5NSUF*?2FO'.T1(6E &<8&3Q5PFT^2>_P"9$Z:DE4I[/IV9\]_MM^/-$\%^
M#](MM3\#Z-XNN-9N?L,$WB#;'96A(SNDE()4?0CZU^?^E_#:\T3Q1:P>(EL(
M-2M+DW=CX3UJ66#2=1M\[L6EX',>#V&0#QR3Q7Z-?%+XY^"/$7@;5+#^PU\9
M-+'A=&U"$P17!]#(ZD+]>M?(WPW^"^A>(&,?Q#UNZT+P;#J#7MGX"TKS;V"(
MD8P;A@2JGNJ]?:OK,JSS+\-A9*=91[^]=OT5[K[E_B1RXG(<SJ5$UAYO_MU_
MG;^NQ]Q_LW?%#1?BS\*].UG0]%'AZVB=[233$5 EO(APRH4 5E]"*]1KQKPO
M\9/AEX*T.UT?0HFTG2[5=D-I::<Z1H/8 ?K6K_PT=X)_Y_+O_P  I/\ "ODZ
MV88.=24J<THMZ79ZD,GS)12E0E?_  L]0HK,\.>(K+Q5H]OJ>GN\EI."49T*
M$_@>:TZUC)22E%Z,\Z<)4Y.$U9K<****H@**** /G']K3XQV_A5]&\!O\/HO
M'UQXGCD"6E]=);6Y"]5#,#E_0#!].:_.O38/%6L7V@-9_8O"VDKK+V>FZEJ%
MQYATF3.#:RSX+K'Z)(N#VXK]!_VRM(\2>.](A\*Z1\*;_P 8[XQ<VGB"SU&&
MV;3;H'Y67=\V1U.#BO"]*_8X^-?CV[U2;7I/#'@Z/5;"*SU7)^W-J#+_ ,O#
M1K\JS#^^"#FOO,JKT,+A4YN,6][N_P ^6[Z>7371Z>)B83J5;)-_+]?^"?2/
M[*G[.^L_ JV\03ZMXGM=:;6YENOLFF6GV>S@?'+1KD_>]@![5ZYX]\+7/C+P
MS=:5::S=Z!/-C;?67^MCP<\<BG^ O"Q\$^#-%T%KV74CIUK';&[G^_+M&-QK
M?KXW$UI8BM*I-W;ZVM^!Z]."A%12/ #^S#K[??\ B[XI/T?'_L](?V6=7;[W
MQ8\6'UQ-C_V:OH"BN:YH?/Q_93OV^_\ %/Q>WTN<?UIO_#)DS'Y_B;XQ?_M\
M_P#KU]!T4@/GW_AD=#]_XB^+W^M[2C]D.R/W_'GBU_K?5] T4[@?/_\ PQ_I
M)^_XT\5O];[_ .M2_P##'6@'[_BOQ2_UOQ_\37??&#XF7/PTT_3[FVL8KXW,
MK1E99"FW SD8!KRW_AJO5/\ H7[/_P "G_\ B:\VMF.'P\W3J2L_1GOX3(\=
MC:2KT(7B_-+;U9J_\,;^%S][Q'XG;_M_'_Q-+_PQCX-/W]9\2-]=0'_Q%9/_
M  U7JG_0OV?_ (%/_P#$T?\ #5>J?]"_9_\ @4__ ,36']KX3^;\'_D=G^K&
M:?\ /M?^!1_S-;_ABWP*?O:CXB;ZZ@/_ (BD_P"&*? !ZW6O-]=0'_Q%+X4_
M:2U'Q%XDT[3)-$M84NIA&9%N')7/<#;7OM=V'Q5+%1<J3ND>-CLNQ&734,3&
MS:ONG^1X&/V*_AZ.KZTWUO\ _P"QJ0?L7?#H=4U9OK?G_P")KWBBNH\T\*'[
M&7PW'6UU)OK?M_A4@_8V^&@ZV%^?K?/7N-% 'B0_8Z^&0ZZ5=M];Z7_&I!^Q
M]\+QUT2<_6^F_P#BJ]IHH ^=/%O[%7A+5;K31H3/X?M8V8WC+(\\DR\8"[R0
MO?G]*]=^'/PK\.?"S2VLM L?LXDP9IW8M),P[LQZUUU% !1110 4444 %9&O
MZ\ND1".-5EO) 3'&S;54#J[G^%!W/X#FM>LNY\,Z7>:D;^>SCGNB N^3+# Z
M<$XX^E9SYFK0W-J3IJ5ZFQQNG:K)HFIV4\D++I[QF+[40<SC))?;V )R/9L]
MJ]$1Q(H92&4C(([U5U+2X-5M#;S A<Y5D.&0CH1[UF>'?"SZ%++(^H7%UN&Q
M(22L,:_[*9(!]_R K*$9TWR[K\CJK5*6(CSO22Z;W_K_ (8WZ***Z3SPHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YSXD?\D\\4
M?]@NZ_\ 1+5T=<Y\2/\ DGGBC_L%W7_HEJ -C2?^079_]<4_]!%?,WQ5^)>N
M^+_'OB2U\.:KIO@KP[X(A\O6O&EU8K<W,<D@!:"W!!(Z $#DD?0'Z9TK_D%V
M?_7%/_017QAX]L='\!:G\4O OQ#DU'0/#7C'5!K.E^*+6U:>%7)5C')@'E64
M?*>V>F0:Y:[:2/ SBI.%**3M%MW=[:I-Q3?1-VUNNUU<W/%%AXDT>?PGH?C'
MQ9;_ !2^'7CN9-.CN+NQ2"ZM)I4S#/$R]N0<]N>E>H_L?:[?ZQ\%;.UU&X:\
MFT>]NM)2X<Y:2.&0JA)_W<#\!7S.-8UCQ_XETJ+PSXKU?XO>)--1HM(E32/[
M.TG269=GVF5B!O=1R. ,@$DXP?L_X,_#2#X1_#?1O#$4WVJ6TC+7%S_SVF<E
MI'_%B<>P%94;RGS+;[^QYN5<U;%NK!/D2:NWS;\NE[N^J;W=K^=CRW]OR]U6
MQ_9<\3-HNL7>@:G->:7;0ZE93/%+ 9=0MXRP9"#T8Y /(R.]?,^G_M9>./!'
MQ ^(=_XBMWF\8>!_!EEHFJ:;>SR1Z8^I'5!"FHXX'DR130S,P (4E<C%?H;X
MB\-:3XNTI],UO3;75M.D>.1K6]A66-F1PZ,588RK*K ]B :H7WPZ\+:GJNJ:
ME>>'-*NM0U2S&GW]S/9QO)=VP)(AE)'SIR?E.17>?8GR9XI_:G^*O@S4]:\$
M!_!NO^+[+7O#^F6^N06L\>G/'J;.H26(2LR2QE-W#G<C*< U6UG]IOXUZ1XJ
MO-)$W@>9=.\9Z9X*D9]-NU^T3W=I&[7'$YV(DCY"#)8<$C&3]3>'O@=\/?"6
MB6^CZ-X*T'3-+M[Y-3BM+73XTC2Z0Y2< #_6*0,-U&!BM.;X:>$[B[FNI?#>
ME27,VH1:M)*UHA9[R-0L=P3CF1550'Z@ 4 ?&7B3]M+XBZ=X"FCM9_#\GC/1
M[W7X+V"TT2YNA>P:;($^T*GGHEM$=PWM)(2/X5;G'I/[+?Q+U;XF?&CQQK-_
M/+';ZCX1\+:M'I@N'>WM)+FWFDD$2L> 21S@$X&:]JUOX ?#7Q(UN=5\!>'-
M1^SW<U_%]JTR&0+<3',TO*_><@%CW(&>E=!X=\ ^&_",TDVB:%I^DS26T%F\
MEE;)$S0P@B&,D#E4#$*.@R<4 ?)?AO\ :Z^(=UXAT^_O_P#A$KOP]>>/=1\#
MC1]/AF&I1^4TWE73.92N0(@638 5.[(S@5_ /[3GQC\;^%OA<;NY\$:)JWQ)
M>YN-.OC8W#VNFVUM$S.CJTP,T\I *@,H4!OO8KWSX6_LM> OA=JVHZU;Z-9:
MIXCO-1O[_P#MR]LH3>1"[E:22%9 H.P;BH[XXS75ZW\%O 7B3P9:>$=4\':'
M?^&+,@VVDW%A&UM 0208T(PA&3R,=30!\50?M<?$B_\ &>F^,7NM,;1-(\$:
M_J-_X=L5E:VU.YL+PV[36[[_ +LA5"C,&V+Y@^8D&KS?M.?$/Q3X,9/%NBVV
M5U3PU=VM]:1S:6-MY>(K1-''=/(R@89)"0LBY#+P0?LBX^#/@.[N/#\\O@[0
MWF\/Q-#I+_8(\V,;#:R1<?(I'&!Q53P_\ _AMX4TFXTS1O GAW2]/N+N._EM
MK338HTDN(VW1R, O+(P!4_P]L4 ?//AS]J3XD7OCW1)+^'PR?"6H_$;4? :V
M5M:SK>A(3+Y=R93*4W#RL% F#G.1V^PP<@&N;B^&GA.$VYC\-Z4AM]2?6(2M
MH@\N]?.^Y7CB4[FR_4Y/-=+0 4444 <IXM_Y&?P;_P!A"7_TEFKJZY3Q;_R,
M_@W_ +"$O_I+-75T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/VP7;X#[^GED8P:V;CP_HNM>,]0N([&XM-2L+VT!NHKDXDW@9&S&%Q[<UWK
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M[6?SE_QKSGXD>%-;O?'&L3V^CW\\#SDI)%:NRL/4$#FN:_X0KQ#_ - '4_\
MP#D_^)K^=,PXWXCP^,JT:5!.,9-+W);)Z=3]5PW#V4U:$*DZCNTF_>6[7H>U
M_P#"X/!__/\ :S^<O^-;UGXL\.WGA:^\1'4M0M])LE=[B>>64;%098X!)./8
M5\[?\(5XA_Z .I_^ <G_ ,37JWA?P/JVN?!+Q'X>\@Z?J.H1W$,0OT>)06&
M6X)Q] :^CX3XISO-\Q^K8^DHPY6[\LEJK6U;/*SO)LNP.$]MAIMRNE\2?Y(Z
M?3OB1X(U;4=#L+3Q/+-=:W:&_P!/C6XG_?P#J^2,*.#][%=$;G1%MHK@ZX1!
M,2L<IU+Y7(." =V#^%?-C?L>>)2\@&MZ<$03VUH6>4B&U9$*0[0H^4N) P!^
MZW&>E;NA_LQ:A;Z[8:OJ^F^&8K*WGN;IM TR-Y+2W<P)'&T*O& 7+(68[5P2
M,9/-?M!^?'M&J>)/#&C6L=S=^(62"2XCM1(E\\@\Q_N*=I.,^IP*TB-*"VK'
M5Y MWQ;G^T#B7_<^;YOPS7RW\._V9M>USP[HEW?:/H&A6NRP%SIPAECEO4BF
M:21[M&CQYI#;=O(/.2!Q6[<_LIZ^(K>VA'AJ>W^>")[H2[]'B^V/,DED F ^
MQ@I7Y,%1\Q'% 'T&+G1"S*-<)96"L/[2Y!)P ?FZDU)(-*B>Y1]7D1[8 S*V
MH$&('IN^;Y<^]?.4O['EX^GN#;^'I=1:SNT:[D5M[W+W:RPRLWEY)6,,N[JI
M.!Q4$O[(/B*;4?%,D^IV-XFI B*:6Y8>>K3I(R3QBWR0 I )D?V"@F@#TKP]
MXTUK6OBG>:*%DDT%,^5+#<2,Q3G$N\-T.%Z\'?\ +]TUW&G^(_"VJ-<+:>)5
MF-O<FSDVZD1MF'6/EN6]A71Z+H]IH.DVFGV-K!96EM&L4=O;1B.*-0. J@
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M;XDGP@O@9=.B%W+I[E!]IWAO,W1AF8,!LQ&V[/8 ^[:*^"/#/[0_Q8U'X>^
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M0KBC\2/6J?!+T/O:/[B_04ZFQ_<7Z"G5^K'\UA1110 4AZ4M(>E 'QW\>/\
MDI^K?1/_ $&O/J]!^/'_ "4_5OHG_H->?5^98O\ WBIZO\S^A<K_ -QH_P"&
M/Y(ZKPS\.K_Q1IHOH+W3K.!K@6J_;;@QEY".% VG.:OI\&?$SZ9<7OV>$"$O
M^Y,A\QPIPS+A<8^I!]JR-)\:7.D:3;6$=O"\<%\M\KN6R6'\)QVK<O\ XQ:G
MJ.GS6\UE:EV+^7-YDO[H,<D! P5L=BP)%:P^JN/OWO;\?N.:L\R53]U;EO\
MA]Z^?X%*/X6:S+J%[9J]GYUH(6D)E;;^\QMP=O/7FIY/A)J<5U<POJFC*ELX
MBFN&O"(HY2>(BVS[Y]/UJY_PN:[ E==$TY+N80B>Z5I \OEXVY&<#IV%9>G_
M !(N+674A<Z99:C:7UR+QK2X+A4E!R&4J0?P/6JMA%9)O\?.WZ7,T\S:;:2M
M;MKM?KZVOY7-7PY\&]0O-8MH-9GMM+MWNFMBCW"K-*5&6\H8(;MUJK=?!SQ
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M2X10I*JJX15 4 8K5_L;QI_T,^E?^"1O_DFC^QO&G_0SZ5_X)&_^2: +M[X
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M5HU#=VD5] 89EW1D@X!(.0<CD<T 2CI2UG?V#:>MQ_X%2_\ Q5']@VOK<?\
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>BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>aciu-20231231x20f004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &* [@# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB@ HHHH **** +UAKNI:7C['J%U:X_YXS,G\C70V/Q;\6V  CUNX=1VEP_\
M,5R%% 'J%C^T1XJM<>=]CNP/^>D./_02*Z*P_:=G4J+W08W]7M[@KC\"I_G7
MAM% 'W9&_F1JV,;@#BG5%;?\>T7^X/Y5+0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% 'DW[2O_ "(MC_V$H_\ T5+7S57TK^TK_P B
M+8_]A*/_ -%2U\U4 %%%% !1110 4444 %%%% !1110 4444 %%%% 'KGAWQ
MW)X4^#6W2M5M[761J!_<YC>7RSC)V-GCCKBN/G\>ZUXIUW2I-;U1[B&"YC8!
MPL<:?,,MA0!T[UR=% 'K7Q%\6Z?;_&33]9MKF+4+*V$#L]M()%.,Y (.,UV7
MB+Q? CWVLV7Q M(+*2+?#8V]I;RW.2!\A!7=U]>G?I7SG10![!I=]HOQ$^'6
MGZ'?ZY;:'J6G3O)ONR$CE5F8Y'(&<-T]15WP)/X6\)_$XK9:\L]DEB4EO;R9
M5C,N1PC' (KQ*B@#V/X7>)I-*\+^38>)=.MYQ-F73-;Q'"%.<M')G//''Z5N
MP>*?"X^,MC>6=U8VL$=E(EU=JRQP/*1QAC@'TS7S_10!ZYX9U;1?%'@W5O">
MHZM#H\WVYKNVNI6Q%(,]&.<'OW]/2M"_\2:%X>@\%>%['58=22QU.&YNK\,/
M*0>;N/S=,<GOP!S7B=% 'MVG^(]+3]H"XU%]3M!IYC<"[,Z^4?W6!\V<=:\=
MUAUEU:]=&#HT[E64Y!&X\BJ=% 'OOB'Q-H\_Q4\%W<>JV4EI;V[+-.MPA2,[
M6X9LX'XUF>&_$.F0>-_B)/+J5I'!=03K;RO.H68DG 0Y^;\*\5HH ]^\->,;
M37_ VC6EMXHLO#5]IX\JXCO8HF$B^J^8#^GJ<U1T/X@Z=-XQU[3M5UXWUEJ%
MH+--7E@2!0R[NR@#;\Y^8^@[5X?10![E;6OA[P;\-O%6EV_B>PU2]NHRP6*9
M0&XPH49^8XZXS3M1\>Z3HFN?#Z_%W!=P6MD\-T+=Q(T.Y%7D \$>GL:\+HH
M]:\2^$_"%NNN:P_BZ.\%UNEM;.RD5I2[<@..3C)[XJ[=>(-+8?"O&HVA^Q>9
M]JQ.O[C_ %?W^?EZ'KZ5XQ10![CH/B/2H?COKNH2:G:)826[*ETTZB)CMCX#
M9P>A_*I/!?C"TU#P,FBV_B*S\.ZE974K"6]CB>.:-I&;CS 1_%VYX]Z\*HH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_#-/AS_H(ZI_W\C_ /B*/^&:?#G_ $$=4_[^1_\ Q%?G9_PNSXB?]#[XG_\
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MI\.?]!'5/^_D?_Q%?G9_PNSXB?\ 0^^)_P#P<W'_ ,71_P +L^(G_0^^)_\
MP<W'_P 71_:D/Y6'_$.\5_T$1^YGZ)_\,T^'/^@CJG_?R/\ ^(H_X9I\.?\
M01U3_OY'_P#$5^=G_"[/B)_T/OB?_P '-Q_\71_PNSXB?]#[XG_\'-Q_\71_
M:D/Y6'_$.\5_T$1^YGZ)_P##-/AS_H(ZI_W\C_\ B*/^&:?#G_01U3_OY'_\
M17YV?\+L^(G_ $/OB?\ \'-Q_P#%T?\ "[/B)_T/OB?_ ,'-Q_\ %T?VI#^5
MA_Q#O%?]!$?N9^B?_#-/AS_H(ZI_W\C_ /B*/^&:?#G_ $$=4_[^1_\ Q%;/
MB35+R#X)17T=W/'>G3K5S<I(PDW'R\G=G.3DY/O7@7_"<>(_^A@U3_P-D_\
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M]!'5/^_D?_Q%>-_\)QXC_P"A@U3_ ,#9/_BJ/^$X\1_]#!JG_@;)_P#%4?\
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M+FIQDY7M;OT[6:_$SGGL94JD(0<>9RM:S^)).]TWTZ6[=C0HHHKVSY ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "OS]N/\ CXE_WC_.OT"K\_;C
M_CXE_P!X_P Z^4S[:E\_T/TO@S?$?]N_^W$=%%%?)'Z:%%%% !1110 4444
M%%%% !1110 5ZY^S%_R46X_[!\O_ *''7D=>N?LQ?\E%N/\ L'R_^AQUWX#_
M 'JGZGB9W_R+J_\ A9\E?M$_\ES\<_\ 86G_ /0C7G=>B?M$_P#)<_'/_86G
M_P#0C7G=>C5_B2]6?H66_P"Y4/\ !'\D%%%%9'HA1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% 'ZK>*?^2!Q?\ 8,M/_:=?.-?1WBG_ )('
M%_V#+3_VG7SC7XWXH?\ (UH?]>E_Z5,_%N%/]VK?]?'^2"BBBOQT^V"BBB@
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M-<3X2_:PEU[5_#\LFH>')K+6=0CLET6T2?\ M&U65]D;NY;8Q!*[@%& >O%
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MJ'X6? ^+2-!\'7FN:EK-]?Z5IT8@TS4+A'@T^=H0LFP!021EE&YFP.E>PT4
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M?R5"E0%R0-Q^8CWKR?XQZ\NN7'Q%U*SDD6VNM!\/W$0)((#WRGIV.#7L.O\
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M?GRWZ\C/TH YSPO\>_%'C:#P/!I&A:6-1\2:3<ZBQN[F1(;8Q3!.<*68$9X
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M>5>Q,Q*EB",%=SCH<ANV*!''Z5^S]X=D\*Z=J[:E?VWBIHHKR3Q5]MD:X,I
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M5*L/?%/M_B3X8NKKP[;Q:Q;O-XAA:XTM!G-T@3>2O''R\X.#VZUS7P"B^T^
M+G4&C(M-8U2_U*W61?O037#LA(]U(/XUXG-\(O&.C66NW=CI4]Q?>"[Q$\(K
MQFYMS<R2.!Z_NIMG_;.@#W2_^+VDPZG]HM]8T^;1(+.^FN(Q#,UR\EO(B.8R
M!M**Q96X))(QP#7'V/[46C7LW@F_GFMM,T'7;&\FN3/'*\T5Q%Y&V), ;O\
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M"1;>Z@+;2=DA+(RMP02>HK;^&_A*Y\%Z#=6-U-%/)-J-Y>!H<X"S3O(HY Y
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M_P"PM/\ ^A&O.Z]&K_$EZL_0LM_W*A_@C^2"BB@ D@ 9)K(]$]D\ ?LG>/\
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M&V-EY"Y^7WKF_'GP$MY-/^%OAKPGI*2>,M9TMM2U2=KE\&-MNQV#,511B3)
M'3O7<Z%:+Y[ZV3\]?U/CZ>;Y5B(?57!<BE*+34>5<BYG)J]N731]^B/.7^/O
MC^3Q!'KC^))Y-7CL#IBWCQ1-)]G)R4)*\Y/.X_-[U@:'\0/$'AO0]9T?3=1>
MUT[64\N_A6-#YZ\\%B"1U/0CK78^+/V<_%'A6TT>]6ZTC6]-U2]73HK_ $:]
M%Q"EPQP(W( (/!Z C@]\58_X9G\5?\)IXD\,B[TEKWP_I_\ :-_.+A_)1,*0
M@;9G>0V<8QP>:R<*]];W_P _^ =T,3DZIW@X<MK[+[+2[?9DU;LWH86E_'7Q
MUHPT;['K\D)T>V>SL&\B)F@A8 ,@)0DC '7/2L>^^)'B34O"2>&;G5))=#2Y
M:\%H40#SF)+.6 W$DD]37=>#OV7/&7C;P?I?B>SETNUTC4%F99KVY:+REC8J
M2_RGJ5.,9S[59T7]DWQIK-A83"[T.QN]1C::PTR^U 17=X@YW1QD=".>2.#S
MBG[/$26SU_K_ "(>,R6C.3<J:E%ZZ*ZDG+RW7O/RU?4Y!_CAXZ?Q7;^)1XCN
MH];@MA:1W42HF(1TCVA0I7V(J'QU\9/&GQ+BM8O$OB"ZU.&V?S(86"QHCXQN
MVH -V,\XSR?6N^^#?P3TFZL/%/BKXB-<Z?X:\,2_9KJRA.V>XN1UA!!XQE<X
MZ[A@]374IX)^%7QF^'?B^_\  _A[4/".N^'+<7FVXO9+B.YB^;@[V;!.T],8
M..M6J=64=9;ZVN]?Z\SEJ8[+,/73CA[^S<8N<8QY8<UK*^CZKX4TKZGE&J_M
M"?$;6_#3:!>^+;^?2GB$+Q$J&=!QM:0#>P(X().>^:QKOXH^*+[3O#MA/JSR
M6?A]UDTR$Q1[;=E(((^7YN0/O9KO(OV4/&C>%+3Q'-<:1::5<Z:NJ++<73(5
M0J&5"NS/F$'[HS]:TYOV,O'4-T+/^T/#K:H]K]LATT:CBYF3&3L0H#QT).!D
M]:3IXB6Z9M''9%1TC*FK-[);[-[;V>K[;Z'COBOQ9JWCC7;G6=<O7U#4[D@R
MW#JJEL# X4 #@#H*[#P]^T7\2/"NA0:/I?BR\MM.@3RXH=L;F->P5F4L .V#
MQ7H_PT_9^T_Q/^S[XAU[4+:RLO$1U3['9ZAJVH/:06<:; [/\P4G<7&"I/'%
M<#J?[.?B[2?B2G@F<:?_ &FUO]K^T_:@MJ(<<R%V P!TZ9]J7LZ\+35_>[>9
M2QN4XISPM51M2;5I*-O=2NXK717MT^X\UO+R?4+N:ZNII+BYG=I)9I6+.[DY
M+$GDDDYS4->K>(/V;O%&A2^&C'>Z-K%CX@O!866HZ5>^?;&8G&UG"\=^@/0^
ME:OB#]DKQGX<TWQ#=37^@7,NA6[7EY96NH;[E8%!8R>7M!"X#$;L$XX%9^PJ
MZ^Z=RS?+THKVT==M?.WYZ'BE%%%8'LA1110!^JWBG_D@<7_8,M/_ &G7SC7T
M=XI_Y('%_P!@RT_]IU\XU^-^*'_(UH?]>E_Z5,_%N%/]VK?]?'^2"BBBOQT^
MV"BBB@ HHHH **** "BBB@ HHHH *^@OV<_^17U/_K\_]D6OGVOH+]G/_D5]
M3_Z_/_9%K]-\.O\ DH*?^&7Y'R/%7_(LGZK\SUFBBBOZV/Q Y#QM\+=#\?ZW
MX9U755N#=^'KP7UEY,NQ1)E3\PQR/E'%97COX#^$OB)XRT+Q3JMK,NM:.RM;
MSVTOE[]K!E$@Q\P!!Q]37HE%92I0E?F6_P"AZ-',<90Y/957'E32L]E+=>CN
M[GE_Q7_9O\#?&6^M[_Q#ITO]HPIY8O+.8Q2LG96/0@<]1WJYI'P#\&Z!\-=2
M\#:;ISV6AZC&T=V8I#Y\V[@LTAR2<<>U>B44O84N9SY5=FO]K9A[&&&]O+D@
MTXJ[LFM4TO+IV/-?$W[/OA/Q9\-]&\#WZ7IT/21$+81W&V7]VI5=S8YX/I7I
M)&01G'N*6BKC",7>*_I')6Q>(Q$5"K-R2;:OWE;F?J[*YQ'PN^$'A_X0V.I6
MVA+<M_:-T;NYFO)O-DDD(P26P/\ )-0O\%?#A^(VJ>-D%W#K6J61T^\\N?$4
MT10+RF.H"KS_ +(KO:*GV4$E&VBV-GF.,=6I7=5\TU:3OJUIH_+1?<CYRB_8
M'^%4;J3#J[@'.QK\X/U^6O=?"7A'2/ OAZST/0[*/3],M%VQ01]!SDDGN222
M2>I-;%%33H4J3O3BD;X[.<QS**AC*\II:I-MJ_>QYMX_^ 'A7XB>*+3Q'?'4
M=/UNVB, OM)O7M97C.1M9EY(P2/H<51T3]F;P5X<\*>*/#>GQ7UOHWB+'VRV
M^U%@N.\9()7\<]*]7HH="DY.7*KA'.,PA2C0C7ER1M97=E9W7W/5=CSCQ1\
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M8P,FT9SMS@C'6DF^,*WGBK3]!T;0;[5GO-*M]7-Y$\<<4%O-(Z!FW$'(V$D
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M%% !1110 4444 %%%% !1110 4444 ?JMXI_Y('%_P!@RT_]IU\XU]'>*?\
MD@<7_8,M/_:=?.-?C?BA_P C6A_UZ7_I4S\6X4_W:M_U\?Y(****_'3[8***
M* "BBB@ HHHH **** "BBB@ KZ"_9S_Y%?4_^OS_ -D6OGVOH+]G/_D5]3_Z
M_/\ V1:_3?#K_DH*?^&7Y'R/%7_(LGZK\SUFBBBOZV/Q ***X#XX?%J#X)^
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M(HZDDY)- '345YAKG[0&B>']1N8[K1O$!TFUNQ97.NI8?Z##(6"_,Y8,5!8
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MOO\ A6VIW.BZOY6MV%Z]SI%C8I)+=S(L)C>+YB1'\[D$LHQU[4 ?1-%>;_\
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MT:O\27JS]"RW_<J'^"/Y(****R/1"BBB@ HHHH **** "BBB@ HHHH ****
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MA'F<?+\Y]^*]CHH$?/FO_!?Q6\U^+&*PN(M3\%P^'IFEN2A@N(U;! VG<I)
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M^S%_R46X_P"P?+_Z''7?@/\ >J?J>)G?_(NK_P"%GR5^T3_R7/QS_P!A:?\
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M %%%% !7Y^W'_'Q+_O'^=?H%7Y^W'_'Q+_O'^=?*9]M2^?Z'Z7P9OB/^W?\
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MJ6#I5+S5^CM[OQ)-JS:OJDW;J<-3 8BE15><;1=NJZ[75[J_2ZU-ZBBBO9.
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MYS[TC?#OQ9XD\3:'K/C;7=)GLM F:^M;#0K"2 23[&4/(TDKDA020HQD]?<
M]6K#\;^,+'P!X3U/Q#J:S/8:?"9IEMU#2%<@?*"0">?6OE%O&FFS^(/!6K:%
M/<QW.H>*[2W-]J'B/S;ZYB>ZV2H]FGRJF"5P0, #O6KXMT&WU#X0?&K7[N:[
MNM2M]1OK2!I;N1HXH<Q_(L>[:!DD],\_2@#ZEU[5QH.C7>H&SO-0%O&9/LMA
M"9IY/9$'WC[5>1MZ*V"N1G##!'UKY?U75-4MO OQ='B6[E@^(4%J99!!<,($
MM&P83:KQA!RI/WMPY/(JUXE\.1>(]0^,>I7E[J7VC1;6VET\07\L26\@L$DW
MJJL!G< ><CVZT ?3%%?)'C[5O[0N;;4]3UNVU,IX:M)IM-EUR32;NR8HS&X@
M/^KF9NO(/*X/'!W(-<\/>./&]\OCG7K_ $?1H?#FGWFBV^H:@UB6CD1S/<%E
M91)*&503VQTH"Y]-UB:[XLMO#^K:%I\]O=32ZQ<M:P201ADC=8VD)D.1M&U&
MYYZ5\T> 4O?B3XN^'-AXDU#4KJQN?#-]*P%U) UY&ET@ADDV,"25VG/&>*](
M^"5W+<?!K53>ZC,'TN\U2SMM1N,SS6T4<KJIW'+-M4#U)Q0![517R_\  W5K
M;2_B#X=L7NX]2N]2L)]NHZ-X@>]M[P*H<S7-O)EH6XX((&6(]J^H*!A1110
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M6A10!G7WAS2=4N'GO=+LKN=X3;M+/;H[-$3DQDD9*YYQTJ0Z+IY%X#86Q%X
MMS^Y7]^ NT!^/F^7CGMQ5VB@#'O_  ;H&JFU-[H>FWAM%"VYN+2-_) Z!,CY
M0/:I=7\,:/X@6!=4TFQU)8#NA%Y;)*(SQRNX''0=/2M.B@"I_9-C]NAO/L=O
M]LAB,,=QY2^8D9P2BMC(4X' XXI;'3+/3('@L[2"TA=VD:."-45F8Y9B .I/
M)/>K5% &5I7A31-"NIKG3=&T_3KB?_6S6EJD3R=_F*@$_C6K110 4444 %%%
M% !1110!\X_M,?\ (VZ7_P!>(_\ 1CUX_7L'[3'_ "-NE_\ 7B/_ $8]>/T
M%%%% !1110 4444 6]-TF^UF?R;"SGO9L9\NWC+MCZ"I-4T'4M#95U&PN;%G
M^Z+B)H\_3(KT?X/>,-*T?1=7TF]OI-#N;UPT6J1)DKQC:3@XQU_$]*V?B'9Z
M[)\.Y FL:?XLT:.57-^ 6N8CG^\&(QV/?!H \0HKU?QKX'T32/%O@^RM++RK
M;4$B-RGFNV\LP!Y)R.O;%;>D?#;PS=?$7Q?I=S8L--T^VCD@1)I,Q$HI)!W9
M)Y)YS0!X;17K.J^%?"7BGP%J6M^&;.YTZYTMP)4FE9_-7CDY)'3GC'2KOC[P
M]X(\%Z+IX;1IY=2U&R#QLEQ)LB;'^L.6YY;ITXZ4 >,U/96-QJ5U';6D$ES<
M2'"10J69C[ =:]S\+_"_P_KOE6G_  C.IQV;6N[^VKR9H9&E]HLXQZ''^-87
MP+T$V^N:YK7DR7(TJ&1(41-[/(0> !R3@$<>M 'EVIZ1?:+<BWU"SGL9RH<1
M7$91L'H<'MP:IU[5\7]/O/$G@30O$UY8S66I0YM[N*:)HV ).,@C.,CC_>J"
M/P[X'\/^"/#&M:WIMQ<S7R%)$@G<"0Y&7;YN-H'1<9W=Z /(+>VENYDA@B>:
M5SA4C4LS'V JS:Z+J%[;7-Q;V5Q/;VPS/+'$66(?[1 X_&OH+PGX3T+P5\7[
MC3[:TD=Y[03VCO(6%N/F$B\GG/RXSDC!KG-)CT35O"_CVZTBSNM-M8K;B W<
MF"X5MQ8!L,#Z'- 'B=%>OS^$?!G@OPWHJ^(;:\O=3U:/S?/@E*_9P0.5 (!Q
MD=0<G/TK6O?@]H=W\3X-)M87MM+ATU+V:*.5BTK;V7&6)(SQ_P#6H \*HKVK
MQ]\+=)A\'W6L:=I-SX?NK)OFMI[@3"9,@;OO-@_B._%:FK>#?A]H/B/1M)N=
M'N9;C5$0+Y=S)LB)XW'YLDD_A[4 >+:-X<N=9BFF5X[:UAP'N)MQ4$]% 4,S
M'V4' Y.!S2:UX>N=$$$DC1W%K."8KF DH^.HY *L,\JP!'IR*].AGL? FKZ[
MH,#I-+:R3B"*ZG$"RK-&@ ,FY0"N.?F4D=.>*Y3QWJUK-:RV\=T+FYNKW[8Z
M)(LJVX\L*$WK\K,>Y!/"C/.: .(HKO?AOX>T[6+._EGT*_\ $-^A"PVD!:*
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M/?![5R"_L]K/9^)DO_$MU?W.O-9/<3M:Q1",VTHD4(B *%(4+C'J<DFO7Z*
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MUZ%110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!\X_M,?\C;I?\ UXC_ -&/7C]>\_'WP=K?B/Q+I\^F:9<7T*6@
M1GA3(#;V./R(KS#_ (5;XM_Z%^^_[]T <K175?\ "K?%O_0OWW_?NC_A5OBW
M_H7[[_OW0!RM%=5_PJWQ;_T+]]_W[H_X5;XM_P"A?OO^_= '*T5U7_"K?%O_
M $+]]_W[H_X5;XM_Z%^^_P"_= &EX"^(EGH&BWV@ZYIS:IHMT_F%(V >-\#)
M&?H.XQBKOB'XDZ)#X1N/#WA;1YM.M;M]UQ-=/N=AZ#D]<#DGH.GI@?\ "K?%
MO_0OWW_?NC_A5OBW_H7[[_OW0!W$?QB\-WT.B7FJZ!<7.MZ9&J1RI(!'D8^;
MK[9P1^-=!\-O%%MXH\>>-=:@@D6VFLT<0SX#$*H4@X)'.TUY/_PJWQ;_ -"_
M??\ ?NK5AX#\=Z49?L6F:M9^:NR3[.63>OH<'D4 :^O_ !*T*/P==:%X9T:;
M3%OW#W3S.&]#A3DD],=N.U4?'_Q#M/%%YX=N+*VE0Z9"J.MR!AV4@\8)XXK,
M_P"%6^+?^A?OO^_='_"K?%O_ $+]]_W[H ]'3XY^'_\ A)(=;?3]7:Z\GR7@
M,ZF"(8Y9%SR>V3CBN7B^*<&@^#)M+\/?;++4I[U[B6\<*,H6. ,$\X" \>M8
M'_"K?%O_ $+]]_W[H_X5;XM_Z%^^_P"_= &_H_Q<DN_#FN:1XHEO-4CO8ML$
MJA6:%\'GDCC.T_A63XI\;6FN^!_#>BPP31W&F!A+(X&QL_W<'/YBJW_"K?%O
M_0OWW_?NC_A5OBW_ *%^^_[]T =E>?&:P?XFVGB2"QN39QVQMI(9-HDYSR,$
MCTZU3'Q'\-Z?I?BBPTK3+VU@U6#RXE<JVU\,"6.[IR.F:YG_ (5;XM_Z%^^_
M[]T?\*M\6_\ 0OWW_?N@#UW2+.X\3>"?#LVK^$VURXMXP+.>WNE",O8R<@J.
M!D8/3\*S_B#\0E\&_%U;D0K>6XTY+2[@4\X+,Q ]QD5P>G^$/B'I,)AL;/6K
M.$G)CMY'C4GUP#5&;X9^,;B5I9=#U"61SEG="23ZDT 7/%_BCPE=Z0;/P]X<
M:RGDDWR7=TVYT']U,$__ *NW/&AXI^)NGZ[XT\.ZS#:W,=OIHC$J.%WMM;)V
MX./SK _X5;XM_P"A?OO^_='_  JWQ;_T+]]_W[H J>//$,'BOQ=J.JVT<D4%
MRZLJ2XW#"@<X)':L"NJ_X5;XM_Z%^^_[]T?\*M\6_P#0OWW_ '[H W/!?Q'T
MW1_!MYX>U2WOTBEF\Y;G3)%CD/3(8GZ=?0^U:6I_%K1[SQ%X3U&"PO+>#1U:
M.2 E6)7 "A3GD^N<5R/_  JWQ;_T+]]_W[H_X5;XM_Z%^^_[]T ;GA;XE:?H
M7C/Q-K$UM<R6^J>?Y2(%W+O<L-V3CIZ9IWA?XCZ,G@Y/#GB?2I]2L[>4R6SV
M[A67))P<D=R>0>AQBL'_ (5;XM_Z%^^_[]T?\*M\6_\ 0OWW_?N@#6^*/Q"T
MWQO8Z#;Z=8S6":<DJ&.3&T!M@4*0><;.^*K^%/'=GH'@3Q%H<T$\ESJ0Q%)&
M%V+\N/FR<_D*H_\ "K?%O_0OWW_?NC_A5OBW_H7[[_OW0!UNK_&>#5K+PA"]
MO<[]*GAN+QR%_>LB@93G_>ZXZTV/XQ6:^,?$%W-ITMWH&LHB3VLA"R#;&%SP
M<=CQGOUKE/\ A5OBW_H7[[_OW1_PJWQ;_P!"_??]^Z -OQ7\1M(E\*_\(YX8
MTJ73-.EE\ZX>X8%Y#QQP3Z#G/:D\:^-[/QYXXT*]LH)X(X1# 5G !)$F<C!/
M'-8O_"K?%O\ T+]]_P!^Z6/X8>+XG5TT&_1U(*LJ$$'U% 'L/Q'\9^&?#/CJ
M&;4]#FO-6M($EMKF%P <YP&!(Z$<'FO.M/\ BK&UCXR_M&":2]UU&6,P@;(\
MJ5 .3G ! []*R]0^'_CG5KCS[[2M4O)\!?-N-TC8'09)S5;_ (5;XM_Z%^^_
M[]T :$?Q!@MOAM8Z#;QSQZE:WHNUN,+Y8PQ88YSGIVKJ%^,'AB[O[?7[[PW-
M)XEAC $D<@$+.!@'KQ^1Q7#_ /"K?%O_ $+]]_W[H_X5;XM_Z%^^_P"_= &[
M:_%6.?PUXLM=1@FDU'6Y3(LD('EIP  <G.!C'>JNM?$"RU+P3X9T6.WN%N-+
ME#RR,%V,.?N\Y[]ZS/\ A5OBW_H7[[_OW1_PJWQ;_P!"_??]^Z .QN?C7:CQ
M^^LP6$TNF7%DMG<VTVT.P!)R,$CO^-<WXP\3>$[W25L_#OAYK&5I-\EW=-ND
M _NKR>*I?\*M\6_]"_??]^Z/^%6^+?\ H7[[_OW0!<^*OCBS\>:U9WEE!/!'
M#;+ RS@ D@DY&">.:XFNJ_X5;XM_Z%^^_P"_='_"K?%O_0OWW_?N@#E:*ZK_
M (5;XM_Z%^^_[]T?\*M\6_\ 0OWW_?N@#E:*ZK_A5OBW_H7[[_OW1_PJWQ;_
M -"_??\ ?N@#E:*ZK_A5OBW_ *%^^_[]T?\ "K?%O_0OWW_?N@#E:ZKX5_\
M)1/#_P#U]+1_PJWQ;_T+]]_W[KHOAU\._$NF>.-%N[O1;N"VBN5:25X\!1ZF
M@#ZBHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
MR_XJ_%V[^'NLVEE;Z?!=K-;^<7E<@@[B,<?2N)_X:;U/_H"VG_?UJK_M,?\
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M_H"VG_?UJ/\ AIO4_P#H"VG_ ']:O%Z* /:/^&F]3_Z MI_W]:C_ (:;U/\
MZ MI_P!_6KQ>B@#VC_AIO4_^@+:?]_6H_P"&F]3_ .@+:?\ ?UJ\7HH ]H_X
M:;U/_H"VG_?UJ/\ AIO4_P#H"VG_ ']:O%Z* /:/^&F]3_Z MI_W]:C_ (:;
MU/\ Z MI_P!_6KQ>B@#VC_AIO4_^@+:?]_6H_P"&F]3_ .@+:?\ ?UJ\7HH
M]H_X:;U/_H"VG_?UJ/\ AIO4_P#H"VG_ ']:O%Z* /:/^&F]3_Z MI_W]:C_
M (:;U/\ Z MI_P!_6KQ>B@#VC_AIO4_^@+:?]_6H_P"&F]3_ .@+:?\ ?UJ\
M7HH ]H_X:;U/_H"VG_?UJ/\ AIO4_P#H"VG_ ']:O%Z* /:/^&F]3_Z MI_W
M]:C_ (:;U/\ Z MI_P!_6KQ>B@#VC_AIO4_^@+:?]_6H_P"&F]3_ .@+:?\
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MY6NJ^%?_ "43P_\ ]?2T ?8E%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 >*?'+X=^(?&/B*PNM(T_[7!%:B-W\Z-,-O8XPS ]"
M*\X_X4;XW_Z G_DW!_\ %U]944 ?)O\ PHWQO_T!/_)N#_XNC_A1OC?_ * G
M_DW!_P#%U]944 ?)O_"C?&__ $!/_)N#_P"+H_X4;XW_ .@)_P"3<'_Q=?65
M% 'R;_PHWQO_ - 3_P FX/\ XNC_ (4;XW_Z G_DW!_\77UE10!\F_\ "C?&
M_P#T!/\ R;@_^+H_X4;XW_Z G_DW!_\ %U]944 ?)O\ PHWQO_T!/_)N#_XN
MC_A1OC?_ * G_DW!_P#%U]944 ?)O_"C?&__ $!/_)N#_P"+H_X4;XW_ .@)
M_P"3<'_Q=?65% 'R;_PHWQO_ - 3_P FX/\ XNC_ (4;XW_Z G_DW!_\77UE
M10!\F_\ "C?&_P#T!/\ R;@_^+H_X4;XW_Z G_DW!_\ %U]944 ?)O\ PHWQ
MO_T!/_)N#_XNC_A1OC?_ * G_DW!_P#%U]944 ?)O_"C?&__ $!/_)N#_P"+
MH_X4;XW_ .@)_P"3<'_Q=?65% 'R;_PHWQO_ - 3_P FX/\ XNC_ (4;XW_Z
M G_DW!_\77UE10!\F_\ "C?&_P#T!/\ R;@_^+H_X4;XW_Z G_DW!_\ %U]9
M44 ?)O\ PHWQO_T!/_)N#_XNC_A1OC?_ * G_DW!_P#%U]944 ?)O_"C?&__
M $!/_)N#_P"+H_X4;XW_ .@)_P"3<'_Q=?65% 'R;_PHWQO_ - 3_P FX/\
MXNC_ (4;XW_Z G_DW!_\77UE10!\F_\ "C?&_P#T!/\ R;@_^+H_X4;XW_Z
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
:%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>aciu-20231231x20f005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &D \L# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5@>,O ?A[XA:6-.\1Z3;:O9JV]8[A
M<[&Z94CE3[@BF^*/$6JZ');KIOAB_P#$ D#%WM)[>,18Q@'S9%)SST]*P_\
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M1E)-+9<\=.NGO:&_X3\":#X&\/#0M#TV*QT@%S]D!9T._P"]G<23GTK!\.?
MCX?^$O$/]N:1X5T^QU0$LEQ&A/ED]2BDE4Z_P@4G_"?^*/\ HFVM?^!UC_\
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M-;BYA=6<;5"Q2'YL#YS@\T ?6Y\:>'A<6T!UW3!/=-M@B^V1[I3NVX09RQW
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M@5X>_P#!E/\ _(]'VOQU_P! KP]_X,I__D>NMHH Y+[7XZ_Z!7A[_P &4_\
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M^@5X>_\ !G/_ /(]=;10!R7VOQU_T"O#W_@SG_\ D>C[7XZ_Z!7A[_P9S_\
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M\8H_X2'QI_T"-!_\&4W_ ,8KY _X;\US_H4]/_\  F3_  H_X;\US_H4]/\
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M (Q7R!_PWYKG_0IZ?_X$R?X4?\-^:Y_T*>G_ /@3)_A1_:&'_F_!A_J5G?\
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MRF_^,5KT4 2>&=6U:_DGBU:TLK65 &3[%</*I!XY+(O/![5OUAZ/_P A2?\
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MS@UVO@OP#H?P^L+FTT2TD@6ZG-S<W%S<RW5S<RD &2:>9GDD;"JN78D!0!P
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M_B:/9S_E8?7L)_S]C_X$O\SC**[/_A2WQ _Z$?Q%_P""N?\ ^)H_X4M\0/\
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M:6$$D4<LB;),AP0^0!C=G;C(&>:V9_@A:S?";3_ AU24VMG)&ZW;0@NX27S
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M(8I2ID"Q[MF6V+\VW=@8S@D5RNO_ +-GPV\40>+H=4\,0W<7BN[BU#54>XF
MDNHXQ''<1@./(E"@?O(MC9&[.[F@#YH^--AXT_9\^#_BVST[XUZWXO$7B?0$
ML_[1O4DUG3(IKJ%9HKBXCVLRRAFPK*!M.!WSZ!\;_CAX7^*7A#Q+I'A?XMW?
MP^MO">H0R>+M6M["YM+R.T1R'M[.:6$*9I'4(ICWDG  ;=M;OM+_ &/_ (2:
M/X2U'PW;>$\Z9J-];:E>-/J-W-<W-Q ZO TEP\IF8(R+A2^W QC!(KJ/C'\#
M/!7Q]\.6VA>.=*EUC2K:Y6\BMXK^XM,2J"%;=!(C'&3C)QWH ^'_ (N?M'^/
M?A3^R'HWA/4O&;Z!\3-8TO4=6@UCQ%=Q6^JQ:3%+(UJIR1OO9D\J(!1O!9V^
M\F:]W^.'Q6UF+]CSPAJ_A;Q-)#?^)VT32'\2Z=,DTL"74D44\\<G(\S!<;^J
ML<@A@"/4T_9@^&1^'MQX)N?"\>I>'YX9K=EU.[GO+D1RDEU6ZED:=,DG&UQC
MMBIM2_9L^'.L:%J>BWGAP3Z/J.EV^CSV#7EQY MH#F$1H),1.IY$J!9,@'=D
M T ?%7B3XF_$_3-,N/A'I/B7QGXJF@^(MWX<M];TW4;:WUZ\LXM/CO%@^VS
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M6R5EV,#"LOF*!R,@UZSXT\")XAT30[#3_(L%TC4K&]MXRF(U2"524 '3]WN
M]#CM7/ZS^S;\/O$%U>3:AH]U<BZ>ZD>!M6O! CW,;Q7#1Q"79&9$E<,45<[L
M]<&@#RC5_P!HWXB:AIUMHT7AW2_#/BS5M.T6_M ]VUT++[;=-"T4_P"[QY@6
M-V7 (^5L_=Y]4\*?&[PS)9ZK+KOBK2K"[BN+^9;&ZOX%ECM+:21&E6,!7,6(
M7<,0W!SN(Q70:O\ "+PIKFO-K5WILG]J-/97!N8+N:%MUH9#;XV. %7SI?E^
MZV\A@<U-=?"WPS>^!+?P;/IS2^&X$BC%BUS+AU1@RJ[[MT@) W!B=_.[.3D
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M R?_ +^1_P#Q57Z* *'V^Z_Z!D__ '\C_P#BJ/M]U_T#)_\ OY'_ /%5?HH
MH?;[K_H&3_\ ?R/_ .*H^WW7_0,G_P"_D?\ \55^B@"A]ONO^@9/_P!_(_\
MXJC[?=?] R?_ +^1_P#Q57Z* *'V^Z_Z!D__ '\C_P#BJ/M]U_T#)_\ OY'_
M /%5?HH H?;[K_H&3_\ ?R/_ .*K!TYB]L692C&1R5)!(^8^E=;7R=XQ_;*T
M/P!XLUCP]<^'M0NI]/NI(7FBE0*YW$Y //>LJE6%%7F['I8'+<7F<W3PD.=I
M7>VWSL?1U%?+/_#?7AW_ *%;5/\ O]'1_P -]>'?^A6U3_O]'7/]=P_\Q[?^
MJ>=_] [^^/\ F?4U%?+/_#?7AW_H5M4_[_1T?\-]>'?^A6U3_O\ 1T?7</\
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MWUX=_P"A6U3_ +_1T?7</_,'^J>=_P#0._OC_F?4U%?+/_#?7AW_ *%;5/\
MO]'1_P -]>'?^A6U3_O]'1]=P_\ ,'^J>=_] [^^/^9]345\L_\ #?7AW_H5
MM4_[_1T?\-]>'?\ H5M4_P"_T='UW#_S!_JGG?\ T#O[X_YGU-5.3_D+V_\
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M]]V'_KJO\ZLU6OONP_\ 75?YU9H **** "BBB@ HHHH **** )]'_P"0I/\
M]<5_]"-;E8>C_P#(4G_ZXK_Z$:W* .2\6_\ (0B_ZYC^9K$K;\6_\A"+_KF/
MYFL2@# \=W-_8^%-0NM.U&WTFXMT\]KR[@:>..-3ND)1>3\H;ITKXM^$OQDT
M_3O%^G#PQXQ\)!=9UTVTFDV'AETU&9'E;+-+O/!Z[CZYQ7W@RA@00"#P0>]?
M('A7Q%XPTOQ5I>@6>AZIIWB2/QA<27=G;Z$(M+72F9AN$X7:1MVL&#9+,<T
M?0GQRT.]U_X7:_!IVOP^%[U+9I5U:>!94@51E\@@D J"-R\CJ.F*\%_9CU:?
MQ'\1=,FU;XBZGK5U:Z([V&EW?AC^QXKV%BBFYCD+?Z2HQPV 3NSZBOI+XDKH
M[?#_ ,1CQ"SKH9L)A>M%]\0[#NV^^.E?.'[--@VH?$#2-2U!?'>KQ6.CM9:#
M?:_HBV5G:VA"D?.I/F.RJ@#'&1GCG@ ^LZ57\ME8@D YPHR?RI*=#_K4_P!X
M4 =LNL1[1_H]WT_Y]G_PI?[8C_Y][O\ \!G_ ,*O+]T?2EH H?VQ'_S[W?\
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M_A5^B@"A_;$?_/O=_P#@,_\ A1_;$?\ S[W?_@,_^%7Z* *']L1_\^]W_P"
MS_X4?VQ'_P ^]W_X#/\ X5?HH H?VQ'_ ,^]W_X#/_A1_;$?_/O=_P#@,_\
MA5^B@"A_;$?_ #[W?_@,_P#A1_;$?_/O=_\ @,_^%7Z* *']L1_\^]W_ . S
M_P"%']L1_P#/O=_^ S_X5?HH H?VQ'_S[W?_ (#/_A6/I\)>W+;D&YW."P!'
MS'K73U\Z>(/VJ_ /@K7M2T/4[F^2_LKF2*98[1F4-N/0]^M9SJ0IJ\W8[<+@
ML3CI.&%IN;6MDKZ'MOD'^_'_ -]BCR#_ 'X_^^Q7@?\ PVI\,_\ G[U'_P
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M_P" L^A/(/\ ?C_[[%'D'^_'_P!]BO _^&U/AG_S]ZC_ . +?XT?\-J?#/\
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M-Y\</#&@>%+7P[IW@>[T_0KS5-5U[3K^X:UEU$EU@-Q;GRH6,94*90 7#<D
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MW!R-XQD@'I6O?&;P[X?U+5]-E-Y<ZGIMQ:VCV5I;-)+--<(7B2(?Q$JK$]
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M:YVR_9:CATG3+87GAK1IK367U9T\*^%8]*M9 ;"ZLQ'Y2S.Q8?:BY=Y'^YM
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M'H__ "%)_P#KBO\ Z$:W* .2\6_\A"+_ *YC^9K$K;\6_P#(0B_ZYC^9K$H
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M5_UW;_T5)0 O]O:?_P _<?YT?V]I_P#S]Q_G5^B@"A_;VG_\_<?YT?V]I_\
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M*.'K8EN-&#DUV3?Y'H_V:7_GFU'V:7_GFU>9?\-'?#/_ *'+3?\ OL_X4?\
M#1WPS_Z'+3?^^S_A6?MJ?\R^\Z_[+Q__ $#S_P# 9?Y'IOV:7_GFU'V:7_GF
MU>9?\-'?#/\ Z'+3?^^S_A1_PT=\,_\ H<M-_P"^S_A1[:G_ #+[P_LO'_\
M0//_ ,!E_D>F_9I?^>;4?9I?^>;5YE_PT=\,_P#H<M-_[[/^%'_#1WPS_P"A
MRTW_ +[/^%'MJ?\ ,OO#^R\?_P! \_\ P&7^1Z;]FE_YYM1]FE_YYM7F7_#1
MWPS_ .ARTW_OL_X4?\-'?#/_ *'+3?\ OL_X4>VI_P R^\/[+Q__ $#S_P#
M9?Y'H.D64\6E6B-$RLL2@@CH<5<^S2_\\VKRC2?VB?AM!IEK')XPTU76)0RE
MSP<?2K7_  T=\,_^ARTW_OL_X4>VI_S+[P_LO'_] \__  &7^1Z;]FE_YYM1
M]FE_YYM7F7_#1WPS_P"ARTW_ +[/^%'_  T=\,_^ARTW_OL_X4>VI_S+[P_L
MO'_] \__  &7^1Z;]FE_YYM1]FE_YYM7F7_#1WPS_P"ARTW_ +[/^%'_  T=
M\,_^ARTW_OL_X4>VI_S+[P_LO'_] \__  &7^1Z;]FE_YYM1]FE_YYM7F7_#
M1WPS_P"ARTW_ +[/^%'_  T=\,_^ARTW_OL_X4>VI_S+[P_LO'_] \__  &7
M^1Z;]FE_YYM52[LIVO+)A$Q"LQ)]/E->>_\ #1WPS_Z'+3?^^S_A56Z_:)^&
MSWEFR^,--*HS%CO/'RGVH]M3_F7WA_9>/_Z!Y_\ @,O\CU?[-+_SS:C[-+_S
MS:O,O^&COAG_ -#EIO\ WV?\*/\ AH[X9_\ 0Y:;_P!]G_"CVU/^9?>']EX_
M_H'G_P" R_R/3?LTO_/-J/LTO_/-J\R_X:.^&?\ T.6F_P#?9_PH_P"&COAG
M_P!#EIO_ 'V?\*/;4_YE]X?V7C_^@>?_ (#+_(]-^S2_\\VH^S2_\\VKS+_A
MH[X9_P#0Y:;_ -]G_"C_ (:.^&?_ $.6F_\ ?9_PH]M3_F7WA_9>/_Z!Y_\
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M(UN5PGHG)>+?^0A%_P!<Q_,UB5M^+?\ D(1?]<Q_,UB4 %%%% '&_$WP#?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?^@/8?\ @,G^%'_"*Z+_ - >P_\  9/\* +']L:?_P _MM_W]7_&D_M?3_\
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M(KHO_0'L/_ 9/\*/^$5T7_H#V'_@,G^% %C^V+#_ )_K;_O\O^-']L6'_/\
M6W_?Y?\ &J__  BNB_\ 0'L/_ 9/\*/^$5T7_H#V'_@,G^% %C^V+#_G^MO^
M_P O^-']L6'_ #_6W_?Y?\:K_P#"*Z+_ - >P_\  9/\*/\ A%=%_P"@/8?^
M R?X4 6/[8L/^?ZV_P"_R_XT?VQ8?\_UM_W^7_&J_P#PBNB_] >P_P# 9/\
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MS]E_X$_\S"_X5A\,_P#H4O"?_@MMO_B:/^%8?#/_ *%+PG_X+;;_ .)KJ?\
MA&](_P"@79?^ Z?X4?\ "-Z1_P! NR_\!T_PH]G#^5!]>Q7_ #]E_P"!/_,Y
M;_A6'PS_ .A2\)_^"VV_^)H_X5A\,_\ H4O"?_@MMO\ XFNI_P"$;TC_ *!=
ME_X#I_A1_P (WI'_ $"[+_P'3_"CV</Y4'U[%?\ /V7_ ($_\SEO^%8?#/\
MZ%+PG_X+;;_XFC_A6'PS_P"A2\)_^"VV_P#B:ZG_ (1O2/\ H%V7_@.G^%'_
M  C>D?\ 0+LO_ =/\*/9P_E0?7L5_P _9?\ @3_S.6_X5A\,_P#H4O"?_@MM
MO_B:/^%8?#/_ *%+PG_X+;;_ .)KJ?\ A&](_P"@79?^ Z?X4?\ "-Z1_P!
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M+_P'3_"C_A&](_Z!=E_X#I_A0!/_ &K9?\_EO_W]7_&C^U;+_G\M_P#OZO\
MC4'_  C>D?\ 0+LO_ =/\*/^$;TC_H%V7_@.G^% $_\ :ME_S^6__?U?\:/[
M5LO^?RW_ ._J_P"-0?\ "-Z1_P! NR_\!T_PH_X1O2/^@79?^ Z?X4 3_P!J
MV7_/Y;_]_5_QJNFJ67V^0_:X,>6O/FKZGWI?^$;TC_H%V7_@.G^%5U\.Z3]O
MD']F6>/+4X^SIZGVH O_ -JV7_/Y;_\ ?U?\:/[5LO\ G\M_^_J_XU!_PC>D
M?] NR_\  =/\*/\ A&](_P"@79?^ Z?X4 3_ -JV7_/Y;_\ ?U?\:/[5LO\
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M *&KSFX,CVVH6.T1-MC<*S%\''S$X'..U8=A8:M%%"UQX@T>2;RT5U:V5@"
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M@XZ[+;7D_B#2M+TB\EGW+!I=T]R"@4 ,\C1Q[FX/\/ P,F@#H**** "BBB@
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MFWCNKK2XY5W(;ACC)'_+*3TH U**H?V%9?\ /$_]_&_QH_L*R_YXG_OXW^-
M%^BJ']A67_/$_P#?QO\ &C^PK+_GB?\ OXW^- %^BJ']A67_ #Q/_?QO\:/[
M"LO^>)_[^-_C0!?HJA_85E_SQ/\ W\;_ !H_L*R_YXG_ +^-_C0!?HJA_85E
M_P \3_W\;_&C^PK+_GB?^_C?XT 7Z*H?V%9?\\3_ -_&_P :/["LO^>)_P"_
MC?XT 7Z*H?V%9?\ /$_]_&_QH_L*R_YXG_OXW^- %^BJ']A67_/$_P#?QO\
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M[/PO_/M!_;>9?\_Y?>>7?\,Z^&/^?G4_^_R?_$4?\,Z^&/\ GYU/_O\ )_\
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M[<U+_H(77_?YO\:HT4<\NX>RI_RK[B]_;FI?]!"Z_P"_S?XT?VYJ7_00NO\
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M^55)+G&J0+Y,7,+G.WGJM $U%2^?_P!,X_RH\_\ Z9Q_E0!%14OG_P#3./\
M*CS_ /IG'^5 $5%2^?\ ],X_RH\__IG'^5 $5%2^?_TSC_*CS_\ IG'^5 $5
M4?\ F.#_ *]O_9JT_/\ ^F<?Y52^U?\ $X">3%_J,[MO/WNE %BBI?/_ .F<
M?Y4>?_TSC_*@"*BI?/\ ^F<?Y4>?_P!,X_RH BHJ7S_^F<?Y4>?_ -,X_P J
M (J*E\__ *9Q_E1Y_P#TSC_*@"*JR?\ (0E_ZYK_ #-7O/\ ^F<?Y576X_TZ
M0>5'_JU.=O/4T /HJ7S_ /IG'^5'G_\ 3./\J (J*E\__IG'^5'G_P#3./\
M*@"*BI?/_P"F<?Y4>?\ ],X_RH BHJ7S_P#IG'^5'G_],X_RH BHJ7S_ /IG
M'^5'G_\ 3./\J *-]]V'_KJO\ZLTR\N-JQ?NHSF11ROO5CS_ /IG'^5 $5%2
M^?\ ],X_RH\__IG'^5 $5%2^?_TSC_*CS_\ IG'^5 $5%2^?_P!,X_RH\_\
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MUX9M;KPGIFD3^(_#,FMZ%-H7B"[OH[:TS&##/'*Y7.UUPZ@+E2 .:^K/C/\
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M%]QXI?QGK4)?58/%5Y<R30-'-,L:K%.<Q?(02 !NR"<\5]+4 %%%% !1110
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MG_/M"_MW,O\ G\_P/+?^&</#O_00U/\ [^1__$4?\,X>'?\ H(:G_P!_(_\
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M/_GE_P"/&@"*BI?,C_YY?^/&CS(_^>7_ (\: (J*E\R/_GE_X\:/,C_YY?\
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M>3L=%##UL3+DH0<GV2;?X'644B.LB*RD,K#((Z$4M4<X4444 3Z/_P A2?\
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M1MO.W=6=:?MK?$G7O#'A*===\(>%;M_ EUXQO+W6K5C;:K,EQ/$ME;_O%,9
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M\,Z=J\XU&S;S?%TDT9D9;4B<^6,+Y0*^:3(&SB@#[XK/U'_C_P!*_P"N[?\
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M/^^&_P :-NJ?W[3_ +X;_&@"\5!.2!GZ4@C0,6"KN/4XY-4MNJ?W[3_OAO\
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MT=11_8^%[/[P_P!:LR[K[CYQ_P"&<?$O_/\ :5_W^E_^-T?\,X^)?^?[2O\
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MIX5_L;4SX$/AVZN+RUM]+TNSGLVFF(9Y6M9HVA\T,-RR[=ZDL003FN2\:_L
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M]1117TY^>!5*\_X_K#_?;_T$U=JE>?\ ']8?[[?^@F@"[1110 4444 %%%%
M!1110 53D_Y"]O\ ]<9/_0DJY5.3_D+V_P#UQD_]"2@"Y1110 4444 %%%%
M!1110 51_P"8X/\ KV_]FJ]5'_F.#_KV_P#9J +U%%% !1110 4444 %%%%
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M9Y71"B,S,I)*H2H)Z D#BKG]J^(?^@#!_P"!X_\ B*/[5\0_] &#_P #Q_\
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MX/[Q_P!FN'%X2GC(J%1M6UT/7RW,ZV5U)5:*3;5M;_HT?.__  I+QI_T!?\
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MA_PI+QI_T!?_ ":@_P#BZ^H-)@>VTJSAE7;)'"B,N<X(4 UG?VEKG_0%A_\
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M2US_ * L/_@:/_B: -NBL3^TM<_Z L/_ (&C_P")H_M+7/\ H"P_^!H_^)H
MVZ*Q/[2US_H"P_\ @:/_ (FC^TM<_P"@+#_X&C_XF@#;HK$_M+7/^@+#_P"!
MH_\ B:/[2US_ * L/_@:/_B: -NBL3^TM<_Z L/_ (&C_P")H_M+7/\ H"P_
M^!H_^)H TK[[L/\ UU7^=6:YR\U'6RL6=&A'[Q?^7P>O^[5C^TM<_P"@+#_X
M&C_XF@#;HK$_M+7/^@+#_P"!H_\ B:/[2US_ * L/_@:/_B: -NBL3^TM<_Z
M L/_ (&C_P")H_M+7/\ H"P_^!H_^)H VZ*Q/[2US_H"P_\ @:/_ (FC^TM<
M_P"@+#_X&C_XF@#;HK$_M+7/^@+#_P"!H_\ B:/[2US_ * L/_@:/_B: .BT
M?_D*3_\ 7%?_ $(UN5S'A:>\N+^Y-Y:):.(E 59?,R,GG.![UT] ')>+?^0A
M%_US'\S6)6WXM_Y"$7_7,?S-8E %/5]'L?$&F7.G:G:0W]A<H8Y[:Y0/'(IZ
MJRG@BOAGP9K*Z?\ $SPCYGPO\">&CJ6M_9[2"V\/R?VE!&DTR-('X4,AA 8\
M8\Q3BOO*OC'X7^)_'6M_$&QD\67'Q5@OSJ\O^C+X52+25A,I"9D*;DC*;<G/
MXGK0!]DW%S#9Q&6>5(8P0"\C!0"3@<GWJ0,& (((/(([UY1^TGX[\,^$/A[/
M:>(Y=(QJA\JWM]<AGDM)2K*6+^4C,-H(8=.0.17C?[/.AQ:EXBGN/!/Q>EOY
M[.>&YOO"UM:7*Z7';LV'51=%Y 2N[:0PP0.,4 ?7E.A_UJ?[PIM.A_UJ?[PH
M ]%7[H^E+7S]^VMXX^(_P^^$-IJWPY6_AD35+9=;U/1]+BU._P!/T[DRSP6L
MOR2L"$!R#A68\8WIYGIW[>6C_#_X)^ M1U3Q!IWQ2\0ZVUW%_:-O<VOAV.1+
M=CO>X%X\20S@&-3$,;F)*#:5% 'V;17R7XM_X*$:/H]K9ZAH/@/7/%>BOX4M
M?&-Y?V=Q;Q"RL99Y86WK(P+.C0GY4W$YXX!-:"_MYZ19:+XQEUGP+K^CZ[HE
MSIMK8:!))!+<ZL^H+NL1&4<HA?(R&.4&<\@K0!]245\KZM^W=;Z#I5Y:ZE\.
M->M/'FG^(].\-7O@XW5L]Q'/?*6M'297,4BNH&"&')Y..3A6W[9&N>#_ !1X
MWB\0>'-=U?4$\2Z+X>LO"4)L1)IUQ>VV[RHYT(6;Y^K.V 3P0M 'V+17RCJW
M_!0'0] ^'XU?5O"=UH_B=?$ESX7F\.:GK%A:""\@B6:3?>RRK;J@C="&+\E@
MHR2,T==_X*):1!X=T?5_#G@'6?%D5YX:O/$]TME>VR+8V]I(T=UO=GVOL*.0
M8RV\ ;0<T ?7E%?.'@#]LC_A8MSXGLM.^'>MV^JZ?HEIXATFPO;ZRA?6+*X9
MEBD5VE"0Y*CB1@<'IG@^=>)/VW->\7^#]"U3P;X=OK#7;/Q[:>&M4\/VMW8:
M@;Y7@,GE17*L\&'RF9%<;,-E@ : /M2BOG+1OC!\1_C?IL4O@/3;/P5J_AW6
MY],\5:)XE"7,L4L:1.D221,49627<60\_+AUYSZ]\2?&-UX4T[3+?3(HI]<U
MJ_CTS3TN 3&LK*SM(X!!94CCD<@$$A, C.: .OHKP'4/VM])T;Q1J.A7&FPW
M]Y;65[=PP:5JUM=74AMGB0K+;HY-N93,NP,Q/9@K<4[Q!^TAK-EK6GZ';^%H
M++6&\0PZ7>PWU\KK!:FSDOI)04&"RP0N",D*Q7E@02 >^45Q?A/Q5?\ CCX?
M:=?6=Y8Z7XAU#3XKX075N9OL?FJ'598%E5B55@I^<9(SQTKR7P1\=_&%M\,M
M.\<>+;WPK<V&L7=S!I\*J-#AC@6XD6"YEN;F[D!$D,:,(T1FW2K_  JS  ^C
MJ*\<T3]I?1]>^'MSXNMM,N#8V^AP:R8Q*C%C*[HD*D9#$E/E8<,&4CK76_#O
MQO?>*==\<Z7J$$,,OA_6$L8V@! >*2SMKI-V2?G47&TD8!*YP,XH [:L_4?^
M/_2O^N[?^BI*T*S]1_X_]*_Z[M_Z*DH T**\O_:'\>:GX,\#067AV]AT[Q7X
MCOX=$TB[G",MK+*3YER5<%6$$*RS88$$Q@$'.#YOIOQ.\2?$W0/A7IMAXQO/
M#>K:AJ^H:+XAOM&M[*2?[396\YD51<031J&DA5^$^ZXQ@&@#Z8HKR_X5^(=?
MMO&OC/P+K^K/XEFT".RO;36[B&*&YN+:Z$VU)UA1(O,1[>4;HT0%#'\N<D\9
MX"_:'\4ZP^FZ=J/A."ZU;5-9UNU@>VOQ'!%:6-TT9=R4)W!<+@9W%<\9X /H
M.BO!?!/[7/A_QUJ,=OIEK:ZA]MM+F[TZ'3-9M;FZE$*[@L\6]1;%Q]TR-M'1
MV2N8UO\ :^U&_N+_ $3PYHVD7'B;3=4T""ZCM];BOK4P7]^;9H_.C'R3*8W4
MJ0=N]6YZ$ ^H:*\/3]HW5;S5;.TL? DUQ#J&LW>@V5Q)JD48DNK<2%RXVDI&
M1$^&Y;( VX.:P=1_;8\,V5O!BSM8KV+3?[2U&RU'6;:RDA7SIH?)M_,8?:9=
MUM/A5P,*F64R*" ?1U%>*P?M*Q7^HW,MGX:N9O#=KJECI4VL2721G?=QP/"R
M0D;F ^T1ALD$=L\@:/PO^+>J:O\ #CQ?XJ\96=KI,>AZGJT3K:2^8JVUI-(N
M22!R%C.3W()X!P #UFBO!=9_:1U;P?I>B#5?",^I:Q>>&Y_%5_!I\GEQZ=;(
M\0$#,^3)+B8H,8WO&<*H)V](OQLGV7,%_HKZ%J4.KVNG&">5;@!)8_/+DH0-
MRPAV8*6"E3@L.2 >K45\UZG^T]XI3X62Z[I?@]-1U>"QL9;QS)Y<-I<WH1H(
M?*+;I=B31&0JZXR=N3P.]^+7QDN? R>#8-&ATW5KS6]:33KEI+K"6D,=O-=7
M,F%R?EAMIL>C%<YZ4 >KT5Y=X'^. \4ZQ9VNJ:#-X:M-3TEM<TNZO;J-C/9B
M6.,-*H_U+GSX6V$G[^"05(K.\;_M#-X6\3ZAI6G^%;SQ!!82:9!-=VMU$@DF
MOY1%!'$K??8%E9N0 A+9.,4 >Q45XU9_M"7.L6-K#I/A2:_\0F34Q=Z=]N2.
M&VCL;F2VFD\\KAPTJ;4 7)R<[=IKG_'G[55Q9>!-9U[P=X5N=>73M+M+NXEF
MD5!:W%VBM:PF/(,I'F1/($8;4<$%B<4 ?0M%>">$_P!K;P_XE\51Z*BV4RN]
M[;)<6VI0O<-+:1.\[O: F2&$F&8([GYMJG #J2_Q-^U"W@_P;8>(]:\.V6BV
M]]:/J4%MJWB&UM)GMA&KJ%1^7G;+ 1*"!MY<$@4 >\45\Y:G^UK_ &)XM\2P
M7VF:=:Z#:WUCHVE7-]J26?VB]DM%O9S/+)B.*-()X>.6WAE^8LH'8^%?CJ/&
MEYX N-.MH!I?B234;:;$HF,<UMGYHY5.UXR8WPP'S J1B@#URO"]6^-=IX=U
M:^TV33)IGM[B1#(L@ /S'VKW2OC'X@_\COKG_7W)_P"A4 >H?\-"V/\ T![C
M_OZO^%'_  T+8_\ 0'N/^_J_X5X?10![A_PT+8_] >X_[^K_ (4?\-"V/_0'
MN/\ OZO^%>'T4 >X?\-"V/\ T![C_OZO^%'_  T+8_\ 0'N/^_J_X5X?10![
MA_PT+8_] >X_[^K_ (4?\-"V/_0'N/\ OZO^%>'T4 >TV'Q]LK.R@@.DW#&-
M A(E7G ^E3_\-"V/_0'N/^_J_P"%>'T4 >X?\-"V/_0'N/\ OZO^%'_#0MC_
M - >X_[^K_A7A]% 'N'_  T+8_\ 0'N/^_J_X4?\-"V/_0'N/^_J_P"%>'T4
M >X?\-"V/_0'N/\ OZO^%'_#0MC_ - >X_[^K_A7A]% 'N'_  T+8_\ 0'N/
M^_J_X5!/\?;*6XMY!I-P!$Q)'FKSD$>E>+44 >X?\-"V/_0'N/\ OZO^%'_#
M0MC_ - >X_[^K_A7A]% 'N'_  T+8_\ 0'N/^_J_X4?\-"V/_0'N/^_J_P"%
M>'T4 >X?\-"V/_0'N/\ OZO^%'_#0MC_ - >X_[^K_A7A]% 'N'_  T+8_\
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M %5D_P"0A+_US7^9JS59/^0A+_US7^9H LT444 %%%% !1110 4444 %%%%
M%:^^[#_UU7^=6:K7WW8?^NJ_SJS0 4444 %%%% !1110 4444 3Z/_R%)_\
MKBO_ *$:W*P]'_Y"D_\ UQ7_ -"-;E ')>+?^0A%_P!<Q_,UB5M^+?\ D(1?
M]<Q_,UB4 0WE[;Z=:RW-W/%:VT2[I)IG"(@]23P!7Q3X$TC63\5-";[9"WB:
M/Q#+=:EXM7Q7#-:ZC8,9-MO':"8G+ H HC&W9UYY^TM3TNTUK3[BQO[:*\L[
MA#'+!,H9'4]00>HKXP\#^,](E^(?AC3;/P5X=LO& \37-GJ'AV#0G2XT^Q7=
MY=QYY 4,FP,6!PWF< 8H ^C_ -HW3]"U'X.>(T\17]QI>FK$KF\LX1-/'()%
M,>Q#]\EPHV_Q9QWKSC]EF9M5\9>+M3U_5=;NO&[VEG!<V6M:*FE-%:+O\ETB
M0D,&);+=>,<5Z/\ M&7.AVOP;\1GQ#97>HZ:T2(;:PD$<[2&11&48\*0Y4[C
MP,9->=_LQ6K:5XV\5V.OVFOGQO\ 8K2:YOM<U*&_+V9+B%$>)55<$-E2,DY.
M: /HZG0_ZU/]X4VA9$B8.[!$4Y+,< "@"Q\8?@UI_P 9M L;&ZU[Q#X7O;"X
M6[LM8\,:@;.\MG P=K%61@RDJ0ZL,'(P0"/(]8_X)\?#;5/!&B:#!JOBC2]1
MTR^N=1/B:TU",ZI=SW  N'G>2)XV\S:A.(QC8-NT9!^BE\1:5M'_ !,[/I_S
MW3_&E_X2/2?^@G9_]_T_QH \;UK]CGP3K=KK%O)J&NPQ:IX1A\&3^7=1$BSC
MFEF$H+1,?.+S/ECE3Q\HIGB7]C+P%XM;Q>^I7&M23>([738&FBNTBDT^6PCV
M6MS:LJ I,A ?+%E)&"NTE3[/_P )'I/_ $$[/_O^G^-'_"1Z3_T$[/\ [_I_
MC0!X;I'[$G@C3+#3A<:UXGUG6[?Q18>+;OQ%JNH1W&HZG=V39MDN)#%M,2KA
M-B*AVCKDECJZM^R/X/UGQUJ/BN;4M;74;_Q-IGBN6*.>$0BZL4V0HH,1/E$?
M>!)8]F6O7?\ A(])_P"@G9_]_P!/\:/^$CTG_H)V?_?]/\: /"?&'[#G@+QG
MI&NVESJ?B&RN]5\43^+5U2RNH4NK*\F@C@E2 F$J(C'$HVNKGDG=TQ<F_8R\
M$SZ=]C?5/$!#>$+[P9)*UU$TDEK=[C-.Q,1_?Y8D-]P?W#7M7_"1Z3_T$[/_
M +_I_C1_PD>D_P#03L_^_P"G^- '@NO?L*^ ?$6G7=G=:KXC1;CPQI_A42PW
MD*/%;V4HE@F4B'_7;@,D@H?[@JM+^P=X.E\.7VEMXP\<_:;S6[?Q'+K)U>-M
M0_M"&#R5G$YA)!(PQ'3<HP N5/T'_P )'I/_ $$[/_O^G^-'_"1Z3_T$[/\
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M$!=8TRZ*D@(.UE#,#Z+_ ,)'I/\ T$[/_O\ I_C1_P )'I/_ $$[/_O^G^-
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M;731?Z.+O<9XXBD:G86=V&\N06(S@ #J?^$CTG_H)V?_ '_3_&C_ (2/2?\
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M@8-?5'_"1Z3_ -!.S_[_ *?XUDZ?!));%T0LC.[*P'!!8D$4 ?*7_"%>(?\
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M!U/_ , Y/_B:^J](L;B+2K1'A=66)001R#BK?V6;_GFWY4 ?)/\ PA7B'_H
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M![3/_ R/_P"*KY-HH ^LO^$U\/?]![3/_ R/_P"*H_X37P]_T'M,_P# R/\
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MVK:SX*MM%TMHI1Y<%P)]0F>W1F *Q1FYMD5L $1 X&W ^NZ* "BBB@ HHHH
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MX4_Y\YO_  (?_&@#YNHKZ1_X4KX4_P"?.;_P(?\ QH_X4KX4_P"?.;_P(?\
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MFJ_^!C444 '_  A\7_04U7_P,:C_ (0^+_H*:K_X&-110 ?\(?%_T%-5_P#
MQJ/^$/B_Z"FJ_P#@8U%% !_PA\7_ $%-5_\  QJ/^$/B_P"@IJO_ (&-110
M?\(?%_T%-5_\#&H_X0^+_H*:K_X&-110 ?\ "'Q?]!35?_ QJ/\ A#XO^@IJ
MO_@8U%% !_PA\7_04U7_ ,#&H_X0^+_H*:K_ .!C444 '_"'Q?\ 04U7_P #
M&H_X0^+_ *"FJ_\ @8U%% !_PA\7_04U7_P,:C_A#XO^@IJO_@8U%% !_P (
M?%_T%-5_\#&IC^"K>1XV;4=49HSN4F\;@X(_D3110 __ (0^+_H*:K_X&-1_
MPA\7_04U7_P,:BB@ _X0^+_H*:K_ .!C4?\ "'Q?]!35?_ QJ** #_A#XO\
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M ,_^I_\ @6U'_"!V?_/_ *G_ .!;444 '_"!V?\ S_ZG_P"!;4?\('9_\_\
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MP@=G_P _^I_^!;4?\('9_P#/_J?_ (%M110 ?\('9_\ /_J?_@6U'_"!V?\
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M0.S_ .?_ %/_ ,"VHHH /^$#L_\ G_U/_P "VH_X0.S_ .?_ %/_ ,"VHHH
M/^$#L_\ G_U/_P "VH_X0.S_ .?_ %/_ ,"VHHH /^$#L_\ G_U/_P "VH_X
M0.S_ .?_ %/_ ,"VHHH /^$#L_\ G_U/_P "VH_X0.S_ .?_ %/_ ,"VHHH
M:_@&R?&;[4S@Y&;MJ=_P@=G_ ,_^I_\ @6U%% !_P@=G_P _^I_^!;4?\('9
M_P#/_J?_ (%M110 ?\('9_\ /_J?_@6U'_"!V?\ S_ZG_P"!;444 '_"!V?_
M #_ZG_X%M1_P@=G_ ,_^I_\ @6U%% !_P@=G_P _^I_^!;4?\('9_P#/_J?_
D (%M110!H:/X<M]$EEDBGNIFD4*?M$QDP!Z9Z=:U:** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>aciu-20231231x20f006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %  \L# 2(  A$! Q$!_\0
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M_P"$\\.?]!S3_P#P)3_&C_A//#G_ $'-/_\  E/\:.:/</8U?Y7]QO45@_\
M">>'/^@YI_\ X$I_C1_PGGAS_H.:?_X$I_C1S1[A[&K_ "O[C>HK!_X3SPY_
MT'-/_P# E/\ &C_A//#G_0<T_P#\"4_QHYH]P]C5_E?W&]16#_PGGAS_ *#F
MG_\ @2G^-'_">>'/^@YI_P#X$I_C1S1[A[&K_*_N-ZBL'_A//#G_ $'-/_\
M E/\:/\ A//#G_0<T_\ \"4_QHYH]P]C5_E?W&]16#_PGGAS_H.:?_X$I_C1
M_P )YX<_Z#FG_P#@2G^-'-'N'L:O\K^XWJ*P?^$\\.?]!S3_ /P)3_&C_A//
M#G_0<T__ ,"4_P :.:/</8U?Y7]QO45@_P#">>'/^@YI_P#X$I_C1_PGGAS_
M *#FG_\ @2G^-'-'N'L:O\K^XWJ*P?\ A//#G_0<T_\ \"4_QH_X3SPY_P!!
MS3__  )3_&CFCW#V-7^5_<;U%8/_  GGAS_H.:?_ .!*?XT?\)YX<_Z#FG_^
M!*?XT<T>X>QJ_P K^XWJ*P?^$\\.?]!S3_\ P)3_ !H_X3SPY_T'-/\ _ E/
M\:.:/</8U?Y7]QO45@_\)YX<_P"@YI__ ($I_C1_PGGAS_H.:?\ ^!*?XT<T
M>X>QJ_RO[C>HK!_X3SPY_P!!S3__  )3_&C_ (3SPY_T'-/_ / E/\:.:/</
M8U?Y7]QO45@_\)YX<_Z#FG_^!*?XT?\ ">>'/^@YI_\ X$I_C1S1[A[&K_*_
MN-ZBL'_A//#G_0<T_P#\"4_QH_X3SPY_T'-/_P# E/\ &CFCW#V-7^5_<;U%
M8/\ PGGAS_H.:?\ ^!*?XT?\)YX<_P"@YI__ ($I_C1S1[A[&K_*_N-ZBL'_
M (3SPY_T'-/_ / E/\:/^$\\.?\ 0<T__P "4_QHYH]P]C5_E?W&]16#_P )
MYX<_Z#FG_P#@2G^-'_">>'/^@YI__@2G^-'-'N'L:O\ *_N-ZBL'_A//#G_0
M<T__ ,"4_P :/^$\\.?]!S3_ /P)3_&CFCW#V-7^5_<;U%8/_">>'/\ H.:?
M_P"!*?XT?\)YX<_Z#FG_ /@2G^-'-'N'L:O\K^XWJ*P?^$\\.?\ 0<T__P "
M4_QH_P"$\\.?]!S3_P#P)3_&CFCW#V-7^5_<;U%8/_">>'/^@YI__@2G^-'_
M  GGAS_H.:?_ .!*?XT<T>X>QJ_RO[C>HK!_X3SPY_T'-/\ _ E/\:/^$\\.
M?]!S3_\ P)3_ !HYH]P]C5_E?W&]16#_ ,)YX<_Z#FG_ /@2G^-'_">>'/\
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M_P#">>'/^@YI_P#X$I_C1_PGGAS_ *#FG_\ @2G^-'-'N'L:O\K^XWJ*P?\
MA//#G_0<T_\ \"4_QH_X3SPY_P!!S3__  )3_&CFCW#V-7^5_<;U%8/_  GG
MAS_H.:?_ .!*?XT?\)YX<_Z#FG_^!*?XT<T>X>QJ_P K^XWJ*P?^$\\.?]!S
M3_\ P)3_ !H_X3SPY_T'-/\ _ E/\:.:/</8U?Y7]QO45@_\)YX<_P"@YI__
M ($I_C1_PGGAS_H.:?\ ^!*?XT<T>X>QJ_RO[C>HK!_X3SPY_P!!S3__  )3
M_&JEW\4O"%A($N?$VDV[$9 EO8U)'XFFFGLR72G%7E%HZFBN0_X6_P"!\_\
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MPR^=9WT+0S1$S2$!E8 @X(//K7L&*+"N^Y1_L73_ /GQMO\ ORO^%']BZ?\
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MXQ+B2,JA!  S@UJ^&? ?BF3PEXKUKPIH?BC0-(TC4++6?#'A_P 12RF]EF@
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M\S,%^\Q$:,509Y=@%'<UU]E8Z3J%I#<VUK:36\R"2.1(E*LI&00<<@@UX/\
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M\$US_P#$4?\ "P++_H%Z[_X)KG_XBNHHH Y?_A8%E_T"]=_\$US_ /$4?\+
MLO\ H%Z[_P"":Y_^(KJ** .7_P"%@67_ $"]=_\ !-<__$4?\+ LO^@7KO\
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M#9?] O7O_!-<_P#Q%=110!R__"P;+_H%Z]_X)KG_ .(H_P"%@V7_ $"]=_\
M!-<__$5U%% '+_\ "P++_H%Z[_X)KG_XBC_A8%E_T"]=_P#!-<__ !%=110!
MR_\ PL"R_P"@7KO_ ()KG_XBC_A8%E_T"]=_\$US_P#$5U%% '+_ /"P++_H
M%Z[_ .":Y_\ B*/^%@67_0+UW_P37/\ \17444 <O_PL"R_Z!>N_^":Y_P#B
M*/\ A8-E_P! O7O_  37/_Q%=110!R__  L"R_Z!>N_^":Y_^(H_X6#9?] O
M7O\ P37/_P 17444 <O_ ,+!LO\ H%Z]_P"":Y_^(H_X6#9?] O7O_!-<_\
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MM?\ GYA_[[%']H6O_/S#_P!]BBZ#V53^5_B13_%#2K>&25[+6E2-2S$Z1<C
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M2?\ "S=++E/L.M9 !/\ Q*+GI_WQ5NH$_P"/Z7_KFG\VH 9_PLO3?^?#6O\
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M%1CCBN%\??M8:[X&N_A_<GX=M>^'?%*Z>AOQK,2S^?= 'R;6VV%[DQ@[G/R
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M_ WQ;JWC;4->T34;%;6ZTO2--FTUKZ>Q:ZCM9+QIHVN(D9HE87,>"JL3L8$
M$&@#LKG]I+X?VMK8S-J]T\EZMT\-G%I-Y)=D6S*MQNMUA,JF,NNX,H(!R> 3
M7H.C:U8^(M)LM4TRZBOM.OH$N;:Z@8/'-$ZAE=6'!!!!!KP'X1?L[>(? OB:
MUU?5+S27$<6M@P64L\OEF^FM9(U5Y06;8(&5F8Y/RD 9*CUCX->#+OX=?"GP
MCX6OIX;F\T72K;3YIK?)C=XXPA*Y ."1QD"@#LZ*** "BBB@ HHHH *_,W]M
M'_DX/7O^N-M_Z)2OTRK\S?VT?^3@]>_ZXVW_ *)2O*S)VH_-'Z+P)%2S9IJ_
MN2_0\.HHHKYCF9_0_LX?RK[@HHHHYF'LX?RK[@HHHHNP]G#^5?<%%%%%V'LX
M?RK[@HHHHNP]G#^5?<'MVHHHHNP]G#^5?<%%%%',P]G#^5?<%'6B@478U2A_
M*ON/??V)?^2VI_V#KC_V2OT#K\_/V)/^2VK_ -@ZX_\ 9*_0.OJ<N=Z%V?SI
MQRE'-K)?904445Z9^>A1110!F7?_ ",.G?\ 7"?_ -"BK3K,N_\ D8=._P"N
M$_\ Z%%6G0 4444 %%%% !1110 4444 %%%% &9X>_X\9?\ K[N?_1\E:=9G
MA[_CQE_Z^[G_ -'R5IT %%%% !1110 4444 %%%% !69XA_X\(O^ONU_]'QU
MIUF>(?\ CPB_Z^[7_P!'QT :=%%% !1110 4444 %%%% !1110 5 G_']+_U
MS3^;5/4"?\?TO_7-/YM0!/1110 4444 %%%% !1110!%<_ZAO\^E=..IKF+G
M_4-_GTKIQU- "T444 %5[_\ X\;G_KFW\C5BJ]__ ,>-S_US;^1H \^'4TM(
M.II: /DSXX6'A;4_C#KMOH]EXZN?&:6MC<7\_A2WBEBM'3<;:5O-P-^QI%QT
M*LW!/3WKX(Z#;>&/A5X;TJSM-4L;:TM1$D&MA1=K@G/F!20#GL.,&O"?C;';
M67QKU>^\/:Q\1I?$8TRV_M6S\%6]H\-G;#>8C+YJ\L?WC 99NN,#%>\?#R]'
MB#X2:9=:#XCN-::[L"]GK6JQ*TKNP.QY44*"5) *@#[I% 'F7Q7_ &C-:^!_
MC*X37;;P_KWAVYD06=EI6H[-;A# #YK9LB;+9QM*_6O5?AM\4=%^*6D7-[I*
MWEM):2B"[L=2M7MKFUDVAMDD;#*G# ^X-?(>I>(/&/@3QK\3-6/B_P"'6E^*
MM&"O-=:CI"V][JC&$.1&6<L$QM4;<@L",#J?KSX5-%J?@C1?$+6L$6JZY86M
M_J%S%:"V>XF:!/G=>2".F"20!C- '7]Z[7PY@Z/!_P "_P#0C7%?A^%=%H6G
M:@^F1-'JAB0EL(($./F/>@#I<48K*_LW4_\ H,-_X#I1_9NI_P#08;_P'2@#
M6HK)_LW4_P#H,-_X#I1_9NI_]!AO_ =* -7%+63_ &;J?_08;_P'2C^S=3_Z
M##?^ Z4 :U)@#M65_9NI_P#08;_P'2C^S=3_ .@PW_@.E &M163_ &;J?_08
M;_P'2C^S=3_Z##?^ Z4 :U%9/]FZG_T&&_\  =*/[-U/_H,-_P" Z4 :U%9/
M]FZG_P!!AO\ P'2C^S=3_P"@PW_@.E &M163_9NI_P#08;_P'2C^S=3_ .@P
MW_@.E &M163_ &;J?_08;_P'2C^S=3_Z##?^ Z4 "_\ (TR_]>:_^AFM4#BN
M5&G:B?$LB_VJ=WV13N\A.F\\8K4&F:GC_D,-_P" Z4 :])@#M65_9NI_]!AO
M_ =*/[-U/_H,-_X#I0!JXHQ65_9NI_\ 08;_ ,!TH_LW4_\ H,-_X#I0!JT8
M%97]FZG_ -!AO_ =*/[-U/\ Z##?^ Z4 :N*,5E?V;J?_08;_P !TH_LW4_^
M@PW_ (#I0!JXHP*RO[-U/_H,-_X#I1_9NI_]!AO_  '2@#5Q1BLK^S=3_P"@
MPW_@.E']FZG_ -!AO_ =* -7%&!65_9NI_\ 08;_ ,!TH_LW4_\ H,-_X#I0
M!K45D_V;J?\ T&&_\!TH_LW4_P#H,-_X#I0!K45D_P!FZG_T&&_\!TH_LW4_
M^@PW_@.E &M163_9NI_]!AO_  '2C^S=3_Z##?\ @.E &M7@OCO]G3P5\3/'
M6M:SKME<S7Q>*,O%=/&"!"F.!Q7LG]FZG_T&&_\  =*QK)6@U/5HYF^T2B9-
MTI 7=^Z3' X'&!42A&:M-71U8;%5\'/VF&FX2[IV9XS_ ,,8_##/_(,OO_ Z
M3_&E_P"&,?AA_P! R^_\#I/\:]TWI_SR'YT;T_YY#\ZQ^K4?Y$>I_;V:_P#0
M3/\ \"9X7_PQC\,/^@9??^!TG^-'_#&/PP_Z!E]_X'2?XU[IO3_GD/SHWI_S
MR'YT?5J/\B#^WLU_Z"9_^!,\+_X8Q^&'_0,OO_ Z3_&C_AC'X8?] R^_\#I/
M\:]TWI_SR'YT;T_YY#\Z/JU'^1!_;V:_]!,__ F>%_\ #&/PP_Z!E]_X'2?X
MT?\ #&/PP_Z!E]_X'2?XU[IO3_GD/SHWI_SR'YT?5J/\B#^WLU_Z"9_^!,\+
M_P"&,?AA_P! R^_\#I/\:/\ AC'X8?\ 0,OO_ Z3_&O=-Z?\\A^=&]/^>0_.
MCZM1_D0?V]FO_03/_P "9\_ZO^QS\-+32KV>+3;T210.ZDWTAP0I([U9B_8S
M^&+Q(W]F7O(!_P"/Z3_&O:==DB&AZB6AW*+>0E=Q&1L/%6XG3RD_=#[H[T?5
MJ/\ (@_M[-?^@F?_ ($SP[_AC'X8?] R^_\  Z3_ !H_X8Q^&'_0,OO_  .D
M_P :]TWI_P \A^=&]/\ GD/SH^K4?Y$']O9K_P!!,_\ P)GA?_#&/PP_Z!E]
M_P"!TG^-'_#&/PP_Z!E]_P"!TG^->Z;T_P">0_.C>G_/,?G1]6H_R+[@_M[-
M?^@F?_@3/+_A]^SGX*^&/B :UH-E<P7XB:$/+=/(-K8SP3CM7IN*?O3_ )YC
M\Z-Z?\\A^=;1A&"M%61Y>(Q5?&3]KB)N4N[=QF*,4_>G_/(?G1O3_GD/SJSE
M&8HQ3]Z?\\A^=&]/^>0_.@#)NQ_Q4.G?]<)__0HJT\51N98O[>L 81N,$V&W
M'CF/-:.]/^>0_.@!F*,4_>G_ #R'YT;T_P">0_.@!F*,4_>G_/(?G1O3_GD/
MSH 9BC%/WI_SR'YT;T_YY#\Z &8HQ3]Z?\\A^=&]/^>0_.@!F**?O3_GD/SH
MWI_SS'YT 97AX?Z#-_U]W/\ Z/DK2Q5'0I8C92[80H%U<C&XGGSGR:T=Z?\
M/(?G0 S%&*?O3_GD/SHWI_SR'YT ,Q1BG[T_YY#\Z-Z?\\A^= #,48I^]/\
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M$!ED+(Q9>1CJ,\^T_!WP]J/P]^$/AS2?$>HQ7-_IE@JW=V9=T:[02?G/557
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M6O\ P"?_  K]2?)D_N-^5'DR?W&_*C^S*?\ ,P_XB%CO^?,?Q_S/RSE^"'Q
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M*?Y,G]QORH\F3^XWY4 ,HI_DR?W&_*CR9/[C?E0 RBG^3)_<;\J/)D_N-^5
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M<D?'"D*2!FOKGX77=QJ'PT\)W5WY_P!JGTJUDE^TP+!+O,2EM\:@*C9)RH
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M!_C-XXU?PKH*ZQ;ZE8P27<,FJ:9+:0ZA;I+Y+SVSN!YB+(0I. <GIUP >O\
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MWGU/YT;SZG\Z2B@"CX@<_P!@ZE@D'[-*<Y_V#5R%CY*<G[H[U1\0?\@'4_\
MKUE_] -78?\ 5)_NB@"3>?4_G1O/J?SI** %WGU/YT;SZG\Z2B@!=Y]3^=&\
M^I_.DHH 7>?4_G1O/J?SI** %WGU/YT;SZG\Z2B@#.NG;_A(=/&3CR)^_O%6
MEN/K^M9=W_R,.G?]<)__ $**M.@!=Y]3^=&\^I_.DHH 7>?4_G1O/J?SI**
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MR7\0OAQ\4/@;=:+IP/@>W>'5O$6E&>+_ (DVJII[V\TD?S?,DVY-P3=AXR>
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MO_\ &:/^&#O 7_09\1?^!-O_ /&:/[-K^7WA_KUD_>7_ ("?"%?H_P#LB_\
M)O?A;ZW?_I7-7'_\,&^ O^@SXB_\";?_ .,U[9\.? 6G_#'P;8>&M+GN+BQL
MO,,<EVZM(=\C2')55'5SVZ8KT,%A*E"HY3ZH^*XLXDP&<8*%#"MN2DGJK:6?
M^9TM%'XBC\17M'Y,%%'XBC\10!G^(/\ D ZG_P!>LO\ Z :NP_ZI/]T52\0?
M\@'4_P#KUE_] -78?]4G^Z* 'T4?B*/Q% !11^(H_$4 %%'XBC\10 44?B*/
MQ% !11^(H_$4 9EW_P C#IW_ %PG_P#0HJTZS+K_ )&'3_\ KA/_ .A15IT
M%%'XBC\10 44?B*/Q% !11^(H_$4 %%'XBC\10 44?B** ,SP]_QXR_]?=S_
M .CY*TZS/#__ !XR_P#7W<_^CY*T_P 10 44?B*/Q% !11^(H_$4 %%'XBC\
M10 44?B*/Q% !69XA_X\(O\ K[M?_1\=:?XBLSQ#Q8Q9X_TNU_\ 1\= &G11
M^(H_$4 %%'XBC\10 44?B*/Q% !11^(H_$4 %%'XBC\10 5 G_']+_US3^;5
M/^(J!/\ C^F_ZYI_-J )Z*/Q%'XB@ HH_$4?B* "BC\11^(H **/Q%'XB@"*
MY_U#?Y]*Z<=37,7/^H>NG'4T +1110 56U(L-.N2@!;RFP"<#IZU9JO?_P#'
MC<_]<V_D: /+_/U3)Q9V9]_M;_\ QNCS]5_Y\K/_ ,#'_P#C57QU-+0!G^?J
MO_/E9_\ @8__ ,:H\_5?^?*S_P# Q_\ XU6A10!G^?JO_/E9_P#@8_\ \:H\
M_5?^?*S_ / Q_P#XU6A10!G^?JI_Y<[/_P #'_\ C5=AH%QK8TJ'9I^GE?FP
M6OW!^\?^F-<^.M=KX<_Y \'_  +_ -"- $?VG7O^@=IW_@PD_P#C%'VG7O\
MH':=_P"#"3_XQ6O10!D?:=>_Z!VG?^#"3_XQ1]IU[_H':=_X,)/_ (Q6O10!
MD?:=>_Z!VG?^#"3_ .,4?:=>_P"@=IW_ (,)/_C%:]% &1]IU[_H':=_X,)/
M_C%'VG7O^@=IW_@PD_\ C%:]% &1]IU[_H':=_X,)/\ XQ1]IU[_ *!VG?\
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M':=_X,)/_C%'VG7O^@=IW_@PD_\ C%:]% &1]IU[_H':=_X,)/\ XQ7,+-K
MUO5S]@L=YE3</MKX!\I,8/D\\5WU>3^)OBAH7A#Q;J]GJ4TJ3L\;@1Q%ACRD
M[CZ5E4JPI*\W9&]&A5Q$N2C%R?9'1?:-9_Y\+'_P.?\ ^,T?:-9_Y\+'_P #
MG_\ C-<;_P +Z\)?\_%S_P" [4?\+Z\)?\_%S_X#M7/]=PW_ #\1W_V5CO\
MGS+[CLOM&L_\^%C_ .!S_P#QFC[1K/\ SX6/_@<__P 9KC?^%]>$O^?BY_\
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MF;G_ %#?Y]*Z<=30 M%%% !5>_\ ^/&Y_P"N;?R-6*KW_P#QXW/_ %S;^1H
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M'6G65]_:S2W-Q;6MQ?R265C+<$&XDMX"=D3R$#<0.:Z]OA;HC?%>+XB&.?\
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MFEI**^&M8_9+KN%%%% <R[A1110',NXM%)10',NXM)110',NXIZ9[U]O6_\
MQ[Q?[H_E7Q">5K[>M^8(_P#='\J^KR)?Q/D?FG&+O[&WF24445]8?F84444
M%%%% !1110 4444 9EW_ ,C#IW_7"?\ ]"BK3K,N_P#D8=._ZX3_ /H45:=
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MP^WB(3FUROF^7DKOV]=N1C.,9H Z.BL?_A#]%_Z!EM_WP*/^$/T7_H&6W_?
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MT %%%% !1110 4444 %%%% !1110!F>'O^/&7_K[N?\ T?)6G69X>_X\9?\
MK[N?_1\E:= !1110 4444 %%%% !1110 5F>(?\ CPB_Z^[7_P!'QUIUF>(?
M^/"+_K[M?_1\= &G1110 4444 %%%% !1110 4444 %0)_Q_2_\ 7-/YM4]0
M)_Q_2_\ 7-/YM0!/1110 4444 %%%% !1110!%<_ZAO\^E=..IKF+G_4-_GT
MKIQU- "T444 %5[_ /X\;G_KFW\C5BJ]_P#\>-S_ -<V_D: //AU-##<I4Y
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M_P"^XO\ XN@#3V$GM^%&RLS^V+S_ * MY_WW%_\ %T?VQ>?] 6\_[[B_^+H
MT]I]J-G6LS^V+S_H"WG_ 'W%_P#%T?VQ>?\ 0%O/^^XO_BZ $UKPKIOB&?2I
M]0M_M$NEW8OK-O,9?+F"L@;Y2,_*[#!R.>F<5J;3@CCVK,_MB\_Z MY_WW%_
M\71_;%Y_T!;S_ON+_P"+H T]A[$4;,G-9G]L7G_0%O/^^XO_ (NC^V+S_H"W
MG_?<7_Q= &IL[<8I0,"LK^V+S_H"WG_?<7_Q=']L7G_0%O/^^XO_ (N@#6HK
M)_MB\_Z MY_WW%_\71_;%Y_T!;S_ +[B_P#BZ -:BLG^V+S_ * MY_WW%_\
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MJ[#_ *I/]T57UV)&T/409D0&VD!8@X'RGD\5;B1?*3]XI^4=C_A0 44_8O\
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M./M5P<@'_GL^1T[=*T=B_P#/1?R/^% #**?L7_GHOY'_  HV+_ST7\C_ (4
M,HI^Q?\ GHOY'_"C8O\ ST7\C_A0 RBG[%_YZ+^1_P *-B_\]%_(_P"% #**
M?L7_ )Z+^1_PHV+_ ,]%_(_X4 ,K,\0_\>$7_7W:_P#H^.M;8O\ ST7\C_A6
M=KT2-91!ID0?:K8Y8'_GLAQT[]* +U%/V+_ST7\C_A1L7_GHOY'_  H 913]
MB_\ /1?R/^%&Q?\ GHOY'_"@!E%/V+_ST7\C_A1L7_GHOY'_  H 913]B_\
M/1?R/^%&Q?\ GHOY'_"@!E%/V+_ST7\C_A1L7_GHOY'_  H 94"?\?TO_7-/
MYM5K8O\ ST7\C_A4*QJ+R4^:O^K3C!]6]J 'T4_8O_/1?R/^%&Q?^>B_D?\
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M]E\&_M ^/[C]JZ_^%WB72/#,.ES:=/J=I%I5U*^H6%NCA8I+IG_=R>=DD+&
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M]Y4VMU937$\L;G:Q#,R'Y64H",D ]GQ1BEHH 3%&*6B@!,48I:* $Q1BEHH
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MG^Z*I>(/^0#J?_7K+_Z :NP_ZI/]T4 /Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@
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M,8Y7B?;SCS*S7WGQMFC-?97_  A?A[_H Z;_ . D?^%'_"%^'O\ H Z9_P"
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M?]?=K_Z/CH TZ*** "BBB@ HHHH **** "BBB@ J!/\ C^E_ZYI_-JGJ!/\
MC]E_ZYI_-J )Z*** "BBB@ HHHH **** (KG_4-_GTKIQU-<Q<_ZEJZ<=30
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MB@"CH,P:QEQ#&@^U7(PHQ_RV<9^IQ6CY@_N+^59/A[_CQE_Z^[G_ -'R5IT
M/\P?W%_*CS!_<7\J910 _P P?W%_*CS!_<7\J910 _S!_<7\J/,']Q?RIE%
M#_,']Q?RH\P?W%_*F44 /\P?W%_*L[7I@EC$?*C;_2K88(X_UZ<_AG-7JS/$
M/_'A%_U]VO\ Z/CH UO,']Q?RH\P?W%_*F44 /\ ,']Q?RH\P?W%_*F44 /\
MP?W%_*CS!_<7\J910 _S!_<7\J/,']Q?RIE% #_,']Q?RH\P?W%_*F44 /\
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MCQ%\2OCS\(OB!?:;,=5\-37'@RTMYAS<7%EH]Q).P&3]^:0>^,9YX'J_A?\
M:F^(EUX=UB]L/B4GC+4I_ ^M:WK&G)I$$!\'ZA!;,\$?" \2?)LFW$[<],U^
MAT6D64+JT=K C*YD4K&H*L1@L..I]:2/1K&(SE+.W0W (FVQ*/,!_O<<]3UH
M ^"/%7Q6^(/@6T^$$'BK]H"X\-V/C#1;_6=0\07>B:>%MG6&S:&!!Y.Q5#/)
MAFR3YA!YVXX9/'_Q,\9^*)?B!!XHD\*>+K#X*2ZS-?1Z7$YOA;ZA=/'F*52L
M:RA$8X7(#'&*_0C7?A)H'B/Q[X<\6WL4DFH:#9W5C:6^5^SF.X,?F;T*G)'E
M)C!&.>#VZIM+M6))MH3F/R3F,<Q_W/\ =]NE 'YW^//VMOB-&D^HMX^A\&ZO
M:>&=%U;P_P"%5T:.<>+;FY@62=0[*7(#G8%A*E<Y-:TOQ<^-WB3XER6]M\0W
M\-VE]X\;P@-'.D6DZZ?&VFBY+K(4W.\;A@NXD'/.>*^^'T:RD>!VM(&>  1,
MT8)CQ_=]/PIXTRU#[_LT._?YN[RQG?C&[/KCC/6@#\L?&/[;/QRC^'7PBN+3
M5HK&?6-"N+RYUR273;!-0O8KMX1&[W:^2!M5&:.+:YW$J0!7T'X8USXM?'KX
MI3>&=4\8GP;9V_@K1M8U+0+*SM+F"XN[CS1/$9L,PA8I@['SC&".<_8TFAZ?
M+;Q026-L\$1S'&T*E4/J!C JREI#'.TRQ()F 5I H#$#H"?2@#YO^&WP0\0_
M"/X;>/#K^HQW\D^DW$43G4YM0F=1&[9>:2*(A02P2,*0BG 8U\1>#[#7_AEX
M&_9<\+7#7.I>#O$_BO0/$VD74O/V"Y)(O+0G'W6>194'^TX[9/ZXR()$*L 5
M(P01D&JQTJT,<"&U@*0$-"OEC$9'0J.Q^E 'QM^R'\>?AWI_P+'@*Z\::-!X
MT?4=>B70I+M!=L[W]VZ*(\YR5(8>Q%?.7P'\$3Z7:_LW7OB/PIX&\":%>W]M
MJ%AX_P!"L_\ B9W]Q&6*6%[,438T_(R2ZMC&=Q%?J>GAS2XI_/CTVS28$D2+
M;H&!]<XJ=M*LW@C@-K ;>,@I$8EVJ1T(&,#% 'YR_ []F?Q-\5YM/UZTT+X>
MZ%I&F_$&^U5O%\,4O_"4RK;ZG*S0%A"%VL5V#,I 7!P>E:_AK6?"NG?M@1:W
M\+O"O]H^((K#7H=2\*(IL=42_5E;SK^ZD>16BG8;8=[*J Y7()"_H1#:16R;
M(HTB7);:BA1DG).!WSS3(M.MH+F2XCMXDN).'E5 '<>A/4T ?GW^U'XZ^+OQ
MJU/POX5T?X37MIXK\-V,_BG4=&M_$-F[:9<AC'ITYG!$<I!663RE^8@CT-8/
M[5_C7P)\6]'^&WQ4GUGPU)JMWX1:X7P9XWLICI]_#(P:6.UNE7$-ZLB-&I1M
M_'&!R?TD6SB6X:=8T65P%9PHW,!T!/?%5Y-"TZ6&*&2PM9(8CF.-H5*H?88X
MH ^!H]:^%6H_$*QUKX]^'[71/"M_X!TD^%=-\7))=6MEE&-W!&TH.;E3Y0W'
M$I R.<U]>?LUQ>&(?@=X13P9;:Q:>%OL>=/@U[S1>)%N; <2DL!_='W0NT+\
MN*]!O-*M-055NK:&Y53E1-&'"GVSTJS&@C4*H 4#  ["@#+7_D:)?^O-?_0S
M7FOQG;3[7QY\.KWQ(8T\(6]W<M<279'V2*]\H"T>;/R@ ^9M9N Y7H=M>E+_
M ,C1+_UYK_Z&:OW%I#>0M%/$DT3##)(H92/<&@#Y0^+.G_#SXBZ]I>C^&+17
MCOO&&F'5=9TP_P"ARW?V6[$;1.K;3<1".-F=1D?NLL2N%P)=4MO%'Q.^(D/B
M[6D\,ZQI%KX8MI[^YL_M%JM]!<ZB\3S)@+Y,@\N3+%5&]?F! K[*@TNTM84B
MAMH8H4;>D<<854;U [&EDTVVF\[S((I/.4++N0'S .@;U'/0T >(_ [Q':?\
M)[XWM9H]!GO'CTZ:?Q+X<G==.U&5UEC6+RF=D2X3ROFV,2R20YZ #/\ CSX<
MOM>^//PPFTAD77],T77K_33(=JO.DFG?NV.#A74M&3C@.3SBO;[[PGIU]9V]
MIY"VUO!<QW:QVRB-3(C!E)Q[@$XZXK4>W225)2JF1 0KD#(!QD ^^!^0H ^%
M]*^,/BR]U1X/#FH6G@W1-;UG7+ZZU'6;Y-.:.[B-LJVAFDM+J-77?,2A0%O*
M.UL*0>\?X[^*=$\%^*!XA\5:-#XHBL=&ET_^S"IM[AYE0326HE17D1VW'YE^
M7/;%?4D^CV5U$T4]I;S1,_F&.2)2I;^]@CK[T3Z/97,R2S6D$LL8VH[Q*64>
M@..* /E[2_B)XOET72]0U?QW>:;IFM^.-6T2[U/[+:I'I-G;37P@5&,.U&=H
M(8C)-N'(  8Y,GPX\<'Q'XC\*>(?B3<VDFEQ6^K6>BZSJ4*Q6T\L5_+#'=9(
M$:236B1LK#;N5Y-@"L17U ^FVLMN\$EO#) Y):)HP48DY)(Z'GGZTD^F6MS:
M_9IK>&6V  $+Q@H .G!XXH ^5=0UN\B^+26OPZUQM!\&^)?$UI9W5[I5O \,
MUU]@O9;QK?>C)EO*M2TBJ07!SN.[-#1/BGXEO[G4K1O'DOB6^;Q+K>A7?AN2
M"UC-KI\*7)2<[(U?<OEQ_/G:V\+C=S7UW'I]O%'#&D$21P\Q*J ",XQ\H[<$
M]/6L'P?\/-(\$6]]'I\1=KR]NKZ66<*S[[B9II%# #Y-SM@>GKUH ^5]-^(7
MB+X/_#GPG#<>*]8U&QU+P;:W$:16U@LEG<&XM8$\AY%CC12+C!:X9E4+N.<8
M,_PV^*'CWQUXM3PI<>.3%''XGN+&74=(FM+^1[8:7#<+&LYLXHV(E9OG$(XR
MN6QFOKV32[6:+RY+:&2/9Y>QHP1M_NX/;@<>U);Z39V@406L,.WD>7&%P<8X
MQTXXH XCX$^(]3\4_#73KW6;PZAJ23W5K)=,BHTWE7$D0=@H"AB$!. !GL.E
M>AU'%;QP*%C147).U1@<]:DH **** "BBB@ HHHH *^/_P!H'_DJ6I_]<X?_
M $6*^P*^8_C#\.?$/BKXB:I=Z7I_VJW41(7\Z-.?+4_Q,/6O$S:G.I0M!7U/
MK>&*]+#X[GK245RO5Z'BM%=Q_P *4\:?] 7_ ,FH?_BZ/^%*>-/^@+_Y-0?_
M !=?&_5,1_S[?W,_5_[4P'_/^/\ X$CAZ*[C_A2GC3_H"_\ DU!_\71_PI3Q
MI_T!?_)J'_XNCZIB/^?;^YA_:F!_Y_Q_\"1P_>OJKX(_\DQT;ZS_ /H^2O#?
M^%*>-/\ H"G_ ,"H?_BZ^@/A;H=[X<\"Z;IVHP_9[R'S=\>X-C,KL.02.A'>
MO=R>A5I5VYQ:T[>A\=Q5C<-B<'"-&HI/FZ-/HSJZ***^P/RP**** ,_Q!_R
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MZF@!:*** "J]_DV-P "28V&!]*L44 >??V==#_EWE_[X-']GW7_/M+_WP:]
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M16U10!B_\)=IW_3Y_P" $_\ \11_PEVG?]/G_@!/_P#$5M44 8O_  EVG?\
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MK:HH Q?^$NT[_I\_\ )__B*/^$NT[_I\_P# "?\ ^(K:HH Q?^$NT[_I\_\
M "?_ .(H_P"$NT[_ *?/_ "?_P"(K:HH Q?^$NT[_I\_\ )__B*/^$NT[_I\
M_P# "?\ ^(K:HH Q?^$NT[_I\_\  "?_ .(H_P"$NT[_ *?/_ "?_P"(K:HH
M Q?^$NT[_I\_\ )__B*/^$NT[_I\_P# "?\ ^(K:HH Q?^$NT[_I\_\  "?_
M .(H_P"$NT[_ *?/_ "?_P"(K:HH Q?^$NT[_I\_\ )__B*/^$NT[_I\_P#
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MF_\ B*/[?M?^>=[_ . ,W_Q%=I10!Q?]OVO_ #SO?_ &;_XBC^W[7_GG>_\
M@#-_\17:44 >=7.M6[:Y8R".\V+#,"?L4W4F/'\'L:T?[?M?^>=[_P" ,_\
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M^>=[_P" ,W_Q%=I10!Q?]OVO_/.]_P# &;_XBC^W[7_GG>_^ ,W_ ,17:44
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>O6QB8".\Y_Z<IO7_ '*[=3G\:=28Q0 M%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>aciu-20231231x20f007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &5 [@# 2(  A$! Q$!_\0
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M@Z4M,S"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M##\0*O5\I^$?%.N^-U^&'A74O$NK:78:EH\U]<:C;7C1W5Y,KD"/SB=W &2
M><UK^+KOQ/-\/[+2O#'Q!C\33VNL/;7$D5XMA?7,*X/V=9F)W2+GEUY((X)S
MFHXB\;V,:F1N%54W42N^J=DKM7O9+=>1]*T5XW^SSXI&I+KFB7-[XA;5-.D1
MI]/\12+/+:AUR LXYD4]<MS["L'XYZK+K/C2?1--O/&UW=Z?IZW4]CX8U.'2
MK:V#,VV2>Y9E;G:>.0 IX%=,)\\;GA8O#2PE:5&6Z_)]3Z"HKY-\#:[XD^)O
M@/X26.H>*]:L7U2[U*UOKW3;_9<3Q1*VP&9,;F&T?O ,GDCDUF^*M4^)'B+X
M@>+=,T*/7KNS\)R1V=H]KXPATSR56%&$]S'(C&XW$[BTAVG!&!S5G&?8E%<G
MX;US5YOA=8ZMJ,<$FMG2Q<3);2++$\PCR=K(2I!(ZJ2*\H^$T-RJ^!O&%W\4
M=0O;[Q.A-WHVH3">TN9&C+F&VB!Q;M$002H/W2&'- 'NNMZW:>'=-DO[YY$M
MHRH8Q0O*PRP4?*@)/)'0<=>E4+SQOHMB==62]WRZ'"L^H101/-) C*67Y$!9
MB0K$*H)XZ<BOFZT37(/@YXA\;2>,?$D^JMJ<UA#$^IRBWMX5U,*-J _>V@KN
M/.TE>E'B?1I_#7B#]I#7].U[7+>_M-(BDA"ZC($C=[5W#  \,A4!".5!.* /
MJJWG2Z@CFC)*2*&7*D'!&1P>14E?.%U_:?Q'\:>([&_\>:QX.@\,Z/875B=/
MO# LC2P>8]U<#/[Y%8;2K';\I[GF3XJ>()/$EYH^DZ?K'C#6KY=%CU&2/PA>
MQ:3;LC$A;F6=G#*K;6PH+ #)- 'NNI^*]+T?7-'T>\NO)U'5VE2RA\MV\XQI
MO<;@"JX7GYB,]N:S?&WQ-\-_#M]-CU[4'M9M1D,5I!#:RW$LS  MA(E9L#(R
M2,#(R:^;?@YXLUCQE=_!&]UN^FU&]BU37K3[1<3+-(T<<+J@:11B0@ #?_%@
M'G->A?%7P9'K'[2/PNOFU?6+5OLNH2B&SOWAB!A$# !!QA]V''\8"@]* />/
MI17R1-K>NVWPCM_BXGQ UF3Q1)=(#H37BG3G8W 0V(M<;0P4E=P^?/.:])^&
MFG:CXH^,/C_5-0\1ZX;70M:%O9:.E\ZV@#V,!8/'G# %LA3\H(+ 9)H ]?NM
M<L[/5['3)7D%Y>I(\*K"[*0@!;+A=J]1@,1GMFHM9\3Z9X?NM*M]0N?L\VJ7
M0L[1?+9O-FV,^W*@A?E1CEL#CKTKS+XP>*M7\-?$/PRVF7%P5&BZS<FR21O*
MGDCBC:/>@.&(.<9Z9.*\RTS3)(=2^"6O7'CO4_$][XAU.._N+.^NUFA\TV<Q
M9[=./*5"Y0JH ^89 (H ^KJ*^)-'\9_%WQ$)/'5G9:@CIJ3Q%[KQA:V^EQJL
MY0V[V+J K8&W)8/DYSTKL_&&G>(]67XS^)8?'7B32G\+7KRZ7I]G?,EM&T=I
M%*0Z<[T8D#8?E')QECD ^D[GQ1I=I?WUE)=K]LLK47MQ;HK/(D)+ /M4$D$H
MP ')P>*Q=9^+7A70+_0K&^U&6.]UQ%DL+:.RN)9)$)4;F5(R8U^8 E]H!.#7
MBG]BS1?%7QQXG37-934&\$V]\(EOW$"R2)./EC' "E-R@?=9F(ZU'HW@<^,_
MC#X(U"\\1^([>ZG\"1W4C6FJRQ;G#P(<X.<-O+,/XF )Y% 'T]5'1M:M-?LC
M=V3R/ )'BS+"\3;D8JWRNH.,@\]#U&17@G@CQIX@\0Z]X/\ AW=:A>-K7AZY
MN9/$5\DSK)/!:X2W:1LY(N#+&Y!/(5LYYK&L7U_QW_P@&D2>+M?TN'4-5U^.
M\GT^^>.>:**4A(]^21MP IZJ.F* /J*BOEG2-5U[5$TWP#?>--8M-/?Q7J.D
M-K:76S49H((5EAA^T=0[,Q&X?,0N.]>@? *[OAXM^)NDW'B:^\46FE:I;VMK
M<WUQYK1H+6,LF>F0V0Q &6!)Y)H ]FJUIG_'VOT-5:M:9_Q]K]#0!LT444 %
M%%% !1110 4444 %%%% !129'K2T %%%)F@!:*2EH *CG_U+_0U)4<PS$X]J
M!K<_.:.K4?6LZWNEDE>(G#JQ7ZX-:,76OD9Q<79G],8>O3KT8RI2NK%J*KT/
M2J,57H?NBA!,OP5>@ZBJ,%7H.HK5'GS-2#K^%:EOVK+@^]^%:D'45O \FJ:<
M'05K6O;ZUDP=!6M:]OK70CQZQK6GW:U;7[WX5E6GW:U;7[P^E="/$K&Q;=!6
MM;=/QK)MN@K5MNGXUO$\2J:UO_#6M;=!63;_ ,-:UMT%=$3QJI8[4FX^M.KB
MOB=\5_#7P@T:#5?$]^UC9SSBWC*1-*SN5+8"J">BDYQ3E)17-)Z&%&C4Q$U2
MHQ<I/9+5L[/<0*,UQWBCXI>'/!_@9?&&I:@5\/ND4BW<,;2[ED(V$!02<[A7
M6PRK+"DBG*L 10I)[,)TJD(\THM*[5_-;KU5]23=SBC)KF(_B)H<WC^7P:MT
M_P#;T5H+Y[?RF"B$DJ#OQMZCIG-=,.,FFFGL34IU*5N>+5U=7ZI[/T%+4HZ5
MB^*_$UIX0T2;5+U+J2VA*AEL[:2XE.6 &$0%CR>PXZUKPR"2)'R<,,C(P:+J
M]A<LN7G:T)**3(HR/6F2!.#2;N:#US7.:!X\T?Q)XAU[1+"X>74-$E2*]C:-
ME$;.NY0"1AN/2I<DM&7&$IIRBKI;^70Z6BDR/6EJB HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH 0]*_/S_@H)_R5S1?^P+'_ .CIJ_0,]*_/S_@H)_R5
MS1?^P+'_ .CIJ\W,/X#^7YGW?!/_ ".J?I+\CYCAD\F:.0<E&#?E7MNJ?M'^
M,OBKXI\.:9J%VEEHR7]L!IUD"D;8D7&\YRV,9YXSVKP^M[P%_P CSX>_["$'
M_HQ:^;I5)0=D]V?ON8X/#XBFZU6"E*,96;Z:=#[B_P""@.1\&M#S_P!!V'_T
MGN*_/\=*_0'_ (*!?\D:T+U&NP_^D]Q7Y_5V9C_'^1\KP+_R)U_BE^A]-_L$
M?\E'\0_]@@_^CHZ^U=?T"P\4Z-=:5JELMWI]TFR:!B0'7.<9&#VKXJ_8(_Y*
M/XA_[!!_]'1U]J^(-87P]HE[J36EW?BVB,GV6P@:>>4CHJ(O+$__ %S@9->Q
M@%?#I'Y?QK)PSN<HNS2C^1E:K\./#>MQ:+'?:5%<)HS*U@&9A]G*@ 8(.3T'
M!S5+Q5\'?!?C?5X]5USP[9:A?Q@ 3R+RP'0-C&X>QS7/:%\='O/%*:#KG@_6
M/"][<6<U[9F^>"1;A(@"XS%(VQ@"#AL&LWP=^TO9>*KWPSY_A37=&TCQ&S0Z
M;J]ZD?DS3*I8QX5RR_=;#$ -MR.*[^2+Z(^*6*Q$6G&HU;S[[_>>E7?@G1+W
M6M*U6;3HFU#2HVBLI02OD(P *J!QC '4=JDT3PEI'AN]U2ZTVR2UN-3G^TW;
MJ2?-DQC<02<?A7B?B7]H&Z\1_P#"-OH.C:WI^A:AXCL[.V\1,L8M;]//"2*H
M#%U5@&PS* V.#7KOQ)\=VOPR\#ZOXGOK>:ZM--B$LD-OC>P+!?ER<=Z?*D[I
M$NM5<>5R;7K\_P RSJ'@70M5UU]9N].CFU-[)M.:X+,";=B28\ XP23[^]4V
M^%_A=M(T32SI$1L-%F6XT^$,V()%S@CG)ZGKGK7G\O[24B7M_IR_#_Q*^KV]
MHNI1V&V --8MN_TC<9-JC*$;&(?/&W-:U_\ 'NUG31(_#/AO5_%U_JFFIJZV
MNGK''Y%J_"O(\K*JDG("YR2#@<4N2/8KZQ6224WIY[';:YX&T+Q)K.E:KJ>G
M17FHZ4Y>SN')#0L<9(P>>@ZBJ?C/X7>%?B%+:2^(=$MM4FM23#)*IW+GMD$9
M'L<CVKA[W]I72AH_AN[TSP]K6K7VMWMQIL>E10I'=6]U""7BE5V 4@C&2<#J
M>*GA^,%GXITC2[F2TUOP_>Q>)8M%NM/#1+)'<9_U<K?,KQ$$$E#R",&APB[W
M6XHXBM%IQFU;1:[>ATS?!CP2?#MSX?/ARS_L>XN3=-98.P2D ;E&?DZ #;BH
M['X(^!],\-W^@6OART@TJ_*M=0H6!FVL&7<^=QP0".:\^\(_'W4--TWQ[J/B
MW1-3@M-,U]].T]8EAFDG=O+2.TCCC8L7R<Y(P?,Z\''4Z5\<UDEU:SUWPKK'
MA?5K'39-62QU#RF^U6Z?>:.2-V0D' *DY&1GK1R1[(T>,Q+_ .7C[[O?N=?X
MB\ >'_%ECIMEJVF17UKITJ36L<A8>4ZC"D8/858\6>#=$\<:2VF:[IL&IV)8
M,(9UR%8="#U! )&1SS7FT7Q=/B6X\#W=QH_B+PW9ZQK"0:<6E@5;]&M990TJ
M99A%A<[3M;(7MFH- _::M-<N+"8^$-=M-"N]4;1EUJ98C MT)&C5=H<N5++C
M<%P"<9S3Y8]C-5ZJY??>FVNUSU'PMX0T7P1I":7H6G0Z98*Q;R85P"3U))R2
M?<^U9OC'X7>%/B!=VESXAT.UU2>T_P!3),#D#.=IQU7/8Y'7BN"\3?M,V7AU
M=5O5\*:YJ'AZPO?[-;7+=8OL\ER)!&R %]^T,2-^W;D8S7LQ('?BCEBURM:"
M5>K&I[52?,^M]3C;'X-^#-,@TR&UT&""+3;QK^T1&<"&<XRX^;V''3 Z50N_
MV?\ X=WU]>WDWA2P>YO6WS2!6!W;MVY<'Y3GNN._K7G'Q)_:$N]0\/._AW1M
M;L=,?6K33[;Q.(T%M<.+R..9%&XN%($B[RH4D8SFNLU3XS:9X*F\422IK&KW
M::]#I%OI[20X>YDMT=8X2=JI'C)S(WWL\\@5/LX=C98W%)W567WF7\6/@KX@
M\7^-XM=TNW\*W\<=N(HAK=K();=AT8-'GS,=0'Z5U_@3X+Z-X3\(^%=)OD75
MKOP\YGMKME*;)B22X /OQG--A^,D%GX*U3Q#X@\.ZSX;.GR+"]C>0K)).[8$
M8@:,LDNXL%&TG!X.,&H_"7QG37=8FTG5_#6K^&=3%K)>VUO=B.X^UQ(0'\MH
M&<%QN7*?>^8<<U*HP4N:VIT5,SQ-2C&@Y6BNVG2WY-G5VG@?0K#5M8U.'385
MO=754OY3EOM"A=H#*3C&./I67X4^#W@OP/JTNIZ%X>L].U"3(,\2'<H/4+DG
M8#Z+CTKE]-^/DC^)]"TK6O!.O^&K;7)OL^GW^HB';))M+!7C60R1D@'[ZBE\
M,_'^/Q9K<<6F^$->NM EO7L$UV!(I(A(CF-B\2N940,K#>R #&:MPB];'']9
MKV:YWKOKV-N3X#^ )O$9UU_"VGG4S+Y_F^6=OF9SNV9VYSSG'7FM#Q!\)_"7
MBG6_[8U/1+>ZU3R&MC='<KF-E*E201GY21SZUROB?]H&TT#6=7M[3PWJ^MZ9
MHLABU75+'RO*M6"AG 1G#RE01NV*V.E>GZ??V^JV%M>VDRW%K<1K-%*AR'1@
M"K#V((HY(]D5];Q%[^T?WG+:K\'_  =K?ABP\/7V@6MUI&G_ /'I;R;CY/\
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M^BM$TR/1-&L-.BCAABM((X%CMHS'$H50H"*2=J\<#)P,5=HH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "K
M6F?\?:_0U5JUIG_'VOT- &S1110 4444 %%%% !1110 4F!2T4 )M%&T4M%
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MK_T,>D_^!L?_ ,51_P +&\*_]#'I/_@;'_\ %5Q?5<)V7WGU'^M/$'_/Q_\
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MJ/\ A+K;_GVNO^^5_P#BJW?^$=B_N?I0?#<7]S]* ,'_ (2^V_Y];K_OA?\
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M10 4444 (:^7?VH?E\=6&.,Z>G_HQZ^HC7R[^U%_R/6G_P#8/3_T8]>+F_\
MNC^1]7PQ_P C.'H_R/'<T9I*DBMY9VVQ1/(WHBDU\$KO8_;'9:L9FC-/FMI;
M<XEB>(^CJ5/ZU'0[K<2LU='KO[-H_P"*JU7_ *\3_P"C$KZ&Q7SS^S;_ ,C5
MJO\ UY'_ -&)7T!=WD%A;27%S,D$$8W/)(P55'J2:^]RA_[(F_,_%>)U?-))
M=H_D38HQ6##X]\-W,J11:[I\DCD*J+<H2Q/0#FM[I7KQG&7PNY\Q.E4I:3BU
MZABC%!XK-'B7220!J5J2;C[* )EYF_YY]?O>W6J<DMR8PE*_*KFEBBBBFM2
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M^AH V:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IK_<-.IK_=-
MUN?F;?<ZO>?]=I/_ $(U:M>@JK??\A:\_P"NTG_H1JU:]!7GGV4=C7MJUK?[
MM9-M6O:]!43CS1:._"5G0K1J+H:$-7H.HJC!5ZWZBO*1^BR:DKHU(/O?A6I!
MU%9<'7\*U(.HK:!Y=8TX.@K6M>WUK)@Z"M:U[?6NA'CUC6M/NBM:V^\*R+3H
M*[KP;H/VQ_M<Z_N5/R _Q'_ZU=,%S.Q\]BZL:,'*1K>'-!VQI<W*\GE$/;W-
M=,!P*%&.U+TKO2MHCXJK5E5ES2%HHHJC(**** "BBB@ HHHH **** "BBB@
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MO7U\U_D>J\PP7+.'+H_+RDOU1PFE^/O$CZ]H=PUU/<:3J-T8 T]K%#$XSUC
M)?\ %CVIFFOK-J/'M_I>JQV"V-]+<&(P*_FE5R0Q/0$# P!WYKM[/X2:%8SV
M<L;WQ:RE$MLKW3,L/.2J@\!3W%+=?";0[NYOIF:]C:]E\VY6*Z9%E_V6 X*^
MWO26&Q-M?S\O\R_[0P*NH*RLOL[VE?5>FAQDWBR0^,;'Q T(,H\,-<F(# +;
MF./I4WA/Q[XEN-:T4WD=Y<6FHG$HN+..*.//(,3*=S 9'7M7H1\$Z2=6BO\
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MHV?-HO/U._ZYE\DTX;M=/-=?2Y@)K'B32/$?A&UN];6_MM4+/,HMT0_<SM!
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M>!_B%=_$KX@/<Z-?@>#['1[:9XUB0FYNKH>8F6(++Y<2C*@CF49SBO4*\V^
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M'6NMHH *:_W33J:_W30-'YFWW_(6O/\ KM)_Z$:M6O056U!=FL7JGG$\@_\
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M$OG#,V>"/[WZ5Y>949U\.X4U=Z'T&0XJE@\=&M7=HI/\CY3HKW?_ (95O?\
MH/P_^ Q_^*H_X95O?^A@@_\  8__ !5?(_V7B_Y/Q1^I_P"LF5_\_?P?^1X1
M17N__#*M[_T,$'_@,?\ XJC_ (95O?\ H8(?_ 8__%4O[+Q?\GXH7^LF5_\
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M#@T5SI\6R ?\@]C_ -M/_K4P^,)!_P PY_\ OY_]:@#I<<T=?>N9_P"$R?\
MZ!S_ /?S_P"M3?\ A-)/^@:__?W_ .M0!U%!KE_^$TD_Z!K_ /?W_P"M1_PF
MDG_0-?\ [^__ %J .H_'-%<Q_P )G)_T#7_[^_\ UJ/^$SD_Z!K_ /?W_P"M
M0!T]%<Q_PF4G_0.?_O[_ /6IP\82'_F'/_W\_P#K4 =+17.?\)=)_P! ]_\
MOY_]:E_X2N0_\N#?]_/_ *U '145@+XHD;_EP;_OY_\ 6IZ^))&_Y<7'_;0?
MX4 ;E%8PU^0_\N3?]]C_  J1=:E;_ES8?\#_ /K4 :M%9RZK(W_+LW_?7_UJ
MD6_D;_EW/_?7_P!:@"[15=;J0_\ +$_G4BR2-_RRQ^- $E%"JY_@-2"!V[8H
M CHJP+-C[4X6+'^(?E0!5HJXNFL?XP/PIW]EM_ST'Y4 4:*O_P!E'_GI^G_U
MZ!I+9_UGZ4 4**T/[(;_ )Z?I1_9#?\ /7_QV@#/JUIG_'VOT-3?V0W_ #U_
M\=J6UT\V\P<ONP.F* +U%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4U_N&G4U_NF@:/S/U([M:OCZW$A_\ 'C5BUZ"JVH?\A>\_Z[O_ .A&K-KT
M%>>?8PV1KVW2M>UK(MNE:]K0;&K;_P!*UK7HE9-O_2M:UZ)2 U8XQ(N._8U/
M&IC;!'(J.VZUI1PB88/7L:SG#FU6YWX;%NC[DOA-'P[IS:OJUI9KUE<*?IW_
M $KZ1MK=+6".*,!410J@=@*\D^#NA[]3N;^496!/+C_WCU/Y#]:]?'2NO#PY
M8W?4^;SO$JM74([+\P[TM%%=1\X%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "&L/6O&F
MA^'+E+?4M1AM)W7>J29R5R1G]#6X:^=OVAQ_Q6%C_P!>:_\ H;U\CQ1G%;(L
MNEC:,5)II6=[:^ECV<GP,,QQD</4;2=]O(]>_P"%J>%/^@W;?K_A1_PM3PI_
MT&[?]?\ "OD^EQ7XI_Q%+,_^?$/_ ";_ #/T+_4S"?\ /V7X?Y'U?_PM3PI_
MT&[;]?\ "D_X6IX4_P"@W;?K_A7R@3CO1]X4?\12S/\ Y\0_\F_S#_4W"?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% "'I7SO^T/\ \CA9?]>2_P#H;U]$'I7SO^T/_P CA9?]>2_^AO7YEXB?
M\B&?^*/YGUG"W_(TAZ/\CRP?=]:?!!+<-B*-I6_NH,G]*DL+4WMY;VX98S+(
ML>YC@#)QDGTKZ)U#7?#WPF\-6GV.WBNY9,1KY)&Z0XY9F_SVK^>\AR&&;0JX
MC$UU2I4]Y-7?HD?J.9YG+ RA2HT^><]E_P $^<YX);9PLL3Q-Z.I%,SFOIO3
M+O1_C#X4N'ELO*;+1'> 7B;&0RG\17S9J%HVGZA<VKD%X)6B8CU4D?TJ^(>'
M5DU.CB:%55:-57C*UG\T1E>:O,)5*-6')4ANCT/X#?\ (PZC_P!>?_M1:]MK
MQ+X#?\C#J/\ UY_^U%KVFXN(K6!YIY$AAC&YY)&"JH]23TK^@O#K_DGZ?^*?
MYGYGQ5_R-)^D?R)**S['Q#I6IS>59ZG9W<N,[()T=L?0&K1O+=6E4SQAH5W2
M N,H/4^@X/6OTP^1)J*H)X@TN18&74K1EN&*0D3J1(W<+SR?I5^@ HHHH **
M*16#9VD'!P<'H: %HJ*>[@M8Y))IHX4C 9VD<*%!Z$D]*E!R,CD'O0 4444
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MQUJW@OQ#XNO]6\*Z5I5I<7EC:IJ$<L*1M%=-$)II0QXV*1L"\G'S#-==X/\
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M 9P<9K3T_P"&=K8ZKX8U!]4U*_NM!M[B".6^G,\EQYP&]I';DGCC& .F, 4
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M)258!MP()&: ,.W_ &A_%]S\.=>O;32/[2U/2]2MK1M6CT:\A@:UE W70M)
M)6\L[@T8)R<8.#7H'P(^)-S\0=/U077B30?$;VLBA9](MY[29 1DK/;39:(Y
M&!\QSZ"M"+X270\,W.GS^.O%%QJL]REW_;)O0DL;J,*J1*HB6/'6/9M8DD@U
M;\ ?"Y?!6J:EJ][KNH>)-<OXXX)M0U!8D;RD+%$"1(B#!=CG&3GK0!W%%%%
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M4*,#@"@!::_W33J1ONF@:/S-U#_D+WG_ %W?_P!"JS:]!52]YU6[_P"NS_\
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MBK17R)R_*L/EO-[%.[W;U;/3/@/SXBU'_KS_ /:BU[;7B/P&/_%0ZC_UZ?\
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M+(:1))YS6ABRA?&-V#T/O6CIGA'1]&T231['3+:VTN161[2.,"-PPPV1WR*
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M=/;5KVM8EA+YB^_>MNUZ5W)IJZ,VK&K;_P!*UK7HE9-O_2M>PC::2*-1EF8
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M1*]F\0Z_I_A70[[6-5N5L]-L86N+BX8$B.-1EF( ).!Z"@#0HKRWPO\ M/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OF[]I;_ )'33O\
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M^D;M%%%>X?E@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P"O+_VHE>B_&'P==^/_ (8^(M T^2**_O;4K;M/D1^8"&4,1D@$J 2 <9H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB@ HHHH **** "BBB@ JUIG_ !]K]#56K6F?\?:_0T ;-%%% !1110 4444
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M-+)TRQ/8=AV [ "L^B@#W[]C?_D?-:_[!I_]&I7UU7R+^QO_ ,CYK7_8-/\
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MNWE<6BBBO5.0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M0G%> _M!?L\ZU\7?%MAJVF:G8V45O9+;%+K?NW"1VR-JGCYQ^5='\?/$>IZ
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M-7W_ $,6H#_ME;?_ !JCV]3_ )]/[X_YAR1_F7X_Y %8_P )_.G")S_#2?\
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M#)417&628X X^7CD>E 'KUQ<1VL1DED2*,8R[M@#/ Y/O3U.1FN4^*NIG2?
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M+ \<Y!XQ6;XWNM7T[QIXNNUNK.XTRWT".4Z?=6AD5^9  26P?F!)^7D8';-
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M%XTC*#'H<,WZ>E=)CFES0(Y[3/ NFZ/KBZK:&XBN/L<=B\8F;RI(T^X63H6
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M (&R_P#Q5'_",P_\_FH?^!LO_P 5111]5H]OQ?\ F'M)=P_X1F'_ )_=0_\
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M_P #9?\ XJBBE]5H]OQ?^8>TEW#_ (1F'_G]U#_P-E_^*H_X1F'_ )_-0_\
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M?\(S#_S^ZA_X&R__ !5'_",P_P#/[J'_ (&R_P#Q5%%'U6CV_%_YA[27</\
MA&8?^?S4/_ V7_XJC_A&8?\ G]U#_P #9?\ XJBBG]5H]OQ?^8>TEW#_ (1F
M'_G\U#_P-E_^*H_X1F'_ )_-0_\  V7_ .*HHI?5:/;\7_F'M)=P_P"$9A_Y
M_=0_\#9?_BJ/^$9A_P"?W4/_  -E_P#BJ**?U6CV_%_YA[27</\ A&8?^?W4
M/_ V7_XJC_A&8?\ G]U#_P #9?\ XJBBE]5H]OQ?^8>TEW#_ (1F'_G\U#_P
M-E_^*H_X1F'_ )_-0_\  V7_ .*HHH^JT>WXO_,/:2[A_P (S#_S^ZA_X&R_
M_%4?\(S#_P _NH?^!LO_ ,5111]5H]OQ?^8>TEW#_A&8?^?W4/\ P-E_^*H_
MX1F'_G\U#_P-E_\ BJ**/JM'M^+_ ,P]I+N'_",P_P#/YJ'_ (&R_P#Q5'_"
M,P_\_NH?^!LO_P 5113^JT>WXO\ S#VDNX?\(S#_ ,_NH?\ @;+_ /%4?\(S
M#_S^ZA_X&R__ !5%%+ZK1[?B_P#,/:2[A_PC,/\ S^ZA_P"!LO\ \51_PC,/
M_/YJ'_@;+_\ %444?5:/;\7_ )A[27</^$9A_P"?S4/_  -E_P#BJ/\ A&8?
M^?W4/_ V7_XJBBCZK1[?B_\ ,/:2[A_PC,/_ #^:A_X&R_\ Q5'_  C,/_/[
MJ'_@;+_\5111]5H]OQ?^8>TEW#_A&8?^?W4/_ V7_P"*H_X1F'_G]U#_ ,#9
M?_BJ**?U6CV_%_YA[27</^$9A_Y_-0_\#9?_ (JC_A&8?^?W4/\ P-E_^*HH
MI?5:/;\7_F'M)=P_X1F'_G\U#_P-E_\ BJ/^$9A_Y_=0_P# V7_XJBBG]5H]
MOQ?^8>TEW#_A&8?^?W4/_ V7_P"*H_X1F'_G\U#_ ,#9?_BJ**7U6CV_%_YA
M[27</^$9A_Y_-0_\#9?_ (JC_A&8?^?W4/\ P-E_^*HHH^JT>WXO_,/:2[A_
MPC,/_/[J'_@;+_\ %4?\(S#_ ,_NH?\ @;+_ /%444?5:/;\7_F'M)=P_P"$
M9A_Y_=0_\#9?_BJ/^$9A_P"?S4/_  -E_P#BJ**/JM'M^+_S#VDNX?\ ",P_
M\_FH?^!LO_Q5'_",P_\ /[J'_@;+_P#%444?5:/;\7_F'M)=P_X1F'_G]U#_
M ,#9?_BJ/^$9A_Y_-0_\#9?_ (JBBCZK1[?B_P#,/:2[A_PC,/\ S^ZA_P"!
MLO\ \51_PC,/_/YJ'_@;+_\ %444_JM'M^+_ ,P]I+N'_",P_P#/[J'_ (&R
M_P#Q5'_",P_\_NH?^!LO_P 5112^JT>WXO\ S#VDNX?\(S#_ ,_NH?\ @;+_
M /%4?\(S#_S^:A_X&R__ !5%%'U6CV_%_P"8>TEW#_A&8?\ G]U#_P #9?\
MXJC_ (1F'_G\U#_P-E_^*HHH^JT>WXO_ ##VDNX?\(S#_P _FH?^!LO_ ,51
M_P (S#_S^ZA_X&R__%444?5:/;\7_F'M)=P_X1F'_G]U#_P-E_\ BJ/^$9A_
MY_=0_P# V7_XJBBG]5H]OQ?^8>TEW#_A&8?^?W4/_ V7_P"*J[8:<FG*RI+/
E+N.29YGD(^FXG%%%5"A3IR4HK\6)RDUJ7:6BBNHR"BBBF!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>aciu-20231231x20f008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %3 \(# 2(  A$! Q$!_\0
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MNO\ X[7IU%'L:7\J^X/[4Q__ $$3_P# I?YGF/\ PS5\.?\ H7C_ .!]U_\
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M^X/[4Q__ $$3_P# I?YGF/\ PS5\.?\ H7C_ .!]U_\ ':/^&:OAS_T+Q_\
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M (9J^'/_ $+Q_P# ^Z_^.T?\,U?#G_H7C_X'W7_QVO3J*/8TOY5]P?VIC_\
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M5]P?VIC_ /H(G_X%+_,\Q_X9J^'/_0O'_P #[K_X[1_PS5\.?^A>/_@?=?\
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M<10WE[J,+F..6?.DW1%FK_<^T$1XA)]'P:]/M[B.[@CFA<212*'1UZ,",@T
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M1V$DN!&'.#C!(]37N^CW-U>:5:3WUF=.O)(E>:T,HE\ER.4WKPV#QD<&KE%
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MSRP3.2KQW,;85O4$CBMW6?@)J"^ ](BL/A[,+Y+Z6\F@A\92C4[5W&/,ANV
M5F/\2L2/K7U110!YK\ O#?B_PMX#2R\97TMWJ'GR/"EQ<BZF@A)^2.28 !V'
M<@5Z5110 4444 %%%% !1110 4444 %<M\4=$O?$GP[\1:7IT0FOKNQEA@C+
MA0SE2 ,G@<^M=310!XA\%/V9/"'P_P!#T'59O".GV?C2"U47%VS&9DGQ\Q!+
M%<Y[K7G%U\*_BUX@\6^'[S7],?47TKQ ;V74#KB&&2V)(7R+7Y5CVC&2?F/O
M7UM10!\\^&/@UXEM?@]\2?#UQ:16NJ:Y>WLUHK7"LLBN<H2RD[<^_2D\#?#G
MQB_C_P"&^M:QX>72K?0]#GTZ[!OHIRDF0$(VGG<!GCIWKZ'HH ^0+G]G+QF?
M#.F7!TR2:^TOQ%?7_P#9=GK/V&:YMYF^5H[B,_NV[X)'I6[;? ;6$M?!<]AX
M4ET>2'Q'_:NJ6UYX@.I2JNS;YC2R8W,>,JN?J:^HJ* /F#XU?"#QEK?C_4-7
M\(^'I]/U&Y2-8/$6C>)39C<.]W;.I60#_8!)KZ0T&WO;31;&'4KA;K4(X$6X
MG08#R #<P^IJ_10 4444 %<=\8/^2:Z__P!>Q_\ 0A78UQWQ@_Y)KK__ %['
M_P!"%9U/@?H=F"_WFE_B7YHZ'1?^0-8?]>\?_H(HHT7_ ) UA_U[Q_\ H(HJ
MUL<T_B9H4444R HHHH *X+Q/_P E>\$?]>.I_P K>N]KS3QSK^F:+\6_!+ZA
MJ-I8(+'4B6NITB SY 'WB.N#^1K*H[1U[K\T>C@(N59J*N^6?_I$CTNBN<_X
M61X2_P"AGT;_ ,&$/_Q5'_"R/"7_ $,^C?\ @PA_^*JN>/<Y_JU?^1_<SHZ*
MYS_A9'A+_H9]&_\ !A#_ /%4?\+(\)?]#/HW_@PA_P#BJ.>/</JU?^1_<SHZ
M*YS_ (61X2_Z&?1O_!A#_P#%4?\ "R/"7_0SZ-_X,(?_ (JCGCW#ZM7_ )']
MS.CHKG/^%D>$O^AGT;_P80__ !5'_"R/"7_0SZ-_X,(?_BJ.>/</JU?^1_<S
MHZ*YS_A9'A+_ *&?1O\ P80__%4?\+(\)?\ 0SZ-_P"#"'_XJCGCW#ZM7_D?
MW,Z.BN<_X61X2_Z&?1O_  80_P#Q5'_"R/"7_0SZ-_X,(?\ XJCGCW#ZM7_D
M?W,Z.BN<_P"%D>$O^AGT;_P80_\ Q5'_  LCPE_T,^C?^#"'_P"*HYX]P^K5
M_P"1_<SHZ*YS_A9'A+_H9]&_\&$/_P 51_PLCPE_T,^C?^#"'_XJCGCW#ZM7
M_D?W,Z.BN<_X61X2_P"AGT;_ ,&$/_Q5'_"R/"7_ $,^C?\ @PA_^*HYX]P^
MK5_Y']S.CHKG/^%D>$O^AGT;_P &$/\ \51_PLCPE_T,^C?^#"'_ .*HYX]P
M^K5_Y']S.CHKG/\ A9'A+_H9]&_\&$/_ ,51_P +(\)?]#/HW_@PA_\ BJ.>
M/</JU?\ D?W,Z&1%EC9&&58$$>U8O@SP7H_P_P##UOH>A6GV+3+=G:.$R-)M
M+,6;YF))R23UJ#_A9'A+_H9]&_\ !A#_ /%4?\+(\)?]#/HW_@PA_P#BJ.>/
M</JU?^1_<SHZ3%<[_P +(\)?]#/HW_@PA_\ BJ/^%D>$O^AGT;_P80__ !5'
M/'N'U:O_ "/[F=%BC%<[_P +(\)?]#/HW_@PA_\ BJ/^%D>$O^AGT;_P80__
M !5'/'N'U:O_ "/[F='17.?\+(\)?]#/HW_@PA_^*H_X61X2_P"AGT;_ ,&$
M/_Q5'/'N'U:O_(_N9T=%<Y_PLCPE_P!#/HW_ (,(?_BJ/^%D>$O^AGT;_P &
M$/\ \51SQ[A]6K_R/[F='17.?\+(\)?]#/HW_@PA_P#BJ/\ A9'A+_H9]&_\
M&$/_ ,51SQ[A]6K_ ,C^YG1T5SG_  LCPE_T,^C?^#"'_P"*H_X61X2_Z&?1
MO_!A#_\ %4<\>X?5J_\ (_N9T=%<Y_PLCPE_T,^C?^#"'_XJC_A9'A+_ *&?
M1O\ P80__%4<\>X?5J_\C^YG1T5SG_"R/"7_ $,^C?\ @PA_^*H_X61X2_Z&
M?1O_  80_P#Q5'/'N'U:O_(_N9T=%<Y_PLCPE_T,^C?^#"'_ .*H_P"%D>$O
M^AGT;_P80_\ Q5'/'N'U:O\ R/[F='17.?\ "R/"7_0SZ-_X,(?_ (JC_A9'
MA+_H9]&_\&$/_P 51SQ[A]6K_P C^YG1T5SG_"R/"7_0SZ-_X,(?_BJ/^%D>
M$O\ H9]&_P#!A#_\51SQ[A]6K_R/[F='17.?\+(\)?\ 0SZ-_P"#"'_XJC_A
M9'A+_H9]&_\ !A#_ /%4<\>X?5J_\C^YG1T5SG_"R/"7_0SZ-_X,(?\ XJC_
M (61X2_Z&?1O_!A#_P#%4<\>X?5J_P#(_N9T=%<Y_P +(\)?]#/HW_@PA_\
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M"*6>OVEI9-9WW]CW5Y>7B*JDRQ3Y\NW1.0=HR:^SO^%C^$O^AHT;_P &,/\
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M (61X2_Z&?1O_!A#_P#%4<\>X?5J_P#(_N9T=%<Y_P +(\)?]#/HW_@PA_\
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M_P  HO\ XFM.DHY5V#VM3^9_>9O_  B^B_\ 0%TS_P  HO\ XFC_ (1?1?\
MH"Z9_P" 47_Q-:=%'*NP>UJ?S/[S,_X1?1?^@+IG_@%%_P#$T?\ "+Z+_P!
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MU/PKH_V'4_$UWXHD5AY5S=V-K:&*,* (U2VC1-HQQQGMTKH: "BBB@ HHHH
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MAK?B37=<U_59()9/$+O#:W4#0$F#R%AC6.,(23C:02?FS5;5/V=D\3V6L?\
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M1@"IY]017EO[5CSI\!O%'DDJC+ DY4X/D&>,2_AL+9]LUXI^T+KE]'X]U?\
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MHQV\2&$%8RL8&P'J!QP/I5'59M$T*QDEU V=E:W$J1L9U5%ED=@J+R/F8L0
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MXH9[AG9B4CW;% )PH!9C@8R3DUK5SG]LW?\ ST'_ 'R*/[9N_P#GH/\ OD4
M='17.?VS=_\ /0?]\BC^V;O_ )Z#_OD4 ='17.?VS=_\]!_WR*/[9N_^>@_[
MY% '1T5SG]LW?_/0?]\BC^V;O_GH/^^10!T=%<Y_;-W_ ,]!_P!\BC^V;O\
MYZ#_ +Y% '1T5SG]LW?_ #T'_?(H_MF[_P">@_[Y% '1T5SG]LW?_/0?]\BC
M^V;O_GH/^^10!T=%<Y_;-W_ST'_?(H_MF[_YZ#_OD4 ='17.?VS=_P#/0?\
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M'_?(H_MF[_YZ#_OD4 ='17.?VS=_\]!_WR*/[9N_^>@_[Y% '1T5SG]LW?\
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M ]A_UPC_ /0115K8YI_$R_1113($/2OB;XG^*!J'B#Q,]I\-/!FJ:+:>)I-
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MX<[X8F&&4<XP?<9K+?X3^#9O&7_"4GP_8MXB5Q+]M ;?OQ@.5SMW8XW$9]Z
M.NHHHH **** "OCC4/#T?BWXB_&,?\*^\;>*]>AUTVVEZUH^LFSM;%OL-N8T
MWF]C$>UV+DB)@-V>>E?8]96C>%]*\/W>KW6G64=K<:M=?;KZ12Q,\_EK'O.2
M<'8B#C XZ4 ?+=OXZ^)GPIO_ (B:O=W6CZ[#X=M_#PUN/4'N'ENIFM52?[*5
M8)%DEGW%6#'&5'6NK\0_M)Z_HOQ0LM,MX=%U3P[/XGA\-R)8Z?J$CPEV">8^
MH$+:B56)S;J&(QC?G@>SZO\ #/POKT'B*&_T>&YB\0^3_:BL[C[5Y(Q%NPPQ
MM']W'OFL.?\ 9\^'=SXC;79?"]N^J&_75%E-Q/LCNPP;SXXO,\N.0D LR*"W
M.[.3D \FM_VIO$GAE?%5WXVT:TTE]/L+^^L= &F7L%S<K;EBOD7K%[:\5HQO
M8Q[&7/W3@UV/P/\ B[XT\<>([K2_%/ABXL+=M/6_M]3&A7NE0J^Y5:V*W3,9
M2 X82I@$ Y5>*ZS1?@'\/?#VIWE_8>%+*&:[2>*2-WEE@1)L^<L<#NT40DR=
MPC5=V3GK5SP%\&_!?PPN+B?PQH$.EW$\2V[S>=-/((5.5A1I7<I$#R(T(4>E
M '%:G::YI_[4'AZ6Z\37M]I5_H>J-;Z,L:PVMH(_L^&PO,LA+-\[G@8"@<D^
M?_!OXM^+O!'@7P!<^*FT>_\ "FNRZE:6\\,D[:C;M"UU,LDTCL4E4B%U*J 4
M^7EN<?2MUX:TR]U^RUN:S235;*":VM[HEMT<<NWS% SC#;%ZCMQ7#Z7^S;\,
M]%>X:R\(6D/GPS0,IFG=524DS;%:0B,OD[F0 L."2* /&O%WA%+KP/H$E[?^
M)]=^*'B*P:XT'0-/U6>W%C=S2-,UWB-E")$)8U>2;<JK&%49;!U?B=^T;XK^
M%^IW%M&VAZ_#H1T^TU2&#3=1N)YI91&LKRW4:K;6;9;<L;[R003MR*]9\5_
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M"U7@NI>07#3X^<84J1P,U] CX9Z0+6>V'AS31;W#1--"+:+9(8@!$6&,'8%
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M_GB?^^A_C0!4HJW_ &3=_P#/$_\ ?0_QH_LF[_YXG_OH?XT 5**M_P!DW?\
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MH_LF[_YXG_OH?XT 5**M_P!DW?\ SQ/_ 'T/\:/[)N_^>)_[Z'^- %2BK?\
M9-W_ ,\3_P!]#_&C^R;O_GB?^^A_C0!4HJW_ &3=_P#/$_\ ?0_QH_LF[_YX
MG_OH?XT 5**M_P!DW?\ SQ/_ 'T/\:/[)N_^>)_[Z'^- %2BK?\ 9-W_ ,\3
M_P!]#_&C^R;O_GB?^^A_C0!4HJW_ &3=_P#/$_\ ?0_QH_LF[_YXG_OH?XT
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M;P5H=_#I48BL8Y;) MO&.=B@8&S_ &3E?:O0?[)N_P#GB?\ OH?XT?V3=_\
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MT/X%\2^+(_#]CJEP]W/-);6US+I]Q%9W<T?^LBAN6012NO=58FO2: "BBB@
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M\M\W(P 1_ KQ[<^.=)U4WWBFP\1ZA97(@GBMO#MUH<UH=N0DMM<RR2 GJ&.
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M1ZTTRHK!2ZAFZ GDU\QZK\._V@M+$<MKX^BOK:T\R8<(T[CYCL:/R )2?E
M9,8[UB^"?A_\<?&UC'JVJZU+H5PDLL=O)J@C^WP1M]XQ_N/D#8'!&0/7%7]5
MC;F]I&Q/UF5^7V;N?7&:X_XP?\DUU_\ Z]C_ .A"O'/A19?&6/XR"R\5:EJ-
MUX<TZU99KLQI':73X C"C9EVSN)<,,_W17L?Q@_Y)KK_ /U['^8KCQ-/V2:N
MGIT/4RZI[7$4W9KWEOZHZ'1?^0-8?]>\?_H(HHT7_D#6'_7O'_Z"**S6Q$_B
M9H5YAXN_LO1M<U28^(;*QU*X>"[BANH]_ER(I0[L<[63C';.:].->5:G_:2^
M/M?&F)H<.1 91K!RTI\OATQR!CC'3*_6OD.)I<M"BE&[<[+23:]R>J491UM?
MJK;[I'M90KU9MNR4;O;7WHZ.Z?Y>6QV/PZAAM_!]A'!?QZE&-Y^T1 A"2[$A
M0>@!) 'M5+Q;]@O/%>@Z=?:=IUU%/'.[S7Z!BJJ!\L>>Y)!/L*W?#/VK^Q;?
M[;]B^T_-N_L[/D_>.-N?;K[YKCOC!?I]BAL?[.L+V3R)KS=J&=J+$!D)M()<
M[NQ'O48^4<)D4)-*T%3T:=G9Q]UI\S5]M;M7NVRL,G7S*26\G+5/:Z>O1:;]
M+FSX)NX$U7Q!I5K:65M:6,\9B:Q0*C!TSAL=6!'/U%9'B+_DLGA/_KUN?_06
MK5\!W%G!<:KI%A86]E;6)@8&W.0YDC#'=U^8$$<GIBLGQ*ZQ_&+PHSL%46MQ
MR3C^%JX*[OE>'U3_ '\%ILK5TN5:+2/PIV5[7ZG335L95TM^[EON_P!WN]]7
MOOI>QZ+14'VZW_Y[Q_\ ?0H^W6__ #WC_P"^A7Z$?+D]%0?;K?\ Y[Q_]]"C
M[=;_ //>/_OH4 3T5!]NM_\ GO'_ -]"C[=;_P#/>/\ [Z% $]%0?;K?_GO'
M_P!]"C[=;_\ />/_ +Z% $]%0?;K?_GO'_WT*/MUO_SWC_[Z% $](!CI4/VZ
MW_Y[Q_\ ?0H^W6__ #WC_P"^A0!/28&<XYJ'[=;_ //>/_OH4?;K?_GO'_WT
M* )Z0@'J,U#]NM_^>\?_ 'T*/MUO_P ]X_\ OH4 3T5!]NM_^>\?_?0H^W6_
M_/>/_OH4 3T5!]NM_P#GO'_WT*/MUO\ \]X_^^A0!/14'VZW_P">\?\ WT*/
MMUO_ ,]X_P#OH4 3T5!]NM_^>\?_ 'T*/MUO_P ]X_\ OH4 3T5!]NM_^>\?
M_?0H^W6__/>/_OH4 3T5!]NM_P#GO'_WT*/MUO\ \]X_^^A0!/14'VZW_P">
M\?\ WT*/MUO_ ,]X_P#OH4 3T5!]NM_^>\?_ 'T*/MUO_P ]X_\ OH4 3T5!
M]NM_^>\?_?0H^W6__/>/_OH4 3T5!]NM_P#GO'_WT*/MUO\ \]X_^^A0!/14
M'VZW_P">\?\ WT*/MUO_ ,]X_P#OH4 3T5!]NM_^>\?_ 'T*/MUO_P ]X_\
MOH4 3T5!]NM_^>\?_?0H^W6__/>/_OH4 3T5!]NM_P#GO'_WT*/MUO\ \]X_
M^^A0!/14'VZW_P">\?\ WT*/MUO_ ,]X_P#OH4 3T5!]NM_^>\?_ 'T*/MUO
M_P ]X_\ OH4 3T5!]NM_^>\?_?0H^W6__/>/_OH4 3T5!]NM_P#GO'_WT*/M
MUO\ \]X_^^A0!/14'VZW_P">\?\ WT*/MUO_ ,]X_P#OH4 3T5!]NM_^>\?_
M 'T*/MUO_P ]X_\ OH4 3T5!]NM_^>\?_?0H^W6__/>/_OH4 3T5!]NM_P#G
MO'_WT*/MUO\ \]X_^^A0!/14'VZW_P">\?\ WT*/MUO_ ,]X_P#OH4 3T5!]
MNM_^>\?_ 'T*/MUO_P ]X_\ OH4 3T5!]NM_^>\?_?0H^W6__/>/_OH4 3T5
M!]NM_P#GO'_WT*/MUO\ \]X_^^A0!/14'VZW_P">\?\ WT*/MUO_ ,]X_P#O
MH4 3T5!]NM_^>\?_ 'T*/MUO_P ]X_\ OH4 3T5!]NM_^>\?_?0H^W6__/>/
M_OH4 3T5!]NM_P#GO'_WT*/MUO\ \]X_^^A0!/14'VZW_P">\?\ WT*/MUO_
M ,]X_P#OH4 3T5!]NM_^>\?_ 'T*/MUO_P ]X_\ OH4 3T5!]NM_^>\?_?0H
M^W6__/>/_OH4 -U*S&HZ?<VI<H)HVCW 9QD$9_6O H/V4+S0K"*V\-^/;[0S
M<Z:-)U=QIT,_VV ,Q!0.?W,@#LNX;A@_=SS7O_VZW_Y[Q_\ ?0H^W6__ #WC
M_P"^A0!X/XF_8[\.:]JGGPZK?6-FN@#1([-5#JCJH6.ZR3S(JC%=9X9_9P\&
M:)X=\-6>H:5::[K&A6K6]MKU[;(UXK-DO(K\E68DGBO3/MUO_P ]X_\ OH4?
M;K?_ )[Q_P#?0H ^9KO]B6&:WTF1/$UE/J=A;R:>+K5/#%G?H]H9"Z 1S;@D
MR$D"52 >Z&M'7OV,M,O?$46J:9K=K:--;V\%^;_PUIU_-)Y0P)+=Y(@+=R,@
MA59/10>:^B/MUO\ \]X_^^A1]NM_^>\?_?0H \?O_P!FNTO-'UC3UUVXCCU#
M7[?7=_V9"8S%MQ%@$ @[>O'TJCX<_9@32?C''X]OO$:ZC=6SS/ T6C6UI>RB
M08\NZNX0K7"*/NJRCMDFO;OMUO\ \]X_^^A1]NM_^>\?_?0H FI:@^W6_P#S
MWC_[Z%'VZW_Y[Q_]]"@">BH/MUO_ ,]X_P#OH4?;K?\ Y[Q_]]"@">BH/MUO
M_P ]X_\ OH4?;K?_ )[Q_P#?0H GHJ#[=;_\]X_^^A1]NM_^>\?_ 'T* )Z*
M@^W6_P#SWC_[Z%'VZW_Y[Q_]]"@">O$?VE/@+JGQMAT---U.STXZ?(SO]K5V
MW9QTVU[/]NM_^>\?_?0H^W6__/>/_OH5A7H0Q%-TJFS/2R[,,1E6*AC,*[3C
M>UU?=6V?J5]"T]]*T6QLI&5WMX$B9EZ$JH&1^57Z@^W6_P#SWC_[Z%'VZW_Y
M[Q_]]"MDK*R//E)SDY/=D]%0?;K?_GO'_P!]"C[=;_\ />/_ +Z%,DGHJ#[=
M;_\ />/_ +Z%'VZW_P">\?\ WT* )Z*@^W6__/>/_OH4?;K?_GO'_P!]"@">
MDZ5#]NM_^>\?_?0H^W6__/>/_OH4 38KC_C!_P DUU__ *]C_P"A"NJ^W6__
M #WC_P"^A7'_ !=NX)/AMKX65&/V8\!O]H5G4^!^AV8/_>:7^)?FCI]%_P"0
M-8?]>\?_ *"**-%_Y UA_P!>\?\ Z"**M;'-/XF6KRY2RM9KB3/EQ(SMCT R
M?Y5XSJ5Q%XON-+FM_#&F2ZYK"R76;UW94MT&$+%2/F8#'X>]>TRQ)/&\;J&1
M@593T(/45Q>G?"G3](BO?L=]?I// ;6*>24.UK$3DI'QP*^.X@R_&9C*G2I1
M4J6O,GRWNFFFN9/5I2BGI;FN_+V\LQ5#"J<YMJ?3>W7>S6B=F^]K&C\-[VSU
M#P9IUQ8V2:? ZM_HT9)5&#D-C/\ M G\:YSQS;ZSJJ7$>I:%HESI4,I,,]Y>
MM$0,\$GC:2.N#7<Z#HEKX<TBVTZS4K;6Z[5W')/.22?4DDUROQ$L#)JFCWUW
MI$^NZ1;"436=NGF,KL%V2>7_ !@ ,/;-9YEA:L,DIT:S]Z,8*2BERO:+;7)+
MW5J[*.RZ+:\)6A+,)3I[-R:O>_5JSYEJ]M66?AK8S:?I<T9TS3=.LRP>$Z=<
M&82GD,68YST'.36!XY_Y*KX7_P"O:?\ D:VOAO8/;RZS=0Z9-HVE74R-:6-P
MNQEPN'?9_#N../:L7QS_ ,E5\+_]>T_\C7!-<N3X2-K6JTEVT59)->['1K6/
MNK2QTQ=\?7=[WA/_ -(?F]5L]7J=!1117Z*?*A117D/[3FF7$7PQUGQ%8ZYK
M>CZCI%HTEO\ V7J,EM$[%T&9$7[^.V>F: /7J*^=?$GQ)U#X*QW-CI6H?\))
M:V7V*XNX-7GN]0OO](95;?<8$=LH!!16WEB3P*W_ !#\;M9TBS\;S16=@S:'
MXHLM#MA(K_/#-Y6YGPW+CS&QC X'!H ]KHKQS]J:ZUFW\#Z1:Z!JMYHVH7NO
M6EDMS93-$^'++C([$XR*\PL_C!K7BWXJ?#_5XM3OK;08%73]1L()66*>[2TD
MFN Z X8J0J\T ?65%>#>'/CIXKN8O#.IZOI.CQ:+XMM+NXTA+*25KBU:&)I$
M%QN^5PRKR4QM/%5M*^,?Q&U/PO\ #_418^%UO/&=VL%I 5N0ENAA=R\C;LD[
ME!"J.G&<\T ?05%?-=]\4_&GBK5_ MO8BQT_Q'!XDU'1;ZW6>8:=<O#;Y#L
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M5;:)CEHX$D=E@0D E(@H.!Q73:EX;TS5]5TG4KRT6>^TF22:RF+,#"[QF-R
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MS>W&DZ>EE->I EPR.S>8L,?EQ [B?NIQQ^.: (/&&B:C=>"[K3= UF3PW<K
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M!P& ()'XUX5?_%;XOZ?-K5L^I^#GDT[PU!XH,HT6X 96 W6@7[1_Y&SD?W*
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M1^7XU1^+/PEU_6_BC<:_=>$;7XC^'YK58;;3;C5/LGV!P.2%)"MGUZUYS/\
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M\'?^!EY_\;H]HNS^X/J<OYX_^!(@'PK\'KK_ /;B^&M.76/M0O1>K%B03_\
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M+^R_B?\ \^/@[_P,O/\ XW1_9?Q/_P"?'P=_X&7G_P ;H]HNS^X/J<OYX_\
M@2,G3/@;\/=&\5?\)+8^#='M-=\UIQ>Q6^"LAZR*N=BN?[RJ#[U3LOV=OAGI
M_B(Z[!X(TE=5-PUY]H>-Y )RVXR!&8H&W'.0O7FNB_LOXG_\^/@[_P #+S_X
MW1_9?Q/_ .?'P=_X&7G_ ,;H]HNS^X/J<OYX_P#@2)O&7@7P]\0](.E>)M&M
M-;T_S!*(+Q-P5QT=2""K#U!!K'U;X*> M=\,:=X<O_"&D7.AZ<VZSL#;A8[<
M\Y*;2""<G//S9.<YK2_LOXG_ //CX._\#+S_ .-T?V7\3_\ GQ\'?^!EY_\
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M/ VG>,7\5VOA/2K?Q&[%VU*.WQ(7(P7QG:&(X+ ;CZU>_LOXG_\ /CX._P#
MR\_^-T?V7\3_ /GQ\'?^!EY_\;H]HNS^X/J<OYX_^!(Z.BN<_LOXG_\ /CX.
M_P# R\_^-T?V7\3_ /GQ\'?^!EY_\;H]HNS^X/J<OYX_^!(Z.BN<_LOXG_\
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MM'(DT:R1L'1@&5E.00>A!I20!D\"OA[XL_%7XK^&_BI\4/!7P]\1:'X5\*>
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3MY_\;H_X7-I?_0#\5?^$[>?_&Z/:P[A]0Q7_/M_<=_17 ?\+FTO_H!^*O\
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M\+FTO_H!^*O_  G;S_XW1[6'</J&*_Y]O[COZ*X#_A<VE_\ 0#\5?^$[>?\
MQNC_ (7-I?\ T _%7_A.WG_QNCVL.X?4,5_S[?W%_P"*OPD\)_&OP?=>&/&6
MCPZUHUP0S0R%E9'!RKHZD,C ]""#7G?PN_8N^%WPCAUUM$TF\FU#6K1K"[U3
M4M0EN[LVY&/*220DHO\ NX_&NU_X7-I?_0#\5?\ A.WG_P ;H_X7-I?_ $ _
M%7_A.WG_ ,;H]K#N'U#%?\^W]QD7?[-/@J]^!]G\)Y+>]/A"TCCBBB%VPFVI
M)YBYDZGYJV?!OP5\,^!/'&O^+-*BN4U?6X+>WO'EN&=&2%=L>U3PO'7UIO\
MPN;2_P#H!^*O_"=O/_C='_"YM+_Z ?BK_P )V\_^-T>UAW#ZABO^?;^X[^N
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M[2[N&FLC$C;E(MVR@;/5L9-5_P#A<VE_] /Q5_X3MY_\;H_X7-I?_0#\5?\
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M?_0#\5?^$[>?_&Z/:P[A]0Q7_/M_<=_17 ?\+FTO_H!^*O\ PG;S_P"-T?\
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M+_Z ?BK_ ,)V\_\ C='M8=P^H8K_ )]O[COZX[XP?\DUU_\ Z]C_ .A"J/\
MPN;2_P#H!^*O_"=O/_C=<[\0OB9:>(_!FJZ;9Z#XH>ZN8?+C#^'[M03D=24P
M*B=2#BTF=>$P.)AB*<I4VDI+IYGJ.B_\@:P_Z]X__0113M(C:/2;)'4JRP("
MK#!!VCBBMUL>1/XF7J***9 4444 %)110 8HQ110 8HQ110 8HQ110 8HQ11
M0 8HQ110 8HQ110 8HQ110 8HQ110!A^(M2N;"2$02; P.?E!]/45D?\)#J'
M_/Q_XXO^%%%?$YAB*T,3.,9M+3J^R/HL+2IRHQ;BF_0/^$AU#_GX_P#'%_PH
M_P"$AU#_ )^/_'%_PHHKS_K6(_Y^2^]G5["E_*ON0?\ "0ZA_P _'_CB_P"%
M'_"0ZA_S\?\ CB_X444?6L1_S\E][#V%+^5?<@_X2'4/^?C_ ,<7_"C_ (2'
M4/\ GX_\<7_"BBCZUB/^?DOO8>PI?RK[D'_"0ZA_S\?^.+_A1_PD.H?\_'_C
MB_X444?6L1_S\E][#V%+^5?<@_X2'4/^?C_QQ?\ "C_A(=0_Y^/_ !Q?\***
M/K6(_P"?DOO8>PI?RK[D'_"0ZA_S\?\ CB_X4?\ "0ZA_P _'_CB_P"%%%'U
MK$?\_)?>P]A2_E7W(/\ A(=0_P"?C_QQ?\*/^$AU#_GX_P#'%_PHHH^M8C_G
MY+[V'L*7\J^Y!_PD.H?\_'_CB_X4?\)#J'_/Q_XXO^%%%'UK$?\ /R7WL/84
MOY5]R#_A(=0_Y^/_ !Q?\*/^$AU#_GX_\<7_  HHH^M8C_GY+[V'L*7\J^Y!
M_P )#J'_ #\?^.+_ (4?\)#J'_/Q_P".+_A111]:Q'_/R7WL/84OY5]R#_A(
M=0_Y^/\ QQ?\*/\ A(=0_P"?C_QQ?\***/K6(_Y^2^]A["E_*ON0?\)#J'_/
MQ_XXO^%'_"0ZA_S\?^.+_A111]:Q'_/R7WL/84OY5]R#_A(=0_Y^/_'%_P *
M/^$AU#_GX_\ '%_PHHH^M8C_ )^2^]A["E_*ON0?\)#J'_/Q_P".+_A1_P )
M#J'_ #\?^.+_ (444?6L1_S\E][#V%+^5?<@_P"$AU#_ )^/_'%_PH_X2'4/
M^?C_ ,<7_"BBCZUB/^?DOO8>PI?RK[D'_"0ZA_S\?^.+_A1_PD.H?\_'_CB_
MX444?6L1_P _)?>P]A2_E7W(/^$AU#_GX_\ '%_PH_X2'4/^?C_QQ?\ "BBC
MZUB/^?DOO8>PI?RK[D'_  D.H?\ /Q_XXO\ A1_PD.H?\_'_ (XO^%%%'UK$
M?\_)?>P]A2_E7W(/^$AU#_GX_P#'%_PH_P"$AU#_ )^/_'%_PHHH^M8C_GY+
M[V'L*7\J^Y!_PD.H?\_'_CB_X4?\)#J'_/Q_XXO^%%%'UK$?\_)?>P]A2_E7
MW(/^$AU#_GX_\<7_  H_X2'4/^?C_P <7_"BBCZUB/\ GY+[V'L*7\J^Y!_P
MD.H?\_'_ (XO^%'_  D.H?\ /Q_XXO\ A111]:Q'_/R7WL/84OY5]R#_ (2'
M4/\ GX_\<7_"C_A(=0_Y^/\ QQ?\***/K6(_Y^2^]A["E_*ON0?\)#J'_/Q_
MXXO^%'_"0ZA_S\?^.+_A111]:Q'_ #\E][#V%+^5?<@_X2'4/^?C_P <7_"C
M_A(=0_Y^/_'%_P ***/K6(_Y^2^]A["E_*ON0?\ "0ZA_P _'_CB_P"%'_"0
MZA_S\?\ CB_X444?6L1_S\E][#V%+^5?<@_X2'4/^?C_ ,<7_"C_ (2'4/\
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M\_'_ (XO^%'_  D.H?\ /Q_XXO\ A111]:Q'_/R7WL/84OY5]R#_ (2'4/\
MGX_\<7_"C_A(=0_Y^/\ QQ?\***/K6(_Y^2^]A["E_*ON0J>(=0+*#<<9_N+
H_A781G=&I/4BBBOH\HJU*O/SR;VW=SR<?",.7E5MQ]%%%?1GDG__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>aciu-20231231x20f009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %S [<# 2(  A$! Q$!_\0
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M^P$\;QP1G(Y2ST[6OC?H>E^*;G0;;1H;BWAD@L)M5D+7,+%9%9I(HPT+*P!
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MUPECYR +CC8.<_G5PXAR^<E'F:OW6@GAZB5[&O16?_;=O_=D_+_Z]']MV_\
M=D_+_P"O7;_;& _Y_(CV-3L:%%9_]MV_]V3\O_KT?VW;_P!V3\O_ *]']L8#
M_G\@]C4[&A16?_;=O_=D_+_Z]']MV_\ =D_+_P"O1_;& _Y_(/8U.QH45G_V
MW;_W9/R_^O1_;=O_ '9/R_\ KT?VQ@/^?R#V-3L:%%9_]MV_]V3\O_KU#-K@
M##RDR,<[^*SJ9WE]./-[5/TU&J-1]#6HK*M]8>:=$,:@,<9!K5KLP>.H8^+G
M0=TM-K$3A*F[2"BO%?VC/VMO!'[+S:"/&,.KRG6O.^S?V7:+/CRMF[=EUQ_K
M%QU[UXFW_!6WX*KTTWQ@WTTN+_X_7?<S/HKQ%X*\;Z;XQU#7O!WB#3Q#J<<2
MW>DZ_#-- CQ@J)83&X*$@X9<8. >M<U:? ;7?#=EH>I:-KFGR^*K'5;S5KA[
MRS9+*=[I"DJ+&C;HU V[2"3D'/4UXJW_  5R^"XZ:/XS;_N&P#_VXJ&3_@KM
M\'1G9H/C)OK86X_]KT706/1O$/P\\4^!V\,HFLV-SX@U;QY)JR7:6CBW0R6;
M@QO'NSM^1ER&S@@YS79'X(ZYJDK:OJVL6,OB"\U[3]6N_LT#I;1PVIPD,0)+
M9QN.YCR6Z 5X!)_P5Y^$P^YX:\7MZ9M;<?\ M:H'_P""OOPN&=GA3Q8WIF&W
M'_M6BZ"Q[]\0/@-JWBSQWK6L0W'A^\M=6M(K59-<TUKNXTO:K*WV8;@F&W;N
M0/FYYZ4[P;^SA:">Q?QO;Z3XFBTS1+/1M/MGMR\<(B!,TN'_ (G8KTZ!<5\\
MR?\ !8#X;#[G@[Q4WU6W'_M2H'_X+!_#X9V>!_$[?5[8?^ST706/HZQ_9_N]
M"UQ(M)O;&R\+VWB6V\06>FK"P-OB%DGB7' #,59>PRWK5OQI\$M4\1MX]EM-
M4L[>;7I]-N;/SHG98GM<'$F""0Q7^'D"OE]_^"P_@89V^ O$C>F9[8?^S5"_
M_!8KP:/N_#SQ$WUN[8?UHN@L>]^//!UYX >7Q?J&L6MAJLOB*#4[:]2REGLK
M9C9^1*ES@AEA?##>/NED)[UC^#_AYJ7QIM?'6KW>IV5Q-<:S87VEZFNGL;"6
M6VA *K%)\TD.6,98_>^8CM7BK_\ !8WPM_#\-=?/UU"V%1'_ (+'^&QT^&.M
MGZZG;_X4706/J6Y^!_B#6?"GB&RO;KPWIESJ36JP6FB:2+>V@6*99&9GQYLC
M-C&"=HP,#J:] 7P5<K\66\6?:8OLAT4Z9]GVGS-_GB3=GIC'&.M?"Y_X+):!
MV^%VKGZZM /_ &2HV_X+)Z-_#\*]2_'68O\ XW1=!8_1RN5^*?A"X\>_#W7O
M#UK<16MQJ-J]NDTRED0D=2!SBO@=_P#@LGI_\/PKO/QUJ/\ ^-4S_A\G9?\
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M,;;85?R\*PZDC8>GK4&N?"/Q9%<^*K'PYK^F66@>*9#/?)>V;R7%G*\2Q2M
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MB'PS_P"@9XF_\ 8O_CU'_#Q#X9_] SQ-_P" ,7_QZJ^O8;_GXCE_U0S_ /Z
MY_<?4-%?+W_#Q#X9_P#0,\3?^ ,7_P >H_X>(?#/_H&>)O\ P!B_^/4?7L-_
MS\0?ZH9__P! <_N/J&BOE[_AXA\,_P#H&>)O_ &+_P"/4?\ #Q#X9_\ 0,\3
M?^ ,7_QZCZ]AO^?B#_5#/_\ H#G]Q]0T5\O?\/$/AG_T#/$W_@#%_P#'J/\
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MMUT?+M>^^@*K%GI-+UKS+1OC'=7GBQ/#>H^%KC2]8N+![^TMQ>QS&0*"?+?
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M,#+/:JS2*.,.68XYR,\UP/C7X,7D$EEJ_A%K;7M-U F6VMM-D,Q !(.U6))
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MPCX;N_"GAZVT:YNM1:&:2%Y&+H(7;:=S$=0#^%?'E???_!2+_D1/"'_85?\
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M82P_@C! Q]/?.UI^N?"_P'\3_$WA^#PA8:#J>FS2VVF:_KES=:I:K/&X*M+
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M2S6>N72%S_%O"2@_E(!^%<CKOP=US66N[<:CIL5DMW>WUHY20RF2XD$FR0=
MJD$94DGTKT;X?>&;_2(M8O=9EM6GO[]KZ5;/<8E)CC0(I;!/$8).!UKKJN&*
MHQHTI)O\E?1OR4;W(C>#NT=+>_NX+6(]53<1]:R-7>\CTJ\;3HTEOQ"YMTD;
M:K28.W)[#.*T+F<W$S2'N>GI45>%B:L:E=SA\*LE?LDDOP1TQ34;,\!\*_LP
M!O!,EMKVO:Q!K%\));VWL-0_T-Y6)P63;A_X<D]:=!\)O'">$/ ]SOTX>*_"
M-Q(MO#/.7@NK<\ %P,J0..G05[Y17>\WQ4FW-IW=]5W337HT[&?L8]#R>_\
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M7]]U)QD'G(HM9Z'''V7UNZ5DM/*Z_P"'_,\ ?[[?6DI7&'8'KFDJCW0HHHH
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M]N@JQ/I\5QM#;@JC 53@"K5)G%=%/*\%2INE"DK/?K?UON2ZLV[ME'^Q;?\
MV_\ OJC^Q;?_ &_^^JOT5/\ 9. _Y\Q^X/:U/YBA_8MO_M_]]4?V+;_[?_?5
M7Z*/[)P'_/F/W![6I_,4/[%M_P#;_P"^J/[%M_\ ;_[ZJ_11_9. _P"?,?N#
MVM3^8H?V+;_[?_?5']BV_P#M_P#?57Z*/[)P'_/F/W![6I_,4/[%M_\ ;_[Z
MH_L6W_V_^^JOT4?V3@/^?,?N#VM3^8H?V+;_ .W_ -]4?V+;_P"W_P!]5?HH
M_LG ?\^8_<'M:G\Q0_L6W_V_^^J/[%M_]O\ [ZJ_11_9. _Y\Q^X/:U/YBA_
M8MO_ +?_ 'U1_8MO_M_]]5?HH_LG ?\ /F/W![6I_,4/[%M_]O\ [ZH_L6W_
M -O_ +ZJ_11_9. _Y\Q^X/:U/YBA_8MO_M_]]4?V+;_[?_?57Z*/[)P'_/F/
MW![6I_,4/[%M_P#;_P"^J/[%M_\ ;_[ZJ_11_9. _P"?,?N#VM3^8H?V+;_[
M?_?5']BV_P#M_P#?57Z*/[)P'_/F/W![6I_,4/[%M_\ ;_[ZJ:UL(K1RT>[)
M&.3FK-%:4\MP=&:J4Z2376PG4FU9L****](S"BBB@ HHHH **** "BBB@#G-
M4A\F\?C ;YA^-.TF?R;M0>%?Y3_2KVMP;X5E Y0X/T-8H)4@CJ*_(,?"65YH
MZD5L^9>CZ?FCUZ;]K2LSK:_)+_@K/\'V\+_%S1?'UI#BQ\2VOV6Z<=!=P# )
M_P!Z(K_W[-?K/:3BYMTD[D<_6O%?VR_@6O[0/P#\0^'8(E?6H$_M#26/5;N(
M%D'_  ,;D/L]?K5.I&M352#NFKH\IIQ=F?@I13I8I()7BEC:*5&*/&XPR,#@
M@CL001^%-H&%%%% !1110!W7PH\92^"O%=M<B\>PM9T%O=3)&) (RP/*GJ,J
M#QSQD<BO4_BG#J%OX8UB)-4EU$22K:F*2T\LRDOYGFQ'HRF,@'!.< U\]H,1
MKW%=EX?^(&N?V</#TRR:[I4JB&/3IF9M@#;AY1'*G(Z\\9' KRL5@_:58UX)
M75KZ+6S[V/KLFS7ZM2J8&HVH5+JZ<M&U;9/5?]NM]DSEH+.>XN4MXX6:=R L
M84[C^'6O8[^!_P"S=&T6S\F6_LX!Y\:2_.^3@HOKRK'.?X2.XR_3M'\57%KB
MST9[574C&KZ@S+&X/!5%()XR,-GZ5A:I\/\ Q)X9@D\2W.K065VCC+6[,&+$
MC: 5  ''0#  '%*4H8B24YI-;*]]?ET/?HY3CLJC4JX6E*<=W-KD2BM7;GL[
M^J$ATJ[-^EJENT-S(@WK&I EV]"%/. .G]:K_$*&"[M-'TR.[!N;5)+F96A8
M,C2[,*<].$!QC(+<BKNLZAXRU;2Q;:GJ=L8)HTD4264:2D,P*E&$8;);: 5.
M3TJ0_"'Q%J:0WL3VEY),<F&*YW2[@=I)&#DYXQDMUR!5\D<-&-:M-*^VNG;=
MVOV/(KYM#,:<L%1IOE6LM->_2]N_G^?GOA>%[7QAHR.OSK?V^1Z_O5KUO]M^
M6XN_VL/B-'+(9Y(M12%6/!($$6!^M8WPR^&^JZK\:/"$%_IC)87&N6<$K1RK
M(H7S4!R5/''/;]*T/VU+J.^_:I^)DJ$,IU782/588E;]0:]---:'QDX.+O;1
M['E=IX=N+YGCAEMY=HR"DN?F/8CJ/3)P!Z^OL'PHTRY\%>!/'.HZG8@M_8MR
M8XW*R*^]4B3."1C,@SSTKPK>S(JELHO0'I7T'H^F3VGP!URV$Z++>P6MC$L[
M'!,DPF8)@'^&$^P'6H;:/E\UG*,J-*4O=E):6Z1U;W\NQXQ<ZGI5SI[9TR&W
MOA@EK?*IU.0%8D#@@]/_ *TWA"RBUW4[328XS]MNI4@A*Q;S([/@+G^$'< 3
MZ9K&U/3Y-,N6@E)+@8;Y2N#Z8/./0X&:]:_98\)S>(/B&U\H7R=/MW9967<%
ME<B)2#D890[29[>633=DKL]*HH4L/*<9.VZU^Y*Y]9>5IWA'X3^'?"%C/*\&
MKW%MI,+GY-R3L$>7Y1S^YCN)23GAP,X(KX6^)'C ^*_'/B#4X%$<%[J%Q.BQ
MDA AD<* /380/PXK[&^*WBVST'4?MDRW%K_PC6A7.IC8H7RKN\46=HH90?G1
M68CG!QZBOB"_N]-DNY6ALI$7.T*T^0>?O9 SD_C^-9T]FT<6 AS>_.-WW_KU
M_K0PW^\?K24Z7!E?;D+DXSUIM;'T 4444 %?0O[!OP>;XR?M*>&+.:W,^D:1
M)_;&H97*^7"055O]Z38OXFOGJOV$_P""6_P%;X;_  :G\::G;^5K7BYEFB#K
MAH[%,B(>HWDL_P!"M-+41]K#@5\6?\%&?B&L.F>'?!=O+^]N)#J5VH[(F5C!
M^K$G_@%?9]U<QV=M+/,ZQQ1*7=V. H R2:_(;X\_$E_BS\5M?\1!B;26;R;-
M3_#;I\L?Y\M]6->1FU?V=#D6\ORZGZOX;Y2\=F_UN:]RBK_]O/2/ZOY'&Z%H
MUSXBUNPTJS0R7=[.EM$H[L[!1^IK]E_!OAJW\&^$]'T*UQ]GTZTBM4(&,A%
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M_P &9_\ B:^EZ*/J6&_Y]K[@_P!;<^_Z#*G_ ($SYH_X=]_"STUW_P &9_\
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M=I1%SX7U%?$4&M6^A76A+-$TL<TZ%X71\['C9=I#9'!.<8-0R_"7QC%%H7B
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MY\0_A[I6C6 NM/U6]FCO/](CC,@6!VV_,"1MQYF1UV;>IK(T#X;_ ! ?Q?X
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M?Y:(H?L\_!O3M=\5^%/$/]FV]AJZW4326UY'-!('\[<+@@R=)%#X#*<<$97
M/Q]^T4Y;X^_$8$ !/$%[&H!SA5F90,]\ "OT ^$/C_PEK7Q#T32HC>ZG"L,%
M\NG:E$UW<>?Y[>2JD@#<1NF)S@L5/R[0*_/GX^WB:C\<_B%<IG;/X@OI%R,<
M&=S79DU2O5A5G7NDY:)W=E:]E=MV5_\ ASR,ZA2I5*=.G9VCJ[)7?5NUE=VZ
M:'%Z7;-=ZE:0HGF-)*J[/7D5[7\?]4_LGP=X4\.PGR5OC)K4]NK?*J8\B!2,
M#^Y,W4\,.E9'PB\':1XQURTD5IK2#28_-O;UU CV*"[R>VU0Q&3SQ7.^/]>U
M7XN>,KS4K"SEOHO+'V:ULX69K:V0!8T*@9^5%7.,\DGG->^DY2T6Q^>1?UK'
M*JU94DUKWE_P+?><<+:\O4,XB>554 L.< 8'/H.0,GCM7U%^R+INIZMX9\8Z
MI<W,K6.GR00SI(<;8RK[BN.=P4OQR#WKP&'Q?9V-O'926DUXL$F5MF8VY@.W
M:Z_*26R>H8=NV37V)^RK>:9:_L]>,]2M[01-+=2,(9"'; C2(G<.2H\P@9Z9
M_&IFWRO0G&U92I-5:=ET>G37UZ=K'F?[2DVL7?AW7)OLUY)_;7B%8U#Y/EVE
MC;*H4?[)GED;'^SV-?,4^GW-H"T\+PX)7#\-GZ=>O&<8SQ7T'^UYXB?PY\9]
M0\/VL@N;/3K?82"T3"2XD:XF(P<$GS%&2#P.*\#N=36Y1$6 (X4Q^9NS\A.0
M,8P"/7_]=5%61WX7VT8I.*Y7_7<R7.78^]-ITG$C?4TVK/4"BBK.F:9=ZUJ-
MKI]A;2WE[=2K#!;PJ6>1V.%50.I)(% 'L/[(G[/EW^T=\9])\.".1=#MR+W6
M+E!Q%:H1N&?[SG"#W;/:OWITZPM]*L+:RM(4MK2WC6&&&,86-% "J!V   KP
M#]B7]F&V_9H^$L%G>1QR>+M6VW>LW*\XDQ\L"G^[&"1[L6/>O=?$GB&P\)Z#
M?ZQJEPEII]E"T\\SG 5%&2:OX5=A&,JDE""NWHD?/'[=/QC'@+X:_P#"-6%Q
MLUKQ"&@^0X:*V'^M?VSD(/\ >/I7YM@= !] *[GXU_%2]^,GQ%U3Q+=[HX9F
M\JSMV.?(MUSL3Z\DGW8UW_['7P7;XL?%*WN[V OX?T,I>7A8?+(X.8HO^!,,
MD>BFOAL14EF&*Y8;;+T[_J?U_D>!H<&9 ZN*TDESS_Q/:*]-(KSUZGVU^R-\
M)S\*?@]IT-U#Y6LZK_Q,+[</F5G'R(?]U,#'J37M=)2U]M2IQI05..R/Y-S#
M&U<RQ=3&5W[TVV_GT]%LO(****U//"BBB@ HHHH **** "BBB@ HHHH *\A\
M&?M.>%O'/Q5U+P!86.K1:Q827$<L]Q!&MN3"</M82$G/;Y1^%>O5Q&@_!3P3
MX8\97?BO2_#MI9^(;II7FOX]_F.9#ER<MCD^U85%5;C[-JU]?3R/6P4\!&E6
M6,C)R<?<Y;64N\M=CK-5F>WTR[EC;:Z1.RL.Q .*\>T/QSKMU^RG_P )1+J4
MCZ__ &%-=?;BB;_- ?#8QMSP.V*]HGA6XADB<95U*GZ&O!T^$/Q$LO T_P /
M+35/#H\(R+):)JLB3_VA%:.Q)C\G'ELX#%0V\#H<5N>2:MM\;=8A%MI%AX3O
M_$^JVVA66K7=Q%=0P(R2H=WWL?/E>% YR>F*)?CYHT%ZNNM)JO\ 9#^%UUI+
M;]UY;!I555";=_G$L%'S[>>G>NE\/_#2XT#QMK.IPS0?V7<Z)::5;1%F,JF'
MS.6XQC#KT.>#Q7GEO^S3JEWH%EI>H:G90B#PK%HOGVV]REU',LJRA2HR@*#J
M03Z4".D/Q[U#3=0OK#7?!-_HE[;:)<ZX$DO(95DBB*#8&3(WDOR#]W ZYK=U
M'XS:?I%]X3BO+.6"WUW3)]4:Y,@VVL<4*RL&'5CAL<>E>9WNB^*_%OQE_L#Q
M=<:1;3WO@W4+:(Z.9)$7?+ KR'S IR3@[<8&.IS6FGP2\9>)]0\-Q^*KO0HM
M*TC1[O1F72FF:6998!$)<NH"GY1\G;GYCTH Z7PE\>E\0:WHMKJ'AZYT2PU[
M/]DWLUW!*9SL+JLD:,6B9D!8 Y]#@\50^/\ XLGT'Q#X$L7\92^"-'U*]GCO
M]3BDMXMJK;NZ O.C(N751T[XJE\-_@;JOA/6M :[T;P+9VNCJ5;5-*TH?VA?
ME4*(S%HP(#T9BK,2>A -=QXZ^'UQXM\;>"-65K1K#1+JXGNH+D%FD5[=XU"#
M:02&8'G' H \-UKXJZUHVD_$:#PS\0I_&>CZ9X>^WP>(/+MI7L;S?@1"6*,1
M297+8VDC;[UUOPW\5Z%K_B72K>T^,7BG7=0D^;^S+FT@2&8A264L+-#CJ>&'
M3K7I/Q5\ S>,?A?XA\-:*+.QNM0M'AA,H,<*N1P6V*3CZ U0\-M\4X+W3X-5
MTSPBFF(52>6TU2[DF" 8)56@ )]B0/>@#@[KPUXIB^,ECX37XH>+/[/N-&GU
M)I=MAYHD2:- H/V7&W#GMG@<UWOQ@US5/"'@_1WT[49DN3JNG6DERRH7E1YT
M1]WRXRP)S@#KQBKUSX&OIOC)8>+EFMQI]OHT^G-"2WFF1Y8W! QC;A#WSR.*
ME^*?@N\\<Z%8V5C-!#+!J=G>LUP6"E(IED8# /)"G'O0!Q>F_&F6!'T[3=*U
M7Q-KUWK.H6MM97%S!'MCMW_>.9-JJD2Y 4$,W(!)/-:6C_&Z]\0>'+J]T_P5
MJ\^JPZO)H[:7OC!BD1%9WEESLCC&3\Q)SQC[PKSSQ#X?N/@]K^DZU/KNB:=J
ML^K:K+ =7::+3IK:Y82>5)<!?W4HV@C(()! S69X/^'OB7XG>"I]3CGTO4X)
M_%5YJ4MA>/<6VG:K T2QJRL@+E%9<J2"&V D<T >CM^T4MOHLTUQX7OQK%MK
M,.B7&E07$,K"64!D9) =KJ0R^F.<XQ5D?'S[!8:W%K'AF^T[Q'IMS:VBZ-'<
M13-=27)(@\N0$*0Q5@2<;=IS7*>%_P!G;7=$\X%] LHI/$UEKJVNF))%##%$
MJAXE4K][Y>#_ !9).WI72>,O@MJOB'Q-XCURSU"SM;V:;2[S2FE#NJ3VC2DB
M90!\C>8!\I)ZGL* .<7XZZUX:\8>-[OQ1IE[IMAI&E64J:,989 )I)73>DPP
M"K?*"S$!<'(&*]4^'WCG4/& O8]2\.76@SV^QDD:9+FVN48'#13Q_*^,$$=1
MQZUP*_#'X@ZIK?BW7-2N_#%OJ&K:=;65K:)%+=VR".1F9)1(B[U<,02!D9X'
M&3K_  :^$^H> -;UW4KBVT?0K744A1-#\/22O9QLA8M-^\5<.VX#"J  HZT
M>L4444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KBM1^,W@S2O$_\
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M[QY>XL  /F(%8\5GK?PK\0>,$C\%:CXHBUZPL4TX6@6YA9X;06YMKEV*[5W
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MU]0U8\:Y\H9/K1DT?_JHI##-&:** "BBB@!02.A(^AI.E%% !0><9YQZT44
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M5TYEW%?.A>3][&S'JK<$ $=": /4[GQ]HMKXP@\,&:>36981.88+261(XR2
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M,9D">6'V[<;@GRY].*GLO ?AO3='M]*M- TVVTRWG6YALX;1$BCE5MRR*H&
MP(!SUS7BUE^T/XBG\+>*Y+:RL]=OM&ELRFK:?IMXEHUO.Y5Y6MVS*3#L8LB,
M<@J01DXDC^._B:Y\#2ZCI-QX6\37YUVRTJTN=/>6.&99V52)H68R6[J2>&)R
M!D#G% 'L<WP^\,7'B1/$,OAW2I-=0@KJ;6<9N 0, ^9C=D#C.:T->\/:7XHT
MR73M8TZUU73Y<>9:WL*RQM@Y&58$'!KQO6OC/XL\#W>M>'=:LM(U7Q,HT_\
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M,Q'X%4HLPN?!%&,U^F7AW_@C? "K:]\3YI #\T>F:0L>?^!22-C\J]I\%?\
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M #^[N1P01VL*0PQK%$BA41%PJ@=  .@J2BBOJC\X;OJPHHHH$%%%% !1110
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MS;CD],#F.'X@^+;CXAZUXFTRV^W6A\'6^IV_AUX)1.&<N1']_ <.#N(3)4
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MC'BY4<1.\=XVVL]G_P $****]H^3"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@"KJ=B-2T^YM&<QK/&T98#)&1C/ZUPUK\';2VT/P
M)IIU&X>/PI*LD3F-<W.(7BP_IPY/'I7=:E%=3:?<QV,\=K>-&PAFFB,J(^."
MR!EW 'MD9]17B6D:O\4[WXH:IX2E\6>&RFG6%MJ#W*^'9095EDD4H%^U_*1Y
M?7)^]TXH Z7P[\$[KPU=6%I:>--;C\*Z?<FYM="B,<:IR6$33*!(\().(R<8
MP#D"L_7?V:]&UNY\>3_VG>VTGBE(E!B"_P"@,A#%XO<NJN<]Q69X<\2?%'QQ
M_P )3J&CZYX;M;?2]9NM.M].O='E8RK$1C=,LXQG/4(<5 /C#XH\=R?#VU\-
MSZ;X<N]>6_74!J-FUZ+::UX>-0LL>1O5AG/3!H$>R>&O#5KX7\+Z;H=IG[)8
MVL=K&2 "550,GW.,_C7EEA^SG/HK:3-I?C+4+.]TE[I+*X:RMY?+MKAP[PE6
M4@D,,A^&[<BMCX;^.?$-QX_\1^#?$EUI6KW.EVMO>)J>D0-;J5D9E\N2)G?:
MXVYX;D&I_CI\4[GX;>$IWT:VBU#Q)/!+)9VLOW%2-2\DTF"/D11D^I*KU- %
M7PK\!+3PM=Z1<#7;_4)-.UBZU@/=JA>:2>(HZNP [L6R /3I7EGQ5\(>(+Z^
M\:^'M!L/%EA%K\X;[%9VL,NF7DCHBF<W1&;=3C$B9R=G'WJ]5\4^+O%@T'0K
M^PO-$\/:5)IHOM2U_65WPQ.40K"L7FH<L6)W%L #N2*I:9\7M7D^'O@WQCJ-
MC;VMA?726NIQJC85))#%'<1$G(0ML;# _*_M0!=O_@I=KJ-U>Z%XPU3PP^I6
MT,&J1V,<3BX,:!!*A=28I-HQN7L!W%6=3^"ZWFOMJ-MXEUBP$VC+HUP(I09Y
M%3)CE$Y^=9 S$ELG=WKTD<TM SS_ ,%_"NX\/^*I?$FM>([OQ+K)L_[/BN)[
M:&W$<.X,05B4;F)5<L?3@"J>O>$+B+XJMJ*VMQ<:/XBTEM(OWM\YMW0L\4A(
MY *M(N[L2M>F44 >-Z%^SS-I4OA1;GQCJ6H6'A>Y2;3;!K2WBB"*C)MDV*#(
MVUL;R<]>,DUW?B[P0^O:=#%I.KW?A>^@G6XBO-,5!EAD;9(R-LB$$Y5AC\:Z
MFB@#POQM\-CX6^&7BG3$M]7\8^(/%4W[VYM;6-"+DH$BD*H%2%$V*=W8C)))
MKK]%^$%OIVG> 8FO)$F\+DRGRU!%S*\3)(S$\C+2,V1WKT6B@#G/"_@R'PQJ
MGB2]CN9)VUN_%^Z.H B(ACBVKCJ,1@\^IKS?6?V:AJEGKNE1>,-4LO#^JWKZ
MB^G16\!(G9PYS*5WNFX9V$^V<5[710!Y_<?"&VN=+\=V3:E.!XL),SB-<V^8
M5B^0=^%SSZUB:]\ S>M?#1_%>J>'8=4L8K+5([2*%Q="./RUD!=28WV\$KU&
M/3->MT4 9'A'P]'X2\+Z3HD4S7$6G6L5JLK@!G"*%!('':M>BB@ HHHH ***
M* "BBB@ HHHH **** "O)_B1^S/X0^*?CG3?%FM-J0U6P2)(1:W?EQXCD+KE
M=ISR3FO6**SG3A57+-71VX3&XG 5/;86HX2LU=.SL]T)7B?CK0?%%YK>M66M
M_#[3OBCX<NI?.TN1YK2":P4H T$@E"_*&!82*2V&((.!7MM%:'$?-L?PW^(W
MAWPMX*T:1-3U?2+2TNA?Z?X?UQ;2>.9YM]O&9Y2K20QQ$Q\,&R <$<58^%_P
MD\5>'7\$?VCI2VPTSQ1J^HW6+\7/EV\]K<)$PD9M\GS2HN3\V<D@5]%44"L?
M+?AGX#:MHL6G>&[WP=-JT=IJHE.NW/B>X73WMEN/.63[(DP83 8 39LWC<6Q
M7K_QLTWQ;J>@Z9%X5^UNJWZ-J5OIMW':7DUKM;*PS2?*C;BA/() (!&:]%HH
M&?+6F?!CQ@$\6.="N+6/4M;T&_M8;[6%O9_)MY5,_F2LY^=0I;:"1R I-=M\
M4_A3X@\9>)_%UWIT,")<:1I'V"6XE CFNK2]N+@PN!EE4AD&XC'S]\&O;Z*!
M6/'_  ?I_B_7?C6?%.M^%#X:TJ/P\VG1B6_@N)6G-RDC!A&QPN!\IYZ'."<5
MN?&_PEJOC'PYH]KI%L+J>WUW3KV53(J;88KA7D;+$9PH)QU/:O1**!G'ZY\.
M_P"VO%$.M?\ "2>(+,1A5_LVUO\ 992;<_?BV\YSSSS@5YUX+\,_$#3O"&@?
M#NXT2VTW2=.MWTZ^\1"ZCE2ZM5B>.,V\0.]96RA)< +AL;LBO=:* /FCX<_!
MC6-&N_!NFZGX*D\S09HWN-<N_$]Q/9/Y*%8Y;6U$QP[<$*Z*J L.>*W?@_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)_\ $T?\+D\'?]!N/_OS)_\ $U\L44?\12S?_GS3^Z7_ ,F'^IN!_GG]Z_\
MD3ZG_P"%R>#O^@W'_P!^9/\ XFC_ (7)X._Z#<?_ 'YD_P#B:^6**/\ B*6;
M_P#/FG]TO_DP_P!3<#_//[U_\B?4_P#PN3P=_P!!N/\ [\R?_$T?\+D\'?\
M0;C_ ._,G_Q-?+%%'_$4LW_Y\T_NE_\ )A_J;@?YY_>O_D3ZG_X7)X._Z#<?
M_?F3_P")H_X7)X._Z#<?_?F3_P")KY8HH_XBEF__ #YI_=+_ .3#_4W _P \
M_O7_ ,B?4_\ PN3P=_T&X_\ OS)_\31_PN3P=_T&X_\ OS)_\37RQ11_Q%+-
M_P#GS3^Z7_R8?ZFX'^>?WK_Y$^I_^%R>#O\ H-Q_]^9/_B:/^%R>#O\ H-Q_
M]^9/_B:^6**/^(I9O_SYI_=+_P"3#_4W _SS^]?_ ")]3_\ "Y/!W_0;C_[\
MR?\ Q-4->^-GANTT>ZET[44O;Y4/DP"-QN;MDE0,=Z^9Z*SJ^)^<5*<H*G3B
MVK72E=>:O*UT7#@_ 1DI.4G;I=:_@>C?"?6-"T[Q!=Z[XCU-([P$F%9$=BSM
M]Z0X!^@^IKV'_A<G@[_H-Q_]^9/_ (FOEBBO'R;CK'9'A5A<-1@U=MMJ3;;Z
MM\R]/1'=C^',-F-;VU:<KV2235DET6A]3_\ "Y/!W_0;C_[\R?\ Q-'_  N3
MP=_T&X_^_,G_ ,37RQ17N?\ $4LW_P"?-/[I?_)GG?ZFX'^>?WK_ .1/J?\
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M5QK,JJKO$123:L][/\3TWP_AIX-8*<I.*=T]+KTTV^1]C_\ "]_ G_0P0_\
M?F7_ .(H_P"%[^!/^A@A_P"_,O\ \17QQFC-=G]N8C^6/X_YGF?ZGX'^>?WK
M_P"1/L?_ (7OX$_Z&"'_ +\R_P#Q%'_"]_ G_0P0_P#?F7_XBOCC-&:/[<Q'
M\L?Q_P P_P!3\#_//[U_\B?8_P#PO?P)_P!#!#_WYE_^(H_X7OX$_P"A@A_[
M\R__ !%?'&:,T?VYB/Y8_C_F'^I^!_GG]Z_^1/L?_A>_@3_H8(?^_,O_ ,11
M_P +W\"?]#!#_P!^9?\ XBOCC-&:/[<Q'\L?Q_S#_4_ _P \_O7_ ,B?8_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?Z_#HLJLB0I+'O,Q;/3YATP/SK6\8_#;3_#"2P6WB%-4U>-U3^S8K?$IS@]
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MCV49Y^M<*.!7K7BSX;^-O%5\DCZ=9VEG GE6MG%=+Y<">@]_4UA_\*-\7?\
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M!R 0H!Y_"KU?VGA8N-"G%[I+\C^?JS3J2:[L****Z3$0]*^$O&/_ "-^N_\
M7_<?^C6K[M/2OE;Q'\ _&>H^(=5NX+&U:&XNYI8R;M 2K.2..W!KYW.:-2M"
M"IQ;U>Q]YPIBJ&%J577FHW2W=NYY'17I?_#.WC?_ )\+3_P,2C_AG;QO_P ^
M%I_X&)7RWU+$_P#/M_<S]'_M;+_^?\?_  )?YGFE207,UK)YD$LD,F,;XG*G
M\Q7H_P#PSMXW_P"?"T_\#$H_X9V\;_\ /A:?^!B4?4L3_P ^W]S$\UR]Z.O#
M_P "1YT]Y<23K.]Q,\Z])6D8N/\ @6<TOVZY_??Z3-^^_P!;^];]Y_O<_-^-
M>B?\,[>-_P#GPM/_  ,2C_AG;QO_ ,^%I_X&)3^IXK_GW+[F+^U,N_Y_0_\
M D>=&\N&6)3<3%8N8U,C$)_NC/'X5)+J=[,KK)>7,BN &#SNP;'3.3S^->@_
M\,[>-_\ GPM/_ Q*/^&=O&__ #X6G_@8E'U/%?\ /N7W,7]J9=_S^A]Z//?[
M3O#*9/MEQYA787\YMVWTSG./;I4,,TEO(LD4CQ2+T>-BI'T(KTC_ (9V\;_\
M^%I_X&)1_P ,[>-_^?"T_P# Q*/J>*_Y]O[F-9IERT]M#_P)'G7VRXV2I]HE
MV2G=(OF-ASZL,\GZTDMU-<!!+-+*(QA!(Y;:/09/'X5Z-_PSMXW_ .?"T_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBU:ZM6:X9AQL\F5QGM@D$]A6Y+K>G0?;/,O[:/[& ;G=,H\@$9!?GY<CGG%
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M>2/G/XD?#5_"/B+X;7G_  E7B?70WBNTC-OK&H"XA7Y9/FVA!\PQP<]S7+:
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MO-6MH+C3HX9KJ-F.Z%)6*1,PQP&8$#Z5T'% A:*3-+0,**** "BBB@ HHHH
M**** "O$_P!J;X&:Q\=O">E:5HVJ6FESVE[]I>2[$A5EV,N!LYSDU[91656G
M&M!PGLST,OQU?+,5#%X9VG!W5U?\&<G\*/"-UX!^''AWP[>W$=W=Z;9QVTL\
M.=CLHY(SSCZUXS\=KS1+'XZ^%)=?\6WO@RQ.A7RC4;&\^RLS^?!B,N5;(/)Q
M[>U?259UQX@TVUUNTTB:\BCU.[BDF@MF/SR(F-[ >@W#/UJXQ48J*Z'+7K3Q
M%6=:I\4FV_5N[/G_ ,1ZYX'U?X.:WI>E>*[_ .(MU<7D,%@9-0%S=QW[D?9A
M'(%&PJR[\XX"L3Q7)V<%KI_A#2K+Q79O->Z3XL2?QV\R&5+EF1S%=2 +\UN3
MY) QM4+@CY37UX<#GCBJ>E:O8ZY:?:]/NH;VVWO%YT#AE+(Q5AD>C @^XJC
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M")$54".]E,S8=6 *JP+9#=.:]L\'?#1?#6OW>O:CKVI>)=<GMULQ>:CY2>5
M&W>6B1(BC+8).,G YXKM: L+129K"TOQUH&M>(]0T&PU6VN]6T]0UU:PMN:'
MI][L#R.,YYH&;U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M82# R[94@YXP16IYIH:[\0?'.@:78-J&D>&-)GN?,FEOM2UIH;&UC 79$S%
M[S-ELA5VC:3GD"M;X9_&/2_''@?3]<OY[#1Y[B6>W,1OD>)WBD,;-$YQO0D
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M\$-X \.RZ8UX+XO>W5WYHC\O'G3-)MQD]-V,]\=JZN@84444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO'_Q/\9>'/&MW-=ZE-X8T!7MFTZ:?13=:5=1,JF3[3<H&DB?<64?= PIYYH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
F%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>aciu-20231231x20f010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %; QX# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "J
M&K:]IVA0F74+V&T3K^]< GZ#J:Y7XI?$5/ ^F+';[9-3N ?*0]$']XU\TZIJ
M]YK5Y)=7UQ)<SN<EG;-?EG%/'5#(:OU3#P]I6ZZV4>U^K?E^)]EDW#E3,H>W
MJRY:?3N_3_,^G5^+_A)I-G]KH/<QOC^5=+::UI]]9FZM[VWFM@,M*D@*J/<]
MOQKXTBADG<)&C2.3@*HR:ZZ&QUOP&D.JVEVH7@2QJW )ZJR]QVS7QN6^).8U
M7*IBL*I4X[N%TX^=FW?TT]3W\7PGA8)1HUFIO92MK]R5CZ3_ .$NT+_H-:=_
MX%Q_XT?\)=H7_0:T[_P+C_QKYP\5:79:]HJ>)M)A%N"_EWUH@XBD/\0_V37%
M5MCO$G&X*KR/#1E%I.,E)VE%[-:?>MT[IF>'X3P^(AS*JTUHU973[?UN?8G_
M  EVA?\ 0:T[_P "X_\ &C_A+M"_Z#6G?^!<?^-?'=%>?_Q%7%?] L?_  )_
MY'5_J71_Y_/[D?8G_"7:%_T&M._\"X_\:/\ A+M"_P"@UIW_ (%Q_P"-?'=%
M'_$5<5_T"Q_\"?\ D'^I='_G\_N1]B?\)=H7_0:T[_P+C_QH_P"$NT+_ *#6
MG?\ @7'_ (U\=T4?\15Q7_0+'_P)_P"0?ZET?^?S^Y'V)_PEVA?]!K3O_ N/
M_&C_ (2[0O\ H-:=_P"!<?\ C7QW11_Q%7%?] L?_ G_ )!_J71_Y_/[D?8G
M_"7:%_T&M._\"X_\:/\ A+M"_P"@UIW_ (%Q_P"-?'=%'_$5<5_T"Q_\"?\
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M,?-6/Z/3X@TL==2M!]9U_P ::?$ND#KJMD/K<)_C7\X1UG4#UOK@_P#;5O\
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MC_AH#X7_ /12/"/_ (/;7_XY7\\6:,T<P6/Z'?\ AH#X7_\ 12/"/_@]M?\
MXY1_PT!\+_\ HI'A'_P>VO\ \<K^>+-&:.8+']#O_#0'PO\ ^BD>$?\ P>VO
M_P <H_X: ^%__12/"/\ X/;7_P".5_/%FC-',%C^AW_AH#X7_P#12/"/_@]M
M?_CE'_#0'PO_ .BD>$?_  >VO_QROYXLT9HY@L?T._\ #0'PO_Z*1X1_\'MK
M_P#'*/\ AH#X7_\ 12/"/_@]M?\ XY7\\6:,T<P6/Z'?^&@/A?\ ]%(\(_\
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M_%5\*4N:/[=J?R+[P_U-H_\ /Y_<C[J_X3?P[_T']+_\#(__ (JC_A-_#O\
MT']+_P# R/\ ^*KX5S1FC^W:G\B^\/\ 4VC_ ,_G]R/NK_A-_#O_ $']+_\
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M$\?XUQ6I^)M0O[6XMBBI;%SG$8W*-Q(4MC. >U='<:TMKJUMIUK^[.09]O\
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M **** "BBB@"UI/_ "%+/_KLG_H0K[-M_P#CWB_W1_*OC+2?^0I9_P#79/\
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MN!;-+]IC*Q.?X7(;Y3]:Z/4OA5'X<UG7[%[4ZW':::UPDL5VD;0L$!,C*#G
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M "R^Y?YGS+17TU_PHSPG_P ^DW_?]_\ &C_A1GA/_GTF_P"_[_XT?\0QSO\
MGI_^!/\ ^1#_ %OR_P#EE]R_S/F6BOIK_A1GA/\ Y])O^_[_ .-'_"C/"?\
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M+_,^9:*^FO\ A1GA/_GTF_[_ +_XT?\ "C/"?_/I-_W_ '_QH_XACG?\]/\
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MP8S*J]>O*I!JS_KL>UE7$F#P6#IX>HI<T5T2[^I\BT5]=?\ #.W@O_GQG_\
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M,Y0^<4W[=KJW3(],=: ///'?QPCL+W3(=)>_M(Y8[B2XDO-&N(R D>X%?.5
MQSV!K5_X7?8V.B3W;:7J^L16%G!<7UY96\*HGF*"/E:4'.#D@9QZFM3XG?#1
MOB(EBJZ@+#[,DZ9,/F;O,CV?WAC'6O)/'7@CQ1H:7_AOPXNI/;ZG96UM<2QZ
M?')!.ZJ$+B4R PX Y!5O:@1VGAOXZ22W7B&34]*U&32[75DLK>]@BB$:(ZJ4
M#YD#$C=R0IKN/'7Q$TOX?1:>VHK++)?S_9X(H3&I9L9))D=5  ZDFN6L/@O+
M;^%]3TM]53S+[4(M0,BP$B/8$RGWN?N]>.O2MWXF_#A?B!:Z<\5U'9:CIL_V
MBVEN+<7$.2,%7C)&Y2/<?6@#SSQI\>[W4;&R;P?#-#()[J.[:XAAF*F"/?M&
M)=I!_O GCWJW\/\ XTW<7AP7?B:6ZU+4KN:UCM[&TL8HF#3Q[E5#YI##'.6*
MD5I6_P ")8],M(9=<$EVKW<L\BVH2(M-$8\1QAL(J]0,GZTD7P&:#2HHHM;,
M6I6C6<UE=K;_ "Q2P1[,LA;YE;)R,CZT!J=0WQ,2*Q>YF\.ZW;>7<M;2I<Q0
MQ>7M&?,+M*$*'L0QK)T7X]:'XFCM!H^G:GJEW<&?%G;+"9$$)VNQ8RA",\##
M'-4=9^#VO:Y96$M[XIAU#5[>[>Y=[_3A/9X90NQ("_R 8R#N.#ZUG>'?@%JG
M@Z&*ZT7Q/#;ZY'-<$7DNG!XFAF;<R&(.!D'D$$?0T ==+\8='M?M*WEGJ5C/
M!IPU,V]S;A)&C+;=H&[[X;C'3D<UO:KXMMM&\.0ZS<VMTMM)Y6Z,(OF1B0@
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MXQ):[U!5@3(1N'49&/?K7>QA@BAR&< 9(&,F@8ZBBB@ HHHH **** "BBB@
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M6:A#F>R5QPBY2MW,RBOHG_A5'PW_ .A<^+7_ (*(O\*/^%4?#?\ Z%SXM?\
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M&CPA$D&[4I?.FNFLDM193FX\Y4WE#%LW@[3GD<BN@T/Q5IOB;1&U72[C[1:
MR*6='C*LA*NK*P#*0RD$$9&*\NT_X2>(;KXH6WC/43IUN[ZFUU-96\S2"*);
M3R$VL4&]R>3D+^-=[X0\+7>@Z+K=I<-"TE[J5_=QF-B0$FGD= >!SAAGW]:
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M<G\*_!T_@'P%I>AW5PES=0>;)-)$,)YDDKRL%!_A!<@>P%=90 4444 %%%%
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MR0Q(Q41@>8-S$]6R..U=O_PHGP:;Z*Z.G3F2&X-W"AOI_+BD.<E$W[5SDY
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M[OX#:AJ?CN#4)CIMII4&IC4M]I)<"20C. 82YB5CGEP,G% 'N-%%% PHHHH
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M)<PK(RF4'NIYV_K1:_M\^,=%\6^.=8TC2-,MX?%$@D:WG5I/L["/RPRL",G
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MAZ?&90RR;;9!O#8W \<YP,_2M";2+&X=WEM()&>'[.Q>,$M'_</^SR>*MT4
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MS*T_E2P*R^8Q)9\$?>)))/?-:M% #(HDAC6.-0D: *JJ,  = *?110 4444
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MA97A,<3Q(?F!Y),RXQQP:O:IX@TO0S"-2U*ST\S';$+J=(O,/HNXC)^E>&_
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M\B!C&2,$J3TXH ^9++XBZS'J4=S9>)KR*UU+2[RY675=0BN"A504D^SQ(?)
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M:]0LO"6B:=JT^J6ND65MJ4_$MW%;JLLGU8#)JXVF6;Z@M^UK";Y8_)6Y*#S
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MKUE)9ZC9PWMK(,/#.@=6'N#7SW\1?V&O!7BR62ZT26;PW=-SL@^>$G_=/(_
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MG^XX!)]WRK\DW^)^:'A']E#XF>-9 _\ 8LFGPM@F?4G\H8]0#R?RKZ"^'_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-$8]2J@$U)0,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7_),_"O_ &#+?_T6M=57W4/A1_'.+_WBI_B?YA1115G*%%%% !1110 4444
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MSC<3B@#TFBO.=1^+'V+4TMHDL;N-]2:P\R*=_P!T!$9-SY3KQT7<,=ZSK/\
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MRB-QQD;]O!%>KZ]XJ?1? E]XA%J)GMK%KS[,LH(8A-VT.,@^F119!SR[FO\
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MYA.\DEO!++93K;RS*"2BRE A/'9JN^#?&/\ ;'P_LO$>K-!9![=KBX9,K'&
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=W8[+::5$9BJY;=T1B,J =O!KG],^/NGVV@:7)<66M:]=2Z3%J\]QI^FJJI
MS.ID=?,(3'EL=NXG'3=S@ ]<HJMIVH0:K86][:R"6VN(UEC<=&4C(-6: "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#C
M/B!\'?"/Q2FT^7Q-I1U*2P):W(N98MA)!/W&7/3OFNPAA2WACBC&U$4*HSG
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#YKTGPS=^'9?#^H>(O!VH>(M,72I;-;.&T%P]M.96)W1'H'4@;NV.:Q;G
MX1^*7T[3-#.EW,-MJ&GI>73(VY;>XMU<11LPSSS%CG^"OJZB@5CSGX':-J-G
MX6N-5UNTDLM;U>Y:[N8)@0\8^ZBG/HH%>%>$_#S>(_A]HMMH7@Z]L]2M(KZ>
M[U4VJHERCQ2KL20',A=F4[>VWG%?7=5-*TFST2PBLK"VCM+2(82&)=JJ/84
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MC_T$?^2__;'VI]OMO^?B+_OL4?;[;_GXB_[[%?%>:,T?\17G_P! 2_\  _\
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M5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?TO\
MZ!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_
M .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_
M  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R
M(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_R
MK_P)_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY
M7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_
M *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH
M_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI
M_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?
MTO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30
MHK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]
MW]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)
M_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"C
MFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!U
MI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$
M?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^
M5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?TO\
MZ!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_
M .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_
M  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R
M(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_R
MK_P)_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY
M7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_
M *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI_P!^5_PH
M_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?TO\ Z!UI
M_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30HK/_ .$?
MTO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]W]W_  30
MHK/_ .$?TO\ Z!UI_P!^5_PH_P"$?TO_ *!UI_WY7_"CFK_RK_P)_P#R(6I]
MW]W_  3C?CM_R3VX_P"N\7\Z^9J^F?CM_P D]N/^N\7\Z^9J_E_Q-_Y'<?\
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M%5X-1M;IE6&YAF9E+*(Y Q(!P2,=L\4 6**** "BBB@ HHHH **** "BBB@
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MT/\ W[%6**/94_Y5]P<\NY7_ +.M?^?:'_OV*/[.M?\ GVA_[]BK%%'LJ?\
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MV5/^5?<'/+N5_P"SK7_GVA_[]BC^SK7_ )]H?^_8JQ11[*G_ "K[@YY=RO\
MV=:_\^T/_?L4?V=:_P#/M#_W[%6**/94_P"5?<'/+N5_[.M?^?:'_OV*/[.M
M?^?:'_OV*L44>RI_RK[@YY=RO_9UK_S[0_\ ?L4?V=:_\^T/_?L58HH]E3_E
G7W!SR[E?^SK7_GVA_P"_8H_LZU_Y]H?^_8JQ11[*G_*ON#GEW/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>aciu-20231231x20f011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %) \L# 2(  A$! Q$!_\0
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M_H-7G_?PT?\ "Q/$O_0:O/\ OX: /LNBOC3_ (6)XE_Z#5Y_W\-'_"Q/$O\
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M_P +$\2_]!J\_P"_AH ^RZ*^-/\ A8GB7_H-7G_?PT?\+$\2_P#0:O/^_AH
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M_#1_PL3Q+_T&KS_OX: /LNBOC3_A8GB7_H-7G_?PT?\ "Q/$O_0:O/\ OX:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&[3%EY6P;FR"!NSGO4OP_MKK0-!\+K&=1U%;Z1FV:?LCMH1D9\U@NYOQ..*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!]!?LQ?\ (*UW_KM%_P"@M7ME>)_L
MQ?\ (*UW_KM%_P"@M7ME 'A_[3?_ !YZ+_OR?R%> U]3_%WPA!XO.G0SSR0+
M%N<&,#)Z#O7G/_"DM/\ ^@A<_DO^% 'CU%>P_P#"DM/_ .@A<_DO^%'_  I+
M3_\ H(7/Y+_A0!X]17L/_"DM/_Z"%S^2_P"%'_"DM/\ ^@A<_DO^% 'CU%>P
M_P#"DM/_ .@A<_DO^%'_  I+3_\ H(7/Y+_A0!X]17L/_"DM/_Z"%S^2_P"%
M'_"DM/\ ^@A<_DO^% 'CU%>P_P#"DM/_ .@A<_DO^%'_  I+3_\ H(7/Y+_A
M0!X]17L/_"DM/_Z"%S^2_P"%'_"DM/\ ^@A<_DO^% 'CU%>P_P#"DM/_ .@A
M<_DO^%'_  I+3_\ H(7/Y+_A0!X]17L/_"DM/_Z"%S^2_P"%'_"DM/\ ^@A<
M_DO^% 'CU%>P_P#"DM/_ .@A<_DO^%'_  I+3_\ H(7/Y+_A0!X]17L/_"DM
M/_Z"%S^2_P"%'_"DM/\ ^@A<_DO^% 'CU%>P_P#"DM/_ .@A<_DO^%'_  I+
M3_\ H(7/Y+_A0!X]17K[?!73EQF_NCDXZ+_A3O\ A26G_P#00N?R7_"@#QZB
MO8?^%):?_P!!"Y_)?\*/^%):?_T$+G\E_P * /'J*]A_X4EI_P#T$+G\E_PH
M_P"%):?_ -!"Y_)?\* /'J*]A_X4EI__ $$+G\E_PH_X4EI__00N?R7_  H
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M_P#00N?R7_"@#QZM#2_$.JZ(LBZ=J=YIZR$%Q:SO&&QTSM(S7J/_  I+3_\
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M<_DO^%'_  I+3_\ H(7/Y+_A0!YA:>)=7L+5+:VU6]M[>-_,2&*X=45LYW
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M .@A<_DO^%'_  I+3_\ H(7/Y+_A0!X]17L/_"DM/_Z"%S^2_P"%'_"DM/\
M^@A<_DO^% 'CU%>P_P#"DM/_ .@A<_DO^%'_  I+3_\ H(7/Y+_A0!X]17L/
M_"DM/_Z"%S^2_P"%'_"DM/\ ^@A<_DO^% 'CU%>P_P#"DM/_ .@A<_DO^%'_
M  I+3_\ H(7/Y+_A0!X]17L/_"DM/_Z"%S^2_P"%'_"DM/\ ^@A<_DO^% 'C
MU%>P_P#"DM/_ .@A<_DO^%'_  I+3_\ H(7/Y+_A0!X]17L/_"DM/_Z"%S^2
M_P"%'_"DM/\ ^@A<_DO^% 'CU%>P_P#"DM/_ .@A<_DO^%'_  I+3_\ H(7/
MY+_A0!X]17L/_"DM/_Z"%S^2_P"%'_"DM/\ ^@A<_DO^% 'CU%>P_P#"DM/_
M .@A<_DO^%'_  I+3_\ H(7/Y+_A0!X]17L/_"DM/_Z"%S^2_P"%'_"DM/\
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M]ZL,P12S$  9)/:O.-5_Y+SHG_8(G_\ 0Q6G\8_$Z^%/A[JMT'V32I]GA/\
MMOQ_+)_"@#IK#Q!I>JV4MY9:C:7=I"2))X)E=$(&3E@<# K*_P"%E^$?^AHT
M;_P/B_\ BJ\A^!OB#0$\4ZEX;TNX:ZTF_LHY DZ%=TRH%F&#_>Y/X^U:NK?#
MCPQ#\9M"TQ-$LUT^;39I9+<1_(S@G!(]: /4;WQWX;TV1([OQ!IEJ[HLJK->
M1H61AE6 )Y!'0TDGCK0%TY;^+4X;ZU:86ZO89NBTAZ(%B#$GV KQ;QOX7U'4
MOBSJ%GH?AW1]92VTVV7R-4!V0H 0-F'7TQ7:Z%X*O(O!]K;ZEX2TZ*[CO6N#
M9:5<F"-?E*K(,L=QYZ%AZ]J /3+6Y2\MHIXQ(J2*& EC:-@#ZJP!!]B :EK+
M\*V-[IGAW3[749_M-[#"J2R@YR?KWQTSWQ6I0 4444 %%%% !1110 4444 %
M%%% &YX2_P"/ZX_ZYC^==57*^$O^/ZX_ZYC^==50!R_B_P#X^K7_ '&_F*P:
MZ'Q3!+<7EL(HFD(1B0HSCD5C_P!FWG_/K+_WS0!6HJS_ &;>?\^LO_?-']FW
MG_/K+_WS0!6HJS_9MY_SZR_]\T?V;>?\^LO_ 'S0!6J*[MDO+6:WDSY<J%&Q
MUP1@U>_LV\_Y]9?^^:/[-O/^?67_ +YH XC3?AAHVE)X?6%KG&AM(]KND!R7
MSNW<<_>/I5E?AYHV_P 0F6*2X3765KR.5LJ< @;>..M==_9MY_SZR_\ ?-']
MFWG_ #ZR_P#?- 'GFD_!O1-(UC3M36ZU2[N[ ,D#7=XTH1"I78 1PH!. ,59
M_P"%3Z"?#$&AE;G[-;SFY@G$VV>&0DG<K@#!Y-=U_9MY_P ^LO\ WS1_9MY_
MSZR_]\T >>?\*8\./H=YILRW=RUW,+B:^FN&>Y:0='WGN,G\ZET?X2:)HUWJ
M%RDM_=3:A:FTNGO+DRM,I.=Q)YW<=CCVKOO[-O/^?67_ +YH_LV\_P"?67_O
MF@#@]#^%.DZ#=:1/%=:C</I7F"U%U<^8$5UVE>1PH'0#&*BF^#GAZ?4Y+IOM
MHMI)_M4FFK=,+1Y<YWF+IG->@_V;>?\ /K+_ -\T?V;>?\^LO_?- '.0^$;"
M#Q+>:XGFB]NK=;60;AL"+TP,<&G^%/"UEX-T2'2M/,IM8BQ4S-N;DY/.!ZUT
M']FWG_/K+_WS1_9MY_SZR_\ ?- %:BK/]FWG_/K+_P!\T?V;>?\ /K+_ -\T
M 5J*L_V;>?\ /K+_ -\T?V;>?\^LO_?- %:BK/\ 9MY_SZR_]\T?V;>?\^LO
M_?- %.7K'_O4^I)M/NU,>;:49< 97KUJ7^S;S_GUE_[YH K459_LV\_Y]9?^
M^:/[-O/^?67_ +YH K459_LV\_Y]9?\ OFC^S;S_ )]9?^^: *U%6?[-O/\
MGUE_[YH_LV\_Y]9?^^: *U9?B;P[;>*]#NM*O'FCM;E=LA@;:Q&>F<&MW^S;
MS_GUE_[YH_LV\_Y]9?\ OF@#E?$'@/2/$GAE="NHFCL4$80PD*Z;,;<''MBL
MC4OA!HFK6NL07$U\PU9X7NF68!F,?W<?+WSS7H/]FWG_ #ZR_P#?-']FWG_/
MK+_WS0!Y]:_"33[?3+S3Y-9UV\L;JV-JUO=Z@TB(AQ]Q2, C&!6I+\/]+EN/
M#DS&??H*E;3#C!!55^?CGA1Z5UO]FWG_ #ZR_P#?-']FWG_/K+_WS0!YZ_P:
M\.OJSWF+Q8'N/M;Z<MRPM&FSG>8NF<_AVZ59U/X5Z+JO]M^>UT/[8EAFN=D@
M&&C.5V\<>_6NY_LV\_Y]9?\ OFC^S;S_ )]9?^^: .9;P9I[>)&ULF;[:;/[
M"1O&SR\YZ8Z\]:R7^$NA/X8T_1/]*2&PD,UK=1S;+B%SG)5P!CK_ "]*[S^S
M;S_GUE_[YH_LV\_Y]9?^^: .!;X1Z"_AB[T-C=O!>3+<7-S).7N)I <[F<@Y
MZ5V:1JD0CQE0-N#Z5;_LV\_Y]9?^^:/[-O/^?67_ +YH \['P7\/"]60OJ#6
M*S_:1I37CFS$F<Y\KIUYQ_2N@\6>#].\9Z='::@LJB*030SV[F.6%QT9&'0U
MTG]FWG_/K+_WS1_9MY_SZR_]\T ><1?!3P_'#JZ&74)6U6%8;N6:Z,DC[2#N
MW,"=Q(Y-6=5^$FC:G+'+'=:GILPMUM99-/O&A,\:C $F.&XKOO[-O/\ GUE_
M[YH_LV\_Y]9?^^: .(U+X6Z#?Z3I=A%'/IRZ9_QYW%A,8IH<]2''//?/7-13
M?"/P_/X;31BMTL:7'VP7:W#?:?/_ .>GF==W-=Y_9MY_SZR_]\T?V;>?\^LO
M_?- 'F\7P1\-1K>[OMTTEYL:2>6Z9I?,4Y$H<_,'YZYQ[5I:)\,=&T8:@TAN
M]6N+^+R+BYU2X,\K1?W-QZ#Z>WH*[;^S;S_GUE_[YH_LV\_Y]9?^^: .%\-?
M"K1O"^I0WL$M_=26R&.U2]NFE2V4]5C4\*.U=C5G^S;S_GUE_P"^:/[-O/\
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M\/>.=<?5M1DODNFC6,_9Y@BX7IQM-;?@7P#IOP]TV>QTM[AX9I?.8W,@=MV
M.#@<<"NM_LV\_P"?67_OFC^S;S_GUE_[YH K459_LV\_Y]9?^^:/[-O/^?67
M_OF@"M15G^S;S_GUE_[YH_LV\_Y]9?\ OF@"M15G^S;S_GUE_P"^:/[-O/\
MGUE_[YH K459_LV\_P"?67_OFC^S;S_GUE_[YH K459_LV\_Y]9?^^:/[-O/
M^?67_OF@"M15G^S;S_GUE_[YH_LV\_Y]9?\ OF@#3\)?\?UQ_P!<Q_.NJKF?
M"]O+;W\PEB>,F(8W#&>:Z:@"C/\ \A-/^N1_F*FJ&?\ Y":?]<C_ #%34 %%
M%% !1110 445XQ\;?&OBK1O&OAG0_#>N:;H0U&"XDEN-45?)!3!&6*G'<?4T
M >ST5X/X#^,^M:3)XPL_%UW8^(1H%HM\=0T/:RR(1R@^Z"1^'>NPMOCEIDOA
MMM<GT;6+*RD,*6?GVZA[YY,[4A4,23P<YP/?% 'I%%>;2_'/2[70]:OKK1]7
MM+O1_+>\TN>%%N8XW(Q)C?M*\YR#6Y-\2]*7Q3I6A01SWES?V+:B)8%5HX8
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M!]T5T.M?%74;7XZ>'O!=E:VLND75K,]]=R!C*LWEM)&D9!"C"KEL@\.F,<T
M>H45ROB;QYI_A+4;K^T;U8;6TTJ?59X5M7>3RHB"[APV.!GY-I)['M2^$/B3
MHOC:]N;33VNH[JWABN3#>6SP,\,F[RY5# ;D;:W(]* .IHKD/#GC"\UCQGXV
MTB:*!+?0Y;9+=T!WN)+=96WY.#R<# '%9OASXD7^H_!I/&4VFK>:@+.6Y-A9
M;E$C*6 5<[B,X'K].U 'H-%>9_#SQEXB\2WUG/\ VSX7\5:)<P[KB704:"73
MG*[D5P\\OF \KTC((SMZ@;OBK6-9TWQEX0M[:6UBT>^O)+:Z1HR\\K?9IY%
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MZ31110 4444 %%%% !1110!5TO\ Y!UM_P!<U_E5JJNE_P#(.MO^N:_RJU0
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ME8/"KQMN*@8RP&"6Y"XH ]<HK"UCQ%%I.N:-837<<3WJSD0FV9VE\M QVN&
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MY)P<8KZ HH ^=_#OPNGL/%GPYT2YN[.6XT?3Q+K5I;OYF?*D+VK'I@>:Q()
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M1M.BAVB# LJG."1U .#S[5E>-?%EKX%\)ZKX@O89[BTTZ!KB2*U4-*ZCLH)
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M)(@8>=B@9^;VK3JC%_R%/^V/_LU7J *,_P#R$T_ZY'^8J:H9_P#D)I_UR/\
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MZG?^.#;Z3K%U!?\ A>U2T/\ PCTNEP/+;SN7A2)UW!@KKCS#N?G;E1Q]944
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MCVH HS#S_P"A4_[)=_\ /U%_WY/_ ,55ZB@"C]DN_P#GZB_[\G_XJC[)=_\
M/U%_WY/_ ,55ZB@"C]DN_P#GZB_[\G_XJC[)=_\ /U%_WY/_ ,55ZB@"C]DN
M_P#GZB_[\G_XJC[)=_\ /U%_WY/_ ,55ZB@"C]DN_P#GZB_[\G_XJC[)=_\
M/U%_WY/_ ,55ZB@"C]DN_P#GZB_[\G_XJC[)=_\ /U%_WY/_ ,55ZB@"C]DN
M_P#GZB_[\G_XJC[)=_\ /U%_WY/_ ,55ZB@"C]DN_P#GZB_[\G_XJC[)=_\
M/U%_WY/_ ,55ZB@"C]DN_P#GZB_[\G_XJC[)=_\ /U%_WY/_ ,55ZB@"C]DN
M_P#GZB_[\G_XJC[)=_\ /U%_WY/_ ,55ZB@"C]DN_P#GZB_[\G_XJC[)=_\
M/U%_WY/_ ,55ZB@"C]DN_P#GZB_[\G_XJC[)=_\ /U%_WY/_ ,55ZB@"C]DN
M_P#GZB_[\G_XJC[)=_\ /U%_WY/_ ,55ZB@"C]DN_P#GZB_[\G_XJC[)=_\
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M?7</_-^8?ZIYW_T#O[X_YGV%17Q[_P /$M*_Z%&\_P# A*/^'B6E?]"C>?\
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M/^'B6E?]"C>?^!"4?7</_-^8?ZIYW_T#O[X_YGV%17Q[_P /$M*_Z%&\_P#
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ME^;"BBBO./O HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_"E_'?\ T*6K?^ K?X4?\*7\=_\ 0I:M_P" K?X4>RJ?RO[@_M#!_P#/Z/\
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MC_A2_CO_ *%+5O\ P%;_  H]E4_E?W!_:&#_ .?T?_ E_F<717:?\*7\=_\
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M%;_"CV53^5_</^T,'_S^C_X$O\SBZ*[3_A2_CO\ Z%+5O_ 5O\*/^%+^._\
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MQ_>:]!X>O;:SF\*-X>CM!*A,;E@0V>Z@#'K7C/\ PI?QW_T*6K?^ K?X4?\
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MG_"E_'?_ $*6K?\ @*W^%'_"E_'?_0I:M_X"M_A1[*I_*_N#^T,'_P _H_\
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MRA6.,\H2,CK7->&OC)JGA'X:>&S))%>7^JW]U#_:6N7$@MH%1_\ EI( 6[@
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M.0A4S"_!C!P.AV]?4^E835--0:W/6PDL=*E+%PJ-JFT[-O5W3VZVLF_DSO\
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MS_PB.I?\\X_^_@H_X1'4O^><?_?P4<DNP?6*7\QC45L_\(CJ7_/./_OX*/\
MA$=2_P"><?\ W\%')+L'UBE_,8U%;/\ PB.I?\\X_P#OX*/^$1U+_GG'_P!_
M!1R2[!]8I?S&-16S_P (CJ7_ #SC_P"_@H_X1'4O^><?_?P4<DNP?6*7\QC4
M5L_\(CJ7_/./_OX*/^$1U+_GG'_W\%')+L'UBE_,8U%;/_"(ZE_SSC_[^"C_
M (1'4O\ GG'_ -_!1R2[!]8I?S&-16S_ ,(CJ7_/./\ [^"C_A$=2_YYQ_\
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M!1_PB.I?\\X_^_@HY)=@^L4OYBYX'_X_+K_KF/YUV-<SX8TJXTN_G6X55+Q
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M,/F=1&,8 &Y48E%]5H **** "BBB@"I_S%!_UQ_]FJW53_F*#_KC_P"S5;H
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M"C[9!_SVC_[Z% $U%0_;(/\ GM'_ -]"C[9!_P ]H_\ OH4 1'_D*+_UQ/\
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MT@V+P@AEDE20ONS_ +&-N.<]:Z;[9!_SVC_[Z%'VR#_GM'_WT* .4\"> )O
MNFZIH\.JM=Z#),[Z99RPX?3HG&6@$FX[T#$E 0"H.W) &.?T3X(+HVGS6O\
M;)F\SPO%X:W?9MN AE/G8W]_-^[_ +/7FO2_MD'_ #VC_P"^A1]L@_Y[1_\
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M?\]H_P#OH4 1?\Q0?]<?_9JMUG_:X?[3!\Y,>3UW#^]5K[9!_P ]H_\ OH4
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M]L@_Y[1_]]"@#S*R^#-_-9RP:WXD353;Z//HFF21:?Y#6\,J;#)+^\82R85
M2OEJ<'Y1GC0N?A((K7P?/I6IKINN^&X8K2/4A:[Q<VP4++!)'O&4? (^;Y6
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M_OD5+10!%]EA_P">,?\ WR*/LL/_ #QC_P"^14M% $7V6'_GC'_WR*/LL/\
MSQC_ .^14M% $7V6'_GC'_WR*/LL/_/&/_OD5+7 _%KXD:Q\.;#3[C2/!FJ>
M,Y+F1DDATL,6@  (9L(W!Z=JF4E!<S.BA0J8FHJ-)>\_-+\79'<_98?^>,?_
M 'R*/LL/_/&/_OD5X9\*/VG+_P")VM) _P /]5T3109EN-<N)2UK;M&I+*[>
M6 #D8Y(QFO6/#_Q!\,>+&N5T7Q#I>K-;#=,+*[CE,8]6VDX_&LX585%>+.O%
MY;B\%-PKPLUO:SMZM-I>C-O[+#_SQC_[Y%'V6'_GC'_WR*P=(^)'A3Q!=+;:
M9XETG4+AHVF$5M>QR,44X9L ] 003VJ.P^*'@_5)H(;/Q3H]U+/.;:*.&^C=
MI)>OEJ W+>W6KYX]SE>%KIM.F]/)G1?98?\ GC'_ -\BC[+#_P \8_\ OD5@
MP?$;PK<ZE>:?#XDTJ:_LT:2YM8[R-I85498LH.0 .N:S?AA\7?#OQ;T^]N]
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M_A1]EN?^?U_^_:_X5;HH J?9;G_G]?\ []K_ (4?9;G_ )_7_P"_:_X5;HH
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M^_:_X4?9;G_G]?\ []K_ (5;HH H?V?/YPE^VON"[?N+T_*I/LMS_P _K_\
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MO^%6Z* *GV6Y_P"?U_\ OVO^%'V6Y_Y_7_[]K_A5NB@"I]EN?^?U_P#OVO\
MA1]EN?\ G]?_ +]K_A5NB@"A_9\_G>;]M?=MV_<7IG/I4GV6Y_Y_7_[]K_A5
MNB@"I]EN?^?U_P#OVO\ A1]EN?\ G]?_ +]K_A5NB@"I]EN?^?U_^_:_X4?9
M;G_G]?\ []K_ (5;HH J?9;G_G]?_OVO^%'V6Y_Y_7_[]K_A5NB@"I]EN?\
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<_A5NB@"K!9O'<&:2=IFV[ "H&!G/:K5%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>aciu-20231231x20f012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &> \L# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BO@>Y_P""@WC&0GR= TB'ZB1O_9JSW_;[^(!;*V&C
M*/3R'/\ [-7F?VC0[O[C]$CP'G3WC%?]O(_0BBOSZA_;]\>H?WFFZ/(/3R7'
M_LU:UG_P4+\3Q$?:/#&E3COLDD0_S-"S'#]_P)EP)G<=H1?_ &\OUL?=]%?'
M>C?\%$;!V5=5\'7$*_Q26EZ'Q_P%D'\Z]"T+]N/X9:N56XN-1TISQB[M,@?B
MA:MXXRA+:9Y%?A7.L-\>&D_2TO\ TEL^@J*XWPI\8_!'C=UCT3Q1IE].W2W6
MX593_P  ;#?I78]:ZHR4E>+N?-UJ%7#RY*T'%]FFG^(M%%%48!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/W*]Q[C(KW*&+I5](NS['XUG'#&8Y->=:/-3_FCJOGU7S.^HHHKM/D@HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\7Z***^"/[;"BBB@
MHHHH **** "BBB@ JYH^LW_A_4(;[3;N:QO(6W1SP.493[$53HHV)E%23C)7
M3/MKX!?MO)?/::#\066&8XCBUQ!A&/;SE'0_[0X]1WK[!M;J&]MH[BWE2>"5
M0Z21L&5@>A!'45^,E>\_L[_M3ZQ\(;NWTG57EU7PH[8:W9LR6N?XHB>W<KT/
ML:]O"Y@X^Y6V[GX_Q'P/"LI8K*ERRW<.C_P]GY;=K'Z3T5E>%_%.E^,]#M=8
MT:\BO]/N4#QS1'(^A]".A!Z5JU]"FFKH_"9PE3DX35FMTPHHHID!1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110!^+]%%%?!']MA1110 4444 %%%% !111
M0 4444 %%%% 'KO[/G[0NK?!/Q N7DO?#ERP%YI^[C']],]&'Z]#7Z7>%_%&
MF>,]!L]9T>Z2\T^[0212H?S!]".A%?CI7N_[+/[1%Q\'O$@TS5)7E\*:A(!<
M1DD_9I#@"91^0([CZ5ZV"QCI/V<_A_(_,.+^%HYG3>-P<;5H[K^=?_)+IWV[
M'Z4T5%:W,-[;17%O*DT$JAXY(V#*RD9!!'4&I:^G/YT:MHPHHHH$%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 ?B_1117P1_;84444 %%%% !1110 4444 %%%
M% !1110 4444 ?:W[$'Q\:X1?A[K<Y9T!?2IY&Y(ZM#S^:_B/2OLJOQJTG5;
MK0]3M=0L9WMKRUE6:&6,X9&4Y!!K]4O@3\5K7XO_  [T_6XF47RCR+Z$=8YE
M'S<>AX(]C7TF7XGGC[*6ZV]#^?>.\A6#K+,L.O<F_>\I=_\ M[\_4]#HHHKV
M3\F"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** /Q?HHHKX(_ML**** "BBB@ HH
MHH **** "BBB@ HHHH **** "OH/]C'XN-\/_B5'HMY+MT?72+=]QXCF_P"6
M;_G\I_WO:OGRGP3R6L\<T3F.6-@Z.IP5(.016M*HZ4U-=#S<QP-/,L)4PE7:
M:MZ/H_D]3]G:*\\^ 7Q&_P"%I?"O1-<D=6O3%Y%YM[3)P_Y]?QKT.OM824XJ
M2V9_'^)P]3"5YX>JK2BVGZH****LY@HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BLO4/%&C:3<""]U:RM)CP(Y[A$;\B:T+>YBNX5E@E2:)N5>
M-@RGZ$4 245#%>03S2PQSQR2Q8$D:."R9Z9':IJ "BH8;R"XEEBBGCDEB($B
M(X+)GID=JJ6_B+2KO4&L(-2M)KU<[K:.=6D&.N5!S0!HT5%<W4-G"TT\T<$2
M]9)&"J.<=34BL&4,I!!&01WH 6BBB@ HHHH **0G J*>[@M3&)IHX3(P1!(X
M7<W8#/4^U $U%%% !1110 44G2EH **** "BBB@ HI,TM !1110 4444 %%%
M% !129YI: "BBB@ HHHH **** "BBB@ HJ&XNX+0(9YHX0[!$\Q@NYCT SU/
MM1)>017$<#SQI/)DI$S@,V.N!U- $U%%% !1110 4444 %%4M4UO3M$C234+
MZVL4<X5KF58P3Z#)JU#-'<PI+$ZRQ2*&1T.58'D$'N* 'T444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 ?B_1117P1_;84444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% 'U[_ ,$_/B ]IKVN^#[B7-O=QB^M5)^[(ORN!]5*G_@-?<=?DO\ !'QH
M_P /OBMX:UL,5B@O$2?'>)SLD'_?+&OUF1Q(H92"I&01W%?3Y;4YZ7(^A_./
M'^ ^K9FL3%:55?YK1_A8=1117K'YD%%%% !1110 4444 %%%% !1110 4444
M %%%% !6'XYO;[3?!FN76F*7U&&SEDMP!D[PI(XK<K#\:^*[?P/X6U#7;N">
MYMK)!))';*"Y7< 2 2!QG)YZ T >!_ KP#\,_'GA.UN=5:WU_P 57(9[];Z[
M8W"ODY 3<#C_ &L<^M>@_#;X6:G\,/'NKQZ7<;_ U[;B2&TFG9Y+:X!'"@_P
MXW<Y[CTJ&Z^"GPX^+>CVGB&#2_LK:C$MREWI\AAD&X9Y497<#UR#R#7-^"3K
M7PD^-6G>!7URY\1Z#J]G)<0B];=-9E%<C)]/D([ YZ#% &=X6^(-AX%^-OQ2
M6YM;_4KV]N;5;:PTRV,\\VU'W$*,<#<,DD=:]8\ _%_1_'^JWVDPVFHZ1K5B
M@DGTW58!#.J<#=@$Y'*_F/6N)^$-I$_Q[^+5RR S1RVL:/CD*RL6'X[5_*I[
MY1%^UEIK( K2^'7#D?Q8D;&?R'Y4 5Y_%OAKPQJWQ.N=!TK7;K7PT<>I-;0B
M51(8Y?+D4;N$7#9/&.*\H\"ZAI7ASX(7FLV?A;75\52VMPK>)8;5BF7=QO6;
M=PH"@$@<&O0_!?\ R//Q[_ZYQ_\ HF:F^$1G]C*3_L&7G_H^2@!VG>+- UK]
MFW9XNTK74T:RMK1+F4P[&NB9%VM"Q;YQN"Y/'6N_\0_&CPQX N]+TB^%ZCW-
M@MS:B.'S-Z_=6, ')<]  /QKS7Q[S^QE:_\ 7E8_^CXZO:G:17G[1/PV$J!Q
M'H1D4$9PP5R#0!V^A?'G1]5\3V>@:AH^N^&M1OB1:+K5EY"S^RD,>>WUXK:\
M??%31?AW)8V]\MW?:G?-MM=,TZ'SKF;M\JY'ZD5P7[1J*-?^&<F!O&O1@-W
MRM-M563]K:[^W8.S0 ;'?V.Y=VWWQO\ UH W(_VBO#\>J6&EZAI>MZ1J]Y<1
MVZ6%_9B.4;^%D^]@IGC()Y[5ZI7AG[1T5I_PE/PSD8+]N_MI%0_Q>7E=WX9V
MU[G0!XA^U5XNN] \&V=E9Q:G&UU>1&2[M$(BV!N8F<$<MQA>^#61\=_%UO?Z
M?\-M=NK.^T6UA\20RRQ:I!Y4L:(<LS+D\8!-=!^U</\ BV=H>PU:U)_-JK?M
M,6D5_=_#>VG0203>)+>.1#T92<$?D: -:3]I'0+.YM#J&B^(=*TN[D$4&KWV
MG^5:N3T.XMG!'.<=.:[SQGXVT?P#HCZKK5T+:T5@BX4LTC'HJ@=2:X7]J*%)
M/@CKX9 =GD,N1T(F3D5Q'QI;4KO7/@U#;-99D<R(=3#-;-<!(O+\P*03R3C!
MZF@#O[3]H#11?V4&KZ+K_AJ"^<1VM[K%CY,$K'H-P8X)]\<<UZ?7A?Q*\.?$
M?Q5X,U'3?$-_X)LM*F5?-N?+N8S$0P(8,SD YQU%>N>#H)K7PEHT-Q=1WT\=
MG$CW43;EF(0#>#W!ZY]Z /'OV@?'=WH?C?P'806FLM;QZE'<SK9Q$QW@!&(D
MP1YCCGY3ZBNS\3_'7P]X-&DC6;;4K"74K5[J*&:W D7;_P LV7=D.3@ #/)Z
MBN>^/0_XKGX4'M_;H&?^^*J_$[3H=4_:0^%T$ZAXQ#=S889&Y(V=?U44 =?I
MWQOT&X\&WOB;4;;4?#]A:3_9WCU2W\N5GP" J@G.<UGV_P"T)HD=U9+JVBZ_
MX=L[UQ';:AJMCY5O(2.!N#'&?<=.:Y7]I;^T9_&7PQM;,VGER:C*RKJ(9K9I
MQY?E"0*02.6QSW-7OB%H'Q*\3>#=4TW7[WP3::3/%MGN#%<H8AD$,&9R 0<8
M)% 'HGCSXDZ+\.[6SDU-YY;B]D\JTLK.(RSW+\<(@Z]1^8]:YBU_: TM-<L-
M,UKP_P"(/#,E_*(K6?5K-8XI&.,#<&.#D]*YG6/%"^'9?A]H5EHUGXS\>KIJ
M&TOC-MACC";6F\P\X8*QXZX^E<I\?#XZDT?PU-XLET"VM3KEN(+/2EE:7?A_
MF+N>@&1P!U% '0?$3XD7>E?M!^&K8:;K]Q8V-M/NLK6W+"Z=D;]Y$F[#@ X+
M=L&N_P#$WQQ\/>$]=.C7T&HMJAM([N*T@M]\D^]MJQ(H.3)UR,8X/-<UXSX_
M:>\!'L=,NOY/47V*&[_:Y,DL:R-;^&A+$6&=K>;MR/?#,/QH U+;]I7PPMQ>
MVFJV.L>']3MU5ET[4K/;<7&XX41HK'<3D<?TYK3\*?''2/$OBE/#MSI6L^'=
M7E0R06^LV@@,ZC)RN&/8'KZ&N6\66%O<_M7>#9)84=DT::0%AGY@9L'\,G%.
M^+0"_'CX5,!AC)<J2.I&%X_6@#N/&OQ9T;P5JMMI#P7^KZW<IYL6EZ5;^?.4
MY^8C( '!ZGM3?!GQ<T;QGK$^C"VU#1=<@3S7TS5[?R)RG]X#)!'/8UX_X:_X
M2ZX^/OQ%E\/OH@U"-XHS_;22N1#CY?+V,,#@9S[5T5[X5\7:A\5_!NL^)=7\
M*V-Y8M*L5OIWG137<3 !EP[-NQVQC[QH Z;4/V@O#]IK6IZ-;:?K&JZU8W#6
M[:?I]H)99"!EG4!ON#N3BM?P!\7=&^(=[J&GVMO?Z9JU@ USINIP>3.@/?;D
M\=._<>M<+\#K2)OB[\6+HH#,NH1QA\<A27)'Z"I;-%3]K:^*@*7\/J6QW^=>
MOY4 8GPH^)=WJGQH\9)<Z9XAEBO)H(8(I[<D:>@!XE!;$2\D\>YKZ(KQ+X0\
M?''XK ]?M$'_ *":]MH XWX@?%?0?AG-I::X\\*:@TBQS1H&1-@!.[G/<8P#
M6%;_ +0&BI?V$&K:-KWAVVU!@EK?ZM9"*WE)Z#<&)7/N!7.?'^WM;KXB_"F*
M]"M;-JCAP_0_ZO&?QQ6S^U)';/\ !37&GV^:CP-;D]1)YR#CWP6_#- '9>//
MB-HOPZL+>YU:64R74GDVUK;1F2>X?^ZB#KU'YCUKDE_:$TJRU.RM-<\.^(O#
M,=[*(K>[U6Q$<+,<8!8.<'G\*Q/%WC&+2$^'M@OAJ+Q)XXN;5)+%;APBVQV#
M>Y8].A_(UQG[0I\?3^"K&;Q2_A^SL?[2@\NSTQ97F9^<$NYQP,]!0!['X^^-
MOAWX<:U#I>KK>&ZFMC<Q?9X@X< X"#Y@2Q/08_&JL?QZ\/1>#AXAU&TU32(G
MNFLXK*]M=MU-* #A(P3GKUSV-<=XJL8M0_:=\ +,H<1Z5+, 1GYE60@_G73_
M !H\66&@ZKX6LH_#<7B;Q1=W+-I-O*P5877&9"QZ8X_+VH CE_:(TK3+NU37
M?#?B3PU9W4BQ17^JV*QP;CV9@YV]_P !FNJ^('Q.T7X;VMH^IFXGN;R3RK6Q
MLHO-GN&]$7(]1U(ZBO#?VBF^(=S\+[N;Q.WAVPTSSX<6FGB62=W+?*-[G QR
M>!V-=.XCN/VFO"BZC@QQ>&=]@).GG;FW$?[6W=^0H POC#\3['QC/X(TMM,U
M70]6A\2V-RUCJ]KY,C1?.N]<$@C) Z]Z].\6S>%T^,?@J/48+U_$K17/]FRQ
M$>0B^6WF;^?3..#7._M)V]DY^'\\H3[<GB2U6%C]_83\X'MPF?H*B^)6_P#X
M:0^&7EX\S[+?;<],^2^* .FUOXZZ-IOB6\T+3M)UKQ+J%E_Q^+HMH)EMO9R6
M'/7@9Y!'6KW@7XR^'OB)K=UI6CFZ:YM;=;B8SP^6$RVTH<G(<'@C'XUQO[)@
M0_#J_DDYU-]5N#>LW^L,F1][OG%,\"0V,/[4'C\6(0 Z= TP3IYI\LM^/<^^
M: -VX_:'T W=]8:=I>M:WJUG=3VLNG:=:"69?*.UI#AL",G@$G)]*ALOVE/"
M^JV*-IUEK.HZLSO&=#MK/?>QE?O%D!P /7-9O[.-A FH_$J]$:BYD\3W<+28
MY**<@9],NWYU!\#;&"/XL_%F=8E64:F$# <A27)'XGF@#OOAW\5='^)*W\=C
M%>6&H6#B.[T_48?*N(2<XRN3Z'O]<5V=>)?#\!/VE_B(JC -E;,0.YPO->VT
M ?+'C/7=-\9_M"+%K_A37]7TRPTPQ0Z4;,LWF>809_+##*'/WN^!QP*]C\1?
M%K0/ FH67ABRTW4=6U5;=3%I&CVWFR0Q!0%W9("@#'?I7-0?\G:7/_8M+_Z-
M%1?L_!;CQS\5+F["G6/[=DB<MRZPAF\L ]=O!Q]!0!W/@;XM:+X\U&\TRWBO
MM,UBS&Z?3-4@\FX1>/FVY((Y'0]Q6#XE_:*\->&M:U31VL]5O]6L)EA:RLK8
M222Y7<60;ON@=2<=>]8?Q*9+;]H[X:26( U&:*YCN0G5K?:<;O8?.1GT/I1\
M)=-AF^/WQ8OV0&XMY+2%&(Y"NC%O_1:T >P:#K$?B#1;+4X89[>*[A69(KE-
MLBAAD!ADX/XU?HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M ^H^(DM;+Q5XZU3Q#HENZN-.:!(!+MZ"5UY?\:];@ACMH8X8D6.*-0B(@P%
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MVXHL2\#<0N6Y/RBNQU_X<P:]\0_#?BQ[V2*;18YHTME0%9?,4J<G/&,UV%%
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M]K-+$A]W5"OY$T >E45YA\5OBSI^B_"2\\0Z)K$?FWD1BTV[A0R!I3GCH0"
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M:\//KFI7J6NE(BNUR5)&&("\ $G.1V[T ;%%<QXI^)7AKP586EYK6JQV$5V
MT"NCF20''2, L>H[5F^$_C7X.\:ZJ-+TS5]VI$$K:7,$D$C >@=1GCGB@#N:
M*XGQ)\9_!GA*[U"TU;6X[2ZL-@GA,4C,I<94 !3NR/3/O4E[\8/!^G>%K'Q%
M<ZU%#I-]G[-*T;[YL'!VQ[=YP1Z4 =E17SK\3/BMH_C+Q%\.O^$:UJ23;KJ1
MW4">9!(%.W =& .#[C%>Q^,OB7X:\ ?9UUW5$LY;C/DP*CRRR?1$!8CWQ0!T
M]%<KX-^)_AGQ_+<1:'JB7EQ;@-+;M&\4J#U*. ?TKJJ "BBB@ HHHH ****
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M )$N*O\ R_JC[^HHHK[$_DX**** "BBB@ HHHH **** "BBB@ HHHH ****
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MX+B^NY9[AI#&#(S)*Z( 2.,;./3-;_PR^#ES\/?#WBS2FU(7RZO/))#/)DN
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MW%M(>K1%/Y' X%:/PH^$>H_#[Q5XFU?4-:&M2:RL+/,Z;9#*NXN2.@!+< =
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M:9JVOS_M$^-]1L/#$7BB]TU(K2W%QJ"VQM(B.J;D;.[GIC&3ZUNW&B>-=?\
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M ;OP%>D?!SX$M\+?%7B#4WOH[RVNAY&G1*&W6\'F,^QL]^5Z>A]:3X:_ ?\
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M\CU^F #D/VA-"L5\=_#/5UAC346UF*V:4##/'N5@">^#T],FK_Q)\&>+M/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:,.&!0C<&!XQZYKYG\"Q^%K/P#::?>_"GQ)K4UW )+O4'TN&5[AV&2ZRM+N
MY^4C&/K6/J>L>)?"?[/6KZ/<6^J:2CZR-/L9-03R[C[#(0P!Y//#*<''.,T
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ME,XZJ!QUJ[\2M<CUS]H*+3-8T+4_$^BZ)8K/#I.G0+*&F?!,DB,RA@,@<Y'
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MS8')/J>: /8K?4K;1?#EI<ZIJEOY4<">;?S2JD<AVC+[B<8/7\:CT+QIX?\
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M7C9D#CZCOFI?CY\-]7\<:1IM]X9=8/$FF3,8)6D"9BD4K(NX].Q'T]Z]4HH
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MVEO=BYGNW7H-P&T+U'KR>O&/;Z* /,O$O@/5=1^-WA#Q+;11?V1IEI/#.QD
M9696"@+U/44OQJ\"ZMXVD\('2XXY!INLPWMQYD@3$:GDC/4^U>F44 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,H
MHHH **** "BBB@ HHHH **** "BBB@ J*Z&ZVF!Z%"/TJ6HKMMEI,QZ!&/Z4
M#6Z/QUU]!'K^J(.BW<RCZ!S5&KNN2";7-2D'1[J5A^+DU2KX)[G]K4_@5^P4
M444&A]??\$]?!S7.O^)?$\L?[JUA2Q@<CJ[G<^/H%7_OJON*O%?V0/!I\'_
MS1#)'Y=QJ>[49,CDA\;/_'0M>U5]C@Z?LZ$5\_O/Y0XJQOU_.*]1/1/E7I'3
M\7=A11178?)A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 ,HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** &4444 %%%% !1110 4444 %%%% !1110!6U/
M4K?1M-NK^[E6&UM8FFED8\*B@DD_@*_(KX@>+)?'7C;6]?FSOU"[DG /55)^
M4?@,"OOG]MOXD1^#?A+)HT,VW4M?D^RH@/(@',K?3[J_\"K\YZ^<S.K>:IKH
M?OGAYEKI8:KCYK6;Y5Z+?[W^0445ZI^S9\)Y?BY\4-/T]XRVDV9%WJ#GH(E(
M^7ZL<+^)/:O(A!U)*,=V?JF+Q5+!4)XFL[1BFW\C[._8S^%G_"O_ (61:G=P
M>5JVND7<FX?,L./W2^W!+?\  J]^IL<:PQJB*%10%50,  =J=7VM*FJ4%!=#
M^0,QQU3,L74Q=7>;OZ=E\EH%%%%:GG!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@!E%%<5\2OC'X3^$U@;GQ%JL=M*5+16<?SW$O^Z@Y_
M$\5,I**O)V1O0H5<345*A%RD]DE=G:D@ DG %?.WQY_;"T'X:+=:1X>,6O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!\%_%?]O'7->22Q\%67]A6AX-
M_<XDN6'^R/NI^IKY?UC6;_Q!J,U_J=Y/J%[,=TEQ<R%W8^Y-4Z*^)JUZE9WF
M[G]A9;E&!RF')@Z:CW>[?JWJ%%:WA;PEK'C768-*T/3Y]2OYC\L,";CCN3Z
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
D@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>aciu-20231231x20f013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &% R8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJ-9XGD:-9$:1?O(&!(^HH
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M=_:M"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@"KJNIV^BZ9=ZA=R"*UM8FFE<_PJH))_(5\T>")KGPKKWA/XDZC
MNMT\8WMQ;:BK$XB29@;3/LNP#_@5>D?M$ZB][X=TKP=9S&/4?%-]'8#;]Y8
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M 8I64\J&8#WQ^% %W2/V;/"+:#'J_P 0+RY\0:Q.BS7.H:AJ$D,<3MU5-KJ
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M)C(R('W[G?IGMQU]L<^O4@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"@#S"U_9]T&&*"RGU;7K_08&#0Z%=W^^R3:<J-H4,0#T#,17IRJ$4*H"J!@
M= *6B@ HHHH **** "BBB@ K@=<^#>G:IK]YK%AK.M^'+R^VF]_L:[6)+DJ,
M NK(PSCC(P:[ZB@#'\*>$],\%:-'I>DP&"U1F<[G+N[L<L[,>68GDDUL444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1574TO)--NUT^2&&_,+BWDN$+Q))@[2Z@@E0<9 ()'
M<5XE_P (_P#M+?\ 0[_##_PE;_\ ^3Z /=Z*\(_X1_\ :6_Z'?X8?^$K?_\
MR?1_PC_[2W_0[_##_P )6_\ _D^@#W>BO"/^$?\ VEO^AW^&'_A*W_\ \GT?
M\(_^TM_T._PP_P#"5O\ _P"3Z /=Z*\(_P"$?_:6_P"AW^&'_A*W_P#\GT?\
M(_\ M+?]#O\ ##_PE;__ .3Z /=Z*\(_X1_]I;_H=_AA_P"$K?\ _P GT?\
M"/\ [2W_ $._PP_\)6__ /D^@#V/Q1X<LO&'AS4]#U)#+I^HV[VMP@Q\T;@J
MPY!'()[5Q?P,^ ?A?]GSP3<>%_"L4L.FSW<UXXE;<V^3KR>3@ #DD\5R'_"/
M_M+?]#O\,/\ PE;_ /\ D^C_ (1_]I;_ *'?X8?^$K?_ /R?0!T'P0_9J\'_
M   O/$=SX6@FBEURX^T7/FMNZ9*J/0 LW3 YZ5%X%_9A\%?#SXO^)?B3I5M*
MOB77RYNYG8$?.0S@#'&2JGC'09S6)_PC_P"TM_T._P ,/_"5O_\ Y/H_X1_]
MI;_H=_AA_P"$K?\ _P GT ;>J?LP>"M8^/%A\7+BVE/BZSB\J.;<-H 4(O&.
MR[QGK\YY' KURO"/^$?_ &EO^AW^&'_A*W__ ,GT?\(_^TM_T._PP_\ "5O_
M /Y/H ]WHKPC_A'_ -I;_H=_AA_X2M__ /)]'_"/_M+?]#O\,/\ PE;_ /\
MD^@#W>BO"/\ A'_VEO\ H=_AA_X2M_\ _)]'_"/_ +2W_0[_  P_\)6__P#D
M^@#W>BO"/^$?_:6_Z'?X8?\ A*W_ /\ )]'_  C_ .TM_P!#O\,/_"5O_P#Y
M/H ]WHKPC_A'_P!I;_H=_AA_X2M__P#)]'_"/_M+?]#O\,/_  E;_P#^3Z /
M=Z*\/T_0?VC4O[9KWQI\-9;,2J9T@\,7R2-'D;@K&_(!QG!(//8U[A0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%>+?M%W_QEL9_"_P#PJ>ST
MF[CDN675/[30L47Y=C+AUR/OY4X!XRZ=]/\ :$O?BCI_P[$WPNM--O?$H8>=
M%J ;88]IR4*G(;=C'# \@X^\ #U:BO./&=S\1H/@D\^AP:=-\1UT^)FAD0BU
M-SM7S0H#D@??VX9L<?>[N^'=S\0[GX-03^*(+"#X@-8R-Y-NA,"S[3Y0(9@3
MSMW9*Y.?N]@#T6BO*?V=K[XI7_A.\D^*MIIEEJ_VIQ:QZ8&VF'<W+ECG.>G
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M?A]_T#/'?_A":S_\BT?\-H_#[_H&>.__  A-9_\ D6O>** /!_\ AM'X??\
M0,\=_P#A":S_ /(M'_#:/P^_Z!GCO_PA-9_^1:]XHH \'_X;1^'W_0,\=_\
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M  K-8_\ DNC_ (=Y_ ?_ *%35?\ PK-8_P#DNOHZB@#YQ_X=Y_ ?_H5-5_\
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M!\++CX?Q>*/"<6G?MC^+/$$@O;5;?1;O4=RWK>8NVW=6&[#G"$$YP<4 ??\
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M >G?%'3X-8'Q+\7^'/%<C-']B;P_;F(0C#;P^0,Y^7'T->M4 %%%% !1110
M4444 %%%% %/5]0.DZ3>WPM;B^-M \PM;- \TVU2=D:DC+'& ,C)(KYZ_P"&
MS[K_ *-]^-G_ (3$'_R57TC10!\W?\-GW7_1OOQL_P#"8@_^2J/^&S[K_HWW
MXV?^$Q!_\E5](T4 ?-W_  V?=?\ 1OOQL_\ "8@_^2J/^&S[K_HWWXV?^$Q!
M_P#)5?2-% 'S=_PV?=?]&^_&S_PF(/\ Y*H_X;/NO^C??C9_X3$'_P E5](T
M4 ?-W_#9]U_T;[\;/_"8@_\ DJO2_@]\99?B['JKR> /&O@7[ 8@%\8Z8ED;
MK?NYAVRONV[/FSC&Y>N:]&HH ^=;[]L:YLKVXMQ\ _C/<"&1H_.@\-0-')@X
MW*?M/(/4'TJ#_AL^Z_Z-]^-G_A,0?_)5>[ZGXUT'1M6M]+OM8L[34+C'EV\L
MRJYSTR.V3P,XR>!DT[7O&.A^%YK2+5]6M--ENRWD)<S!"X4 LP!_A7(RW09&
M2,B@#P;_ (;/NO\ HWWXV?\ A,0?_)5'_#9]U_T;[\;/_"8@_P#DJO>=>\8:
M)X7TZ*_U75;2PM)O]5+-* )?E+83NQV@M@9X!/05937]+DTRWU)-2M&TZXV>
M3=B=3%+O(";7S@[B0!@\DC% 'S[_ ,-GW7_1OOQL_P#"8@_^2J/^&S[K_HWW
MXV?^$Q!_\E5[[X9\4:3XRT2UU?1-0M]4TVZC62*YMG#*P(!'T.".#R.]:E '
MS=_PV?=?]&^_&S_PF(/_ )*H_P"&S[K_ *-]^-G_ (3$'_R57TC10!\W?\-G
MW7_1OOQL_P#"8@_^2J/^&S[K_HWWXV?^$Q!_\E5](T4 ?-W_  V?=?\ 1OOQ
ML_\ "8@_^2J/^&S[K_HWWXV?^$Q!_P#)5?2-8.J^//#FAZS!I.H:Y866I3[=
MEK/<*KG<=J9!/&YN%SC<>!DT >&?\-GW7_1OOQL_\)B#_P"2J/\ AL^Z_P"C
M??C9_P"$Q!_\E5](T4 ?-W_#9]U_T;[\;/\ PF(/_DJO5?A%\59/BSHU[J$G
M@KQ;X'-M<>0+3Q=IZ6<\WRAM\:K(^4YQG(Y!XKO** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH ^??VB/#!\0ZKY*_%S1/#$<D,9G\+>*;.ROM
M.N@I)5FBE*R*2?XE;^'BN"^&>A+;^*M*@'PQ^#_C":"YB=M9\#W=O!<6F)!^
M_P#LTH)&P?/\LI/R\#.*Z#]I'5_V8+'Q[%'\88-!D\4_8T*'4[>623R,MMY4
M$8SNKYSUV;X&ZY\<O@RO[-UG$OC2'Q)!+J,OAZ*>*%-+!'VG[1NPNTID>N,C
MO@@'Z5UX_P#M,_M1^"_V6O DWB'Q3=">[?"V.BVTB_:[Y\](U)^Z.26/  ]<
M ^P5\K?\%$OAUX9U#]FGXE^,;K1+.Y\46?AXV-MJDT>^:"$SHQ6,G[F2QR1@
MGH3B@#O/B)^U/HO@#P+X"UA-$U'7->\<O;PZ#X:L&C%S=2RQB3:7=@B*H8;G
M8@#(K(L/VS/#ES\#?B%\0KS0]3TB\\"2W%EK?AR^,8NK>\BP!#N4E"&9E <$
M@YS7@?Q5NH?"7B+]B?QCK$J6'A?3@MI>:G.=L%M)-8*L7F,>%!.>2>Q]*W/V
M</A[HO[0>I?M:QW5T^H^ O&GB4Z=;7MDXV2^5"5DEA?D'#,F&P02@ZB@#Z6_
M9_\ BSJ/QA\(WVK:GI>CZ;-;7\EFK:#K]OK-I.JJAWK-%C!!8J4=58%#P003
MZ=7AO@#]FJ_^&7@'Q9I7A_XA:G9^*_$=_'J%QXJ&EV/F1.BQ(!':B$6X!BBV
M'*$G<6ZX(X/QM:?%OX+>./A++??&O5?&.E>(_&%OH%]I=]X?TJV1X)+6ZF)$
MD-NK@YMU'!'4T ?5U%%% !1110 45F^(/$FD>$M+DU/7-5LM&TZ(JKWFH7"0
M0H2< %W( R2 .>]<E_PT%\+O^BD^$/\ P>VO_P <H Y;XH_M ZA\//B[X0\&
M6_@S5=;M-<QYVKVEM,\%IEBHWLL9 QC)QG Y;:.:?^T5\?[_ .!9\,?8?!FK
M^+_[7NG@E72;6>=K95"G<PCC; Y/^UQ\JMGCI&^/WPK9U8_$?P>67.UCKEKD
M?3]Y2O\ '[X5OC=\1_![;3D9UVU.#Z_ZR@#'_: ^-M[\%OABGBFP\*ZAXKNI
M&5%TW389991F-FW$*G"KMY+;<#/.<*=K5/BC<:;\'XO'">&]3OKE[*&\&@VM
MO*UXQ?;^Y6,QAS)\V &5>>NT9(;)\?OA7*A1_B/X/=&&"K:[:D'_ ,B4O_#0
M7PN_Z*3X0_\ ![:__'* (/V>_BK=_&KX1^'_ !A?:%<>'+O4K=9)-/N8W1D.
M!DC>H)4YRI&05(.37HU>?1_'WX5PQK''\1_!Z1H JJNN6H  Z #S*=_PT%\+
MO^BD^$/_  >VO_QR@#OZ*RK;Q7HE[X</B"WUC3Y]!6%[DZI%=(UJ(DR7D\T'
M;M7:<MG P?2N5_X:"^%W_12?"'_@]M?_ (Y0!W]%<!_PT%\+O^BD^$/_  >V
MO_QRC_AH+X7?]%)\(?\ @]M?_CE '?T5P'_#07PN_P"BD^$/_![:_P#QRC_A
MH+X7?]%)\(?^#VU_^.4 9_[0_P 8;SX'_#X^([#PS?\ BRX^TI;C3M-ADEF(
M96.X*BMP-HSN*@#)W9 !LZA\6[FQ^"\'CU/"^JWMU):177_"/6UM,;XEV \E
M8C&'\P9QM95YZE1DB9_C]\*Y$*O\1_![J>H;7;4@_P#D2E_X:!^%O_12?"'_
M (/;7_XY0!F?";XRWGQ'^!-C\0+OPY>:/>36#W;Z/-#*)=RJ3A5*;R&Q\NU6
MR",;JJ_LV?'*^^//A#4=9U#PGJ7A":TU">R%IJEO+#(ZI(RA@'49X !P3\P8
M<8Q6Y'\?OA7$BHGQ'\'HB@!577;4 #T'[RDC^/OPKA7:GQ'\'HN2<+KEJ!DG
M)_Y:>M '+?!#]H:_^+OCCQCH%WX*U?PW#H-PT,.H7]K/%#>* G,;/&H;[Q8\
M@[6C."&S7M5>?K\?OA6A8K\1_!ZECN8C7;49.,9/[SV%+_PT%\+O^BD^$/\
MP>VO_P <H [^BN _X:"^%W_12?"'_@]M?_CE'_#07PN_Z*3X0_\ ![:__'*
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M_:.UJUEUW^ROC3XH\2^.-1M]#OM.L)X'D:75&FE6\TY;7&R.)0P#  #"@C/
MH _5B:2>]TF1[)EM[J: M TZ9".5^4LN><'&17QM\4?V</$7CWQ&?$7Q+^#7
MACXIZJENL#:CX8U^?3)W1,[5%M<.$Z$\^;U[5]A:I;1ZEX:N[?4I#9PW%H\=
MS(D@3RE9"'(8\# )Y[8KX@/[(/[-?_1;]6_\+JU_PH ]N_9+\'> /!L'B>U\
M&?#7Q'\-KSS81J-IX@MY4\\@-L:*1G=)%&6&4/\ 2OH2OD7]@G7[@:Q\7/!^
MG^*[[QMX'\-:S#;Z#J]_<&X;8\1,D2R]&52!TXY)'WJ^NJ . D^.W@I/C);?
M"U-92?QM-I[ZF=/@4OY4"G!,C#A&/4*3DCG&,5RGB_\ ;&^$_@7XA2>#=8\2
M/!JEO<0VEY<164\ME8SS?ZJ*XN50Q1.WHS#&><5\Y^"_@?X8^!'_  48\#:1
MX:BN&-_X)U+4+^_OIS/<WEP]TVZ21SU.   ,  # KQK5&@C_ &-OVQHM0,8U
M3_A/;Q9EGQYID-U%Y8.><DYV_I0!]_\ QC_:3T'X.>(])T&XT77O$NKWT!OI
M;/P[8F[EL[,2I$;B5 0=F]P %!)VMQ\IKUI&#J&'0C(R,5\>_&']B_5OCPG@
M;Q6VL6>C^+HO"EKH.IW-_'</);E66<7%L8Y4*SI(TV-^0=_/3GVOXBO\;=.U
M:RM_AW8> ]3T2.RC6:X\6:E>V]VUP"P;"P02*4VA#DG.2W& ,@'K-%>._L\_
M%'QEX_O/'VC>.M+T/3/$'A/68]*E_P"$=N)I[64/:07*LK3(C9Q. <J.1^->
MQ4 %%%% !1110 4444 %%%% !1110 45Y)XV\+?&O4/%%]<>%/B!X2T70'*_
M9;'4O"TUY<1 (H;=*MY&&RP8C"# ('.,G"_X0K]HS_HJG@3_ ,(JX_\ EA0!
MUGCG]GCP9\0_B7X9\=ZS8RS^(?#V?L,ZS,H3G(X!XP>>.O?(J3XQ?L^^#?CL
M_AYO%UA)?C0KO[;9JLK(%DXYP#UX'/48X/6N/_X0K]HS_HJG@3_PBKC_ .6%
M'_"%?M&?]%4\"?\ A%7'_P L* .W^,GP-\*_'?P+_P (EXLMIKS1Q(DHC64J
M=Z A6/\ >QG/.><&M35OA9X;UWX;_P#"!ZA9/=^%VLTL'LI)G/F0* !&S9W$
M$  \\BO-/^$*_:,_Z*IX$_\ "*N/_EA1_P (5^T9_P!%4\"?^$5<?_+"@#T?
MX1?"O0_@I\/-&\&>'$F32-+A$47GR;W8]68GH"QRQ P,DX KL:\'_P"$*_:,
M_P"BJ>!/_"*N/_EA1_PA7[1G_15/ G_A%7'_ ,L* />**\N^'?AOXOZ7XB$_
MC7QSX7\0:)Y3*;/2?#<MA-YG&UO-:[E&!SD;><]172?$O2_&NK:%!#X$U_2?
M#FKK<J\MUK.EOJ$+P;6#((TFB(8L4.[<<!2,<Y !UM%>#_\ "%?M&?\ 15/
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MJMI'=6[E2&4M'("I((!&1P17"?\ #*GP4_Z(_P" ?_"8LO\ XU7J5% 'EO\
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M1FR%!Y [[%R/]D5L4 >6_P##*GP4_P"B/^ ?_"8LO_C5'_#*GP4_Z(_X!_\
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MGE6.ITJU>=)J-&2A-_RR=[)_<U_PZ/3:***W/)"BBB@ HHHH **** "BBB@
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M-8Z?H46L27^K62W,M\TDK1E8PRL-J[0#@ @]2<@  ZGP;^R_K\'B#3-:\?\
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M=L2;4R,8PK?WCGU']DS]E_XE?L]^-;RYU/6/#][X;U&W,=Y:V5S.TH=<F.1
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M^F_4*^@:^?OVL?\ D8OV??\ LIMC_P"F_4* /H&BBB@ HHHH **** "BBB@
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M2_BC,LS\R.58@C'"CZ$]Z]1_9R\!_$_PU\,+'0O%NKC1KK3";6UBB2"[W6X
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M)M]X>U;]CB\O-*T;3TM[6TAT437D#"1MV6&8S#DL5*=2<Y(-?I+8W(O;*WN
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M]&>//!MI\0O"&J>'+^YN[6QU*$V\\EE((Y=A^\ Q! R.#QT)KP[P=^P;\//
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M8_"OQ5XX5K..:74?#S6*VR2$LK18GN8FW#:&X7&'7G.0 #FOV>O^2P?M$_\
M8X6O_IFL*]WKYM_9%\0WGBOQS\>]5O\ 0-0\+W=SXNMS)I.JF(W-OC2;%0'\
MIW3D ,-K'AAWR*^DJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MPRK*PX(([BN5^,_PKT[XW?"[Q%X&U>YN+/3=;MOLT\]H0)47<&RN01GY1U%
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M20DLVW([]\#Z/KD/AU\7O!?Q:TTWW@_Q-IOB"!0"XLKA7>//3>GWE_$"NOH
M\NU?X$6.K_M%Z#\7'U2XCU#2="FT)--6-3%(DDAD,A;J""<8Z5YAXU_8*\-^
M+_%7B:>'Q9KVB>#/%>I1:OXC\&V/E?8]3ND8,7+LADC5V +JIPW/3C'U!10
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M)*<8NZ=]WN?J.(\2^(\50GAJM2#A./*U[.&L;-6VVU=NUPHHHKW#\L"BBB@
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M4 %%%% 'A'[/7_)8/VB?^QPM?_3-85[O7A'[/7_)8/VB?^QPM?\ TS6%>[T
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M*E'9G\VUJ-3#U)4:JM*+::?1K1H****HQ"BBB@ HHHH **** "BBB@ HHHH
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M79#"THX=P"Q8KQD\4 1?LO\ Q#3P_P#LZW.O_$'QH&M]-\0ZU9W/B/Q/?I$
MD>KW%O#YDKE47I&BC@#*JH' KS_]IO\ :0^$NOZ]\#9-,^*/@O48].^(=G>W
MKVGB&TE%K;K8WRM-(5D.Q SHI9L %E&>17U;=>"_#]]H5QHESH6F7&C7$AEF
MTZ6SC:WD<R>86:,C:29/G)(^]SUYKG?^%#?#/_HG7A/_ ,$=M_\ $4 8O_#6
M/P0_Z+)\/_\ PJ+'_P".T?\ #6/P0_Z+)\/_ /PJ+'_X[6U_PH;X9_\ 1.O"
M?_@CMO\ XBC_ (4-\,_^B=>$_P#P1VW_ ,10!B_\-8_!#_HLGP__ /"HL?\
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M_P"%18__ !VC_AK'X(?]%D^'_P#X5%C_ /':VO\ A0WPS_Z)UX3_ /!';?\
MQ%'_  H;X9_]$Z\)_P#@CMO_ (B@#%_X:Q^"'_19/A__ .%18_\ QVC_ (:Q
M^"'_ $63X?\ _A46/_QVOG7]N#X)^%;/Q%^SN- \!:/!%-\3=(CU$:;H\2J]
MJ7.]9MB<QGN&^7UKZD_X4-\,_P#HG7A/_P $=M_\10!B_P##6/P0_P"BR?#_
M /\ "HL?_CM'_#6/P0_Z+)\/_P#PJ+'_ ..UM?\ "AOAG_T3KPG_ .".V_\
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M_P"%18__ !VMK_A0WPS_ .B=>$__  1VW_Q%'_"AOAG_ -$Z\)_^".V_^(H
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M#VUL:GY@DUJ[6<Z?INTJ T_DHSG.XG"X)"G%?-/A6Y\3?M+_ +1/AGPGXO\
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M_93_ &6OA+XP_:5_:<T/6OA_HFIZ1X>UNP@TJSN+8-'91NEP76,=@2JY^@H
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MH']J62I9)=Z9+=2/ LAV%K*&-UB/!!EP Q! )QP >^_L+>"O#O@VQ\7)X?\
MAQXR^'JW,T$DZ>+KCS3=-A_FCY.,=_J*^J*^4OV%?%__  G+^/=9N?C(/BSJ
MES<VIG6VL+FRM=.58V55BCF50-^"3L &1DY)S7U;0 4444 %%%% !7A7[27[
M6>C_ +-NL>$-)O?"GB/Q=JGBB2>*PLO#EO'-,S1!2PVLZDDAN,9Z&O=:^$/^
M"@VD^*-<_:-_9IL/!>LV_A[Q1/J&I+8:G=P>?%;OY49+,G\0P",>] 'MWP)_
M;/\ "OQN\;:MX+F\.^)O 7C#3;0:@^C>+;%;266VR 98\.P*@LN<XZ\9 ./?
M(KJ"<L(IHY-H#'8P. >A_&O@OQ[^ROXS\(_#_P",?Q6^*WQ!C\>^-'\$WNC6
M L;$6=K9VQ4N_P H^\Q('88RW7(QXWX\^'&F?"G]@SX2>(?#&F)97'C*?1;7
MQEJK7<ENU]8MN;R;BX&3'"2P0D#A0!@@ 4 ?JU#-'<1B2)UDC/1D.0?QKS/X
MF_&OP[\+O&_P_P!)OM.GOM2\9:HV@V=W9I&WV=PN\B5BP(3CH,G/:O@+2)/$
MOPYT#]IVT^'1T?PS8V7A2"Y;PYX.U:YU*WTV^.S=/!,8D17>W+L50DAD!/LR
MS\'?!_PAXU_8N?X:WMNVJ:KJ%O>:E#9WAD-R?LR;KBYCR0DWF%U!(4_ZQ<?*
M0H!^IC3QI*D;2*LCYVH2,MCK@=Z2>YBM4WS2I"F<;I&"C/IS7Y07>G^"_%GP
MI_::\??$W5EB^./AWQ#?PZ-<W=^UO?Z8(D3^S8[5=^=C2E@-HP<D=LUUOQI\
M >*OB9KGPH\2^([WP'XR\30> K0ZU\-?'6K&QE261$:XNX0'4)(6^4N00IR,
M' ( /TTDD2&-GD9411EF8X 'N:56#J&4AE(R".AK\H?$?Q*L?BOX-_9CTC0_
M"26?PLOKO5[*X\+>+/$$D>F7%];JHMX9;[:WF1*Q8Q# #$!<<8'T[_P3B;4(
M/#7Q(TZ/4K"Z\)V/B6:'1]/TR[GN[72AR9;2&>6-!)&C8VE,KSUYY /L*BBB
M@#P/XQ_MC>&OA)XQU'PM;^&/%'CC7-)TPZUK%OX8LXIAIEF.?,F:26, D<A1
MDD ]*[F[^+G@OP[\(KWXJSR+IGAIM.&JW%U/;_9YG3;E5=6 /F$G8%/.X@#K
M7PI\1;;4O"_[7/[4M]<?$R_^%\S^&;#7]&:TD@B?4VMK+8GS2JV^-)-ZM$F"
MQD7D;:;XZ^(_C[]HGX5?""/Q]\/O%FM>##X?;Q)X@N/#VEM)#J=^OF+:0R $
M!8U*"=P>#N4  4 ?=G[/OQLTC]HOX1:#\0]!LKW3M*UC[1Y-MJ*H)T\JXD@;
M<$9EY:)B,$\$5Z)7Q]_P2C\0'5/V+O!VG'3=0M!IDM]$+NZ@V07>^_N9-T#9
M^=5W;6/9E([5]@T %%%% !7"_&;XU>$?@)X&OO%7C'58=-T^VC9HXF=1-=R!
M21%"A(WN<< ?4X&37=5X=^UU\*/"?COX1^*?$/B#1+;5M6\->&M9FTF>Y7<+
M622T;>ZKTW?NTP2#C'&* &C]KOPHO[/'A_XO'1]?FTC71&MAH]G9K<:A-*\C
M1I&$5]@)*]2X7IS57P+^UUX,U"S\;6NN:%K/PVU+P99?VIJ^C>(+2.*6.U<%
MQ/'Y+NKJQST.=QQCG)\B^ _[0GA_]F7_ ()M?#KQKX@26Z2'3/L]G86_^MO+
MAYI=D2^F<$DGH 3ST/C>H_"KQMXP_9N_:'^+GCC5+/4/B1XWT"-HO#6E7"S'
M2M-A=)%A*J2=VT#([8Y)9C0!]A?!S]L;PS\7O&6G>&'\->)_!VJZQI8UO14\
M26<<*ZK9'_EK"T<C\XP2K8."#S7OE?G_ *1XHTOXH_M9?LJ7/A'5(-5@TWP-
M<7]^;-M_V>"2WC1!+C_5L6!&UL$$8(K] * "BBB@ KQC]I;]K+P%^RSX8BU3
MQ9>O<7US(L=IHE@R/>W.3@LJ,RX51DEB0.,=2!7L]?$__!3_ .%/A,_L]^-/
M'SZ':2^,#%86"ZM*FZ:* 72G8A/W =QSC!/>@#Z%^)7Q=U'PM9:8UA\,O$GC
MJPU.S^T2OI M#';J0/DE$TR<D'/&1P:\S\$_M[> M;^"6O\ Q'N?#WB#PUX:
MT34%T:"VGM8GFU"YX58;18I&60[OE'S 9'7 S4'[;/Q+O_AO^QQ-'HTP@U_Q
M+%8^&M.<MC$MUM1R.^1$)2,=Q7E7[;WPCB^#W[)'P8T#PM(-"T?P;XQT6XO-
M3$(=;1%29'O)5Z/^^E61L\$GF@#ZA^"W[1.G_&/6_$.@R>%/$W@OQ%H7E-=Z
M7XDLTB<QR*&1T>-W1@0PR-VX$\C&"?6J^/\ ]F?XC>(X?VK/B5\,XO'5[\2_
M NEZ39ZG:ZSJ,L-Q/:7$H7="9X55&!RQ"XR,>QS]@4 %%%% !1110 4444 %
M%%% !1110 4444 %%%% 'BG[9'A'7/''[//B?2?#>D0ZWK3^1-;6]Q=0V\:M
M'*C^8SS$1X7;DAC@@$=Z\3\$?M=_&R_\2>'-+USX:>"+'3[N^MK.[O+/QQIT
MK1(\BHSQPK<,S$ DA!DG@#->V?MD^"M9^(/[/'B?1-#L[O4KN?R'DL+%@L]U
M DR-+''G^(H& 'K7QUIO[,\'@?X]>&K/PC\%-8CF'B^PU_3?%%W \FG6FBM%
M&T]K<B5F5)XF\S:"-X;&#E1D _3"BBB@ HHHH **** &30QW$3Q2HLL3J5='
M&58'@@CN*9:6<&GVT=O:P1VUO&,)%"@1%'H .!4U% %>+3K2"\FNX[6&.ZF
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M>'PWJ'AC2+WP_#CRM+GLHVMX\=-L9&T=3T'>M3P[X:TGPCI$&E:'IEII&F0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJCKL]Y;:)?
MS:?"US?QP.UO"BJS/(%.U0'>-22<##.@]67K0!>HKY=_9.\8?&37O&/C:W^(
M.C7%KI*:I/Y4T@1EMY1C,"$W3,L8^7:(TD3);YQBN]^)'Q"\=V_QCT7P+X.@
MT15U#19M2EO]8BED%LR2J@.U'4N"#C;QR<[N,$ ]EHKP72_VF+C2O &J7WB3
MP_//XET;69M O[;2<"T^T(%83&:5@L,+(Z-ND;(R0-Q'-?XC>.?'NC_!'QWX
MXEUO0X8H]&F_LNT\/DW*P2,0!,URV/,=>P554$G.[ - 'OL=U#-(R1S1NZ_>
M56!(^HJ0D*"20 .237R_KGPST#X"ZG\(==\+V?V'5;S6K71-5NHV8OJD5S$R
MNUQR?,8. X)Z$>E>B?M*R2WGA;PWX>$TMO:>(_$5EI-ZT+E':V8L\B!@01N$
M>TD'.&- 'K,-Q%<KNAE250<91@1^E1+J5H\@C6ZA:0G 02#.?3&:\!A\':5\
M$?CG867@K3CI>E>(/#=_+<:+8J?L[7-HT9CE2,<"1A,RDCK@=\Y\R^&/A%_A
M#IO@7Q)XZ^#WA^V%Y>0QW'B(3+)K%C>3RG9-<(T:A09'"C8[%05!Y&* /M2B
MBB@ HKEOB=J/B;2O!&IW/@[3EU;Q&D?^AVCK&4D?L&WS0@+ZG?D#D!CP?%OV
M3/%GQ7UKX.WUQXUTF\.IP13-I<UPD4DMV06VAB]V&9]V5VR")<!?GY) !])4
M5\N?LH^,/C)KWC;QQ;^/]&N+;1TU2;RI90C+;R@#,*$W3%8P-I41I(F2PWC%
M4OAMXW^.-]^U#KUAKF@74/@\V]L)%DCA"6T?S;)%07KHK-\V_P MI6 5<H,T
M ?6%%?*GQ)\;?'&Q_:;\.V'A_P /7%QX/\B=6&R$)/%O7S)"OVU49D&S89#$
MQW/\AQ7K_P <OB!XC\ :%X;D\,V%EJ.K:MKEKI0@U!F2/$H?+%E.5P5!)^;@
M'@G% 'IE%>)Z%\8?$_A+Q-XG\._$'3[2_OM+TJ/7+2Z\+6LS"\MF=HVC$#,S
M"177'WL$')VBM#X>>/?%7Q9N[36;*XT/0O"\3EIM/BN%U#4I,9 25D;RH#QR
MHWGW!% 'JYNH5F$)E02GD1EAN/X5+7QI_P (%I7C/]G#Q7\7+N)D^(1.H:]:
M:]&["YLVMY7:&&-L_+&JQ*FP<$$\9.:^AO'?C:^TSX ZQXKM3Y.HIX?>_C8#
M&R0P;@?P)H ] 2ZAEE:-)4>1?O(K D?44/<PQ2K&\J)(WW49@"?H*^8;[X3>
M'O@[H?PK\5:!;/;^)FUC3++4M561S/JB71$<_P!H.3YF6?>,_=(&,#BJ^G?"
MK0?BQX,^)GC?Q%;M>^*6U/4X]-U0R,)]*2U+1P+;L#^[VF/><?>+$-D<4 ?4
M\UQ%;)OFD2),XW.P _6GJP=0RD$'D$=Z^7_">EV/[1/CGPTOC:U36M(L/!&G
MZHNDW0)MY+R[SOF=.C,HB(&[.-Y/6NG^$>EZY_P@OCOP=X7UK^QY-!\2W.EZ
M;?7L379M;0K%,$4,WS%%F95W$@87(.* />$D63.U@V#M.#G!]*=7@_['FER:
M)X'\7Z?+?7.J2VOB[5(6O;Q@TTY611O<@ %CU/%>\4 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5\X_%BU\7S_M0>')?!-WI4&M0^%+IQ#K:2&TG0W2 JYC^=<9W @'E<
M=#7T=55M+LWU%-0:T@:_2,PK=&-?-6,G)0-C(4D XSB@#BO@Y\,Y_AUX=U)-
M5OH]6U_6]0FU;5KN-"L4EQ(%!6-3DA%554 \X7/>J>L?L]>#-1TWQ=9V>GG1
M8O%%C+9:C%I[F."0N/\ 7>2#Y8E!YWA03DYSFO2Z* /!_"WPB^(NK^(O"O\
MPL/7= U'0?"4PN=.72()5N-0N%C:.*:YW_*A4,6VID%CUP.>H\<> /%?Q&\(
M:A9:C?:3H^MV6L+J/A^^L$DFCB$+[H#.KXRQ&Y7"\88XKU"B@#Q?PC\*O&VO
M>)K_ ,4?$;6],CUDZ5+HVG6GA3SHX;&.4@RSK-)B0RL0G0 +L&"<\9%E\(/B
MCXD?1?#OC?Q5H>H>"]&NH;K[3903'4]7,#AX5N2YV1_,JLQ0L6*X[DCW^B@
MHHHH **** "BBB@ KQ3]J2SU&_T7P'!I%\FFZF_BZQ^S74L7FI'($E*EDR-R
MY&",C@GFO:ZKWFG6FH^1]JM8;GR)1-%YT8?RY!G#KGHPR<$<\T >8_##X<>*
MK3QKJOCCQ]J.EW?B6\LH],M[/0UD%E9VJ.SX4R?,SN[$DD#& !FNIO\ X5>%
M[_QG8^+1IBVGB.T^4:C9.T$DJ=#'+L($J>S@X[8KK:* /G'4_@!\0'T_6/ .
MF^(M#L_A9J]W-/-(T$IU:WMYI#)-:1#_ %14DLH=CD!NAQSZ[J_A._U^#5O#
M-W%IZ>";K2!8Q")I/MHD8,C@@C9L";-N#G.<\5V-% '@7ACX/_$N]U'PMI7C
M;Q'H.H>$?"MS%=V4FFV\JWVI20KM@-R&^2/;PQV%LE1TJ/7/@Q\2=/O?%&A>
M$/$F@V?@?Q1=375TVH6\K:AIAG&)Q;!?DD#'<PWD;2QZU] T4 >*^*OA#XL\
M,ZWH>O\ PNU'1[6_L-'CT&XTWQ"DIM+FUC(,3;X@75T(., @ACTKL_A%X O/
MA]X9N8-5U&/5M=U.^FU34[R&+RHY+F4C<$7J$4*JC/.%&:[>B@#S[X-?#W4/
MAUIOB:WU&>VG?5/$-]JT)M69@L4SAD5MRCY@!R!D>YKT&BB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>aciu-20231231x20f014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %S WD# 2(  A$! Q$!_\0
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M.TLI+;Q+;76I1-*<0M<6:C,88D A7<IN&X#G%Z?]IC5;'PMXP\57?@L0^&]
MO+G35N/[3!FNKF*Y$'W/+Q'#SN:5F^7:WRD $@'O=%<#\*/B#K'C^SNKG4='
MTNSMDVFVO]#UV+5;2Y!SD*ZJC!EP,@KCD8)YQWU !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5=B^/^@:3X]\7>'_ !1J^C>'(M*O;6SL9;Z^6)[LRVZ2GAR.A;'''K7D>O\
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MO%?/'C']I'QAX:_X)D^'?'TGB6YB\=:O;6ULFM[5:82RW90R;0N"1&&X [4
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MOB3_ +#=W_-:["N/^''W?$G_ &&[O^:UV% !1110 4444 %)UI:* "DQ2T4
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M\\KR2Z5922.=S.]LA+'U)(YK"^%<$=MX;NHH8TBB35+\*D:A54?:9. !P*[
MUR7PR_Y -[_V%;__ -*9* .NHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ I&^Z?I2TC?=/TH Y#X<?=\2?]AN[_FM=A7'_  X^[XD_[#=W_-:["@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M $-<E\,O^0#>_P#85O\ _P!*9*ZTUR7PR_Y -[_V%;__ -*9* .NHHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]6UJ'Q@;6/\ M5;B:_S]KP/-*F)2A4MG:1VQGG-?L!X+72T\':$NAL7T46$
ML6.<F#RU\L\\_=V]>:_,&70?C?X5^%=E^T%JFD?"K4/!,L,6KS>!(_#5HGEZ
M=(P*A)O(W>8%8'[Y/U^[7ZA>%-3M=:\+Z/J%C +6RN[.&>" *%\N-D5E7 X&
M 0,#TH U:*** "BBB@!#7)?#+_D WO\ V%;_ /\ 2F2NM-<E\,O^0#>_]A6_
M_P#2F2@#KJ*** "BBDSB@!:**BN;N"RA,MQ-'!$O5Y6"J/Q- TFW9$M%5;35
M;+4'9+6[@N&4998I5<@>^#5JDG?8<HN+M)6"BDR/6EIDA1110 445A:MX[\-
MZ#>-::EX@TO3[I5#M!=7L43A3T)5F!Q0!NT5#:7D&H6L5S:S1W%O*H>.6)PZ
M.IZ$$<$>XK!\>^-/^$#T%M4_L/6/$ 5PIM=#M1<3@'^+:67Y1W.: .DHKS[X
M/?&6R^-&BG5],\/^(='TUT26WN-<L1;+<JV>8_G8D#'.<=17?N"R, Q4D8##
MM0 N:6OF_P ':9\1#^T-K7AV^^+>M:EH>CV-EJOV*72=.07'G2S*T+ND 8(!
M&H!4AN3S7TA0 45Y?\7OV@-*^#%Q:KJ_ASQ5J5M<;%%[HNC27ENLCR"-(V=3
MP[,P 'N*[?P?XE'B_P /6FK+IFI:.+@$_8M7M3;7,>"1AXSRO3/TQ0!LT5GZ
M[X@TOPOI<VI:SJ5GI&G0X,MW?3K!#'DX&YV( Y(')K*\+_$SPAXWNIK;P[XJ
MT37[F%/,DATO48;ET7.-S!&) R1R: .EKSG4/VC_ (4Z3KD^C7OQ)\)V>KP3
M?9I;"?6;=)TESC84+Y#9XQC->C5X=XGT6PD_:M\&EM/MFW^&]4=B;=26;S[7
MDG')]Z /< 0P!!R#WI:*X3XG_''P/\&8K27QGKT>A170<Q2302NI"XW$E$8+
MC(ZXH [NBN<\!?$+P_\ $[P^NM^&M0&IZ8TC1"<0R199<9&'53W':NCH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M \M^*'BCXEZ!XU\/1^%?#ND:EX/>QU";6]3U&Z$,EG-' S6H4%URKR *QP<#
M)R.M?GY-\/?C%XCUP?%"3]EWX,W]U)_Q,CKZZQ&UG(1\QN&Q>>2W(+%R#SR3
MWKZY_;9TG0OB%HNB^ F^*FI?#/QAJ,5]?:9_9TDRKJ$$%L[7,4P3Y3'L^8Y.
M1MX!Y!_._P &^'/A?_PJW3_#'B+]M36--M'L?LE]X=TJTO9M-1&SOACW;0T9
M![H,Y/% '[$?#;6=7\1?#[PWJFOV]E:ZW>Z=!<7L.G3B>V29XPSB*0$ATR3A
M@2",')KDOVB(?B1>^ I+/X9ZAI&B:K<,R7>M:L'D.GVPC<M+!$O^LFR%"AB%
M&<GI6Y\$[+P]IOP?\%6GA*^;5/"\&C6D6F7KYW7%LL2B.0Y Y90#T'7H*ZK5
M[$ZEI=W:*XC,\+Q!B,XW*1G]: /S/\&_%GQ;X1_X)*Z9K.EZ]?0^)-4U272?
M[9>=WN8EGU1XW=7)W!MF0#G(SQC KJ+K5]6_8Y^,_P 3_!WA+7M9U3PZOPJN
M?%]O;:]J$EZ;?4K=F3S4:0D@/U9>A/L!CVGPC^PS:6O[%Z_ 7Q%XB-X5>:>/
M7-/MS$T,YNVN8I%1F/W&(!&>1GD9XL_#G]CO5)?$OC'Q3\7/&D?Q!\1^(/#G
M_"(B6RTU;"&VTT@^8%7<V9'8[BW8Y]> #YY^#MGK/P;\9?LJ^+;+Q=XBUB]^
M*UO-'XKM]7U.6Z@O9);=)TE5'.(VC9\ KC@#WS]??M*?'FX^#WP?\<>(M(TN
M\N=:T33Y+BW^V:5<M9-(H&-TBJ%*\]0V/>O,?@Y^Q)XA\%^./ &H>,_B/_PF
M7AWX<6]Q;^$M*CTM;1X?-78'N9 Y\UDC 5< ?=!]0?I7XA> M%^)_@G6/"GB
M*U:]T/5;9K6[MUE:,O&>H#*01]0: /S%_9 _X*?^-O'/QBB\.^*?#-E)H.I/
M>7UP/#.D7=W?"3RRPV1HSDKE1GY3@9YK[O\ ^&LO#7_0I_$/_P (G4O_ (S7
MB_P4_8PT'X._$O4_%OPU\%^'[6]TR^NK&RO=4UW4#,L90(ZM&%9#PS 'DX.>
MM?19U?XK6*&27PUX6U-1SY-GK4\,A'H#);[<_4@5SNLD[.+^YGKPRV=2*E&I
M#7HYQ3^=VK?,]$L[I;VTAN$61$E19 LJ%' (S@J>0>>0>E35';N\EO$\L?DR
M,H+1E@VTXY&1UQ4E=!Y+5G8\G\4_M(:#X2\07VCW/AOQM=SV<GEO/IWA._NK
M=S@'*2I$5<<]0365_P -9>&O^A3^(?\ X1.I?_&:ZCQ[\;-*\"W#Q_V=?:Z(
MG2&X;1Y;:4V\KNJ)'(C3*X8EU_A[UV?A_59=;TF"\GTV\TB63.;._P!@FCP2
M/FV,R\XSP3P:RC5A*3@GJCNJX'$4*$<14C:$M%JM>NU[[6Z=5W1Y)_PUEX:_
MZ%/XA_\ A$ZE_P#&:/\ AK+PU_T*?Q#_ /")U+_XS7KGB"/5)-'N5T6>UMM4
M*CR);Z)I85.1G<JLI/&>A%<)\'/$7C3Q9!?7_B.[T.2RBNKJQCATRSFAD\R&
M=HMY9Y&&TA"<8R,CGBB53EFH6>HZ6"E5PT\4II*#2L[WUVMI;6SZ]#GO^&LO
M#7_0I_$/_P (G4O_ (S1_P -9>&O^A3^(?\ X1.I?_&:]LQ]?SI./?\ 6M3S
MSQ3_ (:R\-?]"G\0_P#PB=2_^,T?\-9>&O\ H4_B'_X1.I?_ !FO;,?7\Z,?
M7\Z /$_^&LO#7_0I_$/_ ,(G4O\ XS1_PUEX:_Z%/XA_^$3J7_QFO;,?7\Z,
M?7\Z /PZ_P""BO[2'C'6_P!H^1O#.O\ C+P_H=K!8W5IIM['=::T%RJMB58)
M I5LDD-CGG%??_[)W[5]K'^SGX"7Q)I?Q!\0:Y_9P^UZDGA?4+Y;A][?,)UC
M(DXP-P)Z5ZK^T[96\ES\*W>")W;QUI*EF0$D;I.,^E>W0PI#"B1J(T48"H,
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M6@NL^:8PF[;A&QQR5('(K^B7'U_.O'=(#?\ #6OB8_-M_P"$-TT9YQ_Q^7=
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M(Q@GM0!^Q'PD\1Z5XO\ A=X1US0]-71]'U+2;6\L]/6,1BVADB5DC"J  %!
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MTI:1ONGZ4 <A\./N^)/^PW=_S6NPKC_AQ]WQ)_V&[O\ FM=A0 4444 %%%%
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MEBF0C!5U8$,".H-?$EA\+-"^'-Y\1_B3X-\*Z5IVM> /'$EX(M,L8X7GTO\
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MP;<O]GV8/'I7L6K:39:]I=WINHVL5[87<30SVTZ!XY48896!X((.,5Q7@[X
M?#;X>ZW'K'AGP+H&@ZK&C1K>:?I\<,H5AAAN49Y'!H Y']G6=_ VH^*?A->,
MP/A6=;G1C(>9='N69[<#/)\EQ+![")/45[=7A_Q]'_"NO%/A#XL0#9;Z-/\
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MM9V_4^2Q6#CAJ5&JJBE[1<UDG=*[CK=);I[7):***V/,"BBB@ HHHH ****
M"BBB@ HHHH **** ,GQ7X<LO&'AG5=#U*(3Z?J-K):7$9Z-&ZE6'Y$U\)P?M
M1^"O 'C_ .$?ACXA>+['2O$GP]O]4T;6I+G?\T:6,D-M<G .1,C0GUW,PQQ7
MZ GD&OQ6_;D_8O\ B7K7[5][K,%MI45AX\UW[+H<D^IQQ^=*+<,%8'[A/EL!
MGJ<#N* /V?TC5K37M*LM2T^X2ZL+R%+BWGC.5DC=0RL/8@@U;KF/A?H-WX6^
M&GA+1=05$O\ 3M(M+.X6-MRB2.%48 ]QD'FNGH **** "BBB@ K&\9>%-/\
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MOX+.^!VVEVWHKY\ES[QD\+0![I12 Y%+0 4444 %%%% !1110 4444 %%%%
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M_H7=)_\  &+_ .)H_P"%?^&/^A=TG_P!B_\ B: +G_"3Z/\ ]!:Q_P# E/\
M&C_A)]'_ .@M8_\ @2G^-4_^%?\ AC_H7=)_\ 8O_B:/^%?^&/\ H7=)_P#
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MCW1=_P"$GT?_ *"UC_X$I_C1_P )/H__ $%K'_P)3_&J?_"O_#'_ $+ND_\
M@#%_\31_PK_PQ_T+ND_^ ,7_ ,378?.%S_A)]'_Z"UC_ .!*?XT?\)/H_P#T
M%K'_ ,"4_P :I_\ "O\ PQ_T+ND_^ ,7_P 31_PK_P ,?]"[I/\ X Q?_$T
M7/\ A)]'_P"@M8_^!*?XTG_"3Z,?^8K8_P#@2G^-5/\ A7_AC_H7=)_\ 8O_
M (FC_A7_ (8_Z%W2?_ &+_XF@"Y_PDVC@9_M6Q _Z^4_QKQ7]HKP;HVMZ!JG
MC7PSXL3PAX^TG2[A;?6].GC)GA",QMKF/=B:(GD _,C?,A4YSV.E>"/#C_$_
MQ!"= TDQKIEBP7[##P3)<9/W?\XKK?\ A7_AC_H7=)_\ 8O_ (F@#\/_ -B/
M]I+XG>)/VJ/ASIOB#XD^)-0T>XU-4N;74-8F>"1-K<.K-@CZU^Y8\3Z/@?\
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MOCS\2]&^).K^&;/X7ZI'8Z3X:L8X_L%TD6#,;I64F0OSCD8S7W]\._%!\;^
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M?$36?A]I/@#PO:ZO96>C","\NYH1-FY+*2\8!"[1B@#[^HKR[]F'XFWWQC^
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MX4 %>=^%?@9X=\(?%GQG\0[*2^?7?%<-M#?QSS!H%6!=J>6NT%>.N2:]$HH
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MT#0-/\+:'I^C:3:1V&EV$"6MK:PC"11(H55'L  *T** "BBB@ HHHH ****
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M#?V,=:G_ &/O%/PB\2ZE86NK:IJ5Y?VU[9EIX86:82P,P(4G!49 _ U]>T4
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M#X$\(ZZL*:QH^EQ6ETMO)YD8=<YVMQD>]>GT44 %%%% !1110 4444 %%%%
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M "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN/'_ (DUKPAXH\&W_@GQII=H;U].NG\V*:+^\D@4>HZCGG!.#CI_V;_C//\
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MP=I7Q%_:P^#MAXBL8=8L'\'QW,UM>+YD<S)$[C>IX8;@#@\'O7(3VE[X"O\
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MMHQ''&HZ!5' %7** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M DAE&>N6;\Z;XD^"7@+QAXFA\0ZWX2TG5-9B "WEU:J[X'3.>&QVR#BNWHH
MX!O@)\/GT"ST1_">FOI%G>G4(+)XRT4=P1@N%)ZX/T]JN>#/@UX'^'>J7FH^
M&O"VEZ+?7>1-<6=LJ.P)R0#V&>PP*[.B@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
>*** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>aciu-20231231x20f015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f015.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %O U,# 2(  A$! Q$!_\0
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M_#:]\3WSR27/B/5;O4E9W) B:0K&!GH-J]J]MH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I,\XI:_/K]JSQIXT^'O[96
MG>+/"S3WMEX;\,Q:GJ^DI*V+FQ\]HY\)T) 8-GMM![4 ?H)GKU_*C-?FMXK^
M(2^,?A)^U?XAT369KG3KB]T^YL+B"Y?"1N\3#80?EZ\@8]*Z7XG?'+7O&9^
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MF%/%FNQ:X\ZV:$VS(X?RP-WS XQDX^E?1%A:"QLK>WWF3RHU3<W4X&,U8HH
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M_+DMT&*Z@_LCZ=KWB'Q3JGB_Q%=^*&\2^%[?PWJ8DMH[=Y3%@FY#(<*Y8;@
MN%.,9Q7O]% 'SO\ #+]D3_A#_&/A[7_$_C[7?'S^%K9[3PW:ZK'%'%IL;KL+
M'8,RR; %WMCITX&*=K^Q?96OPCTCP*/%5TT.G^*AXH%[]B3<["0OY)7=@#G&
M[.?:OI2B@!,<5Y#+^SZ!\1_B/XPM?$,]K?>,-'BTKRUME(LBB%1*IW9<\YP<
M?6O7Z* .;^&W@>T^&G@#P[X5L7,MKHUA#8I*RA6D\M I<@< L06/N:Z2BB@
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M[HQT&23Q0!Z77!?$7XS:'\,-6T:RUBTU9UU.58A>66GR36UN6;:IFD'"98X
MY/MCFO![7X]>/?&'@+X-:5I&IV.E^*_&EG+>7NLRV"S)"D:DGRX<A<DX'/05
M8\*:=XI_:S\ ^%]=NO$=IHO]FZA):ZG;)I@DW7%M/C[1:OO#02'&.2XPQXH
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M'_%?QB\8?#_XN3:SI'_",2:/!=6OARZT^:22QEFBS-+%*)E7S3N*!W1MJ9
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MH_L[>#5'C#QUXWU3QIH7C/Q9JCVNEWY\.1^7:6"VB%5AVF1V$A+,[[CU(
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M1_PR%^U!_P!'97__ ((E_P#BZ^X:* /A[_AD+]J#_H[*_P#_  1+_P#%T?\
M#(7[4'_1V-]_X(E_^+K[AHH _//PA_P3N^.G@+6]?U?P_P#M*RZ7J6O3BYU.
MYAT(;KJ09PS9D//)Z8KJ_P#AD+]J#_H[*_\ _!$O_P 77W#10!\/?\,A?M0?
M]'97_P#X(E_^+H_X9"_:@_Z.RO\ _P $2_\ Q=?<-% 'P]_PR%^U!_T=E?\
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M /!$O_Q='_#(7[4'_1V5_P#^")?_ (NON&B@#X>_X9"_:@_Z.RO_ /P1+_\
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MQ$ENNJ_%WXE:FMM*)X5O-4BE$4@Z.NZ,X;W'-:'_  ZYTK_HN'Q6_P#!XO\
M\17V]10!\0_\.N=*_P"BX?%;_P 'B_\ Q%'_  ZYTK_HN'Q6_P#!XO\ \17V
M]10!\0_\.N=*_P"BX?%;_P 'B_\ Q%'_  ZYTK_HN'Q6_P#!XO\ \17V]10!
M\0C_ ()=:4#G_A>'Q6_\'B__ !%9^D?\$F/"OA\70TOXN_$K31=2F><6>J1Q
M>=(>KOMC&YCZGFONZB@#XA_X=<Z5_P!%P^*W_@\7_P"(H_X=<Z5_T7#XK?\
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M?2]6L()_/A65>0T;D E2.>1FO8J "BBB@ HHHH **** "BBB@ HHHH ****
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MX\I_]QOY5/4%]_QY3_[C?RH ^,O^"7/_ "3CXF_]CSJ7\UK[4KXK_P""7/\
MR3CXF_\ 8\ZE_-:^U* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **YK4/B9X0TKQ5;>&;WQ3HMGXCN0#!I$^H1)=RYZ;8BVXY[8%3/X_\,1^+
M$\+OXBTE?$KQ^<NC->Q"\9,9W"'=OQCG.* -^BL"#Q_X8NO%<WA>'Q%I4OB6
M&/SI-'2]B:\1.NXPAMX'3G'>IO%?C3P_X$THZGXDUS3O#^G!Q&;O5+N.VBW'
MHN]R!D^E &S17.Z_\1?"GA31[35M:\3:/I&E795;:^OK^*&"8L,J$=F ;(Y&
M#S2^(_B'X6\'0V$VO>)-(T2'4'$=I)J-]% MPQY"QEV&XG(Z9H Z&N&^.?\
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M *+:OEG_ ()=?\FS'_L.:A_Z/:OJ;Q=_R*FL_P#7E-_Z+:OEG_@EU_R;,?\
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MO/\ Z.:OJB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXVUY?_P2@-V?V?M;-^(Q>_\ "1WOGB+[@??\V/;.: /M>BBB@ HHHH ****
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M_-:^T+A96A<0NJ2D?*S#(!^E)NRN-:LDHK(^S:U_S_6G_@.?_BJYA=*\5?\
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M\J /C+_@ES_R3CXF_P#8\ZE_-:^U*^*_^"7/_)./B;_V/.I?S6OM2@ HHHH
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M/>#M6\:Z9XNNM!MY?$>F6KV5KJ&YUDCA92K)PP##!(^8'&3BN@P/SNN-6^*
M_8WO;)/#?AP^ ?[1ESJ9U&3[?C[:>?)V[<[N.O2MOQM\/Y_'O[0_CFUMO@M;
M?%B<:+IRI+/K<>FC3F:' ?+$%\^W/%?=Q^!_@AOA^_@@Z!#_ ,(L\AE;3O-E
MVEB_F$[MV[[W/6M30OAOX;\,^)-2U_3-+CM=7U&&*"ZNE=R94C&$4@L0,#T
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M[>?_ $<U?5%?*_\ P3(_Y,U\#?\ ;S_Z.:OJB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBD)P"3P* .4U5AJGCG3[4
MG]SI\+7<GH&/"_UK\_/VGC+\<?VGOAGX/3]]!JFN"\EC9NEK;'C/L2":^W=2
MU>2#PYXDUB+_ (^M3G^Q6F.N/N#'ZFOB[X2^(+"3]N/QKXAFMWU"Q\%:9'H=
MHL>,"=AF0Y/XU\YBL12A54ZTK0A[\GZ^[']7]Q]>J52-!X>C&\YV@EZ>]/\
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M_HYJ^J*^5_\ @F1_R9KX&_[>?_1S5]44 %%%% !1110 4444 %%%% !1110
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MR;2V'B?3;)]/AO(YW3="RE=KJ#AL!C@GD9KT2DH \U/[//@L_"R3X>FQN?\
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M +&.OZM]I^)G@V;Q5=>.O#GA+6X]/T?Q#?2B::6-H0\D#RC_ %AB8[<^_88
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M^"9'_)FO@;_MY_\ 1S5]44 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVB7@?F<G\JVJK#*Z=3OMZ+;[]_F>)BZG-4:M;=NW=ZO[MOD%%%%=APA1110
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M444 %%%% !1110 4444 %%%% !7D_P 5_$8O]0AT.&81P1?O[N4GY5"C)S[
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M0_M-_$5PD;,5,G!P#Q_K*N_\$H+)M._9^URU>=[IX?$=[&9Y?O2$/C<?<]:
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MSP9.-WK7S]JO@?XC?M@Z_I][\28;CP#\,X=@TGP)ITACDDB_A:;'0D<Y(SZ
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M_*@#XR_X)<_\DX^)O_8\ZE_-:^U*^*_^"7/_ "3CXF_]CSJ7\UK[4H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KAOCG_
M ,D9\<?]@6[_ /1+5W-<-\<_^2,^./\ L"W?_HEJ /$/^"9'_)FO@;_MY_\
M1S5]45\K_P#!,C_DS7P-_P!O/_HYJ^J* "BBB@ HHHH **** "BBB@ HHHH
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M-+;XD>/M2\->+[B2TODO-1$BP1IMVB-0NP=>C CB@#]7KG4;6RM#=7%S#!;
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M  P[\!!_S2CPQ_X!#_&@#YZU7Q)^Q'I,$%[KOC73_%TSS)%YFI^(+[59"6.
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M[/VJW6H01_%/0(FLIO)=KF<Q)(< YC9@!(O.-RY&0:O_ /##OP$_Z)1X8_\
M (?XT?\ ##WP$_Z)1X8_\ A_C0!0TC]OO]G[67O5B^*>@PFTG-NQNIC"'( .
MY"P&].>&7(X-)HW[?G[/VN)=-#\4M!@%O.]NPO)C 6*_Q(' W(>S#@UH?\,.
M_ 3_ *)1X8_\ A_C1_PP[\!/^B4>&/\ P"'^- %#1OV^_P!G[7+::>'XIZ#
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M?A)J_P *9/'[:M<65P-?\376LVOV-W;9#(%"J^Y5PWRG(&1[UZY110 4444
M%%%% !7E7[0?PGU/XHZ#H4N@W=I:^(?#VK0:SI_]H;Q;22Q'[DA0%E5@2,@'
M&<X->JT4 >!_#+X1^/OAY97]WYWAJ[UKQ1XA;4O$2L]QY-O:,NWR[5MH+R*
M/F<*#D\"N*\.?LC^*+;Q%X?TC5M5T:7P%X<UJ]UO3I+8R_VA,\X;9%)&R^6J
MH7;Y@Q+<<"OK&B@#Y<^$_P"RYXL\)>+?!$>NZIHT_A/P*;TZ,;%IFO+OSV8I
MYZLH2/8&(^5FW<=*]'\$?"35_#?Q]\=^-[FXLWTK7;.UM[:&)W,ZM%G<7!4
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M?"WXH_M ?!WPQI=O9ZK\/A\/[BY>QT^^E-O<3"[D:1'=7W'$[,Q4MPR<CC%
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MG@>]?37[-SS6_P"T_P#M%6< (TM=0TV8 #Y%G:W._'N1@F@#Z?HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#+\0^%M&\6V2VFMZ38ZQ:*XD6"_MDG0,.C!7!&>3S5'0?AUX5\*
MRSRZ-X:T?2))T\J5['3X8#(G]UBBC(]C7144 9&@>$-"\*K<+HNC:?I"W#;Y
MA86L< D;U;8!D_6DTOP;H.B:C=W^G:)IUA?7>?M%S:VD<<LW?YV506_$UL44
M <U;_#3PC:77VF#PMHL-Q]H%WYT>G0J_G#.),A<[QD_-UYZU8D\"^&Y;&\LG
MT#2WL[R?[3<V[641CGESGS'7;AFR =QR:W:* ,76/!7A_P 07%I/JFA:;J4U
MH0;>2[LXY6AQTV%E)7\*EG\*Z-<ZC/?RZ38RWT\'V66Y>V0RR0_\\V8C)7_9
M)Q6K10!C0>#- M6TUH=#TV(Z:K+9%+2-?LH/4187Y >^W%4XOAIX1ANY+J/P
MMHJ7,DXNGF73H0[3#I(3MR6&3\W7FNEHH YY/AWX6CO8[Q/#>D+=QSM<I.MA
M")%E;[T@;;D,>[=370T44 8^G>#=!TC5KG5+'1-.L]2N?]?>6]I''-+_ +SA
M0S?B:6/PCH<.NOK<>C:>FLNNQM16UC%PR^ADQN(_&M>B@#'E\':#.VIM)HNG
M2-J8"WQ:TC)N@!@"7Y?GX_O9IFI^"?#VM:9;:=J&A:9?:?;8\BTN;..2*+'3
M:C*0N/85MT4 9.K>$]%U[2TTW4M(L-0TY,;;2ZM8Y8EQTPC @8^E)+X1T.>U
ML+:31M/DMM/</9PM:QE+9AT,8QA"/5<5KT4 9/\ PB>B%]1?^Q[#?J0Q>M]E
MCS=<8_>\?/Q_>S46D^"?#V@SP3:;H6F:?-;Q&"&2ULXXFCC)R44JHPN>PXK;
MHH YV_\ ASX4U74+F_O?#.CW=]=($GN9]/A>251T#,5)8>Q-6+OP5X>O[Z&\
MN="TVXNX83;QW$MG&TB1$8*!BN0N.,#BMJB@##N? _AV]T.+1;C0=,GT>''E
MZ?)91-;ICIB,KM'X"I[OPKHM_8VME<Z18W%G:,KV]O+;(T<++]THI&%([8Z5
MJT4 4+70=-LM3NM1M]/M8+^Z 6>ZB@5990.@9P,MCW-<=\4?A';_ !'U3PGJ
MT=^VE:QX;U%;^TNUA$N1C$D;+D<,O'7CWKT"B@#QOX6?LS>'_A\OB7^TUL?%
M3ZSJ<VHAK_3(LVXD.3&-Q;(SWXSZ5S/Q>_95U_XF>(;NXL/B?=^']$O(C;S:
M8= L;N6*(C#1VUTZB6!"/X02!7T510!RG@GX8^'O ?AJUT73=.@,$-G'8O-+
M$C2W$2+M E;&7XSP>.:T;;P7X?L_[.\C0]-@_LW/V+R[.-?LV>OEX7Y,_P"S
MBMJB@#!'@+PT(!"/#^E"(7'VL1_88MHFSGS<;?O_ .UU]ZYSX;?"*W\ >)?&
M/B";4&U76/$M_P#:YYVA$0AC VQPH,GY5'?/)YXKT&B@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH Y6_P#A3X*U34Y-2O?"&@W>H2/YKW<^F0/*S]=Q
M<H23[YK>U#1[#5M.DT^]LK>\L)%V/:W$2R1,OH5(((]L5<HH QO^$-T#_A'C
MH/\ 8FG?V&0%_LW[)']FQG./*V[>O/2IAX8T<:E%J(TJQ%_%!]E2Z^S)YJP_
M\\P^,A/]G./:M.B@#F].^&OA+2+B&>Q\+Z-9SPS-<126^G0QLDK##.I"@AB.
M"1R:G7P)X;73ET\>']*%@MQ]K6U%E%Y0FSGS NW&_/.[&?>MVB@#&U/P7H&M
M:I:ZEJ&AZ;?:A:8^SW=S9QR2PXY&QV4E?P-.N/"&A7=QJ%Q/HNGS3ZC$(+R6
M2TC9KF,# 20D9=0.S9%:]% &3!X2T2VN[*ZAT?3XKFR@^RVLR6L8>"+_ )YH
M0,JO^R,"J%C\-/".F7"3V?A?1;6>.<W22P:="C+,1@R A<A\<;NOO72T4 <]
M9_#OPKIUY:W=KX:TBVNK4LUO/#80H\)8DL48+E<DDG'7)KH:** ,>P\':#I>
MLW.KV>BZ=::K=9\^^@M(TGE_WI H9OQ-*OA'0TU\ZZNC:>-;*>6=2%K']I*X
MQCS<;L8[9K7HH R)?"&A3RZI+)HVGR2:J@COW:TC)NU VA93C]X .,-GBH]2
M\$>'=9T>VTF_T'3+[2[4*(+*YLXY(8MHPNU&4JN!P,"MNB@#+U3PMHVN:0NE
M:CI-C?Z8H4+975LDL(V\+A&!7CMQQ4<O@[09[#3[*31=.DL].D6:SMVM(S';
M.OW6C7;A",G!7!&:V** ,H>%=%%QJDXTBP$^JJ$OY/LJ;KM0NT"4XS( I(PV
M>.*@TGP-X<T&>UGTW0-+T^:UA:WMY+6RBB:&)F+,B%5!52Q)('!)S6Y10!SN
MI?#KPKK.HW5_?^&M'OKZZB\BXN;G3X9)9H^/D=F4EE^4<$XX'I5FZ\%^'[Z_
MM;ZXT/39[VTA-O;W$MG&TD,1!!1&*Y52"1@<8)K9HH Q)_ _AVY\/Q:#-H.F
M2Z)%CR]->RB-LF#D8B*[1R2>E2W?A/1+_3+73KG2+"XT^U9'@M);6-HHBGW"
MB$84KVP..U:U% %"#0=-M=6N=4AT^UBU.Z18Y[R.!5FE5?NJS@;F [ GBN,^
M(7P@M_''CCP/XL@U!M*UGPM=RRQS+")!<6TT9CGMVY& PVD-S@J#@UZ%10!X
MU\&OV8O#GPM\*7NCZE%8>+9;C4KG4!>7^EQ!T$L@D$0W;^%90<YZ\X%<?\6?
MV1M>^*?B/5Y7^*E_8>&]64PW>EMH5C<70@8Y>"*^91-'$><)D@9/45]*T4 <
M_HG@'P_X?T1M)L])LULI+:*TG1X$8W,<<8C02DC]YA !\V>*L0>#]!M9]/FA
MT73HIM.B:"SD2TC5K:,C!2,@?(I'!"X%;%% &#%X#\-V\%I##X?TJ*.SN#=V
MR)8Q!8)CUD0!?E?_ &A@^]<Y\)/A%;_"X^*+IM0;5]7\1:O-JU]?/"(B2V!'
M$J@G"QH HR3GD]\5Z#10 4444 %%%% !1110 4444 %%%% !1110 4444 %%
%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>aciu-20231231x20f016.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f016.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %S [D# 2(  A$! Q$!_\0
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M8$IC],C(%'_ _&W^8?\ !_"_^1]4T5\L6\MZ^G:%!J]SK*_#8ZK?*)PTXE:
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MK$E96"BBBD,*:[K&C.[!449+$X %.K \?Z5=Z[X(UW3[!MM[<V<L4/.,L5(
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MPI:* &E%8@E02.A(Z4ZBB@ HHHH *15"?= '?@4M% !1110 FT;MV!GIFC:
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MS6_J/[/EU-X@N]4LO%<]J;N_BO9H##)A@CW#",,DRD+_ *1D=0&7=@[L#F_
MO[/'BEO"4-GXH\4S1Z@,&9K9Y6\UQ!(F\D2C^.0-_M>6"0"W !U,O[,GAJ36
M'O/M-RMNV[%B$C\E,YR%&WA3N;(Z$G-;M_\ #72(+;P/I4^MRVL6C7,9L(&:
M)9+J2(>8J*2,_=C;*K_ &Z=:YQ/V>KL:K+*_C"]DTYF.RR(G!C0W7G>6&$^"
MNW]WRI/ (('RUO77P?EO=8^'FIS>([Q[KPCC(,*,E[_HTD#L=V61F\P$D,>%
MQU(8 'I%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!14=Q.EK;RS2';'&I=CC. !DUYG-\>=-C\):SK_]FW*06&H)IZ0SLL+S,Q7#
M?-C8,-GGL*5_Z_ =CU"BO+;_ ..T&G6-A<OH=S*LMM]MNO(N(I!:V_F^6)-P
M.'R><+VS2^&?C9<ZO\3AX+U;P?J?AZ>YM)[[3[ZYG@EAO(8G1691&Y9?]8I
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MNJ+M0=> !QQ7S_/H?C^9=#AO+G7XWFM5FC>W\V1H+EYV9Q)B5 -BE1A\KM!
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M][CJ^#7T-6CZ$+J%%>?_ !I\1:[X?\'SMH%I=274B2%[NUB$AME5"V[!(ZD
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MFODK_@GGXA^)_P /O ]G:^-?#-]8_#"^A\[2]7NI86:RF+8.] YE$4AW'<Z
M*0"3A\U]@?&^Z6R^#'CRX<,R1:#?.0O4@6[]*\W_ &,/BY9?&3X*0'R-MSI<
MTEA=Q2;65N2RD8)!!1ES[@UU5/9_58I6YW)]7LDM+7LU=[VNK*SLV>IA4UAZ
MM24>:G>"?DWS--/H]&NJ:;NM$>\LL-[;E6"3P2KR" RNI'Y$&O+]>M;KX%Z1
MJ6NZ.?M?@RRCDO+W0YI@K648!:1[1W.%4#)\EB%ZA2O K ETOXI^!?C&O_",
MZ19ZE\)S:$2:8]^B7$-PWS%[<,N5 ("B,MM^<XVX%>JZ/XDT;QQ87-N@$IP8
MKO3;Z$I-'V*2Q.,C\1@CD$@YK/#8R5%N$E=/>+V=OU[-6:^9A6P;475I/FAW
M6ZO_ #+6WY/HV97P>^+?A[XY?#S2?&?A>X:XTG44)42@+)$ZDJ\<BY.&4@@C
M\L@@UVE?./P=NO&GP:\1^+;'QWH6E>'_  #JFMR7'AZYTJ59(=/$I_U5QA1L
M#L-P=N TA7(&P#Z-5@ZAE((/(([UMBJ'LI\T/@?PO?3M=:777S."+OON+17S
MC/\ M$^,K?\ :SU[X;OX>TA/!^EZ)'J9U:>_6*4%U/EER20H9U9-NW(V[NA%
M<-<?MUW]O^UOH'PRDT[0O^$5U"W42ZO9W[712=PVP"10%'("[=O<'/-=D,IQ
ME1<U.-_=YM&GHU?H][=-R74BMS['HHKY%_:Q_;8U/X$_%7P5X1\+:-IWB=[^
M=5UE))V5[17D5(TWCY8V;=D%\].G>N+#86MC)NG1C=I-OLDNK>R^?70IR4=6
M?75%?)_[4?CC]HVWT[PK%\.? L$4=SJ]L]Y<66H"ZN$C5MWERKL54B<@!W!(
MP"#PV:^J[5I7M86N$6.<H#(JG(#8Y /IFG7PTL/&+E*+O?124K6MO9NV^GHP
M4KDM%%%<904444 %%%% !1110 4444 >=?&.WO;K28%$>S3XY4F^TVVI)9W4
M<JD[=AD79_X\#4WPAUBRO](N8H=3U6^N4E)D36KB.6=.!]TH2"ON">:B^.:V
MX\&Q37$D!,%Y%)':W%JURETX)Q$8UY.?;TKC_@KX2BU'Q#_PE,$EE9-"UQ%<
MZ;:6#VKQ22"/$;!L': N[D=6)%$.J_KH$NC/=**** "O&O%/_)V'@+_L6=6_
M]'6M>RUXUXI_Y.P\!?\ 8LZM_P"CK6@#V6BBJMSJEE92!+B[@@<C(6655./7
M!- %JBL__A(-+_Z"5G_W_7_&C_A(-+_Z"5G_ -_U_P : -"OES]CW_DK7[2W
M_8]/_P"B$KZ3_P"$@TO_ *"5G_W_ %_QKYA_9!UBPA^+'[2327UM&LGCEV0M
M*H##R$Y'/- 'U=16?_PD&E_]!*S_ ._Z_P"-'_"0:7_T$K/_ +_K_C0!H45G
M_P#"0:7_ -!*S_[_ *_XU=BE2:-9(W61&&593D$>QH ?1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?-'C+0M0U7QAXGL]1"
MWUA;2SZG+ FL(CW(V!+:,)O!B$>YB2< ]>:]U^'2SKX"\/"YNUOYQ80[[E'W
MB4[!\P;^+Z]^M>#^.?!D\?CYFO3X1D5M4GODM]1U?[//=QR !8Y%V9*@J#CD
M'%?1NC+*FD62SP06LPA0/!:MNBC.!E4.!E1VX%$?@^[^OT^02^/[_P"OU^9=
MKSKXYZIKVB>"WOM%OX]/2&:'[1(%)E96E10J'H,[CD^GUKT6JNHZ9::Q9O:7
MUK#>6KD%H9T#HQ!!&0>." ?PI#3LSQ36O'>O6_Q4NUCU21+:UUBTTN/2 %V2
MPRP[GD(QN)R<@YXQ7BO[9GQ<\>:A\$YM-E^$NKOH]Q)H\\GB5=2LEMR[3V\A
M40F7S1\_R<J.>3@5]E2^%=&GUR/69-+M'U:-=B7K0J90.F-V,]"?SKQ3]ND
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M]7I]LCW%W*>P2",-(Q^BFN;G\&>./&R[?$?BC_A&]-;[^E^%,I-(O=7O''F
M>\*QL.S5U?A/X?>'/ T!CT/2+:P+<R3*I>:4]S)*V7<GN6))H V[2X%Y:PSJ
MDD:RHKA)D*.N1G#*>0?4'I4U%% !1110 4444 %%%% !6;XCOUTS0KZZ>VN;
MQ(X6+06D?F2N,<A5[FM*H;P;K2<>;Y&48>;_ '..OX5,OA94=T>#_!67R=7T
M*#3'\='3##(SV^L0+'80*4) #>6-WS$ 8/IVKWZOF?X*O9O\2[2&W\1:9<O
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MY9.RLO7]#S\355:E%RFI23?V;.VEFWUOYZKN;5%%%;'FA1110 4444 %%%%
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M\6_]@F[_ /1+5]A_L<_\FK_"O_L7K3_T6*B0'L=%%%2 4444 %%%% !1110
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M"Q.2HSP.E6?$.F6J>*O#=\L(%V]V\;2Y.2OV>7C]*ZFL#Q'_ ,AKPQ_U_/\
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M]6-;=>5!/64MW^1>)G3M"E1;Y8K7LY/=I=.B\TKZ7LBBBBM3A"BBB@ HHHH
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M>A['VB]O?DZVM?Y7T*?_  G.@?\ 05M_^^J/^$YT#_H*V_\ WU3?^$!\/?\
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M#?Q%\#^*AJ7B?XS:IXYTSR7C_LJZTFWMD+G&'WH2>,'CWKV>@ HHHH ****
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M$\?>(9&.I^$)WEM8K>%0MPA^9$E+9)V/A@1CG/'- 'JMI;3RV%O,^IWD>^!
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M:2W3:/,8NQ'+"0 8Z<YH ]]TGPG!X?TN'3=*F.F6$ *PVUG!#%'$N& 555,
M#<"..J#WRDM] DT@36)YWW_ZFW5)"NUF)7"H2 ?+=#GN",AL5;.@VLT>RZ\R
M^7.XK<N64\%>5Z$8/3'OUK0CC2)=J*J+DG"C R3DG\SF@#"VZ@X=89;]R%6/
M?*(8P2=BEQ\N<@;FZ8)R,= &KI6NSONDUD6B<GRXHDE/*]-Q4=&9OX>0J=/F
MW=#10!SY\*33+BXUW4[@%0C O&@8 \\(@QD%@2,'!XP0"'KX52,R/'>3)<,&
M"W'E0F1"P/()3LQW8Z9]N*W:* */]GS^:7_M&XVD@^7MCP.2<?=SW _X"/?+
M$TNY01YU6[?:FTY6+YC\GS'Y.ORGIQ\[>V-&B@#..F7&W']J70.2<[8NZL,?
M<[%@?J@[9!?_ &?/EO\ B97/+ @;8_E 8$@?+T(^7Z'UYJ]10!GC3;@*P_M2
MZ)*%0=L?!V@;ON=<@GTRQXQ@"Y;Q-#$%>5YFR3O<#/)SC@ <=/PJ2B@ HHHH
M **** "L/QKXAL_#'AJ\OKZ.>:# B\FV7,LC.0JJHXY)(%;E<O\ $K1SKG@Z
M^M5M+J\D^22..QD5)U96#!D+$+N4C(!/.,5,MAK<\:^&%A!I?Q=M].NSJ7DV
M'GVVE23P11QLZ0@,A*\DB-CUX.">37T;7A7A;4=1F\4V>HZC9>+/$FKVBO%:
MPW6DQ6$%J7&UW=\A2VWC.3QG KW122H)&#CD>E:/9$K=BUX7XMT?4=2\6>+&
ML-,\0V9>QF@6]B5Y!=LRJ#LRZJJH =@')))XXS[I146*3L?-OA[PYXLM/%/A
MN4Z;?_V3;NJVJ,)E 'VAO,DE!D)C8QE3AL@@8XKVOQ";O_A*/#898?L?VQ]K
M!CYF[[/+U&,8Z]ZZ>L#Q'_R&O#'_ %_/_P"DTU5?2Q-M;G-?&8WES:^$=,LD
MW-J/B.SBE8KN"Q1[[AR1Z8@Q^->B5Q5R/[;^+-K"QD-OH6G&["#[AGN&:-6/
MNL<4H'M*:[6M)RERQ@WHNWGW\_\ )'55Y8PA%1L]W\]OE:S7JPHHHK(Y@HHH
MH **** "J.KZ)I^OZ=-8:E9PWUG-CS()T#*V"""0>X(!![$ U>HI-)JS*C*4
M)*4'9KJ<YI'@F'0+V*6PU/58[5,YL9[Q[B$C!  \W<R@=0%8#CI56ZF\::5*
M[Q6^DZ_:[B1&)'LIU7T&0Z.?J4'O76T5G[-)6CIZ'8L9.4N:LE/_ !?YJS^=
M[F!J?C6PT)X$U1+JQ:6)9"[6[O$A/56D0% PQTS65X7^,?@GQGXKU#PUH?B.
MQU+7+&/S;BSMWRR+D GT."1G'3(S79D9&#7G"?L_>#-/\8ZQXOT:PET'Q7J@
M'VC5K"=U?(()Q&Q,8#$+N&W#8&[.*3]HG=6:*I_5)Q:J*49=&FFKW6ZM>UK[
M-N]CQ_\ X*0_#/5_B9^SI<6^CQS7$^G7L>H-!;V:3L5C#98EN4502Q*\G&.A
M-?17@/4KG6/!&@7UYI]QI5W<6$$DUC=@"6W<H"R-C(R#D<>E>:_&SX@/\*OA
M7XBOO'EJ^M^'3 +5KG1<1W4IE81A&C<A%SN)W[L<'@<9])\ ^,K#XA^"=#\3
MZ7'/%IVKV<5Y!'=1[)41U# ,N3@C.#@D>A(YJE5E-\C>BZ:7UW_+NUV-:]%T
ML+!I77-+WE?E>D=/5=59/57Z6WZ***T/*.8F^%_@ZY\37/B*;PKHTNOW/E^=
MJ;V$37$GEX,9:0KN)7"X.>-H]!7GNI_ 36]0_:,TOXBGQUJ+>'K*!@OA:8O)
M LQ1T+)E]BCY]WW-P(P&QP/::*SE",MT==+%5J*:A+=-=]&K.U]M.JU"BBBM
M#D"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#C?BM9:[?^%_+T&]ET^?S
ME:>X@D$;I#@[B"?0X)[X!K%^ <^MWO@Y[W6I;R?[5(LMM+?7(G9XS&N2I' 4
MMN(]JZ+XC>(Y/#&B6]R(D:TDNHX+R62)I%B@8G>Q5>3QQ^-5?A?KT6MZ9?QV
M,,*:+97)MM.DMX&AC> *"H"M_=R5R.#BB/VOZ_KI^(2Z?U_7_#':445E>*/$
MUAX/T.YU;4G=+.WV[S&A=B68* %')))%&P;FK7C7BG_D[#P%_P!BSJW_ *.M
M:ZB\^-?AK3[&QN[DW\$=WO8(]E('BC5@K22+C*H"1R?6N4\22I/^U9X >-@Z
M-X8U4@@Y!!FM:=@/:*^1/VD_V2?B)\3OCQ:_$3P/XKT#0S'H*:++;:Q:RS%@
M)FE+#9QW4?@:^NZ*0'P;_P ,>?M$?]%#\"?^"NX_QH_X8\_:(_Z*'X$_\%=Q
M_C7WE13NP/@W_ACS]HC_ **'X$_\%=Q_C7G/PL^$WQY^*GB;X@:+9^,_!ME-
MX.UDZ-<23Z;.5N'"!]Z8/ Y[\U^G%?+G['O_ "5K]I;_ +'I_P#T0E%V!YA_
MPQY^T1_T4/P)_P""NX_QH_X8\_:(_P"BA^!/_!7<?XU]Y4478'Y_Z[^Q+^T#
MX@T6_P!+NOB)X'^S7MO);2[-,N VUU*G!]<&OL?X'?#^Y^%/P?\ !_@Z\NHK
MZZT33(;&6Y@!"2,B@%E!YP?>NYHI %%%% !17F/[2_Q9O/@9\#?%?CG3["'4
M[W1X$EBM+ARB2%I43!(Y'W\_A7RS;?ME_M W5O%,GPV\&[)$#KG6I,X(R/X:
M /O2BO@__AL3]H3_ *)MX,_\'4G_ ,31_P -B?M"?]$V\&?^#J3_ .)IV8'K
MG[6__)1_V=_^QX7_ -))Z^E*_,[XH_&3X\_$_7_ >J7/@7PE92>$]9&L0QQ:
MPY$[B)X]C97@8<G(]*]!_P"&Q/VA/^B;>#/_  =2?_$T68'WA17P?_PV)^T)
M_P!$V\&?^#J3_P")H_X;$_:$_P"B;>#/_!U)_P#$T68'WA17R]^RM^U!XU^,
MGQ(\7>#_ !KX8TGP_>Z)86U\C:5=O<+()68 $L!_=KZAI %%%% !1110 444
M4 %%%% !1110!YCX_F\ :/K,4&L>$[;6=0G!G<Q:5'<-&K-C>[,.-S<=R37>
M>&KK3;[P_IMQHZQII4ENC6J1)L18]HV@+V &..U>)_M 6=KJWBNVMY&TNSDM
MM-:Y-Q?WTUHTP#_ZI3&?GY&<'IGWKNO@KXKE\1>'&M9+*TLDTY((HDLBWEA&
MB5U7#<AE! (]:(ZQ?]=6@EI)?UV/1***\\^)WQ,N/"OA\WV@VL.L%)TBN)UF
M4Q6H+JOS@')8[L #Z]J!I7/0Z\ _;J_Y-OUK_L(Z7_Z7P5U&I_%S4K+X@3Z>
MMI;'0K74K?29F8MY[2S1[PX[;02!BO(?VV/C5X&U+X!7VEIXJTF/6;JZTFX3
M2Y+R,7(1KJ"49CSD?)S]*:3<>?I_3_(EM*7+U/K6BBBD,*BN9)(86>*$SN,8
MC#!2>>>3Q[U+10!G?\36=1G[):$Q\A2TQ#X;H?EX!VGISSTZT\6$[R*TM],P
M#,=D85 02V >,\ @=?X0:O44 9\.@V,3([0">1/NRW+&9UY4\,Y)',:'CNH/
M7FKX&.E<-\0?C?X)^%\+GQ#K]O;7 P%LH09[ER>@$2 MR>Y&/4@5ROACXD^)
M_C'YY\,3:-X6TZ/&][NZAU+4@ISAC! YBBS@XW2,>#E1C% 'JVM:[IOAS3Y+
M_5;^VTVRC^_<7<JQH/Q) K@9_B[?>)G%MX!\,W7B-F)!U>_)L-*B'J974O+[
M"&-P>Y7K5W0O@MH&GZL-:UAKKQ?XA'*ZIK\GVAH3W\B+ BMQ[1(N>^>M=M=7
MMOIT.Z5Q&HP J@DG)P %')).  !0!Y^_POUSQ6A_X3/Q=>W=NX^?2M +Z9:$
M=U9T8S..V#( >XKJ]$T7P]X TJVTC1=.LM%L4R(;'3[=8US@DX1!R3M)SCGZ
MU<)OM0+[&^P6^0%<J#*XP>0#PO4=1D$'(JQ9Z=!8AC&I+L2S2.<LQ)R>>W))
MP.!V H KI/?7Y1HX?L-N2P)GP93C< 0HR #\K DYQP5!Z/BT: 212S[KN>,D
MK).=VTDYR!T&,X!QD#C-7Z* ,%/ 7AQ/$&L:X-%LO[7UBTBL=0NS""]U!'OV
M1R?WE'F.,'L<'H,<]XC\:?#K]F_P/H\.M:KI/@;PM;E--L%N9!! A"$K$N>^
MU&/X&N_KR/\ :L^ MK^TG\#?$G@>8PQ7UW#YVG7-P2$@NT^:)V(!(7/!(!.&
M/!Z4 =A\./BQX/\ B]H\^J^"_$>G^)M-@F-O)=:=,)8UD !*DCO@@_C765Y-
M^RS\!K/]F[X'^&O ULT,UY9P"34+J$';<7;\RN,@';NX&0#M S7K- !1110
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M:_\ @CN?_CE>[_#*U\8V7@ZRA\>7^EZGXF4M]HN=&MW@MF&X[=J.Q(.,9YH
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M?#[1-;T&]TC[*MA:WDB2S-8HL3NR.'!)P<\J.H]:Z2B@=['$WOPDT6^\:?\
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M[V,T%%%5=4LO[2TZXM1/-;>:A3S;=MLBY_NGL?>I*+58'B/_ )#7AC_K^?\
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M@,]!WQ5HVUUJFTW)^S6A# VR_?<$$#>V>!@\J!G('S8X/AUG\5_BU9L9/^%
M7TURV-]Q+XHLR[?*J_W<#(49 P,\XK \+?M:?$GQ=XP\8>&[#X"WKZCX6N+>
MVOU_X2:U&QYH%F09* 'Y6!X)[=^  ?4$%O%;1[(HUC3).U1@9/4U)7@W_"Z_
MC!_T0"\_\*BS_P#B:/\ A=?Q@_Z(!>?^%19__$T >\T5X-_PNOXP?]$ O/\
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MM,RM]GGD9PT:D#@8 ^7MBO9ZIJW]?(F]PHHJ&\NDLK6:X<.R1(781J68@#/
M')/M2&9'C7P3H_Q"\/2:)KUH+W39)[>Y:$L5S)#,D\1R.>)(T/X5NUX%X_\
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MLU3Q-J6J6$&MZ6;NQG>-HTM6.Y <;P=^#SD''0CFNC^Q>)!_S%+#_P !&_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M OQ8UN?2/#&L/J%_#;M=/$UI-%B,,JDY= .KKQUYK\HJ^G?^"?'_ "6?6O\
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MQQ1976O5?=?<+O7T?W]C9B_:#\.'2-3NKBQUFQO].O(;&;1KFR*WIFF&855
M2#O&2#NQP<D8KJO!'CFT\<V=W-!8ZCIEQ:3FWN++5+8P31/@-R,D$$$$%21[
MUYQXK^$VMZIXD\?:A'INBZS8ZW)I;16&J.X$J6Z.LHW+S$^6!5QG&.E;_P %
M/ FM^!X=<74I#:Z==W"/8:.-0EOEL4"8<":3YCN/.WH,<=:4=;W_ *V_X/\
M6[EI:W];_P# _K;TNBBBD 4444 :6D?=E^HK1K.TC[LOU%:- !1110 4444
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M#LW;CZ_.,5I+J;G6GL#9W"QK )OMA \DDMC8#G.[OTZ5\T> 9_AY/\?O O\
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M %=PSM(JK6NNS(4KJ+[GH-%%%24:6D?=E^HK1K.TC[LOU%:- !1110 4444
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M0E1V+7>(8G!DR?F())!/3-3'WE_7>2_0<O=_KR7^9[9J?C#3=*\0V.B3R/\
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M1HUXRE*.B[GU)7/2??;ZFNAK.;2=S$^;U/\ =_\ KU]2?SL9M%:/]D?]-?\
MQW_Z]']D?]-?_'?_ *] &=16C_9'_37_ ,=_^O1_9'_37_QW_P"O0!G45H_V
M1_TU_P#'?_KT?V1_TU_\=_\ KT 9U8,G@^TD\<1>*#++]NCL#IXCR/+\LR;\
MXQG.?>NO_LC_ *:_^.__ %Z/[(_Z:_\ CO\ ]>CK<.EC.HK1_LC_ *:_^.__
M %Z/[(_Z:_\ CO\ ]>@#.HK1_LC_ *:_^.__ %Z/[(_Z:_\ CO\ ]>@#.HK1
M_LC_ *:_^.__ %Z/[(_Z:_\ CO\ ]>@#.HK1_LC_ *:_^.__ %Z/[(_Z:_\
MCO\ ]>@#.HK1_LC_ *:_^.__ %Z/[(_Z:_\ CO\ ]>@#.HK1_LC_ *:_^.__
M %Z/[(_Z:_\ CO\ ]>@#.HK1_LC_ *:_^.__ %Z/[(_Z:_\ CO\ ]>@#.HK1
M_LC_ *:_^.__ %Z/[(_Z:_\ CO\ ]>@#.HK1_LC_ *:_^.__ %Z/[(_Z:_\
MCO\ ]>@#.HK1_LC_ *:_^.__ %Z/[(_Z:_\ CO\ ]>@#.HK1_LC_ *:_^.__
M %Z/[(_Z:_\ CO\ ]>@#.HK1_LC_ *:_^.__ %Z/[(_Z:_\ CO\ ]>@#.I"
MP((R#P0:TO[(_P"FO_CO_P!>C^R/^FO_ ([_ /7H RH+>*UB$<,:11KT1%"@
M?@*);:&=XWDB21HSN1F4$J?4>E:O]D?]-?\ QW_Z]']D?]-?_'?_ *] &'J]
ME-J.EW5K!>2Z=--&42[@"F2(D<,H8$9'N"*S?!7A"T\#>'+;2+.26>.)GD>X
MG(,DTCL7>1R !N9F)Z5UW]D?]-?_ !W_ .O1_9'_ $U_\=_^O0!G45H_V1_T
MU_\ '?\ Z]']D?\ 37_QW_Z] &=16C_9'_37_P =_P#KT?V1_P!-?_'?_KT
M9U%:/]D?]-?_ !W_ .O1_9'_ $U_\=_^O0 ND?=E^HK1JM9VGV4,-V[=[8JS
M0 4444 %%%% !4-[_P ><_\ US;^535'<1F6"1!@%E*C/N*B:O%I%1TDCXHH
MKU+_ (9V\2?\_NE?]_9/_C='_#.WB3_G]TK_ +^R?_&Z_C#_ %/S_P#Z!)?A
M_F?OW]NY9_S_ $>6T5ZE_P ,[>)/^?W2O^_LG_QNC_AG;Q)_S^Z5_P!_9/\
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M/[)F_O)^9_PH 9IO_'VOT-;-9]II\EO.'9E( /0FM"@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK_P#ZDJH=3A!(^;CVJW7/2??;ZFOL#\L-7^U(?\ :_*C^U(?]K\JR** -?\
MM2'_ &ORH_M2'_:_*LBB@#7_ +4A_P!K\J/[4A_VORK(HH U_P"U(?\ :_*C
M^U(?]K\JR** -?\ M2'_ &ORH_M2'_:_*LBB@#7_ +4A_P!K\J/[4A_VORK(
MHH U_P"U(?\ :_*C^U(?]K\JR** -?\ M2'_ &ORH_M2'_:_*LBB@#7_ +4A
M_P!K\J/[4A_VORK(HH U_P"U(?\ :_*C^U(?]K\JR** -?\ M2'_ &ORH_M2
M'_:_*LBB@#7_ +4A_P!K\J/[4A_VORK(HH U_P"U(?\ :_*C^U(?]K\JR**
M-?\ M2'_ &ORH_M2'_:_*LBB@#7_ +4A_P!K\J/[4A_VORK(HH U_P"U(?\
M:_*C^U(?]K\JR** -?\ M2'_ &ORH_M2'_:_*LBB@#7_ +4A_P!K\J/[4A_V
MORK(HH U_P"U(?\ :_*C^U(?]K\JR** -?\ M2'_ &ORH_M2'_:_*LBB@#7_
M +4A_P!K\J/[4A_VORK(HH U_P"U(?\ :_*C^U(?]K\JR** -VWNDN0Q3/'7
M(J:L[2/NR_45HT %%%% !1110 4R:00Q/(1D*I;'TI]07O\ QYS_ /7-OY4
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M[0P'55"E<GTR3^AKYRKFQU*%#$3ITWHCIR7%UL;@85JZ]YW^=GN%>Q?LM_\
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M/*^A?VF3NT#1#ZW#'_QROGJLT]6:-:(*WO /_(]>'/\ L)6W_HU:P:WO /\
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MW.@ZM96%_>"QM]1N8E2-Y22%!7=O 8@X)6KGPMUR\\0>%Y;N_F\^=;^\A#D
M?(D[JHX]  *\SM_@1XD;5M$O+M]$N+K3-6BOI-5DGN);N\C63<0=RE8CM[+D
M$@#(%>J_#[PM<^%/#LNGWDD4LCWEU<;H"2NV29W4<@<X89]Z=)U6[R7?]/\
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MJ[W][2VBM;EUNM>O1=)!\9-,O='TVZL]/U"[O]0N9K.+2HXU^T"6(D2ALMM
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M  !; YK \9_#7QSK6O:IK^G^'H3=7&MZ%JL-E=7L0&VVAQ,K,"<;6^7(!SU
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M>P>N_P#6B7Z+[D>7WGPQU+7-0^*\$X6RMO$MO#;V=WO#9Q;E"2 <@!CW_"N
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MT44UHD@>K<@HHHH **** "BBB@ HHHH TM(^[+]16C6=I'W9?J*T: "BBB@
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MA2>I]*:WU_X;5?I<;VT_K1_\ ^A;[QUX>TRSU&ZN]8M+:VTZ86UW)+*%$,I
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M[2VS6WEO $ !9&SG<?[GZUV8/+<52Q$)SCHGW1Y6:Y_E^)P56C2J7E)::/\
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M_9#_ //1?RH_LA_^>B_E0!0HJ_\ V0__ #T7\J/[(?\ YZ+^5 %"BK_]D/\
M\]%_*C^R'_YZ+^5 %"BK_P#9#_\ /1?RH_LA_P#GHOY4 4**O_V0_P#ST7\J
M/[(?_GHOY4 4**O_ -D/_P ]%_*C^R'_ .>B_E0!0HJ__9#_ //1?RH_LA_^
M>B_E0!0HJ_\ V0__ #T7\J/[(?\ YZ+^5 %"BK_]D/\ \]%_*C^R'_YZ+^5
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
$ '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>aciu-20231231x20f017.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f017.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %- H # 2(  A$! Q$!_\0
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MZUL>)='O;_4;>T#6UQ"GV\E8SYLN0=T3EC\HP>OM7T+*IDC=%8HS @,!T]Z
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M<D#..:\[U'P-K5G?N?!G@CQIX'\7M=_*ME<B31]A;EFF/&-O;[O;D<5]G4E
M&;?#5$\-W M3%)K(M&\HMQ&T^SY<_P"SNQ^%?'7B30_&WBWP?IPU7PIXQU'Q
M-9:FEQJ-]?L[VX0.P"VL"G!!!4DJF!MZ\U]L44 >+^'/#^HK^U)XGUJ33;M-
M*GT.&*&^D@987?,.5#$8+<'CKP:XGP_X"\0S_#7XU:=_8UY%>:GJMS+90S0F
M,W*[L@Q[L;@0.".M?3U%(#Y:U33M=\4^#_@W'%X5URRFT/6;6"\BN[)E9%C6
M+=-@9Q'UPS8Z&O5G^ FEO\0_^$O.NZ\+O[8+S[$+M?LNX'.W9MSM]LUZ?13
M\:^,GA_4]5^*_P *;RRTZZN[2QOYGNIX(6=(%/EX+L!A1P>OI7._$V3QC/\
M%'4K.^T/Q+KGA::R6/2;709V@MGF*C=]J=67 W;OO' &, U]#TE(#Y!MOAIX
MJE_9GTW3HM!OO[:T7Q ;Z33I(6265%+<H"/F'S@C&<X.,UV$UWXB\?\ Q]^'
MOB(^"]<T31;.*YB>;4;?:RL8WR7"D^6N2H4L1N]*^CZ* /"/VR=W_"IK;8 7
M_M:VP&Z9P]4=<_X2;XO_ !$\"0R^#]4\-V_AN]&H:C>:BJK"77:=D#J2) 2F
M,CU' Q7K?Q&^'.E_%#08](U>2YBM4N$N0;20(^Y,XY(/')[5U.,4P/CF#X4-
MX2U/Q#H_B#P/XM\227-_)+8WF@W+K9SP.1@288*C8SG(/7!P!D]!XV@E\!?&
M;X41Z'H5W=_V?I$P326F5[@1[9-Z!B2K.JEL#/)& :^IZY35OAOI6L^/M%\7
M3R70U3289(+=$D B*N&!W+C)/S'N.U 'E7@[P]KOCOXF^+_&]QH%]X=L+C1C
MI-C::HGE7$[$#+LG\(ROZC&<&O.6\/>)KO\ 9:O?!I\(:]!K6F7L;%)+)B+D
M-.[$PXR7"CJ<8Y')K[%I: /G[5[+7_AG\9F\8Q^&=3\2Z-J^CPV,R:3%YMQ:
MRH$X,9(X.P<Y Y/<8/':=\-/%OCK0?C1;WF@W.A:CK=U:WMG;W7"2%7>3RUD
M^ZQQ@$@X!-?65% 'RY\,O >EW_B;PXMU\/O&NGZCISI/-?ZE>,MI;SI@[DW/
M\ZDK_".F!@BO0/VK= U/Q+\)IK+2=/NM3O#>P.+>TA:5\ G)VJ"<"O8Z*0'S
M_JZ:W\-OCIJ'BF'PWJ7B?2=9TR&TD71T$T]I*BH &3(VJ=@.3@<]>,5R7PU\
M(7GQ2LOCCH^H6ZZ/J&IZBC>6S"1;><-(X4L.#A@ 2/>O;O&WP5T+QMKL>MM=
MZKHFLI&(6O\ 1;UK:61!T5B 0<9],]JV/ 'PYT7X;:3+8:/%+B>4SW%Q<RF6
M:XD/5W8]3Q["F!\X:W+XLU?P5I/@?QI\)]8\03Z2RK;7FF731V\VQ#&C-(BD
M#Y3SS[X%>P?LU?#[5OAO\-ETW6H8[6]GNY;LV\<@<Q*P4!6(X+?+VS7JU% !
M1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKIYM+:XDN?MBQ 2SQ;%86@7[HD3<2S#G Z T >VT444 %%%% !1110 4444
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MGU^9_P#P2,T9/#WQ4_:%TZ/4= U9+:728Q>^%W+Z;-S>?-;D@93TX]:_3"@
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M#XV_&C0O@1X&F\2:Y'>7>Z5;2RT[3K=Y[F_NG5C'!$B@Y9MC<G  !)( K@/
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MQV&2<#TQ7F?QXT'P'\5-8M]:TGQ]HFGZF(A!,ES,3'*HSM;*@D,,XZ<C'3%
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MLH5@ -RD \$ <5J^"O@KXC^'\%S%HWBRT@%RP:5Y-*#LV!@#)DZ#)_,UTO\
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MJJA0@_A '2GX'H*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK3_!^@66C:7#]GL+./RXDSD^I)/<DDDGN2:U* "BBB@ HHHH **** "BBB@
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M)O[(]DO\5^E[[6W\[_(=1117W)\<%%%% !1110 4444 %%%% !1110 4444
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MW2%;5A<+%&&/EGS>6RH+$@Y/8 ]FHHHH **** "BBB@ HHHH **** "BBB@
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MR_!7C;0_B+X6T[Q)X;U*'5]#U"/S;6]M\[)5R5R,@'J"/PKDOV@/A3H/Q?\
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M?VC?AKIEY\2/AS\0].\.> -"T6V74M-$<9NIKLW+(TD:O;N,$2PCF0?=/'J
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M3_$ISJ,"_P"E_+/P/GSGMW%?I=0 4444 %%%% !1110 4444 %%%% !1110
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MU!O'-W871L!;>6;(6]N80I?>?,W<MG"XZ<]: /5:*** "BBB@ HHHH ****
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M5LL5W*!D)N;"=3G;TZ_EBO6/^%H>$]<\177A"#7-NNN9;9H(5=)$=5.[:^W
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MZ;>:XTKW\MXK7-K$[ 1%44D%5P.^3GM5W]I_QG)XKTO7=%TV_A@TO05AEO\
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M:*\3_9S_ &OOAU^U--K\7@.^OKQM$6!KS[99/;[1,9 F-W7_ %3_ $XKVR@
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M--_Z!]K_ -^$_P */[ TW_H'VO\ WX3_  J_10!0_L#3?^@?:_\ ?A/\*/[
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MYM/\.:O+>2'^RK&Y8 7,:P%6=D!57 P3N)/WA0 4444 %%%% !1110 4444
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MH **** "BBB@ HHHH *2FS2K!"\CYVHI8[5+' ]AR?PKXL\+?M;:WXI_:?\
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MX_\ A+XI^#KNUTW4[5!:^(8=5LUO3JT:Q[1<J[?-%>9"[IU(+;F+9)8-]*4
M+1110 4444 %%%% !7D/Q>^.<7@F_73M!O\ 1-2US3)H;O6/#T\['4YK!HIG
MVV,"X,UR_DD(F<'#9[5UWQ:^*GA_X*_#_6/&/BB[-GHVF1!Y9%C9V))"HH"@
M\LQ5<G@9R2!S7P7XW7Q'\4OC)X,\3>*M&L?A3\9[JRBO/AOXHL;XZEH.IH0T
MG]FW9*X$Y25E++]X,"G0!@#ZH\+?'G6/CCXG\%2_#K0+#6_A7JEA->:[XFU*
M< PM\T8L$@!+"Y#X,BR#:%R,G-=5\$?V>]!^ 5QXIA\+7NH0>']:OAJ$'AZ6
M4-8Z5(5_>BU7&45V.XKD@'& *POV<O@M?>!+CQ!XS\1:9I?AWQKXLD$^LZ1X
M8NIFTA9%=MDJQOQY[(RB20 !BO ZD^WT %%%% !1110 4444 %%%% !1110
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M/!'B/P]\/O UEI6N?%#Q&'GT_3-;NGM+1;:-'>69Y IW']WL$:G<2P)PH)H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% "8I:** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
:BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>aciu-20231231x20f018.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f018.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &< Z8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BL#QCXTL?!%C:W-]%=3BYN%M88K2+S9'D8$J N>^*^7?B
MU^V3XST#QC+8^#/"4>J:3'$@:;4-/N#*)N0Z'8X'! XZUQ5L91H/EF]>W4];
M*<LKYUBOJ>$MSV;U:6BMW]3[!HKX*7]N?XN,I8> ],*@D%A87A (Z_\ +2H+
M']O7XJ:G"9K/P7I%U$&*EX;*[=01U&1)UKF_M/#^?W'V?_$/L[[0_P# T??E
M%?.'P:_:KO?$WAF_NO&OA^ZTS5+:9F,.F6$OEI; +B1_,8D?,6&>G2OHFTN4
MO;6&XCSY<J*ZY&#@C(_G790Q-+$?PW<^!QF&G@<54P=5KG@[.SOKZDU%%%=1
MR!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME0PPX/4,NQCT[UO3W7BS2?B/KG@R\\6W6J6M_P"'9=02ZDMHDDMI@Q7,848
MX/'OZC-=Q?? 7PO?3ZG(RWD::AJ,>J30QW&U!<)NPRC'&=[9'?CTKH[CP#I5
MUXU'BF5)6U,6)T_!D_=F(L6(V^N3UH ^9_"]YK'A3]FO0=3M-7F*WFLQ1Q6[
MQ(R6Z>=*KJF0<[B-Q)Z'I7OTGQ6LIO'3>$9/#^N/(TI@-\UD#9'Y=V=^[[O;
MIUK.LOV>?"UCX?FT2.34SICWD=ZD#WA9870L0$R/E'S'/<\9->G8H \,T33K
M1OVI_$,!M8#"-!B81F)=H.Z/G&.M<S\5?'NO6-_XIO- \4ZQ<_V,ZHEMI.F(
M-/LMN-R7$K_?;_=S@]O3W:V\!:7:>.KOQ9&)O[6NK5;.0F3]WY8((PN.ORCF
MN7UC]GSPKK6H:Q<3'4HH-6<S7=C!?/';22G_ ):F,<%@>1G(SVH Q/"WCO6M
M8^-.CZ?<7CC3;OPI#J+V:@",3LPRPXSWQUK7_9_\3ZIXJ\-Z[<:K>R7TL.MW
M5O$\F/EC7;M48'09-7=8^!OAS6I=%FDDU*WN]*M%L8KJTO7AED@48$;LN"1C
M/3!Y/-;_ (%\ :1\.=+N=.T6*2&TGN7NC')(7VLP (7/0 *,"@#RCQAJK:%^
MTA+J2Q^<UGX1GN!&?XBC.V/QQ7(ZMXL\=6/PCT?QO_PF\SSZS>QI+8K;Q+'"
MK2, L1QD$;,$=P3W&:^@-1^'^G77B]O%2(SZTM@UA&)G)@*')PR=^3SSTKYW
MD^!^O:S]FTA? BZ#)_:"3S:FNL>?8P1!LN8(2Q92W'')XQP#P =IX8MK?5OV
MD_'KZS:Q7NI65G -*@N0#B+:"=@/ R2.1TW-[U9^%?B&%OC%K6FW?@*+PAX@
MN-/%W=2PZD)UD4,@4;$ 0$YSD<_G7?>.OA!X=^(-Y;7^HPSV^J6PVQ:A83M!
M.J\_+N'4<GJ.,G'6D\!?![PU\.KNYO=+MII=2N5*37]Y.TT[KD'&X]!D#H.<
M"@#8\<6=O<^%=7>:".5DLI]I= Q7]V>F>E>2?"/&G_LO?VC;QQQ7T.F7SI.(
MU+!@TN#DCG\:]RU"QBU.PN;.;/DW$;1/M.#M8$'!^AKG]%^'6D:#X#;PC:B?
M^R&@EMR'ES)MDW;OFQU^8T ?.4EMJ_BOQ/\ !.[.O75G=W^GS;9H(4S ZJ2[
MJ,8RXP",8 %:>L?$WQKXBU[Q;=Z-=:[ ^CW[V>GZ?IVE+/9OY9PWVASSEOTS
M7KVJ_ OPWJVC^'=/9]0MAH*E+*YM;LQS*IQN!<#G.!Z4SQ#\ _"WB36+W4)_
M[0MA?NLE]:6=Z\5O>,.AE0<$_3'KUH X2]USQIXW^+-MX?L]?N?"=O<>';?4
MKF!+=9'@D)&Y &Z-N(!YZ BL?QUXS\9^&_%NLR:QJ_B'0]-@N0NG:CIEA#>:
M<L QS.O#%B.3SG)Z8KW2Q^'FCZ;XP_X22VCDBOQ8+IJHK_NEA4@@!>Q&!S7-
MZU\ /#&LZIJ-V9=4LH=2D\V_L+&_>&VNVSDF2,=<]\8H [O2KBWU?3+"^CEB
MO4DB2:*Y1,*X90=R@\@$']:OU!964&G6<%K;1+!;P(L4<2#"HH& ![ "IZ "
MBBB@ HHHH **** "BBB@ HHHH X7XWZ"GB7X5^(=/EUF#0(9( \E_=L5@14=
M799""#L8*4;!SACBOGOP-I&B:I\3_!EO;7'PU\-7EM,NH0R^#YIGN[^,(W[C
M<45-KC.Y6); Z=Z^@/CO9Z%?_"G7H?$EW<6.E%(V:>T3S)5E$J&$(F#O8R!
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MM"MNVXL'RP;S 2%SPN-O .37J%%+F8[(\'@@M=%NM'@T^R\CQ"DJ-(EW"^[
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M^&X;JY.7( _2N>G5YYRA;X3V<9EKPF$P^*<[^U3=K;6=OF=M11170>,%%%%
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M=C[THKSGX'^)[GQ-X-L)KDY9;>)<_1%KT:MD>1)6;04444Q!28I:* "BBB@
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MFWG&*U/!_A#4_%&N^*M8\2:/-H=MJMI:6,=D;H&;$08M)OB;Y?F8;2#GC/%
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MB66\MUM+N3Q'J+36Z2>8(G,OS*'P-P!R,X&: /3Z*** "BBB@ HHHH ****
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M.VAO7DMY$6VN#B.4E" C'L#T/L:\Q_9NLI=.T#Q7:SV%OI<T/B&X1[*T;=#
M1%#\B'N!0!Z[1110 4444 %%%% !1110 4444 %%<3XE^+N@^%/$D&A7PU#^
MT)\>4L%C+(KY&?E91@X!YQT[UVU !1110 4444 %%%% !1110 4444 %%%%
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MUUYE^)8HHHK<\L**** /"/VM_B#_ ,(MX%CT)+3SY==#Q&9B0L2(5+'W8DC
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MCPM\2_"_C6\EM-#UJUU*XBC\UXX&)*KD#/3IDC\ZZ>@ HHHH **** "BBB@
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M+'@B4A5\8Z S'H!JD&?_ $*ODWX"_#_3_B'\:;_4]=MVGM9HY];LX\C9*5O
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M]VWNQ&;:I."<#.!7">"?B[9>.-?O=)MM#UVPGLP?/DU&R$4<;<$(QW'#$,"
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MRK8(P<$<@\]10!XC^SC\--"\-:EXOU&TMY#>VNLW>E0RS/N*6Z%2%'N>YZG
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M^F>!_'6E>!?$&@Z+J4,D&K:\TNNN7(W1M(1%;VQ/]Y8D&]B0%V-G[U><>)_
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MKEKJ3JL+OB!"X9L@<D'MU]J]MKQG]H;PGH^M7O@.XOM.@NIYO$=G8R22+DM
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MVH QO@WS\)_!_P#V";;_ -%BNRKC?@U_R2?P?_V"K;_T6*[*@ HHHH ****
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M^89SDXKEY)T?@U7;K\G^C^\]OV^&S'3%6IU/YTO=?^.*V_Q17K%MW/1:\O\
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M10!\?>/_  #X,\2Z_P"*XY;#6O#5W8Q32#3;=%>'4$7+XC#1L8<R%3N'RY;
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MW,A"C)[D\ 5T-5-3TJRUJT:UU"SM[ZU8@M#<Q+(A(.02K CB@#D?@?J%K?\
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MPMU_R[7_ *5(6O+?'_\ R7'X5_35?_285ZE7EOC_ /Y+A\*_IJO_ *3"C$?
MO6/_ *4A9/\ [S/_ *]UO_34SU*BBBND\,**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MN>\:Z[J_AW38;O2=!E\0L)@MQ;6\ZQRK%M.70-PQ!"C;WS70UXS\</&_V>2/
M1+G2O&4-GY\6;[P\BHMV74@0"0G/)/( S\N* .M\*?&;PSXJU'^RA<RZ3K@.
MUM(U6(VURK8SMVMPQ_W2:[FO OA_H'@OQ;?7&@6W@;5_"VH:>]OJCWVI0JMT
MSK*"G[QBSG<0V>Q&[H:]\H 6BBB@# \>^%AXV\&ZQH37!M?M]L\ F SL)'!(
M[C.,CN,U\8>&? _BGX1>'?%OB_1[^V\^POI_#UPD4#2X0, \H)P  P7&0>O.
M*^XM8:^72;PZ8L#ZB(7-LMT2(C+@[0Y'.W.,XYQ7E7P+%W-X/\;#5([<7[^(
M=3^UQV^6A\PD;PN[DKG.,]JYIPBZD)-:ZGM87$5H8+$4HS:B^6Z3=G[RW6S/
M-OV;M<^(?C7P?-HNFZK9:-HVELL,>I36/G3@-D^7&,A#MZDMDC<*]BMO@5HE
MY.EUXEO-2\87BG<&UBY+PJ?]F%<(![8-2_L^QK'\&_"NU0N;0$[1C)W-S7H=
M=)XIXI\6/A_X;F\9?#B)M"L!%)J36KQI J*T0A=PA P"H89P?ZFO:8U"(JJ
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M(D9X<D%OE)'&:]'KSKXYMI]MX0M[Z\UB70[NROH;C3KN&W^T/]J&X(HB_CW
ML"/3GM0!S'P-GFU7Q5J]]XBU'69_&$=G' UKJ]@EEY5J7+*8T0D,"W5L\'C'
MK[97BOP0U=/%/BK5]6U?7+C4/$Z6<=M]BGTPV'V:UWE@50YW;FY+9XX%>U4
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M0!Y+/^TIIEM/;P3>#O&44UPQ2&-])VM*P&2%!?D@ GCL*G_X:&M?^A&\;_\
M@F/_ ,77>:WX5@UO7=!U.6>6.71YY)XD3&UR\31D-WQAB>*V\4 >0Q_M*:9+
M=S6J>#O&3W4*J\D*Z3ET5L[2R[\@'!QGK@U/_P -#6O_ $(WC?\ \$Q_^+KT
MV'2K.WU"YOH[:*.\N41)IU7#R*F=H8]P-S8^IJT10!Y#9_M*:9J,'G6G@[QE
M=0[F3S(=)WKN4D,,A^H((/H12:A^TOI6D6<EW?>$/&%E:QXWSW&E"-%R<#+%
MP!R0/QKT3P=X5@\&Z(-,MYY;B(3SS[Y<;LRRM(1QQ@%R*OZSHMAXATV;3]3M
M(;^QFQYEO<('1\$,,@]<$ _A0!YF/VA[1@"/ _C8@\@C1C_\74,O[2NEP7<%
MK+X.\8QW-P&,,+Z3AY N"Q5=^3C(SCID5ZZJA5  P , "L/5?"5OJWBK0M=>
M>6.XTB.YCBB7&QQ,J!MV1GC8,8H X7_AH:U_Z$;QO_X)C_\ %U!#^TIIEQ<W
M%M%X.\8RW%N5$T2:3EXBPRH8!\C(Y&>HKUZJEMI%E97UY>06L4-W>%&N9D4!
MYBJ[5+'O@# ]J /,_P#AH6U_Z$;QO_X)C_\ %U!8_M*Z7JEI'=6?@[QC=VT@
MRDT&D[T89QPP?!Z5Z]6%X'\)6_@7PKI^A6L\MS;V2%$EFQO8%BW. !WH \\U
M#]IC2=)M_/OO"'C"S@W!/,N-*"+N)P!DOC)-6?\ AH:U_P"A&\;_ /@F/_Q=
M>E:OH=AK]I]EU*SAOK;>LGE7"!UW*<J<'N#5W% 'D+?M*:8EZEFW@[QD+MT,
MJP'2?WC(" 6"[\D D#/N*G_X:&M?^A&\;_\ @F/_ ,77>3^%8)_&-IXB,\HN
M;:REL5A&-A5W1R3WSE!6W0!Y#;_M*:9>/.D'@[QE.\#^5,L>D[C&^ =K8?@X
M(.#ZBI7_ &B;.)&=_!'C9$4$LS:-@ >I^>O3[+2K33I;J2UMHX)+J7SYVC7!
MEDP%W-ZG"@9]A3[ZT6^LKBV9F19HVC++U ((S^M 'E5K^TAIU];17-MX,\9W
M%O*H>.6+2-R.IY!!#X(/K4=]^TQI.F+"UYX0\86BS2K#&9]*"!Y&^ZBY?ECC
M@#DUZ9X6T"'PKX;TO1H)9)H+"VCMDDEQN944*"<<9XJ?5=#T_7$MEU"SAO%M
MIUN81.@;RY5SM=<]&&3@T >:_P##0UK_ -"-XW_\$Q_^+JL?VF-)745T\^$?
M& OVB\X6ITH>:8\XW[=^=N>,]*]@Q7-R^![67XA0^+C<3B\BTTZ:(!CRRADW
M[NF<YXZXH XS_AH:U_Z$;QO_ ."8_P#Q=06G[2NEWXE-MX.\8W AD:&3RM)W
M;)%^\AP_##N#R*]>JIIVD66D"X%E:Q6HN)WN9A"H7S)7.6=L=6/<T >7W'[1
MUA9V\L\_@OQI!!$I>2632-JHH&222^  .<TL'[1EC<PQS0^"O&DL4BATD31]
MRLI&000_((KTKQ%HT7B/P_J>DS2/%%?VLMJ\D>-RJZ%21GC(SWI^B:6FB:-8
M:=$[R1VEO';J[_>8(H4$X[\4 >67?[3&DV$EO'=>$/&%M)<R>5"DNE!3*_\
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MXDB<#]X$=1N&#\N';TK7ADBG3=$R2*#C*D$9% 'GW_"XI_\ HGWC3_P7Q?\
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MRJ =G?)XR!7JM?/G[*(T&*QU**2-H_&PDE-\+U)!=^1O&S<6[?=SCOUKZ#H
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M\E?).6W'Y,8^]S]:AT+P;H/AB6:32-&L-+DF 61K.V2(N <@$J!F@#9HHHH
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M!)(VKUYINI?"+6=2\+:5HDOBQ)X+*W-M)]MT>"Z2=0?D8J^2'"X&0V#C.,T
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M_P!]4?:H?^>J?]]5A44 ;OVJ'_GJG_?5'VJ'_GJG_?585% &[]JA_P">J?\
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MO"'P]\2^#/&ECJH;7+B[%RUK#8CS//CDNG;R[E)-P\L)W(.%P: />_B'X_\
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M-KR)SU .:XW4Y;/4O#/Q/TMGLSHMA_8]_!:6.JS7EK;,TQ69TF?:2,#YMOR
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MQ*A2QVCH,\5YI\.M2\36WC'4M$UG[>+-;!+R*/6[ZSN+Z*0R%#_Q[GF)AT+
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MGW=]I^MC_253PQ=Z?%I9:$R(RW,I*SQY&PDA2<AAQD4 >W+$B.[*BJSG+%5
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MBL@,4963[X*##\8^;UXXYKDO@]X<UCPOX)M-*UU;".\BNKDK'ID9CA2)YW9
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M85E:4#9TSN8\^G%,\)>$[#P587=IIGGB.[O9]0N'N)C(\T\SEY&9CUY. .P
M':M_[%/_ ,\VH^Q3_P#/-J /);O]F[PE/9Z+;6UUXATE-'AN+>R?2=:FM'CA
MFE\UXMR8)0,!M4\  #M75> OAIH'PUL[R'1+><2WLHGO+V]N9+JZNY ,!I9I
M"68@<#L.PKL/L4__ #S:C[%/_P \VH B0A9$)Z!@3^=>._#?X$6NCVIN-?\
MMDET-<O-7735U)Y-/,K74DD$YA!VF0*4/H& )!89KV?[%/\ \\VH^Q3_ //-
MJ /,+_\ 9_\ "FI1SV\SZR-/>^&I1:;'JLRVEM=>=YQEBBSA6,F6P<C+-@#-
M:EU\)- N]2U2\<Z@!J.IVVL3VJWK"W%Y R,DJ)T4DQINQPP6N[^Q3_\ /-J/
ML4__ #S:@#SR^^"?AC4-2N[B5-16RO+L:A=Z-%J$B:;<W.X-YLEN#M)+*K$<
M*Q&2#5^^^%V@:CH/B31YHKDV/B&]?4+]5N"&:9C&24;^$9B3@>_K7:?8I_\
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M -!W4_\ P,D_^*H_X37Q#_T'=3_\#)/_ (JN7^W8?R/[ST/]3:W_ #^7W/\
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M'O7R]Y]MK4^H:OJNG7DW@1OB'=W6JQ7%G*$>#[!&MM--"5W-!YP5CE2.5+#
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M-H#!BNYR>@I(?'/C?QMK6I1Z+K.G^'[*V\*:;KR(^G+=L;B=)G:,EF'[O]V
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MN$=]RASGY<C&2 ?0M1274,,T,,DT<<LQ(BC=P&D(&2%!Y.!R<=!7*^!=8O\
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MQI^E6&AVMI<VT,]@)VFDDM3,T<C;@1'D=1\W/!P.:NA>,_&'Q%U:];1M3L=
ML(]#TW5889[ 7,GG7$4CF-R2/W?RC)'S>A'-+VRO:S_X8K^RZG*YN<4DDWOI
MS6:OIN^9;7ZW/8Z*\/O/BWK/B+1]*O-,U)-)N+C0X=3.G:?H\NJW!F<,<2\;
M(H?D^4E@S#)R .='PWX[\3>.M6\,BVO[;1;&[\+V^OWB1V2W#M(TNUHT+GA2
M,\\D8&.]"KQ;LBY9/B*<7.HU%*][WT_#6_2U_.QZ_17A7@_XL>,/$3Z!K8TW
M4)],U:[B233_ .Q?*MK>VEDVATO"^6=058DC#<@ <5;T;QUXQ.DZ/XCO-4L;
MBPNO$K:*^F)8!,P->/;K)YN[(D7:#TVD#D9.:2Q$7JDRJF35Z;<92C=.V[WU
MTVWT>NWF>U>OM17FOP/M-0M[/Q:U]JC:B&\1Z@B!H$CV%9<,WR]=W''08P*]
M*K:$N>*E8\O%4%AJTJ2ES6Z_\.%%%%6<IXU^U?\ \?/AG_<N?YQUX#7OW[5_
M_'SX9_W+G^<=> U^>9K_ +Y/Y?DC]SX<_P"151^?_I3"@G /(![9HKV[X":Q
MX4O=,O?#VNVEC%?3L_D7=Q&@:5&7!0.1PPYQSWXZ5QX>BJ]14W+EOW/5QV*>
M"H.NH.=MTM[=_D=3\)OBKI'B2&V\'V]A<:'.UF(HKNW=-TC(@#-PORM@$@D'
MI7B?Q.\%S>!/%]UILMPUVC 7$5P_WI$8GEO]K((/KC/>O=_!GP8T;X6ZX_B.
M_P!?6:WMD?[/YZK$L888)9LG<<$CC'6O$_B_XVA\>>-;B_M ?L,4:VUN6&"R
M+D[B.V22?IBO9QL9K"Q6)M[1/3T^6A\GE$Z4LRJ2R^[HN-Y-W^*_1O7Y>IQ-
M%%%?.GWA]7_LT_\ ).3_ -?LW\EKT[4?^/.3\/YUYC^S3_R3D_\ 7[-_):].
MU'_CSD_#^=?I. _W6GZ(_ ,Y_P"1C7_Q,Q@2#D$@CN* 2#D$@^HZU%<W"6EM
M-/(Z1QQ(TCO(<*H )))[  <FOGGPQ\3O%-SXR^'ZMKFLZCI_BFYFM9Y[C0X;
M'3L&VDFBEL"ZB<@;%(,@<,IR<9 KO/&/==*\9:+J^HWUCINN65Y?V4H@N[>V
MNE:2&0@G8X!X;"L<=>#Z5K;CSR>>O/6ODSX:^%-163X02#Q3J[K)XCU]O)6"
MTPI3[47(Q#DF3:=V2?\ 6-MV\8W_  C\5_'_ (@T[0?%RV>L-8ZGJ<<4EC<0
M:;#I"6KW'E%(YC,+@3*.A;)9P5V#(P ?28.#D'!'<5!?:I;:=Y#WEW';>?,E
MO$T\@7S)7.$12>K$] .37G7P>O/$7B237M9UCQ%/>VL6LZGIEKI:VT,<,<4-
MRR1N6";V<!2.6Q@CC(R<KXW>$;*?Q1\/_$<TEU/?P>*-,M;>*2X8V]NK/)O9
M(ONAWX!<Y.  ,#.0#UN_U2#3;:YO+NZ$$-M"UQ-*[_ZN-02S'O@ &H+S7[#2
MM&EU6[U"&RTI(A/)>32B.%8R!AF8\ <CD^M>.>-/@=JOB;XDZSK-O'I2:=JE
MA-:7$UY()W</:-"$$9AW1X;8WRS&/ )\O<<UTGQ$NM0\"_L\ZM-:V]GI>IZ7
MHB*D%NB3V\,B!%*J'0*ZCG&5'TH ]-5V4':S*#UVG&:JVVL6D^HW>GV]]$]_
M:)&]S;1RCS(ED!,9=1R P5L9ZX->'^,?$_C1;CXOZEI_BI],L_!\<-QI]@EA
M!(DK"Q2XD29G4L8V.1A2K#<3NX JOXV^+OB#0=0\62:;$K7$H\-VMFL5M$[V
MSWOF"1_G*"0C "K(X7<5Z G(!] TV:X6&)Y)I1'&.6>1\*/J3Q7SSJ?Q.\=^
M"['Q';W4>HJHM+-]/OO%D-@EU;33WB6S,\5I)B2%1)O#%5^9"I)S4GQNT[6[
M+X=^-/#VH>.FUB2W&F7D(-K!'J$2/=JC"8+&(S$SJ&0A0V4()('(![W;:S:7
M.I7EE!?12W]D(_M-O'+F6 ."8]X'*[@"1GJ!5L2,&W!VW>NXYKPGQ=X]\1>%
M_%'B[1K34HVN/[0\/:/;:K>6D1:W:[#K+<2!542-QD*WRAB  !Q5+XA^./&7
MP\3QCX>MO$;ZK?VFG:9J=AJU_9P">V,]^ML\4R1HJ.I +*=JG!8=@: /H+S&
MR#O;<.AR<BC>P;=N;=_>SS^=><^$M0U[1_BKKWA35==E\164>D6^K6]Q=6T,
M,L+O/+%)&/*504^0,N02.1DU@ZOXF\2ZMK7Q O[7Q?9^%=-\'W<-LEM>6D;V
MDR^1%/++=N09 K"0JOEE=NW/S=* /9-[;MVYMW][//YT%V8@EF)'0DUX=XA\
M8>*M1L_B?XDT[Q*-$M/!=Q-#:Z2;.&2"Y$%LD[-=.ZF3$N_"[&3:,'YC69XA
M\<>,]6A^)FM:=XCFT"S\.:/8ZK8Z8MC!+F5[$W#QS,Z%C&2,$+ALDD,,8H ^
M@]QSG)SUSGFG>:_/[Q^>OS&O M<\9^,/"0DEG\2-JG]J^"=2U](WLH8EL+N"
M*)T\C:N3'^^QMD+GY0<]15JV\9>*?!#>"[[7/%EOK=GXDTBZNKO[7:1P6UC)
M#9"Y$\31*'\@8*N&+D[@00>* /<: Q&<$C/7!KYY\(_$KQ4GCOPG97>J:WJ>
MGZ_IU_--)K&B0Z?!YT, E22R4 3>7STE#<,OS9JG8^/_ !U;?#_X:W4NMZIK
M>L>.-K3'3K"R\RR1+=YF6U238A=P%!,K-C:Y5>BT ?2:NR@A790>H!QFJUIK
M%K=7E[9VU['+<V;(MU!%+EX2Z[D#J.F5Y&>HKP>S^(/CI[RU\*7DUYH]S?\
MB"#3(-;U."R.H0VSVDEPPDAA=XA,3%L1F4!E<-L)'/2?!JSO].^(WQ9M=2U4
MZU<PZCIJ?;)(4BD=/L*E1(J +O ."5 !X.!F@#T+1O#FGZ/XC\1:M9S2F_U=
M[=KU#,&53%$(XP%'W<I@D'KUK;5V0$*S*#UVG&:^;WU76_!?B7XG7&G:Y/\
M:=6\9Z;HT4U[!"\%D;B&W!N-H12S(C;%5FVG"9!.2?2O!VK:UH_Q-UOP9JNL
MS>([>WTJVU>WOKN"**YA\R62)H9?*548$IO4[0<;@<X!H WO%?Q4\&^!+R&S
M\2>+=&\/W,L?G10:E?QP,Z9QN4,1D9!&?:KFM_$'P[X5DL%U?Q)IND2:D0+0
M7M\D)NB<8V;F&[J.GK7C?Q%\/ZW-XW\=^+-#\2^#G.CZ=:"ZTK6]--V\*0PR
M3>7+(7 @63S&;>H8GY?3%,\/?\([\1_$?Q#U?Q5I5CY=SX6TF>.VU.-'-I82
MV<LL@7=]U1*6RPQRH]J /;M0\8:-H>KV&EWNMV6GZGJ!(M+.>Z6.:YP<?(I(
M+<\<=ZNP:K;O?W%E#=H;VW1))K>.3]Y&KYV%@.0&VMC/7!KYGC\":A?_  HT
M'Q;J^K00Z;=^%]%761=0/)?J+.43Q?96!QYDI94PW\14C)XKKOA[\0+[1/$M
MQ8ZQH6;K6/$(T[5-72[!:/5)+43I;K#MR8(H0D(?=]Y2=N"30![B"0002#Z@
M\TV6X6WA:6641Q1*79V; 0 9)SV  S7F_P 6?B!=_#+5_#^LSSY\-30WUK>6
MQ5<&Y$!GMF#8W L89(\ X)<<9Q7#>"_B1XSU4:?X:U:^C;Q+HEKJMWXDDC@C
M"R(D2_9%*[<*',Z'@#/D-VS0![FGB+2YM*75$U*T?3GM?MRW8G4QM;[=WG!L
M\ICG=TJY;W,5[;0SP2K/!*BR1R(VY61AD$'T((/XU\L@:EKPN=<N]8NB]S\(
M/M5Q:1001P2%ED#+A8\JNXE\*1@\#Y?EKT#X=W_B7PQK?PUTK4/$+:WI_B#P
M]+++:RV<,26<L%O Z>0R*&VE7*D.6)P#D=* /:I),(6=SM4$DL> !UK(O/&6
MAV7AI?$5UK=E!H!B29=3FN5%MY;$!6$A.,$D8/?(J+5?%&E1:A?:$]]$FK+I
M<NHM;-D$6PW(9<D8P&X//'TKYJ;Q%%>?#CX'^$9?#NM^*M._L:#6]8TW0K07
M$SVZ0F.W5U+* C3.6SG_ )9#B@#ZN>YC2 SM,BP*GF&5G 15QG=D\ 8YS6'X
M9^(GA?QQ<W,'A_Q-I.OW%L<3QZ=?1W#Q\X^8*Q(],U\W#Q1_PD?P%\)Z%XH2
M\T_3]&\5V/AWQ1;ZFODRBR1CY N1GY4D0VN_G!R>2*]SU?P_X \.^,O ]W/8
MV.D:\;MK313ID(ADFW1-OC(B'SP[%).[Y 0IR#B@#M-*UBTUK3HKW3KV*]L9
M@3'/;2!XWP2IP1P<$$?4&LS_ (3SPV?%'_",_P#"0Z6?$03?_9'VV/[4%QG/
ME9W=.>E>9_!#QC'X>^$G@RT;1M>U%KB.<B;2]+DNHH\WDR_.Z\*>_/;FL;XK
MZ?X<LM)T[Q/H5IX>D\.Z;XHAO=6N]/&-4DOUNPCK%*1C?YC .K'<RAE7&10!
MZ'-XU^'_ (+\?ZM#>^,-*TWQ/J_V2.;3;S4HXY2539"%B)!!8-[Y)%=U>7T6
MF6D]Q=7*6EK"ADFEFD$<<:CJS$D  >IKYO\ %<&M^"+WQW\1=/USP=X@TJVU
M]I+S2IM-,ET=GDV_V473-F*9 HVH$(+'WKT?]H>*"?P7I%OJ"J=%NO$>DPZD
ML_$;6K72[EDSQM+; V>.<&DDEL7.<IN\G?9?<K+[DK'8Z5\0/#FN>'KG7]-\
M1Z;?Z' '>?4K6\22WC"#+%W!P-HY.>E1^$?B3X6\>&Z_X1CQ/I>OFVVFX_LN
M]2?RMV=N_:3C.#C/H:\/^(_AW3_^$O\ BCH&E:AI'A2SU70='BOY[E/+LTNY
M+R2-1(J8P\D("=B04R:M77CWQ1\'+[Q5H=]8Z3XEU2+3;?4;*X\,:"\$D/G7
M!@"7-M$79D3_ %@(.656'7FF0>]VNL65]?7MC;WL$]W8L@NK:.4,]N77<@=1
M]TLO(SU%7-[<_,>>O/6OG']F?Q#I$OQ*^(^FZ=;Z\7N?L%[+>:SI<]K+/*MO
MMFDF\Q1LD=W+!#C*_=&U:^C: %+LP +,P'8G-;6G_P#'G'^/\ZQ*V]/_ ./.
M/\?YT 6*0TM(: /RTU3_ )"5U_UU?_T(U5JUJG_(2NO^NK_^A&JM '1_#OPH
M/'/CG1- :<VL=_<K$\RC)5<$L1[X!Q[XK[$^-?PB\2^+_"&E>$/![Z;I/ANV
MC4313RNC2%>(TPJGY1]XY/+8].?B/2]5O-$U""_T^ZELKV!MT5Q VUT.,9![
M=374/\:?'^QL>,M:S@X_TMJ /L;XQ_"?6/'_ ,)]'\,Z=/:17]I+;/(]P[+&
M1'&5;! )ZGCBO@JY@:UN9H7(+Q.T;$=,@D'^5?5?QA_:!TZ\^%&D6_A;Q?*O
MB59+8W)M&D2;:(SYF6( /S8SS7RE([2R,[L6=B69CU)/)- #:ZOX3_\ )4/"
M'_87M/\ T<M<I75_"?\ Y*AX0_["]I_Z.6@#]*A63JO_ !\C_=']:UA63JO_
M !\C_=']: ,;7-'MO$.BW^E7GF&SOK>2VF$,K1N8W4JP#KRI()&1S6=JW@?1
M-<\$2^$;NR#^'I+-; V:.R@0JH555@<J0%7!'((!ZUM7#%;>4J<,$8@^^#7E
M'PE^*E]J7AKP)!KNEZDKZY:B*#6[J2)EN[A8V=MR*=Z;@CE6(P=O09%9RFHR
M47U_K]3MHX2I7I3JPVC:^NNTGIWLHO;4WO&7P-\'>/-0M=1U6PNEU2WMUM5U
M*PU">SNI(1TCDEB=6D7OAL]36GI7PP\+Z%9>'+33=*CT^U\/W#W6G0V[LJQR
MNCH[MSERPD?);)).>M9MI\6 VNZ':WWAO5-+T[6[LV>GWUXT:-+( S#?!N\V
M-6"-@L/3(&17G</C#Q7K4/@?38I]3FBU36]5CN[RSO8K>=XX)IMD09AD*JJK
M' Y"[<Y-9NM%;:_TO\SMI957J?&U%>;6UI-^6G(TUO<]G\8^#M'\?Z!/HNOV
M2ZAITK*YC9V5D=3E'1U(9'4\AE((-<UI_P "? ^G>$]5\.+HGVK3=5D6:_:]
MN9;BXN9%QLD>=V,A9,#:=V5QQBKWQ5U2^T/1-(ELKB6SDEUW3K9W3@O$]PJN
MASV920:H>'?B!;GQ*^CNNI3_ &W6]1L([J\EC:.&6!5?REV@$1E=Q0')&ULG
MI6CJ)2Y6<D,%5J4?;0U6OX*[_ ET+X*>$_#7A[5M'TZTO8(=69&OKPZE</>W
M!7&S=<LYE^7&  V "1W--\:_ [P5\0M=CU?7=':[OA$D$ICNYH4NHD;<D<Z(
MP69%))"N".:H0_'"TU**R&EZ-<W]W=QS744$EY!;+]E29H5G,DC!<2,I**,L
M0,G I7^.6FWBZ)%H^FSZIJ&JQW$B6<MU;VAB\B012HSR/M:17.-B$YP3G'-3
M[:GW-?[,QB=G#OU6EK[ZZ;/5V3MH7?&WP+\%?$/5DU+6])DEN_(6UE:TO)K5
M;F!22L4ZQ.HE09.%8$#)'2E\:? WP3X_?3VUC1B6L;;[%#]ANI;3-MQ_H[^4
MR[XN!\C9%=AI&H'5M+M;UK2ZL&GC$AM;V/RYHB?X77)P1]37#^-_%\GACXF^
M%%N-1>ST$Z3K%[J$>?W;"!(65V&,G8"Y&/4UJM=3S9)Q;B^AZ!8V\6F6MO:V
MD:6UM;HL<,,0VI&J@!5 '    Q[5S>A?#7P_X;NM(N+"TDBETF.[BM"T[OL6
MYD$LX()^;<X!&>G05R^@_'G3]4U'3(=0T:[T2UU>-Y=,N9KJWG-QMB,VQXHG
M9X9#&K,$8'.",AN*F\$_&V'QGIHU=?#FI6GA^6QDU"#58IX+R,Q(H<K*L+LT
M,A4Y",,D@KP1BF2:]U\(/#%UI\%J+:[M6M[ZYU*WN[*^F@NH)[ABT[1S(P=0
MY8Y7.,<8X%58O@=X/M= @T>UL+JRMK?49-6MYK6_GBN;>ZDR'DCF#;U+ D$9
MP=QSUIOPW^*[?$86UQ#X<O['2[VU^UVFIBZM[J!T^7"2&%V\F0A@0C>C#.5(
MJ;Q)\6].\*3>,H]0L[F,^&]-@U0X93]MBE#A!%_M>8ACP?XB.QH (/@IX0MM
M#GTJ'3YX;>74CK FCOIA<Q7I4*9XYMWF(Y Y(/.6SG)J63X.^%'\/VND#3YH
MX;6[;4(;R*\E2]2Z;.^X%R&\SS&R0S%N0<'CBL;Q;\:Y?!MKJ&HWO@W6AHFE
M>4NIZDTD,2V[.J,PB1V#7 CW@,T?&00,D&IM7^*<DVO>+=!LM U26#0;7??Z
MU;W,$20+):M.C1!SN9\#& IP<$\&@#2'P<\*#03I0L;@(U[_ &F;\7LWV\WF
M,?:?M6[S/-V_+NW?=^7IQ6CX+^'VA_#]-3318)H3J5R+R\DN+J2XDFFV*AD9
MG))8A1DYY.37*K\5+O3O"^CSZ;X8UWQ,@T.VU6ZO)IX(-D3QY >:0JDLY 8E
M$^IVY K"A^+VIZO\2]+?PWI6J>)M'UCP?;:Q:Z;#+#;+&7N7!E=I6 5RI5 N
M221CC!- ';>(_@[X6\5:GJ5[J-K=L=4B6+4;:#4)X+:^55V*9X4<)(0O )'0
M#.<5H:)\/-"\/-,UE;RJ\VF6VCR-)<.Y:U@5UB7D]0)&^;J<\]*X#6?BQ:^(
M;%M0T.\UBTDNO!VK:G;Q$I'%#) ZHWFQD%A<1R94$':,-UR#6!XJ^*^M>'?
MNL7^F3:C?^(;/P7I.IG[3+";1&F9E:<(PR9<ABV20PV8&0<@'IZ?!_PQ$NEK
M%:W<"Z=I#:#$L-]*@DLBNWR90&Q(!DD%LD'D<UU6DZ;;Z'I%EIEFK1V5G!';
M0QLQ;$:*%4$GKP!R>M>?W_QK@T6T\3KJFA7EEJVA16$C:9]HBE>[-WA85B=3
MM.9-T>>F5/:O2B"N01AAP1G.#0!Q&B?!CPEX?U:RO[*PG T^=KFPL9KV:6RL
M96SF2"W9C'&WS-@J.-QQC-=%X8\,Z=X/T6'2M*A:"QB>21(WD+D&21I'Y//+
M.Q]LXKS/P[\5KK2X]8M+F&^\3:Y>>+M3TS2=-AD1',4.'(+N0L<4: DL?4#D
MFM[1/C/8ZIKNF:-=Z3>Z1J5QJ$^DW<-T\9^PW4=N+A4<J2'62++(ZG! .<'B
M@#KK#POIVF:_K&M6\+)J.K+ EY(9&(<0JRQX4\+@,>G7O69_PK3P_P"=++]D
MDWRZXOB-CY[\WR@ 2=>F /D^[[5R_AO]H'0_$^B:+J5O974"ZGJUSI@AN&16
MA2"-YI+E_P#IEY*+(,<XD6CPU\>].\0:EH:2Z1=:9I>ORK!I6I3W=L_GNREX
MQ)"CF2'>JDKN'H#M) H ]0!VD$=JR/"WA73?!FFRV.E1/%;S74]Y+YLK2M)-
M,Y>1V9B226)Z]L#H*P/AC\29OB;I7]K0^'+W2-'D5OLUW>7$+&X99&C<"-"6
M4 H<,V PZ5A:G\>$TR\\5-_PB>L7&B^%KYK+5]7BDA\N$*B.94C+!Y559 S!
M1E0,\]* +L?[/_@RV73?LEKJ6G2:;:RV5G/8:M<6\MO!),97C1T<$*68\=EP
M!P!C1NO@YX5EMM(BM+*YT5M)MVM+*XT6^FLIXH&(9HO,C8,RLP#$,3EN>I)K
M#\1?'W3-#U#6EM])N=6TK0V*:IJ=O=VT8A(19'$<4CB2?8C*6V#V&X@BK'C+
MXT+X5M-2U.W\,:KK/A[2[6.\O=9@DB@@$3QB0& 2LIN"$(8A.F0,EN  =1HG
M@+1/#DFDG2[:6RCTNUEM+:WBN9/)"2,&<NA;#N6&=[9;);GYC6AJ&@6.J:II
M>HW,1>[TQI7M6#D!#(AC?(Z-E21S7D\/QD.F_%?Q5HZR7>OSWB:3_8.@V[JK
ML)+=Y)Y1NP(XP,.[MP, =2 ?0/BKKVI^$?AEXHUS2K;S]1L--GN8 Q4*KJA(
M8[N"%^]C^+&!UI-)[E1E*#O%V_X.C^]:$>B?"OPWX>U2UOK*SG5K)G>RMIKN
M66VLF?.XP0LQ2,D$CY1P"0, U;L_ &AV.DZ%ID5K(MEHETMY8IYS$QRJ7P2<
MY;_6/P>.?:N1T_XNZI/;:7IUMX1U'7/$O]DP:GJ5E:7=LBVL<F50F1F",\A1
MF6->P.2*[OPCXFLO''AC3M?T@2W.GW\(FAWIL?J048'[K!@5(/0@U*A%;(Z9
MXO$3=YU&_F_/_-_>^YY/I_P=UB?Q%H[W]C86EMIFLC5C>6>ISM!*5=W @L6^
M2W=RR[VW$<-C[U=ZWPE\,/JC7IL9MK78OVL/M<OV)KG.[SC;;O++[OFSCKSC
M/->?>#?CKKQ\(Z5<ZWX6O+_6-8\07VCV%O975L/,,;SLH)R%146(H6/7:6Y!
MKHM3^-YTX:Q.OA+5KS3= "C7KVWG@9=/D\M998U4L&N#$C N8^!VW'BHC1A'
MH=5;,\56:?.XZ6T;7GW_ . NB1WVC:!9: M\ME$T0O;N6^GW.6W32$%VYZ D
M#@<"N<U[X/\ A?Q+-JK:A:W<D.JY:^LX[^>.VN'VA?,>%6"%\!?FQGY0>HJ.
M;XL::EIXXNHK6:YM_"MI'>2R1NN+M'M/M*^5Z?+Q\W<^E9.L_'!+*'4I],\*
MZMKUKI&G0ZCJLUG)"GV198//6(*[ RR"/#%4Z @\Y JW"+5FCCIXFO2FZE.;
M4GU3=PC^"]AJ/C'Q/J&K)/)I]_%96T$=OJ,T9G@B@V/%<*C#>I8=&SGGU(J2
MX^#UEK'CW7]5U&*2'3;JPLK&VCT^^EMB\<:R"6&18RH,9W)A3D'':N9MOC%K
M,GCW59].T#5O$&E2>%=*UN/3;>X@C6T67SVD;=(P#2, @VKG=L[ 5ZWH7B2S
M\2>%K#7[ O+I]]9)?0%EVLT;)O7(/0X/YU'L8=O/\_\ ,Z_[3Q?2;^%1W>B7
M+MKHWRJ_<Q]1^%?AK4[OSWLY[8-;1V<UO97DMM!<01@B..6.-@KJH) !'0XZ
M5<\.> M%\*364NF6\D+V6G)I4!>=WV6ROO5.3SAN_7'%<EX=^-%YXG\):;K]
MEX%UQX-7,0TJ 2P-)=!U9F=R&Q;QJ$)+R$ Y7 ).*YWQ/\=M8N=)L#H/AZX@
MU>W\66N@:KIUQ=6Q,98*^Q)=Q1A(K* X^[SG%7R13ND<LL7B)0]G*HW'M=V/
M0+'X3^&-/U2"]@LI@+:Z-[;V+7<K64%P23YL=N6\M7R200."21@U>C^'^AQ:
M+:Z4MK(+&UU :I%'YS9%P)C,&SG)'F,3MZ=NE<A'\5+?1;C7H$MM9UO5I?$S
MZ-9:4TT)9YQ;1RLD+':L<")N8ER2/F/.0*;J7Q^T[1=(NWU'1;VPUZUU.#1Y
M=%N+B!"MQ.ADA8W!;RA$Z L)">VW&[BA4X+9#EB\1-IRJ-V\WTO_ )O[SN]$
M\*:=X=OM5NK!9XFU.X-U<1-<.\7FG[SHA.$+'EMN,FMBL/PAXCN/$^EO<W>B
MWN@W$<IB>VO&1P^ "'BDC)22,@C##N"" 16Y5)):(YYSE4?--W84444R#QK]
MJ_\ X^?#/^Y<_P XZ\!KZ3_:4\*:QXEN/#YTK3+K4!"LXD-O$7V9,>,XZ9P?
MRKQ7_A5OB_\ Z%O4_P#P&:O@LSHU)8N;C%M:=/)'[5P]B:%/+*49U$GKNU_,
MSEJ",]>1[UU/_"K?%_\ T+>I_P#@,U'_  JWQ?\ ]"WJ?_@,U>7["M_(_N9]
M%]=PW_/V/WHYAY&< ,S,!T#$G%-KJ?\ A5OB_P#Z%O4__ 9J/^%6^+_^A;U/
M_P !FH]A6_D?W,/KF%_Y^Q^]'+45U/\ PJWQ?_T+>I_^ S4?\*M\7_\ 0MZG
M_P" S4>PK?R/[F'US#?\_8_>CZ&_9I_Y)R?^OV;^2UZ=J/\ QYR?A_.O/O@#
MHFH:!X$-KJ5G-8W'VN5_*G0JV"%P<'Z5Z)=Q--;LBXR<=:_0\"G'#4T^R/PK
M-Y1GCZTHNZ<F8#HLJ,CJ'1@596&00>""/2N)TCX)>!]!U#3KZP\/0P7>FSBX
ML93/,YM& 9<1;G(C3#$;%PGMP*]$_LN;U3\Z/[+F]4_.NX\@XJ3X7>%I=-TN
MP.D(EKI=Z^HV2QS2HT%P[,SNKJX;YB[Y&<$,01CBH;?X1^#K7Q&-=BT"V34E
MN3>JP>3R4N#UG6'=Y2R').\(&R2<UW?]ES>J?G1_9<WJGYT 8>B:!I_ANUFM
MM-M5M()KF:[D1"2&EE<O(_)/+,2?3GC%&L:!I^OBR&H6RW0LKN*^MPQ(\N>,
MDHXP1R,GKQ[5N?V7-ZI^=']ES>J?G0!3K/U_0-/\4Z+>Z1JMLM[IM[&8;BW<
MD"1"0<$@@]AT-;G]ES>J?G1_9<WJGYT <O<^!]"O(?$,,^G1R1>(5":JI9O]
M*41"'#<\?NP%^7'3UYKE=!^%[76L>-;CQ/8Z5=:9KL5I81:5"SSQ"UMD=4,A
M=5^=M^< ?+M&&)YKU+^RYO5/SH_LN;U3\Z .'TGX4>$=%T[5+&WT*WDM]5B$
M%\+QY+I[F, @1N\K,Q0 G"YP,G %,L_A'X0L?#VK:)%H<3:;JP5;Z.::65[@
M* $#2NYD^4 ;?F^7'RXKN_[+F]4_.C^RYO5/SH XP_#/PQ)8ZG9S:/#=6VIV
M\%M>QW3O-]HCA7;$'+L22H/#9W9YSGFJ]G\)/"-AHU_I<6BQFSU"6*:[\Z>6
M66X>)E:(O*[F1MI5< M@8QC&:[O^RYO5/SH_LN;U3\Z ,1=!L%\0SZZ+91JT
M]JME)=9.YH5=G5,9Q@,S'IGGK6+KOPM\*>)M=CUG5-#M[S44\L-*S.JR^6=T
M?FHK!)=AY7S VWMBNU_LN;U3\Z/[+F]4_.@#AM?^$_A'Q1K;:OJNA6]Y?R>7
MYSN\BI<;/]7YT:L$FV]O,5L5HWG@G0[]?$*W&G1RCQ!"MOJ@+-_I4:QF(*V#
MQA"5^7'7UKJ/[+F]4_.C^RYO5/SH X+QO\.K'Q'X;O[:SMH(-6&A7FBZ==2L
M^VWCGB"%3C/RY2/)P3\O'O6\%?!KPKX.TR*.'1+0W;Z<NGW+L7F0QE )8XUD
M)$<;$$E$"@]Q7HW]ES>J?G1_9<WJGYT >>Z+\%O!7A[4+*_L-!CAOK$.EM<O
M<32R0H\9C:-6=V(CVDC9]T=0 <&M*[^&_AF^\)6/ABXT>"70K%8UM+0L_P#H
M_E_ZMHW#;U9>S!@WO78?V7-ZI^=']ES>J?G0!PT?PF\(1>&KC0!H5N=+N9Q=
MS([R-+).,8F:8L9#(,##[MPP,$5<\(_#_P /> Q?_P!@Z9'IQOY$ENV61Y&G
M=5VAW9V8LV.K$Y/?)KK?[+F]4_.C^RYO5/SH XO4/ACX6U6^UN[O-%@NI=;A
M2'45E9S'=*F-A:/=LW#:N' #?*.>!5KPIX$T+P1'=+HNGK:/=N'N)GEDGFG(
M&%WRR,SM@< %L =,5U7]ES>J?G1_9<WJGYT >?\ B_X,>!_'VMVVL>(?#%AJ
MVI6ZK&MQ.K99%.55P"!(H/(5PP%/\:_!WP5\1KVRO/$OAJPUBYLE\N&6=6!$
M><^6=I&Y,\[&ROM7>_V7-ZI^=']ES>J?G0!B:EH5AJ\-I#>6J3PVEQ%=0Q'(
M1)(SF-MH(!VG! .1D XX%9C?#OPVWB\>*#I$)UX8(O"SYW!/+#[-VS?L^3?M
MW;>,XXKKO[+F]4_.C^RYO5/SH YSQ3X1T;QMI0TW7=/AU.P$\5R()L[1)&X>
M-N"#D, ?Y\4R+P9HD.N:WK$>FPIJFMP1VVHW0SON8T5E16YQ@*S#C'6NF_LN
M;U3\Z/[+F]4_.@#AKCX3>$KE-.231H]NGZ:^CVX2:5-MFR;&@;:XWI@]'S@\
MC!YK63PGI$=YHUVMB@N-&MWM;"3<V;>)T5&4<\@JBCG)XKH_[+F]4_.C^RYO
M5/SH X;QW\)?!_Q.:R?Q3X?M=9>RW"!YRZLBMC<N48$J<#*G*G'2M73/"&C:
M-J]UJEEIT-M?7-M!9R2QY'[B$$11JN<*J[FP% Z\YKI/[+F]4_.C^RYO5/SH
M Y6;P'X>NKG7IY](M;A]>BCAU1)DWQWB1J402(25.%)&<9(QGH*QO _P2\"_
M#;5'U+PUX9LM+U!D,?VI2\DB(>J(TC-L4X'RK@<5Z'_9<WJGYT?V7-ZI^= &
M%H'A[3O"VCVVE:5:)9Z?;!A# A)"!F+'DDGEF8]>]<W-\%? MQXU_P"$NE\+
M:?)XB\T7'VYD;)E P)2F=AD']_;N]Z]!_LN;U3\Z/[+F]4_.@#S[4/@MX%U7
MQFGBR[\+Z?<>(4D6;[:Z-EI%&%D9,[&<8&'*EA@<\5KWO@/P_J5OX@@O-)M[
MVWU\JVJ0W.Z2.Z(0(-RL2!A54?+CIGKS75?V7-ZI^=']ES>J?G0!P>@_!_P5
MX8\+:CX;TWPU80:)J1)O;-T,JW60!^\+EF?@ #)XP,8JSX$^&7A;X8VMS;^%
M]%M]&2Y</.T)=I)2!A=SNS,0!P 3@=J[/^RYO5/SH_LN;U3\Z ,.Q\/Z?INK
MZKJEM;+%J&J&)KV<,Q,QB39'D$X&U>.,5H5<_LN;U3\Z/[+F]4_.@"G6WI__
M !YQ_C_.J']ES>J?G6C:Q&&W1&QD>GUH FI#2TAH _+35/\ D)77_75__0C5
M6O5+_P#9Q^(\U[<2)X7N"K2,P/GP\@D_[=5_^&;/B3_T*UQ_W_A_^+H \SHK
MTS_AFSXD_P#0K7'_ '_A_P#BZ/\ AFSXD_\ 0K7'_?\ A_\ BZ /-*2O3/\
MAFSXD_\ 0K7'_?\ A_\ BZ/^&;/B3_T*UQ_W_A_^+H \SKJ_A/\ \E0\(?\
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M3\.:5]AO=2:2(QB2[^8Q,5)\S 0@N >!P?</L$__ #S/YBC[!/\ \\S^8JC
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MBC%+10 F*,4M% "8HQ2T4 )BC%+10 F*,4M% "8HQ2T4 )BC%+10 F*,4M%
M"8HQ2T4 )BC%+10 F*,4M% "8HQ2T4 )BC%+10 F*,4M% "8HQ2T4 )BBEHH
# __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>aciu-20231231x20f019.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f019.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 'K Q,# 2(  A$! Q$!_\0
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M_/CHW_?A_P#XNOG.B@#Z,_X;H\>_\^.C?]^'_P#BZ/\ ANCQ[_SXZ-_WX?\
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M_GQT;_OP_P#\77SG10!]&?\ #='CW_GQT;_OP_\ \71_PW1X]_Y\=&_[\/\
M_%U\YT4 ?1G_  W1X]_Y\=&_[\/_ /%T?\-T>/?^?'1O^_#_ /Q=?.=% 'T9
M_P -T>/?^?'1O^_#_P#Q='_#='CW_GQT;_OP_P#\77SQ!:373;88FD;T49K4
MB\&:[. 8]*N7!Z$1F@#W/_ANCQ[_ ,^.C?\ ?A__ (NC_ANCQ[_SXZ-_WX?_
M .+KPN3P=K<)P^EW*GT,9JC=:3>6)Q<6TD)_VUQ0!]!?\-T>/?\ GQT;_OP_
M_P 71_PW1X]_Y\=&_P"_#_\ Q=?.>,44 ?1G_#='CW_GQT;_ +\/_P#%T?\
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M /Q=?.?2B@#Z,_X;H\>_\^.C?]^'_P#BZ/\ ANCQ[_SXZ-_WX?\ ^+KYSHH
M^C/^&Z/'O_/CHW_?A_\ XNC_ (;H\>_\^.C?]^'_ /BZ^<Z* /HS_ANCQ[_S
MXZ-_WX?_ .+H_P"&Z/'O_/CHW_?A_P#XNOG.B@#Z,_X;H\>_\^.C?]^'_P#B
MZ/\ ANCQ[_SXZ-_WX?\ ^+KYSHH ^C/^&Z/'O_/CHW_?A_\ XNC_ (;H\>_\
M^.C?]^'_ /BZ^<Z* /HS_ANCQ[_SXZ-_WX?_ .+H_P"&Z/'O_/CHW_?A_P#X
MNOG.B@#Z,_X;H\>_\^.C?]^'_P#BZ/\ ANCQ[_SXZ-_WX?\ ^+KYSHH ^C/^
M&Z/'O_/CHW_?A_\ XNC_ (;H\>_\^.C?]^'_ /BZ^<Z* /HS_ANCQ[_SXZ-_
MWX?_ .+H_P"&Z/'O_/CHW_?A_P#XNOG.B@#Z,_X;H\>_\^.C?]^'_P#BZ/\
MANCQ[_SXZ-_WX?\ ^+KYSHH ^C/^&Z/'O_/CHW_?A_\ XNC_ (;H\>_\^.C?
M]^'_ /BZ^<Z* /HS_ANCQ[_SXZ-_WX?_ .+H_P"&Z/'O_/CHW_?A_P#XNOG.
MB@#Z,_X;H\>_\^.C?]^'_P#BZ/\ ANCQ[_SXZ-_WX?\ ^+KYSHH ^C/^&Z/'
MO_/CHW_?A_\ XNC_ (;H\>_\^.C?]^'_ /BZ^<Z* /HS_ANCQ[_SXZ-_WX?_
M .+H_P"&Z/'O_/CHW_?A_P#XNOG.B@#Z,_X;H\>_\^.C?]^'_P#BZ/\ ANCQ
M[_SXZ-_WX?\ ^+KYSHH ^C/^&Z/'O_/CHW_?A_\ XNC_ (;H\>_\^.C?]^'_
M /BZ^<Z* /HS_ANCQ[_SXZ-_WX?_ .+H_P"&Z/'O_/CHW_?A_P#XNOG.B@#Z
M,_X;H\>_\^.C?]^'_P#BZ/\ ANCQ[_SXZ-_WX?\ ^+KYSHH ^C/^&Z/'O_/C
MHW_?A_\ XNC_ (;H\>_\^.C?]^'_ /BZ^<Z* /HS_ANCQ[_SXZ-_WX?_ .+H
M_P"&Z/'O_/CHW_?A_P#XNOG.B@#Z,_X;H\>_\^.C?]^'_P#BZ/\ ANCQ[_SX
MZ-_WX?\ ^+KYSHH ^C/^&Z/'O_/CHW_?A_\ XNC_ (;H\>_\^.C?]^'_ /BZ
M^<Z* /HS_ANCQ[_SXZ-_WX?_ .+H_P"&Z/'O_/CHW_?A_P#XNOG.B@#Z,_X;
MH\>_\^.C?]^'_P#BZ/\ ANCQ[_SXZ-_WX?\ ^+KYSHH ^C/^&Z/'O_/CHW_?
MA_\ XNC_ (;H\>_\^.C?]^'_ /BZ^<Z* /HS_ANCQ[_SXZ-_WX?_ .+H_P"&
MZ/'O_/CHW_?A_P#XNOG.B@#Z,_X;F\>'_EPT?_OP_P#\717SJ.E% 'WC_P %
M5?\ DI%W_P!AF?\ ]%K7P97WG_P55_Y*1=_]AF?_ -%K7P90 4444 %%%% #
MHHGFD5$4N[' 51DFO=?AE^S5-K.F1Z[XKNQH6CDA@)!^]E'HJ\D_E6Q\"_A-
M8Z!H\7C?Q1$9 S;=-TXK\US)VX].#VKM_&GCS[#=G5];D%YJ3'%MIR']S;*.
M<*.@Z]<4 ;GAW3/"7@T#_A'O!:742<C4]88!3[[00WZ5I7?QBO;6>4?VIHMA
M!C:+>Q@.4]P6S7S[KOC?QA\0[H_8X72T/ P2!Z=>])IGP7UW48)9I[G$@&2J
M#=5QA*;M%"ND?0EI\3+"]"-+XVOXY#P=D46Q?K^[JI%\4;Z&Z^QPZQI>MQ2M
MM']H0C)^NT"OF#5_#]_X=NI-/>Y(,XP688 ]_P!:U8/ &M6%_:KO^68!X9.S
M'Z_A249/H%SZ!\0>&?#GB^3;XA\'0H6'SW^B-@+[E68G]*\=^(O[,PM+&35O
M!NH?VU9+EGMF&V>/V*D G\!4Z^+?&'PUO1=WLQ:V/#X)8#\*]D\!Z_I_C_3D
MU?2[C^SO$D#;@PZ2#T8?Q ^]2TUHQGPW=V<UA.T-Q$T,J\%7&"*AKZ]^,'PF
MM?BOIU]K6D6D>G>+-/!-_IL1XD4?\M$QC(^]V[5\C75M)9W$D,JE)(V*LI[$
M4 1T444 %%%=#X \&7GC_P 5V&AV*%I[J0)D#[HS@D_G0!5\-^%-4\67\5GI
M=G+=3.VWY%) ^IKZ-\,?LT>&O"5I%=>,]4;4-3(W+H^FD,WT9L$#\Z[7S])^
M%^E7/AOP6L(FA39JFN2 %@V 2L9_(9SZUXU=_%&\\\Z7H4&V1B2]V[9EF/J6
MZT ?0.AZI;>&;7_BG_"^@Z!"O)DU#,DQ'K\K$?I5:\^-L\TV7\1VEI&.&^Q6
MX 'TW*:\0\%:1J_Q'>]ANKYX[F!PI5<[C^.:M?$OX8IX>F9HTE5 G&"1DULJ
M,W'G2T);2=CV8?%6RT^U:]E\<23HY^5);="?TCJJWQ6M_$S-%)!X?UQ5&/+N
MX'1V!]P5%?-?A+38M9U2*QO9"8UR1DX/TS7H^A?!1]0>[N_M,D?E\H Y.!VY
MJ84Y3^%#;MN==KOPI^'OC0$W>E7/@VZ;A;JU_>V['U(&XBO&_B-^S1XC\%1/
M?6)CUW21R+JR(? ]U'(_$5MP>*/%_AG6;NPM93?6EH-SQODJ1[CO7J7PV^(J
M:I*9M!F%I?;?]*TE_FAN!W '3/X=JAIK<9\:21M$Y1U*L.H(P:;7U/\ ''X.
MZ1XR\.W?C7P?;/:7%JW_ !,]**\PGN1[<'MVKY8(*D@\$<4@"BBB@ HHK0\/
MZ%>>)=8M=-L(6N+NX<)'&HR230!V/P3^$&I?&/QE;:/9*8X,[I[@CY8T]:^W
M[_3/ O[..F6FB^&M(7Q!XME 0I"N^1CW+'H.3[5V_P !/A!IOP+^&1E<)_:U
MQ 9+JXQR6QPH/IP*\\^ 7AZXUCQ!XWUKB36Y[B4PR2G<R@LVW![8IV KZ:WB
M_P 6:LQOI-+\-7*C<B!F9A['#$9KC_C-XG\6^#]#DN(K^._BM?E:6$,%W'OS
MWXKVBV\%:/H>I00:Q(PO[PDM(PQE\G@'\*ROVIO#5OI'P,FMK>U_TB65  @R
M>O<T@/A_1OC#K^HW]V]]JUZLKH3$\#?=;Z8Z8JGHGQC\3V.JFY>_ENG'WEF;
M[P]#70?!G0X_[=ETZ:VA%Q?1M&EW<1ATA/7.#WXK#M_A]);:_!]H+?8Y;L0"
MXVX4DL ./QH ^JO#D_CSQMX#BU"RM\)*GRK),BH![9.?SKG]*NO#EE>KIGCW
MPQ=?,V&OHPLD(]V*9KZ8M_A-"_A'0=.M[@VEC!:J\C1'&YMH//YFN7T7P?IB
MW=QIUHYU&RN@\5PS_/&AQU Z9H \'^-?[(>BZAX2D\7?#B[%]"J[WL82&&,9
M.WN#['FOCF>"2UF>*5#'(A*LK#!!K] _@,TWPY^.FH^$[34?/T"Z61_LS'(5
M]PQ@9XZFO*OVV?V>?^$,UIO%VBP'^R[Z3-PB+Q$_K]#Q^= 'R=1110 4444
M%%%% !1110 44Z.)YG5$4LS'  [UWWA+X*>(O%A'D6DIS_!&A9_RH \_I\,$
MEPX2*-I&/91DU](Z#^Q=XDU)XFDM;U48\B2W*?K7T'X$_9&\+^!;2*Y\17\%
MJX^9D8@$?\#S0!\$Z=X U_51FWTZ5A_M#;_.M4?!SQ2-N[3BN>GSK_C7Z-'Q
ME\'_  F$MHC;:BV""846<\>M9H^-/PNGNE6/0)G"G[WV 8%.P'P-!\!?%<\9
M9;(^P]:Q;_X7>)=-E*3Z9(I'J1S7ZB:9\4_AO.R(OV:S++Q]HA6,8K9BT#P'
MXZE,UJEAJ#K\I,!4X_*BP'Y 7NF76G2%+F!X6_VEQ5:OU!^+G[*>@^*M,FDT
MV!8I@I/ED9S]*_/?XH?"[4/AYJTD,\;&#<0&(Z>QI <-1110 4444 %%*JEV
M"J,DG  KV_X1?LQZY\17AF:WE6V?'(4A0/=NU 'BUKI]S>MB"WDF/^PA-:UI
MX(UJ]D"1V,FX]F&,?G7WI8?"[X8?!^PC37M56XNT7FVLL"4'WP<FJEK\5O!C
MS,?#?@?^TUB?:;C4/DY]\J: /F[P3^RCXD\4(LCP3!2,E40J?S/%>T>$/V#O
MM 674 ULF.1>,&_]!KMKS]ISQ+#=16MI9Z=I%OC&W(D"_H*X?Q/^T!J^KR26
M^H^+?(3.,6:>3Q]0U/8#MI_V&/#4%J#YEHTP]R!573/V%M-FW&=;$1G[NT,3
M_.O+K_XH6_V0,/$NKR$\ O>/@_K5C0?C3X@T657M_$=T(\@*MS*77'XFG\A'
M2^,OV"E@'FZ8PDYY2$X_G7C_ (P_9&\0Z);236UK<$("?G (_2OHK1?VM-?L
MF07=M::O".KH1$<?@#7J?@?]I3PCX^NH=)NM]A>SKCRKE<1D^@8]?RI;C/RL
MU;1[O1;M[:[A>&13@AABJ5?H7^U+^S7::QIDNKZ5"%/WB$3[O_UJ_/[5-.ET
MJ_FM)E*R1,5(-("K1110 4444 %%%.CC:5U1%+,QP .] #:T]*\-ZCK4BI9V
MLDK'I@5[I\"/V5]4^(TT=Y>(8+!3N:5A\H'U[_2OII+3X8?!.&.TMK9?$>M#
MI'&H9%8>O7;0!\H>!/V3?%WC!%E-E+%$3SD;2/SKVK1/V%+.S4-K.L6%IZK<
MR@&NG\2?M$^)=2T]X[5K;P_9L"!#:J)90/8\$5\Y^(/B9-)J,B7U[?WNUO\
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MRTEL;B2"9"DB'!!I 0T444 %%%% #ATHH'2B@#[Q_P""JO\ R4B[_P"PS/\
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MQ'H<!\0:C<Z;#(JA) QWR<\_48KYC;0^@1=\(:K-JOBC6?%',<_VADAF3[N
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MC6A7ASPV/A3I175?$[P?-X&\::EI,RE6AD(&1CC)KE:R-@HHHH <.E% Z44
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M->2U]'?MW^'O[)^-MQ=JNU+RW23ZG+9KYQKQ3TSWW]B:)W^..GNA(V0RD_\
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M5B36=7.= 4444 %?0G[*/[1,_P */$<>E:I.S^&[Q]LL9/$1)^\!^)KY[HH
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M-:W.NR)$PVL(B5R/SKR&B@"Q>ZA<ZC,TUS,\TC<EG.2:KT44 %%%% !1110
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MBU;@_P""<^D3'_D/S#_@-85K_P %$UMX]O\ PBT9_P"V[?X5:@_X*/K$V?\
MA%8R/^N[?X5^+YRL6[_V=\MOU/EL/2\2?;?OG[OK3.DA_P"":FCS #_A(I1G
M_9K6L_\ @EKH]R!_Q4\RY_V#7+1?\%-!#C'A*)L?]/#?X5J6?_!5+[-_S)D+
M?]O+?X5^+8^EXA.;^JO3UI_J?JV5QSQ6^O/\OT.OM?\ @DIHMSC_ (JR4?\
M #2WW_!)/1;.(O\ \)9*?;RS6/;?\%<S;$8\$0G_ +>7_P *=>_\%=#>1%#X
M'@''_/T_^%>#['Q3YOB5O6D?IF%>$27M]_F86L?\$U='TH-CQ'*^/]DUPVL?
ML-:9IFXKK4C8]JZ;5O\ @ID-5S_Q2,,>>WVAO\*XW5OVY6U='9?#*HO<B5B!
M^.*^HP5+CU6^LO\ &'Z'Z'ET^$]/K:_]*_0X_6OV8;#2@Q&HR/CGI7SMJ=FM
ME?W,"MN$4C)GZ'%?0.L?M.G5T=AHH13QN#DBOG_4[H7M]<SA=OF.SX],G-?I
M^3+,U&2S'?2VWZ'-Q?+AF5&A_8"][7G^+RM\7SV*=%%%?2GY@.'2B@=** /O
M'_@JK_R4B[_[#,__ *+6O@ROO/\ X*J_\E(N_P#L,S_^BUKX,H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4 ?>/_!57_DI%W_V&9__ $6M?!E?>?\ P55_Y*1=_P#89G_]%K7P90 4444
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M-;\736[R6DAB<Y,T@VQC^M>_7/[/7PU^%MI$?%GB>UBE')MX5W-].%_G7/\
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MXG\I]TNG:FOE3QOR"#PV?SKYU^.GA+_A$O'^LV:)MB$V]!C^%AN'\Z[SP_\
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M(W8J>/7FH/?/CC'-=A\,O#,WBOQCI>FPIN>>95QC-<M;P--,$499C@"OM_\
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MKIAB4X&>15Z:]M-&TZUBD?R_*3YJRC>^FYTU.7E?-L2_$W7FT;P]-> ;FD8
M!3TZUHZ)/-_8EM<F($2H&KC_ !M:)XM\)3?893*/OKS75>#FO$\,VBO$'6&/
M!]:UC).33.>::IIK5'.>/K>]FA$]I"5!7YB.M<)'I.J>)4>SNMUG8>60[DD.
MU>I^)-?:VT6YN#!DHO /05Y?!-K'BFTF2.>&TW?Q@YP*U5GL<DKI..UCP36K
M9-!N]1LX6\R"RG4J<\\-_P#6KU/]H[1#K7[//@[7H4!CB#1NP'J6/]*\X^*6
MBP>%-;MM/BE,SW"$S3$Y+MBO:M:']J_L1W$K$R-!.5"GHF"XKYZI'DDT>Q2E
MS04KGP7(,.:;3YCF0TRLS4]4_9F\+IXK^,GAVSD7=&+@2,/]T$_TKZ'^.LTO
MBOX[#19I"T(N?)RO&U-V /RKS+]A*S6Z^-$#L,F*%F'UVFNO^(6LOIGQ^U"[
M,9E>.]!QZ_,>*J.^AE4;4&UO8]=TZ6;P_=WNGEV6W$(6*1CG!XKE/!FJ1V/C
M9[:\E%U/*VY7/&.:T=0U!M6.Z\86Q=<@J>E<O8V\&D^)[>[:7[9O(19 >4.?
M_KU[Z<E%<QXM.C"K25TTVD>W16TXNI;I5)B4=37EGQ-\'V7CF6WF9MD]O(&Z
M?>&17K]C<%M%F4')9<XKS77KR'2[*625@'YP/6E.*E9]#MI2<8N#5K;&%IOP
MRC\4>,[#5X8_*L;)%1V'4LH X_(U[WKMW86>A10VX)*X^M>7?"CQ0VI:9<0;
M1%M<DCOR37?V1@U 36K?,XJX4XP3Y%8X?:3J2M6V78\W^)&N"#P^2L2R(0V=
MW:L#X=2C2M.4M$Z>>"3*_'?M71?%C1[*PL889@TA<G;$O4UQ=OH>N:?I:--*
M2LA_<PG'RKZ4.^W4Z8QI;JUF4OC3$_E6-_"4-K <DKU(XSFMO]F&676-=OM.
MCD0PM"ZNK=T*Y_G7DGQ.\7:GI0FTB:.*42(>4)RE>@_LJ2RVWQ%M8P#BYM'Z
M=S@UXN):=1GHTHJ,;+8^5OB'IB:1XNU6T0[EAG9!^!KF:[KXT6YM/B1K\1&"
MMTX/YUPM<QL:GA?3VU3Q#IMHHW&>YBBQ_O.!_6OT"_:!U>V\,_#:PT"U+13"
M"WM<@\?ZO#<?45\;? /PP=?\<6=RS!8-/FBN)"WLV1_*OK'XD1?VU\4]+L;H
M[[:X5)44\C! (_G37F1*2A%R?0SK?PU9V?A[2+>*1$QAL@\D]:[&W\(7MP3?
M22':L>V-OPK%\8_"YDEBN+._>W=2"(\\&O2[9;S2OAQYLFUY50*">YQ7MT6D
MK\VECY^G6C[!5'O<XW0+Z:'4OL_ERSH&QYH''XUJ^+?#6H^-+7[)IUKYGE ,
M9FX ^AJQ<7 T72C)$BFX=<C ]:],^&6HV=WX0BN&D1+I6(DC/7M7YWF%=U<:
MZCA=1?WETN6I3:C.SG]R/D+2O"^I77B,V$Q87*.4\A>2:]L\$6,>@RW-G<VQ
MMKHMN&\<D5WN@^&M,T[Q]?Z\TD;23)M2,C[K<<_I69\742VM;+5;9@]^LH3R
M4ZL"0#^6:JO.MCYJE.GR*VFG8E0I8)^VC-2=]C U?Q,L&OVMG+;R""5@OG%?
ME%5)_ L">*'OV0*<94>O%7M1TZ37-%(EA^SW&W*D=0:FM;._?2[26:7=/&F&
M]2:][(,5&5)T%'X?QN:5:4O;<TI?$K_\ \]\7^%]:U:PO3;>7$BD[05[<UR_
M[-_CR[\#^(M7T6:=667&7!R NX;A^AKUZ6UN;@LE].D,+=$SC-?,[VK>&/BF
MOE+LCFD(&#G->KBG>HUV-<!5;E.D^ASW[9FB6=K\4Y]2TU MCJ$2S(0, D\G
M^=?/=?57[:%H\DOAZY*; MC$,@<'*BOE4]:XCV0HHHH MZ5$)[^&,]'=5_,U
M^G7@O1K+X3_ !M:T&'=>_901Y<8,DDK+GENN <BOS"L)6@N4D7[RD$5]^?![
M]I.TG^$B66HZ:?M5I'Y2N.4;T.,^U '6_#7X/Z_K/@5GU/0Y1=7<AGDN96*N
M2>O&/2O!OB#X)3X9^/WNA:R2:?G;.''*9_IUKZX_9\U^_P#%XEU.'4Y%M4.U
MK63&T#\O>LS]I[X?P>*;**_LKR*VMEE"3E0".?7CVIIM.Z#<\*^'1\&7%Q)'
M8ZM+:RS'S#&K\ _G5;XT?$&Q\)6D=K971O-0+ HSH,#'OFNJA^ /@=M*>YCU
M%Y+P1YR"5.[VX%?.?B#PJ+SQE#IL,C,GF[6#MG SSS7:L5.UD>=/!J513<M%
MT.Q\(?&6[U:ZN&DM]DBQ8)1NIXYZ5'<^.=5ETJ>)8F.7)\PL?ES7=Z=\$]..
MGJ;,K;2[/F8'EC4%A^SUKNLI-''.B0[OOMUQ7IQDE'WWMN>1*O%5'.F[11S7
M@>.7Q+>J;_59(KU5VPA&*_GSS7J4OP;U+4=*E,K-J5[(/DDQD*.WTK0\!?"4
M>%+E(;@I<S#^(]J](TWP]K0O7D-ZL-ET*#TJY2CRFE2<H>]S*_0\M\+>%Y/
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M:1@^._B9;?#CP_;Q>8)M0D0*L;']37B&M_$*?Q#J4%N"LKN-S[>@^E5/C?\
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MO'_@JK_R4B[_ .PS/_Z+6O@ROO/_ (*J_P#)2+O_ +#,_P#Z+6O@R@ HHHH
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MH?L>?M56?]EGPAXKE5DD7R8VEP=RGZU5_:2^ $O@JXN/$?A5!=>'K@;V6/K
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M>WA59&4(X&W=COD]C7YKV=[-8S++"Y613D&NMM_C'XMM(RD&KSPC&WY&(P*
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MQ9CU)[U7HHH **** "BBB@!\4K1.&4D,#D$5]-_ +]KF_P#!L<.@^)&-_H3
M1Y?DHO3%?,- .*8'W]XR^&7A'XGZ>VN>"KZ"ROR/,-N'&'/T[&O(-=L_'VA0
MRZ3=)>/ ?E^1?,!'U&:^>]!\::SX:D#Z=?SVQ'9)"!^5>G>'/VK?&>AX$MRM
M\F,$3#/\Z:DUL)I/=&U8:+K=@RS^7J2W*<HRPL I_*NDBO?B)XG1-,C_ +2N
M%;CYH]O'U( JE:_MKZN%Q/I<#\>W7\JK:K^VUXIFA\NPMH+(_P!Y0"1^E3YD
MN$6[M'OGPF_9?M-/B76/'MW%#:QGS!9[A\W?YC6G\;OVT= ^&VC/X:\ 0Q+/
M$OEAXA\L=?$GBGX^^-?%ZO'?ZW<&%NL<;E1_.N FN7F<LS%F)R2QSF@LV_&7
MC;5O&^KSZEJ][)>7<K%BSG.,GH*YZBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ H R:* <&FK7U L1V;2'A@*W=(\#7&KD;+B.//\ >!K&AN@A^Z3B
MNL\/>,H-)*[XF;!Z 5]I@J&2RBOK$M?5GG8J6)4'[!:G1Z1^SKJFKE?+U2U3
M/]Y&KM--_8FU_4PI3Q!8(#ZQ/5+0/V@=+TDKOM)6QZ5Z1HG[9GA_3%4/I]P2
M*]N6&X7]DVI^]TUD?F>98KC"#?U.G?Y1_4Q[7_@GAXHNTW+XGTP?6&2K*?\
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M_P#)2+O_ +#,_P#Z+6O@ROO/_@JK_P E(N_^PS/_ .BUKX,H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:I<:??1&&Y@8JZ'L:HU[]\4_#[_$KX<:5\0+1!)?QQBWU1$'(<8^?\2Q_*O
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M_.D!^?\ 178?$?X=WW@'6)()XV^SLQ\N3';T-<?0 4444 %%%*B&1@JC+$X
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MDM?^"BK0>$8II].\S4DPF./O?G[5B?"Z[^(OQZ^(FF^*]6U":WTN*<21VP.
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M]:U_'?PWUSPB-&U*SLQ+%&5;*\MNR.V*^O?ASHUGX7U#788(@8;"+RR$&1C
MZ55TV"SU/3K;5+N+;8Q,8HA<+@,YXZ?B*]&.&IN'*O6YXRQ]6<G422BBS\.O
MVLM/LO"MC%J+AY+: +*#PX(&,8KQGQ9\>/'7C_5;K5=(5$T]"1& /F*>F*2X
M_9V&D^*KS5]5U!7LI?,N!"IPJAFR!^1JG^SG:3ZEX]OC,OD:! YC2-Q\K'_)
MKSXX:4FK=3TXXZE.+E!WLKG+67BYO%\4^GW7^AZQN+!7X^;L17VAH>N1_%']
MG'4[4H#>063P3Q8^ZZC(_3%?(O[2WP6UCP?XGE\7:9A=.W"1 G&.]>X?L?\
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M@.'Z_I7J7[=ND?9_$VD:@%V_:K=&R._RUR?QNL6O/VC?(3'FS7<8ROJ6KO\
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MZC %<Q\9;U[?P[?Q0IB:2%D4?4$574T3DI<CV,CX=_'+PWXUU>?3M'OTN+N
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MXC6NL>++M+I(VW@,V]B<CGK7Z(II"6MM%$-R)"HVX; .*\S\$VS"[MYU!9&
M92>XKTSQ(URVF&Y3CR\9 HHPC%,RQ<ZG/&*V9Y;\1_C-I.DR-;7#;#&=A+#
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MF5>'+1II?WGI^!A"C*:YY7?HOU.NT[P/X(U&].K6OA9GOB.9IDVD?7*UJP^
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M6[^R]8:QX:^'UM?V&HSQ)+<$&+!**03VKS3X*?$B^U+2+;0C+$VF_9VCFAV
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M 94ZG-/UW3=#M/"J#4X5-LJ[\RU@^,_CEX9T*ZM?M CNF641.< E#G%>0?M
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MGSH\9#>H->4>*M,T[5O&FFW6F3F=7D(D#2'CGFO0-=^(;>%S9:/8VWV@2D*
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MIH7)B4NS,.,X]<UQ5JGM)7.A)+8\^_;5\?)\,?AWI'@G0,:>;B+;<1Q<?+@
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MRN8+G4(H)8TPDA?.[ /-?+FL_M,^+?BIHD/@7PK8LL]ZQCN9H@2S_,><@<#
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M^7\TP]&8UCDDG)Y-(9T'B_QSJ_C?4'N]4NY+AV)(#'@5S]%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MDE_X*B?%F="KFR(/;8/_ (FOCNBN3_4_AZ]_J-/_ ,!1[$*M2FK0E8^J+_\
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M$?\ T(>E?]\M_P#%4 ?SK?\ "L?%7_0"O/\ OBC_ (5CXJ_Z 5Y_WQ7]%/\
MPRE\(_\ H0]*_P"^6_\ BJ/^&4OA'_T(>E?]\M_\50!_.M_PK'Q5_P! *\_[
MXH_X5CXJ_P"@%>?]\5_13_PRE\(_^A#TK_OEO_BJ/^&4OA'_ -"'I7_?+?\
MQ5 '\ZW_  K'Q5_T KS_ +XH_P"%8^*O^@%>?]\5_13_ ,,I?"/_ *$/2O\
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M8^*O^@%>?]\5_13_ ,,I?"/_ *$/2O\ OEO_ (JC_AE+X1_]"'I7_?+?_%4
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M/_H0]*_[Y;_XJC_AE+X1_P#0AZ5_WRW_ ,50!_.M_P *Q\5?] *\_P"^*/\
MA6/BK_H!7G_?%?T4_P##*7PC_P"A#TK_ +Y;_P"*H_X92^$?_0AZ5_WRW_Q5
M '\ZW_"L?%7_ $ KS_OBC_A6/BK_ * 5Y_WQ7]%/_#*7PC_Z$/2O^^6_^*H_
MX92^$?\ T(>E?]\M_P#%4 ?SK?\ "L?%7_0"O/\ OBC_ (5CXJ_Z 5Y_WQ7]
M%/\ PRE\(_\ H0]*_P"^6_\ BJ/^&4OA'_T(>E?]\M_\50!_.M_PK'Q5_P!
M*\_[XH_X5CXJ_P"@%>?]\5_13_PRE\(_^A#TK_OEO_BJ/^&4OA'_ -"'I7_?
M+?\ Q5 '\ZW_  K'Q5_T KS_ +XH_P"%8^*O^@%>?]\5_13_ ,,I?"/_ *$/
M2O\ OEO_ (JC_AE+X1_]"'I7_?+?_%4 ?SK?\*Q\5?\ 0"O/^^*/^%8^*O\
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M_13_ ,,I?"/_ *$/2O\ OEO_ (JC_AE+X1_]"'I7_?+?_%4 ?SK?\*Q\5?\
M0"O/^^*/^%8^*O\ H!7G_?%?T4_\,I?"/_H0]*_[Y;_XJC_AE+X1_P#0AZ5_
MWRW_ ,50!_.M_P *Q\5?] *\_P"^*/\ A6/BK_H!7G_?%?T4_P##*7PC_P"A
M#TK_ +Y;_P"*H_X92^$?_0AZ5_WRW_Q5 '\ZW_"L?%7_ $ KS_OBC_A6/BK_
M * 5Y_WQ7]%/_#*7PC_Z$/2O^^6_^*H_X92^$?\ T(>E?]\M_P#%4 ?SK?\
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M?]\M_P#%4 ?SK?\ "L?%7_0"O/\ OBC_ (5CXJ_Z 5Y_WQ7]%/\ PRE\(_\
MH0]*_P"^6_\ BJ/^&4OA'_T(>E?]\M_\50!_.M_PK'Q5_P! *\_[XH_X5CXJ
M_P"@%>?]\5_13_PRE\(_^A#TK_OEO_BJ/^&4OA'_ -"'I7_?+?\ Q5 '\ZW_
M  K'Q5_T KS_ +XH_P"%8^*O^@%>?]\5_13_ ,,I?"/_ *$/2O\ OEO_ (JC
M_AE+X1_]"'I7_?+?_%4 ?SL#X8^*L?\ ("N_^^**_HG_ .&4OA'_ -"'I7_?
)+?\ Q5% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>aciu-20231231x20f020.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f020.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %J :$# 2(  A$! Q$!_\0
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MZ-'IT:JKTU5BK>3W7J9YHH)HKSC8**** "BBB@ HHHH **** "BBB@ HHHH
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M6EHIC3R?+#$8.3WIVF^!8=-T:2&V4+,5"ESS\QJG%I[:1JZ?:7$L:KLD(7!
MK]!RK#RI1<*<>:Z][T-<1AZ=2BZ51VO^9Y_XBT:[L;MEGB=6Z_-W]QZTF@:?
M=7MY%%%$SLYP% Y)KZ+\/:IHFHV@T37M.@U*,?-:W3=2I[9]1]:V;3P]H6CR
M[],TN&S;D;N2WZUYRIUJF8.4J+6MT^:/*_/?G7IRM^?4\OV^.B_9NA[VU[KE
M]>_R.7M[1[3PCK%O>RF-X;(#!/>N1^!UF-1\0;2?-$(+%3V%:_Q%UP6&G:M
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M#1=DENXE,ISMSQ71^&IIKN3]XC1#KDBN0\.S07N]/.*\;C$YR/PKMO#TPM9
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MJTH[I[K^NC6C,ENM,/6I&'-1D5! 4444 %%%% !1110 4444 %%%% !1110
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MS6[(RJ?O8(.*Y/Q/X[&H$1FR2';$$V@YZ=#5SX.2_P!H>-K*WDDV^:3&"YP
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MW/L#PIKZV5U!J$*;[:=,2QL,;T/52*^&/VW?A5:^$_';ZMI%N8]+U >?& .
M#U'X&OKWP;XHC\266"5%S$!O"]/J*Y_]ICP2?&7P4NKW:KOI,O4]0C#G]:^
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MP>S\66LP0/L/(85SLT)FN@54#: /QKV/X:>&(H85FD9&N9 &9<_,B_2O$RW
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MH?<&LVO5OVF[ZRU+XM7UQ8WL%VK6]N)4M9EFAMI!& T,<BY#*F, Y/U->4T
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M_O-KH>5@J<Y.>+K*TZG3M'HOU8E%%%<)Z@4444 %%%% !1110 4444 %%%%
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH [#P_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
B**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>aciu-20231231x20f021.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f021.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &= 9X# 2(  A$! Q$!_\0
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M<Y]778__  .OSS^&?B3P[\7+;Q')\9/C7XP\ ?&HWTZ007<SVUE:.&_=!1C
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MUWT].FXGB_P+';?%:Z\(Z)%<!DOAI\0O"%=WW;=Q] 3R/;%?27B_X5:!X*\
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MX1_#3Q%XG\&^,K_Q4NI>"M2\5ZXVJK:Z;?&.ZLX0B(B-+&?O$)D@''-<//\
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MH[Z6UTO;8]=^-WAG1)_!?Q M[?1K/33X1U.SMM/FMX@CO'(H5D8_Q<_-6?\
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MA\+O^Q?U7_V2OH"OG_QW_P GH?"[_L7]5_\ 9* /H"L/Q1X3M?$T$9=FMKZ
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M HHHH **** "BBB@ HHHH **** (KK_CVF_W#_*O&_V+_P#DU7X8?]@.W_\
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M\>TW^X?Y5XW^Q?\ \FJ_##_L!V__ *#7LEU_Q[3?[A_E7C?[%_\ R:K\,/\
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ME64=LLK#: 6" 9('K7U'7S_X[_Y/0^%W_8OZK_[)0!] 4444 %%%% !1110
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M&_V+_P#DU7X8?]@.W_\ 0:]DNO\ CVF_W#_*O&_V+_\ DU7X8?\ 8#M__0:
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MW-=3^UIJ%_I_@/2"+J^T_P ,R:K"GB&]TLL+J"QVMN:,J"P&X(&*\@$UYO\
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MZ$5X)X[_ .3T/A=_V+^J_P#LE 'T!1110 4444 %%%% !1110 4444 %%%%
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M@FAVA!.\F0,HS# )YS7UA7FWQ/\ @AI_Q&UW2?$$&JW_ (<\2:9&\-OJFFL
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M'_8#M_\ T&O9+K_CVF_W#_*O&_V+_P#DU7X8?]@.W_\ 0: /::*** "BBB@
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MB[X5\5^$OBYX4^)WA3PS)XM>UTN?1=2TJVG2*<QR%721"Y"G:R8(ST-?0%%
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M?$)]:N;"^T]%O+FWFTQ8([L6Z#:Q20ABBC(QSR#6I\5/!/B3X@^+O#_CK1O
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M*9^(7_16;_\ \ (_\:]KHH \4_X4S\0O^BLW_P#X 1_XT?\ "F?B%_T5F_\
M_ "/_&O:Z* /%/\ A3/Q"_Z*S?\ _@!'_C1_PIGXA?\ 16;_ /\  "/_ !KV
MNB@#Q3_A3/Q"_P"BLW__ ( 1_P"-'_"F?B%_T5F__P# "/\ QKVNB@#X[_:#
M@^*/PA3X<FP^)EW>_P#"2^,],\-S^98I^ZAN2X:08/4;17K/_"F?B%_T5F__
M / "/_&N(^,WQ=\8Z9)KGB:Z^'MC??#WP3J)N99]3EVW<K6^-UU;(>/EW/M[
MG''6MOXD?M$Z_HWQ?U3P5X:L]"E&F:?8W-Q/K&H"W)FN6GVQ(.Y"0AC_ +XH
M W/^%,_$+_HK-_\ ^ $?^-'_  IGXA?]%9O_ /P C_QKU_1IKNXTBQEOXXXK
MYX(VGCB;<BR%06"GN <X-7* /%/^%,_$+_HK-_\ ^ $?^-'_  IGXA?]%9O_
M /P C_QKVNB@#Y?^-/A'XE_#3X4^*/%-G\4KRZNM*L7NHX7L8]KLO8\UT'A7
MX7_$;7O"^CZG+\5KZ.2]LX;ED%C'A2Z!B.OO61\1/CEXITGQ'-:Z[X-L7\ 7
M.IKHQBNI\WEV'8+YJ1?Q)D_D#5CXQ?&+XF?"(C^S_"&C7VE37L>G:1;K>E;B
MYW$!%"8XP,D^@% '2?\ "F?B%_T5F_\ _ "/_&C_ (4S\0O^BLW_ /X 1_XU
M[!I4MS/IEK)>Q+!=O$K31*<A'(Y /L:MT >*?\*9^(7_ $5F_P#_   C_P :
M/^%,_$+_ **S?_\ @!'_ (U[710!XI_PIGXA?]%9O_\ P C_ ,:X'P!X;^)O
MBWQ[\0]"G^*%Y#!X;OK:U@D6QCS*LENDI)Y[%B*^D?%_BO3? _AO4-<U>X6U
MT^RB,LLC>W0#U)/ 'J:^</"G[4RZG\';SQYIG@X6OB36O%#>';;3'8(\]T)1
M!$9F[8&,^F* .\_X4S\0O^BLW_\ X 1_XT?\*9^(7_16;_\ \ (_\:M_"#XO
M:[K_ (RUCP)XVTRUTKQCIEE%J3)8R^9!-;2,45E)Y!##!%>P4 >*?\*9^(7_
M $5F_P#_   C_P :/^%,_$+_ **S?_\ @!'_ (U[710!XI_PIGXA?]%9O_\
MP C_ ,:/^%,_$+_HK-__ . $?^->UT4 >)M\%_B"ZE3\6;\@C!_T"/\ QKOO
MA)\/+?X3?#3PYX.M+F2\MM%LH[..XE&&D"C&37744 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5\=>-M5\3>&-*^+GPR3P?JNHWOBW4;Q](U*
MU@+6ICO<Y:1_X?+W-GZ5]BTF 3G'- &7X5TAM \,:3IK-N:TM8H"?4JH!_E6
MK110 4444 %%%% !1110 4444 %%%% 'Q;\2/BGJ'Q$^+&K:-XP\'^*!\//#
MVH*MIIUCISNNL3Q,#YTS#@P[L[4[X!-:GQRL= 3QY\08-9^$%_KVJZY86ZZ7
MK>GPF;[61;^6JLW_ "Q=')7/I@U]>;%]!^5*0#VH Y'X/:'J_ACX3>#-'\03
MFYUVPT:SM;^8MNWSI"BR'/?Y@>:Z^BB@ HHHH ^,OC[>:M\4M1;1!\/M7L_B
M3I6J1IH6N0(S6<48E5A.9.F-N[(->OZEX-U7Q=^T=X7O-7A>71_"VA&YBE*_
MNI=0F8HS#W5%_#=7MN!G..:* %HHHH **** /%OVC?A=XU^)DOA0>%M7TZQL
MM*NVO;RRU*$R174B@>3D#J%;+8]0OI7S9\/OAAXXL/V;O'-KXTT&YU61/&MQ
MJ=K;Z0I@O8<79>2[ASUYVN@[@$=Z^_*3 ]* /D_]EGX>:G/\:O%OQ%N5UTZ=
M<Z1!H]O<>(UV7=RZR;W;9_"@PH'J2:^L:0 #H,4M !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>8?
M'GQ_JWPTTKPSK=C);II7]O6=GJ_GH6/V6:01LRGL5+ Y] :]/KA?CCX"?XG?
M"7Q1X:AV_:K^R=+=GZ+*!E#^# 4 >3K^T5KK?M7'P;Y5LO@-6&CF[9#YAU/R
M'G*ANF-H48]6%3>$OVKK.Q\)7FO^,HYH#J6NWMEH.EZ=;-/=7%K ^S>$7)89
M5R6Z"N,3X#>/H?V6$<6L4WQ=.KMXHD2608-[YG"!_3RPB_A6%\6_V6=:B7X1
M^(+/2-5UJ'PQHDNG:GI&@ZC]CO3--B226.3.#^\+Y'?- 'T'=?M0> ;;P'9^
M*UU&>>TO+AK.&RAMG:\>X7[T/DXW;U[C'%8VJ_M(:;KVC^#M5\*W.VVOO$\6
MC:G#J,!AFMD,$TC*Z-@HW[M3D]J^=M7_ &3=??P=X6UZV\*:Q;O8:Y=ZG>:!
M!KQ.J2Q31A%D%QT$OR@E<]ZZ'2_V6;WQAX!M]-O/#&L:!8ZIXPMM2U"WU#63
M<7[6<=K+$7DD'W2=RKM!/!H ]ZUG]JGP'I&@1:N)]0OK:YOY=/LDL[&262^D
MC&7:!0,N@[N.*[OX>_$#2/B=X6MO$&B-.;&=G0+=0-#*CHQ5E9&&00017RUX
MM^$/C2/X::'X:U_P?<^+X?"FH3VUCJ>@7XL=1:T*#R)H2, ''R2*>I4&O:?V
M7?#OC;PS\.;BV\;W%U+<OJ$\NGPZA(DMW;V9;]U'.Z<-(!G)'J* ,WP[^V;\
M,_$^N:9IUE?WXCU&\_LZ'4)K&1+3[47*+ TI&T.6& .Y('>KNH?M;_#K3?&D
MGAZ;4+O]U?\ ]ERZLMHYT^*[R%\EKC&P,&(4\\-Q7RM\"M+\:_%S]FSP]\-K
M#P<]IH=SXHDOIO%OVE%ABMK?6WGD*K][S]T10#WS7=7/PM^)-C\(_$7P%M?!
MB7EGJ>J7\D/C.6X06BV=U?/<F5U^_P">BRL !_$@(- 'NUY^U/X%L_'\OA(R
MZC->0WRZ9->P6$DEG'=-MQ$TP&T-\R@^A.*A^ ?[047QG\0^/]+_ +/N[)_#
MVM2V,+2VKQH\*QQ8)9N"^]GX]-I[UX3XV^#_ ,0(OB]JUYX,\,ZOX:UF]UM+
MO^W-/U-3HEU;;XRSW%L_/FE 0VT9++D&O1O"/P@UO5_%7Q)\/ZRNO^&M,N?$
MK^(+#7='O5A2\26V@B\H\$Y4QL2"/2@"&;]L#3_!/QF^)'ACQ:+IM.T26S^Q
M-IU@\QABDB9I))F7.%!QR:[WQU^U+X&\"-8B:;4-7%W9KJ"MHUE)=*ENPRLC
M%!@ BO';GP9\1/AGXZ^+$.D^![KQ=I?BZWL["QU1KR,2(4MFB+S[L$KELDCN
M*XJ_^ GQ2\(:?I?@EK+7/$6@0>&X-,LIO#^HQ6<,=R%;S3=,1O9<L,8/04 ?
M1GB']KGX>:#;://'=W^KQ:G9+J,9TJQDN3';$X$D@4?*,@]?0U=\:_M1>!?!
M#Z;'<7%_J4U]:K?+#I=E)<O%;GI)(%&4'U]*^79OV??''ACP%X%M#X+UA_$F
MG:$NGQZQX5U=8)[>X$CG9<*_RR1<@@X/4U+XE_9O\>:;XJMO%'B71_$'C74=
M6T.SLKL^&-8%@\%U$I5O-' 9#P<CH<T >O\ Q-_:<;2O$3R:-KMG:>$YO"<.
MNPZJUJ;C:[W@A!V@Y(*D#'8G/:NF\5?MC_#KP/JNH:7JEWJ,ESI+QQZG/;:=
M))#:;XT</(P&%4AQS]?2O _&W[*?C&3P0NDZ'H"VR_\ "&0:8MH;WS_*N?[1
M6=H_,;EL("<]*]3NO@MXEE^'O[1>G#3D-_XNBE32E+#]_G2XH%!/;]XK#F@#
MT+X@?M0>!OASK4>EWT]_?W?V9+R<:59272VL+C*O*4!V @$C/;FO4-)U:SU[
M2[/4M/N([NPO(4G@N(CE)(V *L#W!!!KX8\=_LU^(]%^(NOZY)X7\2>*K?Q)
M8V"PCP[K?V%;6:&T2!XKA<_,F8PP8=F(K[#^$/A#_A /A=X4\-_95LCI>FP6
MAMDF,RQ%$ *!SRP'3/?% '7T444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% &7X:\,:5X.TB/2]%L(=-TZ-Y)$MX%VHK.Y=SCW9F)]S6I110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!G>(M:C\.Z'>ZG*A>.UC,C*O4@5Q6F?&2WNKC2Q=Z7=6-MJ+!+>XD'RL3TK
M>^)Z-)\/M>5%+,;5@ !DFN&\!?#";5-'\.7^JZK/<V]JBSPV3+A4;M0!WVA^
M-K+6'U@,?LJ:;<FVD>4X!(&<UL6^K65U:M<PW44ENO617!4?C7@U[<OI\'B9
M)=/:X@GUXAG=6V1C:/F('45C65MJ*Z3XEAMQ,]@FIVTTR0HR!K?)W[1Z=* /
MI*UU:ROH'FM[J*:)/O.C@@?6LCQ%XWT_0O#%_K:2K>V]H!O$# GE@N/UKRWQ
M+_9]]X0\2)X0L+J+Y8#/(BLJ.N1N"CU ZU@:U9K<^%_%D^EN?L9T^".2U@A9
M4,GG(0PS_%C.: /H/2M=LM7C4V]Q'))L5VB5@67(SR*DAUBQN+MK6*[ADN%^
M]$K@L/PKPNWMOM/BGP\/"5M/;7<.E7"Z@Q4J/,,)$8;/4[ZKZ7!%+I?A2VTJ
MVN8O%T5ZC7TC*P8 %O,+GN.: /HBBBB@ J&\O(;"UEN+B18H(EW.['  J:J]
M]8P:E:2VMS&)H)1M=&Z,* .>\(_$+3O&(U:2T)6VT^3RVF?@,,9W?2JVB?$[
M3_$=UK<.FQR70TR,.60?ZW(/"_E6-\,]+CBU[QW:M;B.U>_V+'MPI38!@>U,
M^'VFIIGQ.\8Q06_V>V5(%C55PN #TH O:)\6%U?Q+:Z*^C7MI<SJ7S*F J@'
MYC[<8KT"O/OAK$^M:SXB\1W*MYEQ=-;6P<8*0Q\ #ZG)KT&@ HHHH **** "
MBBB@ HHHH *P/&?C33O ^DO>ZA+MX;RXA]Z0@=!6_7'_ !4TBVU#P5J\\ELL
M]S;V4WD,5R5++SC\A0 :M\2+33-#T.]6VEN;C6%4VMI$,NV5#'\@151/BI!>
M>';;5;#3+N]$DSV\L$29>%UZAA_GK7(:COT2'X4:[<0R'3]/M6BN6523&9+=
M54D?4&CP]JE[X<^%'C'6X[:6&34=4NKJR3;\P69D1&Q['G\* /0/ 7CR+QW;
MWLT-E/:);2^23,,;FYR!],?K755B^#/#\?A?PQI^FH,M#$/,;N\AY9C]236U
M0 5RGC'XCZ7X-GM;:X<RWEQ(D:P)]X!CC<?:NKKS'XU:);MI=G?16H>]>_M4
M:55RVT/T^E &[XQ^)%KX3OX[+[+-?71B,\D< R8XQU8U7U+XKV-O;Z:]C:7&
MI27UN;I(X%R5C'4FN3\?W!\-_$'4-0NX97M;_2'MH7C0L/,P1MX]<UCW/BB?
MP;X'\,Z"8'M-1N;0+/>^46:VC/4<=Z /9_"WB2U\6Z);ZG9EO)F!X88*D'!!
M^AK6KF/ALFF1>#[&/2"[V2!E#R*59FS\Q(/J<UT] !1110!QGBOXEVWAK5VT
MV.RN-0NH[?[5,L"Y\J/.,FFZI\4M-M++2IK**74IM3C,MO! ,L4'WB?3%<7\
M68[?3_%\MVEQ?Z?=7.FF)I+>+>EP-QQ'[-_]:N2/A.\\.0>"Y]6EN["S6QFB
MFFM02\3LS,JG'3.10!]!>&M?A\3:/#?PQR0K)D&.5<,I'4&M2N)^#\^HW'@N
M)M2\POY\@A:5<,\6?E)]S7;4 %%%% !1110 4444 %%>:_%WXN2_#R^T+1]-
MTU=4UW6FE%K#+*(HP(U!8LQ^HJS\/?BC-XDT_5V\0Z6_AN\TE@+KSVS"5(R&
M1^A'%<7URC[9T+^\O)VVO:^U[:GG_7\/[=X;F]Y;Z.VU[7VO;7T/0:*Y[3OB
M#X;U;2I]2M-:M)[& XEG60;4^OI55OBMX0079/B*P M,>=^^'R9Z?Y%;.O12
M3<UKYHW>)H))N:U\T=2Z*ZE6 93U!Z&A45%"J JCH!VK#OO'?A[3-%@U>ZUB
MTATV<9BN6D&U_IZT/X\\/1Z7;ZBVLV:V-P2(K@RC8Y R0#ZT_;4]N9=]^A7M
MZ2=N==]UMW-DVT+!@8D(8Y(*CDTJVT2A@(D 88.%'(KC-*^*.G:MKU[##/:/
MHT%FEV-16<$$'KE>P]ZUM-^(/AO6-5&F66M6=S?E-X@CE!8KZCUJ8XBE/:2[
M?\,1#%49[36KMOOZ=S=CMXHE*I&B*>H50 ::MI L;((8PC=5"C!K&T_Q[X=U
M769M*L]9M+C48L[[=) 6&.OUJLOQ/\)M=06P\06'G3*SQIYP^8+G=^6#3]O2
MM?G7WHKZQ1M?G7;='2)!%$S,D:HS=2J@$T+;Q)(9%C17/5@HR?QK"LOB#X;U
M'1[K5;;6;273K5S'/<B0;(V]#Z5S'C3XX:'X?^'>I^*](N8-=M[!XHY(X).A
M>14Y].N?PJ)XJA3BYRFK6;WZ+=F=3&8>E!U)35DF]^BW?F>D45SOA?Q[H?B[
M,6FZG;75VD:O-;Q2 M'D \_G715O"<:D>:#NCHA4A5CS0=UY!115+6M9L_#V
ME76I:A,MO9VR&265NB@53:BKO8N4E%.4G9(M+$B%BJA2QR2!UH6)%=G"@,W5
M@.37EO@?X^Z;XUTCQ=JL%C<1V&@RE!\A\R<;=P(7J":K^!/CK=>(_%UAH6L^
M'9]"EU.T:\L'D;=YB \AAV->>LPPTN2TOBVW[V_/1'F1S/"2Y.6=^?;1VWMO
MTUT5]SUN.-(AA%"#KA1BG5YKI/QNTS7?C%<^!+"$SO:V;W$MZ#\F]652@]<;
MNOJ#7I5=5*O3KINF[V=OFCLHXBEB%)TI72;3]5N%%%%;G0%%%% !1110 444
M4 %(RAU*L RG@@]#2UPWQ;^+>D_"3P\U_J >>ZD1S:VD2DM,5 )^@&1D^]95
M:L*$'5J.T5NS&M6IX>FZM65HK=G:M!&\8C:-6C'12./RH,$;1>68U,?]PCC\
MJ\[\1?&_2/"GPQTOQ;J2.CZE8K=6UC&"SR.8@^T>PR,GM5*[^-SK\-O"OB2R
MT.XU&_\ $311VNGP\[6<$Y9NRC'7WKEECL/%N+EJES?)[??<XY9CA8MQ<]4N
M:WD[6^^ZTW/5:*X3X6?$\?$1-9M;G3I-)UC1[D6U[9N=P0D$J0>X(%=W732J
MPKP52F[IG71K4\1356F[I_\ #?F%->-)0 ZA@#G##-.KS#XJ?'C2/AIJ>GZ4
MT;W^K7<\49MXP<1([;0S'M[4J]>GAH>TJRLB<1B:6%INK6E9'I<L$<V/,C5\
M=-PSBFR6D$QS)#&Y'&64&O,OB=\;'\#^($T73-%EUS4$M'O[E(WVB&%>I^M4
M]=^/DJ>']%U30/#USK$6H6+:@[EMD<,2]0S?WO:N6>88:$I1<M8[Z/\ I[ZV
MV.2>9X6G*<'+6.^C?Z:[ZVV/7(XDA7;&BHOHHP*?7/\ @'QC;>/_  AIFOVD
M;PPWL0D$<G53W%=!7="<:D5.#NGJCT*=2-6"J0=T]4%%%<_XY\;Z9\/O#\NK
MZK(RP*PC1(U+/)(<[44#J3@_E1.<:<7.;LD%2I&E%SF[);LW)8(IB#)&KXZ;
MAG%+)#',NV1%=?1AD5Y-%^T%9#X(V/Q!ET^0"]<Q06"-EGD\YHE7/N5S56V_
M:*2'0/$4FI:#=VWB#19HH9=)A'F.YDQY9!'8YY/:N!YEA5:\]US==FFU^";M
MOH>:\UP:Y;SWCS+1[--K[TF[;Z'LJJ$4!0 !T I:\V^&_P 6Y_&'B74_#FKZ
M-+H>NV,"736[/O5HF. <^N:])KKHUX8B'/3=U_D=U#$4\3#VE)W6W;5;Z,**
M**W.@**** "BBB@#P_\ :+MH;J_\/)K7AF?6O#.7\Z_T\,;NQFQ\K*!SM/&?
MI7BL_A#QGK/@/QK;>'X]8E\(I=VLME!J@)NID1@90 >2.^#UP*^V2 >HS0
M, <5X&*RB.*JRJ2FU>^RUU5K7ZKK9]>I\UB\DCC*TJLJC7,GLDGK&UK]5UL^
MO6Q\<:OX<N==\->/]5TRWU%TN--AM?)&G?98I7$BG*H.2P&0377VOPYMA\6=
M.)T,?85\(@-F#]V9]F.>,%N?K7TQM&,8&*,#TJ(Y-334I2N]'MV;?=]R(9%2
MC)2E*[NGMV;?=[W/CGP;H5_X=LOAQJ^OZ+>W_AS3TO(+BU%N9##(S_NV,?<8
MJO=> M3U>]T^Y.C74'AG4O%8N+33Y(R#%;[,%F7^$$]J^SMHQC QZ48'''2L
MO[#ARJ#GHK=.R2^ZRV,?]7J?(J;J:*W1;I);]K+;N?,7COPA/I_CGXCP:7I<
ML6GMX7BAME@B.PMS\JX[^U9-WX OK;3?@JVD:;+9ZJ;*YBN;E(BK([6Q"F0]
MOF/>OK/ ]*,#CCI6\\GIRE*7-OY;>\I:?D=$\CI3E*7-N^VWOJ>GW6/CCX7^
M%-1?5?!FE7=OJ-GK6D7TLUR\>G! N,[]\_\ &K@X_&H-+^'DS_!_X?\ FZ'*
M=1?QO']K+0'S/LQFE#;N,[-N,]J^SMHSG S1M'H*PCD=.,>5SOHUM_A\]_=_
M$YX<.THQY7.^C6W^'SW]W\3Y&\1Z=K'A35_C#_9?ATW6G3ZOI12)K8O$D6QC
M)*D?1]K!>!ZUQ^N^'-7N-"^*JP6.I74&HVVF36I>R,/VC;,@8K&.!CGCKCFO
MNG:.>!S1M'H*57(XU+KVCM[W3;FYO_DOP%5X>C5NO:M+WM+;<W/Y_P!_\#YN
M\#Z;_;/QN\)7VA:#=Z+8Z-H\MMJ\DT!A620IM1/]HA@3FOI*D  Z#%+7M83"
MK"QDKWN[[6Z);?+[SW\%@U@X2C>[D[[6Z):+T7WA4-W9P7]M);W,23P2##QR
M#*L/<5-17:U?1G>TFK,\%^'LTW@;5/C'JT^ESO;QZD9K>!(3^_ C  08Y&<#
MBN$^'_B#5?'NO:MJ=W8ZI:>/-2LY;33Y;BT9+/3HST53ZX[^M?6F!SQUH"@'
M@ 5X<LLD^2*J>[%MVMU;;OONKZ=MSYZ64R?LXJK[L6W:V[;;OOHU>R[;GR7\
M-?AUX[\#?';PS;W<%D\4&B2QSWD,;%'B:?<^YCUE+<_2OK6DP,Y[TM=F!P4,
M#"5.$FTW?7IHE^AW9?E\,NA*G3DVF[Z]-$K?@%%%%>B>H%%%% !1110 4444
M %<%\<=&35OA;XH*68NKY-,N4M\)N<%DY"]^<#I7>TG6L:U-5J<J;ZJQA7I*
MO2E2?VDT>2/X?-U^S-%!-8>;J4'A)XHHWCS(DAL]I4#J#G KB)?&^N_"[]F7
MP1%I>C7-UX@N+6.V1/L[.;3@EI&7'4<8'J:^DL<8[4;0>PKSJF ;UISY9<O+
M>WIKZZ'EU,M;]ZE4Y9<G)>WFM?70\?\ V;9M)_X1W4[>PL]5COA,L^H7VK0&
M.6\F<'+<]0-N,=N*]AI  .@ I:[L-1^KT8TKWMY6/0PE#ZM0C1O>WE;\-0KQ
MC]ICPZ=0\+Z9/8Z>;B^;6+(R20Q;I"BR@\D<X%>STA&>M+$T%B:,J3=KBQ>&
M6+H2HR=KK<^</B_'J'@WXLZKK_\ 9%[J>GZUH$FG1-9Q&0I/@@ @= <]:HF6
M^\%?"+POX0\3^&-1N](N=*(N9].#--%/R5B(7H#ZU].D ]1F@@'J,UYDLKO.
M<XU+<U]+)K5IOUO8\F647J5*D*EN:^EDTN9IROW3M\CSK]GRQUG3?A-HEMKD
M!MKR-&"0L &2+<?+##UVXS7HU%%>M0I*A2C23ORI+[CVL/16'HPHIWY4E=^0
M51UG3[?4+"1;B!+CRP9(PZAMKA2 1[\FKU%;-*2LS:24E9GR/;>"];G_ &0?
M!2PZ9<R:CHVH#4); H1(R+=2Y&T_[+9Q6I9^,-5T/4_B5\2K/PY?3PZD;6ST
MRRGMV$DKJH!<KU"@U]1X&,8XHVC&,#%?/K*.3D<*C3C%+;K&+BG]S>GH?-+)
M.3D]G5:<8Q6RWC%Q4OND].]CP+]FK5+;4]3U:[OK/5G\67\0N+_4-0MC%'@$
M 11Y_A&>GM7OU(% Z "EKU<)AWA:*I-WMUM;^F>S@L,\)05%RYK=;6O^>O=]
00HHHKL.X**** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>aciu-20231231x20f022.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f022.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &: 8(# 2(  A$! Q$!_\0
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MM_5OF-)6N_Z_K?Y'WU\;_P!HWPK\!?A'_P +'UV+4-1\/$P!!I,4<LSB;[A
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M1:!KGB#3K/[.+4R2-Y]VCXP^XJJ"0<?O00<XJ4_=3[I/[[?YEVO)I=&_PO\
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M,15]L535BNK"BBBI **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-&%CV;MS@;5/SK@$@GG&<&GZQKEAX?TB^U34+J.UT^RA>XN)W/RQQJ"S,?H
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M]*LY_LLMPAW1()9Y63=E<G&#Q7V3JFM:/X;_ +-BO[JUT\7EREG9)*RIYD[
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M>, ]>:^DS:PDQDQ(3'RA*CY?IZ4VXLK>Z9&G@BF9#E#(@8J?;/2H4;)*_?\
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MZ)AX3_\ !/!_\31_PRU\'O\ HF'A/_P3P?\ Q-')'>PO94[WY5]QH1>/?AG
MCI'XA\/HKW/VQ@+V/F;CY_O=>!^558_%7PHBDN9$UGPXK7*/'+B[B^97^\,;
MN >^*A_X9:^#W_1,/"?_ ()X/_B:/^&6O@]_T3#PG_X)X/\ XFCDB^@.E3>\
M5]QHR>/_ (:3),C^(O#[+- EM(#>Q_-$N=J'YN@W-^=5!XJ^%(OC>#6O#@N?
M-$WF?;(\AP00WWNO YJ'_AEKX/?]$P\)_P#@G@_^)H_X9:^#W_1,/"?_ ()X
M/_B:'"+W0.E3>\5]Q<T[QK\+](O6O+/7O#UO<L"#*EY'G!.3_%QDU=E^*'P]
MGOK>\D\4:$]U;JZ12F]CW(&QN Y[[5_*L.;]EKX/>2^/A?X3)VG &D0#_P!E
MK/\ #?[+7PC.B6GG_"KPM!+L^:.33()67GNVWFJ24=$BXQC!6BK'0:MXV^&&
MN7,5Q?Z_X>NIHUVJ\EY&2%SG'WN1[4^W\>_#.UDL)(O$/A]'L(C#:L+R+,*$
M %5YX& !6?\ \,M?![_HF'A/_P $\'_Q-'_#+7P>_P"B8>$__!/!_P#$TRBQ
M%XL^%4-Y-=)K?AQ9Y0P=Q>1<[N&_BXSWQ4MSXW^&%VENLVO^'I%MXUBB#7D?
MR(K*RJ/FZ JI_ 52_P"&6O@]_P!$P\)_^">#_P")H_X9:^#W_1,/"?\ X)X/
M_B: (_%OBOP#XBLYEM_&'AZUNII(WEDEGBE68)D!74L"1SV((]:?X*\7?#_P
MAHDU@/&.A3FXFDN)RMW$B%GZA5W' P ,9-+_ ,,M?![_ *)AX3_\$\'_ ,31
M_P ,M?![_HF'A/\ \$\'_P 30!MVOQ3^']E916D'BK0XK:*,1)$M]'M5 , #
MGIBL637_ (1R[-^K>&V"1B(#[7'C:.@QNYQFD_X9:^#W_1,/"?\ X)X/_B:/
M^&6O@]_T3#PG_P"">#_XF@"U_P )A\+/[2%__;GATW@QB4WD6>!@'KUQQFH(
MO$?PEACNHTUCPVJ7,9BE7[7%AD/)7&[@'T%,_P"&6O@]_P!$P\)_^">#_P")
MH_X9:^#W_1,/"?\ X)X/_B: )XO%?PJ@LKFTCUOPXMO<$&5/MD?SXZ9^;MV]
M*O:3\1_AQH5J;>P\2Z#:PEBY6.]C&6/4GGDUE?\ #+7P>_Z)AX3_ /!/!_\
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M1)HI^+^K#0AI8NQJ7]CP;3/YNTQ>F=O-?45% '@?_"C/BI_T7/5/_!1;T?\
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M?^#U_P#XW7T'10!\^?\ "9?M(?\ 1//"'_@]?_XW1_PF7[2'_1//"'_@]?\
M^-U]!T4 ?/G_  F7[2'_ $3SPA_X/7_^-T?\)E^TA_T3SPA_X/7_ /C=?0=%
M 'SY_P )E^TA_P!$\\(?^#U__C='_"9?M(?]$\\(?^#U_P#XW7T'10!\^?\
M"9?M(?\ 1//"'_@]?_XW1_PF7[2'_1//"'_@]?\ ^-U]!T4 ?+/Q#^.WQT^$
M_@_4/%GB7X>>&1H.F>7)>&SUIWF$9D5"44IR?FKZ@L[@7=I!.!M$J*X![9&:
M\-_;I_Y-.^(G_7G%_P"E$5>UZ+_R!K#_ *]X_P#T$4 7:*** "BBB@ HHHH
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M7;X8*7"8X[_*: /OS_AG_P"&O_0BZ#_X 1_X4?\ #/\ \-?^A%T'_P  (_\
M"N9@_:K\&SP1R"UUP!U# ?V5+W'TJ3_AJ;P=_P ^NN?^"J;_  H Z+_AG_X:
M_P#0BZ#_ . $?^%'_#/_ ,-?^A%T'_P C_PKG?\ AJ;P=_SZZY_X*IO\*/\
MAJ;P=_SZZY_X*IO\* .JT_X+^ ] O(]0TWP?H]E?V^7AN+>S1)$;'56 X-=)
MX:79H%BIBD@Q$/W<S;G7V)[FJOACQ59>-?#4>KZ>EP+6=6VI<1&*3C(/RGD5
M9\+H(_#U@HAEMP(@/*G;+K[$^M &I1110 4444 %%%% !1110 4444 %%%%
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M_$T >O\ EI_=7\J/+3^ZOY5Y!_PUA\./^@K<_P#@%+_\31_PUA\./^@K<_\
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M/[*LO^?.W_[]+_A7DG_#7OPI_P"AF_\ )2;_ .(H_P"&O?A3_P!#-_Y*3?\
MQ% 'K?\ 95E_SYV__?I?\*PO&OPW\/?$#P]-HFL:=%-83212NB*$):.19%Y
M_O**X'_AKWX4_P#0S?\ DI-_\11_PU[\*?\ H9O_ "4F_P#B* /6O[*LA_RY
MP?\ ?I?\*7^RK+_GSM_^_2_X5Y)_PU[\*?\ H9O_ "4F_P#B*/\ AKWX4_\
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M;2/_  3C_&@#UO\ L73O^?"U_P"_*_X4?V+IW_/A:_\ ?E?\*\D_X0;XT?\
M11M(_P#!./\ &C_A!OC1_P!%&TC_ ,$X_P : /6)]%T_R9,6-H/E/)A7'3Z5
M0\-Z-8-H5D7M+"9C&,O! H1O=>.E>9R^!_C0(G)^(VD8P>NCC'\ZM?#_ ,*?
M%&UNM(N=5\;Z1?Z.A#36=GI@C$B>BL#Q]: /5/[%T[_GPM?^_*_X4?V+IW_/
MA:_]^5_PJ[10!2_L73O^?"U_[\K_ (4?V+IW_/A:_P#?E?\ "KM% %+^Q=._
MY\+7_ORO^%']BZ=_SX6O_?E?\*NT4 4O[%T[_GPM?^_*_P"%']BZ=_SX6O\
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MT5X3_P ,JQ?]%%\:_P#@T;_"C_AE6+_HHOC7_P &C?X4 >[45X3_ ,,JQ?\
M11?&O_@T;_"NK^&_P33X<Z[-J:^+/$6N&2W:W^S:M>F:)<LIW!?[WRXSZ$T
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M'&:]5H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
?"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>aciu-20231231x20f023.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f023.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %, 6X# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z3/..]+
M7Q)X*^(>I?\ #06F_%J72M9A\*^,=;N/"0U69HSIKZ=\L6ER1J)2X9[J"0AC
M&H(OSS@+D ^VZ*** "BO*?B=>:AHOC31'C\3ZAIFF75M>W-S AB$2"WA5P03
M$S 'DMU/I6=8?&/Q#JTD-A:66F_VC-JD%BDTZR)%LEM&N Y7)88VXQGD$<*>
M  >ST5X;<_'[5+..ZNWT_3IK80:A-%:13.;F'[-*L0$XZ)N)+<#[H/IDZ&B_
M$SQ+K/BKPI9SK8:?;75Q>P7('*W0B2-E:/DE#^\(VDYRISQB@#V*BO*KSXN:
MG'X\U;1X-,MVL+!W@=I'(FW"V\X2XR 4R0NT<XRV>,5BV7QQU^2SMH[FQTB"
M\OQIDEM<M+(MM#'=QRN#-GG(\HC@X)<#/'(![?17B5A\>M0O+#1;G[)822W$
MR)=V\!D?:CWK6RNKG"@$*6'WB>>%'-0W7[0&J6<5W=MI^G36WV:]N(;6*9OM
M$'D3I"HN!T7)8L<#H#Z9(![G17A^H_&[Q-9:8)AI&FB:WMKZ[G:21]D\5N8>
M8MI)4L)2,-T*^G4U;XZ>(-,DDT_^R-.DU6&\NH'<2O\ 9W6&*&4(I."'83 9
M/ VDXQP #W"BO(+WXL^(?[<N;6'3["WM/M1TZ/SBYGCG-A]J4L!\I52-IP>>
MW3GM_AAK-]XB^'V@:GJ4\%S?7=I'-+);C"DL,\CLPZ,!P"#C% '45&;B(3"$
MRH)2,B/<-Q'KBI*_/K]I2>VL/CW\2-2:70/[5TV;PO>V=M,[)XBNEC<NT&DL
M#D/(1L(VL#N(; .0 ?H+1110 45\\?$J\UU?''BJYMM1O;'3K"73HVOH;Z=1
MIJR("THMU.R5>/FW=,YP1G%^\^,/BV+5O%RV]O93C3H[SRM.9?WT2Q,HBGP&
M+2*P)<\ 8(VD\T >\45\^Z%\4;_1]8O;NZ\10ZMHT^K-;R:GY)6#:-.#QB-<
MG9F50,#.XYQUK3\-?%/7]=U'1K:]U6RT:6ZL+*2.UEL'EDU!YX2TDD9! 4(_
M&,$#!W8R* /;Z*^;O#GQ/\16FB6,[ZFE[.^D6C76H7,3,+(R7C1RO(@;#&)>
MO /J<<5J:C\5_%IT;[19WED/LMAJE\+QK(M'J,=K+&L;HN\;!(&/.2."1VH
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MG(X !ZGL7G@<]>*-BXQM'3'3M7B4OQ-\3-I5Y)83MJ4L+J1*NENOS^0)#"5
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MC;O&=H/ R0!G IZQ5I+?9_Y_\ =H.-VK/T_7I^)ZC!<W$6A-<7*E&(5_F89
M+=^P[5Y]XEUOQ-#K&A#3)M/AL'N<ZHUU&6D:WVDD1X'#9'6O0( \V@R)M\Q<
MA5##.1OKD+HR3N+?*))"!@JP) [9';/(K>F^5:),Y96O9GD/P$\&^#=(UGQ+
MKG@;Q;KFO6MS<>5-8ZG,TD=BV2^Q XSW[Y(&*]HNM3N9K:2..?;+G@JJ\,._
M3I65H?A^P\.S3+IMK%8Q7,KW,RPKM#RM@%C5N:/RY7E<AL*0J9QGN?Y5345I
M&]O-W_$N<W4GS-W^[]#Q[P#\*_B#HG[07B#QIJWCF;4M N;+[%8:23OSE@Q=
MTP%3;CC S\Q[5[C;75U#]Z3<Y 4EE!RM>>OXY\.Z]JOB#PY!J:_;=*6.74DM
MYQYECGD!\'*\<FNOT_4;;4;6SN+.6*ZL980\4D;[MZ-C:1ZY]:2HRI*TFWZ^
M>J_KYCJU95GS.RZ::;&O-X@N0JJ"<R.0N8U^7COQTJSX1UG^U]6F1IX;B6W5
MDD\G;B-OE.TD=#@@X/8@UX;^T7\?+3X">%8YDT;4=7UJ\AG;3[;3;)KB.)8M
MFZ6;'"(HD!YX8C;D9KT#X"ZC:WNE:%)9P75D+W2AJ<UKJ$>V[#S,K&28XQO9
MMQ/OTP *3BVK_P!?YF:B[<Q[)11161(C,%&20!G'-5X]2LY7B1+J!WEW>6JR
M E]IPV.><'KZ5C^-?"$/C+3K&WE9$>SU&TU&)W0L \,R28QD=0I7/;=FN%\-
M?!74=%U2UU(ZS:V.H>7.MS<Z3:&+.]7"B*)V:*-5W(0"C']RN2VYL@'K=1SP
M1W4+PS1I+%(I5XW4,K ]00>HKSWX,ZGK-T?&NFZUK=QX@?1?$#Z?;7MW##%,
MT/V6VE 80HB$AI7Y"CC'I7HU &>GA[2HC:E--LT-J2;<K @\G)R=G'R\\\5?
M90P((!!X(/>EHH K6&F6>E0&&RM(+.$G=Y=O&$7/K@"K-<I>?%;P;I]QX@@N
M?$^E03>'XEGU:-[I UDC?=:49^7/O[>M3V?Q)\*:AJVE:7;>(M,N-1U:T-]8
M6L=TC275N,?O8P#\R\]1Z'T. #I**** "H7LX);F*X>"-[B(,L<K("Z!L;@#
MU&<#/T%344 %8WC.WN+KPAK<-HDDEU)93+$L7WRY0[0/?.*V:* /*_MGC$07
M<MN^K26D%O*UK]HMHDN)GS$H\Q=A^Z3,5 &2%'#<9K:<_C74A 97O[)V$D;W
M:VL:RLBFY,>0R\9Q!_"#ST!)KT3QEXGA\%>%-6UZXM+N^@TZV>YDM[&,/-(J
MC)"@D#./4@>IKCM6^.%AI6J7VGG2;Z6[A<K;PG;&]XB0F:66+>0&C158%@<%
M@%_B&0"+Q=-XMO\ PY#%-!<P"YL9 RZ0@DE:<HFU)0R_NU.9,[3P0/F'&6VL
M_CB[U>ZAN)[BUMVOE1A!:+MAA\T@&.1@0P,8&3@X)['BNGTOXJ^#M8U:STBV
M\4:0VMW<:RQ:2;Z(7A#1^:/W.[?G8=V,=.>E=50!Y7'=>-[32?LMI:RK*EB;
MQ)&A3 DQY?V?'=@<RCUX&:AW^+;V/2X;Y]3F3[3;O&T%FL:RJMT#)]HS\R8C
M"D?=R,Y!/%>M44 <EXV\)VGB&_T*6?3EO3'>!9F(SMA\N3.?]G<5_'%<?=Z'
M.SWRZ=H^H6^L?:KYI[P1O&DMNWG;%#$X?.8PH&<'!XQ4_P 3/&'Q*T/XH^ ]
M+\)^$8-;\(ZC.RZ[JLDH5K% #@@;AGCGMR .2<4?"WQA\2M>^(WCO3?%_A&#
M0O"^GW*IH6I13!VOHRHY(#'''/?EB,@KB@#5\(^$M;\,6_VJVBTU9KB**.2Q
M1I885"AB9#G>3(2P!X P.IKG;S0M=?0==AU?3KV;4I[WSK6XLY6N464V\8W!
M?DVKD%5.,(>>"-Q]CHH X?Q+>>);76]!:PCGD@>,+<V<* IO)&2TQ4C !/!V
MYQD$GBN234OB,=%C9Y+A9VG_ 'SC3@7B?RR=BKGYX]^!NZ?[6"2/9:* /)-0
M;Q<^J7-QYFI0WD,$R$I9J]L@,\.P0[06):-3DG>5.>.U>D>&;B\N_#^GS:A!
M+;7SPJ9HIBI=6QSG: ,_0#Z"M.B@ JGJRH]A*C]'&WIZU<K-UZ4PV>\ D ]A
M_.@:W.;81"-_.<1[3@2#VX ^E?./Q6\&?$1/C?I>H>$]$\.^'[>:;;<^+UW3
MW MWA82R/$0$+J %3=D$D'GMZ]\2)/".J:,VC^,[W[+HFJPM%-YTKVZOC)9"
MX((XSP",BKJV^@>%_#\+7<RV>EZ; ((YM0<XBC0!5//7@  ]36<HRDTX+7T3
M7]?([Z<O9:M7NK=?\U?T9T&A6[:?8VMI>74NH-!"$:\EP9I^/ON% &X_[( Y
MJ2*\\^WAD9#;!QPLA&X'WQW]JX;Q%XJOK72]'7P7:)K2:CG[+?EV>T4]!O(^
M;;GKWXQ67X@GNS\-(-&\46T=IJ<Z$7BZ/<' D+$ P.0"JGKDC(Y!K2_O*+W_
M !_R^1"IW7-W?]:'?ZGX:TSQ'?QR:AIT-U( %\Z1!N1<Y !ZCIZUG^*/#UIJ
MEI9R3W>H:?#I4IE@:QN&CD5BI0$L#E@ Q.#G/?I69=-KFN_#Z&'PU<VNE:M+
M#%&OVTM,D>T@-EA@L=H//<UUD-F;>UM5OG^V7 C59Y%7 +  ;@.V3S4.$8W<
M7K?S7S_IB4I*UWL;%A;!?#@MEN&E,84>;*^YOOY&3ZUYAX=\(6&@>-O$WB"*
MR6#7-8,*7][N8^>D2;8]JYPH4'G &37I*:>EOX>NA;1>49)!*Q/)D._G.?88
MKR[Q/X\TGPMXO\,>&62\;5]=,D-D]O:--' J#),KCA$[9/U/K751525U"^VO
MFEJ[_=?Y',WNNYT\UO-*C%72W4$9V'(P.OYU%<0S%<QSNH#C!4!LKG)X(]J?
M<7<4*%I9%CMT!>Z=FP$C"G+9_#^=9ND37]Y#]MG'DI<SK+;VLBC=%;XPN[OO
M8?.<]-V.U2WK8J,7R\QE)\-O#6CZAXAUJ#181J>MH&U.XLX]L]^J]$?GYN"0
M>F<\UT%C]GTBUMK/3+54@MXEBBA4 A$ PJX] .U7%MWB+,[%@'PJJ<X'T[]*
M\)^)W[2VA_"WX^>$/ &J0*&\1VDUQ->*=OERYVP1Y)Q\Y5EZC!V]C513>B'[
MU3S-SX._"OQ=X(\=>.=6U_QI>^)-)UZX2:PT^[)/V)?F+*5Y4 ;@!CC"CO7N
MW@^%8M6D$8!C$)!/J<C_ .O7)^'M>L=?@DN=(OX[^!+B2T9UR52:-BLBGW5A
M@^]=IX0S).9&=2?+QM QZ9(]1FLN1Q6K;?=[DU)N<FY)+TT_ ZNBBO*OC;XV
MO/!(M+C^U;[3=-DMIA_H-@LK27 *>6IE8%4SDX7[QP<!L8$F9ZK17)>)9_$]
MAX6TA]+>*\U=;JQ2]S;<31M*BSE5W?N_E+-GYMH!X/6N#\,^*OB7-JUL+O2Y
M[FWV;EBGM!;+.3;NTJO)M/E;)Q'&A_C5BWSXS0!O_![_ )&#XI_]C8__ *06
M5>E5Y)^S[>:E?W'Q*N-7TU-'U%_%<AFLH[H7*Q'[#98Q(%4-D8/08SCM2_'_
M .,^N_"*3P-;>'/!-QX[U+Q+K@TK^S[2]BMI8XQ!-/+(ADPC,L<#D*S*#CEA
M0!ZO-*(8GD8,0BEB$4L3CT Y)]J\7_X:T\)_]"S\1?\ P@M8_P#D:N/L?VD/
MC;+=6*7/[,OB&*&35+BWN'C\0:<Q2T4'RI5!E ,A(&58JG'RNV13=(_:1^.%
MS)H@OOV9-?MQ<-=B_P#)\0Z<WD!,^1Y>Z5=V[C=OV8ZKOH @U#XA?!75;OQ5
M=7?PN\9W%QXJA6WUN1_AYK!:_C7[JR?Z/R!V^E6-/^*7P=TK7M"UJS^&?C6W
MU70K$Z9IEW'\/=8#VEJ1CRD/V;A<<8]SZFO5/V>?BIJ/QH^$^E>*M8\/-X4U
M:>>[M+S1VN!<&UFM[F6WD7> ,_-$>U>D4 >*?\-:>$_^A9^(O_A!:Q_\C5[/
M!,MQ!'*H95D4, ZE6 (SR#R#[&I** "BBB@ HKRSXY?&75?@[:Z==VGA&7Q1
M;7DHMU2TO-EP9B"0JQ"-BPVJ26R *[SPCKY\5>%='UHVKV)U"SBNC:RG+PET
M#%&/J,X/TH O:EIUMJ^G75A>0K<6=U$\$T+_ '71@593[$$BN=U'X6>%=6GN
M9KS1XIYKC =V=\@=PAW?(&_B"XW?Q9KJZ* /#OCA8VUK\5_V?O)MXHMOBRY4
M;$ P!HNH@#CMBO<:\5^._P#R5?X ?]C==?\ IEU&O:J "O/-9A^*YU6[.E7?
M@U-,\UOLRWEK=M,(\_+O*R %L=<#%=OJ6K6FD6[37<\<*A20&8 O@9(4'J?:
MO-OV>_VB_#O[1G@9/$VC66I:'&U[/9+8:Y$L%RS1-@L$#'*GU!ZA@>5- $WD
M?&?_ )_? G_@'>__ !VCR/C/_P _O@3_ , [W_X[7I]% 'G6DP_%D:I:'4[O
MP8VG>:OVE;2UNUF,>?FV%I" V,XR,9KT6BB@ HHHH **** "J&M2>58.P7<<
MCC..]7ZS/$1_XED@R #P<CJ.XH&MSR'XK6</B3P^FGW%V;&TNIU,KQP"X>2)
M#N9$!!"LQ"KNP<9XY.:Q?VCOA)JGQA^'-KX>T#Q&WA._FD21;HQ&1HEQAEP"
M#NP<#T-=]X1EN;S3K*XU&S$-XC2*KQ@$1!F.,$<9V;0<5)XH\0:;X;TO^U;R
M!C+&CJ(7DVJB+R[G&>@YSUZ5$82E)N&[[';SNFTNUSG=/\+O\+_A=H^AZ'J<
M6G0Z%;[7OK^$SK(<99W7(/+'( ))S@9--N?#VI>.-"M6O(X+'40RSQEH>$BR
M.'&2=Q!8X!PNX#DKD^=>%_$UE^V1X&_MC3M3U30O!-]YEG:P6Z&*\-U#*5:Y
M\X'[H&-@(Z\\$5[%)X975;"?3+>[NHT,"6_VAV.7V# )/!^I[FG:4:CC*ZL_
M)_/S]-C5N,()W3D]7H]/+S\R#2-/GT:&8R3YL-B-'#<J%>*52=S%EZAAM..V
M/>NALO+U6>W:";?;.2S%#U '4'ZUGGPY'<:-;Z1+([BS\OYTD*NSJ01D@YQD
M<CN.*T+9Y8H+K8%MF3*G:H(+'T_/]:3;N[NYRNS5UN:37UC<Z=J-C9722SV;
M*LZ!\F-B=P#>G%>;Z'K]G>WUSI0U"W?50[&XMXW'F!1@ LN<@' JKX7AL_@Q
M\/\ QCXB\4ZK)+IWVA)I[IHF>0+YFT$A1ELEP.!7G]_\ O#.D_$JW^)&@I>:
M3X@"2322QW#&*_,BY FC.>#N!^7'3GI759**G9N+Z^=E^7D#A'FE#F]--S7A
M\0:=\0O&&O\ @^ZO)K630=0@N&6UF"M<KMWB%A@_+D_,IZ@#M7I4QDENS,TH
M"O\ *BJ,'.>3G\/TKR7PE\*8O"_Q!N-;M[RZC^WEKZ:+S2Y:X. 02> ,8&?0
MFO798)+JQ4H"K,I*J&(YQ^G6LX6:YNO4JO)748OW5^N_WV*-_<7,%K<%'+L&
M(7@$IG^>/\FOG/\ :=_8UL/V@#'>P^()M)U>2[@G=;C#1I&J@2"-L;D8J,@'
M*Y'0=:^E;:QD(EDED4, %7')/'/)K(N3'H=Y?7^H7,<%A&BS[QN+':N&:7^'
M'3&/QJI:+31DTIN$KP_+<T]%T>VTG1[>SC9D55\L,S9)P,;C[D<FJ?PLL?%-
MOXX5KZX2#18;"6U:Q2/*2S+(ICN(VR2H*$J4;N 13?!FMZ3XJTR9--#K;V;+
MC>I!4GD?45V_A-S'K!MS&5*6Y;<&&WJ.,=??-6KTHN%C%O5W.RKR?XT^*9=)
MU#2M-OH,^';ORWN&1 SRLMQ%E<[@4")F3."#@ XS7K%>7>.])U+4?B-;_8;3
M5?*DT.>WFN[ 6Y3:TR?NB)QMR>O!SQR,8KG(/3H91-$DB@A74, >O-/K/\/Z
M5%H.@:;IL E\FRM8K>,3,&DVH@4;B."<#DCO7(Z;\8M+N]2^RWEK/H\0^T%K
MZ_DC2VQ"SJY$FX@_ZJ4_2-FZ<T 4_@]_R,'Q3_[&Q_\ T@LJPOCE_P E8^ 7
M_8V7?_IEU&K_ ,!-<TWQ)>_$S4M(U"UU73I_%<AAN[*99H9 +&R!VNI(."".
M#U!JA\<O^2L? +_L;+O_ -,NHT >ST444 >-?LE_\D?F_P"QF\1_^GJ]KV6O
M&OV2_P#DC\W_ &,WB/\ ]/5[7LM !1110 4444 >$_M=,\G@WP[9C2M0UZ.[
MU?R9=,TF+?>7"?9;@L(CY,I7 &6(494,-PSSWGP2\6:)XP^&.@77A\31V$%I
M%:_9[F-HYH&2-1Y;AE4Y *G.T @@@8(KBOVK?"FO>+/!-C9:'IUUK,T]_%&;
M>&*W=;8[)<3GS(V8+N90Q4@[<@=3FKXLL?$_@WX(^'6\-^%M1^W.L$NLZ3X?
MN8;*[WNJ^:P9('R0_58U7CH0HQ0![S17C?@?5_%>I_ #4M7L+R_3Q&]M>-96
MNK1?;+FSFB:1! _R0M(X:/&'7(8D98 9S?$?C#XC6VMW\5M!?QV"O<>9)!I?
MFFW54S9^3\A\WS6P)/O;/]CK0!<^._\ R5?X ?\ 8W77_IEU&O:J^;?B?K/B
MF^^,_P  K?6O#EOIUDGB25UU&+4%D:68Z'?ET\C9E &+C.X_='KQ[]XI\00>
M$_#.KZY=))+;:99S7LJ1 %V2-"[!<D#.%.,F@#F?B_\ $7P#\+/#4&O?$34M
M,TC1C=):176IQ[T\Z3.U1\I.2%))Q@!23@ FO//AK\6_!:_%Z/X71:!=+XKC
ML+G7$U./2U%EY!NI%"K./XL$=!M[;L\5R.L?M$/\6?"UBNK_ ++_ (^\4:!=
M>3J%M%J%AID\+D8>*4*]T1GD$'&>:G\%_M.>*[#0EB7]GGXF38N;D[XX=/QS
M/(=O-T.F<'CJ#0!]245YQ\$_C.GQFTSQ!,WA?6O!^H:'J9TJ]TK7DB6XCE\B
M&<']U(Z[2DZ$<UZ/0 4444 %%%% !1110 5D^);*74-.$$4C1[Y%#E%R2N?F
M'MD=ZUJ0G% T[.YYQX@\ WFN^!=5\.6%_=^&_M<#6]O?:>2)[0<;&0GN,<^H
M)JD/A=]O\*Z3X;U\R^(C'"D-YJ%TNUKH+][?CINZ8%>GW1<VTPB8"78=A)Q@
MXXKQJT\&>.M%T_0KZ/7+W7-4M+6-M0MH]2*Q7$WVFW9U"R,5YA%RN20,D8"\
M8=W;EOH:JI):K_@_?N=MX;\!6/A6SMM*TC3K72=)LXREO!9Q>7'&,]%4#BN7
M^('A/XH7US:#P)XJ\/\ AJU$+1W$>L:%+J+O)NX=&6>/8,=B#SS3;7P_X_OC
MXG22YN;"&]CNA#Y^IJTB2,\C6[6Y0'R@BF)&!.#@G'&6QY_ GQ,GO?L=GKMY
M968N5\^\O=2,PFA"+M\L)AU*D/NY7=D=1TE))61#FY.[,'P]\)/C_H,5PD7Q
M3\&SO<3-/)+=>#KAW)./ES]M&%   'I]:Y_X@6_[1_A*72H;;Q5X:U\7]XEM
M</IO@.ZD^QQMG]\V+L@A2!Z=>M>\-I'BFV\9Z,\E[<ZCI,%K%%)<1W,=NAD5
M7$SS0[3YA?,94+@*0>5_B[S</44QJ?O7DKG-Z3IE]9>&TL]3:/4[Q8(Q/,D6
MV.:7)WL$.<#/..< CDUS^J^$]1NX9,Q^9(YW#:Y&"!P,XX%>B9S2TT[*Q%];
MGC'@WP#XYCL)W\57>CW%Z;YVM%TN*2-([/C9')N!W28+9(XZ5UZ:!J$2RAT$
MNP!@V"2?8<5W%<?\3X/%]WH$,'@J6UMM5:Y1WN;Q@(TB3+E<8.=Y58S@<!V/
M& :TE4<I.5EKVT$56\+WC?O! BN1N"%B>?RX-1#P??/<%W6+RRIW1\D.#U#<
M>YZ5A1#XEWM_X:EDM+BS2"^F.HPO<VQBEA:?*'<I+$)"2H&W)(Y X<>N5#E?
M<=['DVB_#W5O"+:M=Z1% 8[E#+'8,"N) #A<]ESCZ5N> =/U=KFUO]>L%M=6
M:U83"(DI'EE^7/0D[<^U=[13Y[JS&Y7=^H5Y1^T-?3Z-X=TO4;>365>.\\AD
MTIY@K+(C)F7RG0X4L'!S]Y5'0FO5Z\?_ &D+03:-H4L4\EM?+=3+#)"J[ROV
M:5G7>_RH"$P<@D]!R:@D].\-%V\.:49'NI)#:1%GO5"SL=@R9 . _J!WS5:'
MP7H5O<V5Q'I=LDMFC);D)Q&#NS@=,_._/7YV]35/X9:]9^)OA_H.HV#,]K):
M(BE[?R#E!L8>7_#\RGCIZ5N6^K6-VZ)!>6\S/N"K'*K%MIPV,'L2,^F: //O
M@U&D6N_%)$140>+'PJC '^@658GQR_Y*Q\ O^QLN_P#TRZC6[\'O^1@^*?\
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MGC+Q#J]I+XBEM$T6^D@-C;E-#OE\V,+$) YV$G=(P^=N.F/:OC5_R1OQY_V
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MJ#VY//>K<_Q?\ PZM_9B6"W-\8X'2*WM8I/,,IC"*&#;?^6R?,2%/S ,2I
M,CX%_&;X?V/P2^'UM<^.O#5O<0^'M/CDBEU>W5T86T8*D%\@@C&*]8\.>+M"
M\86TMSH.M:=K=O$_ER3:==1W"(V,[24) ."#CWKFO"6L^"?'5U=1:3I=M<>3
M:VMZTTFFB-)([A6:)D9E ?(0YQG!X/.1796.FV>F1M'9VL%HC'<RP1A 3ZD
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MHY])LIDBV[%>!2%VKM7''8<"N+^(]Y<#4-4MA<2K;_9-.;RU<A<M>LK'CU
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M"T'A.^O=)O[9IYM?C+>1;,!(=I^0KQY: [G5LS1[5?#[>XHH **** "BBB@
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M1^T;X%\*>)=5\&:QI>OZ_>VEK%<:A:Z5X:N]4@BAE#&/S6BB=!N$;G!_NFO
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M\*]$U-M4N]8@OUDO+6YOH9HYA;22L\$;><!(Q2-D3>_+[=V3G->3>-_B39>
M/"&NVM]807T&K17(E%Q=);JD,%GYDFPNC*\I! 2,C#-U( KWCX?II<'@?0;?
M1;R+4-*MK*&VM[B%D972- @^Y\N?EY X!R* .@KAOB%X:UC7-<\.W.DPPL+,
MW)EFEN1%Y8= HP#%*&SR/N\>HSSW-% &9X8T9/#WAW3=,C4JEI;I %,GF8VJ
M!C=A<_7 ^@Z5IT44 %>7_ [_ (^OB3_V.%[_ .BH*]0KR_X'?\?7Q)_['"]_
M]%04 9OQ<_Y+E\"?^PMJG_IIN:]BKQWXN?\ )<O@3_V%M4_]--S7L5 !7B_[
M*'_)/O$O_8[>)O\ T[W5>T5XO^RA_P D^\2_]CMXF_\ 3O=4 0_'8 _%WX%[
ML8_MW4>O_8(O*;\9;)K6ST?QB+R\E@\(SR:K-I.FZ.FHWFJ*(RHMH0WS(Q+
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MU^,-'\-^"?$-KJEZ+"XE\7^(;J..XC="\,NJ7,D4@R.5=&5@>A# ULV_Q/\
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DD5VBC"X(?:BKN)Y)4 &NRHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>aciu-20231231x20f024.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f024.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 'K \L# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MD)P*_/S3?^"B7B*Z_;/_ .$3FT^RC^#$VOR>$;;6Q 3(^I)&!GSMVT@RLHQC
MA'4YH _02BD!R*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHKYT_;V^//B;]G#]GG4?&GA);)M8M[ZTMT&H0&:+9))M;*AEYQ
MTYH ^BZ*_/3XB_M*_M0_LW>#=%^(7CQ?AIXJ\(75Q:PW&FZ+]H@ORLP!'E[B
M 6Q[-CKC&2/T$L;H7UE!<!'B$L:R!)!AER <$>O- $]%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%?.W[87[3VJ_ *P\(:!X/T&'Q/\1?&FH_V9H6FW+E8 P*AY9<$':"Z# (
M^]G( ->>^#_B-^U;\+_BGX2TCXE^%=!^('A+Q)/Y-QJ?@FUE$FB-Q\TV0!Y8
MW DL.0&PV1@@'V7124M !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!XS^V#\:5^ /[.OC/QA&X74H+,VVG*6P6NYCY<./7:S;R/1#7YMWW[(?[1=
MK^QG:Z0VF>"4\/Z;(?'4<Z7%S_PD"7'E&4G.W9YOEG9M_P!D#.1FOV#O+"VU
M"(175O%<Q@A@DJ!QGUP:E**R%2 5(Q@CC% 'DW[*/QHA^/\ \ /!WC57!O;V
MR6._3H4NX_W<XQV^=21[,*];J"SL;?3X?*M8(K>+.=D2!%S]!4] !1110 44
M44 %%%% !1110!X?^UO^TU'^R_\ #NRUV#P_)XNUS4;]-/T[0;>X,,MRQ5GD
M8$(YPB(Q.%/8<9KK/"GQY\'^(_@MHWQ0NM9L=$\*ZCI\5^UYJ%RL45ON'S1N
M[8&Y6RA'J,"OGCXW_!_XN?&_]K;2]6\.WUMX'\-^ -(;^R=:UC25U&WOKZ[&
M)S'"74';'A=Q^Z5..O'SYJGP3^(WP?\ AC:^ ?$NF6OB;P_X#^)&G^(='CO)
M8-/L_$UA*DCS6=LLLFTR)*S,(6/.YL;L8H _13P[\=/AWXMM;^ZT;QOH&IVM
MA9QZA=SVVHQ/';V[YV2R,&PBG:W)QT-4?#_[2'PM\5P/-H_Q!\.:G''8W&I2
M&UU**3R[: XFE;!^54[D],U^</C'PSJ'Q-\1_M>VVG^%[#X=75WIOAFZ.BZI
M?VULGR3K*8;B5'\F*6=4Y7=C<X!.2373:K'?_$G]IKQ''H_PL;P'J&I_!/5K
M6TT1'M6N+MV_=Q,5@8HJEB(XRQ!95!( (  /OJ#]HWX776B:UK$/Q \.2Z3H
MHA.HWJ:E$8;7SEW1!WS@%P#@=3C'6M%?C5X!?X?GQROC+0SX/"[CK@OX_L@[
M8\S.-V>-O7/&,U\4^.OV6_$NE?LM_L]#P]X1NK/4O"=SINK>*M%T.RM6U*>5
M;<K),L4P,5Q/%([D))G.]L5R'B'X0:YH'PPT?Q;-X6U3[/)\4[?Q3+X0\;WN
MG6%WKL0@,;&.UC6.&*5OO?9VR3L)]B ??NC_ ![^&_B#3-3U+3?'?AZ]T[2[
M2*^OKN#4HFBM8) 3')(^["*VTX)/8UPOCG]M3X4^$_@WXB^(VF^*],\6:5HS
M+ ]OHM[%)-+</_JX "1AFP2,]E8C.#7Q59P>+/$7CK]K:7P=\*K*VUNZ3PU+
M_P (?>V=IJ)BCRSRR-;AC ]SL'F^5N(#_P!YAS)J/[//Q%\7>&_VE)8O!?BN
MZ/BWPSI$VBR^)K"QM;N\GMW_ 'JB"V"QPN!N"1X#A< G)Y /NCP7^T/8^/\
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M#XO> /!/P5TB3XBIJLY;7[YX9[.+2;7 _>%W3[R_,Q!&#M"@Y88^PW19$96
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M^/MMXY\8>$-/T2STW4-"\0: ^M+JT&O6KR1.KA3 MLK&20 Y#2+\JLI4\U\
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M,#THP/2EHH 3%&!Z4M% "8Q2T44 %%%% !1110 4444 %%%% !1110 4444
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M_GKG)R?NC'O0 ?%/X<Z?\6_ 6L>$=6N+FWTS58A!<M:%!(T>X%D!96 W 8)
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M]DD/=F,LK9)ZGB@#T>\\9Z!ITBQW6M:?;2,0H66[C4DGH,$ULA@PR#FO,1\
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M2^$_&\ERJD)]G\.ZG>0OCH-QF" #UVU]^)^SI\=--D:73]*F@W#DCQANE/\
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M[>BD\=4;NXQ_\ C^B#E1PS:5\1)>#XC\/0C^]'HLQ/ZW-5I?"/C^<'_BO+*
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M &";7_T4M '6GI7P/\:?^2L>*_\ K_;_ -!6OO@]*^!_C3_R5CQ7_P!?[?\
MH*U^B\$_[Y5_P_JCDQ/PHXB0,8WV$!]IVD],XX_6N"^&EGXJMM1U5M>:<V[<
MJ+APVZ3/)3_9Q^'2N_HK]LIUW3ISI\J?-;5[JW8\YJ[3"OKW]D;_ ))Q??\
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M2EH Q_%'B[1O!6F?VAKFI6^EV>\1B:Y<(I8] /4]?RK3M;J&]MHKBWE2>"5
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MG78IG\V)'W+M;!RYY^\<X('&*_8SPY&D.@:;&BA$6VB5548  08 H T:***
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M9VR2<YWGG(![5DGX+V1\*7&@_P#"3>+?)FO?MQO!KL_VM6QCRUFSN$?^P.*
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M=%^K?F_PT70ZXJVK"BBBN(H**** "BBB@ HHHH **** "BBB@ HHHH ****
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M"HW:UO,XSX:7$?@ZWU35;70O$7C;X@:V/,O]<GTF6TAGD_@A1Y0HAMTX 4=
M"3EJ]>\ >#'\*6%Q/?W*ZCX@U&07.IZ@%QYTN,!4!Y6-!\J+V ]22>IQ2U^<
M8W,I8MRLK<UKZW;2V6R2BND4DMNRMV1ARA1117CF@4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (>E<E\(?\
MDE7A#_L$VO\ Z*6NM/2N2^$/_)*O"'_8)M?_ $4M '6GI7P/\:?^2L>*_P#K
M_;_T%:^^#TKX'^-/_)6/%?\ U_M_Z"M?HO!/^^5?\/ZHY,3\*.*HHHK]C//"
MOKW]D;_DG%]_V$Y/_0$KY"KZ]_9&_P"2<7W_ &$Y/_0$KXKB_P#Y%;_Q1.BA
M\9[C7RK^W+]WP=];K^45?55?*O[<OW?!WUNOY15^&'IGRG1110 5[1^R+_R6
MFS_Z\KG_ -!%>+U[1^R+_P EIL_^O*Y_]!% 'W=1110 4444 %%%% !1110
M4444 %%%% !7#_%OX96'Q3T+2].U*;R[.PUBQU=XS LRS_9IEE\ID;@J^W:>
MO7H:[BO'_P!J'Q-;>&? 6CO?63WVGWWB/2M.NHX9+E)1#-=(CM']G99"X!R
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M&49$;>E %B[^).DV%N]Q<VVLP0)RTCZ-=@#MS^[J7_A/K#_GQUO_ ,$MW_\
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M4?G1)\,?&[1N!X'\39*D?\@B?T_W:_031_'%G;Z3912:?KBR) BLIT6[X(4
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M@,R$$,5Y*DCY2<CG!'144 9UCH5II^JZCJ$*L+F_,;3DMD$HFU<#MQ6C110
M4444 %%%% !1110 4444 %%%% !1110 AZ&OEOQ]\,/'&K3?$:^L=<O[;1;C
MQ/9W \/1:3%+]NB5;#S'64_/@[&&1TV''2OJ6N&\:?%>R\&^(]-T,:/K&MWU
MW']HF72+,S_8[?S!'Y\N"#MW'&%W,<,0I"D@ ^<#-\4;"]^(UW=/XGO-2\K4
MUDTZP@NXXC&;Q5LFMIW#Q*5MSN'V>-G9=^X;PM<?>^!O&_C+X<:[9Z]IGB>\
MM;&?4_[/)-Y]K-C]KT:>)4>3%PX(CN64/\YV$8^4 ?1[_M5>%X[34;HZ3KQM
M8D\W3YEL"5U>(74=JSVN#EP)9HQ@[20P8 @YK%UC]KJQT>ZMKB?PAX@CTA-.
MU*XU%FMX_M%E<VES;P&W9!)\S$SCE<@[X\$Y. #@K/P!XRT2^U&YT2\\26*:
MQ-XJN'6ZNI8[2!DO%N-.?:<"+>0<MU=9'#9'3W7]GK5M8\4_#.R\4ZXMS;WO
MB66364L;E]QLH)CF" =AMB$>0.-Q8]ZX[X@_'_P]J7AKQ'HVH^%=1GB-A<6\
MT>K6JFQ:_6S:Z.G2LKG,GEKS@%>J[BW%>Q^#=0&K>$-$O5@BM5N;&"800C"1
M[HU.U1V S@?2@#6E+"-BBAG X4G )[<U\'IHNL^ O#&LR:1H6MZ5_9WAS4A/
M/<Z1]EU+0)3Y9$,&H+M2_P#-<':Q#$[5<L.<_>=4]6TBRUW3KBPU"UBO;*X3
M9+!.NY'7T(/44 ?(VIP>*OLTBA_B0?AW]OOVT\VPNCK)N/LML;<2<>?Y)N?M
MFW>-N[8&_=[:GU?1_'\/AO5;_6T\77>K:CK]CI]S'9:A=16]K:C3;=Y9$CMD
M>38UUYBEH0"78 NJ!J]K^/'QE'P@TW2;B&*VNIIYVN;J&XEV,FG0+YEY,G]Y
MD0C [E@.];WA7Q[)XD\9>,-*2*%K/1C9FVGB8DSK-;B7)[=\#':@#Y/T33/B
M'XATGX<)XSM/&]SX@AN_#<D4*PR_8UBBU!3>O> #9YB^6K%I/FVB,KU;/>_#
M*U\46OC/PX/%2^.(KE(+!=*BTY'&G^65D^U_;!CR\A_O>9A]IB\ODG/8_ ;X
MY^(/B9XGO=.UNVT73Y5MFN)-'@GFCU/2G#H/(N8957S,[C^]C^3*$<AE)]VH
M *6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQ7]L
MN.6;]FGQLD&/.:" )N4L WVF+!('49[5[53)(DF0I(BNAZJPR#0!\K?&O1/B
M)/\ $CP+"^K:7>:M-IGB2+2FTNQDM7BNFTUA$Q9Y7'WMOIS4WPT\6_",_#SX
M5^'(M(AU#Q5836$<.@6<&-5T[4$55GFG0%7C\L^8TKN<,-V=V[!^HVB1W5V1
M2RYVL1R,]<4Q+.!+E[A88UG<!6E"@,P'0$]30!**21Q&C,Q"J!DD] /6G4A
M8$$9!Z@T ?#%OXC\1VGB2V_:#D\.$:'<>)29-72[0.WAB4+91*T&-^U66.[Z
M\;G/?CV+]GOXB^%M&O?'F@7WB'2[/79_'>M"+3)[N-+B0O=$IMC)R=W&..:^
M@C;Q&#R?+3R=NWR]HVX],=,56.B:>UT+DV-L;@-N\TPKOSZYQG- 'Q%X!O=*
M\/7?@/2]%U/2?%NG)XIC,/@S6M--KXHT*9YV\V4RQ/\ .8-[M(9$ >,-EVR-
MWW2.E1+9P)<M<K#&+AEVM*%&\CT)ZXJ:@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:V5#+SCWKZ+KXP_X*VQO+^QQK*HI9O[5T_  S_RU- &=X8UW]L_6#I-Y+?\
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M: .UHKY1^ '[<VD?&*_^)6MZG>>&_#O@'PM<R00W\VJ'[4\:R;$N)490J1R
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M *JZCI=GK%L;:_M(+VW)!,5Q$LB$CH<$$5:HH P1X!\,J01X=TD$<@BQB_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR(+W0[JZN+=[J22,RK<VZJP1F(0@.P^4#J:]'H **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJS>0#N$9 8;57&1BJ/[-NM?$#7/A\D_Q L8+74/M-R(Y%F8S2*+N8 .AC0*
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M%Y#WAMT\YH_[A?&XK[9Q5VWMXK2".""-(88E")'&H544#   X  [4 24444
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MM,V[ '!/;"CBO._$/P$UZ[\/Z5HVD^*K6#3K?5]0U:]L]0TYIX;]KBY>>-)
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MBBB@ HHHH **** "BBB@#)TW_D-:O_O1?^@5K5S^F:K9MKNM*+J$LAC+#>.
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MHHK8\X*0\4M(>E '@5E\?]'G^+5UHY\,VL=^NJQ:1'="6(W\FZ:X@>0QXWA
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MG&<UY5=?!WQ'>:1??\(]X,\0^&?!L0T3[1X>DU(/J,EQ;7+RSW%FSRL$D5!
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M)BZQ[B=N?E) ]J]#_P""O.DZ-J7[+5M-K&KR:6+378)K6.&V,S7<WDS*L0Y
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M?&+XUZ?9OJ6B#Q%-XKNYDUX7D!EGLE^5].\O;YF](VCBVG@,"VXG*U]2CH*
M%HHHH PO&FJ7VD:!<3Z?HUQKL^"OV6VEBC8*5.6S*ZK@?7/-<O\ LXDG]GSX
M9DC:3X:TTD'M_HT?%=/XU\10^&/#]Q>3VE_>H08_+TVSDNI<E3SLC!...3C
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MHH \J_:-TEM;\&Z-9QW&FQROXATQH[75RXM;UUN59;=]JM]\@ 94C.,UX_\
M#+P+?^'?B)\/TOKCP;I]E;^)_$=S;0Z%+*\L]Q,ET9K55\E5'DY(.2.(0 .
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M07BSXQ?'[Q5%XEDTV??H<U_$+.%T,)>\21PN20 [3$GN=B?W:^N;.TTWXO\
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M6A@<3 8C*J2.A[U]@L#ELH_7%.7L5HU]J_ETMJOQ.7FG\/4][TZ^BU.PMKR
MDPW$2RH2,$JPR./H:X/]H30?%GB?X,>*]+\"W3V?BVZM-FG3QSB%DDWJ<ASP
MO /-=WIMA%I6G6ME!N\FWB6%-QR=J@ 9_*O'M2_;+^#>D7^H65WXYT^&ZL+[
M^S;F-BV8[C+CRSQUS&__ 'R:\3!T<1/$*K@Z3J<C3M9RZZ72Z,UDTE:3L4_V
M-_!?Q.\"?":XTWXL:C+J?B=M4FF2::\6Z(MRD80;QQ]X/Q[U[M7PG<?\%9/
M]O!JTI\(:Z5TZZ2U?!A^8L9 "/FZ?NS^=?<.DZ@NK:59WR*42YA295;J R@X
M/YUZ.>8#,</7>*Q]'V;J-M)62Z-V2;MNB*<H-<L'>Q;HHHKYHV"BBB@ HHHH
M **** "BBB@ HHHH **** .(^,?A[2/%'@2[L-=\/7?B;2VDB>6QL<F8;7!$
MB $%BA ; R3C@'I7A/POU[3O GCJ^;PAKWB'Q?;:LRM>Z#J&@R_;(WBA6"+;
M.$C2)5"*#YJ] ?FS7OGQ7\>2?#KP@^K0VL5W.UU;V<0N9O)@1YI5C#RR8.Q
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M !7&_&+X>-\6/AAXC\'KJDNB_P!LVC6C7\,0D>%6(W,JDCG&0#G@G/:NRHH
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MKOQYX/\ CQXXU7X?^#+W3-6AOIE6-+5[EK.)I"K8!&/G)'/. <#UK]1]!_Y
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M* "BBB@ K@_C9K&M:%X!N;W0[74[NZCN+<2KH\"SW20&51*Z1,#O*J2=H&2
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MW_(IV7_8>T7_ -.EK79EU#!2P#'H,]:XSXO?\BG9?]A[1?\ TZ6M ':T444
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MV<"3^SU\,2V-Q\,Z:3MZ9^RQ]/:M3XL:7<ZOX0E@M?#>D>*I?,#?8=:=5@
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MIXJ4:3OS06D972W5[/;K?96##YYE%'+:^"EEL93FURS<KRC;>S:NOE;=WN?
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M<:)X/TG3(]6MK^>QME0+*K1H).K$!O,3J3A@BGU->ZS_ !.T6V56F6^C5F5
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MQ3T.UFMHIC>12W+F.%'LI09&"LY5?EY.U6/T!H ["BN6_P"%C:7_ ,\M0_\
M ";_ .)JN?BKH0OA9;KS[68S,(/L4N\H#@MC;TR0,T =C17+?\+&TO\ YY:A
M_P" $W_Q-11?%#19Y9HHQ>O)"0LBK8S$H2 0#\O'!!_&@#KJ*Y;_ (6-I?\
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MI;Q??^*=%UO2]7U7PO8W4\%^F+>R"W=T([>+!(P$(&X??=9&]* /JMB%4DG
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MRLCPSW+2IA+0(1LO%"963D@2#"GFOK+PW<R7GA[3+B6">UEEM8I'@N3F6,E
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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2*** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>aciu-20231231x20f025.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f025.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %/ E@# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"OMJ>%HY%*-7'0555(Z):V>CZZ/32Y]M3H4,AG?'0555(:6UY6[.^NCTTO\
M<;_PJ\93?$/X;>&?$US9G3[C5;"&[DMN<1LZ@D#/./3VQ754R&&.WB2*)%CB
M10JH@P% X  ["GU\7)IR;2LCXIM-W04445(@HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME8L[JCDX/.!SC '&0" #LY-+LIKV.\DLX'NXQA+AHE,BCV;&17D/[1?QPO\
MX46MG::/:PRZG=Q/-YURI:.-%(' !&22?7C\:]HKC/B9\)?#OQ9TN&RUZ"8F
M EH;FUE,4T>>H##L<#(((XKT\NK8>EBH3QD>>FMU\M/QZ'K977PM#%PJ8Z'/
M35[KY.WW/6QPG[+7Q^N_CMX<UIM4L(K+5]&NUMKAK;/DS*R;D=022#C((R>G
MO7MU<A\,/A3X;^#_ (<.B^&;(VMJ\K3S22N9)9Y3@%W<\DX 'H   !77USXN
M=&I7G.A'E@WHCAQ$J<ZTI45:+>B\@HHHKD.<**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKSK
M6OC?I&@ZQK%G<Z7J[6FCS1PZAJ<-LKVUL756!8AMVT!ADA>* /1:*S'\3Z/%
MJ46GOJMDE_+'YL=JUP@E=,9W!<Y(QSFE/B32!%YAU2R$?D"YW_:$QY1.!)G/
MW2>-W2@#2HK+M_%&C7>I#3H-6L9K\AC]ECN$:7Y3AOE!SP>OI6I0 4444 %%
M%% !1110 4444 %%%% !1110!Y=^T7X[U;X?_#TWVCMY%S-<I;M=%0WD*P)W
M#/&20 "?7Z5XA^R#\>/%_C+XD>(?"_B'47UC2H+-;J*[N=HDMYC($6+?QN#@
ML0IR?D..,U]1>/);>W\%:[/=:2NO0064T[:8RAOM6Q"WEX((R<8''6OR]^+?
MQYL/BGX7M-$\$^$;;X?>'8+I=3ECLW7[3<W2*0CNZ 8V9..ISWXKZ_+O9XK
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M7Y@PXYP<@L.,U[#10!X6?V=+N+P]?Z9'J=I-]HT6TTQ99H3\KQW+3.<=D.[
M4=,"K7B3X%ZI?Z[?:Q8:A:+/)JLM[#;2/+#'Y<EJD#!GC^8,"F>.""0>M>U4
M4 8W@SPZOA+PII.C(4*V5ND.8PP3('.W<2<>F2:V:** "BBB@ HHHH ****
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M48S:U3OLFWM;7=6./O\ Q%K6@^'M'OKNRM#IH9;:#3KE,W,L2H3O+_PGY>W
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M8]J;8:=::5;+;V5K#9VZDD101A$'X#B@"Q1110 4444 %%%% !1110 4444
M%%%% %/5-/74;4QYV2K\T<G=&'0_Y[5S<=R1]CNB-C1S+O']W)V,/U-=A7'J
MBW,5T#_JY99<8]"QYKY_,H<LXSAN[_A:WW'IX65XN+V_SW*_Q(\3ZAHL^E6-
ME/%IJ7SLLFI7"Y2$ #CZGG\OQ&?I7AS3/$D[-JNNVOB-T4+!+"/(N%Z[E)5L
MLOL:T_$L^K:SX6%GIMO#<:CY\<%R)U5@B'K( W!['\^XKSC6]!T7PQK.H)X@
M,TMW:VT;6,NGM]E^T;BV 57C<#G)Y&!S7FXNN_:^VE'GINWQ-J*T>G5-Z-ZQ
M=G97O8[\/33I^SB^6:OM9R>N_1I:I;[:VW(],AU-GEUSP9HO]G"#>DH:Y%Q(
MXSD[HV^8'V'<&O3/A7:P'0)M2COCJ-QJ,S3W$Q79\^>5QVQ7F_AJ;4++P>/%
MX<6^HV5SY-PY!5;^(E0=P[L">O?!!Y Q[CIUQ#+IL-U&BP0RQB;&  -PW'/Y
MT9+2A*2JMOX>:VR][[22LELTU9]T[/4S&<E%PMUM?KIT;=V]TUJO3MD:P0^M
M#'\%N ?Q;_ZU1J*ABN!?S37@(*SME,?W!PO]3^-6%%5*7M)RFNK?W=/P,$N6
M*CV%I0*2G 8K2*,V+3@,4BTM;)$A1115I$-A1115DA6+XLAU1],672%6>[@D
M$GV9V"B=<$%03P#SD9XR*VJ*YZ]"&)I2HU/ADFG\QIV=T?-OC+X@-;R21ZEI
MNIV%R.#%/9R#'T(!!_ UQ.@67C3QMXBC_P"$9\/7?V1@8[B_U.-K6V5>OWF&
M6.>@4'K7V4'8#&XX],TC,6ZDGZU\SE7#]/)L=3Q^%JR4H.ZV]&GW33L/%*.-
MH2P]:-XRW/F_X=?LZ^)3\1-,\3^,+FPM[729#<6FFV,K3-+/@A7D?  5<D@#
M))QG%?0&F:S8ZTDC65U'<>4Q615.'C/HRGE3]15^L+Q-I>D2H+^_S:W,?RQ7
MELQCN<XX5"O+$]DYSZ5]UCL?7S.K[;$RN[67DO0\O+LLPV4T71PD;)N[\V;=
M84NK7&LN\&C,JQ#A]39=T:<<>4.DI[$YVCWZ5@&#Q/*%;4X7U30P<K;6Y$-^
MZ@@JTP!"MW!C4J3WSTKJ=$UK3=6A,6GRH#  KVFSRI(/9HR 5_+%>:X\NNYZ
ME[DFFZ5;:5&ZP*Q>1BTDTK%Y)#DG+,>3U.!T';%7***P>IJM!IZTPC!J1NE-
M(S63-$-HIDTT=OCS9$BS_?8+_.EBD2<9B=9!ZHP/\J+=1W6PZF2Q+/&4<94^
MG!![$>]/HI-)JS*3MJC2T;5&F/V2Y;_24&5?H)5]?KZBM:N3EB\P*58QR(=R
M2#JK>O\ ];O6[I&I?VA"P=1'<Q?+*@['L1['M7MX+%.7[FH]>C[_ /!7XKYG
MGXBC;]Y';J7Z**^;OVB_C_J^B:S+X-\%S"UUB!4DO]3**_V<,-RQHK @L1@D
MGH#ZGCNQ.)I82DZM5V2/%Q>+IX.G[2IZ)+=OLCZ1HKS7X ?$J\^)O@)+O5%C
M76K&=K*^,2[4>10"' [;E93CL<UV/C#Q1!X-\.WFKW%K=WL=NN[R+&!II7/8
M!5'ZG@=ZUI5(UH*I!W3U1M1K1KTXU8;,V:*Y+3O&6I:[I]K=:9X;N62>-9!)
M>SQP1\C/'+,1_P !JQ_9OB;4O^/O5K72HB>8]-@\R3'_ %TDR/R2M38VM3U:
MRT:U:YO[J&S@7K),X4?3GJ?:N=DN=3\:?NK-;C1M$;_67DBF.ZN5](E/,:G^
M^V&YX ^]6CIO@S2].NENVB>^OUZ7E](9Y1_NEL[?HH K<H K:?I]MI-E#9V<
M*6]M"H2.)!@**LT44 %%%% ',^'O^)1XEUK2#Q%,PU*V&?X9#B4#Z2 M_P!M
M!735Q7C^U\0QZOX<U'P_:07+0W0M[QI'(>.VD*B1@O1L85L9XV@\\UVM $-W
M<I96DUQ)GRX4:1L=< 9->8_#WXE6>L^*KFR\J2)M0)DM\KC 4$D-Z'']:[WQ
M;,L'AG4V9MJF!E)^HQ_6O)?A]I*IX[T]HU9$BC=MK*.FP\YZ\Y_2G]6C6<:K
M^S=_^2V_-H\S$8VIAZBHPVGRK;^\OT3/<:***1Z84444 %%%% !7SU^T!XSU
M02>+-#;6(M&L[;3;:6TLS#F74FDD(D*/U&S:!\O3.3Q7T+44MM#,ZO)$DC*"
M S*"0#UQ0!\YZ]\1==\,V>JOIE[9:7'_ ,)%J,<WRQK-*L<<94IYQ\MCDDL,
MJS<;>]:'_"Y?$M[XYTRVMI8+:RD_L[R[*]B2"2]CGC#2R!6)D##+ !,@%<,>
M:][ELK>="DL$4B%MY5T!&[U^M.:WB>9)FB1I4!"R%1N4'K@]J /FVT^./B6_
MNM?^PZS:26W]F3WEK+J-O'$+>1+E8\,J%B@VL>)<G(!.!3YOC;XD?PWIHBU$
M6[OJ-U;76KW,5L$3RX5DCC60,8'W%C\XQG:0 &KZ-6SMTW;8(UWDEL(!G/7/
MUIOV"U^S"W^S0_9QTBV#8.<].E &9X)U6]USPAHVH:C'#'?7-K'+,MN28]Q4
M$E<\X/4?6MNBB@ HHHH **** "BBB@ HHHH **** "BBJ%]K-O9.8OFFGQGR
M8ADCZ]A^-9U*D*4>:;LBXPE-VBKDVI78L;">?NB$@>I[#\\5SEO%Y%O'&3DJ
MH!/J>]-O=5-_*HN9HXXU.Y;:)MYR.A8CKCTZ?6@W:!=Q64+_ 'C"X'\J^7Q.
M*AB*G,GHE9?J_P CUZ5&5*%FM6/Q)',L\$GE3J,!L9##^ZP[C^55-<TW2/%#
MP/K>E2R30 JLML[8VGJ,J0V/8CBK<<J3)OC=77U4Y%/K!.\7%6<7T:33^3--
MG?9KJM&8,/@GPC:F#R]-O;I(3F."1Y6C4CIPQ _.MZ[NI]241R*MO:C_ )8(
M<EO3<?3V%%%"TBXQ2BGNHI*_KU_&PVW)IR;;7=W,'0!_9.M:GHY^6%F^WV@[
M>7(?WBC_ '9,GZ.*Z,=*X_QQI^MW5[HEUX?EMQ=6MR!<JZDR&V<A9=F.,X .
M".J@CI7722>7DO'+&OJ\; =<>E:W37-<P2>UAXZTX"FHP9<J0P/<'(IXK6)#
M%Q1116J1#84445H2*!FC%<QXU^)6A^ 6M(=2EGFOKO/V>PLH3-/*!P6"CH!Z
MG%.\%_$?1/';7,6GR3P7MK@W%C>PF&XB!Z,4/4>XS6GLY\O/;0FYTE%>;ZI\
M3]?\':Q_Q5?AF*R\.27/V>/6+&Y\T1@G"/(A&0#QGT]Z])QGIR.N1S1*G*%F
M^HQ**1F5%+,P50,EF. !ZFL4ZE=:XYCTIOL]F&Q)J3IG=@C*Q*?O9&?WGW1V
MW5G:X[V+&IZT+6;[):0?;]2896V1MJIWS(^"(QZ9Y/8&DL-$,=U]MOYA?ZAT
M5RNV.$9.!&F3M.#@M]X]SVJUINEVVDV_DVR$ X+R.Q>24XQN=SRQ]S5JH;ML
M-:[B$5F:OX>L-;,;W4'^D1?ZJZB8QS1?[KKAA],X]JU/PIIXJ-M47N<5K-SX
MN\-S:?'IMK_PE5F]PHG:0I#<0P_Q$MD*YZ$8 /'.:[*G'FN(^,?Q3TOX,_#W
M5?%6J_/':IM@MP<-<3-PD8^I_(9JH4YXB<:5.-Y-V7FV2Y*G%RD]$9WQJ^/7
MA3X$>'UU#Q%=EKJ<$6FF6^&N+EA_=7L/5CP*^!/B=^W!\2_B+<S0Z/=CP9H[
M$A+?3>;@K_MS$9S_ +N!7DWQ"\4>)?B7XLD\5>*IGGO=57SH"3^Z6') 2(=E
M7&,>HYJO8Z5P"PXK]KR?AG!X*FJE9*I4[O5+R2\N[U]#X+,LZFVXP=E_6Y5O
MK[6]>F,VHZQJ6H3,<E[F[D<D_B:MZ1J?B+PY*L^E:YJFFRH<A[:\D3!_ UMV
MFF;ONK5[^Q7V_=K[/V,''E<58^+GF\E+1GIWPN_;J^('@.YAMO%.WQEHP(#F
M<".\1?59!PQ]F'XU]Z?"SXM>&?C'X9CUOPS?K=P<+- _RS6S_P!R1.H/Z'M7
MY4ZCHO!W)CWQ5GX7_$S7?@5XZMO$6B2,54A+VQ)_=W<.?F1AZ]P>QKX;.N%<
M-C(.IA(J%3RT3\FNGJOF?893Q#)M0JN\?R/U^J-IFL9TO$ZQ<2*/XH^X_#J/
MI[UC>!?&FF?$3PAI7B31IO/T[48%GB/=<]5/H0<@_2MWZ\BOPV<)TY.+TDG]
MS1^EQE&:36J?Y&CXD\6:3X2TA]3U6\CM;0#Y6)R9#V"CJQ/H*^,OC;I.IRZE
M>_$ZSMH=)L=:NH+.#3KXGS[AMFWSP!T&%&1[<&O6_$?ASQ!JWCB2UT?1I=<U
M&%1Y.K:ZX_LS2XC]U8HA_K),#//MP:Z.Z_9GTGQ/HEZGB[5[_P 0:]=H!_:K
MR;&M6!R# GW4 /;'(XIUEB<W7(X6AV\_-^711^<NA\%F="MC'.A3CK!Z/;7H
M[];KMIKJ^AY'^SY\7E^%TBZ#K]G#_9^KWQF;68'(,4S[542(?X.%&X'CN.]?
M85?+%U^Q'<WT/V:X\>S-;9Q\NFJ'*_7S,9]\5]0VEN+2UA@5F=8D5 SG+' Q
MD^]>KE-+&4*'LL7;3:W;Y%Y5#%4HRI5X<L5;ENTWUNM/U[DH  X&*6BBO;/>
M"BBHX)EG3>G*Y(!]<'%*_0=B2BBBF(**** "BBH[BXBM+>2>9UBAC4N[L<!0
M.IH$VDKLXSXO:G8VO@ZZL;K4DTZ>^4I;EE+&1EPY4 >N,9]Q6%\'M%U:Y\K7
M[^2);.>V*V]NI/F*=W+-QCH/UKF=5"?%'Q1/=%A)! ##;PD$%1C*X[')Z\^W
M:O7?!'AB/PAX9L],0[FC!:1LYW.QRWZG'X5I5I5:56+<_=47[MEO)K6^ZLDE
M;K=GBX6M3QTY5%#KI*[VCLFMG=RD_*RN;M%%%9GMA1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %<MJ$N@Z=XFT[2;G<VHZO
MYTT$3.2K>6 SDC/H1V-<Y\?=#'B7P<FF0Z%=ZWJEU*8['[-<M;):R[2?.EE!
M&U% )Y!R<#&37R;X7T.Z_P"$Y\-6FMP^)0DSWBCQ#82S//JMNF,K CX9(@-P
M(4%F#$C-#PU*NKUK::K1/UTO?\//H?.X_.:^ K*C2A?FMK=K=I6>ENN][+2^
MK2?VKXP\=:!\-='BU'4_-M]/=MOG6EH\J+QG+;%.T>YXKSB]_:K\'GQAI=I9
M:HLVA/;W#W>H/ Z()0%\J*,L 6<G<-H!ZK6S/)I/Q6\&6WASP5XEATO243[/
M?6]NA6]2U5=ODJL@W1Y.%+,IXSCFO#A\-]<^$7C3P;=7NIZ5)I7FWSVMA=1M
M=V>C'<I +95B,L@:;&4;G&*Z*5&&L&G?HEH]%?\ E:UWW./,<PQL91J8>SI/
MEO+?JD]>976NNB?RNU]42VR:OID&KV,$EM/-"L_DS(8W=2,['7LW/U!JI%(L
MT:R(<JPR*?X-USQ)J6^W\1:!%ID\<8<7=E>+<6L^3QL)"N#CG#+^)J* "-KB
M,8"I/(H&>VXU\OF%"-&JI1^U_P #7\=3[S UW7I7=].Z:?W,EJ2SLWU&9D!*
M0)Q(Z\$G^Z#V/K5/^T;474EK]HB-U''YK0;QOV]FQZ<=:Z32;?[/I\*_Q,N]
MCQDD\GI7/A:*K5.66RU9TU:G)"ZW.<\6_$KPA\,VMK?6]5M]*>X!>.':S.PS
MRQ502!G^(\5TVG:C:ZO86][8W$=W9W""2*>%@R.I&001U%?/GQ]^!'BGQEXU
M'B#PVUG>+<VJ6L]M>3>482A.&4X(*D-R.N?7->N?"/P/-\./AWHWAZYNEO+F
MTC;S94R$WL[.0N>=H+8'L*]^FYJ;ARVBMCX_#XK&5<;4I5J=J:VEKKM;79W6
MNFVS-V^TH8::U4),.3&.%DZ\>@/O5**198U=3D&J%S\7?!MIXI'AR;Q%91ZT
M9!#]E+GB0]$+8VAO]DG-:5R@AU"X0'AMLH&?7@_J*\_$TH0:G#KH_7^MSZ'#
M8F%?FC&2DX]G>WDQ****Y4=+"N5\;_$;3O [V5K+;W6IZM?$_9=,L(]\TH'5
MN>%4>IKJ\?K7*ZQ9^%_#GBI?%6KW]OI^IR6PLHI;VZ$:",$DA%)ZDDY-;T^7
MF]Y7$5?"'Q'TOQ=KKZ9=:3=:'XCMHS*EEJD*B4Q]"T;C.1SSCFN%NM>G?]H6
MUU*X@2UL+5Y-%\V)</(74;6E/<;R,>G%/^*7ANSU;Q-:^)[/4X;Q#;I&1:7B
M^?!MSMDBPV2ISR!S]:\I\2_%G2-/\7V>B:WK#Q:K?7$ ,DENRF4 CRW9L85V
MQLR1@G!]:^8QF88J6*6&PL'&2:ZJTH]5=VMZ?C<^BP670JTI5?C7*V[)MQMK
M>RN[+N>E?$/Q-K?Q/U4^#-,BM+71-2N/LOVJ92966,[I)!V ^4X&.>.>:]+^
M(WAV?5?!D\%AJUQHMUIRBZ@NX)-K*T2G ?\ V3W!KYM/Q5TCPSX_M?#4NLO#
MKS*UM%]EA9C"'4-M#]/-<'''0 ]S7>^%/A''XON[BXO];GTJSN1L;2K2\4W%
MW'G)\XY)4$XXZ]>E7@,?C*>(6$Q<'S<S;>EHKMV>W?\ 46-P%.G1AB(^[%Q3
MC=.\K_:UMHUU/6?A[KLGCGX=Z-J>I01M+J%H#<1%04<\JW'H<9Q[UTZJ$554
M!548  P /05R>K>*;+P/K7A'PY%IQCLM3=K*"2(XCM]B?(N.^<8_6NLKZ.HM
M>:UD]CYX*4 D\#/TI*YWQKX(MO'5I:VEW?ZA9VT4GF/%87!A$_&-KXY(]*R2
M3=F[(I'1D$'!&#3#UKROX;WZ:%\1];\(:?K$^M:)!9BZB^TRF9[&4.$>'S#U
M'(..V/K7JAZU,U%?"[KN79IV:L)7P!_P4,^(R7OQ,\*>#I8S=Z1I$2ZE?6:N
M4$\DA(521T^0'GMNK] *_*7]L::2[_:@\8F3/[MK>-<_W1"N*^QX0P\:V8N4
MOLQ;7KHOU9X6<U73PVG5G7C6$U_PYX1ADTC3;'3KRVDD%D+1)"(4EV)''*P)
MC!VDLW'0]\56^&GACPY;?&G[!K-LMWHEO<R(EM.3M<_PJWJ!^N*Y7P?KE@\6
MAM<W4>GSZ; ;=";9YBY,A99.NW(#8&< 8!YKT71)7NGU8:)ID2R7$Y@FU.\0
M3S29YD*?PQ ==P]N:^NS"A6AAL3A*3=/GC*,6FTDV[)I_/65[ZO91N?F,,0E
MB(5JWOJ,D^6UVTMU9?@G;;JV>]^/_@[X!\363'3])@T"_P!N8KG3UV+GT9!\
MK#\ ?>OF;6?#%QH&I3V-TJB:(XW+]UAV(]C7HMO\4+[P[8QP:OON[9?D748%
M9HBW0J3C[P[XR/>NF\.:OH6MZ3)JMQ:VU_<S%D#3(&V(#PH!Z>OXU^7>'.*X
MFP.:ULHS'FG1C%OWVVT[V3@W>Z?57Y>JL]'[G%V'RJM@(X_"-1G=+W=GI>TE
MT:^_H_+YXU'2ED0_+7":]I6T,I7ITKVCQ4+!]<OXK!52*,J=BGA2PS@?E7GG
MB6V !:OZ7:/RO+\6^9-,^CO^"<OCV:2R\5>![F0M'9NNIV:L?NJYVR*/;<%/
MXFOM.OS@_82D>W_:.:-,[)=)N5<#I@%2/UK]'Z_GWBVA&AFLW'[24OGL_P K
MG]&Y)6=;!1;Z:%C0Y/+U:>//$L*OCW4X/\Q705S.GG;KEH?6.1?_ $$_TKIJ
M\O+I7I./9O\ &S_4[<4O?3[K_@?H%-#J<X(..OM45Q'+C? V)!_ WW6]CZ?6
MLR35(FN+*X7,>Z8VLZ-U1B#@-_P(#'^]QUKMJ5E3=I?U_P -U,84W/8V<@TM
M9>E.[WE_&[Y6VE\N-1V4JK\_]]8^@K4JZ<_:1YK=_P -")QY'8*P=-OQ_P (
MY8,IPTC)![[M^UOY&MZN!\,V\_B6ZO5+RV^DV&HW)ADA?:9W+MT/95W,,CJ3
M[5YV,K2IU84X*\I*27_DNODDK_@MVCLP]-3IRE)V46G^>GS9W,<ZRR2(G(3@
MD=,^E2U#''!86VU0D,$8SR< #N2?ZU4TJ^&IR7%S"2UH2%BD[28ZLOJ.< ]\
M5W^TY7&$G[S_ *^[I<Y.2Z<ELC1HHJ&[NX+"VDN+F9(((U+/)(P55'J2:WW,
MFTE=DI( R>!7B/Q2^+NE:I%J?ANWL[B[B:/8;Z.;R4$P8;0#_$H/4]#T]Z[#
M5_'5IJNK7&D),D5LJ*QG$@83!@",8/3!JGI?P>TR?Q!#JUW&7@B82QVC\J\G
M]YO8<8'K6G+&5*7+/EELFNGFNG,NE]$]UT/(Q-2M5G&%*"E"_O)_:79]>5]6
MM6OA?4E^%WPXO/"T:W.JW,<TRKBW@@)V1 J-Q/JW&/3\Z]&HHK)*T5&]['J0
MIQIIJ"M?^OPV7D%%%%,T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *\I\?^,_&#^(];\.^&=.DC-MI'VR+5(H/-99R)"B8<>6P8QA-N=WSYX K
MU:B@#Q_3OB;XYM_%=UHMWX(OKG3H+V*R@UDQE?M"EE5YG51M5=OF/N'R_='!
M.*H'7?BW?^,+;25L5L]+:[GE;5$A1%-KYTXC0EEDQ($2//RX8,I!4DX]OHH
M\]\#>%M;?7[G7O$&LW]U=V\MW86UM)''#";;SOW;[4 RQ50=W4Y[=*]"HHH
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M1RO*Z.7NI4I7]_N^W;R5WY^9B#PK,!_R,6MG_MO'_P#&Z7_A%IO^ABUO_O\
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M-TF[ 5V.<M.Z]03C SZFO0*^WK2DIJ]M.VWH?)6OH<[;:%KL=M$C>)7#*@!
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M7#DG(=U/(!XJOJWP)\;M>RZI9_$26/6VMTLX+V\EE9HU()<+S@$R%F''3"]
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MG;-H4CLT;-=0K);AEYP)%SG(YS@"OEKQII/B6SU::X\56E\E],PED?5$)\P
M89I'.,J5Y$:MQMQCBO2_@U^SKJGCPP:SJT\^EZ-\I2YP1=W@7@&+< 8XF0XR
M<D]AWKYBCFV/Q.,>'P6&22Z26MN\GNOQ\K[GZ55X>RG!8#V^.KMO^:+TOVBM
M4U\F^NB/IW7/#,?B+0"=#OA':WB*287WI-"<%A&V?E++D!AQSTIUIY0MHUAC
M$42*$6(#'EXXVX[8QBMSPYX?L?"FA6.CZ9#Y%A91+##&6+$*!W)ZGWK.U.$6
MVKOM&$N$\S'^T.#^8*_E7VN+PZI0C4BK+JEM=]5\]/Q[GY93J1G4E%-M=&][
M>?RU(U-/6HZ=7G(W8^BBBM$S-H<.E+3*=Q6B9(M*#3:6J3$<E\3_ (8Z=\5M
M#MM*U.\OK.V@N4N@UA((W9E! &2#CKD$8((KD[;]F;PQ;O(XO=1$DB1QL\)A
MA8A&!ZI&,[D!C;.<AW/5B:]:!I:T4FE9,EQ3/%K']E+PMIZ2>7J6J-([,YDE
M\A]Q+[L,ICPR@D_(05R2<9YKO? 'PRT?X:P7<6D&X*W6PS&X<.SLK.0[' +,
M?,(+'DA5]*ZS(I"<T.;>[!10$YI**2LRA:3\:.*:32 4G-)114,I%35M3@T7
M3;F^N2?)@0N0HRS'LH'<DX 'J15/PSID]A8R3WH!U.^D^TW9'(5R !&#Z(H"
MCZ$]ZJ7/_%1>)DMA\VGZ0RS3^DET1F-/^ *=Y]V3TKHB:'HK M7<1C3:*0FL
M6:"&BBBD4%%%% !4-VIDC2,?>DE1%^NX?X5-4^BVQO;L79'^CPY$1_OL>"P]
M@.!]351INM)4EU_+JP<N1.;Z'0T445]B>$5KR\-OA(HC<3MRL:G''J3V%9EW
MH=YK,3Q:C?;+=QAK:T0!2/0NP)/X8K5>2&TW/(ZH7.26/)K-O=3EU%#:Z4Q,
MK_*]V5_=P#N1G[S>@'X\5YV(]FTU5;?:*>_W;W\]._<ZZ7,FG!6\WT_R_,Y/
MPSX2T2W\7WVH6EC!;:?HT?V6*4C.Z8_-*Y8\DJ-JY[?-6S\-+EI?#CPR1-#+
M!<S!ED&&(9S(C'ZJZG\:V8- M;73;?3XT_T2,Y=6.3)W)8]R6Y/K5&"1K#Q?
M?;@!:W<4/S_W9AN&#]5 Q]/>O)P^"6 J4IQBHJ\DTEI>=G]T>6,5Y;G?6Q+Q
M4)Q;;>C5]_=T^]W;?F=#2$9!!Z&EHKZ<\4IW-COCMS$0)+=@R9Z'C!!^H)JR
MLG[LLX\O')W$<4^J>LZ=_:^CWUCO\K[5!)!OQG;N4C.._6H4%%W13DVK,>L%
MM,_F1A-XYWQG!Y&><>U6!T]:\'L?V:]9T'48)M$^(.I:?9VJ(MM8",^4@2.)
M$1\.#(O[O&&.=A"@C&3??]G_ %NXDM3<?$'5Y%+A[TI),C3C>"T:8FPB,N%/
M!(VKM(^;+44MD)MO<]H+J&"E@&/(&>33J\=\,_ _Q!HFOZOJEYX\O=4EN=.D
ML;03PL?LKLB+YPS(?F^1<@8S@'K6-H_[-6M:7:S;_'^HW-[)'&K7#M. Y4@9
M<"<%L(%"\@C;SD$@T(]YWKNVY&[&<9YQ3J^?K']GOQ796]SJ\GC6]NO$ZP21
M6I%Q,L8)9R"[%SG<3&6&W:-F%49.?;_#FF3:+H&G6-S=/?7-O D<MU*26F<
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MKSU"D!N]>@UA^-/%MIX(\.W.KWD<L\<3)&D%N 9)9'8(B*"0,EF Y- &'/\
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MF_97=E\SX[,<8L?B'74%&_3^K!1117OGF!1110 4444 %%%% !1110 4444
M%%%% !63XJ\+V'C+0KG2-21VM9]I)B<HZ,K!E=6'1E8 @^HK6HH X2Q^#>A6
M5RMR\^HW=W]O&I/<7-T6DDG$!@W$@#^ G@8P<8QBJ<?P&\-B&^$\VHWES=+
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MANAU@<;C_L-P?Z'\*S^E?*5Z7L:LJ:VW7H_^#=?(]FG/VD%)A1116)84444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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9** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>aciu-20231231x20f026.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f026.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &M Y0# 2(  A$! Q$!_\0
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ML<]379>*_#.L_!7QY\.]2T[QOXDUH:WK2:5JMIK5\;BWN%D5B72/ $1!' 7
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M[B]RH;*+D#;M()8D 9I/AS\9=*^(>HZGI0T_5/#^OZ8JO=Z/K-N(;E(V^[(
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MMJ_QI^.'B?P[/XEUGP]X9\+VUN!;Z%=FTENKB4%M[R+\VU0,!>E5OV<]"O\
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M0F%.6YXS@>]>HT4 ><>(OASJ.J?&KPKXQBN+5=-TFPO+6:%V;SF:4+M*C;C
MQSDC\:\1^".C?%"70O&#^"]:\/PZ;>>(]3C>+6X)FDLI!-@R0F/A\CG:V!D=
M>37UH1D8/2LCPSX1TCP=:7-KHUC%I\%Q<RWDJ19P\TAR[G)/)/- CR&]_9C6
MS^&GAW1]"UQK/Q3H%^=8M=<N(=XEO6),C2)G[K[B"!T&.N*EB^$_CWQ_XO\
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MPF_AW_H/:9_X&1_XUG>#?#.D2>$-"=M+LF9K" DFV3)/EK[5L?\ "+:-_P!
MFQ_\!D_PK1J";6IA%U)14M-2#_A-_#O_ $'M,_\  R/_ !H_X3?P[_T'M,_\
M#(_\:G_X1;1O^@38_P#@,G^%'_"+:-_T";'_ ,!D_P *7N>97[WR(/\ A-_#
MO_0>TS_P,C_QH_X3?P[_ -![3/\ P,C_ ,:G_P"$6T;_ *!-C_X#)_A1_P (
MMHW_ $";'_P&3_"CW/,/WOD0?\)OX=_Z#VF?^!D?^-'_  F_AW_H/:9_X&1_
MXU#<:=X:M=3M-/EL+!+R[5WAB-JN7"8W'[N.,BLOQCK'@7X?VD-SX@&EZ;%,
MS+'YEJK,Y52S855)("@DG& !DU2C&322>I$IRBFY-)(VO^$W\._]![3/_ R/
M_&C_ (3?P[_T'M,_\#(_\:2PT;P]JEG!=VFGZ=/;3QK-%(EO&0Z,,JPXZ$&I
M_P#A%]&S_P @FQ_\!D_PJ?<\RTZCU5B'_A-_#O\ T'M,_P# R/\ QH_X3?P[
M_P!![3/_  ,C_P :F_X1?1?^@58_^ R?X4G_  C.B$ _V788/3_1H^?TH]SS
M#]YY$7_";^'?^@]IG_@9'_C1_P )OX=_Z#VF?^!D?^-3#PQHIS_Q*K'C_IVC
M_P *#X8T4 DZ58@#K_HT?^%'N>8?O/(A_P"$W\._]![3/_ R/_&C_A-_#O\
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M_P"03?\ _7O+_P"@&FMR9;,U/!7_ ")N@_\ 7A;_ /HM:VJQ?!7_ ")N@_\
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M6==N5[9)%?76*,4 >0:K\$?$FJ^,[O5I/B5K/]C7$K,=!V'[/L*X\O/F=/\
M@->5>"?&?CO]GO0;[P1-\/\ 5/$$D$\C:;J>GHSP2*YX+$*?KZ]CZU]:TF*
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MW(U'PBSS ?>LKT;2?HRY%1_ +X0>&M:\5_VE-XBT?Q-!:QLPTQ8'#[CP'=)
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MU?\ .HJ* )?M4W_/5_SH^U3?\]7_ #J*B@"7[5-_SU?\Z/M4W_/5_P ZBHH
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M;)[@'Y1[+[U]5Z%^S[X/\,>([C6],LY;:\D1EA3S-T5LQ&"T:GH?Y=L5\?\
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M'T&3[5\W:[X6\5^ Y9=/NX;VQBN?E/D2-Y%Q^*G#?0\U1L_#3!1)>2"&,?P
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MFVO=4MGN;B(6)B!>0*$^2;:V!@XQUKZ0HK58N237+'7R,'E\7)2]I+1W6O\
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MG@H4Z?QR25WOY\SV1\]Z#\)/B/X3T^YGTI6L-4&C_8X9+2ZA=_,.H2S%,NP
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MRUU*.$+_ ,)19&2:Q>.,1[HR$;>I50=AV\CK75>%_AG?>'O'-GK#W-C)9P:
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MY/%?3E& .U 'C.JOXS^('A>3PXG@R3P]#_8\MM=7.L&+F?R@B1VQ1VRI;JY
M&,<50T:R\4Z]XL^&#7/@W5=%L_#]O)!?75\T.T2?9O+&P([$H2/O<=1Q7NN
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MK'2Y[A;1-+CCMTF5<J5.2Y4$'AB<]\5H\/.+2;6KL8QQM.<7**;25WMHOO\
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MWF5.G/-<5[>?\*.WG_P_7[C250BA5 50, #H!2T5D^)O$UIX4TX7EX)&C+A
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MI6K6&IV\1Q)-974<R(?1BI('XU\T?$6R6>;XK:79Q"+47U6POIX(;/S99-/
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M3[-"QW1;20G)&[;G&2,2?$P^'?%Q\3+86[V'B3PVT37D4D83SX9.4D!4D,K
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MSSSV_P"!^O6R1W>DN!'<NWG(W]\ <CZBO6:^4],U&?2;^"\MG*30N'4CVKZ
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MU"!"3(O1PO!R.QKO:^=Q<J[J6K/7\/D?<X".&5%2PRLOQ^84445Q'I!1110
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M$4$F-IE^\Y'^\>:UZBO*E*=Z,;+S-<+#$0IVQ,E*7D%%%%<QV!7G?C;XK_\
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M^J-X4JM17A!M>C,NO0/ _P ,H-=TU=4U2_6TLF8A$1@K-CJ23P*Y,^#O% ;
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M>:;:W72[A;<&0 .6B\S:QX&"1Q7QU:?M-_&+2;M+@>,KF[V'/DW=M"\;?4!
M?UKVSX:_M^[I(;+Q]HJVX/RG5--4LGU>(\C_ (":UPW$^&KRM%\K\TOT-,P\
M,,TPU+GIVK):VC)W[[22O\KL]S;POXF?4$OVC\%M?1IY271TJ<RJF,;0_F9
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MRV5O+?6RLL%R\2M)$&QN",1E<X&<>E<]XA_Y*%X._P!S4/\ T0*ZRN3\0_\
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MY%<U\1/%KZI=-HFG^9)"L@BN3 V'GE/W;=".YZL>PJIXT\.IX,U'3[W3;B2
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M .A-6G7]59;_ +C0_P $?R1^+XO_ 'BI_B?YA1117HG*%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 45BZUXST/PY=Q6VIZE#9SRJ'"N&.%+!0S
M$ A%R0-S$#)ZUM4 %%%% !1110 4444 %%%% !1110 4444 %%9.O^*M,\+P
MB;4[B2VAVLYD6VFE55'4L8T8*/KBKVGW]OJMC;WEI*)K6XC66*0 @.A&0<$
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MEBY4J3NE)I?)Z'[/EU7GR[VV)5DX7E_X#=GZG,-K$>E8/@+_ )*#XX_[</\
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MX4?NF8GT&X%3VJ]^T!::AI?B73Y],@D<^*[-O#-P\:DA&=PT;MCH /,&3ZT
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M9WT%AJ&HQV^J0W$?ERVT4;YF20$],KM)&00W%>CC Z *.P'0#TKG? ?B:_\
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M:1V4PBU0_P#/2YN .?PS[8ZU]T>!M4\-ZIX7L&\)WEC>:%#$L%L=/E#Q(B@
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ME545550JJ JJHP !T '84M<I_P )U=_]"7XH_P# :V_^2*/^$ZN_^A+\4?\
M@-;?_)%>O]7GY?>O\SX3ZS3\_N?^1U=87@+_ )*#XX_[</\ T2U4?^$ZO/\
MH2_%'_@-;?\ R15OX9I?77B7Q7JEUI5YI,-ZUJL$5^$61A'&58X1V &3ZUK&
MFZ=.HY6U7=?S(QE4C4J4U&^C[/LST.BBBN([PHHHH **** "BBB@ HHHH XG
MXKQK)X?MU=0ZFX&589!^5J\OKU+XJ?\ ("MO^O@?^@M7EM?B?%27]IR?DC]!
MR;_<UZL4 D@#DFMJR\':K?W4UNEN$EB57<2, !GH/J:QX7\J5'QG:P.*[[5?
M$6GSVCR6DERWVVXC>XD\M@(5&/E#8QV_4UY>78;"UXSGB9VY>ETFU9[7\[>B
MNSLQ56M3<8THWOUM>VWZ7.#N;:6SN)()D,<L9VLI[&HJT_$M]'J>O7MS#GRG
M?Y21C(  S^E9E>77A"G5G"F[Q3:3[J^C.RG*4H1E)6;2/4/#/_(O6'_7,_\
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MIHLI\!1^(IEM]%?7XENG>0QIL*/PS#HIZ'VS7K.F:%IFB^9_9VFV6G^8<O\
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M:])))N\2ZD(B^45"P.,\9.[DXX.,#OC.35FT\":A:^(6U8ZA-/,UJ+4I*AP
M$50XP?O%@6.<CDXP>:^&O^'@7Q5_N^'O_!<__P >H_X>!?%7^[X>_P#!<_\
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M  \"^*O]WP]_X+G_ /CU'_#P+XJ_W?#W_@N?_P"/4?VY0\_N0UX69TM/<_\
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MU,97Y.6"N[2=[?<?85%%%>L?FP4444 %%%% !1110 4444 <7\5/^0%;?]?
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MEW.&:*!G >0*,L57J0.]62<5\\>'77QK\1OAEJP\2:OJ,@TN]66XV_8S(\3
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MZ.D+#!'EJ=F[;@;\$C\37&:W\9[W6OAYJ_A#^R;6VL=1U^37S,DSL\3OC]T
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M)H66Y"C+;)%<H<#D_-Z>M:LO[+OQ8@>R5_ NJ!KR0Q1 ",_, 2=V'^08!Y;
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MUKRKQ3\?-8\+ZJSS:YX3NC'J2VLGARQ26YNDA:0)N:Y1]BR8.XJ5 '3->O\
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M_,ZHH5%!))9@,#UKG-*^->@:AJR:9<6^LZ-?30RSV\6L:3<6?VA8UW2",R*
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MCGEGE:!U=%A!9_D(W?=&1QR"".M'U'#?\^T'^N&?_P#09/[SP_\ X=U?#/\
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M3[\B^:H#*N1G'3(J'P]\</#'B75M/T^)M2L)-3S_ &=-J>ESVD-[A=W[F21
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MQ)1I#\WEY^7C@$D#TVCZCAO^?:#_ %PS_P#Z#)_>?+?_  [J^&?_ $%?$_\
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MX2'2_P#H)6?_ '_3_&J'_" ^&O\ H7]*_P# &+_XFC_A ?#7_0OZ5_X Q?\
MQ-'O^06PG>7W+_,O_P#"0Z7_ -!*S_[_ *?XT?\ "0Z7_P!!*S_[_I_C5#_A
M ?#7_0OZ5_X Q?\ Q-'_  @/AK_H7]*_\ 8O_B:/?\@MA.\ON7^9?_X2'2_^
M@E9_]_T_QH_X2'2_^@E9_P#?]/\ &J'_  @/AK_H7]*_\ 8O_B:/^$!\-?\
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MYE__ (2'2_\ H)6?_?\ 3_&C_A(=+_Z"5G_W_3_&J'_" ^&O^A?TK_P!B_\
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M_P"A?TK_ , 8O_B:/?\ (+83O+[E_F7_ /A(=+_Z"5G_ -_T_P :/^$ATO\
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MHW+_ 'A^=<TNFQ>GZ5.FG18Z?I0!O;A_>'YT;AZC\ZQTTZ+T_2IEL(QQC]*
M-+(]1^=+D>HJFEE&.U3I9ICI0!+D44Y+5/2I5MUH @HQ5Y85%2K$!B@#,Q2X
M/I6LJ"I HH Q<'T-)@^A_*MX+3NE '/X/H?RHP?0_E70CGO3J .<P?0_E1@^
IA_*NCHH YS!]#^5&#Z'\JZ.B@#G,'T/Y5?TD'S)..U:E% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>aciu-20231231x20f027.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f027.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #W HH# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN]6R'->S^$[K7+RTOWUVUALYEU"ZCM4A &ZU65E@=L.XW,@5NH^\,JARH /
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M+$XW22E6*HN<DJK-@'"D\5R]A^SO\,M+OK:]L_ VAVUW;2+-#-'9J&C=2"K
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M3;/E_P!41GYN "/P1\8]<\8_M%ZUX<C:Q/@JWTR\-B\*%II[BUNH;:XD=\X
M6=KB'8!QY.226POM]>6^ _@BG@3Q5X:U2#5&NX-'\+'P\RS1_OKJ5IXY7N7<
M'&YFC8L,<LY.:]2H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUI<GVBYL;S3KW9Y]E=V\[P7$#[&924EB=<J2" ""017SW\,/A=XX^ LG@GQ
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M^U6]U<I<R?N\A4$$<=M:H6PP$$N.'RP!]=T444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5Y5^UC_P FL?&3_L3-9_\
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M9]7TCQ1>ZM=,=Z,(@ER2$1L$L5()*+G/8 ^S:*** "BBB@#Y5_8%_P";C?\
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M5FBQ17AO[-O[05_\;I=6CO+/2-MK9VE[]IT*[>XAM7G\W=87!=5*W,/E@N,
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M>\$?VA\)OB=X[O\ 6O#=CK-QJ/@?PU]OLHI)D.Z)G\Q=L@*EBF.%=#GFN_\
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M_P#'7A+PU8:/'<2Z1>6GB)[FZ+!961G"1*!CCKEL]>,#'/K_ .R3\5-(\?\
MPUM+*U\RVU2T\R>XM)AR%EF=PRG^)?FQG@Y'3D9Y,/B:=3%5:497<;:?F?0Y
MODN*P618#,*M%1A5YO>5KO\ EOK?57?YGN5%%><^,/'/BW0_&FGZ)IN@:9>P
M:GYGV*XN-0>)F\N-7DWJ(SMY) P3G':O4/@ST:LWQ#K+Z#I<EY'IM[JS(5'V
M73T5YFR<9 9E''4\UI44 <K\/?B#!\1M(_M.TTG4]-LF"M#+J,4:"=3GE-CM
MD#'.<=1755Y_\ ?^2-^$_P#KR'_H1KT"@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L74_&OA[1;M
MK34->TRPNE +07-Y'&X!&1E68'I6U7P%_P %,/A]\.;&_P#!GB+Q#J7AKP#/
MK]_)9:GXQU#PR->O0L5L6A1+4YW1Y7:S@$KNC]30!]9_"/XOK\4O$OQ'L(([
M1K'POKD>DVUY9S^:MTC6=O<%R1P"&G9<#^[7I)( ))P!W-?(_P#P39TOP7I7
MPE\2Q^!_B)8?$G3FUQFFU'3_  C_ ,(XD$OD0_NC!M'F';M;S/\ : _AKZ1^
M*-WX9L/AMXIN/&GD'PA%IEPVKK<@F-K3RV\U6 Y(*;A@=<X[T :]MXCTF\TV
M;48-4LI]/AW>;=QW"-%'MY;<X.!CODT^XU[3+33XK^?4;2"QEV^7=23JL3[O
MNX8G!SV]:_,C0;@^,M+TOXG2:9H_A#X9>+OB3X5#>$XY8/*L]$M([F*WNK]%
M.Q#/.UH3GM%$"2H!K2T5?#G]J^#E\7_8/^%0_;?B2-'_ +4*?V;Y7VG_ $?R
MRWR?ZC[3Y?\ L^;LXS0!^E-UJEE8W%M;W-Y!;SW3%((I955I6'4("<L?I7FG
M[6/_ ":Q\9/^Q,UG_P!(9J_/KQ U^?ACJZ>,&<>.S\(?"#>#UU @:B;X73_\
M>V[Y_.^TFVWX^;)CW=J^T/VQ-6^(L7P+^,-MI_A7PO=>$SX2U16U2Y\2W,-\
M(C82>:XM%T]T+*2^U?/ ;:N63<=H!]%4444 %%%% 'R/X0\6_ #X6?$WQ!KF
MD7'C&ZU2VN[_ $WRH/#&M7VGZ=-]I*WD=J8K1H\&:)E)#.%VE4*KD'RK]D7Q
MQX"^#GC'QQJ%YK/B*[6*0:)$UA\/M;274D0)/]MOBMNY:Y)F9?F"L/G<Y$JA
M>O\ AT0++Q22< >,?$_/_<<OJXOX'>-[#Q#KWB]88KJW76+\Z]IKW,6U;RQ:
M&"%9H^3QNCZ-@X=#CYJ\F6)Y9-*.Q^@4LE56E3E*L_WB5]GI9-:^6B7W'V#\
M%_B9\-_&UYX@TWP%:2:;=61AO]3M)O#EWHSL;@RB.8I<01&3>;>4;P&YC.3T
MKU&OF?\ 9L_Y+W\3O^Q9\.?^E6M5],5Z-.?/!2?4^,QN'6%Q$Z*=U%V$50N<
M #)R<4M%%:G$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YM\9-
M%^&?Q,\,7/@SQ_?:3+875[:6OV2YU);6=+V1MUHL;*ZND[,,QA2&;D#(R*R/
M@U^RG\/O@7XAU#Q#X>L]1O/$=]:BQFUG6]3GO[K[.&W^2KRL=B;@"0N,D#.<
M#'S_ /M[?LV^#KF6'XJ7GCCQ[X5U:75](B;1O!TWFR:U>12%+5+: E=M[\VV
M*;<1'@ML;G,G[&T":-\8[_2/$/B+X[Z?XO&C27=OX:^*FOQZA87=H98U>Y@\
MM K21ML4Y(*B0\')P ?;E%%% !1110!\9_L?>#5\<Z-^T9ISZSJ^B(/C5XCD
M:?1;K[/,XVP#86P?E.[)'J!Z5]*_";X467P?\-0:#IFM:WJNFVT$%K:Q:S>"
MX^S11)L1(_E&T;0!CV%>&?L"_P#-QO\ V6;Q'_[;U]54 %1SSQ6L$DTTB0PQ
MJ7>21@JJH&223T '>I*Q?&OA>#QOX/UOP]=326]MJME-922P_?19$*EAVR,]
M^*F3:3<=S6E&$JD8U7:+:N][+J[=3YE^#GC36O&OCOXG0?#OQWX619/$<^H+
MINI:;+<O<1^3;Q^>CI,F8BR;.%.,9S\RUZX-7^->B@M=>'?!OB>,#IINIW&G
MRG_@,L4B_P#C_P#C7@'[&G[+K>!?BGXJ\27NN"\?PSJ5SH-O!;QE!._DQL97
MR>FR8 )S\W.>!G[7KQ,OIUJE#GJWA*[V=^O9W1^H\88O+\%FGU? J&(I*$-9
M0Y7?E6G-'DD]+.]^MNA\;?M.:_H?CJ+P=:?$3P%JW@NY37K:"XUF]BBEMDM&
MW^8J7D3.OHVUP/NDX.#7<_ #X$:*_@NT\06&O:U87=]YT1ETN[2%#$DSHH&$
M/!" ]>M>L>./@AX$^)6K1:GXG\,6.M7\4 MDN+E266,,S!>#TR['\:\=^&'P
MOUKPEX"T_P 5?#:[-OJ7F7 O?#5[.W]G:I''.\:J,Y\B8(BJLB\': X(R:Z*
M=.MAZDZDDI)VV^*R^23]$>/BL9EV;X/"X*G.5&=-2TE=TKR:=DW.4HK?WG=7
MM>RNU[#_ ,*PND=&B\=>*XM@QC[5 X/UWPMFO ?B9\16\%_%;1-/;QOJU]+H
M[2K<7ESIUM*+5I4 (4*$,G&-P/3MD\5]&?#;XD:5\3O#YU'3EFM;B"5K:^TV
M[79<V-PO#PRI_"P/X$8(R#7F'Q2^"WAGQ)\:/"=W=P3@ZP;AKZ**7:DQ@B5D
M/3(SP#@C('8Y->E"<9Q4HNZ9\3B,/5PM65"O%QE%V:?0[B%?B39PQRVVH>&?
M$=LR!U:6":QDD!'&"K2+SP>E>>_'CQOXMN/AOJ&G2^'-4\-7LCIYMW:N+JUD
MAS\R^?'@QYX^^JC (/6OH*.-8HU1%"(H"JJC  ':G59SGSQ^QKI6OV?@[4;N
M^N-VAW4BG3[<RA]K L)& 'W 3CCOC./7Z'KP;X3?#F1OA;X:U_PK?G0/$;V2
MM*>6M+X@G"W$70YZ;UPPZY.,5Z9X)\>KXCGN=)U.U_L?Q/8C-WIDC[OEZ"6)
MOXXV[,.G0X- '6T5RU]\4O"&F:K)IMWXDTVWU".01/;27"B17_ND9Z\UU- !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5\Q?M7^#?BEXQ\4>$+_ ,!W>L>$Y/#L\\T?B'0]*T[6)'6:$1NL
MEM=W$#*H^88C$NXE3M!4$?3M?*W[>7@C5_$FD>!M7MM%\0>(/#VC7]P^LV7A
MCQ&NC7ABDAVQMO=E61!(%RH(;)4@XW9 /1/V8#XQ'A'5X_&WC[5_B!JT>H%5
MN]9\&'PS);)Y:?NEAVA9ESEO.4LI+%03MKUZ]L;;4K66UN[>*ZMI1MDAG0.C
MCT*G@BOAS]B#X7_$?PE\6K[7KG2_%&@?#K5M.O9X;/Q%XH76,JTEH+)6 8JL
MPV7S$KTCDB5B6!9_NJ@#&LO!GA_3;>Z@M-"TVU@ND\NXCALXT69>?E< 88<G
M@^M6[C0=,N]/BL)].M)[&+;Y=K) K1)M^[A2,#';TJ]10!5NM+LKZXMKBYLX
M+B>U8O!++$K-$QZE"1E3]*\T_:Q_Y-8^,G_8F:S_ .D,U>JUY5^UC_R:Q\9/
M^Q,UG_TAFH ]5HHHH **** /B'X<_P#'GXH_[''Q-_Z?+ZN5^"GA/2= U_X@
MR6%DEN\.N-90G<S"&W%O!*(8P2=D8>61MJX&6Z=*UO#NJ7VCZ!XJN-.T:XUV
MY'C3Q*OV2VFBB;!UR^RVZ5E7 ^N:\V^"7Q?O]>\2:_%:^"M6\K7]0&N6\\L]
MM&OV)XH(/.&Z0%U!C)^3/#(?XAGYZ:;E.W?]3]APTX1HX926O*NC_E]/0^DO
M@=!J-U\7/B]%I%PMIJC^$O#XM9W *I+]IUK:3E6&,X_A/T-:TOPW_:''POTS
M35^(&AOXNMM52ZGO5CDCMI[6-UN$BY1I07D06[@LP\J1V^; CJ+]FS_DO?Q.
M_P"Q9\.?^E6M5[A\1O#-GXF\-RK?ZAK>G6]F3=M)H&H3V=PP1&RNZ%@S @GY
M>Y ]*]G#_P *)^;9O_O]7U//E\$_&+_A:,=\?'&G_P#"&_V6+1[;[./M?VGR
M\F<#9Y6/, &TKG#$[L )6Q\!/#/Q*\,:%J</Q*\0V&OW\]Y)<VK6&XK"DKO,
MT1+(I(C:4PIR1Y<$9 0L5'BO[)ZKX[UO4)]4U[QE)>V_V?Q)ID<GC.ZU"U.F
M7;RFUAN%$FSS5$+!T8,K#!5G&[;]=UNFI*Z/(::=F9'B^WUB\\)ZU!X>NH;'
M7Y;&=-.NKE-\4-R8V$3NO=0^TD=P*\I_9FT#XC:):^(#XX;5H+&5K<6%EK^I
M0ZA>I,%?[5+YT3,HAD)B\M"<KM<[4#!!ZQXL;6$\+:RWAY+:37Q93'3DO"1
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M8M&E];),$/0D!@<&O'_V8_ 7AFV\%ZAJ$/AS28K^#QCXI6*Z2QB$L837]01
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MBG6M065(GTVPOI2D)\HY,DBA7D= 5"HA(9B0M>@?M8_\FL?&3_L3-9_](9J
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MF?Y]DHNX3LP &1FP"[57^!'_ !X>-?\ L;M6_P#1YKJ/V>O^1S^.'_8Y6_\
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M-2T44 %%%% 'RK^P+_S<;_V6;Q'_ .V]?55?*O[ O_-QO_99O$?_ +;U]54
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MPK\=/$FB77VW1=8^+.NZA8W/EM'YT$J6LD;[7 9<JP.& (SR :^P* "BBB@
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M/C)_V)FL_P#I#-7JM>5?M8_\FL?&3_L3-9_](9J /5:*** "BBB@#XA^'/\
MQY^*/^QQ\3?^GR^KJZY3X<_\>?BC_L<?$W_I\OJZNOF:O\27JS]OP'^YT?\
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M?W0U/4M;U&]2&"6_U:5))O)AW^3"-B(-J>9(1QN)=BQ8G-? U*RBJM-[MO\
M/^OP^7VM.DY.G/HE^G]?B=[^RS_R%OC/_P!CG%_Z8M(KW>O"/V6?^0M\9_\
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M,0Q)MA.TKS\HS0![7_PUC\$/^BR?#_\ \*BQ_P#CM'_#6/P0_P"BR?#_ /\
M"HL?_CM'_#)WP0_Z(W\/_P#PE['_ .-4?\,G?!#_ *(W\/\ _P )>Q_^-4 '
M_#6/P0_Z+)\/_P#PJ+'_ ..TC?M7_ ]@0?C'\/R#P0?%%CS_ .1:7_AD[X(?
M]$;^'_\ X2]C_P#&J\4^%7[%/A/2_P!I/XYZOXD^$/@]_ .J?V%_PB<=QI-A
M/;IY5FZWODP $P9F*[LJF\\_-C- 'KND?M*?L_>'[5K;2_BI\-=-MF<R&&S\
M1:?$A8\EL+(!D]S5[_AK'X(?]%D^'_\ X5%C_P#':/\ AD[X(?\ 1&_A_P#^
M$O8__&J/^&3O@A_T1OX?_P#A+V/_ ,:I))*R*E.4Y.4W=LYW7?C7^S-XGUFS
MU;6/B#\*]4U2TQY%Y=ZYILLL>#E<,TA/!Y'H>1S71?\ #6/P0_Z+)\/_ /PJ
M+'_X[1_PR=\$/^B-_#__ ,)>Q_\ C5>*?\,4^$_^&T/^$A_X5#X/_P"%3_\
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M:\?V_P"R)\2O&4GB?6OB5X$?5)L&<V_C&TBCG8+M#.HFQD #IC..<Y.?9?\
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M#XFVGA#XN>.M:U?PM\0+33-3T/1;.TG_ .%?ZZ_F2P7&IO,NU;,D;5N83D@
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M57;PRJK?Q5ZK7CO[(6K:;KG[.WA&[TJ3Q ]N5NHY4\47QOM1AN$NIDN(99R
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MSJ5QI]U:N_F7%ND!F$T2QJ\BP[@D4DPX=MVT@G[\HHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
IHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>aciu-20231231x20f028.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f028.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $[ <@# 2(  A$! Q$!_\0
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M (8_'SX?_&6XU"W\&>*+/7;FP"M<P1!TD1&)"OM=5)0D$!P"IQUH [^BBB@
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MN/$EI:^1#=ZOK-WJ!M0R@2>4LTKJA(R"R@'!(S@D5\QS? /XPZ1X)^'&C?\
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M8)L3Q(2S$;^6(?Z@5]C_  \_Y$#PS_V#+;_T4M?''_!33_A=G_"D/B-_9_\
MP@/_  J+[#:_:OM/VW^W\^?%NV;?W&/,VXS_  Y[U]C_  \_Y$#PS_V#+;_T
M4M '04444 %%%% &->7>OQRS"UTS3IHAGRVDU!T9AVRHA('TR?K7C?PK\;?$
MK5_&VIVNIV1N+5 _F17JFVCMV!^4*ZH3[8P<CGWKWVBO!Q>65L3B*-:.)G!0
M;;2M:5^CT_._ZGM87,*6'H5:,L/&3FDDW>Z\UK^5OT*.FS:E+YG]H6EK:XQL
M^S7339]<YC3'ZUYW^U,2/V</B45*JPT&[P7^Z#Y38)]J]2JEK6BV'B/2;S2]
M4M(;_3KR)H+BUN$#QRQL,,K ]01QBO;A%QC9N_F[?HD>/)J3NE;^O.Y\<:)J
M_BJ#X]_!"Y\=>(_!/B:%S>V6EV?@T-%>6]Q)8L3/.CLYD@$<;HVTH%>2,G=P
M*YK3OB'XUL_V:/!^O77Q!\4ZKXN^(.L?8K6W@N[*S$2PFZ)AAN9TV6P9(LO*
MP=V*@* 37U[X%^ OPX^&6IOJ7A/P-H'A[47C,1N]/T^.*;8>JAP,@' R ><5
M>U3X1>"=;\&0^$=1\*:1?>&(6#Q:3<6:/;QMN+;E0C .YB<CGD^M62?'_P #
M/C5X\USPIX9M-8\3OJ-Q9_%R3PQ)<QW\-^TUB-.,_D27,<:).5D<@NJC.T#M
M6I\"?$?Q!M=0^!OBG6?B3K?B2'QU>:C8:AHM_'!]CBBCM[F2$Q!4#AU,"Y<L
M2VYL\8 ^J]$^$'@?PS;P6^C^$M&TJWM[Q=1A@LK*.&..Y6/RUF55  <)\NX#
M.*T++P#X;TZ#18;71+&WAT21Y=-2.%0+-W5E9HQ_"2'<''9CZT ;]%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%5
M-5M[J[TZXALKO[!=.A$=SY0D\MO[VT\'Z&D]"HI2:3=O/_ABW17E/P>UK7_$
MVIZ_+?>,[77;72M3N-.-K;6<*9VXVNS(20>3Q[5ZM6=*HJL>9*W]>5SMQV#E
M@:[H2DI-6VOUU^TD_P  HHHK4X HHHH **** "BBB@#X[_;2\;>)+[XG^#?A
ME\-?AMX/\:_$36=-N-2DU/Q?:PRPZ981R*F5\S&XEV<X!.-OW&W97+_9#\:>
M+?"WQXU7X5_%?X7^"O"?CD:$VMZ7X@\'64$,=[9><D4B/L)93O/&=@/EG*_=
M+>9?MB_'C]EOX\:9X1U+Q7XE\7>&=>L'NSH>O^'[.2.Y@V3>5,K#!!7S(AC.
M",95AN.=C_@G)JW[.MI\3_$-K\.O$_BKQQ\2=4TYIKW7?%5LRRBSC>(-&C$
M!2QB)!+$[5YPH  /T-HHHH **** "BBB@#YJ_P""D/\ R9+\4O\ KRM__2N"
MO=?AY_R('AG_ +!EM_Z*6OBW_@IM^R]X,UGX._$3XNW$FKCQ;9V%JL2QZ@ZV
M>%FBB&8?NGY6/X\U]I?#S_D0/#/_ &#+;_T4M '04444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'+^QMX]^#&B_ /6OA5<:#K7BKX;Z=>Z9J.FZP[VUKJB7BEIGCD524*S/(P!
M+!P2WRE6]7_9P_9?C\"? ;5?!WQ(MM(\5:IXIU6[U[Q+;QP^98SW5Q*KE0'&
M751'$,L,Y3Z5]"T4 ?CY_P %%_AKX(^&FH^+M(\+3?"3PQ;0V-K)%X:BT4Q^
M(=S%"S13+'M7/+?>^[D5^L?P\_Y$#PS_ -@RV_\ 12U\,_\ !3OP1\5KCX<?
M$'Q!96OPY;X:1V%H+B:[M)CXB!$L2GRY1'L WE<9;[N:^H/B-XI\0>"OV5I=
M:\+*K:[::%:-;E@#LRL2NX!X+*A9@#G)4<'I6=2:I0E4>R5_N.S!86>.Q5+"
M4VE*I)13>B3DTE=]%KJ>S45^?/[$GQ=^+GC[QEK6A_\ "3#4K(VC7<EWXDCE
MOA;.'4#RP)4;G<?DW@8!/:OLK_A7>N:GSK7C[6IU/WK;2HX-/A_ HAF'_?W_
M !K@PF.6,I*K3@[?+_,^MX@X6EPWCY8#&8F#DDGHI-M-=N6R?DVCM[J[@L;=
MY[F:.W@C&7EE8*JCU)/ KQ3XY?M0>'_AW\.M<U;PSJ6G>)M<M%5(K:TE^T11
M.SJNZ9HLA -V<$C)P,C.:[FU^"O@J"X2XN-!AUB[0Y2ZUR234IE/J)+AG8'W
M!K=\1CP]I_AJY@U[^S;70'3R)X]0,:6I1N-C!L+@YQ@^M;U57G3DDU%VWW_R
M/)P,\LH8NE.I3G7BI)N.D+J^L=.=N^VC1\>?L7_M6ZKKL6K^&_$VEWE[;6OF
MW\-_HFE7%TZ-+.SR))' KM@M(2I"\8(.>,?4/_"\/"$?_'Q>7]@?2_T>]M2#
MZ$20K@^W45Q_[+=KX&TCP;<6?A5M%COY+R]DNHM/EC>=HENYEB9]I+;0A4+G
MC!&.O/ME<F IUXX:"E44M.U_ENMCZ+B[%Y57SK$3HX.=)7V4E&[6CE9PE;F>
MNCL<-#\=/AU/*L0\=>'8YF^[#-J<,;M[A68$CWQV/I7/?&/XN?#G1/A_<:OK
MGB62XTV!T>./PUK,D%W/(00J(UO,C-GG@L%XR>F1ZM-!'<Q-'-&LL;=4=00?
MJ#7EWQK_ &<O"GQH\&76BW%I;Z/>M(+BWU2SMD$L,P! 8XQO4@D%21G/4$ C
MIKK$>RDH6;MI=?\ !9XF55,G6.HRQ7M*=-27,XR3:5]6K1BU\KOM<\V_9<_:
M ^'6I?#Y+F]\7WEEX@AA@M]43Q9KLTK2SA3EX%GF==KMNXC )X!4?+7L7_"Z
M- NN-*M=<UYCT;3-%NI(F^DQC$7_ (__ "->8?L6? 72?A7\.+3Q#%=/J6L>
M);2WO)IY(P@@0IN6)!D]-YRV?FXX&,5]%UA@8XCZM#VC2=NB_P"#:YZO%-7)
MUG6)^IQJ5(*6CE*VJW5G"_*G=+5.R1P?_";^+M1XTWX>7MN#TDUW4[:U0^^(
M6G8#ZKGVKP_]K_P)\7?B/\)98;2#28[>UN%N[K1]%N9IIIXU5N/,=8Q(%.&V
M;!D@$<J ?JRL7Q7X4MO&&GK9W=WJ-I$&W%M-OI;5V&""K-&P)7GH?:ML1A77
MI2IRFW=>2_)'G9/GD,JS"CC:5"$7"2=[2EMY2G;YJS6Z/E7]B7X4_$W0/AC<
M7%WXCE\,Z5J,J76G:?-:1W3&-DR90&/R!\K@=3MSCD$_1'_"$^,9?];\1KR,
MCI]ETFT0'Z[T?],5M>"? UAX!TL:=IMQJ,UHBI'''?WTMSY2(NU53>QVJ!V&
M*Z*IPN#C0HQIMO1?S/\ X!KGW$=7-<SKXV,86F[K]U#\;J3OW;;N]3@_^$#\
M5MPWQ+UD*>"4T[3PP^A-N1GZ@_2O!/VN_P!F/Q]\3?"FD-H'BO5?&-SIUP[M
MI.KM8VP<.%&^-HH8$++@\2$\$[2#D-];T55?!4L13=*;=GYO]3GRKB7'9/C:
M>/PT:?/!W5Z<+;6:]U)ZI]&GYGS+^R[^S_\ $+X5?#)=/U#Q<VA7US=/=-I*
M6T%Y%;!E48+G^,[<G:Q7GN<FO7O[%^)5MS%XL\-7B_W+GP[.C'_@:7F /^ '
MZ^G>455'"4Z%.-.#=EYO_,RS'B'&9IBZF,Q$8<TVV_W<.OFXM_>V_,X/S_B=
M:_\ +EX2U/'_ $]W5GG'_;*7&?QQ_M5\T_MH_'7XN?#?2= M;2PM?",%\\GG
M:GI%\;X2LNW$8D>",Q]<_=RW8X!S]I53U;1M/U^Q>RU.QMM1LW(+6]W"LL;$
M=,JP(-9XG"U*U&5.G5<6^O\ 6OXG9D>>83+<PI8S&8*%6,7JM5?1K:[AIOK%
M[=-SY\_9H^(/Q:^+GPFT[5KZ70]-?S)(%U74;.6>:\53CS1#&\2CG*YW\E#Q
MZ^I_\*ZUS4^=:\?:Y<*?O6VEQP6$/X%$,P_[^UW,,,=M#'##&L44:A$C0 *H
M'   Z"GUK2PW)3C&I)R:6]WK\CBS#.?K&+JU\'0A1A*3:BHQ?+=[*35_NLNR
M2T.&@^"7@E95FO-"BURX0Y6?7II-3D4^H:Y:0@_2N-^-G[*OAGXWSZ4=0NIM
M*@TV+RK>#3K>% HW;B-VS=@\#;G Z@ DD^UT54\+0J0=.4%9G/A<]S/!XB.*
MHXB2J1O9MWM?1VO?H<OX*^'^F^#/ VF>%E2._P!.L(C"@GMXE#+DD915"YYY
M.,GDDDDDT[[X+> =1G-Q-X-T,71_Y>8K".*;U_UB@,.>>O7FNTHK7V5/E47%
M61Q?VABU5G6C5DI2;;:;5V]7M8X/_A3&A6_.G7WB+2".@LO$%ZL:_2)I3'Z?
MP] !TXKXY_;5_9S\?:OXS\/ZGI-]J/B[2+E8M,MQ?W,7G6MPSD+&>$&ULC#\
MG.=QX&?T"KE?$WPK\(>,]06^USP[I^JWBJJB>ZA#L I) S[9->?C<OIXJBZ2
M5O33]'^1]APSQ=B\BS&..J3<[)KWESO7M>46OE+RLT<'\*_#'Q3^&WPZ\/:)
M=-X>\42V%HD3K<74]G,G?R_-"3+)L!V@[5!"CIUKJO\ A9&KZ;QK7@+7[11U
MN-/\C4(3]!%(9?SB%=AI&D66@:;;Z?IUK%965NNR*"%=J(.N *N5UPHNG!1C
M)JWS_-7/GL5F=/&8BI6KT(R<VVVDX/5WVC+E7W/YG$6WQK\$33I;W'B"WTBZ
M<X2VUM'TV9CZ".X5&)]L9KQ#]H?QS\$-(^)O@D^)K;P[?ZF^H_:M7G;2X[QV
MLS87447G.$;>OFM;D(22-JMC !KZAN;6&]@>"XACGA<8:.50RL/0@]:^)OVE
M_P!BBV\6?%OP]JGAS4K/0;3Q1?#3[BR%KB.VDCM)IFEC5, ADMFRO'SG.<,=
MOG9C]9C17LXJ;NNGGZ_+<^PX-_L.IF<EC*U3#P]G/52O?W7?5035E>2]UZI'
MTUIWB*^\5Z?;6/@*S@TKPY'$L46O7%OMMQ$  JV=OQY@   =ML8&TKYHR*Z3
MPQX(TWPJ\]Q )KS5+H 76JWS^;=7..@9^RC)PB@(N?E4"K'@[PS;>"O"6B^'
M[-Y);32K*&QB>4Y=DC0("V.Y [5L5ZE.F[*4]_P7I_5SX;%XM.4Z.%TIM_\
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M^=W_  4)N_#>@?M-?#?7?%'PCUOXMZ-;^'KJWNM.LX))+>(O/F*4;009%*R
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MVK?L]6P\&0?%D^*H_%T:RSZ/=>"1%]OMX-R[C)YS+$8RZC&?F!5MF,MGC?\
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M/()\_P WS>.T97G[U '2T5YXOQ6U@^"&\0?\*O\ &0O!>?9?^$?(T[^T"O\
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M:UX!\16>C>-];'A2?Q1H\OART?2/M313"%K*2.XN9U1G>2+9*90OS/E1LR>
M\1^'E^//B[]F[5(O!WB_P=X<@M=8%]I\$=_H-SHA^QHD<$DD!AD@7>A1<,J2
M #;N4U[9I?PKTKX1Z5XFUWP7H-WXA\77-D=G]NZ_=7=W?M$K-#:F]O'F>*,L
M3@9V*79MN220#C_"_P 3OB1H/Q.\.>"_&Z^%=6U7Q)H%WK$-KH$$]H=(FMS"
M'AN'>:?SH6:X"+<*D7S1']T=^$Z/X+>-?%OB?5O$UAXBU#P]XAM=+^SQQZYX
M9L9[2S-X6F6[L@)9YO-:W,<6Z56 W3-&41XG%>46%K%\4_C1X)USPCX!\0^
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M\<^$O$=[KW[7'DZ'J4]OK/@ZRM]):.SD87\XTV]1XX"%_>N&:-2JY(+*,9-
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MD4ZC<M&2C $ H48$CD$'O7AW[/GP\\3:.?V3SJ7AG5K$Z'H_B6/4C=6$L?\
M9\DHB$2S;E'E,X#;0V"W.,T ?6W@#XB>'_BAX=77/#5^;_3S/+:N9()+>:&:
M)S'+%+#*JR12*RD%'56'I7BWPP_;&\.ZUJ7BS2O&-['I.H:3XQU'PY'<6>E7
MIT^"..^DMK075YM>W@GD"K\LDB%BZ$* ZYZ3]FK1=7T6^^,/]JZ=>:?'=^/]
M0N[$W=NT0N+9H+;;+'N WH6#@,,@D$9XKY\NK37=5^"GQQ^$8^'WBF+Q3XQ\
M7^(TTFXET*X&G7%O>:A-Y=_)>;/(BC1<OB1U=EC0HK"2/< ?5-S\?O UKX^U
M3P6VK7+^(-)"MJ<4.EW<L&G(T(G22ZN%B,,$;1MD/(ZJ2K@$E& B\%?M#^!/
MB!X@L-%TC4K]+_4K62^TT:GHM]I\>I0)L+RVDMS#&ERH$D;9A9_E=6^Z<UXM
MJ/@GQA8:E^UA)H_AC^W=3U73--AT9-;L1)::S)'HZQE<2CRYQOW*RDE=Q*MU
M-<3X3\/7^K?M)_ WQ+8V_P 5/$=K8MJ::UK7C'1KK3K737ETLQ6]M%9?9[>"
M! 8V!EB@"%F4-*[,  #W7P[^UK\/SHNA1WOBMO$NMZEI?]KPIX<\+:FSW=J9
MI8O/CLT2>945H75LEMN 6P'7*_%+XV:O9?#[0OB%X!U'0]4\%7%NM[)<3:;>
M7K7J,595#PLB6,0C$I>[N-R1$#>@ ->+?L2?#SQ-X4\:^#[G7/#.K:/';_#&
M+3Y)M0L)8!%<?VQ=R&!BZC$FQD?8>=I4XP17>?L\? '2O%W[/WA:T\?^']5L
M]4M9-6M9[*6ZO-,>>UDU&X807443Q_:('0J?*F#HRN3M(8Y /IZBBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\L/B[X!^,GPY^/7A
M[P+J_P"U_?\ AQ/$5K=:JE_J[O9VEM$LH2."-VGQ)*S,0$RG"$YR0I]$_8]U
MCQCX<_;(U7P'X@_:&E^,^G1^$Y-4A6RG-Q:)(;B-&64B1A',@P0H+960DE#M
M#='_ ,%'O&O@.ZUGP?X!UKX%:K\<_%MU:SZG9V.C37%M<V-L&".ZS6\;RD,R
MC*!=OR M_#63_P $\=1MO#OCW5O#FE?LG>(_@C9WE@]W<^*-=N;ZZ:X='C"6
MWF7-LF =Y8*K@?(3M)R: /OZBBB@ KG?'WP]\-_%+PQ<^'/%FC6NOZ'<LCS6
M%ZFZ*0HP921[, ?PKHJ* .4\>_"KP?\ %+PS'X=\7>&]-\1Z)&ZR1V6HVZRQ
MQNH(5ES]U@"1D8."1W-:GA/PCHG@3P]9:#X<TFST/1;)/+MK"PA6&&)<Y.U5
M  R223W))/)K7HH _,__ (*BZY-'IWCO3Q\0OAS:Q-I]GGPI=Z=&WB*7YXSF
M.?[P!^\/]D$5^B'P\_Y$#PS_ -@RV_\ 12U\'_\ !3W2]6?P+\0+Q/V== U7
M3%L+3=\6I=0T];^T_>1#"PM&;D[3^ZX?HQ/3(K[P^'G_ "('AG_L&6W_ **6
M@#H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;!*G %>E? WX+Z+\!?A[:^%=%N+R_59YKR\U+49!)=7]U,Y>:>9@!EV8^G
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MJ^*D_P /--\5WCZGJVBW&APZI MZX ENK7>Z>1(^,MG>I;!*G %?1-% ' ?
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M *+)\/\ _P *BQ_^.T?\-8_!#_HLGP__ /"HL?\ X[63_P ,4? 3_HD/@_\
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M5%C_ /':^4?VLOV8OA+X2^+G[.=AHWPZ\.:79:UXP^QZE;VNGQHEW#Y6?+D
M'S+GL:^F/^&*/@)_T2'P?_X*8O\ "@#6_P"&L?@A_P!%D^'_ /X5%C_\=H_X
M:Q^"'_19/A__ .%18_\ QVLG_ABCX"?]$A\'_P#@IB_PH_X8H^ G_1(?!_\
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M^ G_ $2'P?\ ^"F+_"C_ (8H^ G_ $2'P?\ ^"F+_"@#6_X:Q^"'_19/A_\
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M^5;V106\I3)*K)-E.IY '0G'W[0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%-;0W!C,
ML22&-MZ%U!VMZCT-2T44 1"VA%P9Q$@G*[#+M&XKZ9ZXJ6BB@ HHHH ****
G"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>aciu-20231231x20f029.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f029.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $/ >4# 2(  A$! Q$!_\0
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M&O\ X&1?_%48^(/_ $ U_P# R+_XJ@#U;ST_O#\Z//3^\/SKRG'Q!_Z :_\
M@9%_\51CX@_] -?_  ,B_P#BJ /5O/3^\/SH\]/[P_.O*<?$'_H!K_X&1?\
MQ5&/B#_T U_\#(O_ (J@#U;ST_O#\Z//3^\/SKRG'Q!_Z :_^!D7_P 51CX@
M_P#0#7_P,B_^*H ]6\]/[P_.CST_O#\Z\IQ\0?\ H!K_ .!D7_Q5&/B#_P!
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M% !1110 4444 %%%% !1110 4444 %%%% !1110 C?=->1?&7_CV@_Z[1_\
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M/]E7YFM)&WQ-SS@?PX]O6F!=N=6U^4,IU[65"]XM2N%Z>^_U%0_\)%JZD_\
M$_UM%)R VJ7!XZ==_2K-KJ5AX@*1K++9:AN :!QM.X] ,\$'_&HM4T-H1NV8
M< G"KW%%@,C7/%OB"VTN::W\2:Q%*BAE==3G/.Y>>6].WO7UEHG_ "/6O_\
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M]O0CW/IVJO;ZB(PJR88 $!@?U.*NI=QM+C>"S@,!G.5Z<"@#+O\ 2XK@@S(
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M;]RCKG;GO2 VZ*** "BBB@ HHHH **** "BBB@ HHHH 1ONFO(OC+_Q[0?\
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MY$DU;38KUUB:#+DC=&V-R-@C<IP#M.14R^$='1(U&GP[8[@72@C.)?+\K?\
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MZ\1$[+R21RENP.3E1U 7@>IK'M_AA:>'XXI/$]_-;E/]:(1MB)W8PK#+$GG
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MO_\ 7P/_ $!:^2[[2AI_AK4(H[B0 19$9&>!CD^I-?6FB?\ (]:__P!? _\
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M%WQG;_"JPU>RNM$UN]M]>@TO5=0DM;BQD@A:[AA*M92#?'<E91E&;:OW@6!
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M @JN.0I!'TKZ@HHN%CY>:Y)EC<Z?J$BY/)TZ?(XZ?<I1<'D"UU'UYTVXP?\
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M[F4I"0FYO,V@@"@#U/Q]J'A;Q3\*-8U6_9/$/A.*S?49ET^<.MU'!^]*JRL
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M9E4C:.*]!^+G@/6_',&A?V+JL.F2Z??&YE$JLIE0Q/'A94(DB(WYRA&X J2
MQH J^/KCX:_$:+2_#^O:]I<MU/+#?:8MMJXMKM9&5O)FMY(W612REPK(?F!8
M<@D5S_PJC^&_CKP:= \+V\E[X>FD75I+F>_,MQ<W,=X09)6:1IF?S;8'>_!
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MO/OB-XA_LCQK\/+3S]&B^W:G+&%U*"22X8B!_P#CU900DF"P); VEAWKT&@
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M>55^>;S(]@"Y )8*"<D'C':^#4@7PU8R6KSM;31B:-;B[^U,BL,A?-W-N Z
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M@UWE9E!1110 4444 %>?:'_R/.O_ /7P/_0%KT&O/M#_ .1YU_\ Z^!_Z M
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MO=\.K<>H_P _6@#[)^'OCBU\?^&;?5+<"*4_)<6Y8%H9!U4_S'J"*Z6OF_\
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M,=\4GL5'=$/PNEUN;P?;MX@%R=1\R0&2[14EE3<=KE !LR,?*<D=S57XY?\
M)%/B!_V+VH?^DTE8WPB\3ZU_PIT:KKS37FLVB3FXBU"1()U=,G9.2 L;#OV
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M =_7&?!W_DG&C_27_P!&O79UQGP=_P"2<:/])?\ T:] '9UY]H?_ "/.O_\
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M<;\7-2U/2O E_+I$6IS7[%8HTT>U^T7)W':=HW+M'.2^?E S@D8I/8J.Y@_
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 C?=->1_&0$VT'_ %VC_P#0Q7KAZ5P7Q$T/^TX$
M)( 616/X$&@#OJ*Y2X^*'AVU<K)>.I'_ $Q<_P!*A_X6UX9_Y_G_ ._#_P"%
M '8T5QDGQ=\,QQLWVR1L#.! ^3^8IP^+7ADC_C^?_OP_^% '8T5Q?_"W_#/G
M^7]KE^[NW^0^.O3IG]*?_P +:\,_\_S_ /?A_P#"@#L:*X[_ (6UX9_Y_G_[
M\/\ X4B?%SPRR@_;9!GL8'_PH [*BN-_X6YX9WE?MLG3.?(?'\J7_A;7AG_G
M^?\ [\/_ (4 =C17'?\ "VO#/_/\_P#WX?\ PILOQ=\,Q)N^V2MR!A8'S^HH
M [.BN._X6UX9_P"?Y_\ OP_^%'_"VO#/_/\ /_WX?_"@#L:*X[_A;7AG_G^?
M_OP_^%'_  MKPS_S_/\ ]^'_ ,* .QHKCO\ A;7AG_G^?_OP_P#A0OQ;\,D
M_;9![&!_\* .QHKC(_B[X9D7/VR5>2,- _\ 04[_ (6UX9_Y_G_[\/\ X4 =
MC17'?\+:\,_\_P __?A_\*/^%M>&?^?Y_P#OP_\ A0!V-%<=_P +:\,_\_S_
M /?A_P#"C_A;7AG_ )_G_P"_#_X4 =C7GVAC_BN=>_Z^!_Z M:L'Q2\.7#!4
HO')/_3!_\*CT.TCGUW4+^%MT5Q('4D8R-H']* .O7[HHH7I10!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>aciu-20231231x20f030.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f030.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %! X<# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%Y7:,S")A'OVX+%6/)Y).378^ ?AUH_PYL+VWTL7$LU_=/?7M[>3--<74[
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M$JA2#YJ;8OO#AW].?HRJ6FZS8:S]J^PWD-W]DG:UG\EPWE2K@LC8Z,,C(]Z
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MEY;N/595/]:GCFCFSY<BOCKM(.* /*3\,M:DMHVG>SGN([6&,+M"J62X\S'
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MWVB@#RGX=?"75O!/C.]U ZI -(D\XBSM5=%F9VR'="2JL.F5 W=37JU)WI:
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MV4VIQ6OFYN'FC0N&5<8'M@UH:&P;5M>[$S)QG_IF*0'/MI]K?^#/!@N;:*X
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M^(-7^%_Q9^)WAK6D\!:/<6>F1ZM8^)];TS2+:_LX+EHX1%-YH7-PJ_?WJK;
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M)'X3\/WLYMG34#&#/())%'F<%00I.[&3B@#Z63Q?8:?*MCJ-_&VH!BK"*WD
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M;.72K@,K'9G*2?T-=539(TE7:ZAE]"* /#/BYI%E"^G:O# (+F^=HKA5X63
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M<-)XK\*Z*B^1!JMT\=YJ,J%HK.)4)W,1W)P!FI+[9#=2QQR"1(Y&19!P' )
M8?7K0!HZMXU\8^'ULKCP7HFC:]K%S*;>0:]*4M;:,KS(0O)QZ"N>T6W\26VA
MQ0^*[K3;O6E9O,DTE"D&,G  -74NBA^5L9IDDQ<_,10!6= />NN^#W'Q.\.=
MO],C_G7#W.KP66J1VMU%*MO);33BXC=.&120I5B#SCJ*[[X+6W]H>.-#U*WW
MV\-O?0H\-RR/)*&(VR)L/"G/?D8H ^Z**** "BBB@ HHHH **** /)?C[_Q[
M:'_U\-_Z#7 7'_),=$_["MQ_6N^_: <1VNAEB OVAAD_[M>?W$BCX7:$Y.$.
MK3X;L>M 'JGP(_Y$R;_K]F_G7H]>;_ 9@_@J5ARIO9L$=^:](H **** "BBB
M@ HHHH 3%+110 4444 >,V6H"R\,V@SDR"48'IYKUQ5M%?\ B6Z:-;F.,KO+
MVY)14 ;:!Q\SD]3R *]$\2^";O0I+DVMO-?Z++(TZ+; &XLG8Y8!3_K(R<G&
M01GC-><W&GO'?/-;6\&M1.?WUJDI@G!_O*#AE;U&"#4VL[GTN#JTO8\L':77
MI<>_A2(32VLNDV4>J7$#K97+2.]M/( 2J2JV2.>0>:R=/N];\)Z=96&K^%-%
MOM5D@_?7EC*(;<R,2/+*A"S$CT'//2H?%FG>'=?TR&RN+7Q'H%S;W4=TLMLF
M)24.=FYFQ@]*MZUXC?6]9LKX0O965JVY8XY \Y?^&0]LK_=[Y-9J[G=[6[[_
M "\BUA:];$2FH/E2TUT=]].ZZ/S&2:')J;64>J7EMH$%LVZVLK6P>*VC;L2Y
M;D_7 K)UZ'2+#Q;#X?U>[@O[Z>T:>*.WD< J>%+C/3KP#S76WEM;^--'O-*U
M'Q'9W&E7T9BN(HH%BD93[L<J?I6);:MI+Z-JEA+X92PO;1#H]@PE6>6>V4#9
M(9!]T C/6IDY*<8QM;Y_/R7EK\C&I*O3JT\-0BN67DV]-UHM--FWY6-/2M+L
MO"UB(?#WB5-/"C(M+N-)H"W<>61N7GT-.N_#-I\0#8:\]Q;+KFFAXX)]/B2,
MP2$?,C$<X/OSS5;3?%-_I2PK-%8ZDT8 \Z8>7*<>K#K]<52T6%[-]5BT*PBT
MA-6N3=WIL]\\LLA&#ACPH^@JI^\TFDU_5OQ.VMEU1U()TDX]6^EM4U\_N-GP
MG%;7+PBY22.V"MN$)Y#=.OUKLI8TB\-:JJ#:HM7_ )5S6FV0TN.-+AHM/C P
MJSMF0_1!EB?PKM=)\-W_ (K1+46L^FZ$Q!N;F[&RXO #GRTC_P"6:'N6Y/H*
MM+6X9EBJ2BX*5W:UEL>G:9_R#K3_ *XK_(5:IJ((U55&%48 ]J=5GR 4444
M9?BC7H_"_AS4M7EB:>.R@>=HT."P49P*YVU^*_AV_P#"=_KT%PDT=E;K<7$"
M_?0E<JOU)X!K=\8Z"WBGPKJVCI,+=KZV> 2E=P3<,9QWKSK4_@/)JBM:OJZQ
M:=<+8Q7<4,11Y$MQR P;C<<'\* +U[\<M-LO!.G>(1I%R]Q?7'V1;$LB-'-S
ME9';"KTZFIIOC'"NDZ2UMX=O[K6=3>00:0A0.=GWW+YV[1_>[UF3_ V^L;+4
M[31O$)MK6XNUO(;>^M_M4>XKM=90Q^<'@CH014=A\"]2T33M+N=+\1K:>)+"
M:>1+O[(&M]LN-\8BSPO (P>* .]T[QI93^%CK^I6TVB0Q ^>E^FUX<'!SZC/
M<=:@C^)GA5M)GU%-6MOL<<HAD89SO(R%VXR21[5S_C+P;JX^#NKZ,;V?7M8G
MC),[J 7<N"=J] !V%8]O\$M3E5=7EUN!?$:W,-S"XL\6Z".,H$:/=\QP3DYZ
MT =7=?%?0+?5]-L_,22QO;1[Q+]2#$H5PFTCURWX5H:G\1_#&D23I=ZG!$\,
MP@D!!.)-NX+P.3MYK@+WX,?V'IANY+B;5FBT^\AFMK> !YIIY ^Y!G"@$# J
M?PA\';M/#7A=]1NO+U2VN9-1O_.3S&FED0K@G/4#:/PH Z>Z\7^!_&ME/9S:
ME9WEM$BWL@+87:IR'SWP0*MCXH>%$TV*]&JP"V:;[.AVG=YF,A=N,Y(Y]ZXJ
M3]GM+C1-/TV7555+;3;BP:2&':7:27S _7MTQWJ;P[\"GTEM.FN+ZTDN;;44
MO96AMV42A4V*OS,3GWH [W1O'&@:]J<]CIU]%=7<&3(D:GCUYQC/K4"?$;PR
MVQAJML#+%+.,G!*1DAS^&#7/>%_A3=>'O'UYKXU*"*SF,C?8K.W,0D+G.9/F
M()'J ,URVN_LSQ:OJVJWD>LM;)=W@EAC6,_N(&.9H1ST<DT =7)\:= MK^VM
M'0E;R[%I!)#\X;*;PS#'RC!''O6KX!^*&B^/;=%LY5@OMC.]DS9=%#%<],'D
M=JYRY^#-RFLC4;#5(+=X]5&H1126Y9%C\H1&/[W7'0U>\$_"9_".I:+=F_CG
M^P6<]JRK#M,ADDW[LY[=* /1J*** "OSY\;ZQ\3/C!^T1XVU_P""/PI\ 23^
M#KMM!OO%/BA1]NO[@1@R1)AAM3:X )&2#]X9P/N_Q;XLTGP+X;U#7]=O$T[1
M]/B,]U=RYVQ1CJQQV%?F=XO\4?LR?&CQ_P"+/%VE?&_Q!\'M1O=0>VU2#2M1
M2.WUD(J@72)M;;OSC=GG:<KWH ^VOV/?B?#\4?@U!/\ \(Q:^#=1T>^N-&U+
M1;#!MK>ZA;]YY1'!0[@P_P![J>M>W5\]?L,ZK\.=0^!YM?A;#J/_  B^FZK=
M67V[56#SZA.K!I+DN#APY;(/'3&!C%?0M !1110 4444 %%%% 'FGQ2_Y*-\
M'/\ L8[K_P!,VHUZ77FGQ2_Y*-\'/^QCNO\ TS:C7I= '"?$VXGFN?#MC;V,
M]VQU&*Y?RT# QQABP'/7I7:VDYNK=)3%) 6&?+E&&7ZBLBY'G^-;!?X;>QGD
M(_VG>,*?R5_SK=H *CG$A@D$)19MIV&0$J&QQD#&1FI*\:^,GQ<UGPC<2Z"/
M!VHR6VK17-M::U!J-I$JE;9Y7DVO("NU4<C.,E1ZT >+?$/XH_$+Q;XMOO"E
MMJG@O7=4T+4[6:STO3K.='U%_*9VR7N&0+#C+9&,J 2,UT'PQ^!=]\3]"LO&
M,7B#7/ >F:O;:??P6%D;*YN;V:-I9_MUVTD$JB61I\;$. J+DG.U.3^$7@#4
M?C+KUM;^(/#5SX7O?#YLC+>6UZL AL&@W1P0&%Q*9+@EI)F<)C*I\VP$_5OP
MY^%VA?"O21IF@?;X[!8XXHX+S4)[I8D0854\UVV@#CC';TH W]%L+C3-*M;6
M[U*XU>YB0+)?721I+,?[S"-$0'_=4#VJ]110 4444 %%%% !1110 4444 85
MQX6LK9VN[#3;0ZB,%7F9D'7/) )[GM7/W5MJ6C>$YK34_L$:"9'1K>=F9BUP
M&.0RCIFN]JEJ&C6.K;?MEI%<[?N^:N<4 8VOV=OK6L6%K(S-;W%O<1.T,A4[
M2H!PP.0?<5\M?'#]F?PUIO@;QY+X9\.:MJ.K2W4FV*VD>Y5F^PPX:0._&.,-
MR1@5]07>A:G9:A#=VMUIEG8V8DV1-:N<*W7)$@Y^@%4;;6K*[M_&4<5PLCS.
M\B  _,HM(@2/;((_"F!^=.L:+>^ K7POH2PR>$VU26W2_M=1L(/,#"VD(F@9
MB61N,;QP20<' -6_"=]J?PIC\*^&O \,?_"3Z;+I23WVJQ0/"N^7:9(KM94=
MHY02I@E&!O*[XPH-?>7BSX5>#_%]SX3O];\-:;JEZ9(D,]U;J[[1 ^!D]J^:
M/&/[)^I_#76-;\0Z#K.L^*ELHX&319/L@6:#>=L;@Q*-J#.<$$XHW XS7O%.
MFGP\? ES>Z_J7B^SN(+^SMK"WGM=0ABEUC?>Q2PV[LD@\MI661<C#A02<$^^
M>'OC1XJ\*ZW:>%O"O@'0;[PN;*YU6WUC4O&TZ2"TBE5)7E1[%V212_,9<XP0
M2*^2M%@U#P-X%O-0U?P_INF:@MS;VT0U3$QN8Y=2W*T<L,@DB>$2CGG(^7C
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M- 'TQ16)X2\::-XZTQM1T*]6_L@YC,RQN@W8!Q\P!Z,/SK;H **** "BBB@
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M188U<#;N"#./3-+#;0VY/E1)'GKL4#- $M%%% !1110 4444 %%%% !1110
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M4U-\>ULS\&_%QOY9H;5-/DD9K=-[Y49 "_Q9( QWS38'R_XJ\<>(OVUM7F\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?!WB2T
M_:"_:$^(_P 5K3PE=^!O#?A32]6_X1^?3M=TA+NXOTBC5U><,IWH1+E0W&&.
M!CD_5O[0_P#80^!WC=O$^IWNC>'TTJ=[Z_TZ0I<PQ!26:,CD-QQ[U^6O[/'P
MK^%?QB^+=KX=OQ\8OAWK/B:U>YT75=8U"1%UN")2V1)L4D!02.67C&[. 0#]
M-_V9_ _C?X=_#*+0O'=[H5YJ=O<N+8>'+%;.SAML+LC6)0 "#O/ [UZO7FWP
M#^"&G_ #P1)X9TW6M7UZW>[DO#=:W=&XG#,J@KN/\(VC ]S7I- !1110 444
M4 %%%% 'FGQ2_P"2C?!S_L8[K_TS:C76ZT/M'B3P]#_SSDFNB/\ =B,?_M85
MR7Q2_P"2C?!S_L8[K_TS:C70>(-?TWP[KMQJNKWT&G:=IFFEYKFX<*D8DE Y
M)]3$ !W.!0!\J_MHQ>$+CXJ:5I?C+PE/XHCUO3(+6QFM-$DOY-/A2XD>^D 1
M"3(T9B2-ADQLV?D!);Z,_9TL1IWP;\.6Z6K6%LL3?9K1[9H'@A+L8XV1E4AE
M7 .1U'?K6-\(_%NC_&#XA^*/&NEWBWMCI:#P]8*R-')",K+<LT;@.ADD$0PP
M&5@0U[%0 4444 %%%8_B/QCH'@Z&WFU_7--T.*XE$,,FI7<=NLLAZ(I<C+'T
M'- &Q45Q<PV<+S3RI!"@RTDC!54>Y-? 'QV_X*[>"? NN>,O"GA+1;[6];TQ
M);2RU4A39RWJML(VYW% <G=_%CI@YKX4U/XM_M+?M^Z!>>%K:*Y\66VC3'5)
M[738TM\!CM56Y ?:3\J\GKUH _5SXW_\%!O@[\ O';^#O$FL74VO10>=/#I]
MOYR6Y*;T21LC:S C Y^\"< U^>OC_P#X*Z_%?XE>'O$FA>$O#D/AZ\N=TUIJ
M&F!I[JSM(PSRD@@C.Q<E\?* QXZCL?@[_P $<=>\6:'X9USXD^*IM"U%W!U+
M0XT6>5+=<".,3!BJMM7!Z@# '2OT7^%W[+/PJ^"_B.]U_P &>"]/T+6;R,Q3
M7D 9G*DY(7<2$!/4*!0!^,5C\&/VH_VX/!^C>+)(M2\:Z9I\[6%G=:C=Q6Y4
M$[FD7S"@=03@L,GC':N[\._\$G?BS=^/+6'7=/F.C.4-S?\ G6Y#.6P_28OM
M')W[22/X<\5^V]% 'Y:>%_\ @C(\7AK4=-UOQ+ISW\THE@U6!)3)%@$",)D+
MM.XDYR20N,8.?7_#7_!*KPAH,N@7_P#:&G2:GH:L+<2:4)89VSN1K@,_[P@Y
MZC'.,8 %?=E% 'R'I'[#\WAQ/&W]GV/P_=_%I=;XS^'FPD;1J-D8WG8HD42;
M1QNY[#&G=_LI:_/X0\%^&CH_PSGTWPK=PWEFLVB28W+@R#;D@>81EB.2>N:^
MJ:* /FF[_9^\6VOCO5/'<VF>!/$FLZGID&E7VG?V2+47,*O(7'GL'(W+(%)8
M'*QH#T%>6:C^R'+/\%6\"7'P)\)RS'4SJ(OK+6$4@F[,F"WDH_$#&(<D8]*^
MZ:* /@;Q]^SQ\*]=^)_A[6O$?P!UK3K33;"XLM3AT;39I[,I'&$MV#0A1)M4
M?>49X'7 KYXUW]A+X&W'A[XHBR\1^(?#VI6ES)/X9N=<L+BW@FMH[*&9E+31
M(K$S/-'R0W[L8![_ + 5GZSX?TOQ%;K!JNFV>IP*=RQ7D"3*#TR P(H _&C7
M/^"5ZZEIWPVN/!WQ(TO5U\12Q66HR. ZVMPT#SDKL)X"H1M.#G%8NI_\$P?C
M1X3^)7C&Q\&:Q:WESH5D;JRNK6]-O<WL,P9%B7IM=DW@@MM[9P:_8/4_V?OA
M=K=T;G4?AMX1O[D@+YUUH5K(^!T&6C)Q7-V_[,NC:'=B]\.>(O$7A^^2.&&)
M[>^+PQPQ9V1"$C9L ) 7& .E 'XC7&C?M'_ ;X)1 IXC\-?#W5]7&%A?]V+V
MWFP,[<M$1+'QG 9H^Y6O3[3_ (*0_'CX>?%CPU?>,+%)M0T.P&GWNF:A8F">
M[MY"DC,_ *NP5"& [9P:_475_P!G+QG;>#SX7T/Q[%<:/)>Q:@RZW8"1TF2_
M%X=AB*\,XP<YZ\5GZQX.\=?\+3M?&FK_  L\.^++_3=)NM.^UV5Y!%/=AW0J
M8Q,GR'8'3:S@?.1D F@#\Z[#_@ICH7B[0?B%8?$/X:V.L#59Y]1T7R2'-K=2
MA8\,7Z )EMPYRN.^1V^@?MV_!?3='^&\6C3^+_ 9DO<>*--T"8Q6R1+93PB0
M!2 [M/\ 9I"1SM5AG/%>N>+/V3_AT_@OQ[I6L_L\^+- EUO4)K_1]1TBU@OI
M;9DC)AC_ -$N9WB4L7!&S8<\G(7'DGC7]AOX(7MU\-8[2V^('A4B9;7Q1!/X
M:U!F6(64\QN,M;GDSI#%\N>)<XXS0!]-_#+]J2U\;_$C6_"GA3XZ^'M;FTFV
MM[JRCUNP,4-]"$+76Z8%<M&N"2#GJ3P&QZ%X#_:D\0:MX L?&=]H6G>*=!OQ
M'''<>#+N*5;6X,IC,,QEF&6R4^Z.,\U^;]K_ ,$S8?%OC/QOIG@OXI:#=&SM
MXIM"M;B7RI[XS!F6%P3N4JJE6^4G)&0.:\MUK]FW]H7X*_!W1]:TTZL/"GB:
M\29[7PU=22F.>-BL#3K']TL6;;UY SS@4 ?M?8_M*^%VU&WTG5M*\6:#KL@D
M9M.N_"VI/L5)%C>3SHX&A:(,Z9E5R@WKEAFO2K#7M,U20QV6HVEW( 24@G5R
M!WX!K\(M:_:M_:0^'GQ<TZ+QW#?ZEJNAZ:-/NO#VMZ<'CN;%A&\BS*5.\/Y<
M;L_/(!S4W@[]OF/2/"7C&WO? =AIVO7TUS=:1JWA9WTJ6SDG<EHY'A(9XUSE
M5)P-H% '[S45\T_\$_\ XY:3\?/@2->T^SU2PO;>^>SU&#4]0EO3]H6.,EHY
M9&)V%64@<8.[CN?I:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** /)OVK_ VM_$O]G#XA^%O#=E_:6NZMH\]K9V
MGFI%YLK+@+O=E5?JQ KX6U_PS^V3KWC/X.>(W^ NB6]Q\,X+BWL88O$5CLNQ
M-##$WF_Z7D8$ (VXY8U^H5% 'F7[/GB?XG>+? DE]\6?!UCX&\4"\DC73+"]
MCNHS;A5V2;TDD&22XQN[=*]-HHH **** "BBB@ HHHH \R^*VX_$+X/;.'_X
M2*[QGU_L;4:^<OB!I?CVTN+_ %^1IWO-!OHK_%UN:UN[F.3$%OZ,7D=%0#E6
M93C@U]$_%^ZCL?'7PCN9F"10^(+R1V8X  T7422:\VT[XJ:'\3/B3X"\)JM_
M:Z=%/)XBGN[VS>&VU*Y4/]C@B=OO_.)I@3C)L@5W#)# [OX!_"O7/ J7&I^(
MQ8V^K76GVMA+:Z;,TT1,3S2/,TC(A9WDN)"?E&%"CG&:]?I"0HR3CZUY=\1?
MVG_A;\*[C5K+Q%XVT>SU?3+.2]GT@7:->;$0N0L6=Q8@9"]3UZ4@/4JR]:\4
MZ-X;4'5=4L]/RC2*MS.J,RJ,L0"<G !/%?EA\=O^"RMSXB\&_9/A5X=O/#VN
M?;&$U_JZQSJMJ!\K(JD@.Q."#]W'!;/'@"_ _P#:3_;Y\0:7\4'TB2^L]1D3
M3!JTES';6]NL(56=8V<,(_F)R@(+;\9(- 'UC\>?^"P_AYO#/B?2/AAI>H+X
MEAD$&GZMJ,"M;R*&P\BH"2"!DKN_'TKY+7P5^TA_P4HM8/$Z0Q^(T\->7I0>
M2:.QB'F.\C2+O*H[#@-M.[ CX/%?HI\"/^"6/PP^#'Q!@\83W5[XFNXH2L6F
MZFL<EI%(RX9@NW+CD@!L]:^O_#_AK2/">F)IVAZ59:-IZ$LEII]ND$2DG)(1
M  "3[4 ?#_P#_P""3?@/X;:]X/\ %WB;4[W7O$VEQ17-W9!A]ADOE.[S!D;B
M%;& >NW)'.*^UO"_@;PWX'AN(?#GA_2O#\5P_F31Z791VRR-_>8(HR?<UN44
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4C*'4JP#*1@@C@BE
MHH Y#5_A%X+UNUDM[GPSIJ*[*YDM8!;RY!R")(]K#\#7#:C^RIX4-H++0=0U
MGPKIQ$7F6.FWK-"[12&2-L2[\$,?X<9[U[110!X1JW[/_BY]937;?XCR:KJE
MKI]QIEO%KFCVTT4MM-+'(\4Q50S ^4JY&#@GUKQ#6?V )+WX=>*/"J^#_AVZ
MZW>W.H)>PQW5M/:2NS&$1N-QVQAMH7@8K[FHH \N_9P^$5O\#_AC:>$[70](
MT&&UD9A%H\LDJ3$JNZ61I &:1B#DGL% X&!ZC110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110!\U^+#K?Q#\4_&<CQ+JFA+X0LH8=&&EW)C\FX^RFX,[KC#DL4&&R
M"%(QS7H_@'XS:=?_  ,\$>._%-W#I UO2;*[F9E(03S0*[*H&>,[L>U4O'/P
M$;Q/K'BB]TCQ7J/A=/%-G'8ZU%8PQ.9T0,@>-G4F.0HS)N&>""!D UZ5X?T*
MQ\+:#INBZ9 +73=.MHK.U@7I'%&@1%'T4 4 ?F1^W-_P4ATW0/BUX:\,^%]"
MB\0Z3X>N3?7U[+*\7VOSK6:WDACX^4>7</\ .0><<8!S\MV/_!1+QS::7_96
ME:)9$V,D-SI=V8V>XA-LFRV\S)(:.*/<0HQ\P!8D;@WZD?M+_L>_#CXT_&#X
M:^(O$'A0ZE>3:H]IJES!))&LMM'8W4T8FVD CSHX1D]<[>AKU'PK^RY\)O!'
MB>[\0:'X T/3]7NH6MI;B.T4YC9=K* > &'!P.1QWH _$3Q[^UA^T7^T#X>T
MC[3K.N7%CI<I"SZ'$]OYLK'(,ABQN(Z#/ XKM?!_[$>K?$;QKH7B+XA?$S1+
M:PU58[W6Y+B>:34HB0-\)41E6D[9W8]3GBOW'T/P[I7ABP%CH^FVFE688L+>
MR@6&,$]3M4 9K1H ^#_@!^SA^RS\ =1UV]M=>B\4SZJGD$>(4%PD$.X-Y:+Y
M8'55^8Y/'6OIO2?CQ\*- TVWT_3?$&F:?86Z!(;:VA:..-1V50N *]5HH \P
MC_::^%\T\T*>,;!YH<>9&N\LF1D9&WC(J7_AH_X;?]#99_\ ?+__ !-.\"Z?
M=6WQB^)UU+;R1VUR=,\F5E(63;;$-M/?!X->D4 >:_\ #1_PV_Z&RS_[Y?\
M^)H_X:/^&W_0V6?_ 'R__P 37I5% 'FO_#1_PV_Z&RS_ .^7_P#B:#^TA\-@
M/^1LL_\ OE__ (FO2J9,,PR ==IH \TMOVF?AA>V\5Q;^,;">"50Z21[V5E/
M(((7D5)_PT?\-O\ H;+/_OE__B:M?L^V-QI?P*^'UG>026UU!H-E'+#*I5T8
M0("I!Z$&O0* /-?^&C_AM_T-EG_WR_\ \31_PT?\-O\ H;+/_OE__B:]*HH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX !/:MRN4^*7C#4O ?@+5]<T?PY?>+=5M8LVNC:<,RW,A("KG!PN3DG!( .
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
4 !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>aciu-20231231x20f031.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f031.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $5 [L# 2(  A$! Q$!_\0
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MV@\';DYXQFOK_2-6L]?TJSU/3[A+NPO(4N+>XC.5DC=0R,/8@@_C0!<HHHH
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MTJ32J32OM=I=E^;2^:*C3G--PBW;^OT9L44F1ZT9%;F8M%%% !1110 4444
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M.2H/&<8S0!>HHHH **** "BD+ $#N:6@ HI.E'6@!:*** "BBB@ HHI,\XH
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MD'@\CN >*ZZOG&T_;T^ ]A;QV]OXFNH((P%2./PYJ2JH'8 6U>A_"?\ :,\
M_&^\U"U\':Q/J<]A&DMPLVFW5KM5B0I!FB0'D'@9H ]+HHHH **** "BBB@
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MC8+NMKE)98;RR^<9F5@XQG;C)K[.\2?#7PQXO\2:'KVM:-;:EJNB1W45A/<
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MQ/\ %GA_QI\,/A_X.O\ 3_#^K>.;^]MSXAU.S-Y%816MJUPP6#>@>1]H506
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M.1@XS7FGC7XL1^%-)\.Q^)!I^AV>JSV44>HZA9Q+8NTID\S<8Q\BNH1_F&5
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M !,US5_#5@NHZ?"=1L5N+R^MWMQ"9X?,"P>2"?FW@DD=,*PZE:V>*C3T\O\
MA_\ /L9QPLJNNF_X=/\ +N=YXB\4VUF+74--TB.\%I,764R*@C0G:[IQN(.Y
ML D9/TK1OHHY(S>3JT5U!MD\MR)0023N7&?FX'0]^:Y'X<^-E\166O/=7+R7
M5@RK]IBM?)@D8_+T/!^?(;)X]!7:-97$JV&H+;Q":1',_DY,>Y8]JD)U)4]N
MF*QC-UOWBU3Z;6Z&DH>Q?LWHUU[]3=MKB[ET^2XD\J>-E+11P\N6P"AP>,Y)
MI_@_PU#I'B*&5/FGQ*93$X7!< G>/X@2./0BN=M=-F\,:?&5U2:2T:01QB[F
M^2/H!Y:X[G)VDGKBNP\(QR6^K*H*&!MYWYW%B1G@YXZ=#[UVTVIRCS7NCCG>
M"?+LSN***S_$'B#3/"FBWFKZSJ%MI6EV<9EN+R\E6**%!U9F8@ ?6O1.(T**
MY_P;X_\ #?Q#TTW_ (9US3]=LP$)FT^X691O0.F2IXRK*P]00:W)YX[:&2:5
MUCBC4LSN<!0.22>PH DHKQ?X1?M3>%_BS;^-=1C4Z#H/AW58].BU35I5MX[Y
M'A26.X0/MVQN) 4SRRE6[XKU;0?$FE>*;'[;H^I6FJ6F\Q^?93I,FX8R-RDC
M(R./>@#2I",TM<%I_P =O 6J_%G4/AG:>)K.?QSI]L+NYT92WFQQD YSC:3A
ME)4'(# D8- '=[![_F:-@]_S-<-\+OCGX#^-,FNIX)\2V?B%]#N_L6H"U+?N
M)><#D#*G:V&&5.TX)P:[N@!NP>_YFE"@>OXFEHH **** "BBB@ HHHH *Y3Q
MEI$4\\5XT2R;XS;/N4L=I.<#'.3EA^-=74<\*W$31N"588.#BKC+E=R9*ZL>
M1V$LUMKFO1SR6[VEND7E2!W:1-RDE67&%4 C@'J"<5S7QK^"'A_XU^"+CP;K
MM[?6&B7]Y%?7\>F.(WO3$0VQF(;:N=I..3@5TTT"7NJ>)-'?4W@^RDB4*P\W
MYQO0D]0N"-H!^O&*L:+%J=U#<W<M]<107=O#Y.GRVZJ]F54&3<V<L['KG@=!
M7I3:;MNG_D<25E?:QQOPB_9O^&_P5@D@\(^!]-T=XSY?V\H)[R< 9R9WW/VS
MU ]A7HQNDO)HMRS)<-'OP0"L9]&/0G/;VJ:VDB0.T0PT@WLI/08')_EQZ4J)
M&RNL2H@5]H6->ASSC\_US2T706KZCRQ)0.H &""OR\XY./2I+:!XYKF5K@RK
M*P:-)<!(UP 0,#)]<GN:K74L4#K-(C2M$2 Q7<5W8!QZ^E07T<4<(CG:(Z8K
MB.X5G)VXQMR>2><9!['FCEYK%<UBY<J=1L59;14>4C=%=)N7 .&! /U]NG6D
MBL7LX7D5%D=<^7%"NW"_W1Z=_2I(YXY+ID\W,R L8PYZ-@ E>A'O3-6MVN[;
M[,'/[SL&*D$8(;<.F".G>DF_A&TMRTP28L?**N0,R,O7VS_GUID5PT3$-Q&!
MP0>/:LNWEANM8NB=4EW )!]F\W;&LBDL2H(SD\@^H%7WM&%T;B$[7,!182<0
MN<Y5B,9R.F?0]*+):,$[ZG">+I+>\^,O@.UOAY5N^GZOME#@?-MLR>OIC]:V
M?BM9Z?K>BMH']I7>GF[41O<6PW20ES^ZD#<;&W#C'I6)XQM4/Q6\#2/:FXG_
M +-UB18HB"SLHLB ">.F<>U7-9FEU*75+*Y2XO1._D/9E0'EBVY*QN,;6 ?D
MD]CBJIPNF][7T(G*S2[V*>H:SJVB:7H6GV^D7&KQ.R173H$VD%=@DD).5XPQ
M([9]:N7^EV%E93S+&=,N;&,23*9=D8XR<-SP=O;IG/6A-&&B2?99[D2VTV;B
MXB@;!MHEB5!$!DG[N#D>A/>L^XTH7%O>6FHS$HUZ&MGEE,Q6W"X(!';9SGL3
M@\UTTHR5Y7M?IT[?=U,JDHW2M>W4H^#[^YAU^>$6=K-H]I:R2VMQ!/\ -O=@
M?(0. <<CIP23WJ'4=0O] TRVDM]/AO[J:XMQ+%(WEL\S*6+M)GG;G&TCK75S
M1V&ESZA>06WV_3%C,LMLT.5618_,4,SY/.=PQQGBN*T.XD\9^"$:VDMK-[B1
MKFVDN@T<AG53MF53]U0,=O7@YJJDFXR4'J]N_P#2].P4TN:+FM%]W],Z[PQJ
MLRZ39W^L1V'VN<>7,UNS2;)&YC08& "OS'T/'-6[:?4M3O8_LY2+3T++&68,
MT@SR%Q]TDY&>VW-<E\.KQ+CP];:+?WQOM8FCN5N;FPE?RVGC(WX8@;7Y)!'&
M,XKIM.@T_P ):+&MM%=PQLJ*\#2[IXBQ"[V)/'7)QZUS0DV[I77GN;3@EOH_
MP-J6-[>Q5!\DWD%6\QM^TX(8;N^#P3WIG[-5S+=_ CP*\L?E$:+8J$SD@"VC
M'/Y9_&K85?L\D8):-8BRDMSC;R3ZDXSD>M,_9XR?@?X$+*RL="T\D/U_X]8J
MY:ST-*2LST6DI:_/WXZ>/;/PK\8]1TZ[U+XKZC):WPMWUJW\:PZ/ID4Q6VE>
M)+9"OF+&E[;G'E.S#=@/M8UQ'6?H%16;X<TJ;0]$M+"XU.[UB6W38;Z^V>?*
M >"^Q54G&!D 9QFO'?CU\>_%7PA\5^'K;3? \>N>'KR:TM[K49M2%O-+/<7(
M@2VLX=C&>95+3,I*@(I.>#@ ]THKP+]HK]I;5/@UK"6&A>%H/$S:?H5WXJUL
MW&H_9#;:9;21QR&$;&\R4F0E5.T?NSD\BO1-=^-G@GPO?16>L>(;32[F2..4
M1W3%,+)C82<8&<CO0!W-%(#FEH **** "BBB@ HHHH **** "BBB@ HHHH *
M*\^^/_CO7OAE\&?%WBGPQHA\1:]I=@]Q::>%9A(X(&2J_,RJ"7*KR0A Y-?+
MO['?[8_BSXX_%&T\+RZEI_C/3X+/4WUC4],T>XL8[1X[A/L4H:4 ;)HW=!&<
MN#&6..X!]QT44T.I) ()':@#YX_;&^_\$/\ LJ&A?^UZ^A'FCMX/,E=8XP!E
MG. /QKY[_;&^_P#!#_LJ&A?^UZ]]U'2[36M/>SOK:.[M9 -\,J[E;!!&1]0*
MB?-RODWZ7V*AR\RY]NIR^N_&#PIX=UVWTF]U1%NYMO**72//W=[#A<UUMM?6
M]YN\B>.;;UV.&Q^5>::]^SKX4US7K;45BDL(DQYME:X6*7'3(QD9Z''6N\T3
MPIH_AMI3I>FVU@90!(;>,)NQTSCZFO!P,\WEB*BQL(*G?W>5N]K>FOX==#V\
M9#*XT*;PDYN=O>NE:_WZ?CT.#^-7[0>B_ ^_\)V.IZ/K>MW_ (GNY;'3K30[
M07$LDR1^9MVEEZC@'IZX )K@_AQ^W1X(^)?B;PKH]EH'BS34\1W-QIUIJ.J:
M28+5;^!7:6S9RQ_>J$;.T%<\;L@X[SXJ?!B7XC?$OX5^*4U-+*/P7JESJ#VS
M0ES="6V:':&R-N-V<X/2O*_#W['.J^&=*\!Q6GBJU:]\*^*M9\312RV3%)6O
M%N!'&5W\;&G4D]]IZ9KZ$\(I>"?VQ-7\3?M8ZCX*GTVQC^&MU?7WAS1-:C)\
M^XUBRBAEN8W.[&PAY57CDQ\$\U6\'_MW0:9XC\=V'CO0-6@TG1/'=YX7C\1Z
M5I;MI=C")EBMOM<Q<X=F;YBH(&Y<A<BL'3?^"8?A'PSX2\-ZEX?U:>P^+VCW
MMKJI\9RR32)<WD<PEE9[;S-NR3YEP.<$<GG.W?\ [#_B;6)/&FA7?Q'@7X?^
M,?&DGBW5M%BT?_2<&X2<6\5P9/E#-&@9BI^X",9((!M^-?CO\6/AU\9_">GZ
M[I?A8>&?%/BO_A'=+\/6<DLNLR66TDZF90_EA$QN>,H-JD#=GFOJ,=*^6_#'
M[,?Q&T+]H_6_BG>>-_#NN3:G=K$B:EH<TEQINF!S_H=G)YX2'*'#/L)8\G.2
M#]2T %%%% !1110 4444 %%%% !1110 45&UQ$C;6E16Z8+#-24 %%4M7N[J
MRL))K.S:_G7&V!9%C+<\\MQP*S?!?B2X\5Z+#J4VF2:;%.JR0K+*DA=",Y^4
MG'T- &_117&ZCK'B>'QG;:7;0Z2UC<127*R2R2B41QM$K @+C)\WCG'% '94
M444 %%%% !1110 AKPFXT[3Y]0U-]:T#Q+J5R;N8K<0>8$9-QVX 88P.*]WK
MP_7-5B6[UF34=:UBS\517$@LK*V+^7@']T%0#:RL,9R>YK\\XO5-0HRJ6TYO
MB4>5Z+3WM.;^5;O75*Y]3D3GS5%"^MMKWW\M;=WLM#V725C32[-8HY(HA"@6
M.7[ZC:,!O<=Z;K&D6FO:9<:??0)<VDZ[)(G&0P__ %XJ73FG>PMFNE"7)B4R
MJ.@? W#\\U8K[VDDZ45;2RZ6_#]#YJ;:FW?J? OBGX7Q^&?$=EX=TB*6\T_4
M3):QK?M_I-C?B:21Q')D8A$2'<>A#)[URFO0IIDUYI3PM:^((X9'>_B,<ZHB
ME65@,?*2NWYN!EE!%?3'QX^%-EJ?BG6O%>LZJMKH5CHC3+:DX)G#_-CT5E7:
MQ'4/63X\^%7AG3_V=]/O0S3W%R]M=W6IVV7FG\[8LH5LC:FW:!T"K&/2OF<1
M@WS2Y5:VOR_JY]5A\;'E@YN]]/G^O30_+']OW5(]$U_0/!EG<WTL-O"=1N5O
MX_)F,C_*GF1 D!@ V#W#9'!KDOV)+,?\+?34KKP]J&K+;VLKP:A;P>='I\P&
M%FD##&T9QNY*YR <5]X>,OV3O"6A_M(:YJWB73F\:6-S';&WDU&X%U-' ZJ(
MRL(*Y8>5(BL=V,9(Q7H/A'X0V.E^$-9B\.7>DWJBTFG\^ZA%@]@R2#YERN<*
M #R!G(%=*J^SH_5H1VO?6WW=7_5SEE2]I6^L5)[VMI?[^B_JQ7UOQCXRT'1M
M"OM3\.:9<Z3>(MR)[Y8X_,>3(26,QA6PHP"<9&5/(Q6#J'C%;E+RU63;9V]Y
M-?@R7#O.MPB8"^>0':)PO!'U;I4LFBZJVGZ9;:]X@2?3IH))=(O+B;/V,*"R
MOY1XQ+M(QU!V\<@5@:U91:?'ILEQ8BZNK:#9)--\SR7#R,6\\_PG&X+GJ%P.
M*\"LYJ[>WGN>]2C3=DDK^6W]?UL/LKC2&GEEM[2^B,5S+-/+IUPL<8#9*K&X
M&[);<2.I&<=:Z71-7.F:3:Z5I/V2\6_4W-Y=W4#K.RH0XC"9SM ( YY.2:Y2
MP-_XE-AX:T[19P%9IM@F2VB>4Q#<?,ZL%0':2>!G'7-:L,0T">W:94M;J" Q
M6LNG.+A%SPR,P;C&XC=TX)Q7/&;C[R6G>WWK^OP-IQC+W7OVO]S_ *_$^K?A
M_=1Z!X,T90HL[C;+OM!D1C<V_(&.  <_CVJY;RVMK=+=3/-#)9Q^9=12N(US
M@8R >V3]3]*X?X%-K$_@I=QDFMD><*NILSN'+_Q<\( %XS_%7='0"=5^V7,2
MQR>9YLLS$N)&V@ ,!U*X.">!DU];1DZE*$DG:R_)?Y'Q]9*G5G%O6[_-EF?5
MAI&B2RNI>RA4RI<O"TIC4KUQUSS_ #IU[<7EG>I;!8[HL1RF<.,)N+<Y!] *
M=#+?W1EAN+R!/DV;Q\JS<\A>ZXZ>^>*DNM(^R6MQ<R+OB0>=&P?YS$.2H8=6
M(&TUU>^]4<JY5HS&\0V$EK+),C7;332/(ZN^5;*E=JG^$#;TZ<GI7FMQJL&I
MS7B^5]GOA&?/C$6PD#@[@>HXQGOS@UZW))+=36R1M&$FC(590,HN>@]20<$@
M\;?>O,OBMJ6D_#,/>"VM]3U.YA-F;51G[D;R(K <D'KM/WAG%<M248P<WHNI
MTTXRG-06KZ'*ZOXXAL-)M-&@T^UN;ZTE%N")%=; R)^[=<+O#9!7"Y^]S4^K
MK8^*O&.GV1DN8HM/-I,K691$L7V'?DYRUNN%RO.2Y[CCB_#_ -EFNH7M8ET.
M]NV*/IZPC>TS8VW!D)WJ-S< GIZD<>K^$Y+'Q/=6%E=Z3'J=M<N[W&KS6H@O
M;=%!7#8!W R*^ .@QG)->5!SQ,^7>]K?U]U]-#UYJ.&A?:U[_P!??UU.1U?7
MKC2+Y-*U76M(FN+)9=5BCT%98GGQ)N1$2/Y2-@D8J>3GD=Z]&\'^.;7Q_ITT
M]O:76E0M(P:"YP& "9;&SD]3C/.?I7SOXMUK;XKM]3ATN[L[A3,J+97:I<(,
ML8F*D  A#N]#N"]S6CX;U+P[IWBP:K'_ &OI-U#>0WB272$RW+-A6B;8?E*I
M)D @ DXK*GBYJ;3V_KJS>IA(RIIK>W]:(^A_$5CJE]#)$EU(ME<+DC< %(7=
M&ZO@D,K G&.375^!KU9/%-N2UN?M%OG?]V:2102V1]&!Z9'(R:XSPAXMM=7:
M2^TJ>6YMGN7:..89954@%21D@\@C=U#'T->C^%G'_"00QF)(F"R2;4C' /0[
MNO/M7NT.6<E.+Z_U8^?K.4%R21WM>0?M8#3?^%':RVK:%KOB&S2ZL'^R>&5+
M:C&XO(2D\"A6W-"P$NTJ01&000<5Z_7F7[2.C:KKWP9\06>C:W!H%ZPA<W5S
M?M81R1+/&TL#7*?- )4#1>8O*^9D5[1Y1PG['OAOP5H&C>(CX5G\9ZC>R36Z
M7^I>-M-FLKF541A"D:O#"I1%+@;%XW<GI7NOB?PWI_C'PWJN@ZO;_:]*U.UE
MLKN#<5\R&12CKD$$94D<5XM^RAX.USPE9^,8]2FM].T]]31+/PK;^()=;_L8
MK"OFHUS+\RM(S!_*^Z@P1]\U[Y0!XS\&?V4_!/P-U7QC=:!%=3VWB2:VDDL=
M1N'NHK=((1''&GF%B1P3DY(R #M4 ;?P?L[>Q\1_%"&V@BMH5\4<1PQA%'_$
MLT_L !7I1Z5YU\*O^1J^*?\ V-'_ +C-/H [+Q3XGTKP7X<U+7M<OH=,T?3K
M=[J[O+AML<,2C+,3[ 5X OCC]FWPR!^TJ-0T*T;7U33/^$N'F;[@_P"K\O9U
M#@1X;Y0P$?/ KW[Q3X7TGQMX<U+0-=L(=3T?4K=[6[L[@92:)AAE/U'ISZ5Y
MIJ'[,7P>OOA9I_PTN_".DOX-TZ<7-OI+.RB.8$L9-V[?N.YLDG)#$'B@#%\+
M7GP"_9I\4:;HN@S:#X1UGXCW*W=K!;2,3JCG[C Y(5"9"$&0N7(7DU[U7G&O
M? GX:^-_$7A+7=1\,Z7J.K>$M@T:Y .;(+C8JA3@JI4%0P(!&17H] !1129H
M 6BBB@ HHHH **** "BBB@#S;Q#X7M8/'DFK11N;NXB_?;Y3AT\L)@+SE<JO
MI@\\YIMP(0GVBZ3;L8'!9BRLOW,*/O \],YP.M=)XVL1.ME<LVU(6=68<'YE
MX^;J,D ?B*XT1LX,LWF+;%&:2W50[1MO))5^N#TQVX[9KU**4H)G!5;4F:-S
M#'%9R2P+(DDHC4/ N]L Y7CTYJ]<R2Q;5A4&5QU&.!U+$=_PYYK-GOXM*M)+
MJ1F@A#Y>%\N!ZG:N3GD^W%+"1/&DL:F5Y "IWAO*!SN(SS@\?D*O<GH3W22(
M7DCVRR[?]4[;5/'*C!XSQR:H1+')</9QW >98E6>!9<R*K=2Y[YX()P2!Z5<
MD1G8ON2 F/<ETB#H0.2,=Q^@H=X1<R!!(3.=K2Q1!6''R@M^!P6IKF6PG;J,
MBM#%?6\Z*(Y;=F1FWG8T+DXR3U.0.!TS@5>N[NVTJT07#[(594WN"Q7+!1D\
M]R!FJJ6@BAF9H9BSRM(4D;.3N 0#C'88STK\^_VDO^"A7BC]G']I$>%Y+2V\
M3:+INDM#J>G ?9P;J9GEA9&Y(*1M"C Y!^?&#@U%2:5G+8N";O8^_(;2.[\3
M)>-&]KJ"6O,,B%D/) .[L00"<<\^YK4O+J:TM7G<"XV*H\J!>2Y.#R3]WG]*
M_.C_ ()PZK\9OC+\6?$WQ8\2>)[B'P?J@EMY=-E7?!?3(,(D*$XB6'</G')S
MM^;+$?HO;_:+B=Q.L;VR,P5 -QD]&/I]*GFYO>:T_0JUM$>6_%GQ;_PBGQ;^
M%1-L)WODUFR%PV?+M2T-LPEDQSLR@4_[]=K=/=W\=_=PPZDD^Y8TLDV#SU0
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MSCS7B &TG S\PSQVQ2Z?J^DOX@N]&LM2$6MV=K#YEK= N(T8A@_0;B<XR.X
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M)>>(OC@OQ+\6^$M*O+#2K*T\.#2+<PO+''=3)(!BY :.-<*=JGD>M>Y?M4?
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MQZE8VUW$'$4\:RH)%*L P!&0>0>>AJQ45K:PV5M%;V\20P1((XXHUVJB@8
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M*OG#]N'X@0^#?AI9V%_<^"4TK7;M-.N;7QK)<I#-ODC"E/(4L"A;S&?C8%W
MY%?>'PQI?LI>+];\0Q>+=/\ $WB;Q7J_B#2[J".YTOQ?I-A8W5@KQEXROV,>
M7(D@.0VYL%".""*]]KY3_8,U#2TTGQIHVDKX.G@LKRVEDU#P==7U]#<R2Q,3
MYMW=Y>9U5$& QV# XX%?5E "8P#7G7PJ_P"1J^*?_8T?^XS3Z]%[5YU\*O\
MD:OBG_V-'_N,T^@#YK_X*?\ _(M_"7_L:W_](+FOAG4O#46J^8)KZ_6-V5C%
M'<;4!!!&!CU K[F_X*?_ /(M_"7_ +&M_P#T@N:^,!TH QM0T[[#H.L'[5=7
M.^SF_P"/F7?C]VW3@8K]</V5/^37O@__ -B=H_\ Z10U^36O_P#( U3_ *\Y
M_P#T6U?K+^RI_P FO?!__L3M'_\ 2*&@#/\ VJ_A3XX^,GPJ;P_\/O'$O@'7
MOMT-Q_:43.OF1+G=$73YE!R&R.I0 \$UR_Q+^ GQ3\5^+_@WJ.A?%FZT:P\)
M^4/$4(C93K90)OD*+\I,FUU*MPHD)'(P?HJB@#PG2_@O\1;3]K#5OB+<?$FX
MF^'ESIBVL'@[:Q2.4(JYP?D #!I-X^8EBIXZ^[444 %%%% !1110 4444 %5
M[ZUCN[=DEQM'.2 <58I&4.I4\@C!H \EN[/^S]3>\AFN+V&251-:O*0&C' "
M9'W<MDK^ ]_.?B1:^']%^ OQ"T&PE 6R\-WN+=W8E$\F1D5@QW##$XSZ8/ Q
M7K.KV$NBW$D;0B1 Q,)49)3C]?\ "N%\>?#NT\5Z7J$210-)J2"TOFD0J9[-
MN)(BR$-GDX;.>2,CJ/8T<;GFW:=C;U#09=1UJ6YNDBN+:!-]I&JB1(R2<LV,
M$$#CCC!]A5^>&-!"T?G)+Y0D<MEBP/! &,XSGCT KQ[3/#NE1:9!;7=QXBN=
M:NKS[/';Q>+-2@MIG0DLNYIL@JBYSTZ>HKI['X-VL-]%.FN>(9--(3=$/%FH
MGRU )8IMFR[9(QG P#WJ5/EU2+<;Z-G3:Y/+%"4L]/@O[B&,-+ )%@CC &[=
MDY(^96  /)W9K+\=Z<]I\(?&ZIJE[.\>BZF^^Z9690]I*P!(&&"[L*.PZTT?
M!O0VTR2>'4O%AGW^:Y@\2:B6F7.20K7'(P,9_*J-G\#="O=*O]*OM4\4ZC;3
MM)%<1R>);\HBO]^W9//Y&UL<CD'FE-.744;):'?>&E9M!TE]O[LZ;:D*O7/E
M+GK^ K20&* QXC$>0RQYY53D8/X<TU;?[%8"W4#;%'Y<<<)P?+ "H!D]@ *2
M) KLCKA3(&W/R<_7UX%"V#J.MP!,2L@# [7(7!X' Y]CU]ZDN9/(5I$C+-P3
MMX^O7K_]:DN&GD,>T#:I^;/WB&S^6"?TJ,JEOLVE%!^7D\L .@Y_SS1YL-=D
M$\@=B3NCW895(QO..5_.GW#+"(I!"T;"/S'DVXP  <MCN!C\C7F>M_M"^$-'
M\1:]H-SKM@EYX:9+G71=SB'[!;/%YB3E2,N#E5^7H6&<9&>(_9L_;0\$_M.Z
MKXITOPZFHVEWIDYV1:C$N)[1FV+.A' !)YC8[AD=><3=72*L[7/>?(#)&\"&
M59'\X,7*A0V26&/O @G@^H/:JNI2Q[ L43SK'EW5\E2"<-DCH=N<#V[TY-3>
MPN)+%R?M*EH[>!R(VF554DJ3][ )Y'I5:6"72WOC!<SW8N5,QAN%&R)0H78I
MZ8)!..>2:I.\O==P:TU18CTC$\NU\B4$A]Q!#=., #&!_G-,N[Z2-=MLRW$.
MQKAU=\$9&$P<=R3ST%+;W%Q*;:1;-H)MF'B,@7RAG!'/W@"!T]L5#J,%U>36
M^GQR2P9=9':U4*!&&YCR>1NY)XZ9QBJ;:W)2.8^'6IV7B"36;E81"1-!+(TC
MDD/Y70< 8&6&1U.3]/9?"(QITOS;OWI[YQP*\>\&65GHVJ:M#!/;G^TIA>1V
M46,(%#*"KYY QCG SG'>O8?"$OFZ8_#*5D*D,!UP/2L*]W"[-:=N>R-ROB?X
MYV'C*7X\7JCXVZ/X2T-]5L?[+TY]?>VG2]>.V5;:2 (05$274HC+8F:XC#8
M!'VN:_/_ .(GAC2_%'Q4\7^,]:^'FIFVBO(;/5IO^$STZ.RM),V9=_+/SJTL
M4%HK@')0[1@M7GG6?H *6D%+0 5YK^TC_P D-\9_]>#?^A+7I->;?M(_\D-\
M9_\ 7@W_ *$M 'I$?W3]3_.LWQ+X<TKQAH&HZ)K5C!JFDW\#VUU9W"[HYHV&
M&5AZ$5HI]T_4_P Z^0O$'P)\?_#/3_VA?%VK?'2XL])\2VLMQIEQ?B7RO#\6
M2S2 !OE9(SY:^6!D!2<GB@"AX+^'.G^+OC+JGP8\0_L]6&G?!KP4@U'PUKD\
M<C0R7)9#D,?ED,F^0LN2?W?S@YX^S00#M&![5^3FJ>)]?O/@?\/M#D_:DT_1
M]'TR]M+FS\81_;3+JDD\UT/L\F?GQ;FVQ^\ &&&_;@9^Y]-^ WCM/VK?^%I7
M/Q,NI?"+Z,EDW@^)7%MYWE!"0"Q4)O!E#8W;CCI0![]1136!92 <'U]* %#
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M]L)]Q?I7SQ^V-]_X(?\ 94-"_P#:]?0Z?<7Z4 .HHHH **** "BBB@ HHHH
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MG7SQ_P $^_\ DTGP-_O:C_Z<;JO;_&<.OS^%M23PM<:?;>(3$392ZM$\MJ)
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M5)9A:7,FT1QK&5R[;N3MZ<YQQ7G.I:%=:A>W>N:=K3^'(M=A/VR=[Q?-CC*
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M,!"TLF1([(8RQ,8QEL^M>M0I0IVB]7H_RO\ UV9YU>I*5Y-V7R^7_#=T=?\
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M(J#'3@>E?K-_P39\-^'K/X&:7+:^"=6\):_;L_VZ\U6!U_M61UQ]HB8@"2,
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MSTY[LMB]A^;D;@,E=HRR_*=XQT->[5\>?'1+@?&_]G0)\?T\,H7A#:+O9?\
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MWW2M;OT/"M?^!%UXA^(>GZCK&MJ\U]NN;M+6$H%,6P!(R22!@@9/(QFO2?\
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MD_Z/<#8 Y9AAH_F;##^/Z5!KDUGXMUKPU8Z197%K!I%I%%%#J-RJAHB?XFY
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MBGX+>'O"?BRPUO6(?B5HUQ):6S,76-&F#-R.@+#\Z^TD^XOTKYW_ &Q5"O\
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MB'38K=XY$GB+Y3,CA?WK ^G  X&#FONBZ^(4T.FP7;VD<2O)Y,D<CDLK8/!
M'7/&#6,?B9?66KM8ZKX>A\PLJQS6DHF+.<D;DP&0;0.>17D5<'A;64K7\K_\
M,>O2Q^);O*-[>=O^'^1XAX&T?POHNER_V?/=IJEL]O=!+>W=HKBYC8I(JLPR
MKNQ)"$@'(;'6BR\!P^'](TWQKIOAS^T=0EU)A;V]U=!9G0S@JB1CY5?@YW<
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MSL.#\P/&5P.N:EA\?2S61F^SQI\@=6+,R,",J00#D<=J['BHO=G$L-);([4
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M G:B@ 9))X'4FO43TKSKX5?\C5\4_P#L:/\ W&:?0!\U_P#!3_\ Y%OX2_\
M8UO_ .D%S7Q@.E?9_P#P4_\ ^1;^$O\ V-;_ /I!<U\8#I0!1U__ ) &J?\
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M?8O9RL]^_7R/?XG=:60P>(OS<VMTD_M=%IL?;5%%%?T,?AH4444 %%%% !2
M =!BEHH **** /G;]L;[_P $/^RH:%_[7KZ'3[B_2OGC]L;[_P $/^RH:%_[
M7KZ'3[B_2@!U%%% !1110 4444 %%%0W5W!90O-<2I#$@RSR,% 'N32;45=C
M2;=D9^H^*=,TJ[6VNKI8IVZ(0<GC/IZ5YU\<O$T5XMCX)COUL!JZ&?5;S?M-
MIIJD"4@]GE)$2]_F8C[M<)\7_P!I,>&_%=N=)>RN-.TQ#</-(Q(F)1@VTCL
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M%9 >V/IS[@TJ0F&%$#Q/!@*%*#Y@  ,GN1BFSSK8:8TLL7[J, >5 A8@9P,
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M0SP6K3Z;;M$$E1D?<H(SPQQSZ4 ?5^O_ /(#U#_KWD_] -?EW\ ?^2)>!O\
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MA9]<_MG5I@;K2[:=_LTFH7#VPW8/ @:( 9^4 #C&* /=_P#A9OA+_H9=)_\
M V/_ .*H_P"%F^$O^AETG_P-C_\ BJX37/V=/@7X:TJXU/5?AOX'L+"W7=+<
M3Z+;*B#.!DE/4@?C7SIX[\!_ 6_^/GPMU32/#?@9?!UA9:TFNK%I]LD+2R1V
MPM/,CVC>=RS;3@[>>F: /L;_ (6;X2_Z&72?_ V/_P"*H_X6;X2_Z&72?_ V
M/_XJO+O"'P?_ &=?'K7*Z!X$\!:H]N 94@T:V+(#T)&S.#@\^U=(?V5_@WC_
M ))5X-_\$5M_\10!UO\ PLWPE_T,ND_^!L?_ ,51_P +-\)?]#+I/_@;'_\
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M >Y_\+-\)?\ 0RZ3_P"!L?\ \56AH_B[1/$-P\&F:M97\R+O:.VN$D8+G&2
M>F2*X/\ X97^#?\ T2OP;_X(K;_XBJWAOX%^&OAW\8=)UOP?X-T7PWIS:%J%
MG?7&DV4-MYDKW%B\*N$ +?+%,1V&#ZB@#URBBB@ HHHH **** .9^(E[>Z?X
M4NIK%Y8I T8DE@3?)'$7 D91W(7)KA?$%SXE\":/>217EWKFBWMFXCN7_P"/
MFSD9#L8D=LD?3^?J&N:Y9>'=/>]U"<6]LK*K.03@DX'2O$[SQK'=6.I:J?&-
MS!JD<LAMM/BCS 5#'RUP1R"N,GW-?F7%-:AAZW,Z[C4<-$I)<J5[NTI)2YKV
MY;7=M&K:?89-3J5:=O9)P4M;Q;NW:RNDVK6O>]E?5:GN&C.\FDV32,6=H$+,
MW4G:,U\B_MA^'+2T\>6WB.Y2>8KI?E", >6P$H51D88-NDSGO@#IDU]?:?*T
M]A;R,5+/&K'9TY /'M7R-^UQJ^CZS\7O"?AMKZ*#4EM3)(9I-D,<;EP"[?PD
M$#!/ W>]?9XR*>"2O?:WX'D9>VL9=>=_0\.%M>:N9+'SC--)(1^Y ;@;44EC
MV#,HQQP1SQ5Q]'74Q;W,4UQ!)II(B1(W9P[':D;!5VJ5VGH.3D=:PM+EBTG5
M[;48%NK"=IS/%,R!U<(2J&-3C&[  ;)'(/ Q736\=Q8^(KG3Y5>QMU*V=U(R
MX(9761G+, 1L)ZXX)))(-?&*,6KM?UT/LY-K1/\ KJ.?3+R_U6:$;XKG(CBB
MNRS _+OB3<>2SDG"@9^F#4%_I*66IQR6]N-0@MHTC$%N6VM(K,)#(V,%BP)Q
MZ#&:@%XRN7LKN5)8;F7^SI&F V]?F/3<WS'#C.<GK4UJLEK<R:?;V3W15P I
M<)CHQ^7. >G0]"W<U#UV7]?U^@*ZW?\ 7]?J1Z>JLJQS222Z>=[F3+ G!R0
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MS#X9;58A:R:WIDIMKFWEOX0%WF.9&V@JH?RXW9>.0#Z^HHHH **** "BBB@
MJ"^M8;ZRN+:X4/;S1M'(I[J1@C\C4](1D4 ?-?AW5E\&W<EC/9"TM?/\L7#A
ME60-Q&(R20=H!R.,@9%>DPR-(A5MH)X&.>.V*?KNCPVFH7%L+='B#B6*-QD
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MTK2;32O FM>([32[K5YY%EN-1:2*622&./'[M$"#+DY+$ < UTW[.G[-%_\
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M/Q/XIM[O7V77M0^P^&;9XIFMK2:90T[+D%3L9=\@ +87G0\ 1OKME^S)K_Q
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M%Y# K+MW?*2V"<CUX&#VS0EV"Y-/!$D30R*)5*@-$PR&4GG/^>E/2V2S?-K
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M2XMC>:!=:7>$QW,16:*3:"4!R<$8. .A).37!^/;PMXHU*>.PCM76**SCLF
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MM% "8'H*,"EHH 3 ]*-H]!2T4 )@9Z4;1Z"EHH 3 ]!1BEHH **** "BBB@
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M, G.,\D@DXQC(JUJ\_VGSKW3KBUE\F0W-JEK"7\M4"LK,1]W [=0<^]?4_\
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*BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>aciu-20231231x20f032.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aciu-20231231x20f032.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" +M Y(# 2(  A$! Q$!_\0
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M$\5N"(TDEA5V"Y). 6.,FOF;X/\ _!1#PA=W_CNP^*WB7P[X.OM*\87V@:5
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M^'_#FGO?:A=!!F1UB7&%7(R21^.#CD-5_;N^%.C_  ATWXD3WVI_\([=:R-
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M^)/B37_A=K_Q)T;XA:!IL&@RZ1IBWJH4MT22RN-_%NKG&3)@;0">.GS;\./
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M;K-^;R_U77;\W%YJ%TPQNEE?&YCC@#WXR37J= !1110 4444 %%%% !1110
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M,9,W[,'[6WB;XX:KJEAJNO?#7Q;I+:+)?;_#%U<V=_:R[>8);*Y)D=1R#*A
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M[P9XG_LOP!J&KVWB/P1]H6RF'E>6\)$Q)8J9!\P..#Z\?3?["/\ R9]\)?\
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M.: ,?]H/]I[XB:G-^U#X$\-)I6COX%\/VU[9:L'GCNO*FBW7#!U8XE52?+(
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M01P0:POVM_ASX8^$G[2?[-/B/X?:#IGA7Q7JGBO^R[K^Q[=+07MF^Q9!*D8
M8 .1DCHYYZ5ZGX@_X)_>%?%GPQLO!6M^//'VKP66NC7[;5;[65FOX9Q%Y:JD
MK1G:@^\ !D-SFMSX2?L.^!/A9X^MO&]SJWBCQWXKLXFAL=3\8ZLU^]B&R&,(
M( 4D$C/)&3C&30 GPW_:;^'?[3_C+5OAZW@O79S8127<P\4Z"JV,GDRJGRER
MP+;G!7(S@$]J\8_88^&OA"_^-G[2QN?"NB7!TGQSMT[S=.A;[&%,A40Y7]V
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M@!>>M=1^W/XY^*?@/X:Z->_#*QU699-6CCUV]T#3H]0U*SL-C%WMX)/E9MP
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M[40V[;)I#,NV)O1CG /L:Y;XE_$>?P9X NO$N@>'[SQU+$\:QZ;HL\7FSAI
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MFV^^%?[1.A?!_P"V:K]E\*1ZS=VVE7<EQX?@GA^:WDB<,1]H!RQ&X@C?P<,
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M%%% !1110 4444 %%%% '$>/OC5X'^%U[:VGBKQ-8:'<W49EABNW*ET!P2,
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MM7+O]IWX5Z?KMQHUWXZT:UU*WN6M)H)[C88Y5;:RL2, A@0<FO,_"?@[0?\
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MA\.O"7B72=7L+!_&?CLZ9I O;%6B@TMO-CB#CAF):/?NSD@@ U+XY_:+\?\
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M'\2:EIUVEC82:9H5E86C1M!"[EB\SL3ODP2O&!AC@"NP_P"%.^ O^A)\._\
M@J@_^(H_X4[X"_Z$GP[_ ."J#_XB@#SBS_98\/ZO\3?'WB7QCIND>)[+7[RT
MN["VNK4N]H8HO+8$GKNXX'!QS7HGC7X.^"/B-;V$/B7POIFL1V VVHN;<'R%
MX^52,$+P/EZ<#BG_ /"G? 7_ $)/AW_P50?_ !%'_"G? 7_0D^'?_!5!_P#$
M4 6M9^''A?7_  I#X8O]"LI_#T/E>7IGE!8$$9!0!%P %(&!TXJ?Q1X%T#QJ
MFFIK>E6^I#3;I+VS\Y3^XG3[LB$="*SO^%.^ O\ H2?#O_@J@_\ B*/^%.^
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MPY_X*H/_ (BC_A3W@+_H2?#O_@J@_P#B* .OS1FN0_X4]X"_Z$GPY_X*H/\
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M\T ?4=[N-G/M(#>6V,C/.*X'&U,G&<<D5W]TP%I,Q.!L)R?I7!2#C"G&.]-
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MOF+,>!ZC^6*6654WC.V3.U25W8SCT[<_I44<1AL5@EE>XDC50\DJ@LV/XB%
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M"&=0H8.L+2 *I^<!SP&WXQ_NGCC-26MP8[MI)E2.+_CVWFX!)?.5&W ^8\#
MYR,>E,1TNBW N].BE560-GY74J1@XZ$ ]JO50T49L0^9?G8OMF&&7/;';'I5
M^F 4444 %?'?[2GQ'\':QXK\/:S'\4/$7@+4-(DU#38Y-(T%[AY)$D1)P6*'
MY<A1CE6P".F:^Q*^4?B=>?%70?C5HOABU^-=IH=CXA%[?6XOO#]J([2"(KM@
M1V/[Z3YQU*\*2>PH ZG]D;Q?:^++3Q2UM\3=?^) @DM@SZ[I7V$V>5DX3Y5W
M[L9/IM'K7T+7@W[-7BKQ9JGBGXC:!XJ\<VOCR70KNTBMK^PLH;>!4DB9RN8^
MLF>&4YVX&#\W'9_%'QOXST&ZMM-\&^$;;6KNX0,=0U;4TLK&)B2 G\4DC\9V
MJN,$?-VH ]&I!TKQWPIXZ^+5IX@@L/%_@;1+BTE9 ]YX9UGS)+96; >2"959
MD'.2I)XX4UV7@31](T"RU?4=,\2WNLZ3>7,EQNOM5-[!:,I*RI%(Q)1 RME"
MQ"D$ +R* .#_ &TO^39/'G_7I'_Z415[8.E>'?MDW,-Y^RYXWG@E2:&2RB9)
M(V#*P,\6""."*]Q'2@!:\?\ VP/^36?BQ_V+&H?^B&KV"O'_ -L#_DUGXL?]
MBQJ'_HAJ /6;'_CR@_ZYK_(5/4%C_P >4'_7-?Y"IZ "J6LOJ,>G2MI4-M/?
M#'EI>2M'$>><LJL1QGL:NT4 >&2^#[N7XVP^)W\ ^#6\<Q:243Q ;VX\Y;??
ML\O=]GZ_,1GK@D9Q7LFB2:G)IZ-J\-I;WV3N2RF:6,#/&&95/3VKYJO],T _
M\%"=-O6^*E[#KP\)NB^!!-^XE7<W.,XZ9EV8W93=G:,5]24 %%%% !1110 4
M444 %%%% "'H:\J^!W_(Q_%[_L=)?_3=8UZJ3P:\J^!W_(Q_%[_L=)?_ $W6
M- 'JU%%% 'COP<_Y+'\=_P#L8]/_ /3+85[%7%1WO@7P)XE\07+:KI6D:UK-
MQ%>:D+G4522658(X48H[_+^ZBC&  #C/4DF[_P +1\&_]#;H7_@R@_\ BJ *
M6L_&;P9X?\?:;X*U#Q!:6OBC41FUTUV_>R9QC ]\G!Z?*WH:[6O(M:TKX.>(
M?B%I7CB_U'PU<^)]+0I:Z@VHP^9&#MQ@[^VW@=/F;KFNU_X6CX-_Z&W0O_!E
M!_\ %4 =117-V_Q)\)7<\<$'BC19II&"I''J,+,Q/0 !N3724 %%%% !7E.D
M?\G1^*?^Q/TG_P!+-0KU:O*=(_Y.C\4_]B?I/_I9J% 'JU%%% !1110 4444
M ?'_ .U7\&O!&B>-/#WC36]&U^30=0U&5_$NH:/=W,CQ 08AS$K$)&S@;F4
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M@JOR%!\N0!DBOJT=*\3_ &TO^39/'G_7I'_Z415[8.E "UX_^V!_R:S\6/\
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MNTXRQ]A@9/UJ[;Q?;(XQ)'+&&*DY;:PP01T/3C^E5;J(Z&LC5HY&N&(EPAC
M"8QM.<YSUY''I6O65JC*MP Y"J4 !;D$DXQC\:$,HQS;81,BLR.3*P,F]@2,
MX7J/3@''-+YTPA+K$IEW; IDQ\H8C.<=<<X]>_>I8<(A  " D[1R /3V^@]*
M4)QZC/KU%(!K!UCD",HD))#,,J,XZXQFHY#M=P[!D(+;-N2!GCD?C[U,V-WW
MAYF,[<\X_KSQ5)K?8L'G#[9+ PVR2 !MP!!/' )#8P!3 MHRKD$[1T7G ./3
M-,C<W$C)'ED QN!XSN((ZYIT?[N-78R2!FV=,X/<DCMQBG.B2J05##=DJ#C!
M_K2N!7)BN;FYM59EE6(%GVXVJ<XPW3(P?H<4D,J,0!GS,AI1.2KJ.5#;?<C]
M:=(9[>:U$-NLT+R!)=I ,2[3\P]1D 8].U/VL9-Z EB"IW$A0<9SCODD4")=
M@=!D*4!X'84WR7;(2;"L#\RXS[8[>OUJ12&7:<-CA@.1GO4;2PV%L\COLBA!
M=CC.Q>O  Z>PIA<>07)EZ@=UZ-VJ,[XY'E;RS%M.YMF''(P,]P!G\:Y[XCW_
M (CTSP7K=SX.TNVU/Q"ML?L-K=2B*-Y-ORDD\'&>%XR>,C.:\._9L_:NT_XC
MR1^!?%EK+X8^(=@&MKBTNW\L74JG#&,L=P?/)C//'!-<\J\(3C3D[-[?Y7[G
MK4,KQ6*PM3&4(\T:?Q)/WDN[COR^>Q]*1SB==R-P<@,I!_$5 ,6OFW$H(N"-
MF859RR[L*Q7'7GG'\A5F*,(SA0%&<D 8YZ4V>ZCARCNT;MD)T!8X)PI/!/%;
MGDES24,2/%E2(]JY48SQS_D5CB[:?5KB#)M4BBR\;PX^9F)5UDSM;A2" #@D
M9]*V]-<L&RI7Y5.&QD'N#BLN<0O?W#*6,RKLW%>%&2?E.,=1^@XH&5[2XEDR
MRVIB'FD,\A #)M)$@&.23C@XQ3KI6>2V:*W$XWE]_F!=AQPWOU(HD@"W4,BQ
MQR7>!"TKY!\O(9^G3IGTS5>WV1S"=DDMTF.<.NS<X^4#;GG< " !_#GJ:6P$
MXT\?9)(3<33;I"Z/A=T9)R N !@9[Y]\TZ4P7SQPO)(&4DKO)7S NTD@CJ 2
M/QXQQ56[O)UF^T1((88=J[IN/-W+PH]/FVY.,]14<&I:=?W-W9V\AFN41%FC
MC^8VQ(#(2A^[D,&!QR!GG% $R ZI*+A[>:)(G>/R[A"FX!L%MI/*DJ"K>@SQ
MFJC65K:ZK>/]GCDO-0.&59&995C11\ZD[0P!/0<C&:O"T331+()7#2N)96<Y
MRX #')X4,%' P,].35:&Y/F+&+DV\UPSEI/*+KD/C&YL '  VCT/IF@"T[3?
M;1!';H+<G?+-(^TXV\>6,'/8'.!SWJ?*G.0@_B3:>2#R<5#&LE];V\\L4MO*
MNY3;NXV/V^8#(.0,CTS5;4I;+1?.G+K'(^&7)P0HQD@#D@%LE1VZ"@ T^\MR
M1',4@O7R7@4D*=G4H#C(^8'('.<FGSF>"-T2*2X>4,;:9?GP3V)XVJ.O7D<#
MFFVTDE]<^5<Q RVER"KQ2 @#9R2.P.2,<GUIEU!-:V[+'/<?:Y2B/)!;@@NS
M8$AZ[5 &#@\#FF(B@ML2V#S:V[Q^6IVB2/;=R?-ELXW$8R,#' 'O4JPR%W:.
M4+!''B.V@C+@,22'8'!)VE3CMSSS59K6=&BBMS#E9?/MY;F(^8B@J9%.5P,Y
M(&W!Q[Y-20)+<->03Q!Y%G:6#:SQ0R9<F-2W7<-@+<$ GC(.*74#'/@VR\3-
MJ-CK&F:;=Z(92TUE=6_F/-<,,N[$DJ%X0J%XYQP5J]?Z2EC;Z3#II:RCT]EM
MA*K$O' 5 9=SG!7:$R22>./F&:ET*]N+K1+9[IXYKQ 6)C1HQ(<-M+J1N09!
M'?HI&<XJ.XNY8-1M(9;D"6:%HQ&JL-[;T*L&VD#CY3OQGJ,<T>0_,['P_:+8
M:5#;H[.D>0K.Q9L9XR3R3[UI55TQ!'9Q@9Q_M')JU3 **** "OB/]H[X]_#C
MQE\6=#\+^(/&.N6?@[2S>P:Y8:,EU;,;U"@B$KHH9XL"0?(3SCL<U]N5Y8_[
M1WPR@\37>@:EXCM=#UBWN'MWM]:A>RW,I()1Y557!QD%201B@#S?]C#Q5HNN
M7OQ$T[PCXAU?6_!.FWMJ-)BUR222XM@\3&4*T@W>477Y W(VG/49Z7]LK6I-
M$^$MK(FI/IB3:S96\S6MBEY>RQ.Y#I:QNK S%<D9 X5AD9KVK3+ZQU*V6XT^
MXM[JW< B6V=71O3E>#7CG[3&A:WXPTFQT>VT7Q'_ &9;7,&J+KOA6XM3>VUQ
M$S%5$,S*>/E;<ASV]<@'(_LE6^D0^(?$']FZSXVU1S:Q;T\5: NG1H-YYC81
M)N;U&3@5[A\+;J"\\&PRV\5G#$;J[&RP@CABR+F0$A8Y'7)()8[LELDA22H\
ML_9LN$.O:[;S?$#QKXGU&*"/S=(\86)MFM!O/SI^[56R>#M9NE=J=+U_Q%\'
M-3T[P]JT5CK=V;J"#4);I+@0[KAPS"2!% 8)N"X4E&QNW%3D YW]M+_DV3QY
M_P!>D?\ Z415[8.E?'O[07@+QQX:_9 ^R:AXF@L[;2/#]E9ZEHZ6HO#<R1S1
MAF^UNP?)&T$[3R">]?80Z4 +7C_[8'_)K/Q8_P"Q8U#_ -$-7L%>/_M@?\FL
M_%C_ +%C4/\ T0U 'K-C_P >4'_7-?Y"IZ@L?^/*#_KFO\A4] &-XR_Y%+6O
M^O*?_P!%M7X0^&(VE\&:2B2&)VT^)5D R5/ECG\*_=[QE_R*6M?]>4__ *+:
MOPB\*R)%X0T5W9446,&68X ^1:^-XE_ATK=V?TIX))/&XY2VY(_FSF1I/B;P
M_I#V]C?KK&LA"RRW0P-AD&0,GM[GN?:NHULS'PEJ!N HG^PR>8$^Z&\LYQ[9
MI?M]M_;(/VB+'V?KY@_O4OB&5)O#.JM&ZNIM)?F4Y'W#7R,JLJE2'-%7O>]K
M;_A8_H>E@:&#PF)5"K)Q4'%1<N9)13UUN^9WLVV[I+L?NWX0_P"14T;_ *\H
M/_1:UKUD>$/^14T;_KR@_P#1:UKU^P'^<A6U+3;36=.NK"_MHKRQNHFAGMYT
M#QRQL,,K*>"""00:XKX#^&M)\(_"/PQI>B:;:Z3IL-FICM;.(1QJ6)9B .Y)
M))[DUWU<G\*?^2<^'?\ KRC_ )4 =91110 4444 (>AKRKX'?\C'\7O^QTE_
M]-UC6,EM\7E^)OQ$OK:"P&G36%G#X<BU.]9M-0QS2"5G6(>:)71MS'&!B-<D
M FG_ +,9UQC\43XE73DUW_A,9OM2Z0TC6H;[!98V&0!_N[<Y'7..,4 >V444
M4 >._!S_ )+'\=_^QCT__P!,MA7L5>._!S_DL?QW_P"QCT__ -,MA7L5 !11
M10!Q&J_&KP3HEQ<PW_B*TM'MG,<OG;E",#@@G;CKQ6CX=^)/AOQ9?FRTG58;
MVZ"&0QQJP.T$ GD#U%<!^UE\6?"OP<^#FH:OXKUE-'M+B>"U@8AF>:4R*VQ%
M7))VH[''0*37J/ACQ'I?C#P]INNZ+?1ZEI&I6Z7=I=PL2DT3C<C#V((H U**
M** ,_7-4ETBQ^T0Z=>:H^X+Y%D$,G/?YV48'UKX[\!?"?Q[X;_;4\7_$V[\0
M^,=4\/WUGN7PJ\$>$24%8HVS<^5Y<9B<J4&[(YQR6^TR,BOD_P"'O[+VN^&?
MVY_&WQ2G^(>H7^E7NGI(N@.'QB;>BPN2VTQQ&(L@ !RPZ8)8 ^I],O7U"PAN
M9+2>Q>1<FWN0HD3V;:S#/T)JU110 4444 %%%% '@?[6T^@6.B^&+V[U?7]'
M\6P7SGP]+X7M?M-_),8R)8UB/#H4^\"0.G/:LG]DNYT?4M6\5WM[K/B?5?B(
MZV\>K)XNL197=O;KN\E$A7*B/)<Y4G)]*V?VH]+U2WN/!7BO2/&7AGP/>:!=
MW#+J'B1B$D$T0C,2]B&&=PZ\*01@UYE\+8OB5XP^).K^(]#^*_PW\4ZG/#:P
M7XT^"2=X+.-V*QH%^X"7D.3G+'KP* /HGX\^#=5^(7P?\5^'=$:!=5U"R:&W
M%T!Y;-D':<@XW $9[$Y[5\VVOPYUSQSK_A:/_AGG1O!-GX=,L^H3SO:S+J$8
MMW3['&H7YQ(Y7YWSMP#GU^E/CEXWU'X;_"?Q)XFTJ*"XU#38!-%#<1NZ2'>H
MVD)R202!COC/%</X)_;&^'OCSQ!I.B:>-:BU/4I5ABBN=)FC57(Z,^-H^N<4
M =5\!/!.J?#SX'>&/#FN;/[4L; I<1H^]8B69O+#=P@8)D<?+6ER'QC&>%/O
MS797/-K+@X^0\_A7&M( K,6P$&6.<"@:'@!E']XC!(XJ&0 $$<D'H!S0DRNN
M]2LF0""A!RIZ4.-X!"ABIR"?I3&1D[2I$8..."/2H9=T1RQ)08"J.N>A)%3%
M=ZGE58 ^^VH;@;1N4+DL.IQ[4T(S[&TNK:>Y+WK7$;L/)C=1F/\ V<CK6A]H
M-QGR@H ^ZV.#@\_GT]JKP[FDG#1")-_WE;YGX')&/3^50SZ[ID.N0:1+J-M%
MJUS&\\%D\BB:6-3AV12<D#(!.*';J5&,I:15_P#@&G($=49TW>4P=<C)!]O>
MG!,)L7D<CYCSWJ+R]L3(@5<CH<?,0,#-.AD; W\,OH1@G';_ .OZ4$DRC_1T
M1NH4 @]N]/2)A"$&$!7:0G 'N*J373+<K"JLK%!(SDC:JYQCKW/%74<,.HS2
M&-*&9HV61D$;;@$8$.,8PW^>U%U;F[M0JNT3JP968'!P>0?8CC/:I0VTG+9[
MCCI4>[S&^5P0IRPZ\8X%%@N11*WV8HA!DS@E6W;3GD9SVY_*I3,!*L<A1'8D
M1KN^9@.I'YTD;(C<84D\>YJ3RD?82HW(<J?3C']:+6 Z:8HFGQ[W"\+U.,G\
M:SX0Z#YV69B"=X&._P#+_"KERD0TR!'A\U/D 7;NQTP>?3UJ!(V!.3GTQQ@?
MRH1 Q9AAG3?(H&< =. 1BH\10R(@8N[$L%9B3UY)/L3_ "J6[=XXA*FPE""Q
MDW<)_%C'.<=/>E9$E D559P#L+=!G_(H RK&VN;74-3EGEDDM',;0(S;O+&T
MJP'4\D9_'@<'.E&AV!5=D* #.,C'7OU]*&MQ'$RH% ;DKV))Z#VZU%J#7<<$
M*V<,4[F11(99"NU.2S# .X]..^:!DC/-&H=]C$,2=@.=N>/7)QC\:08MECBA
M@*H)-N#\H4<G</49./QH,KA@1M#$_NT<[=W //OUI]R'"!L9S@95=V"3U(H$
M5KL27*A1">0T;,K;"%(Z@]1SCH1SS2;DBMV#8>)0?-!48[YX^O\ *GJS21/L
M#HRLP#2#!W=,CU'H>E136L=W',$F#RJ!$YQA2<9P1@XSU^G2DQEM((C;K$J*
M(1M*H. ._;M46 5\QY4DB0LS>8O1@1@C'3'TS4BQBWB$<,8<*H7&["\'!'?F
MHKMV)")Y65F0NLS%2RX) 3'&[@  \<'-" JB\%Q<6[!+F)'3>LS$QQ EEPK+
MGJ0W&<]#3T@B&R>1=X6/82C%E8 \?*<Y]<\G@>E27$<<VV&01W$PD$^V3&%.
M3M./7(VY['FJ=Q:V&K7.GW%S"4O83OA>-R3'AL$!EX/7!!Z@T :-OM9HA&I4
M*2PVY7!_KG-/LKA;B[;RV/DQGRS'LP=V?O ^G;%*R1^1()'*(WWFWE<=NO:B
M.X2V6.5R51F15C88*DD#ZYY'6BPC<K+U-5:YB)X=>58=0<'_ #S6I6-K4K0W
M",J,[':JA1ZMSS_GI0,$140*&) Y'//O49F^=MC!E7"A%&6!([_F#]*>H <@
M!N1G(Z?_ *ZACA6#SY"-CSR;SERW& ,@'H<+T''>F(<2BI,V/G! !![D_I3)
MI(X\RN B;,LV0%4#!Y/UR?YTV-EDN)0D8_=R8<E,?,0,X/?Y2.:;)%!>/]FE
M>.5D99=I_A&3M) [=1[XI#+!<,#DC:?E49Y'/'UI5#1L 0SDC&>/S-1+<1>6
MA?:ID?;'D$C=@D?IG_)IS1AHPB +@G+,N1MSR/QH D0[U)QC(/:E@79!$N-H
M"@;< 8XZ8''Y5%9,YB.^(0D,5"APV5!(!XZ9&#CMG%3[MNT,PW>GOC/%,09&
M[&>3R!3<E9%"CW))QCZ4U(88'+A I8 ' ZJ,X^@Y//O5>SN(H<0QQ&-%"E>I
M0@DC /MBD N#-#_I $ISM.Y=H+ C! ],BO$?VG?V6=*^.6C1ZAI<-MI/CRUD
MC:SUL.T) #9(E**2X R5XW XP0,U[7*DI6X:*7<[+^Z&W.S [ G!Y^GUJV)F
M6-&:)LA,E,9(/'%95:4:T'":NCT,#CL1EN(CBL++EG'^K/NGU6S/,/A5:S?!
MOX7Z'X:\7>)K;4/$"></[0NC(J7$CRNR@O)R6.<#)RV.*]%:Y6ZN3%',OG1#
M<4CVL0.@W _=R<XZ'.:;JED+Z,!L.T3JY78LF1N!(VMP,XZ]1CBGVMG96;2+
M:111, /-$7<CH/Y_G51BH14%LCGKUI8FM.O4^*3;?35Z[&II<GF!V'0X/3%5
M9R4>3!)8,QQW/7@5-I$DIDF1H]J)@*PP W)YQV[5GW-TD#,9Y@IGGV1 H>23
MA5/7OWX'2J,"%5>!)Y;N4O"K-)N"X**&R%PO4 <9[XZ585"S2+(SRH9"N&3!
M&<8P1_"/7K[U6AO(+3='->LJQO'!FY.UC)C(^<XW%LCIQV]:NRQREQ(CDX4K
MY3<(2<<DXSD8_4T 4++R;KS&1=US&S@EU4-D$KO*@]"4X/<#M4%OX=TW2=6U
M37+33X4U;4(XQ>7()5KCRQA-Y/\ =' /858^Q?:U)O BSOLD\E"/W3*<Y#C!
M8;LGGUQBFW=BNK3SQ/<2IL01$6MQM*;L,2PZ*2!@=?E8^M,1,6@OK9((R[P7
M,+!77D $8ZGZ\9J.&1EA<&/S5B^5%/+!4  )/J>3Z\XJOJ*&(6947!\B\#*8
M%*QJI!P&VG[G0'/<U#IX_M">:^8LZNS-%;%<;&!YQS]X@],XY^M3?5(JQKV4
M4$B><H??(%8>9N'''\)^[U]!UJG817-HC&Z+7,CR*7>+YER202H/*J.,_0D4
MD=A!&MN@ED=#,"BLQ.YQD[2>IQ@GDXXQ6AG+8##G)(SU'?\ I3$47FC^TP(D
MABD1C(Z0@,O3)5SVW;@1ZXIEB9GNI=SF.! (XK9U(;)&[>6/5CGH"0 .O/#+
MQG%_;1FVMS:R8D_?-^^:9&&T*F#G RQ;.5P.,9P'61()Y0#!:6TZI]ID?9'(
M3PQ]0H8@<C!)&..:8%B":YFNE+ P6SN52+;O:8$*5=N 8\'<,<]N>:I+)<1:
M;-<R79>2;<//C4200J ?WBJ,C:,=R2>GM5_RQ!91M#)*JAD)=VR[<Y.6)ZGI
MUJ),6X<11+-&K,@6VC4  MCR\ \;3R3]:0#;2UN++RO):V);;N9+;8 @3 4
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MDDA2<  XO]M+_DV3QY_UZ1_^E$5>V#I7B?[:7_)L?CS_ *](_P#THBKVP=*
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M"W_A+R?_ "96)X)^/7QEM?".D16WBGPQ' ELH17\,NQ [9(NQG\JH5C>#?\
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M<OA#\2/BE\2-'\!ZRM]XK@O$N=>CV2J)9(HTM!)&7&UE40I&2G&0#_%D^X4
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M6J^*-)\+:-X\OO'=]/XUN/->[B:22;119Y,S':!"BRG*J,<\8]?K7XD#4?\
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MXY^,=OX,\66?ANW\,^(?$VK7%B^H^3H=M#((H5D$99S)+&!\S 8&:^7/VO\
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MI_Y.FTO_ +%#5/\ TKL:^Y:^&OV:?^3IM+_[%#5/_2NQK[EK^F>"O^1!AO\
MM[_TN1_/7%O_ ".J_P#V[_Z3$*0]*6BOMSY \/TO6?B+?_%/XA'1K&9-&L((
M;;3+3Q1));VVHW9<--/#*D+F*!$/EJ &,C[B0  QL?LURZO-<?%1]>MK&TU<
M^,IOM$.FW#SVZG[!98V2.B,WRX)RHY)'O7LYZ&O*O@=_R,?Q>_['27_TW6-
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M!B<NK/#XN#C-='^?FNS6C%$0C154!H@ %&>0,8[TV)U5D@<($;=\A7;O(QG
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ME(G*?PIC/)[^E3)L@58]YX& 7;)/IR>M(JO%YAR9-Q&%XPIQ_*@9)(P49Q]
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M/?/S <']?\:+B!C',BSS1LXP'4ABF#U52#ZT 9R?Z3:V:S64MO=W$?1=JR0
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MN VU0,_\>_M7S&>X2OBZ<%0C=IOM^I^Z>%/$.5\/8O%5,TK>S4XQ2TD[M/\
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M,FOYJ_U-S[_H&?\ X%'_ .2/Z"_ULR7_ *"%]TO\C=_9I_Y.FTO_ +%#5/\
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M3^S_ .'/CC!IG]L7&I:;>Z=YJV]_I%SY$ZQRJ%EC)P<HX&",?US5TO\ 9O\
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MI2HO5='L_(]S*JV7QE*CF--N$[+F3]Z#[I;-=T]ULT=W) )[]) 7V*N5C#;
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M^,+J37+*\GN+:[U#3]-UB>UL=3FM\>1)<P(P61DVK@\9"@-N K-UO]CSX?\
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M_*@#/N-)::/8ER\/.3M13GD<'(Z=?SIXTP!PPD( SQ@8Z\5=S]?RHS]?RI6
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MWOYC;VSO#))YD@&2OR*V./6NTKYX_:>B2?XG_ *.1%DC;Q:P97 ((^S2=0:
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M#]FFYEM?VA];M=1\067C[5+GP=ITR^(],C6"*U@5R%M'C0E<DG>')W$#D 4
M?7%%%% !1110 4444 <5\2OC)X.^$$6F2>+M:31TU*8V]H7ADD\UQC(^13CJ
M.N*\>T7Q9H?A?X]>(-8M+_47T:#2M1N/$0NEN@VG2Q3(XDF#Y5T9,K"L8!"!
MC\P.1>_:2B2?XV_L^1R(LD;>(+O*N 0?]$/8UZ+^T+Q\!OB#Z?V!>_\ HEJ
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M^&I?C%_T5/QE_P"#VY_^+KR^E1=[ 9 SW- 'I_\ PU+\8O\ HJ?C+_P>W/\
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M?[=N?_BZ3_AJ7XQ?]%3\9?\ @]N?_BZ\OHJA'J'_  U+\8O^BI^,O_![<_\
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M -=K_P#]*Y:^MJ^2?^"5W_)DW@?_ *[7_P#Z5RU];4 %%%% !7R#\>=9LO\
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MX1_%2?6_$&G+%%J'@C3;>^O1<1OYFKFZN+B\3:K$\/,?F^Z<\$U]=4 %%%%
M!1110 4444 %8GC71[G7_"6L:=9WMYIUU<VLD<5UI\PAN(V*G!1R#M;/?M6W
M10!\@7OPR^-,D>GYGU.1(]*TV._CCU4*;B%([$7%LI\P?OB\5ZQD^7(DQO\
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MFBDF"!N/F;&S&[G.W% 'T%K'[8/A'3?V@?!?PFM['4=2U7Q18I?V^I6PC-G
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M\5>$+GPK-&)I(YH9F;RG3^(#')';K6".M?1'[)/@[PW\7O'M_9^.;G^TTL;
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M%Q^>B2^@JXG_ &#DE2C&3LD^5)M*^NU_)M/Y;F/\2?%T/AOP_=QQZA%9:K-
MQM1)U)&,D<8SZ9[XKC=#UK3+3Q'H*:+XLO\ 5)[V;;=P7TQ=&0H23@CY7S@
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M\$')^@[4?$7Q[\0['69-*\$^!;74EBVF35]=U5+.T)(SB-%W2/CH20H!Z9H
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MC9^-?_)&O'G_ & +_P#])I*_F,;K^ K^G/XU\?!KQY_V +__ -)I*_F,;K^
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M#K_D-?&'_KAI/_H=U7P!^T?_ ,G"?$[_ +&?4_\ TJDK[_\ ^"'7_(:^,/\
MUPTG_P!#NJ^ /VC_ /DX3XG?]C/J?_I5)0!YU1110 4444 %6]1U)]2-N7CC
MB\F%80(EV@A>Y'J>Y[GGO52BI<4VGV'=I6"B@'@\450@HHHH * "Q ')-%%
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MOA.\T]8M.CM),'RUE4&0,J$'=R<YY/< Z;_A@K]GS_HD_AS_ ,!V_P#BJ/\
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M<370UB>$3"PMTB#R[4/#29) STVGUR #4_X8*_9\/_-*/#G_ (#M_P#%4O\
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M% 'G'P%^$ ^"W@3^Q9M5?7-4N[R;4M2U)XQ']HNIFW2,JC.U>@ SVKT>BB@
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MAE-^T/X3\3VZRM9>#K[XC7&M:C#=QS6]S>6@1&CC3&"NYB"3D$8&#D5]RT4
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MPIHTVGKJ-IK?B"RCBLKQ&90HBD5VW$AMP]@:]X# ]Z %HI,TM !12 @T;A0
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MA[P1X?T;2=44K?65GIT4<5TI&"LJA?G&"1@Y')JIX7_9U^%_@FYTNYT#X?\
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M"_AW\2M:LM7\5^"/#_B+5+/'D7FIZ=%/*@!R &92< \X/%=O%$D$21QHL<:
M*J*,!0.@ [4 ?D-\0=6U)OV5_P!H9X=4O+>YC^-K10W$=PP>(>9%C:<\8[#I
MQ7T1X>^&=C^SW_P4-^'>@^$]3UI-.\4^$KZXUN+4=5GO/M]Q'O(GD,K'YR44
MY&!QP!DU]>W/P1^']YI&IZ5/X,T.73=3U#^UKVT>QC,5S>9!\]UQAI,@?,>>
M*V[OP/X?O_%EAXGN=%L9_$5A ]K::I) IN((G^^B/U"G)R!ZT ?*G_!4$7<O
MP=\!V]EJ-WI4]SXZTN 7=E,8I8]WFC<K#N,Y'N!7EO\ PC5U^S7^V=X[\.?#
M&XU407GPLO==32[W4)KX7.J1L1'*?-9B7+*/J68=Z^_?%G@CP_X[L[2U\1:-
M8ZW;6EU'>P17\"RK%.G*2*".&7)P>U(W@;P\WC%?%AT6Q/B9;4V(U<P+]J%N
M6W>5YF,[<\XZ4 ?D?'/X6\,?LV?#3XN>"?B#JVI_M$ZIKMJETIUV6>[OKAYV
M$]I+:%R/+4$#[@R".3N%>Q7/PCTCXW?M7?M86?BJ\U>;3M$TJQN[33[359[>
M".Z-F2LI2-P&9"AVALK\Q)!K[MTGX!?#;0?&LOB_3? ?ARQ\42L7;5[?3(4N
M2QZMO"Y#'N1R:W+3X>>&+#6M=U>WT#3H-4UV-8M4O([91+?(JE565L9<!20,
M]C0!\7?LZ?%CX[Q_L<?!O4/A]X,L?B7>7-E>Q:G=:WJ_V:2 17+)  68%\J"
M,YXV"N!T'X):5\=?VK?VHSXW34+<Z?HVD7,NE:;JDT$*7K6!8.QB9?-,3(X3
M=E?F)P:_1KPIX1T7P+H%IH?A[2K/1='M 5@L;&%8H8@26(51P,DD_C5:R\ >
M&M-US7-9M-"T^WU7742/5+V*W59;U44J@E;&7 4D#/0&@#\O/ 7Q(U._^%?[
M"OB7Q1K\HMX?%&I65YJ=]=%4\M+GRH5E<G!PB!06/0?6M+XH>/+7Q9X[_;EO
M]"UT:GIL/A?3HX+BSNC)"KHJI($93CA@RDKW!K]%;WX#_#K4? =OX*NO!&@3
M^$K>0RP:+)I\9M8G+%BR1XPI)9CD<_,?6BT^ WPYL+'5+*U\#>'[6SU2SCT^
M^MX--B2.YMHQB.)U  9%[*>!0!^<#?!;2].^*O[)]A%KGB8'XE^'G_X2Z<:]
M="35D6UCF\ISO^1"3LVIM^7 [9IMGXIT7X4?!3]HOP3JM]XJG\(Z;\18="T/
M3-*UTVDJ"0L5MVNY0_DP$1?.3U ]2:_39_AAX2DO_#E\WAO2VO/#<1AT:<VJ
M;]/0J$*P''[L;0!@=A5&^^"G@'4]-\0Z?=^#=#N;'Q#<?:M7MY;"-DOINTDH
M(^=O]H\T ?F%\.1<>!/'W[27A'36TSP]HZ_"R[U!O#WAOQ+<:O9VET @#&>4
MY,P5R6*\#?[U?MO $/PM^&?['?Q-TC6M=_X37Q'K^DV&I:A<ZM/,L]G,N?LW
MELVQ8U4! H XSG).:_2'2/V>_AEX?C*:9X!\.:>C:=)I+"UTR*/?:2',D#;5
M&48\D'KWK6N/A-X,N]'\/:3/X6TF73/#TL4^D6CV:&.PDC&(VA7&$*]B.E '
M5CI2T44 %%%% !1110 4444 %%%% !1110!\#?M2?M >/+K]L?P+\*-"/C_P
MUX=\DS7=QX5L8&GU-VVE9HVE#!K>+I(<<8?@X%>N^ /V\?"OQ$^(&H>%M+\*
M^*3#H^HW^GZSKTUH@TW3/LJNQEGGW857$;D=^.0,BM#QQ\(O%.L_MQ_#7XAV
MFGK)X3T;PW?Z?>WIG0&.>0OL783N.<CD#%<?^SK^S!XCT?X._'KP;XNM1H,G
MCGQ)K4]K<0S),QM+F,)%-\AXZD[3@\=LT 7/#_\ P4<\ :UJ^E2W'AGQAHO@
MC6+[^S=,\=:GI7E:1=3EBJ@2;MRJ2" S*.ASC!Q:^(G_  4"\*^ ?%_Q!\-1
M^"_&'B/5/!#QOJPT:P2:**V:(2-<M(7"I&H('S88G.!@$CPA_P!G;X__ !!^
M"7A']G/Q#X+T30/"FA7ULMYX]AU=)DN;.WD+IY%J!Y@E88'S8&1SC)QZE:_L
MZ>.8/%7[8-X-'C%OX_TB*S\-R&[C)NW73YH<-SF/YW49?'7- '7>#/V__ ?C
M?QYX.T.UT'Q59Z+XQ9H/#_BG4-+,&G:A<*!OA0L=^0QV;BN-W?'->_\ COQG
MIWP[\%ZYXHU>7R=+T>RFOKE\@$1QH6(&>YQ@>YKXSL_V8?B'!X$_8^TTZ'&M
MW\/]5CNO$4?VR+_1$ 7+ [L2=#]S->N?MT?#?Q_\:/A-8?#WP-9[K;Q%JMM;
MZ_J)N8XOL6FJX>5@&.7)(7Y5SD CO0!X!^Q#^TQ\4M6^,MII'Q9U.2YTSXG:
M++XF\(Q2;=MF$GE!M5( ZQ#< <\*G=C7:_"S]I7QAH/Q#_:7FU33?%'Q'L/#
M7BRTTW2=!T&V2XN;6&03;O+3Y?D&U2<D]!7&?%;_ ()W>)OAM;>"O&GPE\;>
M,_'/C/P7J5M+I>B>+=9@DM5M%($L,),:"($!01G!4$8SBK=_\(/VAO 5O^TG
MJWP\\.PVWB+Q_P")+6;2+F34+=9(+(I-YTRDOA9%W(HW<@L6&=M '63?MZ6W
MQC^&OQQT_P *>&?%G@OQ1X+\+7]_+>ZM;11_8[I(V"1Y5FQ*&!8*P_@;TIG[
M-G[>=AJ/A+X-Z!XTT;Q>=1\5V<&GQ>,]1TX1Z=J&I[0)(U?(9OG^7>%VD].,
MFN5^"GP;^+?AO]FOX@_".?X+V7A./4_"VHJNNGQ+#>W6L:M+#L!FP!@N6/).
MU  *W=<_9E^(5S\'?V2]"MM$C;4_ 6M:;>Z_ ;R("UCB3$C [L/@YX7.: /1
M_&W[?O@GP9XN\1Z<OAOQ9K?ASPM>+I_B+Q=I.F>?I>E7!(!21]VYMI(#%5./
M>J6L?'ZS\._M1>+PWBK7M3T'1_AR?%'_  CUM:P'3I(D.\W$4V_>TK*,!2H7
M#?>]/G7Q1^Q5\0_#7C/XF:-8_#2W^(FC>,/$$VK:?K=SXSN=-L+6&=]\L5[9
MQ2(TI7G#*"3QUP!7J_B;]EWQLGQK\<ZGI&AV_P#PCEU\'7\&Z;)%>+L:^$91
M(0';>%X WOVQDYH W+/_ (*;?#Z6/PI?7?@_QS8:!XGMS_9>LRZ,6@O+Q0-U
MG"%8M))O(CRHVENAQ\U=CX/_ &[O .M^#OB)K?B&PUOP)=> 6C&NZ-X@M52\
M@\S_ %.U49@YD/RJ <Y([$$^2R?LP?$%OAC^R)HXT*+[;X!UBVO/$,7VN+%I
M&@&Y@=V'((_@R:QOBU^Q1X^^*_BW]J4)!;:79^-/[#N_#E[/=*8[J:R&YHY%
M4ED!(*Y(XR#VH ]Y^'G[:_AWQIJ>I:3J_A'Q9X$UR#19O$-EIOB>P6VDU*QC
M4LTEN0Q!( Y4D$?@<<EX5_;'_P"&H?AQXKC^&GAGQUH=Q_PCEQ>67B;^R(Y(
MDO%(06\&Y]LTZLR\ [>&R1@FO.OA'^S5XWOO%U]K>M?"*'P7-IOAB^TVTO=5
M\:W6M7EQ?3V[Q,+<-,T4<#;^=XR.,$]OHK]B3X7Z]\&OV7_ W@_Q/8+IFO:;
M!.MW:I*DH1GN)7'S(2IR&!X/>@#A7_:PU#X-VG@[X;^(?#/BCXF?%J#PS;ZM
MK]MX;MH97A&T+)(Q9T#,7#?+&#^HKZ%^&OC^Q^*'@C2O$^GV>HZ=:ZA%YBVF
MKVCVMU"02"DD3<J00?4'J"00:^2?VTOV>O$?Q0^*%CK4/P<T[X@:7%I@M[/6
MM"\0MHFO:?<AF(WR._ER0C)(&PD;CR.A]W_9"\!>/_AK\!?#V@_$S7)-?\60
M>:TTTUT;IX8V<F.%ICS(47 +?@"0 : &_'G]J30O@9K_ (:\-'0=>\9>,/$/
MF/8>'O#5JL]T\4?WY6W,JJH]2><'T)'Q]'^UAXB\2_#C]JKQ/=>,O%OAG2/#
M^O:9#H[P:=$=2T>.2;:\"V\I0 EAL8,W R0?7WS]H[X4_$;2?VD/ 7QM^'/A
MVU\<7.DZ5<:!J?ARXU!+&1X)&9EFBE?Y009&SGG@<$$X\$US]E'XV^+O@W^U
M!:ZQX5TZV\5_$+6M,U33+"PU.)X'5)Q)*HD8C&Q>,MMW$' YH ^C/%?[:ND>
M!M=M_!^D^$?&/Q)\1:=H=KJ^KCP_91226D$D:LKR*TBEG92&*QAL;A71>/OV
MP_"W@OP_X)N+/0/$WB7Q%XRA:?1_">F::1JLB*N96DBD*^4$Z,6/4'&0":^<
M?VE_V8/&7C+Q9IM^GP9L?%LD/A^TL]-\2^&?$QT76M/NXX0A%TSOY<T:MG:5
M7(7 SVJCXS_8W^+HT3X)>+]?$WQ8\6^%M*N=*\1:3!XCETN\N(I9))(FAO@R
MEFB$@1BQ^?8.H)H ^E+7]M3P;J'P;N_'MCHGB>^FM-4.@W/A>VTIGU>WU('!
MM9(0<(PZ[BVW!ZYXK(\+_MZ^"[_0OB+=^*/#WB;P'J?@*UBO=9T;7+)1="*7
M B,81B&+$J "1RR]CFO#+O\ 9L^,^@?L\7'_  A?A6+P7XEUKQ;'J_B#PUH7
MBNX-]J&F!2IB?4)I&VSM_&R, 1@]<K5;X7_LG_$CP[XE^-]_%\*_#FDZ5XP\
M-6T&E:!XAUN35;1Y8W7?;W<HD\TR,-S;PVT-MPV!0!]-?!_]K6R^*.OC2M1\
M >,O PGTXZM9ZCX@L%%C=6P&XL+B)W13MYVL0< ]^*YSP?\ M_\ @?Q=XGT6
MV'AWQ7I?A+7]1.D:)XVU'31%H^HW>XJL:2;MPWLK!2R@$@],''@?[/G[(?Q&
MTSXER"W\+:G\%OAS=:#?:=K^@/XL_M>UU"YG@>)6M8028U1G#@N<_+@'DYQO
MA)^Q9\0- N?!/@3Q)\++'4-.\/ZL+F[\9WGC2\?3Y[>.5GBEMM/CF'ES\\ K
MMSU W$T ?H7\4=3NM&^&?BW4+&9K:]M-(O)X)D^]'(L+LK#/<$ U\7?LR_\
M!0BUL/@U\,3\1]+\8W@U:7^R[SQ_=Z<HTMKYYG"1M)D$X7:"X7 P>N#C[5^)
M.CW?B'X<^*=*L(Q-?7VE7=M!&6"AI'A=5&3P,DCFOSSTS]FG]H/Q/^SA\.OV
M?M<\$:-H^@6>H6]_J/BU-9CD-M;).\Q@-N/F,P+8W*64\<CD@ ^F]1_;D\/Q
M?'/5_A3I?@KQ=XA\2Z5J=K87DFEV*2VT$<P3_29)-^$B4NH);!ZX'%9?B/\
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M\S\6_P!KBZ\.?M2_!^Y\.7VN>*? ?B;PC<ZE;^'_  [:_:)=5G<OY!5" 0P
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M7B#2O!=SHYD\/7%E;QKIGVA67R[5A(3)EF&_?MQL&,]:T1_P4=\''Q/;Z"?
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MVM%T33_#>DV>EZ596^G:;9Q+!;VEK&(XH8U&%55'  '85=HH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH P/!W@+P
MY\/;"ZLO#6B6.A6EU=27T\%A L223OC?(P'5FP,GV%;]%% "8HI:* $I:**
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M20/>L;PG^TCX*\6^+[;PM#=3V.OSVR3BPO8PDJ.V_= P!.)$$9+#[N&7#'-
M'J5%%% !24M% 'S/:_ _XB:+\'_B-H>AZI:Z1X@UOQ;>:S:2PW3H);.65&,1
ME4;HF958$KR/7G(\]E^ .I::WQ.TO7KSPOX.F^(6DVEGI%B-9DN&2YA8_NV>
M8"24L=I:09Y;&.E?6_Q%\:6_PZ\"Z[XGNK>6ZMM)LY+R2&$@.ZH,D GC/UKP
M+QOJ^M_'_P"'NB:GHWPUU*ROM66*2SO[V2W7R1'<QRHEVK$,;5PHE^0DL4 P
M#@T 7/!'PL^)5Y\9? 'BWQ58:%ING>'="GT=X=.OWN)&<H%$IW1J,,1]T?=
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MO[17[?OPP_9@\=6WA+QE'KKZK<6$>HH=-L5FC\IWD1<L77G,3<8]*\'^)?\
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M ]D_:BCTO1OB3\.K76-2OOA_X-M-,O88_%.B1F.:&4H$2S\P*P2,H =I'S$
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MPMJUS\/?$?A_4/#DTL]I/HWB>*-V,@4.K$VI."%QQC@FO2'_ ."X6F2(R/\
M!ZY92,%3XA0@_P#DM2 ]&\;?"+7/#W[/?P[\1W7Q&\1ZS83SZ"ZZ!>,AM(A(
MT155 YPF<+]!7J/Q#^($7PL_:-^*GBJ5?,.F^ +:6&,_QS&Y98E_%V4?C7S,
MW_!;W27C6-O@W<%%QA3X@CP,=./LU>:^#?\ @J3X:\(?$SQ'XX;X>>(]<U/7
M(C;R0:KXFAEAMXO,\Q8XO]$R%4\ $\"G8#Z7\#Z=XR^ WBCX/^*?$_A>UT/2
M&:30]5U6#4A<RWK7[F82S1A08]LI+=3CIV%=/\*_C-H'[,WASQMX&\>:9?Q>
M*3K-]=VUFMA),FN),08S&X4AMW"G=T'XBO"Y?^"W^E3H%D^#EQ(N<X;Q A&?
M_ :B3_@M]I,KHS_!RX9D.5+>($)'T_T;BD!]/7E]JFJ_'SX+WD7AZ'PGJT_A
M35Y(M&N,&.SD**4C?8!@ XR  1DCK7HEOX,\8^*?!FL#XPV/@[69[ F]TE=#
MAG:**189 9'6?JPW?+CID]\5\/-_P6_TII5D/P<N#(H(#GQ F1ZX/V:G'_@N
M+II&#\'[H@_]3$G_ ,C4[ >QQ6>DQ?L/_";6M4O];T.;1KN*[M-<T2T6Y?39
M?-F432QDC,0!(.,G)'!Z5YO=>"_$6M_!7QSXQL-1UK6-*G\;V.K1:Y/8;;FZ
MMX5=9;Y8 /NAY 0N.B<]#6"/^"WVDK#Y*_!NX$6,;!X@3;CTQ]FIR_\ !</3
M%0(OP>N0H& !XA3 '_@-2 ]E\ ?'JT\(^"?B/XA\2W]W\3? 6G7=E_PCVK:U
MIRQW.H7S(Q:%2R_,(V .\CY #CL*Y7Q!<Z?\:?@C\6-?T'7U\6_$C4CIVIZS
M::=8S)!9VL$H,=M LB@R!%#$GJQ7./7S]O\ @MSHSPK$?@S,8E.0AU^/:/P^
MS4L'_!;O1[8L8?@S/$3UV:_&N?RMJ /I_P#9#\<ZMXJ\>^*K>S\4ZKX\\&Q:
M?;2KKNL:?]FFAOBQWVRG:"5"Y.WHI  ZY/U;7Y:Q?\%P-*@7;'\'+A%SG"^(
M$ S_ . U:.A?\%LM/UO6]/T\?".ZB-W<1V_F?\) AV[V"YQ]G&<9H _3FBD'
M-+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% 'XF_\ !9J0K^U9HH !_P"*3L^HS_R\W=?!.!@Y
MK[T_X+-J3^U;HIQQ_P (G9\_]O-W7P9VJM]Q" E3D4]-S$;1S3*[OX=?#UO%
MDJ2SW2V-EYPA:9AD@D9Z#G%=N"PE;'5E0H*[9S8G$4\+3=6J[)''R33':, %
M>,@<GZT^WAAD'[T,'/&1TKZGT?X#>%]-:+[5!)>.&P6DD.QCZ<#![5<'PI\'
M^=N.DQ*-V<EC@>AZ]*_2:? F822E4J0]&V_T/BY<5X-/EA"7JDO\SSCX5_LG
M^+?B?=7$%LUGI;0PI-F_FPS*X^7:HSG/'YUZQX5_8HT_2',7B]];U2\C9<6>
MDPB.-EYR?-;)&" ,8YW<=*ZO1)9?"\UA>:/.EC]DVM"X),8P>A4'YE]N]>M>
M"_V@;5K]I_%"207K1BW\^U4&"5=W#*N<Y/?->IB^%Y9=S3H456CRZ*[4N:^W
M\MFNMDU^*_-,VXCSRIS2PLO<[15I+\WYZ/\ S/&_&_[,/A6PT"6/POX2NVO1
M&$N)Y;]KB2T=@,%U!"\9.1[\=*^=_B!\,O'URD=E_P ([<7>G::!91W.GV99
M'V?*"2HR3SR3S7ZA:=JWA^19(K34;2WA=]\L6_:'D;G.3]X_GTJW(UIJVEW-
MGIM^D-S+$9$>"0*X/]]MO/7J:^;S*O3C2=!8=P5XIR5U:+W<ER=+-V3VY;-W
M=OE<KXXQV!DG7A[3=WFY-I^K;?70_&?5_ FO:'!YU_H]]9PB1HC+-;NJ[UZK
MDC&1GI6"T;(.17["> / &[PSXCTOQ-:PZG::O>23NM\&<(3@':IS@%0?FZY.
M:\!^-?\ P3_T34'?5/ .H#35D5I$TF_E+;N,@(YZ>GS5\=CL+#"XZ6!U6ONR
MWA+1/XEI%_%I*R]UN^J3_7<KX_R_%-QQ,E!KK?3\;/MM??R=OSW-%>L^-OV8
M/B)X$EF74_#%^(X\8FMXC-&X(R,,N<__ %C7E<MM+ Y62-HV!P588(/XUP5*
M%2E9R6CUONGV:?9].Y^EX?%X?%QYJ$U)>3N1LQ8Y8DGU-"]?P-)2KU_"N<ZS
MVC]K8Y^-MT#T_L/0#_Y1K*O&BH.3G\:]F_:W4'XW7!/_ $ M _\ 3-95XV_?
M'3M6UM-3/J, /_ZJ,8)XS6UX9\*WOBB[:"R@:=U7<0O0#UKL;?X0SQ&-KF7'
M.TQI]XX/.,\_C7M8/)<=CH*I0IMQ[]#@KX_#X>7)4EKV/.(XDDF17?RT9@&?
M&=H[G'M6AI_A^\U6[\BQM+B].[:IAB9MWH0*]!'PSL#,,M,B'(RC;OS..U>H
M_"G7D\!S:7#"\4EO;3239=<B17&#D>I'ITX/6OI\OX2K5:W)BY*,>ZU;VTUV
M]3Q,=G?L:+GA8\\NST7WZ^AY?I_[./CS6($E3P_+;(2T>;AU3<PY/!/3MZ9J
MWI_[.VHW-W;VMSJVGVES-(L:+)(0K$CH'(V^WUK]"?"WCKPMXL\,W5X]R((H
M86DN/. 1T .W(R/NX  )Z^E9^G^%_!OQ7\.VEWHT4YM\NC7;JD<RKD\J6Y&?
MICITK[&EPQE-)OVL)/S;T]=+'XY+Q#S.$IK$T?9QB[-I.R;O:[?_  #\S?%O
MAF#PW/\ 9O.DDO48B6-TVA><#![Y]JYIP03D$$<$5^D.N?LA:#K6I+-=POLG
M@4K-+&=P !'S'@DC R?IBO+/BS^R7:06$=QHUIY9 >'S8& _>  @$$\C Z^_
M%?.X[A"I6G.I@IQMTCK?\=+_ #W['W&6\?Y5B'"C.;YGNWL?%V/FQBDS^5=?
MXQ^&>M^#'D:[MC);I@-/'R%)[$=0?K7)%=M?G.*P=?!5'1Q$'&2Z,_3Z%>EB
M8*I1DI)]AHZY[4AR.*<.G2@GGU%<1T#>PK[A_P""9O\ R"/VB_\ LG5]_)J^
M'VK[?_X)FG_B4_M%_P#9.[[^34F-'P^W6B@F@4 &>* >M7;;29K@#:GX9YQZ
MUHKX;^6)E8N'XXX%=M/!UZGO1CH82KTX:-F$%+< $GTJRFFW#JK&-E5^58],
M5LIHRVT;@D[B0,C&1^/I3HY!&$W/Y>,XV<#\_3BNR& Y?XVAA+$7^ RFTORA
MN=\IZ*,FH)X%B56"G!'>M^)0[@X D#?>"YY]/_KTV6U6:Y5,;T8L1SD5M/!1
M<?<,XUVG[QS)^M'UKI)M,B4MM1'5CRX&T8^G4&LZ]TLQ-^[&<?P]?RKAJX*K
M25]SHAB(2T,PGG/Y4=C3S$Z-RI7ZTS&:X&FMSIN@SGL!0S$TIXI>V*-0/K+_
M ()9L6_;9\"9_P">=_\ ^D<U>._M3_\ )RWQ4_[&C4O_ $I>O8O^"6;$?ML^
M!%SQY=__ .D<U>/_ +4X_P",E?BIG_H9]2Y_[>7I;L9Y7BE W'THX' SBK4=
MA/)&D@4A')VECC=CKBM(0<W:*N3*2CN5MH)QG\Z0+[D5?33!(F3* <@%?2M?
M2]+2VE+DB8@Y^7JN.I_2NVE@JE626R.>>(C!7,2UTJYN\^5$SJHRSXP /7)J
MP_AZYCA,K[0BYW$'.W''-=Q:B/R04+.K,JE,9QZGT_ U/):B?<5=%:,<IRP]
MP<=1S^=?44\AI.%^:[_#^OF>3+,)J6UD>;7-C+:DAP,@]%.:@,+ 9*L.,\BO
M17L#*H,=L"I_OD N,>W^?K4,NEQF<[ 'BXVC.3C YQ[$]NM<53(Y7O%Z>AO'
M,%LT>>_3I2"NHO="MWF<K\@_O ' K$NM,FMB 0'4CAE.0:\*O@JM!ZJZ\CT*
M>(A4V*5%/V$'[I'M28]?SK@L=-QM;W@'_D>/#O\ V$;;_P!&K6$:W? /_(\^
M'O\ L(VW_HU:D9_42.E+2#I2T@"BBB@ HHHH **** "BBB@ HHHH **** "B
MBD(R* .$\&_'+P3X^U/QGI^BZT+B\\'W36>N136\L'V.0!B03(JAAA&.Y<CC
MK6+\+_VH_AC\9?!'B#Q=X1\3IJGA[0/,_M*\:TG@^SA(_-8E9$5B G.0"#CB
MO@#]L#QU<_LM_'_X_6EFTL"?%CP7;S:8(5)S?F06L@'^UL,[?5EKS?XDVEQ^
MP]I7Q6^$MIY\2?$/P-HLFGQ$DYU LEM>*I_VM]R?^^1VH _3[PC^UI\+/'6L
M>"=+T7Q*]U?>-+6XO="B?3[F+[7#"TBROEXP$P8I/O[<XXSD5Z\"#7YE_%7X
M.ZIX?_:M_94^'7AGQ!<>#;VQ\%SZ>VK64227$"I#+YYC#@J)& D 8@X+9YQ1
MIO[3/Q,^ 'PX_:JT>X\6:AXZO?AYJ5E9Z!J^NJLUU#]JD,6^5L?.$^5@#QN'
M3!P #]-,CUKB?A[\:/!_Q4UKQ9I/AC5O[2O_  M?G3-7B^S2Q?9K@;LIEU ?
M[K<J2..M?$'B;4OBI^RI>? SQK=?&37?B1;>-]:L=(UW0=8,;VLOVI-_FV8
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ME7\ME-QN:,\,/<=ZZ_7_ (SZAXHT.2RU*UB:Y9-OVF([<G(.2OKD'/X5YSW
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M/0 #'!_'G]*R]<B7[*, AQG=T]>*\[&4OW$KHZJ$_P!XK'T?_P $M,?\-M>
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M@#ZCGMCI7SS\0/'5QJUVL$;!5C7;N#9*CG R>X'&:SS;-\-D.%LM9/9==_\
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M%YADE?&UG+G7+>]ODO\ (]YO/$^DZ=KG]F:I=QV]R4P# $E\L@\D-_=/0X[
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M/OQ^5.U#3K'54>.5,8;Y),GD\],]!6'#X \;VZ%(_#6N(K')VZ=-_P#$U(?
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M2!H[QWA8 1B*3=YCQF( 2+\S<_<I4'U_.C%  .E+110 4444 %%%% !1110
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M2,&W8ER25SZ)'_!1/]HXJ3_PM/5O^_%O_P#&J#_P42_:-&!_PM352?:"W_\
MC5>2^#="TB?Q!IZ:\]W%HS2@WALE#2B,?>V9XW=:BO\ P]80W]R+>20VJ.?*
M\S&YES\NX#H<8->O'*ZTJ:J:6V_4X'C8*HZ=GM?R_P"'/8#_ ,%$?VCL_P#)
M4]5_[\6__P :I#_P42_:-!/_ !=/5O\ OQ;_ /QJO$9[-%@)$02</@!.0<>M
M9KV-S)(=\9)/>N6IA)0:5K_(Z(5E+4]^/_!13]HW_HJFJC_MA;__ !JD_P"'
MBG[1O;XJ:M_WXM__ (U7SL\10E64@_2F$8 K@<;/4Z$[GT9_P\4_:-_Z*IJW
M_?BW_P#C5'_#Q7]H[_HJFK?]^+?_ .-5\Y XHS4E'T;_ ,/%/VC?^BJ:M_WX
MM_\ XU6QX/\ ^"A'[0^H^+=%M+GXH:K);SWT$4B&&W 96D4$?ZOT-?+5;W@'
MGQSX>S_T$;;_ -&K0(_J(%+2#I2TAGG7QI^*VJ?"[1;*30O ?B#X@ZU?RF"U
MTS0XU"J0,EYYG(2&/MN.<D@ &O$T^-'[5\4OVV;]G?09=/\ O&PA\90?:POI
MN(V%L=L5ZI^T=\$+'XT>&K)=1\=>+? EIH[RWLEWX3U(6<DJ[/F$I*-N4 $@
M8ZU^<^@:0OB+[#JOANU_:Z\0^'[IUEL=536(%M[N'=\LH!BSL;&>O2@#]//A
M!\2;[XG>&)-0U3P=KG@;5+>X:UNM(UZ)5D1P =T;H2LL9###J>>>!BNYJ.W&
M((^&&%'#]>G>OF_XL?M^?#;X2^.-9\+3Z=XI\37N@HLFN7/AK2&O+;1U8 @W
M,FY0HP1G&<=.O% &A_P4#_Y,S^*__8(/_HU*OA?/_9X^%=K_ ,_)\.18_P"!
M6Y/_ *#7)_ME^-M%^(_[ OQ \3^';^/4]$U7P^MU:748($D;2)@X/(/8@\@@
M@UUEB=WP=^!T7_/2XT+_ ,=MM_\ [)6-;^&SU,K_ -\IR[._W:_H>Z"N+^,>
M@3>(?AWJR6:YU.S5=1L2.HN8&$T>/JR ?C7:#H*1AE2,9^M:3BIQ<7U./#5Y
M8:M"O#>+3^YW,[PQK]KXJ\.Z9K-DX>TU"VCNHF!_A=0P_G6G7A?[+ESXJTJW
M\6>$/%-O9V3Z!J %E;6S9*6TVZ5,')W1\X0GG@@]*]TK.C/VE-2>_P"O4[,S
MPBP.,J4(-.*=TT[WBU>+OZ-!1116QY84444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 ?+7Q7^ GPRU/XPZ%I&H>'=9U?6/&<][>7<L6N7$,-M%$H>24
MINP07>-0@Q][VQ71?L^>#?!_PS^)WQ!\'^'= O\ 1+K3(+%Q-<ZG)=QWEM(K
ME'56)\LAQ(I'< &G?M9V^@ZI;^%M-?2_$6J^-Y[B=M 3PG>"TOXL(//?SC\J
M18*!BP(Y6H?V3;;P_I*^+=,&E>(]*\=P2P/KR^+;P7E_*"A\AQ./EDBP'"E0
M.<T ?C[_ ,%)U,G[:GQ0P/N7-L2?^W2&OF"OI[_@I,5_X;5^*"D'<;JUP<\#
M_1(:^9!C(XX[^]7:]B=KG7^ _#%OJDGVNZ)*1L-J=F/O7K5K>36RD0N(U3!#
M D9Y_G7 ?#_7=.BMVMGDC@E?A58\YQ_6MG6+R2T5)XGWX^5T!^\<<5^J91*C
M@\'&I2:;>[6Y\1CU4Q&(<)[=+GL&@^,#>6T<<C*MR/NMGKD]/\^E;;Z[)9QJ
M)B1W ?\ B.>I]Z^?/ /BBXOM;D@FD!W?<0#H37KR78N8/*E(^0X!XR/K_P#6
MK])RG./K^']HGJM/N[GQN/RV.&J\K7F;%]X;T7Q)J46I2V<2WB8(?8.<#&"0
M,]ZMV'@"RM%NC!-+$Y;'E.O!^E<H;^[MMB+(Q*#.]7XQ_.NDTKQ+YV\-( S?
M( PZ#ZUZU)X:I4NX)2[]WU/,K0Q,()0F^7L2/X8N(]TG+QH 0P!Y^H'^>*JW
M>@FYGAE<L@4X';)[YKK5N(KBTEGRS.R9(S@C XY%<KX9UF;7+(7@M9K5EE:,
MK.O+@<?UKLE"BI*E+=ZKY6_S.6E5K24I]M/O,[4_#4%]YBS1[XNK+MX]B3Z=
M!7EWB7X&"XGEN+0FW0GA57(ZUZO?>/-*TGQ1:>'Y#,UU<JQ5F7*@=L_4Y->@
MQ:';S6_FLRON&$!7 P#WYZUXF,RO+<V4H5$I.+L[;I]OQ/1AFF+ROEGJE+;S
M1\.>(? &K:"'D>VDDMUZR8Z<^E<\B,WR@-OZ$9ZU]QZMX)M[MI&" J022R@X
M'/%?/?Q(^$#Z>]Q>Z?"Z!"3)&$PJY_E7Y9G?!M3!1>(P;<H]5U7H?>95Q+2Q
MC5*MI+N>56<:@@N6>+DLG;(Z9^M.,0NI'<1I!&G+C=P/IZU!%=SV3/&K,I.4
M=.S#/0_E4)E.YL8&[/ '3Z5^<\\%%1L?9<LF[GL'[7@ ^.5V <C^PM Q_P""
M:RKQZ*$NP RQ/15ZD^E>Q_M;?-\<[O/ .A:!_P"F:RKA?"FEL2ER\?F*?N\8
MP>Q!J\'A7BZJIQ_X8*]948<S)M'\&R-%#)-'DL0=I."..,YJX=-:T'S*@7OG
MKQTQ^'\ZZ))_L[C+(027Y.XAL< ^PZ9]J&N%U(RJ44JH)&\#*_7W/2OTFGEF
M&I4U&GI+\SY:6*JSE>6QS@MXHF,CQKD'&3U7TX'&,XK2TZZ$41+)M[!U8@Y]
M1]?2EN[%H)Y&0,Z-&2%V]",\@=*J"8RLK$#<,;8L8R.W _STK.,7AI]OZ_KS
M+;56)W.F:G%(%GD'EH,[U(^Z2,9!'MTK0=-,6&1]@N%QGR7D7&3GG(SR !_*
MN"COXSL)*1H.0,9X^A^G2K]IJXCY0+M9B)>/N@C@[?3TQ7U5#,X.*C.S_K^O
M(\:I@W>\;HZ?6=)M]1A@2 2R(8R6VH""!Q_/N?2N+USX>PS-)$9([>6(<N<X
M!ZDY[BNYL]153YWVF,PD%3'$N.#CKC/ [X]:I:K,\B;!N?)\P*Z$2#/HV.GU
M_G73CL'A,9!RJQ3;_KN8X:O7H248NQXCJVA7&DMEP)8FX6:/E6K-YKU[4]*2
M1 2P8%>48%< YP.>M<EJ_A)40R1;<8!RHP2#_L_7 K\FS#(*E"3E1U78^SPV
M8QJ)*IN<:*7/;%37=E-9R%9D*$=\5!^E?)2C*#Y9*S/934E=!7VM^PM_R;)^
MUQ_V*,/\KFOBFOM;]A?_ )-D_:X_[%&'^5S4E'Q5C\*N6\"AERN#_M5!#'N8
MY.<5?,A#!F&..!VKKHP7Q,PJ2Z(U(+2(H%W!D/"\$XSV_.I4B"%@\)=,[P <
M<]@/UK-?49(-CQ-O!&,]!]*U].UN2[B-NZG<0!OX&W@\@>_2OI*%2A.7)L_2
M]SRZD:D5S;HRY[4F;YCN'&=ISMSVS5>6"1<Y^8].O05U!MHWB^^ISMR ,C)[
M #W]:KWMG',K*A?:F0 .X'K^-.K@'9R3%'$:I,YMB6?E2, 9!/'M0IP3O^4>
MG6M&]L@QC .">Q')/<G'\ZHR18D=>W7G@FO)J4Y4Y-,[(S4D-=59AC*]LD?K
M5:=(T)W$?\!ZU;!P<(,D#C=W_P#U8JDD+7$P''/?/:N:JKZ)7;-8>8TVX*A@
M>/7%,="@(QWYJ^P5AL& @&.O;ZTW:6P< ''YUFZ*Z%J?<SR._2C SUJ69"IY
M!&.#41Z^M<C5G9FR=S[;_P""0'_)X-KZ?V'?_P HZ^=_VJ/^3EOBIZ_\)1J7
M_I2]?17_  2!'_&8%K_V [_^4=?._P"U./\ C)?XI\]?%&I=!_T\O0EJ,\NA
MA,T@ &1WK52S1$'EH1R<,_//I4FGVR1VZ8 $AY))XQ5QF$@C+ L22%SQGVXK
MW,/AE&-Y;L\ZK5;=D9S-MA1%# #DK_7-2Q2[67^'T .,_C4DUDK$$G;R=HZ#
MIUJJB[%/WL@X!%4U.G+4E-26AKV-Z &5R 6.W/;;D9JU#<KMF._[YW*%;!&#
MZ5@1M(%QG:N3@GC'U^M6XIV=<[MA(+;5'/X5Z%'%222?0YYTENC;,4<I=5<;
MU7+YSD$G&"3P?K35MXI=X&'+<B1SDG! _#UK-2_82E<AR!@ @%><?K5E[N)I
M%,GKN*@8 'TKT%7I3ULCG=.2*M[:1S99U)7)&_\ NXXK$NM-:,KL^?/4#KGT
MQ717!64OO< [MQ4GY@,]1V[BJMT-RGD[>N,XW>]>5BL/"I=G72J2AH<TZ,C8
M8$4P5O36PDY(#@MSD<X[5G7-DJ/^ZR1^=>%5PLH:H]&%92T93K=\ _\ (\^'
MO^PC;?\ HU:PW&&(P01V-;O@'_D>?#W_ &$;;_T:M<3-S^H@=*6D'2EJ1F9X
MFN6LO#NJ7"&V5HK65P;PXA!"$_O/]GCGVS7Y/_!#XE:#:_#WP[%<?MJ:CX)N
MBN9O"]IHWF6^G2%SNMX6((\I3PN/EVXP .*_2[XU^'/%NN>'H[CPGX\M_ TE
MB)9KN2_T>+4;2ZAV<I,CE650 3E&!]<CBOAS3/VL?#?@R6/^V;;]GWX@6"D#
M[3X;O5TF\49^\8;F%T)QS@2#ZT ?I) 084._S!M'SGOQUKXB_:<^).BGQEXN
M^"OPBL?#6C^/O&%N&\:^*;UX;2UTRUD4J9)V)!GN&25MJ#) ?)ZU]B>"O&WA
M_P"(GANTUWPQK%CKNC70/DWNG3K-"^#@@,O&0>".U>"^,_\ @G+\ OB#XNUC
MQ/K_ (+FU#6]7NI+V\NGUB]7S)7;<QVB4 #)Z  #H.* /G[]J3X&^.?AQ^QK
MK&F^"?BQIT_PBT+PQ#:OHIT>&XFU HX\Z07@8E=\A+87A>E?3^@,7\!_L\VK
M-N9_L,AP,9*:5(V:XW]KCX;>'OA#_P $^_B%X0\*V']F:!I>B/':VIE>7RU:
M=7/S.2Q^9B>2>M6K'POJ>M:E^S/=6FOW&GVMOI,4DEE&N4D\NQ1V/7JZDQG/
M0,<>_/7;4-%?5?FCV\GA&>*?/+EM"H[Z]*<GT/J =!2T@Z4M=!XAYMXK(\(_
M%OPQKH79::[$^@7CCH)1F:U8_B)DS_TT%>DUR7Q5\,W'BOP'JME8X&J)&+JP
M?'W;J)A)"?;YT4?0FM'P1XH@\:^$=(UVW4I%J%LD_EGK&Q'S(?=6R#]*PC[L
MW'OK_G_7F>MB/W^$I5^L?<?YQ;]5>*\H&Y1116YY(4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 ?)'[1'QP^'=QXPLCIWQ'N/!7Q!\)7-Q:I=MH%U
M>P;7 6>"11$5=244Y4G!4$9KH_V3?$GASQAK/C#6XO'<GC[QI>);?VG?#2)M
M.@@@3>((HHY$7@$N21R2>0.]G]H+XLRGQAX7\&>'?B/HG@A+^:Z75M;::WGG
MLWB52EOL=L1L^7^9L?<QG)P;W[-_CG7=6\4>-O"VH^,[+XBZ9H8M7M/$ELD4
M;NTJN7@<1DJQ3:IW#/WL$YX !^-__!2@X_;:^)O_ %]6W_I)#7S3("$&5('8
MXZU]+_\ !2<@?MM?$T_]/-M_Z20U\T2S--C). , =A]*M6LR7N-CD96!4X(Z
M&NDL/%5U;0>3-_I* <;CR/QKF>]7E7;$&_'I79A:U2BVZ<K'/6IPJ)*2N;O@
M>^">*8)"_P!G5G/.,CZ5]#Z,B/9D%]V,?*3G [X_SQ7S'9/]FN8954DJX9<G
MT-?0NASM=Z5#=PPK)(^TX:38-Q[\]:_4.#\1RQJ4Y:M:]>I\7G]*[A->AJ:I
M9(@VK(%D=-R\YX_K_P#JK%:26U)+2."I'<G/O^E;XTL_:9//E#LK8Z<+_G%4
M)+25/,"OM+$G'/'MGTK[VO2DWS)6/EZ4TERMW-G1M:GD3$DAVJ.S8/X^U=9I
MFMVC@VLZ%0S862)L?EQ7DD'B&.RU-+"1@7<$J" ?8]^GI78V_P"]F=XOWK8"
MX88QTSGTKT,%C?:QY4[M:,X<7@UO)6OJCN[?PQILVIP:Q+#;W5W ACC.T%LD
M\]>0*ZB:QNXM(DEM[5GF)^52<C;@XKQ?X-ZQXFN[W65U^)8+9)?]&=UZ 'D+
MZCOFO;M O[E9$ZY!SL).!SCGZBNS#UXXF@L33@X\S;LU9Z::_=]Q\KFM&MA:
MO)*2GRVZZ6WM_F4--T^Z_LB$ZC$UI/\ PY;''TK@_B:YTK2[J>_E2&S*#;C^
M(=A[\\UZCK6JH[ 395L!5#+SZ_Y->._'OP;>?$?PY8'3;ORI+$/FU.0)@Q'(
M]QCO66-JXB&#J3HT^>5G9=_ZWMU*RB7M,73==\D9/5]%UT_(^0M;:*35+IX7
M$D;2%@1WS5*/Y<^XJWJ.D7&E2/'.A5D<H>,<BJ:@$@>QK^5JW,JDN=6?8_I:
MGR\BY7='L7[71/\ PO&Z_P"P%H'_ *9K*O+-/URZL$\N)QY><[6'2O4_VN?^
M2X77_8"T#_TS65>-YXK.E5G1ES4W9E2A&:M)7/1=-\3P:I;1PRN([D(0=X^4
M^P_PS49U06FOJD9WQ7 5",\#)YR>_';WK@(Y"G0_G4\,SJX*L0PY!]*^FCGM
M:<8*:]Y-:^AY;R^$6[/1]#VL1QW,$40#RIM(CR0<=@2/K65JNBES,%0 *O4\
M$D]2!Z=??BKOA&X6ZTB&X;8[..&R<YS@DCUS^@%:$HR%G2-%)#E(\Y .2.?P
M&?3'UK]3]E3Q>'C-KXDG\CY#GE0J.*Z/\3BY-.D\EY K Q#<S @_7'MT_.JR
M3& ?=4LQVD%>%S^/Z5UFH2 M&Q;8F["*WS [>< XSC%8;WMLDS*Q;<3N&?FQ
MQUZ<BOGL3A849+EG;U/3I5936J'Z1XB^QMY3E/*+?*K@$(<8/']#TK9&HK=M
MS,"/X0WWE.#CYOK7-7.GPF5I(FC4H20,'DG''ZU21GMT*S(@8YPYZG\<^]33
MQU?#+V=36/\ 7]+_ (8<L/3J^]'1G0:A>'RI(QS&@7YBPY;/7&:KQN'D&75"
MG!=1GOR",YYK--T?GQ&T@C&[)<]0/?K].V!ZU$URR1,8U!CW<.S '/O]1BL9
MXQ.7,]32-&RLAFL6L%U"SR90CY03R#GG(/\ 2N(8 ,0.1ZUU^HB1[!O+ .[.
M3WY[5R!SDYKXC-VI5(M*Q[V"346KB5]K?L+_ /)LG[7/_8HP_P KFOBG'/K7
MVO\ L+?\FR_M<?\ 8I0_RN:\$]$^+XY=F/E!'Y8JZD@N%(3+L  >>WI5':!@
M D9ZTGW.1D'ID&NJ%1PT>QA**D3><R2;, #.>16DDPB<-@X[[3W]O:L4L68;
MCFM.SF6:!%9F>16)*8 &..]=&'J7DT9U8Z)FE!J,\A=VD*DY!+')YXP/?%2)
M?/$RDC*QGY58C&/?ZU2CB(VE5.<9R?7ZTP72"8QHC,2,<G&"3SC_ .O7K*O.
M*7-+4XG3B]D;$-U$R)')&?F !VX _#\!4%S$)X@P(SO&#V8=JI.R*RJ0.,G)
MZ'Z?E4MO/O1E&[GEB%_STXK9U_:>Y(CV?+[R*UU;2VK%?E*MR<'GFH!N$8P"
M/<#M[&M*5M[9*YW+C/X<?UJ![=25/W<$9^;CZUQSI:ODV-XSTU,\AMRDM@$]
M3WI8VVL3[\ #C\*L2ID;&R#G.#].*@D.\\@@#C/0@=JXG'E9NG=$=P"R8VA
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MPARS9X6F3K&SAD "#&0222?7VS6,M?>-%V%1&4@!@>Q([T,<MY8)/.2,YS3
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M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD/ H
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MQ/TI(X',?R DD8]Q]*)9-H/S%C@9)'4#UINY&C)ZG@XSCBL'RW-%>Q$D)A+
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MRAV-Z'\J-C>A_*OU>_X6#_P3D_Z -E_X*]3_ ,:/^%@_\$Y/^@#9?^"O4_\
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MC_A8/_!.3_H V7_@KU/_ !I<S"R/RBRXSC=SUI29#@$,0*_5S_A8/_!.3_H
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M[G.TXMIJS0M%)D4M @HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.QYXZCZGCG^5<5K/A)XX9+^QC/V->2&8$ =MI_BS@\=:S-;0K>O+$)%#*K=
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M4X\S,9+$#!&2>H'?'L*Z;0KV#R[LR%78 L75<\ <+CI@''?^5>9B:5US;_\
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M#5@K=\!_\CQX>_["-M_Z-6L*MWP'_P CQX>_["-M_P"C5IB/ZBATI:0=*6@
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M%BRK9C3V\PI'*<*L33;?+5\X&UG!SQC- 'EO_"\OVL?^C;]&_P#"R@_PI/\
MA>7[6/\ T;?HW_A90?X5]=\48H ^1/\ A>7[6/\ T;?HW_A90?X5'_PNC]JO
M[3]I_P"&:="^T;/+\[_A+[??MSG;NVYQGG%?7^*,4 ?#WC'Q)^T-\0+:&#Q#
M^R?X7U6.&99T$_BNWR''0Y ![G(Z'O4%QJOQXND=)?V// S*X*M_Q/K(9!&#
MT2ONC%9OB3Q'I7@_0K[6M<U"VTG2;&)I[F]O)1'%"@ZLS'@"ME6J))*3LO,G
MDBW>Q^;GCWQWX_\ @'X3TZXUS]DSPGI.E7FIQ:=;S/XF6ZD>YG8A$+@%^2"
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M*^%WAH:+I#7,L+7$UW-<7DOF33S2R%Y'=NY)/Y 4 ?E1_P %N/\ DJOPX_[
MEQ_Z45^:]?I1_P %N/\ DJOPX_[ EQ_Z45^:] !1110 H..:MVFI36LD;J=P
M1]X1N5)^E4SUXH!Q4N*EN;4ZLZ4N:#LS<G\57LR.LGENKJ5(*=C6.!DXZ ]
M*8O)J[I<<;WD8EB\V(G#+NVY'UK/EC23<4=LJ]?'U(QJS;Z*_2_XEO1M!-]-
M&\K".WR=Q[\?YZUV,=A&81;,ZQ8&T2?=.TG[O_UZ?I]O'#;@PMYB*/W;')W#
MVJ<W<<<I:;8F&V<\@=\?SKQ:U:526G0_4\MRNA@*.MKRW??Y]NQ+N6W7RQ(Z
MG)P<=%'?ZURWB4W=_'!?E7CL&#11SE#\P'#<^_2K6JZZT+)]EEC9<A?E0G=G
MH.?3O52;4;^6&&UFE9[*VD#0JP/R!V^8XXSR.].E3E!J?Y_UOL99CC*&)ISP
MMWIM;:]TU=W^&W-MUMTU,66-A"+8R,LD,F/F.%"GH<'O4RVSJV+91N!PTC=9
M,<Y4$<?_ %JGN;1KM@'MVP<N9-_[R4$XS]>F!6I8:.(L31B90QR%9\OM'3./
M\\5W2J**U/E:&!G6JM16FFNMTO*Z]%?KZ%;1--$43_:-[*_R;<C:0#W]?Z5G
MZ19FT\7V$711>1;2QZCS!6^Q\J)Y&D5I&;E2V#G^59]C)L\5Z5,K>;&\\2*6
M/0[QT%%&;<V^Y6:X6E3PL(K[/7K9]_ZT/O'_ (+:_P#):OA__P!B\_\ Z525
M^<5?H[_P6U_Y+5\/_P#L7G_]*I*_.*O1/A@HHHH ZKX:>)8_"OBJ*]EC:2-H
MI(2%<+@.NTGGV)XXKV30]0,.C37]\R-,9BEM#9[%5T#;023DYP2.>>/QKYQZ
M5N6OC#4+>V2W+AX4"A5"A<;<;3P.HQU[]Z\',,M^MR]I#?1/T7_#G)6H^T=T
M=-XI\9M&EW D[2:@MTY6<QCE"?EY]0N!ZY]>M<E?>)+_ %)6%S,9F9!&7?DX
MXZ>G050N9VO+AI"H#-R0HZGN:V?#_AZ6^BDN@KLL9 4( QW'D9YZ<?I79"C1
MPM-.25S10A35V1>'-/BNI'DDD9'C&Z-4QEFS^@YZUZC=:M'/H=G%,0A5/+"A
M>BAMJD]S@9P<GK@UB:5:PVVUE$;2*A500H# DXQ@=>O/TQ6E=:08;))S"D04
M%_(>4[MO0!L= <@\<C->+BZL:]1.71Z'#5DIRU,#Q?I=BNG6\H/^D2@>7*6(
M C!;@J.I/KVQ7(6T0@ES^]C51EF0<@$=OUKM=4665U58A;/ GE8D)^5<@+SS
MGN,<?K5.T\,E]0*Q6[S22-\H Y8'IA<]>>!_]>NVA65.E:;-H2Y8V;,RP\M+
MF06Z#RA$28ILQLS>@.<D@\CGM78: D#:;=326JIO'E))*04+G@@^A/'(']:<
M?"]M;6376H!OLI8H' &]O]G/8?=]<^O%,NY9PTD7R-9;!MBB(' ^9LG&-P Y
M)Y%<56M&OI#[S&4N?1&'XST9[2"Q$_E@F1LJC[L_(,$MT XZ9S]*^^?^"0][
M!?6/QY>WM([-%T&R0I'G!(2ZRW)/)K\Y]?UYKTB)'D:%,E%=]VWD_P!*_0S_
M ((Y?\@CX^?]@6T_]!NJ]W"4I0@O:;G=2BU%7/S6;M]*2E;M]*2N\W"BBB@
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M '.,8XH ]^^&=S=7OPY\*W%\SO>RZ5:23M)]XR&%"Q/OG-=+3418U"J J@8
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MC\*_&4C(^\"32I6!)ZY&*D?]DK]HN0N6^%OC(%P-Q&E2\XZ$\5@\IFU9SO\
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MQ$_87_:>?QIJY\*^&?$FI>'WEW6MUK&HZ9#=RJ;46S&1$N&4'RBT?!/RX[T
M?"M%?4'_  [*_:7_ .B8S_\ @VL/_C]'_#LK]I?_ *)C/_X-K#_X_0!\OT5]
M0?\ #LK]I?\ Z)C/_P"#:P_^/T?\.ROVE_\ HF,__@VL/_C] 'R_17U!_P .
MROVE_P#HF,__ (-K#_X_1_P[*_:7_P"B8S_^#:P_^/T ?+]%?4'_  [*_:7_
M .B8S_\ @VL/_C]'_#LK]I?_ *)C/_X-K#_X_0!\OBBOJ#_AV5^TO_T3&?\
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M"C ]!2T4 )@>@HP/04M% "8'H*,#TI:* "BBB@ HHHH **** "BBB@ HHHH
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%110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>43
<FILENAME>aciu-20231231.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.5.0.8 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/13/2024 5:02:26 PM-->
<!--Modified on: 3/13/2024 5:02:26 PM-->
<xsd:schema targetNamespace="http://acimume.com/20231231" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:fact-explanatoryFact="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-roles="http://fasb.org/srt-roles/2023" xmlns:attributeFormDefault="unqualified" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:aciu="http://acimume.com/20231231">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://acimume.com/role/StatementConsolidatedBalanceSheets" id="StatementConsolidatedBalanceSheets">
        <link:definition>00100 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss" id="StatementConsolidatedStatementsOfIncomeLoss">
        <link:definition>00200 - Statement - Consolidated Statements of Income/(Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss" id="StatementConsolidatedStatementsOfComprehensiveIncomeLoss">
        <link:definition>00300 - Statement - Consolidated Statements of Comprehensive Income/(Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows" id="StatementConsolidatedStatementsOfCashFlows">
        <link:definition>00500 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails" id="DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails">
        <link:definition>40502 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities - Statement of income/(loss) and cash flow (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureAssetAcquisitionDetails" id="DisclosureAssetAcquisitionDetails">
        <link:definition>40601 - Disclosure - Asset acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails" id="DisclosurePrepaidExpensesAndAccruedIncomeDetails">
        <link:definition>40901 - Disclosure - Prepaid expenses and accrued income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails" id="DisclosureOtherCurrentReceivablesDetails">
        <link:definition>41101 - Disclosure - Other current receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails" id="DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails">
        <link:definition>41301 - Disclosure - Trade and other payables and accrued expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureExpensesByCategoryDetails" id="DisclosureExpensesByCategoryDetails">
        <link:definition>41501 - Disclosure - Expenses by category (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails" id="DisclosureRelatedPartyTransactionsDetails">
        <link:definition>41601 - Disclosure - Related-party transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails" id="DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails">
        <link:definition>41701 - Disclosure - Income taxes - Summary of Income Tax Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails" id="DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails">
        <link:definition>41801 - Disclosure - Retirement benefit plan - Summary of Benefit Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails" id="DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails">
        <link:definition>41802 - Disclosure - Retirement benefit plan - Amounts recorded in consolidated statements of income (loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails" id="DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails">
        <link:definition>41806 - Disclosure - Retirement benefit plan - Change in other comprehensive gains (losses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity" id="StatementConsolidatedStatementsOfChangesInEquity">
        <link:definition>00400 - Statement - Consolidated Statements of Changes in Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails" id="DisclosureSummaryOfMaterialAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails">
        <link:definition>40302 - Disclosure - Summary of material accounting policies, Right-of-use assets and lease liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPropertyPlantAndEquipmentDetails" id="DisclosureSummaryOfMaterialAccountingPoliciesPropertyPlantAndEquipmentDetails">
        <link:definition>40303 - Disclosure - Summary of material accounting policies, Property, plant and equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails" id="DisclosurePropertyPlantAndEquipmentDetails">
        <link:definition>40401 - Disclosure - Property, plant and equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails" id="DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails">
        <link:definition>40501 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails" id="DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails">
        <link:definition>40503 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities - Contractual undiscounted cash flows for lease obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureIntangibleAssetsDetails" id="DisclosureIntangibleAssetsDetails">
        <link:definition>40701 - Disclosure - Intangible assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails" id="DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails">
        <link:definition>40801 - Disclosure - Cash and cash equivalents and financial assets, Cash and cash equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails" id="DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails">
        <link:definition>40802 - Disclosure - Cash and cash equivalents and financial assets, Cash and cash equivalents and short-term financial assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureAccountsReceivableDetails" id="DisclosureAccountsReceivableDetails">
        <link:definition>41001 - Disclosure - Accounts receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareCapitalNarrativesDetails" id="DisclosureShareCapitalNarrativesDetails">
        <link:definition>41201 - Disclosure - Share capital - Narratives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails" id="DisclosureShareCapitalCapitalStructureDetails">
        <link:definition>41202 - Disclosure - Share capital - Capital Structure (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForFinancingAndOtherPurposesDetails" id="DisclosureShareCapitalConditionalShareCapitalForFinancingAndOtherPurposesDetails">
        <link:definition>41204 - Disclosure - Share capital - Conditional share capital for financing and other purposes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails" id="DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails">
        <link:definition>41205 - Disclosure - Share capital - Conditional share capital for employee benefit plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareCapitalFollowOnOfferingDetails" id="DisclosureShareCapitalFollowOnOfferingDetails">
        <link:definition>41206 - Disclosure - Share capital - Follow-On Offering (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails" id="DisclosureShareCapitalShelfRegistrationStatementDetails">
        <link:definition>41207 - Disclosure - Share capital - Shelf registration statement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails" id="DisclosureShareCapitalAtMarketEquityOfferingDetails">
        <link:definition>41208 - Disclosure - Share capital - At the market equity offering (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails" id="DisclosureShareCapitalConvertibleNoteAgreementDetails">
        <link:definition>41209 - Disclosure - Share capital - Convertible note agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails" id="DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails">
        <link:definition>41401 - Disclosure - Contract revenues - Contract Revenue Attributable to Licensing Arrangements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" id="DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails">
        <link:definition>41403 - Disclosure - Contract revenues - Morphomer Tau small molecule - 2018 license agreement with Eli Lilly and Company (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails" id="DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails">
        <link:definition>41404 - Disclosure - Contract revenues - Tau Vaccine in AD - 2014 Agreement with Janssen Pharmaceuticals (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" id="DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails">
        <link:definition>41405 - Disclosure - Contract revenues - Tau-PET imaging agent -2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails" id="DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails">
        <link:definition>41406 - Disclosure - Contract revenues - Grants from the Michael J. Fox Foundation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" id="DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails">
        <link:definition>41702 - Disclosure - Income taxes, Unrecognized Deductible Temporary Differences, Unused Tax Losses and Unused Tax Credits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails" id="DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails">
        <link:definition>41803 - Disclosure - Retirement benefit plan - Changes in Defined Benefit Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails" id="DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails">
        <link:definition>41804 - Disclosure - Retirement benefit plan - Changes in Fair Value of Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails" id="DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails">
        <link:definition>41805 - Disclosure - Retirement benefit plan - Change in Net Defined Benefit Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" id="DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails">
        <link:definition>41807 - Disclosure - Retirement benefit plan - Actuarial Assumptions and Sensitivity Analysis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails" id="DisclosureShareBasedCompensationPlansOutstandingDetails">
        <link:definition>41901 - Disclosure - Share-based compensation, Plans Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" id="DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails">
        <link:definition>41903 - Disclosure - Share-based compensation, Outstanding Options, Range of Exercise prices and Expiration Dates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" id="DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails">
        <link:definition>41904 - Disclosure - Share-based compensation, Weighted Average Grant date Fair Value and Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails" id="DisclosureShareBasedCompensationNonVestedShareAwardsDetails">
        <link:definition>41905 - Disclosure - Share-based compensation, Non-vested Share Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails" id="DisclosureCommitmentsAndContingenciesDetails">
        <link:definition>42001 - Disclosure - Commitments and contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureEarningsPerShareAntidilutiveSecuritiesDetails" id="DisclosureEarningsPerShareAntidilutiveSecuritiesDetails">
        <link:definition>42102 - Disclosure - Earnings per share - Antidilutive securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails" id="DisclosureFinancialInstrumentsAndRiskManagementDetails">
        <link:definition>42201 - Disclosure - Financial instruments and risk management (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureSubsequentEventsDetails" id="DisclosureSubsequentEventsDetails">
        <link:definition>42401 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureGeneralInformation" id="DisclosureGeneralInformation">
        <link:definition>10101 - Disclosure - General information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureBasisOfPreparation" id="DisclosureBasisOfPreparation">
        <link:definition>10201 - Disclosure - Basis of preparation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPolicies" id="DisclosureSummaryOfMaterialAccountingPolicies">
        <link:definition>10301 - Disclosure - Summary of material accounting policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosurePropertyPlantAndEquipment" id="DisclosurePropertyPlantAndEquipment">
        <link:definition>10401 - Disclosure - Property, plant and equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilities" id="DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilities">
        <link:definition>10501 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureAssetAcquisition" id="DisclosureAssetAcquisition">
        <link:definition>10601 - Disclosure - Asset acquisition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureIntangibleAssets" id="DisclosureIntangibleAssets">
        <link:definition>10701 - Disclosure - Intangible assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssets" id="DisclosureCashAndCashEquivalentsAndShortTermFinancialAssets">
        <link:definition>10801 - Disclosure - Cash and cash equivalents and short-term financial assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncome" id="DisclosurePrepaidExpensesAndAccruedIncome">
        <link:definition>10901 - Disclosure - Prepaid expenses and accrued income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureAccountsReceivable" id="DisclosureAccountsReceivable">
        <link:definition>11001 - Disclosure - Accounts receivable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureOtherCurrentReceivables" id="DisclosureOtherCurrentReceivables">
        <link:definition>11101 - Disclosure - Other current receivables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareCapital" id="DisclosureShareCapital">
        <link:definition>11201 - Disclosure - Share capital</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpenses" id="DisclosureTradeAndOtherPayablesAndAccruedExpenses">
        <link:definition>11301 - Disclosure - Trade and other payables and accrued expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureContractRevenues" id="DisclosureContractRevenues">
        <link:definition>11401 - Disclosure - Contract revenues</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureExpensesByCategory" id="DisclosureExpensesByCategory">
        <link:definition>11501 - Disclosure - Expenses by category</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRelatedPartyTransactions" id="DisclosureRelatedPartyTransactions">
        <link:definition>11601 - Disclosure - Related-party transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureIncomeTaxes" id="DisclosureIncomeTaxes">
        <link:definition>11701 - Disclosure - Income taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlan" id="DisclosureRetirementBenefitPlan">
        <link:definition>11801 - Disclosure - Retirement benefit plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareBasedCompensation" id="DisclosureShareBasedCompensation">
        <link:definition>11901 - Disclosure - Share-based compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureCommitmentsAndContingencies" id="DisclosureCommitmentsAndContingencies">
        <link:definition>12001 - Disclosure - Commitments and contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureEarningsPerShare" id="DisclosureEarningsPerShare">
        <link:definition>12101 - Disclosure - Earnings per share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagement" id="DisclosureFinancialInstrumentsAndRiskManagement">
        <link:definition>12201 - Disclosure - Financial instruments and risk management</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureCapitalRiskManagement" id="DisclosureCapitalRiskManagement">
        <link:definition>12301 - Disclosure - Capital risk management</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureSubsequentEvents" id="DisclosureSubsequentEvents">
        <link:definition>12401 - Disclosure - Subsequent events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies" id="DisclosureSummaryOfMaterialAccountingPoliciesPolicies">
        <link:definition>20302 - Disclosure - Summary of material accounting policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesTables" id="DisclosureSummaryOfMaterialAccountingPoliciesTables">
        <link:definition>30303 - Disclosure - Summary of material accounting policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosurePropertyPlantAndEquipmentTables" id="DisclosurePropertyPlantAndEquipmentTables">
        <link:definition>30403 - Disclosure - Property, plant and equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesTables" id="DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesTables">
        <link:definition>30503 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureAssetAcquisitionTables" id="DisclosureAssetAcquisitionTables">
        <link:definition>30603 - Disclosure - Asset acquisition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureIntangibleAssetsTables" id="DisclosureIntangibleAssetsTables">
        <link:definition>30703 - Disclosure - Intangible assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssetsTables" id="DisclosureCashAndCashEquivalentsAndShortTermFinancialAssetsTables">
        <link:definition>30803 - Disclosure - Cash and cash equivalents and short-term financial assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeTables" id="DisclosurePrepaidExpensesAndAccruedIncomeTables">
        <link:definition>30903 - Disclosure - Prepaid expenses and accrued income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureOtherCurrentReceivablesTables" id="DisclosureOtherCurrentReceivablesTables">
        <link:definition>31103 - Disclosure - Other current receivables (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareCapitalTables" id="DisclosureShareCapitalTables">
        <link:definition>31203 - Disclosure - Share capital (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesTables" id="DisclosureTradeAndOtherPayablesAndAccruedExpensesTables">
        <link:definition>31303 - Disclosure - Trade and other payables and accrued expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureContractRevenuesTables" id="DisclosureContractRevenuesTables">
        <link:definition>31403 - Disclosure - Contract revenues (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureExpensesByCategoryTables" id="DisclosureExpensesByCategoryTables">
        <link:definition>31503 - Disclosure - Expenses by category (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRelatedPartyTransactionsTables" id="DisclosureRelatedPartyTransactionsTables">
        <link:definition>31603 - Disclosure - Related-party transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureIncomeTaxesTables" id="DisclosureIncomeTaxesTables">
        <link:definition>31703 - Disclosure - Income taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanTables" id="DisclosureRetirementBenefitPlanTables">
        <link:definition>31803 - Disclosure - Retirement benefit plan (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareBasedCompensationTables" id="DisclosureShareBasedCompensationTables">
        <link:definition>31903 - Disclosure - Share-based compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureCommitmentsAndContingenciesTables" id="DisclosureCommitmentsAndContingenciesTables">
        <link:definition>32003 - Disclosure - Commitments and contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureEarningsPerShareTables" id="DisclosureEarningsPerShareTables">
        <link:definition>32103 - Disclosure - Earnings per share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementTables" id="DisclosureFinancialInstrumentsAndRiskManagementTables">
        <link:definition>32203 - Disclosure - Financial instruments and risk management (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureGeneralInformationDetails" id="DisclosureGeneralInformationDetails">
        <link:definition>40101 - Disclosure - General information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureBasisOfPreparationGoingConcernDetails" id="DisclosureBasisOfPreparationGoingConcernDetails">
        <link:definition>40201 - Disclosure - Basis of preparation - Going concern (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesFunctionalAndReportingCurrencyDetails" id="DisclosureSummaryOfMaterialAccountingPoliciesFunctionalAndReportingCurrencyDetails">
        <link:definition>40301 - Disclosure - Summary of material accounting policies - Functional and reporting currency (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesIncomeTaxesDetails" id="DisclosureSummaryOfMaterialAccountingPoliciesIncomeTaxesDetails">
        <link:definition>40304 - Disclosure - Summary of material accounting policies, Income taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesSegmentReportingDetails" id="DisclosureSummaryOfMaterialAccountingPoliciesSegmentReportingDetails">
        <link:definition>40305 - Disclosure - Summary of material accounting policies, Segment reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareCapitalAuthorizedCapitalDetails" id="DisclosureShareCapitalAuthorizedCapitalDetails">
        <link:definition>41203 - Disclosure - Share capital - Authorized capital (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureContractRevenuesRecognizedRevenuesDetails" id="DisclosureContractRevenuesRecognizedRevenuesDetails">
        <link:definition>41402 - Disclosure - Contract revenues - Recognized Revenues (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails" id="DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails">
        <link:definition>41902 - Disclosure - Share-based compensation, Weighted Average Exercise Prices (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://acimume.com/role/DisclosureEarningsPerShareDetails" id="DisclosureEarningsPerShareDetails">
        <link:definition>42101 - Disclosure - Earnings per share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="aciu-20231231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="aciu-20231231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="aciu-20231231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="aciu-20231231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://acimume.com/role/DisclosureStandardAndCustomAxisDomainDefaults" id="DisclosureStandardAndCustomAxisDomainDefaults">
        <link:definition>99900 - Disclosure - Standard And Custom Axis Domain Defaults</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full" schemaLocation="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
  <xsd:element name="OtherCurrentReceivablesAbstract" id="aciu_OtherCurrentReceivablesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfOtherCurrentReceivablesTextBlock" id="aciu_DisclosureOfOtherCurrentReceivablesTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ExpensesOperatingAbstract" id="aciu_ExpensesOperatingAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="IssueOfEquityRestrictedShareAwards" id="aciu_IssueOfEquityRestrictedShareAwards" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="IncreaseDecreaseThroughAcquisitionOfAssetsEquity" id="aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" id="aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="CashAdvancesForRentDeposit" id="aciu_CashAdvancesForRentDeposit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="ProceedsFromIssueOfConvertibleDebt" id="aciu_ProceedsFromIssueOfConvertibleDebt" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="RepaymentOfConvertibleDebtEquitySettlementAmount" id="aciu_RepaymentOfConvertibleDebtEquitySettlementAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="ChangesInWorkingCapitalAbstract" id="aciu_ChangesInWorkingCapitalAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AdjustmentsForIncreaseDecreaseInAccruedExpenses" id="aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="AdjustmentsForDepreciationExpenseRightOfUseAssets" id="aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="SupplementalNonCashActivityAbstract" id="aciu_SupplementalNonCashActivityAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition" id="aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities" id="aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="ExpensesByCategoryAbstract" id="aciu_ExpensesByCategoryAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CommitmentsAndContingenciesAbstract" id="aciu_CommitmentsAndContingenciesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="LaboratoryEquipmentMember" id="aciu_LaboratoryEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PercentageIncreaseInPropertyPlantAndEquipment" id="aciu_PercentageIncreaseInPropertyPlantAndEquipment" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ConditionalShareCapitalForEmployeeBenefitPlansMember" id="aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ConditionalShareCapitalAbstract" id="aciu_ConditionalShareCapitalAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions" id="aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions" id="aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="TaxLossesSplitByExpiryDateAbstract" id="aciu_TaxLossesSplitByExpiryDateAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AtTheMarketEquityOfferingAbstract" id="aciu_AtTheMarketEquityOfferingAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CommissionsPaidForIssuanceOrdinaryShares" id="aciu_CommissionsPaidForIssuanceOrdinaryShares" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="CommonSharesAuthorizedForIssuanceSalesInInOpenMarket" id="aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="AtTheMarketEquityOfferingMember" id="aciu_AtTheMarketEquityOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="SecondOpenMarketSalesAgreementMember" id="aciu_SecondOpenMarketSalesAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="SaleOrIssueOfTreasurySharesShares" id="aciu_SaleOrIssueOfTreasurySharesShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfOtherCurrentReceivablesTable" id="aciu_DisclosureOfOtherCurrentReceivablesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfOtherCurrentReceivablesLineItems" id="aciu_DisclosureOfOtherCurrentReceivablesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ScheduleOfContractualUndiscountedCashFlowsTableTextBlock" id="aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock" id="aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract" id="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" id="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="EscrowDepositAmount" id="aciu_EscrowDepositAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="NumberOfDepositsInEscrowAccounts" id="aciu_NumberOfDepositsInEscrowAccounts" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
  <xsd:element name="RightOfUseLeasedAssetsAbstract" id="aciu_RightOfUseLeasedAssetsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ExpenseRelatingToLeases" id="aciu_ExpenseRelatingToLeases" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="CollaborationAndLicenseRevenueAgreementsMember" id="aciu_CollaborationAndLicenseRevenueAgreementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="OtherAgreementMember" id="aciu_OtherAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborationAgreementWithLillyMember" id="aciu_CollaborationAgreementWithLillyMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ContractRevenueAbstract" id="aciu_ContractRevenueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" id="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborationAgreementOf2014JanssenPharmaceuticalsMember" id="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborativeAgreementMilestonePaymentReceived" id="aciu_CollaborativeAgreementMilestonePaymentReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="CollaborativeAgreementPotentialValue" id="aciu_CollaborativeAgreementPotentialValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="CollaborativeAgreementNoticeOfContractTerminationPeriod" id="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborativeAgreementJointResearchCollaborationPeriod" id="aciu_CollaborativeAgreementJointResearchCollaborationPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="SkaneUniversityHospitalMember" id="aciu_SkaneUniversityHospitalMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="GrantRevenueMember" id="aciu_GrantRevenueMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="GrantsMichaelJFoxFoundationMember" id="aciu_GrantsMichaelJFoxFoundationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfGrants" id="aciu_NumberOfGrants" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfRepresentativesInJointSteeringCommitteeByEachParty" id="aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborativeAgreementMilestonePaymentNumberOfInstallments" id="aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="TauMorphomerSmallMoleculeMember" id="aciu_TauMorphomerSmallMoleculeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RightOfUseLicenseMember" id="aciu_RightOfUseLicenseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ResearchAndDevelopmentMember" id="aciu_ResearchAndDevelopmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="MilestonePaymentsClinicalAndRegulatoryMilestonesMember" id="aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="MilestonePaymentsCommercialMember" id="aciu_MilestonePaymentsCommercialMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborationAgreementWithLillyFirstAmendmentMember" id="aciu_CollaborationAgreementWithLillyFirstAmendmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborationAgreementWithLillySecondAmendmentMember" id="aciu_CollaborationAgreementWithLillySecondAmendmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="BasisOfPreparationAbstract" id="aciu_BasisOfPreparationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="GoingConcernAbstract" id="aciu_GoingConcernAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock" id="aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock" id="aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="TauVaccineInADMember" id="aciu_TauVaccineInADMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="GeneralInformationAbstract" id="aciu_GeneralInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock" id="aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfTechnologyPlatforms" id="aciu_NumberOfTechnologyPlatforms" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
  <xsd:element name="ConvertibleNoteAgreementAbstract" id="aciu_ConvertibleNoteAgreementAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AthosServiceGmbHMember" id="aciu_AthosServiceGmbHMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" id="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ConvertibleNoteAgreementMember" id="aciu_ConvertibleNoteAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="FirstCapitalPartnerGmbHMember" id="aciu_FirstCapitalPartnerGmbHMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="FinancialResultNetAbstract" id="aciu_FinancialResultNetAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfInformationAboutCommitmentsAndContingenciesTable" id="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems" id="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CommitmentsAbstract" id="aciu_CommitmentsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RentalContractPeriodForNoticeOfCancellation" id="aciu_RentalContractPeriodForNoticeOfCancellation" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="WeightedAverageAssumptionsAbstract" id="aciu_WeightedAverageAssumptionsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="OtherComprehensiveGainsLossesAbstract" id="aciu_OtherComprehensiveGainsLossesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="EstimatedLeaseTerm" id="aciu_EstimatedLeaseTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="LeaseholdImprovementsAndFixturesAndFittingsMember" id="aciu_LeaseholdImprovementsAndFixturesAndFittingsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract" id="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="OperatingSegmentsNumber" id="aciu_OperatingSegmentsNumber" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ReportableSegmentsNumber" id="aciu_ReportableSegmentsNumber" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock" id="aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock" id="aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="TauPETImagingAgentMember" id="aciu_TauPETImagingAgentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AccruedStampDuty" id="aciu_AccruedStampDuty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="CurrentAccruedResearchAndDevelopmentCosts" id="aciu_CurrentAccruedResearchAndDevelopmentCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="NumberOfPersonsKeyManagementBoardOfDirectors" id="aciu_NumberOfPersonsKeyManagementBoardOfDirectors" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfPersonsKeyManagementExecutiveManagement" id="aciu_NumberOfPersonsKeyManagementExecutiveManagement" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock" id="aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfNonVestedSharesAbstract" id="aciu_NumberOfNonVestedSharesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement" id="aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedPaymentArrangementAbstract" id="aciu_ShareBasedPaymentArrangementAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement" id="aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RestrictedStockUnitsMember" id="aciu_RestrictedStockUnitsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="BoardOfDirectorsMember" id="aciu_BoardOfDirectorsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" id="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ExecutiveManagementMember" id="aciu_ExecutiveManagementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="WeightedAverageExercisePriceAbstract" id="aciu_WeightedAverageExercisePriceAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RestrictedSharesAndRestrictedShareUnitsMember" id="aciu_RestrictedSharesAndRestrictedShareUnitsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="SensitivityAnalysisActuarialAssumptionsAbstract" id="aciu_SensitivityAnalysisActuarialAssumptionsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember" id="aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember" id="aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ChangesInFairValueOfPlanAssetsAbstract" id="aciu_ChangesInFairValueOfPlanAssetsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfOptionsAbstract" id="aciu_NumberOfOptionsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="WeightedAverageRemainingAbstract" id="aciu_WeightedAverageRemainingAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="FinancialAssetsAndLiabilitiesAbstract" id="aciu_FinancialAssetsAndLiabilitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AccruedExpensesMember" id="aciu_AccruedExpensesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="TradeAndOtherPayablesMember" id="aciu_TradeAndOtherPayablesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="FinancialRisksAbstract" id="aciu_FinancialRisksAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets" id="aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="LongTermFinancialAssetsMember" id="aciu_LongTermFinancialAssetsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CashOnHandAndCashEquivalentsMember" id="aciu_CashOnHandAndCashEquivalentsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShortTermFinancialAssetsMember" id="aciu_ShortTermFinancialAssetsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShortTermLeaseLiabilitiesMember" id="aciu_ShortTermLeaseLiabilitiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RightOfUseFinancialAssetsMember" id="aciu_RightOfUseFinancialAssetsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock" id="aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" id="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfEquityBasedInstrumentPlans" id="aciu_NumberOfEquityBasedInstrumentPlans" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="StockOptionPlanC1Member" id="aciu_StockOptionPlanC1Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="Two016ShareOptionAndIncentivePlanMember" id="aciu_Two016ShareOptionAndIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="Two016ShareOptionAndIncentivePlanVestingTrancheOneMember" id="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember" id="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedPlansOutstandingAbstract" id="aciu_ShareBasedPlansOutstandingAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" id="aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="EmployeesMember" id="aciu_EmployeesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember" id="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="IncomeTaxLossCarryforwardPeriod" id="aciu_IncomeTaxLossCarryforwardPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PrepaidExpensesAndAccruedIncomeDisclosureAbstract" id="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock" id="aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock" id="aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="GrantIncomePolicyTextBlock" id="aciu_GrantIncomePolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock" id="aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CashAndCashEquivalentsTable" id="aciu_CashAndCashEquivalentsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CashAndCashEquivalentLineItems" id="aciu_CashAndCashEquivalentLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="InProcessResearchAndDevelopmentIPRDAssetMember" id="aciu_InProcessResearchAndDevelopmentIPRDAssetMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans" id="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" id="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="IncreaseThroughSharesIssuedUnderIncentivePlans" id="aciu_IncreaseThroughSharesIssuedUnderIncentivePlans" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock" id="aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities" id="aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="WithholdingTaxReceivables" id="aciu_WithholdingTaxReceivables" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="AccruedExpensesAbstract" id="aciu_AccruedExpensesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AlphaSynucleinPetImagingDiagnosticAgentMember" id="aciu_AlphaSynucleinPetImagingDiagnosticAgentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="FollowOnGrantFundingReceived" id="aciu_FollowOnGrantFundingReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="FollowOnGrantFundingReceivedTotalForJointArrangement" id="aciu_FollowOnGrantFundingReceivedTotalForJointArrangement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts" id="aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions" id="aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="AssetAcquisitionsAxis" id="aciu_AssetAcquisitionsAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="SignificantAssetAcquisitionsTotalDomain" id="aciu_SignificantAssetAcquisitionsTotalDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CashAcquiredAsPartOfAssetAcquisition" id="aciu_CashAcquiredAsPartOfAssetAcquisition" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="IntangibleAssetsAcquiredAsPartOfAssetAcquisition" id="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="TotalAssetsAcquiredInAssetAcquisition" id="aciu_TotalAssetsAcquiredInAssetAcquisition" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="SharesTransferredAsConsiderationInAssetAcquisition" id="aciu_SharesTransferredAsConsiderationInAssetAcquisition" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition" id="aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="IprDIntangibleAssetAssociatedWithAci7104.056Member" id="aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AssetAcquisitionsAbstract" id="aciu_AssetAcquisitionsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="SignificantAssetAcquisitionsAxis" id="aciu_SignificantAssetAcquisitionsAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AllSignificantAssetAcquisitionsDomain" id="aciu_AllSignificantAssetAcquisitionsDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember" id="aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="MiscellaneousOtherCurrentReceivables" id="aciu_MiscellaneousOtherCurrentReceivables" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="MaturityPeriodOtherCurrentReceivables" id="aciu_MaturityPeriodOtherCurrentReceivables" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ReconciliationOfNumberOfTreasurySharesOutstandingAbstract" id="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DecreaseInNumberOfTreasurySharesFromSalesOrIssuance" id="aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue" id="aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
  <xsd:element name="AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue" id="aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="PotentialIncreaseIsEquityThroughConversionOfDebtInstruments" id="aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments" id="aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
  <xsd:element name="CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement" id="aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="NumberOfConvertibleNoteAgreements" id="aciu_NumberOfConvertibleNoteAgreements" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
  <xsd:element name="IfNotesAreConvertedMember" id="aciu_IfNotesAreConvertedMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AggregatePrincipalAmountOfEachConvertibleNote" id="aciu_AggregatePrincipalAmountOfEachConvertibleNote" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="ProceedsFromConversionOfConvertibleDebtPerIndividualNote" id="aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements" id="aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="OtherAccruedExpenses" id="aciu_OtherAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="Quarter32019Member" id="aciu_Quarter32019Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="March312020Member" id="aciu_March312020Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member" id="aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborativeAgreementUpfrontPaymentsReceived" id="aciu_CollaborativeAgreementUpfrontPaymentsReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="ClinicalMilestonesMember" id="aciu_ClinicalMilestonesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RegulatoryAndSalesBasedMilestonesMember" id="aciu_RegulatoryAndSalesBasedMilestonesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AdvanceSmallMoleculePdProgramsMember" id="aciu_AdvanceSmallMoleculePdProgramsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ResearchAndDevelopmentExpensesMember" id="aciu_ResearchAndDevelopmentExpensesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="EmployeeBenefitsExpenseExcludingShareBasedCompensation" id="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" id="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="RightOfUseAssetsAndLeaseLiabilitiesNetMember" id="aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RetirementBenefitPlanMember" id="aciu_RetirementBenefitPlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="December312024Member" id="aciu_December312024Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="December312025Member" id="aciu_December312025Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="December312026Member" id="aciu_December312026Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="December312027Member" id="aciu_December312027Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="December312028Member" id="aciu_December312028Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="December312029Member" id="aciu_December312029Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits" id="aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="DefinedBenefitPlansPercentageOfContributionsByEmployees" id="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DefinedBenefitPlansPercentageOfContributionsByEmployer" id="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" id="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" id="aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
  <xsd:element name="ActuarialAssumptionOfInterestRateOnSavingsCapitalMember" id="aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="WeightedAverageRemainingContractualLifeOfShareOptionsExercisable" id="aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="Chf0.15Member" id="aciu_Chf0.15Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="Chf9.53Member" id="aciu_Chf9.53Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="Usd5.04ToUsd12.30Member" id="aciu_Usd5.04ToUsd12.30Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="Usd2.76ToUsd4.57Member" id="aciu_Usd2.76ToUsd4.57Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RestrictedStockUnitsFirstVestingConditionsMember" id="aciu_RestrictedStockUnitsFirstVestingConditionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="RestrictedStockUnitsSecondVestingConditionsMember" id="aciu_RestrictedStockUnitsSecondVestingConditionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" id="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited" id="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised" id="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted" id="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" id="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" id="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="ContractualCapitalCommitmentsOtherThanForLeases" id="aciu_ContractualCapitalCommitmentsOtherThanForLeases" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="OtherCurrentReceivablesMember" id="aciu_OtherCurrentReceivablesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="LongTermLeaseLiabilitiesMember" id="aciu_LongTermLeaseLiabilitiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" id="aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates" id="aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" id="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates" id="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfAssetAcquisitionsTextBlock" id="aciu_DisclosureOfAssetAcquisitionsTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfAssetAcquisitionsTableTextBlock" id="aciu_DisclosureOfAssetAcquisitionsTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock" id="aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock" id="aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock" id="aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock" id="aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" id="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock" id="aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock" id="aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock" id="aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock" id="aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock" id="aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses" id="aciu_TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="AdditionalGrantAwarded" id="aciu_AdditionalGrantAwarded" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="ItAndLaboratoryEquipmentMember" id="aciu_ItAndLaboratoryEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="Usd2.03ToUsd2.32Member" id="aciu_Usd2.03ToUsd2.32Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="December312030Member" id="aciu_December312030Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost" id="aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="ProceedsFromIssuanceOfPublicOfferingsOfCommonSharesNetOfUnderwritingFeesAndTransactionCosts" id="aciu_ProceedsFromIssuanceOfPublicOfferingsOfCommonSharesNetOfUnderwritingFeesAndTransactionCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="TransactionCostAndStampDutyAssociatedWithPublicOfferingsOfCommonSharesRecordedInAccruedExpenses" id="aciu_TransactionCostAndStampDutyAssociatedWithPublicOfferingsOfCommonSharesRecordedInAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits" id="aciu_NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" />
  <xsd:element name="FollowOnOfferingMember" id="aciu_FollowOnOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CollaborationAgreementMileStonePaymentReceived" id="aciu_CollaborationAgreementMileStonePaymentReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="IfrsSubsequentEventTypeAxis" id="aciu_IfrsSubsequentEventTypeAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="IfrsSubsequentEventTypeDomain" id="aciu_IfrsSubsequentEventTypeDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ProceedsFromPublicOfferingsNetOfUnderwritingFeesAndTransactionEquityShares" id="aciu_ProceedsFromPublicOfferingsNetOfUnderwritingFeesAndTransactionEquityShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="JJInnovativeMedicineMember" id="aciu_JJInnovativeMedicineMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions" id="aciu_ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="NumberOfSharesIssuedDuringPeriod" id="aciu_NumberOfSharesIssuedDuringPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="NetProceedsFromIssuanceOfShares" id="aciu_NetProceedsFromIssuanceOfShares" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="DecreaseInResearchAndDevelopmentExpenseThroughReductionsInVariousCostCenters" id="aciu_DecreaseInResearchAndDevelopmentExpenseThroughReductionsInVariousCostCenters" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="DecreaseInGeneralAndAdministrativeExpenseThroughReductionsInVariousCostCenters" id="aciu_DecreaseInGeneralAndAdministrativeExpenseThroughReductionsInVariousCostCenters" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="IncreaseInResearchAndDevelopmentExpenseThroughIncreaseInSalariesAndRelatedCosts" id="aciu_IncreaseInResearchAndDevelopmentExpenseThroughIncreaseInSalariesAndRelatedCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="ReceiptOfMilestonePaymentsMember" id="aciu_ReceiptOfMilestonePaymentsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="IncreaseInGeneralAndAdministrativeExpenseThroughIncreaseInShareBasedCompensationExpense" id="aciu_IncreaseInGeneralAndAdministrativeExpenseThroughIncreaseInShareBasedCompensationExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="ConditionalShareCapitalForFinancingAndOtherPurposesMember" id="aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="DisclosureOfAccountsReceivableTableTextBlock" id="aciu_DisclosureOfAccountsReceivableTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>44
<FILENAME>aciu-20231231_cal.xml
<DESCRIPTION>EX-101.CAL
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.5.0.8 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/13/2024 5:02:26 PM-->
<!--Modified on: 3/13/2024 5:02:26 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#StatementConsolidatedBalanceSheets" roleURI="http://acimume.com/role/StatementConsolidatedBalanceSheets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#StatementConsolidatedStatementsOfIncomeLoss" roleURI="http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#StatementConsolidatedStatementsOfComprehensiveIncomeLoss" roleURI="http://acimume.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#StatementConsolidatedStatementsOfCashFlows" roleURI="http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails" roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureAssetAcquisitionDetails" roleURI="http://acimume.com/role/DisclosureAssetAcquisitionDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosurePrepaidExpensesAndAccruedIncomeDetails" roleURI="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureOtherCurrentReceivablesDetails" roleURI="http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails" roleURI="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureExpensesByCategoryDetails" roleURI="http://acimume.com/role/DisclosureExpensesByCategoryDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRelatedPartyTransactionsDetails" roleURI="http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails" roleURI="http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <calculationLink xlink:role="http://acimume.com/role/StatementConsolidatedBalanceSheets" xlink:type="extended" xlink:title="00100 - Statement - Consolidated Balance Sheets" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Assets" xlink:label="Assets" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssets" xlink:label="ifrs-full_NoncurrentAssets_638459461413923653" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="ifrs-full_NoncurrentAssets_638459461413923653" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets_638459461413923653" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets_638459461413923653" xlink:to="ifrs-full_RightofuseAssets_638459461413923653" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment_638459461413923653" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets_638459461413923653" xlink:to="ifrs-full_PropertyPlantAndEquipment_638459461413923653" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentRestrictedCashAndCashEquivalents" xlink:label="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_638459461413923653" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets_638459461413923653" xlink:to="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_638459461413923653" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_638459461413923653" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets_638459461413923653" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_638459461413923653" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssets" xlink:label="ifrs-full_CurrentAssets_638459461413923653" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="ifrs-full_CurrentAssets_638459461413923653" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents_638459461413923653" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets_638459461413923653" xlink:to="ifrs-full_CashAndCashEquivalents_638459461413923653" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="ifrs-full_CurrentPrepaidExpenses_638459461413923653" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets_638459461413923653" xlink:to="ifrs-full_CurrentPrepaidExpenses_638459461413923653" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:label="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_638459461413933647" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets_638459461413923653" xlink:to="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_638459461413933647" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" xlink:label="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_638459461413933647" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets_638459461413923653" xlink:to="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_638459461413933647" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="ifrs-full_OtherCurrentReceivables_638459461413933647" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets_638459461413923653" xlink:to="ifrs-full_OtherCurrentReceivables_638459461413933647" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="ifrs-full_CurrentTradeReceivables_638459461413933647" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets_638459461413923653" xlink:to="ifrs-full_CurrentTradeReceivables_638459461413933647" order="6" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAndLiabilities" xlink:label="EquityAndLiabilities" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity_638459461413933647" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EquityAndLiabilities" xlink:to="ifrs-full_Equity_638459461413933647" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapital" xlink:label="ifrs-full_IssuedCapital_638459461413933647" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity_638459461413933647" xlink:to="ifrs-full_IssuedCapital_638459461413933647" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TreasuryShares" xlink:label="ifrs-full_TreasuryShares_638459461413933647" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity_638459461413933647" xlink:to="ifrs-full_TreasuryShares_638459461413933647" order="2" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremium" xlink:label="ifrs-full_SharePremium_638459461413943646" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity_638459461413933647" xlink:to="ifrs-full_SharePremium_638459461413943646" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarnings" xlink:label="ifrs-full_RetainedEarnings_638459461413943646" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity_638459461413933647" xlink:to="ifrs-full_RetainedEarnings_638459461413943646" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_638459461413943646" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity_638459461413933647" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_638459461413943646" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Liabilities" xlink:label="ifrs-full_Liabilities_638459461413943646" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EquityAndLiabilities" xlink:to="ifrs-full_Liabilities_638459461413943646" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="ifrs-full_NoncurrentLiabilities_638459461413943646" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Liabilities_638459461413943646" xlink:to="ifrs-full_NoncurrentLiabilities_638459461413943646" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_638459461413943646" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities_638459461413943646" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_638459461413943646" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:label="ifrs-full_NoncurrentProvisionsForEmployeeBenefits_638459461413943646" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities_638459461413943646" xlink:to="ifrs-full_NoncurrentProvisionsForEmployeeBenefits_638459461413943646" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilities" xlink:label="ifrs-full_CurrentLiabilities_638459461413943646" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Liabilities_638459461413943646" xlink:to="ifrs-full_CurrentLiabilities_638459461413943646" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="ifrs-full_CurrentLeaseLiabilities_638459461413953649" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities_638459461413943646" xlink:to="ifrs-full_CurrentLeaseLiabilities_638459461413953649" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_638459461413953649" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities_638459461413943646" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_638459461413953649" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_638459461413953649" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities_638459461413943646" xlink:to="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_638459461413953649" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_638459461413953649" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities_638459461413943646" xlink:to="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_638459461413953649" order="4" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss" xlink:type="extended" xlink:title="00200 - Statement - Consolidated Statements of Income/(Loss)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="ProfitLoss" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="ifrs-full_ProfitLossBeforeTax_638459461413953649" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ProfitLoss" xlink:to="ifrs-full_ProfitLossBeforeTax_638459461413953649" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_638459461413963652" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax_638459461413953649" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_638459461413963652" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue" xlink:label="ifrs-full_Revenue_638459461413963652" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities_638459461413963652" xlink:to="ifrs-full_Revenue_638459461413963652" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_638459461413963652" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Revenue_638459461413963652" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_638459461413963652" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OperatingExpense" xlink:label="ifrs-full_OperatingExpense_638459461413963652" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities_638459461413963652" xlink:to="ifrs-full_OperatingExpense_638459461413963652" order="2" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="ifrs-full_OtherOperatingIncomeExpense_638459461413963652" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OperatingExpense_638459461413963652" xlink:to="ifrs-full_OtherOperatingIncomeExpense_638459461413963652" order="1" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_638459461413963652" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OperatingExpense_638459461413963652" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_638459461413963652" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_638459461413963652" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OperatingExpense_638459461413963652" xlink:to="ifrs-full_GeneralAndAdministrativeExpense_638459461413963652" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncomeCost" xlink:label="ifrs-full_FinanceIncomeCost_638459461413963652" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax_638459461413953649" xlink:to="ifrs-full_FinanceIncomeCost_638459461413963652" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_638459461413963652" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinanceIncomeCost_638459461413963652" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_638459461413963652" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncome" xlink:label="ifrs-full_FinanceIncome_638459461413973646" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinanceIncomeCost_638459461413963652" xlink:to="ifrs-full_FinanceIncome_638459461413973646" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceCosts" xlink:label="ifrs-full_FinanceCosts_638459461413973646" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinanceIncomeCost_638459461413963652" xlink:to="ifrs-full_FinanceCosts_638459461413973646" order="3" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_638459461413973646" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ProfitLoss" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_638459461413973646" order="2" use="optional" weight="-1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss" xlink:type="extended" xlink:title="00300 - Statement - Consolidated Statements of Comprehensive Income/(Loss)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ComprehensiveIncome" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="ifrs-full_OtherComprehensiveIncome_638459461413973646" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ComprehensiveIncome" xlink:to="ifrs-full_OtherComprehensiveIncome_638459461413973646" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_638459461413973646" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherComprehensiveIncome_638459461413973646" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_638459461413973646" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_638459461413973646" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherComprehensiveIncome_638459461413973646" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_638459461413973646" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss_638459461413973646" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ComprehensiveIncome" xlink:to="ifrs-full_ProfitLoss_638459461413973646" order="2" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows" xlink:type="extended" xlink:title="00500 - Statement - Consolidated Statements of Cash Flows" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:label="IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_638459461413983647" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_638459461413983647" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_638459461413983647" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_638459461413983647" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_638459461413983647" order="1" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ProceedsFromIssuanceOfPublicOfferingsOfCommonSharesNetOfUnderwritingFeesAndTransactionCosts" xlink:label="aciu_ProceedsFromIssuanceOfPublicOfferingsOfCommonSharesNetOfUnderwritingFeesAndTransactionCosts_638459461413983647" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_638459461413983647" xlink:to="aciu_ProceedsFromIssuanceOfPublicOfferingsOfCommonSharesNetOfUnderwritingFeesAndTransactionCosts_638459461413983647" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ProceedsFromIssueOfConvertibleDebt" xlink:label="aciu_ProceedsFromIssueOfConvertibleDebt_638459461413983647" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_638459461413983647" xlink:to="aciu_ProceedsFromIssueOfConvertibleDebt_638459461413983647" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions_638459461413983647" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_638459461413983647" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions_638459461413983647" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts" xlink:label="aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts_638459461413983647" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_638459461413983647" xlink:to="aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts_638459461413983647" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="ifrs-full_PaymentsForShareIssueCosts_638459461413983647" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_638459461413983647" xlink:to="ifrs-full_PaymentsForShareIssueCosts_638459461413983647" order="6" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions" xlink:label="aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions_638459461413983647" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_638459461413983647" xlink:to="aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions_638459461413983647" order="7" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions" xlink:label="aciu_ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions_638459461413983647" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities_638459461413983647" xlink:to="aciu_ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions_638459461413983647" order="8" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_638459461413993653" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_638459461413993653" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_638459461413993653" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities_638459461413993653" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_638459461413993653" order="1" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CashAdvancesForRentDeposit" xlink:label="aciu_CashAdvancesForRentDeposit_638459461413993653" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities_638459461413993653" xlink:to="aciu_CashAdvancesForRentDeposit_638459461413993653" order="2" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities" xlink:label="aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities_638459461413993653" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities_638459461413993653" xlink:to="aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities_638459461413993653" order="3" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_638459461413993653" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_638459461413993653" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:label="ifrs-full_InterestPaidClassifiedAsOperatingActivities_638459461413993653" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities_638459461413993653" xlink:to="ifrs-full_InterestPaidClassifiedAsOperatingActivities_638459461413993653" order="1" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities" xlink:label="ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities_638459461413993653" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities_638459461413993653" xlink:to="ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities_638459461413993653" order="2" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:label="ifrs-full_InterestReceivedClassifiedAsOperatingActivities_638459461413993653" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities_638459461413993653" xlink:to="ifrs-full_InterestReceivedClassifiedAsOperatingActivities_638459461413993653" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperations" xlink:label="ifrs-full_CashFlowsFromUsedInOperations_638459461414003644" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities_638459461413993653" xlink:to="ifrs-full_CashFlowsFromUsedInOperations_638459461414003644" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets" xlink:label="aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets_638459461414003644" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638459461414003644" xlink:to="aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets_638459461414003644" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss_638459461414003644" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638459461414003644" xlink:to="ifrs-full_ProfitLoss_638459461414003644" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_638459461414003644" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638459461414003644" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_638459461414003644" order="3" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDepreciationExpense" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense_638459461414003644" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638459461414003644" xlink:to="ifrs-full_AdjustmentsForDepreciationExpense_638459461414003644" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:label="ifrs-full_AdjustmentsForFinanceIncomeCost_638459461414003644" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638459461414003644" xlink:to="ifrs-full_AdjustmentsForFinanceIncomeCost_638459461414003644" order="5" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_638459461414003644" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638459461414003644" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments_638459461414003644" order="6" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_638459461414013648" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638459461414003644" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_638459461414013648" order="7" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForInterestExpense" xlink:label="ifrs-full_AdjustmentsForInterestExpense_638459461414013648" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638459461414003644" xlink:to="ifrs-full_AdjustmentsForInterestExpense_638459461414013648" order="8" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_638459461414013648" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638459461414003644" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_638459461414013648" order="9" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_638459461414013648" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638459461414003644" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_638459461414013648" order="10" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses" xlink:label="aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses_638459461414013648" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638459461414003644" xlink:to="aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses_638459461414013648" order="11" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_638459461414013648" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638459461414003644" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_638459461414013648" order="12" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_638459461414013648" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638459461414003644" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_638459461414013648" order="13" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_638459461414023649" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638459461414003644" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_638459461414023649" order="14" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets_638459461414023649" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperations_638459461414003644" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets_638459461414023649" order="15" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails" xlink:type="extended" xlink:title="40502 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities - Statement of income/(loss) and cash flow (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ExpenseRelatingToLeases" xlink:label="ExpenseRelatingToLeases" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="ifrs-full_DepreciationRightofuseAssets_638459461414213654" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ExpenseRelatingToLeases" xlink:to="ifrs-full_DepreciationRightofuseAssets_638459461414213654" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_638459461414213654" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ExpenseRelatingToLeases" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities_638459461414213654" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_638459461414213654" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ExpenseRelatingToLeases" xlink:to="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_638459461414213654" order="3" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/DisclosureAssetAcquisitionDetails" xlink:type="extended" xlink:title="40601 - Disclosure - Asset acquisition (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TotalAssetsAcquiredInAssetAcquisition" xlink:label="TotalAssetsAcquiredInAssetAcquisition" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CashAcquiredAsPartOfAssetAcquisition" xlink:label="aciu_CashAcquiredAsPartOfAssetAcquisition_638459461414223633" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="TotalAssetsAcquiredInAssetAcquisition" xlink:to="aciu_CashAcquiredAsPartOfAssetAcquisition_638459461414223633" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition" xlink:label="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition_638459461414223633" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="TotalAssetsAcquiredInAssetAcquisition" xlink:to="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition_638459461414223633" order="2" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails" xlink:type="extended" xlink:title="40901 - Disclosure - Prepaid expenses and accrued income (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets" xlink:label="CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="ifrs-full_CurrentPrepaidExpenses_638459461414223633" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets" xlink:to="ifrs-full_CurrentPrepaidExpenses_638459461414223633" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" xlink:label="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_638459461414223633" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets" xlink:to="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_638459461414223633" order="2" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails" xlink:type="extended" xlink:title="41101 - Disclosure - Other current receivables (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="OtherCurrentReceivables" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_MiscellaneousOtherCurrentReceivables" xlink:label="aciu_MiscellaneousOtherCurrentReceivables_638459461414223633" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OtherCurrentReceivables" xlink:to="aciu_MiscellaneousOtherCurrentReceivables_638459461414223633" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentValueAddedTaxReceivables" xlink:label="ifrs-full_CurrentValueAddedTaxReceivables_638459461414223633" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OtherCurrentReceivables" xlink:to="ifrs-full_CurrentValueAddedTaxReceivables_638459461414223633" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WithholdingTaxReceivables" xlink:label="aciu_WithholdingTaxReceivables_638459461414223633" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OtherCurrentReceivables" xlink:to="aciu_WithholdingTaxReceivables_638459461414223633" order="3" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails" xlink:type="extended" xlink:title="41301 - Disclosure - Trade and other payables and accrued expenses (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:label="CurrentAccruedExpensesAndOtherCurrentLiabilities" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CurrentAccruedResearchAndDevelopmentCosts" xlink:label="aciu_CurrentAccruedResearchAndDevelopmentCosts_638459461414233635" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:to="aciu_CurrentAccruedResearchAndDevelopmentCosts_638459461414233635" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_OtherAccruedExpenses" xlink:label="aciu_OtherAccruedExpenses_638459461414233635" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:to="aciu_OtherAccruedExpenses_638459461414233635" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals_638459461414233635" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:to="ifrs-full_ShorttermEmployeeBenefitsAccruals_638459461414233635" order="3" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/DisclosureExpensesByCategoryDetails" xlink:type="extended" xlink:title="41501 - Disclosure - Expenses by category (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseByNature" xlink:label="ExpenseByNature" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OperatingExpense" xlink:label="ifrs-full_OperatingExpense_638459461414233635" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ExpenseByNature" xlink:to="ifrs-full_OperatingExpense_638459461414233635" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation" xlink:label="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation_638459461414233635" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ExpenseByNature" xlink:to="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation_638459461414233635" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_638459461414233635" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ExpenseByNature" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_638459461414233635" order="3" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails" xlink:type="extended" xlink:title="41601 - Disclosure - Related-party transactions (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="KeyManagementPersonnelCompensation" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_638459461414243633" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_638459461414243633" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_638459461414243633" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_638459461414243633" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_638459461414243633" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_638459461414243633" order="3" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails" xlink:type="extended" xlink:title="41701 - Disclosure - Income taxes - Summary of Income Tax Expense (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="IncomeTaxExpenseContinuingOperations" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_638459461414243633" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_638459461414243633" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" xlink:label="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes_638459461414243633" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseContinuingOperations" xlink:to="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes_638459461414243633" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TaxEffectOfTaxLosses" xlink:label="ifrs-full_TaxEffectOfTaxLosses_638459461414243633" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_TaxEffectOfTaxLosses_638459461414243633" order="3" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails" xlink:type="extended" xlink:title="41801 - Disclosure - Retirement benefit plan - Summary of Benefit Plan (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SurplusDeficitInPlan" xlink:label="SurplusDeficitInPlan" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue_638459461414243633" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="SurplusDeficitInPlan" xlink:to="ifrs-full_DefinedBenefitObligationAtPresentValue_638459461414243633" order="1" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PlanAssetsAtFairValue" xlink:label="ifrs-full_PlanAssetsAtFairValue_638459461414253637" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="SurplusDeficitInPlan" xlink:to="ifrs-full_PlanAssetsAtFairValue_638459461414253637" order="2" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails" xlink:type="extended" xlink:title="41802 - Disclosure - Retirement benefit plan - Amounts recorded in consolidated statements of income (loss) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:label="PostemploymentBenefitExpenseDefinedBenefitPlans" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpenseDefinedBenefitPlans" xlink:label="ifrs-full_InterestExpenseDefinedBenefitPlans_638459461414253637" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:to="ifrs-full_InterestExpenseDefinedBenefitPlans_638459461414253637" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PastServiceCostDefinedBenefitPlans" xlink:label="ifrs-full_PastServiceCostDefinedBenefitPlans_638459461414253637" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:to="ifrs-full_PastServiceCostDefinedBenefitPlans_638459461414253637" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestIncomeDefinedBenefitPlans" xlink:label="ifrs-full_InterestIncomeDefinedBenefitPlans_638459461414253637" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:to="ifrs-full_InterestIncomeDefinedBenefitPlans_638459461414253637" order="3" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentServiceCostDefinedBenefitPlans" xlink:label="ifrs-full_CurrentServiceCostDefinedBenefitPlans_638459461414253637" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:to="ifrs-full_CurrentServiceCostDefinedBenefitPlans_638459461414253637" order="4" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails" xlink:type="extended" xlink:title="41806 - Disclosure - Retirement benefit plan - Change in other comprehensive gains (losses) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans_638459461414253637" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans_638459461414253637" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans_638459461414253637" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans_638459461414253637" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans_638459461414263633" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans_638459461414263633" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans_638459461414263633" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:to="ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans_638459461414263633" order="4" use="optional" weight="1" />
  </calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>45
<FILENAME>aciu-20231231_def.xml
<DESCRIPTION>EX-101.DEF
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.5.0.8 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/13/2024 5:02:26 PM-->
<!--Modified on: 3/13/2024 5:02:26 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DocumentDocumentAndEntityInformation" roleURI="http://acimume.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#StatementConsolidatedStatementsOfChangesInEquity" roleURI="http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureSummaryOfMaterialAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails" roleURI="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureSummaryOfMaterialAccountingPoliciesPropertyPlantAndEquipmentDetails" roleURI="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPropertyPlantAndEquipmentDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosurePropertyPlantAndEquipmentDetails" roleURI="http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails" roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails" roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureAssetAcquisitionDetails" roleURI="http://acimume.com/role/DisclosureAssetAcquisitionDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureIntangibleAssetsDetails" roleURI="http://acimume.com/role/DisclosureIntangibleAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails" roleURI="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails" roleURI="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureAccountsReceivableDetails" roleURI="http://acimume.com/role/DisclosureAccountsReceivableDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureOtherCurrentReceivablesDetails" roleURI="http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareCapitalNarrativesDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalNarrativesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareCapitalCapitalStructureDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareCapitalConditionalShareCapitalForFinancingAndOtherPurposesDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForFinancingAndOtherPurposesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareCapitalFollowOnOfferingDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalFollowOnOfferingDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareCapitalShelfRegistrationStatementDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareCapitalAtMarketEquityOfferingDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareCapitalConvertibleNoteAgreementDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureExpensesByCategoryDetails" roleURI="http://acimume.com/role/DisclosureExpensesByCategoryDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails" roleURI="http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" roleURI="http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareBasedCompensationPlansOutstandingDetails" roleURI="http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" roleURI="http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" roleURI="http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareBasedCompensationNonVestedShareAwardsDetails" roleURI="http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureCommitmentsAndContingenciesDetails" roleURI="http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureEarningsPerShareAntidilutiveSecuritiesDetails" roleURI="http://acimume.com/role/DisclosureEarningsPerShareAntidilutiveSecuritiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureFinancialInstrumentsAndRiskManagementDetails" roleURI="http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureSubsequentEventsDetails" roleURI="http://acimume.com/role/DisclosureSubsequentEventsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosureStandardAndCustomAxisDomainDefaults" xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureStandardAndCustomAxisDomainDefaults" />
  <link:roleRef roleURI="http://acimume.com/role/DisclosureEarningsPerShareDetails" xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureEarningsPerShareDetails" />
  <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosureEarningsPerShareDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://acimume.com/role/DisclosureStandardAndCustomAxisDomainDefaults">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="EntityAddressesAddressTypeAxis" xlink:title="EntityAddressesAddressTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="AddressTypeDomain" xlink:title="AddressTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="EntityAddressesAddressTypeAxis" xlink:to="AddressTypeDomain" xlink:title="definition: EntityAddressesAddressTypeAxis to AddressTypeDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ClassesOfPropertyPlantAndEquipmentAxis" xlink:title="ClassesOfPropertyPlantAndEquipmentAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="PropertyPlantAndEquipmentMember" xlink:title="PropertyPlantAndEquipmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="PropertyPlantAndEquipmentMember" xlink:title="definition: ClassesOfPropertyPlantAndEquipmentAxis to PropertyPlantAndEquipmentMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ClassesOfAssetsAxis" xlink:title="ClassesOfAssetsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="ClassesOfAssetsMember" xlink:title="ClassesOfAssetsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassesOfAssetsAxis" xlink:to="ClassesOfAssetsMember" xlink:title="definition: ClassesOfAssetsAxis to ClassesOfAssetsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:title="CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="CarryingAmountMember" xlink:title="CarryingAmountMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="CarryingAmountMember" xlink:title="definition: CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis to CarryingAmountMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAxis" xlink:label="MaturityAxis" xlink:title="MaturityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="AggregatedTimeBandsMember" xlink:title="AggregatedTimeBandsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="MaturityAxis" xlink:to="AggregatedTimeBandsMember" xlink:title="definition: MaturityAxis to AggregatedTimeBandsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:title="ClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="IntangibleAssetsOtherThanGoodwillMember" xlink:title="IntangibleAssetsOtherThanGoodwillMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="IntangibleAssetsOtherThanGoodwillMember" xlink:title="definition: ClassesOfIntangibleAssetsOtherThanGoodwillAxis to IntangibleAssetsOtherThanGoodwillMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnobservableInputsAxis" xlink:label="UnobservableInputsAxis" xlink:title="UnobservableInputsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnobservableInputsMember" xlink:label="UnobservableInputsMember" xlink:title="UnobservableInputsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="UnobservableInputsAxis" xlink:to="UnobservableInputsMember" xlink:title="definition: UnobservableInputsAxis to UnobservableInputsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AssetAcquisitionsAxis" xlink:label="AssetAcquisitionsAxis" xlink:title="AssetAcquisitionsAxis" />
    <link:loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SignificantAssetAcquisitionsTotalDomain" xlink:label="SignificantAssetAcquisitionsTotalDomain" xlink:title="SignificantAssetAcquisitionsTotalDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AssetAcquisitionsAxis" xlink:to="SignificantAssetAcquisitionsTotalDomain" xlink:title="definition: AssetAcquisitionsAxis to SignificantAssetAcquisitionsTotalDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="CurrencyAxis" xlink:title="CurrencyAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="AllCurrenciesDomain" xlink:title="AllCurrenciesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CurrencyAxis" xlink:to="AllCurrenciesDomain" xlink:title="definition: CurrencyAxis to AllCurrenciesDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="TypesOfContractsAxis" xlink:title="TypesOfContractsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsMember" xlink:label="TypesOfContractsMember" xlink:title="TypesOfContractsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TypesOfContractsAxis" xlink:to="TypesOfContractsMember" xlink:title="definition: TypesOfContractsAxis to TypesOfContractsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ClassesOfShareCapitalAxis" xlink:title="ClassesOfShareCapitalAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ClassesOfShareCapitalMember" xlink:title="ClassesOfShareCapitalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassesOfShareCapitalAxis" xlink:to="ClassesOfShareCapitalMember" xlink:title="definition: ClassesOfShareCapitalAxis to ClassesOfShareCapitalMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="RangesMember" xlink:title="RangesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangesMember" xlink:title="definition: RangeAxis to RangesMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain" xlink:title="definition: StatementScenarioAxis to ScenarioUnspecifiedDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesAxis" xlink:label="CounterpartiesAxis" xlink:title="CounterpartiesAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesMember" xlink:label="CounterpartiesMember" xlink:title="CounterpartiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CounterpartiesAxis" xlink:to="CounterpartiesMember" xlink:title="definition: CounterpartiesAxis to CounterpartiesMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ComponentsOfEquityAxis" xlink:title="ComponentsOfEquityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityMember" xlink:label="EquityMember" xlink:title="EquityMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ComponentsOfEquityAxis" xlink:to="EquityMember" xlink:title="definition: ComponentsOfEquityAxis to EquityMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ProductsAndServicesAxis" xlink:title="ProductsAndServicesAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ProductsAndServicesMember" xlink:title="ProductsAndServicesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ProductsAndServicesAxis" xlink:to="ProductsAndServicesMember" xlink:title="definition: ProductsAndServicesAxis to ProductsAndServicesMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PerformanceObligationsAxis" xlink:label="PerformanceObligationsAxis" xlink:title="PerformanceObligationsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PerformanceObligationsMember" xlink:label="PerformanceObligationsMember" xlink:title="PerformanceObligationsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PerformanceObligationsAxis" xlink:to="PerformanceObligationsMember" xlink:title="definition: PerformanceObligationsAxis to PerformanceObligationsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" xlink:title="LegalEntityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="EntityDomain" xlink:title="EntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="LegalEntityAxis" xlink:to="EntityDomain" xlink:title="definition: LegalEntityAxis to EntityDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="BorrowingsByNameAxis" xlink:title="BorrowingsByNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="BorrowingsByNameMember" xlink:title="BorrowingsByNameMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BorrowingsByNameAxis" xlink:to="BorrowingsByNameMember" xlink:title="definition: BorrowingsByNameAxis to BorrowingsByNameMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:label="AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:title="AttributionOfExpensesByNatureToTheirFunctionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LineItemsByFunctionMember" xlink:label="LineItemsByFunctionMember" xlink:title="LineItemsByFunctionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:to="LineItemsByFunctionMember" xlink:title="definition: AttributionOfExpensesByNatureToTheirFunctionAxis to LineItemsByFunctionMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:title="TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:title="TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:title="definition: TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis to TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="GeographicalAreasAxis" xlink:title="GeographicalAreasAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasMember" xlink:label="GeographicalAreasMember" xlink:title="GeographicalAreasMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="GeographicalAreasAxis" xlink:to="GeographicalAreasMember" xlink:title="definition: GeographicalAreasAxis to GeographicalAreasMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="DefinedBenefitPlansAxis" xlink:title="DefinedBenefitPlansAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefinedBenefitPlansMember" xlink:label="DefinedBenefitPlansMember" xlink:title="DefinedBenefitPlansMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="DefinedBenefitPlansAxis" xlink:to="DefinedBenefitPlansMember" xlink:title="definition: DefinedBenefitPlansAxis to DefinedBenefitPlansMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:label="NetDefinedBenefitLiabilityAssetAxis" xlink:title="NetDefinedBenefitLiabilityAssetAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:label="NetDefinedBenefitLiabilityAssetMember" xlink:title="NetDefinedBenefitLiabilityAssetMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="NetDefinedBenefitLiabilityAssetAxis" xlink:to="NetDefinedBenefitLiabilityAssetMember" xlink:title="definition: NetDefinedBenefitLiabilityAssetAxis to NetDefinedBenefitLiabilityAssetMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionsAxis" xlink:label="ActuarialAssumptionsAxis" xlink:title="ActuarialAssumptionsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionsMember" xlink:label="ActuarialAssumptionsMember" xlink:title="ActuarialAssumptionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ActuarialAssumptionsAxis" xlink:to="ActuarialAssumptionsMember" xlink:title="definition: ActuarialAssumptionsAxis to ActuarialAssumptionsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="TypesOfRisksAxis" xlink:title="TypesOfRisksAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="TypesOfRisksMember" xlink:title="TypesOfRisksMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TypesOfRisksAxis" xlink:to="TypesOfRisksMember" xlink:title="definition: TypesOfRisksAxis to TypesOfRisksMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:title="RangesOfExercisePricesForOutstandingShareOptionsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:title="RangesOfExercisePricesForOutstandingShareOptionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:title="definition: RangesOfExercisePricesForOutstandingShareOptionsAxis to RangesOfExercisePricesForOutstandingShareOptionsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:label="CategoriesOfFinancialAssetsAxis" xlink:title="CategoriesOfFinancialAssetsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsCategoryMember" xlink:label="FinancialAssetsCategoryMember" xlink:title="FinancialAssetsCategoryMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CategoriesOfFinancialAssetsAxis" xlink:to="FinancialAssetsCategoryMember" xlink:title="definition: CategoriesOfFinancialAssetsAxis to FinancialAssetsCategoryMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis" xlink:label="CategoriesOfFinancialLiabilitiesAxis" xlink:title="CategoriesOfFinancialLiabilitiesAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesCategoryMember" xlink:label="FinancialLiabilitiesCategoryMember" xlink:title="FinancialLiabilitiesCategoryMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CategoriesOfFinancialLiabilitiesAxis" xlink:to="FinancialLiabilitiesCategoryMember" xlink:title="definition: CategoriesOfFinancialLiabilitiesAxis to FinancialLiabilitiesCategoryMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="ClassesOfFinancialAssetsAxis" xlink:title="ClassesOfFinancialAssetsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember" xlink:label="FinancialAssetsMember" xlink:title="FinancialAssetsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassesOfFinancialAssetsAxis" xlink:to="FinancialAssetsMember" xlink:title="definition: ClassesOfFinancialAssetsAxis to FinancialAssetsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="ClassesOfFinancialLiabilitiesAxis" xlink:title="ClassesOfFinancialLiabilitiesAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="FinancialLiabilitiesMember" xlink:title="FinancialLiabilitiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassesOfFinancialLiabilitiesAxis" xlink:to="FinancialLiabilitiesMember" xlink:title="definition: ClassesOfFinancialLiabilitiesAxis to FinancialLiabilitiesMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="BusinessCombinationsAxis" xlink:title="BusinessCombinationsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="EntitysTotalForBusinessCombinationsMember" xlink:title="EntitysTotalForBusinessCombinationsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessCombinationsAxis" xlink:to="EntitysTotalForBusinessCombinationsMember" xlink:title="definition: BusinessCombinationsAxis to EntitysTotalForBusinessCombinationsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SignificantAssetAcquisitionsAxis" xlink:label="SignificantAssetAcquisitionsAxis" xlink:title="SignificantAssetAcquisitionsAxis" />
    <link:loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AllSignificantAssetAcquisitionsDomain" xlink:label="AllSignificantAssetAcquisitionsDomain" xlink:title="AllSignificantAssetAcquisitionsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="SignificantAssetAcquisitionsAxis" xlink:to="AllSignificantAssetAcquisitionsDomain" xlink:title="definition: SignificantAssetAcquisitionsAxis to AllSignificantAssetAcquisitionsDomain" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="ClassesOfOrdinarySharesAxis" xlink:title="ClassesOfOrdinarySharesAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OrdinarySharesMember" xlink:label="OrdinarySharesMember" xlink:title="OrdinarySharesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassesOfOrdinarySharesAxis" xlink:to="OrdinarySharesMember" xlink:title="definition: ClassesOfOrdinarySharesAxis to OrdinarySharesMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="TypesOfSharebasedPaymentArrangementsAxis" xlink:title="TypesOfSharebasedPaymentArrangementsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="SharebasedPaymentArrangementsMember" xlink:title="SharebasedPaymentArrangementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TypesOfSharebasedPaymentArrangementsAxis" xlink:to="SharebasedPaymentArrangementsMember" xlink:title="definition: TypesOfSharebasedPaymentArrangementsAxis to SharebasedPaymentArrangementsMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="CategoriesOfRelatedPartiesAxis" xlink:title="CategoriesOfRelatedPartiesAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="EntitysTotalForRelatedPartiesMember" xlink:title="EntitysTotalForRelatedPartiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CategoriesOfRelatedPartiesAxis" xlink:to="EntitysTotalForRelatedPartiesMember" xlink:title="definition: CategoriesOfRelatedPartiesAxis to EntitysTotalForRelatedPartiesMember" use="optional" order="1" />
    <link:loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IfrsSubsequentEventTypeAxis" xlink:label="aciu_IfrsSubsequentEventTypeAxis_1" xlink:title="aciu_IfrsSubsequentEventTypeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IfrsSubsequentEventTypeDomain" xlink:label="aciu_IfrsSubsequentEventTypeDomain_1" xlink:title="aciu_IfrsSubsequentEventTypeDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="aciu_IfrsSubsequentEventTypeAxis_1" xlink:to="aciu_IfrsSubsequentEventTypeDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:aciu_IfrsSubsequentEventTypeAxis_1 To aciu_IfrsSubsequentEventTypeDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:title="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="ifrs-full_NonadjustingEventsMember_1" xlink:title="ifrs-full_NonadjustingEventsMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:to="ifrs-full_NonadjustingEventsMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1 To ifrs-full_NonadjustingEventsMember_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:label="ifrs-full_TypesOfAntidilutiveInstrumentsAxis_1" xlink:title="ifrs-full_TypesOfAntidilutiveInstrumentsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AntidilutiveInstrumentsMember" xlink:label="ifrs-full_AntidilutiveInstrumentsMember_1" xlink:title="ifrs-full_AntidilutiveInstrumentsMember_1" />
    <link:definitionArc xlink:type="arc" xlink:from="ifrs-full_TypesOfAntidilutiveInstrumentsAxis_1" xlink:to="ifrs-full_AntidilutiveInstrumentsMember_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:ifrs-full_TypesOfAntidilutiveInstrumentsAxis_1 To ifrs-full_AntidilutiveInstrumentsMember_1" order="1" />
  </link:definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="dei_EntityAddressesTable" xlink:to="dei_EntityAddressesAddressTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="dei_AddressTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="dei_AddressTypeDomain" xlink:to="dei_BusinessContactMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_DocumentType" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityRegistrantName" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_DocumentRegistrationStatement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityCentralIndexKey" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_DocumentPeriodEndDate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_DocumentFiscalYearFocus" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_AmendmentFlag" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_CurrentFiscalYearEndDate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_DocumentAnnualReport" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_DocumentTransitionReport" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_DocumentShellCompanyReport" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityFileNumber" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressAddressLine1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="17" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressAddressLine2" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="18" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressPostalZipCode" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="19" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressCityOrTown" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="20" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressCountry" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName" xlink:label="dei_ContactPersonnelName" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="21" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_ContactPersonnelName" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="22" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_CityAreaCode" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="23" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_LocalPhoneNumber" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="24" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_Security12bTitle" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="25" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_TradingSymbol" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="26" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_SecurityExchangeName" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="27" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="28" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="29" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityVoluntaryFilers" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="30" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityCurrentReportingStatus" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="31" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityInteractiveDataCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="32" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityFilerCategory" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="33" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityEmergingGrowthCompany" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="34" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="35" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_DocumentAccountingStandard" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="36" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityShellCompany" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="37" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_AuditorFirmId" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="38" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_AuditorName" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="39" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_AuditorLocation" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="40" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity" xlink:type="extended" xlink:title="00400 - Statement - Consolidated Statements of Changes in Equity" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="ifrs-full_StatementOfChangesInEquityTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ifrs-full_ComponentsOfEquityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityMember" xlink:label="ifrs-full_EquityMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_EquityMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapitalMember" xlink:label="ifrs-full_IssuedCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_IssuedCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremiumMember" xlink:label="ifrs-full_SharePremiumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_SharePremiumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TreasurySharesMember" xlink:label="ifrs-full_TreasurySharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_TreasurySharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarningsMember" xlink:label="ifrs-full_RetainedEarningsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_RetainedEarningsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_StatementOfChangesInEquityTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_Equity" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_ProfitLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="ifrs-full_OtherComprehensiveIncome" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_OtherComprehensiveIncome" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ifrs-full_ComprehensiveIncome" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_ComprehensiveIncome" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost" xlink:label="aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" xlink:label="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesIssuedAbstract" xlink:label="ifrs-full_NumberOfSharesIssuedAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_NumberOfSharesIssuedAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" xlink:label="aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract" xlink:to="aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity" xlink:label="aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract" xlink:to="aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" xlink:label="ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract" xlink:to="ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" xlink:label="ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract" xlink:to="ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IssueOfEquityRestrictedShareAwards" xlink:label="aciu_IssueOfEquityRestrictedShareAwards" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract" xlink:to="aciu_IssueOfEquityRestrictedShareAwards" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract" xlink:to="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails" xlink:type="extended" xlink:title="40302 - Disclosure - Summary of material accounting policies, Right-of-use assets and lease liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BuildingsMember" xlink:label="ifrs-full_BuildingsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_BuildingsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="ifrs-full_OfficeEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_OfficeEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="ifrs-full_ComputerEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_ComputerEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_EstimatedLeaseTerm" xlink:label="aciu_EstimatedLeaseTerm" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:to="aciu_EstimatedLeaseTerm" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPropertyPlantAndEquipmentDetails" xlink:type="extended" xlink:title="40303 - Disclosure - Summary of material accounting policies, Property, plant and equipment (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="ifrs-full_ComputerEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_ComputerEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_LaboratoryEquipmentMember" xlink:label="aciu_LaboratoryEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="aciu_LaboratoryEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_LeaseholdImprovementsAndFixturesAndFittingsMember" xlink:label="aciu_LeaseholdImprovementsAndFixturesAndFittingsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="aciu_LeaseholdImprovementsAndFixturesAndFittingsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract" xlink:label="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails" xlink:type="extended" xlink:title="40401 - Disclosure - Property, plant and equipment (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="ifrs-full_FixturesAndFittingsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_FixturesAndFittingsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="ifrs-full_ComputerEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_ComputerEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_LaboratoryEquipmentMember" xlink:label="aciu_LaboratoryEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="aciu_LaboratoryEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="ifrs-full_LeaseholdImprovementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_LeaseholdImprovementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="ifrs-full_ConstructionInProgressMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_ConstructionInProgressMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ItAndLaboratoryEquipmentMember" xlink:label="aciu_ItAndLaboratoryEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="aciu_ItAndLaboratoryEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="ifrs-full_CarryingAmountMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="ifrs-full_GrossCarryingAmountMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:label="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_PropertyPlantAndEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DisposalsPropertyPlantAndEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PercentageIncreaseInPropertyPlantAndEquipment" xlink:label="aciu_PercentageIncreaseInPropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:to="aciu_PercentageIncreaseInPropertyPlantAndEquipment" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails" xlink:type="extended" xlink:title="40501 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ifrs-full_ClassesOfAssetsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="ifrs-full_ClassesOfAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BuildingsMember" xlink:label="ifrs-full_BuildingsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_BuildingsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="ifrs-full_OfficeEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_OfficeEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="ifrs-full_ComputerEquipmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_ComputerEquipmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="ifrs-full_AdditionsToRightofuseAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:to="ifrs-full_AdditionsToRightofuseAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:label="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:to="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RightOfUseLeasedAssetsAbstract" xlink:label="aciu_RightOfUseLeasedAssetsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:to="aciu_RightOfUseLeasedAssetsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_RightOfUseLeasedAssetsAbstract" xlink:to="ifrs-full_RightofuseAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="ifrs-full_DepreciationRightofuseAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_RightOfUseLeasedAssetsAbstract" xlink:to="ifrs-full_DepreciationRightofuseAssets" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails" xlink:type="extended" xlink:title="40503 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities - Contractual undiscounted cash flows for lease obligations (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:to="ifrs-full_MaturityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_AggregatedTimeBandsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="ifrs-full_NotLaterThanOneYearMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="ifrs-full_NotLaterThanOneYearMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" xlink:label="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:to="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossLeaseLiabilities" xlink:label="ifrs-full_GrossLeaseLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" xlink:to="ifrs-full_GrossLeaseLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfDepositsInEscrowAccounts" xlink:label="aciu_NumberOfDepositsInEscrowAccounts" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" xlink:to="aciu_NumberOfDepositsInEscrowAccounts" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_EscrowDepositAmount" xlink:label="aciu_EscrowDepositAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" xlink:to="aciu_EscrowDepositAmount" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureAssetAcquisitionDetails" xlink:type="extended" xlink:title="40601 - Disclosure - Asset acquisition (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AssetAcquisitionsAxis" xlink:label="aciu_AssetAcquisitionsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="aciu_AssetAcquisitionsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SignificantAssetAcquisitionsTotalDomain" xlink:label="aciu_SignificantAssetAcquisitionsTotalDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="aciu_AssetAcquisitionsAxis" xlink:to="aciu_SignificantAssetAcquisitionsTotalDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember" xlink:label="aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_SignificantAssetAcquisitionsTotalDomain" xlink:to="aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member" xlink:label="aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:to="aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnobservableInputsAxis" xlink:label="ifrs-full_UnobservableInputsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="ifrs-full_UnobservableInputsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnobservableInputsMember" xlink:label="ifrs-full_UnobservableInputsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_UnobservableInputsAxis" xlink:to="ifrs-full_UnobservableInputsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DiscountRateMeasurementInputMember" xlink:label="ifrs-full_DiscountRateMeasurementInputMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_UnobservableInputsMember" xlink:to="ifrs-full_DiscountRateMeasurementInputMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SharesTransferredAsConsiderationInAssetAcquisition" xlink:label="aciu_SharesTransferredAsConsiderationInAssetAcquisition" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="aciu_SharesTransferredAsConsiderationInAssetAcquisition" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition" xlink:label="aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantUnobservableInputAssets" xlink:label="ifrs-full_SignificantUnobservableInputAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="ifrs-full_SignificantUnobservableInputAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CashAcquiredAsPartOfAssetAcquisition" xlink:label="aciu_CashAcquiredAsPartOfAssetAcquisition" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="aciu_CashAcquiredAsPartOfAssetAcquisition" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition" xlink:label="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TotalAssetsAcquiredInAssetAcquisition" xlink:label="aciu_TotalAssetsAcquiredInAssetAcquisition" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="aciu_TotalAssetsAcquiredInAssetAcquisition" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureIntangibleAssetsDetails" xlink:type="extended" xlink:title="40701 - Disclosure - Intangible assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_InProcessResearchAndDevelopmentIPRDAssetMember" xlink:label="aciu_InProcessResearchAndDevelopmentIPRDAssetMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:to="aciu_InProcessResearchAndDevelopmentIPRDAssetMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="ifrs-full_CarryingAmountMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="ifrs-full_GrossCarryingAmountMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnobservableInputsAxis" xlink:label="ifrs-full_UnobservableInputsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="ifrs-full_UnobservableInputsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnobservableInputsMember" xlink:label="ifrs-full_UnobservableInputsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_UnobservableInputsAxis" xlink:to="ifrs-full_UnobservableInputsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DiscountRateMeasurementInputMember" xlink:label="ifrs-full_DiscountRateMeasurementInputMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_UnobservableInputsMember" xlink:to="ifrs-full_DiscountRateMeasurementInputMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantUnobservableInputAssets" xlink:label="ifrs-full_SignificantUnobservableInputAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract" xlink:to="ifrs-full_SignificantUnobservableInputAssets" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails" xlink:type="extended" xlink:title="40801 - Disclosure - Cash and cash equivalents and financial assets, Cash and cash equivalents (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CashAndCashEquivalentsTable" xlink:label="aciu_CashAndCashEquivalentsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="aciu_CashAndCashEquivalentsTable" xlink:to="srt_CurrencyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="currency_AllCurrenciesDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_CurrencyAxis" xlink:to="currency_AllCurrenciesDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_CHF" xlink:label="currency_CHF" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="currency_AllCurrenciesDomain" xlink:to="currency_CHF" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_EUR" xlink:label="currency_EUR" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="currency_AllCurrenciesDomain" xlink:to="currency_EUR" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_USD" xlink:label="currency_USD" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="currency_AllCurrenciesDomain" xlink:to="currency_USD" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CashAndCashEquivalentLineItems" xlink:label="aciu_CashAndCashEquivalentLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="aciu_CashAndCashEquivalentLineItems" xlink:to="aciu_CashAndCashEquivalentsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAbstract" xlink:label="ifrs-full_CashAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_CashAndCashEquivalentLineItems" xlink:to="ifrs-full_CashAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_CashAbstract" xlink:to="ifrs-full_CashAndCashEquivalents" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="ifrs-full_ClosingForeignExchangeRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_CashAbstract" xlink:to="ifrs-full_ClosingForeignExchangeRate" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails" xlink:type="extended" xlink:title="40802 - Disclosure - Cash and cash equivalents and financial assets, Cash and cash equivalents and short-term financial assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CashAndCashEquivalentsTable" xlink:label="aciu_CashAndCashEquivalentsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="aciu_CashAndCashEquivalentsTable" xlink:to="srt_CurrencyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="currency_AllCurrenciesDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_CurrencyAxis" xlink:to="currency_AllCurrenciesDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_CHF" xlink:label="currency_CHF" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="currency_AllCurrenciesDomain" xlink:to="currency_CHF" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_USD" xlink:label="currency_USD" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="currency_AllCurrenciesDomain" xlink:to="currency_USD" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CashAndCashEquivalentLineItems" xlink:label="aciu_CashAndCashEquivalentLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="aciu_CashAndCashEquivalentLineItems" xlink:to="aciu_CashAndCashEquivalentsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MiscellaneousCurrentAssetsAbstract" xlink:label="ifrs-full_MiscellaneousCurrentAssetsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_CashAndCashEquivalentLineItems" xlink:to="ifrs-full_MiscellaneousCurrentAssetsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:label="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_MiscellaneousCurrentAssetsAbstract" xlink:to="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureAccountsReceivableDetails" xlink:type="extended" xlink:title="41001 - Disclosure - Accounts receivable (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="ifrs-full_DisclosureOfFinancialAssetsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesAxis" xlink:label="ifrs-full_CounterpartiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfFinancialAssetsTable" xlink:to="ifrs-full_CounterpartiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesMember" xlink:label="ifrs-full_CounterpartiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CounterpartiesAxis" xlink:to="ifrs-full_CounterpartiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_JJInnovativeMedicineMember" xlink:label="aciu_JJInnovativeMedicineMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_CounterpartiesMember" xlink:to="aciu_JJInnovativeMedicineMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:label="ifrs-full_DisclosureOfFinancialAssetsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="ifrs-full_DisclosureOfFinancialAssetsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="ifrs-full_CurrentTradeReceivables" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="ifrs-full_CurrentTradeReceivables" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails" xlink:type="extended" xlink:title="41101 - Disclosure - Other current receivables (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfOtherCurrentReceivablesTable" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="aciu_DisclosureOfOtherCurrentReceivablesTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfOtherCurrentReceivablesLineItems" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="aciu_DisclosureOfOtherCurrentReceivablesLineItems" xlink:to="aciu_DisclosureOfOtherCurrentReceivablesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_DisclosureOfOtherCurrentReceivablesLineItems" xlink:to="ifrs-full_TradeAndOtherReceivablesAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_MiscellaneousOtherCurrentReceivables" xlink:label="aciu_MiscellaneousOtherCurrentReceivables" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="aciu_MiscellaneousOtherCurrentReceivables" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentValueAddedTaxReceivables" xlink:label="ifrs-full_CurrentValueAddedTaxReceivables" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="ifrs-full_CurrentValueAddedTaxReceivables" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WithholdingTaxReceivables" xlink:label="aciu_WithholdingTaxReceivables" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="aciu_WithholdingTaxReceivables" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="ifrs-full_OtherCurrentReceivables" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="ifrs-full_OtherCurrentReceivables" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_MaturityPeriodOtherCurrentReceivables" xlink:label="aciu_MaturityPeriodOtherCurrentReceivables" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_DisclosureOfOtherCurrentReceivablesLineItems" xlink:to="aciu_MaturityPeriodOtherCurrentReceivables" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureShareCapitalNarrativesDetails" xlink:type="extended" xlink:title="41201 - Disclosure - Share capital - Narratives (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="ifrs-full_OrdinarySharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapital" xlink:label="ifrs-full_IssuedCapital" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_IssuedCapital" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="ifrs-full_NumberOfSharesIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails" xlink:type="extended" xlink:title="41202 - Disclosure - Share capital - Capital Structure (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ifrs-full_ComponentsOfEquityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityMember" xlink:label="ifrs-full_EquityMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_EquityMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapitalMember" xlink:label="ifrs-full_IssuedCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_IssuedCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremiumMember" xlink:label="ifrs-full_SharePremiumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_SharePremiumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TreasurySharesMember" xlink:label="ifrs-full_TreasurySharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_TreasurySharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="ifrs-full_OrdinarySharesMember" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_OrdinarySharesMember" xlink:to="ifrs-full_TreasurySharesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xlink:label="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="ifrs-full_NumberOfSharesOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xlink:to="ifrs-full_NumberOfSharesOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xlink:to="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xlink:to="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ProceedsFromPublicOfferingsNetOfUnderwritingFeesAndTransactionEquityShares" xlink:label="aciu_ProceedsFromPublicOfferingsNetOfUnderwritingFeesAndTransactionEquityShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xlink:to="aciu_ProceedsFromPublicOfferingsNetOfUnderwritingFeesAndTransactionEquityShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" xlink:label="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xlink:to="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract" xlink:label="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract" xlink:to="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance" xlink:label="aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract" xlink:to="aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ChangesInEquityAbstract" xlink:label="ifrs-full_ChangesInEquityAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_ChangesInEquityAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ChangesInEquityAbstract" xlink:to="ifrs-full_Equity" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost" xlink:label="aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ChangesInEquityAbstract" xlink:to="aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" xlink:label="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_ChangesInEquityAbstract" xlink:to="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseThroughSharesIssuedUnderIncentivePlans" xlink:label="aciu_IncreaseThroughSharesIssuedUnderIncentivePlans" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_ChangesInEquityAbstract" xlink:to="aciu_IncreaseThroughSharesIssuedUnderIncentivePlans" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_ParValuePerShare" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForFinancingAndOtherPurposesDetails" xlink:type="extended" xlink:title="41204 - Disclosure - Share capital - Conditional share capital for financing and other purposes (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember" xlink:label="aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ConditionalShareCapitalAbstract" xlink:label="aciu_ConditionalShareCapitalAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aciu_ConditionalShareCapitalAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments" xlink:label="aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_ConditionalShareCapitalAbstract" xlink:to="aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments" xlink:label="aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_ConditionalShareCapitalAbstract" xlink:to="aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_ConditionalShareCapitalAbstract" xlink:to="ifrs-full_ParValuePerShare" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails" xlink:type="extended" xlink:title="41205 - Disclosure - Share capital - Conditional share capital for employee benefit plans (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember" xlink:label="aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ConditionalShareCapitalAbstract" xlink:label="aciu_ConditionalShareCapitalAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aciu_ConditionalShareCapitalAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions" xlink:label="aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_ConditionalShareCapitalAbstract" xlink:to="aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions" xlink:label="aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_ConditionalShareCapitalAbstract" xlink:to="aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_ConditionalShareCapitalAbstract" xlink:to="ifrs-full_ParValuePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits" xlink:label="aciu_NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_ConditionalShareCapitalAbstract" xlink:to="aciu_NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureShareCapitalFollowOnOfferingDetails" xlink:type="extended" xlink:title="41206 - Disclosure - Share capital - Follow-On Offering (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_FollowOnOfferingMember" xlink:label="aciu_FollowOnOfferingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="aciu_FollowOnOfferingMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfSharesIssuedDuringPeriod" xlink:label="aciu_NumberOfSharesIssuedDuringPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aciu_NumberOfSharesIssuedDuringPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="ifrs-full_ShareIssueRelatedCost" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_ShareIssueRelatedCost" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NetProceedsFromIssuanceOfShares" xlink:label="aciu_NetProceedsFromIssuanceOfShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aciu_NetProceedsFromIssuanceOfShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails" xlink:type="extended" xlink:title="41207 - Disclosure - Share capital - Shelf registration statement (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement" xlink:label="aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails" xlink:type="extended" xlink:title="41208 - Disclosure - Share capital - At the market equity offering (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AtTheMarketEquityOfferingMember" xlink:label="aciu_AtTheMarketEquityOfferingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="aciu_AtTheMarketEquityOfferingMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SecondOpenMarketSalesAgreementMember" xlink:label="aciu_SecondOpenMarketSalesAgreementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="aciu_SecondOpenMarketSalesAgreementMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AtTheMarketEquityOfferingAbstract" xlink:label="aciu_AtTheMarketEquityOfferingAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aciu_AtTheMarketEquityOfferingAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" xlink:label="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_AtTheMarketEquityOfferingAbstract" xlink:to="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="ifrs-full_NumberOfSharesIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_AtTheMarketEquityOfferingAbstract" xlink:to="ifrs-full_NumberOfSharesIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_AtTheMarketEquityOfferingAbstract" xlink:to="ifrs-full_ParValuePerShare" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket" xlink:label="aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_AtTheMarketEquityOfferingAbstract" xlink:to="aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SaleOrIssueOfTreasurySharesShares" xlink:label="aciu_SaleOrIssueOfTreasurySharesShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="aciu_AtTheMarketEquityOfferingAbstract" xlink:to="aciu_SaleOrIssueOfTreasurySharesShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares" xlink:label="ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="aciu_AtTheMarketEquityOfferingAbstract" xlink:to="ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CommissionsPaidForIssuanceOrdinaryShares" xlink:label="aciu_CommissionsPaidForIssuanceOrdinaryShares" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="aciu_AtTheMarketEquityOfferingAbstract" xlink:to="aciu_CommissionsPaidForIssuanceOrdinaryShares" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="ifrs-full_ShareIssueRelatedCost" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="aciu_AtTheMarketEquityOfferingAbstract" xlink:to="ifrs-full_ShareIssueRelatedCost" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails" xlink:type="extended" xlink:title="41209 - Disclosure - Share capital - Convertible note agreement (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ConvertibleNoteAgreementMember" xlink:label="aciu_ConvertibleNoteAgreementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="aciu_ConvertibleNoteAgreementMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="srt_StatementScenarioAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IfNotesAreConvertedMember" xlink:label="aciu_IfNotesAreConvertedMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="aciu_IfNotesAreConvertedMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesAxis" xlink:label="ifrs-full_CounterpartiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_CounterpartiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesMember" xlink:label="ifrs-full_CounterpartiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CounterpartiesAxis" xlink:to="ifrs-full_CounterpartiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AthosServiceGmbHMember" xlink:label="aciu_AthosServiceGmbHMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_CounterpartiesMember" xlink:to="aciu_AthosServiceGmbHMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_FirstCapitalPartnerGmbHMember" xlink:label="aciu_FirstCapitalPartnerGmbHMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_CounterpartiesMember" xlink:to="aciu_FirstCapitalPartnerGmbHMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ConvertibleNoteAgreementAbstract" xlink:label="aciu_ConvertibleNoteAgreementAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="aciu_ConvertibleNoteAgreementAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfConvertibleNoteAgreements" xlink:label="aciu_NumberOfConvertibleNoteAgreements" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_ConvertibleNoteAgreementAbstract" xlink:to="aciu_NumberOfConvertibleNoteAgreements" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AggregatePrincipalAmountOfEachConvertibleNote" xlink:label="aciu_AggregatePrincipalAmountOfEachConvertibleNote" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_ConvertibleNoteAgreementAbstract" xlink:to="aciu_AggregatePrincipalAmountOfEachConvertibleNote" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote" xlink:label="aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_ConvertibleNoteAgreementAbstract" xlink:to="aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ProceedsFromIssueOfConvertibleDebt" xlink:label="aciu_ProceedsFromIssueOfConvertibleDebt" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_ConvertibleNoteAgreementAbstract" xlink:to="aciu_ProceedsFromIssueOfConvertibleDebt" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="aciu_ConvertibleNoteAgreementAbstract" xlink:to="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements" xlink:label="aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="aciu_ConvertibleNoteAgreementAbstract" xlink:to="aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails" xlink:type="extended" xlink:title="41401 - Disclosure - Contract revenues - Contract Revenue Attributable to Licensing Arrangements (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_TypesOfContractsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="ifrs-full_TypesOfContractsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TypesOfContractsMember" xlink:to="aciu_CollaborationAndLicenseRevenueAgreementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAgreementWithLillyMember" xlink:label="aciu_CollaborationAgreementWithLillyMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:to="aciu_CollaborationAgreementWithLillyMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" xlink:label="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:to="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" xlink:label="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:to="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_OtherAgreementMember" xlink:label="aciu_OtherAgreementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:to="aciu_OtherAgreementMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ContractRevenueAbstract" xlink:label="aciu_ContractRevenueAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="aciu_ContractRevenueAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_ContractRevenueAbstract" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" xlink:type="extended" xlink:title="41403 - Disclosure - Contract revenues - Morphomer Tau small molecule - 2018 license agreement with Eli Lilly and Company (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_ProductsAndServicesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TauMorphomerSmallMoleculeMember" xlink:label="aciu_TauMorphomerSmallMoleculeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ProductsAndServicesMember" xlink:to="aciu_TauMorphomerSmallMoleculeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_TypesOfContractsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="ifrs-full_TypesOfContractsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TypesOfContractsMember" xlink:to="aciu_CollaborationAndLicenseRevenueAgreementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAgreementWithLillyMember" xlink:label="aciu_CollaborationAgreementWithLillyMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:to="aciu_CollaborationAgreementWithLillyMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAgreementWithLillyFirstAmendmentMember" xlink:label="aciu_CollaborationAgreementWithLillyFirstAmendmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_CollaborationAgreementWithLillyMember" xlink:to="aciu_CollaborationAgreementWithLillyFirstAmendmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAgreementWithLillySecondAmendmentMember" xlink:label="aciu_CollaborationAgreementWithLillySecondAmendmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_CollaborationAgreementWithLillyMember" xlink:to="aciu_CollaborationAgreementWithLillySecondAmendmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PerformanceObligationsAxis" xlink:label="ifrs-full_PerformanceObligationsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_PerformanceObligationsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PerformanceObligationsMember" xlink:label="ifrs-full_PerformanceObligationsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_PerformanceObligationsAxis" xlink:to="ifrs-full_PerformanceObligationsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember" xlink:label="aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_PerformanceObligationsMember" xlink:to="aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_MilestonePaymentsCommercialMember" xlink:label="aciu_MilestonePaymentsCommercialMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_PerformanceObligationsMember" xlink:to="aciu_MilestonePaymentsCommercialMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ResearchAndDevelopmentMember" xlink:label="aciu_ResearchAndDevelopmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_PerformanceObligationsMember" xlink:to="aciu_ResearchAndDevelopmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RightOfUseLicenseMember" xlink:label="aciu_RightOfUseLicenseMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_PerformanceObligationsMember" xlink:to="aciu_RightOfUseLicenseMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_MaturityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_AggregatedTimeBandsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Quarter32019Member" xlink:label="aciu_Quarter32019Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="aciu_Quarter32019Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_March312020Member" xlink:label="aciu_March312020Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="aciu_March312020Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member" xlink:label="aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementPotentialValue" xlink:label="aciu_CollaborativeAgreementPotentialValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementPotentialValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments" xlink:label="aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementMilestonePaymentReceived" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementMilestonePaymentReceived" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReceivablesFromContractsWithCustomers" xlink:label="ifrs-full_ReceivablesFromContractsWithCustomers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_ReceivablesFromContractsWithCustomers" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty" xlink:label="aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContractAssets" xlink:label="ifrs-full_ContractAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_ContractAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails" xlink:type="extended" xlink:title="41404 - Disclosure - Contract revenues - Tau Vaccine in AD - 2014 Agreement with Janssen Pharmaceuticals (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_ProductsAndServicesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TauVaccineInADMember" xlink:label="aciu_TauVaccineInADMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ProductsAndServicesMember" xlink:to="aciu_TauVaccineInADMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_TypesOfContractsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="ifrs-full_TypesOfContractsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TypesOfContractsMember" xlink:to="aciu_CollaborationAndLicenseRevenueAgreementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" xlink:label="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:to="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementPotentialValue" xlink:label="aciu_CollaborativeAgreementPotentialValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementPotentialValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementMilestonePaymentReceived" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementMilestonePaymentReceived" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="ifrs-full_CurrentTradeReceivables" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_CurrentTradeReceivables" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementUpfrontPaymentsReceived" xlink:label="aciu_CollaborativeAgreementUpfrontPaymentsReceived" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementUpfrontPaymentsReceived" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" xlink:type="extended" xlink:title="41405 - Disclosure - Contract revenues - Tau-PET imaging agent -2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_ProductsAndServicesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TauPETImagingAgentMember" xlink:label="aciu_TauPETImagingAgentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ProductsAndServicesMember" xlink:to="aciu_TauPETImagingAgentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_TypesOfContractsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="ifrs-full_TypesOfContractsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TypesOfContractsMember" xlink:to="aciu_CollaborationAndLicenseRevenueAgreementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" xlink:label="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:to="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PerformanceObligationsAxis" xlink:label="ifrs-full_PerformanceObligationsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_PerformanceObligationsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PerformanceObligationsMember" xlink:label="ifrs-full_PerformanceObligationsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_PerformanceObligationsAxis" xlink:to="ifrs-full_PerformanceObligationsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ClinicalMilestonesMember" xlink:label="aciu_ClinicalMilestonesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_PerformanceObligationsMember" xlink:to="aciu_ClinicalMilestonesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RegulatoryAndSalesBasedMilestonesMember" xlink:label="aciu_RegulatoryAndSalesBasedMilestonesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_PerformanceObligationsMember" xlink:to="aciu_RegulatoryAndSalesBasedMilestonesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementPotentialValue" xlink:label="aciu_CollaborativeAgreementPotentialValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementPotentialValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementMilestonePaymentReceived" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementMilestonePaymentReceived" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails" xlink:type="extended" xlink:title="41406 - Disclosure - Contract revenues - Grants from the Michael J. Fox Foundation (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_TypesOfContractsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="ifrs-full_TypesOfContractsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_GrantRevenueMember" xlink:label="aciu_GrantRevenueMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TypesOfContractsMember" xlink:to="aciu_GrantRevenueMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_GrantsMichaelJFoxFoundationMember" xlink:label="aciu_GrantsMichaelJFoxFoundationMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_GrantRevenueMember" xlink:to="aciu_GrantsMichaelJFoxFoundationMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesAxis" xlink:label="ifrs-full_CounterpartiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_CounterpartiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesMember" xlink:label="ifrs-full_CounterpartiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CounterpartiesAxis" xlink:to="ifrs-full_CounterpartiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SkaneUniversityHospitalMember" xlink:label="aciu_SkaneUniversityHospitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_CounterpartiesMember" xlink:to="aciu_SkaneUniversityHospitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_ProductsAndServicesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AlphaSynucleinPetImagingDiagnosticAgentMember" xlink:label="aciu_AlphaSynucleinPetImagingDiagnosticAgentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ProductsAndServicesMember" xlink:to="aciu_AlphaSynucleinPetImagingDiagnosticAgentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AdvanceSmallMoleculePdProgramsMember" xlink:label="aciu_AdvanceSmallMoleculePdProgramsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ProductsAndServicesMember" xlink:to="aciu_AdvanceSmallMoleculePdProgramsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="dei_LegalEntityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="dei_EntityDomain" xlink:to="aciu_SkaneUniversityHospitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_FollowOnGrantFundingReceivedTotalForJointArrangement" xlink:label="aciu_FollowOnGrantFundingReceivedTotalForJointArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_FollowOnGrantFundingReceivedTotalForJointArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_FollowOnGrantFundingReceived" xlink:label="aciu_FollowOnGrantFundingReceived" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_FollowOnGrantFundingReceived" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfGrants" xlink:label="aciu_NumberOfGrants" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_NumberOfGrants" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementPotentialValue" xlink:label="aciu_CollaborativeAgreementPotentialValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementPotentialValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReceivablesFromContractsWithCustomers" xlink:label="ifrs-full_ReceivablesFromContractsWithCustomers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_ReceivablesFromContractsWithCustomers" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementJointResearchCollaborationPeriod" xlink:label="aciu_CollaborativeAgreementJointResearchCollaborationPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_CollaborativeAgreementJointResearchCollaborationPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="ifrs-full_OtherOperatingIncomeExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_OtherOperatingIncomeExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AdditionalGrantAwarded" xlink:label="aciu_AdditionalGrantAwarded" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="aciu_AdditionalGrantAwarded" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" xlink:label="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureExpensesByCategoryDetails" xlink:type="extended" xlink:title="41501 - Disclosure - Expenses by category (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:label="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LineItemsByFunctionMember" xlink:label="ifrs-full_LineItemsByFunctionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:to="ifrs-full_LineItemsByFunctionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ResearchAndDevelopmentExpensesMember" xlink:label="aciu_ResearchAndDevelopmentExpensesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_LineItemsByFunctionMember" xlink:to="aciu_ResearchAndDevelopmentExpensesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseMember" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpenseMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_LineItemsByFunctionMember" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpenseMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OperatingExpense" xlink:label="ifrs-full_OperatingExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_OperatingExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation" xlink:label="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseByNature" xlink:label="ifrs-full_ExpenseByNature" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_ExpenseByNature" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AverageNumberOfEmployees" xlink:label="ifrs-full_AverageNumberOfEmployees" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_AverageNumberOfEmployees" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="ifrs-full_GeneralAndAdministrativeExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_GeneralAndAdministrativeExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DecreaseInResearchAndDevelopmentExpenseThroughReductionsInVariousCostCenters" xlink:label="aciu_DecreaseInResearchAndDevelopmentExpenseThroughReductionsInVariousCostCenters" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="aciu_DecreaseInResearchAndDevelopmentExpenseThroughReductionsInVariousCostCenters" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseInResearchAndDevelopmentExpenseThroughIncreaseInSalariesAndRelatedCosts" xlink:label="aciu_IncreaseInResearchAndDevelopmentExpenseThroughIncreaseInSalariesAndRelatedCosts" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="aciu_IncreaseInResearchAndDevelopmentExpenseThroughIncreaseInSalariesAndRelatedCosts" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DecreaseInGeneralAndAdministrativeExpenseThroughReductionsInVariousCostCenters" xlink:label="aciu_DecreaseInGeneralAndAdministrativeExpenseThroughReductionsInVariousCostCenters" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="aciu_DecreaseInGeneralAndAdministrativeExpenseThroughReductionsInVariousCostCenters" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseInGeneralAndAdministrativeExpenseThroughIncreaseInShareBasedCompensationExpense" xlink:label="aciu_IncreaseInGeneralAndAdministrativeExpenseThroughIncreaseInShareBasedCompensationExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="aciu_IncreaseInGeneralAndAdministrativeExpenseThroughIncreaseInShareBasedCompensationExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_FinancialResultNetAbstract" xlink:label="aciu_FinancialResultNetAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="aciu_FinancialResultNetAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncome" xlink:label="ifrs-full_FinanceIncome" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_FinancialResultNetAbstract" xlink:to="ifrs-full_FinanceIncome" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceCosts" xlink:label="ifrs-full_FinanceCosts" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_FinancialResultNetAbstract" xlink:to="ifrs-full_FinanceCosts" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_FinancialResultNetAbstract" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncomeCost" xlink:label="ifrs-full_FinanceIncomeCost" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_FinancialResultNetAbstract" xlink:to="ifrs-full_FinanceIncomeCost" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails" xlink:type="extended" xlink:title="41701 - Disclosure - Income taxes - Summary of Income Tax Expense (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageMember" xlink:label="ifrs-full_WeightedAverageMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_WeightedAverageMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="ifrs-full_GeographicalAreasAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="ifrs-full_GeographicalAreasAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasMember" xlink:label="ifrs-full_GeographicalAreasMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH" xlink:label="country_CH" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="country_CH" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxAssets" xlink:label="ifrs-full_DeferredTaxAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DeferredTaxAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="ifrs-full_DeferredTaxLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DeferredTaxLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ApplicableTaxRate" xlink:label="ifrs-full_ApplicableTaxRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_ApplicableTaxRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:label="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccountingProfit" xlink:label="ifrs-full_AccountingProfit" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="ifrs-full_AccountingProfit" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" xlink:label="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TaxEffectOfTaxLosses" xlink:label="ifrs-full_TaxEffectOfTaxLosses" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="ifrs-full_TaxEffectOfTaxLosses" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" xlink:type="extended" xlink:title="41702 - Disclosure - Income taxes, Unrecognized Deductible Temporary Differences, Unused Tax Losses and Unused Tax Credits (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnusedTaxLossesMember" xlink:label="ifrs-full_UnusedTaxLossesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:to="ifrs-full_UnusedTaxLossesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember" xlink:label="aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:to="aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RetirementBenefitPlanMember" xlink:label="aciu_RetirementBenefitPlanMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:to="aciu_RetirementBenefitPlanMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="ifrs-full_MaturityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_AggregatedTimeBandsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_December312024Member" xlink:label="aciu_December312024Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="aciu_December312024Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_December312025Member" xlink:label="aciu_December312025Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="aciu_December312025Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_December312026Member" xlink:label="aciu_December312026Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="aciu_December312026Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_December312027Member" xlink:label="aciu_December312027Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="aciu_December312027Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_December312028Member" xlink:label="aciu_December312028Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="aciu_December312028Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_December312029Member" xlink:label="aciu_December312029Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="aciu_December312029Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_December312030Member" xlink:label="aciu_December312030Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="aciu_December312030Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:label="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:to="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TaxLossesSplitByExpiryDateAbstract" xlink:label="aciu_TaxLossesSplitByExpiryDateAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="aciu_TaxLossesSplitByExpiryDateAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:label="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_TaxLossesSplitByExpiryDateAbstract" xlink:to="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits" xlink:label="aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_TaxLossesSplitByExpiryDateAbstract" xlink:to="aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails" xlink:type="extended" xlink:title="41803 - Disclosure - Retirement benefit plan - Changes in Defined Benefit Obligation (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:label="ifrs-full_PresentValueOfDefinedBenefitObligationMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:to="ifrs-full_PresentValueOfDefinedBenefitObligationMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:label="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:to="ifrs-full_LiabilityAssetOfDefinedBenefitPlans" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:to="ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:to="ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:to="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" xlink:label="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:to="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:to="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails" xlink:type="extended" xlink:title="41804 - Disclosure - Retirement benefit plan - Changes in Fair Value of Plan Assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PlanAssetsMember" xlink:label="ifrs-full_PlanAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:to="ifrs-full_PlanAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ChangesInFairValueOfPlanAssetsAbstract" xlink:label="aciu_ChangesInFairValueOfPlanAssetsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="aciu_ChangesInFairValueOfPlanAssetsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract" xlink:to="ifrs-full_LiabilityAssetOfDefinedBenefitPlans" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract" xlink:to="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract" xlink:to="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract" xlink:to="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" xlink:label="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract" xlink:to="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract" xlink:to="ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xlink:label="ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract" xlink:to="ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" xlink:type="extended" xlink:title="41807 - Disclosure - Retirement benefit plan - Actuarial Assumptions and Sensitivity Analysis (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionsAxis" xlink:label="ifrs-full_ActuarialAssumptionsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:to="ifrs-full_ActuarialAssumptionsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionsMember" xlink:label="ifrs-full_ActuarialAssumptionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ActuarialAssumptionsAxis" xlink:to="ifrs-full_ActuarialAssumptionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRatesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ActuarialAssumptionsMember" xlink:to="ifrs-full_ActuarialAssumptionOfDiscountRatesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_ActuarialAssumptionsMember" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_ActuarialAssumptionsMember" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_ActuarialAssumptionsMember" xlink:to="aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="ifrs-full_TypesOfRisksAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:to="ifrs-full_TypesOfRisksAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="ifrs-full_TypesOfRisksMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember" xlink:label="aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TypesOfRisksMember" xlink:to="aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember" xlink:label="aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_TypesOfRisksMember" xlink:to="aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:to="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:to="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRates" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract" xlink:to="ifrs-full_ActuarialAssumptionOfDiscountRates" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract" xlink:to="aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SensitivityAnalysisActuarialAssumptionsAbstract" xlink:label="aciu_SensitivityAnalysisActuarialAssumptionsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:to="aciu_SensitivityAnalysisActuarialAssumptionsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:label="ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_SensitivityAnalysisActuarialAssumptionsAbstract" xlink:to="ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:label="ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_SensitivityAnalysisActuarialAssumptionsAbstract" xlink:to="ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_SensitivityAnalysisActuarialAssumptionsAbstract" xlink:to="ifrs-full_DefinedBenefitObligationAtPresentValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:label="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_SensitivityAnalysisActuarialAssumptionsAbstract" xlink:to="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:label="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="aciu_SensitivityAnalysisActuarialAssumptionsAbstract" xlink:to="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails" xlink:type="extended" xlink:title="41901 - Disclosure - Share-based compensation, Plans Outstanding (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_StockOptionPlanC1Member" xlink:label="aciu_StockOptionPlanC1Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="aciu_StockOptionPlanC1Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Two016ShareOptionAndIncentivePlanMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="aciu_Two016ShareOptionAndIncentivePlanMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_Two016ShareOptionAndIncentivePlanMember" xlink:to="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_Two016ShareOptionAndIncentivePlanMember" xlink:to="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_Two016ShareOptionAndIncentivePlanMember" xlink:to="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_EmployeesMember" xlink:label="aciu_EmployeesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="aciu_EmployeesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ShareBasedPlansOutstandingAbstract" xlink:label="aciu_ShareBasedPlansOutstandingAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="aciu_ShareBasedPlansOutstandingAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfEquityBasedInstrumentPlans" xlink:label="aciu_NumberOfEquityBasedInstrumentPlans" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_ShareBasedPlansOutstandingAbstract" xlink:to="aciu_NumberOfEquityBasedInstrumentPlans" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_ShareBasedPlansOutstandingAbstract" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" xlink:label="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_ShareBasedPlansOutstandingAbstract" xlink:to="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" xlink:label="aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_ShareBasedPlansOutstandingAbstract" xlink:to="aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" xlink:type="extended" xlink:title="41903 - Disclosure - Share-based compensation, Outstanding Options, Range of Exercise prices and Expiration Dates (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Chf0.15Member" xlink:label="aciu_Chf0.15Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="aciu_Chf0.15Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Chf9.53Member" xlink:label="aciu_Chf9.53Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="aciu_Chf9.53Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Usd5.04ToUsd12.30Member" xlink:label="aciu_Usd5.04ToUsd12.30Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="aciu_Usd5.04ToUsd12.30Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Usd2.76ToUsd4.57Member" xlink:label="aciu_Usd2.76ToUsd4.57Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="aciu_Usd2.76ToUsd4.57Member" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Usd2.03ToUsd2.32Member" xlink:label="aciu_Usd2.03ToUsd2.32Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="aciu_Usd2.03ToUsd2.32Member" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="srt_CurrencyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="currency_AllCurrenciesDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_CurrencyAxis" xlink:to="currency_AllCurrenciesDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_CHF" xlink:label="currency_CHF" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="currency_AllCurrenciesDomain" xlink:to="currency_CHF" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_USD" xlink:label="currency_USD" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="currency_AllCurrenciesDomain" xlink:to="currency_USD" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" xlink:label="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" xlink:to="ifrs-full_NumberOfOutstandingShareOptions" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageSharePrice2019" xlink:label="ifrs-full_WeightedAverageSharePrice2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" xlink:to="ifrs-full_WeightedAverageSharePrice2019" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" xlink:type="extended" xlink:title="41904 - Disclosure - Share-based compensation, Weighted Average Grant date Fair Value and Assumptions (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:to="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageAssumptionsAbstract" xlink:label="aciu_WeightedAverageAssumptionsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:to="aciu_WeightedAverageAssumptionsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_WeightedAverageAssumptionsAbstract" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_WeightedAverageAssumptionsAbstract" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageSharePrice2019" xlink:label="ifrs-full_WeightedAverageSharePrice2019" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_WeightedAverageAssumptionsAbstract" xlink:to="ifrs-full_WeightedAverageSharePrice2019" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_WeightedAverageAssumptionsAbstract" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="aciu_WeightedAverageAssumptionsAbstract" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="aciu_WeightedAverageAssumptionsAbstract" xlink:to="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="aciu_WeightedAverageAssumptionsAbstract" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails" xlink:type="extended" xlink:title="41905 - Disclosure - Share-based compensation, Non-vested Share Awards (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RestrictedSharesAndRestrictedShareUnitsMember" xlink:label="aciu_RestrictedSharesAndRestrictedShareUnitsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="aciu_RestrictedSharesAndRestrictedShareUnitsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RestrictedStockUnitsMember" xlink:label="aciu_RestrictedStockUnitsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="aciu_RestrictedStockUnitsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RestrictedStockUnitsFirstVestingConditionsMember" xlink:label="aciu_RestrictedStockUnitsFirstVestingConditionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_RestrictedStockUnitsMember" xlink:to="aciu_RestrictedStockUnitsFirstVestingConditionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RestrictedStockUnitsSecondVestingConditionsMember" xlink:label="aciu_RestrictedStockUnitsSecondVestingConditionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_RestrictedStockUnitsMember" xlink:to="aciu_RestrictedStockUnitsSecondVestingConditionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_BoardOfDirectorsMember" xlink:label="aciu_BoardOfDirectorsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="aciu_BoardOfDirectorsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ExecutiveManagementMember" xlink:label="aciu_ExecutiveManagementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="aciu_ExecutiveManagementMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_EmployeesMember" xlink:label="aciu_EmployeesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="aciu_EmployeesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ShareBasedPaymentArrangementAbstract" xlink:label="aciu_ShareBasedPaymentArrangementAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="aciu_ShareBasedPaymentArrangementAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_ShareBasedPaymentArrangementAbstract" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" xlink:label="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_ShareBasedPaymentArrangementAbstract" xlink:to="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement" xlink:label="aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_ShareBasedPaymentArrangementAbstract" xlink:to="aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfNonVestedSharesAbstract" xlink:label="aciu_NumberOfNonVestedSharesAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="aciu_NumberOfNonVestedSharesAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_NumberOfNonVestedSharesAbstract" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_NumberOfNonVestedSharesAbstract" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement" xlink:label="aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_NumberOfNonVestedSharesAbstract" xlink:to="aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_NumberOfNonVestedSharesAbstract" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="aciu_NumberOfNonVestedSharesAbstract" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageExercisePriceAbstract" xlink:label="aciu_WeightedAverageExercisePriceAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="aciu_WeightedAverageExercisePriceAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_WeightedAverageExercisePriceAbstract" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_WeightedAverageExercisePriceAbstract" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_WeightedAverageExercisePriceAbstract" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_WeightedAverageExercisePriceAbstract" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="aciu_WeightedAverageExercisePriceAbstract" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="aciu_WeightedAverageExercisePriceAbstract" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails" xlink:type="extended" xlink:title="42001 - Disclosure - Commitments and contingencies (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable" xlink:label="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable" xlink:to="ifrs-full_MaturityAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_AggregatedTimeBandsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="ifrs-full_NotLaterThanOneYearMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="ifrs-full_NotLaterThanOneYearMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanFiveYearsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="ifrs-full_LaterThanFiveYearsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems" xlink:label="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems" xlink:to="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CommitmentsAbstract" xlink:label="aciu_CommitmentsAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems" xlink:to="aciu_CommitmentsAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ContractualCapitalCommitmentsOtherThanForLeases" xlink:label="aciu_ContractualCapitalCommitmentsOtherThanForLeases" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_CommitmentsAbstract" xlink:to="aciu_ContractualCapitalCommitmentsOtherThanForLeases" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RentalContractPeriodForNoticeOfCancellation" xlink:label="aciu_RentalContractPeriodForNoticeOfCancellation" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_CommitmentsAbstract" xlink:to="aciu_RentalContractPeriodForNoticeOfCancellation" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContractualCapitalCommitments" xlink:label="ifrs-full_ContractualCapitalCommitments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_CommitmentsAbstract" xlink:to="ifrs-full_ContractualCapitalCommitments" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureEarningsPerShareAntidilutiveSecuritiesDetails" xlink:type="extended" xlink:title="42102 - Disclosure - Earnings per share - Antidilutive securities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:label="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:label="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:to="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AntidilutiveInstrumentsMember" xlink:label="ifrs-full_AntidilutiveInstrumentsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:to="ifrs-full_AntidilutiveInstrumentsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareOptionsMember" xlink:label="ifrs-full_ShareOptionsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_AntidilutiveInstrumentsMember" xlink:to="ifrs-full_ShareOptionsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RestrictedShareUnitsMember" xlink:label="ifrs-full_RestrictedShareUnitsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_AntidilutiveInstrumentsMember" xlink:to="ifrs-full_RestrictedShareUnitsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ConvertibleInstrumentsMember" xlink:label="ifrs-full_ConvertibleInstrumentsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_AntidilutiveInstrumentsMember" xlink:to="ifrs-full_ConvertibleInstrumentsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareLineItems" xlink:label="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareLineItems" xlink:to="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" xlink:label="ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareLineItems" xlink:to="ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails" xlink:type="extended" xlink:title="42201 - Disclosure - Financial instruments and risk management (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="ifrs-full_TypesOfRisksAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xlink:to="ifrs-full_TypesOfRisksAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="ifrs-full_TypesOfRisksMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrencyRiskMember" xlink:label="ifrs-full_CurrencyRiskMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TypesOfRisksMember" xlink:to="ifrs-full_CurrencyRiskMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CreditRiskMember" xlink:label="ifrs-full_CreditRiskMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_TypesOfRisksMember" xlink:to="ifrs-full_CreditRiskMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiquidityRiskMember" xlink:label="ifrs-full_LiquidityRiskMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_TypesOfRisksMember" xlink:to="ifrs-full_LiquidityRiskMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestRateRiskMember" xlink:label="ifrs-full_InterestRateRiskMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_TypesOfRisksMember" xlink:to="ifrs-full_InterestRateRiskMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xlink:to="ifrs-full_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember" xlink:label="ifrs-full_FinancialAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_FinancialAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RightOfUseFinancialAssetsMember" xlink:label="aciu_RightOfUseFinancialAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_FinancialAssetsMember" xlink:to="aciu_RightOfUseFinancialAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_LongTermFinancialAssetsMember" xlink:label="aciu_LongTermFinancialAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_FinancialAssetsMember" xlink:to="aciu_LongTermFinancialAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_OtherCurrentReceivablesMember" xlink:label="aciu_OtherCurrentReceivablesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_FinancialAssetsMember" xlink:to="aciu_OtherCurrentReceivablesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeReceivablesMember" xlink:label="ifrs-full_TradeReceivablesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_FinancialAssetsMember" xlink:to="ifrs-full_TradeReceivablesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ShortTermFinancialAssetsMember" xlink:label="aciu_ShortTermFinancialAssetsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="ifrs-full_FinancialAssetsMember" xlink:to="aciu_ShortTermFinancialAssetsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CashOnHandAndCashEquivalentsMember" xlink:label="aciu_CashOnHandAndCashEquivalentsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="ifrs-full_FinancialAssetsMember" xlink:to="aciu_CashOnHandAndCashEquivalentsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="ifrs-full_FinancialLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_FinancialLiabilitiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_LongTermLeaseLiabilitiesMember" xlink:label="aciu_LongTermLeaseLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_FinancialLiabilitiesMember" xlink:to="aciu_LongTermLeaseLiabilitiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TradeAndOtherPayablesMember" xlink:label="aciu_TradeAndOtherPayablesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_FinancialLiabilitiesMember" xlink:to="aciu_TradeAndOtherPayablesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AccruedExpensesMember" xlink:label="aciu_AccruedExpensesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_FinancialLiabilitiesMember" xlink:to="aciu_AccruedExpensesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ShortTermLeaseLiabilitiesMember" xlink:label="aciu_ShortTermLeaseLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="ifrs-full_FinancialLiabilitiesMember" xlink:to="aciu_ShortTermLeaseLiabilitiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:to="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_FinancialAssetsAndLiabilitiesAbstract" xlink:label="aciu_FinancialAssetsAndLiabilitiesAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:to="aciu_FinancialAssetsAndLiabilitiesAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssets" xlink:label="ifrs-full_FinancialAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_FinancialAssetsAndLiabilitiesAbstract" xlink:to="ifrs-full_FinancialAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilities" xlink:label="ifrs-full_FinancialLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_FinancialAssetsAndLiabilitiesAbstract" xlink:to="ifrs-full_FinancialLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_FinancialRisksAbstract" xlink:label="aciu_FinancialRisksAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:to="aciu_FinancialRisksAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="aciu_FinancialRisksAbstract" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" xlink:label="aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="aciu_FinancialRisksAbstract" xlink:to="aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" xlink:label="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="aciu_FinancialRisksAbstract" xlink:to="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates" xlink:label="aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="aciu_FinancialRisksAbstract" xlink:to="aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates" xlink:label="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="aciu_FinancialRisksAbstract" xlink:to="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets" xlink:label="aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="aciu_FinancialRisksAbstract" xlink:to="aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://acimume.com/role/DisclosureSubsequentEventsDetails" xlink:type="extended" xlink:title="42401 - Disclosure - Subsequent Events (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="ifrs-full_TypesOfContractsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="ifrs-full_TypesOfContractsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" xlink:label="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_TypesOfContractsMember" xlink:to="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="ifrs-full_ProductsAndServicesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TauVaccineInADMember" xlink:label="aciu_TauVaccineInADMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_ProductsAndServicesMember" xlink:to="aciu_TauVaccineInADMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="ifrs-full_NonadjustingEventsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ReceiptOfMilestonePaymentsMember" xlink:label="aciu_ReceiptOfMilestonePaymentsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="ifrs-full_NonadjustingEventsMember" xlink:to="aciu_ReceiptOfMilestonePaymentsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAgreementMileStonePaymentReceived" xlink:label="aciu_CollaborationAgreementMileStonePaymentReceived" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="aciu_CollaborationAgreementMileStonePaymentReceived" priority="1" use="optional" />
  </definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>46
<FILENAME>aciu-20231231_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.5.0.8 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/13/2024 5:02:26 PM-->
<!--Modified on: 3/13/2024 5:02:26 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cover [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesTable" xlink:to="dei_EntityAddressesTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Addresses [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Addresses, Address Type [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="dei_AddressTypeDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AddressTypeDomain" xlink:to="dei_AddressTypeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AddressTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Address Type [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Contact [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Contact [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressesLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Addresses [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Registration Statement</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Fiscal Period Focus</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Fiscal Year Focus</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Fiscal Year End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Annual Report</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Transition Report</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Shell Company Report</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line Two</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Country</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName" xlink:label="dei_ContactPersonnelName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contact Personnel Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Common Stock, Shares Outstanding</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Well-known Seasoned Issuer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Voluntary Filers</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Current Reporting Status</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Interactive Data Current</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Filer Category</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ICFR Auditor Attestation Flag</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Accounting Standard</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Shell Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Auditor Firm ID</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="dei_AuditorName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Auditor Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Auditor Location</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Financial Statement Error Correction [Flag]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_StatementOfFinancialPositionAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consolidated Balance Sheets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AssetsAbstract" xlink:label="ifrs-full_AssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssetsAbstract" xlink:to="ifrs-full_AssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="ifrs-full_NoncurrentAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment, end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment, beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_RightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance, end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_RightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance, beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible asset</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentRestrictedCashAndCashEquivalents" xlink:label="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents" xlink:to="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current restricted cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term financial assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssets" xlink:label="ifrs-full_NoncurrentAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total non-current assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="ifrs-full_CurrentAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="ifrs-full_CurrentPrepaidExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPrepaidExpenses" xlink:to="ifrs-full_CurrentPrepaidExpenses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentPrepaidExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentPrepaidExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" xlink:label="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" xlink:to="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current accrued income including current contract assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued income</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="ifrs-full_OtherCurrentReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentReceivables" xlink:to="ifrs-full_OtherCurrentReceivables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherCurrentReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_OtherCurrentReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total other current receivables</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="ifrs-full_CurrentTradeReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTradeReceivables" xlink:to="ifrs-full_CurrentTradeReceivables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTradeReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentTradeReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts receivable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:label="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:to="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term deposits, not classified as cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term financial assets due in one year or less</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents at end of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Company's cash position</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssets" xlink:label="ifrs-full_CurrentAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total current assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Assets" xlink:label="ifrs-full_Assets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_Assets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Assets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Assets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="ifrs-full_EquityAndLiabilitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAndLiabilitiesAbstract" xlink:to="ifrs-full_EquityAndLiabilitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAndLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SHAREHOLDERS' EQUITY AND LIABILITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EquityAndLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shareholders' equity and liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAbstract" xlink:label="ifrs-full_EquityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_EquityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shareholders' equity</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapital" xlink:label="ifrs-full_IssuedCapital" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapital" xlink:to="ifrs-full_IssuedCapital_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issued capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IssuedCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IssuedCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issued share capital</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremium" xlink:label="ifrs-full_SharePremium" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharePremium" xlink:to="ifrs-full_SharePremium_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SharePremium_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share premium</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SharePremium_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share premium</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TreasuryShares" xlink:label="ifrs-full_TreasuryShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TreasuryShares" xlink:to="ifrs-full_TreasuryShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TreasuryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Treasury shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_TreasuryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Treasury shares</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reserve of exchange differences on translation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Currency translation differences</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarnings" xlink:label="ifrs-full_RetainedEarnings" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarnings" xlink:to="ifrs-full_RetainedEarnings_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetainedEarnings_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retained earnings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RetainedEarnings_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated losses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Equity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_Equity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance, end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_Equity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance, beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Equity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total shareholders' equity</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentLiabilitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLeaseLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term lease liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:label="ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:to="ifrs-full_NoncurrentProvisionsForEmployeeBenefits_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentProvisionsForEmployeeBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current provisions for employee benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentProvisionsForEmployeeBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net employee defined benefit liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="ifrs-full_NoncurrentLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total non-current liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="ifrs-full_CurrentLiabilitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade and other current payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade and other payables</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:to="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current accrued expenses and other current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:to="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current deferred income including current contract liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred income</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="ifrs-full_CurrentLeaseLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLeaseLiabilities" xlink:to="ifrs-full_CurrentLeaseLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term lease liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilities" xlink:label="ifrs-full_CurrentLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total current liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Liabilities" xlink:label="ifrs-full_Liabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_Liabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Liabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Liabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAndLiabilities" xlink:label="ifrs-full_EquityAndLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_EquityAndLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAndLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity and liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_EquityAndLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total shareholders' equity and liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="ifrs-full_IncomeStatementAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_IncomeStatementAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeStatementAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consolidated Statements of Income/(Loss)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueAbstract" xlink:label="ifrs-full_RevenueAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueAbstract" xlink:to="ifrs-full_RevenueAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contract revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromContractsWithCustomers" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue from contracts with customers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contract revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total contract revenues</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue" xlink:label="ifrs-full_Revenue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_Revenue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Revenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Revenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total revenue</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ExpensesOperatingAbstract" xlink:label="aciu_ExpensesOperatingAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ExpensesOperatingAbstract" xlink:to="aciu_ExpensesOperatingAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ExpensesOperatingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expenses, Operating [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ExpensesOperatingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and development expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research &amp; development expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and development expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="ifrs-full_GeneralAndAdministrativeExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeneralAndAdministrativeExpense" xlink:to="ifrs-full_GeneralAndAdministrativeExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General and administrative expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General &amp; administrative expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General and administrative expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_OtherOperatingIncomeExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherOperatingIncomeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other operating income (expense)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherOperatingIncomeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income from grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherOperatingIncomeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other operating income/(expense), net</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OperatingExpense" xlink:label="ifrs-full_OperatingExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OperatingExpense" xlink:to="ifrs-full_OperatingExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OperatingExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="ifrs-full_OperatingExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OperatingExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Profit (loss) from operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating loss</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncome" xlink:label="ifrs-full_FinanceIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncome" xlink:to="ifrs-full_FinanceIncome_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinanceIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial income</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceCosts" xlink:label="ifrs-full_FinanceCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceCosts" xlink:to="ifrs-full_FinanceCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_FinanceCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exchange differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exchange differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign exchange gains (losses)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncomeCost" xlink:label="ifrs-full_FinanceIncomeCost" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncomeCost" xlink:to="ifrs-full_FinanceIncomeCost_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceIncomeCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finance income (cost)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_FinanceIncomeCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finance result, net</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="ifrs-full_ProfitLossBeforeTax" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossBeforeTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income/(loss) before income tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLossBeforeTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss before tax</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income tax expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income tax expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effective income tax rate (benefit)/expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss for the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss for the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss for the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfitLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net income/(loss) for the period</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="ifrs-full_EarningsPerShareAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_EarningsPerShareAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EarningsPerShareAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EarningsPerShareAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss per share:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="ifrs-full_BasicEarningsLossPerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShare" xlink:to="ifrs-full_BasicEarningsLossPerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BasicEarningsLossPerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basic earnings (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BasicEarningsLossPerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basic loss per share for the period attributable to equity holders</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShare" xlink:to="ifrs-full_DilutedEarningsLossPerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DilutedEarningsLossPerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Diluted earnings (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DilutedEarningsLossPerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Diluted loss per share for the period attributable to equity holders</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:label="ifrs-full_StatementOfComprehensiveIncomeAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_StatementOfComprehensiveIncomeAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfComprehensiveIncomeAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consolidated Statements of Comprehensive Income/(Loss)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Items that may be reclassified to income or loss in subsequent periods (net of tax):</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Items that may be reclassified to income or loss in subsequent periods (net of tax):</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive income, net of tax, exchange differences on translation of foreign operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Currency translation differences</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Items that will not to be reclassified to income or loss in subsequent periods (net of tax):</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Remeasurement gains/(losses) on defined-benefit plans (net of tax)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total other comprehensive gain</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="ifrs-full_OtherComprehensiveIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncome" xlink:to="ifrs-full_OtherComprehensiveIncome_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive income/(loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_OtherComprehensiveIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive income/(loss)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ifrs-full_ComprehensiveIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComprehensiveIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ComprehensiveIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total comprehensive loss, net of tax</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="ifrs-full_StatementOfChangesInEquityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfChangesInEquityAbstract" xlink:to="ifrs-full_StatementOfChangesInEquityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfChangesInEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consolidated Statements of Changes in Equity</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="ifrs-full_StatementOfChangesInEquityTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_StatementOfChangesInEquityTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfChangesInEquityTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement of changes in equity [table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ifrs-full_ComponentsOfEquityAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComponentsOfEquityAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Components of equity [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityMember" xlink:label="ifrs-full_EquityMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_EquityMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapitalMember" xlink:label="ifrs-full_IssuedCapitalMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalMember" xlink:to="ifrs-full_IssuedCapitalMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issued capital [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IssuedCapitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share capital</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremiumMember" xlink:label="ifrs-full_SharePremiumMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharePremiumMember" xlink:to="ifrs-full_SharePremiumMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SharePremiumMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share Premium [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SharePremiumMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share premium</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TreasurySharesMember" xlink:label="ifrs-full_TreasurySharesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TreasurySharesMember" xlink:to="ifrs-full_TreasurySharesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TreasurySharesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Treasury shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TreasurySharesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Treasury shares</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarningsMember" xlink:label="ifrs-full_RetainedEarningsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarningsMember" xlink:to="ifrs-full_RetainedEarningsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetainedEarningsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retained earnings [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RetainedEarningsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated losses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reserve of exchange differences on translation [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Currency Translation Differences</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_StatementOfChangesInEquityLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement of changes in equity [line items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:to="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) through share-based payment transactions, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based payments</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost" xlink:label="aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost" xlink:to="aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase (decrease) in equity from sale or issue of public offerings net of underwriting fees and transaction costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale or Issue of Public Offerings, Net of Underwriting Fees, Transaction Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from public offerings, net of underwriting fees, transaction costs and stamp duty</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from public offerings, net of underwriting fees, transaction costs</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" xlink:label="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" xlink:to="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase (decrease) in equity from sale or issue of treasury shares net of underwriting fees and transaction costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale or issue of treasury shares net of underwriting fees and transaction costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesIssuedAbstract" xlink:label="ifrs-full_NumberOfSharesIssuedAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract" xlink:to="ifrs-full_NumberOfSharesIssuedAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesIssuedAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfSharesIssuedAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of shares, net of transaction costs:</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" xlink:label="aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" xlink:to="aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase (decrease) in equity resulting from purchase of IPR&amp;D assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) through purchase of in process research and development asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IPR&amp;D asset purchase</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity" xlink:label="aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity" xlink:to="aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">'The increase (decrease) in equity resulting from the issuance of shares as part of an asset acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) through acquisition of assets, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Asset acquisition - common shares</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" xlink:label="ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" xlink:to="ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) through conversion of convertible instruments, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Conversion note agreement</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" xlink:label="ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" xlink:to="ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) through treasury share transactions, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Held as treasury shares</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IssueOfEquityRestrictedShareAwards" xlink:label="aciu_IssueOfEquityRestrictedShareAwards" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IssueOfEquityRestrictedShareAwards" xlink:to="aciu_IssueOfEquityRestrictedShareAwards_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IssueOfEquityRestrictedShareAwards_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase in equity through the issue of restricted share awards.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IssueOfEquityRestrictedShareAwards_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issue of Equity, Restricted Share Awards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_IssueOfEquityRestrictedShareAwards_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted share awards</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:to="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) through exercise of options, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise of options</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_StatementOfCashFlowsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Consolidated Statements of Cash Flows</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows from (used in) operating activities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating activities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments to reconcile profit (loss) [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments to reconcile net loss for the period to net cash flows:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDepreciationExpense" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDepreciationExpense" xlink:to="ifrs-full_AdjustmentsForDepreciationExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for depreciation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation of property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets" xlink:label="aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets" xlink:to="aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for depreciation expense for right-of-use assets to reconcile profit (loss) to net cash flow from (used in) operating activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for depreciation expense, right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation of right-of-use assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:label="ifrs-full_AdjustmentsForFinanceIncomeCost" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:to="ifrs-full_AdjustmentsForFinanceIncomeCost_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForFinanceIncomeCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for finance income (cost)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AdjustmentsForFinanceIncomeCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finance (income)/expense, net</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForSharebasedPayments" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based compensation expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for increase (decrease) in employee benefit liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Change in net employee defined benefit liability</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForInterestExpense" xlink:label="ifrs-full_AdjustmentsForInterestExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForInterestExpense" xlink:to="ifrs-full_AdjustmentsForInterestExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForInterestExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for interest expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForInterestExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for gain (loss) on disposals, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">(Gain)/loss on sale of fixed assets</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ChangesInWorkingCapitalAbstract" xlink:label="aciu_ChangesInWorkingCapitalAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ChangesInWorkingCapitalAbstract" xlink:to="aciu_ChangesInWorkingCapitalAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ChangesInWorkingCapitalAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in working capital [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ChangesInWorkingCapitalAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in working capital:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for decrease (increase) in prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">(Increase)/decrease in prepaid expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for decrease (increase) in accrued income including contract assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">(Increase)/decrease in accrued income</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for decrease (increase) in trade accounts receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">(Increase)/decrease in accounts receivable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for decrease (increase) in other operating receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">(Increase)/decrease in other current receivables</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses" xlink:label="aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses" xlink:to="aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for increase (decrease) in accrued expenses to reconcile profit (loss) to net cash flow from (used in) operating activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for increase (decrease) in accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">(Decrease)/increase in accrued expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for increase (decrease) in deferred income including contract liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">(Decrease)/increase in deferred income</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for increase (decrease) in trade accounts payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">(Decrease)/increase in trade and other payables</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperations" xlink:label="ifrs-full_CashFlowsFromUsedInOperations" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperations" xlink:to="ifrs-full_CashFlowsFromUsedInOperations_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows from (used in) operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash used in operating activities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:label="ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:to="ifrs-full_InterestReceivedClassifiedAsOperatingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestReceivedClassifiedAsOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest received, classified as operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestReceivedClassifiedAsOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest received</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:label="ifrs-full_InterestPaidClassifiedAsOperatingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:to="ifrs-full_InterestPaidClassifiedAsOperatingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestPaidClassifiedAsOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest paid, classified as operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_InterestPaidClassifiedAsOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest paid</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities" xlink:label="ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities" xlink:to="ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finance costs paid, classified as operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finance expenses paid</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows from (used in) operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net cash flows used in operating activities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows from (used in) investing activities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Investing activities</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities" xlink:label="aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities" xlink:to="aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments (proceeds) from purchases (sales) of short-term financial assets, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments (proceeds) from purchases (sales) of short-term financial assets, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term financial assets, net</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Purchase of property, plant and equipment, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Purchases of property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CashAdvancesForRentDeposit" xlink:label="aciu_CashAdvancesForRentDeposit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CashAdvancesForRentDeposit" xlink:to="aciu_CashAdvancesForRentDeposit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CashAdvancesForRentDeposit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The cash outflow or inflow for deposit of rent.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CashAdvancesForRentDeposit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash Advances for Rent Deposit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aciu_CashAdvancesForRentDeposit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Rental deposits</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows from (used in) investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net cash flows provided by/(used in) investing activities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows from (used in) financing activities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financing activities</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ProceedsFromIssueOfConvertibleDebt" xlink:label="aciu_ProceedsFromIssueOfConvertibleDebt" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ProceedsFromIssueOfConvertibleDebt" xlink:to="aciu_ProceedsFromIssueOfConvertibleDebt_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ProceedsFromIssueOfConvertibleDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The cash inflow from the issuing of convertible debt.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ProceedsFromIssueOfConvertibleDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issue of convertible debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ProceedsFromIssueOfConvertibleDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issuance of convertible loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_ProceedsFromIssueOfConvertibleDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net proceeds</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="ifrs-full_PaymentsForShareIssueCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsForShareIssueCosts" xlink:to="ifrs-full_PaymentsForShareIssueCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsForShareIssueCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments for share issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PaymentsForShareIssueCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transaction costs on issuance of shares</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ProceedsFromIssuanceOfPublicOfferingsOfCommonSharesNetOfUnderwritingFeesAndTransactionCosts" xlink:label="aciu_ProceedsFromIssuanceOfPublicOfferingsOfCommonSharesNetOfUnderwritingFeesAndTransactionCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ProceedsFromIssuanceOfPublicOfferingsOfCommonSharesNetOfUnderwritingFeesAndTransactionCosts" xlink:to="aciu_ProceedsFromIssuanceOfPublicOfferingsOfCommonSharesNetOfUnderwritingFeesAndTransactionCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ProceedsFromIssuanceOfPublicOfferingsOfCommonSharesNetOfUnderwritingFeesAndTransactionCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of cash inflow from issuance of public offerings of common shares net of underwriting fees.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ProceedsFromIssuanceOfPublicOfferingsOfCommonSharesNetOfUnderwritingFeesAndTransactionCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Issuance of public Offerings of Common Shares, Net of Underwriting Fees and Transaction Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ProceedsFromIssuanceOfPublicOfferingsOfCommonSharesNetOfUnderwritingFeesAndTransactionCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from public offerings of common shares, net of underwriting fees and transaction costs</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts" xlink:label="aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts" xlink:to="aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions" xlink:label="aciu_ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions" xlink:to="aciu_ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issuance of common shares in connection to asset acquisitions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issuance of common shares in connection to asset acquisitions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issuance of common shares - asset acquisition, net of transaction costs</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromExerciseOfOptions" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issuance of common shares - equity plan, net of transaction costs</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments of lease liabilities, classified as financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Principal payments of lease obligations</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions" xlink:label="aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions" xlink:to="aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments for share issue costs associated with issuance of shares in relation to asset acquisitions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments for share issue costs associated with issuance of shares in relation to asset acquisitions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transaction costs associated with issuance of shares in relation to asset acquisition previously recorded in Accrued expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash flows from (used in) financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net cash flows (used in)/provided by financing activities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in cash and cash equivalents before effect of exchange rate changes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net increase/(decrease) in cash and cash equivalents</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effect of exchange rate changes on cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exchange gain/(loss) on cash and cash equivalents</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SupplementalNonCashActivityAbstract" xlink:label="aciu_SupplementalNonCashActivityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_SupplementalNonCashActivityAbstract" xlink:to="aciu_SupplementalNonCashActivityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_SupplementalNonCashActivityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Supplemental non-cash activity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_SupplementalNonCashActivityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Supplemental non-cash activity</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities" xlink:label="aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities" xlink:to="aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of property plant and equipment acquired through noncash investing activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Purchase of property, plant and equipment, classified as noncash investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital expenditures in Trade and other payables or Accrued expenses</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition" xlink:label="aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition" xlink:to="aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The Issuance of shares for purchase of IPR&amp;D asset in asset acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of shares for purchase of IPR&amp;D asset in asset acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of shares for purchase of IPR&amp;D asset in asset acquisition</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="ifrs-full_ShareIssueRelatedCost" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareIssueRelatedCost" xlink:to="ifrs-full_ShareIssueRelatedCost_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShareIssueRelatedCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share issue related cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShareIssueRelatedCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ShareIssueRelatedCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transaction costs associated with issuance of shares in relation to the asset acquisition recorded in Accrued expenses</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RepaymentOfConvertibleDebtEquitySettlementAmount" xlink:label="aciu_RepaymentOfConvertibleDebtEquitySettlementAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RepaymentOfConvertibleDebtEquitySettlementAmount" xlink:to="aciu_RepaymentOfConvertibleDebtEquitySettlementAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_RepaymentOfConvertibleDebtEquitySettlementAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The gross value of the settlement of convertible debt that is settled via shares of entity's common shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RepaymentOfConvertibleDebtEquitySettlementAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Repayment of convertible debt, Equity Settlement, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_RepaymentOfConvertibleDebtEquitySettlementAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Settlement of convertible notes recorded within Shareholders' equity</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TransactionCostAndStampDutyAssociatedWithPublicOfferingsOfCommonSharesRecordedInAccruedExpenses" xlink:label="aciu_TransactionCostAndStampDutyAssociatedWithPublicOfferingsOfCommonSharesRecordedInAccruedExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_TransactionCostAndStampDutyAssociatedWithPublicOfferingsOfCommonSharesRecordedInAccruedExpenses" xlink:to="aciu_TransactionCostAndStampDutyAssociatedWithPublicOfferingsOfCommonSharesRecordedInAccruedExpenses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_TransactionCostAndStampDutyAssociatedWithPublicOfferingsOfCommonSharesRecordedInAccruedExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of transaction cost and stamp duty associated with public offerings of common shares recorded in accrued expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_TransactionCostAndStampDutyAssociatedWithPublicOfferingsOfCommonSharesRecordedInAccruedExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transaction Cost and Stamp Duty Associated with Public offerings of Common Shares Recorded in Accrued Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_TransactionCostAndStampDutyAssociatedWithPublicOfferingsOfCommonSharesRecordedInAccruedExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transaction costs and stamp duty associated with the public offerings of common shares recorded in Accrued expenses</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses" xlink:label="aciu_TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses" xlink:to="aciu_TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transaction costs associated with the sale of treasury shares in public offering recorded in Accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transaction costs associated with the sale of treasury shares in public offering recorded in Accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transaction costs associated with the sale of treasury shares in public offering recorded in Accrued expenses</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_GeneralInformationAbstract" xlink:label="aciu_GeneralInformationAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_GeneralInformationAbstract" xlink:to="aciu_GeneralInformationAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_GeneralInformationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General information</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock" xlink:label="aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock" xlink:to="aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The entire disclosure for general information about the entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of general information about the entity explanatory [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General information</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_BasisOfPreparationAbstract" xlink:label="aciu_BasisOfPreparationAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_BasisOfPreparationAbstract" xlink:to="aciu_BasisOfPreparationAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_BasisOfPreparationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basis of preparation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:to="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of basis of preparation of financial statements [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basis of preparation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:label="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of material accounting policies</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:label="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:to="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of material accounting policy information [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of material accounting policies</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment.</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of property, plant and equipment [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_PresentationOfLeasesForLesseeAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use assets, long-term financial assets and lease liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfLeasesExplanatory" xlink:to="ifrs-full_DisclosureOfLeasesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of leases [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use assets, long-term financial assets and lease liabilities</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AssetAcquisitionsAbstract" xlink:label="aciu_AssetAcquisitionsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AssetAcquisitionsAbstract" xlink:to="aciu_AssetAcquisitionsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AssetAcquisitionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Asset acquisitions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AssetAcquisitionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Asset acquisition</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfAssetAcquisitionsTextBlock" xlink:label="aciu_DisclosureOfAssetAcquisitionsTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfAssetAcquisitionsTextBlock" xlink:to="aciu_DisclosureOfAssetAcquisitionsTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfAssetAcquisitionsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The entire disclosure for asset acquisitions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfAssetAcquisitionsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of asset acquisitions [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfAssetAcquisitionsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Asset acquisition</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of intangible assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:label="ifrs-full_DisclosureOfFinancialAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:to="ifrs-full_DisclosureOfFinancialAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents and financial assets</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock" xlink:label="aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock" xlink:to="aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of cash and cash equivalents and short-term deposits not classified as cash equivalents.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of cash and cash equivalents and short-term deposits not classified as cash equivalents [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents and short-term financial assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract" xlink:label="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract" xlink:to="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid expenses and accrued income</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock" xlink:label="aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock" xlink:to="aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of prepaid expenses and accrued income including contract assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of prepaid expenses and accrued income including contract assets [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid expenses and accrued income</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="ifrs-full_TradeAndOtherReceivablesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other current receivables [abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfAccountsReceivableTableTextBlock" xlink:label="aciu_DisclosureOfAccountsReceivableTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfAccountsReceivableTableTextBlock" xlink:to="aciu_DisclosureOfAccountsReceivableTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfAccountsReceivableTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of accounts receivable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfAccountsReceivableTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of accounts receivable [table text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfAccountsReceivableTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts receivable</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_OtherCurrentReceivablesAbstract" xlink:label="aciu_OtherCurrentReceivablesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_OtherCurrentReceivablesAbstract" xlink:to="aciu_OtherCurrentReceivablesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_OtherCurrentReceivablesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other current receivables [Abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfOtherCurrentReceivablesTextBlock" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfOtherCurrentReceivablesTextBlock" xlink:to="aciu_DisclosureOfOtherCurrentReceivablesTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of other current receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of other current receivables [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other current receivables</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share capital</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of share capital, reserves and other equity interest [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share capital</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued expenses</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock" xlink:label="aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock" xlink:to="aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of trade and other payables and accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of trade and other payables and accrued expenses [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade and other payables and accrued expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRevenueExplanatory" xlink:label="ifrs-full_DisclosureOfRevenueExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRevenueExplanatory" xlink:to="ifrs-full_DisclosureOfRevenueExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRevenueExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of revenue [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfRevenueExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contract revenues</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ExpensesByCategoryAbstract" xlink:label="aciu_ExpensesByCategoryAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ExpensesByCategoryAbstract" xlink:to="aciu_ExpensesByCategoryAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ExpensesByCategoryAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expenses by category [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfExpensesExplanatory" xlink:label="ifrs-full_DisclosureOfExpensesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfExpensesExplanatory" xlink:to="ifrs-full_DisclosureOfExpensesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfExpensesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of expenses [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfExpensesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expenses by category</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related-party transactions [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of related party [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Related-party transactions</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income taxes [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income taxes</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income taxes</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDefinedBenefitPlansAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retirement benefit plan</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:label="ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:to="ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of defined benefit plans [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retirement benefit plan</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based compensation [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:to="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of share-based payment arrangements [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based compensation</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CommitmentsAndContingenciesAbstract" xlink:label="aciu_CommitmentsAndContingenciesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CommitmentsAndContingenciesAbstract" xlink:to="aciu_CommitmentsAndContingenciesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CommitmentsAndContingenciesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and contingencies [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:label="ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:to="ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of commitments and contingent liabilities [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and contingencies</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of earnings per share [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings per share</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial instruments and risk management [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of financial risk management [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial instruments and risk management</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract" xlink:label="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract" xlink:to="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital risk management [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory" xlink:label="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory" xlink:to="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of objectives, policies and processes for managing capital [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital risk management</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:to="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsequent events</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of events after reporting period [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Subsequent events</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for functional currency [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Functional and reporting currency</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfBasisOfConsolidationExplanatory" xlink:label="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory" xlink:to="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basis of consolidation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for foreign currency translation [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign currency transactions</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock" xlink:label="aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock" xlink:to="aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The description of the entity's accounting policy for the basis for how the entity classifies assets and liabilities as current and non-current.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for classification of assets and liabilities [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current vs. non-current classification</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for recognition of revenue [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue recognition</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for research and development expense [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and development expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General and administrative expenses</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_GrantIncomePolicyTextBlock" xlink:label="aciu_GrantIncomePolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_GrantIncomePolicyTextBlock" xlink:to="aciu_GrantIncomePolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_GrantIncomePolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The description of the entity's accounting policy for grant income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_GrantIncomePolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Grant income [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_GrantIncomePolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Grant income</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leases</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for property, plant and equipment [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for intangible assets other than goodwill [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for fair value measurement [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair value of financial assets and liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for issued capital [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share capital and public offerings</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for treasury shares [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Treasury Shares</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for employee benefits [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employee benefits</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for provisions [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Provisions</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for income tax [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Taxation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for earnings per share [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings per share</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock" xlink:label="aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock" xlink:to="aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The description of the entity's accounting policy for judgments that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognized in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for accounting judgments and estimates [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Critical judgments and accounting estimates</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Description of accounting policy for segment reporting [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Segment reporting</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock" xlink:label="aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock" xlink:to="aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The description of the entity's accounting policy for changes to accounting policies recently adopted by the entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure Of Accounting Policy For Changes In Accounting Policies Recently Adopted [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounting policies, new standards, interpretations and amendments adopted by the Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory" xlink:label="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory" xlink:to="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of effect of changes in foreign exchange rates [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of exchange rates used for translation of financial statements</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock" xlink:label="aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock" xlink:to="aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of detailed information about the estimated lease term by right-of-use asset by category.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of information about contract lease term by right-of-use asset categories [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimated Lease Term by Right-of-use Asset Categories</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:label="aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:to="aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of detailed information about the useful life of property, plant and equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of information about property, plant and equipment useful life [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimated useful life</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about property, plant and equipment [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of movement in the net book values of property, plant and equipment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of quantitative information about right-of-use assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of the movements in the net value book value of right-of-use assets</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock" xlink:label="aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock" xlink:to="aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of right-of-use assets impact on the company's statements of income/(loss) and statements of cash flows.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of right-of-use assets impact on statements [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of impact on condensed consolidated statements of income/(loss) and cash flows</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock" xlink:label="aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock" xlink:to="aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tabular disclosure of information related to the contractual undiscounted cash flows.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of contractual undiscounted cash flows [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of contractual undiscounted cash flows for lease obligations</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfAssetAcquisitionsTableTextBlock" xlink:label="aciu_DisclosureOfAssetAcquisitionsTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfAssetAcquisitionsTableTextBlock" xlink:to="aciu_DisclosureOfAssetAcquisitionsTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfAssetAcquisitionsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tabular disclosure of asset acquisitions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfAssetAcquisitionsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of asset acquisitions [table text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfAssetAcquisitionsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Transferred Assets acquired</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about intangible assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of net book value of intangible assets</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock" xlink:label="aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock" xlink:to="aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of cash and cash equivalents by currency</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of cash and cash equivalents by currency [table text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of cash and cash equivalents by currency</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock" xlink:label="aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock" xlink:to="aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of short-term deposits not classified as cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of short-term deposits not classified as cash equivalents [table text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of short-term financial assets</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock" xlink:to="aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about prepaid expenses and accrued income including contract assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about prepaid expenses and accrued income including contract assets [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid expenses and accrued income</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock" xlink:to="aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of detailed information about other current receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about other current receivables [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other current receivables</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of classes of share capital [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of capital structure</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AccruedExpensesAbstract" xlink:label="aciu_AccruedExpensesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AccruedExpensesAbstract" xlink:to="aciu_AccruedExpensesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AccruedExpensesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AccruedExpensesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade and other payables and accrued expenses</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock" xlink:to="aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of detailed information about trade payables and accrued liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about trade payables and accrued liabilities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of trade and other payables and accrued expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:label="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:to="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of revenue from contracts with customers [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of contract revenues</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory" xlink:label="ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory" xlink:to="ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Explanation of effect that timing of satisfaction of performance obligations and typical timing of payment have on contract assets and contract liabilities [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of contract revenue of performance obligations satisfied</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" xlink:label="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of research and development expense [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and Development</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:label="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of general and administrative expense [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General and Administrative</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of finance income (cost) [text block]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:label="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:to="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of information about key management personnel [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Key management compensation</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock" xlink:to="aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of detailed information about income tax reconciliation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about income tax reconciliation [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income tax expense reconciled to loss</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of temporary difference, unused tax losses and unused tax credits [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecognized deductible temporary differences, unused tax losses and unused tax credits</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock" xlink:to="aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of detailed information about the expiration of income tax losses that may be carried forward.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about income tax losses expiry [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax losses carry forwards and respective expiry dates</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock" xlink:label="aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock" xlink:to="aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of amounts recognised in balance sheet from defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of amounts recognised in balance sheet from defined benefit plans [table text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of amounts recognized in balance sheet from defined benefit plans</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock" xlink:label="aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock" xlink:to="aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of amounts recognised in statement of profit and loss from defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of amounts recognised in statement of profit and loss from defined benefit plans [table text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of amounts recognized in statement of profit and loss from defined benefit plans</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" xlink:to="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of net defined benefit liability (asset) [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of changes in defined benefit obligations, fair value of plan assets and net defined benefit liability</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock" xlink:label="aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock" xlink:to="aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of amounts recognised in statement of other comprehensive income from defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of amounts recognised in statement of other comprehensive income from defined benefit plans [table text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of amounts recognized in statement of other comprehensive income from defined benefit plans</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:to="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of sensitivity analysis for actuarial assumptions [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumptions and sensitivity analysis</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of terms and conditions of share-based payment arrangement [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based compensation plans outstanding</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of number and weighted average exercise prices of share options [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number and weighted average exercise prices of options under share option programs</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of number and weighted average remaining contractual life of outstanding share options [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding options, exercise price range and expiry dates</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted-average assumptions</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of number and weighted average exercise prices of other equity instruments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of non-vested share awards (restricted share and restricted share units)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:to="ifrs-full_DisclosureOfCommitmentsExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of commitments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of commitments</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EarningsPerShareExplanatory" xlink:label="ifrs-full_EarningsPerShareExplanatory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EarningsPerShareExplanatory" xlink:to="ifrs-full_EarningsPerShareExplanatory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EarningsPerShareExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings per share [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EarningsPerShareExplanatory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of earnings per share</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023" xlink:label="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023" xlink:to="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of antidilutive securities</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock" xlink:to="aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The disclosure of detailed information about carrying amounts of financial assets and financial liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about carrying amounts of financial assets and financial liabilities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Carrying amounts of financial assets and financial liabilities</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfTechnologyPlatforms" xlink:label="aciu_NumberOfTechnologyPlatforms" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfTechnologyPlatforms" xlink:to="aciu_NumberOfTechnologyPlatforms_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfTechnologyPlatforms_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of unique proprietary platform technologies to discover, design and develop medicines and diagnostics to target misfolded proteins.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfTechnologyPlatforms_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of technology platforms</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_NumberOfTechnologyPlatforms_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of proprietary technology platforms</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_GoingConcernAbstract" xlink:label="aciu_GoingConcernAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_GoingConcernAbstract" xlink:to="aciu_GoingConcernAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_GoingConcernAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Going Concern [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_GoingConcernAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Going concern</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ForeignExchangeRatesAbstract" xlink:label="ifrs-full_ForeignExchangeRatesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ForeignExchangeRatesAbstract" xlink:to="ifrs-full_ForeignExchangeRatesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ForeignExchangeRatesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Functional and reporting currency</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="ifrs-full_ClosingForeignExchangeRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClosingForeignExchangeRate" xlink:to="ifrs-full_ClosingForeignExchangeRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClosingForeignExchangeRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Closing rate, USD 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ClosingForeignExchangeRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Translation rate into CHF</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AverageForeignExchangeRate" xlink:label="ifrs-full_AverageForeignExchangeRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AverageForeignExchangeRate" xlink:to="ifrs-full_AverageForeignExchangeRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AverageForeignExchangeRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average exchange rate, USD 1</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of quantitative information about right-of-use assets [table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Classes of property, plant and equipment [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment [member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BuildingsMember" xlink:label="ifrs-full_BuildingsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BuildingsMember" xlink:to="ifrs-full_BuildingsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BuildingsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Buildings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BuildingsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Buildings</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="ifrs-full_OfficeEquipmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OfficeEquipmentMember" xlink:to="ifrs-full_OfficeEquipmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OfficeEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Office Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OfficeEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Office Equipment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="ifrs-full_ComputerEquipmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComputerEquipmentMember" xlink:to="ifrs-full_ComputerEquipmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComputerEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IT Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ComputerEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IT Equipment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of quantitative information about right-of-use assets [line items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of quantitative information about leases for lessee [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use assets and lease liabilities:</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_EstimatedLeaseTerm" xlink:label="aciu_EstimatedLeaseTerm" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_EstimatedLeaseTerm" xlink:to="aciu_EstimatedLeaseTerm_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_EstimatedLeaseTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The estimated lease term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_EstimatedLeaseTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimated lease term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_EstimatedLeaseTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimated lease term</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about property, plant and equipment [table]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_LaboratoryEquipmentMember" xlink:label="aciu_LaboratoryEquipmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_LaboratoryEquipmentMember" xlink:to="aciu_LaboratoryEquipmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_LaboratoryEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for a class of property, plant and equipment representing laboratory equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_LaboratoryEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Laboratory equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_LaboratoryEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lab Equipment</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_LeaseholdImprovementsAndFixturesAndFittingsMember" xlink:label="aciu_LeaseholdImprovementsAndFixturesAndFittingsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_LeaseholdImprovementsAndFixturesAndFittingsMember" xlink:to="aciu_LeaseholdImprovementsAndFixturesAndFittingsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_LeaseholdImprovementsAndFixturesAndFittingsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement and fixtures and fittings that are not permanently attached to real property.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_LeaseholdImprovementsAndFixturesAndFittingsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leasehold improvements and fixtures and fittings [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_LeaseholdImprovementsAndFixturesAndFittingsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leasehold Improvements/Furniture</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about property, plant and equipment [line items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract" xlink:label="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract" xlink:to="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property plant and equipment estimated useful life [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimated useful life</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Useful life measured as period of time, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimated useful life</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncomeTaxLossCarryforwardPeriod" xlink:label="aciu_IncomeTaxLossCarryforwardPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncomeTaxLossCarryforwardPeriod" xlink:to="aciu_IncomeTaxLossCarryforwardPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncomeTaxLossCarryforwardPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The period or time limit over which financial losses of the entity for preceding years can be deducted from the taxable revenue for a period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncomeTaxLossCarryforwardPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income tax loss, Carryforward period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_IncomeTaxLossCarryforwardPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax loss carryforward period</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxAssets" xlink:label="ifrs-full_DeferredTaxAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxAssets" xlink:to="ifrs-full_DeferredTaxAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred tax assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of operating segments [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Segment reporting</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_OperatingSegmentsNumber" xlink:label="aciu_OperatingSegmentsNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_OperatingSegmentsNumber" xlink:to="aciu_OperatingSegmentsNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_OperatingSegmentsNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of operating segments reported by the entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_OperatingSegmentsNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating segments, number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_OperatingSegmentsNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of operating segments</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ReportableSegmentsNumber" xlink:label="aciu_ReportableSegmentsNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ReportableSegmentsNumber" xlink:to="aciu_ReportableSegmentsNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ReportableSegmentsNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of reportable segments reported by the entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ReportableSegmentsNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reportable segments, number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ReportableSegmentsNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of reportable segments</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="ifrs-full_FixturesAndFittingsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FixturesAndFittingsMember" xlink:to="ifrs-full_FixturesAndFittingsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FixturesAndFittingsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Furniture</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="ifrs-full_LeaseholdImprovementsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseholdImprovementsMember" xlink:to="ifrs-full_LeaseholdImprovementsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseholdImprovementsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Leasehold Improvements</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="ifrs-full_ConstructionInProgressMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ConstructionInProgressMember" xlink:to="ifrs-full_ConstructionInProgressMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ConstructionInProgressMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Construction in progress [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ConstructionInProgressMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets under construction</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ItAndLaboratoryEquipmentMember" xlink:label="aciu_ItAndLaboratoryEquipmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ItAndLaboratoryEquipmentMember" xlink:to="aciu_ItAndLaboratoryEquipmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ItAndLaboratoryEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for IT and laboratory equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ItAndLaboratoryEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IT and laboratory equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_ItAndLaboratoryEquipmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Laboratory and IT equipment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Carrying amount, accumulated depreciation, amortization and impairment and gross carrying amount [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="ifrs-full_CarryingAmountMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_CarryingAmountMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CarryingAmountMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Carrying amount [member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="ifrs-full_GrossCarryingAmountMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossCarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GrossCarryingAmountMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross carrying amount [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GrossCarryingAmountMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross Carrying Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_GrossCarryingAmountMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Acquisition Cost</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated depreciation and amortisation [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Amortization</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:label="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reconciliation of changes in property, plant and equipment [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, plant and equipment:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additions other than through business combinations, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additions</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) through transfers from construction in progress, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transfers</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:to="ifrs-full_DisposalsPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disposals, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disposals</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PercentageIncreaseInPropertyPlantAndEquipment" xlink:label="aciu_PercentageIncreaseInPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PercentageIncreaseInPropertyPlantAndEquipment" xlink:to="aciu_PercentageIncreaseInPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PercentageIncreaseInPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The percentage of increase in property, plant and equipment during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PercentageIncreaseInPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage increase in property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_PercentageIncreaseInPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of increase in equipment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ifrs-full_ClassesOfAssetsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfAssetsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Classes of assets [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="ifrs-full_ClassesOfAssetsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfAssetsMember" xlink:to="ifrs-full_ClassesOfAssetsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets [member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="ifrs-full_AdditionsToRightofuseAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsToRightofuseAssets" xlink:to="ifrs-full_AdditionsToRightofuseAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsToRightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additions and reassessment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:label="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:to="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average lessee's incremental borrowing rate applied to lease liabilities recognised at date of initial application of IFRS 16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average incremental borrowing rate</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RightOfUseLeasedAssetsAbstract" xlink:label="aciu_RightOfUseLeasedAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RightOfUseLeasedAssetsAbstract" xlink:to="aciu_RightOfUseLeasedAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RightOfUseLeasedAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use leased assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_RightOfUseLeasedAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use of leased assets:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="ifrs-full_DepreciationRightofuseAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationRightofuseAssets" xlink:to="ifrs-full_DepreciationRightofuseAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationRightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation, right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DepreciationRightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DepreciationRightofuseAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation of right-of-use assets</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract" xlink:label="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract" xlink:to="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Impact on statements of income/(loss) and cash flows [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statements of income/(loss) and cash flows</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest expense on lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest expense on lease liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:to="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expense relating to short-term leases for which recognition exemption has been used</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expense for short-term leases and leases of low value</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ExpenseRelatingToLeases" xlink:label="aciu_ExpenseRelatingToLeases" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ExpenseRelatingToLeases" xlink:to="aciu_ExpenseRelatingToLeases_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ExpenseRelatingToLeases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The expense for leases recognized through profit and loss.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ExpenseRelatingToLeases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expense relating to leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="aciu_ExpenseRelatingToLeases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashOutflowForLeases" xlink:label="ifrs-full_CashOutflowForLeases" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashOutflowForLeases" xlink:to="ifrs-full_CashOutflowForLeases_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashOutflowForLeases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash outflow for leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashOutflowForLeases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total cash outflow for leases</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of maturity analysis of operating lease payments [table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MaturityAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maturity [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="ifrs-full_AggregatedTimeBandsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AggregatedTimeBandsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Aggregated time bands [member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="ifrs-full_NotLaterThanOneYearMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotLaterThanOneYearMember" xlink:to="ifrs-full_NotLaterThanOneYearMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NotLaterThanOneYearMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Less than one year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NotLaterThanOneYearMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Within 1 Year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NotLaterThanOneYearMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2019 [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">1-3 years</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:to="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">3-5 years</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of maturity analysis of operating lease payments [line items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" xlink:label="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" xlink:to="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contractual undiscounted cash flows for lease liabilities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contractual undiscounted cash flows for lease liabilities:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossLeaseLiabilities" xlink:label="ifrs-full_GrossLeaseLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossLeaseLiabilities" xlink:to="ifrs-full_GrossLeaseLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GrossLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GrossLeaseLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contractual undiscounted cash flows for lease obligations</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfDepositsInEscrowAccounts" xlink:label="aciu_NumberOfDepositsInEscrowAccounts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfDepositsInEscrowAccounts" xlink:to="aciu_NumberOfDepositsInEscrowAccounts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfDepositsInEscrowAccounts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of deposits in escrow accounts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfDepositsInEscrowAccounts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of deposits in escrow accounts</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_EscrowDepositAmount" xlink:label="aciu_EscrowDepositAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_EscrowDepositAmount" xlink:to="aciu_EscrowDepositAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_EscrowDepositAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of deposits held in escrow.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_EscrowDepositAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Escrow deposit, amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_EscrowDepositAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Escrow deposits</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about intangible assets [table]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AssetAcquisitionsAxis" xlink:label="aciu_AssetAcquisitionsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AssetAcquisitionsAxis" xlink:to="aciu_AssetAcquisitionsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AssetAcquisitionsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AssetAcquisitionsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Asset acquisitions [axis]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SignificantAssetAcquisitionsTotalDomain" xlink:label="aciu_SignificantAssetAcquisitionsTotalDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_SignificantAssetAcquisitionsTotalDomain" xlink:to="aciu_SignificantAssetAcquisitionsTotalDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_SignificantAssetAcquisitionsTotalDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Significant asset acquisitions, total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_SignificantAssetAcquisitionsTotalDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Significant asset acquisitions, total [Domain]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember" xlink:label="aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember" xlink:to="aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents the acquisition of the program portfolio of therapeutics targeting a-syn from Affiris</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Program portfolio of therapeutics targeting asyn from Affiris [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Program portfolio of therapeutics targeting asyn from Affiris</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Classes of intangible assets other than goodwill [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets other than goodwill [member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member" xlink:label="aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member" xlink:to="aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents the IPR&amp;D intangible asset associated with ACI 7104.056</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IPR&amp;D intangible asset associated with ACI 7104.056 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IPR&amp;D intangible asset associated with ACI 7104.056</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnobservableInputsAxis" xlink:label="ifrs-full_UnobservableInputsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnobservableInputsAxis" xlink:to="ifrs-full_UnobservableInputsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UnobservableInputsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unobservable inputs [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnobservableInputsMember" xlink:label="ifrs-full_UnobservableInputsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnobservableInputsMember" xlink:to="ifrs-full_UnobservableInputsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UnobservableInputsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unobservable inputs [member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DiscountRateMeasurementInputMember" xlink:label="ifrs-full_DiscountRateMeasurementInputMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DiscountRateMeasurementInputMember" xlink:to="ifrs-full_DiscountRateMeasurementInputMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DiscountRateMeasurementInputMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Discount rate, measurement input [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DiscountRateMeasurementInputMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Discount rate, measurement input</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about intangible assets [line items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SharesTransferredAsConsiderationInAssetAcquisition" xlink:label="aciu_SharesTransferredAsConsiderationInAssetAcquisition" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_SharesTransferredAsConsiderationInAssetAcquisition" xlink:to="aciu_SharesTransferredAsConsiderationInAssetAcquisition_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_SharesTransferredAsConsiderationInAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares transferred as consideration in asset acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_SharesTransferredAsConsiderationInAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares transferred as consideration in asset acquisition</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition" xlink:label="aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition" xlink:to="aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total consideration transferred, acquisition-date fair value, asset acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total consideration transferred, acquisition-date fair value, asset acquisition</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantUnobservableInputAssets" xlink:label="ifrs-full_SignificantUnobservableInputAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SignificantUnobservableInputAssets" xlink:to="ifrs-full_SignificantUnobservableInputAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SignificantUnobservableInputAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Significant unobservable input, assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SignificantUnobservableInputAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Discount rate</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CashAcquiredAsPartOfAssetAcquisition" xlink:label="aciu_CashAcquiredAsPartOfAssetAcquisition" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CashAcquiredAsPartOfAssetAcquisition" xlink:to="aciu_CashAcquiredAsPartOfAssetAcquisition_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CashAcquiredAsPartOfAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash acquired as part of asset acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CashAcquiredAsPartOfAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash acquired as part of asset acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CashAcquiredAsPartOfAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition" xlink:label="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition" xlink:to="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets acquired as part of asset acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible assets acquired as part of asset acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IPR&amp;D asset</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TotalAssetsAcquiredInAssetAcquisition" xlink:label="aciu_TotalAssetsAcquiredInAssetAcquisition" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_TotalAssetsAcquiredInAssetAcquisition" xlink:to="aciu_TotalAssetsAcquiredInAssetAcquisition_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_TotalAssetsAcquiredInAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total assets acquired in asset acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_TotalAssetsAcquiredInAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total assets acquired in asset acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="aciu_TotalAssetsAcquiredInAssetAcquisition_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total assets acquired</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_InProcessResearchAndDevelopmentIPRDAssetMember" xlink:label="aciu_InProcessResearchAndDevelopmentIPRDAssetMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_InProcessResearchAndDevelopmentIPRDAssetMember" xlink:to="aciu_InProcessResearchAndDevelopmentIPRDAssetMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_InProcessResearchAndDevelopmentIPRDAssetMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for an intangible asset that is a clinically-validated active vaccine candidate for the treatment of Parkinson's disease.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_InProcessResearchAndDevelopmentIPRDAssetMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Acquired IPR&amp;D Asset</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of intangible assets material to entity [abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CashAndCashEquivalentsTable" xlink:label="aciu_CashAndCashEquivalentsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CashAndCashEquivalentsTable" xlink:to="aciu_CashAndCashEquivalentsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CashAndCashEquivalentsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of cash and cash equivalent balances, including foreign currencies in which the balances are denominated.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CashAndCashEquivalentsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CurrencyAxis" xlink:to="srt_CurrencyAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CurrencyAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Currency [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="currency_AllCurrenciesDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_AllCurrenciesDomain" xlink:to="currency_AllCurrenciesDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_AllCurrenciesDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">All Currencies [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_CHF" xlink:label="currency_CHF" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_CHF" xlink:to="currency_CHF_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_CHF_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Switzerland, Francs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="currency_CHF_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CHF [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_EUR" xlink:label="currency_EUR" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_EUR" xlink:to="currency_EUR_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_EUR_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Euro Member Countries, Euro</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="currency_EUR_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">EUR [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_USD" xlink:label="currency_USD" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_USD" xlink:to="currency_USD_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_USD_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">United States of America, Dollars</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="currency_USD_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">USD [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CashAndCashEquivalentLineItems" xlink:label="aciu_CashAndCashEquivalentLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CashAndCashEquivalentLineItems" xlink:to="aciu_CashAndCashEquivalentLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CashAndCashEquivalentLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CashAndCashEquivalentLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalent [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAbstract" xlink:label="ifrs-full_CashAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAbstract" xlink:to="ifrs-full_CashAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MiscellaneousCurrentAssetsAbstract" xlink:label="ifrs-full_MiscellaneousCurrentAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MiscellaneousCurrentAssetsAbstract" xlink:to="ifrs-full_MiscellaneousCurrentAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MiscellaneousCurrentAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Miscellaneous current assets [abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract" xlink:label="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract" xlink:to="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid expenses and accrued income, Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid expenses and accrued income [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets" xlink:label="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets" xlink:to="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current prepayments and current accrued income including current contract assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total prepaid expenses and accrued income</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="ifrs-full_DisclosureOfFinancialAssetsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialAssetsTable" xlink:to="ifrs-full_DisclosureOfFinancialAssetsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialAssetsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of financial assets [table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesAxis" xlink:label="ifrs-full_CounterpartiesAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CounterpartiesAxis" xlink:to="ifrs-full_CounterpartiesAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CounterpartiesAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Counterparties [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesMember" xlink:label="ifrs-full_CounterpartiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CounterpartiesMember" xlink:to="ifrs-full_CounterpartiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CounterpartiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Counterparties [member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_JJInnovativeMedicineMember" xlink:label="aciu_JJInnovativeMedicineMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_JJInnovativeMedicineMember" xlink:to="aciu_JJInnovativeMedicineMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_JJInnovativeMedicineMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents J&amp;J Innovative Medicine</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_JJInnovativeMedicineMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">J&amp;J Innovative Medicine [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_JJInnovativeMedicineMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">J&amp;J Innovative Medicine</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:label="ifrs-full_DisclosureOfFinancialAssetsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="ifrs-full_DisclosureOfFinancialAssetsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialAssetsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of financial assets [line items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfOtherCurrentReceivablesTable" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfOtherCurrentReceivablesTable" xlink:to="aciu_DisclosureOfOtherCurrentReceivablesTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule disclosing information related to other current receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of other current receivables [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Range [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_RangesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ranges [member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TopOfRangeMember" xlink:to="ifrs-full_TopOfRangeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TopOfRangeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Top of Range [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TopOfRangeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Top of Range [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TopOfRangeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfOtherCurrentReceivablesLineItems" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfOtherCurrentReceivablesLineItems" xlink:to="aciu_DisclosureOfOtherCurrentReceivablesLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of other current receivables [Line Items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_MiscellaneousOtherCurrentReceivables" xlink:label="aciu_MiscellaneousOtherCurrentReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_MiscellaneousOtherCurrentReceivables" xlink:to="aciu_MiscellaneousOtherCurrentReceivables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_MiscellaneousOtherCurrentReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Miscellaneous other current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_MiscellaneousOtherCurrentReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Miscellaneous other current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_MiscellaneousOtherCurrentReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other current receivable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentValueAddedTaxReceivables" xlink:label="ifrs-full_CurrentValueAddedTaxReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentValueAddedTaxReceivables" xlink:to="ifrs-full_CurrentValueAddedTaxReceivables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentValueAddedTaxReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current value added tax receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentValueAddedTaxReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Swiss VAT</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WithholdingTaxReceivables" xlink:label="aciu_WithholdingTaxReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_WithholdingTaxReceivables" xlink:to="aciu_WithholdingTaxReceivables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_WithholdingTaxReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Withholding tax receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_WithholdingTaxReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Withholding tax receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_WithholdingTaxReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Withholding tax</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_MaturityPeriodOtherCurrentReceivables" xlink:label="aciu_MaturityPeriodOtherCurrentReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_MaturityPeriodOtherCurrentReceivables" xlink:to="aciu_MaturityPeriodOtherCurrentReceivables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_MaturityPeriodOtherCurrentReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maturity period, other current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_MaturityPeriodOtherCurrentReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maturity period, other current receivables</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of classes of share capital [table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Classes of share capital [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="ifrs-full_ClassesOfShareCapitalMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfShareCapitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share Capital [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ClassesOfShareCapitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share capital [member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OrdinarySharesMember" xlink:to="ifrs-full_OrdinarySharesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OrdinarySharesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ordinary shares [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OrdinarySharesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OrdinarySharesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Shares</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of classes of share capital [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share capital</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="ifrs-full_NumberOfSharesIssued" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares issued (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:to="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares in entity held by entity or by its subsidiaries or associates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Treasury shares outstanding at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Treasury shares outstanding at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of treasury shares outstanding</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xlink:label="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xlink:to="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reconciliation of number of shares outstanding [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common shares</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="ifrs-full_NumberOfSharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesOutstanding" xlink:to="ifrs-full_NumberOfSharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common shares outstanding at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NumberOfSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common shares outstanding at beginning of period</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" xlink:to="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase in the number of ordinary shares issued under a convertible debt arrangement upon conversion of the debt.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase in number of ordinary shares issued under conversion of convertible debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Conversion of note agreement, net of transaction costs (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares issued through conversion of convertible notes</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans" xlink:to="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase in the number of ordinary shares issued under incentive plans.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase in number of ordinary shares issued under incentive plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of shares - incentive plans, net of transaction costs (in shares)</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ProceedsFromPublicOfferingsNetOfUnderwritingFeesAndTransactionEquityShares" xlink:label="aciu_ProceedsFromPublicOfferingsNetOfUnderwritingFeesAndTransactionEquityShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ProceedsFromPublicOfferingsNetOfUnderwritingFeesAndTransactionEquityShares" xlink:to="aciu_ProceedsFromPublicOfferingsNetOfUnderwritingFeesAndTransactionEquityShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ProceedsFromPublicOfferingsNetOfUnderwritingFeesAndTransactionEquityShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from public offerings, net of underwriting fees and transaction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ProceedsFromPublicOfferingsNetOfUnderwritingFeesAndTransactionEquityShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from public offerings, net of underwriting fees and transaction, equity, shares</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" xlink:label="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" xlink:to="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase (decrease) in equity shares resulting from treasury share transactions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) through treasury share transactions, equity, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of shares to be held as treasury shares, net of transaction costs (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of shares to be held as treasury shares</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract" xlink:label="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract" xlink:to="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reconciliation of number of treasury shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reconciliation of number of treasury shares outstanding [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Treasury shares</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance" xlink:label="aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance" xlink:to="aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease in number of treasury shares from sales or issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease in number of treasury shares from sales or issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ChangesInEquityAbstract" xlink:label="ifrs-full_ChangesInEquityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ChangesInEquityAbstract" xlink:to="ifrs-full_ChangesInEquityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ChangesInEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in equity [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ChangesInEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in equity</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseThroughSharesIssuedUnderIncentivePlans" xlink:label="aciu_IncreaseThroughSharesIssuedUnderIncentivePlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseThroughSharesIssuedUnderIncentivePlans" xlink:to="aciu_IncreaseThroughSharesIssuedUnderIncentivePlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseThroughSharesIssuedUnderIncentivePlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The increase in equity resulting from the issue of shares under incentive plans.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseThroughSharesIssuedUnderIncentivePlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase through shares issued under incentive plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_IncreaseThroughSharesIssuedUnderIncentivePlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of shares - incentive plans, net of transaction costs</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParValuePerShare" xlink:to="ifrs-full_ParValuePerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ParValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Par value per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ParValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Nominal value per share (in CHF per share)</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue" xlink:label="aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue" xlink:to="aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional share capital that Board of Directors are authorized to issue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional share capital that Board of Directors are authorized to issue</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue" xlink:label="aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue" xlink:to="aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of additional shares that Board of Directors are authorized to issue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of additional shares that Board of Directors are authorized to issue</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember" xlink:label="aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember" xlink:to="aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for conditional share capital for financing and other purposes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Conditional share capital for financing and other purposes [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Conditional share capital for financing and other purposes</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ConditionalShareCapitalAbstract" xlink:label="aciu_ConditionalShareCapitalAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ConditionalShareCapitalAbstract" xlink:to="aciu_ConditionalShareCapitalAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ConditionalShareCapitalAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Conditional share capital [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ConditionalShareCapitalAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Conditional Share Capital [Abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments" xlink:label="aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments" xlink:to="aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Potential increase is equity through conversion of debt instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Potential increase is equity through conversion of debt instruments</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments" xlink:label="aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments" xlink:to="aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Potential number of shares issued from conversion of debt instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Potential number of shares issued from conversion of debt instruments</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember" xlink:label="aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember" xlink:to="aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for share capital of the conditional share capital for employee benefit plans.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Conditional share capital for employee benefit plans [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employee Benefit Plans [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions" xlink:label="aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions" xlink:to="aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The potential increase in equity from share-based payment transactions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Potential increase is equity through share-based payment transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum aggregate amount of ordinary shares</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions" xlink:label="aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions" xlink:to="aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The total number of potential shares issued through share-based payment transactions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Potential number of shares issued from share-based payment transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Issuance of ordinary shares (in shares)</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits" xlink:label="aciu_NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits" xlink:to="aciu_NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares issued upon exercise of options and restricted share units.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of Shares Issued Upon Exercise of Options and Restricted Share Units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares issued upon exercise of options and restricted share units</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_FollowOnOfferingMember" xlink:label="aciu_FollowOnOfferingMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_FollowOnOfferingMember" xlink:to="aciu_FollowOnOfferingMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_FollowOnOfferingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Follow on offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_FollowOnOfferingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Follow on Offering [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_FollowOnOfferingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Follow on Offering</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfSharesIssuedDuringPeriod" xlink:label="aciu_NumberOfSharesIssuedDuringPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfSharesIssuedDuringPeriod" xlink:to="aciu_NumberOfSharesIssuedDuringPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfSharesIssuedDuringPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares issued during the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfSharesIssuedDuringPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of shares issued during the period</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NetProceedsFromIssuanceOfShares" xlink:label="aciu_NetProceedsFromIssuanceOfShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NetProceedsFromIssuanceOfShares" xlink:to="aciu_NetProceedsFromIssuanceOfShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NetProceedsFromIssuanceOfShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net proceeds from issuance of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NetProceedsFromIssuanceOfShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net proceeds from issuance of shares</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issue of ordinary shares</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement" xlink:label="aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement" xlink:to="aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital authorized to be issued under shelf registration statement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital authorized to be issued under shelf registration statement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital authorized to be issued under Shelf Registration Statement</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AtTheMarketEquityOfferingMember" xlink:label="aciu_AtTheMarketEquityOfferingMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AtTheMarketEquityOfferingMember" xlink:to="aciu_AtTheMarketEquityOfferingMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AtTheMarketEquityOfferingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">An "at-the-market" offering is an offering of securities into an existing trading market for outstanding shares of the same class at other than a fixed price on, or through the facilities of, a national securities exchange, or to or through a market maker otherwise than on an exchange.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AtTheMarketEquityOfferingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">At the Market Equity Offering [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_AtTheMarketEquityOfferingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">At the Market Equity Offering [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SecondOpenMarketSalesAgreementMember" xlink:label="aciu_SecondOpenMarketSalesAgreementMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_SecondOpenMarketSalesAgreementMember" xlink:to="aciu_SecondOpenMarketSalesAgreementMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_SecondOpenMarketSalesAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for entity entered into a second Open Market Sales Agreement (the "New Sales Agreement") with Jefferies to continue the ATM program.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_SecondOpenMarketSalesAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Second Open Market Sales Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_SecondOpenMarketSalesAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">New Sales Agreement [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AtTheMarketEquityOfferingAbstract" xlink:label="aciu_AtTheMarketEquityOfferingAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AtTheMarketEquityOfferingAbstract" xlink:to="aciu_AtTheMarketEquityOfferingAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AtTheMarketEquityOfferingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">At the Market Equity Offering [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_AtTheMarketEquityOfferingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">At the Market Equity Offering [Abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket" xlink:label="aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket" xlink:to="aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of common shares authorized for sale in the open market.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common shares authorized for issuance sales in in open market</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares authorized for sale</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SaleOrIssueOfTreasurySharesShares" xlink:label="aciu_SaleOrIssueOfTreasurySharesShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_SaleOrIssueOfTreasurySharesShares" xlink:to="aciu_SaleOrIssueOfTreasurySharesShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_SaleOrIssueOfTreasurySharesShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of treasury shares issued or sold.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_SaleOrIssueOfTreasurySharesShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sale or issue of treasury shares, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_SaleOrIssueOfTreasurySharesShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of treasury share issued (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares" xlink:label="ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares" xlink:to="ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from sale or issue of treasury shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from issuance of treasury shares, net of underwriting fees and transaction costs</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CommissionsPaidForIssuanceOrdinaryShares" xlink:label="aciu_CommissionsPaidForIssuanceOrdinaryShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CommissionsPaidForIssuanceOrdinaryShares" xlink:to="aciu_CommissionsPaidForIssuanceOrdinaryShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CommissionsPaidForIssuanceOrdinaryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of commissions paid for issuance ordinary shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CommissionsPaidForIssuanceOrdinaryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commissions paid for issuance ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CommissionsPaidForIssuanceOrdinaryShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commissions paid</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ConvertibleNoteAgreementMember" xlink:label="aciu_ConvertibleNoteAgreementMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ConvertibleNoteAgreementMember" xlink:to="aciu_ConvertibleNoteAgreementMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ConvertibleNoteAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The member represents to convertible note agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ConvertibleNoteAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible Note Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ConvertibleNoteAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible Note Agreement with Lilly [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_ConvertibleNoteAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible note agreements</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Scenario [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Scenario [Domain]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IfNotesAreConvertedMember" xlink:label="aciu_IfNotesAreConvertedMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IfNotesAreConvertedMember" xlink:to="aciu_IfNotesAreConvertedMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IfNotesAreConvertedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents the scenario that notes get converted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IfNotesAreConvertedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">If notes are converted [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_IfNotesAreConvertedMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">If notes are converted</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AthosServiceGmbHMember" xlink:label="aciu_AthosServiceGmbHMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AthosServiceGmbHMember" xlink:to="aciu_AthosServiceGmbHMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AthosServiceGmbHMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents Athos Service GmbH</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AthosServiceGmbHMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Athos Service GmbH [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_FirstCapitalPartnerGmbHMember" xlink:label="aciu_FirstCapitalPartnerGmbHMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_FirstCapitalPartnerGmbHMember" xlink:to="aciu_FirstCapitalPartnerGmbHMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_FirstCapitalPartnerGmbHMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents First Capital Partner GmbH</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_FirstCapitalPartnerGmbHMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">First Capital Partner GmbH [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ConvertibleNoteAgreementAbstract" xlink:label="aciu_ConvertibleNoteAgreementAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ConvertibleNoteAgreementAbstract" xlink:to="aciu_ConvertibleNoteAgreementAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ConvertibleNoteAgreementAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible Note Agreement [Abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfConvertibleNoteAgreements" xlink:label="aciu_NumberOfConvertibleNoteAgreements" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfConvertibleNoteAgreements" xlink:to="aciu_NumberOfConvertibleNoteAgreements_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfConvertibleNoteAgreements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of convertible note agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfConvertibleNoteAgreements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of convertible note agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_NumberOfConvertibleNoteAgreements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of separate convertible note agreements</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AggregatePrincipalAmountOfEachConvertibleNote" xlink:label="aciu_AggregatePrincipalAmountOfEachConvertibleNote" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AggregatePrincipalAmountOfEachConvertibleNote" xlink:to="aciu_AggregatePrincipalAmountOfEachConvertibleNote_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AggregatePrincipalAmountOfEachConvertibleNote_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Aggregate principal amount of each convertible note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AggregatePrincipalAmountOfEachConvertibleNote_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Aggregate principal amount of each convertible note</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote" xlink:label="aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote" xlink:to="aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The cash inflow from conversion of convertible debt, per individual note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from conversion of convertible debt, per individual note</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements" xlink:label="aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements" xlink:to="aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding equity or cash consideration due under convertible note agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding equity or cash consideration due under convertible note agreements</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CurrentAccruedResearchAndDevelopmentCosts" xlink:label="aciu_CurrentAccruedResearchAndDevelopmentCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CurrentAccruedResearchAndDevelopmentCosts" xlink:to="aciu_CurrentAccruedResearchAndDevelopmentCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CurrentAccruedResearchAndDevelopmentCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of current accrued research and development costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CurrentAccruedResearchAndDevelopmentCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current accrued research and development costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CurrentAccruedResearchAndDevelopmentCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued research and development costs</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:to="ifrs-full_ShorttermEmployeeBenefitsAccruals_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term employee benefits accruals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrual of performance-related remuneration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued payroll expenses</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_OtherAccruedExpenses" xlink:label="aciu_OtherAccruedExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_OtherAccruedExpenses" xlink:to="aciu_OtherAccruedExpenses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_OtherAccruedExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_OtherAccruedExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other accrued expenses</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AccruedStampDuty" xlink:label="aciu_AccruedStampDuty" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AccruedStampDuty" xlink:to="aciu_AccruedStampDuty_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AccruedStampDuty_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of current accrued stamp duty.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AccruedStampDuty_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued stamp duty</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_AccruedStampDuty_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued stamp duty</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of disaggregation of revenue from contracts with customers [table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfContractsAxis" xlink:to="ifrs-full_TypesOfContractsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfContractsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Types of contracts [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfContractsMember" xlink:to="ifrs-full_TypesOfContractsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfContractsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Types of contracts [member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:to="aciu_CollaborationAndLicenseRevenueAgreementsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaboration and License Revenue Agreements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaboration and License Revenue [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaboration and License Revenue Agreements [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAgreementWithLillyMember" xlink:label="aciu_CollaborationAgreementWithLillyMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborationAgreementWithLillyMember" xlink:to="aciu_CollaborationAgreementWithLillyMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborationAgreementWithLillyMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The collaboration agreement with Lilly for research and development.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborationAgreementWithLillyMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaboration Agreement with Lilly [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CollaborationAgreementWithLillyMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Lilly [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_CollaborationAgreementWithLillyMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2018 License Agreement with Eli Lilly and Company [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" xlink:label="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" xlink:to="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The 2014 contractual research agreement associated with collaboration with Janssen Pharmaceuticals.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaboration agreement of 2014, Janssen Pharmaceuticals [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2014 Agreement with Janssen Pharmaceuticals [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Janssen</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" xlink:label="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" xlink:to="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The 2014 contractual research agreement associated with collaboration with Life Molecular Imaging.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">License and collaboration agreement of 2014, Life Molecular Imaging [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Life Molecular Imaging [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_OtherAgreementMember" xlink:label="aciu_OtherAgreementMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_OtherAgreementMember" xlink:to="aciu_OtherAgreementMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_OtherAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">contractual research agreement associated with collaboration with other.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_OtherAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_OtherAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of disaggregation of revenue from contracts with customers [line items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ContractRevenueAbstract" xlink:label="aciu_ContractRevenueAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ContractRevenueAbstract" xlink:to="aciu_ContractRevenueAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ContractRevenueAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contract Revenue [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ContractRevenueAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contract Revenue [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:label="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:to="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amounts included in the contract liability at the beginning of the period</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" xlink:label="ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" xlink:to="ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Performance obligations satisfied in previous periods</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProductsAndServicesAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Products and services [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProductsAndServicesMember" xlink:to="ifrs-full_ProductsAndServicesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProductsAndServicesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Products and services [member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TauMorphomerSmallMoleculeMember" xlink:label="aciu_TauMorphomerSmallMoleculeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_TauMorphomerSmallMoleculeMember" xlink:to="aciu_TauMorphomerSmallMoleculeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_TauMorphomerSmallMoleculeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The research and development of medicines for the treatment of Alzheimer's disease and other neurodegenerative diseases.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_TauMorphomerSmallMoleculeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tau Morphomer Small Molecule [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_TauMorphomerSmallMoleculeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Morphomer Tau Small Molecule [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAgreementWithLillyFirstAmendmentMember" xlink:label="aciu_CollaborationAgreementWithLillyFirstAmendmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborationAgreementWithLillyFirstAmendmentMember" xlink:to="aciu_CollaborationAgreementWithLillyFirstAmendmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborationAgreementWithLillyFirstAmendmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The first amendment to the collaboration agreement with Lilly for research and development.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborationAgreementWithLillyFirstAmendmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaboration Agreement with Lilly, First Amendment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CollaborationAgreementWithLillyFirstAmendmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2018 License Agreement with Eli Lilly, First Amendment [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAgreementWithLillySecondAmendmentMember" xlink:label="aciu_CollaborationAgreementWithLillySecondAmendmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborationAgreementWithLillySecondAmendmentMember" xlink:to="aciu_CollaborationAgreementWithLillySecondAmendmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborationAgreementWithLillySecondAmendmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The second amendment to the collaboration agreement with Lilly for research and development.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborationAgreementWithLillySecondAmendmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaboration Agreement with Lilly, Second Amendment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CollaborationAgreementWithLillySecondAmendmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2018 License Agreement with Eli Lilly, Second Amendment [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PerformanceObligationsAxis" xlink:label="ifrs-full_PerformanceObligationsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PerformanceObligationsAxis" xlink:to="ifrs-full_PerformanceObligationsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PerformanceObligationsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Performance obligations [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PerformanceObligationsMember" xlink:label="ifrs-full_PerformanceObligationsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PerformanceObligationsMember" xlink:to="ifrs-full_PerformanceObligationsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PerformanceObligationsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Performance obligations [member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember" xlink:label="aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember" xlink:to="aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Refers to a milestone payment arrangement related to clinical and regulatory milestones.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Milestone payments, clinical and regulatory milestones [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Clinical and Regulatory [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_MilestonePaymentsCommercialMember" xlink:label="aciu_MilestonePaymentsCommercialMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_MilestonePaymentsCommercialMember" xlink:to="aciu_MilestonePaymentsCommercialMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_MilestonePaymentsCommercialMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Refers to a milestone payment arrangement related to certain commercial milestones.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_MilestonePaymentsCommercialMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Milestone payments, commercial [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_MilestonePaymentsCommercialMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commercial [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ResearchAndDevelopmentMember" xlink:label="aciu_ResearchAndDevelopmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ResearchAndDevelopmentMember" xlink:to="aciu_ResearchAndDevelopmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ResearchAndDevelopmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Performance obligation related to research and development.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ResearchAndDevelopmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and development [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ResearchAndDevelopmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and Development [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RightOfUseLicenseMember" xlink:label="aciu_RightOfUseLicenseMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RightOfUseLicenseMember" xlink:to="aciu_RightOfUseLicenseMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_RightOfUseLicenseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Performance obligation related to right-of-use license.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RightOfUseLicenseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use license [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_RightOfUseLicenseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use License [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Quarter32019Member" xlink:label="aciu_Quarter32019Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_Quarter32019Member" xlink:to="aciu_Quarter32019Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_Quarter32019Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents Quarter 3 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_Quarter32019Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Quarter 3, 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_Quarter32019Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Quarter 3, 2019</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_March312020Member" xlink:label="aciu_March312020Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_March312020Member" xlink:to="aciu_March312020Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_March312020Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents March 31, 2020</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_March312020Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">March 31, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_March312020Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">March 31, 2020</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member" xlink:label="aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member" xlink:to="aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents the time upon which the first patient is dosed in a Phase 2 clinical study of a licensed product in the U.S. or EU.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Upon first patient dosed in a Phase 2 clinical study of a licensed product in the U.S. or EU. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Upon first patient dosed in a Phase 2 clinical study of a licensed product in the U.S. or EU.</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of disaggregation of revenue from contracts with customers [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contract revenues</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementPotentialValue" xlink:label="aciu_CollaborativeAgreementPotentialValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborativeAgreementPotentialValue" xlink:to="aciu_CollaborativeAgreementPotentialValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborativeAgreementPotentialValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The total potential value of the collaborative agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborativeAgreementPotentialValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative agreement, potential value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CollaborativeAgreementPotentialValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total potential collaboration agreement value</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments" xlink:label="aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments" xlink:to="aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of installments for satisfying a milestone payment associated with a collaborative agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative agreement, milestone payment, number of installments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of installments</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementMilestonePaymentReceived" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborativeAgreementMilestonePaymentReceived" xlink:to="aciu_CollaborativeAgreementMilestonePaymentReceived_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payment(s) received for milestone payments associated with a collaborative agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative agreement, Milestone payment received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Milestone payment received</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReceivablesFromContractsWithCustomers" xlink:label="ifrs-full_ReceivablesFromContractsWithCustomers" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReceivablesFromContractsWithCustomers" xlink:to="ifrs-full_ReceivablesFromContractsWithCustomers_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReceivablesFromContractsWithCustomers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Receivables from contracts with customers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReceivablesFromContractsWithCustomers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Milestone payment receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ReceivablesFromContractsWithCustomers_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Eligible grant amount receivable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Transaction price allocated to remaining performance obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total potential collaboration agreement value remaining</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected transaction price allocation</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" xlink:to="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Period of time that notice is required to be given for cancellation of the collaborative agreement contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative agreement, Notice of contract termination period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Period to provide notice of termination of agreement</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty" xlink:label="aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty" xlink:to="aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of representatives in a joint steering committee by each party as per the agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of representatives in joint steering committee by each party</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of representatives in joint steering committee by each party</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContractAssets" xlink:label="ifrs-full_ContractAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContractAssets" xlink:to="ifrs-full_ContractAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contract assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ContractAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred research and development costs</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TauVaccineInADMember" xlink:label="aciu_TauVaccineInADMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_TauVaccineInADMember" xlink:to="aciu_TauVaccineInADMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_TauVaccineInADMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The research and development of a vaccine for the treatment of Alzheimer's disease.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_TauVaccineInADMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tau Vaccine in AD [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_TauVaccineInADMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tau Vaccine in AD [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementUpfrontPaymentsReceived" xlink:label="aciu_CollaborativeAgreementUpfrontPaymentsReceived" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborativeAgreementUpfrontPaymentsReceived" xlink:to="aciu_CollaborativeAgreementUpfrontPaymentsReceived_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborativeAgreementUpfrontPaymentsReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative agreement, upfront payments received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborativeAgreementUpfrontPaymentsReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative agreement, upfront payments received</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TauPETImagingAgentMember" xlink:label="aciu_TauPETImagingAgentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_TauPETImagingAgentMember" xlink:to="aciu_TauPETImagingAgentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_TauPETImagingAgentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The research and development of medicines for the treatment of Alzheimer's disease through molecular imaging.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_TauPETImagingAgentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tau-PET imaging agent [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_TauPETImagingAgentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tau-PET Imaging Agent [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ClinicalMilestonesMember" xlink:label="aciu_ClinicalMilestonesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ClinicalMilestonesMember" xlink:to="aciu_ClinicalMilestonesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ClinicalMilestonesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents clinical milestones</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ClinicalMilestonesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Clinical milestones [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ClinicalMilestonesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Clinical milestones</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RegulatoryAndSalesBasedMilestonesMember" xlink:label="aciu_RegulatoryAndSalesBasedMilestonesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RegulatoryAndSalesBasedMilestonesMember" xlink:to="aciu_RegulatoryAndSalesBasedMilestonesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_RegulatoryAndSalesBasedMilestonesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents regulatory and sales-based milestones</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RegulatoryAndSalesBasedMilestonesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Regulatory and sales-based milestones [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_RegulatoryAndSalesBasedMilestonesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Regulatory and sales-based milestones</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_GrantRevenueMember" xlink:label="aciu_GrantRevenueMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_GrantRevenueMember" xlink:to="aciu_GrantRevenueMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_GrantRevenueMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue earned from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_GrantRevenueMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Grant revenue [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_GrantRevenueMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Grant revenue [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_GrantsMichaelJFoxFoundationMember" xlink:label="aciu_GrantsMichaelJFoxFoundationMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_GrantsMichaelJFoxFoundationMember" xlink:to="aciu_GrantsMichaelJFoxFoundationMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_GrantsMichaelJFoxFoundationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Funding provided for certain types of expenditures in connection with research and development activities over a contractually-defined period from the Michael J. Fox Foundation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_GrantsMichaelJFoxFoundationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Grants, Michael J. Fox Foundation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_GrantsMichaelJFoxFoundationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Grant from Michael J. Fox Foundation</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SkaneUniversityHospitalMember" xlink:label="aciu_SkaneUniversityHospitalMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_SkaneUniversityHospitalMember" xlink:to="aciu_SkaneUniversityHospitalMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_SkaneUniversityHospitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Skane University Hospital is a university hospital in Scania, Sweden.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_SkaneUniversityHospitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Skane University Hospital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_SkaneUniversityHospitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Skane University Hospital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_SkaneUniversityHospitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Skane University Hospital</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AlphaSynucleinPetImagingDiagnosticAgentMember" xlink:label="aciu_AlphaSynucleinPetImagingDiagnosticAgentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AlphaSynucleinPetImagingDiagnosticAgentMember" xlink:to="aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Alpha Synuclein PET Imaging Diagnostic Agent.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Alpha-synuclein PET imaging diagnostic agent</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AdvanceSmallMoleculePdProgramsMember" xlink:label="aciu_AdvanceSmallMoleculePdProgramsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AdvanceSmallMoleculePdProgramsMember" xlink:to="aciu_AdvanceSmallMoleculePdProgramsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AdvanceSmallMoleculePdProgramsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents advance small molecule PD programs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AdvanceSmallMoleculePdProgramsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Advance small molecule PD programs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_AdvanceSmallMoleculePdProgramsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Advance small molecule PD programs</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BottomOfRangeMember" xlink:to="ifrs-full_BottomOfRangeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BottomOfRangeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Bottom of Range [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BottomOfRangeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Minimum</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Legal Entity [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity [Domain]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_FollowOnGrantFundingReceivedTotalForJointArrangement" xlink:label="aciu_FollowOnGrantFundingReceivedTotalForJointArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_FollowOnGrantFundingReceivedTotalForJointArrangement" xlink:to="aciu_FollowOnGrantFundingReceivedTotalForJointArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_FollowOnGrantFundingReceivedTotalForJointArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Follow-on grant funding received, total for joint arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_FollowOnGrantFundingReceivedTotalForJointArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Follow-on grant funding received, total for joint arrangement</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_FollowOnGrantFundingReceived" xlink:label="aciu_FollowOnGrantFundingReceived" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_FollowOnGrantFundingReceived" xlink:to="aciu_FollowOnGrantFundingReceived_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_FollowOnGrantFundingReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Follow-on grant funding received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_FollowOnGrantFundingReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Follow-on grant funding received</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfGrants" xlink:label="aciu_NumberOfGrants" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfGrants" xlink:to="aciu_NumberOfGrants_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of grants received.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_NumberOfGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of grants received</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementJointResearchCollaborationPeriod" xlink:label="aciu_CollaborativeAgreementJointResearchCollaborationPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborativeAgreementJointResearchCollaborationPeriod" xlink:to="aciu_CollaborativeAgreementJointResearchCollaborationPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborativeAgreementJointResearchCollaborationPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The period over which collaborating entities are contracted to perform research, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborativeAgreementJointResearchCollaborationPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative agreement, Joint research collaboration period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CollaborativeAgreementJointResearchCollaborationPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Period of joint research agreement</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AdditionalGrantAwarded" xlink:label="aciu_AdditionalGrantAwarded" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AdditionalGrantAwarded" xlink:to="aciu_AdditionalGrantAwarded_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AdditionalGrantAwarded_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional grant awarded</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AdditionalGrantAwarded_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional grant awarded</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_AdditionalGrantAwarded_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional grant awarded</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about borrowings [table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:label="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:to="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Attribution of expenses by nature to their function [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LineItemsByFunctionMember" xlink:label="ifrs-full_LineItemsByFunctionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LineItemsByFunctionMember" xlink:to="ifrs-full_LineItemsByFunctionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LineItemsByFunctionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Line items by function [member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ResearchAndDevelopmentExpensesMember" xlink:label="aciu_ResearchAndDevelopmentExpensesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ResearchAndDevelopmentExpensesMember" xlink:to="aciu_ResearchAndDevelopmentExpensesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ResearchAndDevelopmentExpensesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents research and development expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ResearchAndDevelopmentExpensesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and development expenses [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ResearchAndDevelopmentExpensesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and development expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseMember" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpenseMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SellingGeneralAndAdministrativeExpenseMember" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpenseMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Selling, general and administrative expense [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General and administrative expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of detailed information about borrowings [line items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation" xlink:label="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation" xlink:to="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employee benefits expense excluding share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employee benefits expense excluding share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payroll expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expense from share-based payment transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based compensation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseByNature" xlink:label="ifrs-full_ExpenseByNature" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseByNature" xlink:to="ifrs-full_ExpenseByNature_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseByNature_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expenses, by nature</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ExpenseByNature_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total expenses by category</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AverageNumberOfEmployees" xlink:label="ifrs-full_AverageNumberOfEmployees" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AverageNumberOfEmployees" xlink:to="ifrs-full_AverageNumberOfEmployees_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AverageNumberOfEmployees_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Average number of employees</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DecreaseInResearchAndDevelopmentExpenseThroughReductionsInVariousCostCenters" xlink:label="aciu_DecreaseInResearchAndDevelopmentExpenseThroughReductionsInVariousCostCenters" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DecreaseInResearchAndDevelopmentExpenseThroughReductionsInVariousCostCenters" xlink:to="aciu_DecreaseInResearchAndDevelopmentExpenseThroughReductionsInVariousCostCenters_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DecreaseInResearchAndDevelopmentExpenseThroughReductionsInVariousCostCenters_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease in research and development expense through reductions in various cost centers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DecreaseInResearchAndDevelopmentExpenseThroughReductionsInVariousCostCenters_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease in research and development expense through reductions in various cost centers</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseInResearchAndDevelopmentExpenseThroughIncreaseInSalariesAndRelatedCosts" xlink:label="aciu_IncreaseInResearchAndDevelopmentExpenseThroughIncreaseInSalariesAndRelatedCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseInResearchAndDevelopmentExpenseThroughIncreaseInSalariesAndRelatedCosts" xlink:to="aciu_IncreaseInResearchAndDevelopmentExpenseThroughIncreaseInSalariesAndRelatedCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseInResearchAndDevelopmentExpenseThroughIncreaseInSalariesAndRelatedCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase in research and development expense through increase in salaries and related costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseInResearchAndDevelopmentExpenseThroughIncreaseInSalariesAndRelatedCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase in research and development expense through increase in salaries and related costs</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DecreaseInGeneralAndAdministrativeExpenseThroughReductionsInVariousCostCenters" xlink:label="aciu_DecreaseInGeneralAndAdministrativeExpenseThroughReductionsInVariousCostCenters" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DecreaseInGeneralAndAdministrativeExpenseThroughReductionsInVariousCostCenters" xlink:to="aciu_DecreaseInGeneralAndAdministrativeExpenseThroughReductionsInVariousCostCenters_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DecreaseInGeneralAndAdministrativeExpenseThroughReductionsInVariousCostCenters_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease in general and administrative expense through reductions in various cost centers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DecreaseInGeneralAndAdministrativeExpenseThroughReductionsInVariousCostCenters_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease in general and administrative expense through reductions in various cost centers</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseInGeneralAndAdministrativeExpenseThroughIncreaseInShareBasedCompensationExpense" xlink:label="aciu_IncreaseInGeneralAndAdministrativeExpenseThroughIncreaseInShareBasedCompensationExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseInGeneralAndAdministrativeExpenseThroughIncreaseInShareBasedCompensationExpense" xlink:to="aciu_IncreaseInGeneralAndAdministrativeExpenseThroughIncreaseInShareBasedCompensationExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseInGeneralAndAdministrativeExpenseThroughIncreaseInShareBasedCompensationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase in general and administrative expense through increase in share-based compensation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseInGeneralAndAdministrativeExpenseThroughIncreaseInShareBasedCompensationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase in general and administrative expense through increase in share-based compensation expense</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_FinancialResultNetAbstract" xlink:label="aciu_FinancialResultNetAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_FinancialResultNetAbstract" xlink:to="aciu_FinancialResultNetAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_FinancialResultNetAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial Result, net [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_FinancialResultNetAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial result, net [Abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfPersonsKeyManagementBoardOfDirectors" xlink:label="aciu_NumberOfPersonsKeyManagementBoardOfDirectors" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfPersonsKeyManagementBoardOfDirectors" xlink:to="aciu_NumberOfPersonsKeyManagementBoardOfDirectors_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfPersonsKeyManagementBoardOfDirectors_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of persons that are the included in Board of Directors excluding the Chief Executive Officer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfPersonsKeyManagementBoardOfDirectors_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of persons, key management, Board of Directors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_NumberOfPersonsKeyManagementBoardOfDirectors_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of individuals, Board of Directors</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfPersonsKeyManagementExecutiveManagement" xlink:label="aciu_NumberOfPersonsKeyManagementExecutiveManagement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfPersonsKeyManagementExecutiveManagement" xlink:to="aciu_NumberOfPersonsKeyManagementExecutiveManagement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfPersonsKeyManagementExecutiveManagement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of persons that comprise key management of the entity that are Executive Management.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfPersonsKeyManagementExecutiveManagement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of persons, key management, Executive Management</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_NumberOfPersonsKeyManagementExecutiveManagement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of individuals, Executive Management</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:to="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term employee benefits</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:to="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Post-employment benefits</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:to="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based compensation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="ifrs-full_KeyManagementPersonnelCompensation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Key management personnel compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_KeyManagementPersonnelCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total compensation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of temporary difference, unused tax losses and unused tax credits [table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageMember" xlink:label="ifrs-full_WeightedAverageMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageMember" xlink:to="ifrs-full_WeightedAverageMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="ifrs-full_GeographicalAreasAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GeographicalAreasAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Geographical areas [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasMember" xlink:label="ifrs-full_GeographicalAreasMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="ifrs-full_GeographicalAreasMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GeographicalAreasMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Geographical areas [member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH" xlink:label="country_CH" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CH" xlink:to="country_CH_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CH_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">SWITZERLAND</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="ifrs-full_DeferredTaxLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxLiabilities" xlink:to="ifrs-full_DeferredTaxLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred tax liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ApplicableTaxRate" xlink:label="ifrs-full_ApplicableTaxRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ApplicableTaxRate" xlink:to="ifrs-full_ApplicableTaxRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ApplicableTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Applicable tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ApplicableTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Applicable tax rate</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:label="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reconciliation of accounting profit multiplied by applicable tax rates [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income tax expense reconciled to Income / (loss) [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccountingProfit" xlink:label="ifrs-full_AccountingProfit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccountingProfit" xlink:to="ifrs-full_AccountingProfit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccountingProfit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounting profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AccountingProfit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss before income tax</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:to="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax (benefit)/expense calculated at the domestic rates applicable in the respective countries</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax benefit calculated at the domestic rates applicable in the respective countries</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" xlink:label="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" xlink:to="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax effect of income not subject to tax and expenses not deductible for tax purposes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax effect of income not subject to tax and expenses not deductible for tax purposes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">(Income not subject to tax)/expenses not deductible for tax purposes</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TaxEffectOfTaxLosses" xlink:label="ifrs-full_TaxEffectOfTaxLosses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxEffectOfTaxLosses" xlink:to="ifrs-full_TaxEffectOfTaxLosses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxEffectOfTaxLosses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax effect of tax losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TaxEffectOfTaxLosses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effect of unused tax losses and tax offsets not recognized as deferred tax assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary difference, unused tax losses and unused tax credits [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Temporary difference, unused tax losses and unused tax credits [member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnusedTaxLossesMember" xlink:label="ifrs-full_UnusedTaxLossesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnusedTaxLossesMember" xlink:to="ifrs-full_UnusedTaxLossesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UnusedTaxLossesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unused tax losses [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_UnusedTaxLossesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax Losses</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember" xlink:label="aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember" xlink:to="aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Right of use assets and lease liabilities, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right of use assets and lease liabilities, net [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right of use assets and lease liabilities, net</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RetirementBenefitPlanMember" xlink:label="aciu_RetirementBenefitPlanMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RetirementBenefitPlanMember" xlink:to="aciu_RetirementBenefitPlanMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_RetirementBenefitPlanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for retirement benefit plan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RetirementBenefitPlanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retirement benefit plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_RetirementBenefitPlanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retirement benefit plan</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_December312024Member" xlink:label="aciu_December312024Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_December312024Member" xlink:to="aciu_December312024Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_December312024Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents December 31, 2024</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_December312024Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2024 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_December312024Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2024</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_December312025Member" xlink:label="aciu_December312025Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_December312025Member" xlink:to="aciu_December312025Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_December312025Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents December 31, 2025</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_December312025Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2025 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_December312025Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2025</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_December312026Member" xlink:label="aciu_December312026Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_December312026Member" xlink:to="aciu_December312026Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_December312026Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents December 31, 2026</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_December312026Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2026 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_December312026Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2026</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_December312027Member" xlink:label="aciu_December312027Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_December312027Member" xlink:to="aciu_December312027Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_December312027Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents December 31, 2027</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_December312027Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2027 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_December312027Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2027</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_December312028Member" xlink:label="aciu_December312028Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_December312028Member" xlink:to="aciu_December312028Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_December312028Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents December 31, 2028</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_December312028Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2028 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_December312028Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2028</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_December312029Member" xlink:label="aciu_December312029Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_December312029Member" xlink:to="aciu_December312029Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_December312029Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents December 31, 2029</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_December312029Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2029 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_December312029Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2029</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_December312030Member" xlink:label="aciu_December312030Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_December312030Member" xlink:to="aciu_December312030Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_December312030Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents December 31, 2030</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_December312030Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2030 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_December312030Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">December 31, 2030</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of temporary difference, unused tax losses and unused tax credits [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecognized deductible temporary differences, unused tax losses and unused tax credits [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:label="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:to="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deductible temporary differences for which no deferred tax asset is recognised</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TaxLossesSplitByExpiryDateAbstract" xlink:label="aciu_TaxLossesSplitByExpiryDateAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_TaxLossesSplitByExpiryDateAbstract" xlink:to="aciu_TaxLossesSplitByExpiryDateAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_TaxLossesSplitByExpiryDateAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax losses split by expiry date [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_TaxLossesSplitByExpiryDateAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tax losses split by expiry date [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:label="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:to="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unused tax losses for which no deferred tax asset recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrecorded tax loss carryforwards</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits" xlink:label="aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits" xlink:to="aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in tax losses available for offset against future taxable profits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in tax losses available for offset against future taxable profits</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:to="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of net defined benefit liability (asset) [table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of net defined benefit liability (asset) [line items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees" xlink:label="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees" xlink:to="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined benefit plans, percentage of contributions by employees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined benefit plans, percentage of contributions by employees</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer" xlink:label="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer" xlink:to="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined benefit plans, percentage of contributions by employer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined benefit plans, percentage of contributions by employer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SurplusDeficitInPlanAbstract" xlink:label="ifrs-full_SurplusDeficitInPlanAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SurplusDeficitInPlanAbstract" xlink:to="ifrs-full_SurplusDeficitInPlanAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SurplusDeficitInPlanAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Surplus (deficit) in plan [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SurplusDeficitInPlanAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined benefit pension plan amount recognized in balance sheet [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:to="ifrs-full_DefinedBenefitObligationAtPresentValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined benefit obligation, at present value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined benefit obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Potential defined benefit obligation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PlanAssetsAtFairValue" xlink:label="ifrs-full_PlanAssetsAtFairValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PlanAssetsAtFairValue" xlink:to="ifrs-full_PlanAssetsAtFairValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PlanAssetsAtFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Plan assets, at fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PlanAssetsAtFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair value of plan assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SurplusDeficitInPlan" xlink:label="ifrs-full_SurplusDeficitInPlan" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SurplusDeficitInPlan" xlink:to="ifrs-full_SurplusDeficitInPlan_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SurplusDeficitInPlan_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Surplus (deficit) in plan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_SurplusDeficitInPlan_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total liability</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentServiceCostDefinedBenefitPlans" xlink:label="ifrs-full_CurrentServiceCostDefinedBenefitPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentServiceCostDefinedBenefitPlans" xlink:to="ifrs-full_CurrentServiceCostDefinedBenefitPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentServiceCostDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current service cost, defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentServiceCostDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current service cost</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpenseDefinedBenefitPlans" xlink:label="ifrs-full_InterestExpenseDefinedBenefitPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpenseDefinedBenefitPlans" xlink:to="ifrs-full_InterestExpenseDefinedBenefitPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestExpenseDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest expense, defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestExpenseDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest cost</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PastServiceCostDefinedBenefitPlans" xlink:label="ifrs-full_PastServiceCostDefinedBenefitPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PastServiceCostDefinedBenefitPlans" xlink:to="ifrs-full_PastServiceCostDefinedBenefitPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PastServiceCostDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Past service cost, defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PastServiceCostDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Past service cost</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestIncomeDefinedBenefitPlans" xlink:label="ifrs-full_InterestIncomeDefinedBenefitPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestIncomeDefinedBenefitPlans" xlink:to="ifrs-full_InterestIncomeDefinedBenefitPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestIncomeDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest income, defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_InterestIncomeDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest income</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:label="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:to="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Post-employment benefit expense in profit or loss, defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net pension cost</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net defined benefit liability (asset) [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net defined benefit liability (asset) [member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:label="ifrs-full_PresentValueOfDefinedBenefitObligationMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:to="ifrs-full_PresentValueOfDefinedBenefitObligationMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PresentValueOfDefinedBenefitObligationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Present value of defined benefit obligation [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PresentValueOfDefinedBenefitObligationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Defined Benefit Obligation [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:label="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:to="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in net defined benefit liability (asset) [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in defined benefit obligation [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Change in net defined benefit liability [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:to="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net defined benefit liability (asset)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">At end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">At beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net defined benefit liabilities, end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net defined benefit liabilities, beginning of period</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:to="ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase in net defined benefit liability (asset) resulting from current service cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current service cost</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset" xlink:to="ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in net defined benefit liability (asset) resulting from past service cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Past service cost</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:to="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest income</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effect of changes in demographic assumptions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Change in demographic assumptions</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effect of changes in financial assumptions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Change in financial assumptions</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Change in experience assumptions</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" xlink:label="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" xlink:to="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in net defined benefit liability (asset) resulting from benefits deposited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in net defined benefit liability (asset) resulting from benefits deposited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Benefits deposited</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:to="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease (increase) in net defined benefit liability (asset) resulting from contributions to plan by plan participants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employees' contributions</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PlanAssetsMember" xlink:label="ifrs-full_PlanAssetsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PlanAssetsMember" xlink:to="ifrs-full_PlanAssetsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PlanAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Plan assets [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PlanAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value of Plan Assets [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ChangesInFairValueOfPlanAssetsAbstract" xlink:label="aciu_ChangesInFairValueOfPlanAssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract" xlink:to="aciu_ChangesInFairValueOfPlanAssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ChangesInFairValueOfPlanAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in fair value of plan assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ChangesInFairValueOfPlanAssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in fair value of plan assets [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:to="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease (increase) in net defined benefit liability (asset) resulting from resulting from contributions to plan by employer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employer's contribution</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employer's contributions</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:to="ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Return on plan assets excluding interest income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Return on plan assets excluding interest income</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xlink:label="ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xlink:to="ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimate of contributions expected to be paid to plan for next annual reporting period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected contributions by the employer to be paid to the post-employment benefit plans during the annual period beginning after the end of the reporting period</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" xlink:label="ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" xlink:to="ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in net defined benefit liability (asset) resulting from expense (income) in profit or loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net pension cost through statement of income/(loss)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:to="ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Remeasurement through other comprehensive income/(loss)</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_OtherComprehensiveGainsLossesAbstract" xlink:label="aciu_OtherComprehensiveGainsLossesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_OtherComprehensiveGainsLossesAbstract" xlink:to="aciu_OtherComprehensiveGainsLossesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_OtherComprehensiveGainsLossesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive gains (losses) [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_OtherComprehensiveGainsLossesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive gains/(losses) [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial gains (losses) arising from changes in demographic assumptions, net of tax, defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effect of changes in demographic assumptions</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial gains (losses) arising from changes in financial assumptions, net of tax, defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effect of changes in financial assumptions</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial gains (losses) arising from experience adjustments, net of tax, defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Effect of changes in experience assumptions</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans" xlink:to="ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Return on plan assets excluding interest income or expense, net of tax, defined benefit plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Return on plan assets excluding interest income</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xlink:label="ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xlink:to="ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average duration period for defined benefit obligation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:to="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of sensitivity analysis for actuarial assumptions [table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionsAxis" xlink:label="ifrs-full_ActuarialAssumptionsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialAssumptionsAxis" xlink:to="ifrs-full_ActuarialAssumptionsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialAssumptionsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumptions [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionsMember" xlink:label="ifrs-full_ActuarialAssumptionsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialAssumptionsMember" xlink:to="ifrs-full_ActuarialAssumptionsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialAssumptionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumptions [member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:to="ifrs-full_ActuarialAssumptionOfDiscountRatesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRatesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumption of discount rates [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRatesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Discount rate</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumption of expected rates of salary increases [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Future salary increase</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumption of expected rates of pension increases [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Future pension cost</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember" xlink:to="aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for the interest rate on savings capital used as actuarial assumptions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumption of interest rate on savings capital [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest rate on savings capital</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="ifrs-full_TypesOfRisksAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfRisksAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Types of risks [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="ifrs-full_TypesOfRisksMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfRisksMember" xlink:to="ifrs-full_TypesOfRisksMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfRisksMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Risks [member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember" xlink:label="aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember" xlink:to="aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The reasonably possible percentage of the increase in the actuarial assumption used to determine the present value of defined benefit obligation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of reasonably possible increase in actuarial assumption [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">+0.5% Increase [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember" xlink:label="aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember" xlink:to="aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The reasonably possible percentage of the decrease in the actuarial assumption used to determine the present value of defined benefit obligation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of reasonably possible decrease in actuarial assumption [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">-0.5% Decrease [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:to="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of sensitivity analysis for actuarial assumptions [line items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract" xlink:to="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of sensitivity analysis for actuarial assumptions [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumptions [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRates" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:to="ifrs-full_ActuarialAssumptionOfDiscountRates_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumption of discount rates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Discount rate</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumption of expected rates of salary increases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Rate of future increase in compensations</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumption of expected rates of pension increases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Rate of future increase in current pensions</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" xlink:to="aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The expected rate of interest rates on retirement savings capital is used as a significant actuarial assumption to determine the present value of a defined benefit obligation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Actuarial assumption of interest rate on retirement savings capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest rate on retirement savings capital</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SensitivityAnalysisActuarialAssumptionsAbstract" xlink:label="aciu_SensitivityAnalysisActuarialAssumptionsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_SensitivityAnalysisActuarialAssumptionsAbstract" xlink:to="aciu_SensitivityAnalysisActuarialAssumptionsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_SensitivityAnalysisActuarialAssumptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sensitivity analysis, actuarial assumptions [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_SensitivityAnalysisActuarialAssumptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sensitivity analysis [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:label="ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:to="ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of reasonably possible increase in actuarial assumption</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage increase in actuarial assumption</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:label="ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:to="ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of reasonably possible decrease in actuarial assumption</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage decrease in actuarial assumption</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:label="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:to="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease/(increase) from actual defined benefit obligation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:label="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:to="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease/(increase) from actual defined benefit obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Decrease/(increase) from actual defined benefit obligation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of terms and conditions of share-based payment arrangement [table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Types of share-based payment arrangements [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based payment arrangements [member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_StockOptionPlanC1Member" xlink:label="aciu_StockOptionPlanC1Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_StockOptionPlanC1Member" xlink:to="aciu_StockOptionPlanC1Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_StockOptionPlanC1Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">A share-based payment arrangement that existed at any time during the reporting period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_StockOptionPlanC1Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock option plan C1 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_StockOptionPlanC1Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share Option Plan C1 [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Two016ShareOptionAndIncentivePlanMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_Two016ShareOptionAndIncentivePlanMember" xlink:to="aciu_Two016ShareOptionAndIncentivePlanMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_Two016ShareOptionAndIncentivePlanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_Two016ShareOptionAndIncentivePlanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2016 Share Option and Incentive Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_Two016ShareOptionAndIncentivePlanMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2016 SOIP [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember" xlink:to="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vesting tranche one of the 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2016 Share Option and Incentive Plan, Vesting Tranche One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2016 SOIP, Vesting Condition 1 [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember" xlink:to="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vesting tranche two of the 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2016 Share Option and Incentive Plan, Vesting Tranche Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2016 SOIP, Vesting Condition 2 [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember" xlink:to="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vesting tranche three of the 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2016 Share Option and Incentive Plan, Vesting Tranche Three [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">2016 SOIP, Vesting Condition 3 [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Categories of related parties [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity's total for related parties [member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:to="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Executives and Directors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Executives and Directors [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_EmployeesMember" xlink:label="aciu_EmployeesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_EmployeesMember" xlink:to="aciu_EmployeesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_EmployeesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Refers to personnel employed by the entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_EmployeesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employees [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_EmployeesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employees [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of terms and conditions of share-based payment arrangement [line items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ShareBasedPlansOutstandingAbstract" xlink:label="aciu_ShareBasedPlansOutstandingAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ShareBasedPlansOutstandingAbstract" xlink:to="aciu_ShareBasedPlansOutstandingAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ShareBasedPlansOutstandingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based plans outstanding [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ShareBasedPlansOutstandingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based plans outstanding [Abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfEquityBasedInstrumentPlans" xlink:label="aciu_NumberOfEquityBasedInstrumentPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfEquityBasedInstrumentPlans" xlink:to="aciu_NumberOfEquityBasedInstrumentPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfEquityBasedInstrumentPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of equity-based instrument plans approved by the entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfEquityBasedInstrumentPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of Equity-based Instrument Plans</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Granted during the year (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of options awarded (in shares)</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" xlink:label="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" xlink:to="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">For vesting requirements for a type of share-based payment arrangement that existed at any time during the period, this element represents the period which an employees' right to exercise an award is no longer contingent on satisfaction of a service condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vesting requirements for share-based payment arrangement, award vesting period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vesting conditions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vesting conditions</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" xlink:label="aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" xlink:to="aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The maximum term of options granted for a type of share-based payment arrangement that existed at any time during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum term of options granted for share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contractual life of options</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of number and weighted average remaining contractual life of outstanding share options [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number and weighted average exercise prices of options under the share option programs [Abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfOptionsAbstract" xlink:label="aciu_NumberOfOptionsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfOptionsAbstract" xlink:to="aciu_NumberOfOptionsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfOptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of Options [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_NumberOfOptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of options [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOutstandingShareOptions" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding Options (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding at end of period (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding at beginning of period (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of share options forfeited in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Forfeited during the year (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of share options exercised in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercised during the year (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of share options exercisable in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercisable (in shares)</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageExercisePriceAbstract" xlink:label="aciu_WeightedAverageExercisePriceAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_WeightedAverageExercisePriceAbstract" xlink:to="aciu_WeightedAverageExercisePriceAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_WeightedAverageExercisePriceAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Exercise Price [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_WeightedAverageExercisePriceAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average exercise price [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_WeightedAverageExercisePriceAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average grant date fair value [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average exercise price of share options outstanding in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding at end of period (in CHF per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding at beginning of period (in CHF per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Forfeited during the year (in CHF per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercised during the year (in CHF per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Granted during the year (in CHF per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average exercise price for options granted (in CHF/USD per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average exercise price of share options exercisable in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercisable (in CHF per share)</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageRemainingAbstract" xlink:label="aciu_WeightedAverageRemainingAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_WeightedAverageRemainingAbstract" xlink:to="aciu_WeightedAverageRemainingAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_WeightedAverageRemainingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Remaining [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_WeightedAverageRemainingAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average remaining term (years) [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:to="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average remaining contractual life of outstanding share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average remaining term (years), options outstanding</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable" xlink:label="aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable" xlink:to="aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average remaining contractual life of share options exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average remaining contractual life of share options exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average remaining term (years), options exercisable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of number and weighted average remaining contractual life of outstanding share options [table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ranges of exercise prices for outstanding share options [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ranges of exercise prices for outstanding share options [member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Chf0.15Member" xlink:label="aciu_Chf0.15Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_Chf0.15Member" xlink:to="aciu_Chf0.15Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_Chf0.15Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for CHF 0.15</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_Chf0.15Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CHF 0.15 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_Chf0.15Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CHF 0.15</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Chf9.53Member" xlink:label="aciu_Chf9.53Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_Chf9.53Member" xlink:to="aciu_Chf9.53Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_Chf9.53Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for CHF 9.53</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_Chf9.53Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CHF 9.53 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_Chf9.53Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CHF 9.53</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Usd5.04ToUsd12.30Member" xlink:label="aciu_Usd5.04ToUsd12.30Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_Usd5.04ToUsd12.30Member" xlink:to="aciu_Usd5.04ToUsd12.30Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_Usd5.04ToUsd12.30Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for USD 5.04 to USD 12.30</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_Usd5.04ToUsd12.30Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">USD 5.04 to USD 12.30 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_Usd5.04ToUsd12.30Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">USD 5.04 to USD 12.30</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Usd2.76ToUsd4.57Member" xlink:label="aciu_Usd2.76ToUsd4.57Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_Usd2.76ToUsd4.57Member" xlink:to="aciu_Usd2.76ToUsd4.57Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_Usd2.76ToUsd4.57Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for USD 2.76 to USD 4.57</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_Usd2.76ToUsd4.57Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">USD 2.76 to USD 4.57 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_Usd2.76ToUsd4.57Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">USD 2.76 to USD 4.57</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Usd2.03ToUsd2.32Member" xlink:label="aciu_Usd2.03ToUsd2.32Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_Usd2.03ToUsd2.32Member" xlink:to="aciu_Usd2.03ToUsd2.32Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_Usd2.03ToUsd2.32Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for USD 2.03 to USD 2.32.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_Usd2.03ToUsd2.32Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">USD 2.03 to USD 2.32 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_Usd2.03ToUsd2.32Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">USD 2.03 to USD 2.32</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" xlink:label="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" xlink:to="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding Options Exercise Price Range and Expiry Dates [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Outstanding options, exercise price range and expiry dates [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageSharePrice2019" xlink:label="ifrs-full_WeightedAverageSharePrice2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageSharePrice2019" xlink:to="ifrs-full_WeightedAverageSharePrice2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageSharePrice2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average share price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_WeightedAverageSharePrice2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share price, weighted average (in USD per share)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable" xlink:to="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of range of exercise prices of outstanding share options [table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of range of exercise prices of outstanding share options [line items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:to="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average fair value at measurement date, share options granted</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageAssumptionsAbstract" xlink:label="aciu_WeightedAverageAssumptionsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_WeightedAverageAssumptionsAbstract" xlink:to="aciu_WeightedAverageAssumptionsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_WeightedAverageAssumptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Assumptions [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_WeightedAverageAssumptionsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average assumptions [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercise price (USD)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average share price, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share price (USD and weighted average)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Risk free interest rate, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Risk free interest rate</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected volatility, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected volatility</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Option life, share options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected term (in years)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Dividend yield</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RestrictedSharesAndRestrictedShareUnitsMember" xlink:label="aciu_RestrictedSharesAndRestrictedShareUnitsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RestrictedSharesAndRestrictedShareUnitsMember" xlink:to="aciu_RestrictedSharesAndRestrictedShareUnitsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_RestrictedSharesAndRestrictedShareUnitsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RestrictedSharesAndRestrictedShareUnitsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Shares and Restricted Share Units [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_RestrictedSharesAndRestrictedShareUnitsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-vested Share Awards [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RestrictedStockUnitsMember" xlink:label="aciu_RestrictedStockUnitsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RestrictedStockUnitsMember" xlink:to="aciu_RestrictedStockUnitsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_RestrictedStockUnitsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for equity instruments that are convertible to stock after a specified period of time.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RestrictedStockUnitsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Stock Units [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_RestrictedStockUnitsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Stock Units</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RestrictedStockUnitsFirstVestingConditionsMember" xlink:label="aciu_RestrictedStockUnitsFirstVestingConditionsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RestrictedStockUnitsFirstVestingConditionsMember" xlink:to="aciu_RestrictedStockUnitsFirstVestingConditionsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_RestrictedStockUnitsFirstVestingConditionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Restricted Stock Units, first vesting conditions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RestrictedStockUnitsFirstVestingConditionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Stock Units, first vesting conditions [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_RestrictedStockUnitsFirstVestingConditionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Stock Units, first vesting conditions</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RestrictedStockUnitsSecondVestingConditionsMember" xlink:label="aciu_RestrictedStockUnitsSecondVestingConditionsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RestrictedStockUnitsSecondVestingConditionsMember" xlink:to="aciu_RestrictedStockUnitsSecondVestingConditionsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_RestrictedStockUnitsSecondVestingConditionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Restricted Stock Units, second vesting conditions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RestrictedStockUnitsSecondVestingConditionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Stock Units, second vesting conditions [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_RestrictedStockUnitsSecondVestingConditionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Stock Units, second vesting conditions</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_BoardOfDirectorsMember" xlink:label="aciu_BoardOfDirectorsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_BoardOfDirectorsMember" xlink:to="aciu_BoardOfDirectorsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_BoardOfDirectorsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Key managers of an entity who collectively have responsibility of governing the entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_BoardOfDirectorsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Board of Directors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_BoardOfDirectorsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Directors [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ExecutiveManagementMember" xlink:label="aciu_ExecutiveManagementMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ExecutiveManagementMember" xlink:to="aciu_ExecutiveManagementMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ExecutiveManagementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Key managers, or ranking officers of an entity, appointed to their position by the board of directors.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ExecutiveManagementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Executive Management [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_ExecutiveManagementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Executives [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ShareBasedPaymentArrangementAbstract" xlink:label="aciu_ShareBasedPaymentArrangementAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ShareBasedPaymentArrangementAbstract" xlink:to="aciu_ShareBasedPaymentArrangementAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ShareBasedPaymentArrangementAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based payment arrangement [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of other equity instruments granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Granted during the year (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of non-vested share awards granted (in shares)</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement" xlink:label="aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement" xlink:to="aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The maximum term of other equity instruments (ie other than share options) granted for a type of share-based payment arrangement that existed at any time during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum Term Of Other Equity Instruments Granted For Share Based Payment Arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contractual life of options</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfNonVestedSharesAbstract" xlink:label="aciu_NumberOfNonVestedSharesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfNonVestedSharesAbstract" xlink:to="aciu_NumberOfNonVestedSharesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfNonVestedSharesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number Of Non-vested Shares [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_NumberOfNonVestedSharesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of non-vested shares [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of other equity instruments outstanding in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-vested at end of period (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-vested at beginning of period (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of other equity instruments forfeited in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Forfeited during the year (in shares)</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement" xlink:label="aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement" xlink:to="aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of other equity instruments (ie other than share options) exercised in a share-based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of other equity instruments exercised in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Exercised during the year (in shares)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of other equity instruments exercised or vested in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vested during the year</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of other equity instruments exercisable in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Vested and exercisable (in shares)</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, non-vested at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, non-vested at beginning of period</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, forfeited during the year</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, exercised during the year</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, granted during the year</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments vested</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments vested</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, vested during the year</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments vested and exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, other equity instruments vested and exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant date fair value, vested and exercisable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expense from share-based payment transactions with employees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expense charged against the income statement</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable" xlink:label="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable" xlink:to="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of disclosing information related to commitments and contingencies.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of information about commitments and contingencies [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanFiveYearsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanFiveYearsMember" xlink:to="ifrs-full_LaterThanFiveYearsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanFiveYearsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">More Than 5 Years [Member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems" xlink:label="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems" xlink:to="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of information about commitments and contingencies [Line Items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CommitmentsAbstract" xlink:label="aciu_CommitmentsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CommitmentsAbstract" xlink:to="aciu_CommitmentsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CommitmentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CommitmentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and contingencies [Abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ContractualCapitalCommitmentsOtherThanForLeases" xlink:label="aciu_ContractualCapitalCommitmentsOtherThanForLeases" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ContractualCapitalCommitmentsOtherThanForLeases" xlink:to="aciu_ContractualCapitalCommitmentsOtherThanForLeases_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ContractualCapitalCommitmentsOtherThanForLeases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contractual capital commitments other than for leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ContractualCapitalCommitmentsOtherThanForLeases_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contractual capital commitments other than for leases</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RentalContractPeriodForNoticeOfCancellation" xlink:label="aciu_RentalContractPeriodForNoticeOfCancellation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RentalContractPeriodForNoticeOfCancellation" xlink:to="aciu_RentalContractPeriodForNoticeOfCancellation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_RentalContractPeriodForNoticeOfCancellation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The period of time required by the lessee in a lease agreement to provide notice of cancellation of a lease to the lessor, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RentalContractPeriodForNoticeOfCancellation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Rental contract, period for notice of cancellation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_RentalContractPeriodForNoticeOfCancellation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Notice period for cancellation of rental contract</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContractualCapitalCommitments" xlink:label="ifrs-full_ContractualCapitalCommitments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContractualCapitalCommitments" xlink:to="ifrs-full_ContractualCapitalCommitments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ContractualCapitalCommitments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contractual capital commitments</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BasicEarningsPerShareAbstract" xlink:label="ifrs-full_BasicEarningsPerShareAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsPerShareAbstract" xlink:to="ifrs-full_BasicEarningsPerShareAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BasicEarningsPerShareAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basic earnings per share [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BasicEarningsPerShareAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basic income/(loss) per share (EPS) [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Profit (loss), attributable to ordinary equity holders of parent entity [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Numerator</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating basic earnings per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net loss attributable to equity holders of the Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DilutedEarningsPerShareAbstract" xlink:label="ifrs-full_DilutedEarningsPerShareAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsPerShareAbstract" xlink:to="ifrs-full_DilutedEarningsPerShareAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DilutedEarningsPerShareAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Diluted income/(loss) per share (EPS) [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract" xlink:label="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract" xlink:to="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average ordinary shares used in calculating basic and diluted earnings per share [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Denominator</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageShares" xlink:label="ifrs-full_WeightedAverageShares" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageShares" xlink:to="ifrs-full_WeightedAverageShares_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average number of ordinary shares used in calculating basic earnings per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_WeightedAverageShares_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted-average number of shares outstanding used to compute EPS basic attributable to equity holders</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:label="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:to="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:label="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:to="ifrs-full_TypesOfAntidilutiveInstrumentsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfAntidilutiveInstrumentsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Types of antidilutive instruments [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AntidilutiveInstrumentsMember" xlink:label="ifrs-full_AntidilutiveInstrumentsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AntidilutiveInstrumentsMember" xlink:to="ifrs-full_AntidilutiveInstrumentsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AntidilutiveInstrumentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Antidilutive instruments [member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareOptionsMember" xlink:label="ifrs-full_ShareOptionsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOptionsMember" xlink:to="ifrs-full_ShareOptionsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShareOptionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share options [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShareOptionsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share options issued and outstanding (in-the-money)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RestrictedShareUnitsMember" xlink:label="ifrs-full_RestrictedShareUnitsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RestrictedShareUnitsMember" xlink:to="ifrs-full_RestrictedShareUnitsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RestrictedShareUnitsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted share units [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RestrictedShareUnitsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted share awards subject to future vesting</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ConvertibleInstrumentsMember" xlink:label="ifrs-full_ConvertibleInstrumentsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ConvertibleInstrumentsMember" xlink:to="ifrs-full_ConvertibleInstrumentsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ConvertibleInstrumentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible instruments [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ConvertibleInstrumentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible shares</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareLineItems" xlink:label="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareLineItems" xlink:to="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [line items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" xlink:label="ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" xlink:to="ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of instruments that are antidilutive in period presented</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xlink:to="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of nature and extent of risks arising from financial instruments [table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrencyRiskMember" xlink:label="ifrs-full_CurrencyRiskMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrencyRiskMember" xlink:to="ifrs-full_CurrencyRiskMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrencyRiskMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Currency risk [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrencyRiskMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign Currency Exchange Risk [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CreditRiskMember" xlink:label="ifrs-full_CreditRiskMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CreditRiskMember" xlink:to="ifrs-full_CreditRiskMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CreditRiskMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Credit risk [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CreditRiskMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Credit Risk [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiquidityRiskMember" xlink:label="ifrs-full_LiquidityRiskMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiquidityRiskMember" xlink:to="ifrs-full_LiquidityRiskMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiquidityRiskMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liquidity risk [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LiquidityRiskMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liquidity Risk [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestRateRiskMember" xlink:label="ifrs-full_InterestRateRiskMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestRateRiskMember" xlink:to="ifrs-full_InterestRateRiskMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestRateRiskMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest rate risk [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestRateRiskMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest Rate [member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Classes of financial assets [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember" xlink:label="ifrs-full_FinancialAssetsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsMember" xlink:to="ifrs-full_FinancialAssetsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial assets, class [member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RightOfUseFinancialAssetsMember" xlink:label="aciu_RightOfUseFinancialAssetsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_RightOfUseFinancialAssetsMember" xlink:to="aciu_RightOfUseFinancialAssetsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_RightOfUseFinancialAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for right-of-use financial assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_RightOfUseFinancialAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right of use financial assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_RightOfUseFinancialAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use Assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_RightOfUseFinancialAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Right-of-use assets</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_LongTermFinancialAssetsMember" xlink:label="aciu_LongTermFinancialAssetsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_LongTermFinancialAssetsMember" xlink:to="aciu_LongTermFinancialAssetsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_LongTermFinancialAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents financial assets classified as long-term.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_LongTermFinancialAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term Financial Assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_LongTermFinancialAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term financial assets</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_OtherCurrentReceivablesMember" xlink:label="aciu_OtherCurrentReceivablesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_OtherCurrentReceivablesMember" xlink:to="aciu_OtherCurrentReceivablesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_OtherCurrentReceivablesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents other current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_OtherCurrentReceivablesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other current receivables [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_OtherCurrentReceivablesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other current receivables</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeReceivablesMember" xlink:label="ifrs-full_TradeReceivablesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeReceivablesMember" xlink:to="ifrs-full_TradeReceivablesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeReceivablesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade receivables [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeReceivablesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts receivable</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ShortTermFinancialAssetsMember" xlink:label="aciu_ShortTermFinancialAssetsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ShortTermFinancialAssetsMember" xlink:to="aciu_ShortTermFinancialAssetsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ShortTermFinancialAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents financial assets classified as short-term.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ShortTermFinancialAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term Financial Assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ShortTermFinancialAssetsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term financial assets</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CashOnHandAndCashEquivalentsMember" xlink:label="aciu_CashOnHandAndCashEquivalentsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CashOnHandAndCashEquivalentsMember" xlink:to="aciu_CashOnHandAndCashEquivalentsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CashOnHandAndCashEquivalentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member represents cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CashOnHandAndCashEquivalentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash on hand and cash equivalents [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_CashOnHandAndCashEquivalentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and Cash Equivalents [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_CashOnHandAndCashEquivalentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Classes of financial liabilities [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="ifrs-full_FinancialLiabilitiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesMember" xlink:to="ifrs-full_FinancialLiabilitiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial liabilities, class [member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_LongTermLeaseLiabilitiesMember" xlink:label="aciu_LongTermLeaseLiabilitiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_LongTermLeaseLiabilitiesMember" xlink:to="aciu_LongTermLeaseLiabilitiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_LongTermLeaseLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for Long-term lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_LongTermLeaseLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term lease liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_LongTermLeaseLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-term lease liabilities</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TradeAndOtherPayablesMember" xlink:label="aciu_TradeAndOtherPayablesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_TradeAndOtherPayablesMember" xlink:to="aciu_TradeAndOtherPayablesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_TradeAndOtherPayablesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for trade and other payables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_TradeAndOtherPayablesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade and Other Payables [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_TradeAndOtherPayablesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trade and other payables</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AccruedExpensesMember" xlink:label="aciu_AccruedExpensesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_AccruedExpensesMember" xlink:to="aciu_AccruedExpensesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_AccruedExpensesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for accrued expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_AccruedExpensesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Expenses [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_AccruedExpensesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued expenses</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ShortTermLeaseLiabilitiesMember" xlink:label="aciu_ShortTermLeaseLiabilitiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ShortTermLeaseLiabilitiesMember" xlink:to="aciu_ShortTermLeaseLiabilitiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ShortTermLeaseLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for short-term lease liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ShortTermLeaseLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term lease liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ShortTermLeaseLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term Lease Liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aciu_ShortTermLeaseLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Short-term lease liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:to="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of nature and extent of risks arising from financial instruments [line items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_FinancialAssetsAndLiabilitiesAbstract" xlink:label="aciu_FinancialAssetsAndLiabilitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_FinancialAssetsAndLiabilitiesAbstract" xlink:to="aciu_FinancialAssetsAndLiabilitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_FinancialAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial assets and liabilities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_FinancialAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial assets and liabilities [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssets" xlink:label="ifrs-full_FinancialAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_FinancialAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilities" xlink:label="ifrs-full_FinancialLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_FinancialLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial liabilities</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_FinancialRisksAbstract" xlink:label="aciu_FinancialRisksAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_FinancialRisksAbstract" xlink:to="aciu_FinancialRisksAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_FinancialRisksAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial risks [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_FinancialRisksAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial risks [Abstract]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" xlink:label="aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" xlink:to="aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of reasonably possible strengthening or weakening of reporting currency against other relevant currencies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of reasonably possible strengthening or weakening of reporting currency against other relevant currencies</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" xlink:label="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" xlink:to="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in profit (loss) resulting from reasonably possible strengthening or weakening of reporting currency against other relevant currencies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in profit (loss) resulting from reasonably possible strengthening or weakening of reporting currency against other relevant currencies</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates" xlink:label="aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates" xlink:to="aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of reasonably possible increase or decrease in interest rates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Percentage of reasonably possible increase or decrease in interest rates</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates" xlink:label="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates" xlink:to="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in profit (loss) resulting from reasonably possible increase or decrease in interest rates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (decrease) in profit (loss) resulting from reasonably possible increase or decrease in interest rates</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets" xlink:label="aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets" xlink:to="aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The number of financial institutions holding the entity's deposits of cash and cash equivalents and short-term financial assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of financial institutions holding, cash and cash equivalents and short-term financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of financial institutions holding cash and cash equivalents and short-term financial assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of non-adjusting events after reporting period [table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-adjusting events after reporting period [axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="ifrs-full_NonadjustingEventsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NonadjustingEventsMember" xlink:to="ifrs-full_NonadjustingEventsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NonadjustingEventsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-adjusting events after reporting period [member]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ReceiptOfMilestonePaymentsMember" xlink:label="aciu_ReceiptOfMilestonePaymentsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_ReceiptOfMilestonePaymentsMember" xlink:to="aciu_ReceiptOfMilestonePaymentsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_ReceiptOfMilestonePaymentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This member stands for receipt of milestone payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_ReceiptOfMilestonePaymentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Receipt of milestone payments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aciu_ReceiptOfMilestonePaymentsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Receipt of milestone payments</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of non-adjusting events after reporting period [line items]</label>
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAgreementMileStonePaymentReceived" xlink:label="aciu_CollaborationAgreementMileStonePaymentReceived" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aciu_CollaborationAgreementMileStonePaymentReceived" xlink:to="aciu_CollaborationAgreementMileStonePaymentReceived_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aciu_CollaborationAgreementMileStonePaymentReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The amount of milestone payment received under the collaboration agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aciu_CollaborationAgreementMileStonePaymentReceived_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaboration Agreement, Mile Stone Payment Received</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>47
<FILENAME>aciu-20231231_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.5.0.8 -->
<!--Based on XBRL 2.1-->
<!--Created on: 3/13/2024 5:02:26 PM-->
<!--Modified on: 3/13/2024 5:02:26 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DocumentDocumentAndEntityInformation" roleURI="http://acimume.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#StatementConsolidatedBalanceSheets" roleURI="http://acimume.com/role/StatementConsolidatedBalanceSheets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#StatementConsolidatedStatementsOfIncomeLoss" roleURI="http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#StatementConsolidatedStatementsOfComprehensiveIncomeLoss" roleURI="http://acimume.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#StatementConsolidatedStatementsOfChangesInEquity" roleURI="http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#StatementConsolidatedStatementsOfCashFlows" roleURI="http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureGeneralInformation" roleURI="http://acimume.com/role/DisclosureGeneralInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureBasisOfPreparation" roleURI="http://acimume.com/role/DisclosureBasisOfPreparation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureSummaryOfMaterialAccountingPolicies" roleURI="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPolicies" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosurePropertyPlantAndEquipment" roleURI="http://acimume.com/role/DisclosurePropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilities" roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureAssetAcquisition" roleURI="http://acimume.com/role/DisclosureAssetAcquisition" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureIntangibleAssets" roleURI="http://acimume.com/role/DisclosureIntangibleAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureCashAndCashEquivalentsAndShortTermFinancialAssets" roleURI="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosurePrepaidExpensesAndAccruedIncome" roleURI="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureAccountsReceivable" roleURI="http://acimume.com/role/DisclosureAccountsReceivable" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureOtherCurrentReceivables" roleURI="http://acimume.com/role/DisclosureOtherCurrentReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareCapital" roleURI="http://acimume.com/role/DisclosureShareCapital" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureTradeAndOtherPayablesAndAccruedExpenses" roleURI="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureContractRevenues" roleURI="http://acimume.com/role/DisclosureContractRevenues" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureExpensesByCategory" roleURI="http://acimume.com/role/DisclosureExpensesByCategory" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRelatedPartyTransactions" roleURI="http://acimume.com/role/DisclosureRelatedPartyTransactions" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureIncomeTaxes" roleURI="http://acimume.com/role/DisclosureIncomeTaxes" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRetirementBenefitPlan" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlan" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareBasedCompensation" roleURI="http://acimume.com/role/DisclosureShareBasedCompensation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureCommitmentsAndContingencies" roleURI="http://acimume.com/role/DisclosureCommitmentsAndContingencies" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureEarningsPerShare" roleURI="http://acimume.com/role/DisclosureEarningsPerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureFinancialInstrumentsAndRiskManagement" roleURI="http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagement" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureCapitalRiskManagement" roleURI="http://acimume.com/role/DisclosureCapitalRiskManagement" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureSubsequentEvents" roleURI="http://acimume.com/role/DisclosureSubsequentEvents" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureSummaryOfMaterialAccountingPoliciesPolicies" roleURI="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureSummaryOfMaterialAccountingPoliciesTables" roleURI="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosurePropertyPlantAndEquipmentTables" roleURI="http://acimume.com/role/DisclosurePropertyPlantAndEquipmentTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesTables" roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureAssetAcquisitionTables" roleURI="http://acimume.com/role/DisclosureAssetAcquisitionTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureIntangibleAssetsTables" roleURI="http://acimume.com/role/DisclosureIntangibleAssetsTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureCashAndCashEquivalentsAndShortTermFinancialAssetsTables" roleURI="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssetsTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosurePrepaidExpensesAndAccruedIncomeTables" roleURI="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureOtherCurrentReceivablesTables" roleURI="http://acimume.com/role/DisclosureOtherCurrentReceivablesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareCapitalTables" roleURI="http://acimume.com/role/DisclosureShareCapitalTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureTradeAndOtherPayablesAndAccruedExpensesTables" roleURI="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureContractRevenuesTables" roleURI="http://acimume.com/role/DisclosureContractRevenuesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureExpensesByCategoryTables" roleURI="http://acimume.com/role/DisclosureExpensesByCategoryTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRelatedPartyTransactionsTables" roleURI="http://acimume.com/role/DisclosureRelatedPartyTransactionsTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureIncomeTaxesTables" roleURI="http://acimume.com/role/DisclosureIncomeTaxesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRetirementBenefitPlanTables" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareBasedCompensationTables" roleURI="http://acimume.com/role/DisclosureShareBasedCompensationTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureCommitmentsAndContingenciesTables" roleURI="http://acimume.com/role/DisclosureCommitmentsAndContingenciesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureEarningsPerShareTables" roleURI="http://acimume.com/role/DisclosureEarningsPerShareTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureFinancialInstrumentsAndRiskManagementTables" roleURI="http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureGeneralInformationDetails" roleURI="http://acimume.com/role/DisclosureGeneralInformationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureBasisOfPreparationGoingConcernDetails" roleURI="http://acimume.com/role/DisclosureBasisOfPreparationGoingConcernDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureSummaryOfMaterialAccountingPoliciesFunctionalAndReportingCurrencyDetails" roleURI="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesFunctionalAndReportingCurrencyDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureSummaryOfMaterialAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails" roleURI="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureSummaryOfMaterialAccountingPoliciesPropertyPlantAndEquipmentDetails" roleURI="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPropertyPlantAndEquipmentDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureSummaryOfMaterialAccountingPoliciesIncomeTaxesDetails" roleURI="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesIncomeTaxesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureSummaryOfMaterialAccountingPoliciesSegmentReportingDetails" roleURI="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesSegmentReportingDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosurePropertyPlantAndEquipmentDetails" roleURI="http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails" roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails" roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails" roleURI="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureAssetAcquisitionDetails" roleURI="http://acimume.com/role/DisclosureAssetAcquisitionDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureIntangibleAssetsDetails" roleURI="http://acimume.com/role/DisclosureIntangibleAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails" roleURI="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails" roleURI="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosurePrepaidExpensesAndAccruedIncomeDetails" roleURI="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureAccountsReceivableDetails" roleURI="http://acimume.com/role/DisclosureAccountsReceivableDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureOtherCurrentReceivablesDetails" roleURI="http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareCapitalNarrativesDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalNarrativesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareCapitalCapitalStructureDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareCapitalAuthorizedCapitalDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalAuthorizedCapitalDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareCapitalConditionalShareCapitalForFinancingAndOtherPurposesDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForFinancingAndOtherPurposesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareCapitalFollowOnOfferingDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalFollowOnOfferingDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareCapitalShelfRegistrationStatementDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareCapitalAtMarketEquityOfferingDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareCapitalConvertibleNoteAgreementDetails" roleURI="http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails" roleURI="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureContractRevenuesRecognizedRevenuesDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesRecognizedRevenuesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails" roleURI="http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureExpensesByCategoryDetails" roleURI="http://acimume.com/role/DisclosureExpensesByCategoryDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRelatedPartyTransactionsDetails" roleURI="http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails" roleURI="http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" roleURI="http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" roleURI="http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareBasedCompensationPlansOutstandingDetails" roleURI="http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails" roleURI="http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" roleURI="http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" roleURI="http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureShareBasedCompensationNonVestedShareAwardsDetails" roleURI="http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureCommitmentsAndContingenciesDetails" roleURI="http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureEarningsPerShareDetails" roleURI="http://acimume.com/role/DisclosureEarningsPerShareDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureEarningsPerShareAntidilutiveSecuritiesDetails" roleURI="http://acimume.com/role/DisclosureEarningsPerShareAntidilutiveSecuritiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureFinancialInstrumentsAndRiskManagementDetails" roleURI="http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="aciu-20231231.xsd#DisclosureSubsequentEventsDetails" roleURI="http://acimume.com/role/DisclosureSubsequentEventsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <presentationLink xlink:role="http://acimume.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable_638459461415533651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressesTable_638459461415533651" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis_638459461415533651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesTable_638459461415533651" xlink:to="dei_EntityAddressesAddressTypeAxis_638459461415533651" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="dei_AddressTypeDomain_638459461415533651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis_638459461415533651" xlink:to="dei_AddressTypeDomain_638459461415533651" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember_638459461415533651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_AddressTypeDomain_638459461415533651" xlink:to="dei_BusinessContactMember_638459461415533651" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems_638459461415533651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesTable_638459461415533651" xlink:to="dei_EntityAddressesLineItems_638459461415533651" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638459461415543649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_DocumentType_638459461415543649" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638459461415543649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_EntityRegistrantName_638459461415543649" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement_638459461415543649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_DocumentRegistrationStatement_638459461415543649" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638459461415543649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_EntityCentralIndexKey_638459461415543649" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638459461415543649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_DocumentPeriodEndDate_638459461415543649" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus_638459461415543649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_DocumentFiscalPeriodFocus_638459461415543649" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus_638459461415543649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_DocumentFiscalYearFocus_638459461415543649" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638459461415543649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_AmendmentFlag_638459461415543649" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate_638459461415543649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_CurrentFiscalYearEndDate_638459461415543649" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport_638459461415543649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_DocumentAnnualReport_638459461415543649" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport_638459461415543649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_DocumentTransitionReport_638459461415543649" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport_638459461415553649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_DocumentShellCompanyReport_638459461415553649" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638459461415553649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_EntityFileNumber_638459461415553649" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638459461415553649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_EntityIncorporationStateCountryCode_638459461415553649" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638459461415553649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_EntityAddressAddressLine1_638459461415553649" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2_638459461415553649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_EntityAddressAddressLine2_638459461415553649" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638459461415553649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_EntityAddressPostalZipCode_638459461415553649" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638459461415553649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_EntityAddressCityOrTown_638459461415553649" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry_638459461415553649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_EntityAddressCountry_638459461415553649" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName" xlink:label="dei_ContactPersonnelName_638459461415553649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_ContactPersonnelName_638459461415553649" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638459461415563649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_CityAreaCode_638459461415563649" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638459461415563649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_LocalPhoneNumber_638459461415563649" order="22" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638459461415563649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_Security12bTitle_638459461415563649" order="23" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638459461415563649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_TradingSymbol_638459461415563649" order="24" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638459461415563649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_SecurityExchangeName_638459461415563649" order="25" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding_638459461415563649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_EntityCommonStockSharesOutstanding_638459461415563649" order="26" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer_638459461415563649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_EntityWellKnownSeasonedIssuer_638459461415563649" order="27" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers_638459461415563649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_EntityVoluntaryFilers_638459461415563649" order="28" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus_638459461415573649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_EntityCurrentReportingStatus_638459461415573649" order="29" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent_638459461415573649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_EntityInteractiveDataCurrent_638459461415573649" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory_638459461415573649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_EntityFilerCategory_638459461415573649" order="31" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638459461415573649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_EntityEmergingGrowthCompany_638459461415573649" order="32" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag_638459461415573649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_IcfrAuditorAttestationFlag_638459461415573649" order="33" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard_638459461415573649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_DocumentAccountingStandard_638459461415573649" order="34" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany_638459461415573649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_EntityShellCompany_638459461415573649" order="35" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId_638459461415583650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_AuditorFirmId_638459461415583650" order="36" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="dei_AuditorName_638459461415583650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_AuditorName_638459461415583650" order="37" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation_638459461415583650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_AuditorLocation_638459461415583650" order="38" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_638459461415583650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638459461415533651" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_638459461415583650" order="39" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/StatementConsolidatedBalanceSheets" xlink:type="extended" xlink:title="00100 - Statement - Consolidated Balance Sheets" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AssetsAbstract" xlink:label="ifrs-full_AssetsAbstract_638459461415593649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_AssetsAbstract_638459461415593649" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="ifrs-full_NoncurrentAssetsAbstract_638459461415593649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AssetsAbstract_638459461415593649" xlink:to="ifrs-full_NoncurrentAssetsAbstract_638459461415593649" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment_638459461415593649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract_638459461415593649" xlink:to="ifrs-full_PropertyPlantAndEquipment_638459461415593649" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets_638459461415593649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract_638459461415593649" xlink:to="ifrs-full_RightofuseAssets_638459461415593649" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_638459461415593649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract_638459461415593649" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_638459461415593649" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentRestrictedCashAndCashEquivalents" xlink:label="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_638459461415593649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract_638459461415593649" xlink:to="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_638459461415593649" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssets" xlink:label="ifrs-full_NoncurrentAssets_638459461415593649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract_638459461415593649" xlink:to="ifrs-full_NoncurrentAssets_638459461415593649" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="ifrs-full_CurrentAssetsAbstract_638459461415593649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AssetsAbstract_638459461415593649" xlink:to="ifrs-full_CurrentAssetsAbstract_638459461415593649" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="ifrs-full_CurrentPrepaidExpenses_638459461415593649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract_638459461415593649" xlink:to="ifrs-full_CurrentPrepaidExpenses_638459461415593649" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" xlink:label="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_638459461415593649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract_638459461415593649" xlink:to="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_638459461415593649" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="ifrs-full_OtherCurrentReceivables_638459461415593649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract_638459461415593649" xlink:to="ifrs-full_OtherCurrentReceivables_638459461415593649" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="ifrs-full_CurrentTradeReceivables_638459461415593649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract_638459461415593649" xlink:to="ifrs-full_CurrentTradeReceivables_638459461415593649" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:label="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_638459461415603650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract_638459461415593649" xlink:to="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_638459461415603650" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents_638459461415603650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract_638459461415593649" xlink:to="ifrs-full_CashAndCashEquivalents_638459461415603650" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssets" xlink:label="ifrs-full_CurrentAssets_638459461415603650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract_638459461415593649" xlink:to="ifrs-full_CurrentAssets_638459461415603650" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Assets" xlink:label="ifrs-full_Assets_638459461415603650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AssetsAbstract_638459461415593649" xlink:to="ifrs-full_Assets_638459461415603650" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="ifrs-full_EquityAndLiabilitiesAbstract_638459461415603650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_EquityAndLiabilitiesAbstract_638459461415603650" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAbstract" xlink:label="ifrs-full_EquityAbstract_638459461415603650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAndLiabilitiesAbstract_638459461415603650" xlink:to="ifrs-full_EquityAbstract_638459461415603650" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapital" xlink:label="ifrs-full_IssuedCapital_638459461415603650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract_638459461415603650" xlink:to="ifrs-full_IssuedCapital_638459461415603650" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremium" xlink:label="ifrs-full_SharePremium_638459461415603650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract_638459461415603650" xlink:to="ifrs-full_SharePremium_638459461415603650" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TreasuryShares" xlink:label="ifrs-full_TreasuryShares_638459461415603650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract_638459461415603650" xlink:to="ifrs-full_TreasuryShares_638459461415603650" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_638459461415603650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract_638459461415603650" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_638459461415603650" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarnings" xlink:label="ifrs-full_RetainedEarnings_638459461415613649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract_638459461415603650" xlink:to="ifrs-full_RetainedEarnings_638459461415613649" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity_638459461415613649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract_638459461415603650" xlink:to="ifrs-full_Equity_638459461415613649" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract_638459461415613649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAndLiabilitiesAbstract_638459461415603650" xlink:to="ifrs-full_NoncurrentLiabilitiesAbstract_638459461415613649" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_638459461415613649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract_638459461415613649" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_638459461415613649" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:label="ifrs-full_NoncurrentProvisionsForEmployeeBenefits_638459461415613649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract_638459461415613649" xlink:to="ifrs-full_NoncurrentProvisionsForEmployeeBenefits_638459461415613649" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="ifrs-full_NoncurrentLiabilities_638459461415613649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract_638459461415613649" xlink:to="ifrs-full_NoncurrentLiabilities_638459461415613649" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="ifrs-full_CurrentLiabilitiesAbstract_638459461415613649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAndLiabilitiesAbstract_638459461415603650" xlink:to="ifrs-full_CurrentLiabilitiesAbstract_638459461415613649" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_638459461415613649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract_638459461415613649" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_638459461415613649" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_638459461415623650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract_638459461415613649" xlink:to="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_638459461415623650" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_638459461415623650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract_638459461415613649" xlink:to="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_638459461415623650" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="ifrs-full_CurrentLeaseLiabilities_638459461415623650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract_638459461415613649" xlink:to="ifrs-full_CurrentLeaseLiabilities_638459461415623650" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilities" xlink:label="ifrs-full_CurrentLiabilities_638459461415623650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract_638459461415613649" xlink:to="ifrs-full_CurrentLiabilities_638459461415623650" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Liabilities" xlink:label="ifrs-full_Liabilities_638459461415623650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAndLiabilitiesAbstract_638459461415603650" xlink:to="ifrs-full_Liabilities_638459461415623650" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAndLiabilities" xlink:label="ifrs-full_EquityAndLiabilities_638459461415623650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAndLiabilitiesAbstract_638459461415603650" xlink:to="ifrs-full_EquityAndLiabilities_638459461415623650" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss" xlink:type="extended" xlink:title="00200 - Statement - Consolidated Statements of Income/(Loss)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueAbstract" xlink:label="ifrs-full_RevenueAbstract_638459461415633652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ifrs-full_RevenueAbstract_638459461415633652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_638459461415633652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RevenueAbstract_638459461415633652" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_638459461415633652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue" xlink:label="ifrs-full_Revenue_638459461415633652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RevenueAbstract_638459461415633652" xlink:to="ifrs-full_Revenue_638459461415633652" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ExpensesOperatingAbstract" xlink:label="aciu_ExpensesOperatingAbstract_638459461415633652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="aciu_ExpensesOperatingAbstract_638459461415633652" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_638459461415633652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ExpensesOperatingAbstract_638459461415633652" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_638459461415633652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_638459461415633652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ExpensesOperatingAbstract_638459461415633652" xlink:to="ifrs-full_GeneralAndAdministrativeExpense_638459461415633652" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="ifrs-full_OtherOperatingIncomeExpense_638459461415633652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ExpensesOperatingAbstract_638459461415633652" xlink:to="ifrs-full_OtherOperatingIncomeExpense_638459461415633652" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OperatingExpense" xlink:label="ifrs-full_OperatingExpense_638459461415633652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ExpensesOperatingAbstract_638459461415633652" xlink:to="ifrs-full_OperatingExpense_638459461415633652" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_638459461415633652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_638459461415633652" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncome" xlink:label="ifrs-full_FinanceIncome_638459461415633652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ifrs-full_FinanceIncome_638459461415633652" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceCosts" xlink:label="ifrs-full_FinanceCosts_638459461415633652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ifrs-full_FinanceCosts_638459461415633652" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_638459461415633652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_638459461415633652" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncomeCost" xlink:label="ifrs-full_FinanceIncomeCost_638459461415643650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ifrs-full_FinanceIncomeCost_638459461415643650" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="ifrs-full_ProfitLossBeforeTax_638459461415643650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLossBeforeTax_638459461415643650" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_638459461415643650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_638459461415643650" order="9" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss_638459461415643650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLoss_638459461415643650" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="ifrs-full_EarningsPerShareAbstract_638459461415643650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ifrs-full_EarningsPerShareAbstract_638459461415643650" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="ifrs-full_BasicEarningsLossPerShare_638459461415643650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EarningsPerShareAbstract_638459461415643650" xlink:to="ifrs-full_BasicEarningsLossPerShare_638459461415643650" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="ifrs-full_DilutedEarningsLossPerShare_638459461415643650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EarningsPerShareAbstract_638459461415643650" xlink:to="ifrs-full_DilutedEarningsLossPerShare_638459461415643650" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss" xlink:type="extended" xlink:title="00300 - Statement - Consolidated Statements of Comprehensive Income/(Loss)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:label="StatementOfComprehensiveIncomeAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss_638459461415643650" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_ProfitLoss_638459461415643650" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_638459461415653651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_638459461415653651" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_638459461415653651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_638459461415653651" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_638459461415653651" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_638459461415653651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_638459461415653651" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_638459461415653651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_638459461415653651" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_638459461415653651" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="ifrs-full_OtherComprehensiveIncome_638459461415653651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_OtherComprehensiveIncome_638459461415653651" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ifrs-full_ComprehensiveIncome_638459461415653651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_ComprehensiveIncome_638459461415653651" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity" xlink:type="extended" xlink:title="00400 - Statement - Consolidated Statements of Changes in Equity" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="StatementOfChangesInEquityAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="ifrs-full_StatementOfChangesInEquityTable_638459461415653651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfChangesInEquityAbstract" xlink:to="ifrs-full_StatementOfChangesInEquityTable_638459461415653651" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ifrs-full_ComponentsOfEquityAxis_638459461415653651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityTable_638459461415653651" xlink:to="ifrs-full_ComponentsOfEquityAxis_638459461415653651" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapitalMember" xlink:label="ifrs-full_IssuedCapitalMember_638459461415653651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis_638459461415653651" xlink:to="ifrs-full_IssuedCapitalMember_638459461415653651" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremiumMember" xlink:label="ifrs-full_SharePremiumMember_638459461415653651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis_638459461415653651" xlink:to="ifrs-full_SharePremiumMember_638459461415653651" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TreasurySharesMember" xlink:label="ifrs-full_TreasurySharesMember_638459461415653651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis_638459461415653651" xlink:to="ifrs-full_TreasurySharesMember_638459461415653651" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarningsMember" xlink:label="ifrs-full_RetainedEarningsMember_638459461415663649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis_638459461415653651" xlink:to="ifrs-full_RetainedEarningsMember_638459461415663649" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_638459461415663649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis_638459461415653651" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_638459461415663649" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityMember" xlink:label="ifrs-full_EquityMember_638459461415663649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis_638459461415653651" xlink:to="ifrs-full_EquityMember_638459461415663649" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems_638459461415663649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityTable_638459461415653651" xlink:to="ifrs-full_StatementOfChangesInEquityLineItems_638459461415663649" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity_638459461415663649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_638459461415663649" xlink:to="ifrs-full_Equity_638459461415663649" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss_638459461415663649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_638459461415663649" xlink:to="ifrs-full_ProfitLoss_638459461415663649" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="ifrs-full_OtherComprehensiveIncome_638459461415663649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_638459461415663649" xlink:to="ifrs-full_OtherComprehensiveIncome_638459461415663649" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ifrs-full_ComprehensiveIncome_638459461415663649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_638459461415663649" xlink:to="ifrs-full_ComprehensiveIncome_638459461415663649" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_638459461415663649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_638459461415663649" xlink:to="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_638459461415663649" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost" xlink:label="aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost_638459461415663649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_638459461415663649" xlink:to="aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost_638459461415663649" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" xlink:label="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_638459461415663649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_638459461415663649" xlink:to="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_638459461415663649" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesIssuedAbstract" xlink:label="ifrs-full_NumberOfSharesIssuedAbstract_638459461415663649" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_638459461415663649" xlink:to="ifrs-full_NumberOfSharesIssuedAbstract_638459461415663649" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset" xlink:label="aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset_638459461415673652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract_638459461415663649" xlink:to="aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset_638459461415673652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity" xlink:label="aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity_638459461415673652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract_638459461415663649" xlink:to="aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity_638459461415673652" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" xlink:label="ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_638459461415673652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract_638459461415663649" xlink:to="ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_638459461415673652" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions" xlink:label="ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions_638459461415673652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract_638459461415663649" xlink:to="ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions_638459461415673652" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IssueOfEquityRestrictedShareAwards" xlink:label="aciu_IssueOfEquityRestrictedShareAwards_638459461415673652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract_638459461415663649" xlink:to="aciu_IssueOfEquityRestrictedShareAwards_638459461415673652" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_638459461415673652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NumberOfSharesIssuedAbstract_638459461415663649" xlink:to="ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_638459461415673652" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity_638459461415673652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems_638459461415663649" xlink:to="ifrs-full_Equity_638459461415673652" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows" xlink:type="extended" xlink:title="00500 - Statement - Consolidated Statements of Cash Flows" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_638459461415683651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_638459461415683651" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss_638459461415683651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_638459461415683651" xlink:to="ifrs-full_ProfitLoss_638459461415683651" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_638459461415683651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_638459461415683651" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_638459461415683651" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDepreciationExpense" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense_638459461415683651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_638459461415683651" xlink:to="ifrs-full_AdjustmentsForDepreciationExpense_638459461415683651" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets" xlink:label="aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets_638459461415683651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_638459461415683651" xlink:to="aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets_638459461415683651" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:label="ifrs-full_AdjustmentsForFinanceIncomeCost_638459461415683651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_638459461415683651" xlink:to="ifrs-full_AdjustmentsForFinanceIncomeCost_638459461415683651" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_638459461415683651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_638459461415683651" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments_638459461415683651" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_638459461415683651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_638459461415683651" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_638459461415683651" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForInterestExpense" xlink:label="ifrs-full_AdjustmentsForInterestExpense_638459461415683651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_638459461415683651" xlink:to="ifrs-full_AdjustmentsForInterestExpense_638459461415683651" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_638459461415683651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_638459461415683651" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_638459461415683651" order="7" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ChangesInWorkingCapitalAbstract" xlink:label="aciu_ChangesInWorkingCapitalAbstract_638459461415683651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_638459461415683651" xlink:to="aciu_ChangesInWorkingCapitalAbstract_638459461415683651" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_638459461415683651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInWorkingCapitalAbstract_638459461415683651" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_638459461415683651" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets_638459461415693654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInWorkingCapitalAbstract_638459461415683651" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets_638459461415693654" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_638459461415693654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInWorkingCapitalAbstract_638459461415683651" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_638459461415693654" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_638459461415693654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInWorkingCapitalAbstract_638459461415683651" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_638459461415693654" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses" xlink:label="aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses_638459461415693654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInWorkingCapitalAbstract_638459461415683651" xlink:to="aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses_638459461415693654" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_638459461415693654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInWorkingCapitalAbstract_638459461415683651" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_638459461415693654" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_638459461415693654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInWorkingCapitalAbstract_638459461415683651" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_638459461415693654" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperations" xlink:label="ifrs-full_CashFlowsFromUsedInOperations_638459461415693654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_638459461415683651" xlink:to="ifrs-full_CashFlowsFromUsedInOperations_638459461415693654" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:label="ifrs-full_InterestReceivedClassifiedAsOperatingActivities_638459461415693654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_638459461415683651" xlink:to="ifrs-full_InterestReceivedClassifiedAsOperatingActivities_638459461415693654" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:label="ifrs-full_InterestPaidClassifiedAsOperatingActivities_638459461415693654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_638459461415683651" xlink:to="ifrs-full_InterestPaidClassifiedAsOperatingActivities_638459461415693654" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities" xlink:label="ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities_638459461415693654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_638459461415683651" xlink:to="ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities_638459461415693654" order="7" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_638459461415703651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_638459461415683651" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_638459461415703651" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_638459461415703651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_638459461415703651" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities" xlink:label="aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities_638459461415703651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_638459461415703651" xlink:to="aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities_638459461415703651" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_638459461415703651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_638459461415703651" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_638459461415703651" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CashAdvancesForRentDeposit" xlink:label="aciu_CashAdvancesForRentDeposit_638459461415703651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_638459461415703651" xlink:to="aciu_CashAdvancesForRentDeposit_638459461415703651" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_638459461415703651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_638459461415703651" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_638459461415703651" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638459461415703651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638459461415703651" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ProceedsFromIssueOfConvertibleDebt" xlink:label="aciu_ProceedsFromIssueOfConvertibleDebt_638459461415703651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638459461415703651" xlink:to="aciu_ProceedsFromIssueOfConvertibleDebt_638459461415703651" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="ifrs-full_PaymentsForShareIssueCosts_638459461415713652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638459461415703651" xlink:to="ifrs-full_PaymentsForShareIssueCosts_638459461415713652" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ProceedsFromIssuanceOfPublicOfferingsOfCommonSharesNetOfUnderwritingFeesAndTransactionCosts" xlink:label="aciu_ProceedsFromIssuanceOfPublicOfferingsOfCommonSharesNetOfUnderwritingFeesAndTransactionCosts_638459461415713652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638459461415703651" xlink:to="aciu_ProceedsFromIssuanceOfPublicOfferingsOfCommonSharesNetOfUnderwritingFeesAndTransactionCosts_638459461415713652" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts" xlink:label="aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts_638459461415713652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638459461415703651" xlink:to="aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts_638459461415713652" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions" xlink:label="aciu_ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions_638459461415713652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638459461415703651" xlink:to="aciu_ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions_638459461415713652" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="ifrs-full_ProceedsFromExerciseOfOptions_638459461415713652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638459461415703651" xlink:to="ifrs-full_ProceedsFromExerciseOfOptions_638459461415713652" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_638459461415713652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638459461415703651" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_638459461415713652" order="7" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions" xlink:label="aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions_638459461415713652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638459461415703651" xlink:to="aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions_638459461415713652" order="8" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_638459461415723655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_638459461415703651" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_638459461415723655" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_638459461415723655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_638459461415723655" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents_638459461415723655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashAndCashEquivalents_638459461415723655" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_638459461415723655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_638459461415723655" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents_6384594614157236551" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashAndCashEquivalents_6384594614157236551" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SupplementalNonCashActivityAbstract" xlink:label="aciu_SupplementalNonCashActivityAbstract_638459461415723655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="aciu_SupplementalNonCashActivityAbstract_638459461415723655" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities" xlink:label="aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities_638459461415723655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_SupplementalNonCashActivityAbstract_638459461415723655" xlink:to="aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities_638459461415723655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition" xlink:label="aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition_638459461415733652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_SupplementalNonCashActivityAbstract_638459461415723655" xlink:to="aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition_638459461415733652" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="ifrs-full_ShareIssueRelatedCost_638459461415733652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_SupplementalNonCashActivityAbstract_638459461415723655" xlink:to="ifrs-full_ShareIssueRelatedCost_638459461415733652" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RepaymentOfConvertibleDebtEquitySettlementAmount" xlink:label="aciu_RepaymentOfConvertibleDebtEquitySettlementAmount_638459461415733652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_SupplementalNonCashActivityAbstract_638459461415723655" xlink:to="aciu_RepaymentOfConvertibleDebtEquitySettlementAmount_638459461415733652" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TransactionCostAndStampDutyAssociatedWithPublicOfferingsOfCommonSharesRecordedInAccruedExpenses" xlink:label="aciu_TransactionCostAndStampDutyAssociatedWithPublicOfferingsOfCommonSharesRecordedInAccruedExpenses_638459461415733652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_SupplementalNonCashActivityAbstract_638459461415723655" xlink:to="aciu_TransactionCostAndStampDutyAssociatedWithPublicOfferingsOfCommonSharesRecordedInAccruedExpenses_638459461415733652" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses" xlink:label="aciu_TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses_638459461415733652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_SupplementalNonCashActivityAbstract_638459461415723655" xlink:to="aciu_TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses_638459461415733652" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureGeneralInformation" xlink:type="extended" xlink:title="10101 - Disclosure - General information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_GeneralInformationAbstract" xlink:label="GeneralInformationAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock" xlink:label="aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock_638459461415743652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationAbstract" xlink:to="aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock_638459461415743652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureBasisOfPreparation" xlink:type="extended" xlink:title="10201 - Disclosure - Basis of preparation" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_BasisOfPreparationAbstract" xlink:label="BasisOfPreparationAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_638459461415743652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasisOfPreparationAbstract" xlink:to="ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_638459461415743652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPolicies" xlink:type="extended" xlink:title="10301 - Disclosure - Summary of material accounting policies" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:label="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:label="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_638459461415743652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_638459461415743652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosurePropertyPlantAndEquipment" xlink:type="extended" xlink:title="10401 - Disclosure - Property, plant and equipment" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="DisclosureOfPropertyPlantAndEquipmentAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_638459461415753653" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_638459461415753653" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilities" xlink:type="extended" xlink:title="10501 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="PresentationOfLeasesForLesseeAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory_638459461415753653" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfLeasesExplanatory_638459461415753653" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureAssetAcquisition" xlink:type="extended" xlink:title="10601 - Disclosure - Asset acquisition" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AssetAcquisitionsAbstract" xlink:label="AssetAcquisitionsAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfAssetAcquisitionsTextBlock" xlink:label="aciu_DisclosureOfAssetAcquisitionsTextBlock_638459461415753653" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionsAbstract" xlink:to="aciu_DisclosureOfAssetAcquisitionsTextBlock_638459461415753653" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureIntangibleAssets" xlink:type="extended" xlink:title="10701 - Disclosure - Intangible assets" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="DisclosureOfIntangibleAssetsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_638459461415753653" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfIntangibleAssetsAbstract" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_638459461415753653" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssets" xlink:type="extended" xlink:title="10801 - Disclosure - Cash and cash equivalents and short-term financial assets" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:label="DisclosureOfFinancialAssetsAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock" xlink:label="aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock_638459461415763655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfFinancialAssetsAbstract" xlink:to="aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock_638459461415763655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncome" xlink:type="extended" xlink:title="10901 - Disclosure - Prepaid expenses and accrued income" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract" xlink:label="CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock" xlink:label="aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock_638459461415763655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract" xlink:to="aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock_638459461415763655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureAccountsReceivable" xlink:type="extended" xlink:title="11001 - Disclosure - Accounts receivable" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="TradeAndOtherReceivablesAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfAccountsReceivableTableTextBlock" xlink:label="aciu_DisclosureOfAccountsReceivableTableTextBlock_638459461415763655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TradeAndOtherReceivablesAbstract" xlink:to="aciu_DisclosureOfAccountsReceivableTableTextBlock_638459461415763655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureOtherCurrentReceivables" xlink:type="extended" xlink:title="11101 - Disclosure - Other current receivables" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_OtherCurrentReceivablesAbstract" xlink:label="OtherCurrentReceivablesAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfOtherCurrentReceivablesTextBlock" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesTextBlock_638459461415773654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherCurrentReceivablesAbstract" xlink:to="aciu_DisclosureOfOtherCurrentReceivablesTextBlock_638459461415773654" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareCapital" xlink:type="extended" xlink:title="11201 - Disclosure - Share capital" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="DisclosureOfClassesOfShareCapitalAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_638459461415813676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfClassesOfShareCapitalAbstract" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_638459461415813676" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpenses" xlink:type="extended" xlink:title="11301 - Disclosure - Trade and other payables and accrued expenses" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:label="TradeAndOtherCurrentPayablesAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock" xlink:label="aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock_638459461415823655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TradeAndOtherCurrentPayablesAbstract" xlink:to="aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock_638459461415823655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureContractRevenues" xlink:type="extended" xlink:title="11401 - Disclosure - Contract revenues" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueAbstract" xlink:label="RevenueAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRevenueExplanatory" xlink:label="ifrs-full_DisclosureOfRevenueExplanatory_638459461415823655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueAbstract" xlink:to="ifrs-full_DisclosureOfRevenueExplanatory_638459461415823655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureExpensesByCategory" xlink:type="extended" xlink:title="11501 - Disclosure - Expenses by category" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ExpensesByCategoryAbstract" xlink:label="ExpensesByCategoryAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfExpensesExplanatory" xlink:label="ifrs-full_DisclosureOfExpensesExplanatory_638459461415823655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesByCategoryAbstract" xlink:to="ifrs-full_DisclosureOfExpensesExplanatory_638459461415823655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRelatedPartyTransactions" xlink:type="extended" xlink:title="11601 - Disclosure - Related-party transactions" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="DisclosureOfTransactionsBetweenRelatedPartiesAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory_638459461415833654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory_638459461415833654" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureIncomeTaxes" xlink:type="extended" xlink:title="11701 - Disclosure - Income taxes" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="MajorComponentsOfTaxExpenseIncomeAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory_638459461415833654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory_638459461415833654" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlan" xlink:type="extended" xlink:title="11801 - Disclosure - Retirement benefit plan" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="DisclosureOfDefinedBenefitPlansAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:label="ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_638459461415833654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_638459461415833654" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareBasedCompensation" xlink:type="extended" xlink:title="11901 - Disclosure - Share-based compensation" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_638459461415843653" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_638459461415843653" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureCommitmentsAndContingencies" xlink:type="extended" xlink:title="12001 - Disclosure - Commitments and contingencies" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CommitmentsAndContingenciesAbstract" xlink:label="CommitmentsAndContingenciesAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:label="ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_638459461415843653" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesAbstract" xlink:to="ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_638459461415843653" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureEarningsPerShare" xlink:type="extended" xlink:title="12101 - Disclosure - Earnings per share" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory_638459461415843653" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory_638459461415843653" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagement" xlink:type="extended" xlink:title="12201 - Disclosure - Financial instruments and risk management" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" xlink:label="DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_638459461415843653" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_638459461415843653" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureCapitalRiskManagement" xlink:type="extended" xlink:title="12301 - Disclosure - Capital risk management" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract" xlink:label="DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory" xlink:label="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_638459461415853655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract" xlink:to="ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_638459461415853655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureSubsequentEvents" xlink:type="extended" xlink:title="12401 - Disclosure - Subsequent events" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_638459461415853655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_638459461415853655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies" xlink:type="extended" xlink:title="20302 - Disclosure - Summary of material accounting policies (Policies)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:label="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_638459461415863655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_638459461415863655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfBasisOfConsolidationExplanatory" xlink:label="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_638459461415863655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DisclosureOfBasisOfConsolidationExplanatory_638459461415863655" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_638459461415863655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_638459461415863655" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock" xlink:label="aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock_638459461415863655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock_638459461415863655" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_638459461415863655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_638459461415863655" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_638459461415863655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_638459461415863655" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory_638459461415863655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory_638459461415863655" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_GrantIncomePolicyTextBlock" xlink:label="aciu_GrantIncomePolicyTextBlock_638459461415863655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="aciu_GrantIncomePolicyTextBlock_638459461415863655" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_638459461415863655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_638459461415863655" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_638459461415863655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_638459461415863655" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_638459461415863655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_638459461415863655" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_638459461415863655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_638459461415863655" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_638459461415863655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_638459461415863655" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_638459461415873656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_638459461415873656" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_638459461415873656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_638459461415873656" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_638459461415873656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_638459461415873656" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_638459461415873656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_638459461415873656" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_638459461415873656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_638459461415873656" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock" xlink:label="aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock_638459461415873656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock_638459461415873656" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_638459461415873656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_638459461415873656" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock" xlink:label="aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock_638459461415873656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock_638459461415873656" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesTables" xlink:type="extended" xlink:title="30303 - Disclosure - Summary of material accounting policies (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:label="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory" xlink:label="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_638459461415883654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_638459461415883654" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock" xlink:label="aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock_638459461415883654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock_638459461415883654" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:label="aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock_638459461415883654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock_638459461415883654" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosurePropertyPlantAndEquipmentTables" xlink:type="extended" xlink:title="30403 - Disclosure - Property, plant and equipment (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="DisclosureOfPropertyPlantAndEquipmentAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_638459461415883654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_638459461415883654" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesTables" xlink:type="extended" xlink:title="30503 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="PresentationOfLeasesForLesseeAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_638459461415893652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_638459461415893652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock" xlink:label="aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock_638459461415893652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PresentationOfLeasesForLesseeAbstract" xlink:to="aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock_638459461415893652" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock" xlink:label="aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock_638459461415893652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PresentationOfLeasesForLesseeAbstract" xlink:to="aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock_638459461415893652" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureAssetAcquisitionTables" xlink:type="extended" xlink:title="30603 - Disclosure - Asset acquisition (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AssetAcquisitionsAbstract" xlink:label="AssetAcquisitionsAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfAssetAcquisitionsTableTextBlock" xlink:label="aciu_DisclosureOfAssetAcquisitionsTableTextBlock_638459461415893652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionsAbstract" xlink:to="aciu_DisclosureOfAssetAcquisitionsTableTextBlock_638459461415893652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureIntangibleAssetsTables" xlink:type="extended" xlink:title="30703 - Disclosure - Intangible assets (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="DisclosureOfIntangibleAssetsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_638459461415893652" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfIntangibleAssetsAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_638459461415893652" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssetsTables" xlink:type="extended" xlink:title="30803 - Disclosure - Cash and cash equivalents and short-term financial assets (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:label="DisclosureOfFinancialAssetsAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock" xlink:label="aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock_638459461415903663" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfFinancialAssetsAbstract" xlink:to="aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock_638459461415903663" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock" xlink:label="aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock_638459461415903663" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfFinancialAssetsAbstract" xlink:to="aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock_638459461415903663" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeTables" xlink:type="extended" xlink:title="30903 - Disclosure - Prepaid expenses and accrued income (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract" xlink:label="CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock_638459461415903663" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract" xlink:to="aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock_638459461415903663" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureOtherCurrentReceivablesTables" xlink:type="extended" xlink:title="31103 - Disclosure - Other current receivables (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_OtherCurrentReceivablesAbstract" xlink:label="OtherCurrentReceivablesAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock_638459461415913654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherCurrentReceivablesAbstract" xlink:to="aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock_638459461415913654" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareCapitalTables" xlink:type="extended" xlink:title="31203 - Disclosure - Share capital (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="DisclosureOfClassesOfShareCapitalAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_638459461415913654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfClassesOfShareCapitalAbstract" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_638459461415913654" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesTables" xlink:type="extended" xlink:title="31303 - Disclosure - Trade and other payables and accrued expenses (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AccruedExpensesAbstract" xlink:label="AccruedExpensesAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock_638459461415913654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedExpensesAbstract" xlink:to="aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock_638459461415913654" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesTables" xlink:type="extended" xlink:title="31403 - Disclosure - Contract revenues (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueAbstract" xlink:label="RevenueAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:label="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_638459461415923654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueAbstract" xlink:to="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_638459461415923654" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory" xlink:label="ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory_638459461415923654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueAbstract" xlink:to="ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory_638459461415923654" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureExpensesByCategoryTables" xlink:type="extended" xlink:title="31503 - Disclosure - Expenses by category (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ExpensesByCategoryAbstract" xlink:label="ExpensesByCategoryAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" xlink:label="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_638459461415923654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesByCategoryAbstract" xlink:to="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_638459461415923654" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:label="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_638459461415923654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesByCategoryAbstract" xlink:to="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_638459461415923654" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_638459461415923654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesByCategoryAbstract" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_638459461415923654" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRelatedPartyTransactionsTables" xlink:type="extended" xlink:title="31603 - Disclosure - Related-party transactions (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="DisclosureOfTransactionsBetweenRelatedPartiesAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:label="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_638459461415933660" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_638459461415933660" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureIncomeTaxesTables" xlink:type="extended" xlink:title="31703 - Disclosure - Income taxes (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="MajorComponentsOfTaxExpenseIncomeAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock_638459461415933660" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock_638459461415933660" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_638459461415933660" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_638459461415933660" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock_638459461415933660" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock_638459461415933660" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanTables" xlink:type="extended" xlink:title="31803 - Disclosure - Retirement benefit plan (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="DisclosureOfDefinedBenefitPlansAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock" xlink:label="aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock_638459461415933660" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock_638459461415933660" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock" xlink:label="aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock_638459461415943655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock_638459461415943655" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_638459461415943655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_638459461415943655" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock" xlink:label="aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock_638459461415943655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock_638459461415943655" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_638459461415943655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_638459461415943655" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareBasedCompensationTables" xlink:type="extended" xlink:title="31903 - Disclosure - Share-based compensation (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory_638459461415943655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory_638459461415943655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_638459461415943655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_638459461415943655" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_638459461415943655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_638459461415943655" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_638459461415943655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_638459461415943655" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_638459461415943655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_638459461415943655" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureCommitmentsAndContingenciesTables" xlink:type="extended" xlink:title="32003 - Disclosure - Commitments and contingencies (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CommitmentsAndContingenciesAbstract" xlink:label="CommitmentsAndContingenciesAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory_638459461415953656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesAbstract" xlink:to="ifrs-full_DisclosureOfCommitmentsExplanatory_638459461415953656" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureEarningsPerShareTables" xlink:type="extended" xlink:title="32103 - Disclosure - Earnings per share (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EarningsPerShareExplanatory" xlink:label="ifrs-full_EarningsPerShareExplanatory_638459461415953656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ifrs-full_EarningsPerShareExplanatory_638459461415953656" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023" xlink:label="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023_638459461415953656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023_638459461415953656" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementTables" xlink:type="extended" xlink:title="32203 - Disclosure - Financial instruments and risk management (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" xlink:label="DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock" xlink:label="aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock_638459461415963657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" xlink:to="aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock_638459461415963657" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureGeneralInformationDetails" xlink:type="extended" xlink:title="40101 - Disclosure - General information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_GeneralInformationAbstract" xlink:label="GeneralInformationAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfTechnologyPlatforms" xlink:label="aciu_NumberOfTechnologyPlatforms_638459461415963657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationAbstract" xlink:to="aciu_NumberOfTechnologyPlatforms_638459461415963657" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureBasisOfPreparationGoingConcernDetails" xlink:type="extended" xlink:title="40201 - Disclosure - Basis of preparation - Going concern (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:label="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_GoingConcernAbstract" xlink:label="aciu_GoingConcernAbstract_638459461415963657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="aciu_GoingConcernAbstract_638459461415963657" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents_638459461415973657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_GoingConcernAbstract_638459461415963657" xlink:to="ifrs-full_CashAndCashEquivalents_638459461415973657" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:label="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_638459461415973657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_GoingConcernAbstract_638459461415963657" xlink:to="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_638459461415973657" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesFunctionalAndReportingCurrencyDetails" xlink:type="extended" xlink:title="40301 - Disclosure - Summary of material accounting policies - Functional and reporting currency (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:label="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ForeignExchangeRatesAbstract" xlink:label="ifrs-full_ForeignExchangeRatesAbstract_638459461415973657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_ForeignExchangeRatesAbstract_638459461415973657" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="ifrs-full_ClosingForeignExchangeRate_638459461415973657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ForeignExchangeRatesAbstract_638459461415973657" xlink:to="ifrs-full_ClosingForeignExchangeRate_638459461415973657" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AverageForeignExchangeRate" xlink:label="ifrs-full_AverageForeignExchangeRate_638459461415973657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ForeignExchangeRatesAbstract_638459461415973657" xlink:to="ifrs-full_AverageForeignExchangeRate_638459461415973657" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails" xlink:type="extended" xlink:title="40302 - Disclosure - Summary of material accounting policies, Right-of-use assets and lease liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:label="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_638459461415973657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_638459461415973657" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_638459461415983659" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_638459461415973657" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_638459461415983659" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember_638459461415983659" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_638459461415983659" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember_638459461415983659" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BuildingsMember" xlink:label="ifrs-full_BuildingsMember_638459461415983659" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638459461415983659" xlink:to="ifrs-full_BuildingsMember_638459461415983659" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="ifrs-full_OfficeEquipmentMember_638459461415983659" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638459461415983659" xlink:to="ifrs-full_OfficeEquipmentMember_638459461415983659" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="ifrs-full_ComputerEquipmentMember_638459461415983659" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638459461415983659" xlink:to="ifrs-full_ComputerEquipmentMember_638459461415983659" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_638459461415983659" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_638459461415973657" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_638459461415983659" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_638459461415983659" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_638459461415983659" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_638459461415983659" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_EstimatedLeaseTerm" xlink:label="aciu_EstimatedLeaseTerm_638459461415983659" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_638459461415983659" xlink:to="aciu_EstimatedLeaseTerm_638459461415983659" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPropertyPlantAndEquipmentDetails" xlink:type="extended" xlink:title="40303 - Disclosure - Summary of material accounting policies, Property, plant and equipment (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:label="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_638459461415983659" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_638459461415983659" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_638459461415983659" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_638459461415983659" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_638459461415983659" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember_638459461415983659" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_638459461415983659" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember_638459461415983659" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="ifrs-full_ComputerEquipmentMember_638459461415993656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638459461415983659" xlink:to="ifrs-full_ComputerEquipmentMember_638459461415993656" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_LaboratoryEquipmentMember" xlink:label="aciu_LaboratoryEquipmentMember_638459461415993656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638459461415983659" xlink:to="aciu_LaboratoryEquipmentMember_638459461415993656" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_LeaseholdImprovementsAndFixturesAndFittingsMember" xlink:label="aciu_LeaseholdImprovementsAndFixturesAndFittingsMember_638459461415993656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638459461415983659" xlink:to="aciu_LeaseholdImprovementsAndFixturesAndFittingsMember_638459461415993656" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_638459461415993656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_638459461415983659" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_638459461415993656" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract" xlink:label="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract_638459461415993656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_638459461415993656" xlink:to="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract_638459461415993656" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_638459461415993656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract_638459461415993656" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_638459461415993656" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesIncomeTaxesDetails" xlink:type="extended" xlink:title="40304 - Disclosure - Summary of material accounting policies, Income taxes (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:label="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_638459461415993656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_638459461415993656" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncomeTaxLossCarryforwardPeriod" xlink:label="aciu_IncomeTaxLossCarryforwardPeriod_638459461415993656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_638459461415993656" xlink:to="aciu_IncomeTaxLossCarryforwardPeriod_638459461415993656" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxAssets" xlink:label="ifrs-full_DeferredTaxAssets_638459461416003656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_638459461415993656" xlink:to="ifrs-full_DeferredTaxAssets_638459461416003656" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesSegmentReportingDetails" xlink:type="extended" xlink:title="40305 - Disclosure - Summary of material accounting policies, Segment reporting (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:label="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract_638459461416003656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsAbstract_638459461416003656" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_OperatingSegmentsNumber" xlink:label="aciu_OperatingSegmentsNumber_638459461416003656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract_638459461416003656" xlink:to="aciu_OperatingSegmentsNumber_638459461416003656" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ReportableSegmentsNumber" xlink:label="aciu_ReportableSegmentsNumber_638459461416003656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract_638459461416003656" xlink:to="aciu_ReportableSegmentsNumber_638459461416003656" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails" xlink:type="extended" xlink:title="40401 - Disclosure - Property, plant and equipment (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="DisclosureOfPropertyPlantAndEquipmentAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_638459461416003656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_638459461416003656" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_638459461416003656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_638459461416003656" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_638459461416003656" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember_638459461416003656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_638459461416003656" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember_638459461416003656" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="ifrs-full_FixturesAndFittingsMember_638459461416013655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638459461416003656" xlink:to="ifrs-full_FixturesAndFittingsMember_638459461416013655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="ifrs-full_ComputerEquipmentMember_638459461416013655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638459461416003656" xlink:to="ifrs-full_ComputerEquipmentMember_638459461416013655" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_LaboratoryEquipmentMember" xlink:label="aciu_LaboratoryEquipmentMember_638459461416013655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638459461416003656" xlink:to="aciu_LaboratoryEquipmentMember_638459461416013655" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="ifrs-full_LeaseholdImprovementsMember_638459461416013655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638459461416003656" xlink:to="ifrs-full_LeaseholdImprovementsMember_638459461416013655" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="ifrs-full_ConstructionInProgressMember_638459461416013655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638459461416003656" xlink:to="ifrs-full_ConstructionInProgressMember_638459461416013655" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ItAndLaboratoryEquipmentMember" xlink:label="aciu_ItAndLaboratoryEquipmentMember_638459461416013655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638459461416003656" xlink:to="aciu_ItAndLaboratoryEquipmentMember_638459461416013655" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_638459461416013655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_638459461416003656" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_638459461416013655" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="ifrs-full_CarryingAmountMember_638459461416013655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_638459461416013655" xlink:to="ifrs-full_CarryingAmountMember_638459461416013655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="ifrs-full_GrossCarryingAmountMember_638459461416013655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountMember_638459461416013655" xlink:to="ifrs-full_GrossCarryingAmountMember_638459461416013655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember_638459461416013655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountMember_638459461416013655" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember_638459461416013655" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_638459461416013655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_638459461416003656" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_638459461416013655" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:label="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_638459461416013655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_638459461416013655" xlink:to="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_638459461416013655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment_638459461416023658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_638459461416013655" xlink:to="ifrs-full_PropertyPlantAndEquipment_638459461416023658" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_638459461416023658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_638459461416013655" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_638459461416023658" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_638459461416023658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_638459461416013655" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_638459461416023658" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_638459461416023658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_638459461416013655" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment_638459461416023658" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment_638459461416023658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_638459461416013655" xlink:to="ifrs-full_DisposalsPropertyPlantAndEquipment_638459461416023658" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment_6384594614160236581" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_638459461416013655" xlink:to="ifrs-full_PropertyPlantAndEquipment_6384594614160236581" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PercentageIncreaseInPropertyPlantAndEquipment" xlink:label="aciu_PercentageIncreaseInPropertyPlantAndEquipment_638459461416023658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_638459461416013655" xlink:to="aciu_PercentageIncreaseInPropertyPlantAndEquipment_638459461416023658" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails" xlink:type="extended" xlink:title="40501 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="PresentationOfLeasesForLesseeAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_638459461416033656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_638459461416033656" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ifrs-full_ClassesOfAssetsAxis_638459461416033656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_638459461416033656" xlink:to="ifrs-full_ClassesOfAssetsAxis_638459461416033656" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="ifrs-full_ClassesOfAssetsMember_638459461416033656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis_638459461416033656" xlink:to="ifrs-full_ClassesOfAssetsMember_638459461416033656" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember_638459461416033656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsMember_638459461416033656" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember_638459461416033656" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BuildingsMember" xlink:label="ifrs-full_BuildingsMember_638459461416033656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638459461416033656" xlink:to="ifrs-full_BuildingsMember_638459461416033656" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="ifrs-full_OfficeEquipmentMember_638459461416033656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638459461416033656" xlink:to="ifrs-full_OfficeEquipmentMember_638459461416033656" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="ifrs-full_ComputerEquipmentMember_638459461416033656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember_638459461416033656" xlink:to="ifrs-full_ComputerEquipmentMember_638459461416033656" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_638459461416033656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_638459461416033656" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_638459461416033656" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_638459461416033656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_638459461416033656" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_638459461416033656" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="ifrs-full_AdditionsToRightofuseAssets_638459461416033656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_638459461416033656" xlink:to="ifrs-full_AdditionsToRightofuseAssets_638459461416033656" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:label="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_638459461416033656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_638459461416033656" xlink:to="ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_638459461416033656" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RightOfUseLeasedAssetsAbstract" xlink:label="aciu_RightOfUseLeasedAssetsAbstract_638459461416033656" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract_638459461416033656" xlink:to="aciu_RightOfUseLeasedAssetsAbstract_638459461416033656" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets_638459461416043655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_RightOfUseLeasedAssetsAbstract_638459461416033656" xlink:to="ifrs-full_RightofuseAssets_638459461416043655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="ifrs-full_DepreciationRightofuseAssets_638459461416043655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_RightOfUseLeasedAssetsAbstract_638459461416033656" xlink:to="ifrs-full_DepreciationRightofuseAssets_638459461416043655" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets_6384594614160436551" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_RightOfUseLeasedAssetsAbstract_638459461416033656" xlink:to="ifrs-full_RightofuseAssets_6384594614160436551" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails" xlink:type="extended" xlink:title="40502 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities - Statement of income/(loss) and cash flow (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="PresentationOfLeasesForLesseeAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract" xlink:label="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract_638459461416043655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PresentationOfLeasesForLesseeAbstract" xlink:to="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract_638459461416043655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="ifrs-full_DepreciationRightofuseAssets_638459461416043655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract_638459461416043655" xlink:to="ifrs-full_DepreciationRightofuseAssets_638459461416043655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_638459461416043655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract_638459461416043655" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities_638459461416043655" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_638459461416043655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract_638459461416043655" xlink:to="ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_638459461416043655" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ExpenseRelatingToLeases" xlink:label="aciu_ExpenseRelatingToLeases_638459461416043655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract_638459461416043655" xlink:to="aciu_ExpenseRelatingToLeases_638459461416043655" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashOutflowForLeases" xlink:label="ifrs-full_CashOutflowForLeases_638459461416043655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract_638459461416043655" xlink:to="ifrs-full_CashOutflowForLeases_638459461416043655" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails" xlink:type="extended" xlink:title="40503 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities - Contractual undiscounted cash flows for lease obligations (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="PresentationOfLeasesForLesseeAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_638459461416053657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_638459461416053657" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis_638459461416053657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_638459461416053657" xlink:to="ifrs-full_MaturityAxis_638459461416053657" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember_638459461416053657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis_638459461416053657" xlink:to="ifrs-full_AggregatedTimeBandsMember_638459461416053657" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="ifrs-full_NotLaterThanOneYearMember_638459461416053657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638459461416053657" xlink:to="ifrs-full_NotLaterThanOneYearMember_638459461416053657" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_638459461416053657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638459461416053657" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_638459461416053657" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_638459461416053657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638459461416053657" xlink:to="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_638459461416053657" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_638459461416053657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_638459461416053657" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_638459461416053657" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract" xlink:label="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract_638459461416053657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_638459461416053657" xlink:to="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract_638459461416053657" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossLeaseLiabilities" xlink:label="ifrs-full_GrossLeaseLiabilities_638459461416053657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract_638459461416053657" xlink:to="ifrs-full_GrossLeaseLiabilities_638459461416053657" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfDepositsInEscrowAccounts" xlink:label="aciu_NumberOfDepositsInEscrowAccounts_638459461416053657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract_638459461416053657" xlink:to="aciu_NumberOfDepositsInEscrowAccounts_638459461416053657" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_EscrowDepositAmount" xlink:label="aciu_EscrowDepositAmount_638459461416053657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract_638459461416053657" xlink:to="aciu_EscrowDepositAmount_638459461416053657" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureAssetAcquisitionDetails" xlink:type="extended" xlink:title="40601 - Disclosure - Asset acquisition (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AssetAcquisitionsAbstract" xlink:label="AssetAcquisitionsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable_638459461416063655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionsAbstract" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsTable_638459461416063655" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AssetAcquisitionsAxis" xlink:label="aciu_AssetAcquisitionsAxis_638459461416063655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable_638459461416063655" xlink:to="aciu_AssetAcquisitionsAxis_638459461416063655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SignificantAssetAcquisitionsTotalDomain" xlink:label="aciu_SignificantAssetAcquisitionsTotalDomain_638459461416063655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AssetAcquisitionsAxis_638459461416063655" xlink:to="aciu_SignificantAssetAcquisitionsTotalDomain_638459461416063655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember" xlink:label="aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_638459461416063655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_SignificantAssetAcquisitionsTotalDomain_638459461416063655" xlink:to="aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_638459461416063655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_638459461416063655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable_638459461416063655" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_638459461416063655" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_638459461416063655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_638459461416063655" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_638459461416063655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member" xlink:label="aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_638459461416063655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_638459461416063655" xlink:to="aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_638459461416063655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnobservableInputsAxis" xlink:label="ifrs-full_UnobservableInputsAxis_638459461416063655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable_638459461416063655" xlink:to="ifrs-full_UnobservableInputsAxis_638459461416063655" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnobservableInputsMember" xlink:label="ifrs-full_UnobservableInputsMember_638459461416063655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_UnobservableInputsAxis_638459461416063655" xlink:to="ifrs-full_UnobservableInputsMember_638459461416063655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DiscountRateMeasurementInputMember" xlink:label="ifrs-full_DiscountRateMeasurementInputMember_638459461416063655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_UnobservableInputsMember_638459461416063655" xlink:to="ifrs-full_DiscountRateMeasurementInputMember_638459461416063655" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsLineItems_638459461416063655" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable_638459461416063655" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsLineItems_638459461416063655" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SharesTransferredAsConsiderationInAssetAcquisition" xlink:label="aciu_SharesTransferredAsConsiderationInAssetAcquisition_638459461416073657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems_638459461416063655" xlink:to="aciu_SharesTransferredAsConsiderationInAssetAcquisition_638459461416073657" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition" xlink:label="aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition_638459461416073657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems_638459461416063655" xlink:to="aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition_638459461416073657" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantUnobservableInputAssets" xlink:label="ifrs-full_SignificantUnobservableInputAssets_638459461416073657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems_638459461416063655" xlink:to="ifrs-full_SignificantUnobservableInputAssets_638459461416073657" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CashAcquiredAsPartOfAssetAcquisition" xlink:label="aciu_CashAcquiredAsPartOfAssetAcquisition_638459461416073657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems_638459461416063655" xlink:to="aciu_CashAcquiredAsPartOfAssetAcquisition_638459461416073657" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition" xlink:label="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition_638459461416073657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems_638459461416063655" xlink:to="aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition_638459461416073657" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TotalAssetsAcquiredInAssetAcquisition" xlink:label="aciu_TotalAssetsAcquiredInAssetAcquisition_638459461416073657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems_638459461416063655" xlink:to="aciu_TotalAssetsAcquiredInAssetAcquisition_638459461416073657" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureIntangibleAssetsDetails" xlink:type="extended" xlink:title="40701 - Disclosure - Intangible assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="DisclosureOfIntangibleAssetsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable_638459461416073657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfIntangibleAssetsAbstract" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsTable_638459461416073657" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_638459461416073657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable_638459461416073657" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_638459461416073657" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_638459461416073657" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_638459461416073657" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_638459461416073657" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_InProcessResearchAndDevelopmentIPRDAssetMember" xlink:label="aciu_InProcessResearchAndDevelopmentIPRDAssetMember_638459461416083658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwillMember_638459461416073657" xlink:to="aciu_InProcessResearchAndDevelopmentIPRDAssetMember_638459461416083658" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_638459461416083658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable_638459461416073657" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_638459461416083658" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember" xlink:label="ifrs-full_CarryingAmountMember_638459461416083658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_638459461416083658" xlink:to="ifrs-full_CarryingAmountMember_638459461416083658" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="ifrs-full_GrossCarryingAmountMember_638459461416083658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountMember_638459461416083658" xlink:to="ifrs-full_GrossCarryingAmountMember_638459461416083658" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember_638459461416083658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountMember_638459461416083658" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember_638459461416083658" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnobservableInputsAxis" xlink:label="ifrs-full_UnobservableInputsAxis_638459461416083658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable_638459461416073657" xlink:to="ifrs-full_UnobservableInputsAxis_638459461416083658" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnobservableInputsMember" xlink:label="ifrs-full_UnobservableInputsMember_638459461416083658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_UnobservableInputsAxis_638459461416083658" xlink:to="ifrs-full_UnobservableInputsMember_638459461416083658" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DiscountRateMeasurementInputMember" xlink:label="ifrs-full_DiscountRateMeasurementInputMember_638459461416083658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_UnobservableInputsMember_638459461416083658" xlink:to="ifrs-full_DiscountRateMeasurementInputMember_638459461416083658" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsLineItems_638459461416083658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable_638459461416073657" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsLineItems_638459461416083658" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract_638459461416083658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsLineItems_638459461416083658" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract_638459461416083658" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_638459461416083658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract_638459461416083658" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_638459461416083658" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SignificantUnobservableInputAssets" xlink:label="ifrs-full_SignificantUnobservableInputAssets_638459461416083658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract_638459461416083658" xlink:to="ifrs-full_SignificantUnobservableInputAssets_638459461416083658" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails" xlink:type="extended" xlink:title="40801 - Disclosure - Cash and cash equivalents and financial assets, Cash and cash equivalents (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:label="DisclosureOfFinancialAssetsAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CashAndCashEquivalentsTable" xlink:label="aciu_CashAndCashEquivalentsTable_638459461416093658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfFinancialAssetsAbstract" xlink:to="aciu_CashAndCashEquivalentsTable_638459461416093658" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis_638459461416093658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CashAndCashEquivalentsTable_638459461416093658" xlink:to="srt_CurrencyAxis_638459461416093658" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="currency_AllCurrenciesDomain_638459461416093658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CurrencyAxis_638459461416093658" xlink:to="currency_AllCurrenciesDomain_638459461416093658" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_CHF" xlink:label="currency_CHF_638459461416093658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="currency_AllCurrenciesDomain_638459461416093658" xlink:to="currency_CHF_638459461416093658" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_EUR" xlink:label="currency_EUR_638459461416093658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="currency_AllCurrenciesDomain_638459461416093658" xlink:to="currency_EUR_638459461416093658" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_USD" xlink:label="currency_USD_638459461416093658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="currency_AllCurrenciesDomain_638459461416093658" xlink:to="currency_USD_638459461416093658" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CashAndCashEquivalentLineItems" xlink:label="aciu_CashAndCashEquivalentLineItems_638459461416093658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CashAndCashEquivalentsTable_638459461416093658" xlink:to="aciu_CashAndCashEquivalentLineItems_638459461416093658" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAbstract" xlink:label="ifrs-full_CashAbstract_638459461416093658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CashAndCashEquivalentLineItems_638459461416093658" xlink:to="ifrs-full_CashAbstract_638459461416093658" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents_638459461416093658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashAbstract_638459461416093658" xlink:to="ifrs-full_CashAndCashEquivalents_638459461416093658" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="ifrs-full_ClosingForeignExchangeRate_638459461416093658" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashAbstract_638459461416093658" xlink:to="ifrs-full_ClosingForeignExchangeRate_638459461416093658" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails" xlink:type="extended" xlink:title="40802 - Disclosure - Cash and cash equivalents and financial assets, Cash and cash equivalents and short-term financial assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:label="DisclosureOfFinancialAssetsAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CashAndCashEquivalentsTable" xlink:label="aciu_CashAndCashEquivalentsTable_638459461416103662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfFinancialAssetsAbstract" xlink:to="aciu_CashAndCashEquivalentsTable_638459461416103662" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis_638459461416103662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CashAndCashEquivalentsTable_638459461416103662" xlink:to="srt_CurrencyAxis_638459461416103662" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="currency_AllCurrenciesDomain_638459461416103662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CurrencyAxis_638459461416103662" xlink:to="currency_AllCurrenciesDomain_638459461416103662" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_CHF" xlink:label="currency_CHF_638459461416103662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="currency_AllCurrenciesDomain_638459461416103662" xlink:to="currency_CHF_638459461416103662" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_USD" xlink:label="currency_USD_638459461416103662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="currency_AllCurrenciesDomain_638459461416103662" xlink:to="currency_USD_638459461416103662" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CashAndCashEquivalentLineItems" xlink:label="aciu_CashAndCashEquivalentLineItems_638459461416103662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CashAndCashEquivalentsTable_638459461416103662" xlink:to="aciu_CashAndCashEquivalentLineItems_638459461416103662" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MiscellaneousCurrentAssetsAbstract" xlink:label="ifrs-full_MiscellaneousCurrentAssetsAbstract_638459461416103662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CashAndCashEquivalentLineItems_638459461416103662" xlink:to="ifrs-full_MiscellaneousCurrentAssetsAbstract_638459461416103662" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:label="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_638459461416103662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MiscellaneousCurrentAssetsAbstract_638459461416103662" xlink:to="ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_638459461416103662" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails" xlink:type="extended" xlink:title="40901 - Disclosure - Prepaid expenses and accrued income (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract" xlink:label="CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract" xlink:label="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract_638459461416113728" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract" xlink:to="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract_638459461416113728" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="ifrs-full_CurrentPrepaidExpenses_638459461416113728" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract_638459461416113728" xlink:to="ifrs-full_CurrentPrepaidExpenses_638459461416113728" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" xlink:label="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_638459461416113728" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract_638459461416113728" xlink:to="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_638459461416113728" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets" xlink:label="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets_638459461416113728" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract_638459461416113728" xlink:to="ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets_638459461416113728" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureAccountsReceivableDetails" xlink:type="extended" xlink:title="41001 - Disclosure - Accounts receivable (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="TradeAndOtherReceivablesAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="ifrs-full_DisclosureOfFinancialAssetsTable_638459461416113728" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TradeAndOtherReceivablesAbstract" xlink:to="ifrs-full_DisclosureOfFinancialAssetsTable_638459461416113728" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesAxis" xlink:label="ifrs-full_CounterpartiesAxis_638459461416113728" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialAssetsTable_638459461416113728" xlink:to="ifrs-full_CounterpartiesAxis_638459461416113728" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesMember" xlink:label="ifrs-full_CounterpartiesMember_638459461416113728" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CounterpartiesAxis_638459461416113728" xlink:to="ifrs-full_CounterpartiesMember_638459461416113728" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_JJInnovativeMedicineMember" xlink:label="aciu_JJInnovativeMedicineMember_638459461416113728" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CounterpartiesMember_638459461416113728" xlink:to="aciu_JJInnovativeMedicineMember_638459461416113728" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:label="ifrs-full_DisclosureOfFinancialAssetsLineItems_638459461416113728" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialAssetsTable_638459461416113728" xlink:to="ifrs-full_DisclosureOfFinancialAssetsLineItems_638459461416113728" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="ifrs-full_CurrentTradeReceivables_638459461416113728" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems_638459461416113728" xlink:to="ifrs-full_CurrentTradeReceivables_638459461416113728" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails" xlink:type="extended" xlink:title="41101 - Disclosure - Other current receivables (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_OtherCurrentReceivablesAbstract" xlink:label="OtherCurrentReceivablesAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfOtherCurrentReceivablesTable" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesTable_638459461416123677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherCurrentReceivablesAbstract" xlink:to="aciu_DisclosureOfOtherCurrentReceivablesTable_638459461416123677" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638459461416123677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_DisclosureOfOtherCurrentReceivablesTable_638459461416123677" xlink:to="ifrs-full_RangeAxis_638459461416123677" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638459461416123677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638459461416123677" xlink:to="ifrs-full_RangesMember_638459461416123677" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638459461416123677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638459461416123677" xlink:to="ifrs-full_TopOfRangeMember_638459461416123677" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfOtherCurrentReceivablesLineItems" xlink:label="aciu_DisclosureOfOtherCurrentReceivablesLineItems_638459461416123677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_DisclosureOfOtherCurrentReceivablesTable_638459461416123677" xlink:to="aciu_DisclosureOfOtherCurrentReceivablesLineItems_638459461416123677" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract_638459461416123677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_DisclosureOfOtherCurrentReceivablesLineItems_638459461416123677" xlink:to="ifrs-full_TradeAndOtherReceivablesAbstract_638459461416123677" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_MiscellaneousOtherCurrentReceivables" xlink:label="aciu_MiscellaneousOtherCurrentReceivables_638459461416123677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract_638459461416123677" xlink:to="aciu_MiscellaneousOtherCurrentReceivables_638459461416123677" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentValueAddedTaxReceivables" xlink:label="ifrs-full_CurrentValueAddedTaxReceivables_638459461416123677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract_638459461416123677" xlink:to="ifrs-full_CurrentValueAddedTaxReceivables_638459461416123677" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WithholdingTaxReceivables" xlink:label="aciu_WithholdingTaxReceivables_638459461416123677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract_638459461416123677" xlink:to="aciu_WithholdingTaxReceivables_638459461416123677" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="ifrs-full_OtherCurrentReceivables_638459461416123677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract_638459461416123677" xlink:to="ifrs-full_OtherCurrentReceivables_638459461416123677" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_MaturityPeriodOtherCurrentReceivables" xlink:label="aciu_MaturityPeriodOtherCurrentReceivables_638459461416123677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_DisclosureOfOtherCurrentReceivablesLineItems_638459461416123677" xlink:to="aciu_MaturityPeriodOtherCurrentReceivables_638459461416123677" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareCapitalNarrativesDetails" xlink:type="extended" xlink:title="41201 - Disclosure - Share capital - Narratives (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="DisclosureOfClassesOfShareCapitalAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416133671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfClassesOfShareCapitalAbstract" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416133671" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_638459461416133671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416133671" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_638459461416133671" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember_638459461416133671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis_638459461416133671" xlink:to="ifrs-full_ClassesOfShareCapitalMember_638459461416133671" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember_638459461416133671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalMember_638459461416133671" xlink:to="ifrs-full_OrdinarySharesMember_638459461416133671" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416133671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416133671" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416133671" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapital" xlink:label="ifrs-full_IssuedCapital_638459461416133671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416133671" xlink:to="ifrs-full_IssuedCapital_638459461416133671" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="ifrs-full_NumberOfSharesIssued_638459461416133671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416133671" xlink:to="ifrs-full_NumberOfSharesIssued_638459461416133671" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_638459461416133671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416133671" xlink:to="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_638459461416133671" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails" xlink:type="extended" xlink:title="41202 - Disclosure - Share capital - Capital Structure (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="DisclosureOfClassesOfShareCapitalAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416143668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfClassesOfShareCapitalAbstract" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416143668" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ifrs-full_ComponentsOfEquityAxis_638459461416143668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416143668" xlink:to="ifrs-full_ComponentsOfEquityAxis_638459461416143668" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityMember" xlink:label="ifrs-full_EquityMember_638459461416143668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis_638459461416143668" xlink:to="ifrs-full_EquityMember_638459461416143668" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapitalMember" xlink:label="ifrs-full_IssuedCapitalMember_638459461416143668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityMember_638459461416143668" xlink:to="ifrs-full_IssuedCapitalMember_638459461416143668" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremiumMember" xlink:label="ifrs-full_SharePremiumMember_638459461416143668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityMember_638459461416143668" xlink:to="ifrs-full_SharePremiumMember_638459461416143668" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TreasurySharesMember" xlink:label="ifrs-full_TreasurySharesMember_638459461416143668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityMember_638459461416143668" xlink:to="ifrs-full_TreasurySharesMember_638459461416143668" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_638459461416143668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416143668" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_638459461416143668" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember_638459461416143668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis_638459461416143668" xlink:to="ifrs-full_ClassesOfShareCapitalMember_638459461416143668" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember_638459461416143668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalMember_638459461416143668" xlink:to="ifrs-full_OrdinarySharesMember_638459461416143668" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TreasurySharesMember" xlink:label="ifrs-full_TreasurySharesMember_6384594614161436681" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OrdinarySharesMember_638459461416143668" xlink:to="ifrs-full_TreasurySharesMember_6384594614161436681" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416143668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416143668" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416143668" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract" xlink:label="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_638459461416143668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416143668" xlink:to="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_638459461416143668" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="ifrs-full_NumberOfSharesOutstanding_638459461416143668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_638459461416143668" xlink:to="ifrs-full_NumberOfSharesOutstanding_638459461416143668" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt_638459461416153668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_638459461416143668" xlink:to="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt_638459461416153668" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans_638459461416153668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_638459461416143668" xlink:to="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans_638459461416153668" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ProceedsFromPublicOfferingsNetOfUnderwritingFeesAndTransactionEquityShares" xlink:label="aciu_ProceedsFromPublicOfferingsNetOfUnderwritingFeesAndTransactionEquityShares_638459461416153668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_638459461416143668" xlink:to="aciu_ProceedsFromPublicOfferingsNetOfUnderwritingFeesAndTransactionEquityShares_638459461416153668" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" xlink:label="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares_638459461416153668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_638459461416143668" xlink:to="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares_638459461416153668" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="ifrs-full_NumberOfSharesOutstanding_638459461416153668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract_638459461416143668" xlink:to="ifrs-full_NumberOfSharesOutstanding_638459461416153668" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract" xlink:label="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract_638459461416153668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416143668" xlink:to="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract_638459461416153668" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_638459461416153668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract_638459461416153668" xlink:to="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_638459461416153668" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" xlink:label="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares_6384594614161536681" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract_638459461416153668" xlink:to="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares_6384594614161536681" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance" xlink:label="aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance_638459461416153668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract_638459461416153668" xlink:to="aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance_638459461416153668" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_6384594614161536681" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract_638459461416153668" xlink:to="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_6384594614161536681" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ChangesInEquityAbstract" xlink:label="ifrs-full_ChangesInEquityAbstract_638459461416163665" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416143668" xlink:to="ifrs-full_ChangesInEquityAbstract_638459461416163665" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity_638459461416163665" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInEquityAbstract_638459461416163665" xlink:to="ifrs-full_Equity_638459461416163665" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost" xlink:label="aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost_638459461416163665" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInEquityAbstract_638459461416163665" xlink:to="aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost_638459461416163665" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts" xlink:label="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_638459461416163665" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInEquityAbstract_638459461416163665" xlink:to="aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts_638459461416163665" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseThroughSharesIssuedUnderIncentivePlans" xlink:label="aciu_IncreaseThroughSharesIssuedUnderIncentivePlans_638459461416163665" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInEquityAbstract_638459461416163665" xlink:to="aciu_IncreaseThroughSharesIssuedUnderIncentivePlans_638459461416163665" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity_6384594614161636651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInEquityAbstract_638459461416163665" xlink:to="ifrs-full_Equity_6384594614161636651" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare_638459461416163665" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416143668" xlink:to="ifrs-full_ParValuePerShare_638459461416163665" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareCapitalAuthorizedCapitalDetails" xlink:type="extended" xlink:title="41203 - Disclosure - Share capital - Authorized capital (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="DisclosureOfClassesOfShareCapitalAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue" xlink:label="aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue_638459461416173668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfClassesOfShareCapitalAbstract" xlink:to="aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue_638459461416173668" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue" xlink:label="aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue_638459461416173668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfClassesOfShareCapitalAbstract" xlink:to="aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue_638459461416173668" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare_638459461416173668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfClassesOfShareCapitalAbstract" xlink:to="ifrs-full_ParValuePerShare_638459461416173668" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForFinancingAndOtherPurposesDetails" xlink:type="extended" xlink:title="41204 - Disclosure - Share capital - Conditional share capital for financing and other purposes (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="DisclosureOfClassesOfShareCapitalAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416173668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfClassesOfShareCapitalAbstract" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416173668" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_638459461416173668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416173668" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_638459461416173668" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember_638459461416183671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis_638459461416173668" xlink:to="ifrs-full_ClassesOfShareCapitalMember_638459461416183671" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember" xlink:label="aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember_638459461416183671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalMember_638459461416183671" xlink:to="aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember_638459461416183671" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638459461416183671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416173668" xlink:to="ifrs-full_RangeAxis_638459461416183671" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638459461416183671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638459461416183671" xlink:to="ifrs-full_RangesMember_638459461416183671" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638459461416183671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638459461416183671" xlink:to="ifrs-full_TopOfRangeMember_638459461416183671" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416183671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416173668" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416183671" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ConditionalShareCapitalAbstract" xlink:label="aciu_ConditionalShareCapitalAbstract_638459461416183671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416183671" xlink:to="aciu_ConditionalShareCapitalAbstract_638459461416183671" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments" xlink:label="aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments_638459461416183671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConditionalShareCapitalAbstract_638459461416183671" xlink:to="aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments_638459461416183671" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments" xlink:label="aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments_638459461416183671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConditionalShareCapitalAbstract_638459461416183671" xlink:to="aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments_638459461416183671" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare_638459461416183671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConditionalShareCapitalAbstract_638459461416183671" xlink:to="ifrs-full_ParValuePerShare_638459461416183671" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails" xlink:type="extended" xlink:title="41205 - Disclosure - Share capital - Conditional share capital for employee benefit plans (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="DisclosureOfClassesOfShareCapitalAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416193663" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfClassesOfShareCapitalAbstract" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416193663" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_638459461416193663" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416193663" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_638459461416193663" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember_638459461416193663" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis_638459461416193663" xlink:to="ifrs-full_ClassesOfShareCapitalMember_638459461416193663" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember" xlink:label="aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_638459461416193663" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalMember_638459461416193663" xlink:to="aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_638459461416193663" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638459461416193663" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416193663" xlink:to="ifrs-full_RangeAxis_638459461416193663" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638459461416193663" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638459461416193663" xlink:to="ifrs-full_RangesMember_638459461416193663" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638459461416193663" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638459461416193663" xlink:to="ifrs-full_TopOfRangeMember_638459461416193663" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416193663" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416193663" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416193663" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ConditionalShareCapitalAbstract" xlink:label="aciu_ConditionalShareCapitalAbstract_638459461416193663" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416193663" xlink:to="aciu_ConditionalShareCapitalAbstract_638459461416193663" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions" xlink:label="aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions_638459461416193663" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConditionalShareCapitalAbstract_638459461416193663" xlink:to="aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions_638459461416193663" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions" xlink:label="aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions_638459461416193663" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConditionalShareCapitalAbstract_638459461416193663" xlink:to="aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions_638459461416193663" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare_638459461416193663" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConditionalShareCapitalAbstract_638459461416193663" xlink:to="ifrs-full_ParValuePerShare_638459461416193663" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits" xlink:label="aciu_NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits_638459461416193663" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConditionalShareCapitalAbstract_638459461416193663" xlink:to="aciu_NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits_638459461416193663" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareCapitalFollowOnOfferingDetails" xlink:type="extended" xlink:title="41206 - Disclosure - Share capital - Follow-On Offering (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="DisclosureOfClassesOfShareCapitalAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416203667" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfClassesOfShareCapitalAbstract" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416203667" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_638459461416203667" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416203667" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_638459461416203667" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember_638459461416203667" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis_638459461416203667" xlink:to="ifrs-full_ClassesOfShareCapitalMember_638459461416203667" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_FollowOnOfferingMember" xlink:label="aciu_FollowOnOfferingMember_638459461416203667" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalMember_638459461416203667" xlink:to="aciu_FollowOnOfferingMember_638459461416203667" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416203667" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416203667" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416203667" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfSharesIssuedDuringPeriod" xlink:label="aciu_NumberOfSharesIssuedDuringPeriod_638459461416203667" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416203667" xlink:to="aciu_NumberOfSharesIssuedDuringPeriod_638459461416203667" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="ifrs-full_ShareIssueRelatedCost_638459461416203667" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416203667" xlink:to="ifrs-full_ShareIssueRelatedCost_638459461416203667" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NetProceedsFromIssuanceOfShares" xlink:label="aciu_NetProceedsFromIssuanceOfShares_638459461416203667" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416203667" xlink:to="aciu_NetProceedsFromIssuanceOfShares_638459461416203667" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares_638459461416203667" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416203667" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares_638459461416203667" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails" xlink:type="extended" xlink:title="41207 - Disclosure - Share capital - Shelf registration statement (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="DisclosureOfClassesOfShareCapitalAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416213665" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfClassesOfShareCapitalAbstract" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416213665" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638459461416213665" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416213665" xlink:to="ifrs-full_RangeAxis_638459461416213665" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638459461416213665" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638459461416213665" xlink:to="ifrs-full_RangesMember_638459461416213665" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638459461416213665" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638459461416213665" xlink:to="ifrs-full_TopOfRangeMember_638459461416213665" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416213665" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416213665" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416213665" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement" xlink:label="aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement_638459461416213665" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416213665" xlink:to="aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement_638459461416213665" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails" xlink:type="extended" xlink:title="41208 - Disclosure - Share capital - At the market equity offering (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="DisclosureOfClassesOfShareCapitalAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416213665" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfClassesOfShareCapitalAbstract" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416213665" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_638459461416213665" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416213665" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_638459461416213665" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember_638459461416213665" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis_638459461416213665" xlink:to="ifrs-full_ClassesOfShareCapitalMember_638459461416213665" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AtTheMarketEquityOfferingMember" xlink:label="aciu_AtTheMarketEquityOfferingMember_638459461416223669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalMember_638459461416213665" xlink:to="aciu_AtTheMarketEquityOfferingMember_638459461416223669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SecondOpenMarketSalesAgreementMember" xlink:label="aciu_SecondOpenMarketSalesAgreementMember_638459461416223669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalMember_638459461416213665" xlink:to="aciu_SecondOpenMarketSalesAgreementMember_638459461416223669" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416223669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416213665" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416223669" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AtTheMarketEquityOfferingAbstract" xlink:label="aciu_AtTheMarketEquityOfferingAbstract_638459461416223669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416223669" xlink:to="aciu_AtTheMarketEquityOfferingAbstract_638459461416223669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares" xlink:label="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares_638459461416223669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AtTheMarketEquityOfferingAbstract_638459461416223669" xlink:to="aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares_638459461416223669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="ifrs-full_NumberOfSharesIssued_638459461416223669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AtTheMarketEquityOfferingAbstract_638459461416223669" xlink:to="ifrs-full_NumberOfSharesIssued_638459461416223669" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare_638459461416223669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AtTheMarketEquityOfferingAbstract_638459461416223669" xlink:to="ifrs-full_ParValuePerShare_638459461416223669" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket" xlink:label="aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket_638459461416223669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AtTheMarketEquityOfferingAbstract_638459461416223669" xlink:to="aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket_638459461416223669" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SaleOrIssueOfTreasurySharesShares" xlink:label="aciu_SaleOrIssueOfTreasurySharesShares_638459461416223669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AtTheMarketEquityOfferingAbstract_638459461416223669" xlink:to="aciu_SaleOrIssueOfTreasurySharesShares_638459461416223669" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares" xlink:label="ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares_638459461416223669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AtTheMarketEquityOfferingAbstract_638459461416223669" xlink:to="ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares_638459461416223669" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CommissionsPaidForIssuanceOrdinaryShares" xlink:label="aciu_CommissionsPaidForIssuanceOrdinaryShares_638459461416223669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AtTheMarketEquityOfferingAbstract_638459461416223669" xlink:to="aciu_CommissionsPaidForIssuanceOrdinaryShares_638459461416223669" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="ifrs-full_ShareIssueRelatedCost_638459461416223669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_AtTheMarketEquityOfferingAbstract_638459461416223669" xlink:to="ifrs-full_ShareIssueRelatedCost_638459461416223669" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails" xlink:type="extended" xlink:title="41209 - Disclosure - Share capital - Convertible note agreement (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="DisclosureOfClassesOfShareCapitalAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416233667" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfClassesOfShareCapitalAbstract" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416233667" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_638459461416233667" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416233667" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_638459461416233667" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="ifrs-full_ClassesOfShareCapitalMember_638459461416233667" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis_638459461416233667" xlink:to="ifrs-full_ClassesOfShareCapitalMember_638459461416233667" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ConvertibleNoteAgreementMember" xlink:label="aciu_ConvertibleNoteAgreementMember_638459461416233667" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalMember_638459461416233667" xlink:to="aciu_ConvertibleNoteAgreementMember_638459461416233667" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638459461416233667" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416233667" xlink:to="ifrs-full_RangeAxis_638459461416233667" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638459461416233667" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638459461416233667" xlink:to="ifrs-full_RangesMember_638459461416233667" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638459461416233667" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638459461416233667" xlink:to="ifrs-full_TopOfRangeMember_638459461416233667" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis_638459461416233667" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416233667" xlink:to="srt_StatementScenarioAxis_638459461416233667" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_638459461416233667" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis_638459461416233667" xlink:to="srt_ScenarioUnspecifiedDomain_638459461416233667" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IfNotesAreConvertedMember" xlink:label="aciu_IfNotesAreConvertedMember_638459461416233667" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_638459461416233667" xlink:to="aciu_IfNotesAreConvertedMember_638459461416233667" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesAxis" xlink:label="ifrs-full_CounterpartiesAxis_638459461416243669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416233667" xlink:to="ifrs-full_CounterpartiesAxis_638459461416243669" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesMember" xlink:label="ifrs-full_CounterpartiesMember_638459461416243669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CounterpartiesAxis_638459461416243669" xlink:to="ifrs-full_CounterpartiesMember_638459461416243669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AthosServiceGmbHMember" xlink:label="aciu_AthosServiceGmbHMember_638459461416243669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CounterpartiesMember_638459461416243669" xlink:to="aciu_AthosServiceGmbHMember_638459461416243669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_FirstCapitalPartnerGmbHMember" xlink:label="aciu_FirstCapitalPartnerGmbHMember_638459461416243669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CounterpartiesMember_638459461416243669" xlink:to="aciu_FirstCapitalPartnerGmbHMember_638459461416243669" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416243669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalTable_638459461416233667" xlink:to="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416243669" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ConvertibleNoteAgreementAbstract" xlink:label="aciu_ConvertibleNoteAgreementAbstract_638459461416243669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_638459461416243669" xlink:to="aciu_ConvertibleNoteAgreementAbstract_638459461416243669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfConvertibleNoteAgreements" xlink:label="aciu_NumberOfConvertibleNoteAgreements_638459461416243669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConvertibleNoteAgreementAbstract_638459461416243669" xlink:to="aciu_NumberOfConvertibleNoteAgreements_638459461416243669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AggregatePrincipalAmountOfEachConvertibleNote" xlink:label="aciu_AggregatePrincipalAmountOfEachConvertibleNote_638459461416243669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConvertibleNoteAgreementAbstract_638459461416243669" xlink:to="aciu_AggregatePrincipalAmountOfEachConvertibleNote_638459461416243669" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote" xlink:label="aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote_638459461416243669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConvertibleNoteAgreementAbstract_638459461416243669" xlink:to="aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote_638459461416243669" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ProceedsFromIssueOfConvertibleDebt" xlink:label="aciu_ProceedsFromIssueOfConvertibleDebt_638459461416243669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConvertibleNoteAgreementAbstract_638459461416243669" xlink:to="aciu_ProceedsFromIssueOfConvertibleDebt_638459461416243669" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt" xlink:label="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt_638459461416253665" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConvertibleNoteAgreementAbstract_638459461416243669" xlink:to="aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt_638459461416253665" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements" xlink:label="aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements_638459461416253665" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ConvertibleNoteAgreementAbstract_638459461416243669" xlink:to="aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements_638459461416253665" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails" xlink:type="extended" xlink:title="41301 - Disclosure - Trade and other payables and accrued expenses (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AccruedExpensesAbstract" xlink:label="AccruedExpensesAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_638459461416253665" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedExpensesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_638459461416253665" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CurrentAccruedResearchAndDevelopmentCosts" xlink:label="aciu_CurrentAccruedResearchAndDevelopmentCosts_638459461416253665" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedExpensesAbstract" xlink:to="aciu_CurrentAccruedResearchAndDevelopmentCosts_638459461416253665" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals_638459461416253665" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedExpensesAbstract" xlink:to="ifrs-full_ShorttermEmployeeBenefitsAccruals_638459461416253665" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_OtherAccruedExpenses" xlink:label="aciu_OtherAccruedExpenses_638459461416253665" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedExpensesAbstract" xlink:to="aciu_OtherAccruedExpenses_638459461416253665" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_638459461416253665" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedExpensesAbstract" xlink:to="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_638459461416253665" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals_6384594614162536651" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedExpensesAbstract" xlink:to="ifrs-full_ShorttermEmployeeBenefitsAccruals_6384594614162536651" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AccruedStampDuty" xlink:label="aciu_AccruedStampDuty_638459461416263671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedExpensesAbstract" xlink:to="aciu_AccruedStampDuty_638459461416263671" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails" xlink:type="extended" xlink:title="41401 - Disclosure - Contract revenues - Contract Revenue Attributable to Licensing Arrangements (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueAbstract" xlink:label="RevenueAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416263671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueAbstract" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416263671" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis_638459461416263671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416263671" xlink:to="ifrs-full_TypesOfContractsAxis_638459461416263671" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember_638459461416263671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsAxis_638459461416263671" xlink:to="ifrs-full_TypesOfContractsMember_638459461416263671" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember_638459461416263671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsMember_638459461416263671" xlink:to="aciu_CollaborationAndLicenseRevenueAgreementsMember_638459461416263671" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAgreementWithLillyMember" xlink:label="aciu_CollaborationAgreementWithLillyMember_638459461416263671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember_638459461416263671" xlink:to="aciu_CollaborationAgreementWithLillyMember_638459461416263671" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" xlink:label="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_638459461416263671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember_638459461416263671" xlink:to="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_638459461416263671" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" xlink:label="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_638459461416263671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember_638459461416263671" xlink:to="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_638459461416263671" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_OtherAgreementMember" xlink:label="aciu_OtherAgreementMember_638459461416263671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember_638459461416263671" xlink:to="aciu_OtherAgreementMember_638459461416263671" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638459461416333687" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416263671" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638459461416333687" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ContractRevenueAbstract" xlink:label="aciu_ContractRevenueAbstract_638459461416333687" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638459461416333687" xlink:to="aciu_ContractRevenueAbstract_638459461416333687" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_638459461416343663" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ContractRevenueAbstract_638459461416333687" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_638459461416343663" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesRecognizedRevenuesDetails" xlink:type="extended" xlink:title="41402 - Disclosure - Contract revenues - Recognized Revenues (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueAbstract" xlink:label="RevenueAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:label="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_638459461416343663" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueAbstract" xlink:to="ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_638459461416343663" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" xlink:label="ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods_638459461416343663" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueAbstract" xlink:to="ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods_638459461416343663" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" xlink:type="extended" xlink:title="41403 - Disclosure - Contract revenues - Morphomer Tau small molecule - 2018 license agreement with Eli Lilly and Company (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueAbstract" xlink:label="RevenueAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416343663" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueAbstract" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416343663" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis_638459461416353666" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416343663" xlink:to="ifrs-full_ProductsAndServicesAxis_638459461416353666" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember_638459461416353666" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis_638459461416353666" xlink:to="ifrs-full_ProductsAndServicesMember_638459461416353666" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TauMorphomerSmallMoleculeMember" xlink:label="aciu_TauMorphomerSmallMoleculeMember_638459461416353666" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesMember_638459461416353666" xlink:to="aciu_TauMorphomerSmallMoleculeMember_638459461416353666" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis_638459461416353666" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416343663" xlink:to="ifrs-full_TypesOfContractsAxis_638459461416353666" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember_638459461416353666" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsAxis_638459461416353666" xlink:to="ifrs-full_TypesOfContractsMember_638459461416353666" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember_638459461416353666" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsMember_638459461416353666" xlink:to="aciu_CollaborationAndLicenseRevenueAgreementsMember_638459461416353666" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAgreementWithLillyMember" xlink:label="aciu_CollaborationAgreementWithLillyMember_638459461416353666" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember_638459461416353666" xlink:to="aciu_CollaborationAgreementWithLillyMember_638459461416353666" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAgreementWithLillyFirstAmendmentMember" xlink:label="aciu_CollaborationAgreementWithLillyFirstAmendmentMember_638459461416353666" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CollaborationAgreementWithLillyMember_638459461416353666" xlink:to="aciu_CollaborationAgreementWithLillyFirstAmendmentMember_638459461416353666" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAgreementWithLillySecondAmendmentMember" xlink:label="aciu_CollaborationAgreementWithLillySecondAmendmentMember_638459461416353666" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CollaborationAgreementWithLillyMember_638459461416353666" xlink:to="aciu_CollaborationAgreementWithLillySecondAmendmentMember_638459461416353666" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PerformanceObligationsAxis" xlink:label="ifrs-full_PerformanceObligationsAxis_638459461416353666" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416343663" xlink:to="ifrs-full_PerformanceObligationsAxis_638459461416353666" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PerformanceObligationsMember" xlink:label="ifrs-full_PerformanceObligationsMember_638459461416353666" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PerformanceObligationsAxis_638459461416353666" xlink:to="ifrs-full_PerformanceObligationsMember_638459461416353666" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember" xlink:label="aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember_638459461416353666" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PerformanceObligationsMember_638459461416353666" xlink:to="aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember_638459461416353666" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_MilestonePaymentsCommercialMember" xlink:label="aciu_MilestonePaymentsCommercialMember_638459461416363662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PerformanceObligationsMember_638459461416353666" xlink:to="aciu_MilestonePaymentsCommercialMember_638459461416363662" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ResearchAndDevelopmentMember" xlink:label="aciu_ResearchAndDevelopmentMember_638459461416363662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PerformanceObligationsMember_638459461416353666" xlink:to="aciu_ResearchAndDevelopmentMember_638459461416363662" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RightOfUseLicenseMember" xlink:label="aciu_RightOfUseLicenseMember_638459461416363662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PerformanceObligationsMember_638459461416353666" xlink:to="aciu_RightOfUseLicenseMember_638459461416363662" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis_638459461416363662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416343663" xlink:to="ifrs-full_MaturityAxis_638459461416363662" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember_638459461416363662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis_638459461416363662" xlink:to="ifrs-full_AggregatedTimeBandsMember_638459461416363662" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Quarter32019Member" xlink:label="aciu_Quarter32019Member_638459461416363662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638459461416363662" xlink:to="aciu_Quarter32019Member_638459461416363662" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_March312020Member" xlink:label="aciu_March312020Member_638459461416363662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638459461416363662" xlink:to="aciu_March312020Member_638459461416363662" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member" xlink:label="aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member_638459461416363662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638459461416363662" xlink:to="aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member_638459461416363662" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638459461416363662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416343663" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638459461416363662" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416363662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638459461416363662" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416363662" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementPotentialValue" xlink:label="aciu_CollaborativeAgreementPotentialValue_638459461416373661" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416363662" xlink:to="aciu_CollaborativeAgreementPotentialValue_638459461416373661" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments" xlink:label="aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments_638459461416373661" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416363662" xlink:to="aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments_638459461416373661" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementMilestonePaymentReceived" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived_638459461416373661" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416363662" xlink:to="aciu_CollaborativeAgreementMilestonePaymentReceived_638459461416373661" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReceivablesFromContractsWithCustomers" xlink:label="ifrs-full_ReceivablesFromContractsWithCustomers_638459461416373661" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416363662" xlink:to="ifrs-full_ReceivablesFromContractsWithCustomers_638459461416373661" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_638459461416373661" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416363662" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_638459461416373661" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_638459461416373661" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416363662" xlink:to="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_638459461416373661" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty" xlink:label="aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty_638459461416373661" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416363662" xlink:to="aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty_638459461416373661" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContractAssets" xlink:label="ifrs-full_ContractAssets_638459461416373661" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416363662" xlink:to="ifrs-full_ContractAssets_638459461416373661" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_638459461416383666" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416363662" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_638459461416383666" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_638459461416383666" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416363662" xlink:to="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_638459461416383666" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails" xlink:type="extended" xlink:title="41404 - Disclosure - Contract revenues - Tau Vaccine in AD - 2014 Agreement with Janssen Pharmaceuticals (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueAbstract" xlink:label="RevenueAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416383666" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueAbstract" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416383666" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis_638459461416383666" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416383666" xlink:to="ifrs-full_ProductsAndServicesAxis_638459461416383666" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember_638459461416383666" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis_638459461416383666" xlink:to="ifrs-full_ProductsAndServicesMember_638459461416383666" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TauVaccineInADMember" xlink:label="aciu_TauVaccineInADMember_638459461416383666" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesMember_638459461416383666" xlink:to="aciu_TauVaccineInADMember_638459461416383666" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis_638459461416383666" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416383666" xlink:to="ifrs-full_TypesOfContractsAxis_638459461416383666" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember_638459461416383666" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsAxis_638459461416383666" xlink:to="ifrs-full_TypesOfContractsMember_638459461416383666" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember_638459461416393669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsMember_638459461416383666" xlink:to="aciu_CollaborationAndLicenseRevenueAgreementsMember_638459461416393669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" xlink:label="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_638459461416393669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember_638459461416393669" xlink:to="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_638459461416393669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638459461416393669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416383666" xlink:to="ifrs-full_RangeAxis_638459461416393669" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638459461416393669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638459461416393669" xlink:to="ifrs-full_RangesMember_638459461416393669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638459461416393669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638459461416393669" xlink:to="ifrs-full_TopOfRangeMember_638459461416393669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638459461416393669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416383666" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638459461416393669" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416393669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638459461416393669" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416393669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementPotentialValue" xlink:label="aciu_CollaborativeAgreementPotentialValue_638459461416393669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416393669" xlink:to="aciu_CollaborativeAgreementPotentialValue_638459461416393669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_638459461416393669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416393669" xlink:to="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_638459461416393669" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementMilestonePaymentReceived" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived_638459461416393669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416393669" xlink:to="aciu_CollaborativeAgreementMilestonePaymentReceived_638459461416393669" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="ifrs-full_CurrentTradeReceivables_638459461416393669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416393669" xlink:to="ifrs-full_CurrentTradeReceivables_638459461416393669" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_638459461416403669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416393669" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_638459461416403669" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_638459461416403669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416393669" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_638459461416403669" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementUpfrontPaymentsReceived" xlink:label="aciu_CollaborativeAgreementUpfrontPaymentsReceived_638459461416403669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416393669" xlink:to="aciu_CollaborativeAgreementUpfrontPaymentsReceived_638459461416403669" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" xlink:type="extended" xlink:title="41405 - Disclosure - Contract revenues - Tau-PET imaging agent -2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueAbstract" xlink:label="RevenueAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416403669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueAbstract" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416403669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis_638459461416403669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416403669" xlink:to="ifrs-full_ProductsAndServicesAxis_638459461416403669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember_638459461416403669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis_638459461416403669" xlink:to="ifrs-full_ProductsAndServicesMember_638459461416403669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TauPETImagingAgentMember" xlink:label="aciu_TauPETImagingAgentMember_638459461416403669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesMember_638459461416403669" xlink:to="aciu_TauPETImagingAgentMember_638459461416403669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis_638459461416403669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416403669" xlink:to="ifrs-full_TypesOfContractsAxis_638459461416403669" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember_638459461416413669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsAxis_638459461416403669" xlink:to="ifrs-full_TypesOfContractsMember_638459461416413669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAndLicenseRevenueAgreementsMember" xlink:label="aciu_CollaborationAndLicenseRevenueAgreementsMember_638459461416413669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsMember_638459461416413669" xlink:to="aciu_CollaborationAndLicenseRevenueAgreementsMember_638459461416413669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember" xlink:label="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_638459461416413669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CollaborationAndLicenseRevenueAgreementsMember_638459461416413669" xlink:to="aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_638459461416413669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638459461416413669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416403669" xlink:to="ifrs-full_RangeAxis_638459461416413669" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638459461416413669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638459461416413669" xlink:to="ifrs-full_RangesMember_638459461416413669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638459461416413669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638459461416413669" xlink:to="ifrs-full_TopOfRangeMember_638459461416413669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PerformanceObligationsAxis" xlink:label="ifrs-full_PerformanceObligationsAxis_638459461416413669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416403669" xlink:to="ifrs-full_PerformanceObligationsAxis_638459461416413669" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PerformanceObligationsMember" xlink:label="ifrs-full_PerformanceObligationsMember_638459461416413669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PerformanceObligationsAxis_638459461416413669" xlink:to="ifrs-full_PerformanceObligationsMember_638459461416413669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ClinicalMilestonesMember" xlink:label="aciu_ClinicalMilestonesMember_638459461416413669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PerformanceObligationsMember_638459461416413669" xlink:to="aciu_ClinicalMilestonesMember_638459461416413669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RegulatoryAndSalesBasedMilestonesMember" xlink:label="aciu_RegulatoryAndSalesBasedMilestonesMember_638459461416413669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PerformanceObligationsMember_638459461416413669" xlink:to="aciu_RegulatoryAndSalesBasedMilestonesMember_638459461416413669" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638459461416413669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416403669" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638459461416413669" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416413669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638459461416413669" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416413669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementPotentialValue" xlink:label="aciu_CollaborativeAgreementPotentialValue_638459461416423669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416413669" xlink:to="aciu_CollaborativeAgreementPotentialValue_638459461416423669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod" xlink:label="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_638459461416423669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416413669" xlink:to="aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod_638459461416423669" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_638459461416423669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416413669" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_638459461416423669" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementMilestonePaymentReceived" xlink:label="aciu_CollaborativeAgreementMilestonePaymentReceived_638459461416423669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416413669" xlink:to="aciu_CollaborativeAgreementMilestonePaymentReceived_638459461416423669" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_638459461416423669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416413669" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_638459461416423669" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails" xlink:type="extended" xlink:title="41406 - Disclosure - Contract revenues - Grants from the Michael J. Fox Foundation (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueAbstract" xlink:label="RevenueAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416423669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueAbstract" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416423669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis_638459461416423669" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416423669" xlink:to="ifrs-full_TypesOfContractsAxis_638459461416423669" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember_638459461416433683" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsAxis_638459461416423669" xlink:to="ifrs-full_TypesOfContractsMember_638459461416433683" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_GrantRevenueMember" xlink:label="aciu_GrantRevenueMember_638459461416433683" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsMember_638459461416433683" xlink:to="aciu_GrantRevenueMember_638459461416433683" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_GrantsMichaelJFoxFoundationMember" xlink:label="aciu_GrantsMichaelJFoxFoundationMember_638459461416433683" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_GrantRevenueMember_638459461416433683" xlink:to="aciu_GrantsMichaelJFoxFoundationMember_638459461416433683" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesAxis" xlink:label="ifrs-full_CounterpartiesAxis_638459461416433683" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416423669" xlink:to="ifrs-full_CounterpartiesAxis_638459461416433683" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesMember" xlink:label="ifrs-full_CounterpartiesMember_638459461416433683" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CounterpartiesAxis_638459461416433683" xlink:to="ifrs-full_CounterpartiesMember_638459461416433683" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SkaneUniversityHospitalMember" xlink:label="aciu_SkaneUniversityHospitalMember_638459461416433683" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CounterpartiesMember_638459461416433683" xlink:to="aciu_SkaneUniversityHospitalMember_638459461416433683" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis_638459461416433683" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416423669" xlink:to="ifrs-full_ProductsAndServicesAxis_638459461416433683" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember_638459461416433683" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis_638459461416433683" xlink:to="ifrs-full_ProductsAndServicesMember_638459461416433683" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AlphaSynucleinPetImagingDiagnosticAgentMember" xlink:label="aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_638459461416433683" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesMember_638459461416433683" xlink:to="aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_638459461416433683" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AdvanceSmallMoleculePdProgramsMember" xlink:label="aciu_AdvanceSmallMoleculePdProgramsMember_638459461416433683" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesMember_638459461416433683" xlink:to="aciu_AdvanceSmallMoleculePdProgramsMember_638459461416433683" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638459461416433683" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416423669" xlink:to="ifrs-full_RangeAxis_638459461416433683" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638459461416433683" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638459461416433683" xlink:to="ifrs-full_RangesMember_638459461416433683" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember_638459461416443678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638459461416433683" xlink:to="ifrs-full_BottomOfRangeMember_638459461416443678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis_638459461416443678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416423669" xlink:to="dei_LegalEntityAxis_638459461416443678" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_638459461416443678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis_638459461416443678" xlink:to="dei_EntityDomain_638459461416443678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SkaneUniversityHospitalMember" xlink:label="aciu_SkaneUniversityHospitalMember_638459461416443678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain_638459461416443678" xlink:to="aciu_SkaneUniversityHospitalMember_638459461416443678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638459461416443678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_638459461416423669" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638459461416443678" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416443678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_638459461416443678" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416443678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_FollowOnGrantFundingReceivedTotalForJointArrangement" xlink:label="aciu_FollowOnGrantFundingReceivedTotalForJointArrangement_638459461416443678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416443678" xlink:to="aciu_FollowOnGrantFundingReceivedTotalForJointArrangement_638459461416443678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_FollowOnGrantFundingReceived" xlink:label="aciu_FollowOnGrantFundingReceived_638459461416443678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416443678" xlink:to="aciu_FollowOnGrantFundingReceived_638459461416443678" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfGrants" xlink:label="aciu_NumberOfGrants_638459461416443678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416443678" xlink:to="aciu_NumberOfGrants_638459461416443678" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementPotentialValue" xlink:label="aciu_CollaborativeAgreementPotentialValue_638459461416443678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416443678" xlink:to="aciu_CollaborativeAgreementPotentialValue_638459461416443678" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReceivablesFromContractsWithCustomers" xlink:label="ifrs-full_ReceivablesFromContractsWithCustomers_638459461416453679" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416443678" xlink:to="ifrs-full_ReceivablesFromContractsWithCustomers_638459461416453679" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborativeAgreementJointResearchCollaborationPeriod" xlink:label="aciu_CollaborativeAgreementJointResearchCollaborationPeriod_638459461416453679" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416443678" xlink:to="aciu_CollaborativeAgreementJointResearchCollaborationPeriod_638459461416453679" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_638459461416453679" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416443678" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_638459461416453679" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="ifrs-full_OtherOperatingIncomeExpense_638459461416453679" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416443678" xlink:to="ifrs-full_OtherOperatingIncomeExpense_638459461416453679" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AdditionalGrantAwarded" xlink:label="aciu_AdditionalGrantAwarded_638459461416453679" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416443678" xlink:to="aciu_AdditionalGrantAwarded_638459461416453679" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets" xlink:label="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_638459461416453679" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416443678" xlink:to="ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets_638459461416453679" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_638459461416453679" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_638459461416443678" xlink:to="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_638459461416453679" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureExpensesByCategoryDetails" xlink:type="extended" xlink:title="41501 - Disclosure - Expenses by category (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ExpensesByCategoryAbstract" xlink:label="ExpensesByCategoryAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_638459461416463668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesByCategoryAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_638459461416463668" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:label="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_638459461416463668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_638459461416463668" xlink:to="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_638459461416463668" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LineItemsByFunctionMember" xlink:label="ifrs-full_LineItemsByFunctionMember_638459461416463668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_638459461416463668" xlink:to="ifrs-full_LineItemsByFunctionMember_638459461416463668" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ResearchAndDevelopmentExpensesMember" xlink:label="aciu_ResearchAndDevelopmentExpensesMember_638459461416463668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LineItemsByFunctionMember_638459461416463668" xlink:to="aciu_ResearchAndDevelopmentExpensesMember_638459461416463668" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseMember" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpenseMember_638459461416463668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LineItemsByFunctionMember_638459461416463668" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpenseMember_638459461416463668" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638459461416463668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_638459461416463668" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638459461416463668" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OperatingExpense" xlink:label="ifrs-full_OperatingExpense_638459461416463668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638459461416463668" xlink:to="ifrs-full_OperatingExpense_638459461416463668" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation" xlink:label="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation_638459461416463668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638459461416463668" xlink:to="aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation_638459461416463668" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_638459461416463668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638459461416463668" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_638459461416463668" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseByNature" xlink:label="ifrs-full_ExpenseByNature_638459461416463668" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638459461416463668" xlink:to="ifrs-full_ExpenseByNature_638459461416463668" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_638459461416473673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638459461416463668" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_638459461416473673" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AverageNumberOfEmployees" xlink:label="ifrs-full_AverageNumberOfEmployees_638459461416473673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638459461416463668" xlink:to="ifrs-full_AverageNumberOfEmployees_638459461416473673" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_638459461416473673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638459461416463668" xlink:to="ifrs-full_GeneralAndAdministrativeExpense_638459461416473673" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DecreaseInResearchAndDevelopmentExpenseThroughReductionsInVariousCostCenters" xlink:label="aciu_DecreaseInResearchAndDevelopmentExpenseThroughReductionsInVariousCostCenters_638459461416473673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638459461416463668" xlink:to="aciu_DecreaseInResearchAndDevelopmentExpenseThroughReductionsInVariousCostCenters_638459461416473673" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseInResearchAndDevelopmentExpenseThroughIncreaseInSalariesAndRelatedCosts" xlink:label="aciu_IncreaseInResearchAndDevelopmentExpenseThroughIncreaseInSalariesAndRelatedCosts_638459461416473673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638459461416463668" xlink:to="aciu_IncreaseInResearchAndDevelopmentExpenseThroughIncreaseInSalariesAndRelatedCosts_638459461416473673" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DecreaseInGeneralAndAdministrativeExpenseThroughReductionsInVariousCostCenters" xlink:label="aciu_DecreaseInGeneralAndAdministrativeExpenseThroughReductionsInVariousCostCenters_638459461416473673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638459461416463668" xlink:to="aciu_DecreaseInGeneralAndAdministrativeExpenseThroughReductionsInVariousCostCenters_638459461416473673" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseInGeneralAndAdministrativeExpenseThroughIncreaseInShareBasedCompensationExpense" xlink:label="aciu_IncreaseInGeneralAndAdministrativeExpenseThroughIncreaseInShareBasedCompensationExpense_638459461416473673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638459461416463668" xlink:to="aciu_IncreaseInGeneralAndAdministrativeExpenseThroughIncreaseInShareBasedCompensationExpense_638459461416473673" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_FinancialResultNetAbstract" xlink:label="aciu_FinancialResultNetAbstract_638459461416473673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_638459461416463668" xlink:to="aciu_FinancialResultNetAbstract_638459461416473673" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncome" xlink:label="ifrs-full_FinanceIncome_638459461416473673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialResultNetAbstract_638459461416473673" xlink:to="ifrs-full_FinanceIncome_638459461416473673" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceCosts" xlink:label="ifrs-full_FinanceCosts_638459461416473673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialResultNetAbstract_638459461416473673" xlink:to="ifrs-full_FinanceCosts_638459461416473673" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_638459461416483670" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialResultNetAbstract_638459461416473673" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_638459461416483670" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncomeCost" xlink:label="ifrs-full_FinanceIncomeCost_638459461416483670" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialResultNetAbstract_638459461416473673" xlink:to="ifrs-full_FinanceIncomeCost_638459461416483670" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails" xlink:type="extended" xlink:title="41601 - Disclosure - Related-party transactions (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="DisclosureOfTransactionsBetweenRelatedPartiesAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfPersonsKeyManagementBoardOfDirectors" xlink:label="aciu_NumberOfPersonsKeyManagementBoardOfDirectors_638459461416483670" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="aciu_NumberOfPersonsKeyManagementBoardOfDirectors_638459461416483670" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfPersonsKeyManagementExecutiveManagement" xlink:label="aciu_NumberOfPersonsKeyManagementExecutiveManagement_638459461416483670" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="aciu_NumberOfPersonsKeyManagementExecutiveManagement_638459461416483670" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_638459461416483670" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_638459461416483670" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_638459461416483670" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_638459461416483670" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_638459461416483670" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_638459461416483670" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="ifrs-full_KeyManagementPersonnelCompensation_638459461416483670" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensation_638459461416483670" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails" xlink:type="extended" xlink:title="41701 - Disclosure - Income taxes - Summary of Income Tax Expense (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="MajorComponentsOfTaxExpenseIncomeAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_638459461416493672" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_638459461416493672" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638459461416493672" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_638459461416493672" xlink:to="ifrs-full_RangeAxis_638459461416493672" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638459461416493672" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638459461416493672" xlink:to="ifrs-full_RangesMember_638459461416493672" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember_638459461416493672" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638459461416493672" xlink:to="ifrs-full_BottomOfRangeMember_638459461416493672" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageMember" xlink:label="ifrs-full_WeightedAverageMember_638459461416493672" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638459461416493672" xlink:to="ifrs-full_WeightedAverageMember_638459461416493672" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638459461416493672" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638459461416493672" xlink:to="ifrs-full_TopOfRangeMember_638459461416493672" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="ifrs-full_GeographicalAreasAxis_638459461416493672" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_638459461416493672" xlink:to="ifrs-full_GeographicalAreasAxis_638459461416493672" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasMember" xlink:label="ifrs-full_GeographicalAreasMember_638459461416493672" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis_638459461416493672" xlink:to="ifrs-full_GeographicalAreasMember_638459461416493672" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH" xlink:label="country_CH_638459461416493672" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasMember_638459461416493672" xlink:to="country_CH_638459461416493672" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_638459461416493672" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_638459461416493672" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_638459461416493672" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_638459461416493672" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_638459461416493672" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_638459461416493672" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxAssets" xlink:label="ifrs-full_DeferredTaxAssets_638459461416503674" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_638459461416493672" xlink:to="ifrs-full_DeferredTaxAssets_638459461416503674" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="ifrs-full_DeferredTaxLiabilities_638459461416503674" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_638459461416493672" xlink:to="ifrs-full_DeferredTaxLiabilities_638459461416503674" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ApplicableTaxRate" xlink:label="ifrs-full_ApplicableTaxRate_638459461416503674" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_638459461416493672" xlink:to="ifrs-full_ApplicableTaxRate_638459461416503674" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:label="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_638459461416503674" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_638459461416493672" xlink:to="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_638459461416503674" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccountingProfit" xlink:label="ifrs-full_AccountingProfit_638459461416503674" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_638459461416503674" xlink:to="ifrs-full_AccountingProfit_638459461416503674" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_638459461416503674" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_638459461416503674" xlink:to="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_638459461416503674" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes" xlink:label="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes_638459461416503674" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_638459461416503674" xlink:to="aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes_638459461416503674" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TaxEffectOfTaxLosses" xlink:label="ifrs-full_TaxEffectOfTaxLosses_638459461416503674" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_638459461416503674" xlink:to="ifrs-full_TaxEffectOfTaxLosses_638459461416503674" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_638459461416503674" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_638459461416503674" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_638459461416503674" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" xlink:type="extended" xlink:title="41702 - Disclosure - Income taxes, Unrecognized Deductible Temporary Differences, Unused Tax Losses and Unused Tax Credits (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="MajorComponentsOfTaxExpenseIncomeAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_638459461416513684" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_638459461416513684" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_638459461416513684" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_638459461416513684" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_638459461416513684" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_638459461416513684" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_638459461416513684" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_638459461416513684" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnusedTaxLossesMember" xlink:label="ifrs-full_UnusedTaxLossesMember_638459461416513684" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_638459461416513684" xlink:to="ifrs-full_UnusedTaxLossesMember_638459461416513684" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember" xlink:label="aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_638459461416513684" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_638459461416513684" xlink:to="aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_638459461416513684" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RetirementBenefitPlanMember" xlink:label="aciu_RetirementBenefitPlanMember_638459461416513684" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember_638459461416513684" xlink:to="aciu_RetirementBenefitPlanMember_638459461416513684" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis_638459461416513684" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_638459461416513684" xlink:to="ifrs-full_MaturityAxis_638459461416513684" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember_638459461416513684" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis_638459461416513684" xlink:to="ifrs-full_AggregatedTimeBandsMember_638459461416513684" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_December312024Member" xlink:label="aciu_December312024Member_638459461416513684" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638459461416513684" xlink:to="aciu_December312024Member_638459461416513684" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_December312025Member" xlink:label="aciu_December312025Member_638459461416513684" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638459461416513684" xlink:to="aciu_December312025Member_638459461416513684" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_December312026Member" xlink:label="aciu_December312026Member_638459461416523671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638459461416513684" xlink:to="aciu_December312026Member_638459461416523671" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_December312027Member" xlink:label="aciu_December312027Member_638459461416523671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638459461416513684" xlink:to="aciu_December312027Member_638459461416523671" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_December312028Member" xlink:label="aciu_December312028Member_638459461416523671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638459461416513684" xlink:to="aciu_December312028Member_638459461416523671" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_December312029Member" xlink:label="aciu_December312029Member_638459461416523671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638459461416513684" xlink:to="aciu_December312029Member_638459461416523671" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_December312030Member" xlink:label="aciu_December312030Member_638459461416523671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638459461416513684" xlink:to="aciu_December312030Member_638459461416523671" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_638459461416523671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_638459461416513684" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_638459461416523671" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract_638459461416523671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_638459461416523671" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract_638459461416523671" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:label="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_638459461416523671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract_638459461416523671" xlink:to="ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_638459461416523671" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TaxLossesSplitByExpiryDateAbstract" xlink:label="aciu_TaxLossesSplitByExpiryDateAbstract_638459461416523671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_638459461416523671" xlink:to="aciu_TaxLossesSplitByExpiryDateAbstract_638459461416523671" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:label="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_638459461416523671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_TaxLossesSplitByExpiryDateAbstract_638459461416523671" xlink:to="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_638459461416523671" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits" xlink:label="aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits_638459461416523671" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_TaxLossesSplitByExpiryDateAbstract_638459461416523671" xlink:to="aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits_638459461416523671" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails" xlink:type="extended" xlink:title="41801 - Disclosure - Retirement benefit plan - Summary of Benefit Plan (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="DisclosureOfDefinedBenefitPlansAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees" xlink:label="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees_638459461416533673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees_638459461416533673" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer" xlink:label="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer_638459461416533673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer_638459461416533673" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SurplusDeficitInPlanAbstract" xlink:label="ifrs-full_SurplusDeficitInPlanAbstract_638459461416533673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_SurplusDeficitInPlanAbstract_638459461416533673" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue_638459461416533673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SurplusDeficitInPlanAbstract_638459461416533673" xlink:to="ifrs-full_DefinedBenefitObligationAtPresentValue_638459461416533673" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PlanAssetsAtFairValue" xlink:label="ifrs-full_PlanAssetsAtFairValue_638459461416533673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SurplusDeficitInPlanAbstract_638459461416533673" xlink:to="ifrs-full_PlanAssetsAtFairValue_638459461416533673" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SurplusDeficitInPlan" xlink:label="ifrs-full_SurplusDeficitInPlan_638459461416533673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SurplusDeficitInPlanAbstract_638459461416533673" xlink:to="ifrs-full_SurplusDeficitInPlan_638459461416533673" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails" xlink:type="extended" xlink:title="41802 - Disclosure - Retirement benefit plan - Amounts recorded in consolidated statements of income (loss) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="DisclosureOfDefinedBenefitPlansAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentServiceCostDefinedBenefitPlans" xlink:label="ifrs-full_CurrentServiceCostDefinedBenefitPlans_638459461416533673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_CurrentServiceCostDefinedBenefitPlans_638459461416533673" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpenseDefinedBenefitPlans" xlink:label="ifrs-full_InterestExpenseDefinedBenefitPlans_638459461416543676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_InterestExpenseDefinedBenefitPlans_638459461416543676" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PastServiceCostDefinedBenefitPlans" xlink:label="ifrs-full_PastServiceCostDefinedBenefitPlans_638459461416543676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_PastServiceCostDefinedBenefitPlans_638459461416543676" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestIncomeDefinedBenefitPlans" xlink:label="ifrs-full_InterestIncomeDefinedBenefitPlans_638459461416543676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_InterestIncomeDefinedBenefitPlans_638459461416543676" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:label="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_638459461416543676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_638459461416543676" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails" xlink:type="extended" xlink:title="41803 - Disclosure - Retirement benefit plan - Changes in Defined Benefit Obligation (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="DisclosureOfDefinedBenefitPlansAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_638459461416543676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_638459461416543676" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetAxis_638459461416543676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_638459461416543676" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetAxis_638459461416543676" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetMember_638459461416543676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetAxis_638459461416543676" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetMember_638459461416543676" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PresentValueOfDefinedBenefitObligationMember" xlink:label="ifrs-full_PresentValueOfDefinedBenefitObligationMember_638459461416543676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetMember_638459461416543676" xlink:to="ifrs-full_PresentValueOfDefinedBenefitObligationMember_638459461416543676" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_638459461416543676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_638459461416543676" xlink:to="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_638459461416543676" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:label="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638459461416543676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_638459461416543676" xlink:to="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638459461416543676" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_638459461416553675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638459461416543676" xlink:to="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_638459461416553675" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_638459461416553675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638459461416543676" xlink:to="ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_638459461416553675" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset_638459461416553675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638459461416543676" xlink:to="ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset_638459461416553675" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_638459461416553675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638459461416543676" xlink:to="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_638459461416553675" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_638459461416553675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638459461416543676" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_638459461416553675" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_638459461416553675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638459461416543676" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_638459461416553675" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset_638459461416553675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638459461416543676" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset_638459461416553675" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" xlink:label="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited_638459461416553675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638459461416543676" xlink:to="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited_638459461416553675" order="8" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_638459461416553675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638459461416543676" xlink:to="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_638459461416553675" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_6384594614165536751" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638459461416543676" xlink:to="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_6384594614165536751" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails" xlink:type="extended" xlink:title="41804 - Disclosure - Retirement benefit plan - Changes in Fair Value of Plan Assets (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="DisclosureOfDefinedBenefitPlansAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_638459461416563670" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_638459461416563670" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetAxis_638459461416563670" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_638459461416563670" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetAxis_638459461416563670" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetMember" xlink:label="ifrs-full_NetDefinedBenefitLiabilityAssetMember_638459461416563670" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetAxis_638459461416563670" xlink:to="ifrs-full_NetDefinedBenefitLiabilityAssetMember_638459461416563670" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PlanAssetsMember" xlink:label="ifrs-full_PlanAssetsMember_638459461416563670" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NetDefinedBenefitLiabilityAssetMember_638459461416563670" xlink:to="ifrs-full_PlanAssetsMember_638459461416563670" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:label="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_638459461416563670" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_638459461416563670" xlink:to="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_638459461416563670" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ChangesInFairValueOfPlanAssetsAbstract" xlink:label="aciu_ChangesInFairValueOfPlanAssetsAbstract_638459461416563670" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_638459461416563670" xlink:to="aciu_ChangesInFairValueOfPlanAssetsAbstract_638459461416563670" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_638459461416563670" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract_638459461416563670" xlink:to="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_638459461416563670" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_638459461416563670" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract_638459461416563670" xlink:to="ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_638459461416563670" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_638459461416563670" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract_638459461416563670" xlink:to="ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_638459461416563670" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_638459461416563670" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract_638459461416563670" xlink:to="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_638459461416563670" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited" xlink:label="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited_638459461416573675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract_638459461416563670" xlink:to="aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited_638459461416573675" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_638459461416573675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract_638459461416563670" xlink:to="ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_638459461416573675" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_638459461416573675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract_638459461416563670" xlink:to="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_638459461416573675" order="7" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xlink:label="ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_638459461416573675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ChangesInFairValueOfPlanAssetsAbstract_638459461416563670" xlink:to="ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_638459461416573675" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails" xlink:type="extended" xlink:title="41805 - Disclosure - Retirement benefit plan - Change in Net Defined Benefit Liability (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="DisclosureOfDefinedBenefitPlansAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:label="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638459461416573675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638459461416573675" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_638459461416573675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638459461416573675" xlink:to="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_638459461416573675" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss" xlink:label="ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss_638459461416573675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638459461416573675" xlink:to="ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss_638459461416573675" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_638459461416573675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638459461416573675" xlink:to="ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_638459461416573675" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_638459461416573675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638459461416573675" xlink:to="ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_638459461416573675" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_6384594614165736751" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_638459461416573675" xlink:to="ifrs-full_LiabilityAssetOfDefinedBenefitPlans_6384594614165736751" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails" xlink:type="extended" xlink:title="41806 - Disclosure - Retirement benefit plan - Change in other comprehensive gains (losses) (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="DisclosureOfDefinedBenefitPlansAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_OtherComprehensiveGainsLossesAbstract" xlink:label="aciu_OtherComprehensiveGainsLossesAbstract_638459461416583675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="aciu_OtherComprehensiveGainsLossesAbstract_638459461416583675" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans_638459461416583675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_OtherComprehensiveGainsLossesAbstract_638459461416583675" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans_638459461416583675" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans_638459461416583675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_OtherComprehensiveGainsLossesAbstract_638459461416583675" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans_638459461416583675" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans_638459461416583675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_OtherComprehensiveGainsLossesAbstract_638459461416583675" xlink:to="ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans_638459461416583675" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans" xlink:label="ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans_638459461416583675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_OtherComprehensiveGainsLossesAbstract_638459461416583675" xlink:to="ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans_638459461416583675" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_638459461416583675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_OtherComprehensiveGainsLossesAbstract_638459461416583675" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_638459461416583675" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xlink:label="ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_638459461416583675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_OtherComprehensiveGainsLossesAbstract_638459461416583675" xlink:to="ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_638459461416583675" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" xlink:type="extended" xlink:title="41807 - Disclosure - Retirement benefit plan - Actuarial Assumptions and Sensitivity Analysis (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="DisclosureOfDefinedBenefitPlansAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_638459461416593678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfDefinedBenefitPlansAbstract" xlink:to="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_638459461416593678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionsAxis" xlink:label="ifrs-full_ActuarialAssumptionsAxis_638459461416593678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_638459461416593678" xlink:to="ifrs-full_ActuarialAssumptionsAxis_638459461416593678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionsMember" xlink:label="ifrs-full_ActuarialAssumptionsMember_638459461416593678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ActuarialAssumptionsAxis_638459461416593678" xlink:to="ifrs-full_ActuarialAssumptionsMember_638459461416593678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRatesMember_638459461416593678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ActuarialAssumptionsMember_638459461416593678" xlink:to="ifrs-full_ActuarialAssumptionOfDiscountRatesMember_638459461416593678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_638459461416593678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ActuarialAssumptionsMember_638459461416593678" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_638459461416593678" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_638459461416593678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ActuarialAssumptionsMember_638459461416593678" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_638459461416593678" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_638459461416593678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ActuarialAssumptionsMember_638459461416593678" xlink:to="aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_638459461416593678" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="ifrs-full_TypesOfRisksAxis_638459461416593678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_638459461416593678" xlink:to="ifrs-full_TypesOfRisksAxis_638459461416593678" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="ifrs-full_TypesOfRisksMember_638459461416593678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksAxis_638459461416593678" xlink:to="ifrs-full_TypesOfRisksMember_638459461416593678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember" xlink:label="aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_638459461416593678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksMember_638459461416593678" xlink:to="aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_638459461416593678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember" xlink:label="aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_638459461416593678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksMember_638459461416593678" xlink:to="aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_638459461416593678" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_638459461416593678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_638459461416593678" xlink:to="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_638459461416593678" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract" xlink:label="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract_638459461416603673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_638459461416593678" xlink:to="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract_638459461416603673" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:label="ifrs-full_ActuarialAssumptionOfDiscountRates_638459461416603673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract_638459461416603673" xlink:to="ifrs-full_ActuarialAssumptionOfDiscountRates_638459461416603673" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_638459461416603673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract_638459461416603673" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_638459461416603673" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:label="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases_638459461416603673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract_638459461416603673" xlink:to="ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases_638459461416603673" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital" xlink:label="aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital_638459461416603673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract_638459461416603673" xlink:to="aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital_638459461416603673" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_SensitivityAnalysisActuarialAssumptionsAbstract" xlink:label="aciu_SensitivityAnalysisActuarialAssumptionsAbstract_638459461416603673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_638459461416593678" xlink:to="aciu_SensitivityAnalysisActuarialAssumptionsAbstract_638459461416603673" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:label="ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_638459461416603673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_SensitivityAnalysisActuarialAssumptionsAbstract_638459461416603673" xlink:to="ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_638459461416603673" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:label="ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_638459461416603673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_SensitivityAnalysisActuarialAssumptionsAbstract_638459461416603673" xlink:to="ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_638459461416603673" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue_638459461416603673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_SensitivityAnalysisActuarialAssumptionsAbstract_638459461416603673" xlink:to="ifrs-full_DefinedBenefitObligationAtPresentValue_638459461416603673" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:label="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_638459461416603673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_SensitivityAnalysisActuarialAssumptionsAbstract_638459461416603673" xlink:to="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_638459461416603673" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:label="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_638459461416613673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_SensitivityAnalysisActuarialAssumptionsAbstract_638459461416603673" xlink:to="ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_638459461416613673" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails" xlink:type="extended" xlink:title="41901 - Disclosure - Share-based compensation, Plans Outstanding (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_638459461416613673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_638459461416613673" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_638459461416613673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_638459461416613673" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_638459461416613673" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember_638459461416613673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_638459461416613673" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember_638459461416613673" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_StockOptionPlanC1Member" xlink:label="aciu_StockOptionPlanC1Member_638459461416613673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_638459461416613673" xlink:to="aciu_StockOptionPlanC1Member_638459461416613673" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Two016ShareOptionAndIncentivePlanMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanMember_638459461416613673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_638459461416613673" xlink:to="aciu_Two016ShareOptionAndIncentivePlanMember_638459461416613673" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember_638459461416613673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_Two016ShareOptionAndIncentivePlanMember_638459461416613673" xlink:to="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember_638459461416613673" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember_638459461416613673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_Two016ShareOptionAndIncentivePlanMember_638459461416613673" xlink:to="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember_638459461416613673" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember" xlink:label="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember_638459461416613673" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_Two016ShareOptionAndIncentivePlanMember_638459461416613673" xlink:to="aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember_638459461416613673" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_638459461416623677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_638459461416613673" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_638459461416623677" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_638459461416623677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis_638459461416623677" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_638459461416623677" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_638459461416623677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_638459461416623677" xlink:to="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_638459461416623677" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_EmployeesMember" xlink:label="aciu_EmployeesMember_638459461416623677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_638459461416623677" xlink:to="aciu_EmployeesMember_638459461416623677" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_638459461416623677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_638459461416613673" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_638459461416623677" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ShareBasedPlansOutstandingAbstract" xlink:label="aciu_ShareBasedPlansOutstandingAbstract_638459461416623677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_638459461416623677" xlink:to="aciu_ShareBasedPlansOutstandingAbstract_638459461416623677" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfEquityBasedInstrumentPlans" xlink:label="aciu_NumberOfEquityBasedInstrumentPlans_638459461416623677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ShareBasedPlansOutstandingAbstract_638459461416623677" xlink:to="aciu_NumberOfEquityBasedInstrumentPlans_638459461416623677" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_638459461416623677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ShareBasedPlansOutstandingAbstract_638459461416623677" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_638459461416623677" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" xlink:label="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod_638459461416623677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ShareBasedPlansOutstandingAbstract_638459461416623677" xlink:to="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod_638459461416623677" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement" xlink:label="aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement_638459461416623677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ShareBasedPlansOutstandingAbstract_638459461416623677" xlink:to="aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement_638459461416623677" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails" xlink:type="extended" xlink:title="41902 - Disclosure - Share-based compensation, Weighted Average Exercise Prices (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_638459461416633688" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_638459461416633688" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfOptionsAbstract" xlink:label="aciu_NumberOfOptionsAbstract_638459461416633688" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_638459461416633688" xlink:to="aciu_NumberOfOptionsAbstract_638459461416633688" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_638459461416633688" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfOptionsAbstract_638459461416633688" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_638459461416633688" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_638459461416633688" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfOptionsAbstract_638459461416633688" xlink:to="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_638459461416633688" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_638459461416633688" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfOptionsAbstract_638459461416633688" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_638459461416633688" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_638459461416633688" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfOptionsAbstract_638459461416633688" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_638459461416633688" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_6384594614166336881" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfOptionsAbstract_638459461416633688" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_6384594614166336881" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_638459461416633688" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfOptionsAbstract_638459461416633688" xlink:to="ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_638459461416633688" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageExercisePriceAbstract" xlink:label="aciu_WeightedAverageExercisePriceAbstract_638459461416633688" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_638459461416633688" xlink:to="aciu_WeightedAverageExercisePriceAbstract_638459461416633688" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_638459461416643678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638459461416633688" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_638459461416643678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_638459461416643678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638459461416633688" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_638459461416643678" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_638459461416643678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638459461416633688" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_638459461416643678" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_638459461416643678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638459461416633688" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_638459461416643678" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_6384594614166436781" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638459461416633688" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_6384594614166436781" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_638459461416643678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638459461416633688" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_638459461416643678" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageRemainingAbstract" xlink:label="aciu_WeightedAverageRemainingAbstract_638459461416643678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_638459461416633688" xlink:to="aciu_WeightedAverageRemainingAbstract_638459461416643678" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_638459461416643678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageRemainingAbstract_638459461416643678" xlink:to="ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_638459461416643678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable" xlink:label="aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable_638459461416643678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageRemainingAbstract_638459461416643678" xlink:to="aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable_638459461416643678" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" xlink:type="extended" xlink:title="41903 - Disclosure - Share-based compensation, Outstanding Options, Range of Exercise prices and Expiration Dates (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_638459461416653675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_638459461416653675" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_638459461416653675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_638459461416653675" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_638459461416653675" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_638459461416653675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_638459461416653675" xlink:to="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_638459461416653675" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Chf0.15Member" xlink:label="aciu_Chf0.15Member_638459461416653675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_638459461416653675" xlink:to="aciu_Chf0.15Member_638459461416653675" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Chf9.53Member" xlink:label="aciu_Chf9.53Member_638459461416653675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_638459461416653675" xlink:to="aciu_Chf9.53Member_638459461416653675" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Usd5.04ToUsd12.30Member" xlink:label="aciu_Usd5.04ToUsd12.30Member_638459461416653675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_638459461416653675" xlink:to="aciu_Usd5.04ToUsd12.30Member_638459461416653675" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Usd2.76ToUsd4.57Member" xlink:label="aciu_Usd2.76ToUsd4.57Member_638459461416653675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_638459461416653675" xlink:to="aciu_Usd2.76ToUsd4.57Member_638459461416653675" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_Usd2.03ToUsd2.32Member" xlink:label="aciu_Usd2.03ToUsd2.32Member_638459461416653675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember_638459461416653675" xlink:to="aciu_Usd2.03ToUsd2.32Member_638459461416653675" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638459461416653675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_638459461416653675" xlink:to="ifrs-full_RangeAxis_638459461416653675" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638459461416653675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638459461416653675" xlink:to="ifrs-full_RangesMember_638459461416653675" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember_638459461416653675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638459461416653675" xlink:to="ifrs-full_BottomOfRangeMember_638459461416653675" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638459461416663674" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638459461416653675" xlink:to="ifrs-full_TopOfRangeMember_638459461416663674" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis_638459461416663674" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_638459461416653675" xlink:to="srt_CurrencyAxis_638459461416663674" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_AllCurrenciesDomain" xlink:label="currency_AllCurrenciesDomain_638459461416663674" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CurrencyAxis_638459461416663674" xlink:to="currency_AllCurrenciesDomain_638459461416663674" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_CHF" xlink:label="currency_CHF_638459461416663674" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="currency_AllCurrenciesDomain_638459461416663674" xlink:to="currency_CHF_638459461416663674" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_USD" xlink:label="currency_USD_638459461416663674" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="currency_AllCurrenciesDomain_638459461416663674" xlink:to="currency_USD_638459461416663674" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_638459461416663674" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_638459461416653675" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_638459461416663674" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract" xlink:label="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract_638459461416663674" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_638459461416663674" xlink:to="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract_638459461416663674" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_638459461416663674" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract_638459461416663674" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_638459461416663674" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_638459461416663674" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract_638459461416663674" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_638459461416663674" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_638459461416663674" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract_638459461416663674" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_638459461416663674" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageSharePrice2019" xlink:label="ifrs-full_WeightedAverageSharePrice2019_638459461416673675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract_638459461416663674" xlink:to="ifrs-full_WeightedAverageSharePrice2019_638459461416673675" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" xlink:type="extended" xlink:title="41904 - Disclosure - Share-based compensation, Weighted Average Grant date Fair Value and Assumptions (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable_638459461416673675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable_638459461416673675" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638459461416673675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable_638459461416673675" xlink:to="ifrs-full_RangeAxis_638459461416673675" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638459461416673675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638459461416673675" xlink:to="ifrs-full_RangesMember_638459461416673675" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember_638459461416673675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638459461416673675" xlink:to="ifrs-full_BottomOfRangeMember_638459461416673675" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638459461416673675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638459461416673675" xlink:to="ifrs-full_TopOfRangeMember_638459461416673675" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems_638459461416673675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable_638459461416673675" xlink:to="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems_638459461416673675" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_638459461416673675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems_638459461416673675" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_638459461416673675" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_638459461416683676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_638459461416673675" xlink:to="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_638459461416683676" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageAssumptionsAbstract" xlink:label="aciu_WeightedAverageAssumptionsAbstract_638459461416683676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract_638459461416673675" xlink:to="aciu_WeightedAverageAssumptionsAbstract_638459461416683676" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019_638459461416683676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageAssumptionsAbstract_638459461416683676" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019_638459461416683676" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_638459461416683676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageAssumptionsAbstract_638459461416683676" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_638459461416683676" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageSharePrice2019" xlink:label="ifrs-full_WeightedAverageSharePrice2019_638459461416683676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageAssumptionsAbstract_638459461416683676" xlink:to="ifrs-full_WeightedAverageSharePrice2019_638459461416683676" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_638459461416683676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageAssumptionsAbstract_638459461416683676" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_638459461416683676" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_638459461416683676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageAssumptionsAbstract_638459461416683676" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_638459461416683676" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_638459461416683676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageAssumptionsAbstract_638459461416683676" xlink:to="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_638459461416683676" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_638459461416683676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageAssumptionsAbstract_638459461416683676" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_638459461416683676" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails" xlink:type="extended" xlink:title="41905 - Disclosure - Share-based compensation, Non-vested Share Awards (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_638459461416693678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_638459461416693678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_638459461416693678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_638459461416693678" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_638459461416693678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember_638459461416693678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_638459461416693678" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember_638459461416693678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RestrictedSharesAndRestrictedShareUnitsMember" xlink:label="aciu_RestrictedSharesAndRestrictedShareUnitsMember_638459461416693678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_638459461416693678" xlink:to="aciu_RestrictedSharesAndRestrictedShareUnitsMember_638459461416693678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RestrictedStockUnitsMember" xlink:label="aciu_RestrictedStockUnitsMember_638459461416693678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember_638459461416693678" xlink:to="aciu_RestrictedStockUnitsMember_638459461416693678" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RestrictedStockUnitsFirstVestingConditionsMember" xlink:label="aciu_RestrictedStockUnitsFirstVestingConditionsMember_638459461416693678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_RestrictedStockUnitsMember_638459461416693678" xlink:to="aciu_RestrictedStockUnitsFirstVestingConditionsMember_638459461416693678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RestrictedStockUnitsSecondVestingConditionsMember" xlink:label="aciu_RestrictedStockUnitsSecondVestingConditionsMember_638459461416693678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_RestrictedStockUnitsMember_638459461416693678" xlink:to="aciu_RestrictedStockUnitsSecondVestingConditionsMember_638459461416693678" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_638459461416693678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_638459461416693678" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_638459461416693678" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_638459461416693678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis_638459461416693678" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_638459461416693678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_BoardOfDirectorsMember" xlink:label="aciu_BoardOfDirectorsMember_638459461416693678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_638459461416693678" xlink:to="aciu_BoardOfDirectorsMember_638459461416693678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ExecutiveManagementMember" xlink:label="aciu_ExecutiveManagementMember_638459461416693678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_638459461416693678" xlink:to="aciu_ExecutiveManagementMember_638459461416693678" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_EmployeesMember" xlink:label="aciu_EmployeesMember_638459461416693678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember_638459461416693678" xlink:to="aciu_EmployeesMember_638459461416693678" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_638459461416703678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_638459461416693678" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_638459461416703678" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ShareBasedPaymentArrangementAbstract" xlink:label="aciu_ShareBasedPaymentArrangementAbstract_638459461416703678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_638459461416703678" xlink:to="aciu_ShareBasedPaymentArrangementAbstract_638459461416703678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_638459461416703678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ShareBasedPaymentArrangementAbstract_638459461416703678" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_638459461416703678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod" xlink:label="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod_638459461416703678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ShareBasedPaymentArrangementAbstract_638459461416703678" xlink:to="aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod_638459461416703678" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement" xlink:label="aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement_638459461416703678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_ShareBasedPaymentArrangementAbstract_638459461416703678" xlink:to="aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement_638459461416703678" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfNonVestedSharesAbstract" xlink:label="aciu_NumberOfNonVestedSharesAbstract_638459461416703678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_638459461416703678" xlink:to="aciu_NumberOfNonVestedSharesAbstract_638459461416703678" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_638459461416703678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfNonVestedSharesAbstract_638459461416703678" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_638459461416703678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_638459461416703678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfNonVestedSharesAbstract_638459461416703678" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_638459461416703678" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement" xlink:label="aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement_638459461416703678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfNonVestedSharesAbstract_638459461416703678" xlink:to="aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement_638459461416703678" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_6384594614167036781" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfNonVestedSharesAbstract_638459461416703678" xlink:to="ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_6384594614167036781" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_638459461416713674" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfNonVestedSharesAbstract_638459461416703678" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_638459461416713674" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_638459461416713674" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfNonVestedSharesAbstract_638459461416703678" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_638459461416713674" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_638459461416713674" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_NumberOfNonVestedSharesAbstract_638459461416703678" xlink:to="ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_638459461416713674" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageExercisePriceAbstract" xlink:label="aciu_WeightedAverageExercisePriceAbstract_638459461416803693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_638459461416703678" xlink:to="aciu_WeightedAverageExercisePriceAbstract_638459461416803693" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding_638459461416803693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638459461416803693" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding_638459461416803693" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited_638459461416803693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638459461416803693" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited_638459461416803693" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised_638459461416803693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638459461416803693" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised_638459461416803693" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted_638459461416803693" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638459461416803693" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted_638459461416803693" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested_638459461416813672" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638459461416803693" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested_638459461416813672" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding_638459461416813672" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638459461416803693" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding_638459461416813672" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable" xlink:label="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable_638459461416813672" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_WeightedAverageExercisePriceAbstract_638459461416803693" xlink:to="aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable_638459461416813672" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_638459461416813672" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_638459461416703678" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_638459461416813672" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails" xlink:type="extended" xlink:title="42001 - Disclosure - Commitments and contingencies (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CommitmentsAndContingenciesAbstract" xlink:label="CommitmentsAndContingenciesAbstract" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable" xlink:label="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable_638459461416813672" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesAbstract" xlink:to="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable_638459461416813672" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis_638459461416823676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable_638459461416813672" xlink:to="ifrs-full_MaturityAxis_638459461416823676" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="ifrs-full_AggregatedTimeBandsMember_638459461416823676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis_638459461416823676" xlink:to="ifrs-full_AggregatedTimeBandsMember_638459461416823676" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="ifrs-full_NotLaterThanOneYearMember_638459461416823676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638459461416823676" xlink:to="ifrs-full_NotLaterThanOneYearMember_638459461416823676" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_638459461416823676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638459461416823676" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_638459461416823676" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_638459461416823676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638459461416823676" xlink:to="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_638459461416823676" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanFiveYearsMember_638459461416823676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AggregatedTimeBandsMember_638459461416823676" xlink:to="ifrs-full_LaterThanFiveYearsMember_638459461416823676" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems" xlink:label="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems_638459461416823676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable_638459461416813672" xlink:to="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems_638459461416823676" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CommitmentsAbstract" xlink:label="aciu_CommitmentsAbstract_638459461416823676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems_638459461416823676" xlink:to="aciu_CommitmentsAbstract_638459461416823676" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ContractualCapitalCommitmentsOtherThanForLeases" xlink:label="aciu_ContractualCapitalCommitmentsOtherThanForLeases_638459461416823676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CommitmentsAbstract_638459461416823676" xlink:to="aciu_ContractualCapitalCommitmentsOtherThanForLeases_638459461416823676" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RentalContractPeriodForNoticeOfCancellation" xlink:label="aciu_RentalContractPeriodForNoticeOfCancellation_638459461416823676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CommitmentsAbstract_638459461416823676" xlink:to="aciu_RentalContractPeriodForNoticeOfCancellation_638459461416823676" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ContractualCapitalCommitments" xlink:label="ifrs-full_ContractualCapitalCommitments_638459461416823676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_CommitmentsAbstract_638459461416823676" xlink:to="ifrs-full_ContractualCapitalCommitments_638459461416823676" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureEarningsPerShareDetails" xlink:type="extended" xlink:title="42101 - Disclosure - Earnings per share (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BasicEarningsPerShareAbstract" xlink:label="ifrs-full_BasicEarningsPerShareAbstract_638459461416833675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ifrs-full_BasicEarningsPerShareAbstract_638459461416833675" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract_638459461416833675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BasicEarningsPerShareAbstract_638459461416833675" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract_638459461416833675" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_638459461416833675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract_638459461416833675" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_638459461416833675" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DilutedEarningsPerShareAbstract" xlink:label="ifrs-full_DilutedEarningsPerShareAbstract_638459461416833675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ifrs-full_DilutedEarningsPerShareAbstract_638459461416833675" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract" xlink:label="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_638459461416833675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DilutedEarningsPerShareAbstract_638459461416833675" xlink:to="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_638459461416833675" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageShares" xlink:label="ifrs-full_WeightedAverageShares_638459461416833675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_638459461416833675" xlink:to="ifrs-full_WeightedAverageShares_638459461416833675" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="ifrs-full_BasicEarningsLossPerShare_638459461416833675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_638459461416833675" xlink:to="ifrs-full_BasicEarningsLossPerShare_638459461416833675" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="ifrs-full_DilutedEarningsLossPerShare_638459461416833675" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_638459461416833675" xlink:to="ifrs-full_DilutedEarningsLossPerShare_638459461416833675" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureEarningsPerShareAntidilutiveSecuritiesDetails" xlink:type="extended" xlink:title="42102 - Disclosure - Earnings per share - Antidilutive securities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="ifrs-full_EarningsPerShareAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable" xlink:label="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable_638459461416843676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable_638459461416843676" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfAntidilutiveInstrumentsAxis" xlink:label="ifrs-full_TypesOfAntidilutiveInstrumentsAxis_638459461416843676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable_638459461416843676" xlink:to="ifrs-full_TypesOfAntidilutiveInstrumentsAxis_638459461416843676" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AntidilutiveInstrumentsMember" xlink:label="ifrs-full_AntidilutiveInstrumentsMember_638459461416843676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfAntidilutiveInstrumentsAxis_638459461416843676" xlink:to="ifrs-full_AntidilutiveInstrumentsMember_638459461416843676" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareOptionsMember" xlink:label="ifrs-full_ShareOptionsMember_638459461416843676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AntidilutiveInstrumentsMember_638459461416843676" xlink:to="ifrs-full_ShareOptionsMember_638459461416843676" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RestrictedShareUnitsMember" xlink:label="ifrs-full_RestrictedShareUnitsMember_638459461416843676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AntidilutiveInstrumentsMember_638459461416843676" xlink:to="ifrs-full_RestrictedShareUnitsMember_638459461416843676" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ConvertibleInstrumentsMember" xlink:label="ifrs-full_ConvertibleInstrumentsMember_638459461416843676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AntidilutiveInstrumentsMember_638459461416843676" xlink:to="ifrs-full_ConvertibleInstrumentsMember_638459461416843676" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareLineItems" xlink:label="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareLineItems_638459461416843676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable_638459461416843676" xlink:to="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareLineItems_638459461416843676" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented" xlink:label="ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented_638459461416843676" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareLineItems_638459461416843676" xlink:to="ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented_638459461416843676" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails" xlink:type="extended" xlink:title="42201 - Disclosure - Financial instruments and risk management (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" xlink:label="DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_638459461416853677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_638459461416853677" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="ifrs-full_TypesOfRisksAxis_638459461416853677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_638459461416853677" xlink:to="ifrs-full_TypesOfRisksAxis_638459461416853677" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember" xlink:label="ifrs-full_TypesOfRisksMember_638459461416853677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksAxis_638459461416853677" xlink:to="ifrs-full_TypesOfRisksMember_638459461416853677" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrencyRiskMember" xlink:label="ifrs-full_CurrencyRiskMember_638459461416853677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksMember_638459461416853677" xlink:to="ifrs-full_CurrencyRiskMember_638459461416853677" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CreditRiskMember" xlink:label="ifrs-full_CreditRiskMember_638459461416853677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksMember_638459461416853677" xlink:to="ifrs-full_CreditRiskMember_638459461416853677" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiquidityRiskMember" xlink:label="ifrs-full_LiquidityRiskMember_638459461416853677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksMember_638459461416853677" xlink:to="ifrs-full_LiquidityRiskMember_638459461416853677" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestRateRiskMember" xlink:label="ifrs-full_InterestRateRiskMember_638459461416853677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksMember_638459461416853677" xlink:to="ifrs-full_InterestRateRiskMember_638459461416853677" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis_638459461416853677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_638459461416853677" xlink:to="ifrs-full_RangeAxis_638459461416853677" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember" xlink:label="ifrs-full_RangesMember_638459461416853677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis_638459461416853677" xlink:to="ifrs-full_RangesMember_638459461416853677" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember_638459461416853677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangesMember_638459461416853677" xlink:to="ifrs-full_TopOfRangeMember_638459461416853677" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis_638459461416853677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_638459461416853677" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis_638459461416853677" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember" xlink:label="ifrs-full_FinancialAssetsMember_638459461416863677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis_638459461416853677" xlink:to="ifrs-full_FinancialAssetsMember_638459461416863677" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_RightOfUseFinancialAssetsMember" xlink:label="aciu_RightOfUseFinancialAssetsMember_638459461416863677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialAssetsMember_638459461416863677" xlink:to="aciu_RightOfUseFinancialAssetsMember_638459461416863677" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_LongTermFinancialAssetsMember" xlink:label="aciu_LongTermFinancialAssetsMember_638459461416863677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialAssetsMember_638459461416863677" xlink:to="aciu_LongTermFinancialAssetsMember_638459461416863677" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_OtherCurrentReceivablesMember" xlink:label="aciu_OtherCurrentReceivablesMember_638459461416863677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialAssetsMember_638459461416863677" xlink:to="aciu_OtherCurrentReceivablesMember_638459461416863677" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeReceivablesMember" xlink:label="ifrs-full_TradeReceivablesMember_638459461416863677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialAssetsMember_638459461416863677" xlink:to="ifrs-full_TradeReceivablesMember_638459461416863677" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ShortTermFinancialAssetsMember" xlink:label="aciu_ShortTermFinancialAssetsMember_638459461416863677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialAssetsMember_638459461416863677" xlink:to="aciu_ShortTermFinancialAssetsMember_638459461416863677" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CashOnHandAndCashEquivalentsMember" xlink:label="aciu_CashOnHandAndCashEquivalentsMember_638459461416863677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialAssetsMember_638459461416863677" xlink:to="aciu_CashOnHandAndCashEquivalentsMember_638459461416863677" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis_638459461416863677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_638459461416853677" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis_638459461416863677" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="ifrs-full_FinancialLiabilitiesMember_638459461416863677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis_638459461416863677" xlink:to="ifrs-full_FinancialLiabilitiesMember_638459461416863677" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_LongTermLeaseLiabilitiesMember" xlink:label="aciu_LongTermLeaseLiabilitiesMember_638459461416863677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialLiabilitiesMember_638459461416863677" xlink:to="aciu_LongTermLeaseLiabilitiesMember_638459461416863677" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TradeAndOtherPayablesMember" xlink:label="aciu_TradeAndOtherPayablesMember_638459461416863677" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialLiabilitiesMember_638459461416863677" xlink:to="aciu_TradeAndOtherPayablesMember_638459461416863677" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_AccruedExpensesMember" xlink:label="aciu_AccruedExpensesMember_638459461416873678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialLiabilitiesMember_638459461416863677" xlink:to="aciu_AccruedExpensesMember_638459461416873678" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ShortTermLeaseLiabilitiesMember" xlink:label="aciu_ShortTermLeaseLiabilitiesMember_638459461416873678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_FinancialLiabilitiesMember_638459461416863677" xlink:to="aciu_ShortTermLeaseLiabilitiesMember_638459461416873678" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_638459461416873678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable_638459461416853677" xlink:to="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_638459461416873678" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_FinancialAssetsAndLiabilitiesAbstract" xlink:label="aciu_FinancialAssetsAndLiabilitiesAbstract_638459461416873678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_638459461416873678" xlink:to="aciu_FinancialAssetsAndLiabilitiesAbstract_638459461416873678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssets" xlink:label="ifrs-full_FinancialAssets_638459461416873678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialAssetsAndLiabilitiesAbstract_638459461416873678" xlink:to="ifrs-full_FinancialAssets_638459461416873678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilities" xlink:label="ifrs-full_FinancialLiabilities_638459461416873678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialAssetsAndLiabilitiesAbstract_638459461416873678" xlink:to="ifrs-full_FinancialLiabilities_638459461416873678" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_FinancialRisksAbstract" xlink:label="aciu_FinancialRisksAbstract_638459461416873678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_638459461416873678" xlink:to="aciu_FinancialRisksAbstract_638459461416873678" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_638459461416873678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialRisksAbstract_638459461416873678" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_638459461416873678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" xlink:label="aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies_638459461416883679" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialRisksAbstract_638459461416873678" xlink:to="aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies_638459461416883679" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies" xlink:label="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies_638459461416883679" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialRisksAbstract_638459461416873678" xlink:to="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies_638459461416883679" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates" xlink:label="aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates_638459461416883679" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialRisksAbstract_638459461416873678" xlink:to="aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates_638459461416883679" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates" xlink:label="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates_638459461416883679" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialRisksAbstract_638459461416873678" xlink:to="aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates_638459461416883679" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets" xlink:label="aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets_638459461416883679" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aciu_FinancialRisksAbstract_638459461416873678" xlink:to="aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets_638459461416883679" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://acimume.com/role/DisclosureSubsequentEventsDetails" xlink:type="extended" xlink:title="42401 - Disclosure - Subsequent Events (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_638459461416893678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:to="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_638459461416893678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="ifrs-full_TypesOfContractsAxis_638459461416893678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_638459461416893678" xlink:to="ifrs-full_TypesOfContractsAxis_638459461416893678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfContractsMember" xlink:label="ifrs-full_TypesOfContractsMember_638459461416893678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsAxis_638459461416893678" xlink:to="ifrs-full_TypesOfContractsMember_638459461416893678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember" xlink:label="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_638459461416893678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfContractsMember_638459461416893678" xlink:to="aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_638459461416893678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis_638459461416893678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_638459461416893678" xlink:to="ifrs-full_ProductsAndServicesAxis_638459461416893678" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="ifrs-full_ProductsAndServicesMember_638459461416893678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis_638459461416893678" xlink:to="ifrs-full_ProductsAndServicesMember_638459461416893678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_TauVaccineInADMember" xlink:label="aciu_TauVaccineInADMember_638459461416893678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesMember_638459461416893678" xlink:to="aciu_TauVaccineInADMember_638459461416893678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_638459461416893678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_638459461416893678" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_638459461416893678" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="ifrs-full_NonadjustingEventsMember_638459461416893678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_638459461416893678" xlink:to="ifrs-full_NonadjustingEventsMember_638459461416893678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_ReceiptOfMilestonePaymentsMember" xlink:label="aciu_ReceiptOfMilestonePaymentsMember_638459461416893678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsMember_638459461416893678" xlink:to="aciu_ReceiptOfMilestonePaymentsMember_638459461416893678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_638459461416893678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_638459461416893678" xlink:to="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_638459461416893678" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="aciu-20231231.xsd#aciu_CollaborationAgreementMileStonePaymentReceived" xlink:label="aciu_CollaborationAgreementMileStonePaymentReceived_638459461416893678" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_638459461416893678" xlink:to="aciu_CollaborationAgreementMileStonePaymentReceived_638459461416893678" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824827069808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AC IMMUNE SA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001651625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37891<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">V8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">EPFL INNOVATION PARK<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Building B<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">1015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Lausanne<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">CH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Shares, nominal value CHF 0.02 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ACIU<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">99,197,829<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">International Financial Reporting Standards<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">PricewaterhouseCoopers SA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Lausanne, Switzerland<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">EPFL INNOVATION PARK<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Building B<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">1015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Lausanne<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">CH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Andrea Pfeifer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">21 345 91 21<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824823812416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">SFr 3,376<span></span>
</td>
<td class="nump">SFr 4,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">3,508<span></span>
</td>
<td class="nump">2,808<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible asset</a></td>
<td class="nump">50,416<span></span>
</td>
<td class="nump">50,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentRestrictedCashAndCashEquivalents', window );">Long-term financial assets</a></td>
<td class="nump">361<span></span>
</td>
<td class="nump">361<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">57,661<span></span>
</td>
<td class="nump">57,844<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepaidExpenses', window );">Prepaid expenses</a></td>
<td class="nump">6,437<span></span>
</td>
<td class="nump">4,708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets', window );">Accrued income</a></td>
<td class="nump">246<span></span>
</td>
<td class="nump">408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Other current receivables</a></td>
<td class="nump">622<span></span>
</td>
<td class="nump">392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Accounts receivable</a></td>
<td class="nump">14,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents', window );">Short-term financial assets</a></td>
<td class="nump">24,554<span></span>
</td>
<td class="nump">91,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">78,494<span></span>
</td>
<td class="nump">31,586<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">125,153<span></span>
</td>
<td class="nump">128,094<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">182,814<span></span>
</td>
<td class="nump">185,938<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Shareholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">2,089<span></span>
</td>
<td class="nump">1,797<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share premium</a></td>
<td class="nump">474,907<span></span>
</td>
<td class="nump">431,323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TreasuryShares', window );">Treasury shares</a></td>
<td class="num">(105)<span></span>
</td>
<td class="num">(124)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation', window );">Currency translation differences</a></td>
<td class="num">(51)<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Accumulated losses</a></td>
<td class="num">(316,197)<span></span>
</td>
<td class="num">(264,015)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total shareholders' equity</a></td>
<td class="nump">160,643<span></span>
</td>
<td class="nump">168,991<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Long-term lease liabilities</a></td>
<td class="nump">2,825<span></span>
</td>
<td class="nump">2,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisionsForEmployeeBenefits', window );">Net employee defined benefit liabilities</a></td>
<td class="nump">5,770<span></span>
</td>
<td class="nump">3,213<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Total non-current liabilities</a></td>
<td class="nump">8,595<span></span>
</td>
<td class="nump">5,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade and other payables</a></td>
<td class="nump">1,679<span></span>
</td>
<td class="nump">929<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses</a></td>
<td class="nump">11,087<span></span>
</td>
<td class="nump">9,417<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities', window );">Deferred income</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">587<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Short-term lease liabilities</a></td>
<td class="nump">672<span></span>
</td>
<td class="nump">548<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">13,576<span></span>
</td>
<td class="nump">11,481<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="nump">22,171<span></span>
</td>
<td class="nump">16,947<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total shareholders' equity and liabilities</a></td>
<td class="nump">SFr 182,814<span></span>
</td>
<td class="nump">SFr 185,938<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current accrued expenses and other current liabilities. [Refer: Accruals; Other current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current accrued income including current contract assets. [Refer: Accrued income including contract assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current deferred income including current contract liabilities. [Refer: Deferred income including contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentProvisionsForEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provisions for employee benefits. [Refer: Provisions for employee benefits]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentProvisionsForEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentRestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentRestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current other receivables. [Refer: Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2023-01-01<br> -Paragraph 52<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_52_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharePremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharePremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of short-term deposits held by the entity that are not classified as cash equivalents. [Refer: Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An entity&#8217;s own equity instruments, held by the entity or other members of the consolidated group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2023-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824823982288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income/(Loss) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Contract revenue</a></td>
<td class="nump">SFr 14,801<span></span>
</td>
<td class="nump">SFr 3,935<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="nump">14,801<span></span>
</td>
<td class="nump">3,935<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ExpensesOperatingAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research &amp; development expenses</a></td>
<td class="num">(54,606)<span></span>
</td>
<td class="num">(60,336)<span></span>
</td>
<td class="num">(62,282)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General &amp; administrative expenses</a></td>
<td class="num">(15,305)<span></span>
</td>
<td class="num">(15,789)<span></span>
</td>
<td class="num">(17,910)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Other operating income/(expense), net</a></td>
<td class="nump">1,486<span></span>
</td>
<td class="nump">1,343<span></span>
</td>
<td class="nump">1,182<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OperatingExpense', window );">Total operating expenses</a></td>
<td class="num">(68,425)<span></span>
</td>
<td class="num">(74,782)<span></span>
</td>
<td class="num">(79,010)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating loss</a></td>
<td class="num">(53,624)<span></span>
</td>
<td class="num">(70,847)<span></span>
</td>
<td class="num">(79,010)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Financial income</a></td>
<td class="nump">1,044<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">6,485<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Financial expense</a></td>
<td class="num">(176)<span></span>
</td>
<td class="num">(355)<span></span>
</td>
<td class="num">(581)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Exchange differences</a></td>
<td class="num">(1,467)<span></span>
</td>
<td class="nump">393<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncomeCost', window );">Finance result, net</a></td>
<td class="num">(599)<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="nump">6,017<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Loss before tax</a></td>
<td class="num">(54,223)<span></span>
</td>
<td class="num">(70,740)<span></span>
</td>
<td class="num">(72,993)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax expense</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the period</a></td>
<td class="num">SFr (54,233)<span></span>
</td>
<td class="num">SFr (70,753)<span></span>
</td>
<td class="num">SFr (72,996)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Loss per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic loss per share for the period attributable to equity holders</a></td>
<td class="num">SFr (0.64)<span></span>
</td>
<td class="num">SFr (0.85)<span></span>
</td>
<td class="num">SFr (0.97)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted loss per share for the period attributable to equity holders</a></td>
<td class="num">SFr (0.64)<span></span>
</td>
<td class="num">SFr (0.85)<span></span>
</td>
<td class="num">SFr (0.97)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ExpensesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ExpensesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income or cost associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2023-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2023-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all operating expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherOperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income (expense) that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherOperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2023-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2023-01-01<br> -Paragraph IE33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 126<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 114<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824821663776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income/(Loss) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_StatementOfComprehensiveIncomeAbstract', window );"><strong>Consolidated Statements of Comprehensive Income/(Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the period</a></td>
<td class="num">SFr (54,233)<span></span>
</td>
<td class="num">SFr (70,753)<span></span>
</td>
<td class="num">SFr (72,996)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract', window );"><strong>Items that may be reclassified to income or loss in subsequent periods (net of tax):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Currency translation differences</a></td>
<td class="num">(61)<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract', window );"><strong>Items that will not to be reclassified to income or loss in subsequent periods (net of tax):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans', window );">Remeasurement gains/(losses) on defined-benefit plans (net of tax)</a></td>
<td class="num">(1,669)<span></span>
</td>
<td class="nump">4,426<span></span>
</td>
<td class="nump">956<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income/(loss)</a></td>
<td class="num">(1,730)<span></span>
</td>
<td class="nump">4,436<span></span>
</td>
<td class="nump">956<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss, net of tax</a></td>
<td class="num">SFr (55,963)<span></span>
</td>
<td class="num">SFr (66,317)<span></span>
</td>
<td class="num">SFr (72,040)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [member]; Plan assets [member]; Net defined benefit liability (asset)] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2023-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824822108400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Equity - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th"><div>Share capital</div></th>
<th class="th"><div>Share premium</div></th>
<th class="th"><div>Treasury shares</div></th>
<th class="th"><div>Accumulated losses</div></th>
<th class="th"><div>Currency Translation Differences</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, beginning of period at Dec. 31, 2020</a></td>
<td class="nump">SFr 1,538<span></span>
</td>
<td class="nump">SFr 346,890<span></span>
</td>
<td class="num">SFr (100)<span></span>
</td>
<td class="num">SFr (132,850)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 215,478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income/(loss) for the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(72,996)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(72,996)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income/(loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">956<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(72,040)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(72,040)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts', window );">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,097<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssuedAbstract', window );"><strong>Issuance of shares, net of transaction costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset', window );">IPR&amp;D asset purchase</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">49,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity', window );">Asset acquisition - common shares</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">4,587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,599<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments', window );">Conversion note agreement</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">16,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,744<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions', window );">Held as treasury shares</a></td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IssueOfEquityRestrictedShareAwards', window );">Restricted share awards</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(178)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of options</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">1,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,086<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, end of period at Dec. 31, 2021</a></td>
<td class="nump">1,794<span></span>
</td>
<td class="nump">431,251<span></span>
</td>
<td class="num">(124)<span></span>
</td>
<td class="num">(200,942)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">231,979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income/(loss) for the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(70,753)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(70,753)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income/(loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,426<span></span>
</td>
<td class="nump">SFr 10<span></span>
</td>
<td class="nump">4,436<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(66,327)<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(66,317)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts', window );">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssuedAbstract', window );"><strong>Issuance of shares, net of transaction costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IssueOfEquityRestrictedShareAwards', window );">Restricted share awards</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of options</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, end of period at Dec. 31, 2022</a></td>
<td class="nump">1,797<span></span>
</td>
<td class="nump">431,323<span></span>
</td>
<td class="num">(124)<span></span>
</td>
<td class="num">(264,015)<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">168,991<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income/(loss) for the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,233)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,233)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income/(loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,669)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="num">(1,730)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,902)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="num">(55,963)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,365<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost', window );">Proceeds from public offerings, net of underwriting fees, transaction costs and stamp duty</a></td>
<td class="nump">286<span></span>
</td>
<td class="nump">40,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts', window );">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,631<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssuedAbstract', window );"><strong>Issuance of shares, net of transaction costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IssueOfEquityRestrictedShareAwards', window );">Restricted share awards</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(645)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of options</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, end of period at Dec. 31, 2023</a></td>
<td class="nump">SFr 2,089<span></span>
</td>
<td class="nump">SFr 474,907<span></span>
</td>
<td class="num">SFr (105)<span></span>
</td>
<td class="num">SFr (316,197)<span></span>
</td>
<td class="num">SFr (51)<span></span>
</td>
<td class="nump">SFr 160,643<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>'The increase (decrease) in equity resulting from the issuance of shares as part of an asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from purchase of IPR&amp;D assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IssueOfEquityRestrictedShareAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of restricted share awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IssueOfEquityRestrictedShareAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity from sale or issue of public offerings net of underwriting fees and transaction costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity from sale or issue of treasury shares net of underwriting fees and transaction costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the conversion of convertible instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from treasury share transactions. [Refer: Equity; Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssuedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssuedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2023-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824820970432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the period</a></td>
<td class="num">SFr (54,233)<span></span>
</td>
<td class="num">SFr (70,753)<span></span>
</td>
<td class="num">SFr (72,996)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract', window );"><strong>Adjustments to reconcile net loss for the period to net cash flows:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationExpense', window );">Depreciation of property, plant and equipment</a></td>
<td class="nump">1,672<span></span>
</td>
<td class="nump">1,793<span></span>
</td>
<td class="nump">1,897<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets', window );">Depreciation of right-of-use assets</a></td>
<td class="nump">543<span></span>
</td>
<td class="nump">566<span></span>
</td>
<td class="nump">509<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForFinanceIncomeCost', window );">Finance (income)/expense, net</a></td>
<td class="nump">922<span></span>
</td>
<td class="num">(559)<span></span>
</td>
<td class="num">(6,769)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based compensation expense</a></td>
<td class="nump">4,365<span></span>
</td>
<td class="nump">3,330<span></span>
</td>
<td class="nump">4,126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities', window );">Change in net employee defined benefit liability</a></td>
<td class="nump">888<span></span>
</td>
<td class="nump">541<span></span>
</td>
<td class="nump">590<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForInterestExpense', window );">Interest expense</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">355<span></span>
</td>
<td class="nump">573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment', window );">(Gain)/loss on sale of fixed assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ChangesInWorkingCapitalAbstract', window );"><strong>Changes in working capital:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses', window );">(Increase)/decrease in prepaid expenses</a></td>
<td class="num">(1,748)<span></span>
</td>
<td class="num">(1,718)<span></span>
</td>
<td class="nump">791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets', window );">(Increase)/decrease in accrued income</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">567<span></span>
</td>
<td class="nump">594<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable', window );">(Increase)/decrease in accounts receivable</a></td>
<td class="num">(14,800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables', window );">(Increase)/decrease in other current receivables</a></td>
<td class="num">(232)<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="num">(99)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses', window );">(Decrease)/increase in accrued expenses</a></td>
<td class="nump">1,137<span></span>
</td>
<td class="num">(6,114)<span></span>
</td>
<td class="nump">5,214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities', window );">(Decrease)/increase in deferred income</a></td>
<td class="num">(449)<span></span>
</td>
<td class="num">(130)<span></span>
</td>
<td class="nump">425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable', window );">(Decrease)/increase in trade and other payables</a></td>
<td class="nump">770<span></span>
</td>
<td class="num">(1,073)<span></span>
</td>
<td class="num">(84)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperations', window );">Cash used in operating activities</a></td>
<td class="num">(60,827)<span></span>
</td>
<td class="num">(73,159)<span></span>
</td>
<td class="num">(65,216)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestReceivedClassifiedAsOperatingActivities', window );">Interest received</a></td>
<td class="nump">595<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsOperatingActivities', window );">Interest paid</a></td>
<td class="num">(163)<span></span>
</td>
<td class="num">(470)<span></span>
</td>
<td class="num">(465)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities', window );">Finance expenses paid</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash flows used in operating activities</a></td>
<td class="num">(60,408)<span></span>
</td>
<td class="num">(73,568)<span></span>
</td>
<td class="num">(65,689)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities', window );">Short-term financial assets, net</a></td>
<td class="nump">66,446<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="num">(51,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(801)<span></span>
</td>
<td class="num">(1,239)<span></span>
</td>
<td class="num">(2,635)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CashAdvancesForRentDeposit', window );">Rental deposits</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash flows provided by/(used in) investing activities</a></td>
<td class="nump">65,645<span></span>
</td>
<td class="nump">23,763<span></span>
</td>
<td class="num">(53,664)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ProceedsFromIssueOfConvertibleDebt', window );">Proceeds from issuance of convertible loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">23,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsForShareIssueCosts', window );">Transaction costs on issuance of shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ProceedsFromIssuanceOfPublicOfferingsOfCommonSharesNetOfUnderwritingFeesAndTransactionCosts', window );">Proceeds from public offerings of common shares, net of underwriting fees and transaction costs</a></td>
<td class="nump">41,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts', window );">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</a></td>
<td class="nump">2,677<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">12,121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions', window );">Proceeds from issuance of common shares - asset acquisition, net of transaction costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromExerciseOfOptions', window );">Proceeds from issuance of common shares - equity plan, net of transaction costs</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">1,082<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Principal payments of lease obligations</a></td>
<td class="num">(548)<span></span>
</td>
<td class="num">(569)<span></span>
</td>
<td class="num">(513)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions', window );">Transaction costs associated with issuance of shares in relation to asset acquisition previously recorded in Accrued expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(776)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Net cash flows (used in)/provided by financing activities</a></td>
<td class="nump">43,250<span></span>
</td>
<td class="num">(1,346)<span></span>
</td>
<td class="nump">40,746<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges', window );">Net increase/(decrease) in cash and cash equivalents</a></td>
<td class="nump">48,487<span></span>
</td>
<td class="num">(51,151)<span></span>
</td>
<td class="num">(78,607)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">31,586<span></span>
</td>
<td class="nump">82,216<span></span>
</td>
<td class="nump">160,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Exchange gain/(loss) on cash and cash equivalents</a></td>
<td class="num">(1,579)<span></span>
</td>
<td class="nump">521<span></span>
</td>
<td class="num">(70)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at end of the period</a></td>
<td class="nump">78,494<span></span>
</td>
<td class="nump">31,586<span></span>
</td>
<td class="nump">82,216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SupplementalNonCashActivityAbstract', window );"><strong>Supplemental non-cash activity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities', window );">Capital expenditures in Trade and other payables or Accrued expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition', window );">Issuance of shares for purchase of IPR&amp;D asset in asset acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">50,416<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Transaction costs associated with issuance of shares in relation to the asset acquisition recorded in Accrued expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_RepaymentOfConvertibleDebtEquitySettlementAmount', window );">Settlement of convertible notes recorded within Shareholders' equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">16,920<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TransactionCostAndStampDutyAssociatedWithPublicOfferingsOfCommonSharesRecordedInAccruedExpenses', window );">Transaction costs and stamp duty associated with the public offerings of common shares recorded in Accrued expenses</a></td>
<td class="nump">521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses', window );">Transaction costs associated with the sale of treasury shares in public offering recorded in Accrued expenses</a></td>
<td class="nump">SFr 27<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation expense for right-of-use assets to reconcile profit (loss) to net cash flow from (used in) operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in accrued expenses to reconcile profit (loss) to net cash flow from (used in) operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CashAdvancesForRentDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow or inflow for deposit of rent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CashAdvancesForRentDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ChangesInWorkingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ChangesInWorkingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Issuance of shares for purchase of IPR&amp;D asset in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments for share issue costs associated with issuance of shares in relation to asset acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments (proceeds) from purchases (sales) of short-term financial assets, classified as investing activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of common shares in connection to asset acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ProceedsFromIssuanceOfPublicOfferingsOfCommonSharesNetOfUnderwritingFeesAndTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash inflow from issuance of public offerings of common shares net of underwriting fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ProceedsFromIssuanceOfPublicOfferingsOfCommonSharesNetOfUnderwritingFeesAndTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ProceedsFromIssueOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuing of convertible debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ProceedsFromIssueOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of property plant and equipment acquired through noncash investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_RepaymentOfConvertibleDebtEquitySettlementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of the settlement of convertible debt that is settled via shares of entity's common shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_RepaymentOfConvertibleDebtEquitySettlementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_SupplementalNonCashActivityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_SupplementalNonCashActivityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_TransactionCostAndStampDutyAssociatedWithPublicOfferingsOfCommonSharesRecordedInAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of transaction cost and stamp duty associated with public offerings of common shares recorded in accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_TransactionCostAndStampDutyAssociatedWithPublicOfferingsOfCommonSharesRecordedInAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transaction costs associated with the sale of treasury shares in public offering recorded in Accrued expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for the decrease (increase) in accrued income including contract assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Accrued income including contract assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in other operating receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for the decrease (increase) in prepaid expenses to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Current prepaid expenses; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForFinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for net finance income or cost to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance income (cost); Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForFinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gain (loss) on disposals of property, plant and equipment to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Property, plant and equipment; Disposals, property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for the increase (decrease) in deferred income including contract liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred income including contract liabilities; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for interest expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Interest expense; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash from (used in) the entity's operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A_TI<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for finance costs paid, classified as operating activities. [Refer: Finance costs]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestReceivedClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from interest received, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestReceivedClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsForShareIssueCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for share issue costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsForShareIssueCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2023-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824825909872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_GeneralInformationAbstract', window );"><strong>General information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock', window );">General information</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">1.</b></span>General information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune SA was founded in 2003. The Company controls a fully-owned subsidiary, AC Immune USA,&#160;Inc. (&#8220;AC Immune USA&#8221; or &#8220;Subsidiary&#8221; and, together with AC Immune SA, &#8220;AC Immune,&#8221; &#8220;ACIU,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;ours,&#8221; &#8220;us&#8221;), which was registered and organized under the laws of Delaware, USA in June&#160;2021. The Company and its Subsidiary form the Group.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune SA is a clinical-stage biopharmaceutical company leveraging our two proprietary technology platforms to discover, design and develop novel proprietary medicines and diagnostics for prevention and treatment of neurodegenerative diseases (NDD) associated with protein misfolding. Misfolded proteins are generally recognized as the leading cause of NDD, such as Alzheimer&#8217;s disease (AD) and Parkinson&#8217;s disease (PD), with common mechanisms and drug targets, such as amyloid beta (Abeta), Tau, alpha-synuclein (a-syn) and TDP-43. Our corporate strategy is founded upon a three-pillar approach that targets (i)&#160;AD, (ii)&#160;focused non-AD NDD including Parkinson&#8217;s disease, ALS and NeuroOrphan indications and (iii)&#160;diagnostics. We use our two unique proprietary platform technologies, SupraAntigen (conformation-specific biologics) and Morphomer (conformation-specific small molecules), to discover, design and develop novel medicines and diagnostics to target misfolded proteins.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company was initially incorporated as a limited liability company on February&#160;13, 2003 in Basel, and effective August&#160;25, 2003 was transformed into a stock company. The Company&#8217;s corporate headquarters are located at EPFL Innovation Park Building B, 1015 Lausanne, Switzerland.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for general information about the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_GeneralInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_GeneralInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824825194000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of preparation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_BasisOfPreparationAbstract', window );"><strong>Basis of preparation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory', window );">Basis of preparation</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">2.</b></span>Basis of preparation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Going concern</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company believes that it will be able to meet all of its obligations as they fall due for at least 12&#160;months from the filing date of this Form 20-F, after considering the Company&#8217;s cash position of CHF 78.5 million and short-term financial assets of CHF 24.6 million as of December&#160;31, 2023. Hence, these consolidated financial statements have been prepared on a going-concern basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To date, the Company has financed its cash requirements primarily from its public offerings, share issuances, contract revenues from license and collaboration agreements (LCAs) and grants. The Company is a clinical stage company and is exposed to all the risks inherent to establishing a business. Inherent to the Company&#8217;s business are various risks and uncertainties, including the substantial uncertainty as to whether current projects will succeed and our ability to raise additional capital as needed. These risks may require us to take certain measures such as delaying, reducing or eliminating certain programs. The Company&#8217;s success may depend in part upon its ability to (i)&#160;establish and maintain a strong patent position and protection, (ii)&#160;enter into collaborations with partners in the pharmaceutical and biopharmaceutical industries, (iii)&#160;successfully move its product candidates through clinical development, (iv)&#160;attract and retain key personnel and (v)&#160;acquire capital to support its operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Statement of compliance</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) Accounting Standards as issued by the International Accounting Standards Board (IASB). These consolidated financial statements were approved for issue by the Board of Directors on March&#160;13, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Basis of measurement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The consolidated financial statements have been prepared under the historical cost convention except for items that are required to be accounted for at fair value.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_BasisOfPreparationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_BasisOfPreparationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the basis used for the preparation of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824825666192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of material accounting policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract', window );"><strong>Summary of material accounting policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory', window );">Summary of material accounting policies</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">3.</b></span>Summary of material accounting policies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The principal accounting policies adopted in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all the&#160;years presented, unless otherwise stated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Functional and reporting currency</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">These consolidated financial statements and accompanying notes are presented in Swiss Francs (CHF), which is AC Immune SA&#8217;s functional currency and the Group&#8217;s reporting currency. The Company&#8217;s subsidiary has a functional currency of the U.S. Dollar (USD). The respective functional currency represents the primary economic environment in which the entities operate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following exchange rates have been used for the translation of the financial statements of AC Immune USA:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">CHF/USD</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Closing rate, USD 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.851</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.933</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.923</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Weighted average exchange rate, USD 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.908</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.965</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.929</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The results and financial position of AC Immune USA are translated into the presentation currency as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">i.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">assets and liabilities for each balance sheet presented are translated at the closing rate at the date of that balance sheet;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">ii.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">income and expenses for each statement of income/(loss) are translated at average exchange rates; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">iii.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">all resulting exchange differences are recognized in other comprehensive income/(loss), within cumulative translation differences.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Basis of consolidation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The annual closing date of the individual financial statements is December&#160;31. The Company fully-owns its Subsidiary and fully consolidates its financial statements into these consolidated financial statements. All intercompany transactions have been eliminated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Foreign currency transactions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Foreign currency transactions are translated into the respective functional currency using prevailing exchange rates at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at&#160;year-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognized in the consolidated statements of income/(loss). Any gains or losses from these translations are included in the consolidated statements of income/(loss) in the period in which they arise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Current vs. non-current classification</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company presents assets and liabilities in the consolidated balance sheets based on current/non-current classification. The Company classifies all amounts to be realized or settled within 12&#160;months after the reporting period to be current and all other amounts to be non-current.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Revenue recognition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company applies IFRS 15&#160;<i style="font-style:italic;">Revenue from Contracts with Customers</i>. This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. Under IFRS 15, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of IFRS 15, the entity performs the following five steps: (i)&#160;identify the contract(s)&#160;with a customer; (ii)&#160;identify the performance obligations in the contract; (iii)&#160;determine the transaction price; (iv)&#160;allocate the transaction price to the performance obligations in the contract; and (v)&#160;recognize revenue when (or as) the entity satisfies a performance obligation. The Company applies the five-step model to contracts only when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of IFRS 15, the Company assesses the goods or services promised within each contract, and determines those that are performance obligations, and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company enters into LCAs which are within the scope of IFRS 15, under which it licenses certain rights to its product candidates and intellectual property to third parties. The terms of these arrangements typically include payment to the Company of one or more of the following: non-refundable, upfront license fees, development, regulatory and/or commercial milestone payments;&#160;payments for research and clinical services the Company provides through either its full-time employees or third-party vendors, and royalties on net sales of licensed products commercialized from the Company&#8217;s intellectual property. Each of these payments results in license, collaboration and other revenues, which are classified as contract revenue on the consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Licenses of intellectual property</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the license to the Company&#8217;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, upfront fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are sold in conjunction with a related service, the Company uses judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time. If the performance obligation is settled over time, the Company determines the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, upfront fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Milestone payments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At the inception of each arrangement that includes development, regulatory and/or commercial milestone payments, the Company evaluates whether the milestones are considered highly probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is highly probable that a significant cumulative revenue reversal would not occur in future periods, the associated milestone value is included in the transaction price. These amounts for the performance obligations under the contract are recognized as they are satisfied. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of such milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments recorded would affect contract revenues and earnings in the period of adjustment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Research and development services</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has certain arrangements with our collaboration partners that include contracting our employees for research and development programs. The Company assesses if these services are considered distinct in the context of each contract and, if so, they are accounted for as separate performance obligations. These revenues are recorded in contract revenue as the services are performed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Sublicense revenues</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has certain arrangements with our collaboration partners that include provisions for sublicensing. The Company recognizes any sublicense revenues at the point in time it is highly probable to obtain and not subject to reversal in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Contract balances</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company receives payments and determines credit terms from its customers for its various performance obligations based on billing schedules established in each contract. The timing of revenue recognition, billings and cash collections results in billed other current receivables, accrued income (contract assets), and deferred income (contract liabilities) on the consolidated balance sheets. Amounts are recorded as other current receivables when the Company&#8217;s right to consideration is unconditional. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be 1&#160;year or less.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For a complete discussion of accounting for contract revenue, see &#8220;Note&#160;14. Contract revenues.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Research and development expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Given the stage of development of the Company&#8217;s products, all research and development expenditure is expensed as incurred as it does not meet the capitalization criteria outlined in IAS 38 <i style="font-style:italic;">Intangible Assets</i>. The Company has not capitalized any R&amp;D expenses to date. Research and development expenditures include:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the cost of acquiring, developing and manufacturing active pharmaceutical ingredients for product candidates that have not received regulatory approval, clinical trial materials and other research and development materials;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fees and expenses incurred under agreements with contract research organizations, investigative sites and other entities in connection with the conduct of clinical trials and preclinical studies and related services, such as administrative, data-management and laboratory services;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fees and costs related to regulatory filings and activities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">costs associated with preclinical and clinical activities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">employee-related expenses, including salaries and bonuses, benefits, travel and share-based compensation expenses; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">all other allocated expenses such as facilities and information technology (IT) costs.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For external research contracts, expenses include those associated with contract research organizations, or CROs, or contract manufacturing organizations, or CMOs. The invoicing from CROs or CMOs for services rendered do not always align with work performed. We accrue the cost of services rendered in connection with CRO or CMO activities based on our estimate of the &#8220;stage of completion&#8221; for such contracted services. We maintain regular communication with our CRO or CMO vendors to gauge the reasonableness of our estimates and accrued expenses as of the balance sheet date in the consolidated financial statements based on facts and circumstances known at the time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Registration costs for patents are part of the expenditure for research and development projects. Therefore, registration costs for patents are expensed when incurred as long as the research and development project concerned does not meet the criteria for capitalization.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">General and administrative expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">General and administrative expenses are expensed as incurred and include personnel costs, expenses for outside professional services and all other allocated expenses. Personnel costs consist of salaries, cash bonuses, benefits and share-based compensation. Outside professional services consist of legal, accounting and audit services, IT and other consulting fees. Allocated expenses consist of certain IT, facilities and depreciation expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Grant income</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has received grants, from time to time, from the Michael J. Fox Foundation (MJFF), the Target ALS Foundation (Target ALS) and other institutions to support certain research projects. Grants are recorded at their fair value in the consolidated statements of income/(loss) within other operating income/(expenses), net when there is reasonable assurance that the Company will satisfy the underlying grant conditions and the grants will be received. In certain circumstances, grant income may be recognized before formal grantor acknowledgement of milestone achievements. To the extent required, grant income is deferred and recognized on a systematic basis over the periods in which the Company expects to recognize the related expenses for which the grants are intended to compensate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Leases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company applies IFRS 16 <i style="font-style:italic;">Leases</i>, which provides the model for lessee accounting in which all leases, other than short-term and low-value leases, are accounted for by the recognition on the consolidated balance sheet of a right-of-use asset and a lease liability, and the subsequent amortization of the right-of-use asset over the earlier of the end of the useful life or the lease term. In accordance with IFRS 16, the Company (i)&#160;does not recognize right-of-use assets and lease liabilities for leases of low value (i.e. approximate fair value of USD 5,000). For a complete discussion of accounting, see &#8220;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Right-of-use assets and lease liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At inception of a leasing contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company recognizes a right-of-use asset and a lease liability at the lease commencement date. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company&#8217;s incremental borrowing rate. The lease liabilities are classified as current or non-current based on the due dates of the underlying principal payments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Lease payments generally are fixed for the contract term. The lease liability is measured at amortized cost using the effective interest method. The lease liability is re-measured if there is a change in the estimated lease term, a change in future lease payments arising from a change in an index or rate, a change in the Company&#8217;s estimate of the amount expected to be payable under a residual value guarantee or a change in assessment of whether it will exercise a purchase, extension or termination option.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At inception, the right-of-use asset comprises the initial lease liability and any initial direct costs. The right-of-use asset is depreciated over the shorter of the lease term or the useful life of the underlying asset. The right-of-use asset is periodically reduced by impairment losses, if any, and adjusted for certain re-measurements of the lease liability performed on as certain potential triggering events may arise (e.g. lease modifications). When the lease liability is re-measured, a corresponding adjustment is made to the carrying amount of the right-of-use asset or is recorded in profit or loss if the carrying amount of the right-of-use asset has been reduced to zero.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The estimated lease term by right-of-use asset categories are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Buildings</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Office equipment</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">IT equipment</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">years</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Both the right-of-use-assets and lease liabilities are recognized in the consolidated balance sheets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Property, plant and equipment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Equipment is shown at historical acquisition cost, less accumulated depreciation and any accumulated impairment losses. Historical costs include expenditures that are directly attributable to the acquisition of the property, plant and equipment. Depreciation is calculated using a straight-line method to write off the cost of each asset to its residual value over its estimated useful life as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">IT equipment</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;">3</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Laboratory equipment</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Leasehold improvements/furniture</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The assets&#8217; residual values and useful lives are reviewed, and adjusted if appropriate, at each balance sheet date. Where an asset&#8217;s carrying amount is greater than its estimated recoverable amount, it is written down to its recoverable amount.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Gains and losses on disposals are determined by comparing the disposal proceeds with the carrying amount and are included in the consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Intangible assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune&#8217;s acquired in process research and development (IPR&amp;D) asset is stated at cost less any impairments. The Company does not deem this asset ready for use until the asset obtains market approval. Therefore, during the development period after the date of acquisition until market approval, the IPR&amp;D asset is not amortized. Upon market approval, the Company will determine the useful life of the asset, reclassify it from IPR&amp;D and commence amortization. If the associated R&amp;D effort is abandoned, the related IPR&amp;D will likely be written off and we will record the relevant impairment charge. Finally, the Company will not capitalize future development costs in respect to this IPR&amp;D asset until they meet the criteria for capitalization of research and development costs in accordance with IAS 38 <i style="font-style:italic;">Intangible Assets</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our IPR&amp;D asset is subject to impairment testing at least annually or when there are indications that the carrying value may not be recoverable until the completion of the development process. The determination of the recoverable amounts include key estimates which are highly sensitive to, and dependent upon, key assumptions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company uses a discounted cash flow method to determine the fair value less costs to sell (recoverable amount) of our IPR&amp;D intangible asset. The Company starts with a forecast of all the expected net cash flows, which incorporates the consideration of a terminal value and then the Company applies a discount rate to arrive at a risk-adjusted net present value amount.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any impairment losses are recognized immediately in the consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Fair value of financial assets&#160;and liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The Company&#8217;s financial assets and liabilities are composed of receivables, short-term financial assets, cash and cash equivalents, trade payables and lease liabilities. The fair value of these financial instruments approximates their </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">respective carrying values due to the short-term maturity of these instruments, and are held at their amortized cost in accordance with IFRS 9, unless otherwise explicitly noted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Receivables</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Receivables are recognized at their billing value. An allowance for doubtful accounts is recorded for potential estimated losses when there is evidence of the debtor&#8217;s inability to make required payments and the Company assesses on a forward-looking basis the expected credit losses associated with these receivables held at amortized cost.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Short-term financial assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Short-term financial assets are held with external financial institutions and comprise fixed-term deposits with maturities ranging from more than 3 through 12&#160;months in duration.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company assesses whether there is objective evidence that financial assets are impaired annually or whenever potential impairment triggers may occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Cash and cash equivalents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Cash and cash equivalents include deposits held with external financial institutions and cash on hand. All cash and cash equivalents are either in cash or in deposits with original duration of less than 3&#160;months.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Trade payables</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Trade payables are amounts due to third parties in the ordinary course of business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Share capital and public offerings</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Common shares are classified as equity. Share issuance costs are capitalized as incurred and will be shown in equity as a deduction, net of tax, from the proceeds received from existing or future offerings. Should a planned equity offering not be assessed as probable, the issuance costs would be expensed immediately in the consolidated statements of income/(loss). See &#8220;Note&#160;12. Share capital.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Treasury shares</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Treasury shares are recognized at acquisition cost and deducted from shareholders&#8217; equity at the time of acquisition, until they are subsequently resold, distributed or cancelled. Where such shares are subsequently sold, any consideration received is included in shareholders&#8217; equity. See &#8220;Note&#160;12. Share capital.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Employee benefits</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Post-employment benefits</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company operates the mandatory pension schemes for its employees in Switzerland. The schemes are generally funded through payments to insurance companies. The Company has a pension plan designed to pay pensions based on accumulated contributions on individual savings accounts. However, this plan is classified as a defined benefit plan under IAS 19.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The net defined benefit liability is the present value of the defined benefit obligation at the balance sheet date minus the fair value of plan assets. Significant estimates are used in determining the assumptions incorporated in the calculation of the pension obligations, which is supported by input from independent actuaries. The defined benefit obligation is calculated annually with the assistance of an independent actuary using the projected unit credit method, which reflects services rendered by employees to the date of valuation, incorporates assumptions concerning employees&#8217; projected salaries and pension increases as well as discount rates of highly liquid corporate bonds that have terms to maturity approximating the terms of the related liability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To the extent that the fair value of the plan assets is greater than the present value of the defined benefit obligation as calculated by our independent actuary, the Company accounts for the effect of the asset ceiling test under IAS 19.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Re-measurements of the net defined benefit liability, which comprise actuarial gains and losses and the return on plan assets (excluding interest) are recognized immediately in the consolidated statements of other comprehensive income/(loss). Past service costs, including curtailment gains or losses, are recognized immediately as a split in research and development and general and administrative expenses within the operating results. Settlement gains or losses are recognized in either research and development and/or general and administrative expenses within the operating results. The Company determines the net interest expense/(income) on the net defined benefit liability for the period by applying the discount rate used to measure the defined benefit obligation at the beginning of the annual period or in case of any significant events between measurement dates to the then-net defined benefit liability, considering any changes in the net defined benefit liability during the period as a result of contributions and benefit payments. Net interest expense/(income) and other expenses related to defined benefit plans are recognized in the consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Share-based compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company operates an equity-settled, share-based compensation plan. The fair value of the employee services received in exchange for the grant of equity-based awards is recognized as an expense. The total amount to be expensed over the vesting period is determined by reference to the fair value of the instruments granted, excluding the impact of any non-market vesting conditions. Non-market vesting conditions are included in assumptions about the number of instruments that are expected to become exercisable. At each balance sheet date, the Company revises its estimates of the number of instruments that are expected to become exercisable. It recognizes the impact of the revision of original estimates, if any, prospectively in the consolidated statements of income/(loss), and a corresponding adjustment to equity over the remaining vesting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Stock options granted under the Company&#8217;s stock option plans C1 and the 2016 Stock Option and Incentive Plan are valued using the Black-Scholes option-pricing model (see &#8220;Note&#160;19. Share-based compensation&#8221;). This valuation model as well as parameters used such as expected volatility and expected term of the stock options are partially based on management&#8217;s estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and share premium when the options are exercised.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We estimate the fair value of restricted share units using a reasonable estimate of market value of the common shares on the date of the award. We classify our share-based payments as equity-classified awards as they are settled in common shares. We measure equity-classified awards at their grant date fair value and do not subsequently re-measure them. Compensation costs related to equity-classified awards are equal to the fair value of the award at grant date amortized over the vesting period of the award using the graded method. We reclassify that portion of vested awards to share capital and share premium as the awards vest.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Provisions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Provisions are recognized when the Company has a present legal or constructive obligation as a result of past events where it is more likely than not that an outflow of resources will be required to settle the obligation, and a reliable estimate of the amount can be made.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Taxation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Current income tax assets and liabilities for the period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the tax amounts are those that are enacted or substantively enacted, at the reporting date in accordance with the fiscal regulations of the respective country where the Company operates and generates taxable income. Deferred tax is provided using the liability method on temporary differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes at the reporting date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the&#160;year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted at the reporting date. If required, deferred taxation is provided in full using the liability method, on all temporary differences at the reporting dates. It is calculated at the tax rates that are expected to apply to the period when it is anticipated the liabilities will be settled, and it is based on tax rates (and laws) that have been enacted or substantively enacted at the reporting date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Deferred income tax assets are recognized to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilized. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized. Although the Company has substantial tax loss carry-forwards, historically, due to the fact that the Company had limited certainty on the achievement of key milestones, it has not recognized any deferred tax assets as the probability for use is low.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As disclosed in &#8220;Note&#160;17. Income taxes,&#8221; the Company has tax losses that can generally be carried forward for a period of 7&#160;years from the period the loss was incurred. These tax losses represent potential value to the Company to the extent that the Company is able to create taxable profits before the expiry period of these tax losses. The Company has not recorded any deferred tax assets in relation to these tax losses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Earnings per share</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company presents basic earnings per share for each period in the consolidated financial statements. The earnings per share are calculated by dividing the earnings of the period by the weighted-average number of shares outstanding during the period. Diluted earnings per share reflect the potential dilution that could occur if dilutive securities such as share options or non-vested restricted share units were vested or exercised into common shares or resulted in the issuance of common shares that would participate in net income. Anti-dilutive shares are excluded from the dilutive earnings per share calculation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Critical judgments and accounting estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The areas where AC Immune has had to make judgments, estimates and assumptions relate to (i)&#160;revenue recognition on LCAs, (ii)&#160;clinical development accruals, (iii)&#160;net employee defined benefit liability, (iv)&#160;share-based compensation, (v)&#160;right-of-use assets and lease liabilities and (vi)&#160;our IPR&amp;D asset. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Segment reporting</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is managed and operated as one business. A single management team that reports to the chief operating decision maker comprehensively manages the entire business. Accordingly, the Company views its business and manages its operations as one operating segment. Non-current assets are located in, and revenue is allocated and recorded within, the Company&#8217;s country of domicile, Switzerland.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Accounting policies, new standards, interpretations and amendments adopted by the Company</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">There are no new IFRS standards, amendments or interpretations that are mandatory as of January 1, 2023 that are relevant to the Company. Additionally, the Company has not adopted any standard, interpretation or amendment that has been issued but is not yet effective. Such standards are not currently expected to have a material impact on the entity in the current or future reporting periods and on foreseeable future transactions.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of material accounting policy information applied by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824824071760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory', window );">Property, plant and equipment</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">4.</b></span>Property, plant and equipment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following tables show the movements in the net book values of property, plant and equipment for the&#160;years ended December&#160;31, 2023 and 2022, respectively:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:40.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:57.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2023</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Laboratory</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Leasehold</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assets under</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Furniture</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">improvements</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">construction</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquisition cost:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 285</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,909</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,765</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,640</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13,602</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 278</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 468</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 801</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Disposals</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (19)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (12)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (31)</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Transfers</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 309</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,168</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10,233</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,662</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,372</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated depreciation:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (159)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,599)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,017)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (568)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,343)</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (53)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (271)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,084)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (264)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,672)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Disposals</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (212)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,851)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (8,101)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (832)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10,996)</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying amount:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 126</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 310</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,748</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,072</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,259</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 97</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 317</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,132</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 830</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,376</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:42.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:56.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2022</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Laboratory</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Leasehold</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assets under</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Furniture</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">improvements</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">construction</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquisition cost:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 265</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,754</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,142</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 810</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 695</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12,666</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 151</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 576</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 184</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 936</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Transfers</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 47</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 646</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (697)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 285</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,909</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,765</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,640</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13,602</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated depreciation:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (106)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,316)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,739)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (389)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,550)</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (53)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (283)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,278)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (179)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,793)</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (159)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,599)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,017)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (568)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,343)</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying amount:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 159</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 438</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,403</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 421</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 695</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,116</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 126</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 310</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,748</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,072</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,259</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune continues to enhance its laboratory equipment to support its R&amp;D functions. This effort has continued for the&#160;year ended December&#160;31, 2023, with CHF 0.7 million invested in lab equipment and IT equipment, representing an increase of 6%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2023, 2022 and 2021, the Company incurred CHF 1.7 million, CHF 1.8 million and CHF 1.9 million in depreciation expenses, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS16_g73-79_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824826066848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use assets, long-term financial assets and lease liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PresentationOfLeasesForLesseeAbstract', window );"><strong>Right-of-use assets, long-term financial assets and lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfLeasesExplanatory', window );">Right-of-use assets, long-term financial assets and lease liabilities</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">5.</b></span>Right-of-use assets, long-term financial assets and lease liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company recognized additions and reassessment of right-of-use of leased assets for buildings or for office equipment totaling CHF 1.2 million and CHF 0.5 million for the&#160;years ended December&#160;31, 2023 and 2022, respectively. In 2023, these increases are predominantly associated with a new lease and the reassessment of our existing leased office space.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Regarding lease liabilities, the amortization depends on the rate implicit in the contract or the incremental borrowing rate for the respective lease component. The weighted averages of the incremental borrowing rates as of December&#160;31, 2023 are 3.5% (3.5% for 2022) for buildings, 5.3% (5.3% for 2022) for office equipment and 2.6% (2.6% for 2022) for IT equipment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following tables show the movements in the net book values of right-of-use of leased assets for the&#160;years ended December&#160;31, 2023 and 2022, respectively:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:61.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:61.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Office</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:61.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Buildings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,708</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 74</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,808</p></td></tr><tr><td style="vertical-align:bottom;width:61.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions and reassessment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,243</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,243</p></td></tr><tr><td style="vertical-align:bottom;width:61.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (505)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (24)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (14)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (543)</p></td></tr><tr><td style="vertical-align:bottom;width:61.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,446</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,508</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:61.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:61.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Office</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:61.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Buildings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2,776</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">98</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">40</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,914</p></td></tr><tr><td style="vertical-align:bottom;width:61.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions and reassessment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 460</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 460</p></td></tr><tr><td style="vertical-align:bottom;width:61.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (528)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (24)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (14)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (566)</p></td></tr><tr><td style="vertical-align:bottom;width:61.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,708</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 74</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,808</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">For the&#160;years ended December&#160;31, 2023, and 2022, the impact on the Company&#8217;s consolidated statements of income/(loss) and consolidated statements of cash flows is detailed in the table below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Statements of income/(loss)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation of right-of-use assets </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 543</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 566</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest expense on lease liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 90</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expense for short-term leases and leases of low value </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 793</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 750</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,426</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,384</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Statements of cash flows</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total cash outflow for leases</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,431</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,388</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table presents the contractual undiscounted cash flows for lease liabilities as of December&#160;31, 2023 and 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Less than one year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 784</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 638</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">1-3 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,526</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,230</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">3-5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,505</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,187</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,815</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,055</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company also has two deposits in escrow accounts totaling CHF 0.4 million for the lease of the Company&#8217;s premises as of December&#160;31, 2023 and 2022, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Section Presentation<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g47-50_TI<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g51-60_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PresentationOfLeasesForLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PresentationOfLeasesForLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824825905872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset acquisition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AssetAcquisitionsAbstract', window );"><strong>Asset acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfAssetAcquisitionsTextBlock', window );">Asset acquisition</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">6.</b></span>Asset acquisition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In 2021, the Company closed its acquisition with Affiris AG (Affiris) for the program portfolio of therapeutics targeting a-syn, notably ACI-7104.056 (previously PD01), a clinically-validated active immunotherapy candidate for the treatment of Parkinson&#8217;s disease (the Transferred Assets). The Company acquired the Transferred Assets and USD 5.0 (CHF 4.6) million in cash in exchange for 7,106,840 shares of the Company at closing, for a total value of USD 58.7 (CHF 55.1) million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">With the closing of this transaction, the Company recorded an IPR&amp;D intangible asset associated with ACI-7104.056 for USD 53.7 (CHF 50.4) million. The Company used a risk-adjusted discounted cash flow method to determine the fair value of the intangible asset using a discount rate of 15%. See &#8220;Note&#160;7. Intangible assets&#8221; for further details on assumptions used.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As the Company transferred its own equity instruments in consideration for the asset transferred, the acquisition was assessed in accordance with IFRS 2 <i style="font-style:italic;">Share-based Payment</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company determined that the acquisition of the Transferred Assets did not qualify as a business combination in accordance with IFRS 3 <i style="font-style:italic;">Business Combinations</i> and therefore was accounted for as an asset acquisition. Most of the fair value of the Transferred Assets is attributable to a single identifiable asset which is the in-process research and development asset. The purchase consideration for the Transferred Assets was allocated based on their relative fair values.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table summarizes the amounts of the Transferred Assets acquired:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:86.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:86.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:86.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Cash</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">4,634</p></td></tr><tr><td style="vertical-align:bottom;width:86.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">IPR&amp;D asset</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">50,416</p></td></tr><tr><td style="vertical-align:bottom;width:86.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">55,050</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AssetAcquisitionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AssetAcquisitionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfAssetAcquisitionsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for asset acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfAssetAcquisitionsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824825822736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory', window );">Intangible assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">7.</b></span>Intangible assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">AC Immune&#8217;s acquired IPR&amp;D asset is a clinically-validated active immunotherapy candidate for the treatment of Parkinson&#8217;s disease. The asset is not yet ready for use until the asset obtains market approval. The carrying amount and net book value are detailed below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net book</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net book</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> value</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Acquired IPR&amp;D asset</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td></tr><tr><td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total intangible assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In accordance with IAS 36 <i style="font-style:italic;">Impairment of Assets</i>, the IPR&amp;D asset is reviewed at least annually for impairment by assessing the fair value less costs to sell (recoverable amount) and comparing this to the carrying value of the asset. The valuation is considered to be Level&#160;3 in the fair value hierarchy in accordance with IFRS 13 <i style="font-style:italic;">Fair Value Measurement</i> due to unobservable inputs used in the valuation. The Company has determined the IPR&amp;D asset was not impaired as of December&#160;31, 2023 and 2022, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The key assumptions used in the valuation model in accordance with an income approach to determine the recoverable amount include observable and unobservable key inputs as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Anticipated research and development costs;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Anticipated costs of goods and sales and marketing expenditures;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Probability of achieving clinical and regulatory development milestones in accordance with certain industry benchmarks;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Target indication prevalence and incidence rates;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Anticipated market share;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">General commercialization expectations such as anticipated pricing and uptake;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Expected patent life and market exclusivity periods; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Other metrics such as the tax rate.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s valuation model calculates the risk-adjusted, net cash flows through the projected period of market exclusivity across target sales regions. The Company uses a discount rate of 17% (17% for 2022), based on the assumed cost of capital for the Company over the forecast period.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS38_g118-128_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824822572784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and cash equivalents and short-term financial assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsAbstract', window );"><strong>Cash and cash equivalents and financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock', window );">Cash and cash equivalents and short-term financial assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">8.</b></span>Cash and cash equivalents and short-term financial assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The Company&#8217;s cash and cash equivalents are maintained in the following respective currencies as of December&#160;31, 2023 and 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 78,494</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,586</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 78,494</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,586</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">By currency</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">CHF</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 52,437</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24,418</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">EUR</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,155</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,313</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17,902</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,855</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total cash and cash equivalents</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 78,494</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,586</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2023 and 2022, the Company&#8217;s funds were held in CHF, EUR and USD currencies. Funds held in EUR and USD were translated into CHF at a rate of 0.942 and 0.851 and 0.994 and 0.933, respectively, for each currency and&#160;year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table summarizes the Company&#8217;s short-term financial assets as of December&#160;31, 2023 and 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term financial assets due in one year or less</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24,554</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 91,000</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24,554</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 91,000</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">By currency</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">CHF</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 22,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 91,000</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,554</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total short-term financial assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24,554</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 91,000</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of cash and cash equivalents and short-term deposits not classified as cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824822050400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid expenses and accrued income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract', window );"><strong>Prepaid expenses and accrued income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock', window );">Prepaid expenses and accrued income</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">9.</b></span>Prepaid expenses and accrued income</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Prepaid expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,437</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,708</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 246</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 408</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total prepaid expenses and accrued income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,683</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">5,116</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s prepaid expenses relate mainly to research contracts with down-payments at contract signature with the related activities to start or continue into 2024, prepaid expenses recorded as part of our cost sharing arrangement with Janssen, as well as prepaid payroll-related expenses. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of prepaid expenses and accrued income including contract assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824825896320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts receivable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Accounts receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfAccountsReceivableTableTextBlock', window );">Accounts receivable</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">10.</b></span>Accounts receivable</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 8pt 0pt;">As of December 31, 2023, accounts receivable includes the CHF 14.8 million milestone payment due from Janssen as part of our collaboration and license agreement for reaching the programmed launch of the Phase 2b clinical study. This balance was not overdue as of December 31, 2023.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfAccountsReceivableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfAccountsReceivableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824827035488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other current receivables<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OtherCurrentReceivablesAbstract', window );"><strong>Other current receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfOtherCurrentReceivablesTextBlock', window );">Other current receivables</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">11.</b></span>Other current receivables</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other current receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 45</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 124</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Swiss VAT</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 259</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 249</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Withholding tax</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 318</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total other current receivables</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 622</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 392</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The maturity of these assets is less than <span style="-sec-ix-hidden:Hidden_JBrWQoLofk6Gyr7gN4-sJQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3&#160;months</span></span>. The Company considers the counterparty risk as low and the carrying amount of these receivables is considered to approximate their fair value.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfOtherCurrentReceivablesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other current receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfOtherCurrentReceivablesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_OtherCurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_OtherCurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824825907872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract', window );"><strong>Share capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory', window );">Share capital</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">12.</b></span>Share capital</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2023 and 2022, the issued share capital amounted to CHF 2,088,823 and CHF 1,796,675, respectively, and is composed of outstanding common shares of 99,197,829 and 83,620,364, respectively, and treasury shares of 5,243,958 and 6,214,021, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The table below summarizes the Company&#8217;s capital structure:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Common</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Treasury</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Treasury</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">premium</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 89,700,630</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,221,617)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,794</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 431,251</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (124)</p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,596</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (8)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0</p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Issuance of shares &#8211; incentive plans, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 133,755</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 80</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 89,834,385</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,214,021)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,797</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 431,323</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (124)</p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Proceeds from public offerings, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,300,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 286</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 40,249</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 970,063</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,631</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19</p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Issuance of shares &#8211; incentive plans, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 307,402</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 704</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 104,441,787</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,243,958)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,089</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 474,907</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (105)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The common shares and treasury shares have nominal values of CHF 0.02 per share. All shares have been fully paid. These treasury shares held by the Company are not considered outstanding shares as of December&#160;31, 2023 or 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Authorized capital</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s Board of Directors is authorized to increase the share capital, in one or several steps, until June 24, 2024, by a maximum amount of CHF&#160;114,000 by issuing a maximum of 5,700,000 registered shares with a par value of CHF&#160;0.02 each, to be fully paid up. An increase of the share capital (i) by means of an offering underwritten by a financial institution, a syndicate or another third party or third parties, followed by an offer to the then-existing shareholders of the Company and (ii) in partial amounts, shall also be permissible.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Conditional share capital for financing and other purposes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The Company&#8217;s share capital may be increased by a maximum aggregate amount of CHF&#160;100,000&#160;through the issuance of a maximum of 5,000,000 registered shares, payable in full, each with a nominal value of CHF&#160;0.02&#160;per share, through the exercise of conversion and/or option or warrant rights granted in connection with bonds or similar </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">instruments, issued or to be issued by the Company or by subsidiaries of the Company, including convertible debt instruments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Conditional share capital for employee benefit plans</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s share capital may be increased by a maximum aggregate amount of CHF&#160;93,795&#160;through the issuance of not more than&#160;4,689,750&#160;common shares, payable in full, each with a nominal value of CHF&#160;0.02&#160;per share, by the exercise of options rights that have been granted to employees, consultants, members of the board of directors, or other person providing services to the Company or a subsidiary. As of December 31, 2023, 97,540 of our common shares, which were issued upon the exercise of options and restricted share units, have not yet been registered with the commercial register of the Canton of Vaud.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Follow-On Offering</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On December 19, 2023, the Company announced that it had closed an underwritten offering of 14,300,000 common shares, resulting in gross proceeds of approximately USD 50.1 (CHF 43.8) million. Net underwriting fees and transaction costs totaled CHF 3.3 million for net proceeds of CHF 40.5 million. Transaction costs associated with these offerings and related to the issuance of new shares were charged directly against the share premium account thereby reducing the total equity reported.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Shelf registration statement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On April&#160;28, 2021, the Company filed a Shelf Registration Statement on Form&#160;F-3 (Reg. No.&#160;333-255576) (the &#8220;Shelf Registration Statement&#8221;) with the SEC. The Shelf Registration Statement was declared effective by the SEC on May&#160;5, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Shelf Registration Statement allows the Company to offer and sell, from time to time, up to USD 350,000,000 of common shares, debt securities, warrants, purchase contracts, units, subscription rights or any combination of the foregoing in one or more future public offerings. The terms of any future offering would be determined at the time of the offering and would be subject to market conditions and approval by the Company&#8217;s Board of Directors. Any offering of securities covered by the Shelf Registration Statement will be made only by means of a written prospectus and prospectus supplement authorized and filed by the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">At the market equity offering</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In Q3 2020, AC Immune issued 5,000,000 common shares with a nominal value of CHF 0.02, which became treasury shares. The Company also established an &#8220;at the market offering program&#8221; (&#8220;ATM&#8221;) for the sale of up to USD 80.0 (CHF 68.1) million worth of our common shares issued from time to time by entering into an Open Market Sale Agreement (&#8220;Sales Agreement&#8221;) with Jefferies LLC (&#8220;Jefferies&#8221;) as the sales agent under a prior registration statement on Form&#160;F-3 which expired in Q2 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In Q2 2021, the Company filed a new registration statement on Form&#160;F-3 and an accompanying prospectus supplement in order to renew its ATM program. The Company also entered into a second Open Market Sale Agreement (the &#8220;new Sales Agreement&#8221;) with Jefferies to continue the ATM program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In Q3, 2021, the Company issued 2,393,160 common shares with a nominal value of CHF 0.02 to be held as treasury shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Through December 31, 2023, the Company has sold 2,149,202 common shares previously held as treasury shares pursuant to the new Sales Agreement, raising USD 16.3 (CHF 14.8) million, net of underwriting fees and transaction costs. We have paid commissions to Jefferies totaling USD 0.5 (CHF 0.5) million through December 31, 2023, for share issuances in accordance with our ATM programs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Convertible note agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Concurrently with the Asset Purchase Agreement, the Company entered into two separate Convertible Note&#160;Agreements with entities affiliated with each of Athos Service GmbH and First Capital Partner GmbH, both of which entities are shareholders of Affiris.&#160;Each Convertible Note&#160;Agreement provided for the sale of an unsecured subordinated Convertible Note&#160;of the Company with an aggregate principal amount of USD 12.5 (CHF 11.7) million for total net proceeds of USD 25 (CHF 23.5) million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In 2021, the affiliated entities exercised their options to convert their respective USD 12.5 (CHF 11.7) million notes. As a result of these conversions, 1,513,317 <span style="-sec-ix-hidden:Hidden_RHGPfxiSZ0Wm65Cc6mThNQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">common</span></span> shares were issued to each Investor, totaling 3,026,634 common shares. The Company recorded an increase to its share capital for the nominal value of its shares and share premium for the difference associated with settlement of this liability. The Company also settled its derivative financial assets, which were embedded conversion features associated with the convertible debt, via an offset to its share premium. These convertible notes and derivative financial assets were fully settled in 2021 and there is no further equity or cash consideration due to the affiliated entities thereunder.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share capital, reserves and other equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824826292144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade and other payables and accrued expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract', window );"><strong>Accrued expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock', window );">Trade and other payables and accrued expenses</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">13.</b></span>Trade and other payables and accrued expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Trade and other payables </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,679</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 929</p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total trade and other payables</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,679</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 929</p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued research and development costs </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,722</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,360</p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued payroll expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,649</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,898</p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other accrued expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,716</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,159</p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total accrued expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11,087</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,417</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The increase in accrued payroll expenses is mostly due to the timing of certain payroll-related payments and an increase in performance-related remuneration. Additionally, CHF 0.4 million was recognized as accrued stamp duty within other accrued expenses for the issuance of shares as part of the Company&#8217;s follow-on offering as of December 31, 2023.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other payables and accrued expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824826292432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract revenues<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRevenueExplanatory', window );">Contract revenues</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">14.</b></span>Contract revenues</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2023, 2022 and 2021, AC Immune generated contract revenues of CHF 14.8 million, CHF 3.9 million and nil, respectively. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following tables provide contract revenue amounts from its LCAs for the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Janssen</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,800</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Life Molecular Imaging</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,935</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total contract revenues</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,801</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,935</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">During the&#160;years ended December&#160;31, 2023, 2022 and 2021, the Company recognized the following contract revenues as a result of changes in the contract asset and the contract liability balances in the respective periods:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Revenues recognized in the period from:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Amounts included in the contract liability at the beginning of the period </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Performance obligations satisfied in previous periods</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,801</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,935</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">14.1</b></span> Licensing and collaboration agreements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Morphomer Tau small molecule&#160;&#8211; 2018 license agreement with Eli Lilly and Company</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In December&#160;2018, we entered into an exclusive, worldwide licensing agreement with Eli Lilly and Company (Lilly) to research and develop Morphomer Tau small molecules for the treatment of AD and other neurodegenerative diseases. More specifically, this is an exclusive license with the right to Lilly to grant sublicenses under the ACIU Patents, the ACIU know-how, and ACIU&#8217;s interests in the Joint Patents and the joint know-how to Exploit the Licensed Compounds and Licensed Products. The agreement became effective on January&#160;23, 2019 (the &#8220;effective date&#8221;) when the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, expired. In Q3 2019, the Company and Lilly entered into the first amendment to divide the first discretionary milestone payment under the agreement of CHF 60 million into two installments, with the first CHF 30 million paid in Q3 2019 and the second CHF 30 million to be paid on or before March&#160;31, 2020 unless Lilly terminated the agreement earlier. In Q1 2020, the Company and Lilly entered into a second amendment to replace the second CHF 30 million to be paid on or before March&#160;31, 2020 with two milestone payments, one of CHF 10 million to be paid on or before March&#160;31, 2020 and the other of CHF 60 million following the first patient dosed in a Phase 2 clinical study of a licensed product in the U.S. or EU.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Per the terms of the agreement, the Company received an initial upfront payment of CHF 80 million in Q1 2019 for the rights granted by the Company to Lilly. To date, the Company has completed a Phase 1 clinical study with ACI-3024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Additionally, the Company and Lilly have continued candidate characterization across the research program, identifying new and highly differentiated candidates with desired cerebrospinal fluid exposure and selectivity for pathological aggregated Tau. These will be broadly developed in Tau-dependent neurodegenerative diseases by Lilly. Lilly is responsible for leading and funding further clinical development and will retain global commercialization rights for all indications.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Per the terms of the agreement, the Company may become eligible to receive additional milestone payments totaling up to approximately CHF 880 million for clinical and regulatory milestones and CHF 900 million upon achievement of certain commercial milestones. In addition to milestones, we will be eligible to receive royalties on sales at a&#160;percentage rate ranging from the low double-digits to the mid-teens. The agreement will terminate by the date of expiration of the last royalty term for the last licensed product. However, under the terms of the agreement, Lilly may terminate the agreement at any time by providing <span style="-sec-ix-hidden:Hidden_9VUHy5QxNUOhdyJftjpzFw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3&#160;months</span></span>&#8217; prior notice to us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that Lilly is a customer. The Company identified the following significant performance obligations under the contract: (i)&#160;a right-of-use license and (ii)&#160;research and development activities outlined in the development plan. Per the agreement, the Company was responsible for the preclinical and Phase 1 activities for the first clinical candidate, ACI-3024, which the Company determined was distinct and capable of being completed by Lilly or a third party. Preclinical activities for which AC Immune was responsible prior to their completion in Q2 2019 included final manufacturing of materials for use in the regulatory submission of the protocol and in the Phase 1 study. For the completed Phase 1, AC Immune was responsible for leading the study design, obtaining relevant regulatory agency approvals, arranging necessary third-party contracts, completing patient selection, ensuring patient treatment, following up with patients, drafting the clinical study report </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">development and other relevant clinical activities to ensure that the primary objective of the study was completed. The Company used CMOs for certain of its preclinical activities and CROs to complete certain Phase 1 activities and to issue the final clinical study report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Finally, per the agreement, each party has three representatives on a joint steering committee (JSC). Depending upon the agenda, additional field experts can attend the JSC to provide the technical and scientific contribution required. The JSC meets on a regular basis depending on agreements between the representatives. The JSC is responsible for serving as the forum to (i)&#160;discuss, review and approve certain activities by reviewing and discussing the development progress with updates on back-up candidates, (ii)&#160;discuss, review and approve all amendments to the global development plan, (iii)&#160;periodically discuss and review commercialization of licensed products and (iv)&#160;review and approve reports related to development costs among other activities. The JSC is intended to ensure that communication between the parties remains consistent and that the development plan is progressing as intended.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The valuation of each performance obligation involves estimates and assumptions with revenue recognition timing to be determined by either delivery or the provision of services.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company used the residual approach to estimate the selling price for the right-of-use license and an expected cost plus margin approach for estimating the research and development activities. The right-of-use license was delivered on the effective date. The research and development activities were delivered over time as the services were performed. For these services, revenue was recognized over time using the input method, based on costs incurred to perform the services, as the level of costs incurred over time is thought to best reflect the transfer of services to Lilly. The Company determined the value of the research and development activities to be CHF 6.9 million and deferred this balance from the effective date. To date, the Company has cumulatively recognized CHF 6.9 million in contract revenue, resulting in no deferred income (contract liability) on the consolidated balance sheets. The remaining CHF 73.1 million from the upfront payment was allocated to the right-of-use license and recognized on the effective date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At inception of the agreement, none of the clinical, regulatory or commercial milestones had been included in the transaction price, as all milestone amounts were fully constrained. To date, the Company has recognized CHF 40 million from milestone payments triggered in Q3 2019 and Q1 2020 related to the right-of-use license for intellectual property as there were no further constraints related to these milestones. In assessing that future clinical, regulatory or commercial milestones are fully constrained, the Company considered numerous factors to determine that these milestones are not highly probable to obtain, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials and the licensee&#8217;s efforts. Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as they were determined to relate predominantly to the license granted to Lilly and therefore have also been excluded from the transaction price. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2023, 2022 and 2021, we have recognized no revenues from this arrangement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Tau active immunotherapy in AD&#160;&#8211; 2014 agreement with Janssen Pharmaceuticals,&#160;Inc.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In December&#160;2014, we entered into an agreement with Janssen Pharmaceuticals, Inc. (Janssen), part of the Janssen Pharmaceutical Companies of Johnson &amp; Johnson, to develop and commercialize therapeutic anti-Tau active immunotherapies for the treatment of AD and potentially other Tauopathies. The value of this collaboration is potentially up to CHF 500 million and includes upfront and clinical, regulatory and commercial milestones. In addition to milestones, we will be eligible to receive royalties on sales at a&#160;percentage rate ranging from the low-double digits to the mid-teens for the ACI-35.030 active immunotherapy program. In April&#160;2016, July&#160;2017, January&#160;2019, November&#160;2019, December 2022, and November 2023, the companies entered into the first, second, third, fourth, fifth and sixth amendments, respectively. These amendments allow for the alignment of certain payment and activity provisions with the Development Plan and Research Plan activities. We and Janssen have completed the co-development of the second-generation lead active immunotherapies, ACI-35.030 and JACI-35.054, through Phase 1b/2a. In November 2022, it was announced that ACI-35.030 was selected to advance into further development based on interim data from the ongoing Phase 1b/2a trial. In December 2023, it was announced that Janssen has programmed the launch of Phase 2b clinical </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">study to evaluate ACI-35.030 (JNJ-64042056) in patients with preclinical AD, those individuals not yet showing symptoms. AC Immune and Janssen will jointly share research and development costs until the completion of the first Phase 2b (AC Immune&#8217;s contribution to the first Phase 2b trial is capped). From Phase 2b and onwards, Janssen will assume responsibility for the clinical development, manufacturing and commercialization of ACI-35.030.  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Under the terms of the agreement, Janssen may terminate the agreement at any time after completion of the first Phase 1b clinical study in 2016 by providing <span style="-sec-ix-hidden:Hidden_0OEUZRutDEesJMh1BBGUqQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">90&#160;days</span></span>&#8217; notice to us. If not otherwise terminated, the agreement shall continue until the expiration of all royalty obligations as outlined in the contract.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The agreement also allows for the expansion to a second indication based on the same anti-Tau active immunotherapy program and based on intellectual property related to this program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company received an upfront, non-refundable license fee of CHF 25.9 million, which we recognized as revenue in 2014. In May&#160;2016, we received a payment of CHF 4.9 million for reaching a clinical milestone in the first Phase 1b study. In December 2023, we were entitled to receive a milestone payment of CHF 14.8 million for the commencement of the first Phase 2b clinical study. The Company recognized this income as revenue because we deemed it highly probable that this milestone would be obtained and would not be subject to reversal in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that Janssen is a customer. The Company identified the following performance obligations under the contract: (i)&#160;a right-of-use license and (ii)&#160;research and development services including a development and chemistry, manufacturing and controls work plan. The Company considered the research and development capabilities of Janssen, Janssen&#8217;s right to sublicense, and the fact that the research and development services are not proprietary and can be provided by other vendors, to conclude that the license has stand-alone functionality and is distinct. The Company&#8217;s obligation to perform research and development services does not significantly impact or modify the licenses&#8217; granted functionality. Based on these assessments, the Company identified the license and the research and development services as the performance obligations at the inception of the arrangement, which were deemed to be distinct in the context of the contract.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At execution of the agreement, the transaction price included only the upfront consideration received of CHF 25.9 million. At inception, none of the clinical, regulatory or commercial milestones has been included in the transaction price, as all milestone amounts were fully constrained. The Company did receive a payment of CHF 4.9 million for reaching a clinical milestone in the first Phase 1b study in May&#160;2016 and was entitled, in December 2023, to receive a milestone payment of CHF 14.8 million for the commencement of the Phase above. The Company could also receive up to more than CHF 443 million in clinical, regulatory and commercial milestones as well as tiered, low-double digits to mid-teen royalties on aggregate net sales for the ACI-35.030 active immunotherapy program. In assessing that future clinical, regulatory or commercial milestones are fully constrained, the Company considered numerous factors to determine that these milestones are not highly probable to obtain, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials and the licensee&#8217;s efforts. Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as they were determined to relate predominantly to the license granted to Janssen and therefore have also been excluded from the transaction price. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2023, 2022 and 2021, we have recognized CHF 14.8 million, nil and nil, respectively, from this arrangement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"><i style="font-style:italic;">Tau-PET imaging agent&#160;&#8211;2014 agreement with Life Molecular Imaging (LMI)</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In May&#160;2014 (as amended in June 2022), we entered into an agreement, our first diagnostic partnership, with LMI, the former Piramal Imaging SA. The partnership with LMI is an exclusive, worldwide licensing agreement for the research, development and commercialization of the Company&#8217;s Tau protein PET tracers supporting the early diagnosis and clinical management of AD and other Tau-related disorders and includes upfront and sales milestone payments totaling up to EUR 160 (CHF 151) million, plus royalties on sales at a&#160;percentage rate ranging from mid-single digits to low-teens. LMI may terminate the LCA at any time by providing 3&#160;months&#8217; notice to us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In connection with this agreement, AC Immune received a payment of EUR 500 (CHF 664) thousand, which was fully recognized in 2015. In Q1 2017, we recorded a milestone payment of EUR 1 (CHF 1.1) million related to the initiation of &#8220;Part&#160;B&#8221; of the first-in-man Phase 1 study. In Q3 2019, the Company recognized EUR 2 (CHF 2.2) million in connection with the initiation of a Phase 2 trial of Tau-PET tracer in patients with mild cognitive impairment and mild&#8211;to-moderate AD in comparison with non-demented control participants. In Q3 2022, the Company recognized EUR 4 (CHF 3.9) million linked to the progression of the Tau-PET tracer into late-stage development in AD. The Company is eligible to receive additional variable consideration related to the achievement of certain clinical milestones totaling EUR 4 (CHF 4) million should the compound make it through Phase 3 clinical studies. We are also eligible to receive potential regulatory and sales-based milestones totaling EUR 148 (CHF 139) million. Finally, the Company is eligible for royalties from the mid-single digits to low-teens.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that LMI is a customer. The Company has identified that the right-of-use license as the only performance obligation. The Company determined that transaction price based on the defined terms allocated to each performance obligation specified in the contract.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The upfront payment constitutes the amount of consideration to be included in the transaction price and has been allocated to the license. None of the clinical, regulatory or commercial milestones has been included in the transaction price as these variable consideration elements are considered fully constrained. As part of its evaluation of the constraint, the Company considered numerous factors, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials and the licensee&#8217;s efforts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as these amounts have been determined to relate predominantly to the license granted to LMI and therefore are recognized at the later of when the performance obligation is satisfied or the related sales occur. The Company considered LMI&#8217;s right to sublicense and develop the Tau protein PET tracers, and the fact that LMI could perform the research and development work themselves within the license term without AC Immune, to conclude that the license has stand-alone functionality and is distinct. The Company believes that the contracted amount represents the fair value. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2023, 2022 and 2021, the Company has recognized nil, CHF 3.9 million and nil, respectively, from this arrangement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">14.2</b></span> Grant income</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Grants from the Michael J. Fox Foundation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In May&#160;2020, the Company, as part of a joint arrangement with Sk&#229;ne University Hospital (Sk&#229;ne) in Sweden, was awarded a USD 3.2 (CHF 3.0) million grant from the MJFF&#8217;s Ken Griffin Alpha-synuclein Imaging Competition. As part of this grant, AC Immune was eligible to receive USD 2.5 (CHF 2.3) million directly from the MJFF. Sk&#229;ne was to receive USD 0.7 (CHF 0.7) million of the total grant directly from the MJFF over <span style="-sec-ix-hidden:Hidden_fQR8tACVGEO4UDivdKvMdQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">two</span></span>&#160;years to conduct and support the clinical arm of the project. In August 2022, the Company received follow-on grant funding as part of its joint arrangement with Sk&#229;ne in Sweden totaling USD&#160;0.5&#160;(CHF&#160;0.5) million for the continued development of its alpha-synuclein PET imaging diagnostic agent. As part of this grant, AC Immune received USD&#160;0.4&#160;(CHF&#160;0.4) million directly from the MJFF. Sk&#229;ne received USD&#160;0.1&#160;(CHF&#160;0.1) million of the total grant directly from the MJFF over the duration of the grant period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In December&#160;2021, the Company announced that it had been awarded two grants totaling USD 1.5 (CHF 1.4) million to advance small molecule PD programs. One award supported an existing early-stage program to develop small molecules that can prevent intracellular aggregation and spreading of a-syn. The other award funded research on the therapeutic potential of chemically and mechanistically novel, brain penetrant small molecule inhibitors of NLRP3 inflammasome activation for the treatment of PD.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In February 2023, the Company announced that it had been awarded a new grant totaling USD 0.5 (CHF 0.4) million from the MJFF to support the development of its TDP-43 PET tracer program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2023, 2022 and 2021, the Company has recognized CHF 1.2 million, CHF 1.2 million and CHF 1.1 million, respectively, from its MJFF grants, under &#8220;Other operating income/(expense), net&#8221;. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRevenueExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRevenueExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824827052480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Expenses by category<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ExpensesByCategoryAbstract', window );"><strong>Expenses by category [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfExpensesExplanatory', window );">Expenses by category</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">15.</b></span>Expenses by category</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;">Research and development</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Operating expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 33,198</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 41,166</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 44,289</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Payroll expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,499</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17,548</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16,465</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based compensation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,909</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,622</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,528</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total research and development expenses </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 54,606</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 60,336</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 62,282</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The decrease in 2023 is mainly driven by a decrease of CHF 5.8 million in direct R&amp;D expenditures across various programs. This is partially offset by an increase of CHF 2.2 million in salaries and related costs, including share-based compensation expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2023, 2022 and 2021, the Company had 115.4, 122.4 and 108.6 FTEs in our research and development functions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;">General and administrative</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Operating expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,729</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,207</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,031</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Payroll expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,755</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,874</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,281</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based compensation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,821</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,708</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,598</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total general and administrative expenses </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,305</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,789</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17,910</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The decrease in 2023 compared with the prior&#160;year predominantly relates to a reduction of CHF 1.5 million across various cost centers. This is partially offset by an increase of CHF 1.1 million in share-based compensation expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;years ended December&#160;31, 2023, 2022 and 2021, the Company had 26.2, 22.5 and 27.3 FTEs in our general and administrative functions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;">Financial result, net</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Financial income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,044</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 69</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,485</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Financial expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (176)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (355)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (581)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exchange differences</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,467)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 393</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 113</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Finance result, net </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (599)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 107</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,017</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our finance result primarily consists of interest expense associated with our short-term financial assets and lease liabilities as well as foreign currency exchange differences.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For the&#160;year ended December&#160;31, 2023, the decrease in financial result, net relates primarily to unfavorable foreign currency exchange differences related to movement in the CHF versus foreign currencies, predominantly the US Dollar. This is partially offset by an increase in financial income, combined with a decrease in financial expense, due to the transition from negative to positive interest rates for our interest-bearing deposit accounts.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ExpensesByCategoryAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ExpensesByCategoryAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfExpensesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfExpensesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824825986208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related-party transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Related-party transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRelatedPartyExplanatory', window );">Related-party transactions</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">16.</b></span>Related-party transactions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Board of directors and executive management compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Key management includes the board of directors and executive management. For 2023, there were eight members (2022 and 2021: eight) of the Board (excluding the CEO) and seven members (2022: seven and 2021: six) of executive management (including the CEO). Compensation was as follows:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term employee benefits </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,661</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,187</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,403</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Post-employment benefits </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 446</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 295</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 266</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based compensation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,251</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,503</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,997</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total compensation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,358</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,666</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Section Disclosures<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS24_g13-24_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824825910320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Income taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIncomeTaxExplanatory', window );">Income taxes</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">17.</b></span>Income taxes</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Group recognized less than CHF 0.1 million in income taxes and no deferred tax asset or <span style="-sec-ix-hidden:Hidden_HV19mOg_skeZVhyj5rvzCA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">liability</span></span> positions for the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively. The Group&#8217;s expected tax expense for each&#160;year is based on the applicable tax rates in each jurisdiction. In 2023, these rates ranged from 13.6% to 33.8% (13.6% - 33.8% for 2022 and 13.6% - 32.9% for 2021) in the Group&#8217;s respective tax jurisdictions. The weighted average tax rate applicable to the Group was 13.6% (13.6% for 2022 and 2021, respectively). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The Group&#8217;s income tax expense for each&#160;year can be reconciled to loss before tax as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Loss before income tax </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (54,223)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (70,740)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (72,993)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Tax benefit calculated at the domestic rates applicable in the respective countries </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,371)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,616)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,930)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">(Income not subject to tax)/expenses not deductible for tax purposes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 611</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 455</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (375)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of unused tax losses and tax offsets not recognized as deferred tax assets </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,770</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,174</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10,308</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Effective income tax rate expense </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Swiss tax rate used for the 2023 reconciliations is the corporate tax rate of 13.6% (13.6% in 2022 and 2021, respectively) payable by corporate entities in the Canton of Vaud, Switzerland on taxable profits under tax law in that jurisdiction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The below table details the total unrecognized deductible temporary differences, unused tax losses and unused tax credits:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unrecognized deductible temporary differences, unused tax losses and unused tax credits</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Deductible temporary differences, unused tax losses and unused tax credits for which no deferred tax assets have been recognized are attributable to the following:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Tax losses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 312,972</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 264,089</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 197,152</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Deductible temporary differences related to:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 18pt;">Right-of-use assets and lease liabilities, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 18pt;">Retirement benefit plan </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,770</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,213</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,098</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 318,742</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 267,302</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 204,250</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table details the tax losses carry forwards of the Company and their respective expiry dates:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Tax losses split by expiry date:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,231</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,231</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,231</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 48,894</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 48,894</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 48,894</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 57,824</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 57,824</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 57,824</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 75,204</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 75,204</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 75,204</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2029</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 66,936</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 66,936</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2030</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 48,883</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total unrecorded tax loss carryforwards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 312,972</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 264,089</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 197,153</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The tax losses available for future offset against taxable profits have increased by CHF 48.9&#160;million from 2022, representing the amount of tax losses that are additionally available as an offset, subject to expiration as disclosed in the table above, against future taxable income.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Consistent with prior&#160;years, the Company has not recorded any deferred tax assets in relation to the past tax losses available for offset against future profits as the recognition criteria were not met at the balance sheet date.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS12_g79-88_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824821679264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement benefit plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract', window );"><strong>Retirement benefit plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory', window );">Retirement benefit plan</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">18.</b></span>Retirement benefit plan</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company participates in a collective foundation covering all of its employees including its executive officers. In addition to retirement benefits, the plan provides death or long-term disability benefits.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Contributions paid to the plan are computed as a&#160;percentage of salary, adjusted for the age of the employee and shared approximately 47% and 53% by employee and employer, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">This plan is governed by the Swiss Law on Occupational Retirement, Survivors and Disability Pension Plans (BVG), which requires contributions to be made to a separately administered fund. The fund has the legal form of a foundation and it is governed by a board of trustees, which consists of an equal number of employer and employee representatives of its members. The board of trustees is responsible for the administration of the plan assets and for the definition of the investment strategy. The Company has no direct influence on the investment strategy of the foundation board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The assets are invested by the pension plan, to which many companies contribute, in a diversified portfolio that respects the requirements of the Swiss BVG. Therefore, disaggregation of the pension assets and presentation of plan assets in classes that distinguish the nature and risks of those assets is not possible. Under the plan, both the Company and the employee share the costs. The structure of the plan and the legal provisions of the BVG mean that the employer is exposed to actuarial risks. The main risks are investment risk, interest risk, disability risk and the life expectancy of pensioners. Through our affiliation with the pension plan, the Company has minimized these risks, as they are shared between a much greater number of participants. On leaving the Company, a departing employee&#8217;s retirement savings are transferred to the pension institution of the new employer or to a vested benefits institution. This transfer mechanism may result in pension payments varying considerably from&#160;year to&#160;year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The pension plan is exposed to Swiss inflation, interest rate risks and changes in the life expectancy for pensioners. For accounting purposes under IFRS, the plan is treated as a defined benefit plan in accordance with IAS 19.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table sets forth the status of the defined benefit pension plan and the amount that is recognized in the consolidated balance sheets:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Defined benefit obligation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (41,060)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (32,410)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (33,889)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Fair value of plan assets </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 35,290</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 29,197</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 26,791</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total liability </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,770)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,213)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,098)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following amounts have been recorded as net pension cost in the consolidated statements of income/(loss):</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Current service cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,453</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,712</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,648</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Past service cost</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 903</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 804</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 126</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 79</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (705)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (87)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (48)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net pension cost </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,455</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,751</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,679</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The changes in defined benefit obligation, fair value of plan assets and unrecognized gains/(losses) are as follows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">A. Change in defined benefit obligation</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Defined benefit obligation as of January 1 </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (32,410)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (33,889)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (30,213)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Current service cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,453)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,712)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,648)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Past service cost</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (903)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (804)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (126)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (79)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Change in demographic assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 136</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 29</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Change in financial assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,908)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,397</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 156</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Change in experience assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (57)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,726)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (252)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Benefits deposited </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,265)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,327)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (894)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employees&#8217; contributions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,396)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,056)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (959)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Defined benefit obligation as of December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (41,060)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (32,410)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (33,889)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Change in fair value of plan assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair value of plan assets as of January 1 </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 29,197</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 26,791</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 22,749</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 705</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 87</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 48</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employees&#8217; contributions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,396</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,056</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 959</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employer&#8217;s contributions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,567</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,210</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,089</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Benefits deposited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,265</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,327</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 894</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Return on plan assets excluding interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,160</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,274)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,052</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair value of plan assets as of December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 35,290</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 29,197</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 26,791</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Expected contributions by the employer to be paid to the post-employment benefit plans during the annual period beginning after the end of the reporting period amount to approximately CHF 1.6 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Change in net defined benefit liability</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net defined benefit liabilities as of January 1 </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,213</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,098</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,464</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Net pension cost through statement of income/(loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,455</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,751</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,679</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Remeasurement through other comprehensive income/(loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,669</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,426)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (956)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employer&#8217;s contribution </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,567)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,210)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,089)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net defined benefit liabilities as of December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,770</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,213</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,098</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Other comprehensive gains/(losses)</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of changes in demographic assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 136</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 29</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of changes in financial assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,908)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,397</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 156</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of changes in experience assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (57)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,726)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (252)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Return on plan assets excluding interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,160</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,274)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,052</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total other comprehensive gain/(loss)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,669)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,426</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 956</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In 2022, the change in experience assumptions results from an increased sum of insured salaries.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The fair value of the plan assets is the cash surrender value of the insurance with the insurance company (AXA). The investment strategy defined by the board of trustees follows a conservative profile.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The plan assets are primarily held within instruments with quoted market prices in an active market, with the exception of real estate and mortgages.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The weighted-average duration of the defined benefit obligation is 15.5&#160;years and 14.9&#160;years as of December&#160;31, 2023 and 2022, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The actuarial assumptions used for the calculation of the pension cost and the defined benefit obligation of the defined benefit pension plan for the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively, are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:52.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:52.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:44.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Discount rate </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Rate of future increase in compensations </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:44.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Rate of future increase in current pensions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest rate on retirement savings capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:44.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Mortality and disability rates </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">BVG 2020 GT (CMI)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">BVG 2020-CMI</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">BVG 2020-CMI</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In defining the benefits, the minimum requirements of the Swiss BVG and its implementing provisions must be observed. The BVG defines the minimum pensionable salary and the minimum retirement credits.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">A quantitative sensitivity analysis for significant assumptions as of December&#160;31, 2023 is shown below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Interest&#160;rate&#160;on</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Discount&#160;rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;salary&#160;increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;pension&#160;cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">savings&#160;capital</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assumptions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="17" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:68.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In&#160;CHF&#160;thousands</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Potential defined benefit obligation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 38,132</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 44,390</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 41,997</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 40,205</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 42,681</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 39,578</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 42,158</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 40,030</p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Decrease/(increase) from actual defined benefit obligation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,928</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,330)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (937)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 855</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,621)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,482</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,098)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,030</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">A quantitative sensitivity analysis for significant assumptions as of December&#160;31, 2022 is shown below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Interest&#160;rate&#160;on</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Discount&#160;rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;salary&#160;increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;pension&#160;cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">savings&#160;capital</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assumptions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="17" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:68.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in&#160;CHF&#160;thousands</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Potential defined benefit obligation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 30,201</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 34,916</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 32,940</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,841</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 33,601</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,322</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 33,322</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,545</p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Decrease/(increase) from actual defined benefit obligation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,209</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,506)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (530)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 569</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,191)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,088</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (912)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 865</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The sensitivity analyses above are subject to limitations and have been determined based on a method that extrapolates the impact on net defined benefit obligation as a result of reasonable changes in key assumptions occurring at the end of the reporting period.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of defined benefit plans. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 138<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_138&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824827047296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract', window );"><strong>Share-based compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory', window );">Share-based compensation</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">19.</b></span>Share-based compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Share-based option awards</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2023, there are equity-based instruments outstanding that the Company has granted under two different plans.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s 2016 Share Option and Incentive Plan (SOIP) was approved by the shareholders at the ordinary shareholders&#8217; meeting in November&#160;2016. The 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights. The Company only grants equity-based instruments from the SOIP as of December&#160;31, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table summarizes equity-settled share option grants for plans that existed during the period:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">options&#160;awarded</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractual</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Plan</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(since&#160;inception)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vesting&#160;conditions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">life&#160;of&#160;options</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share option plan C1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,775,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">4 years</span><span style="font-size:10pt;">&#8217; service from grant date</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">10 years</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">2016 SOIP:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:top;width:39.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Executives and directors</p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,831,325</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;width:26.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">1 year</span><span style="font-size:10pt;">, </span><span style="font-size:10pt;">3 year</span><span style="font-size:10pt;"> and </span><span style="font-size:10pt;">4 years</span><span style="font-size:10pt;">&#8217; service from the date of grant, quarterly and annually</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:16.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">10 years</span></p></td></tr><tr><td style="vertical-align:top;width:39.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employees</p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,811,687</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">4 years</span><span style="font-size:10pt;">&#8217; service from the date of grant, annually</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">10 years</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The number and weighted-average exercise prices (in CHF) of options under the share option programs for Plans C1 and the 2016 SOIP are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted-</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted-</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">average</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">exercise&#160;price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">remaining</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(CHF)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">term&#160;(years)</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,900,667</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.90</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 8.2</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (207,331)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (218,561)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.97</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,110,914</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.34</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December&#160;31,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,585,689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.21</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 7.8</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,613,242</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 6.8</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,585,689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.21</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 7.8</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (304,738)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.32</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (110,250)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,090,316</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December&#160;31,&#160;2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,261,017</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.65</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 7.6</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,345,648</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#ff0000;font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.41</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 6.6</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,261,017</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.65</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 7.6</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (824,084)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.34</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (42,037)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.52</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,554,281</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December&#160;31,&#160;2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,949,177</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 7.2</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable at December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,022,345</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.88</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 6.4</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The outstanding stock options as of December&#160;31, 2023 have the following range of exercise prices:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Range&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">expiration</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total&#160;options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">dates</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Range of exercise prices</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">CHF 0.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 92,875</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2024&#8211;2026</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">CHF 9.53</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 109,665</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2027</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD 5.04 to USD 12.30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,417,545</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2027&#8211;2031</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD 2.76 to USD 4.57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,034,326</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2032&#8211;2033</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD 2.03 to USD 2.32</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,294,766</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2032&#8211;2033</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total outstanding options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,949,177</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The weighted-average exercise price for options granted in 2023, 2022 and 2021 is USD 2.08 (CHF 1.75), USD 3.44 (CHF 3.18) and USD 6.95 (CHF 6.34), respectively. The range of exercise prices for outstanding options was CHF 0.15 to CHF 9.53 for awards previously granted in CHF (prior to 2018) and USD 2.03 to USD 12.30 for awards granted in USD as of December&#160;31, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For awards issued in 2023, the volatility is based on the Company&#8217;s actual volatility for the period congruent with the expected term of the underlying option. The risk-free interest rate is based on yields of long-dated U.S. Treasury notes that align with the expected term of the award. The weighted-average share price of common share options exercised in 2023 is USD 3.18 (CHF 2.68).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The weighted-average grant date fair values of the options granted in 2023, 2022 and 2021 are USD 1.57 (CHF 1.33), USD 2.38 (CHF 2.20) and USD 5.23 (CHF 4.78), respectively. The following table illustrates the weighted-average assumptions for the Black-Scholes option-pricing model used in determining the fair value of these awards:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:31.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:31.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercise price (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2.03-3.11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2.76-4.57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">5.31-7.72</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share price (USD and weighted average)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.08</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.44</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.95</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">4.0-4.6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">0-2.4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">0 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">72-86</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">67-80</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 80</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expected term (in years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">5.5-6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">5.5 - 6.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">5.1 - 6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Dividend yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Restricted share awards</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">A summary of share awards (restricted share and restricted share units) activity as of&#160;December&#160;31, 2023&#160;and changes during the&#160;year then ended is presented below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractual</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">life&#160;of&#160;non-</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">share&#160;awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">vested&#160;share</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grantee type</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">granted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vesting&#160;conditions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">awards</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Restricted share units</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:top;width:38.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Directors</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 257,329</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">1 year</span><span style="font-size:10pt;"> service from date of grant, annually</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">10 years</span></p></td></tr><tr><td style="vertical-align:top;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Executives</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 905,803</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">3 year</span><span style="font-size:10pt;"> and </span><span style="font-size:10pt;">4 years</span><span style="font-size:10pt;">&#8217; service from the date of grant, quarterly and semi-annually</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">10 years</span></p></td></tr><tr><td style="vertical-align:top;width:38.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employees</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 458,335</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;width:35.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">3 years</span><span style="font-size:10pt;">&#8217; service from the date of grant, annually</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:11.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">10 years</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted-</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">average</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">grant</b>&#160;<b style="font-weight:bold;">date&#160;fair</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">value&#160;(CHF)</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at January 1, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,494</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9.51</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,471)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9.46</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Vested during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (18,697)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9.52</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 797</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9.41</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vested and exercisable at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 65,515</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9.48</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 797</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9.41</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 239,194</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.06</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Vested during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (23,505)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.28</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 216,486</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.06</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vested and exercisable at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 89,020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7.84</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 216,486</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.06</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (134,947)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.05</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (55,503)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.37</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,187,570</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.89</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Vested during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (265,366)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.46</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,003,743</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.97</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vested and exercisable at December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 298,883</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.08</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The weighted-average grant date fair values of the remaining non-vested share awards as of the respective&#160;year end for the restricted share units were CHF 1.97, CHF 3.06 and CHF 9.41 for the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively. The fair values of these non-vested share awards granted were determined using a reasonable estimate of market value of the common shares on the date of the award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The expense charged against the income statement was CHF 4.4 million, CHF 3.3 million and CHF 4.1 million for the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively. The expense is revised by the Company based on the number of instruments that are expected to become exercisable.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 44<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_44&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824822149632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CommitmentsAndContingenciesAbstract', window );"><strong>Commitments and contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory', window );">Commitments and contingencies</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">20.</b></span>Commitments and contingencies</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s commitments and contingencies relate to its ongoing operating activities, mainly research and development programs, as well as its leased corporate space.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In the normal course of business,&#160;we conduct product research and development programs through collaborative programs that include, among others, arrangements with universities, contract research organizations and clinical research sites. We have contractual arrangements with these organizations. As of December&#160;31, 2023, we have contractual obligations, other than for leases (see below), totaling CHF 21.4&#160;million for 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">We lease our corporate, laboratory and other facilities under multiple leases at the EPFL Innovation Park in Ecublens, near Lausanne, Canton of Vaud, Switzerland. Our lease agreements have no termination clauses longer than a 12-month contractual notice period. The Company recognizes a right-of-use asset for its leases, except for short-term and low-value leases as indicated in Note&#160;3<i style="font-style:italic;">.</i> See &#8220;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities&#8221; for the contractual undiscounted cash flows for lease obligations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Within 1 year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21,746</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 23,336</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Between 1 and 3 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16,920</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,516</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Between 3 and 5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,632</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,229</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">More than 5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,270</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,407</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 47,568</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 52,488</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CommitmentsAndContingenciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CommitmentsAndContingenciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of commitments and contingent liabilities. [Refer: Contingent liabilities [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824824066160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory', window );">Earnings per share</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">21.</b></span>Earnings per share</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.07212067%;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands except for share and per share data</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Loss per share (EPS)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Numerator</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Net loss attributable to equity holders of the Company</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (54,233)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (70,753)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (72,996)</p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Denominator</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Weighted-average number of shares outstanding used to compute EPS basic and diluted attributable to equity holders</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 84,694,616</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 83,554,412</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 74,951,833</p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted loss per share for the period attributable to equity holders</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.64)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.85)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.97)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">In periods for which we have a loss, basic net loss per share is the same as diluted net loss per share. We have excluded from our calculation of diluted loss per share all potentially dilutive in-the-money (i)&#160;share options, (ii)&#160;non-vested restricted share awards and (iii)&#160;shares that were issued upon conversion of two different convertible notes as their inclusion would have been anti-dilutive. The weighted-average number of potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:30.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:30.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share options issued and outstanding (in-the-money)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 97,683</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 135,827</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,140,388</p></td></tr><tr><td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Restricted share awards subject to future vesting</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,160,240</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,292</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,264</p></td></tr><tr><td style="vertical-align:bottom;width:66.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Convertible shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 41,461</p></td></tr><tr><td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total potentially dilutive securities </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,257,923</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 253,119</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,188,113</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS33_g70-73A_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824822656560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial instruments and risk management<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract', window );"><strong>Financial instruments and risk management [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory', window );">Financial instruments and risk management</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">22.</b></span>Financial instruments and risk management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s activities expose it to the following financial risks: market risk (foreign exchange and interest rate risk), credit risk and liquidity risk. The Company&#8217;s overall risk management program focuses on the unpredictability of financial markets and seeks to minimize potential adverse effects on the Company&#8217;s financial performance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table shows the carrying amounts of financial assets and financial liabilities:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Financial assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,508</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,808</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Long-term financial assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 361</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 361</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other current receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 622</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 392</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accounts receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,800</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term financial assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24,554</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 91,000</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 78,494</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,586</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total financial assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 122,339</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 126,147</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Long-term lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,825</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,253</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Trade and other payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,679</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 929</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11,087</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,417</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 672</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 548</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16,263</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13,147</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Foreign exchange risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is exposed to foreign exchange risk arising from currency exposures, primarily with respect to the EUR, USD and to a lesser extent to GBP, DKK and SEK. The currency exposure is not hedged. However, the Company has a policy of matching its cash holdings to the currency structure of its expenses, which means that the Company holds predominately CHF, with lesser balances of EUR and USD (see &#8220;Note&#160;8. Cash and cash equivalents and short-term financial assets&#8221;). The Company recognized a loss of CHF 1.5 million, a gain of CHF 0.5 million and a loss of CHF 0.1 million for the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively, within &#8220;Finance result, net.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December&#160;31, 2023, if the CHF had strengthened/weakened by 10% against the EUR and the USD with all other variables held constant, the net loss for the period would have been lower/higher by CHF 2.6 million (2022: CHF 0.7 million), mainly as a result of foreign exchange gains/losses on predominantly EUR/USD denominated cash and cash equivalents and short-term financial assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Interest rates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s CHF cash holdings (inclusive of those held in short-term financial assets) were subject to positive interest rates at certain counterparty thresholds through 2023. As of December&#160;31, 2023 if the interest rates granted by the counterparties had increased/decreased by 10%, the net income for the period would have been higher/lower by CHF 0.1 million. Interest income and interest expense are recorded within finance results, net in our consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Credit risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company maintains a formal treasury risk and investment management policy to limit counterparty credit risk. As of December&#160;31, 2023, the Company&#8217;s cash and cash equivalents and short-term financial assets are held with five financial institutions, each with a high credit rating ranging from A+ to AA- assigned by international credit-rating agencies. The maximum amount of credit risk is the carrying amount of the financial assets. Accounts receivable and other receivables are fully performing, not past due and not impaired (see &#8220;Note&#160;8. Cash and cash equivalents and short-term financial assets&#8221;, &#8220;Note 10. Accounts receivable&#8221; and &#8220;Note&#160;11. Other current receivables&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Liquidity risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Inherent in the Company&#8217;s business are various risks and uncertainties, including the high uncertainty that new therapeutic concepts will succeed. AC Immune&#8217;s success may depend in part upon its ability to (i)&#160;establish and maintain a strong patent position and protection, (ii)&#160;enter into collaborations with partners in the pharmaceutical and biopharmaceutical industries, (iii)&#160;acquire and keep key personnel employed and (iv)&#160;acquire additional capital to support its operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s approach of managing liquidity is to ensure sufficient cash to meet its liabilities when due. Therefore, management closely monitors the cash position on rolling forecasts based on expected cash flow to enable the Company to finance its operations for at least 12&#160;months. The Company has CHF 1.7 million in trade and other payables, and CHF 11.1 million in accrued expenses which are due within 12&#160;months from the reporting date. Finally, as it relates to the Company&#8217;s lease liabilities please see &#8220;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities&#8221; for detail of when corresponding lease liabilities are due.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the entity's financial risk management practices and policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialRiskManagementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824872952176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital risk management<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract', window );"><strong>Capital risk management [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory', window );">Capital risk management</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">23.</b></span>Capital risk management</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company&#8217;s objectives when managing capital are to safeguard the Company&#8217;s ability to continue as a going concern and to preserve the capital on the required statutory level in order to succeed in developing a cure against (i)&#160;AD, (ii)&#160;focused non-Alzheimer&#8217;s neurodegenerative diseases including NeuroOrphan indications and (iii)&#160;diagnostics.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information that enables users of financial statements to evaluate the entity's objectives, policies and processes for managing capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 134<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_134&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824822596160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract', window );"><strong>Subsequent events</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory', window );">Subsequent events</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">24.</b></span>Subsequent events</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Management has evaluated subsequent events after the balance sheet date, through the issuance of these consolidated financial statements, for appropriate accounting and disclosures. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">On January 22, 2024, the Company announced that it will regain all global rights to the anti-amyloid beta antibody crenezumab and the anti-Tau antibody semorinemab following termination of the collaboration agreements with Genentech, a member of the Roche Group, and Roche, which termination will be effective in April 2024. Both antibodies have been evaluated in clinical studies for AD. AC Immune will also regain rights to existing GMP drug-product for clinical testing as well as associated data generated under each of the agreements. AC Immune will carefully </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">review and evaluate available data sets, including the final open label extension results from the Lauriet trial when they become available and are received in full by AC Immune, before decisions are made on potential further development and other opportunities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On February 1, 2024, the Company received the milestone payment of CHF 14.8 million due from Janssen for the commencement of first Phase 2b clinical study.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for events after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS10_g17-22_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824827314112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of material accounting policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract', window );"><strong>Summary of material accounting policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory', window );">Functional and reporting currency</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;">Functional and reporting currency</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">These consolidated financial statements and accompanying notes are presented in Swiss Francs (CHF), which is AC Immune SA&#8217;s functional currency and the Group&#8217;s reporting currency. The Company&#8217;s subsidiary has a functional currency of the U.S. Dollar (USD). The respective functional currency represents the primary economic environment in which the entities operate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following exchange rates have been used for the translation of the financial statements of AC Immune USA:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">CHF/USD</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Closing rate, USD 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.851</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.933</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.923</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Weighted average exchange rate, USD 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.908</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.965</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.929</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The results and financial position of AC Immune USA are translated into the presentation currency as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">i.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">assets and liabilities for each balance sheet presented are translated at the closing rate at the date of that balance sheet;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">ii.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">income and expenses for each statement of income/(loss) are translated at average exchange rates; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">iii.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">all resulting exchange differences are recognized in other comprehensive income/(loss), within cumulative translation differences.</span></td></tr></table><div style="margin-top:12pt;"></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBasisOfConsolidationExplanatory', window );">Basis of consolidation</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Basis of consolidation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The annual closing date of the individual financial statements is December&#160;31. The Company fully-owns its Subsidiary and fully consolidates its financial statements into these consolidated financial statements. All intercompany transactions have been eliminated.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory', window );">Foreign currency transactions</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Foreign currency transactions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Foreign currency transactions are translated into the respective functional currency using prevailing exchange rates at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at&#160;year-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognized in the consolidated statements of income/(loss). Any gains or losses from these translations are included in the consolidated statements of income/(loss) in the period in which they arise.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock', window );">Current vs. non-current classification</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Current vs. non-current classification</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company presents assets and liabilities in the consolidated balance sheets based on current/non-current classification. The Company classifies all amounts to be realized or settled within 12&#160;months after the reporting period to be current and all other amounts to be non-current.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue', window );">Revenue recognition</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Revenue recognition</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company applies IFRS 15&#160;<i style="font-style:italic;">Revenue from Contracts with Customers</i>. This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. Under IFRS 15, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of IFRS 15, the entity performs the following five steps: (i)&#160;identify the contract(s)&#160;with a customer; (ii)&#160;identify the performance obligations in the contract; (iii)&#160;determine the transaction price; (iv)&#160;allocate the transaction price to the performance obligations in the contract; and (v)&#160;recognize revenue when (or as) the entity satisfies a performance obligation. The Company applies the five-step model to contracts only when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of IFRS 15, the Company assesses the goods or services promised within each contract, and determines those that are performance obligations, and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company enters into LCAs which are within the scope of IFRS 15, under which it licenses certain rights to its product candidates and intellectual property to third parties. The terms of these arrangements typically include payment to the Company of one or more of the following: non-refundable, upfront license fees, development, regulatory and/or commercial milestone payments;&#160;payments for research and clinical services the Company provides through either its full-time employees or third-party vendors, and royalties on net sales of licensed products commercialized from the Company&#8217;s intellectual property. Each of these payments results in license, collaboration and other revenues, which are classified as contract revenue on the consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Licenses of intellectual property</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">If the license to the Company&#8217;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, upfront fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are sold in conjunction with a related service, the Company uses judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time. If the performance obligation is settled over time, the Company determines the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, upfront fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Milestone payments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At the inception of each arrangement that includes development, regulatory and/or commercial milestone payments, the Company evaluates whether the milestones are considered highly probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is highly probable that a significant cumulative revenue reversal would not occur in future periods, the associated milestone value is included in the transaction price. These amounts for the performance obligations under the contract are recognized as they are satisfied. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of such milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments recorded would affect contract revenues and earnings in the period of adjustment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Research and development services</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has certain arrangements with our collaboration partners that include contracting our employees for research and development programs. The Company assesses if these services are considered distinct in the context of each contract and, if so, they are accounted for as separate performance obligations. These revenues are recorded in contract revenue as the services are performed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Sublicense revenues</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has certain arrangements with our collaboration partners that include provisions for sublicensing. The Company recognizes any sublicense revenues at the point in time it is highly probable to obtain and not subject to reversal in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Contract balances</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company receives payments and determines credit terms from its customers for its various performance obligations based on billing schedules established in each contract. The timing of revenue recognition, billings and cash collections results in billed other current receivables, accrued income (contract assets), and deferred income (contract liabilities) on the consolidated balance sheets. Amounts are recorded as other current receivables when the Company&#8217;s right to consideration is unconditional. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be 1&#160;year or less.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For a complete discussion of accounting for contract revenue, see &#8220;Note&#160;14. Contract revenues.&#8221;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory', window );">Research and development expenses</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Research and development expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Given the stage of development of the Company&#8217;s products, all research and development expenditure is expensed as incurred as it does not meet the capitalization criteria outlined in IAS 38 <i style="font-style:italic;">Intangible Assets</i>. The Company has not capitalized any R&amp;D expenses to date. Research and development expenditures include:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the cost of acquiring, developing and manufacturing active pharmaceutical ingredients for product candidates that have not received regulatory approval, clinical trial materials and other research and development materials;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fees and expenses incurred under agreements with contract research organizations, investigative sites and other entities in connection with the conduct of clinical trials and preclinical studies and related services, such as administrative, data-management and laboratory services;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">fees and costs related to regulatory filings and activities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">costs associated with preclinical and clinical activities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">employee-related expenses, including salaries and bonuses, benefits, travel and share-based compensation expenses; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">all other allocated expenses such as facilities and information technology (IT) costs.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">For external research contracts, expenses include those associated with contract research organizations, or CROs, or contract manufacturing organizations, or CMOs. The invoicing from CROs or CMOs for services rendered do not always align with work performed. We accrue the cost of services rendered in connection with CRO or CMO activities based on our estimate of the &#8220;stage of completion&#8221; for such contracted services. We maintain regular communication with our CRO or CMO vendors to gauge the reasonableness of our estimates and accrued expenses as of the balance sheet date in the consolidated financial statements based on facts and circumstances known at the time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Registration costs for patents are part of the expenditure for research and development projects. Therefore, registration costs for patents are expensed when incurred as long as the research and development project concerned does not meet the criteria for capitalization.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory', window );">General and administrative expenses</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">General and administrative expenses</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">General and administrative expenses are expensed as incurred and include personnel costs, expenses for outside professional services and all other allocated expenses. Personnel costs consist of salaries, cash bonuses, benefits and share-based compensation. Outside professional services consist of legal, accounting and audit services, IT and other consulting fees. Allocated expenses consist of certain IT, facilities and depreciation expenses.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_GrantIncomePolicyTextBlock', window );">Grant income</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Grant income</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has received grants, from time to time, from the Michael J. Fox Foundation (MJFF), the Target ALS Foundation (Target ALS) and other institutions to support certain research projects. Grants are recorded at their fair value in the consolidated statements of income/(loss) within other operating income/(expenses), net when there is reasonable assurance that the Company will satisfy the underlying grant conditions and the grants will be received. In certain circumstances, grant income may be recognized before formal grantor acknowledgement of milestone achievements. To the extent required, grant income is deferred and recognized on a systematic basis over the periods in which the Company expects to recognize the related expenses for which the grants are intended to compensate.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory', window );">Leases</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Leases</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company applies IFRS 16 <i style="font-style:italic;">Leases</i>, which provides the model for lessee accounting in which all leases, other than short-term and low-value leases, are accounted for by the recognition on the consolidated balance sheet of a right-of-use asset and a lease liability, and the subsequent amortization of the right-of-use asset over the earlier of the end of the useful life or the lease term. In accordance with IFRS 16, the Company (i)&#160;does not recognize right-of-use assets and lease liabilities for leases of low value (i.e. approximate fair value of USD 5,000). For a complete discussion of accounting, see &#8220;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Right-of-use assets and lease liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At inception of a leasing contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company recognizes a right-of-use asset and a lease liability at the lease commencement date. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company&#8217;s incremental borrowing rate. The lease liabilities are classified as current or non-current based on the due dates of the underlying principal payments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Lease payments generally are fixed for the contract term. The lease liability is measured at amortized cost using the effective interest method. The lease liability is re-measured if there is a change in the estimated lease term, a change in future lease payments arising from a change in an index or rate, a change in the Company&#8217;s estimate of the amount expected to be payable under a residual value guarantee or a change in assessment of whether it will exercise a purchase, extension or termination option.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">At inception, the right-of-use asset comprises the initial lease liability and any initial direct costs. The right-of-use asset is depreciated over the shorter of the lease term or the useful life of the underlying asset. The right-of-use asset is periodically reduced by impairment losses, if any, and adjusted for certain re-measurements of the lease liability performed on as certain potential triggering events may arise (e.g. lease modifications). When the lease liability is re-measured, a corresponding adjustment is made to the carrying amount of the right-of-use asset or is recorded in profit or loss if the carrying amount of the right-of-use asset has been reduced to zero.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The estimated lease term by right-of-use asset categories are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Buildings</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Office equipment</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">IT equipment</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">years</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Both the right-of-use-assets and lease liabilities are recognized in the consolidated balance sheets.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory', window );">Property, plant and equipment</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Property, plant and equipment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Equipment is shown at historical acquisition cost, less accumulated depreciation and any accumulated impairment losses. Historical costs include expenditures that are directly attributable to the acquisition of the property, plant and equipment. Depreciation is calculated using a straight-line method to write off the cost of each asset to its residual value over its estimated useful life as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">IT equipment</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;">3</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Laboratory equipment</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Leasehold improvements/furniture</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The assets&#8217; residual values and useful lives are reviewed, and adjusted if appropriate, at each balance sheet date. Where an asset&#8217;s carrying amount is greater than its estimated recoverable amount, it is written down to its recoverable amount.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Gains and losses on disposals are determined by comparing the disposal proceeds with the carrying amount and are included in the consolidated statements of income/(loss).</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory', window );">Intangible assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Intangible assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">AC Immune&#8217;s acquired in process research and development (IPR&amp;D) asset is stated at cost less any impairments. The Company does not deem this asset ready for use until the asset obtains market approval. Therefore, during the development period after the date of acquisition until market approval, the IPR&amp;D asset is not amortized. Upon market approval, the Company will determine the useful life of the asset, reclassify it from IPR&amp;D and commence amortization. If the associated R&amp;D effort is abandoned, the related IPR&amp;D will likely be written off and we will record the relevant impairment charge. Finally, the Company will not capitalize future development costs in respect to this IPR&amp;D asset until they meet the criteria for capitalization of research and development costs in accordance with IAS 38 <i style="font-style:italic;">Intangible Assets</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Our IPR&amp;D asset is subject to impairment testing at least annually or when there are indications that the carrying value may not be recoverable until the completion of the development process. The determination of the recoverable amounts include key estimates which are highly sensitive to, and dependent upon, key assumptions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company uses a discounted cash flow method to determine the fair value less costs to sell (recoverable amount) of our IPR&amp;D intangible asset. The Company starts with a forecast of all the expected net cash flows, which incorporates the consideration of a terminal value and then the Company applies a discount rate to arrive at a risk-adjusted net present value amount.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory', window );">Fair value of financial assets and liabilities</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Fair value of financial assets&#160;and liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The Company&#8217;s financial assets and liabilities are composed of receivables, short-term financial assets, cash and cash equivalents, trade payables and lease liabilities. The fair value of these financial instruments approximates their </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">respective carrying values due to the short-term maturity of these instruments, and are held at their amortized cost in accordance with IFRS 9, unless otherwise explicitly noted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Receivables</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Receivables are recognized at their billing value. An allowance for doubtful accounts is recorded for potential estimated losses when there is evidence of the debtor&#8217;s inability to make required payments and the Company assesses on a forward-looking basis the expected credit losses associated with these receivables held at amortized cost.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Short-term financial assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Short-term financial assets are held with external financial institutions and comprise fixed-term deposits with maturities ranging from more than 3 through 12&#160;months in duration.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company assesses whether there is objective evidence that financial assets are impaired annually or whenever potential impairment triggers may occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Cash and cash equivalents</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Cash and cash equivalents include deposits held with external financial institutions and cash on hand. All cash and cash equivalents are either in cash or in deposits with original duration of less than 3&#160;months.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Trade payables</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Trade payables are amounts due to third parties in the ordinary course of business.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory', window );">Share capital and public offerings</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Share capital and public offerings</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Common shares are classified as equity. Share issuance costs are capitalized as incurred and will be shown in equity as a deduction, net of tax, from the proceeds received from existing or future offerings. Should a planned equity offering not be assessed as probable, the issuance costs would be expensed immediately in the consolidated statements of income/(loss). See &#8220;Note&#160;12. Share capital.&#8221;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory', window );">Treasury Shares</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Treasury shares</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Treasury shares are recognized at acquisition cost and deducted from shareholders&#8217; equity at the time of acquisition, until they are subsequently resold, distributed or cancelled. Where such shares are subsequently sold, any consideration received is included in shareholders&#8217; equity. See &#8220;Note&#160;12. Share capital.&#8221;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory', window );">Employee benefits</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Employee benefits</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Post-employment benefits</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company operates the mandatory pension schemes for its employees in Switzerland. The schemes are generally funded through payments to insurance companies. The Company has a pension plan designed to pay pensions based on accumulated contributions on individual savings accounts. However, this plan is classified as a defined benefit plan under IAS 19.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The net defined benefit liability is the present value of the defined benefit obligation at the balance sheet date minus the fair value of plan assets. Significant estimates are used in determining the assumptions incorporated in the calculation of the pension obligations, which is supported by input from independent actuaries. The defined benefit obligation is calculated annually with the assistance of an independent actuary using the projected unit credit method, which reflects services rendered by employees to the date of valuation, incorporates assumptions concerning employees&#8217; projected salaries and pension increases as well as discount rates of highly liquid corporate bonds that have terms to maturity approximating the terms of the related liability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">To the extent that the fair value of the plan assets is greater than the present value of the defined benefit obligation as calculated by our independent actuary, the Company accounts for the effect of the asset ceiling test under IAS 19.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Re-measurements of the net defined benefit liability, which comprise actuarial gains and losses and the return on plan assets (excluding interest) are recognized immediately in the consolidated statements of other comprehensive income/(loss). Past service costs, including curtailment gains or losses, are recognized immediately as a split in research and development and general and administrative expenses within the operating results. Settlement gains or losses are recognized in either research and development and/or general and administrative expenses within the operating results. The Company determines the net interest expense/(income) on the net defined benefit liability for the period by applying the discount rate used to measure the defined benefit obligation at the beginning of the annual period or in case of any significant events between measurement dates to the then-net defined benefit liability, considering any changes in the net defined benefit liability during the period as a result of contributions and benefit payments. Net interest expense/(income) and other expenses related to defined benefit plans are recognized in the consolidated statements of income/(loss).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Share-based compensation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company operates an equity-settled, share-based compensation plan. The fair value of the employee services received in exchange for the grant of equity-based awards is recognized as an expense. The total amount to be expensed over the vesting period is determined by reference to the fair value of the instruments granted, excluding the impact of any non-market vesting conditions. Non-market vesting conditions are included in assumptions about the number of instruments that are expected to become exercisable. At each balance sheet date, the Company revises its estimates of the number of instruments that are expected to become exercisable. It recognizes the impact of the revision of original estimates, if any, prospectively in the consolidated statements of income/(loss), and a corresponding adjustment to equity over the remaining vesting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Stock options granted under the Company&#8217;s stock option plans C1 and the 2016 Stock Option and Incentive Plan are valued using the Black-Scholes option-pricing model (see &#8220;Note&#160;19. Share-based compensation&#8221;). This valuation model as well as parameters used such as expected volatility and expected term of the stock options are partially based on management&#8217;s estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and share premium when the options are exercised.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We estimate the fair value of restricted share units using a reasonable estimate of market value of the common shares on the date of the award. We classify our share-based payments as equity-classified awards as they are settled in common shares. We measure equity-classified awards at their grant date fair value and do not subsequently re-measure them. Compensation costs related to equity-classified awards are equal to the fair value of the award at grant date amortized over the vesting period of the award using the graded method. We reclassify that portion of vested awards to share capital and share premium as the awards vest.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory', window );">Provisions</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Provisions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Provisions are recognized when the Company has a present legal or constructive obligation as a result of past events where it is more likely than not that an outflow of resources will be required to settle the obligation, and a reliable estimate of the amount can be made.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory', window );">Taxation</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Taxation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Current income tax assets and liabilities for the period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the tax amounts are those that are enacted or substantively enacted, at the reporting date in accordance with the fiscal regulations of the respective country where the Company operates and generates taxable income. Deferred tax is provided using the liability method on temporary differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes at the reporting date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the&#160;year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted at the reporting date. If required, deferred taxation is provided in full using the liability method, on all temporary differences at the reporting dates. It is calculated at the tax rates that are expected to apply to the period when it is anticipated the liabilities will be settled, and it is based on tax rates (and laws) that have been enacted or substantively enacted at the reporting date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Deferred income tax assets are recognized to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilized. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized. Although the Company has substantial tax loss carry-forwards, historically, due to the fact that the Company had limited certainty on the achievement of key milestones, it has not recognized any deferred tax assets as the probability for use is low.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As disclosed in &#8220;Note&#160;17. Income taxes,&#8221; the Company has tax losses that can generally be carried forward for a period of 7&#160;years from the period the loss was incurred. These tax losses represent potential value to the Company to the extent that the Company is able to create taxable profits before the expiry period of these tax losses. The Company has not recorded any deferred tax assets in relation to these tax losses.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory', window );">Earnings per share</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Earnings per share</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company presents basic earnings per share for each period in the consolidated financial statements. The earnings per share are calculated by dividing the earnings of the period by the weighted-average number of shares outstanding during the period. Diluted earnings per share reflect the potential dilution that could occur if dilutive securities such as share options or non-vested restricted share units were vested or exercised into common shares or resulted in the issuance of common shares that would participate in net income. Anti-dilutive shares are excluded from the dilutive earnings per share calculation.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock', window );">Critical judgments and accounting estimates</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Critical judgments and accounting estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The areas where AC Immune has had to make judgments, estimates and assumptions relate to (i)&#160;revenue recognition on LCAs, (ii)&#160;clinical development accruals, (iii)&#160;net employee defined benefit liability, (iv)&#160;share-based compensation, (v)&#160;right-of-use assets and lease liabilities and (vi)&#160;our IPR&amp;D asset. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory', window );">Segment reporting</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Segment reporting</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company is managed and operated as one business. A single management team that reports to the chief operating decision maker comprehensively manages the entire business. Accordingly, the Company views its business and manages its operations as one operating segment. Non-current assets are located in, and revenue is allocated and recorded within, the Company&#8217;s country of domicile, Switzerland.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock', window );">Accounting policies, new standards, interpretations and amendments adopted by the Company</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Accounting policies, new standards, interpretations and amendments adopted by the Company</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">There are no new IFRS standards, amendments or interpretations that are mandatory as of January 1, 2023 that are relevant to the Company. Additionally, the Company has not adopted any standard, interpretation or amendment that has been issued but is not yet effective. Such standards are not currently expected to have a material impact on the entity in the current or future reporting periods and on foreseeable future transactions.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for judgments that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognized in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for the basis for how the entity classifies assets and liabilities as current and non-current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for changes to accounting policies recently adopted by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_GrantIncomePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for grant income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_GrantIncomePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for fair value measurement. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for foreign currency translation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for the currency of the primary economic environment in which the entity operates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for issued capital. [Refer: Issued capital]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for provisions. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for recognising revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for research and development expense. [Refer: Research and development expense]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for treasury shares. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBasisOfConsolidationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the basis used for consolidation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBasisOfConsolidationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824825858352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of material accounting policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract', window );"><strong>Summary of material accounting policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory', window );">Schedule of exchange rates used for translation of financial statements</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following exchange rates have been used for the translation of the financial statements of AC Immune USA:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">CHF/USD</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Closing rate, USD 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.851</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.933</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.923</p></td></tr><tr><td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Weighted average exchange rate, USD 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.908</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.965</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.929</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock', window );">Estimated Lease Term by Right-of-use Asset Categories</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Buildings</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Office equipment</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">IT equipment</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">years</p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock', window );">Estimated useful life</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">IT equipment</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;">3</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Laboratory equipment</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr><tr><td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Leasehold improvements/furniture</p></td><td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;">5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"> years</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about the estimated lease term by right-of-use asset by category.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about the useful life of property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the effect of changes in foreign exchange rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS21_g51-57_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824826054176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory', window );">Schedule of movement in the net book values of property, plant and equipment</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following tables show the movements in the net book values of property, plant and equipment for the&#160;years ended December&#160;31, 2023 and 2022, respectively:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:40.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:57.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2023</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Laboratory</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Leasehold</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assets under</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Furniture</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">improvements</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">construction</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquisition cost:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 285</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,909</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,765</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,640</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13,602</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 278</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 468</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 801</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Disposals</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (19)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (12)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (31)</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Transfers</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 309</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,168</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10,233</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,662</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,372</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated depreciation:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (159)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,599)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,017)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (568)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,343)</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (53)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (271)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,084)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (264)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,672)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Disposals</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (212)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,851)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (8,101)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (832)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10,996)</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying amount:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 126</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 310</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,748</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,072</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,259</p></td></tr><tr><td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 97</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 317</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,132</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 830</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,376</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:42.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:56.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2022</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Laboratory</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Leasehold</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assets under</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Furniture</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">improvements</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">construction</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquisition cost:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 265</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,754</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,142</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 810</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 695</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12,666</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 151</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 576</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 184</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 936</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Transfers</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 47</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 646</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (697)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 285</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,909</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,765</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,640</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13,602</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated depreciation:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (106)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,316)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,739)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (389)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,550)</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (53)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (283)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,278)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (179)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,793)</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (159)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,599)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,017)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (568)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,343)</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying amount:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 159</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 438</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,403</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 421</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 695</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,116</p></td></tr><tr><td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 126</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 310</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,748</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,072</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,259</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824822652192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use assets, long-term financial assets and lease liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PresentationOfLeasesForLesseeAbstract', window );"><strong>Right-of-use assets, long-term financial assets and lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory', window );">Schedule of the movements in the net value book value of right-of-use assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following tables show the movements in the net book values of right-of-use of leased assets for the&#160;years ended December&#160;31, 2023 and 2022, respectively:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:61.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:61.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Office</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:61.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Buildings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,708</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 74</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,808</p></td></tr><tr><td style="vertical-align:bottom;width:61.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions and reassessment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,243</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,243</p></td></tr><tr><td style="vertical-align:bottom;width:61.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (505)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (24)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (14)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (543)</p></td></tr><tr><td style="vertical-align:bottom;width:61.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,446</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,508</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:61.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:61.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Office</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">IT </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:61.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Buildings</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">equipment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2,776</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">98</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">40</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,914</p></td></tr><tr><td style="vertical-align:bottom;width:61.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Additions and reassessment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 460</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 460</p></td></tr><tr><td style="vertical-align:bottom;width:61.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (528)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (24)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (14)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (566)</p></td></tr><tr><td style="vertical-align:bottom;width:61.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance as of December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,708</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 74</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,808</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock', window );">Schedule of impact on condensed consolidated statements of income/(loss) and cash flows</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">For the&#160;years ended December&#160;31, 2023, and 2022, the impact on the Company&#8217;s consolidated statements of income/(loss) and consolidated statements of cash flows is detailed in the table below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Year Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Statements of income/(loss)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Depreciation of right-of-use assets </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 543</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 566</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest expense on lease liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 90</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expense for short-term leases and leases of low value </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 793</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 750</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,426</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,384</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><i style="font-style:italic;">Statements of cash flows</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total cash outflow for leases</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,431</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,388</p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock', window );">Schedule of contractual undiscounted cash flows for lease obligations</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table presents the contractual undiscounted cash flows for lease liabilities as of December&#160;31, 2023 and 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Less than one year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 784</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 638</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">1-3 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,526</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,230</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">3-5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,505</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,187</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,815</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,055</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of right-of-use assets impact on the company's statements of income/(loss) and statements of cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to the contractual undiscounted cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PresentationOfLeasesForLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PresentationOfLeasesForLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824825861072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset acquisition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AssetAcquisitionsAbstract', window );"><strong>Asset acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfAssetAcquisitionsTableTextBlock', window );">Schedule of Transferred Assets acquired</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table summarizes the amounts of the Transferred Assets acquired:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:86.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:86.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:86.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Cash</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">4,634</p></td></tr><tr><td style="vertical-align:bottom;width:86.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">IPR&amp;D asset</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">50,416</p></td></tr><tr><td style="vertical-align:bottom;width:86.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">55,050</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AssetAcquisitionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AssetAcquisitionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfAssetAcquisitionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of asset acquisitions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfAssetAcquisitionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824836742016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract', window );"><strong>Intangible assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory', window );">Schedule of net book value of intangible assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of December&#160;31,&#160;2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net book</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net book</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> value</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Acquired IPR&amp;D asset</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td></tr><tr><td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total intangible assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,416</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 118<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_118&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824821527920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and cash equivalents and short-term financial assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsAbstract', window );"><strong>Cash and cash equivalents and financial assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock', window );">Schedule of cash and cash equivalents by currency</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The Company&#8217;s cash and cash equivalents are maintained in the following respective currencies as of December&#160;31, 2023 and 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 78,494</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,586</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 78,494</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,586</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">By currency</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">CHF</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 52,437</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24,418</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">EUR</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,155</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,313</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17,902</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,855</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total cash and cash equivalents</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 78,494</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,586</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock', window );">Schedule of short-term financial assets</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table summarizes the Company&#8217;s short-term financial assets as of December&#160;31, 2023 and 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term financial assets due in one year or less</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24,554</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 91,000</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24,554</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 91,000</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">By currency</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">CHF</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 22,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 91,000</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,554</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total short-term financial assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24,554</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 91,000</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of cash and cash equivalents by currency</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of short-term deposits not classified as cash equivalents</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824822609600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid expenses and accrued income (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract', window );"><strong>Prepaid expenses and accrued income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock', window );">Prepaid expenses and accrued income</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Prepaid expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,437</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,708</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 246</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 408</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total prepaid expenses and accrued income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,683</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">5,116</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about prepaid expenses and accrued income including contract assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824836731760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other current receivables (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OtherCurrentReceivablesAbstract', window );"><strong>Other current receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock', window );">Other current receivables</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other current receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 45</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 124</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Swiss VAT</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 259</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 249</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Withholding tax</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 318</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19</p></td></tr><tr><td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total other current receivables</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 622</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 392</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about other current receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_OtherCurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_OtherCurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824827147072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract', window );"><strong>Share capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory', window );">Summary of capital structure</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The table below summarizes the Company&#8217;s capital structure:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Common</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Treasury</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Treasury</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">premium</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 89,700,630</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,221,617)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,794</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 431,251</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (124)</p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,596</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (8)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0</p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Issuance of shares &#8211; incentive plans, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 133,755</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 80</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 89,834,385</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,214,021)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,797</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 431,323</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (124)</p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Proceeds from public offerings, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,300,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 286</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 40,249</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 970,063</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,631</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19</p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Issuance of shares &#8211; incentive plans, net of transaction costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 307,402</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 704</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 104,441,787</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,243,958)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.76%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,089</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 474,907</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (105)</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of classes of share capital. [Refer: Share capital [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824822660080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade and other payables and accrued expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AccruedExpensesAbstract', window );"><strong>Trade and other payables and accrued expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock', window );">Schedule of trade and other payables and accrued expenses</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Trade and other payables </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,679</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 929</p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total trade and other payables</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,679</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 929</p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued research and development costs </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,722</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,360</p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued payroll expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,649</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,898</p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other accrued expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,716</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,159</p></td></tr><tr><td style="vertical-align:bottom;width:73.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total accrued expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11,087</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,417</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AccruedExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AccruedExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about trade payables and accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824825165312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract revenues (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory', window );">Schedule of contract revenues</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Janssen</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,800</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Life Molecular Imaging</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,935</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total contract revenues</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,801</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,935</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory', window );">Schedule of contract revenue of performance obligations satisfied</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Revenues recognized in the period from:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Amounts included in the contract liability at the beginning of the period </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">&#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Performance obligations satisfied in previous periods</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,801</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,935</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for revenue from contracts with customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Section Presentation<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IFRS15_g105-109_TI<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IFRS15_g110-129_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The explanation of the effect that the timing of satisfaction of performance obligations and the typical timing of payment have on the contract assets and the contract liabilities. [Refer: Performance obligations [member]; Contract assets; Contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824826226656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Expenses by category (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ExpensesByCategoryAbstract', window );"><strong>Expenses by category [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory', window );">Research and Development</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;">Research and development</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Operating expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 33,198</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 41,166</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 44,289</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Payroll expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,499</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17,548</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16,465</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based compensation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,909</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,622</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,528</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total research and development expenses </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 54,606</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 60,336</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 62,282</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory', window );">General and Administrative</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;">General and administrative</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Operating expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,729</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,207</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,031</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Payroll expenses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,755</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,874</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,281</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based compensation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,821</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,708</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,598</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total general and administrative expenses </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,305</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,789</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 17,910</p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory', window );">Disclosure of finance income (cost) [text block]</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;">Financial result, net</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Financial income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,044</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 69</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,485</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Financial expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (176)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (355)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (581)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exchange differences</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,467)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 393</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 113</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Finance result, net </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (599)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 107</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,017</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ExpensesByCategoryAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ExpensesByCategoryAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of finance income (cost). [Refer: Finance income (cost)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of general and administrative expenses. [Refer: Administrative expenses]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of research and development expense. [Refer: Research and development expense]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824822635952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related-party transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Related-party transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory', window );">Key management compensation</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">Key management includes the board of directors and executive management. For 2023, there were eight members (2022 and 2021: eight) of the Board (excluding the CEO) and seven members (2022: seven and 2021: six) of executive management (including the CEO). Compensation was as follows:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term employee benefits </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,661</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,187</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,403</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Post-employment benefits </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 446</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 295</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 266</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share-based compensation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,251</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,503</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,997</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total compensation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,358</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,985</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,666</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824827279424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Income taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock', window );">Income tax expense reconciled to loss</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The Group&#8217;s income tax expense for each&#160;year can be reconciled to loss before tax as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Loss before income tax </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (54,223)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (70,740)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (72,993)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Tax benefit calculated at the domestic rates applicable in the respective countries </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,371)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,616)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,930)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">(Income not subject to tax)/expenses not deductible for tax purposes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 611</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 455</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (375)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of unused tax losses and tax offsets not recognized as deferred tax assets </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,770</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,174</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10,308</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Effective income tax rate expense </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory', window );">Unrecognized deductible temporary differences, unused tax losses and unused tax credits</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The below table details the total unrecognized deductible temporary differences, unused tax losses and unused tax credits:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unrecognized deductible temporary differences, unused tax losses and unused tax credits</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Deductible temporary differences, unused tax losses and unused tax credits for which no deferred tax assets have been recognized are attributable to the following:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Tax losses </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 312,972</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 264,089</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 197,152</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">Deductible temporary differences related to:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 18pt;">Right-of-use assets and lease liabilities, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 18pt;">Retirement benefit plan </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,770</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,213</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,098</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 318,742</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 267,302</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 204,250</p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock', window );">Tax losses carry forwards and respective expiry dates</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table details the tax losses carry forwards of the Company and their respective expiry dates:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Tax losses split by expiry date:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,231</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,231</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15,231</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 48,894</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 48,894</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 48,894</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 57,824</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 57,824</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 57,824</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 75,204</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 75,204</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 75,204</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2029</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 66,936</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 66,936</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">December&#160;31,&#160;2030</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 48,883</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total unrecorded tax loss carryforwards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 312,972</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 264,089</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 197,153</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about the expiration of income tax losses that may be carried forward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about income tax reconciliation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of types of temporary differences, unused tax losses and unused tax credits. [Refer: Unused tax credits [member]; Unused tax losses [member]; Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_g&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824823751456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement benefit plan (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract', window );"><strong>Retirement benefit plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock', window );">Schedule of amounts recognized in balance sheet from defined benefit plans</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table sets forth the status of the defined benefit pension plan and the amount that is recognized in the consolidated balance sheets:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Defined benefit obligation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (41,060)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (32,410)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (33,889)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Fair value of plan assets </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 35,290</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 29,197</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 26,791</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total liability </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,770)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,213)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (7,098)</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock', window );">Schedule of amounts recognized in statement of profit and loss from defined benefit plans</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following amounts have been recorded as net pension cost in the consolidated statements of income/(loss):</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Current service cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,453</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,712</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,648</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Past service cost</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 903</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 804</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 126</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 79</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (705)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (87)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (48)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net pension cost </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,455</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,751</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,679</p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory', window );">Schedule of changes in defined benefit obligations, fair value of plan assets and net defined benefit liability</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The changes in defined benefit obligation, fair value of plan assets and unrecognized gains/(losses) are as follows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">A. Change in defined benefit obligation</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Defined benefit obligation as of January 1 </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (32,410)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (33,889)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (30,213)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Current service cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,453)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,712)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,648)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Past service cost</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (903)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest cost </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (804)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (126)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (79)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Change in demographic assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 136</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 29</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Change in financial assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,908)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,397</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 156</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Change in experience assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (57)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,726)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (252)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Benefits deposited </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,265)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,327)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (894)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employees&#8217; contributions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,396)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,056)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (959)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Defined benefit obligation as of December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (41,060)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (32,410)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (33,889)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">B.</b></span>Change in fair value of plan assets</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair value of plan assets as of January 1 </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 29,197</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 26,791</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 22,749</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 705</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 87</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 48</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employees&#8217; contributions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,396</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,056</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 959</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employer&#8217;s contributions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,567</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,210</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,089</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Benefits deposited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,265</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,327</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 894</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Return on plan assets excluding interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,160</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,274)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,052</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair value of plan assets as of December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 35,290</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 29,197</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 26,791</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Expected contributions by the employer to be paid to the post-employment benefit plans during the annual period beginning after the end of the reporting period amount to approximately CHF 1.6 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">C.</b></span>Change in net defined benefit liability</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net defined benefit liabilities as of January 1 </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,213</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,098</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,464</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Net pension cost through statement of income/(loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,455</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,751</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,679</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Remeasurement through other comprehensive income/(loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,669</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,426)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (956)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employer&#8217;s contribution </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,567)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,210)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,089)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net defined benefit liabilities as of December&#160;31</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,770</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,213</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,098</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock', window );">Schedule of amounts recognized in statement of other comprehensive income from defined benefit plans</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">D.</b></span>Other comprehensive gains/(losses)</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of changes in demographic assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 136</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 29</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of changes in financial assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,908)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8,397</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 156</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Effect of changes in experience assumptions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (57)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,726)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (252)</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Return on plan assets excluding interest income </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,160</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,274)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,052</p></td></tr><tr><td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total other comprehensive gain/(loss)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,669)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,426</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 956</p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory', window );">Actuarial assumptions and sensitivity analysis</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The actuarial assumptions used for the calculation of the pension cost and the defined benefit obligation of the defined benefit pension plan for the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively, are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:52.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:52.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:44.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Discount rate </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Rate of future increase in compensations </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:44.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Rate of future increase in current pensions </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.00</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Interest rate on retirement savings capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:44.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Mortality and disability rates </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">BVG 2020 GT (CMI)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">BVG 2020-CMI</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">BVG 2020-CMI</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">A quantitative sensitivity analysis for significant assumptions as of December&#160;31, 2023 is shown below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Interest&#160;rate&#160;on</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Discount&#160;rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;salary&#160;increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;pension&#160;cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">savings&#160;capital</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assumptions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="17" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:68.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In&#160;CHF&#160;thousands</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Potential defined benefit obligation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 38,132</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 44,390</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 41,997</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 40,205</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 42,681</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 39,578</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 42,158</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 40,030</p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Decrease/(increase) from actual defined benefit obligation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,928</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,330)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (937)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 855</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,621)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,482</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,098)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,030</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">A quantitative sensitivity analysis for significant assumptions as of December&#160;31, 2022 is shown below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Interest&#160;rate&#160;on</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Discount&#160;rate</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;salary&#160;increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future&#160;pension&#160;cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">savings&#160;capital</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">0.5%</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assumptions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">increase</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">decrease</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="17" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:68.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in&#160;CHF&#160;thousands</b></p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Potential defined benefit obligation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 30,201</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 34,916</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 32,940</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,841</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 33,601</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,322</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 33,322</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,545</p></td></tr><tr><td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Decrease/(increase) from actual defined benefit obligation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,209</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,506)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (530)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 569</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,191)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,088</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (912)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 865</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of amounts recognised in balance sheet from defined benefit plans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of amounts recognised in statement of other comprehensive income from defined benefit plans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of amounts recognised in statement of profit and loss from defined benefit plans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 140<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_140_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a sensitivity analysis for significant actuarial assumptions used to determine the present value of a defined benefit obligation. [Refer: Actuarial assumptions [member]; Defined benefit obligation, at present value]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 145<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_145&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824825905872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract', window );"><strong>Share-based compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory', window );">Share-based compensation plans outstanding</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table summarizes equity-settled share option grants for plans that existed during the period:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">options&#160;awarded</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractual</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Plan</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(since&#160;inception)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vesting&#160;conditions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">life&#160;of&#160;options</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share option plan C1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,775,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">4 years</span><span style="font-size:10pt;">&#8217; service from grant date</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">10 years</span></p></td></tr><tr><td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">2016 SOIP:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:top;width:39.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Executives and directors</p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,831,325</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;width:26.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">1 year</span><span style="font-size:10pt;">, </span><span style="font-size:10pt;">3 year</span><span style="font-size:10pt;"> and </span><span style="font-size:10pt;">4 years</span><span style="font-size:10pt;">&#8217; service from the date of grant, quarterly and annually</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:16.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">10 years</span></p></td></tr><tr><td style="vertical-align:top;width:39.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employees</p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,811,687</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;width:26.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">4 years</span><span style="font-size:10pt;">&#8217; service from the date of grant, annually</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">10 years</span></p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory', window );">Number and weighted average exercise prices of options under share option programs</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The number and weighted-average exercise prices (in CHF) of options under the share option programs for Plans C1 and the 2016 SOIP are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted-</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted-</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">average</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">exercise&#160;price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">remaining</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(CHF)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">term&#160;(years)</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,900,667</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.90</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 8.2</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (207,331)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (218,561)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.97</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,110,914</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.34</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December&#160;31,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,585,689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.21</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 7.8</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,613,242</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.13</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 6.8</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,585,689</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.21</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 7.8</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (304,738)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.32</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (110,250)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,090,316</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December&#160;31,&#160;2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,261,017</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.65</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 7.6</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,345,648</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="color:#ff0000;font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.41</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 6.6</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,261,017</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.65</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 7.6</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (824,084)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.34</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (42,037)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.52</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,554,281</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December&#160;31,&#160;2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,949,177</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 7.2</span></p></td></tr><tr><td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable at December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,022,345</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.88</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="font-size:10pt;"> 6.4</span></p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory', window );">Outstanding options, exercise price range and expiry dates</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The outstanding stock options as of December&#160;31, 2023 have the following range of exercise prices:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Range&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">expiration</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total&#160;options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">dates</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Range of exercise prices</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">CHF 0.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 92,875</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2024&#8211;2026</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">CHF 9.53</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 109,665</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2027</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD 5.04 to USD 12.30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,417,545</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2027&#8211;2031</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD 2.76 to USD 4.57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,034,326</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2032&#8211;2033</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;">USD 2.03 to USD 2.32</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,294,766</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2032&#8211;2033</p></td></tr><tr><td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total outstanding options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,949,177</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory', window );">Weighted-average assumptions</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:31.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:31.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercise price (USD)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2.03-3.11</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2.76-4.57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">5.31-7.72</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share price (USD and weighted average)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.08</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.44</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6.95</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">4.0-4.6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">0-2.4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">0 </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">72-86</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">67-80</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 80</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Expected term (in years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">5.5-6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">5.5 - 6.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;">5.1 - 6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Dividend yield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory', window );">Summary of non-vested share awards (restricted share and restricted share units)</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">A summary of share awards (restricted share and restricted share units) activity as of&#160;December&#160;31, 2023&#160;and changes during the&#160;year then ended is presented below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractual</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">life&#160;of&#160;non-</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">share&#160;awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">vested&#160;share</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grantee type</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">granted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vesting&#160;conditions</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">awards</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Restricted share units</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:top;width:38.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Directors</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 257,329</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:35.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">1 year</span><span style="font-size:10pt;"> service from date of grant, annually</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">10 years</span></p></td></tr><tr><td style="vertical-align:top;width:38.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Executives</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 905,803</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;width:35.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">3 year</span><span style="font-size:10pt;"> and </span><span style="font-size:10pt;">4 years</span><span style="font-size:10pt;">&#8217; service from the date of grant, quarterly and semi-annually</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">10 years</span></p></td></tr><tr><td style="vertical-align:top;width:38.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Employees</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 458,335</p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;width:35.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">3 years</span><span style="font-size:10pt;">&#8217; service from the date of grant, annually</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:top;white-space:nowrap;width:11.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;">10 years</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted-</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">average</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">grant</b>&#160;<b style="font-weight:bold;">date&#160;fair</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">value&#160;(CHF)</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at January 1, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,494</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9.51</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,471)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9.46</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Vested during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (18,697)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9.52</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 797</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9.41</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vested and exercisable at December&#160;31,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 65,515</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9.48</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 797</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9.41</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 239,194</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.06</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Vested during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (23,505)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.28</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 216,486</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.06</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vested and exercisable at December&#160;31,&#160;2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 89,020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7.84</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 216,486</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.06</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Forfeited during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (134,947)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.05</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Exercised during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (55,503)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.37</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Granted during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,187,570</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.89</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Vested during the year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (265,366)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.46</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Non-vested at December&#160;31,&#160;2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,003,743</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.97</p></td></tr><tr><td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vested and exercisable at December&#160;31,&#160;2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 298,883</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.08</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the general terms and conditions of share-based payment arrangements. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824824019216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CommitmentsAndContingenciesAbstract', window );"><strong>Commitments and contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCommitmentsExplanatory', window );">Schedule of commitments</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Within 1 year</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21,746</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 23,336</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Between 1 and 3 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16,920</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,516</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Between 3 and 5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,632</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,229</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">More than 5 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,270</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,407</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 47,568</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 52,488</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CommitmentsAndContingenciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CommitmentsAndContingenciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCommitmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCommitmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824836741984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareExplanatory', window );">Schedule of earnings per share</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.07212067%;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For&#160;the&#160;Year&#160;Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands except for share and per share data</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Loss per share (EPS)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Numerator</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> <span style="margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Net loss attributable to equity holders of the Company</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (54,233)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (70,753)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (72,996)</p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Denominator</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Weighted-average number of shares outstanding used to compute EPS basic and diluted attributable to equity holders</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 84,694,616</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 83,554,412</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 74,951,833</p></td></tr><tr><td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Basic and diluted loss per share for the period attributable to equity holders</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.64)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.85)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.97)</p></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023', window );">Schedule of antidilutive securities</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:30.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:30.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:66.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Share options issued and outstanding (in-the-money)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 97,683</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 135,827</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,140,388</p></td></tr><tr><td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Restricted share awards subject to future vesting</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,160,240</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 117,292</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,264</p></td></tr><tr><td style="vertical-align:bottom;width:66.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Convertible shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 41,461</p></td></tr><tr><td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total potentially dilutive securities </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,257,923</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 253,119</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,188,113</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of instruments (including contingently issuable shares) that could potentially dilute basic earnings per share in the future, but were not included in the calculation of diluted earnings per share because they are antidilutive for the period(s) presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 70<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_70_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824825600896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial instruments and risk management (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract', window );"><strong>Financial instruments and risk management [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock', window );">Carrying amounts of financial assets and financial liabilities</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;">The following table shows the carrying amounts of financial assets and financial liabilities:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Financial assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,508</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,808</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Long-term financial assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 361</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 361</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Other current receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 622</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 392</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accounts receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 14,800</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> &#8212;</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term financial assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24,554</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 91,000</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 78,494</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,586</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total financial assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 122,339</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 126,147</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&#160;31,&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In CHF thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Long-term lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,825</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,253</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Trade and other payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,679</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 929</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Accrued expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11,087</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,417</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">Short-term lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 672</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 548</p></td></tr><tr><td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total financial liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16,263</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13,147</p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about carrying amounts of financial assets and financial liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824823771072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>General information (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>item</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_GeneralInformationAbstract', window );"><strong>General information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfTechnologyPlatforms', window );">Number of proprietary technology platforms</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_GeneralInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_GeneralInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfTechnologyPlatforms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of unique proprietary platform technologies to discover, design and develop medicines and diagnostics to target misfolded proteins.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfTechnologyPlatforms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824822451344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of preparation - Going concern (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_GoingConcernAbstract', window );"><strong>Going concern</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Company's cash position</a></td>
<td class="nump">SFr 78,494<span></span>
</td>
<td class="nump">SFr 31,586<span></span>
</td>
<td class="nump">SFr 82,216<span></span>
</td>
<td class="nump">SFr 160,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents', window );">Short-term financial assets</a></td>
<td class="nump">SFr 24,554<span></span>
</td>
<td class="nump">SFr 91,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_GoingConcernAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_GoingConcernAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of short-term deposits held by the entity that are not classified as cash equivalents. [Refer: Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824821535040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of material accounting policies - Functional and reporting currency (Details) - SFr / $<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ForeignExchangeRatesAbstract', window );"><strong>Functional and reporting currency</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Closing rate, USD 1</a></td>
<td class="nump">0.851<span></span>
</td>
<td class="nump">0.933<span></span>
</td>
<td class="nump">0.923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AverageForeignExchangeRate', window );">Weighted average exchange rate, USD 1</a></td>
<td class="nump">0.908<span></span>
</td>
<td class="nump">0.965<span></span>
</td>
<td class="nump">0.929<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AverageForeignExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average exchange rate used by the entity. Exchange rate is the ratio of exchange for two currencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AverageForeignExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClosingForeignExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The spot exchange rate at the end of the reporting period. Exchange rate is the ratio of exchange for two currencies. Spot exchange rate is the exchange rate for immediate delivery.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClosingForeignExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ForeignExchangeRatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ForeignExchangeRatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824827316848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of material accounting policies, Right-of-use assets and lease liabilities (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract', window );"><strong>Right-of-use assets and lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_EstimatedLeaseTerm', window );">Estimated lease term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember', window );">Office Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract', window );"><strong>Right-of-use assets and lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_EstimatedLeaseTerm', window );">Estimated lease term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">IT Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract', window );"><strong>Right-of-use assets and lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_EstimatedLeaseTerm', window );">Estimated lease term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_EstimatedLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated lease term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_EstimatedLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824823744272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of material accounting policies, Property, plant and equipment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">IT Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract', window );"><strong>Estimated useful life</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_LaboratoryEquipmentMember', window );">Lab Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract', window );"><strong>Estimated useful life</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_LeaseholdImprovementsAndFixturesAndFittingsMember', window );">Leasehold Improvements/Furniture</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract', window );"><strong>Estimated useful life</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_LeaseholdImprovementsAndFixturesAndFittingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_LeaseholdImprovementsAndFixturesAndFittingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824827155008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of material accounting policies, Income taxes (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Income taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncomeTaxLossCarryforwardPeriod', window );">Tax loss carryforward period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncomeTaxLossCarryforwardPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period or time limit over which financial losses of the entity for preceding years can be deducted from the taxable revenue for a period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncomeTaxLossCarryforwardPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824827147072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of material accounting policies, Segment reporting (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Segment reporting</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OperatingSegmentsNumber', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ReportableSegmentsNumber', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_OperatingSegmentsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments reported by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_OperatingSegmentsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ReportableSegmentsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of reportable segments reported by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ReportableSegmentsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824820041088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">SFr 4,259<span></span>
</td>
<td class="nump">SFr 5,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="nump">3,376<span></span>
</td>
<td class="nump">4,259<span></span>
</td>
<td class="nump">SFr 5,116<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Acquisition Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">13,602<span></span>
</td>
<td class="nump">12,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">801<span></span>
</td>
<td class="nump">936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="num">(31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="nump">14,372<span></span>
</td>
<td class="nump">13,602<span></span>
</td>
<td class="nump">12,666<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="num">(9,343)<span></span>
</td>
<td class="num">(7,550)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation expense</a></td>
<td class="num">(1,672)<span></span>
</td>
<td class="num">(1,793)<span></span>
</td>
<td class="num">(1,900)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="num">(10,996)<span></span>
</td>
<td class="num">(9,343)<span></span>
</td>
<td class="num">(7,550)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Furniture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="nump">159<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Furniture | Acquisition Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">285<span></span>
</td>
<td class="nump">265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="nump">309<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="nump">265<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Furniture | Accumulated depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="num">(159)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation expense</a></td>
<td class="num">(53)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="num">(212)<span></span>
</td>
<td class="num">(159)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">IT Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">310<span></span>
</td>
<td class="nump">438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="nump">317<span></span>
</td>
<td class="nump">310<span></span>
</td>
<td class="nump">438<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">IT Equipment | Acquisition Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">1,909<span></span>
</td>
<td class="nump">1,754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">278<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="nump">2,168<span></span>
</td>
<td class="nump">1,909<span></span>
</td>
<td class="nump">1,754<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">IT Equipment | Accumulated depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="num">(1,599)<span></span>
</td>
<td class="num">(1,316)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation expense</a></td>
<td class="num">(271)<span></span>
</td>
<td class="num">(283)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="num">(1,851)<span></span>
</td>
<td class="num">(1,599)<span></span>
</td>
<td class="num">(1,316)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_LaboratoryEquipmentMember', window );">Lab Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">2,748<span></span>
</td>
<td class="nump">3,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="nump">2,132<span></span>
</td>
<td class="nump">2,748<span></span>
</td>
<td class="nump">3,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_LaboratoryEquipmentMember', window );">Lab Equipment | Acquisition Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">9,765<span></span>
</td>
<td class="nump">9,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">468<span></span>
</td>
<td class="nump">576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="nump">10,233<span></span>
</td>
<td class="nump">9,765<span></span>
</td>
<td class="nump">9,142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_LaboratoryEquipmentMember', window );">Lab Equipment | Accumulated depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="num">(7,017)<span></span>
</td>
<td class="num">(5,739)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation expense</a></td>
<td class="num">(1,084)<span></span>
</td>
<td class="num">(1,278)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="num">(8,101)<span></span>
</td>
<td class="num">(7,017)<span></span>
</td>
<td class="num">(5,739)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">1,072<span></span>
</td>
<td class="nump">421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="nump">830<span></span>
</td>
<td class="nump">1,072<span></span>
</td>
<td class="nump">421<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember', window );">Leasehold Improvements | Acquisition Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">1,640<span></span>
</td>
<td class="nump">810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="nump">1,662<span></span>
</td>
<td class="nump">1,640<span></span>
</td>
<td class="nump">810<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember', window );">Leasehold Improvements | Accumulated depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="num">(568)<span></span>
</td>
<td class="num">(389)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation expense</a></td>
<td class="num">(264)<span></span>
</td>
<td class="num">(179)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="num">(832)<span></span>
</td>
<td class="num">(568)<span></span>
</td>
<td class="num">(389)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember', window );">Assets under construction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">695<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember', window );">Assets under construction | Acquisition Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, beginning of period</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment', window );">Transfers</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(697)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 3<span></span>
</td>
<td class="nump">SFr 695<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_ItAndLaboratoryEquipmentMember', window );">Laboratory and IT equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">SFr 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PercentageIncreaseInPropertyPlantAndEquipment', window );">Percentage of increase in equipment</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PercentageIncreaseInPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of increase in property, plant and equipment during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PercentageIncreaseInPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_e_vii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 75<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_75_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisposalsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_e_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisposalsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from transfers from construction in progress. [Refer: Property, plant and equipment; Construction in progress]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_ItAndLaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=aciu_ItAndLaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824827357344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use assets, long-term financial assets and lease liabilities (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract', window );"><strong>Right-of-use assets and lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions and reassessment</a></td>
<td class="nump">SFr 1,243<span></span>
</td>
<td class="nump">SFr 460<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_RightOfUseLeasedAssetsAbstract', window );"><strong>Right-of-use of leased assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Balance, beginning of period</a></td>
<td class="nump">2,808<span></span>
</td>
<td class="nump">2,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation</a></td>
<td class="num">(543)<span></span>
</td>
<td class="num">(566)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Balance, end of period</a></td>
<td class="nump">3,508<span></span>
</td>
<td class="nump">2,808<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember', window );">Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract', window );"><strong>Right-of-use assets and lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions and reassessment</a></td>
<td class="nump">SFr 1,243<span></span>
</td>
<td class="nump">SFr 460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16', window );">Weighted average incremental borrowing rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_RightOfUseLeasedAssetsAbstract', window );"><strong>Right-of-use of leased assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Balance, beginning of period</a></td>
<td class="nump">SFr 2,708<span></span>
</td>
<td class="nump">SFr 2,776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation</a></td>
<td class="num">(505)<span></span>
</td>
<td class="num">(528)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Balance, end of period</a></td>
<td class="nump">3,446<span></span>
</td>
<td class="nump">2,708<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_OfficeEquipmentMember', window );">Office Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract', window );"><strong>Right-of-use assets and lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions and reassessment</a></td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16', window );">Weighted average incremental borrowing rate</a></td>
<td class="nump">5.30%<span></span>
</td>
<td class="nump">5.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_RightOfUseLeasedAssetsAbstract', window );"><strong>Right-of-use of leased assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Balance, beginning of period</a></td>
<td class="nump">SFr 74<span></span>
</td>
<td class="nump">SFr 98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Balance, end of period</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_ComputerEquipmentMember', window );">IT Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract', window );"><strong>Right-of-use assets and lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions and reassessment</a></td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16', window );">Weighted average incremental borrowing rate</a></td>
<td class="nump">2.60%<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_RightOfUseLeasedAssetsAbstract', window );"><strong>Right-of-use of leased assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Balance, beginning of period</a></td>
<td class="nump">SFr 26<span></span>
</td>
<td class="nump">SFr 40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Balance, end of period</a></td>
<td class="nump">SFr 12<span></span>
</td>
<td class="nump">SFr 26<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_RightOfUseLeasedAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_RightOfUseLeasedAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsToRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_h&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsToRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average lessee's incremental borrowing rate applied to lease liabilities recognised in the statement of financial position at the date of initial application of IFRS 16. The incremental borrowing rate is the rate of interest that a lessee would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph C12<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_C12_a&amp;doctype=Appendix&amp;subtype=C<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824825567632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use assets, long-term financial assets and lease liabilities - Statement of income/(loss) and cash flow (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract', window );"><strong>Statements of income/(loss) and cash flows</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation of right-of-use assets</a></td>
<td class="nump">SFr 543<span></span>
</td>
<td class="nump">SFr 566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Interest expense on lease liabilities</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed', window );">Expense for short-term leases and leases of low value</a></td>
<td class="nump">793<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ExpenseRelatingToLeases', window );">Total</a></td>
<td class="nump">1,426<span></span>
</td>
<td class="nump">1,384<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashOutflowForLeases', window );">Total cash outflow for leases</a></td>
<td class="nump">SFr 1,431<span></span>
</td>
<td class="nump">SFr 1,388<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ExpenseRelatingToLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expense for leases recognized through profit and loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ExpenseRelatingToLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashOutflowForLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_g&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashOutflowForLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the expense relating to short-term leases accounted for applying paragraph 6 of IFRS 16. This expense need not include the expense relating to leases with a lease term of one month or less. Short-term lease is a lease that, at the commencement date, has a lease term of 12 months or less. A lease that contains a purchase option is not a short-term lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824822352000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Right-of-use assets, long-term financial assets and lease liabilities - Contractual undiscounted cash flows for lease obligations (Details)<br> SFr in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CHF (SFr) </div>
<div>item</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract', window );"><strong>Contractual undiscounted cash flows for lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Contractual undiscounted cash flows for lease obligations</a></td>
<td class="nump">SFr 3,815<span></span>
</td>
<td class="nump">SFr 3,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfDepositsInEscrowAccounts', window );">Number of deposits in escrow accounts | item</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_EscrowDepositAmount', window );">Escrow deposits</a></td>
<td class="nump">SFr 400<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less than one year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract', window );"><strong>Contractual undiscounted cash flows for lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Contractual undiscounted cash flows for lease obligations</a></td>
<td class="nump">784<span></span>
</td>
<td class="nump">638<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember', window );">1-3 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract', window );"><strong>Contractual undiscounted cash flows for lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Contractual undiscounted cash flows for lease obligations</a></td>
<td class="nump">1,526<span></span>
</td>
<td class="nump">1,230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember', window );">3-5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract', window );"><strong>Contractual undiscounted cash flows for lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Contractual undiscounted cash flows for lease obligations</a></td>
<td class="nump">SFr 1,505<span></span>
</td>
<td class="nump">SFr 1,187<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_EscrowDepositAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deposits held in escrow.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_EscrowDepositAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfDepositsInEscrowAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of deposits in escrow accounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfDepositsInEscrowAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual undiscounted cash flows in relation to lease liabilities before deducting finance charges. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 58<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_58&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph B11D<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B11D_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824821865568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset acquisition (Details) - Program portfolio of therapeutics targeting asyn from Affiris<br> SFr in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SharesTransferredAsConsiderationInAssetAcquisition', window );">Shares transferred as consideration in asset acquisition | shares</a></td>
<td class="nump">7,106,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition', window );">Total consideration transferred, acquisition-date fair value, asset acquisition</a></td>
<td class="nump">$ 58.7<span></span>
</td>
<td class="nump">SFr 55,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CashAcquiredAsPartOfAssetAcquisition', window );">Cash</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">4,634<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition', window );">IPR&amp;D asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,416<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TotalAssetsAcquiredInAssetAcquisition', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,050<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AssetAcquisitionsAxis=aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember', window );">IPR&amp;D intangible asset associated with ACI 7104.056</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition', window );">IPR&amp;D asset</a></td>
<td class="nump">$ 53.7<span></span>
</td>
<td class="nump">SFr 50,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AssetAcquisitionsAxis=aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember', window );">IPR&amp;D intangible asset associated with ACI 7104.056 | Discount rate, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputAssets', window );">Discount rate</a></td>
<td class="nump">0.15<span></span>
</td>
<td class="nump">0.15<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CashAcquiredAsPartOfAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash acquired as part of asset acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CashAcquiredAsPartOfAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible assets acquired as part of asset acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_SharesTransferredAsConsiderationInAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares transferred as consideration in asset acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_SharesTransferredAsConsiderationInAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_TotalAssetsAcquiredInAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total assets acquired in asset acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_TotalAssetsAcquiredInAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total consideration transferred, acquisition-date fair value, asset acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantUnobservableInputAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of significant unobservable input used in the measurement of the fair value of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantUnobservableInputAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AssetAcquisitionsAxis=aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AssetAcquisitionsAxis=aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_DiscountRateMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_DiscountRateMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824823873968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible assets (Details)<br> SFr in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract', window );"><strong>Disclosure of intangible assets material to entity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="nump">SFr 50,416<span></span>
</td>
<td class="nump">SFr 50,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract', window );"><strong>Disclosure of intangible assets material to entity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="nump">50,416<span></span>
</td>
<td class="nump">50,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract', window );"><strong>Disclosure of intangible assets material to entity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=aciu_InProcessResearchAndDevelopmentIPRDAssetMember', window );">Acquired IPR&amp;D Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract', window );"><strong>Disclosure of intangible assets material to entity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="nump">SFr 50,416<span></span>
</td>
<td class="nump">SFr 50,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=aciu_InProcessResearchAndDevelopmentIPRDAssetMember', window );">Acquired IPR&amp;D Asset | Discount rate, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract', window );"><strong>Disclosure of intangible assets material to entity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputAssets', window );">Discount rate</a></td>
<td class="nump">0.17<span></span>
</td>
<td class="nump">0.17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=aciu_InProcessResearchAndDevelopmentIPRDAssetMember', window );">Acquired IPR&amp;D Asset | Gross Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract', window );"><strong>Disclosure of intangible assets material to entity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="nump">SFr 50,416<span></span>
</td>
<td class="nump">SFr 50,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=aciu_InProcessResearchAndDevelopmentIPRDAssetMember', window );">Acquired IPR&amp;D Asset | Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract', window );"><strong>Disclosure of intangible assets material to entity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantUnobservableInputAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of significant unobservable input used in the measurement of the fair value of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantUnobservableInputAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=aciu_InProcessResearchAndDevelopmentIPRDAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=aciu_InProcessResearchAndDevelopmentIPRDAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_DiscountRateMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_DiscountRateMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824822350976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash and cash equivalents and financial assets, Cash and cash equivalents (Details)<br> SFr in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CHF (SFr) </div>
<div>SFr / &#8364; </div>
<div>SFr / $</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr) </div>
<div>SFr / &#8364; </div>
<div>SFr / $</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr) </div>
<div>SFr / $</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAbstract', window );"><strong>Cash and cash equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">SFr 78,494<span></span>
</td>
<td class="nump">SFr 31,586<span></span>
</td>
<td class="nump">SFr 82,216<span></span>
</td>
<td class="nump">SFr 160,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Translation rate into CHF | SFr / $</a></td>
<td class="nump">0.851<span></span>
</td>
<td class="nump">0.933<span></span>
</td>
<td class="nump">0.923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CHF', window );">CHF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAbstract', window );"><strong>Cash and cash equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">SFr 52,437<span></span>
</td>
<td class="nump">SFr 24,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">EUR [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAbstract', window );"><strong>Cash and cash equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">SFr 8,155<span></span>
</td>
<td class="nump">SFr 1,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Translation rate into CHF | SFr / &#8364;</a></td>
<td class="nump">0.942<span></span>
</td>
<td class="nump">0.994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">USD [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAbstract', window );"><strong>Cash and cash equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">SFr 17,902<span></span>
</td>
<td class="nump">SFr 5,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Translation rate into CHF | SFr / $</a></td>
<td class="nump">0.851<span></span>
</td>
<td class="nump">0.933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClosingForeignExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The spot exchange rate at the end of the reporting period. Exchange rate is the ratio of exchange for two currencies. Spot exchange rate is the exchange rate for immediate delivery.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClosingForeignExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CHF">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CHF</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824821649312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash and cash equivalents and financial assets, Cash and cash equivalents and short-term financial assets (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousCurrentAssetsAbstract', window );"><strong>Miscellaneous current assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents', window );">Short-term financial assets due in one year or less</a></td>
<td class="nump">SFr 24,554<span></span>
</td>
<td class="nump">SFr 91,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CHF', window );">CHF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousCurrentAssetsAbstract', window );"><strong>Miscellaneous current assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents', window );">Short-term financial assets due in one year or less</a></td>
<td class="nump">22,000<span></span>
</td>
<td class="nump">SFr 91,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">USD [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousCurrentAssetsAbstract', window );"><strong>Miscellaneous current assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents', window );">Short-term financial assets due in one year or less</a></td>
<td class="nump">SFr 2,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of short-term deposits held by the entity that are not classified as cash equivalents. [Refer: Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CHF">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CHF</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824824067712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaid expenses and accrued income (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract', window );"><strong>Prepaid expenses and accrued income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepaidExpenses', window );">Prepaid expenses</a></td>
<td class="nump">SFr 6,437<span></span>
</td>
<td class="nump">SFr 4,708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets', window );">Accrued income</a></td>
<td class="nump">246<span></span>
</td>
<td class="nump">408<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets', window );">Total prepaid expenses and accrued income</a></td>
<td class="nump">SFr 6,683<span></span>
</td>
<td class="nump">SFr 5,116<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current accrued income including current contract assets. [Refer: Accrued income including contract assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current prepayments and current accrued income including current contract assets. [Refer: Prepayments; Accrued income including contract assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824822094848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts receivable (Details) - Dec. 31, 2023<br> SFr in Thousands, $ in Millions</strong></div></th>
<th class="th"><div>CHF (SFr)</div></th>
<th class="th"><div>USD ($)</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Accounts receivable | SFr</a></td>
<td class="nump">SFr 14,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=aciu_JJInnovativeMedicineMember', window );">J&amp;J Innovative Medicine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Accounts receivable | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=aciu_JJInnovativeMedicineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=aciu_JJInnovativeMedicineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824827267680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other current receivables (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Other current receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_MiscellaneousOtherCurrentReceivables', window );">Other current receivable</a></td>
<td class="nump">SFr 45<span></span>
</td>
<td class="nump">SFr 124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentValueAddedTaxReceivables', window );">Swiss VAT</a></td>
<td class="nump">259<span></span>
</td>
<td class="nump">249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WithholdingTaxReceivables', window );">Withholding tax</a></td>
<td class="nump">318<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Total other current receivables</a></td>
<td class="nump">SFr 622<span></span>
</td>
<td class="nump">SFr 392<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Other current receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_MaturityPeriodOtherCurrentReceivables', window );">Maturity period, other current receivables</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_MaturityPeriodOtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maturity period, other current receivables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_MaturityPeriodOtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_MiscellaneousOtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Miscellaneous other current receivables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_MiscellaneousOtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WithholdingTaxReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Withholding tax receivables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WithholdingTaxReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentValueAddedTaxReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current value added tax receivables. [Refer: Value added tax receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentValueAddedTaxReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current other receivables. [Refer: Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824827343152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share capital - Narratives (Details) - CHF (SFr)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Issued share capital</a></td>
<td class="nump">SFr 2,089,000<span></span>
</td>
<td class="nump">SFr 1,797,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates', window );">Number of treasury shares outstanding</a></td>
<td class="nump">5,243,958<span></span>
</td>
<td class="nump">6,214,021<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Common Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Issued share capital</a></td>
<td class="nump">SFr 2,088,823<span></span>
</td>
<td class="nump">SFr 1,796,675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares</a></td>
<td class="nump">99,197,829<span></span>
</td>
<td class="nump">83,620,364<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares in the entity held by the entity or by its subsidiaries or associates. [Refer: Associates [member]; Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79_a_vi&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824821845712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital - Capital Structure (Details) - CHF (SFr)<br> SFr / shares in Units, SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract', window );"><strong>Treasury shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates', window );">Treasury shares outstanding at beginning of period</a></td>
<td class="num">(6,214,021)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates', window );">Treasury shares outstanding at end of period</a></td>
<td class="num">(5,243,958)<span></span>
</td>
<td class="num">(6,214,021)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInEquityAbstract', window );"><strong>Changes in equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, beginning of period</a></td>
<td class="nump">SFr 168,991<span></span>
</td>
<td class="nump">SFr 231,979<span></span>
</td>
<td class="nump">SFr 215,478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost', window );">Proceeds from public offerings, net of underwriting fees, transaction costs</a></td>
<td class="nump">40,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts', window );">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</a></td>
<td class="nump">2,650<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">12,121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, end of period</a></td>
<td class="nump">SFr 160,643<span></span>
</td>
<td class="nump">SFr 168,991<span></span>
</td>
<td class="nump">SFr 231,979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Nominal value per share (in CHF per share)</a></td>
<td class="nump">SFr 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Common Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract', window );"><strong>Common shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Common shares outstanding at beginning of period</a></td>
<td class="nump">89,834,385<span></span>
</td>
<td class="nump">89,700,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans', window );">Issuance of shares - incentive plans, net of transaction costs (in shares)</a></td>
<td class="nump">307,402<span></span>
</td>
<td class="nump">133,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ProceedsFromPublicOfferingsNetOfUnderwritingFeesAndTransactionEquityShares', window );">Proceeds from public offerings, net of underwriting fees and transaction, equity, shares</a></td>
<td class="nump">14,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Common shares outstanding at end of period</a></td>
<td class="nump">104,441,787<span></span>
</td>
<td class="nump">89,834,385<span></span>
</td>
<td class="nump">89,700,630<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_TreasurySharesMember', window );">Treasury shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract', window );"><strong>Treasury shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates', window );">Treasury shares outstanding at beginning of period</a></td>
<td class="num">(6,214,021)<span></span>
</td>
<td class="num">(6,221,617)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance', window );">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs (in shares)</a></td>
<td class="nump">970,063<span></span>
</td>
<td class="nump">7,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates', window );">Treasury shares outstanding at end of period</a></td>
<td class="num">(5,243,958)<span></span>
</td>
<td class="num">(6,214,021)<span></span>
</td>
<td class="num">(6,221,617)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember', window );">Share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInEquityAbstract', window );"><strong>Changes in equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, beginning of period</a></td>
<td class="nump">SFr 1,797<span></span>
</td>
<td class="nump">SFr 1,794<span></span>
</td>
<td class="nump">SFr 1,538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost', window );">Proceeds from public offerings, net of underwriting fees, transaction costs</a></td>
<td class="nump">286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseThroughSharesIssuedUnderIncentivePlans', window );">Issuance of shares - incentive plans, net of transaction costs</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, end of period</a></td>
<td class="nump">2,089<span></span>
</td>
<td class="nump">1,797<span></span>
</td>
<td class="nump">1,794<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_SharePremiumMember', window );">Share premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInEquityAbstract', window );"><strong>Changes in equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, beginning of period</a></td>
<td class="nump">431,323<span></span>
</td>
<td class="nump">431,251<span></span>
</td>
<td class="nump">346,890<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost', window );">Proceeds from public offerings, net of underwriting fees, transaction costs</a></td>
<td class="nump">40,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts', window );">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</a></td>
<td class="nump">2,631<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">12,097<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseThroughSharesIssuedUnderIncentivePlans', window );">Issuance of shares - incentive plans, net of transaction costs</a></td>
<td class="nump">704<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, end of period</a></td>
<td class="nump">474,907<span></span>
</td>
<td class="nump">431,323<span></span>
</td>
<td class="nump">431,251<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_TreasurySharesMember', window );">Treasury shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInEquityAbstract', window );"><strong>Changes in equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, beginning of period</a></td>
<td class="num">(124)<span></span>
</td>
<td class="num">(124)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts', window );">Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance, end of period</a></td>
<td class="num">SFr (105)<span></span>
</td>
<td class="num">SFr (124)<span></span>
</td>
<td class="num">SFr (124)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in number of treasury shares from sales or issuance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in the number of ordinary shares issued under incentive plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseThroughSharesIssuedUnderIncentivePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in equity resulting from the issue of shares under incentive plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseThroughSharesIssuedUnderIncentivePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ProceedsFromPublicOfferingsNetOfUnderwritingFeesAndTransactionEquityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from public offerings, net of underwriting fees and transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ProceedsFromPublicOfferingsNetOfUnderwritingFeesAndTransactionEquityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reconciliation of number of treasury shares outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity from sale or issue of public offerings net of underwriting fees and transaction costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity from sale or issue of treasury shares net of underwriting fees and transaction costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares in the entity held by the entity or by its subsidiaries or associates. [Refer: Associates [member]; Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79_a_vi&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_TreasurySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_TreasurySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_SharePremiumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_SharePremiumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_TreasurySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_TreasurySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824822575792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital - Authorized capital (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>CHF (SFr) </div>
<div>SFr / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract', window );"><strong>Share capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue', window );">Additional share capital that Board of Directors are authorized to issue | SFr</a></td>
<td class="nump">SFr 114,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue', window );">Number of additional shares that Board of Directors are authorized to issue | shares</a></td>
<td class="nump">5,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Nominal value per share (in CHF per share) | SFr / shares</a></td>
<td class="nump">SFr 0.02<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional share capital that Board of Directors are authorized to issue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares that Board of Directors are authorized to issue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824827421184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital - Conditional share capital for financing and other purposes (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>CHF (SFr) </div>
<div>SFr / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ConditionalShareCapitalAbstract', window );"><strong>Conditional Share Capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Nominal value per share (in CHF per share)</a></td>
<td class="nump">SFr 0.02<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember', window );">Conditional share capital for financing and other purposes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ConditionalShareCapitalAbstract', window );"><strong>Conditional Share Capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Nominal value per share (in CHF per share)</a></td>
<td class="nump">SFr 0.02<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember', window );">Conditional share capital for financing and other purposes | Top of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ConditionalShareCapitalAbstract', window );"><strong>Conditional Share Capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments', window );">Potential increase is equity through conversion of debt instruments | SFr</a></td>
<td class="nump">SFr 100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments', window );">Potential number of shares issued from conversion of debt instruments | shares</a></td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ConditionalShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ConditionalShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Potential increase is equity through conversion of debt instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Potential number of shares issued from conversion of debt instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824820031344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital - Conditional share capital for employee benefit plans (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>CHF (SFr) </div>
<div>SFr / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ConditionalShareCapitalAbstract', window );"><strong>Conditional Share Capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Nominal value per share (in CHF per share) | SFr / shares</a></td>
<td class="nump">SFr 0.02<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits', window );">Number of shares issued upon exercise of options and restricted share units | shares</a></td>
<td class="nump">97,540<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember', window );">Employee Benefit Plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ConditionalShareCapitalAbstract', window );"><strong>Conditional Share Capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Nominal value per share (in CHF per share) | SFr / shares</a></td>
<td class="nump">SFr 0.02<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember', window );">Employee Benefit Plans [Member] | Top of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ConditionalShareCapitalAbstract', window );"><strong>Conditional Share Capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions', window );">Maximum aggregate amount of ordinary shares | SFr</a></td>
<td class="nump">SFr 93,795<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions', window );">Issuance of ordinary shares (in shares) | shares</a></td>
<td class="nump">4,689,750<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ConditionalShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ConditionalShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued upon exercise of options and restricted share units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The potential increase in equity from share-based payment transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total number of potential shares issued through share-based payment transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824822480512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital - Follow-On Offering (Details)<br> SFr in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 19, 2023 </div>
<div>CHF (SFr) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 19, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Share capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 776<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_FollowOnOfferingMember', window );">Follow on Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Share capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfSharesIssuedDuringPeriod', window );">Number of shares issued during the period | shares</a></td>
<td class="nump">14,300,000<span></span>
</td>
<td class="nump">14,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Issuance costs</a></td>
<td class="nump">SFr 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NetProceedsFromIssuanceOfShares', window );">Net proceeds from issuance of shares</a></td>
<td class="nump">40,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Proceeds from issue of ordinary shares</a></td>
<td class="nump">SFr 43,800<span></span>
</td>
<td class="nump">$ 50.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NetProceedsFromIssuanceOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net proceeds from issuance of shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NetProceedsFromIssuanceOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfSharesIssuedDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfSharesIssuedDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssueOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_FollowOnOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=aciu_FollowOnOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824825657568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share capital - Shelf registration statement (Details)<br></strong></div></th>
<th class="th">
<div>Apr. 28, 2021 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement', window );">Capital authorized to be issued under Shelf Registration Statement</a></td>
<td class="nump">SFr 350,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital authorized to be issued under shelf registration statement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824827364240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital - At the market equity offering (Details)<br> SFr / shares in Units, SFr in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>SFr / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>CHF (SFr) </div>
<div>SFr / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CHF (SFr) </div>
<div>SFr / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AtTheMarketEquityOfferingAbstract', window );"><strong>At the Market Equity Offering [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Nominal value per share (in CHF per share) | SFr / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Issuance costs | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 776<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_AtTheMarketEquityOfferingMember', window );">At the Market Equity Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AtTheMarketEquityOfferingAbstract', window );"><strong>At the Market Equity Offering [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares', window );">Issuance of shares to be held as treasury shares | shares</a></td>
<td class="nump">2,393,160<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Nominal value per share (in CHF per share) | SFr / shares</a></td>
<td class="nump">SFr 0.02<span></span>
</td>
<td class="nump">SFr 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket', window );">Shares authorized for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 68,100<span></span>
</td>
<td class="nump">$ 80.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_SecondOpenMarketSalesAgreementMember', window );">New Sales Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AtTheMarketEquityOfferingAbstract', window );"><strong>At the Market Equity Offering [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SaleOrIssueOfTreasurySharesShares', window );">Number of treasury share issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,149,202<span></span>
</td>
<td class="nump">2,149,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares', window );">Proceeds from issuance of treasury shares, net of underwriting fees and transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 14,800<span></span>
</td>
<td class="nump">$ 16.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CommissionsPaidForIssuanceOrdinaryShares', window );">Commissions paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 500<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AtTheMarketEquityOfferingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AtTheMarketEquityOfferingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CommissionsPaidForIssuanceOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of commissions paid for issuance ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CommissionsPaidForIssuanceOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of common shares authorized for sale in the open market.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity shares resulting from treasury share transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_SaleOrIssueOfTreasurySharesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of treasury shares issued or sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_SaleOrIssueOfTreasurySharesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale or issuing of treasury shares. [Refer: Sale or issue of treasury shares; Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_AtTheMarketEquityOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=aciu_AtTheMarketEquityOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_SecondOpenMarketSalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=aciu_SecondOpenMarketSalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824822192304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share capital - Convertible note agreement (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr) </div>
<div>agreement </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>agreement</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ConvertibleNoteAgreementAbstract', window );"><strong>Convertible Note Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ProceedsFromIssueOfConvertibleDebt', window );">Net proceeds | SFr</a></td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 23,463,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_ConvertibleNoteAgreementMember', window );">Convertible note agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ConvertibleNoteAgreementAbstract', window );"><strong>Convertible Note Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfConvertibleNoteAgreements', window );">Number of separate convertible note agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AggregatePrincipalAmountOfEachConvertibleNote', window );">Aggregate principal amount of each convertible note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 11,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote', window );">Proceeds from conversion of convertible debt, per individual note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 11,700,000<span></span>
</td>
<td class="nump">$ 12.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt', window );">Number of shares issued through conversion of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,026,634<span></span>
</td>
<td class="nump">3,026,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements', window );">Outstanding equity or cash consideration due under convertible note agreements | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_ConvertibleNoteAgreementMember', window );">Convertible note agreements | Athos Service GmbH [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ConvertibleNoteAgreementAbstract', window );"><strong>Convertible Note Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt', window );">Number of shares issued through conversion of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,513,317<span></span>
</td>
<td class="nump">1,513,317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_ConvertibleNoteAgreementMember', window );">Convertible note agreements | First Capital Partner GmbH [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ConvertibleNoteAgreementAbstract', window );"><strong>Convertible Note Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt', window );">Number of shares issued through conversion of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,513,317<span></span>
</td>
<td class="nump">1,513,317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_ConvertibleNoteAgreementMember', window );">Convertible note agreements | Top of Range [Member] | If notes are converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ConvertibleNoteAgreementAbstract', window );"><strong>Convertible Note Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ProceedsFromIssueOfConvertibleDebt', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 23,500,000<span></span>
</td>
<td class="nump">$ 25.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AggregatePrincipalAmountOfEachConvertibleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate principal amount of each convertible note</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AggregatePrincipalAmountOfEachConvertibleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ConvertibleNoteAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ConvertibleNoteAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in the number of ordinary shares issued under a convertible debt arrangement upon conversion of the debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfConvertibleNoteAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of convertible note agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfConvertibleNoteAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Outstanding equity or cash consideration due under convertible note agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from conversion of convertible debt, per individual note</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ProceedsFromIssueOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuing of convertible debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ProceedsFromIssueOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=aciu_ConvertibleNoteAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=aciu_ConvertibleNoteAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=aciu_AthosServiceGmbHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=aciu_AthosServiceGmbHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=aciu_FirstCapitalPartnerGmbHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=aciu_FirstCapitalPartnerGmbHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=aciu_IfNotesAreConvertedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=aciu_IfNotesAreConvertedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824823877408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Trade and other payables and accrued expenses (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AccruedExpensesAbstract', window );"><strong>Trade and other payables and accrued expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade and other payables</a></td>
<td class="nump">SFr 1,679<span></span>
</td>
<td class="nump">SFr 929<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CurrentAccruedResearchAndDevelopmentCosts', window );">Accrued research and development costs</a></td>
<td class="nump">4,722<span></span>
</td>
<td class="nump">5,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermEmployeeBenefitsAccruals', window );">Accrued payroll expenses</a></td>
<td class="nump">4,649<span></span>
</td>
<td class="nump">2,898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OtherAccruedExpenses', window );">Other accrued expenses</a></td>
<td class="nump">1,716<span></span>
</td>
<td class="nump">1,159<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities', window );">Total</a></td>
<td class="nump">11,087<span></span>
</td>
<td class="nump">9,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermEmployeeBenefitsAccruals', window );">Accrual of performance-related remuneration</a></td>
<td class="nump">4,649<span></span>
</td>
<td class="nump">SFr 2,898<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AccruedStampDuty', window );">Accrued stamp duty</a></td>
<td class="nump">SFr 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AccruedExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AccruedExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AccruedStampDuty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current accrued stamp duty.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AccruedStampDuty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CurrentAccruedResearchAndDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current accrued research and development costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CurrentAccruedResearchAndDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_OtherAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other accrued expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_OtherAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current accrued expenses and other current liabilities. [Refer: Accruals; Other current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermEmployeeBenefitsAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermEmployeeBenefitsAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824827430256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract revenues - Contract Revenue Attributable to Licensing Arrangements (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ContractRevenueAbstract', window );"><strong>Contract Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total contract revenues</a></td>
<td class="nump">SFr 14,801<span></span>
</td>
<td class="nump">SFr 3,935<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember', window );">Janssen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ContractRevenueAbstract', window );"><strong>Contract Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total contract revenues</a></td>
<td class="nump">14,800<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember', window );">Life Molecular Imaging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ContractRevenueAbstract', window );"><strong>Contract Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total contract revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,935<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_OtherAgreementMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ContractRevenueAbstract', window );"><strong>Contract Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total contract revenues</a></td>
<td class="nump">SFr 1<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ContractRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ContractRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 114<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_OtherAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_OtherAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824822601600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract revenues - Recognized Revenues (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod', window );">Amounts included in the contract liability at the beginning of the period</a></td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods', window );">Performance obligations satisfied in previous periods</a></td>
<td class="nump">SFr 14,801<span></span>
</td>
<td class="nump">SFr 3,935<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from performance obligations satisfied (or partially satisfied) in previous periods. [Refer: Performance obligations [member]; Revenue from contracts with customers]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 116<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_116_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue that was included in the contract liability balance at the beginning of the period. [Refer: Contract liabilities; Revenue from contracts with customers]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 116<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_116_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824820115744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract revenues - Morphomer Tau small molecule - 2018 license agreement with Eli Lilly and Company (Details)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">42 Months Ended</th>
<th class="th" colspan="1">59 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>CHF (SFr) </div>
<div>installment</div>
</th>
<th class="th">
<div>Jan. 23, 2019 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>CHF (SFr) </div>
<div>installment</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CHF (SFr) </div>
<div>item</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 14,801<span></span>
</td>
<td class="nump">SFr 3,935<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities', window );">Deferred income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 138<span></span>
</td>
<td class="nump">587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 587<span></span>
</td>
<td class="nump">SFr 138<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember', window );">Morphomer Tau Small Molecule [Member] | 2018 License Agreement with Eli Lilly and Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementMilestonePaymentReceived', window );">Milestone payment received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod', window );">Period to provide notice of termination of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty', window );">Number of representatives in joint steering committee by each party | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities', window );">Deferred income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember', window );">Morphomer Tau Small Molecule [Member] | 2018 License Agreement with Eli Lilly and Company [Member] | Clinical and Regulatory [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations', window );">Expected transaction price allocation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">880,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">880,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember', window );">Morphomer Tau Small Molecule [Member] | 2018 License Agreement with Eli Lilly and Company [Member] | Commercial [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations', window );">Expected transaction price allocation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember', window );">Morphomer Tau Small Molecule [Member] | 2018 License Agreement with Eli Lilly and Company [Member] | Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContractAssets', window );">Deferred research and development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 6,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 6,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember', window );">Morphomer Tau Small Molecule [Member] | 2018 License Agreement with Eli Lilly and Company [Member] | Right-of-use License [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 73,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember', window );">Morphomer Tau Small Molecule [Member] | 2018 License Agreement with Eli Lilly, First Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementPotentialValue', window );">Total potential collaboration agreement value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments', window );">Number of installments | installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember', window );">Morphomer Tau Small Molecule [Member] | 2018 License Agreement with Eli Lilly, First Amendment [Member] | Quarter 3, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomers', window );">Milestone payment receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember', window );">Morphomer Tau Small Molecule [Member] | 2018 License Agreement with Eli Lilly, First Amendment [Member] | March 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomers', window );">Milestone payment receivable</a></td>
<td class="nump">SFr 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember', window );">Morphomer Tau Small Molecule [Member] | 2018 License Agreement with Eli Lilly, Second Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments', window );">Number of installments | installment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember', window );">Morphomer Tau Small Molecule [Member] | 2018 License Agreement with Eli Lilly, Second Amendment [Member] | March 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomers', window );">Milestone payment receivable</a></td>
<td class="nump">SFr 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember', window );">Morphomer Tau Small Molecule [Member] | 2018 License Agreement with Eli Lilly, Second Amendment [Member] | Upon first patient dosed in a Phase 2 clinical study of a licensed product in the U.S. or EU.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomers', window );">Milestone payment receivable</a></td>
<td class="nump">SFr 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of installments for satisfying a milestone payment associated with a collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementMilestonePaymentReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment(s) received for milestone payments associated with a collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementMilestonePaymentReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time that notice is required to be given for cancellation of the collaborative agreement contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementPotentialValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total potential value of the collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementPotentialValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of representatives in a joint steering committee by each party as per the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an entity&#8217;s right to consideration in exchange for goods or services that the entity has transferred to a customer, when that right is conditioned on something other than the passage of time (for example, the entity&#8217;s future performance).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 105<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 116<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_116_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current deferred income including current contract liabilities. [Refer: Deferred income including contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReceivablesFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an entity&#8217;s right to consideration in exchange for goods or services that the entity has transferred to a customer that is unconditional. A right to consideration is unconditional if only the passage of time is required before payment of that consideration is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 105<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 116<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_116_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReceivablesFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 114<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 120<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_120_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=aciu_TauMorphomerSmallMoleculeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementWithLillyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementWithLillyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PerformanceObligationsAxis=aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PerformanceObligationsAxis=aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PerformanceObligationsAxis=aciu_MilestonePaymentsCommercialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PerformanceObligationsAxis=aciu_MilestonePaymentsCommercialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PerformanceObligationsAxis=aciu_ResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PerformanceObligationsAxis=aciu_ResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PerformanceObligationsAxis=aciu_RightOfUseLicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PerformanceObligationsAxis=aciu_RightOfUseLicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementWithLillyFirstAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementWithLillyFirstAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=aciu_Quarter32019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=aciu_Quarter32019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=aciu_March312020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=aciu_March312020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementWithLillySecondAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementWithLillySecondAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824821895552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract revenues - Tau Vaccine in AD - 2014 Agreement with Janssen Pharmaceuticals (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>May 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Current trade receivables</a></td>
<td class="nump">SFr 14,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 14,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,801<span></span>
</td>
<td class="nump">SFr 3,935<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember', window );">2014 Agreement with Janssen Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 14,800<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauVaccineInADMember', window );">Tau Vaccine in AD [Member] | 2014 Agreement with Janssen Pharmaceuticals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod', window );">Period to provide notice of termination of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementMilestonePaymentReceived', window );">Milestone payment received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Current trade receivables</a></td>
<td class="nump">14,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 14,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="nump">14,800<span></span>
</td>
<td class="nump">SFr 4,900<span></span>
</td>
<td class="nump">SFr 25,900<span></span>
</td>
<td class="nump">14,800<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementUpfrontPaymentsReceived', window );">Collaborative agreement, upfront payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 25,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauVaccineInADMember', window );">Tau Vaccine in AD [Member] | 2014 Agreement with Janssen Pharmaceuticals [Member] | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementPotentialValue', window );">Total potential collaboration agreement value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations', window );">Total potential collaboration agreement value remaining</a></td>
<td class="nump">SFr 443,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 443,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementMilestonePaymentReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment(s) received for milestone payments associated with a collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementMilestonePaymentReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time that notice is required to be given for cancellation of the collaborative agreement contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementPotentialValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total potential value of the collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementPotentialValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementUpfrontPaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative agreement, upfront payments received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementUpfrontPaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 114<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 120<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_120_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=aciu_TauVaccineInADMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=aciu_TauVaccineInADMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824821068336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract revenues - Tau-PET imaging agent -2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) (Details)<br> &#8364; in Thousands, SFr in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2017 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Mar. 31, 2017 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>May 31, 2014 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>May 31, 2014 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 14,801<span></span>
</td>
<td class="nump">SFr 3,935<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember', window );">2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">3,935<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauPETImagingAgentMember', window );">Tau-PET Imaging Agent [Member] | 2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod', window );">Period to provide notice of termination of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="nump">SFr 664<span></span>
</td>
<td class="nump">&#8364; 500<span></span>
</td>
<td class="nump">SFr 3,900<span></span>
</td>
<td class="nump">&#8364; 4,000<span></span>
</td>
<td class="nump">SFr 2,200<span></span>
</td>
<td class="nump">&#8364; 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="nump">SFr 3,900<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementMilestonePaymentReceived', window );">Collaborative agreement, Milestone payment received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 1,100<span></span>
</td>
<td class="nump">&#8364; 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauPETImagingAgentMember', window );">Tau-PET Imaging Agent [Member] | 2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) [Member] | Clinical milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations', window );">Total potential collaboration agreement value remaining</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauPETImagingAgentMember', window );">Tau-PET Imaging Agent [Member] | 2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) [Member] | Regulatory and sales-based milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations', window );">Total potential collaboration agreement value remaining</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 139,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 148,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=aciu_TauPETImagingAgentMember', window );">Tau-PET Imaging Agent [Member] | 2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) [Member] | Top of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementPotentialValue', window );">Total potential collaboration agreement value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 151,000<span></span>
</td>
<td class="nump">&#8364; 160,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementMilestonePaymentReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment(s) received for milestone payments associated with a collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementMilestonePaymentReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time that notice is required to be given for cancellation of the collaborative agreement contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementPotentialValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total potential value of the collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementPotentialValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 114<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 120<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_120_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=aciu_TauPETImagingAgentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=aciu_TauPETImagingAgentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PerformanceObligationsAxis=aciu_ClinicalMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PerformanceObligationsAxis=aciu_ClinicalMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PerformanceObligationsAxis=aciu_RegulatoryAndSalesBasedMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PerformanceObligationsAxis=aciu_RegulatoryAndSalesBasedMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824819325568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contract revenues - Grants from the Michael J. Fox Foundation (Details)<br> SFr in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 28, 2023 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Feb. 28, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr) </div>
<div>item</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 14,801<span></span>
</td>
<td class="nump">SFr 3,935<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Income from grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,486<span></span>
</td>
<td class="nump">1,343<span></span>
</td>
<td class="nump">1,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets', window );">Accrued income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246<span></span>
</td>
<td class="nump">408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities', window );">Deferred income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="nump">587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_GrantRevenueMember', window );">Grant revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Income from grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 1,200<span></span>
</td>
<td class="nump">SFr 1,200<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_GrantsMichaelJFoxFoundationMember', window );">Grant from Michael J. Fox Foundation | Alpha-synuclein PET imaging diagnostic agent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FollowOnGrantFundingReceivedTotalForJointArrangement', window );">Follow-on grant funding received, total for joint arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 500<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FollowOnGrantFundingReceived', window );">Follow-on grant funding received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementPotentialValue', window );">Total potential collaboration agreement value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 3,000<span></span>
</td>
<td class="nump">$ 3.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomers', window );">Eligible grant amount receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_AdditionalGrantAwarded', window );">Additional grant awarded</a></td>
<td class="nump">SFr 400<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_GrantsMichaelJFoxFoundationMember', window );">Grant from Michael J. Fox Foundation | Alpha-synuclein PET imaging diagnostic agent | Skane University Hospital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FollowOnGrantFundingReceived', window );">Follow-on grant funding received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 100<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomers', window );">Eligible grant amount receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 700<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_GrantsMichaelJFoxFoundationMember', window );">Grant from Michael J. Fox Foundation | Alpha-synuclein PET imaging diagnostic agent | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementJointResearchCollaborationPeriod', window );">Period of joint research agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_GrantsMichaelJFoxFoundationMember', window );">Grant from Michael J. Fox Foundation | Advance small molecule PD programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfGrants', window );">Number of grants received | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborativeAgreementPotentialValue', window );">Total potential collaboration agreement value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 1,400<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_GrantsMichaelJFoxFoundationMember', window );">Grant from Michael J. Fox Foundation | Skane University Hospital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Contract revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomers', window );">Eligible grant amount receivable | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_AdditionalGrantAwarded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional grant awarded</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_AdditionalGrantAwarded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementJointResearchCollaborationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period over which collaborating entities are contracted to perform research, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementJointResearchCollaborationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborativeAgreementPotentialValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total potential value of the collaborative agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborativeAgreementPotentialValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_FollowOnGrantFundingReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Follow-on grant funding received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_FollowOnGrantFundingReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_FollowOnGrantFundingReceivedTotalForJointArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Follow-on grant funding received, total for joint arrangement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_FollowOnGrantFundingReceivedTotalForJointArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current accrued income including current contract assets. [Refer: Accrued income including contract assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current deferred income including current contract liabilities. [Refer: Deferred income including contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherOperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income (expense) that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherOperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReceivablesFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an entity&#8217;s right to consideration in exchange for goods or services that the entity has transferred to a customer that is unconditional. A right to consideration is unconditional if only the passage of time is required before payment of that consideration is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 105<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 116<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_116_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReceivablesFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 114<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2023-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_GrantRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_GrantRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_GrantsMichaelJFoxFoundationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_GrantsMichaelJFoxFoundationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=aciu_AlphaSynucleinPetImagingDiagnosticAgentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=aciu_AlphaSynucleinPetImagingDiagnosticAgentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=aciu_SkaneUniversityHospitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=aciu_SkaneUniversityHospitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=aciu_AdvanceSmallMoleculePdProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=aciu_AdvanceSmallMoleculePdProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=aciu_SkaneUniversityHospitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=aciu_SkaneUniversityHospitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824822196976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Expenses by category (Details)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CHF (SFr) </div>
<div>employee</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr) </div>
<div>employee</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr) </div>
<div>employee</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OperatingExpense', window );">Operating expenses</a></td>
<td class="nump">SFr 68,425<span></span>
</td>
<td class="nump">SFr 74,782<span></span>
</td>
<td class="nump">SFr 79,010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">54,606<span></span>
</td>
<td class="nump">60,336<span></span>
</td>
<td class="nump">62,282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">15,305<span></span>
</td>
<td class="nump">15,789<span></span>
</td>
<td class="nump">17,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DecreaseInResearchAndDevelopmentExpenseThroughReductionsInVariousCostCenters', window );">Decrease in research and development expense through reductions in various cost centers</a></td>
<td class="nump">5,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseInResearchAndDevelopmentExpenseThroughIncreaseInSalariesAndRelatedCosts', window );">Increase in research and development expense through increase in salaries and related costs</a></td>
<td class="nump">2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DecreaseInGeneralAndAdministrativeExpenseThroughReductionsInVariousCostCenters', window );">Decrease in general and administrative expense through reductions in various cost centers</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseInGeneralAndAdministrativeExpenseThroughIncreaseInShareBasedCompensationExpense', window );">Increase in general and administrative expense through increase in share-based compensation expense</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialResultNetAbstract', window );"><strong>Financial result, net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Financial income</a></td>
<td class="nump">1,044<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">6,485<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Financial expense</a></td>
<td class="num">(176)<span></span>
</td>
<td class="num">(355)<span></span>
</td>
<td class="num">(581)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Exchange differences</a></td>
<td class="num">(1,467)<span></span>
</td>
<td class="nump">393<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncomeCost', window );">Finance result, net</a></td>
<td class="num">(599)<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="nump">6,017<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=aciu_ResearchAndDevelopmentExpensesMember', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OperatingExpense', window );">Operating expenses</a></td>
<td class="nump">33,198<span></span>
</td>
<td class="nump">41,166<span></span>
</td>
<td class="nump">44,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation', window );">Payroll expenses</a></td>
<td class="nump">19,499<span></span>
</td>
<td class="nump">17,548<span></span>
</td>
<td class="nump">16,465<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Share-based compensation</a></td>
<td class="nump">1,909<span></span>
</td>
<td class="nump">1,622<span></span>
</td>
<td class="nump">1,528<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseByNature', window );">Total expenses by category</a></td>
<td class="nump">SFr 54,606<span></span>
</td>
<td class="nump">SFr 60,336<span></span>
</td>
<td class="nump">SFr 62,282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AverageNumberOfEmployees', window );">Average number of employees | employee</a></td>
<td class="nump">115.4<span></span>
</td>
<td class="nump">122.4<span></span>
</td>
<td class="nump">108.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=ifrs-full_SellingGeneralAndAdministrativeExpenseMember', window );">General and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OperatingExpense', window );">Operating expenses</a></td>
<td class="nump">SFr 4,729<span></span>
</td>
<td class="nump">SFr 6,207<span></span>
</td>
<td class="nump">SFr 7,031<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation', window );">Payroll expenses</a></td>
<td class="nump">7,755<span></span>
</td>
<td class="nump">7,874<span></span>
</td>
<td class="nump">8,281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Share-based compensation</a></td>
<td class="nump">2,821<span></span>
</td>
<td class="nump">1,708<span></span>
</td>
<td class="nump">2,598<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseByNature', window );">Total expenses by category</a></td>
<td class="nump">SFr 15,305<span></span>
</td>
<td class="nump">SFr 15,789<span></span>
</td>
<td class="nump">SFr 17,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AverageNumberOfEmployees', window );">Average number of employees | employee</a></td>
<td class="nump">26.2<span></span>
</td>
<td class="nump">22.5<span></span>
</td>
<td class="nump">27.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DecreaseInGeneralAndAdministrativeExpenseThroughReductionsInVariousCostCenters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in general and administrative expense through reductions in various cost centers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DecreaseInGeneralAndAdministrativeExpenseThroughReductionsInVariousCostCenters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DecreaseInResearchAndDevelopmentExpenseThroughReductionsInVariousCostCenters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in research and development expense through reductions in various cost centers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DecreaseInResearchAndDevelopmentExpenseThroughReductionsInVariousCostCenters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee benefits expense excluding share-based compensation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_FinancialResultNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_FinancialResultNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseInGeneralAndAdministrativeExpenseThroughIncreaseInShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase in general and administrative expense through increase in share-based compensation expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseInGeneralAndAdministrativeExpenseThroughIncreaseInShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseInResearchAndDevelopmentExpenseThroughIncreaseInSalariesAndRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase in research and development expense through increase in salaries and related costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseInResearchAndDevelopmentExpenseThroughIncreaseInSalariesAndRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AverageNumberOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of personnel employed by the entity during a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AverageNumberOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseByNature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseByNature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 51<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_51_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income or cost associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2023-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all operating expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 126<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=aciu_ResearchAndDevelopmentExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=aciu_ResearchAndDevelopmentExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=ifrs-full_SellingGeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=ifrs-full_SellingGeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824826122144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related-party transactions (Details)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CHF (SFr) </div>
<div>person</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr) </div>
<div>person</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr) </div>
<div>person</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Related-party transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfPersonsKeyManagementBoardOfDirectors', window );">Number of individuals, Board of Directors | person</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfPersonsKeyManagementExecutiveManagement', window );">Number of individuals, Executive Management | person</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Short-term employee benefits</a></td>
<td class="nump">SFr 4,661<span></span>
</td>
<td class="nump">SFr 4,187<span></span>
</td>
<td class="nump">SFr 4,403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits', window );">Post-employment benefits</a></td>
<td class="nump">446<span></span>
</td>
<td class="nump">295<span></span>
</td>
<td class="nump">266<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Share-based compensation</a></td>
<td class="nump">3,251<span></span>
</td>
<td class="nump">2,503<span></span>
</td>
<td class="nump">2,997<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Total compensation</a></td>
<td class="nump">SFr 8,358<span></span>
</td>
<td class="nump">SFr 6,985<span></span>
</td>
<td class="nump">SFr 7,666<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfPersonsKeyManagementBoardOfDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of persons that are the included in Board of Directors excluding the Chief Executive Officer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfPersonsKeyManagementBoardOfDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfPersonsKeyManagementExecutiveManagement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of persons that comprise key management of the entity that are Executive Management.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfPersonsKeyManagementExecutiveManagement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of post-employment benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824822341872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes - Summary of Income Tax Expense (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax expense</a></td>
<td class="num">SFr (10)<span></span>
</td>
<td class="num">SFr (13)<span></span>
</td>
<td class="num">SFr (3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Applicable tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.60%<span></span>
</td>
<td class="nump">13.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract', window );"><strong>Income tax expense reconciled to Income / (loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AccountingProfit', window );">Loss before income tax</a></td>
<td class="num">(54,223)<span></span>
</td>
<td class="num">SFr (70,740)<span></span>
</td>
<td class="num">SFr (72,993)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate', window );">Tax benefit calculated at the domestic rates applicable in the respective countries</a></td>
<td class="num">(7,371)<span></span>
</td>
<td class="num">(9,616)<span></span>
</td>
<td class="num">(9,930)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes', window );">(Income not subject to tax)/expenses not deductible for tax purposes</a></td>
<td class="nump">611<span></span>
</td>
<td class="nump">455<span></span>
</td>
<td class="num">(375)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxEffectOfTaxLosses', window );">Effect of unused tax losses and tax offsets not recognized as deferred tax assets</a></td>
<td class="nump">6,770<span></span>
</td>
<td class="nump">9,174<span></span>
</td>
<td class="nump">10,308<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Effective income tax rate (benefit)/expense</a></td>
<td class="nump">SFr 10<span></span>
</td>
<td class="nump">SFr 13<span></span>
</td>
<td class="nump">SFr 3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_CH', window );">SWITZERLAND</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Applicable tax rate</a></td>
<td class="nump">13.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Applicable tax rate</a></td>
<td class="nump">13.60%<span></span>
</td>
<td class="nump">13.60%<span></span>
</td>
<td class="nump">13.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_WeightedAverageMember', window );">Weighted average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Applicable tax rate</a></td>
<td class="nump">13.60%<span></span>
</td>
<td class="nump">13.60%<span></span>
</td>
<td class="nump">13.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax expense</a></td>
<td class="num">SFr (100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Applicable tax rate</a></td>
<td class="nump">33.80%<span></span>
</td>
<td class="nump">33.80%<span></span>
</td>
<td class="nump">32.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract', window );"><strong>Income tax expense reconciled to Income / (loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Effective income tax rate (benefit)/expense</a></td>
<td class="nump">SFr 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax effect of income not subject to tax and expenses not deductible for tax purposes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AccountingProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AccountingProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2023-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfTaxLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfTaxLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxExpenseIncomeAtApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824821001808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes, Unrecognized Deductible Temporary Differences, Unused Tax Losses and Unused Tax Credits (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract', window );"><strong>Unrecognized deductible temporary differences, unused tax losses and unused tax credits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised', window );">Deductible temporary differences for which no deferred tax asset is recognised</a></td>
<td class="nump">SFr 318,742<span></span>
</td>
<td class="nump">SFr 267,302<span></span>
</td>
<td class="nump">SFr 204,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TaxLossesSplitByExpiryDateAbstract', window );"><strong>Tax losses split by expiry date [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised', window );">Unrecorded tax loss carryforwards</a></td>
<td class="nump">312,972<span></span>
</td>
<td class="nump">264,089<span></span>
</td>
<td class="nump">197,153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits', window );">Increase (decrease) in tax losses available for offset against future taxable profits</a></td>
<td class="nump">48,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=aciu_December312024Member', window );">December 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TaxLossesSplitByExpiryDateAbstract', window );"><strong>Tax losses split by expiry date [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised', window );">Unrecorded tax loss carryforwards</a></td>
<td class="nump">15,231<span></span>
</td>
<td class="nump">15,231<span></span>
</td>
<td class="nump">15,231<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=aciu_December312025Member', window );">December 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TaxLossesSplitByExpiryDateAbstract', window );"><strong>Tax losses split by expiry date [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised', window );">Unrecorded tax loss carryforwards</a></td>
<td class="nump">48,894<span></span>
</td>
<td class="nump">48,894<span></span>
</td>
<td class="nump">48,894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=aciu_December312026Member', window );">December 31, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TaxLossesSplitByExpiryDateAbstract', window );"><strong>Tax losses split by expiry date [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised', window );">Unrecorded tax loss carryforwards</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=aciu_December312027Member', window );">December 31, 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TaxLossesSplitByExpiryDateAbstract', window );"><strong>Tax losses split by expiry date [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised', window );">Unrecorded tax loss carryforwards</a></td>
<td class="nump">57,824<span></span>
</td>
<td class="nump">57,824<span></span>
</td>
<td class="nump">57,824<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=aciu_December312028Member', window );">December 31, 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TaxLossesSplitByExpiryDateAbstract', window );"><strong>Tax losses split by expiry date [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised', window );">Unrecorded tax loss carryforwards</a></td>
<td class="nump">75,204<span></span>
</td>
<td class="nump">75,204<span></span>
</td>
<td class="nump">75,204<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=aciu_December312029Member', window );">December 31, 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TaxLossesSplitByExpiryDateAbstract', window );"><strong>Tax losses split by expiry date [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised', window );">Unrecorded tax loss carryforwards</a></td>
<td class="nump">66,936<span></span>
</td>
<td class="nump">66,936<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=aciu_December312030Member', window );">December 31, 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_TaxLossesSplitByExpiryDateAbstract', window );"><strong>Tax losses split by expiry date [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised', window );">Unrecorded tax loss carryforwards</a></td>
<td class="nump">48,883<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember', window );">Tax Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract', window );"><strong>Unrecognized deductible temporary differences, unused tax losses and unused tax credits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised', window );">Deductible temporary differences for which no deferred tax asset is recognised</a></td>
<td class="nump">312,972<span></span>
</td>
<td class="nump">264,089<span></span>
</td>
<td class="nump">197,152<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember', window );">Right of use assets and lease liabilities, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract', window );"><strong>Unrecognized deductible temporary differences, unused tax losses and unused tax credits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised', window );">Deductible temporary differences for which no deferred tax asset is recognised</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=aciu_RetirementBenefitPlanMember', window );">Retirement benefit plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract', window );"><strong>Unrecognized deductible temporary differences, unused tax losses and unused tax credits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised', window );">Deductible temporary differences for which no deferred tax asset is recognised</a></td>
<td class="nump">SFr 5,770<span></span>
</td>
<td class="nump">SFr 3,213<span></span>
</td>
<td class="nump">SFr 7,098<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in tax losses available for offset against future taxable profits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_TaxLossesSplitByExpiryDateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_TaxLossesSplitByExpiryDateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deductible temporary differences for which no deferred tax asset is recognised in the statement of financial position. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of unused tax losses for which no deferred tax asset is recognised in the statement of financial position. [Refer: Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=aciu_December312024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=aciu_December312024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=aciu_December312025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=aciu_December312025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=aciu_December312026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=aciu_December312026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=aciu_December312027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=aciu_December312027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=aciu_December312028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=aciu_December312028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=aciu_December312029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=aciu_December312029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=aciu_December312030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=aciu_December312030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=aciu_RetirementBenefitPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=aciu_RetirementBenefitPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824825905712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement benefit plan - Summary of Benefit Plan (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract', window );"><strong>Retirement benefit plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees', window );">Defined benefit plans, percentage of contributions by employees</a></td>
<td class="nump">47.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer', window );">Defined benefit plans, percentage of contributions by employer</a></td>
<td class="nump">53.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SurplusDeficitInPlanAbstract', window );"><strong>Defined benefit pension plan amount recognized in balance sheet [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation</a></td>
<td class="num">SFr (41,060)<span></span>
</td>
<td class="num">SFr (32,410)<span></span>
</td>
<td class="num">SFr (33,889)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Fair value of plan assets</a></td>
<td class="nump">35,290<span></span>
</td>
<td class="nump">29,197<span></span>
</td>
<td class="nump">26,791<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SurplusDeficitInPlan', window );">Total liability</a></td>
<td class="num">SFr (5,770)<span></span>
</td>
<td class="num">SFr (3,213)<span></span>
</td>
<td class="num">SFr (7,098)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined benefit plans, percentage of contributions by employees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined benefit plans, percentage of contributions by employer</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitObligationAtPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitObligationAtPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PlanAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of defined benefit plan assets. Plan assets comprise assets held by a long-term employee benefit fund and qualifying insurance policies. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PlanAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SurplusDeficitInPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of any plan assets, less the present value of the defined benefit obligation. [Refer: Plan assets [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SurplusDeficitInPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SurplusDeficitInPlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SurplusDeficitInPlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824825495648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement benefit plan - Amounts recorded in consolidated statements of income (loss) (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract', window );"><strong>Retirement benefit plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentServiceCostDefinedBenefitPlans', window );">Current service cost</a></td>
<td class="nump">SFr 1,453<span></span>
</td>
<td class="nump">SFr 1,712<span></span>
</td>
<td class="nump">SFr 1,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseDefinedBenefitPlans', window );">Interest cost</a></td>
<td class="nump">804<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PastServiceCostDefinedBenefitPlans', window );">Past service cost</a></td>
<td class="nump">903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestIncomeDefinedBenefitPlans', window );">Interest income</a></td>
<td class="num">(705)<span></span>
</td>
<td class="num">(87)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans', window );">Net pension cost</a></td>
<td class="nump">SFr 2,455<span></span>
</td>
<td class="nump">SFr 1,751<span></span>
</td>
<td class="nump">SFr 1,679<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentServiceCostDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expense of employee service in the current period arising from defined benefit plans. [Refer: Post-employment benefit expense in profit or loss, defined benefit plans] [Contrast: Increase in net defined benefit liability (asset) resulting from current service cost]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentServiceCostDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense arising from defined benefit plans. [Refer: Interest expense; Post-employment benefit expense in profit or loss, defined benefit plans] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestIncomeDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income arising from defined benefit plans. [Refer: Interest income; Post-employment benefit expense in profit or loss, defined benefit plans] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestIncomeDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastServiceCostDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense (income) resulting from past service cost. Past service cost is the change in the present value of the defined benefit obligation for employee service in prior periods, resulting from a plan amendment (the introduction or withdrawal of, or changes to, a defined benefit plan) or a curtailment (a significant reduction by the entity in the number of employees covered by a plan). [Refer: Post-employment benefit expense in profit or loss, defined benefit plans; Defined benefit plans [member]] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from past service cost]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastServiceCostDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of post-employment benefit expense included in profit or loss relating to defined benefit plans. [Refer: Profit (loss); Defined benefit plans [member]] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from expense (income) in profit or loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 5<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_5&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824822346464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement benefit plan - Changes in Defined Benefit Obligation (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract', window );"><strong>Changes in defined benefit obligation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">At beginning of period</a></td>
<td class="num">SFr (3,213)<span></span>
</td>
<td class="num">SFr (7,098)<span></span>
</td>
<td class="num">SFr (7,464)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">At end of period</a></td>
<td class="num">(5,770)<span></span>
</td>
<td class="num">(3,213)<span></span>
</td>
<td class="num">(7,098)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PresentValueOfDefinedBenefitObligationMember', window );">Defined Benefit Obligation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract', window );"><strong>Changes in defined benefit obligation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">At beginning of period</a></td>
<td class="num">(32,410)<span></span>
</td>
<td class="num">(33,889)<span></span>
</td>
<td class="num">(30,213)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset', window );">Current service cost</a></td>
<td class="num">(1,453)<span></span>
</td>
<td class="num">(1,712)<span></span>
</td>
<td class="num">(1,648)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset', window );">Past service cost</a></td>
<td class="num">(903)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset', window );">Interest cost</a></td>
<td class="num">(804)<span></span>
</td>
<td class="num">(126)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset', window );">Change in demographic assumptions</a></td>
<td class="nump">136<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset', window );">Change in financial assumptions</a></td>
<td class="num">(2,908)<span></span>
</td>
<td class="nump">8,397<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset', window );">Change in experience assumptions</a></td>
<td class="num">(57)<span></span>
</td>
<td class="num">(1,726)<span></span>
</td>
<td class="num">(252)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited', window );">Benefits deposited</a></td>
<td class="num">(1,265)<span></span>
</td>
<td class="num">(2,327)<span></span>
</td>
<td class="num">(894)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset', window );">Employees' contributions</a></td>
<td class="num">(1,396)<span></span>
</td>
<td class="num">(1,056)<span></span>
</td>
<td class="num">(959)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">At end of period</a></td>
<td class="num">SFr (41,060)<span></span>
</td>
<td class="num">SFr (32,410)<span></span>
</td>
<td class="num">SFr (33,889)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in net defined benefit liability (asset) resulting from benefits deposited</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in demographic assumptions that result in remeasurements of the net defined benefit liability (asset). Demographic assumptions deal with matters such as: (a) mortality; (b) rates of employee turnover, disability and early retirement; (c) the proportion of plan members with dependants who will be eligible for benefits; (d) the proportion of plan members who will select each form of payment option available under the plan terms; and (e) claim rates under medical plans. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_141_c_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions that result in remeasurements of the net defined benefit liability (asset). Financial assumptions deal with items such as: (a) the discount rate; (b) benefit levels, excluding any cost of the benefits to be met by employees, and future salary; (c) in the case of medical benefits, future medical costs, including claim handling costs (ie the costs that will be incurred in processing and resolving claims, including legal and adjuster's fees); and (d) taxes payable by the plan on contributions relating to service before the reporting date or on benefits resulting from that service. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_141_c_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from experience adjustments that result in remeasurements of the net defined benefit liability (asset). Experience adjustments deal with the effects of differences between the previous actuarial assumptions and what has actually occurred. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_141_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in the net defined benefit liability (asset) resulting from contributions to a defined benefit plan by plan participants. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 141<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_141_f&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from employee service in the current period. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 141<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_141_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from the passage of time. [Refer: Interest expense; Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 141<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_141_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 140<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_140_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilityAssetOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from past service cost. Past service cost is the change in the present value of the defined benefit obligation for employee service in prior periods, resulting from a plan amendment (the introduction or withdrawal of, or changes to, a defined benefit plan) or a curtailment (a significant reduction by the entity in the number of employees covered by a plan). [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 141<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_141_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PresentValueOfDefinedBenefitObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PresentValueOfDefinedBenefitObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824821320416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement benefit plan - Changes in Fair Value of Plan Assets (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ChangesInFairValueOfPlanAssetsAbstract', window );"><strong>Changes in fair value of plan assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">At beginning of period</a></td>
<td class="num">SFr (3,213)<span></span>
</td>
<td class="num">SFr (7,098)<span></span>
</td>
<td class="num">SFr (7,464)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset', window );">Employer's contributions</a></td>
<td class="nump">1,567<span></span>
</td>
<td class="nump">1,210<span></span>
</td>
<td class="nump">1,089<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">At end of period</a></td>
<td class="num">(5,770)<span></span>
</td>
<td class="num">(3,213)<span></span>
</td>
<td class="num">(7,098)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan', window );">Expected contributions by the employer to be paid to the post-employment benefit plans during the annual period beginning after the end of the reporting period</a></td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PlanAssetsMember', window );">Fair Value of Plan Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ChangesInFairValueOfPlanAssetsAbstract', window );"><strong>Changes in fair value of plan assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">At beginning of period</a></td>
<td class="nump">29,197<span></span>
</td>
<td class="nump">26,791<span></span>
</td>
<td class="nump">22,749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset', window );">Interest income</a></td>
<td class="nump">705<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset', window );">Employees' contributions</a></td>
<td class="nump">1,396<span></span>
</td>
<td class="nump">1,056<span></span>
</td>
<td class="nump">959<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset', window );">Employer's contributions</a></td>
<td class="nump">1,567<span></span>
</td>
<td class="nump">1,210<span></span>
</td>
<td class="nump">1,089<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited', window );">Benefits deposited</a></td>
<td class="nump">1,265<span></span>
</td>
<td class="nump">2,327<span></span>
</td>
<td class="nump">894<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset', window );">Return on plan assets excluding interest income</a></td>
<td class="nump">1,160<span></span>
</td>
<td class="num">(2,274)<span></span>
</td>
<td class="nump">1,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">At end of period</a></td>
<td class="nump">SFr 35,290<span></span>
</td>
<td class="nump">SFr 29,197<span></span>
</td>
<td class="nump">SFr 26,791<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ChangesInFairValueOfPlanAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ChangesInFairValueOfPlanAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in net defined benefit liability (asset) resulting from benefits deposited</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in net defined benefit liability (asset) resulting from contributions to a defined benefit plan by the employer. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 141<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_141_f&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in the net defined benefit liability (asset) resulting from contributions to a defined benefit plan by plan participants. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 141<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_141_f&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimate of the expected contributions to be made to a defined benefit plan for the next annual reporting period. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 147<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_147_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 148<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_148_d_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from the passage of time. [Refer: Interest expense; Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 141<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_141_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 140<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_140_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilityAssetOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in the net defined benefit liability (asset) resulting from the return on plan assets, excluding amounts included in interest income or expense. The return on plan assets is interest, dividends and other revenue derived from the plan assets, together with realised and unrealised gains or losses on the plan assets, less any costs of managing plan assets and less any tax payable by the plan itself, other than tax included in the actuarial assumptions used to measure the present value of the defined benefit obligation. [Refer: Plan assets [member]; Net defined benefit liability (asset); Actuarial assumptions [member]; Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_141_c_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PlanAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PlanAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824821891632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement benefit plan - Change in Net Defined Benefit Liability (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract', window );"><strong>Change in net defined benefit liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net defined benefit liabilities, beginning of period</a></td>
<td class="nump">SFr 3,213<span></span>
</td>
<td class="nump">SFr 7,098<span></span>
</td>
<td class="nump">SFr 7,464<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss', window );">Net pension cost through statement of income/(loss)</a></td>
<td class="nump">2,455<span></span>
</td>
<td class="nump">1,751<span></span>
</td>
<td class="nump">1,679<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Remeasurement through other comprehensive income/(loss)</a></td>
<td class="nump">1,669<span></span>
</td>
<td class="num">(4,426)<span></span>
</td>
<td class="num">(956)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset', window );">Employer's contribution</a></td>
<td class="num">(1,567)<span></span>
</td>
<td class="num">(1,210)<span></span>
</td>
<td class="num">(1,089)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net defined benefit liabilities, end of period</a></td>
<td class="nump">SFr 5,770<span></span>
</td>
<td class="nump">SFr 3,213<span></span>
</td>
<td class="nump">SFr 7,098<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in net defined benefit liability (asset) resulting from contributions to a defined benefit plan by the employer. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 141<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_141_f&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from the remeasurement of that net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_141_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from expense (income) included in profit or loss. [Refer: Net defined benefit liability (asset); Profit (loss)] [Contrast: Post-employment benefit expense in profit or loss, defined benefit plans]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 141<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_141&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 140<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_140_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilityAssetOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824825396000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement benefit plan - Change in other comprehensive gains (losses) (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OtherComprehensiveGainsLossesAbstract', window );"><strong>Other comprehensive gains/(losses) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans', window );">Effect of changes in demographic assumptions</a></td>
<td class="nump">SFr 136<span></span>
</td>
<td class="nump">SFr 29<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans', window );">Effect of changes in financial assumptions</a></td>
<td class="num">(2,908)<span></span>
</td>
<td class="nump">8,397<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans', window );">Effect of changes in experience assumptions</a></td>
<td class="num">(57)<span></span>
</td>
<td class="num">(1,726)<span></span>
</td>
<td class="num">(252)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans', window );">Return on plan assets excluding interest income</a></td>
<td class="nump">1,160<span></span>
</td>
<td class="num">(2,274)<span></span>
</td>
<td class="nump">1,052<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans', window );">Total other comprehensive gain</a></td>
<td class="num">SFr (1,669)<span></span>
</td>
<td class="nump">SFr 4,426<span></span>
</td>
<td class="nump">SFr 956<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019', window );">Weighted average duration period for defined benefit obligation</a></td>
<td class="text">15 years 6 months<span></span>
</td>
<td class="text">14 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_OtherComprehensiveGainsLossesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_OtherComprehensiveGainsLossesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, resulting from actuarial gains (losses) arising from changes in demographic assumptions that result in remeasurements of the net defined benefit liability (asset). Demographic assumptions deal with matters such as: (a) mortality; (b) rates of employee turnover, disability and early retirement; (c) the proportion of plan members with dependants who will be eligible for benefits; (d) the proportion of plan members who will select each form of payment option available under the plan terms; and (e) claim rates under medical plans. [Refer: Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in demographic assumptions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, resulting from actuarial gains (losses) arising from changes in financial assumptions that result in remeasurements of the net defined benefit liability (asset). Financial assumptions deal with items such as: (a) the discount rate; (b) benefit levels, excluding any cost of the benefits to be met by employees, and future salary; (c) in the case of medical benefits, future medical costs, including claim handling costs (ie the costs that will be incurred in processing and resolving claims, including legal and adjuster's fees); and (d) taxes payable by the plan on contributions relating to service before the reporting date or on benefits resulting from that service. [Refer: Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, resulting from actuarial gains (losses) arising from experience adjustments that result in remeasurements of the net defined benefit liability (asset). Experience adjustments deal with the effects of differences between the previous actuarial assumptions and what has actually occurred. [Refer: Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from experience adjustments]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [member]; Plan assets [member]; Net defined benefit liability (asset)] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, resulting from the return on plan assets, excluding amounts included in interest expense (income) arising from defined benefit plans. The return on plan assets is interest, dividends and other revenue derived from the plan assets, together with realised and unrealised gains or losses on the plan assets, less any costs of managing plan assets and less any tax payable by the plan itself, other than tax included in the actuarial assumptions used to measure the present value of the defined benefit obligation. [Refer: Other comprehensive income; Defined benefit plans [member]; Plan assets [member]; Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from return on plan assets excluding interest income or expense]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average duration of a defined benefit obligation. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 147<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_147_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824820823056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Retirement benefit plan - Actuarial Assumptions and Sensitivity Analysis (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract', window );"><strong>Actuarial assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfDiscountRates', window );">Discount rate</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases', window );">Rate of future increase in compensations</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases', window );">Rate of future increase in current pensions</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital', window );">Interest rate on retirement savings capital</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SensitivityAnalysisActuarialAssumptionsAbstract', window );"><strong>Sensitivity analysis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Potential defined benefit obligation</a></td>
<td class="nump">SFr 41,060<span></span>
</td>
<td class="nump">SFr 32,410<span></span>
</td>
<td class="nump">SFr 33,889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember', window );">+0.5% Increase [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SensitivityAnalysisActuarialAssumptionsAbstract', window );"><strong>Sensitivity analysis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption', window );">Percentage increase in actuarial assumption</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember', window );">-0.5% Decrease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SensitivityAnalysisActuarialAssumptionsAbstract', window );"><strong>Sensitivity analysis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption', window );">Percentage decrease in actuarial assumption</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfDiscountRatesMember', window );">Discount rate | +0.5% Increase [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SensitivityAnalysisActuarialAssumptionsAbstract', window );"><strong>Sensitivity analysis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption', window );">Percentage increase in actuarial assumption</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Potential defined benefit obligation</a></td>
<td class="nump">SFr 38,132<span></span>
</td>
<td class="nump">SFr 30,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Decrease/(increase) from actual defined benefit obligation</a></td>
<td class="nump">SFr 2,928<span></span>
</td>
<td class="nump">SFr 2,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfDiscountRatesMember', window );">Discount rate | -0.5% Decrease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SensitivityAnalysisActuarialAssumptionsAbstract', window );"><strong>Sensitivity analysis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption', window );">Percentage decrease in actuarial assumption</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Potential defined benefit obligation</a></td>
<td class="nump">SFr 44,390<span></span>
</td>
<td class="nump">SFr 34,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption', window );">Decrease/(increase) from actual defined benefit obligation</a></td>
<td class="num">SFr (3,330)<span></span>
</td>
<td class="num">SFr (2,506)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember', window );">Future salary increase | +0.5% Increase [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SensitivityAnalysisActuarialAssumptionsAbstract', window );"><strong>Sensitivity analysis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption', window );">Percentage increase in actuarial assumption</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Potential defined benefit obligation</a></td>
<td class="nump">SFr 41,997<span></span>
</td>
<td class="nump">SFr 32,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Decrease/(increase) from actual defined benefit obligation</a></td>
<td class="num">SFr (937)<span></span>
</td>
<td class="num">SFr (530)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember', window );">Future salary increase | -0.5% Decrease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SensitivityAnalysisActuarialAssumptionsAbstract', window );"><strong>Sensitivity analysis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption', window );">Percentage decrease in actuarial assumption</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Potential defined benefit obligation</a></td>
<td class="nump">SFr 40,205<span></span>
</td>
<td class="nump">SFr 31,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption', window );">Decrease/(increase) from actual defined benefit obligation</a></td>
<td class="nump">SFr 855<span></span>
</td>
<td class="nump">SFr 569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember', window );">Future pension cost | +0.5% Increase [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SensitivityAnalysisActuarialAssumptionsAbstract', window );"><strong>Sensitivity analysis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption', window );">Percentage increase in actuarial assumption</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Potential defined benefit obligation</a></td>
<td class="nump">SFr 42,681<span></span>
</td>
<td class="nump">SFr 33,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Decrease/(increase) from actual defined benefit obligation</a></td>
<td class="num">SFr (1,621)<span></span>
</td>
<td class="num">SFr (1,191)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember', window );">Future pension cost | -0.5% Decrease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SensitivityAnalysisActuarialAssumptionsAbstract', window );"><strong>Sensitivity analysis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption', window );">Percentage decrease in actuarial assumption</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Potential defined benefit obligation</a></td>
<td class="nump">SFr 39,578<span></span>
</td>
<td class="nump">SFr 31,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption', window );">Decrease/(increase) from actual defined benefit obligation</a></td>
<td class="nump">SFr 1,482<span></span>
</td>
<td class="nump">SFr 1,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember', window );">Interest rate on savings capital | +0.5% Increase [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SensitivityAnalysisActuarialAssumptionsAbstract', window );"><strong>Sensitivity analysis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption', window );">Percentage increase in actuarial assumption</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Potential defined benefit obligation</a></td>
<td class="nump">SFr 42,158<span></span>
</td>
<td class="nump">SFr 33,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Decrease/(increase) from actual defined benefit obligation</a></td>
<td class="num">SFr (1,098)<span></span>
</td>
<td class="num">SFr (912)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember', window );">Interest rate on savings capital | -0.5% Decrease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_SensitivityAnalysisActuarialAssumptionsAbstract', window );"><strong>Sensitivity analysis [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption', window );">Percentage decrease in actuarial assumption</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Potential defined benefit obligation</a></td>
<td class="nump">SFr 40,030<span></span>
</td>
<td class="nump">SFr 31,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption', window );">Decrease/(increase) from actual defined benefit obligation</a></td>
<td class="nump">SFr 1,030<span></span>
</td>
<td class="nump">SFr 865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected rate of interest rates on retirement savings capital is used as a significant actuarial assumption to determine the present value of a defined benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_SensitivityAnalysisActuarialAssumptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_SensitivityAnalysisActuarialAssumptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionOfDiscountRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 144<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_144&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionOfDiscountRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected rate of increases in pension that is used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 144<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_144&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected rate of salary increases used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 144<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_144&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitObligationAtPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitObligationAtPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in a defined benefit obligation that would have been caused by a decrease in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 145<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_145_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in a defined benefit obligation that would have been caused by an increase in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 145<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_145_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The reasonably possible percentage of the decrease in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 145<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_145_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The reasonably possible percentage of the increase in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 145<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_145_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfDiscountRatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfDiscountRatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824819326688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation, Plans Outstanding (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">86 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>Options </div>
<div>plan</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Options</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Options</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>Options</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPlansOutstandingAbstract', window );"><strong>Share-based plans outstanding [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfEquityBasedInstrumentPlans', window );">Number of Equity-based Instrument Plans | plan</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options awarded (in shares)</a></td>
<td class="nump">1,554,281<span></span>
</td>
<td class="nump">1,090,316<span></span>
</td>
<td class="nump">1,110,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_StockOptionPlanC1Member', window );">Share Option Plan C1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPlansOutstandingAbstract', window );"><strong>Share-based plans outstanding [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options awarded (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,775,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod', window );">Vesting conditions</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement', window );">Contractual life of options</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanMember', window );">2016 SOIP [Member] | Executives and Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPlansOutstandingAbstract', window );"><strong>Share-based plans outstanding [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options awarded (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,831,325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement', window );">Contractual life of options</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanMember', window );">2016 SOIP [Member] | Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPlansOutstandingAbstract', window );"><strong>Share-based plans outstanding [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options awarded (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,811,687<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod', window );">Vesting conditions</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement', window );">Contractual life of options</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember', window );">2016 SOIP, Vesting Condition 1 [Member] | Executives and Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPlansOutstandingAbstract', window );"><strong>Share-based plans outstanding [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod', window );">Vesting conditions</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember', window );">2016 SOIP, Vesting Condition 2 [Member] | Executives and Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPlansOutstandingAbstract', window );"><strong>Share-based plans outstanding [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod', window );">Vesting conditions</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember', window );">2016 SOIP, Vesting Condition 3 [Member] | Executives and Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPlansOutstandingAbstract', window );"><strong>Share-based plans outstanding [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod', window );">Vesting conditions</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum term of options granted for a type of share-based payment arrangement that existed at any time during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfEquityBasedInstrumentPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of equity-based instrument plans approved by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfEquityBasedInstrumentPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ShareBasedPlansOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ShareBasedPlansOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For vesting requirements for a type of share-based payment arrangement that existed at any time during the period, this element represents the period which an employees' right to exercise an award is no longer contingent on satisfaction of a service condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_StockOptionPlanC1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_StockOptionPlanC1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=aciu_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=aciu_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824821895584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation, Weighted Average Exercise Prices (Details)<br></strong></div></th>
<th class="th" colspan="7">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>Options </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>Options </div>
<div>SFr / shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Options </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Options </div>
<div>SFr / shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Options </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Options </div>
<div>$ / shares </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>Options </div>
<div>SFr / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfOptionsAbstract', window );"><strong>Number of options [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding at beginning of period (in shares)</a></td>
<td class="nump">4,261,017<span></span>
</td>
<td class="nump">4,261,017<span></span>
</td>
<td class="nump">3,585,689<span></span>
</td>
<td class="nump">3,585,689<span></span>
</td>
<td class="nump">2,900,667<span></span>
</td>
<td class="nump">2,900,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Forfeited during the year (in shares)</a></td>
<td class="num">(824,084)<span></span>
</td>
<td class="num">(824,084)<span></span>
</td>
<td class="num">(304,738)<span></span>
</td>
<td class="num">(304,738)<span></span>
</td>
<td class="num">(207,331)<span></span>
</td>
<td class="num">(207,331)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Exercised during the year (in shares)</a></td>
<td class="num">(42,037)<span></span>
</td>
<td class="num">(42,037)<span></span>
</td>
<td class="num">(110,250)<span></span>
</td>
<td class="num">(110,250)<span></span>
</td>
<td class="num">(218,561)<span></span>
</td>
<td class="num">(218,561)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Granted during the year (in shares)</a></td>
<td class="nump">1,554,281<span></span>
</td>
<td class="nump">1,554,281<span></span>
</td>
<td class="nump">1,090,316<span></span>
</td>
<td class="nump">1,090,316<span></span>
</td>
<td class="nump">1,110,914<span></span>
</td>
<td class="nump">1,110,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding at end of period (in shares)</a></td>
<td class="nump">4,949,177<span></span>
</td>
<td class="nump">4,949,177<span></span>
</td>
<td class="nump">4,261,017<span></span>
</td>
<td class="nump">4,261,017<span></span>
</td>
<td class="nump">3,585,689<span></span>
</td>
<td class="nump">3,585,689<span></span>
</td>
<td class="nump">2,900,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Exercisable (in shares)</a></td>
<td class="nump">3,022,345<span></span>
</td>
<td class="nump">3,022,345<span></span>
</td>
<td class="nump">2,345,648<span></span>
</td>
<td class="nump">2,345,648<span></span>
</td>
<td class="nump">1,613,242<span></span>
</td>
<td class="nump">1,613,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageExercisePriceAbstract', window );"><strong>Weighted average exercise price [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding at beginning of period (in CHF per share) | SFr / shares</a></td>
<td class="nump">SFr 5.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 6.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 5.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">Forfeited during the year (in CHF per share) | SFr / shares</a></td>
<td class="nump">5.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Exercised during the year (in CHF per share) | SFr / shares</a></td>
<td class="nump">1.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Granted during the year (in CHF per share) | (per share)</a></td>
<td class="nump">1.75<span></span>
</td>
<td class="nump">$ 2.08<span></span>
</td>
<td class="nump">3.18<span></span>
</td>
<td class="nump">$ 3.44<span></span>
</td>
<td class="nump">6.34<span></span>
</td>
<td class="nump">$ 6.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding at end of period (in CHF per share) | SFr / shares</a></td>
<td class="nump">4.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 5.90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercisable (in CHF per share) | SFr / shares</a></td>
<td class="nump">SFr 4.88<span></span>
</td>
<td class="nump">$ 4.88<span></span>
</td>
<td class="nump">SFr 6.41<span></span>
</td>
<td class="nump">$ 6.41<span></span>
</td>
<td class="nump">SFr 6.13<span></span>
</td>
<td class="nump">$ 6.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageRemainingAbstract', window );"><strong>Weighted average remaining term (years) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining term (years), options outstanding</a></td>
<td class="text">7 years 2 months 12 days<span></span>
</td>
<td class="text">7 years 2 months 12 days<span></span>
</td>
<td class="text">7 years 7 months 6 days<span></span>
</td>
<td class="text">7 years 7 months 6 days<span></span>
</td>
<td class="text">7 years 9 months 18 days<span></span>
</td>
<td class="text">7 years 9 months 18 days<span></span>
</td>
<td class="text">8 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable', window );">Weighted average remaining term (years), options exercisable</a></td>
<td class="text">6 years 4 months 24 days<span></span>
</td>
<td class="text">6 years 4 months 24 days<span></span>
</td>
<td class="text">6 years 7 months 6 days<span></span>
</td>
<td class="text">6 years 7 months 6 days<span></span>
</td>
<td class="text">6 years 9 months 18 days<span></span>
</td>
<td class="text">6 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfOptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfOptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WeightedAverageExercisePriceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WeightedAverageExercisePriceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WeightedAverageRemainingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WeightedAverageRemainingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual life of share options exercisable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824822405024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation, Outstanding Options, Range of Exercise prices and Expiration Dates (Details)<br></strong></div></th>
<th class="th" colspan="6">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>Options </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>Options </div>
<div>$ / shares </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Options </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Options </div>
<div>SFr / shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Options </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Options </div>
<div>$ / shares </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>Options </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>Options </div>
<div>SFr / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract', window );"><strong>Outstanding options, exercise price range and expiry dates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding Options (in shares)</a></td>
<td class="nump">4,949,177<span></span>
</td>
<td class="nump">4,949,177<span></span>
</td>
<td class="nump">4,261,017<span></span>
</td>
<td class="nump">4,261,017<span></span>
</td>
<td class="nump">3,585,689<span></span>
</td>
<td class="nump">3,585,689<span></span>
</td>
<td class="nump">4,949,177<span></span>
</td>
<td class="nump">2,900,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price for options granted (in CHF/USD per share) | (per share)</a></td>
<td class="nump">SFr 1.75<span></span>
</td>
<td class="nump">$ 2.08<span></span>
</td>
<td class="nump">SFr 3.18<span></span>
</td>
<td class="nump">$ 3.44<span></span>
</td>
<td class="nump">SFr 6.34<span></span>
</td>
<td class="nump">$ 6.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement | SFr / shares</a></td>
<td class="nump">4.11<span></span>
</td>
<td class="nump">$ 4.11<span></span>
</td>
<td class="nump">SFr 5.65<span></span>
</td>
<td class="nump">$ 5.65<span></span>
</td>
<td class="nump">SFr 6.21<span></span>
</td>
<td class="nump">$ 6.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 5.90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePrice2019', window );">Weighted average share price | (per share)</a></td>
<td class="nump">2.68<span></span>
</td>
<td class="nump">$ 3.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Minimum | Switzerland, Francs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract', window );"><strong>Outstanding options, exercise price range and expiry dates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement | SFr / shares</a></td>
<td class="nump">0.15<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Minimum | United States of America, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract', window );"><strong>Outstanding options, exercise price range and expiry dates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of Range [Member] | Switzerland, Francs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract', window );"><strong>Outstanding options, exercise price range and expiry dates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement | SFr / shares</a></td>
<td class="nump">SFr 9.53<span></span>
</td>
<td class="nump">$ 9.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of Range [Member] | United States of America, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract', window );"><strong>Outstanding options, exercise price range and expiry dates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Chf0.15Member', window );">CHF 0.15</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract', window );"><strong>Outstanding options, exercise price range and expiry dates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding Options (in shares)</a></td>
<td class="nump">92,875<span></span>
</td>
<td class="nump">92,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Chf9.53Member', window );">CHF 9.53</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract', window );"><strong>Outstanding options, exercise price range and expiry dates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding Options (in shares)</a></td>
<td class="nump">109,665<span></span>
</td>
<td class="nump">109,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Usd5.04ToUsd12.30Member', window );">USD 5.04 to USD 12.30</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract', window );"><strong>Outstanding options, exercise price range and expiry dates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding Options (in shares)</a></td>
<td class="nump">2,417,545<span></span>
</td>
<td class="nump">2,417,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,417,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Usd2.76ToUsd4.57Member', window );">USD 2.76 to USD 4.57</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract', window );"><strong>Outstanding options, exercise price range and expiry dates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding Options (in shares)</a></td>
<td class="nump">1,034,326<span></span>
</td>
<td class="nump">1,034,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,034,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Usd2.03ToUsd2.32Member', window );">USD 2.03 to USD 2.32</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract', window );"><strong>Outstanding options, exercise price range and expiry dates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding Options (in shares)</a></td>
<td class="nump">1,294,766<span></span>
</td>
<td class="nump">1,294,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,294,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePrice2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePrice2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CHF">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CHF</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Chf0.15Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Chf0.15Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Chf9.53Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Chf9.53Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Usd5.04ToUsd12.30Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Usd5.04ToUsd12.30Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Usd2.76ToUsd4.57Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Usd2.76ToUsd4.57Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Usd2.03ToUsd2.32Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=aciu_Usd2.03ToUsd2.32Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824823855936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation, Weighted Average Grant date Fair Value and Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>Y </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>Y </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>Y </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Y </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract', window );"><strong>Number and weighted average exercise prices of options under the share option programs [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted', window );">Weighted average fair value at measurement date, share options granted</a></td>
<td class="nump">$ 1.57<span></span>
</td>
<td class="nump">$ 1.57<span></span>
</td>
<td class="nump">$ 2.38<span></span>
</td>
<td class="nump">$ 5.23<span></span>
</td>
<td class="nump">SFr 1.33<span></span>
</td>
<td class="nump">SFr 2.20<span></span>
</td>
<td class="nump">SFr 4.78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageAssumptionsAbstract', window );"><strong>Weighted average assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Share price (USD and weighted average)</a></td>
<td class="nump">$ 2.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.44<span></span>
</td>
<td class="nump">$ 6.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePrice2019', window );">Share price, weighted average (in USD per share) | (per share)</a></td>
<td class="nump">$ 3.18<span></span>
</td>
<td class="nump">$ 2.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageAssumptionsAbstract', window );"><strong>Weighted average assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price (USD)</a></td>
<td class="nump">$ 2.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.76<span></span>
</td>
<td class="nump">$ 5.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">72.00%<span></span>
</td>
<td class="nump">72.00%<span></span>
</td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected term (in years) | Y</a></td>
<td class="nump">5.5<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
<td class="nump">5.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageAssumptionsAbstract', window );"><strong>Weighted average assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price (USD)</a></td>
<td class="nump">$ 3.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.57<span></span>
</td>
<td class="nump">$ 7.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate</a></td>
<td class="nump">4.60%<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">86.00%<span></span>
</td>
<td class="nump">86.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected term (in years) | Y</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">6.25<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WeightedAverageAssumptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WeightedAverageAssumptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The option life of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOptionLifeShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exercise price of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of share options granted during the period at the measurement date. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePrice2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePrice2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824819400352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation, Non-vested Share Awards (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">86 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CHF (SFr) </div>
<div>EquityInstruments</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr) </div>
<div>EquityInstruments</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr) </div>
<div>EquityInstruments</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CHF (SFr) </div>
<div>EquityInstruments</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average grant date fair value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Expense charged against the income statement | SFr</a></td>
<td class="nump">SFr 4,400,000<span></span>
</td>
<td class="nump">SFr 3,300,000<span></span>
</td>
<td class="nump">SFr 4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedSharesAndRestrictedShareUnitsMember', window );">Non-vested Share Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPaymentArrangementAbstract', window );"><strong>Share-based payment arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of non-vested share awards granted (in shares)</a></td>
<td class="nump">1,187,570<span></span>
</td>
<td class="nump">239,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfNonVestedSharesAbstract', window );"><strong>Number of non-vested shares [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Non-vested at beginning of period (in shares)</a></td>
<td class="nump">216,486<span></span>
</td>
<td class="nump">797<span></span>
</td>
<td class="nump">19,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement', window );">Forfeited during the year (in shares)</a></td>
<td class="num">(134,947)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement', window );">Exercised during the year (in shares)</a></td>
<td class="num">(55,503)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,471)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted during the year (in shares)</a></td>
<td class="nump">1,187,570<span></span>
</td>
<td class="nump">239,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Vested during the year</a></td>
<td class="num">(265,366)<span></span>
</td>
<td class="num">(23,505)<span></span>
</td>
<td class="num">(18,697)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Non-vested at end of period (in shares)</a></td>
<td class="nump">1,003,743<span></span>
</td>
<td class="nump">216,486<span></span>
</td>
<td class="nump">797<span></span>
</td>
<td class="nump">1,003,743<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement', window );">Vested and exercisable (in shares)</a></td>
<td class="nump">298,883<span></span>
</td>
<td class="nump">89,020<span></span>
</td>
<td class="nump">65,515<span></span>
</td>
<td class="nump">298,883<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average grant date fair value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding', window );">Weighted average grant date fair value, non-vested at beginning of period | SFr</a></td>
<td class="nump">SFr 3.06<span></span>
</td>
<td class="nump">SFr 9.41<span></span>
</td>
<td class="nump">SFr 9.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited', window );">Weighted average grant date fair value, forfeited during the year | SFr</a></td>
<td class="nump">2.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised', window );">Weighted average grant date fair value, exercised during the year | SFr</a></td>
<td class="nump">2.37<span></span>
</td>
<td class="nump">3.06<span></span>
</td>
<td class="nump">9.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted', window );">Weighted average grant date fair value, granted during the year | SFr</a></td>
<td class="nump">1.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested', window );">Weighted average grant date fair value, vested during the year | SFr</a></td>
<td class="nump">2.46<span></span>
</td>
<td class="nump">3.28<span></span>
</td>
<td class="nump">9.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding', window );">Weighted average grant date fair value, non-vested at end of period | SFr</a></td>
<td class="nump">1.97<span></span>
</td>
<td class="nump">3.06<span></span>
</td>
<td class="nump">9.41<span></span>
</td>
<td class="nump">SFr 1.97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable', window );">Weighted average grant date fair value, vested and exercisable | SFr</a></td>
<td class="nump">4.08<span></span>
</td>
<td class="nump">7.84<span></span>
</td>
<td class="nump">9.48<span></span>
</td>
<td class="nump">4.08<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedStockUnitsMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average grant date fair value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding', window );">Weighted average grant date fair value, non-vested at beginning of period | SFr</a></td>
<td class="nump">3.06<span></span>
</td>
<td class="nump">9.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding', window );">Weighted average grant date fair value, non-vested at end of period | SFr</a></td>
<td class="nump">SFr 1.97<span></span>
</td>
<td class="nump">SFr 3.06<span></span>
</td>
<td class="nump">SFr 9.41<span></span>
</td>
<td class="nump">SFr 1.97<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedStockUnitsMember', window );">Restricted Stock Units | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPaymentArrangementAbstract', window );"><strong>Share-based payment arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of non-vested share awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">257,329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod', window );">Vesting conditions</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement', window );">Contractual life of options</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfNonVestedSharesAbstract', window );"><strong>Number of non-vested shares [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted during the year (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">257,329<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedStockUnitsMember', window );">Restricted Stock Units | Executives [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPaymentArrangementAbstract', window );"><strong>Share-based payment arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of non-vested share awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">905,803<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement', window );">Contractual life of options</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfNonVestedSharesAbstract', window );"><strong>Number of non-vested shares [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted during the year (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">905,803<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedStockUnitsMember', window );">Restricted Stock Units | Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPaymentArrangementAbstract', window );"><strong>Share-based payment arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of non-vested share awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">458,335<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod', window );">Vesting conditions</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement', window );">Contractual life of options</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfNonVestedSharesAbstract', window );"><strong>Number of non-vested shares [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted during the year (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">458,335<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedStockUnitsFirstVestingConditionsMember', window );">Restricted Stock Units, first vesting conditions | Executives [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPaymentArrangementAbstract', window );"><strong>Share-based payment arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod', window );">Vesting conditions</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedStockUnitsSecondVestingConditionsMember', window );">Restricted Stock Units, second vesting conditions | Executives [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ShareBasedPaymentArrangementAbstract', window );"><strong>Share-based payment arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod', window );">Vesting conditions</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum term of other equity instruments (ie other than share options) granted for a type of share-based payment arrangement that existed at any time during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfNonVestedSharesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfNonVestedSharesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ShareBasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ShareBasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For vesting requirements for a type of share-based payment arrangement that existed at any time during the period, this element represents the period which an employees' right to exercise an award is no longer contingent on satisfaction of a service condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WeightedAverageExercisePriceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WeightedAverageExercisePriceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant date fair value, other equity instruments exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant date fair value, other equity instruments forfeited</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant date fair value, other equity instruments granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant date fair value, other equity instruments outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant date fair value, other equity instruments vested</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant date fair value, other equity instruments vested and exercisable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedSharesAndRestrictedShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedSharesAndRestrictedShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=aciu_BoardOfDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=aciu_BoardOfDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=aciu_ExecutiveManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=aciu_ExecutiveManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=aciu_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=aciu_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedStockUnitsFirstVestingConditionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedStockUnitsFirstVestingConditionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedStockUnitsSecondVestingConditionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=aciu_RestrictedStockUnitsSecondVestingConditionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824821214576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies (Details) - CHF (SFr)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CommitmentsAbstract', window );"><strong>Commitments and contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_RentalContractPeriodForNoticeOfCancellation', window );">Notice period for cancellation of rental contract</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContractualCapitalCommitments', window );">Contractual capital commitments</a></td>
<td class="nump">SFr 47,568<span></span>
</td>
<td class="nump">SFr 52,488<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Within 1 Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CommitmentsAbstract', window );"><strong>Commitments and contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_ContractualCapitalCommitmentsOtherThanForLeases', window );">Contractual capital commitments other than for leases</a></td>
<td class="nump">21,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContractualCapitalCommitments', window );">Contractual capital commitments</a></td>
<td class="nump">21,746<span></span>
</td>
<td class="nump">23,336<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember', window );">1-3 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CommitmentsAbstract', window );"><strong>Commitments and contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContractualCapitalCommitments', window );">Contractual capital commitments</a></td>
<td class="nump">16,920<span></span>
</td>
<td class="nump">18,516<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember', window );">3-5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CommitmentsAbstract', window );"><strong>Commitments and contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContractualCapitalCommitments', window );">Contractual capital commitments</a></td>
<td class="nump">7,632<span></span>
</td>
<td class="nump">9,229<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">More Than 5 Years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CommitmentsAbstract', window );"><strong>Commitments and contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContractualCapitalCommitments', window );">Contractual capital commitments</a></td>
<td class="nump">SFr 1,270<span></span>
</td>
<td class="nump">SFr 1,407<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CommitmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CommitmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_ContractualCapitalCommitmentsOtherThanForLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual capital commitments other than for leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_ContractualCapitalCommitmentsOtherThanForLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_RentalContractPeriodForNoticeOfCancellation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time required by the lessee in a lease agreement to provide notice of cancellation of a lease to the lessor, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_RentalContractPeriodForNoticeOfCancellation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContractualCapitalCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of capital commitments for which the entity has entered into a contract. [Refer: Capital commitments]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContractualCapitalCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824820028592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share (Details) - CHF (SFr)<br> SFr / shares in Units, SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract', window );"><strong>Numerator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity', window );">Net loss attributable to equity holders of the Company</a></td>
<td class="num">SFr (54,233)<span></span>
</td>
<td class="num">SFr (70,753)<span></span>
</td>
<td class="num">SFr (72,996)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract', window );"><strong>Denominator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Weighted-average number of shares outstanding used to compute EPS basic attributable to equity holders</a></td>
<td class="nump">84,694,616<span></span>
</td>
<td class="nump">83,554,412<span></span>
</td>
<td class="nump">74,951,833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic loss per share for the period attributable to equity holders</a></td>
<td class="num">SFr (0.64)<span></span>
</td>
<td class="num">SFr (0.85)<span></span>
</td>
<td class="num">SFr (0.97)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted loss per share for the period attributable to equity holders</a></td>
<td class="num">SFr (0.64)<span></span>
</td>
<td class="num">SFr (0.85)<span></span>
</td>
<td class="num">SFr (0.97)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 70<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_70_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824820130032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share - Antidilutive securities (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareLineItems', window );"><strong>Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented', window );">Number of instruments that are antidilutive in period presented</a></td>
<td class="nump">1,257,923<span></span>
</td>
<td class="nump">253,119<span></span>
</td>
<td class="nump">1,188,113<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_ShareOptionsMember', window );">Share options issued and outstanding (in-the-money)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareLineItems', window );"><strong>Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented', window );">Number of instruments that are antidilutive in period presented</a></td>
<td class="nump">97,683<span></span>
</td>
<td class="nump">135,827<span></span>
</td>
<td class="nump">1,140,388<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_RestrictedShareUnitsMember', window );">Restricted share awards subject to future vesting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareLineItems', window );"><strong>Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented', window );">Number of instruments that are antidilutive in period presented</a></td>
<td class="nump">1,160,240<span></span>
</td>
<td class="nump">117,292<span></span>
</td>
<td class="nump">6,264<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_ConvertibleInstrumentsMember', window );">Convertible shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareLineItems', window );"><strong>Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented', window );">Number of instruments that are antidilutive in period presented</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,461<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of (units of) instruments that are antidilutive in the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 70<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_70_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_ShareOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_ShareOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_RestrictedShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_RestrictedShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_ConvertibleInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_ConvertibleInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824820603488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial instruments and risk management (Details)<br> SFr in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>CHF (SFr) </div>
<div>Institution</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">SFr 122,339<span></span>
</td>
<td class="nump">SFr 126,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">16,263<span></span>
</td>
<td class="nump">13,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialRisksAbstract', window );"><strong>Financial risks [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Foreign exchange gains (losses)</a></td>
<td class="num">(1,467)<span></span>
</td>
<td class="nump">393<span></span>
</td>
<td class="nump">SFr 113<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_LongTermLeaseLiabilitiesMember', window );">Long-term lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">2,825<span></span>
</td>
<td class="nump">2,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_TradeAndOtherPayablesMember', window );">Trade and other payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">1,679<span></span>
</td>
<td class="nump">929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_AccruedExpensesMember', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">11,087<span></span>
</td>
<td class="nump">9,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_ShortTermLeaseLiabilitiesMember', window );">Short-term lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">672<span></span>
</td>
<td class="nump">548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=aciu_RightOfUseFinancialAssetsMember', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">3,508<span></span>
</td>
<td class="nump">2,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=aciu_LongTermFinancialAssetsMember', window );">Long-term financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">361<span></span>
</td>
<td class="nump">361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=aciu_OtherCurrentReceivablesMember', window );">Other current receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">622<span></span>
</td>
<td class="nump">392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_TradeReceivablesMember', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">14,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=aciu_ShortTermFinancialAssetsMember', window );">Short-term financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">24,554<span></span>
</td>
<td class="nump">91,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=aciu_CashOnHandAndCashEquivalentsMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">78,494<span></span>
</td>
<td class="nump">31,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember', window );">Foreign Currency Exchange Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialRisksAbstract', window );"><strong>Financial risks [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Foreign exchange gains (losses)</a></td>
<td class="num">SFr (1,500)<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="num">SFr (100)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies', window );">Percentage of reasonably possible strengthening or weakening of reporting currency against other relevant currencies</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies', window );">Increase (decrease) in profit (loss) resulting from reasonably possible strengthening or weakening of reporting currency against other relevant currencies</a></td>
<td class="nump">SFr 2,600<span></span>
</td>
<td class="nump">SFr 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CreditRiskMember', window );">Credit Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialRisksAbstract', window );"><strong>Financial risks [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets', window );">Number of financial institutions holding cash and cash equivalents and short-term financial assets | Institution</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember', window );">Liquidity Risk [Member] | Trade and other payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">SFr 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember', window );">Liquidity Risk [Member] | Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialAssetsAndLiabilitiesAbstract', window );"><strong>Financial assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">SFr 11,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest Rate [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialRisksAbstract', window );"><strong>Financial risks [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates', window );">Percentage of reasonably possible increase or decrease in interest rates</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest Rate [member] | Top of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_FinancialRisksAbstract', window );"><strong>Financial risks [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates', window );">Increase (decrease) in profit (loss) resulting from reasonably possible increase or decrease in interest rates</a></td>
<td class="nump">SFr 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_FinancialAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_FinancialAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_FinancialRisksAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_FinancialRisksAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in profit (loss) resulting from reasonably possible increase or decrease in interest rates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in profit (loss) resulting from reasonably possible strengthening or weakening of reporting currency against other relevant currencies</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of financial institutions holding the entity's deposits of cash and cash equivalents and short-term financial assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of reasonably possible increase or decrease in interest rates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of reasonably possible strengthening or weakening of reporting currency against other relevant currencies</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 35H<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 35M<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 35N<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 35I<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2023-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_LongTermLeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_LongTermLeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_TradeAndOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_TradeAndOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_AccruedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_AccruedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_ShortTermLeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=aciu_ShortTermLeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=aciu_RightOfUseFinancialAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=aciu_RightOfUseFinancialAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=aciu_LongTermFinancialAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=aciu_LongTermFinancialAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=aciu_OtherCurrentReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=aciu_OtherCurrentReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_TradeReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_TradeReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=aciu_ShortTermFinancialAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=aciu_ShortTermFinancialAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=aciu_CashOnHandAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=aciu_CashOnHandAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CreditRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_CreditRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139824821510816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details)<br> SFr in Millions</strong></div></th>
<th class="th">
<div>Feb. 01, 2024 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember', window );">2014 Agreement with Janssen Pharmaceuticals [Member] | Tau Vaccine in AD [Member] | Receipt of milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aciu_CollaborationAgreementMileStonePaymentReceived', window );">Collaboration Agreement, Mile Stone Payment Received</a></td>
<td class="nump">SFr 14.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aciu_CollaborationAgreementMileStonePaymentReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of milestone payment received under the collaboration agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aciu_CollaborationAgreementMileStonePaymentReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aciu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfContractsAxis=aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=aciu_TauVaccineInADMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=aciu_TauVaccineInADMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=aciu_ReceiptOfMilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=aciu_ReceiptOfMilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>154
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M*EXN6,(WYQVG4S^XBY<K53SH#L_6=,GF3'U>SP3<=1N4*$Y9)F.>$<$6YYW
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M> %^7W"NZIOB \V!__ ?4$L#!!0    ( ,X[;EAVN[9)T 4  $0;   8
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M^A&P/(V 99=&1T; I[K>MUO@ULN#W?V96S;QG<[%):2+D&(!I%@(*19!BL5
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M" F;&=*)PG-QZ3C*W['61!5V8,]7?%2C;(J)HTPH#3K!RA6B+HI8EF\3>:Z
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MBDX8G[HFR\7-!#)")]H7,;G]Z2\D#G_!/'1)8^F%C!UXC^^\QWW6;_\NNRZ
MA!BHE0C DZ4L,.<-1N+>B$Z.+[?3B%,&T?.R[Q8$EH1)9,!2#$87BW@'.Z 2
M[:A$WD#X7/P7,L P(96$-)O+.B\K$=10$"J;IP;IKW(]<Y=ZYG["J$>7C)M+
M&DLO9.S V?'.V;$W;E(!1O,RZ\L1I+^FA>+:JK>/05-EM0H@UP7BSTW9Z/'
MW#J8C_9B@,0)->() 24+,YH0T'R1X+&4[.@E9]%K=4&<RN5TTXD@ZSJAT!R3
M6+<2<7..()@X-B@AF'"!,YKO&,V]C+Z6=5;G(K@JZURNQ8>9^ %JJ!,?]1S
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M 'R_E##)MV_T#^R>*+K]'U!+ P04    " #..VY8"RW23AX%  !B"P  &
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M:&#T\L+MLJ+N-.2$*A;"WB&0T;\?6<R#9D*R8*%$U250ADY<V>)CZYR &QK
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MM<,;K']=<%9Q0P(X/]/:M1]DH/L38O(O4$L#!!0    ( ,X[;EA::X1== 0
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M8I-C MS/K W-A@6T_R!&?P%02P,$%     @ SCMN6(<%P]AN P  F D  !D
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MD0-N/H-GKN$JU3CFP]66:U"A99K&(L/6= .E)-%B78>9S"FQ4-3?4$;)2I;
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M'5BV)C:>A% #FL1)S4GYXBW]E83SRSLK2@2A2S"^0@N-V(NU0A>V1%'8%DO
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MN!)O+'\+RF5C1;D;"\P;^Q#V$OAE7AQD]$4:7I,Z5K?>3QQYB9]0XGMAB%N
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M9SCK"64%L%Y*:;8OUD%_>KSX&U!+ P04    " #..VY8K-C<X1H#  !<!P
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M4C[1.T?$D5C:'>6@\ 05_'-*D]FMU=ST$U:C\E_K!&-[WOJ0WV.:W98W!02
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M*HERD ;@_;H$[/P-+=!^:'GV?U!+ P04    " #..VY8MWPZ2:4*  !Z(@
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M$?F0(TJ#B(-X$ITF0XAGT3A^EDF#S+B3F4:3-('3*$E.Z::QV.9C=QI'R90
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M0+5]6[LPLG:]TDH:ZKS<M*!6%Y45H/.U)%^[A370-\_+_P!02P,$%     @
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MG,^^$5 < HK,NT^46=Z(*-9+[W;DDS?0TD,N-4>#G+)I4QZCQUN%N+A^[,K
M7SNVD7B+W["<1L"FEU-Y@+CJ(8IO0,P+NG,V-H%^LA57+P&FX#.0*HZDKHHW
M$6]83NAL/J9B5IR]@7<V%'F6\<[^3Y$]Q.)UB-0;%Z$5DE<C'/[ ?LNC]???
MS3_,?GR#X&(@N'@+_;\1?!NB6$SH3E@TDDDPC0B $KH3D2NTW#_P2=21/<6&
M<::UL)*IGP$5_,>P>]=MFOQ>A=!E!U>G=6"2S@:G596A:V7Q5@E-(<*0DH<Q
M85J0:%OO6J]@1?-)U]FH[(:$K:A206H7.B@YH5\M_2QLAY% 19'W?#'.F:^=
M:87=(\(B6")9;$0D%=$C6F,D;#!T2.!QHQW*()]:,%!T.5P@WSMA]MJIBDJ.
M(EM*5^U)>K;\5V=$F>D,WK^)[MDIL'$>*B>OVFF,KT0?LJ$-11XIO2+00VM1
M.M\;Q<9S+P-HQH8^(I6-+)LQ"3)L2NA^"'QPF+'T$5JWXTPD&\:T:Y1L7F3*
M!9=,7-><YQBA\DN(J[->$[IR2'6@KCA@_^%3,MN34X 0B6.C9-ZL+ONEC;J\
MF=#E-7TVIK/<IQ(ZN*/ SZKRDPIY#S_>W5/EN\T[['#5R9AA!NS(O1>.X(X3
M&(Y;"$ZJS +'1M &HOB\[# S/+% P0=5G@7\%RTI,+,[K??@MDTC/XEV+)#$
M5BALA.8^1^!T$I65&J6FG0-V.JV:TI5&\&2-DN)PPP1,<BCBG<F^OXC.*[1$
M].ET[QK$P+R'JM*9TVR)!(@!03*V)@N=6%*Y?RY@C#BH!&XL54H8<HP1%3K+
M4NO (Z9$=>>1QL-OBRNSS=V<,KAL=6WK?.RLBNK0.[=<^MP\\]=Z9^"4C$9I
M;(V#FJW89V!(?OWIEN:+R7EZJY,05<>]".C*$%!UVMS^G!L$23Y&ULJ'2/<8
M-4Q%^?)L[2>OC<7IR45EV&_R=1PHSX;^SAJLPXU_V5]TS^[]Y\*=\!L%$377
M")U-?G@_ZD_J<1%=FZ^]TD5<HOFQP5<+^^2 ][6#Y(=%2C!\!ZW_!E!+ P04
M    " #..VY8H+<I3R0D   R>P  &0   'AL+W=O<FMS:&5E=',O<VAE970S
M,2YX;6S%75MOVU:V_BM$!B@<0)9CITF:I@W@ILTT@W8:Q.DISB--;DEL*%+#
MBQ7UUY_UK<O>FQ3%.),"YZ&I;9'[LNYW?;>OFP_MQKDN^;@MJ_;[!YNNVWU[
M<=%F&[=-VV6]<Q5]LJJ;;=K1K\WZHMTU+LWYI6UY<?7HT=.+;5I4#UY^QW][
MV[S\KNZ[LJC<VR9I^^TV;0X_N++>?__@\H']X5VQWG3XP\7+[W;IVMVX[O?=
MVX9^N_"KY,7656U15TGC5M\_N+[\]H>KK_$"/_$_A=NWT<\)KG);UQ_PRYO\
M^P>/<")7NJS#$BG][\Z]<F6)E>@<_]%%'_@]\6+\LZW^FB]/E[E-6_>J+O\H
M\F[S_8-O'B2Y6Z5]V;VK]S\[O= 3K)?59<O_)GM]]M&#).O;KM[JRW2";5')
M_]./"HC[O'"E+USQN64C/N6/:9>^_*ZI]TF#IVDU_,!7Y;?I<$4%K-QT#7U:
MT'O=RQO!1E*O:-7.-45:$J2RNJ^ZHEHGN[HLLL*UR=E;_>GA=Q<=[8NW+S+=
MXP?9X^K$'I=7R:]UU6W:Y*<J=_EP@0LZL#_UE9WZAZO9%7]TV3)Y?+E(KAY=
M/9Y9[[&'PF->[_&706'JZK+PU],+@Z>^;7=IYKY_0$S3NN;./7CYU3\NGSYZ
M,7/LK_VQOYY;_>7KOF+:QFFKG)AD5S=\X*QO&E=EAZD#?^&2R?L-W2/)ZJHE
MJ.0$K3Q9%55:90!:V]$?B&F[EE\'#+>[M#I@A:KNB)#2QB4,B@IO%E5RLR_:
M-GG=T I$9J]^?OUPD>PW1;9)BC:Y?I6\V6[[RB4WUU_]XYNKRV<OVF05SNA/
MA=VZC4O^V=3]SC]Y?/PESI^\DE/YY]K^MBWR B2P2>F,DUL0<6"'WY<WR^3'
MNBS3)CG[_>;'A[(D76GG6,1,ODPGD4NWO,BN*9C@',&QWA99XJJ[HJDK@ Y
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MN'IT^527_&WGZW/>$+XJUC-OV31H=,!*7*S[0YEF'\YO,O)\@2Y^^1RC0?#
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MU$Z SG.E[';A#+0_(I,_4$L#!!0    ( ,X[;EA F=2=B00  '@/   9
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M+)0]@/*9E*9;V OZQ_;D)U!+ P04    " #..VY8RET1S98$  ")#@  &0
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M D'FH)<(A7Q$:C6"STN[4!(?/#)1(YB.:H<D7+V.QC[?^JT_D(%<"B($7BY
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M3&OW\J'V#FZ_4LH>#)]@>$OSWU!+ P04    " #..VY87-NO9HH"   6!P
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M^&%05"F;0F!ODVIO9A?\GD(*\DD58*?@%NMVV;1QIH(LH&MY0J[GKD5TIJ,
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M^%?3[36EG5A5NZO!4EF\:+C7 F]VH$D OZ^4LML)&>COBHM_ 5!+ P04
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M&J])%N^]V(X-. 9H^GCI6X.^A>*P\V\6;$CPZXTQ> I"'\W_ M434$L#!!0
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MLPT7?<<V\:+<GI.EEF:6&IY.)T11A42.S"FKB"0N>U?HFZ!\C3+!,Y <7<Q
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M2@:#'QB9:D9!LS&R<LWQ01ILM6Y9X/0$90%X?R6EV6WL [IYG+P 4$L#!!0
M   ( ,X[;EA#]064EP(  & )   9    >&PO=V]R:W-H965T<R]S:&5E=#4T
M+GAM;+666T_;,!3'OXJ52=,F#7+I#;HV$@6F\8"&8)=G-SEI+!P[V Z%;[]C
M)PV=U)H)T9?$M_/W[YR3^'BVENI>EP"&/%5<Z'E0&E-/PU!G)514'\L:!,X4
M4E748%>M0ETKH+DSJGB81-$XK"@303IS8S<JG<G&<";@1A'=5!55SPO@<CT/
MXF S<,M6I;$#83JKZ0KNP/RJ;Q3VPEXE9Q4(S:0@"HIY<!9/%[$S<"M^,UCK
MK3:QKBREO+>=JWP>1)8(.&3&2E!\/<(Y<&Z5D..A$PWZ/:WA=GNC_LTYC\XL
MJ89SR?^PW)3SX"0@.12TX>96KK]#Y]#(ZF62:_<DZVYM%)"LT496G3$25$RT
M;_K4!6++(![O,4@Z@\1QMQLYR@MJ:#I3<DV478UJMN%<==8(QX3-RIU1.,O0
MSJ1W;3:(+%#5@&*48Z0RV0C#Q(K4DK.,@?Y"7+Z.9''4:"!4:S":4)$3#A@3
MPAE=,LX,+B6?+L!0QO7G66B0T.X39AW-HJ5)]M#$";F6PI2:7(H<\G\%0G2M
M]R_9^+=(O(H7D!V30?R%)%$R\.@-^G@-G-YPC]ZB83S'R.A=SGE-[?\UU37-
M8![@#Z1!/4*0?OP0CZ.O'K!A#S9TZH,]8/^=G^DN\N$!R$<]^<@;TDMMF/WV
M-JSX%5:[&/TJ(_(,5&D/S[CG&7N5?A0%RX!</C2LQO/'[&+Q*KPQ7I.>;W+
M3$\.0'[2DY^\2Z;]*J]G^K3G.?4J7?WT9]EK_<98Q='+R1P=,,^=^#O#;Y65
M^%U2_8J,)]?A5M&K0*U<:=?$E:ZV_O6C_?7AK"V:+\O;N\<U52LF-*(6:!H=
M3_"H46TY;SM&UJZ$+J7!@NR:)5Z!0-D%.%](:38=NT%_J4K_ E!+ P04
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MC8XGYDQ1;6EN.RAK5PY7$DUQ=<W27&= V0GF?2$E;CMV@?Z"E/X%4$L#!!0
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MF*%Y?(.2*)DC'<A>P9U/]9E[W/FE^OPM^YS8 '%['L*-U4IWM( ,V[G1H Z
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M40"=X "-UG02:!=@<Z-C((:;NX()O!5CLU3,G)S9\ &KZB0VQ)HE2%Q^Z&!
MI::;H>@ZF78S"%Q^:!<YJG%D[@9"7IR[$P7'"5ZR_9S>%65:%^7/O0.?OBD3
MP*Q)R9A435"IZ4XJ,DX"XJDZ(5U63*HFJ-1T,Q59)Q?LCG8\MML3(M<:K$@+
MT%1JNAV*L),S!6A9+INK*'V0[:"4Y<NRK=>VW]^#]]:#:M(=T]^:VQ M\',/
M=HH4F.>=+T7:R/)A_^5257.3L<OKP_<*G7Y[^@*K]_NO;3)^_\%[)PY?0Z5D
M#M^*]4=:-MQ7.6MYWTBZ;]O/&LK#%TT=7M3%=O_52W=%71>;_8^/,FWN==J
MYN_W15$_OVA/</JZK]O_ U!+ P04    " #..VY8OP8Y?O($  "A&P  &0
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MWM0#$=G@0RR_L.-'4@0TTG@ABT7V"8Z%K>^!\" D2PIGQ2"A:?Z-?Q>).'&
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MT!/@>\BY>AWH!>KN>?8W4$L#!!0    ( ,X[;EC;D+T1O ,  +$5   9
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MQFB)J300QU>$\(>%?%=<__<A^ =02P,$%     @ SCMN6,JQN*7) @  !PL
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M3*RO\Y7(<0132]U7 7P#5OC]VV#D_#BDNB>RE@=>[8'7Q1XN.LH@+D ?.*.
MW@!SQ#A*01P\]W*3D=E$_XTVH3OT_6%@;YI"]Z,F \=QZJB6@F&M8-BI0!?H
MTQUD2^ 'CZH3?>Q1]436$NK70OW/*E>_3P]Z(FMY,*H]&'U%N9:;^,UR=9N%
M6 H='5.NE[6"RTX%CXMY9[EVHH\]JI[(6D+'M=#Q9Y7KN$\/>B)K>3"I/9A\
M1;E.]O^N^S_7SDR.U6DWVA3=(MYAOB94J Q7BMZYN%1WAY=M5SF1+#>=RY))
MU0>98:(Z5> Z0'U?,29W$]T,U;UO^!]02P,$%     @ SCMN6%-Z<@]9 @
M;@8  !D   !X;"]W;W)K<VAE971S+W-H965T-C8N>&ULK57;CILP%/P5BTK5
MKM2&.XFV@)1-%&T?*D6;;?M0]<&!DV"MP=1V+OW[VH:@7$BZ4OL"OIP9SPQP
MB'>,OXH"0*)]22N16(64]8-MBZR $HL!JZ%2.RO&2RS5E*]M47/ N0&5U/8<
M)[)+3"HKC<W:G*<QVTA**IAS)#9EB?GO1Z!LEUBN=5AX)NM"Z@4[C6N\A@7(
MK_6<JYG=L>2DA$H05B$.J\0:NP^34->;@F\$=N)HC+23)6.O>O(Y3RQ'"P(*
MF=0,6-VV, %*-9&2\:OEM+HC-?!X?&"?&>_*RQ(+F##ZG>2R2*R1A7)8X0V5
MSVSW!*T?(S!C5)@KVC6UP]!"V49(5K9@I: D57/'^S:'(X ;7 %X+<![*\!O
M ;XQVB@SMJ98XC3F;(>XKE9L>F"R,6CEAE3Z*2XD5[M$X60ZYU!CDB/8J_="
M@$"XRE6V&=] CDB5L1+0W10D)E3<HX]H\C1#=XL9OT?JH@K02\$V0H%$;$NE
M1[/:67OV8W.V=^7L*60#Y+L?D.=X?@]\\G:X=PJW50I=%%X7A6?X_'^(XL=X
M*217[][//KL-?]#/K[_'!U'C#!)+?7 "^!:L]/T[-W(^]9G_3V0G4?A=%/XM
M]HLH^LPV#)%AT+UBFT:!/XSM[;&)RZ)@Z(RZHA-Q02<NN"EN?/)(^J0U^/#H
M5"^(SI1=U@37A(6=L/"FL!<F,47UWU^C/LWA99S1R#\3?5D4NFYTIMH^Z@:Z
M$W_!?$TJ@2BL%,P9Z-[%F^[63"2K38-8,JG:C1D6ZH< 7!>H_15C\C#1/:?[
MQ:1_ %!+ P04    " #..VY84M$D$XH"   4"   &0   'AL+W=O<FMS:&5E
M=',O<VAE970V-RYX;6RU5EU/VS 4_2M6AA!(K/EJ"X(T$K1"@(2$Z-@>ICVX
MSDUCX=B9[;1,VH^?[82HG4(U4/?2^-KW'/L<?]PF:R&?50&@T4O)N)IXA=;5
MN>\K4D")U4!4P,U(+F2)M0GETE>5!)PY4,G\* C&?HDI]]+$]3W(-!&U9I3#
M@T2J+DLL?UT!$^N)%WJO'8]T66C;X:=)A9<P!_U4/4@3^1U+1DO@B@J.).03
M[S(\GXYMODOX2F&M-MK(*ED(\6R#VVSB!79!P(!HRX#-9P538,P2F67\;#F]
M;DH+W&R_LE\[[4;+ BN8"O:-9KJ8>&<>RB#'-=./8GT#K9Z1Y2."*?>+UDWN
MJ4DFM=*B;,%F!27ES1>_M#YL ,+X#4#4 J)_!<0M('9"FY4Y63.L<9I(L4;2
M9ALVVW#>.+110[G=Q;F69I0:G$XO"1$UU\KL" &ZP@L&Z&@&&E.FCM%G- ,R
M0'%X@J(@BM'\6B+*T9="U KS3)V@ QO?4\;,GJC$UV9)EM@G[?17S?31&]-/
M;Z[1D6$][H%.=T.?YC-T=/ 7T#?R.P^BSH/(,<5O,,VH(DRH6@(2.<HIQYQ0
MS!!6"HPSWVT^HAI*]:-/84,^[">WM_!<59C Q#/73(%<@9<>?@K'P46?YCV1
M;?D0=S[$N]A[S\)ON^=]JANJL:.R3\4J#8=G09#XJTTY.R?\H)QA)V>X4\[=
M(2ZKBSMTR[E88?M:H'O(*#%I?8)VDKUW&_=$MJ5[U.D>_<_C/-JG#WLBV_)A
MW/DP_L!Q/NC3O)/HO9H;LC#<NAJ#L^YF-&+\C3?;ULM[+)>4*\0@-[!@<&JL
MDTT-:@(M*O>,+X0V1<$U"U.V0=H$,YX+H5\#6QFZ/P+I'U!+ P04    " #.
M.VY8.O8!S?L"  !@"@  &0   'AL+W=O<FMS:&5E=',O<VAE970V."YX;6RU
M5EUOVC 4_2M6)DVMM#5?$*"#2"U=U3V@5:5K'ZH]F.1"K#IV9AMH__UL!U(H
M(1T2>TEBYYYSS[F.X]M?<O$L,P"%7G+*Y,#)E"K.75<F&>18GO$"F'XSY2+'
M2@_%S)6% )Q:4$[=P/,B-\>$.7'?SMV*N,_GBA(&MP+)>9YC\7H)E"\'CN^L
M)^[(+%-FPHW[!9[!&-2OXE;HD5NQI"0')@EG2,!TX%SXYT/?,P ;\4!@*3>>
MD;$RX?S9#'ZD \<SBH!"H@P%UK<%#(%2PZ1U_%F1.E5. ]Q\7K-?6_/:S 1+
M&'+Z2%*5#9RN@U*8XCE5=WQY RM#;<.7<"KM%2W+V*CMH&0N%<]78*T@)ZR\
MXY=5(38 ?K0'$*P P7M :P\@7 %":[149FU=887CON!+)$RT9C,/MC86K=T0
M9I9QK(1^2S1.Q3]5!D(G$@*8TNN2 %G@"06)3JY 84+E*?J*AC?7Z&1\+4Z1
MOB#"T'W&YQ*S5/9=I548+C=99;PL,P9[,OH!&G&F,HF^LQ32;0)7RZ\\!&L/
MET$CXQ4D9RCTOZ# "\(:0<-_AP<-<L*JI*'E"P\NZ1.>2"7TE_N[KFPE:ZN>
MU6SG<UG@! :.WJ\2Q *<^/,G/_*^U5D^$ME6 5I5 5I-['L+4&>Z9(HLD_GE
M+.)6N^\N-JWLAOA!JXK94MBN%+8;%8Z71$KT<'%?)ZF$MC?R!>W>.TTU,:U>
MO::HTA0U:GHD*LLX30F;(85?ZI1%.UE#O_M.V6Z,OT=8IQ+6:11VSQ6FB._[
MJNN$=G:6+#);:TOH;DS8"^J5=BNEW0^4%HA/T1UF,T!/(\@G(&JW6B/-H5OM
M2&1;CGN5X]Y_^=?TCEF (Y%M%<#WW@XPKW'11UC-!5&OJ !!>/KEL"_U _(0
MY?:LJK/=##W4M[MQAN<@9K:UD2CA<Z;*X[R:K=JG"]LTN&_A9>\UPF)&F$04
MIAKJG77TWT"4[4PY4+RP'<&$*]U?V,=,MX @3(!^/^5<K0<F0=54QG\!4$L#
M!!0    ( ,X[;E@(6_28RP(  !L)   9    >&PO=V]R:W-H965T<R]S:&5E
M=#8Y+GAM;+U676^;,!3]*Q:3IE;:"ICPD8X@K:FJ]J%5U6C;0[4'!VZ"58.9
M;9+VW\\&BD)#HTZ*]@*VN>?XG&M?FWC+Q9/, 11Z+E@I9U:N5'5NVS+-H2#R
MC%=0ZB\K+@JB=%>L;5D)(%D#*IB-'2>P"T)+*XF;L7N1Q+Q6C)9P+Y"LBX*(
MEPM@?#NS7.MUX(&N<V4&["2NR!H6H'Y4]T+W[)XEHP64DO(2"5C-K._N^3PR
M\4W 3PI;N=-&QLF2\R?3N<EFEF,$ 8-4&0:B7QN8 V.&2,OXTW%:_90&N-M^
M9;]JO&LO2R)ASMDOFJE\9D46RF!%:J8>^/8:.C^^X4LYD\T3;=M8'ULHK:7B
M10?6"@I:MF_RW.5A!^!.W@'@#H _"O Z@-<8;94UMBZ)(DDL^!8)$ZW93*/)
M38/6;FAI5G&AA/Y*-4XEBYP(0"FIJ"(,?45W1 AB,BO1R24H0ID\U</SZRMT
MLK@2I[&M]*P&:Z?=#!?M#/B=&2XA/4.>^P5A!WLC\/G'X7@(M[77WC#N#>.&
MSWN/C\J4<5EKUWR%4D:DU%YU4PXR\6APB"HHY.\QS^TDD_%)3.F=RXJD,+-T
M;4D0&["2SY_<P/DVEH$CD0WRX?7Y\ ZQ)S=2UI -W8\9;EF"AL4<#9L$.]'4
M<9S8WNQZV8]SPVFX&S>0.>EE3@[*O*N+)0BS3DH?5GKY7EK)>NEJ)14I,UJN
MQW2WM/Z.'A]/O*D?O=&]'Q=@=^)@=URWW^OV#^J>\Z+0I]6BU?IX"\;&Z(XZ
MR/.O.^I(9 /+06\Y^!\5%APS'T<B&^0C[/,1'J7"PK$*BR)S: YVZGZ<KK @
M"/WQG1KU,J,/5EA;6&,2H[TBF4[=:1CAZ1N-^X&1%V#'"R9O1-H[5Y?Y;;@E
M8DU+B1BL--0Y"S6':*_BMJ-XU=QF2Z[TW=@T<_WW L($Z.\KSM5KQUR0_?]0
M\A=02P,$%     @ SCMN6&,T$E7J!@  \BX  !D   !X;"]W;W)K<VAE971S
M+W-H965T-S N>&ULS5K;;MLX$/T5P@LL6B")15(7*YL8:*(MVH<N@J;=?59L
MVA:JBRM22?OWI2XQS8L9.6%VMP^I)<T<<8XXPZ,1+QZJ^AO=$,+ CR(OZ>5D
MP]CV?#JEBPTI4GI6;4G)KZRJND@9/ZS74[JM2;KLG(I\BCPOG!9I5D[F%]VY
MFWI^434LSTIR4P/:%$5:_[PB>?5P.8&3QQ.?L_6&M2>F\XMMNB:WA'W=WM3\
M:+I#668%*6E6E: FJ\O).WB>^%[KT%G\G9$'NO<;M*'<5=6W]N#C\G+BM2,B
M.5FP%B+E_]V3:Y+G+1(?Q_<!=+*[9^NX__L1_7T7/ _F+J7DNLK_R99L<SF9
M3<"2K-(F9Y^KAP]D""AH\1953KN_X&&P]29@T5!6%8,S'T&1E?W_Z8^!B#T'
M&!YP0(,#4AW\ PYX<,!C'?S!P>^8Z4/I>$A2ELXOZNH!U*TU1VM_=&1VWCS\
MK&R?^RVK^=6,^['Y[2:M"5BDVXRE.3@%U\,O;M,L6,.OO4D(2[.<OFVO?G@/
MWMR^K]\"_@=, 6V]*<A*\+7,&#WI3O.C+YNJH6FYI!=3Q@?9WFJZ& 9TU0\(
M'1@01.!35;(-!7^62[*4 :8\NEV(Z#'$*V1%3,CB#&!X I"'L&% U^/=D<$]
M&>\.+='@W0/#'1X^@/>%9S=MZI\#]R:">P#?#- 6DG.Z31?D<L(K!27U/9G,
M?_\-AMX?)G)<@B6.P"3B_!UQO@U=)0[P(D@9GZ-9N08I W=DG95E>U"MP);4
M6;4T<=O?(^CNT=;4^_EIB*#?/=O[?=ZL@SF6-T=@$F_!CK?@);R1<FEG+- 9
M"Y"/XV"F,&8P-%*;6,?[3#;"'1NA-?VN-VFY[DL>^=YD[*<IY-!E KH$2QR!
M2=1%.^HBZT2Z2O.T7)"3L:G6HX5[\P&&LSA6$TTW0QC&4:Q,&H,9#/Q(3$(I
MIMDNIIDUIINZ6A"RI&!55P78-G=YMN!1K7A0Y9JOAR57;CS(AB]E]4.=L3;H
M%2'\"JO3DJ:]^%E4E!DK^4Q+"=\+<* P8!WBL3/$$9C$9KQC,SZ"39KFI"6/
M*06(I]YXH@&O5..XCC6N41AX"M6ZT:E2QA+=!"*X5\,D9J G=)HW+GN>++@#
MD)PX7NAC)1:CG9Y@B<%.R3 YI#WI":TA_55Q0<NUYGV:-Z0-J'_"X U_PJW2
MW)UY:PRS!X_VAN6=>4@-TCJ$8Y/#%9I,&!*$(2MAUU51\"E\>U#YV?V/77F<
MHB6NT&3NA&R&=MT\<'=8-4.GLMDI6N(*3>9.*&=HE\X2=\\4SE!7SK-XAGT\
M4Y<SHV7D>2'VU,KT&KH8"F$,[<KX(Z5-6Y/;P =N3OGJM"!EV\L 6UZPQ<JD
MK4%=F>O=S/5-U\/8BWR]PNEV$.,H"%2R7D,V0Z&;H55;/ELIJ0OXR:"[3VRI
M'.J4^-AK_ZGD.577KM!DBH6^AG:!;4W3IV5#I)/F^;X/HUFDLJ:;FG,Y,5HJ
MN2Q'*Y0WM$OO$8T0.\+1)=VISG:%)K,GE#:,7]I&@E:Q?C1[+M$25VAR0U&(
M<607XVYZ2<--1C23S)8(AE!)S<0^\.<2(R0]LDOZ?^T-[JG5<QCG/F-]W5&9
MU>VB( Y55E]#]R.A^Y%=][^T!3? C^C!F2S-33BSI3PEY7"%5$=6.2M_DS#&
MXU2J.T5+7*')W FICOR7]R>1R^;TM5.TQ!6:S)_0],BNZ8]M4@YP4A,EBE7!
M9+;RU90R6 7X0(<2">6-7D=YC^Q1(EULHUFH$N!49[M"DPD5.AO9=?;+WON,
M'.HR66-0-\'J_+$.^[FT"$&.[()\?(<2Z7UMY,UB-6+=2D^MQ&SE'T@:H8^1
MO17=KT&<IR)K"F,,3M6Q4[3$%9K\@5JH8^R]? W"CH3J\)7:)5KB"DWF3XAH
M;!?1QZY!6->P/H88J5K7;(<"5=H9[+ ?SN(#K^Q8Z%ALU[&OO!)A79)RX>JK
M=<4^R*/GRFNTM?'>;A"[5OY//YD-8Y._F6'UY=5@I7TT,]A Y,4'7B6PD,/8
MWKEVOU1CO3L=>;X:LJ&%K3:O[2-_[L010A>/%+I/KM98;S#[D1][JL@UV1G*
M4&*VVR]#<DA"Z&*[T!VS-<KIU@RG:(DK-)D]H6IQY&#5=B0Q!_Y<HB6NT&3^
MA/S%(^7OV%5;%ZZG$&F59(Q58K3R#JW70@3C__%^#&S82*$MY;J-5F8-^SH.
MO!WX0N'ZKC9C^/KF"?YDU$^>1BOM*3]EU0<SW=L,7)!ZW6VJIISGIF3]IMG=
MV=W&[7?==F7E_!4\3_KMUP*FWPW^*:WY%*<@)RL.Z9U%G-VZWV#='[!JVVTY
MOJL8JXKNYX:D?"JT!OSZJJK8XT%[@]TV]_DO4$L#!!0    ( ,X[;E@F,A[2
MD@(  $D&   9    >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;)V5VV[;, R&
M7X7P@*$%MEAV#ATZQT#2K.@N.A0-METK-A,+E2U/DI-VV,-/!T=-BS08=A-+
M,OGS(V4RV4[(!U4A:GBL>:.F4:5U>QG'JJBPIFH@6FS,F[60-=5F*S>Q:B72
MTCG5/$X)F<0U94V49^[L3N:9Z#1G#=Y)4%U=4_DT1RYVTRB)]@?W;%-I>Q#G
M64LWN$3]O;V39A<'E9+5V"@F&I"XGD:SY'(^L?;.X ?#G3I8@\UD)<2#W7PM
MIQ&Q0,BQT%:!FL<6KY!S*V0P?O6:40AI'0_7>_5KE[O)94457@G^DY6ZFD:?
M(BAQ33NN[\7N!OM\QE:O$%RY7]CUMB2"HE-:U+VS(:A9XY_TL:_#@<-H](9#
MVCNDCML'<I0+JFF>2;$#::V-FEVX5)VW@6.-O92EEN8M,WXZ7U94(A2T99IR
M^ BS3E="LM]8AL.S!6K*N#K/8FTB6K^XZ-7G7CU]0SU)X58TNE+PI2FQ?"D0
M&]3 F^YYY^E)Q046 Q@F'R EZ1"N;J[A;'DMS\'\0 S*9J/ZQXEHPU"=H8LV
M_)?J'$O?NX^.N]N&NE0M+7 :F8Y1*+<8Y>_?)1/R^03<*,"-3JGGL[)D]LLV
M5Z1>W**NJ(:YH+($L88%DZ8#A%1@;>CS_6H!3*D.X8^MWK'L?/R)BV^[>YLG
MR8@0DL7;(]SCP#T^R?VMJU<H+1I]E8'Z#_1C=^WI/<7X@'Y\0<B;^). /SF-
M+TP;&N(MY0:@-9GXZI^QQGV/X>3<%S9\EL<8?:B+ T8R(.DKP/B@O6N4&S?$
M%!2B:[3O]' :YN3,CX=G<S]D;ZG<L$8!Q[5Q)8,+4Q[I!Y??:-&Z8;$2VHP>
MMZS,K$=I#<S[M1!ZO[$!PK]'_A=02P,$%     @ SCMN6)].D-X3 P  &PH
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M":(R0-Q/">'/!=E =X 6_ 902P,$%     @ SCMN6$IEPK%& @  % 4  !D
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MU61/D3<+>VV!<0%V/]>:CHX[2OU%F/P!4$L#!!0    ( ,X[;EB\/(33< 4
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MUX>)_<2&+E3_ZOKMRT?XS?4CG;-=)J1"\^(EP!,1*M)B'\_=H&4F4)H-2G-
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M!G:.4V(%(SUWQX(1+426$KACB!=YCMG?"\CH>FRYUF;B/ETD0DW8P6B)%_
MXL?RCLF175/B- ?"4TH0@_G8FKCGH>LK!VWQ,X4UWSE'*I49I<]J<!V/+4=%
M!!E$0B&P/*Q@"EFF2#*./Q74JN^I''?/-_1+G;Q,9H8Y3&GV*XU%,K:&%HIA
MCHM,W-/U%50)]14OHAG7OVA=V3H6B@HN:%XYRPCRE)1'_%()L>/@#EYQ\"H'
M;]^A]XJ#7SGX;W7H50X]K4R9BM8AQ ('(T;7B"EK25,G6DSM+=-/B5KW!\'D
MU53ZB6!*B6!2?+F&*R %</09U7/WY1R:",'262'P+ ,D*+I)([7R9($FC&&R
M /D@"(Z.0A XS?BQ8EQ=HJ.'2W:,Y ]*"7I,:,$QB?G(%C)N=7<[JF*\*&/T
M7HG1]="M#"GAZ"N)(6X";)EPG;6WR?K"ZR2&$)T@W_V$/,?S6P*:OMW=:W$/
MW^[N=F3CUVOH:Y[_OS7<K-?39,;US.\VL4M8KQVFWC/G?(DC&%OR1<*!K< *
M/GYP!\Z7-J%,PD)#L(:(O5K$7A<]>*0"9RC:+X<V 4O00(/4>W45N+VA(U=R
MM:O,H95_YO>;1N&AD5-;--+HUVGT.]/XA@GG0-K"[G1\[[J;A(6&8 W!!K5@
M Y/%,S IHDE8: C6$/&T%O'45/&4H/Y>\3A[Q7-HM6<1=EDT<AC6.0P[<[A)
MYR"_,W)#4F28H>L<+]07[ND6\AFPUH>A$_C>A\$D+#0$:PAY5@MY9K*BSDR*
M:!(6&H(U1'2=[<;,,553%:FC7*8M)BV?HTY0,X^=#:;;F<=WD0#K+*-NP'L?
M :.TT!2M*9ZW%<\S64L5S922)FFA*5I3R>T>V>W</;ZKG/S##=Y^.1V:['^@
M.DW*).R=OBT'MM#]+Y=!%D24S4P]6_?8$]U9[LU?J-Y;]X-;3-FXWV(F/V,<
M93"72.?D5-8V*WOA<B#H4G>',RIDKZE/$\ Q,&4@K\\I%9N!ND']CT3P#U!+
M P04    " #..VY8SZPB6*0"  #,!@  &0   'AL+W=O<FMS:&5E=',O<VAE
M970X,"YX;6RM5=MNVS ,_17! X86V.I;DE[F&&C2%=U#@2#=Y5FQ:5NH+'F2
MG+3]^E&RXZ5M&A3#7BR)(@]Y*.DXV4AUKRL 0QYJ+O34JXQI+GQ?9Q745)_(
M!@3N%%+5U.!2E;YN%-#<!=7<CX)@XM>4"2]-G&VATD2VAC,!"T5T6]=4/<Z
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M:W-H965T<R]S:&5E=#@Q+GAM;,W=87.CN!T&\*^B<6<Z=S.WL0$[<=+$,YN
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MBKY?QGI3Q&J^$RM&MRK:K4!V$M"@16^?T)L:0%\U7-5ZYFOKW9A:HD7]"S3
MWU3SF(.6@)9Z^2UY*=5XW**VSJX<#]M:XW.Q.^?+S1:Y>[X<M\B]#]][K2,'
MU6,PR'F#<Q^#-G<6B&$[(IMDKL1./0;SGII%!.5[VEO\_!,>&[^V.0,29D'"
M;$B8 PES(6$>$*QFMV%EMZ&.OEBFG&?#J/)<0)7G?!KNR2IJMUV!&N>H;"FR
M7^#AQ#!F_?U;/VDK[.HG2)A]5OP.9)4N),P#@M6,,JJ,,M(:Y;X8CM":LQCY
MY2 EBNFW6!U0WFH:+;;K6 4)LR!A=@$;-;R%&]X:'3EP,!V,ZH7<XT(-BWI
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M%UN@BQ/)=OF&VA63ZJTQ/]Q2$E">%5"_KYGR=7F255!M1%_\!U!+ P04
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MXF]Q,&F<3<8(M::]F\7AM#=S9^-V)W69H<6B9X:$;BV%7&,^6NJL24(V5((
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M3-1$PGSJG8=G66KLK<%7!ANU]4X,DUR(GV;PJ9QZ@0D(.!3:(%!\K.$2.#=
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M\O+:HGR1+"L.\FLF)4N+QSV0"+@&J/8M8_+E17=07QXM_P502P,$%     @
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M=QE:BFVH1&2K:=)N:MK#FE/3'N>]=.*FAR*GSEYUW.;%<YMWMZHI9*N"%.-
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M+^(L3&*2BLW#Z-'^P%U6-"@M?@O%:W;VFA1#>4Z2;\6;7]8/(ZNX(A&)55Y
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MV<<EE4:?JP;R[W/&Q.Z+.L#^]3W7_P%02P,$%     @ SCMN6!TE*L^! @
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M%     @ SCMN6)>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q
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M+LP?5BZ>_Z7'\[\C^?P?4$L#!!0    ( ,X[;ECB50\<^ (  + ]   :
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M56\/T-LW#TL >GO5VP/T]JJW!^CM56\/T-NKWAZ@MU>]/4!OKWI[@-Y!]0X
MO8/J'0!Z!]4[ /0.JG< Z!V:A]T O8/J'0!Z!]4[ /0.JG< Z!U4[P#0.ZC>
M :!W5+TC0.^H>D> WE'UC@"]H^H= 7I'U3L"]([-GY4 O:/J'0%Z1]4[ O2.
MJG<$Z!U5[PC0.ZG>":!W4KT30.^D>B> WDGU3@"]D^J= 'HGU3L!]$[-81.
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MC(>Z&U_SD^7?MC<_ 5!+ 0(4 Q0    ( ,X[;E@'04UB@0   +$    0
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M965T,RYX;6Q02P$"% ,4    " #..VY8Z2M99J\#   Y#0  &
M    @($U&@  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @
MSCMN6-4Y_!UQ"   F$   !@              ("!&AX  'AL+W=O<FMS:&5E
M=',O<VAE970U+GAM;%!+ 0(4 Q0    ( ,X[;E@0@)$P40H  %TT   8
M          " @<$F  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4
M    " #..VY8"RW23AX%  !B"P  &               @(%(,0  >&PO=V]R
M:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ SCMN6 %?G7QJ!0  / P
M !@              ("!G#8  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+
M 0(4 Q0    ( ,X[;E@-V!H=%R,  !EQ   8              " @3P\  !X
M;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " #..VY81OGZ<20%
M  #N$   &0              @(&)7P  >&PO=V]R:W-H965T<R]S:&5E=#$P
M+GAM;%!+ 0(4 Q0    ( ,X[;EAXLT,K@P4  ) 0   9              "
M@>1D  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ SCMN
M6%IKA%UT!   ZPD  !D              ("!GFH  'AL+W=O<FMS:&5E=',O
M<VAE970Q,BYX;6Q02P$"% ,4    " #..VY8Q@RZ"N\$  !-#   &0
M        @(%);P  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0
M   ( ,X[;EB'!</8;@,  )@)   9              " @6]T  !X;"]W;W)K
M<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ SCMN6&$*2[S; @  ZP8
M !D              ("!%'@  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q0
M2P$"% ,4    " #..VY8UT&ZRH("  "E!0  &0              @($F>P
M>&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( ,X[;EC:9VDA
M=P(  -(%   9              " @=]]  !X;"]W;W)K<VAE971S+W-H965T
M,3<N>&UL4$L! A0#%     @ SCMN6%*DL0-A"P  !R   !D
M ("!C8   'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    " #.
M.VY8('VDI38#  #*!P  &0              @($EC   >&PO=V]R:W-H965T
M<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( ,X[;EC'F$VT[1<  %-1   9
M          " @9*/  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#
M%     @ SCMN6)DQQJ5+!0  20X  !D              ("!MJ<  'AL+W=O
M<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " #..VY8K-C<X1H#  !<
M!P  &0              @($XK0  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM
M;%!+ 0(4 Q0    ( ,X[;EAE+7N5% 8  !H0   9              " @8FP
M  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ SCMN6.IA
M^5V #   ="D  !D              ("!U+8  'AL+W=O<FMS:&5E=',O<VAE
M970R-"YX;6Q02P$"% ,4    " #..VY8MWPZ2:4*  !Z(@  &0
M    @(&+PP  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    (
M ,X[;EA'3=J:6@0  *X)   9              " @6?.  !X;"]W;W)K<VAE
M971S+W-H965T,C8N>&UL4$L! A0#%     @ SCMN6,F2&C%V!   2 L  !D
M             ("!^-(  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"
M% ,4    " #..VY8L7STZA,)  ",%P  &0              @(&EUP  >&PO
M=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( ,X[;EBFTI:$QP(
M  \&   9              " @>_@  !X;"]W;W)K<VAE971S+W-H965T,CDN
M>&UL4$L! A0#%     @ SCMN6/1&>BXY!   $PD  !D              ("!
M[>,  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    " #..VY8
MH+<I3R0D   R>P  &0              @(%=Z   >&PO=V]R:W-H965T<R]S
M:&5E=#,Q+GAM;%!+ 0(4 Q0    ( ,X[;E@DJ0,T/ ,  )0(   9
M      " @;@, 0!X;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%
M  @ SCMN6$"9U)V)!   > \  !D              ("!*Q ! 'AL+W=O<FMS
M:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " #..VY8RET1S98$  ")#@
M&0              @('K% $ >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+
M 0(4 Q0    ( ,X[;ECMQ&ZG80(  %<%   9              " @;@9 0!X
M;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @ SCMN6%S;KV:*
M @  %@<  !D              ("!4!P! 'AL+W=O<FMS:&5E=',O<VAE970S
M-BYX;6Q02P$"% ,4    " #..VY8C<,[<CH#   T"0  &0
M@($1'P$ >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( ,X[
M;EBX"?U-30(  *@%   9              " @8(B 0!X;"]W;W)K<VAE971S
M+W-H965T,S@N>&UL4$L! A0#%     @ SCMN6-7$CH!? @  G 4  !D
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M=#0S+GAM;%!+ 0(4 Q0    ( ,X[;EB_.%JA'0,  "D'   9
M  " @10U 0!X;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @
MSCMN6%*'_,7/!   -PX  !D              ("!:#@! 'AL+W=O<FMS:&5E
M=',O<VAE970T-2YX;6Q02P$"% ,4    " #..VY8ZFQ%A1,(  #.'P  &0
M            @(%N/0$ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4
M Q0    ( ,X[;E@4JPB6XP<  '4;   9              " @;A% 0!X;"]W
M;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ SCMN6)_>IE*1 @
MS04  !D              ("!TDT! 'AL+W=O<FMS:&5E=',O<VAE970T."YX
M;6Q02P$"% ,4    " #..VY8?^1W=LP#  "F"0  &0              @(&:
M4 $ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    ( ,X[;ECI
M+6[U2@,  %P(   9              " @9U4 0!X;"]W;W)K<VAE971S+W-H
M965T-3 N>&UL4$L! A0#%     @ SCMN6,UTH1;O 0  $00  !D
M     ("!'E@! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,X[;EA"CY\\>0(  'X&   9              "
M@81E 0!X;"]W;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#%     @ SCMN
M6*7?A! V @  .@4  !D              ("!-&@! 'AL+W=O<FMS:&5E=',O
M<VAE970U-RYX;6Q02P$"% ,4    " #..VY89]X3\$@+  #Z:P  &0
M        @(&A:@$ >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0
M   ( ,X[;EB_!CE^\@0  *$;   9              " @2!V 0!X;"]W;W)K
M<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @ SCMN6.M@"XX6 P  R @
M !D              ("!27L! 'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q0
M2P$"% ,4    " #..VY85MDNLG8#  "<#P  &0              @(&6?@$
M>&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    ( ,X[;E@?*35V
M_@,  $D/   9              " @4." 0!X;"]W;W)K<VAE971S+W-H965T
M-C(N>&UL4$L! A0#%     @ SCMN6-N0O1&\ P  L14  !D
M ("!>(8! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6Q02P$"% ,4    " #.
M.VY8LTG]Y/$#  ")&   &0              @(%KB@$ >&PO=V]R:W-H965T
M<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( ,X[;EC*L;BER0(   <+   9
M          " @9.. 0!X;"]W;W)K<VAE971S+W-H965T-C4N>&UL4$L! A0#
M%     @ SCMN6%-Z<@]9 @  ;@8  !D              ("!DY$! 'AL+W=O
M<FMS:&5E=',O<VAE970V-BYX;6Q02P$"% ,4    " #..VY84M$D$XH"   4
M"   &0              @($CE $ >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM
M;%!+ 0(4 Q0    ( ,X[;E@Z]@'-^P(  & *   9              " @>26
M 0!X;"]W;W)K<VAE971S+W-H965T-C@N>&UL4$L! A0#%     @ SCMN6 A;
M])C+ @  &PD  !D              ("!%IH! 'AL+W=O<FMS:&5E=',O<VAE
M970V.2YX;6Q02P$"% ,4    " #..VY88S025>H&  #R+@  &0
M    @($8G0$ >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    (
M ,X[;E@F,A[2D@(  $D&   9              " @3FD 0!X;"]W;W)K<VAE
M971S+W-H965T-S$N>&UL4$L! A0#%     @ SCMN6)].D-X3 P  &PH  !D
M             ("! J<! 'AL+W=O<FMS:&5E=',O<VAE970W,BYX;6Q02P$"
M% ,4    " #..VY8?@DA1D0#  "&"@  &0              @(%,J@$ >&PO
M=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0    ( ,X[;EB<GD^:N@,
M $P3   9              " @<>M 0!X;"]W;W)K<VAE971S+W-H965T-S0N
M>&UL4$L! A0#%     @ SCMN6$IEPK%& @  % 4  !D              ("!
MN+$! 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q02P$"% ,4    " #..VY8
MO#R$TW %  #8)0  &0              @($UM $ >&PO=V]R:W-H965T<R]S
M:&5E=#<V+GAM;%!+ 0(4 Q0    ( ,X[;EB>;!TR;@4  (4F   9
M      " @=RY 0!X;"]W;W)K<VAE971S+W-H965T-S<N>&UL4$L! A0#%
M  @ SCMN6%'W,@OA @  .PD  !D              ("!@;\! 'AL+W=O<FMS
M:&5E=',O<VAE970W."YX;6Q02P$"% ,4    " #..VY8";=TD68#  "=$
M&0              @(&9P@$ >&PO=V]R:W-H965T<R]S:&5E=#<Y+GAM;%!+
M 0(4 Q0    ( ,X[;EC/K")8I (  ,P&   9              " @3;& 0!X
M;"]W;W)K<VAE971S+W-H965T.# N>&UL4$L! A0#%     @ SCMN6,;ZY,#?
M"@  ZHH  !D              ("!$<D! 'AL+W=O<FMS:&5E=',O<VAE970X
M,2YX;6Q02P$"% ,4    " #..VY85UQ0,J\%  "4+@  &0
M@($GU $ >&PO=V]R:W-H965T<R]S:&5E=#@R+GAM;%!+ 0(4 Q0    ( ,X[
M;EB,HWRV%P@  $)A   9              " @0W: 0!X;"]W;W)K<VAE971S
M+W-H965T.#,N>&UL4$L! A0#%     @ SCMN6&;.]2AE"0  OW   !D
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M=#@X+GAM;%!+ 0(4 Q0    ( ,X[;EB)/YKS8 ,  !P,   9
M  " @2\" @!X;"]W;W)K<VAE971S+W-H965T.#DN>&UL4$L! A0#%     @
MSCMN6)A6/=,/ P  % H  !D              ("!Q@4" 'AL+W=O<FMS:&5E
M=',O<VAE970Y,"YX;6Q02P$"% ,4    " #..VY8#9)R>%T$  "4$@  &0
M            @($,"0( >&PO=V]R:W-H965T<R]S:&5E=#DQ+GAM;%!+ 0(4
M Q0    ( ,X[;E@4AKC&= 0  $@2   9              " @: - @!X;"]W
M;W)K<VAE971S+W-H965T.3(N>&UL4$L! A0#%     @ SCMN6-)T'TI@ P
M9PH  !D              ("!2Q(" 'AL+W=O<FMS:&5E=',O<VAE970Y,RYX
M;6Q02P$"% ,4    " #..VY896&HLZ0#  "G"P  &0              @('B
M%0( >&PO=V]R:W-H965T<R]S:&5E=#DT+GAM;%!+ 0(4 Q0    ( ,X[;EAG
MJ1\46 <  .!    9              " @;T9 @!X;"]W;W)K<VAE971S+W-H
M965T.34N>&UL4$L! A0#%     @ SCMN6 +Q6+%J!0  #RX  !D
M     ("!3"$" 'AL+W=O<FMS:&5E=',O<VAE970Y-BYX;6Q02P$"% ,4
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M,"YX;6Q02P$"% ,4    " #..VY8^4KB<L,#   R$@  &@
M@('H10( >&PO=V]R:W-H965T<R]S:&5E=#$P,2YX;6Q02P$"% ,4    " #.
M.VY8!_(ML5<#  #\"@  &@              @('C20( >&PO=V]R:W-H965T
M<R]S:&5E=#$P,BYX;6Q02P$"% ,4    " #..VY8%81@MNH#  !R$P  &@
M            @(%R30( >&PO=V]R:W-H965T<R]S:&5E=#$P,RYX;6Q02P$"
M% ,4    " #..VY8K3'MQ(4(  #*1P  &@              @(&440( >&PO
M=V]R:W-H965T<R]S:&5E=#$P-"YX;6Q02P$"% ,4    " #..VY8'24JSX$"
M  !F!0  &@              @(%16@( >&PO=V]R:W-H965T<R]S:&5E=#$P
M-2YX;6Q02P$"% ,4    " #..VY8_R?]KH(#  "M&   #0
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:+GAM;%!+!08     <0!Q !0?   R;P(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>396</ContextCount>
  <ElementCount>415</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>127</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>20</UnitCount>
  <MyReports>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00100 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/StatementConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00200 - Statement - Consolidated Statements of Income/(Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss</Role>
      <ShortName>Consolidated Statements of Income/(Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00300 - Statement - Consolidated Statements of Comprehensive Income/(Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Income/(Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00400 - Statement - Consolidated Statements of Changes in Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity</Role>
      <ShortName>Consolidated Statements of Changes in Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00500 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>10101 - Disclosure - General information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureGeneralInformation</Role>
      <ShortName>General information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>10201 - Disclosure - Basis of preparation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureBasisOfPreparation</Role>
      <ShortName>Basis of preparation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>10301 - Disclosure - Summary of material accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPolicies</Role>
      <ShortName>Summary of material accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>10401 - Disclosure - Property, plant and equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosurePropertyPlantAndEquipment</Role>
      <ShortName>Property, plant and equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>10501 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilities</Role>
      <ShortName>Right-of-use assets, long-term financial assets and lease liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>10601 - Disclosure - Asset acquisition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureAssetAcquisition</Role>
      <ShortName>Asset acquisition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>10701 - Disclosure - Intangible assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureIntangibleAssets</Role>
      <ShortName>Intangible assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>10801 - Disclosure - Cash and cash equivalents and short-term financial assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssets</Role>
      <ShortName>Cash and cash equivalents and short-term financial assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>10901 - Disclosure - Prepaid expenses and accrued income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncome</Role>
      <ShortName>Prepaid expenses and accrued income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>11001 - Disclosure - Accounts receivable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureAccountsReceivable</Role>
      <ShortName>Accounts receivable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>11101 - Disclosure - Other current receivables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureOtherCurrentReceivables</Role>
      <ShortName>Other current receivables</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>11201 - Disclosure - Share capital</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareCapital</Role>
      <ShortName>Share capital</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>11301 - Disclosure - Trade and other payables and accrued expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpenses</Role>
      <ShortName>Trade and other payables and accrued expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>11401 - Disclosure - Contract revenues</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureContractRevenues</Role>
      <ShortName>Contract revenues</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>11501 - Disclosure - Expenses by category</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureExpensesByCategory</Role>
      <ShortName>Expenses by category</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>11601 - Disclosure - Related-party transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRelatedPartyTransactions</Role>
      <ShortName>Related-party transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>11701 - Disclosure - Income taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureIncomeTaxes</Role>
      <ShortName>Income taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>11801 - Disclosure - Retirement benefit plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRetirementBenefitPlan</Role>
      <ShortName>Retirement benefit plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>11901 - Disclosure - Share-based compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareBasedCompensation</Role>
      <ShortName>Share-based compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>12001 - Disclosure - Commitments and contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>12101 - Disclosure - Earnings per share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureEarningsPerShare</Role>
      <ShortName>Earnings per share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>12201 - Disclosure - Financial instruments and risk management</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagement</Role>
      <ShortName>Financial instruments and risk management</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>12301 - Disclosure - Capital risk management</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureCapitalRiskManagement</Role>
      <ShortName>Capital risk management</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>12401 - Disclosure - Subsequent events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureSubsequentEvents</Role>
      <ShortName>Subsequent events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>20302 - Disclosure - Summary of material accounting policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies</Role>
      <ShortName>Summary of material accounting policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>30303 - Disclosure - Summary of material accounting policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesTables</Role>
      <ShortName>Summary of material accounting policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPolicies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>30403 - Disclosure - Property, plant and equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosurePropertyPlantAndEquipmentTables</Role>
      <ShortName>Property, plant and equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosurePropertyPlantAndEquipment</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>30503 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesTables</Role>
      <ShortName>Right-of-use assets, long-term financial assets and lease liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilities</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>30603 - Disclosure - Asset acquisition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureAssetAcquisitionTables</Role>
      <ShortName>Asset acquisition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureAssetAcquisition</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>30703 - Disclosure - Intangible assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureIntangibleAssetsTables</Role>
      <ShortName>Intangible assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureIntangibleAssets</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>30803 - Disclosure - Cash and cash equivalents and short-term financial assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssetsTables</Role>
      <ShortName>Cash and cash equivalents and short-term financial assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssets</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>30903 - Disclosure - Prepaid expenses and accrued income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeTables</Role>
      <ShortName>Prepaid expenses and accrued income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncome</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>31103 - Disclosure - Other current receivables (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureOtherCurrentReceivablesTables</Role>
      <ShortName>Other current receivables (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureOtherCurrentReceivables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>31203 - Disclosure - Share capital (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareCapitalTables</Role>
      <ShortName>Share capital (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureShareCapital</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>31303 - Disclosure - Trade and other payables and accrued expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesTables</Role>
      <ShortName>Trade and other payables and accrued expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpenses</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>31403 - Disclosure - Contract revenues (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureContractRevenuesTables</Role>
      <ShortName>Contract revenues (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureContractRevenues</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>31503 - Disclosure - Expenses by category (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureExpensesByCategoryTables</Role>
      <ShortName>Expenses by category (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureExpensesByCategory</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>31603 - Disclosure - Related-party transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRelatedPartyTransactionsTables</Role>
      <ShortName>Related-party transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureRelatedPartyTransactions</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>31703 - Disclosure - Income taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureIncomeTaxesTables</Role>
      <ShortName>Income taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureIncomeTaxes</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>31803 - Disclosure - Retirement benefit plan (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRetirementBenefitPlanTables</Role>
      <ShortName>Retirement benefit plan (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureRetirementBenefitPlan</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>31903 - Disclosure - Share-based compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareBasedCompensationTables</Role>
      <ShortName>Share-based compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureShareBasedCompensation</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>32003 - Disclosure - Commitments and contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureCommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureCommitmentsAndContingencies</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>32103 - Disclosure - Earnings per share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureEarningsPerShareTables</Role>
      <ShortName>Earnings per share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureEarningsPerShare</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>32203 - Disclosure - Financial instruments and risk management (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementTables</Role>
      <ShortName>Financial instruments and risk management (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagement</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>40101 - Disclosure - General information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureGeneralInformationDetails</Role>
      <ShortName>General information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureGeneralInformation</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>40201 - Disclosure - Basis of preparation - Going concern (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureBasisOfPreparationGoingConcernDetails</Role>
      <ShortName>Basis of preparation - Going concern (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>40301 - Disclosure - Summary of material accounting policies - Functional and reporting currency (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesFunctionalAndReportingCurrencyDetails</Role>
      <ShortName>Summary of material accounting policies - Functional and reporting currency (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>40302 - Disclosure - Summary of material accounting policies, Right-of-use assets and lease liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails</Role>
      <ShortName>Summary of material accounting policies, Right-of-use assets and lease liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>40303 - Disclosure - Summary of material accounting policies, Property, plant and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPropertyPlantAndEquipmentDetails</Role>
      <ShortName>Summary of material accounting policies, Property, plant and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>40304 - Disclosure - Summary of material accounting policies, Income taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesIncomeTaxesDetails</Role>
      <ShortName>Summary of material accounting policies, Income taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>40305 - Disclosure - Summary of material accounting policies, Segment reporting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesSegmentReportingDetails</Role>
      <ShortName>Summary of material accounting policies, Segment reporting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>40401 - Disclosure - Property, plant and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails</Role>
      <ShortName>Property, plant and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosurePropertyPlantAndEquipmentTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>40501 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails</Role>
      <ShortName>Right-of-use assets, long-term financial assets and lease liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>40502 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities - Statement of income/(loss) and cash flow (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails</Role>
      <ShortName>Right-of-use assets, long-term financial assets and lease liabilities - Statement of income/(loss) and cash flow (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>40503 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities - Contractual undiscounted cash flows for lease obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails</Role>
      <ShortName>Right-of-use assets, long-term financial assets and lease liabilities - Contractual undiscounted cash flows for lease obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>40601 - Disclosure - Asset acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureAssetAcquisitionDetails</Role>
      <ShortName>Asset acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureAssetAcquisitionTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>40701 - Disclosure - Intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureIntangibleAssetsDetails</Role>
      <ShortName>Intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureIntangibleAssetsTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>40801 - Disclosure - Cash and cash equivalents and financial assets, Cash and cash equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails</Role>
      <ShortName>Cash and cash equivalents and financial assets, Cash and cash equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>40802 - Disclosure - Cash and cash equivalents and financial assets, Cash and cash equivalents and short-term financial assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails</Role>
      <ShortName>Cash and cash equivalents and financial assets, Cash and cash equivalents and short-term financial assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>40901 - Disclosure - Prepaid expenses and accrued income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails</Role>
      <ShortName>Prepaid expenses and accrued income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>41001 - Disclosure - Accounts receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureAccountsReceivableDetails</Role>
      <ShortName>Accounts receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureAccountsReceivable</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>41101 - Disclosure - Other current receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails</Role>
      <ShortName>Other current receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureOtherCurrentReceivablesTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>41201 - Disclosure - Share capital - Narratives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareCapitalNarrativesDetails</Role>
      <ShortName>Share capital - Narratives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>41202 - Disclosure - Share capital - Capital Structure (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails</Role>
      <ShortName>Share capital - Capital Structure (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>41203 - Disclosure - Share capital - Authorized capital (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareCapitalAuthorizedCapitalDetails</Role>
      <ShortName>Share capital - Authorized capital (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>41204 - Disclosure - Share capital - Conditional share capital for financing and other purposes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForFinancingAndOtherPurposesDetails</Role>
      <ShortName>Share capital - Conditional share capital for financing and other purposes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>41205 - Disclosure - Share capital - Conditional share capital for employee benefit plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails</Role>
      <ShortName>Share capital - Conditional share capital for employee benefit plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>41206 - Disclosure - Share capital - Follow-On Offering (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareCapitalFollowOnOfferingDetails</Role>
      <ShortName>Share capital - Follow-On Offering (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>41207 - Disclosure - Share capital - Shelf registration statement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails</Role>
      <ShortName>Share capital - Shelf registration statement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>41208 - Disclosure - Share capital - At the market equity offering (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails</Role>
      <ShortName>Share capital - At the market equity offering (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>41209 - Disclosure - Share capital - Convertible note agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails</Role>
      <ShortName>Share capital - Convertible note agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>41301 - Disclosure - Trade and other payables and accrued expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails</Role>
      <ShortName>Trade and other payables and accrued expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>41401 - Disclosure - Contract revenues - Contract Revenue Attributable to Licensing Arrangements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails</Role>
      <ShortName>Contract revenues - Contract Revenue Attributable to Licensing Arrangements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>41402 - Disclosure - Contract revenues - Recognized Revenues (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureContractRevenuesRecognizedRevenuesDetails</Role>
      <ShortName>Contract revenues - Recognized Revenues (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>41403 - Disclosure - Contract revenues - Morphomer Tau small molecule - 2018 license agreement with Eli Lilly and Company (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails</Role>
      <ShortName>Contract revenues - Morphomer Tau small molecule - 2018 license agreement with Eli Lilly and Company (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>41404 - Disclosure - Contract revenues - Tau Vaccine in AD - 2014 Agreement with Janssen Pharmaceuticals (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails</Role>
      <ShortName>Contract revenues - Tau Vaccine in AD - 2014 Agreement with Janssen Pharmaceuticals (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>41405 - Disclosure - Contract revenues - Tau-PET imaging agent -2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails</Role>
      <ShortName>Contract revenues - Tau-PET imaging agent -2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>41406 - Disclosure - Contract revenues - Grants from the Michael J. Fox Foundation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails</Role>
      <ShortName>Contract revenues - Grants from the Michael J. Fox Foundation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>41501 - Disclosure - Expenses by category (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureExpensesByCategoryDetails</Role>
      <ShortName>Expenses by category (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureExpensesByCategoryTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>41601 - Disclosure - Related-party transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails</Role>
      <ShortName>Related-party transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureRelatedPartyTransactionsTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>41701 - Disclosure - Income taxes - Summary of Income Tax Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails</Role>
      <ShortName>Income taxes - Summary of Income Tax Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>41702 - Disclosure - Income taxes, Unrecognized Deductible Temporary Differences, Unused Tax Losses and Unused Tax Credits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails</Role>
      <ShortName>Income taxes, Unrecognized Deductible Temporary Differences, Unused Tax Losses and Unused Tax Credits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>41801 - Disclosure - Retirement benefit plan - Summary of Benefit Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails</Role>
      <ShortName>Retirement benefit plan - Summary of Benefit Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>41802 - Disclosure - Retirement benefit plan - Amounts recorded in consolidated statements of income (loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails</Role>
      <ShortName>Retirement benefit plan - Amounts recorded in consolidated statements of income (loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>41803 - Disclosure - Retirement benefit plan - Changes in Defined Benefit Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails</Role>
      <ShortName>Retirement benefit plan - Changes in Defined Benefit Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>41804 - Disclosure - Retirement benefit plan - Changes in Fair Value of Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails</Role>
      <ShortName>Retirement benefit plan - Changes in Fair Value of Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>41805 - Disclosure - Retirement benefit plan - Change in Net Defined Benefit Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails</Role>
      <ShortName>Retirement benefit plan - Change in Net Defined Benefit Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>41806 - Disclosure - Retirement benefit plan - Change in other comprehensive gains (losses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails</Role>
      <ShortName>Retirement benefit plan - Change in other comprehensive gains (losses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>41807 - Disclosure - Retirement benefit plan - Actuarial Assumptions and Sensitivity Analysis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails</Role>
      <ShortName>Retirement benefit plan - Actuarial Assumptions and Sensitivity Analysis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>41901 - Disclosure - Share-based compensation, Plans Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails</Role>
      <ShortName>Share-based compensation, Plans Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>41902 - Disclosure - Share-based compensation, Weighted Average Exercise Prices (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails</Role>
      <ShortName>Share-based compensation, Weighted Average Exercise Prices (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>41903 - Disclosure - Share-based compensation, Outstanding Options, Range of Exercise prices and Expiration Dates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails</Role>
      <ShortName>Share-based compensation, Outstanding Options, Range of Exercise prices and Expiration Dates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>41904 - Disclosure - Share-based compensation, Weighted Average Grant date Fair Value and Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails</Role>
      <ShortName>Share-based compensation, Weighted Average Grant date Fair Value and Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>41905 - Disclosure - Share-based compensation, Non-vested Share Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails</Role>
      <ShortName>Share-based compensation, Non-vested Share Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>42001 - Disclosure - Commitments and contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails</Role>
      <ShortName>Commitments and contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureCommitmentsAndContingenciesTables</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>42101 - Disclosure - Earnings per share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureEarningsPerShareDetails</Role>
      <ShortName>Earnings per share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureEarningsPerShareTables</ParentRole>
      <Position>102</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>42102 - Disclosure - Earnings per share - Antidilutive securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureEarningsPerShareAntidilutiveSecuritiesDetails</Role>
      <ShortName>Earnings per share - Antidilutive securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>42201 - Disclosure - Financial instruments and risk management (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails</Role>
      <ShortName>Financial instruments and risk management (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementTables</ParentRole>
      <Position>104</Position>
    </Report>
    <Report instance="aciu-20231231x20f.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>42401 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acimume.com/role/DisclosureSubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>aciu-20231231.xsd</File>
    <File>aciu-20231231_cal.xml</File>
    <File>aciu-20231231_def.xml</File>
    <File>aciu-20231231_lab.xml</File>
    <File>aciu-20231231_pre.xml</File>
    <File doctype="20-F" isDefinitelyFs="true" isIfrs="true" original="aciu-20231231x20f.htm">aciu-20231231x20f.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>aciu-20231231x20f001.jpg</File>
    <File>aciu-20231231x20f002.jpg</File>
    <File>aciu-20231231x20f003.jpg</File>
    <File>aciu-20231231x20f004.jpg</File>
    <File>aciu-20231231x20f005.jpg</File>
    <File>aciu-20231231x20f006.jpg</File>
    <File>aciu-20231231x20f007.jpg</File>
    <File>aciu-20231231x20f008.jpg</File>
    <File>aciu-20231231x20f009.jpg</File>
    <File>aciu-20231231x20f010.jpg</File>
    <File>aciu-20231231x20f011.jpg</File>
    <File>aciu-20231231x20f012.jpg</File>
    <File>aciu-20231231x20f013.jpg</File>
    <File>aciu-20231231x20f014.jpg</File>
    <File>aciu-20231231x20f015.jpg</File>
    <File>aciu-20231231x20f016.jpg</File>
    <File>aciu-20231231x20f017.jpg</File>
    <File>aciu-20231231x20f018.jpg</File>
    <File>aciu-20231231x20f019.jpg</File>
    <File>aciu-20231231x20f020.jpg</File>
    <File>aciu-20231231x20f021.jpg</File>
    <File>aciu-20231231x20f022.jpg</File>
    <File>aciu-20231231x20f023.jpg</File>
    <File>aciu-20231231x20f024.jpg</File>
    <File>aciu-20231231x20f025.jpg</File>
    <File>aciu-20231231x20f026.jpg</File>
    <File>aciu-20231231x20f027.jpg</File>
    <File>aciu-20231231x20f028.jpg</File>
    <File>aciu-20231231x20f029.jpg</File>
    <File>aciu-20231231x20f030.jpg</File>
    <File>aciu-20231231x20f031.jpg</File>
    <File>aciu-20231231x20f032.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="44">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="1123">https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>161
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "aciu-20231231x20f.htm": {
   "nsprefix": "aciu",
   "nsuri": "http://acimume.com/20231231",
   "dts": {
    "schema": {
     "local": [
      "aciu-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "aciu-20231231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "aciu-20231231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "aciu-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aciu-20231231_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "aciu-20231231x20f.htm"
     ]
    }
   },
   "keyStandard": 282,
   "keyCustom": 133,
   "axisStandard": 30,
   "axisCustom": 1,
   "memberStandard": 43,
   "memberCustom": 79,
   "hidden": {
    "total": 11,
    "http://acimume.com/20231231": 5,
    "http://xbrl.sec.gov/dei/2023": 5,
    "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 1
   },
   "contextCount": 396,
   "entityCount": 1,
   "segmentCount": 127,
   "elementCount": 739,
   "unitCount": 20,
   "baseTaxonomies": {
    "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 1123,
    "http://xbrl.sec.gov/dei/2023": 44
   },
   "report": {
    "R1": {
     "role": "http://acimume.com/role/DocumentDocumentAndEntityInformation",
     "longName": "00090 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://acimume.com/role/StatementConsolidatedBalanceSheets",
     "longName": "00100 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:NoncurrentRestrictedCashAndCashEquivalents",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss",
     "longName": "00200 - Statement - Consolidated Statements of Income/(Loss)",
     "shortName": "Consolidated Statements of Income/(Loss)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:Revenue",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://acimume.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss",
     "longName": "00300 - Statement - Consolidated Statements of Comprehensive Income/(Loss)",
     "shortName": "Consolidated Statements of Comprehensive Income/(Loss)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity",
     "longName": "00400 - Statement - Consolidated Statements of Changes in Equity",
     "shortName": "Consolidated Statements of Changes in Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_XpmQIKbzzk-A4QLCviO8sw",
      "name": "ifrs-full:Equity",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_4Nainf_0SEuwFd4uqOjiSQ",
      "name": "ifrs-full:Equity",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows",
     "longName": "00500 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:AdjustmentsForDepreciationExpense",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://acimume.com/role/DisclosureGeneralInformation",
     "longName": "10101 - Disclosure - General information",
     "shortName": "General information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://acimume.com/role/DisclosureBasisOfPreparation",
     "longName": "10201 - Disclosure - Basis of preparation",
     "shortName": "Basis of preparation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPolicies",
     "longName": "10301 - Disclosure - Summary of material accounting policies",
     "shortName": "Summary of material accounting policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://acimume.com/role/DisclosurePropertyPlantAndEquipment",
     "longName": "10401 - Disclosure - Property, plant and equipment",
     "shortName": "Property, plant and equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilities",
     "longName": "10501 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities",
     "shortName": "Right-of-use assets, long-term financial assets and lease liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://acimume.com/role/DisclosureAssetAcquisition",
     "longName": "10601 - Disclosure - Asset acquisition",
     "shortName": "Asset acquisition",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfAssetAcquisitionsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfAssetAcquisitionsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://acimume.com/role/DisclosureIntangibleAssets",
     "longName": "10701 - Disclosure - Intangible assets",
     "shortName": "Intangible assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssets",
     "longName": "10801 - Disclosure - Cash and cash equivalents and short-term financial assets",
     "shortName": "Cash and cash equivalents and short-term financial assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncome",
     "longName": "10901 - Disclosure - Prepaid expenses and accrued income",
     "shortName": "Prepaid expenses and accrued income",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://acimume.com/role/DisclosureAccountsReceivable",
     "longName": "11001 - Disclosure - Accounts receivable",
     "shortName": "Accounts receivable",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfAccountsReceivableTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfAccountsReceivableTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://acimume.com/role/DisclosureOtherCurrentReceivables",
     "longName": "11101 - Disclosure - Other current receivables",
     "shortName": "Other current receivables",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfOtherCurrentReceivablesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfOtherCurrentReceivablesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://acimume.com/role/DisclosureShareCapital",
     "longName": "11201 - Disclosure - Share capital",
     "shortName": "Share capital",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpenses",
     "longName": "11301 - Disclosure - Trade and other payables and accrued expenses",
     "shortName": "Trade and other payables and accrued expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://acimume.com/role/DisclosureContractRevenues",
     "longName": "11401 - Disclosure - Contract revenues",
     "shortName": "Contract revenues",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfRevenueExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfRevenueExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://acimume.com/role/DisclosureExpensesByCategory",
     "longName": "11501 - Disclosure - Expenses by category",
     "shortName": "Expenses by category",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfExpensesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfExpensesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://acimume.com/role/DisclosureRelatedPartyTransactions",
     "longName": "11601 - Disclosure - Related-party transactions",
     "shortName": "Related-party transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://acimume.com/role/DisclosureIncomeTaxes",
     "longName": "11701 - Disclosure - Income taxes",
     "shortName": "Income taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://acimume.com/role/DisclosureRetirementBenefitPlan",
     "longName": "11801 - Disclosure - Retirement benefit plan",
     "shortName": "Retirement benefit plan",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://acimume.com/role/DisclosureShareBasedCompensation",
     "longName": "11901 - Disclosure - Share-based compensation",
     "shortName": "Share-based compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://acimume.com/role/DisclosureCommitmentsAndContingencies",
     "longName": "12001 - Disclosure - Commitments and contingencies",
     "shortName": "Commitments and contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://acimume.com/role/DisclosureEarningsPerShare",
     "longName": "12101 - Disclosure - Earnings per share",
     "shortName": "Earnings per share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagement",
     "longName": "12201 - Disclosure - Financial instruments and risk management",
     "shortName": "Financial instruments and risk management",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://acimume.com/role/DisclosureCapitalRiskManagement",
     "longName": "12301 - Disclosure - Capital risk management",
     "shortName": "Capital risk management",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://acimume.com/role/DisclosureSubsequentEvents",
     "longName": "12401 - Disclosure - Subsequent events",
     "shortName": "Subsequent events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies",
     "longName": "20302 - Disclosure - Summary of material accounting policies (Policies)",
     "shortName": "Summary of material accounting policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "31",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesTables",
     "longName": "30303 - Disclosure - Summary of material accounting policies (Tables)",
     "shortName": "Summary of material accounting policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory",
       "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory",
       "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentTables",
     "longName": "30403 - Disclosure - Property, plant and equipment (Tables)",
     "shortName": "Property, plant and equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesTables",
     "longName": "30503 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities (Tables)",
     "shortName": "Right-of-use assets, long-term financial assets and lease liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://acimume.com/role/DisclosureAssetAcquisitionTables",
     "longName": "30603 - Disclosure - Asset acquisition (Tables)",
     "shortName": "Asset acquisition (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfAssetAcquisitionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "aciu:DisclosureOfAssetAcquisitionsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfAssetAcquisitionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "aciu:DisclosureOfAssetAcquisitionsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://acimume.com/role/DisclosureIntangibleAssetsTables",
     "longName": "30703 - Disclosure - Intangible assets (Tables)",
     "shortName": "Intangible assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssetsTables",
     "longName": "30803 - Disclosure - Cash and cash equivalents and short-term financial assets (Tables)",
     "shortName": "Cash and cash equivalents and short-term financial assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "aciu:DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "aciu:DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeTables",
     "longName": "30903 - Disclosure - Prepaid expenses and accrued income (Tables)",
     "shortName": "Prepaid expenses and accrued income (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "aciu:DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "aciu:DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://acimume.com/role/DisclosureOtherCurrentReceivablesTables",
     "longName": "31103 - Disclosure - Other current receivables (Tables)",
     "shortName": "Other current receivables (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "aciu:DisclosureOfOtherCurrentReceivablesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "aciu:DisclosureOfOtherCurrentReceivablesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://acimume.com/role/DisclosureShareCapitalTables",
     "longName": "31203 - Disclosure - Share capital (Tables)",
     "shortName": "Share capital (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesTables",
     "longName": "31303 - Disclosure - Trade and other payables and accrued expenses (Tables)",
     "shortName": "Trade and other payables and accrued expenses (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "aciu:DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "aciu:DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://acimume.com/role/DisclosureContractRevenuesTables",
     "longName": "31403 - Disclosure - Contract revenues (Tables)",
     "shortName": "Contract revenues (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://acimume.com/role/DisclosureExpensesByCategoryTables",
     "longName": "31503 - Disclosure - Expenses by category (Tables)",
     "shortName": "Expenses by category (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfExpensesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfExpensesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://acimume.com/role/DisclosureRelatedPartyTransactionsTables",
     "longName": "31603 - Disclosure - Related-party transactions (Tables)",
     "shortName": "Related-party transactions (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://acimume.com/role/DisclosureIncomeTaxesTables",
     "longName": "31703 - Disclosure - Income taxes (Tables)",
     "shortName": "Income taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://acimume.com/role/DisclosureRetirementBenefitPlanTables",
     "longName": "31803 - Disclosure - Retirement benefit plan (Tables)",
     "shortName": "Retirement benefit plan (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://acimume.com/role/DisclosureShareBasedCompensationTables",
     "longName": "31903 - Disclosure - Share-based compensation (Tables)",
     "shortName": "Share-based compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "47",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://acimume.com/role/DisclosureCommitmentsAndContingenciesTables",
     "longName": "32003 - Disclosure - Commitments and contingencies (Tables)",
     "shortName": "Commitments and contingencies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "48",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfCommitmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DisclosureOfCommitmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://acimume.com/role/DisclosureEarningsPerShareTables",
     "longName": "32103 - Disclosure - Earnings per share (Tables)",
     "shortName": "Earnings per share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "49",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementTables",
     "longName": "32203 - Disclosure - Financial instruments and risk management (Tables)",
     "shortName": "Financial instruments and risk management (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "50",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://acimume.com/role/DisclosureGeneralInformationDetails",
     "longName": "40101 - Disclosure - General information (Details)",
     "shortName": "General information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "aciu:NumberOfTechnologyPlatforms",
      "unitRef": "Unit_Standard_item_lel3bReemU2v4xdKyUvjzA",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "aciu:DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "aciu:NumberOfTechnologyPlatforms",
      "unitRef": "Unit_Standard_item_lel3bReemU2v4xdKyUvjzA",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "aciu:DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://acimume.com/role/DisclosureBasisOfPreparationGoingConcernDetails",
     "longName": "40201 - Disclosure - Basis of preparation - Going concern (Details)",
     "shortName": "Basis of preparation - Going concern (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:CashAndCashEquivalents",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R53": {
     "role": "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesFunctionalAndReportingCurrencyDetails",
     "longName": "40301 - Disclosure - Summary of material accounting policies - Functional and reporting currency (Details)",
     "shortName": "Summary of material accounting policies - Functional and reporting currency (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:ClosingForeignExchangeRate",
      "unitRef": "Unit_Divide_CHF_USD_FPtD7vL32kaT4HamUiI0aw",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
       "ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory",
       "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:AverageForeignExchangeRate",
      "unitRef": "Unit_Divide_CHF_USD_FPtD7vL32kaT4HamUiI0aw",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
       "ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory",
       "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails",
     "longName": "40302 - Disclosure - Summary of material accounting policies, Right-of-use assets and lease liabilities (Details)",
     "shortName": "Summary of material accounting policies, Right-of-use assets and lease liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_aaNuoy-t_Eiw3M3BbRrSzA",
      "name": "aciu:EstimatedLeaseTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_aaNuoy-t_Eiw3M3BbRrSzA",
      "name": "aciu:EstimatedLeaseTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPropertyPlantAndEquipmentDetails",
     "longName": "40303 - Disclosure - Summary of material accounting policies, Property, plant and equipment (Details)",
     "shortName": "Summary of material accounting policies, Property, plant and equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_5KJXBEAcDUOmq3jDvWNEeA",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock",
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_5KJXBEAcDUOmq3jDvWNEeA",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock",
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesIncomeTaxesDetails",
     "longName": "40304 - Disclosure - Summary of material accounting policies, Income taxes (Details)",
     "shortName": "Summary of material accounting policies, Income taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:IncomeTaxLossCarryforwardPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:IncomeTaxLossCarryforwardPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesSegmentReportingDetails",
     "longName": "40305 - Disclosure - Summary of material accounting policies, Segment reporting (Details)",
     "shortName": "Summary of material accounting policies, Segment reporting (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:OperatingSegmentsNumber",
      "unitRef": "Unit_Standard_segment_uSnHfk8yHkqj2bvGJo9Fng",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:OperatingSegmentsNumber",
      "unitRef": "Unit_Standard_segment_uSnHfk8yHkqj2bvGJo9Fng",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails",
     "longName": "40401 - Disclosure - Property, plant and equipment (Details)",
     "shortName": "Property, plant and equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_kkPxG2DcNk29JpuIBItYrw",
      "name": "ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails",
     "longName": "40501 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities (Details)",
     "shortName": "Right-of-use assets, long-term financial assets and lease liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:AdditionsToRightofuseAssets",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:AdditionsToRightofuseAssets",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails",
     "longName": "40502 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities - Statement of income/(loss) and cash flow (Details)",
     "shortName": "Right-of-use assets, long-term financial assets and lease liabilities - Statement of income/(loss) and cash flow (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:DepreciationRightofuseAssets",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:InterestExpenseOnLeaseLiabilities",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails",
     "longName": "40503 - Disclosure - Right-of-use assets, long-term financial assets and lease liabilities - Contractual undiscounted cash flows for lease obligations (Details)",
     "shortName": "Right-of-use assets, long-term financial assets and lease liabilities - Contractual undiscounted cash flows for lease obligations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:GrossLeaseLiabilities",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:ScheduleOfContractualUndiscountedCashFlowsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:GrossLeaseLiabilities",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:ScheduleOfContractualUndiscountedCashFlowsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://acimume.com/role/DisclosureAssetAcquisitionDetails",
     "longName": "40601 - Disclosure - Asset acquisition (Details)",
     "shortName": "Asset acquisition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2021_To_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_rCWc9moZ-UuoKzp2P9kXqQ",
      "name": "aciu:SharesTransferredAsConsiderationInAssetAcquisition",
      "unitRef": "Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "aciu:DisclosureOfAssetAcquisitionsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2021_To_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_rCWc9moZ-UuoKzp2P9kXqQ",
      "name": "aciu:SharesTransferredAsConsiderationInAssetAcquisition",
      "unitRef": "Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "aciu:DisclosureOfAssetAcquisitionsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://acimume.com/role/DisclosureIntangibleAssetsDetails",
     "longName": "40701 - Disclosure - Intangible assets (Details)",
     "shortName": "Intangible assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_41heKF3EykimTDNXOnweeg",
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails",
     "longName": "40801 - Disclosure - Cash and cash equivalents and financial assets, Cash and cash equivalents (Details)",
     "shortName": "Cash and cash equivalents and financial assets, Cash and cash equivalents (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:CashAndCashEquivalents",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2023_srt_CurrencyAxis_currency_CHF_JfNLzHvH80WbSrRE58qKYg",
      "name": "ifrs-full:CashAndCashEquivalents",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock",
       "aciu:DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails",
     "longName": "40802 - Disclosure - Cash and cash equivalents and financial assets, Cash and cash equivalents and short-term financial assets (Details)",
     "shortName": "Cash and cash equivalents and financial assets, Cash and cash equivalents and short-term financial assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2023_srt_CurrencyAxis_currency_CHF_JfNLzHvH80WbSrRE58qKYg",
      "name": "ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock",
       "aciu:DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails",
     "longName": "40901 - Disclosure - Prepaid expenses and accrued income (Details)",
     "shortName": "Prepaid expenses and accrued income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:CurrentPrepaidExpenses",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock",
       "aciu:DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://acimume.com/role/DisclosureAccountsReceivableDetails",
     "longName": "41001 - Disclosure - Accounts receivable (Details)",
     "shortName": "Accounts receivable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:CurrentTradeReceivables",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2023_ifrs-full_CounterpartiesAxis_aciu_JJInnovativeMedicineMember_vsI7p2vgBE6RmjAsmPNw1A",
      "name": "ifrs-full:CurrentTradeReceivables",
      "unitRef": "Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "aciu:DisclosureOfAccountsReceivableTableTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails",
     "longName": "41101 - Disclosure - Other current receivables (Details)",
     "shortName": "Other current receivables (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "aciu:MiscellaneousOtherCurrentReceivables",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock",
       "aciu:DisclosureOfOtherCurrentReceivablesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "aciu:MiscellaneousOtherCurrentReceivables",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock",
       "aciu:DisclosureOfOtherCurrentReceivablesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://acimume.com/role/DisclosureShareCapitalNarrativesDetails",
     "longName": "41201 - Disclosure - Share capital - Narratives (Details)",
     "shortName": "Share capital - Narratives (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:IssuedCapital",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_Aj1yGEPLv0OsHOLlVg5leg",
      "name": "ifrs-full:IssuedCapital",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
     "longName": "41202 - Disclosure - Share capital - Capital Structure (Details)",
     "shortName": "Share capital - Capital Structure (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA",
      "name": "ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates",
      "unitRef": "Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_6KGZQVq8r0a0vl5N0ZyV-g",
      "name": "aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans",
      "unitRef": "Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://acimume.com/role/DisclosureShareCapitalAuthorizedCapitalDetails",
     "longName": "41203 - Disclosure - Share capital - Authorized capital (Details)",
     "shortName": "Share capital - Authorized capital (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForFinancingAndOtherPurposesDetails",
     "longName": "41204 - Disclosure - Share capital - Conditional share capital for financing and other purposes (Details)",
     "shortName": "Share capital - Conditional share capital for financing and other purposes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:ParValuePerShare",
      "unitRef": "Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember_IjKN6eosDESMY_UjEdsFrQ",
      "name": "ifrs-full:ParValuePerShare",
      "unitRef": "Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails",
     "longName": "41205 - Disclosure - Share capital - Conditional share capital for employee benefit plans (Details)",
     "shortName": "Share capital - Conditional share capital for employee benefit plans (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:ParValuePerShare",
      "unitRef": "Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "aciu:NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits",
      "unitRef": "Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R74": {
     "role": "http://acimume.com/role/DisclosureShareCapitalFollowOnOfferingDetails",
     "longName": "41206 - Disclosure - Share capital - Follow-On Offering (Details)",
     "shortName": "Share capital - Follow-On Offering (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:ShareIssueRelatedCost",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_12_19_2023_To_12_19_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_FollowOnOfferingMember_TqOyBPKfi0OoLSsHlenN0Q",
      "name": "ifrs-full:ShareIssueRelatedCost",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R75": {
     "role": "http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails",
     "longName": "41207 - Disclosure - Share capital - Shelf registration statement (Details)",
     "shortName": "Share capital - Shelf registration statement (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "Duration_4_28_2021_To_4_28_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_wJ7EdKp2Ok2kaiso3_KHVw",
      "name": "aciu:CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_4_28_2021_To_4_28_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_wJ7EdKp2Ok2kaiso3_KHVw",
      "name": "aciu:CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails",
     "longName": "41208 - Disclosure - Share capital - At the market equity offering (Details)",
     "shortName": "Share capital - At the market equity offering (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:ParValuePerShare",
      "unitRef": "Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_7_1_2021_To_9_30_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_I1T_yUrSRkSlCVKjmbusrw",
      "name": "aciu:IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares",
      "unitRef": "Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R77": {
     "role": "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails",
     "longName": "41209 - Disclosure - Share capital - Convertible note agreement (Details)",
     "shortName": "Share capital - Convertible note agreement (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:ProceedsFromIssueOfConvertibleDebt",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_gz-ausjwKkGgVkKLeTU3Ng",
      "name": "aciu:AggregatePrincipalAmountOfEachConvertibleNote",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R78": {
     "role": "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails",
     "longName": "41301 - Disclosure - Trade and other payables and accrued expenses (Details)",
     "shortName": "Trade and other payables and accrued expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:TradeAndOtherCurrentPayables",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "aciu:CurrentAccruedResearchAndDevelopmentCosts",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock",
       "aciu:DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R79": {
     "role": "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails",
     "longName": "41401 - Disclosure - Contract revenues - Contract Revenue Attributable to Licensing Arrangements (Details)",
     "shortName": "Contract revenues - Contract Revenue Attributable to Licensing Arrangements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfContractsAxis_aciu_OtherAgreementMember_V2ITfmJTz0yHhlWkR5uY7A",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R80": {
     "role": "http://acimume.com/role/DisclosureContractRevenuesRecognizedRevenuesDetails",
     "longName": "41402 - Disclosure - Contract revenues - Recognized Revenues (Details)",
     "shortName": "Contract revenues - Recognized Revenues (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
     "longName": "41403 - Disclosure - Contract revenues - Morphomer Tau small molecule - 2018 license agreement with Eli Lilly and Company (Details)",
     "shortName": "Contract revenues - Morphomer Tau small molecule - 2018 license agreement with Eli Lilly and Company (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2019_To_3_31_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_BPMBGqeh1UCBtCXz0LDlDg",
      "name": "aciu:CollaborativeAgreementMilestonePaymentReceived",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R82": {
     "role": "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails",
     "longName": "41404 - Disclosure - Contract revenues - Tau Vaccine in AD - 2014 Agreement with Janssen Pharmaceuticals (Details)",
     "shortName": "Contract revenues - Tau Vaccine in AD - 2014 Agreement with Janssen Pharmaceuticals (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:CurrentTradeReceivables",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_5_1_2016_To_5_31_2016_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_z6odcKKiUk6PMIxagqtGiA",
      "name": "aciu:CollaborativeAgreementMilestonePaymentReceived",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R83": {
     "role": "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
     "longName": "41405 - Disclosure - Contract revenues - Tau-PET imaging agent -2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) (Details)",
     "shortName": "Contract revenues - Tau-PET imaging agent -2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_wERnesaBIkyF2ZYGAWOS5g",
      "name": "aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R84": {
     "role": "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
     "longName": "41406 - Disclosure - Contract revenues - Grants from the Michael J. Fox Foundation (Details)",
     "shortName": "Contract revenues - Grants from the Michael J. Fox Foundation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfContractsAxis_aciu_GrantRevenueMember_Kn--ZLK--EWCGZTxnKU9YQ",
      "name": "ifrs-full:OtherOperatingIncomeExpense",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R85": {
     "role": "http://acimume.com/role/DisclosureExpensesByCategoryDetails",
     "longName": "41501 - Disclosure - Expenses by category (Details)",
     "shortName": "Expenses by category (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:OperatingExpense",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DecreaseInResearchAndDevelopmentExpenseThroughReductionsInVariousCostCenters",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfExpensesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R86": {
     "role": "http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails",
     "longName": "41601 - Disclosure - Related-party transactions (Details)",
     "shortName": "Related-party transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:NumberOfPersonsKeyManagementBoardOfDirectors",
      "unitRef": "Unit_Standard_person_7ny7-oR7aEaZQqs0BxZVCQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:NumberOfPersonsKeyManagementBoardOfDirectors",
      "unitRef": "Unit_Standard_person_7ny7-oR7aEaZQqs0BxZVCQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R87": {
     "role": "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails",
     "longName": "41701 - Disclosure - Income taxes - Summary of Income Tax Expense (Details)",
     "shortName": "Income taxes - Summary of Income Tax Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:IncomeTaxExpenseContinuingOperations",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw",
      "name": "ifrs-full:ApplicableTaxRate",
      "unitRef": "Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "ifrs-full:ApplicableTaxRate",
       "p",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R88": {
     "role": "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails",
     "longName": "41702 - Disclosure - Income taxes, Unrecognized Deductible Temporary Differences, Unused Tax Losses and Unused Tax Credits (Details)",
     "shortName": "Income taxes, Unrecognized Deductible Temporary Differences, Unused Tax Losses and Unused Tax Credits (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R89": {
     "role": "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails",
     "longName": "41801 - Disclosure - Retirement benefit plan - Summary of Benefit Plan (Details)",
     "shortName": "Retirement benefit plan - Summary of Benefit Plan (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DefinedBenefitPlansPercentageOfContributionsByEmployees",
      "unitRef": "Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:DefinedBenefitPlansPercentageOfContributionsByEmployees",
      "unitRef": "Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R90": {
     "role": "http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails",
     "longName": "41802 - Disclosure - Retirement benefit plan - Amounts recorded in consolidated statements of income (loss) (Details)",
     "shortName": "Retirement benefit plan - Amounts recorded in consolidated statements of income (loss) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:CurrentServiceCostDefinedBenefitPlans",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:CurrentServiceCostDefinedBenefitPlans",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R91": {
     "role": "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails",
     "longName": "41803 - Disclosure - Retirement benefit plan - Changes in Defined Benefit Obligation (Details)",
     "shortName": "Retirement benefit plan - Changes in Defined Benefit Obligation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA",
      "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_ncAHP2PXEEG29m0kCbCu1w",
      "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R92": {
     "role": "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails",
     "longName": "41804 - Disclosure - Retirement benefit plan - Changes in Fair Value of Plan Assets (Details)",
     "shortName": "Retirement benefit plan - Changes in Fair Value of Plan Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA",
      "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R93": {
     "role": "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails",
     "longName": "41805 - Disclosure - Retirement benefit plan - Change in Net Defined Benefit Liability (Details)",
     "shortName": "Retirement benefit plan - Change in Net Defined Benefit Liability (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA",
      "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R94": {
     "role": "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails",
     "longName": "41806 - Disclosure - Retirement benefit plan - Change in other comprehensive gains (losses) (Details)",
     "shortName": "Retirement benefit plan - Change in other comprehensive gains (losses) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R95": {
     "role": "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails",
     "longName": "41807 - Disclosure - Retirement benefit plan - Actuarial Assumptions and Sensitivity Analysis (Details)",
     "shortName": "Retirement benefit plan - Actuarial Assumptions and Sensitivity Analysis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:ActuarialAssumptionOfDiscountRates",
      "unitRef": "Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:ActuarialAssumptionOfDiscountRates",
      "unitRef": "Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R96": {
     "role": "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails",
     "longName": "41901 - Disclosure - Share-based compensation, Plans Outstanding (Details)",
     "shortName": "Share-based compensation, Plans Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:NumberOfEquityBasedInstrumentPlans",
      "unitRef": "Unit_Standard_plan_aEIYineoxU60B5qoFDN6Ig",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:NumberOfEquityBasedInstrumentPlans",
      "unitRef": "Unit_Standard_plan_aEIYineoxU60B5qoFDN6Ig",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R97": {
     "role": "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails",
     "longName": "41902 - Disclosure - Share-based compensation, Weighted Average Exercise Prices (Details)",
     "shortName": "Share-based compensation, Weighted Average Exercise Prices (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "Unit_Standard_Options_74cudJavrEyukn77nvN4Jw",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019",
      "unitRef": "Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R98": {
     "role": "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails",
     "longName": "41903 - Disclosure - Share-based compensation, Outstanding Options, Range of Exercise prices and Expiration Dates (Details)",
     "shortName": "Share-based compensation, Outstanding Options, Range of Exercise prices and Expiration Dates (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "Unit_Standard_Options_74cudJavrEyukn77nvN4Jw",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_srt_CurrencyAxis_currency_USD_fZkHo-Mvv0iaC9kcViPDDQ",
      "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
      "unitRef": "Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R99": {
     "role": "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails",
     "longName": "41904 - Disclosure - Share-based compensation, Weighted Average Grant date Fair Value and Assumptions (Details)",
     "shortName": "Share-based compensation, Weighted Average Grant date Fair Value and Assumptions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "99",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted",
      "unitRef": "Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA",
      "name": "ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted",
      "unitRef": "Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "unique": true
     }
    },
    "R100": {
     "role": "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails",
     "longName": "41905 - Disclosure - Share-based compensation, Non-vested Share Awards (Details)",
     "shortName": "Share-based compensation, Non-vested Share Awards (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "100",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R101": {
     "role": "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails",
     "longName": "42001 - Disclosure - Commitments and contingencies (Details)",
     "shortName": "Commitments and contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "101",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:RentalContractPeriodForNoticeOfCancellation",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "aciu:RentalContractPeriodForNoticeOfCancellation",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R102": {
     "role": "http://acimume.com/role/DisclosureEarningsPerShareDetails",
     "longName": "42101 - Disclosure - Earnings per share (Details)",
     "shortName": "Earnings per share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "102",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:EarningsPerShareExplanatory",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:EarningsPerShareExplanatory",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R103": {
     "role": "http://acimume.com/role/DisclosureEarningsPerShareAntidilutiveSecuritiesDetails",
     "longName": "42102 - Disclosure - Earnings per share - Antidilutive securities (Details)",
     "shortName": "Earnings per share - Antidilutive securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "103",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented",
      "unitRef": "Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew",
      "name": "ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented",
      "unitRef": "Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R104": {
     "role": "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails",
     "longName": "42201 - Disclosure - Financial instruments and risk management (Details)",
     "shortName": "Financial instruments and risk management (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "104",
     "firstAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:FinancialAssets",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA",
      "name": "ifrs-full:FinancialAssets",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "aciu:DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    },
    "R105": {
     "role": "http://acimume.com/role/DisclosureSubsequentEventsDetails",
     "longName": "42401 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "105",
     "firstAnchor": {
      "contextRef": "As_Of_2_1_2024_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_aciu_ReceiptOfMilestonePaymentsMember_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_zyTb0RhISEWfD4ePpEx1Hg",
      "name": "aciu:CollaborationAgreementMileStonePaymentReceived",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "As_Of_2_1_2024_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_aciu_ReceiptOfMilestonePaymentsMember_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_zyTb0RhISEWfD4ePpEx1Hg",
      "name": "aciu:CollaborationAgreementMileStonePaymentReceived",
      "unitRef": "Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aciu-20231231x20f.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ifrs-full_AccountingProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AccountingProfit",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting profit",
        "terseLabel": "Loss before income tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r39",
      "r40"
     ]
    },
    "aciu_AccruedExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "AccruedExpensesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued expenses",
        "label": "Trade and other payables and accrued expenses"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_AccruedExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "AccruedExpensesMember",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for accrued expenses.",
        "label": "Accrued Expenses [Member]",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_AccruedStampDuty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "AccruedStampDuty",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of current accrued stamp duty.",
        "label": "Accrued stamp duty",
        "terseLabel": "Accrued stamp duty"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AccumulatedDepreciationAndAmortisationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AccumulatedDepreciationAndAmortisationMember",
     "presentation": [
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails",
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated depreciation and amortisation [member]",
        "terseLabel": "Accumulated depreciation",
        "verboseLabel": "Accumulated Amortization"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for accumulated depreciation and amortisation. [Refer: Depreciation and amortisation expense]"
       }
      }
     },
     "auth_ref": [
      "r53",
      "r271",
      "r281",
      "r282",
      "r283"
     ]
    },
    "ifrs-full_ActuarialAssumptionOfDiscountRates": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ActuarialAssumptionOfDiscountRates",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Actuarial assumption of discount rates",
        "terseLabel": "Discount rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]"
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "ifrs-full_ActuarialAssumptionOfDiscountRatesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ActuarialAssumptionOfDiscountRatesMember",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Actuarial assumption of discount rates [member]",
        "verboseLabel": "Discount rate"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the discount rates used as actuarial assumptions. [Refer: Actuarial assumptions [member]]"
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ActuarialAssumptionOfExpectedRatesOfPensionIncreases",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Actuarial assumption of expected rates of pension increases",
        "terseLabel": "Rate of future increase in current pensions"
       }
      },
      "en": {
       "role": {
        "documentation": "The expected rate of increases in pension that is used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]"
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Actuarial assumption of expected rates of pension increases [member]",
        "verboseLabel": "Future pension cost"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the expected rates of pension increases used as actuarial assumptions. [Refer: Actuarial assumptions [member]]"
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ActuarialAssumptionOfExpectedRatesOfSalaryIncreases",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Actuarial assumption of expected rates of salary increases",
        "terseLabel": "Rate of future increase in compensations"
       }
      },
      "en": {
       "role": {
        "documentation": "The expected rate of salary increases used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]"
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Actuarial assumption of expected rates of salary increases [member]",
        "verboseLabel": "Future salary increase"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the expected rates of salary increases used as actuarial assumptions. [Refer: Actuarial assumptions [member]]"
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "aciu_ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital": {
     "xbrltype": "percentItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expected rate of interest rates on retirement savings capital is used as a significant actuarial assumption to determine the present value of a defined benefit obligation.",
        "label": "Actuarial assumption of interest rate on retirement savings capital",
        "terseLabel": "Interest rate on retirement savings capital"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ActuarialAssumptionOfInterestRateOnSavingsCapitalMember",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the interest rate on savings capital used as actuarial assumptions.",
        "label": "Actuarial assumption of interest rate on savings capital [member]",
        "terseLabel": "Interest rate on savings capital"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ActuarialAssumptionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ActuarialAssumptionsAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Actuarial assumptions [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "ifrs-full_ActuarialAssumptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ActuarialAssumptionsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Actuarial assumptions [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all actuarial assumptions. Actuarial assumptions are the entity\u2019s unbiased and mutually compatible best estimates of the demographic and financial variables that will determine the ultimate cost of providing post-employment benefits. It also represents the standard value for the 'Actuarial assumptions' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effect of changes in demographic assumptions",
        "terseLabel": "Change in demographic assumptions"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in demographic assumptions that result in remeasurements of the net defined benefit liability (asset). Demographic assumptions deal with matters such as: (a) mortality; (b) rates of employee turnover, disability and early retirement; (c) the proportion of plan members with dependants who will be eligible for benefits; (d) the proportion of plan members who will select each form of payment option available under the plan terms; and (e) claim rates under medical plans. [Refer: Net defined benefit liability (asset)]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Actuarial gains (losses) arising from changes in demographic assumptions, net of tax, defined benefit plans",
        "terseLabel": "Effect of changes in demographic assumptions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, resulting from actuarial gains (losses) arising from changes in demographic assumptions that result in remeasurements of the net defined benefit liability (asset). Demographic assumptions deal with matters such as: (a) mortality; (b) rates of employee turnover, disability and early retirement; (c) the proportion of plan members with dependants who will be eligible for benefits; (d) the proportion of plan members who will select each form of payment option available under the plan terms; and (e) claim rates under medical plans. [Refer: Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in demographic assumptions]"
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effect of changes in financial assumptions",
        "terseLabel": "Change in financial assumptions"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions that result in remeasurements of the net defined benefit liability (asset). Financial assumptions deal with items such as: (a) the discount rate; (b) benefit levels, excluding any cost of the benefits to be met by employees, and future salary; (c) in the case of medical benefits, future medical costs, including claim handling costs (ie the costs that will be incurred in processing and resolving claims, including legal and adjuster's fees); and (d) taxes payable by the plan on contributions relating to service before the reporting date or on benefits resulting from that service. [Refer: Net defined benefit liability (asset)]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Actuarial gains (losses) arising from changes in financial assumptions, net of tax, defined benefit plans",
        "terseLabel": "Effect of changes in financial assumptions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, resulting from actuarial gains (losses) arising from changes in financial assumptions that result in remeasurements of the net defined benefit liability (asset). Financial assumptions deal with items such as: (a) the discount rate; (b) benefit levels, excluding any cost of the benefits to be met by employees, and future salary; (c) in the case of medical benefits, future medical costs, including claim handling costs (ie the costs that will be incurred in processing and resolving claims, including legal and adjuster's fees); and (d) taxes payable by the plan on contributions relating to service before the reporting date or on benefits resulting from that service. [Refer: Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions]"
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in experience assumptions"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from experience adjustments that result in remeasurements of the net defined benefit liability (asset). Experience adjustments deal with the effects of differences between the previous actuarial assumptions and what has actually occurred. [Refer: Net defined benefit liability (asset)]"
       }
      }
     },
     "auth_ref": [
      "r274"
     ]
    },
    "ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Actuarial gains (losses) arising from experience adjustments, net of tax, defined benefit plans",
        "terseLabel": "Effect of changes in experience assumptions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, resulting from actuarial gains (losses) arising from experience adjustments that result in remeasurements of the net defined benefit liability (asset). Experience adjustments deal with the effects of differences between the previous actuarial assumptions and what has actually occurred. [Refer: Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from experience adjustments]"
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "aciu_AdditionalGrantAwarded": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "AdditionalGrantAwarded",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional grant awarded",
        "label": "Additional grant awarded",
        "terseLabel": "Additional grant awarded"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAuthorizedCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional share capital that Board of Directors are authorized to issue",
        "label": "Additional share capital that Board of Directors are authorized to issue"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions other than through business combinations, property, plant and equipment",
        "verboseLabel": "Additions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "ifrs-full_AdditionsToRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdditionsToRightofuseAssets",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions and reassessment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in accrued income including contract assets",
        "terseLabel": "(Increase)/decrease in accrued income"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for the decrease (increase) in accrued income including contract assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Accrued income including contract assets; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r285"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in other operating receivables",
        "terseLabel": "(Increase)/decrease in other current receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in other operating receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r285"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInPrepaidExpenses",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in prepaid expenses",
        "terseLabel": "(Increase)/decrease in prepaid expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for the decrease (increase) in prepaid expenses to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Current prepaid expenses; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r287"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in trade accounts receivable",
        "terseLabel": "(Increase)/decrease in accounts receivable"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r285"
     ]
    },
    "ifrs-full_AdjustmentsForDepreciationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForDepreciationExpense",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for depreciation expense",
        "terseLabel": "Depreciation of property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r287"
     ]
    },
    "aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "AdjustmentsForDepreciationExpenseRightOfUseAssets",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments for depreciation expense for right-of-use assets to reconcile profit (loss) to net cash flow from (used in) operating activities.",
        "label": "Adjustments for depreciation expense, right-of-use assets",
        "terseLabel": "Depreciation of right-of-use assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForFinanceIncomeCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForFinanceIncomeCost",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for finance income (cost)",
        "negatedLabel": "Finance (income)/expense, net"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for net finance income or cost to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance income (cost); Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r287"
     ]
    },
    "ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for gain (loss) on disposals, property, plant and equipment",
        "negatedLabel": "(Gain)/loss on sale of fixed assets"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for gain (loss) on disposals of property, plant and equipment to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Property, plant and equipment; Disposals, property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r287"
     ]
    },
    "aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "AdjustmentsForIncreaseDecreaseInAccruedExpenses",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in accrued expenses to reconcile profit (loss) to net cash flow from (used in) operating activities.",
        "label": "Adjustments for increase (decrease) in accrued expenses",
        "negatedLabel": "(Decrease)/increase in accrued expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in deferred income including contract liabilities",
        "terseLabel": "(Decrease)/increase in deferred income"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for the increase (decrease) in deferred income including contract liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred income including contract liabilities; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r285"
     ]
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in employee benefit liabilities",
        "terseLabel": "Change in net employee defined benefit liability"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r287"
     ]
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in trade accounts payable",
        "terseLabel": "(Decrease)/increase in trade and other payables"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r285"
     ]
    },
    "ifrs-full_AdjustmentsForInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForInterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for interest expense",
        "terseLabel": "Interest expense"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for interest expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Interest expense; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r287"
     ]
    },
    "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForReconcileProfitLossAbstract",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile profit (loss) [abstract]",
        "terseLabel": "Adjustments to reconcile net loss for the period to net cash flows:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForSharebasedPayments",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for share-based payments",
        "terseLabel": "Share-based compensation expense"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r286"
     ]
    },
    "aciu_AdvanceSmallMoleculePdProgramsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "AdvanceSmallMoleculePdProgramsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents advance small molecule PD programs",
        "label": "Advance small molecule PD programs [Member]",
        "terseLabel": "Advance small molecule PD programs"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_AggregatePrincipalAmountOfEachConvertibleNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "AggregatePrincipalAmountOfEachConvertibleNote",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate principal amount of each convertible note",
        "label": "Aggregate principal amount of each convertible note"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AggregatedTimeBandsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AggregatedTimeBandsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails",
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregated time bands [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r137",
      "r150",
      "r151",
      "r155",
      "r156",
      "r157",
      "r163",
      "r183",
      "r221",
      "r240",
      "r245"
     ]
    },
    "currency_AllCurrenciesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2023",
     "localname": "AllCurrenciesDomain",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails",
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_AlphaSynucleinPetImagingDiagnosticAgentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "AlphaSynucleinPetImagingDiagnosticAgentMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Alpha Synuclein PET Imaging Diagnostic Agent.",
        "label": "Alpha-synuclein PET imaging diagnostic agent"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AntidilutiveInstrumentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AntidilutiveInstrumentsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareAntidilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive instruments [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for antidilutive instruments. Instruments are antidilutive when their conversion to ordinary shares would increase earnings per share or decrease loss per share from continuing operations. The calculation of diluted earnings per share does not assume conversion, exercise, or other issue of potential ordinary shares that would have an antidilutive effect on earnings per share. It also represents the standard value for the \u2018Types of antidilutive instruments' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "ifrs-full_ApplicableTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ApplicableTaxRate",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Applicable tax rate",
        "terseLabel": "Applicable tax rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The applicable income tax rate."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "aciu_AssetAcquisitionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "AssetAcquisitionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisitions",
        "label": "Asset acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_AssetAcquisitionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "AssetAcquisitionsAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table.",
        "label": "Asset acquisitions [axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r122",
      "r123",
      "r125",
      "r200",
      "r203"
     ]
    },
    "ifrs-full_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_AtTheMarketEquityOfferingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "AtTheMarketEquityOfferingAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "At the Market Equity Offering [Abstract]",
        "terseLabel": "At the Market Equity Offering [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_AtTheMarketEquityOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "AtTheMarketEquityOfferingMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An \"at-the-market\" offering is an offering of securities into an existing trading market for outstanding shares of the same class at other than a fixed price on, or through the facilities of, a national securities exchange, or to or through a market maker otherwise than on an exchange.",
        "label": "At the Market Equity Offering [Member]",
        "terseLabel": "At the Market Equity Offering [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_AthosServiceGmbHMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "AthosServiceGmbHMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents Athos Service GmbH",
        "label": "Athos Service GmbH [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AttributionOfExpensesByNatureToTheirFunctionAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Attribution of expenses by nature to their function [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r261",
      "r263"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r253",
      "r254",
      "r255"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r253",
      "r254",
      "r255"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r253",
      "r254",
      "r255"
     ]
    },
    "ifrs-full_AverageForeignExchangeRate": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AverageForeignExchangeRate",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesFunctionalAndReportingCurrencyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exchange rate, USD 1"
       }
      },
      "en": {
       "role": {
        "documentation": "The average exchange rate used by the entity. Exchange rate is the ratio of exchange for two currencies."
       }
      }
     },
     "auth_ref": [
      "r263"
     ]
    },
    "ifrs-full_AverageNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AverageNumberOfEmployees",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average number of employees"
       }
      },
      "en": {
       "role": {
        "documentation": "The average number of personnel employed by the entity during a period."
       }
      }
     },
     "auth_ref": [
      "r263"
     ]
    },
    "ifrs-full_BasicEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BasicEarningsLossPerShare",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareDetails",
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic earnings (loss) per share",
        "terseLabel": "Basic loss per share for the period attributable to equity holders"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r85"
     ]
    },
    "ifrs-full_BasicEarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BasicEarningsPerShareAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic earnings per share [abstract]",
        "terseLabel": "Basic income/(loss) per share (EPS) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_BasisOfPreparationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "BasisOfPreparationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of preparation"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_BoardOfDirectorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "BoardOfDirectorsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Key managers of an entity who collectively have responsibility of governing the entity.",
        "label": "Board of Directors [Member]",
        "verboseLabel": "Directors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BottomOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BottomOfRangeMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bottom of Range [Member]",
        "terseLabel": "Minimum"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r157",
      "r174",
      "r229",
      "r230",
      "r292"
     ]
    },
    "ifrs-full_BuildingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BuildingsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails",
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Buildings",
        "terseLabel": "Buildings"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r270"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "terseLabel": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r254",
      "r255"
     ]
    },
    "country_CH": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "CH",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SWITZERLAND"
       }
      }
     },
     "auth_ref": []
    },
    "currency_CHF": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2023",
     "localname": "CHF",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails",
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Switzerland, Francs",
        "terseLabel": "CHF [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital authorized to be issued under shelf registration statement",
        "label": "Capital authorized to be issued under shelf registration statement",
        "terseLabel": "Capital authorized to be issued under Shelf Registration Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails",
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying amount, accumulated depreciation, amortization and impairment and gross carrying amount [axis]",
        "terseLabel": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r50",
      "r92",
      "r93",
      "r97",
      "r98",
      "r99",
      "r100",
      "r101",
      "r180",
      "r188",
      "r189"
     ]
    },
    "ifrs-full_CarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CarryingAmountMember",
     "presentation": [
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails",
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying amount [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      }
     },
     "auth_ref": [
      "r50",
      "r93",
      "r97",
      "r99",
      "r100",
      "r180",
      "r188",
      "r189"
     ]
    },
    "ifrs-full_CashAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash [abstract]",
        "terseLabel": "Cash and cash equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_CashAcquiredAsPartOfAssetAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "CashAcquiredAsPartOfAssetAcquisition",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails": {
       "parentTag": "aciu_TotalAssetsAcquiredInAssetAcquisition",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash acquired as part of asset acquisition",
        "label": "Cash acquired as part of asset acquisition",
        "terseLabel": "Cash"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_CashAdvancesForRentDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "CashAdvancesForRentDeposit",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow or inflow for deposit of rent.",
        "label": "Cash Advances for Rent Deposit",
        "negatedLabel": "Rental deposits"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_CashAndCashEquivalentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "CashAndCashEquivalentLineItems",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails",
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.",
        "label": "Cash and cash equivalent [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureBasisOfPreparationGoingConcernDetails",
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails",
      "http://acimume.com/role/StatementConsolidatedBalanceSheets",
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of the period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period",
        "terseLabel": "Company's cash position",
        "verboseLabel": "Cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r11",
      "r107",
      "r120"
     ]
    },
    "aciu_CashAndCashEquivalentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "CashAndCashEquivalentsTable",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails",
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of cash and cash equivalent balances, including foreign currencies in which the balances are denominated.",
        "label": "Cash and cash equivalents [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities",
        "totalLabel": "Net cash flows (used in)/provided by financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r108"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities [abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities",
        "totalLabel": "Net cash flows provided by/(used in) investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r108"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities [abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities",
        "totalLabel": "Net cash flows used in operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r108"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities [abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInOperations",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operations",
        "totalLabel": "Cash used in operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash from (used in) the entity's operations."
       }
      }
     },
     "auth_ref": [
      "r226",
      "r227"
     ]
    },
    "aciu_CashOnHandAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "CashOnHandAndCashEquivalentsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value.",
        "label": "Cash on hand and cash equivalents [Member]",
        "terseLabel": "Cash and Cash Equivalents [Member]",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashOutflowForLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashOutflowForLeases",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash outflow for leases",
        "terseLabel": "Total cash outflow for leases"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for leases."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "ifrs-full_CategoriesOfRelatedPartiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CategoriesOfRelatedPartiesAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of related parties [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ifrs-full_ChangesInEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ChangesInEquityAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in equity [abstract]",
        "terseLabel": "Changes in equity"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ChangesInFairValueOfPlanAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ChangesInFairValueOfPlanAssetsAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in fair value of plan assets [Abstract]",
        "terseLabel": "Changes in fair value of plan assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ChangesInNetDefinedBenefitLiabilityAssetAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in net defined benefit liability (asset) [abstract]",
        "terseLabel": "Changes in defined benefit obligation [Abstract]",
        "verboseLabel": "Change in net defined benefit liability [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ChangesInWorkingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ChangesInWorkingCapitalAbstract",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in working capital [Abstract]",
        "terseLabel": "Changes in working capital:"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_Chf0.15Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "Chf0.15Member",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for CHF 0.15",
        "label": "CHF 0.15 [Member]",
        "terseLabel": "CHF 0.15"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_Chf9.53Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "Chf9.53Member",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for CHF 9.53",
        "label": "CHF 9.53 [Member]",
        "terseLabel": "CHF 9.53"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfAssetsAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r91",
      "r126",
      "r148"
     ]
    },
    "ifrs-full_ClassesOfAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfAssetsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r126",
      "r148"
     ]
    },
    "ifrs-full_ClassesOfFinancialAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfFinancialAssetsAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r193",
      "r194",
      "r209",
      "r210"
     ]
    },
    "ifrs-full_ClassesOfFinancialLiabilitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfFinancialLiabilitiesAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial liabilities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r194",
      "r209",
      "r210"
     ]
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails",
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of intangible assets other than goodwill [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfPropertyPlantAndEquipmentAxis",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails",
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPropertyPlantAndEquipmentDetails",
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "ifrs-full_ClassesOfShareCapitalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfShareCapitalAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails",
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForFinancingAndOtherPurposesDetails",
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails",
      "http://acimume.com/role/DisclosureShareCapitalFollowOnOfferingDetails",
      "http://acimume.com/role/DisclosureShareCapitalNarrativesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of share capital [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "ifrs-full_ClassesOfShareCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfShareCapitalMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails",
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForFinancingAndOtherPurposesDetails",
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails",
      "http://acimume.com/role/DisclosureShareCapitalFollowOnOfferingDetails",
      "http://acimume.com/role/DisclosureShareCapitalNarrativesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital [member]",
        "terseLabel": "Share capital [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "aciu_ClinicalMilestonesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ClinicalMilestonesMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents clinical milestones",
        "label": "Clinical milestones [Member]",
        "terseLabel": "Clinical milestones"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClosingForeignExchangeRate": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClosingForeignExchangeRate",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails",
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesFunctionalAndReportingCurrencyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Closing rate, USD 1",
        "terseLabel": "Translation rate into CHF"
       }
      },
      "en": {
       "role": {
        "documentation": "The spot exchange rate at the end of the reporting period. Exchange rate is the ratio of exchange for two currencies. Spot exchange rate is the exchange rate for immediate delivery."
       }
      }
     },
     "auth_ref": [
      "r263"
     ]
    },
    "aciu_CollaborationAgreementMileStonePaymentReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "CollaborationAgreementMileStonePaymentReceived",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of milestone payment received under the collaboration agreement.",
        "label": "Collaboration Agreement, Mile Stone Payment Received"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "CollaborationAgreementOf2014JanssenPharmaceuticalsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails",
      "http://acimume.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The 2014 contractual research agreement associated with collaboration with Janssen Pharmaceuticals.",
        "label": "Collaboration agreement of 2014, Janssen Pharmaceuticals [Member]",
        "terseLabel": "2014 Agreement with Janssen Pharmaceuticals [Member]",
        "verboseLabel": "Janssen"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_CollaborationAgreementWithLillyFirstAmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "CollaborationAgreementWithLillyFirstAmendmentMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The first amendment to the collaboration agreement with Lilly for research and development.",
        "label": "Collaboration Agreement with Lilly, First Amendment [Member]",
        "terseLabel": "2018 License Agreement with Eli Lilly, First Amendment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_CollaborationAgreementWithLillyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "CollaborationAgreementWithLillyMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The collaboration agreement with Lilly for research and development.",
        "label": "Collaboration Agreement with Lilly [Member]",
        "terseLabel": "Lilly [Member]",
        "verboseLabel": "2018 License Agreement with Eli Lilly and Company [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_CollaborationAgreementWithLillySecondAmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "CollaborationAgreementWithLillySecondAmendmentMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The second amendment to the collaboration agreement with Lilly for research and development.",
        "label": "Collaboration Agreement with Lilly, Second Amendment [Member]",
        "terseLabel": "2018 License Agreement with Eli Lilly, Second Amendment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_CollaborationAndLicenseRevenueAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "CollaborationAndLicenseRevenueAgreementsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity.",
        "label": "Collaboration and License Revenue Agreements [Member]",
        "terseLabel": "Collaboration and License Revenue [Member]",
        "verboseLabel": "Collaboration and License Revenue Agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_CollaborativeAgreementJointResearchCollaborationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "CollaborativeAgreementJointResearchCollaborationPeriod",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period over which collaborating entities are contracted to perform research, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Collaborative agreement, Joint research collaboration period",
        "terseLabel": "Period of joint research agreement"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "CollaborativeAgreementMilestonePaymentNumberOfInstallments",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of installments for satisfying a milestone payment associated with a collaborative agreement.",
        "label": "Collaborative agreement, milestone payment, number of installments",
        "terseLabel": "Number of installments"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_CollaborativeAgreementMilestonePaymentReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "CollaborativeAgreementMilestonePaymentReceived",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment(s) received for milestone payments associated with a collaborative agreement.",
        "label": "Collaborative agreement, Milestone payment received",
        "terseLabel": "Milestone payment received"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "CollaborativeAgreementNoticeOfContractTerminationPeriod",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time that notice is required to be given for cancellation of the collaborative agreement contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Collaborative agreement, Notice of contract termination period",
        "terseLabel": "Period to provide notice of termination of agreement"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_CollaborativeAgreementPotentialValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "CollaborativeAgreementPotentialValue",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total potential value of the collaborative agreement.",
        "label": "Collaborative agreement, potential value",
        "terseLabel": "Total potential collaboration agreement value"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_CollaborativeAgreementUpfrontPaymentsReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "CollaborativeAgreementUpfrontPaymentsReceived",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative agreement, upfront payments received",
        "label": "Collaborative agreement, upfront payments received"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_CommissionsPaidForIssuanceOrdinaryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "CommissionsPaidForIssuanceOrdinaryShares",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of commissions paid for issuance ordinary shares.",
        "label": "Commissions paid for issuance ordinary shares",
        "terseLabel": "Commissions paid"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_CommitmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "CommitmentsAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments [Abstract]",
        "terseLabel": "Commitments and contingencies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_CommitmentsAndContingenciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "CommitmentsAndContingenciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingencies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "CommonSharesAuthorizedForIssuanceSalesInInOpenMarket",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of common shares authorized for sale in the open market.",
        "label": "Common shares authorized for issuance sales in in open market",
        "terseLabel": "Shares authorized for sale"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ComponentsOfEquityAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of equity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Items that may be reclassified to income or loss in subsequent periods (net of tax):",
        "terseLabel": "Items that may be reclassified to income or loss in subsequent periods (net of tax):"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]",
        "terseLabel": "Items that will not to be reclassified to income or loss in subsequent periods (net of tax):"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity",
      "http://acimume.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive income",
        "totalLabel": "Total comprehensive loss, net of tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r30",
      "r110",
      "r112",
      "r117",
      "r228"
     ]
    },
    "ifrs-full_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails",
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails",
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPropertyPlantAndEquipmentDetails",
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IT Equipment",
        "terseLabel": "IT Equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing computer equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r270"
     ]
    },
    "aciu_ConditionalShareCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ConditionalShareCapitalAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForFinancingAndOtherPurposesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conditional share capital [Abstract]",
        "terseLabel": "Conditional Share Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ConditionalShareCapitalForEmployeeBenefitPlansMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for share capital of the conditional share capital for employee benefit plans.",
        "label": "Conditional share capital for employee benefit plans [Member]",
        "terseLabel": "Employee Benefit Plans [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ConditionalShareCapitalForFinancingAndOtherPurposesMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForFinancingAndOtherPurposesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for conditional share capital for financing and other purposes",
        "label": "Conditional share capital for financing and other purposes [Member]",
        "terseLabel": "Conditional share capital for financing and other purposes"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Construction in progress [member]",
        "terseLabel": "Assets under construction"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for expenditure capitalised during the construction of items of property, plant and equipment that are not yet available for use (ie not yet in the location and condition necessary for it to be capable of operating in the manner intended by the management). [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r270"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ContractAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ContractAssets",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract assets",
        "terseLabel": "Deferred research and development costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of an entity\u2019s right to consideration in exchange for goods or services that the entity has transferred to a customer, when that right is conditioned on something other than the passage of time (for example, the entity\u2019s future performance)."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r131"
     ]
    },
    "aciu_ContractRevenueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ContractRevenueAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract Revenue [Abstract]",
        "terseLabel": "Contract Revenue [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ContractualCapitalCommitments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ContractualCapitalCommitments",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contractual capital commitments"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of capital commitments for which the entity has entered into a contract. [Refer: Capital commitments]"
       }
      }
     },
     "auth_ref": [
      "r263"
     ]
    },
    "aciu_ContractualCapitalCommitmentsOtherThanForLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ContractualCapitalCommitmentsOtherThanForLeases",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual capital commitments other than for leases",
        "label": "Contractual capital commitments other than for leases"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contractual undiscounted cash flows for lease liabilities [Abstract]",
        "terseLabel": "Contractual undiscounted cash flows for lease liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from resulting from contributions to plan by employer",
        "negatedLabel": "Employer's contribution",
        "verboseLabel": "Employer's contributions"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease (increase) in net defined benefit liability (asset) resulting from contributions to a defined benefit plan by the employer. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]"
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from contributions to plan by plan participants",
        "terseLabel": "Employees' contributions"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from contributions to a defined benefit plan by plan participants. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]"
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "ifrs-full_ConvertibleInstrumentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ConvertibleInstrumentsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareAntidilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible instruments [member]",
        "terseLabel": "Convertible shares"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of antidilutive instrument representing convertible instruments."
       }
      }
     },
     "auth_ref": [
      "r280"
     ]
    },
    "aciu_ConvertibleNoteAgreementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ConvertibleNoteAgreementAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Note Agreement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ConvertibleNoteAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ConvertibleNoteAgreementMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member represents to convertible note agreement.",
        "label": "Convertible Note Agreement [Member]",
        "terseLabel": "Convertible Note Agreement with Lilly [Member]",
        "verboseLabel": "Convertible note agreements"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CounterpartiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CounterpartiesAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureAccountsReceivableDetails",
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparties [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "ifrs-full_CounterpartiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CounterpartiesMember",
     "presentation": [
      "http://acimume.com/role/DisclosureAccountsReceivableDetails",
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparties [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the parties to the transaction other than the entity. It also represents the standard value for the 'Counterparties' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CreditRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CreditRiskMember",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit risk [member]",
        "terseLabel": "Credit Risk [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge an obligation. [Refer: Financial instruments, class [member]]"
       }
      }
     },
     "auth_ref": [
      "r158",
      "r159",
      "r160",
      "r238"
     ]
    },
    "srt_CurrencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CurrencyAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails",
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrencyRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrencyRiskMember",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency risk [member]",
        "terseLabel": "Foreign Currency Exchange Risk [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a type of market risk representing the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. [Refer: Financial instruments, class [member]]"
       }
      }
     },
     "auth_ref": [
      "r158",
      "r159",
      "r160",
      "r161",
      "r197"
     ]
    },
    "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentAccruedExpensesAndOtherCurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 3.0
      },
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails",
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current accrued expenses and other current liabilities",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current accrued expenses and other current liabilities. [Refer: Accruals; Other current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r265"
     ]
    },
    "ifrs-full_CurrentAccruedIncomeIncludingCurrentContractAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentAccruedIncomeIncludingCurrentContractAssets",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails": {
       "parentTag": "ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails",
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current accrued income including current contract assets",
        "terseLabel": "Accrued income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current accrued income including current contract assets. [Refer: Accrued income including contract assets]"
       }
      }
     },
     "auth_ref": [
      "r265",
      "r267"
     ]
    },
    "aciu_CurrentAccruedResearchAndDevelopmentCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "CurrentAccruedResearchAndDevelopmentCosts",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails": {
       "parentTag": "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of current accrued research and development costs.",
        "label": "Current accrued research and development costs",
        "terseLabel": "Accrued research and development costs"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets",
        "totalLabel": "Total current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      }
     },
     "auth_ref": [
      "r18",
      "r113",
      "r228"
     ]
    },
    "ifrs-full_CurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentAssetsAbstract",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets [abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentDeferredIncomeIncludingCurrentContractLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current deferred income including current contract liabilities",
        "terseLabel": "Deferred income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current deferred income including current contract liabilities. [Refer: Deferred income including contract liabilities]"
       }
      }
     },
     "auth_ref": [
      "r265",
      "r267"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current lease liabilities",
        "terseLabel": "Short-term lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "ifrs-full_CurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities",
        "totalLabel": "Total current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r115",
      "r228"
     ]
    },
    "ifrs-full_CurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentLiabilitiesAbstract",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities [abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentPrepaidExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentPrepaidExpenses",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails": {
       "parentTag": "ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails",
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current prepaid expenses",
        "terseLabel": "Prepaid expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised."
       }
      }
     },
     "auth_ref": [
      "r263"
     ]
    },
    "ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current prepayments and current accrued income including current contract assets",
        "totalLabel": "Total prepaid expenses and accrued income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current prepayments and current accrued income including current contract assets. [Refer: Prepayments; Accrued income including contract assets]"
       }
      }
     },
     "auth_ref": [
      "r265",
      "r267"
     ]
    },
    "ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and accrued income"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentServiceCostDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentServiceCostDefinedBenefitPlans",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails": {
       "parentTag": "ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current service cost, defined benefit plans",
        "terseLabel": "Current service cost"
       }
      },
      "en": {
       "role": {
        "documentation": "The expense of employee service in the current period arising from defined benefit plans. [Refer: Post-employment benefit expense in profit or loss, defined benefit plans] [Contrast: Increase in net defined benefit liability (asset) resulting from current service cost]"
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentServiceCostNetDefinedBenefitLiabilityAsset",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in net defined benefit liability (asset) resulting from current service cost",
        "negatedLabel": "Current service cost"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from employee service in the current period. [Refer: Net defined benefit liability (asset)]"
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "ifrs-full_CurrentTradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentTradeReceivables",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureAccountsReceivableDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails",
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current trade receivables",
        "terseLabel": "Accounts receivable"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables. [Refer: Trade receivables]"
       }
      }
     },
     "auth_ref": [
      "r214",
      "r215"
     ]
    },
    "ifrs-full_CurrentValueAddedTaxReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentValueAddedTaxReceivables",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails": {
       "parentTag": "ifrs-full_OtherCurrentReceivables",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current value added tax receivables",
        "terseLabel": "Swiss VAT"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current value added tax receivables. [Refer: Value added tax receivables]"
       }
      }
     },
     "auth_ref": [
      "r266"
     ]
    },
    "aciu_December312024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "December312024Member",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents December 31, 2024",
        "label": "December 31, 2024 [Member]",
        "terseLabel": "December 31, 2024"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_December312025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "December312025Member",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents December 31, 2025",
        "label": "December 31, 2025 [Member]",
        "terseLabel": "December 31, 2025"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_December312026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "December312026Member",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents December 31, 2026",
        "label": "December 31, 2026 [Member]",
        "terseLabel": "December 31, 2026"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_December312027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "December312027Member",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents December 31, 2027",
        "label": "December 31, 2027 [Member]",
        "terseLabel": "December 31, 2027"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_December312028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "December312028Member",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents December 31, 2028",
        "label": "December 31, 2028 [Member]",
        "terseLabel": "December 31, 2028"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_December312029Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "December312029Member",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents December 31, 2029",
        "label": "December 31, 2029 [Member]",
        "terseLabel": "December 31, 2029"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_December312030Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "December312030Member",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents December 31, 2030",
        "label": "December 31, 2030 [Member]",
        "terseLabel": "December 31, 2030"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_DecreaseInGeneralAndAdministrativeExpenseThroughReductionsInVariousCostCenters": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DecreaseInGeneralAndAdministrativeExpenseThroughReductionsInVariousCostCenters",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in general and administrative expense through reductions in various cost centers",
        "label": "Decrease in general and administrative expense through reductions in various cost centers"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_DecreaseInNumberOfTreasurySharesFromSalesOrIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DecreaseInNumberOfTreasurySharesFromSalesOrIssuance",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in number of treasury shares from sales or issuance",
        "label": "Decrease in number of treasury shares from sales or issuance",
        "terseLabel": "Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_DecreaseInResearchAndDevelopmentExpenseThroughReductionsInVariousCostCenters": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DecreaseInResearchAndDevelopmentExpenseThroughReductionsInVariousCostCenters",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in research and development expense through reductions in various cost centers",
        "label": "Decrease in research and development expense through reductions in various cost centers"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deductible temporary differences for which no deferred tax asset is recognised"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deductible temporary differences for which no deferred tax asset is recognised in the statement of financial position. [Refer: Temporary differences [member]]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "ifrs-full_DeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DeferredTaxAssets",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails",
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r13",
      "r15",
      "r42"
     ]
    },
    "ifrs-full_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]"
       }
      }
     },
     "auth_ref": [
      "r13",
      "r15",
      "r42"
     ]
    },
    "ifrs-full_DefinedBenefitObligationAtPresentValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DefinedBenefitObligationAtPresentValue",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails": {
       "parentTag": "ifrs-full_SurplusDeficitInPlan",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined benefit obligation, at present value",
        "negatedTerseLabel": "Defined benefit obligation",
        "terseLabel": "Potential defined benefit obligation"
       }
      },
      "en": {
       "role": {
        "documentation": "The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]"
       }
      }
     },
     "auth_ref": [
      "r279"
     ]
    },
    "aciu_DefinedBenefitPlansPercentageOfContributionsByEmployees": {
     "xbrltype": "percentItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DefinedBenefitPlansPercentageOfContributionsByEmployees",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plans, percentage of contributions by employees",
        "label": "Defined benefit plans, percentage of contributions by employees"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_DefinedBenefitPlansPercentageOfContributionsByEmployer": {
     "xbrltype": "percentItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DefinedBenefitPlansPercentageOfContributionsByEmployer",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plans, percentage of contributions by employer",
        "label": "Defined benefit plans, percentage of contributions by employer"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DepreciationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DepreciationPropertyPlantAndEquipment",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation, property, plant and equipment",
        "negatedLabel": "Depreciation expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r49",
      "r52"
     ]
    },
    "ifrs-full_DepreciationRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DepreciationRightofuseAssets",
     "calculation": {
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails": {
       "parentTag": "aciu_ExpenseRelatingToLeases",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails",
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation, right-of-use assets",
        "negatedLabel": "Depreciation",
        "terseLabel": "Depreciation of right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for judgments that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognized in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year.",
        "label": "Description of accounting policy for accounting judgments and estimates [Policy Text Block]",
        "terseLabel": "Critical judgments and accounting estimates"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for the basis for how the entity classifies assets and liabilities as current and non-current.",
        "label": "Description of accounting policy for classification of assets and liabilities [Policy Text Block]",
        "terseLabel": "Current vs. non-current classification"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForEarningsPerShareExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for earnings per share [text block]",
        "terseLabel": "Earnings per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for employee benefits [text block]",
        "terseLabel": "Employee benefits"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment."
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForExpensesExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for expenses."
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for fair value measurement [text block]",
        "terseLabel": "Fair value of financial assets and liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for fair value measurement. [Refer: At fair value [member]]"
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for foreign currency translation [text block]",
        "terseLabel": "Foreign currency transactions"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for foreign currency translation."
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for functional currency [text block]",
        "terseLabel": "Functional and reporting currency"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for the currency of the primary economic environment in which the entity operates."
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for income tax [text block]",
        "terseLabel": "Taxation"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for income tax."
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for intangible assets other than goodwill [text block]",
        "terseLabel": "Intangible assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIssuedCapitalExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for issued capital [text block]",
        "terseLabel": "Share capital and public offerings"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for issued capital. [Refer: Issued capital]"
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time."
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for property, plant and equipment [text block]",
        "terseLabel": "Property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForProvisionsExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for provisions [text block]",
        "terseLabel": "Provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for provisions. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for recognition of revenue [text block]",
        "terseLabel": "Revenue recognition"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for recognising revenue. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for research and development expense [text block]",
        "terseLabel": "Research and development expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for research and development expense. [Refer: Research and development expense]"
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForSegmentReportingExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for segment reporting [text block]",
        "terseLabel": "Segment reporting"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForTreasurySharesExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for treasury shares [text block]",
        "terseLabel": "Treasury Shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for treasury shares. [Refer: Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility, share options granted",
        "terseLabel": "Expected volatility"
       }
      },
      "en": {
       "role": {
        "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "ifrs-full_DescriptionOfOptionLifeShareOptionsGranted": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfOptionLifeShareOptionsGranted",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Option life, share options granted",
        "terseLabel": "Expected term (in years)"
       }
      },
      "en": {
       "role": {
        "documentation": "The option life of share options granted."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk free interest rate, share options granted",
        "terseLabel": "Risk free interest rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "ifrs-full_DilutedEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DilutedEarningsLossPerShare",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareDetails",
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted earnings (loss) per share",
        "terseLabel": "Diluted loss per share for the period attributable to equity holders"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r85"
     ]
    },
    "ifrs-full_DilutedEarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DilutedEarningsPerShareAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted income/(loss) per share (EPS) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for changes to accounting policies recently adopted by the entity.",
        "label": "Disclosure Of Accounting Policy For Changes In Accounting Policies Recently Adopted [Text Block]",
        "terseLabel": "Accounting policies, new standards, interpretations and amendments adopted by the Company"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_DisclosureOfAccountsReceivableTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DisclosureOfAccountsReceivableTableTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureAccountsReceivable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of accounts receivable.",
        "label": "Disclosure of accounts receivable [table text block]",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of amounts recognised in balance sheet from defined benefit plans",
        "label": "Disclosure of amounts recognised in balance sheet from defined benefit plans [table text block]",
        "terseLabel": "Schedule of amounts recognized in balance sheet from defined benefit plans"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of amounts recognised in statement of other comprehensive income from defined benefit plans",
        "label": "Disclosure of amounts recognised in statement of other comprehensive income from defined benefit plans [table text block]",
        "terseLabel": "Schedule of amounts recognized in statement of other comprehensive income from defined benefit plans"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of amounts recognised in statement of profit and loss from defined benefit plans",
        "label": "Disclosure of amounts recognised in statement of profit and loss from defined benefit plans [table text block]",
        "terseLabel": "Schedule of amounts recognized in statement of profit and loss from defined benefit plans"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_DisclosureOfAssetAcquisitionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DisclosureOfAssetAcquisitionsTableTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of asset acquisitions",
        "label": "Disclosure of asset acquisitions [table text block]",
        "terseLabel": "Schedule of Transferred Assets acquired"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_DisclosureOfAssetAcquisitionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DisclosureOfAssetAcquisitionsTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for asset acquisitions",
        "label": "Disclosure of asset acquisitions [text block]",
        "terseLabel": "Asset acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfBasisOfConsolidationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfBasisOfConsolidationExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of consolidation"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the basis used for consolidation."
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureBasisOfPreparation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of basis of preparation of financial statements [text block]",
        "terseLabel": "Basis of preparation"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the basis used for the preparation of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "aciu_DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of cash and cash equivalents and short-term deposits not classified as cash equivalents.",
        "label": "Disclosure of cash and cash equivalents and short-term deposits not classified as cash equivalents [text block]",
        "terseLabel": "Cash and cash equivalents and short-term financial assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfClassesOfShareCapitalAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share capital"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfClassesOfShareCapitalExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [text block]",
        "terseLabel": "Summary of capital structure"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of classes of share capital. [Refer: Share capital [member]]"
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfClassesOfShareCapitalLineItems",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails",
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForFinancingAndOtherPurposesDetails",
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails",
      "http://acimume.com/role/DisclosureShareCapitalFollowOnOfferingDetails",
      "http://acimume.com/role/DisclosureShareCapitalNarrativesDetails",
      "http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [line items]",
        "terseLabel": "Share capital"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfClassesOfShareCapitalTable",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails",
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForFinancingAndOtherPurposesDetails",
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails",
      "http://acimume.com/role/DisclosureShareCapitalFollowOnOfferingDetails",
      "http://acimume.com/role/DisclosureShareCapitalNarrativesDetails",
      "http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to classes of share capital."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of commitments and contingent liabilities [text block]",
        "terseLabel": "Commitments and contingencies"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of commitments and contingent liabilities. [Refer: Contingent liabilities [member]]"
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "ifrs-full_DisclosureOfCommitmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfCommitmentsExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of commitments [text block]",
        "terseLabel": "Schedule of commitments"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of commitments."
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDefinedBenefitPlansAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement benefit plan"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDefinedBenefitPlansExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of defined benefit plans [text block]",
        "terseLabel": "Retirement benefit plan"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of defined benefit plans. [Refer: Defined benefit plans [member]]"
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsLineItems",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about borrowings [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about borrowings [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of borrowings."
       }
      }
     },
     "auth_ref": [
      "r292"
     ]
    },
    "aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about carrying amounts of financial assets and financial liabilities.",
        "label": "Disclosure of detailed information about carrying amounts of financial assets and financial liabilities [Table Text Block]",
        "terseLabel": "Carrying amounts of financial assets and financial liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about the expiration of income tax losses that may be carried forward.",
        "label": "Disclosure of detailed information about income tax losses expiry [Table Text Block]",
        "terseLabel": "Tax losses carry forwards and respective expiry dates"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about income tax reconciliation.",
        "label": "Disclosure of detailed information about income tax reconciliation [Table Text Block]",
        "terseLabel": "Income tax expense reconciled to loss"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [text block]",
        "verboseLabel": "Schedule of net book value of intangible assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about other current receivables.",
        "label": "Disclosure of detailed information about other current receivables [Table Text Block]",
        "terseLabel": "Other current receivables"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of detailed information about prepaid expenses and accrued income including contract assets",
        "label": "Disclosure of detailed information about prepaid expenses and accrued income including contract assets [Table Text Block]",
        "terseLabel": "Prepaid expenses and accrued income"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [text block]",
        "terseLabel": "Schedule of movement in the net book values of property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about trade payables and accrued liabilities.",
        "label": "Disclosure of detailed information about trade payables and accrued liabilities [Table Text Block]",
        "terseLabel": "Schedule of trade and other payables and accrued expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of disaggregation of revenue from contracts with customers [abstract]",
        "terseLabel": "Contract revenues"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails",
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of disaggregation of revenue from contracts with customers [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails",
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of disaggregation of revenue from contracts with customers [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ifrs-full_DisclosureOfEarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfEarningsPerShareExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of earnings per share [text block]",
        "verboseLabel": "Earnings per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of effect of changes in foreign exchange rates [text block]",
        "terseLabel": "Schedule of exchange rates used for translation of financial statements"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for the effect of changes in foreign exchange rates."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureSubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of events after reporting period [text block]",
        "terseLabel": "Subsequent events"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for events after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "ifrs-full_DisclosureOfExpensesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfExpensesExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategory"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of expenses [text block]",
        "terseLabel": "Expenses by category"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of expenses."
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFinanceIncomeExpenseExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of finance income (cost) [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of finance income (cost). [Refer: Finance income (cost)]"
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "ifrs-full_DisclosureOfFinancialAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFinancialAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents and financial assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFinancialAssetsLineItems",
     "presentation": [
      "http://acimume.com/role/DisclosureAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial assets [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFinancialAssetsTable",
     "presentation": [
      "http://acimume.com/role/DisclosureAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to financial assets."
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "ifrs-full_DisclosureOfFinancialRiskManagementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFinancialRiskManagementExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial risk management [text block]",
        "terseLabel": "Financial instruments and risk management"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the entity's financial risk management practices and policies."
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfGeneralAndAdministrativeExpenseExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of general and administrative expense [text block]",
        "terseLabel": "General and Administrative"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of general and administrative expenses. [Refer: Administrative expenses]"
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureGeneralInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for general information about the entity.",
        "label": "Disclosure of general information about the entity explanatory [Text Block]",
        "terseLabel": "General information"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIncomeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfIncomeTaxExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for income taxes."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]",
        "terseLabel": "Weighted-average assumptions"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options."
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.",
        "label": "Disclosure of information about commitments and contingencies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DisclosureOfInformationAboutCommitmentsAndContingenciesTable",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of disclosing information related to commitments and contingencies.",
        "label": "Disclosure of information about commitments and contingencies [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureRelatedPartyTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of information about key management personnel [text block]",
        "terseLabel": "Key management compensation"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of material accounting policies"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [text block]",
        "terseLabel": "Schedule of antidilutive securities"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of instruments (including contingently issuable shares) that could potentially dilute basic earnings per share in the future, but were not included in the calculation of diluted earnings per share because they are antidilutive for the period(s) presented."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareLineItems",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareAntidilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [line items]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareAntidilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [table]"
       }
      }
     },
     "auth_ref": [
      "r280"
     ]
    },
    "ifrs-full_DisclosureOfIntangibleAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIntangibleAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureIntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of intangible assets [text block]",
        "terseLabel": "Intangible assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for intangible assets."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ifrs-full_DisclosureOfIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsLineItems",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails",
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsMaterialToEntityAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of intangible assets material to entity [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsTable",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails",
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of intangible assets."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "ifrs-full_DisclosureOfLeasesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfLeasesExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of leases [text block]",
        "terseLabel": "Right-of-use assets, long-term financial assets and lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for leases."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r154"
     ]
    },
    "ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfMaterialAccountingPolicyInformationExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of material accounting policy information [text block]",
        "terseLabel": "Summary of material accounting policies"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure of material accounting policy information applied by the entity."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis of operating lease payments [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis of operating lease payments [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the maturity analysis of operating lease payments."
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial instruments and risk management [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of nature and extent of risks arising from financial instruments [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of nature and extent of risks arising from financial instruments [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the nature and extent of risks arising from financial instruments."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r186"
     ]
    },
    "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of net defined benefit liability (asset) [text block]",
        "verboseLabel": "Schedule of changes in defined benefit obligations, fair value of plan assets and net defined benefit liability"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of a net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetLineItems",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of net defined benefit liability (asset) [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetTable",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of net defined benefit liability (asset) [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the net defined benefit liability (asset)."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent events"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems",
     "presentation": [
      "http://acimume.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodTable",
     "presentation": [
      "http://acimume.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to non-adjusting events after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of number and weighted average exercise prices of other equity instruments [text block]",
        "terseLabel": "Summary of non-vested share awards (restricted share and restricted share units)"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options)."
       }
      }
     },
     "auth_ref": [
      "r291"
     ]
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of number and weighted average exercise prices of share options [text block]",
        "terseLabel": "Number and weighted average exercise prices of options under share option programs"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [abstract]",
        "terseLabel": "Number and weighted average exercise prices of options under the share option programs [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [text block]",
        "terseLabel": "Outstanding options, exercise price range and expiry dates"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the number and weighted average remaining contractual life of outstanding share options."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital risk management [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureCapitalRiskManagement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of objectives, policies and processes for managing capital [text block]",
        "terseLabel": "Capital risk management"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of information that enables users of financial statements to evaluate the entity's objectives, policies and processes for managing capital."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ifrs-full_DisclosureOfOperatingSegmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesSegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [abstract]",
        "terseLabel": "Segment reporting"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_DisclosureOfOtherCurrentReceivablesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DisclosureOfOtherCurrentReceivablesLineItems",
     "presentation": [
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.",
        "label": "Disclosure of other current receivables [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_DisclosureOfOtherCurrentReceivablesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DisclosureOfOtherCurrentReceivablesTable",
     "presentation": [
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule disclosing information related to other current receivables.",
        "label": "Disclosure of other current receivables [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_DisclosureOfOtherCurrentReceivablesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DisclosureOfOtherCurrentReceivablesTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureOtherCurrentReceivables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of other current receivables.",
        "label": "Disclosure of other current receivables [Text Block]",
        "terseLabel": "Other current receivables"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of prepaid expenses and accrued income including contract assets",
        "label": "Disclosure of prepaid expenses and accrued income including contract assets [Text Block]",
        "terseLabel": "Prepaid expenses and accrued income"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant and equipment."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of property, plant and equipment [text block]",
        "terseLabel": "Property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for property, plant and equipment."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails",
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails",
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of property, plant and equipment."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails",
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about leases for lessee [abstract]",
        "terseLabel": "Right-of-use assets and lease liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [text block]",
        "terseLabel": "Schedule of the movements in the net value book value of right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails",
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails",
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to right-of-use assets."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of range of exercise prices of outstanding share options [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of range of exercise prices of outstanding share options [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the range of exercise prices of outstanding share options."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ifrs-full_DisclosureOfRelatedPartyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfRelatedPartyExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureRelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of related party [text block]",
        "terseLabel": "Related-party transactions"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for related parties."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfResearchAndDevelopmentExpenseExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of research and development expense [text block]",
        "terseLabel": "Research and Development"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of research and development expense. [Refer: Research and development expense]"
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "ifrs-full_DisclosureOfRevenueExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfRevenueExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenues"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of revenue [text block]",
        "terseLabel": "Contract revenues"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for revenue."
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfRevenueFromContractsWithCustomersExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of revenue from contracts with customers [text block]",
        "terseLabel": "Schedule of contract revenues"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for revenue from contracts with customers."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r139"
     ]
    },
    "aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of right-of-use assets impact on the company's statements of income/(loss) and statements of cash flows.",
        "label": "Disclosure of right-of-use assets impact on statements [Text Block]",
        "verboseLabel": "Schedule of impact on condensed consolidated statements of income/(loss) and cash flows"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of sensitivity analysis for actuarial assumptions [abstract]",
        "terseLabel": "Actuarial assumptions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of sensitivity analysis for actuarial assumptions [text block]",
        "terseLabel": "Actuarial assumptions and sensitivity analysis"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of a sensitivity analysis for significant actuarial assumptions used to determine the present value of a defined benefit obligation. [Refer: Actuarial assumptions [member]; Defined benefit obligation, at present value]"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of sensitivity analysis for actuarial assumptions [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of sensitivity analysis for actuarial assumptions [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the sensitivity analysis for actuarial assumptions."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapital"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of share capital, reserves and other equity interest [text block]",
        "terseLabel": "Share capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for share capital, reserves and other equity interest."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of share-based payment arrangements [text block]",
        "terseLabel": "Share-based compensation"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangements."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [abstract]",
        "terseLabel": "Unrecognized deductible temporary differences, unused tax losses and unused tax credits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [text block]",
        "terseLabel": "Unrecognized deductible temporary differences, unused tax losses and unused tax credits"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of types of temporary differences, unused tax losses and unused tax credits. [Refer: Unused tax credits [member]; Unused tax losses [member]; Temporary differences [member]]"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails",
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails",
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to temporary differences, unused tax losses and unused tax credits."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [text block]",
        "terseLabel": "Share-based compensation plans outstanding"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the general terms and conditions of share-based payment arrangements. [Refer: Share-based payment arrangements [member]]"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "aciu_DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of trade and other payables and accrued expenses",
        "label": "Disclosure of trade and other payables and accrued expenses [text block]",
        "terseLabel": "Trade and other payables and accrued expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related-party transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DiscountRateMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DiscountRateMeasurementInputMember",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails",
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discount rate, measurement input [member]",
        "terseLabel": "Discount rate, measurement input"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a discount rate used as a measurement input used in valuation techniques based on a present value calculation."
       }
      }
     },
     "auth_ref": [
      "r289"
     ]
    },
    "ifrs-full_DisposalsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisposalsPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposals, property, plant and equipment",
        "negatedLabel": "Disposals"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r254"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r253",
      "r254",
      "r255"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r253",
      "r254",
      "r255",
      "r257"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r249"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r254"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r256"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "currency_EUR": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2023",
     "localname": "EUR",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "EUR [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings per share",
        "terseLabel": "Loss per share:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EarningsPerShareExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings per share [text block]",
        "terseLabel": "Schedule of earnings per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of earnings per share."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effect of exchange rate changes on cash and cash equivalents",
        "terseLabel": "Exchange gain/(loss) on cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r104",
      "r105"
     ]
    },
    "aciu_EmployeeBenefitsExpenseExcludingShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "EmployeeBenefitsExpenseExcludingShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails": {
       "parentTag": "ifrs-full_ExpenseByNature",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee benefits expense excluding share-based compensation",
        "label": "Employee benefits expense excluding share-based compensation",
        "terseLabel": "Payroll expenses"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_EmployeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "EmployeesMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to personnel employed by the entity.",
        "label": "Employees [Member]",
        "terseLabel": "Employees [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r251"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r251"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r251"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r251"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r258"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r251"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r251"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "ifrs-full_EntitysTotalForRelatedPartiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EntitysTotalForRelatedPartiesMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity's total for related parties [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ifrs-full_Equity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Equity",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/StatementConsolidatedBalanceSheets",
      "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity",
        "periodEndLabel": "Balance, end of period",
        "periodStartLabel": "Balance, beginning of period",
        "totalLabel": "Total shareholders' equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r22",
      "r109",
      "r111",
      "r122",
      "r123",
      "r125"
     ]
    },
    "ifrs-full_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EquityAbstract",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders' equity",
        "terseLabel": "Shareholders' equity"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EquityAndLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EquityAndLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity and liabilities",
        "totalLabel": "Total shareholders' equity and liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]"
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "ifrs-full_EquityAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EquityAndLiabilitiesAbstract",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHAREHOLDERS' EQUITY AND LIABILITIES",
        "terseLabel": "Shareholders' equity and liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EquityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EquityMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "aciu_EscrowDepositAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "EscrowDepositAmount",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of deposits held in escrow.",
        "label": "Escrow deposit, amount",
        "terseLabel": "Escrow deposits"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EstimateOfContributionsExpectedToBePaidToPlan",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Estimate of contributions expected to be paid to plan for next annual reporting period",
        "terseLabel": "Expected contributions by the employer to be paid to the post-employment benefit plans during the annual period beginning after the end of the reporting period"
       }
      },
      "en": {
       "role": {
        "documentation": "The estimate of the expected contributions to be made to a defined benefit plan for the next annual reporting period. [Refer: Defined benefit plans [member]]"
       }
      }
     },
     "auth_ref": [
      "r69",
      "r71"
     ]
    },
    "aciu_EstimatedLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "EstimatedLeaseTerm",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated lease term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Estimated lease term",
        "terseLabel": "Estimated lease term"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ExecutiveManagementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ExecutiveManagementMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Key managers, or ranking officers of an entity, appointed to their position by the board of directors.",
        "label": "Executive Management [Member]",
        "verboseLabel": "Executives [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExercisePriceShareOptionsGranted2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ExercisePriceShareOptionsGranted2019",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise price (USD)"
       }
      },
      "en": {
       "role": {
        "documentation": "The exercise price of share options granted."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ExpectedDividendAsPercentageShareOptionsGranted",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend yield"
       }
      },
      "en": {
       "role": {
        "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "ifrs-full_ExpenseByNature": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ExpenseByNature",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses, by nature",
        "totalLabel": "Total expenses by category"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails": {
       "parentTag": "ifrs-full_ExpenseByNature",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense from share-based payment transactions",
        "terseLabel": "Share-based compensation"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets."
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense from share-based payment transactions with employees",
        "verboseLabel": "Expense charged against the income statement"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]"
       }
      }
     },
     "auth_ref": [
      "r263"
     ]
    },
    "aciu_ExpenseRelatingToLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ExpenseRelatingToLeases",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expense for leases recognized through profit and loss.",
        "label": "Expense relating to leases",
        "totalLabel": "Total"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails": {
       "parentTag": "aciu_ExpenseRelatingToLeases",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense relating to short-term leases for which recognition exemption has been used",
        "terseLabel": "Expense for short-term leases and leases of low value"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of the expense relating to short-term leases accounted for applying paragraph 6 of IFRS 16. This expense need not include the expense relating to leases with a lease term of one month or less. Short-term lease is a lease that, at the commencement date, has a lease term of 12 months or less. A lease that contains a purchase option is not a short-term lease."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "aciu_ExpensesByCategoryAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ExpensesByCategoryAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses by category [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ExpensesOperatingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ExpensesOperatingAbstract",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses, Operating [Abstract]",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Explanation of effect that timing of satisfaction of performance obligations and typical timing of payment have on contract assets and contract liabilities [text block]",
        "terseLabel": "Schedule of contract revenue of performance obligations satisfied"
       }
      },
      "en": {
       "role": {
        "documentation": "The explanation of the effect that the timing of satisfaction of performance obligations and the typical timing of payment have on the contract assets and the contract liabilities. [Refer: Performance obligations [member]; Contract assets; Contract liabilities]"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "ifrs-full_FinanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss": {
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails",
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance costs",
        "negatedLabel": "Financial expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of costs associated with financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinanceCostsPaidClassifiedAsOperatingActivities",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance costs paid, classified as operating activities",
        "negatedLabel": "Finance expenses paid"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for finance costs paid, classified as operating activities. [Refer: Finance costs]"
       }
      }
     },
     "auth_ref": [
      "r288"
     ]
    },
    "ifrs-full_FinanceIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinanceIncome",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss": {
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails",
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial income",
        "terseLabel": "Financial income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income associated with interest and other financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r269"
     ]
    },
    "ifrs-full_FinanceIncomeCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinanceIncomeCost",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails",
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance income (cost)",
        "totalLabel": "Finance result, net"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income or cost associated with interest and other financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r269"
     ]
    },
    "ifrs-full_FinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinancialAssets",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r184",
      "r188",
      "r189",
      "r191",
      "r239"
     ]
    },
    "aciu_FinancialAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "FinancialAssetsAndLiabilitiesAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial assets and liabilities [Abstract]",
        "terseLabel": "Financial assets and liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinancialAssetsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial assets, class [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r164",
      "r193",
      "r194",
      "r209",
      "r210"
     ]
    },
    "ifrs-full_FinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r184"
     ]
    },
    "ifrs-full_FinancialLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinancialLiabilitiesMember",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial liabilities, class [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes financial liabilities. It also represents the standard value for the 'Classes of financial liabilities' axis if no other member is used. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r193",
      "r194",
      "r209",
      "r210"
     ]
    },
    "aciu_FinancialResultNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "FinancialResultNetAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Result, net [Abstract]",
        "terseLabel": "Financial result, net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_FinancialRisksAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "FinancialRisksAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial risks [Abstract]",
        "terseLabel": "Financial risks [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_FirstCapitalPartnerGmbHMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "FirstCapitalPartnerGmbHMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents First Capital Partner GmbH",
        "label": "First Capital Partner GmbH [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FixturesAndFittingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FixturesAndFittingsMember",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing fixtures and fittings that are not permanently attached to real property. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r218"
     ]
    },
    "aciu_FollowOnGrantFundingReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "FollowOnGrantFundingReceived",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Follow-on grant funding received",
        "label": "Follow-on grant funding received"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_FollowOnGrantFundingReceivedTotalForJointArrangement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "FollowOnGrantFundingReceivedTotalForJointArrangement",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Follow-on grant funding received, total for joint arrangement",
        "label": "Follow-on grant funding received, total for joint arrangement"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_FollowOnOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "FollowOnOfferingMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalFollowOnOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Follow on offering.",
        "label": "Follow on Offering [Member]",
        "terseLabel": "Follow on Offering"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ForeignExchangeRatesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ForeignExchangeRatesAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesFunctionalAndReportingCurrencyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Functional and reporting currency"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income",
        "negatedLabel": "Remeasurement through other comprehensive income/(loss)"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from the remeasurement of that net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]"
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss": {
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails",
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails",
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange differences",
        "terseLabel": "Exchange differences",
        "verboseLabel": "Foreign exchange gains (losses)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]"
       }
      }
     },
     "auth_ref": [
      "r8",
      "r72"
     ]
    },
    "ifrs-full_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss": {
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails",
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative expense",
        "negatedLabel": "General &amp; administrative expenses",
        "verboseLabel": "General and administrative expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense relating to general and administrative activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r263"
     ]
    },
    "aciu_GeneralInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "GeneralInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "General information"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GeographicalAreasAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GeographicalAreasAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical areas [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r220",
      "r232",
      "r237"
     ]
    },
    "ifrs-full_GeographicalAreasMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GeographicalAreasMember",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical areas [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r220",
      "r232",
      "r237"
     ]
    },
    "aciu_GoingConcernAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "GoingConcernAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureBasisOfPreparationGoingConcernDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Going Concern [Abstract]",
        "terseLabel": "Going concern"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_GrantIncomePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "GrantIncomePolicyTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for grant income.",
        "label": "Grant income [Policy Text Block]",
        "terseLabel": "Grant income"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_GrantRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "GrantRevenueMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue earned from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.",
        "label": "Grant revenue [Member]",
        "terseLabel": "Grant revenue [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_GrantsMichaelJFoxFoundationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "GrantsMichaelJFoxFoundationMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Funding provided for certain types of expenditures in connection with research and development activities over a contractually-defined period from the Michael J. Fox Foundation.",
        "label": "Grants, Michael J. Fox Foundation [Member]",
        "terseLabel": "Grant from Michael J. Fox Foundation"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GrossCarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GrossCarryingAmountMember",
     "presentation": [
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails",
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross carrying amount [member]",
        "terseLabel": "Gross Carrying Amount",
        "verboseLabel": "Acquisition Cost"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      }
     },
     "auth_ref": [
      "r46",
      "r92",
      "r98",
      "r101",
      "r180",
      "r189",
      "r191",
      "r239"
     ]
    },
    "ifrs-full_GrossLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GrossLeaseLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross lease liabilities",
        "terseLabel": "Contractual undiscounted cash flows for lease obligations"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of contractual undiscounted cash flows in relation to lease liabilities before deducting finance charges. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r149",
      "r241"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r253",
      "r254",
      "r255"
     ]
    },
    "aciu_IfNotesAreConvertedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "IfNotesAreConvertedMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents the scenario that notes get converted",
        "label": "If notes are converted [Member]",
        "terseLabel": "If notes are converted"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impact on statements of income/(loss) and cash flows [Abstract]",
        "terseLabel": "Statements of income/(loss) and cash flows"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_InProcessResearchAndDevelopmentIPRDAssetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "InProcessResearchAndDevelopmentIPRDAssetMember",
     "presentation": [
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for an intangible asset that is a clinically-validated active vaccine candidate for the treatment of Parkinson's disease.",
        "label": "Acquired IPR&amp;D Asset"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Statements of Income/(Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncomeTaxExpenseContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails",
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax expense",
        "negatedLabel": "Income tax expense",
        "totalLabel": "Effective income tax rate (benefit)/expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]"
       }
      }
     },
     "auth_ref": [
      "r33",
      "r38",
      "r39",
      "r40",
      "r82",
      "r121",
      "r199"
     ]
    },
    "aciu_IncomeTaxLossCarryforwardPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "IncomeTaxLossCarryforwardPeriod",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period or time limit over which financial losses of the entity for preceding years can be deducted from the taxable revenue for a period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Income tax loss, Carryforward period",
        "terseLabel": "Tax loss carryforward period"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in cash and cash equivalents before effect of exchange rate changes",
        "totalLabel": "Net increase/(decrease) in cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease/(increase) from actual defined benefit obligation",
        "negatedLabel": "Decrease/(increase) from actual defined benefit obligation"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in a defined benefit obligation that would have been caused by a decrease in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [member]]"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption",
        "negatedLabel": "Decrease/(increase) from actual defined benefit obligation"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in a defined benefit obligation that would have been caused by an increase in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [member]]"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "aciu_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in net defined benefit liability (asset) resulting from benefits deposited",
        "label": "Increase (decrease) in net defined benefit liability (asset) resulting from benefits deposited",
        "negatedLabel": "Benefits deposited"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in net defined benefit liability (asset) resulting from expense (income) in profit or loss",
        "terseLabel": "Net pension cost through statement of income/(loss)"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from expense (income) included in profit or loss. [Refer: Net defined benefit liability (asset); Profit (loss)] [Contrast: Post-employment benefit expense in profit or loss, defined benefit plans]"
       }
      }
     },
     "auth_ref": [
      "r275"
     ]
    },
    "aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in profit (loss) resulting from reasonably possible increase or decrease in interest rates",
        "label": "Increase (decrease) in profit (loss) resulting from reasonably possible increase or decrease in interest rates"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in profit (loss) resulting from reasonably possible strengthening or weakening of reporting currency against other relevant currencies",
        "label": "Increase (decrease) in profit (loss) resulting from reasonably possible strengthening or weakening of reporting currency against other relevant currencies"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in tax losses available for offset against future taxable profits",
        "label": "Increase (decrease) in tax losses available for offset against future taxable profits"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "IncreaseDecreaseThroughAcquisitionOfAssetsEquity",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "'The increase (decrease) in equity resulting from the issuance of shares as part of an asset acquisition.",
        "label": "Increase (decrease) through acquisition of assets, equity",
        "terseLabel": "Asset acquisition - common shares"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseThroughConversionOfConvertibleInstruments",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) through conversion of convertible instruments, equity",
        "terseLabel": "Conversion note agreement"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the conversion of convertible instruments."
       }
      }
     },
     "auth_ref": [
      "r262"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughExerciseOfOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseThroughExerciseOfOptions",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) through exercise of options, equity",
        "terseLabel": "Exercise of options"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the exercise of options."
       }
      }
     },
     "auth_ref": [
      "r262"
     ]
    },
    "aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from purchase of IPR&amp;D assets.",
        "label": "Increase (decrease) through purchase of in process research and development asset",
        "terseLabel": "IPR&amp;D asset purchase"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) through share-based payment transactions, equity",
        "terseLabel": "Share-based payments"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]"
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) through transfers from construction in progress, property, plant and equipment",
        "terseLabel": "Transfers"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from transfers from construction in progress. [Refer: Property, plant and equipment; Construction in progress]"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseThroughTreasuryShareTransactions",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) through treasury share transactions, equity",
        "verboseLabel": "Held as treasury shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from treasury share transactions. [Refer: Equity; Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails",
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in equity shares resulting from treasury share transactions.",
        "label": "Increase (decrease) through treasury share transactions, equity, shares",
        "terseLabel": "Issuance of shares to be held as treasury shares, net of transaction costs (in shares)",
        "verboseLabel": "Issuance of shares to be held as treasury shares"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_IncreaseInGeneralAndAdministrativeExpenseThroughIncreaseInShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "IncreaseInGeneralAndAdministrativeExpenseThroughIncreaseInShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase in general and administrative expense through increase in share-based compensation expense",
        "label": "Increase in general and administrative expense through increase in share-based compensation expense"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase in the number of ordinary shares issued under a convertible debt arrangement upon conversion of the debt.",
        "label": "Increase in number of ordinary shares issued under conversion of convertible debt",
        "terseLabel": "Conversion of note agreement, net of transaction costs (in shares)",
        "verboseLabel": "Number of shares issued through conversion of convertible notes"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase in the number of ordinary shares issued under incentive plans.",
        "label": "Increase in number of ordinary shares issued under incentive plans",
        "terseLabel": "Issuance of shares - incentive plans, net of transaction costs (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_IncreaseInResearchAndDevelopmentExpenseThroughIncreaseInSalariesAndRelatedCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "IncreaseInResearchAndDevelopmentExpenseThroughIncreaseInSalariesAndRelatedCosts",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase in research and development expense through increase in salaries and related costs",
        "label": "Increase in research and development expense through increase in salaries and related costs"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_IncreaseThroughSharesIssuedUnderIncentivePlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "IncreaseThroughSharesIssuedUnderIncentivePlans",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase in equity resulting from the issue of shares under incentive plans.",
        "label": "Increase through shares issued under incentive plans",
        "verboseLabel": "Issuance of shares - incentive plans, net of transaction costs"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_IntangibleAssetsAcquiredAsPartOfAssetAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "IntangibleAssetsAcquiredAsPartOfAssetAcquisition",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails": {
       "parentTag": "aciu_TotalAssetsAcquiredInAssetAcquisition",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets acquired as part of asset acquisition",
        "label": "Intangible assets acquired as part of asset acquisition",
        "terseLabel": "IPR&amp;D asset"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails",
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible asset",
        "terseLabel": "Intangible Assets",
        "verboseLabel": "Intangible asset"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r10",
      "r93"
     ]
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IntangibleAssetsOtherThanGoodwillMember",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails",
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets other than goodwill [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r94",
      "r223",
      "r234"
     ]
    },
    "ifrs-full_InterestExpenseDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InterestExpenseDefinedBenefitPlans",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails": {
       "parentTag": "ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense, defined benefit plans",
        "terseLabel": "Interest cost"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of interest expense arising from defined benefit plans. [Refer: Interest expense; Post-employment benefit expense in profit or loss, defined benefit plans] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]"
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InterestExpenseIncomeNetDefinedBenefitLiabilityAsset",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)",
        "negatedLabel": "Interest cost",
        "negatedTerseLabel": "Interest income"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from the passage of time. [Refer: Interest expense; Net defined benefit liability (asset)]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "ifrs-full_InterestExpenseOnLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InterestExpenseOnLeaseLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails": {
       "parentTag": "aciu_ExpenseRelatingToLeases",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesStatementOfIncomeLossAndCashFlowDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense on lease liabilities",
        "terseLabel": "Interest expense on lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ifrs-full_InterestIncomeDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InterestIncomeDefinedBenefitPlans",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails": {
       "parentTag": "ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest income, defined benefit plans",
        "negatedLabel": "Interest income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of interest income arising from defined benefit plans. [Refer: Interest income; Post-employment benefit expense in profit or loss, defined benefit plans] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]"
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "ifrs-full_InterestPaidClassifiedAsOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InterestPaidClassifiedAsOperatingActivities",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest paid, classified as operating activities",
        "negatedLabel": "Interest paid"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for interest paid, classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ifrs-full_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate risk [member]",
        "terseLabel": "Interest Rate [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the type of risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. [Refer: Financial instruments, class [member]]"
       }
      }
     },
     "auth_ref": [
      "r158",
      "r159",
      "r160",
      "r161",
      "r197"
     ]
    },
    "ifrs-full_InterestReceivedClassifiedAsOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InterestReceivedClassifiedAsOperatingActivities",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest received, classified as operating activities",
        "terseLabel": "Interest received"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from interest received, classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "IprDIntangibleAssetAssociatedWithAci7104.056Member",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents the IPR&amp;D intangible asset associated with ACI 7104.056",
        "label": "IPR&amp;D intangible asset associated with ACI 7104.056 [Member]",
        "terseLabel": "IPR&amp;D intangible asset associated with ACI 7104.056"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Issuance of shares for purchase of IPR&amp;D asset in asset acquisition.",
        "label": "Issuance of shares for purchase of IPR&amp;D asset in asset acquisition",
        "terseLabel": "Issuance of shares for purchase of IPR&amp;D asset in asset acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_IssueOfEquityRestrictedShareAwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "IssueOfEquityRestrictedShareAwards",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase in equity through the issue of restricted share awards.",
        "label": "Issue of Equity, Restricted Share Awards",
        "terseLabel": "Restricted share awards"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IssuedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IssuedCapital",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalNarrativesDetails",
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issued capital",
        "terseLabel": "Share capital",
        "verboseLabel": "Issued share capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      }
     },
     "auth_ref": [
      "r216"
     ]
    },
    "ifrs-full_IssuedCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IssuedCapitalMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issued capital [member]",
        "terseLabel": "Share capital"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "aciu_ItAndLaboratoryEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ItAndLaboratoryEquipmentMember",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for IT and laboratory equipment",
        "label": "IT and laboratory equipment [Member]",
        "verboseLabel": "Laboratory and IT equipment"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_JJInnovativeMedicineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "JJInnovativeMedicineMember",
     "presentation": [
      "http://acimume.com/role/DisclosureAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents J&amp;J Innovative Medicine",
        "label": "J&amp;J Innovative Medicine [Member]",
        "terseLabel": "J&amp;J Innovative Medicine"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_KeyManagementPersonnelCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "KeyManagementPersonnelCompensation",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Key management personnel compensation",
        "totalLabel": "Total compensation"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationPostemploymentBenefits",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-employment benefits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of post-employment benefits. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationSharebasedPayment",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term employee benefits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ifrs-full_KeyManagementPersonnelOfEntityOrParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "KeyManagementPersonnelOfEntityOrParentMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executives and Directors [Member]",
        "terseLabel": "Executives and Directors [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for those persons having authority and responsibility for planning, directing and controlling the activities of the entity, directly or indirectly, including any director (whether executive or otherwise) of that entity."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "aciu_LaboratoryEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "LaboratoryEquipmentMember",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails",
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing laboratory equipment.",
        "label": "Laboratory equipment [Member]",
        "terseLabel": "Lab Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LaterThanFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LaterThanFiveYearsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "More Than 5 Years [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than five years."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r151",
      "r163",
      "r240",
      "r244",
      "r246"
     ]
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LaterThanOneYearAndNotLaterThanThreeYearsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "1-3 years"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than three years."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r242",
      "r246"
     ]
    },
    "ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LaterThanThreeYearsAndNotLaterThanFiveYearsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "3-5 years"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than three years and not later than five years."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r243",
      "r246"
     ]
    },
    "aciu_LeaseholdImprovementsAndFixturesAndFittingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "LeaseholdImprovementsAndFixturesAndFittingsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement and fixtures and fittings that are not permanently attached to real property.",
        "label": "Leasehold improvements and fixtures and fittings [Member]",
        "terseLabel": "Leasehold Improvements/Furniture"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leasehold Improvements"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement."
       }
      }
     },
     "auth_ref": [
      "r270"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r122",
      "r123",
      "r125",
      "r200",
      "r204"
     ]
    },
    "ifrs-full_LiabilityAssetOfDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LiabilityAssetOfDefinedBenefitPlans",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net defined benefit liability (asset)",
        "negatedPeriodEndLabel": "At end of period",
        "negatedPeriodStartLabel": "At beginning of period",
        "periodEndLabel": "Net defined benefit liabilities, end of period",
        "periodStartLabel": "Net defined benefit liabilities, beginning of period"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The 2014 contractual research agreement associated with collaboration with Life Molecular Imaging.",
        "label": "License and collaboration agreement of 2014, Life Molecular Imaging [Member]",
        "terseLabel": "2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) [Member]",
        "verboseLabel": "Life Molecular Imaging [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LineItemsByFunctionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LineItemsByFunctionMember",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line items by function [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value of the \u2018Attribution of expenses by nature to their function' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r261",
      "r263"
     ]
    },
    "ifrs-full_LiquidityRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LiquidityRiskMember",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidity risk [member]",
        "terseLabel": "Liquidity Risk [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities that are settled by delivering cash or another financial asset. [Refer: Financial assets; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r158",
      "r159",
      "r160",
      "r238"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "aciu_LongTermFinancialAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "LongTermFinancialAssetsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents financial assets classified as long-term.",
        "label": "Long-term Financial Assets [Member]",
        "terseLabel": "Long-term financial assets"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_LongTermLeaseLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "LongTermLeaseLiabilitiesMember",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Long-term lease liabilities",
        "label": "Long-term lease liabilities [Member]",
        "terseLabel": "Long-term lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "MajorComponentsOfTaxExpenseIncomeAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes [Abstract]",
        "terseLabel": "Income taxes"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_March312020Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "March312020Member",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents March 31, 2020",
        "label": "March 31, 2020 [Member]",
        "terseLabel": "March 31, 2020"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MaturityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "MaturityAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails",
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r137",
      "r150",
      "r151",
      "r155",
      "r156",
      "r157",
      "r163",
      "r183",
      "r192",
      "r221",
      "r240"
     ]
    },
    "aciu_MaturityPeriodOtherCurrentReceivables": {
     "xbrltype": "durationItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "MaturityPeriodOtherCurrentReceivables",
     "presentation": [
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maturity period, other current receivables",
        "label": "Maturity period, other current receivables"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement": {
     "xbrltype": "durationItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum term of options granted for a type of share-based payment arrangement that existed at any time during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum term of options granted for share-based payment arrangement",
        "terseLabel": "Contractual life of options"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement": {
     "xbrltype": "durationItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum term of other equity instruments (ie other than share options) granted for a type of share-based payment arrangement that existed at any time during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum Term Of Other Equity Instruments Granted For Share Based Payment Arrangement",
        "terseLabel": "Contractual life of options"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "MilestonePaymentsClinicalAndRegulatoryMilestonesMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to a milestone payment arrangement related to clinical and regulatory milestones.",
        "label": "Milestone payments, clinical and regulatory milestones [Member]",
        "terseLabel": "Clinical and Regulatory [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_MilestonePaymentsCommercialMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "MilestonePaymentsCommercialMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to a milestone payment arrangement related to certain commercial milestones.",
        "label": "Milestone payments, commercial [Member]",
        "terseLabel": "Commercial [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MiscellaneousCurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "MiscellaneousCurrentAssetsAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Miscellaneous current assets [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_MiscellaneousOtherCurrentReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "MiscellaneousOtherCurrentReceivables",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails": {
       "parentTag": "ifrs-full_OtherCurrentReceivables",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Miscellaneous other current receivables",
        "label": "Miscellaneous other current receivables",
        "terseLabel": "Other current receivable"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NetDefinedBenefitLiabilityAssetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NetDefinedBenefitLiabilityAssetAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net defined benefit liability (asset) [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "ifrs-full_NetDefinedBenefitLiabilityAssetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NetDefinedBenefitLiabilityAssetMember",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net defined benefit liability (asset) [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the net defined benefit liability (asset). It also represents the standard value for the 'Net defined benefit liability (asset)' axis if no other member is used. [Refer: Net defined benefit liability (asset)]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "aciu_NetProceedsFromIssuanceOfShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "NetProceedsFromIssuanceOfShares",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalFollowOnOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net proceeds from issuance of shares",
        "label": "Net proceeds from issuance of shares"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NonadjustingEventsAfterReportingPeriodAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "ifrs-full_NonadjustingEventsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NonadjustingEventsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "ifrs-full_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets",
        "totalLabel": "Total non-current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      }
     },
     "auth_ref": [
      "r18",
      "r114",
      "r228"
     ]
    },
    "ifrs-full_NoncurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentAssetsAbstract",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets [abstract]",
        "terseLabel": "Non-current assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current lease liabilities",
        "terseLabel": "Long-term lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "ifrs-full_NoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities",
        "totalLabel": "Total non-current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r19",
      "r116",
      "r228"
     ]
    },
    "ifrs-full_NoncurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentLiabilitiesAbstract",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities [abstract]",
        "terseLabel": "Non-current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentProvisionsForEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentProvisionsForEmployeeBenefits",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current provisions for employee benefits",
        "terseLabel": "Net employee defined benefit liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current provisions for employee benefits. [Refer: Provisions for employee benefits]"
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "ifrs-full_NoncurrentRestrictedCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentRestrictedCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current restricted cash and cash equivalents",
        "terseLabel": "Long-term financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r265"
     ]
    },
    "ifrs-full_NotLaterThanOneYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NotLaterThanOneYearMember",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails",
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less than one year",
        "terseLabel": "Within 1 Year",
        "verboseLabel": "2019 [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of not later than one year."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r150",
      "r151",
      "r163",
      "r240",
      "r246"
     ]
    },
    "aciu_NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAuthorizedCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares that Board of Directors are authorized to issue",
        "label": "Number of additional shares that Board of Directors are authorized to issue"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_NumberOfConvertibleNoteAgreements": {
     "xbrltype": "integerItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "NumberOfConvertibleNoteAgreements",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of convertible note agreements",
        "label": "Number of convertible note agreements",
        "terseLabel": "Number of separate convertible note agreements"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_NumberOfDepositsInEscrowAccounts": {
     "xbrltype": "integerItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "NumberOfDepositsInEscrowAccounts",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesContractualUndiscountedCashFlowsForLeaseObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of deposits in escrow accounts.",
        "label": "Number of deposits in escrow accounts"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_NumberOfEquityBasedInstrumentPlans": {
     "xbrltype": "integerItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "NumberOfEquityBasedInstrumentPlans",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of equity-based instrument plans approved by the entity.",
        "label": "Number of Equity-based Instrument Plans"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets": {
     "xbrltype": "integerItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of financial institutions holding the entity's deposits of cash and cash equivalents and short-term financial assets.",
        "label": "Number of financial institutions holding, cash and cash equivalents and short-term financial assets",
        "terseLabel": "Number of financial institutions holding cash and cash equivalents and short-term financial assets"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_NumberOfGrants": {
     "xbrltype": "integerItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "NumberOfGrants",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants received.",
        "label": "Number of grants",
        "terseLabel": "Number of grants received"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of other equity instruments granted in share-based payment arrangement",
        "terseLabel": "Granted during the year (in shares)",
        "verboseLabel": "Number of non-vested share awards granted (in shares)"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r291"
     ]
    },
    "ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareAntidilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of instruments that are antidilutive in period presented"
       }
      },
      "en": {
       "role": {
        "documentation": "Number of (units of) instruments that are antidilutive in the period presented."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "aciu_NumberOfNonVestedSharesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "NumberOfNonVestedSharesAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Non-vested Shares [Abstract]",
        "terseLabel": "Number of non-vested shares [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_NumberOfOptionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "NumberOfOptionsAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Options [Abstract]",
        "terseLabel": "Number of options [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of other equity instruments exercisable in share-based payment arrangement",
        "periodEndLabel": "Vested and exercisable (in shares)"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r291"
     ]
    },
    "aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) exercised in a share-based payment arrangement.",
        "label": "Number of other equity instruments exercised in share-based payment arrangement",
        "negatedLabel": "Exercised during the year (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of other equity instruments exercised or vested in share-based payment arrangement",
        "negatedLabel": "Vested during the year"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r291"
     ]
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of other equity instruments forfeited in share-based payment arrangement",
        "negatedLabel": "Forfeited during the year (in shares)"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r291"
     ]
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of other equity instruments outstanding in share-based payment arrangement",
        "periodEndLabel": "Non-vested at end of period (in shares)",
        "periodStartLabel": "Non-vested at beginning of period (in shares)"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r291"
     ]
    },
    "ifrs-full_NumberOfOutstandingShareOptions": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfOutstandingShareOptions",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Options (in shares)",
        "periodEndLabel": "Outstanding at end of period (in shares)",
        "periodStartLabel": "Outstanding at beginning of period (in shares)"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options outstanding in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r170",
      "r174"
     ]
    },
    "aciu_NumberOfPersonsKeyManagementBoardOfDirectors": {
     "xbrltype": "integerItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "NumberOfPersonsKeyManagementBoardOfDirectors",
     "presentation": [
      "http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of persons that are the included in Board of Directors excluding the Chief Executive Officer.",
        "label": "Number of persons, key management, Board of Directors",
        "terseLabel": "Number of individuals, Board of Directors"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_NumberOfPersonsKeyManagementExecutiveManagement": {
     "xbrltype": "integerItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "NumberOfPersonsKeyManagementExecutiveManagement",
     "presentation": [
      "http://acimume.com/role/DisclosureRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of persons that comprise key management of the entity that are Executive Management.",
        "label": "Number of persons, key management, Executive Management",
        "terseLabel": "Number of individuals, Executive Management"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty": {
     "xbrltype": "integerItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "NumberOfRepresentativesInJointSteeringCommitteeByEachParty",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of representatives in a joint steering committee by each party as per the agreement.",
        "label": "Number of representatives in joint steering committee by each party",
        "terseLabel": "Number of representatives in joint steering committee by each party"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfShareOptionsExercisableInSharebasedPaymentArrangement",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of share options exercisable in share-based payment arrangement",
        "terseLabel": "Exercisable (in shares)"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options exercisable in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of share options exercised in share-based payment arrangement",
        "negatedLabel": "Exercised during the year (in shares)"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options exercised in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of share options forfeited in share-based payment arrangement",
        "negatedLabel": "Forfeited during the year (in shares)"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options forfeited in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted during the year (in shares)",
        "verboseLabel": "Number of options awarded (in shares)"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options granted in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ifrs-full_NumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfSharesIssued",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails",
      "http://acimume.com/role/DisclosureShareCapitalNarrativesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares issued",
        "terseLabel": "Number of shares",
        "verboseLabel": "Shares issued (in shares)"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity."
       }
      }
     },
     "auth_ref": [
      "r262"
     ]
    },
    "ifrs-full_NumberOfSharesIssuedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfSharesIssuedAbstract",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common shares",
        "terseLabel": "Issuance of shares, net of transaction costs:"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_NumberOfSharesIssuedDuringPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "NumberOfSharesIssuedDuringPeriod",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalFollowOnOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period",
        "label": "Number of shares issued during the period"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued upon exercise of options and restricted share units.",
        "label": "Number of Shares Issued Upon Exercise of Options and Restricted Share Units",
        "terseLabel": "Number of shares issued upon exercise of options and restricted share units"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfSharesOutstanding",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares outstanding",
        "periodEndLabel": "Common shares outstanding at end of period",
        "periodStartLabel": "Common shares outstanding at beginning of period"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "aciu_NumberOfTechnologyPlatforms": {
     "xbrltype": "integerItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "NumberOfTechnologyPlatforms",
     "presentation": [
      "http://acimume.com/role/DisclosureGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of unique proprietary platform technologies to discover, design and develop medicines and diagnostics to target misfolded proteins.",
        "label": "Number of technology platforms",
        "terseLabel": "Number of proprietary technology platforms"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OfficeEquipmentMember",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails",
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Office Equipment",
        "terseLabel": "Office Equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing equipment used to support office functions, not specifically used in the production process. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r219"
     ]
    },
    "ifrs-full_OperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OperatingExpense",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails": {
       "parentTag": "ifrs-full_ExpenseByNature",
       "weight": 1.0,
       "order": 1.0
      },
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails",
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expense",
        "negatedTotalLabel": "Total operating expenses",
        "terseLabel": "Operating expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of all operating expenses."
       }
      }
     },
     "auth_ref": [
      "r269"
     ]
    },
    "aciu_OperatingSegmentsNumber": {
     "xbrltype": "integerItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "OperatingSegmentsNumber",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesSegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments reported by the entity.",
        "label": "Operating segments, number",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OrdinarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OrdinarySharesMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/DisclosureShareCapitalNarrativesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares [member]",
        "terseLabel": "Common Shares [Member]",
        "verboseLabel": "Common Shares"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments. It also represents the standard value for the 'Classes of ordinary shares' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r268"
     ]
    },
    "aciu_OtherAccruedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "OtherAccruedExpenses",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails": {
       "parentTag": "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other accrued expenses",
        "label": "Other accrued expenses"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_OtherAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "OtherAgreementMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "contractual research agreement associated with collaboration with other.",
        "label": "Other agreement [Member]",
        "verboseLabel": "Other [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_OtherComprehensiveGainsLossesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "OtherComprehensiveGainsLossesAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive gains (losses) [Abstract]",
        "terseLabel": "Other comprehensive gains/(losses) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity",
      "http://acimume.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income",
        "terseLabel": "Other comprehensive income/(loss)",
        "totalLabel": "Other comprehensive income/(loss)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]"
       }
      }
     },
     "auth_ref": [
      "r2",
      "r29",
      "r34",
      "r119"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income, net of tax, exchange differences on translation of foreign operations",
        "terseLabel": "Currency translation differences"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r20",
      "r34"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": 1.0,
       "order": 2.0
      },
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails",
      "http://acimume.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans",
        "terseLabel": "Remeasurement gains/(losses) on defined-benefit plans (net of tax)",
        "totalLabel": "Total other comprehensive gain"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [member]; Plan assets [member]; Net defined benefit liability (asset)] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r20",
      "r34",
      "r273"
     ]
    },
    "ifrs-full_OtherCurrentReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherCurrentReceivables",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 5.0
      },
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails",
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other current receivables",
        "terseLabel": "Other current receivables",
        "totalLabel": "Total other current receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current other receivables. [Refer: Other receivables]"
       }
      }
     },
     "auth_ref": [
      "r215"
     ]
    },
    "aciu_OtherCurrentReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "OtherCurrentReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other current receivables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_OtherCurrentReceivablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "OtherCurrentReceivablesMember",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents other current receivables",
        "label": "Other current receivables [Member]",
        "terseLabel": "Other current receivables"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherOperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherOperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss": {
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other operating income (expense)",
        "terseLabel": "Income from grants",
        "verboseLabel": "Other operating income/(expense), net"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of operating income (expense) that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r269"
     ]
    },
    "aciu_OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding equity or cash consideration due under convertible note agreements",
        "label": "Outstanding equity or cash consideration due under convertible note agreements"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Options Exercise Price Range and Expiry Dates [Abstract]",
        "terseLabel": "Outstanding options, exercise price range and expiry dates [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ParValuePerShare",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails",
      "http://acimume.com/role/DisclosureShareCapitalAuthorizedCapitalDetails",
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForFinancingAndOtherPurposesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Par value per share",
        "terseLabel": "Nominal value per share (in CHF per share)"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value per share."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "ifrs-full_PastServiceCostDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PastServiceCostDefinedBenefitPlans",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails": {
       "parentTag": "ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Past service cost, defined benefit plans",
        "terseLabel": "Past service cost"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense (income) resulting from past service cost. Past service cost is the change in the present value of the defined benefit obligation for employee service in prior periods, resulting from a plan amendment (the introduction or withdrawal of, or changes to, a defined benefit plan) or a curtailment (a significant reduction by the entity in the number of employees covered by a plan). [Refer: Post-employment benefit expense in profit or loss, defined benefit plans; Defined benefit plans [member]] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from past service cost]"
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "ifrs-full_PastServiceCostNetDefinedBenefitLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PastServiceCostNetDefinedBenefitLiabilityAsset",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in net defined benefit liability (asset) resulting from past service cost",
        "negatedLabel": "Past service cost"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from past service cost. Past service cost is the change in the present value of the defined benefit obligation for employee service in prior periods, resulting from a plan amendment (the introduction or withdrawal of, or changes to, a defined benefit plan) or a curtailment (a significant reduction by the entity in the number of employees covered by a plan). [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "ifrs-full_PaymentsForShareIssueCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PaymentsForShareIssueCosts",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments for share issue costs",
        "negatedLabel": "Transaction costs on issuance of shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for share issue costs."
       }
      }
     },
     "auth_ref": [
      "r284"
     ]
    },
    "aciu_PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for share issue costs associated with issuance of shares in relation to asset acquisitions",
        "label": "Payments for share issue costs associated with issuance of shares in relation to asset acquisitions",
        "negatedLabel": "Transaction costs associated with issuance of shares in relation to asset acquisition previously recorded in Accrued expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of lease liabilities, classified as financing activities",
        "negatedLabel": "Principal payments of lease obligations"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r225"
     ]
    },
    "aciu_PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments (proceeds) from purchases (sales) of short-term financial assets, classified as investing activities",
        "label": "Payments (proceeds) from purchases (sales) of short-term financial assets, classified as investing activities",
        "negatedLabel": "Short-term financial assets, net"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_PercentageIncreaseInPropertyPlantAndEquipment": {
     "xbrltype": "percentItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "PercentageIncreaseInPropertyPlantAndEquipment",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of increase in property, plant and equipment during the period.",
        "label": "Percentage increase in property, plant and equipment",
        "terseLabel": "Percentage of increase in equipment"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PercentageOfReasonablyPossibleDecreaseInActuarialAssumption",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of reasonably possible decrease in actuarial assumption",
        "terseLabel": "Percentage decrease in actuarial assumption"
       }
      },
      "en": {
       "role": {
        "documentation": "The reasonably possible percentage of the decrease in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [member]]"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The reasonably possible percentage of the decrease in the actuarial assumption used to determine the present value of defined benefit obligation.",
        "label": "Percentage of reasonably possible decrease in actuarial assumption [Member]",
        "terseLabel": "-0.5% Decrease [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PercentageOfReasonablyPossibleIncreaseInActuarialAssumption",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of reasonably possible increase in actuarial assumption",
        "terseLabel": "Percentage increase in actuarial assumption"
       }
      },
      "en": {
       "role": {
        "documentation": "The reasonably possible percentage of the increase in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [member]]"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The reasonably possible percentage of the increase in the actuarial assumption used to determine the present value of defined benefit obligation.",
        "label": "Percentage of reasonably possible increase in actuarial assumption [Member]",
        "terseLabel": "+0.5% Increase [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates": {
     "xbrltype": "percentItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of reasonably possible increase or decrease in interest rates",
        "label": "Percentage of reasonably possible increase or decrease in interest rates"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies": {
     "xbrltype": "percentItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of reasonably possible strengthening or weakening of reporting currency against other relevant currencies",
        "label": "Percentage of reasonably possible strengthening or weakening of reporting currency against other relevant currencies"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PerformanceObligationsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PerformanceObligationsAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Performance obligations [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ifrs-full_PerformanceObligationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PerformanceObligationsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Performance obligations [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all performance obligations. A performance obligation is a promise in a contract with a customer to transfer to the customer either: (a) a good or service (or a bundle of goods or services) that is distinct; or (b) a series of distinct goods or services that are substantially the same and that have the same pattern of transfer to the customer. This member also represents the standard value for the 'Performance obligations' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ifrs-full_PlanAssetsAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PlanAssetsAtFairValue",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails": {
       "parentTag": "ifrs-full_SurplusDeficitInPlan",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan assets, at fair value",
        "terseLabel": "Fair value of plan assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value of defined benefit plan assets. Plan assets comprise assets held by a long-term employee benefit fund and qualifying insurance policies. [Refer: At fair value [member]]"
       }
      }
     },
     "auth_ref": [
      "r279"
     ]
    },
    "ifrs-full_PlanAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PlanAssetsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan assets [member]",
        "terseLabel": "Fair Value of Plan Assets [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for defined benefit plan assets. Plan assets comprise: (a) assets held by a long-term employee benefit fund; and (b) qualifying insurance policies."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PostemploymentBenefitExpenseDefinedBenefitPlans",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanAmountsRecordedInConsolidatedStatementsOfIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-employment benefit expense in profit or loss, defined benefit plans",
        "totalLabel": "Net pension cost"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of post-employment benefit expense included in profit or loss relating to defined benefit plans. [Refer: Profit (loss); Defined benefit plans [member]] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from expense (income) in profit or loss]"
       }
      }
     },
     "auth_ref": [
      "r273",
      "r278"
     ]
    },
    "aciu_PotentialIncreaseIsEquityThroughConversionOfDebtInstruments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "PotentialIncreaseIsEquityThroughConversionOfDebtInstruments",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForFinancingAndOtherPurposesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential increase is equity through conversion of debt instruments",
        "label": "Potential increase is equity through conversion of debt instruments"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The potential increase in equity from share-based payment transactions.",
        "label": "Potential increase is equity through share-based payment transactions",
        "terseLabel": "Maximum aggregate amount of ordinary shares"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForFinancingAndOtherPurposesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential number of shares issued from conversion of debt instruments",
        "label": "Potential number of shares issued from conversion of debt instruments"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of potential shares issued through share-based payment transactions.",
        "label": "Potential number of shares issued from share-based payment transactions",
        "verboseLabel": "Issuance of ordinary shares (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "PrepaidExpensesAndAccruedIncomeDisclosureAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosurePrepaidExpensesAndAccruedIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and accrued income, Disclosure [Abstract]",
        "terseLabel": "Prepaid expenses and accrued income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PresentValueOfDefinedBenefitObligationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PresentValueOfDefinedBenefitObligationMember",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInDefinedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Present value of defined benefit obligation [member]",
        "terseLabel": "Defined Benefit Obligation [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the present value of a defined benefit obligation. The present value of a defined benefit obligation is the present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "ifrs-full_PresentationOfLeasesForLesseeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PresentationOfLeasesForLesseeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets, long-term financial assets and lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ProceedsFromConversionOfConvertibleDebtPerIndividualNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ProceedsFromConversionOfConvertibleDebtPerIndividualNote",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from conversion of convertible debt, per individual note",
        "label": "Proceeds from conversion of convertible debt, per individual note"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProceedsFromExerciseOfOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProceedsFromExerciseOfOptions",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from exercise of options",
        "terseLabel": "Proceeds from issuance of common shares - equity plan, net of transaction costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from the exercise of options."
       }
      }
     },
     "auth_ref": [
      "r284"
     ]
    },
    "aciu_ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance of common shares in connection to asset acquisitions",
        "label": "Proceeds from issuance of common shares in connection to asset acquisitions",
        "terseLabel": "Proceeds from issuance of common shares - asset acquisition, net of transaction costs"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ProceedsFromIssuanceOfPublicOfferingsOfCommonSharesNetOfUnderwritingFeesAndTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ProceedsFromIssuanceOfPublicOfferingsOfCommonSharesNetOfUnderwritingFeesAndTransactionCosts",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash inflow from issuance of public offerings of common shares net of underwriting fees.",
        "label": "Proceeds from Issuance of public Offerings of Common Shares, Net of Underwriting Fees and Transaction Costs",
        "terseLabel": "Proceeds from public offerings of common shares, net of underwriting fees and transaction costs"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ProceedsFromIssueOfConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ProceedsFromIssueOfConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails",
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuing of convertible debt.",
        "label": "Proceeds from issue of convertible debt",
        "terseLabel": "Proceeds from issuance of convertible loan",
        "verboseLabel": "Net proceeds"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProceedsFromIssueOfOrdinaryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProceedsFromIssueOfOrdinaryShares",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalFollowOnOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issue of ordinary shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]"
       }
      }
     },
     "auth_ref": [
      "r284"
     ]
    },
    "aciu_ProceedsFromPublicOfferingsNetOfUnderwritingFeesAndTransactionEquityShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ProceedsFromPublicOfferingsNetOfUnderwritingFeesAndTransactionEquityShares",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from public offerings, net of underwriting fees and transaction.",
        "label": "Proceeds from public offerings, net of underwriting fees and transaction, equity, shares"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs",
        "label": "Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs",
        "terseLabel": "Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProceedsFromSaleOrIssueOfTreasuryShares",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale or issue of treasury shares",
        "terseLabel": "Proceeds from issuance of treasury shares, net of underwriting fees and transaction costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from the sale or issuing of treasury shares. [Refer: Sale or issue of treasury shares; Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r284"
     ]
    },
    "ifrs-full_ProductsAndServicesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProductsAndServicesAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails",
      "http://acimume.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Products and services [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r231"
     ]
    },
    "ifrs-full_ProductsAndServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProductsAndServicesMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails",
      "http://acimume.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Products and services [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r231"
     ]
    },
    "ifrs-full_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 2.0
      },
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 2.0
      },
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows",
      "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity",
      "http://acimume.com/role/StatementConsolidatedStatementsOfComprehensiveIncomeLoss",
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss for the period",
        "terseLabel": "Loss for the period",
        "totalLabel": "Loss for the period",
        "verboseLabel": "Net income/(loss) for the period"
       }
      },
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r1",
      "r28",
      "r103",
      "r110",
      "r112",
      "r200",
      "r202",
      "r228",
      "r235"
     ]
    },
    "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating basic earnings per share",
        "terseLabel": "Net loss attributable to equity holders of the Company"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to ordinary equity holders of parent entity [abstract]",
        "verboseLabel": "Numerator"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProfitLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfitLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income/(loss) before income tax",
        "totalLabel": "Loss before tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r181",
      "r211",
      "r212",
      "r247",
      "r248"
     ]
    },
    "ifrs-full_ProfitLossFromOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfitLossFromOperatingActivities",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss) from operating activities",
        "totalLabel": "Operating loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r222",
      "r269"
     ]
    },
    "aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents the acquisition of the program portfolio of therapeutics targeting a-syn from Affiris",
        "label": "Program portfolio of therapeutics targeting asyn from Affiris [Member]",
        "terseLabel": "Program portfolio of therapeutics targeting asyn from Affiris"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails",
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant and equipment",
        "periodEndLabel": "Property, plant and equipment, end of period",
        "periodStartLabel": "Property, plant and equipment, beginning of period",
        "terseLabel": "Property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r9",
      "r50"
     ]
    },
    "aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property plant and equipment estimated useful life [Abstract]",
        "terseLabel": "Estimated useful life"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PropertyPlantAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PropertyPlantAndEquipmentMember",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails",
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails",
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPropertyPlantAndEquipmentDetails",
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesRightOfUseAssetsAndLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant and equipment [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r51",
      "r223",
      "r234"
     ]
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of property, plant and equipment, classified as investing activities",
        "negatedLabel": "Purchases of property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r224"
     ]
    },
    "aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of property plant and equipment acquired through noncash investing activities.",
        "label": "Purchase of property, plant and equipment, classified as noncash investing activities",
        "terseLabel": "Capital expenditures in Trade and other payables or Accrued expenses"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_Quarter32019Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "Quarter32019Member",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents Quarter 3 2019",
        "label": "Quarter 3, 2019 [Member]",
        "terseLabel": "Quarter 3, 2019"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RangeAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails",
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails",
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails",
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForFinancingAndOtherPurposesDetails",
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails",
      "http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r157",
      "r174",
      "r229",
      "r230",
      "r292"
     ]
    },
    "ifrs-full_RangesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RangesMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails",
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails",
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails",
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForFinancingAndOtherPurposesDetails",
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails",
      "http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ranges [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r157",
      "r174",
      "r229",
      "r230",
      "r292"
     ]
    },
    "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RangesOfExercisePricesForOutstandingShareOptionsAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ranges of exercise prices for outstanding share options [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RangesOfExercisePricesForOutstandingShareOptionsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ranges of exercise prices for outstanding share options [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated ranges of exercise prices for outstanding share options that are meaningful for assessing the number and timing of additional shares that may be issued and the cash that may be received upon exercise of those options. It also represents the standard value for the 'Ranges of exercise prices for outstanding share options' axis if no other member is used. [Refer: Ranges [member]]"
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "aciu_ReceiptOfMilestonePaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ReceiptOfMilestonePaymentsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for receipt of milestone payments",
        "label": "Receipt of milestone payments [Member]",
        "terseLabel": "Receipt of milestone payments"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReceivablesFromContractsWithCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ReceivablesFromContractsWithCustomers",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables from contracts with customers",
        "terseLabel": "Milestone payment receivable",
        "verboseLabel": "Eligible grant amount receivable"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of an entity\u2019s right to consideration in exchange for goods or services that the entity has transferred to a customer that is unconditional. A right to consideration is unconditional if only the passage of time is required before payment of that consideration is due."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r131"
     ]
    },
    "ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of accounting profit multiplied by applicable tax rates [abstract]",
        "terseLabel": "Income tax expense reconciled to Income / (loss) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosurePropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of changes in property, plant and equipment [abstract]",
        "terseLabel": "Property, plant and equipment:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReconciliationOfNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ReconciliationOfNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of number of shares outstanding [abstract]",
        "terseLabel": "Common shares"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ReconciliationOfNumberOfTreasurySharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ReconciliationOfNumberOfTreasurySharesOutstandingAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation of number of treasury shares outstanding",
        "label": "Reconciliation of number of treasury shares outstanding [abstract]",
        "terseLabel": "Treasury shares"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_RegulatoryAndSalesBasedMilestonesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "RegulatoryAndSalesBasedMilestonesMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents regulatory and sales-based milestones",
        "label": "Regulatory and sales-based milestones [Member]",
        "terseLabel": "Regulatory and sales-based milestones"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_RentalContractPeriodForNoticeOfCancellation": {
     "xbrltype": "durationItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "RentalContractPeriodForNoticeOfCancellation",
     "presentation": [
      "http://acimume.com/role/DisclosureCommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of time required by the lessee in a lease agreement to provide notice of cancellation of a lease to the lessor, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Rental contract, period for notice of cancellation",
        "terseLabel": "Notice period for cancellation of rental contract"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_RepaymentOfConvertibleDebtEquitySettlementAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "RepaymentOfConvertibleDebtEquitySettlementAmount",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of the settlement of convertible debt that is settled via shares of entity's common shares.",
        "label": "Repayment of convertible debt, Equity Settlement, Amount",
        "terseLabel": "Settlement of convertible notes recorded within Shareholders' equity"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ReportableSegmentsNumber": {
     "xbrltype": "integerItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ReportableSegmentsNumber",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesSegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reportable segments reported by the entity.",
        "label": "Reportable segments, number",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss": {
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails",
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development expense",
        "negatedLabel": "Research &amp; development expenses",
        "verboseLabel": "Research and development expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "aciu_ResearchAndDevelopmentExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ResearchAndDevelopmentExpensesMember",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents research and development expenses",
        "label": "Research and development expenses [Member]",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ResearchAndDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ResearchAndDevelopmentMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance obligation related to research and development.",
        "label": "Research and development [Member]",
        "terseLabel": "Research and Development [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ReserveOfExchangeDifferencesOnTranslation",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reserve of exchange differences on translation",
        "terseLabel": "Currency translation differences"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ReserveOfExchangeDifferencesOnTranslationMember",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reserve of exchange differences on translation [member]",
        "terseLabel": "Currency Translation Differences"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing accumulated exchange differences on the translation of financial statements recognised in other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r213"
     ]
    },
    "ifrs-full_RestrictedShareUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RestrictedShareUnitsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareAntidilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted share units [member]",
        "terseLabel": "Restricted share awards subject to future vesting"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of antidilutive instrument representing restricted share units."
       }
      }
     },
     "auth_ref": [
      "r280"
     ]
    },
    "aciu_RestrictedSharesAndRestrictedShareUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "RestrictedSharesAndRestrictedShareUnitsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Shares and Restricted Share Units [Member]",
        "terseLabel": "Non-vested Share Awards [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_RestrictedStockUnitsFirstVestingConditionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "RestrictedStockUnitsFirstVestingConditionsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Restricted Stock Units, first vesting conditions",
        "label": "Restricted Stock Units, first vesting conditions [Member]",
        "terseLabel": "Restricted Stock Units, first vesting conditions"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_RestrictedStockUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "RestrictedStockUnitsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for equity instruments that are convertible to stock after a specified period of time.",
        "label": "Restricted Stock Units [Member]",
        "verboseLabel": "Restricted Stock Units"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_RestrictedStockUnitsSecondVestingConditionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "RestrictedStockUnitsSecondVestingConditionsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Restricted Stock Units, second vesting conditions",
        "label": "Restricted Stock Units, second vesting conditions [Member]",
        "terseLabel": "Restricted Stock Units, second vesting conditions"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RetainedEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RetainedEarnings",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained earnings",
        "terseLabel": "Accumulated losses"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r217"
     ]
    },
    "ifrs-full_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained earnings [member]",
        "terseLabel": "Accumulated losses"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r213"
     ]
    },
    "aciu_RetirementBenefitPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "RetirementBenefitPlanMember",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for retirement benefit plan",
        "label": "Retirement benefit plan [Member]",
        "terseLabel": "Retirement benefit plan"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return on plan assets excluding interest income or expense, net of tax, defined benefit plans",
        "terseLabel": "Return on plan assets excluding interest income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, resulting from the return on plan assets, excluding amounts included in interest expense (income) arising from defined benefit plans. The return on plan assets is interest, dividends and other revenue derived from the plan assets, together with realised and unrealised gains or losses on the plan assets, less any costs of managing plan assets and less any tax payable by the plan itself, other than tax included in the actuarial assumptions used to measure the present value of the defined benefit obligation. [Refer: Other comprehensive income; Defined benefit plans [member]; Plan assets [member]; Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from return on plan assets excluding interest income or expense]"
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return on plan assets excluding interest income",
        "terseLabel": "Return on plan assets excluding interest income"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from the return on plan assets, excluding amounts included in interest income or expense. The return on plan assets is interest, dividends and other revenue derived from the plan assets, together with realised and unrealised gains or losses on the plan assets, less any costs of managing plan assets and less any tax payable by the plan itself, other than tax included in the actuarial assumptions used to measure the present value of the defined benefit obligation. [Refer: Plan assets [member]; Net defined benefit liability (asset); Actuarial assumptions [member]; Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "ifrs-full_Revenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Revenue",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue",
        "totalLabel": "Total revenue"
       }
      },
      "en": {
       "role": {
        "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r118",
      "r181",
      "r198",
      "r201",
      "r205",
      "r206",
      "r208",
      "r211",
      "r212",
      "r228"
     ]
    },
    "ifrs-full_RevenueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RevenueAbstract",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract revenues",
        "terseLabel": "Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RevenueFromContractsWithCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RevenueFromContractsWithCustomers",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss": {
       "parentTag": "ifrs-full_Revenue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails",
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails",
      "http://acimume.com/role/StatementConsolidatedStatementsOfIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from contracts with customers",
        "terseLabel": "Contract revenue",
        "verboseLabel": "Total contract revenues"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity\u2019s ordinary activities in exchange for consideration."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r130"
     ]
    },
    "ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesRecognizedRevenuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Performance obligations satisfied in previous periods"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of revenue from performance obligations satisfied (or partially satisfied) in previous periods. [Refer: Performance obligations [member]; Revenue from contracts with customers]"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesRecognizedRevenuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amounts included in the contract liability at the beginning of the period"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of revenue that was included in the contract liability balance at the beginning of the period. [Refer: Contract liabilities; Revenue from contracts with customers]"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "RightOfUseAssetsAndLeaseLiabilitiesNetMember",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Right of use assets and lease liabilities, net",
        "label": "Right of use assets and lease liabilities, net [Member]",
        "terseLabel": "Right of use assets and lease liabilities, net"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_RightOfUseFinancialAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "RightOfUseFinancialAssetsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for right-of-use financial assets.",
        "label": "Right of use financial assets [Member]",
        "terseLabel": "Right-of-use Assets [Member]",
        "verboseLabel": "Right-of-use assets"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_RightOfUseLeasedAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "RightOfUseLeasedAssetsAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use leased assets [Abstract]",
        "terseLabel": "Right-of-use of leased assets:"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_RightOfUseLicenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "RightOfUseLicenseMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance obligation related to right-of-use license.",
        "label": "Right-of-use license [Member]",
        "terseLabel": "Right-of-use License [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RightofuseAssets",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails",
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets",
        "periodEndLabel": "Balance, end of period",
        "periodStartLabel": "Balance, beginning of period",
        "terseLabel": "Right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r147"
     ]
    },
    "aciu_SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in equity from sale or issue of public offerings net of underwriting fees and transaction costs.",
        "label": "Sale or Issue of Public Offerings, Net of Underwriting Fees, Transaction Cost",
        "terseLabel": "Proceeds from public offerings, net of underwriting fees, transaction costs and stamp duty",
        "verboseLabel": "Proceeds from public offerings, net of underwriting fees, transaction costs"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in equity from sale or issue of treasury shares net of underwriting fees and transaction costs",
        "label": "Sale or issue of treasury shares net of underwriting fees and transaction costs",
        "terseLabel": "Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_SaleOrIssueOfTreasurySharesShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "SaleOrIssueOfTreasurySharesShares",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of treasury shares issued or sold.",
        "label": "Sale or issue of treasury shares, shares",
        "verboseLabel": "Number of treasury share issued (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of cash and cash equivalents by currency",
        "label": "Schedule of cash and cash equivalents by currency [table text block]",
        "terseLabel": "Schedule of cash and cash equivalents by currency"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ScheduleOfContractualUndiscountedCashFlowsTableTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to the contractual undiscounted cash flows.",
        "label": "Schedule of contractual undiscounted cash flows [Table Text Block]",
        "terseLabel": "Schedule of contractual undiscounted cash flows for lease obligations"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about the estimated lease term by right-of-use asset by category.",
        "label": "Schedule of information about contract lease term by right-of-use asset categories [Table Text Block]",
        "terseLabel": "Estimated Lease Term by Right-of-use Asset Categories"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about the useful life of property, plant and equipment.",
        "label": "Schedule of information about property, plant and equipment useful life [Table Text Block]",
        "terseLabel": "Estimated useful life"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndShortTermFinancialAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of short-term deposits not classified as cash equivalents",
        "label": "Schedule of short-term deposits not classified as cash equivalents [table text block]",
        "terseLabel": "Schedule of short-term financial assets"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_SecondOpenMarketSalesAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "SecondOpenMarketSalesAgreementMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for entity entered into a second Open Market Sales Agreement (the \"New Sales Agreement\") with Jefferies to continue the ATM program.",
        "label": "Second Open Market Sales Agreement [Member]",
        "terseLabel": "New Sales Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r250"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r252"
     ]
    },
    "ifrs-full_SellingGeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SellingGeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://acimume.com/role/DisclosureExpensesByCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling, general and administrative expense [member]",
        "terseLabel": "General and administrative expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the amount of expense relating to selling, general and administrative activities of the entity. This member is used to attribute an expense by nature to a functional line item in the statement of profit or loss."
       }
      }
     },
     "auth_ref": [
      "r261",
      "r263"
     ]
    },
    "aciu_SensitivityAnalysisActuarialAssumptionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "SensitivityAnalysisActuarialAssumptionsAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sensitivity analysis, actuarial assumptions [Abstract]",
        "terseLabel": "Sensitivity analysis [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ShareBasedPaymentArrangementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ShareBasedPaymentArrangementAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based payment arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ShareBasedPlansOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ShareBasedPlansOutstandingAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based plans outstanding [Abstract]",
        "terseLabel": "Share-based plans outstanding [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShareIssueRelatedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ShareIssueRelatedCost",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalAtMarketEquityOfferingDetails",
      "http://acimume.com/role/DisclosureShareCapitalFollowOnOfferingDetails",
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share issue related cost",
        "terseLabel": "Issuance costs",
        "verboseLabel": "Transaction costs associated with issuance of shares in relation to the asset acquisition recorded in Accrued expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cost related to the issuance of shares."
       }
      }
     },
     "auth_ref": [
      "r262"
     ]
    },
    "ifrs-full_ShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ShareOptionsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareAntidilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share options [member]",
        "terseLabel": "Share options issued and outstanding (in-the-money)"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of antidilutive instrument representing share options."
       }
      }
     },
     "auth_ref": [
      "r280"
     ]
    },
    "ifrs-full_SharePremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SharePremium",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share premium",
        "terseLabel": "Share premium"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value."
       }
      }
     },
     "auth_ref": [
      "r216"
     ]
    },
    "ifrs-full_SharePremiumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SharePremiumMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Premium [Member]",
        "terseLabel": "Share premium"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the amount received or receivable from issuance of the entity's shares in excess of nominal value."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ifrs-full_SharebasedPaymentArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SharebasedPaymentArrangementsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based payment arrangements [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/DisclosureShareCapitalNarrativesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares in entity held by entity or by its subsidiaries or associates",
        "negatedPeriodEndLabel": "Treasury shares outstanding at end of period",
        "negatedPeriodStartLabel": "Treasury shares outstanding at beginning of period",
        "terseLabel": "Number of treasury shares outstanding"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares in the entity held by the entity or by its subsidiaries or associates. [Refer: Associates [member]; Subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "aciu_SharesTransferredAsConsiderationInAssetAcquisition": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "SharesTransferredAsConsiderationInAssetAcquisition",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares transferred as consideration in asset acquisition",
        "label": "Shares transferred as consideration in asset acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ShortTermFinancialAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ShortTermFinancialAssetsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents financial assets classified as short-term.",
        "label": "Short-term Financial Assets [Member]",
        "terseLabel": "Short-term financial assets"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_ShortTermLeaseLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "ShortTermLeaseLiabilitiesMember",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for short-term lease liabilities.",
        "label": "Short-term lease liabilities [Member]",
        "terseLabel": "Short-term Lease Liabilities [Member]",
        "verboseLabel": "Short-term lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ShorttermDepositsNotClassifiedAsCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureBasisOfPreparationGoingConcernDetails",
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails",
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term deposits, not classified as cash equivalents",
        "terseLabel": "Short-term financial assets",
        "verboseLabel": "Short-term financial assets due in one year or less"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of short-term deposits held by the entity that are not classified as cash equivalents. [Refer: Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r265"
     ]
    },
    "ifrs-full_ShorttermEmployeeBenefitsAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ShorttermEmployeeBenefitsAccruals",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails": {
       "parentTag": "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term employee benefits accruals",
        "terseLabel": "Accrual of performance-related remuneration",
        "verboseLabel": "Accrued payroll expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current]"
       }
      }
     },
     "auth_ref": [
      "r267"
     ]
    },
    "aciu_SignificantAssetAcquisitionsTotalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "SignificantAssetAcquisitionsTotalDomain",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant asset acquisitions, total",
        "label": "Significant asset acquisitions, total [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SignificantUnobservableInputAssets": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SignificantUnobservableInputAssets",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails",
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant unobservable input, assets",
        "terseLabel": "Discount rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The value of significant unobservable input used in the measurement of the fair value of assets."
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "aciu_SkaneUniversityHospitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "SkaneUniversityHospitalMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Skane University Hospital is a university hospital in Scania, Sweden.",
        "label": "Skane University Hospital [Member]",
        "terseLabel": "Skane University Hospital [Member]",
        "verboseLabel": "Skane University Hospital"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Statements of Cash Flows"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "StatementOfChangesInEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Statements of Changes in Equity"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "StatementOfChangesInEquityLineItems",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "StatementOfChangesInEquityTable",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ifrs-full_StatementOfComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "StatementOfComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Statements of Comprehensive Income/(Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Balance Sheets"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_StockOptionPlanC1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "StockOptionPlanC1Member",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A share-based payment arrangement that existed at any time during the reporting period.",
        "label": "Stock option plan C1 [Member]",
        "terseLabel": "Share Option Plan C1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_SupplementalNonCashActivityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "SupplementalNonCashActivityAbstract",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental non-cash activity [Abstract]",
        "terseLabel": "Supplemental non-cash activity"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SurplusDeficitInPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SurplusDeficitInPlan",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Surplus (deficit) in plan",
        "totalLabel": "Total liability"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value of any plan assets, less the present value of the defined benefit obligation. [Refer: Plan assets [member]]"
       }
      }
     },
     "auth_ref": [
      "r279"
     ]
    },
    "ifrs-full_SurplusDeficitInPlanAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SurplusDeficitInPlanAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanSummaryOfBenefitPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Surplus (deficit) in plan [abstract]",
        "terseLabel": "Defined benefit pension plan amount recognized in balance sheet [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_TauMorphomerSmallMoleculeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "TauMorphomerSmallMoleculeMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The research and development of medicines for the treatment of Alzheimer's disease and other neurodegenerative diseases.",
        "label": "Tau Morphomer Small Molecule [Member]",
        "terseLabel": "Morphomer Tau Small Molecule [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_TauPETImagingAgentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "TauPETImagingAgentMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The research and development of medicines for the treatment of Alzheimer's disease through molecular imaging.",
        "label": "Tau-PET imaging agent [Member]",
        "terseLabel": "Tau-PET Imaging Agent [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_TauVaccineInADMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "TauVaccineInADMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails",
      "http://acimume.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The research and development of a vaccine for the treatment of Alzheimer's disease.",
        "label": "Tau Vaccine in AD [Member]",
        "terseLabel": "Tau Vaccine in AD [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax effect of income not subject to tax and expenses not deductible for tax purposes",
        "label": "Tax effect of income not subject to tax and expenses not deductible for tax purposes",
        "terseLabel": "(Income not subject to tax)/expenses not deductible for tax purposes"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TaxEffectOfTaxLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TaxEffectOfTaxLosses",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax effect of tax losses",
        "terseLabel": "Effect of unused tax losses and tax offsets not recognized as deferred tax assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TaxExpenseIncomeAtApplicableTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax (benefit)/expense calculated at the domestic rates applicable in the respective countries",
        "terseLabel": "Tax benefit calculated at the domestic rates applicable in the respective countries"
       }
      },
      "en": {
       "role": {
        "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "aciu_TaxLossesSplitByExpiryDateAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "TaxLossesSplitByExpiryDateAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax losses split by expiry date [Abstract]",
        "terseLabel": "Tax losses split by expiry date [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary difference, unused tax losses and unused tax credits [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary difference, unused tax losses and unused tax credits [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for temporary differences, unused tax losses and unused tax credits. It also represents the standard value for the 'Temporary difference, unused tax losses and unused tax credits' axis if no other member is used. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "ifrs-full_TopOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TopOfRangeMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails",
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails",
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails",
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails",
      "http://acimume.com/role/DisclosureShareCapitalConditionalShareCapitalForFinancingAndOtherPurposesDetails",
      "http://acimume.com/role/DisclosureShareCapitalConvertibleNoteAgreementDetails",
      "http://acimume.com/role/DisclosureShareCapitalShelfRegistrationStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Top of Range [Member]",
        "terseLabel": "Top of Range [Member]",
        "verboseLabel": "Maximum"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r157",
      "r174",
      "r229",
      "r230",
      "r292"
     ]
    },
    "aciu_TotalAssetsAcquiredInAssetAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "TotalAssetsAcquiredInAssetAcquisition",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total assets acquired in asset acquisition",
        "label": "Total assets acquired in asset acquisition",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total consideration transferred, acquisition-date fair value, asset acquisition",
        "label": "Total consideration transferred, acquisition-date fair value, asset acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeAndOtherCurrentPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradeAndOtherCurrentPayables",
     "crdr": "credit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureTradeAndOtherPayablesAndAccruedExpensesDetails",
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other current payables",
        "terseLabel": "Trade and other payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]"
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentPayablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradeAndOtherCurrentPayablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued expenses"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_TradeAndOtherPayablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "TradeAndOtherPayablesMember",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for trade and other payables.",
        "label": "Trade and Other Payables [Member]",
        "terseLabel": "Trade and other payables"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeAndOtherReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradeAndOtherReceivablesAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable",
        "terseLabel": "Other current receivables [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeReceivablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradeReceivablesMember",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade receivables [member]",
        "terseLabel": "Accounts receivable"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for trade receivables. [Refer: Trade receivables]"
       }
      }
     },
     "auth_ref": [
      "r187",
      "r190",
      "r239",
      "r263"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://acimume.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "aciu_TransactionCostAndStampDutyAssociatedWithPublicOfferingsOfCommonSharesRecordedInAccruedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "TransactionCostAndStampDutyAssociatedWithPublicOfferingsOfCommonSharesRecordedInAccruedExpenses",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of transaction cost and stamp duty associated with public offerings of common shares recorded in accrued expenses.",
        "label": "Transaction Cost and Stamp Duty Associated with Public offerings of Common Shares Recorded in Accrued Expenses",
        "terseLabel": "Transaction costs and stamp duty associated with the public offerings of common shares recorded in Accrued expenses"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses",
     "crdr": "debit",
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction costs associated with the sale of treasury shares in public offering recorded in Accrued expenses",
        "label": "Transaction costs associated with the sale of treasury shares in public offering recorded in Accrued expenses",
        "terseLabel": "Transaction costs associated with the sale of treasury shares in public offering recorded in Accrued expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TransactionPriceAllocatedToRemainingPerformanceObligations",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction price allocated to remaining performance obligations",
        "terseLabel": "Total potential collaboration agreement value remaining",
        "verboseLabel": "Expected transaction price allocation"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [member]]"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "ifrs-full_TreasuryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TreasuryShares",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Equity",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://acimume.com/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury shares",
        "negatedLabel": "Treasury shares"
       }
      },
      "en": {
       "role": {
        "documentation": "An entity\u2019s own equity instruments, held by the entity or other members of the consolidated group."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r216"
     ]
    },
    "ifrs-full_TreasurySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TreasurySharesMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareCapitalCapitalStructureDetails",
      "http://acimume.com/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury shares [Member]",
        "terseLabel": "Treasury shares"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the entity\u2019s own equity instruments, held by the entity or other members of the consolidated group."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "aciu_Two016ShareOptionAndIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "Two016ShareOptionAndIncentivePlanMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights.",
        "label": "2016 Share Option and Incentive Plan [Member]",
        "terseLabel": "2016 SOIP [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "Two016ShareOptionAndIncentivePlanVestingTrancheOneMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting tranche one of the 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights.",
        "label": "2016 Share Option and Incentive Plan, Vesting Tranche One [Member]",
        "terseLabel": "2016 SOIP, Vesting Condition 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting tranche three of the 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights.",
        "label": "2016 Share Option and Incentive Plan, Vesting Tranche Three [Member]",
        "terseLabel": "2016 SOIP, Vesting Condition 3 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting tranche two of the 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights.",
        "label": "2016 Share Option and Incentive Plan, Vesting Tranche Two [Member]",
        "terseLabel": "2016 SOIP, Vesting Condition 2 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TypesOfAntidilutiveInstrumentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TypesOfAntidilutiveInstrumentsAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareAntidilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of antidilutive instruments [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "ifrs-full_TypesOfContractsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TypesOfContractsAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails",
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails",
      "http://acimume.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of contracts [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r236"
     ]
    },
    "ifrs-full_TypesOfContractsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TypesOfContractsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails",
      "http://acimume.com/role/DisclosureContractRevenuesGrantsFromMichaelJFoxFoundationDetails",
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauPetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails",
      "http://acimume.com/role/DisclosureContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails",
      "http://acimume.com/role/DisclosureSubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of contracts [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all types of contracts with customers. It also represents the standard value for the 'Types of contracts' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r236"
     ]
    },
    "ifrs-full_TypesOfRisksAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TypesOfRisksAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of risks [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r159",
      "r160",
      "r162",
      "r182",
      "r185",
      "r186"
     ]
    },
    "ifrs-full_TypesOfRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TypesOfRisksMember",
     "presentation": [
      "http://acimume.com/role/DisclosureFinancialInstrumentsAndRiskManagementDetails",
      "http://acimume.com/role/DisclosureRetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r159",
      "r160",
      "r162",
      "r182",
      "r185",
      "r186"
     ]
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TypesOfSharebasedPaymentArrangementsAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "currency_USD": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2023",
     "localname": "USD",
     "presentation": [
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShortTermFinancialAssetsDetails",
      "http://acimume.com/role/DisclosureCashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States of America, Dollars",
        "terseLabel": "USD [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_UnobservableInputsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "UnobservableInputsAxis",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails",
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unobservable inputs [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r290"
     ]
    },
    "ifrs-full_UnobservableInputsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "UnobservableInputsMember",
     "presentation": [
      "http://acimume.com/role/DisclosureAssetAcquisitionDetails",
      "http://acimume.com/role/DisclosureIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unobservable inputs [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all the unobservable inputs. It also represents the standard value for the 'Unobservable inputs' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r290"
     ]
    },
    "ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unused tax losses for which no deferred tax asset recognised",
        "terseLabel": "Unrecorded tax loss carryforwards"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of unused tax losses for which no deferred tax asset is recognised in the statement of financial position. [Refer: Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "ifrs-full_UnusedTaxLossesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "UnusedTaxLossesMember",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unused tax losses [member]",
        "verboseLabel": "Tax Losses"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for tax losses that have been incurred and are carried forward for use against future taxable profit."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member",
     "presentation": [
      "http://acimume.com/role/DisclosureContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents the time upon which the first patient is dosed in a Phase 2 clinical study of a licensed product in the U.S. or EU.",
        "label": "Upon first patient dosed in a Phase 2 clinical study of a licensed product in the U.S. or EU. [Member]",
        "terseLabel": "Upon first patient dosed in a Phase 2 clinical study of a licensed product in the U.S. or EU."
       }
      }
     },
     "auth_ref": []
    },
    "aciu_Usd2.03ToUsd2.32Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "Usd2.03ToUsd2.32Member",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for USD 2.03 to USD 2.32.",
        "label": "USD 2.03 to USD 2.32 [Member]",
        "terseLabel": "USD 2.03 to USD 2.32"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_Usd2.76ToUsd4.57Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "Usd2.76ToUsd4.57Member",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for USD 2.76 to USD 4.57",
        "label": "USD 2.76 to USD 4.57 [Member]",
        "terseLabel": "USD 2.76 to USD 4.57"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_Usd5.04ToUsd12.30Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "Usd5.04ToUsd12.30Member",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for USD 5.04 to USD 12.30",
        "label": "USD 5.04 to USD 12.30 [Member]",
        "terseLabel": "USD 5.04 to USD 12.30"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
     "presentation": [
      "http://acimume.com/role/DisclosureSummaryOfMaterialAccountingPoliciesPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Useful life measured as period of time, property, plant and equipment",
        "terseLabel": "Estimated useful life"
       }
      },
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationPlansOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For vesting requirements for a type of share-based payment arrangement that existed at any time during the period, this element represents the period which an employees' right to exercise an award is no longer contingent on satisfaction of a service condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Vesting requirements for share-based payment arrangement, award vesting period",
        "terseLabel": "Vesting conditions",
        "verboseLabel": "Vesting conditions"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_WeightedAverageAssumptionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "WeightedAverageAssumptionsAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Assumptions [Abstract]",
        "terseLabel": "Weighted average assumptions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageDurationOfDefinedBenefitObligation2019",
     "presentation": [
      "http://acimume.com/role/DisclosureRetirementBenefitPlanChangeInOtherComprehensiveGainsLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average duration period for defined benefit obligation"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average duration of a defined benefit obligation. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "aciu_WeightedAverageExercisePriceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "WeightedAverageExercisePriceAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted average exercise price [Abstract]",
        "verboseLabel": "Weighted Average grant date fair value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options exercisable in share-based payment arrangement",
        "terseLabel": "Exercisable (in CHF per share)"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercised during the year (in CHF per share)"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forfeited during the year (in CHF per share)"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted during the year (in CHF per share)",
        "terseLabel": "Weighted average exercise price for options granted (in CHF/USD per share)"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement",
        "periodEndLabel": "Outstanding at end of period (in CHF per share)",
        "periodStartLabel": "Outstanding at beginning of period (in CHF per share)"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r166",
      "r170"
     ]
    },
    "ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageFairValueAtMeasurementDateShareOptionsGranted",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average fair value at measurement date, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average fair value of share options granted during the period at the measurement date. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant date fair value, other equity instruments exercised",
        "label": "Weighted average grant date fair value, other equity instruments exercised",
        "terseLabel": "Weighted average grant date fair value, exercised during the year"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant date fair value, other equity instruments forfeited",
        "label": "Weighted average grant date fair value, other equity instruments forfeited",
        "terseLabel": "Weighted average grant date fair value, forfeited during the year"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant date fair value, other equity instruments granted",
        "label": "Weighted average grant date fair value, other equity instruments granted",
        "terseLabel": "Weighted average grant date fair value, granted during the year"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant date fair value, other equity instruments outstanding",
        "label": "Weighted average grant date fair value, other equity instruments outstanding",
        "periodEndLabel": "Weighted average grant date fair value, non-vested at end of period",
        "periodStartLabel": "Weighted average grant date fair value, non-vested at beginning of period"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant date fair value, other equity instruments vested",
        "label": "Weighted average grant date fair value, other equity instruments vested",
        "terseLabel": "Weighted average grant date fair value, vested during the year"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable",
     "crdr": "credit",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationNonVestedShareAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant date fair value, other equity instruments vested and exercisable",
        "label": "Weighted average grant date fair value, other equity instruments vested and exercisable",
        "terseLabel": "Weighted average grant date fair value, vested and exercisable"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16",
     "presentation": [
      "http://acimume.com/role/DisclosureRightOfUseAssetsLongTermFinancialAssetsAndLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average lessee's incremental borrowing rate applied to lease liabilities recognised at date of initial application of IFRS 16",
        "terseLabel": "Weighted average incremental borrowing rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average lessee's incremental borrowing rate applied to lease liabilities recognised in the statement of financial position at the date of initial application of IFRS 16. The incremental borrowing rate is the rate of interest that a lessee would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment."
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "ifrs-full_WeightedAverageMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageMember",
     "presentation": [
      "http://acimume.com/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average [member]",
        "terseLabel": "Weighted average"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for an average in which each quantity to be averaged is assigned a weight that determines the relative effect of each quantity on the average."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r157",
      "r229",
      "r230",
      "r292"
     ]
    },
    "aciu_WeightedAverageRemainingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "WeightedAverageRemainingAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining [Abstract]",
        "verboseLabel": "Weighted average remaining term (years) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average remaining contractual life of outstanding share options",
        "terseLabel": "Weighted average remaining term (years), options outstanding"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "aciu_WeightedAverageRemainingContractualLifeOfShareOptionsExercisable": {
     "xbrltype": "durationItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "WeightedAverageRemainingContractualLifeOfShareOptionsExercisable",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageExercisePricesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual life of share options exercisable",
        "label": "Weighted average remaining contractual life of share options exercisable",
        "terseLabel": "Weighted average remaining term (years), options exercisable"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageSharePrice2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageSharePrice2019",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails",
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average share price",
        "verboseLabel": "Share price, weighted average (in USD per share)"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average share price. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageSharePriceShareOptionsGranted2019",
     "presentation": [
      "http://acimume.com/role/DisclosureShareBasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average share price, share options granted",
        "verboseLabel": "Share price (USD and weighted average)"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "ifrs-full_WeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageShares",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of ordinary shares used in calculating basic earnings per share",
        "verboseLabel": "Weighted-average number of shares outstanding used to compute EPS basic attributable to equity holders"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract",
     "presentation": [
      "http://acimume.com/role/DisclosureEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average ordinary shares used in calculating basic and diluted earnings per share [abstract]",
        "verboseLabel": "Denominator"
       }
      }
     },
     "auth_ref": []
    },
    "aciu_WithholdingTaxReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://acimume.com/20231231",
     "localname": "WithholdingTaxReceivables",
     "crdr": "debit",
     "calculation": {
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails": {
       "parentTag": "ifrs-full_OtherCurrentReceivables",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://acimume.com/role/DisclosureOtherCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Withholding tax receivables",
        "label": "Withholding tax receivables",
        "terseLabel": "Withholding tax"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "134",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_134&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "k",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_k&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "o",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_o&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "56",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_56&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "61",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_61_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "61",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_61&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "69",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_69&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iv&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_vi&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "81A",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "82",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "82",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "99",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2023-01-01",
   "Paragraph": "21",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI",
   "URIDate": "2023-03-23"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "81",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI",
   "URIDate": "2023-03-23"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_vii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "75",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_75_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "75",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_75_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI",
   "URIDate": "2023-03-23"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "138",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_138&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "140",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_140_a_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "140",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_140_a_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "140",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_140_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "141",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "141",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "141",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_c_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "141",
   "Subparagraph": "c",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_c_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "141",
   "Subparagraph": "c",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_c_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "141",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "141",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "141",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_f&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "145",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_145_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "145",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_145&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "147",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_147_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "148",
   "Subparagraph": "d",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_148_d_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2023-01-01",
   "Paragraph": "52",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&anchor=para_52_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2023-01-01",
   "Paragraph": "52",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&anchor=para_52_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS21_g51-57_TI",
   "URIDate": "2023-03-23"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "19",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19_f&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "19",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Section": "Disclosures",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI",
   "URIDate": "2023-03-23"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2023-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "32",
   "IssueDate": "2023-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Paragraph": "67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Paragraph": "70",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Paragraph": "70",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI",
   "URIDate": "2023-03-23"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2023-01-01",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2023-01-01",
   "Paragraph": "130",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_130_d_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS38_g118-128_TI",
   "URIDate": "2023-03-23"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2023-01-01",
   "Paragraph": "76",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_76&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2023-01-01",
   "Paragraph": "50",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ix",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "93",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "93",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "14",
   "IssueDate": "2023-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2023-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "105",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_105&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "113",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_113_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "114",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_114&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "116",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_116_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "116",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_116_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "116",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_116_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "119",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_119&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "120",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_120_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "120",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_120_b_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS15_g110-129_TI",
   "URIDate": "2023-03-23"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Section": "Presentation",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS15_g105-109_TI",
   "URIDate": "2023-03-23"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_g&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_h&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "Subparagraph": "j",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_j&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "58",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_58&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "94",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "97",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "C12",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_C12_a&doctype=Appendix&subtype=C",
   "URIDate": "2023-03-23"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI",
   "URIDate": "2023-03-23"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Section": "Presentation",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI",
   "URIDate": "2023-03-23"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "109",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_109&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "109A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_109A&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "120",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "124",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_124&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "125",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_125&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "127",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "128",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_128_a_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "128",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_128_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "132",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_132_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "C32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_C32&doctype=Appendix&subtype=C",
   "URIDate": "2023-03-23"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "44",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_44&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_iv&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_vi&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_vii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "51",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_51_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2023-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "21C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_21C&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "23B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_23B_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35H",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H_b_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35H",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35M",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M_b_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35M",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "42E",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42E_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "42I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42I&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_6&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "B52",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B52&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Section": "Defined terms",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&doctype=Appendix&subtype=A&dita_xref=IFRS07_APPA_TI",
   "URIDate": "2023-03-23"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "23",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2023-01-01",
   "Paragraph": "7.2.34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_7.2.34&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2023-01-01",
   "Paragraph": "7.2.42",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_7.2.42&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "102",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "68",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_68&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "IG6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2023-03-23"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "37",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_g&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "37",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_h&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_138_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "32",
   "IssueDate": "2023-01-01",
   "Paragraph": "IE33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2023-en-r&anchor=para_IE33&doctype=Illustrative%20Examples",
   "URIDate": "2023-03-23"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2023-01-01",
   "Paragraph": "127",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Section": "A Statement of cash flows for an entity other than a financial institution",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A_TI",
   "URIDate": "2023-03-23"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "B6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "IE63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2023-03-23"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "B89",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "B89",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "B89",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_B89_d&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "96",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_96_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "96",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_96_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35N",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35N&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "B11",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B11&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "B11D",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B11D_a&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "B35",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35_e&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "B35",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35_f&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "B35",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "B35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "IG31A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance",
   "URIDate": "2023-03-23"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r260": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r261": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "104",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_104&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r262": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r263": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r264": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r265": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r266": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r267": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r268": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r269": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "85",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r270": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r271": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r272": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r273": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "135",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_135_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r274": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "141",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r275": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "141",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r276": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "144",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_144&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r277": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "145",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_145&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r278": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "5",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_5&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r279": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "57",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_57_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r280": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Paragraph": "70",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r281": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r282": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r283": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r284": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r285": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r286": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r287": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r288": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r289": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "93",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r290": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "93",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_h&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r291": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r292": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2023-03-23"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>162
<FILENAME>0001558370-24-003164-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-24-003164-xbrl.zip
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MPMBX)\^PC4A7*\(VV28"?I,CH 7 /D6U8/[2!%/P<1)DCCL(P;\X47*@BFR
MCO#JQF3B,[[W^DA#J#^Y#4B8HU7ZK760]BRO!?I7U:C-*G >!#<'[]2JF,MZ
M'*QH1+LGVI,57H+%8)Y&S,/=1?<!<!]EV()]AZXTSR-:=44V DUFW@K8Z#AN
M^=PKKIQ[9=L@<08Q*E0_A3I?DG !L[_8_)2/@O\@?A@CPJWF]O8,.Y3FK;G2
MB&I1581M[E9.M1=8M5 1.BJ)0DFD9TWV_[!GN@P3/]E<A_.(K7C3)?HFE-I#
M[>-W>*B=E2__$[=1@IE3XC9B9'H)P8= ?!U>_IU"'YI>1=1*:;%[W>M"0G#&
M,2EXCTC6I^3<^+J!CF-X+>!R+Q<_7-Q"K[H^C>LW"8HK@Y;I>;?,M4>79\WU
MO63QK63]>$8B&^"L90M^5EU,M%P^C-/V-HITRZ(UA=TT+M)\VH8QN>93^6#U
MZ639H31G@Y4FJ_EGOOZ+I8-FM8^*HKO>Z*<%VT'\6G6E,2+WG>^P=WY';7@'
MW3P?V,D=]*@C+Z C8,<EC+A)2H*OH0<,<<ZEN==!?!4Q7F3Z$/@+HCT*_A%M
MZ-#$QD*S*V^(4I.=M-3FP@\B=F G(\M&1<-'+=8=8R>P<T!'<:$JK4?6:C*M
M+BB/IS,^&=HC-JW8X&"4WDAH"CR2 +=[\$MM>*OI6I#<#5,M[HK3:NXPE_LL
MT8(A_[$^!?RLH1_UY87T!7Z9+2.6*-:/%U$E@_HZM*RQ#]Z=EN&/,;:N98T:
MM;#=X4[L(>/"K:?-Y:Z54'M4?:QPNI.<2IX_(T*: XPEP<&[]A,2?"$,WX8]
MMI]L:8FU2)TVD>+<8+AQ=O!WP7$$S PP^7^SA*5@"K.VP652I .\YC%C#3S)
MU\D9CQ@:8AC!]@6K!U!*/\.>2RZ$X2+WK$O9.FJ_%MP1UPY->-VI"475L&R6
MO^&&;)Y57_;GDRT8569;E;E<K8-H0VGI7G@[;=$Q[%"4-]LI"I4U5RZ<1Q4Q
M5)&K* BBIVDXG<\I@]%FH 1M13I@;O@*U&$6? ^FH9-Q'D$T W&VI,'\CB[\
M.!%O]O-[7@,XNPMW /M+%["\!C"SBRH*#Z$18C.()\D-8=]H(B[J>XQ6?<$.
M:'_M@G:2.+ R.RM>!=\,)W@Y. [?GLOT(V4)'G!^B1(Z63!J.GB[BG;@^\Y@
MZ<WX.R%4X)"LAA%<S9F:O'2XHX\T3(M[$_GW1 :^P".'^^BS[Z(3'-C9L*L-
M%\(]I^WP;&>,M8JAN!7.:H)I7%1=_DU6[Y3K=Y+(R5O@E)LP:HZYYMQ$;+V,
M5I3=DW2V(D%P _0@#3T]/OE5=&\QZ/_RD^5EX'_V@V"#1Z?1:DW"MI<[+UA3
MAVXU[OI4NI4WQX'V.#$VR%G)%L%G;)03B%:5YB0>;PP:YO"6\9VC;-NH=.9*
M!SW^)W%A[TVOPXD'7?VZ OPGV%Y!I]S"4K$B+DT3'X0UG;&VXMVA6(T3!Y5B
MH3K)%J#CX^1":--K9U+5(MD2I]:448]ZZ=$M3:Y79(&+T +D;^#]V9]3.=$0
M)BDQ'!1EP>;69P3&O?QU1LPU["5J[="]QB%&B^X=W%[>.[Y@#A,7]]%5J1\V
MT<G;Z,CF.#_-93,=V<[\RVPRNLWWT,T_P!Y)XBL6K6Y\=TEH\.DJ>KZ*TM#C
M\ACJFB&7#MUIG(RH=$=4Y<RA+K[EDA4ZGPX=J-,I*AVUP.C]Y=<0GR\M0O^_
MJ7=!O=3EFYQ[NEI'C+#-A8^;6!JZ2(FM@D+B:0S8._DOYXQZOL;_Y45KTVK5
M+\V;F/(KSY^=<HN<HDE.WB:GU"@DQT;PAZ"B8=RX*OTJ&S=JWZ#W7?$U3!;0
M(NK)3X4+7?^W70;,M+KSJ\(=K^-=%W]$(BO-'Y 6U8Y:,50KKHC/_B1!2J=S
M_OY3YUJS!:<.?6A8UD;Z@#4ZO$I\+\"?$T]&3YAM'H%^H4EU9&?.N6V[_"VY
M=:A%P^@U>?X)M39FBKSB43/ZOC='UV8FG.#2U9J[+J.3')Z[)?XC=.DD),$F
M]OL],^_-M4-3&G=$FM?E6=U.J7)N;92J=[+Z1X7IN&/@4?7Q$ PZCS>;7\U/
MTP2C'WL==TC&A;7P*^*F<>X'#SSBOUOB_S-?)F*G5,6(<%^$2YTW%</G#B??
MZ?SRF3+7C^DM\UV^M;A\7OOB1O:")'I_H=W7TJ$SS;>'K3I3UA;9EI\=WAHT
M/++V.&O>(/&*/6^2P]LT*EE?)?N+X@L=ZDT>*2,+RH\GL"MS,Q/#NA43>"_5
M&LB[0Z'4#FE*A<H:X,@6B-,7!Q_1EZU:U*3R(C4J44\E^A*%?](8 Q[@Y\D3
M85X_3=$QZ% 'M=N94AV@EH-'7HV\(!<5C7CKSEM7*S]9R3<;>* )DS,-W?;7
MK@8E=(B>*ES\2RS%BXTRTQ$]3?Q'PD+HJ/B6,C&PH-\\/TC1Z7Y&W93IGBWW
M*ZS%]*1YBIEQ=]:426]0V#.4JG#BO(X1XG:(\]=3UV&<L#0;=W=^_.V&A&2A
M\T#J558+L.*U1\[<\0ON?/@RX.^L\@I&='7A1AYB^G<*<EX^:OR)VLBTF"F\
M@PH^CF T8M..S1\T!*,R:$;NTE%H$#DY5@2WEBP<?XS3U8X$F)-^/)WS(.Y,
MB82"0HN$8C[C+' ?NBZ8C% ,B(\T(/Z1'BQ%!''#^$8C?L9ABXSC%>FQZANH
M:$1H=Z%G=A= 1H_Q2P4D&G6A*[]-5V(;/6XF&6U&#+J"Z'1%S]%C8!(V9\3
M./A)6Y 1XV@FK0RT*/8.@J,)-S*BW3-S5,^447HDA^6*&C'K#@S3'1%&BXQA
M*)@1"<-<789)NO28],G.-2*C>TNJ>RRJQZ K\,[8[P-SH0U,@J9':]OL9R.:
M72]$NMY^Z/$Q>4([8M"==ZX[X9P>!\-,<R,4IOGE3!/+Z6'IE5%N!$?SCDGS
MZ$@/04<>N+'3C?ROC=RI]4"8YVD;,3%S*S/S'=.CTL-I>82EA_=7#[<O+4"]
M_;U&E+J\O+H<N?1X*/;P35^M$81!?EB#'+#T<&WC>36BV+Q(X&<D>M341%J4
M%-O\+(#NB$E/'[@NYS<]$GJO-\HYC!@,27L6#7;O,7'S.=TB]YWS4U;#Z,8X
M!-I[Y0V!>4$-K&=;9*=S?A+\1U#-W;C44':1:P%41(+KR#TWPK9SWRXUKEOS
MTP+_8NF^1@4Q=?A2P]Y"I07S;1/,AO/7"(RQ%Y@:F!8J+3"_-(%1)%(;@=F5
M:Y@:N:%LM- J C1MD95J5(%A_F)M)I%)(2V\BM@'!KYC(Y!]79?4 .J)=<"=
MG#2!:W5C&N$R\F=JV4(V*;3 G+9$$\DCW8]@;.GDI,:I7V$MA(KM?B^'IQ'B
M'G&;E9:,FDH+FE&P]Q$8<W<H-32M=%IP%-MPE6O4B$]O'ZF60Q4]M18KQ2Z[
MW5]J1,S$<:IMIUTGT.*BW&073E0C$OV\J=H&3CNI%IT>@8Q'H/JY6&GL\C9:
M+50]XOV-6 WQNVHSZKH*Z% [/5;9=]J86R-TALY8+9:>FDH+DN)40A%$:T1F
M*P\M-5Q]BFHQ5!Q@&'MKC=#V",74$BBKG5 #VVO#P$QCL*P^(9K^B&#F@I7*
MI:P-+;-"6N0, SDAH,@:ESGD/4*YE</051KR+2Q\@UF2KB.&7\5AO-N6XV!G
M?+4*,3Q8%,[5>?UB@LY:("\&W#'OP79Z4]JU#U<2!9,.C6A&E#;3B)]KAP0C
M]EM@/Z.+%;^JDV-JN *T<>K0@F8@:5,MD!66YH-1%<RRH:?),F*8NDS^8)((
MO:V,#M[NF\,#IV!<7">.,)I>-MWE6>BR7PQS+[87U +ZNND-KDJW6'#/LEN/
M\_2V.2*JB4&VR0BAYJ3%_9WB%8!Y_H<\AXBH<50%\X,LPRCQAO'@#=X8_D\!
M!_^#RGM'Y\XS_R4!F@^O8G^UQC!9XK<EH_,/KP"O].#T^/3L!/[W+Q#U\'D5
M9"3(/D?VZ>GI\/F!!8<16QSA :_ M]X[LN*,!6%N@\O3&>=Q\N[=NR-.!4RX
M>S_8/D=9XU\Y1[N2"G#H*U4-.@N% B7I*U15KRR4*2 /?66"(C1X47$&K7J8
M=(HP#Z].TCB)5I-G/[Z(5L3'!*PD#12/#@V*:*9 D.GXN+&.29X.,'4$5P?9
M.H*ODS'^]YP.?SMZCKWW9+W&$U7\2?X0AI%H/?\-?_(QLW'BA&1%XS5QI=;$
M@#'7.'_.8JXYL"N/PFBU.4*-/3@^.S@].\*/!_,T *V-W25=D<^1R[GW88+E
M_X44Q;\.W(C]JR YA'9*U=0T.:LLIN[A(GJ$$>_S:CK:5B?'?_!1.:Q6OJ%E
MFSXUEXMD?VS3 GEZUJL)Y3+Y7_T:49^DWHF)(:0+],A1-Z1>+&"L4NH ^1R<
MG!Z<O-V^'4GO-B2[J!^&28B)^%QJ5C\O@G\=9.6P%6?8BK.3?BHAV;WA?WF&
M\I<*8,5OC*N<D_B!<XA98J)\#?HC"O,Q_K6%XGD).\(E%QF>XO1Q=M+>C*Z2
M_.^XWA :B!M$;,F'5RV>\9.'F&^?Q5*'2_V_.BF%J8 -\M_#;V# 7R=TA9,Z
MB) "F9^D_-Z&1>DZ(_2!Y)5#)),/KQ*6 GGH!P%RS_X6M+#>^Y%WSZOQTBRY
M1YMD)>__>9O_/WU./@:1^ZTD9K]B0F;H^P/>U^^3[-, T><DB'<D>^;S.85B
M! \A%7AJ:"Q#\CJ.,<,YOK5*-G<46^16TP.6Q#(A+LNWBF"B)&RS:\ >2("3
MWX=7+J.>GPR4/(328-E>4/'_]TMHSV)9>LXYG8LG9D+><C_T+KKOO7*;,G<)
M?T[GU^$MBUP:QX _A>T$OM:[H(\TB/BC<RYV=U?UY;<W_<??+WJ/R"B^BM@=
MQ<1NZRCVRYVB(]H;23ELU(NO6+22$\-Y%#[BOA$JO* /98E-B+^KY!Y]&"KX
M'5V3#?[=D$&,]AE-$E%@LD*3O=0-_8ONC3J<+S%_='P=_A6Q;^@L(&^1FHMC
M)Z5E2^3$^Z\T%AZ:,%CK$]IUJ Q?S27M77)OT*Y*!I,7HZ[/RTAAZA$Q6GO%
MJ.R^3 VS=+T6/Y#@2Q3R>=Y-_$<8VHJ!8$1MV6# R1N[:3KG5A\B6%K+;^\N
M.&2@VLJ,2;D5.8S%OJA!(4YKP)_S@,2Q/_>I-XD!>XQ"<!UBSFS<+ @E\"MS
MR0YY[LTLTWRGI]EKJ8@L&SR:UP.J==*$VC()/Y.'"&@ A%PK;^CJ@;*27!J:
M^I;?XP?R/U2B6\I<G*$7-%N_^8Y%E[Q1C-=^Y>J2KT7Q'WO4 3KG^<(/L^P9
M!!/VY6H=1!M*2P_,X@;0PXI;J ,M@BC'; >E9>/U-DK@#Q_LCQ1[/UN2^1;-
MP\U:X5YR*W8NS=P&0MVW9%3I%U'TAZI^+D\^>N59CCS Z-TOP_CLS5)]3YX_
M1V"PQ;-UX"<?-[ J^VQS 2NR8I28$%LV4";)_9+>$/:-RJWZ=#ZG3'WZ:T!K
MF73<U #;$73NEO@>;E8S(YUY?@A*)X9SW3HQ*K(O5CM*%(6BU86/:DFP&0GP
MV.(ZG(+%*?"M=4C_XGLSP%N5NK'L=U):N,+/J LK=P$,QVJR8)0J35@S<AOE
MA(9.F3R!O<<%*<T&:F.$&]#:MFJ;7# 6.3&-[R1%D0%SMI>\7V[0E$\?Z/6/
MO(W][(>\ 7$_R4O%+%NQ9NZ2>FD@[A$X]Y0$7\'XCKF;#.41)*^"Z$F@I[J-
M'L["TIOI,J#U,]3KU1JJFX:S!*PL?J;0=4'?BX.E/=)L,UXXXE,RM#]EG%$.
ML<*,&U+8LE'2I=A@G=0#4JLWM<.Y6-8CE['+HB=YV]JXGU-^M<-^%1Y?2;MD
MV<9;MAXL32%-EJRY)&8W:5EF'\!>4/:2([E3N&(RXIKFR7CJ35WM(K1-'>6-
M%\8F@[;<1[S5<?-XNTEAAUJ:S$'(.1)D& '?=X5 _)58;C2KC@_[%;30W.9F
M5?LV0OW90CFJ4&0-_LM/EI^!^Z8#NE9Z*R6MO)K4K(8-"LNF%CE<^-61"HWI
M_/3XY/5G?TYOHH#B$P1VO2(+U8Y^>U96(MTNRB<2PKH1WL*6=D5<"LUR89HT
M5',3%G;WQV,QN][XL U,8'F1Q]-B<XA.^ZI>,"JXAPM72:[\0/]/$J2TLQOJ
MY'8(WVEOJ87Y$H$6E_;+F([!#WDWWG+NG=UAP*'<0QE(/_H:5"7*I\A'K19.
MJY69P+ ONAG8UQ6S;R2D7T,0@\'&8?./*.;WF\T#4CV=A=/?'XR$V9K>$$?U
MT589XAO?71(:?+J*GJ]@.^?Q0FJ1]+062ICM7$7K%5O:[,-WWL":M_R.%B]%
M'_$^B$\#LX3R*Q+A\P-_?-Q<$G?)8U\KI!S"Q+H>,;,;,I$Q(B0) K[CZVU\
MJ)E8UR/W)+V)V'H9K2B;K:"ATIQN3DB=E!:.W=+1C-A/-*1JI;!1&N5SE:9(
M6C(+Y:H/G?@\\$/<N_!(@ M\J1ZQ34[5W!0-9; 7?0$S*P:V45@\!K062MAQ
M4'/ELSB9P$^>4KD'E=Z_7A"W_8.[H:6XA?W0C .K./_2$5EV!%:.8JN01/W9
M,AG*5[(B3A.FQLMC(4\>HC3)(W%B%+;0]0/QG*;UYGN'/"V]^.TEH?!%%$Z(
MN^DS'4=+>PPLRC^)ZZ+#1SBY4!F<BL\6SF'-R..JD:\ALGC\JYH-:G>_I)<A
M- O]: ,2<ONJ2X6'L;)4=[/MW3UUEV$41 M\89&@9*HC B65;1?>I>?!7Z*D
MV-FJ+Z0Z2"U3Z4FRC.(998^PR?MC]? /A0>IFL#"Z:9XW).I5]7]63R ^!IZ
ME F<T&-:]U)^5PPKF%O@FMFFI:I70UI""Y6 ;W3D4Q\\;8.I5:G7'7162B:3
MIMS1. V2+U0U >F(+)MZRDM@?>WKRNW4LI+V9S.@3[Z_(W$/L;J<BX>QLDQS
MRHU6K<&*KY9)@&%F2)#=O(H[QJN(Y5>R>&<<!)))Z0"S1RG[+BQK@; GL'JN
MUEA$A:()L66@"L?]:+5F=$G#V'^D?\":$8L-:&NDN4YZRZ2\A HQ-83'G1_1
M::#BM-O\:)\B\L8MH\"[AKZ/'FDV_5WYSTG*J/AG@C-A\TA]0%D+;8G6U^\Y
M@%]C.D\#]"-3:.ZPXI8I<AX04*8RB8617QZ@;136W5:*O"_(I568=A+KI"E>
M S7-%;'VY=/+QTWM;8P,/))9>/K'1KMD;^EY3+NPK8.X&+L#NG  5TM[[IZD
MMY?WTGEVLE#MC]M)+)SS982S64)6ZXNTXLO2_%2>$W[@6^CNLSGQ3E(*H+[A
M/X_BJI^*>9E]Z8;L? KV!#&8R/^7;HH<K1\CPKSI_,)GU$TBICJ&-2MFW3JA
M:_[E,W53=$0J?C(47%G2.ME-[L#N&?'0!T($L X]J?&EMX%;7;'U9V_I3)]I
MPY<H_)/&611EU9:MD](R&S<_M\:MIH@ 44KGG&6& F0;L6\FC&%HT)9QLR6_
MRI:0NK!E"'ZPE:1IKBI:I!&Y9;IP0YXQ&PR:M6T <H]='BC%4!]VR-.^8X)2
M5/4$YJBOH:]X&:DCLM (K*_J#7G:""R4Y4\13O..@LHQ<1#3H64\,+XLUG@9
MLAMV]JFQPIYIH*ZAL1!X74;%[J/D%G++9NM:2H>8>^Q6?NJ<CTS*68CN#,_"
M9>CED 2;V(\G&/"")S[6WAGT+FD9YD6<4GQ60F!G APWMU$<"U^"(E9Y0ZB&
M'NR EX6ZH9>J\-?8OH>,>%G80WE$_ROB,_[0%7:Y 0E;HW28%K!LK.0[D=;9
MH)7",DEJR],=11U21[/L)K5,MMP=16I3Z.G#&QG26R9E+7=$TX=._=W"V8,?
MZ4"O\ZU<=K33//;645DH5>$4Y<??M&I7([!,S[(9+6\N;K-E$^)_1('',[C$
M2QD/#;?BCR20%]2S9<3X&__:&%/,F#OF;]W9Z><H7"A:VKSKU]-9J.D(RS3\
M!PF])D9-[TX#8@ME;%.T9N"##D*;9:L'\6L7KHW20NF*N_0NZ#HI+93.Y,KD
MG#"V08.-QS.,2U-M;O#DO^SJFF9'=5IZ=S--$[P;Q:5)&OJ5\YT[W-R@&T(>
MUE[IB;<%$TMM!'$.SP\NB\-XGMQ#L>#KB*U;O?DYNX )FWA^TIP;VR@LG#7N
MGZ+CD[?\8$ZT&/3L.L2#"?^18NN;UK=IB7V45IZFPPXC=)=T&BK";0QFL?_]
M >3;]D>)A87]4;IMP=FG-"_K;V%;B2V;G:OWI6*IV?+2M1\3"Z^G9/ZIIA'8
M^&*APO8=?4M&MY[2*DPL[)/*TWMN?8)!BE>EC2O73DK[U)7'VO#SL[S"[4G(
M4ACD2K?YWF4MF[_*^PT9H1SOOJ/ =S<P]^1W";5OL)W F*-A$FPF7K2&B:IK
M,[,KYI;N6BYH[#*?CW6EK,5/GU)OD;TQR5Y7Q().V8<[9FQI__'E3HR:]K[0
M$5DJ5Q=\65I9ET@2Q37)<.48Q-W2GE2?4]<?#VNI!LR]W^=ML++5JI>_7826
MK2X\*ZM+XUCMDY_GHVX84'T+VFDTF<::J)B&<=6<&LJCH@D6A*C(1,D<562*
MSDKJL_M2>DYQ@M7(F[8=&UL[I9ROM)=BF!8L"VYU)D23\V]=)KFA9^J&/"U=
M&[.PF'S2I%Z,.8&SG/8QSY^(.8/5EV?EQ/;*C/;%;N<E:]D;#<70DTMQ=2X"
M^&6Z4G;K::?YKG(.SU%0\W!1['U;*2RS02;!>DEFFS!U ^J'MS21KSLO?+((
M(VB-JWX*VK.<A1;(510$T=,TY-NFJY0?I"I2C.C)[-#7[82]CQ(2P':(!W)7
M'\$.*[XOG5.>L7GFV5K*63"WTP?8!F;)A.,O%"_KT9)X8CY.U5>4'V^53*OZ
M(]P7K&-ONEDND-FA/3?(N RP"$:P&";4PZ4A3^8]S[I&9*"+PON(+Y<3%\Q6
M]'ROY;M_&?Y[L_0VVCYY]LO]T_)]V+;?\U?X^D <3[_0Y9B_"/GI#$PK]:;S
M2>>"+R+E&S+3$A8N1_SLPN5OL< (Q!!]\D"J)$3]J*.3W(ZIH=.<N@[A^P*?
M(<@C./-^Z%]T3_J$ZVM5INM0TQ&&]'LBO9B9^5H'ZR''\QP&L>]1>2FFZXHA
MA6T[^^!P5EI=EJ=H.7IGY2]9NM1C>WZ6+(;=,\J:7=2FAJH1,'']7TZ.7Q\>
MOWG;/%X=4-C"%:6YWBNVJ>TTEFU4=6M[S=#I)K76YID$@:[U#8O'D-Y"[80-
MT8*1U6W$DGD4^!%LB)8P,ZUYNM+XGK %Y8=@\2;$/=-D/O>9WW2:V8Z-A?UR
MX\<\JFE(HS1N.7>MY/XQ(=^35?^&)"EL=C?"'<9 >#-Z^[QJJHE-IO,\/T#E
M3$#O#K@%#\NF]N)UMEJ&[,PDGK)L[UZYY1]0VC9S+VOZQ//XS$T":<0N22,R
MV83129HL(^;_-YZ^\6,.A9/[<%;?MW.Z#]NK@L@@]@-Z9EM&EAB_!FMKEODY
MOR&7-[WR0K2<O0%3-I3"%Y67UFVX[%]?9>.F?%N,<T?/SAK$QK(1)T=&>0A\
MI*7[\]F2!O,[NO"Q:FS7+(&M4>W.8!LF>Z,]&=IMF4-4KX\TM&6Y;4@%=#W'
M%N)T*!M-O>9NN9W&0O-ZLH#N7H"BW8+9X_IK4%#^3G ZQWS%-6C*:T>_<I8H
M<"? Y6LI34Z?6_29\?Q'WTMAAJOVS' 6=NQ*>KVY% O@E.'Q>^4T[2*EI<1(
M^HE@1_SV1<?XOJSF#U%/"]'XO"_"_;^4P(S'SDZ/3]XUID;51POGQ!MT(3T[
M.3T^/6[F%FY^LU""K^LHY!FN;H$0?KZ(^-/>6_2].LV20,^2U-M,YS*_MP?S
MEI>Z8(=]/8P/I^PR/6P(OUNV%O:;.H7]U_6<16&2W:<KG&)ZEMN7B3Z#5)-B
MO)W$0GB+G.<8L ;/0/A#28UXQB4LE';B/:(&S%8D"&ZB@+II0&\]>4"LB%)E
M1&ZAG&JG_]9H7&;D%LJ9O8?]2$,Z]S'<-F_RY;,;I&@[%2]_,:D4?"*U.\^A
M#/9ENKHGSY?S.7433$N"S[[ 0IRE#_\%O]Q'\%&$\. PPY<+BNL2&I)7$8.O
MMRE;1U53;%<,]Z4#:\EN^-.O6GBA+XKG-_V*63BR[F@B0S[+H:$,O*&ELE"J
M"[ WL''<6GW=$$?]V78YWNCE>+,O<C2]+-2?;9?C%[T<O^R+'+_JY?AU7^1H
M;KK5GRV4H_Y8[SJ4D2%H/'DD/N</*^MT/D>OC@7FRDRN4LRZ"'3X$6Q5-&LT
M[_^&L]R7)?P"%J:0>J45*BX'NN89[OP'$=+SXR8/L5+1EX$<ZBJU%J5^](OZ
M =*P;;M#,<"LZ(WF> ##K"IA9K1MN"TGTHCC:PL6K;)]PP4%NQ9:Z6E'VI:<
M+3GP-(G^W(@/C]N%A#(:)W<DH=.PL!QGY!$?L\B[P,K[N"VX_ !=,W@2V"E0
M50Q%V.R!'"Q<V]HBMV<91U/"4V/*:_)J$,I:S(KM696'EAW^7^?+^?'A2=.V
MK_UN(;#0PG>';\Y4+2__;F'+O\;>F\/CU_<1_./D]/"L>=?12F&G-*>'O[SE
M;7U]^*:Y+6DCL% 654XQ?NTBX\#!2!>.6V;IR/1%]T3^&7IW>L,ZH*.LA3U0
MF^/Y,^/*2Q1UKKW217K[@C&(F2766*?5,5!6V /.:<VBW9Z5)9WV8NJ6Y_O<
MOM=*K/[=>TV&:MV^SW)&_^X])E+M;M]A&9__&?W%+Z<,-A#;<;6D+[M=>(O=
MD=PMGD>KE9^(I0X%OE^2$"9O?G-5":+7M^2^=$G+^Z"&2=5!9Z'YE"7NZ<RB
MTD5HH6SZM(6S!%!: &!X(C!E?U'R3?P3:-<1XP8P1]+=R.-NCNX=U/$(RB*_
MU0)Y?:\:K3PRU4N?'7M.67'P63ZB,N]' TY6]D_SX%?<F> M2^6,]_LHJQW-
ML60)>%'T^JC^RU:S-[U=B7#>",C3%1)=4Z ^,U@2:%+??), G)VE+)5\YBZI
MEV)8,W6(Z8^;;"II[8;A+"SMDPJN(AD9OME>A#[W(O\H1MAL26F"4X'BXM5,
M97;">C_[,'\R.)V+"19=\6 BW7%_;EG-WO>MV!%%JS6C2XR \DB%>^C+=?.6
M-5K:XSSP(X]"T(C_.""DY$ZX[:4MT9V45SI6H)MR.;9R/?%!AXZ^0#VV:F:^
M^/85K7LYWY*CI3U6UI-[58+P(MU1YC/?I6[]V>Q!WW0D@8+_BL<8V;&C<*GO
MZJJMN>Y!S[4%XQ\HN\FB_+)56MKG]46Q&NO/)%@S&C',XP$W6Y\YOV@MWW45
MW\);MXC PV]A)IC[KG+3U4:P-V;*-=\;B+>Q$=O@NL;?VS7#9G006G@4SUV*
MCL^X2]'IX=FIVN=(06"A+.57 @I7,/5G"^6H; ),0LC7YJ&V_<0@5GLS2LLQ
M2XIP\#69T=E]!6(,WJ"]:"W[,N776HZ;IX2LUA<I]XLO+8':?AFPPNZ^IGWI
M<E4(,@QED3D=Y5F4H8M*_H-(S?T'%3&KAK,J=YH%H<VR3"89^HV9OXW PKF_
M%(4#[/0L"@?&:IAAK 89AT,?OL.HX%:*WP.T!N M4WY[N#(6SZ U].\40QP\
MPG^PAEIX:"U515V'1H;N VY=,7K*UH@(W4&WI1J_A&35A&E]D^"T9$+<)=,M
MIK!A_26UOZW#/GVZ#L/HD0??N8$1X?IA,\FZCLAR)2ALI?+"? VK>AA2CD]'
M(J#M>;WPC*<!76T&]%GJ+U)4<Q$3NV,IKY+:IN<P4-50-D9[)^6^X%GX?&C#
M]L@(O'<B @MH['7X)X'FI#%:ON<4_46J;YQWR=::SNRR!PJQ_Z A923 @TMO
MY8<RYNPCW;H_=\-X;WJT2+ELHD@%]0PJ8#X5VX0 -V+US?+..5O3IQU#GIO9
M:S!)\B!K60 ]Q6.O+E(+5_8"*K.Q4H)6&9]+4BM59\<U[(L*Y6_\JI'MKR(F
M\PR'B_Q:40;I:C[@'<[#0J6K>)JX;N9J(GWYS1Q4.HMM?Y^UK=GTVQ&*'KM+
MNB*__W]02P,$%     @ SCMN6/>_W_+)$@  2A(! !4   !A8VEU+3(P,C,Q
M,C,Q7V-A;"YX;6SM75%SXC@2?K^J^P\^[F6OZ@@A))E):F:W2,C,I2XS<$GF
M=M^V'"- >\;B)#L)__XD60;;6+9D#%CF7G8S6&KIZVZU6BVI]>F7][EKO0),
M(/(^M[HGIRT+> X:0V_ZN160MDT<"%N__/SG/WWZ2[O]V\WC@S5&3C 'GF\Y
M&-@^&%MOT)]9SVBQL#WK&\ 8NJYU@^%X"BRK>WIR<7)Z\M%JMP6-&YO0.LBS
M.+&SD^[JRZV@A[QKJ]?I]CIGIV?GUL7UZ=GUV:4U^K8J^(WV;P(+2[K0^\\U
M^\\+;=*B0#UR_4[@Y];,]Q?7G<[;V]O)6^\$X2FM?]KM_/;MX<F9@;G=AA[Q
M;<\!+8N6OR;\QP?DV#[G4JSZ^PMV(P*]SJHM:0GVKW94K,U^:G?/VKWNR3L9
MMT07V6>%1J+B["O,*1_#$I;?H"]XT+VZNNKPKRW*/<OZA)$+'L'$XK]=^\L%
M^-PB<+YP&2W^VPR#R>>6[<" 8CGK=<]")']]\JD@F8[<(H\@%XZ97&]LE_7C
M:0: 3UH6H_[C\7[5$TIE3O7JQ$'S#OO642'"(2DQJ[,33*L?R7!R3\?-'#P@
M4AJ<C%J=4-ZB^0*#&? (? 750I:2KA5^F\R^N.BM&L1K8GO$.(#$<1$),'B$
MTYD_G/P@H$\('5 /R)L^ SS_ CTZRJ#MAC_WO?$#H&T_0/L%NM"'@*Q0Q#65
MEHL0#8!O0U>%27OMS4&XS+O==_X;0 +9#%*&-U(:!T$TPF!AP_'=^X(.5L X
MW7<<'(!QR/TR %5)'@3OT)\!?!M@3%7L$3@ OMHO+B!E<!:1.@B^9VR/ 64Y
M[]S(7O(NK440":4,7EW2!\$?]>)F>4L-R13A91FH.50.8]V!RR:<D8W])16#
M1VR'F8Y28BRD=1"$H6UXMM_I%!#,YS9>1A, _4V(HPQ:+;H'DJT/,9_R;H '
M)M ?4;]XU=?8;^6$K4N\/CSHSU% ?2MJ6A$>L]FCV,&NC$7;M%T?#M[.;&]*
MAT X4\5]\J\V74RR7I>;"BIH39M+CNTZ@<L7[@_TF^ ,Z]B6"\\8U\&[#SPJ
M[]6OT&?D3T^[IZ=6VUJ1HW_'*5J"I*6]F.70*#@7.8F.N"Q$@7!2_HP<H?0X
M+3C!A!/T[7?DH?F214YZ[=->^ZS7F02N^SLKL?ZK337Y]W41KC[\=UXB],>C
MYES[!;B?6]&/G;KT\CORG-#?RNROO.#OE[V/YQ=7YY?=\V[OZJQW>=&+P8II
M5A\G$=K8B1JA?R:4;5.JHD2',/O*J+4A59>H_@2C^9JGHA&DW6MFC_#G5K=E
M!81V!BU80[;;LMX 6W3Q+[41&%\'HDD0K0.E DL7K(_ -,63)5<E<$;)=831
M E#_D9E]GRX![NAJ=L$,HU3 TAJ-DK0>2B'R,R-$ON;)(R ^A@Z=]UA01L1F
M&-)7VV5.D8)5+B+1**78$K;0DIX16G+O^=0)A"^N,'7<%WRFCN%7A,9OT'6E
MRE%8LU$Z40ZM4(5S(U3A5LE3NS7/32ONLE&&7=.(FV.PB^64*5UMRVR&RR:X
MD0K.%XW+5/$&B5D=GU&C^6F&L.\#/!^ !2+0)]^1?^O:A/!C%GVB.LPUZ209
MU^M=GG\P5#&J &Z4RQ:Q*;Y'1__K!NSDD/AXBSP?VX[J9*Y.JCEZ4Q%VHUP\
MR0ZH5#\DY9NC!#H A:0OC)"TP,2W@%4D+2G?'$GK !22OC1"TFQN\Y?L9,[Z
M4$Y*S-E%:H9 JIKAY_IH8A[#DSJ7TW.CEB+WA 0L!+: OIT3$(J7JH^XE,21
M&?(IQ&.4$)\QL$F ET\S&^=,!,EB#1"C J#"!6.[3H+D0.@Z> Z#N52,\4))
MS.<4\Z5I0BR$8]0*[I&=J?# ^,[&'EULY.RRI@HV0))*D(Q:5#T" O K&$[N
MWAU^HF8 )Q- G4T'D*''3^R%0LD1LR*%1LA_&ZQ&K<'D#GEFF?H(5]W#+>J^
M4:'8]>:@BN0R2]='ANHRRM\"5Y2P&3YP#%;J&HN*F%-5ZBAK=;D52%T%JZ&B
M'V'T"MFE6_(%X;OYPD5+ ,2Q6!4]R*W?9*70!VZ4^;]5M_V;1>LH]S+25D1F
MI&!53;ZD?)(1%Y015P<7L:*X\B2M@M(H2Y^X]A8=&Q"WWW+"7O)*#1.\-E03
M!WOJCF,*KH854";4,"VI!+Y143F!:0 F@/Y1<") 0X.T"393DZIA@WID\%,G
M=0&MXEMITHPA,8%(KZ>=Y5]/6].VT,0*J7=^8O3_UC+OKAI=-] 50IP[8JC$
M/]3&#*P[=0,F"+-KQ](1GE&V/H-WD^T;=U^4.F^4\[<&]84R8;@ F++'F_8=
M'[[F6^O"FDGF7/8N+\X.;I9599@O?QW 1FG#(W@%7@"D,A??ZRU9'>ED[[C(
M09HH3<:/R%T@OT)_=AL0GTZ0.&\?M:!F'34@3VXY<M8$:90&K(:!6(_(#ZZF
M"M91OM6-<"6T9AURX:O,%:[0 RX4NKQ.'>6O)+5,<6OB+!SBM9(\.R! &<GN
M= VH17,1OX]=)/O<6HV2OCY2H^)W7X%'&>.R-&7C.?0@\1F;7@L'?T&]1JE
M&:Q&A>+"M),B%]@M(O(T%1LEZRCH;59I:@#-&N+K[%)#K^@8&,OH-:4JS@*'
M(1^'.".45#'U.FJ1FB9DVHN=L<2HU4."@6H6)0GZ0RVV]<OK03$TH^R(@,-8
M(#<'\4*-E*8<6>&47RN_/YWDD\4PH!=0]TCX2<B32UFE<GVD7Q29+XU&8XV_
MS^TQ>79YE;VRGLY>6:(IXW?.,AB7&@*9)6HSIC<SBQ9,OK(*]1F[.6BRKI8K
M0C'*CY(A^P[\X81;K9+W8+8E7!\M*:D&.GJT%5,:I6^)Y<TCG0O8?<]H[AF
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M=OA"#/'Y<"&:2JS-5@LVDV?&I#<46^3&]4>^EZ!?O9I(6J+91T  '1(LO]
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M7L=)2K(==^["Y*]/7NRM&H</[09VD\_VF*!_912,RZ>FT4#I&+8(<9AW6-D
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M5H9TJ'%(?;7V*2_?*)![3:N"7M)6T#$62K^VG1QK]RM QS!LCE]Y%4B&9>M
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MGN6(4/32'FS5V5VU$=!#NT8LK6JG*IY =Y+Y:D70BEW78*64SN@2UQTG*'I
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MTK?RPREM%Q#VKLTIE1:C/DIELO+)P6*+XGQB7N!XOB*(;\)RZIOU V&^V+#
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MYP&K4%+)N167IK&]D?S!Y$8RNX=<@#(+X]G\(K^&_&&V!RB_?ER -*O!-%U
M[CZ^/UU [BI99[J /%U AG8!^:#W+Y2WC@7M0!P$65TU%B !="5,]XNG^\73
M_>+I?O'W<;_X)9<1'>P6<M]E1+_?=\H'O_\XO6'>X\8UO6'N?L-R^H8YH+#-
MS90G/.4)@Y'&*4\8@E1.><)3GO"4Z@,U0QA JL^4'CRE!YN<^S\0+T"E+%?=
ML?YQ^Y>> BQ%? Q<GI)^O[^DWREA#%)&L)N$,2NKX,N64H&:ID4](7NC0#K
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M+PB;OT^^&U&A[U1"!@35:'ZZ.XG_C-/[[/&_Z#</F%FG<; KZ4%_N<AS:"F
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M PBC&KR4CBLA3'V2?(4)+^C]&=<3I:^30]411=YQ%X.#\) [7ZCU).4N*#5
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MO3 G81+&*_;N<2D NMG5,J3891N.2-)4H'J>%4067#>2US.E7I*([E^E&%!
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M<-AN$!!.BH5 5YEMAVL/^W%1C$JR[,1-0+@CEB078P)T&;79+8Z23SH-2=Z
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M-^&2]BC1KKS-6+S4U?&44"P8+C])7:[I0I6 KXS=-AL,:%Y(/T)6JPG<B&!
MC6%;9#01PZ;#00D3MUE9[:2DQ\CB^7IY\N;THSRN6&L (I#;3C!+3PM54.N'
MNC^_^?A>2=UR Q AF^ZH6T:M!^I^28*/;TX^/&#ZQ^F[-^]/Y'26-@5Q@;$C
MBDN1[(?V[][\^ .?Z\.;CS\J22]L">)^<'>4%^+8%^%/WO.I*(_?:0@O:.GP
MLD _A!?@"-FBTEO<H!,C!C.C1V ;&UF\(.U8G7$*?"&=X33%F\62 ZOA@K M
M(#M6E7D@A!TH3Q[PUHPAQPT!V;TJ;AP#WADKEE[RR)%(2,JY\!9%:<(^<1N
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MKJ,3AQP!9O(V%@/-$$.R_X>^V*_!<0QLWTGP1?@4!H@=$A^>#;3AO?4X0PK
MCYV:^Y:(@LD1^(QY/7 4\)]YA2SK1("/YHD =+K73WR^O-$LG_&EG/1/;T--
M;T--;T-II4$)^?0VE!6J/01[[ZB"IK[L;E-@4EO[Z@LEJJ(BN.4 ($+^%C*Y
M#^1:XMDOJ]B;5N9\.6H-(@[?D@E'2 U$\:N0)&E16/2@W^WXH![#=1Q<+V=*
M?JB1&XA+]\BG4[=DDV80UR'KEGS28 ?4G)B>!VIH2$[/ TW/ W6E<<\P=>07
MRXN0()_V4:A564L09F"39V-D"/7Q',\WY&?L(;?#JT"*AWGDC4%8>XV>Z)'C
M]!V^?B0M>C.]?C2]?C2]?F3X^M'Q0Q%F[Q\I^H'0K[V_@*0@P!B.N785#0[O
M!26+=(U(_I10Z5O=.9?]0*[]>1OI%Y>!,,=U>EG'943 EM.C?5M')82MG]II
M-;CK)+=&(M A_D.]AU<]RU9FIFN[@+#B^]G M;B/:>\62Z9Q90[MEMYZ?-<[
MO>'BD-1Z:HO]^$6):K<E"MN_PMAR=-=F1 ]B9(S[4/N'&,S=58X=F!8V1$<#
MN[8?+'C?)=KCUQU[5!<D)UPO.L1Z%M=I]SWH$FL:O!CA8E&U/L7*9'S7:?O]
M"90)]@/?O:U<+;2X?2OI!^(QI'X<'3,"#,R^XRIL6B/;@+F-1G7MFM@(MHRI
MC1 'RO*]0=PAPTMCNG8AAF1W"6V@S-Y;+!TRNS2F:Y]A2&:7T ;*;/$!4B<C
MNC;FAV2TJW(GIO#EQF>'7-X-Z-K 'I+).YQ!\YB7"]Y[")USO#X\L(NQ _"_
M3H$Q^.OL%FB<H"M*MR.'Y8%BGU J,7_FCS!=[Y.MY)FJS48#\<9JCRE(#<GB
MX,+M.=YLPI3+=(X^.QLOWHRRN6'[[N3DM'[#MC0VKYKMET?O_3:M1*.6N7X=
M+S'9\%N_\T><I0IBB"[!=C >%*WPR4LS)GG*NPC51LZOL';&SNK:K6()5(O/
M5RN"5BQ=]H&2Z8RN+MV= D4/*#<)1$)8Y8T"":",^HS3&PHO>5A[\2)&_XD\
MHF&4H@>(RP=:T:M%L.7H &59'5RJ.\I(/%  ^/>Z%6<]#HA\7$OV6B,)G>D'
MB&NH7(5/=FPW'PE$'E=3QINC"9WUUAQVRDCI.5531G;*KVZM[R-WJP,+_,;A
M/9A.:;&/9;2SA:'<>2E#JC@X%C9S?7K4.4N%6/8=="S5CC[WMF%*_SN P>-A
M7%U@<H.H4RY<D]9#N#[F54A=B1F62/7-J#LZ,0,B!RN_T4"GIYLP?P;PW(M]
M%$5<!$5,LNKN>FF9,,@*H3$$:Y42)[5/-+U<G[IJ.&F,AX-HZ:5'6'%]5C@Q
M+T5(E7@01ORN]SWR6?3".G!Z>O*N'CC=33/;(C)+> G"U[/R7+-D/]E+J4I8
M.EQA4?%;3,F5AEYTE:7T]XL"\<OE$ODI7=#7L1]E 4NA//<B/\L7-2MO0-NA
MH,XG\Q*&0X !1;L4A=_*@E5"WZ32H;*K\P"Q:T$3%D14D@SH-B2!61=Q5O>"
M$G4V7P6U6+0:/:"L+!?Z-2EB66L*(P)M(HZ"*I4U7(!RR+B*I5D7&$%E>X[U
M5:.R7VO]"9$TY.GXIEI2W0E&9-B>>VJL@/)O,"M!%LYT"PJ0:D##4EY>.F@(
M._$E/2XJJ+GRL/;2>=5+OH[SL,PM00FRK5=C-AZ('0^*1#>FHH/HRE48>[%/
M"5.VO^. O5UT**1G%UQY=YR5MI]E%AZFX?EIA$XTV^QG>BF1E<\LK0;Q7%4F
M>/EC4,F<8DOEB*4HBNAN'C%I,SP4W57X@#GD!G&/4D.@48[V3!=&+TJ( S7B
MRH#JGKP7- 46E3B22#E7@!O7YQDA*/:?N3;7N$2"IB "#W+9JGD_ @2@LH6@
M($Q-F'+4$(2=9<R2(_"!,N0F_%=&[;+49*$(VX((&9BR18@!4,Z4W\XT8(ZL
M.8@<,5/^R)  RJ([=C]':<"56@!].J%KRZV$,62N:6/<E490S+0C@1/0'KIE
M]H"W5,@8I#I[^:@A"*M,)#XU,_D(<*"L.(^\)&&*>;_&Y_2SYBQ>W6EX+6=4
M*;1K+:<F E!VUV#5+#]):RBJT$1VJSR3(-1'HB2[Y+U8?DF0"<G-NH#0?4IT
M#GF1.EQZ(/D-CE?L5K4QP34=0'B;9N368-(#L7GR<1YU2.^0C\(GIBD5Q-9T
M .%#FA%;@PE0S?] O #I.*5O#L*7U/))CT</2^)^C4EJI8!T/4 4K3!;%#I4
M^K@TXB7K1?Q/+V954=@'5C/ER8ND*3#&O1S6E;&ENPDZ0#72L?EV$WJ/813J
MGZC4]QS>"3&JXMF_$W)$":#<%P%LZHX(NL#U221"+7%,!*CU:"KS:V,Z!ACU
M@.6;2%$ZLIAE^/1 =&Z*T*7/[<=;[UEC,"N;P_)-].16(M,#K>>^3S(4%%6Q
M%%26-(3ECNCI*T&C3RO77'=HN\!R*O34UB($=,]M;8G<6*41MYT"2'IP-Y22
MI_VVL0FAE%"H1V#CH&SV*(HJ&'8$L=_U(Q0V9!C##?(:*J:'"^X+,EC)L/)<
M862,*J%IY7NY+]'0!<LJ"/5=/V,_:ZXN3!1CK24(RW0(35C#>PPKZE=*P^0&
M\P! ?/G-7[,$@(MPN40L.9-]R4OQYO<K[I"/5W'^XM<MP<LP71#65[H$.QH=
MC)H5+H'J(NT(Y;Y7]2TB/BL$LZ++X8ZZ!'3DQ^CYEL[-KB/>IQ38%75\V2V:
M!?D#>7_E?]*V6^I(T#]WZ;OS%4,XY5[R'8K0DQ>GQ6_'RGG8J<&H>JG8#$N/
MOF7J.O8)\RXO4/[_3J:91-^A)(O20KT.+' PX')=4<A0&F$0RZWZV]%@00Y4
M*"?Y-E!K!D.Z?O^E$W5E@"=@-=2(\?W.Y_K!F/[5!@"1V5T KMC]89KQ4BC_
MQ!%[;(Z=5!\?6--O9'D$(EGI:2+7K\H8"DE/V#NXA7V?/2;H7QD%[?*)P6=W
MX?K#\87KPX"S?,07<[&:\B'XKRQAZS_';+Y,V:9?6 3YG7J+F]0VXT'QLHN;
M1+M:C4;7IVN-H5ZAMF>O\'9N#5N@T9(ZL&9WIX^:0\G\4(FEFDM]YLCAB!(2
MD[PH](H@?B*T6+X[.?WPFQ=3G1_?KCVR\7Q$-P[?BU29<XW' I$<HA:W4LGE
MIE@"76;4= PR/]_U$7D*?4URG;0]U-N+;96F%.'Q,%2C.A4]H&A/C91J.=9G
MWI:7_>[Y/CNQB.<7BH0M83L0ND\K,H=$+2$20%>"V=)7:CN;(:!>;&RK &UH
M,!I)T*A$>0<H&M%>N'5<[?.Z([MALZ5FTJ<P0DF*8U2\/:JZ[ZCM T)WZD2K
M]!:$#A^@B\=>F1P=WW<09;B!E_C7C!:*3#\;30TEM4_L$#$9OR_)>'[%3OS*
MN^T(\)+]F@M"(P(TB,'^_6U.]B)X^6__/U!+ P04    " #..VY8G!1M)_>[
M  "J;0P %0   &%C:74M,C R,S$R,S%?;&%B+GAM;.R]>W/DN)$O^O^)N-\!
M9V[$3G>$-.T>K_<>>Q\GJO68D5?=I974.\>WXX:#(E%5]+#(,LB26O[T%PGP
M700)@B"9;#O"GI940"(S*_.'!)!(_-O__KH/R#-EL1^%__[=^Q]^\QVAH1MY
M?KC]]^^.R>;\?WWWO__C__H?__8_S\__SX?[6^)%[G%/PX2XC#H)]<B+G^S(
M8W0X."'Y2!GS@X!\8+ZWI82\_\T/O_OA-S_\+W)^_A^"Q <GYEVBD A:/_[P
M/OO@(J46A7\@OWWW_K?O?OS-C_],?O>'W_SXAQ__A=Q]S-I]Y)QM_*Z&@1_^
M^@?XSQ,?CW )P_@/7V/_W[_;)<GA#^_>O;R\_/#RVQ\BMN7=?_/^W?_Y>/O@
M[NC>.??#.'%"EWY'>/L_Q.*/MY'K)$(]I>Y?GUB0$?CMNWPL90OX[3QK=@Y_
M.G__X_EOW__P-?:^2UF$CS4&R9K#IUZ2=R@W_MT[^6'>](1T*O[[W__^]^_$
MI]_]Q_\@Y-]8%-![NB'B3W](7@_TW[^+_?TA@%'%WW:,;IJ9#!A[!_W?A70+
M7R9(^7N0\OV_@)3_=_KG6^>)!M\1:/GY_D8I[^\KM-).0AHM%;V;2IS'*'$"
M(YG*/1$*=D>9'WE7H=D75N^-5L"'Q&') !'+_1$*^<BAG9J99ZEG7\$D $/?
M6_Y313[Z-:&A1[U,0ABRA;+@*,<G(!VY%7H!H'/$3A469Y@84_>';?3\SJ,^
MS!:_A1_.X0>A)_[+GR\B/@.NGN*$.6Z241+L__MW39_WTP8P#;16K,JYP]QL
M+/YCAQ[2%N_<B,].A^0\2+\8T7W#HGTSIW*XJ.'#/P=/_;_83)2*'(S&T9&Y
MM-<W6F9?I>F<1=X"PA$:GG]^Z,'S?PAJY$M&[__[-SGNB)9T%29^\KKR/*Z4
MF,:/SE/ARR4Q%<WPVE6;7)EY-;7!:66MG)H:FR1*<JKDBZ [O=&E/SQR^JNO
M?MPM_VF'Q1BB0E:%2=9:+\(X53S;,M.S[$<"0W"PY(-,8+,EL2ZCO>.'#9IH
M:H/7,I429<9XT@"G_:G9-#6YJH%)HA.8V(=C[(=\W(LH3/CL_Y'NGRAK$%C5
M#J^IM4J6F5MC(YPFU\ZJJ=EE5$E*EGR1A.NF9T6TI+Q:PB7?^!$'7^31FX3N
M-6*-<E.\#M8EGR*^R-OA=+-.;NV%OD";".(36.-ENB<-\TN#V+6/\5I=DQR9
MI94_PVE=C1R:6E1&3,0,4^'9/=WZL%,0)I^<O7K9?M(,KT6UR57%L&H;G!;6
MRNE ["JH$B ['6AE \,)TT/B<,CD?VQQ+U5[O$:H)6D=YQH;XS1+/98'(V&9
M/,GI3X6-%WPLY@0WH4>__B=]57KG:3N\AMDJ614>:XUP&F([JP,!,B5+!%W"
M"4\'D?E9XB4W^A8'K+?#:WFMDM6AL-((I^6ULSH8^B19PND2(#R=Y5W[L>L$
M<OAK_K>F!6Y;6_P6J)2P;H4G#7%;HIK=P=8H26=&*8A/;9%_H@[3L\=RRZ58
MXXETS;:8-UN")9XR:\L.@?)45KCB WM"J,#9-IT=U#[':W&-DN0G->4/<5I7
M,XO&)S09-0+DQK>CBR-C%==0!W<M3?%:5Y=\>4:.HAU.F^ODUCA/1Q*N(-KT
MP=XJ#(].<$\/$6O;@*DUPVN$;7+59]1R&YS&U\KIX+E44B62[(0G%LP)8Q]V
M=#K-KJ$I?M-3R7=RJE%KA]L$E=P./^W(*4]NB@\[&@07T?[@A*^=QMC8&+\Y
MJF6L&^1I2]PFV<+O8*,4M$E*?#*[E-N.UWY /QT5B3L-3?#:H$J>ZCYS\3E.
M>U-R.7!W&2@227(JT[H)W8AQ6R[.:RZB8YBPUXO(4Q_^=O7";H!:4E=MLK4+
M9C/58WR@Y58&.9,'<R1B)!V*P%@3)V2E_]SZ(7VO5$YS6^SFVR)A8TY6N2%F
M4VUCUTY65I'G#=3).IS1*G_LH8<?%VF5/^I:Y8_+LLH?Q[7*QY=H8JN\B^+$
M"?Y?_] ZZRL:+\0N&V5L-,Q*RP589C._MDQ34B><_!RS^ 7_<<T>HY>FJS'J
ME@NQR5/I&@VR:+8 :VQ@UI8I FF(*H'XU'8H ]E.X?-F2[' JES-YB?;+,'V
M:IQ:,SQ)=X(C07F)Y8ZR. I#&BA2L!7-\-I<FUS%Q?S3-CAMKI53\VOZ\OY2
M3G6B%&P U16CCB+TJWV,V,0:Y,A-J_094I-JXM#8E 1X<6H316Q0&RJXVT6A
M>I>ZH0E>4U+)DYE3_7.<)J7DTM2L!$$B*$ZV2_U W2/CYOS^QZ='/VDL(]+0
M!*]IJ>3)3*O^.4[34G)I:EJ""HDVY/V/;Y[>DHS^^/;UR!RH\O?PNG^*FB2M
M?X[7LAHER<RJ\B%.FVIFT=B@)#4BR4V'4U=?W1WGF"H"=T4SO%;5)E<=L\IM
M<-I8*Z>FII81)1G5B0+W]*)3M-_#N5[D_OJP<[BRUL<$JG>"]2N7RQV=\)JC
MOLRUFVLM/7"::@^^A]YI$V,0,<@9D<.0TCA36?(O- C^,XQ>P@?J\!4P]6[B
M^-B2\J)NC]U^.R2MFJZB,6:K[6)YH,$"^?-?@3[)!B!RA*E,];^CX!@F#A,Y
M0$Q=\.6T'7;35$A6-<E:(\RFJ&)UH GF9(FD.]EL+^\(R/1#B)83)VF\_];1
M'+L9MLM9F]L;VV(VR@Z.A\[GZ3V2G#R1]*=+*4PH%)KUG^FEDS@I.TIE*)MC
MM]%V.>O9@TUM,=MH!\>#\P5SZG"_R<F,=LJ,:G;A)'0;M1SJUEMAM\A&J4Y3
MJ_,FF.VOF5$+"=:,9%2G,K:K/65;CL,_L>@EV:57")2"JUIC-[Y6*:M&V-@4
MLS&V,SS0*#/B1%+/[IB,;YTW[H:MCI[/Z:R2A/+U/F1O*RZUMS;&:YO=,F:F
MJ6Z)TS(U^#4US)N+ZWN2TB8EXA/=B\\ON;HNY-W( #GT'.8UJ*&U,5Z[[);Q
MY'+R24N<=JG![_"+RCEMDA&?:C(OWS%4SA>U1GC-4"U3=<8NM\!I=BU\#IR?
M*S<_)Z@N(W'WVF?[FR; JW^.U[@:)<FKRY0_Q&E2S2P:5Y=)YU,@1VXN)S,D
MQ4ET]5/T1M1T[ESZ"+4!63EESLQGFK/E=+3LT4>U;*46Z&VH+DW-CK*/4=O2
M"9-#[2DC.&7QOO AV2=7C$7L(F*,NBW+3JU.>"U/7^;3ZGZJ'CCMLP??%FK^
MA4[H^DY05( F8D!2C$B^P)B#WUWP-RP6O"3.URB,]J_"N,]_\]MS;N*;8Q#\
M&5H4/YV[$?MST408O_B[:)&SN][D,MQ%LM:-XN7%WIUQ.H.9#L I^O7$YQR&
M_ ^X1A)'@>^)AZ0_. &\XPQ+&)H,/@"TZPNK..8\=5K]23/L]MTL5]62JVTP
MVZR"4^.H0Y C7QS%8Z16)%*^0C6R6+C\ZQ,W5GFHJNEI+1VP^UR7K%7O4[7&
M[(>=/)N:+B=\GE(F#A+OG%!87#Y[QZ(#9<GK'9<O687>U5^/_J'A*1R]'MB]
MME/:JMLJFV/VVVZF36TYHWQ&#D";.*%':$9]#,<]9,]:M#OO3!*?$<I_C39$
MLCF> G@4SQ*D*GBB6S\,X5AL5$5H0#@.NY\9SN_][2Z)-L>8RGE,J:V&AMC!
M6R5;%;/KK3!#M9)74TL5!,^CS3DGV1QN3(G+UL5+-Q<P >]X,N)!UAG,=&88
MO0D3+IG_%*02KY,=98\[)_PIBKP7/U#K2J<G=J#5EKZ*O)W=,$.Q/O/&*6[Y
M"-+D9W+F205MW*6R(NDS94\1*EF;OE0T&W+W-$Z8[R;4NW#B'8^.X1^(D)^=
M@'^LCA-[D< .;/WUH=K&Z^J/&>H,I+"Q^\7RP8C+AQ&K*/$#+0:<??=O=(W<
M1N'VG+.T)YO\2!EC!%3?$-7>.5T4#+0M).NMEN'2EB+TSFUK.ZX9)4[0;V-^
M>)D>&).$R+?E+WJ=HZE:8W?$5BFKWMC8%+-+MC-LG&N![-QL"BE1>N8=HP?'
M]ZZ^'F@84_7TJ&R^$-]4R-GHG+6V"_!.%<=##?<@Z1*:$I[7.VU+>=<N'0X'
M7;DN.U(/G@G:4_[?X B5I=(/H?(Q(%5';&M$:B&.;:"?YAE9G\X" ,%$FL&S
MG!R3^&)0^$>.2K( U4W''3,2UY_J)]30JJ(97# C]A+SLCHN]9^=IZ E$%"W
MQPX8'9)644'1&+/K=[%L:KV";N[$K* \DP-_&W)V;QF,):?<.8@TI<41!4%1
M8JH#3^KVV.&I0]+&H*7>&#,\=;$\-/Q(@# ">!I+SK1R0UP2$9>K/NPBEL"1
MP"4]P-V<^%.47 0\UO,W/O56L>Y177\ZV%W;4#.U.US]B&"& E-1C.N,PWCR
MM,I+1SPC8<17)/F@?$V"Y11O1NUTG.5-E_& 2 ?$.\)BEL#;+:_48?",'L=S
M;'%2OW2(Q:8^]$ES6%Y*PTB']1=3YBEH)M5.+2IQDBS=EJ]\,*3<SJ$!/,FX
M8TDOBTU]G\[FA_22^&P3V<P>/?>LI)5Z4V^%?@[J3KJI-$$]XUA-2FD]\)YJ
MW\RN2'*W#'..38=W+<:MVOP)OR/9.BJ:TW.LN@Q&5X$I.'GE\_&M[SSY 0\-
M:'=66D<G[&ZE(W/5V=IZ8'9!+;Z-=PA^7MU?_;R^O;RZ?_B>7/W7YYO'/Y'5
MITMR>[/Z<'-[\WAS]3!3*#VNW/"JV2X*/,[']R+23%Y%Y!D4@Z%T<DVW7IPC
MZ[CN<IQU3#.=UQTGE&SN6Z;P@AQ?XAY\/N\KU5)OA=W=&J6JW10M-\'L;,V,
M&E\6%-2(*\G-=?_3JDC"R<:42.^>YQA?4]PBVNPGQIRU.T;W_G'?<A14:80=
M-IIDJA_D%BTP@T8CG\,<[""IS7:P.I% ,[O5(Z-.?&2O\D%BI3I.FF%WK6:Y
MJLY5;8/9O12<&F^ZI.0DWMO=0?J]E">D6ZB-V^YDDXHU=Y4J&E/V3->;[/WZ
M2W^SH8QR6X[7X2-SPCAH>@7 C )V]^RMC5K!*]WNF)VZOQ#&M8?D2'".2].Q
MB%<,1J(0,B*SX>:JN#29.N2AC_M:%KJL#VS D3A^2+TKA\%A?$MYN].&^&&@
M6;:ZMU=;X79J!:_FOBL)$II2G,T]+0NV<MWC_AB("OI!%*.[4RFWYCIV[A;@
M8U4YFK: ,?M3C4-38[L:;9-7,X7-DAP(JT':EFRJM+/N(VY+DLDC[AC]UGQ1
M=J;/B7=7+^SPJ"6UJDK2P@Z]]1BW43^I=. [?\&66<1&Z]N4<UW2@X[63KLL
MR*L5\BI=NM9^(?ZLXMJ*50/Q%MN>P8]MBUN4*.P2%HTCW['HV8_]*(RO(W:U
M/P31*Z4?:$@WOE;IPJ[^RW%Q+4VH_+VU\S*<7T\$&TAPR$<BFX@1FH[%8W8Y
MV.S ,+(J:%+(['&:L"^3RKX$R.@Y[2]UQN\QV2]NGA]KBA]Y<N]3]-2FC*>5
M3]&ZZ47_M7=K%^P.VRUOXS6IA2VY-;@>>H$*U5I[6GEQ>; HX[(*O7(QICOG
MM;T(44<G[%ZL(W,]ZT;= [,G:_%MGKH"!8G@JD2UUM8A'6 F;YY49H6L.*;E
MM"QC5D^VIA.=P-J $';G-]5-6U'5;BJ80<)8%EL%5;/ZQ U8,O\&WN3:6=6T
M,O,M\\GD%LL>E#AZ23>4_]!12[<'GIH07 BN&NNJ$5][4UL SIK+-!1OO71D
MC0K6:'!W>FU=5K6$$I&T#T35[1>")WI'H8K&"T #ZZ>"^8X#D@/0L>0L531$
M?OS9?[VU3$_5==)E^><8KCG[P<58X;O&NFUF9]3QPF6Y7Z??+<3AK*;&S.YA
M]ET+K4LUE>=1ZD71&+N3M<G875P*L]NU\COLZD)'&:6I7'$4"=4)\KB+1\EU
M]$/B)'0/VWM=Q_7J]MA=MD/26J6;YL:8';>+9?,*PV$<!;XG+KGEY&.XV2*'
M?/?F-HKCM[CL^IX^T_!(.^WYM!UV.U9(5K]N6FF$V6Y5K ZP5[EGR23A^2Z;
MVI4KI8?2S:ZYC69ZCW_QD]W%,4XX-+"VF][=/1?BBMW2-SJGNML"W%6#^8&&
M3D#;^0E$3%[X(,3-1IG7J4>4O@Y?LQ5G&U_4=(NH Z]Q(%R7FI:#5JV8M #D
M&6DBG6KU:4L*Z3S-(*'C,H[K'\_!ZM_S_PF;A[_\.4OL6!\H<Q(_W"HBZ,[&
M.+U!3T9PC?:6^/Q$DU_C'9R4\AG):9,OJUD2M4>6M)!/D7$U^X044V[I\,K.
M)??^(#K >CS51POLM/?"Z:X]I3XML*;L@L^!^S(^I) :4!?[DEY!/S/WV2HI
M3B3V/SG[P[\V"3[?ZX_S?N'(\.TG&G( #K@N5M[>#WV ]<1_IET(U]T/.\9I
M2EY%N8Y.F'%.EW53PT_I"[MW*B/,CG53B2[!KEGX^?!N_B\>&>:)'/H\\)3'
M*EUXU]X'.]9I2%S%N98.F#%.AVWCE8JX&A/EZY4TC?M-:N/U$[FI]DC'%%E2
MDUO#6^:,]*2O%HA-_\V^R[_9,Q+2!!F$9<QVXM9I0_1@I9"MAE"U5JAA2<6K
MM5V3$4.KQ^Y=5NORR>W6J&MO:#*,'?W[0Q8AW;%HXR>0: ('4L6NG\NCNO8,
M0YV>V %(6_HJ(G5VPPQ1^LR;VKP<@;R!RMUO94Q1.+B3CS/30='X\A<^#QK
MY>_7?@BEE&58I=11O15V/VZ4JNJSE2:8_;.945-;E-1\/L<V7K.<:EZ=5"@<
M+G81Q2VU-FN-%N)@%9D:_4NT6(![5?D<9HB4N$!MMDW/$40"WVI><,Q]BN'X
M87PKG@19AUVO =U3-]J&?@S7VN6TOV;05[V!:HDZ=G>VJL7:N8D-TI@!Q*Z
MYGDCIV]US32W_WTI1.\@!H5*KB-&_6U8O.NV!;;DNHQBNUA2B1!A*M.+)=.6
MV %7*5W+(@6:809"-;-#PZGLP 7"JG%.6[JW"<:3CC-\#!*$1PW%SL@'NN'8
M\>A\U=A%*;?%[H8M$JIV^/*&F%VQC=UA1X+OTEV\)T$W\TQN;K/OWMF3%*AE
M IY*AN(B,1<S/9& .R-^>/3#;;K-&(7J]8QF9^QNVT<'3?>-VWMB=NQ>_ \\
M_.?F.GO^UK<@KSZ832+M%5]UN")'JP!OPHGS^"I]GN3M.Y1;/074:\P&"T"Q
M4WE4,0=F1&K@<M"\"V\%)3LZYFN>W5L8"Q2J3ZBT%*&T]E8LB@5O-OF5,+=5
MQKGK/Z6O:]]1]@#U<#IK<+1TP(Z57;+6:D$I6F/&T4Z>C>?[E##8L"R<-!.H
MCB:A0*-<NC_@\M(/3NR[F>C :2:^4D]M/;#[::>T54=5-L?LJ=U,FQJRH$QH
MYK#I'#2WWXXM;U!QW]J42YPD8?[3,8'G7D@29<7>TN)ON'S]T@^.?$G;R]O;
M^V#W=PV)JQ[?T@&SS^NP;>H%*6UT?C^%S-^.[^<5^]:;BVA_8'1'P]A_3@^,
M.F-S[>[8$:&?'JK@H-<7,T[TE&"$6I&583%7C@1&HQ#87F_DVT:G"GO<.<DO
M?A!\H/?4#9PX]C<^W$LIIT7P1?MZ\^A\[7X!=;P!L3OEV+JN/3@PTFB8'7]T
MF8T/-S@VQ'Q2=1*R=U[)$^0;%(/#K)H> _"I5\S&?DCBXU/,YUKQJ*28B7E,
M$M($X(6[_MOZ"GNJ@.3O6<=SWSI5J#M395=.F_([M4 8._C:TEW#/?T!5#&#
MJ379AMT+=RNAE'1AD::5.NE9D4E92C(E44B2@A=HNTD3+Z/\%'?.D@%S*E8^
M@..^5C2DSM!=4(CZ*4HFCU+[CXD=*R?0N'FLVG- S @[A=CFB]N,-\#.2 G%
M,N!ZX1R2,$J:HJZ#O'B<1EUEZ"9?G%EJ:B[C&RC%L[EZN3K_#N/:RL6->[JG
M3GQD<K-EO;FD&S^DW@>9-77'E:W.3!IA(.Q8/I9N^\7!?4?!C-JCR3IVG%R]
M: 01,JMP!PT]R1])DQ#) 3A$&B=/KNC*&%*=[\KJ3)5W7E%>!7AG2CI#I\FT
MP%"#X8)6ES$[]=;V@F>+?JB_1/0>$861P>>(DJ8)F\A0;G*!$6R8Z&+5,F%*
M&Z$6!DYC&._%5(BD\?#V".)ESRJ5A:SO,^!RSW)V@MCGC6_"])76/ODIRJ[8
MG5=??G5>2G,_S*[=@_LQ\E'DD+ U) ==BDL\0M:9@5*S?LMUAHKDNIX@.BW3
M#:JLF_I 3A^LWBVL/DU:_"*R&.N[S0CBM6P3.H6$K[YZ$U/9'+NMM\NI/A$J
MVF*V[ Z.[9S#9&;L<-+(K%C*_)'NGRA3*JG6"+O%-LE4N^16:H'9.AOY-+[,
MEEJA)(?,#F_B^$B]"^?@\X5!ASDVM\5NE2T2UNILG#;$;*-M[!H?H@J:Q)5$
MR9=]H\E.M24WAH3B*D@F("Y7%*S=,;KWC_L.3VQLBMT1U?+5XO63=IC=L(7;
M83::TE3-&U,YX6CR'21-7#[XR,1AWJM@,>[P0D5C['[8)F/5$YM:8O;%5GZ-
MMTQ3HO*Z7SRW/TXA(RZ?O*>) T?JV:7.#J]4-L?NE^URUM\O;FJ+V3<[.#9/
M,I%DBYO(,P>M(\FY<MWC_A@XV05D?$X:4_9,UYNN=/Q.[^U+![];&VGF]+WR
M'D1P X&9*.8((<83^X$:5U]FAX]IM9-?;BF1)I=8+[>HST-N.>:*%'"#LY1R
M7^QHTD,#NJ=@>4?,J-&'_;%.PWA+2GP8"MLF;NA" $\OJ?SW<<>BXW8GE@@@
MFG?GO()<PL?A\;J.>LLFQ+ [SA =G=1C[DT)LVL-DF= _6(Q&'GCI<.^)8D<
M6"Y"S\70Y"#'EE-T.OA9ZI%S;4O/H:^'4YV8S,V.ZQ_/ 4?>\_\)%(&__/G!
M">B:B?WV]>;N^!3X[AI" %C B*SWSZ%'V0OSX47(:TKCDFP-[YS8HHD34ZQJ
M#*#%"L%Y$<:+^/*4VV13X02[XAEO<>U$.N<)Z!3SNWCD->9\PM5 'SB%.. @
M>.4_I<QFB9+'$K]DPQDF3NB584H^J/?#&"#5A.<XM/R0JN\F4Y]D@N1<G)%/
M4G]E3@BP<D9*S!#@9E)\QZ&_.Q:YE'JQ-,:Z[9TIC>_LU/*$/<:)LS\0[SC.
M9-E2Z_J;4^=(DVUU.[]1*:O0J^FE'KQ;)+N4*7>8WIIG73.:2YIX!THX]=R;
MU([>^DV]\\V\,ZGY ;_^>DR_,RFQ.F5(DSS5)+=<_=E$2[TS;R%].L)V\GHC
MM2TSKSHOV'1TPCF7]).YNO73U@/S%H\6WP-RKO?<J!M3!Z;:DQE50" G7KWD
MSBVE+*[+U;W:I%:,(DY4[#/=<?7M^*_KC7AJUZ5Q#(=&W/)W' \OZ3,-H@.$
M!*LXIHT[,[8(X_1O^[K+HT4K5)''BW9E'"]BE"_0BBE6KNTD?^"4-W?W_\27
MO?]Z21Q@9N(]&!P*;-M?+^L* AG)#6A4L"/"%:]@2&IQ^F@0B2*KQI0K;W2<
M7[G<T&,?_'2]$;+$\L"SAZ[::"P/O3LUT@742@++Q.1N<4R-_OO>^ LO8/@G
M<1+W&7)PF B5G##U(*=@&P4RCZ?&-A N:4%H1XP[R\GF/+I9U6V!G$-="N5*
M F>*Q444/G.]"O7(GQ/_*: W(5]Z")_NG6>A11$G=EO4EE;&13<YS&ORX4*-
M 4MN/KQ(@BH8X-"?<X S 6,"S15#0'U92IPMHR)C;!%@5=E1'9(+UD9HH=#4
MJ1LM1%)262 0=<LR!OY4-]HG2_O2>K5Y<D7]3 ,/0NC:Z8/%I:<\:I$A'5]%
M)\QW$^K)IVY?'.8UGC1K]<*) SVE+A:4G5VP+R'U!;"R9U<L%'//3E>(8GG(
M<@Y21W<$#Q.O!\?729X')0<Y(\4P1%Z#E@/-L. ;7_C[YB]Y$;'2U5?*7!]V
M&=<'HQBIB0!.3#37A59,=-)[@;&06H8Q8B":CB:>$CD@3GFWKY:K4]%QP47Y
M'I(3[ZZ#Z"7N58BTH1-V6-"167W9K-X#L_MK\3U&P5$^&!&CX;+V7 G7W"0^
MQ]2["=?R/;APN^*+G&<_\6FW_?<F@]TCS/12J]G8BP9FKS&4Q-B/P%DV,)X\
M>GISA$M1?O@V>ZLPW!(G'Q;!JUG3JF?=H 1<J++R_G*,$P%^UQ&[I^!R?D#E
M\V#PKDHGH/2A@!U+>FNC"B/:W3$C2'\AC(\=BY'@+3B6#96]NR=?J)@?-!!H
M!%(<Q0MYFXB)W1OY-AXT@H_<'(:1O8]75=TE/7"1?+$Q=O7U0,-872!=I^>R
MX*1%^C88:>BV'/AH8]Z&DX [>*4Q^'I=#(("*<80ODQ37(EE$&C!;B8\V9:(
M?$'8GC@8GH0J#B<Z!;OWMSNX%1)3F9G2M,UI0@2GBP_327Z2T9L"\H,-<WG&
MQ +Q 8.1SZ/-.5^@I E>;3%'?5[56=U,>V""4]=G38J>_D!E>N74<;E;#:@B
MLVL_A&Q1^;)50Q61/OUP0G9OR=MBLI-.RXG(U*S;PH6-'"%[V_L-W,6R^[#B
M[Z78(=W"_FV?D,R^]"E%\D:*^_9=CH3AR44-5"Y_4B-)?:RJT7%93J^6O<WK
M3WLMQ^U;>+?E]PVEPN:Z@CJZ[.428/""(_?XMO4G*L>O'R#?A%?[0Q"]4IH^
ME'WK.T]^(&):30WW)+DLL##15QN,]*&W'( QDLH6]*BN1Z4<D.Q9^Z#@ 04R
M3:HT6:L5] )+VUPW'A\'BK;7=83LH<VZXKBN:9STVT4^[;4T)&J4NAUL*EV6
MA"?-C-N##$D?U8ZQ;:%OVH5$Y=(_.7X(AVGK\-*/#U'L!/%=NKE]!UO;J]"[
MRC:V-=79D^2RP,!$7VU(T8?><F#$2"I;&+/E@V<[RGQMX&4<G/4ZMIEKKV12
MU;V!T=Z^$V?<<.TXK?6U\;]2SWS_5'&:E5>M_R5BO_KA-GW64)'JHMD%)WKT
MD3<_E^IHC\_[>W$]+'X6]>9>Y C%XYRK65)49A8;>:Y)MJ3*_KUC].#X7AI;
MZ6YMZ-#!Z?J#-=.>E=)!!!](#!?%WLEIMEV1;5R\E<6?Q+!9L(YCBV)\[;S)
M2+]]ERNF6QO(P6;ENNP(Z<5P*,3_&QP]P.8H%*#<F"-CG?C28:F/#OMAE0[E
M)0-8+_E&1C5'\I(=!_L9-U#01+ S1Y8(,E4J(+"JNF4!X"-S/,J5%QW#Y)ZZ
MU']VG@+]=%]M<DL'N78]]8.U9EI+!K(.B4:&K@1&!R^$X:$H9\8 4JP:25MJ
M=.K0"W*(6B<[RO(K6H7"S .S-HI+!ZI.;?7#*B6Y)<-5MU C(U8$#)2RDPO7
MQ!I?C:<R!6Q)%;GBK=VD14'6;DN<'O*G,:5B)\J0!$Y\&:(/Q3V)SOZ+NB6A
M+\W(R3+98B/;;_F6KD>@5?+$1WVSJ.9-1OKMNW))L@Y5H(H=3Y5T23>4SR"J
M?0$;*92]AL")_F/JLU^*I3[]Y<2?5J0<&?"\E*.6[3_\29D3JE4!EC4U+@LK
MR]L2=\YKCWU 75I+1[\6#?6#N09"2\:S-G%&!J[:WM]!CHX4H,;0DP*)4KV$
M7KJ03A6#+'Q3UWEJ*Q_:U0L[S&A)K5OY#'EU4#W&1ZMK=EH,TPX61(D3M&/!
M!(*GPC8NXW'Y>9;@+O<-J7<1.''L;WSJK>*&PFY*I?:G@QT+##53+R/<BPAF
MO# 59?#5"Y8.>$;<?$AX2$##N:8*+V;7#4Y0N7/\P8"B1V,I8-)#(\U HD%@
M"2#21XS!3@)9D).#1Y]K([-I!1=LI)5 H*I(/ 0Z^M/!#A^&FJE"2$\BF&'$
M5)2A-6K$J^CX\60N]>0GG_BP1:]NM<&:<6%(TD\/)D7>,>-&3PFF*>J.;AO$
MJBX^5:HK+VAGI$$_-^$SCYP&/Q?13F:!"**AETXD::&Q,$31D<0^LOC9J-B?
MBQA3/3<-2K"7E9@5/[MCD4NI)V2ZXTK;\;'C!R>@\7KSL(M8\DC97L9$OA/(
M&R[E$*Q! TUI1N,.AQ-FIM)SGADYXEC(LRBGD-S4CS/>R)M#RMU;B7>'C$'R
M!BI<0%F0#8F!RW..1ONT="KG,[T35U^F-:'DI&F5_]#Z/(MC],I_:%,GNDJX
MF=;6&V5%FWXSGF72.&>W,?17#:R'T\4<;%N4SA@C4Q8ZGPY!B($H%1E/^ @+
MK$96WC/L5<J'J,+DDAZBV&^N6-76&B? :$I9U*E2-D4>O&HP;FJ8\/*[V+"*
MCHFXFB-2'.4E'?EH!PPCWWT/DVDOY8PHMMA9R&@+28$Z2<G/$:V-*"S0XN%5
M^ETN<N-QX)8+6@@SU8/)!B/F6*>G!--L*.(YJAA#%[6C"AZ4//L>%/9^?==+
M+?CP(UW+#CVX:">S0#S1T$LGKK306!B^Z$AB'V<VV:C8#R[&5,]U@Q(L'ER4
M]KMNXOC(UWT7$<<QEOA/ ;VD3XWK'ZU>.)V^I]3%:4!G%^3KHAX"#%X?98LB
M<&=X4=GGXX$%\Y616XS)@^RGB5=)$R@A&T)*#Y+3)KFG+V8\B^PB^:LF?A Y
MX1CB\P&>HGD5 '%B=D*"*_3+#CBR-[N$ D0:H'HKL*T+3G3O(V]M>US9'G.H
MIL'UX".__/VY%,Q$INM\^]/C2?S(G#"&("L*TW1>_D,9Q(061@R^8)SUYN[X
M%/CN>K.AC,^9,8#4?A^%0MJ8 \QZ\SGT*'MA/JPUKRF/-4.OQ'N34T\P'$Y
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MYN,N8D(M:>6U_[I-U7=);M2A@;857&/'I;A(%_NVUG)B%"+= ]E,.Y8*U)B
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MEM"4W:Q:&3"<59SV,Y:+NW2-T#+=7O8_=(_CV'$QW\E=MZJGG2?%6\=R?9A
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MR_QF^_N+6Q_\/:A^8:N&>;^2G@L(&[Z :"WQ "(D_C.$,:$3O,9^?!VQ%;P
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M^#CBCLZL <#?@>P=E6ZF4H#%K)_:=I0)6AG00(Q<IAHI\GUZ$D".:,;BV$N
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M>D>9'WE]5C.:'1$C2R_9B_6,3B_DB--/!O-M0#D*.8AASK L:G +CR@?ZR*
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MPE/;VV-W5$WNC0V6)N10J?_DQ_6R!M.Z*#Z!YZ[-4%,'K;]W45-COYXX/=U
M^EHYAZYN^#+M39BW4_(M+W$SVBE2ECI?NJ_X@99*LSSL:+"YIUL?TMX!"Q\X
M)(K'PQHS)(90PVGPEK14I%\9DT(^(5H0S#B/*,T:JMYU?:+50D@Q,$!8B0-8
M<4L6ILVU^H>F>J5=85>78("4.2 /"G4-J5V3/.[H1X?]2A.9VM"]A]C=!3'F
M:LI;E)=I;X\</76Y-RYV$I+OG.2<KW//]V*4[_*=14CP<8J-1A%M4_<(16-%
MK4EN\0[LF'/K%DMEYHABYI*,V*TLUSA/E]=IXFOL["EQ R>.X75J>;<UV7%R
M#MGX7^'@F?D0X(=G4-TW?QB$]]PX4*Q<L!!MSGC[T,DR10OFZ%=7E,24O:,R
M#2=C<._\"@M_&/K%%[7R0-A0RB2[3[NW.OI7G0@%RA&(' +#?BM*N0< \@-4
MU/?6!QK*(47UYU7VMJX:E37[(8;F/I+G^*S3"3E(]Q+!\HD0I,5P>^;_4,9Q
M4\(R8"'GB !+F>$+IDC.%7D#3O'=)_I2_^2[M^3%3W;DCU3XB'P<AY/C*'^D
MPI56CQ]A2V;+G/VT$#F)HA^Z=3<?6$ZB@0:C& $GE;C?5GM"IQ-BA-26N3M\
M15Z!0I_OD>;U&>M0H)5]T.W+_9XOH4447RRYKZ/\50L!&#?A35B 4^.JW8P.
M8I\>HIG2[<O^1)!'18-$&I(D7ERR< 4+V=JSM%LC;F3"NRGIF_,13/9R83CU
M_<H9E'31II;\=$T^KL,5Q/]7TL\<]RMGT-&#TF8LKA0Y-?DL$*T_&Z3.!=#I
MA!@MM64N%HA=/9#CH#[_0T!/_5)6NB<-UAL%WL0+MM%E?Q"O7['B2/3D"=SQ
M<B*Z;JV,+_TGQ;>>?>EHW^\JGYBWJ$GKQ+V]/TXL--:$.FNBI3.^-:*Y"'8R
M*.(.V)CK-8U9E%%.J%*](*[Y8J#=!2=G#*Y@W#E^.=QK3:;JVQ<G/!AIH+*8
MU.F(/'#J+8;Q;DIEP9@.20Y\S.J*J)9M-?U*<1)M7/31P3RKP5GT8+62&0\=
M$_\IH)^BA&J<#7;V0 UC.M*6ZY"U-$</65K,#UGHI4> C!ZX!%!A+SV>R\8E
M802%1K*1)R\7-J;\)?($Z*,XDIM/9G%,>^L'P>NHXG<M<R=40-6V!^?];YSX
M20P9LT0L9]_1((GA-X': K'Y+W_.T_8>7,IG&#]:??7K@6=;.YSHW"D98+*R
M$;XU93>KQIM,*3'R!<B9G*J9F5TZ[.<P/E#7W_C4NXSVCE^?>KK:(C:_+@ES
M$U0U1&J&G>P.-T5)T.(1[\T&X!N>J4HAEWKJB+2M,4Y[TY.Q>*Q;U1)Y"-K-
MMXT,M'+X"?F\F56*)\=@EH[)EB997$JGO34\G@IN-JEPL,>>"S=C\#FUJ#;3
MOW91_$#9L^_2G_9//[==5U"T1(PS[=*5LKN:FB%'F ZF+<.+&(VDPQ$8;^*L
M_%&$/95JA S+:Y_%27I7Z<YA24A9NZ=U=4#L<%JR%J6&VEHC=S\]WBU[H1@T
M?^XJ'79Z;QQ7=K60(SBG:M>DX^6]KCZ(7517XLZM8.2IS]ILC[$-.D+J;U:$
M1R57:[71MDZ(;55;YI,"4\H>R*<5??[MI*FICRPFKE\SNMR?YI)9KQ+G%(+'
M]. P*("OKX$A2\NLWOX=\T/7/SB!/.%?;ZX<=U>3MS'H[TD ,9 9Z:)8G_;I
MC1S@S&0Q7N#E;SX<LN%*%Q,H'_'$%Z9=URY,&T->Q"@EU97?RRL)"4_GW5%V
M$WK^L^\=G4"%# -H(0:)H1HJWK\P)(0<.@:+-21D<IUX1_QP ]5C&QY<+/L-
M/+YX!@4K>?N,C^FA939M5;-:AZMI .:LB](GZ150=L&_1ZZ"V/>HK 9T>:2B
M4%&O=94MPHC1R*KN<FBR0A4Y3MF5T=0-2UQD+X1%3,*86^:$>$>:ELK"LAC\
M.U#@D"W+(V.PC^6Z[$CA=0;*77JW"KU+^DR#Z ##7< M@,9=L1Z=$8-3;QT4
MNYFZ/9&#3'\Y+%WFEN,21PX,;W*(D<5%%*\86UY$F3CO=3*=7/32P@S9L)-I
M8F6B@9FO/3[L(I9P!>YK+P/'0A@G4%]XU.F)$S8-I*]><NSLAN\<R(1Y\TH%
M?(1S&.+D:>Q8P@0?9:;[C.-+GQ(2CT%2MHG8'JX"G3,:.(D A_TQ3,.EB7/C
M)]>"?*^1LQ40^O5 P]AF0? U%,I,A[E*J3=&T,WM<$)3IV3%ZK&A$?(XK95E
MXZ6)*-6:!1\*,QMYC3:;7$..I"3EA\39'RZ/R6OCEOQI&\1NHY*H.#NJ-4#N
M+DIVQUF]Q# .7\ GKQ-7&;8MYNI$H!D*[DTNU,SKB$L_=H,H/C*ZWO"?LP?F
MQ3;[/5\"A4>:[KZ+9*#X%S_971SC)-IS/3XZ3T']<,LR:9RX-8;^JDN5X70Q
MKV4L2F?JF 4+ *I>A0GX"Y-LY"= DA%Y4];-6"%?$F!F\#T^NS[]R$>-Q2F9
M9+KACFEG8^Q^UR9CU9.:6F+VC59^C4,(()J>7J:6_,6Q<0-U7,MMO&"@T7QI
MUGMZN:"K[9(LV-:%@@8;WMM/I@\XJ4CN\ZQ"[]9W80&73DK%T5Q;A96>%' :
MZP!ME-+N^W1'OJPS%&9 :KXP<MB2=!B#5V3$682X%^N'SU'P# \JO(@W:?81
M#V,.#A-OUH@63U&R^P-YX[\E4%3MF0:O\G/(F$M$M6*'_"7R84EY$+N:X5:V
MA#-B./]XXT-?3I9^/42Q?)<J]K>AO_%=AW=C?OQK]J3]B\.\=%R/'BC_6R2K
M(4,5+,I<'Q[5.;HNC?-W>U1C3UUE9N+OM#2<T%TZ($E'+.Y?Q+/6H4&FE7EK
MTB!31K>)6)O^LI%@^26J ^G.>NJ.BYGL.F17S'&*7HN:VKID&)2"6C7OI@)4
M4"10=1(_Y^PPEEJJ'C]Y3:X^4\%8*L!0>6P*.7_\S?O_E>-Y[9N^"OSTVP:;
MOXCV!R=4ZL0ZPJ\WG+=__J,3QC$-[W8.VSLN/?)PT0FTESJ]:"UN'M#74,?4
MT$UHD;-%#[&&3" P2+X! &NC8JK(_<F)XXBO.2!K0V[75A!6/DDG^20U1C',
M+Q,H\D(Q"_.U&8Q]IE(/NHEH ET)@ZMA]1SJ,9O!)E!02MS>#)5.D'RMU2;3
MK;^A'[EBW&/@L)N]LVU]J-H"3<0SEBV-Y3/74(+(9S!KXB&8R8!+DK-)4CZG
MG<AFUV<64T/HK%IBYI-;L\9FG-MF5U_3'*?0TAM(C*6,+U/N?.;LN=EFGSRL
MWLXZ <ZNQ7YV-3B#MKO6OZ(=XHFL3;):!NVBJOFWLFQJ;\/GC@C8FG:J&$43
M:<[M)"7\NV!H1 $'( G6#,);/Z0W"=VK\Y.LD<<)>V/IT6(V84X;<\Z)90EG
MSBKD!"GQ@2.[=2+%<-G197MY2$53G%ZD(U^Y&&13.WS6K<7MT/R2XI!]QG?N
MYQ=RYDDTY>]QYR2_./%-Z 9'CWHW82; K>\\^8&?O'YP KB6N$H^4+ZZ"/D"
M8[VYH\R//"4TVJ&-T_%'T6!U[K1 &!^TC".>\249<;D)GHB7HT-ZFDP?2]TW
MR)@@3B(^><IXR/+)#H(3E$X-<<==<:-X_13X,B"('_@_,3SILF90(]IW@N U
M_]M->,>C!3\ZQE++ZA#9_C@+<7;;FFUT?%N#+  $K(MJ7'^M8()$!1<DSH8$
MA#BD@Z:^CZQ QQV+O"-<WPB]]'&&]GLXZO;8G;%#TI-WQIL:8W:.+I8'%!D4
M=,6I19Q21GDMIT$#'3=SVGHLT)[;[N<HFR_,IBUM52JLVOI%G4?G^#%BAQWL
MF#SL^7R4GKQ0]7E(=Q><IME'WGR7HZ,]\@,37>Z'', KRWWQ)<6>>K[KA]QR
M(1T9%A@)HTZ2?;P*_K:C/N?M^Q@V^:B3GCV+ Q42TB-W KJELE[0,\W:3)Q?
M-KH2G2/)!R!BA.S\<]P[&^V;26.+78@,"M 3>[PK&>*IH17_D]?U\+L)&<2
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MJ/N@=B!HVHZE-N>T+]JT(],#U)/P&%,'F;8_].[^_ZJNP;=Y(^YO1[??[!G
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MM!ZS%:9!G%RE"5N L7+\1YF1LC9IFD79,$G&"8+%;,668.![S];-[)&U6"B
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MAP,L1K@.&%@D3K*'%KO0@595Z%R@;W^5"-KK06:!#MJ;A]C))O+W1V&Y_Y
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M>R#6'CVA*7 *I-O'K/Z3D.K2:IFWCW)_'&C[J\NC/6,"5[33(?@$((-=9NM
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M>*$)W57O=:?A%?^SA[:R&83W[8"]3"@S*<Z7U_N#D3DCT.A2G)>4_K4MNL=
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M%Y=8O. =,UH0A[N*?0?]6M [NY;5U<[>6 5R9]=3W+2S"^F(9.(YYV?I7O_
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M4!"=-6K^LQNM?\&_^T6,#.%*2%Z_M&3K.4'@Q .YB<(X"GP/8_7:";!TGU<
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M5T;_#^0#Q2"<([.Z=ER0)K[K!%K@UN[#AHAN#I*'M;/$QF*)!G[ Q:._ #E
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MA<T!C*,P! $C5X/6S!*M"K-6Y&H,(*:%K<X4 H>QR)9_767U:K!:;&*IT-X
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MI44(%GL[N01N<S[XF=\2J),F:#/Z] AC9!G3PB$ 1GN; 27$J\472.57P;$
M0PP3-EXD%0&#T2C0LO,ZEE$P$  T^4FE,%H*"6%6NS(.G1?(V_TPGBTR'^LQ
MBD4KY5WP*^7M:4^BQ22C_LN_8?K__M/@RN9EP]^QQ A<,5N9,M.?P!L(4] 8
M=ZNUJX(>UYB\Z&5^-VBAGB[0S(/%T9"<_7LDN&*?%/_N)ZN;-$Z0$ \>79+H
M:0H<Y'3-P8@DJ_:CI@D;UB& I^?6T2M5EP^MX2FI<WR._D\4A7_R1Q&+FVT
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MU.:FP*&=@INV:PW\VHF/RL-%7\#Z%4 F."AMS4.&A$:I"46"/%J\T2@_:M2
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M&Q'8A\B,REH00V_MA$@DFZ@-<G5^;@2H[5Q<1REDIO.MW%L_=H,(L0]^!2&
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MFFB+F,.6M4 BA*JSZP.:79>]VQUAG;--C#+KP_**ZJ]O/T;ADE+("@F@?GE
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M-94H5V;3I_/+JX]7O8<AA-# #GOJD\.PK$K% <I?'2_M5^HW?!H,#B6/DWR
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MD@UZ HILFF,'IJQH"FB.\9 &[4+?_!C+7-.^_Y#:V.$H+I0"B&,\;)$K J9
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M@P*'K^&<?.)%/%O#T1P1"4.7_,F;**9&-=K2M 4JW0E#DYNNJ^2$"+:J"[[
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M$^0_?79D$_H_"";TOYO?O4S\["L3!P]S\HZ6TX_'.MD-=I*/:_)OBWR\DWS
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M/F(=N6Z\5U.;>UF(*5&3V49"?4?RCI<5PIY2 E9/@98I@&R##H&<$651]+T
M-SQ$OG^3?3]%WQP_<+(+2[/% K$X7>*7))/[-$&S'+7#O\SN&U"OF.FB;1>T
MNA=-US51NGJ6D9)IL7NUH?0SN1L4GVCO-!9?FKQF9"<;1+?Z=D/^P0G^XI!O
M0U0?-5^@-=8KR5+DP49N+SVQN8,/S %T,9:6Z/OXLA'T7]/LI9-M\:07U>0H
MDJI.H\O>GIB65%8II*>/;1.S#Q2X8T1W52B-$AUTKNU,6'I.X29(8RPGUT\>
M0BRBQN@7K]. $=."P;[/UKNMP582WNPU\)>9_I)YILW?G"#E7*03ZFX*:EI
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MA[J^CI(D6L\6A/T&E5/:&JIYL65"GK.^-W)=/ML8;<104&]8%=05$M3[(4)
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MU8J\F[?#N8X<Z,T6MSX$+NK#6:+H+<U3L:IN:JN2!+N:M*K?:[W[ =PT\=_
M%R=T,D/)UB^SL;4JEN/8V+W)W7H31%O ,-BT)O9J5(#/OI\T,O1LYU'JBI\R
M]8I*/IX9 +WCN9W=";#'BNP,H[0_WQ8^9Q7N9Q>&^)JM&3AE\=AY5E.4V'P(
M$>LIB4W.DA6 =_]*T7)2^FE3"HXL(5,@V X4-".E11+&>L1Y1.D)(&ZR&W;X
MU36N '%*3-YM#J ?U4&DC:YMF.I6,,:ZXU^<'SCK"R\#LP5WZC0(@H8S;<2M
M!%NWTNE[X\# 6V&PJ[F#W$NU#5U,P48/_I6*9"P^>=B5,*?.)>$:N(UN5TOZ
MI@!6&4(\1ZP+V6CRSS9D>7Y.')@,"KC(^B^ WUBX7!&V@M1'"-HVDFEK93]G
MD W!$D<6.UA_Z2P7]^<+EB5\/2V$+4)9QT)IZ]ZU!]A( B7G0P6@;BE8?.%7
M<)K.8*:&3M9AR:]4=73>[UL7QUF/=4BH[?7A09C-0>U_1@'==K+1="DYV__<
MA<.";3[K\='E_]_>U?:V;0/AOY(_,*Q-VVT%A@&NDVP9W-IPO!7[R,ATK$VA
M,KT$R[\?*26*9%'D42*E,]U/31.2XCWW\.6.Y)W+>5??_@G2=A@VEEXW#Z(M
M++I?(VR807P_:;T&%C]Q[#^^.Q5_9&]XIH]E!"-*.Z6/=KX'T*A'JUA(-DSM
M:OK8@L69^]!UT%$H )6CRB+7JC:_,0T*BH.3%2P,JTPOBPRKVOS&,"@H#LYT
ML3!,[LFST.(W=L$@<>#>P\*MTD*R2*VRP2:,PN@Y/UEF*1!Q$+$/"[%&WN:?
M-L5TL#CRDF'A6CG"BOR\E5/&^I36;/X;^WK@8\GK96>Z<QQ.DJ7TBFNHY3_:
M<%!3K@_A7OH:9OOJH5/W\]P^K6'AY[B>-A>@6=K\2?QO;N)1SN/[^S K!F:)
ML+A^35D04K, E+SK;P\#4-;:+A)D!_76G0>;[%@T% )W^*M!-6RL9W7.7[-=
MG-R78^XVSC-%)V31&0>WAV5&,%!7M3!9E]O/1U2?29:+Q5 93*1>J(G-^;0!
MB*TK6;8N:*7WDQFSN[NDO)>Q">_I)SYWZX*"=-; PAD#G<J(8":?GZSX$F<+
MCD"RV1.V9/0O2A(-*SIKX&.%F8*E%P",A)TZJ)E#GARBP*?@.C8;WH'B][HY
MQ; ='SEE P(_(UA),#@ YRI\-*,9M"6OB38(A G#48Q!-6-&G1)Q#/@QU#EB
M,5Q)3RMBT1$TQTJ;6&CBVLQR!]:$2Q[ ZZ2X%2DIY@,;U-HZ8 04@ZEWT)V:
MKO(ZS\E#F/%_7@4J3D2*V3).%I2D+3]^GR90,02JO9;2AXN,/ _Z6J@A>A&T
MC'#"!>)[K##@PVE.6$"CJ%"4C!0&U7T@Q%!Q/0[.H!PKG9M29:TC9\P0*>W:
M+.U9P\VQW25)&%]>1::\XL#2[*SN;?NL[J7!LP>:G*5%4K@CS@9W"$_'GJN[
M&):Q_HFD80"4!EBK.0K>\5'P89*QKI.J.;#-19IZ?^B0%:LDWH79(D[3698E
MX6V>"7-K$R^3;<A(\E3>N?DMCC@"Z7*W*G1P683:U7+'0MM8&#:$/3(.NH)F
M^JB).+GJ@J/XN.F*5989/-8<B_**WD48Y1G=&B_$FGI8R&BV%/<1RL]#J(,;
ML%62N]GV[UQ<<I7_74>:0:UBH=0PNLAH9Q\6K]==*1QFG,/')?L< #/M]!C4
MV#2+/</+T(79G?4:I\HD,T \]ED>+ (@-BGJG"J?3"%Q%;IZ'*?FC!L>6R%Q
M^$AO:"!N;1H_2WC[YAS@ZOSNK/ZML[3ZV DX02$5\$PC]?/GZDF9>):SBCD#
MLI!$5WG&_W[QK,O+W8X&V9<XNV9!E&]%J+LYB8*\/#H2>=ZDNU/9FXJINM$<
MV>\17!LRM1<G1\O/"]D;_M5TN:M/735\E<\Z]%7QL0X!CV3T[@FEGY3L0$'W
M>D15"Q\1>VI<1AYSR?WD33'NEH4L.K*TB^)CB+E:9>0 2NKQ06<M1;S HI9@
MOI,>W55\I8FAQ!Y[&>8QX^9U%A915J&+CZJ2KY0QEGGJ'%@^V)0+HTR[XW0%
M'\&1[O*1J,;/<U1)6HW-GF2SI@OPFI77@%<E+<V2E4#:.^'!H&:=;$#8Q-CU
MS7TW[NJKD!$6< W4C3^V78?I/Y\)(V4L(C-O]7G[8F[UE;/P]3-%.)V$?^CL
MOOK2,;NJZSS_(N(ST"(^F&#X<B< 36=<6DY8$:%)BKO<MVVQ72QSY6"1X*[M
M_LTW1_D'/LI_G&0FM<ZK[DV!9;#\=/,\>\Y*: #^Z:H@%D*-HGN%EUD-B/^D
MT=CR[:+XB /2I(X""N'\),$\YSUGP5.QN](X=%I%<9- T4>I[P8FGL=>X3GO
M?)A!F'!0T"\>0(3SV-F["/_-N9V90:8$25FON "5SV,W[C7CO:)IMB89!3!"
M7MPK4AB(Z'%&VK6("JVT-:H2^+0_LI&A1L)/WW,AL_90N58('TO4:NM4].D9
M$9OX@0\;(;O.CCPHB%3GIBL"2"R?#8>(I*E83JNI<L;_K[DJJ:J$CQ<CKQC&
MX/@9(O) >LWL(BW=1.L'!%0RUJV,('!9)UQRNB)VB2<[R]T?*87H%U(%GY+A
MW7S5;F])IW\NV:'I1<SN1)89L)Z5%3S2LKF<4WN<.C1<Q! L7:?9F@8T?!3K
MG$+#R@H>:=A<3H^=2)N$;*F.'KKB?I"CEY13^Y$Z!O_-/DXRH_E=7<,/#?<5
MU$$:4BN!=TFZ7[+?"!.Y!<5_1#"C1Q)U7@$'UO)(V3V%M90/%&>4B[:5LPC)
M;1@5S[\-'0,'-?$Q9W+O  2A";,$C.$BJ$$ ]1.TJN!C5C]5*ST&,*GQN0U>
M;*8B5+E.VX :^)1MJ*(.F]) VJE]TAV:+G;&? 8M;*@5>=*8E(KBONG85%2D
M7H-9$"0YW3ZG!U:H5EJP*>F/[XKTPT>L5+B04[L(='8@?&K65/%-Q7W$=9?R
M&L&V;?".>6'TZG/8)_"Q<62#PS&4ECP?%O>:AT=S;%O?=BLR38$J>L@GM8(/
M9L/^($V]81WOK!MZRHV%2P,5"SCC=DF((W!J&+DS3H$5.G'Q92NLNE[.J)!E
MI%$2BU8G7S?TJ$QM^#J<''XE(2M"U-)TR2[_"_;BXN%%N.-B41:(7VX2PM(R
M,L&:!O$="U,1L*#,4K%,1-W.V<1*ZUB(:LH:V7SC#A"TUW96- F$AN[XJ%YS
M@Y7WZC9Z6G$Y1&2CFXP+?I?MJ8ATL4R^4O)/^2,O^\#-7/[CRUNZV9T +RN\
M56L:T4?"LN>_M5>T,3_=U,=/7!\?CXR@DZ-E=WFUGA;TF@6)\+5<T/+?E_$H
M1N.:IGF4/:]*(Q,<0[\\83]:*%WGOG0ZO;^@NDQ><:T_>>LQ;6N;](20+E"P
M>VJ/:9KM1327W_.$A:-#9-=]:YVB+Q'5&N9GF.5%_%^1DT],]B3=M^]N\=]T
MW>.3<=/)ASPAY7C86+I5-U)NEIO\-J7_YKR%RT<AK5E<N_?MN':O#9Z5+7H3
MOXYKL4CZPYE22C;;96)+]KQ?*P,B E)']F\2BP?(7 :#X'3P]IK#[R,V=V0O
MOBC./0<"X^=)Q7,<C7G,"AA!T><:A7T@4;?29:0"HW :C(&%GCLHCH\U8*U"
M**$0$M^]W'D<\=;BI,3[+J%%V-SE[OS-V_>_$\9W:FRU)\D]"2C?[@4D4CT;
MZ=D6?CXH^GFP5;:*@<<7)KA5N\V#TD"@R6,8:-Z5=)3'1QW7"Y )$'X&)Y(@
MH%F&.FO@HX^)>H'T.*KU:$/R/TD0B(L%;':A>#8@*7<4VH0O)6 1_=QJ DU
MU:(!;P(?=5RO(P.Q\3-D41L4S<K250$?GP;J&T8AG)-45R0C$;WA@>_-/X<1
M3;.8T15YZDZ.!JIS#'J'KT"]I/78:#&?DQ=F#UW,VL1'-M>+EFVP)GQ5;^2/
M$>/OIC;^RL SK61?/5KP@4-J'8,<-$;P3)&9Z^?O2T4_G_']\C]02P,$%
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MH&7.U<!DH(2SC!.L2"(*1U\:T-_/8V@G;CS*)('[[]]QPO/'76<AT?O_6"=
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M\TM#&J2MA8U,*6 @A11B9]OC\IU)<#'IF@GRG43OS-/;$R=5SIM%@O7)/C<
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MJ.FS#9N&N:28E CE3L_DT/.X7ZS,^H(73"B)&F9M.<<U)W6J^LWI<>W$\49
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M[G3L4H4^-KMS%$J.?E&AY4[0]Q!46;$%CG5[/#OOSIQ5:DP0NG,GU-<76F"
M\?$#/6&#,:D@9CYC#QH:,J1E-X^.W5[A7B_\>AA#=B@I(7@^[SQLSN4;=BR
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M#)U7@182,#B.5R"Q70.PE@7)VZK'ZT_A2!2K!2 *-J<Z:%L>(&0'' [:3SJ
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M<<9",83.VD5R_[,G]^U:Y=<$?XZRQ!M[:+Y'96>LDL"UF684*^1/CA6B2Z_
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MR5)?7KEZ&##'']BY.U[>MDQ>G/F1GDV9"J(^N(3D :<';,N)O^NL'[&[UE0
MJAV%O2U5!ZYGF:##A[$<7LYPA2T!"OM3M*?4&&HHE=*@8U-+K HQ;4_7S./2
MU]=5<PY"W;.R ^S>F0J91E!\A]OGFCR&8QL'N=Z=6)C[JJO&'=[AQ6:^="<"
MAV3IJD5+?04XO+WNMMOG'1G$J"'<T"P[ED%(DNJH6V[D>59INP7#8Y&^XRMF
MEE-G:>ABP0=_=4@$&S!\1@87 L399G@_AEAI#L\_[B+P].&=4Y@6]1PE-FR<
MUG"-5UTKQ36J XCGKGYNCL]G77;DK],(GC_%9>]=>I%U*)\['EA>(;SOSA8-
MK2(/M$83]-E4&V)'",_QP!?E]9%E^NV9.!NQX9QF*RSE+$$[IP^-BQ/UO02!
M<3>?5BTE-[!,:X16!OB2YM0%7>Q?? +E!TP+='N&Y#I2HS:@IF.T4E:-?*JU
M*G$ .LQ]Z0P ?$=R^,8)7[S.\9FJA=\@E#(*4AY*6U*YXPV[13JYBU6^[;*K
M?0;@)S,@NO0"80G.Y3N]6<FK<(%&=MJ 0YUB?W7Y(97W>6O\O L/=IQ,J=Q#
MN/FHM=+P4K=<G1/>A$G!8"HOM\ITQU%H?;\0Z,UBB<()RZ -SPVR%F2Z_]16
M*[ZI/G2=C?[@F.A.D7=$KA8UHGK^@R<857+T,*@MM7EO0<H3DK$[]2<$&.O=
MA,"#J=BY;_O [>_;S_$3WWCZPX8E<5N.OZ[O<#W"'WGE&EZD5,=BIS8[[:]<
M^? [O+C[$V\2"<^-Q[_,,(=8O1Q/\9/NW$6+R\F [!Y^_,,MGWCFQEIR/F-6
M)2T?5K7Y#)\&E;I5*)M'^KRYY_U/+:E!A#R.K)8YEBEQD=\LY8)F*LJ9^^DJ
M;[!J#>6?="VNK]YMJ1V).(H8+&?_M:*4.XUCN3]1RZ^]U8O[XR]+P+0,U7RM
MV>AE7VOV60N_G[_\Z9H AJU;(0#<F*MZ]&R.EE&5*X! #'/^;'B$ MN;/J4+
M=[TW%T=E9V'=XXIEB@DZ-H'UI &_L\OYUZMCXY?7;WLQ?>S(A6)[G->A!\ZD
MV.M3#6W<JC07-!BD8<1H]+*7Q^B8"RIM'ETR604U\B6/7U$I4JD>L1/C#Z,R
MM@X;5'KL&,U;%=-B_2Y>]9B:URJV/H7*-]@,)2H?-1#C,EB,<STL)?109C!3
MM6ZU7EN EP[B1,"]\4#:7M>%N5Q:\,4Z'SA4Z&MF+F<&[?0QQ[RYYS.N,+J>
M:ZWTE<L;)10%B_&@LRRY=3'U$FN;R"/Z\Q,/C!%7LG/4JCBV6AJH9F4!:YH^
M"(_+]0T<O?' =>2DZVOGVQXVFK/9=$)3_JQ5D-"T5:@RQ&'9[MSWF: G,FU=
M>UX:9NNB0<WM0;5D%ZM+(OU2O"<:F+?BC <VEXVAV,T-6W-JF"$:Z&PP:)>Y
M8RI]FU-O/)3?%B^Y#)!11@S&>6W>K:44=2#:$G(DIGJ\ZS/:]8#!Z4!/37M1
M6RP>I)=B(V2#V>J86J,;/L,7G3<YGJJ-51-82S:+%C-SJUQJ9VM';'-\P^O/
M^ZTN_T3BMWQ' .[#1P7PXCIEB.S6OW]'__KA>J$>91X&OT06JN@I?S 4_=]_
MV;P8'TZ#Z$#R_J1_I7-/7SFJK#Q^9ST,.D6/T=>;5O_U<Z]51U9-Q+/L/SCV
M*VM[?^T\([K4WEXH16D&(O&&JH=__M-7#>#^:(/%CYYE\.9__N?AF^C_W2@Y
MD?[SU_IJ5UV!/Q@6M:E'(D,4L'XO[!=6^.OAL7]0V_L1_Y/:_!$_D7_VQ(<V
MUC_]4!P@_?/SO_HT&5WFVKSY_,KX[S^FY1B\_O#\Q<,#-U_]_+?/3W7PPY)^
MQ#61ASPB;B62-1_]8Q^0N: #WODSM3SEKWWQ'Y+KYX5U2%9;M4[7,T[6UVR_
MBM46?XX30(375=G\(T0= \[#-ZH9YZ"QE/^:6DX$J\<V?L4"=RU=%7_\%[K^
MS_:*N,G4@9^?-!;U]'_6XOI\=]%#_7V[,\_>Y0 2XK8SC]<]=AJ/O@I45WTX
M-_>/HHI1BU$+__U?>1Q-_?6(!CL&8<Q_3A!S: : %%?(YE-<.AME#CPOH5P>
MRZ*I7 HM\%/QYP-^X! &VZ[UJ=(/ID_T*08B)3$4R?9J_1K%_"#:I1_4B*P2
M[0KU@Z1;K1K#U.@V1"\[Y%TE8I=GF?_SH_2+_/4#1S/I D0O^/?TV6ML[-S4
MTL7HQS+=:_WW?T4 C0 ]_??OR*68EKD.N%7AQZ98U(L-Z0?'5'Z8?%P(BT_[
M+5G"NB 3EYI_KAG3YAV':SC-='^J43I%NY4&-ULZ>F71?>.U<10IKU_X][,W
M_O?B8K^J7;EZ1];N-?/H7?]/O"/L#]H$_W?7S.7S ).F.8'+Y:9I+BWR.2Z?
M%7$.GQ:$E"BD<IDLOS%S#W?T!2YO%=,B5VY)&EX<9@,MU[9[C46,I,V5WMK;
M;KJ[<2Y"//?)=L&?[1^[/8N#CTVG8F<K/#CIYX$.NN/\'L(<]$7(XCG;IVY%
M]*!/3]Q^OQY\%WA]0[G(Y6V:0']A4<RT X/-L[:0V D-=MJVHO8DW5IL-;_]
MC"P<WOXS=0"O(8M( &\&8X^_\]/(^?H>^"OVQB][>(F@#,_OHR;_%),=I@)V
M.NX?(JO-OSWQ)&6D?N'X71F0**.0_94IW+5Q#6W\]IS8B)W%8'VYX_RXJSR7
MF?@2$3R/NJ0X _7^^:E&M[A B$(>2Y_RNFYY4VOY\T)!60_(FY.J+)/Q>&]=
M;OFY==\-J=!KLS75I>BA,D2RE?0H/Y3CIQ["]%9J#) M\(.M_6!"(XK;_K/6
MW/]G[\V;VT:2].'_]U,@>F,W['@I-N_#WIT(2J)L=EM'Z[#;L_$+1A$LDK!
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MTGCV+UHL;I*=A*@],94%R_7'/GUY),*A^&Y]</T!$,DA[(*,K' ^A>M:M#I
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M(087II_-G!D6500%R_?&/EU,K#X$MQKG;L-7M*@P@KGB<^FT08T*Z<KZ)"N
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M?*!,T$7KMCG#^P8B1.O6HS&GRT6,>'B^2V \Q"J-B34*JFF4=##6$T"UYTJ
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M:]65(Z]UDUG*&4O3-O%3Z8;R&A.^UB$0=R4+\#O.P_%P$$*&W@?HF4W+!$U
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ML8(>)]"XAA2NEB'J2CGUY=1W3^HC!0O42^DFJJJR1L.,0P8KU! >PL .8N'
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MC@0_N8)3+!./P2RRC)8:9A![3#>1DS7@GJ#NQ/3,#95$DK"71OW9^94<]Z;
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MJ(?PH\,_=QH5//(]&5Q)$?]^* /[DE?UX?P$B 1SX;V4"DZ "!J5$I>DP=G
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MW=&U=$*9<Z6T&JZL@A/ EH+4_Y15H?2@G.3"P\?ZEFU#-D USP;(LP%>=S;
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M7A=:L)&D$ISBNJO.8!WMX8L@B#U18P%*RL6%4<[V$18YB_3($^9S$<E<0C0
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MS+[ER>UI3;!YZ36.0'#(8;V3<&2?+[[+L&"":7>ZV]'N-SV'&2&/ZT.KNF<
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MVYT&OS C;["@QH).98(I]1;Q-PL&,^+KSH!KPM;/*@^OVQNDONH=M1$X\))
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M!RZ5S2X3F=+)5-(*!C/2 ?G EJZ* A?H3%3NFK!Q0?5APTPG9AL;P%_5HK%
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MS286-JX0A?*,.I(A8]ZTC9[4^L21#;<]\8'%EYI]\>6QR0!HSC?[&&M>JUV
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MP7)0P2&4-Z=C[EEX?-?!#95O.:/Y]RT#B='C+(RH'"8O>V+*PE"MW!GZB7<
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MF(,2I)8\(LA6LS\LJX(MQ=@K.324):$G8$>;Y[JNN,&2L):* V"6!RHPH9>
M:TO-2H&O&R@=C]_4X6E[; Y/EO"(W@P\*AS=YN"G"!R5"\B+/EZ'QVQ^K>0>
M5)F^W=1D\8?W)>K[:]M6N1,C-X4?99AI\VX!1X,(4$[K&_I-@5M*Q]"13_-1
M"TJ4,U#UO*;R:]PU21[G+WY#[2V3/J0@R9555!3"6V\"EN,FJJ=K0" Y%VRT
MHRHB^H>ZI8\02?_(Y1OJ__=#07U:,?FN)+KW=F(B4Y,7SS6^,TRWD-B@(>7Y
MY#("<1XL"+/&8T1B,DJR4<2]KXERZ1*GP^ !M%)B03)1EDP@,UC7$N@']4 (
M9B27(\2_0J1!P)^Y@5#6YPZ(.WRTUJ^C9Y979D=;*YIT DTVPLR9A'<!+P.(
MX*$_'X4RD"*-**VXA,3Q>1&?W#  JLH32=>:TU_/[7"4J^<Q /2/X_Q *6V>
M]=H)]3E)\4K;H+Y X))GJ;1&DYK:-Q]?SXPQ\G$8'"RY,_LB@$VQ$NO_M4&0
M$7./.>)U:-EC"0.&[Q9C-;+Y4#K+81/;P:6I^QRJ8(]/5;!3%>SW6@6+;2M8
M<,D2K,;-"D 29*HLPT]HXY\]#QA.#F CZ!B'FD5(.D^N2#3^BO:+44P'%+XE
M/Q9PLC_37VEG:)H_:0042R)_P$D%]1V#]@X>)^#Q:<!CPI&4!N,0C*)>&7(0
M;]PD>O;KH'&KFD:5* OE;O]&%_,33,>\-H,[*U:/+KQR-MREA(F@)VDS-6&+
M71&;VO^YXOPPU"442JRH.+F"@<()#V7.A31?4_^%UT@H!^\0R]BSBL@*:;[K
M4)$^D*'-N]]::@56CXITF< -(-ZGW+)'_!TC^Q<_MOY[P.LR8&]!F\0 0@85
M)R^A:ENWR8=+S6@J5_Z,*N M<\J5O#2&SJ "[LEB?N]$<]IV3:.3+LV@8)8T
M.&&!OJ@?Z]R?M-&X$S@_D-<F* H_@XV[:J&G&9#(K3]'9'BI*9J.FJ 0C8N"
MJ6Y;K.Y-@W"LYH:S+2D:S(+; X[CY^@_DGT3>4+65\8A%%5[#C0&$@\MN61+
M^T\1(B+)(Z0N&O&K5H#M[Y@[UK%\' ]9=KBF.R9R#D(7,*EF43<SU<K-)HC6
M01[IHI.=[L^,.%=AU;DD22F2HS(*(0:=F0LUQ4!5.C+/37AJ"?2Q@ZU5/7G6
M 9MM)]S5.V2\) F*0#ZSV1L4 &I8^,<$&;ALV!F+CMWV I;$B[JJ(&ZO!_LZ
M&!EO05J$4EWERC%1HK*QL+M P;'_Z8[333&JQP"*8-<)^;@L/"E)$;XJ7CFI
M!U(:%LP<RI@-OX![_1DSH$N;AKLK&JK,%<)^6_3+=D==1-(T &Y,YFS&=$"#
M_0/;-JBLMQ-3+^-?F.L=-/U=_GF@H8OXESN;YE'X,<OTFNX@THVK!Z;X8@L
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M*Y=ML'1^H%UO)!M-PA %3/PUC-A-!.;?\7S*HTF$8;TD)(S'Z5-554#E0&8
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M4 'E+BRM^CM_:/S.D2>A6@:>\C=K^)_@8ZL'<J<GA;?,CN1]V8GO#.8O$7N
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MV@S8+EM*YV@LB7BY]=M2MK7F+'@,J2%,6@XU4:JF  ND@4@8*_G^VQ0YE\,
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MR5M<QHS'F/J)QP;@;,BH*(TNY\\ASO@Y_M_B?F7J)T)L"2Q2Q:X(\LBYB*/
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MO/GN:O(%1W%E_(FL>0^&UC>5GEK)1.$6"Q)KT)+ >CX.Y=0QG1RW&>4?@E&
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M4'D>G.4D;*:8X0RB)Z$U,T7@5;OTSD5@Q?%S(!+A@>R":-&&81-XK2FZ,ID
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M,2PMUC59\OL&V<*#VE?N_4)2U%]A75_6G!.FO"DF# 3(<1C-W1 7?[B;OPV
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M2\I-3.*D$0(39&S+BKU*U@D!1,/8XX)(4Z^*?X,DL0Y3>/KH<;,=)Y<=Q=+
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M_)':@\^"^#*P2<"E[ORFI&I1V300XUV6?<U -V#[1:+H]N "(7J@RO%]X"]
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M70=Y9J\P(@ !>J/;I%VB[JO9;$$2@_)RP36BJ%4("!U/4R;/+"(56^2>HXW
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M;E<29]Z'NKNA_J,U9[DEU7+'X) ;57P_BHKD.I9!G3,6S**HP$F>,^]=[!6
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M6I^6K(&\_6(=VO>!!UPE-YD6J\(KB&UI1OEZ1.X'(PO)&E<RMKDH/B6#UJ?
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MN8)Y;;FI7OT98G$DS/G2"_)&CP31UU9UNOE B9V'#[8$\GWH.<EK:HP2,4/
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M=G9R]$([.=V73XR#SAI^&F<':"G"JLAW.6 [EH "J:/TU-G8XA&=3O,REP8
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M?V+=\/#Q9X8BI2<P4- (405YQFCWT/IVP'H?(35P*I'B29Y7>B=M01P9Z19
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M*BHT"! UQ7\-YHNU*&. 8)DHUX+2A BW6-V'/\1;I/2:(VE.MWFG@1#&^4P
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MCREHB'XOR=!N4ONV>!/NV82I:$+_3)E-89F@GAF$EDYY#['K'<I\"*-&5]4
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MLW("E0(T>ON?$N_IK)V B\CX8W=(/NOXYW> "3"^EQZ.WX/&.V#HT-O/K(Z
M0)"_$L->I1D*T;9-EK[TV\5)L+]C!BAX'?S? &Q]:2&WL#VT06M-#VU;1TM:
M9/M'G0K1W6:D"MX90*_#K#=$-0Z*F^!?6GXO.,LT#2G$CJ\%$DQORN2)#0%3
M-3"PD8#@"^[XT(BC6R;KXK,HCZ_*>72?#R]/(BU5ZKMWR#K+:HM'2DM!GWQ!
M+UIWZ/G6N)_@7"0AP&&.\<GO)K2#%MWL+JU@G?_7]/WHF2DD+=$G_#>/&&]M
ML.T^-EMP]AZXMVV>S#ZQ#8W,L)B$Q4W,O5<XF_G)T,OL7GX4SD2"R^3+=-B\
MO!F[!6$@;4H0![F1CN7&$&WQ_(D(69^H_IF6-#,I+K?3M0F?SKT)W@W9<'BA
M**4_FO7'[1G\7IIO@&?%*:N[#$B3_Y15[XV[',B*TYI">V##F[[BKU^ RGY(
MZ_,F2OV\,*>HD*VGSUS%3A3=*LM;H2W['0Z&5^69_>LQ0:O_76[=(T/NTNQ&
MC]#>F[9%0Y.&6<=*((!6?(';5+@ BVH3BI^ JQ!(>-:(97$ 1;(,I8ZSP:2O
M%?.$='4VG3(2G7;.59Z%8\AUW43K:\?FI9O6J3<2#"%B5H-0JR>\KU/I$+4M
M!?4TDK51-A7C.FV\0 %Y;566-4F<BB#SQFP&(+-"GD,+*5Q:OGAOM_@:RS=Q
M4:'P0.G6S_-K <L=,_B\IOF-/%XU)>-8+GC=H>'5 RQ*IF_=&OAUU1ZTG0^-
M"T^"B5"^PTX1_& A#V$RIC*G$Y!78!+/T SL$L]3\@Y'&H?A%KBR+YW'=U<_
M16\I?3OJ9N'50],2%((AI'G7!PS%K&S%D,Y*7@->&0;C*JEZAMEZE)U"7!F9
M4CP:K,P[*&BS6+4U19_!7(N^CW[?L1S=(Z[D<*NB=Q&[)F37WC5=E3;X)*)
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M9Q0*[(K"KNNN@P2M?BEV)ZTW&[3$LRQF$S#+( -/L=PHD>KZ5%XXQ.=C2+;
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M/WL-7KGC?00;<1<TC+!3LN)6*=;1??RL*L[*&=E/SOH[6F0M^UDN8CG@ZO)
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M$7?L%M[Q@TFH$6)X8?$RQ4930 @/;&,&8RF*U9R),]X/CD0A5Y&;)IJEG<=
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MI#A];+<=G"^M8*%"7$;3*Z^=$"*:<'1#0DCND[F@"!_IA\Y#J A["("9>'#
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M[G%86C,<FM>%*><L'"=^*F?HZ8>3%\>7PVZ4HB.I4EB0MI_!GL(+4TX:0CI
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M2(NFS+GWP2I%>1,L=0P+KRT,.1H094@%(*=^4<[R<$A#<Q.E%O?*\>A@9^>
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M/PXZ'TN=J5Y#:N.F?OA&?KI8[%LJ%N_"VRQO: K9QEM;8V3+0*Y+IUH'LO9
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MW3;%BJ=;.O<BH?L'1S3Y.;EBN0W8SR_>?N@';P>'.T-K>CK<P&TXH7@_<'+
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M@OR<2X2R'7O'&ELDT,%1609X_\9^C"- @234D-HA2BY>1V"/9VA:@I0W3#;
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M<*K/:"U94MBJMUG=4GMWN]^" X:X%H,NVN?4R;O*^) EK[2=((WXK,U]HC_
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MC[..<D.U^=(_V#NLL+:B?"?P"1FF/$A-PLP(S7\L:Z0O6R,[_UTWRMGM5[1
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M>Y+0E(B:N<UD6BS59E+7Y83+49EDI. "J)'YP=#265OZGJW[B!.O+-*!LV?
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M=ZN-/!V>!S/I7+%44OJ)@:!<J#H,_:,D^92AAR5#""1ECG. ^@T1N*3B.(/
M !J;AKJGQ;%DL["?%"9?<K[1AW]!?*C#^H<;"?S#\M+^N1.<APQFZB*,UR6+
M?<+?Z+Z8<Y,PYS?9(@#_=>>>,$*^2[93>&9#<DK.MGL5]"&::HBD)X 1' OI
MIW322NT AXZ[+Q4W7-,<WPM:=V_XT[<N<FX/5?C@R;)TJTS5!!&FW*2$1S J
M=1C((M"B2T118"OF$]4>Q79N<T2.:UX)\V5E[L!3]%+616+KX'ZWZ5\LLH:%
MKV=+#O'C OP48(_]#=AC _;XJX(]*K"2TCO%]W,-(.'.,/;$T )33>4PUOY8
MVXE6ZSM,_M]@)WE))'Y,TP7A/S 3"*8K)G^J:S#G_BT #:[Z8[  UN?)OT39
M.=!&F) .2LM$_<?"XD\'":R7M OV@'L8<3+E-MO:"?A#R9"%% TQ[$W/>E 1
M%F#8H,WWA@$CK[)<J@Q(1:82<^!Y0 @S92T1)X?38X-<C-%(ZH\Z*]IJ2R8&
MJ]F2W)T&F*+D8]N#R.W=\&@ZOZ4<$;XY)>.^0RUS<.0 .B:M1K,U)9PTE>K(
M$9]I\D0=-1^!1"ADE;C8G!0[P*-G,_>I?J#B/>FT".S>EEN"]N#+.S4)P_"&
MV/_=@2JL!/%H!6=94HFI#$$2AG/L-0T+O"@S.CB3?%EG722W,XGH#!P1F 4^
M:UI.VCEGP'&X-=RHG=Q%5*XQ A!>MM 0 !E\,-[L%DM2UA<((8Y9SZ!:D]SR
MAX%BG[A;NM KR(L#L#ABUR9PN(Y$'\4,(VNH))_0O_-2:CO);\#"3?Q_B4E(
MN4W WX*&%SG>JTUT*0GXI_!D^P(*D]T?+\/25>L^6,_-5\QTNM^Q7W<.AK5F
MS,'F!D\1 Q>O0#IC"E,P@OFLK.<I%N:?PHBV7IV?G6X[5%_:8S"PR'HW#JJK
M:=*%P5&/4ZSE0\YCC(<0",Z43*$3YPN6[*-8"^:>)'83S]\$7O_C?PNF'4_8
M@4):I^F7A%?7=H_9G&JJ\0\^?J= ]M>7%KJZ2?EO1.\>T:,:+LTP^FI/+-7&
M>%I@>J)NNVDQ;.K#A%HM+D!/C%J/X>P!@R(EO#+J?]&8G5NUD)4*.L#_W@CJ
M1E!7""K'8#/NDT9>)4A5"9:-PV2BX*9@HDQJ%\5,HRU."VP_R22PS[D,]@BC
M<8FNPA:>S=O"W41R*#X7/)D%5DR:C2+=R.=]BE0*QQ(IJW5ET\P0 5Z6J8)=
MH0G1:-9B1%MBZ@+=IL*W9W^3=J:<#!89ES4%$Y0 2'U<L10P=#!!!\&7O6#B
M-Z!QV(C[1MQ78E#3$=(T&-M!,JPL2Y3TQ7P/A?99KT[3Z?9&I#8B]86F*(C;
M1GHVTG./]("L8)Q[[_AYC8=;NF@2PW"QD9^-_*R6'T[[4EWJLA.,@8&@%KJ$
M(^]4 \87/LFR=7EZL?UYFJ&FSS["Q:!3QDK4-1<NAJ7(5!F\L<DV(OP%*E"<
M7->![5:P+G24<FTSHW26EE'#1Z[AYSK)G?ZD6+>)9J^S(&YPQ-]1#B\4)(@$
MTW4&[THJ5YF=?LHHANUS+%>Q :UZNE +_L&(."Q<!;=3WKDL].Y.A1NAHJ*W
M)2ZV0"DMD0 \YR:YY=XCF(=)<T;X,L T88"I"R:]?$,T= SHC#ZDDYNBS,OK
M971*NIK>2;2[Q+4G1'DR3H9\249?<NL@>)BWWKJ\2>HTVM_6B&D'P6308?R%
MQ&>%+!$#P8(&D0>-9'V14WA1+AQC!?-F,JQ8*NXQ=3?V; +9?-Q6M4=8H=64
M,TFHG%,3 2PRVT$9WO/#([P_B(=Q0^S.A-!TK&0V@^]!GS'8 4*;R_HUCD[=
MI$TC9R#@;+Y [)-B^3X0I'-I0:,6PFPE -X+=]8IHPR7 :8\5LA@*G7A5E9T
MO69$BH&CLS1J'=+2)Z7C^^..9TA2QH!?_H1Q4C-Q<=U6,"<$5Q14 0-&,0'-
MV$Z0<,+ 5Q$";>])$&.NE"GMF'JAQC0!'S"U0T/"6[L<%'*6^;5)""^)QA*1
MXRE-Y3 X]YIHVZ8=D.Y.]%MYA[#$&,&)!9(<)P-!-67@XVGM?":/VP]+75;\
M3DPQ8PWN!&?8(6SZ+RA*I9_#$(I6%A138=+'MPXP*O[5$8D'&T3B!I'X8R,2
M'WL0>>7E&K>%IL&C53_6$J#=+H2BJ%]<;X )'&+(T;,378$K2]J%"%C\/43U
M#KLY(\9J>/ *]<H$_TNAGL*_FUX>A-;CDQ6> %HL'6&!!Q*]"Q6/$&P2+[?C
M_Y2O4M(E+BR88IU$U!;S%+^%2V"*-)UZ'G/WN)U5@TV$T=M1%L['F?S4R:LH
M6+26Z;')%'R?6&_DQH^)$Y0-LZE@AI J$4\,/%9T4NE@0'\>ZR#TL"!:1AYA
MZETMHA$)98*')81<:) 9/E1G'=JC,_RB'6J,0DFB3PE&.&(Y<9C.IDI'%&F
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M:Q&Z'M26@POY>LI2+7O,'VOV6+ XC7@B3!%?:,F+Q#XM_YI>*4X[.@E-L#]
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MI@NZF5SO*:6X!-D9>R<C(/HAHI@F<^6["VT=(=D<0^+F.&4<X89A.G1)I].
ML ,<80P9=@IN7+V&,_!<+&$ZU09TMB[9X:P4W2)9K[@WX<189:C2;13+T=<1
M-HEI1F1!8H7K._^^9Z]@^*777,B3'@;%%1X=3!_FKZX"ZH=I0*E,-8 A:K];
MTQ'6Q2@FV,+:UB9"9PTC:6'GOCNPO<GO-&2<SL8R-Z@YY%%7CGP$X5BN[>"@
M1\*V=6>!G. J:J5F&GULG:OPOH'=S+NJ+3 RUQ+OOT6,]CG4-7/F'DP+RIAN
M@C)95+<7.##"PAT3@E =>0:U=$)0&D4WU6VCN26<O$/WNFWA$\P<_&9K/YN+
M@*%]S[O'0,P-TV/H8(E6JRK? @YW"1AWF=Q+=CA]'AGQR'-BJ2%I685GQY;9
MR+:C?&@W>T>%?#<9J#N. (9RU2O[9. U0QNI?L74"F%12WB[8U@ M9!JZPP!
M<:(N*])EK"@R)#Y06A/T<DP>7^?F[V<<GLV8LH$FPB_^NNS5=TPS%C08D-['
M8:XL:'CDKY[U!#K()I@%E8TF#7[$+='IX7.6DOC@,Z<(.9A,VLHD1GT<#($5
M6C:!*GDG>LUMDY4T1*H4/1B P5[NT0)%=0>0#W"<OJ25Q#W>9,C BUNJ1G=1
M@JW"X$<L7H,4]+(]4\Z,SRP'DT_[KY@BC1PKWQ)^0JUQ_N#L=$<A]SAEP *G
MG0/O.?/D0GWVJ'N FX9;Q#Q:H+>X4,%S0^6LQ[5B9ND#M)DBHGI]N[IW=*'W
M8Q$IS?/K.Q4,64-,("D,;^(UD8N#'E.>+.KT%_V/YW^&KZ!>*/6F-XX,;BD:
MU2A/EF7;_#++/J53Z\6H)\;N15/!_Z;Z"7(96<I/[ ]_2#F0B0=+*SXLJ088
MZW,P49IT!#['!!V5NRI9/#<#$)=.!OI?_WER='SR_'\]::9V7.%%?2_H*S@=
M][E0@8 Y;BU7]]!!R_<8M5SM04AK9G5-KZ5;9</Q29[7SYW;AE/S!!?T"4G
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M,0#5+LP]FR<V[F:;=G3"'U@?8CI9U4(*L[R/P55SDFDO&N=BCQ@'TV[-$SX
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M[8@>*Z#(I*5DCLR7M)36&3M2<"ZCU\Y/@$\C&GU:MZNA6ZOE(E\VQ0NEXTP
M;KP\UV_EV+6N"2 ^$JG;WT#]&=<MH_'D4(OHXQ#95@)&6*\,-">/<E5"J[;8
MX3!<+W3+'']BF&!:;H5I J8]99]0#!"3 ,)N.CL!ORG#2GUQ]14LN9C6K3GB
MEFX4D_V9+Z]OEB5J<X+#X4'$6D_OB>$D%2B2K<T7J$^V7GSPN6O5'H*?&;X0
M0)R5:/H$OK0(=8>UI%9MCFO7<;-O@\FWXSDY?@F/:R+-LQJ, PKFE2;TSMX!
MF- '=OH@9_:I90 ,#]I>E["!-3L2J%1QSC ;W)%8CH"[_"8A*D&M4WS2_V]S
M.:+A ;99;.XI5^#_D_15*76>6() EU -$D]SOH(S*MZ>0:;9Z!AZ6J*A9#+@
M W@E2!2&DH> L>0:CURP%,!+V]M@&ME '!TZSQ1Q#V2+8/U;8/RL&^8O[&(Q
MA:9N@5/$F$7+H<3LK7L65&60D*R4-+? UKEV^;PT T,ZO?!$EJC[OVP@?F&(
M<DQPMCJE8P=3,8J?1U/T ((W.@"QJY:!VP5K7H+F30?!JSI$0P4&V?\5.NQZ
M0QGNX )M:F\4RI^M3YV P=/RW.N/ -0(*M(&>C3,3JR5%A105J:RJ%?M,L^A
MB<);Z\53,;,0[SRH%>IN"7+[M= ])7@C:8N)BEOP"VAV8KJNDC4Q5*#47<KA
M,3XF=.(]#VW//O;3/U2>TR4\G &1)F>9]5S1[L%@%!='U3!= 9M] VK+P?Y@
M^MK1>9'C;8BE;*>4$\$^.P?XFA!5C/T=DFGGV"QA9[\+*GZX&8.^@O U*",?
M[+H\9TZ86KX=VEQB*AZ\_1G9$V@*A@(/9@.9$_H+F0 T:S5)U0F+QEM2N;R=
MOF5QN(M,REHDT=$ T*13[1<#W18N&-6)6:O\JD6!!5!_+JP)-*&2"5\I0Z81
MS!@!9GIVPEX_K-8/%;9!HC./Y1! EE52*1[46UMQ)I_[6J<K,#- EK%0Q-6]
M>:3T)F30;_9AL?.^^<4TK-@?FN!ZA"RI"EI(K +-'8C3D!*2HB)"'Z*A/7AN
MQ94VQO[.,[(&2TB5@BJ:+ HIZ18:0TQ 2S-[X"<[2!$L^V7SPWDRN/H-2\3Z
M,EDCM4;>U;6^[_KR?%F54&E4' ;1>4>M+1FO>)).68]V/:-WA##VKW^# #+A
MD1)"Z#4KR&H6H$?,@0V=.$2<1I,8UO;*9U>\JUS#?TF%5"0X,T*!*CP*5!Q>
M@W4,'*&/B 7.NCU6%#MZ"8[.73M;BZ8!==JMWG].$L^K>CT?,BQA^ 7=- YJ
MKGR5"#="K[0':>-&X9^09=!QT:65,^B^<_0R8:W<7CT^'08X*$P]J<[]QV*V
M-IPC  Y&&WBVD$)0?[Q2L($"T/C_^C!3F:^ORK!VAH.>OK3R0UWL&0^F/(=F
M[$9N]B*Q2P+VAX%PC*/0T34@6&H9UJ-9!8]?0CQ6;P#]$ G,K3Z!V2<P'VL"
M$^A0[4RDLK$M7? ^KT"780&PR]/9^Q]!7N(UNI\#^HZYY5HZ'-.%6G%;%=S'
M57J_"?PF(XG=(#7=%#P1-/N;,XP-:_,-O*&S%#.F7'RH"JA+,\JSL2_@?]%E
M+[X7QT<@CABDDI0 9GV6.NCT'TBF!$B7\*T7]A%=ELP^OG3/@EG78V&>0J(_
M@3\F7@!_%<3,7N[2<R@W,NM)+<&"G^RC2]C-#!T1UC,25#(N107W!JY^:"US
MZ5T4>?3,B@<?(OJ [I@*1'N/JY;S4S$X20D#-E$VJN6+7=,U.:D2UYD88H2R
M_XTNDQ2*:JB'M,BKW)YR*$I-N;,_^K#"I72\0-9;+"I. ]2K. )J, =X5@=>
M[7 *\UVC1SA >Q5@=Z*]-!U);6JTD*"4>_OG@QTIY49 1,"('A-:)68D!*QN
MFERVXR.W=4[;SP6U'=C;W(J7&Y!TE]R8^:>C3Q2PN&"-7<DBKS%M @<@/= <
M]'@3D%F]2WGTR[OC@)C.]V]ECFR;PM?V3]PR)$Q<@H5*>/V Y*NG'HL$BW!
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MG85"Q5]3"E 6;LVZN7"4*N@. "#^Y=5QAZ7^<(RN$MR.'1'O>N5KD<]RV1&
M'K5*94X!2-<!&8HOACQ+HRMEE9F@M2-GU[Q)I?L"/118:::3C0!\'03RB9V.
ME0;Y^2E4G[JU#![U][0E$,V;]],_\/:P;E::_/WG]!]*X!VY?4I 3 3I:MVB
M#6S4GYF"<&3HC8 @,]6_6+->RC0#)X)@@7UB$D3=F73.'CQ9S&8),1$*<\/+
M\P2::JT(V*M\Q'>7/!Q/-,#'6@,"7 X3"QO'V)'_S>P:6>^2AG^MH=M?>W@>
MXGC:L/Z7F1+P1"4 )8/H!!JTZT3& C&;X >]<"%&,.;HID),U/IZCSL@;<ZI
M9I#W?E,<F91]1?O8K'Y5=U@CD(N[@C"Z(SKB,(O>';Z5!';#=$Q+!Y:4GT[3
M,]JKR6(Z@:QY C!<IQ38PS^S\7J*O(S5 HT=K *U[A34J6%MA7T?W1+P8HBW
M6!UOSAQL00@A@4D?>&M2?B[I2DV+,0',:+(S=^- 27Y 2 4?S= \<R@^',/!
M@FU\-1?R*9 5J+9C#',^916/&#-!V"@E,,[L1E!#/UDYC"C]8Z#3;O>)WS[Q
M^Z 2OTU%?RV]OKWGT&&TNB.S'G2#Q"<I]<LH07U6MHO9AO0[6 SN6#0#JQ17
MXA@2F*O?/?W!W8Q6;$M!?#Q;)%B#H.RZ6O!S;@H6>NVZN58HC*12S,;19L6Z
MG>>7=\>E@HAD*Z,6^PH#ST'E_G4#8_*.1A@OJ-WRT5B%KL9[0A0J',CJ<@ZQ
M/];W=JP/*67E#3\?E>8 YGV>[*NC6]^8&%GG.,@1#^WR"=<UI>.VKZ"7"W64
MTV3DX7(XJM[DE2W/[:=CS7&+L5EY35J$ICFZ"R;#](0^[VK?@,)GP31E^!#
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M@;$!-8$8K_8]*MJD4!0DXB2U<D28KN]]%].7 \_HQ*@7($-&/.Y =D*^N0Y
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MP@ $4K-QNMR _S+6I>('&BUF"[+^I \O)]!6TAF":S%*"_M)0DPI@24'":[
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M.>MIG$)Y&MF'"+1&SP0/1QFO$%%PO1.054,/CJ"@9L)Z$U.@FRR"D3"V._/
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M*FB-YA*!UL( >\? F:#"Y-587Y0TLY?%R GI)*WX.3<.\? YX7=WI7:8^XB
MR#YVZ=>PE@%-@P#EB!20( NQRUK'ZZJ3&+81:JMP!:,W82(%T8N@>!Y['FK)
M8*Z\)_H+>1EUS^*U*02,SC0[);\X=8VPT^22MEX0K,A "1*>/L*+#Y7W( #.
M):!Y<7^-0(BA9F=0G#>ZT9R6QK>IY7-O4T%"-H3"PF &&PA8Z OQUQ5DK-HJ
M Y/#H87I8(["X_>F6E,5T,6$\%G.K2[7O/=\804%;E)K0X6T%PSM TL/(0[I
M!21'7:[@)F01K@9G-;!=EG#YX1$$A 1Y"DP_:FP$3WZ>2P)-'=&PDX,H2B1
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MQI1JK=LCW##A:G?&"LNDKAX<1L)-=#,:%03O,M81D[#)8Y2@S1F 2<8.U8\
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M(S.1EQD$%@1(* :^L^.:3QFGI<EELFZ2M#H(R O\CAO3/$=8,=7]@CI:8!<
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MKTZ0@/?,ZI9@#VGO2'?@47*ZHB,:=JW\8LA*$.K+]AEJ]<=XIXZ:4IWC"P)
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MI_88N1O*WW%L()9Y[&\WSAI1Q07<>Z6Q^@FNBQ6WIURV7N_SU5GP%=WP@>M
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M+735:LH(NG*+7R$L>E^"]NFVO8>"U[ J%VS=@@JF* @N/9CAI2L-FYB45ME
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M<;\._(.^@A^M3/P@BF+-Q2G(O'?>['J%M;Y"!+["?+__+K5VEG1/D![RH]>
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MBR&UF9N>=MOS;>"@)T5B3R-$GYP_AF:EU5WI&)>4C[YGE3TUHV11DOU"2P/
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MB1M[=,VMV]BC:V[=QAY=<^LV]NB:JJ4/?73URS)<9_FZ)3// \7D;TZNX?U
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ME-.IBU-00N8EYF?$&UR10U(MG!;$GO\;AR!OI%-)*TQ!#(%GIGGJ$[^6&4E
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M*I*KR-=AH0#>8!D EJ5F0:AFZ5P\ 7TN2.04J3P%W<(8&7SAJTQ.&=7.)5
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M^G)58ONM \#;[5<];0G=>,KI(D*U?0FI3BS1+=VA)V>2^D:=ROE3&A+!H2(
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MFAKT?ZBBC) [8]'X0U?L/(_CD4LA3J@)*35/Q]X@?_9VV]V&2MR!2IRX5(*
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M+4]E$M(2EAJ.283!@6SX/F#3&(-6OM*/H;=9.^?VY)P2&52YIBL?]!=TT4+
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MF-D^UP8+61=HK(3N(E4_ZG^\_A)J6AN 2->O+1L"29Q6=1"ZRSC/?B14$]N
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M= ,C.'<N?L_5+N:'T[,C4XI9&$Y4QDF=;U%AA)4P5!H6*F>E7E37U(5Q_.E
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MEQK22P!@\*<"J+Z(EMHTHA_&]]ET3FOPTJ@I!8&.O") =U.( JNM/YCA'PB
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M\PFBBA_@:-6O-V5M5O#(A-;UW2$2JLLMF;RR.R3%EZUZO8_&/EOQ8;='H!@
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M18!=YH)_.;I"8/P3@S/QGG$FZ)G\MV*0HOR-"A^E)@NQ,R-'82&I>2&N@KM
MX8&1-7C=5UAAQN 6NCQ K]"_\X)DF-],@U%\S/7DW7;7/6CW]Y34C=3#-NQ+
MB804I4OAD TOK^?C5)?.<WGN7!Y/5ZB6$8'#DUJ RE?Y',\K26+!8B54?YSH
M*!,,L*\E"?37YTWG!/Z();IF68U-%H-1'CVP@8:58Y%CS%4;F.]/7#TNPR3N
M&5I/'FB5,V]+C<;[AU$KU63QF":JX-J0V&A.MSES1^;5)XS#2Y]+4_IWFL^Q
M;>O?&E?%PB:T4%H9.KP"#U6">:K,DS((*+,@I":K-8@I7#N"0,,(GU1!C+7G
M8S+F#%:A(22P[D;>5"S<<L!8P"+%38LDH*$=,0/KZLW[RA,TF0+(T6R]N(N2
MB_"[65IJPVG$D92FAGQQ.\7X2%^A.&=3[U1&A:(6=S[R0CA<E^K2#<EOD:2P
M:N!HSDVZP($[>@*2*:/47*LK*>EG'R<$T$"E#?=-'$ ,2!5>P>UZ:B9ZJA8]
MZ3TU.&SX7@;D7\@PV.G2N4D"\*LBKE6GCK*25"O&VDKO8)T>;-SC_5B^2A79
M"4\ECA.:8 !R:1ZD5G^2\R&)_^0:5*-2RT9#6>MB,2%WY[$<7.EP81"T]%,!
M.$="G$%FJ3T,5JOO<5ILFH]:)M-$7%>:-AB97N"W&1!!)F.  U.T YF&V(!!
M<"UUP76\V.I!HQRW16?^\4![\4%6H5UV"F>;>]G&UF%\+ZKGXE2JD_: X+&_
MQ@+>1Z9C!KM]Y,N9?M\1OX^_0U*P_9J0#2\34I2GB3M7-W'R29[Z*OAIK]-J
M=_>1XZ3$<HY\Q[V5*&CB!-?Y/KETH^#?Q:3H3&9D^3= +O0MFE<#;%G4GP(5
M%@?6>'KKO<X>VOSH;T#0%5:1>XNS\GW4;G9W:;)=FNQ9TV1'AR!I4M;5S)?Q
MC#H.-6SA(I]BU&UG&3^R?L8Z9PTV9\8J&XA(/FR-@L^ 7\E\2[3_Q>-5[6T2
MGD!"IC@TRP6-)!;HAP24S TVO5[%8',=Q1CI29WS0VQSP 8A:G;B]K<[3I$"
M-@;MG\<)B^:*L5?J4LSJTX-.<_U[>83/7&D4"5+85Z[^\0._6KKY7&K6*!!M
M5Q!LI5+IB,W(H.*-AGB.YA@3M>/!1U8L'17F^K?FA'*PD8 =B$>BV'8^ZOJ,
M-N=*\#DD8E=,RL,)JL 9:UB53#U:C&Y(1T1<D@W8>(?12,*^E2 AHLM]PM -
M!8DJ7VC<3X:4<C^#5D]U9IW99#3LM"<]KS>:N)WN;-*;MKVI-_![W59_-?<S
M^'AR?O+QGR?'DQ'.WOAZE8#E#,^@Z?Q_>F7___-4KE5YN6Q#(T5N6+^F:VZ&
M:N1-!^/)>-;K3'HSOS693EO3B7+'?L]MJ<Y@T*VYC\-#E/B>]GO,K>M9&./M
M&8]BW]=ATZ&%.V;E%L'RVK=$>F 8:!J[B<^S]S3B]U5Y1"1Q]>]Q%'QRG3?_
M^1^=?N=U%LK4.M'*MVR5HE8<]JA$K<2OI6D"+D^EMS4W36^^4F9X)+F])T<,
M?EYB=U=U.SU_W)JTI[WII(=97K<S]B?C;E_-!JVQ&M0E\@=OCF)?Q;.3["KP
MTLFH/^R.MJ<>W":H-TT'EXH'P(M]ZO[]AX)PR*+>Z ;X(P[(,+K94Z_T28"^
M_'A!\2)G@[5K2%2"JT?S;IK$KN\D%$9EK+J,>]=+'?WP &ISIM!>- .[CV=R
M:)28AAWQHZ$ ]N@*/072B@'JD15!A,A:B!7D^CJBS%-F8PK.YI'&]-&]L4E
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ML<Z3"'U3O/GC?R"<\VSV18EM-9]VAYG&"6T,_S\9,VW[EG6E=O6_3\<66W
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MM6:,6[-[\*CX<](>5]Q7W;!9>TIG4'3)FR>86658Q^ORM=XYP9;KK._;FFA
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MG!C_P@ 45"I/Z;$F\(/NDP.6)L7V4-^4U9 X=4T'@6,H1%@*14PQEPR4(+(
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M@?];4Y5FUZV9B;42;-"ZQE)4[Z\)F>\JDS# WA]18#)EZ;[#=6A<I8"O%8Q
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M\^TS"$$(00C!SP?!C[]WD&8(WGN</CK9R,U!Z," G"?M8(P>QNA33[<[#]+
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MT[N.K>I>,[1.7PI]=#UE7B)]NL$W$+6$,5AY)\<=LZ/0!XT]L"QUQ<@'#'-
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MY0[$W?X>)7F>$_M>"C5.?.&ORRA<)%._8-V^+YOQ][Y2K"C#+[Z+%/LZ,"@
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M=0$%@RW%F(7J"C/2-#V<N;3 <P#<U 44[*J&G>5-NVP,"SFP8@2?)I<;D;J
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M^7G<RV?0UE=(PJ'01M\CSWR7_99/O-B2[9ZJ,V[KJ):G7J %W$:M+N<WW9)
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M<W*]4693TD0<AY9_-IM%9/V7(.N_@'?P3J#T\(S$&UJORQ6:(WIE!+M6B=M
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MS?;] I=6!6NML NIC[$0#]DH$81Z-1$DR?SHW@GHNY+E'?9:AAT84^"'4U_
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M5+ON50*,%(U^D%N;C7R1(UA[R2]];\W8'Q+RT)I!?\E[U)2KK_MTSBS/NGP
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M]Z'L[D%S5JV#WN0.:O/"X=4?C#9UH3-H"'4FS(LE2>RNL^#PBKJ_)K7]Y3V
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M'VZP>;] :+1+Y--6_4]Z :O?4G,7*M7_V^<+%U$-?P9*!RA+<__]A[*JAX\
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M5<V4RC,K2T*I[*FM9'A><,FLBAKZCEFV9FF[L#EFI$VD&DE/6GI[G_J!<V>
M*2:!%1D"]P]OZ1!%Z,A<8!RKQK4*?CA&(E'O#E1123<(6LN*U<F^M:PJT$E
MO:U]__@9<WG_U'7WQX2"1;??.05NLT<(_)ZT\]6*ZM,I!(@6')+\/0EW=V[^
MG8N.^*.;[J8ZY?>5>9C^W-_:DB\WHG)&5S0JW3+1; RKY4QF&1/_6/(5V&25
M&K4R;=GBJ/DD49*:I@4=E%\O^7PE%$*?(N?\+LR+G3\5>W[0:QY2$OIAXQY
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M8P0:=]F'5:/^%@ZPT6NHNP0C7'SW"+;4%0K7$&/0^+#Y@(T\M8/2$:$1>>:
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MH3FOJ6C_W$' 6X[,]]XMW%$*@*WW.HX'I''"R_ UU'=S [ UZKV=#XF83LI
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M8.BUN6BTYQ$CEKH7XG"6FZ]&B[(883*$GLK-(PM!R6S&29B@&@G@2;]-2FG
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MH%?MA]L[F1KIQ4G?[),3]OY(%=*^D36*PI"A-:73&-(]HQ5#[$[_^)EX(8F
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M[(==")*$@D,/\D2"0__FV0(W:5T0A(N_2[@XD")!R/ASVR#XZF#?M(ONU>C
M5SORS%W4SG-?[HA6]WDU*,7IOC MFK."7*?Y"3>L)_;BYE9)#*>Y"_E1DAR/
MZ4A:WA5[5$YN2,V*+HY)^EKI2< FC]:=[J'8Y%KAAM"EUXS&45-&Z,H;<1EM
M1F>[6Q5NG#))+ZOGI,TJ5>I2:B2L[B,C,]EH0B:)_O@9C9QG<@9,\F@]_QZ
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M6*82Y<DHKZ>I_\_>FS:GJFW[P^_OI[#6K?.OLZMB#KVZSGU6%2KVO6+WAD)
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MAUQHHE4B+(FPG!] _1W,7IB.U5E_C#!,P= 8N]CW!*9# V;/0C\J^ZH?]:G
M+%8L_8!^<82L<A7YVI]V#?\N>?T$HO>[PB=Q2Y 6GFZZ2-W3LVJUKPCBEVS<
M>S!='C5 I82-*');'K%UQO.;-7JT+.$T1X03'.\PXD(C0Q+92&3CO2&36>&"
M=E>7$;7<S#N(-3?KG/7J/+FM9)LB[RR^*AS]WE+IT*-:4>47:DVRVI-EJP\Q
M^8@HN8MB_[V<0WBSXG'ADHS;%8\7!Y?67$/,ZEP5D8Q*,;?5&FS:>M6$G$M
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MJNB5BKM'):3)$Z+@$XZ$\!VJ1&]'IF98?@1I1Y)W"/DF(LF^"^Q'4O#OSHS
M,ZY/3V,\>W_;FRM%7EWH%Y9V_8,ET62P9#)8\IL&2_(B1:(X(7 (FI,X@A!F
M')^C<"['SP02$]!Y!C]JU+)YKRUD1IL!$D@-$BGB4[(OGQPL62^,1D.J/S39
M=)U8K-OYM-R%XZ.YHV&598Q 4*6W]!&JTUR;X\"E../D",I"4>@X@F'ED':G
MKVR&5A,9EWQPY=$]>U*A6%?H):]2:G[8ICQ2&(KRJ1&4[)HUU$J'5ME574SW
M.T4.I:GNJ1&4BB2./*;N%=5 [54Z77WB&$784$8]OW(QVO2WQE:Q$,H,QL;"
M)HKHU@=7'KUGNB)S5!O'&BKFI+G5PL7&,P_>$SWN9Y,!8;-RWU=7Z[:28UA:
M:PGP1='C-4TT24/&ZPG"YX8(D<U;J]GTY+#,.<[V9TVTJ;!]LZCT\5S+U:O=
MR$(^O7)D9@<;,V>6D7X^)^,39IM9N=T(\/+96$UW4*C5A6#(*IN.-6NK#=S.
MP"N/]JGCS<STTN_Y:K!"+$JJ%4JB $$TC_:IX^<&#-5$^XS4,_@Y;XG3Y1"N
MZ'B?-H$CCOJLZB"2;\W'""*S" -O>KQ/JM :KXKM#*5B=@.U>&U4QWWZU*A0
MM57=;JUQ,8\$O%0N$EL'8S;=@U&AEZHM>*RL.BPP>!Z@,1M+XPW>->W@H;A
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MM?!<;+RSKT1IM\U+V%G4?<Q1DU\\!CJ;$,5]!\Z(Z1/JUP0W^J=AYDZ?&IZ
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M;P)7[@ .Z#Y5"J_?7WIX57@/U^8-)QQ\"O[LFF$3%^^F^'>B!!>5M2)*H9#
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M?2%<F"._\P/(*:+B6!H?_%:,\$LSN(HC$=EU,6=/^;M?>NGP1H"T0!-KQ\L
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MX;AA^%+1TVN\ 9C6N(/?\B5-"[^]NS5X>]O4M/3^[?:/ND^=["7ZMAX ((M
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MD2N[Q"#3!5>B1XV86J]BS(IBL<BV]9R6U3O&@/!/SIUE*VVREI?2(AO,+)K
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M];E#SX2WSE??<.6L%5]7^50Y1#5-"VXCGZZQ02T_:@^7"P63/SFT?6\I!@M
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MRS\+:V&L)$O(ZN,>NTI[E+[%-R*]D;D<+&;(99 [A+K2HZA;$,4$V")ABFL
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MR$GWS)@2@[I4'?$LQDO:C.0:DX)_85@*<^:0"&4AS&HBK.UUM= 9R:$U"2M
MD&. O>>X%/]Q>< #?_;7@: *T$ZX3*8,S1WRV.NIL1<DY1.YLDLP+UA)R+R*
M 1X+/LA:1\R+8@^L.UA(@/-T'?#LKBHEZA-YVFFRX-=2RC!U$#MKJ36O>> S
M<YX"[/R&<2@J:T640K[?!2@,M0QJ+I<O,?UUQZ+1WGS(+^DWV%\=>+FUUL@7
M&8PV];;N.FO*?*+CL0]Q;X>WAW 5'<D.Q>1YR-#B;>!X48Z]S.?;-N-EQ^5T
M/I?NE,SNKS] ](^+ 5*69$>[=9^B->W)QLTDR4C!YP8IBU?$^Q38=$<ZWF00
MXJ1F0<H%)(%2SAM!"OP![+L+=P?$.I(MB2GS,9OP0+*0&D<9MQ3<NY1IP_]C
M]V=DN.A7>*/?T%%5A/\>)0!?D:[G+$A[[L*TP<W%E!!YOC&2C1TAPO1MYK].
M*F\"/1[NMF)+@FO:3DH!!'A<@FO">J[PQ"*D9$BB_<+N8,\6T-Z0*(X$3"40
M)\>5+.<.R(VK:*F:!_Z($2'IP+^ &_B4SF\4W=-3O&Z"BW9RMS/ WWLHE.G,
MZ]4A,YL@Y9*B9_'FMLA)3T(1Y+VG.C0PXO!1O':8:1@L>#?<X?;\87]I6WKD
MD($9AD@GY;64&:U4'0]ZK#0CN,G4W@K+F@],#<2;/ $& G=7 7>#@O2XRV![
MOR'C\K9"^T EU#[;^&Q/G2_M9IZM9@@S([=5/3VCF^7 S?7G79@MR;P KI*R
M)5D!W R5U$XQ^8J[ 'MK\79D-3[ O-=L.>83U1T7%T:3Z3>,:KO>E'+^^D7+
M(?'"X@[JC9ET8"52G@4LB?&H3&!!Z'-]DOJW\@]D8UWBC= & )]EWPOZV +J
M O,3:I(YL-^&H(#O*8;C*JX'7^ ._,$)@#T1>#=43#PP. M@S=R% E0=H)T;
MP(\??U4DH*_FIJ:9OA1:K/U3X2+@.X+_C+0$W%+WP4@M@%&0;&>_B@?[!IR-
M?RM@$;"7%=X:O%NDY\ CP!>!)05$"K<&&%@=B*L"7,+XVK*":>QE\!FE (_M
M]Q_J&[#N:)<MS[9,1W)^R.:]8.:>OKO.!Y ">U84G]DE60:2#YGGYRW4>S+9
M4&=R!X0ZO*!DVJ4]D6A#;$,2=784VH52CX_H\88L/8^^3*L]#_^PN]RB1ZZQ
MEB<\H@P-S1P[KCD9=C]E,SNF"RL=>.VA]-6)PK!=:018$W I'+ HH/"EF5L%
M0FZ#H,EPCW+BH9K::&;5$YDMQ4H%;M44JOZ(*4"#^8*"CRCJ1@\+Q5@Y*&K_
M;A,:/U*/,*Q8+5N; HMU"A-N;;+UN?%9H_Y [*=GB5&&&':N?I3:TTJUDI_]
M_^R]:9.BRK8__/[_*8R^<6_L':%U$.?>Y]D1J#C/BM,; R%5! $95/ST3V8R
MB$K95=5EE55-Q+UG=RE"DFO(-?[6L 28M)"N9=2%-ADW]^A )UY\H$>ADK:0
M4X[T-=J$*#Z]W'/^S$/\^+/^ SBBNJZWTD#1BW2_.9DQ:QKAVW7O;$[HN:0N
MQWNENMCO@C$]ZVYF[<;^&7/"WF_/&X6&A4]>P0%HG& ;$YS'/^@T^@\\GA05
MTP;^:P\?RT)-CD-?>F2)_H!,(* ^%%D&-@TQT>=P*W7LS@CPL()VGAW#N8C8
M_(<7=O_^%_Z/>[YQ$F U%!Q<701/$NA,<A.XQ/_>*\+G'HIVA \5D '-/17)
MI!OC\X[U4@S!J*KNB^#__7_^]SD5+,4X15*TGV[@TO>BSL-)',-<@M@<ZG Q
MQB[@HW^RTIZU=#=KD'ORL@8_O=AG IL:Q%,B];\1W[_1#EUM+]3$,=\F.B'3
MF 06QD_G9^YGFKTCSH>*CN7BIP8D%M74H;N?W1?3RE#4GV3\*8TL"?BG\V+)
M^%,F=0?J_2)8A\F4.-'JO^PS8;L?D96&],;_#-J%P  ?-@)E)+S2F1'H? 0M
M):SZD%Y#:DA&#5E.+(_]U\<>S_'Y.4V"MAJ*#=)P@FQB*\<.I<YG$[7&[)E=
M:TD74N/B<$>W2"I'S="E<5LGPE\ GC)^=35Y/W%ZWB863@=3%%L,*(BE.0Z/
M\_=%V M^#3_1?0G^"\<!!5(XR<1!,%N1&<@Q@'IX;D1\#_RJG@+8J))B 10[
ME,%",.S.P >.B_W!#@/MT"IODPJ7(;_-@)SSI;S93NU58C1:;&*M7FJQBU-W
M\17P.^01;3JLA43%U](;;#_N&O6F)5E%D;!6]+2=ES<I"IID_^82T4SN.IES
MVUE ,>V-HJ%0 2N_BO ?W-'X0+1_3^?A]>3/]6JY.978'@BK2JN4>LSVT_GN
MCW^3T70V%\VDGG,7SY)+W]Y_N,$/[7DB0^:,RIQ@^UQIV6DGBMQP?V?789LN
M5I31M!JC26:<'TD%2M@6GHM$7KD.SJGL]QIL'T%W/0,HOH8OR>4Z"O!L=T\P
M2'.4O#(E*,#( -C@W?#.\[F;3^'="'44G?Y.; Q>"(FM:@JD+PXE FTG</"@
M<P*-/GN!/9D+UE.$.LN(1=QD6/3+QO;/VEY41:8=FK07;9LBT&'M 6CW"!PD
M +X:O5&P+#?F_*9M'I8[!DR[!1.TNY7Z9HG@K**I9$ < -'=U"(7HKQ?"4AT
M@>99<29<V+,<@T*>FK="QV! VP]OY>27C8@%#)N3?*$'K!P,)T^-[@LUA/NU
M9Q9"YD*NZR(R9$W^<:V^$HZ:Q]IRQ$57?1";#J[(DY9XSI66\U"]#(TU#DDW
M$GH!R3T?X20%V7>L?)YN\)(0=XD%G@YV<A;/^8]V]Z\7JW*;(&W9)8>CK ?;
MMI7OU!<"T58:?;TB ;E%O!6'+DB&X2O IT'=+2A\\'E+2_5RE0,9IA!O9.8]
MHY(J[JB;TPTN!13^#U2[B H"4LV*KB-5:@.+HH"M"O^"%CDTQ"4KPO2++Z44
MO'165#/T,3]1FB*HI)=<O $=4.M9V_OSR!1+O>Y0]0VM<!!QSEM&/%JE?;1J
MZGQQT)34'%,H ;(U&K<3"Q;2*D4\7>-.1?[Z==G,;[@YWWRKC9F8; HTN2'*
MO6Y7;(,]W=M3:"C84T#]?@0J4@G^ZPEJ4>.EF+C0N( ; I5:2">O#P,3J(<B
M58 _@_OVTV:3(5=3$YX73+N8*#=)7:7I_O['OXFG:X1,ES(XVH'PCOR:Z4_>
M>/O$ ,:E>"#/V3U" G=?MDK=R;A;GS*;RIIB>YV56.60@T8\77OG)\$87+$_
MZW;2G$PO;,DY$-..(8=9P;7#SUQ[:*^XY1_(-N3@OY?P4MO AR<-NV11A,Y7
MS:#:!=T1EN-P/ @9_P Z']#Z,W&Z'!<5(*F, !S$@-^HB@87\+B67G\%I(5C
MI]JL!Q<)]PPYVX]C\U&J)DA.9VX66WWQ<ZMO(2!-R$;LU^GY7Z?OODX$_@%]
MWXU]GU(L$?D+7@AUKO+DU"(F$C$RE4IETG]'_D)W1V%#DOCGUDWQ)?%__CZ9
M_WVZ@$LG;Z]ES^I(Y"06N0X ,BV'D=4<5Q;> ZVVR5KVRE+V.[\G&_UN9/7F
MV[%(]>AG%((B:!??(+G4 8JI8-1X ZX2RR?\;Q2Z9NC?KS#R7JU8DS,RBS1I
M'.G5TQ^O#(/M:QF:KZMD6R1%5M"5Q*Q>&;ZMQ-!5W+YRMSSP 4?@C?;OL[?-
M@09Y,4LN"NO>>,[T&SFJU&TD)&J"3K<4\7P&'>=9SXQRG*'0 6<B.P2[T7:N
M%<7&3 TJ2QW@_46WP&6AV$%&L0U.$^P$K1-[P:5:%KK_'%I-=NK6]H;A_H"E
MXAC^3KDICK8N3,-$^O9B:H M5M"=WCA%9)9[I>?'[14352>C# NZ#O(XU JV
M#L>,YCS9NQXQH_<;N/HUE$/$@9#W18#KF>T(FGV<8%=D!]7[>1[H1M4MJHVS
MSMS,TY["N^]PY, 5^IOZ AZ$:(T;EH?+E^'Y=%9/%W$]6KA 787/-NT5^_[4
M3565'/$\U0&CBVSE>?Y.CWMB438Y'0HY!ZWR6&&*JASI)I#*)J(1JA"I;C:H
M8-H)/]TQT)"Q,P@$TFVY68*P_WBQR4@94,":>&/M+,R%[1B+EU.R/)0!W;9B
M\\Y<W^R;VS=T3Y\!YKCP]T[&YZPOR!_NOS5J$6N^P7J5FM56@PK!ED71,#95
M:E5?WJP<.F\IN1'>OV/_R!WH-.^I^>RH>-@2HT(EUEJ!,9%B[UW^LRVT]Z12
M-.+,9CYE\\/A:-9:/U?^XX9EYX!C-U<])K:B]R)ZJ+(6Z*C+2M!7=A3/L<S8
M,UW@J5FH]98:NW%LL\A?SM74H.F9:PM<*@R\H36O-CQ>'5WZ=-E\N5]7P&)A
MB]K)+H&VL^OAX7$45;DJMU4@VXL*=/867*%5VBW&>W'4KR?4)M_CCRB"GX5,
M\<$1IS]Q^Z?YZIS.9]<3&FQV=,7,98=[ _K:Z6Q P,^+0D&#2(.*,"B;XAYA
M5Y8[LAYP=9IMS<%/H9"BU47LY470DB/44@.V!>**)'Z3T^?GWE0-X#V&%S0:
M!>\GWJ?>Q:SNB3*T>I;H_CB&AEHZ- $*>K![>^T/VCH)'%1!L\L(N^1#^5U5
M;T7!WB^*:;ST7;$]*^-8!KZ)HS<#K$5DG*,:/T1K#:!G0%L_ I6IJV>#U+5L
M)\5L5D!&+[2D;S*$S]]&CW@A8\"[NW5E>$?\JWH@HB6"8A8?9@[&_3HO_GXZ
MKQH?S"Q&Z_?$OE08UM>;N:EK;W."W]T8M.95)ED:5VB"/636/5DD&5FB$#Y(
M(I>(0B%X;&/P':E4DT;Y>J*RSXNQJ5$:YHS#L,W<NZ!#:$QF8,6LADR_-)K5
M\\U4T<P_VUIFUUCBQF*DRR^,P0>18X<E@ZHU_%*]@F^@0Y?V0:'O,<OTL3H^
M&0]8V7JZUN&;73T^ZB87G2K!\GUYD%DVU<7FK2CX-X9WW!#B$<6;\GK$9<1Z
M)L7-A7V+(,0N$N)X,A<E@UCI7(A5#>P$Q=0EZSGN0M$L9%09;HX@X/")1C16
MT-$!>=?L\V,0]3?2HS>('&B>KC.=X6)HM&KB=KD'VW6R/]I546-7.B@3=]]\
M]!^W^9EN)[>7]:S"U,4,4]EFC<QXA38_>2M#_=K!K4^1$;#+IG"S,)).U!R+
M JI0WOQV' H,AA)V[0@ZV]6!V^?S %]0@I"9=<5E;B7S1'\M;VK9+MG;"_@(
M#LBSAL+U;OL^VL6+)E-:Q^CTBE.RR48L6UX^L^\GG]MXWKI H2H[ >WFK_%,
M9>2Y:3Q.9V-;%3GK/O?'L9O^<]&K\RV:W%)ADUO8Y/9X36[OU[;V[CU<7N>9
MK*!^)E=W/HAK!1?(F9H&KX2&NE=(0<$SP8ATW&RSSQSW^UMGD:87GF#>^\]2
M8$GT^=TD*VZ[U<1*&/+J(G8;Y>X5KKEOXUMPWR^/K.4QQIKZ>E\7R\NA6&^
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M5Q(8FKLP]U7MC7G9G.E, H^L>W[>EB_OZ[L_:KA<2,K>W37W[Q@:]?73+@)
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MV(MMH0B&@QK\_C[0KYCKCMRRIWLRT-E\5;1*Y'12ID;M?FIY;7KQIH:'R+R
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MXFF3V0[J7&E)S@KR$HD7M)C39)3,WO*'L<G\'XR_]*][F8/=]9T ICX?PGF
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MCTTJN?6J(<8(DQE48E.+0$#09.8I<1OX]D;P\U.A;TO(\N+@.09/E%MXMTG
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M$$[A"@/3F;_;O^G]NQQ="T'@=30RZ6U,V+CD$",GB==]CX6D2\$C?V/*7QG
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M59$L25T]-'W=@2"9IJK+0*5="83[1P!=*C"2-)? XA,0*K #G0V<E[F&.(O
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M' (GU0IJ4=8D*2IER0*=;0Y7XI[PG20>*!R[X GS:[ ]!+7/@QK^,5#+[<2
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M;A^-,^S]<+;&)5F/MWU34)HYO:_$[67'^D2<$;MZ:1LYTXH5C8=.RW(F06D
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M (0-A(U;]9;?@XWQ1E[QV,29"B0Y,_L,7AF62W[8#N!2V$!1WJLOYE"1-[S
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MEL<Y:(Y9@&?B+IU.(CPC//]D/)\G[_I:>!Y4)H.DLTI/>:^D->N"T\]EY1G
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M4R2)$(T0_7V(CGU6WK60O-%X@TS7ZTE>U5EG*(E3:]@.;#,=V&:$Y//=E8C
M:A&0KYV?=2T@JTQ::VXK=D-H9#6\-VB,I'([,,EL8)(9^E0V5G0;DWP8K =V
M_?/7X9[7WXFI;1D)"7+OM</U.-PU^78W!*FJR!V[?<NI^>&EO[7C2RHKYRE=
MZ^,U @##P:1.:+C=)C.LFDFBC3?2;(F@-O)F)LS$)#QV)^](/'TY1P4!^TK
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MK<4RM>+$H&$D@:?OV$OU[D";@6]6[,E;WP0(G5R"N<?IA&LEX&>"O*=PM"-
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M]U>-"=-QF[Y#!0<VU.<BEE\5M!C0K,609:FY*1B:5YO.U7RKDW;+'*09>7R
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MX7]2P4K;BN,"LL+#MR#3==\#]AM:P(+W@*TM9\K/TEJ?U'UQP/;4G2LVO_(
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M+RK&("A\8]HOS'MU+<JK*%A<-5A\8[5;B9J[C1!_Y4J%OZ\1(L+>K54WC7C
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M?7X\)(L%56>9VB8O@"-O$T^^JE+!!Y,N6*9^8H!=J !V,"][H#I37E]HI@^
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M14G &UNF.YG";VJ:.$:3A['T\,\P$$(<KKDR@%*#^024/<K"D P/4D7"@_@
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M*?M^IO2ARAR0=$,GN&6JQD'M,JOUEJWZDYCVR\:VDF#CR@($+]*4\  Q%5>
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M2?E^5IZ$8&$NV,T,#!-=+=NQ2=<OV:W*AF>&K19:H=,7I>U7"$X!>>7 ?_I
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M! OS/U(_MOH^M@.P2+!)7PK(/273_(+#[$PN^",^]QF+?'47A=8DDO7-5Y>
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M;8M=FK@//9181G:4#DAR.?!<S59%FD_^5#9H+^U6B, ]^SKP;YDGM;50; ^
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MQKT)A$7!/]9Z&BFLB6+\F!([11@YDQT=^EK7+=,_NC$!C<L0@WA9!EE9*ZA
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MY'_H)O7D0&M&V(?ZT<76!3>9#M/V4I_\\F?B/(GQY8Z!HLRR$?R4X"\S=?7
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M'2# 00H$E9]X&3D!5^_I%4GP[*9Y7AG_!?6-1*7]V8+)TX'/\I<[F&DS=>A
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M.@5*@5@7VTK"&JABK&)6M5)_1P/';>K=N_M6AXYSW-Z[=)DY\(<'0#7?S0-
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M;T*&\G<5N6&_,X)OM5>UZW:Z?@-(N0&4P682$+@PT_QZQXN1F/Q3KF78G]T
M[/D-H$-[*G]"&G;._><&$ [,4G SPWQ8IOQ[S"+<8TU;#3G(UFQL3KR'3LC]
M'<L=_T!/ K[Y;8TGC_\)CDXWZ0:@ZKI[ R " ='57JOP_)6DV#EX9$4_!J@U
MSDC^</@'2+M"&^Z=(HV>??S.1ZG8(Q]==L5T.PJL<@/XQE^#>]28IA4S)XG
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M2@W,NPPZ4EC)K)[M Q*3'W9I'VI?QZ]#Z+NKAD"Z2:;C-2Y<#AK5!5"6U /
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ME)D*E*XB8TENMK]M*:JP[2C.='B2H#5U+@+1MW)$_O[3/)']G:GX?>TCM\#
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M)RM;2@E*&@.K93G]@MIZOT2:8'CN599JLL\?\>#8APDQJ2*V##[P&LE J#M
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M5[3AA]7AW!>?66LH?I]I]N.(I\A=3?:QJ@<?L9@,GZQ.77-X>>5:GF5IU&I
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M,@16Y;2$L@0(W9#IS9[W@.(&R7<_V70)Z,J=1=\!8M-=[@"&(W> 3?Z-6<[
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MG<36DR++B5R\J]-G!<='7!!;V^KI*_/W=X"8?\KGESL#+P%%FMK_X_DR4B)
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M\X#.Y>.C1K:Y@A?HE40$4+%V>\$P-=&NU2OQK6.":HYE&6 ,X$T9AY5'#-T
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M6^-\+(<]+O+S"^"CXK2^SQFQRIFW[M*2PQ.!5096/:][YNNKAB#9%8GL'AY
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ML>3S><[R2.$>QYLD!HHV8_:WB'91*TPUT@]&9Q+CP%#A8GK==NG"J,'I#[8
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M8R##SWD-M.YOR?ER\+!A]B,<2KEO^?)B8@>Y*1M5.$ZQ!5ICN=AL8@4:-OV
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M;V-RV[^AX#\M_ZG\)>O<DG^+&<=_N?6/;<'O-X US1M K( XZ ^I/3N&^@:
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M)!#OP:NKH?Y;*$5\#(_%T7UOJ(->S^Q\9"/UV-9#?(QD\$FI'/Z2L7"93Z9
M-44HHMW^:+,MQ8%IR@7,R/@2+SEX(L+B7=MN#835"E*+U9W2+B]N9M&I>,]N
M-WU6[JRGZ5T\3Z9+>[WRB"SP4*F5X&!KJM+&N[,W4R##BZZ2(L.!>R.[WNOU
MF'Q=R)=: IECR:-A%K@\(F<>A?2,+\GX[53U,.J143IIH<=K&S)79OP#2!^<
M[TBG+U 6_<K%;&\V=<1)_\(X$D^@',9[[[6KCOQNF6'V$S^-A*E#2J#601P/
M4AY76>T]?F(VY4A1!'3?:"NG$S$O_.89]M W07BVK=4:7BTV19XED236JO9U
M?^&E.X"BW1?NL;;_<>K5E8&;=X1&0U/+AQO BVGUB)\#G@F]&ZPN.-I?YICD
M'BN.N"=GUR+>XER621;S*!L4>"U'IPH8+J*G4;%RS3A0>.@'$7R+G-?D;YL]
MSK ^Y/5?,1VT+G)W7HHA[%4KM@6@KG)/L0'EM4=Q,;?K@ !CKT/UZ8)]P65I
MB ,':Y[*$<XBG_39'C(@LR7BE#.F0B[;JD0#6ROQ-:?I!M03YE<LEHJFM0L(
MVMX_65>C4'T-8(-.\(J57<%_"*A#W=B-9C[X50L8?$J@N,> S*W3D?_9[\;D
MD@32:"RV_V5I!V^ )U=0/V+TWS%^5A#B3,R6HZUECC;O1CG1*.0X.8XZ^3 '
M9+V0%&DIIYJ2'O[#IO7/5/'2HP:I]I25]9:/R8)19WM XC0V8."YP7:D3$Z7
ML36*DGT8T4EC]X<_TOLT6^R1? (WW=ONAT/=ES_&Y8&U:*?P9QV,.^&@^P5*
M?N[#6^E=;BP^2"%Y\T[%D=HV922KH"4$!\Q^)/]QTBYVK$(R;R:9PGC#?>=X
MW9V3PPB=/R/Y^/=XD[Y+[$_%J(XG$?UT\ 4':"9&8YE+:U90*M.DD2K%\&T;
MWWV=FK=C'S')_>P/_-F+Y<]@BYTUZPW'[S/GUU,Y:9Q-57F;]'P8;F_'/-WQ
MX3CI*;.+OI:S=0C_+-LC&^ATOJ ]3BUQ^,M3_@UL.33RF? O>(ZER2)681+J
M1&G? H;[.NR.WH\;L(T!W07YL"GIC]#$11!EP8NLOMIH3;M>WALWGH!\0+!J
M([=TF12S]C?+$C#,S#FM.26^I[!HIF2L^ \M&9-*<=F9"++9Y$'7!'= \XO>
M:ALK>;88KP),\\>:3QW#CV=?NP[0@!'!ZR'"PUA@_I%B&%20WKS_N]UCF$[:
MD'#+XD)VW4E2H/8Z&VYE9FV04J,B'](P=U9CLC"GIJ6GN3)E_6O=O?I^0W[C
M!X3>8V[-NP8#VMI"A%*$T-_US*2?"FU\Q"Y>A^PP/S7!$.P/[\IX50"M\?9\
MY=MJQVOJYY^K9H2_41H-D]I9W;-J1)AKB2"O^<_D!8T='OL8K09$Q8+_29S.
M"J%0W1D4WYXN>:J@N;!%6(M)O%#%TDA:-1[1_[XNLUCDY5)',D>>YZU1W6U6
MU&Y_4E5R3HL>BPC#4>\)[63-+0&G8,RTRN_D(FDV2;N<DHEVE/T>H(9I:8B:
M-5&=V*]\\7\0]+A0*S^KL*-5G ;MX+5SS-\\I_+5R+B_[\IMBN(Z-$]L3Q_K
MW  >[;(CK!-TE6F/MVH>Z"H#:/DK*^"-PHO=S%IB8%HJ0DV:.?W3:YDMP[;H
MV4DZ"%(_[!^6S#T!#U)KO.?G9A83RWMQ10(>#QC-_<_B./?F&C>LBFD(RY7A
MU0)FNLMG3I?O6D;1YJV<<>U>A*53QM_F ZOKL']85IH+-'.MOTEOA)O.*"6\
MN H1QE$'J/H;!? )?^1*4E]/7DEJXAVA_N:.^G1JW)Y6K5],HO%4:SG'9"?G
M&&^B<V^ _1I@<$:8<0/@8&7&M;W]^\Z9CO6*B>*%O37".A$[;XV9.@.EZUKY
M(13C(41'C?%GH+MV3-U-1X^_3A7-?%O49)LB@U@$R3XQZF7K^W-:T*/([D^)
MJF:W[R";$ ]O/Z)(?RQIA%PP-*"2BCUZ^+HR_(T4CWQY3=<I[Y,JHUZD5X2X
M(+L]CBP$VQCI_NU]6UO#)TLCJ?2G1BLJ4[W5@(M<BK+H30_%R#^$&6^+K0.J
M-/>T5,[<KWSJ]WP$OHZHLZ3/-'SG57(+8QUSGP;H6E1'!_)X>W5#.-'G8>56
MT(:2ZI\.IYA_*)#&#$//<L-VI=_QE>7>B7YR6S9.XZ,"V>!R+A7>+\;/BN"G
MZ7I^HS:DWV/9F;6/)2 %>>+3K_&475<H,!F(0W;[P$=3IYJSK:WHZSV[/]%B
M@NPI,JEWE=[@NY:D#"%;,@%/JH!(^CY+(H1M^,<CHBA!ID&-L%G)C+<^:A^E
MV'GO^%X9OW1P85UNT^_S4N8E>@E^3Y7XG/H_)Y?U S[VR!O)"U=S,($3,Y+@
MWB<D^"&+OBCY[3L;__U(E784LX6TC>A@ =G< )Q6H#GG4*3=N=];'[GA+(3Q
M!A&[?K E80&(+JUDV0K6.=0059P\^F(?JL1#DIOD+(.7_)SN244UJ7?FX  3
M:T-E24#!;R] .F[&@;LMB\4U"=!;XF)6_W\]>_W_50R7>7 *YM>]V'Z]\A8=
MK'_C5<1E-&#V?\\=BLC!\'9&0YT(O8FZF(JC7!M\P;Y]96D4*GWD%!2_C\#&
M/?!,[4[RXIAJ"VMR>\VFMAW!V:7DS2UN%2'5VD&%E L>+"U(5T:G=Q6P'.E0
M(K1'K3#Z_9_2/M-AHCCYO0T0D;]7//*5<WLQ>,*TV_Z'?6/2B[OM'1,A96VI
M^UT#HA:&I67PF)W*'OBN:RW6#(Z7XO5,K_P^[OUSEFMRTU"+(\'H%V-N%5H.
M- V_;-A%_YP.TM;Z -<";/IL#.&"'VR;N;=^0-/L.5B>"."1#KZ]A.=MKU++
M2>=NXVNG(9;#;@#AB)0-&KN+HDV]T<8TN2L4Q\>V0%6OI]H[GF(%#S9\XU]N
M+>MKPM\E,1YP-*6NF)J^:VI.^^R:<M6OOE$[J+1D+(H$46L6F8PR%URGRH43
M-RW'N27/MFLBM_K$,$4^)9?GYPV>3)J2YQ[0"O-7#VNDN^40SP=<K"S+MF<S
ME^> "7"J$.)7=[OQ&5!8/SA7MM2T]A\&G?D!G:_QW0J24P>/G 2U,P?^>=WM
MN;$!*Y;>S]P[S:&Q-_)=AIX5/OW =)^;)ALF9GJ9_$G.=AI"_F;A)1TDZF[;
M/2?V]TKQ-P!+\[O!9'A&BOT64V4% K[V?4\5(J;H)Q:\#U5J6GZT?V6("E X
M5DPU>4] ,U48%)RCBS%.]=[J=4!>?H#\$Z-U-):?L?Q6P;+A>[;<^B"IT(%P
M^#DGD6"7@E1:3Z.>@)D?,SB@ZE<#?C#VS:F1E3,(O]\WKH N'G7UZ8MQB#'/
M.+0U*BBYED(H\&*9V^]:V?=K"8MAF?F*JF46JGA+&@TZCYV54P3=S0%'KRX*
M:9HXSH0L/<5WG U$Q<4W^1FWZ91A1)&&X(;4'8?OXZP%FA_ /MMKU*O-2Z)@
M<+H)6^ 6[<D-H(\28(&9'0E0_[RF(%1#"%S\9,-F54)R QA=Y\3YD@4>J4I?
MULZVR;Z:YL)->]5"S$EA]8.<5@X/._2<'YQO7<*5Y3[O[.A^?ONDJ5VGYO0&
M$(+CG/1@A_HK=+;0R#0!Q1+ 0D1/.S<&K^IX<UX Q\XZ(_YD;T4CDLX^H''%
MQ^D'[L O-*F'+1PY[?HYAX1KZ('&-IJK#_9L+)TQNM/NIVVI*W3!CAOX[A$,
M! E>B;AAF/9,-V8+=1'=P;V76=B@D=H)S/!BYGADBB=U67LB-&B1N>>]8-%V
M= /@-%F&1%1@W'HA3.AV7!&*0'313K<\H!9V^#KC >_7>#>'X2TW?-R8 VX8
M(ABG&*GP9+KJ5,VFOFE2Z.W$_KKWK"CO6HU3>^)P#VJAS=S\J&C*^P-6OGRE
M8K:NKG]],:0V8&WD>=<P60'CF?@V&]UU@9PA8JX^EO)52_.G?8Y/!(VU]]BV
MZX.02JU!1",5E",RF\VHV(*G*NJ?6C('P&6C27OZO^0,T2>]"GPM24<<$=I-
M-F&M4W=ZD-KIG^8N7;T0ILPG53+6(695L1_\RNW-L*#YUPK(MY&#+D^?$3*H
M0VTX_B3O0\XW,:-VK)7MR\LQYJMR7>IV7-LKSN1# FV)"2HLDH' 9,S643ZY
MEV[TJ ;$DE15*#=ZP.A$0OU_$?>646T]W=MP*,6M4-Q;M%"DN 9*BQ<K[A0I
M[A8@$ K%'0JT%"U>K+B[0W%)<1*L>((&"/#RN^_[+^^SGO5^?3],UIRL?:X]
ML^>:O6>?,VM.UMCI)CIW/3@WB&*%7@T_A[@\^LN>5DIQ8 RM2P7LADB9IWP:
MMZKG>$WP*IGPD:]P;Q&.QI4M$]Q^E>GVIT8HVL>ZJ:%Q/K<&1J/:*Q#7U.VA
M;#,A)@W:[O!O0A8NDW!\P2 [83L:^U.]YW\/X+(92MX>YFBPLYW%=THU<'[I
M;YU]#U YY8*7#2A+4ZD2+)0M7]P#*,#@!J1KM#"/#8RTVY,__>!W,UU#B=@$
MYF-Z]QS_G7.FJ#N^V;JE)6<9_32H4E:C$.5Q?<Z?$XU],RTK1R'HJ\5562?#
MJ2C?*\^D0;/V,N  ["6O&;=MJK48A^?MM$22H4ZI48N#X)47WX+"O$2,I*@M
MZ]#.F$M%LBI3A;?_9V?R:D-9 BFM,.J-[9O\<]8[BC>]EVD9<7V^N+"MAJO-
M"/OUC4WQLXF3LFSK6IZQWTY$O;=C.[DXECM(7@C^$@$.M?BY/SWZIP1C'N+;
M!T1\8X#P]>CCI+?@]!AIN4?-%J"1C82+B$(/,V8$;L[[C&NH<<VL$7+1#QQE
MW=@\O!6*<R9.\WCN$/BZR-[U*;CD48G6GI_5>4])I<)2+]2WXWD:)^].0W-[
MW):^ *")VJ.)H^HQQIJ0I0.'EK9".YGT7- +-/><%)Y[[EX'5NM4FUF:N:W:
MQWG9C4,Z?G:;E^(KP]3"FQ()?<((^@M71U:CAD+VB^^:S9%]8R?!CWYD_=1Q
MS_;LKFP*&K\'D'L;.P;J,1&;.8CP,>[;6UE;3)W&\A[<63;'.7:_>=.>HX8D
MB9B'&D?-_F[LBLJ5:TV2\Q=1GIANJ.*@%4T+/XG6:C\'AB$2#B&5=G=TIJ+O
M9^:M>%)8H=QN\=:NG K)SQ8?'>+CO:=C/:>(0"Y=Y$UWO'A38,^BW#*S'O(G
M?Y"UFK\IT0KGF8?DF?1^KS,C5'5^HR5[Q;:>_XK,T&6Q_-O$R!])#08W1QSM
M7ZWMK1]K$H;KE0D48L38, 9_[0"LX6V[5A0JX,9EK4V'6[6R">*E.-Y%-0WU
M.-NOM82-7ZD>?VIDB+Q+32]_[7!M,M*8+$\..GWW]DA.'=M]B&;C'@ UAI!6
MIG0O"G<4>F+MU=9IM7D^ BP74P\QN,]Z]VO !A&!_0VA'F1RC>/,L]E[:M4_
M*;%:1)FMF!-Q!U4&TFCF@D[K8V\SK3V C*K?G8R-S$Q'Z9C.RS<)?1G$*1K]
M?N[K93C_UC+KN^A'5]Q@R/EO%-?[SR5T)^"!0K4-O*1]]M5G+8>?#:"B<1<:
MN8G]F F?2)[X,[+ %:.%2(A!/A,*->; D9%W$Q*>+"OTW"_D<*@?GTZW.GZ
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M6ZZ&!.2^SK1U]J)DNDAMTM>FI1GZT*38C>J2^HEHT8SYQNU:X^4WCPI_/:+
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M#(X[)?J97)4&1NN%DZ>.J@&J6:]XV6=L&R+?6J<6CE]R]WIUT[ P;RRVJ 7
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M$O!S.6;P4T2@V(ACO^2Q"55?9X:<\S+3G.&030)8Y"5"/]3M0K)>LBV+-5Y
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MIQ][WD/O&^19U<?JY9*I&??M*1WC\\$#VC/A-N1HG#0>2KI") 6&^8H8N03
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MX%M 5MQS[]&K7;IR?DP22MX071@%-QMO9;-MI?>KBG*M$/F]A(C3BWTM1]%
M>Q$F^=F\A;C3]-6XMUN.?,D6?31]00:/0"F*&?]YUW.BI(^>@7A4(YBNM<(
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M5#=E,/?2'@H3T_&U3FX=V;.*$;$^?+T9Z197/AK29G-#U.V6R3QYJL;-0K*
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M#X[KB&+;0KSL*U9]&+KYB7<:U6+S4.G=,\D#SS7.W?#C.G_7^(6FVK>LB=7
M%!E4KY1.T.9"NR4*20(<+UCX$GH=HWV%K=G^>G* 8>!EXAI2=>R.ZY7:-?7Y
M!^/*B_$^MJO7DOX]H<OGH7C#ENX:/893,V>$A;Q'767&.Q%,DRGT1Y6UVR(#
MY+.W@##B>$(\ OS42Y5-.3B_[K"]T*[R]/"TT2?>!YU$9HT#"4<)L[%)#]P_
MO(W2@^@(>1%,,<!V$-GIMX!V=--I-CGY5/55<34Y!;@$MH/:H7"OV/MD4V[,
MH5F#[-5\YKH&SLQ>BW8N]%:$)W9=BL8Y?RHV8^)CG3B0:VP I1)Z93,E??\J
M)NNX:[J#H$Z=/FIWWI4GJ/(I4(HFKEE?8/C#3LM7C]]4IFC3-%8]?_RZ$;YO
MK]:9\\<JQ.C//3=6N]@WF8J>S-_P5K!\,_;>3Q"7[NR&3=.?L)VB'Y*;P&U5
M YM/(O ?N5;$Y-DY,PA&EN2"#4.2UKMU:03D(2(A;KQ;6%;ZH/XA9BW+WG>?
M&<^9?$JV2'FZ$+HAE./;C9:968S#C=HU=4I!6;H/"#6FL^'7;-G;Q,ZUXL\R
M/M>I:*T8(8"TWYE_H@A73[/)G%9&OM5FXD] ,W>.<,:C.A2TWMS@$0%IJ7M<
M5VZ[+JE0#LIZZ!+1S%-H#+JT#N,K%]V9*>=6G!$H"7W9W4#WM/7X1G:CQ7=B
M@IC8!K;_,W9IZ>E]QO=<V@I, 'Q_'L"U ,KKG94TY=B?_+H?9!ED^W,C3G4P
M@(?:&:QP6YH$ \LSTZ TK+Z,F8N=6[C/:>!_=(=?MY^51'>S!TJ&F'=7[<*Y
M<:4:L*<'*>"GJ^^4M-6#R[Q(_B);1':[#!7.\@E_.N4;&)MU=(MJS>>JLER5
M*0)7;*<.,L#%W16F1O)NCQK[BR4_M;N\U@6<$\5[:1)%N4>.YV+&D2(XDR(3
MRF<]P;=>G?K<(F[X?OW+A144[*NVYT8+_BIAKN.OZ]?C]F4_(^^;LF,+V!Z)
MD<@ZY ;4?VJCWQ*.(P-)L^FGZ$SLU0A'U"GR\TUHADW:$Q&6Y_#:%$524'[D
MC@9(<>%OUE6&:6-85@B:HXV);TSG#KJ#I,$#/!=IK7FIY2YG;?>NY5$R@8>9
MRA#G??V%;;<OZ2E5K\3N]4T+'MV\,IW*QC"/*M0U5B>P-O\6'?8!07D!-TG?
M#]B41Q5YY0 68C"OF\?J4Y9UR6>=TT=&7WIIZD-,<A=>SBLS?G9PG/:7]IC,
M08O&\>(4NH5?-A!GSG(;)VJ()B6+S6.'!W_JUS(>=(<=DER$-F9 #28D+<IM
M4C/B(NR]66"+V_>E:G.6#&H;(KXG!Y=D_4@(5>IGE]J=+3W9-1$?E) PLH'
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M1B/>7C)N:$^4OD!.K@,*>NRXV:2.NAPVLX<][];FYKGK=0@LSR\SM#SI73+
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MGHQ41+69QH4\YZ2YF^6A;_(\M%V/68"ELG3^PES;;G['4ZD;BE*PB5#FP41
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MX&OE(&UOD0/<.O-K"<_QB#!,,&U&ML"Y;DENT-*0T&04XJ7"BY,B*E6WPP.
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MV7NHOG*)34EY]% R(-[DX@ND1M$+M? 8A?7+2[$OW13CET__8RCW"!;W@TO
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M1O#-KM'[;!(.<YPHUZV&0'EOI\V=6/\G.G>,_:*5B00)7#/UX.MN9K#R)1+
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MD=*B&7"-OXD ;SLA!AII>O<55DK6>LO X4'\A+&_&<[QD<!/U"UC>6%G&DB
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M1VXR!&HC]N//HVXYZ7&3KI.]#@,I^L4-H>*_:#N-_TPG'FRWM]_>DGBG]D'
M']W3&O#E3?%87YILNBV^\Q(\Z^ICB/1"2,Z.UB7AQ]@'3MC1L(?.WM8<@Q]5
M;V73[4N*S<7.'1R&O0Q?5!\B0A3/HCRA/P=+4DS_,6^D.I-K=8XUUI*AX.('
MYG$(JM?Q3QC$?P;NL90N_:0+@F#Y0XTFNK-)" F\[]3YA9;\ZJ[TI-8-V9!
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M\+O[652YN88*8HLQ-W!*S9CFO Q2I(?:V-%6:9328NMONL^56>P.+Z0+26E
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M7/C]%BMLO"$SW\<YIN6V P$8B3RYQM,4"_J.*C[-4R($CB%'YM%6O7/%B.4
MT@X%4Z&?O>0?///'B8 ,CKKOVQ*,U6'V\HC5_NF))C1X1F]0T(?:V=":']O6
M*1<3Y6'7,L8]TW-3!?&6YU#_U&TV&P,.]Z!F<!S99([L-,T,LEZ(\A6(_F&L
MYDN^LO ?KWHM1=_YW6FYBS0;T8A[%LY0%ZL:M5NBM)DT3_NC9]ZCPK&FB7]1
M'=V2*T0$[,SK>#_H."P(&?J]N?OC[KH_%> YARZKJA.5\J[@FE#[\LF%OE*9
MUN);[-)M)%_W7YODBK(=KAG\PZ"?&8(-7TT?%HP\MDE@Y'91QJNY4V+DJ'>,
MZN0>#D^IV;$E-GFB/L7JT/#O"<2D*?ZT+I#?;^%&%F*4:KV*IP7R:JF;<@[U
M?U-G95%_EV33=#R[D^E7*.AV^6T@83\0[[AU;;%.]'UJA".(JNK'3OT.2I."
M]^O;)[ Y'DB+)$D7=DHS0F/4N4DM?XK;K#KRSO+I4[UJSDO]M!DA+M,D]U"Z
M_F[C3Z?+=Q*;6UGSOI6%^X=VEV6RPKI3*C!$0(26"*S7E%HQ$8$X-VTB -=$
M')(83G0]:-[4UO.=0DNNYX3GIO_;\$R6W50S!P7FRX/) 9)$H$=C7"D.MEY=
MP=D(B[KW)]BI.-,><6B&O-D/HW'EYCZ(-$J>2EZ%J;S<UQ'-AD\J6[^P(@)=
MY85_ C6[S)MCEBX*I)W*H>L7^2TE>K5B&Q%$ A%XH\0;Q1S01I@E E/:G_35
M8,J@E'_K(/Q?2"1_ IG7_GBT0_\UCN 2>^+IW+FO(Y4;I@#U.S-I2N<C=:E$
M E[P\/XAO!\^]<%99FDUJS#'U)SOP@V2P$-Z^ZQWA1IS#W4OAWLWSVGV'BI<
M#3]3.?9_<3[/7IN#37AX+GG&[<DPI";5I#]%*>U2\BR1S&]#YD9'6/< F9O9
M8YT";)H^EM3#:0&[_3JJ8SNLX.F-E8\FP/OZ[MFN9]P)/;P;5J#Q&F3M*0@.
M<Y8MF!%.3W#41FFD^&_X>&>*#%N=G.L-NBZR@*]!T\[-#1M&CTC=8QU0'66/
M+<SH$B D*T57KI-)Q(N-K3;1U&^.'ANZ*DXW,F)^VR-=5]Z<F*,&9@PNIKM*
MQ1O_*]3;R++]D@M%IS\?Y:0C!*O3:H:(ECJW9%&MC"<"C^N=BNE@Q=QH8%?O
M$D+S8H3%3+9I87ER*98GBZ!)*QHH>/<".>X@ID[_-*%G^S*X\J35F0)*_</3
MK."]%UFM;W$KW+4LBRFA7FTWG)K%9]FM&_ZRB8$:(HYJT'!Y$CJK-IW=2$/"
M!"_Z.;^D)1 _GCDP;=A![\;?2Q[2Y,!K-]R+[.W=NV<=2@1HMA5("U:.IQT-
M8J;-R):)0-5L!&YKQ?D&] ,1:#_+0P7GREM8:'KSYD3_(G\F.(2S0[MUUC)'
M#62[&)JG&@N-_.3M\_^0[KDMV.]\V-@OX/GA>,17*[E$CTD%?$EP'"PK\#]?
M2U\DDL/"[:E[,#(KM0RNQC>*XCG-+P_A;/B409PA<R'>/P8/F'S[<Q? 4LPI
MS='<&3KSPG.M-D,C<1&I)GB?"],UZVKI_PNLW\^:JY!@(6H]-)(3+JCZ^=\.
MTKI!1P^Z=]FN.0XG"4QVE;6IZIM[-[@)L@6P5IE\V)#T* $'QQHGTO>AJ[BG
M7$P.U4H2M'_I[4F %UA'&AUJ$"<KL%8XHTTLT%U&_C Z49@^7TYR W:=WT>0
MXI?!3"P^'G2ZG)EXNRJ"X,V[8CAL3F,B_0TV* 4*DD2IH:1P)0-\'8 AY %A
MD6#$8@8_T5@Q^36J?17H]WW^.R"1U!SD@Q0C?727]#YCS!M\6!'[K#[N(9AY
MG0I>+3D9B'IW+^5VNGL<$9"#<YN8+CJ ]THV4[O96S]/7/6]"BRSB<KK\>(/
M'2EHSA4L'F'O5?1ME*[SA^A8:P,+<^<:U7US)Y-%%IO6!T=@_#&D04Z;O6V_
M0#HZ<R;K.L64(6C_Q)4(^*<&91KM^+J =[(KB, YO?\5L2IN<-O98_),R=1:
M'!&P( )S;?J2*,3%\_2?9ZM@=SK"WL9#)9 J#IP/>&]90-C@N["]A:+^SN]$
M0)D2?HZ%#(,7V/5V"9]"VKYESF=1WSO7K?X'Z,S^'X\L%X^08=@"J]YNS*\$
MPLT.PH5?),_ /(B__ :QMU'HGVMVT<]!2#Q.:EVC+0R/NN@0Z]UPX&"P:@M\
M>*.!"" *TK]O61[]36X(L<!V ;7&:AB>(RYX.ALL@PVI;!$(4@HZ9;!!_. %
MFCGJZ]D$9BCZ#.;Y3O:F2(4&#O:G;9W%]$=O3FK!)V@D5)(.U'9FV/DQ<P;/
M1QID6))YZE]_02BX0&_GX8'WW]+:03Y0QG'M%U9$_A&C&(.!XIO"BPFN_VF4
MZ/ET/[:^HLF!#QR<T6 6/4;2JT&_L>4J>M%#?2XS7JFJ1.!219S["EN0IA"=
M)QW)8,>5GUM<F9UE/$V(61OLQ.\J?51&399GUK5/M0$2J5]K9L=SA'_LZ-Z(
MT0;R:DK7P0)Q3H^/E$^-OC'2K=R7?WSE.01TPK!?6)YG?= /$_@6?I?O$G7E
MQ?!02-XOI-2$K<43C$3$=.[?^%M)$8F@ER%_*ZG^/TLR_S^5(!(?_8_1/K%A
MG3Y7:_NY%KL\<J5UL, <,;:"/#-9']ZP)B,"/U7<59V6X%2;[P/,2QE"E/)!
MX)X.[Y2/SLJG(-B/(R.%53&8H[@U?-T/Z;T4<V-3"12HVC"QMRMI_Y?84RV7
M_JLV!0RRBZ6B84?N,0^C/.3S'XFEE*G\:MON2'-C/#U].XV9_<X'3UY-=COC
M>;[>8:K,T]+K55^^J'=K*^!NDTZSFU'3^*Z^M%!M@F19Z3J%PM6>G/!'M:62
M0;(&X1]I="HO)O6XK/_2G'='1&#RX#ALG/#75AIK#VRA- D$&3WQ'R4"BER#
MZJ!WBN<WS_06J!D<E.X-.7E\H=F7WU%:\>+^EI&1%=WN11YG'2.U.0>T@"&@
MRWXJ[#0GJ52],;4.[>BE@D/"5O2]O4B0LS5YE+LUCT;V:2$=NDQ"MLF*RJQR
MQCT9Q]ZU^4IY5Z#Z.-.A6'7%RES5#71RYW[;49DS*79) QNVT/O(2[71O)'E
M4[=@V^W=,KG2Z_/CB)OV=I9?[7,:4ULWE,4LINJ-5?>B<\?8!>=*#?0+UK05
M!E""*"(@@2;7:BVL+-VMVMX;6O931O.V-JQ:L=B-\BKL??<372SDVN_P7FT^
ME]I,^K7O(/>)H>3>35V%0J4?^]1+X=]],3*=UM1'@8400?HS7H&1.W-B_D8A
M1_1CZW-5M\(\[R.J,W5MQM\=,!RP$A(QGP,D?PF,0_T>S B$378Z3@0T!O#6
MFW!TJ5PMESWHV$SWN#"?L>PWRZ'D[4KL,\=XSDTZJ\K+LX&$R^*"I,W^Q?E0
MN"9RR>3KF-.N,H'.M<[?I*ALQVT!'MST8. D]5%]8D,OS>D;_QX+.PR\*M<J
MB5/ _55>8Z';CW3>1_O]IJ>9[ 8F0^P<^-37:\)WHDJT7G<1GLX4Q=I-!O^%
M4X8K(%LHH-]536*?PNQ5FE]6.M^]F ; OH?EW;(" N9IIMO+8H/78KOE\D*?
MQ/P8>P+HZVC=!VD1^K]NHYVV/R_L#H+5K#%P,T7!P0#2WU+);?Z*7SRKV^/[
ML0P<H!XUGYL;]YF4A&KBSUO/FJL$6TS+5J,8QL-OD*_:HZ/ZO*SHA@NB C5X
MTH4*Q^CH"[ ;T=4_'$Q0&2GPW@)L0+^')=D][5[N?>]+ X_:*]6G-!/5?:XY
M<41UY;2=6$Z./I+[-,WP2$^E^RA7RO"Q4(-_[VV!UCNWWR^SLJOYC1>803_X
MD^K&-6DLWCU1HJL;VY5QI$F2$6L(_:%HLO>6C-(F_<#8#:2V%< WTB0O_,DG
M(_M*Q&R?\$Z2W=1JM]Y5Q5-Z!9_^]-2JAA?3N=8=5P>.YW%;+#2D-]<UN=#P
M-(_/"OJ85RADSPC2T$FF+6FJ0J3BT7<-F#AWOT!4B!NU,(E^;?%:JET8SM2Y
M!!K\Z,WN@?7(&V<%T3=.:5JFR3+O5]K?,G993I*8 P<98R1[=AW[X.@$%<T:
M%0Y/;TL640Z42R$CBO2M6X_L-B0G>I-?A/N]K7'JW?PA]B>L2UPU+C"!#K2%
MUXD5W5"%1U'(\5!ES X5)[!QVVB6.KM[V2=\L4G#,;?SK$3#P\O9S4,DE>E9
M8Y+XT&F0M3W5CW4*-AD/IF72<4?!T@ME6LGP-F;D--C77+L:3J;%^Q4PB879
M.[I D\SM$-*H2+-*C<L&<]/=^V8?ZB@=N036A]?$DV1??[^+<NUS1/43:J_G
M7YJ>:2X_"9'BDDII2O6^M:)2*11R-:XW:NF7&B.PYL+Y3BDL6BU)RN/9KQ\W
M-%QUNX_@USX(II4Z.:XBC<8?/MYLL&S.#B;8,+=BIB@N1?WFV/-+R-"%2MD]
M1HP=XCW*5AOC%!2I5J9?F,\8^#X&O11FKIJ7B M.!M)I.]\"6=2.=[)K&\-W
M3+,3;8T\57Z])>7_"7H,A=]V*['82/:*W_0ZL$!M&+_]<7R@1R.1DM]+=]N+
M)MNMWGLK6LT31B6<535\Q,CIS90[#B>EL/5FTLM8OO0T7LF@<.[>7C>Y[1\C
M_Y'P>]V"##[255AD9DTXC@<;4@RU)MR4*/&/>@%V9" 8XS&E^#GA;U&_MU!U
M<"RTE0@,!<]AI8C CM0B$:AY1GH<BA$%_800@3P,,FRQY56-7)6 MIB/*-<)
M+O-C9;J5M<9-X[2WGPQ]$ =*HV"T?B(1R+Y&D(,3 0?XUY=C*<\^J"F?CU,%
M3KV#E0=(15>?4W-T9C[O!+N#8^&J)*'%UFE?=FP6L8,\/U\2VC9=:V6DCIPA
MYC"#KN-&(C HA5LG(&&GJX@OCW.:;0Y4B,#_5OQ.E A $+@#ZX&8'2\BD $Y
M';_Z)S+P/RM._&=%F&/MGWK)YZ9$8"V5X*$2#B#P943@H-\!7&U]'O'$/HMR
M#G7!NL)$PKD^XD\5[7"@$5\P=[$VRX&KI@C>\+4G15F4F:A'%Y60!_F$4>?3
MU>J+2O7XG(M*]H3A/WG=<* 6GP5;2QW^^W=<F^_2W/'[/[QI3 W^X:!$__XM
MPNP%B.#NW_0WFYOY="1NY_<OGGEP&^ J:MR!6;$:8$$8!O]7K/7XO+^IC#CO
M"O\)7X0YR)PP'.0SIU&?OJK^UZQ>M ??D>58 5Y)'6?^6R[?_Q#,(XP[_Q&+
M_C_D)TL$DB"GP_B*/\* R66K =;_%# (M?=W4TOH'E^YT(I_2/C_EXIV76?5
MN"V#^K:31^[N_\UX"<GWJS\/@*I5QP2;6372K%IR'I(KQ6E+9^*\;?"030D+
MC<Y,,ID8 @,T1CF2K*ZQRI7,Q_O=&ST<]&IKDV(^_X-C<3_K,;>KLA$;3()G
MBJ#Y &U]W2298)-H-7Y.,6-C1H[HG#1K6H@]S+P@M>'"V'@?]"^<;/84M,12
M32U:IUUELR=C3ZN.PVJC#*NE<9)\7B$/^H'<\&K;"S43;1^\-@5)I4=9FCV\
MJ^Z" ;M[$&ZQ9T8%J"!S_.BPDQ5^]!A)G^ OMS-U$]\UCZ:TZ 01(N5E#OM]
M/C^TR3KE+8-Q';3P+=B_&H:FBU?;GNCTG)[BUS;V(OV8GB\]XB\7-8%$OT@)
MP#EM@EM;GF&</SKCV$H5$_==>\*-SBM%BXC U3.=A<+V?MK%PJ"=ZN;KRSJ7
M<VE4VKUCP>ZNO\-','8?MQ6L\WIL_=F55^^9[*G[*\,S%@=HLMLE [ZI#%<D
MQ>0U9:Z?@>)L[S7[)7UO6Z1=;D[U[3BQGBCL=NW&R$(GXT)4"LD:OE NQH2Y
M [>H=+460?N_UDX"CY8#R(JAO3]K"5?'S4:.O-2GVUQR5^+\-1#5SY 'Y#5]
M;Q\^*%9_FV\@)^49@_3/H!7/*5@L9*@U1+GKH?@#!1Q3K4R::J)&"9=@G<WD
MZMAO"U&02XJZ\E[@_8&U$SMP#*C<K\A-8VBQ94\4PR+;:B:%*FD:SYR-2>MP
M*2!KJ=HC7RG!Z56*'GZ1L*KMF,FO/GPH>V!C<MGW59VPU[$_>J#(=+O]S"(D
M7>4\ ;Q; U,1;'6/H=U$D9#K(3+&KGOF?D$D:^\>@F+.5C.KI2BA4GQ=QER]
M"0>L 8EG5M:+;TQ#JUQ=$F6(P'O19@@6Q!6^P&HKV$!C:.V&<\=ISW+@OTCM
M*"2/OG$ZTFSD5WJ2&;=T!%<:;P*5VXN7^02GN-F;UI1J,:&TUF7<X3GNUC%6
M;&,I!@>#HR\57AE-IYS!L29>A5MFGM77MW1Z?:N>$P&A/*HXZ[QYM[)&,9-6
M9&0S.\)SK6?QKFP95[7/&["P$CX8:_>0632DJO<*XZV)X0YL$#"1DO78QZ3*
M):6%J\5)5'G,^<D;",3A#G BD$<$M,OG&Z]\0R?%_/6BW>R!Y:#)BZSOH+=:
MO-/#%TX\K=2_=N*#,&RW\!T7?J6JJI,(RDQ@P%5,?<AG9/C^7[)Y@@GIHT59
M9-MD[][9H+ZH 7?XI:,=QAZ3>OH.?Y^^@/R]SYR&^O)HYSXHQ;K&#I>N$0:;
MKB$"(]"M]JTI\.O!4]D8&B)0[_2/Y0?9L8B( 1N>M84@E@V#+SPQW#L/^.\4
MQ#+H0AH6(?OTV&TYY/;#N7WJKX?[%]G-%6OGE;/,-&S4GZ.$QT2 @#+>VKN_
M5@C6WM]CQ>EB3-KV;DQK><]/14%:N6]'Z ]/Z[A2]QQ0/.=5N/M&@['+QRO4
M3\\?X[PP:HD3Q]#GI_7*AONKN'OXNC.* _E:UTE8;\@=L3(?6S[=3,+'_%I*
MGG"D=>+3V;':\$$='RJ"1V<CGRUE'\*3 ^C]+)"2<"H_W>8$Z^1.']&0!9/1
M:L%U7+UMLL-TOM;,=T\Y OL0%-S1(H-6*D7/62-QIN!0=P1S7?!BJ_VX\>0R
MT&ES^/-Y.LGTBZ]G8Z^K"#6*#BYX:#W<OJ)F;O;$NZQJ>*HYIN2M1.2!FE]0
M*4X%<Q(J"6;P>SCJ9W3G2\&Z7'9-S1 -Q[,D.EO#5=JQV+<^1[)<X6>U;:@&
MR!E96G%GHTU3;?2"1I8'%1[BZ&&D/E[FC<555)#=3%_^,O.E09[7[N10D@^>
M48%XS<+R=&\7O'!]HO#KJ+/5P-DQ5?DU1O^LW7D:[U/HSJ#4"%;G./:"[E(S
MN V>[=A@P5RE)Y)8--M1*3]N)*0=V'V9-/!P(U7GIE:C1?UR2I"L7$+>B%9M
MK9H7LJ8EY.MC*)."25_#7,S19P*3GUU+Y<31;=^\K;?F4WI<[R9*>/0K.>5$
M*$BE&L&1U1W8?+3C#\=D0;L2A[>]O@ L::']2J#LKEN_Q@07WN<W\IRF.FW5
MTO<P1F;9=X/Q;-B*=]XZ?"(#--QR9RN#8]S9;O30/V#U"H/LB_"[MQCO;XK?
M!Y;@LL4*/.<ZJ*T KI&J9DAKPV#0T@2%I?3)X\B_*G3%R: _[S%N]> <QZ$.
M7O6#0KD,WK(JFXH!)B-GC<+;OFKT"[.<^,+<89S6XJ/K73]1G;6^.3HU-B](
M"Y/(S-1E3^\?KBD<PC70,NWRHJ$MI-48I8AKE:JNM)7FVBJR<12&3(HDTWEV
MA3[YQC2>>H;,IZ]$J72E'%N'/;^/EC2<#X\_)H/TB;8H."3)@3Y42W_]LH01
M&FZ_<;<_ZP7==TRWL:WA:(+.8F8HNJ>BJU ]&:UA"W_JL.-J)Y>5:JJ^'WTU
M/>N**DG/H'YXP 1;!VLC#4I7NID(D-MA,])B?6,&DEK>@&D5GGLOP")'9J:L
M' JUD_3MO(Z+?J/$.S^'J;"N?3EO\/N]916R,!=IXI6Z&E:XF4$W=@BA>N;M
MXUD,Q=!_:65H4R\S$[_/_89I*?\!1$6W2\TB]Z:VPIF\9^U^<8 >6E$N?*6%
M!WHVMP /FC)OJ$[=OUP73!9^W?HDFI;#JW.ARZ<#C>Q(*]=H=[%'G01)B5):
M6+4?..QY<QOP_"KJ%;&Q^?9C[?D:<&8<G4=7;SZV&'RU6=L*)7;B@9,9]1?Q
M8:-?/J/N:A^ODL<'++69!26'"+](8([08O$^*/L YI0]J ^S>>="ILQT-'Y!
MQ[<4[TDEV*[$T(+.0\8I3(A;]M,5NQ3)B">PL$4S?"G_#=).-*9^!5&HI;_^
MQMYIM07F9=65/03=ZIIHZFJ#,2]CV+^]X$)GE).'2#&A9GLM_:-8RR2"Q0*;
M;]:DBS$J^"#Y"/>:JKYCJAJ"<XL_ERL\OQ*%^%WX=#E:>A^(O&4@;1M]G_6#
MBQJOF:#!4I*)4Z=VO_FCLRFTXFKX?K_-DG$V>:@4GO<!VKAPD<E=RTADI2:5
M+_>)6.D'REC3EA?2(GKL1Y+6-.X[OM9H*GS56>0MLXXOXR/J/$]"'-L93[N5
MN>&R/QDYCNCP9>Q]R4F+-J4Q.@36N:3"@F$KVP6]*+W%+^:Z% N/C)%MJ+PH
M]B_EW?JYZ>\TA1GEEXRONO2108]*9KFP*]XY6B56YEC>IPCT:J*@FG=I2#B'
M=+J\!NU7;SJ[/9+ P7PPA-)JN:R19FW[U./(ZLL)XM&@<0=;);3+VO% !TP[
M8XWS"NZDG.0>?H5N]^IQKCNU12V\2V#/=U'Z?&&#1S>LA5;8CBCPSY]W?4/N
M)4%6ZT*CAE6OOKSNXQS;F7Z6JENB_W;[B?CIKRJ^FF3QYG-1B8GU#2MA#.4B
MVRKB7+YMT9)S?TF[N?F6XZBY= ^'9X;LRF/?FP?",AT9U!CJUD&J62A<$],5
M*E4OV4U NA9"$M04&.Z*BG.T.QI]BV=1N+FG-6[)D)+W=G6'J5]=5Y=?::O?
M)V.\SHZ)Z6P$&8?=</\"T2$"'].TSR61Z.;$\;X=+JGIF[9L-#=TN>P,U,E(
MW]PCE]JBG>:IKOK>DQ@M*=+%Q$&2T&4U(ZC9F_)[L5SU=ZOXGK^B,.'E)P\X
M;^!2^9C,F4(J_(.'/^C^A$C\2*]Q7=(MH;TO&2]OUW9>IYZE\[N+@8<U*6-X
MN\P\2W.GS1UJ3#1C=7BF19*(0*,%A]$]^9\'$@,2@?VFW3X=]*TX56S6+-E$
ME2+GE&H#TN/1RX?"PN4O'PAA@GBT_("[[<NQ@.&.11&VRWDAQ<\25F(*N;2/
MLI2;.^<T_YS_I.Z+TM,77%>;,C\G<2QQ'&=1O\QIRC3#)I=N*I%B&F;LY6(^
M2NU(:,=OB@D-]Y5=5>J*MN\Q4+;2T.\J=_13PD80 8K+/M?CG.@:JD<<7"P<
M4:&P&53W,/^3%P&'D5KR&AQO77]PL(>IN64H8)KA[ZI$=UC2?",V;%.$G5Z7
MC;HC)>I;U0/']KVWJ=[6@!FDY(NJRY4.6AE0,N%"VV:$*>WZ^J")W=N=RRE/
M"ZG>*7,QL5>1;%29Q ;T(0-N(Q6NH_9"*SP<=JNE37/EHJ8E'IADIEZ.)*5)
MGR\]V(_^4( !=?;F*]VVI&U-K8'G.9#I^,Z\F5S47$@T6=T?_JS02,$D(/MS
M\PK@,R&V<Y0'OXX&M3MS::/99JN+-M_VRP3=&1?)/_CTDR/RME><=)+=V@I'
M=&%@Z@:."1.\UWY6D'SEY*.4XJTVDZC\40\FGN!%_D\BV^"DOA<\/F1[76;
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MY=4+)[DJN2R%DDS9:2#%,,!1>&N@09>[R?WJ,816DJ\_5#+4WH$;V<:TQ:1
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M@&O\/71/3J^)E%3Z+UL4F;5^O&Z_#N\ 'E_*P@61^ <0M [.WSJBX>"T]RC
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MP?W2V]+V/4=Z7U($/%!!]C]F18,T[<WUN!H%\9MD\*^JR<$N$+<&X-XU-3H
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MQ.<2XHQ4[/#1E*^>T+53G<4SL.TN[ZAD/OI:HOVN?6MD.A/Z,R3C.N,N#K?
M#E"B@Q 70=S@G#*_A_0S0J2#;CGA*A2/LVB>9-U18FXNU1^CFVXWB$_/?$@9
M@0*\BI<4JI&GR_I@ERS7!N0?=*%AFO@)[ILI@0N[83>2X4JF5'R22T74C1_\
M=%?SULS#['-QC&#PD"$;@[/16;%G4DUFS@#Q>U"NS2V0UJ"CF>7*1?=@V97<
M@*;GM:9L9SM;66EI'=,'1SDF;'2_<G-.;84DG.[=..FI94.\F/UC\03+!.JO
MD1%!4H=B7Q8E1T_M'@Q#Z6:X8)W7M2^%AQ-L+*VYXQ=Y^=[!CP%B=[V"F%N"
MT>YSW),#\EHW<,@&MMPVL9:HFJU.:1"4V[);&=XM=$N(:]1C\?*O8V![(+#
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M,+OR533BY?7ZD4#57"+ 87US91KO(@B3&_7ON)6N$6/-T,6PG4G^#9%]R5&
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ME#AH/>KB\MK*)XFV1_)GI]83MO<K%8%2.# 8%Y2</Y'F55C7_1GT]C/OMUF
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MG! !W9!3]2@]J\D_;)46TS-.PVG/U"]Z.JU^]*I=:1](!"2I$P&)P%\9 D1
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M?S@:0&K46WC L:G[R4UO_@X-\.BX10-^G<P[DR44(0H4)[7[7T'E^N\K ^S
M \[W#OI+5HO]$2N_*Y4KM<U)],W9Z-."P6;WLEGJ!1]7PK?C[M9NGDZ6A-9N
M-C'6[\:>G=PF"BSE0,M,Z*@G&G2[NA0&M8XCZ"G6[N_F3(K)WF,"7$N1SS_6
MC;\*;*O^ZN(&]!@K*J->C6>E&?7JV._G]HQ)*)I"F"*NP6_^2:I;_V5=LN-M
M6J2OM[2TH-,4M0WO,9&<P7$4/\@N5^O;GYW<:SB(V_S,=R$P9E"G.'_8Q<H)
M5[[U 9(L@<T11)]4:&5LUPG7VI@S#_N;+@4RR#)KH">99VZ3M=V3N$*Q*L?]
MOX 8%^5U5*]-9"B=OU+),20X-4-"CR\4+;K=K*B[WHL5F8RB 6 3GV8DB#,F
M0G7;-=CL]H9F(GU[C<5.S:L-)7=)BP80782^T![ZC(><>UZ_=>M*%NT#*D;(
MJ[O;;67^3>?ZO#3-<-PH#EREO-6\W(FXF&?2_&E4/S#<*(,C1%^JC(^8$_>
M+HV8K&J;-OSXLUZ""XU=1X'\]"\-<.\))\]$*M$ O33D?JOG.;AS^I#?1D,@
MG"Q#/<<<U.=90IA=,4>\KM ;= 4=&-#)P+P?TF@@))3<=#"H$J(J7R03SQ-@
M:]J&%A8+Z).O$ )[E:^4GUMJ8:9_)4;,F>JS8+2J06>3A.OJA:E0NV*F^^ $
M-Y=,NG-Y)[UW-N'Z,06*QXD=_\Q6Y?G/_Y#S__0Z\#*ZG.HE0CK;=XS6F,-]
M8VQE!2<&NFN%?Z$!L-^SCD6XWHK,VI-%P"#N^\A4KL0T*'9J^D>0"\<EYS/?
M F >.0I89_X(.NOE##R;"L8\\(=,5MW.T"PE[]YF,LUMBJ1R0=K@]1E62\;F
MK;:H]]@R][B_.''OO;Z#9W577EQIV&U:MBJ2'FZ&:LL?&4AFB).-%43Q]]V-
MB(#;,,&2:CP1SD% ^'4#<G>9:$N]9!)LZ;/9*N!RQ;!LHZ*B9_#1XUGB$U6+
M,6GI@2+0MY-BX47+A8>T^5GR?TFN=]+R?=Z:>.91=GEW9Q8S'')&^]J+ !YM
MK4YBB>*<DO#R45K3D$(#$K7>A,PC<=$ ZAV7;PW^]\"_1^H<@Z]UBU%N1GD=
MSXM2!5+99*@TL8CWGSJL8C>^HTCRU!\)QN$D<OW,[&LZ;-=7ON<K&*4 J=I/
M/,E;)2"0NR8J$*\YZ<\2H B[X IH--!37+E*'K DEI9C_"I$-_H6#PT@27=Y
M5)4^?:29V=J205HT!'E'7Y^^))&D!YH_8"^U(T0DKADVT,A&[:E3! O#[H:\
M*CK6[=W+4@\B<@1&*+)VU LX5>U3:Q[BI)'R+W7&(9-[5F)%=.^7X*T(N'^8
M""J>@RI8PFRS<8?HV+SL><5",SB6A"N.<=P_3P@*B>+%P\9J4-5I>J7, G$$
MC?3.-AS#SL4CGA+=^/ D/52.),AOJ&7NN.*;U#-E2PS^22=)X=PBLT")\26P
MQ2+-1-H+QG,<NRLW<$WZ]VPV =4EU>KI5"@7J/!U*CGOWQC9<E/;_3_T1%5%
M;1F=2QNV<ZA:\1!36M6Y%^MMWAG-!E.Q^\")3=/K:?"3:X;"6RW=LU>RHX?$
MI-]J: %<>T4:D=I..9LE$PEX440H6A<RB"F4CD<];:AFNNSU5M_1+Z7R^<L_
M ED:2KF<Y5:.BAY69NSRA).:)L_]XB8;N4$]6NTOI@DS\NR>Q6HYFX/DHG(;
M3G]?[H,S.R+NI>@"X^OM!YYNED1PH 'J!24,RG:Z1I@6'0NW=HO?%./T 1]B
MAJ0E=E$=D0Z:<64J7_RG*F[H,W!EB.2@5EP=U9!MR5QOB;HZ#= .A>+<H&0U
MHT^_YKWRAH&^0RYOL71Q2 Z&^E<,I>SFO8E 5@LN6C+0=/F)RC+'$\ WN/Y:
MB)B-76Y-IW7V_I'[5T(2OB6'RRO:V<_T]+.M7SXUUTTM+C8P85.R@%O&P7^J
M050F%(*L G_1 .S]T1!C!I[:XAO3G98+&>/'969.SC99S4$Z7<>\.4&,GG#-
M T&9TZ.@@ AN1MR_;R9Y7XU<OJPMR:>]NKX^$[9RY/ ]OCI_R.6E ^S988#_
MU$J?FO:"<O?E+*RWDA-6=0RTF)&_E/_Z%*-2RA>L%K1?TELA=_5M8GR+/4H3
MM(4="XI:"]4C2)>=OS^L0-UD[._NL<-'MP)_OYK]/#$JW*[=K\\1T=/6E]_!
M*Y0;F\RV%*H=X6B@ZNWW2EY]TB&HJ^(798CIA]K;!*NH(F;T$9Z;N4R.C=8D
MC\>)OB@[:+<3)'";M:2::V?+/FL1_D,;-\*Z,HT2GL;.J-]U+@RQS&/&1N(@
MB/I:+U4O2#W;B ^&(JMLLR=Y:^S@]Q^[=/E%NL4O9PI!OF*Y<<<U;M;.$BD"
M2YQ87XH?%:YC_"%=\G(_^BIK\B7F-UZQ*%YL"_ND>HYM049(^<'(<,$G!Y1
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M,DDIIT_3A>5F;SI9PFGD511PITYX,7]?"[P0H.T-L*E\A!"5W,M<J/@$W?4
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M6ZZ,W8OVYHX#)S74 WT* [88HP&^1&@ F<P]#QI "G;M1MTSH#B+"KKON R
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M,FMRZOYYWORODR>M\6"ZP;4;0O^SLENN>B%=7C<5L1M3WN>:3DC@"[(/[!H
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MOTJ(F9+/$[%L^IARTR9Q@F##]]CP<=TLSW)QHIO99$R&!2Z^4UEF)@ H*\G
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M(]&5,O/MG")GF$9&<[IVV&LA]Y65_C/PY-M[A;S\#-^:3^^65F+I<*3BIGU
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MWJ[]RT9%8DB<-K: VHYZ9601.W+(S$;]^G 2+'D4MUI3:X!=U^_0-/N'][R
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M-E2)A;[EHX1MLJ6PIF3N:V]VFGJBV)@U(8JC>CMP*6\< A4C74^:?VT#E?E
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MU$L!:;3T3P>M>T!^U=_AAX9Z>J/^EI?]3+GPTMB.?QZH\0K4F0J>AG[O?4^
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M3U.G#@OGY_:LN("Q;I,0P98TU=?@87G&0.>\>=\DA]LULFX#E?.7Q82\>J5
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M@&Q$3-25, 7V34FE?>;$ITF1=7AO.5FYA\22 K""JZT@=MD^@F(33K]EO:?
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MY2T$M(PV_].)^.Y%6;%W?ML _1$DL)$< <Q>^_^:-5, 3K0=:^*)#*2QL?J
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M0 _4="X'9%0Z5DPI[J\0=P\QWR8/C/+_%I Z"?W*'36Q<N")_WV[44'G.IA
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MTK:V#&WK0UP5!6"F*"T6B7$<JK3N"!R!LV0@=G[JFG>I6HN"J>RB1^Z\;Z9
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M;X\_TVA//UB$^L!ANT[SAJ?/3D^9!G&"J_,2'8DJLG\;5F(,PP[9/UJ>]A$
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MKF"Z.PZU4K9[9[%]<2BUA2Y#YI:U"%SY[F]6_$&K6.O&Z#U2NO'K-S&R$J?
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MT7O?M<W=#RR6A[\&/O+Q2A^".CQH\'3A.&4P/0HWQ\ PI77]I)),"19/0 1
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M#]6RYZV,X>MXR0.[KZT/S5["L&$649VG!D?00FX"0(\?>N9+GKH]/M7<V4T
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MR#H=D[DT<EJ=>Y^L5J_/JR*GI,@9$]*:!F*&E_&XW+1V5*;[?:-,6ZW_;,M
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MXC2\%^GDN4QQ8N/'ES] =+"8 2B]D0U/';$4W>WF.CP#3)< R F\#L0WL@F
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MMS=_B]7\Z^DDZG5S'NPVJNT.*)5![V*1\9=P4U_=7',TQMT(B!D/),>O%1$
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M*"=ZQ3F>_UAFC15;9,86DBF_H0RGH(YIQIX^?WG<![,>!SH(D1IM3E6H-":
MT;KO!<!_ !#?9G_.C_RNXAG(:GC;$JM>FI4[P_?[_#Q*IIOR(/,K"3D&Q.]
MALKZ6/1BYX4-98\W1R52J:QHXJ$D=.N_>;(MOY8_?1H353GG696"&OB,_3AI
M^N^7 _8ORW$D]/\\W?_6(@Z&@JRC+SLO:86OUX7B,LXDMSD)S^#23@#,31
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M"=\F#BCW.Z5',79M[)3XYH$SO?Y32$CHIX#23IRH SH.&=4M3^M"C777PA
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M%'5IC..?7#GH34//RZB'M2/#Q\553QB_HUY_6[K1\#%9\(WEDFW"9R;])EP
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MP6R_1E1 L *Q>6:^N[9-XR#;0"Z.8,VWW[8>R/QT3=17B>10R)$X9@>GC5$
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MX.9ZH"+S,7W>I-V@]5//=0:OX&Z]823!U-.-<<;*TMQ<VXWCT[R+TF/MQF-
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MZZ.!*^9?*  <HQ$N_W<(;RB&YY#;"TG;./6E$\].Z'#QR<:?8PHI@% /[!B
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M!^=UKV&W,OL6(^.[4UB0K]<6Z?YH='RPZH[H#2IT71AZ"]# &EIY[Y=W+Y,
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MR>4[PP6:[/6\[_%]E@.$_26G%$PX#&?/3115?TJZ&V;&("IZZ[>'KUP=8_*
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M99-C-TZ#TG7#R_;FYNAF&RJ?1I%>FF25N"8J6KU*PE'(37FB.6Y<C=G&$@7
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M+V"@>PTJYHAX/%G^A*?7>.G5@,/ +8)AY+X6K'3J-I5#Z 7=!RLJN^@"V[D
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M3J2+(-MGKA:_?RMW2WX@N9!9Z_[F6.<4H3>@[2'+_R.L^^59^/7S.%J699(
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M^^F#JI7>>J GOV4V$7V@.FUC[L->(:-%VF@OY6[,Y.63LBV&%,M@K]PM03-
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MW6;)G&E>JD0L#TH TEPNSWL4O?9:+[1AS8HX9,3^)5G90.Y&$R+[M(3\1.Q
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M E (6';*7SLA!WI$:]GB8:/PHPZ$4JIQ&WI_\++)#H6R]KV#IHR4HD@HL%&
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M&%EB'8^SED"1?L)X"[85/T:DH\CWBF=6,<]*RY7?A! 3#6L-^LR?[B!_#EX
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M2 Q0,.-+KGG80*ZT0Q-SQVI'8'LO?4!\8"SB9!3I -\]VX#ET6KIL__YC[/
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MF,VVXF9TZV]&UUW=1+U+"KZ($MO@8M!S94P?80UV(?E[5U/ZT#1'D3I+3;6
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MD/:L^W]-L8PJ<?Q? ,Y%.]2"M%):E^E[2ZNRM,Y-RO:QPO+\& :.W#5/>(^
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MO@"<.=,4!?D'/YL'SY4ZU;+5ZYCR]D5PAXXLN U;<\APDB_BJ=$F^$[@[&G
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MN/QAP +M067VT'&/;N104\,/>39&=U45XN>)H_^X#C#>(8>ZLC[+'DU]/K>
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M>-$MOB_!WU.2)'[<\=2/ZQ+3(;T7%!HB&XB;BZB$DF!CC&<0X&$:J)5LZU\
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M.03/P?X"8.^N3</EELJ#YP;^*R+%(3'_I3'IW?\X.D)O,O]A7>#T7\#^R5^
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M.)B]#!SDC17]%-DO_MP:)S(BUG.C&- NJ\FAT(Z]K:XCD!D:D?T5DZU^W9>
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M(L$%XC7FX4UWP3C,SHD?'X"X7\(QUJ.C]&R3>]D-C@<)_ E=_BBH$$XLQVX
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M_2_B!2-9?V4._T8D6N),-T";@3:X+V>9)Q][<8*MS 1@^",(>R63Z!A_E"S
M?Q\<<!H<B2<;\,4'1+_5.'?^!D\&$UU8BJB#URS(A9/]4.),C+^'FS^*D(+_
MS'T)P!N;!+B*(8X2C'L#+SN)^[= X0Y"9^/,"("J"WSQ]N^[XH^2!W&%_XBH
M01AJ-\/5(J)^B8X23W?8*HDW/A_&#=G@F:RBX*M#=+C+AI@*<ZS"$HUA>P/G
M=DT!@Z9TK>JS5RXG%L5* <*1?PTT1AT+"-Y ?@Q-6+(T?ZV<VYNF,>]&)S^4
M]?"JY8I^^[47VE'&LR+Y*XFFB,D&CTCE+?@5E!0;'9V)=M+,\]V";X>G@MFM
M:JK6O[_B%BH+2['-X^VW=;B8.BAL>&.FJY!+ZVSH!\>7'4/^,J,@_R>8XRAE
MHZ762&95]E&/>@0G[2C*H"GAR(=APX>F9?W>]4>%ET$Q"[#8GUETCID=J7P3
MS5N,]J?^WRW[5RTT^8IO#1& >1<M5K2"@HQH7#BB^=97B)**[-#HZ,N3&K1:
M!,>'^P5NP:%[00I;0 5E,^8,R[;GMPWNC'=,K8X+EAY(2C<UE!PIY]6/OJ2=
MG"G]JCAYN?F+4^=1=/,7M%VDYYR^-,TSSEOR^KFG-!C)89%HHZ_QO"=(H1FW
M;Q+J\NMJY7[WB#FI$\)S],7H5OYHTF/F'CT/^PNQ0=?9792H']'#E-1"?FXC
MOQ_\V)YCD(L0Y;G\M:S^4;1U4-=;)2Y(OS_+F9J58PMO/?K\!+WSI:@_;Z#P
M1__2G%H3+0;ESR#]_L>"Q/7AKVHJDI'.K_'*FT9<2J/*X.**L&J!"=%R6^,F
M)=_]00<129\P!6^:LK>4RWYG]\FKTQ5'*EJFH4_E,JP2CT)9]V7ME+P]>WQZ
M[Y;E8NVTO_-FZ$O=_3*66Z>4#]%[_J8OP+CP&@[2&\B.\YMH,BH3<M1=PI8.
M(J989+UJ'_)_*GAIT6X;>9\*?9GO$@G7QTF[5V"'D\-FH\XJ2[EP>*7G9C<B
MI*?G)'>\3+GCCOXM>L2O10FKQCK/E>",Y5RLT9WO8OR9]T:VI-=7B;M=-*_X
MSBB\Z=$%.%M5B?UT8/.+R=3TF)H<^R[&B[/"(L]CPR$7A,F1VA&>8$JL^W;J
M(T6/%%'%.Z,;M<_FI\G OMHV_:0@3Q^%"L':\QP9UR4K-O,H*)W)^ '%R^1K
MB+0(MJ%U)[X[I*+[PC2]XQY9=,XIG;YW3N5'GX]NY8Z&O&86=0H#I-[*VCB!
M*2/%R=<DU+YW9SN,= RR2SLXL#ZT(0!/='H?;Z]/-]6<H:S>*%/X(,VLKCGX
M0@P+[#N-:_ ]J5HF).ZLKW%M$C-',9W1').!F7XHI=U82Y*4;M_ 1,>X/,=;
M;:>/1N4?=C",U+DHL'+$TAK>N\\S#[D!(E^3/=[V8XXHT/0=/?]4_G!4\GHB
MF;-H]$ZGQ+"E89E/Z[8 >J&32P#KB=3W?CP"=3X,4-+-W$I)%+/D$):8#LQ-
M7<*9H2LZ+#G.T\MH/V29_(1#55_)@&Y*'GV<4S\^#SR#+V@%J88CT/@4:U'-
MFC0')]%[,4XW@HWZQ73=WH/$D+KRFQD. NCY1,\\SEM0L:]0Z03]C\EKW_=T
MP==9-W37QZ?"86=MIG1MVS;MEMQHK51IX:CFP"G=YJK*%_26,\/U)A92(9TD
M[P[)C&BRB5Q&(TZ,UQ&WL 4=WKY'K02 0O^T4S0CQ57YM5O:55O-Z5+6A%MM
MT:N1P&D^'?7:48W7Y-OU)Q+39CI\(9>WXVTB>K4>DU)J%^9OJK*,--WY7E.2
M:[SQ@O']X'*E_F<"4%7'$7AUI94ZD-MAGAR=\@HGC(+3F_[ ?H7 WCH<'W//
MR1X+,V3NRFF>1BX2<8",L?M([9"FNRW<U7$:E1B!']*;DFY!=S-?U.T[Y9JO
M7ARAIUB3.C\%3G4]9J0;]?*J@YT2Q*\+T =M<JG_8+]&]996T46X \\+ZU0/
M1V:&*E^C6O.:?IQ?#$9XG(S2-YA8)QBWQ33X=YM_YD!$#>D66R&L0D0.2O2-
MNO7R-J9WWXAY56=\87JEN;3V77"?Q6&6I>1M<7?+RT6C&HT"AT">,03GPU^]
MA>P2M34IP6](OMGZMX<HELA9F0*I^^W3EW*>)WO[<J5YODB0'G"6R75FZ^M*
M=LFUEN1-\$W05\ )?.HOF#56C2EHCNDD3_U9=K];& !$ZMJYA6(#R/-@!3U$
M0P1R8H/1)V7^H)(?V)1'-1,'J",EI2#C^GJU2$/TCI.4A6AM-XAYG6VG<6G0
M3W/T!>9B3=QY54&Z[$$OQ)TU<>"Y]WN:U^85 B&TL"R[[#F8AGI+<TU3_8CT
M9M2 -3-5!)3'X09IUA,>X3C'Q$?HH;BR6777PO4G<OOM^'RSDN?QQ/CN\9DW
M\"J*".2\I!\YTWSI%$R'#7'--7=\LMHQ=4L_XH;P>RO8AK>+=H&!HR'@#Q^7
MJ?-4VK;&!D)5!^ZF/<Q0N;&.G[(?";IWJU.0VD!JGR2ZHBY+N]9TNM,&>K49
M(3DST_6))Y*/\DU.%N!R\<4,%JR.&.<ZI6$T"#OYM9^ZHJ0SJ16HA6RS4\[P
MW8/T*%.=Z<Q!,GC0R_DE F&_:C DST,6=%H<RDLSGWJ8C$=S!(<8Y;@.FW9B
MM*.;K#"D=[%P)%69L%XUNOP34DFA[(Y4WU2\]@H]^UW*+:5P:QBOYRH 4K.
M"7=.34K\-%]3M.W^*/8\<MY,?EK:S<WD43F)0-'54%1<F$V7XJV?:]Y>&9S.
M"(H5C7Q-=XCWWO:,LH"]Z_?0M^H/!@6Z"0#'1@8)>C#]**:@O6B#Q32F^977
M,>T#NM0S]SJ/7I3Y<BO16@[>@0(C,ND@G90N7^@KWY@/5<V2IN9WMGY;]7%=
MWK)VS\C) U[BE+!R3Q<']!]M/#2#3(<5>5^=^Y;?(2\ZD:VI<^<^]9L.H6@W
M Y]!;^&\GZ*XV@$'H#E9DBGE!M\^)PGOS9?/@Q-[#2 =I2URL#C31@PH'-6
M[MXI8HZ0S7$HM$^Y-4 M$@[A_;#JLD&9^;5N]_(&7FG"WP1=><0\6@VZ8H&U
M7!\<^B0];_3.\@;7O0O?5NM8KTF3'*S$+P6PJYUI'UG&/\T_SUIQKC3CM7Q*
M "#VUS9\QSPR*=9\J:L&\HDQ(%VTEU'EO\4%:KS,,C.(':=;_@/K?'<,H:^B
M_+1X?H/97;1K]TC8]?F20*(+^WN&/B87@YTF(R4,2T]#001"!:PW52JZY3E(
MUY-J6S;\(]>N]IW<+@^1?"0N&KOX7 I2V=5'ET?EZ%0ZG*J\CHYJI8&^C(]O
M"L$*D<\+U1^V#=^U$.]45(UP=W4O<)"596$AE]*#O(QO*JCX]GNDPFRVQG*)
M6M%:P59F.J<A6.;1D^UO;N9UX[:UNDTI=0]B0E>H;W.Y*(X@G6,"):&@'CP/
MNB4\UQ+KW+%B;U&QPV>65A#)O=<@%/.)T67Q8\UD.Q/U3I,&.KNS&T1_0  8
M-[2F3T>G[J480,5V1FQUJ?K*>?EB+\FBV TMJ\?FL>X&3=4AC#:.^3^OB9KU
M_7;TLGRVMW>@O9<5%8DN@Z#XB%SU #GGJT_Y?4,WR^'6>=X+#ZE^)?E8.9&[
MQ<(<OZ@7/ZZ4KUDA;/<M-GTM9GU9WGA"++CT38?Q]'ZUJ3=QE:0=,V&+;95O
M7?N&29DH5[/]Q;"_Y>%DT/,IUF]_+C@FN[""C,RD(WU27.4%^(+:>^2XDD9T
ME_09H$\]':0#5 X?]XBG3E"C."6P<Z=3Z3A.[)=BG/J$V'8%'WI[N\EK0"+S
M3J,;NF6+-2_L/@?]E)?D085)U@MWF/==GXP78R+31NE.IAI.KU,?LYI0](J0
MDS1$NGZ7[G0\ZC5 R [+3;,Q7MAR\';>O]Q#Y712-:5\6')P_]*3O"5]1I/F
ML/W[(UOB%<1T\+&KNV."+NBLM"T>^R3Z"&/>SLNHE=!YXQUL3D/X)BMW:#N9
M5Y%@%G6S8<>I;+4M349.KO'"S_8XH?F-G[RQRM0TQ6W!P;U7K>V/+I@I:"9]
M3A@T$<W\:MZ6"]SF\,\*(NE]:B2817D\R=R07E_;5!.Y<^%Q]&]9GKQ7U-M1
M(21<R-('FL!3.A*LO?F@B[)2'E7$1UV1UJ=1?I\5J'N==,D_9AQZXE3R^FV]
M7YQ"TTPMOOB]9R.3_-9;Y-G#^I$Z<=V4Z?XES^-PZ?2'2ZO-HUOEJS#]1CV5
M!B7I.[]Z=*\)9[B.YBJ*96@NRC)W60*UX'JKA:!&M4!5YY18/U<C^RQJ/V)"
MO<965"W7P)4&@S*)UM<A8G!O%<GZ3M2.BCSAU/9X;F.61Z,O/?F"=EY9FO%F
M2_4*UW%X<*H(&T0"1>>)-D=KSJJ]SD=]SR1Z79?%W\=_9(C\T?=;<!LJTHSS
MUO"]X,4J1,@HBU=\3HB,Y@N;Y&? AB'O<<DCHB62B):XW9"ZJC^".%=$P@^K
M3$US#07@[PO)\#(E?_Y2A60_;IN8/O(XI1  2V+ZIJ4"._<C_P^7_O2/K]F8
M1]KV"SA_QY#?SR^98O.WMN.RBF3TR1]^_VGTX'/]%[NS;"1_'/A>Y $\=%YB
M%!' 8C3J[)S[?<?97-HT5S>AR<9!7K[7JNN@+/.-E^]6)NTOBE('O,A(3I+Y
M0I#I"D_F[B4>SCA_-@!#*3R!@RP&,.I@G$.WRD2:2J#J-^1NKC0ZB[1QZ?9M
MSERMS?6710].=5FQK'O+BDC/J4XK<-])O==U]R8OYT^!!)]!  :]NJE8\=J?
M#YE)XFBZ$/9RQV,S7;0MB3\I<]!208'78S7:HZ1%%7T<HLR2O;Z$<%@>KV;G
MQE2:ZU;R]YYV)J\FKX_%OB-!R:@DQ?3D>7)6YS*8S^JXQ-_.^Q#WF1,RBQ-'
MMW:>[B8Y$(#+0P6<::8[^.FF#Y_B\XZBY'L_]6(G6=J:R68V4U>J?_6[21<^
MUWG Z*?\B@O@2 S2YD*0+$]GQ =DST8%W![RN_8UG-Y<Z\%G7PZN6;8"RPD,
MW+ )(Q L+<YH:3QH6Z21YE>7'Y%C32'?QR/?ASK?" '38D&=^,OHGNJR]5H6
M*:OKN@P4LQ2T6A8M3K+!(Z[I<VND?:+;>8T?KH<(I!K)/XK1DP)9"PV61Q5:
MSIC/FOTT-W1^*:7\I<OD&6C[BCP.LB9.@36\C3;J/HM1G1[5]MDF.XK=8V9&
MK3"("WS$U0WIM)>[Z\;=F6@21\V4W1C:U*^.G'E#,_M>[&HM,\GGME..[^01
M(Y:MX%?^UQ9;:=9*D.R0@3G#)W&#^XOO*GZVDR8!0:[QXQP?SX5-CQ>/PKTQ
MJC3\DRPUHTMC#X_L<Y*B[L[\=$WFC<80@,DL.LKLYI+>!2J/]_X@SU*':?WA
M\)W2M)6:C,5[_/>"&W=EZ9!*&-/4VM! D+TJSP@B+9UKQ2SFP17Q%'?^O@B4
MZTFE+CB\&H#5Q"P-I+^XF6\4.SW)05Z7YGK?4)-$0PID2TZ:&#S(7[VTF7Y%
MG3>&L[MT\7VY-6\.JO#7A5*IKY_)?-V$QSYE]+:EMC1FM:U+UU0:<$=NN%[X
M6J451,J_#)0KG+R+'\L0?H>9+X/(E-9@YJC2TDH6:A1YHX1FXD0$]3?WJKA^
M,79$[Z<"2,'RXZ76<,3VLR&\R8$P ;BR\(F*)O=B=A#MUEZ(1 !Y[?+D9BNU
MM+X2$O0:ROQ5YZ7GG3E7ZWTIGY?D0AP<^.9"TF[["B\$6BZH>E"O2_'BZZ19
MW["/E> 94Z\V:QVA'/GKAAS1'SUWS7="EZRH8.Y+AP5OFO0=7(OT"_L>SL]?
MN^?'Q"#5?DV9<;B6B62595H4GW(1,95LQ/QYMLB>-_5&B2!K_T-M%6W#!P_7
M+=DFJG_\2C08$]M%16][U03G4@;0DE_= '.QC> 4%MV?F?],\\%E2NU"N^2'
MFQWQPZ<)ZUS4&,[-RFQUQ48I#D#V]YK]^6L-854>1Y/,<BRUE_-2!6_869.T
M\Y)L:&K""V;7O=U,Y\T&(.Y<<IVWF#S[^OJ48R]7Y#8I+/U"BT<U:12_Y++,
M@T.='>IBG]A18T^=P,>#[K['H1YE$*1 C$RS9RY46-<X0^<ZM.RF1/DEWZ/M
M6%?B3M>_NJ'*B\X,(Z8>%PR1<*H9<X?LK\[\R%$?JM"QM[H"8(E=LWD5]$*P
M/Q_<)H\_7+KA]5Y/'W)%/_["C)O;[&HJD7#J[7*L-IAKY61K?ILUFQ%;SXN\
M-<"ZF<Q38'"XH[CP*I#3?EZR&KTUK;\PO9MT6Y>S*XU;M./0R2W 77<13F,&
M,QU&RL85WMNV@7+]Y(MC_Z8E^S+NJ"9S*$B9-O*P@@'&T]E 7$< I)/9W6%T
M;KXL)5&Y=.E#FI.!;J]J1G690*@_21XV<J;]^(GWE"*BF+Z:[\,[D>A;$O6]
M:W V 'TJ/-T$1@]W3AM\0*Y@:)I2"K3KIZLZ>7A8C\)8 10O_=1DP7B3,)H
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M>TVG+*].B.# T+(!1R.]^L2OD8LZN5+N/21]9V7C7EET#PE 6-HX 5BC<B
M<-.X?[=*R4"I\LWB#5_1E0IG2*M!E7S&4JXF98 "=V+?HEUA:21P](>;"_\\
M3%,EF&K##>NK[PK5'46]O3/%/A6V:./D/NM56OP/G[/\Q\/^J_M_0W>)30<(
M<>G3[P6M&\Q3]1&2<_=N.#!H\:GO"*^>;K1<)0#]=XCYP7F *! 0\4_4[OP_
MW<B'P(A>7$R#U3DL[ISU$'6X!?J3?/#/%S7\["_#T[U A3-<*CC)K[6JG@G]
M<<A* (+%-RW!%N)$@F4;7A2GYR]@ CM&]XSH.5G9O<_U&**5N)V17DA:C\F%
MH\-Q-]&[86VVC>.9VRGV.2O*(>1+22 TVY:R"GK?8'PGX>MNA^RI5\)1G6YY
M7O>^[ES+$WG0P$$%"%/0I5?!@JVA<3&+,JSR@=O5BJ^0_7#O;QLR$\@Z**^D
MB_5RP;[=7$!'Y3@FW+F>^IO_#Z%+J@^JEK<WU6AU+M:VJ;RXHDN_T4BB@MX0
M<F;'&NE^QH8NG@E#55G+G')>#5**#UP7'8+$92(9^A=CM#N+"ICT&L>\Q*A/
M?LB1UCK-^]HH@.ZN+6*7J;3S!@.6TLS.S0QC;&+/5[D7;=(;8<J^:'O2XDJL
MS](A)B7:V4D$FMJK)\G+_/#K]2"I.Z5ZDHO4&?CJ"!2(%B:+PM.?K2V/(?(3
MMJ^/BVR))W@:1[FU%1W@1;R/2LW@T7O=R #G^XFZD2C]B8DG*/UD\[BD"^?G
M+?/IFP)6V%"'0O/ULGR8L_XHM#03GF!C$MT[\J-P5O+'=_)B8K9#6_I\3$:@
M&KV2Z9<O?;'4Z2 "/'H?%3*31K?96^ _-32QG@QG%?4P<2X_<*;5SMN0<]VR
MB]UZST0 ?)Y. ^ 8G_1_.EN].N$O3  2(I8(P.FIZ5\"+<D1WS_QU_;_Z<9U
M$S.PM/#&WP8I3%7&8WAF3F_Z9@ZW-D;3'"OQC>ZV\!!X20N[@ _*/)$C)P L
M5B8/U$#\!* C!M-Z3@+><Z+#B\5A'[3($8 L ;P^\83=/37YZ#YY?RLZQ]^9
M&#(,<6FA!" J!\_D'$-D# H"D.@"QW@>)C&1[#GC!!?8B:<41@+ OT@ D&O$
MXPT["GYZ ?YK%H2S"+#]O?@M\:PBUT, #LB(M%$'QC;\"\^_\/P+SU_QE!$
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MQ[CN='/9:$SH-_=9J6[QQ5*X[UT0G*]OXT\1D^J 7@SE"11K7R";.*@DGQE
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MT@G>2!?5(C4*D<$#%*VQ$,,R5],4ZPY/Q)9VL1C'55-Q[OO\*<HDUC#KB^B
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M.?)K#5NFWAQ!X-&?"8P_XR3;X!>!JPN3(<#'.]"#3/-S@<KG4$?/2)PT"@_
MZ:A=.8HC_<J5NUE@W[\V?$I7')/?"TMW .Q?J1>UX"KS^VV7=8H:<#%84)*;
M<?E;XS01$4F-JM:95X8:S%N@S$@">7FSA <J/<\S*TU )XETIT=X8/H#\>%O
M'W$B^Q>LLLHD%7>3X,$I.9SC<R5HC TC82Z(;GT<%<RE9=+:LG@4+"'Z8TCD
MOM7@3^^K'Y5AH_6S!C-Z^E]0&5&'Y9X:$^_#S1+L@_LY;TD45FR\=.6^J:7J
M!#"^4%QQ*L-$HV:@[(L;YNG9E9:8 -.QSL^%\TWT PTBK&ZY6J0^84.N^_V[
MTT8J T)#=[BEQTW[.!7+N5EK$R9O71X0O3HDLJ_ JSWD,U/_47G3(-EES%,*
M(SSYZ'&J;@2+J&G:^6[<T7'ME]JY<L^ X&E.#IMM=IJ!UE@/255^I'RT]OC"
M-TY.1GG4>X<W*V0\*Z\,B%(KW.RZ6CF>', B67*41M^SFBI( ?<;A20^[)':
MSC\U@_5]EI.:WMS9,FEMJ$)G+\#(!DN$RFI='I,F:XG'?KD33:I^G6T^N[Z'
M?;76"</KIM#N#OX6??_US'0O9_GL3:IZ'<@WRK7+![(9D^)CO[9KSZD^?#%1
M-@X?RU3M7\"X[WK4M3I-G##S8-">99A&B]$F!2?6>/=?ONL>[U.UONI0C^GP
M&HC7^O,E7K0-)!>J@["B&?:[;"A9NUJGQ8_+7>3:-VK+[%VX%&SE%'O%[Q/!
MC4VK*Z,FS14ZN?2Z6+Z(7S@V2/PVK4&9)PF7:.4O48+?G0A K(7S8Z (&O"-
MN(U*_FIJTITP/8=X7]+3R4\F0<UKBSBB-:2K ZYOG/?CTX7CT*TU@Z*C:;^Q
M6Q$-F"ZD'IAA/;TJ4+^\.JNWK&PE<WN!,RK'=V[U2A\B19+D\LJC"3\,6BH&
M8HP,X;R=.#JS>*=:IUQ.99)3<N7:B<,]&;ZE3Z(%GTCWWYEVUZ&@QI.A G1,
M,-8Y#4"C#O==7EH[WA/KE5]K?@W[<XQFR)KL%H)N&MYN38XNF%G-\$#/RKVI
M3M+/?.@8I^X]\):KSMZK^B5M?F;WQ.R7&9P%U$9FQ.1:X.AJRO&)28J16^:Q
MR[Y<I;X4I\)*@#75Y&)G"_U(S<,[^A(_"XRU'YD^.&8FJXTB^OQNF:^VY$,\
M@RA?A :;B>%S\O?%9MX-IDZ]XZ\=%*Z4"AW],FTY^T0H!A.<GV.I3<@/Z-9'
M/*!<=>?[E?_Q;M__7# M//"J  \<=D$/^"W2H@FS68\1]!39>DI?W@>L-%D0
MA@**UJTW.,?/8IY=K7N7XG%?DU;=&/[&MY4J8U^Y!MC0071HXQPYFC(AO<[N
M/0Q!A116!:^(AB!3O5 *<8@=:@N> QJO7HS$"5?5XKKES2>^3O$V<$1.7PD=
M-M49'*[W[WL>^N01Y6GI,A$)PB;>Y]F,,ZZ_'@_H:3A*A_["_K ./%IM8CT*
MP7#Z(*1B&Q3B9 O&+-I'UW7[_3T6@K-B'>,8VQ6_!S]T4*E*J2"Z_)3H4%G:
MWNA^";\ ]X0 >,OX'*%?? M7 UY@(OII4P?K[L(8HJJT1K:;=/P0$L9=F07*
MMEOI]'H2W5FN90(-7Q/X3+W[.;8Y[[_KH7/=.S.8<;+$=)VI8;G&9,&L0XAR
MNZX<?FXZ-'EL^?)LP)/'B09R>?MFTOI/2SCYK\ZU/.6YP ZRG\>0WQB'N!=B
M6E;A@VC:+">YA.Q9?2'>.*.BZY]WIM-_M,K/_V ;O,C<MX4'JIPZ/)EN(-?]
M#*AO!;#&[2#'Y>X'QSY/V53L])K3)$GBN_<^=$\B(;E1Y>M[NDQUV1^!8T<0
M#!@YJZ:R;%V'1+/&'I!6X4::=>2RKXE4Y#[,JZ]/<KO6Q_ZI[+V[(M?^.H@3
MIQAH@\R(4-4K(/R>7^S8\KRX>:D7N6V^T+XZNJ=RVYM[8=#E,:5C\CC?F^.4
MIX#[K$7+*!X@G'\1F>"(&A#-;*"!LF-^B'N)M>QIPMR4@L(EY28:P8X^QT<O
MXR.EZDC8VO@:DEY"2529T<<=Z3.LB;XE?@FB,S\]^>KB<,@QA@^\%KX,_)?M
MEX6YUDD0>" >5@U-"F7"]3Q3B#B48F\)0\L\&#WD,J>QZS3SLMC\["*MQV]>
MTLNYZV@@RL/D29;=LN?8O+@<W>7N*/5COYVC-;))7T !)^S.J UEV!@3&/V6
M8:3!M \7YO_>YM7Z\7,/[W/^\;&C1QC[4.ZY0*&U=O2F-2B'O7S:3^7KKN1M
M[Q0KT\V''+Z]PIR6=K6B[GI'3S ^9<[F.?%!B#;UI \;_J>J1S1!7BM4SK2/
MZ=^GTBOGW/[ <N=Y@#W)=1!S8"K2L_-<YDX]1JL D]$=*II)%U,7>KEN\F!>
M<V;1NJDJWB 1_>CLR;?;*>2.\_Q$>S3U'W/X,6W+T)A0NM'J;3%D0'R3LJHP
M:M8$[9N9]\;=8_=012_V,<MQP86'1C)$U$R(XQVUTFV2,R&L*)@V'W45U;)(
MIP7QD[L_+IF^;L5-C0=<&4YPCT$BGC*"H=;O3* ,H7 8.=8"44GKS $+YTW5
M06$-+L!(%3*N,B7T7-/BA_-5]ZP0]_,^@J=<?$_% F.5\S_/@? B$0ZD.%$T
M+:Q(HJ9L6IOC=-N.TN9R3(>VY7+V1Z\![ZK042/,+219=*34FZU32(!!\?Q6
MKY-?TC65@$RSH.5:"T&'']_:OYS$D?/S3)5AQK[%(KD8;WT:P\:3C<J)<<X&
M]MG*:0L:W2,:.PY^?J"X;8FK.I/'JJ/))E9FHI+\O"5S-K7":MS:B-6^>S)W
M:%W*L'>\G=;!9#+XZ[#M/=V5"3S@O!B3&97MGJ^!F)?J4!>?J-YFP0VKS5I1
M2=7.RTHPX8%&^!L6!8=O_#^?G"^$&+?#.)MD!'-*)1N1Y:+M.V+Q)^G=FSBR
M=!4]%P'--#LBRZX8JXY+<Y=W^)F'7?$ 19-(A=M N=7&%ZBK[)'9A56JK[GN
MDU&W/!,2 9/]PI/0+4_>L %]/U1=AT(+:1WJR:F/'J*>X4I7O&5_]/U'?15G
M==H729[:!NPW*BD!)[!OBS6@&$BP'5IH_\Z4^*Z'IV^\A'%[@T;=]$*(N*6!
MVA<-=:+.18FFBI25W-<55Z6M F);7>?MVJT)U"M"?JN#_![ZQ?S=+UPL_?<F
M).QJXSB#.!SU+%R<0'+CTGB@=(;*N^-Y2'PWE$)5!$UB$FTT);OAX9E;>W;9
MIR-8K5$\U-?GN6J=]>U7W6TMJ+8VX)7WVGD.ED95WNT\*YAFH'1.>9/EM'G%
M[ O[T0G2XO5K/='6#.Z?R3] $HHG9@"W<1%NM$7T:\:#J1H:(1H2W6C=,9XZ
M%*Z$K,^FHM2K02NF_97LWM67EV_'6&Z#A,7-G!"+VR2EV)MHNHZ3T>FR)WXA
MMZQ&/)]PSVB'JQ5_S^!UBE-"BCYV[E.NH"YCUZ'4REW$DJ'NYCDZC7DL!4E*
M5$SJZ1OMS",R%QBIC6Z/]!4)T4O?O%?B("#O"GL>2K8.I6NZD]%@]<7<)1/"
M>M5%7DPV->C")K3:^LX K[BUCM=<I E@)W"/O.B/#UB86E?Q=_D55GO);A]%
MG3 ]-]B!C8>9I\$^$/@H+@T/6,WB 0V=ZU1'9Y6G%PSP )2?P*P_G(5,G9,(
MXX'69 );-@F- W+_>?\_\7XI^5W;HZZWNM+)O48W^%?5TR:G>A>DS[]4@X'
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M2X9]97W>1]6*.3BGDW&(;.6",_V&K  *5I7MYXJ<GYB]6Y42.#UA1&ZQ%YG
MXZ\E&,)T5S,R27Q!O$0.K>D\+R./T,F*A!GW^'F,@<893S)YJN_<[\$$)1''
MG=V^&O&*VF[SH!\ <6XO-^HK6(TS>%4MD"4DTW[MS>O@9X76>6>C2?218X'"
MSJ2V6^8?UN(FM).4+.\8/* A?TOD0(4FWBT,9'K@Z;0!WBCM#^E%'CSM3N&R
M$VPPKM4RX*AV[-&=(23_TJHF2>T&NAV45&.X2SX))8[LE7$;JN4>&!91S7Q&
MZJ=77*6C13V>@3>>V^6V@,+C032RHO::1NMB%W*G;5LVA>-#M0V?E;%L=R]X
M:49/RSJ<<3'I]T1VMGKBKAE[K[35N9UT=Y?S[L>M6U+53$S6+3XQ7S,46/7V
M->BM*]-OK4O^^)JC_KSTIS<L@;RKU.+YC^UNW\S.WAF>\"JF@GAIQ7+WM<4G
M#NAXUH]+E<@ 9\:]0V\5#RUV_Y7:&['?J:<^=0>OZ-@ ,D)O_7B=\0/B[L40
MQCL]P5W#G73^CT@U[G;ADHG9EA-X!!]6BK(IO;3-BS7 3OWB175NE:\!R8O%
M^^P>W),;\XW<#]&N!$^<$!P$TD%4%M11QK@,R[(PI5$=7'.O<8*EC^4UA(25
M@^#6V6@A.:"N[V_UY4,X-DCTAL9'OT>?6&6].,O>O!U*OZ=R1H*)Q:I)Y?1M
M@RU"37?^G;=5PMPTI_*P;(\KAZ[D#>Q>=L,UTZOBGESR7MF>3WQ[""O^''\Q
MK.Z@["7T]5V,QG#1/@;SWC),S?# G.Z(Z,)CJ;L+&Z''.X?R*)*@S 5NKRU9
M#C14NWZ$QV!^KRW1.G!^:%G_SN67@ND<#]J/6C;D@.9:'_  @[0=,D?)_Q3"
MCXK\, #U"8:@/GO7$E'X'B9M/,^]ZJ;&YJ5M[)CS+N7HAAZ]Z5ENGO8[5X_U
MKJ[0KX@"+_FJHH#R:/T< TC97IM!TX=".V;^UR7"23YB*4X.6RN"7+!VP4\O
MLEZ)73@R,F>BWS3A1VLB=H"0&,61!GF;NG;OQT*=SCDFG2RCEDN3"09B\@D
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M#<^]/MW##9X8=P;&Z%=\/2!?)N?JLR2^%B<1KX$Y^_29'#\'HID)1YPZ4KX
M#:@RX4-=LO>4;*KFK>NQ]^(,SDRD+C6:,JA" P7O#]YO"5CLX# M#9JZ0'H%
MD=9\18WX7FV,MN#DNG=:R K*<@16T3(?H5L7M\QM]-:5Q?FJ:S736R$*XE!
MH3U&M2K3K]!F5)8:WH"2C71W9<C,SIZZRSL?<-G2UG?>HTJA787.M?ZI.)F:
M*9K],']8Q/G<6ET$#,&=(,+]ZF/(0NEU$?N-)7U>AP'6A.K72Z\_;]Y+OQ'2
M29S==!I?H9SV*+&M'7=S@%]$V9USV&G_>.O56-3,%ZLX!NL755PL7,(^'-H:
M8C%]=J#-/<0^LMQF-#$"EMN="&NJ="PP5&6<@#FEA]XRLYAF"G\>2J=6_(9L
M\:(-<6+28?;]^F'A/"PPKV>>E4L5?:!*X\H8:WVH]R3E6]^1OL&5/'TEIAM5
M;\^+AQF<%@N#R<=?EJQ1(C8VXLI$14^J,IT=Z?*?17\.Y]EN%5?)HF70X8A\
M2]DQS!:F?IHD+69J6_3)7<9J><]@J+CB5%$S%1+>T57SQ+K&C!V@TJ+MKT&C
M3:_]^%;'M.N<;'S!QEC=5FHCS,9@_R34[J*=@8]A L_A^(VT&%HUBJCW;VST
MBEXO2D<T1[Z[14J# $6.@AE]?>;RL/P+W*HD-55UJ9BV#'N)P%[E&^WG[L?$
MQ].VO+MSL5Z^?%&0;#\M0)9[6-H6V:,T(J(?MZ)I+GSI2VC!#4@.) PA1RPE
M]%R@SV1D'^8JCR1?\V>IB=<>?75]@GS+;,&5U+QB2N7;<95%K0*QE,<;E["F
M,TC'W+:=<VMLK*6><9,/J_7.#B[X%LGN58%"WL?)+C\7V]CU.7R)!T2/+ZAC
M+JAB-PZ"X +^XE@^5&HYRJ=CK [ZRGUR0Z*2R8 [S%'4EOVM=4%9_ED_[L^]
M&4L/18W5A]!G*B7%U[]DO=/EU'7*0]EQ?\0# L4(B< )#9:0?06$1>*N1Z*U
M_$&_L[%IZ%LU>, \]\KO[&M:G9\/^;^0O2?_)ME;?^%[\8 _"5_9T$T00@V-
M!^!>06FA<QD$@->9.+I90@*XJHCBQ)'Q@="A?]*]\#_IWLB,>NJ_P?X[]?]!
M9//_262O%M?*4D,.O]\.  G_?CM S-.[P*,.J?^\^MI^A?[;QO[!F_\GF3*G
MNF6'K9 K[2SDC9 ;J7)-UXGO.Q\)/(";NL04NK()1=[ 6;,K> "1.5CH=\([
M!(34=,$#V@F+5C+G3CQ@GQU-2,M)&(%8A;\0Y^ _B?,!XV#L;3B0D+!'SJMC
MZ8R@*#IH:Q(*#S@]C^/  UH4".(T?R'.&?]*G._KFOXM]-]6_P=S'OA7YCS9
MC_[;WT'_58%?FP;\.TW34B>8)/@"'G!>\?41S5OXN!@3.PY]]#>R_Y5F<4\K
M\\0F,[[" V9K\8!!6_O]:#BAMZW4@_SO?)45__X& "UD3G6N7NL8F^7(3(JP
MYDW')6)7P>>"2BQ'U^%RW&N"WVH&/8VA]_TI.RMM1WOSNY-CC,*LH957,T*Y
M1T$B9)EX@$ +'F RBQ$Q*0#ML0 /"(E^N0;)^J]+@Z*TW8OQN-J2/1&K0D[L
MJQN$)8$]M@^@_\N*[?=56^71=#"NKF2O4,0 L]V&!QCK'H\D O[#N-([TIZN
M4'.$VKV-A\..^TEA;GL3N]OG4L47M.KN:7J!;CFE<,_/OH(S"9]*=9P\17:^
M\>5@U!]3JTA4"PXR%F&*6G(H5VU >F_+UG;XS75?OBAW%7EW!WP5HMMN<F<0
MJYV]RN#-EI\+B09=-E+VM';^<+ZB<C#AO=.EP(D'TT67154%^@!^%U ]\HUC
M.$9[I.T$5I:Q4=4JUMUV3O\1B6;\YZMOR0+$^-GSUD*1X/%(G;1V*(U;5Z7S
MZ[K42G?[#*EOMI[^EW&=H8<,MW*6)<BA67F=E,\?;IZ$GJC.JZQN(0GCR;R=
M9^-#TH7 #86C=BFJK2;T&EC<OT^4,L]7;E"$]ZZO9V&'>69EW$N_DM4P2VM[
MFWM1>_FRYF4%@$XFIH54@&QYMN[NN%Z G$3KF[3NZ!3JDV$\ *)!ZE#7[J-X
M(C.K?GP(16;COD7B_+;Q "03'M!:PC\-5#$ ?#@M!6(QTX3 (42(-<!)&D(8
M:9S%$8/0VB>WS@0?MD/W=CSQ@.?].#JH Z'_9(^@: H\ *&[FD[V8VG-GW#
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M2#%_-& ZVC3F%+,NU.']L<^IY-G70B^R\$X@)/81A%2BQ!!5TA9^I?-3UX&
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M"'G !>A&(AX@),?8]/\-\A\7L%Q*[BTU$Q6/4M_0^>/+G_BP'PSYG?;ZPPK
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M"HHD+^8A&OJ_R'OOL*:Z9W]T(R+2!4$Z0:E*DZY2@OK21$%Z)RHB34 $I!-
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MU-\)V8+!K$#W]L'HX!TFOIA#,!D.D.U;@MHL0+:P$-=Y.+*[#A\U)B>J87$
MSZ_E-$4+_<&+BYIXOFTXH%$WNT]QUXL>ZYF"'>^$+6+JMCI@,XD>PGB7X$;R
M$5;MN"JI.80<VM.=A0_5WQZGWZFGAG_'"&$.;QZ5QT)[]CT78Z --]"F6"\G
M\"$F^;C2YPF>)FGRH&]HR/[NRT,[$?P_-@][N 9@YG *XU'#SCVF0%<.G6NQ
MPI'@B3SPOW0-2H6VLG5@*PHW\TJAYC/0Q3&JM9H.++1C0[KZWU4(+[;GN'9J
M*6C<-0:# V*F7)U/#%_].)5R)GQ_?Q ';&Q"470K8NI'R<<U22W G[>$]G&
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M45DS:;D;U\[7,>ZN;)=U*)ZK=B7-2*4HN>/U^2V)QA=C(L]>NQ'JK#9Y\>
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M/U3%J"(EO669)Y>3I(:S>O.E[]&.W:67&-X0W7#I?I9-TLIR.-(#+C;Y8(.
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MU!R?F&AC WG8Z[-F[&]NGCYG36:,UIQ.IKV7>2\?+24WE-F/N*JG[)GQ5=1
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M/%TITX[E]\Y&':UY>N=M_/S\-WGEF+8(;F7;R0LDV^4-0)>57WJZ#^+@ [;
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M4J\RQ3EO]:5*!R0!2[#_Y7I+B1XZND63+LB"<A"OE:\@\<4C\\IL>270Y?F
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MBJB'S\'C2DM%+]4-[E_@=4Z]&3U/'\_2?6%Y"B'*&W(#Y -MD<G% _V7.O$
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M\=8CXRE&SYQGJF/#@H2Q"8&G4=#%FL+3D#+P@=8I":RO;RP9I^V(!\;D%_#
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MV:,$/V#554U(Z$3F#A[(;H7.R>N?9A01QELC4%R")*;17;C>(4+H79O%T+R
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M-DXO.>1.%U58Y5F\ZHQB%EG?Y"BYL@E:@(@<(U4!:#?Q]!S">%^FR=TM+0)
M11M/=.&H'0[V^<@Z+0]?@UE*&IFP+Y/I"\!73YI':L7I)TC$6VOQ1J%:)_'#
MQA/;H5-T(Q[7>PI!9PR@Z6SJSU8:P+P$X$7>YG>M-FM2XP]!Z.^DZL,W6)/U
M J2_U#9Z4.*X94P/CPFBUA=3_^2L2>$0"*-ZA]75Q]#FINEY1A.'9;G:^"U3
MB<G5,P)J],4L0487^.J\KW89)2SF0/ZER$HAG43F@6H$(,6_Y/"0 5YW(XTX
MG5X?P^-#@)[W!:CI\\0):O$\<7*%*X)^TK&WN-7']3_UK/RGE"DTK/RR_WL,
M@_^T?\2CL+9W_!K<9'"N%2ZVH7K?YTLGFIWY.K]4.)7XKCVC<%_IS<RK2B?:
MQNI<A^63UH5:B"MFLATV=*>6$+^+*"U\%L> ;HZHO%F^EG%8XI"=^WXX,1S4
M8!#QYIM"7F?FBJV<S918V9Z/7,**N/J)^GH#]?3X-/WZC*7!_*"4(A_)#S8R
M +GPOVB ,SCPYX%*?L<4J$_ZX,>,"JG;)6=:52[ 923H*HM/QUZ1,CM!(=)X
M'R-5"R>'-C>XE7\KF!XS/-395?6DG_EVO:;-HE<@0!+P?KI\5E+J$OMI8^6_
M9T1)"[><) =[.\<7#CS6*,Y+D:"2.+Q6=+'T/M]G0<S;K[ZG/I]4H1CD[W[I
M@%6;0OI6GHS76DP&^7:RY5@6)#!%JYI%,\?IOSDA*SI5V1O3C#%+ 5S^Y6C)
M"/"B@HK5/;?(2A^QZG"TS*HK'M):+G%:9IO2O*Y 4U^F=Y^>Z6*=$%0K(5 !
MRSRU3GM8]"X?59VPUO.=T]-,K[+?(F*\B?/LX[($I0#)67X6K9I9GXCF?]D=
MVG$:!U>A#HT38KT2ZHJ\,CIOWB=Q3FH45985FW%N/T)RW\V*YM$^T0.>@]'4
M3.FJ.Z&=:H=T1G,K$[B]E'*R])=W';E[LUM<;,XQK9&6M)XRJ-W(8_@^Q_YV
M:_)?5)'3EO=[ ;K7HES,2DJ7W]'!R7K>:(6YM_$8\XDV.4VNVSK'OXJTWF2P
MI&31BMAIKAU5>C-CV'7*4&_O>>-X;#5"HB:JQ0/*JA,L&5-H)W;K&<#KQCWU
M:/U?]!'O)37]?R4(J[B.V[] "V=,^D5-OXP8DE1%RY]'#>3G(0I8L>*V#S]Z
MG856-,+9M\<.N>J?QZ59F)5<D\^M4'ES*EU)8:6W>O]G@HR!-BON.3:;"C>[
M*UN*^EXZTI/Y&6TO9J/G+"MB+ 9$GV@,6BNJCN3"NMHA6"WX*=3B[4$4FHHX
M\B)_?43=A;V!E$[&<MY&?'5HK5S_W@IO[R*^B8/\(P@ 0@2GT>;PG\"//$*O
MQU]@DL7#FC%$(VEC#,]@VB"\?T8"B2.%HU-_>4+V(W@TUJ3FE6-X=]DV4@]$
M$9M7_N0,;\<1U>_/C*'&O^@@VG0  L?WEV?^;=Z6F(/P/:VYEL,F7":^/0/7
M#IDY;X9::(>#-B&"J&E%W'6B92=F0 !J>(\R'OSUCT/5C<?X6:_[[J)P1]1E
M2 '1;A2CPP;IK>]M@IIQ76W27L=A"KZ\43BV7&XK:C$VJ1JRZ.>ZRQ<S+XR>
M>_X"U)HRE#OO2:>EQ784K4G2ORKQC._Q1LR<0[FLKCV(FEU^SV2A9>'M#4/Y
M':_1$W(EHX?70^"_U?:'X+H/-U+Y,O9^,)?[H4= ])<"FF3_'DRA/HD+DW$[
M?(H@&KTAA<O^ Y49II\<!(N#>(_-^K2[I/VF&9)7]W _-9,WBR+D9\7])\&B
M,'FBR2A*--[&N_"1T87+$7YVE_5OL4K>V\F)\95E^1K2\YM6@=9+^-_ZQ8]V
M5CCY'O$;Q?\@N!U#AX/^N9[WXV_M1*3AK1TM__#7H3EFWO*\U^&W -1_J3I_
M!<?^L=VGC?PAF":WJ&?QO?S\^0P'UQ2J_U)[D7L@MFGPGOP9'.I.NB*E/AL9
M&WFO7,2!PJ,=1Q,"@)>SAZ\DPKET?C&0O>6P+N(9/LF^+UW$1USW-$K-7=^&
M 'N4LXII_@N-N4[&U>AB/XRMXH!XIH#SF+M+A8JA:JS4GM^3O(H;<3J;I];8
M'*,:/:G1(,5^.5DTO"[!(B>S/L>&J?@20XG.)E544%?K9[I*!EC9>MC0PH<H
MV-5$W825:>W!I+0Q56GK1]A0M[2J>,I7>O/CS[PW6Y,];;?4IBH^(J@KP5]&
MR;)*.F'"41F>L_C4F T\[]MNRE9XH6F# P@+GZ$+X2VN*.P6EZ5^4:($IVY^
MWLE=9"WX353\MIZJP#/EYA/7HREL5Q#^0VZL@?4:5./&1)?,!G&K*-JTL.:3
M6F5#6DE3RF5)U59O8)'<N5<I.DM78?F.RL,$%X!Q&.LZRM-[CH>;>VTN$X_)
MN^J2FWNOB=6MGNAJLD8&N[A!MSHN#]JV^;&N>09'7X^8FP7<N#4I[^WH01;"
MX+M?4K]_@G>=)0#K44:[?E[GK:IET/;!,YZ22[IJ ZMW-T;RCH?OB*[57Y(3
MW7HX[+>DFH-307\+S+5^+C^1;U5>G,50H*?WT2>]7*7)Z'U$BG/7=16..WQD
M[P\$0)M-D(,YK=_YY(E4"UJ_A%TH)VHQ8[G<-=SV0\='#7-/JX?5(6=3K3D,
M>+CHBC1:-4RVV["V.QEHJ= MNH#]SBCY^?G 2/N)MEO.WN8759*5]0/68TBE
M*%D6-E/H#/^9"UD]G!TG.X/TM9Q)BC:)/!DNZJGWX9-_Z<8C'<L]J=,5QX?9
MJJ21,EC;@Z=0J1F-()AT6B0U=K8.@XV"SZAG86/J>_6'EP4+VN\'P&*??:$^
M^51AI>\<Z+IG'-W>+.AP@^]WEKH=!("6 #A$ KB;@S!Y2U @SC9E"7^NS%:0
MWV1PBTIPJZ+-I^*T\C.6V->O8*Y[=QQ#OGN=\1I(IL1VS(:;UI6?6&':CPVC
M-Z[GR4I7LZ9]9Q^])RQ?4,KY2.#%I:N4O!E&P',",/*  "2+$(#)"Y&?:PF
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M)#9U-+YH)NEZ*W<R7IZ53_])3^VEJK2X*^TU]%S7N\(X2LV_4-K^<__4J^;
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MZXQ1CY-%KO)07SL9=$'(D3M*U.RI*#U3$9C?J[]:%FN)Z6MZS@J]T*6#U@W
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M2N+G76UNPAYHBF,G> H1@N?+QYB&"GYW05(WC.J,F^J<47]>0F5W"=$>;\O
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M3NL=[JQS>(R0;N;^4(]EF@O3Y$@/U$*V2M,P5$U^B,<P]NZG50&WN:USE@D
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MYLN[!?*^VSU!!PRDEHHX3++<BY9[->8++/@UR8R(>U#2)+)9"%*.1#PR>40
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M>4ZPOZ1L_J'A+]24HHV$]]\3-3?_:1$0?E:9!;@5KJ,,L&>RZ"A0\3>S:%/
M?_YNH>_7<KKT<K^(]T.ONQ6N%OY<X0KW _=O7>Z6N<K;35K']@T1 8:[6:I_
M^/ @[\?U004>;YE$*.?7-,Y\Q.[Q8[B\9P3M_LB4/,^'2AC++%9[NBJ&1\*#
M:J,R7<<FPURCFE?<!&-D;M=.38@3BW*]>3#9,Z%@*15***;VPX "&Y6B^@D_
MO18O_W#_\)E$LE.A"?%>FXN'T><E-$0@N!+-XEX[$SNY8[DHN'5O9:SLT#OE
MV'<T[!(N--&1Y^3],*C@%_540:G^5-D9\R%:CT^;8\6(/ATUGZ!Q#A"1:OH
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M]*%*+T]+PQ@KFF-L>&S)TMK2G.;E1M0^B)N*D0=*1X%'\J5OY[(/U@O?ZF4
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M#?G'8_\SY!1OJ;6[=8.W9H:8_&R=!+A4NTD3K/N?-']-0P,A??A?4$L#!!0
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MZ:1=OIR=2[YGY)"P?+3F?^5\_8>B!EN5O&/)9R7)+P.3M&M14&MPNJJM/E*
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MQ0"SM^.'KS/8L*5N=;JSMB@)?8]+;6W+B,>"OPC[WZ]]X887WP1XQN/ E;V
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M5)*^:=W0G:&11V*:;@'W,-KE9@BO+5H-U'H+10-$*2#5L9[;]OTGAY7HX-]
MSP?'?0[EHIF/5Q W8YU6TS93:-"$<48.DNQ)#-*PJ?MJ9#QY'KOOK]PQILKB
M/#>V'*GZE"P2 ' V#B# W"NU$P,S//)2:5? F[ >YZVNF9"3JQIVJ^[+%\R9
ML;Q="G><XHU+BSS;YL-? U$&#"V(A71CB2;+W;3(IA5"BE2<?0/9BSV]O?W2
MU)L.D@)>%=1:K:[$1R(F6F]A$M^@)WS*9!E"FY]X21(T)G8ST^]-MG2-EN5$
MMF2?L_UXIMLR;95 _ RDJOV40\(KY=2^28O9*^%BH#W@-EJOMLX/$;S-SD5#
M&L6;R#)1<N_HM90A>=]'Y]0+@1?C7*,28')9ON4P 56N3Y:UT;TTH:^S[R=X
M0%G)TLGT$/_'A][^@7\]:IHT_M>S)\"'T?]B\W3>ZHP^O5.C7?.?,@TE !W\
M,N:X4!>T+SWV"3+\IPEZ?F<^$&Z =7>9^,B? ;_ZO-^V4XH#R#: 1PPR_5/G
M%F .HW'F27F4\_1)5CZ1DV'-D5_7$E6VF0*X=F0,^_=KK#'\QVQ*VF'09Q-O
M\HQ2O_[+812F;,'HY[,I.>'WE]FUC^C#H$X0JW_E;ER]96!C?\0D[+)SRT@_
MRP/F$("Z,'@NIS[+<O=?#B/_;#;$Q#$KQHD\CJ88XG0E"7$8T=>L^^=YE!FU
MG'UWB/FSE;8X\AS,T%F',4<83(1VVT,*]&$"I&4[^6'EW6%B2]BZ_'/\1$2+
MWS&4"LW1D<5D!Z2'M3%X">\HB7H%]PAH*I,;_H;0]DCE5^[J-JUMY\=F@/F'
MU(1UZP3"[KI;GY3:MLS6)B9-[7F#UKW..H!1!F<(R@Y/^$D;M=DV<WEU($D-
M0V3E;ZJ?=]>,U-R9EAXR;DRU6'9PP.@"9*;NFW&U(UKV/_$<3"M#/HS^[O-T
M.&*?-_P=?R9H #"@7SJ8L>F^(*SKY&EL&UT D6VGU,%_/K:^-V81^L([VBJF
MD'.E[D$*Z/K[U3NH5XG0<SI47;@3#>K5PH,1[@98B]>95<@'H)MI[)WWP+'Z
MMVCJR/&Z\KY+P3<N+Y7LC.UX_XRW1BTDU8RV/ :!E#T59*Z+W0[N>*49C>VZ
M";2X+#XG<0</>"]'FUC9W(YM+^#$_YH='SF&WM@C)0ZMN68_4T==K[>!BXVN
M6X2;-R%"":SX?\:JRK$!-U'*DYO "P*9QXQW,_^,H0QUUPBDDOWMV*QH]:!^
MW*J':5F71?#'ZMX'LD\'&8%WL4,+]Q2$4=C"7!R@0[YT9MJV-/\ZT?1S+WUI
MV#"",U:"CR7= 4^%<=!N..*L!@O%JF16S/!L&8/!376E:\8*"R=[Y_(+,;U[
MGMG205>22%*V^Z?[!Z#&A-_CFC:Q]WD4P\D%'CW-7B'/=)%'CU(B;L%?8KS+
MO J[6CDFY:0D^@FT[#Y&X@"V[WN&[RL]X2%(MWXE"\_T\CQU07N$HCP&.J0?
M>2F"4A>UZQN29]_$VM1E2EO\UG^:D^.<.&HR?5:""-Q-@\Q=2:"=P@Y.P&:B
M[AI1OAG2+VLRP0/R<MV)0>-^NZPK'WO?387**26G>%PY8*V'2>-=)9D0_!XM
M^W./&SW.?*$9Q_+BR^%[> XKBW<UES-4E.I1^_5"2KM21Z:*'Q,5TZW-'W!Q
MGNCV04VAQ!A)E+@^*C"F 'T76HC14GI3<[?"T,M&2XGL_+S +I7G*^WXVR<!
ML -ZN-)@S]'<>?08HZ%!+>URU<P\"))UQ;!-IZWDZ(VG1/?Z?P6WJ!,$-N(0
M'*<Z:2M9T8+N?5?JJ=(S9<DCOZ:4';J>M.Z>1UU?6;*U[&RZ@+D,T.91V4,5
MV\:PV"R!\C6-TL\Q$5M?&>-\>LK>R2!^]N8$]5A\E)STXZJ!)PW' 9?GX(8W
M'M2AR!4]!U9> P>@6&_$ 7+^A8.,;R9"#PIZ3>:CA27JQ0&ZM7$ 4I:.MF/1
M+2"&A0,'H#<%Z75X@+Q/.':TJ *'_Q[TAQXJJ., X:YF@2/G#%B2&P>./?\&
M=S.C/,_BP@':;T2L3)[470DZD>  ([TW94L? J_T.%"5S?R45]$^6LN^?P5K
M;=>_&CB@/,F+ &[LX "_#,[9Q5'XIZ_K,5Q(,PU])QJ5,O_RX=W<>^_?SAZ5
M.@Y_G[FL[WER G7']J==]I]GH7YNL?./GNR$AVM.?CA8>]:05YO!;<V>CS\&
M.S*KR;O]?.)4 <01W;52VHBI\VYRJYUE LV(!WH#Q;%T63.Z_US00U+%C3.]
M$Z]31,X2CX#+JF[]*FC>=3!(XGLV64BA^A/HNMW/GF?7B&F$_$,22GM SR5W
MR%CJ6V=$;7.%KPXCW6DVF2)+W+)$#T_@I]*/LR&(5(<WIU>;^+<'X\[?XP!)
MC^9O0D7!U:MPS!2Z6G%:5S.8?0(OR)V0X_ WJ"\PYM%V!' M>O$K#L"\29$:
MC@E4?S<V?ME6 'C+9B%ZP_C@YLZO@AFG:*#" 9)I<8!%KBMPMNQSCN7KA^%*
M<?]4Y*#J *XMK&#/.59>*G '!0ZT]%X? GL:\7-?!'[6I0BAQE+9X@,PN7@X
M@# <>/8;!XBYA]:KQP%2P%F7RX&8DD4%C@@<@'A+4X']G_PI(W%W;2?6K+SM
M(!0'0!;A )\;9['^-VC2#5KJB:6>;FNX>.TGS7 &5 >TWQ2WWA0[_EOMXL!E
MX5H<( L,_4?VW$VIH\C^S8RX/0>:XT@"O,NZ.TMY[G$S!5L-<(#(/"S-CM/Y
MZ;^CD&&,\@IV8TOEBLL9!W ]SB831<Y:_FTXZ&_#T6_:4$FS6?_&SO"W?OMR
M7R\JX-L!1B47NW15A$^)I4D+/#]M^"OORD[E2S;P<,\5!_"#8J:64%>@N>N'
MG<\B O_J:-GU]490P[_U;WC$?>#AP<U?^L6A(94Y+X"?=7N^4&$YQH)$B1J8
M_J/K[3H-%/]C4*:0F^A3T%C&=4+(S; !NI@3LLXM15:!/9DBSVXX= (4K\ ?
M[)SCE@O)Y8G?/67L6 $>#N( ][3TA:[(S_4[9O@V:]#VV6[7?/BL7!S+$FC\
MS,ERH0F/PMMT'C<T3F-5_X<=/8KS8,,7Q/:O0Q!!8F$9#_?;?A1@_WP[T[IQ
M"4/M]PJZ =:!U@/7JU?#&!T<P%KSGRO]<MO!&[K5X#^8]G6B]#]SV[@A3P(O
MZ=\Q7:-I-2<9#VM._)'4ME2\;,+_G8_SL_^,9>O5/[]/N8Z$#[#//4$GDSC
M,9>!D ]):1% ,FI$UOLP<%,98GQ,OY%EVY1Z6DC /!U>8#GK!@$'*#E;<-7$
ME?>5(G1R+[9MVPVRM_FC)7TH<NM'C\<E.?]U2,:4PQ<%496-7"!.,AP/R8:
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MB.+ .0!$98,Q1IT)RA\)+H^7"MUN:M!X^.1^-Y?UX_?[^LP.M">PI88[?Y]
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M\'_MXO\@D4-H3="Y(<C>3U5C%2Q0'H_Y@CNNAMRVA^+5D'7GZ>OP]A=6!-X
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M8SI;/N:,/VC:H24H%D&)%U["N."CT\10Q/Y-!";K%&'\<V%?+"0+&RT \IQ
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M=-0/4:H GV=K&(Z<7M3:]D\NW:;@*\XK8UF-'^)M@]]4/Z#H[1BM& 0"1Y.
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M>UZ7YZTS[4W4K,NT,4J\$A/AO^$Q^$R!4ZH(:S3FS^R PLH,KPW[RI[=?O^
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MN](Z=6/:9(/^0AC1I50CV"/C\9T,=%I>GK%<;I85QX&Q;%NL_HBV8?P C>J
MZ("]DS\-)K85&9\3C,@Q;9=-:A[SX* 8U(V_U$86>"5UA><-\4HPB6PT/+WU
M560K81XF W'78"%:8[ZN!Q@5];)O$U\SF&H=JQZ:^I8:9=N<!I[,7Q;MNI.+
M<4.UMM?:AF:K_A;"WD9^$+P3O*U9.SZI'65KPQ?,R'J7J*5;JKE32GSOO/W%
M%J?8J "4ND=V$BTX5 ;_C;%8R6YH)24#/'G>S@?(DK0LE.V6YCIX"Z7Z(<-O
M<B9['7^H5S@KWTVD*Z)/,Z_MDE#K6BF1%/]](L\V)@X*-S 90^6/N,\)J4*S
MA;(KVGX('51)L3PFX?8LZ5,E[Y>\/D0\_+]<Q^B[=_X(#W0A;?" A<:?W6:_
MJ]Z& WB@7'(PPK%INQM^^*"TK_XQ'HBAP@/MH+ZS 6;"<[8<:,7+]YI<77;,
M=\.'K$8>I.[B._/7,7/96R8/IV )?75!%'NK'[@29PLV#]?J962I..T&1YJ2
M?SCB ?:8'BWR\9QZDUK__ O;>SVHTUCU'^..HV4J=1 PNSOU-36)1O8R8EV:
MYIMT;>]/.KW1E#/=%>PU)276(H.BB9Y..1_6TED87E^R\&@S^GW4_M)$)VHX
MK-RP*Z6)KW6U?KY=IF%FO&Q4GN1@Z1]G6N9DY60H]C(8K;T%/MK$ V7%/AYP
M%8P''N"^ *,U#L!\?SG01L ?=908SU[LW_POHXU8_YN?H"4DFD\Z?]T&(/I?
M*1W_'FS&-_$%#X @A^(&_^>=SL^L.9D!5^\R0!G*M8D9+T>0:"@!=WCM"'B4
MSW,3_L@@VKZZP5.*.3PP:8L'AB)-*S;X<M:Q04)X8+OL3P!%\?3?UR[\=P$4
M52C&ZF3# _(E;AZTK&%>RW0U..3-#+3$B?R\[ZH_"6+=?(6CZ$?2B9-OH[3O
M$2(F@TS1$+FM=V.'\-\DS>L-7[SWF([^Y\68: HX'T!F$F_?:WO']36?3<4-
MU];]],M_R:'5$ X"7E@$!<"< XO#Q*FB!G?N%P\6;268Z(G O%E&-+;?!QG7
M#[VFO'JE>=-B+H)B558%5?4S36BL<>'KAH1W)%(1E"IM4QD56%J33BN&&46S
M+3]#M!QS,HPMCKG/&1RK$HP0<?&0/@_*2E!Y+I+3\UHG#W&-51'F)RTQIG%)
M4!GY"M68=VF63BC[Q/56R9.)_?X*WW&2E*O>!Q8[M*T@BA;DJ9C8D$!P#'>:
MFPG+CR!TY"\YV@:[S32ZX4,HO29GYY/*RI$5 Y7RJ'M<KUNI8Q9N!<B;CLGS
MP!)\+G1-S95/?L\_F*%Y)]MI64;G>@N:@@UY,: L=:O*5[$$$]+BG=" 6O7P
M4U[6F1!VG%%I2D#.NU=]>LM+\U1Y03#$0D33Y]"?"'54[_VP,VNZ<)/*I)ET
M:38M1XX_.1K9D5?DJU^%?E7G\4*P\0O51_LW$Z]%:D-XUN,_IWPCC9)<EV0@
MRD)+S/R&7ZE_!'A^4LKI>KORLN_7$^NXL12/TJNHXK9Y%E3I3ZBI"OI.CJ=G
M@?FC%RZY#5,^GN_?<1,+A5DULY+('EAJ.DC[-1:]D(N?Y7>!2+.L?NC0'T,I
M'I<0EHHY4HMVZ_66M&?(;X&]%UI",J$91./>K^&E)@"ZMU]YNVUYZ55Q(:Q*
M9^B(EM9,DR,RO@+YCA\V+,H0S0*NGY_UG=KL-(D=;4M:B/;51!VH3WIHS%'T
M:@\M:'\R,JLHFIM]ISS2&QB0+D&T"_EU5!H\SXRF*>#,*=A@8J[:4+S62R[8
M^>0,)V[;YG]EJ-X<ZNS\=5.B-D)BW5U-]GGH8%4.X-N._'S$(=PJ+S5Y*&>Q
M:R\F?,VO4HTKY:V/4QX]60?)NZ8'LJ\A4_XTVU7RTI.RADO?O5R$HEU<*TV@
M=>KSZIWT 2-\UP*,H]S")M!DK7G?4959.; [DZI#JV,IX9755:\B8SX5,>IS
MK:]827' B@=#<%25&/CBCK!"A;.(C&3E%_7%KI78_JBIEYJ ET21&SA,G@^V
M-6B$ECL.LL^P1_>^@$(\5VX:/+2PM8@B E[\D'<XV*.&3(^7MCH'33-]6;M(
MUD]#/?EHF7PY-0:GVK;(\45 ZWHEP'@X7X<Z;_7G&;O1-%ZN(?APGRATK3I4
ME&AS5[[B.H+&5_1!R*TAZZ'?"RJAB5']F3TWN6,5=L:&R :\!\.PSVA_[K@R
M3Y0\]P%?G9DVG35UH)5%\?+X"LN/'TB@!^6\2FI!U)9J:,]GJ";L;?E;;#I#
MB;H>N.&X/M&]J8^G/:52T]E4YX;?JEKW:.0#:4+=315S'MV(%V225;Y^/;AY
M+^W('09Y8OY*T\SXL?B#JG-^<^AIG_% WYEM$G :!0KUYQ^3Y\#*?F=.9-8J
MW&(VJ'H <I*(>\KEJ$)7W7+WZ6YU]S3?6L%2-(/] H7\S5:A/!?',YN5^R;U
MWLFSLR;W7ZP]GI31JY0\:;DQ.62)*I65F.?$M4#IA\O]UA1?#:_=:XLUHNF,
M.QTI;5V@44%6#5U3+M=D'##IMFIS=*51Y7BJD$[+\[UR3 P4YL\XTM'TU6(:
M,GU]WZ+=$[8KVXSPOX^82X.'L)0*#4^LMX+(Y_& YK@XOT:-K(7 *IVE*G,O
MZ0HC]=B)'$HTZ6P*>S^GN]!H2].*KO%[: M4RC*)6TY?*\=* Y7U4W3010;C
MW=M?_<7I]BU9YQ@UODZ.%IZ#=%HB3,[2CJ6^,QM$FK,@_U=K^IQ@D9D9A)J"
M.ZSES2,H6T!SRL%-1\+2@[W<-<4#U)N&HJFCFA"&J/FOVO009CV,,5+0]EGU
MF+.O5-Z<I9G0E&T"8-QQ?["IR6334>#YJ,#S\HI012@IA$&G]+$^"^ #W"7^
MCW8ON8_A9ZPF1M-CN=^)<L,YL_)QP$/=Q]RH/K<6/.#0(%\#9_!5)1C_@<Y9
MY>-[D5_WE6_K[UO[%G#;KCZ;9=MWDRVC3GXQS\S,WC*U!XVJOR-425%8K#BM
MNI]U+N7 3= ;+&9P%P\PPWB :CF?((7^O(+0)><XYKQW\ VA!0SE SQ IX(5
MMB0E?&O>A&)RQMUJE,'=Q"GB 7E+'.F@Y\6K?O#Z^F)3UR(<F>(!.J.<@2]D
MX<3@K9);/+B7QPLG&W@@TG,!U?#GI]84W^"!9N,F3!@8Z0WCP;W;P0,!97 T
M QY8 JV #E;QP.(3\(3C*,[?GQ(;,1B"(-_%LA::S?;G/WK]HW45&DG>,DOC
M)3^^\"><]A 4;XWQ7+(,\37T$&Q,]'6R^2#;^8ST0U 7:^_=717U#7#Y<QQ!
MDD)^N_:547]ZD7#M"KNBQ$GC>E!8^T3'N$=177<\_ <[SINV)_JO*,G _2++
MZ7MP^*$8W*[E@M#AR4)71O /T[]+Y((Z:)$&!,WJ+Z!VN.$J<.<9&Y#K/@GJ
M/'OV-*T5$[)JZ+_@_*<B'@BZC%LX)^AC>( "R#AFMEC>SY:(D@EK.MZ&[^&"
MXW8JUS$A*_"? :*1=8$CGU^Z8,5SG7:BT;@0+"]U_W<<^ \(P(9C&6><9._%
MG&T]\;VZ G>R ?^99%,![@!SX1B(HIP(,YC&<Y#+7L.,,[J/A4#Z*G 8;#3F
MF7$Q^7DK[A2,5&#)TX[#^?W"<6%Y0YY]A/>6X:RP_(X7<2"8OPJ6EV(:M'1!
MB]&^S#J^ MK?P@,G!+04D16)H/V-=1PI/[RW'(<B -1E@8+K_\+Y]J)VN_,7
M G>6F^K7B:T!7QR9KE&*8A_]0:985=8Y#SKI_M/E]2;D+1<\("0"7]"#_R2H
MGP?+/!<GA"5B0X"(!QJU,#K'&F!M^.*= "D\@%&=P?E:$[()M/(^IFF]0^M\
MMY;VA_%9]/E:W.\W_EFXTW0J$$;U%Q[H_80XF0.A8IJP& (BOXF3*8$+!0(5
M)<EWVV_18DF'+M-BN9_"5]OQP%Z&NBSAJX.59=PETX4_B$&H:SB&S.G!\];]
M/V-C9>E&:*(6 8RV1Q5X?X70_W&G4Z;44$)+-(7C[<"A\ 4>[%V2JQ 1^& 6
M'EC00Q=V+?S;.$W3&4<O@6((3]J5" +SZ=0$K*B5"=JXT.!I-"HO?(H<#T2_
MP6Z;42KX_]WG9V__'D_MRZJU'PE](3D=G3!FQQG382;R?12QCPBM4K_]]QQJ
M7WY.L[#?-_:.!]QJ(N]7>H(''N$8FAPJ_Q ?@6[N"M;%C:0>J\B_*Z6L>X&%
M_R&TUPU5?Y$F<>AW-P*PO$BIID8P7]7QM@OA^YQSOZ:_@1 ].[\_B([N^62O
M>8$^9:NXR/@7S0H?1U832&_HDM;OA+_60PZNR_ET \Q7<9%%]J>RRG$$:.&"
M&M#_)Q_\]_(I_F>]#/]33('QGW656S$:6=_2&]R\&19WKDQ+H'P$X\HS23W'
MJJ$ATL/_272@ZFQ!.FWOS"FK>'+?-5S-GSL+3=Z(?KA'2VJ@M#E0#/-[!;\@
M'Y^Q()?;;M:_;CW8H/.4?\7]>+P48I1 ?QJ^-U^YXVWH:E^4)?'U?U&=+7Y*
M)*EFZ22\ BBN>#MX$UCH#JX_TY1W\=N\?U[2YDZ'*J-E:RW#2?=U;2&NB$LB
MH%K^AA$L&)H'N*SU7AR#N@S3X^.CPPN$O&I8IOUCW%X33:WFG2#"9JN&K<(O
M_:HYW.!782COXE+5!=<&/$.'F?R_W4[]'U-I<I/]2Y5(L=_7X6T-\$/K^,-(
MW[ES#7C79A[\EQPAXQ/1BA'GIY>$HNTL11-G3#F>=D[IH[NYE:Q]PS_[4CQ.
M SH9E0/D#(\)W8V)UL,#I<(7^?&[XTAPV20VPCOOP@N^\[CT%9JF*0]C^*AQ
M0MPTOFS4\04D/#R8-'19)^$EP+WH30$,9=97_23P03SP<X$5DE K'[/,+I.J
MOEE??0.V^KZK,[/ 7=OHF+5[QR)GEF8M@()?WO*J_;>MTESQWUPZ&E:PB8RR
M6S_9G3_KN57QL.ZZ;=B[4WNWMDL+)A3GS%+V2Q_?3IOWT"4-559L 7 O X2'
ME9Z-5R1S7.Z:VWKP>LJ43!4[-<N7^(JB\,J6QE5@5S6=\M-?!+/ <7%W)VT,
MT#%.8T<+?5G:X147O+7C[&AA_,(XQH@87:>\3$K2RD7[L_S,JM(.R,S?]EY#
M(!M$H"IZ]<$_.ZY2Q<W>TS=+(8J;C04X!AE]<@@PL=O"K3B>$>RS2[/3^M/S
M2O:>@A%]A:W6:(FI:Q^EJ,@/TZF?Z*B45C  KR*&GA+Q5-C"?-I,/,,.0\4U
M[VPZ"_ (<7U1) K[KKP8 +/A0J53L_&E)I3:Y,]9S)C,*;G(?7K'_WGY=0<S
M'PN_-T?V=6\ZP_NG9P1;E44^N,C!)#4W,F_6TM*LW=X6RII@O_:\@(THMD]+
MX1)@G)G,4"2KQFWK+1ULP-'">CD%EDX<-C#BJYBW7>9 9S0;_D'L/,[6/4/U
M_A-&HXRNZ\A/Z$[Q3%@';%#+&[B;E3_H;"**(#P!-&/N694^!)0W;Q"K+1K*
MY/@^0NU6W8GC2,B-:_S* [E!UYER$_ICF2LR+\HE;2J=)BI,>HB&,'Q%#M+Q
MN3%YLPM_VF<#8=>4:]NENZ5$6G9?%@"XXS9U9\Q4O)P94)()K-JJ40VLJEW@
M1#&BVPSPLR)*'?1 8(ZBC_A$ ;&*E0MC3K>N6:M8T!NN2]VD>T_E6#@_$=4I
M,5PKIX>Q#"(5+C$BTK<G.'E&GH\=UKWU?"&_)V2C2_(B+(V<+)\+54SQ/S/+
M]2I2G9^B=I-=\K>JCJ=?(9SJUNKJO[P,NWUD^Y(XVM6.>(?Q@\=R-(W1G\LY
M7$HW7QLY/(TQFM/P8FMWWQ4)O\;4FL!!O"Y79"W)=2-"FR0_>U;.;Z,?$&1(
M#BGFL"/ZUYDT7MI'&JH+?RZ&W5\ZP#VL@O]SS6IQ8=#40(&[BI;X7Z\[16OS
MO\\QOG>GOT,CJ-T3WM.UNQD@6DW/("M0N:+<3\59#)//G!;.#%U0K6J:GATF
MT.PO]X-%&A>46''/#2DIH: @'^'?J[FL1W/J%\%*]90LW)YN. JX]$9$8KGV
M_T?;>T!%$7SYPHU(4))(CJ,((I*4()E!D2P,&8FC I($1-(0AR Y"2@(2)",
MY)QS!LEYD)SS#'& 8>;#W?^^#6_WV_W>>=\Y4SVW^W3?[KKUZQNJJ^K*:?_L
M]<L+20F=-"F67=C;2Z\,>1=P@RT<>*QLP#T&!O]WW2#_XW)>?WIM)Z+'U/Y.
MWKJV/+W<6XS_V[%'^#WY:4B1SWP-MLM,7N)_:%ZX#O!;KK! CEE7=:DU&D8S
M'?+<F -T\-ECAV]?"+XH+4>S(/=MY9&WA)-*;JGMW0?QF,ZXL5]9XC=,".7;
MTK543](Z!-NFE7ZCU"LAAE\YH[*\=)98Y%?TT )GU9H,=A:5]3$*4KUNW&L&
MP ET9@<K+Z6%;6@^3=>SNI2E!>%+NJC?6%&L0=QJX7S;4L3_[[7A[OQ]Y%50
M:(7$'DC;?\_ ^9B7H$-B1B2#E/+;O:B64 "E"FEOIL1RHQT5AH6;R6 >,B,W
M)UT%MI]:QYC\>?QRZQXE9XPO2Y5O30S [C%%A$KMNC@R0B^\1DZ%8&P_(FZ6
MR4=DR=I8I<\T*(O(<:O&U9B_<:614@)<B@OO^?*^B:0/G%Y1#ZT=!.AIUN?O
M7R5Y,\/R]<:%>2'M-HZ.N8)*3GZ'2_<2>M80-%_DH4U[]>6#C@. 6U=4CHGU
MM4IF-F&+-YY@JXUM*;&FL"$-KEI+Z.&J^"DAPH(>E'7MIND?0I%TS_.--#'"
M'%7M*8T'O):^30J3#-R^&)V\6#=> H[L(O]P]=JFQ=8XW6@*L_]L0F4+E9\
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M&9+(UU/I%Q3V @=HQ6K&'.F6Q4PO0,BJ%CCPN\Q"V-\^A#* ZR4=_7<8BUM
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MNJ]*^XPZ4:\->FO3Y4*25OS%K&RFG"-!*,]A]&TUI01YP^29@Q\NG0 ,['N
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M0A<KWS5N?V<SU]6((W+C>2+N$;HAR7FI +/O-.AP$=A"S/M4T_+GZ9O8Z+Y
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M<%P81ISHQA9":#S]B#5S:FCL6Z7%EHXMC7GU.>L&,DKMDC](M97>)H0$WJ*
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M*6'%)F.\3L1JJ1DFPI6=*_,![^G9:50;4L3O$C6^W8*S9M:A F/3Y[;B-'"
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MJFAM[(.QL+F \&C"LP--'YZ7\C,?5M]@&@4/JJI*9_3;;>\&A+)3ID?ZRK2
MOM"L-3&AN1Q_PE1:#"2VO_S&,DZD:L1H4-YPM@>OXDN"%LB](@"%#$\S%&WI
MDM0[&(;3NHEM5-AUE+\@53=20I&>K3G1CN4Y5^54.FWO5J>I);CB?7Z^E;>H
M+O(TR;$ ;4!?M.ZO,*E[BEBF[?6**7"[^S@_.> Y.]ZPOT(HW,)85E_UO:$Q
M5,UM'Z,V?S]T3+M4Y)D=6</'<RV%&KI6U1:_)PY;$*1".Y<WJ3&ZNQ/[>*+
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M2-KH^,*>27;_]='%OGT1$H\'M0,K;UZP2>FS76%85V#NV]-597?HRY5]],B
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M6F":!:0@4_,#)>$2\X,61V.2*\S8W,;&!G+Q\3B]1[Z<LO>1;[K1AO5ES&=
M3P2R:JHKRQ$<50,N*7/VM[H')V9>GGI)Z1^$!SPL&;\Z:AIF&YOY7K$*,7/V
MD3Y3D)2NZ?YKPE'M[(;DE%T-LL;'"/8!;G7.Y"VOQ-&<[$U-(EH34+AD;]&2
MI>V_P^1*Y/A^=*D(ECRO7QS=O@B;]G)DB+3NG8KRNG_GF1LW<6I_(&66H_3B
M8,&-#;/2]'L>K,G['I>"&MIZWY\G68X(:6*AV*X[LZ0=Y#6L+EX69<O[T:T5
MTN39F#WU7ITU):PR\&@HN<J29DP:+QOTY=<:%):8.\<^O/?V=4O621Y$RP/Q
M&"KSL3&GRY-.DI=5M1.YK(O>"%31[_0H#1@J'CTN8*$XIL5@FCK)]V9.DL,6
MQF%7O/E&!&^(0,BN36C!ZQ<7^'+3"7NUXV_C"2XX%W$##CTF0/,\3?R4"8^8
MB@.1PS<O O[194/"E;G$Y)\_ED?/S(M2B9MF*08[C4JTC.SY^<;%,Q6E5JKN
M*=\&-\2APK'$J7C #S9X #+[;;6LEG;2G:7*P045O8"R>'MO?A?>2'V>08C&
M6V=2# _+"7#O%3P Q:F-XXU!Z\E3X0&O/8^^T2\5<XO&4.B@YAD>T"L.1-$X
M8S.B\(#4/CR@/OG;(H0-'ML4Y0$I$'>L#0_XI*O,LG3T7T 4>@G!.F!':_#\
M=AV*DP65'GB1<'6></4Y$)T+G%)#*^$>]. !#T3!&_JZJK\68T$83>YCA3!D
MX7^#\*:9W!_6/)X\AF$E 1=;_@0O+Q.U%[K=0VY<^NZ%4]G&V?)-H_@E]1FX
MLH_59F0=*1 4_H:^HU)=#%HF>=9"-L'IBF!7&<@KWURCP<2ER,-%$.EGPW:^
MO9YH1>P3C>$;@U#^:U=X/TG,>3:DYW1 *3KS"-OB/:4>C+\D%@O>R"!P$? F
M9M_+]?  #YA6IFW$/G]8A[+>8_-^VF0<O(%=F2@IB6@>9PT]YOZZ7E<O+M93
MF7;QJDBDOE[OG'-5F;ZSX.05;G6Y8&L-;)(S'B#;@]UV>%NL[PC+U\V2K8KM
M>6NJS7"574%[(EI%A>4JA1,E6L6*97,_&_SE;AV!$ ./!KCK%$M)DIL\8S@.
M+$&).9V$!T2DXP&/[%CVL0- U&5+'&\$KWR>*@R)!W3*I5>%8]B$\8">N3<$
M(3[@ 1OZX 8Q2@S.B07-)(0'T"K3!!G$N'[" Y(#U'V.JA%<,*Z$!Q#;_BC]
M[_)R'Q0P3SX]^O0)9(T%%4DX  $KPW$D'4>NP -.= *W#G]&JKMC(E='A[-:
MY1@#3C'\!FL:CCH9/+^E0[#)"!B=RYVV5!(0+(1I1&B4_XALZ2=DJM\"UU4=
M=-C%6.Z'$]K_/;"8;W&_3?V;T*Y?0Y.^/S0F%[Z*KMNB=!2<^GV[WY*AS'(K
M;70#/,?<9][X^WY_3\;;B#\JM?:-4DN_*(7[![&U_S4'0/^= _:^VP%K?^$
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MBB(>Q  X1UV(0U]/*C\&RR^=J^BIZZ*QAQ@ =@^2OJ4 &[$D@^Q8*"!8/3'
MH ,&"'="N&. !_#KEJ^JT3(662HL VDGU<T*#4(8X >% O*&Y99/PK^$J593
MB"P_(C]\#$'A7A/'3ON9;8T!2*9AV^BP=0P0=&&)?). L*N.4/@AR(HD;\4
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M9ZS"82UL-.'CX3\I-#8VO#Z5CUSIR6WW^:V0[,HS-73%?SN2T9!=<B,&[4H
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M%KD1[2/?#9WW:':>8S.F=(BXG!X:DM$X##(/3X$)H_?[NRA6ISPV0WI;EQ-
MQ?,:YRDI47$WUJN.WZUOL=EU*$,%^YEIUW(BCAO,598WC,M$4U-?QLG//,\]
MX)/\O ?RD54IIJX[?;7:F'I(O1;NHV_S6E65ZGUV1PG.U@H>^IL%_U0G-6)O
MLM_K9C?TT(WZ8[#570]3;\.74K;?<*RYF\L"F%%98G%>2C/.8@K$*]Y^1L[T
M/^;$G)7[)_8B#SYA4]YZFY@D,D6Q:_G %*D#0\WV$>?@]WLSFC8UFI9R#-V@
M>H]'(-ODGVM#UE#C6M5W[C5:1-C@MZBOL//F@I"NRX;S_3WY'UBG6Q&KD"CI
MXX1.NA50 $7-N.@Q\</SIEM*I8,RFE<=P2HZ^#?7B[FYW_*V(?97,0 EJ+4K
M2"R';#>JXG/N7L^)'\>;U -X"L^C.GABQ@Z:'JS2"I]JW2Q$IY&E0PJ^\[?O
M._H*K/$-MSDD.R&'Q\,EY4:\1+%.SE9Z1B-;Y:/6(?B[G<R3GG*\_5YNY@(M
M\GDUJ"C;@;,,]K;WU3*/-EB=+GE[&,B1[,LT$QX0J2KY7A!S4\:2I5-0SD3#
M/P37OQDY'B($=D,PJHOIZ5,X31"H#*%]17$H.[]$K/;:-+@\ZU/0>&"5].*J
M1/QA -.>/*&I*1'_#WX#?DW%SB3U]7@TIW\/_33^:F_1N<EEU?4*:*V3=;]3
M%AY0#KV>@':E(2$>S3^D/!)M+D.][FAA %]C3C.>7#3%>Q1O'"H;+ 0]=%^[
MB)/5+'(RF$0DKDK3A 7,"='Q?]9_KLZQ=3; NT^J^;ANYJ5=;5=]\.4WVWG^
MCJ\OU#<L5?4(.?95LXH6'&ETC><6>FT=;QS&$WOWN>;^N $ _M>=XI![=;8O
M3KO/)+ZRW.&I$M=LN/W$\/+^9W^1[XG=+]0)*WQQZ7"J> O' Z@1B[W233U9
MJOQD,O#\G5I'DW?$$"KGEZ/(Y]E,Y"H;LQ/7:[!!M?-7\*RF<+"(]X+9K$EX
M<NG*L'BR=24&L!_ENR7% _\^,&=PAAO/ZV6,("H1#/P162'/\E4PZ=+T<V[$
M@%[<D^GOUE_##P,-K)&/^A(J_755 )_J3X*DB*Z>91Q-07I+3:\2GQ/9>ZYN
M D7!E 'J&[\!S!%N>+[Z?\[2?JU[F_J9*2_Z<LB0*H6[XT3550>VX83#822;
MZCC<0:.5GJ(Z!)%@*E2Z[.WKK%QYS-.XG:-X'C%!K$]+^W+ 3@-^>E.3^IM?
MI4__;$]7C 4;W"7B6 PE=$8[T:[H8CM%UAQ.SQ]U&QQCF6*]()048'UL::JK
MR"J+L%Z=C7(.( =KP,[Z"PQ:BUK\_,3R&GIJAZK<0FN3F^11]V1)8=L#@NL8
M(/QRIF9M<Z+RAQR9O_0!XT[QO3N*#\2SO;"RI;VJ/UQ/HV\%(/:"]#DDNVD$
MCY- AX)]AK,88/Z-[^B<74M3>J=!/%3DJO$X6*WPU2(8?X9RMMM]SEO/G$4=
MK(8J+S.U\ [<TRL[6-P2K;5V9Q$NSRFM+BG))?]-7@S,!D]M6D<I&\(2(HHG
MSQC?Q3V'T\1!G]I)D%V\^59H@X,*U*@N$&7T6]2B&6!^M/:J@7!5I3D+'V<(
M^-Z[YX2B G15J !#9G@(6J.JZWK-/X@!'E#/S?ZI($L[Z)+Y-\&+#$NH988T
M\S^D$_DJ&."M6 3*[[I>;C3/S*#H?_Y48D36O7HW0["_"[?S0\F"$5O-5!2H
M=()-9 /K(G(_Y"?#E_QZSZ,N45])PA8#)Y[C5,CEPP3-O)91A#$+)0;XD*-Z
MG8>%*B#U66&ULES7WI:/PP AA!!$697WA12ZTO(GZ_=O\=';"FLVWIKH<']&
M#(!_$P/ GT%ZAF!I*))+"33);0P +=E.>'W9 -F N$M+\[[' &&):X*7]#]<
MD'3*&*!?%P,0<_18_A#964'<C\  T?G9<KU[TQ@@$?5U9Z?*'4VC%MJU8S_>
M!;,BQP#4:DB^!"+(V&@^9+6'%<T3[WU!7FZ(5KL0R?^O )=:_R[_%^[_&+>-
M2JJX*KT!+L6A42<)S"+ANH_WSERRA#F>\PLO9>6'#DTX\_5G;KW0^,QY5O+?
MP?'84.:?KOMGA63](J;+,0#'5?KXB]C_7OUQL^T_ZIOP9TF9X$>L!M7(A"-[
M-17WG#_K^T]4W >;_4VZ3A1:LIBIO_V9US]).LJR=N:$ 8;06QX>AE)_ ?\+
M^/]CP,5.Z]>K)*O\_JN#%E2;96=!KCI4UJ<8E$TW)1# _;E*[(MEG+ C<^7C
M:&O/]_=T;UK<.$+R; \FU#K-HKD;70@+L[L<'6UFO%;F+@S3TB++"H:I?IX<
MCDL1.'RNKNM:LT9<@XO[!>[^_QQ+!J^%)&6X%M+J6LC2T[^!S1$ ^>*^!IO-
M%-=.R%9"C&&A6OF6_"&WN(Y&LU)U0OG"O/G4Y<HESGT0_F3EU;N?':'&]7(6
MS *F6D]&-6&QEQZK'WO]\W:'U3C+OD<\USBT-,$ OSOM[]?ZY;2$:Z<QB%X[
MK?>/3GN*L()!6</0+ S\1:5>I<8<KR(M5+!K;UU$":EFQK!HBFO([7_\5X-_
MVE_A^!?POX#_WP_\STOS/X^/9CG]EBP(NZNUHQ:\ILCZ].TDTE(FKW$1H>^2
M@+B6BL9@XO[8?O?:/I^6^"J::_Q"!O4?KN9Y]6NVM:%V852ZCP-_W[*2B;Z_
MH.1W]0PL'+U%6,7N+'[EX:[*_(1Z:(@M^O)!IP>B!@-PF\-ZT=U-&. 29U:
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MB#TB^3Q\&JRR=OA &W='U2.B%[+HY34K48X[\T#%E2[NQL?$J7Q*(IS-7/*
MO'8.5<15Z1SB#2_ODK"<<E^.W?C(6Y\O&,"1N%]?N)%VDV?M!. (FA1; DO
MY3^4>J<-^N(7OIY-VLG(J[CU$<CTR:=D9\+**G8+V8T&?FU.^OW]PI.$!:^!
MRXC>E5"OC&^951+A6Z97Q#YB^N%2<?7"2_U,530//3DY)/05'L%S*)!N<)J0
M/.^>XV[(S6HTET-&0!C7_KZ7M%B[<_$R?Y\&U3W.URI410\=%=X\2YDC4Q3[
M,=C'BFT"5H$A?;4.I_L+[OF!P)P-BUW@6P5#\L]5B56QCH-=]9 :,.>N/@R
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M4/81:T@3)=(05E3.7U@@SPI+S3S7DE]=HG]5S>I M%4T5L;Q,U)*BKO!,QN
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M^J%R OYNZZKQZ*4S4^]4GY=](2/J<VM&U3I$!/B!HB7_>+<J'G&=[7/.6F*
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ME;C%%1<-=S@?;W)#>& @+"Z%?A)+H1-#.H[&6_43[+YDS?<4T\Z\,S_?21I
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M0C=S )BK<+AE\M7@'+^OH0CIX"R[V"KD!/Q5'.GN67_WI7_(ZOF$Q#XUO/>
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M(]QZ&.Z[+]]76MT^'0)JCO=>U]B)T<<YN]#CIX*G8_9_9XJ(> /5-1W7?1X
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MAYF!0=\WO7Z4\G>R1)LLMJ#XN#&,(/,^,?+")I&BHL[K[#+YY(LH8,U\(&V
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MLW_1KX!-65F<HKYG8N)"XO]@J>(:?WJ&B?F/_L7:>2 0]T^%0K;:_B[7_1)
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M=HCJ*]O]:ER[N!%PX8-9ZIM19'7G#GGEE3^S4]L@7%#=6EO=$KO*X2?XK5J
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MI^)]0A.6M2O$ZRF".;42-7RK\ A_Y^2]H?1JE ;=6'_>8 [G@]\M#O4)+$T
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M72CL&(;7M]M;F,QXCU@_Q@GWU(&S8&?Y974V_%$XH?]LU:LY?H\O&N5IL"/
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MY0.TNK276T#'*ZCL(C(5(QCZ%5!+ P04    " #/.VY8=A2\LJP  0 N%0$
M&    &%C:74M,C R,S$R,S%X,C!F,# Y+FIP9^RZ=UB3W[8_& 1$BO3>@A11
MJDJO$1 0$1&DMXB(-.E56@0$!.D(*""A=XATJ:$7D=XD]-XA$0@!0C+YGGO.
MG;GGGF?N_<TS]YEYYIF==_^1O&OMM3Y[O^]GK96]\;_QRP#:)QI:&@"B:P
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M0\R::/3MJ[S"L7VL-G?S2EC!'KO2:58&5\)DGOWAU@^+OJBOAOJ*+X]<PN0
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M0['6I_UEPI\UT4SJ>6]TN4DPI]^$(1QCXUUJNI/:U_7B<R/SC&U'N"$3Z^O
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M5<R;@ ,^\[ 7/V9F#P4FO26U/MWS\>:E-U@O327YW_CZRJ X@&[+(;@'=TF
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M!"^'61V)5TI+E-H#8@B85C78/N__(H4"E/:E#G(+T\N0FO0#<%RB;A$F/+!
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M>;M][S'-R[(@S,G^8A#\Q%7>BBDBP1%*Y_8GWP.5SAIU#X SSL'!M%BJHIG
MOA2NUK6AJ5*J>+-R9-,H%VQ29@)7R5LJ5\.5MD)8#9%C2!C#).X(LIQ;[*Q_
M! Z-EAV<$ Z+OYW4X!UXZ@'!U0X;1^.$85;]X^*C,[,.@PE;]PVW56J?6W+4
M%.[+&3I[@5\8YJ1^2@&^X!1%V8L1VCX\/K9V6Z<BC,N? 80/((]VQ9ITL2)$
M+C>K9K]4?'E$RM%J(+[/^6G"O7IUGP.?"2;2<M=@@*+V*PPF-'GMI_S/:2W*
M,;A[,@B7!(KADC,G*P*3516KL\9YH4 )X>,GD[U *;#W;Y41T04Q,9ZMTF=
M<?=C\_FI;Z90@B^,3G]2>1:R?O9TIA6"Q41EY2D"T#F6/WD&P'UF-TO[?/$Q
MN))M\22G?QE6/S2U?!$V>TSZG6!Z;HQYCQ\PP;.UPO;T"AD_5U+L146M4CD:
M'D)..R9OZ=)S:1P8W350%5N!>5)X6M+HZQ/8"W0B$LFQ%'P&U,&3.\6<UNU.
ME9J+ BD"AMD*HF\F!_XG_X?1CJ8QY@SX([AK-;0N@) /+T%@?KL\13L,V=LR
M=3#><[>!P&X_5.P6^N_K](#Z&FZV9P1';7@$?)=>BZ0I&)'>IS+J9#]0XGO
M4>4:XM]0:-^YI_'U8([5RQD+OY?P>IN/Y_3"SWF^"-Z5 $N@8R \:.-N=*PN
M[2U1]'#S98[(R=5)3_L=SFKIDO#Q_#(OAIYDD;.AO9W.\NWFW#F-6N-K453!
MWR'Z;S1:Y5!495"B$>(.PH/&E$A3>,D$':MN3?S"P-8\MT"<&$V.QOBU*1&Y
MNB<';;@%6BRA_AA\\MN#UD\;(CL*8]K%LQ551+OMQ8IAY&YWYO3I;VRI]^1R
M-.'O+WOI9%](1@1&2E+$/P,TXHWT%W!S^& T-"4MCQNI BO*+F=?4+A:G5&
MB6(+Z5%^GXK!XO)Y6@M.!;.72)<N&S4J5@! E#D9 "!6[*FF@_\SG'[\$+_W
M"+5(H&C%(75 =:5NC$*50V]J:J&"UDCX)D8O<%?>&%PUNOT]ES&FMQ8484]_
MM\L#@7HV-\0?[6%]".JHD64=N:C6PBPUGD/IW-R(HJ=#W'8:$7ZZ_]RD7.&&
M5J.(-DU.930]7-Y#2TO[!9:/2!\(Q$&^.*)Q\-(B]R(>M"1B)AX;I13A$XDS
M^(KZH!)\;@R"+_X.X)GS<]KFZ#XE)#O@^&5SS6%1=>R95NVZ;IB<03'*9B;]
MU[FR/4CTLBR &:FF.],8@YL!VN*?:VR<A:Z"*_J2#-J-&-[5-+<U8+U>XL/Z
MRKLH<H9R<F>5\"!1:;@A;57>"TS3KC6>T!'7QO[<X(K!A%?$X5IT6>5Z?QT*
MQ\BAY0%%OHAR^-JE9:"XUC7)R,+"SL3\AG0W$N"2;:Z3!+[O,V9KF/7#W#-8
M60:']D.MX;D0_,QR9A0$ZX_H;K:+WTH]FXXBL$X*6;CAG55_-?4?\E1FG\^9
MZ'%QWTM 2;^Q@^/4_%YDT,.">(Y-B)P@#WH6S&K,] 3)N'H8$/J\_5Y^Y1V4
MO=M0VVVK5P8T%\X<]0B3V 8GU$,S]46>F=_S1;J)=?4-\1L>1*3DGI+1V%6$
M6SJ_C\F0_IM_/"!B>QO:33.5!6T-:=Y$^@J?28G[:>Q([;>=1<JZQ)5@(NYK
M."H8(V=@377MSK:9DX*.KH88,Q1FHF&<LU4I3CXIUA=! B;;5D%.0%&A:J%V
M1X&6JK01R]:0#[RJ2] $FGQS5B::H I]DT$&#%MCAGE!7W]'RH93YK!.N\BB
M9CM'OI^%25KA\JJBIYEP$"&8L/\F<[#4Q;\ &;*'6TU^D/Y'J"6IL;]I.JE+
M_@*>STV@0_4I=E$30=)C_&K>SV#;7T9M>K\]BF6:9RL"14>=?&;XHO];-OF@
MV,V*%-U^2(# ,O@>)E><?_A:/(YO5CGZYE0Y>>!=4A&[&;A(BV,0:WA?,!5A
M]H^>7W9@ED%'2VVZJ-JGSZ]P_<6FJ\[.-#:!16PV+P8_ _HO61-\(K8>)XIA
M3O'Z&U',\*KJ?!N- W5]69?RE4AC;W++KT(A"CT2C_?:BT,JN)\6W3=PW^18
M2!RO(,-_PSZ]../M3PZ9\ ?0IDA10C<2GI@. QCA0^%,,P^<3XSSIAVMJ>MG
M!_J#B=^AI)$W::_B77D'2!YL%Q_$B\$SH_T^9*EYT>[XKZXBB2<.=^N[@C!0
M4D<B#-_UO>#CPRJ$Y4S\W)J,_<>;M,9T"XWC0C.#3]@3<9:.^L(IH\M)2;&;
M3UICX$)I!$-_2\ K<,4348Z20K@)KEJ!C;[#!?OZ6OONVICMT)=A6755-0&4
M+DD.\$T?^3KM E"S .S] *I8-3"@F.$I%1;:<WW!JVB&$L3)AS+N*_CXV)5A
M)K$[5X;>@#6CR!F!4XZAR#K3,=23!WC@*EI"^FJVULQQ"_IR@"UB;=N*YZ$K
M:C46:6_-S;4Q17JV&Z5A>:'KW BY%)?2-3_YEJZ&3)BH_LJGZ=-,XNB5CI*7
MM\HC8#3R'4(W*7RXTQ"7S+_-$1%?;['E6Q$Q4_40)Z[Z+:_!F$DN@::&:6>M
M@\&",7.B"[D,"R08K;:&+L24Y+U<7EY96\EYX^T(>0;XLT69)9)I$U"&!M]$
M*&OQH!Z8$'50\/1WR@_7+SHQ=RG:GT#[EUD01!^HMIUX:X1"@M5HPKW,HJU"
M@+B840%,Q]1A>:&-##A@U6> FOF\@Z#(T]CB8HFL>9(9@8(YS5_&H75*5E*4
M>6F$YJ=I ;8K?--7+<V-\^FJ<VN0]1D[A1T<8OG(^GBJN9Q*:9E$MR1CB+$$
MHK[/DYX:R0/C$E:+UG/TD%=0G^2?%!P8JTKZR;U33WN*F@N@3SW6Y@62.\LR
M.;G+:CMI -"F^'S^GZH;'.5H_=O"[?V0)_[C;LH&W&< ZA'%]3IQ-(>I-UE7
M>1JB'CLJG3<-O4O9<[_85+^PF-Z"_)'0A+.GC[?J8 Y"_7'\K\JRS>S\I61Z
M%>% '@V0;G/-TI]#<\[*[AZ\8/"CLI*;^VDLEH_:C-2>"<WM+]&0X-KU7@?.
M[O+3:^31?J^Q4!.\J16]WTIOZD'1BK9I$:^F9/2[^()L7&'/*C:53(]@ZPY]
M^^8H(6%)GDL%V+E/,+=5=-[X"%NYS(4Y,G\8FQF@11$</*3:.$7K,71H(NPG
M@/A.71W516(L:V6SE<-WKK!00.W_K9C36&$_DB+2F<K ;K@H]O2KOXJKF($)
M>%&FAMQGH*J1!IG23_(FV+]*[:N@;IHS44$NG^)%\+#,!4SY&NV%)&0.*%MR
MF-F57KQF6*ESEZ70E$C&/&*F<AY+\*X0N)!.=7BG,Z)/-=6A!B,,I8X;M:V^
MIHG[.K\S[X$*/%H8.:$8CPH9*Q\-VA:?E[+_JT?-$YD)(O;C11 DMJ4V!# N
MFB7<ZV@A>* \'@8VVAKK%LF6 LH.(C3*8.G8O:#6JZ:D2H/C-,N]96YB'E[8
MP'A#HN2GZ+S4.5IS9Y>0=W+2&-7.Z'Z%F^.B#R[52%S%^48N52-)6"!)XQBO
MR3A1"]'ZKP^>VGA:OGC70ZIOIXYQH 0YF\<9@N,!GQ&2]6:EAS&5_G'<#I"<
MIN+Q6;I=)H(6]94?81-2 NB3Q8T;I#:Y-'D?8]2S>]^4>C8)Y<N-[RF/C%$$
MN?QN9D6-!LK"<OA_IRTT4Q?M03DJ6NP+G+BRW&=J%!8!M.:)?&"ZXQT#W.&K
M9P">39MV=;FB6>&RGY*1)$7S OV._F\'Q0NS=GM>HY/1]A#AEX2 17D(I[YV
M-03IIMS5T@F?2-\F)/!/8FWS3;(32,;(14\=I<636U$45XY8)$6?K  # S]B
M41X.^+G8^,,<C.G4!I)MQ2R38%A ):Y?\X(,I*O]#IY&MS:6]MKDL15R9.\O
M#,;PLW,E;K;WZNV*P7P3T#T53<_2LA5=&:<BH^*B= UQXE<V*_2?[4G#OT@/
M 7:F,(M=XK/]V2@O'SFV:3HU-6JFGCBM/5,F\U>6N\+AR\MV=;88O_4<W_^I
M\]S5#2K*9T9-T#]Z8G[LWB*OV*X@Q+$5RVDLRB6-^.0B>-*LXL2S@J>Q^C/I
M1P56#&_OH#JMBY3A'7<@^:'V.D<C?"<=W2.K0H_G:_/%REX4E=:*IU LA3'V
MGW$19*'R,^!;Z1/1!O 98.^?<"\S?+'RJ):Q>[86Z[\=:R6XM4X)WX\ \M[+
M@QT7^]J*%J= X=Q[8,LYXQMKFY\K;%:63&,[N<Z>.SC-"-2^-L)HD/4]#5W
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MUS\MW%XO%"?+JBA4D'V5Z]8@3![C]6&E;6PBIWDS/SG\HA0&CKWM/75)A]4
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M&^?=;UWV]-=_UPTNB5)IH]%2(SKMMD$Q0$(O"-A+OVY&T(2$;?894,=:J^<
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M_AE^#2$E/Q1ZY!:%<#OLL.*3+M3SBZ#6PPF9R'SN/^69(*$+-*O+8"=%BF-
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M5_G]. ]1R2@TBN@84]VF<Q 86@>0:@.#IF1$,?HJ"5W)VLBZA<LXZ3[2BVX
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M9 .2ZPF9D6R=L1ZD$YQS> FFSZ/1' PKK(;/:+:>'N2YP_:R&C%[;_L@1=K
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MD47N3B)@<&?UE]^XF,PFR&#1@=+<B3XX<=*JV-D]F+ZJB@T%8!J7XEA^WU]
MFMB\J3T@>,Q"4'=G6K0"I'\J+OU5B:B2%_'<P)/\&TY?X] >?S;&_%@26;%Y
ME/JZ%&IQ T'$H_8>*,Q-D%_-'33\.@D=S9^:R*R?:S9D_+RF'JB[DMPW7.Q(
M#*F%"##\>.#RBTZ_>-?2UIQ M7[0,:G3X"J2?!!G=2,VZ^:(O2_'HS5[*AI/
MH[L@0&.&\92UYMN\2G:<=B@=(LXTVI*,':-?,7/Y^!?@X<--2U>7@+W+!QH)
M>")/-3-<'NF YBJ0^-( @HUJNG/4%^Z\T9[H>S)9HR@U_L<AQG9>%4PYSH[S
M!C<S41'?!(#Y.=#!-V1!AK%C#G9$K'6/1")%L$U5V#W<=*K$%6\WGH]?,:?]
M",2#/S!.56+8I@=]2?X"*-> 8*9?4SG$V$=_ 9VZ+[?NY[[-$0%NHYWKST&;
M5RX?)X;HE=,KR\U&?<JW7F50WY SEB37XQJQO"(0\PA69#:&!>YQG"J/P'HQ
MRJ[RH[WEF=<579L]MUX!5$AY@#^^>D:_=&*B=:O\4WJ#4N*XM<_R=CD2HSI)
M/7<A56<T3TPKB/"Y>DJ6[]B!<! ]<]7<A$M@B=9<OZCD!'NE.IMSZ&<K%=6J
M2L:8[L"ZHS_F#]EV$.^G-"9QM<0E_&[STL5J7WM*V$3\L0I(DP38%^ZH=LRY
MAZ7-XX?$O3/6>D)+E/8;U1 2-0'#E_F9.F]C/C#'W#>99_0%$DZ7P[3_ L+>
M&G%(@P>AK@5-6<J[:^C%(M8;-G+6?PHIV5)+=QC+9D16>=><?9BE^3-/#="K
MHT0'JKLE>?',6-=H$Z"UA.. DSCT9SGA*( BD 9JN+L52F:;?)5/WF\_1+DO
MZXT]QGX_$)UH'?/GYOT2KZ?C3LJ?<P;E/%M$U-==[[&S%C+?%"U S<J=S^YO
M,++!W&!E<\*/*R?I_%G6+N4D=)0%RCWI7X']W4_NXQY2(*H+=V]] LCWO0>M
MG)")\TGEPRA3=\V#EUS\X%>1#=9K>+EH(.%@\4G65B7CG#I7-8>>.D-PRQ,5
M,MQ1V> \$"A4&5M>'S-?_DK6'\VV]FTRT-D2XZ>=_OS,>AT">:3-O8[SAGAR
M2QL'.T4\\>WQ';Y"."0_7EKL<-#43^U*QI\"R>3DPK\RZ/QI]CZ=NP_PM43-
M3>6 H6FI._ ])GAWD^U"%]&U6%O0-E\< :I83?BA9_""4G 4ZPN9?-J,NV)X
M4:KH?^_1SC/T%^ $#LX:'04_/C(QB*\R 7JL6=R7[G=24-FM3 0WY>PO(W2-
M]<OI9]SR)J^$[R"P)BHB"[HU-V]#PSNZ\;OGJ/CEH !&J/=@:ROYYN81PGU=
M0U9JY;0X1>2;?,N> A-<5(,EH>=IAB7:Y2*45RL<5JS;T'7+(_(;]5'XP)3U
MTOWLS%+= #(:);IN[CJOEG7Y_)=,6TD6H;V";-27K3Y?XD$%D[9AE9<\A1,6
MS6@J!Y/R8:[U7ZZGO_\"AGP/@W\%AF9M_6,-=7\!2+[%X7U!(SHQ+ ]OIMOD
M:VO&8)6!FLZ?"8\:9 VY'7#K\G>)7TX,>X'%SE.10_FC8&$ZO8-,QF$(*^%/
MT]3])*&65SN)GY>7(['S)*M\#> V=2;^<.V.B.MUO^%#Q=W/C4(&=,QQ!/+(
MBK[?[T?/=C=-MK5[46GQB.0=R2ZU1J>LG#\>YD!#BOO/83FFD8K6QN(\@FN=
M?38Y])KT(W,\(%"M@&&LX=QYEWM)AWAV,2*_G#?TD0KB/7LD_L'&1' ;<]?R
M,N-_4AXYSI<GLBLS97"C.2\K1ET,+[8 ^;ZW7'WMM>PP(5QVI<^)$VR>@#5V
MK S&O!_PU:KT1BU]\[8D^^'-S+EP[K+DSUE3*^Z?.V9DY1VX <;-X,:7)?K8
MTXQLOTUDP7@MZZ4/F%LLR8S5[=9#C1_L\G2_%/\%^$2RZN!/_CE/*_J1_N?8
MW,C$%.JG@8FWX>%(/[GV,S)VF1RE'7@VSK>>>F)1>JLS9=]+W+Q:OL#RKI[^
M6\ZEY;KZ03/Y[^-W,1@9-RE\?*K3%:K\XI,_WE$49\TG;7#JN8,S;B'&WQY<
M$L]NZ)YB_:2.]BLV@[TU[GJ&W%1%$C>O4=U)EWXO%EA7R:55G/WMX:P3O@TH
MEPG"KZ_C5E^ R7$/*N &6D%O#-"J<;4D^9R]H8<=MR[56C69\;5#-D[E'!0!
MF@6',;>),8+/"5DX3VYZR".1WD.W@>1W:HMW-.YB5Z]D^&3T;B5SB4M>!TS%
MF1VRAWX3,K\89 E?"QQB";.@RK>8ZVV",$"1:O81U(BTLX(V 9(?E^(7^D1*
M=!,I@J!-3%&0+/BZA-X)IC#W%]"RZW.5MBRZYT'QPLNQ9Z8S")L#G9?V_5\
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MUK).D)#RL*LRC$4&O"I[PRSV^:[7I9>$[O,1"9MRL;//8=@+]HW5I$!\PI:
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MS;59B-^)E\]-](,(IE-KX0[JF4]TU-JA';K*? ZJ54*F?Q=Y-#E!$36VA:4
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M88B-#KBK(2N;:1_CC+HPMJ!J;4![1:*^F7]4NRAJ1I?>AS?GKU%HTRM6BG
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M<=Q\3>IS4K-[5RX0[5@-EXG5MTBC-6*#AN2M)7JGC9^T0\)SUOQ4.:ON3)M
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MA:0,UZ53X=YUER&MJSG(TL2LHSC[3:B"X6?FE8V0;_X9$\@L^&@;!W=,9:Z
MPF!*T4N%=\>B\CE+]+VF)]HLOIS=C(P@I$MG;(E\&^2MDY.;@'^@NZ)LZ4<A
M;E%<,L &C8L#GG<V$W*7J\'R08K^6!V#>+.%B4#%\>N8!XR<I9_)O^)22KD_
MRSB2\T)0:2"#:+/G8@8$TD]OLPGS1$JP*0J/J@& K"!CLUR!>,!E-4A;(\A
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M.\=C!""&"-8B$[ @;6R7=O@6LBQ_WMW2T'!!SF"7_'AO23&P[#2.*LP<&J/
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ME?<S]87="M(T73?539==_.LMDB&.CGR<N/O)C^BS#F+RA08K Q6']%AN+2M
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M7(J/7QN\4#4)B/T6*6(("9X#O/L[_RI9:IJ9.N2MFX_P"2<X?V8S#>O7HMC
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M%+_W71:U:'2MD8%ST1S_PQQX]0RAM]M& =OJ,<6KZ!C9>*">_Q2+YOQ#PFK
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M#3;P?'3"L6D0X?W%I@$_Y0?>-#[C=5C*5:_]8$G6]Y'C($2%8\S.6YNHSRZ
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M]_/NY113I%;C+.=8U$1R=.5X]QH/US-JD5<L5^"^,_359=.N%ZU.],G<;;4
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M/U%Z?-O$>_N *DXUA#%P4S*R\6Z\.7?!KD5Z>JLQZ.Q+C$--V(B9(;WS:KL
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MCOH2BTUT]4RZ[*V];:&.RP1OF5XE&37NS,'T =LO8#2'UOWC)6!YQ#U >UQ
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M+SLHEZ>$VZ[/]R+;8U5YFWV:7/]7/^5<6E_"*-X XOD373,J<L+6@<-W",C
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MUB#RER7^LL1?EOC+$O^Q)>YG_Q=02P,$%     @ SSMN6 F!IO"WI@  :NT
M !@   !A8VEU+3(P,C,Q,C,Q>#(P9C Q,2YJ<&?LO'5<5/N[*+QHI;M+0E!*
MND.4$I&2CE%ID&X8'+H[E99NI!ND!:0[) 8D!89TJ)G+/O><O??O'/=]S[GO
MN><]]_/NQ3Q_#-_U='[76K.0<\A5@/"9O)(\@((* "BW?P!R$7@"H*&B_O:Y
M/=!O/QAW,##0T3&PL; P[^!BX^+B8./@X.$3$^+A$^'CX!"2$Q*1D)*1D>$2
M4%"2DU(2DY*1_D8$!>T6!QWC+@;&75(\'#S2__"!_ P0W4%10AM"0V$"4(E0
MT(A0D#T PZV<&"C_= #_?*"@WLJ(B77G+C;.[0EUA  J"AH:*CK:;U+?KOK<
MK@/H1!C$]W@?8Y*HO\9B<B3E\XO[>(=9MJJ33&,<QL+_QLG_+C8Y!245->M]
M-O8'#P4$A81%1,6>/)635U!4>J;Y4DM;1U=/W\34S-S"TLK:V<75S=W#TRL@
M,"@X)#0L/#XA,2DYY?V'U)S<O/R"PJ+BDNJ:VKKZAL:FYJ[NGMZ^_B\#@Q.3
M4],SLW/S"VO0]8WOFUO;.[M'QR>G9^<_X1>7O^F% J"A_,OQ2[V(;O5"14='
M0\?Z32\45/??3B!"Q[C'BTG\6!WKM2,)$Y_?'5+9N(]5G7>9^35@9&^<QK')
M60366(]^4^V?-/OW*>;_OZ79[XK]H=<"@(N&<NL\-") &KC1S&GU/@^:K:/#
M7%3TD3JVD8]+YPVKBNOUJ+SF5"5& F/6)P@$-7#%'0Z?1)"SA4&V!3V1  2/
M 58EH8P$'I>.7L$MT7XT<ZRKPG4S69% ]O36S;4 I*OGB.<&LU+Z<"V;H'J[
M,DIZ[8U'"B) )^LG;!P)X)#T=)Q2MR*!CF!?J:&<=@$D$!0&!5WB&4-6NA7^
MYOPWY[\Y_\WY;\Y_<_YOQ[DUXMQSM@[/6W7&=,J>M=7C>Y1Z_MM]=%IHFYNO
MA/1Y&A*(D:2XN9".K42I?'=3@ 361^60P#O5#8[/ED!../O_4:A(D8%I[K53
MS HFM>CJ*-_1)_[ 9S?Z)%-,1]"X!E;YO'E&B@:^,#)(WMB<*%M,?682G$W
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M6=,0/XV><I=SMX!,DLI/FEVJH+);P)V(I4IL@*3(S$44ET 6#[P.5:QL%:T
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MCD@I@#_1GG*I2Y:4G_EJ37Y^69[^*2(-PJN>+^.6HM[H(CD[XRMI'@[E1/#
MO6PX=@XR#U62!RD/6!O::^.I]%ALB[X$FG7S8O.FQV-8V#!0[*_(>V?04Q@L
MVNJ/JK363NUG4MT[R7L<'X+%"F(\O1S#RE,W-ED%12W8-:PJ"D:9/ZV=8JZO
M3SW \0!9\C<I!K[:J-^\\&#+? @*AI"8'\U&7H/>7 1/JC[RB?ZVORQ*1O"^
M;$07-]D,';_[M]06^%=QH#5Q6Y/I;&\+^.R%5DEI/A+X(K:(:*H\+GT)J!M"
MHBK YCQ<:[#/XV6VY'?O-TW5O5]VP97:4"9UDI?W9!UZA?)3Q<&+H@]$ I:I
M_J2*KV>E37%DN:X[A7<YY(@3P!+7CRNNSX<>_(#RV?P"ZG54BR_!VYPF'^'^
M>J^4;D4)4ZPX$^Y$0=EJAC.K[YZ!)/MC-QPCUUQ',=KV*""/-)WI4Q5]RUIX
MA7Q,H97SW !IM2UV@9Y%@I>=;4L2<)@YA;*?J!,)#X VA(,)+,KF]A[D@6P(
MYPU6#(P7#)0QRM2'^+KV!6PYJG25[<WQA=DE[O,;2!.\8]W-%/ 1&E,PD=B>
M'"@"Z>?Z?-@?7Q#)"Z5@?5[&EUT#5'6P!<C0I\F9>N3VBD$"3@NF!!_0W5NN
M8I*CBE<R-0EZ*C=@SN:+X3D;@1!JA!#H>9C?A=2ZTIE:N8/L)^\GSD'O)P5T
M5=+8/<3D^_PJ>8.;'6V6O8S+I$?=2FPSZK7@DJ/D[LC3^_,9^<=CO MKOL]=
M-X2\<'5X\L!@F%NE70/J\>;(@C+%5';F^82B!O3;LQ"/(8(TC"E"T8N0<L"+
MBVQ=/Z9_KC^26Z!69_S'J^KZ)D]7%6Z(.'C6L<OW_NG@)S F@TMZNN_C/=>8
MB$SZR6O.R_[%5$K]72,I(6^=N&2HY)5?Y.M0$%?8AH-8="W*DKJQ#Y0GTDLZ
M1,"$7^(R"+H3H!$[/S>X0_H\KZRZ:"#J+I:_LZ_GNB!#@!3O3O.LKX[1U :A
MX8+N@I&U$CI/]?U,UCA9M'B%K^+I:E@YXX8N$+)K:>'05Q/$!@DL/U5-R&;G
MLWZ,.ODF!RI'M?3-H'L5T\DY+]/"U\W<"S]-V5;8"8HLNV?B,0WJ]1!R'LO1
M#$3UNGO:GBW,T:IA%:MKF4V59T^"U)+-@H>9^%NKP1_5\'JCO5XY#SOR@IUA
MN90])\NZM4.TL5S?$V,_Y'B2"R:A$7P0%D/]UH![EDT@D]/XS0(Z&E)K9+ZE
M&&^05JY]UR1P?GY18D*\U5RFA-1)%J]_C"@SYR,H\AUMZOK3>K]#;KLS9[%%
M@R<6S,]P.2,>N?:I?8QS;J&[84=KS*F24(;N,6#G%S4KIT5$%#S *$_'$YB(
MY9N3VP*<5-XH'05T9\U[R>VW-N@,EUP$3TR,3']O<F2XG#!!<YCS>'O*@G^*
MLJAN[%EP[0ZK:,C3W:4V3;E,76[K>F)O9<(Q\I28\KL)/1^9+E'"OH'82C0T
M9&WZ,+Q6$;^!ULW>U197#_,-%LY8W*AZ9"0].UI)3JO8Y'I!<>'VPM(LWW;F
M@]0[/X*2#H*K'UO_%-8(U5A0F5 .UC%C#;"PN@KW&BZ_5CHR_^#NO:;<\7"K
MIVI)#[U]C$N;B+7M\WO_.,,OV]'4WR:WW(Q?'J4#!#8YGR0P2@<J/<25VE/7
M*K:243:_PN[HI9L9L)<-XC\>F9#W<@Q?R;[S!@G$%MY4(8'YDC/U"(1LUGG_
M[61>.H4B#[FX6WCC)/WUY33N'R-@T>_/E%>RP/-AN0ARZ9Z.NRK%5J %*>JZ
M^B;EF2N%E+HY-(9O9LY?]N&SY>,R]"90Z4 Q[0!89<\E08"+8GE%'8Z"7!C+
MT-<-!]QX(0B_GRY"&JY3#"]=8PMRJ:M6SE!0L+'Z/IG7>#SC$Y?H\;/XLT0Z
MH;=KI7F.KX3[6D-7FK@-A# B"T-N35>0P\3TC8_ZH7DRWQW;>3<9/H_.80LP
M/5P="L&;AV<>ZJ<,SK+4(P8G#G##%[G6-:N.\];9K/K5&_*],TA1CG\&OR.$
MYPQIPUZ>>/")&Y3SO-0[4]&KH]Q,A=EMJB>SL._JB)Z2%9=>D\R>56+;.(P6
ML#3@0$.FLZOBMYF6972LC+97[C&FF_KS+K1'Y?A*F<^\P[:F:,<\0O?B\<V%
MG7]T.]_!J['!W/149\'MC?ABHO9(L7/8B[QME0ND!>_-M1ZRUE&(D4GM\O[(
M].Y >PE8S.@OVL#5*;VU&MLJ%PT4*[#6B*-S!18S3R<VX4GL8WLP.13_[4,:
MN^\AP8D[Y9=KFWB8^V>E4X-%.G$U&%W;=7)#VF(/L0T?BRKAV]([VL\/=_J6
M'$'/QV7N8 +TB;5_S'ED]N_.*F_<&+Y,EY1Z_RR'['U"R)?_J]GA#\ T[RA8
MWIV171[23I-W6FT;KE5O;?$..B%+).EG-8@\RE00629H@IFG,%PS"7TR6JK;
M6K#7T6F*5[)'T2 X7*KA0&N@)0-L 5R3^ELGZB%PK?7[PQBGZP1K"5=V=5(6
MHOP'1V+[N7SKB#XNH"74DHL8;ER^?'<'_@1JQ*P/LRLM,YS_!MJ9%9[8Y>]G
M)F%J:^Y$,8Q^,66X1;E%ME^KAO4!K %W+H$/[NG'=^XGV4OP0'+[MT1!*U\Q
MNQP(AG8ASZ;'6JD@!==/?9RT0WY8=)^G&I.%081$S=Q$^K]U5^#[>%1 PX&3
MB!5\>%KW.[XCH<IL75WK3S;CGT=2W&WM9D[D&)()[BQ.%6GZ^3_RL9[Q6QVV
M[UHAX)+@RE^1LW*W+=R/T05$##+FI9M>.04FC'@Y'AKMDZ)LG&?>F3T[I/:P
M $V=<M%TSRZ\V&SJF+1[7@-Z$#;Y1;I%EFEI$=9SG(LF,9O?;<>S5I.E5N7'
MPV@O2,$$NC>8Q$KK-S+S.A8+5\&KY==CX+]_%,3$"KOF$@Y_9C!4!M*U,J.R
MXQ+X2=C6YTT5<DAH@O!,M#\OC4I8:UOQOU9U+_504/[4XH\$GH4H)X\<K.4\
MNE#AX/27K0"YIR[Z?0_%$AWVBB)%^0J6A'T;]6_ER(&[#BXM[C2#A9# VY.[
M?&*1C^84</II3]=I=6B*P%PSW*U4)5:*YQU634>,T[$?\%?8]A]PW^U?7BB,
M,3[;$U##\N?Y/$K(M?/-T8PK(R;T;85+MJGMN-7XM[JA/H\U/Z?PW*BJ2JD,
M^[Z6(A<J,#-4E*>L+&_"5<B4.GT8HRQ'D24J:1-;FSEXL.8HEJ(4^W27'6V3
M />:?QK!#>E2+_DF6)[YH6Q7++5\N+2&N5<P4&B'!?>E9PD5I?V:@=WWP3@C
MBB@I$H_9_G,'%7?RN(*5'7W.9K-$)8>)?F?.^,_#S%4RZD #I2'O$+U'I<]M
M!.O\]H 0V!:Z7K3;LV I5CE7?@KG^L&S)##.U:4L?2F;4RLW_8R#?=""<;,:
M+ U3[J%V]@C2'NSJ6M28$1C68!%+G'7R0^-)94V6XV&.]3UDV4BG?=/N>UM"
MW&&'73L_)/1@6T^;6FJ2UQ4F>YJG\ULN/ASG\5CW%V"E]OC+C'1'GYV2NKG!
MEH8=8N532#"(!XO0&@WW<;W23=<E^:RM_\TO@% K4I  XY[]Y6;'8+F6$0_B
M\<S*V3 D23^;@!?>L%9)"F^_4IWD_%%>><WX!:19(^97FWP4@/>IYL[B3S8L
M)W]AG\E.QMEV6$C8#\&32DO]%TGV4A]S"N)<"]J6O^SCOMC'C:ON/RDB;N0(
M0M#JE*K+T#*$(.BLI4AA%1D%5N]8FC0+=QZ\QD@_ATDF/*NR)6X.[2GD&D"5
MX4@^4NU:(00K-UVYU= EA[E;Y:D6&O1:.5@HY<?KLA+SSK6H"3:B.+P[$H6V
M)8<#JV"NM2B[DSYA*=8CLOR,Q-NV-5#PQ,Q&M%'C8T1+3:)Q(< M@K;<:!_:
M@0%^#/W"9?>1G&1967(IA3SAN08[B\>,N$'HW(.AQ9*,7+0/E/YXWFVD*-WP
MJ\Z%Y*8<^#LC*=T*P2CL2SQ9EF:GN*5F#F;F1^@5J_L! 0'1>,[D$-S6Q][0
M*WL24'E2^=>%:_VDWG1^"MU7T7T&KBCG40=ZG1(H,?E>-Z0H7SQJNE*:5R):
M^8L7:V577BCWOA<G[!\.?;A/N14W[%E0"6,PF)$07S626)KO% KZ:#@WRNCV
MT(ZJG%X"%V\@S0VK$-W!9KDHFP#C"-+-0PN6F3T0Y-CC8E96K9XSZ"75&>4U
M#T;0A%%F<;XBB_*E;_,Z@H#@#TIWE\6/R(Z7%K((5,S<'0OU:@@'BI=D/DE$
M]:$&:C,>._,??:ZTN0U?-U (@A,&76D/L2_8Y=M=H*OXX,!CE\E:GTJ9^F@O
MT';[24+#=PGO67XKF'W? D^@( _!?&_>M_NE!3O))X9#;COG5K90W0T4-[K5
M0(P7"IIQH*?J,@R2TITQ%,/K*@QZK0:V+[94CDAV91&'.HT.;^?S<$C)>Y\[
M\,GOWGU\\OY"5+2X$H%CLU.0LV U4[5GW6!C6VFU\*TOR]5V<TFBI.(-:*6/
M+^I[N\Z]QBW!PU,U+$%HS%UEZ&&(5U9P925!5M%.O.ZP6T1 TSK["-;4%ME6
M2@<V^,GZ4(L56(D\*[\@(_N;%?F>&6_ZL$ ?\U:\NMO#BSNRQTZJ$CJUO\GY
M&(9C+"8?5+KK#+&$U_%4'-:9?IKAKAT734?'H>O!,$4560^3D2 L9&JV1[]F
M;8,=1H#Y2\L3J5W(8W>#CTE*#%<&)Y;:JN3Y7R@W]7 UQO/V8?SF]*TLLNM[
MY1X5MC17$D/.!9\G;AI4 W2RGEO]Y";\\/%BL'A$4^3MR41KX8NQBG?H2JM#
M^QJ',I.'MEQG*J*V%17+(UV*]S-%$_L=QG]$R_$6$35PME1E%#+<-F\&3K $
M7+1B5Q\S!NIIRVU\X%EGGMRU:-@VKA3N?6$1KN7QK$FC#'^6CI(6S;A%N.LB
M#\[EN(;#$J+8G/HM)+E!T["/Q6)Y<&+P>33E!B\;V_VVA^$ [,9^#;]MG6*:
M9ZMN$BSJP?4V?F1DPEE"8]36H8&HM?#-JIU,.JJ,R:CU[BE#R(G-PL\PP0XJ
M*S'30IWZNBK$P)N&6)9'5)3DW+Z\%A^B>3_C&$?( 7(V-AA1M=HS8_WV]L2!
MT>R)#YG\? %: .NUQK@<\(3B.DAZ/P8QK%,2"3HF10+UTE>"QMFXBXN6=JZ4
M/54LV4\=Z![W,\_$_&CAN3@-0-SPP%\FW&YI5:3WXA!O"K*Q.^;=0"<[6#>7
M(%CN%?<0PH<1"70H(\BLPX'2FQ0S)" 5"UG)_^VG#=4_.K8F"*Y..]:TB_XW
M\4K3C[:B7L/P@VZ*I3**=N,N2BGB"F194]@D]ED<^\N!MTC ;!XRFL?P<P?2
M]2>1=9+@!N=)XZT&E8L[0IDT1RR:R@[UHYSGBLQ^84@@.5#1S6\E_ Q'Q5FE
MHRE^85:MKJDQYK 7=W"D0PU?#E#Z*WG4>J%XW-Y!#1$:M?%N;E%OE*:J7D_+
MC#B)AS^!<K%+A+J*/QIO#)M:NJ\U*B<!4\T'5/^*DHI8F__*3>#R8L22W15O
M$OBKZ\C29G6KX/H^0>_L95)F"H3LZR6XCRI)US06A57>Z:4=FB2_#/5MM?TO
MM'Y1-N[0L-"X_B+Y)]Q!E!Z33((Z/<10-1+(4I0^G$ "010=7K.(%H(-ZVE
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MGJZE'=;>D&OE=1K;:U9D+)C;8VSVC? UZ<%>BR]?XP  S;6/*K[)*+6.@RN
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MI>I^\,Z1"I'A#" 1G5L')!J<*IP!<K1-SNF.R3\.P/\WJ?O&*LDGS2<YH6>
M[('S2U(/_U=6T_B'T>@VKG*13N-/*9I^SBW#A_Z3B?ZS4*5DX$+PZ^"7S\X
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MFH5E3J*Y)H] 7%$<Z.>I!+':ZRM^,3O?9:Y[W'0DMZ)NN'S!X)=ZYP?6P,%
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MFJWFIZ%:0ZI?5I[ 0ZZW);O'%R7+KH $S4AE("CF7A+/AC$K.5_2]RT;IL*
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M]M=?%N)HY<E"T[*=M5; ]7%A;WZ6-#HJ>&@$@:P%!6U.1)(;YX"1660C>V<
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M\\93P^ ,D'7>GT\W:_#446/X@\5BU5Z==W[<)<']LF> K9F\4WH.[5/?SC-
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M%Q%&W!43[I;Q"N"HX=GC$+,Y_@N-F?J^E@4"O:U4Y=0T)JM16A8')CZ'WJC
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M6&&_@IM).";*I[SY-4P6Z@!R- &40QJR#D_J/;,K0.@Y!LUJ^OII;-7*3I)
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M,7@R,&8P,3(N:G!GY+MW5!3?VR?8Q 9)DC.M!$')2$X-(DD$!"1(%!$)+4E
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MIR.MEP9.,SSNX?JKL3"=@ EN 4/'Z,.;YL%;0/Z'8LQSFS.1I)ONU)Q+^1>
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ME3/ZO7%?V([V>J77VVY,'7^9LS'VN1RC>C<H(9?,#FS'BOO[[]@.DV"X6X7
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M4)>:VM%?^DXLS:W,1[>)D&/6Y%IC [\M^'"[(G. N^>7I[\+2J%>RU#9X7>
M)4;*+[4L* 7'Y>1_#.TI&HBX249S]\(+[4<>1$%3'N<YU"@]V-KQ9M-T;K3
MJ0??-UG87GZ$/JBHLA42:3SS?A9_T>I%_-XB;7"F/3 2<-S)@F5I0,M_*X P
MJ7P#AXJ-/A*LG5]^,U"9+S!>9Q-8P(VW.$,? ;,I1M=_5T>"Z.V-BRM(.(R7
MOB9*5OSHROI12:@EI,YYH[]W)TTV5AVC?@L@/B@HL)]IV5@).QWED^Z%?<A-
MK!3J"E3M]-NL,)OT8RJ*ZWN-]FG);#0L4#=[C(1V4822ON>64V>5VZW/]Y<B
M4T4L2H?U+?$.:'JS:UN^/X/8WZ=U[N]X-S=TM5(DT0\F?X!6C?$11CX6?!]H
M1E;X/N 5;2H4+RE;.'+/-I="%EW5O26KCC3RT2B$T&<SH%E<PHTOAPBI'VS5
MJ$!A@V->]^)Z.@D'4I']:-5PL5TX+61<Y5V@=^D,SZK>['M(EYSGN=C6R2L@
MZVIGV'VH1%_'XQGV]L2_FEX;CFS<"OGL$L[DGE=3JB@DT<UCC36+AB%'SA]T
MH/=_Q /B/1Q_NPZ^^$<*L2:,J"4F53#J)(?2PH[L,[K].O@%$V_%5P";"@Y>
M=OON1.E=N"$Y2QY_BP9%=S!NIPKR.9O94_7!2?;=X:D_L_L,U?SP%W<]SH#]
MV<)3;7I%?]2X&B<KV=7B?VQ96_]5.CT_%=N6C@THWCG_;&C8(&1F^@:<YL!7
MRICG**7W!\7[S%]2,'R%.!<]4U"X,Y->]#N@RN[Y=>+-M/Y9T/0;"GQO[UDQ
M9-S<CA/K]I6L^AJKMGYG^+?ZG.%8'H>AM^I&AH!$'$;.TZIW^?Z2$1T,_2YH
M$D7T^_3@T,T7-1!A0+1#ZJ<??%K0JZ7'G50WM M8I53U]BB]YG&QBD=Z_"EY
M]GBB[]<>?%L-"NCWN#.,.&C.F4_&8(N)":9DP#B[UCGJ)AI)$\C S"' KL58
MG9#H/:NT!@JF\Q.><'N>I-OR8^;DO8Y-^;REM<H]'$ZW!ZM4O&,\N11L'=<Y
M-FC"HL*=;'9T:%[%3HO#HN%]34YB%K7PA4@^C:[%9QO-8)[*00N,*V$[FJ+7
MC\][CCU#.=9V8N[.1G[IEG#+6HG]T5$ R2T80Y7ZEOG0=$4%T$%=C&=YQ4CO
M]S]B?:\\*TO^)EDE2FW^9;NII]\[+;"+0%L-,H6%;6:\&LL/)'D^5?SEIV-Q
MEYV%YU7?#ZL<EUWS?N1=?D:-UC]<$(-1V)V?FWZPRR6 3YUC(1"U\7)1$H:]
MN@5)/@>.JQ\+ Y2JJSQX>%T@"@2*>/:71*+9+0"RDV3OU(Y[X?!()(A58= X
MKKN3_"W*(\)'IUS9FVMDM_'9!M+M'CN'+%ZVUZRE,L!E'M0;+JH=WG(>I7NF
M_F$Z+Y:^X3V.%7&LXF_M.]N[\R!\C#NNCT[20*=#_*)\IN@MH.8C,V"I]?/>
MIOQT'+(J*.H[IKY-+Q<RFTTWNQ&M[.("81IA[?$''',X,JR2^X9XR='@;"X3
M8A2=$!:4IIBXU],'6 VD1CBV>$I0WW!$^V @*!BDO6OL1X/QI@CQL42.^LD,
M"W"A\>/5.?G\B7SJWP+DCCM/*EO^WZUX7GCW6OP !8I.&4R?:NH9?<&)9WW[
M\IK&!A3CI15QQ8_E'W.V1/F&C%"LM1.N7OM]@DS;5MHB2GMM"[:$610SWF6<
M-:5ALU(7RZ/Y9;K\F"8LC<K;P,4F*NUTO)(#X!?CFB#M:,N/#E^\B%[#7C0K
M.^:G#*&YC N7-A[=?'!;9IX0P*':-A )FMN/OP6\6*]?\8>18]585C R:@DK
MY1$?JYLN158C#TL+$8R.,=_>H6E 8D\2HXX<0%*8@C,:C$=%0998/1FAU;EF
MV\T["@S)YL5L .;XC!+=&8:?M$7_.?M1O6E\Q%4$^F:7!=1==L(>N?8M($]O
M;V'LLIR"85.2'FON/F]\(W/#O1;;C+C6[I6.;O&K*EG<;JQFD:7785CT(RPU
MW!V,E6>&0I JZ3/R'./[]9)J#\V5^Q*NRF)?7Y/Y:*('SQ[-R%*37@X&%698
M3-Q/21P.=<RUT(GEQ%O(L4=#-DX?>X]-^W'O-@NRO*U]_$2R:.^[_.&27UQ)
MP=7<,0%-905SC4BRM>03%2+YT,2VVI/X_VL65]5P"UC-FB^03UHCD\U)D<K-
MI#@/PKNKC2,QB1UUMX! Z'(-=*5?/.WB_62BJ7?Y=_"9_4%7ZSN.:S=YP>AO
M5Z9QE!LVY^J@SSK*M*>;1UW_ZH.YCK+G60GZN,M+LU;3I6JP;\+DPJ6;=[B=
M'+1^3POGAL]JV5^.,+(;!8MU$P395<!R[87MQ8<66.-I>9:<?W918B('T-H#
M<808"5T'\.N9@M@+3V\H>Z)'-*R.PV !,P9T4GZW)?]T7%8[3[RZR%YHQ>Y[
M^:CL\ZPFQ@>QN0%_HJ>6&='B:6NLY M&XP<A?[-<6W]F\O(XE.LWO:4@+73;
M5V#Z8D"7M!9#;19GY,V\D>464=C8\9#!4^211Q5'YMN345=G'V\4ZTQ!D5%W
M5>&L<9H.A,7YA0:=0UE.ZL;PS9F<URM@[KBI:F2'*%2B.SUMLE[3FJ-3)[4A
MD)';C:W\3L9!V9GS$!^K?,S*2Z;0L-+>TGD;.VC$SQP5(#[H'0_>ATB$CP:Z
MM=N<:GI%8ZJ^+O82?/JCES2)H7.%IU!PS32NQX**.T)>S$<]&ZXC'?IEW.[0
M7E<7#;!<+_T-E//=PIOGJ>3NMV#$,J^./M^^+*YG\?@I<H92YCP(F@ZV7X"Q
MW%6BH;)O"C!P#3-5Y:F'4Q__[!^SRU'D >-]8P"0<7/?[SZ^*+JXLI'B14P@
MN*YGP5I8B2^ASS5:-+)(5;ZXQ8D,,_D<[9.Z76!/N0.R_*(D\YQ\^IT(0++7
M9?']*\(EVB[("ILL":)=RX1DR>NN Q>1A5[.$?JKO<AG-X]:;+%6^:.("!]E
MN@+2>;Y7];W+SS5*8U2,T'  FW Z8"Z_;5/_.L\/M#6IQ H/MUIZPID62OR>
MJ%RD*/+;/6=5(# [>=%.>CJTM4CQFY%9O[NEB&?"HLJ<BH7I&,$.[^\JF*UV
MV*5?[EDB)I0=W3&8PL.52..DQ/[-PORZ[-N,CT/>%AL+T^E! 8V7U%Q4W:]P
MCWAZ9L7?ZC0XS<HNZ: !02 FM:]VB^E#+>O?$MS:-I>!*X!%^_'^O,MI>=0M
M8%X"<9;CRBE8Y=DC/L<Y<U:K007R>,U[0:W EJSL&=;O%"7M%X5*/.Z3?E0-
MRO"DC-)L#2$-*)):RP/X,Q^Z)+RY!,6X:;/YD#5#JNXOFI#X2DO6R[V07*?J
M?OCJ3<" T:9LI2W>[%8E;T^V .H@R0H!IE"ND-L?/<MBWCY:5$$<LAO= F8<
M.9C#&1]D'D\T^N@AE[B[C=6GZLOZJVO(JSVCR^<^2 ((\!-]0P ?=4SA43><
M&*<NY^Y'S=]5WTU&]Q,;>%IL,P7>)6#=G=0^3]>.1;:,RSUJE7[]H+'=T/X4
MBV>U0H,SI:.L/U4OH\G4X[VP&[[/_T#W:)37X;7.8CJ@7AE:%2<O>Y=/F>.B
ME5/BD*3V_,6+UVG1NMU_A:)O 66?7Q%?LDP9QA3O@&OC0M;1%.&'HB1V_'SS
MFB]P#Q_[%@ 2$C]YC0$;QTU3HSIX,!9=9!#"QN\5]?T]CJ%+[)[6\5[!RMPL
M;"YZ& FD=BC6KQ'T1[K< ^X4)\T?PY*P.<U""$H&N$T94B)S8MA(48Z%\W[?
M*E19CS[]8^.'#+< 6Y6*1G2_FSPCVCQAC?6Q&#_=#>NSX0BVCZIY!T2R07NV
M>,:1QQ569T$HN@AON?++K70CYH\#$_-V$X)FO\(-3RNKE-#9$4AMBBQ7S:G<
MYHEGM6)C'Y\0,#K,#2QZC (<=,P=Z/?I46<F"43H>]]3CV8\ZM,L/_P6XGS<
M>%JY8H1F2\VUH_AN+X$RMON9%_.K$O>^U]MS^$?W7+(GO(&H6\"@!1XF1S]*
M\\>L3M4CR5"IU13*Q[> MRW^*P&59_[W>#,P$<@%)WR,C-YTI0#!MT@ZH_?"
MJ=?;>C_>XF&-=@<K7%9J-_M:84P8W%$G,8..68=W=N[T:8R?#Q*&N,+OJ0A/
MYN92Z.>W(=?.(C#>$)^S*B3/7 *V,5W&TYS62>G!L\XJ^QVQ*C9;-M"DZ+7*
ME6XD+\E%(@GD"QGG)YG U]:*>)*RV3QX?I%]:(\840M<.TCI;N-PR5Q=X$..
M,G&C$X97VE;:LSXFA5!(+[S2WO ;I(B=MWY85X7!OPV@_EO5\02G6MF5[3$F
M&5%%8&1L#C$N_TQIYC_&6Y#&"63E %3OR!@X!=^(860&6DHG3D8M/A<J\MJY
MXL>K=7D!=;*ED/XRZ;P1:.X!&"'TQ>&KNNGZIGV!<G%BA+#:KZ*!UP":@Z$3
M>+NZ-SJH^](CI-Q'V;5"F3S)-Z?VQ7C'Q0_GSX.-GMUL7W#F="RDL2\Q%068
MD3X+\DX$TTQADF-+PI)"]GLJ AEG5@:\H -A\\$UP0@_)A1P;M9LFNJW2?2%
MT!/9FN&3YP3AY_T MQ-#WM65B!M&-+:1TM8KW]S4Q']BH<Z)IO3.8X$GE=__
M]?:"?P'&?V_M>Q1<5[679(FF(ZFBA.H2W<V[-*3#_"V ! NOS9K.*[.KR]G-
MZYL<UR(+;1MO)ZZ*17*K%.(O905X@41R9'XCAK_ ]>=["Z#8DS2L)6)$V8)R
M;K!EARB4;$_IVZ"'3J97K!QO_\#JEZ0R3<@TJ,HYC Y.(;F!N3"G4!N^SA[N
M6&KU<D 1T-Q7?!!-V0VLIST..\S[-_$L7MT"NN4W'J--C!7'3\* -S=]D(V=
MRZ@;XG-*6.3\0FQ$H13X_.RAV5?P6N_4A?F=/2<(/+D%C%P6'.[PY'?TW6C]
MJ^&X?U)%>)U\8J+,)C7=]D5B C)+5_Q.WI)IWZ'Y9"3IPK#=$ \5A!A=Z8V1
M,6]L;0W=KV<U=E D?> ?B5#0RUYS +A8D%IJ,J_%]6=X\P2+(_@="=J4[-/N
M/:6.3>.*VS1-W3NMA-; >U+3.U)7H;**KM_-1\1FO@E4QFMPA [T%(L_(/<^
MAWN=@>]AI5O&Y!]A.OLFS93$*AOB^9QY9-:.9H&?H9OSS1G@X!L!#*QLYQ.&
MQ'32<D*,,1UQTOX.:+L:?RI<XXKQ?D6H&B@KB'3@Z.^0GG:2!0-#3QQ,M#P<
MI)=/!6@=:?TP]^@) JPF.[VV;@'6Q60HWEX%-L46X"T U[H"' 8C<6R3\"W?
ME7\X'=N*)'O[L2G-<"24YQ;0S/295>J,=A@*05#T@0#SB[9^3&C'#(K0OVGK
M$97[C <.>"P)#%<E:$FX) V.]BH:J(GYK3@DO9R'3:_T^WE#/UE^0V;74CJY
MVM31FN(=&C] &CW,FP]06V.6/!EUPHI@I%Q1Y[W+?!,9NO0C97#.>/@C#?_Q
M_5]AK39)D5M^]S'L:XC!WG;NWD8/8;/%-Q<+Q<'W8SILXJUD3YS!]P (L+4,
MB3<<L(A)<:[=36_?.S)?:OH5K11/+Q?FXSVMR:C7 ZX[:RW9IBP7-\Z..-LM
MDU3Y\VNGER*@BSNG'UX!,<'RH&W\ZRL,UKJ,ES.<BNSUQ/K2M:KPZEZ]\*JS
ME@)I97K?6\+8H2IA1+M,C>&G2WI7'OW2E73>W:"4A 'A\#7SD:Y;0(?J"\!?
ML#6_]/P:HFW^),!F^C1J;J.CR27U [F"KJ_P;_"\F 7B49@5 A;32;-WTD3'
MK*^AGKC\T#]ZY^ UN?_[3/*Y"F;M$#8!%%OM=W" V*CX@LK4)B3"[=IX:=%$
MS:M.&9S0M6H0UQ,7[!77>T@+S3"<$LNK4"\OYSN6=HC_V1J5* W0< 8J '(I
M!*^S3^%T)M!WMP#C25E*8+CCJ<F<=<LTU_0$L5F0E:4>\WU@L???N@JW*@:,
MRCG2,()>(:R73J*%;Y;$&N*3%-SZG/,%;DAWM^OD<67#+ (<Y8-789_*ACLK
M^D>TXH65RZ/D<H5]%A&V"F9N<-B/"B<"'[&D'D$DB!):I7^S/"/&8[*?R/=<
MD07@RN)RG!"PG10P6(KK![]AFBCO(-M2)RL7$2BPYV[C"VB[ ,F<;Q["/+)[
M:3<M2-]IXT&=UKQLW^9O>QA:O+_WR6J.)D2U8]$ON78U!W]7"..RT 6F?!#5
M+:')&1^5\9"OP5Y]F>,#!X/459=5Y>/.6L(@6]%.MD*1CI("TUVJ!2579P_F
MTFEGT^RK(/?S7-*5@,NXR!-0:(N]'8A\W]T$,@6)J ?.%,0<S$6,2'^-8/O*
MN4:SQ-%S\Q!5U9L35;UC_%*:+L;;6FXI-H-@7BOEU[MXM=Q2!B#Q'W+>TG%Y
M.LPY8DJ"R2*H3;UH.%>=0Y;N<K2U+24C5NU9NXIG]]I"I;NH4Q"U'9BBS;!(
MLZRAY&Z$>H5:IP5H0D2D1:)YMG*K)=E*_@!(0'@^7$5OL'1C'SOZ2>/MQ4GD
MYD5PN>T,^5MG@^)R:=<ZZ&<%Z\!_UDRS?[ZALSW@:E#5^^72WL-A-1GF]+LC
M'L4=MH'*"3R1H_/4]:R[DJS(5NN^UT^#J^+M8AK66Q4T@J@*:<PFGWT4IANZ
MORE2]R!DX>$:XX'TYM0K(.]J1@[MG81U^U0C"/V0F3BN=$*R2N6:+9' WSOO
MI)8R,S<KG)=Y47\[$8)S07V7!LT?&^SHRIC_+%3\A*\OU(TGL"%FR5HG*[Q4
MDE&;2%CP"0RC>J)-;Z>[-1[$6K^<9[_OZ0"R-O6IB)V[!M**UZ-(AU'FN]W2
MGTM:SG;<FG-TVA=]YIY'_NHC3>CQ!]8#W*BAACU^9!A#3J:0.CIIY8Z4MZU-
M >)JXS4XW+\ZA05@5)HN'13HT#+7U2LSP6X0Z0<8V==H@W.F]KW/Z*$PJ4_!
M=,Z?U.6.9]K! ]GW@@9N@)VHC<514@\#)(>H%1?#VS*<%7QRWJ#Q-ASTD]G>
M!*@]C'IK9OZE,(EU9UU=_#*#PH#\.TH3%IM,7\]<"B$4M0161"(Z(;Q'PQGW
MVQ!(Q%FN;!RK?0MX5"1X'86&;9$8RC*BQ"W(L2)HB<#*4\[L$=UT5P=7IBST
MP"K!,@5! "#317.B@P[3?$,#,2>;J6^7/AZM-Y&3AEJ^IU0A!'L.:"ON*K"$
MQ8AF?.T ^$BC/V07[I@SU%=W/"O(X1EDB/<5HLEY"[$:\ J&T74\@9(\JY/_
MG&#CV,'1AI<\ $RD0+K< O"J=% KP88O,1[%F'?7!2UJHD,G%W.*<P\H\3_B
M_3DVA=V%J*"GV"<WL^FW !U-W:.]05(]'JG89>%@+5^YIM57P&R[](9.\#[U
MFJ]*;R\E-/]<4ZV"OW\@MV%@@EVZ>/WCP6:Q<-*N22,3=XS[+2"J@P[]/)NB
M 35IG!IX8WMJM GYRH 3B/M-QO-T1_I=2PX]EF?Z%H"0E!=&?:@FC*L8O1]X
M-'_$P54Q'QOBO\Z6&:<XF5FK@+% RND-TID_05<V0KS=2PJX4K**!L87GFL;
M<#5;G9Z=] .\BJ"#^\\&=GOEZ2>X$O(F3\W\9B;04VOGJBX<8'\PBNG,:Z.#
MRP=<C4E#R&217ZH&O.?E-*2,KA,17'*YO,$?(P0-Q!%MG:\ Q1:(/^;&SO1T
M;]3K*Q"TJC0_Z_@Z(+FG=FBNC5:ZT23IN06<]FK?/&LE<T+8],4Q0,UA9+O9
M I/@&FQ^H+>,H4E4&T7\2^U[(C19;9GOZK!FJ ^W@#X8?ET<?G^IB;*G-6N-
MV$B9I\-&K#-0=HS0(KJ->PU,AGV9-'!#45^-QFGY$3NQJ]GFG*A2%G?JD.#O
M3#$KRV3C+^N1!\FA='_LA.7V18!!ZN^6WTMP)C?%J/CI=3FU2/'^ED:;W#S"
M6"-EM)F'D7!"B$&#Q+DS5_MI; FSNH/D*]P?"S_C =O76MK$6/Y93O06.B?Z
MSKR4#$/_S!O/;_^H,>D*SCQ:><IF4O4MET+X.KL>3O<&HW5L.(&E (8+N&O,
M??C/,\-[WS]_7@_TX<#]+@[-+'H/*2#9;.C&&/<*)^6@'C_&J;V7L^(IY]LB
M_>QQZ8IU L2ZFP_(ZXML4#G]*Q2GOEH6.+OI'XU5\IZ:RJ>6=^VS4+$5BVO!
M*.S'49W=GI8UZ.<WW#,@XQFLJN-9HP>E8"J-L$CR M79@"IX+ZX/+Q7COB95
MX2/2 "*[85XVW\)5/3HE4T'SZW[F\Y#B(Y&$,YX-,E3"$/3!E3YFJ%UD5:AU
M"BL=).8=M,%$_&UCTL;/JBO&5YTO]MMX48=(PQ!9,"BT0E8[OSC.L9C7^_C#
MOB?+^T3"Q> A./XFNK2-XTJV(0R1PXAQO 480)9X39(?!2+4Z875I 0V\V0"
MLZ57-RL GUK"(MKT5F\!^'%DV&<8KY;.D-4 _H57XYP_R]4(&>-M&+ID:NI-
MD UE$"1)7+ T+$ST%K"?0V&:VM0XR=UTI+OV4Y^8N95P@%#UP:6AC40O/#+5
MCPE&L@@M4TI23:2VO0RXBS=U^ X#\G]?H+,[+O[6MRFBZ+6G9(ES;8T=\\33
M8+DB(R4[]GE9G"R)JL[:G-[W !ORC]] -Y&JP=83CS N=B6_HFN,5V".S_?M
M=U0855.:UF*)=LUG$3F-L!Z98C)MT#S[O+!K*%F:>,P@1]!OR(A87"B,4M;;
MCC .645CYVS[8F<6]&?F()5>44OA@R/][,;A?'O@[PE^^0D2(^J10!JC-6UE
M/(#?:YRDM9P+*A_%NV+Q*NZ:;GKUJ7VC,7A/&W_FXS;O I'Q<\DG<1[UG4)J
M6,@VJ\J G+9V2VVJO'Z?)LE:)<-]6):GJO\-V:XQ.*A>FP"39% [C7W,24:0
MZ?Q,%WHNY?M+;8=X:'TU0($5'M+&F&^7C5LS]J"F,54-HAR#?$^:1*C3_)6M
MJ"71%[)Y"R#8^H2I6@7V49!SR/5)RQ<XN\UP/Q)FI"+0.R6[!?BF'^[YL?AH
MC]51(BJ>#C#IC.O(AKN39*A*C/6.\73/J['@>EX+KV"E,-XE/N*H3";6"+LQ
MND3/C:O)H17/C-VNP5P:'$0VU[3JX)4%SA;!>5L+_^\*6!V*FU)4.%N.B]QE
M.[*,(B('"0OJH(&*Q5Y4"L#/"E63-N:M7S36XK2B:+=!0'G\QIX56FB0GO?6
M(7]E6$+)\[Q&D^Z_3_<^GF]X>8&,M4,[<>["(SXF%4E!K>%).UH_E[I']Y/<
MH2^6\3C[J3^0M5;A/N:\SX]E7%[ :-0:L7L+H,4<R? GF!A+##L0#Y/V=[SF
M=G6=)3LTU8X3<Z+<6:'O8%B!=# THGHSSB,!J2.NLF5'CN2O 8"AKLU#IA,+
M&BP_FJRS+TT6LGJMVS-_LS/GX,1W:I26EZ  $'H\)(D7Y]13<UH5Q,:+!D>V
MR2%]3?I2/)@J4SU9RFS(6I4A+("-:2D^TWAYJQL:G 0$C.P/!%9O&"-0Y6#9
M(B[N+,LK0GCO5[@$P'M-]FHZJ<1XI[/>NCUFBC)*COG9\<F5;ZXJ2\B4M6$N
MAXNL%\6+@S8IU-_#YYAJ)(Q.W8,TI:6^36C0,??P68 BY\F^?@<'EK\=31%>
M!Z>%.NEI,O<S?6)(?%.P0M!G<_-F""BY?B3G]Q6P#K;5O-?OXX&"&QI9:2K7
M?ZU(?R4$9]MX2WP8-#GYJ JKCK*)NBME(QK\)%'!XDRC4Y\MK#(TVIVCZ:46
M@Q,"77? +-.^%JLK,;+6R+M@O\R!9LOB&DCR9!FQLL(K:AE@H)O7>I,9+R5+
M:JB\YA2:?CH8LXH."W8O%5UZ:W*=@IQ]%5/8T!0GQ;@P)$N>'50$<,TF1)_%
M5&(-@Z%!/?0=]]'K9S%.S*9TPDLJN=4X_C@8O4!5E#\%;GM/6YD"Q@S):CC8
MP": ;JBP\O8N5D'_,=I^5:-(^5;QD\E?JT"H''K;O.Q?;D7_5R#]]_9,%%3<
M%?N;L/TLE*(\*W185K70^,*8L&[O5T)<XO)FF> /1R-85SOOYI-K>TP_:F<%
M6=5;8=6;M/_&\1V_ R_%J:L@STJ.Q3O(D8?.Y(%HUK._ P<<9--U%:35C?KN
MDAS'M$=-EVP#):*?;4XZ"6RT1;N\[_T^??P&+#9^$S?YJTJ9QO"K7_@_/]#0
MGN9@J0>&.F-E]3SB4N2DV.&M+TKN*M.J)-[]' SWYTP];73,!8ML"BKHA%S[
MF'8IP+#O.:9#^-O>D:S2H?7Y,,AJ_'_F@_^_#]W[1 ^B@S24 9Z^MX"]N569
MJ^'-FU_9<X[,/@UGC9^427+<@+0K6VQLDVW\A0O;Z?J%G\6%2%5)E0!>.9]\
M-6W'_Y>U\K\#_ZZF_]/:RF_!!2O$(?9A#H/UU*IF@_0).]I9DBHN1?'"?P7U
MY)JUZBO8J9/X%F"/%9AT_S,I8B?QD[4U?.-"^T:NIFW/%VRGV#&?X]%MM!GX
M^_' S;ZV._8,JRN/DQ_)NP[?^<^O&(O[PZQZ1=%#LHL4<G)_3 1WCBS#'EMD
MGUYF7 E!O6\HJP+8*!NL23@;.NUAKKSTH (<C&%%RL!IQE[<+UG%/F^^[Z(M
MOR$'ZIV_![_=J?1D\_CK?Z\N?3.-U[7CY<L'-SO,O*^[/ \XB:(2 <.RI(G
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MP84X[ &5URJ+(7#U%D $,1>Y3N??KS-Q@?%W-)SK;>]=R<]2-0IOQK:Y["N
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MM"5;AH[OPS4=:NY:J.N:JW3L(P7<S^$)$&Y#Z,T;=:_9:9&,Q<DU,CJNSJP
M*/ZJ[-NH,Z 0T^S?55\SH<%+?YW-#1+S0Z0#7SE^BGCG.Q2/2@W$]*LF]VS;
M5[]14^V-E9,P (+),3(&#/:UOV6?\</L,_F_LL_IWCICLALG4I3VNYJZ9O@9
MIH1=]B@Y&58N5DPX-NWO!9:W1VJ("U4 : >'0"J^V7^E99;5HAZ^^=G>&>.>
ML"2A6RM*>VV+-P?M.HK9P3VMYXGGW\Z>6KJ/E]Q+6]G"J32-EJ04/7*Z>MK;
M/RSTGMY]S8K I"\W_#1B/4)NX"T^<@6L"<VK/9D@_";DC^*R91\+E\1K)$N<
M@^I_OW,DR"F0O]G?-,H51<I9?)B:_OF:\NB]\@)H6"&$W'"$"GU/P8_R4.YG
M%GT3V_1_2I_4^S2M@7@:CYT4T.!CY3T.;G8:S,PS9T+V<I!7:P2.V]A2+'2R
M&LJ#7*/26>3.W6SZ$#X;L)L*VIK0;H.*_CS]"T]8N=IK<><"MKOFS_4/ZX+E
MOC(<H0]+F+HYCKN/_=,'"QW<\N]D)JQ:A#UZ)WZ3Z_XQR,9V,$I\?E\-H-'4
M+%]V0.1T.2/#O$D)ME/G;#[C;]VXQ;*26DCA[((NS731WQ?X6CR@28>3 X3D
MEZ_$*(_8QTH_ZZMNCUT\1N15VSRD]O?#*;BS+;R5-=!BNR*M1C^<C-FM/>_$
MZ+(\9W-494(#-M -&7\]5JLZZ>DQ8M$'<1X"<LMW0[%YBM-YGQL(I/!PZ])S
MJP;J5C3/56<,M'/=S2X=_R)S3:S\/KOG/I\)X,ZXX;P+$G^81(F$$5PY[#Y;
M;15!&]51( ,.?%6%=4W60@1]W$D>_$&>J_CWVVY5EV[W-O/OM<#A)Y_494#G
MFOU-ZNGN=$<W"3.5A1"/U)W1 U"S3\(S*T&4K/F7";F\5SE=0RX7_HS)L;JY
MP<I3 "DDJ[L='P&XA^[4 GH45Y,2^8$2/%8W_%>&UN/*5Y=27LPFY)P*_AD$
M?=4/L9"7[< K/I^NK'QL[S=[+%2298,_5H>-]BFM)Q)QAK2EE&_I^TJWNE$C
M,-6B??#>KJL,9"/CL]<2;,2X>=>[V@[]Q 5R+*MTOU<O$8+'<FK7)K9+83A*
M!>=1YP$(60\V_3S_[+/!"BMBCJZWUYG7D,['E^%,XJ6S%9\]NY7:[H*6H<K,
MFX=$V8_*,!K /7?E-SZ%SM1^2>0KL^-PFCW]U67:1&Z*M_HUE)>S2Z6E2DV/
M,6:Q,_KU/9<W"1E.Y'V1,R=TV"G6336?@I>@VKR'AJ@M?GYN>6VS/5=L,E3F
M9'_IS(I]Y(H> G)SAA=@Y?7?AT?&1BX/GC9JEZ<\(GYY]K(KN .:GPJBRP7>
M'8-3?^5V%Q99[!A^S7!E_BS2/C^JS(AJY;%JS>ZM<SQD<P+J>7&'_4YV_N4J
MGTN7V/K#I>O^6'C!U **I_%<3B/86S_K(-Q%@_K[)7ZQ_6<Q-)8D9N06CF?T
M;%.J5=!F#+@5)5I>U0=)5]X7X'O4?)Y?JXU=S)0%(]9V+_8MR\I0*CTMWQ*'
M&\QT=GW95UG,19+] F?\8+G^==4I-FH&S^V;\ M7F1Z@UU]RYGKTSQ5)F]@Z
M5CU??$O@"5+K%!@E/FPEH1DS$%:NQTTY$JT*;6TS>*$LJQ^+X.NK$Z988?R[
M@_/,YVLP]-FK75)A<L=\AU\7LX/ ]P/X+K+-J_T#)D[^)Q"!C)O/."EN(9-*
MI;+":?H)#WKL;]:!F=[U1RN8</L:#&9+W538#)?S.JXHWO#:!KSMRU#8)RJ0
MZI5,2T![? $HW'!YZ+,?QG?"K(L%)>8=DZCY=%]#N !71>X(-+=PU/Q/3AV-
M0K[@\3(06FT/0Z4GIXH'YRVT@W1UGTV#T.4?T7>9K7O)==(:-C12$[T[;9KP
MF>%9YQX90<,6LX-C4#E#O;]>5-I!YZ;W)2C]94)(6<:E#N9$RFQ3]$7\"^:+
M?S]N+-?1Z!2W<S[C_ '(?^P =%<";U;B0>$)N;POX7MWF[B]H<>>V_>Z[@VO
MJ(N7^^L0M8*//(JDMI8J*AR+P;E<>1\V&,6%D&0@B*+PHYRW8R:M$<K7>B!N
M+0<@=H65 Y #:=J*9\?'Y_L3U_72&#MWY;J81%(#[ 3])+3KRA*G\YV.IR&0
M*%VO\UI'T;)EA^RQ,1Q7ISO=L7GR#KABPCPPU163M./^)O#F;*!<)Q/B2+,E
M_P[+.$OH\\3R69@71K>9!$R=RT+SO!>>G1DK93J//?O(<[$"4"]<@IT@H+F!
MXL>)Q@-;V@&8VG&$NM_Q[T<X@ >Q'QQD<NV$&A3QX0<@\FD1K3=VZZAVC3\5
M2[,T7*=^V7KO-48$F%89WA"'4-"AHUF^'N36^+Q[7A(?G4]OIZ2H&I'3!1*6
M58827C2\$W3:O@?$3..%G<_L2OX!$&_UC]]-5DV9_+/*;5SBJM:D/EC_?N#S
M:!#MD *JT@0F%6FJ,1IP]HRTPL4JK>Z3"M_UED2F/20V[:=?:B[QZ "<.!VJ
M U'$>!R>ZTLD;K^<'.D&_X@QR[,?;?;B.K%W3'QKK=^ (](7JP_@:1(WT5R3
M"R*F$3B%MW!T$3%PSJ]L[O>C&=&2-2W-X\(X=&3CB=6U.L5IS3-$FL38O!HA
MO3G#)?A8B)1UUZH?A_C6DH !!P^MHBD5$PL]LY0J_C9*:F^T^8*9Z(7T"@G1
M1%(XA 1X?[=4)>[:Y4P?_TB(E@'-'GT VM@2S(:#[(&$[Y:ZQ-'T')!P/B%9
M\LCT:;MS'EN0[TP^:FSVM%OX+A13E*5=8''\SU=G,88UIC;M] NUWR^R=:-8
M 9D'5(Z@QG)"Y$STQDIB5]4EMIA/(Z+1;52>IK/OZL[,Q/$ L5*Q4Y8#"B42
M?[0+16*?M\UDLZJ$+B#JX2!?+,8:J)[6/ KCMIBOT8[,(NA+=YH&3,FXH(F_
M6_V>:-:K;^' @-%H1",UE4%$20_9]1-J.V+(C9?-K-/.%=Q !]D*S12VR@W.
M?^3AK2L%ON" 6W--*6KVB4[FPZ,=>*G5-37-SSM/%H4Q1Q(X)"G9_2A^WX@Y
MNIT^NR1ONJ_DC6;[LU"+\#?,">@\9-73@"/>MYJ<'VD]P%2B]'!IXIF2:GH)
M(X]'+,M.6<(K66LQM[A741EOAYG79_"1&8I]BDP]1XYP3SUQJTI<3-(:5GZ\
MOKIF^HB0:  6H8DZ])9.;(3Y<LU<*V=N!%BNN>J4Q4);E["/A<_M6D:C"C=A
M#"E#75D+:Q"=%X%F1:<,>C==,A'ZXV1B;RQAL.^&N":52&8?P#0==NB :7/?
M9><BR\=*ZU)<MZ!72R4RCSA0BU"B54#%]$EV#577K 6H1,@ ,DW>; T9<]AO
M\Z0)_RI;&?990HS!0>Y3G$BY3X QT94G$A(%P3WY[? YP_YE>WACL$J?-KE_
MR)KX,KZ]1]3H\*T\U+DF*UXHM_D4$'"O]\H:[T*"I69+0Z$44.WVCH4Q<"[!
M5PQFW@>X4:=:)L\"V108KS/)?/$X;AB?YNXR]O!2**B,76/%1(ACV+3B\'GN
M5+9O(GCB5$25_]4*47<KN$9WIT#P$-=LK#;!&/"@CC*TAZ 25=5N_(X-Y_LE
MDP7-V/S>-%!]6$CGB_O_9EAJ/@8EA90M2R&J*:3E 7%_FGKD+YXQS;@])L?G
M_?U=)^@^RJJ'Y#"M3^Q"?U6DM-*.]%D^=C*/JK5X]PZL?F[U"0PCF7'2GR#
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M_5Y%2,J1U?Z2P*=7GS>7M4F3]4;1H(T]%3(D&GGVU==JWW7SYIM7HD:--\Z
MM0_+[]O>%,H!*-3S&%.=.R;'.6\05C'J;(38<2H+#E/^4^OW.=O\?%3^Z&'D
M"=#TF_3YK9@<_4P5Z8)#1A_EEA=+,5NU;WK.+R%X:T) EJKIL82(I[CR+3T
M?(H6>&73QF)D+>[T5['$9\H>#53V']*&@_P@U4TK1DMT+_TCX^]<MSQL9D4;
MYIN#MV.UGW- $@M]86T(>8"ST-?TX<]E'*1@III0R?LX)+%-.&[.-D$@';=K
M6GVX.M<I;N&3$M7UU)1HI JD$B755[E9^J6BYN7YVDA%I56Q/W2M]WB<\O&^
M*FTP88B\[%"+N6M*>)V*[8MJXU&+B5?O5R?\3WYUY>SW7_>GQ;D=>GIG<P/;
M@!<X9I*7)E]IB'[JF)Q(5!<&V=D_/,&ZI0E7;,6S+DY>36SBT(V]?C3M$S'
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MD_1HX*-&X&?2_8>T^B[G-/0K/)+5%EI8U;=63[3*AE7D+W?E(L^0C/8WM0N
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MX*!GXN+F9.=F9>=@_V,2,A#I'@K*<Y24Y]@9Z!C8_\L7L0M@H2&+ 5T$D5T
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M">[+?E&/PMA2X_* Z;>)(UB9A(9.ZO5FU8[Z$('85P_)<D)DM8:[ ,!0)!T
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M4HV2_Z4/Q>F#3TYL>(/)""&8(<[Q!&0<7CI8\76L/(0Q?7>/FV;Z/5\^CYB
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M#HX6C,-$>G0HS;R=5?>\\"R\@Z='.+.P=6WX;(F)^H*CMO?82X#)]&U;VF$
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M+96/R5(J<'*])\A8OM[0U)A2)"[PK5W0Y.6JE<SQ@19$+">E8C(]_=V[EJ]
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MKS_EIX<E%T%7V,D.CGI\4S4I<1O%2YL1(*QH;<)#J3+..38$-1U_OHZWVK.
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MB?/=B_RU/-[P$O=@%H_,;H/6C(!/(?,^-]RPRPFI=\ NFZ#'8*5^!R7\;%0
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MGEDN_$ Q"3+V;5A>85@7J.N#B)VFD!EQSKVE&!E&@V_:D!M@?M'6);:2[O1
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MJ%O7ZZ>;=U BR;[J<;KD4)W.$*VP[J1#KL9#X@]?9+UR)E9U.ZE;U:9Y!H&
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M=O"8Y.!W&WU?FUKQ.T#RI6V1F*>$15Z&[KY.:&4(E4NM$WPHZ71*X]N%&T\
M['I\&.($F [\IP8!/@%TO.T] :3]=>V],]& FOQ751K*%1D4>1V&ZH@CNY\
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ME'L[EF>M8RG217#):PW#"/![K$>S8<.F:$\/=QQ?HT(P-@G [_8HHE^ES*9
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M>41(%865W,N:U5(J43T/YA*<D>6\G[76*417.WW0RZH=;@#,W716KZJE7J0
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M;TF99ILG&_618DXV)\7@K3 $V8#K)%3\+O/OT0KO70W9-R-/:!4,?E]F/$K
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M>77 5B7;NR)&K('A-1VXV8,T)E)[YX_V,1)7'0J;W[?Y@8Y4N%H,[VH;"X7
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MB2FKH+W[^/[H?I*W,-&4&A-^9944+P->&.B&,&.HFA9FMNVIQ%\/<A )91R
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M"\XXVO#NMM$^UP :M:-X]7V%0-QL&P5 N"CA?YIH/L_ND;P K%P#YF[X^#5
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M2M<J,6QU/O$I]B<T]-7,W:M"8M]=294];G.<<F4;ZT$6@N,LG=&3BV!0E!1
MMG?44VUOBB&+:%>MV&/G [N;MWV/#*EFRQ4<LM"P9O"6:4CO4+'4>@[J\G"W
MQ@AUTQ+O=O(E]4!771H#E2.9%K1ZNI,%=>R;\U4L76\<]ZE8%O!OZS5I?-7O
M2ICH_?\#IRUY_N\A])]F)UI1;,7EPYU5<O]%:@53=':B_X-P6?G&IASMCQ+B
MF\T?ONMJ7KS;4C%F'3!RGP"J5O'0N60II]6V3U%/&TC.G=YJ_Q;W1FT_,0,6
MZY-AIW=I2+N"$UG'.X\(-;5G'KB?ZTQ&,"=LA0:5@[,?HW$96#.]J=,\6]N
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MO(%H&"(,+D;9O5T'T>H@030[[-GO5@:>Y-I,GW(44F7YZA#)E3^Q?0.]0S%
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MZ?'&!FI.RMF4;S;_>J&4Y77O?:6#.5&GM,]>^-I8CU>".CU>/I1[MMUUC;*
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M.^^!,$T .;XFJVA,[,NJ I7>6[LV5GC1V<\TWB$20C!UX:?PM#.==R!C!71
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M.4R?L4%%JZ4_\@<;/SR^&[$+'6#^)-)U'6.^_FP9S,Z]RW)DCI@(4Q2P7"Y
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M-:-4E*<B68]BKU(&M7I:*N'N0%1?5!W2,M)JZ(Y(YGFQFD,U4OAR':_DV/Y
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MG!/[CN@E[&7Y'PKQ])>);M+455=Z21SBNL)G2Q?[LG.-E$IK/%[(PQS$1YN
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M,'FV4BG[QQ \A)7Y)\8$!OLZ!6SSV,9 S6TU<#QRV*3!&)0!N(H?'.B?SS2
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M'/_#O2>^\783AAJZ^Z+0)/WU U$=F"P"W45U)<*H!/I:0F+-3<II^2[FU\%
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M!VY<MVY.AG]>X+C5U#[?LEE31M3 /:F9\V)Q=V#^6(V??L>X.-H=ZRES1RW
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M/R; HBOA;%!.A*UMHLFPZN7[:=I&+R\F=Y\I2M2 ][*=E3PO<==)3"_R ]*
M\+V% )[CJ,(U*:_;#TH,5\FIU?FJJM?'E[;5H%W\7"'L0J>_7%4NOR4:Q@X$
M\<VB!5?1G$CI7$2*8>K2T*Z)<T-U@)/K1,[QN.+'X/+2^H5F'B*_>02*G:P[
MY^:GZ1<YY,$]OEFAV"[A\,KNW0=0;W'*<\ 95X\%Y+)C #E,)NIA?WRF)E$-
MOS9O@3>/#!X];;!LOSYN"OGANT+N,-]]Z',F#L::=?>Q^37Q0!S-.2T0C7@U
M)3!1V^KCH&V[ QNM=34?PIMT[*F JW&#N\WLIP/7)W6*=9Z&<O03?N:)XL)#
M>G)WB/PXW6ONU@JB4 ]; 77+_I/:G?2F U?619( R80K7S &HC$'6ZUZ$ *L
M2TD0"276J5?DHMK.R20RCF(B%2L/<E]TW<G^-M0I]]JZ3SL&Y.M1E 2<,3[D
M],UB_%-';>A&B^D$Y%*&'1CP=N+BPDKA:B(_2O-&E80UI4=^W/T-?A'R*T%-
MBKT[39(^] MHB.$Y0TJ(=L8\F87@TH[BKC+GFB ^W9FI#O>MMD[)IJSWR;\H
MG.F,NYO\6<>ZKXATE;A(MM"YY5D"#C5/, ]+"'F("EH,XYPZRGFR27$DO7FR
M*=XX/A@,(OI.<Q+0\6K]5=VJ>A*U-1G:KG,_]KQ%'>XP++.G] ,6(.]_FA_+
MN/8!"KRO<U2!JL6G5*#U]6Y+8@:X@[ZP(\TF.-DOW_CN/>D%%:<E\%O@W##?
M6D!6\@7(.:3JT:N\ :1/EI%27&4?K,V!;41):2=>9FC<8T'%CE];T?DW<T?@
MI.?H]< =3,&%SY@HE*.,[%[<4;Z^+ 2?+*.,FL;45%Q@^ZO5*Z\_B!LX-IY.
M&80Q>S:K([7U1"M&W@\M:8S5H%PS99*]>3\L/F+6E+C7!%5]$*+WD-A)TK1'
M-'0+=]0KQ>TTL2H)NGF["8^A"VT.AK\R>*"5Q[D5(4)6M6>7=8M7S,$KU121
M@<I-F0$NN).76,F%W8D87A<\'R%R\_@,H1P50B\+<6S<^B6_.8N@>3V%M@1_
MS+7!#,#FE(JA*QV<IXLB[L5/A-H,7K]?$TC2]$A[8-_*5F27/%/J0=,;U"<<
MN3%9A+">ZV\WWY@16+4QBD&RT]MV%JT]R2OQO'[AYNCPMUL.=8*>V4U.L["V
M2:]P*L#Q4 ?J%:QF-",]U;F699#I=KNAOE"6U7C6F3#=:$)A?>1-DD2D@R"K
M_%/@(U5,$%$/A1M%7$(?/,-2@96\+(ZVO]+0-;=/Z$^*ZZ18$<7]H/'8@@3%
M7;F$U*"YO<'['[F2)1C>];><[V+9M%-J3?SQ::L]4QX_71PX+Z;1D2F&CR_M
MC(R<'2Y5O\)OV ./UNDZOJ9GP2NW*X1!$;RI0(S5G66*73X5&/2 G:&%B6(/
MM.)<CRQ%-B,2=OAKA&YWD]?R N,?PM>%O$,LSD6*XF.)D381>VLSFUPVG1X%
M%V5J,^Z(N)\\(2F%?MHP"Q;NF6\"DZZ:@^'!PMJ]08D.U;=E)5#\H_Z"4!M@
MM?#?[-$$QU(8TW$N[1 >A U;;OF;6^4O!A6E+JX+.<8E,<LT7L+YMU;,R8,C
M#TO1B940%B+:9$BD+=8?HU\_=GCJQK'"S'MGD\[^S)'5;.7;V8/CO(BG#G_A
MQ]N.EZ%PM>5KNBOT:XG/(.P;S=Q(C0&DK..C_22WZJ]@K+-%J8J?B\0C9>/S
M^V6]6154(/$*]"=LT>HOL;%MNQ7:7TA&C>@$^11>DDD/G/.96_6=D8OFN*\(
M"_:.XSX7-UZR%(;( J<%TY&9JS\2RJ(?S7#Z>@FNPCC>-PRIPDU/ S7J?>=$
M.N>C!0-B0B18B[ME,PXSFT]2@;!'BC/\P8,012BNOFX%^@-3H_+GA/&!\>C(
M*B7JB1'1[8]^2N=BFU_[W$WG/N$7GQ>== X(NR![ONR/G=.S)T2VYA.]YM#A
MZ=7->G@J$(%TFF/7(3X=VH(]>R-F_CWT)(+<H@9Y8FD/.'UI91#>2PRE JP/
M*2QDQ0&DR/TGA\]L'EX3_W69>;CWUY"QS(#9U/<-[Y30T!28 BT(+$;48_%6
MI\%DZ^KS7S UDM &6!Z@]Z][<U&9.></%1!-1RF2!-#S8-45X>;:[$D<4_E1
ML9=N:=W,W5[)<R^$/BXZJ.DX23C%$7)(V@@UHS@=O_D@JZX,@3CRG0^Z9>G!
M2$U(NMO=ZJB;CECG)]S<W[9J=R4  ./GLYU!3*>P)*BW$_;C4)V=(]J!K #I
M\;_E!/UWJ&OB<VN(, 5,#&^M3B>XI0MG&!;[Z3PP,/V4\[90XNUF][R#%6%K
M%M>-@P?!S8FA[Q'*5* C TP^8;V.L=VRK16JD;<%JYU[E%L]X'],)+D;:K;4
M3"-48:\5-TUF(5_1Q+)2;0O0Q#03/CX]!"GRG@@W4WSH&ROW\*YR$"XYR\*\
MKLO4\SI]YY]CF;^Q 6?>)I(H0KY.],%-[,H]W"2?\O;Q5FM,YG?K2'Y(=YM3
M0'QW3:A0J66^%W6X--,;HG<;W[]!N#\/YO]&@1!^Q9>0-:H(@8C\(*TVL-:V
M[A6GH JS3[Q<6W1?)D2J@NR8&)%WJ !#G2#1FZ 10HN=D8; TJ"B?\W-?U0>
MPP348F? 2$7"@X+\_CV/B_TF=9G3#UV<8WGXSN])6-O::71##R3USE.!CPHS
ME&AW@"B[YTET)%VC#$)!.^;BMI3AC(1H\8(E+B>9%RF">W6P9B&?85WYX9:Y
MI!9W\*&V/!4@<RE1 0'[?C*/).7:^.>9O=]4(">CN3 +'/EWHXS(R@*;^E3
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MPX@BRL^)V*KCA]R;U6LS+#YUNGF.%1_SOS<4FK("+(]8WRF@A=A-E(OM5Y&
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M<D4-L+MA3AW*TWF5(5HDVHJI&:%4%_I(B9Q8]\_"4!IX5EG_G!9QYXB;XIR
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M&BA(WI=JQYGI!I$Y\LB*^,Q4S #3B**2A$Z0$R9*^NDBHS.?"E?D\F?&1&V
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M5[I&W7@X4XUN)(QQWQ\,B?.+59Z^*A$PP-;?D=BDUOTP_:SHIU5[.0%&=&+
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M;D 4PXC>CSFS0Y&YEW%.)ANCS=L'_-NW^AFK(,^['>6G-ZR2M-2%'*?LQI[
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M2=>5HIOT^]JR'%4;V\J'O&3W;FKV'@0H6;S QJ$@*6!)$%E<3VXRDJ$BR:4
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M90"%X%ZW*\S"9<M7K1:L"BD\.840^[N<P_P)IH4N''#Q^H[W&1I;O,4L_5>
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M24L):(-<71J5/=[6^L%?S#7:2$C8'#*K8J P>)!GLTK9W".B1K>X8S%^;FZ
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M8.^9;F43%KO>M?/I9XU*#U_FBH$'SQA6?/<^\^F&0Q0!-[EKE.H.9B"!J;>
MK6&.L_M<U^;MRO-C=U!2_ M>6GZ3Z0&HO_7'9T_-Q8LD"0Q4 J<9_KQ Z6)^
M5Z]= 18*-7'5H.?MU+8_F0X&Q<7M5_HC#=PRG9;T7SO?AM7J;Q0^?KC3;0P\
M<9L-^J9F-E,+YNC!&B)'NG.FQ] :CO!D#5[0(GUFX[? )5; A:$![8-=A_G[
M)I1^D2)OL16]>W2=K8B8HQ2=K4BCWIQUT^F]FI)#CE6/D)"M39VG=_.:.1L/
MXW8GU_)Y46I[OMBDKG;&5&_Y'DF/7)?=<,?6C&<&R^ 7TKS2/HJ*?*=GYE>
M7M+LG9-#G!?QQ&A^<TRPXNYIT.'\WINTR)?NA-MIC5J;^X>/74-^+TD6/IB"
M8_OUW9YR^W"_N:<"SOHC#\%:=-==#N="7]E8-G$*9J*UAF7JY_.&SPT[\IK/
MWSV2#QKG\'J\SM=..F-Q\F8&S.-YRKC**"9K5:.L0I1SJ*<V3_:2R*^[IA$=
M) #68#,QD;Y.^(2PI-=904^!%&8\5OS!?B7NM:UL4:S*9)46UWO>-K?-AS=9
MCKDM3,1YN LE_4C0H92D-2!ZP[".'E7^5C:7>HQ;5UND\C,LQ^Q><^X50&M3
M,_J2V-X#<[JF]]I7V1MSVS#C/K8"-]W-9,%YI]GN$<KBL:0FITPFI:J.PA\2
M)C(2A2*JB=5X+J8CJEADQ>M=V< @5ZQ<6:[=RZ:X[X^E;^@>IC?Z*1V:7W+@
M'TRJ"GB<Y<^E\"U,R[(<M8U$7&<*#E\3O@R/9.YVGA*QX@]PH8$B>*F+#S4N
MK1EAS\'\QFZ^6T;P 5KIU^JFC@6DWR)ES^65YZZ+IRO 'H,;@-?(3LOX'4!5
M)[]F#!^1_NH:@K/_GXVS_^F2PFNAO-GZFHP\:K;EE/I*OJ8[=#093-S[V65+
M4V JJZ>!"T8!R4:46^5C89$\!M/#6;M!. <I@5/+DN0T9SL&>H+THC M34S5
MDGA2J<>9YI+<GYB8SWZWV&:;"#*/RZ;P;$4_<U.6+_-+/.:8$"_.=49KROQ'
MY"'Y61J^O7-]] 2C-G@93$HY NF :4JB&$ 2K^9SYI-U?)!.D&*ZWV\ZBBAH
M=#*]@?.Q81L1F)!I;H 7[LG+[;G0I+X(+)1$^+#4$RP%>(4D OKFE!E05P!J
M6VO3*G=KGW+98I(5HS:%37?_:4>7NQ"R; C93X12\NG!MIS4JBGI@DM+Q#.I
M(2K\H2OO7<B" $.U#L!98VWTQBQL+DYKVDG)LWZ!'I8"'J8R8V3:(&U?>JK0
MSAJFR]8B7HII2LR1,A$O<)DNIIRFS*!KOAM[/<W<;?<BRA>J'#CK^_/[=#WA
MFLL#]VW+=AQOIKOX?N/V;B&/:'YL1T'_D$0U?VV95'^V-MB(@\ZD8:86@EBQ
M0>JQ3UT!X"@M>;2',R8UCK+U;"E<KB!WI+9_QGQ.TF_DY[-^M!HKHB1*<A,3
M$GW?TYL_J4(?^>XVR'I*RB>*^08P9VO]?.&C)_@6YJ3QHXT',C;F(]#C9/Y
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MM))B<ZS.A*41[]Z!6H=0LEI&)<_P9\PZDW?P"D[123_(BEQ)R>*0HYBFO<,
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MT6Q>Y-?JHNH#CN^!UZUT\+*4\Q.1(>)/$H_'-63K1\UDXQA-+)Q?Q3!K_VU
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MWN[&\^,.$<Q#_GI7:S@5232H'\[00=6JQ[:3]G=%O5GO=E7R>XO;@6U7'#>
M4X85P .J_*;Q .48C \B)SA 3H$-7-%1[31D*OP7QIUYAY[6[XS;8-'\O]!/
M66)MPZ'0D=R(^:STUUGI"E@ZK&/P3.9!?LG:?UQ\%$C%?%\+].A7H&V>PLHB
MRA*)':JK64[]3:P;P<$6JJ18C@2!'CQ@+;W]"1XP.;R;@]$RAL0# B64 P30
MB5T0=APS)F.M/I5FGZ+<'!KKM5:@QIO.^9/=Z_'0?12!;.)0'(<7],T-2SI@
M;AA21:02LB9OCQ,G.)EE1 +)%:BPRBA03$01 A('+T[P'.=#XGXW3SGM)S7U
M _WHP%W(Y;;L?[FI^9^/% TM6': K>_O$1R#@/=H- J6.HCK?D;&H1M\DZR1
M[0+EJ+%/).&M\C^VF48.7:R<T[:. C?(15,.'(?:1>KZQF/W>>.>EOXHRHNN
ML$2SV;?K=EWP.@]SN TBVDRZ<XX$[0WCNA6&@0=PY/[M(.V!#"SDT&?W11!P
M=X0/#3%[6?>/C0[&<@RS:2.F&#RY[=[6MEQC7SI01M7^SK6/&A:7N<Z!CO-(
M/Z)98%ZCB1;/":5S:+A1P(IG3ZNW)M369C6LK(V<A9"\DJD;@6L=:;O[Y@X&
MP4%+YD=.E[#K,,^.:Y'04K42?X4<E- %'2+SXA(/Z&K:'__QKEF5N,PS/(0@
MM._+H/-+G?HUV-6G%3%VLI$-K7V*X**:O_N)=JPD0!\I)*?_+/R1^A,=C29=
M99FZA=2XN^^K;!( BT&O6^D'@*+('YS7W]TR\0 'T\"SCTZQ>2OA5UG$:PEX
MP+U-N<UG,8!QW&CCHM99%FQ9O__/Y:U"Z.*6=Y(_=C_.+<Q)>+V@9-:YR^XW
M,063[FI\S_IN2LZKA&^(6KM<\F?=;C)#UWFNNJ+WQ:KV>7B1!YN-G) P_\T>
MR$<G$X1+L *!8_9#C&UE-3A222E0W$??]74#TV#!&+NZJ^+M(U&LZ2^2]I9R
M*^&NEXI#4NN9!!=SGO#^'*^/6Z3M$:_ZAQ@^Z+D:\+J2<I?FTN3@ 9;C#%@=
M3!F*0@N=V+ODX5U6.7BN?P=NV..R#F<48.7FYXL6NQ7(7.]QI+5O>N44\!%#
M<F4^N@JN.VHG;VRI;:R/$:(FJS2>,RTJB$J2K/?)E1Y_=6S^@PEA"GH=,_!R
M<JVFOBY*R84AW")4_,WOF)C@I(+W;L%/?_6[*ON:]R7.:W3C :SM@F#Z@>6[
MGQ.*U\B630PKUMXTD 99JVE89R5&$%EEHD<!?A5%M4=_3$8NL];]5Q4#UJ,-
M1?58+6L(JF6HQ082OE4V"+G5[9U2+)P\^J ?<D]4M9SL#4?)V\>[H338&E9Y
MC_QTOER+HWYGZW[)1=$D/(#$JG-#7(Y@<-P8HX,C_X2RU;PND.,O@(,E8&:8
MK+6K/M63-@G*H[K:0L'2N^_*E5_/$Q^U"GCQOB%9(%&>$Y$DJRO=0]B\&W"N
MJOF4D['Y<"(8%,GC :F),V?7^@%F[_&+O\8#8J=[=-Z9U)6S%5T$?_E6%E4?
M:;XLUI*FN\D?9X%H;3D+P("0.8  ;M1 B&#[P(UF;Y;/C1056]EI<'_">O]S
M@ERL^Y1L)HTL5&]+[NILYSJZ7$$82S2[/O&^;0YWUQ[<\:MM!LKEG]'6L2LT
M4P4/^>I&&J+[RXSXAN$HKA[@ILWK$ONA< H#E-=<:<'B'[!=RRZA]E3:&&V3
M=2+?^V-BY/'M[C1R7S/5JWZ1D//ENPT-+IS@:7WTJS5 ^MB\?L]KC]3Q2QGK
M)._/D3Y7 PO +^:WVB6QWM=?]K"F*&37"DVK5,,R4[631R]SQ0?KQNP_ (0:
M'Z5<G][7OP, 6\[C2\DK2JPE)N/J.9;3G -\(/3D90QN'_;JT^LZ&WNA:;MC
MEI8[PV0 ENTQ.\(5SQRRKK5K84Y)]6_;:;2W?BT8=5%J]S9:,.KI *@Z$V1R
MSW]K!-[2Y-9\[[L"N<SP4B/?_\#G6J)*,NPI?4 Z^%&O)A<^RC4,%;OP:*P8
M3M/I,C/(8Y$7/9RKY8F_9UKR,S;9M8"0=SUG9"/X<?T.-:=EVO6@7F) /DL7
M__NO0&%WXHWM4'?1">+*U,JQJ\(YY7SW@,9\-2V!:3?MR>\=D4FETQM+$Y.*
M'!>HPFEA88FEUZN,I)VM=BR$XZ2?6&^'\)"0Q-&2^F'T>,3D?%+X>H@IW/X^
MLW[6>43V>L3'ZD=@8P7\P:W$LP"</62?/;[PTXV?(4QV._=8I,&0G@_3:S0I
M<7F9-, S7NN+?,/FB%[(8(N+@;+^5B]C &,R-OV+$ =3PF2/>N&='J!'E450
MB:PU,QY@.YZ&!T2GC@N2LEM=*%JH D6>*9CGG6Y M159D9J-Y#U7;[>2PY46
M@"1V[.V;[T(#Q0;B+"C2T.*BMWW-/@S)+E(>>20 .#RQC]3_YT'%<A ;)F*\
MAXNMM;T]P3>W,W:H_MTPCS3YSX($-6[]O^YX %VM1R58YG+621C*>\&;(,O*
MR*^O3\E*0=OR)2Y82ZKO53W;(AH:P41K#V%V.MFM*?5]RA58G\J+4N;XN$U*
M&0;EC?ISNKJ:K1G(;L:XYJ2BG='WU"^AP 8Q3N=P%H,V[O$J[+.\7>I6M[1R
M5\,)*2UG>ZMM4NT1&8O4NI]^HK7Z4JP9,V()J#W3:H3H_S4M]_R#6;\=TQF?
M[^T%L1)9L9V?)01_2'B3P4B%;67EF-<#H^U<J,U8(3F=M:;7&9#K%.>=^I)N
M&T!@7NL0'_$S*RM6G8A!;JN8LP[:C Z,NMQ35LLKX +0D5CAPV'-\(P5R^YR
MLU_G?PTKZYEKT#LY>YBSQO\=A89Y#O,NPA.C]A"I,0<4#/X'')^WHT0QL'P#
M1G=0/4X0WMW_W"7/OG^/^RK"/\)N-K%Y@"'77]VQKH+_H7L_U5:+[_DQ'L#K
MI?<W[BXCN_S*N$MJ.:SL9IVNE@[]S\!GR<[E_1SH]K2A@[[KBM%HHAC9A%@]
M*7>2?R@!215@=N>A>'K-([$OO$4D'YHS-SZO?O.D^%/T:^;4<%]'NBH;?7"7
MAP@@MS22ZT5@2"VC9U+::E^D?LC8G@*%'_"^Y/5_.!M(_+P@IU3IT-2),:=&
MS5C&CS.655HCO?I&?S)?E(&R#BP<@B1^3603S=+M]!5%6PO/':#ORNL5*KYY
M//!JSB <)XKA[P\2F)&3R,,D#+R%"5H=.PONKPC&)I&=2/':<HH],?W.RB*Q
M278% C_10B=4(:[9NDU)^OQR@7:SY?Q> :%DO1]?68A2-#KU6#B//0399<VF
M/\J9Y6?Z^?"E*9M]V9)SA;_QU=-#JP$\8+401'D*B<ZI*>IK3^2 T6_#JG:H
M;K>EO^ZSHDKC:U)^HT'7FFF5)W%B$'PJD&75Q7;[="/'K<ATT5")=T[2@LQI
M,5<P/B[NT^>!(E]H_W@4#:ILS3P*VNKK<+D2^>K6;*7G.Q6OAZEAEFR2=YEE
MHU=:.+A(6$]R )C?/0A@J">(?MMMG"FK;+[/E\A'>R_USLQCRB8I'BDI7C\Z
MZ9]Z-I*#R[$_OL(@PRVF\8Z3GK]^V9MZ:"P;_/53T=*;-9+7NS0)BGE00?-@
MXS[&?'4WA_X=)L:%?&MJ]US!/*NT+4S3C?_K)U9[\@,^UT9II-T)XV9S3J>F
MRYOK O&.J.(!XUBPWXUP6+./';HUHCU1;7/VX.(\<+0SCGB $&Y7_I=TV--K
MJD\_/SVL0=-GLDS6W$FFXMF-/6K%_']-,?&?#V$\IL*F<@5C/CSA8C.]>9Q:
MW!BJQ%XH)1O%/[&:C2&N"B(8KUC&2!]ZE;KP7^G&"M4VP.YY@T<<DPM=&>H1
M\F7YF'B$M)QHOLEBU.<*WN8$BB'KZ$+#W/<^57KKZ &D7A#S[J2CGPW6^W%W
MNE#J4/UT84-(7OPJ.7EPQ?5BZN J(NH:NGNYC0EKAIC#L*)P;64;<$'O'!?-
MQ(&7D]J2X/[9H6B>-]^W!P0JO,G*[,0;%?_*2R6M&-A:A4)__\'Z2A?G\AGI
MV5N2& F+"M[8N)^W5/CGFK3HU%-PL]D \!\9R0B)MZ321*P5]G]H[*"?0?:@
M>7X$?^]A(E/''3D:1!OA<]&MA_G#3N7&PZ(6]^TUJ#)]M#%LEP<QB@'L> "E
M[]4+R.1S%#^._ #4GXBQ&H?SX&* (2"4@1M.XCR5X: 3(XEC.3Z+P@/R(U>U
ML(R+D'C?\>[QL!6NH$?@# 1QK"T21#RON;IOO06CT_HQIK_63;+\38[:_]B\
MF/%H<\\?#^!S/+OQ[U7;>,#),VUODF^0'JZ@2>#)&RP9'A#:DGB#1/]D(/"O
M,K-%$&2WHTIDGQ!!Q80':#1CHE<A-68+0T["HV*K3V%OBTE@Q.T#&$X4;G--
MZX;,2# R1SL"NQ7TKR+Z3;X1D/'<"S92VB19;DE_^#\".V965QI8HU8,*TJR
M+TAZ>N_NS*$GF,ZP0I@C7]58]Q6=-! ""@^H<;JRP4U(WHB''*I6]NH7U$US
MA6.D@S@VP-54# :$8Z<_"[NIJ=/J.)93#0_HG<0#J**OGD$FGZ)L<=2%> #"
M?CYD-Z>N _L%,K^"&PC' Z;4=K?5L6.8 G0*<KSW&M+I5S0>$L!GPQ]V^KG\
M.8=QSV?9J&SY^-15RZ'!$ZC2#2GU7N>!MC+ -[Q%\A:"%C<*.0]G1$&P3_GW
M;WKLQ4)7#D8FY6;!+/C7VGP@668P&%ZI;MA70IK'Y=#)F:[B 6P8*S74]4&T
MI5- ?)%I6_<@WP< 72?$NSVO\-^&@KYA<"X N\N1-XY<]/5S7F1=62/&NCY4
M;#56_C74DI*<0Q++8(==S784+L.MH-R^2,TYWN'S_5[#L_A<$0MBJ7TS_BM%
M(_C.LD!]P^?:%FFAVKDF2>;S:6/Q3M!ED6A.SN=,KN_GE;NKT)B_:.9(MCD-
M 0W>Z632?(U[RX8OHTT-J 9MB&[)VR5406#ZH<9J$-/$%_DQQ^/1*_3"<@)K
MQX&Y\)YRAJQ[C5D?=!A+A,N.@]T-#SH)=^$A11X3NYT@9^C%TVM'7+>,.>YK
ME^G+8K3'VVI,B$)V?=K L[J9BI/OWV-]]P4G#ZEEG8A"8HZ "U9(@Y ZD6 #
MN#&X3"W1J+EYRIE>(_E(U/U.9>Z7#W+K 9G7#PL7?2\A6D=\M47#,Y=S_\B_
M75)IG<QBA @;0[+$/7[KNYDRT*:A#+"%],YYL5[QY8D>,=3V*K#G78!)[+?'
MY66F^\(.[]4V3#^F'+"V?$.K8<'UI)/;"T?K<,I D$/]R8J>I_:6+_W!L'N_
MK9DN:DR-HS\R88?&S '#LOU.LA<8CR/#F%/DT.Z>G<$("3[F$?M_Y<^]PRTT
M=/!27I7Q-\8*H16-$[W8[*&W6V::+N@_;VF.?#L3FKD61RL=([B*](P#2VO'
MO2$I<S0^R%@;5="XUL<M:%8G'BZ:_J[*Q:K=:F3%":^ O_<U! <\\4(\?:\T
M>SCT:RJ?ZX?!VZ,K4BM7_]1= T^14#AQ3AF5HZ$CE!D3YM[\HX,?SD:_,AA[
M2\!MGT[8?[/"&V90?^DI6^3&%@?X2<;/#[C-D?P: 'A#DM/1?>W19P=9>X+V
MVE]J2<Q1GZ#83@OST?>T>I+P1PS@'[-SHLG<LPR8JJB-9WY=/?E1YQX[I\*2
MU;O5E#"E(5FU,>G+V6Z7NEM7['M,%P3O2L0:N]8)NT\Y7RJ1W"LWVIXPC! M
M%>ZM4=T4[,W,]G=7ZUSUOA4L4'@.^\LF%=3CK''+MNL+TI7HP2  6TXF/7!;
M:0M3:T?T64-AMPG)6YZ2M: F/<A)_"38+4EJU#P_^+%.IQF'%JTCV^KDQXZZ
MTUC5<B^*&E(1+R+_,Q7^\R^^"8_].;@^<9Q'8>U1NV<N*(5$ZKJ?VPK$J+HF
MS:==SM:TBF%W!>@VVV>L,&R'NX,W?#T>7-]1F].Y0@?FLJ(T@+E>P+U&N^YR
MMVBE\[\GN.O1Q4T?(<?UA>!/@!2FZF;6QL+E+J&A6)5B3(9FJ)4+WUS6XS2)
M)(!ZLNSJ)PS,R$SS2A!+7'.=T4Z"<>R<&Z6$I;F225"4*"VX>6-_([DY6QI9
M ?N$$KOB_[?Q;ET##W9'HR)=,7&[$5JOCY2(HA(71K,Q+V_2B*>4 [DLZS/#
MMI85XW<Q@>@"0_37V-H%5O$%Z^G* B^?*+7VATPBH@FJ_;-\5J!]MC-U%/23
MW[3);AJ;7-#CQAG/OT;Z<W.[RE<@.(/P7N' A@7!(ME5EY;QN?'D@@9=:&L/
M$M1+9=Y-OU7/)O.[@1D7D"C.9.[H93C#07HD[RN]2KC<IO KP& U'MC_2XFI
MS/GH@M+XX=WO:YZ#/8!!I2Z..V\.)XILFC8Z4&T1>8@.LFUCKZ6XN08A.@>#
ML#W*HQ=&;\6M/D_0:6G^EH%Y(*ETE:%@Y^4)9=^@AI'^Z7%=UXCE=U7CS@XP
MK( +I<OT.[NTF$N/\K3RZ-J"1_MO5:_^ )?'*ZP#C%SN\&4G+=,GOD[IO;5C
M7BW\<ZS^+V[TJ>07UGXWW#WH,PFYPS,G3#@2RH6)1&@>QK2R7 +J9^(K"EH;
MZ7P5BY/)@(_?60]V/!1V6VXK<6"#SE?D7-T-V.8HKPHLA7AV+(\IN!2!!_:J
M"@,<)Q2XWAD'O(E4DNE*.T \Y/YR,:7)^T/1Y@@V#-< "0RROQ28?9$MCAN;
M5OND=.7[[;HI8!M;%"O'DC"2-G >S%CD<*='+XM%X_O]T\D5TY.)':@IPG;_
MG:ZG^N\S?34OIY.#C^S#:'E$O!1+_JLN_FQ0P)_MN( .'>WK#IVCO<2S-RL"
M[]>"ICH:67<S Q8]^O1LT: %+]<J>Y#5'4AO[7>;8[97D&'+!@*/Z\5,72[;
M.+EXX#D;,-/Z9C7Z=OP#7MJ",PS($5VXWO,PO%'O'3,A;?UI-*EX !<>L"UP
MA0=,_\7:*Q_DF_5R/K[]!5((K!4Y &EEH,HW(,RVA@O4L2%X /?(J.3H.+;A
M(L@,U)+NUQ'3.LKN*0-*4\+-]%;_U6(Y4C#/Z%CN [R3O,Q)!?>HWT98<&O5
M0@\C_#:!(D@MDR7%1>.[TXHQ+ZC$<^S,%QO.W1(S=@2$"M&1\W4!2GG7N:J@
M&J5TI[COTL?MKS[%!2Z>EUI!&*X[U&FH$\]X2'$3 H+M[X<37O XDV]R5!$'
M"T'L'#JLFE*NN /S@!_?7)="_)JN%JJ.KA]!ZE8"ZTD[:@;FL^6GM#83E^H5
M#A8]QEG+79[TY\S+A!R) _=%'U_174S[WA<\3=H;_&@;3O2AT@7-?S::=%0+
MW4LAN=3QK?9%.!6'L7NGCDGS<GP(YL--S;9W'^$!5E#XBPQ]FCKHP^O]/P-K
M^LI+VQUWV %" 6TK=L>1*[B#15MTN<B3 >"?ZIP:#.3*?)\E/N "F\C#J3;?
M JD7/31^M'P/MTB0/PVJ:A]/1J@I3&Y>6CDO95^,UP&D=HP;SOR&K^,Z'$1J
M%P(KP.:'SOT@\E^PKX@S<'\V5;-*LS06?=4_L+20H% 798T>.*.T-KFQXC@N
M.S$.FF^M[.7,:/"W8O1=Z>U8D,R[-]51_8)DKWQJ>//[K\>\[-YA8[Y$F=ZY
MMTZ6=OQTM<WL:$T%#ZL18_:3DSI7 SQ4)WW&:H="ZXVA0D)T<Z0#\_/W]>AH
MB9F=%;1QC%^JP=-7 EKWJ4BN5,=QW_+M6S_3E-M^T+BB)6DS]D&#SA)*F(3X
M]VZ)8+Y6I9E+%'8BM&\&9$ZSVK8B4SCNA],^Q[:B!L\=.8B]^6+<Z9B"LW1G
M,?N2BM<6;H3]/7!K<Y_BZGC[9B Z/K1&?YT7S^S*"RP97($K:C[MTUP12?:V
MSO1:2G!XCQ,X]LI\7N!K"4$87,V[#^ RL!T/ML\]%)G#SXIPG_  NJZK%0P&
M#U U7PS*D5Q3=3D5Y=QF>R-TY];M*W4<UC8E,Z#58U2;!C&R-1_Y\D:B)A4?
M_KCP!>[<#."XZSU=)_ZX@'BKCS?3AP7R@5!\P<AC/.O(U2W.:5R<X&=#<TCV
MZ.MTHK?"MBG[A.?\TRP7[?D%,A&E9X[%N"$N3Y=ZEO:9CC;S0UN@R,2L+H0A
ML$&-AOKSV1,@]I5JFKFH.?"HUZF+=6"YZ^<^?UQ'39T8]T3[XGT\0%%'?%E'
M.;LZZSM5PF_27*H0WP"7O*CM51-Q_VR(7$!\8DL#JQPZ?6369JY.A'IQ@"O3
M2:1(P;C<Q_&+#M:R*NY*=Q#'AX/74C&E7B=9X %JEH+MX Q.6B>X@=1ZDMN[
MS6@Y-220'$/S9DY$\,2H3D#RF(W"B!\,)X ![R,NMD03_0 U3FMXP)VNLI?Q
M/Q>'+%F,--*TEBTL>I6&-EL^9-D6.,P=V<,<J;HU.!8^U/LC[WT;VZOB7;T^
MR )7&FA=YWG*Z_31&BE5V-\;VW3*O*/:0.$)&Y%*Y#(;;7-_SJ%[@QI,<L^2
MMKQA<,VBRC+(S\!D92XKQ:2+"J95I)33< )X6*0"X#?[;Q(1<3FA,[HC#:;R
MV^LF-^8JTU3SLN=D-^M7G%EJ+*+O*(U[G*SK?^UV>D3%WW.L[+1V-4[=.\W$
M!/N*!WS\L!K0U=!.4N^O)Y(P[(@'D(KZ#U\Y/N!IBH\Q$XQG'#!?>AS')+W;
M*2\O #H#T^:0+(H;QTE>?-<.;]7A=4N-9B8<!21['_!26D]2%8::LNZD_@[0
M1/4N"Z,RFP.8O-,_?<__NM<P-<3@'N[Z1XB5B$MJY\D,V\Y6X6Q_5F+.>)<Y
MTX(],0M?5>JADW#MA47ZWWE!B_0W.SSO"]LGLZEEYA2B45][.B@ACC2D0S=L
MJ^Q6 G;4\6_B;\MVXRFO7_PYN$=?NJ;(>-+W+S3ZCY.%AW?V:K65N<D?0!DP
M#?D!@3-R>AM8:33HDW@.C>\CA?&*[10MMPV/Q@,#0D[1/H"_:4#3U8W+'S*^
M+NK8\X-<TWXYQ"AW.$(ON=K9\(#5A'\< S2@1UV=@:^+%=@<E\5F3R!< 2#)
M(,%9ZHJ2P +51B_Z5(HC*J3#*K5T+DW=%O1KQQK3=67'EA_FIG-#9?]Q:O 0
M]1O6_]2,NCIRX.NE63'"1N@L-HMM:;7>LG$?GM#[*<XV';!3\G^&22]6<.0T
M>,!]+S0_KHW[!LJ^E6TN,>,4YX"GAT!<J, 6#>:!#M%U@@*?J-2M,;H;F()^
M*T.TB9PEH0+8; J=(,3KX0QX0)'RS(,;*9>O9ZF!]):GO$](G[!QV2I=T5YV
M:OM+VTS[A@8%5E<N\( ;_W K_X8&2VYP+A7E@L4#;AQ B#8$K0<R+L"N?-^"
M6'PP/]Y%)UYD0Y5]5;#BT$^031P-ECP6#X@IP+$9=/TCDP,)[K8R'M"G??H3
M-'H1>49L@P<H=+#@ =]W3@R^0'K4;]@<<B,5.TLZ,#]!:T7_('H0"K*J:X[5
M _[#S+?_:67IBO7F#YG'ZMV0N(\&'C"Q#FW:/3X_(T1[YR A<"M$0NF/5RG&
M[2$_!IHXW]VJ5B4=Y#788K0K+*RLEU.O+7[I7JQM5/&/>[LCH?^4DX>&"3-U
M^04G.+T/E_^X369G8S!9JWKX1ZL#^$0FJ]7S5IM&MW8X:B,3DS.23+JLTA+\
M7+9*.^TS@,!\QEMBW1QHF2K18O07S2'CU S_=#O68>6]_3NU8_3*([!SG^AR
MF\[:T6#[[0FB:66/!U5AXA/JUBJR)",<R89<38<O@DAV<98BT7Z0SQ,&DI4!
M"I,2;<3GJE>/_A@OJR:/S#VHDJV6<E7K&G\DDVB\_2#7IZIW&<L[Z=)JCP>0
ML0^#:\2CW?C2AV/M/R@_2*Y&RH;FO'.5@C)<U^.XP+::UUEU%%'BG%)F)J;;
MCU6\YTH^D#8D<;.C<YI%846!S\T(KKP@0PV[YF=WIO" DW9R^SHNL[#:C(T=
M_VL&;55+[7=+SVU<>,_I"FE?%F6KL3PJ.>4]810";PX<PCW65#H3?VV;TWNE
M3M^;N^<=P7JR?6"9Q1#<^27^:RGPX28\^.D'S"QQFZ]08HBGXSC[NW[UH4#'
M*/%&+:UT-"I!:>?719QLB&9.IX((NI$",<Y0G_I#<F42^\!LYC>HA6]>P0UX
M.OQ;8;/(TYPBZ"[&!0$-KDUDP#Q;7\*XO(F/_[+R(7E1C*?6]DYS&<$7*221
M15PHE9<NP5_0'3S@PS@1YFKU,+J=:Z  ;B_C76>'8MVWO*7Z=Y>CK[E&(/QC
MRICTCN/OCM7LG.J/*]6)W;*[$-H^Y^PG<X>OX%_0@Y5$=NHFO1RNNK?&9#=T
M3H":BSMAFGQUF4)>GE$<B2ULFZ[OJDX?]!#RNB6)/8A5/[816U$7X:5IHLTU
M1 QH%J3\X5+;_)P03/!YAYDMY6YUO/YD",@AZ?JP)3Y&)I3BR"VT()0JH,$%
M#[A-BK$M#/!(61-/9XZ'RKFGETYRJ=5NJ:99=,EU!JQ%9=@E.2F_I5XMD#AM
M Y<%_3:[ X%'!TF).<-@:C+N<);(M/MC"K,M(,CO$?# ,ZUW%H3PDO^-_"4"
M_'U^G[:#@&V-T4(V7U[JW6O-5&*( Y._"R7VB)FK!"*%1I>*0SZD]2\)'X3/
MEJCR$G[\GD5,QAV2\\YM[H=Q&4.#''1U+J6A/UUB2)/K83*KW!\K-&D;& _P
M?/F'&^C!26V$:F*%%@B,MC+^</#&W8TP@4; @9'WX!<S'Z'ODW5EM0CT&?GE
M:>1WIQQ?'EJ),VCK>6F([ O)(&:T)!K2P^46O!?N;5X55YV7/J@SY.*YT2"P
M"-#NC7\Z27= [X)N8YH'>K/)OU<(WZ^IJ0OEX8AT#>\]L+%U6BT]^IVY5A-G
M4(Z)6%9"N%"]<BZRBT>6--Q]2GCFZTOBO(>3RG. [M"H6!7_W^S&_LM3<B"$
M: E9R^9-9V8WDV80^W7"?5KZ()?\SI:,M1@9SW0%G>+"N2 Y]4'3F,S5;&15
M_><"VX;H]*?+X4ET%>,\$T<0F?\FS\SQ87R]SU<S^OKD$3-"IT"&HZ'B6D<Y
MNZ9A'K6C4J[BY8J ^]F.4.HA\9I='P'>W@'A)G&QP>&0<S9N9I?3T3>8 VXM
MHD+8$Q/>-V;/13[[):#>)8&CNV^Y!F4IEFL%!]V?K.29V>-NG5Z=$:[DVK,W
M#G#GU=^Z5:J[3.S+*L6II7[W[.OI!-\D'F"J9?F_<V/ZW[=F! V,J(6RV'TU
M5F@H7MAIUIL*RQX[$.5]&ZQ$\ 7E"\ Q;N:@?D-(0%O?,58W\^ S)-ROCN%F
M]O[3C\!_>O?*H9>CX.^%D)K::8,C#5$M8X,];R>*#9T+X)UK1JD1U(_!T)ME
M,D*@ P_(/T8;X '$* @Z';#:X4 SCUQ+"T$>AC!=N@2?4+!( %DJZM9=#5^6
MN3'/_W!* /QU)^@Z@>9"UK[@J"&33U #.(I[> #YD:D'CNS*$>'8]FA7#S..
M?HI#JC==V<2E["2)-F38FVY?95.SQ%W--6!%3?& :^:<F Z,Y,WR&3=!D@_I
M>8CEN*F)[5HBEDD9Q_!/[XQ9J((SUV:,.2*O0A.M,6 FK$31<YV%H'IVLR)_
M#%C0EY!F06:?[IT0#(*!:\RA06Q:7I+A<D)%8#^3(C+9[;E2LB3")':[34;8
MY+]/NPBFB:Y=<C%" V.PFL6[/U0]W3_&\?>@W]DP'%@_FZ+Z2^WN*GL*M47%
M=R]A3%2SA),O;&JC^T9<H_3?Z')VD9#3F+:5I<XIW(F]?OXF;;BWN3W1JE1U
M:OF/L8RO>PVEZ%O=U*45XI9 $<V&R=H%$PI5;)F)81I+$H3\ 8!F4)N3QT4+
MPWWZCQQY]V89#.*P>NBZHKDLKGT50]3UU!!?75'&^_%]C\]'@]96N H:WI/+
MD\*EB-3Q#_]\5<!V 3-@%CN0Q+O,G7QPN:+]:WIJC%4I%+&L$3CUFS9P+[/^
MT.$8M*""L.U5PQ%J6HGTL&Y.\P5RV7LAR[K8OK]"29OSW.ZWOI#>SIS+3$S)
M&5L)'[GX*LE_4[/G^\T"71UK7M@;%L@G\,4#PI5S\ !Z%:QP1QSP1%$$A"JI
MN=%!#A3R&ZWT9[^OOWA"X;"UK.)(YTH=S5G/*XS+1R^FMP%YC61)R&2N>TC@
M,JG_^RP\@ **)+FFI1C'/A+$ S#I,;M(K7Z?D/".3HVH'T@:D6@A3A4YE.B"
M_(TB^D*PQT8<7XB50_WXG&?_*S#CU;336E5M?;B8'H.@'0 8/*ZTPFBW8.J0
MH3ET)9%'255]?4Y$*UD/9I$K81T$/I52X+1%FR-F,UA!:XKFFNY_5MQ$8@2'
M&WZ772]2AK,2$LHA?LD)71D'J*%]XN0LUUIH@AN@)1ACQ#+\&K)VOXZ=RX[)
MFO4!P84A%]G^2C#!*1$3VD2E^L&<^)"LKH7UJ00?6/*?NL/NII]@Z$^XJ-N;
M.$8F"%83X#_*N+J":L8]ADP"6O& [OSQ_]CA9S;OI[GD9L[!Z!KA 6AQ@D6L
MXG5N$'O P]F\:3E+9"!-CU_<I"\:OF-0RA#/I;K(D(GD/MXW=8EHU2@"#RA5
MS9W(/UO1GQ+)IX<OPU5Y8ZSE60U=E8-N1'27<BL54BLAB [5$=VJA'(^[!$#
M^^O6-V1?>RV81#36-V5+*8R' T)MDH4J!M_5JT@##6]4A'F?"!G&_]6D>,?\
MQ@9,<]JIH+8^1$[K Y-4P9N?N4Y[@%R:_!(H\3\W#_C/+<NE\<UO9?_GYD&Z
M=S$W.OG%K1OM2QX+PMT/EM^(N8CM[JC3ZEUAW@UZ,+6G<&M9'A;I\E6KS1RC
MMO]RWICE+^$7 +9:Y!5,[5]&#> \_7]E<-H1+MO]:YT]S&2O?[;?#Y"KFCHX
M-0_^6J5<LE.?_H(?1^>H\_V S[" X^[."(F<WV=%H):V&=6_& ?]BUU%KF/E
M_[=#H2)Q?@4Y5H9NUN+H*@,_<KF]##8PEN&=T"P9\-WX?4^-)32FQ957ZXW[
M8[]@@CWQ_TP;&X+,8<@A ;L'J@E1G:PA(]@MUN2&.+L?"/I1_MIHV.7I:^9+
MC J0#;0J5=Z8'V*U)8A),M@@>KQ.J\B=J*XY_\Y1WZT9U)OEK145G>MP2>G-
MYK68TF/C79U\)*?*65UH97_[5T\C5 V:UBJ"U#@D=TBWC9+@O&]JN\]4+5\T
MBP=$A8_\,HEC_A,>I,^=0$VV#8NYC&$EFN2-3>)\3GDU"Q^B#S2\?)!?:/EN
M,U:8IW:F55:N^*.VF>J>6R:!DZA$"-(E1FVM@QWCWS-!BAT>FC =>JJHNG+W
MUF45#XIP47\ERGD8G-/CC7O1*81LR-3UM;WF,B,8-^\._]DHSYGPMN<L K61
M=[LVF@KA>^G47U"'D-:+KO\"VN=2W9^>T3]+1)N\G#O-(M1L,.J%CV7#PVXC
MN1_%=_#X2?+C+LX9_RXS$5[)JB!QUFWF>("Z926R^Q/NT0H1'O"G2 07::_(
ME?'?W*<B)HEOM;=:E6?U$E*RL6,#[W=&^SS=M" 8R-W%Z*/N!G.O<YT.8M_B
M 9_? Z](YR';+[Q@$__Q\;O-<#FO8DS'&]C'O3F]%-66*][^%]S2<.J_9^N)
M/8L&*N^T>A(OR#&'N'Z2&XXU<0#L_S]IUF-07/;=7W5UH=UKIP*.@\:RNXX5
MH"'!2I:2"VLOJA4>EH& .9]N+1K#W?1$+-]]/$"_I3UDXR5;3'=(81*W+07]
M8^"C1R'9_868[\4T+."#@9YZ/\G( PFB:?B1IHIIM4GR9]^,%VZEK'+KV:X"
MCFL$&J8@PZD,]:G:EK:GF(5%3K8[C*W[5892;XBI66[1/'L0:;![L8 #:/A#
M3,=P_Y&#S[$/=.3-=>L&3FWU\8#)N;IH5(M^2Q,F.^.4HB7^M6\=WVR%3=:\
MY8LD"DA2I@A+/PEWNDL4C@)K/(M[,(_Y/8W@CW2RF=ZO+"^O*$0A!^G(LE@B
M0?;LWWP=QSDQ!?F!/66FB;DE4&8\($P6V7#-D$.&!ZP)\>,!?#?03NHSX'+Y
M4('^9K(9:^'4<VGL\EO-<;2'"2LG;P-NRH35YF!35;!W5S@[M@HQ6C?L: ^Z
M>!0LGQ^#AF">M\M")M50.3BZ*<B1GKLYS>9UKIP]*(:G&0V).'$KV'VR[5J+
M8_YR72G5?4=F8S6@HC$$=G":2U-D]_]_=8"HR #O&R>4L@;"\A7B >L_ 6<Q
M GTWQJ@Q^WB ,G\W!*-QXSB'="'=G.@%7(Q6&!Z 2DO! Y)+".$/_M<KV.Z,
MML3<%.FX@]%Z]:G?C&WF_=RA=5WZC@C%</V0/G.2*AZPS1_Z1H37?7;FYKO_
M3\;^%WMC78%S6T%BJL*%N3_[[A162;8YPU=\5*(\S#'A.:'  2\R6P#Z[[,,
M5Y_FD&^U\]AEZ$_N2;R,NL/:5J<68ULI21@SDQ\LAD#5QQ/GN01RI=AP[K>:
MO9(D<PY516[7F; 2_C$@NU+%BLPJB ;<GY$3*7AG!%]9-)T?JUZ1+5>R;$K0
M)_I9-:3+[0;CE($903$1EK["T3^B[\[9! _='CE+EO_I7Q,2APIZ=VGP>1D<
MV^<#H0B0/3.US-%OG*GD:6SV_[//I1M?M&;419B[2MA9N'2CP"H&K%:VH.F>
M*]'I_64E1LL+C@:H/J?K5 ZVP.$\QRK9ZI$IBX#-!-)^T?1+X](R^L"/#-JJ
M P[)?M3VE,:; :!5*IIN'!_Z:<>/^=A @]Z4'H_2\=8<!=4\0RLI?D+2&*E*
M&@0DOLYDG+*K%!QTM*E66S]347$0=I9(>>S\G=F!B9 B0II'>OO=00'R.F@!
M\?0'VB$%]+E<(8,K=B#-@BG;(L7Y2=;B ?:A^>55QRCU"FP%IS)Q(V<#:-!F
M%66.TW S1WI'_>.M,WA*[4C%F>^Z+15;DA0+X=_]F#._'Q77 =%MW3&/V(<+
MJ^O2UWJJ7X3_>5GT+?A))T?*ONH'E?@ ^@+L,]1)^OTV.Q'/>?Z&)CL-QI&D
MD91>=VF$Z@2.L<7L-O)F(?(K&H@N/Q52V,&-]]1/=,.>EKJG?14<?3K:3\;0
MDI#]G;6K#$@1X%3A:"93*^E7>QY=4I\O++Y-OE=#^YM)Z">Q00*UWT:Z 18"
M\ L"1A_\C_W0'X-]5N^)58E"=M5:!$*BUPZ)MG!,LU[7&IJU3.?I^_ 5!SIG
M_K%O+SX3=VT?O?R4J+X$I< \1 :ZF*+URGTN:^%?_-)2):Y'6\,8:[X[>S]Z
M0/B7_?7CP"=FVWI.]+@6$OV6V_](C/VKU7PU"SB@GQY866<G<O?7C%"=AI>@
M@4U?:ZAA3N)!\Z>$B ;'C<,[ <_1DI&MSQ&.F^W9=D8NL%<1\,N'^='YL3PC
M8;>&X^B3E_QBTO;>&BA\SF]M6,UN*W'0V9V3-*Z%+]7EUJ:Q#_UYXIS&>71_
M;89PH=YQIDQ-V. ]?7.CMC(C#_EF /_-0.EB;K_7,KG75XCCGLG0GS'Q=9'Y
M6Y @ALU6,$RR<.OS:!><\=H'(8K#WB=<T[]HN7K+_N!+1.H<7&4X>Y6VD7"J
M-6$787N#5.0;."IOQ,[FFU_IODCW\F;_V"[2!Z)'EBPH_TI[LTN(^5RXX65H
MS/'AI^:^@R)+*'S)@6YG8AM>GI8&FWYLF_8XJD=0ZB,3C\26A*9AV,&-U+D;
M;@L.I7J-5$^7YT+ 86^DCOZV1 VS;&:6<&<_6:ZURZ5YA/K:+=#&;YJVJU.'
M*C_[RBIY9]Z>^"''IOOJ5VZJ-<,XCYA3Q<>/9=Y.JB3](QK >."Y:P*+/A#*
MRUISXW42M(QYO-4C3R.O;(N)56F:67F=/K8C:[17_*1,@^OT8_^6$BMP97S-
MA&'(BO[%%IB2/--_RJ<^9,>7)OBDQ87!?L]S>%2P[@O]MA.#F_JR:6NRLT *
M_]TS 6+6$Y(*K[-VFEG!RKU*RY;I*7_9YU:$U^G/J^G>?-EX[1LO+8>&5>AB
M3% ;NYVB2T*S>P;A>:%3]'2,O=K$Y";\AYR;(/5#AYRD1,$.S%>^(F1O-L]4
M8<R<OL:VP@#W$<DC4O8.W^^ 5\*^$K/VU;M^?6',]<9S66Z.,F3W4H78*8OS
MKDX''<S)ZZ[?7^FTM\R<P)K]2YP_&EFX<AL645?=R7222U;A2P@L:T.91R;>
MX'.QO=#C1G^[L]9@BR=TAJO>K/>3YR3]XP]_]']H*'%H9Y^^/R,A[_^JNCKL
MUK&&72=E)@VRO(,:W/ 639WG4ZQ<:?_I;;WMRD<ACJR07RR<?^2K":3&J!^M
M])E'BF%5)V]_,2Y/=WP)K?75X'4>:5&R4/F8>6=P5!NEU<-^2 F.=W&N>P 5
MJIA:<SKKJ]=_(M/R=;_+[+'L1,,,5^SSHBOF:,C60TL\(-@)#^B#<?X,4 ^4
M4A]&: KKUC>;^/]@<@_:E8U0&3U>+04*^P'53]G0#X((=OP"SM_^V7W,;9(B
M7_NV/"%!0UU#E2)PM3KIZ:K;J)"SO*"?<OHN["QI<<&1S?/LF#M9^NUL3//G
M)*65B9@1&%;9?\U7*$4739UA=TX4U6,X.-\O]IIEE3+A-<F]9A&R+8$U"*6]
MC,QO6Q,*P_VP,(OV64)0@L!73 8*L3G@8_SQE^ESTCHU^H]=[<_Z5#][?TYC
M]WNJ-*I;7F13]>@,YBY"B:G113\M^FFH5+']X:#?)[Y 0U\VB<.%)(A&FH23
M=*,95 5.@HR\[<$#"-CQ@-A*_TX(E3"6![IH.@YAG*WF1<-_OOP_V/ONH"C>
MI\]50100E)Q1HA(E9Q"1) *"DL,2)"P++#G#BDB0*""@9,EI0<*R9"0GR7D)
M2T;RDA=8=H_O^_ZJ+E]=W=5=W1]7-5,U-573S]3T\W1_/MW3_>B=#4C]B$I?
M^JIU5\8@^U%\2&]N#EG9,;/="E^#WI=&( 5(Q*0KB(\[WLDT8@8PYN'L54RP
M&CDQCM5Q+]G1W1+/Y!S;G& WVR,V:GUSVV7NEPN]VRW)WD%K,(I(H'S/DV,<
MXL3/L(W;6'ZT+&_JJNGX2WB)M4D\F;F^-),<\\Y]&4HQ9\:(*1POZQQT#K[W
MK::8H?8XW<+7U'H:^<T3=3E2;.3((@Z?'#/COC+HE-9L23[GB8.(Y8:E.O5;
MSH4/*07W:/ENZ0UW@IS@S%9#YYU^9F6I[LO!U?%1%?UY'QD3F#\M?=AD@<]@
M>MK[5DH9#:NIW$T6E%P2>M,B=^.-/I[TFAI0EP<(3,.;H;H3&Q,>4[;)4J+8
MWQ>(]TFF*K[==.6&P0FN,[<T3$*38@O?U$]Y9H@_>#E@.N[,5Z@M+#4V6EMU
M>7W9V7@(GPABR3*J/62)=[4D'$.J*\Q^?PP1TD%K'$<G=KO'\A:@%4)5/V.?
M6.<,\BQ\U_E<@2#>_6/T2TZX)^[ULEAKL-LVDGGAL_3TS!T'6H-?JM0-HKP;
MB%M)P>LJ+]B9M9ZU?BG/0K^JE6;F[42DGN7Z%H(6V<?V(3#WC<Y:9_&O+K[\
M(2%MW2X^)30CVU#RFJBH/3NST5W;UL;C\@*:,>ID;V14#>V05PDI0-J.V0%R
M*T"D&9U<=VX@'6V0?*@JZ]7&SON$8G"C/K%649(.A@>P8A0#P,M]'DNCRE()
M$K&^[[R3]96MXXIT%1@"0^<W\@[7NS)SRXS-?:(T:IU$-U3$G17?1JCW.GZ@
M[1X=UI*BKL\UW\8]&<]I&3]MEMZ8>K,7[SCO1G;O<=WC3](,*_"XX)24RRFX
MMU-)#X1Z=]CCXQ>ZFM!<&R-:K[&2T<V/Y(/FH4MQ9-K+,0_GS#29SG7G-3U%
M.O.X+I@JB<DEZ;LXJUI6_?^Z(\^C(#52Y7L?#N]^FSZK13DFSR!KUSY+%[L?
M'PZ026=.DD(?ZAI4*1_JI[0<_G$I->PG6YJ[9V&R=M$"3&,ZU&^R0P\V:90N
MHDQ,E6RGC=\TN.-V4FR3)4@[O3K] WU7ZJ,$@Y&AN>VTNO#810,\0#U89VY
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MY!0J=@8.;?P%8XV=DG 9>3O/!ZFO5 F\$:X\UZDD/]@H[O7RMQX2O^CM*\L
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M0:I;&FJCCJ(D5%7C?+"3JU=]AORYC[*Y*^Y$-OY/-2VSP*RJ1QFBN["Z@^Z
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MXFA0!UM_I6M^/>QXG\25GJY_H,>UA'R-G 4"WZO#L#;H\_":9A4<9KZ#.JQ
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M&T_"8"NUDS_'(5P)B\.F=94?QO?SHH5LU+6O8CZ]( *UB87)/P13V+<2E7T
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MA!_T(Z<D=B 8P@_?&S#S#*41Q@NE>YZC,[S_13R)HA;[  ]@1X3C ;M/('A
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M@.>A["\1,!(88>=/,LI.5/,A=B$XCFA=BIO#\^ =I@I*6I/U"+HL<?7.9]_
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M <E))6=%@A)%! 0$%,D%E J2R@+)12P!R4E 0$! ),=2<B[)27+.5)%S%;&
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MX_L0E=>M.&]:>(RUS=Z,?:0IU:0#"^XA M=^V4J/.\&7W2\N;)%LSEGW/9A
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MNW.(Z(^"T_KU\.:H9[YJ(W[+8U##43+JCAR^"<F8A@2[<^WL5F:0!J-:H(Q
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MVTJ*3[0J'-<V_R-OXIH8ERNKPM580ST"7S:RMR5H#16)AS$*%4)?EY3ZDCJ
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MV;6\3,- JWT=+M#14RO7 7SB6R4"Q9,^\N O4I4'<WAD$65J'QH<X$)UHR(
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MJX,9 U;U&;;B)U4+A<!<<U)]78+;]N&HATB4'=3^VR7U:0WG"4O'@JYBCEN
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MZA6W7K[--RAZT'@C])4#+'.,%%S__R8 4$L#!!0    ( ,\[;EB!4^AJ=&0
M ,=P   8    86-I=2TR,#(S,3(S,7@R,&8P,3<N:G!GU+MW0!/?UBX\2*^A
M]R)%46G2D8Z%*E*47B+2B8#T%@A2!2D" M)1NI0(TGL)3:0WJ0%"KPD@1 AP
M^9VWW'O//>_[W?-^]_YQ=V;],9F])VOMF7F>9ZW9N?IUM010:ZIJJ )X-P
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MW]#8V87H[NGMZ_\Q-CXQ.37]:V9V>06UNK:^L;FUC3D\.OY]<HK]<_977'@
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MY3R/.EMAIG"N'XOM:(:][4T/9^.J3%T/+2-LY:0C5K8G14:@R\<_24+>E%-
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M;/!%[6@0U/F$!C-W+=-D5*5G*^-.4*IWYFUI19=B^Q<I%@_O2GAK^MLML2W
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MF+8OQV&.HMM@7/ "N02#]OK"9!6=A>-?SDF;%U,LM5AZY=H=[ZA74+AR*M\
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MN];(SW'B5Q-P2T&24YZ:"7;IR3/ZFEPWBX[(]4&L9.X8-(.*#$Y$+D#6!F2
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MY=CE4*]049H#;X)X\()N$B-\H-W2*0,WST4H5X=4O(,__.XT?%'CZ>2U3F+
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MHL*T"&5 0/!RZ6FE",,=CH"]$QFK^B!=C>H$WI57R]3^X-D-IL(97?(GN9E
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M#K(H%7IG? 7IOT T(H09'^DA W[( 5?M/ IL7<?;?!6Y5I[USU2^M@A1JR\
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M&7*AX1]W,F,#Y2Y4=\KDXN-\_!7E^$PP&"3R&][H!>"-2 FI\&1[ 7PBQ7Z
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MV,Y'12&-.6U.N^CGS*8=%%YW (#(QX%FPP_W%MLY)Y$.@FX'$@&MJC.G3?+
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MY.F,,RCF;08BK!WZ %)]H_XYZ#BU9/MZF&7ES8 ?V97)MW8,?%/GWL*P=&P
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MAC#D240.8>#[\1[#=M:).B H\3Y-M]S$-^?EJ#5>QL"I%P@?5$<_C B3AG%
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MBCPZP\+?L*](%F9%+NP+M%TW-VQC.Z14V76JUJ2V/O$XXRG55TX0</W'4H1
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MA%J]Y\))=9@E/8#6]X/:3N_P#(X<W,Y"\7N8LG6A[C+?+[*K_@BB)GMZ&G9
MB#[2EKP.2MPUQB'C::Z@VS?&#2(%7GO\2>1-$X[</&]"'>:@+B9'M]_JO?Z^
MND!I!.R<#\,"*?W 1>M7+Z8JP.[CDZQO=X;3-E+M_V::ET'[>[!N5]U[(Y<L
M++XQ/N+((A3W =O*!KA(-T6A,3KX81#S$"L=7&?'K#+>Y,0+!M^.LQ71T.E8
M@ XB\4"^JM'Q$AL>Z'?!ZI],0D^^Z1?K)V/QP)5Z6$=K02D>R.N(5FEKO@YS
M\A]8X8$C$3P ]V@]F1C1_H]S@O_#EN9_9]0?,>XUM(:YSSB>9-PRO_OC&U\W
MLFF/N91V/$5^7HCH\=R2V*_I:)PSIG5V/>Y%_5B3-3D,1NO4)!,9Y6FJ>O?V
M[1'.8V!D\!_FGR>8M$ZYIQ/0JI"?#:_K**;&Q QBD ,U(K5@Y][+,7 ]_ 86
MFN4MT%T[S7BS]A,22OJ!T6]N-RZ@6+'4?;@J"-;T?MCK[NR^\F%H\_%'VG]J
MA"E9L0;><^T-/9^G;TT?G(T W\CV.9U5#T6B8]?$,&&A_I2KL,]F+!BGJ!._
M"R>YCG,HI0FGEFB=?)M,5CI >+-'86^8YY#O'3Q%K>G9^[;S\)"AJH5[#X67
M#RA4I-VBU]+UD_Q)Z=R\03V=;V/GS5O#/4#(7J?DL)^<3J2-"?7#(JCZ0I*&
M+XE&NWX&)DIV%I74N>(Y?QT3/0./%QQ&Q"_3D"/A@6)H?Q1_6LFL'4H\>9#,
M]^N4G/NRN&8*?=_SVF*^!(D[9SQ.GXRXUG<\5HV'U'OH(KUN3?&K=Q1>?M,G
M(:XA5[^0ZZG$,:$K)DG3Y%^/1F<,#?FRN&<^6871RK%A'9T8_"4C$#P$U*F)
M1DWV-W(0BG3.G\EN9(<Z0XOA]C&*#TL^EMP"" ']-/]_&LTMK11>AE[#9,P+
M_I+E)L#W_Y'T^W\9;E=B&*61SX@Z>-:HP.G$;T4-BM3LS1A!->?/,3/L9!0^
M%4%-3FMA7=(+##EC[%48W<_DH@JGIA1C4C++RY_('+?">%78;2.! YDG&-N.
M16'8?@UCGGU1+)MFH\[- =ASIF58I]B,_C#K7;3Y9SEVTP\H!O1(^ F(JI-9
M'UZQAP=DM]^QSPSL=ZT?R +$Q&,ML<Q:-\:T1^49Y/BL-._L\7'\=8EZ$@5*
M?8^2J>E?))@[;>\U8<2NM2=@S76P+AB;CCUM/O=C%3\(L]>C57TJ"%7MMS=>
MP9R1><OW&_,#(M:D&9 @$G"RYZZ97Q3#:HR*]A 3 !(Q)_;G0HM79 K7CB^/
M'Q9.W3L(64SR#EID>%A[O/EX+$'U_0H!DW??5J8D3T,+*B&RR0D^CP>>[PG7
M+4.K7<;@;TJ:BI6X<DU&?;>OQM3= Y@N.'"2->BC8- *MX2 V&%5_BLES[(G
MS-&-*L6<5K"L\XL#G^FVH?M=<K1H$R.!<-$97K/^I?YDTFR)=):%?G;*E)N5
M2V+;R$7_;__!$_QO0S\%YX8'#-%_KGKV*"\SFQ6;6M=@YR-AK6<2!M#]TZ&(
MJ_M7#9F+ZE=X0'/KVI)4488;A92Q,072W^9_%]U[6=@D^I%FP3';;83A8,^L
M[)F^4+F_(!H6(>92LIO)]J-U0GGII'B%# \(+&RA&B)+G+]:2_!7X($@\^Q8
M$2IE))GL,_UFR;K&?'#]2Z,/>.![.>1:O4HT]1O,L&[X7ZX6 3SP0VGI*N(#
M; 6&2XR[@P=F'HWC@1?E"ACPE9I3%![8I_+" SE&A5A;/,"YUM%Z=AN!!T9Y
M3):.\<#&>>;<-::OO1<<=F$_-O8^.7)'1D'H+7*(<;KKF>SA=]]0=?4^L]MO
MF>^5Y;^FM R>@FLS:CPJ&XC.O_U$:3:WO=4F+A3%'8)D8_P@3O4J1?Q\<C&.
MP4>=P(GIP9O8+=F]\G\K^H_$>OU[T?\$]$;KI/?%5<_"\[_Y:A=BUT:9!GTT
M=:VYE]9P 7+Z]O$W>F/FZ9H-PWN37<_IGHVY!H[%PJ^:)V7%$V\D1YYJ!M^G
M4='ZA5@PO+-D?U8;Z5O>1<H.^E9ZHFTO.Q"]0>S=*!(RT7++'S19RQ1'8@_4
MZH7.OG,:$@1S7S%,=WA^:JW*FT(\]&61,*B+8Y,WB1MK5HQL7]EN-J&;]_TQ
M+,((3I:,F*L5J5WP8Z/")I[Y8QX&_J*MT4LM'3S[?JOP5KZ/.U?#W:YMAIFD
M]B_WVSC2]4>'T-.])&[$W1IJ 05CY9QLYR0%8+9CEY9_ C+?WWA 1<4LUT32
MG^OQRWQXJV>##YM..N:6>#,O-V+=LZ#V,]<D' &S1L8).-WP5X^[-.\FR2/,
M@G7^8)N0A*>U"&(I5]UPEN.YR6=;!BW->.!+P$(BZ8LOG"]MJ J_7S0)D/<M
M')D[3_^[-XO[3V]F=N]^0=+B7JD?HF&I#NL'ZEK!N*54%^ !+YTKTPX0&7-M
M9-1DSXAIFJQR<B3/U/]=#/KD VHJ(PL5E?'Z:OIU#>_]X<;O[S5ZLP;OBK2O
M-G7V+B&)@V0(_< 0OHF&<4V&+VJYHOHDWR0[6=:(4<W2!K\01W=1I*;:'=/:
M-61L_8TAUAJ=V9TW1/KA(IC6_<YE<V:SN?E!BW.%4!'Z.!6J.8[?Z3](7 /V
MXJA.8\WGC:YL1S?89JXFH1_<CO<"C?V;AAL5L*4K E2&]N,H;)B&H5-NS"HB
M^?B!)#\!B8[G\]]!+4WZAB:QP>BT#E86Q'@.$GWXS;I2=8JGF'?5OE\><+UP
M-8\^/-ULV%V$(6J/^* <@ST!.BAHY6_7/8SQ1N5Z*VN+T"Z,-&?,XI>['?+@
M]0:_4V%-@K(Y_P!*]G>?.!Z@>TK->EL,W-U*<\IP2DENUT(\ON^186M>&:#'
M@&1*#AI;'%(,/!W@$:$5?AKR9E>MK611\!*&6 I?HA+P5UH%[Y66"KUCA17.
MS"QHVEB\JGYENN9L[L/3^^KQ,)A)[1+F,4)JM\@((>[^,HL-ZXSP>&?MYV9A
M&PIY9BC!U83Y^S'ADPY%F939-\GRUX1NK[$IJX.:-%B.SBM.]$%L8D#Y8%&O
M,P2NT0&IC3#E"O\HI]__U^2&D$HO9:09!]8<#"FV;V#-@.9V95<4MK8><V4J
M[A:#(?1$3<.W.=@%Z(O8EBN0%;MF#,T8E2AS4]CKJS$Z#7+XS&#^_$,AYEOB
MY/<**.B3'7TCBU?QP$>CC*,P/+#"C.Z-.A2%DB\8#5E#WY4JHDJ?]74A*M5Y
MCM3DN12XOMX0S(H$1C"@ ^*B'3S N(HV+?J%N! %/]Y,,TK8E#(S;+>DAC!#
MZ)T;Y2D&DQW(IC4QX-78^A4-L,8O?X$\PP^HH>Z8Q=+'$XY&) FH)<?E.Z7W
M]H=+FL,X)RFI<?>F_36*YNS'O(>?+WLD]_BX^^PG'3XW^OJT<MZ*1M]N,LVU
MVE:2G=&<V9\-HQG%OW_JYT0SLQ/XH#;VVCY?:-O;J)IU;'P-_VEC\K>(BL1_
M^8MKG6066>M=''2:CQ?' +</9*F"=1J=Z)$%;6G-!7CP#0+OD)\)FW-TFJ,L
MJ-+=2^_BO";SL$')A2\0K!10*E (+1XXT#@;J2FSCOI6<W <]42SN;'UI6U$
MJVVS^=M?[JUW=A:%_=AN/;>TM70IU"S,&R^J98_@VR2BSSB+Z0KM$:XK=<81
M-D:MWMCE[GJY2*/A@7N=*C$3EBZ $@X3.=SD3;CPW.*N>$Q8-B''J62-H5B3
M=ZIN+[1/%0$S5F2[/!IU++MX;Z[P):&2.^O-GN[X6NNGM!<3I[93N"@6<4G;
M!G"4X:KW:E)-MT!R'T/N>V^/FYIPFI_8SA4W;-JJ2N3^X4H#(V44CK_!O?9L
M#623>9L9T)0WM"6K7_XVHW\=4"R/1#C)D*]"](YQWE%=B?;)C'SIC,J9[TF=
M6/9=$:'"AV:*@99]6G2 I2C!HG?A60RZXE.6>K%1VH+NRD0YHK_\056JU(K/
M-P?;F"^"VH6NZ?ZXF_WLND578G;G-L452N6[XLEG4R@$HVZJT=Q\O[-U\JRM
M0;ZF0 3)O/RK:(M[3)%;'DL?4UO#US#\N7ZK/,]79;4O7C5&VI4Q\+TWOBW1
M$</VS;#V7G>XRY^Z-IH/FI\D:EEY4XQ3C(+]6YY48YBZDG_>>E!U(?V" @^L
M.OQP[(QF11",;INSX$A751[VFL=\K+YV4#]3;[_3?,01D>:7Q1#]A<4MZ?#F
M>^_6LX]C?/ZWR\&!#!X31^[U^Y:IP^>W#PSO;=J-,I>6U$RI\);=HG@V19.R
MOU TN]T@^U7NJ;@78^#W<@.^@_)*0YJCPM]Z;P?1ECM'TP^+4(&#?S#;9KQ5
MB2;CJRGF&CPNR,JOG)JV@IZ6+;:VP@2#(K;<=?19E.\P3EU\I.W",\]+%[_Q
M.\U.32T^YLPT]"0?;N?0@Y1(V?0 N^ 0M.8!3?8'$ 5.&HY-V&01Q@.Z-9EH
ME*&26%\LR8:5?6SW^\IHLL9WRK[3S]=@8:G)]:M'E-A<Q<GRDV;SEZ&;OZ(&
M=5S(?FA60P=85#V$2@G3G16(&)=QLA=2>W*4H^Y]""@UJJ"0-4+\DY^;1\%W
MCF3BN@3K9-%[_/W4??/WWF[%MV51OFC!#BX?2.N&::88Q11\-:Y-(Q-6)WH/
M/66U&BB0Q(VL+'9ZT9=2^;]%=T]'S'7^V(U$%64< ()JZVDA&@<D:4[)UKI_
MH]_5$J":J@TND[IJ40_&D'V(;<2@- ^]T]3L^)L@:8O<C50I*BL*NGAA29.,
M)@MR/NXSQR@U[)=%=H@R:8:01P1R^V"C-JF"=E6^U\)2()G&\'LP22<>N"TY
M+"]+N *-9>M=I*&;%M^Q+38VU2Q<0O5T)_.$6]FMW]'D4M/JG WQF-PR)Y21
M#<C!ZF@W3Y3G5S9/BT4=O#MX9 J_,R0D5$HQM/&9TY-S.N?7?W8#,O/ #(EB
M<1P0/Z^21;OI9/U1C4*3&86MGXX_^HHJH8,:[=\@<"6X%':;%]+$;5\\OV>?
M9;J3@C&=66BZY>P(6-_>B#5WK2:CR/#3(I9 \R^#,Q].GIK:&DZ>4M*J0%@0
MR0T]Z0U^<W-TO(WOM17(.H]L:QVO)LT$T"KZF@S>N?J86X7P]F)LK+3JOM$
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M]'>R+ !9(7E6==#!DP)C32>B10K,5QT3(57+ &[PRS:KD)M_V6]X[S^%8NW
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MQ.@R/' '2]AY12+!_7QL95QC>$FRLW%K+J.^7U:";?BCS-Z9^11'*[J@WD[
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MDPR71XY][?_%WGL'1?5T[:*C(* @")*C2I8D.2<1AB @2(X"(DE <F8(DI.
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MX9*?X:R-2/.GQ(*2VLND!XL]E,]U*92V/)_=2] RTX7+WD,-PQMZS*F6[3+
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M%4AHW,[#CG4R>D_ANM5B#T>S_>YELH2>ZXI$:[LU!^EWFI\G THV-RU;6Y2
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M;K&B1/I%PJ,-O3Q&XUW+I+73PHXDW5/#:W[JBMS<9RKGXALIZW#6NJ_!SDZ
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M,E!1.X(KEO; @9;PNX(/<[S1Q?5;2\0'OZS[,-JL^R?R*"-$PNF*K_#=P ,
M076O>O[1W2_$X&;D;K_W6W/WYA.DP!U 5. 6(Q11=$\L0/H F$+7?^1,J@\
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M(<\6G&";BBM&9!ON?V3:_6]^!/"@+>C7(3J47](,?G^E!VSS'LK %]+P$6U
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M5*!K?LZR?Y7K^&;MU*C^:#DP&"<0=LAC[G&BG*#N6;D,W].[8?=[.NO)7>;
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M]48M[;'7D<LVZH$>*3SBA?PON7Z_/0D%TYGQK/0E>OCTT!I@VC8TD15\/L)
MYF,&&"7X*?5*80U8QEN2'=^:?5_RBS>>\99H6);6TE]UT1_M_S/=X?!LA?B;
M"I"ZA8;=5L9 Z3O*LI^1'>59Y&=Z5",RSC-$FR#@Q"Y4_+%[Z:Q]6748.Z?E
MI?;J[TDKM.,L<=TE,TUW3Q&?2^1S?\XO?:S/#DR2 8'9E8R=Q>/?&0QEM4>U
M>%E2UCE&Z=R**OW#CGHNQMVA4?4;!7'7.I<6E6"^\63HQI)]S>^5W\K>[IGO
M;?&DF',XU'^C$TJ^&?2[08FY_GF4HNAQB_U=Y//>YCH:;?<C-RKC]&:_]%ZY
MIWSH^-DUR>QW^9Q793HB&W MK8+D3X:)9C0DFNG,&Y)B1/4=2_:138D-24Q(
MSRVV+>25K)HN6SA19F:):]6MT<5_3-QU?67(7'M) WF!DF38B[RUAEEB.5G0
M(VK2*Q1 X J\;FSC'#5^ZXQM91,;>:&12#H:+FX/P7&/-4Z$3K2,9]6M9Q=2
M.P<8ZEMLINSJZ.U+#12YL9O]B.S@]8^_*E[WV,AD\"LD\NU>%%GEWEU8N]*K
MKVMI V<B5E;8=80#6&N?)O\8YR^N!D+%4^^^EID"[P/_Z@77;+*<,=U4MB0.
M__:TP(,5H!G?:J(TKK/?TV+%R@2Z;U9*7$@GVFR)4^*"@WJ0V^(9G"9YJL?]
MXAPM17T!1!_O1?S:#=N0!!]#V&:*$#Y)7K,UBA!VG]EA82TQ0D6U7_&MBRFZ
M5E-84[\EAR3/RYQ/'N6A=_X,C*Z,.H4C_.6^&CLQ-KN; M94.,]H%]:M:M.C
M*O=&G&C/YQBVS)]XC>GR4[UNRQ8WY+!US+,5+.>N4'>@GM 6?C<<(6,/ZPP.
M0O^VOPBUC/ZVP+I8VI%-P"E&<I>-8'=X5D<LN.:9&ZYN@U-(5%A!!QH+[&5I
MSG\^H"^B;>-VPQ!RFLM([8N5:L&QV1W+^ *9N\: F#--S,RHFN2O:XMJI,SG
M(,RDXG&1^<S05*EF;KR=4DCO3?T3I0,+]E5<:+ACW(5-F(BZTJ.B"+2.CBZ_
M#STS?3D=KOZZ[HF*CONC<W#&(=6[.%$Y;Y$$BU%_!'C_0 1DK ._F3F10F.?
M%A=WIKT38QLAU5#GQG/_R<[04A9DAA0>[**F)8K2VFDJAZP[B2_4.^4SS8:L
MBKB9#=7A0UUPL_#9$X32#%2,T5, 6"US+];,5L9D="?)Z\Q:DNP2^T5>O[2J
M0ONKC2TA&R.Z";4<.*%W2H-;4&73B( M=1?L:Z/-Y\Y3T1N_^X0"@7(C[RK&
M4VP!>:5T?5MQ:R@&UW(HJA36(#6XVGG_E2G&6IW_:./4T(J7[[+V=5YU,PU@
M2W((BQSM4,0H^M8250#Q"S5 TDLQMI.3[K=YK Z7&K\7.DA3Y\J<(?'G?&+V
M%5<LK#?NV", 5RW(<RN4#F3Z*8"_OA05,KK<E^W2$7/ML5K;DL?IDY!I?=.]
M&J:S=LZ6#;B$ER2M<66:D#Z;UJQO?VJ@*Z3.58A>?O2*;-@3WU.)50L_CH$]
M,8*GG :#I!?# QN2ZQRD7(4J&#R"[78E4;O<4_-7<Z8LQ/+2A+[X_--%XV^!
MX*3>:3[/3(<H4D?S!P(27=C>U$7[,9NC>EG5MN@=GD*.'N=\!MNIKMM+NC"+
MQ][MWX%PF1C];';OG*V1_/%\9_*?^&SG"H&:>W2*6!.>RS00.I0W,G#8@KD+
MX0-Q+SDP,G7H=G>]C!='/ "6P+R%GUW463J$7-(=WDA_6,/AIOI@ =P\>;J*
M6M_4_OH-WHU1Y4V@I)>CUQPQY&M$25PA;?Z+<N/' T -4W@6G;UP&#-,;BCI
M<@WTY:BH)?:8&>H0:?=T:T6H/4OR79C:Y#OWMR=!6D7PIMF5-:?KX.+.CG7'
M;%!\RY9:\>%.O3"@>N2OCLPY!'>6%159%&2#W(%\K+Z5K&HP#8FEN)B,<3EF
M]DT%O\/4>4XGV4_63I_ZSOPNJKW*3]RD<:ZA@&@-E;0%&^ 1RW,[X<_B'7IV
M;^B@=42SQ5X27(9^8,XT""6**4UCX'HW<V%29'["D'C^IJ[&/8TD%EW&;GXY
M46-BYF !&MCNQ^_R)7.-QM[ /X;&*D[;^,//(3>>,)3R1K52OY"3D51WA S!
M9F K!5N4)=90;W%RVAB/B)H;MCY@Y'"?9T!.TF]3U#5FC7V.]QQ"[&1:$+[5
M&/TR1V-ZK[W)#+5CEM-YQIJA-<H6%C'E,DF.=I&\S'>_P">#ZIJS/?M(-_RE
M7F*]67(Y7SC!,2Z[0^C@2A?U 5G?GYWU470,S#JKC]"!WJ\L@'RYTJYB1LH2
M%"^L6W(W\ FU59S7*6\]*_>A%+]>3-H[=;LTS3<R$>WW&Z28FZV*X/8M%00L
MMZ@&C]+O[8P,J6%--9)GZ?:+O/@IXCXFR/ILM0>(3<.BL+WAX3YEQ+-A;O,
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M$%'G)%77DY5&0QU-7,GK]Z9O0Q"^V.D0VM> > #D\7;;I0>UP5")R?FWZ\\
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MD+X,#/!N_NC-X#G0O?3"*2 CHWBUCJ_*PU[W"TVX\(C>%UN+GNVXXULV&$B
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MDBF/L.NVQ@M3M;F+=TC#0>U:QWF(*\?.]E\UI[&<":G259H*M.8P]1<PU,R
M_N1HS<.+8(F&YM0RI&:N-DN7EVF>*-9-^17%I.C.-5VGRA3KT?&AD,K?DT!)
M"9;&DE!)[75%Y\4LKV9$T?IQ+):XK\'H9^>,T*;:V\-FH"X^G+?OCCU@F)4=
MH:_M_]YJUB/A=U/58X3LE!N(TO03.*_WCF'&^8#/6GPFY;-[WQ6/2L.Q10%B
M$<[CD)A6PQ!:<+%Z5L%Y9^=,\(E \XZEE-'1-8=1C>GE7Q;UGWN$G86S4Q@
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M]@'1Q7GT2P2P-UY<8_9 3W%JN:[O0]>QQ ':=E?/N1LDD,9 7X9=+A7\E/=
M>P%TH93QHC[)=.QBV&4JV;S%+PB]O\DTJ/;1F2/XPU,VY@?V6&34.O)X]TK.
MPOW=(S=0#OD_JTC=C-X1EV$ G&S'=]W"&,!.+>PS-R WBAL TT3A(.# B#9Q
M59=!E0)C9>?*)2\EI@BTO.C6VP]KGK#J-DJT-"L9ZO$[WX1?,S+:4L$JEM4Q
MM, 7S&-X0"IPUPH1YW215LH7@81"$X\'?>W\:[*OA'-\UVM^T/4Z*5O6]%Z
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M/Z-$=*\D^68<-8)W(D!H9X%OIH!JR:RG ' [!M-"A'=K"72=F%F[\YX%;#6
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M,AKP"@'-2 W9H;UOK&E;[2\@2B)RU#.'(K5I[R;1 ODA\LK>ZGM&5]]A21B
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MM_P1H6#=[WCEMO"3.98%/U5<#,4PEKS=PFJ))C_ C0DUS4)"ZK:EZL>$B_B
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M^J_O8#\(XEN%[UH*0OH_8.CD?1A#HTIR[2CZJ3HB>1-U/50 <@)4^CQQ/Y5
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M>Z?_'2;5HWL[OU?,->XB&B9^CKZ\=8(Y9G;N#Q!3;.Q7<?LY9Q&C[?$H]+)
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MHT1,]UT/*QR?O\20?EXR,IZ]%526W 4V.C\DM"@CJZ_'T;2OE;D"1%7J70$
M$K7S6 V%NP/WKP#8%,W IM^O3^:QQD^<5,%T=ZZ3(?4:B+SV"4S_YIZ_Q'.1
M=!$N(7CCT!VXP1H^N=D!5/#6DHYO]_3LJVD7@<%8;3C4JMT=!9F41,- O\:_
M%;@(E:E/G)2G7Q?!D&_4QA"<.IHK(/![2UO=K-G)JK,%9RI:,'HF\O4'_!(J
M]Y96O"&J\@K $A2QX>>)U]4M0UX*'<E<PD[>_AH.I2OJQJ_GPW>+)\N2+_]2
M3'_4%[?;<(,^W095;8X-3=A_9\35R=Y'(4;WPG:/_RYZG\4-QK_(P&R>B?\=
MM?[->50S_[V_XV#QF][WR^#F73^BJ! <JA#EJ:<2*' 6O#@<1:[YD'0?A!=$
M$KY$MUQ0#5X!?HRCJ)!-5X"%GRT'^B)7@)TG$&*T*5X\^+]7%?C_WU"0/T&,
MEDG,LZJ/6'05SFFXWC>UZ"6;R)N8R3@_0D)'JI$T:K@PR="B*=TG&U"KF\$D
MHWIT)CU@JCJKK.2#%/N>:^U=7[9NN(9A!J_:(=&\4<_QY!<^XLL>F=&-.9SL
M/(6.BT7_K].>@Q85IAWF;Q+,4]DRRWJWW(0SY)PJ[W\%?HVQE5TY$OHP*'G8
MP2I!<DR6&;!P*;W 1 SS*>$UKJF5#K).R7%)TRY9.;Z9_ BHDWQP)BMAG?:?
MN1H2=#XCS;4KGH/\OX4<ZG<%:#5$K.197 $F;!&7=ZNQ-O]7(W_]78E;O L>
M3^^HO$A)5)?11U"T."\&ZF!M*37R03OW)$B256#:BQ;Z,_%2O=:#/]ERW=X*
M_]Y-8&4?"G]XHYFQ-,SAOZ>*_CL,624 7UZ5L ;=($I6Y^$=UPWOO?V0M\Y*
M&@7XDTL^C,K FUSP]2&GK@ PWT2WO,WH[L,@?30FPSC'$70CB/IW8 J$H8-J
MZ/),AR(HH(AT"0S2M,CSECRI2<?J+MC&!]5*SSV..YA[K*7" A*[ J!*<L<5
M[\!9<39YKHN[+N.=:TI59MU,Z?P?9MX%*]YJ_8%*QY==<,'F:,-<=NE<RKZZ
M %T/RQ5TY(P'IE*BW0K,P=)TXN(9GCE44P(F%,/_2TE77P;\([4O3A%> ;1\
M*H]XCGU0B'P^:.<T(ACSV^H#_A^YF*H0<E21?=N(_46*N-RR;*S6NZH@%KR(
M*"-^7W-H+R%%8/WUK%MHR%,)DC],/$7W$U%GUWQAEQT1)-30A-U+O3TB*<](
M8?>(HG%W@&29?PKU! <)6?]7/7G4(IR?)4OE2SD0](6D1\_B,KL506\^%9A?
M^H*N=O80I0_+'&_B*[+7_])4:U^_^.E,]]\_,B;&M9CO:VFJU/_/)1K^OXJ7
MC+6:*>P:+NQ.;K^S55AS;A>526#'"^_OF0ET'].E1072$"<8A$LKXHV>/;P1
M>WTMQ=QQ#E7_C_+[/] ,0];U:C[%AW]C@Y\\I2BRYB;I"!!M14SVF>)S'S8$
M-EA&9?0%>ASDD)8KP(KQ?%AV'5>:EEBPP_L:4UYR,=.$B[[0C=QB0LEOW'['
M%6"7W<Q9;ASXR]>2*C!=Y>.RMYQ$9N2"-^=#4F]YT8_SMTNS>J>UDCKETMZ[
M$'<H9L^3(?E2P/@RWZ5IW<IAN*2]\;[9="0[5X1_&FZ>_3IW'<<=BGF%')R>
MOJK6D8K[UB&MCWU0O+@/5/)_U?L;,'Q#CB+_[LDS9^%!^!!*BEU]\LGW;>R]
M5=&R-C'%#D:CL"M )(J%\+(B $2+%[V@\",CR[>)%P:62]N!PGR90\&W^*,]
MIWMR;:L?+Y0/!>N"QXUR;980=V8RP&5LB+[G_ Y<1S-\C.E/TP+8LIDA-@$M
M5%.HWXNPC2:U[U+J*?.INK;Z))="ZQ?I:C5?NGB=V9$OT62H0KP9COYDV+AA
MQ,[,#$=$T7LPM67];;X@>DFW0R.(G/C?-EY%&^-H51R8PG()'9N4M0O2[4O[
MD,W'P9%U--58_+K'QHM7_%[<<QE!]$U#P?\82H'N.V\$JG-S-MVW33.;OU"B
MEGSH?L2M_"-WQJ8N>I?@=-NEIFQ3G8;OON?$M<6M8";GL:%XK1/WFO#6I8AV
M1<$Z$JOH(N5S*JK3 @)DA.?R&YC!H7 3J^*US.DH*@X+03O_\,_6"6WQQ\73
M.YY'? (;"FX:M[B,SX@UM"14OCX7S=F>2]-NO"=M58$[C;I7$:?50K_5XM#
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M :.&\5"=>JUA'II$*Y! )\GZOZASTD77'2?4S2'MM>KWJ::A#]OM'_.L8](
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M/1W+@);V^+%?%V)DQ[(E#H.B:]G48G9MLOJ'94\2[M>2Y6ZEN18/X\1TYX9
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MSO<I5$4$/%4P4*@_+F<_R;I,6ZSZK<OBJVVTK50/E9!0DU=00C)@D5$B!/D
M6ED>'I)&XPE0)?(3ICVBG4@YQFOB>:GZ;V8*?:_;>.%-T'.,P/>S20E;:1Z6
M+KT7Y>O+S!^ML7;Q7H&2&/LH6PJQZ0=UCO^S5_[,$@%2HY)",&OV-!,FP'$/
MLEB1S[1OL0R(GF-]^D9+AEY-:>H9V0[Q69/: G\$,$I1$._?;D7M3FGW[P8B
M/^ *T+5=9XNO+3&]H=D!_EP.U'G_\. &D&S*44KN%:V%B3+5DPJ;.H^>[5W+
M/FPU?^UHGHG(L/W)\AO9#C>WWO$@SE^5S;$/;)0J#5<XCDJ(M"/5%B"S\-,^
M:$5/*T4 J+/Y7"A1RJZ_4SP]V>[DVPY;=D1J@&Z=.(27 GL%B'VI,^4SN6-U
M)AWF%5^T8ES7O)7^TH=AX$:2):(,KWGZ<HSO,?62$V>>IZ1S25%N)0>V8%4R
MX*XBHZ]%SK"3;6,\W$UPV8?7S>(DK\)R/K^__4T7H)M*H42TK48ZS3;ID72.
MJ@%9@4-!4]SKD#W56^Z!@E6FM,7UHC"8/!=L:9YIT_CTL%]R,H2EY^DGQ/GQ
M4A;_R/<TXS&N-_\'9^\5UM3SQ7NCB(B 2.]%JAB*E(!T$>D_NO2F("!$0'KH
M"@)2([T'D2XE4D,)O?=.Z! ZA))0 P1X_9_+\[Q7YV)?[?W,?O;,FK6_GYDU
M:SE$GC"+><"7F[6/4-RBZ M1[>C*+*@.*VBXA2_@56M#AD&A^27=>:>HFGDX
MV^(,[62R9,%P<;&*D_III4+G$76LS!I12Q[E0_[[5/=65Q- HZU.KH^#.^2P
M0M@N?ZI_?S"WL2/=WLN9G'"AC$F=R:ZO+G&6F2WUM,C;V9G^P$*<ZCL&1YZJ
MX[G>P'KV"037M+P.U\,HH^N>A*^L#(/?T-:.8&O%X(>W(W[20_@]L9O\HE][
M"MD!OJA!L6)0'5V[#Z-#K,C9>\"APCQ/;SA> ;5"\1JJW_GA,<TIST.=W=<L
M/AU'3W3*6.VOYM'[Q]]JZ7$F;F9L#-'Z8WBU\6$62>H&5.\]-W2WE_63 *[B
M3QDT=$.<Z4+T0[Y<JQ5.)1-K<*QI./FP^]%%=8^85=UC*O4&G['+%1!C8[5K
MH/QZ"=:K>:02Q3RKF91B@FV@6()1XOS7+4$HXZB\R5KUY77-' #;.3?U B,>
ML+M3?H B=>6\+,AK9SL[OCA@?FQJ/=M)=>E>UF!PJ1>)8)<UW4-M_&EWS%T,
M^ ^'#'0H*B](F9IRN34QXNIC:QVH:748)09)>"RO['FHBZ=2;L(;/K,UHSM/
M34SP&A,M\_^EJT4=G;T [!\(*>Q;/^0RYZ!6OR@5$+=TA/,RI \D48=,[X!3
M(0$.)3A-B_ICSI/? <6/>[V#DD.=)7]XR=&M[?E#_F91$4)!E5A(6%@!!DM3
MEO"G1) L:ZNL-;Q<_IGY7!_\S93JB:P>E,&/Z2B&=:&A]\7I2M."-U@U'$8^
MO;3OX\*;G),><2T%4[_Y+3Z%U6G+)C55:M%D1(3NU]OBT3^Q6Y$4X0AWHRG:
MNODO-._MFW54*G68\418Y^\??<<ZSW_DC?(1*?:BK6C64+SIZ#=.^>_RJN5)
M4H\RG'7\V5._H&/>K_TJ%B VNZ'X!T@NN^<SRW0SKFEAZ8=ZC!"M5HG@Y"!?
ME::LQS= '$6A8S!IL -(<YO-LGN?7#:[>C%8FN#D:%ZU-[H,?'6[-X=82+H_
M/^?W52R[\P2XO8L"#0[S+^A-?31/T>H VK9S3?S"5$.HP&O;)BUO9ESYGS[<
MM=P(>A)GS?2(.T,MKX$HVN'7'0%O,],KG^=2M3N^8(12R)?0J8T 5I0:L)2D
MG.I<>8J:.V$;<V3)_JV%M;W,!"W//)/$6YA;5-O8RWVR@J&M6B$5\CQPW)P4
M[BC%E^D8&,($:H4?[?V'%-P2L5"6A-7Z,N"=!60YBV6T;HFAE4!0M[?Y%=3Z
M#]C:,H6Y7':4#K<P&!/:?[!K]8VO8WLLB,E10J)=J';FIZ9X9T+>9M^H54\5
MMV93>F%VH46ZJ.]6XR!);:"F?@BKQ'^;03:+W\XJU+> #2A&4TOTCI:LEGH1
M[W).>K=FWNPN'9S2Z<E$7]YP5JJ",!QM%5BPD]&]M#F]E<!@=L@KSI= ##RJ
MPG,VU3<W-4QQQRD)D73S?GN87 @.T23X9O7J!R&+)_!0SR1 HYEN7M7Z_'OR
MVNIA?!M>'%O0??CK/?1E8VQ9W]YP_[H4;*P99%DWT\*R%^:^5^?,O/%%)S4#
MOS:#YR_&V78A,X9_D5.+?/GJ$>*N'!B-4>WY@KM V6W6?-::A7M]"90XPZ.A
M;E^2T]&3&25$P"E\#7;"UXISZFG@='($VF+:6X%&8&,RP+;,K*\>?&BI'518
MOQ?ZOS23!*Q.PV7DXC^B"M+C"&@?@!J^PEQO,F[)K *TL4LQ\IK,#&GJXM^_
MT%!F$)Q!(N8! :PX+=:UWNJN(.Z;X6K;K7#V-;<=-3) !#9P NS.'9:A$NUB
MI7(]Y)]U 7/%M7V8"?!XL5"LI: 8^7DM3E0BE27Q$A@PO.X_F.W394QW/EY3
MRJ9-\>L7*9/P=^$ U5)%-VY[UI<26SP0@!5TF2U5:4I_O3-%!I7"R5C SM^V
M)WTUH]"1+:8[5>[,59]5&^Y62\RQG7L.<XC0C^LTC5:GFXU5O4+J$X\9UX85
MT1)Q0[CHI?A-FX2'4.+6).I_!%1-FJ#FT2&&7,;/C!<8*XK4)%NH&JK'IM=>
MIE[J&!%.%GSZ))$PO)Z:\:;\ >&CT*]RZ-(I04\>7^#3=Y8.S/TC%+4^9@/;
MS ''&[MCZPB?&WAQWY5=<J,:SX^?70>LS41*F%Y43]$OG%OY%L1K(>&:.88E
M^,7A!^3I48TRJ;/C^88(.JI$,FYU[&PCSHVJI[]>K?>!5[&C^N+X@.?:.IWO
MPUP,!ES:*V:^U_=WB?,;T[/5Z\3>6N]&^K8;PG;ZIY9+-HZ+*$*6C5O@K(75
M3N-A'NA%S)+((HQA8X9\$S&?&DLK5)&U8([Z#9$B1AL\YZU9W"@W:]0034Y7
M7;?NO)%W?1R8R_6VV7")Z=<FI #\)/K\!V)!YN<Y7 ^_PQSR:-?Z'<CL,%-N
M-@.M4Y_3M\KV1^3 6@%O<R*(MW,,?L#VGP\H#)*+#WYQ>?'X[X53N7\VF.QM
M4O/WT;\MCW C[+&M]P[%EY2H]LP\M5Q%@M1?("37/*PS[@B89+F7:; IN4[&
MI%LB^G)BUI^"VBZ.[@A(4J,]&T:X,KB#A66] I#)MTM0<BWJ;E(?&ADN[Q?@
MLZU?%Z-Q(L/>[&0(,<DHO&W![M_";:B=A2UPT+QM\C]*%=,X AC\CN!CSG<C
M*!&F^8Z@*YA2I3@EOGJ!&\$2MW[\BUPX*H@O3LMEY2W<#J*).2NN4Y:3'=&4
MD(^UND<77P*^Z*)2_+QA4I8CYL#<4#&Y%M:%1DT&]3HOYXGI<+Q0;%]G_UD!
M6SWHB2_!N3"#RXWDM%1-[S$WHPO#>(R,[(%._J].S+9@W_&,?.'[\CTSRW8U
M)=\$;)//AAUQ]LN]2E.\=(U%Z2P6_:X<B\0PLVF$LZ;!Q,>:O]\[.>3-[[6S
MK55W0U,Q\P,+UU8D%9L>+8YJJVS;!?Y9?^@L*5B!EI*!IIR@J]'HS12D3L0^
M)K]58*"^O)2" E2U-ZY3;+KY>JY%_G8[:N:.X#M:D4EUP;-;^8>MC,P,ZU$O
M("5XT30X]ZV\/=<6WT3Y@FVXD$C&YGA>20YJ<4*5;PY%Q,U@1U@!2AMOH1M&
M15^G\53S?S[:$JA,8-Z],LPF7;^92J&JD8AR(71C)NRXRJ@NP7],VM%U2GU9
ML?U9E/_BP#1_JF86K5UNZCXR(W;6E/UZS[' <?Y+"I%%(I_V$KBLE7;'^*HP
M^2;]P>_E]]^'WGW)&S/^#0[N_H*#OG*HCK;]*>EJP5[@:??+LLM,M3Y&AK(?
MJ'VPN%7VI_1Y,R2^ *=C:X?2O'2AG-^2Z[:(^3=O>N XON*=928M.Y?@0+XA
MP:_;+J#=<,SWJY8F 7C"[]F'BW^?H\_*26^>4#[X9D7]S#*2\D,;3(&6045V
M,0\JT4R7*.^)X\'JNX8'4]8<F&;GU2;/+)\I?,]]U7_!"-P+AOMT%I]E\RYT
M9_@1PZ$\22]9%5F,1X.?UJB?*E#OG5<7MJT.,BCU^ET=H<+P"DS!=OR"%;TY
M_H5Y;Q8:N!X<W  &O'64=G.!^B\T2RX#O:'F\5$P2_983^^QLVNTQ -??=JM
MA@'EKVCK@ "^ADS4'<&^0<5*=XM,YM;'V*F?*DK&[75ZOA<_58)C.V[M6U_+
M"YE3D-X.W%)./&NCO\?]_M'VMUOQ>YNMCV3%'OZ^(W!I^ID$X;COESAZ5J[P
M%"\;QTY3T(74HJVN_S3GSW):#@N79]2$/#;5='@1'@_ONX<'3&W6_0U9?N8>
M_4I;V[<[D(CA^821++V1H0B%)25O!,@F@UO$\G75UX>,J0JQCDN[=//-C2K<
MQX*-=4_$M. -==.KRM7S-KL0C<OK=<D86?-5&#-_=8;79-W72LY-DOX1IP)Y
MY:'A/'5MK/;0$4(=E0Z)/.VN-O>JH[+]XI)W7+&WTNEMQ9PVZBRF@7PLJ6+R
M=[0.U..9$PN#@5U,%SH_S<?"5!]\/3CE XY^@DIB1V-D0?;VZOMEN3_I8FF^
MMQT,4Q>7E=EI/IXZDH2O^>?\J/$OJ/6)8X5PH+##8.(?+4R9%#5[\^5#"5+]
MRD&*<F&!'Y<Y:UO^_K H7/I*V.V145>-TJ'7<-:G25E;B7FYJRILM95C4IR@
MS:H3'R"'^;/>Y6T\7[Z\P_6#FLES/0..F>R6;&'&5H3Y@.3[!87?:BNVVTDQ
M*&0'BI68=]K9<T0]&A+U824**"TSB>7KF0_M:F.OR:OH;-L$#7?KQPB,CX=W
M-4XFL2N5WK0$2+&E8]6%<V-46?<!PJS]_; 4"K-K^O--I>#?8, [/@^MC[F0
MEO%;('9\#S0J]_3_+58PD/F:% P&*3#^RIX2-7M]XK%/@4,JKC$/6KJN'Y8
MT0]J$G921#U'UKL=_[4@Z]F;VG7+TP)A^R@A1"T'H1UVG"&VQL5Z"G''<M.[
MC(Q\>?($7,X/&.:2CAMSJ%@&VYQ56%F^6),I58K]V<H1"/B#F8+_!D8=+PR
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MAWV2^2G/#;KUO/+VY-L-Z)3T_-OT 4(,,]_YNE:0IH/4WR*T]PHAR:YGS1Q
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MH\:X,/!8&"^RC+7F(M5=AW/3U&,NUL<L..ZH5J6R):X'!#(?KE"2 @"H^WM
ME;C40.^,S_,>;\YGC+GNN]UOY8,)/!$YT)*12>09RN#&D$$9IBH83],2!^3>
M?E9(]O/J:7WR/9JY1^)E6P>RS^P?1& J<'L9!L&?.CHOXJ\=ZBM&7.?]9IRY
M!IO^)ED>%[QF,#A(M !GS#:Y*RW'-C/)2FU&-C4$P>6"NUL DS5-JO%L\R2+
M=N[M)!4^MW3&834+AAE[Y_RN(GVFA%&XA5XV><24ZZ$9*%)[[3_'IK '&\:
M(J=$*P#)1W=%=&-]B=V(:*SZ5$#?J14;5?YN,<]ECA5ZA5G\$\F<GYV^N^Z[
M1H6>%0HSQ^/+GQJVF24??H*Z\22KEO1F8=PINX?</:;:7XHF&@<A849FB9PE
MX-_:]_/80&C'8?>30:-1J<U*9RLS:"7JZ,<M"R*,;GZ<,KO>YB&H++7GO)W5
MS%Y9,3D>;+C>#(9%'(@?$4D9Q=-QLXNI][-G?VF1P872P7T%"Y/=T0]RN."O
M_;<:L%8SO[?T:_S-#3+WJ+-=C Z;XG!%ZY&R7NO<YC1/;%QY^8VSMU\-!^9A
M(CIU,(GG@2U-K:XOUM:X9#ZN7L!^*MA#B!;!U6L6>MW.VV;F<3P?XN.76TIN
MJA'N4"J<&&\:9&-4X,W39@H=UP(W7ZZ=W7:#J)"=H$_X-UA"7&KW?&%^%SQ'
M[.6P!Y"[BMY^U",C+E3)NL-O'>=C#F^)$P'T@ U6N&C/!'NC#F4U,?.3NAG+
M=M"Y:)I$A2;65EDW:RY%D9"//[WT'\$^X0+72EMI')D*LX[A\QN*E<'?BQ]X
MXC^1G\HW_[OE'TR[XUU5]EYE_.LHGR%7U%Y9;68@R8KVVYATW7AA)_QUQ%IK
M)$+0P:M 4<;\PX]1KRLC0MQU5RH2(-Y8/OF*@=B7H?3/0O[N1*K@Z#V["7U'
M!:]FR/B-N(DE2= X4S<5>[IAO?@1Z9Y1Z9KOQD1\^;Y--'6Q C_?*]CW !XL
MR"KN:IGDR*XAYB^1::6U5H \MC:Q9CX #@ %BC"0K00AG!B5G:8O2[4QZ%N5
MZN^./!J4U8$^<BGK78JNU35I2<=.L!^U6ZWC0N7[DOSSEJ%L?Z2XL/<;BI6[
M4E48M6ERFC-&IQ%V(,P5(+*B;K3Y<?[[C=I S8X)=?]7@/)F;5^48WU3@-'U
M2'0G]-E8IMIWP:J%0?B6(8>'(;6IN935-3]M7MU$T3>(@?4+\$)/8_-P[,%F
M=EM-V(80P:L/_:O&Z4[_9%?MC?WTYT,O=2@W*V4=9*)%.\4\JF/ZO*(@_Z)R
MYX]NE[[>1I6Y4U"(4Y# ^%NRQL\I2*$\SWZ6T"_L80']V,P>;S:>F8/<R5G)
M(<IP7S[@21(;Q]0^KT/X[9H$UX-("F#E:K2EDC56J^9;]AS[D(\< >W10%Z"
M\?0%'_DW$[^X(N"H*RYV_9XSRM^26;<N04X>X"!3V6!F9/%$AB7JTB_ -Q9>
M"&K&0=8URS7-I@77ZT7--/F&&,BH2#;\C',2$[1L_#[\(T[""(WGK,]_42""
M_^]CA"TG_W\)=O]/).YUZ"U)P]II%9;G-OXKFVV3_"QMZ?5[L(TK*=Y9ZP-C
M;H3>NT!T.Y&Z@ <..:)0%1$WV99#5].4;G><FXZH^[QJO,-W\&TU%$N!<HZ(
M%)^B&B[*D0N)J7X[NW)Y[UUV=M?T-$1Z?"U4#5/CDZ)YWE_Q5$:&I7*MH?61
MM6J14RK5XNQW_\CH%+Y$BXCV(];!(B=0WHI("J.*X-SH8SER;S;^25?/5CI6
M%='6N:&O=I#'OAO&Y6^J4E(N<V2T0PJDQE,MC=/WYWWF@,P_TEIH[ATG6OFL
M-8C[RBKZ?CY?8"$\\=Z=:8 1XBHTT4MF*#YO^(\#%;Z8N/JR8?:>E!; M'"9
MRYL[@D]O\_-*4-W>$OG[5QG:W]?IC@KJI 4EC;1(=<(_%=C0]A$\41OVF9AK
M/OL*I5@2C]]@6T6FS3O-#-/60<\+-</DB+R#1+"OJ\96XWFNGWU3)+VY(W :
M27ZN!^$VBA!D'B_<4[2VU)8@=38V@@8*W>+SH2XT"LQ);(M(@_+^@H6Y?D?O
M@1S["/+6W%4/*^<U2.3/E9OP36>K%=W8Y*1OQ\E'^G@37%&!DQ55U$"7LGR!
M=X@4H^J+X+ZR2L,B#1'/Z3/DF%S2WCN+/TA9^#7?+36,SE+'9ER TH9'H,U5
M0*WM#):KX*PE<TO9.G?1<64J;\ZM%Y#7\%S]!C02;"<<AKR5P$78NG!QJ4]R
MFS<UN+6_=X^^+'<);E=%!)+/M!;@O)?:X^9\&D/;7JU?(F,%+4>+->;925K)
M'/DG D^BG-5&'6\2 ^P#V+$@3?<%_<VN_W0* B>O/^$>KEAAO"%K?1U= AN&
M"89[E)6C&X#CB]?3=N->_IJS::7M+_H>G4O!9F!$H+K6&M5]I.\'ET&>C7/>
MIT795?MM-X[?5N4)9UP#'%'QKB#WE$0S>++XRC*KBM0I9V,3,X-GIDR2J=FA
M-[/I%7(DB Q9(4N_5E#=XBMH)#5<NV_:\T6;^8Y $58NSE7T7\2@<@*O100K
M>KH#SCU]*N_^&VQVA1=^YWL;7V0ROSCJ$VC++*N5E(Y,QH-@38WP^FI!UQ=#
M./*_;,GI;L4+3D9^R>DQ]QDJY$I'Q<O?@96L_*="MHZ')S\0)-S;GKI&ZD=I
M+V17E6UJ3<6ESIY:$X-.3/?@%((EPC]I8'IF4 ',83:63LFY["T+KRF%%[#_
M4Y!HU11J2JB<IM=SFY0ZAC*J:?7ZYLUVET'ZHMH#4QD_PD03U%]L?J;&<%-U
M;^? NTGWN"8_5I?07V9@<]6XF;$<7GD"X+9?772P1+5 O-,SRA5.*7/(MM6/
MZEZW9P_?&S*3T1>"0O^QY]PGB0NJO4<SV#^)S*$7<:\J&F1\69TGW71;F\>.
MV6.&Q>?+"^-%57[D#258A+;!<N59=NGN",CN".R<=0SCW_KX=6EKKC,2)+/_
MCKHTZ)Q_6(JEZ#J7MLS3]/$OU>8BVTBD>?M5_8K0VOQV3M0<KX C*MRA'*E4
M^RGP[%[/&K%"!6A[;Q1J+#?PU'.W&.X=9+-GX'OA+G7+E5&J_7-S6*)*4B+@
MV9_@C^!HK48^4MHN%YV_[T%G7&LCB<Y8G?,/T;J3Z]269@OE0_Z^'&%W!&CD
MQE7=9,;-BW\>+1"O&MTC_Z@54W[M"WE\,(O?E.H]_44AA%-8JYT6YT?([]AE
MYG"([,A AI@.8"X<F,/(F[2);WXF:FW>,%9<+NI 9]6GA_F:=NG!_=51![[7
M.W[_.K"I:%YSC50ST&F]?W@ 8 O3R_*L6&1.<N!>AA2EK]EP%AO&M RUBN5-
MKUZ_,Z/M^OPHWOL$-Z,-HRM 75]2_DK8XF&SGWX0XT-;7FK27VPRWVOOK>ZB
M])P8<C+L,EQ6"X4:70^2O0.(/7&S*GC[1V5IQ&G*Z;B^5 :]!>;[@?C@)E?>
MV5V<=D"3,'-Y&7$-' M@YC(8/WR[VNOFP7O0_!C&P#Y2H8DYT6R8/G359\7P
MGYCJJ%P%>37GFLR;K\C=)-#&*NK^<INH#(DY,^>[I%16HM2:B'%V:;'OC:@P
M[FRL/?DC\O2M>>@4UO @P)']AU=@VO.-X_S3<HJ(O8R:QCR+"CM[0.(D;0]X
M1>>.X#NA?F(7!:0Z]UY\\ ^'.P*8^;N20;H9&-QMX$\!;\)%W?, 3^S&O/W/
M>6#U'4'^4D ZW^]3(/R: V<H;DG18R7BU3M7GC'#2.'QM0LRA/R*6^]"YM#@
M/SB)1ZOZ-U4)'G <JK=QW[Z"P1"V=J[7LD$#FOE+:B4E@Y_?UN]-B-P1$%X9
MCRRU^FD,[]WH@$B4QPL<FA2 +7QHUS5VYKV+"1'[%-2(SA028"2\+4DOJJ:M
M*<(][>?P_G\Y0\? =,#4KA2-);(^!3WK.NLG7!':.*_?52JF-C6Q(<7;AT^2
M<1&HZ)PJI[$!Z;R'[-]@<Z-S33V4X$F44*0/\\-/:T_KB7/UX%>ZQ/S8JFN-
MQ$ZD69DZMX)SQ(!8SW=9ER=?UHM'M0.==![DLU,J.)S_-3*%<< _35/PF*K0
M1YVSJG9*NQ3RQFU-\'.F>S?^7;U>+PQ$]Y<'T!8'B,\<;DV,560,;W'<4D,U
MUC()3PX'WP4"NAO#,_W"N.-6?QE?>N?TM$!P_H[$>,[4^=@NSJME))CMOZ^T
MW&[0!A;C[*#Q989)EZ!GEB"1!6#>$BTW'T/B-TO)]J;,T<?H%"C[E(IXT[;E
MA"3'H1S_O0C!I8+]2[5<?9,$149".7(_UQ $R0>O@N4]Z<',0.']XT=E&S%?
MY_1)8-K8E;9A0)=(.PCEYF@G_7-2^Z5O;[#BZ1\_6.AVY1AJS!XA>>"4KR/Z
M]:%:.R&[!@&.L-/JWB00PFB==VANV/R3@[1-JY=] H;+6]T\"@5N0UU?R/&>
M4C]=E+:-NN(-#DN!DDX<N<J/#+MY>23Q_1&64VU]V$PWNLIS1Q ;H.#XI<IT
M3^+PZZ5Q7-\'5YM[OR@B\#*E$'*ZZN0V5=NZMY=?K]8+7-"-S1F[#^2+Q$->
M!YGD,)X##X-I6^V$]W]6:P7GSSVSLHES6,*1(Y"INROW3Z<:.OH]2A@NG[=Z
M>JQD^+SW%0[# Q5^N Z8=HWDWQ&4N1W#UJT_WXXJ/"R3E1A;M$Z#GJ^SO9NE
M>NBJ+?V%W 9'T6ZK UT>6=&@U.$G81%F>!!< ]IG?PSF[-2>J-E,F'L[L_ZB
M$Y*9A<5EO'Z/]VAP%D9!<S>Y OZ^O"3626FE#U"6JI^!95>I9X\J'#'=%-[\
MXCZ^I4>K/KA%W1&<4EM'7=T1X,-@%&7E^&&)A["0 WUT%Y-[\NJB"L7-*>"\
MM-U[4GG5^;X,1RG30A<K<^,^(RTN$R6HZWA56]/EQO)G&R,%FQ_]GK$)CPIB
MQ?GKUB5>.#M0_51 /"6\&H,3KJ\LY*PJSV3:M/",.]MJO1QN7'N.3.8C]&'#
MP6("Y%!-.4_!(0 :1H%.#NCT-?F:G,3"#4"[!3I_K=%$9#:#;2!>B+J\[FHA
MPQEB0O4MK5YQ^6H>/F+^8N7+DO':UA+/,'VJ$,XDD4=6G59S9BI;V+]TXLW:
MB,S##?:<8_&R$V$;UI_KF^"ZV*-[&JL?<X) $[(\6-<.]J<!\AS5]3J\:OAJ
MZGLQMK6^PMTK#W8NI)V3_)Z4@UAFT'][?0$O:-<+_]D *^;PZRWO3'[=Q+:_
MY,_D!9E#"Z\><$7*^KG#),)QU=),4PST$/[>RNC+0Y-[4-_UW+(CHD\2?FS5
M[JY'RWMKX//7@G%<QMP4S>UG,,?QFNBC\#L"TK-F::FP<Y@ORU>UV4O:5 ;!
MJ?AA@B /<&F;>ZRQK46W1&>5$L,J93NK$P/^R<^W6DWXKA##YF;TA*NL)"=:
ML[#B8W96JA?C9=K&;>U.$.M-VIEF*-F%#_6@ ]^0)0U!4-*]4,R1=DW#V)29
M.FWM!)DZR6HE*WKJM)EJ9ENGDR[JLWO;B05%K#S)GCS[5"^>DRWP8'D\4_9G
MUT6['(C= '-'T!4KV>^L2*]^?(M)T9F,01K768VFR*,/?=.RY)SF5;R5\!ZH
M86;MDP4#!"C$S[>*[-LI3 +CTZD)8P'_('T%97VI_E7'F!UEV0'FU?+0-5_R
MWM),L7IKTI&#A>7>,N(Y:IHJ:QM2WUGR9!VJY;'L[^)WC?Z@Q:IB);4E7/:/
M[@@<7.^;@I_E329J70LL6]T1 $U>?H@3?;V*[,_!Z$)H95O$X>,SMMQN(?MB
M*_B,&UI,482SN"4_U6PZ\R#I=B5/9AP"N:EP4%9%$=/XTY?L*V5(4$C#\"C4
MO"2_X$.HNAJ)<[E=4[IM)),ZA;)> FA6P0%=2BI,HUZT\G;<^C\RMR9(HW^,
MH?#<:(<")AG_IEJE+_RIY4"%CE(,1?D_EI9^="OJ&C*D#*QIJZHZ6!I]\&T,
MBOM%(8*[7#T=E]5B?KOL \T<A/3B 2ECGGVUY)R:'D]%4Y@_'@)F;T7 FGI8
M^JYHRQ=/%8)KGW[$_[HC2+3*7A.>ZUA!W49^*&R/SGX#1LSQLM+^E==[S2[0
MCSD^Y/_^5STMD2A3-FKO0)9TC6]2H?:#Z?<OQ]Q\#VP+O!-QJD:5!HYRI:H"
M973/EB[14?L!6BAK%IQ,I]C"(3Q3.T'P9#6@;3UY5TNBCOQ"BIT$=V&5JMP<
M<D>@ZU,?>2]R\.-7P'=L86LQ+L(XSJ[1F_G^ ?G8R?S?0Y[F2:&MQ8^0(2M%
MN5A)95.>*3I]UO4W)(0E1<-"&\?E99HPL('I-1G(@Z7O(^.;5528C0E>?LI5
M.#<*^,2:Y^LV ^/V,>Q7#8@<U UE;H7N+;M6+O0$C90S4,2/;4^4@$D[&A$^
MP\$>135TJZ*E"HRK$\[-/<DU\E^PM$7Q)>I/8WJK-^=5I(W'K*N1(>76[=++
ME7Z[S)RL83]&%1>:+7%'&/>>T8XK^^8/K_P7OCX8>[Z;]1ZIBE'JH-JS)H4E
M]54V5JOH16XXYXMM*%!;*'N46B#XJT2W">>K #NNY/BGUR[5_C2-'Y'JC._M
M?AX87KP"KK$]G\R;!)8.@M4^K24G<LV./53^?ZT8<]]?)J4VFT?EQ4Y[<H0-
MX!1Y+G;SV_.(%:?-3@::Y$[]V;T1+X)",ARAK=.\X"AKVA6<IF&$[F0%&^F/
M/BD5+@6S]X')U]H!+ TXVW6NXEUT]>N68(D9D\8WVPGYUUD9FRA<E; X\?A9
M?H)E93(5S"..W!_6;AUW2X\[PUP&/%L;COVR6^V_VBAISY9C=JP3'5QM_$.>
M:=G"LIT9Q,:,IMV0;11V[H1OF[W)+\'SNG__. EZYV'%B)6E!K^QE.[9_5SQ
M7VRX1VA,EC'4LK!ZM3Q0:"(X>X%4%,K 1*\3)3,J2B?Z<OO!3W+!F^F16@%
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M+G[1I:=#D_%@QHT%/A0ZW6IBUTE\U#[>MC/N_"ED4B.:OZG^PR_OZT_AQ8!
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M;S#<_&MZ-;'Y2N/)4E?+EKR;% F,K3X7B'<^'RA1$8M]GU4K^^L6?2BX_*(
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M'HQ5U*;86_?W4E5!R* YWM'B!EH\ 3MD:%AN_: WST!5ZM.YE86:!UYYYSV
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M@J&Q_N.%SYDU%D&??>;]E2_ /3O**9%G_!2##\!$D<2)F0[Y:[T)!X&#S)<
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MI:[)8WRZU2B?EHU,NI>0B]STDVO!"J3QD3)RME?E$GRLE:0=R+W%M/J/57?
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MJ)IP9',]%%'BSPJ'5 QGERO%O!%BQ-3$CW*-YI/4*PEB=:*)GQ+<.7\KI!6
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MAFC;VY///203T+.%< %\^@ *J1U0,+#FW,Z@%N-=*ND!S=>\F3 JKF^ODZW
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M>S0'2/ HA<%D:K7&74JBXHM8.77OB8&RW0(R'#3CFG1K5CEIUUI2):(;)94
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MIFG5,_B2J/@D#;44U7;F'4\G,Q4B5[UHG=:WNIZP_EL+BXLKF5:6@O.(B,D
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M/6V%BN45T^[JC#=@UQKZ^JI> ET.I*."&5Q.)18R;S@DKF*^5Y3OK#QI-J]
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MA,<JF,!8B$*)42H=,2ECB*Q_T@IK;DM^!'S*VM)HA3:87L"GS[@ZU,AV)X'
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M?'.>;J8_?5K7#7Y-B<D1K=B&LI284'HS69+&S)SRC)4?HEXJK9"3<4(L+-P
M3Y4>9U%]F;@"Q^S2^H5'_TDSGBBKZ$ABMJF#_$0VA)%%CW6<^@L*Z7?Z<Q>J
M70\.4RE9E3F.F"O1#K\4MHZW?M?]8\EX#"M?$""%D3S09S7,"NPP33W]AY2I
MFCIPXIA#:7S]NA)A2G5R6OJ#J./+(4==11I5L?4K^H_P?,\VS^(W,.]DF^ET
M%<]-QF+]^:L';1F7,V:*!6\R]Q'O-9B>N"I-OD.&*3@OA1J@J'!S.[/*]7$:
M$T0Y] \^DVOC&2_/6U$OXCI2#;F4!UZ[/A[? >;<_)&E#+#!ZNR<.S9N"Y_*
MO7FU>8K\// I>6U=)[>J*N;J#B XJ*&\SATM] GQIEG6U'/CW&8S,*?(;H.&
MAFO 7+,CX0[@%5&PNYP=;OB_U!KWBE<R7:NAM%LJ[AA4SO@SDGB51W.,]^*T
M@)N" *4-Z B;$N1-_IZ!2]%^6AK@);*B;TMMI?Y2W&>D(C9/_D6+203'9ZKU
MP_GNJW_Z2/),)--;9V<KVM'7+9SA+7_+? PC%AW+C50&C'WO6\"_^B!_-\G\
MVC:GQLY3?'VTE4L:JU86^V*PT+K.29Z-G(CWV"?NW+]E_%!!#L/GCM 14C_V
M]WT>WFZ;I#26/:[S%?!UO1G*@7&.22U&D"IIO$YZ.R-#EQ2Y]7L!\\UXC&VA
M<.=&!(Q^R\HZ(F!I3^G];#DI7C,(HDJA(?@?5;.?G8ZUOM"M"!@V&XX.M7E3
M47HV/O<'T0NG.97QWRYE?.P5*QK'%-'*4X<4OC+MF1?2/[C7!9V49]\^UO!X
MKDF7JOWM'TOQH$TE89S8Y93-?\JR=%M5=<YL>/[%Q-F$E>CY6XI>COYN#K&3
M\."/DV*:(AIC3J.)LWKDLA%2KO\)N/:3&):W09XA'!SVMSAD21! ^4PR^W'H
M6U]JZF&+;5/)"TL8G+<T3KMIWQJYI'*KH?MO"+<$;E,776H:6FUGI1Z_%K*V
M/,I5MC@NW]&$'78FT(6+&2)/ J,X) 8 .\"I)E=7-T2EUI$%\18Y?9F8+(/=
M*@5GEZU0P28S>F/F0:P15\XJK[KG9EY*V8]+!3S/!KU:H%F)ONV\W\4%J\E_
MM)#ZAY)YY=1WS Z#/J=YNGD8*KNB@=]ZNCVX<<0//;#X"AM@_@C-[B^ET2[4
M^MX':8'=C&.OPJY_R9!(]+T7\='/[;H<TB"U(L)'PV?^>-FQ7\.DYP;"TSE>
MK'$.(7_KZ[KO3UI]EIZWJ*(8T. ?[8U,_&X1@2Q4<"Q>DM84?JKW_.T 6';M
M../"^3_S1&-XY?M*Q<_M3YA7M<T\G5DSKV2WMHNOU<8I7Y/D'K:>;:#2<8,3
M'C $6'C@S5SG^B_2V__$,".V949#ZTHU9JT>F%/Y;T@A[13Y'D>)RBV"4@H]
M34U59LIDP2JD!-RJJ6%$>L]"Z9%9"'@OL][^Z23/J,+X]4"C1F+#*V' $'WB
M(/I^#G:IU0/6=^9;(=ZC9NE'N&\TVU@=%O4I[YB11JHL:L7K.H,UN5+-8_WM
MC@3O.7+J)KI<Q/-EM6>5JUX.0A=!P_NWO5['.\DN#Z_>=MXJ?OG56Y"YIUZW
M-HN\"^EPRQ'2,67;M<PGP57C^E'(R(^V(JFIU(+I/>?*N;CBH+-2[LQ,7?:[
MM]9_KTF]X79C8%@XG0QB(.7'V-%>P,"K/H3LKN-4K<G\YK51_A)>W+>4<CNF
M>LPY@<.%)1"X!J'G2YV]6;,4(0ARFXV6 F0#]X99[8VS:FEU*\,CLM;.S">/
MN[O8GO!/7F?DUQO88RN[9/P8+TQM"*-:VZF("WL/5JMOI%D/]+_!,DB$$Y-4
MDQP?Q;A3 !1>;#3DA+;N71M!7[V^(F</]:A\8]M J$?ZD[RK.6X%$?8\C"9#
M1:4^_J'-\$#4"9**_Y]ZM1>3R[ 9EZ94_Z\=:=88GE@Q;::> WV5.\"KFU5C
M5@'LC^KHLTMHGRX^/5SI/38LTR]-(LF(4ER"P(N#1KS6(;!PD&:B9]%3U6+1
M#[TX?A;URA &5J> D"S>VG4:%,NJ"/?]^=$TP*(N1Z;)J '5LS_D6!UP.=W,
MT# UA,4KAMK?3]HHV,R>W ;+,U2BLNT2WR3N+_.4NM&>%>;/.PK)W+\U3!1/
M/B+)2M"/R]=*_>O<*].XV[+E7P^-MI&F<RUK^;4/>2)X!ZBP-)H260,)F]"8
M=S:B;5:C>OGEJ6%%G7:)&S(1_0]>#I&![C>UKQP@W3T;X]@9P9'O-@USNX?N
M;2*=&'<#K 5=93D*N^\+(Q*-HOQRU/%#P*R_OLZ.8S59J:[7;N6QKERR5!\6
M=[%VFV1%CUIR9%FZQ0R0NP6ZNED29MUB;U""3^NAF@)[)YFH7\K48,G@_S.8
M7+;EQW7^32R*'_B^%MK\YLRZMO:+4(,:_8J>7:Q:D?X6&T"@9$]>%":_^Z$N
M<FQHZ4.L W=ZVV_"3<[L'R\>B*-7V*(%O>X E%OQ6W2N17A'IJ@8<S1 +/D3
M);==;W=_2);=G&C#4AN$&N_:1BO//2F*+ZDJGHS9OYZ;)FS/^_Q][4K^#B#*
M0<@II8DH1R*=;E_"I(]9V<,-R^,@^+C?CK1^U_R\A96I:%!]+3<(5-7W+-DO
M56S#1YZV!O\-NZ28UFVE.'+]-B9WVX^V&EK\^K# 6(3/1L R5F6:/82@IU5]
MCV0^&R ?A -]#E!:+I8CVS4=0XP[GS8*%3B,O7\HX-Q/0U8G)YSW<?G*G7?S
M2Q -/@?S9DGMYW:Q&]22>F%QP;3= >I:M_(V:6";,2GDLPD/$<V)75=<1 [I
MK0","6P"VF?#_Z[&KY57-Z)".9O'_BBZ<GKGJ1Y]]??W?:7TE,MCU]0@!V$8
MH(NGOZ7%OL5N-\1F8HRJU43Y(7IA+P_V\VO"1!-LX/Q<0DTZZRJ/*(/OK8T0
MA>[Z<2V%>T4U"UQPF,P9O1<N$>'LH?=J_\7;OJ!&@W;,N7?+;A^N3'?[=)+?
MQ#B!?3SUW2,HPFL^,J202TM9&\?6'NCZ#[L-]OM>H=)<GTK_//9 RMWR4TEG
M<O),W?(K2S+R_$!"3&IC[&:;.4^2.G8PO$MB:K[;PJYHKA?J;YFZ2CG/)MG-
MY'I/=U-GU9L($$^>%>"&/>QH(?5ZYWE(;8\V9CDI)UX-WA>O9.?RN;>=PH$M
M\VZ&GGT;;9+)W95GO.VM'3_9]UY]9]2D],>!#NY85=DLTG>?\\MWZS9V[P\#
M-%G1:T]E4S_+D(=KITYBGED?T!Q6*-*VRP[41\73^W3"?-JV*#5M^0=KL] U
MRD6<PO=>D%)8U56L?I9$3E3XP?<\UU;]S;8;CWBKP6^2\ZJ]GV'UVQ?P#8N<
MWUA5+FJSW08#B=V8.IE5E,%O7MUC!L=>$TR>I%_;%"CZ,)94P(N];RFV@'.R
M#FZ_C8V*Y']_F;@N*AV"'IE+%.!,-;2^%LKKI?8=@$^VLG.X@S2S=+V$4"?>
MM65_3+8;8IJ42U>>EH0#D,:UJQH%UX++P17U_JDZK=^&Q7P^X+1R?N,=NS2B
M.IRG;]FSP"\Q<9'R-!-[ LX'W)1UT45?&9!TCY]T,T7FZ_RAU/FEY?^&7\+.
M&:[;CR Y+5*^XL;DO(6Q#*"#7F1X>RYV+$M)TI?"B?%$K34#UE/K#@M:WKG,
M06*A_J6J3_8XHO=[9]A^GA=E9#&NB8_.E^BV$X2P?[71NQ6[.G V3_$+:J/*
MHEUJ=!0<N[SI92O2ZU\WS[+205:"K*OLK%;)]Z027U1!18.I9:7,-3WA3Q8U
M7X<:6=.5!W9"M"8QY;#@,X .?)%]AQZLO>+Z+6[YJK7@]>?RMA2QM89DJ(U'
M_]_]0F1X-KAQ;\Y$)(<F29T>K/%D/B?]U.OVQQV ^&$: 5V?-CJLVR_I-5:_
M-OSM2*O \SJ&=G#6%EN50%SQ3"X$GCM$CA50+,L/XMF2SE+_<RNYQK%&L(Q>
M_MY4&_$7YE?W4B?QY\*L1@;=04;]1:FI@,1C.O52*?<E_9$C2*SPGZ3B.9,*
MBX#6<#G@7ZQ9R>/?OAYJ3,4_MD/F(W'#L4'\X48HVE_G%\YU[Z2*EXBOWQQK
MN#*]?V]!]H!U&7P")OU8_*'_[W<'E!'G11*$TM]/'K%@\]WXY--$L>I"S6TH
M^:SW0M.-_&JCR9>,BW(4#IE_*\EG7!MB\+:)3H)6P$"Q-I[<"3VP68C,P>3]
MBHZ1W$N41PF[![L6'BI4+%:S9F*DEF$SJ%'6>]H]ST+,TPM,HH9IS$#"]QB;
M$O]:C%@GQ/4UN9YYH'^-!KA9VH;^B7UC]3&$TZYE&V(";1!(H(V1SR^<BWJ_
MN==)1KPP'7N!3._'X9URY8)+:1>YGT9"S?0RYFJ6O(8S.E9W+$2(B%OK1$M=
M8@T@OXZ[XTYIPC63#PDT8@KD+DI!7VLT2_NM2 \.G^6DJ/H=([])_\[L-WDK
M21%=VV)A@B+$_R /G9HRB/E1>D&2BUR%(-II&#!%THSV8^C2JFM00<>;W#9U
MH2D#^503X/?#_-$3()& ROM\W[)@='LMBG74?-/D#>30Y@J<8M]2O<9H^^>X
MTW;%)LI*I(# /\3T,%;!H;=)@]E @BJUQK;+@K[M"IV(N_AAV);*_2I?#>E[
M;([(7H#\B(O^%3: (U9L?4/NO8CP604]=91.36?*^QY:9RI^']EL@<]L-S;/
M_=-$EP:?:7&(5!#V:J?J=C6=(N^8RR%#Y?Q4^RV_S<HFC!&+_\OLEN.W5G7E
MK-%Q/JKH4K%@*D7,K);*,TTV.7HZK8-@%B"R"?H&A)M4[OPUE/SH(*9=*H::
M]4TI"V+:EG:>L#6YZ'BB1DE Y*V0XL<3[AE(8J#Z-^LBMOB!0GKX):8BP 2;
MV\7*,#:UJS_FREX=1Y_>M08IDP830P/E<[R35#J-M ZDP3'A USJ>8[CB5F"
M3<;00[#,2D1^9,QVKYHOZQT@=X<_#Q\,O"?\$SQMS7_^URW)_-NJZT.YK@C!
M9\U,^CZUB?,;J#>30<\T;,J:*EP("IZ=/6\HD)>6BPO?B'U\GC#_,9<U96>#
M M:DS^<-,1?=9&&$JF1?'J0?P>9SGNYTH6CRIF[MBF VBYOJJ.Q/P8;4*7Q2
MCE@X/3X4_>%[0?O#KM>KB\C% -_4W;>1G7R3IN39GZ9MY4\W_,XCLV^&1JCM
M?%BK=RUQK_**^G]H9$\=J04U9J,@(<5:)<7Z.X$2V-CMCA'3CGX.V2?:BJT]
M2I_]/<Q T6+-$ V\]7E#<&#VD?T/KHA5*89NK?\L<4V#-IOJB1^N$8]S9)LJ
M=6RAJ\Y'39T,.KR?Y2M9H=4C>-'U$"BK0DZ>M1P8RV&HQGFCJQGT0N3%&ST;
M+2WT))O ;JQU2\)<,:6F,=8G^+0E0IZ]>J1)!J%1M(.6.G*VZ-K\U]OUCN7>
M']@W:C,Z4,. FWGFU0M\XG!K"[6+UVY_CU-8YF]'\"O9 VK1?J=;XR>GEM,
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M7E\T_9G<?\[E&CPXD!V09?4_72(?!] WH?.2/J0/,/+7LP:.FH.N@#N:;I;
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M(T<^24:+RW]U$]5)A@2.[W.-EA6<O?K>)WFIGO_2KZP OW$'.',>-_C$?^K
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MS5(^ND9;,$U[M#QI9V)9+];.-C%Q?*Q_A.4L'3R-^*/:KBS6T_J<!!S+@B-
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M\,+N)M;54WZF#;GM;XJP.PCA9OPMK,*16>-(PIM#$=<*>_]/;;2QU,^U)VD
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MHRU%*&YIWG#\3/7?7_Z[^(S>)"H7D !R&(AB6\=;B7IF\Y%GP=LDX( ;IXO
MXS+..@BEW23@_ZI@C\,62$""^ $S_\:P7Z 9NJRPQG'[L [R$C6H]@XHE;YT
M_@*7?4ZWS'=9J380A=9\ LA"^.W!+(M:L:7&E4'"5(=_;@]/2-/6#CN'($4G
MBBROH.98W_!<[$!G6G:;3WI\Z^?^ HU73$N)6D4#KPT>#'^^JI-[<SEDW29M
M;B"*7_%WD*!CU@5\6.%:"++O[D[-9O,%,_NX+Q,K&M?JJ=ROS4?2I .XC?^L
M&U28]<RRHX0QC;]F-KLLM[.BF#J.7V<4RWWDN7Q5R_@>GPF4!/P771DH%49P
M^N)' M0C+3 [Q2YE3DE)K"MC]]8>;LAL*(MUH_Z/X/_K5Q&MR"^PW+PD8S'S
M+4UN6!(=K_9.PS(G^ X7PJV%^X]0[1?!.N)EGTZS@7UM^[6JK/6UZ2:TJT9+
MH4.H0 /RHP*OM$+B2304H^7)T"4J7GE']/OBU9 -VHI+$,79"#23^[.D63]G
MK6G9#\=9WWT=SXQ' WT^R\M(M?!LM)QO3#;&4&TR"DNI1DJ:GR79_>F$+R=[
MK[<=E.^>)Q@,0RWN#E<()&MAJ=2/3O36)D2SEN$MK=OT&U[]C]'FE=%[/U[4
MU[YWU;ZXQ-V!S>Z8%NBYM(X;3^<9]Z\;D8CO>\LSRNNADBDVX"6LMF];2S2K
MZZM;7A[9Y^?V\^T/GSJVF95:AD>F&1?DH JD+ODESWOU.BW4SUIA\%QZ09.J
M62Q3 VHDX,L%L:&#9M,!2_+WM:^(-5D\D=9EHS9203:+/W"NX\NKTX?CW62_
M#&JQT??W.$D,3\/3]RTOK>5$KRNT_R,8_3=&6]&Z..EVQ+R'X#F+(0%+HT%<
M\/$+LR1 #?&BD1RU3JU_5'^@W'!2)"#9!&]+ IXIPL^H@Y4+_F$,YH0654<Z
MK%E/D-@PBA,SI8M5J<O)HS0;01S>$-?5_:K-#OE*6&+DS:+H<B8.S-Q5$<1'
M?8%D26'*N!W>*NGFR>,D\R'0HYL?GM$*O16#E[@:?&+.0$<?,D>!JA,BH/Z(
M/YM[&P&MD6Z2SUF<6=>.^E_5)19]8UT,"^D.6*B%2F#LVF8N8OG32M9_<S15
M#7=G%S[83]7U WA0^<*AX]8_[RH9T'SY.Y.8Q1%\L,S!!);2-<N=YERM!6:N
M*EW[+TX_0BU6'(!Z#26*;WU98<V!0OZ(SH$)]+=L3N2VJ@56,][M4(PVG0<2
MGKGHF-B"X7FX>8]7N!W.X-<T1P+:LR\ZC]F *L=0QA7.NR6]\]O2\U=KD?MR
M8=RJ^N\EM7>T*\0TL&ZQ2A:GME"EY*X99G*RK.GGI:SW+&8[RGWU!D/JCX.V
MA99$O#]F^![>*E<[WR]@3-=*^/W/7L&!&W\"/E5>1^7VP/<"0 RM6^!1.$X'
M./G/97P7K$G[G0Q==V#Z'4<S+"W)IIBM()?J3'3 PSMFA^1]V3@SS>35 L(R
MI45Y'395I04<>"DIN4R;^URKV4S TH1+OMHEA]^F1$L!S6YY HMU@N:!2D2P
MPL1S[47')8U$+MN4"#7^PY7&P@X&$L  UBW%7UCW6L^0D(R[I6I7KXQ1#4DH
MJNAI)XHCL>+2HJ568*O,-+FD6"6],ZTOY3]6R;R2M#+]Z@2AZ6G:,5R1)K?Y
ML@8R^$DUC'AC G(T.W[RB=711B .[E]HC;$:Z9[FA8G55P1V\U,-$MSLEYQ-
MI_)LGC>^W4IGVXB_2UV?@H;J8S+?*&SH+8 9/K<[_[Z^6>J^+LJ,HCD*]PRT
M_  3VP2M@$\]SDRS(H5K2\.'6<K@'^';?84EP[\/ \14U=$U)(!UO1*\GN9N
M,ZDC7=4Y 5)?@Y7>;SXO).37E#L4^S[IO?7P75",BG3V_&Y'LUNGW&^AGS@6
M\2CV2/K.1H1JIO?H"J@&37B7S0E'5\'71A"/^<22V)([?S&MY7(>-<SN:?&*
M:B]L&+MI<+5F>+8NA>=$BWW=^9=5VO^P:_]ZOS4G_6L> G#I_S"(DAVN= CE
M64:XAKVMPM!2'9PINNWJLESK5)A]BU=<X^'D3&9 ]/YN!)$?'V./%9AG;!&O
MCR9.,M$?ZXY/HFZX,OHTL;Y*3OONVA+1[-D-HA8:11X?[C+A$6:8H,K7-)/<
M76-6@:'4%$F7*:^JS%'NFO=CY+OX!<688XC"$,N6#\P#A>L8=5O>OC.TX_N[
M-/54E/?XO],*""3J&IA/J!=,M$%<0^]<5>-U5!3A.E?X/\R9_OEEIQ6HX3QE
MB?ZE_()^')/S[(<*=BB"V!>_X02]M4A1JG\]HZCC++O\FVK@JYY(T*PZ00>2
M7R;%[J<SU?F[NVMFZ(1ZULV?F?7!K,WBB 'UMH"(M^@WZ2Q:@;"G:9$H*W?J
MS^F@MX8NWE#0=7L28.*3VYC5OX%$&]!D0+(97&LRC5Q\VSA+<YSC961C8B>F
MX2W9[?!)#L]V.,>5$:3&;^]3+<QNU/W5K32:([(V1C)F\@9ZXRIP7PE6<\V@
M[A.K<6><DR?+,CBW>_JCN4=>0/1<*O^3;)7+4XV!JGM!D)6/*WU,"A(#]-LS
M4O/P)0*Z7R;VK*!UZ0V^B=B<3 (T\P->KX,I@T;Y%;%F;UR3YPE! ME/,.MO
M'M6Q!K_\Z)NRM^1^U'[[1<"2YU!+]%EBD,A&*[L*5[]*DU=:0$%V "[B:8+T
MPW8!L?K#X^\#L)8&!!M=^A B_4G'':3D$V0MUH.<@^O\QMRTZ.?5=#.C7UA4
M^<^KP[^/R,'64G1Z\;]Y[_.<V+],DB 3DO^*>CXS._W#&)0]JDX#G,XSK)B"
MB%=(;:AB[JPS9F)3Y4J8ZYG<8$K4NTM4U\VO[0HL3]O</;U%>#:",EF8I5A/
M-XMWP#:C3F0GT-M+F9+AR5JB,?Y9)I<M!/OB\O8X[RPTZ^/JL?U'(2CF+[V@
MJ!R,3UP1Y.+XQLE\_(WK2*0W],.0B;W@5P-MXV#M+L_9ZFET!QYJCW.C)_@T
M8*>'IYIJW[C>'N:Y('-#-]!O5JSG;L]MBLULCB!9/\6YK S[(K\^$]BU'SBW
MZK:;->G>3G?:LR5XJ%9C%Y6KGSX U4:V*W[,C5:].,N9&%I$;&^]+#@'[Z-?
M(ZKZI<T7I,WYU[A%6U9D%^ #K:C1W&^Z6<0862J[Z>L5'UX)I:7R$&-X=%;:
M0F_5!K%SPS)KI#TON[7;,+/]FS&Y5V4E6/F+N72H K^3$P4C!<V5O1M_52/V
MLA-F+TD%@?"!IU(=%]6+\;NFT29#KUX\8Y&[ZE"?5A]]4UH_".B]\YG9]/_8
M>>6@":T%FR\+V1,9;3-BV)8FQI/\/Q?<9,5RW@FT?MI0L-6Z!U3X=@8)#$$U
M3E]"I6%BQM4C2<J43\P@VF,&A4MSV\+L% =Q[(;WSO^37<ZZBEE.B*K!U;3$
M!+!>MGZ,CHO4-+I+92:?[Q=]VNZ+69L1>J?-7E[59];-"GZ0?(HXX=[>*"C.
MMX28LEF K?+[R_J0B^]>L-R[%/(]O^(<G^;1?-XFI*1?Z"B"]TW="'@EZ7=6
ME'S)B:KKX4S/-3WNQIM>MN]^>-!^9LYHD?.3T< R;Y& !64C8ON-0SY)'$Y7
M-^DFEBW@6[#6<^;'*6M').#<@8O"V"\XC5T[]U@V2_S87E>0Z=/5%]_]4NB6
M5K/OBR7A\TG ]>%%^,EQ$PD8VK?!*)C%8FJ<%T4;-,"IW(<S,-^6F!VM-YCW
M8G8E#6W6W>1+ ;.!:\@]K4P_\$(L[J2&GQM;GKZF(N#^]J617AP)0+&"R(+!
M]FO'3#-W%51_WEJLVU+IQ*;:GN/L?<=*O-IOG&A ,=_;);-,A@%6PJ7G=?W>
M"P.45\XIIH!E#(;-B.G,QRY<1,QQ\.8G,ZV:XO A1#/SRD9K9ZO)OJYGX:1)
MV[K53.2^-WC!NA75XN0:,,VAKH[V^HL4WSDK6"^9C1E7K*V$U]T K2+!"#59
MP4_6@^N:.MHZDNLILM::RB!=5.L'&74(PZ]Y:O.28F%^@@F8'A\_U47D'3XL
MO9VD:+5FZCCVC#)<69I"B2A+$]^ZI(VE.0O;43VP,N7\-GLLJ,)* KY"X3\:
MK"U@]D;K/V87XK5,==F+#I;=5KU:C1O(=%FV_3=&6U527ABNP&=T-NI/O &/
M[ZMS9C2IN.([5KD6^<1R$0IX& D0DEK0/X--D(#U.Q66P^^=C:,WIDD YA)9
MC\0CM>_GBW2M3>F3 (IDPN!:C:&&-U^(!KL!!=FHS,#8;?G3R&.S..)_/7E
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MC@0,>ML]Q5CQ#)<Z&L?)F_)^I3R2YQ^2@B,LR?G[,3>*3$7@2C+P-VZ+4'[
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MHX<\G"4V%3S-= !/*WQ^P"WDL'G+>;F\<@;HCB,9*E]K62TY5V_^$G+!LJO
M2NV+ W'RO<RJRVUSO:-BVK@5$WN*+F7LXY/[9X"<*N09()#A#! #^LM"3661
M (+NWZ^F<2*4&6ZU9W+>2N$O*A-0\)Q )4,RXU"GV)&P[!F = 'TYR_^OU<8
MLYH%9#RG,9($&G+DP!F #- @2R';/Y)"S@!J+\\ YU# <TZXB/6"_^*F2#O$
MX&!<7#LCZ;43A!\V>VX=[06P9(?[8;+0<:&+=NC[9_L<:CY#?[_7,IX%V:XY
MUK4$> 9_/<G7VA]_T*8049?L_P16^QK=+ N#WEI8^G7L^\EMHH;,&S"L0(XA
M((WPIJ$E>T+J'PM^_OJE6^)X\=?',@O_BIO;]^^SG@&:!2G<_QOE)_<<RK:E
MHMA<%V*%5X)D,N327HN$J#XK^$HE)_WZ7[-="EF*I(&SZM -@0@2=#*[A/N+
M2^]T;7\.V;3&;#;%2?] F&*1G<Z^[4>0 K$N^.IB4U7HTGNSGI"[;\,W=LQ!
M#!!Y1($6@7.B?B?8R:J512%UM5NX:-?;DROHL(B%P*^[2&=&ZB)$X>S:;RM7
MG=SZ;.5@:-E3X,"\X6."6W&[P,@OU]H+"=2CTOK+[NS_XE3I37:C6LFUY$K+
MSG)8XZ/1AP6W.&-5(-VE/Z@B_]'?_^!J7QCC!5SF7_S]%01 N.)<H_Q\"<#[
MF;B0Q7L(ER/,Q%7F;J6^2FAN;H8O\^WF> (R<F^.@N2J-RGM&X(>W<R1Z.?Q
M?4,Q]J&5.[_Y%;Y@ZW%]9MOT$+=#!CUS,^]$H]XL5\TH5Y#2P7W]2^HOM]Y&
M'[T(5!SZ/X9Z,?(*1 Q^7BVBT7$7$=./T2.-UOGF:D429OW+JM+5T?KF6HO7
M.BZ9ENO]SY7]:^I.J@$0:7XLI*!UHQ/SEIO1H+T_GVK8>9<)%"7?\)/"KP27
MWK5IK!EV^EP5B],/?2_8K>,Q]D_'%_ZW6'$AIHT)LJ%2J*A,V@]M1V6??7$S
MZH2]F$<3%R?R%7\MY2*QOP]D I*(HOP7_ISM3<'";E4#:1T4X#++U>C(B_Z/
M"JD.34K_R91$5\MUB-#Z>=R).&)DHY5 N+?XW0Y,4&E^NG6!8EF%TF-@NB0]
MK6(56G'^AD4F9\F;2X253E;IS'<L1\3B,C-H64KI&OYC\X1:2_*7\] 2@7$F
M#>73^7M7^%,M/5(!%U+$D\#9ZV16DL[\ *CS1EJZ9X=Z%;KECYJMW5S!2LZ#
MP[?+]4?_:\8FNADRZSC'B&8>INK8LAS"/4GZHI[*7'=1TKR+-<GLB<U:3$,E
MG0\Y;W[&M&NNVBMD1QIA"0.U8QCJ(@U:ZE/T/D9* CW43F1-:^;MY)8C 19_
M.VL )<:08 M6$0DD/034=+3$J;JXIJFQ<BQ;0LWC]MO%1?ILJ&B<7G/2KEW'
M3BBW7/EI6J,[?$'G\HIQO!+<K0@SO4;]K"F,Q7:Q(0SLC5E5#-3P.?[]@6(D
M$*)[FAS [>A^XDAP[80F33Y)=\]5_3S]"Q'C"?M5W]LT;8?/:G^[KH4J<0!0
M9'7]:[W(?R5,RR!N/V2QG]1(HV3ISUZ75%/B?GH&:B7;FFB>RU EM&E4+K]W
MN0GRU2H6<A$9,7?53Q];Z'GZA=P[,I.9TW=9CTQ+"?!6( ];; 2,][0U&U>2
MZ,SLE[?>'X89_N9^G5UO;:\?9\(D^Z[%<4,1=-423I:(M:?/*YN=LE>P3'<:
MG7EJT7HL^^YI,ILI7SWUPHUYV;CLTV2&KA)#/YA" R+G8;)JL._RJ[>G2N51
M)!.6KI8I.XN(  92T)#FN$>AGWB.=H&CCWIPX6GLWH ,;X+9XB!PAV;1:P#@
M3^5QK(>X/-WJ&2 ,4_?>$KO+/L@AZ)R.XL8&[$&>R+I:+G":R!0?:SK4$^/F
MMTS;:Q6=48VZS#%%'86MSU.G:&]H]JW^%)QK,/R :?8</^_<9_Q/N+#./M/M
MJ5T-/^$I/NG+;R\W/BD2,51GL&'ANM0BR.<^6\\E1C1O(H0%.N]-#]'"V2EC
MBQ9HG+7U:L>D/[@%3+AA^AF\>4%OTOL:5)78 0>E=L0B/'=\EEIQQ#[-!CSM
M\,TQ;U5%@KE8;K0MAI+B;G!#K' #R9= H4E*Q\)=K]G'R%>DIU^<4?G1%QMM
MG!0?JGJ)P4H448L%QO"0'+))<"N\_U 4%I^?#4;'%F1917&IE5(#;]MKME*!
M>"-]DBXW%1!A^)V81DG\,FZZ^X#%X%=SME*]G\*["-&9IH^N,QJ*!70WV7JY
M<P(E_12/7YY($B!U^0X3I@<XL/KNL0+7?3C;]=$MM3X1.B&.!\FL%'4WO8KK
MP[9<\1LZA-P,[C2]AM-S4Q&?UE=BY$=Q#=^L^,K$R^^]8-SM<+,2]J,>.8$3
MW(E.^(,..) *G!_FCHL0RR>X8O2?1V+FH-Z+=UI\AV885,"[L/&A]KD(&>4K
M)VIXYLFV"&^[HO64WP\6Y%VN68BFC^_^^@@+. -D1 D#J @W;_Z@:K ,&"-3
M5A%.FJ]+K$M:/O"KMYDL-]/B^^2E4\L@U>I,MRL(>8?+)E$=JZH1,CLARB-G
M@*KMS<P.S%C-O>H:%+N2,*<97UK0\11I#^,[^8XT/7_.SZXTBSE.9M#B!U'8
MTI<'4.V6K0%E0\,<&-0UNNH75!GBH/+ F4VD[G(31[OR%>DFJRZKZW[*)64M
MV%*)E4X4CH;.2Z/)S(# 5Q,D)HA_8M3=&006O,C6XD2GW*;,ULR+L.[*6:O>
MN@Y5KI!)?[;+^B*!WX'W8XJ<GEMOV4&/%5KL;>.5B=L.:+JGL*FRK-+/YEIO
MBEPZA'D860&1A.G,RWX/278+J*AK:Q"J>H)G"F[#5Y&&2Q_%<_V6]LOPQN/R
M1TN5FMO"D2VDJP3M=O: E/GDRDDEM2Q5[%>I?J%&Y<(N.UJO6] !V<?JQ*?E
MW4!5%9 Z(HQ81_+.FK;?[?%"%G<53=W]S#928E,G/GWC+>];C3X)H-4#4S_X
ML3Z"I0V8W^/FABS2\7>L[:=/L>7K[W+QT;JIGPBR>G3HZ3IUT,/-BF=YZPP,
MV@\C\*=GW\WDKL#"8,\R9N<U5VS;6_IYGP;1 PT-2"E$5\)R&J[8E1&1HD&@
MBO'@@CZHJFR L$Y0!K=Y7$]RE7K%!J3BR1X ^)S[9 [C5HUB4$J5:;!SP,HW
M"M WT'^9R%^ -\V_X\I:#,JE]10 %^<33+?B\!NM1V79>>LI/M$I"MH]W 7@
MFG3>]QC7&$ZEZ,M,FFY#DR.-P.ZYRLQH&_S]-07NP)K^,\ 5&_87&(XYY;XZ
M\K Y1EF\SNFF %AX;+N9!I%L%=92;?E):E&6?#?2:"2Q_)3\YFN6GJ[KK#"]
M/<6/YIL!8]R72>ZE&GESNDBD%]&F\9.#B0%,M.2N!$I(Q?/B!1YP'4IOQ ,.
M]M6N&JL^#M_>%+NE-?\U?(DW)O!.Z\&E:W!L'!=Y((!G..#VQM%B!@M!(++T
M1,OZ67D<_0;R.=0\NUJ36SADZ/O'Z'O/I\)1Y>1KI ?D:\"064;\W)3)MS4?
M)^;0*7Y)$;5K%]\.B5 ]/N@">.S]#X'AGXDM"=[!;AI<';[7Q-S.)?LD9C%>
M=!Y66+(-&P1/_9'I;I'XK_UZ_KM3,+.W)S[CM\-\B_I"%M#1W_J:-)FZ'#+9
M1+?+I"J\\F;,IAU%KL_B5']7@(5]<3Y2F4#TDII(]W@@P"85VTB);W<VU, O
MD8N_#+F[.D8IR3S^:N0R=F'./D"F<@)D1AO0E^K<6Q._)'?I[:>)KN926P_'
MR7LS:GSU^_%/F4 Q".FM_C4\XB/?* 9W=1_'-@.UL;8_#.=2LS:'.@KGDI(Y
MW"1_\A<X2_522URN[9VK]GF3!<PM]8 +KW+#?0OS(R"[GX.H)BJ5U!;\E>_C
MN\@U":5;35D<G;17EX(6]E&B!#&B_\$[)<V,:^7U44N!0[>%[R@LNE"#53;,
MV,=3?Y&LNCZLN01TOR'Q)$Q<,=?K7;E%*WEB-FA/L0H6AE6.+QBZNG$F.)G:
M)[VU_39T.S?,K.)K ]RL#)MPCF2/YLM/A-NWMII'<9E X%6HKK,7?=*K^F"F
M.TH=5QE"APR;B]=>J=U-P6H[W\$LB[&H^<3X\PA?!C#OTF0LI *.;O_9Q68W
M-H:V3T"C(I@%;\,&-U\!BKXT[4>S)^76U(I'9"4ZOW&)%J3(P,=UBBIV\Y@D
M_$BJ&5W\C;&;O]?MY7^G)H*@J$O@FJBE3^-,>? X6MX&M/$:2'-H(ML!OBN'
MWN'"H+_&CN\017Q?Y<E<>+OUF.2?G_^1H-@MKNI*]+759)8V;I\_ISQB]IG,
M+*8$T;+((^FMO._K5A+Y%PNIEB&_7C1=;#S&ENB6PB&W"5Q]M1_=WDQ,M'53
M/P !@$6]*-5_[,K+E>P6=!1;C[1GUZ]O81N_ALV^?_O#Y-3M#, D%>7\H,VB
M\3=4Y$"&:.A-:\JG+29W$@)@K^V,TI%\\&/'! --BWENA,$\E-A*HD7>5#/2
MC7QOB?"<-BX?O;OS\ .XL?SA1P3,)Q2T4OJ:/?;T.BB$?:M3@DM9%VU?9F[T
M@2UAQE@+I&>/)Q;Y8H="N,4G%FJ2V:2Y#-;7>V5.VE[:/'3RY492 _: %Q"_
MQ;BF9P?H$HD1SF()CSLXTCZ]W>O9@!F_($EV$$A6'>P!J<&BM ^^N^S<6OKC
M5$L:K4+Y.D.<%)='DO&%PL,D9I]JQI=</0BTCNG!U-?O@F(L^!H</+V&+<*:
M?(^-'(Q?3S_8.]*[O!,=P&M!>D)6%*L<\'_S0K*7DX)?KL=$VLJ A+)V=<UO
MBLGKSN/;KZO7G'^:%.W!7Z<,^@6B.U$=DZ;Y:NL+/;VUE8WX4;Y[3WT6[&YV
M !',;&NFP@\&/?/545_^(7+0K/^R)GJ?TRL+:(>OC1#U@^9 USUM&S^^Q892
MOW^E>L0^46:-K72(1T"ZP3<;IF[: F\GO70ZZ0Q>=X>!_[VFN&4(DU*<L:6P
MZI^;9=(TA5OD<8G6NM^?!R4<Z@NZ1&5&^A^E]@EY"*'EOM?@522ZJ&8%1IFZ
M3LQCYW0)?K4.;LB"F:=K^?P)LZ)KKV0Y-3;G3AT7X][M*,E3!:V,YS645T'9
M<E+A>MJ=F]_["K@DXU5 J@BX55@G1DD6W\,KS*\::]PAQ*5:^@@7 !PJ_(6X
MRS_6V$[V"V).>C7$'&#@/^ Y]O?'5BSA!"_<8@M0K%H4I#-J:C3ID9]HT2&2
M(]@:H_KB>T!.R0F8]%DV0NH4UO@@KR5T1RKYXL:04[M1=*C&J@93UWX?9.I'
M2V-C>DT3"KU5M'**!&[-<J3-0E>WT%O^*&=_H&I.W98B#ABZ[WS'_]&H175&
M-T6$G?GEL:,C8Q-2*?82BPTILI7FL?=<,XC?!QD/5=@ST!F +\?,\@=IU97Z
M#8_5"Q>97$C<I\K.UM>_7TC].8NKF/ZX)X![5,I,VK?TQ0B7C-L?91:J:')&
MM7*<$I@[Q;6PINIEC>RE\#+:S];O)50@U:=H<%V*_Q'3UIJ B\><1ZV[S?3]
MMK<15ZP3J&-U[DP_S Z, #P/#N&,7)!"12IXEJ(L.VB)<9]57Z98ZYNW7>*N
ML^R815?/A4,X)J3U\\WA)EZR2[+A/(G,PNM@1^OP/'!N [*#@=:8;4NZN.;X
MR$O6NC:2[TY\CM ZD\KEU)KW(DY!K.VRQM3WX!RZA)TP#]A+YSM#YM5?QUX,
M'K]YS\RZL?^EGZ#<[NQ!64Z@#$N7J.K.>'48M.*U%*P[/8(^G)R-/.KBL$KW
MG.&ZK<KX^'O\%TF/.UDW[D]W)K Q2YF"S01[3^#4_7\:F8M[P[AFPIEOM/1I
M#_C;>Z>8)F">.[<4"9M-0F)G"W!-MY?I/&?;<+&:\Q^RO9GD]S8RVW,07QAQ
M*T+%YDU'HE/ICU]R)W)IZ9CS'ZS6!MCEZC_="3GQS28UB#O4IZ/',>HHZ4:#
MB\.+%$,K,";7J]VYWEG;L>%&(6:[JC/>E(S&HG#S*CPQR:/(\89H4WHE&U]2
MO2"33F%Q4U1BHF%B>H*HB&9(9*%!#^_;B9 (IJGVP('QP,7)9!)H83MM <;3
MA2EAEF7X:2^1"+JU*\#A=9&ED+^8=&.A=#+\!/8\&P[ARKR?8E@-[Z>*K_4.
M!]X*L[;T^7YO9+&Z6;1VQW7HH7?\=WS"XE+Z(7%XVM=U%,9T ':1&[GU3B^X
MC/%%NB4\]\1E5'HNVA1RJ?S=(+'&U4UT59E_W]8@>)*C_BC8,@EF5#Q:EI:_
M8^>:JBB($WK!F"X$XQ_=AX8PZD/3_^[+@&8?UZ-RVH(@X /MI[)=+5$^NNVZ
M0&ER%K=O$<- :>XC[<=&%P,";6R.)XP=V]]Q6<0.0ZO8QXNP:_5H6_O2*4PU
M0^,+F1@+\6'-A=]9;1QJ2W^,]9RVRYT4#YZH$5HT\04=7&)=]0D*D+P7M283
MXD%#/'\$;W%W\ B@#1I(OS;PT^W-O)4_MJ4YS@ ,4OJ8-?PN^M.-9)<^\<G9
M.MO8CJZO=8XILKU;![\6DJU#HMS<Q^_"O16A._6C[N/V93>P=IT$ H-T&C1=
M04? ;'A;#;V5EMYV]5(1U=>;IEXPJ2_MC4R/7-;2W\ -.PV-'1H*S@!TAR'2
M"UHJ]-F!\AVTH\7?(7?\$",0=D>?@,3A)G*IEY)^&J*M4W.K6I)[=JQXLB T
MK+I8^+8;:ZJ9A4NI@SEWB@C#0)R$M-^;7Y*13LGO'[OSBM=QVB:R[XI%S'&
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M2G,=*J?6\_N6A=,2PXMYT!74-N!FZ]GFJM:]SQ2Q"B:[O6M]!BDR9*AOGT6
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MCV()-:N__ED 7CKT"2+64XB0Q0T6H\X -I;K/@'H+*V"AQ-N;-2Z08";;ZC
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M#OSO1PJ6=7S]VVCNV=2_ 5!+ P04    " #/.VY81(XP[-99  !J:0  &
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M/$BPUT0'O^?)JYIU-)^N%=P<VS!3Q'YUTA80'@D?O8Z5UC73L3XZ@>F>7I5
MP<1P!*"J]RB" (1FX21_Y\'3>H+EPKIN6U%KX:#7PTVT["3JP&\AP8N88UE8
M+<1BSGIAV]CXV+M6L*^RUUG<4,/]4_RM"OJ7JA1PT4^>,!;<E?/WWS%5W?!X
M96YL OKZ7/ T*+0-^BP;FBJT=/22SH,W^*5BC1ZO-QBR@)_B46#E(6]$;W2Z
M>)BC9QJ+MXXE*^:6"F5.?=\"FS8B#_FX#MG9MC2&D(C# J%C&.)PJAT#._J)
M%N[.X;+&RD^J8S23VC1+- 2G?K:!BH,:S^2T1O?>MI1]\*B[HAEHUPY>B1J
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MXX8KVU$&4P>#NT]2)VY0/TS<)+M*FZSYB$Z>P^3SS[FM%V37*/-08;$H9;9
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M''I^+8SRTDVGY&]SU&7N<(Y -"?PO'UK,XT4&\;M+OI/++JKNQN<&0S)+"*
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MQCVN;6AH:9A\<4C1TES?ZMN8!F6XIQJJ(AAC1P!\F*D9*1L/*^,SE%^GUOC
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MR;R,&(+7@CISHJP5L+9>E;Y)G:<4K166OE'FC! G#D]#75ZK^ZLF'C6I+\N
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M?;U=G;-[6/ZUQI^_43!:K#$>93(#91!?;0B=N/M@6-$VK83\R8^.I@E^!R+
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MBA=3=]F]T ?"#C?GT[,[,C:B<5I?L'Y79X/:]=PY]K,9+H==?[QB"/'I<Q8
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MZ]OC6<&,4F]:S;LKDGR]#&/_*@?WG< WG@U1)<_?0^/&@R3R4\[>X^W8M^9
M$ D[[(RZ3B-$[9]8ZLXD31QQ)0@X7']:[-6_SY<BD2IFO*&UQGI.;6F'_<+2
MIL-;7CE+UM&BXV\6>E%,=1,_[/=V36L+#U)XI]O9K3[AG_2$;2.LDN;5G"&9
M6S@Z2<=:O6H8''+NEG_F>@?1T"+!MFC-5L4_27G56(6L:7.TCB0I>RT@^.;=
M+#/F%ZY8^LM$*'R3M<VE\"<Q$X.%BA<[*&@>)+I-;)]PR!4\U"YO=&[F\NMG
M^;.K;>*F<FU*EE*\C8!2$,>"8R"<$VI)PD#HTSN(:*);@M301FZ)H^<E+[CK
M(]--I OQP_?ZX_DN(XU J'V@>?73Y,CO]9"H8/G%J#U ;@E$BIWO,!8FI?&@
M%74]PW!(]?8@#L=+Q*ZJ%FG(2%@?#CQ&H0K-$*I%&)GUD2!K?P).,+  -I76
M]H#827$\C)HQWS[I^&IH)H4F9M:=7O0I +C(]L56HCAK8U9P.!&RHE0_Z!H.
M56.)*[_+7C]$@[,$1F _"L68\SZ0:P7%[0'4K#=[ -GK2U./"&/-9O?;A4TD
M828#/2D=#M7^]Z8IP<?UWB6?6V%FDFOJS#L8)[; N2CP0Z&?="ZN1/G$F#91
M_4RG%C(GJZ7J[>^/#K[JW37]BMCTA9>T$Z6YU8__J.O:>:P.&#<*1E-A!+M,
M?>*&FO6GMW7:I-Z&8@_V0D* '\W:U"F;'2XD2.,/+&3_Z/G=Q;&C>_7:T'2;
MZV!-TUJ&N\6S@HN9JPJ[4/A:%VPEV5!2_-^;)N"_>P<ILKA*L:%9/"_>C]?W
M_Z,#G?86'0D368?'.\KTSQV9Y[Y[129])6!;1>@3^]D$'5&(XMQ W#)"*N%J
MM]&Y@A.HS_D<21OPEG#TS=%7L[=5?GDLV[!TGE(B^82M\)_]9_&W;]2KE7"7
M;UOF"FQ3DWY_#[#>K%NJ_5M7X:_CTF]FM_F%+DX=%C\6'I+ $IS_QZ\'>@\_
MOS"++%?D6,4]JIU\F"T(NX.+J#Y;RM!Y-12 X)4ILJ1KV8JY$UV/1]REK"0I
M+XJM]3R$B3/XIO2=-&%'X"_>I,AD(%UJ4T@JN:Y*U=9V9HD'%8%7NI+OPW5:
MZ:6T]+ZK8?QC0C>X8>-@[CXL!,&R$-01L;)8%A\(KP]Q 5=X<DH_)C\R40&0
M]@P5M43(NOE) A5)^-%FJVW21/?)5(/J#B0S-*'E6ENNSTU'F 5ABO1Q6YIL
M5B8U8Z*H5TNX?P7:=5M!@+NO>_)Q<JQ(QAR:Y($"43C/_ [(XD&-3E8>5('Z
MDM)H$Y.12_?$+Y$#:EF#KP?($/SAM /39S@D+)*L0P*KTL*ARBQA;#MF1R8-
M3H?"?_2!'.%BL-F4J^@I&IH>M^6HP#&-X0_K(PA!57!(A%D3W<I'36LW7>7D
M>R^ITH#$ KVD;LXAK3[T^_X?ZN5<RB=0N(#4K-7>CH+ - %46&Q2<M7\>>5/
M,)4J'^%^\QL#C.;=&LVRPEM?^$1/1#X.]^J?Y7A/^*O_"G_;N'MYX5 .._I;
M6DJ+)?X-EJ2"Q?*HG4"W+DJRIR#'>BS:Z+ZT+?)($HHKAQ[Y&]W*=5@LL2#H
ML$ %]VJ%SG:@[SJN0$MOUTG-N@'?E"I54Q];F''UD-!AGI<&HUV^:-XP#:0>
M^;<MQZ#HY6\BPK8%T]WD?DO[7]6/RYK<<^I[R<6CLV/+!1*-@Y844R:_I1I#
M4NUG(_)/$;Q?*<A&@O\UC#U767UH(03>OQ1IK?9@> \@$D.?:0\H#AN>/5;Q
M\:G>F3/&;:%*UIPV%FMP7@:**A*'<FV03"^I;7C^Z0/"VV_83T8$)TR1-E:W
MK18DC@&;.EV '^$OJPC^/0(-?8:20G_U^/I6$MH=%T?@"] <JD,\&%YPWPH<
M-FRKB#:XO2:C3JLIFKD^TC^T?[9^]U3C*&:1AE%/R/%VPB^?66_W_WDM^#_=
M@)">" 8BEV%,9>C.Q&@=K7.2<TO16<[M[G"?2*8]TM5XP5#V^]<YEU^Y$"@I
MWJ^F964]KR=AT"V7<3\VB5_S0HIY#E^*:I@4PYQ9AE?A3/6B[DP:]U<PKGE(
M+.>>+CK62@S+%WQ\\S3OY+S#H?LCHW4MJ-/TER38P^IYX:\2:>XSM=)7*ZON
M%M3Y55F/&364*HW*:(<L_TL*\+^I $?[YE?9M[TRF/=!.X&9%=B+6+'"\B]&
M(K!?%:H>I.@>&VF?%,(+D;T%R&JMF5U^"ZTB!L=' I9T$8<^D-ZZ"6N+)(]S
M.Y\148E:<^D>.\!V6[Y4:\M$,^_EOG"S6;,Y0Z%U7.USU9ZELOC@;\7/7C)[
M=\]/Z==DU(%H9L]+>:OVT-_SU6.ZL5VO=\#L@/;ID,*$ZD]Z',]DXJ4?=%)D
MKTD$SSEU";+18IKY (8C%;MD?K,46=[2H"<^R?.E"%?EZ&PNE?YU"2+UA .I
M5%;:*[70%IIM_L>SK<(<]C<K$H[TO#4C=;JI[4! %_SS1?DA;^=IB>S6T\JY
M/;E= 9JV7)T04?PM(EB#<0;'D/$M.PF.^UY<,R=7(L[WW4$LO8DXOGJ\/; C
MRO:SN<ZVJ9'7 LG,Y:+?98%EQ<$?@,S6@@J@+NT!\6&\R'&3_L&F?'3!]?'Q
M$IV32^( 3* M&/N^\G?4>?ID$1)CV5NG(F_>AX>H/@Y2S7?WKG>R]/66-LIA
MKJC<>"SSNW;"/5QN:5E<.A'HR<GA^H'V'QQD?#YKY/ ;BG;BGC2)(LF3Y.QV
M*Z$Z/IYYEE _5/^>7Y9X/[KZ6YS&M+9IP^O'XO9^(J.112QS>4R%8IX6UW%#
M@]?_L&3_F-77)$&;C$<==RF@2TOHWGO=:%S65N*D3\CTS'F9*"'T\&NSL>]6
MT*&-!;!8_1'6YJ@=CSI##;-2:W/DS8XA3MH13J<-5Y\*6ZHJ='GT[L9MQNOY
MU_H+DQY AX4CH/QA#_!$'_"2U*'SDAM/&/$W%9]4_R!V%J/^WB+IXYNIEW92
M',U:/RQWPVL"P"_L(%?KI=E^9-S">US1N&)VZ\O73YTYO>>C6'>]FT\L1_8W
M)1:5*?$H_*(?I?LO!>K_:6@P;'+1[RUSX!YH[X:!IB%1S-(5C6!_DZS9"4PC
MZ@_J@AV-JR6;EV%-JZ%'MAIH-%%[$JI0VL7NQ+0B5"SYU+66HW<Q>)Z.:5SM
M0O=-N@"I4Y./W^,7GZ9/.'HDB]\2_VDMM+P[#OZ$$C7![CN7 5!7^%E$QYD(
MU(7[>0MBDE&RDS$)ZO2(X8^;@<\+'G&-NS9=D1D7/R'QW<^/4W> <7_W)CVR
MA:6:>:ZV'V] ]131%G/.D![\>FVTV.$.<OJY'8_G@U:_W'K>3\G#C5[MD)J@
M& :<<K 1-9_1GLK,ZS,HO5GL%&SK*?<KN^CY4X\ +@]1#B[I-W28"X++I-S4
M;Z?HC7Y44ZG<2X]"\V!6HK>OW!Z@GFKX86+Z]79L.R7!EBO=([LNIA7-P]"J
M'JJS.3 7\G$V2V  :H[[6I0SNR+4^KAJU-ZM2]',COI[3IKHW#66*A,'-:7N
M7.OAHV-:0DYG4^0'<VNJ+Y1\W EI4\%CV<T+CJSLORAW4<C:(>&&?:[''E#=
M$[4$Y:BD6\S8#MT3EX"?K^_UD7_S3#2J@/\W:MZ+"Q%Y@;:^??;]M="@71VZ
M5T?&TO);K>[\HH4!*X0_HG34IMK+_&8L^0I&*NFB_95]A\]^L^5*F8/7;25
M?8.*/9P/4P-3T142\K:#".(JRZ$R[[1_F\"VU??E>[X*2H$8_*G>D9M4 ;",
MQ+&44)=IM[%IPVE-?*SF/BW]T_N?U%+K!M5.<(H;?HOFRIZ"7W+"/M@#W%;X
MD)9V]4/2;P=Q=3KKF8V2EF_'(T]T2;3V=2D3(,A:RX0;;.^$7-[!.&KAT43Z
MX/JU"2.I@&OZ_);FLKP\R<1HA]M2"=M_7(WV[]17X/A (/EZO6 $V1SY<%^*
M[KY#H8OFR6^9!WV/ML0AUE.]_-!S.56[FU'TKG*&7'V__?FZWN]9-/DT\[JE
MLY44$XS;QX=QW<MM]'?OB'[!0MU6NV+N]@;\")XN"DS$*E=_9%SRP\;A"T5K
M#.;,]X5IQMA&%87L]BY4GASX)G=!Q+$)5^BIZU0[;!2J\>W<B/#JT\_),*Z(
M6\;)$>K-T^'0W:F8=H((RI[>)I/B..:(E :+;H9UHYN/G&N6HFK0X^1:]B!E
MG//#XE*IX(Z$IA/(Y1ZC@75><<<WH?!FL;3*2B^_:#65[ZG/.F_4HR\H.<F/
M?-!:UV[9 \)U(2WPPQZZ18GH4JF!=6ZHKHKL4\U+UPP_WU153UEX$WYF!CI=
M&S 9D24V /6F0 1->2I+D%7#RE8FDK^U7Q#"?H>39-1[JK@* =0>4,8:PF9)
M-@UKQ1^H6!%I;5AL"(JA#*O*1+>+6RH[_+8F(';J3E'J".#_1X_@A/WF6DHH
M[+RWB-' I0M>!Q ;RE;.R^YG5Y=EPSON?A) G*1VVCU54+J<A0]9G*S>BKI)
MU8Z&:A=,S(<<H(Y;$'V*;_Z^?U#N^C;A%/M1@^!]DI']9?/P:DQT567 X,OA
M#:;D-+&OP@=Q%_<PBR6<7' G?93?;WGF]V;Q).Z<0Q 2UY)\$ 43MT.(JBU(
MV5RP;<)</C=T\%Q&&';302)B#PAQ6BTYDI3N*@.<<MNL8.;)4_67<-$H[:JK
M'B&5!9O:&6UMK665O+7U"O'\BKM=4FL'6/.E\B4XBYC- .KSPD61X8CE?M:X
M7;Q]_=LX/YFX<U$W1OD"W$>\%#O/:%72(%/82);BV*=#;_.OV6A6&Y^8J+"<
M@2@.#2+:?5,Y)--S^#(9]K3,:[T&BD[P+\C'5S"7;8YZ$$TPT5/U:C?]\[^8
M(XYF_^Y4\")]U& Q&K@%PIW26^9SE/Y]2B?*5(55XIV'C[S@Q V*JYR#KXT>
M%JW2GE6U2KGY7#[FVGCEWT+J_S_^WPS8WMC_ E!+ P04    " #/.VY8/*J+
M0WR$  !1AP  &    &%C:74M,C R,S$R,S%X,C!F,#(S+FIP9ZR[=5!<P=<M
M>G!W#QH\:' (G@0/[DZ"0X#@-KB[!0@>++B[NP4-[C*XSZ"#/WY???>^>G5?
MU=,]9_]U>KIZ3>_9:ZT^=5X67S8!7'EI.6D #AX X%X_P,L*\ E @(?_S_4:
MB*\7$BH2$B(B$CH*"C(J)CHF)@8Z!@86-CXN%C8>-@8&+C$N'@$A$1$1)@X)
M*3$A*3XA$>%_)H%#>/T.(A(:$A(:(18&%N'_XWCI!O!0X;[ V2/ T0+P>' (
M>' O_0#UZSJ1X/XK@/\../C7-2*CH**A8[P.:, %X.$0$. 1$?ZSZM>[/J_W
M 40\)/RW7)+(!*I?46@=";D#$G)1Z3[6]!"I_8/0\WQS"D1#)R8A)7O#P,C$
M_(Z%EX]?0%#HPZ?/4M(RLG+RZAJ:6MHZNGJF9N86EE;6-LXNKF[N'IY>0<$A
MH6'A$9&)23^34U)_I:7GY1<4_BDJ+BFMK:MO:&QJ;FGM[>L?&!P:'OD[/3,[
M-[^PN+2\!=[>V=W;/S@\@EY<7EW?W,+N[O^#"PY @/L?\7^*"^\5%SPB(@(B
MRG]PP<&[_V< 'B+26RYD?$E5E*^.!+3< :B$'Q-R:WK0Z'C4($3?G/ZA$]/S
M;C% _P/MOY#]WP,6^/\*V?\$]K_C6@8P$>!>-P\!#Q 'GM0+)@7/%8SQ/5C!
M5(4O !;2GT>]5/GYKY"J:->V.#0L+8OHPZHB4(VUDW2>VE;V$1JJZ9M SDE!
MC'B<QH.\2("YZATLR[/8JI/W'Y4XP=$;BS17.V]G9WC28%GV+6U$ H+W*(EK
MRH66.B!3*'8%/3]QBI[#3?1R ?$[WF-:J5I]Z69L;890_FVR';S>; "E[I\1
MN3/T0:,N]NCTZNF#[5?D7%ZMA"][>]1U\C5P@@<9$>S=#[_OS0ZLN@A$%,IA
M9;TISA6A.7:NCMY(PQ054Q%TYE9W##CGJ,M*3D4BW_Q%(R,ORB:CTC-]1>;J
M/7A'W:JKW0.696CM>E<F\+=I"$<PZIVC&ST&OBV!'!=VZAIC]X9D R\>K1/U
M#>IKV>NYUH98@_@]AR_"-S=3$42<X$ZOM"-T0%ZSG&R\^CFU.G+L_<.I;A R
M:AO18WW6LDQFQ'=?;R/V0RAF!8SKD4LLB=96K.]=YC<L.II#Y]]EG.)Z$A2P
M<*!(C7P;0O@MED9#M2_EX9L/;>N?US/Y9?W&*GU]^?[,+5%F241KC^K;LIQ:
MK]K[-?1[5SZ'V&R:&?HDY>?AF8*YK^VM :OR+X"E:RBS.6K!9MC7]V0B6 7;
M% #.C[SVP%OP9+A?$X?=UYD3]E.Q69>#1_">QSX_M8U:-ZA0(Z8()7M-Z/29
MU%9@G1;F\]O&ZR?$8,-P68:W5C_Z'1O/\$E?/EPWS38AW*R&!?CM^^"_@6K<
M=*L">,>1B5UB7=9RI^5BHH^RL^F&" _:BAF]MXUN,\),X94I AQ3UFS8GX:E
M>_FKA<._(\3#W6-($:K 28&@4)9+0V,*C]*]%=6.FIERAIE\VP.'(M4_Y>$8
M\NRS)\D>=TTN$S^D'7TOMW&BOLVU&S3>W*C'?!">9%4R?[I2(&".!"&STU8S
M3 (F,067$E10*=!#+DBUZ]]UU$I;%=ZG,JN9HW$'QJ*=Y""KF:!!.H.LM&2)
M[HGM3-<*<2R0^L+UFHQT8\?<]WIK^W*V@MAY?9041<G]X/I$:4FXC^*D/0@H
M;MS,""L'51GM0E#Q?JUTANCSDL*3\P(]OOE<9X+WM=Q&O$[MX>28WXS:$8X<
M!VQLQ(D>]5P<ZG77=7%J%VU2>Z'E43+%0[9LMN1YY^2( 7%"=($R-L#M,NND
M&#UL007RE!H6T[';&69;/-Q[K-/J/T[TAY8C4ILN]6L]OH]W@JXX9L.:\X"1
M4$O7W$[BE)_)HA+OV(<AS,0T]_C"FJ0Z\?=,F"CDGL!U.FLWR/7/9,%1%[Y%
MW=QU\XK2%+BC7K74@##6VG>*(F0C;LL .XCB6QU?A[U;[9P=Z%VES8?!T!=@
MB74_2\UBQ9UA?>2M0J("LQ6T#?%TPAOL+Y:0U[[2IP#.@3L@\?L^?=YPQ]2<
M8FLK["-AR)<I2?+=CG> [**GQM\Q_=)'?,"K8C]41)\ZHD'45&86N1Q3@&#X
M)@7R=SXW92V;>YS"9M6?J^W64^@;,\+A&]8Q/C\*FS<R?=08QCYYWH;2SX)T
MGN=V4V+;:!;<]N:R(ZRS^Y7PB=*"6]"B?N?&"/HF?CUG@[Y"/(OY\G$O>WH,
MX<'=ZERQ,Z&>(R<IP.>UD X=H4T#JD,EW&N+&?W5+:UV@DO<'<$CGIBLA,%-
MXQ="HG#[HER&E$/]RB36U'C4?6<W7F%+'YD#95/07)'>D[VQZG1RHMY%AR-5
M3TID1EAFKLJICXMY,PN1YW#-D%M64$##;)R'0RJX_ N6-?8.,0QP.S<-6"48
M,#=X5(%RY'^E*G$L*:>VFOJ6]EV-4;;@ES&OTM$G9$RB3[@XGV)_PETU$&V]
M"1O$P5\Q@ 7WW]0JVMJ6RBZ;U']E3+LQ 470._T &R!,6?Y8F5IPAKP  ^F%
MPU"1#T_C'?^FZ2-"9G%))6-.\W\%ML6MK4L[3S C=.9U>D&:^OU(Y.R*1-S?
MA^]US.0E8ORBTD[7'[3>D=B]B*+ SHKEWP18I\3H8&W]5-10CJC" ^@ UWS%
M7F,C)_$6UK!'>/+=+C%_<OAYK;\H<>1=3R<#+'+]7+VK;HXR/X6\;%18R!3)
MTKV-V.VW/?UI+QEZ)3"\G7Y$#PL"=W .Q1\(D,R[IW(9ZRUG$%:;)=Z0:8,6
MT%=BA\&(_IXCT6="-"JO'5N*$-"@-FE\X-;WR>:L&VHRTT<>6)9\+4-$>%$N
M]7\22(3:B4?B6(_&WH[%AM0$1FB6<[LM3:$8=UNR=B(MGQTSN;3NHF7@M$F%
MUE819BMY'_1;3%.\K2P2W_^-H_\:B4QJ@G:8T'-=FN)+]N_JDJQA^KM=>Q,^
M4]+WB 9_FO?=FUN_+*=R]"X-J3_!(@3"3ZK.]$]L&B$%T-4C"WTW# SZB%T:
M!&]9+4F:'L!TSI9$&V8')2:UMZNW<[MC2GS7'O508:.+3S'IY%;_'>W;-V]S
MK$<D-$2\2\!++ W2)CT#4G6O(FYI;V_65;>;*1N,>DO>32XIM(PRIA\0H#__
M_&::;:LQ%(OE+VI%SGB@X.D_+:;G"W\Q]3-6_]E'ZNVU#T-]6LL"X?GMSQ,=
MWL=WG%&A'7%^HU9H;#W\PEMKO_8$+[,=CWCAI.U0OC3/BFUP9%DSW/21+!LA
M<9_0(;F;"NX76M@^(TXW/#$JB@S<H&:9?KR1#1^@F^@74D.O5"(,1/FN_4D*
M<$X7Z)O$.4C7C GV,N\8<[/YK+8V6/L7S>G$_?V$ OZJ.Y^"'$P_[U",H6.!
MQ]';TR6Q?]3MZ*#L+5(WN?3)J6H*VP\NW6R1?^VV)4?W!>E4)0RA.521O>,T
M'L%QQ00<&YW17/T29S3.UY7>ZDG@#\DU]5':UNP<]M/D4]_;V_SE,Z1_)27A
M&F[=E'8Z!DS[BW[DQ+"J7JZH]Y(*=CLF[W^K;X:*!S%TC/Y:S2V\:9'EOE5!
M^\P4NR]?VQRS>[G$T"2-Q0BL2U(T F3'_JQC[>I?H41\45&C&#%?])7IC0R3
M@V\29> N&"<P:TJX[O*PEO:1JC_,L%]M1#;FX%P?GKNBGH&D1!(R%!3$F7]I
M&%#SYG.71O=*: K7- E'V .B^@_DRI?M&]4KGIT..5TCANL6:QF7<1U-NY,&
MCM,%U3,5O&4:C;4-H1-+:*Q8[5]QS78VL87H<P9K0:BN=9M/3,_X[Y%;=CB7
MH4WGM^*<HX<SD>N_X7_;LKJW*J0$,C9+AOSZS9$_1=4@ZK@\'[0'&Q1N'G\!
M^ G&0&TEP49.]1_%X_G'MMU)][.Q #=>[:B>F]$*_ E1S&,29 5]S5FU,^_B
MV0E+?Q/AW:ED'OMWW48=936U#5#QT"OO9KOR_%G&Y'59N@]!\NR2Z/ H/Y&3
MXB='*'\(POL+V^5GHXCZ'*"C2"!Y,B;SES?ZDCY\LI4KEW%O +=P=^7@+%,(
ML86-HMBC;>3\Q&H>YO,>>.:',B: R\IL,2R\F?-,B!6T6)]_#S.LO_H(_HL^
M>B($D2F4/Z=401?Y5ML!0_+0$%A&^?.Y17&2!*=41_N^HHD##Z]C\M<7@ U2
MKK3M+W<S8!U'Y#&]?BZ/1:&.=CK0)\->D!"AF];W&;T$;;<T=Y3[Z20S%D I
M.3'RH+@&QT1%VU%RS31X_.PB 'U9UMQ)(6@L9.,HD&_5KYK<0<-DD# =I8!'
MH?'9BLZR<CW'6UI==VANXR)/(U9H83/Z9$V@-.#V>ZM;\9>@(%92+]A?U*28
M[K7/8)&230A=5XE AL)%U/W*%CON"6L2-9L\%).DY7_1^PDF.K4PY[P[; ^:
M8"D*;S<%>SL0'6GQXQ$VQ))I,68/:GW^BM\ZTD*X0[S:H:S<UC.,4D2$(@3L
M5]!((<!)4/VJ8@T:$F.2J[][,W$$?L=.SXA8S:B5\+DYH?7=IT81.Q//7>FM
MX'^/#F#/S;K('U5\>[^706I\=6]WZ7XJAF*T:"(>R9(.&SM)B!K%%PMM.B]$
MZC'#H6*^EY;I,+')1IBZSK)8T6BOLSX[7:+D$0ED'W:*-L6J"1>DB9>E\=*6
ME )^9.,']3C"0KTK:,1O"ON5$%,90;Q? QSQ4G=7FM_1B@E2S2U.NEI-$=#7
MU#N]%?>@' U4$O5 *?Q!(HYUG:7]*4ZN?9;M]/24-IF]H$%[_60S>EB.U+ P
M &/!735R/&J+'=(9"Z3@ZH?C/M7AT%<+-B=^K*[CHJ,IIM\$#2$T *[9U-,B
M3%NL0M?Z*+&H#FK$B4=[>W*Z^:8/N6FDR6K& =VCVHI8NPV]=*R5%%PJV]8T
M5$HXHK:CIYT8JRL9H8E[$V?2L>PQ/^A-QOX0+XYDM<%% 9N9>#,H_ 4P!:]]
MA^5R)0A:BY7.)!KYL^R*")W#75C;]5HW2N$@5*EPVRQ!&>EG(#9+S$3'GZ55
MG1Z&65^[AWJW@QRNGP$I@SS="(D>1 %_0.)O'$)=*]Z@;=>%/K]/R-"Y"5=>
MVHZ(%3P:UF]T/A[7G!*C'"DZYO?*ZK6N;N<9?=]0$_1=Y2R$KM_S0&E\?$;H
M9@0XKG]2&WHU'V?3'G^:XNVUU6/7GP1+GF<0!(WYN>]68OJ$1+L^W6G_&H&$
MWDP/"M:OM*$R\/N9IX+8:Y;RT^A_^GLZK',:M?WPUFSNQ"W@H3^ZL75I\:M'
M%?/C.?7U %T/*R>)ST0"5P2.MM%I7WN;4K/Z0I_/%XJ(Q)"=8WULA\N?4==(
MS]3N]WI=$OE1\_ UY$T2WW+@ +M]/P2'U#RK=!MC<ALC!>S.P@F;2A J (7_
M"&S=3IJ$),4$TQ9]N8*G5:=$Y'FZ0!2G#]O+]64\QB%F]=IF.+O-7[/7KX@H
M)]&?,CLI0%\@%F7@MKAP*A8?:TX.[1-<AI6QFM[?CW<.K08YK:)(KE2L$*J6
M,M@+( >ES(EHP- 7QM ]99S*3QAH.);5&&+[];5^*%0(V*%P-/PHTGC?NGZ*
M2>E6B] $5Q.(XIM\N=!_'K6,,ZAHJ@;3];$#8V"PEO77=[1-G_F.NY(/L8A-
MIN[IK*"3!: @!D3/1&;F#%2-3IW:NUH<,5<E_J-:<H!B[30U+YPUH/*^ .@%
M1E(_SXJ>& +NSJ*H/H/L)!\E2 Y&-5V,8WQ)H-Q'QHMB=#4+9]_3&5J"E%H)
M1+ X$+W_*>V.T&5J?TX'T9+;6A/<XM+FY5NR +UQODB>37UQ2ZE;Y[W&9+9B
M[R&^"8Y%MNE7=E@/<LYT^:P*>UR+_5M1@&]@W5Y=$ZO[4?K,G%]"IH:0J]>S
MWXZ;$0TL[ 5 K0@9F&C86Y&RA6O)]EAQ.E6?PKP6@9YJ@GB@\J.&';-&?8:-
M<U(-M09R?U:&:PWTPU0.*"6'&62[Q>I? ,KC=>*VGS!U55KP\QG-I#6BA5PP
M0^<SBF2\I^@Q^=9"SSDJC&E 6XP&<N/?J->8;Y.RD'HQ."K:;QW3-N@6U#T"
M6,)GUV@E;E@^^T%0K 37RL25%XK 7M$D GA6BHY.A:0A?FFA$NP;U:=&/F!#
MA_ZIXS>X,XPS6]7>F4<QKF36;S:LZ64"^LQ<JR3\198Q(YK&#$)4^H3(C^-;
MN97 &\R)'Y'1J^FQERCKABL..S7SONPF5UEXXG0K(\,$9.=!"I4>Y .M>QVV
MSHZ[BJ8E8],RWY8X:Q"B;\\3D5F7.1J$TRH*8H5N1K/12R%]74K)R;DPW[Z^
MNB^M=N5:7 9_;WG86.M%*OQUYEKR+W8]#4)[XTLR+5N>-16EK,E7QC>@',ZN
M3&-KS^=3T'/@D146E.<[940#_5.QG=; #K\W>J+U1D[X,@73< 9.W5ZP>W+,
M6[MYQ=#PTVW!Z@X2PT^*"L]CV'Y?ZTT9& =;LJ1JQ:4PUE".?9_*/-83#N+4
M[F1;-7--;B<]/P&>T*DL-P\649-^:,HWM:9JN2XH_IM8G^';Z55UO/>AP5SW
M4I@CW;JF2B"<XV-IH#-=?$N,KY$P=+H<)J/[O##W1SJ;/,)N+E&9R9[.X><I
MO8L@S>8-S4+H\S\_:G8Q> \MH23I65<?FPNR%>7&F>_I8,$4]HS"# I:YG@J
MCV_\.Q8=")L<^;;>A59JNCVN9IPNN27CML4RC2<B8^5FO[;)EYH(SF< ="7V
MLA? >,\B[W3,FX%051>?[KUJH@39$)^1J/R$=@3^$8JGNZ=-+;RQ=9]I]@^O
M>RWQ&-!;G.CZ8W)/7;R3:W)%:287-H0^;KEH,U=T;=$FBV9C+!#1K(NAVH+:
MA_&*V-S=B2:!#XJY4<)SO>%Y;E;YFJO!\-%^3BWL+;5PQZX4$!E7C#Y>:S:U
M=]HQL]S5HI(HQ56B,)Z28P&9P5;[AHI5CX K8URQ'#MO=TRN+U-/*<LJI!_#
M@T.3[] %APJ]^ #+HK#ZXI@21?YQK!+&U7)4D<S,K$Q0^^6 L3DF*@VN!\UM
M89X_JXYUBI<&,CFK+-L6DWNJ ZG49"50QO?7"*0%L<]Q!*-R@)0+)07"P+K7
M5NN'"+IT/O,_+7<GNYHJE"VA3+WIH16%UF[KM#,<?)1Z4QLZ>D,N,0QSS4/G
MIL#CZ*3J@0\V\$&>.<\?/>1D,V6/-2Q0H#F<>XB5AB.@IAEAUA)!7%)=50+)
MU&-B'7S<^V:5/X(^54WW2PV;,:CE4ST."-QH]1N']<$R^C.)TTIG!4,!\45#
MU3)[GD)$#A?S)<G7AX(Q#;A$PA^K%HV9SWRSP<C:7;5N^-*WMK9O_@[_V1F*
M'QUT1($$34K(57V&ID9L0;1#^.R\P--G]U@?EL[,FFJB1:99HN-_Q_/$J:&4
M5 IKP;:^%MJD+GM..Q2VA?Q=Z74;O V/3RM,8=]!CB'2(49!\C<&DP%1 S,>
MC2] 7_P +\E[C PR!([X0#D]IX@&!LRN-O4TGGJ(Q%T8F5WYLV#;W%EN<S9X
M?JTJF532JNUKV#@-Z8[))P12,D%!IAIPJP\GN"JH(49O4K81*AV_O+9JRZ8G
MUQENA/OO+O]6N&G_ZUJTRWZAJP;<KN.:Q_J,W -[87D9BTY&?T+N%S2NW:<<
MRD6*OZ(>9,7NL,8;40[R_=D]Y?J5=CND],':TC4$IF6>2T8Z=)FUX0E)$>T*
M50F*U)AV)FLP^1.Z[M5N!]<Z4EKXQ"*HA2?GQIWHT=' 9SU,6/3B<%DLUZ'<
MI_2NJ!VOW9J]S7.%D$L0M/?^MR4*2K3&"T @\A7*^@F6ORG*V>N+%Z0/B<T7
MYF@K'6'6JI' 1B4/]=AOHL&6&Z#& +V.,X+%;'<(##SC!7V$=.8XE>3:J'ZA
MK,IG$:+A&J*XW0T?9HT$YB!QP0U=F/I/I<OL?!;-D<P[-=(II!K,W\R$UK\$
M5Z/XO_^0ON_ R^YZ1>E&::S4D:&6?3O1T%R77*EJS@^-Z?%5+(O75'H?EHVZ
MZA,;"6P]*GB"]0T=)&U1]Q-1HMG',YG1'>C-Z@=DNQ$A;OMDB-FLB8H*8*Y_
MII:)6Y;6+P!H6PD)[,>6%=ERM[T1T%;TH$,?9Y[G+Y*DXD B5N+LN&>CLOX)
M<5A>MVR%AJ>O^E,],4.^>J)[LM!V@Y=,J#TGQZ-XT7BQ)'O#9>\?JS\LAOH4
M^U8(XA)B@?4'O^%+CO[&?641ER'W\IK[.[Y0^'[I'(C'^?IX\&9U;_$SG9]0
MO[<28M"*OUCR9=R  S+HLW+,O5'NEBA!7R=U4[I=DQBGX<PJAGM(<*W(9T2.
MWTB*2XCQGJ?'&_CTD-B2?/ZX;>&-VH/T<G;"=9<J^ZKHE(^;@8*30'1D:^,]
M2LBC.(;A6*.74080*-2 (AC)"Z=QN> /B"I:,O]5%&3W(3!>&#XOXC0OTVYM
M,K[4OK*4S-5OS#&UM?9TY?@]]1&OBJ$GW5?L(02P%S_Q%RJA;;\\W4J(7T&A
M8 NV1]F@?"H+A9)$5E6X=%""2*S2IVV$'MCOW+RE1)$OQ.Q:CC>BM8S#F=K$
ML6C^M:O:4?XI^H#GT2K:TQU? W3OP)=Z[43'2E9PGC-WO #4%W>X)6O.[G[S
M87XE,-LO4,I')YLW+@)J ,E$ O*.P0[@%9O=D ..P]&S24EQ4G8OMH8<JJ69
MV)*'QDI]*X1CP]8!^C?W1>^US&=LT\_[#KY"YL8KD\L4,%6K5A2^))S2\.N8
MU"SCB(Z[QB]E>.MK=OHU&J#.629H ]6 /4*C,A\V7LRJ4=.EL?AAA+S\@C<Y
M,7$/2) ]9:N0*X3J>U5+Y[.T<H5G6!CH[=??'BO]ZS21(R8+?$'HQNMGIOL%
M<HVB99G,*I[=9'R'[XH*N\(J0^J-5!,E60E&XL_WA6Y(JSB@XG&\.1@>77U4
M9&;M=L:&W)_,;FYB>'^P8":QQN()FSTI5[BJ:C*X8IQ6I>NU/2W<48R?M66)
MS%_*1VM.KTF2+3J]__#L2M3/0S3FW.J_C23QO=+)@VXYQ]&=D%E/EUC8!>DL
M*P..#MUIZ5$\R^*0P'C]T\W24&(J3WGC32WS&E'G^[:V\Z^7F5=KL7/LQ]_R
M24;'S)GZ'+"L[L/"78MY=:2+*G[;*8$G1.LV2J]D]O<VX[TL118D36]\:.>7
M)[\T: 2N,T0R:\#C ;V5HL"I-O$:F&UBP!_$4C*!,M,E#\F)V*AO#(,T;>\'
MB\"52N2VRUCS]2]$NMTY[7_'V\D$[>IZ15-VQ&BH>[U]F!,9GPSJ0G\TW(RC
M]-C76GBT]@8K,ADURY7S/M0J+Z;NL15ZJB!O(@OVQEZ?K>.$?)LKP/,WQ8U7
M+AE^ 8X7F+9.O8:, Q6R:)^%8?A@!6G7$8UT?E;:'->O0>>&1<$\]'O2KDRC
M@U-<AXFBTK8<,D1E=K?>26KV3O9RG(KB"&5YD1=5,9W\[1#9^N;GN<X9ER7V
M/]0'_!BL<C_0/6W,331YDD(>AE#@:@(8+4O_&:1&6$)%PT+JPZ;76<<-[<O5
M;OE7%<GEHX0TUQZZ?M99[BW#;5Y7XO2)L<!2^2N^<URUG-G=V.L4U1./"O&?
M39>-U-_I,^$-AL'FHD"P<<#AD>H%2 @"YSS%Q+T !<2:AYH[.76G>X5^CE"6
M;>T9=9E9XP$GLO+\5A)6O >L%"X:3:R$H"E3P5,%Z NP+=8&B51&T/=P[A&@
M$IYM5ZC$8GT0F[YAM3:-EN2]& []0L<]A!!?_A=;Z*L$515O'FFV-.;'=]_P
M% CB)(28EMN-G]_,]/I=L3U*O0"]&#HOP([-]HF?-4Y,[9I.X>3)*)@T-TFC
MN:G9XU&RB$M!"N5OLN1/A+<TYCJECA=M9NHN<<LRVR%CZ32=3VE\#XX_%KZ]
M "-0[,QUB2]W5$:'VFYG @Y+L66=_C2S8F]!1'/VCYJN[I"V07<2*I80N^L6
MZJV]:KUGOH<RIGMQ&K=[S1AQ<&K/&JO15$.9>*@O7].<"RO!'^M4QT?1>81E
MO82X=SA+S0:.<<Y'MG/BECF1Z7&#<<'WVI$-<3@"(7S6^VWU[?^6-PW(=2O.
MS)L2W/UY+C][:Q>HH$3Z]>EY*#^'Y(1WP21MJ1]CC"811QT1G8K-=0G?8Q?J
MP/,,BP2=V,@S WF1K]E>MYTZ:*B]>5J9Y6Z]1092M?-D;M*H;U_Z84$37X8;
M$X55*O?=G[4=$ML)TMPRI-;CK_KFBB%8&5->Q(GF@JD:5SR!,^W/::/GVEA5
M9*AC]+&)V%U5A.#C"^#Z+T!+_422MF5-9LLRQ-7ZS*+]'SC;-AK%S7V8LI=R
M@\8!C!&S,9!^=/ ;!QNV96IG"S6^\;VP T<Y1'%H?)=XCQQ5["]X&GG[!FH<
M^P)<:#X#?HMKKB_ 'T/ICE)_],MQ"^K(?<VV#YH;0>I?+O5/1CUMW690+R_.
M66F0:A80B%:.]!K^)-C/&$Y2L!#&D_ES!B024A4MMZ_<>#_E/0H_2'N0B2CF
MZ]KH4=AYBR8NVB:PD;#]X\= Q'0JFJ7*#=A5!!1W0)8O0,X&O-\FY?FKD<H?
MADV^ .*=B"] M_#&L[!1CA3@.9^$,Y!0JD>I=-X34^19=I-<W]"F&^UYUT@<
M[[\XP<V5?J7'_!L^\K^SV%;-4PN[QYTBEB?VVK=.Y+,?6)=F&( X?8@%!U1,
MOH556.)$B(BE^PPLU=2W9GVIHH#?VHG WON,B%O>SW+6,^BQLU?C9W4>G%XT
M2!W&WTDU)2*]3M"5_CG!/EI:.L(QU  >^X0"YY/A;;!Y2_M,>24?.1<6F#>R
MBA3Q,UGL>QFRI7H*C6QF*'+&5@?G@]8%,O=@;!Y)DDT>)\<^V8'0I%$R7G A
MXU;;B=MEJQW'@M":>.\YI&O++2[WP"M3S^4#4>="9U?P1"V%>=8"S<40#;S<
M!+(B_W[?<FHL+ZM6>RP&Y6?N23(K#]E:0<=$=UR=30J.32'6I'TC$BA?ZFG"
MIL-IC+#Z'"\GXH9GBENU?FXD9.W3.ZV6RX"'WZ8F=%4B>$8#3*':FM4Y7YK:
M6F,PT1QNPDQ3%]^CB5"7G%DOJQ9OLY:),UU>7BW.-?>BK0F)&L4I<XIS8]$I
MYTB'FM+?52_&4 BP$(&3Y58'4HN_UF\WBA[GUEY<ZYXNHS6M"+$-X*B@J/@V
M9(.$* =C' H4Z)KK+IY=XLOJ2A#-@C+-G(1C63\N[49B5 38I7$7V01B4"M/
M7A>LM+6U_#V9F]]+,M99/5R.B4F>5A#-8)D(N##]Y@ZL9VIG''@]99U>3_SD
MPW"?^U33W!0S](O0!'XTT_\'2U7(5AV,"_("#(K10I7*Z%O=E_&MS](9/>'O
M,B3?2NLS=&]JYVP\PD,FDJ L&V#IP-1TY7!X.=[$H1^#K)>T.VCY0IMG*+M#
M2E[:FHF161E1Q_OF=YX(P9Z%V Z* GQ;4.0L*,;@FQ<@Z*R*L2%)<I:FV;SA
M%ZM!Y1J8F%2<0WFLJ!BAP4MC4,Y^;)P9_05@88FFV$_*Z;NJ8H"D]OYJYX0B
M;^LWM;?&G>Y6_8D:Y]#;W,25V\0TL9Q*OUXR23P:D(<O_RM?_$UHZ'"^+B1]
M[WBV]$);->I6^[AKXUO,T\ 8<1,211OR6P_$/W[9XB-5F2^ ]<;B?-^-/]=Z
M'QBM/LM(H9G)M;E/.J$T@":FIH6T>!B%-6'*M:K0KMR,5I<AX1- Y#@BXCQ2
M'I5$%>;IXU=L,(04;%5W3AY%619J[1=&R14W6*K'SFLVG1%<A3/JK"SU[[0^
MBVI]@M],TYB-AU^N>W#[3(:QY)&M!JK8%4M458F/14R.9J<W0/=7@7OXCW#X
M"GTQL_Q/^TT\18A%4P&L[$L:[]2Q@\5HS)&DFB>UJF%7\.I0.;DSF5K*;A,R
MN5<LU\(&G\U5WI8I\;6[,,N%7XS8NU2Y6=X*_GM,F-OYJ'?H9\R+VE6IY(E-
M%5J++YM!_M@\1C5&AML=3&JSOG3Z3Z$SFA<%4_M-Z6?=^C^79YC.PC/M1HY[
M)BFBO[4,BWX@^_R//A)56Z6;JGWF6+SO7D,/.^#/834:*(-5IV*;X+TU?QX2
M>?AF)K;LN4%L!C1*H6VV\[6YB<7A/DC:'M_1*7S_.%'Y.2-<_*A07':IU5F"
M\!G';[@'JOP\./0"3&.P],)V7P &TTV2IYA4OWOS69O7?J7HK AE..\?5Y"=
M97<U_.!'-/RUK3;-(E2"[7O \I&L($TLCHI-V!#G'2LUT'7RO>T%F.'(EZ":
ME")408GQ'?&[D-E[ 6HR^OWNO3JJS*O>/"6^$FC<^ M@*A#^ EQ=>QN-2B 1
MJOY74A$\&/*,;&Y@+\6PJBSDM\T]IKF,,[+?IJ+=Z ?VTNW\U0;,PU63,04P
M+]=!^%"+B&V<T ]("V']_Q8EK8FJELY,K?8"$OFH]$,UA8"2B2E4FH! ULBG
M,M"[*H^Z'GY^/:HLU_)QT4?5#(]O3:Z-P@S]^V,QOSCV5 9DA9U0U-,[7RM!
M/,@7%>;:+K!E)W,Z4:U0?BA&W1+Z]]R[]*Z<C 84_Z3%9_0!-Y\0[IQ7.P9&
MK0TU*H(@J,V=<'+.]#O8><QKM=8;?V^I2V=,0,2Y^#@M: 4-,PBE-_<G&X=2
M1XO1Z=NZ0_4E_2@#.X;2Z-\8I]O-J?/[*@^#-OBJZ1]6Q!>/)4C$A%_U@38,
M[O47<EUX3G-]<U-ZUP3VK0-GG$>_ $#%=16V_N&\'%C.T)6T 2FA\->!^^[,
M\-)/N*CH,W$7+^CY^CLH(A4!9**JTI ^<<4ZQ=GH;P)@F,C+T>,D,4&XS>@O
ME!/U N"!$"!U?2JV&WA\[#RR_V*F]:1<2X8Z1 YY&F3^*LFJR0T":DH 8_OE
M5M5 %U+5P,$SB=1O0\[([>J6!0+U. 55\QWR$D*6"?$H1!=R;_M)HN%CZOI/
MC[J0ALBC%Z#V!8AK5_UMZ/DAI%XO)#1-A$.:ZMW'CG]D.[B.V39^2,\SV:S5
M4RD,3]F^C(I1&4F=@BZ/SB)A#@*?_OSP.,("?.2D/(=ZQ*,/H1E?H(CC6SZV
M/?>A8259++?R"XD,S;'&M&0]3[.Q;?)*P<Y&<?^S@/XKS6 I?PT_*>%*T<ET
M2F&K.LGO[U$M41[KQ6>J\)Z<>0Z%BR!X5L)(-"&[(4\;H<\+"/HK&]8[$:<H
MY&1H9UR3Q8PE."$;#I#*I*T.T"B8CN(=UEZN2YO> >?Z1FQ&JXEVT1H)_PSJ
M+S0WRN!,D^U(:)DRLL>QU,P5Z\'UZ)JS1GU#3 .&U35MC8'B38:;*P8=T1Z>
M4PL]9H)_^]>UE93[-Z6)>E4P<=]]NZTN.!V8UL2*_#3OL2&37%UT83NQHZ?C
M(,\_#6S65%C EG@DR0)_4'<VRRL+A%9\9J?L]QH,X<@[9SRC)+.,,QGZAB,R
M8P<2WW[8!KLD[NWUDB^>!8OY_JF@E9VDTV]HD0#]COPFC;BYF>F8,I33G4/
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M[3UCQ]>WRB:@S?X^N Y?2W0U>(2>P^-/T2AQ1=E%UU'7YMT;!J+6KHU[+(A
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M87.2X%%FKEWA#^CS/Y?B^@R%GZE]]X,)/T:<J7;HO/9_[7R*E=P7'$1R\<,
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M(YE\WUZ//!0[,!A%Q38ZA]-\0UC\)ZR _]UT)7?/"3:\'"CU.-RRXFSW/;1
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M(>*(MT."W>0M2Y4L,.+4=B,C6XWU0B-IS&S&!#+15#5S>1&?I4G352_,@<Q
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M$V,7]>AQU*Y8O6.>9P#CNE.8(?'_)@!02P,$%     @ SSMN6+=5Y8W(3@$
M_%\! !@   !A8VEU+3(P,C,Q,C,Q>#(P9C R-"YJ<&>TNW<\7-_?+SIZ)WHW
M@N@E1 MBE) @3!(1W1"B1F^#8?3>DY#HA""B&[WWWDN,/D0O,Q%,8G!\?\\]
M]]YSG^<\K_.<>^_:^_W77GOO]5G[O3Z?]^?S6OOFQ\TZX(ZVII8F  \? ,"[
M/0 W2P!U  $^_C_G;2.\/8E(B8@("8G(24B(22G)*2DIR"DHJ*CI[E!1TU)3
M4-QAND-+S\#(R$A)P\S"Q,!"Q\#(\,]#\ AN[R$D(B,B(F.@HJ!B^"^WFTX
M+2G> <$( 1X/ )\6CX 6[Z87 +P=)Q'>OQK@_VAX^+=C)"8A)2.GN.V N /
MQR,@P"<D^&?4MU<#;Z\#"&F)Z.Y*JA+3O[ BX7%GD I)R2?E5:ON8GPYA>9[
M\,8CE(R<B9F%E>T>OX"@D+"TC*R<_$,%]<<:FD^>:FGKOS)X;6AD;&)M\];6
MSM[!T=/+V\<7ZN<?%AX1&14=$YOZ_L/'M/1/GS,*OA06?2TN*?U64UN'J&]H
M;&KN[NGMZQ\8'!J>GIF=FU_XL8C<0&UN_=S>V=W;Q_PZ_7UV?H']\_<?N_
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M^.[L#01-B$@EE)%7NYA7X8EJK2\X7-+!2#Y=#P01HM-[0320W;^)2>4C93<
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MT=-. Z001T!(=_75"_=_F3K\LGS&\?T2.!RQ\TH$D8E-]R&3QONK<ZLZ$VX
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MFJ4GMO-!:[N#9.9RQOGGZY8\+\M$;+H:7N _8-V4/'D[?D[?=]?LH]IGPH6
MC3\[[U'IL=.F6\V)BNRT#!2.;V0W \=?-0F,#NUP4WI]3Z+#GKQ&7\1X,W:O
M&?>$<2+JIPV4\HQ&"TF><8[RF0]J,@-.S8U@TIB7;L7-AO<0G./B:YN0N**%
M5A7G[]\K#B=K?B#!'%4?$UYZB%,6J7V*B<&;\",9_<):5HQSP[0B^TN%9NZ^
MU]:Q]F4P9/.:'(Y-0]L0M(9R.=SKH:\3M2-,^N0S"7LU:SOG_8*2*5UV\&E]
M\/"+<Z(/G^-HDT3_6&>=N4G)C\KF,B&,726R?O2)99@B9AV'^#R$127I%#B.
M4WX0[^)S/=UNZ:BI-BD3J^PX*U6>%J!WQEP,D/.UY*K50VUZW3NY4]1:G3TJ
MND9@W=;DA/T^.TD/>)7G?"NPH2!6!P48%Y!NUU<V=<3[&_M'?6?A#XM<HS8[
MGD$6_8WAV)[2,-'R8@T^?K"P#.4K_$BWL<:L.T=TW_XR78OC_7:0<9J;/Q2C
MU_EX),Z=:NPJ5_'#B*&;-FOK&)0^WW2P[F2%-*";OS+4O0%4-CIJ'4+[2S%.
M?3X6]UK23$TOJ4B>S^9%Z60$R(\Z$#)7JWOUQM?$6/OQZ7.SO!I>T/\*'3!I
MPM:_FS^YU.E9$!\A^5$?\JY@Q<QOJLXJ-FWYM5=RJ6C)JSNZLG N; KUVEWK
M\-5]M\ OEN\TJ ;2$NH\?WTUO2IO/YLV@X;:PZ0OF)HKS\/5_HBMZ=^/H%4S
M5P?I5M;1R84T-'&P-?T\<T >.1ZME;? NWX128^SG?8'<:=KS9K+;,_@U+@,
M,G4;:\?*,\I1/-MO8^(#"N2I-V9/UA*^.710MH(WP8S8XZ=G#'-B=3HZ%(8\
MA@VDT[4K(MG=M#ME?NY6D\5$>E.I(I[ZF*^E5H$TB]XR<Z(9Q+]R6%+>^M)P
M+V.2*;[BPS <5-_[M%/,<T..74]P#ZQ\2UJ/O-T)/1JS-.]K"\F3 @CXT'[?
M#RR_/2\^XIMK][W,(.);2?@K6-!(02Y8$/S_&G]R46S[&&SNIDS"1()+7;8R
MJD<%*N'-EZ:C*WFOJ5$KA0D__MM@\(,30J;E<<#F7NPS@@P IB,\1Q##L49>
M)^252[VXKUUK8?IGI&3$E1(SX+;'V6L!35/G&%;JHQS "R:*I/*W"X.IP(PW
MQ)A-G:QMD0E9<K;+C7#!9F*11KP6UG[W<1'+WQ4Z&S2XU$I2^ _^A1N AAC
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M;A>"?8W.?UC_\6-+78=LA.?)!$G0Y!I5*[RLIW"72V8*(?;:TD2$Y?@#F)M
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M^*>'E?,_+6RL#N/5FZD\YOCCUMWD]Y4P7'?Z6()7N)(,D[EYG(+9'%B@W4^
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M@ 0#!/D5$?PF A3EDL%.H%]P8GC @#$:> VIQP75GG?L  FQ#C?752';+_$
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M7_-%#--N=2TS-*'"@H3DWA0!24E; R>-0Y&[9M4<J2/WQX\2O-\FJ-WK#N(
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MMBHG"1+],#>YPOYZX?KP:)/U7N/I['Z-'?'^\!6?UEKSPNVFJ567>KCQS\,
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MW;WN8;EK?/>^7ZE<7W>KJ$K+=%X5;*H6I,W>[<V;(O%MN?_(H4BIXPFM)A[
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ML27[7\Q:K]L_A^+^I%L_/0ME70E=5A>^"7T"E;DNJ^*[<//7N%'%^RWOU_"
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M+$D$7U!MR+T>=XQ_MZEWQ^A]>_B#"ZUF"_V#E,YC)F^&6.!3M@OS'\3OP#=
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MH, B/IG3&%*VK\P:8H(^BOD8R.)C^==BZEU3 ZQNH4V6YW[UHV]2A+]&-*4
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M-)E_*AL>!5&E7Q/#;_"OZ-N-&3',X\84K6U*/@<BT>97@(B11;Y'J$#/53S
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M>00$U$JEN0%+XXR3[JOU-=)5.!D;T78^*B?C(_DDJRM8W#:)F:K;B;E_"F9
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MF+ADGJ@EXE7#&7O2(RZTJI76:&1CO$@&^:=HCHK.*Q7Z:$U.M=BA1R5L_,?
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M994J$W;7_!&IS[ZH]%V2HG"Y3_2/TJUBO47Z<MER05[Y;18$APLKZ!\ W1^
MPR@;\<E7@FO9\HZ)6KMG_AQ<;U#41U*=WS''E:>9;V@H^U&82_T$\=IE+E%[
M;27R2I+@O=9^?9Y@V7/%T5#7]A&2$=Q6GT$5[/4&7VI(:E7*C0E6/(P^F^SY
M V@0B&ACOQJ7_P,(;K'S+H*[=Y][1\ \(^MC!BNKI2:&; X?V60!3/D4:3S9
MD7MDT&)_(P(DOZ/!-^U]2] ;#X]LWY& U>5'H7:Q:^OW^>]$?WVX^,$F X"7
MOT_2_V\]G4!)[2X)\Q08P\X#1O^_]MNMFA\$A<^^1CP7KGHT2M]X^,2_G*9
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MOKQ5)>4<(SW^Y^++D"4(E]R981E3@)V>C11"3R_/^+7?_T)B(&<7?U]6><D
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MTW*4. \I-)\ 1D0H /5Z+#G4OM0<#7?)G9PSDP59G3*MJBMUL>Y'V?.+V!D
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MV$_17NDFAL5?WD2%-U1Q31KS.W/+;UA-5E_*O]T2$9<!X*,O[^HZR=<P,_<
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MU(WNA0M'<TO8;DH*&\U<^4AZ])[S(^S$O' ?=W_F_\89&RR&%&S[UPU&AGM
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MN@ :SG5R-;;,\+(9\)P\&7&8:!N@DO8POQ4PD![H:'*G^?L]87K7:R2HF*T
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MTB@N]]&AG&BXR5#A'U1[]/-)!:><E!5!I_;MTO/\Z*6+X$2$BJ*W.EZ0@6_
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MN"37>YE=<P]@R5R_V;@'W#S.)9&X2[\';*]T4MT#EFJ*[P$' NX'5[O,M?<
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M\;K 3M*A;D3B[Z?1C.[F1;8+![9 (,4OG&@V]?*"ZRS @_J S:?S ?L&G?>
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MFN=Y5;_J);U-%__4U&4SAZ/N[X'A0YHY[3M?-T,F$Y98D<Z(H9Z$<":I3D1
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M#U]-A)7X=ZZ9SV7I @!..3QQHD3+7I)S9H?K O^\A_F:!)KUTL$T[(Y2&A/
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M'KDGC3#8BOA ;,$M?YGZ5IQ;E65E< =PT1? .4QO'LPR,?U6>:DF]_@@<?Y
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M@6R+1!/57+?%WA\68BGBC>D$FKZ;M3C'"I; XTY] (3'%CX QGGE'P  ]@<
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MK&K_^(_%,JJ 2UKNKX_K<G%=XX:V;AR%0SZ'W%@G=]=%.'XOW\$C[-Z*$QJ
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MMGN/'TD]>GH[;Z=N2.02?YZ#1.^-1$5]71_SCX8\1W#[^Y%PNJ\8&QRL] 0
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MC.,-;;09XM[ZENDOZ2Z;1XBD^<9*RS@F0YCNI8XH[2*+^']P\AS!Y/J%8Y#
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M9@:;#03S.)J!#).YG!?H:$PF(\LZ9!6MM92>D+F(*27EK_"+6J&PX#7GZ\B
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MWX$'WCCQF&[_ENX@^0?6',(#CVD;)W4?UHC4_&@^X208XXJ]$ E]E:B0E[F
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MRKWL -P*UL.F@!B.A9H@YX$_L?ZV7N =KM1@5NW"X)[N 86JLJD831>PN[>
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MF=+S" Q^Y>4?#[7S&;O5[0%VC48T<7<,"RSLZI 2#KOMB(*5/^%RY&-5 N(
MR.2,M\22G?X_O 2[J3&NQ:D+="*TL&YN,:KTK0#4Y3S>>%(HP6F[?H(^%"^
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MUO41<1_"\%Q\-QA.<_!0F*7#K:$I5& >3RA:ZL#PE+%[1CRM],TA171@\)Q
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M#8PU?IA!A4(I/6X1@\$7=>B 1UK#RV%;C=99[K7*&D4'V$D!OI0#C4%^? P
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MLJ7;3.*_DJ(56+,$PV['REC;MPCW37SKNS+I$?<".]8MDA<=!R0!)2^ +PT
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M6M,&SN344?[D[+SSVXG]@LP5 )!,]HR-\1,!57JP[:J?N>59EP-]<S@%7QE
M(E%%ESV$.C)<4#8:_0,D*5ID-W%)5CR\@5]JL8QJAP0KI>FM%OX2.;;@N6/1
MB+C#4"O\4^5IE;F<6W8JH*4SA_ZBO).A!I$>H(TD"-G>:=[^Y(GX!=DG]AK>
M]T=DN\1,=&:==$'B)>!]344#&AGW-__ME,3_""Q1&+K^BD?'8%<"7^'#Q(31
MNTF&P;FC<D6RD6_!:!*UPQYM:W71FY+X@^7+*T IL4HIJOB_^[4MO\3Z^CCR
M8>+2<92M7MCF=Y/==5GH9\<C,$^JZEY"1M#K!E1%*S?T\-]Q/ 8!6V.H5"\
MM"O*5AYJB34U9Q!-)7.=Q<\RCD1149X_[$&_G'LGTT83UU1#!+(X\ENG\D,X
M"%6D+TNL KE0]GX?/Y,@24EV?#C53_/O?M)UP%\V/!"H CEU5Q1FU-DL6Z?;
MSD4=E>N<)_R-&\R(PG).:RSR&S>D_B?$N5VK+9VQ\ 91/LC9!*89,$&*PW##
M?^)?8@@<$R'50Q&TDZZ)Y3P'I#,)=JEEOA*=E'GOPV5K>O8&!FNEVM'0XF1M
M^\\P/QJ1<4 <:I4I:?_T%JY(8?_MOFXBT&%B4GQF)C<IPI)7@A8_CZ7)AH7D
MS,JEN_*W_1+38V,)] G]'G" $8>A.*(MW^RX UOP<1@_];'D"DI)1:?_>.K*
MWO-3"R_5(^I/?"*HYUJ3MQOPI?LL6RY(?YFQ"<AM]+RB@_.>Y0+QIU5B9V79
M]T"2U(=A @':H#314F]M946)5^*83AQ<I;27SB_QN']<)+,_U? 1N>O-]U%H
M2YL86/$&R5:M=.ZT..S\':X1[!NNK([*,P^5)U[]'_VI@@(@P1'-R_">]R;M
M_#::<<;ABL%6('V](?S-P'=9MSRP?=I72U [$G%@7SN,G6?H;8KYLF?W8+\?
MS*JY_G[/VU-"1TNHFX-?^-TUY.;"!)BZY2V^>TR]ADGM_LBC B%[I0.SD+XI
MO6,9Y,&*GJ-N$SFM@;BKGA-'N3>97,-S0'18U49]U*J^W7Y.7Q[$;VI+C0SV
MZVY);R_CZL:[VO8)7]]/VF69JS125H\Y TT1@#ML_[.> Q-+K;9/+0WU7W#2
M04,*!9W!#"^ 07FRGB.<H@KPSC?C2^HT73MMTNIGZP+XTVI!MO=7WU@\QQV#
MI/6I=9/2E FNT?23:E.8:GH27-(',-7B6SR\P<F@#CK=#)#CZU\TLT;_&[Y%
M52(:N#B6E:^7ZB/VE-(BM5'/>QC8(EQHG?0C%RAA'J*NB]N,#Z#-2/ M.QK8
M;9%B22^6A; G!P^L$+JA1&<X'P8NKC154R5RN\*;-;'KFUH3'<I> (&WXKC<
M2%WWR5@\[9H)BIS4M8HN)K3#D@-S*SAWD+71T!';2>A:K#J;KHKT 9!GYZ/7
M]F)69V!,\D3;#XX7P'9<RC]5.OEN1)(W\&&&YE%4*\ LZH&+]\%9LZ8*/:IP
M8;.?VNK#&5J%R.89-"<J^9VW"'Z411-3_;9#PSF[M/Z/1^-/!<(2T!< \!?_
M\?5(<:$@L-J(MI6BSJ0WA^'W#6WF^__,5$0#X$RQHZH/2&GRH.^!P!A*6CZ7
M[F8)$=M*?>]R(SX"-C)GTC\*_58A:I'9P*1]LR<26ETR8/:G,K"")8[5@EC.
M SE![2.:YL<*K\U-EJ!CZYH(-3Q##"X-*UGLS%(-((<7]\"!I_B376]7&51B
MM/V6\,#+102:.VHO,>A,%X,:-Q))J=2%QZ#'-J3 \,9#G+TK+,8/^\Y62X7M
M4O8+MYEKBD+-8%C3Y+HG)7;E]T"W77NY]@2]X!B1MT331Y;,DY7'(F$]N"C[
M[H?6KAN^(NRY1JR[MF8Z;AQ=CD3HJXD]<B+QAC2TYZ=A"+WBI?DO"U!X"7\+
M_M+ #!3.+\_(/234O^!QO )W;SD/^VND%V)[-GV@*![1N?W.!O]OCCH#Y&?Q
MO5*=\R+C"8J>ZUHVS1V:PAA_*[B=@G^SMB42S-F29<5V7EX*I2?'^-B8U(B,
MU2M,SI\7FLXC' O)34X%X\^B$<U81Y-G!M$'#0TY J@5^9.'.02,OISX5#(J
M<O7B!$Y15XB\OY*XOB2-]5_+>0%@P6D1TMF=@BE-W=O0@O::EIGCMW)U01_=
MX$1UMSIB)!ISFT(5V9VT]:0=DL0^"O5GUJ'-WYJ2AWOGRT^Y.!9$14NJ ^('
MO"O7%0&"EGTP[+OF%P#*2N6Y9,RUN,_=R6+G,W93D_?B7,5:U\S :=,G TR4
M=L;U=+*^M=E)ZSLQ3I&J4(=AU?,6%[L70/ ]U37C/=/1=8+$;EUCZ,T"9;JG
M+M@SWCI&6UA/CEP7;2P(^]^7!]^7Z,Y6):QSUJV^B;,< PSFS#@4\V90#T#3
ME*)#,KR^Y!FO<9'7UIBMQ:B!$CS?+$R?%M4';BM_>;[ZCG5,?!$6X2=Q8)BH
MR _[P5)'A4@YH<<XCLFC0<Q.>16V\JR^ &Q [PMV"HG$H&_I*;7%*:2%^X^"
M$X^$RY^\U_6"Q;3<[*]CW^Q3),]O%V4-8U9>LY!+1KNJE[T!4CDXL[:/KMMV
MP,7NQKTW. 46P"H.&O!S+&!3")3)K>$R;!F=L&1$"#GM<?/O*%1M#?I*#:^'
M$ B10)W20,-TVHY][_0\8S<2N[[,TEE7:00RU$GYY4#ZT #EG& ":@H$CK8Z
M2^)+4*ML+JO))-E5[Z<L.&;.&5$I77R(ZM%I"Z.DW#D,I7/EYS_L:4W057BK
M,MG<.K*$=;43MRO4R[_-L'X;4U%CXJTZ)6;,_7J['']1=:0]+]F$?'5;]IV0
MZUKF8J"H4T1;L8=,MU=1, <G\Y19S53-NOTY4W170_(Z"@E(=>*Q1T+.&+F?
MI9Z%[03B/G>E^28#3^J*3X_Z++'C 1;<@F%><,B;?WM>W;=B//PNZL-RM3?
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M,TD<2)7Z.RWNH!@&''?%YMIJ6@0:*8)9H]:#FH@9:8TI:F4U$U7W<$=I,5X
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M<+'I!L7JE3 1:0"E/0/_\U -_.C.L=O"H 2*^"=<-@Y<"Q/XO^P9CTHE-=4
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M+:T]O7W] X/?AH:GIF=FYU _?LZC,6N_?O]9W]C<PAT<'AV?G.+_GOV#BPA
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MN9UM?'351Y+OW&_*^"PN2[R73<5^AW]7,ET;$5*,S*]?T'1=+1@$4D+\^9A
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MT81.B845V%.N-DU#LU?Z$<5;YNQ2U79'M FUQQPLZP6UGE> 9,L*V(_>LBO
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M;S<M^Q@55#"*J%'A:?3V81"FRN1<M,IU'O;S\E:FZ;FW-WWDEJK6/=];J8S
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MVEQO"X5P>Y[$IEF= ?CL,H+#I _!%M-",/9 FW 9^<S[YC1B%R6WZ/9;1NZ
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M'VDUC!-HL:=]>9SCF(!!-R$M"8:%09+6XB)VW_E;6[I97Z%E /KP&-".V'T
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M%ZYW0VQ&>ZL7-, O_0" 1$F=/ST]>\=%J: [69NF>Q# 2KACT+"Q'OK]!#N
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M:@L#_5RVB!?<JB$-?NS9)C*7-'R4357S0S(\H9'978KS2O'N<_8:XW<_GM8
M_;S \38B1'_DL6 KWY@Q:) XE>Q,6/YSSX=:>U_&[45RY .@CR@B30JW1:M)
MMR^/H9 U!OYF)*:N/I4)OS6!,<Z?PJ;;H*4 9U<<Z&4]M<!AZ!YX-C<TW'C>
M:.T7,EY5EL510NZ>/@-MGCQ<-G("KUH$=4/'-W,(5-<5G?BU:E>]"E(EJOJL
MH(PG&(V*5Q&M/N#MV2XY_T*Z9TO/ H!U!P^ QT <5'F?Z_X*2TU#A-+46I/R
MBX:&Y3;36%RV7%<1)N9@T*'H7P^1];L]7/ 7+1[T\,5I2('/Q/X\G,L#%J3#
MAQOTR3,^KAN5-,Q&M=?1VNT6KZ36]S-\[&G@C"%G?W.W?6'/LYYRH5'<O%_F
MU7;CWWM+;P\S 0*GX94I"B4N=C'*M)68UO(,6Q_NR8]6:Q\ /0G/T&]0080E
MZYOX^B0KKUK22!683U-"1)]Z#SXG!.TPQ@5BSP0"T*K0&8$@OD5UN_N9HF6
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MMD^^O)@B#/<I2[9MN*B?B!.]<$FNOH)/)HYQ-@28A&OEW_0/.-9^HRV1#A5
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MFD1+128!"YQ*S+S3Y5-A?JQ>0N!+%VKF%.UNS%C/<\$NE,UEP)P Y)FWAF:
M5)>O^:5 <V7QE%I/FOY";&GB=J(KH;JG^^!A+\!=3 J.[?'+KLFZQFUML9F1
MT.R <:$=QA5$6CUD]2;\&1Q_L &C^?DMG5YO?R]<8??]C'K8VJB<^9_:\AHK
MKU_&I@K5U K"D1^8W//X^ <N1RU+.EL_!I+LF5$(>THY_9Y)NE?VDOH^P!T[
MKPT5K\]T?9->#63TWNP^ S79A'O$L8^_G;G ;C>575.]/"1]\40W[M%W_\WG
M553C<M+XLT&V5!6.=3\K_($WJ1$%*A_;I@F+L$C"W^-=ZYV<*=<R^)BY/@'-
M</+D3A\Y0+@R51W<2-1($S84,+[?O]6/6$8_FJX0E'006!;N]&VM+'5WG-)%
M4F3LKB[P8[1@;%>/\/%A\@4K0YQ_UU)04,QVE#[KJ?J2&#D-!S@7A-&YTQ%^
M"6;-CV:C^K_-TJE[QW3W.4<E[Y^#<VR86O^H8();%)IK&]85_;,2]_\ZL[%H
M0J04J80@HN8M#33JPJ"V62B(FZ^C>>C.,Q\_560W>AAE@X1V!E'E-3T OIH;
MJ%X[=/##ADGE^5ZOO5&@9O>UM-3/N)\SKYFM0?;+_[%!W"WAEMGQL'!QKP['
MN_O;$/PQ(*?W9IIL9%Q@O-1'2G5I4)BB"GKY%XW&',PF5S5J,]^I;PCS_][$
MI,/(]H%H"3A#GAZ(93\ G%",I6LZO1:SDN_C.";OG497G1+AEXPUN]T!_#W=
M/11M^),?9WJR[<=^9W+LBJ?@SA/ZA9B%S49SC'W?E8J#'OCI[&L7>:B_-J^N
M.N/IA\PW,<8")8+(#+R_[T$I56E,.R6K?AK\>DJ-\T&F@XZ!8SF0UOO)^'I$
M2&T"OH&RP&63.U!K5&HUL5KUS1&?\II[14*\KTVT1T(8\$4-PF04.[(HE ).
MEVT2RR=<)HRH,@D&[3#.3ZW_Q=4<?+124_,<6#".H]OL;8P/126\WD?I6HB#
M1!5S;'U1XLRL[/+'7YO+P 1IYH=5:ZKS:S58I>\==8636E/;O3+F;]HWH+&5
M@0QH4211Y-$188E',4P "8M='^C8I5NS8:4/@:2V6X_##OMRR.[9C+V->SS%
M/(M*[%^_(+ !;6>8EAF[;(6K\WJY#>RT\O?EU-Z7K$,24LT)YSKY5^VN2+HQ
M5RF<^&2>4R<)P'3R=S.S^XO\],+6$@A1>CL; ;0R4P(_CXE.BJIJXRF2#W0>
MV3,-A^?/V'NYZ<>T]25?_CA22:6I*U"#:=;,W+>V0!6I-\?#],Z,E7_MN=RE
M'K_8$6SQY]C,29NX3S%?G^OE%^\O KE^,F\F6,RT? !XW-T] ,0NC$ZE(LV?
M<ENWI&G]L2")PO5QP,:G;30WN=%K\$7TR,U_,B^ GS%1AI=__55E\.J>K;*=
MY_!,TC4:F8"-UFQ!3'&G0;KYI7/8!X;>5A')$JTP@GUGD\'SH-0-/[R&RH)C
M"T?%:0_R[LBNZ>YV'[O5O/WU-],NH"7/-)TK^:G)QO;'[G/M1SQN#X#J.25?
M?>&URO2KN[#CH$NC'7,\L6UD_X[[=TUYF5__:5+<_YN[_<^?=1'QHZX> "_!
M:7>!//=?9M;)_\(YPP-@2[?Z 0#I?0!,&+6\;%/D>P!X!T;>R3U_ +B85;#E
M1Y\F%$AJKQ=2&"6$)V%GSU) IU,/]AVI'OUAWW;)<4'?V4,36I09(]$OZ$=J
M"J> I3P+X0"KK_@6UXQ]68C^[AO_&Z,#4CO-0V$2,W Y<TRC0\%SJZ&UFP=
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M"&LF:4<NT?O\*C3K!IRC[X;//EVRV\2(OT5Q)"X_25@[7%$!4(XY36P2]P"
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MJYQRZ2E.+<3&1M#%^*5/;7:AJ9'!ED86L (4<B%KLTIU8 ->9DH AGY@ZKF
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M^J6SC\=,!S):@'^%;$WXU3K8/=Q/#&:%P>TE#Q+%Y/RH2G*[:*WJX)C*IK9
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M%/F<O:TCW2]%C'ONX4_>AVLRBKB(/<O3:EI44B"TQ+;U=/YRZ(VA.?%[3:=
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M*9/SRW\77XY+M:>-1C3P@'7+#'T?F^SKQ)%J:NG,Z,RN+>A3:]$;]I.W-_;
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M0UGAPLN<(K3)M/C=0[-IBSU7>VVPVOYQA)AC!=N6@S[$>$3*XG)^+#0Z@/"
M)ZB.T\C;Z!*_YQ(N[&<PT6&\(A%)#H_$8A>IO7&<G,[CS)SF*XW):N2!+0Q4
M;%DG:RNWO"FA]1"/-_Q!::. GTROR11H#^5I,-VRN&4Y-6D(^ZC]XSYPA*W>
MA2G!"^.)VMZR5OTW4&DW[2?55%8K,CK$U;U=CX)T$?SMIF7;5\;A;R?TIZ]L
M6]3  JX+,3KU+_N]S-0?#M(U;=&PD06]EF= NZ.%_YAU1,7(BH^+K>NKD(]%
M:NN_>/-YZ"<]8Z$3'J'WUB<L/0;Q$SE+TK%&K-I+ZSVU:I4_W4B,I$QA(2H0
M'GJ@J[KP%I8B1?'K1G'JAL^I!"1M%0Z&YX@W>O&?60"G (&9!*[9#+ Y ,[/
M/2LY%3$&P^=])_Q#PS\NCJJ7@\%.^N?\%,]:K'Q_'2)FAVWWCV:OZS\6M$2@
MWV3IQ%2V*Y15Z'@&59Y#/RO72=T+-Y$<I8B4L:5/3$,@Q_4AA,B-!1FQF7-Y
M&ZHP2/BZMU&J^3C(2>7 PM]"K%Q+%*&>3ZHQ,BZ]JW!V*X =!JH6VV_G>#-=
M83/N ':0,=GS.T#8U5F=JF]1\Y/Y-O^!I26 AWQ!AWVG 4*,YO0;1H ON^AW
MLS?;;.<'U$5O!SFP1MVN(Q*^3KJH* /F#ER^H#B>22?3*&D,;PV\RO-,M5G>
M"21,X&1H'Y\V3@H"HPG-+8!.CVML'I[8]]NS 4*L1IMDK="Q0W :OE,CJHQ7
M-@?4M[.!\;=K5\;DRP($EGX(X+7WLD^MJ>Q@2>BE\\SH[\#4*_WN=SFDYUE7
M'#4G]-9]9@01%]E0D.M>RP'CXXAE5.>7% <_J/G63A:RZ!^2 ,#WMSBSZ>WJ
MP[G:%F/%):0.]TF&NI6?OJ']WY[6_"<C*/]?.L8/8O_37803A:308^Z94.3J
M'6";S](.=0%K#>D(#7[VHV[0R>X]DIB(*>2U#_5FA\3:TDULD]49INOJD?'7
M(#F$&%C)W'Y"P$ [_4%\BOE0B+)V%%NS?-H)=6.0<VOG+%/^1D)E<2._Q=EE
M3MH_%%2<S^)*M7[L2.AX9?EU1 ]S/6ILVY(<RBV<;4_OL,2.F2+:V?Q+JN-.
MG?;3)3R)7A-5D9@49%](K2VVU\VN0%Q8,P$"= 0XD2J*(^ZK$^W!<\%+^;L;
M5=IB<EBP5YMK299JP8TD^ED:N/A'3NF2_!?4(F1UZ.G^5X"\"MN.7I R&C_U
M68K7B/!9(YO8R9*ZH#Z9W,PE%1+BZF<,[^1" \=$'SN>IW]VYYOZ9:>G4V()
MHEI-PW:^!X//GI_NO.=P9Y<(",BI^LDHK-/A/3A'?-A6]7=Q?<3\.=[I_\:8
M/95SY&)[=@?XZ;H%PA*XHJZQKSHXL2T2V,BIWTBY?PN2$1C$7M$KH-YM=[&M
M"G4=&8;VW@'$^9YS!)#)?TE+6#VBVF'$^\WO#?'8-]EIPIP\>SZJH@:XKZO.
MGOR3HJ473,F^GJ+3\KU63EW!P/#T>EO,[%'@G/K]/DBOIJA^B8H*X.,E;6UC
M\Z6.G.3>BX>I>QK4U2]5?T]\LG[XH)>D"+>/686-Q21)]SF.<+"3AZJG:>M2
M-&^0%,.7K'CX@@!_0=V'R_=SF\E-!2@2X<!<@H")/W.:8 Y5@\3GN#GHL8]C
MB5Y*Q?+5I4[B=4W\H?4S%%6LW<3D(EPLVOX\'[=!'A,3=(_4^"!K)N#E!.M$
M,7KN4@#.*4#/UY,A(?O"@*SF10)[XM.<<GSUM=GRG=:#].I\X!YEJG^K]TCK
M0I]XC\2KX6;Q"6%)J6Z:[\3$_9/H(T5K]Q1MN;T<E$(O,>ZJ?/1L5Y0K/+^D
MLAI7<Z/=SB($Q;W\9-*G/("TSY4(4S"D.<)Z#E:9E7NUH\/1D3U*N>Q-\+ G
M_O;D. D(V(L3\;8.^9'0>Z&00T=',^MS.BIYL\<#PW(@V@V(3UO-#SP9TN;3
MC8DWA#]EB419OA@5F71_0?L^?_S+>B2U[%FU3"-&X)[%'[ZCF+-;,Q7$8=_!
MCX1@45<B?7S>EE2'K-VB=1XAW"2-4SN5MQH5@@QN(K$4IHD4FDPO1/Y.1/96
M'E X&,1_W7OE\JW:*4MLI#M)?_)3Y#037U+F1M76.A$1J3Z/UE?N=#G X/?[
M!76R?*LC O"LE[L!<H-MM4ZVGS1L;"_'8VM@ #_FV#BXI=CX#6YAJ#/(E\S,
MU+_L@2-D/2>NMJ=4;>IK2O!]@$N4W79O,#&+E)1LUGJ0 -K@!3JQ[#;O1X*)
M^;Z3 L++;/C5S[V38;*JX/JLO2%!N&%D@*WW=[Q"SND,&]N$$K;2?HVM(*>U
M!?*5LXC&3:B[Z./YT:;?<8&F+I;J)&[Y;$;6?J??2>+8;5+[[L?LJE]E;<AR
MH"64T(VG35E6YWDY3T- P6UJ;?46+;B166)X)[_ID49Z&33Z(@@VFN^ >@DC
MSEU'_MZWM6R_L\2;U&8]I..]"FW>YD#")I=_ VBB7JJNJ?W#;<3U5+"F[D<U
MA$OCHR:AF5GXQ BS_MP;HM2P$5K#&^G%'%"H[8@<9%)35OMQP@",VTU%E: #
M8%)0N@CR$:?-B<R1^YEX?M,ZIQ0.U(^U0(?-*,HB&L! X@#$@7B<^\9E$B-G
M4PK54#93\J2XL*1D]Z[("ZKGQ;,S;$X#NT(3D?HE1(1Y+X5>/%3VO*I.$K6@
MZTVGO=][TED=T&EK-#V=,OK2@6Z^X'-<:L*O%U51(,_C7&GTQ >R6/UX' X3
MG,G/SI%M$%.,JTK[5",-[9).0_RP:#?-^?-=-QQ.U/='DT8^F=6SSA>I9L#;
M_/78YYN\YQ/L[U.(RHSM"/L97J:H!AFE\O!+<)F?#L =<9X7/_]I6X&#9*?5
M^+_Q&/@OO,$XSSF$'FT5S[\1I]L1IS*A])BY$3S&NE76;]6+I>C@=BZ\*"K(
M."O8]32&<*M[* YV+E7,T':R8KX5^/EGL4EUMM+[4S9;D^:[A->L306!UWCI
M>!QOY-XN//L:@DIZ'X]]8:RYL@1P[*0AG)XN,$N^ PB0WQSEN<!054D0+^D&
M)R<-B> -K%GP%FU^3#7$_[AJ_-;R#N"=I/!Q^2RA^\0[6./B3;.<:=&L LF/
M!E:,YDIT[3>"+U?M1[</JGKJ9?7<^4JBQ*3R/5**V^IJ=DFD)RN-6(N^^,]V
M#1_S+==\*=C81T"]?3&YIF@E&"/U;Z]):7_-8,U?N .)^NO50>':0I;O-/8M
MAH5X>]=3/+1<_:Q@, -/=S?2&=UE@8NQDHG.GNP0B,84^\;FV.C>I$EY^^1R
M01L;XYQ.:SM>MRO[3U]E]A"OO03^XW%?+1 OZ'93*6FT0_&)]8OH_,=N%"J
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M;&!IS7@9D0?PVDCT05%)_1SU<'NYVW7_P/N &Z8UF9CL_\ZZC>]MZJN8](7
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M,@]7E)]*Y7)GG!Z26@^[4'LWT=Z/I4T%IC^S1YZU QZHU#0-G\H2YRYC1>\
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MYK-SKH":%M<-VYQBN9GA)?IF;&+IYF4M9.MV1^Q4JE@UF"N\]K-X!DE=RN>
M2#DJE\7S+9F:+$4QR,"K*<A"[#7@&346%C5R;@G?/H&<0+6/KVBWF'CPY]<
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MC-V9,VE"0!_)4C3U()8'KR@"G&<=:8DEA5O'.J?!F'Q?[N_.2> &DB$MD]<
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M[.2R8<FRA:2\!@@*BPY@I72Q&^TJ,4?@=Q6ZWF%0OPYB\BBCLCOGP+851:8
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MYM$O[@E "NFS"M#]1A^<]MO Y7;K*_:?!S22>%MN2>:0*]5V<[2#*4X>ZQ;
M+YQT:-P.$5U^Z<:^3HD+QNTF8X$.0IL]FD+O1@\T7J][Z0@,M72YLE!DL]P7
M*Z/K:^! +9II29H)"2)GQ5JD>FP\2_0T^\BT,K,Q";7>2X&4.]!L10X[D=Q=
MLX@L$5&S(30-'D-.C*;>0!*5XIG0&^%EW8E"52=ZPK*;+JR(&Y@;@F";"N+
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MVFI]V*1R:S,AZ_)^3L5@\6.^FNCVK'9/1%]M[V1)^,?DH!WSXBMQH^9C^+Y
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M#G'X!%8EVS@+";[,^RM'VYKFG</X)9I[0B_6W+C;T1E?_[F2&$K[B<O[#9V
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M1C9-GP:M[*I.831M,YW14&0J$[SLY2-&K$*7Q%T0%?#K!94)'<47!C_&PW#
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M'HL9H7%FKAY8M4<Q@2STI<8=/\_+LM )_$&@:9;&W\C#Y+6O#MVJF4ZH=SI
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M/#>B0 2W>:F7D,3Z3Q^ /D/UU3-W+M^UC,"=N2,6"6T^@^/4V/NP(CZ*U34
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MKQ[ENAH [=R,OKG6$_)@\<%0M"//QF1!"]YWSI@?:I6+O[MX19GKR=V")J[
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MTI6^#$_7.CS D9)2>VF",4FK$'?F_(90N9G+R-UQ:)/%_*J\H:\&_7Q>%.H
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MH11R0-@CIJ.57IKP93DLI4 81 TBY(E4U&KH<-+M1)^&>[G#%:3\S*,ZZB*
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MID<4F$91*I3'[C(7SFCX_-%_IJ%&NV#AL' ?L0_:1>#B1],0TZOBRE>O7%2
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M;3/;JUT'5U*\U)O;9JZU-N\:H*%/9?S)]IZDQ6CL,3DQU[?0ISP=O:>O&R.
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M35\U[:S;V=&RMI?K#$=,3TK;[W'ZGP51\T:WWC_-('8@%GX)KM[-+4=U>!A
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M05ZW85,+S,=\>"R6+-KWG]#_Y+WW@)VM@.T6PL;#,*O4_E(4HH'.&8QL=RH
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M3S [2U.FQPRQ % [.<Y\NB^_^Y*L,_CR12QI!E[39>>OOPOP37.W:/];+0F
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M((#ZEHC%S:!)K<46_2N=5J"1:NHK)$V!9VF'(-IYF)!Q:'O=.*K#'99@6ML
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M48%\ $36P(?)!&Q":<4JH>2P"%\B2RS[_*9?X.A72UB2CZ1XMK=D-6NLHGQ
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MM+*+]51Q:G^[U+U*:F%"'W72%&OZ\,(<'+RB-9^JUSQ\:0*2R'PT@L;-#!
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MAT#[((<O[OC;P>!*AQK9&WK57#X4KAR^'*XF&EN9-K^!ZE>Q>U6*5CBM1>Q
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ME7681_GP=P97;N_J$BG1X_+=*JS9V_7B81AJS\T?]'9>*YE&"?B[@"/FZHH
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M8'V7PH6NV2'3Z3Z>(24YHGK##4TXOH+!DG*ET5>J_*I\#DX4=G-<';RW\KM
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M&/B=.,+O3!^$UR=V;?&!L:N]Y1WVQQ_HA+2^4:O_MA=Z>X&HL!H,,9<-.XV
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M88#%JP4=6%UR8H_RB6 ?/E>KOMH%RS !^F6YE\:AX@'?610Z(/9!6.[[K*<
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M!Y#E^D<'$$X;@)^>S!/'6+,5!FW^<<'Z2./?MM6A_TX<H7  Z33&W88]Q/'
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M#N3).0OR,;6",#ZB5^SG3VR/-@#UIX2O[%#IM$/GE_A.UZ$_C'0J8$]C>DR
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M\,LM]PD-NZLLI]72/D4,BXB[H31^QO:)>$S^+N/$\?\$I_F!K;U3H"I03K1
M;G4ML#>,4R]POEZXT/1LJ58M5I:BQ[ER+O20V<=22%;3X12&SV#^3->+&HYB
MH97IZ9;_<(-/J&CZJ72MDSXX=T=H?N"_>XOS\MU7!-?HD?UT&X8O4D;I@<(G
MWR\(30384VS<G9],:2JF[AHXNA=<V"18#7]-\]+;P3@QHLM6-[1V/YIZ8ADG
MBL1='BW)="8_N-?[7J]JW.1>]LOT:Q=Z2KA>Q0IPS?]RV>_<^G( (<AW( 01
MR,Q.2;[,B],J!-^ .OW)?<D+2M_Q"A>JNF25S$] 1L;;<__C!DC_T?AEE7$
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M*AH:!B8N-@8F#B8:&C8A-@X>/@$! 3H6$3$A/C$N/@'^/XO P+W.@4= 04!
MP<= P\#_7QXOOP <9!@LF!TX&!H %@<&#@?FI1^@>K43 >;?!O#O P;VU49$
M)&045+17A29L !8&#@X6'NX?JU^O^KY>!^!Q$'#?<$H@XJD:(]$XX7,%)N0A
MTTK6]1*H39W3<7]U#D)!)20B)B%]2\_ ^([I/0\O'[^ H-0':1E9.?F/G[^H
M:VAJ:>N8F)J96UA:6;M\<W5S]_#T"OX>$AH6'A&9F/0C.27U9UIZ?D%A47%)
M:5EY?4-C4W-+:UO[[[[^@<&AX9'1Z9G9N7G0PN+2)GAK>V=W;__@\.+RZOKF
M]@YR__"/7S  ',Q_C/_2+YQ7OV#AX>'@D?[Q"P;6_1\%''B$-YR(N!*J2,9.
M>#1<@<CXD@EY=;THM-QJYP1?G:=0">G>;[Z]^,>U?_/L_YEC0?^O//M/Q_XO
MOY8 =#B8US\/#@<0 YX_YT<R O\[4LB"I(,%V]:##PFPPK80XWPC?B>L@B1I
MKKJBNE=R%[9G8.$C[+J;0RNC:3!THHKUG%Z^!<9Z!D O !S-"P NA9OKO(:>
M/^U?S3SV7=6\&^JG>H"I@2)*OP #JG'A8M=PAD_H42] 9"Z6QK^I%$PHGV&-
M=Y908?OO(_9 2(A>  (94>H78!+#_YR+'<H4(*+[;RIQ(F*=8H*7F3X2+T N
MZ0NP86KXI$X,"7X!Q'E>@%_#/9!RX,;AWY2$_['@:-3I @D:8/,"!";X7WPQ
M^?^M_%^U4@#+21D=Z^/E(^=6SWO/):[\O9HEL-@CC^L29M7[Z1$[YWRAG[&+
M>-0;6R+2P+=O:I@_5&"GI/$!U?\-B;E3].@Y@:L8RX-HJLS2+)DU!)ZJ\*VR
M1&K!Q2X2G&"\7EX?TB5V5215($MFMW.%QC$%!ZE"-4A.>H4GD13/L08,:"]
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MIT1,N8@)'AL.*P75;GM=U+S[^9$ XW\A,O]#ANMUY#MC('V1"A7)?0&JIUZ
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MU=&GM5K3TA]"1%LB(<\3:<V;.X+::+PPM->/+-*"8(\L?+56;FCEO!BW5J^
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M;&:7>V;:M758K&'?GOME'<J],[O8:'O]Z#VR)P8-Z"Y":TK.'EF'?A]=!JG
M1>L+7L+P[R@:R4++Q%:I1MMK8KQX0K,NI,#2)U69A'?N+P"Z??:IQQ;JU8^T
M9+2$N]I.]-MJ#;$;>>@^5%T5CU>4\ 48\3[W?PYN,MRQ,Y1\^G)>7+<5%V9
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M$,N($>H[%N R7"6Z2IB/P61H/843P_2J(#WY3-6P22MWR3B9Y@3]-/9\2]%
M7<U;S&178=U#-8JHFH-#N<Y(*^D4PW%KW08(F77Q*$V5W/F'"0V#-.+>AH=1
MFGYXY]%/2'*AC1RGBX?6-R"#.:] /_-1SEC@P:BE;"C"8C2*IJKL5>8)&QE:
ME/SJ_%VKPV5/A<?=$/LP>*WG9W8*,#<O^]E5KTE><&>//M@0-5P>3-Y?0 QI
M>,G:$</R^2 @QX\;UL0 J'"HT @O=E$>1;1LJ87H0(9R%B&SI4*86+>?]EC
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MBTY*/"M+HU^=E6P:%GB(DX?:,1BZF6C(YCD6V,>]_B@@4-R$D:<?3C+(++7
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M0%U4,OR*%[_F#\ />:S$AIW[#U!+ P04    " #/.VY8W7Z7]S>1  #/G@
M&    &%C:74M,C R,S$R,S%X,C!F,#,P+FIP9^R[950<7[PE6C@$=X('#Q:"
MNR1H@& )+@D2:!K7!AH/$C1 @ 0([M 0W-TAN#N-!N]&.T#@Y7_7?3/WS9VY
M<]^L-6_-A_?KVI^JJM?9J^KLL_>O3S\L/&P )*^4U90!-'0 0/O[ 1Z6@9<
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M.^"KD@POMOIN#"+:YYU9ZPIVZE;VZ4P5\T^4M;<=+!=L#KJ;.V+7*56Z PE
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M,'5!'&1)4**./'V2NPFYA]0WW^^K;UZN]Y84P69_)L%:?5BY@SL':3B]Q/L
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MP9I7:J?AS'N5,!NM!X!MS_0!\#I\ %[8S\V]7>Z3I%'&W:6#E2N[N&1L?F9
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M\>@&I-\7G(NQLA+$]=%Q^\ZWZ<C3)**,I;YK:<Q\:)\A'(T),%2MV([#BY,
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M\VF?D-!-'Y-;. 6)3(3"!<RF6BCN.,M,[9KN%WB#^#$]I,5 [@+)R13K?_\
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M<UN2726E, F^U1C7]2=3%LA/AUVOQ&N=_.KW#W\]QP9@3.(#WLO'/"G&SPO
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MFZ<_@H2I7.?F>_HTVE)$WV"$3T%IEB[D]00RSWS.&Q%Y;Y*%5_D+4ACS(F*
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M?\E$Q%/@WP^1M8"G,>+?C(Y-7F%TC7FO/L<XNY E>&!#:ZNCG*9$?58M[&#
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M73E$ZMLFP%?EN9>''42VML35:)['%^@%CTM&GG80&/K;0!#O9BNNEWO!OOA
M<=XX]E_ARZSV0*X)/X67F">1_W%PI2).[WQL_"^1ZS=$3E1,9Q_=U&_Q5_P-
M3CMM<)_!]RW#":Y":61/%K)7E/(V/;YM;Q)7R-!5'\DQEB#9'MX/=QY=@?=,
MXDS 2)I@-+<.?4G[3RS/W7;6_^XAY,_K_FLN@;!E,8$ (9QP>XB#FC'+;H'"
M@>(?EW-,%VV.%6H=74[4U,"!XS())\V> 6#O40)!CA=<_*H5;0LWO#4B^PU=
M=%&<YBD8ZC=#P\,#;V@0HGOBM#Z#T'-#P^Z*]WO7\R5<04[^;3F;R>T*>*)B
MM<T739)U[7&\# 4+!8.=(:SD*G;\29:,)<Z8%<FC2J<.P "R$NX&I;UXK_),
MF5-#9%:FI5D96EN^8\XB^'HA12C<X7>TTMG(-]Z^N#<3TMQ,E* UAH6+(?M*
M/JABCM'RJJ);S?(+#@YB#T>K 9(/C160F,MVJQ'TVRL=G8IF\UBY\]0'&A)[
MV+7/]KSMB:>/8<<C0(!UGK+=_GUASE^M&6.&ZYF6_;L!Y5_#)?7?O0MV&@*Q
M:QT;:NJK(!5YCGW-CNH+3VK<]]VB2"A[-^]-3@AN#XYI(7F-"5W<$"V$M"22
M1'1^S= 0/:/8-EW/]&QI!:0[]:.2-1([4D'[9)#;+SG"H0PDD&>;0H:VY!5P
M(-V_(N30W\E:DEMBB?>=Q)LP2)/@&A"L[_"7Y=B!#0WDE\V4J1.]Y4DQ46T7
M-^ 366K<,5?_,/VGC>\K"_(Z0EL=7XB/'Z&<P[?B9>%HXDLD>=HKEDU*%-IV
M33E:"?J%"/*588_N9F$2$J3?N#T?TYF!:OL7\/*(Z$@F*0#."QF-BAC+)>^=
M/]7IF8Q=ZM7QX-5]FZM473VH70?6#"D04R/S]KF+3D725?UU[M3@2^Z*6D^G
MU:0-#QRT366;EI 9.@L">,W*; WXR]\XXU<E[^UJ4D2B>@U*<^"Y<X^ 9%<#
MA_AI1 P_+9_,JU=E4E;O+MZD<"(K%Y21JX^ R"D^^?(;QV]]=#]_5M=L(3&S
M^=@> 2DV/BG;-_AU]4U6>J4?^/%U/>I3!HM V6?$=8^ 2IZ[$(/"7+RYSPH4
M"H"KHL_9S/\EE\P2G6<2U_- /UOO]16$J G<LYG<J-+,P-]S\.-!>SP">CQO
M+JB>BGCH'#D[/[F_X' IN^0,L/,<D"2 %/6T-,0F$7AT-$"P"O[A!L$,3YCD
M[ /F<"F/04=E-6B!P)QB1:-/<UO%>8B0+F80%YE#L-!)7[<L@'6PQD(K/[IB
M:N2;8*_"*N+JFIRPC-\NF9X.CG:J3,JO;PP#G]1GJFZ3@O T)):N5SH\CIG6
M3O63[H@ZJFMFCT7 I#_M#*/JVT+7;M:/-4]XZN<U!O=P@R1)Y17-D ):4R+'
M_'LJ*%HX)+$'M*W268/3N,PO/L Z0=#%AAL).'4[I=57WS2''>K,V,3WD62E
M'M1O=G=/%$\XS^?$;5F'&"IG:ZH:+/]Q'F%)"'5MBPY9CDY4K'=]$$(Z5LH0
M']X(MF>;S'-&)TD58Z\T<=I> #PHXL!(%>UD7=U4PT"H0N.KE9ZM"<I]MN@<
MA3C/WTYJ:MZ3N+KN*%.YQKF+95E!]NKV.I^^3BW"#Q0]#FP+?&B=T"(44R_M
M^Z2"M2(L=<*>IQA86ZJM04@)*:_*)]<;@U>,/QRWFW[JV-3=#EDU- ;@IH.V
M29IQG')(7W'[XT$96M6)(,:7=#"!3PW-29J=YTF_004)^!L9EY@V_Q!<40O*
M/_#.SE(Z YZ<N5.GU%CS9-&XU(5)&BE79KX5%D*N&GEA6T5@]?//OD?FFI40
ME:-PHL1U);?ZTC&_B*JL:NKGSRH.8EO=^:$,!7!E:->]C]N@]\_>SB?9R@Z2
M=E%'ROP.]<_;DW\U6I*%J$9V"I-G>__[QF!Z&]JK(NG83%^*N14:(79;R.4>
M]42%7/:S-J%E:MN&KM'GM=$99 F)] _4HA,0TTW5A; V7R]8S >\\ETA\<7R
MX]]OW^Y)).TR)QP"QES@IW\F*&%EMHT)1WSVJ9Y!>N9Z$R?,YFF_Z"]<5 'N
M+E#0)!_LN(+AJ>%H-0@K_FZSYF?OJ\&15XJ,EV4;3)&T G$.4_8[>@(-PNU)
M8L;/!8TNNK<]*EWV-L9&[-@TJ^:8&R&7FL7RSU-V$LS/OBG(MB\P$)D@U7NL
MD;$%N:L_T7NWV!E7Y67$,RR)JK>U6:LO,:>*__=M1GL#-X-]$]%,=8HQ]8^
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MYZ9 "!0C=U_2(SF_.X9LZD_YR0FILE/"4'?!_2;-[UAQV>NX%ZWX+S'QF7!
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MTV/SC=?_C/#D$2"'?@3X%"RC0Z^DI-4F^H1^'D6)&7J<,Z1OM"H4FO):L\B
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MB-W1*(4_Y]7*:=NY5)C:3X,"E5=A13U/1=<5GXJ(B"$^O$ 12^ABJ*%)3P:
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M!Y.!5PU&8N(T@T7*R+?%!/\/:O_)['^/6-#_+V;_E=A_XP4!X* @_7MX* 0
M"<"3>GX$*^ _T2%^?M,'0TT]9;.'2<G,^V]QI2&12;UZP!K]SAN&DW'K62Q*
MT^YXB0>"WD\CST@3 U3_?\/RY'Z>EGJZD4;SR,P;1&7-5:0=P*7QNA9 R..
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M<L$03:(#;RU*RFH1KIG%*H5(1QY;ES8FM]L0]']7J">\JZ 09J6CP))#IQ@
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ME3NLFLS.[;<+DMQWCVKE/W1UM[TY(;?WG>>A/KB%1ZF4C>T0@^2PX1J[@W<
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M0@$CD1:<7$W*YCC'0$%QZ+C8/D'4FRX1"E$O.FI:1%-Y%;K^/J-V3N@^'>;
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MFY.4Z8L+L)^1=FR+J=WV\+$$%T$_%39&]ZOI5R:,L";)4GVNQ,".RA&,<1P
MN'W[[[:\O*G!;)EKN+O&5;RN0NEO2QYI_U753_M=1G'(#F <A0=<.^F[GM!D
M:E\TFW>M,ID:4-67XZBLBKSS0+^55,&MK.3.S-[O%MV^5I2**M=3L@^733YL
MN&W8?]9H7_I6[:OT^6!"5>H>"MKPYP2O_6T02Y77GE.HURY(8/W!2BKL=Q]=
M@-0YY&576Z@+@I@/YO@BZT.4VAG#!S_AOP ,V0V$2[RQ+=I44IF9>$H/Z5 <
M'B\U@>?6C$?2>@I<*8\2G_:+(1GNQS[8VSDA<(1EOYLAS>S;E$OE^:\IM54/
M_H7+&^&%\?U.9B8$A#1#>3C9UZ.@Z>(T_OTD6&--&$.HK#<BRKG\;;+Y=^Z+
MA'8_.S0=29*KH:'8$ '=G C7&I*3#^600\T/#%^;"C?3^AZ7KS0U(/VN^#KB
MH@B-K2R)&_>Y\T]\MV3OP.ZN95#S_9S)Y;H0V^BR9BL:Y$K3V2Y+@F"?V3W-
MINYWQP<+QO#:O>",SJN[YTX^"0Y_^S4U,2*C:5$*2V=?#H%_D=>>_<Z%!8_$
M:+;9QSARP+)8GYD#*.$IG&/HD?-JOKI#K-1FS!X$["G5ZSF0+1E'([5&P0%3
M#)Y].:"GUEJGY7E*[&#*>YZEW*_:-A#NL#9UIJEM3E1M(5.712D/&^W%VON9
M_!9(LSPH-^"%_\/O]?*1W^M%$]C>>J)7_JSUXT.I=/ RCYRX^>@!%D T,#/0
M@+VFON#:2A:TH>>[9G3MG/*ML\B^\EOV35/JP_V[XP%?^T%QGFD7,-:#.FP_
MS;EP_>UJ^'F*T.-0XANFJ$&2WP6 3#-S90:2X%*/ 3NUBP4SJ*6])S^"1U]D
MLAGC%_9!'$V^0P?!M5TR1SI7.<0O#5SC$<@R5QPD[Q(Y%EY_\SZWKCO)H[]=
M;DC%#3Y,$EBE(UTR5#SB:,)5796[PCCG,\74-SS0<?G(0A5T4*J/!_Q3N5^]
MONZ=?<TZYR8/O ,_^>OAU[7,4GJ:-S=TA0TX<\R-E>AS. :LL->V4-7I.3*4
M40SI'KDHZA^E*U8G%SXEP.WG5]<-UCZ>B+"_WGZ?-CF-@9*M)%^M]F<#D;3L
M 5*:L432*5YF5K#*5G^]ZC-928($D=^TI''6_=W/AWD*,5?0*Z7GUATK$6J1
MGL*)ZFD9W!9TV<S4$K78.6<J\?8]N7_$+2$?6_.^Z5Y] =3TWS=O/<U[H0?S
MF6-QG F,=4V;R0@*/ ;& - E8FU:[3FKJF;7OEY^8LKT,Y]7:XEV#HP*\#9[
M4IYM\0]4K%3>+%HU2U^A=:@HJQ?Y^>Y1'Q: NB,Q8# SC;G@M^),.,22MC_&
M2[@M P'@H*NU"+$$)AKIR2@5L<JS@-Z-^,?#KQ-*-!WM];HG4BP70N/S%8!E
MWJS?1E/?87\Q5>MT7!)] 7QP/1W8RSK60XTYK*4N=MC!;&D61I_&<N'96*,P
M;ND(%%?,&!JM=QXV/(G)OMLN;)L5'P$Y.K\]#T?/HD*_&_^4D/=3DQ[,OW#>
MJ3K:JADU",?]D5(WPL,/5>2+9:CHTJ@K<BM[?BUP=31R9 AR+.\IF_#HTEHY
M_V$Y%27].TY()/!8:-#[,MBPF3%A3=$VOL&8.2I$Y^,HEQ>^FF0//;QYO6-L
MNZFH\)$7WX.SZEI,:9_( OS-\DSFXNUOZCBO4PD/2Y(Q-=4HZO7(LCDEGLQY
MTIJ\T>-GH= ^^8:9W+E3._LJ)M+-<)+%/\,Y[:Z]Y[AQ6M@YG1/*%56Q$1VF
M)2L47":1R@*)0)VDS[6^/_V4G!9/0D8O$PY:=B)A+X 5B[:04Q,#O)O3"/'L
MW]&GO*;@GKBL8T%!0'9VH>/Q,U'"4/^M)JF6UU>OK,:Q]E6;2]VP=^ 927T!
MI%6<" 1*[J"3HJ>*<_]4JC=D8VG-ET_,LW0KS[?*^P5@Y&^@)*NU5,T7N3O;
M: "22]\>,5\PB974,?&$,^]^EGM6$\ D+]L]B%_OI.IY%FZ$/V?QW=RDZG[C
M9$ +.D *P$P9G%16C[K,*?(YWUX#V4><7@NYM+>+A/"R<R9#BGIQ:L,CX@!O
M\,X_M;QSUA6GFN\0*?'X;5/[ @ =":JL?_)(,'C#LUIOK,N\[*=6QOR1'ED)
MR.[16M9P\]Q6[_5+;C0=Y.VORW#H3Z!]G#H]0F@@UZ2%G2 (( Y9HZK8C!O]
MDVF::& 46*.I3 Q-6#PX);W;N+5(D'[5)#L3>!0_/%+-VTO+V;@ 43AE][0#
M9^]!A/8IS#7H21C-@H<9W%6&II<*$#I#CXRO!TWD?G$D@.6& %<B;9>GAJ=X
M.B-*[VJN30].A"6=Y&E./=%/O_-M(%0A8S80TO9M*KZVW_YU'N8*-MPM'3\*
M8:R:J]._"4_9)0GB)-%)3J[WC1IBHLM/-M!\)"T+0 Y69)5OG%V=_18)1@BG
MJ!10]$LF ,DHTOOO@/MF6@V>LI@/M C['EVTZ&V&+9U'R]+U$?XVHV-#@3F+
MNM9D57*I^(H^K"1I+K2!'7>6(N^:\$?!$L10GU=U< 7TJ>;+_*EY77NPHQ$/
M!7%!M>0K<WEJK4B_45J\)5$FRQWR:[:JJU.Q:SX%"2PH(LC _H&\$KA?H#]V
M"90;IQM]*'TON\%_GH2T(X'F;R[QZA%WP<?4-5?:5:PYG+DI08%&9NLLOUGN
M#<$0I6=(.#518@(/0.0;4C/,;W)]J-^?^$U3$-!*:X!:%L>8V+^_7ODO@.1(
MMLASJ;?FCK*+[06P//,":)D0#Q!Y1XS(^0(S^LG/Z:W?]?/KS-6)>UM[1PNX
MMH\PJI[H+ZH',F+G!@P;IFLHG><#RBPM\$TA%'ZF=6V^ "HN;ESQ7GG8)[TG
MN/Q3XP=7#KG*H?)P5IOFAV*XBM&I-7OKM8L$)J4SDYM+J!Y-%7D6YSUP^]!V
M(71*'OG:83$)S[AS)60"]PHBK#'?%2@$[39:SFP3G#Z]]LC%,<(V]$%^2O=1
M+3YLPX'@_W#-";L%NH-0&Z*42@_.W@N_44G#D(QK=2)+-+PV=*SQP42 =OP)
M/!0,YGUXBXX_-/]HPJ7<1<F@;UDN)]XL3T;]A(Q$07)X]<_+8K9"LLK_'Q-1
ME_:O$8:+^+3R%=)4&>UAW;Y=ZC^5.9B1+Y-':XKQ1?<S'-Y@WD060FL#>RPX
M*KN=L<1AHE>3#A^6Y'= !!]6].O!<CH+OQS\S'?VCWD^TH55\\E,XM1[1MJJ
MIBNXJIQ2V3,F^[6(<4-C5FK4(M2"+%$UY],*G'$<=48XL-_*LT9_^M,.!>QY
M7.W7Z(]PZ&F2H&G1R C1*!!LP [2)[*?.=EG%<HH<G^(&Y*-!1Z[52MYBJ^J
M]7Z&%]:6)>\"RM:I1M%%PJ:$1/VD:IR\B-88PPSE;L:X-JZ5H-_@HU&TO$/,
MI9]K1QQN'%?1TTPTLE%3>=B;U0ZZ/.@S"=&+].,IEKMV W[=,LW2'W[<C7*G
MR\U;)W"FEWS#FU7%H8IJ/#2*[8>.6E9M_CNK+2IB^M^:_X$U1L_-S&+=C8]+
MB4=9/4Z(AC=0J_KLM*'B,QE^'8FYXADVR1@JA>@MO45Y46X$15K>K_K16>+X
M^L265RA1;N137QX?G@J[-_,,69\R_:T)MCPY.3L4\X_:%#Z5'?WQS:0J2]L+
MB6^E+P3_7Z2]552<4=,FV@02W(-;"!HTP5U"\.#N%B#0N+L&=R=8)[@W 1IW
M#1#<0N/NTDC30 .3[\S,6O/_9\[5N:B;NJBU]G[?5?4\S]Y5&^N],/K^$!ZN
MK&*)+6=<F!-< ADY(]I-S+0M!V\+,[S"B3; 9T1M_X7VPG528@_"S57:"/%=
MP4Z(+1H-]>52Q6=\7 M60AX\ \)<CKHINGB0!C#!P20BGX(M.O2C,"-?CR6]
M ++9-WV,K*IO];WQ\]S<F_?&".^YG>%Q,2NJOSKK>5]*"5*(D]\'LOFV=NXU
M/F)!&N4S_T5Q1KX%D3Z1$#NP^.\L.$3TVXY!.'$;,+\,B_*$JCW<0%?%5Y'>
MMR[]%8P/F7SU*N&3VH#O#,-,1EZ\<Y:MY]1KTMR#W8#&<3[9:L_,I+&DU&4'
MA+G\9]ND$D\)*MBK_"J,'-'LM:^6"JF7S(HOHBBLJ0*Q-O*PVNPUDOC;_I6'
M&&*[+ET+'YL^-2Q9OOM\9"K&TA[I26] ]BB,BHB782=946*U"E\M5QW&^W;=
M+EG>V@F>]<ODKU)OWCO.O>'&S0RWV/YN8722.9_F?KV<H7QZY=#7ZK]_&"G\
MW,Z0V6UN7NNE&US(=2WKMRB6<23I@')V8(%?*TA.AV.Z#1!>4<?G^5%6"8^>
MKG>#C##Y29:OF>>XTW1#"R^)-$]C2(P']QW?2%*_-\>GD2?)V'P&X!@=+/A]
M$:$:DP#949VUM+=RX:BU,X:U-P-\#N_TM*K6.$\RX>-H+IQS)19VBQ;QK*MS
M5YE#TK09WRVG(+-*"5Z_C*1V-Q.0/S-%U=TDW)32"I8D((V.P&6S*Q[OSEIK
M^\P]](X.2"3*VY:69*,)L<5HE,8\'&2_F-<@%ZCJD'L+NY-R3),0Z.55=Y?9
M+-620!Z)/^7$(O3[#'"J?I1Z?#O3)R; M\XW_';UB!@7=B[W;B<T+^P][TU5
M&VY-/=2.['X(9.U<HT;0D'-&&)DCU8\1\N6$)67RQ:]\5;,( \^G;C"O?M\S
M@+C]P"FNG<9PX5+9J.89P-'T4"0D&NF-6K"=R&:V-->*H-F09L8)EZE#_[K]
M)%XX?!@;IS%[&F)G+)O[Y?MI4]DX=KVCU[7P89KR@]#2,/!"JQ=,Q<MW+_ZM
MGM1M77")GOI%D$:($'60YX@ALOR@Q&;I4 ?6/+2<%-OP-'5L6Q(@V A[%0&O
M4DY@.U+#@ZXNQ1016)X=W>P22;.]:H\'A!1^L^9L)X%+@R?IDH($D_Y]F=-W
M6[DU[\1<2YB+*I=Z@X/MMAY,)-5:VQ.A?QR4Y2)V V1<,:'=?#^M_^+U)S(4
M/^*1['03!]LJX\>L$_+A4XQOG;\^$*F-0EU>DB\RE:7^$.4PNFS*TB^$0A&*
M_G5(:B+PJ^84>ER W&,Z\@-,4W\7]JIURZ $UQ]G\E4AO:" H&9UO=WEJ5K.
M7[ZO)$$7V DK>6=!TQJ<W3U@<D:#!&)5:QVMD%?:5I=@%3#_8W'P3B1B\JF#
MZAGPT1!P'?UT> _:5RT=OE6;^P]2!;S^MD'DITF*Y<L7,1?&*T4-"GOB\A'=
M8JZHM%NC@I&"JM<.$XF.J!3#&WUUS'V.ND42^N-W/-'PNCHF-YU/'C>2P@OH
M8<R0S3B*4WY\ E4N[IW,(\6 (6A1\L#.KK*30Y-):R_ 3R^[JQ%P] [UU:'R
M?^D,I+5]4/IJR@+C[EDGMUO#_<>J;F.L&\8SJ\2W#9F*V*N^4^J@E6-5^YE?
MBQ&;,CTP(VT1()C@$,\2D/8M0GJ+YM4HIF1C\0773X[%*@F _!=)5LVED<,#
M(+3;KAO5($ 1\7(;C&<O\2:I;T$0:EPE\$OT9>2\'IZI<;)8=QH>#T])E-_=
M+-P*P5]]"*)K7"?P*=-$&!4>Y:A%EJA(RB" ]@OU1P)ZW 1&51GFV)^ZS$9"
M7";GO $/UM& 5!=TYBX:A&/I7Z3((QB)+Q&W=:HV8$H*Z\JOP? <7J32HH3_
M2,7,MXDGI&DS*A21FR[%PTKE-7-=S/<1A/L@G"]NAP2[V"[VPQL[&<PZKL26
ME[]&6^P)' IP>0VWA*CV\*Z%2'Q%W,+0M_1BD"87EOV#W5B@WARV *7I-7&#
M#FF[ $:7630U-NYL)[2\@E?"X*:T,^Z9+I__JN']G/WG#*'Y_VB=^9]&0GTU
M[$BLR!%'#9S_CPX8PECXHZFSN0/'/$<X["*@"3=IM!5,&R _*X;YLD.+ QH)
M]OOL12D;>Y>EYWP0]Q?OS*52F%$=G6&;*@E5!@;J)S7,GHIL\'1V&V+/WN)5
M9+:XC/D]<9[1M%^ QSYSP^FO,OWSROD&VXCU&=#MRO,#.0).0>H]L-L_ PB?
M>.U,W\)T:UYE231.!GJ7ZI^G+S/2JNOK6LKI5^'4 5#S6[>Z8F>[4)$2LRQ7
MA1>)&1S[U<WJV%&2NFFN?"@3R,^/91VX&]PX9NO+0 &11Z0"FD@0R*->K%H!
M8.WV&F<G;0K5V*Q'#9HE"\,/<>2L]3"Q%Y=1?3&CT'@JX'^PC)W<N_V1C*'!
M?+'5WA3G8J6+MF.FUB-0V",W&]E:\QDC1>2> $#CJB^)&B!<Z&.[V93D6&BP
M;"##B,TWYIA4((?*,=PJYO;UQ4_$@C4%Y$(POG;8LDTQ2<SVR9!G<?*)^;&\
MP\[Y0?%KVR=:PIS1WSSZ7%F!>-Q?8MV)Q;[KLF&P8O2^>2E\Y I7!-SL=3P#
M]&"T2>B#XJRCQ2O+^JN&WX-^GVBL*5M6=7 )HSS<3[TZ'\!V)C%!6/H@*<KM
M#$V[3,2J\NTGE*NL3?I]OFZG"C#&;T222T &@D8E7WN"X]<!'>Q;_W:9J1!H
M&&;,.?4K(94(9J*"IZ&?BD(8'J9F>)-UB$C:-Q,+[I5X!NS,!. ^P8N> 654
ME8![YO],<OB/=81KP?YD+M"^A73.E]3#"%J3#8Q*2O<3I!^A],-_J%$F'^0Z
M@UK]DV@0;N*&EVO*Y="C/E[&\]W4M^I2D@*BI!0ONJS$RB8Q@ALK!?=,;T[.
MV@S5 Z8-R[P=3QM,ATPD#)1ON4HG5>9!.9E)MJ6E3[F,,X?P2;<"D_Y/I9^>
MC@EX),7F<^Q%?H>F1VKR8!S(BG2E8F>^,WVR36/Q6JWV!0UW8YL"UPB43WDP
MRN:NO\_ R7??L'^SMI6;?*D4AB'F/JET!^>F&MP2)^K_!%%NI\/V296?=VA<
M.B,I RBSMD8RJZ(Q9?-D#@F<#K_M&FEKBH5#C7RW#<PS<-SDMNG3XPD"H\'1
M3_0^-K<;:]U5*P.PU2->FS$%QN\2_98S  H N1[50 !<757%5_] J/MKT_&C
M[^DM;=<KUU2X6A!H,?,IZ\S-5/!B=_X<_C)A[7OP#T3F2R.*&P/'OT;&CAZR
M/J.IJ@. E/6T<0\0%K\D<776A='7)L/SN+>IYTIAP'I3(2G'/R=XRC^DM-^A
M,@)$OISXX ^9BL#H(F:433X.'+XWZO>G&4<H=DV[S+:)MV9$$[XH]ST>>>.N
M+:96 Z*6KS!#F.DILY[FL .-V-\-UO//.-'QM?OJ)LJ]N<7B3>CK,+,E83+$
M/3Y$!.<GV4)5-3R8,_,]D0$=M9Z\"-JCX-"%@M>+'D;LN#)RL0*))IKZF\Z,
M39LNB:BODXE&("TLUQ?=Y,L^H1RE25I3IP6S :Y\A@[UK :82SC>4JZAOU91
MA,<R#P?]UH<D\8[W-ZTC.MHB)F-HK-=LVCS??M(/43E=D+VB8T77E'5$!/=!
MAV/W"PX+.V>X;")9(U,J213.30*:4W=[Z-BCB-A2IKP&'<WPCL8U%5>9;@-7
MQ3^[("*4N*KL2M<#GYZZ0*&[.:"P&_RH9!^GRZO/OZ:W.]?MK%D[!+4PQ>H8
MTL:&IL)_FF-@J5D92)#,%K<4((P.FKOH(P78'XO0S Y&TD*F-P#]?R;\4<)G
M.KVW\<";XWCGRC ,;<K=;)V9DYU6%*Q([%3 W13MAV3>E E9WZ:XK6X:GZ1A
M7?7']K%\[C :@?$P T;E$9T(A3L7$>\11ECLUL#FX53%:/XC__J96>A2%%BS
MD\NKYKATLO0<)I$[$W$6Y6CGS?ZRX)*0"BJP_=J*38H!G5% 07CRC_W@P.+E
M45)II?&W*YVR%'VV$TF1"'2$&U:!FY]WI;>BER<V]F$!,%#R<Z3!V_1]-Z7M
M,P61]UB2QO/CBE^:NIH*[*37"11?=ZW^^>;(\IB7ZKX(LK^G$O+_U9EFMOCG
M+K?"_C9X<<.$,N^X?/GO78H,D6\,YV _]Y_#>%;3[W=1XG)LX#A/CRFSSQ&U
M>6Q%'1KEO2OB+I@<BN1OO"NA2+M7^39<3IQGA'4X#4:91&$/_0 1U]Z;WWNE
M*BS*@4I[>RHCW)G) ]F3&61F62O"DYNJ[OF?-IIGC4X?]36^F<^M0:]7.$@_
M-:VU%RHZ"3*JD#NSO1_%9O8C=?*=9.'?-"/A%Q5W'LJ9C#[ESMG"&(WA_!3D
MH-GXP5)VM'97"$7F&> #?]$6'!?L\ SX]I9\45L@U6B-*;U^VR&MS\@%^F-'
MXF,!;^HK'_X>Y:VQ]E,=?A/FJ]]S3IS6#92F!:@=:;R;^1F1),VO'#PX$.,^
MV;&_4K5!:>)_."F8C\I6@^3)JGR:J,(]F?*S9Q7,!/95UB8& '(XQ6?4"4=%
M#.%77Q:[GB:"R9 ,,''FV6LPY3+0E&V68]7S:R&*341)X.\>\R_T=YC&(3[B
M59<,\%S$\E;48Y&87KD=='Z^&AYQG?+V5*O.Z>IU.?GF$FS%W'T(>**&8(SJ
MIP.,EQS3BCVM/,T@DJAKOL*%Z1N7;9XXR\XIZMP> 9I%>8N_,C=*Y()FU#P:
MD6KL'X;DJL73=<>/$31%QWZY*V-\MQIV]?0Y-#D&'_<^_BGT9F%(&Z&J)[\F
M*;&RK?SJQEQ5$C7WN:2LN:%5[F4?[P^ODQ\TQ4Z]:+8%[ M=(D"K7D/FN(UQ
MLC[=S!H[HG7#(_?7FO%1O#SQYET+'-ZT;JJ\IA]^+H$(Y9D0<Q$G;>EA\Z=G
M9H]N[0VD;'BJZRF=>/=W>;+<5AJSJN>7MK/J5:<5E9GUP;%/'9,*%QFKYZ&0
MX5CR:L>(B?R!7PKU5(^5J:VRFJ_SSQ0MKLQ#XW$6I\W0 QS$?*WL*ATO#>6R
M _.GG".T3W4L)>-0<^Z(5%!NEJ>]^O86%2^6>*1?_ZE@JI>3$@4<[;#B#,?'
MZ_T*^@.-K/I7ZJ*;NQCS5&B*IPFQA@EC5Z2TL-H5)=];[]PRPL'RJ-'I['*8
M7^^#NKF/M<:'+;9%5(O\:KO+)N^G[ILZ].!E"V(D@F$.'2S;-'+/ !45OP-%
MH'OI &/F?'7W;,YA.#M+!D8SWD,OFFMX.\FIS@ZHL2Q,@@R1VQ,,72<9>._C
M_C%]%;+3[ :-[D]B*K))".=1H!O[>H??@D/+?CR9)D3WMUWO8C@Z>%-\OIH_
MB?#HB;N[J[%U\0M,X#MIKHN,896A0A.,K; X.7FSU6;RCQN 3KD=3?//QW(*
MQFN2?XMKL(U^(O#Y&6!2$<#6U3RWVSFG>V[8(9>_X[NJEDE10H%5WJY!MBM+
MKO[2;SC&L=993+C2:$G:T=.7L[H"AZPXFM'M&]MO.=4^%SSA7CX4K;X@D8O]
MI&J6SHN%SM)CN,OHPN5DJ<FP2\R;HXCD9/(OKN?&S?]-">L(AYLA5+9JV"2C
M]?R2(JT14CF[$_F,I&W*?T?X-'OMZR9^O4S8(EV2U;]ER9:#6V62W]"%MCG<
MR]7 >&;VM=H7F),&]CU/+Z)5F#V64:]\%6*&7/L2 4>^/_"JMD!1_& RI!",
M.69SW!/)"[8G)3;2/X+5[C5^3X](QNN@W4Z9<S<C#;!]C ]0[_[UE+'YJ#;8
MIEH$HUW4:0Q4'FRPTQ@1WU'S(*2W6Q);P-R3\_XUAE'GP[_R#QXK!EAM.6,A
M)#?G:"EA$N!-.WY)0DC-^$*<Y\YG&+;PSG([>L+OLC)[Y U,+4:"0\75G_\9
M,(1/9GJ@!K=6-O"4YW4FIM<<I@K2O0M%%1XN>T-7TL7TF!%@A#X0'.&W'RKF
M:+U10]>_Q[#E**D\L]WPM/IEZ)#&0KW6V-D$?%EZJ9<*/$*9Z2;DZ+"%Q<G/
MWBSGRV^KQ>][7M5R#I96'KPG (%<Q%+140'F]XO'S2?K-6:()+@WPJ3*/LMM
M_<C[B73FK+9VWW%&A1WZ:>+$/W4@-5 %X,?OHS9L%BY))$&/U$58;]&A(Q5R
M>Y]H+VX.008S5KH,&DEN>>8!X R<["! 8'^*Z9$JZSC@16::V,S4_\D(T+P)
M2@:XJ<JM&7Y2@'F6O8N.4,??T:0N)Q.Q!R56!]DXW+ !4.?TRA=IMJE\3IT+
M6[53K+_KOMGZ+(=WMKV(#KZLK22Z;34=%K<NXQ'F)OIKO'R@:;1T%KL[;6A
M<*>1E.V>DJ2IM.."<6[<?8IS'YGQ(.$S"E_;G8%=5Y6J_5JY^RP=VL_S:U>*
MPIPLKQP0O]=^^DF,N+INI9TD;2*3HGYZA +M_?+$])EHN*G=@\QP^P8HH:[N
M/U?R,!ZO8P@8[^3';!A"YP(Z\<L<%JWS,I;&@TP(98-P?"@-N*X[N942#PS>
MA^FT='<1"8Y<UIY+HFT?^!SJ< :1^PAL/T@S3/UQ^P@K2W5VAI^Y_:%R!>WU
MU;K^?2)97QFC;O,SD?7F@\<SL@X^^4?#"80F.5.I&&I=;ZIJC+J2RNP.2_5)
MC:JJOD!1W(D(_@5/_+;]YEHBH_$U \FX)1VO'_50UL7R)KSBY9A\L3$'J<.8
M6.JZO>0'==7I[Y';O9,5/13@,4<U^!M$.ZQ[0$(0$>6Z>;4QB2O<N4 O\2;G
M4];)=-7OE+<?[/2_Z:@;)8HL'G,F?,ML;@O)'G<MM;=GC(GYRSF"FZ[^K4GY
MZDB0VJ,JF( )?=,Y82N!7)HLZ@9-_<Q@\IZC9X?6WV6UIU9QUM&^2>1U:M#Q
M"FS][R1<XQD0:3:MON0SJ;M8<[/,W]HQNQ\O\S4MXV.]+"W> G:K,NG+4%1J
MG,!/MHD*?SX+RKX5''6?;(:8(P+"?QRDD5E@_342Z!E ??@V(BD].YL#'<W.
M8GS/@)V" ('M2TA>5\ND.6M-/C$<B)S5;)GAV]^+)T16.%O0W%0O>/N%&Y*2
M83O7555K6J3W^?3T0MVA+<'X/BS#IB^3U).4IAS*$H\VK16880(P AN)KVC0
M^*H7JIB;D?(E_M--$5>7\9E$^^3[OQ@60W4*B/DL^72PO#%1:>5__$:RI9V6
MA(_DO1W9_I3QS11GVO*;JDWJAZVR@=PL*A='5TA;RO&X\1P_7?0BSS#K16T*
MCGWJNT0ZXO<4#A;UCKS)Z,<F.HU<J4-?A/]64:)9 JA=W,]$G@$))J-F2O21
MFY_\T]$_2IB+X ]W_RI>5KVE5*Q)1.%/HNL'.M(LAC?ZKO0EQ[# V-\'V#*&
MVZT7^%V-<U55(1[49VE7$'KRL9HM9)(7J=9%O;^%'IA??<@Y1<9T_2670!@8
M_4D(H5?:!@VW'.K\N:+Y^'6GZ?+D2[2",RIJ)F-8L5</8+_E7F->-!;*;Q4U
M<Q-,:3C"GQZ$/85P%MV!4;$&WHF!ZMT"U2I(2',K$7M]ZG!3O*G!Q-44&;KH
MW"\H>G2L#RQH5VG7M7OTG/,+>^^<65=*!:VYB N;Q_Z>_IZT4E>C;Z)TKQ3%
M5-1<;O8-=#,N*(HG7GY;P9@!;LF=V^02D]DV(UH5R&7YQA?.GQ:S  PF;J,/
M_"- Q.G+4/0.637_A'4P@_#>!$4U?M]-M+M^P :^,R3Z;+T5)K3N)"6T4I:'
MM7-=TI@T0#93.BTB^_K5)\:8C*[ /R+.OWLM#F.ON['?J?"GEW]D%,/+;ZWU
M@^T:YFIZ^SDX+$ZL$W;;)T4%$2"^E_M8&5[LGI[<B\'/W:L>$]'#J*JE=RN=
M71D48GRI=K4W>%\RAD&N50(^/"A,.I(-VWF*L_TKX_-(.PM_*Y+(%.Y^FZXV
M]<_"VG.NS?0&><)",D-RO,8L&K?\5L "WBFD8,7!O5=%E:'^^C$9G?7L:5DV
M1Y9F!(<N_]$ 6]IPB4,L3"UA_54Q+&O@_-L3]PR?LFB"D33LM9:]2.Z)473C
M;E.[2>QP:I?#@1>WICLT1!040T>.)+N(Q)4P(T>DJ5V<^(4W>I4^6=#EC:*8
M=[6@V1[K=S<:5TCV))$K4J'+S\:QXWTC*M:+#IJGP^QB"#"?"Y"L_L>)]!;:
MGM)HJTH/O9O6V&('[%*5.=[B?OR$]0G&,U!KN=J.W5BQFG)HUNC\[<9.@M G
M23UW$-H!?)43YL@#%96V$^5:75I%27\E_)L(WT$=O47^?RF! I)M065W"WIQ
M'0;%/L3](J!HS^.#QG&JS\W^5>VM#?6LZ=;9V_?JZ&0P%GC@1?.@BA>-F5$K
M[+6@JU%-96W:ENBI!&?H]TBK,&W-)?<KPM3WO"'LZ?\R"@\B\!D@N2;P#.A;
MUWL&[.0T!#_8(JEGGF@05L-D00+US1>+T6<)!?F^;Q7$EG2:VNI/5W+QUS@
MIC>G(9& \&3_6, %&&'%';5^];CMC.2\"7Y2+'HB']N\1?[#_<O/ .Q LV=
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M29Q2N:=,F@J4OP+'2=I,0O'[0 W[)\"+MF? 8.I*OV.EV=K?GH4+OA!1>V]
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M]>I,[UM<FM6Y+ ZQF6\.ZJZ_+>57X1*0TT#K>=4/WFWG)8LWMW02%T<9)4Q
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MP_#TS\=[GUI7"3WNTJDC?Q^IH_;RCR&5$9@PM<$@;H1@^8$9J5,C$!_S3F9
M/7I)M4F=^0Z+>_1SKHE2,Q8CH]O[H-C"$#$6900WC'067C??]78E0+$E=W-W
M(KNISD<4^#I1/;:U]PZ 0ZFRO<<46R#R /EOY^HZYS56[<U?LJCDA=]0Z\3*
MJ1]I7V+T_L!G:F]XFIQ;NZ2HY;9(U2$V["A^%>_RXDO@2I/2$^KZ1!"C(2)8
M%H$-PY:N2W]9?[%ZQKGZ-UV-64[6?-BEGSC^WOSB@VE#U5_EPA5%JH^,4@-]
MVE_2MV^> 5B; ;X79[.#?J8_B611%2O>-';9$504C+>DOOTM8YL6.>'+P% .
MYW-MW5LMLW)6G[*>\ZQP<DIEC_M*'%AL7_@I/M5M/)Y :COQ?6"$60'YU,?I
MNQ'N=$:W)<N>"RGR"=X"<0"8=E9,M$2V5-K1VW6+/=_^Z.H$MCRX-:Z$;9>/
MR=&>XQ!6WCJI6E#8YD\7[E6W+BL"+*!/4Z$7_"1F4 [BE&**=<SE6F*@Z.D1
M/]*^\U1HICI8F@6FC;UFXKA&<)_1Q_/589)B; .<5M-2):S- 6+Y2]7=-(>3
M=A=10T<Y)2?GM'$570^ENM;X=NP !7+S]KJBNF,5NE?7 K.,!33*@Y&!3\!L
M,<7RS._NJ1\APPRH%,C*!%#/*M:M4O<,&*+V^DA@MC'%6)XEQGGT;?=Z\Y>K
M.RHCZD3IO?39+ VYD:_>:Y2ZCNB*@=WM(HX56)WNNUQ^3R\:D\E_?-CZ0"O#
MX;NKO6/^1#VKNWZB^V)5:OEUD+%KGTM W8L?%.(A+U(9L4X26[3>.$Z.3"XN
MAG[\*Y+8#/BL]!L5%?+;F!8=%62UN%;<FO9;-X6!8X6X.0ELVOUHKQQ9($,[
M)5!QUW ;[?"DSW)=/EK2-5[RFBXK;0P@@A<\R>=;M_B%^#=-C&C1:J0. ]6$
ML-D$R&4,(U8:6ZY/\L/.<CP 9<RJA1R9X%O0_/ 1(2,/(^W\L7+<A.F[6:J<
M[V$R0?_PLF%PCW%782P\PRSKIT7>%]OHQUQ)1WRTI]DV<*Q'-UYID9UWJ:J7
M;/E 2\%TKN7$-Q<4ENR_9Q0TO@.K)F^K3]W7 D)&J'HB=5*0&X.C$;BI^E;G
M+S W[L.AE4>:PW4<&F+'M";SE]IA+DL,/Y?S\)VN=^;6^K:4R5A.V0Q%?:BC
MH=8ZFDIIMW68.WXZ=N99RO[;+__<6NY^'J**H'JK_M/KW6&8M-!^JGU:1^>B
M"U!%PU*<@7@,<LF$%K4BC3L;#_@0^N3^N;TKE7_98<P5;ZC%T[N7@OPSM3?C
MU93F\HJQDF.QD4"88[9/?&C SSS"R35 Z.PR"5[1R_F=A?L -^57)E^\(.H_
MY*BR+WVI6ED2OP^QY0+=-(63H@SSLZ(9%YQT"3&)I3D2&%)E[DS0 >;6D?):
M:==P,XQXNQGD<K>?_SXU%NS\E8'! ;2T!H=X&73Z+F+'2\,*XS5/&+A :DBX
M9\)UK3.JC^BNS>IB5/=C\7L:%W%VK%N7=OXR)W\&MRX6Q+[%]KL@,=-RQ'(1
M0EDF4'?X@5LU,/"T3'DQ<4D7JO""0/M3EF;TF*5-2[P  "VP%GCU#-ABB>3K
M?AV@#0N.OP%'Y7QOBKVD$C=T1GR^/CBI81S_[GTY.5'#H6[('N*F?DK.:>J[
M$!2"92BM+/72%WS*\ Q@%!P*OME8OR=:+%[,#9J1O)0)L'T&F.(^ WYR OP^
M!7L\JEU5KQ,AW)5@D:'E!SGS\92E:<&HRR8&*UP'>PF1%/I^A(;O_J<\=(<]
M0/<B(/AB4NWQ9X!)58!'2\-,@#*0<^B[:Q#398<DJ3)?R*L[ P8)PSOS+R]9
M6&(!/S>ZHT2"X[IXCD"OQ&0>Q/7MUE]UO [7N%AH%7/CXS'.E$D>WDT>Z?HX
MEAKL?15>(#&.AMIH[J^WLU>Q%1ATM1'<?XJG!DU3F[X.Y('/[$T.$3XVCE4J
MBBW*G%S:[@^V-@V? \@MNIU>!>W/!J'ZG$K:KR,,]22)N4HNX@Y&OJSAQQ@;
M^:ZI?Y3BT&:^L,9-6$X444?OUI#E#[5^0TUGI@10[[D6+@%C/&9UH?FL;^0]
MB023(Q6[8/?'.16=OY3K_C8D[4T($D<ZCF68I3N0'P%7#_[/43NH/<$.RF;$
M=FL 6H[IKO<KR+?3':(XMR*0\:8HO-+%Z#7#H9^,;R)Q,%""8&DT$0&P!TJD
M"XP[24+(P$XPF )I#7LQ4@W^DJ4RC\1]E>)0RO'.7:35H2JY7>K(Q=5,[VGN
M=&/^$23FMDX@,?\,P,B>_;L6&/XDX=X9T,W2_'WOSM]]Z,0V]M(,)4#L@CM,
MTOY1Y-X?3"&]Y4QXT.PW\;W,?E$!JJ2Z15B>723SK=5AZ#+^)=.(,1QPW]G0
MN!'B;]/%C[#=XJ:Q,X/8Q&PL!\<LKA/M1ZZKM\&N;198KSOIC7(Q-K!:8QT'
MM8=,8M0'V_66B(:L8Z9$Z<WE=H_$!WW,>KN7L/N? :B>5Q4^WH-=W#[6'2#U
M]EFP)_EN4V=+AE)'&CX';[-HO5'Y:Y1M$)V$Z#",8;#[%9_LA6"BF(@%(J-H
M'/X,(/3Q\Z>2_SN+6\5^H7_VFZ:'']X7.'BO-TG7)+B.H'\&6,M\_%?A;ZY%
M_GG54<O_VQWT_VVJ&1?/@,'N\'OP, C*>2-.IDUXP.Z68]==\!'-S6B(<I.S
M9R?B,%E^X@_O$/!P/4Z"=8[!"!_#Q\V9>Y#RZ6 K#^<Q;,EUWZ3N&6!.S5U5
MGV08BQ_5!HHLNU@%1;V=?3/-Q[HFQ-"::B:B<@A9BM84)%(F7DE5,P2<B@EO
M!K+TB1@;>B64&=DU:<1S"$RCF54,:_JGC53Y9>:_JK%FJOF=W,\LB%'R=3F\
M@$*!H<Q*MY(]M]SAAUTMDX*E6<?E>QVZF&*HTHF=P$G\)"Y"3?DBH<K(3EW1
M&=7JUMF5\8>5N."O8:V9)K::Q K;BBK^_#E!I>P5"Y>_]ULUFO%%_.-D'L*R
M@U"E/_N>[/F&W(1+4&E/^\S%=XS9_EXVZKE"$["\,_&6VMB61^<!J$I24J,H
M58(<E&HHS).@(^0#AQ7TPWGC]B+)XADMI#>B G.NNH@=JKL&O]5JSJS)SXY6
MXCL4EEM,@$-N[)_\26Y0/3B-E^X^!GW8WW?N<AU7OX \PJN*^WW]F@YF"W_'
MO3H!R ?,GRIK0&9.6-K;"T2!7Y,;4T>7=>0K^'\CC(;7:!HO=+][<C78U%6S
MTP9,YV]7ALZ!'+1U!S2+8F(K-&3=FFUFEFJ"2>V4(I1:?(6TG->4#@7;_(+0
M7?6SM(:Z/LP6\;"Z6[E_6QUYW*'IQAIZ!GS;UUJH%Q/?/*XJGUSMG N>?C-<
MOB+8O '9S6GN,R,_ I%Y/!J>ZT#T4B*6"I96,#0%I'['^CZ]0;=*5?&ER 0*
M]=%I%K$UIVL!/V7<JE1)0.U6B^;&+G\KN=^O6BM-IRD>+3>-LWA>+=9+1 2%
M'TGF!\"> 6@/SX TQ0O!!VC24YY3U3+2%J];,@+"> $9 CEN$1,*:!Y-BS45
M2DF_D$W(:"J0D_X]X>(:/A@T3H<)#D(/(+I8#(/0?,35? :H*/ZY]?I5_^F<
M<Z"!YF<KP+=E?Z:K^BYM]N!__=U?&A@Q3.6UI>>S-_3B[7.D8/GC:^5X:9OM
MHG;6S$]+8R8M<O1)__B,WUYGN.:L(\2?HOJ<WN"TU"2)ZOIMQV<$4+[QP7,7
M%&ZD/75BG<'<D7,10TXO.LHL]W$CM* %/('XI5U^J)5NQ6;8E)MQ5@-NQ524
M8]>=3;R'E#Q5,;I&B6U!"V*?3JOO_6=BVP]R@J+*$6_'M.H@K8E7&B*0.!Y%
M*V]FL>&$9.)VVD=<#XB96B9F-6=Q$\"H0VD:\%X@^<.]9;7>\D;Y,'Y4A)!B
M8UO3VOW93?V2F9'^W8JLO&YU&9/MH7.OY_D>">YNL=["C-&?]L)DBP@56:^\
M_4%*YZ@.@Z*C((Z9VO/]CD;!YLG ESEHZ2/9:^^Z.]L4@C2:&=*&,$D.H9'?
M\2HNEN4:YK?C9!.O_H3::,+4L%>ZID)_,RI).\#1T>O *K#FJ(!'7?8X]I0R
M^RRL9X!MYU\*JW1F5)%G #GJCTD*^ZT VYJ^G,!(4,TXYUFQ,5G+['Q3S<"7
MU^KHJVCY?\6L: L[!B.TTW.72^#B[RSS]5ZW&<+7D4D9#MU?U# #J,*&SL94
M9J]'.&C]X^+:B^ @B*_FD*$P8Z]KLCJKJI&_!U@:?XN. +&O/T_UL?YB(9MK
MFG94VPXJ'ZJAWJ$82;C/'H+Q\FK>W20I6N_SU(G3#:YZYWZ4HP-+ZHVG=J:%
MG3OS-#60PKC=:>?T<,)UT'>BY*>)/5FSWUY^C634VT4+28?\<[+Q1)Z0MXV
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M3]F0"NE^7T*AP=IAJI&/04![%NG$,4G;KHXC5$Z8E:*90.+0*I97:&SM]!F
M"][K_LC3*J_"W_64+W@=7+%'6L#:/7/MS\X^%B<Z3CHA?.98<W*J/>G(L<15
M_,+[%*4OK9>E(..0KIXDHO3G-A"?H'-L8C8N%R@TK]2R3'EN)R\E\.UXQ!8.
MIIIS*)OA%P5F._$=D[RLM<[\W1CC3)'NHBAL<SJ\=CRDXG=[DN%+@6AAB!2R
M2AII3;!@S)1:[UQIN?,=#1]Y^.$%SNE30N38FU!*9)%1650*W7Q^<.OHAR=-
MW=#X;^I<BZ@,)B2<>'NY4ST<..X^4+.[4^1\'>RY[)B/%OZ(='K1*=&!#Y\!
MJ78A^-U_F#:-0-C;#1RA@5C'>I!59W><7=NP5<4O]!\@75IYU/&+ZR" 1= @
MKP_41'+P<)LF,.#CE(E1KZ-'5B811ZZ5!6/*\)<7\L1-%-ZA]!0XKZ9!19Y9
MK7$*G?[";R)/S=UQL@PN,^#Y);")*=<\K_& 9\ #M;WZD8A:#)2&M]_0W"B;
MIXOZ(G ]*J,^X4^<2Z6U1(0?3OA"U[?NNJ9Y#B<.\)O$HYDM@<BOS.HC;]_3
M9X1NA&&BT1D"[OSA!HB*;4[;?HGW\S=JA"M(_1G+%DC2YX[9FAK+@BV5ZN8D
M''NM1^)Q\ICB_OHJNFQ'EKFGE_;UQWZ@@:JEQN5Q9H, M<R&.4+=K[#2O_C9
M[._W*<A9PD0\:L&]=)A(DHL_:W08"'F9B]8.#"[5I#)9>YOE_'8DA.I7ZZ^"
M[Q*0F(NR)SEPK!F<+_B,5^T'?LXSX/^FWK&?/ /^NP 8UO7&I^FX-P<PQ\E7
MX>G[>8PLC9#AJ_!=(HKXK]F*'[@)P4]2E&6/OI//@$)HMT&PM=H=_WGX,P#.
M\O49<"^+&Z1TE,8_&0$N_9I#FMJG]Z%[[:.E5?@9^TT57/L?P#)%2#X#++V2
MG@'%ZE/H%7K? KS^$5"U"]!6=S\=UM=N/ @WZ6$!>R<0N&KXITY%7(8MU:68
M")4";ZO(GC90_._U-9@4IANW+4XV6( W:XY(JLSFSST\W5LM6R*JS$S[+ !B
MKSV8<R_@E:*=P;,#LO2+J,#C2@-!&@M._,L))^O MEBA=?3"+7Z=GGM=R/_K
MS1N-!;Z6&R.!F#I&ZJ)G@,<B)G^NW15Y[5MVD5J!,R%)-=-.X(Q]Z<]2HR.-
MB.\HUKO4+J.!"1Z:52-%?X<\[B!&!;*N1<*9.MPQ3.Z[$3N5H7GA\?')0I--
MKL:WH?P+<Q S M5?*R/6KF[UC/?QG"B14B%C1.6 ")-PW E%<3G@#->U_RJ1
M)9:R*YY;?:F1\''!-MU,?>DOQ;*F[.(HMN#Y#4<:>50:7XI;L!P2[BW,.5IC
M.0)3Z:HH'?1&#;&%<B"K+48<<%#G<*A!KKK-;XV5G?!3=YS<DZN]:8ON@DAZ
M.(O]Y)IQ<P5^BC=,-&NHB +J&'V8=*7D1Q56]+K43%<#(Z[,F-IEB5;U/P]:
MM1BGXF%R+(?TG6EV\M[:>\0J_H1X>XS[[GZ5TOEX'"+H(08*ZCSJR$J1?Q_2
MQ/Q&9,B%RNFT)/IZXEUS%J>S6RA)F9=Y#:T"BN+._IPM;-SJ&-O9O:PF82O&
MO(#'0)EFXI6B])";JM"$#^UUNM%'1\[Q%#?";3EG'E^%B34=Q8E_V770\BAG
MS+"'VYHT >AP:;Q"85S%U.9$) )+Z$$-7='V&N<?WQ'D*5Z 01L&:(4N\.91
M;_,*BH1[]K'#1VKUMLPB3SKT-L:!_?<9CVLI%E6RG$7VV&\,WB9^VF%^$L)9
M]<.QREE<6KME*5B0Q.CB"U#H1-3 @H=,.8@GWRWR4^P9IU+\X'YH9)AZ^V-8
M%;TDJ"&X5R! </-8,C3'N*D+<[Z#";S<\-AVI1.Z^* K;QQ8R/P&DP%@H45'
M/VF<*9%TH0?708A??!NX)PNOL>RR@'@F:)%YBRI0?9$/B& 1IOH(6X3XQY5S
M,;!QF0K*]349XRG<$_BBEKA]C(L',_AJMS4J!"@T?^PQAAK*02.:3-<G :^$
MZ-/$OV>YP8YUR$PR;XT3^]A%VWTM%<ZX4']>?C?\$*&W082/3G$8OO!S<<GQ
MU"8,#E5^")3QD%"['XB9\&HGDGL=NAP2C 4N1$1</[(H=K3Q&(\2"10 /:QU
MW=X3OGV37\:R8NZOFV"0VB2RM O)F;=,M*,HX-D,RZ,I?N&"3IOQQZ=9VT14
MK8,T36JQQGY-*OV*7B.>&<_'O)7FP>U=SGX,N.,?4D9Y6?.T"PEC'_R2>+23
M5QCO9N5P*?\F7/^)M:X.]L7/I D,W%LG1R*LFRU)H3H] T[".AR*^Q18TONQ
M+665B5NS\IR)MJH&7">OJL2";>8#,E*0N5+C=-D[A-3RDN]8F/RLL5UP U'^
MP4_<'PTQJ9OQ9Y3:YLO10L(,W20[:AO8ZP2'BT [L=$&:\G&QGG"MFH?UN_[
M+F\(TW[C]75J;?HTJN'R>7EU6R8*K]("XG^:)0PX[>SD[;<RU]5"$_(3["Z;
M/3R'NCCB/B%02A%;\*NGUWIQC//,\UVSG#MKA-VIZZ<H<[X_DM69=_!![6M=
MLV)Z>^?#0! @X!,"LL5-K!_P9;IKW7H+&_B.KWU<]4Q>_Y.NU1BD,58J3429
M:L.1=6_+.N#UR-5$T75L!]WV?HR8[692G-DKU8PMC,9G -;1&J,*B_K,-@27
M?YN_9J[5+CO_5Q+3^TH4QE0C5/2UE]K=TR>>B@Z['?7-[:D3%JX.5P.UYEEV
MZ@<*=T8X_0QYQ,=2= Q!?]>I.Z0W53QD-\$T9=].^4#81SF/#<LU'6/51YG-
M!)]RW.]"8\B]<&*BF(8E.?V<3VFVG(D$^[H)H2P1IH%<@1\H'3^;]9-_:YIY
M!K19=9Q>H[) _"##_6 L4T9,R4@/WX4UV V&KC)&MKS;OOM$JRFCI2*7,$LJ
M,.NQ6/*_=*EZ/)0=!><'22 -$),P[B&_]8%3,GU$?F7OI@T,[U=15^9"DZ,#
M)T-[ZNOHL^@\!X";^[E9G>+_5"J1Q@OIDDE!#)$HH;#2SEX*NDN"S!"Q[*]>
M>EZZ3Q2@(0<H7A)<.9><=FVJ\G>-R^KG8 'L7\(3_U"2@,L'./Y)R8-4@/9"
M,- ,Q4?+%!%7B<CJ;^N,+')UM?5_65]$?KI:]&:8L@ #'>RL=*?<#Z]X!F!;
M#: A4JEV+^61BB^NG&]]>\GO EOO6L&>CVE#DDZ3$>8NDO60X$?FU!!)DPKR
M4TVID>L2\/?@C1^%S@B-IAKT00A"9*P:"CK-]"4^I1:ZY"6;7 \>>P:(/3EG
M,0(\0/7/@*%G &W %]"PXG9PY&TW_JS<?,ZDJG_]W\ZHO1TG5":O^'IDF<^P
MC.FI&6V AW(HK!ON@0E[%..)V,0M/+=^!GS+>HG__9LHU<0S0.]A,MWYSFT8
M_43DOVAH,#5HXO:@H 1VZ]1U4F1.\$ POKV?XQ&0]#ZS@32?VN*3J29IT&2;
M5@=AW0">+\D5_HGX9MG%^E : _+=+!^%[6Q9J.=($*,1(G(/2A])T/\B=;1:
M:@RE!Y6%)BCEL:EFUNPQ+P"XZ>][$MP$J1'>KJ_OG+><C1A:>LO],$(A-X]&
M2@$(;TQIZW)[C&\<HS)+$% AZ\6/6L-H,:(*\03A(4;7-=O,DJUUT5)R@1XL
M=>=2=#_^\WQ]P.G_KWMO6-",BUF'DM;WXRX,%)>GVSP**W"-D5J#(+:#HCX_
M4/39R]W$- LJ9<9;+S#I!2;:&XLKFGXG=#=TOX,.:;#=$_FT,[^C[I$HI\@$
M+]\M41[;FR.5@*N+X '*X.&J<8&9"5?!;QV<[SI;(^:*3-?%9L10DJ]V!UJ"
M?+CT'DI#Q/\';6\9%4?4M0L6@02"AP37!$L@!(($AQ (&B! H/%. @3IX.[N
M#@$2W!T:=W=W;=P=NM'&NH=WW6_NO?/-S)I?\Z-^5*VJ4[7VV76>Y]FU:V^9
M-?Z :FP(&J!$1F 2!=NO%INGQ>;!WGWYD#7FY2A>5.F">P"]4S;*7>DUYJH_
MV[SU$3:EX:<4>"DK0%HL4,QAB :Z%=+10+,X*K14]\L.#JMB]G%\X6U58^F.
M$AUQ,BQQ8G@OM[]EM+SY2PQ?'&Y#@-H45U^^936[(O=27F-]"(ST@&F$5&8=
M,NIFA!!R'24TPVR/3W!I22]/27"X'!J3V7>D>2(P HSRC8;UKL&__BD<_):T
MI=V_4+&4](-+'6$KGSBQI[>;4#1/"_;>B*#'FZO(E/DCR :,#D'$T$#O^NFQ
MHGBG@WGI2L8"4] "A_GH/6]"KN>\;IK9F:=/@W*0B//:'JB;']0I56L5/Y-U
M]>I D&.;JY,[XHD -FLI^^);WEL]M@EA'6&G(_,L"MF,KX59<[B(TR9I1NYV
MU8+/0M\6-4I<1V FU7(.%E>'5<8E?\<R$C;8.HK469+&W=A+H=(K=B46]T2X
MLR@L/:? =;JT_ ,J6-/L0JG%Q R)]Q<=0+:?R=OGB3(C)50.#?@K9WF.CD#1
M@._##K*PM@BB0>PT*A>AT$<B%;!&J?T1-_ZTQO>B-#</,V;KS_XZS9L"?@Z=
MJY3#-)T+RVT-'OXA8R6?..F8B&#7PEE(3@/SJ<ALMS@6;XFC1&-%"!I0]3$E
M?\,T.S$4TK9I1%DF0XK=3N]?0T< /W2LN ;!XK99^ EPAA3"L#XYT^5-S6;M
M@^"F\9:BG=?6^(_F6*&8WEIT6*T!9YT:*EU#^C@Q@J31?XH,<G%(,P=L8,YQ
M0H@\4I7/"R=Z'_8ORM,N4W^H<19(JU/[QK0NWMS#='?9DYJG$L7)8&7E+4Z9
MM8E/_G'\S=UVDMV9Q%V\!2G(A=S@3FUIO/F\\ VU8]N9HZ)F7NU.=7M.%O*Z
MU/=_-2)[@>!%48=<;F4US"K&34^M[RB5_Y9\&?G$E,O3-S;9OAVJA7A2>>^;
M,^AZJ1"ZY"\3:Y:T*2BP"@H3++O5S[-*E DA/[)6(&&=ER [8+>(-;Y=1/UJ
M%5@__&*N3$2G;ZZSK3COK*,@S#OI"MN?%:MDS#YA*[U<D*Y& P'C*S.PU*V?
M<#DCBYFY6V'I7([F#ZL&] %L+@790;,*E<^DX%(O/T;+<O5]",,\9EOR\)>K
M5>*XU#$_%=-VD4O/#&%7Q;V*YUKI(C'$Q^@3;;\L90<A%?/ 2X/6%"J,+^P-
MHOKZ:TWQ!1F.*"_:SDLO0V@3*Q_;'4<^0HP$P/0S[@NLLU?,J#J9?EA^Q_"O
ME[SMF>O]@2W(2,F8)W_MM]]"U31]>/>C2%>L!.*<S]MJ4!?'U/R+_B6=JG<=
M39?D!X )M-M5UBMT%$TFL=O)MYE&@@9^<>*X24Z@1O$YUA:JWR&6]H+R!X:^
MQ89Y.A.C@3;W@X&>[TO&HTK+D3=WHSJ/P\(?]ZM>NN@YH!KI69&EQY.=5-JF
ME^R6]H42+:;V17U^N<_>BS<LW6_*(NH,#3="UN\,MA9W]9]-$=2UUD_]$9TW
M54<#3B./(MG$#!9\DCR#:&:KG3HOU1 .<09K2:(?!F;!+95U,3R%35L,(>3F
M*\V!)USZUE6QL<F@P%I_/K!?*DN$.42V/D112+W6* Y'VC.!,'*VB)W=)<QE
M=OCGKGKN"J\YK9C.P]I;<$$A7U7(/,@^" :U+MU0@4FRDN01X9-@DX)<@L_I
M9,^>,&N_;(OUPC>37I51I::9K7#BOE*!YU;BWP2D_2A"FE*15TZ7+ S1?>I^
M^2QC=5TTO+:\?72Y$$RT,2O&["99$W.LP/'I^J?T/\O?N,.6OQSB:]VV# :)
M/Q[3CCAM#&0BB_@32IV<.4B$1<4@190&G5GN?_2XADQL:*-J1#]N1$$RP^F-
M."$.L18K[RX%]T<7>N?F]9C=;RY;]?!0 @BZVLS/Z7H#/\/=)&EFM0*MN/HY
M#F.Z?*%P>\I]YSV-'W#[ %^K(@B4P%)G"O,+ A:+BK3Z &S]_9%UG80O'KGW
M%1*KA:S5AD]'1!M90YY$F[Y0D<Q?+ P(2ENW^"AHD9>!S9H8J5(W(R)<@'3I
MH=1_LU:A^></JR'U7,=J/L.6TGUZ\M%.B1';8HP9[H&BV\W<#&]]9NGAA</I
MGONED.*CRY.OB!?$_1P])2Z7W.W9.LTPSCD+VH'^-V$$WCB+#O>'.V'KC1BV
M1)WF:@K5\$6ADHNF^+&EI6;_PB'_M-_6O&9/-"NQ!PA!E+L0-@Y;^2DIARA]
M.>="MY[E,[G*;TFCOX3_2=!LJ?N^V<4N**$EUX6G\W^8H0J_XWR+&X];5A!M
MO!7QZ8PQ\/6G9$!@3UM5XU;[JO5B;\\@M;2Q>Z&Z%:J^8\N]SF'0HQV>4AU^
MMJR']!$.%>0X::\V7'K5S[+U8ZO\^J,T^*]!"_M2"XV3#0'C$?FSY</FVI02
M>W42RK" ]UXE(^,]0H2^,TWN]@(G39(YGXMZ\WNBEV!=9=V<-[P3W(WKKT]U
MAI:?GO%XR=&$@2J0,I_<B;Y.5>,598[H0TS2W^-0OHI18;6@#25Y2N?3_!N+
M4RW)\^#F8NZT_+3ZG5ZKGB=4,N.6KWO0G# ?^B;:TP%'V#:B?E?VQU[8[.@*
M?9-Z/C)!.["3*JYCL>EE*2/X33JH!I?RW]_(/ZG?4@.-?\].Q/13%<GAV,6!
M\!5^^*SBNY)(H &6<CXB7&CP(1^%94ZE0F.HUM'WN@\+*:3>NCY*2L_SL3 3
M+ZV16C]_'#>*'TCVM/TT"$C9+&TM40XJ<7ONB09PSCW>4#V>@V]M'$W:4V=K
M<1RE!"^>^C.G/-7+:"!L/M-/NF7L-G5&Q"]O]QY)S\ &-"6)-01I>G*6HMPG
MANO.>K_80PWA>8=HP"J5K Q^WU-K:[WF^KH#MO>AV'Q-;2K P] (7TY]E.8"
M"H)S=NKAK2TES%<IX-@A5SA>=33U]1;QT&G>)L+SMVSR5'EBJUMN[QKH4(Q\
M_O*V?FJ.#7JD32>SDY)%4*)[Z-OBDI87BTXAI^#GGEV)FDLOX=O-UMG'W'W1
MY'7QSZ/Q76L;B1=(M<H@B^RC8F++D _BN!?.3:+OJI^443VNB?U8Z7.\ISGD
M&Y3'3LWR=*7>ZVG=I@'?.>MPJL0M+G)4$9$7*")GGX,&.B2L'\F9,#5-NRG:
MENJ(Y)),R%CRKA(;_%3O"*/)$+42RX2FM6 Z)6Q$MTP>>C X*7=V2B8/^*I,
M<(Z_.^S(,!D>;DB(?"<]N24[]U:@1]%U^G[3Q3Z\>[%]Z*OT1%TX7LT+$JLL
MIE0A0D7@B\M_3WK;A[:M1-2 J>W S_??FURA:/6(].O'LFNGISX+.JFRO.M/
MBQ4SN=:)CC#K[3 E 3^_4[7[ON^FTOFF3QSQ]C\I<RO_/6(6)L&8P7 +FE^!
MJZ&!:S+4 P;,S:"!&PE;, 7A'PP9,!J(>O(@*_1MT<!N#70&/*^&4G1=10/W
MP3!Q5+0D.%;[84 O/N6;LS0T\+G:HP(UD'8*6<%& X=*XVC@/(0*."."/;^$
M(BP[6L,03G@=*+R).ZD5>&1[J:)C_@&1496"K0C&HV+.9&?!$9GE2VBJ/13Y
MFC541'%=%/.;;X<'OAU\.<MNEH633)C)_/+-M%_XY8^RQ^\<OV^6BAZ4W>?7
MW5=MHX$*USPTL#=RV:(^W42[%OD8HM&@Y@16F/!<8VQ*R2NOGR'F0R$-0PV_
M1_YY\H?X"< :80V.VUZ4"VW?KH;S+D>K6&M$GBZ#&L'L;H>1XZ>+O@0A@_GK
MV]6Q9MHMEQH5GL)WU6+0,32PFBG&,\W1)%[XX J/UY*@A/N)):E_+:M6GO<+
M<Z;91%G@F@?(5YX^I64_>3;L(:NX)BR.Y434?B,:$-% 6TSW;EP>AA<I<E;P
M48'\6([O9ED(- 9O,=<1R-"N!ME3UO5*-4_%@BK-;@Z,#3K7:2KB0=IQ;&;#
M[?PM-\NSE;7Y#QK#_=^I]_^HE*-_>K/<3GK,K!D7,::YP9((FL-[H6%\QY3X
MB^=R]^-.RIWU5VVG0:G6:G(R6$IU%RN#B,T3;'KY4CD'UD31X4)VP2;)//;"
MI#[O']%G:CWUWY7$IND\EW,&;@EWZW8K&!F!@4XL.C\-NHPU=M/QQ"D\+0=S
M#)G!R<B\-9!.EY#-4+E[*>?[@$\!.W35;Z8/>WBL?,5R"]]9S<5G<8R\$L53
M!7,+'E+]\/)[#Y+L_>G,<+YW42C&&*DV=MZX$,3;V"PSW!$JH#2#%4592]^0
M;HBB%0)EIN@/V==%GN5G(9ZD\,;T)%@GA&+TN!@:@F1JDG8-#C,;DMGQTJH4
ML>=+.WCE7HT0KW^5H']U,>#%C4,+26FMGCH?3.'+'H<)2XF+U#X#7M2HD&K9
MJ%=L)-LM];$T^YG-_.9^1QQ90@^;D=HX>K:)")MF.Y5?S+QDNZK?<"!^5_DN
M+T\VH2:F1A+/60*'>M-8AJ*=$NM]/[4T>W+K..>%B9V.0G \Q>\MS9-7PKG<
M3+]M%D8HA/%/W95G6KPA*1Q9KC:76[A')@%"]&;#L4KPS6759X_JU2H));_;
M6(_6#XO_SD%\]LG=@%<.\!$]O&I&BUK%9(XVSI/%J=_ S1@4=T>Q/=T_JKR<
M*'K,+A/6#P:;-=8ISGM"),_<D\M(9+,$A5TNO])'89SHYY#6A&6+O7)8"!]R
MB53.JU;$VR.[TO\-L4AX_.$Z0_HTJ^:XKM!^8N(]LZJEQJC(Y#D1">3IL^9J
M!<VI@O<R8T"V_TX 1H0-ER>;S\%:1*6G58$U;ZQ.=O1K.6:-\$S).H)B96$$
M\C5456@XIG3#QMM=KA"!S)./7W<BN2&+)[H(H8Z[0=D3-LN9TXKB?5NCG=^Y
MD?&J3B'I>0;)W<O4-(Y^]5S)R&3=87&H=+!'EIY5PMNW6Z,.[AE2;,X9T=7\
M\T#H6KFLKUOI8M]IJ78R3T4_EP_R08 <1\EZYB]L.F2@G#K?+^PICJ:A]VQ(
MT$Q^RI%-BH!87MSGC:03W-U.12$=3:5;51ZFWQC1+9=$:J/ /9'+@1B)F<U^
M"TU]O G5_,2QK-_OM8@7&#%"!2(U1(Q\XTMFL&^]A[//V[:_L0Y&^=:[4%D$
M-(AF+2Z8>AJ'ASI/=#_=L08L&%&/L-?453.3Z>M_7; 06\=<E9K-=J:1O4)$
M!J)$(5>IE).<'(_,:KCWKJB4XG)I 6@"1KV[]K;$CHPXYWB<SS4SYO/11>,<
M-_$"U*!0:>Q&^*\U,9+^]48]-774A&LD4C/A_=XIUYO*D9JH1Q]/)]DTOA@
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M_+(SX_*YZA%<MPF++H3U='&_\%1K2YQJU0;QH_QT?G[K$C[!I.P?M56'<%!
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M<7+@EETZE<5RA7-:_LV5LK&&5^_;4\8?M;V)TT2$%TYAG!'^A_ 1J*&:=M#
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MPD(ZHR1H?/=4>_-[[?I4W :U,@EH[DBCZ.9N;(\)V#[]\"<647[RR/^UV'<
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M!G[3VJ[+A+L]NR]:2^+@;$\C3M)0QEMN=YG0>U+VJZ\^+%^=.U,X7]6ZRO<
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M%]T=7:'8[9OC]F9HN_L+U8&-+=F!K+[B4$G;-F".0'<9*F,!;K--L8;M'X1
M1C\34YLGMHN3JDA6R3>0LH,ELS5' B@]+TV4-NF<6Q4TR0*FH-$_4&0Q(0N3
MPF1](W*:KY*&7T6PK7/Y1H-^)_:;LQZ. [SYMRH8J&HR>&,]RU6:+$;HU(V1
M ,DCDJN']BUB$VU]2*/J)"CO'HK6>_B[,'M<H+X!D!(KNL[OEB'?[BDMK"5<
M_G5$B5H/90$(B>?TX>4H9;3YH%M!/'*2+S(X0-X0K)S6TZ8  8M]T.8=[=AS
MFSP!_]G*<^"8,T#R#+'HXT,1^X$31A/YSI;)2B)GABG<S="$ 8-ZEZ456^[G
M*[P1K!$&AIMJJ:4,=7_Q1B>>^]J[\$$UF=N'Q&R_%\#'/W.GU$,G]$W9U1@\
MUL"0Q.CD_D@)7EA#CU5KPJ/XSZQQC7>@(>[X+!H8B2*-*@@3QE)1(F'ONTNH
M8<2BKJDY(XWQ7RVRH+.5&-+P>X(<17.YQ*%<LNSG774>A?>X,L)O4T)W,'/E
MU*'8UO/4PX-O>-+\NX(^I)QQPVW(OP1NO159\"!_W.A-T7]:6AKE85Z*B!]P
MJAR;64+,?&WE]K)KX)(.IZ]L2&Q-(JV(3T(Z_>>8 B4,'[4"M&06.=(&<B5F
M2+DJ"OC[-7[FK:XLCX;L&_[BT9$6V]B(OJF\H%G*NO55BR)NR=SKRC_TU>D0
M+/%S*[&]?4^1,FU?BV)8_34]I/T]HP/7]*NJCWW2E'F!^:]::6*E"/,V/>.+
MNG)C7+:H0(;S6[/\$X)K\C&3K>Y>%#NNQ (8!$DCTTA)TL6((OAZ;P^:XS6[
M$QD"/#<P"TH:?1.SAE_?01\9,!'+"@#KA?RB.MZI(_#_BA@M\=X;_Y1L8NQE
MVN+GX\]9=D N.U7L/0:=? $ DX#!YB!^%]%]'&*)K&?+0(!D'T(&+CJPC3[0
M13#D27RE-U+>/[FHJW=5LZ-HLQOW4VGL%[B-DJI3U]I$YD'J>0(FU6OHH'%Z
M(W;J];DGUVAM7>BM(?_E!%631E@SGH$N"V7C>WQ?I.-KP'^H[7\#TF7+J5.-
MO^I%VC=Q ?3@0+IF<,?6JNJZXHP__U]^@@_5) $3@\GO'?&*/YXYX^#,K'7G
MS7W)75>%1!]MG^KR#E9Q/ CZQ )0(;>CHR/V4((MM7#!7&;$Z,;Z-Q*ARYAX
M;+UUF,$?'[-ADP.%.BZWA#YS]MZ#X0Y.1<.YZYP\AZY0J!^JJ:AT&TL^63XN
M&B)D6P6T.3*@!J,8DJ0T9(:Z9RUQG08U,6( W.<XP$9)2+UD@,0DP+E1U$D,
MO&HHCYCSF>5PC7XQ_CO_*CG[>_/RM<.@)=W).9A/(V-J>%)]U5N\J3=79MFZ
M^8^63WD":M_7R.%W$84+[HA'H6V^AK4A#R>Z7(P//$/M0CK#Z(D4P8I&88E&
M4P,T2RU;+ /_F4M?-JC[+#[7J;WEA&^PK&=B]S<U]^C0X17?A^^4]E7#MU_5
M.-3L +<T(327'[II7@!_NLJ"#CD\+KU.C1_T$-!-DL$IZJZH;]<YR,H7"CG%
MIDO>7NJ-N"S1\O-#CBBNJ:@H=H)Q(3\'6*(?U/K6R*/ZNO%GW+%\3$ !7&-8
MI#L)_I/U"N48=W0R==2(_0<6VQ< =:<:T5K+5H L-^XXBL[=WW]1M4]1NGX7
M'!*C2P7L?I8<N *@$R*=_K5\]"W-<?!Y2R_V+4D;F\=Y[/74!FC/"3:R[338
M$VDBA; L0X"4FWY>1%9MQ3$HSS>/I^DSM0J];Q"HUO#L9]Y+N%X![ O<H&A4
M\U;21\@#4)$!N!^OZN*"4.V[!0R]92E6%0*$O=T&4R49O_61.HDJ6W'40]0P
MEW; -LA[YS%Y36F#:CC>T"V:Z.LXG>'E/BE<?[4B;\_C@0:]J#0MY2) :_I4
M!V]#5O$? ,..R+')"^#ATY%O9/S%XN*_[C2[;+C V?Q$;VC,RXB75:'SC)\8
MZ4CBAC2ZX7%JU/*?WS=S<(=[\&YHW@*W)'3&918]Q*A 1A>#].]!Y6OZIY>,
M7 H[IHE"E4^G,;^&?-<'I3" V]RXBN8.WJE"BW>0]KCJ6<4]VLPU]PQD5MH4
M)H P[09<FD8H<*J'\IG'^WC3:ZCC5$YFSN.?0B-'CRN[N(F,<7"E;8)(0_*K
M5&(;Y/>53A#C*,)'[Z2^QD=+TB/FBA#HPX$<K9'G@Z+Q40(1;;EK>/AXQ+6)
M^9BB@$KT8^.Z?JD0$W&$A%!<R9RX?/X:#1$"O#_8(KLW[+0R)3I<0_[E^0 /
MVSI71>\I]05@Y3>U=#[0KI#L53=0/5"T9*RGG^X0^Z%D:*D]L9@)K'K""@
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MURW($@0Y:!&$-L+$QO%;S1Y"$SZ$**XX.K^??M#- 6?;3&@9Y(+1<*J-%5\
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M/.5+V701;$KF5=CRVB7J(XH/A\_(SNRMV^KGPAH548>./Y2-!8\)GC&ZF\\
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M\;(_.'\;?@ZM+O&U<&7#>O!;2C095MIL55!+,C-@4?=]*TKI3M^:AU#T]V?
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MBC^9FRA8?/?R+:=0$P\56S"<\#SO[^8*/G)1!/F;V:SI&$^1VL IVJWW_(4
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M6I3#1=?4!I9WAC?<'X6797.FH_7M']:%B%I_K^XFL[E=XP%K5"RGZ1'?:DC
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M?->'*:1$TOZ0EO-G, ^ R;6L/?9K=]U%2]AU/+HMCYZM04#S#]Y\K9UAPC8
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MU?%0&)+D8$F14@]/]5+QENPP[F(5&A1:*'#TXOC)**2U;2 Q>B.L.@;J!4V
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M%M7)R5/+?T+$;SJ+#^:AR'=#7WRY+*VTD9X2DPU?Y5&5Q?8N#..W<#!Q>,
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M SGS\]L.D=,.Q:WA$7+S[I]6V'3D* 6NLBM#9O[K,RL4WG6+5<MDB!B"I0Z
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M-2[<+T"A =3WU)<K$DNK*<[\!81P?1.U.'\8"W6W3'$YUTP"@$Q"/>?!Y.3
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MP-SWM9SA(R1T:S\\4/"%[:4Z%/*@,Z/7E4@<D1G6HS,K1_);&1I_RAJB8P3
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ME&LN.O-][7YEM^@;.]AOHB)Z\_ KJ9[0QEP52X%N5^_=,P#-K\?LB@[J_@Q
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MZE6O$S3_>W3=NHA>1!J5][L^2CK(36:1<MH&37!EHTBK<V':T0XWRHKU!WT
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M/;:]4",AK\%VGY$\#DK2*WA]Q<?MP#,2^=&A>@2NEUA"%22>JLGQQG3/!5?
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M%"M;1(-E]Y =]AD9\^[1+K&A,N+\SX!I&<@G&$XSU6-- 0Q'+;;[2L.?["5
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M:XLW0G\;-_LW,1G6'@EF8I:YGM:#/G3OLF_1%'X6N"W^# AW_^%PNXAS)#R
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MX,!DEXOG7;E<.'[*+'2/EY73E?U$'_BFR!IP@40.N'5;+>W+90;C1 M04IB
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M?TW(%,2LKPRFIZIVNG4%\QLW$PPT\G*CR#M_ KK$=:;O(V9(\&TCKJC+F>J
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M>'TD@]MK!;CCM54ZGGU  V=8\Z>Y\M 8;C S6I]FUUH?[TQ;[XQ/7#]"I#G
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M1U'HGQB-3G"AT8/4JQW3\<V*@O5NZD3V&*4*$?Y'@GA,1[=DPD3_J#%<\[O
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M%"CR2]6(0[.JN$(S;T 8QGOUK[ACZ#1^E\*_:&REQ--0D'3+;TWY5#2$?^6
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MFB Q:+L+!,5D^?.GW6??@:R:>**J>^*.PRY-/D6/HP?G*!$@WG<&E"0%E&K
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M[5J#R+IO ?S= ,%&6-@<SQ@JQ,3!C-K/D*J#I+99BNR*CX.?,N%F=4>.R>O
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M'/NLEI?XES;*EA'A93,MWEO+X)EF+;4L7>PHY7+PZM[], [7$LMU:QM<=^'
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M>YJ*9BZE%3S[1Z3?A"/4RW[_GARLFQI79Z6-84MD![*[37+9'-"/41>(O=X
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MW$S):NW"%=-D=TN^2]%.M:;T],F2=QI]DKHS[Y-KW:JLZWRMKO(Q@@%"'?U
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M3IP&65<DEKV,D%,[]@G</Y\_BEU?:AEIKS\7<?*Y]/E,4U;=5]XZF6S.!A
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M-*C::E\N5X5_M%_0^Z&W-IQ2;4[=?P#&V872L-A__X*)00J-[SDO\3-&]3
M2]9Q,YS_))YL[E$;,>8H,B6>MBG4R:GD#,Y5Q?->'(;F^OV)$WXN@ZZ@1B)0
M7=:+)1D<.@42HCWZ 17<5#8_?\N3)Z6N$0ANUK_VXO'L&+01&)N_@NZ&)8=9
MEBAY\G4!B7*#Y:4#9:AA\52;%:B\1<H59H&U\M+PC]3NP/L>RWJ@SVN%P\$=
M0Q9&%3VA;FZN'VP]#@\M4SV\A$$:ALXNBP[#3]1I8;9]DT 7T'D/'<;QW\=
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M0L\CO*$8NQ[7"GM2<*]0@OGG+[#]R$@__U<:@H"CYJ15'4'2-VB"X]E)Q*T
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M6MX(*X]'Z'WT%*3/\IJ<+VUL>\/\Y@D;7;VO8<F@$*T[P*?&VVS(B!C3#6R
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M/9E&R<C>F3@ZNVLCUUCJY^7Y21RK>Z, 1KTY7Q)9$)&#P7MW%L9!637N!M?
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M*)(,$BGSJ\J+$^G48C K%FSA>9^7FP$#"(R_.U4*7P[D3WO5P;PEK##6YA
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M*TB>;C0+3,TR64/1Z^*;(GB<;>:3AF"G@!7OH&N90_*W%A<P7LQ-S!3V:(P
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M!UDQ?>S7<+U2Z ,8X7=- 'W\($:8:?P_F=2X<HP3WZ^?G!?]?@TUI[7RDTZ
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M=\<.HQ?]^BUQT+DT.\*;[/Y\M8V=\6XP_]+<XK;EA3NG#VZP'CQF^BA=Y%/
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M@]-/1%!,9:CV7K@[^<M_PE]Q/?G!L_3,\)7Z_.:%O.=KFFY?P"8([W-0YEN
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ML[Z_50)26S^SA6;5(KM>*GSD\432W63SRY.-O\Q$ 8*BVQ84;RL#L9T^.M-
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M"R4-YOTW'&$J$[SV[@"R4T8B5ER.W;B3J7A@O7D)%=F2PT*!,<[:Z;MW0'\
M\V--5EQ(#^5IZ]'C2A.ORO!\EYD7*\@9+$#VALDC"XG1CW$OENJV[PABHK;^
M.\PE<F5HN<$4%;@2P:C0T2QL6H:KR<2B?*"H%=HT2@FWS%__[H/09Z!_0V_3
M+G)V3;G[_MTW[;2TD*BDMD,E3\ERDL^<'(7:9HHOE_N[U^Y2D-U=UF6]B,<"
MZGU"T+G=3$XW8 Q1+GA=]^;M7=*1[L:H*R<RD;:8<+*'O;SO7\38Y M7SEU]
M5(FRSP]<B$.Y;<5FQD=O).'[SO;!*H\57M"H=$DZ_/Y(T0)X$L(]YMA"\FU8
M7#]4/UG-8,QAW(4N7&/]Y<BPXL:N1I(\C?K4UH;D[U[TK63MR#LI<.*7CW74
M*.*R&?27MA6NG6+VH@+\6/WP?++EEG6M(Q) BL3RPX(0X/79;Q<#4*::FP*O
MHA1E(T+;XY)XP[S\F'[T>OJ\-LU%^#E?$]E\,O_]Z>1R+="+2U4AB:-A#[0L
MF'NM*KQ*V=+K*TV,ZFO! J\K[5^S/S02QS*O9X5R5QUK)O.*)H-P7@N)EL=9
M_"K6DJN_ZQ[C.C>X?6\.%E!PA['7BF+^QX>:6  ''U(7,YRHB@6H6'3%8XCL
M!D/A<GAFR*T5+&"7?G[CCJ;OP#0A$U59>$U[S@\^W-IU'0ZPX'JY%,*YZBX2
MU\3P\40A#9^%_G-IDH1U+8^2_,0B]^:8BG1F<[A'X62*0!MEB&C?,YLQG!'\
M$!Y+U9F919W-V!BIJ\#:%X4S'8[OONFGF;(6^,?TF0TVS=2ZGFZ]F?PF/)4
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MOZ]9X.XI_(8* #!GFV3+#E1D4;Q_M2OZ*W+*A3L+3B[XL+$ %TRE 'S='@=
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M"D"?WZ6$'^84MY6B#O7NP5QV2EA 2UX[BO)3B\G-..:AU%UJ,/]Z%['*[;&
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M$*[IQDJ?SPK+DX^'C4N,?I+J@.9[0%;)B3"9.^)[PH>;?!-A;.!W<%GM#U)
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MIR?J8NVPT<.])DFG5??Y/>Z&<$]3N9Z "Z:#IO6Z*C0P;V \F-G#^]@SJ<W
M@(GCI?*4IO4YQ 25OC:A:(38FFNGW[\M=G'M5B,G_1/UL/>=NX+2"$="[A7'
MQ7MD<#<CLB3+8:_2-^>5!M"_QX]@QZ3[;Z=X>V93$9^[*VQ37RGG33E.75K
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M,Q<+&**C!XW/P][#Q]-4PA+<@X+.*<\Q_9G.;#O>:>#$FT*FB1>TWZIH]MK
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M6>9D%!:]'SD$_VH1WS3OT!+WS<<Y/X?HA&ZZX>\$G]/+@!8N9C*/%VZ!#[&
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M4K0/,3MTB 4(-S=-@0_N6HJ;,5,68S2:45[IP/341FF/=6$<]5R,'6U[0K&
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MF3?;FJ$;Q=.L=H3I27\HN!?T.'Z$ ,(M:G14R0,.&3\7;!"^]IF/YKZS[ &
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M</$Y_^FTO0=6%A7,&WC^1\-(Q.S1O9O 3Z@.]ISMS0J?R^\\)!E4Q&E'R=;
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M@I\_!X40Q23)EE.QJ B- 'S%4<@@-S5P:PU2:;]-%NC.NG4);C6&Y+>MY/:
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ML!T4T]+8\=G2Z*ZNB'I7FMN4J6%!$8"3Y-' GE$I;+&OQ(U32-UMA6$U%+5
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MI6Z1:\BQKB8S_YC]T4AUZ)[WVAV7C3&F>C7WYTM49$&F!(&/AR@2-HMU+_9
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M/?"Z#)P=%7;,=X"/;2=:A4A U-.80>JH'3"KP,L<>/&%]Q\?(?P$C&!L4TA
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M<'NX1=0;#+8]CW5Z_Z?D2%#D,6%ORDP#3L&N>GKFVZ,#Y018Q:@39$5%XR#
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MV#2-@5X9H7*E49_A=)P6M?HZ9<M2'@PP$4Y1_QW8VX2O\E?%KEI1!F.0L7M
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M13\)$Q\LH[DCA2Y.;N+-NQLW<?)]K;,?(6UE#?+ I86FG'#I&2H5'*P8U%)
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M2BNS(<+L>[@6R:O5Q#;)O@>%,&JS ,[V(<Z(!DAN&8X]^EYD[)"<TXG[3AQ
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M3D&"A^*"%;%4=2LLOJ62" %#6"_%OL/.8;H;3<].WD=!]?RT?W9L(1X72A#
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M:C0A_0A0/$<#,>$+HT3KWI.3P?CHAVE;D>+8,,1'_,U%^!''V?\!4$L#!!0
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MRR.SC6%6 S7P8PFNJ0'<OJ2+73&#06+'",L1(-7R[E7(FBKKLWE:Z&^=",X
MLPA=8I67*)A8GI^\II3-=&A/\>.1&2[-%(LS(._>2B85H<K))>>X;FBT_3&,
MXR,X+[O#W4R5IJJ@;/9G5A/@_L1J5@8#J'&LMEY[:T&7E2:[G PGYICW<P?P
M:V]B"A8&4/2>MK ,)N"!90G6"CCPM_!LGYVUPG64P;\?]\X:TO_'J7JWC[-&
M\E;3V(SV?\^O&_+[3TW><&*>5N9U?H<,OP].+]!K7N.A9PYYVU,_"@97N )N
M^]%1^,9$]P0#S]+JMDM>"?D/&[?<L6^&\_N5DJT@AO>EBM[Y]B\>7!_L;_3D
M$T(@'.8)IW_V^PB'UQ;]RO#6XNE]2(U7U.EH"A<P<43X03+2O][9S TG[^/^
M7.K6?%L?W3V+O;@Y^0M02P,$%     @ SSMN6/QXL!>' P  A D  !@   !A
M8VEU+3(P,C,Q,C,Q>&5X,35D,2YH=&W%5FV/VC@0_BMS5+WM2N0=*!LH4I>7
M%FEA5Y!5[SXZR4"L)G;D&%+ZZV^2 (6]]L-)=[=(Q/*\SWC\C(>_&<94)$Q$
M&,/G8/$ L8QV&0H-D4*FB5IRG4 @\YP)6*!2/$WA7O%XBP".;79-QW5-VS!&
M0[(U/BI)X8-G.9[EVFX'[*YON[[3A:<%O'L.QK>U].1Q'/SY-&W</CW?/\S'
MT#(LZXLWMJQ),&D8'=-V(%!,%%QS*5AJ6=-E"UJ)UKEO6659FJ5G2K6U@I65
MZ"SM6*F4!9JQCENC846A+[)X-,Q0,X@2I@K4'UK/P<SHDX3F.L71T#JMC6PH
MX\-H&/,]%/J0XH=6QM26"T/+W/?L7 ](TR+V"YEO1LECG?B.;;\=Y"R.N=@:
M*6ZTWS7[_1\DQ;?)F2:;U'R%*=-\CY7M"ZM1BDSYH=3)X*6#GVGF)[V-%-K8
ML(RG!_\FX!D6L,025C)CXJ;=4&@M4/'-S:"6+OAW)-.4WBE0<JMEYCLNT31^
MTP9+^98<5O$/FIKXQW*$5XY+K%,,91H3<_K'Y_G]/ "'VF5HA52[_"+24*H8
M555;HZ;X0@H<_-_Q5Q9^F<*>%SSD*=<'/^%QC((T?G_3=VUO,+0JZ5=/*:)+
MB^HZI_'C<CU=!O X@_ER,GV:TH>VJ^FG^3J8KJ:3T[W[.!X_/B^#^?(3S.:K
MQ:OD<A7Y%X0$%88'B*0H*CS2$G2"P$4D52X5JQH?B*]P0X($8,2J)5:XY84^
M"JPUX5&%9P5A$LRDRF!F>/!N*4WP/,]P.W>];A>8B.%,ZG:[[WNW->VDLS;Z
ME4[#=WI=[ZX-YZW7[[VPX'FV<W<+<D.%A7F6[03"^F.UESM%$5/\&N(:*1=,
M10DXG3;44-G<9+$]I;OA@L"9LY0.XYQ)Y:MBXF:#477O!19%99U7+4 8615-
M*YF"W*.ZL-%X)O-M*!-.?EF>$[@43>EXT23KVL;,?/T6L H+GA2/L*3$52)W
M!8ZES)'"I5K^Y_']B 6J?Z]9*:X'MBN8$-B&-<W&[ZA2.H]AJ$;71UD'^+<1
M<07F]40YYE\/E0ML_]>0_-<@]T\Q[77#:$K9?!-U/G@6?=TJN1.Q$<E4*O^-
M7?\&%X6^9B0-JE?MEG*!QG%OG\[C8EH?*9?#^N4S(&=;-$)Z]7PUV(;:U&=[
MR>/C0?;[IMMY.S@V9T.SZY=#\[RHWRNCOP!02P,$%     @ SSMN6%5%Y'J3
MO   G(\( !<   !A8VEU+3(P,C,Q,C,Q>&5X,V0Q+FAT;>R]>W/;.)8V_E7X
M9FIG[2I9\25Q+N[MJDPZLYM?9;J[.NEYZ_T3(B$)W12I!DC9WD__.Q> !"E*
MEFTI%F5LU4['$D4"('#.<V[/^>'_G)Q\RJ8BBV42_<^W?WV)DCPN9S(KHEA+
M4<"GUZJ81M_R^5QDT;^DUBI-HW]HE4QD%)V=#E\/S\[/AZ<G)S_^ /?Z:'^4
M9^^CBY=G%R_/3\]?1:>OWY^>O7_U)OKU7]'1[]\^'M/5/_WR\=O_^_43/_;7
MW__QY?/'Z,7)RY?_]^+CRY<_??N)OW@U/#V+OFF1&56H/!/IRY>??GX1O9@6
MQ?S]RY?7U]?#ZXMAKB<OO_WV<EK,TE<OTSPW<I@4R8L??\!/X'^E2'[\828+
M$<53H8TL_NO%[]_^>?(6KBA4D<H??WCI_LO7CO+D]L<?$K6(3'&;RO]Z,1-Z
MHK*3(I^_OSB=%U?PRY?P=>N:FY-KE133]V>GI_]Q-1=)HK+)22K'Q?NSL^&[
ML_HSK2;3XOW;X<4%?);SW-YKF8I"+23>O/O19^^&;U_#TV?P]U32/2XN^2/O
MP?;G(E63[+]>X.-QGF*42G?+4:X3J4_B/$W%W,CW[A]7XSPK3HSZ7_G^[!)N
M:I^!$XOA&]@75W2?DU3<YF7Q?JQN9-)Z=*'A_Q/WI(74A8I%>D*C>0^3L)=?
M7 PO7OW'%4_N/2ZI71O\=_1Z^ K^M_H7WG?N;DEC'(N92F_?_^>_I4Y$)O[3
M'_EI<X5@E^(GA;PI["ABF(C4_K/A_GB#:M3*J)%*57'[?JJ21&9PP=__]O;\
M].+JAY=X(;S].6Z:9..YGC_17/\H3:'&M\]CLG>^V,8C_EMH,<NSI/&,"_@1
M_7G-#QGE:7)UGR5ZB0?@)1T3)R/V\G6VI5><2J%ANL7TJBW(N@34P^?T:OBZ
M.2<2AFY&EW9[V/_BHT:=C_JF9M)$/\OKZ+=\)K+_'/ G\%\CM1K_Y_);?/'C
MIYLIK$T170S/?G@YXH78G:AT2W@Q/+^THM'=U:T%3W"#4_7JS?#=?0Z5]V*]
M9^5P_W&:7[N=X?X^N=9B_GX$VOO/DVN8\)TZJ?I>C$R>EH6\0O5TNJ2'[K=+
MEM[8VFUC#SM]HC*83O&^.BP%(H9QKF?OR_E<ZEC "UN]P59*B#OWF*^;W\+-
M-CQ\6SP\39&WT]/36*=$F3F@@/<J2U4F3T9I'O_9,7W>#CR4UD*,4$Z.MCG
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MA@J!NXPT:#XW'E8B.!AXER:*8?JPN+#= P+=N]W]S4,U,W$;R6PB)N0(Q4\
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MU$M0+T&]/)%ZR<L%2FHV8N*XU.BE CL"SCA[QV7A= E;'O8>L-LFDB3\W6J
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M&:=B(2T>M$B0)X;I'IS$44]L^=>QT/JV3KK &W$"5):8@4ML2!2?3Y<G(6\
M *@:9<XQQ62.8LVE;B!2PV_@U>0%T]^,.RXKIB Y: * (F$&(-W=O1/FS.IX
MX4QV G!RQ;/7W13G)V_F"J47,G057%&?BE@R]F[@5F1GF+K;PN5+RS=8,008
M+R_ZBF$ BBXLNYV_OO"(D@V7&?.U7.,B6R)4A3H1I5@3%!]Z*"1@]8#5 U9_
M6JP^5C<$PDBE),M@>% 'HSN_1#=(5N%&)LOT$"Q"OBPO%S*MP5\#*P^JAUL
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M5DEX3E8TP,8*6!$=.?IG[$OYGA.YX4DJ$04H%$=LK&8SOG>B1,%%:G7B^6;
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MJ]"YX'87<CS&4@%!)Z;1 @1OA$W4+:4R_1E=PX4C(MG(L6@TI0ZTJ-DYB8D
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MVJPG@?1GS/X?\C<>3 6!4OCQ*1SDKV+,:629D@N+7,Q<!<[>+(_.@)S20A>
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M34USW:X$QOTQ4'?'K3']K#&!S@QDIZ85&]V8;WC^^NQ*R\J()15J3%M+,YQ
M4P(!12./Y_FHS)YZ-0\F1GCY?+R:GSQRGZ]>2"CZC6@7#L$U6#E%#.$==N@9
MHD%Q2,ZY);2,\TD&@P; E"&U'#8+Y-B@EG.X \A4L@@0,?%- V(*B*F?B*FG
M6N:)8F?=163/2O'L>@D^U745IBZL: 8=#D$A^?4;MGB@4DD.\2_[J:C-4XSK
M@!^\O2J<KZG,F-@?-90%Z:BF;!=:?M#SP<Z]V07??()'8GEW:(0S>BSO&6C#
M0JB,&,OR2"PSR&':$(&544W52"$4T8J?1*4IQ[J,BQ+I#9'-C5V<4B*A+E)
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MY00K)U@Y00WT1 UT6CG]T .D!,H%V3413(ED/^#:B30DSBWW+%@#<VK[!]I
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MAG]AQ[/"LL\Q#[+?J+5.TO)$!1,SV$0I$ABM#+7UM7]!8VVXWPZ*<N'-CC(
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M47 ?>S%#%2M=/4@B"ZEAE7 4+EK&*E]+.+Y25ZT,C%S01-Q51+_4N@Y&YY5
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MBZ4BT:>YZ2!4-2FHF8\9 U[GK#,Q'@S[\IEY^E]]9H< &$< XZNSE]N);U-
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M<?XP[JXTE@G9CY\Y "E 4*!LBZJ-2ZJ7 @EPK>MAT&1'WLC5[/-L'V_KHP#
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M7TK.=NFI$*_U!KIYV)8^K=+E4G!2$4#]7(.S4E_35;/B,/V"KL_3JA*:TVI
M1"!DY)AL5'.!O SS/<I01' $;7+4$/,!?1,O[@=B_HV-U^GA2>AXI[_%&6%:
M99ID!V.5(U<5EQG^/;17(G6N.4>>5;GX*Y@ZD/_.\P:]F^3CRA5R@VV_J.B;
M4B-;AUEZLJQHZ\GI@@47KC&!E2D@XWHQ]AGX1>&'<,I,Y$7<M8(,P"< GVF]
MV"/13 _H_+@GS?1WVY1P>LKI@^%E'O9&;&S>T"+50D>XAEH2VFDE3?JZS?NX
MKPOW[JM80:$N6DO_.E9+0M%F"P.]Q%SS8";S=C7EVQE-E?!^:^:>A;1)6VXA
M^$;:BO#'R(8ST8#XFT<6$ \1\:%U8>Z;W.2I"P;.N+\(^[,J-C]#HE-(= J)
M3E.1ZX\MT2G(]:%U^4, VJIQ'D[AG*Q]UEZ@1945%XW>+^0#>CNJ4WX7Z.T&
MF_=N$ZG9/#S_=L?WH2?\NQ3-&M>>I11P\&N4SC  L. Y.P7/V41E[5T@JH<6
M/8]5UDKWY7(8#>TIBMXA=J?C:E2CD_?Z(>^K#C>L \EL@!C"YY/8;GB--M1S
MOUWUR&CJHN88_.%=Y<3M*7^;RQ RKZ*J2<%X7OW5EZ?#K'"O98';PW!]Z33*
MH=856[<_,R,;B8\K/:=HZK\NTJ\Z&=I;'D^<C->>Z=N)TEM%$*XMAUE]=F62
M>GH307;S\W2M((CYZ+N?D28RLNWQQG PT 2^U?];XN;(M^:(H?NHM^9\$EL3
M2F"!?E><8P3&B*JR^]*E(UD6(M<3M-.4=;?J")OZE#9U/(E-#7G;B6N0F0<>
M)"8 &VX6-Z%M^CQLTWW;-)G(-D6VZ;S4/2YKQ\55K$WZIZ%R&V!YD[H&6X+0
M,L7U:*04K+\?7ISMWN5[\'$@J@Y$U8&H^AC]:I/Q1B KMZ.9U^J*W[.A)-O;
MV,>V;$/_-H\]&HD+2*,U7--SB!UW%_9!;%1FFPWU2W_,9>R!Z(Q.,GX7M->*
M2URHI<-8<"R<&((X?W7V<MO!.PW?@F)3+8$#(8U=0?FW'D6I5PT.E7A-'V8,
M$X+PP=(\Y !.PX-B#V#LZ#87^!\ZKQ7EGY9]WGXWJMC"[CVQW3L-5XF*LF9%
M\+%9;7E,7 /("6W-X!LY9&M.PSVBHKRQ32*L)X0[U"A$+ W2=\UG5!4MFI++
M]NBU9DRS0]>\NS/'QXGEV)QD?LE))RI.U\A/P8>2\GF,5;6T7:&X&/> PWT6
M?6*;WD"FQ*,\=TVG3+^IA$ST"RY?0&/<6@SXSEA:*"9%P8Z5*[HH%=H8ZJ^Z
MC-&B Z-$X$"G:/&!(%<B2;-GT7MN#DY;JLE4R0^Y8@(1RP'"3!\%-\2Q[9!C
M$JFZ=.V"R&!BEP3-9Z,K*2_>_^09WWFMKJ1G0REC=BV,[1SGW&HGU->&+,%)
M2O')"+KQW"IT]*"7X?KF:GS$_"'G:(_B.NQ@9^E>M,>%?VP\:*3%SUGT0>_K
MZ3'CFDW%]T@ZJ5(7;1+8PA;2SOHM0'9DSJ$U*[!S:8I/K8AJ4[^*&&0HL_8#
MD6^Q9(SQG-:V!<Z*YWX6_=H*UE239$TS867Q^B$SKQ:"N%5#H'=F UQQW)F>
MU]6$EH[.+JF5RD[8'ZWY-?A74L.B-C381U/,.IG#UZQ1L%B1Y0IM3X] .X5X
MF>J-Z4=,ZG$A_S.*= 9<H>D:G AM08;>:%&AM$6>>1R=_#F2">EZ-*$$YUQ^
MH9\5"PXME47&+5?:7I6XA[)]?JV"ELYCI-(O2LWC$C!C.PD:T!!S5Q;36I.Y
MP@P0JI=ET5PLHW53TN.K%AK1FOZI:9*+LEA%-:C$FO+*_HJ>.[^*F@HQ"X$A
M%V8XJJF714FOSSQAG%8H@(4 %D[OQ3Z@O.KINIE+KB/3R/5@\S6GU_!K1 D3
MSK< H^)V@O9"FD_5ZO>"PZ3IHF)%6)C?5-SUW/0A[&MBTS[0T&S21IZYUG:Q
M:R]O5+))S);0:+\77)<5LP8QA>V;EQN)NA+#C245?OS##V^E^V$[GXHVMYF/
M^RVN5K5PKDEVHM?#SLA=@DA#S><84@@AFV%;,T@K;QO8(5=,:#P3OF"I6!GP
M&Z,-$B]M!@XNJ;Q[@'&#A7 #["7= 6&D(4_2D#\Z_)%K'K5"MRW;0_#Q\&9,
MYNA^[+:IWI-/,#LPDP&ZG_ZMP<CBQT];-TD=Q30O&E5YY6-69B--2.@74/GH
MU V3 N49W/JZ:.K*$)&F3#BJ8M(,P# R"--Z=V$:QG6[P/D]D&/^)TC2&MR:
MN=H-]!$4,\*A6J))-R$AO'^,&"M5Y&+M'+@V &I?8[TV/X\#4VK * &CW+^@
M&^CZ.U#(=>TBK4/+S$@QLS4&L<BF_@[PTW>IN!HT3U(NU1P=X;/,UC) ESN)
MB:$T&3A6%R(^:?(Z)QMP"1&$F:/%WY=&9;Y#9+N?J@5RPYT 1[M-#W?M9;=0
M5>1=.$1 YCHDMORRT'T9Q1HB>P']O"JY;BK\H>^'UY@]**1-G( F%/.(V+XF
M<YBWPC"LGK.J()4O\1@&$@1;-RE3H::YI_)K KS,52KAEHP1 2D3^Y<! IET
M,_&1 Z(7>)1]2N]K<4XH\ZC^C=(ZJ/F@YH.:?Z"X!6L/&R"0;.>H[28NG,56
M^3B%:D2(U6!.2="/2RW)VDR!SAR2OEHS=ZJ,C'%>$"MFY /32F-;B>K: 89V
MC%[4I1K_*3P?2N#%]I<#0^2K@2,>CYZ;*%?'Z? BO7QT7!U[>)$&6ML'8J0
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M%&*L<49HI5I1.$]94U=-JR!719*2\NLYN3D$D2+WC=6EBI>Z-CHY*8NT]F-
M@[K9N/EC;:7CJ-Y'Z9](*)-VQO[_MA#$A3V>;5+V[.?%ZG!-#:^ENJ*A:Q+6
M!5FQJ5<-I44PI9I!Q+H4#T+WJ<&V/;I=_J]U@?R0VKC%MVU5E56%5!4<I,VB
M>9DF%Z">L3O:V9LU.^G+M$#N2'VI:<=H59)::Q\?*9K8N7/XT]M(<Q @*$$6
M_CAI/W+6Q];SD@(9FH4DEA)6>?%\VP6/S4M/R1O5,^7-!29A)MW8+!LZ;Q5V
M?QJ<Z4'S!LU[OS+I^[^\>'/./EAK@.[2=ZWO621('(N?"R[JPWS/PN+K7.F\
M-U,)X;'[V  !^(0M0W"1:&'-\T=)$H5]^SU?,@LTKB'(+ OP^>NW%U:\V70%
M?[952MJ>!"I]1 K?CH@S&W)MP<@:[@'V'+.(:SW=2+(O\Y36P"5/[')^0PXR
M<P"+1=SQRLX SFZA=[82<1%T^+WWGIUH"N^+^TF3^FUM=FD2?5PBM/T[ OQW
MEBQU/^V _^6H$+N>_ \%(95/NEQ%[W,<5B ,S&<VVDBM 4!#M*BHVE34X<S5
M&8&U##4N6G(2VC0,I@(\S!<Q5GYJ,AS:/FW%VJ1=E<CXA925YG#11E?\0)2!
M1KQY!9XQ\N-<#WN%?/;T+'I72V)RGMCA=2^9M7.1, E?,[28 9W=+SJ[TW,2
MT-G$M<T#)N7>J[9AM(9$,NO!D.J];Y"A>\=ZZ-<<J:EU U!HY_/3^8L?WZ9Y
M;=-R$60R6:"<^@"I6I-4'0W[<+;&[M8:2" 5I96V/3X.2"*=@3D ":NZ@]\[
MTG^?CVI?8G&3V\XAG"XBUSAMUG1?N30M80O!Q_Y)JZ&XII7U'+P43VC!OO_2
M%/7;WWO7_]M<+]^2TFO-'!,!HW^-_&C&3K50^1DJ/T/EYZDK\OM1!# RA 1<
MPJ[,L\Z4E&DE':VM!'0,,A<*10LV.<D"<_#]_8D 98IRP$]<<&=_BB*[F%.L
MK4G0S?YFD\"8*(F]1)6=*CW.;%)5&N,1.<E\2+Z*Q#K",&FO;?0@9?EUE^8_
MYN7/M[_/@6?SV!C? NGAR71X3FO4)? 9+3*PPE8Q B9M5&/ K*<#E^@83>TO
MEYHS#7"&S1$=,/'90U#0Q<7*_CM!-)/VC$B1C<H:%TKA_A"=^(HV7MHB=P?=
M>22\\UXO58VT*/2G%I% .(@6.JV6OBSJW+K4ZZ*L)T2V&([>R72DYHU^12#K
MCOQX]%;73>8<>=M.-YP]<R1-OQ2K5F4$"1_?A?W8.E#["CR<EM,Z+=/H0&7:
M!O&N1/5:28);FM2089X;[Z,N,=X9,N&>Z=4:MLF,]S!L"1H\U !C>1]U*MJ7
M94VXU3LR70>\')H)[?OG8=_OW_?))/:]L5[@3F?9[.7,VHXS3U1;6;HCR@%K
M[BE@6:()$XD;:C$0;I+=/AN(J!B6%D1<GJB85H<Y91)[U5.G+CS7F_G-_  C
M$OH&VBZBNRH+\W*CFB39E8^Y>-D$[YG[=9.)[<)TYGK)Q>Z(7^GD+'K/N%?5
M-X:^K)K')<(IAI%"".4AO?(==[:ZB6>>BP:7/H6@8YO@\VBX-AQ<%*>Z*T0T
MQ(2V)(2C V7ZU;B^Y43#O?.+=P_K%L=1[;K(QZI#MGWIO6'P+*JB67'G23C\
MC0UHJ,@A*&T3BJWN$L>DI ,X/9VNU2EX(C+IM[*Q,3#NHL*%6B;8E![4NQZ_
M3NPO$J:\YG1K+]IDSP:?A?X!T>[L<U?YVKN?<;J4;5(9V&2<]R5A)0H.'?G&
MRRG?0>&"L%VFY. )F:L]CMPFPQ*Y9.@6X,DE;P3BI:F<6*$] ;?,^#,G!,7#
M*3^=+M[F<"C;1TG?:U"; \V9MG'G;LA9]_6I.58V$EYR]BM[=,QUM>-T,A0/
M \H[G*L3.U?3\.V8<V6\.\R(4=;<N8UKG>#@$<MO84\(>WG U"DTXO)#JV?M
M53 X.4<9@4#+<>:.S9?&IDV4>)+S ?FG;0]8G=!Q"1ZA0X[+-%Q"INJ>Z?L<
MV[UX/RQ4Z[08BY[4M.^9&M&CQ;%WN;8=^10(%)4!*K& UN.J'T__&DU4@KLV
M3SBAZ8EU.*DX[F!0<[2?6MWE.9C ]Z.MJ/#T6<^<A2)&2A;C5.ME8@7^N6#F
M0HS0]R\!O2JL9-*D;AGVK#16QMP030!^>/.VNU(JZI$MM7EH!E*<1>]';8D]
M[J904W%=%XU?@\3)Q+?UT1P4JFO#YLP!F*N<";,+3F=)Z01$2[4!50_MZI5N
MH]-[$W#EU;X\^\%,);36/"65-=!74$]"7PE+!0TQ35 [>T!-B2&K&G# =\M3
M]D0[.$W,=$Y)Y\R!5R(UC15,?A75ZJN61!6AK#>=SOK4\XAJ+#B6$&>JE.<:
M^LP2XVH33E13+POIE39X:K_%:M]-9MKPR61%X/TMHO_Y@5FF4P/)H9/IML19
M3$+BI+>-[GF);4RN(7!OIZRY; G_YH5TJ-A*4;,IJ=(T4>B.,#+.3B!\GM9W
MT#WUQ**.#UV\%J@%CN+%W@36/[\C6'_K$,YMW,!5*F:L6 >+REH,#*'RNF=0
M*L)/9,176_GC ?R?FBJ>!OCWV9RM$:"S/05Y17- IX^TQXM]TXP(UUHQ$]*/
M-L$![!:&%CI=K<7)(PTI_88=<$/;P9=N0J9%2#?^"OM!E]9ND*=X)-;-5]/,
MT:9G!.Q\2@=V(MCYCE,9$,[)7/K!C3S.+<]LEJZXUTPWS\ 0R19Y;-.:XO09
M75(UIGNLR3:@9^FRI/&4^@YP=G"WWL;=>@<9<7ZC0[#.29(JUA^TIV"=':DH
M)*LKY1@CP@?P[F"K/<-6LVT.M3"F*ZEXB.::749M+^$:S(6&'VZNL^)2W#\@
M>K_0T:;(FI4V)TLGYB;&'&12N)?/$6K >T!J:VNJUD7\)SCH.,1P%OUC;[=&
MFW$[Y$4S+0UM1Q=9A72@)#Q8C,%B/+T7>VP][IAXSB.$0#Z<*4Q<( GA@"@J
M0\1*P0MM-9T39'[BGZ<ZF>*MR27;QZ;;"5YVC='IFY8)3C6L.@%\;8;OBB0B
M>.WRI!.,%=)Y&K7(.]'*)-D,D5S%<5"_S_D<?VOI>W)7?>6WV]%)2Q3!#,R*
M75R4:K6BYP8NC,"%$;@P'J^4O^N*#)$LTDG0UKI+42&#LE+/K]KR)P[1Z\3B
M2BFH0D477 ",";D8N!H04R>&SP(V><A=^\&#&2!K267/5AR>*G%CVJE?VG("
M R#Z7%:NKUE!]Z"]RVW7'PW-Z\V\;UTGVZT=6M?V25FBUYZ'Z9;VTD['_8@?
M<,R"NB4I8)>6[]_OW[\_<_1[-W"]G>K"_*^F(DA:5='_9?:)=W%,R%8HX]ZU
MW ^DFWXOBT5:5[TU//4ZU[OV'W1P]<LW[8LV/H5G_F<'^A7L;^["M]#/ZKE;
M7\.*?DG2;H(J?:)"_G40\D'(?_?SKZ:F:\81F-HO^YY%?]AN +2Y7 K_=D.^
MO9+_5/'=@WD:)TKC?WX_Q,H=H/(-B)3O(4 U$+,1ET"7 J^JZ2BZ:([':=_E
M9IG;!8&KX/0]!2&2$[PEQR-?'Y"X_I[DJ\4(TQ.M'W;7W?<(+Y!U8CZ9-S77
M$+8$ZIT*^+'(6^A@=-1'\P&AS\O[.9JM4V9ZAQ.XQS1*5#(-9H^JZ'BV11'P
M+)GD&\(SA']JKYGD7&7<TKA::FT^(KV\C!9(M>E=2T_27QUTHB$I4YTKY+XS
MRWLJ89BD5)=YU*S19KIJ$ DWM5LT(FAD9M@QT.LWVT*HR;CG)'W^#G\BYOWF
MU4\.?J6WV7.\R5(T1HV1U$N+KK^0M$EOV<<:@[=K<J%S77)6%%C[UDA)(IMP
M!8F'WMIM?0I39=+6H+N65U'99#9W2M4M]%2E5J&A94"> 7D^!N1Y3^KME[Y/
M:GI:[@-S(M(T6'#F7-502;YS41DF,_F>>W5+*(5[1-%! L$J?4\+@#Y^]"]V
M4*J&'7&+K/DJ345-EE=1TD.%\4;@*NL\;9*C/+JT"]!GH&H(>J1HJX.88 TZ
M&-+&8W5#/ADVILEBX70L: [;F)LT7VK:CBM?\U75F5Q7]Q@8G5ZA3R\Z_L32
M-ELM-8TC;RK[XU)RS2\R_GE3-ZM4/N'T,)/%5:%> C0=CI=GDP9H?JQ'XSW:
M;IM$F/D5&527!L/1%L/LF36X9;YP@*[JXS0"']*;E]$@]XK<QFH&DT5O7I_3
MI@S0I+,+MI#(?;SQ "@F<"@_IG(H*\G;561XI=(CSBJ)NE-<:@^KS33>UB<Z
MMRK%)>=RYSLNI.MH%:>W]AS5(+F/"'4^H%/EAWMRJNS,;IG.2>YV/LOT!9OQ
M3B>6]$$IQ47PB%K:3YJR0:&SC@\&6K<@9>OZ*WF^EU8AMSW8YL+%_Y_B58C^
M09>9\B@ 7(]I@]/2@?=TNO8]/\R1=4A54U#EP<L00,$C\#+<D[R_=IK+=%0
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M6^L2Z2DXM\]8ADA/L:W][/;M5G3Z@%T<S)Y@]AS5ZPB@\X:%:6VY52T(M."
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MM^: V!2I5>"C%!#_8UXD5_2?9;W*?O[_4$L#!!0    ( ,\[;EBO]#X+(CL
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ML<-[@#'FY5)KQ["#]RC_;- WYN0H<-&A'BZ*MQ1+<K"U>:,\5Y9GDE;"F["
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MH$\B7UIZH9&0LIW'6J#KYT>KOK%OQB.5M(4A=YJ[:D=H;^6+WBH?DJ#.6>)
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M)&"3FHF)P)KV))!!Y'@;D  N!AKNL"[ ^FAN]+7KLR,@;^;)8#)++=.4<5'
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M\TA/L76GA8AB<B52O 4)\FKNN-DB7[T2:+#XD<BGRZZS(/6H>TH(.XBJ _7
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M,C,Q7V-A;"YX;6Q02P$"% ,4    " #..VY8**TD#IY1  "*H 4 %0
M        @ %".P  86-I=2TR,#(S,3(S,5]D968N>&UL4$L! A0#%     @
MSCMN6)P4;2?WNP  JFT, !4              ( !$XT  &%C:74M,C R,S$R
M,S%?;&%B+GAM;%!+ 0(4 Q0    ( ,X[;E@.4?5[88(  &$("@ 5
M      "  3U) 0!A8VEU+3(P,C,Q,C,Q7W!R92YX;6Q02P$"% ,4    " #.
M.VY8R<_-ST&$!@";&#X %0              @ '1RP$ 86-I=2TR,#(S,3(S
M,7@R,&8N:'1M4$L! A0#%     @ SSMN6 S7]>!8N $ 4<D! !@
M     ( !15 ( &%C:74M,C R,S$R,S%X,C!F,# Q+FIP9U!+ 0(4 Q0    (
M ,\[;EC*VB8T;^(  &_]   8              "  =,("@!A8VEU+3(P,C,Q
M,C,Q>#(P9C P,BYJ<&=02P$"% ,4    " #/.VY8C>\2-A;=  !>[   &
M            @ %XZPH 86-I=2TR,#(S,3(S,7@R,&8P,#,N:G!G4$L! A0#
M%     @ SSMN6"$C>%#2\0  /A<! !@              ( !Q,@+ &%C:74M
M,C R,S$R,S%X,C!F,# T+FIP9U!+ 0(4 Q0    ( ,\[;E@*V^FGTO   +5/
M 0 8              "  <RZ# !A8VEU+3(P,C,Q,C,Q>#(P9C P-2YJ<&=0
M2P$"% ,4    " #/.VY8]U%D)NRC  !)U   &               @ '4JPT
M86-I=2TR,#(S,3(S,7@R,&8P,#8N:G!G4$L! A0#%     @ SSMN6*Y>EBPW
MX@  OOP  !@              ( !]D\. &%C:74M,C R,S$R,S%X,C!F,# W
M+FIP9U!+ 0(4 Q0    ( ,\[;EB\7T4/+LT  .$8 0 8              "
M 6,R#P!A8VEU+3(P,C,Q,C,Q>#(P9C P."YJ<&=02P$"% ,4    " #/.VY8
M=A2\LJP  0 N%0$ &               @ ''_P\ 86-I=2TR,#(S,3(S,7@R
M,&8P,#DN:G!G4$L! A0#%     @ SSMN6+I TX"]L   1-,  !@
M     ( !J0 1 &%C:74M,C R,S$R,S%X,C!F,#$P+FIP9U!+ 0(4 Q0    (
M ,\[;E@)@:;PMZ8  &KM   8              "  9RQ$0!A8VEU+3(P,C,Q
M,C,Q>#(P9C Q,2YJ<&=02P$"% ,4    " #/.VY8[G<CEE5=  #^<   &
M            @ &)6!( 86-I=2TR,#(S,3(S,7@R,&8P,3(N:G!G4$L! A0#
M%     @ SSMN6'G!V@FSS0  A.0  !@              ( !%+82 &%C:74M
M,C R,S$R,S%X,C!F,#$S+FIP9U!+ 0(4 Q0    ( ,\[;EB/[OVR;I0  &BF
M   8              "  ?V#$P!A8VEU+3(P,C,Q,C,Q>#(P9C Q-"YJ<&=0
M2P$"% ,4    " #/.VY8J*L6^=VR  #4Q@  &               @ &A&!0
M86-I=2TR,#(S,3(S,7@R,&8P,34N:G!G4$L! A0#%     @ SSMN6&":TSM'
M!0$ J1T! !@              ( !M,L4 &%C:74M,C R,S$R,S%X,C!F,#$V
M+FIP9U!+ 0(4 Q0    ( ,\[;EB!4^AJ=&0  ,=P   8              "
M 3'1%0!A8VEU+3(P,C,Q,C,Q>#(P9C Q-RYJ<&=02P$"% ,4    " #/.VY8
M#4_SNCI8 0!Y:@$ &               @ ';-18 86-I=2TR,#(S,3(S,7@R
M,&8P,3@N:G!G4$L! A0#%     @ SSMN6%C<S%]2,P$ V$T! !@
M     ( !2XX7 &%C:74M,C R,S$R,S%X,C!F,#$Y+FIP9U!+ 0(4 Q0    (
M ,\[;ECJ[U)7K'T  "B!   8              "  =/!& !A8VEU+3(P,C,Q
M,C,Q>#(P9C R,"YJ<&=02P$"% ,4    " #/.VY8 $X?);UH   &<P  &
M            @ &U/QD 86-I=2TR,#(S,3(S,7@R,&8P,C$N:G!G4$L! A0#
M%     @ SSMN6$2.,.S660  :FD  !@              ( !J*@9 &%C:74M
M,C R,S$R,S%X,C!F,#(R+FIP9U!+ 0(4 Q0    ( ,\[;E@\JHM#?(0  %&'
M   8              "  ;0"&@!A8VEU+3(P,C,Q,C,Q>#(P9C R,RYJ<&=0
M2P$"% ,4    " #/.VY8MU7EC<A. 0#\7P$ &               @ %FAQH
M86-I=2TR,#(S,3(S,7@R,&8P,C0N:G!G4$L! A0#%     @ SSMN6"E%;4^=
M@@  S8<  !@              ( !9-8; &%C:74M,C R,S$R,S%X,C!F,#(U
M+FIP9U!+ 0(4 Q0    ( ,\[;E@-U9H\WET!  QV 0 8              "
M 3=9' !A8VEU+3(P,C,Q,C,Q>#(P9C R-BYJ<&=02P$"% ,4    " #/.VY8
MN*?,\)AN  "_>   &               @ %+MQT 86-I=2TR,#(S,3(S,7@R
M,&8P,C<N:G!G4$L! A0#%     @ SSMN6'*/9"?_;@  %WD  !@
M     ( !&28> &%C:74M,C R,S$R,S%X,C!F,#(X+FIP9U!+ 0(4 Q0    (
M ,\[;EA5^HI#Z5H  ,5B   8              "  4Z5'@!A8VEU+3(P,C,Q
M,C,Q>#(P9C R.2YJ<&=02P$"% ,4    " #/.VY8W7Z7]S>1  #/G@  &
M            @ %M\!X 86-I=2TR,#(S,3(S,7@R,&8P,S N:G!G4$L! A0#
M%     @ SSMN6+-7Y%)) P$ LPH! !@              ( !VH$? &%C:74M
M,C R,S$R,S%X,C!F,#,Q+FIP9U!+ 0(4 Q0    ( ,\[;EB8;_-9;I0" &2M
M @ 8              "  5F%( !A8VEU+3(P,C,Q,C,Q>#(P9C S,BYJ<&=0
M2P$"% ,4    " #/.VY8GX4<7WP'  !F(@  &               @ ']&2,
M86-I=2TR,#(S,3(S,7AE>#$R9#$N:'1M4$L! A0#%     @ SSMN6-;V-UA]
M!P  F2(  !@              ( !KR$C &%C:74M,C R,S$R,S%X97@Q,F0R
M+FAT;5!+ 0(4 Q0    ( ,\[;EBC+65<8 0  *\0   8              "
M 6(I(P!A8VEU+3(P,C,Q,C,Q>&5X,3-D,2YH=&U02P$"% ,4    " #/.VY8
MAX S49D$  "-$@  &               @ 'X+2, 86-I=2TR,#(S,3(S,7AE
M>#$S9#(N:'1M4$L! A0#%     @ SSMN6/QXL!>' P  A D  !@
M     ( !QS(C &%C:74M,C R,S$R,S%X97@Q-60Q+FAT;5!+ 0(4 Q0    (
M ,\[;EA51>1ZD[P  )R/"  7              "  80V(P!A8VEU+3(P,C,Q
M,C,Q>&5X,V0Q+FAT;5!+ 0(4 Q0    ( ,\[;EBO]#X+(CL  *F" 0 8
M          "  4SS(P!A8VEU+3(P,C,Q,C,Q>&5X-&0Q-RYH=&U02P$"% ,4
M    " #/.VY8=9*M9AD#   ^"P  %P              @ &D+B0 86-I=2TR
M,#(S,3(S,7AE>#AD,2YH=&U02P$"% ,4    " #/.VY8N=N-0J >  #!S0
M&               @ 'R,20 86-I=2TR,#(S,3(S,7AE>#DW9#$N:'1M4$L%
3!@     O "\ P@P  ,A0)     $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>163
<FILENAME>aciu-20231231x20f_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:aciu="http://acimume.com/20231231"
  xmlns:country="http://xbrl.sec.gov/country/2023"
  xmlns:currency="http://xbrl.sec.gov/currency/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="aciu-20231231.xsd" xlink:type="simple"/>
    <context id="Duration_1_1_2020_To_12_31_2020_ohLEZMTSR0Cbq8KqJ4eLSg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_srt_CurrencyAxis_currency_USD_6KDez0fNPESv6PiMVQDs7w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_srt_CurrencyAxis_currency_CHF_EovKNEREAkumK2wjyAvm6g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_srt_CurrencyAxis_currency_USD_fZkHo-Mvv0iaC9kcViPDDQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_srt_CurrencyAxis_currency_CHF_8K3Jpoq190ueOAUG42rgKg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LeaseholdImprovementsAndFixturesAndFittingsMember_5r6Agu4tSEaOWsUui3fyog">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LeaseholdImprovementsAndFixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_a18c9vqNJ0Gpex9n_raHoQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312030Member_O4olP_9OfE6MhoH0EV3nbQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312029Member_RxSJlFvxd0uLTKolUL3zSQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312028Member_r0Sy7JDN_k2I6y5Q8lYXcQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312027Member_1R5SXknjqkWUWP0mLRRZ_A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312026Member_iGQ4s9Lt50alrF3FP1KcQA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312025Member_1bi1vT0nc0u2Xh-S7Lt9PQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312024Member_9PsLbtvfWkWuSDEFjmSZYA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312030Member_UxPXRokBZESrDLq3Evh4eQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312029Member_AnOPccdCO0yOmasUrlkU1A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312028Member_PSDaq1Iknkqy7hP1uOdwxw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312027Member_4_H5GnUE2EO-6fMiAfFadQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312026Member_AZE5FSsJIkCOiIDjG4AMqg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312025Member_GGbghK-VE0StWeUg1GPupQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312024Member_ODQ0kdFPZUG27qH4k1wNgA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312030Member_5kb1PG5AuUO0S-gCtjrH-Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312029Member_3dOqpfnfckCEIMcHBimfcQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312028Member__3-rt4ONB0WjYegP6jLv5A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312027Member_focY9wr8pUGC-t4W6eLn8w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312026Member_R-5b-bEhfk2AijECdFfhAg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312025Member_qeqHInhEQkOUN0SZFu9S6g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312024Member_aAlt2XZpC0uOboJTpNYv4g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:December312024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_R3OS4EvnIk6VR8SwYkbQTw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_RegulatoryAndSalesBasedMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_dbU2qmyhJ0Wd2ybcWsnSQQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:RegulatoryAndSalesBasedMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_MilestonePaymentsCommercialMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_I-ylj3lgB0ySClC4h_2t1A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:MilestonePaymentsCommercialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_KLZBu4QGhUm541e0XMZ9xA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:MilestonePaymentsClinicalAndRegulatoryMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_ClinicalMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_URY6Jrdr0k-HLTt2WogjzA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:ClinicalMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_w6UU7BFQQ02Es-wkhoNeRA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_MFct5TYRLEOKaNzhRr9ydA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_eiJAYeQIpEq75LD86tbZwQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aciu:AssetAcquisitionsAxis">aciu:ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:IprDIntangibleAssetAssociatedWithAci7104.056Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:DiscountRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_axPzzAyDNE2qnFNbJxmuAw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_3hsE5ajj2EqsW8OwqIjDRQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_zn6P6shP0UCItAsEakOVgw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_FgXJNffw_kyxmi2k_Q8KhQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_-Hj-hSllxE-LEUa_Gmj16A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_ezBq1LNFIUGJdNTu7a4HwQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_Y2dI5zRkP0aEdOSvnjsAaA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_Ecik1PzbbE2L7iBY1hl-Tg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_w5Il_SwGi0K8Y_peNUATtA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_mEjjRoDiAEuxYNk_x45n1g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_kiGHGOXq1EeHpusggsUgOg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_MOvL_KRv-0GMjYdNMWJfSw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_12_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_bZFp8RtyQk6ZpSOXniefvg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfContractsAxis_aciu_OtherAgreementMember_V2ITfmJTz0yHhlWkR5uY7A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:OtherAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_BnlIEVOTy0C3K8dqAK4rRg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_FFPrWYguC0WQvj3Hxaw5Vg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2022_To_9_30_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_hMfnkYwHjk67Rec2qW4oRA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_oPmjvi14mk-DBu82Bl8nzQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_l0LL76dIKke62bpBgsqmmQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_lCg_5YHbNEWrV3IHIK-hlw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_OtherAgreementMember_jXhHVI8hAkaS4H4FPEcpag">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:OtherAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_-kkhAXq1C0GMDfXoDk10TQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_RcIGZbdaj0SjODk2XEasNg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_8EC0rLfa2kiP5VlheRCDlg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_VGUKHPz2X0mctIHDOt8IbQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_WpYdq5tOqkCYnWaYgg7hoQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_OtherAgreementMember_kOOLpfgr3EGhGolAWb9Uwg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:OtherAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_VvfAYTJbdkC0T1wF_MSJTg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_jafX0AFm5kKHcXl4f6GawA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2019_To_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_RightOfUseLicenseMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_oqIIqklRBUe5UQlvHuNHMA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:RightOfUseLicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2019_To_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_l5M7oS6RAUSbE60FpTK73g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_23_2019_To_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_ResearchAndDevelopmentMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_N22GJ9LsrUiWJLyFN-RIXQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:ResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-23</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_23_2019_To_1_23_2019_ifrs-full_PerformanceObligationsAxis_aciu_RightOfUseLicenseMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_bs5y_HFUuE2bgfNkGXeFQQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:RightOfUseLicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-23</startDate>
            <endDate>2019-01-23</endDate>
        </period>
    </context>
    <context id="Duration_12_31_2015_To_12_31_2015_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_7HL2iR7LZEGx9pYpDWzsWg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-12-31</startDate>
            <endDate>2015-12-31</endDate>
        </period>
    </context>
    <context id="Duration_12_1_2014_To_12_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_zDLbltOLTEaxOQqGKQjBBw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-12-01</startDate>
            <endDate>2014-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_5_31_2020_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_gl9YWNvWuka0-golVkbkyA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">aciu:SkaneUniversityHospitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AlphaSynucleinPetImagingDiagnosticAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="As_Of_5_31_2020_ifrs-full_CounterpartiesAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_QTd8z-CMpECa_iMHqUPauA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">aciu:SkaneUniversityHospitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_vQvK76RUJ0KnStBAGwXxYA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillySecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_0EMLps-d40CSIT6HT2so_w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:March312020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillySecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_76PTD23ZjE2mpl9bl8usJw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:March312020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyFirstAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2019_ifrs-full_MaturityAxis_aciu_Quarter32019Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_G-GdzKub6UqJhnJZLbz4Xw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:Quarter32019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyFirstAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2019_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_nsmmt4NryUSnwKwUgB5e9A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">aciu:March312020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyFirstAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_pNs8WMywAEOk7jBfV42CCg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_iv5cJCl-0E6vtlPSj3s5AQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_Y_Ay0M36UkuaBV4tSfcAjg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_jydRYd9OWEWk671dwbd0rw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember__IeyEFArwEeikIeuLj91BA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_DuVSPEFd10mbFQqwmoueOg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_jTG84pzUu0O1uFc9oRxVZg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_OAXVMW-Syk2ZrIbWtW1baA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_SHu6D0sv4U-6qvxwsj--IA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_ym4hANZchU2ZB9m4tnIJFw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_W50NBzU5qEa09mv6NhCP5A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_Ahyp8QOgJU6aUxLJFusyPw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_6VOKv2eGyUeHs3MGzC7vIw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_Cj6a41-HWECUkiVv0bW4qQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_g2VJr2LWH0mkATiItb2LEg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_yA_PZPRqLUu_kKp2zZYt1A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_CCFaY6n0-UeoiGMVZgAhJA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_HJ03XueB8EKX-2gIlzBjqw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_d7-guilVV0mvoM9Oa34iJg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_fJB_6ZN-dU6RdeM0v4FQzA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_Qn1sc58q206NmPfW1osPPQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_oO6Nlwpj2ECOa1vYcsigFA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_4w7KMGsDgUqUG5MpjLDW-g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_MUVGPZ2Zo0C3Z2S_N5wdKA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_0r2ljY84p02g_MFTZyXL2A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_Su1JgXKRt0O2ssj-e_25TQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_nzoCPNgdt0WOxkRNR6rgNg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_6lS4zjbF4Eac-GIZUgE2jw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_058A2xbE90SyAgqdMWXaeQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_mfV4owp-bEem-93-p6NYFQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_NZr3F8nBAUuCT_VetHuh3A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_oYg1VVE1MUmNWowfojvvlw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_unPNYQAq0U61GM9DA5BHWQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_F9b8H9FLJ02EvHvZhkDIBA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_obdYBDyo_E-bUxAogvIKSw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_Bj1308vFcUO5rHCNyanwEg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_15_CvNFzPUOQfoII6rlmNA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_IfzHfIthHkO6dbcYO8zgwg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_9RCvElW3fUCypuHlovaGjA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_eU6vEoc2fEeUkwgp4Q4hyA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_n8Zissrm5UiC3zmhjJsmyw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_xOhhxIMNr063CjxwJupX8w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Bpznvb8IJkGFAZJKePilRQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_qq5UY0wRK0iOGrB4wG2l3A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_AlsPMZbssk6ZJn1U2wtykg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_k-R7euyY30qLrbKzofgXgw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember_IjKN6eosDESMY_UjEdsFrQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConditionalShareCapitalForFinancingAndOtherPurposesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_Ob3729tHb0aScFgPO3DcVw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConditionalShareCapitalForEmployeeBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_JlWBK3HwBk-ZtFV9txVOUw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:AtTheMarketEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_bRpB8WDxq0WCH-NheX05aQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:AtTheMarketEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfContractsAxis_aciu_GrantRevenueMember_Kn--ZLK--EWCGZTxnKU9YQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_GrantRevenueMember_7FTossETZUGpmYwf0I08Iw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_GrantRevenueMember__Ki26gI4UUqU71aLzAD8KQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_FsucBjEq20ymDerczI9DZw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_11_1_2016_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_bPPz5P3NMUuhICp34QnZTQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-11-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_11_1_2016_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_5cV-aWe_h0Wf6H9bD9joXg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-11-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_11_1_2016_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_StockOptionPlanC1Member_FrVjSQB1UkeUeoCfQYkO8Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:StockOptionPlanC1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-11-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Usd5.04ToUsd12.30Member_aFkOCQ_l5E2NLCrRmzt_fg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aciu:Usd5.04ToUsd12.30Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Usd2.76ToUsd4.57Member_ei0vM12DHU2YvZXAIwnk_A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aciu:Usd2.76ToUsd4.57Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Usd2.03ToUsd2.32Member_JcYFgrKmAkGmDL6Nc1PZGw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aciu:Usd2.03ToUsd2.32Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Chf9.53Member_QyUb_OU0dUmrWfmJfQRjJA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aciu:Chf9.53Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Chf0.15Member_bCuGS8xth02AS1EG44_CZw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">aciu:Chf0.15Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_ShareOptionsMember_JiVYK5fqYUO7VCxTOIhfZA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_RestrictedShareUnitsMember_1v9vOL78NEaUqskdXpyvxQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_ShareOptionsMember_xjjfByq3kEexxYKCccxAuA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_RestrictedShareUnitsMember_7RuOmuGIaUSc_wFc7wHO3A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_ShareOptionsMember_hb7EZRsk9k2Xc_o9Y1Cx3w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_RestrictedShareUnitsMember_xIISRYveiEabLLH78AYB7w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_ConvertibleInstrumentsMember_fIduMxC3S0aqyPa52saM_A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:ConvertibleInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_11_16_2016_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_9q9dI6YGDkGRYsQk62I2nA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:ExecutiveManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-11-16</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_11_16_2016_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_la6xlFr4Qk-ItVH571xacw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-11-16</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_11_16_2016_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_BoardOfDirectorsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_Mg69nDEnSECdfeZEURGoNw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:BoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-11-16</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_JjEtusAETU-e1_9QP3d1Ig">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_1XJ24mu0_k2BAymKVrDuJA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_VqvB-19b-ky0XrrBCaxruQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_WNkxs9Sy4kSxSAoCQwsxGw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_8zOs7UR4806DfHazcSGULA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_lp_ntzhbq0OJga_mHVbrOw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_ncAHP2PXEEG29m0kCbCu1w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_v1U_eyxTiEaM8eTayPpQkw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_Aj1yGEPLv0OsHOLlVg5leg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_HTCG4hUqoUOTQ98ao4z1DA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_bOl8wEKNyEqYyzQR0ioW-w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_ml_R3Ylar0-YvNfrWq7Svg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_41heKF3EykimTDNXOnweeg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_s9rQXTEfUUmFpg2sTDXMlQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_MVjsqGrUmkGNOKc737qEYQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_CaCTeKx2c0qPmNfApsv9IQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_xfEun2NfTUKZr40nuUKpOA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_GjTctvZEfEW6pg7_LZJEHA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember__d04PmuBgEKP0NcNI_xEpg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_aGfEhz_sAkK6Z9G5vRsASQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:InProcessResearchAndDevelopmentIPRDAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_E9kBrJ2W50Sic6i55dJjIg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_LiquidityRiskMember_I2s7qAhdwEmG_1icOvNOVw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_LiquidityRiskMember_7cEHP4wXJk6XdglcX0L3aA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:AccruedExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_oD9AY5W7QE2lsvFz7v9VSA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:TradeAndOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_ShortTermLeaseLiabilitiesMember_9v_cqh_W1kSGuzLlAQyFFQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:ShortTermLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_LongTermLeaseLiabilitiesMember_hTP2bhts4kGVi8zQZgg2Lw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:LongTermLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_V5SiFGlhwU2nqSRCE0iIlg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:AccruedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_hN_4u153REGiz2cDaHHvaQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:TradeAndOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_ShortTermLeaseLiabilitiesMember_7EJHTDPGpE2MU58MnWl9gw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:ShortTermLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_LongTermLeaseLiabilitiesMember_iE9c6Qe9dkmCxyhOVMjHlQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:LongTermLeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_SxsHygJzykiKANoKiEryBA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">aciu:AccruedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_ifrs-full_TradeReceivablesMember_LwJz8BFRY0mDYAyF8DxskQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_ShortTermFinancialAssetsMember_GQvxTZCyeUSHnqXgqhDQ9g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:ShortTermFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_RightOfUseFinancialAssetsMember_8nM6TuHsfUWJ_Eb5DPpcMw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:RightOfUseFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_OtherCurrentReceivablesMember_uVd4y6WmRkq8Gnp7VhbSAg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:OtherCurrentReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_LongTermFinancialAssetsMember_2GPCrMxC3kuP50IVhioaJQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:LongTermFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_CashOnHandAndCashEquivalentsMember_Tt_fmEFayUCvEgmVza7MFQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:CashOnHandAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_ShortTermFinancialAssetsMember_7XpjIGDTfUu8O9YtHM9T2Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:ShortTermFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_RightOfUseFinancialAssetsMember_tR8m7PTQZE-3qL6hTCbwPg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:RightOfUseFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_OtherCurrentReceivablesMember_sZ3Yzb3XREu_tDsA08-5Sw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:OtherCurrentReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_LongTermFinancialAssetsMember_Sp4G8pRwNkqsYvkUz4YI2g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:LongTermFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_CashOnHandAndCashEquivalentsMember_W820bIc2s0iHiLwstBYlKg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">aciu:CashOnHandAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_nZ4TKeIWaU2aelb5_LYCwg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_uUyHwiQf7UuXXrnxpFOqyA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_LnJjfw_Os02BiS6mZGfzUQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_VgBLVB9e1Uq5yTwvVD7SXQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_BScHwbOd1k6qH5tEPUdwhw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_gyBgxwFR8kautCu5uepUmg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EBAKwd98FkqCN-vAl_B6vg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_xRUXLA2a4UCunihbdGlUlg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_VRz4mc9TT0moisjLJVOICA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_BQ7VKwgtOkWlTCNJHXciww">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_YIPudTTsa0KFHmU0vwZo5w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_qGLJKw1KlEeLkJJRaoX5Rw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_3boVlL-e1EKk5lMRqO3nuA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_M0EemXYDV0aBwNXVy2D5wA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_N2SF2wL5eUe8CGabD_HwrA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_x2Rf-qjjC0q1OoOX5aYBuw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_4Nainf_0SEuwFd4uqOjiSQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_XpmQIKbzzk-A4QLCviO8sw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_XAtED10_YUaz8Tcq-re46w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_NtOri1sWtESc64I6yGlDKA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_pYUVZEM920exX1Cwj8qiVg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_5xasXe81HU2amQaNWKJlDA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_wEOJWOe0kkyVwPPcjL51Bg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_kZxWf5plpkyqcnxdVx9WnA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_CvwXkZmKrE2y_nrcwbCWUQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_FT-o_AOWWUmsEyj11IwpRQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_aTa03kZvVk2UVSOXZ_yZVQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_dAA0zRsjHUGlsbYsE9T1jQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_hzU9_UsRaUqQjrz3YAAlrQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_Ch-n85pVKk-WOgs80YsR9A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Wgnl3QSM2k-AdkHzUwxq5w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_8n56hl5TbUu6RGNb82sfRQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_L9p_QHOSw06twWSsiEgdWA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_pm-qrsouoE6flbV62qtS-Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_pTeQuKx_DkypZ9jWGI7C8A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_5DSHt4xHMUioT5NnjVwFog">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_iSoz2SOpp0qMTfUmXq481w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">aciu:ActuarialAssumptionOfInterestRateOnSavingsCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_SYvFKt1x10y-adlxxUg4jg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">aciu:ActuarialAssumptionOfInterestRateOnSavingsCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_982Pjk152UCG0tmlUgcu9w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_1VZZ1KUX8k2zfVZBeU_XRA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Z7UvVqXOEUmoT9JRq5CiYA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_Vku2j2aw2USeLFl-mDb8ow">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_9z7dk_eBH0qm1qbNW_X2xQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_UfDNPUrGmUWnzu7Kv8E6RQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_fdq-KvKHrE64gHajV_F_bQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">aciu:ActuarialAssumptionOfInterestRateOnSavingsCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_FSXKfZmS80elUOwthR4Uxw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">aciu:ActuarialAssumptionOfInterestRateOnSavingsCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">aciu:PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_2nj8zIQ95U6QDxkvALWpOw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_7dWOVnOSFUq1x4XujqX_oA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RightOfUseAssetsAndLeaseLiabilitiesNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_sNU1oHf-Q0i6Of2JKbOZPA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RetirementBenefitPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_vDSFPVowe067uhYZQdHFgQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_RA7Xt4V3fUCJ2nNa8SxwcA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RightOfUseAssetsAndLeaseLiabilitiesNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_TabmlKnxSE2DHBh6lcLTdA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RetirementBenefitPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_DnkavB3_kUKnU6RtWKx2Ow">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_ikz_e9A97Ea1rUgxFPK-vg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RightOfUseAssetsAndLeaseLiabilitiesNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_vxoJ2RbCcEe-EQHCnzF_IQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aciu:RetirementBenefitPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_BxvFqCM4M0ufUbFvjtlCMQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_CounterpartiesAxis_aciu_JJInnovativeMedicineMember_vsI7p2vgBE6RmjAsmPNw1A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">aciu:JJInnovativeMedicineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_NUhuhpmnrEShL-ErqVzeXQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_CD3sQ6Iqhk-fx5WexG8VXQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_UEQ5-Qdp-ECfZVHJXapb-w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_VKrtDLypPEOuxz3CjSgM6A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_ZpFwqYls3EejWQUqS6jVtA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_vnWZvKBRW0CV9s94BbcDrg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_O05oIcvQHECcE7b4dXGvbQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_aAOfPJhSHU-AqBUvHn8pLQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_1_23_2019_ifrs-full_PerformanceObligationsAxis_aciu_ResearchAndDevelopmentMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_blE7iuHcaUG9QmZUisEt3A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PerformanceObligationsAxis">aciu:ResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-23</instant>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_yMfhf5U-BEOkEesawNwGtw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_O8tZdJpRvEaGkATdj9JKqA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2023_srt_CurrencyAxis_currency_USD_hCYaW1c4MEeE5iAbGkvRtw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_srt_CurrencyAxis_currency_EUR_CKOjyw5J1Um-SGovJ4ejYw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_srt_CurrencyAxis_currency_CHF_JfNLzHvH80WbSrRE58qKYg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_srt_CurrencyAxis_currency_USD_vlpq5OPW5UKEsC2zk4jyEg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_srt_CurrencyAxis_currency_EUR_gXKgjdqF5ECk_GGPperSYA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_srt_CurrencyAxis_currency_CHF_9dJzU0_HhECZUKUigq7XAg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_kISrj4aRVketNj-9seXAtQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_WeightedAverageMember_4FG0vtdOM0qVouBNBJxDYA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:WeightedAverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_A0fLCvnZXkWCpt0V9v-hlQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_GeographicalAreasAxis_country_CH_hI8bZ3TK70-bfSp_6iHWkw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_WeightedAverageMember_X-fZxVt670yVn-ag8aFnSg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:WeightedAverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_mTTN5Hw7J0uG4plqeYxbIg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_kJ9M4JxOBEuo1siTgMfdYQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_WeightedAverageMember_ZWzC0poj30O0x-cniAS5CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:WeightedAverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_kF_Z_GmDe0uYNVNKIyLhww">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ZaXds3ifpU6wdPGK9Rol-A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_oH_yOQmg0kGMBs0pfoK_pQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_0Jtnd8m_I0enHD9zlLU-pg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_dz45p3-Mt0Kum8kISicdTg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_JX8Xpx6XvkGjBXaj4z4PEA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_SK2Ewb7ptEmzydRvB1J-Mw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_Gl68ge7NsE6HRhfhKLgLLg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_hLWNWYEvyU-dudu8IMjYcQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_LgaMFEMN_kKAtkztR9a8KA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_jU5Jt8mUF0iciQdpO6t7sA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_SGqTYRos7Eu0uaWKvQowsQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_kkPxG2DcNk29JpuIBItYrw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember__F425--_EEOXAYSsaoxgOA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_W-r0ii74bU-k1a5qR2sk3Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_yNTxg0S0g0mhMxkN6R3p8g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_FrBVzS7Gp0e3Hgpbb7-EyQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_KQhq8CmXDUufwm79fj3u-A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_JgXeFoa0LUuPeRfQafgJng">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_46FANMS68kquMVeskjfbwA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_Ks574WurXUmKeYPNctUQnw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_u5V2Ukxsi0ip1fGh-0PIFw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_5pdQTfFdGEKkjeGhrAzNRw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_pY3XYcoQoUeP48UTVCm8pg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_E1XpL1U-zkqFSbWZ-KwCTA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_eitFANd6O0-px2XAzxnmbA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_uW0txdsBO0WLBMLzEw4mWQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_RaV3Vku3aUu2A_2JfVmVng">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember_vo7YKlf8sk2Zu9M-P0T-9A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember_nRoCAsTLTkuEeahglu5EzQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember_li18Qm89cUyqRwPnUzHoyQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanVestingTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsSecondVestingConditionsMember_E41WId3rVUaJryS3yoer-A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:ExecutiveManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsSecondVestingConditionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsFirstVestingConditionsMember_b85Kv7MimEGfeEIsinaPEA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:ExecutiveManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsFirstVestingConditionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_rCWc9moZ-UuoKzp2P9kXqQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aciu:AssetAcquisitionsAxis">aciu:ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_Xg5G0gTL6EuVoA1i-tphyA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_tP2T60QRpUq6QbSwDp-rdw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_VpbnclTokEKa1COLbTmtgQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_srt_StatementScenarioAxis_aciu_IfNotesAreConvertedMember_mHIt3iiUYEiJe-LbY2MlYg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">aciu:IfNotesAreConvertedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConvertibleNoteAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_W22DIGpxCU2PCY_voUKfnA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConditionalShareCapitalForFinancingAndOtherPurposesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_bdFBuO5wp0WWfm-NR5fv1A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConditionalShareCapitalForEmployeeBenefitPlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_pAWtnvgYa0iVnloXstoYVQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConditionalShareCapitalForFinancingAndOtherPurposesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfRisksAxis_ifrs-full_InterestRateRiskMember_RtyTGF5IIEeDAR3KKFiYmQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_ItAndLaboratoryEquipmentMember_KRQK-6opkEi3py3xSmjCrA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aciu:ItAndLaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_0CVyLgPoV0-0eUUJiC7Vxg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_QwGnbZHs2kOQD9MkvKz_JQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedSharesAndRestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_12_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_AdvanceSmallMoleculePdProgramsMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember__xRQy4sDnU2wuTVhB0eVUA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AdvanceSmallMoleculePdProgramsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_wNVuSSWxUEaFOSDEm36rwg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_12_19_2023_To_12_19_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_FollowOnOfferingMember_TqOyBPKfi0OoLSsHlenN0Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:FollowOnOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-19</startDate>
            <endDate>2023-12-19</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_T_CAdfRv-0yh8ZcvUy-2eA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:ExecutiveManagementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_XCIxfyCaLUqoZoXevZDdCg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_BoardOfDirectorsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_oEAbzyJtoEmkfKv74BICBg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:BoardOfDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_wf3hN50uXkG2UnV3ktGKUw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_L33vJ60m_km7tdKwdLwwQQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aciu:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:Two016ShareOptionAndIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_StockOptionPlanC1Member_-sFGqj5mB02y1Y2vj-EJCg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">aciu:StockOptionPlanC1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_N4NtcRpK7UmEpR8gT_3kcQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_-N7k4qC--ki40tn2usH_qQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_vS7Y6wSi3Um8_4n891ZL5w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_JT6GJaAKkE28v8kpSUYthw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_BBkqnTW0KUyG6jmwGuQriQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aciu:AssetAcquisitionsAxis">aciu:ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">aciu:IprDIntangibleAssetAssociatedWithAci7104.056Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EY1gzyuyDkGmaP05xj1GQw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_orlAcRiayEeFUpKo8cWUgA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_SWcjwMgDv0e8bZSucJUMHQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_I-ActLB-JUyJBWOVjhi2gA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_6KGZQVq8r0a0vl5N0ZyV-g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_FjH3oKJjQkm4GluJmDL1ig">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_CounterpartiesAxis_aciu_FirstCapitalPartnerGmbHMember_ysIhGOhpH0C61mPSZDx7HA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConvertibleNoteAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">aciu:FirstCapitalPartnerGmbHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_CounterpartiesAxis_aciu_AthosServiceGmbHMember_G1spMOk49EyTvfHJIEKQUA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConvertibleNoteAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">aciu:AthosServiceGmbHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_B7geHyH670-gkbX2o14NvA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConvertibleNoteAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2021_To_9_30_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_I1T_yUrSRkSlCVKjmbusrw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:AtTheMarketEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_0AVWXMYRNE20fsfI1erXKg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_qxkJG_5AGkCst7uW2JVkmg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_BX74hOhBS0CUAeUr_BZQyA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_7S9fMiZwfUK5NJDPYOhCdA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfRisksAxis_ifrs-full_InterestRateRiskMember__VIlp5fvWECjGqiYiWCbsA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_vEGhjd8tq0OSqur2Fe4jnA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_u2Lf31padU-hQMejGWu9Jg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_-rFc59jcN0aZx3IBH9mm7A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_JOULfIYynEyk9vA-N_O54Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_BeNb7Z3yiUS-lTANhWp0_g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PresentValueOfDefinedBenefitObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_NAuDi-J-j0OrVs4jx0zGUw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_8_1_2022_To_8_31_2022_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_i3ZUuVbirEiuOT-5rYcByg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">aciu:SkaneUniversityHospitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AlphaSynucleinPetImagingDiagnosticAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="Duration_8_1_2022_To_8_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_zfR7x4gHWUCfKEves1438g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AlphaSynucleinPetImagingDiagnosticAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OfficeEquipmentMember_FZ2FsUgsLUK0QPYMKCCp5g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_5KJXBEAcDUOmq3jDvWNEeA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_aaNuoy-t_Eiw3M3BbRrSzA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6gI4nc20YE2v2UMn230IjA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_mVdbPS_pZEOvR8-xErVVJg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">aciu:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_018DD5MHx0yR9siTflNYPw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_i4oh9OLRKk237CD7aWKajQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">aciu:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_bid3n8U3yUu4WF-DywHH4Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_elQwz5L0xki93eiu__qmNA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">aciu:ResearchAndDevelopmentExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_QSzyXEXHe06wEWxr_MXXgQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_IkPNS4jBTECfjFa4xwgBQQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_PEDQ9Y0GpEGR7Fz3aVtJ5Q">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="Duration_7_1_2020_To_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_-1G5nnVneEOy-bPbsmwMqw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:AtTheMarketEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_vK1WQ4fPI0adSnT7gMpfmg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:SecondOpenMarketSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2014_To_12_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_ai62qsBmbECbBpWbHN1gqg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-01-01</startDate>
            <endDate>2014-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_AdvanceSmallMoleculePdProgramsMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_BWrRdrxLXEiE2A8T_eUqAA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AdvanceSmallMoleculePdProgramsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_5_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_yFg7_K4Sj06ntHrtmFJMMw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AlphaSynucleinPetImagingDiagnosticAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="As_Of_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_vLBVN6gNy0CM2OL-a8F6nw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyFirstAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember__-SkUIIH_UKKHcFlP4uAVA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="As_Of_5_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_lWKxGd9870-RZpUwXYweFQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-05-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_uOvzhs9BoEiLV6rS9IZVFg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_wERnesaBIkyF2ZYGAWOS5g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_ShYkYUEckEG0-k_MozRQGg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2019_To_3_31_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_BPMBGqeh1UCBtCXz0LDlDg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2017_To_3_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_ufWSkNfIkECZWt_mcMr6vA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauPETImagingAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-03-31</endDate>
        </period>
    </context>
    <context id="Duration_5_1_2016_To_5_31_2016_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_z6odcKKiUk6PMIxagqtGiA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-05-01</startDate>
            <endDate>2016-05-31</endDate>
        </period>
    </context>
    <context id="Duration_3_31_2020_To_3_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_ClmKil5lr0WdBtvIaUaFEA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillySecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-31</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="Duration_7_1_2019_To_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_DUqbXvvbHUeikVmBLUHq3A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauMorphomerSmallMoleculeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementWithLillyFirstAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_ByH_9hbrL0KcrDFzfvtYQg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AlphaSynucleinPetImagingDiagnosticAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="As_Of_2_1_2024_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_aciu_ReceiptOfMilestonePaymentsMember_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_zyTb0RhISEWfD4ePpEx1Hg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">aciu:ReceiptOfMilestonePaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:TauVaccineInADMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:CollaborationAgreementOf2014JanssenPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-01</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_8aUhNs9mtU-Truhn6_ij4A">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aciu:AssetAcquisitionsAxis">aciu:ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_4_28_2021_To_4_28_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_wJ7EdKp2Ok2kaiso3_KHVw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-28</startDate>
            <endDate>2021-04-28</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_gz-ausjwKkGgVkKLeTU3Ng">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">aciu:ConvertibleNoteAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="Duration_2_1_2023_To_2_28_2023_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_uKAhF0e3t0OofFPtWQBOnw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">aciu:AlphaSynucleinPetImagingDiagnosticAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">aciu:GrantsMichaelJFoxFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001651625</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <unit id="Unit_Standard_Institution_2XG7OWvIxkqRwCgZCSpPJw">
        <measure>aciu:Institution</measure>
    </unit>
    <unit id="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg">
        <measure>aciu:EquityInstruments</measure>
    </unit>
    <unit id="Unit_Standard_person_7ny7-oR7aEaZQqs0BxZVCQ">
        <measure>aciu:person</measure>
    </unit>
    <unit id="Unit_Standard_segment_uSnHfk8yHkqj2bvGJo9Fng">
        <measure>aciu:segment</measure>
    </unit>
    <unit id="Unit_Divide_CHF_USD_FPtD7vL32kaT4HamUiI0aw">
        <divide>
            <unitNumerator>
                <measure>iso4217:CHF</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>iso4217:USD</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_Standard_employee_Y_HtOjq0F0i_9evdy7ujWw">
        <measure>aciu:employee</measure>
    </unit>
    <unit id="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">
        <divide>
            <unitNumerator>
                <measure>iso4217:CHF</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_Divide_CHF_EUR_tPOVrZBRTEKkYMGLwOeV4w">
        <divide>
            <unitNumerator>
                <measure>iso4217:CHF</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>iso4217:EUR</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_Standard_Y_vGNa0xS6h0m8DtazE3ChHg">
        <measure>aciu:Y</measure>
    </unit>
    <unit id="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">
        <measure>iso4217:CHF</measure>
    </unit>
    <unit id="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">
        <measure>aciu:Options</measure>
    </unit>
    <unit id="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">
        <measure>pure</measure>
    </unit>
    <unit id="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Unit_Standard_installment_NWKLjjbZOEujM9f04o9HSA">
        <measure>aciu:installment</measure>
    </unit>
    <unit id="Unit_Standard_EUR_QpqDW6JdmEqpVHDpBHxA4g">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">
        <measure>shares</measure>
    </unit>
    <unit id="Unit_Standard_agreement_5eg0SdvY8kqQI3hiVdpf-Q">
        <measure>aciu:agreement</measure>
    </unit>
    <unit id="Unit_Standard_item_lel3bReemU2v4xdKyUvjzA">
        <measure>aciu:item</measure>
    </unit>
    <unit id="Unit_Standard_plan_aEIYineoxU60B5qoFDN6Ig">
        <measure>aciu:plan</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tc_n4TQPYT_8Ee7ClZEsTMCUw_2_1">0001651625</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tc_uWL2PN3j40GgM7eE_kR8ug_3_1">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tc_EbslL9GZ8U-1R_6l8nGqdg_4_1">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tc_LmjSJ9a_8Uq2f8CS3rIv6w_5_1">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tc_8EyFCVY0PkGv17vQ_ETVdw_6_1">false</dei:AmendmentFlag>
    <aciu:MaturityPeriodOtherCurrentReceivables
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_N4NtcRpK7UmEpR8gT_3kcQ"
      id="Hidden_JBrWQoLofk6Gyr7gN4-sJQ">P3M</aciu:MaturityPeriodOtherCurrentReceivables>
    <aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_CounterpartiesAxis_aciu_FirstCapitalPartnerGmbHMember_ysIhGOhpH0C61mPSZDx7HA"
      decimals="0"
      id="Hidden_RHGPfxiSZ0Wm65Cc6mThNQ"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">1513317</aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt>
    <aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_ShYkYUEckEG0-k_MozRQGg"
      id="Hidden_9VUHy5QxNUOhdyJftjpzFw">P3M</aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod>
    <aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_uOvzhs9BoEiLV6rS9IZVFg"
      id="Hidden_0OEUZRutDEesJMh1BBGUqQ">P90D</aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod>
    <aciu:CollaborativeAgreementJointResearchCollaborationPeriod
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_ByH_9hbrL0KcrDFzfvtYQg"
      id="Hidden_fQR8tACVGEO4UDivdKvMdQ">P2Y</aciu:CollaborativeAgreementJointResearchCollaborationPeriod>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-5"
      id="Hidden_HV19mOg_skeZVhyj5rvzCA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:DeferredTaxLiabilities>
    <dei:DocumentType
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_KrL4TbkElEOsGK_jxrlGwQ">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tc_Kf9RNUIisEOWhW-6G4X8Wg_1_1">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tc_wVP8GHkAB0OmRXzxzC0t7g_1_0">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_pwQRRJoKGEOoESecuGUMlA">2023-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tc_CRluZi6GwEWkIQDklB7HQw_1_0">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tc_6pt20wBe_U6fFiD_nw9rLQ_1_0">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_MeT-KeyF9kqCk_FVxGUXYA">001-37891</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_6LyBJpP1gUas4DLZQRtNyA">AC IMMUNE SA</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_pJlmJoJL00WrAAhisZiWEw">V8</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_NpPIpukbM0S-si9-IM4hSA">EPFL INNOVATION PARK</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_0RpKE8t44USNZZlVYiLepg">Building B</dei:EntityAddressAddressLine2>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_jy3mLcueCUyG5A6PfJisTg">1015</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_K9B5T70GWkCMy-SwyOJqMw">Lausanne</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_bqV2V5XGbkCVefME4e2rvg">CH</dei:EntityAddressCountry>
    <dei:ContactPersonnelName
      contextRef="Duration_1_1_2023_To_12_31_2023_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_46FANMS68kquMVeskjfbwA"
      id="Narr_0tV4_Y1SBU6HHNQtn-ceOQ">Andrea Pfeifer</dei:ContactPersonnelName>
    <dei:CityAreaCode
      contextRef="Duration_1_1_2023_To_12_31_2023_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_46FANMS68kquMVeskjfbwA"
      id="Narr_OauvTsufIkO52YTBIyf9nA">41</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_1_1_2023_To_12_31_2023_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_46FANMS68kquMVeskjfbwA"
      id="Narr_8KGYefYkA0a8KoLs6RM6Og">21 345 91 21</dei:LocalPhoneNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_1_1_2023_To_12_31_2023_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_46FANMS68kquMVeskjfbwA"
      id="Narr_ywBzYpeKlkiXOnGxlQDM4w">EPFL INNOVATION PARK</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="Duration_1_1_2023_To_12_31_2023_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_46FANMS68kquMVeskjfbwA"
      id="Narr_sOtY_vExNkiJzgFH_-RBVQ">Building B</dei:EntityAddressAddressLine2>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_1_1_2023_To_12_31_2023_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_46FANMS68kquMVeskjfbwA"
      id="Narr_BISRy9IK6kuzXbExCrynPw">1015</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_1_1_2023_To_12_31_2023_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_46FANMS68kquMVeskjfbwA"
      id="Narr_GTW1iCwCyUS0jrYqFk6GEA">Lausanne</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="Duration_1_1_2023_To_12_31_2023_dei_EntityAddressesAddressTypeAxis_dei_BusinessContactMember_46FANMS68kquMVeskjfbwA"
      id="Narr_RI9qToB6AEe-0xTBDNTEUg">CH</dei:EntityAddressCountry>
    <dei:Security12bTitle
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tc_zntIGR7qakKnwVhbt_UCaw_2_0">Common Shares, nominal value CHF 0.02 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tc_Rzx3U_pRGkWjj0dyurHHcg_2_2">ACIU</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tc_7MPHqy97dEGU5B6cvwuscA_2_4">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="INF"
      id="Narr_1Bkof3hECkm0lbvXx0O66A"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">99197829</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_Y75PeUWdjE6_tEW09MaiMw">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_oVisrm9tMUyqs5DjXjH3Qw">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_clS8XpqEoUOX8a-Xd1O3ig">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_o52whONl4EegXDzUIcBsBg">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_TIGO7rBbrkGbgBimUw-cxA">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_9moG08PV50Sz2BjAqnwMoA">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_huYeCZVgGUOpFuOe-yp5Pw">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_W6n3E7CP-kGnI7h1Ahr6Ew">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:DocumentAccountingStandard
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_tSufsKnzZUaJ64o1YvPe3w">International Financial Reporting Standards</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_05GB2CKUoUWXsWogtEvgzQ">false</dei:EntityShellCompany>
    <dei:AuditorFirmId
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_K5A5tZ4pG0u00cAANpf3LA">1358</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_fvjOURydu0SVrb1aRuRZWw">PricewaterhouseCoopers SA</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_tNZtCQVjC0ekM4RB5IA9UA">Lausanne, Switzerland</dei:AuditorLocation>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_KqTx97iDtEepw0dieCNGiw_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3376000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_r9d1JRzby0m19cKpEkQNdA_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4259000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_JfMvRZAciUCELlAsDbyh9A_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3508000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_Rz1pwDDghUCMbA3YPyWw9A_7_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2808000</ifrs-full:RightofuseAssets>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_aZIMjUgMXkeAqlmwMwgUvw_8_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">50416000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_FpWBThdx80yHOrr1PFeBcg_8_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">50416000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:NoncurrentRestrictedCashAndCashEquivalents
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_WqLWRqtE5U6awMgu2ZEVMw_9_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">361000</ifrs-full:NoncurrentRestrictedCashAndCashEquivalents>
    <ifrs-full:NoncurrentRestrictedCashAndCashEquivalents
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_dRwRWPq4lEGqKGyePLvlCg_9_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">361000</ifrs-full:NoncurrentRestrictedCashAndCashEquivalents>
    <ifrs-full:NoncurrentAssets
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_H_TX4-RBgEusUcjZsVg5kQ_10_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">57661000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_iSS5gdub0UWxIygGJxLUKw_10_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">57844000</ifrs-full:NoncurrentAssets>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_jss4oqSGk0K6yQhI7j0EPg_13_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">6437000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_STuYkcoPnkau9h43f1I6nw_13_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4708000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_1lt4CLRnJ0yYCNF5hCdyVg_14_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">246000</ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets>
    <ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_gex5Nc9NdkK-OYR031GS2Q_14_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">408000</ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets>
    <ifrs-full:OtherCurrentReceivables
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_74uceI5_C0WMpjxARFGFUA_15_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">622000</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_FcTrdD39QkK8F1TGa16Whg_15_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">392000</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_gONCKNjjmUK3uvEpK0tixA_16_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">14800000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_KFkfxVbp7EqiNJxj7Q8XUA_17_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">24554000</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_pdpOQbzuU0efFmGP-leiTg_17_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">91000000</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_qFf6rwHw60SNgxsS-M1CKg_18_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">78494000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_eVyQQb8h50mKuj2JxKysqg_18_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">31586000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CurrentAssets
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_YxwJQa-4FUyobQoYMdHSPg_19_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">125153000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_Mn7zIig9W0amVaeiH_6tlA_19_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">128094000</ifrs-full:CurrentAssets>
    <ifrs-full:Assets
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_tXWyMYc9Q0St-PdzerykGw_20_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">182814000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_z-czZT9HFECpGCbrk9yGWQ_20_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">185938000</ifrs-full:Assets>
    <ifrs-full:IssuedCapital
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_R8MkcRHD1EKSxbfW0E2paw_25_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2089000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_SIX1gXlHUUeB0yiOHFsbuQ_25_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1797000</ifrs-full:IssuedCapital>
    <ifrs-full:SharePremium
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_gM3NKdHh6EKIlByASVEx7w_26_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">474907000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_s_ef3GDCF0ec68B86LIqAA_26_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">431323000</ifrs-full:SharePremium>
    <ifrs-full:TreasuryShares
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_isN3V_GfVUWNehOy7DfU7Q_27_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">105000</ifrs-full:TreasuryShares>
    <ifrs-full:TreasuryShares
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_lgT5gsKzZUqFsy3l1e11jg_27_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">124000</ifrs-full:TreasuryShares>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_hv5MfWAWd0Wkp-6bdXr_tw_28_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-51000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_WlvyqTB1EEuutO9K_e6aRA_28_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">10000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:RetainedEarnings
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_LMH-0FuLCkSRRgKNycVyrQ_29_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-316197000</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_8vHCXkhYpUi9LeD-wGlqfg_29_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-264015000</ifrs-full:RetainedEarnings>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_DMVbkRupgkmWqEFv3_D4xw_30_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">160643000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_menIu7meSU6u6AayG1cIng_30_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">168991000</ifrs-full:Equity>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_OhjKNiliAU6aQpfL2BNwZg_33_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2825000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_y_k-rlykR0eHSBSWDye-zQ_33_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2253000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentProvisionsForEmployeeBenefits
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_2MgioHri00O2DCFyZ6-DwA_34_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">5770000</ifrs-full:NoncurrentProvisionsForEmployeeBenefits>
    <ifrs-full:NoncurrentProvisionsForEmployeeBenefits
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_Pa-eKAgp502QpQiNEgEbYA_34_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3213000</ifrs-full:NoncurrentProvisionsForEmployeeBenefits>
    <ifrs-full:NoncurrentLiabilities
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_zbYFpENmJUuHGd6IycCzNw_35_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">8595000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_yWDf7CD0RUaARAYwKftcUw_35_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">5466000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_LJsxB-SuEEK1fODKiSHKJA_38_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1679000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_82xj4tPbhkyaoCkvSkQyIg_38_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">929000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_gFOYNiIvhUeOqPXs2PL-2A_39_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">11087000</ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities>
    <ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_NbXA44Q2zkawN0gX0_hCKg_39_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">9417000</ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities>
    <ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_0AfHkTfQ-Uu2APdKCvjMEQ_40_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">138000</ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities>
    <ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_gm5cBTqAJUu2i74YYWCseQ_40_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">587000</ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_UXq4o_SIJES51qs3bAIeAg_41_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">672000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_gQmVLL5pB024ah3_8ZWbYA_41_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">548000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_mk90Bo1yH0a16v3mqtBRlw_42_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">13576000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_r9p7iPcfSU-NVOG1NxWQOQ_42_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">11481000</ifrs-full:CurrentLiabilities>
    <ifrs-full:Liabilities
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_L1YiS6twXkeQosa2UYitcw_43_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">22171000</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_9EDizDlzm02A-mU6R547BQ_43_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">16947000</ifrs-full:Liabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_J0108HVN60WgtM3K-xGZqg_44_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">182814000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_jxnC5gL4H02PCPWy_GqENA_44_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">185938000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_3zdeJSxeL0qpsd6zTHIr5A_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">14801000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_wahkRDWxOEuCC26KOt1dGg_5_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3935000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_Hm2fTpBJ2kuzLieBc3_w3Q_5_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:Revenue
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_2-aVimowUEu7bRMi5kEIIw_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">14801000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc__W_xLPcJoU-3dqmJ8DgXFQ_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3935000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_wbpuKNVFX06pRyebAKMuoA_6_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:Revenue>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_HXu7guXQLEWyZ_MkOxj-VA_9_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">54606000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_oF7kDP__iEOisR4Fc7h4JQ_9_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">60336000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_LFObzgdiP0SUW4hpGGOfnw_9_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">62282000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_KvVy_L_q9UGNDtECOlfjZg_10_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">15305000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_vD0wpJKlBkWVIPH_eRljlA_10_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">15789000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_PIK56W-UYk-RO3FPolWlbw_10_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">17910000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_X1bcJOIm9km9Vb2l6AHOow_11_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1486000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_4B9ZfnlsdkeHuNvjJHis2w_11_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1343000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_MRZuWtya8EWdAXaRUAc0GA_11_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1182000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OperatingExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_3HzZFduTx0u_Dn8muaqdGg_12_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">68425000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_M2qWhv0aBkiNzeKY6uJ0NQ_12_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">74782000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_q6Kjk9Tl10-c12pwPpMLdw_12_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">79010000</ifrs-full:OperatingExpense>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_0pz8TFTYNUWti-UAe5vlUA_13_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-53624000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_2Zswfw5FX061opAAcaFEkQ_13_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-70847000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_LhFVOnLUEkWH-JUz2rs6jA_13_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-79010000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceIncome
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_32hddMMjwUuDGMmYetqn1g_15_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1044000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_y84j-vyrJkmMXoSVYghXbw_15_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">69000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_wbHpj6jEAUqZSgu-jww7xA_15_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">6485000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceCosts
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_2CSNeL-id0SMYwMeg78iJA_16_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">176000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_kdpYILw4ZkK1vb6MmEqPjg_16_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">355000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_XuxqCtZe50K7GWyrBw8kzw_16_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">581000</ifrs-full:FinanceCosts>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_n0RL7pEXeEG4zd1eXItzPQ_17_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1467000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_nmnhTj2zHE-R4Uwqxpxkpw_17_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">393000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_bs6ryLm_DEWtxgPvwnrskg_17_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">113000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:FinanceIncomeCost
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_9w2gA47-IE-BG08hbeXwAA_18_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-599000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_Js8dnHqXu0i4iiQ9NGl1kw_18_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">107000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_u1WEqhzmA0CkEhlHbmYBuQ_18_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">6017000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_3Z6wVYfcMUWLwN5S9AfGlg_20_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-54223000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_ti3315O680mQ-fvIq2X-Rw_20_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-70740000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_olehwZ_PQUqyJTzzrlnr4g_20_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-72993000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_XvxTf42A_0KoVHjHCTUWGA_21_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">10000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_EjH3t1e7GkuT9NEutOMyxQ_21_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">13000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_qXkZnRudG0e5oW0HTfPLiw_21_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_sMaaySHJZ02YSYcPJrCndw_22_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-54233000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_yVIdrTAg1Eq-7PhtfXxdOQ_22_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-70753000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_u1pRzKfLq0u9S_iANJK6hQ_22_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-72996000</ifrs-full:ProfitLoss>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="2"
      id="Tc_Nv-5J-YKrEKRVYEGaBG31g_25_4"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">-0.64</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="2"
      id="Tc_Nv-5J-YKrEKRVYEGaBG31g_25_4_2"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">-0.64</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="2"
      id="Tc_HVarc84yLku9Lsla63hEwA_25_6"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">-0.85</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="2"
      id="Tc_HVarc84yLku9Lsla63hEwA_25_6_2"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">-0.85</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="2"
      id="Tc_dWDUubRAIkGrsqOrNWOz7w_25_8"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">-0.97</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="2"
      id="Tc_dWDUubRAIkGrsqOrNWOz7w_25_8_2"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">-0.97</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_7OyHC7KvQUWkIiWjRtRqdg_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-54233000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_F4ihZhMEZ0S-xEc9EeG1gw_4_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-70753000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_YATofSVHw0W47HOBCwpukg_4_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-72996000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_NcT3t1hYc0656hEqKnwaSA_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-61000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_6kFOQHU2S0a3GSEzrIY0dg_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">10000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_9HT8HTmCakKvTbpIVM2_ag_6_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_Kj-AryQPbk2I3HgntYWSWw_8_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1669000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_dfmIeKpezkWH8A-AjxSoKQ_8_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4426000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_jwjadhRwF0-LNdrPOUPgmA_8_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">956000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_au1svJ5K80qZmPRfZlWDsw_9_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1730000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_PySK_L3N5Eqa0yMr-OCNzg_9_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4436000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_xw5TyRE_5kWU0Akh8z2Aew_9_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">956000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc__ne9MlVkPEWK_Jcyds1Y1g_10_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-55963000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_5rmCwe5hokeyLmkUJEM4BA_10_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-66317000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_APVn7niRzkayFrWQFQwzog_10_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-72040000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_XpmQIKbzzk-A4QLCviO8sw"
      decimals="-3"
      id="Tc_Wid9JSUllUaqPebUi1enVw_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1538000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_x2Rf-qjjC0q1OoOX5aYBuw"
      decimals="-3"
      id="Tc_N8Ravae_okqABtt0d-iQXQ_4_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">346890000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_N2SF2wL5eUe8CGabD_HwrA"
      decimals="-3"
      id="Tc_79nF2h-ty02JzgfJNUszSw_4_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-100000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_4Nainf_0SEuwFd4uqOjiSQ"
      decimals="-3"
      id="Tc_CFX0Pf2dPkaRaVisaP1z-w_4_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-132850000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2020_kISrj4aRVketNj-9seXAtQ"
      decimals="-3"
      id="Tc_PeAoRhZCKkaLbGcVbTIuWw_4_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">215478000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_JT6GJaAKkE28v8kpSUYthw"
      decimals="-3"
      id="Tc_PtdbD5u7KEK0fD282FxcFA_5_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-72996000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_b3jY_NfPn0KdFd0W1KjYjw_5_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-72996000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_JT6GJaAKkE28v8kpSUYthw"
      decimals="-3"
      id="Tc_ZsJ6A9YNQUm0dvvnTUHxCQ_6_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">956000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_7Lea8Q86f0y_dBiiooh2dw_6_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">956000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_JT6GJaAKkE28v8kpSUYthw"
      decimals="-3"
      id="Tc_jUlMSsP5jE2YGo_rGMkgSw_7_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-72040000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_aPHuBmRojEWdBOAjR-utjw_7_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-72040000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_JT6GJaAKkE28v8kpSUYthw"
      decimals="-3"
      id="Tc_FN-zQ1xVZU2GP8n4u2fbYw_9_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4126000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_1qz6hah4NEKPlcBOnYz0SA_9_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4126000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_0AVWXMYRNE20fsfI1erXKg"
      decimals="-3"
      id="Tc_fptv6iWu9Eqn6hnbR8aydA_10_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">12097000</aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_VpbnclTokEKa1COLbTmtgQ"
      decimals="-3"
      id="Tc__KqnZVXfREO_gxI2Mpalhg_10_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">24000</aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_hK7_PYUv9E-SNkYQ3O4XTw_10_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">12121000</aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_qxkJG_5AGkCst7uW2JVkmg"
      decimals="-3"
      id="Tc_bz9KBFaP30CIMcpMv1oeFg_12_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">130000</aciu:IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset>
    <aciu:IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_0AVWXMYRNE20fsfI1erXKg"
      decimals="-3"
      id="Tc_gtuUl1RCzkaJIrqJySs1Rw_12_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">49741000</aciu:IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset>
    <aciu:IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_7vyaXyrfWUy7rqubq23mww_12_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">49871000</aciu:IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset>
    <aciu:IncreaseDecreaseThroughAcquisitionOfAssetsEquity
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_qxkJG_5AGkCst7uW2JVkmg"
      decimals="-3"
      id="Tc_DlzAd9b2pEC_PTeAioI1YQ_13_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">12000</aciu:IncreaseDecreaseThroughAcquisitionOfAssetsEquity>
    <aciu:IncreaseDecreaseThroughAcquisitionOfAssetsEquity
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_0AVWXMYRNE20fsfI1erXKg"
      decimals="-3"
      id="Tc_vbZnZBOMl0W7pP4AvNYx3A_13_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4587000</aciu:IncreaseDecreaseThroughAcquisitionOfAssetsEquity>
    <aciu:IncreaseDecreaseThroughAcquisitionOfAssetsEquity
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_jnBixp-3y0W_VyNYQaNCww_13_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4599000</aciu:IncreaseDecreaseThroughAcquisitionOfAssetsEquity>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_qxkJG_5AGkCst7uW2JVkmg"
      decimals="-3"
      id="Tc_c_1YCjI-ZUmG6W_iLTAMLg_14_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">61000</ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_0AVWXMYRNE20fsfI1erXKg"
      decimals="-3"
      id="Tc_9224pxVsi0KVuJkAzTnFiw_14_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">16683000</ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_3t1tUG9TNE2YxvR-8a69sg_14_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">16744000</ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments>
    <ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_qxkJG_5AGkCst7uW2JVkmg"
      decimals="-3"
      id="Tc_hSEj08DS5kyv02pt17-KMA_15_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">48000</ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions>
    <ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_VpbnclTokEKa1COLbTmtgQ"
      decimals="-3"
      id="Tc_aO31JmUwt0CBTw_AiMCbKQ_15_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-48000</ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_qxkJG_5AGkCst7uW2JVkmg"
      decimals="-3"
      id="Tc_ymS9drJQQU2w-k7aoRyFNA_16_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1000</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_0AVWXMYRNE20fsfI1erXKg"
      decimals="-3"
      id="Tc_z7GvliuWaEmL9xvI9wBF0Q_16_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">171000</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_JT6GJaAKkE28v8kpSUYthw"
      decimals="-3"
      id="Tc__yvQ2y7IaEC3WTWNaYFr7Q_16_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-178000</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_gZdDalFZBU-38AL53SN0kw_16_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-6000</aciu:IssueOfEquityRestrictedShareAwards>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_qxkJG_5AGkCst7uW2JVkmg"
      decimals="-3"
      id="Tc_Irgq7QhifkmeBnpsxhzmcg_17_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_0AVWXMYRNE20fsfI1erXKg"
      decimals="-3"
      id="Tc_0jXnp6q21kWOnuY0utxcaQ_17_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1082000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_Rv3zTKW1YkerFaae916eLA_17_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1086000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_M0EemXYDV0aBwNXVy2D5wA"
      decimals="-3"
      id="Tc_KZ-z9t-gFU-fx1LY0K0BJg_18_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1794000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_qGLJKw1KlEeLkJJRaoX5Rw"
      decimals="-3"
      id="Tc_GrjnK2VfK0iSwY_909yxlQ_18_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">431251000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_YIPudTTsa0KFHmU0vwZo5w"
      decimals="-3"
      id="Tc_LFyVktCBfkieIWD30lVBvQ_18_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-124000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_3boVlL-e1EKk5lMRqO3nuA"
      decimals="-3"
      id="Tc_5kaBTl74PE272Qb8izK8uQ_18_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-200942000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="-3"
      id="Tc_ILI9LGejcUCCqEQ2fdDAkQ_18_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">231979000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_M0EemXYDV0aBwNXVy2D5wA"
      decimals="-3"
      id="Tc_-G5IxysNIEGuMtDNn69t_A_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1794000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_qGLJKw1KlEeLkJJRaoX5Rw"
      decimals="-3"
      id="Tc_0pAuzO5e4UmKvjMuDWJ0dg_4_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">431251000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_YIPudTTsa0KFHmU0vwZo5w"
      decimals="-3"
      id="Tc_upu9XhA14k2_BiTWAr0cGw_4_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-124000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_3boVlL-e1EKk5lMRqO3nuA"
      decimals="-3"
      id="Tc_DD06s3mJ4ECpTr7z8Ec1yw_4_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-200942000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="-3"
      id="Tc_pBWQSsq_GkSiS-tI0pE07g_4_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">231979000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_vS7Y6wSi3Um8_4n891ZL5w"
      decimals="-3"
      id="Tc_02pU0KLjnkCNmqxn-1z5Iw_5_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-70753000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_Mie1xR7-rUqr_BdUAHNCsg_5_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-70753000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_vS7Y6wSi3Um8_4n891ZL5w"
      decimals="-3"
      id="Tc_2yow6WcHTE6SVv68Je4RmQ_6_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4426000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_O8tZdJpRvEaGkATdj9JKqA"
      decimals="-3"
      id="Tc_v5_Cyvz40k2Otx9Mpgb8WQ_6_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">10000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_LEWvJezpOEOgB3Hglc3kBQ_6_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4436000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_vS7Y6wSi3Um8_4n891ZL5w"
      decimals="-3"
      id="Tc_9xL38Y93OUOyUE-MOGZYGg_7_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-66327000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_O8tZdJpRvEaGkATdj9JKqA"
      decimals="-3"
      id="Tc_tn1GazP9H0S9grVqSDAaRg_7_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">10000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_OlekY10TSE-pUX35PqzkpA_7_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-66317000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_vS7Y6wSi3Um8_4n891ZL5w"
      decimals="-3"
      id="Tc_xF-OIN1d_06uJ0hclcV5_g_9_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3330000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_Y_KYZf8vt0-Vp0t3odjgWA_9_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3330000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_SWcjwMgDv0e8bZSucJUMHQ"
      decimals="-3"
      id="Tc_eojbgN3k7kOs4yzcrZdlsw_10_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-8000</aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_tP2T60QRpUq6QbSwDp-rdw"
      decimals="-3"
      id="Tc_WxjQe5apVUS4S2OgxaczcQ_10_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_GPe9EIpDaUG_QrLrnpELnw_10_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-8000</aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_I-ActLB-JUyJBWOVjhi2gA"
      decimals="-3"
      id="Tc_MSmczdU0XEiiO_Mv5_EBwg_12_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_SWcjwMgDv0e8bZSucJUMHQ"
      decimals="-3"
      id="Tc_zsRhUBZHrUKBEJ66LM8Iag_12_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">76000</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_vS7Y6wSi3Um8_4n891ZL5w"
      decimals="-3"
      id="Tc_zpcZO-Im2EuYrFYSnlleGQ_12_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-76000</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_9iUksCYFsEyUfNLzz7U27g_12_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</aciu:IssueOfEquityRestrictedShareAwards>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_I-ActLB-JUyJBWOVjhi2gA"
      decimals="-3"
      id="Tc_sLyw2qaa2Ea70sqV255izA_13_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_SWcjwMgDv0e8bZSucJUMHQ"
      decimals="-3"
      id="Tc_gkeemmdUT0CIb1F_NUaEFQ_13_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_mxoe8g0VKkGc3b8XJud0RA_13_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">7000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_BQ7VKwgtOkWlTCNJHXciww"
      decimals="-3"
      id="Tc_DjyqYgd8VU6oHl3RcPYH2A_14_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1797000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EBAKwd98FkqCN-vAl_B6vg"
      decimals="-3"
      id="Tc_icQ_D4CV70C0RdsCazlibg_14_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">431323000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_gyBgxwFR8kautCu5uepUmg"
      decimals="-3"
      id="Tc_vgGmmQFTrEa3y2dcJrxGgg_14_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-124000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_xRUXLA2a4UCunihbdGlUlg"
      decimals="-3"
      id="Tc_yqP7szhkzEyCsjEMpVnQKw_14_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-264015000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_VRz4mc9TT0moisjLJVOICA"
      decimals="-3"
      id="Tc_XkgPrsYZw0CtPXKv6DCSOQ_14_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">10000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_B134O9-KXUS7hfchpQAr6g_14_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">168991000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_BQ7VKwgtOkWlTCNJHXciww"
      decimals="-3"
      id="Tc_6kHp3aSiH0WP1JzcQ3Hxxw_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1797000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EBAKwd98FkqCN-vAl_B6vg"
      decimals="-3"
      id="Tc_aiK3E6AB5UWEdd7J-Ysivg_4_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">431323000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_gyBgxwFR8kautCu5uepUmg"
      decimals="-3"
      id="Tc_4uy2QUsMukmfeUJQpRLHTA_4_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-124000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_xRUXLA2a4UCunihbdGlUlg"
      decimals="-3"
      id="Tc_cOwYI0qY-UCUuuEsp8h9dw_4_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-264015000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_VRz4mc9TT0moisjLJVOICA"
      decimals="-3"
      id="Tc_n_3z3-0Dhky4EGRY6WAQAw_4_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">10000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_pq3Vqm2vx0ONWY0eyCzdWA_4_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">168991000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_-N7k4qC--ki40tn2usH_qQ"
      decimals="-3"
      id="Tc_7PgWBmIIykSgOkU0QnAEIQ_5_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-54233000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_orEyWOfHxU2Y5lkdFzZRdQ_5_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-54233000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_-N7k4qC--ki40tn2usH_qQ"
      decimals="-3"
      id="Tc_FeyFfFVQ6EaWTv4LunEzyg_6_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1669000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_yMfhf5U-BEOkEesawNwGtw"
      decimals="-3"
      id="Tc_sQFz6DUa1EWE7XMFyaTRcg_6_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-61000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_0GAojcIQbESwYmEkILcEGQ_6_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1730000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_-N7k4qC--ki40tn2usH_qQ"
      decimals="-3"
      id="Tc_NtimvQKrGEC0mGl0KKBXvw_7_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-55902000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_yMfhf5U-BEOkEesawNwGtw"
      decimals="-3"
      id="Tc_wvfI_hbgR0mN45Y3MxPNsw_7_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-61000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc__oN3dam3VESqo7ShbXgydA_7_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-55963000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_-N7k4qC--ki40tn2usH_qQ"
      decimals="-3"
      id="Tc_xncdO_Dp30SZPC5hmCMmag_9_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4365000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_xLVtE-zsOEShumktib2apQ_9_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4365000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <aciu:SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_orlAcRiayEeFUpKo8cWUgA"
      decimals="-3"
      id="Tc_1tm6Xp2X9k6nBJFc02yPJw_10_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">286000</aciu:SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost>
    <aciu:SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EY1gzyuyDkGmaP05xj1GQw"
      decimals="-3"
      id="Tc_LNmdsqins0u35RLvqF67oQ_10_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">40249000</aciu:SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost>
    <aciu:SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_oOQ7E_ljc02ITh_DRFMdRw_10_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">40535000</aciu:SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost>
    <aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EY1gzyuyDkGmaP05xj1GQw"
      decimals="-3"
      id="Tc_DTfRViSLIUmK6P3rodcguA_11_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2631000</aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_Xg5G0gTL6EuVoA1i-tphyA"
      decimals="-3"
      id="Tc_P8VtG8iL_kqhyAY6tUG5AA_11_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">19000</aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_xYkMD1UkPUGo3O0kton5Sg_11_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2650000</aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_orlAcRiayEeFUpKo8cWUgA"
      decimals="-3"
      id="Tc_bX99uWU-e0-n_4tX0kX93w_13_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">5000</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EY1gzyuyDkGmaP05xj1GQw"
      decimals="-3"
      id="Tc_Oh6GR0jnHEyZkDjo27xk6A_13_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">645000</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_-N7k4qC--ki40tn2usH_qQ"
      decimals="-3"
      id="Tc_kGcQEwU03USKzP3VfOPphw_13_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-645000</aciu:IssueOfEquityRestrictedShareAwards>
    <aciu:IssueOfEquityRestrictedShareAwards
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_pgQvKEVOfkS_E8wVeCAmnw_13_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">5000</aciu:IssueOfEquityRestrictedShareAwards>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_orlAcRiayEeFUpKo8cWUgA"
      decimals="-3"
      id="Tc_vn5NnDbMRUuqW0VYZSmdsw_14_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EY1gzyuyDkGmaP05xj1GQw"
      decimals="-3"
      id="Tc_2ME7JT9Z_kiav0C77pjJvQ_14_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">59000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_AX7WWrnIUk2p6mm3SdY9SA_14_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">60000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_BScHwbOd1k6qH5tEPUdwhw"
      decimals="-3"
      id="Tc_Ch6HN_P2kUGLX05X3w3hRQ_15_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2089000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_uUyHwiQf7UuXXrnxpFOqyA"
      decimals="-3"
      id="Tc_lMTRnhZAokW82Gs6f7LC5Q_15_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">474907000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_nZ4TKeIWaU2aelb5_LYCwg"
      decimals="-3"
      id="Tc_jkkBLgme6k6l-NHbpkT20g_15_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-105000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_RetainedEarningsMember_LnJjfw_Os02BiS6mZGfzUQ"
      decimals="-3"
      id="Tc_86hXcGCdz0em9GWoEI0tRQ_15_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-316197000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_VgBLVB9e1Uq5yTwvVD7SXQ"
      decimals="-3"
      id="Tc_DQtzEDc1Q0GEzUITeOIW3Q_15_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-51000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_ALIxMup3k0CqpQ3DDZnGCg_15_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">160643000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_kv77R65N80OB3qoOilzkpg_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-54233000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_dGCot9bTWEWNvO87iv4sFA_5_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-70753000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_CCTYAayMe0eOjcvSD-5PJA_5_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-72996000</ifrs-full:ProfitLoss>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_rLJKcBwRFU2ZKCc8xxYTqg_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1672000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_Fn3gclFlKka9y6Vq4AOk2g_7_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1793000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_Ac51hWn5kEyvGMtiU83cdQ_7_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1897000</ifrs-full:AdjustmentsForDepreciationExpense>
    <aciu:AdjustmentsForDepreciationExpenseRightOfUseAssets
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_cfOPlutlpkS48GuiELhX2w_8_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">543000</aciu:AdjustmentsForDepreciationExpenseRightOfUseAssets>
    <aciu:AdjustmentsForDepreciationExpenseRightOfUseAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_s-1Y-KgB002XfHZQTY7qvw_8_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">566000</aciu:AdjustmentsForDepreciationExpenseRightOfUseAssets>
    <aciu:AdjustmentsForDepreciationExpenseRightOfUseAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_pkW2ebuVOkmUpTKVBMBYmw_8_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">509000</aciu:AdjustmentsForDepreciationExpenseRightOfUseAssets>
    <ifrs-full:AdjustmentsForFinanceIncomeCost
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_Pm2KmD4KukWf4M81LWZBhg_9_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-922000</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <ifrs-full:AdjustmentsForFinanceIncomeCost
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_uJnVAroxAEm7LwkwlrYeBg_9_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">559000</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <ifrs-full:AdjustmentsForFinanceIncomeCost
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_FxXY5pUlKUKawJucyeGfqg_9_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">6769000</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_5xYtcCgX60--g_62eVXn8Q_10_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4365000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_Y6wSI7N5j0G6BS6jgDzu-w_10_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3330000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_XZcHLCgzqESK_kvzmCVwEQ_10_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4126000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_COZNW8ocBkOMSfp9SX7wFg_11_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">888000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_S17aOkgSRECMX5qkuzNFEw_11_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">541000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_x7dc2Q_RWU2Y6TBTyZ3p-w_11_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">590000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForInterestExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_MrkxeZbLK0OmVbgJmr8_Xw_12_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">176000</ifrs-full:AdjustmentsForInterestExpense>
    <ifrs-full:AdjustmentsForInterestExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_qlezLuFG7ka5L9KF5PXzAQ_12_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">355000</ifrs-full:AdjustmentsForInterestExpense>
    <ifrs-full:AdjustmentsForInterestExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_WBB4lRgJ1UGTjjt9Y4ondg_12_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">573000</ifrs-full:AdjustmentsForInterestExpense>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_8wzoMGTt7UOGvAqK0IOeDg_13_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_8_2Wbi1yJUq00iz26z69Ag_13_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_1BBlb9stV02gIxy0jFGAsw_13_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-13000</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_-oyPhVlTl0CksHSXHgEruw_15_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1748000</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_s4jjnMLi-E-enZtq465jlg_15_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1718000</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_IV3Ip0X0sUKhDU1NdYRYHA_15_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">791000</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_R5EDizm16kS5WCccYn86CA_16_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">162000</ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_Yvp72E-F6U6cp0aOvCB7Dg_16_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">567000</ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_WgUmmxud30u8MrmO4OytZQ_16_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">594000</ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_5rjqox6OWE6BropSoHGPFg_17_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-14800000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_OUpFKinshEeVBhIGm9uVgA_18_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-232000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_CN9DgTUqVUelj0oWY61vuw_18_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">36000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_dJWDVa7Za0aJLXG-R7vzeg_18_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-99000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <aciu:AdjustmentsForIncreaseDecreaseInAccruedExpenses
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_fLSXybMOJ06XomHbthP_0w_19_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1137000</aciu:AdjustmentsForIncreaseDecreaseInAccruedExpenses>
    <aciu:AdjustmentsForIncreaseDecreaseInAccruedExpenses
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_u2MExGnvSUSpVAyi3lCygg_19_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">6114000</aciu:AdjustmentsForIncreaseDecreaseInAccruedExpenses>
    <aciu:AdjustmentsForIncreaseDecreaseInAccruedExpenses
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_3SYrpY--IEytYq93j_edoQ_19_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-5214000</aciu:AdjustmentsForIncreaseDecreaseInAccruedExpenses>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_ygDSA_yEw02g69FXS4dpHA_20_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-449000</ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_gnGhhgIzUkWdGB-ftL7e5A_20_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-130000</ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_pOOZVstyUE-bG-lo8BQMUw_20_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">425000</ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_YIBmC7UJukGEFUQLwcVHEg_21_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">770000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_KJcSKn3T5EqJnTDfw4a_Ew_21_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1073000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_aRf7CLt9EU-tpOgyGe8U1A_21_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-84000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:CashFlowsFromUsedInOperations
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_sGVIo89W00axl1cO7viczQ_22_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-60827000</ifrs-full:CashFlowsFromUsedInOperations>
    <ifrs-full:CashFlowsFromUsedInOperations
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_ftMciTjs3U2yIh12iTpQCQ_22_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-73159000</ifrs-full:CashFlowsFromUsedInOperations>
    <ifrs-full:CashFlowsFromUsedInOperations
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_udfdZIWHsEaUIsYXkOGQZg_22_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-65216000</ifrs-full:CashFlowsFromUsedInOperations>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_b5eOJibDWkaGS_b0iVS7_Q_23_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">595000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_EmdHDZT4XUe9snx61i17jg_23_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">69000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_Z1_kmFfbnUSYe3ihLDQ3bA_23_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_zGE4LOSrt0qyfadAHQruNw_24_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">163000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_FRkkN4Ujuk6QlVStSRsKSg_24_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">470000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_0w5gSP6wj0CfGOzUKIXanA_24_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">465000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_-ww_pMLEa0WFwcAOh34oXw_25_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">13000</ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities>
    <ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_6gqTj-Z3pUW7R9-056iPiQ_25_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">8000</ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities>
    <ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_SrET3LVfwU2Au9Ey8sei3w_25_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">8000</ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_ZKT-xfcMxkydxHBOnj9A_A_26_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-60408000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_DaAbyJ9uhkSyoHqbR7FrkQ_26_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-73568000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_lOqWa_idp02gXW77_RMnOQ_26_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-65689000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <aciu:PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_wgPTdhrUxkeFd-jH1MW13Q_29_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-66446000</aciu:PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities>
    <aciu:PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_4nCzRUBH0UGqAGPCJiaZDA_29_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-25000000</aciu:PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities>
    <aciu:PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_z-A1_mvoCkK2Gg1VYD0RbA_29_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">51000000</aciu:PaymentsProceedsFromPurchasesSalesOfShortTermFinancialAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_ojYK8kVbOEOnf9-67UfZdw_30_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">801000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_emarYhn71ESdJwiEPltxLg_30_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1239000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_SGspuO4JDkaOd12MJq0Krg_30_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2635000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <aciu:CashAdvancesForRentDeposit
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_ni2WiWO5xEOkfXycoH5pzw_31_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</aciu:CashAdvancesForRentDeposit>
    <aciu:CashAdvancesForRentDeposit
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_DiYImNB5SEybksQRKPOqfA_31_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-2000</aciu:CashAdvancesForRentDeposit>
    <aciu:CashAdvancesForRentDeposit
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_VXZ6kO9sgkOF8IKKm42CSQ_31_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">29000</aciu:CashAdvancesForRentDeposit>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_nGS9aw625UGCgm0IRJTZKg_32_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">65645000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_F-QrekcNXk2mtx3RkSyM_g_32_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">23763000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_Jok31FD_tUOYXOSHlhZQAQ_32_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-53664000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <aciu:ProceedsFromIssueOfConvertibleDebt
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_iK0v0pgWj0Kih0kqnN0_7g_35_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</aciu:ProceedsFromIssueOfConvertibleDebt>
    <aciu:ProceedsFromIssueOfConvertibleDebt
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_UDSo-ve5SEiVNnwDcET2xQ_35_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</aciu:ProceedsFromIssueOfConvertibleDebt>
    <aciu:ProceedsFromIssueOfConvertibleDebt
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_-R-s5ATtCE-eUnvdAjaT0A_35_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">23463000</aciu:ProceedsFromIssueOfConvertibleDebt>
    <ifrs-full:PaymentsForShareIssueCosts
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_jDGB5Ugwi0ipXvXHDuANIg_36_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:PaymentsForShareIssueCosts>
    <ifrs-full:PaymentsForShareIssueCosts
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_aDvrxqXnNUmDp9OwFFxAQA_36_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:PaymentsForShareIssueCosts>
    <ifrs-full:PaymentsForShareIssueCosts
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_QtiG1U2lREGSxg5opC08FA_36_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">6000</ifrs-full:PaymentsForShareIssueCosts>
    <aciu:ProceedsFromIssuanceOfPublicOfferingsOfCommonSharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_ocXxnuWw2k24co-UlH4Mog_37_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">41056000</aciu:ProceedsFromIssuanceOfPublicOfferingsOfCommonSharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_Ju9nTkl67kWs9JPbtyNiSg_38_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2677000</aciu:ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_Z9T348MtH0Ww_3xHNFIHwg_38_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-8000</aciu:ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_9EhT5rmsOE6JmkliFyEFaw_38_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">12121000</aciu:ProceedsFromSaleOfTreasurySharesInPublicOfferingsNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_F49IcXt2qUaN1p1yen_TdQ_39_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</aciu:ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions>
    <aciu:ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_NKPxT_0HskSPI5s8e7scCw_39_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</aciu:ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions>
    <aciu:ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc__NTLZ1djHkqqwYOMF1dnjg_39_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4599000</aciu:ProceedsFromIssuanceOfCommonSharesInConnectionToAssetAcquisitions>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_lmfmcSXpekyEc_-Eykadkg_40_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">65000</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_CZgVTYLzOkOzl4-JOI6scA_40_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">7000</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_jyCzQHu47kaxRphirF5Ftw_40_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1082000</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_lGkijVhPc0K4zMiZw3qC8w_41_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">548000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_5iJIChGurkiK4_6JG4s6BQ_41_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">569000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_SJnbR5ICBEOttwWTJ91YdA_41_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">513000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <aciu:PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_nS87Vm4IzkyFNKntCUT5qA_42_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</aciu:PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions>
    <aciu:PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_90SyVeuSoUG_UsH-QE_YAw_42_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">776000</aciu:PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions>
    <aciu:PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_YkyvAF2ON0K8o-OXVySDmQ_42_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</aciu:PaymentsForShareIssueCostsAssociatedWithIssuanceOfSharesInRelationToAssetAcquisitions>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_DPjsh0iZw0eHf1QDU3Rgiw_43_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">43250000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_5o_6h5ZFN0yuco1Qgq2Tww_43_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1346000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_LpPDkeipI0S9EiAdyb7PhA_43_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">40746000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_b_oOi2KDFk6fzgTzaiB1eA_45_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">48487000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_-TFbz6P4oE64IRyMfwmjcA_45_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-51151000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_W1myTgom0kOnet95Gxm7KQ_45_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-78607000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_ypCqup6GikmMjSkcqJiu5g_47_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">31586000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="-3"
      id="Tc_0L6699zwxUmSVpNJnzup4w_47_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">82216000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2020_kISrj4aRVketNj-9seXAtQ"
      decimals="-3"
      id="Tc_fALkBBaTKEiVha2Zr5Bk2g_47_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">160893000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_Xsh5xVnlckia2OAX-qring_48_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1579000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_FSN7LtIe0kuOCQkb7oyQ4A_48_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">521000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_cLF6WMXzQkekSplC7DnrTQ_48_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-70000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_gMuTmOs4bEKvT59lGfROug_49_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">78494000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_Z-18I-Rzx06msoCpbNUSbQ_49_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">31586000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="-3"
      id="Tc_sU5P5qrrmky1L5gPdMjiGQ_49_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">82216000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_elGzBL4JP0a6f4MBoGQtXg_51_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">48487000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_bxHEIlJA306VQo9-gtQ5nQ_51_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-51151000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_4fh3reOVU0yvoSFrjNwSVw_51_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-78607000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <aciu:PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_LfaMLkn-AkmZYqZXUHJrIQ_54_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</aciu:PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities>
    <aciu:PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_x2XCQlDtf0eHiWwTr8wcmQ_54_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</aciu:PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities>
    <aciu:PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_SzN-BHWf2UKHMonpNNZ4zg_54_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">303000</aciu:PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities>
    <aciu:IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_gSWQWPwC-kWsKsXj-O7N6Q_55_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</aciu:IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition>
    <aciu:IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_KyMS9U4OdEWE7lVRb4yzeA_55_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</aciu:IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition>
    <aciu:IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_Z4eXT1OOC0anANii23C7lw_55_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">50416000</aciu:IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_Lc-6GCfJkkybhYy41g8BVw_56_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_sNdTEfOQSUaWdYJkpe6Ahw_56_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_ReReOyl2-kmEhG54I0OCmQ_56_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">776000</ifrs-full:ShareIssueRelatedCost>
    <aciu:RepaymentOfConvertibleDebtEquitySettlementAmount
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_raJtKKjMJU2f3xLGs2GT_Q_57_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</aciu:RepaymentOfConvertibleDebtEquitySettlementAmount>
    <aciu:RepaymentOfConvertibleDebtEquitySettlementAmount
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_NlAN4l6-UUGfg3jZPdO7uA_57_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</aciu:RepaymentOfConvertibleDebtEquitySettlementAmount>
    <aciu:RepaymentOfConvertibleDebtEquitySettlementAmount
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_zY7A-jrM7kiMjmZMXgS2gg_57_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">16920000</aciu:RepaymentOfConvertibleDebtEquitySettlementAmount>
    <aciu:TransactionCostAndStampDutyAssociatedWithPublicOfferingsOfCommonSharesRecordedInAccruedExpenses
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_TVXwKUQVLUK6yB_Fa_Rv8g_58_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">521000</aciu:TransactionCostAndStampDutyAssociatedWithPublicOfferingsOfCommonSharesRecordedInAccruedExpenses>
    <aciu:TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_FzuWPfRlgEiL2wOXyCqPcA_59_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">27000</aciu:TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses>
    <aciu:TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_AlNXvsR5n0iE9s301dFN9A_59_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</aciu:TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses>
    <aciu:TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_63E6DL3Xs0KOdhj_7AwXaQ_59_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</aciu:TransactionCostsAssociatedWithSaleOfTreasurySharesInPublicOfferingRecordedInAccruedExpenses>
    <aciu:DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_eZhSdobZh0u4STdIQZoiww">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;1.&lt;/b&gt;&lt;/span&gt;General information&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;AC Immune SA was founded in 2003. The Company controls a fully-owned subsidiary, AC Immune USA,&#160;Inc. (&#x201c;AC Immune USA&#x201d; or &#x201c;Subsidiary&#x201d; and, together with AC Immune SA, &#x201c;AC Immune,&#x201d; &#x201c;ACIU,&#x201d; &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;our,&#x201d; &#x201c;ours,&#x201d; &#x201c;us&#x201d;), which was registered and organized under the laws of Delaware, USA in June&#160;2021. The Company and its Subsidiary form the Group.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;AC Immune SA is a clinical-stage biopharmaceutical company leveraging our two proprietary technology platforms to discover, design and develop novel proprietary medicines and diagnostics for prevention and treatment of neurodegenerative diseases (NDD) associated with protein misfolding. Misfolded proteins are generally recognized as the leading cause of NDD, such as Alzheimer&#x2019;s disease (AD) and Parkinson&#x2019;s disease (PD), with common mechanisms and drug targets, such as amyloid beta (Abeta), Tau, alpha-synuclein (a-syn) and TDP-43. Our corporate strategy is founded upon a three-pillar approach that targets (i)&#160;AD, (ii)&#160;focused non-AD NDD including Parkinson&#x2019;s disease, ALS and NeuroOrphan indications and (iii)&#160;diagnostics. We use our two unique proprietary platform technologies, SupraAntigen (conformation-specific biologics) and Morphomer (conformation-specific small molecules), to discover, design and develop novel medicines and diagnostics to target misfolded proteins.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company was initially incorporated as a limited liability company on February&#160;13, 2003 in Basel, and effective August&#160;25, 2003 was transformed into a stock company. The Company&#x2019;s corporate headquarters are located at EPFL Innovation Park Building B, 1015 Lausanne, Switzerland.&lt;/p&gt;</aciu:DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock>
    <aciu:NumberOfTechnologyPlatforms
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="INF"
      id="Narr_D028PsB190CDna1AwSdfLQ"
      unitRef="Unit_Standard_item_lel3bReemU2v4xdKyUvjzA">2</aciu:NumberOfTechnologyPlatforms>
    <aciu:NumberOfTechnologyPlatforms
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="INF"
      id="Narr__y25ibHWgUmTr6nvvUL9_A"
      unitRef="Unit_Standard_item_lel3bReemU2v4xdKyUvjzA">2</aciu:NumberOfTechnologyPlatforms>
    <ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_wD3l96j440-xO4h7Q7ut2A">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;2.&lt;/b&gt;&lt;/span&gt;Basis of preparation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Going concern&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company believes that it will be able to meet all of its obligations as they fall due for at least 12&#160;months from the filing date of this Form 20-F, after considering the Company&#x2019;s cash position of CHF 78.5 million and short-term financial assets of CHF 24.6 million as of December&#160;31, 2023. Hence, these consolidated financial statements have been prepared on a going-concern basis.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;To date, the Company has financed its cash requirements primarily from its public offerings, share issuances, contract revenues from license and collaboration agreements (LCAs) and grants. The Company is a clinical stage company and is exposed to all the risks inherent to establishing a business. Inherent to the Company&#x2019;s business are various risks and uncertainties, including the substantial uncertainty as to whether current projects will succeed and our ability to raise additional capital as needed. These risks may require us to take certain measures such as delaying, reducing or eliminating certain programs. The Company&#x2019;s success may depend in part upon its ability to (i)&#160;establish and maintain a strong patent position and protection, (ii)&#160;enter into collaborations with partners in the pharmaceutical and biopharmaceutical industries, (iii)&#160;successfully move its product candidates through clinical development, (iv)&#160;attract and retain key personnel and (v)&#160;acquire capital to support its operations.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Statement of compliance&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) Accounting Standards as issued by the International Accounting Standards Board (IASB). These consolidated financial statements were approved for issue by the Board of Directors on March&#160;13, 2024.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Basis of measurement&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The consolidated financial statements have been prepared under the historical cost convention except for items that are required to be accounted for at fair value.&lt;/p&gt;</ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-5"
      id="Narr_3O1B-mnWJ0Gk_gvJNE6eXA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">78500000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-5"
      id="Narr_8afOsZH4XEaFGLtfKf48cQ"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">24600000</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
    <ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_hP8KXO1zrky32kAxTn0NcA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;3.&lt;/b&gt;&lt;/span&gt;Summary of material accounting policies&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The principal accounting policies adopted in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all the&#160;years presented, unless otherwise stated.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;"&gt;Functional and reporting currency&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;These consolidated financial statements and accompanying notes are presented in Swiss Francs (CHF), which is AC Immune SA&#x2019;s functional currency and the Group&#x2019;s reporting currency. The Company&#x2019;s subsidiary has a functional currency of the U.S. Dollar (USD). The respective functional currency represents the primary economic environment in which the entities operate.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following exchange rates have been used for the translation of the financial statements of AC Immune USA:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the Year Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;CHF/USD&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Closing rate, USD 1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.851&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.933&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.923&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Weighted average exchange rate, USD 1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.908&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.965&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.929&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;The results and financial position of AC Immune USA are translated into the presentation currency as follows:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;i.&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;assets and liabilities for each balance sheet presented are translated at the closing rate at the date of that balance sheet;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;ii.&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;income and expenses for each statement of income/(loss) are translated at average exchange rates; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;iii.&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;all resulting exchange differences are recognized in other comprehensive income/(loss), within cumulative translation differences.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"&gt;&lt;/div&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Basis of consolidation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The annual closing date of the individual financial statements is December&#160;31. The Company fully-owns its Subsidiary and fully consolidates its financial statements into these consolidated financial statements. All intercompany transactions have been eliminated.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Foreign currency transactions&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Foreign currency transactions are translated into the respective functional currency using prevailing exchange rates at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at&#160;year-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognized in the consolidated statements of income/(loss). Any gains or losses from these translations are included in the consolidated statements of income/(loss) in the period in which they arise.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Current vs. non-current classification&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company presents assets and liabilities in the consolidated balance sheets based on current/non-current classification. The Company classifies all amounts to be realized or settled within 12&#160;months after the reporting period to be current and all other amounts to be non-current.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Revenue recognition&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company applies IFRS 15&#160;&lt;i style="font-style:italic;"&gt;Revenue from Contracts with Customers&lt;/i&gt;. This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. Under IFRS 15, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of IFRS 15, the entity performs the following five steps: (i)&#160;identify the contract(s)&#160;with a customer; (ii)&#160;identify the performance obligations in the contract; (iii)&#160;determine the transaction price; (iv)&#160;allocate the transaction price to the performance obligations in the contract; and (v)&#160;recognize revenue when (or as) the entity satisfies a performance obligation. The Company applies the five-step model to contracts only when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of IFRS 15, the Company assesses the goods or services promised within each contract, and determines those that are performance obligations, and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company enters into LCAs which are within the scope of IFRS 15, under which it licenses certain rights to its product candidates and intellectual property to third parties. The terms of these arrangements typically include payment to the Company of one or more of the following: non-refundable, upfront license fees, development, regulatory and/or commercial milestone payments;&#160;payments for research and clinical services the Company provides through either its full-time employees or third-party vendors, and royalties on net sales of licensed products commercialized from the Company&#x2019;s intellectual property. Each of these payments results in license, collaboration and other revenues, which are classified as contract revenue on the consolidated statements of income/(loss).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Licenses of intellectual property&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;If the license to the Company&#x2019;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, upfront fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are sold in conjunction with a related service, the Company uses judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time. If the performance obligation is settled over time, the Company determines the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, upfront fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Milestone payments&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At the inception of each arrangement that includes development, regulatory and/or commercial milestone payments, the Company evaluates whether the milestones are considered highly probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is highly probable that a significant cumulative revenue reversal would not occur in future periods, the associated milestone value is included in the transaction price. These amounts for the performance obligations under the contract are recognized as they are satisfied. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of such milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments recorded would affect contract revenues and earnings in the period of adjustment.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Research and development services&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company has certain arrangements with our collaboration partners that include contracting our employees for research and development programs. The Company assesses if these services are considered distinct in the context of each contract and, if so, they are accounted for as separate performance obligations. These revenues are recorded in contract revenue as the services are performed.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Sublicense revenues&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company has certain arrangements with our collaboration partners that include provisions for sublicensing. The Company recognizes any sublicense revenues at the point in time it is highly probable to obtain and not subject to reversal in the future.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Contract balances&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company receives payments and determines credit terms from its customers for its various performance obligations based on billing schedules established in each contract. The timing of revenue recognition, billings and cash collections results in billed other current receivables, accrued income (contract assets), and deferred income (contract liabilities) on the consolidated balance sheets. Amounts are recorded as other current receivables when the Company&#x2019;s right to consideration is unconditional. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be 1&#160;year or less.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For a complete discussion of accounting for contract revenue, see &#x201c;Note&#160;14. Contract revenues.&#x201d;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Research and development expenses&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Given the stage of development of the Company&#x2019;s products, all research and development expenditure is expensed as incurred as it does not meet the capitalization criteria outlined in IAS 38 &lt;i style="font-style:italic;"&gt;Intangible Assets&lt;/i&gt;. The Company has not capitalized any R&amp;amp;D expenses to date. Research and development expenditures include:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;the cost of acquiring, developing and manufacturing active pharmaceutical ingredients for product candidates that have not received regulatory approval, clinical trial materials and other research and development materials;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;fees and expenses incurred under agreements with contract research organizations, investigative sites and other entities in connection with the conduct of clinical trials and preclinical studies and related services, such as administrative, data-management and laboratory services;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;fees and costs related to regulatory filings and activities;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;costs associated with preclinical and clinical activities;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;employee-related expenses, including salaries and bonuses, benefits, travel and share-based compensation expenses; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;all other allocated expenses such as facilities and information technology (IT) costs.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"&gt;&lt;/div&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For external research contracts, expenses include those associated with contract research organizations, or CROs, or contract manufacturing organizations, or CMOs. The invoicing from CROs or CMOs for services rendered do not always align with work performed. We accrue the cost of services rendered in connection with CRO or CMO activities based on our estimate of the &#x201c;stage of completion&#x201d; for such contracted services. We maintain regular communication with our CRO or CMO vendors to gauge the reasonableness of our estimates and accrued expenses as of the balance sheet date in the consolidated financial statements based on facts and circumstances known at the time.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Registration costs for patents are part of the expenditure for research and development projects. Therefore, registration costs for patents are expensed when incurred as long as the research and development project concerned does not meet the criteria for capitalization.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;General and administrative expenses&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;General and administrative expenses are expensed as incurred and include personnel costs, expenses for outside professional services and all other allocated expenses. Personnel costs consist of salaries, cash bonuses, benefits and share-based compensation. Outside professional services consist of legal, accounting and audit services, IT and other consulting fees. Allocated expenses consist of certain IT, facilities and depreciation expenses.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Grant income&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company has received grants, from time to time, from the Michael J. Fox Foundation (MJFF), the Target ALS Foundation (Target ALS) and other institutions to support certain research projects. Grants are recorded at their fair value in the consolidated statements of income/(loss) within other operating income/(expenses), net when there is reasonable assurance that the Company will satisfy the underlying grant conditions and the grants will be received. In certain circumstances, grant income may be recognized before formal grantor acknowledgement of milestone achievements. To the extent required, grant income is deferred and recognized on a systematic basis over the periods in which the Company expects to recognize the related expenses for which the grants are intended to compensate.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Leases&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company applies IFRS 16 &lt;i style="font-style:italic;"&gt;Leases&lt;/i&gt;, which provides the model for lessee accounting in which all leases, other than short-term and low-value leases, are accounted for by the recognition on the consolidated balance sheet of a right-of-use asset and a lease liability, and the subsequent amortization of the right-of-use asset over the earlier of the end of the useful life or the lease term. In accordance with IFRS 16, the Company (i)&#160;does not recognize right-of-use assets and lease liabilities for leases of low value (i.e. approximate fair value of USD 5,000). For a complete discussion of accounting, see &#x201c;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities.&#x201d;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Right-of-use assets and lease liabilities&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At inception of a leasing contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company recognizes a right-of-use asset and a lease liability at the lease commencement date. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company&#x2019;s incremental borrowing rate. The lease liabilities are classified as current or non-current based on the due dates of the underlying principal payments.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Lease payments generally are fixed for the contract term. The lease liability is measured at amortized cost using the effective interest method. The lease liability is re-measured if there is a change in the estimated lease term, a change in future lease payments arising from a change in an index or rate, a change in the Company&#x2019;s estimate of the amount expected to be payable under a residual value guarantee or a change in assessment of whether it will exercise a purchase, extension or termination option.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At inception, the right-of-use asset comprises the initial lease liability and any initial direct costs. The right-of-use asset is depreciated over the shorter of the lease term or the useful life of the underlying asset. The right-of-use asset is periodically reduced by impairment losses, if any, and adjusted for certain re-measurements of the lease liability performed on as certain potential triggering events may arise (e.g. lease modifications). When the lease liability is re-measured, a corresponding adjustment is made to the carrying amount of the right-of-use asset or is recorded in profit or loss if the carrying amount of the right-of-use asset has been reduced to zero.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The estimated lease term by right-of-use asset categories are as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Buildings&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Office equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;IT equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Both the right-of-use-assets and lease liabilities are recognized in the consolidated balance sheets.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Property, plant and equipment&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;Equipment is shown at historical acquisition cost, less accumulated depreciation and any accumulated impairment losses. Historical costs include expenditures that are directly attributable to the acquisition of the property, plant and equipment. Depreciation is calculated using a straight-line method to write off the cost of each asset to its residual value over its estimated useful life as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;IT equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Laboratory equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Leasehold improvements/furniture&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The assets&#x2019; residual values and useful lives are reviewed, and adjusted if appropriate, at each balance sheet date. Where an asset&#x2019;s carrying amount is greater than its estimated recoverable amount, it is written down to its recoverable amount.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Gains and losses on disposals are determined by comparing the disposal proceeds with the carrying amount and are included in the consolidated statements of income/(loss).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Intangible assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;AC Immune&#x2019;s acquired in process research and development (IPR&amp;amp;D) asset is stated at cost less any impairments. The Company does not deem this asset ready for use until the asset obtains market approval. Therefore, during the development period after the date of acquisition until market approval, the IPR&amp;amp;D asset is not amortized. Upon market approval, the Company will determine the useful life of the asset, reclassify it from IPR&amp;amp;D and commence amortization. If the associated R&amp;amp;D effort is abandoned, the related IPR&amp;amp;D will likely be written off and we will record the relevant impairment charge. Finally, the Company will not capitalize future development costs in respect to this IPR&amp;amp;D asset until they meet the criteria for capitalization of research and development costs in accordance with IAS 38 &lt;i style="font-style:italic;"&gt;Intangible Assets&lt;/i&gt;.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Our IPR&amp;amp;D asset is subject to impairment testing at least annually or when there are indications that the carrying value may not be recoverable until the completion of the development process. The determination of the recoverable amounts include key estimates which are highly sensitive to, and dependent upon, key assumptions.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company uses a discounted cash flow method to determine the fair value less costs to sell (recoverable amount) of our IPR&amp;amp;D intangible asset. The Company starts with a forecast of all the expected net cash flows, which incorporates the consideration of a terminal value and then the Company applies a discount rate to arrive at a risk-adjusted net present value amount.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Any impairment losses are recognized immediately in the consolidated statements of income/(loss).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Fair value of financial assets&#160;and liabilities&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The Company&#x2019;s financial assets and liabilities are composed of receivables, short-term financial assets, cash and cash equivalents, trade payables and lease liabilities. The fair value of these financial instruments approximates their &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;respective carrying values due to the short-term maturity of these instruments, and are held at their amortized cost in accordance with IFRS 9, unless otherwise explicitly noted.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Receivables&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Receivables are recognized at their billing value. An allowance for doubtful accounts is recorded for potential estimated losses when there is evidence of the debtor&#x2019;s inability to make required payments and the Company assesses on a forward-looking basis the expected credit losses associated with these receivables held at amortized cost.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Short-term financial assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Short-term financial assets are held with external financial institutions and comprise fixed-term deposits with maturities ranging from more than 3 through 12&#160;months in duration.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company assesses whether there is objective evidence that financial assets are impaired annually or whenever potential impairment triggers may occur.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Cash and cash equivalents&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Cash and cash equivalents include deposits held with external financial institutions and cash on hand. All cash and cash equivalents are either in cash or in deposits with original duration of less than 3&#160;months.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Trade payables&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Trade payables are amounts due to third parties in the ordinary course of business.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Share capital and public offerings&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Common shares are classified as equity. Share issuance costs are capitalized as incurred and will be shown in equity as a deduction, net of tax, from the proceeds received from existing or future offerings. Should a planned equity offering not be assessed as probable, the issuance costs would be expensed immediately in the consolidated statements of income/(loss). See &#x201c;Note&#160;12. Share capital.&#x201d;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Treasury shares&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Treasury shares are recognized at acquisition cost and deducted from shareholders&#x2019; equity at the time of acquisition, until they are subsequently resold, distributed or cancelled. Where such shares are subsequently sold, any consideration received is included in shareholders&#x2019; equity. See &#x201c;Note&#160;12. Share capital.&#x201d;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Employee benefits&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Post-employment benefits&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company operates the mandatory pension schemes for its employees in Switzerland. The schemes are generally funded through payments to insurance companies. The Company has a pension plan designed to pay pensions based on accumulated contributions on individual savings accounts. However, this plan is classified as a defined benefit plan under IAS 19.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The net defined benefit liability is the present value of the defined benefit obligation at the balance sheet date minus the fair value of plan assets. Significant estimates are used in determining the assumptions incorporated in the calculation of the pension obligations, which is supported by input from independent actuaries. The defined benefit obligation is calculated annually with the assistance of an independent actuary using the projected unit credit method, which reflects services rendered by employees to the date of valuation, incorporates assumptions concerning employees&#x2019; projected salaries and pension increases as well as discount rates of highly liquid corporate bonds that have terms to maturity approximating the terms of the related liability.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;To the extent that the fair value of the plan assets is greater than the present value of the defined benefit obligation as calculated by our independent actuary, the Company accounts for the effect of the asset ceiling test under IAS 19.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Re-measurements of the net defined benefit liability, which comprise actuarial gains and losses and the return on plan assets (excluding interest) are recognized immediately in the consolidated statements of other comprehensive income/(loss). Past service costs, including curtailment gains or losses, are recognized immediately as a split in research and development and general and administrative expenses within the operating results. Settlement gains or losses are recognized in either research and development and/or general and administrative expenses within the operating results. The Company determines the net interest expense/(income) on the net defined benefit liability for the period by applying the discount rate used to measure the defined benefit obligation at the beginning of the annual period or in case of any significant events between measurement dates to the then-net defined benefit liability, considering any changes in the net defined benefit liability during the period as a result of contributions and benefit payments. Net interest expense/(income) and other expenses related to defined benefit plans are recognized in the consolidated statements of income/(loss).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Share-based compensation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company operates an equity-settled, share-based compensation plan. The fair value of the employee services received in exchange for the grant of equity-based awards is recognized as an expense. The total amount to be expensed over the vesting period is determined by reference to the fair value of the instruments granted, excluding the impact of any non-market vesting conditions. Non-market vesting conditions are included in assumptions about the number of instruments that are expected to become exercisable. At each balance sheet date, the Company revises its estimates of the number of instruments that are expected to become exercisable. It recognizes the impact of the revision of original estimates, if any, prospectively in the consolidated statements of income/(loss), and a corresponding adjustment to equity over the remaining vesting period.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Stock options granted under the Company&#x2019;s stock option plans C1 and the 2016 Stock Option and Incentive Plan are valued using the Black-Scholes option-pricing model (see &#x201c;Note&#160;19. Share-based compensation&#x201d;). This valuation model as well as parameters used such as expected volatility and expected term of the stock options are partially based on management&#x2019;s estimates.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and share premium when the options are exercised.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;We estimate the fair value of restricted share units using a reasonable estimate of market value of the common shares on the date of the award. We classify our share-based payments as equity-classified awards as they are settled in common shares. We measure equity-classified awards at their grant date fair value and do not subsequently re-measure them. Compensation costs related to equity-classified awards are equal to the fair value of the award at grant date amortized over the vesting period of the award using the graded method. We reclassify that portion of vested awards to share capital and share premium as the awards vest.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Provisions&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Provisions are recognized when the Company has a present legal or constructive obligation as a result of past events where it is more likely than not that an outflow of resources will be required to settle the obligation, and a reliable estimate of the amount can be made.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Taxation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Current income tax assets and liabilities for the period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the tax amounts are those that are enacted or substantively enacted, at the reporting date in accordance with the fiscal regulations of the respective country where the Company operates and generates taxable income. Deferred tax is provided using the liability method on temporary differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes at the reporting date.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the&#160;year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted at the reporting date. If required, deferred taxation is provided in full using the liability method, on all temporary differences at the reporting dates. It is calculated at the tax rates that are expected to apply to the period when it is anticipated the liabilities will be settled, and it is based on tax rates (and laws) that have been enacted or substantively enacted at the reporting date.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Deferred income tax assets are recognized to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilized. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized. Although the Company has substantial tax loss carry-forwards, historically, due to the fact that the Company had limited certainty on the achievement of key milestones, it has not recognized any deferred tax assets as the probability for use is low.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;As disclosed in &#x201c;Note&#160;17. Income taxes,&#x201d; the Company has tax losses that can generally be carried forward for a period of 7&#160;years from the period the loss was incurred. These tax losses represent potential value to the Company to the extent that the Company is able to create taxable profits before the expiry period of these tax losses. The Company has not recorded any deferred tax assets in relation to these tax losses.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Earnings per share&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company presents basic earnings per share for each period in the consolidated financial statements. The earnings per share are calculated by dividing the earnings of the period by the weighted-average number of shares outstanding during the period. Diluted earnings per share reflect the potential dilution that could occur if dilutive securities such as share options or non-vested restricted share units were vested or exercised into common shares or resulted in the issuance of common shares that would participate in net income. Anti-dilutive shares are excluded from the dilutive earnings per share calculation.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Critical judgments and accounting estimates&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The preparation of financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The areas where AC Immune has had to make judgments, estimates and assumptions relate to (i)&#160;revenue recognition on LCAs, (ii)&#160;clinical development accruals, (iii)&#160;net employee defined benefit liability, (iv)&#160;share-based compensation, (v)&#160;right-of-use assets and lease liabilities and (vi)&#160;our IPR&amp;amp;D asset. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Segment reporting&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company is managed and operated as one business. A single management team that reports to the chief operating decision maker comprehensively manages the entire business. Accordingly, the Company views its business and manages its operations as one operating segment. Non-current assets are located in, and revenue is allocated and recorded within, the Company&#x2019;s country of domicile, Switzerland.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Accounting policies, new standards, interpretations and amendments adopted by the Company&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;There are no new IFRS standards, amendments or interpretations that are mandatory as of January 1, 2023 that are relevant to the Company. Additionally, the Company has not adopted any standard, interpretation or amendment that has been issued but is not yet effective. Such standards are not currently expected to have a material impact on the entity in the current or future reporting periods and on foreseeable future transactions.&lt;/p&gt;</ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_QGlLdlajHkmkOXiy700puA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 18pt;"&gt;Functional and reporting currency&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;These consolidated financial statements and accompanying notes are presented in Swiss Francs (CHF), which is AC Immune SA&#x2019;s functional currency and the Group&#x2019;s reporting currency. The Company&#x2019;s subsidiary has a functional currency of the U.S. Dollar (USD). The respective functional currency represents the primary economic environment in which the entities operate.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following exchange rates have been used for the translation of the financial statements of AC Immune USA:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the Year Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;CHF/USD&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Closing rate, USD 1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.851&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.933&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.923&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Weighted average exchange rate, USD 1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.908&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.965&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.929&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;The results and financial position of AC Immune USA are translated into the presentation currency as follows:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;i.&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;assets and liabilities for each balance sheet presented are translated at the closing rate at the date of that balance sheet;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;ii.&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;income and expenses for each statement of income/(loss) are translated at average exchange rates; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;iii.&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;all resulting exchange differences are recognized in other comprehensive income/(loss), within cumulative translation differences.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory>
    <ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_kw4Ckp6KpEeaDBPpRn0Dtw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following exchange rates have been used for the translation of the financial statements of AC Immune USA:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the Year Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;CHF/USD&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Closing rate, USD 1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.851&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.933&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.923&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Weighted average exchange rate, USD 1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.908&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.965&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.16%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.929&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="3"
      id="Tc_psyornBPzkuGThOjaSjNFQ_5_2"
      unitRef="Unit_Divide_CHF_USD_FPtD7vL32kaT4HamUiI0aw">0.851</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="3"
      id="Tc_MvMdThf6zUuYQxTKen3Ksw_5_4"
      unitRef="Unit_Divide_CHF_USD_FPtD7vL32kaT4HamUiI0aw">0.933</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="3"
      id="Tc_qv5oVkiZlEmMzUXiLKZj8w_5_6"
      unitRef="Unit_Divide_CHF_USD_FPtD7vL32kaT4HamUiI0aw">0.923</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:AverageForeignExchangeRate
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="3"
      id="Tc_qEVRPgf4_kueCaXhZYa4Cw_6_2"
      unitRef="Unit_Divide_CHF_USD_FPtD7vL32kaT4HamUiI0aw">0.908</ifrs-full:AverageForeignExchangeRate>
    <ifrs-full:AverageForeignExchangeRate
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="3"
      id="Tc_cnrFZl3FnUCSq5kiNyKNsA_6_4"
      unitRef="Unit_Divide_CHF_USD_FPtD7vL32kaT4HamUiI0aw">0.965</ifrs-full:AverageForeignExchangeRate>
    <ifrs-full:AverageForeignExchangeRate
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="3"
      id="Tc_qayPoGxYBUaUzqtoRqYOGA_6_6"
      unitRef="Unit_Divide_CHF_USD_FPtD7vL32kaT4HamUiI0aw">0.929</ifrs-full:AverageForeignExchangeRate>
    <ifrs-full:DisclosureOfBasisOfConsolidationExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_cSvTbwWtzkWjcfWjBm9hIw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Basis of consolidation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The annual closing date of the individual financial statements is December&#160;31. The Company fully-owns its Subsidiary and fully consolidates its financial statements into these consolidated financial statements. All intercompany transactions have been eliminated.&lt;/p&gt;</ifrs-full:DisclosureOfBasisOfConsolidationExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_-525khLp0UeS4_m1Jjifug">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Foreign currency transactions&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Foreign currency transactions are translated into the respective functional currency using prevailing exchange rates at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at&#160;year-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognized in the consolidated statements of income/(loss). Any gains or losses from these translations are included in the consolidated statements of income/(loss) in the period in which they arise.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory>
    <aciu:DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_qQ_MbnTRVUW1MDIHqUMCFA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Current vs. non-current classification&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company presents assets and liabilities in the consolidated balance sheets based on current/non-current classification. The Company classifies all amounts to be realized or settled within 12&#160;months after the reporting period to be current and all other amounts to be non-current.&lt;/p&gt;</aciu:DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_H7d-2ctrWUCx_bjOvcY_dg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Revenue recognition&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company applies IFRS 15&#160;&lt;i style="font-style:italic;"&gt;Revenue from Contracts with Customers&lt;/i&gt;. This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. Under IFRS 15, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of IFRS 15, the entity performs the following five steps: (i)&#160;identify the contract(s)&#160;with a customer; (ii)&#160;identify the performance obligations in the contract; (iii)&#160;determine the transaction price; (iv)&#160;allocate the transaction price to the performance obligations in the contract; and (v)&#160;recognize revenue when (or as) the entity satisfies a performance obligation. The Company applies the five-step model to contracts only when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of IFRS 15, the Company assesses the goods or services promised within each contract, and determines those that are performance obligations, and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company enters into LCAs which are within the scope of IFRS 15, under which it licenses certain rights to its product candidates and intellectual property to third parties. The terms of these arrangements typically include payment to the Company of one or more of the following: non-refundable, upfront license fees, development, regulatory and/or commercial milestone payments;&#160;payments for research and clinical services the Company provides through either its full-time employees or third-party vendors, and royalties on net sales of licensed products commercialized from the Company&#x2019;s intellectual property. Each of these payments results in license, collaboration and other revenues, which are classified as contract revenue on the consolidated statements of income/(loss).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Licenses of intellectual property&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;If the license to the Company&#x2019;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, upfront fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are sold in conjunction with a related service, the Company uses judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time. If the performance obligation is settled over time, the Company determines the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, upfront fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Milestone payments&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At the inception of each arrangement that includes development, regulatory and/or commercial milestone payments, the Company evaluates whether the milestones are considered highly probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is highly probable that a significant cumulative revenue reversal would not occur in future periods, the associated milestone value is included in the transaction price. These amounts for the performance obligations under the contract are recognized as they are satisfied. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of such milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments recorded would affect contract revenues and earnings in the period of adjustment.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Research and development services&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company has certain arrangements with our collaboration partners that include contracting our employees for research and development programs. The Company assesses if these services are considered distinct in the context of each contract and, if so, they are accounted for as separate performance obligations. These revenues are recorded in contract revenue as the services are performed.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Sublicense revenues&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company has certain arrangements with our collaboration partners that include provisions for sublicensing. The Company recognizes any sublicense revenues at the point in time it is highly probable to obtain and not subject to reversal in the future.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Contract balances&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company receives payments and determines credit terms from its customers for its various performance obligations based on billing schedules established in each contract. The timing of revenue recognition, billings and cash collections results in billed other current receivables, accrued income (contract assets), and deferred income (contract liabilities) on the consolidated balance sheets. Amounts are recorded as other current receivables when the Company&#x2019;s right to consideration is unconditional. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be 1&#160;year or less.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For a complete discussion of accounting for contract revenue, see &#x201c;Note&#160;14. Contract revenues.&#x201d;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue>
    <ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_uLFvyx7k50-_OuQOsQc9oQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Research and development expenses&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Given the stage of development of the Company&#x2019;s products, all research and development expenditure is expensed as incurred as it does not meet the capitalization criteria outlined in IAS 38 &lt;i style="font-style:italic;"&gt;Intangible Assets&lt;/i&gt;. The Company has not capitalized any R&amp;amp;D expenses to date. Research and development expenditures include:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;the cost of acquiring, developing and manufacturing active pharmaceutical ingredients for product candidates that have not received regulatory approval, clinical trial materials and other research and development materials;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;fees and expenses incurred under agreements with contract research organizations, investigative sites and other entities in connection with the conduct of clinical trials and preclinical studies and related services, such as administrative, data-management and laboratory services;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;fees and costs related to regulatory filings and activities;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;costs associated with preclinical and clinical activities;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;employee-related expenses, including salaries and bonuses, benefits, travel and share-based compensation expenses; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;all other allocated expenses such as facilities and information technology (IT) costs.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"&gt;&lt;/div&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For external research contracts, expenses include those associated with contract research organizations, or CROs, or contract manufacturing organizations, or CMOs. The invoicing from CROs or CMOs for services rendered do not always align with work performed. We accrue the cost of services rendered in connection with CRO or CMO activities based on our estimate of the &#x201c;stage of completion&#x201d; for such contracted services. We maintain regular communication with our CRO or CMO vendors to gauge the reasonableness of our estimates and accrued expenses as of the balance sheet date in the consolidated financial statements based on facts and circumstances known at the time.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Registration costs for patents are part of the expenditure for research and development projects. Therefore, registration costs for patents are expensed when incurred as long as the research and development project concerned does not meet the criteria for capitalization.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForExpensesExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_htPhSDWiXkW6gfTN1DyKbg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;General and administrative expenses&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;General and administrative expenses are expensed as incurred and include personnel costs, expenses for outside professional services and all other allocated expenses. Personnel costs consist of salaries, cash bonuses, benefits and share-based compensation. Outside professional services consist of legal, accounting and audit services, IT and other consulting fees. Allocated expenses consist of certain IT, facilities and depreciation expenses.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForExpensesExplanatory>
    <aciu:GrantIncomePolicyTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_GWbCfHpgLkCeCkXTxJXwug">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Grant income&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company has received grants, from time to time, from the Michael J. Fox Foundation (MJFF), the Target ALS Foundation (Target ALS) and other institutions to support certain research projects. Grants are recorded at their fair value in the consolidated statements of income/(loss) within other operating income/(expenses), net when there is reasonable assurance that the Company will satisfy the underlying grant conditions and the grants will be received. In certain circumstances, grant income may be recognized before formal grantor acknowledgement of milestone achievements. To the extent required, grant income is deferred and recognized on a systematic basis over the periods in which the Company expects to recognize the related expenses for which the grants are intended to compensate.&lt;/p&gt;</aciu:GrantIncomePolicyTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_Fg7ygjJGyEef-Hvl7eMqgQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Leases&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company applies IFRS 16 &lt;i style="font-style:italic;"&gt;Leases&lt;/i&gt;, which provides the model for lessee accounting in which all leases, other than short-term and low-value leases, are accounted for by the recognition on the consolidated balance sheet of a right-of-use asset and a lease liability, and the subsequent amortization of the right-of-use asset over the earlier of the end of the useful life or the lease term. In accordance with IFRS 16, the Company (i)&#160;does not recognize right-of-use assets and lease liabilities for leases of low value (i.e. approximate fair value of USD 5,000). For a complete discussion of accounting, see &#x201c;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities.&#x201d;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Right-of-use assets and lease liabilities&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At inception of a leasing contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company recognizes a right-of-use asset and a lease liability at the lease commencement date. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company&#x2019;s incremental borrowing rate. The lease liabilities are classified as current or non-current based on the due dates of the underlying principal payments.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Lease payments generally are fixed for the contract term. The lease liability is measured at amortized cost using the effective interest method. The lease liability is re-measured if there is a change in the estimated lease term, a change in future lease payments arising from a change in an index or rate, a change in the Company&#x2019;s estimate of the amount expected to be payable under a residual value guarantee or a change in assessment of whether it will exercise a purchase, extension or termination option.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At inception, the right-of-use asset comprises the initial lease liability and any initial direct costs. The right-of-use asset is depreciated over the shorter of the lease term or the useful life of the underlying asset. The right-of-use asset is periodically reduced by impairment losses, if any, and adjusted for certain re-measurements of the lease liability performed on as certain potential triggering events may arise (e.g. lease modifications). When the lease liability is re-measured, a corresponding adjustment is made to the carrying amount of the right-of-use asset or is recorded in profit or loss if the carrying amount of the right-of-use asset has been reduced to zero.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The estimated lease term by right-of-use asset categories are as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Buildings&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Office equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;IT equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Both the right-of-use-assets and lease liabilities are recognized in the consolidated balance sheets.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory>
    <aciu:ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_FaS6AuAT8U2A7PY-PWkIcg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Buildings&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Office equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;IT equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</aciu:ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock>
    <aciu:EstimatedLeaseTerm
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_BuildingsMember_aaNuoy-t_Eiw3M3BbRrSzA"
      id="Tc_0OUXngmBP06oDgMbzRpMmA_1_2">P5Y</aciu:EstimatedLeaseTerm>
    <aciu:EstimatedLeaseTerm
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_OfficeEquipmentMember_FZ2FsUgsLUK0QPYMKCCp5g"
      id="Tc_Ha9M2ZRCSkuc2jb8JiQtuw_2_2">P5Y</aciu:EstimatedLeaseTerm>
    <aciu:EstimatedLeaseTerm
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_5KJXBEAcDUOmq3jDvWNEeA"
      id="Tc_xD1M8OQ6u0yF3vjByKHbIA_3_2">P5Y</aciu:EstimatedLeaseTerm>
    <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_eOCVcC21kUmdoYRQ8FQoNA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Property, plant and equipment&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;Equipment is shown at historical acquisition cost, less accumulated depreciation and any accumulated impairment losses. Historical costs include expenditures that are directly attributable to the acquisition of the property, plant and equipment. Depreciation is calculated using a straight-line method to write off the cost of each asset to its residual value over its estimated useful life as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;IT equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Laboratory equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Leasehold improvements/furniture&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The assets&#x2019; residual values and useful lives are reviewed, and adjusted if appropriate, at each balance sheet date. Where an asset&#x2019;s carrying amount is greater than its estimated recoverable amount, it is written down to its recoverable amount.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Gains and losses on disposals are determined by comparing the disposal proceeds with the carrying amount and are included in the consolidated statements of income/(loss).&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
    <aciu:ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_Ji8XAmsHMkOofzyufE_cTw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;IT equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Laboratory equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:83.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Leasehold improvements/furniture&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:4.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt; years&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</aciu:ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_5KJXBEAcDUOmq3jDvWNEeA"
      id="Tc_-TPVh-eTsEmfw6v2yZ4WqA_1_2">P3Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_a18c9vqNJ0Gpex9n_raHoQ"
      id="Tc_jzHrVXV1okiEnl6hTAfw3w_2_2">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LeaseholdImprovementsAndFixturesAndFittingsMember_5r6Agu4tSEaOWsUui3fyog"
      id="Tc_pfh1Fv5TxkS-FCvHGeMLsw_3_2">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_3tvKS8EDEUSNR25vtQDFrQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Intangible assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;AC Immune&#x2019;s acquired in process research and development (IPR&amp;amp;D) asset is stated at cost less any impairments. The Company does not deem this asset ready for use until the asset obtains market approval. Therefore, during the development period after the date of acquisition until market approval, the IPR&amp;amp;D asset is not amortized. Upon market approval, the Company will determine the useful life of the asset, reclassify it from IPR&amp;amp;D and commence amortization. If the associated R&amp;amp;D effort is abandoned, the related IPR&amp;amp;D will likely be written off and we will record the relevant impairment charge. Finally, the Company will not capitalize future development costs in respect to this IPR&amp;amp;D asset until they meet the criteria for capitalization of research and development costs in accordance with IAS 38 &lt;i style="font-style:italic;"&gt;Intangible Assets&lt;/i&gt;.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Our IPR&amp;amp;D asset is subject to impairment testing at least annually or when there are indications that the carrying value may not be recoverable until the completion of the development process. The determination of the recoverable amounts include key estimates which are highly sensitive to, and dependent upon, key assumptions.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company uses a discounted cash flow method to determine the fair value less costs to sell (recoverable amount) of our IPR&amp;amp;D intangible asset. The Company starts with a forecast of all the expected net cash flows, which incorporates the consideration of a terminal value and then the Company applies a discount rate to arrive at a risk-adjusted net present value amount.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_I1GB47gkgE2TVGqs1TzqdQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Fair value of financial assets&#160;and liabilities&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The Company&#x2019;s financial assets and liabilities are composed of receivables, short-term financial assets, cash and cash equivalents, trade payables and lease liabilities. The fair value of these financial instruments approximates their &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;respective carrying values due to the short-term maturity of these instruments, and are held at their amortized cost in accordance with IFRS 9, unless otherwise explicitly noted.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Receivables&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Receivables are recognized at their billing value. An allowance for doubtful accounts is recorded for potential estimated losses when there is evidence of the debtor&#x2019;s inability to make required payments and the Company assesses on a forward-looking basis the expected credit losses associated with these receivables held at amortized cost.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Short-term financial assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Short-term financial assets are held with external financial institutions and comprise fixed-term deposits with maturities ranging from more than 3 through 12&#160;months in duration.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company assesses whether there is objective evidence that financial assets are impaired annually or whenever potential impairment triggers may occur.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Cash and cash equivalents&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Cash and cash equivalents include deposits held with external financial institutions and cash on hand. All cash and cash equivalents are either in cash or in deposits with original duration of less than 3&#160;months.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Trade payables&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Trade payables are amounts due to third parties in the ordinary course of business.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_-0YXPc5AcUC2zJjaAKPX9Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Share capital and public offerings&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Common shares are classified as equity. Share issuance costs are capitalized as incurred and will be shown in equity as a deduction, net of tax, from the proceeds received from existing or future offerings. Should a planned equity offering not be assessed as probable, the issuance costs would be expensed immediately in the consolidated statements of income/(loss). See &#x201c;Note&#160;12. Share capital.&#x201d;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_v48LLGy4BEeSTUoJA4bLDQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Treasury shares&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Treasury shares are recognized at acquisition cost and deducted from shareholders&#x2019; equity at the time of acquisition, until they are subsequently resold, distributed or cancelled. Where such shares are subsequently sold, any consideration received is included in shareholders&#x2019; equity. See &#x201c;Note&#160;12. Share capital.&#x201d;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_abIdVLvMIkqMUVyNHmD53g">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Employee benefits&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Post-employment benefits&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company operates the mandatory pension schemes for its employees in Switzerland. The schemes are generally funded through payments to insurance companies. The Company has a pension plan designed to pay pensions based on accumulated contributions on individual savings accounts. However, this plan is classified as a defined benefit plan under IAS 19.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The net defined benefit liability is the present value of the defined benefit obligation at the balance sheet date minus the fair value of plan assets. Significant estimates are used in determining the assumptions incorporated in the calculation of the pension obligations, which is supported by input from independent actuaries. The defined benefit obligation is calculated annually with the assistance of an independent actuary using the projected unit credit method, which reflects services rendered by employees to the date of valuation, incorporates assumptions concerning employees&#x2019; projected salaries and pension increases as well as discount rates of highly liquid corporate bonds that have terms to maturity approximating the terms of the related liability.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;To the extent that the fair value of the plan assets is greater than the present value of the defined benefit obligation as calculated by our independent actuary, the Company accounts for the effect of the asset ceiling test under IAS 19.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Re-measurements of the net defined benefit liability, which comprise actuarial gains and losses and the return on plan assets (excluding interest) are recognized immediately in the consolidated statements of other comprehensive income/(loss). Past service costs, including curtailment gains or losses, are recognized immediately as a split in research and development and general and administrative expenses within the operating results. Settlement gains or losses are recognized in either research and development and/or general and administrative expenses within the operating results. The Company determines the net interest expense/(income) on the net defined benefit liability for the period by applying the discount rate used to measure the defined benefit obligation at the beginning of the annual period or in case of any significant events between measurement dates to the then-net defined benefit liability, considering any changes in the net defined benefit liability during the period as a result of contributions and benefit payments. Net interest expense/(income) and other expenses related to defined benefit plans are recognized in the consolidated statements of income/(loss).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Share-based compensation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company operates an equity-settled, share-based compensation plan. The fair value of the employee services received in exchange for the grant of equity-based awards is recognized as an expense. The total amount to be expensed over the vesting period is determined by reference to the fair value of the instruments granted, excluding the impact of any non-market vesting conditions. Non-market vesting conditions are included in assumptions about the number of instruments that are expected to become exercisable. At each balance sheet date, the Company revises its estimates of the number of instruments that are expected to become exercisable. It recognizes the impact of the revision of original estimates, if any, prospectively in the consolidated statements of income/(loss), and a corresponding adjustment to equity over the remaining vesting period.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Stock options granted under the Company&#x2019;s stock option plans C1 and the 2016 Stock Option and Incentive Plan are valued using the Black-Scholes option-pricing model (see &#x201c;Note&#160;19. Share-based compensation&#x201d;). This valuation model as well as parameters used such as expected volatility and expected term of the stock options are partially based on management&#x2019;s estimates.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and share premium when the options are exercised.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;We estimate the fair value of restricted share units using a reasonable estimate of market value of the common shares on the date of the award. We classify our share-based payments as equity-classified awards as they are settled in common shares. We measure equity-classified awards at their grant date fair value and do not subsequently re-measure them. Compensation costs related to equity-classified awards are equal to the fair value of the award at grant date amortized over the vesting period of the award using the graded method. We reclassify that portion of vested awards to share capital and share premium as the awards vest.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_MgO8KxcyakuPTD-xYugIpA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Provisions&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Provisions are recognized when the Company has a present legal or constructive obligation as a result of past events where it is more likely than not that an outflow of resources will be required to settle the obligation, and a reliable estimate of the amount can be made.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_t9GvV07STUuusEulYQTk4A">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Taxation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Current income tax assets and liabilities for the period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the tax amounts are those that are enacted or substantively enacted, at the reporting date in accordance with the fiscal regulations of the respective country where the Company operates and generates taxable income. Deferred tax is provided using the liability method on temporary differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes at the reporting date.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the&#160;year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted at the reporting date. If required, deferred taxation is provided in full using the liability method, on all temporary differences at the reporting dates. It is calculated at the tax rates that are expected to apply to the period when it is anticipated the liabilities will be settled, and it is based on tax rates (and laws) that have been enacted or substantively enacted at the reporting date.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Deferred income tax assets are recognized to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilized. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized. Although the Company has substantial tax loss carry-forwards, historically, due to the fact that the Company had limited certainty on the achievement of key milestones, it has not recognized any deferred tax assets as the probability for use is low.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;As disclosed in &#x201c;Note&#160;17. Income taxes,&#x201d; the Company has tax losses that can generally be carried forward for a period of 7&#160;years from the period the loss was incurred. These tax losses represent potential value to the Company to the extent that the Company is able to create taxable profits before the expiry period of these tax losses. The Company has not recorded any deferred tax assets in relation to these tax losses.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory>
    <aciu:IncomeTaxLossCarryforwardPeriod
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_EfFfb5yYRUq-2gTudoN3Uw">P7Y</aciu:IncomeTaxLossCarryforwardPeriod>
    <ifrs-full:DeferredTaxAssets
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Narr_Ml41wDGVGESUVf_5Yf1uWg"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_XSzMrATwu0e1s6Qc0pGSdA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Earnings per share&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company presents basic earnings per share for each period in the consolidated financial statements. The earnings per share are calculated by dividing the earnings of the period by the weighted-average number of shares outstanding during the period. Diluted earnings per share reflect the potential dilution that could occur if dilutive securities such as share options or non-vested restricted share units were vested or exercised into common shares or resulted in the issuance of common shares that would participate in net income. Anti-dilutive shares are excluded from the dilutive earnings per share calculation.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory>
    <aciu:DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_rlK88uqpD0eA8IIdZPlxmg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Critical judgments and accounting estimates&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The preparation of financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The areas where AC Immune has had to make judgments, estimates and assumptions relate to (i)&#160;revenue recognition on LCAs, (ii)&#160;clinical development accruals, (iii)&#160;net employee defined benefit liability, (iv)&#160;share-based compensation, (v)&#160;right-of-use assets and lease liabilities and (vi)&#160;our IPR&amp;amp;D asset. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.&lt;/p&gt;</aciu:DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_NtrYGYm2ik-ZK71dmTDNkQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Segment reporting&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company is managed and operated as one business. A single management team that reports to the chief operating decision maker comprehensively manages the entire business. Accordingly, the Company views its business and manages its operations as one operating segment. Non-current assets are located in, and revenue is allocated and recorded within, the Company&#x2019;s country of domicile, Switzerland.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory>
    <aciu:OperatingSegmentsNumber
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="INF"
      id="Narr_XydYXzDx_kCml49Sa2tQ9g"
      unitRef="Unit_Standard_segment_uSnHfk8yHkqj2bvGJo9Fng">1</aciu:OperatingSegmentsNumber>
    <aciu:ReportableSegmentsNumber
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="INF"
      id="Narr_0lPMr2XxNEO3xWM-cvUWyQ"
      unitRef="Unit_Standard_segment_uSnHfk8yHkqj2bvGJo9Fng">1</aciu:ReportableSegmentsNumber>
    <aciu:OperatingSegmentsNumber
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="INF"
      id="Narr_WnqN8JJ9GUSbtOmkgQv_Dg"
      unitRef="Unit_Standard_segment_uSnHfk8yHkqj2bvGJo9Fng">1</aciu:OperatingSegmentsNumber>
    <aciu:DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_4laWSXrKH0KDxu3IzmLZiw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Accounting policies, new standards, interpretations and amendments adopted by the Company&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;There are no new IFRS standards, amendments or interpretations that are mandatory as of January 1, 2023 that are relevant to the Company. Additionally, the Company has not adopted any standard, interpretation or amendment that has been issued but is not yet effective. Such standards are not currently expected to have a material impact on the entity in the current or future reporting periods and on foreseeable future transactions.&lt;/p&gt;</aciu:DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock>
    <ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_bQnBrxZKMkO64fLIQYQqpA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;4.&lt;/b&gt;&lt;/span&gt;Property, plant and equipment&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following tables show the movements in the net book values of property, plant and equipment for the&#160;years ended December&#160;31, 2023 and 2022, respectively:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:40.8%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:40.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:57.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:40.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;IT&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Laboratory&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Leasehold&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Assets under&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Furniture&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;improvements&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;construction&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Acquisition cost:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 285&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,909&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,765&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,640&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 13,602&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 24&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 278&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 468&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 801&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Disposals&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (19)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (12)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (31)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Transfers&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 309&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,168&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 10,233&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,662&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,372&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated depreciation:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (159)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,599)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,017)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (568)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (9,343)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (53)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (271)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,084)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (264)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,672)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:40.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Disposals&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (212)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,851)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (8,101)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (832)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (10,996)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Carrying amount:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 126&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 310&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,748&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,072&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,259&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 97&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 317&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,132&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 830&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,376&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:42.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:42.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:56.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:42.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;IT&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Laboratory&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Leasehold&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Assets under&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Furniture&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;improvements&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;"&gt;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;construction&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Acquisition cost:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 265&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,754&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,142&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 810&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 695&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 12,666&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 20&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 151&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 576&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 184&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 936&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Transfers&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 47&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 646&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (697)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 285&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,909&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,765&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,640&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 13,602&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated depreciation:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (106)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,316)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,739)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (389)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,550)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (53)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (283)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,278)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (179)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,793)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (159)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,599)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,017)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (568)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (9,343)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Carrying amount:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 159&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 438&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,403&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 421&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 695&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5,116&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 126&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 310&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,748&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,072&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,259&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;AC Immune continues to enhance its laboratory equipment to support its R&amp;amp;D functions. This effort has continued for the&#160;year ended December&#160;31, 2023, with CHF 0.7 million invested in lab equipment and IT equipment, representing an increase of 6%.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;years ended December&#160;31, 2023, 2022 and 2021, the Company incurred CHF 1.7 million, CHF 1.8 million and CHF 1.9 million in depreciation expenses, respectively.&lt;/p&gt;</ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb__6mBxQb5o0eC65pToWMKeA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following tables show the movements in the net book values of property, plant and equipment for the&#160;years ended December&#160;31, 2023 and 2022, respectively:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:40.8%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:40.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:57.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:40.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;IT&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Laboratory&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Leasehold&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Assets under&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Furniture&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;improvements&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;construction&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Acquisition cost:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 285&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,909&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,765&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,640&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 13,602&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 24&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 278&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 468&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 801&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Disposals&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (19)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (12)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (31)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Transfers&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 309&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,168&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 10,233&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,662&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,372&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated depreciation:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (159)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,599)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,017)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (568)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (9,343)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (53)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (271)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,084)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (264)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,672)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:40.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Disposals&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (212)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,851)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (8,101)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (832)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (10,996)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Carrying amount:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 126&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 310&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,748&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,072&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,259&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:40.8%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 97&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 317&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,132&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 830&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.56%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,376&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:42.09%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:42.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:56.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:42.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;IT&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Laboratory&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Leasehold&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Assets under&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Furniture&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;improvements&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;"&gt;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;construction&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Acquisition cost:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 265&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,754&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,142&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 810&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 695&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 12,666&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 20&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 151&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 576&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 184&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 936&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Transfers&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 47&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 646&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (697)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 285&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,909&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,765&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,640&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 13,602&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated depreciation:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (106)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,316)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,739)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (389)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,550)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (53)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (283)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,278)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (179)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,793)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance at December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (159)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,599)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,017)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (568)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (9,343)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Carrying amount:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 159&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 438&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,403&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 421&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 695&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5,116&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:42.09%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.96%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 126&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 310&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,748&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,072&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,259&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_Cj6a41-HWECUkiVv0bW4qQ"
      decimals="-3"
      id="Tc_9rsEK4YsGUufP8wK1FDyeg_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">285000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_yA_PZPRqLUu_kKp2zZYt1A"
      decimals="-3"
      id="Tc__EOTeSpPbESfRLzh9E8yfg_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1909000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_CCFaY6n0-UeoiGMVZgAhJA"
      decimals="-3"
      id="Tc_AgCPy7GH4ki3yJ8XaHyMog_5_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">9765000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_6VOKv2eGyUeHs3MGzC7vIw"
      decimals="-3"
      id="Tc_3GxqC52Q2EaEZXCCrUMsCA_5_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1640000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_g2VJr2LWH0mkATiItb2LEg"
      decimals="-3"
      id="Tc_sWCMEE2hg0mT5UHO7U5Juw_5_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_GjTctvZEfEW6pg7_LZJEHA"
      decimals="-3"
      id="Tc_cu0FUEcuYkKSIY4SozabNg_5_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">13602000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_LgaMFEMN_kKAtkztR9a8KA"
      decimals="-3"
      id="Tc_I9u5r6yY0Ui6tRGmu2VKwQ_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">24000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_jU5Jt8mUF0iciQdpO6t7sA"
      decimals="-3"
      id="Tc_MF5fYoNS8ESSkUr2jsHY5A_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">278000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_SGqTYRos7Eu0uaWKvQowsQ"
      decimals="-3"
      id="Tc_34LhJy-5JECteJlgmOMTBg_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">468000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_hLWNWYEvyU-dudu8IMjYcQ"
      decimals="-3"
      id="Tc_bdENm1h6i0OZ3KXmFGDKgA_6_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">31000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_kkPxG2DcNk29JpuIBItYrw"
      decimals="-3"
      id="Tc_zKOgntQhyUmqdONwW9vyQQ_6_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">801000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_LgaMFEMN_kKAtkztR9a8KA"
      decimals="-3"
      id="Tc_72Mg_WI2YU-dPekd6TxgLg_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_jU5Jt8mUF0iciQdpO6t7sA"
      decimals="-3"
      id="Tc_M6hLUdC5x0K6d3gQWOlJSA_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">19000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_SGqTYRos7Eu0uaWKvQowsQ"
      decimals="-3"
      id="Tc_BVFD0xJyQ0WUhjpoBvbLKQ_7_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_hLWNWYEvyU-dudu8IMjYcQ"
      decimals="-3"
      id="Tc_iWJ4i4l3HUWMyAU6chNBrg_7_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">12000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_XAtED10_YUaz8Tcq-re46w"
      decimals="-3"
      id="Tc_ZSae2vCjfkCEw_Kj00xszA_7_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_kkPxG2DcNk29JpuIBItYrw"
      decimals="-3"
      id="Tc_R6CJ_b1ME0KkpukeyUk0Rg_7_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">31000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_hLWNWYEvyU-dudu8IMjYcQ"
      decimals="-3"
      id="Tc_cp51sQCzm0qpx-N9gpFLmQ_8_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_XAtED10_YUaz8Tcq-re46w"
      decimals="-3"
      id="Tc_Tn-hYA4jx0-QbLDi9dCsnw_8_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-3000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_iv5cJCl-0E6vtlPSj3s5AQ"
      decimals="-3"
      id="Tc_DcjqZlKg3EC0rAFj3lemCw_9_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">309000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_Y_Ay0M36UkuaBV4tSfcAjg"
      decimals="-3"
      id="Tc_vipdgPtK_kq6pCl-sqLGaA_9_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2168000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_jydRYd9OWEWk671dwbd0rw"
      decimals="-3"
      id="Tc_2FFHeHeHzU6EM23PL--BHw_9_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">10233000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_pNs8WMywAEOk7jBfV42CCg"
      decimals="-3"
      id="Tc_jM1KzrQNRkaF7jj0NvCdpQ_9_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1662000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_41heKF3EykimTDNXOnweeg"
      decimals="-3"
      id="Tc_rk1Klssn502RVFm0iMPQMw_9_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">14372000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_d7-guilVV0mvoM9Oa34iJg"
      decimals="-3"
      id="Tc_OMrCL_jJ6UKRmRlso9E7FA_12_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-159000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_fJB_6ZN-dU6RdeM0v4FQzA"
      decimals="-3"
      id="Tc_97DKDxrKLkWxk2jafPYNOQ_12_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1599000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_Qn1sc58q206NmPfW1osPPQ"
      decimals="-3"
      id="Tc_xLGPjnJJKkqMsXC6TXwCNw_12_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-7017000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_HJ03XueB8EKX-2gIlzBjqw"
      decimals="-3"
      id="Tc_zwHdzSMYlUGcml4DQJeE-Q_12_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-568000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember__d04PmuBgEKP0NcNI_xEpg"
      decimals="-3"
      id="Tc_fKk57GqzYkuZu5wVL9j4YQ_12_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-9343000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_pYUVZEM920exX1Cwj8qiVg"
      decimals="-3"
      id="Tc_J3PYtxCMgESYkRmofyvJ1Q_13_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">53000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_5xasXe81HU2amQaNWKJlDA"
      decimals="-3"
      id="Tc_tcGjMe9f9k-xq4FvALqYiA_13_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">271000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_wEOJWOe0kkyVwPPcjL51Bg"
      decimals="-3"
      id="Tc_9JhWjMOXdESsDVJbvoj7Zw_13_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1084000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_NtOri1sWtESc64I6yGlDKA"
      decimals="-3"
      id="Tc_j5DShYMwzUqL_p-8MHiCEw_13_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">264000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_kZxWf5plpkyqcnxdVx9WnA"
      decimals="-3"
      id="Tc_tGZmoRaaMkaSWvHdcTTT2A_13_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1672000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_5xasXe81HU2amQaNWKJlDA"
      decimals="-3"
      id="Tc_SlKEqCaDMk6R6wwxR573Kg_14_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-19000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_kZxWf5plpkyqcnxdVx9WnA"
      decimals="-3"
      id="Tc_Brn_02bpBE6xOdTA2NxEQg_14_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-19000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_DuVSPEFd10mbFQqwmoueOg"
      decimals="-3"
      id="Tc_Z1NBW-z3tU28oXV-m6C_fQ_15_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-212000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_jTG84pzUu0O1uFc9oRxVZg"
      decimals="-3"
      id="Tc_sq5ssPAg60OdzhkJyDP52g_15_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1851000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_OAXVMW-Syk2ZrIbWtW1baA"
      decimals="-3"
      id="Tc_9izPDsIeYE6omTPY6VsR5g_15_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-8101000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember__IeyEFArwEeikIeuLj91BA"
      decimals="-3"
      id="Tc_hhUaVLgADUSKjLCvKlZCdw_15_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-832000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_s9rQXTEfUUmFpg2sTDXMlQ"
      decimals="-3"
      id="Tc_AaBetvPK_EmvxW4B3WnI6w_15_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-10996000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_4w7KMGsDgUqUG5MpjLDW-g"
      decimals="-3"
      id="Tc_tLkpumbnGEqLtxxHwciqvg_18_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">126000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_0r2ljY84p02g_MFTZyXL2A"
      decimals="-3"
      id="Tc_6TrZL8EmoEqvKlsNUnGR2Q_18_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">310000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_Su1JgXKRt0O2ssj-e_25TQ"
      decimals="-3"
      id="Tc_Nwl1MIgqQ0OuozkyWJdi-w_18_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2748000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_oO6Nlwpj2ECOa1vYcsigFA"
      decimals="-3"
      id="Tc_poUFvmLZDUO2qeDfNDyi2Q_18_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1072000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_MUVGPZ2Zo0C3Z2S_N5wdKA"
      decimals="-3"
      id="Tc_VaHGEGVC_E6JphIf9lRXmw_18_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_xU5GyUcvgkiPWTq9YrfnaQ_18_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4259000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_ym4hANZchU2ZB9m4tnIJFw"
      decimals="-3"
      id="Tc_918cnvN-mk2ClNJoqJpsPA_19_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">97000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_W50NBzU5qEa09mv6NhCP5A"
      decimals="-3"
      id="Tc_oEzrf6bQCUeOGSvo7QgNMg_19_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">317000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_Ahyp8QOgJU6aUxLJFusyPw"
      decimals="-3"
      id="Tc_z0eHmQmkJ0u1TGbJiMgqQw_19_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2132000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_SHu6D0sv4U-6qvxwsj--IA"
      decimals="-3"
      id="Tc_r30_uXLED0aTaqsGTsi6yA_19_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">830000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_RSgXYisKw0ieDH_MtkA0ag_19_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3376000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_6lS4zjbF4Eac-GIZUgE2jw"
      decimals="-3"
      id="Tc_dMatj5rEd06xUr93SjJtZg_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">265000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_mfV4owp-bEem-93-p6NYFQ"
      decimals="-3"
      id="Tc_V_SJrX-AxkCCN8_wt1SetQ_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1754000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_NZr3F8nBAUuCT_VetHuh3A"
      decimals="-3"
      id="Tc_pcS5JQbQ6U-wyOBAG11W_w_5_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">9142000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_nzoCPNgdt0WOxkRNR6rgNg"
      decimals="-3"
      id="Tc_0ls3c9vLQEqAwgEXXmeDbA_5_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">810000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_058A2xbE90SyAgqdMWXaeQ"
      decimals="-3"
      id="Tc_yhJIUz4oTUuU6U1CFo-ZoA_5_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">695000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_15_CvNFzPUOQfoII6rlmNA"
      decimals="-3"
      id="Tc_GDFhOmWbgUq91mj-S1VVPg_5_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">12666000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_W-r0ii74bU-k1a5qR2sk3Q"
      decimals="-3"
      id="Tc_wP7BsDuJRU-I-qMI_lr2zA_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">20000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_FrBVzS7Gp0e3Hgpbb7-EyQ"
      decimals="-3"
      id="Tc_scAfyIg4LUGKbQ5OTaHIPw_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">151000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_KQhq8CmXDUufwm79fj3u-A"
      decimals="-3"
      id="Tc_8hab46Zjc0SB1W0vdeSzUQ_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">576000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember__F425--_EEOXAYSsaoxgOA"
      decimals="-3"
      id="Tc_SyzL_LRKhk6ff_Vnhff6gg_6_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">184000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_yNTxg0S0g0mhMxkN6R3p8g"
      decimals="-3"
      id="Tc_HgTHB0cAAkSzFQRT1HSWiQ_6_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">5000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_JgXeFoa0LUuPeRfQafgJng"
      decimals="-3"
      id="Tc_LPPo-0vVPkamtIGHpP2AlA_6_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">936000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_FrBVzS7Gp0e3Hgpbb7-EyQ"
      decimals="-3"
      id="Tc_Oz75KeVVPEqb41Z_6n_vTg_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_KQhq8CmXDUufwm79fj3u-A"
      decimals="-3"
      id="Tc_qA0I5D9m-EGKTw2wZ-p62Q_7_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">47000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember__F425--_EEOXAYSsaoxgOA"
      decimals="-3"
      id="Tc_IS1VTE6tAU--t2Y2mcObZw_7_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">646000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_yNTxg0S0g0mhMxkN6R3p8g"
      decimals="-3"
      id="Tc_3Texu1uE8EKOfYazTQRszw_7_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-697000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_Cj6a41-HWECUkiVv0bW4qQ"
      decimals="-3"
      id="Tc_cPu9SmKn7k-XoYRHEuSU4w_8_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">285000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_yA_PZPRqLUu_kKp2zZYt1A"
      decimals="-3"
      id="Tc_XycCC4MfjE2DBwygptGR_w_8_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1909000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_CCFaY6n0-UeoiGMVZgAhJA"
      decimals="-3"
      id="Tc_cC8ws9zpI0uE4Vu6wVn_tQ_8_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">9765000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_6VOKv2eGyUeHs3MGzC7vIw"
      decimals="-3"
      id="Tc_KTA21gYtcUaVMjMxnVtipw_8_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1640000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_g2VJr2LWH0mkATiItb2LEg"
      decimals="-3"
      id="Tc_ro4SYCyrgE2CtLwPnWEgZw_8_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_GjTctvZEfEW6pg7_LZJEHA"
      decimals="-3"
      id="Tc_4M26Pb_iEUayHxTwOylhPQ_8_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">13602000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_unPNYQAq0U61GM9DA5BHWQ"
      decimals="-3"
      id="Tc_yS9tOkM5ZkuWj5ML_24e1g_11_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-106000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_F9b8H9FLJ02EvHvZhkDIBA"
      decimals="-3"
      id="Tc_KDY-Gnzv-k6uG5b0FD-JXA_11_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1316000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_obdYBDyo_E-bUxAogvIKSw"
      decimals="-3"
      id="Tc_it1FhZkEH0mTInW0MiidBw_11_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-5739000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_oYg1VVE1MUmNWowfojvvlw"
      decimals="-3"
      id="Tc_9TYvJBhFykSL4HS6uzG1cw_11_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-389000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_n8Zissrm5UiC3zmhjJsmyw"
      decimals="-3"
      id="Tc_Ruh-eqdHP0eF-7OozPkytQ_11_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-7550000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_FT-o_AOWWUmsEyj11IwpRQ"
      decimals="-3"
      id="Tc_YhIRkKsrREapxpjqPopV7g_12_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">53000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_aTa03kZvVk2UVSOXZ_yZVQ"
      decimals="-3"
      id="Tc_cVA185WQzkyw3hqBAyh4FA_12_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">283000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_dAA0zRsjHUGlsbYsE9T1jQ"
      decimals="-3"
      id="Tc_TO4MveAm7kGqjxPKUf8JQw_12_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1278000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_CvwXkZmKrE2y_nrcwbCWUQ"
      decimals="-3"
      id="Tc_LJGXO0YVi0-9sLE2tgPD7Q_12_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">179000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_hzU9_UsRaUqQjrz3YAAlrQ"
      decimals="-3"
      id="Tc_5clT40VxyEmsltSmenrRTw_12_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1793000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_d7-guilVV0mvoM9Oa34iJg"
      decimals="-3"
      id="Tc_qyaeX5gpXEGUxRQS5m-tLg_13_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-159000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_fJB_6ZN-dU6RdeM0v4FQzA"
      decimals="-3"
      id="Tc_c5TPSbW-kECiSW80VCsJ0A_13_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1599000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_Qn1sc58q206NmPfW1osPPQ"
      decimals="-3"
      id="Tc_T8asuq0KCEGDcF_FV1Cs8Q_13_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-7017000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_HJ03XueB8EKX-2gIlzBjqw"
      decimals="-3"
      id="Tc_xEljYLQ4CUaCjJ-9L4cXFA_13_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-568000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember__d04PmuBgEKP0NcNI_xEpg"
      decimals="-3"
      id="Tc_sDT-WBibGEqx6Oh3eQT4_A_13_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-9343000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_IfzHfIthHkO6dbcYO8zgwg"
      decimals="-3"
      id="Tc_GZ91__63BkyIV2FkPiQLrg_16_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">159000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_eU6vEoc2fEeUkwgp4Q4hyA"
      decimals="-3"
      id="Tc_VDrFiwqAJU2n3-nz3Zt9PQ_16_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">438000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_xOhhxIMNr063CjxwJupX8w"
      decimals="-3"
      id="Tc_lzT7p3peiEOFQvdWSA-2iw_16_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3403000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_Bj1308vFcUO5rHCNyanwEg"
      decimals="-3"
      id="Tc_mZNQ91uzj0O8j6gPM9fYeQ_16_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">421000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_9RCvElW3fUCypuHlovaGjA"
      decimals="-3"
      id="Tc_CLIJ3e1JV0yIrzbD-O1UVg_16_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">695000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="-3"
      id="Tc_oyGyaoUit0ya8jUc61B3lQ_16_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">5116000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_FixturesAndFittingsMember_4w7KMGsDgUqUG5MpjLDW-g"
      decimals="-3"
      id="Tc_QplKknaJrEGGKvpyJj0Kmg_17_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">126000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ComputerEquipmentMember_0r2ljY84p02g_MFTZyXL2A"
      decimals="-3"
      id="Tc_aBIU8XnrwEuhB0MKGlPfkQ_17_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">310000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_LaboratoryEquipmentMember_Su1JgXKRt0O2ssj-e_25TQ"
      decimals="-3"
      id="Tc_m3e4xLpw50a7BPKTWJdu4A_17_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2748000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_LeaseholdImprovementsMember_oO6Nlwpj2ECOa1vYcsigFA"
      decimals="-3"
      id="Tc_cNmc9NkHb0SXulZF9W5MwQ_17_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1072000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full_ConstructionInProgressMember_MUVGPZ2Zo0C3Z2S_N5wdKA"
      decimals="-3"
      id="Tc_mj0aAvZtD0Of0jvH4nlnvg_17_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_aSe2B9MldkuwnQTbYr9INg_17_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4259000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_ItAndLaboratoryEquipmentMember_KRQK-6opkEi3py3xSmjCrA"
      decimals="-5"
      id="Narr_4zYjbTtwEkaZQPWBGzsMhw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">700000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <aciu:PercentageIncreaseInPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_aciu_ItAndLaboratoryEquipmentMember_KRQK-6opkEi3py3xSmjCrA"
      decimals="INF"
      id="Narr_M2FKgFFKSE-WSEtMdZpQpA"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.06</aciu:PercentageIncreaseInPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_kZxWf5plpkyqcnxdVx9WnA"
      decimals="-5"
      id="Narr_lO6CAheeLU6XII2UWqZvRw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1700000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_hzU9_UsRaUqQjrz3YAAlrQ"
      decimals="-5"
      id="Narr_AWMU47-c50KwEDv83F1mig"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1800000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_Ch-n85pVKk-WOgs80YsR9A"
      decimals="-5"
      id="Narr_b4jRXiZy-kityiqYVJnxEg"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1900000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DisclosureOfLeasesExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_vJl5h82DvE2y5uC_1rl0HQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;5.&lt;/b&gt;&lt;/span&gt;Right-of-use assets, long-term financial assets and lease liabilities&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company recognized additions and reassessment of right-of-use of leased assets for buildings or for office equipment totaling CHF 1.2 million and CHF 0.5 million for the&#160;years ended December&#160;31, 2023 and 2022, respectively. In 2023, these increases are predominantly associated with a new lease and the reassessment of our existing leased office space.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Regarding lease liabilities, the amortization depends on the rate implicit in the contract or the incremental borrowing rate for the respective lease component. The weighted averages of the incremental borrowing rates as of December&#160;31, 2023 are 3.5% (3.5% for 2022) for buildings, 5.3% (5.3% for 2022) for office equipment and 2.6% (2.6% for 2022) for IT equipment.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following tables show the movements in the net book values of right-of-use of leased assets for the&#160;years ended December&#160;31, 2023 and 2022, respectively:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:61.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:61.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Office&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;IT&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Buildings&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance as of December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,708&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 74&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 26&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,808&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions and reassessment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,243&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,243&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (505)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (24)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (14)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (543)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance as of December&#160;31,&#160;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,446&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 12&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,508&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:61.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:61.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Office&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;IT &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Buildings&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance as of December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2,776&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;98&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;40&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,914&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions and reassessment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 460&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 460&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (528)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (24)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (14)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (566)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance as of December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,708&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 74&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 26&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,808&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;For the&#160;years ended December&#160;31, 2023, and 2022, the impact on the Company&#x2019;s consolidated statements of income/(loss) and consolidated statements of cash flows is detailed in the table below.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the Year Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Statements of income/(loss)&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation of right-of-use assets &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 543&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 566&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest expense on lease liabilities &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 90&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 68&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Expense for short-term leases and leases of low value &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 793&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 750&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,426&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,384&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Statements of cash flows&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total cash outflow for leases&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,431&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,388&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table presents the contractual undiscounted cash flows for lease liabilities as of December&#160;31, 2023 and 2022:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Less than one year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 784&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 638&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;1-3 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,526&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,230&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;3-5 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,505&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,187&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,815&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,055&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company also has two deposits in escrow accounts totaling CHF 0.4 million for the lease of the Company&#x2019;s premises as of December&#160;31, 2023 and 2022, respectively.&lt;/p&gt;</ifrs-full:DisclosureOfLeasesExplanatory>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-5"
      id="Narr_02r8X2psfkKrwFcB74LBmQ"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1200000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-5"
      id="Narr_0ki5qAgWjkumBGBOXWZufg"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">500000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_ezBq1LNFIUGJdNTu7a4HwQ"
      decimals="3"
      id="Narr_ZSEqbmzwRUO7fcJ36_1P2g"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.035</ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16>
    <ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_w5Il_SwGi0K8Y_peNUATtA"
      decimals="3"
      id="Narr_9j7yZlyUakWhtKYm8he5Qg"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.035</ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16>
    <ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_FgXJNffw_kyxmi2k_Q8KhQ"
      decimals="3"
      id="Narr_hubZjBQdfkuK9veYnZu0Jw"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.053</ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16>
    <ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_Y2dI5zRkP0aEdOSvnjsAaA"
      decimals="3"
      id="Narr_mMPXPzSRZk2doaPebZbb0Q"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.053</ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16>
    <ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_-Hj-hSllxE-LEUa_Gmj16A"
      decimals="3"
      id="Narr_JYbuHaFT6k6L5qkDhyX6WA"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.026</ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16>
    <ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_Ecik1PzbbE2L7iBY1hl-Tg"
      decimals="3"
      id="Narr_9SlsvUB8rk-1IPc0EtRW3g"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.026</ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16>
    <ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_dKCp2YYv8UauQcouYRLD2A">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following tables show the movements in the net book values of right-of-use of leased assets for the&#160;years ended December&#160;31, 2023 and 2022, respectively:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:61.5%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:61.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Office&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;IT&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Buildings&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance as of December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,708&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 74&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 26&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,808&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions and reassessment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,243&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,243&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.5%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (505)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (24)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (14)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (543)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.5%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance as of December&#160;31,&#160;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,446&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 12&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.67%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,508&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:61.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:61.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Office&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;IT &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Buildings&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;equipment&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance as of December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2,776&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;98&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;40&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,914&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Additions and reassessment&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 460&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 460&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (528)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (24)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (14)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (566)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:61.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Balance as of December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,708&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.92%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 74&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 26&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,808&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_w5Il_SwGi0K8Y_peNUATtA"
      decimals="-3"
      id="Tc_xbTp1kVWIEeA35XhhQ2j2Q_3_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2708000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_Y2dI5zRkP0aEdOSvnjsAaA"
      decimals="-3"
      id="Tc_r5AqGrtMg0m2J88RLPuUGw_3_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">74000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_Ecik1PzbbE2L7iBY1hl-Tg"
      decimals="-3"
      id="Tc_RAqSVBO0zUKaTjSnE9_5og_3_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">26000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_CZXkbSX0EECnlErDSucEPA_3_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2808000</ifrs-full:RightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_dz45p3-Mt0Kum8kISicdTg"
      decimals="-3"
      id="Tc_HF2W65zGWUKEuwMJAWjF3A_4_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1243000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_oH_yOQmg0kGMBs0pfoK_pQ"
      decimals="-3"
      id="Tc_SRjiPAWJDkahkJepOYjNSg_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_0Jtnd8m_I0enHD9zlLU-pg"
      decimals="-3"
      id="Tc_Dl3E0NGBa0uAzLL0SPPYBQ_4_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_mhNR4Sn_40--rPrm8iOeqA_4_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1243000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_dz45p3-Mt0Kum8kISicdTg"
      decimals="-3"
      id="Tc_7MBz8olxD0WtW9230pKhnQ_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">505000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_oH_yOQmg0kGMBs0pfoK_pQ"
      decimals="-3"
      id="Tc_WuPYrLUPAUGuhWYVGd1XfA_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">24000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_0Jtnd8m_I0enHD9zlLU-pg"
      decimals="-3"
      id="Tc_6Ts5xsO-9k6OJrOcX_4Ryg_5_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">14000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_yoy4-QkyY0CUdcIbDxG_ng_5_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">543000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_ezBq1LNFIUGJdNTu7a4HwQ"
      decimals="-3"
      id="Tc_PNSzYQmXiEO4Phm06u5cKw_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3446000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_FgXJNffw_kyxmi2k_Q8KhQ"
      decimals="-3"
      id="Tc_M61zHs3NH0S1A8FnaZYoTw_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">50000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_-Hj-hSllxE-LEUa_Gmj16A"
      decimals="-3"
      id="Tc_Si3Aayo7QUGQwKD9VCb9SA_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">12000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_kIElU8O4RUWNvtWbSwx61Q_6_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3508000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_MOvL_KRv-0GMjYdNMWJfSw"
      decimals="-3"
      id="Tc_flCpEXYITUOq_O_DYEAH3g_3_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2776000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_mEjjRoDiAEuxYNk_x45n1g"
      decimals="-3"
      id="Tc_j1Z3_INPGkybD3cy9kROeA_3_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">98000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_kiGHGOXq1EeHpusggsUgOg"
      decimals="-3"
      id="Tc_Rw-_RUN2tUSPMtjzeMAMqg_3_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">40000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="-3"
      id="Tc_YBl5IvFQUES5CUTqDJ9_PA_3_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2914000</ifrs-full:RightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_Gl68ge7NsE6HRhfhKLgLLg"
      decimals="-3"
      id="Tc_nAibFLYHi0-w0ApeYrwMNw_4_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">460000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_JX8Xpx6XvkGjBXaj4z4PEA"
      decimals="-3"
      id="Tc_xdzywVddUUymt5b5qgPPGA_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_SK2Ewb7ptEmzydRvB1J-Mw"
      decimals="-3"
      id="Tc_XhuAmijBikyeZgZCoAZaAA_4_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_qKCnqKeFuES_p3wmtm_KwA_4_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">460000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_Gl68ge7NsE6HRhfhKLgLLg"
      decimals="-3"
      id="Tc_qu9tJBG0o02O_hJJrv78Qg_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">528000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_JX8Xpx6XvkGjBXaj4z4PEA"
      decimals="-3"
      id="Tc_sOx-XVJTsEmVq5OQvzi6mw_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">24000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_SK2Ewb7ptEmzydRvB1J-Mw"
      decimals="-3"
      id="Tc_UOfEg8DXeEetLNf0nBSzmA_5_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">14000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_oqiSuj48mEqwD3UJVyGP8w_5_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">566000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_BuildingsMember_w5Il_SwGi0K8Y_peNUATtA"
      decimals="-3"
      id="Tc_O9X7X2mHKUSKcOJSwZ7PFw_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2708000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_OfficeEquipmentMember_Y2dI5zRkP0aEdOSvnjsAaA"
      decimals="-3"
      id="Tc_8EyGMBpFwkukyNGRoWJIDw_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">74000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfAssetsAxis_ifrs-full_ComputerEquipmentMember_Ecik1PzbbE2L7iBY1hl-Tg"
      decimals="-3"
      id="Tc__DADJaQegEmJ69oXWAT5sw_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">26000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_lAsUo90n6kic_XT7SYnfUQ_6_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2808000</ifrs-full:RightofuseAssets>
    <aciu:DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_Jqz_vma7dEuU51_fxjdHMA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;For the&#160;years ended December&#160;31, 2023, and 2022, the impact on the Company&#x2019;s consolidated statements of income/(loss) and consolidated statements of cash flows is detailed in the table below.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For the Year Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Statements of income/(loss)&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Depreciation of right-of-use assets &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 543&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 566&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest expense on lease liabilities &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 90&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 68&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Expense for short-term leases and leases of low value &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 793&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 750&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,426&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,384&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;i style="font-style:italic;"&gt;Statements of cash flows&lt;/i&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total cash outflow for leases&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,431&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,388&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</aciu:DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_npuE-0zSdk-n-AKkd1fpdw_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">543000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_SVP6yrzAnEiPr33KG6vnoQ_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">566000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_qkDqMJaWKk-cyrGi5YXb6w_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">90000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_9XpugJSQE0SBWtI0Xytlxg_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">68000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_OH3iIcqUaUG4kYmdQYvuHQ_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">793000</ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed>
    <ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_3SvOfAc_70C2uP7ysSYIxw_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">750000</ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed>
    <aciu:ExpenseRelatingToLeases
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_EhPOipuYRkGBt85RIAG52g_8_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1426000</aciu:ExpenseRelatingToLeases>
    <aciu:ExpenseRelatingToLeases
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_ehJ6IDlU5kCjhIKfPffpVA_8_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1384000</aciu:ExpenseRelatingToLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_Y7PudUmjk0mv6lUh1QwjIw_11_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1431000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_7Z-lAibSikCsKlAhowT1iw_11_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1388000</ifrs-full:CashOutflowForLeases>
    <aciu:ScheduleOfContractualUndiscountedCashFlowsTableTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_Tmh-_GLafEujibvI1WlAAQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table presents the contractual undiscounted cash flows for lease liabilities as of December&#160;31, 2023 and 2022:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Less than one year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 784&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 638&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;1-3 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,526&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,230&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;3-5 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,505&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,187&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,815&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,055&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</aciu:ScheduleOfContractualUndiscountedCashFlowsTableTextBlock>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_PEDQ9Y0GpEGR7Fz3aVtJ5Q"
      decimals="-3"
      id="Tc_Z5FQ9Lwigk6-rU8aag8_ag_4_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">784000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_ZpFwqYls3EejWQUqS6jVtA"
      decimals="-3"
      id="Tc_NpS1e5XDrk2YqCOtHJ3qGg_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">638000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_UEQ5-Qdp-ECfZVHJXapb-w"
      decimals="-3"
      id="Tc_Wig30PxVh0W5u5T14HDXNA_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1526000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_O05oIcvQHECcE7b4dXGvbQ"
      decimals="-3"
      id="Tc_hbTQhha2-kmAw2n96Yy63g_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1230000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_CD3sQ6Iqhk-fx5WexG8VXQ"
      decimals="-3"
      id="Tc_XXgH2RQM7kqeGNayqIX3FA_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1505000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_vnWZvKBRW0CV9s94BbcDrg"
      decimals="-3"
      id="Tc_GkhRoM3jN0u3IjjXrbl4FQ_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1187000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_jqUGM-Fd00ili1vuY9Nw2A_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3815000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_H0OJptAxL0CDQDWiEaWO0w_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3055000</ifrs-full:GrossLeaseLiabilities>
    <aciu:NumberOfDepositsInEscrowAccounts
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="INF"
      id="Narr_Co8nfHuAWk-cJWQmYYm3fA"
      unitRef="Unit_Standard_item_lel3bReemU2v4xdKyUvjzA">2</aciu:NumberOfDepositsInEscrowAccounts>
    <aciu:EscrowDepositAmount
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-5"
      id="Narr_W09uRrR1b0-LtWnJs9983g"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">400000</aciu:EscrowDepositAmount>
    <aciu:EscrowDepositAmount
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-5"
      id="Narr_fr9TeBepkE6XAcXFO5H7gQ"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">400000</aciu:EscrowDepositAmount>
    <aciu:DisclosureOfAssetAcquisitionsTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_NCtBl8yOAECrTI90zQV4Cg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;6.&lt;/b&gt;&lt;/span&gt;Asset acquisition&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In 2021, the Company closed its acquisition with Affiris AG (Affiris) for the program portfolio of therapeutics targeting a-syn, notably ACI-7104.056 (previously PD01), a clinically-validated active immunotherapy candidate for the treatment of Parkinson&#x2019;s disease (the Transferred Assets). The Company acquired the Transferred Assets and USD 5.0 (CHF 4.6) million in cash in exchange for 7,106,840 shares of the Company at closing, for a total value of USD 58.7 (CHF 55.1) million.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;With the closing of this transaction, the Company recorded an IPR&amp;amp;D intangible asset associated with ACI-7104.056 for USD 53.7 (CHF 50.4) million. The Company used a risk-adjusted discounted cash flow method to determine the fair value of the intangible asset using a discount rate of 15%. See &#x201c;Note&#160;7. Intangible assets&#x201d; for further details on assumptions used.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;As the Company transferred its own equity instruments in consideration for the asset transferred, the acquisition was assessed in accordance with IFRS 2 &lt;i style="font-style:italic;"&gt;Share-based Payment&lt;/i&gt;.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company determined that the acquisition of the Transferred Assets did not qualify as a business combination in accordance with IFRS 3 &lt;i style="font-style:italic;"&gt;Business Combinations&lt;/i&gt; and therefore was accounted for as an asset acquisition. Most of the fair value of the Transferred Assets is attributable to a single identifiable asset which is the in-process research and development asset. The purchase consideration for the Transferred Assets was allocated based on their relative fair values.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table summarizes the amounts of the Transferred Assets acquired:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:86.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Cash&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;4,634&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;IPR&amp;amp;D asset&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;50,416&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;55,050&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</aciu:DisclosureOfAssetAcquisitionsTextBlock>
    <aciu:CashAcquiredAsPartOfAssetAcquisition
      contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_8aUhNs9mtU-Truhn6_ij4A"
      decimals="-5"
      id="Narr_ceOMX5YHAkezvploOUPl2A"
      unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">5000000.0</aciu:CashAcquiredAsPartOfAssetAcquisition>
    <aciu:CashAcquiredAsPartOfAssetAcquisition
      contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_8aUhNs9mtU-Truhn6_ij4A"
      decimals="-5"
      id="Narr_W9UC67--80GVO2ldBgf7oA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4600000</aciu:CashAcquiredAsPartOfAssetAcquisition>
    <aciu:SharesTransferredAsConsiderationInAssetAcquisition
      contextRef="Duration_1_1_2021_To_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_rCWc9moZ-UuoKzp2P9kXqQ"
      decimals="INF"
      id="Narr_NLydTM62p0effhfvOgJ0sA"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">7106840</aciu:SharesTransferredAsConsiderationInAssetAcquisition>
    <aciu:TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition
      contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_8aUhNs9mtU-Truhn6_ij4A"
      decimals="-5"
      id="Narr_-5XRXXXlTE2r1vxuGVWKlA"
      unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">58700000</aciu:TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition>
    <aciu:TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition
      contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_8aUhNs9mtU-Truhn6_ij4A"
      decimals="-5"
      id="Narr_uOP9esEKUkGozHoRjoY-qA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">55100000</aciu:TotalConsiderationTransferredAcquisitionDateFairValueAssetAcquisition>
    <aciu:IntangibleAssetsAcquiredAsPartOfAssetAcquisition
      contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_BBkqnTW0KUyG6jmwGuQriQ"
      decimals="-5"
      id="Narr_xLMxddKNzEWEQMlp7iKtlQ"
      unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">53700000</aciu:IntangibleAssetsAcquiredAsPartOfAssetAcquisition>
    <aciu:IntangibleAssetsAcquiredAsPartOfAssetAcquisition
      contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_BBkqnTW0KUyG6jmwGuQriQ"
      decimals="-5"
      id="Narr_Wb_lm3hLdku3w1rX9T5LyQ"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">50400000</aciu:IntangibleAssetsAcquiredAsPartOfAssetAcquisition>
    <ifrs-full:SignificantUnobservableInputAssets
      contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_IprDIntangibleAssetAssociatedWithAci7104.056Member_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_eiJAYeQIpEq75LD86tbZwQ"
      decimals="2"
      id="Narr_clw7c-RaLkCSiODPKwWwlw"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.15</ifrs-full:SignificantUnobservableInputAssets>
    <aciu:DisclosureOfAssetAcquisitionsTableTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_GlUEowlfo02ceOtRgufO3A">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table summarizes the amounts of the Transferred Assets acquired:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:86.46%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Cash&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;4,634&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.46%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;IPR&amp;amp;D asset&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;50,416&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:86.46%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;55,050&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</aciu:DisclosureOfAssetAcquisitionsTableTextBlock>
    <aciu:CashAcquiredAsPartOfAssetAcquisition
      contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_8aUhNs9mtU-Truhn6_ij4A"
      decimals="-3"
      id="Tc_6CDS4v4mhk6qoMHSEcRpwg_2_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4634000</aciu:CashAcquiredAsPartOfAssetAcquisition>
    <aciu:IntangibleAssetsAcquiredAsPartOfAssetAcquisition
      contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_8aUhNs9mtU-Truhn6_ij4A"
      decimals="-3"
      id="Tc_Iw1d00C4wUyZC_Q5-QZHlg_3_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">50416000</aciu:IntangibleAssetsAcquiredAsPartOfAssetAcquisition>
    <aciu:TotalAssetsAcquiredInAssetAcquisition
      contextRef="As_Of_12_31_2021_aciu_AssetAcquisitionsAxis_aciu_ProgramPortfolioOfTherapeuticsTargetingAsynFromAffirisMember_8aUhNs9mtU-Truhn6_ij4A"
      decimals="-3"
      id="Tc_lgY4Cw4se0aP6FAzWolnpw_4_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">55050000</aciu:TotalAssetsAcquiredInAssetAcquisition>
    <ifrs-full:DisclosureOfIntangibleAssetsExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_d6Y_P7x7XEWoDMroFdlnXQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;7.&lt;/b&gt;&lt;/span&gt;Intangible assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;AC Immune&#x2019;s acquired IPR&amp;amp;D asset is a clinically-validated active immunotherapy candidate for the treatment of Parkinson&#x2019;s disease. The asset is not yet ready for use until the asset obtains market approval. The carrying amount and net book value are detailed below:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Gross&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Gross&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net book&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net book&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amortization&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amortization&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Acquired IPR&amp;amp;D asset&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total intangible assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In accordance with IAS 36 &lt;i style="font-style:italic;"&gt;Impairment of Assets&lt;/i&gt;, the IPR&amp;amp;D asset is reviewed at least annually for impairment by assessing the fair value less costs to sell (recoverable amount) and comparing this to the carrying value of the asset. The valuation is considered to be Level&#160;3 in the fair value hierarchy in accordance with IFRS 13 &lt;i style="font-style:italic;"&gt;Fair Value Measurement&lt;/i&gt; due to unobservable inputs used in the valuation. The Company has determined the IPR&amp;amp;D asset was not impaired as of December&#160;31, 2023 and 2022, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The key assumptions used in the valuation model in accordance with an income approach to determine the recoverable amount include observable and unobservable key inputs as follows:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Anticipated research and development costs;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Anticipated costs of goods and sales and marketing expenditures;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Probability of achieving clinical and regulatory development milestones in accordance with certain industry benchmarks;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Target indication prevalence and incidence rates;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Anticipated market share;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;General commercialization expectations such as anticipated pricing and uptake;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Expected patent life and market exclusivity periods; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="width:18pt;"&gt;&lt;/td&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;&#x25cf;&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;Other metrics such as the tax rate.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt;"&gt;&lt;/div&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s valuation model calculates the risk-adjusted, net cash flows through the projected period of market exclusivity across target sales regions. The Company uses a discount rate of 17% (17% for 2022), based on the assumed cost of capital for the Company over the forecast period.&lt;/p&gt;</ifrs-full:DisclosureOfIntangibleAssetsExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_AhQ3VXKaPUaLGiN8Efp3Ng">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Gross&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Gross&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net book&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;carrying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Accumulated&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net book&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amortization&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amount&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;amortization&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt; value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Acquired IPR&amp;amp;D asset&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total intangible assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 50,416&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_bOl8wEKNyEqYyzQR0ioW-w"
      decimals="-3"
      id="Tc_ONITgH43RkSDOIchAa5NcQ_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">50416000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_ml_R3Ylar0-YvNfrWq7Svg"
      decimals="-3"
      id="Tc_YpxC39MRNESEYUxKZ7oEKw_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_MVjsqGrUmkGNOKc737qEYQ"
      decimals="-3"
      id="Tc_T0e61wsLNk-tFxzs_0jkjw_5_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">50416000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_CaCTeKx2c0qPmNfApsv9IQ"
      decimals="-3"
      id="Tc_-ZNWJtD8X0Kv6XZ7dSp1AQ_5_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">50416000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_xfEun2NfTUKZr40nuUKpOA"
      decimals="-3"
      id="Tc_67poRgpHOUiRE_ebq7p-jw_5_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_aGfEhz_sAkK6Z9G5vRsASQ"
      decimals="-3"
      id="Tc_UEs_N49HgUiFYs9zFjKhlw_5_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">50416000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_41heKF3EykimTDNXOnweeg"
      decimals="-3"
      id="Tc_1Z_E6I9d1kKzs9QM-ioLTQ_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">50416000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_s9rQXTEfUUmFpg2sTDXMlQ"
      decimals="-3"
      id="Tc_T3lXkhOIMUy3upmAsvHDxA_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_JATE2Nxegku2uYzlRfZAtw_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">50416000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_GjTctvZEfEW6pg7_LZJEHA"
      decimals="-3"
      id="Tc_EbK7kfNWOkmidHntrCMKcw_6_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">50416000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2022_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember__d04PmuBgEKP0NcNI_xEpg"
      decimals="-3"
      id="Tc_96poi-gzU0arOVHILWS0iw_6_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_iFqJvbNiHUyCP5_y19cPKg_6_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">50416000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:SignificantUnobservableInputAssets
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_w6UU7BFQQ02Es-wkhoNeRA"
      decimals="2"
      id="Narr_BnYa6hIAZ0-fMSCDo7_9Og"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.17</ifrs-full:SignificantUnobservableInputAssets>
    <ifrs-full:SignificantUnobservableInputAssets
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_aciu_InProcessResearchAndDevelopmentIPRDAssetMember_ifrs-full_UnobservableInputsAxis_ifrs-full_DiscountRateMeasurementInputMember_MFct5TYRLEOKaNzhRr9ydA"
      decimals="2"
      id="Narr_GTCldp2Qf0SZKoJ8L94tAQ"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.17</ifrs-full:SignificantUnobservableInputAssets>
    <aciu:DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_x0HiLTXBVU674WMU_DqKpQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;8.&lt;/b&gt;&lt;/span&gt;Cash and cash equivalents and short-term financial assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The Company&#x2019;s cash and cash equivalents are maintained in the following respective currencies as of December&#160;31, 2023 and 2022:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 78,494&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,586&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 78,494&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,586&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;By currency&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;CHF&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 52,437&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 24,418&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;EUR&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,155&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,313&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;USD&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 17,902&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5,855&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total cash and cash equivalents&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 78,494&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,586&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December 31, 2023 and 2022, the Company&#x2019;s funds were held in CHF, EUR and USD currencies. Funds held in EUR and USD were translated into CHF at a rate of 0.942 and 0.851 and 0.994 and 0.933, respectively, for each currency and&#160;year.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table summarizes the Company&#x2019;s short-term financial assets as of December&#160;31, 2023 and 2022:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Short-term financial assets due in one year or less&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 24,554&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 91,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 24,554&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 91,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;By currency&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;CHF&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 22,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 91,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;USD&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,554&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total short-term financial assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 24,554&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 91,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</aciu:DisclosureOfCashAndCashEquivalentsAndShortTermDepositsNotClassifiedAsCashEquivalentsTextBlock>
    <aciu:ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_FzM6DkslPkGG4TUMWdzLmg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The Company&#x2019;s cash and cash equivalents are maintained in the following respective currencies as of December&#160;31, 2023 and 2022:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 78,494&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,586&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 78,494&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,586&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;By currency&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;CHF&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 52,437&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 24,418&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;EUR&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,155&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,313&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;USD&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 17,902&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5,855&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total cash and cash equivalents&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 78,494&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,586&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</aciu:ScheduleOfCashAndCashEquivalentsByCurrencyTableTextBlock>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_GX3Q2SMazE-Y7a86rGaluQ_4_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">78494000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_hJtiq80T_kecwA6aZW_bJQ_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">31586000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_BJOd-y2_zUKXx0cgJNKHNQ_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">78494000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_MDhtftzU9U28OpDWdWbyLw_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">31586000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2023_srt_CurrencyAxis_currency_CHF_JfNLzHvH80WbSrRE58qKYg"
      decimals="-3"
      id="Tc_wt_bU7MI2kqkDablQXIvCA_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">52437000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2022_srt_CurrencyAxis_currency_CHF_9dJzU0_HhECZUKUigq7XAg"
      decimals="-3"
      id="Tc_ADn8PbzPXEiCPJvM2dSa4Q_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">24418000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2023_srt_CurrencyAxis_currency_EUR_CKOjyw5J1Um-SGovJ4ejYw"
      decimals="-3"
      id="Tc_KNngDcWbHEe6GqZDZzZT_Q_8_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">8155000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2022_srt_CurrencyAxis_currency_EUR_gXKgjdqF5ECk_GGPperSYA"
      decimals="-3"
      id="Tc_9zrGAzVZlUWZo6bV-5xjqg_8_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1313000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2023_srt_CurrencyAxis_currency_USD_hCYaW1c4MEeE5iAbGkvRtw"
      decimals="-3"
      id="Tc_n1RhQ-QIxkqd4Xf-p4hHsg_9_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">17902000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2022_srt_CurrencyAxis_currency_USD_vlpq5OPW5UKEsC2zk4jyEg"
      decimals="-3"
      id="Tc_xhYuA7LhR0e5zFcF0B0puA_9_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">5855000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_2k6yN90e_kiBS0kjubVT4A_10_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">78494000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_SwviPZNoh0CcQqLDPu2C2g_10_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">31586000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2023_srt_CurrencyAxis_currency_EUR_CKOjyw5J1Um-SGovJ4ejYw"
      decimals="3"
      id="Narr_aKyQ2oz1S0qeWGGw42fF4Q"
      unitRef="Unit_Divide_CHF_EUR_tPOVrZBRTEKkYMGLwOeV4w">0.942</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2023_srt_CurrencyAxis_currency_USD_hCYaW1c4MEeE5iAbGkvRtw"
      decimals="3"
      id="Narr_uDitPxHAvUuVqALyrCkgYQ"
      unitRef="Unit_Divide_CHF_USD_FPtD7vL32kaT4HamUiI0aw">0.851</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2022_srt_CurrencyAxis_currency_EUR_gXKgjdqF5ECk_GGPperSYA"
      decimals="3"
      id="Narr_ZGQUaDYEeU2NiYEg4X9aSA"
      unitRef="Unit_Divide_CHF_EUR_tPOVrZBRTEKkYMGLwOeV4w">0.994</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="As_Of_12_31_2022_srt_CurrencyAxis_currency_USD_vlpq5OPW5UKEsC2zk4jyEg"
      decimals="3"
      id="Narr_s5pIKgIQBEqBeiutuZiBFA"
      unitRef="Unit_Divide_CHF_USD_FPtD7vL32kaT4HamUiI0aw">0.933</ifrs-full:ClosingForeignExchangeRate>
    <aciu:ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Group_7ht7pSyCckO_8Ube1bufyQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table summarizes the Company&#x2019;s short-term financial assets as of December&#160;31, 2023 and 2022:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Short-term financial assets due in one year or less&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 24,554&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 91,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 24,554&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 91,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;By currency&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;CHF&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 22,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 91,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;USD&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,554&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total short-term financial assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 24,554&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 91,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</aciu:ScheduleOfShortTermDepositsNotClassifiedAsCashEquivalentsTableTextBlock>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_Z7xbCWn9-UeyY-EmZwX3eA_4_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">24554000</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_2zoWvsTHUUqZ31m5VRZq4Q_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">91000000</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_ibdftW7QrEe0Q5GtKkHDHw_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">24554000</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_sEdhYQQOSkmi-92DXTgIvA_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">91000000</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents
      contextRef="As_Of_12_31_2023_srt_CurrencyAxis_currency_CHF_JfNLzHvH80WbSrRE58qKYg"
      decimals="-3"
      id="Tc_vg_aLtSa1E6vclvWtWq2Xw_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">22000000</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents
      contextRef="As_Of_12_31_2022_srt_CurrencyAxis_currency_CHF_9dJzU0_HhECZUKUigq7XAg"
      decimals="-3"
      id="Tc_D86FTiuBnEOlT3Hxp_CVkQ_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">91000000</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents
      contextRef="As_Of_12_31_2023_srt_CurrencyAxis_currency_USD_hCYaW1c4MEeE5iAbGkvRtw"
      decimals="-3"
      id="Tc_goIZrcy37U2_GSKuE_ZRzA_8_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2554000</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_nIhK7SK5NUWRUz7rivgZuQ_9_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">24554000</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_7L6tI5tL7U6u2JcwTawNhw_9_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">91000000</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
    <aciu:DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_JLtq8eYb1kWUlelVrHMf6A">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;9.&lt;/b&gt;&lt;/span&gt;Prepaid expenses and accrued income&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Prepaid expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,437&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,708&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Accrued income&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 246&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 408&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total prepaid expenses and accrued income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,683&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;5,116&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s prepaid expenses relate mainly to research contracts with down-payments at contract signature with the related activities to start or continue into 2024, prepaid expenses recorded as part of our cost sharing arrangement with Janssen, as well as prepaid payroll-related expenses. &lt;/p&gt;</aciu:DisclosureOfPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTextBlock>
    <aciu:DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_IWK5voygSkCflC9Fu0JQkw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Prepaid expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,437&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,708&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Accrued income&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 246&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 408&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total prepaid expenses and accrued income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,683&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;5,116&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</aciu:DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeIncludingContractAssetsTableTextBlock>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_zbE4VpAJvky2EJ8xP5KQLA_4_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">6437000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_v8cJDdciBE6Di4Sio46_FA_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4708000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_eini_tiK2UqJC8pzYBV88w_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">246000</ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets>
    <ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_zS7qFosjwEKqVG7sB8rI3g_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">408000</ifrs-full:CurrentAccruedIncomeIncludingCurrentContractAssets>
    <ifrs-full:CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_e1UK3gKAG0SPrDEmpabzig_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">6683000</ifrs-full:CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets>
    <ifrs-full:CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_HmZrsNqZMkma5xwmKShluQ_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">5116000</ifrs-full:CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets>
    <aciu:DisclosureOfAccountsReceivableTableTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_wQfOFgZOhkmEdx7YVU1geQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;10.&lt;/b&gt;&lt;/span&gt;Accounts receivable&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-indent:18pt;margin:0pt 0pt 8pt 0pt;"&gt;As of December 31, 2023, accounts receivable includes the CHF 14.8 million milestone payment due from Janssen as part of our collaboration and license agreement for reaching the programmed launch of the Phase 2b clinical study. This balance was not overdue as of December 31, 2023.&lt;/p&gt;</aciu:DisclosureOfAccountsReceivableTableTextBlock>
    <ifrs-full:CurrentTradeReceivables
      contextRef="As_Of_12_31_2023_ifrs-full_CounterpartiesAxis_aciu_JJInnovativeMedicineMember_vsI7p2vgBE6RmjAsmPNw1A"
      decimals="-5"
      id="Narr_IiNH4H_cUkygS-XxdcP3GQ"
      unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">14800000</ifrs-full:CurrentTradeReceivables>
    <aciu:DisclosureOfOtherCurrentReceivablesTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_8Phb2F1joUuZ7ZzfNb2uFQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;11.&lt;/b&gt;&lt;/span&gt;Other current receivables&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Other current receivable&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 45&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 124&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Swiss VAT&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 259&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 249&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Withholding tax&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 318&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total other current receivables&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 622&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 392&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The maturity of these assets is less than &lt;span style="-sec-ix-hidden:Hidden_JBrWQoLofk6Gyr7gN4-sJQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;3&#160;months&lt;/span&gt;&lt;/span&gt;. The Company considers the counterparty risk as low and the carrying amount of these receivables is considered to approximate their fair value.&lt;/p&gt;</aciu:DisclosureOfOtherCurrentReceivablesTextBlock>
    <aciu:DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_fM63yE5MA0CSXjJUMX8t-w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;min-height:0.0pt;margin:0pt;"&gt;&lt;span style="font-size:0pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:21.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Other current receivable&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 45&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 124&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Swiss VAT&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 259&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 249&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Withholding tax&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 318&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total other current receivables&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 622&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.42%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 392&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</aciu:DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock>
    <aciu:MiscellaneousOtherCurrentReceivables
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_fi_YXGYPfEyNfyJv4bEBiw_4_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">45000</aciu:MiscellaneousOtherCurrentReceivables>
    <aciu:MiscellaneousOtherCurrentReceivables
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_QkIAPoUoWEq67WX8cRvr3g_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">124000</aciu:MiscellaneousOtherCurrentReceivables>
    <ifrs-full:CurrentValueAddedTaxReceivables
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_fE8D_hhUsUm-flkWI3ZebQ_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">259000</ifrs-full:CurrentValueAddedTaxReceivables>
    <ifrs-full:CurrentValueAddedTaxReceivables
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_cYcf4IqtFEGHnz91V010tA_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">249000</ifrs-full:CurrentValueAddedTaxReceivables>
    <aciu:WithholdingTaxReceivables
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_53C8M05gyEydswc6GiNhXg_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">318000</aciu:WithholdingTaxReceivables>
    <aciu:WithholdingTaxReceivables
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_a7Vj-1RnAE6lotbNrCP26Q_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">19000</aciu:WithholdingTaxReceivables>
    <ifrs-full:OtherCurrentReceivables
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_mLxYPU71XUuWnf2G4dsOlw_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">622000</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_y6yagdnpYkGx8ome41rUCQ_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">392000</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_YpJUwUvNgEC5XDVvEN2A9A">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;12.&lt;/b&gt;&lt;/span&gt;Share capital&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December&#160;31, 2023 and 2022, the issued share capital amounted to CHF 2,088,823 and CHF 1,796,675, respectively, and is composed of outstanding common shares of 99,197,829 and 83,620,364, respectively, and treasury shares of 5,243,958 and 6,214,021, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The table below summarizes the Company&#x2019;s capital structure:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.76%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Common&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Treasury&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Share&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Share&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Treasury&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;capital&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;premium&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 89,700,630&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,221,617)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,794&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 431,251&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (124)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,596&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (8)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Issuance of shares &#x2013; incentive plans, net of transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 133,755&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.76%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 80&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 89,834,385&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,214,021)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,797&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 431,323&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (124)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Proceeds from public offerings, net of underwriting fees and transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,300,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 286&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 40,249&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 970,063&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,631&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Issuance of shares &#x2013; incentive plans, net of transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 307,402&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.76%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 704&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 104,441,787&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,243,958)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.76%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,089&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 474,907&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (105)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The common shares and treasury shares have nominal values of CHF 0.02 per share. All shares have been fully paid. These treasury shares held by the Company are not considered outstanding shares as of December&#160;31, 2023 or 2022.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Authorized capital&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s Board of Directors is authorized to increase the share capital, in one or several steps, until June 24, 2024, by a maximum amount of CHF&#160;114,000 by issuing a maximum of 5,700,000 registered shares with a par value of CHF&#160;0.02 each, to be fully paid up. An increase of the share capital (i) by means of an offering underwritten by a financial institution, a syndicate or another third party or third parties, followed by an offer to the then-existing shareholders of the Company and (ii) in partial amounts, shall also be permissible.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Conditional share capital for financing and other purposes&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The Company&#x2019;s share capital may be increased by a maximum aggregate amount of CHF&#160;100,000&#160;through the issuance of a maximum of 5,000,000 registered shares, payable in full, each with a nominal value of CHF&#160;0.02&#160;per share, through the exercise of conversion and/or option or warrant rights granted in connection with bonds or similar &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;instruments, issued or to be issued by the Company or by subsidiaries of the Company, including convertible debt instruments.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Conditional share capital for employee benefit plans&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s share capital may be increased by a maximum aggregate amount of CHF&#160;93,795&#160;through the issuance of not more than&#160;4,689,750&#160;common shares, payable in full, each with a nominal value of CHF&#160;0.02&#160;per share, by the exercise of options rights that have been granted to employees, consultants, members of the board of directors, or other person providing services to the Company or a subsidiary. As of December 31, 2023, 97,540 of our common shares, which were issued upon the exercise of options and restricted share units, have not yet been registered with the commercial register of the Canton of Vaud.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Follow-On Offering&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;On December 19, 2023, the Company announced that it had closed an underwritten offering of 14,300,000 common shares, resulting in gross proceeds of approximately USD 50.1 (CHF 43.8) million. Net underwriting fees and transaction costs totaled CHF 3.3 million for net proceeds of CHF 40.5 million. Transaction costs associated with these offerings and related to the issuance of new shares were charged directly against the share premium account thereby reducing the total equity reported.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Shelf registration statement&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;On April&#160;28, 2021, the Company filed a Shelf Registration Statement on Form&#160;F-3 (Reg. No.&#160;333-255576) (the &#x201c;Shelf Registration Statement&#x201d;) with the SEC. The Shelf Registration Statement was declared effective by the SEC on May&#160;5, 2021.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Shelf Registration Statement allows the Company to offer and sell, from time to time, up to USD 350,000,000 of common shares, debt securities, warrants, purchase contracts, units, subscription rights or any combination of the foregoing in one or more future public offerings. The terms of any future offering would be determined at the time of the offering and would be subject to market conditions and approval by the Company&#x2019;s Board of Directors. Any offering of securities covered by the Shelf Registration Statement will be made only by means of a written prospectus and prospectus supplement authorized and filed by the Company.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;At the market equity offering&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In Q3 2020, AC Immune issued 5,000,000 common shares with a nominal value of CHF 0.02, which became treasury shares. The Company also established an &#x201c;at the market offering program&#x201d; (&#x201c;ATM&#x201d;) for the sale of up to USD 80.0 (CHF 68.1) million worth of our common shares issued from time to time by entering into an Open Market Sale Agreement (&#x201c;Sales Agreement&#x201d;) with Jefferies LLC (&#x201c;Jefferies&#x201d;) as the sales agent under a prior registration statement on Form&#160;F-3 which expired in Q2 2021.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In Q2 2021, the Company filed a new registration statement on Form&#160;F-3 and an accompanying prospectus supplement in order to renew its ATM program. The Company also entered into a second Open Market Sale Agreement (the &#x201c;new Sales Agreement&#x201d;) with Jefferies to continue the ATM program.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In Q3, 2021, the Company issued 2,393,160 common shares with a nominal value of CHF 0.02 to be held as treasury shares.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Through December 31, 2023, the Company has sold 2,149,202 common shares previously held as treasury shares pursuant to the new Sales Agreement, raising USD 16.3 (CHF 14.8) million, net of underwriting fees and transaction costs. We have paid commissions to Jefferies totaling USD 0.5 (CHF 0.5) million through December 31, 2023, for share issuances in accordance with our ATM programs.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Convertible note agreement&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Concurrently with the Asset Purchase Agreement, the Company entered into two separate Convertible Note&#160;Agreements with entities affiliated with each of Athos Service GmbH and First Capital Partner GmbH, both of which entities are shareholders of Affiris.&#160;Each Convertible Note&#160;Agreement provided for the sale of an unsecured subordinated Convertible Note&#160;of the Company with an aggregate principal amount of USD 12.5 (CHF 11.7) million for total net proceeds of USD 25 (CHF 23.5) million.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In 2021, the affiliated entities exercised their options to convert their respective USD 12.5 (CHF 11.7) million notes. As a result of these conversions, 1,513,317 &lt;span style="-sec-ix-hidden:Hidden_RHGPfxiSZ0Wm65Cc6mThNQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;common&lt;/span&gt;&lt;/span&gt; shares were issued to each Investor, totaling 3,026,634 common shares. The Company recorded an increase to its share capital for the nominal value of its shares and share premium for the difference associated with settlement of this liability. The Company also settled its derivative financial assets, which were embedded conversion features associated with the convertible debt, via an offset to its share premium. These convertible notes and derivative financial assets were fully settled in 2021 and there is no further equity or cash consideration due to the affiliated entities thereunder.&lt;/p&gt;</ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory>
    <ifrs-full:IssuedCapital
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_Aj1yGEPLv0OsHOLlVg5leg"
      decimals="0"
      id="Narr_STbaD7VQKUugRw_3tQVd9g"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2088823</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_HTCG4hUqoUOTQ98ao4z1DA"
      decimals="0"
      id="Narr_J2KSbMlLN0W4qkIPxhaUBg"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1796675</ifrs-full:IssuedCapital>
    <ifrs-full:NumberOfSharesIssued
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_Aj1yGEPLv0OsHOLlVg5leg"
      decimals="0"
      id="Narr__z0C5kpebEmBI3MIjlsTlA"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">99197829</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_HTCG4hUqoUOTQ98ao4z1DA"
      decimals="0"
      id="Narr_Y7tJv8UXjkeog59p-gzXyw"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">83620364</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="0"
      id="Narr_mSx61I_wek2LPQDQu2bZhw"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">5243958</ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates>
    <ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="0"
      id="Narr_Mm6twDKQk0GRa8bDtVNpDQ"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">6214021</ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates>
    <ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_Xpo18v2ltU--zqnsgdB-dQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The table below summarizes the Company&#x2019;s capital structure:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.76%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Common&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Treasury&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Share&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Share&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Treasury&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;capital&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;premium&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 89,700,630&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,221,617)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,794&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 431,251&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (124)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,596&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (8)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Issuance of shares &#x2013; incentive plans, net of transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 133,755&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.76%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 80&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 89,834,385&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (6,214,021)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,797&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 431,323&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (124)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Proceeds from public offerings, net of underwriting fees and transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,300,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 286&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 40,249&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 970,063&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.76%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,631&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.07%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Issuance of shares &#x2013; incentive plans, net of transaction costs&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 307,402&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.76%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 704&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:50.07%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 104,441,787&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,243,958)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:5.76%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,089&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 474,907&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (105)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_FsucBjEq20ymDerczI9DZw"
      decimals="INF"
      id="Tc_lG6GGGL9YkSwb3aW5FpMYg_4_2"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">89700630</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_zn6P6shP0UCItAsEakOVgw"
      decimals="INF"
      id="Tc_OStCuordckW1qoQMTF4dXQ_4_4"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">6221617</ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_M0EemXYDV0aBwNXVy2D5wA"
      decimals="-3"
      id="Tc_VBkRrMeUrEuL81THNQAlTQ_4_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1794000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_qGLJKw1KlEeLkJJRaoX5Rw"
      decimals="-3"
      id="Tc_9G5TIaSMSk-BgblFSgtpLQ_4_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">431251000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2021_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_YIPudTTsa0KFHmU0vwZo5w"
      decimals="-3"
      id="Tc_1ZcrJSlMAUGDzr92ktHf0Q_4_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-124000</ifrs-full:Equity>
    <aciu:DecreaseInNumberOfTreasurySharesFromSalesOrIssuance
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_IkPNS4jBTECfjFa4xwgBQQ"
      decimals="INF"
      id="Tc_4_6AcQDJGE2K6glR_A9AUw_5_4"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">7596</aciu:DecreaseInNumberOfTreasurySharesFromSalesOrIssuance>
    <aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_SWcjwMgDv0e8bZSucJUMHQ"
      decimals="-3"
      id="Tc_AYmmKBvwfkC6PlNn-xLOfw_5_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-8000</aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_tP2T60QRpUq6QbSwDp-rdw"
      decimals="-3"
      id="Tc_SGKP2aP-s0KFGh0sEP0tow_5_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_FjH3oKJjQkm4GluJmDL1ig"
      decimals="INF"
      id="Tc_JidavHhESkCF_c4r1_eeVg_6_2"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">133755</aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans>
    <aciu:IncreaseThroughSharesIssuedUnderIncentivePlans
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_I-ActLB-JUyJBWOVjhi2gA"
      decimals="-3"
      id="Tc_cXH8r-uMRk-kQZvwio8fsw_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3000</aciu:IncreaseThroughSharesIssuedUnderIncentivePlans>
    <aciu:IncreaseThroughSharesIssuedUnderIncentivePlans
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_SWcjwMgDv0e8bZSucJUMHQ"
      decimals="-3"
      id="Tc_jU-ENS2md0SMErZ1t2p0pQ_6_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">80000</aciu:IncreaseThroughSharesIssuedUnderIncentivePlans>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_HTCG4hUqoUOTQ98ao4z1DA"
      decimals="INF"
      id="Tc_BiF68naQhkGn4TtCd4E0NQ_7_2"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">89834385</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_3hsE5ajj2EqsW8OwqIjDRQ"
      decimals="INF"
      id="Tc_o06qHYjvGEKZoZpA3Li7GA_7_4"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">6214021</ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_BQ7VKwgtOkWlTCNJHXciww"
      decimals="-3"
      id="Tc_09KKVf89OUun3Pddomp1PQ_7_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1797000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EBAKwd98FkqCN-vAl_B6vg"
      decimals="-3"
      id="Tc_i997QNej20qnTo-dgkuO2Q_7_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">431323000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_gyBgxwFR8kautCu5uepUmg"
      decimals="-3"
      id="Tc_TtZXKsQ6j0GF2mt5luMbNA_7_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-124000</ifrs-full:Equity>
    <aciu:ProceedsFromPublicOfferingsNetOfUnderwritingFeesAndTransactionEquityShares
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_6KGZQVq8r0a0vl5N0ZyV-g"
      decimals="INF"
      id="Tc_oOc03tsWRECXuOLXPJ8fLQ_8_2"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">14300000</aciu:ProceedsFromPublicOfferingsNetOfUnderwritingFeesAndTransactionEquityShares>
    <aciu:SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_orlAcRiayEeFUpKo8cWUgA"
      decimals="-3"
      id="Tc_bTYq85LjLkyOT-kgPWinrA_8_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">286000</aciu:SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost>
    <aciu:SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EY1gzyuyDkGmaP05xj1GQw"
      decimals="-3"
      id="Tc_Mx4MQVbbaECNdFCi14y9hA_8_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">40249000</aciu:SaleOrIssueOfPublicOfferingsNetOfUnderwritingFeesTransactionCost>
    <aciu:DecreaseInNumberOfTreasurySharesFromSalesOrIssuance
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_QSzyXEXHe06wEWxr_MXXgQ"
      decimals="INF"
      id="Tc_nqepc8mXRUq-u6mz3xdAxg_9_4"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">970063</aciu:DecreaseInNumberOfTreasurySharesFromSalesOrIssuance>
    <aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EY1gzyuyDkGmaP05xj1GQw"
      decimals="-3"
      id="Tc_3LTtxFu6RUm5eJ4_OBD99w_9_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2631000</aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_Xg5G0gTL6EuVoA1i-tphyA"
      decimals="-3"
      id="Tc_0GZMPMiXrEyGhiA_Z9E9mA_9_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">19000</aciu:SaleOrIssueOfTreasurySharesNetOfUnderwritingFeesAndTransactionCosts>
    <aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_6KGZQVq8r0a0vl5N0ZyV-g"
      decimals="INF"
      id="Tc_8qdWcER1n0SLXtQwVJYy8w_10_2"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">307402</aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans>
    <aciu:IncreaseThroughSharesIssuedUnderIncentivePlans
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_orlAcRiayEeFUpKo8cWUgA"
      decimals="-3"
      id="Tc_E4xO20ss2ESUfUVpNU0B5w_10_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">6000</aciu:IncreaseThroughSharesIssuedUnderIncentivePlans>
    <aciu:IncreaseThroughSharesIssuedUnderIncentivePlans
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_EY1gzyuyDkGmaP05xj1GQw"
      decimals="-3"
      id="Tc_EhbkYwKNtUSBYGcSCAwxjw_10_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">704000</aciu:IncreaseThroughSharesIssuedUnderIncentivePlans>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_OrdinarySharesMember_Aj1yGEPLv0OsHOLlVg5leg"
      decimals="INF"
      id="Tc_vM6qOLJYzk69O4eHT6Rk6A_11_2"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">104441787</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_ifrs-full_TreasurySharesMember_axPzzAyDNE2qnFNbJxmuAw"
      decimals="INF"
      id="Tc_xDHxB4GBDU-gckvYpI9KCw_11_4"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">5243958</ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_IssuedCapitalMember_BScHwbOd1k6qH5tEPUdwhw"
      decimals="-3"
      id="Tc_on3mY5z3SE6lBinb53dhPw_11_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2089000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_SharePremiumMember_uUyHwiQf7UuXXrnxpFOqyA"
      decimals="-3"
      id="Tc_oC0zXpVYKE2CYIZ8_hwIZg_11_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">474907000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="As_Of_12_31_2023_ifrs-full_ComponentsOfEquityAxis_ifrs-full_TreasurySharesMember_nZ4TKeIWaU2aelb5_LYCwg"
      decimals="-3"
      id="Tc_Tobs506p0EqYcvrvICPWgw_11_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-105000</ifrs-full:Equity>
    <ifrs-full:ParValuePerShare
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="2"
      id="Narr_B6srjBBOrEu8XG-B9-PFoQ"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">0.02</ifrs-full:ParValuePerShare>
    <aciu:AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="0"
      id="Narr_F7Wqkm3yRUeb4_YZrzcjJw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">114000</aciu:AdditionalShareCapitalThatBoardOfDirectorsAreAuthorizedToIssue>
    <aciu:NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="INF"
      id="Narr_BUI74o7gOkm-bAMGyt9SfQ"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">5700000</aciu:NumberOfAdditionalSharesThatBoardOfDirectorsAreAuthorizedToIssue>
    <ifrs-full:ParValuePerShare
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="2"
      id="Narr_fYktXDhnMESLnIOKMe9wvQ"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">0.02</ifrs-full:ParValuePerShare>
    <aciu:PotentialIncreaseIsEquityThroughConversionOfDebtInstruments
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_pAWtnvgYa0iVnloXstoYVQ"
      decimals="0"
      id="Narr_xloIudEz6UeC_qMcIwWECw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">100000</aciu:PotentialIncreaseIsEquityThroughConversionOfDebtInstruments>
    <aciu:PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_W22DIGpxCU2PCY_voUKfnA"
      decimals="INF"
      id="Narr_ZHIHBbVFeU6i6J7pfrYXMw"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">5000000</aciu:PotentialNumberOfSharesIssuedFromConversionOfDebtInstruments>
    <ifrs-full:ParValuePerShare
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForFinancingAndOtherPurposesMember_IjKN6eosDESMY_UjEdsFrQ"
      decimals="2"
      id="Narr_s94sn1RFKkSQeXE_Qm_OLw"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">0.02</ifrs-full:ParValuePerShare>
    <aciu:PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_bdFBuO5wp0WWfm-NR5fv1A"
      decimals="0"
      id="Narr_vLKMylyDk0yhEZOBnm5AjA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">93795</aciu:PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions>
    <aciu:PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_bdFBuO5wp0WWfm-NR5fv1A"
      decimals="INF"
      id="Narr_9RJ9bA3qx0yIEpApz8S6BQ"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">4689750</aciu:PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions>
    <ifrs-full:ParValuePerShare
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember_Ob3729tHb0aScFgPO3DcVw"
      decimals="2"
      id="Narr_q6DHoWZI-E2UXBWlCAiqCQ"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">0.02</ifrs-full:ParValuePerShare>
    <aciu:NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="INF"
      id="Narr_LbdmOuxgvUeZQCueOQHKmg"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">97540</aciu:NumberOfSharesIssuedUponExerciseOfOptionsAndRestrictedShareUnits>
    <aciu:NumberOfSharesIssuedDuringPeriod
      contextRef="Duration_12_19_2023_To_12_19_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_FollowOnOfferingMember_TqOyBPKfi0OoLSsHlenN0Q"
      decimals="INF"
      id="Narr_9ElKGIce7UC1L7bRtH5DvA"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">14300000</aciu:NumberOfSharesIssuedDuringPeriod>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="Duration_12_19_2023_To_12_19_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_FollowOnOfferingMember_TqOyBPKfi0OoLSsHlenN0Q"
      decimals="-5"
      id="Narr_MsdDTMlp9UCFe2NWXO3faA"
      unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">50100000</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="Duration_12_19_2023_To_12_19_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_FollowOnOfferingMember_TqOyBPKfi0OoLSsHlenN0Q"
      decimals="-5"
      id="Narr_t_k4MiE2m0GRQQkOewERwA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">43800000</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="Duration_12_19_2023_To_12_19_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_FollowOnOfferingMember_TqOyBPKfi0OoLSsHlenN0Q"
      decimals="-5"
      id="Narr_m72hZuComUOD3GM2spEESw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3300000</ifrs-full:ShareIssueRelatedCost>
    <aciu:NetProceedsFromIssuanceOfShares
      contextRef="Duration_12_19_2023_To_12_19_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_FollowOnOfferingMember_TqOyBPKfi0OoLSsHlenN0Q"
      decimals="-5"
      id="Narr_nyFQYXQKZUmHjAaRPhkIcQ"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">40500000</aciu:NetProceedsFromIssuanceOfShares>
    <aciu:CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement
      contextRef="Duration_4_28_2021_To_4_28_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_wJ7EdKp2Ok2kaiso3_KHVw"
      decimals="0"
      id="Narr_D82fCjRXbUSL9AFQL3lAYw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">350000000</aciu:CapitalAuthorizedToBeIssuedUnderShelfRegistrationStatement>
    <aciu:IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares
      contextRef="Duration_7_1_2020_To_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_-1G5nnVneEOy-bPbsmwMqw"
      decimals="INF"
      id="Narr_Tjh5_JhTH0aGkkttmIAhKg"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">5000000</aciu:IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares>
    <ifrs-full:ParValuePerShare
      contextRef="As_Of_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_bRpB8WDxq0WCH-NheX05aQ"
      decimals="2"
      id="Narr_qCOw2oDt1UmbZaBVVW_Njw"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">0.02</ifrs-full:ParValuePerShare>
    <aciu:CommonSharesAuthorizedForIssuanceSalesInInOpenMarket
      contextRef="Duration_7_1_2020_To_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_-1G5nnVneEOy-bPbsmwMqw"
      decimals="-5"
      id="Narr_fcCNFvfXwkWSK3pMdRdzmg"
      unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">80000000.0</aciu:CommonSharesAuthorizedForIssuanceSalesInInOpenMarket>
    <aciu:CommonSharesAuthorizedForIssuanceSalesInInOpenMarket
      contextRef="Duration_7_1_2020_To_9_30_2020_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_-1G5nnVneEOy-bPbsmwMqw"
      decimals="-5"
      id="Narr_ZBIbEB8jYEemvEHu98VwtQ"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">68100000</aciu:CommonSharesAuthorizedForIssuanceSalesInInOpenMarket>
    <aciu:IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares
      contextRef="Duration_7_1_2021_To_9_30_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_I1T_yUrSRkSlCVKjmbusrw"
      decimals="0"
      id="Narr_ybIU4FXHE0ax7jRnk2UnlA"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">2393160</aciu:IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares>
    <ifrs-full:ParValuePerShare
      contextRef="As_Of_9_30_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_AtTheMarketEquityOfferingMember_JlWBK3HwBk-ZtFV9txVOUw"
      decimals="2"
      id="Narr_iLY_ehUhVUSFW_KBM5DuBQ"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">0.02</ifrs-full:ParValuePerShare>
    <aciu:SaleOrIssueOfTreasurySharesShares
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_vK1WQ4fPI0adSnT7gMpfmg"
      decimals="INF"
      id="Narr_WAdunjWc7kK75cbiwN00kQ"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">2149202</aciu:SaleOrIssueOfTreasurySharesShares>
    <ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_vK1WQ4fPI0adSnT7gMpfmg"
      decimals="-5"
      id="Narr_j7PVfVtNJkqgweqj4SWvIw"
      unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">16300000</ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares>
    <ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_vK1WQ4fPI0adSnT7gMpfmg"
      decimals="-5"
      id="Narr_7QP9wns8oUKk7UHq8t7Xhw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">14800000</ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares>
    <aciu:CommissionsPaidForIssuanceOrdinaryShares
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_vK1WQ4fPI0adSnT7gMpfmg"
      decimals="-5"
      id="Narr_7_Qkg9hnd0SjnmJ8Q2RwiQ"
      unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">500000</aciu:CommissionsPaidForIssuanceOrdinaryShares>
    <aciu:CommissionsPaidForIssuanceOrdinaryShares
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ClassesOfShareCapitalAxis_aciu_SecondOpenMarketSalesAgreementMember_vK1WQ4fPI0adSnT7gMpfmg"
      decimals="-5"
      id="Narr_Wv1DuUFj-E6hco84L-8GgQ"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">500000</aciu:CommissionsPaidForIssuanceOrdinaryShares>
    <aciu:NumberOfConvertibleNoteAgreements
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_gz-ausjwKkGgVkKLeTU3Ng"
      decimals="INF"
      id="Narr_KQRSohtmeUKdU_teA9szUQ"
      unitRef="Unit_Standard_agreement_5eg0SdvY8kqQI3hiVdpf-Q">2</aciu:NumberOfConvertibleNoteAgreements>
    <aciu:AggregatePrincipalAmountOfEachConvertibleNote
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_gz-ausjwKkGgVkKLeTU3Ng"
      decimals="-5"
      id="Narr_IsEYgb56vkChzBHVZWaswQ"
      unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">12500000</aciu:AggregatePrincipalAmountOfEachConvertibleNote>
    <aciu:AggregatePrincipalAmountOfEachConvertibleNote
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_gz-ausjwKkGgVkKLeTU3Ng"
      decimals="-5"
      id="Narr_0TAbFIkSx0m1u4LHXWFhyw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">11700000</aciu:AggregatePrincipalAmountOfEachConvertibleNote>
    <aciu:ProceedsFromIssueOfConvertibleDebt
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_srt_StatementScenarioAxis_aciu_IfNotesAreConvertedMember_mHIt3iiUYEiJe-LbY2MlYg"
      decimals="-6"
      id="Narr_QMJK3gKgoU2KaGFMCPpu5A"
      unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">25000000</aciu:ProceedsFromIssueOfConvertibleDebt>
    <aciu:ProceedsFromIssueOfConvertibleDebt
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_srt_StatementScenarioAxis_aciu_IfNotesAreConvertedMember_mHIt3iiUYEiJe-LbY2MlYg"
      decimals="-5"
      id="Narr_tbFs0HFi-EGrLxdBLPs5kg"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">23500000</aciu:ProceedsFromIssueOfConvertibleDebt>
    <aciu:ProceedsFromConversionOfConvertibleDebtPerIndividualNote
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_B7geHyH670-gkbX2o14NvA"
      decimals="-5"
      id="Narr_F-hwV43XS0Oo_ieXGx0sdA"
      unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">12500000</aciu:ProceedsFromConversionOfConvertibleDebtPerIndividualNote>
    <aciu:ProceedsFromConversionOfConvertibleDebtPerIndividualNote
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_B7geHyH670-gkbX2o14NvA"
      decimals="-5"
      id="Narr_NjADuL9GGkmV9bRqAMPQUg"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">11700000</aciu:ProceedsFromConversionOfConvertibleDebtPerIndividualNote>
    <aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_ifrs-full_CounterpartiesAxis_aciu_AthosServiceGmbHMember_G1spMOk49EyTvfHJIEKQUA"
      decimals="0"
      id="Narr_pqdKGp9rgkiACO0QZtcjMw"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">1513317</aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt>
    <aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_B7geHyH670-gkbX2o14NvA"
      decimals="0"
      id="Narr_XGjQPdOia0mN2YKW0DdYMw"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">3026634</aciu:IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt>
    <aciu:OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements
      contextRef="As_Of_12_31_2021_ifrs-full_ClassesOfShareCapitalAxis_aciu_ConvertibleNoteAgreementMember_gz-ausjwKkGgVkKLeTU3Ng"
      decimals="0"
      id="Narr_onR2pP-cj0yk1Wjd23oAHw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</aciu:OutstandingEquityOrCashConsiderationDueUnderConvertibleNoteAgreements>
    <aciu:DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_yeUKHJkr9Uii5KugOlTqFw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;13.&lt;/b&gt;&lt;/span&gt;Trade and other payables and accrued expenses&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Trade and other payables &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,679&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 929&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total trade and other payables&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,679&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 929&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Accrued research and development costs &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,722&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5,360&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Accrued payroll expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,649&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,898&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Other accrued expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,716&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,159&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total accrued expenses&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 11,087&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,417&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The increase in accrued payroll expenses is mostly due to the timing of certain payroll-related payments and an increase in performance-related remuneration. Additionally, CHF 0.4 million was recognized as accrued stamp duty within other accrued expenses for the issuance of shares as part of the Company&#x2019;s follow-on offering as of December 31, 2023.&lt;/p&gt;</aciu:DisclosureOfTradeAndOtherPayablesAndAccruedExpensesTextBlock>
    <aciu:DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_17cZcm5zdESdvVSOECQbvQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.53%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Trade and other payables &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,679&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 929&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total trade and other payables&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,679&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 929&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Accrued research and development costs &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,722&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5,360&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Accrued payroll expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,649&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,898&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Other accrued expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,716&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,159&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:73.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total accrued expenses&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 11,087&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.63%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.45%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,417&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</aciu:DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_1Oqsd_UiVE-XQQzk7z7VFg_4_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1679000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_Ospn8-d4wka4CY_I12gWuA_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">929000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_WvqaNK_Y6U2EgXyNnFJxJg_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1679000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_ODP_FxouN0CDdPX-nc3oWA_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">929000</ifrs-full:TradeAndOtherCurrentPayables>
    <aciu:CurrentAccruedResearchAndDevelopmentCosts
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_krIFUMy2I0WxB_GgS6oDsA_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4722000</aciu:CurrentAccruedResearchAndDevelopmentCosts>
    <aciu:CurrentAccruedResearchAndDevelopmentCosts
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_iOhvRoV4vEyFX6GMeNnNUQ_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">5360000</aciu:CurrentAccruedResearchAndDevelopmentCosts>
    <ifrs-full:ShorttermEmployeeBenefitsAccruals
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_3AXSCrU_BE-gaQ5-ahp_zw_8_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4649000</ifrs-full:ShorttermEmployeeBenefitsAccruals>
    <ifrs-full:ShorttermEmployeeBenefitsAccruals
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_RxMrQQKbpk6EoGW4d6ILwA_8_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2898000</ifrs-full:ShorttermEmployeeBenefitsAccruals>
    <aciu:OtherAccruedExpenses
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_94-pK_yhIkaqp3d7EXzv9A_9_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1716000</aciu:OtherAccruedExpenses>
    <aciu:OtherAccruedExpenses
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_hA-T-aJvO0abZ9C4mBCyQA_9_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1159000</aciu:OtherAccruedExpenses>
    <ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_YhRzrGe8LEKy0UppUT_XDA_10_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">11087000</ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities>
    <ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_bO2vEWfUVEeBG61ghMUBUQ_10_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">9417000</ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities>
    <aciu:AccruedStampDuty
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-5"
      id="Narr_A6o0aml6C0CymsGQFe_vXA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">400000</aciu:AccruedStampDuty>
    <ifrs-full:DisclosureOfRevenueExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_LC1JdTUSnkCBH58-47IFcA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;14.&lt;/b&gt;&lt;/span&gt;Contract revenues&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;years ended December&#160;31, 2023, 2022 and 2021, AC Immune generated contract revenues of CHF 14.8 million, CHF 3.9 million and nil, respectively. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following tables provide contract revenue amounts from its LCAs for the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Janssen&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,800&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Life Molecular Imaging&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,935&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Other&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total contract revenues&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,801&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,935&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;During the&#160;years ended December&#160;31, 2023, 2022 and 2021, the Company recognized the following contract revenues as a result of changes in the contract asset and the contract liability balances in the respective periods:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Revenues recognized in the period from:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Amounts included in the contract liability at the beginning of the period &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Performance obligations satisfied in previous periods&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,801&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,935&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;14.1&lt;/b&gt;&lt;/span&gt; Licensing and collaboration agreements&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;"&gt;Morphomer Tau small molecule&#160;&#x2013; 2018 license agreement with Eli Lilly and Company&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In December&#160;2018, we entered into an exclusive, worldwide licensing agreement with Eli Lilly and Company (Lilly) to research and develop Morphomer Tau small molecules for the treatment of AD and other neurodegenerative diseases. More specifically, this is an exclusive license with the right to Lilly to grant sublicenses under the ACIU Patents, the ACIU know-how, and ACIU&#x2019;s interests in the Joint Patents and the joint know-how to Exploit the Licensed Compounds and Licensed Products. The agreement became effective on January&#160;23, 2019 (the &#x201c;effective date&#x201d;) when the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, expired. In Q3 2019, the Company and Lilly entered into the first amendment to divide the first discretionary milestone payment under the agreement of CHF 60 million into two installments, with the first CHF 30 million paid in Q3 2019 and the second CHF 30 million to be paid on or before March&#160;31, 2020 unless Lilly terminated the agreement earlier. In Q1 2020, the Company and Lilly entered into a second amendment to replace the second CHF 30 million to be paid on or before March&#160;31, 2020 with two milestone payments, one of CHF 10 million to be paid on or before March&#160;31, 2020 and the other of CHF 60 million following the first patient dosed in a Phase 2 clinical study of a licensed product in the U.S. or EU.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Per the terms of the agreement, the Company received an initial upfront payment of CHF 80 million in Q1 2019 for the rights granted by the Company to Lilly. To date, the Company has completed a Phase 1 clinical study with ACI-3024.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Additionally, the Company and Lilly have continued candidate characterization across the research program, identifying new and highly differentiated candidates with desired cerebrospinal fluid exposure and selectivity for pathological aggregated Tau. These will be broadly developed in Tau-dependent neurodegenerative diseases by Lilly. Lilly is responsible for leading and funding further clinical development and will retain global commercialization rights for all indications.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Per the terms of the agreement, the Company may become eligible to receive additional milestone payments totaling up to approximately CHF 880 million for clinical and regulatory milestones and CHF 900 million upon achievement of certain commercial milestones. In addition to milestones, we will be eligible to receive royalties on sales at a&#160;percentage rate ranging from the low double-digits to the mid-teens. The agreement will terminate by the date of expiration of the last royalty term for the last licensed product. However, under the terms of the agreement, Lilly may terminate the agreement at any time by providing &lt;span style="-sec-ix-hidden:Hidden_9VUHy5QxNUOhdyJftjpzFw;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;3&#160;months&lt;/span&gt;&lt;/span&gt;&#x2019; prior notice to us.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that Lilly is a customer. The Company identified the following significant performance obligations under the contract: (i)&#160;a right-of-use license and (ii)&#160;research and development activities outlined in the development plan. Per the agreement, the Company was responsible for the preclinical and Phase 1 activities for the first clinical candidate, ACI-3024, which the Company determined was distinct and capable of being completed by Lilly or a third party. Preclinical activities for which AC Immune was responsible prior to their completion in Q2 2019 included final manufacturing of materials for use in the regulatory submission of the protocol and in the Phase 1 study. For the completed Phase 1, AC Immune was responsible for leading the study design, obtaining relevant regulatory agency approvals, arranging necessary third-party contracts, completing patient selection, ensuring patient treatment, following up with patients, drafting the clinical study report &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;development and other relevant clinical activities to ensure that the primary objective of the study was completed. The Company used CMOs for certain of its preclinical activities and CROs to complete certain Phase 1 activities and to issue the final clinical study report.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Finally, per the agreement, each party has three representatives on a joint steering committee (JSC). Depending upon the agenda, additional field experts can attend the JSC to provide the technical and scientific contribution required. The JSC meets on a regular basis depending on agreements between the representatives. The JSC is responsible for serving as the forum to (i)&#160;discuss, review and approve certain activities by reviewing and discussing the development progress with updates on back-up candidates, (ii)&#160;discuss, review and approve all amendments to the global development plan, (iii)&#160;periodically discuss and review commercialization of licensed products and (iv)&#160;review and approve reports related to development costs among other activities. The JSC is intended to ensure that communication between the parties remains consistent and that the development plan is progressing as intended.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The valuation of each performance obligation involves estimates and assumptions with revenue recognition timing to be determined by either delivery or the provision of services.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company used the residual approach to estimate the selling price for the right-of-use license and an expected cost plus margin approach for estimating the research and development activities. The right-of-use license was delivered on the effective date. The research and development activities were delivered over time as the services were performed. For these services, revenue was recognized over time using the input method, based on costs incurred to perform the services, as the level of costs incurred over time is thought to best reflect the transfer of services to Lilly. The Company determined the value of the research and development activities to be CHF 6.9 million and deferred this balance from the effective date. To date, the Company has cumulatively recognized CHF 6.9 million in contract revenue, resulting in no deferred income (contract liability) on the consolidated balance sheets. The remaining CHF 73.1 million from the upfront payment was allocated to the right-of-use license and recognized on the effective date.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At inception of the agreement, none of the clinical, regulatory or commercial milestones had been included in the transaction price, as all milestone amounts were fully constrained. To date, the Company has recognized CHF 40 million from milestone payments triggered in Q3 2019 and Q1 2020 related to the right-of-use license for intellectual property as there were no further constraints related to these milestones. In assessing that future clinical, regulatory or commercial milestones are fully constrained, the Company considered numerous factors to determine that these milestones are not highly probable to obtain, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials and the licensee&#x2019;s efforts. Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as they were determined to relate predominantly to the license granted to Lilly and therefore have also been excluded from the transaction price. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;years ended December&#160;31, 2023, 2022 and 2021, we have recognized no revenues from this arrangement.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;"&gt;Tau active immunotherapy in AD&#160;&#x2013; 2014 agreement with Janssen Pharmaceuticals,&#160;Inc.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;In December&#160;2014, we entered into an agreement with Janssen Pharmaceuticals, Inc. (Janssen), part of the Janssen Pharmaceutical Companies of Johnson &amp;amp; Johnson, to develop and commercialize therapeutic anti-Tau active immunotherapies for the treatment of AD and potentially other Tauopathies. The value of this collaboration is potentially up to CHF 500 million and includes upfront and clinical, regulatory and commercial milestones. In addition to milestones, we will be eligible to receive royalties on sales at a&#160;percentage rate ranging from the low-double digits to the mid-teens for the ACI-35.030 active immunotherapy program. In April&#160;2016, July&#160;2017, January&#160;2019, November&#160;2019, December 2022, and November 2023, the companies entered into the first, second, third, fourth, fifth and sixth amendments, respectively. These amendments allow for the alignment of certain payment and activity provisions with the Development Plan and Research Plan activities. We and Janssen have completed the co-development of the second-generation lead active immunotherapies, ACI-35.030 and JACI-35.054, through Phase 1b/2a. In November 2022, it was announced that ACI-35.030 was selected to advance into further development based on interim data from the ongoing Phase 1b/2a trial. In December 2023, it was announced that Janssen has programmed the launch of Phase 2b clinical &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="white-space:pre-wrap;"&gt;study to evaluate ACI-35.030 (JNJ-64042056) in patients with preclinical AD, those individuals not yet showing symptoms. AC Immune and Janssen will jointly share research and development costs until the completion of the first Phase 2b (AC Immune&#x2019;s contribution to the first Phase 2b trial is capped). From Phase 2b and onwards, Janssen will assume responsibility for the clinical development, manufacturing and commercialization of ACI-35.030.  &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Under the terms of the agreement, Janssen may terminate the agreement at any time after completion of the first Phase 1b clinical study in 2016 by providing &lt;span style="-sec-ix-hidden:Hidden_0OEUZRutDEesJMh1BBGUqQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;90&#160;days&lt;/span&gt;&lt;/span&gt;&#x2019; notice to us. If not otherwise terminated, the agreement shall continue until the expiration of all royalty obligations as outlined in the contract.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The agreement also allows for the expansion to a second indication based on the same anti-Tau active immunotherapy program and based on intellectual property related to this program.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company received an upfront, non-refundable license fee of CHF 25.9 million, which we recognized as revenue in 2014. In May&#160;2016, we received a payment of CHF 4.9 million for reaching a clinical milestone in the first Phase 1b study. In December 2023, we were entitled to receive a milestone payment of CHF 14.8 million for the commencement of the first Phase 2b clinical study. The Company recognized this income as revenue because we deemed it highly probable that this milestone would be obtained and would not be subject to reversal in the future.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that Janssen is a customer. The Company identified the following performance obligations under the contract: (i)&#160;a right-of-use license and (ii)&#160;research and development services including a development and chemistry, manufacturing and controls work plan. The Company considered the research and development capabilities of Janssen, Janssen&#x2019;s right to sublicense, and the fact that the research and development services are not proprietary and can be provided by other vendors, to conclude that the license has stand-alone functionality and is distinct. The Company&#x2019;s obligation to perform research and development services does not significantly impact or modify the licenses&#x2019; granted functionality. Based on these assessments, the Company identified the license and the research and development services as the performance obligations at the inception of the arrangement, which were deemed to be distinct in the context of the contract.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;At execution of the agreement, the transaction price included only the upfront consideration received of CHF 25.9 million. At inception, none of the clinical, regulatory or commercial milestones has been included in the transaction price, as all milestone amounts were fully constrained. The Company did receive a payment of CHF 4.9 million for reaching a clinical milestone in the first Phase 1b study in May&#160;2016 and was entitled, in December 2023, to receive a milestone payment of CHF 14.8 million for the commencement of the Phase above. The Company could also receive up to more than CHF 443 million in clinical, regulatory and commercial milestones as well as tiered, low-double digits to mid-teen royalties on aggregate net sales for the ACI-35.030 active immunotherapy program. In assessing that future clinical, regulatory or commercial milestones are fully constrained, the Company considered numerous factors to determine that these milestones are not highly probable to obtain, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials and the licensee&#x2019;s efforts. Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as they were determined to relate predominantly to the license granted to Janssen and therefore have also been excluded from the transaction price. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;years ended December&#160;31, 2023, 2022 and 2021, we have recognized CHF 14.8 million, nil and nil, respectively, from this arrangement.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 18pt;"&gt;&lt;i style="font-style:italic;"&gt;Tau-PET imaging agent&#160;&#x2013;2014 agreement with Life Molecular Imaging (LMI)&lt;/i&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In May&#160;2014 (as amended in June 2022), we entered into an agreement, our first diagnostic partnership, with LMI, the former Piramal Imaging SA. The partnership with LMI is an exclusive, worldwide licensing agreement for the research, development and commercialization of the Company&#x2019;s Tau protein PET tracers supporting the early diagnosis and clinical management of AD and other Tau-related disorders and includes upfront and sales milestone payments totaling up to EUR 160 (CHF 151) million, plus royalties on sales at a&#160;percentage rate ranging from mid-single digits to low-teens. LMI may terminate the LCA at any time by providing 3&#160;months&#x2019; notice to us.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In connection with this agreement, AC Immune received a payment of EUR 500 (CHF 664) thousand, which was fully recognized in 2015. In Q1 2017, we recorded a milestone payment of EUR 1 (CHF 1.1) million related to the initiation of &#x201c;Part&#160;B&#x201d; of the first-in-man Phase 1 study. In Q3 2019, the Company recognized EUR 2 (CHF 2.2) million in connection with the initiation of a Phase 2 trial of Tau-PET tracer in patients with mild cognitive impairment and mild&#x2013;to-moderate AD in comparison with non-demented control participants. In Q3 2022, the Company recognized EUR 4 (CHF 3.9) million linked to the progression of the Tau-PET tracer into late-stage development in AD. The Company is eligible to receive additional variable consideration related to the achievement of certain clinical milestones totaling EUR 4 (CHF 4) million should the compound make it through Phase 3 clinical studies. We are also eligible to receive potential regulatory and sales-based milestones totaling EUR 148 (CHF 139) million. Finally, the Company is eligible for royalties from the mid-single digits to low-teens.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;AC Immune assessed this arrangement in accordance with IFRS 15 and concluded that LMI is a customer. The Company has identified that the right-of-use license as the only performance obligation. The Company determined that transaction price based on the defined terms allocated to each performance obligation specified in the contract.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The upfront payment constitutes the amount of consideration to be included in the transaction price and has been allocated to the license. None of the clinical, regulatory or commercial milestones has been included in the transaction price as these variable consideration elements are considered fully constrained. As part of its evaluation of the constraint, the Company considered numerous factors, including that receipt of the milestones is outside the control of the Company and contingent upon success in future clinical trials and the licensee&#x2019;s efforts.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as these amounts have been determined to relate predominantly to the license granted to LMI and therefore are recognized at the later of when the performance obligation is satisfied or the related sales occur. The Company considered LMI&#x2019;s right to sublicense and develop the Tau protein PET tracers, and the fact that LMI could perform the research and development work themselves within the license term without AC Immune, to conclude that the license has stand-alone functionality and is distinct. The Company believes that the contracted amount represents the fair value. The Company will re-evaluate the transaction price in each reporting period and as uncertain events are resolved or other changes in circumstances occur.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;years ended December&#160;31, 2023, 2022 and 2021, the Company has recognized nil, CHF 3.9 million and nil, respectively, from this arrangement.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;14.2&lt;/b&gt;&lt;/span&gt; Grant income&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;"&gt;Grants from the Michael J. Fox Foundation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In May&#160;2020, the Company, as part of a joint arrangement with Sk&#xe5;ne University Hospital (Sk&#xe5;ne) in Sweden, was awarded a USD 3.2 (CHF 3.0) million grant from the MJFF&#x2019;s Ken Griffin Alpha-synuclein Imaging Competition. As part of this grant, AC Immune was eligible to receive USD 2.5 (CHF 2.3) million directly from the MJFF. Sk&#xe5;ne was to receive USD 0.7 (CHF 0.7) million of the total grant directly from the MJFF over &lt;span style="-sec-ix-hidden:Hidden_fQR8tACVGEO4UDivdKvMdQ;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;two&lt;/span&gt;&lt;/span&gt;&#160;years to conduct and support the clinical arm of the project. In August 2022, the Company received follow-on grant funding as part of its joint arrangement with Sk&#xe5;ne in Sweden totaling USD&#160;0.5&#160;(CHF&#160;0.5) million for the continued development of its alpha-synuclein PET imaging diagnostic agent. As part of this grant, AC Immune received USD&#160;0.4&#160;(CHF&#160;0.4) million directly from the MJFF. Sk&#xe5;ne received USD&#160;0.1&#160;(CHF&#160;0.1) million of the total grant directly from the MJFF over the duration of the grant period.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In December&#160;2021, the Company announced that it had been awarded two grants totaling USD 1.5 (CHF 1.4) million to advance small molecule PD programs. One award supported an existing early-stage program to develop small molecules that can prevent intracellular aggregation and spreading of a-syn. The other award funded research on the therapeutic potential of chemically and mechanistically novel, brain penetrant small molecule inhibitors of NLRP3 inflammasome activation for the treatment of PD.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In February 2023, the Company announced that it had been awarded a new grant totaling USD 0.5 (CHF 0.4) million from the MJFF to support the development of its TDP-43 PET tracer program.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;years ended December&#160;31, 2023, 2022 and 2021, the Company has recognized CHF 1.2 million, CHF 1.2 million and CHF 1.1 million, respectively, from its MJFF grants, under &#x201c;Other operating income/(expense), net&#x201d;. &lt;/p&gt;</ifrs-full:DisclosureOfRevenueExplanatory>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-5"
      id="Narr_R0iZSFkPYESsBHe9xC24cg"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">14800000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-5"
      id="Narr_VuE5f0hUv0a2m8CZVXhDcw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3900000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-5"
      id="Narr_hnOOG7susEO9dyQrfj_qoA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_njXc_y6DRE2hyNg_BratYw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Janssen&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,800&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Life Molecular Imaging&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,935&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Other&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total contract revenues&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,801&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,935&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_FFPrWYguC0WQvj3Hxaw5Vg"
      decimals="-3"
      id="Tc_3gd1WB89JUqq7eQx5uSFmg_4_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">14800000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_RcIGZbdaj0SjODk2XEasNg"
      decimals="-3"
      id="Tc_QZ-nzgJvfEKMWlQrBSeA3Q_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_jafX0AFm5kKHcXl4f6GawA"
      decimals="-3"
      id="Tc_Wg7UXeR5W0KKiTkZv4R_ag_4_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_BnlIEVOTy0C3K8dqAK4rRg"
      decimals="-3"
      id="Tc_p2jWL8OIhUWebUM324ebTA_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_-kkhAXq1C0GMDfXoDk10TQ"
      decimals="-3"
      id="Tc_opta8W-wBkGLPNJ9lDwjOw_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3935000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_VvfAYTJbdkC0T1wF_MSJTg"
      decimals="-3"
      id="Tc_k-m5JU7B9EK2M4RS0mqEuA_5_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfContractsAxis_aciu_OtherAgreementMember_V2ITfmJTz0yHhlWkR5uY7A"
      decimals="-3"
      id="Tc_Sez3LvO4l06Qv6YgZO2JNw_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_OtherAgreementMember_jXhHVI8hAkaS4H4FPEcpag"
      decimals="-3"
      id="Tc_8xADK_Pvr0OFW2wQFJ2H4A_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_OtherAgreementMember_kOOLpfgr3EGhGolAWb9Uwg"
      decimals="-3"
      id="Tc_hTeNpX-stUad1E808zi2gQ_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_Zw6JOypVx0qigQl9TCwMvg_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">14801000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_vHteYg2neUOkLgwRnnnCmw_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3935000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_6GGFKcDZu0eN9iqurwrrRg_7_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_3k2CwMgUZUyBcw9GChwpHA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Revenues recognized in the period from:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Amounts included in the contract liability at the beginning of the period &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Performance obligations satisfied in previous periods&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,801&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,935&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:ExplanationOfEffectThatTimingOfSatisfactionOfPerformanceObligationsAndTypicalTimingOfPaymentHaveOnContractAssetsAndContractLiabilitiesExplanatory>
    <ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc__bkPOPkwAEGHK1puYjNK4g_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod>
    <ifrs-full:RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_2k_pEs7BoUCgDuOnOOzhOQ_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">14801000</ifrs-full:RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods>
    <ifrs-full:RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_99Vb8uICEUGtaoYR_w4SDw_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3935000</ifrs-full:RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods>
    <aciu:CollaborativeAgreementPotentialValue
      contextRef="As_Of_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_vLBVN6gNy0CM2OL-a8F6nw"
      decimals="-6"
      id="Narr_aHZAjp0FSkan1rGzifHYAA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">60000000</aciu:CollaborativeAgreementPotentialValue>
    <aciu:CollaborativeAgreementMilestonePaymentNumberOfInstallments
      contextRef="Duration_7_1_2019_To_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_DUqbXvvbHUeikVmBLUHq3A"
      decimals="INF"
      id="Narr_2yKF5NCpakGA0Z5QTWIphw"
      unitRef="Unit_Standard_installment_NWKLjjbZOEujM9f04o9HSA">2</aciu:CollaborativeAgreementMilestonePaymentNumberOfInstallments>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="As_Of_9_30_2019_ifrs-full_MaturityAxis_aciu_Quarter32019Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_G-GdzKub6UqJhnJZLbz4Xw"
      decimals="-6"
      id="Narr_hXPoGkECv0mldtn6pAHRXQ"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">30000000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="As_Of_9_30_2019_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_nsmmt4NryUSnwKwUgB5e9A"
      decimals="-6"
      id="Narr_4EGsVI61fUm23rQPGC4X6w"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">30000000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyFirstAmendmentMember_76PTD23ZjE2mpl9bl8usJw"
      decimals="-6"
      id="Narr_LXsgoTOIgkCCx16yhC5sVg"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">30000000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <aciu:CollaborativeAgreementMilestonePaymentNumberOfInstallments
      contextRef="Duration_3_31_2020_To_3_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_ClmKil5lr0WdBtvIaUaFEA"
      decimals="INF"
      id="Narr_qellxOwBUUa48exIpsjB_w"
      unitRef="Unit_Standard_installment_NWKLjjbZOEujM9f04o9HSA">2</aciu:CollaborativeAgreementMilestonePaymentNumberOfInstallments>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_March312020Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_0EMLps-d40CSIT6HT2so_w"
      decimals="-6"
      id="Narr_6R0z_b8QPEWah8vnmFQF_A"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">10000000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="As_Of_3_31_2020_ifrs-full_MaturityAxis_aciu_UponFirstPatientDosedInPhase2ClinicalStudyOfLicensedProductInU.s.OrEu.Member_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillySecondAmendmentMember_vQvK76RUJ0KnStBAGwXxYA"
      decimals="-6"
      id="Narr_sDlqOhrA90-vhMAmkqOadg"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">60000000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <aciu:CollaborativeAgreementMilestonePaymentReceived
      contextRef="Duration_1_1_2019_To_3_31_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_BPMBGqeh1UCBtCXz0LDlDg"
      decimals="-6"
      id="Narr_U76A5hF5U0iRpRYlMNJKUQ"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">80000000</aciu:CollaborativeAgreementMilestonePaymentReceived>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="As_Of_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_KLZBu4QGhUm541e0XMZ9xA"
      decimals="-6"
      id="Narr_1DmfhXT0RkKXiBc5N60aXA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">880000000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="As_Of_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_MilestonePaymentsCommercialMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_I-ylj3lgB0ySClC4h_2t1A"
      decimals="-6"
      id="Narr_AKjSRENpWkCbI1zaKp_J8Q"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">900000000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <aciu:NumberOfRepresentativesInJointSteeringCommitteeByEachParty
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_ShYkYUEckEG0-k_MozRQGg"
      decimals="INF"
      id="Narr_LoJloJQtnkG0mXpVeat0Hw"
      unitRef="Unit_Standard_item_lel3bReemU2v4xdKyUvjzA">3</aciu:NumberOfRepresentativesInJointSteeringCommitteeByEachParty>
    <ifrs-full:ContractAssets
      contextRef="As_Of_1_23_2019_ifrs-full_PerformanceObligationsAxis_aciu_ResearchAndDevelopmentMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_blE7iuHcaUG9QmZUisEt3A"
      decimals="-5"
      id="Narr_XrrHPattIk-Q9HkL2bxv0Q"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">6900000</ifrs-full:ContractAssets>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_23_2019_To_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_ResearchAndDevelopmentMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_N22GJ9LsrUiWJLyFN-RIXQ"
      decimals="-5"
      id="Narr_a9mbykm2fkayYyO5OS5-xA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">6900000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities
      contextRef="As_Of_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_NUhuhpmnrEShL-ErqVzeXQ"
      decimals="-6"
      id="Narr_bCro6UTdnkuv1dEWBoXQnQ"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_23_2019_To_1_23_2019_ifrs-full_PerformanceObligationsAxis_aciu_RightOfUseLicenseMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_bs5y_HFUuE2bgfNkGXeFQQ"
      decimals="-5"
      id="Narr_Aw33KmuPk0ytGMkjRy6nzA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">73100000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_7_1_2019_To_12_31_2022_ifrs-full_PerformanceObligationsAxis_aciu_RightOfUseLicenseMember_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_oqIIqklRBUe5UQlvHuNHMA"
      decimals="-6"
      id="Narr_J5FUV60RVUeicJI0ShKBew"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">40000000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_WpYdq5tOqkCYnWaYgg7hoQ"
      decimals="-5"
      id="Narr_uyehSOTB1Uu23h3Rkqnr6w"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_lCg_5YHbNEWrV3IHIK-hlw"
      decimals="-5"
      id="Narr_xgnh_2EZlk6kDWdwQkLecA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauMorphomerSmallMoleculeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementWithLillyMember_ShYkYUEckEG0-k_MozRQGg"
      decimals="-5"
      id="Narr_e9qHvHrkLkmRI1JQY-pO5Q"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:RevenueFromContractsWithCustomers>
    <aciu:CollaborativeAgreementPotentialValue
      contextRef="As_Of_12_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember__-SkUIIH_UKKHcFlP4uAVA"
      decimals="-6"
      id="Narr_nUo5nANFREuSP9EXbyeQeA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">500000000</aciu:CollaborativeAgreementPotentialValue>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_12_1_2014_To_12_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_zDLbltOLTEaxOQqGKQjBBw"
      decimals="-5"
      id="Narr_AV3npfzTMkmnwIAVkDsgDQ"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">25900000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_5_1_2016_To_5_31_2016_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_z6odcKKiUk6PMIxagqtGiA"
      decimals="-5"
      id="Narr_7bwae9Tzqk6nx2MPOnqUSw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4900000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_12_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_bZFp8RtyQk6ZpSOXniefvg"
      decimals="-5"
      id="Narr_gce5T_dfQ0KoNazn-JRwrQ"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">14800000</ifrs-full:RevenueFromContractsWithCustomers>
    <aciu:CollaborativeAgreementUpfrontPaymentsReceived
      contextRef="Duration_1_1_2014_To_12_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_ai62qsBmbECbBpWbHN1gqg"
      decimals="-5"
      id="Narr_Wy8F9T4nPUqJ1oMRz6ujXg"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">25900000</aciu:CollaborativeAgreementUpfrontPaymentsReceived>
    <aciu:CollaborativeAgreementMilestonePaymentReceived
      contextRef="Duration_5_1_2016_To_5_31_2016_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_z6odcKKiUk6PMIxagqtGiA"
      decimals="-5"
      id="Narr_dw254aWnNE2Imab8umM_Fw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4900000</aciu:CollaborativeAgreementMilestonePaymentReceived>
    <ifrs-full:CurrentTradeReceivables
      contextRef="As_Of_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_BxvFqCM4M0ufUbFvjtlCMQ"
      decimals="-5"
      id="Narr_Htp1ddP6uEWlC_ksBQ1N2w"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">14800000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="As_Of_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_R3OS4EvnIk6VR8SwYkbQTw"
      decimals="-6"
      id="Narr_0kVoJ_17GU2R5PH9PzrXBg"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">443000000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_uOvzhs9BoEiLV6rS9IZVFg"
      decimals="-5"
      id="Narr_LBG2A6L2g0GTeuzB_dBxxw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">14800000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_oPmjvi14mk-DBu82Bl8nzQ"
      decimals="-5"
      id="Narr_GMpcCthoy0GvGE5e9pQGcw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_8EC0rLfa2kiP5VlheRCDlg"
      decimals="-5"
      id="Narr_JxZ_D7J5UUWeFDd8H8ap_g"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:RevenueFromContractsWithCustomers>
    <aciu:CollaborativeAgreementPotentialValue
      contextRef="As_Of_5_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_lWKxGd9870-RZpUwXYweFQ"
      decimals="-6"
      id="Narr_ZJo-tLT7gEqfG4HqqjFDFQ"
      unitRef="Unit_Standard_EUR_QpqDW6JdmEqpVHDpBHxA4g">160000000</aciu:CollaborativeAgreementPotentialValue>
    <aciu:CollaborativeAgreementPotentialValue
      contextRef="As_Of_5_31_2014_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_lWKxGd9870-RZpUwXYweFQ"
      decimals="-6"
      id="Narr_7WSUyz5saUO9lncSOASifw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">151000000</aciu:CollaborativeAgreementPotentialValue>
    <aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_wERnesaBIkyF2ZYGAWOS5g"
      id="Narr__bd7i7UZPUWNRXOw9blOGA">P3M</aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_12_31_2015_To_12_31_2015_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_7HL2iR7LZEGx9pYpDWzsWg"
      decimals="-3"
      id="Narr_RbaM3-n-nE2bO3YLNUOM1w"
      unitRef="Unit_Standard_EUR_QpqDW6JdmEqpVHDpBHxA4g">500000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_12_31_2015_To_12_31_2015_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_7HL2iR7LZEGx9pYpDWzsWg"
      decimals="-3"
      id="Narr_WruP7rDrPUG_jtgDBeHHbA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">664000</ifrs-full:RevenueFromContractsWithCustomers>
    <aciu:CollaborativeAgreementMilestonePaymentReceived
      contextRef="Duration_1_1_2017_To_3_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_ufWSkNfIkECZWt_mcMr6vA"
      decimals="-6"
      id="Narr_obaGZIaZDUCgZqH7pzgpaA"
      unitRef="Unit_Standard_EUR_QpqDW6JdmEqpVHDpBHxA4g">1000000</aciu:CollaborativeAgreementMilestonePaymentReceived>
    <aciu:CollaborativeAgreementMilestonePaymentReceived
      contextRef="Duration_1_1_2017_To_3_31_2017_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_ufWSkNfIkECZWt_mcMr6vA"
      decimals="-5"
      id="Narr_X3Ss2l1fH0mqKXkZ4-S_TQ"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1100000</aciu:CollaborativeAgreementMilestonePaymentReceived>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_7_1_2019_To_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_l5M7oS6RAUSbE60FpTK73g"
      decimals="-6"
      id="Narr_3LYJkmzwbE-7KYVJVSkH_Q"
      unitRef="Unit_Standard_EUR_QpqDW6JdmEqpVHDpBHxA4g">2000000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_7_1_2019_To_9_30_2019_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_l5M7oS6RAUSbE60FpTK73g"
      decimals="-5"
      id="Narr_-ZGLDMmLpUqdxNPj4JdYWQ"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2200000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_7_1_2022_To_9_30_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_hMfnkYwHjk67Rec2qW4oRA"
      decimals="-6"
      id="Narr_0SWgXJtiyEOgsJXUzMRjrA"
      unitRef="Unit_Standard_EUR_QpqDW6JdmEqpVHDpBHxA4g">4000000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_7_1_2022_To_9_30_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_hMfnkYwHjk67Rec2qW4oRA"
      decimals="-5"
      id="Narr_-XhsMpqq2UOftYcjfLto1g"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3900000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="As_Of_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_ClinicalMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_URY6Jrdr0k-HLTt2WogjzA"
      decimals="-6"
      id="Narr_hOyK-qhRVkWlv8wMzTESSA"
      unitRef="Unit_Standard_EUR_QpqDW6JdmEqpVHDpBHxA4g">4000000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="As_Of_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_ClinicalMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_URY6Jrdr0k-HLTt2WogjzA"
      decimals="-6"
      id="Narr_w8ge9es1jEK3VNHYeqpOEg"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4000000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="As_Of_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_RegulatoryAndSalesBasedMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_dbU2qmyhJ0Wd2ybcWsnSQQ"
      decimals="-6"
      id="Narr_OGw7ibnU4kGY9FsY2dSHfw"
      unitRef="Unit_Standard_EUR_QpqDW6JdmEqpVHDpBHxA4g">148000000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="As_Of_12_31_2023_ifrs-full_PerformanceObligationsAxis_aciu_RegulatoryAndSalesBasedMilestonesMember_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_dbU2qmyhJ0Wd2ybcWsnSQQ"
      decimals="-6"
      id="Narr_aYK-oxrdKU27_Wlx_DIoGA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">139000000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_wERnesaBIkyF2ZYGAWOS5g"
      decimals="-5"
      id="Narr_5-alL4wC4E-g_clZdYuzDQ"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_wERnesaBIkyF2ZYGAWOS5g"
      decimals="-5"
      id="Narr_Dl-fv0szP0GyPAmW8Q84pA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_l0LL76dIKke62bpBgsqmmQ"
      decimals="-5"
      id="Narr_MwmcXN1YekqWMriP8cJwFA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3900000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_TauPETImagingAgentMember_ifrs-full_TypesOfContractsAxis_aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember_VGUKHPz2X0mctIHDOt8IbQ"
      decimals="-5"
      id="Narr_9H8A9SNWM0quS7Ko7LdbHw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:RevenueFromContractsWithCustomers>
    <aciu:CollaborativeAgreementPotentialValue
      contextRef="As_Of_5_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_yFg7_K4Sj06ntHrtmFJMMw"
      decimals="-5"
      id="Narr_7QQZKZ9eZEy1Zw-cyaznIQ"
      unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">3200000</aciu:CollaborativeAgreementPotentialValue>
    <aciu:CollaborativeAgreementPotentialValue
      contextRef="As_Of_5_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_yFg7_K4Sj06ntHrtmFJMMw"
      decimals="-5"
      id="Narr_X2oNVw8VAEiFz7pbzvkyCg"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3000000.0</aciu:CollaborativeAgreementPotentialValue>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="As_Of_5_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_yFg7_K4Sj06ntHrtmFJMMw"
      decimals="-5"
      id="Narr_4x5jeO2LgEeltnCWYXZ_0A"
      unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">2500000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="As_Of_5_31_2020_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_yFg7_K4Sj06ntHrtmFJMMw"
      decimals="-5"
      id="Narr_RBvt41vCDE-CflZYW7Kdjw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2300000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="As_Of_5_31_2020_ifrs-full_CounterpartiesAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_QTd8z-CMpECa_iMHqUPauA"
      decimals="-5"
      id="Narr_19dfnu0I2UyTOPbtm7j9qA"
      unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">700000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="As_Of_5_31_2020_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_gl9YWNvWuka0-golVkbkyA"
      decimals="-5"
      id="Narr_tbAFhlzO7EmiqvVxhDnkEQ"
      unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">700000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="As_Of_5_31_2020_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_gl9YWNvWuka0-golVkbkyA"
      decimals="-5"
      id="Narr_LvKVo_yhJEm0bbvqiHpi1A"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">700000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <aciu:FollowOnGrantFundingReceivedTotalForJointArrangement
      contextRef="Duration_8_1_2022_To_8_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_zfR7x4gHWUCfKEves1438g"
      decimals="-5"
      id="Narr_9xleVYKGJ0ikMxPKAoDG8A"
      unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">500000</aciu:FollowOnGrantFundingReceivedTotalForJointArrangement>
    <aciu:FollowOnGrantFundingReceivedTotalForJointArrangement
      contextRef="Duration_8_1_2022_To_8_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_zfR7x4gHWUCfKEves1438g"
      decimals="-5"
      id="Narr_IM6rlZcML06TWRA37iHurw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">500000</aciu:FollowOnGrantFundingReceivedTotalForJointArrangement>
    <aciu:FollowOnGrantFundingReceived
      contextRef="Duration_8_1_2022_To_8_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_zfR7x4gHWUCfKEves1438g"
      decimals="-5"
      id="Narr_Jy1oROOeZkS85CGlnOmkwQ"
      unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">400000</aciu:FollowOnGrantFundingReceived>
    <aciu:FollowOnGrantFundingReceived
      contextRef="Duration_8_1_2022_To_8_31_2022_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_zfR7x4gHWUCfKEves1438g"
      decimals="-5"
      id="Narr_1UmkOxX7yUWB_BOu8evzTg"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">400000</aciu:FollowOnGrantFundingReceived>
    <aciu:FollowOnGrantFundingReceived
      contextRef="Duration_8_1_2022_To_8_31_2022_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_i3ZUuVbirEiuOT-5rYcByg"
      decimals="-5"
      id="Narr_zuW6YOKs3EmoPjTfDQrl4A"
      unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">100000</aciu:FollowOnGrantFundingReceived>
    <aciu:FollowOnGrantFundingReceived
      contextRef="Duration_8_1_2022_To_8_31_2022_dei_LegalEntityAxis_aciu_SkaneUniversityHospitalMember_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_i3ZUuVbirEiuOT-5rYcByg"
      decimals="-5"
      id="Narr_U2-85bXnzUuilKcT9_pd5A"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">100000</aciu:FollowOnGrantFundingReceived>
    <aciu:NumberOfGrants
      contextRef="Duration_12_1_2021_To_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_AdvanceSmallMoleculePdProgramsMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember__xRQy4sDnU2wuTVhB0eVUA"
      decimals="INF"
      id="Narr_N70Su9tUYUeaF4Kp1Jx1Hg"
      unitRef="Unit_Standard_item_lel3bReemU2v4xdKyUvjzA">2</aciu:NumberOfGrants>
    <aciu:CollaborativeAgreementPotentialValue
      contextRef="As_Of_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_AdvanceSmallMoleculePdProgramsMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_BWrRdrxLXEiE2A8T_eUqAA"
      decimals="-5"
      id="Narr_yIqo8-pnf0CG_zgKixjZNA"
      unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">1500000</aciu:CollaborativeAgreementPotentialValue>
    <aciu:CollaborativeAgreementPotentialValue
      contextRef="As_Of_12_31_2021_ifrs-full_ProductsAndServicesAxis_aciu_AdvanceSmallMoleculePdProgramsMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_BWrRdrxLXEiE2A8T_eUqAA"
      decimals="-5"
      id="Narr_Uuo9rXdeoUCgtLkEWbrSoQ"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1400000</aciu:CollaborativeAgreementPotentialValue>
    <aciu:AdditionalGrantAwarded
      contextRef="Duration_2_1_2023_To_2_28_2023_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_uKAhF0e3t0OofFPtWQBOnw"
      decimals="-5"
      id="Narr_jVatzcX_UkmycmGd8SnBRw"
      unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">500000</aciu:AdditionalGrantAwarded>
    <aciu:AdditionalGrantAwarded
      contextRef="Duration_2_1_2023_To_2_28_2023_ifrs-full_ProductsAndServicesAxis_aciu_AlphaSynucleinPetImagingDiagnosticAgentMember_ifrs-full_TypesOfContractsAxis_aciu_GrantsMichaelJFoxFoundationMember_uKAhF0e3t0OofFPtWQBOnw"
      decimals="-5"
      id="Narr_b1ueMrf56Umk2TGOVjbBcA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">400000</aciu:AdditionalGrantAwarded>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfContractsAxis_aciu_GrantRevenueMember_Kn--ZLK--EWCGZTxnKU9YQ"
      decimals="-5"
      id="Narr_0RNT7YHvEUGg2CoQcLRvfQ"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1200000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfContractsAxis_aciu_GrantRevenueMember_7FTossETZUGpmYwf0I08Iw"
      decimals="-5"
      id="Narr_Da9Mi3mJyUmOyTnXAP2FOg"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1200000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfContractsAxis_aciu_GrantRevenueMember__Ki26gI4UUqU71aLzAD8KQ"
      decimals="-5"
      id="Narr_3-iU9zxoFkmp1UIpey1n-w"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1100000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:DisclosureOfExpensesExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_aeuiJiVHy0qxi4GZ1ZEA-w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;15.&lt;/b&gt;&lt;/span&gt;Expenses by category&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;"&gt;Research and development&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Operating expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 33,198&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 41,166&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 44,289&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Payroll expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19,499&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 17,548&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 16,465&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share-based compensation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,909&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,622&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,528&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total research and development expenses &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 54,606&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 60,336&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 62,282&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The decrease in 2023 is mainly driven by a decrease of CHF 5.8 million in direct R&amp;amp;D expenditures across various programs. This is partially offset by an increase of CHF 2.2 million in salaries and related costs, including share-based compensation expenses.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;years ended December&#160;31, 2023, 2022 and 2021, the Company had 115.4, 122.4 and 108.6 FTEs in our research and development functions.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;"&gt;General and administrative&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Operating expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,729&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,207&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,031&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Payroll expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,755&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,874&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,281&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share-based compensation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,821&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,708&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,598&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total general and administrative expenses &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,305&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,789&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 17,910&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The decrease in 2023 compared with the prior&#160;year predominantly relates to a reduction of CHF 1.5 million across various cost centers. This is partially offset by an increase of CHF 1.1 million in share-based compensation expenses.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;years ended December&#160;31, 2023, 2022 and 2021, the Company had 26.2, 22.5 and 27.3 FTEs in our general and administrative functions.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;"&gt;Financial result, net&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Financial income&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,044&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 69&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,485&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Financial expense&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (176)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (355)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (581)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exchange differences&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,467)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 393&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 113&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Finance result, net &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (599)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 107&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,017&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:17.85pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Our finance result primarily consists of interest expense associated with our short-term financial assets and lease liabilities as well as foreign currency exchange differences.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For the&#160;year ended December&#160;31, 2023, the decrease in financial result, net relates primarily to unfavorable foreign currency exchange differences related to movement in the CHF versus foreign currencies, predominantly the US Dollar. This is partially offset by an increase in financial income, combined with a decrease in financial expense, due to the transition from negative to positive interest rates for our interest-bearing deposit accounts.&lt;/p&gt;</ifrs-full:DisclosureOfExpensesExplanatory>
    <ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_6PnoAc9w5EG8MGLI3_pCJQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;"&gt;Research and development&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Operating expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 33,198&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 41,166&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 44,289&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Payroll expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19,499&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 17,548&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 16,465&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share-based compensation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,909&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,622&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,528&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total research and development expenses &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 54,606&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 60,336&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 62,282&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory>
    <ifrs-full:OperatingExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_mVdbPS_pZEOvR8-xErVVJg"
      decimals="-3"
      id="Tc_KQ0AnDfqKE-pvpM8tA86Iw_4_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">33198000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_i4oh9OLRKk237CD7aWKajQ"
      decimals="-3"
      id="Tc_ktHPAhFJlEehwJCuKes5bw_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">41166000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_elQwz5L0xki93eiu__qmNA"
      decimals="-3"
      id="Tc_hfKsJH-fkky2VRz9iqZ2Rg_4_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">44289000</ifrs-full:OperatingExpense>
    <aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_mVdbPS_pZEOvR8-xErVVJg"
      decimals="-3"
      id="Tc_U1kVVHjOEk-Y-fqk3n94iA_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">19499000</aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation>
    <aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_i4oh9OLRKk237CD7aWKajQ"
      decimals="-3"
      id="Tc_Z7e8WBdarUyFU7B5blTmMQ_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">17548000</aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation>
    <aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_elQwz5L0xki93eiu__qmNA"
      decimals="-3"
      id="Tc_GEg9tYbQKEe14t3fywTBRw_5_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">16465000</aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_mVdbPS_pZEOvR8-xErVVJg"
      decimals="-3"
      id="Tc_9dVgZ6SRqEmsBBvySVnnJA_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1909000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_i4oh9OLRKk237CD7aWKajQ"
      decimals="-3"
      id="Tc_C9J7V71PM0KM_HQAZ0ovoQ_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1622000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_elQwz5L0xki93eiu__qmNA"
      decimals="-3"
      id="Tc_Z6k5FiBNkE2cFZLZAko9zw_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1528000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseByNature
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_mVdbPS_pZEOvR8-xErVVJg"
      decimals="-3"
      id="Tc_Lpz4_pfLZ0mDBh5b2pi2XA_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">54606000</ifrs-full:ExpenseByNature>
    <ifrs-full:ExpenseByNature
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_i4oh9OLRKk237CD7aWKajQ"
      decimals="-3"
      id="Tc_GTYqfXzYoU-2VaXv0tt8PQ_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">60336000</ifrs-full:ExpenseByNature>
    <ifrs-full:ExpenseByNature
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_elQwz5L0xki93eiu__qmNA"
      decimals="-3"
      id="Tc_QQdqoi16uUqTKcFg2_CngQ_7_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">62282000</ifrs-full:ExpenseByNature>
    <aciu:DecreaseInResearchAndDevelopmentExpenseThroughReductionsInVariousCostCenters
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-5"
      id="Narr_Ka3cBouJyEiAifRN-0PIyQ"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">5800000</aciu:DecreaseInResearchAndDevelopmentExpenseThroughReductionsInVariousCostCenters>
    <aciu:IncreaseInResearchAndDevelopmentExpenseThroughIncreaseInSalariesAndRelatedCosts
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-5"
      id="Narr_UmKUiskZCU6dzdoutQGYWw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2200000</aciu:IncreaseInResearchAndDevelopmentExpenseThroughIncreaseInSalariesAndRelatedCosts>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_mVdbPS_pZEOvR8-xErVVJg"
      decimals="1"
      id="Narr_VlgyVwY710OrAdl7Gh5aLA"
      unitRef="Unit_Standard_employee_Y_HtOjq0F0i_9evdy7ujWw">115.4</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_i4oh9OLRKk237CD7aWKajQ"
      decimals="1"
      id="Narr_BSsGmXy8HUKcfaiWL-8oKg"
      unitRef="Unit_Standard_employee_Y_HtOjq0F0i_9evdy7ujWw">122.4</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_aciu_ResearchAndDevelopmentExpensesMember_elQwz5L0xki93eiu__qmNA"
      decimals="1"
      id="Narr_jGOJGs34ikSO4RII-FiAKQ"
      unitRef="Unit_Standard_employee_Y_HtOjq0F0i_9evdy7ujWw">108.6</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_qFu7P49dCUyWcunI7lXoQA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;"&gt;General and administrative&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Operating expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,729&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,207&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,031&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Payroll expenses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,755&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,874&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,281&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share-based compensation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,821&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,708&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,598&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total general and administrative expenses &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,305&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,789&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 17,910&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory>
    <ifrs-full:OperatingExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6gI4nc20YE2v2UMn230IjA"
      decimals="-3"
      id="Tc_fNcGyOaPp0qiJ42-ervJYw_4_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4729000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_018DD5MHx0yR9siTflNYPw"
      decimals="-3"
      id="Tc_BmzltLtNDUuhYQ05Z_DHiQ_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">6207000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_bid3n8U3yUu4WF-DywHH4Q"
      decimals="-3"
      id="Tc_LYY1R8b-NUWy0qf7PrxTpA_4_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">7031000</ifrs-full:OperatingExpense>
    <aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6gI4nc20YE2v2UMn230IjA"
      decimals="-3"
      id="Tc_yuPFIZ8M4kyC86c-0apqjw_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">7755000</aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation>
    <aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_018DD5MHx0yR9siTflNYPw"
      decimals="-3"
      id="Tc_Ey_NUFZ1KUaRdji8pY-2PQ_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">7874000</aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation>
    <aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_bid3n8U3yUu4WF-DywHH4Q"
      decimals="-3"
      id="Tc_EraAxZ3gyUyUdrerVYs66w_5_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">8281000</aciu:EmployeeBenefitsExpenseExcludingShareBasedCompensation>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6gI4nc20YE2v2UMn230IjA"
      decimals="-3"
      id="Tc_F8DTJkwyA0mfGIIkTkbDag_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2821000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_018DD5MHx0yR9siTflNYPw"
      decimals="-3"
      id="Tc_JDAcba11r02XIwYkLkrgVQ_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1708000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_bid3n8U3yUu4WF-DywHH4Q"
      decimals="-3"
      id="Tc_UiwaVXyDmke8pviO-UExFQ_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2598000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseByNature
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6gI4nc20YE2v2UMn230IjA"
      decimals="-3"
      id="Tc_LywFyL7lWE2EbaBii5cP_g_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">15305000</ifrs-full:ExpenseByNature>
    <ifrs-full:ExpenseByNature
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_018DD5MHx0yR9siTflNYPw"
      decimals="-3"
      id="Tc_fBiOnw_sykaAVPc2yd6nBw_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">15789000</ifrs-full:ExpenseByNature>
    <ifrs-full:ExpenseByNature
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_bid3n8U3yUu4WF-DywHH4Q"
      decimals="-3"
      id="Tc_6ksbtp7RDkSR5DOSNyZBmQ_7_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">17910000</ifrs-full:ExpenseByNature>
    <aciu:DecreaseInGeneralAndAdministrativeExpenseThroughReductionsInVariousCostCenters
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-5"
      id="Narr_AlIqWdjEGU-D94QfkPWfoQ"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1500000</aciu:DecreaseInGeneralAndAdministrativeExpenseThroughReductionsInVariousCostCenters>
    <aciu:IncreaseInGeneralAndAdministrativeExpenseThroughIncreaseInShareBasedCompensationExpense
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-5"
      id="Narr_1BTVxK-yyUaodi8_aBlKQg"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1100000</aciu:IncreaseInGeneralAndAdministrativeExpenseThroughIncreaseInShareBasedCompensationExpense>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_6gI4nc20YE2v2UMn230IjA"
      decimals="1"
      id="Narr_9otZ-3mt_UCM0hFHDLXGHg"
      unitRef="Unit_Standard_employee_Y_HtOjq0F0i_9evdy7ujWw">26.2</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_018DD5MHx0yR9siTflNYPw"
      decimals="1"
      id="Narr_AUMkb3hVFUqK7AmPeYwGuw"
      unitRef="Unit_Standard_employee_Y_HtOjq0F0i_9evdy7ujWw">22.5</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_bid3n8U3yUu4WF-DywHH4Q"
      decimals="1"
      id="Narr_Zb-YH9jhLk-0uUTH-Zy0LA"
      unitRef="Unit_Standard_employee_Y_HtOjq0F0i_9evdy7ujWw">27.3</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_4edXN6rzvUCziMKTS4DH9g">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt;"&gt;Financial result, net&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Financial income&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,044&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 69&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,485&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Financial expense&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (176)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (355)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (581)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exchange differences&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,467)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 393&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 113&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Finance result, net &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (599)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 107&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,017&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory>
    <ifrs-full:FinanceIncome
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_lhOQWvERg0WNEtmBAfZEag_4_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1044000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_HxsN1Qm7p02YGvRWkQI5Yw_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">69000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_GCZBM79IHESid7-9YDbiFg_4_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">6485000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceCosts
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_HBAwpQZ9okCuhpl-s0izJw_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">176000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_eEXqXUk-VEWf8Fy-YYibVQ_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">355000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_dt0tZUf64k-pW_rU_KZMXg_5_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">581000</ifrs-full:FinanceCosts>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_HvyGv22v8Eq9sRyoPKP6UQ_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1467000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_OeHF-Yu7qU2P_i11NVsX5Q_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">393000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_IRXwsJy9XEmE2DrHoWPUmQ_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">113000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:FinanceIncomeCost
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_owWox-sRt0yXSJ9FKkLPpw_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-599000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_UHZHg03sskaa33eIfnFZNQ_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">107000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_nPKjmdH63UKn92rZZKty9Q_7_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">6017000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_gXvK2VwpgEeZg5i4d35m-Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;16.&lt;/b&gt;&lt;/span&gt;Related-party transactions&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Board of directors and executive management compensation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;Key management includes the board of directors and executive management. For 2023, there were eight members (2022 and 2021: eight) of the Board (excluding the CEO) and seven members (2022: seven and 2021: six) of executive management (including the CEO). Compensation was as follows:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Short-term employee benefits &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,661&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,187&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,403&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Post-employment benefits &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 446&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 295&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 266&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share-based compensation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,251&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,503&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,997&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total compensation&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,358&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,985&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,666&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_tjqr7RpvT0eyEkt3F2C--g">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;Key management includes the board of directors and executive management. For 2023, there were eight members (2022 and 2021: eight) of the Board (excluding the CEO) and seven members (2022: seven and 2021: six) of executive management (including the CEO). Compensation was as follows:&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Short-term employee benefits &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,661&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,187&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,403&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Post-employment benefits &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 446&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 295&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 266&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share-based compensation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,251&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,503&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,997&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total compensation&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,358&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,985&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,666&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory>
    <aciu:NumberOfPersonsKeyManagementBoardOfDirectors
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="INF"
      id="Narr_ZG7saATdTkGPsZzWGrnNdA"
      unitRef="Unit_Standard_person_7ny7-oR7aEaZQqs0BxZVCQ">8</aciu:NumberOfPersonsKeyManagementBoardOfDirectors>
    <aciu:NumberOfPersonsKeyManagementBoardOfDirectors
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="INF"
      id="Narr_4aGtjUNbREixjzQFzIzKig"
      unitRef="Unit_Standard_person_7ny7-oR7aEaZQqs0BxZVCQ">8</aciu:NumberOfPersonsKeyManagementBoardOfDirectors>
    <aciu:NumberOfPersonsKeyManagementBoardOfDirectors
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="INF"
      id="Narr_LDGY3UAbxEyKgUL3wuWkqA"
      unitRef="Unit_Standard_person_7ny7-oR7aEaZQqs0BxZVCQ">8</aciu:NumberOfPersonsKeyManagementBoardOfDirectors>
    <aciu:NumberOfPersonsKeyManagementExecutiveManagement
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="INF"
      id="Narr_bNxyvN6lUE-AFJG7HxFBfw"
      unitRef="Unit_Standard_person_7ny7-oR7aEaZQqs0BxZVCQ">7</aciu:NumberOfPersonsKeyManagementExecutiveManagement>
    <aciu:NumberOfPersonsKeyManagementExecutiveManagement
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="INF"
      id="Narr_MS8TQPHqo0qYEvvWSU5_AQ"
      unitRef="Unit_Standard_person_7ny7-oR7aEaZQqs0BxZVCQ">7</aciu:NumberOfPersonsKeyManagementExecutiveManagement>
    <aciu:NumberOfPersonsKeyManagementExecutiveManagement
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="INF"
      id="Narr_gZ6-ySvz70iH2HPjgV89Pw"
      unitRef="Unit_Standard_person_7ny7-oR7aEaZQqs0BxZVCQ">6</aciu:NumberOfPersonsKeyManagementExecutiveManagement>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_ZySttk5Z6E6gyUrRX64sLA_4_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4661000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_jaQu8FyyQkuEXTALx7kJtg_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4187000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_dT1ZS9L9i0mmM71sfn203A_4_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4403000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_xoZqyT9XFUabkaeK0fV_JQ_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">446000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_AIEUEVFL2U2bn1ajtAUkBQ_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">295000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_hgMYBRxtjEakXpPFT5hhNA_5_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">266000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_yDzXxkwHEkm11q8rI0M6oQ_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3251000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_8bgXmc2pQEqFslMMed-JvQ_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2503000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_kft0ewVzeUW9GVy0ASdyvg_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2997000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_Wz9mhmQ090uM0MFZZ3Mdpw_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">8358000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_-jxCr7Z4ukGOzv48EGNvxQ_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">6985000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_6yPGJKfWWUaftiLuInqDag_7_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">7666000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:DisclosureOfIncomeTaxExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_-aIyargqz0St4vG3XzZZ3Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;17.&lt;/b&gt;&lt;/span&gt;Income taxes&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Group recognized less than CHF 0.1 million in income taxes and no deferred tax asset or &lt;span style="-sec-ix-hidden:Hidden_HV19mOg_skeZVhyj5rvzCA;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"&gt;liability&lt;/span&gt;&lt;/span&gt; positions for the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively. The Group&#x2019;s expected tax expense for each&#160;year is based on the applicable tax rates in each jurisdiction. In 2023, these rates ranged from 13.6% to 33.8% (13.6% - 33.8% for 2022 and 13.6% - 32.9% for 2021) in the Group&#x2019;s respective tax jurisdictions. The weighted average tax rate applicable to the Group was 13.6% (13.6% for 2022 and 2021, respectively). &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The Group&#x2019;s income tax expense for each&#160;year can be reconciled to loss before tax as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Loss before income tax &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (54,223)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (70,740)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (72,993)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Tax benefit calculated at the domestic rates applicable in the respective countries &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,371)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (9,616)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (9,930)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;(Income not subject to tax)/expenses not deductible for tax purposes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 611&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 455&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (375)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Effect of unused tax losses and tax offsets not recognized as deferred tax assets &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,770&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,174&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 10,308&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Effective income tax rate expense &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 10&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 13&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Swiss tax rate used for the 2023 reconciliations is the corporate tax rate of 13.6% (13.6% in 2022 and 2021, respectively) payable by corporate entities in the Canton of Vaud, Switzerland on taxable profits under tax law in that jurisdiction.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The below table details the total unrecognized deductible temporary differences, unused tax losses and unused tax credits:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Unrecognized deductible temporary differences, unused tax losses and unused tax credits&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Deductible temporary differences, unused tax losses and unused tax credits for which no deferred tax assets have been recognized are attributable to the following:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;Tax losses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 312,972&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 264,089&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 197,152&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;Deductible temporary differences related to:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 18pt;"&gt;Right-of-use assets and lease liabilities, net&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 18pt;"&gt;Retirement benefit plan &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5,770&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,213&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,098&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 318,742&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 267,302&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 204,250&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table details the tax losses carry forwards of the Company and their respective expiry dates:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Tax losses split by expiry date:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,231&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,231&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,231&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 48,894&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 48,894&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 48,894&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2026&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2027&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 57,824&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 57,824&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 57,824&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2028&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 75,204&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 75,204&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 75,204&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2029&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 66,936&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 66,936&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2030&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 48,883&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total unrecorded tax loss carryforwards&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 312,972&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 264,089&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 197,153&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The tax losses available for future offset against taxable profits have increased by CHF 48.9&#160;million from 2022, representing the amount of tax losses that are additionally available as an offset, subject to expiration as disclosed in the table above, against future taxable income.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Consistent with prior&#160;years, the Company has not recorded any deferred tax assets in relation to the past tax losses available for offset against future profits as the recognition criteria were not met at the balance sheet date.&lt;/p&gt;</ifrs-full:DisclosureOfIncomeTaxExplanatory>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_N4NtcRpK7UmEpR8gT_3kcQ"
      decimals="-5"
      id="Narr_2CMe3YXz7U2GpnPsBJIzBg"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">100000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:DeferredTaxAssets
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-5"
      id="Narr_3YHlZ05ycEKdUjgdgW3gBg"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:DeferredTaxAssets>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_A0fLCvnZXkWCpt0V9v-hlQ"
      decimals="3"
      id="Narr_OQjYdgkSV0GgDylZfGtciA"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.136</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_N4NtcRpK7UmEpR8gT_3kcQ"
      decimals="3"
      id="Narr_4U5uZjl4A02C592TbClP4g"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.338</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_kJ9M4JxOBEuo1siTgMfdYQ"
      decimals="3"
      id="Narr_sMkYxWUxMUarBplfgdTQuQ"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.136</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_mTTN5Hw7J0uG4plqeYxbIg"
      decimals="3"
      id="Narr_CIrRc5esm0ykb06utdeehQ"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.338</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="3"
      id="Narr_8Bc9-4UKrUm1j0Wj8jL6XQ"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.136</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ZaXds3ifpU6wdPGK9Rol-A"
      decimals="3"
      id="Narr_2Lg1vApRH0KSeUDArhrdhQ"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.136</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_kF_Z_GmDe0uYNVNKIyLhww"
      decimals="3"
      id="Narr_rOYlNkellkSOvVXedhBCNw"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.329</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_WeightedAverageMember_4FG0vtdOM0qVouBNBJxDYA"
      decimals="3"
      id="Narr_cENN7tG1S0CQHU6IS0P0Ig"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.136</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_WeightedAverageMember_ZWzC0poj30O0x-cniAS5CA"
      decimals="3"
      id="Narr_Dofu4HogWkqBaqeTnrFq8g"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.136</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_WeightedAverageMember_X-fZxVt670yVn-ag8aFnSg"
      decimals="3"
      id="Narr_JHArfPSexEekE9mbhOF2rA"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.136</ifrs-full:ApplicableTaxRate>
    <aciu:DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_SmIZ2Gkb7EO3eoVpnQkBrw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The Group&#x2019;s income tax expense for each&#160;year can be reconciled to loss before tax as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Loss before income tax &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (54,223)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (70,740)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (72,993)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Tax benefit calculated at the domestic rates applicable in the respective countries &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,371)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (9,616)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (9,930)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;(Income not subject to tax)/expenses not deductible for tax purposes&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 611&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 455&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (375)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Effect of unused tax losses and tax offsets not recognized as deferred tax assets &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,770&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,174&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 10,308&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Effective income tax rate expense &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 10&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 13&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</aciu:DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock>
    <ifrs-full:AccountingProfit
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_fTgydbH3skCU6XGYT3cz7g_4_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-54223000</ifrs-full:AccountingProfit>
    <ifrs-full:AccountingProfit
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_leYI750fNUKCsyHDrdjeXw_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-70740000</ifrs-full:AccountingProfit>
    <ifrs-full:AccountingProfit
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_MUc1SBSZ4UmXg-LA5ms11w_4_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-72993000</ifrs-full:AccountingProfit>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_joKZbwVVO0y54OiPix0Zrg_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-7371000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_w6Fmw0PiC0GOOjEIFM7s5A_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-9616000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_PqfJPmwvaEu5dVmMz4ds6Q_5_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-9930000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <aciu:TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_6oARy5De1kGs7FIazhmpnQ_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">611000</aciu:TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes>
    <aciu:TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_pgC66Skk-0atw9TM0TyxXw_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">455000</aciu:TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes>
    <aciu:TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_CADJYtv3B0GneaX_Ri_Evw_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-375000</aciu:TaxEffectOfIncomeNotSubjectToTaxAndExpensesNotDeductibleForTaxPurposes>
    <ifrs-full:TaxEffectOfTaxLosses
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_V649yho-w06R37RZuvrVmQ_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">6770000</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:TaxEffectOfTaxLosses
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_TwKDOoXl2EOQsXsXHnuRHg_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">9174000</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:TaxEffectOfTaxLosses
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_u0H48-MUTkiKDst1HzHlKA_7_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">10308000</ifrs-full:TaxEffectOfTaxLosses>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_psBcifw2z0qJaNQYMNevdQ_8_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">10000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_qECH2RrxRECCFaMFqtyT_g_8_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">13000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_7XNBo_22IUOOtJoTcrVtbQ_8_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_GeographicalAreasAxis_country_CH_hI8bZ3TK70-bfSp_6iHWkw"
      decimals="3"
      id="Narr_zeLnkTCQq0aYPq9HCrEU4w"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.136</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="3"
      id="Narr_8c82EEneiU6KZyv_9C-IyQ"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.136</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="3"
      id="Narr_HU9I7mRaVUuGK2XzV8tAtA"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.136</ifrs-full:ApplicableTaxRate>
    <ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_SxvluN1mO0O-n_X6IdtTSg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The below table details the total unrecognized deductible temporary differences, unused tax losses and unused tax credits:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Unrecognized deductible temporary differences, unused tax losses and unused tax credits&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Deductible temporary differences, unused tax losses and unused tax credits for which no deferred tax assets have been recognized are attributable to the following:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;Tax losses &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 312,972&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 264,089&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 197,152&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;Deductible temporary differences related to:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 18pt;"&gt;Right-of-use assets and lease liabilities, net&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 18pt;"&gt;Retirement benefit plan &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5,770&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,213&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,098&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 318,742&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 267,302&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 204,250&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2023_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_2nj8zIQ95U6QDxkvALWpOw"
      decimals="-3"
      id="Tc_JYB5rmGR90a_Km2cNA8sMw_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">312972000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_vDSFPVowe067uhYZQdHFgQ"
      decimals="-3"
      id="Tc_GEwQ3vCWMkyHp_unhI7yoA_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">264089000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrs-full_UnusedTaxLossesMember_DnkavB3_kUKnU6RtWKx2Ow"
      decimals="-3"
      id="Tc_MxvoyS-pqk2uVSlg0Lda8Q_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">197152000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2023_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_7dWOVnOSFUq1x4XujqX_oA"
      decimals="-3"
      id="Tc_VkzG74TYEkO_xjPsPbchiw_8_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_RA7Xt4V3fUCJ2nNa8SxwcA"
      decimals="-3"
      id="Tc_bEMA6Ea09UmwdVAnXWuUuA_8_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RightOfUseAssetsAndLeaseLiabilitiesNetMember_ikz_e9A97Ea1rUgxFPK-vg"
      decimals="-3"
      id="Tc_imLWY1IwREiVDWmbXDp2gA_8_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2023_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_sNU1oHf-Q0i6Of2JKbOZPA"
      decimals="-3"
      id="Tc_kR0o2GecOUuLNf0FY3wMzw_9_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">5770000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2022_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_TabmlKnxSE2DHBh6lcLTdA"
      decimals="-3"
      id="Tc_h7voRhWAUEyMNKbiuPg-Dw_9_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3213000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2021_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_aciu_RetirementBenefitPlanMember_vxoJ2RbCcEe-EQHCnzF_IQ"
      decimals="-3"
      id="Tc_qsP82sffiESwn6mII0v89Q_9_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">7098000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_dZ5oJ1E38UOuDCmRo9g2Jg_10_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">318742000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_0upwON2YtkqfioClev5GCQ_10_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">267302000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="-3"
      id="Tc_-57LrJb7mUmM7wh_C2U3fg_10_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">204250000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <aciu:DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_ofEh2lE5q0av3g1DE2pc4Q">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table details the tax losses carry forwards of the Company and their respective expiry dates:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Tax losses split by expiry date:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,231&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,231&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 15,231&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 48,894&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 48,894&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 48,894&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2026&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2027&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 57,824&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 57,824&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 57,824&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2028&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 75,204&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 75,204&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 75,204&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2029&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 66,936&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 66,936&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;December&#160;31,&#160;2030&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 48,883&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total unrecorded tax loss carryforwards&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 312,972&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 264,089&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 197,153&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</aciu:DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312024Member_9PsLbtvfWkWuSDEFjmSZYA"
      decimals="-3"
      id="Tc_XqkW7jR8yUqZu_F-KdiEFQ_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">15231000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312024Member_ODQ0kdFPZUG27qH4k1wNgA"
      decimals="-3"
      id="Tc_PxhaZ9zI-0CMiY1px5UNhg_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">15231000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312024Member_aAlt2XZpC0uOboJTpNYv4g"
      decimals="-3"
      id="Tc_GarT8MRyFUWNNH7ScdADqA_5_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">15231000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312025Member_1bi1vT0nc0u2Xh-S7Lt9PQ"
      decimals="-3"
      id="Tc_vcKgsQDT0kytNGrOMpJzAQ_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">48894000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312025Member_GGbghK-VE0StWeUg1GPupQ"
      decimals="-3"
      id="Tc_ihGbNHjdl0m2DxKEnWWXJw_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">48894000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312025Member_qeqHInhEQkOUN0SZFu9S6g"
      decimals="-3"
      id="Tc_MfbkenJuk0WoKu2LhroyWQ_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">48894000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312026Member_iGQ4s9Lt50alrF3FP1KcQA"
      decimals="-3"
      id="Tc_V8yxxJYUPUyQmPLrO6VsTQ_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312026Member_AZE5FSsJIkCOiIDjG4AMqg"
      decimals="-3"
      id="Tc_DrcdnUSB-0m9BzZVUulObQ_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312026Member_R-5b-bEhfk2AijECdFfhAg"
      decimals="-3"
      id="Tc_dpiv_sev206OEo8FBZptYw_7_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312027Member_1R5SXknjqkWUWP0mLRRZ_A"
      decimals="-3"
      id="Tc_xTv-TYNhaEuA_Y7Ofl93_w_8_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">57824000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312027Member_4_H5GnUE2EO-6fMiAfFadQ"
      decimals="-3"
      id="Tc_S_XZf97TbUqnZAnPX76BRg_8_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">57824000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312027Member_focY9wr8pUGC-t4W6eLn8w"
      decimals="-3"
      id="Tc_IDGAlCw9YEyVOtbAnUyuNw_8_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">57824000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312028Member_r0Sy7JDN_k2I6y5Q8lYXcQ"
      decimals="-3"
      id="Tc_Czt-neBkHUen8qDML3msbg_9_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">75204000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312028Member_PSDaq1Iknkqy7hP1uOdwxw"
      decimals="-3"
      id="Tc_d_ev2AwZs0a-Pay9dSMRWw_9_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">75204000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312028Member__3-rt4ONB0WjYegP6jLv5A"
      decimals="-3"
      id="Tc_u4hL3D2MTkyj__O6Fmm3gg_9_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">75204000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312029Member_RxSJlFvxd0uLTKolUL3zSQ"
      decimals="-3"
      id="Tc_P5jyEO4J9k-Q-t_ijF_syQ_10_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">66936000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312029Member_AnOPccdCO0yOmasUrlkU1A"
      decimals="-3"
      id="Tc_m1Mw3kHjCUuh0jHLXXEE0w_10_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">66936000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312029Member_3dOqpfnfckCEIMcHBimfcQ"
      decimals="-3"
      id="Tc_92jBAtRoWE2O3-EAy-WG2Q_10_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_aciu_December312030Member_O4olP_9OfE6MhoH0EV3nbQ"
      decimals="-3"
      id="Tc_JYNRAgg5J0e5V0J8vFKCqw_11_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">48883000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_aciu_December312030Member_UxPXRokBZESrDLq3Evh4eQ"
      decimals="-3"
      id="Tc_kGeAZcYo-E6gokKxIqA_2g_11_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2021_ifrs-full_MaturityAxis_aciu_December312030Member_5kb1PG5AuUO0S-gCtjrH-Q"
      decimals="-3"
      id="Tc_AuZX9y-RV02T5HH_A5Zepg_11_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_6_m7YMFHEke8YbwXqqacWw_12_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">312972000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_dv12CS6VrUedA1akDA5ixQ_12_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">264089000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="-3"
      id="Tc_nqfoSiAZ3UGwZvWUYgVOCw_12_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">197153000</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <aciu:IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-5"
      id="Narr_kb9txZolNEO_W2yyKAEEIA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">48900000</aciu:IncreaseDecreaseInTaxLossesAvailableForOffsetAgainstFutureTaxableProfits>
    <ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_SD-XVkt9XUG0GQTxUaHzNg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;18.&lt;/b&gt;&lt;/span&gt;Retirement benefit plan&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company participates in a collective foundation covering all of its employees including its executive officers. In addition to retirement benefits, the plan provides death or long-term disability benefits.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Contributions paid to the plan are computed as a&#160;percentage of salary, adjusted for the age of the employee and shared approximately 47% and 53% by employee and employer, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;This plan is governed by the Swiss Law on Occupational Retirement, Survivors and Disability Pension Plans (BVG), which requires contributions to be made to a separately administered fund. The fund has the legal form of a foundation and it is governed by a board of trustees, which consists of an equal number of employer and employee representatives of its members. The board of trustees is responsible for the administration of the plan assets and for the definition of the investment strategy. The Company has no direct influence on the investment strategy of the foundation board.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The assets are invested by the pension plan, to which many companies contribute, in a diversified portfolio that respects the requirements of the Swiss BVG. Therefore, disaggregation of the pension assets and presentation of plan assets in classes that distinguish the nature and risks of those assets is not possible. Under the plan, both the Company and the employee share the costs. The structure of the plan and the legal provisions of the BVG mean that the employer is exposed to actuarial risks. The main risks are investment risk, interest risk, disability risk and the life expectancy of pensioners. Through our affiliation with the pension plan, the Company has minimized these risks, as they are shared between a much greater number of participants. On leaving the Company, a departing employee&#x2019;s retirement savings are transferred to the pension institution of the new employer or to a vested benefits institution. This transfer mechanism may result in pension payments varying considerably from&#160;year to&#160;year.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The pension plan is exposed to Swiss inflation, interest rate risks and changes in the life expectancy for pensioners. For accounting purposes under IFRS, the plan is treated as a defined benefit plan in accordance with IAS 19.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table sets forth the status of the defined benefit pension plan and the amount that is recognized in the consolidated balance sheets:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Defined benefit obligation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (41,060)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (32,410)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (33,889)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Fair value of plan assets &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 35,290&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 29,197&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 26,791&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total liability &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,770)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,213)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,098)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following amounts have been recorded as net pension cost in the consolidated statements of income/(loss):&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Current service cost &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,453&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,712&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,648&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Past service cost&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 903&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest cost &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 804&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 126&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 79&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest income &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (705)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (87)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (48)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net pension cost &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,455&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,751&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,679&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The changes in defined benefit obligation, fair value of plan assets and unrecognized gains/(losses) are as follows.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;A. Change in defined benefit obligation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Defined benefit obligation as of January 1 &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (32,410)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (33,889)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (30,213)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Current service cost &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,453)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,712)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,648)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Past service cost&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (903)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest cost &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (804)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (126)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (79)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Change in demographic assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 136&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 29&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Change in financial assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,908)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,397&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 156&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Change in experience assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (57)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,726)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (252)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Benefits deposited &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,265)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,327)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (894)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Employees&#x2019; contributions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,396)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,056)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (959)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Defined benefit obligation as of December&#160;31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (41,060)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (32,410)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (33,889)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;B.&lt;/b&gt;&lt;/span&gt;Change in fair value of plan assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair value of plan assets as of January 1 &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 29,197&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 26,791&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 22,749&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest income &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 705&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 87&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 48&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Employees&#x2019; contributions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,396&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,056&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 959&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Employer&#x2019;s contributions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,567&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,210&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,089&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Benefits deposited&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,265&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,327&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 894&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Return on plan assets excluding interest income &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,160&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,274)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,052&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair value of plan assets as of December&#160;31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 35,290&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 29,197&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 26,791&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Expected contributions by the employer to be paid to the post-employment benefit plans during the annual period beginning after the end of the reporting period amount to approximately CHF 1.6 million.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;C.&lt;/b&gt;&lt;/span&gt;Change in net defined benefit liability&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net defined benefit liabilities as of January 1 &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,213&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,098&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,464&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Net pension cost through statement of income/(loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,455&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,751&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,679&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Remeasurement through other comprehensive income/(loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,669&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (4,426)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (956)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Employer&#x2019;s contribution &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,567)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,210)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,089)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net defined benefit liabilities as of December&#160;31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5,770&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,213&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,098&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;D.&lt;/b&gt;&lt;/span&gt;Other comprehensive gains/(losses)&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Effect of changes in demographic assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 136&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 29&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Effect of changes in financial assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,908)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,397&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 156&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Effect of changes in experience assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (57)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,726)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (252)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Return on plan assets excluding interest income &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,160&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,274)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,052&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total other comprehensive gain/(loss)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,669)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,426&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 956&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In 2022, the change in experience assumptions results from an increased sum of insured salaries.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The fair value of the plan assets is the cash surrender value of the insurance with the insurance company (AXA). The investment strategy defined by the board of trustees follows a conservative profile.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The plan assets are primarily held within instruments with quoted market prices in an active market, with the exception of real estate and mortgages.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The weighted-average duration of the defined benefit obligation is 15.5&#160;years and 14.9&#160;years as of December&#160;31, 2023 and 2022, respectively.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The actuarial assumptions used for the calculation of the pension cost and the defined benefit obligation of the defined benefit pension plan for the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively, are as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:52.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:52.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Discount rate &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1.50&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2.25&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.30&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Rate of future increase in compensations &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1.75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1.75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1.75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Rate of future increase in current pensions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest rate on retirement savings capital&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1.50&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2.25&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Mortality and disability rates &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;BVG 2020 GT (CMI)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;BVG 2020-CMI&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;BVG 2020-CMI&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In defining the benefits, the minimum requirements of the Swiss BVG and its implementing provisions must be observed. The BVG defines the minimum pensionable salary and the minimum retirement credits.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;A quantitative sensitivity analysis for significant assumptions as of December&#160;31, 2023 is shown below:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Interest&#160;rate&#160;on&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Discount&#160;rate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Future&#160;salary&#160;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Future&#160;pension&#160;cost&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;savings&#160;capital&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Assumptions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:0pt;visibility:hidden;"&gt;&lt;td colspan="17" style="padding:0pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:68.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In&#160;CHF&#160;thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Potential defined benefit obligation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 38,132&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 44,390&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 41,997&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 40,205&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 42,681&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 39,578&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 42,158&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 40,030&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Decrease/(increase) from actual defined benefit obligation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,928&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,330)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (937)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 855&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,621)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,482&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,098)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,030&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;A quantitative sensitivity analysis for significant assumptions as of December&#160;31, 2022 is shown below:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Interest&#160;rate&#160;on&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Discount&#160;rate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Future&#160;salary&#160;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Future&#160;pension&#160;cost&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;savings&#160;capital&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Assumptions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:0pt;visibility:hidden;"&gt;&lt;td colspan="17" style="padding:0pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:68.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in&#160;CHF&#160;thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Potential defined benefit obligation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 30,201&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 34,916&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 32,940&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,841&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 33,601&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,322&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 33,322&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,545&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Decrease/(increase) from actual defined benefit obligation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,209&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,506)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (530)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 569&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,191)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,088&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (912)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 865&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The sensitivity analyses above are subject to limitations and have been determined based on a method that extrapolates the impact on net defined benefit obligation as a result of reasonable changes in key assumptions occurring at the end of the reporting period.&lt;/p&gt;</ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory>
    <aciu:DefinedBenefitPlansPercentageOfContributionsByEmployees
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="2"
      id="Narr_IdL_34__w0aqSNpr9qDciA"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.47</aciu:DefinedBenefitPlansPercentageOfContributionsByEmployees>
    <aciu:DefinedBenefitPlansPercentageOfContributionsByEmployer
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="2"
      id="Narr_5M9YoSYkhUO1X9iuMKd9xg"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.53</aciu:DefinedBenefitPlansPercentageOfContributionsByEmployer>
    <aciu:DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_owVyOu-Yekio5kOdPUfTtw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table sets forth the status of the defined benefit pension plan and the amount that is recognized in the consolidated balance sheets:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Defined benefit obligation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (41,060)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (32,410)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (33,889)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Fair value of plan assets &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 35,290&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 29,197&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 26,791&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total liability &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (5,770)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,213)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (7,098)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</aciu:DisclosureOfAmountsRecognisedInBalanceSheetFromDefinedBenefitPlansTableTextBlock>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_T4RUiYena0iebgdROd5Ygw_4_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">41060000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_YUiWoM7oXU6hiZ2-b-ktHQ_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">32410000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="-3"
      id="Tc_zDFBZPyQAEO-ClVPRmCL2g_4_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">33889000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_nHzHsleX7UGh8_1ru_1qjg_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">35290000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_g9DtPbS4RkyFILqt-3ZT1Q_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">29197000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="-3"
      id="Tc_A7cDxQvgmUGP1BRj7MXctA_5_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">26791000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:SurplusDeficitInPlan
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_ipHmqd1egEWqT5_dhX_Uog_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-5770000</ifrs-full:SurplusDeficitInPlan>
    <ifrs-full:SurplusDeficitInPlan
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_gvk5732V20y35pInX-vmUg_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-3213000</ifrs-full:SurplusDeficitInPlan>
    <ifrs-full:SurplusDeficitInPlan
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="-3"
      id="Tc_LO6xDPqpMEyinIg8XoLgRw_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-7098000</ifrs-full:SurplusDeficitInPlan>
    <aciu:DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_-hm33go8q0OJ1kJwYaSOaw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following amounts have been recorded as net pension cost in the consolidated statements of income/(loss):&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Current service cost &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,453&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,712&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,648&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Past service cost&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 903&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest cost &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 804&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 126&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 79&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest income &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (705)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (87)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (48)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net pension cost &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,455&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,751&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,679&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</aciu:DisclosureOfAmountsRecognisedInStatementOfProfitAndLossFromDefinedBenefitPlansTableTextBlock>
    <ifrs-full:CurrentServiceCostDefinedBenefitPlans
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_HmYCdzxnCU6mNJHtvsqw7w_4_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1453000</ifrs-full:CurrentServiceCostDefinedBenefitPlans>
    <ifrs-full:CurrentServiceCostDefinedBenefitPlans
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_wqoUBtacvEy8YXdOS8VKmA_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1712000</ifrs-full:CurrentServiceCostDefinedBenefitPlans>
    <ifrs-full:CurrentServiceCostDefinedBenefitPlans
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_SfvaBjqzLESr0OsxRCWd6g_4_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1648000</ifrs-full:CurrentServiceCostDefinedBenefitPlans>
    <ifrs-full:PastServiceCostDefinedBenefitPlans
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_O133A6iQEEmgc0GNcacoSg_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">903000</ifrs-full:PastServiceCostDefinedBenefitPlans>
    <ifrs-full:InterestExpenseDefinedBenefitPlans
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_S6Yruhx2lEOyIJ9xHOSDaA_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">804000</ifrs-full:InterestExpenseDefinedBenefitPlans>
    <ifrs-full:InterestExpenseDefinedBenefitPlans
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_oUaYgZAyHkuPVC7cOFgJPA_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">126000</ifrs-full:InterestExpenseDefinedBenefitPlans>
    <ifrs-full:InterestExpenseDefinedBenefitPlans
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_bIsD4c2YrEK9CqdF647TMQ_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">79000</ifrs-full:InterestExpenseDefinedBenefitPlans>
    <ifrs-full:InterestIncomeDefinedBenefitPlans
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_wIyJx2d3XEu0pA_8NTrtwg_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">705000</ifrs-full:InterestIncomeDefinedBenefitPlans>
    <ifrs-full:InterestIncomeDefinedBenefitPlans
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_UAO879tVPU2PzrBsoEuEGQ_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">87000</ifrs-full:InterestIncomeDefinedBenefitPlans>
    <ifrs-full:InterestIncomeDefinedBenefitPlans
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_mllZAQyCLEOHyYV6yEUeQw_7_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">48000</ifrs-full:InterestIncomeDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_EXZ6gN6O7EyrGZlGzA0e7A_8_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2455000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_3uED-SSSKEu_BoHyUI_ytg_8_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1751000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_6vly2y0g906G0o1JYzQ-iQ_8_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1679000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_cSy3P_Sd10ix4CiX8hG_WQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The changes in defined benefit obligation, fair value of plan assets and unrecognized gains/(losses) are as follows.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;A. Change in defined benefit obligation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Defined benefit obligation as of January 1 &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (32,410)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (33,889)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (30,213)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Current service cost &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,453)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,712)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,648)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Past service cost&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (903)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest cost &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (804)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (126)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (79)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Change in demographic assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 136&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 29&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Change in financial assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,908)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,397&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 156&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Change in experience assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (57)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,726)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (252)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Benefits deposited &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,265)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,327)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (894)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Employees&#x2019; contributions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,396)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,056)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (959)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Defined benefit obligation as of December&#160;31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (41,060)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (32,410)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (33,889)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;B.&lt;/b&gt;&lt;/span&gt;Change in fair value of plan assets&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair value of plan assets as of January 1 &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 29,197&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 26,791&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 22,749&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest income &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 705&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 87&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 48&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Employees&#x2019; contributions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,396&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,056&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 959&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Employer&#x2019;s contributions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,567&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,210&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,089&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Benefits deposited&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,265&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,327&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 894&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Return on plan assets excluding interest income &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,160&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,274)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,052&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Fair value of plan assets as of December&#160;31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 35,290&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 29,197&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 26,791&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Expected contributions by the employer to be paid to the post-employment benefit plans during the annual period beginning after the end of the reporting period amount to approximately CHF 1.6 million.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;C.&lt;/b&gt;&lt;/span&gt;Change in net defined benefit liability&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net defined benefit liabilities as of January 1 &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,213&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,098&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,464&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Net pension cost through statement of income/(loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,455&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,751&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,679&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Remeasurement through other comprehensive income/(loss)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,669&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (4,426)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (956)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Employer&#x2019;s contribution &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,567)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,210)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,089)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Net defined benefit liabilities as of December&#160;31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5,770&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,213&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,098&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_VqvB-19b-ky0XrrBCaxruQ"
      decimals="-3"
      id="Tc_9UJCcD_dUUuF-3C5-MWqOw_4_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">32410000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_8zOs7UR4806DfHazcSGULA"
      decimals="-3"
      id="Tc_pMx4je6pFk6QZ2R1YFc73Q_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">33889000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_ncAHP2PXEEG29m0kCbCu1w"
      decimals="-3"
      id="Tc_kFTkscGb2ESuWwWn0NXncg_4_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">30213000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_vEGhjd8tq0OSqur2Fe4jnA"
      decimals="-3"
      id="Tc_jc7BVsBi5UW4JPjVVehwWA_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1453000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_-rFc59jcN0aZx3IBH9mm7A"
      decimals="-3"
      id="Tc_ZEMqdEO6xEag21yshqEy8w_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1712000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_BeNb7Z3yiUS-lTANhWp0_g"
      decimals="-3"
      id="Tc_9FRLhbqj7EmboUZaRjPjMA_5_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1648000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_vEGhjd8tq0OSqur2Fe4jnA"
      decimals="-3"
      id="Tc_uXcMORbExEilJbWDTnWNNQ_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">903000</ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_vEGhjd8tq0OSqur2Fe4jnA"
      decimals="-3"
      id="Tc_e6R8C6GWX0mdOrZYjaEHdg_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">804000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_-rFc59jcN0aZx3IBH9mm7A"
      decimals="-3"
      id="Tc_W2EckpyZw029Gr0tUSwU8Q_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">126000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_BeNb7Z3yiUS-lTANhWp0_g"
      decimals="-3"
      id="Tc_Ttp96B6cpEmpqZxgOgX3mw_7_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">79000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_vEGhjd8tq0OSqur2Fe4jnA"
      decimals="-3"
      id="Tc_nWatZh-ZIkqjWdmvPa0NoA_8_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">136000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_-rFc59jcN0aZx3IBH9mm7A"
      decimals="-3"
      id="Tc_l8TtXdqwOUKvIfy8AT_v1g_8_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">29000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_BeNb7Z3yiUS-lTANhWp0_g"
      decimals="-3"
      id="Tc_PZFIe_VVAUKvCBStV3yTLQ_8_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_vEGhjd8tq0OSqur2Fe4jnA"
      decimals="-3"
      id="Tc_8o8cEY-K_0KHoN2dg57ojA_9_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-2908000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_-rFc59jcN0aZx3IBH9mm7A"
      decimals="-3"
      id="Tc_FULMdSe_D0-7PWQEDGwaJg_9_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">8397000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_BeNb7Z3yiUS-lTANhWp0_g"
      decimals="-3"
      id="Tc_s9XVZIsNSkmyRjujCcDapg_9_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">156000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_vEGhjd8tq0OSqur2Fe4jnA"
      decimals="-3"
      id="Tc_sekSSrqREEmOdc9NvhbprA_10_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-57000</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_-rFc59jcN0aZx3IBH9mm7A"
      decimals="-3"
      id="Tc_dhE9AAjaHEGeRPgm7Irm-g_10_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1726000</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_BeNb7Z3yiUS-lTANhWp0_g"
      decimals="-3"
      id="Tc_99QS5eW5QkOQYFP-j35BMw_10_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-252000</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset>
    <aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_vEGhjd8tq0OSqur2Fe4jnA"
      decimals="-3"
      id="Tc_PJ-55GRShUW1I9YdOK1fxw_11_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1265000</aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited>
    <aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_-rFc59jcN0aZx3IBH9mm7A"
      decimals="-3"
      id="Tc_kLH2z7xbBkmcK86Mu9E5aw_11_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2327000</aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited>
    <aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_BeNb7Z3yiUS-lTANhWp0_g"
      decimals="-3"
      id="Tc_l2gNph9Epkq7qUz0I_i9YA_11_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">894000</aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_vEGhjd8tq0OSqur2Fe4jnA"
      decimals="-3"
      id="Tc_FohUsvyCJUKaYqtVun5Qbg_12_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1396000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_-rFc59jcN0aZx3IBH9mm7A"
      decimals="-3"
      id="Tc_WJQls0gEzEuTYY4xDE_ehg_12_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1056000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_BeNb7Z3yiUS-lTANhWp0_g"
      decimals="-3"
      id="Tc_AS7Q3jWE30WxT1szgorxzg_12_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-959000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_JjEtusAETU-e1_9QP3d1Ig"
      decimals="-3"
      id="Tc_W-PhQDkWwkmuOXDepwkC-w_13_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">41060000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_VqvB-19b-ky0XrrBCaxruQ"
      decimals="-3"
      id="Tc_GU0TmoQn_0uS7m2orWlYDA_13_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">32410000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PresentValueOfDefinedBenefitObligationMember_8zOs7UR4806DfHazcSGULA"
      decimals="-3"
      id="Tc_1gOmK67jl0-CUXHH_JBbqg_13_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">33889000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_WNkxs9Sy4kSxSAoCQwsxGw"
      decimals="-3"
      id="Tc__i75Ex4m6ECl4f87C6izYQ_4_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-29197000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_lp_ntzhbq0OJga_mHVbrOw"
      decimals="-3"
      id="Tc__IWKEbJhTEyRHA56muWFXA_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-26791000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2020_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_v1U_eyxTiEaM8eTayPpQkw"
      decimals="-3"
      id="Tc_2zKFxumbHkuYWmNkmZsFVQ_4_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-22749000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_u2Lf31padU-hQMejGWu9Jg"
      decimals="-3"
      id="Tc_6_bbnPwdakiKQI31MkL7ZQ_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-705000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_JOULfIYynEyk9vA-N_O54Q"
      decimals="-3"
      id="Tc_QzXrjmaUHE6l1AIFV0CRcA_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-87000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_NAuDi-J-j0OrVs4jx0zGUw"
      decimals="-3"
      id="Tc_X5YQt6I9LUmQJ8HcY3KcRQ_5_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-48000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_u2Lf31padU-hQMejGWu9Jg"
      decimals="-3"
      id="Tc_4H_y4S6ycUeqj8a79Fjmfw_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1396000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_JOULfIYynEyk9vA-N_O54Q"
      decimals="-3"
      id="Tc_agZTyb_yiEmQoq7naLyaKg_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1056000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_NAuDi-J-j0OrVs4jx0zGUw"
      decimals="-3"
      id="Tc_dJ7RT2HDQUerjIgrz1F5yw_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">959000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_u2Lf31padU-hQMejGWu9Jg"
      decimals="-3"
      id="Tc_Al_DxBS7nEKi-IEo9BZb8g_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1567000</ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_JOULfIYynEyk9vA-N_O54Q"
      decimals="-3"
      id="Tc_xz4L-7LvUES0SCOeoidQ_A_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1210000</ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_NAuDi-J-j0OrVs4jx0zGUw"
      decimals="-3"
      id="Tc_xM5uB4WftUytB27ALI3UUA_7_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1089000</ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset>
    <aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_u2Lf31padU-hQMejGWu9Jg"
      decimals="-3"
      id="Tc_U87JFrORYUyab8toGOR4oA_8_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1265000</aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited>
    <aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_JOULfIYynEyk9vA-N_O54Q"
      decimals="-3"
      id="Tc_TvnVvpeP1kC3Z8c_Fp6SVg_8_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-2327000</aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited>
    <aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_NAuDi-J-j0OrVs4jx0zGUw"
      decimals="-3"
      id="Tc_s9VL3fm35U-9gSK65TafZA_8_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-894000</aciu:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromBenefitsDeposited>
    <ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_u2Lf31padU-hQMejGWu9Jg"
      decimals="-3"
      id="Tc_n-5W5HQ_mUSGgx_fNY7LLw_9_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1160000</ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_JOULfIYynEyk9vA-N_O54Q"
      decimals="-3"
      id="Tc_1bhwM6sZ4kacPVdqCCOerw_9_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-2274000</ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_NAuDi-J-j0OrVs4jx0zGUw"
      decimals="-3"
      id="Tc_SErQXpAg8EaJLlgQkljF6w_9_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1052000</ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2023_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_1XJ24mu0_k2BAymKVrDuJA"
      decimals="-3"
      id="Tc_JUupohq6jkGtvkuovIyhow_10_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-35290000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2022_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_WNkxs9Sy4kSxSAoCQwsxGw"
      decimals="-3"
      id="Tc_M0f6Da7BjkqoHm2Cltj_Yg_10_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-29197000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2021_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_ifrs-full_PlanAssetsMember_lp_ntzhbq0OJga_mHVbrOw"
      decimals="-3"
      id="Tc_T4QqQHIdJkKgev53XmNkVQ_10_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-26791000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-5"
      id="Narr_Kvbs9-NcDkeYmIR9mjpKPA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1600000</ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_VZUvtm0scEiDHAjPTYdSSw_4_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3213000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="-3"
      id="Tc_iUnfAljRlkKEXuN_d7ymWQ_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">7098000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2020_kISrj4aRVketNj-9seXAtQ"
      decimals="-3"
      id="Tc_8tEobPIq2U6ObErzhOK6tw_4_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">7464000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_LREuZrdsuUevji7H26RJ2w_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2455000</ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_FZNKzdJc-ESEMGKhD66J4w_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1751000</ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_t14Z84JwtkyE2VqT81lTKw_5_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1679000</ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromExpenseIncomeInProfitOrLoss>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_OhnUeuyoXEGLt8wB_vTqlQ_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1669000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_9Ow-l3KqAUK5aUTnXoCg1A_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4426000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_JYgVW6kfSk2z4-ilDmd5fQ_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">956000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_aqEB8ZTeiE-YGnx-pq0m4Q_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1567000</ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_GLMP_6AAwUOVo-Wo47sNig_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1210000</ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_lTysNqnt8EOxrd6PqWkWeg_7_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1089000</ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_aJzGcAh3-U-towRfGolrZA_8_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">5770000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_5Pv_CO2P10mropOooQmprQ_8_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3213000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="-3"
      id="Tc_D8Yg46OL40SuFwjWVVFc0w_8_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">7098000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <aciu:DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_Tl1BgA-X9UKGibLxf2wWuw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;D.&lt;/b&gt;&lt;/span&gt;Other comprehensive gains/(losses)&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:32.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Effect of changes in demographic assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 136&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 29&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Effect of changes in financial assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,908)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 8,397&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 156&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Effect of changes in experience assumptions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (57)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,726)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (252)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Return on plan assets excluding interest income &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,160&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,274)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,052&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.27%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total other comprehensive gain/(loss)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,669)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,426&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 956&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</aciu:DisclosureOfAmountsRecognisedInStatementOfOtherComprehensiveIncomeFromDefinedBenefitPlansTableTextBlock>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_r3xAFZOL-0SGbmldxK5s7w_4_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">136000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_RpYe4Cd130mlyT5eHWnU_Q_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">29000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_fxeNG6Qk5USkkeOfmO2UtQ_4_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">0</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_qY9sRc2dLk2a5x1Toy-IBw_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-2908000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_cVueCX75_kGyaanDPw9W4Q_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">8397000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc__FH8C1ZLR0-xPx_2kLEyQA_5_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">156000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_bQCM2Ew7skKo672UXl8VsA_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-57000</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_yOzY8SDnOUiwZ5-G21NPsg_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1726000</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_UiGmBBP_K0mv73HuztFcEg_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-252000</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_Bc3zMn905kagoXDsBzLZIQ_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1160000</ifrs-full:ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_nhpz3opD-0-PwM7-PtaRkA_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-2274000</ifrs-full:ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_jQv04Mounk-tEUR9U4I4Aw_7_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1052000</ifrs-full:ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_sYXwWTfj6kSOTLGbmcdpMg_8_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1669000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_MGKtTf5smEiaRYoz1as_hQ_8_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4426000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_LEoEhReE5kOjcMuzNRworQ_8_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">956000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_ZFX2pWnfG0CrA4dTsRVLfA">P15Y6M</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      id="Narr_nmUOCaBH8kC13SKg3fan-g">P14Y10M24D</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Group_PCsCG1bA0EGglTrD9KqjyA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The actuarial assumptions used for the calculation of the pension cost and the defined benefit obligation of the defined benefit pension plan for the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively, are as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:52.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:52.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Discount rate &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1.50&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2.25&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.30&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Rate of future increase in compensations &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1.75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1.75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1.75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Rate of future increase in current pensions &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.00&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.1%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Interest rate on retirement savings capital&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1.50&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2.25&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:44.1%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Mortality and disability rates &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:18.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;BVG 2020 GT (CMI)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;BVG 2020-CMI&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:14.18%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;BVG 2020-CMI&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;A quantitative sensitivity analysis for significant assumptions as of December&#160;31, 2023 is shown below:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Interest&#160;rate&#160;on&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Discount&#160;rate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Future&#160;salary&#160;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Future&#160;pension&#160;cost&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;savings&#160;capital&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Assumptions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:0pt;visibility:hidden;"&gt;&lt;td colspan="17" style="padding:0pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:68.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In&#160;CHF&#160;thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Potential defined benefit obligation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 38,132&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 44,390&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 41,997&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 40,205&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 42,681&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 39,578&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 42,158&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 40,030&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Decrease/(increase) from actual defined benefit obligation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,928&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (3,330)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (937)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 855&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,621)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,482&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,098)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,030&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;A quantitative sensitivity analysis for significant assumptions as of December&#160;31, 2022 is shown below:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Interest&#160;rate&#160;on&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Discount&#160;rate&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Future&#160;salary&#160;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Future&#160;pension&#160;cost&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;savings&#160;capital&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;0.5%&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Assumptions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;increase&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;decrease&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:0pt;visibility:hidden;"&gt;&lt;td colspan="17" style="padding:0pt;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;white-space:nowrap;width:68.34%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;in&#160;CHF&#160;thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Potential defined benefit obligation &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 30,201&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 34,916&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 32,940&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,841&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 33,601&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,322&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 33,322&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.9%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,545&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:29.86%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Decrease/(increase) from actual defined benefit obligation&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,209&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,506)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (530)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 569&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (1,191)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,088&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (912)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:6.9%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 865&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="4"
      id="Tc_JmKKEFSuhUWCGq1anXQOzg_4_2"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.0150</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="4"
      id="Tc_O2_tlSwMEkSDk2geWaaDOQ_4_4"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.0225</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="4"
      id="Tc_NCN6i1LFGkiPWbD7zX5otQ_4_6"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.0030</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="4"
      id="Tc_QGUz2df4UUWkcL8Y6X9ahg_5_2"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.0175</ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="4"
      id="Tc_R0dzhcFPC0KX3L1rc8w02Q_5_4"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.0175</ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="4"
      id="Tc_cJxzbVdtrEONTDy0Os7nVQ_5_6"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.0175</ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="4"
      id="Tc_t2Z9Ae0XQEKAqh3CvqU70A_6_2"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.0000</ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="4"
      id="Tc_nAg__9-8DUSlsO7hYBC6vw_6_4"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.0000</ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="4"
      id="Tc_bxdqE-csfU22gnW50KYJIw_6_6"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.0000</ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases>
    <aciu:ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="4"
      id="Tc_ksaaVO26wEeiuaW05D6pOA_7_2"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.0150</aciu:ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital>
    <aciu:ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="4"
      id="Tc_qdaUrBSIVkehjRZmkbMSHA_7_4"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.0225</aciu:ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital>
    <aciu:ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="4"
      id="Tc_SViwxF5BzEuLa5g-IdmaNg_7_6"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.0075</aciu:ActuarialAssumptionOfInterestRateOnRetirementSavingsCapital>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_pTeQuKx_DkypZ9jWGI7C8A"
      decimals="3"
      id="Tc_dyepyaCC-EqDGldJohFVsw_3_2"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2023_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_AlsPMZbssk6ZJn1U2wtykg"
      decimals="3"
      id="Narr_GHGEibaYJ0WG0y0H4HRwFA"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_5DSHt4xHMUioT5NnjVwFog"
      decimals="3"
      id="Tc_sMK5e37SdEmS5DQbJ7XqHA_3_4"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2023_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Bpznvb8IJkGFAZJKePilRQ"
      decimals="3"
      id="Narr_AIoaz07IDk-hnSPRIt0ByA"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Wgnl3QSM2k-AdkHzUwxq5w"
      decimals="3"
      id="Tc_pQyIBujgSk2RHQW3UO6VYA_3_6"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2023_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_AlsPMZbssk6ZJn1U2wtykg"
      decimals="3"
      id="Narr_sp9Np68QDE274ELdTho4vg"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_8n56hl5TbUu6RGNb82sfRQ"
      decimals="3"
      id="Tc_ay8IH11A00mDvzHu3AKBQg_3_8"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2023_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Bpznvb8IJkGFAZJKePilRQ"
      decimals="3"
      id="Narr_IQQ8W79My0Gz2eRU54g3CA"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_L9p_QHOSw06twWSsiEgdWA"
      decimals="3"
      id="Tc_o9P4mT4EFkKKmf1brLyEsQ_3_10"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2023_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_AlsPMZbssk6ZJn1U2wtykg"
      decimals="3"
      id="Narr_mt550t3fZ0SRO53UptnwLA"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_pm-qrsouoE6flbV62qtS-Q"
      decimals="3"
      id="Tc_T5yXCqVXPk2nQkgOozz5sA_3_12"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2023_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Bpznvb8IJkGFAZJKePilRQ"
      decimals="3"
      id="Narr_j2GWIzGNOkGf1Qbf3O6qKg"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_iSoz2SOpp0qMTfUmXq481w"
      decimals="3"
      id="Tc_XOwt0yw2uE2TnzB3hF_INw_3_14"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2023_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_AlsPMZbssk6ZJn1U2wtykg"
      decimals="3"
      id="Narr_iExxwUkKGkSr-R6mHXnVXg"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_SYvFKt1x10y-adlxxUg4jg"
      decimals="3"
      id="Tc_OCj5nEgQKEahqT6GnZdh8g_3_16"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_pTeQuKx_DkypZ9jWGI7C8A"
      decimals="-3"
      id="Tc_LOk5mYAALESooAIuPNcryQ_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">38132000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_5DSHt4xHMUioT5NnjVwFog"
      decimals="-3"
      id="Tc_M6RQXvrd9kqoK7uQ7Kiwnw_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">44390000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Wgnl3QSM2k-AdkHzUwxq5w"
      decimals="-3"
      id="Tc_sdbJPboknEiH6d45zddbDQ_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">41997000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_8n56hl5TbUu6RGNb82sfRQ"
      decimals="-3"
      id="Tc_XKcX7sq9fEuIkPNUsWDCdg_6_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">40205000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_L9p_QHOSw06twWSsiEgdWA"
      decimals="-3"
      id="Tc_SI3luqPB_Ua5AUTgTMuEow_6_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">42681000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_pm-qrsouoE6flbV62qtS-Q"
      decimals="-3"
      id="Tc_V-M7BQHG_UuAiiTSyLpkOg_6_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">39578000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_iSoz2SOpp0qMTfUmXq481w"
      decimals="-3"
      id="Tc_ACDAjXaVgkqdSZLF8Rxy4Q_6_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">42158000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_SYvFKt1x10y-adlxxUg4jg"
      decimals="-3"
      id="Tc_N23A6WYloUWdKNMT4UyyoA_6_16"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">40030000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_pTeQuKx_DkypZ9jWGI7C8A"
      decimals="-3"
      id="Tc_qtbY4R1SnEeRUdaoFdFNZQ_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-2928000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_5DSHt4xHMUioT5NnjVwFog"
      decimals="-3"
      id="Tc_j6aue2hbJ0y2T11pkZV-cQ_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3330000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Wgnl3QSM2k-AdkHzUwxq5w"
      decimals="-3"
      id="Tc_wZ3Q1i5NpUuYrJEInwpZTw_7_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">937000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_8n56hl5TbUu6RGNb82sfRQ"
      decimals="-3"
      id="Tc_aM3Pe3pisk6gD5_HKqMREQ_7_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-855000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_L9p_QHOSw06twWSsiEgdWA"
      decimals="-3"
      id="Tc_wEsMkwYrBkS8Wtv_0vApiw_7_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1621000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_pm-qrsouoE6flbV62qtS-Q"
      decimals="-3"
      id="Tc_QD9rQi5G4kqjod3p4tU8yA_7_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1482000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_iSoz2SOpp0qMTfUmXq481w"
      decimals="-3"
      id="Tc_x0tWYBCBfEu9M6mLN3bM7Q_7_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1098000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2023_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_SYvFKt1x10y-adlxxUg4jg"
      decimals="-3"
      id="Tc_rHP_y08qN0yM9SMg6jlBbA_7_16"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1030000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_qq5UY0wRK0iOGrB4wG2l3A"
      decimals="3"
      id="Narr_Fhg4f3REG0CQVyb5Ln-mUQ"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_9z7dk_eBH0qm1qbNW_X2xQ"
      decimals="3"
      id="Tc_iT5oKHOd9USm7oBWkeCjjA_3_2"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_k-R7euyY30qLrbKzofgXgw"
      decimals="3"
      id="Narr_IoMufbagt0Oi0jKqp1L0MA"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_UfDNPUrGmUWnzu7Kv8E6RQ"
      decimals="3"
      id="Tc_e7dk8l3gtEioXeTfihnY_Q_3_4"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_qq5UY0wRK0iOGrB4wG2l3A"
      decimals="3"
      id="Narr_PUpUoUGYKEaj2--YWdEiyg"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_982Pjk152UCG0tmlUgcu9w"
      decimals="3"
      id="Tc_PhuMQ8_XgkiF2RendVnQBQ_3_6"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_k-R7euyY30qLrbKzofgXgw"
      decimals="3"
      id="Narr_EKWstZUQh0OqqCLO3JTszA"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_1VZZ1KUX8k2zfVZBeU_XRA"
      decimals="3"
      id="Tc_nw4yA4J_QUuvmsdeVdCm2A_3_8"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_qq5UY0wRK0iOGrB4wG2l3A"
      decimals="3"
      id="Narr_P4hfwMptjUCiBElRYxqRsw"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Z7UvVqXOEUmoT9JRq5CiYA"
      decimals="3"
      id="Tc_H3EeKtvu1k2ANHTL4WrQKQ_3_10"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_k-R7euyY30qLrbKzofgXgw"
      decimals="3"
      id="Narr_uzV7byXth0CGNWtiHqrPMA"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_Vku2j2aw2USeLFl-mDb8ow"
      decimals="3"
      id="Tc_x260BT4y6Ue0zYXCr6rR-A_3_12"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_qq5UY0wRK0iOGrB4wG2l3A"
      decimals="3"
      id="Narr_Mtk7dHVQtUKP79D1aini_g"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_fdq-KvKHrE64gHajV_F_bQ"
      decimals="3"
      id="Tc_Uy0VXNSczES8Y5Ie31Tdnw_3_14"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_k-R7euyY30qLrbKzofgXgw"
      decimals="3"
      id="Narr_C45W52SIJUCJmVr7YuwCoQ"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_FSXKfZmS80elUOwthR4Uxw"
      decimals="3"
      id="Tc_lMHUkuQjvU-mCCs3vjP7sg_3_16"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.005</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_9z7dk_eBH0qm1qbNW_X2xQ"
      decimals="-3"
      id="Tc_ZXb067J8f0SsOxfH5og52Q_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">30201000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_UfDNPUrGmUWnzu7Kv8E6RQ"
      decimals="-3"
      id="Tc_axYPdwuZNU2SBGanowkx6g_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">34916000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_982Pjk152UCG0tmlUgcu9w"
      decimals="-3"
      id="Tc_RprlaC-iT0yEYyGwIbaqjg_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">32940000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_1VZZ1KUX8k2zfVZBeU_XRA"
      decimals="-3"
      id="Tc_uuevBtmJCUmDaBZDMv0P7Q_6_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">31841000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Z7UvVqXOEUmoT9JRq5CiYA"
      decimals="-3"
      id="Tc_WIC45Ot-IEKZTsoDsSrUDg_6_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">33601000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_Vku2j2aw2USeLFl-mDb8ow"
      decimals="-3"
      id="Tc_6AuwZ6lLv0ij_mBRofwg0w_6_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">31322000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_fdq-KvKHrE64gHajV_F_bQ"
      decimals="-3"
      id="Tc_xkEm29NN7Eil6sYa_foYRg_6_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">33322000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_FSXKfZmS80elUOwthR4Uxw"
      decimals="-3"
      id="Tc_i59kPyKrOUOCk0VXOZaJRw_6_16"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">31545000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_9z7dk_eBH0qm1qbNW_X2xQ"
      decimals="-3"
      id="Tc_zxBYLn71R0O96I13xdxgUg_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-2209000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_UfDNPUrGmUWnzu7Kv8E6RQ"
      decimals="-3"
      id="Tc_FDK3v7b5DkGrMqckpGB3wA_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2506000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_982Pjk152UCG0tmlUgcu9w"
      decimals="-3"
      id="Tc_X-8r1Pk7aECpmuCH1A0Rqg_7_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">530000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_1VZZ1KUX8k2zfVZBeU_XRA"
      decimals="-3"
      id="Tc_iVlDB3KGwkiikAK-5Qk-GA_7_8"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-569000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_Z7UvVqXOEUmoT9JRq5CiYA"
      decimals="-3"
      id="Tc_QO6QPKjX10q-ktmwJ8tEzQ_7_10"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1191000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_Vku2j2aw2USeLFl-mDb8ow"
      decimals="-3"
      id="Tc_6vHF45ey3E6atB2uZSdMEw_7_12"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1088000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember_fdq-KvKHrE64gHajV_F_bQ"
      decimals="-3"
      id="Tc_t7aMSadb0UeayODWaB8A2g_7_14"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">912000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="As_Of_12_31_2022_ifrs-full_ActuarialAssumptionsAxis_aciu_ActuarialAssumptionOfInterestRateOnSavingsCapitalMember_ifrs-full_TypesOfRisksAxis_aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember_FSXKfZmS80elUOwthR4Uxw"
      decimals="-3"
      id="Tc_fKbfM5pVFUyhEgK6JyDDnA_7_16"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-865000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_cQZp6FwNWUmVOzNSgPLPrw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;19.&lt;/b&gt;&lt;/span&gt;Share-based compensation&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;"&gt;Share-based option awards&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December&#160;31, 2023, there are equity-based instruments outstanding that the Company has granted under two different plans.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s 2016 Share Option and Incentive Plan (SOIP) was approved by the shareholders at the ordinary shareholders&#x2019; meeting in November&#160;2016. The 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights. The Company only grants equity-based instruments from the SOIP as of December&#160;31, 2023.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table summarizes equity-settled share option grants for plans that existed during the period:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;options&#160;awarded&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contractual&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Plan&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(since&#160;inception)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vesting&#160;conditions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;life&#160;of&#160;options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share option plan C1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,775,250&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;4 years&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;&#x2019; service from grant date&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;10 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;2016 SOIP:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:39.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Executives and directors&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,831,325&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:26.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;1 year&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-size:10pt;"&gt;3 year&lt;/span&gt;&lt;span style="font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;"&gt;4 years&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;&#x2019; service from the date of grant, quarterly and annually&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:16.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;10 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:39.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Employees&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,811,687&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:26.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;4 years&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;&#x2019; service from the date of grant, annually&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;10 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The number and weighted-average exercise prices (in CHF) of options under the share option programs for Plans C1 and the 2016 SOIP are as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted-&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted-&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;average&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;average&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;exercise&#160;price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;remaining&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(CHF)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;"&gt;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;term&#160;(years)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at January 1, 2021&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,900,667&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5.90&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 8.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Forfeited during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (207,331)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.13&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (218,561)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4.97&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,110,914&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.34&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at December&#160;31,&#160;2021&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,585,689&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.21&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 7.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Exercisable at December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,613,242&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.13&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 6.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at January 1, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,585,689&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.21&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 7.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Forfeited during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (304,738)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.32&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (110,250)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.15&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,090,316&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3.18&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at December&#160;31,&#160;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,261,017&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5.65&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 7.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Exercisable at December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,345,648&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#ff0000;font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.41&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 6.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at January 1, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,261,017&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5.65&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 7.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Forfeited during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (824,084)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5.34&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (42,037)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1.52&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,554,281&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1.75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at December&#160;31,&#160;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,949,177&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4.11&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 7.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Exercisable at December&#160;31,&#160;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,022,345&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4.88&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 6.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The outstanding stock options as of December&#160;31, 2023 have the following range of exercise prices:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Range&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;expiration&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&#160;options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;dates&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Range of exercise prices&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;CHF 0.15&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 92,875&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2024&#x2013;2026&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;CHF 9.53&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 109,665&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2027&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;USD 5.04 to USD 12.30&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,417,545&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2027&#x2013;2031&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;USD 2.76 to USD 4.57&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,034,326&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2032&#x2013;2033&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;USD 2.03 to USD 2.32&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,294,766&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2032&#x2013;2033&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total outstanding options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,949,177&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The weighted-average exercise price for options granted in 2023, 2022 and 2021 is USD 2.08 (CHF 1.75), USD 3.44 (CHF 3.18) and USD 6.95 (CHF 6.34), respectively. The range of exercise prices for outstanding options was CHF 0.15 to CHF 9.53 for awards previously granted in CHF (prior to 2018) and USD 2.03 to USD 12.30 for awards granted in USD as of December&#160;31, 2023.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;For awards issued in 2023, the volatility is based on the Company&#x2019;s actual volatility for the period congruent with the expected term of the underlying option. The risk-free interest rate is based on yields of long-dated U.S. Treasury notes that align with the expected term of the award. The weighted-average share price of common share options exercised in 2023 is USD 3.18 (CHF 2.68).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The weighted-average grant date fair values of the options granted in 2023, 2022 and 2021 are USD 1.57 (CHF 1.33), USD 2.38 (CHF 2.20) and USD 5.23 (CHF 4.78), respectively. The following table illustrates the weighted-average assumptions for the Black-Scholes option-pricing model used in determining the fair value of these awards:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:31.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:31.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercise price (USD)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2.03-3.11&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2.76-4.57&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;5.31-7.72&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share price (USD and weighted average)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2.08&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3.44&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.95&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;4.0-4.6&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;0-2.4&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;0 &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;72-86&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;67-80&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 80&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Expected term (in years)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;5.5-6&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;5.5 - 6.25&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;5.1 - 6&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Dividend yield&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.19;margin:0pt 0pt 12pt 18pt;"&gt;Restricted share awards&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;A summary of share awards (restricted share and restricted share units) activity as of&#160;December&#160;31, 2023&#160;and changes during the&#160;year then ended is presented below:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contractual&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;life&#160;of&#160;non-&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;share&#160;awards&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;vested&#160;share&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Grantee type&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;granted&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vesting&#160;conditions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;awards&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Restricted share units&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:38.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Directors&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 257,329&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;1 year&lt;/span&gt;&lt;span style="font-size:10pt;"&gt; service from date of grant, annually&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;10 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Executives&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 905,803&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;3 year&lt;/span&gt;&lt;span style="font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;"&gt;4 years&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;&#x2019; service from the date of grant, quarterly and semi-annually&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;10 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:38.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Employees&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 458,335&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:35.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;3 years&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;&#x2019; service from the date of grant, annually&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;10 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted-&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;average&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;grant&lt;/b&gt;&#160;&lt;b style="font-weight:bold;"&gt;date&#160;fair&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;value&#160;(CHF)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at January 1, 2021&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19,494&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9.51&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,471)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9.46&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Vested during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (18,697)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9.52&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at December&#160;31,&#160;2021&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 797&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9.41&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vested and exercisable at December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 65,515&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9.48&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at December&#160;31,&#160;2021&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 797&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9.41&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 239,194&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3.06&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Vested during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (23,505)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3.28&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at December&#160;31,&#160;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 216,486&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3.06&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vested and exercisable at December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 89,020&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7.84&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at December&#160;31,&#160;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 216,486&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3.06&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Forfeited during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (134,947)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2.05&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (55,503)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2.37&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,187,570&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1.89&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Vested during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (265,366)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2.46&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at December&#160;31,&#160;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,003,743&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1.97&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vested and exercisable at December&#160;31,&#160;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 298,883&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4.08&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The weighted-average grant date fair values of the remaining non-vested share awards as of the respective&#160;year end for the restricted share units were CHF 1.97, CHF 3.06 and CHF 9.41 for the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively. The fair values of these non-vested share awards granted were determined using a reasonable estimate of market value of the common shares on the date of the award.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The expense charged against the income statement was CHF 4.4 million, CHF 3.3 million and CHF 4.1 million for the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively. The expense is revised by the Company based on the number of instruments that are expected to become exercisable.&lt;/p&gt;</ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory>
    <aciu:NumberOfEquityBasedInstrumentPlans
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="INF"
      id="Narr_e_XjTef-WEamUrGWH9PQQg"
      unitRef="Unit_Standard_plan_aEIYineoxU60B5qoFDN6Ig">2</aciu:NumberOfEquityBasedInstrumentPlans>
    <ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_0TKmS9FokUGK-fOSdyEPEw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table summarizes equity-settled share option grants for plans that existed during the period:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;options&#160;awarded&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contractual&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Plan&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(since&#160;inception)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vesting&#160;conditions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;life&#160;of&#160;options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share option plan C1&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,775,250&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;4 years&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;&#x2019; service from grant date&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;10 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;2016 SOIP:&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:26.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:39.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Executives and directors&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,831,325&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:26.14%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;1 year&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-size:10pt;"&gt;3 year&lt;/span&gt;&lt;span style="font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;"&gt;4 years&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;&#x2019; service from the date of grant, quarterly and annually&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:16.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;10 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:39.99%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Employees&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,811,687&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:26.14%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;4 years&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;&#x2019; service from the date of grant, annually&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:16.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;10 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_11_1_2016_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_StockOptionPlanC1Member_FrVjSQB1UkeUeoCfQYkO8Q"
      decimals="INF"
      id="Tc_w5K4j8Rq8kCK-UB3CAt-cw_4_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">6775250</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_StockOptionPlanC1Member_-sFGqj5mB02y1Y2vj-EJCg"
      id="Narr_6iH0tvgzHESRNukH1GR2Cg">P4Y</aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod>
    <aciu:MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_StockOptionPlanC1Member_-sFGqj5mB02y1Y2vj-EJCg"
      id="Tc_l6a7jFdepUKGVYuiKrsKrQ_4_6">P10Y</aciu:MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_11_1_2016_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_bPPz5P3NMUuhICp34QnZTQ"
      decimals="INF"
      id="Tc_QvirM0rt8kWBvzbz-j4K5g_6_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">4831325</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember_li18Qm89cUyqRwPnUzHoyQ"
      id="Narr_1xC6dHLvh0a6rdxPbUeTWA">P1Y</aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod>
    <aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember_vo7YKlf8sk2Zu9M-P0T-9A"
      id="Narr_OIHyyWkcPkOKZW7NxM42Sg">P3Y</aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod>
    <aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember_nRoCAsTLTkuEeahglu5EzQ"
      id="Narr_2KrXz4iIXkKIgvvxzDg9DQ">P4Y</aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod>
    <aciu:MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_wf3hN50uXkG2UnV3ktGKUw"
      id="Tc_QhJBRUA8fECe79eJcYXumg_6_6">P10Y</aciu:MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_11_1_2016_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_5cV-aWe_h0Wf6H9bD9joXg"
      decimals="INF"
      id="Tc_VE7w7AIYDEyFA8KefpWh9w_7_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">1811687</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_L33vJ60m_km7tdKwdLwwQQ"
      id="Narr_r7TgKxSp10KtQO-chi2xtg">P4Y</aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod>
    <aciu:MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_Two016ShareOptionAndIncentivePlanMember_L33vJ60m_km7tdKwdLwwQQ"
      id="Tc_EA6lQL6w2kKqbOd52IzOaw_7_6">P10Y</aciu:MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_waslBDuVcUutIdeUy1QcVA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The number and weighted-average exercise prices (in CHF) of options under the share option programs for Plans C1 and the 2016 SOIP are as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted-&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted-&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;average&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;average&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;exercise&#160;price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;remaining&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;(CHF)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;"&gt;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;term&#160;(years)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at January 1, 2021&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,900,667&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5.90&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 8.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Forfeited during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (207,331)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.13&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (218,561)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4.97&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,110,914&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.34&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at December&#160;31,&#160;2021&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,585,689&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.21&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 7.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Exercisable at December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,613,242&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.13&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 6.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at January 1, 2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,585,689&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.21&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 7.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Forfeited during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (304,738)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.32&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (110,250)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 0.15&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,090,316&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3.18&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at December&#160;31,&#160;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,261,017&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5.65&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 7.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Exercisable at December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,345,648&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="color:#ff0000;font-weight:bold;"&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.41&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 6.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at January 1, 2023&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,261,017&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5.65&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 7.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Forfeited during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (824,084)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 5.34&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (42,037)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1.52&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,554,281&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1.75&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Outstanding at December&#160;31,&#160;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,949,177&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4.11&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 7.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.79%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Exercisable at December&#160;31,&#160;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,022,345&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.57%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4.88&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt; 6.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2020_kISrj4aRVketNj-9seXAtQ"
      decimals="INF"
      id="Tc_JPn6s21L0Uu_vUtnWDAPGQ_5_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">2900667</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2020_kISrj4aRVketNj-9seXAtQ"
      decimals="2"
      id="Tc_d6AtGJ9icEerceQL5vLX3A_5_4"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">5.90</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="Duration_1_1_2020_To_12_31_2020_ohLEZMTSR0Cbq8KqJ4eLSg"
      id="Tc_x1JGN1O-3EqdnDumMfP-zA_5_6">P8Y2M12D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="INF"
      id="Tc_43e5ePvxuE-FdXRXKs9ygg_6_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">207331</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="2"
      id="Tc_AK1rBd5Ga02aTlhdutAAAw_6_4"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">6.13</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="INF"
      id="Tc_CTKBvQb530GLrWKiPOcpSg_7_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">218561</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="2"
      id="Tc_ZrYLokthBkeRbrw2kYonSQ_7_4"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">4.97</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="INF"
      id="Tc_r1F166wwMk2GVliZbT-ZKw_8_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">1110914</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="2"
      id="Tc_QrUBnndGC02p1M9fIp7ELw_8_4"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">6.34</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="INF"
      id="Tc_CKZJoiky802tc0clEczeDQ_9_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">3585689</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="2"
      id="Tc_owiA4_lHoU6dgG9ujr_sGw_9_4"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">6.21</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      id="Tc_My1_pRW5_0iSpQIjmQ3hiQ_9_6">P7Y9M18D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="INF"
      id="Tc_e0hmxa2A70OglhtudGBUQQ_10_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">1613242</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="2"
      id="Tc_HlXnZv74EEKfVa1v6EjthQ_10_4"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">6.13</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <aciu:WeightedAverageRemainingContractualLifeOfShareOptionsExercisable
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      id="Tc_o9zGcj3jE0GBQRSDtz0ffw_10_6">P6Y9M18D</aciu:WeightedAverageRemainingContractualLifeOfShareOptionsExercisable>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="INF"
      id="Tc_qDuTq4d0FUetnq9Lt1IP6A_11_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">3585689</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="2"
      id="Tc_6uqyycddvU2GLcVrKom2PA_11_4"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">6.21</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      id="Tc_-R4F-RT8jEOW_q6aOIeDeQ_11_6">P7Y9M18D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="INF"
      id="Tc_az5C9scxdkaYS6yTNPh5vA_12_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">304738</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="2"
      id="Tc_5bM4tHuDz0atePQnAEbm-Q_12_4"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">6.32</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="INF"
      id="Tc_IIP89khAP0yqnNWeA3HCqg_13_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">110250</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="2"
      id="Tc_U96gnPce4EaZmJCjYXDiAQ_13_4"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">0.15</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="INF"
      id="Tc_hs4OUG1r2Ummeh07VXk9BQ_14_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">1090316</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="2"
      id="Tc_V5PNraCBKUmDJkBIp7vX_A_14_4"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">3.18</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="INF"
      id="Tc_J78dNXyCqE-ZMtxLJuUnAQ_15_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">4261017</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="2"
      id="Tc_uN-JxyUdyUqgkdTKzYvB1Q_15_4"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">5.65</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      id="Tc_OzMKbsMGG0StBMJclhGxEQ_15_6">P7Y7M6D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="INF"
      id="Tc_1xooaeWFeUi1whF_KLrLeg_16_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">2345648</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="2"
      id="Tc_kfpQIUcMiUOGWeB59fsKfw_16_4"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">6.41</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <aciu:WeightedAverageRemainingContractualLifeOfShareOptionsExercisable
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      id="Tc_uxye7Kz8UEKOk8Lt9f0vhw_16_6">P6Y7M6D</aciu:WeightedAverageRemainingContractualLifeOfShareOptionsExercisable>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="INF"
      id="Tc_Ae_zvdAPVkSPZ2OuGmb-wQ_17_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">4261017</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="2"
      id="Tc_HshaC8NCZU2gAUl63O-RXg_17_4"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">5.65</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      id="Tc_XET25zq6OkSNh4242OhVVw_17_6">P7Y7M6D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="INF"
      id="Tc_I7NT1O8I3EigGuEoxmEtkw_18_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">824084</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="2"
      id="Tc_wIcOrwOc0EG48WwxzY2ytw_18_4"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">5.34</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="INF"
      id="Tc_dNQmUqWPdkyGQgSnsPfedQ_19_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">42037</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="2"
      id="Tc_nrVMH3s-CUWAEVBIcPd3oQ_19_4"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">1.52</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="INF"
      id="Tc_wWvi4pZxgUOLL2RHpIpXTw_20_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">1554281</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="2"
      id="Tc_gyH20Eoe10OJdSOXeCIKiw_20_4"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">1.75</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="INF"
      id="Tc_xKWfjaottEGvs48K_SxGXg_21_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">4949177</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="2"
      id="Tc_icdsfYuMLEuOtjjkCRIY2g_21_4"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">4.11</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tc_WcptmSj8Yk2TIUYymJcm_w_21_6">P7Y2M12D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="INF"
      id="Tc_2CCLcA7f9UC3LZjXLSxtPQ_22_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">3022345</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="2"
      id="Tc_JYw1yzwbeEGS7hkhClBWCg_22_4"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">4.88</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <aciu:WeightedAverageRemainingContractualLifeOfShareOptionsExercisable
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tc_UvY__VhGZE6GnMrToKs8Jw_22_6">P6Y4M24D</aciu:WeightedAverageRemainingContractualLifeOfShareOptionsExercisable>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_mDGDuhKCJU6qdL-PEPOCdw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The outstanding stock options as of December&#160;31, 2023 have the following range of exercise prices:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Range&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;expiration&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&#160;options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;dates&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Range of exercise prices&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;CHF 0.15&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 92,875&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2024&#x2013;2026&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;CHF 9.53&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 109,665&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2027&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;USD 5.04 to USD 12.30&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,417,545&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2027&#x2013;2031&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;USD 2.76 to USD 4.57&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,034,326&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2032&#x2013;2033&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 6pt;"&gt;USD 2.03 to USD 2.32&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,294,766&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2032&#x2013;2033&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.22%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total outstanding options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4,949,177&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.89%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2023_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Chf0.15Member_bCuGS8xth02AS1EG44_CZw"
      decimals="INF"
      id="Tc_XlS6OyLb60-s8GT7CuC9fw_5_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">92875</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2023_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Chf9.53Member_QyUb_OU0dUmrWfmJfQRjJA"
      decimals="INF"
      id="Tc_RZ1dWW0SVUuUj8BHojp8qA_6_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">109665</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2023_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Usd5.04ToUsd12.30Member_aFkOCQ_l5E2NLCrRmzt_fg"
      decimals="INF"
      id="Tc_7IaOWn56aEqdxDKTAYvrrA_7_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">2417545</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2023_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Usd2.76ToUsd4.57Member_ei0vM12DHU2YvZXAIwnk_A"
      decimals="INF"
      id="Tc_KkdCfOHfmUCSXvn73Q3FwQ_8_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">1034326</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2023_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_aciu_Usd2.03ToUsd2.32Member_JcYFgrKmAkGmDL6Nc1PZGw"
      decimals="INF"
      id="Tc_2pgX-WIiKUiZXa8Bt4qPwA_9_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">1294766</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="INF"
      id="Tc_Gud-cZ4MGU63Ht_-wumHGA_10_2"
      unitRef="Unit_Standard_Options_74cudJavrEyukn77nvN4Jw">4949177</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="2"
      id="Narr_prDCgOu2jkqYryD4Xy7uMQ"
      unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA">2.08</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="2"
      id="Narr_z3v2TxtJCkuMbPEpIe_IQw"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">1.75</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="2"
      id="Narr_7WeACYPXHk2cqUwd4Yhlkw"
      unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA">3.44</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="2"
      id="Narr_dmF2uu-4O0mDsiVLIDfBCw"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">3.18</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="2"
      id="Narr_g---t9HJkkO_Kxd9dmAbXg"
      unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA">6.95</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="2"
      id="Narr_8pYPBthfj02Dwhly9S4Vgg"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">6.34</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_srt_CurrencyAxis_currency_CHF_8K3Jpoq190ueOAUG42rgKg"
      decimals="2"
      id="Narr_qPBHxNxwyUqrEG7OUpM7vQ"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">0.15</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_srt_CurrencyAxis_currency_CHF_EovKNEREAkumK2wjyAvm6g"
      decimals="2"
      id="Narr_ft7YkUEr_UO4GtpvN5hksg"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">9.53</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_srt_CurrencyAxis_currency_USD_fZkHo-Mvv0iaC9kcViPDDQ"
      decimals="2"
      id="Narr_wF3K1Vxmp0i8g600OyePHw"
      unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA">2.03</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="As_Of_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_srt_CurrencyAxis_currency_USD_6KDez0fNPESv6PiMVQDs7w"
      decimals="2"
      id="Narr_RKIrCV5H_Ue3Uof2QzCZZw"
      unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA">12.30</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageSharePrice2019
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="2"
      id="Narr_-H1zQ-am7EWuZ2bGvXJdQA"
      unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA">3.18</ifrs-full:WeightedAverageSharePrice2019>
    <ifrs-full:WeightedAverageSharePrice2019
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="2"
      id="Narr_pDMOBLQr5EKRr9RO6MRNWg"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">2.68</ifrs-full:WeightedAverageSharePrice2019>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="2"
      id="Narr_QYlv3Q4ZqE23ZmGZlzKvWg"
      unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">1.57</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="2"
      id="Narr_q964l5HwVESddeMLeyx-Aw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1.33</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="2"
      id="Narr_M6RJ9QWk20WqOc5StPws3w"
      unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">2.38</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="2"
      id="Narr_Q52JaPxGmkuMfhiFQS9tJA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2.20</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="2"
      id="Narr_2t6bIMF3RE-6tbTh4dHWGg"
      unitRef="Unit_Standard_USD_Dp7EzBYoMkeH6gc1LnueyQ">5.23</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="As_Of_12_31_2021_DFR-_qXMzk2DQFHqAtZS3w"
      decimals="2"
      id="Narr_xCBXn5a-nkmIoIxYVWTAmg"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4.78</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_LK-MJEXiaU-QcQsjG51QoQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:31.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:31.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercise price (USD)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2.03-3.11&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;2.76-4.57&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;5.31-7.72&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share price (USD and weighted average)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2.08&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3.44&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6.95&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;4.0-4.6&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;0-2.4&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;0 &lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;72-86&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;67-80&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 80&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.15%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Expected term (in years)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;5.5-6&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;5.5 - 6.25&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt;5.1 - 6&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:65.15%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Dividend yield&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_A0fLCvnZXkWCpt0V9v-hlQ"
      decimals="2"
      id="Narr_lIutJRcYs0KCC6quPX9b7Q"
      unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA">2.03</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_N4NtcRpK7UmEpR8gT_3kcQ"
      decimals="2"
      id="Narr_CvBBRCEjl0mI5eXaxiF5Ow"
      unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA">3.11</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_kJ9M4JxOBEuo1siTgMfdYQ"
      decimals="2"
      id="Narr_AFE9IKqLsUWYaQGLQ7ewnw"
      unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA">2.76</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_mTTN5Hw7J0uG4plqeYxbIg"
      decimals="2"
      id="Narr_LMJ0J1nE4USa5WVsrujG1g"
      unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA">4.57</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ZaXds3ifpU6wdPGK9Rol-A"
      decimals="2"
      id="Narr_Gi4XCARGmkuEkMGyDOftAA"
      unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA">5.31</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_kF_Z_GmDe0uYNVNKIyLhww"
      decimals="2"
      id="Narr_zoUwZWQUcEazoIpaBi-n2Q"
      unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA">7.72</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="2"
      id="Tc_1KrEwp4SI02OFVMB8TpDuQ_5_2"
      unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA">2.08</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="2"
      id="Tc_L9KiXwnu30Sp5uf-JEgp9A_5_4"
      unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA">3.44</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="2"
      id="Tc_wg3LSuEPdUKWlSIEVER1Nw_5_6"
      unitRef="Unit_Divide_USD_shares_tUY08oGnoUuQ2HtSItMBMA">6.95</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_A0fLCvnZXkWCpt0V9v-hlQ"
      decimals="2"
      id="Narr_URucbdZIBEaQhMj7TyoiOw"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.040</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_N4NtcRpK7UmEpR8gT_3kcQ"
      decimals="3"
      id="Narr_ARM_bMKdnk-v8uW731I1KA"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.046</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_kJ9M4JxOBEuo1siTgMfdYQ"
      decimals="2"
      id="Narr_jxkicBiKuE6f-LUiCsU3tg"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_mTTN5Hw7J0uG4plqeYxbIg"
      decimals="3"
      id="Narr_9L7lQFpR8kGjknCzWNKoaQ"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.024</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="2"
      id="Tc_s8opL-gDYkWgl15zHwP__Q_6_6"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_A0fLCvnZXkWCpt0V9v-hlQ"
      decimals="2"
      id="Narr_MtXF_x0stU2vpQDi-2JN_w"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.72</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_N4NtcRpK7UmEpR8gT_3kcQ"
      decimals="2"
      id="Narr_j_o_9V4rnki-eoxxEN9VKA"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.86</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_kJ9M4JxOBEuo1siTgMfdYQ"
      decimals="2"
      id="Narr_-CSmKkN0G0OFlHsO3N43oQ"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.67</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_mTTN5Hw7J0uG4plqeYxbIg"
      decimals="2"
      id="Narr_-WtBX9IQHkG-PBnImpEKTw"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.80</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="2"
      id="Tc_FNQcACSWbE699F0UCf4NwA_7_6"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.80</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_A0fLCvnZXkWCpt0V9v-hlQ"
      decimals="1"
      id="Narr_jza-bmF5eku_kDXxryimtw"
      unitRef="Unit_Standard_Y_vGNa0xS6h0m8DtazE3ChHg">5.5</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_N4NtcRpK7UmEpR8gT_3kcQ"
      decimals="0"
      id="Narr_Nn7qd23Q_kq59zMBVIRUGg"
      unitRef="Unit_Standard_Y_vGNa0xS6h0m8DtazE3ChHg">6</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_kJ9M4JxOBEuo1siTgMfdYQ"
      decimals="1"
      id="Narr_3pcKeN90fEC73IXOLXu5xQ"
      unitRef="Unit_Standard_Y_vGNa0xS6h0m8DtazE3ChHg">5.5</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_mTTN5Hw7J0uG4plqeYxbIg"
      decimals="2"
      id="Narr_-tZbPvOXM0GPdls_r7g6DQ"
      unitRef="Unit_Standard_Y_vGNa0xS6h0m8DtazE3ChHg">6.25</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ZaXds3ifpU6wdPGK9Rol-A"
      decimals="1"
      id="Narr_lRxf2qdxJU687S7-kcYLMA"
      unitRef="Unit_Standard_Y_vGNa0xS6h0m8DtazE3ChHg">5.1</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_kF_Z_GmDe0uYNVNKIyLhww"
      decimals="0"
      id="Narr_xxiST3yBBkmVdxv-Gae2XQ"
      unitRef="Unit_Standard_Y_vGNa0xS6h0m8DtazE3ChHg">6</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="2"
      id="Tc_I0xs7Nqa4UecYlLodE_vMw_9_2"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="2"
      id="Tc_9K2K4KQfkUOB3Nt8Vnbl6A_9_4"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="2"
      id="Tc_r6FbWM6Nb0e6xiphmMDkiw_9_6"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_C2dXit67fkyqTFLknRvDMQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;A summary of share awards (restricted share and restricted share units) activity as of&#160;December&#160;31, 2023&#160;and changes during the&#160;year then ended is presented below:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Contractual&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;life&#160;of&#160;non-&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;share&#160;awards&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;vested&#160;share&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Grantee type&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;granted&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vesting&#160;conditions&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;awards&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Restricted share units&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:38.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Directors&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 257,329&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:35.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;1 year&lt;/span&gt;&lt;span style="font-size:10pt;"&gt; service from date of grant, annually&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:11.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;10 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:38.73%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Executives&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 905,803&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:35.01%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;3 year&lt;/span&gt;&lt;span style="font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;"&gt;4 years&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;&#x2019; service from the date of grant, quarterly and semi-annually&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.89%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;10 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;width:38.73%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Employees&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 458,335&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;width:35.01%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;3 years&lt;/span&gt;&lt;span style="font-size:10pt;"&gt;&#x2019; service from the date of grant, annually&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;white-space:nowrap;width:11.89%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;"&gt;10 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Weighted-&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;average&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;grant&lt;/b&gt;&#160;&lt;b style="font-weight:bold;"&gt;date&#160;fair&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;value&#160;(CHF)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at January 1, 2021&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 19,494&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9.51&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (2,471)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9.46&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Vested during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (18,697)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9.52&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at December&#160;31,&#160;2021&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 797&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9.41&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vested and exercisable at December&#160;31,&#160;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 65,515&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9.48&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at December&#160;31,&#160;2021&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 797&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9.41&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 239,194&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3.06&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Vested during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (23,505)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3.28&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at December&#160;31,&#160;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 216,486&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3.06&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vested and exercisable at December&#160;31,&#160;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 89,020&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7.84&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at December&#160;31,&#160;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 216,486&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3.06&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Forfeited during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (134,947)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="color:#ff0000;font-size:10pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2.05&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Exercised during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (55,503)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2.37&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Granted during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,187,570&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1.89&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Vested during the year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (265,366)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2.46&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Non-vested at December&#160;31,&#160;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,003,743&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1.97&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:76.12%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Vested and exercisable at December&#160;31,&#160;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 298,883&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.02%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 4.08&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_11_16_2016_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_BoardOfDirectorsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_Mg69nDEnSECdfeZEURGoNw"
      decimals="0"
      id="Tc_MbswrOiREE6yoYh40kTocA_6_2"
      unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg">257329</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_BoardOfDirectorsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_oEAbzyJtoEmkfKv74BICBg"
      id="Narr_mEhlpT30ZE68pmBtRlcoiA">P1Y</aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod>
    <aciu:MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_BoardOfDirectorsMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_oEAbzyJtoEmkfKv74BICBg"
      id="Tc_cHtRArW4JEC1kD3of6KIpg_6_6">P10Y</aciu:MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_11_16_2016_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_9q9dI6YGDkGRYsQk62I2nA"
      decimals="0"
      id="Tc_siQTG5uy7Ue4vlOg_JZmEA_7_2"
      unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg">905803</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsFirstVestingConditionsMember_b85Kv7MimEGfeEIsinaPEA"
      id="Narr_wx844IXaSk-Tmd0NI7nGKA">P3Y</aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod>
    <aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsSecondVestingConditionsMember_E41WId3rVUaJryS3yoer-A"
      id="Narr_6Of0UB_GjUWrkEh3UEA1YA">P4Y</aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod>
    <aciu:MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_ExecutiveManagementMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_T_CAdfRv-0yh8ZcvUy-2eA"
      id="Tc_9jiPbQ_QlkyiL7oAyhSVDw_7_6">P10Y</aciu:MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_11_16_2016_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_la6xlFr4Qk-ItVH571xacw"
      decimals="0"
      id="Tc_YEF9OQijZk24mq8rgm6K0g_8_2"
      unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg">458335</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_XCIxfyCaLUqoZoXevZDdCg"
      id="Narr_TSePuOSUBkmOyiydetuKRQ">P3Y</aciu:VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod>
    <aciu:MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_CategoriesOfRelatedPartiesAxis_aciu_EmployeesMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_XCIxfyCaLUqoZoXevZDdCg"
      id="Tc_wjniJmyWzUmwCvet7n5cdQ_8_6">P10Y</aciu:MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_uW0txdsBO0WLBMLzEw4mWQ"
      decimals="INF"
      id="Tc_q2V6wD0d_EynPkHR19lSFw_5_2"
      unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg">19494</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding
      contextRef="As_Of_12_31_2020_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_uW0txdsBO0WLBMLzEw4mWQ"
      decimals="2"
      id="Tc_D8pHWvqof06Y2FGQ__SziA_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">9.51</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding>
    <aciu:NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_QwGnbZHs2kOQD9MkvKz_JQ"
      decimals="INF"
      id="Tc_B3xThjRSfEiitlNiEjzEBA_6_2"
      unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg">2471</aciu:NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_QwGnbZHs2kOQD9MkvKz_JQ"
      decimals="2"
      id="Tc_KooqsU3PqUyea1gpzL7ygw_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">9.46</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_QwGnbZHs2kOQD9MkvKz_JQ"
      decimals="INF"
      id="Tc_Ev15Bm79S0aWRt9OXbCzWg_7_2"
      unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg">18697</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_QwGnbZHs2kOQD9MkvKz_JQ"
      decimals="2"
      id="Tc_cfzHcNP-a0SVsjXYCBRtBw_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">9.52</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_eitFANd6O0-px2XAzxnmbA"
      decimals="INF"
      id="Tc_DRvutG3z6Um5989lYHTWvw_8_2"
      unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg">797</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_eitFANd6O0-px2XAzxnmbA"
      decimals="2"
      id="Tc_pWnyxc7txEO0mE3mAmlw8Q_8_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">9.41</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_eitFANd6O0-px2XAzxnmbA"
      decimals="INF"
      id="Tc_8FKnhAXWSUqWVGZbWN3DTQ_9_2"
      unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg">65515</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_eitFANd6O0-px2XAzxnmbA"
      decimals="2"
      id="Tc_IeH_qgTiX0qLqCeuf1zpoQ_9_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">9.48</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_eitFANd6O0-px2XAzxnmbA"
      decimals="INF"
      id="Tc__3ki0TTs8kOr8uWZJYGY3Q_10_2"
      unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg">797</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_eitFANd6O0-px2XAzxnmbA"
      decimals="2"
      id="Tc_VIYpX5sGYUWFHVUei0WhDQ_10_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">9.41</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_RaV3Vku3aUu2A_2JfVmVng"
      decimals="INF"
      id="Tc_7RKOfkABSUe8kAhbz6S7SA_11_2"
      unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg">239194</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_RaV3Vku3aUu2A_2JfVmVng"
      decimals="2"
      id="Tc_Pk2gfe2GiUWv73wji1KaSA_11_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3.06</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_RaV3Vku3aUu2A_2JfVmVng"
      decimals="INF"
      id="Tc_fe8YgQ2dJ0OBYQqcc2K8FQ_12_2"
      unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg">23505</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_RaV3Vku3aUu2A_2JfVmVng"
      decimals="2"
      id="Tc_XGy87PWo6UOdMr0GUAAfBw_12_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3.28</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_pY3XYcoQoUeP48UTVCm8pg"
      decimals="INF"
      id="Tc_AwRa_92W5USu0f6uzOB0Aw_13_2"
      unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg">216486</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_pY3XYcoQoUeP48UTVCm8pg"
      decimals="2"
      id="Tc_F8s3oqBZYUKLxZ7BWemB3Q_13_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3.06</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_pY3XYcoQoUeP48UTVCm8pg"
      decimals="INF"
      id="Tc_Ahfqie8egEamVoyFmn7M5A_14_2"
      unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg">89020</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_pY3XYcoQoUeP48UTVCm8pg"
      decimals="2"
      id="Tc_fAgwG8IJDUSofGeEHB688w_14_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">7.84</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_pY3XYcoQoUeP48UTVCm8pg"
      decimals="INF"
      id="Tc_FsmboiSrpkiVio3IozYw7A_15_2"
      unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg">216486</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_pY3XYcoQoUeP48UTVCm8pg"
      decimals="2"
      id="Tc_5X3GibOd8U6j3JFV-bTFiA_15_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3.06</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding>
    <ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_0CVyLgPoV0-0eUUJiC7Vxg"
      decimals="INF"
      id="Tc_DiITQcFwSkG1QQQWnTAtNA_16_2"
      unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg">134947</ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_0CVyLgPoV0-0eUUJiC7Vxg"
      decimals="2"
      id="Tc_Q4U6GWxF6kuqI-yx4v_n4Q_16_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2.05</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsForfeited>
    <aciu:NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_0CVyLgPoV0-0eUUJiC7Vxg"
      decimals="INF"
      id="Tc_l6yCy8XBH0Cw8FwpBhOeLg_17_2"
      unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg">55503</aciu:NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_0CVyLgPoV0-0eUUJiC7Vxg"
      decimals="2"
      id="Tc_7FV13IK0g0OUdm2hn5BFIg_17_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2.37</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsExercised>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_0CVyLgPoV0-0eUUJiC7Vxg"
      decimals="INF"
      id="Tc_ccvdcp3l2UGA58co_bn3zw_18_2"
      unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg">1187570</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_0CVyLgPoV0-0eUUJiC7Vxg"
      decimals="2"
      id="Tc_iVwVNtuMxk6GXPaqCkYZ8A_18_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1.89</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_0CVyLgPoV0-0eUUJiC7Vxg"
      decimals="INF"
      id="Tc_V5-EDetBO0y9R0dmzpOV1w_19_2"
      unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg">265366</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_0CVyLgPoV0-0eUUJiC7Vxg"
      decimals="2"
      id="Tc_r90jOzoUqEmLN-TtHqFhcw_19_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2.46</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVested>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_u5V2Ukxsi0ip1fGh-0PIFw"
      decimals="INF"
      id="Tc_BmJOCbjrcEyp7Kr1lrOBew_20_2"
      unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg">1003743</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding
      contextRef="As_Of_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_u5V2Ukxsi0ip1fGh-0PIFw"
      decimals="2"
      id="Tc_AhW3YisJhkKnW-OWavN0NA_20_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1.97</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement
      contextRef="As_Of_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_u5V2Ukxsi0ip1fGh-0PIFw"
      decimals="INF"
      id="Tc_9nXYfSwCUE6EbjZILvBCHg_21_2"
      unitRef="Unit_Standard_EquityInstruments_RAuXtFI2BEiroUbpUbTzsg">298883</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable
      contextRef="As_Of_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedSharesAndRestrictedShareUnitsMember_u5V2Ukxsi0ip1fGh-0PIFw"
      decimals="2"
      id="Tc_LBjoPTsdYku88f46j5ypaQ_21_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4.08</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsVestedAndExercisable>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding
      contextRef="As_Of_12_31_2023_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_Ks574WurXUmKeYPNctUQnw"
      decimals="2"
      id="Narr_ufVWB6rTj0i3NUYbMGhgSw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1.97</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding
      contextRef="As_Of_12_31_2022_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_5pdQTfFdGEKkjeGhrAzNRw"
      decimals="2"
      id="Narr_Pq2Dq59JPUidiQzNh9rB3A"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3.06</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding>
    <aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding
      contextRef="As_Of_12_31_2021_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_aciu_RestrictedStockUnitsMember_E1XpL1U-zkqFSbWZ-KwCTA"
      decimals="2"
      id="Narr_-7fYoq3N602_ENogxMtaYA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">9.41</aciu:WeightedAverageGrantDateFairValueOtherEquityInstrumentsOutstanding>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-5"
      id="Narr_RQw91cahZEOlLdwLlZF8SQ"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4400000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-5"
      id="Narr_eE3Pd10KR06_NQa9uq4Vmg"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3300000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-5"
      id="Narr_cwql16Z-L0y9vOdzxsSLWA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">4100000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_w4BbEcCVUkmNc7Su6S_G3A">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;20.&lt;/b&gt;&lt;/span&gt;Commitments and contingencies&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s commitments and contingencies relate to its ongoing operating activities, mainly research and development programs, as well as its leased corporate space.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;In the normal course of business,&#160;we conduct product research and development programs through collaborative programs that include, among others, arrangements with universities, contract research organizations and clinical research sites. We have contractual arrangements with these organizations. As of December&#160;31, 2023, we have contractual obligations, other than for leases (see below), totaling CHF 21.4&#160;million for 2024.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;We lease our corporate, laboratory and other facilities under multiple leases at the EPFL Innovation Park in Ecublens, near Lausanne, Canton of Vaud, Switzerland. Our lease agreements have no termination clauses longer than a 12-month contractual notice period. The Company recognizes a right-of-use asset for its leases, except for short-term and low-value leases as indicated in Note&#160;3&lt;i style="font-style:italic;"&gt;.&lt;/i&gt; See &#x201c;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities&#x201d; for the contractual undiscounted cash flows for lease obligations.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Within 1 year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 21,746&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 23,336&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Between 1 and 3 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 16,920&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 18,516&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Between 3 and 5 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,632&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,229&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;More than 5 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,270&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,407&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 47,568&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 52,488&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory>
    <aciu:ContractualCapitalCommitmentsOtherThanForLeases
      contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_PEDQ9Y0GpEGR7Fz3aVtJ5Q"
      decimals="-5"
      id="Narr_BywtZGRBwk-S68B_7tiS2w"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">21400000</aciu:ContractualCapitalCommitmentsOtherThanForLeases>
    <aciu:RentalContractPeriodForNoticeOfCancellation
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Narr_h0EeSk41AkGStE-iGiaipQ">P12M</aciu:RentalContractPeriodForNoticeOfCancellation>
    <ifrs-full:DisclosureOfCommitmentsExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_f1aaoIWIFkiLaNEbC7r-nQ">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Within 1 year&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 21,746&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 23,336&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Between 1 and 3 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 16,920&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 18,516&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Between 3 and 5 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 7,632&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,229&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;More than 5 years&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,270&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,407&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 47,568&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 52,488&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfCommitmentsExplanatory>
    <ifrs-full:ContractualCapitalCommitments
      contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_PEDQ9Y0GpEGR7Fz3aVtJ5Q"
      decimals="-3"
      id="Tc_Lh6MrYZe0kGt8B1QiVnLVg_4_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">21746000</ifrs-full:ContractualCapitalCommitments>
    <ifrs-full:ContractualCapitalCommitments
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanOneYearMember_ZpFwqYls3EejWQUqS6jVtA"
      decimals="-3"
      id="Tc_RwwSFEsydUa63Jn82XsVyw_4_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">23336000</ifrs-full:ContractualCapitalCommitments>
    <ifrs-full:ContractualCapitalCommitments
      contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_UEQ5-Qdp-ECfZVHJXapb-w"
      decimals="-3"
      id="Tc_B6xUTdHlHUCnnDP4q05pLg_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">16920000</ifrs-full:ContractualCapitalCommitments>
    <ifrs-full:ContractualCapitalCommitments
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_O05oIcvQHECcE7b4dXGvbQ"
      decimals="-3"
      id="Tc_7hD8R7x4IUKaNnxT1lQeKQ_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">18516000</ifrs-full:ContractualCapitalCommitments>
    <ifrs-full:ContractualCapitalCommitments
      contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_CD3sQ6Iqhk-fx5WexG8VXQ"
      decimals="-3"
      id="Tc_J7UXiOVi1Uq3Ln0uDoRcxQ_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">7632000</ifrs-full:ContractualCapitalCommitments>
    <ifrs-full:ContractualCapitalCommitments
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_vnWZvKBRW0CV9s94BbcDrg"
      decimals="-3"
      id="Tc_Tsp0VWt1d0Om5_0zxCOPjw_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">9229000</ifrs-full:ContractualCapitalCommitments>
    <ifrs-full:ContractualCapitalCommitments
      contextRef="As_Of_12_31_2023_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_VKrtDLypPEOuxz3CjSgM6A"
      decimals="-3"
      id="Tc_ZcZ10evDOUuXwj91MYvVXg_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1270000</ifrs-full:ContractualCapitalCommitments>
    <ifrs-full:ContractualCapitalCommitments
      contextRef="As_Of_12_31_2022_ifrs-full_MaturityAxis_ifrs-full_LaterThanFiveYearsMember_aAOfPJhSHU-AqBUvHn8pLQ"
      decimals="-3"
      id="Tc_babIs3ge5UWInmqc3IAnHA_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1407000</ifrs-full:ContractualCapitalCommitments>
    <ifrs-full:ContractualCapitalCommitments
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_B96DbKCv-E2jNHydkpAWGg_8_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">47568000</ifrs-full:ContractualCapitalCommitments>
    <ifrs-full:ContractualCapitalCommitments
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_alvp02huL0aLObPmd5A0EA_8_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">52488000</ifrs-full:ContractualCapitalCommitments>
    <ifrs-full:DisclosureOfEarningsPerShareExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_Q60D0j_aPEy_FCP9VU0ZGw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;21.&lt;/b&gt;&lt;/span&gt;Earnings per share&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.07212067%;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands except for share and per share data&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Loss per share (EPS)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Numerator&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; &lt;span style="margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Net loss attributable to equity holders of the Company&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (54,233)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (70,753)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (72,996)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Denominator&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Weighted-average number of shares outstanding used to compute EPS basic and diluted attributable to equity holders&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 84,694,616&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 83,554,412&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 74,951,833&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Basic and diluted loss per share for the period attributable to equity holders&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0.64)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0.85)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0.97)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;In periods for which we have a loss, basic net loss per share is the same as diluted net loss per share. We have excluded from our calculation of diluted loss per share all potentially dilutive in-the-money (i)&#160;share options, (ii)&#160;non-vested restricted share awards and (iii)&#160;shares that were issued upon conversion of two different convertible notes as their inclusion would have been anti-dilutive. The weighted-average number of potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:30.7%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:30.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share options issued and outstanding (in-the-money)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 97,683&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 135,827&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,140,388&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Restricted share awards subject to future vesting&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,160,240&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 117,292&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,264&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Convertible shares&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 41,461&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total potentially dilutive securities &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,257,923&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 253,119&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,188,113&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfEarningsPerShareExplanatory>
    <ifrs-full:EarningsPerShareExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_xBQ6yfs7v0q2BCw9XMNNxg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="font-size:10pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.07212067%;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.28%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;For&#160;the&#160;Year&#160;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands except for share and per share data&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Loss per share (EPS)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Numerator&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; &lt;span style="margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Net loss attributable to equity holders of the Company&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (54,233)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (70,753)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (72,996)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Denominator&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.65%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Weighted-average number of shares outstanding used to compute EPS basic and diluted attributable to equity holders&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 84,694,616&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 83,554,412&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 74,951,833&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:64.65%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Basic and diluted loss per share for the period attributable to equity holders&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0.64)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0.85)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt; (0.97)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:EarningsPerShareExplanatory>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="-3"
      id="Tc_zwlWPtCIvk-n0t8SdWcZwg_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-54233000</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="-3"
      id="Tc_0fvZ2srAA02Fd0mGKRgyBg_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-70753000</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="-3"
      id="Tc_g212Lja00E6-EaFz_jud_w_6_6"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-72996000</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:WeightedAverageShares
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="INF"
      id="Tc_TrN7mibnnkuLmaLkTJ5n4A_8_2"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">84694616</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="INF"
      id="Tc_iucRZ0gtHE-vTdsWm78CaQ_8_4"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">83554412</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="INF"
      id="Tc_iRaYx19QUEe01ndxKuPUoA_8_6"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">74951833</ifrs-full:WeightedAverageShares>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="2"
      id="Tc_qa26pu8t_0KFxgJEuHePCQ_9_2"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">-0.64</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="2"
      id="Tc_LKQ87iRHq0m62shoORRehA_9_4"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">-0.85</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="2"
      id="Tc_19XQ4G39rkugvYop-oxL1w_9_6"
      unitRef="Unit_Divide_CHF_shares_E6jyJt_BFESvPpA1RfVajA">-0.97</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_OcyMrFfyJk2RLMS3RDGnow">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:30.7%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:30.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2021&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Share options issued and outstanding (in-the-money)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 97,683&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 135,827&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,140,388&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Restricted share awards subject to future vesting&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,160,240&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 117,292&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 6,264&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.91%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Convertible shares&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.31%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 41,461&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:66.91%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total potentially dilutive securities &lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:0.31%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,257,923&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:7.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 253,119&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,188,113&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;</ifrs-full:DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023>
    <ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_ShareOptionsMember_JiVYK5fqYUO7VCxTOIhfZA"
      decimals="INF"
      id="Tc_Jv12yoWMAkm9jC3EStKURg_4_3"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">97683</ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_ShareOptionsMember_xjjfByq3kEexxYKCccxAuA"
      decimals="INF"
      id="Tc_RdjLkVIDBEWxRJqGLQKTCQ_4_5"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">135827</ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_ShareOptionsMember_hb7EZRsk9k2Xc_o9Y1Cx3w"
      decimals="INF"
      id="Tc_8JbpVYnMRkKKMWckMvUQ7Q_4_7"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">1140388</ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_RestrictedShareUnitsMember_1v9vOL78NEaUqskdXpyvxQ"
      decimals="INF"
      id="Tc_oaV3Zn4-_k60aXzoCKCzXg_5_3"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">1160240</ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_RestrictedShareUnitsMember_7RuOmuGIaUSc_wFc7wHO3A"
      decimals="INF"
      id="Tc_N83UfwyYSE-yqDh_Q_i_HQ_5_5"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">117292</ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_RestrictedShareUnitsMember_xIISRYveiEabLLH78AYB7w"
      decimals="INF"
      id="Tc_GXdExj0_JUCEDKiP1H50JA_5_7"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">6264</ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfAntidilutiveInstrumentsAxis_ifrs-full_ConvertibleInstrumentsMember_fIduMxC3S0aqyPa52saM_A"
      decimals="INF"
      id="Tc_n15aeKnUU0iciX8Hl-8WTA_6_7"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">41461</ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      decimals="INF"
      id="Tc_pwUJCCW1rEWxHyd2k3npAw_7_3"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">1257923</ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented
      contextRef="Duration_1_1_2022_To_12_31_2022_NjdjXUyqOUGUErxeN7lWmw"
      decimals="INF"
      id="Tc_8bl64QbKHkyunvauNPRQsA_7_5"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">253119</ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented
      contextRef="Duration_1_1_2021_To_12_31_2021_MI3gK15MX0GV2xO_iwOBTQ"
      decimals="INF"
      id="Tc_jidLC_2WxEONtOTVqm8EHw_7_7"
      unitRef="Unit_Standard_shares_FmWdQ7WMqEW5AK0jVVNF_g">1188113</ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:DisclosureOfFinancialRiskManagementExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_8Zzq9ZycO0K-wygzKEqkFw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;22.&lt;/b&gt;&lt;/span&gt;Financial instruments and risk management&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s activities expose it to the following financial risks: market risk (foreign exchange and interest rate risk), credit risk and liquidity risk. The Company&#x2019;s overall risk management program focuses on the unpredictability of financial markets and seeks to minimize potential adverse effects on the Company&#x2019;s financial performance.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table shows the carrying amounts of financial assets and financial liabilities:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Financial assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Right-of-use assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,508&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,808&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Long-term financial assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 361&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 361&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Other current receivables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 622&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 392&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Accounts receivable&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,800&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Short-term financial assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 24,554&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 91,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 78,494&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,586&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total financial assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 122,339&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 126,147&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Financial liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Long-term lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,825&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,253&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Trade and other payables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,679&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 929&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Accrued expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 11,087&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,417&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Short-term lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 672&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 548&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total financial liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 16,263&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 13,147&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Foreign exchange risk&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company is exposed to foreign exchange risk arising from currency exposures, primarily with respect to the EUR, USD and to a lesser extent to GBP, DKK and SEK. The currency exposure is not hedged. However, the Company has a policy of matching its cash holdings to the currency structure of its expenses, which means that the Company holds predominately CHF, with lesser balances of EUR and USD (see &#x201c;Note&#160;8. Cash and cash equivalents and short-term financial assets&#x201d;). The Company recognized a loss of CHF 1.5 million, a gain of CHF 0.5 million and a loss of CHF 0.1 million for the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively, within &#x201c;Finance result, net.&#x201d;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;As of December&#160;31, 2023, if the CHF had strengthened/weakened by 10% against the EUR and the USD with all other variables held constant, the net loss for the period would have been lower/higher by CHF 2.6 million (2022: CHF 0.7 million), mainly as a result of foreign exchange gains/losses on predominantly EUR/USD denominated cash and cash equivalents and short-term financial assets.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Interest rates&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s CHF cash holdings (inclusive of those held in short-term financial assets) were subject to positive interest rates at certain counterparty thresholds through 2023. As of December&#160;31, 2023 if the interest rates granted by the counterparties had increased/decreased by 10%, the net income for the period would have been higher/lower by CHF 0.1 million. Interest income and interest expense are recorded within finance results, net in our consolidated statements of income/(loss).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Credit risk&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company maintains a formal treasury risk and investment management policy to limit counterparty credit risk. As of December&#160;31, 2023, the Company&#x2019;s cash and cash equivalents and short-term financial assets are held with five financial institutions, each with a high credit rating ranging from A+ to AA- assigned by international credit-rating agencies. The maximum amount of credit risk is the carrying amount of the financial assets. Accounts receivable and other receivables are fully performing, not past due and not impaired (see &#x201c;Note&#160;8. Cash and cash equivalents and short-term financial assets&#x201d;, &#x201c;Note 10. Accounts receivable&#x201d; and &#x201c;Note&#160;11. Other current receivables&#x201d;).&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;Liquidity risk&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Inherent in the Company&#x2019;s business are various risks and uncertainties, including the high uncertainty that new therapeutic concepts will succeed. AC Immune&#x2019;s success may depend in part upon its ability to (i)&#160;establish and maintain a strong patent position and protection, (ii)&#160;enter into collaborations with partners in the pharmaceutical and biopharmaceutical industries, (iii)&#160;acquire and keep key personnel employed and (iv)&#160;acquire additional capital to support its operations.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s approach of managing liquidity is to ensure sufficient cash to meet its liabilities when due. Therefore, management closely monitors the cash position on rolling forecasts based on expected cash flow to enable the Company to finance its operations for at least 12&#160;months. The Company has CHF 1.7 million in trade and other payables, and CHF 11.1 million in accrued expenses which are due within 12&#160;months from the reporting date. Finally, as it relates to the Company&#x2019;s lease liabilities please see &#x201c;Note&#160;5. Right-of-use assets, long-term financial assets and lease liabilities&#x201d; for detail of when corresponding lease liabilities are due.&lt;/p&gt;</ifrs-full:DisclosureOfFinancialRiskManagementExplanatory>
    <aciu:DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_lS_cHlXb0UmGrYgsq7nvhA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;The following table shows the carrying amounts of financial assets and financial liabilities:&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"&gt;&lt;span style="line-height:1.28;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Financial assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Right-of-use assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 3,508&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,808&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Long-term financial assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 361&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 361&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Other current receivables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 622&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 392&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Accounts receivable&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 14,800&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:10pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; &#x2014;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Short-term financial assets&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 24,554&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 91,000&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 78,494&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 31,586&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total financial assets&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 122,339&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 126,147&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:0pt;margin:0pt;"&gt;&lt;span style="margin-bottom:12pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;As&#160;of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;font-weight:bold;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:19.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;December&#160;31,&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;In CHF thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:8pt;margin-bottom:8pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.28;text-align:center;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Financial liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Long-term lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,825&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 2,253&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Trade and other payables&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 1,679&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 929&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Accrued expenses&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 11,087&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 9,417&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;Short-term lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 672&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 548&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;width:78.32%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Total financial liabilities&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 16,263&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:8.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.28;text-align:right;margin:0pt 3pt 0.05pt 0pt;"&gt; 13,147&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</aciu:DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_RightOfUseFinancialAssetsMember_8nM6TuHsfUWJ_Eb5DPpcMw"
      decimals="-3"
      id="Tc_NjtWXXqOr0udsqRz1Bfbhg_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">3508000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_RightOfUseFinancialAssetsMember_tR8m7PTQZE-3qL6hTCbwPg"
      decimals="-3"
      id="Tc_pFDZvDiNokGOwysEWZw_3w_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2808000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_LongTermFinancialAssetsMember_2GPCrMxC3kuP50IVhioaJQ"
      decimals="-3"
      id="Tc_9Vd99Y9SDUicg2UTHdmYUw_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">361000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_LongTermFinancialAssetsMember_Sp4G8pRwNkqsYvkUz4YI2g"
      decimals="-3"
      id="Tc_8l_AR_j82EiMBXtsbqZsHA_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">361000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_OtherCurrentReceivablesMember_uVd4y6WmRkq8Gnp7VhbSAg"
      decimals="-3"
      id="Tc_8fNDgRaJVEqcnsxU5sDQxQ_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">622000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_OtherCurrentReceivablesMember_sZ3Yzb3XREu_tDsA08-5Sw"
      decimals="-3"
      id="Tc_mCpLPbYq90C93d8rbnOlSw_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">392000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_ifrs-full_TradeReceivablesMember_LwJz8BFRY0mDYAyF8DxskQ"
      decimals="-3"
      id="Tc_sH9TP-ORlk2Ulg7Dd4tJ2w_8_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">14800000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_ShortTermFinancialAssetsMember_GQvxTZCyeUSHnqXgqhDQ9g"
      decimals="-3"
      id="Tc_j5yUda6yYEylZEtaOmvMlw_9_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">24554000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_ShortTermFinancialAssetsMember_7XpjIGDTfUu8O9YtHM9T2Q"
      decimals="-3"
      id="Tc_j2wL7eYZgE6-G2eoQazY3w_9_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">91000000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_CashOnHandAndCashEquivalentsMember_Tt_fmEFayUCvEgmVza7MFQ"
      decimals="-3"
      id="Tc_IpV4lXf7EEOkNv4dGtLoIg_10_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">78494000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialAssetsAxis_aciu_CashOnHandAndCashEquivalentsMember_W820bIc2s0iHiLwstBYlKg"
      decimals="-3"
      id="Tc_pB-XS0lHxk-R__4xxSXxog_10_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">31586000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_7YZ6FiyQuESSw3LJivPHfA_11_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">122339000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_WeWcnqXRrUKkTyL10YIl-Q_11_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">126147000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_LongTermLeaseLiabilitiesMember_hTP2bhts4kGVi8zQZgg2Lw"
      decimals="-3"
      id="Tc_Y6DI8pt-nEu-7lcCWhGktg_5_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2825000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_LongTermLeaseLiabilitiesMember_iE9c6Qe9dkmCxyhOVMjHlQ"
      decimals="-3"
      id="Tc_CPvkZh4rbUGoy2JluLtAPw_5_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2253000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_oD9AY5W7QE2lsvFz7v9VSA"
      decimals="-3"
      id="Tc_zDyfbORZ5Eq3tTkvrzVkQg_6_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1679000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_hN_4u153REGiz2cDaHHvaQ"
      decimals="-3"
      id="Tc_w8ClRdCG1kGdYCD1LnpXdw_6_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">929000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_V5SiFGlhwU2nqSRCE0iIlg"
      decimals="-3"
      id="Tc_szjUuoWpskiSohQVkySK8Q_7_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">11087000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_SxsHygJzykiKANoKiEryBA"
      decimals="-3"
      id="Tc_lSSltJ1gIkWVw9Pig54V3g_7_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">9417000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_ShortTermLeaseLiabilitiesMember_9v_cqh_W1kSGuzLlAQyFFQ"
      decimals="-3"
      id="Tc_R-v_ZAfmKE2fk_Ij_9peSg_8_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">672000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2022_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_ShortTermLeaseLiabilitiesMember_7EJHTDPGpE2MU58MnWl9gw"
      decimals="-3"
      id="Tc_GnswF16UJU6U78RZu0smEg_8_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">548000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2023_kTu9vlLBDE2AomOmtsv6oA"
      decimals="-3"
      id="Tc_9_0ng22kckmv2FQcJmxwwA_9_2"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">16263000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2022_8PRjDtG_vkCPNe_0rBTzEA"
      decimals="-3"
      id="Tc_RLkqNRPDtEeHSW6UkFEYjA_9_4"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">13147000</ifrs-full:FinancialLiabilities>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_BX74hOhBS0CUAeUr_BZQyA"
      decimals="-5"
      id="Narr_ce5h2QT9EUyWNtBAhMcL8g"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-1500000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_7S9fMiZwfUK5NJDPYOhCdA"
      decimals="-5"
      id="Narr_QI1Ep-w9Tk-YVK56NqDCGw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">500000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="Duration_1_1_2021_To_12_31_2021_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_E9kBrJ2W50Sic6i55dJjIg"
      decimals="-5"
      id="Narr_jeY4TlBSs0uyHsQKzE3YQQ"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">-100000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <aciu:PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_BX74hOhBS0CUAeUr_BZQyA"
      decimals="2"
      id="Narr_5J4KlzbGo0eOurvsKjNHiQ"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.10</aciu:PercentageOfReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies>
    <aciu:IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_BX74hOhBS0CUAeUr_BZQyA"
      decimals="-5"
      id="Narr_irBURrn7002vwEUv9ys2vQ"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">2600000</aciu:IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies>
    <aciu:IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies
      contextRef="Duration_1_1_2022_To_12_31_2022_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_7S9fMiZwfUK5NJDPYOhCdA"
      decimals="-5"
      id="Narr_oxaiuFlomkuLIv9TgG8Kgg"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">700000</aciu:IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleStrengtheningOrWeakeningOfReportingCurrencyAgainstOtherRelevantCurrencies>
    <aciu:PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfRisksAxis_ifrs-full_InterestRateRiskMember_RtyTGF5IIEeDAR3KKFiYmQ"
      decimals="2"
      id="Narr__k4eACEjlEKHWI97mPLA0w"
      unitRef="Unit_Standard_pure_MzlzsamD00ewYVPxDsJd3g">0.10</aciu:PercentageOfReasonablyPossibleIncreaseOrDecreaseInInterestRates>
    <aciu:IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_RangeAxis_ifrs-full_TopOfRangeMember_ifrs-full_TypesOfRisksAxis_ifrs-full_InterestRateRiskMember__VIlp5fvWECjGqiYiWCbsA"
      decimals="-5"
      id="Narr_AYIEpD2t_0WWImUlK-6RnA"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">100000</aciu:IncreaseDecreaseInProfitLossResultingFromReasonablyPossibleIncreaseOrDecreaseInInterestRates>
    <aciu:NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets
      contextRef="Duration_1_1_2023_To_12_31_2023_ifrs-full_TypesOfRisksAxis_ifrs-full_CreditRiskMember_wNVuSSWxUEaFOSDEm36rwg"
      decimals="INF"
      id="Narr_Hnhg8MTyJUaludl_4g8lBA"
      unitRef="Unit_Standard_Institution_2XG7OWvIxkqRwCgZCSpPJw">5</aciu:NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_TradeAndOtherPayablesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_LiquidityRiskMember_I2s7qAhdwEmG_1icOvNOVw"
      decimals="-5"
      id="Narr_qfrKStnuzUS8iFveucQZSQ"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">1700000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_aciu_AccruedExpensesMember_ifrs-full_TypesOfRisksAxis_ifrs-full_LiquidityRiskMember_7cEHP4wXJk6XdglcX0L3aA"
      decimals="-5"
      id="Narr_IyF_mxyj1kuTqoys17ykZw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">11100000</ifrs-full:FinancialLiabilities>
    <ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_3l_mKRf0-061RsiFzzmfpA">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;23.&lt;/b&gt;&lt;/span&gt;Capital risk management&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;The Company&#x2019;s objectives when managing capital are to safeguard the Company&#x2019;s ability to continue as a going concern and to preserve the capital on the required statutory level in order to succeed in developing a cure against (i)&#160;AD, (ii)&#160;focused non-Alzheimer&#x2019;s neurodegenerative diseases including NeuroOrphan indications and (iii)&#160;diagnostics.&lt;/p&gt;</ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory>
    <ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory
      contextRef="Duration_1_1_2023_To_12_31_2023_7PfKIVEbY0GFim83MzD_ew"
      id="Tb_ZX48rcfG2E67hhpHkOKe8w">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;&lt;span style="display:inline-block;text-indent:0pt;width:18pt;"&gt;&lt;b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"&gt;24.&lt;/b&gt;&lt;/span&gt;Subsequent events&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;Management has evaluated subsequent events after the balance sheet date, through the issuance of these consolidated financial statements, for appropriate accounting and disclosures. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt;"&gt;On January 22, 2024, the Company announced that it will regain all global rights to the anti-amyloid beta antibody crenezumab and the anti-Tau antibody semorinemab following termination of the collaboration agreements with Genentech, a member of the Roche Group, and Roche, which termination will be effective in April 2024. Both antibodies have been evaluated in clinical studies for AD. AC Immune will also regain rights to existing GMP drug-product for clinical testing as well as associated data generated under each of the agreements. AC Immune will carefully &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"&gt;review and evaluate available data sets, including the final open label extension results from the Lauriet trial when they become available and are received in full by AC Immune, before decisions are made on potential further development and other opportunities.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"&gt;On February 1, 2024, the Company received the milestone payment of CHF 14.8 million due from Janssen for the commencement of first Phase 2b clinical study.&lt;/p&gt;</ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory>
    <aciu:CollaborationAgreementMileStonePaymentReceived
      contextRef="As_Of_2_1_2024_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_aciu_ReceiptOfMilestonePaymentsMember_ifrs-full_ProductsAndServicesAxis_aciu_TauVaccineInADMember_ifrs-full_TypesOfContractsAxis_aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember_zyTb0RhISEWfD4ePpEx1Hg"
      decimals="-5"
      id="Narr_G2Ai2OwgHU2fgjyXJD9Ssw"
      unitRef="Unit_Standard_CHF_vwY7R13cR0SVjikQHJIweQ">14800000</aciu:CollaborationAgreementMileStonePaymentReceived>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
